STUDYID|DOMAIN|USUBJID|LBSEQ|LBGRPID|LBREFID|LBSPID|LBTESTCD|LBTEST|LBTSTCND|LBBDAGNT|LBTSTOPO|LBCAT|LBSCAT|LBORRES|LBORRESU|LBRSLSCL|LBRESTYP|LBCOLSRT|LBORNRLO|LBORNRHI|LBLLOD|LBSTRESC|LBSTRESN|LBSTRESU|LBSTNRLO|LBSTNRHI|LBSTNRC|LBNRIND|LBSTAT|LBREASND|LBNAM|LBLOINC|LBSPEC|LBSPCCND|LBSPCUFL|LBMETHOD|LBANMETH|LBMTHSEN|LBLOBXFL|LBBLFL|LBFAST|LBDRVFL|LBTOX|LBTOXGR|LBCLSIG|VISITNUM|VISIT|VISITDY|TAETORD|EPOCH|LBDTC|LBENDTC|LBDY|LBENDY|LBTPT|LBTPTNUM|LBELTM|LBTPTREF|LBRFTDTC|LBPTFL|LBPDUR
TRIAL STUDY 134XCP|LB|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||||CMPK2|CYTIDINE-URIDINE MONOPHOSPHATE KINASE 2|||||||GBQ/MG|||||||INDETERMINATE||L/L||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|FRESH|Y|PHOTOGRAPHY|FIBROTEST FORMULA||NA|NA|U|Y|||NA|1||38||RUN-IN|1960-07-20|1965-12-28|||||1971-03-05||1972-01-08|NA|1963-11-25
TRIAL STUDY 134XCP|LB|28FBEC95-59B8-4821-BD7A-125E2C87D71C|2||||FVIIAAC|FACTOR VII ACTIVITY ACTUAL/CONTROL|||||||BQ/G|||||||INVALID||MPS U||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|NON-HEMOLYZED|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||NA|NA|Y|Y|||U|1||38||CONTINUATION TREATMENT|1964-12-25|1963-01-11|||||1963-09-03||1970-10-02|Y|1973-05-12
TRIAL STUDY 134XCP|LB|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||||COPEP|COPEPTIN|||||||UG/KG/H|||||||TRACE||UG/KG/DAY||||HIGH|NOT DONE||||ISOLATE|REFRIGERATED|U|MULTIPLEXED BEAD BASED IMMUNOASSAY|FIBROSIS 4 FORMULA||NA|N|NA|N|||Y|2||58||SCREENING|1972-02-27|1968-08-29|||||1963-08-21||1960-11-26|NA|1967-03-27
TRIAL STUDY 134XCP|LB|28FBEC95-59B8-4821-BD7A-125E2C87D71C|2||||SLTFRNRC|SOLUBLE TRANSFERRIN RECEPTOR|||||||UG/L/H|||||||BORDERLINE||VG/KG||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|HEMOLYZED|NA|HIGH RESOLUTION CT|MDRD FORMULA||U|NA|N|N|||NA|2||58||SCREENING|1970-04-05|1971-04-24|||||1961-01-26||1961-06-21|NA|1970-11-22
TRIAL STUDY 134XCP|LB|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||||LDH3|LDH ISOENZYME 3|||||||MNFI|||||||TRACE||APPLICATION||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|DRIED|Y|LC-FL|CKD-EPI FORMULA||NA|NA|NA|NA|||N|3||39||RUN-IN|1962-08-23|1963-03-03|||||1965-06-09||1963-10-23|Y|1972-04-16
TRIAL STUDY 134XCP|LB|28FBEC95-59B8-4821-BD7A-125E2C87D71C|2||||GLCTN3|GALECTIN-3|||||||CMH2O/ML|||||||BORDERLINE||GLOBULE||||NORMAL|NOT DONE||||GASTRIC FLUID|GELLED|Y|IMMUNORADIOMETRIC ASSAY|ASH FIBROSURE FORMULA||NA|U|Y|NA|||N|3||39||LONG-TERM FOLLOW-UP|1962-08-06|1965-11-03|||||1972-09-09||1966-03-20|U|1969-10-01
TRIAL STUDY 134XCP|LB|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||||OXAEXR|OXALATE EXCRETION RATE|||||||10^3 CFU|||||||INVALID||/MBP||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|ICTERIC|U|IRON HEMATOXYLIN STAIN|ASH FIBROSURE FORMULA||NA|U|N|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1962-12-11|1963-05-23|||||1967-07-02||1969-01-28|Y|1967-09-05
TRIAL STUDY 134XCP|LB|28FBEC95-59B8-4821-BD7A-125E2C87D71C|2||||IL2RB|INTERLEUKIN 2 RECEPTOR SUBUNIT BETA|||||||SBE/ML|||||||BORDERLINE||PA||||LOW|NOT DONE||||SOFT TISSUE|ICTERIC|NA|TURBIDIMETRY|MDRD 4 VARIABLE FORMULA||N|N|N|Y|||N|4||88||TREATMENT|1965-05-20|1967-06-05|||||1960-11-06||1961-05-02|Y|1965-08-24
TRIAL STUDY 134XCP|LB|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||||HGBSHGB|HEMOGLOBIN S/TOTAL HEMOGLOBIN|||||||CAPSULE|||||||BORDERLINE||BISCUIT||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|CALCIFIED|NA|CHROMATOGRAPHY|FIBROMETER FORMULA||N|Y|Y|Y|||Y|5||7||INDUCTION TREATMENT|1962-03-31|1970-02-17|||||1973-06-07||1972-05-21|Y|1972-11-15
TRIAL STUDY 134XCP|LB|28FBEC95-59B8-4821-BD7A-125E2C87D71C|2||||PUS|PUS|||||||ENZYME U|||||||INVALID||KN/CM2||||LOW|NOT DONE||||CEREBROSPINAL FLUID|UNEXPECTED ODOR|N|LAPAROSCOPY|FIBROTEST FORMULA||Y|U|U|U|||Y|5||7||CONTINUATION TREATMENT|1971-05-20|1967-01-02|||||1970-04-14||1969-06-17|Y|1970-09-08
TRIAL STUDY 134XCP|LB|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|1||||B2G1GGAB|BETA-2 GLYCOPROTEIN 1 IGG ANTIBODY|||||||PLUG|||||||INDETERMINATE||FT2||||LOW|NOT DONE||||PUS|HEMOLYZED|NA|QUANTITATIVE COMPUTED TOMOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|U|NA|||U|1||38||LONG-TERM FOLLOW-UP|1960-09-02|1962-01-13|||||1966-06-03||1970-01-08|U|1963-08-25
TRIAL STUDY 134XCP|LB|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||||RENINA|RENIN ACTIVITY|||||||MESF|||||||BORDERLINE||PACKET||||HIGH|NOT DONE||||PLATELET RICH PLASMA|FRESH|NA|FLUORESCENT MICROSCOPY|FIBROMETER FORMULA||NA|Y|U|NA|||NA|1||38||BLINDED TREATMENT|1968-12-23|1967-10-22|||||1962-07-30||1965-01-18|NA|1963-05-26
TRIAL STUDY 134XCP|LB|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|1||||PTSAC|PROTEIN S ACTUAL/CONTROL|||||||ML/BREATH|||||||NEGATIVE||U/DL||||ABNORMAL|NOT DONE||||SEMEN|LIPEMIC|N|ELECTROMYOGRAPHY|MDRD FORMULA||N|N|U|Y|||NA|2||58||FOLLOW-UP|1967-08-06|1965-07-17|||||1968-04-15||1970-01-17|NA|1963-03-19
TRIAL STUDY 134XCP|LB|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||||RETILRTC|LOW ABSORPTION RETIC/RETICULOCYTES|||||||/MM2|||||||INVALID||BLOCKS||||LOW|NOT DONE||||SALIVA|AGGLUTINATED|U|ACCELERATOR MASS SPECTROMETRY|GMI % FORMULA||N|Y|N|U|||NA|2||58||WASHOUT|1967-04-22|1969-06-22|||||1965-06-22||1960-06-10|Y|1971-03-22
TRIAL STUDY 134XCP|LB|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|1||||PEPSNGII|PEPSINOGEN II|||||||YD|||||||BORDERLINE||DPM/MG||||HIGH|NOT DONE||||FLUID|SOLIDIFIED|N|KARYOTYPING|FIBROSIS 4 FORMULA||Y|NA|N|Y|||N|3||39||LONG-TERM FOLLOW-UP|1962-12-18|1968-08-19|||||1972-07-22||1968-11-12|Y|1973-07-20
TRIAL STUDY 134XCP|LB|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||||OHDG8|8-HYDROXYDEOXYGUANOSINE|||||||CI/ML|||||||INVALID||10^6 CFU/ML||||ABNORMAL|NOT DONE||||VENOUS PLASMA|PARAFFIN-EMBEDDED|N|ULTRASOUND|CKD-EPI CREATININE FORMULA||NA|U|N|Y|||U|3||39||INDUCTION TREATMENT|1973-08-28|1970-08-11|||||1964-03-30||1972-10-16|NA|1966-04-28
TRIAL STUDY 134XCP|LB|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|1||||IOHEXOL|IOHEXOL|||||||MJOULE/CM2|||||||TRACE||WEBER||||HIGH|NOT DONE||||LEUKOCYTE|FRESH|U|PERCUSSION|CKD-EPI FORMULA||NA|Y|U|Y|||U|4||88||SCREENING|1967-06-03|1960-09-20|||||1966-02-28||1965-11-01|NA|1970-03-07
TRIAL STUDY 134XCP|LB|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||||SCN|THIOCYANATE|||||||BREATHS/MIN|||||||NEGATIVE||NL||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|AGGLUTINATED|NA|SANGER SEQUENCING|CKD-EPI FORMULA||U|N|N|N|||Y|4||88||LONG-TERM FOLLOW-UP|1971-11-05|1966-03-04|||||1970-05-13||1965-02-26|Y|1971-12-17
TRIAL STUDY 134XCP|LB|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|1||||PTHCT|PARATHYROID HORMONE, C-TERMINAL|||||||MV|||||||INVALID||ML/G/MIN||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|CLOTTED|N|OPHTHALMOSCOPY|FIBROTEST FORMULA||U|U|NA|Y|||Y|5||7||CONTINUATION TREATMENT|1967-02-15|1971-02-10|||||1971-05-19||1965-09-17|N|1968-04-28
TRIAL STUDY 134XCP|LB|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||||LACTULOS|LACTULOSE|||||||10^6/L|||||||POSITIVE||ML/CAGE||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|FRESH|NA|SPIRAL CT SCAN WITHOUT CONTRAST|GMI % FORMULA||Y|U|NA|Y|||N|5||7||BLINDED TREATMENT|1970-05-03|1963-11-01|||||1972-10-25||1966-04-26|Y|1970-06-02
TRIAL STUDY 134XCP|LB|1117C221-3530-45CB-82B2-B831C4DAD86B|1||||SERTRAL|SERTRALINE|||||||BE/ML|||||||BORDERLINE||JDF UNIT||||LOW|NOT DONE||||SEMINAL FLUID|LIPEMIC|Y|PYROSEQUENCING|FIBROMETER FORMULA||NA|N|U|NA|||NA|1||38||TREATMENT|1960-09-05|1973-03-02|||||1960-05-29||1961-12-08|Y|1960-05-27
TRIAL STUDY 134XCP|LB|1117C221-3530-45CB-82B2-B831C4DAD86B|2||||BASOMM|BASOPHILIC METAMYELOCYTES|||||||TBSP|||||||INVALID||MM2||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|FROZEN|Y|OLIGO ACGH|COCKCROFT-GAULT FORMULA||N|Y|U|Y|||Y|1||38||BASELINE|1967-05-21|1960-08-08|||||1966-10-18||1966-06-12|Y|1969-09-14
TRIAL STUDY 134XCP|LB|1117C221-3530-45CB-82B2-B831C4DAD86B|1||||HRYCELE|HAIRY CELLS/LEUKOCYTES|||||||PMOL|||||||BORDERLINE||KG/CM||||LOW|NOT DONE||||PLASMA|GELLED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|FIBROMETER FORMULA||Y|NA|N|NA|||NA|2||58||CONTINUATION TREATMENT|1961-06-17|1971-11-19|||||1972-07-14||1972-02-16|N|1970-05-23
TRIAL STUDY 134XCP|LB|1117C221-3530-45CB-82B2-B831C4DAD86B|2||||CYCAOXA|CALCIUM OXALATE CRYSTALS|||||||ML/H|||||||NEGATIVE||BAG||||NORMAL|NOT DONE||||SALIVA|NON-HEMOLYZED|NA|SICKLE CELL SOLUBILITY TEST|COCKCROFT-GAULT FORMULA||NA|NA|Y|NA|||Y|2||58||SCREENING|1967-07-02|1973-08-16|||||1960-01-27||1965-04-20|NA|1963-10-26
TRIAL STUDY 134XCP|LB|1117C221-3530-45CB-82B2-B831C4DAD86B|1||||C130092|WESTERN RAGWEED POLLEN IGE|||||||U/M2/MIN|||||||INDETERMINATE||10^6 ORGANISMS/G||||LOW|NOT DONE||||MECONIUM|NON-HEMOLYZED|U|ANTIBIOTIC AGAR SCREEN|MDRD 5 VARIABLE FORMULA||U|U|U|Y|||U|3||39||FOLLOW-UP|1966-05-30|1971-09-26|||||1971-07-06||1970-09-26|N|1967-06-24
TRIAL STUDY 134XCP|LB|1117C221-3530-45CB-82B2-B831C4DAD86B|2||||NEUTSGB|NEUTROPHILS, SEGMENTED + BAND FORM|||||||ML/100G/MIN|||||||BORDERLINE||MM/H||||ABNORMAL|NOT DONE||||TRANSUDATE|UNEXPECTED ODOR|N|SEQUENCING|MDRD 4 VARIABLE FORMULA||U|NA|U|N|||NA|3||39||SCREENING|1962-02-18|1973-05-23|||||1961-07-09||1960-12-14|U|1966-02-20
TRIAL STUDY 134XCP|LB|1117C221-3530-45CB-82B2-B831C4DAD86B|1||||TXB2|THROMBOXANE B2|||||||10^11/L|||||||NEGATIVE||PACK||||HIGH|NOT DONE||||URINE|LIPEMIC|Y|DOUBLE IMMUNODIFFUSION|MDRD 6 VARIABLE FORMULA||Y|N|N|U|||NA|4||88||SCREENING|1965-11-19|1965-04-13|||||1969-05-05||1964-06-17|Y|1972-11-24
TRIAL STUDY 134XCP|LB|1117C221-3530-45CB-82B2-B831C4DAD86B|2||||CAION|CALCIUM, IONIZED|||||||BP|||||||INDETERMINATE||KDA||||LOW|NOT DONE||||CORD SERUM|CONCENTRATED|Y|RADIOGRAPHY|MDRD ENZYMATIC FORMULA||NA|Y|NA|NA|||N|4||88||INDUCTION TREATMENT|1961-02-26|1971-12-10|||||1966-12-09||1970-01-30|U|1961-01-18
TRIAL STUDY 134XCP|LB|1117C221-3530-45CB-82B2-B831C4DAD86B|1||||HGBB|HEMOGLOBIN B|||||||MBQ|||||||TRACE||MU/L||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|FRESH|U|THICK SMEAR|MDRD 4 VARIABLE FORMULA||U|U|NA|Y|||N|5||7||BASELINE|1965-10-08|1968-05-01|||||1964-10-28||1962-08-12|U|1967-02-07
TRIAL STUDY 134XCP|LB|1117C221-3530-45CB-82B2-B831C4DAD86B|2||||TIMP1|TISSUE INHIBITOR OF METALLOPROTEINASE 1|||||||VG/KG|||||||TRACE||IU||||HIGH|NOT DONE||||PLATELET|PARAFFIN-EMBEDDED|Y|MECHANICAL CLOT DETECTION|HEPASCORE FORMULA||Y|NA|N|U|||NA|5||7||RUN-IN|1967-01-24|1968-07-22|||||1960-03-06||1973-02-22|NA|1966-07-30
TRIAL STUDY 134XCP|LB|3ACFF838-5B16-4898-9640-A60C85096F64|1||||CK|CREATINE KINASE|||||||ARBITRARY U|||||||BORDERLINE||MG/L||||HIGH|NOT DONE||||AMNIOTIC FLUID|GELLED|NA|FUNCTIONAL MRI|HEPASCORE FORMULA||Y|U|U|N|||NA|1||38||OPEN LABEL TREATMENT|1962-09-13|1970-08-26|||||1963-11-23||1962-11-15|NA|1969-03-15
TRIAL STUDY 134XCP|LB|3ACFF838-5B16-4898-9640-A60C85096F64|2||||COAGIDX|COAGULATION INDEX|||||||BU/ML|||||||INVALID||G/CAGE/WK||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|UNEXPECTED ODOR|N|CELLULAR PROLIFERATION ASSAY|MDRD 5 VARIABLE FORMULA||U|U|N|U|||Y|1||38||OPEN LABEL TREATMENT|1970-12-07|1970-09-26|||||1964-04-08||1969-11-03|NA|1972-03-02
TRIAL STUDY 134XCP|LB|3ACFF838-5B16-4898-9640-A60C85096F64|1||||GSTMU|MU GLUTATHIONE-S-TRANSFERASE|||||||BREATHS/30S|||||||TRACE||DAYS||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|DRIED|Y|FLUORESCENT SPOT TEST|ASH FIBROSURE FORMULA||Y|N|NA|NA|||Y|2||58||SCREENING|1966-05-25|1960-09-20|||||1963-12-02||1962-02-09|U|1970-09-07
TRIAL STUDY 134XCP|LB|3ACFF838-5B16-4898-9640-A60C85096F64|2||||COPPER|COPPER|||||||10^6 ORGANISMS/ML|||||||INDETERMINATE||MMAL||||LOW|NOT DONE||||REFLEX TEAR|AGGLUTINATED|NA|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA||U|NA|N|NA|||NA|2||58||BASELINE|1964-08-14|1972-05-27|||||1968-01-25||1969-11-22|NA|1965-11-16
TRIAL STUDY 134XCP|LB|3ACFF838-5B16-4898-9640-A60C85096F64|1||||AMYLASEP|AMYLASE, PANCREATIC|||||||BE/ML|||||||POSITIVE||BQ/G||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|HEMOLYZED|N|IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||U|NA|N|U|||Y|3||39||CONTINUATION TREATMENT|1965-04-09|1964-02-17|||||1964-10-31||1966-05-20|U|1963-09-04
TRIAL STUDY 134XCP|LB|3ACFF838-5B16-4898-9640-A60C85096F64|2||||ALT|ALANINE AMINOTRANSFERASE|||||||CPM|||||||POSITIVE||MG/M2/H||||ABNORMAL|NOT DONE||||ABSCESS FLUID|CALCIFIED|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD 4 VARIABLE FORMULA||N|U|U|N|||U|3||39||CONTINUATION TREATMENT|1972-01-22|1970-08-29|||||1962-03-28||1961-11-15|Y|1973-01-04
TRIAL STUDY 134XCP|LB|3ACFF838-5B16-4898-9640-A60C85096F64|1||||CRYSTALS|CRYSTALS|||||||TITER|||||||BORDERLINE||10^3 RNA COPIES/ML||||LOW|NOT DONE||||SEMEN|CLOTTED|Y|PERIPHERAL ANGIOGRAPHY|FIBROTEST FORMULA||NA|Y|Y|U|||Y|4||88||BASELINE|1973-05-06|1960-08-07|||||1972-11-09||1965-05-03|N|1963-03-25
TRIAL STUDY 134XCP|LB|3ACFF838-5B16-4898-9640-A60C85096F64|2||||GHB|GAMMA-HYDROXYBUTYRATE|||||||LOG10 TCID 50/UL|||||||POSITIVE||10^9 ORGANISMS||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|CALCIFIED|U|GRAM STAIN|MDRD 4 VARIABLE FORMULA||N|U|Y|NA|||N|4||88||RUN-IN|1971-07-27|1968-09-18|||||1963-08-27||1966-04-22|U|1969-06-20
TRIAL STUDY 134XCP|LB|3ACFF838-5B16-4898-9640-A60C85096F64|1||||CYAMPURT|AMORPHOUS URATE CRYSTALS|||||||UG|||||||TRACE||KPA/L/SEC||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|THAWED|Y|LYMPHANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|N|U|||Y|5||7||WASHOUT|1963-05-17|1970-04-16|||||1967-04-30||1972-10-06|U|1971-07-09
TRIAL STUDY 134XCP|LB|3ACFF838-5B16-4898-9640-A60C85096F64|2||||VITB5|VITAMIN B5|||||||CM2|||||||NEGATIVE||FMOL/G||||ABNORMAL|NOT DONE||||ISOLATE|CONCENTRATED|U|INTRAVASCULAR ULTRASOUND|FIBROSIS 4 FORMULA||U|NA|U|U|||NA|5||7||SCREENING|1972-12-26|1971-01-14|||||1961-12-21||1969-04-19|U|1961-03-16
TRIAL STUDY 134XCP|LB|308F422A-B02B-4C76-86E7-834AAC127FE3|1||||FLUOXTN|FLUOXETINE|||||||UMOL/DAY|||||||POSITIVE||HZ||||LOW|NOT DONE||||ADIPOSE TISSUE|ROOM TEMPERATURE|N|IMMUNOFLUORESCENT STAIN|CKD-EPI CYSTATIN C FORMULA||NA|Y|U|N|||Y|1||38||BLINDED TREATMENT|1961-07-17|1966-08-25|||||1967-10-03||1970-01-23|U|1972-02-26
TRIAL STUDY 134XCP|LB|308F422A-B02B-4C76-86E7-834AAC127FE3|2||||C147281|EGG WHITE ANTIGEN IGE ANTIBODY|||||||MBP|||||||TRACE||10^9/G||||NORMAL|NOT DONE||||EPITHELIAL CELL|SOLIDIFIED|N|PALM METHOD|FIBROTEST FORMULA||NA|Y|U|N|||Y|1||38||FOLLOW-UP|1967-07-28|1960-09-24|||||1969-11-16||1964-08-19|U|1970-01-31
TRIAL STUDY 134XCP|LB|308F422A-B02B-4C76-86E7-834AAC127FE3|1||||CRYOFBRN|CRYOFIBRINOGEN|||||||10^3 CFU/G|||||||NEGATIVE||LENS||||ABNORMAL|NOT DONE||||CELL PELLET|PARAFFIN-EMBEDDED|U|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD 4 VARIABLE FORMULA||N|U|U|NA|||Y|2||58||BASELINE|1971-08-08|1966-01-15|||||1969-05-03||1961-08-19|N|1968-02-18
TRIAL STUDY 134XCP|LB|308F422A-B02B-4C76-86E7-834AAC127FE3|2||||CD14|CD14|||||||CI/L|||||||POSITIVE||MG/KG/H||||NORMAL|NOT DONE||||BILE|PARAFFIN-EMBEDDED|U|IMMUNOFIXATION ELECTROPHORESIS|HEPASCORE FORMULA||NA|U|U|NA|||U|2||58||OBSERVATION|1971-04-11|1960-09-01|||||1973-04-14||1973-07-15|U|1970-04-08
TRIAL STUDY 134XCP|LB|308F422A-B02B-4C76-86E7-834AAC127FE3|1||||HLAA2AB|HLA-A2 ANTIBODY|||||||ELISA UNIT/ML|||||||TRACE||L/DAY||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|ICTERIC|NA|MALDI|MDRD 5 VARIABLE FORMULA||Y|Y|NA|U|||U|3||39||TREATMENT|1967-08-07|1968-12-07|||||1967-01-21||1970-10-29|U|1967-04-22
TRIAL STUDY 134XCP|LB|308F422A-B02B-4C76-86E7-834AAC127FE3|2||||ADPNHMW|ADIPONECTIN, HIGH MOLECULAR WEIGHT|||||||PACKAGE|||||||BORDERLINE||/10^3||||LOW|NOT DONE||||LYMPH|LIPEMIC|NA|SNELLEN EYE CHART|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|NA|NA|||NA|3||39||BASELINE|1972-10-21|1967-05-28|||||1962-06-02||1962-09-20|N|1969-01-13
TRIAL STUDY 134XCP|LB|308F422A-B02B-4C76-86E7-834AAC127FE3|1||||IBCT|TOTAL IRON BINDING CAPACITY|||||||TRANSDUCING UNIT/ML|||||||TRACE||ROENTGEN||||ABNORMAL|NOT DONE||||BONE|AGGLUTINATED|N|SECONDARY ION MASS SPECTOMETRY|FIBROSIS 4 FORMULA||N|NA|N|U|||NA|4||88||OBSERVATION|1970-07-18|1965-03-21|||||1967-09-28||1971-10-28|U|1961-12-14
TRIAL STUDY 134XCP|LB|308F422A-B02B-4C76-86E7-834AAC127FE3|2||||B2G1GGAB|BETA-2 GLYCOPROTEIN 1 IGG ANTIBODY|||||||U/L|||||||INDETERMINATE||UKAT/10^12 RBC||||NORMAL|NOT DONE||||LEUKOCYTE|LIPEMIC|NA|SISH|FIBROTEST FORMULA||Y|N|N|N|||U|4||88||TREATMENT|1966-08-21|1967-03-15|||||1964-10-16||1968-08-31|NA|1966-01-15
TRIAL STUDY 134XCP|LB|308F422A-B02B-4C76-86E7-834AAC127FE3|1||||CHOLHDL|CHOLESTEROL/HDL-CHOLESTEROL|||||||10^3/HPF|||||||TRACE||VOXEL||||LOW|NOT DONE||||ERYTHROCYTES|LIPEMIC|Y|PET SCAN|MDRD 6 VARIABLE FORMULA||NA|NA|U|Y|||U|5||7||BLINDED TREATMENT|1972-01-25|1970-09-01|||||1964-04-17||1970-04-04|U|1965-11-13
TRIAL STUDY 134XCP|LB|308F422A-B02B-4C76-86E7-834AAC127FE3|2||||MSPIKEPT|MONOCLONAL PROTEIN SPIKE/TOTAL PROTEIN|||||||%/MIN|||||||BORDERLINE||TRANSDUCING UNIT||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|UNEXPECTED ODOR|Y|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD ENZYMATIC FORMULA||NA|N|N|Y|||Y|5||7||OPEN LABEL TREATMENT|1973-03-14|1966-05-31|||||1968-09-06||1970-05-29|NA|1970-08-05
TRIAL STUDY 134XCP|LB|34A3AA01-3595-42C2-95C3-44E3AF77B28D|1||||C165932|DOG DANDER IGE AB RAST SCORE|||||||LX|||||||INDETERMINATE||10^6/HPF||||HIGH|NOT DONE||||VENOUS CORD BLOOD|AUTOLYZED|NA|MULTIPLE BREATH WASHOUT|GMI % FORMULA||N|U|Y|NA|||U|1||38||BLINDED TREATMENT|1965-09-23|1963-08-05|||||1963-10-21||1960-05-13|Y|1967-11-04
TRIAL STUDY 134XCP|LB|34A3AA01-3595-42C2-95C3-44E3AF77B28D|2||||IC512AB|ISLET CELL 512 ANTIBODY|||||||MPL U/ML|||||||NEGATIVE||ML*CMH2O||||ABNORMAL|NOT DONE||||TISSUE|AUTOLYZED|NA|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|HEPASCORE FORMULA||NA|NA|Y|NA|||N|1||38||WASHOUT|1970-05-23|1960-07-23|||||1960-04-14||1969-03-14|N|1971-11-24
TRIAL STUDY 134XCP|LB|34A3AA01-3595-42C2-95C3-44E3AF77B28D|1||||TPAAG|TISSUE PLASMINOGEN ACTIVATOR ANTIGEN|||||||PACK|||||||BORDERLINE||UG/DOSE||||NORMAL|NOT DONE||||STOOL|CONCENTRATED|U|WEBER GREEN STAIN|GMI MMOL/MOL FORMULA||U|U|NA|U|||NA|2||58||TREATMENT|1963-01-23|1966-12-29|||||1962-03-31||1965-10-31|NA|1973-02-20
TRIAL STUDY 134XCP|LB|34A3AA01-3595-42C2-95C3-44E3AF77B28D|2||||NITRATE|NITRATE|||||||10^9 CFU|||||||TRACE||FOZ_BR||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|HEMOLYZED|Y|URANYL ACETATE STAIN|CKD-EPI CREATININE FORMULA||NA|U|U|Y|||NA|2||58||BASELINE|1970-08-26|1961-11-16|||||1961-01-13||1969-04-10|NA|1964-10-08
TRIAL STUDY 134XCP|LB|34A3AA01-3595-42C2-95C3-44E3AF77B28D|1||||VWFAAC|VON WILL FACTOR ACT ACTUAL/CONTROL|||||||BOLUS|||||||POSITIVE||STEPS/MIN||||LOW|NOT DONE||||MIXED VENOUS BLOOD|ICTERIC|N|MODIFIED ACID FAST STAIN|GMI MMOL/MOL FORMULA||U|N|U|Y|||U|3||39||FOLLOW-UP|1973-08-28|1964-04-15|||||1972-10-11||1968-09-03|Y|1967-12-06
TRIAL STUDY 134XCP|LB|34A3AA01-3595-42C2-95C3-44E3AF77B28D|2||||CGA|CHROMOGRANIN A|||||||CI/UG|||||||POSITIVE||FT2||||HIGH|NOT DONE||||URINE SEDIMENT|AUTOLYZED|Y|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|ASH FIBROSURE FORMULA||NA|Y|U|N|||NA|3||39||WASHOUT|1970-08-10|1972-07-01|||||1965-09-28||1969-01-17|U|1969-11-17
TRIAL STUDY 134XCP|LB|34A3AA01-3595-42C2-95C3-44E3AF77B28D|1||||HGB|HEMOGLOBIN|||||||TUBE|||||||BORDERLINE||PMOL/L||||LOW|NOT DONE||||SERUM|PARAFFIN-EMBEDDED|U|ENZYMATIC ULTRACENTRIFUGATION|HEPASCORE FORMULA||N|N|NA|NA|||U|4||88||SCREENING|1963-09-05|1962-03-08|||||1962-02-13||1971-08-23|Y|1968-02-22
TRIAL STUDY 134XCP|LB|34A3AA01-3595-42C2-95C3-44E3AF77B28D|2||||LKM1IMAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGM AB|||||||APL U|||||||NEGATIVE||RFU||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|CLOTTED|U|MAGNETIC RESONANCE ANGIOGRAPHY|NASH FIBROSURE FORMULA||Y|Y|N|Y|||N|4||88||OBSERVATION|1964-05-30|1966-12-03|||||1972-12-24||1962-09-16|U|1973-03-07
TRIAL STUDY 134XCP|LB|34A3AA01-3595-42C2-95C3-44E3AF77B28D|1||||CPEPCRT|C-PEPTIDE/CREATININE|||||||FL|||||||INDETERMINATE||DRAM||||ABNORMAL|NOT DONE||||CALCULUS|CLOTTED|U|ICC|GMI MMOL/MOL FORMULA||Y|N|Y|N|||NA|5||7||OBSERVATION|1972-05-12|1961-01-24|||||1972-05-21||1966-04-25|Y|1961-10-07
TRIAL STUDY 134XCP|LB|34A3AA01-3595-42C2-95C3-44E3AF77B28D|2||||INTLK19|INTERLEUKIN 19|||||||MG/M2/DAY|||||||POSITIVE||LM||||ABNORMAL|NOT DONE||||LOCHIA|ICTERIC|U|IN SITU HYBRIDIZATION|CKD-EPI FORMULA||Y|U|NA|NA|||NA|5||7||FOLLOW-UP|1963-10-25|1963-05-05|||||1971-07-01||1969-03-22|N|1963-05-27
TRIAL STUDY 134XCP|LB|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|1||||LEIM|IMMATURE LEUKOCYTES|||||||MM/MIN|||||||TRACE||NMOL/L||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|HEMOLYZED|U|HIGH RESOLUTION MELT ANALYSIS|FIBROTEST FORMULA||NA|NA|N|Y|||Y|1||38||TREATMENT|1970-06-28|1970-06-25|||||1961-07-08||1965-02-18|NA|1965-07-27
TRIAL STUDY 134XCP|LB|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|2||||ADP|ADENOSINE DIPHOSPHATE|||||||10^3/L|||||||NEGATIVE||SUPPOSITORY||||NORMAL|NOT DONE||||MUCUS|LIPEMIC|Y|FLOCCULATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|N|||U|1||38||LONG-TERM FOLLOW-UP|1961-03-18|1960-09-25|||||1961-10-13||1962-03-17|N|1962-05-31
TRIAL STUDY 134XCP|LB|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|1||||POIKILO|POIKILOCYTES|||||||ML/CAGE|||||||POSITIVE||ECL UNIT||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH|Y|ENZYMATIC COLORIMETRY|CKD-EPI CREATININE FORMULA||NA|NA|NA|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1964-09-07|1967-03-05|||||1965-08-25||1969-05-09|NA|1964-10-17
TRIAL STUDY 134XCP|LB|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|2||||TPROT|TAU PROTEIN|||||||/200 HPFS|||||||TRACE||MEQ/DL||||NORMAL|NOT DONE||||PLASMA|THAWED|NA|ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD FORMULA||NA|Y|N|NA|||U|2||58||WASHOUT|1968-03-03|1970-08-27|||||1967-04-28||1965-03-22|U|1966-05-17
TRIAL STUDY 134XCP|LB|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|1||||BACT|BACTERIA|||||||/MBP|||||||TRACE||ML/MIN/MMHG||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|CLOTTED|Y|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA||Y|Y|NA|U|||N|3||39||FOLLOW-UP|1964-11-27|1962-02-11|||||1966-12-05||1972-10-19|U|1964-02-28
TRIAL STUDY 134XCP|LB|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|2||||LYMPL|PLASMACYTOID LYMPHOCYTES|||||||FMOL/L|||||||NEGATIVE||GBQ||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|REFRIGERATED|NA|FLOW MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|N|||Y|3||39||OPEN LABEL TREATMENT|1960-10-23|1970-05-22|||||1968-12-11||1971-02-24|NA|1966-10-15
TRIAL STUDY 134XCP|LB|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|1||||HAPTOG|HAPTOGLOBIN|||||||G/G/DAY|||||||POSITIVE||CMH2O*S/ML||||HIGH|NOT DONE||||SPERMATOZOON|ROOM TEMPERATURE|NA|DISK DIFFUSION|MDRD 4 VARIABLE FORMULA||U|Y|NA|Y|||N|4||88||BASELINE|1961-09-20|1968-07-27|||||1971-07-16||1970-11-24|NA|1969-09-14
TRIAL STUDY 134XCP|LB|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|2||||HGBF|HEMOGLOBIN F|||||||10^5/L|||||||INVALID||MG/M2||||HIGH|NOT DONE||||URINE|PARAFFIN-EMBEDDED|U|GC/MS-CI|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|N|Y|||Y|4||88||CONTINUATION TREATMENT|1970-10-19|1971-02-13|||||1964-08-24||1972-05-03|NA|1965-07-04
TRIAL STUDY 134XCP|LB|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|1||||G6PDA|GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACT|||||||%(V/V)|||||||INDETERMINATE||NMOL/L||||LOW|NOT DONE||||PERITONEAL FLUID|THAWED|U|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD ENZYMATIC FORMULA||U|N|N|U|||Y|5||7||INDUCTION TREATMENT|1968-04-25|1969-11-02|||||1968-09-24||1973-08-03|U|1964-02-09
TRIAL STUDY 134XCP|LB|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|2||||MDZLM|MIDAZOLAM|||||||FT2|||||||NEGATIVE||FARAD||||LOW|NOT DONE||||BREAST MILK|UNEXPECTED ODOR|Y|BETA LACTAMASE|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|NA|NA|||NA|5||7||BASELINE|1973-07-06|1967-02-14|||||1967-01-22||1968-09-20|Y|1964-12-24
TRIAL STUDY 134XCP|LB|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|1||||IAA5OHCR|5-HYDROXYINDOLEACETIC ACID/CREATININE|||||||NU/CL|||||||INDETERMINATE||VG/DOSE||||ABNORMAL|NOT DONE||||SPUTUM|CONCENTRATED|NA|ENZYMATIC ULTRACENTRIFUGATION|FIBROMETER FORMULA||Y|N|N|Y|||NA|1||38||TREATMENT|1968-06-08|1961-12-19|||||1966-04-22||1968-05-11|U|1963-09-24
TRIAL STUDY 134XCP|LB|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|2||||SARCOSIN|SARCOSINE|||||||DAYS/MONTH|||||||INVALID||TSP||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|AGGLUTINATED|NA|CHROMOGENIC ASSAY|CKD-EPI CREATININE FORMULA||U|U|U|N|||NA|1||38||BASELINE|1965-11-08|1971-10-16|||||1963-05-25||1962-05-10|NA|1968-07-27
TRIAL STUDY 134XCP|LB|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|1||||CACRALB|CALCIUM CORRECTED FOR ALBUMIN|||||||10^6 CFU|||||||BORDERLINE||NEBULE||||HIGH|NOT DONE||||SYNOVIAL FLUID|LACTESCENT|N|HIGH RESOLUTION MELT ANALYSIS|MDRD ENZYMATIC FORMULA||Y|U|U|U|||Y|2||58||SCREENING|1964-12-27|1963-08-26|||||1970-08-25||1972-01-31|NA|1972-05-22
TRIAL STUDY 134XCP|LB|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|2||||BAFF|B-CELL ACTIVATING FACTOR|||||||PPM|||||||INDETERMINATE||UG/M2/DAY||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|CLOTTED|N|AMSLER GRID|MDRD ENZYMATIC FORMULA||N|U|U|N|||Y|2||58||TREATMENT|1972-11-22|1964-09-18|||||1968-11-23||1969-11-24|N|1963-02-10
TRIAL STUDY 134XCP|LB|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|1||||LTF|LACTOFERRIN|||||||BISCUIT|||||||TRACE||ELISA UNIT||||NORMAL|NOT DONE||||SEMEN|CONTAMINATED|Y|SMEAR|GMI % FORMULA||Y|Y|N|NA|||Y|3||39||FOLLOW-UP|1964-10-22|1972-01-24|||||1967-06-09||1966-10-22|Y|1961-04-06
TRIAL STUDY 134XCP|LB|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|2||||CELLSIM|IMMATURE CELLS|||||||LOG10 PFU/ML|||||||INDETERMINATE||UMOL/H/MMOL||||LOW|NOT DONE||||AQUEOUS HUMOR|SOLIDIFIED|U|OPTICAL DENSITY MEASUREMENT|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|NA|||U|3||39||CONTINUATION TREATMENT|1964-11-16|1962-01-16|||||1971-04-24||1962-02-24|N|1970-11-25
TRIAL STUDY 134XCP|LB|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|1||||NEUTHYGR|HYPOGRANULAR NEUTROPHILS|||||||ML|||||||TRACE||GPELISA UNIT/ML||||LOW|NOT DONE||||BONE|CONCENTRATED|Y|LASER CAPTURE MICRODISSECTION|COCKCROFT-GAULT FORMULA||NA|N|NA|Y|||NA|4||88||BASELINE|1969-05-19|1960-12-27|||||1971-05-31||1970-10-11|N|1966-03-30
TRIAL STUDY 134XCP|LB|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|2||||CATNINB|BETA CATENIN|||||||KN/CM2|||||||TRACE||U/G/DAY||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|LACTESCENT|NA|WHOLE TRANSCRIPTOME SEQUENCING|HEPASCORE FORMULA||Y|NA|N|Y|||U|4||88||LONG-TERM FOLLOW-UP|1973-01-09|1964-06-10|||||1969-01-01||1965-03-24|NA|1970-01-28
TRIAL STUDY 134XCP|LB|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|1||||NEUTSG|NEUTROPHILS, SEGMENTED|||||||/LSQN|||||||TRACE||YEARS||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|HEMOLYZED|N|PULSE OXIMETRY|FIBROSIS 4 FORMULA||NA|NA|NA|Y|||N|5||7||CONTINUATION TREATMENT|1963-12-19|1970-07-21|||||1966-04-04||1969-02-28|Y|1962-04-13
TRIAL STUDY 134XCP|LB|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|2||||DGNWBC|DEGENERATED LEUKOCYTES|||||||KS|||||||POSITIVE||GY/H||||HIGH|NOT DONE||||AQUEOUS HUMOR|AGGLUTINATED|Y|GC/FID|FIBROSIS 4 FORMULA||NA|N|U|U|||U|5||7||BASELINE|1967-01-09|1966-06-06|||||1962-11-04||1963-04-17|NA|1968-09-08
TRIAL STUDY 134XCP|LB|ECA054C6-EA0F-4D7B-905C-849EA4592624|1||||PH|PH|||||||SCOOPFUL|||||||INDETERMINATE||PFU/ML||||LOW|NOT DONE||||BLOOD|LIPEMIC|NA|CRYOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|Y|||U|1||38||OBSERVATION|1969-12-08|1969-05-07|||||1963-02-28||1962-12-29|U|1967-05-20
TRIAL STUDY 134XCP|LB|ECA054C6-EA0F-4D7B-905C-849EA4592624|2||||INTLK20|INTERLEUKIN 20|||||||CMOL/L|||||||BORDERLINE||NSEC||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|SOLIDIFIED|Y|ACRIDINE ORANGE STAIN|MDRD FORMULA||N|NA|U|Y|||N|1||38||SCREENING|1972-06-20|1969-10-29|||||1967-08-02||1961-07-17|Y|1972-04-19
TRIAL STUDY 134XCP|LB|ECA054C6-EA0F-4D7B-905C-849EA4592624|1||||IGF2|INSULIN-LIKE GROWTH FACTOR-2|||||||LB|||||||NEGATIVE||CAN||||LOW|NOT DONE||||RETICULOCYTES|FROZEN|U|APPLANATION TONOMETRY|CKD-EPI FORMULA||Y|N|NA|NA|||Y|2||58||BLINDED TREATMENT|1963-09-03|1970-11-18|||||1962-10-12||1967-06-16|Y|1967-04-30
TRIAL STUDY 134XCP|LB|ECA054C6-EA0F-4D7B-905C-849EA4592624|2||||PAROXET|PAROXETINE|||||||MDFI|||||||BORDERLINE||DPM/100MG||||LOW|NOT DONE||||RETICULOCYTES|PARAFFIN-EMBEDDED|N|ELISA|MDRD FORMULA||U|N|N|N|||N|2||58||FOLLOW-UP|1965-03-07|1964-05-06|||||1965-09-13||1970-07-27|N|1963-12-20
TRIAL STUDY 134XCP|LB|ECA054C6-EA0F-4D7B-905C-849EA4592624|1||||DKK1|DICKKOPF WNT SIGNALING PATH INHIBITOR 1|||||||10^9 ORGANISMS|||||||POSITIVE||NMOL BCE/NMOL||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CONTAMINATED|NA|INTERRUPTER TECHNIQUE|MDRD 5 VARIABLE FORMULA||Y|Y|U|U|||Y|3||39||WASHOUT|1972-03-14|1973-08-21|||||1970-11-26||1965-06-19|U|1968-02-10
TRIAL STUDY 134XCP|LB|ECA054C6-EA0F-4D7B-905C-849EA4592624|2||||DRUGSCR|DRUG SCREEN|||||||MMHG/L/MIN|||||||BORDERLINE||/LSQN||||NORMAL|NOT DONE||||ADIPOSE TISSUE|AUTOLYZED|NA|MYELOPEROXIDASE STAIN|MDRD 5 VARIABLE FORMULA||Y|U|U|U|||N|3||39||LONG-TERM FOLLOW-UP|1971-07-19|1962-05-06|||||1965-06-02||1964-10-20|NA|1960-06-05
TRIAL STUDY 134XCP|LB|ECA054C6-EA0F-4D7B-905C-849EA4592624|1||||APLSMA2A|ALPHA-2 ANTIPLASMIN ACTIVITY|||||||MMOL2/L2|||||||POSITIVE||/MM||||ABNORMAL|NOT DONE||||SEMEN|FRESH|U|DIFFUSION WEIGHTED MRI|MDRD ENZYMATIC FORMULA||Y|N|NA|NA|||Y|4||88||RUN-IN|1971-09-10|1973-07-10|||||1969-07-08||1966-08-19|Y|1972-01-31
TRIAL STUDY 134XCP|LB|ECA054C6-EA0F-4D7B-905C-849EA4592624|2||||PNCTPP|PANCREATIC POLYPEPTIDE|||||||IU/G HB|||||||TRACE||CI/L||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|THAWED|N|EPSILOMETER|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|Y|NA|||N|4||88||LONG-TERM FOLLOW-UP|1963-07-08|1963-05-19|||||1963-07-28||1966-07-14|Y|1970-11-26
TRIAL STUDY 134XCP|LB|ECA054C6-EA0F-4D7B-905C-849EA4592624|1||||GFR|GLOMERULAR FILTRATION RATE|||||||MEQ/UG|||||||INDETERMINATE||PMOL/10^9 CELLS||||ABNORMAL|NOT DONE||||SEBUM|HEMOLYZED|NA|MICRONEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA||U|U|U|N|||N|5||7||INDUCTION TREATMENT|1965-02-20|1965-10-12|||||1960-10-01||1964-04-16|N|1967-05-19
TRIAL STUDY 134XCP|LB|ECA054C6-EA0F-4D7B-905C-849EA4592624|2||||LEIMLE|IMMATURE LEUKOCYTES/LEUKOCYTES|||||||UG/MOL|||||||NEGATIVE||KHZ||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|SOLIDIFIED|N|TARGETED GENOME SEQUENCING|HEPASCORE FORMULA||N|U|U|U|||NA|5||7||OPEN LABEL TREATMENT|1972-10-04|1965-05-23|||||1967-10-29||1961-09-25|Y|1966-02-18
TRIAL STUDY 134XCP|LB|83823CA3-1C1D-455E-BE49-DC5E3651A939|1||||VITD23OH|VITAMIN D2 D3 25-OH|||||||LENS|||||||TRACE||EQ||||LOW|NOT DONE||||URINE|LACTESCENT|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|NASH FIBROSURE FORMULA||NA|Y|U|NA|||NA|1||38||BASELINE|1968-09-21|1972-07-04|||||1969-08-25||1970-12-21|N|1966-01-03
TRIAL STUDY 134XCP|LB|83823CA3-1C1D-455E-BE49-DC5E3651A939|2||||HYDMRPHN|HYDROMORPHONE|||||||M|||||||POSITIVE||ML/M2/DAY||||LOW|NOT DONE||||EMESIS|ROOM TEMPERATURE|N|FLUORIMETRY|FIBROTEST FORMULA||Y|U|NA|NA|||N|1||38||CONTINUATION TREATMENT|1962-01-15|1960-01-12|||||1961-04-04||1962-05-22|U|1970-10-19
TRIAL STUDY 134XCP|LB|83823CA3-1C1D-455E-BE49-DC5E3651A939|1||||HEINZ|HEINZ BODIES|||||||1/(S*KPA)|||||||INVALID||MMAL||||HIGH|NOT DONE||||SEBUM|LACTESCENT|N|MYELOPEROXIDASE STAIN|CKD-EPI CYSTATIN C FORMULA||U|NA|U|U|||NA|2||58||WASHOUT|1966-07-21|1963-08-08|||||1960-02-03||1963-06-28|N|1964-01-20
TRIAL STUDY 134XCP|LB|83823CA3-1C1D-455E-BE49-DC5E3651A939|2||||C130081|ORCHARD GRASS POLLEN IGA|||||||MM/MIN|||||||TRACE||ML/MMHG/MIN/L||||LOW|NOT DONE||||PLASMA|HEMOLYZED|N|IODINE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|N|U|||NA|2||58||OPEN LABEL TREATMENT|1961-05-14|1966-03-05|||||1966-06-23||1968-03-22|U|1967-12-06
TRIAL STUDY 134XCP|LB|83823CA3-1C1D-455E-BE49-DC5E3651A939|1||||C165930|SHELLFISH MIX IGE AB RAST SCORE|||||||H/WK|||||||BORDERLINE||%||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|NON-HEMOLYZED|U|LC/MS|FIBROTEST FORMULA||NA|Y|U|NA|||U|3||39||BASELINE|1964-12-16|1970-03-17|||||1967-01-08||1967-12-22|N|1969-03-10
TRIAL STUDY 134XCP|LB|83823CA3-1C1D-455E-BE49-DC5E3651A939|2||||EUDCA|EPIMERIZED URSODEOXYCHOLATE|||||||MM3/MM2/YEAR|||||||NEGATIVE||UG/MIN||||HIGH|NOT DONE||||PLATELET POOR PLASMA|CONTAMINATED|U|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||N|U|Y|N|||U|3||39||INDUCTION TREATMENT|1960-01-15|1965-10-13|||||1961-10-28||1970-05-28|NA|1965-07-17
TRIAL STUDY 134XCP|LB|83823CA3-1C1D-455E-BE49-DC5E3651A939|1||||PO2ADJT|PARTIAL PRESSURE OXYGEN ADJ FOR TEMP|||||||MPS U|||||||INDETERMINATE||CAPFUL||||LOW|NOT DONE||||PLASMA|UNEXPECTED ODOR|NA|BRDU CELLULAR PROLIFERATION ASSAY|MDRD 6 VARIABLE FORMULA||NA|N|Y|NA|||N|4||88||RUN-IN|1971-09-02|1960-01-29|||||1972-09-16||1967-02-18|N|1967-08-03
TRIAL STUDY 134XCP|LB|83823CA3-1C1D-455E-BE49-DC5E3651A939|2||||ROUNDCE|ROUND CELLS|||||||MG/M2/MIN|||||||BORDERLINE||CFU/G||||LOW|NOT DONE||||AQUEOUS HUMOR|UNEXPECTED ODOR|NA|AGAR DILUTION|FIBROMETER FORMULA||NA|N|U|N|||U|4||88||OBSERVATION|1972-05-08|1964-11-30|||||1970-04-25||1972-05-09|U|1962-03-02
TRIAL STUDY 134XCP|LB|83823CA3-1C1D-455E-BE49-DC5E3651A939|1||||NORMETA|NORMETANEPHRINE|||||||APPLICATION|||||||INDETERMINATE||APL U/ML||||ABNORMAL|NOT DONE||||HAIR|PARAFFIN-EMBEDDED|U|ETDRS EYE CHART|MDRD 4 VARIABLE FORMULA||NA|Y|U|N|||N|5||7||RUN-IN|1970-11-23|1967-09-06|||||1960-05-04||1966-09-03|NA|1963-03-14
TRIAL STUDY 134XCP|LB|83823CA3-1C1D-455E-BE49-DC5E3651A939|2||||PAP|PROSTATIC ACID PHOSPHATASE|||||||PMOL/G|||||||INDETERMINATE||TCID 50/DOSE||||NORMAL|NOT DONE||||GASTRIC FLUID|UNEXPECTED ODOR|Y|FLUORESCENT ENZYME IMMUNOASSAY|MDRD 4 VARIABLE FORMULA||N|Y|U|N|||U|5||7||BLINDED TREATMENT|1964-09-24|1969-01-01|||||1970-03-18||1971-01-02|U|1968-12-04
TRIAL STUDY 134XCP|LB|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|1||||ANAIGGAB|ANTINUCLEAR IGG ANTIBODY|||||||PLUG|||||||BORDERLINE||FARAD||||LOW|NOT DONE||||FLUID|REFRIGERATED|NA|IMMUNOBLOT|MDRD FORMULA||U|U|NA|U|||Y|1||38||OPEN LABEL TREATMENT|1972-09-11|1961-09-17|||||1963-06-20||1962-09-04|NA|1965-04-11
TRIAL STUDY 134XCP|LB|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|2||||PG|PROSTAGLANDIN|||||||KG/CM2|||||||NEGATIVE||G/M2/DAY||||NORMAL|NOT DONE||||ISOLATE|CONTAMINATED|N|FLUORESCENT MICROSCOPY|FIBROTEST FORMULA||NA|NA|Y|NA|||NA|1||38||CONTINUATION TREATMENT|1964-08-15|1964-01-22|||||1960-06-22||1961-04-26|NA|1961-02-26
TRIAL STUDY 134XCP|LB|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|1||||IGFBP1|INSULIN-LIKE GROWTH FACTOR BINDING PROT1|||||||%(W/V)|||||||INDETERMINATE||JOULE||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|GELLED|Y|MALDI-TOF|MDRD ENZYMATIC FORMULA||N|Y|NA|Y|||N|2||58||OPEN LABEL TREATMENT|1961-07-14|1964-09-21|||||1970-01-29||1964-03-31|Y|1971-12-10
TRIAL STUDY 134XCP|LB|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|2||||RENINA|RENIN ACTIVITY|||||||MM/2H|||||||INDETERMINATE||BOX||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE|U|INDIA INK STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|N|U|||N|2||58||SCREENING|1966-09-20|1967-05-18|||||1964-01-24||1972-06-23|U|1965-10-31
TRIAL STUDY 134XCP|LB|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|1||||INTLK17|INTERLEUKIN 17|||||||BREATHS/30S|||||||TRACE||MG/M2/DAY||||NORMAL|NOT DONE||||EMOTIONAL TEAR|SOLIDIFIED|U|LISSAMINE GREEN STAIN|FIBROMETER FORMULA||Y|Y|NA|U|||NA|3||39||LONG-TERM FOLLOW-UP|1967-11-05|1972-01-26|||||1961-03-08||1970-11-06|N|1968-05-18
TRIAL STUDY 134XCP|LB|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|2||||ESTROGEN|ESTROGEN|||||||EVENTS|||||||POSITIVE||10^6 COPIES/ML||||LOW|NOT DONE||||SUPERNATANT, SERUM|ROOM TEMPERATURE|Y|TONOMETRY|HEPASCORE FORMULA||U|NA|U|NA|||Y|3||39||OBSERVATION|1967-10-01|1965-05-28|||||1971-04-04||1960-07-08|NA|1973-04-12
TRIAL STUDY 134XCP|LB|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|1||||IFIT3|INTERFERON-INDUCED 60 KDA PROTEIN|||||||U/G/DAY|||||||BORDERLINE||OI50||||ABNORMAL|NOT DONE||||EMESIS|ROOM TEMPERATURE|N|LC/MS/MS|FIBROSIS 4 FORMULA||N|NA|N|NA|||N|4||88||BASELINE|1962-07-29|1969-02-17|||||1968-09-15||1973-07-22|NA|1969-01-17
TRIAL STUDY 134XCP|LB|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|2||||LIPASET|LIPASE|||||||INHALATION|||||||BORDERLINE||MM2||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|CLOTTED|Y|DIRECT SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|Y|N|||U|4||88||OPEN LABEL TREATMENT|1960-02-08|1967-08-31|||||1963-11-23||1960-07-14|NA|1971-12-02
TRIAL STUDY 134XCP|LB|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|1||||TPRONP|NON-PHOSPHORYLATED TAU PROTEIN|||||||USIEMENS|||||||INDETERMINATE||U/KG/H||||LOW|NOT DONE||||MIXED VENOUS BLOOD|AGGLUTINATED|NA|PULSE OXIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|Y|||U|5||7||SCREENING|1973-06-14|1968-08-18|||||1961-02-03||1973-03-31|N|1961-11-29
TRIAL STUDY 134XCP|LB|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|2||||C130108|WEED MIX POLLEN ANTIGEN IGA ANTIBODY|||||||BQ/UL|||||||NEGATIVE||G/G||||ABNORMAL|NOT DONE||||ERYTHROCYTES|LIPEMIC|U|CRYOSCOPY|FIBROMETER FORMULA||N|N|Y|Y|||N|5||7||SCREENING|1967-09-15|1962-06-22|||||1960-01-16||1960-11-24|NA|1963-07-25
TRIAL STUDY 134XCP|LB|9C24F018-315A-4B9C-B89B-F54CA26452E7|1||||HSP70|HEAT SHOCK PROTEIN 70|||||||MG/KG/H|||||||BORDERLINE||LOG10 CCID 50/DOSE||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|CONTAMINATED|N|OLIGO ACGH|MDRD FORMULA||U|U|Y|NA|||U|1||38||CONTINUATION TREATMENT|1961-11-23|1960-06-10|||||1964-11-30||1968-07-12|NA|1965-02-06
TRIAL STUDY 134XCP|LB|9C24F018-315A-4B9C-B89B-F54CA26452E7|2||||CD11B|CD11B|||||||MHZ|||||||INDETERMINATE||/100 WBC||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|DRIED|U|LINE PROBE ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|NA|Y|||U|1||38||BLINDED TREATMENT|1964-12-14|1968-09-25|||||1966-10-28||1971-11-13|NA|1965-07-08
TRIAL STUDY 134XCP|LB|9C24F018-315A-4B9C-B89B-F54CA26452E7|1||||HISTAMIN|HISTAMINE|||||||NMOL BCE/NMOL|||||||POSITIVE||MEQ/G||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|DRIED|U|ICP-MS|COCKCROFT-GAULT FORMULA||Y|Y|U|N|||N|2||58||RUN-IN|1967-08-11|1960-09-01|||||1965-07-02||1962-06-16|Y|1961-06-25
TRIAL STUDY 134XCP|LB|9C24F018-315A-4B9C-B89B-F54CA26452E7|2||||V25HD3|25-HYDROXYVITAMIN D3|||||||UG/KG/DAY|||||||NEGATIVE||KHZ||||ABNORMAL|NOT DONE||||FLUID|UNEXPECTED ODOR|N|DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI CREATININE FORMULA||NA|Y|U|U|||N|2||58||TREATMENT|1965-12-18|1961-06-29|||||1962-09-17||1964-11-15|U|1964-05-30
TRIAL STUDY 134XCP|LB|9C24F018-315A-4B9C-B89B-F54CA26452E7|1||||MIP1B|MACROPHAGE INFLAMMATORY PROTEIN 1 BETA|||||||BEL|||||||BORDERLINE||PATCH||||HIGH|NOT DONE||||SOFT TISSUE|REFRIGERATED|Y|THICK SMEAR|FIBROMETER FORMULA||N|NA|U|NA|||Y|3||39||CONTINUATION TREATMENT|1960-02-21|1971-11-08|||||1960-01-03||1969-10-07|NA|1966-11-12
TRIAL STUDY 134XCP|LB|9C24F018-315A-4B9C-B89B-F54CA26452E7|2||||AST|ASPARTATE AMINOTRANSFERASE|||||||LOZENGE|||||||INVALID||10^4/HPF||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|CONCENTRATED|NA|ELECTROGASTROGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|Y|||NA|3||39||FOLLOW-UP|1967-01-27|1970-10-27|||||1967-05-30||1973-07-20|U|1960-05-14
TRIAL STUDY 134XCP|LB|9C24F018-315A-4B9C-B89B-F54CA26452E7|1||||ACETONE|ACETONE|||||||HZ|||||||TRACE||10^3 CFU/G||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|CALCIFIED|U|WESTERGREN|MDRD ENZYMATIC FORMULA||N|Y|NA|Y|||U|4||88||RUN-IN|1971-10-30|1972-04-17|||||1972-09-28||1963-11-04|N|1966-09-29
TRIAL STUDY 134XCP|LB|9C24F018-315A-4B9C-B89B-F54CA26452E7|2||||KLHIGMAB|KEYHOLE LIMPET HEMOCYANIN IGM ANTIBODY|||||||KIT|||||||NEGATIVE||KM||||LOW|NOT DONE||||FLUID|CLOTTED|NA|GEL ELECTROPHORESIS|MDRD 5 VARIABLE FORMULA||Y|U|N|Y|||NA|4||88||OBSERVATION|1971-11-11|1963-06-21|||||1966-06-19||1973-06-10|N|1970-10-07
TRIAL STUDY 134XCP|LB|9C24F018-315A-4B9C-B89B-F54CA26452E7|1||||CYCASULF|CALCIUM SULFATE CRYSTALS|||||||10^9/DOSE|||||||TRACE||YEARS||||LOW|NOT DONE||||INTERSTITIAL FLUID|HEMOLYZED|N|HEMATOXYLIN AND EOSIN STAIN|CKD-EPI FORMULA||NA|U|NA|U|||N|5||7||FOLLOW-UP|1970-04-04|1967-01-21|||||1968-04-23||1968-06-16|NA|1966-07-17
TRIAL STUDY 134XCP|LB|9C24F018-315A-4B9C-B89B-F54CA26452E7|2||||PAPPA|PREGNANCY-ASSOCIATED PLASMA PROTEIN-A|||||||POINT|||||||INVALID||10^3 CFU/G||||HIGH|NOT DONE||||GASTRIC FLUID|LIPEMIC|N|LINE PROBE ASSAY|NASH FIBROSURE FORMULA||NA|Y|U|Y|||NA|5||7||OPEN LABEL TREATMENT|1960-09-19|1964-04-07|||||1961-12-22||1968-02-19|N|1967-08-18
TRIAL STUDY 134XCP|LB|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|1||||HBOXHGB|OXYHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||BQ/UL|||||||NEGATIVE||L/H||||NORMAL|NOT DONE||||SERUM OR PLASMA|DRIED|N|DIGITAL PCR ARRAY|CKD-EPI CREATININE FORMULA||NA|Y|U|NA|||N|1||38||OBSERVATION|1960-06-20|1970-06-03|||||1966-03-07||1966-01-16|Y|1960-07-14
TRIAL STUDY 134XCP|LB|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|2||||INTLK15|INTERLEUKIN 15|||||||PIXELS/CM|||||||INDETERMINATE||GLOBULE||||HIGH|NOT DONE||||TUMOR TISSUE|GELLED|Y|LIGHT SCATTERING SPECTROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|Y|N|||N|1||38||OBSERVATION|1970-12-25|1966-12-28|||||1965-11-14||1970-07-15|U|1971-05-25
TRIAL STUDY 134XCP|LB|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|1||||CD3|CD3|||||||FMOL/L|||||||BORDERLINE||GTT||||HIGH|NOT DONE||||RETICULOCYTES|AGGLUTINATED|NA|TRYPAN BLUE STAIN|MDRD 6 VARIABLE FORMULA||Y|N|U|U|||N|2||58||BASELINE|1965-02-02|1968-08-19|||||1973-03-01||1960-04-08|NA|1965-02-03
TRIAL STUDY 134XCP|LB|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|2||||VITB2|RIBOFLAVIN|||||||LENS|||||||INDETERMINATE||/LPF||||HIGH|NOT DONE||||EXUDATE|LACTESCENT|Y|IMPULSE OSCILLOMETRY|MDRD ENZYMATIC FORMULA||N|Y|NA|N|||U|2||58||CONTINUATION TREATMENT|1972-08-22|1965-10-19|||||1971-04-25||1960-05-07|Y|1972-06-26
TRIAL STUDY 134XCP|LB|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|1||||THCCOOH|11-NOR-DELTA9-THC-9-CARBOXYLIC ACID|||||||M3|||||||INVALID||EJACULATE U||||HIGH|NOT DONE||||BONE MARROW|AGGLUTINATED|U|BRDU CELLULAR PROLIFERATION ASSAY|COCKCROFT-GAULT FORMULA||N|NA|NA|NA|||NA|3||39||INDUCTION TREATMENT|1966-01-16|1973-03-03|||||1963-06-28||1963-09-25|NA|1964-03-28
TRIAL STUDY 134XCP|LB|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|2||||NPY|NEUROPEPTIDE Y|||||||RAD|||||||INDETERMINATE||LB||||ABNORMAL|NOT DONE||||VENOUS PLASMA|LIPEMIC|NA|MACRO BROTH DILUTION|CKD-EPI FORMULA||NA|U|NA|NA|||Y|3||39||LONG-TERM FOLLOW-UP|1969-06-14|1967-07-31|||||1961-05-18||1967-11-07|N|1967-10-02
TRIAL STUDY 134XCP|LB|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|1||||MBP|MYELIN BASIC PROTEIN|||||||DEG2|||||||INDETERMINATE||CFU/G||||LOW|NOT DONE||||NAIL|AUTOLYZED|N|ICC|GMI MMOL/MOL FORMULA||NA|U|U|N|||NA|4||88||INDUCTION TREATMENT|1971-02-24|1967-10-17|||||1971-07-28||1962-06-23|U|1962-02-04
TRIAL STUDY 134XCP|LB|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|2||||AST|ASPARTATE AMINOTRANSFERASE|||||||/H|||||||INDETERMINATE||LOG10 ELISA UNIT||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|THAWED|U|RULER MEASUREMENT METHOD|ASH FIBROSURE FORMULA||N|U|U|N|||N|4||88||SCREENING|1963-11-10|1969-08-04|||||1973-05-17||1961-04-17|NA|1960-06-13
TRIAL STUDY 134XCP|LB|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|1||||G6PDRBC|G6PD-DEFICIENT ERYTHROCYTES|||||||PFU/ANIMAL|||||||TRACE||%||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|UNEXPECTED ODOR|Y|THICK SMEAR|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|U|U|||NA|5||7||LONG-TERM FOLLOW-UP|1971-09-25|1960-02-05|||||1965-02-25||1973-09-06|N|1962-08-22
TRIAL STUDY 134XCP|LB|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|2||||BASO|BASOPHILS|||||||KM|||||||NEGATIVE||CL||||HIGH|NOT DONE||||VENOUS CORD BLOOD|DRIED|NA|EPSILOMETER|ASH FIBROSURE FORMULA||N|U|N|N|||NA|5||7||RUN-IN|1972-04-18|1967-07-28|||||1965-03-18||1964-04-22|U|1973-08-27
TRIAL STUDY 134XCP|LB|8D48F229-F38B-4335-B8A7-0AA24C928707|1||||HETRPHLE|HETEROPHILS/LEUKOCYTES|||||||ANTIBODY UNIT|||||||NEGATIVE||PHERESIS UNIT||||HIGH|NOT DONE||||RETICULOCYTES|CLOTTED|N|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA||NA|N|Y|N|||N|1||38||LONG-TERM FOLLOW-UP|1968-01-25|1969-01-23|||||1968-01-30||1963-06-13|NA|1969-07-16
TRIAL STUDY 134XCP|LB|8D48F229-F38B-4335-B8A7-0AA24C928707|2||||A73OXC|7-ALPHA-HYDROXY-4-CHOLESTEN-3-ONE|||||||MEQ|||||||INDETERMINATE||PG/DL||||LOW|NOT DONE||||SOFT TISSUE|FRESH|NA|CT SCAN WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA||Y|N|U|N|||Y|1||38||RUN-IN|1965-10-30|1968-03-21|||||1970-12-18||1970-09-30|Y|1964-02-28
TRIAL STUDY 134XCP|LB|8D48F229-F38B-4335-B8A7-0AA24C928707|1||||ASTCREAT|ASPARTATE AMINOTRANSFERASE/CREATININE|||||||/7.5 ML|||||||POSITIVE||NKAT||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CLOTTED|Y|ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||N|Y|Y|NA|||U|2||58||BASELINE|1971-09-10|1971-10-01|||||1961-12-02||1967-06-13|N|1961-04-22
TRIAL STUDY 134XCP|LB|8D48F229-F38B-4335-B8A7-0AA24C928707|2||||CCK|CHOLECYSTOKININ|||||||/7.5 ML|||||||INVALID||AFU||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|FRESH|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|HEPASCORE FORMULA||NA|Y|N|N|||U|2||58||RUN-IN|1968-02-02|1969-10-10|||||1960-12-05||1966-03-30|Y|1972-06-26
TRIAL STUDY 134XCP|LB|8D48F229-F38B-4335-B8A7-0AA24C928707|1||||PDL1S|SOLUBLE PROGRAMMED DEATH LIGAND 1|||||||ENZYME U/G HB|||||||INVALID||FEU||||LOW|NOT DONE||||ISOLATE|CONTAMINATED|NA|MEDIASTINOSCOPY|MDRD 6 VARIABLE FORMULA||NA|Y|Y|Y|||N|3||39||SCREENING|1965-06-30|1971-02-11|||||1960-03-28||1963-08-25|Y|1967-04-24
TRIAL STUDY 134XCP|LB|8D48F229-F38B-4335-B8A7-0AA24C928707|2||||PLSPCE|PRECURSOR PLASMA CELLS|||||||CFU/ML|||||||TRACE||MOL||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|ICTERIC|Y|ETDRS EYE CHART|MDRD 4 VARIABLE FORMULA||Y|N|NA|N|||NA|3||39||CONTINUATION TREATMENT|1969-05-14|1973-01-31|||||1964-10-24||1970-06-10|Y|1973-06-04
TRIAL STUDY 134XCP|LB|8D48F229-F38B-4335-B8A7-0AA24C928707|1||||RANKL|RECEPTOR ACTIVATOR NUCLEAR KAPPAB LIGAND|||||||F|||||||POSITIVE||DAMOL/L||||NORMAL|NOT DONE||||LAVAGE FLUID|FRESH|Y|FLUORESCENT SPOT TEST|NASH FIBROSURE FORMULA||Y|NA|N|Y|||U|4||88||TREATMENT|1962-12-20|1962-08-12|||||1965-09-18||1966-06-29|Y|1970-04-30
TRIAL STUDY 134XCP|LB|8D48F229-F38B-4335-B8A7-0AA24C928707|2||||FACTIX|FACTOR IX|||||||RAD|||||||POSITIVE||KG/MOL||||ABNORMAL|NOT DONE||||BONE MARROW|UNEXPECTED ODOR|NA|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 6 VARIABLE FORMULA||Y|Y|Y|NA|||NA|4||88||SCREENING|1971-03-10|1964-11-20|||||1961-03-18||1963-08-07|U|1967-05-18
TRIAL STUDY 134XCP|LB|8D48F229-F38B-4335-B8A7-0AA24C928707|1||||ASN|ASPARAGINE|||||||KCAL/DAY|||||||BORDERLINE||UG/G/DAY||||ABNORMAL|NOT DONE||||LYSATE|CLOTTED|U|POLYSOMNOGRAPHY|MDRD FORMULA||Y|U|NA|N|||U|5||7||SCREENING|1972-06-03|1972-06-20|||||1965-07-06||1972-10-01|NA|1971-09-08
TRIAL STUDY 134XCP|LB|8D48F229-F38B-4335-B8A7-0AA24C928707|2||||C130117|BEE MIX ANTIGEN IGG ANTIBODY|||||||MIN*MG/ML|||||||NEGATIVE||LOG10 TCID 50/DOSE||||HIGH|NOT DONE||||CAPILLARY BLOOD|ROOM TEMPERATURE|U|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|CKD-EPI CREATININE FORMULA||U|Y|NA|N|||Y|5||7||BLINDED TREATMENT|1961-10-31|1964-11-01|||||1963-08-24||1966-05-05|NA|1970-12-23
TRIAL STUDY 134XCP|LB|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|1||||LYMPHOID|LYMPHOID CELLS|||||||KPA|||||||INVALID||UV*SEC||||NORMAL|NOT DONE||||SALIVA|CALCIFIED|N|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|FIBROMETER FORMULA||N|NA|N|NA|||U|1||38||WASHOUT|1973-02-11|1966-10-20|||||1967-06-12||1963-09-07|Y|1960-01-23
TRIAL STUDY 134XCP|LB|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|2||||GAD2|GLUTAMIC ACID DECARBOXYLASE 2|||||||UG/DAY|||||||INVALID||MS2||||LOW|NOT DONE||||EPITHELIAL CELL|AGGLUTINATED|U|TELLER ACUITY CARDS|FIBROTEST FORMULA||N|N|NA|U|||NA|1||38||BLINDED TREATMENT|1961-08-06|1960-09-14|||||1970-12-03||1963-08-18|N|1973-07-01
TRIAL STUDY 134XCP|LB|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|1||||PHOS|PHOSPHATE|||||||HOMEOPATHIC DILUTION|||||||INDETERMINATE||UG/G/H||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|THAWED|Y|AUTOREFRACTION|FIBROTEST FORMULA||NA|U|Y|U|||Y|2||58||BLINDED TREATMENT|1963-12-15|1963-05-24|||||1973-01-08||1969-07-15|Y|1964-12-19
TRIAL STUDY 134XCP|LB|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|2||||CTXICRT|TYPE I COLLAGEN C-TELOPEPTIDES/CREAT|||||||NMOL/ML/MIN|||||||INVALID||DPM/100MG||||NORMAL|NOT DONE||||EPITHELIAL CELL|REFRIGERATED|Y|RADIAL IMMUNODIFFUSION|MDRD FORMULA||NA|Y|N|NA|||NA|2||58||SCREENING|1971-11-21|1970-10-20|||||1965-11-27||1964-03-01|N|1966-01-01
TRIAL STUDY 134XCP|LB|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|1||||MIP1G|MACROPHAGE INFLAMMATORY PROTEIN 1 GAMMA|||||||BREATHS/30S|||||||NEGATIVE||MDFI||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|NA|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|N|U|||NA|3||39||INDUCTION TREATMENT|1964-08-17|1962-06-14|||||1965-01-10||1968-09-08|N|1968-09-18
TRIAL STUDY 134XCP|LB|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|2||||MPXI|MYELOPEROXIDASE INDEX|||||||MG/KG/DOSE|||||||INVALID||U/L||||HIGH|NOT DONE||||PLEURAL TISSUE|PARAFFIN-EMBEDDED|N|ANTIBIOTIC AGAR SCREEN|MDRD ENZYMATIC FORMULA||N|NA|Y|Y|||NA|3||39||TREATMENT|1969-04-11|1964-04-01|||||1964-09-28||1962-04-08|Y|1968-06-09
TRIAL STUDY 134XCP|LB|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|1||||CKBB|CREATINE KINASE BB|||||||NG|||||||NEGATIVE||PSEC||||LOW|NOT DONE||||HAIR FOLLICLE|CONTAMINATED|NA|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROMETER FORMULA||Y|N|N|U|||Y|4||88||BASELINE|1965-07-01|1964-12-25|||||1969-12-23||1965-04-17|NA|1967-08-07
TRIAL STUDY 134XCP|LB|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|2||||INTLK9|INTERLEUKIN 9|||||||IU/G|||||||TRACE||MEQ/DL||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|FRESH|U|INTERRUPTER TECHNIQUE|CKD-EPI FORMULA||NA|N|Y|Y|||N|4||88||SCREENING|1969-09-10|1963-02-04|||||1964-02-14||1968-12-18|U|1973-06-29
TRIAL STUDY 134XCP|LB|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|1||||GATCPHRL|GAMMA TOCOPHEROL|||||||KM|||||||TRACE||KEV||||NORMAL|NOT DONE||||BONE MARROW|PARAFFIN-EMBEDDED|NA|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|FIBROMETER FORMULA||N|NA|Y|NA|||Y|5||7||WASHOUT|1965-10-19|1963-01-21|||||1961-07-08||1971-11-12|NA|1964-08-26
TRIAL STUDY 134XCP|LB|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|2||||BITECE|BITE CELLS|||||||BOTTLE|||||||BORDERLINE||STEPS/MIN||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|FRESH|N|LISSAMINE GREEN STAIN|CKD-EPI CREATININE FORMULA||Y|Y|Y|U|||U|5||7||BLINDED TREATMENT|1968-06-07|1969-10-16|||||1965-07-01||1970-12-27|U|1972-05-25
TRIAL STUDY 134XCP|LB|C882CB1F-C0DE-4BE5-B762-611333949C74|1||||C130093|WESTERN RAGWEED POLLEN IGA|||||||ARBITRARY U|||||||TRACE||LM||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|AGGLUTINATED|NA|FUNCTIONAL MRI|CKD-EPI CREATININE FORMULA||Y|NA|N|Y|||Y|1||38||SCREENING|1961-12-31|1962-04-27|||||1962-07-02||1963-02-06|Y|1960-02-21
TRIAL STUDY 134XCP|LB|C882CB1F-C0DE-4BE5-B762-611333949C74|2||||RPTLAAC|REPTILASE ACTIVITY ACTUAL/CONTROL|||||||MEQ/ML|||||||NEGATIVE||PPB||||NORMAL|NOT DONE||||CORD SERUM|ICTERIC|N|QUANTITATIVE CORONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|U|||U|1||38||CONTINUATION TREATMENT|1961-04-11|1965-11-30|||||1964-02-03||1960-10-12|U|1966-12-05
TRIAL STUDY 134XCP|LB|C882CB1F-C0DE-4BE5-B762-611333949C74|1||||APOA|APOLIPOPROTEIN A|||||||S*KPA|||||||INVALID||/10^3||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|THAWED|NA|VIRUS PLAQUE ASSAY|MDRD 4 VARIABLE FORMULA||NA|NA|Y|U|||N|2||58||BLINDED TREATMENT|1969-04-23|1960-07-07|||||1962-09-15||1966-08-05|U|1961-07-02
TRIAL STUDY 134XCP|LB|C882CB1F-C0DE-4BE5-B762-611333949C74|2||||METHQLDN|METHAQUALONE|||||||% INHIBITION|||||||INDETERMINATE||KG/MOL||||NORMAL|NOT DONE||||NAIL|LACTESCENT|NA|ERGOSPIROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|N|NA|||N|2||58||BLINDED TREATMENT|1961-06-16|1960-09-29|||||1966-04-18||1971-09-14|N|1969-06-24
TRIAL STUDY 134XCP|LB|C882CB1F-C0DE-4BE5-B762-611333949C74|1||||GSTCREAT|GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||U/G HB|||||||INVALID||KN/CM2||||ABNORMAL|NOT DONE||||SPERMATOZOON|CONCENTRATED|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD FORMULA||Y|NA|Y|NA|||NA|3||39||FOLLOW-UP|1966-11-28|1962-06-09|||||1973-02-14||1967-12-05|NA|1964-03-27
TRIAL STUDY 134XCP|LB|C882CB1F-C0DE-4BE5-B762-611333949C74|2||||CEMORPH|CELL MORPHOLOGY|||||||U/G/MIN|||||||POSITIVE||ML/M2/DAY||||HIGH|NOT DONE||||HAIR|LIPEMIC|Y|CYSTOSCOPY|NASH FIBROSURE FORMULA||NA|U|N|Y|||N|3||39||OBSERVATION|1968-03-21|1960-06-10|||||1960-09-09||1961-11-22|N|1963-03-05
TRIAL STUDY 134XCP|LB|C882CB1F-C0DE-4BE5-B762-611333949C74|1||||PROMONO|PROMONOCYTES|||||||S/H|||||||BORDERLINE||10^3 ORGANISMS||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|AUTOLYZED|NA|FLUORESCENT ENZYME IMMUNOASSAY|MDRD ENZYMATIC FORMULA||N|NA|Y|NA|||N|4||88||RUN-IN|1960-10-18|1965-06-28|||||1970-09-02||1964-12-21|NA|1965-05-30
TRIAL STUDY 134XCP|LB|C882CB1F-C0DE-4BE5-B762-611333949C74|2||||CCL19|CHEMOKINE (C-C MOTIF) LIGAND 19|||||||UG/L|||||||BORDERLINE||U/KG/H||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|THAWED|Y|HIGH RESOLUTION CT|MDRD 4 VARIABLE FORMULA||U|Y|U|N|||U|4||88||SCREENING|1966-04-22|1967-09-19|||||1962-12-11||1965-09-18|U|1960-07-13
TRIAL STUDY 134XCP|LB|C882CB1F-C0DE-4BE5-B762-611333949C74|1||||SAHOMC|S-ADENOSYLHOMOCYSTEINE|||||||MOSM/L|||||||POSITIVE||WAFER||||NORMAL|NOT DONE||||PROSTATIC FLUID|SOLIDIFIED|N|SPECTROPHOTOMETRY|MDRD ENZYMATIC FORMULA||NA|U|NA|U|||N|5||7||WASHOUT|1960-05-17|1962-12-06|||||1961-09-30||1967-02-10|U|1966-11-28
TRIAL STUDY 134XCP|LB|C882CB1F-C0DE-4BE5-B762-611333949C74|2||||SERTRAL|SERTRALINE|||||||INHALATION|||||||INVALID||MMAL||||HIGH|NOT DONE||||VENOUS BLOOD|REFRIGERATED|U|MULTI-SLICE SPIRAL CT|FIBROSIS 4 FORMULA||N|NA|N|N|||N|5||7||SCREENING|1960-04-25|1966-05-29|||||1964-01-05||1960-11-04|U|1964-04-18
TRIAL STUDY 134XCP|LB|7F3C3801-607B-4141-AA83-383FDFFD7152|1||||UROTHCE|UROTHELIAL CELLS|||||||POINT|||||||BORDERLINE||L/S||||LOW|NOT DONE||||COLOSTRUM|ICTERIC|N|ELISPOT|CKD-EPI CYSTATIN C FORMULA||Y|Y|N|Y|||Y|1||38||WASHOUT|1964-12-23|1961-01-18|||||1973-03-25||1964-05-20|N|1971-04-08
TRIAL STUDY 134XCP|LB|7F3C3801-607B-4141-AA83-383FDFFD7152|2||||VTD2D3IT|25-HYDROXYVIT D2 + 25-HYDROXYVIT D3|||||||UM2|||||||POSITIVE||UMOL/DL||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|UNEXPECTED ODOR|U|MALDI-TOF|NASH FIBROSURE FORMULA||U|U|Y|N|||Y|1||38||TREATMENT|1960-06-12|1971-08-19|||||1966-08-16||1960-02-10|N|1960-08-12
TRIAL STUDY 134XCP|LB|7F3C3801-607B-4141-AA83-383FDFFD7152|1||||LGLUCLE|LARGE UNSTAINED CELLS/LEUKOCYTES|||||||MU|||||||INVALID||CG||||ABNORMAL|NOT DONE||||LYSATE|CLOTTED|Y|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|CKD-EPI CREATININE FORMULA||Y|N|NA|N|||NA|2||58||BLINDED TREATMENT|1964-04-18|1971-04-11|||||1971-07-21||1967-04-08|NA|1964-09-13
TRIAL STUDY 134XCP|LB|7F3C3801-607B-4141-AA83-383FDFFD7152|2||||LIPASEP|LIPASE, PANCREATIC|||||||CG|||||||NEGATIVE||/MIN||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|UNEXPECTED ODOR|NA|TRANSMISSION ELECTRON MICROSCOPY|ASH FIBROSURE FORMULA||N|U|U|N|||Y|2||58||BASELINE|1965-12-20|1965-07-27|||||1966-11-30||1964-08-21|N|1966-10-30
TRIAL STUDY 134XCP|LB|7F3C3801-607B-4141-AA83-383FDFFD7152|1||||C165922|MIXED ANTIGEN IGE AB RAST SCORE|||||||DPM/MG|||||||BORDERLINE||AU/ML||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|AGGLUTINATED|NA|FORCED OSCILLATION TECHNIQUE|FIBROSIS 4 FORMULA||N|U|N|NA|||NA|3||39||BLINDED TREATMENT|1960-06-04|1961-07-04|||||1969-01-29||1962-07-10|U|1969-01-27
TRIAL STUDY 134XCP|LB|7F3C3801-607B-4141-AA83-383FDFFD7152|2||||GSTTH|GLUTATHIONE S-TRANSFERASE, THETA|||||||CCID 50/DOSE|||||||INDETERMINATE||10^6/EJACULATE U||||ABNORMAL|NOT DONE||||DERMAL TISSUE|NON-HEMOLYZED|U|DIFFUSION WEIGHTED MRI|GMI % FORMULA||NA|U|U|NA|||Y|3||39||TREATMENT|1970-12-08|1965-08-14|||||1964-12-08||1967-02-28|N|1968-05-25
TRIAL STUDY 134XCP|LB|7F3C3801-607B-4141-AA83-383FDFFD7152|1||||IAA5OHCR|5-HYDROXYINDOLEACETIC ACID/CREATININE|||||||UG/KG/H|||||||POSITIVE||MG/MIN||||ABNORMAL|NOT DONE||||ERYTHROCYTES|ICTERIC|NA|HPLC|MDRD FORMULA||U|Y|N|N|||Y|4||88||OPEN LABEL TREATMENT|1966-10-06|1965-08-10|||||1961-09-21||1970-05-26|N|1963-03-13
TRIAL STUDY 134XCP|LB|7F3C3801-607B-4141-AA83-383FDFFD7152|2||||FDP|FIBRIN DEGRADATION PRODUCTS|||||||U/G|||||||NEGATIVE||U/CL||||ABNORMAL|NOT DONE||||CORD BLOOD|GELLED|Y|ELECTRONEUROGRAPHY|COCKCROFT-GAULT FORMULA||N|Y|N|Y|||Y|4||88||WASHOUT|1960-05-06|1973-04-27|||||1963-01-18||1965-01-13|N|1967-03-28
TRIAL STUDY 134XCP|LB|7F3C3801-607B-4141-AA83-383FDFFD7152|1||||YEAST|YEAST CELLS|||||||DAMOL/L|||||||INDETERMINATE||MCI/L||||NORMAL|NOT DONE||||REFLEX TEAR|GELLED|N|QUANTITATIVE CORONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|Y|Y|||N|5||7||FOLLOW-UP|1970-02-21|1968-12-08|||||1964-01-04||1961-01-19|U|1973-01-15
TRIAL STUDY 134XCP|LB|7F3C3801-607B-4141-AA83-383FDFFD7152|2||||C165876|BIRCH POLLEN IGE AB RAST SCORE|||||||ELISA UNIT|||||||INDETERMINATE||CYCLE/MIN||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|PARAFFIN-EMBEDDED|Y|NO INFORMATION|HEPASCORE FORMULA||Y|N|U|Y|||U|5||7||OPEN LABEL TREATMENT|1968-07-01|1966-04-26|||||1966-02-15||1960-07-03|U|1967-11-09
TRIAL STUDY 134XCP|LB|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|1||||HOMOCY|HOMOCYSTEINE|||||||U/M2/DAY|||||||INDETERMINATE||UCI/KG||||HIGH|NOT DONE||||SALIVA|UNEXPECTED ODOR|U|RADIOGRAPHY|FIBROTEST FORMULA||NA|Y|Y|NA|||U|1||38||SCREENING|1973-08-17|1962-09-05|||||1967-08-09||1968-09-14|NA|1964-08-15
TRIAL STUDY 134XCP|LB|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|2||||IOTCLRBS|IOTHALAMATE CLEARANCE ADJUSTED FOR BSA|||||||DAYS|||||||TRACE||CIGARETTE||||HIGH|NOT DONE||||LOCHIA|DRIED|N|ULTRASONOGRAPHIC ELASTOGRAPHY|COCKCROFT-GAULT FORMULA||U|U|NA|NA|||Y|1||38||BLINDED TREATMENT|1968-11-14|1963-06-25|||||1972-01-15||1972-04-19|U|1971-02-16
TRIAL STUDY 134XCP|LB|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|1||||PLSPCE|PRECURSOR PLASMA CELLS|||||||DAMOL/L|||||||INDETERMINATE||U/KG/MIN||||ABNORMAL|NOT DONE||||URINE SEDIMENT|LACTESCENT|Y|NUCLEIC ACID HYBRIDIZATION|FIBROTEST FORMULA||U|Y|NA|U|||N|2||58||OBSERVATION|1973-06-17|1969-09-27|||||1960-02-15||1971-11-13|U|1968-06-09
TRIAL STUDY 134XCP|LB|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|2||||NACREAT|SODIUM/CREATININE|||||||ANTI-XA IU/ML|||||||POSITIVE||MG/DAY||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|FROZEN|U|AUSCULTATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|N|||NA|2||58||FOLLOW-UP|1967-02-01|1963-07-24|||||1969-01-12||1969-12-09|N|1968-11-01
TRIAL STUDY 134XCP|LB|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|1||||PHENYTN|PHENYTOIN|||||||COPIES/UL|||||||TRACE||APL U||||ABNORMAL|NOT DONE||||KERATINOCYTE|SOLIDIFIED|Y|QUANTITATIVE ULTRASOUND|MDRD 5 VARIABLE FORMULA||N|Y|U|NA|||N|3||39||TREATMENT|1972-04-15|1961-04-28|||||1971-05-22||1962-03-02|NA|1968-03-19
TRIAL STUDY 134XCP|LB|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|2||||OXALATE|OXALATE|||||||AMOL|||||||POSITIVE||MG/MIN||||ABNORMAL|NOT DONE||||TISSUE|FROZEN|NA|ELECTROGASTROGRAPHY|MDRD 5 VARIABLE FORMULA||U|NA|Y|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1965-06-08|1966-01-01|||||1964-08-04||1962-04-20|NA|1969-04-17
TRIAL STUDY 134XCP|LB|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|1||||AMPHET|AMPHETAMINE|||||||KBQ|||||||TRACE||G/DL||||HIGH|NOT DONE||||SEMEN|CONCENTRATED|NA|DIPSTICK|FIBROMETER FORMULA||NA|U|N|U|||Y|4||88||FOLLOW-UP|1973-01-04|1967-08-26|||||1970-11-30||1960-05-23|NA|1968-09-21
TRIAL STUDY 134XCP|LB|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|2||||MONOBL|MONOBLASTS|||||||IU/G|||||||POSITIVE||NKAT/G HB||||ABNORMAL|NOT DONE||||SKIN TISSUE|CLOTTED|Y|CONGO RED STAIN|MDRD 5 VARIABLE FORMULA||Y|NA|U|N|||U|4||88||SCREENING|1960-04-27|1967-06-20|||||1966-11-02||1963-11-20|Y|1968-02-17
TRIAL STUDY 134XCP|LB|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|1||||CH50|COMPLEMENT CH50|||||||POINT|||||||NEGATIVE||MG/KG/MIN||||NORMAL|NOT DONE||||LOCHIA|UNEXPECTED ODOR|U|FUNCTIONAL MRI|FIBROTEST FORMULA||Y|U|Y|Y|||Y|5||7||TREATMENT|1965-10-19|1967-05-05|||||1972-06-20||1969-06-28|N|1960-03-15
TRIAL STUDY 134XCP|LB|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|2||||GRANSGCE|GRANULOCYTES SEGMENTED/TOTAL CELLS|||||||L/H/M2|||||||INDETERMINATE||ML/KG/H||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|LIPEMIC|NA|TARGETED TRANSCRIPTOME SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|NA|U|N|||Y|5||7||BLINDED TREATMENT|1962-04-12|1969-08-11|||||1973-04-23||1968-12-18|U|1973-05-17
TRIAL STUDY 134XCP|LB|67025219-DBC0-4222-9D04-7F23EE3D5806|1||||SPERMMTL|SPERM MOTILITY|||||||GRAIN|||||||INVALID||G/U||||LOW|NOT DONE||||DERMAL TISSUE|UNEXPECTED ODOR|N|WESTERGREN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|N|||NA|1||38||RUN-IN|1961-08-18|1970-10-11|||||1961-01-31||1973-02-15|U|1960-09-19
TRIAL STUDY 134XCP|LB|67025219-DBC0-4222-9D04-7F23EE3D5806|2||||CLCTONN|CALCITONIN|||||||MGEQ|||||||POSITIVE||TUBERCULIN UNIT/ML||||HIGH|NOT DONE||||CORD BLOOD|THAWED|Y|DISK DIFFUSION|FIBROMETER FORMULA||NA|NA|U|Y|||U|1||38||RUN-IN|1966-08-12|1973-01-07|||||1965-04-13||1961-11-10|U|1966-01-18
TRIAL STUDY 134XCP|LB|67025219-DBC0-4222-9D04-7F23EE3D5806|1||||BLSTMKCE|MEGAKARYOBLASTS/TOTAL CELLS|||||||NMOL/G|||||||NEGATIVE||GRAIN||||HIGH|NOT DONE||||BONE|DRIED|Y|PET SCAN|CKD-EPI CREATININE FORMULA||N|N|N|N|||Y|2||58||FOLLOW-UP|1970-07-19|1963-11-08|||||1970-02-06||1967-02-01|N|1968-06-23
TRIAL STUDY 134XCP|LB|67025219-DBC0-4222-9D04-7F23EE3D5806|2||||HBA1CHGB|HEMOGLOBIN A1C/HEMOGLOBIN|||||||LX|||||||POSITIVE||UL/ML||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|PARAFFIN-EMBEDDED|U|GC/MS-CI|GMI % FORMULA||NA|Y|Y|N|||Y|2||58||LONG-TERM FOLLOW-UP|1972-06-15|1968-01-27|||||1963-10-15||1968-05-10|NA|1963-09-17
TRIAL STUDY 134XCP|LB|67025219-DBC0-4222-9D04-7F23EE3D5806|1||||RETIH|HIGH ABSORPTION RETICULOCYTES|||||||10^9/L|||||||INVALID||MG/ANIMAL||||LOW|NOT DONE||||VITREOUS HUMOR|FROZEN|N|MICROBIAL CULTURE, LIQUID|HEPASCORE FORMULA||U|NA|N|Y|||U|3||39||SCREENING|1964-11-03|1966-07-22|||||1961-04-16||1965-04-14|Y|1963-06-04
TRIAL STUDY 134XCP|LB|67025219-DBC0-4222-9D04-7F23EE3D5806|2||||C3M|COLLAGEN III NEO-PEPTIDE C3M|||||||HZ/S|||||||BORDERLINE||10^3 ORGANISMS/G||||HIGH|NOT DONE||||EXUDATE|CLOTTED|NA|COMPLEMENT FIXATION|MDRD 4 VARIABLE FORMULA||NA|U|N|N|||N|3||39||SCREENING|1962-04-02|1966-11-04|||||1972-11-26||1960-10-15|Y|1971-09-16
TRIAL STUDY 134XCP|LB|67025219-DBC0-4222-9D04-7F23EE3D5806|1||||VITD23OH|VITAMIN D2 D3 25-OH|||||||MMOL|||||||TRACE||ML/CM3/MIN||||NORMAL|NOT DONE||||LUNG SURFACTANT|FRESH|Y|ELECTROPHORESIS|FIBROSIS 4 FORMULA||N|N|Y|N|||Y|4||88||WASHOUT|1967-03-16|1961-11-02|||||1966-03-11||1968-03-22|N|1969-04-29
TRIAL STUDY 134XCP|LB|67025219-DBC0-4222-9D04-7F23EE3D5806|2||||VITECHOL|VITAMIN E/CHOLESTEROL|||||||DPM/0.5 ML|||||||POSITIVE||%(W/V)||||LOW|NOT DONE||||LUNG SURFACTANT|CLOTTED|Y|AURAMINE STAIN|COCKCROFT-GAULT FORMULA||U|U|U|U|||N|4||88||SCREENING|1962-09-19|1969-04-23|||||1969-08-12||1967-04-21|NA|1969-08-09
TRIAL STUDY 134XCP|LB|67025219-DBC0-4222-9D04-7F23EE3D5806|1||||DNAAB|ANTI-DNA ANTIBODIES|||||||NL|||||||BORDERLINE||MOL/L||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|CLOTTED|Y|MULTIPLE BREATH WASHOUT|CKD-EPI CYSTATIN C FORMULA||NA|N|Y|N|||Y|5||7||LONG-TERM FOLLOW-UP|1968-10-24|1964-06-08|||||1964-02-12||1970-08-29|Y|1961-01-31
TRIAL STUDY 134XCP|LB|67025219-DBC0-4222-9D04-7F23EE3D5806|2||||FABP3|FATTY ACID BINDING PROTEIN 3|||||||CMH2O*S/ML|||||||BORDERLINE||U/KG/H||||LOW|NOT DONE||||PLEURAL TISSUE|DRIED|Y|HILLMEN COLOR CHART|MDRD 4 VARIABLE FORMULA||U|NA|NA|NA|||N|5||7||OPEN LABEL TREATMENT|1965-08-08|1961-10-20|||||1966-12-29||1969-04-08|N|1966-09-12
TRIAL STUDY 134XCP|LB|A865B860-E5F2-423D-8110-58EBF7E470F3|1||||NEUTBNE|NEUTROPHILS BAND FORM/ NEUTROPHILS|||||||CAPLET|||||||BORDERLINE||U/G/H||||LOW|NOT DONE||||INFRANATANT, SERUM|UNEXPECTED ODOR|U|FLAME PHOTOMETRY|CKD-EPI CREATININE FORMULA||NA|U|NA|Y|||Y|1||38||FOLLOW-UP|1968-09-17|1967-09-18|||||1963-02-20||1967-01-09|Y|1967-05-19
TRIAL STUDY 134XCP|LB|A865B860-E5F2-423D-8110-58EBF7E470F3|2||||ICAM1|INTERCELLULAR ADHESION MOLECULE 1|||||||PPM|||||||INDETERMINATE||DPM||||NORMAL|NOT DONE||||TRANSUDATE|FROZEN|U|ULTRASOUND|MDRD ENZYMATIC FORMULA||Y|N|U|U|||Y|1||38||CONTINUATION TREATMENT|1966-04-02|1961-03-09|||||1965-07-31||1965-08-11|U|1964-08-27
TRIAL STUDY 134XCP|LB|A865B860-E5F2-423D-8110-58EBF7E470F3|1||||CREAT|CREATININE|||||||UL/ML|||||||TRACE||C||||LOW|NOT DONE||||SEMINAL FLUID|LIPEMIC|NA|MUGA|COCKCROFT-GAULT FORMULA||Y|N|N|NA|||U|2||58||RUN-IN|1968-12-24|1961-04-29|||||1961-04-25||1967-07-26|N|1964-02-24
TRIAL STUDY 134XCP|LB|A865B860-E5F2-423D-8110-58EBF7E470F3|2||||MACROBLD|MACROSCOPIC BLOOD|||||||MG/KG/WEEK|||||||TRACE||UG/G/DAY||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|CALCIFIED|U|FLAME PHOTOMETRY|CKD-EPI CYSTATIN C FORMULA||NA|Y|NA|NA|||NA|2||58||WASHOUT|1973-06-12|1969-10-29|||||1964-05-24||1970-09-04|N|1971-05-22
TRIAL STUDY 134XCP|LB|A865B860-E5F2-423D-8110-58EBF7E470F3|1||||OXZPM|OXAZEPAM|||||||USIEMENS|||||||BORDERLINE||MS2||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|FRESH|NA|CONGO RED STAIN|COCKCROFT-GAULT FORMULA||Y|N|U|Y|||N|3||39||FOLLOW-UP|1970-06-28|1966-12-08|||||1969-11-12||1961-12-11|NA|1964-10-16
TRIAL STUDY 134XCP|LB|A865B860-E5F2-423D-8110-58EBF7E470F3|2||||VITECHOL|VITAMIN E/CHOLESTEROL|||||||MG/KG/DAY|||||||INVALID||MM/SEC||||NORMAL|NOT DONE||||CERUMEN|FROZEN|NA|CALIPER MEASUREMENT METHOD|NASH FIBROSURE FORMULA||N|NA|N|U|||U|3||39||FOLLOW-UP|1968-05-03|1969-05-11|||||1967-07-09||1964-03-14|NA|1961-09-11
TRIAL STUDY 134XCP|LB|A865B860-E5F2-423D-8110-58EBF7E470F3|1||||VITECHOL|VITAMIN E/CHOLESTEROL|||||||SBE/ML|||||||INVALID||CARTRIDGE||||LOW|NOT DONE||||LYSATE|SOLIDIFIED|N|SURFACE PLASMON RESONANCE|MDRD FORMULA||N|N|U|Y|||U|4||88||LONG-TERM FOLLOW-UP|1971-03-03|1971-05-23|||||1965-08-29||1972-04-19|Y|1971-09-06
TRIAL STUDY 134XCP|LB|A865B860-E5F2-423D-8110-58EBF7E470F3|2||||AAMBTAC|ALPHA-AMINOBUTYRIC ACID|||||||U/M2/H|||||||NEGATIVE||DNA COPIES/UG||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|CALCIFIED|N|ULTRASONOGRAPHIC ELASTOGRAPHY|HEPASCORE FORMULA||NA|U|U|NA|||U|4||88||BASELINE|1969-08-22|1963-10-12|||||1971-01-05||1964-08-21|N|1965-06-28
TRIAL STUDY 134XCP|LB|A865B860-E5F2-423D-8110-58EBF7E470F3|1||||C130131|DOG DANDER ANTIGEN IGG4 ANTIBODY|||||||LX|||||||POSITIVE||MG2/DL2||||NORMAL|NOT DONE||||CAPILLARY PLASMA|HEMOLYZED|Y|STATIC PERIMETRY|FIBROMETER FORMULA||Y|N|U|NA|||N|5||7||OBSERVATION|1968-12-10|1964-06-29|||||1971-02-01||1972-05-20|U|1969-10-31
TRIAL STUDY 134XCP|LB|A865B860-E5F2-423D-8110-58EBF7E470F3|2||||PEPSNGI|PEPSINOGEN I|||||||SV|||||||BORDERLINE||G/G/DAY||||ABNORMAL|NOT DONE||||FLUID|ICTERIC|Y|CLIP SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|U|NA|||NA|5||7||BLINDED TREATMENT|1968-12-11|1964-08-22|||||1968-12-11||1965-12-01|N|1960-09-28
TRIAL STUDY 134XCP|LB|E78B2C0E-81D6-4898-B78A-FE136029AEA4|1||||GSTPIEXR|PI-GST EXCRETION RATE|||||||SACHET|||||||TRACE||U/KG/DAY||||ABNORMAL|NOT DONE||||CALCULUS|AGGLUTINATED|Y|ELECTROPHORESIS|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|N|NA|||N|1||38||BLINDED TREATMENT|1960-08-26|1964-03-06|||||1965-08-04||1966-11-26|Y|1967-09-22
TRIAL STUDY 134XCP|LB|E78B2C0E-81D6-4898-B78A-FE136029AEA4|2||||HRYCECE|HAIRY CELLS/TOTAL CELLS|||||||HPA|||||||BORDERLINE||G/MOL||||HIGH|NOT DONE||||PLEURAL TISSUE|DRIED|U|FLUORESCENT SPOT TEST|HEPASCORE FORMULA||Y|U|NA|Y|||Y|1||38||INDUCTION TREATMENT|1971-07-13|1961-01-19|||||1972-04-15||1968-07-21|U|1966-01-06
TRIAL STUDY 134XCP|LB|E78B2C0E-81D6-4898-B78A-FE136029AEA4|1||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||LOG10 CFU/ML|||||||TRACE||CFU/ML||||NORMAL|NOT DONE||||SERUM|LACTESCENT|U|ISHIHARA COLOR PLATES|HEPASCORE FORMULA||NA|NA|NA|N|||U|2||58||BLINDED TREATMENT|1967-12-21|1961-01-16|||||1968-09-16||1963-02-02|N|1967-04-14
TRIAL STUDY 134XCP|LB|E78B2C0E-81D6-4898-B78A-FE136029AEA4|2||||GLP1|GLUCAGON-LIKE PEPTIDE-1|||||||DPM|||||||INVALID||MBP||||HIGH|NOT DONE||||CALCULUS|ROOM TEMPERATURE|Y|ELECTRONEUROGRAPHY|CKD-EPI CREATININE FORMULA||U|NA|Y|U|||NA|2||58||BASELINE|1968-09-28|1969-08-07|||||1968-07-16||1967-08-09|Y|1966-09-09
TRIAL STUDY 134XCP|LB|E78B2C0E-81D6-4898-B78A-FE136029AEA4|1||||C165910|BEE MIX IGG AB RAST SCORE|||||||POUCH|||||||INDETERMINATE||GENEQ/ML||||ABNORMAL|NOT DONE||||VENOUS BLOOD|DRIED|U|ACRIDINE ORANGE STAIN|MDRD ENZYMATIC FORMULA||N|U|N|NA|||Y|3||39||BASELINE|1962-10-29|1963-04-14|||||1973-09-03||1962-12-29|Y|1971-12-29
TRIAL STUDY 134XCP|LB|E78B2C0E-81D6-4898-B78A-FE136029AEA4|2||||FRUCTOSE|FRUCTOSE|||||||TUBERCULIN UNIT|||||||INVALID||IU/KG/H||||HIGH|NOT DONE||||FLUID|FRESH|NA|DIGITAL PCR|MDRD 5 VARIABLE FORMULA||NA|N|N|N|||U|3||39||SCREENING|1971-09-12|1963-05-03|||||1969-01-30||1963-03-20|U|1965-07-18
TRIAL STUDY 134XCP|LB|E78B2C0E-81D6-4898-B78A-FE136029AEA4|1||||CARNTEXR|CARNITINE EXCRETION RATE|||||||BQ/UL|||||||POSITIVE||MMU/ML||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|FRESH|N|NEPHELOMETRY|FIBROSIS 4 FORMULA||U|N|Y|N|||NA|4||88||WASHOUT|1969-04-25|1963-06-11|||||1970-03-09||1969-05-08|Y|1972-11-01
TRIAL STUDY 134XCP|LB|E78B2C0E-81D6-4898-B78A-FE136029AEA4|2||||C130125|CAT DANDER ANTIGEN IGG ANTIBODY|||||||LOG10 PFU|||||||POSITIVE||MJOULE/CM2||||ABNORMAL|NOT DONE||||FLUID|NON-HEMOLYZED|N|MALDI-TOF|HEPASCORE FORMULA||NA|N|U|U|||NA|4||88||INDUCTION TREATMENT|1966-09-07|1962-03-08|||||1967-05-03||1968-07-14|U|1972-09-26
TRIAL STUDY 134XCP|LB|E78B2C0E-81D6-4898-B78A-FE136029AEA4|1||||TGFB2|TRANSFORMING GROWTH FACTOR BETA 2|||||||100 IU/ML|||||||INVALID||ENZYME U/G HB||||LOW|NOT DONE||||SWABBED MATERIAL|CLOTTED|U|TARGETED GENOME SEQUENCING|MDRD 4 VARIABLE FORMULA||U|NA|N|NA|||N|5||7||BLINDED TREATMENT|1969-11-15|1960-07-24|||||1972-02-20||1966-07-21|Y|1961-07-13
TRIAL STUDY 134XCP|LB|E78B2C0E-81D6-4898-B78A-FE136029AEA4|2||||OPG|OSTEOPROTEGERIN|||||||MANSON U/ML|||||||INDETERMINATE||BEAM BREAKS||||LOW|NOT DONE||||FLUID|FROZEN|Y|HPLC-FL|MDRD FORMULA||Y|U|Y|N|||Y|5||7||TREATMENT|1966-09-25|1963-08-28|||||1966-09-13||1971-10-24|Y|1960-09-30
TRIAL STUDY 134XCP|LB|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|1||||CAMP|CYCLIC ADENOSINE 3,5-MONOPHOSPHATE|||||||EVENTS|||||||TRACE||ML/BEAT||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|PARAFFIN-EMBEDDED|NA|BETA LACTAMASE|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|N|U|||N|1||38||FOLLOW-UP|1966-01-05|1971-08-08|||||1971-10-16||1970-02-07|Y|1973-07-21
TRIAL STUDY 134XCP|LB|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|2||||HBA1C|HEMOGLOBIN A1C|||||||NEWTON|||||||NEGATIVE||10^7 CFU/ML||||LOW|NOT DONE||||WHITE MATTER TISSUE|DRIED|U|POPULATION SEQUENCING|FIBROSIS 4 FORMULA||N|U|U|Y|||N|1||38||BLINDED TREATMENT|1961-04-13|1969-07-18|||||1973-08-14||1968-01-15|NA|1971-04-04
TRIAL STUDY 134XCP|LB|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|1||||VITE|VITAMIN E|||||||/200 HPFS|||||||INDETERMINATE||FT2||||HIGH|NOT DONE||||PERITONEAL FLUID|NON-HEMOLYZED|N|HEMOCYTOMETRY|ASH FIBROSURE FORMULA||Y|NA|N|U|||Y|2||58||INDUCTION TREATMENT|1968-03-19|1961-04-17|||||1972-02-29||1971-11-27|U|1961-10-31
TRIAL STUDY 134XCP|LB|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|2||||SH2D1A|SH2 DOMAIN CONTAINING 1A PROTEIN|||||||DEG2|||||||INVALID||NEBULE||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|HEMOLYZED|NA|GRADIENT DIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|U|NA|||N|2||58||FOLLOW-UP|1960-08-21|1961-04-12|||||1973-08-28||1969-03-05|U|1972-08-08
TRIAL STUDY 134XCP|LB|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|1||||GLP1|GLUCAGON-LIKE PEPTIDE-1|||||||G/U|||||||INDETERMINATE||PHERESIS UNIT||||HIGH|NOT DONE||||EMESIS|THAWED|NA|TWO-COLOR MICROARRAY|CKD-EPI CREATININE FORMULA||U|N|NA|N|||NA|3||39||RUN-IN|1963-09-16|1971-04-24|||||1972-11-23||1964-01-05|U|1969-07-28
TRIAL STUDY 134XCP|LB|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|2||||C130124|CAT DANDER ANTIGEN IGE ANTIBODY|||||||L/MIN/M2|||||||BORDERLINE||MEQ/MMOL||||NORMAL|NOT DONE||||BONE MARROW|NON-HEMOLYZED|U|OBSERVATION|MDRD 6 VARIABLE FORMULA||N|NA|NA|U|||N|3||39||BLINDED TREATMENT|1961-12-18|1969-05-27|||||1967-03-15||1964-09-03|U|1970-01-27
TRIAL STUDY 134XCP|LB|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|1||||VCAM1|VASCULAR CELL ADHESION MOLECULE 1|||||||PATCH|||||||TRACE||MMHG*MIN/L||||ABNORMAL|NOT DONE||||TRANSUDATE|CONCENTRATED|U|IN SITU HYBRIDIZATION|COCKCROFT-GAULT FORMULA||NA|U|U|Y|||U|4||88||LONG-TERM FOLLOW-UP|1965-09-21|1963-07-12|||||1967-05-07||1972-09-06|U|1960-01-20
TRIAL STUDY 134XCP|LB|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|2||||NEUTVAC|VACUOLATED NEUTROPHILS|||||||TITER|||||||INVALID||BP||||LOW|NOT DONE||||EMESIS|THAWED|NA|SLOAN LETTER EYE CHART 1.25%|MDRD FORMULA||NA|Y|Y|U|||U|4||88||INDUCTION TREATMENT|1971-05-02|1963-02-21|||||1966-02-24||1972-07-13|U|1969-05-14
TRIAL STUDY 134XCP|LB|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|1||||CD10|CD10|||||||U/MG|||||||BORDERLINE||PMOL/L||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|DRIED|Y|GC/MS-EI|GMI MMOL/MOL FORMULA||U|U|N|U|||NA|5||7||BLINDED TREATMENT|1969-05-06|1964-02-01|||||1961-10-01||1969-09-21|N|1967-05-26
TRIAL STUDY 134XCP|LB|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|2||||APOA|APOLIPOPROTEIN A|||||||CUP EQ|||||||INVALID||UV2||||HIGH|NOT DONE||||GASTRIC FLUID|LACTESCENT|NA|CONTACT SPECULAR MICROSCOPY|ASH FIBROSURE FORMULA||N|NA|N|U|||Y|5||7||FOLLOW-UP|1964-11-15|1972-12-22|||||1960-12-12||1971-07-29|Y|1966-10-10
TRIAL STUDY 134XCP|LB|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|1||||VEGFR2S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC2|||||||L/S/KPA|||||||NEGATIVE||G/G||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|FROZEN|NA|TRYPAN BLUE STAIN|FIBROSIS 4 FORMULA||N|NA|U|N|||Y|1||38||BASELINE|1966-12-07|1970-08-28|||||1966-12-07||1961-03-14|Y|1964-01-13
TRIAL STUDY 134XCP|LB|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|2||||EPITUCE|TUBULAR EPITHELIAL CELLS|||||||CD*S/M2|||||||NEGATIVE||UV||||HIGH|NOT DONE||||BONE|AGGLUTINATED|N|IMMUNOCHEMILUMINOMETRIC ASSAY|GMI MMOL/MOL FORMULA||U|U|Y|NA|||NA|1||38||FOLLOW-UP|1963-12-12|1970-12-19|||||1961-02-09||1971-08-10|NA|1966-06-30
TRIAL STUDY 134XCP|LB|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|1||||POIKILO|POIKILOCYTES|||||||/HPF|||||||INVALID||GBQ/G||||HIGH|NOT DONE||||NAIL|CONTAMINATED|NA|X-RAY FLUORESCENCE SPECTROMETRY|MDRD ENZYMATIC FORMULA||U|U|Y|N|||Y|2||58||BASELINE|1960-08-22|1963-06-19|||||1969-07-31||1968-07-30|U|1960-01-06
TRIAL STUDY 134XCP|LB|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|2||||PPI|INORGANIC PYROPHOSPHATE|||||||PM|||||||POSITIVE||KM/H||||LOW|NOT DONE||||SERUM|UNEXPECTED ODOR|NA|PERFUSION MRI|FIBROSIS 4 FORMULA||N|N|N|Y|||Y|2||58||FOLLOW-UP|1972-03-19|1968-05-30|||||1960-07-01||1969-02-04|U|1962-09-12
TRIAL STUDY 134XCP|LB|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|1||||C130069|BERMUDA GRASS POLLEN IGA|||||||AMOL|||||||TRACE||UMOL/KG/MIN||||ABNORMAL|NOT DONE||||ISOLATE|DRIED|Y|SPIROMETRY|ASH FIBROSURE FORMULA||NA|Y|NA|Y|||Y|3||39||BLINDED TREATMENT|1962-05-29|1960-09-12|||||1969-11-24||1961-05-27|NA|1967-02-13
TRIAL STUDY 134XCP|LB|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|2||||ASP|ASPARTIC ACID|||||||ENZYME U/M2|||||||BORDERLINE||NG/L||||ABNORMAL|NOT DONE||||STOOL|LACTESCENT|Y|KNEMOMETRY|FIBROMETER FORMULA||NA|N|NA|Y|||Y|3||39||CONTINUATION TREATMENT|1961-02-06|1970-12-04|||||1973-04-13||1969-01-08|Y|1973-04-06
TRIAL STUDY 134XCP|LB|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|1||||FAS|FAS CELL SURFACE DEATH RECEPTOR|||||||PSEC|||||||INDETERMINATE||DPM||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|FROZEN|U|HIGH RESOLUTION MELT ANALYSIS|GMI % FORMULA||NA|Y|NA|U|||U|4||88||CONTINUATION TREATMENT|1962-02-28|1961-12-21|||||1967-03-11||1961-01-09|N|1967-10-07
TRIAL STUDY 134XCP|LB|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|2||||ISOPRF2|F2-ISOPROSTANE|||||||MONTHS|||||||INVALID||10^7 TCID 50/DOSE||||NORMAL|NOT DONE||||ABSCESS FLUID|THAWED|NA|IMMUNOCHROMATOGRAPHY|HEPASCORE FORMULA||Y|NA|Y|NA|||NA|4||88||BLINDED TREATMENT|1966-10-10|1968-09-29|||||1970-05-05||1964-04-10|NA|1965-03-27
TRIAL STUDY 134XCP|LB|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|1||||COCAAOM|COCAINE AND/OR METABOLITES|||||||TRANSDUCING UNIT/ML|||||||POSITIVE||CIGAR||||ABNORMAL|NOT DONE||||SOFT TISSUE|LACTESCENT|N|MRI WITHOUT CONTRAST|MDRD 4 VARIABLE FORMULA||U|NA|N|Y|||NA|5||7||INDUCTION TREATMENT|1972-09-28|1967-06-24|||||1972-08-01||1969-09-01|Y|1962-06-03
TRIAL STUDY 134XCP|LB|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|2||||SERTRAL|SERTRALINE|||||||ML/CM|||||||NEGATIVE||KIU||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|FROZEN|NA|GC/MS-EI|CKD-EPI CYSTATIN C FORMULA||Y|Y|N|NA|||Y|5||7||OBSERVATION|1964-07-06|1966-03-20|||||1960-10-11||1968-10-25|Y|1961-11-28
TRIAL STUDY 134XCP|LB|55210E20-F6B9-446F-994D-2D9149E33BAF|1||||GLYHLACD|GLYCOCHOLIC ACID|||||||10^6 ORGANISMS/ML|||||||INVALID||INHALATION||||ABNORMAL|NOT DONE||||FLUID|LACTESCENT|NA|CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA||N|N|N|NA|||NA|1||38||SCREENING|1963-03-27|1968-09-26|||||1963-12-27||1962-11-14|U|1961-05-23
TRIAL STUDY 134XCP|LB|55210E20-F6B9-446F-994D-2D9149E33BAF|2||||C130102|TREE MIX POLLEN ANTIGEN IGG ANTIBODY|||||||PM|||||||INVALID||AFU||||ABNORMAL|NOT DONE||||LEUKOCYTE|GELLED|Y|RADIAL IMMUNODIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|U|NA|||U|1||38||BLINDED TREATMENT|1964-11-18|1972-09-12|||||1960-10-18||1962-12-17|Y|1963-04-28
TRIAL STUDY 134XCP|LB|55210E20-F6B9-446F-994D-2D9149E33BAF|1||||SPERM|SPERMATOZOA|||||||MESF|||||||POSITIVE||CYCLE/MIN||||HIGH|NOT DONE||||LYSATE|AGGLUTINATED|NA|SNELLEN EYE CHART|GMI % FORMULA||Y|N|N|Y|||U|2||58||RUN-IN|1960-11-14|1971-08-11|||||1963-10-07||1964-01-07|NA|1969-06-07
TRIAL STUDY 134XCP|LB|55210E20-F6B9-446F-994D-2D9149E33BAF|2||||MG|MAGNESIUM|||||||MAC50|||||||INDETERMINATE||MMOL2/L2||||HIGH|NOT DONE||||LOCHIA|LIPEMIC|NA|MECHANICAL CLOT DETECTION|FIBROSIS 4 FORMULA||Y|NA|Y|U|||Y|2||58||BASELINE|1966-09-17|1961-01-19|||||1961-11-08||1962-06-20|U|1966-04-12
TRIAL STUDY 134XCP|LB|55210E20-F6B9-446F-994D-2D9149E33BAF|1||||CHOLOH4B|4-BETA-HYDROXYCHOLESTEROL|||||||DEG/S|||||||TRACE||CAL||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|ROOM TEMPERATURE|NA|CRYOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|N|||NA|3||39||SCREENING|1970-04-13|1964-06-17|||||1970-01-06||1963-08-10|Y|1964-01-22
TRIAL STUDY 134XCP|LB|55210E20-F6B9-446F-994D-2D9149E33BAF|2||||PLATBIZ|BIZARRE PLATELETS|||||||UMOL|||||||TRACE||UG/G/DAY||||NORMAL|NOT DONE||||GASTRIC FLUID|LIPEMIC|N|BETA LACTAMASE|GMI % FORMULA||U|Y|Y|U|||N|3||39||CONTINUATION TREATMENT|1965-01-01|1969-11-05|||||1966-08-05||1973-02-05|NA|1960-05-24
TRIAL STUDY 134XCP|LB|55210E20-F6B9-446F-994D-2D9149E33BAF|1||||HCG|CHORIOGONADOTROPIN BETA|||||||GRAIN|||||||INVALID||MG/KG/H||||ABNORMAL|NOT DONE||||STOOL|FROZEN|NA|SISH|ASH FIBROSURE FORMULA||U|Y|Y|N|||U|4||88||TREATMENT|1970-04-30|1971-10-15|||||1967-06-08||1968-03-02|NA|1960-06-01
TRIAL STUDY 134XCP|LB|55210E20-F6B9-446F-994D-2D9149E33BAF|2||||MPOAB|MYELOPEROXIDASE ANTIBODY|||||||QUANTITY SUFFICIENT|||||||NEGATIVE||CD/M2||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|CLOTTED|U|NO INFORMATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|N|NA|||U|4||88||SCREENING|1970-10-15|1962-04-01|||||1960-12-05||1967-02-04|U|1965-11-27
TRIAL STUDY 134XCP|LB|55210E20-F6B9-446F-994D-2D9149E33BAF|1||||LDH1|LDH ISOENZYME 1|||||||RAD|||||||TRACE||MCI/L||||LOW|NOT DONE||||CERUMEN|THAWED|Y|FISH|GMI MMOL/MOL FORMULA||NA|NA|Y|NA|||NA|5||7||FOLLOW-UP|1962-03-29|1971-08-21|||||1971-09-01||1971-07-25|N|1967-03-29
TRIAL STUDY 134XCP|LB|55210E20-F6B9-446F-994D-2D9149E33BAF|2||||CRTRONE|CORTICOSTERONE|||||||KBQ|||||||POSITIVE||%(W/V)||||ABNORMAL|NOT DONE||||PUS|LACTESCENT|Y|RAJI CELL RIA|MDRD 5 VARIABLE FORMULA||NA|U|Y|U|||U|5||7||OPEN LABEL TREATMENT|1967-07-14|1967-05-13|||||1966-01-29||1961-09-30|N|1961-08-02
TRIAL STUDY 134XCP|LB|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|1||||PDGFAA|PLATELET DERIVED GROWTH FACTOR ISOFORMAA|||||||G/CAGE|||||||INVALID||LOG10 IU/ML||||HIGH|NOT DONE||||PLATELET POOR PLASMA|THAWED|NA|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA||Y|NA|N|N|||U|1||38||FOLLOW-UP|1965-01-22|1970-10-16|||||1965-09-30||1965-03-03|N|1961-01-12
TRIAL STUDY 134XCP|LB|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|2||||FACTIII|FACTOR III|||||||AFU|||||||BORDERLINE||UL||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|HEMOLYZED|Y|OPTICAL MAPPING|FIBROSIS 4 FORMULA||NA|NA|Y|Y|||U|1||38||OBSERVATION|1966-11-05|1965-07-09|||||1960-08-03||1963-09-11|Y|1966-01-06
TRIAL STUDY 134XCP|LB|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|1||||MDEA|3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE|||||||/MBP|||||||INDETERMINATE||UKAT/10^12 RBC||||LOW|NOT DONE||||BILE|DRIED|Y|TONOMETRY|FIBROTEST FORMULA||U|NA|Y|NA|||N|2||58||RUN-IN|1960-04-01|1967-03-02|||||1962-11-17||1972-03-16|Y|1965-09-23
TRIAL STUDY 134XCP|LB|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|2||||CKMM|CREATINE KINASE MM|||||||10^6 ORGANISMS/G|||||||NEGATIVE||AMOL||||NORMAL|NOT DONE||||ALVEOLAR AIR|FROZEN|U|CLAUSS METHOD|CKD-EPI CYSTATIN C FORMULA||N|U|NA|Y|||N|2||58||SCREENING|1966-08-19|1963-05-30|||||1962-10-29||1964-05-19|N|1964-10-16
TRIAL STUDY 134XCP|LB|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|1||||MMP9|MATRIX METALLOPROTEINASE 9|||||||MOL/ML|||||||BORDERLINE||PACK YEAR||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|LIPEMIC|Y|ANGIOGRAPHY|GMI MMOL/MOL FORMULA||U|N|Y|Y|||U|3||39||BLINDED TREATMENT|1967-09-27|1973-03-07|||||1963-01-22||1969-10-14|U|1968-07-30
TRIAL STUDY 134XCP|LB|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|2||||MYPCERPC|MYELOID/ERYTHROID RATIO|||||||NMOL BCE/MMOL|||||||INDETERMINATE||CY/CM||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|LIPEMIC|N|PERCUSSION|MDRD 5 VARIABLE FORMULA||U|Y|N|U|||Y|3||39||WASHOUT|1971-09-15|1965-07-11|||||1972-03-01||1961-01-01|U|1967-02-06
TRIAL STUDY 134XCP|LB|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|1||||TGLOBRR|THYROGLOBULIN RECOVERY RATE|||||||CM/MIN|||||||INDETERMINATE||JOULE||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|DRIED|Y|MANUAL CLOT DETECTION|ASH FIBROSURE FORMULA||U|U|NA|NA|||NA|4||88||TREATMENT|1969-03-22|1961-02-08|||||1962-01-28||1969-11-11|NA|1971-10-19
TRIAL STUDY 134XCP|LB|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|2||||SJSSAAB|SJOGRENS SS-A ANTIBODY|||||||VOXEL|||||||NEGATIVE||CD||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|UNEXPECTED ODOR|U|POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||U|N|NA|Y|||N|4||88||BASELINE|1965-05-06|1961-02-10|||||1970-10-25||1962-07-09|N|1967-04-12
TRIAL STUDY 134XCP|LB|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|1||||IL18EXR|INTERLEUKIN 18 EXCRETION RATE|||||||PG/CELL|||||||BORDERLINE||IU/DAY||||NORMAL|NOT DONE||||LUNG SURFACTANT|CONTAMINATED|NA|PLETHYSMOGRAPHY|MDRD ENZYMATIC FORMULA||U|Y|U|Y|||N|5||7||TREATMENT|1968-10-11|1969-06-25|||||1960-07-26||1962-01-03|Y|1960-04-07
TRIAL STUDY 134XCP|LB|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|2||||CHRMTNAB|CHROMATIN ANTIBODIES|||||||DNA COPIES/ML|||||||NEGATIVE||MIN/DAY||||NORMAL|NOT DONE||||LYSATE|LACTESCENT|N|CLINICAL EVALUATION|FIBROTEST FORMULA||U|NA|U|Y|||N|5||7||BASELINE|1969-11-25|1973-02-18|||||1963-02-05||1960-01-17|NA|1966-07-17
TRIAL STUDY 134XCP|LB|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|1||||IMMGLC|IMMUNOGLOBULIN LIGHT CHAINS|||||||/7.5 ML|||||||INVALID||L/MIN||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|REFRIGERATED|Y|CT SCAN WITHOUT CONTRAST|COCKCROFT-GAULT FORMULA||Y|NA|U|Y|||NA|1||38||FOLLOW-UP|1962-08-09|1973-02-02|||||1963-07-31||1963-06-01|N|1964-10-04
TRIAL STUDY 134XCP|LB|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|2||||FLUDOUTE|FLUID OUTPUT, ESTIMATED|||||||DL|||||||NEGATIVE||AG||||LOW|NOT DONE||||PLEURAL TISSUE|REFRIGERATED|NA|TARGETED TRANSCRIPTOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|N|N|||U|1||38||WASHOUT|1965-04-23|1970-10-01|||||1969-05-12||1960-08-20|N|1969-06-29
TRIAL STUDY 134XCP|LB|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|1||||C130083|ORCHARD GRASS POLLEN IGG4|||||||SACHET|||||||INDETERMINATE||UG/MOL||||HIGH|NOT DONE||||CAPILLARY PLASMA|SOLIDIFIED|N|MICRO BROTH DILUTION|MDRD 5 VARIABLE FORMULA||U|NA|NA|N|||NA|2||58||RUN-IN|1962-07-27|1973-03-03|||||1966-05-09||1965-11-02|U|1964-02-14
TRIAL STUDY 134XCP|LB|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|2||||C130120|SHELLFISH MIX ANTIGEN IGE ANTIBODY|||||||AMOL|||||||POSITIVE||ML/CAGE/DAY||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|HEMOLYZED|Y|CT SCAN|GMI % FORMULA||Y|U|Y|N|||N|2||58||OBSERVATION|1967-08-15|1960-01-03|||||1960-04-03||1962-04-04|U|1962-01-06
TRIAL STUDY 134XCP|LB|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|1||||BASOCE|BASOPHILS/TOTAL CELLS|||||||10^5/L|||||||POSITIVE||UG/DOSE||||LOW|NOT DONE||||EMOTIONAL TEAR|AGGLUTINATED|U|OPTICAL DENSITY MEASUREMENT|MDRD FORMULA||U|NA|Y|NA|||N|3||39||TREATMENT|1965-04-03|1961-03-02|||||1961-06-13||1965-11-20|U|1962-02-07
TRIAL STUDY 134XCP|LB|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|2||||GLP1AC|GLUCAGON-LIKE PEPTIDE-1, ACTIVE FORM|||||||ML/MIN/1.73M2|||||||POSITIVE||10^9 ORGANISMS/MG||||LOW|NOT DONE||||COLOSTRUM|REFRIGERATED|N|HEMOCYTOMETRY|MDRD FORMULA||Y|U|N|NA|||N|3||39||WASHOUT|1969-12-16|1971-08-08|||||1970-09-22||1966-06-06|NA|1963-07-05
TRIAL STUDY 134XCP|LB|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|1||||ARR|ALDOSTERONE/RENIN ACTIVITY|||||||FMOL/G|||||||POSITIVE||GY/MIN||||HIGH|NOT DONE||||MENSTRUAL BLOOD|CONCENTRATED|U|INCISION-INDUCED BLEEDING METHOD|MDRD ENZYMATIC FORMULA||Y|Y|NA|N|||N|4||88||FOLLOW-UP|1970-01-28|1963-03-21|||||1963-07-04||1962-11-06|NA|1967-04-17
TRIAL STUDY 134XCP|LB|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|2||||NEUTSG|NEUTROPHILS, SEGMENTED|||||||1/(S*KPA)|||||||TRACE||UG/ANIMAL||||HIGH|NOT DONE||||NAIL|CALCIFIED|U|DISK DIFFUSION|FIBROSIS 4 FORMULA||NA|U|NA|U|||N|4||88||SCREENING|1961-04-18|1966-08-21|||||1963-12-04||1968-11-20|U|1967-05-01
TRIAL STUDY 134XCP|LB|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|1||||RANKL|RECEPTOR ACTIVATOR NUCLEAR KAPPAB LIGAND|||||||BAU/ML|||||||TRACE||LX||||NORMAL|NOT DONE||||PLEURAL FLUID|LIPEMIC|N|SINGLE-MOLECULE ARRAY|MDRD ENZYMATIC FORMULA||N|NA|U|U|||U|5||7||BLINDED TREATMENT|1971-12-03|1961-02-16|||||1961-05-30||1971-04-24|N|1970-01-03
TRIAL STUDY 134XCP|LB|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|2||||UNSPCECE|UNSPECIFIED CELLS/TOTAL CELLS|||||||UG/MIN|||||||TRACE||BU||||NORMAL|NOT DONE||||FLUID|SOLIDIFIED|NA|HPLC/IEX|MDRD 5 VARIABLE FORMULA||NA|Y|U|N|||Y|5||7||OBSERVATION|1971-07-21|1972-02-05|||||1965-09-24||1969-01-21|N|1967-11-20
TRIAL STUDY 134XCP|LB|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|1||||CYSTARCH|STARCH CRYSTALS|||||||BP|||||||POSITIVE||ML/CM3/MIN||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED|N|CAPILLARY ELECTROPHORESIS|GMI MMOL/MOL FORMULA||Y|U|NA|U|||U|1||38||WASHOUT|1965-08-25|1967-03-08|||||1973-05-23||1960-03-27|NA|1963-07-28
TRIAL STUDY 134XCP|LB|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|2||||GHB|GAMMA-HYDROXYBUTYRATE|||||||CMOL/L|||||||INDETERMINATE||UM2||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|HEMOLYZED|N|CHROMOGENIC ASSAY|NASH FIBROSURE FORMULA||U|N|N|U|||N|1||38||RUN-IN|1961-12-31|1965-10-21|||||1963-07-31||1964-08-14|U|1970-01-10
TRIAL STUDY 134XCP|LB|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|1||||NAGASE|N-ACETYL-BETA-D-GLUCOSAMINIDASE|||||||PA|||||||NEGATIVE||MMHG||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED|U|THERMAL IONIZATION MASS SPECTROMETRY|COCKCROFT-GAULT FORMULA||U|N|NA|NA|||Y|2||58||BLINDED TREATMENT|1964-07-03|1964-06-25|||||1972-11-03||1962-03-30|U|1968-06-02
TRIAL STUDY 134XCP|LB|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|2||||GLUCCLR|GLUCOSE CLEARANCE|||||||PM|||||||BORDERLINE||CM2||||LOW|NOT DONE||||DERMAL TISSUE|ROOM TEMPERATURE|U|RADIAL IMMUNODIFFUSION|GMI % FORMULA||NA|Y|N|N|||N|2||58||BASELINE|1970-05-24|1972-11-29|||||1966-12-08||1969-01-30|Y|1964-02-17
TRIAL STUDY 134XCP|LB|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|1||||LIPID|LIPID|||||||ELISA UNIT/DOSE|||||||TRACE||FRAMES/S||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|THAWED|U|OSCILLOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|Y|Y|||NA|3||39||RUN-IN|1968-12-27|1970-02-16|||||1967-10-06||1970-02-12|N|1969-02-17
TRIAL STUDY 134XCP|LB|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|2||||C130094|WESTERN RAGWEED POLLEN IGG|||||||KIU|||||||BORDERLINE||PIXELS/IN||||NORMAL|NOT DONE||||VENOUS BLOOD|SOLIDIFIED|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD 4 VARIABLE FORMULA||Y|N|U|U|||NA|3||39||WASHOUT|1961-03-18|1971-11-02|||||1972-07-06||1970-10-15|U|1964-06-25
TRIAL STUDY 134XCP|LB|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|1||||GRANIM|IMMATURE GRANULOCYTES|||||||U.CARR|||||||INVALID||/H||||HIGH|NOT DONE||||BILE|AGGLUTINATED|Y|PHOROPTER|NASH FIBROSURE FORMULA||U|N|NA|Y|||Y|4||88||OPEN LABEL TREATMENT|1968-07-04|1961-09-02|||||1971-03-17||1973-04-13|N|1963-05-18
TRIAL STUDY 134XCP|LB|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|2||||ALBGALB|GLYCATED ALBUMIN/ALBUMIN|||||||KALLIKREIN INHIBITOR UNIT|||||||INDETERMINATE||COPIES/ML||||LOW|NOT DONE||||HAIR FOLLICLE|ROOM TEMPERATURE|Y|ULTRASOUND|COCKCROFT-GAULT FORMULA||U|U|Y|U|||NA|4||88||RUN-IN|1964-01-23|1972-06-03|||||1965-03-23||1973-03-26|Y|1969-02-23
TRIAL STUDY 134XCP|LB|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|1||||COCAM|COCAINE METABOLITES|||||||NMOL/L/H|||||||TRACE||UMOL/MG/MIN||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|LIPEMIC|NA|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA||Y|Y|U|U|||NA|5||7||INDUCTION TREATMENT|1961-11-18|1970-04-27|||||1967-01-12||1970-11-13|N|1969-12-26
TRIAL STUDY 134XCP|LB|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|2||||GLOBB|BETA GLOBULIN|||||||BLOCKS|||||||TRACE||HR/DAY||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|SOLIDIFIED|N|TEST STRIP|MDRD ENZYMATIC FORMULA||NA|U|Y|Y|||N|5||7||BLINDED TREATMENT|1964-09-24|1961-10-23|||||1963-04-04||1970-03-30|Y|1963-12-10
TRIAL STUDY 134XCP|LB|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|1||||FIXAAC|FACTOR IX ACTIVITY ACTUAL/CONTROL|||||||NL|||||||INDETERMINATE||PUFF||||LOW|NOT DONE||||CEREBROSPINAL FLUID|LIPEMIC|N|CLIP|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|NA|U|||N|1||38||FOLLOW-UP|1962-01-20|1970-09-22|||||1965-06-17||1971-01-14|NA|1965-10-21
TRIAL STUDY 134XCP|LB|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|2||||KRCYMG|MEGAKARYOCYTES|||||||PKAT/L|||||||BORDERLINE||10^6 COPIES/ML||||NORMAL|NOT DONE||||DERMAL TISSUE|ROOM TEMPERATURE|U|IMMUNORADIOMETRIC ASSAY|ASH FIBROSURE FORMULA||U|U|N|U|||N|1||38||OPEN LABEL TREATMENT|1966-11-03|1967-03-31|||||1972-07-24||1973-01-31|Y|1972-06-08
TRIAL STUDY 134XCP|LB|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|1||||NPAP|NON-PROSTATIC ACID PHOSPHATASE|||||||IU/DL|||||||INVALID||/MS||||HIGH|NOT DONE||||CALCULUS|SOLIDIFIED|N|EPSILOMETER|MDRD 6 VARIABLE FORMULA||NA|Y|N|U|||U|2||58||TREATMENT|1972-11-09|1971-10-01|||||1962-04-26||1972-05-18|NA|1966-01-28
TRIAL STUDY 134XCP|LB|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|2||||INTLK4|INTERLEUKIN 4|||||||ML/M2/DAY|||||||INDETERMINATE||EU||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|NON-HEMOLYZED|NA|PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE FORMULA||N|NA|N|N|||N|2||58||RUN-IN|1963-01-10|1966-04-14|||||1961-09-03||1967-04-10|N|1963-01-03
TRIAL STUDY 134XCP|LB|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|1||||AST|ASPARTATE AMINOTRANSFERASE|||||||APS U|||||||TRACE||MAC50||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|ROOM TEMPERATURE|U|FLUORESCENT LIFETIME IMAGING MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|NA|||U|3||39||INDUCTION TREATMENT|1973-07-31|1973-03-14|||||1967-02-26||1964-03-29|N|1969-03-24
TRIAL STUDY 134XCP|LB|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|2||||PRABC|CALCULATED PANEL REACTIVE ANTIBODY|||||||PHERESIS UNIT|||||||BORDERLINE||ML/KG||||HIGH|NOT DONE||||SEMINAL FLUID|UNEXPECTED ODOR|U|MUGA|HEPASCORE FORMULA||U|N|U|Y|||NA|3||39||CONTINUATION TREATMENT|1962-01-15|1970-06-11|||||1962-01-09||1973-01-14|Y|1970-07-31
TRIAL STUDY 134XCP|LB|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|1||||NTRLFAT|NEUTRAL FATS|||||||KIT|||||||BORDERLINE||ANTI-XA IU||||NORMAL|NOT DONE||||PUS|ICTERIC|U|ATOMIC ABSORPTION SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA||U|Y|U|U|||N|4||88||SCREENING|1966-05-26|1969-10-20|||||1966-06-05||1964-02-17|NA|1964-03-10
TRIAL STUDY 134XCP|LB|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|2||||FAT|FAT|||||||YEARS|||||||INDETERMINATE||UMOL/KG/MIN||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CALCIFIED|U|EEG|FIBROTEST FORMULA||Y|U|Y|U|||Y|4||88||RUN-IN|1969-04-05|1970-09-19|||||1972-06-08||1965-10-29|U|1967-04-30
TRIAL STUDY 134XCP|LB|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|1||||SDMA|SYMMETRIC DIMETHYLARGININE|||||||DPM/100MG|||||||BORDERLINE||MHZ||||NORMAL|NOT DONE||||SEBUM|PARAFFIN-EMBEDDED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD 4 VARIABLE FORMULA||Y|NA|NA|NA|||N|5||7||LONG-TERM FOLLOW-UP|1961-05-21|1962-08-13|||||1967-10-02||1964-03-25|N|1963-10-12
TRIAL STUDY 134XCP|LB|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|2||||ANP|ATRIAL NATRIURETIC PEPTIDE|||||||10^3 ORGANISMS|||||||INDETERMINATE||ML/S/M2||||LOW|NOT DONE||||URINE|ICTERIC|Y|AUTOREFRACTION|MDRD 6 VARIABLE FORMULA||NA|NA|U|U|||NA|5||7||OPEN LABEL TREATMENT|1960-09-26|1962-09-25|||||1973-03-24||1964-05-22|N|1963-10-03
TRIAL STUDY 134XCP|LB|CAD0ED37-954A-4935-8A7E-589EC108E141|1||||CD4CD8|CD4/CD8|||||||CONTAINER|||||||TRACE||MG/KG/DOSE||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|PARAFFIN-EMBEDDED|N|CLINICAL EVALUATION|FIBROMETER FORMULA||NA|Y|Y|U|||U|1||38||RUN-IN|1968-12-15|1972-07-09|||||1970-11-12||1963-04-28|NA|1960-02-09
TRIAL STUDY 134XCP|LB|CAD0ED37-954A-4935-8A7E-589EC108E141|2||||CD10|CD10|||||||HOUNSFIELD UNIT|||||||POSITIVE||P||||ABNORMAL|NOT DONE||||MECONIUM|DRIED|Y|FREEZING POINT DEPRESSION|CKD-EPI CREATININE FORMULA||NA|Y|U|NA|||N|1||38||WASHOUT|1967-12-26|1969-10-14|||||1971-06-22||1966-04-01|N|1964-02-27
TRIAL STUDY 134XCP|LB|CAD0ED37-954A-4935-8A7E-589EC108E141|1||||NEUTNSQE|NEUTROPHILS/NON-SQUAM EPI CELLS|||||||CM/MIN|||||||INDETERMINATE||U/10^12 RBC||||LOW|NOT DONE||||BILE|LACTESCENT|NA|ELASTOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|NA|Y|N|||Y|2||58||BLINDED TREATMENT|1971-07-16|1964-10-20|||||1970-12-20||1967-11-03|N|1960-10-21
TRIAL STUDY 134XCP|LB|CAD0ED37-954A-4935-8A7E-589EC108E141|2||||B2MICG|BETA-2 MICROGLOBULIN|||||||U/ANIMAL|||||||POSITIVE||CIGAR||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|Y|||Y|2||58||BASELINE|1960-06-01|1966-08-13|||||1970-01-15||1960-02-05|U|1963-02-24
TRIAL STUDY 134XCP|LB|CAD0ED37-954A-4935-8A7E-589EC108E141|1||||ACPHOS|ACID PHOSPHATASE|||||||CIGARETTE|||||||BORDERLINE||UG/H||||NORMAL|NOT DONE||||DERMAL TISSUE|CLOTTED|Y|SMEAR|GMI MMOL/MOL FORMULA||N|NA|NA|N|||N|3||39||SCREENING|1972-12-02|1963-07-01|||||1971-05-27||1960-01-24|Y|1964-07-20
TRIAL STUDY 134XCP|LB|CAD0ED37-954A-4935-8A7E-589EC108E141|2||||ETP|ENDOGENOUS THROMBIN POTENTIAL|||||||/MM|||||||POSITIVE||10^3 ORGANISMS/G||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|DRIED|Y|PHOTOGRAPHY|FIBROTEST FORMULA||NA|Y|U|U|||Y|3||39||LONG-TERM FOLLOW-UP|1964-01-01|1964-09-19|||||1969-11-02||1961-03-31|U|1967-12-10
TRIAL STUDY 134XCP|LB|CAD0ED37-954A-4935-8A7E-589EC108E141|1||||FACTXIIA|FACTOR XII ACTIVITY|||||||ABSORBANCE U|||||||INDETERMINATE||MU||||LOW|NOT DONE||||SMEGMA|UNEXPECTED ODOR|NA|SLIT LAMP PHOTOGRAPHY|MDRD ENZYMATIC FORMULA||U|NA|NA|NA|||U|4||88||WASHOUT|1964-06-21|1960-04-08|||||1960-06-12||1971-06-03|U|1970-01-14
TRIAL STUDY 134XCP|LB|CAD0ED37-954A-4935-8A7E-589EC108E141|2||||INTLK8|INTERLEUKIN 8|||||||IU/DL|||||||POSITIVE||U/KG/H||||ABNORMAL|NOT DONE||||LEUKOCYTE|DRIED|Y|CONFOCAL MICROSCOPY|NASH FIBROSURE FORMULA||U|U|U|NA|||U|4||88||RUN-IN|1970-01-23|1967-04-14|||||1970-06-17||1966-04-21|U|1966-01-28
TRIAL STUDY 134XCP|LB|CAD0ED37-954A-4935-8A7E-589EC108E141|1||||PTA|PROTHROMBIN ACTIVITY|||||||ML/DOSE|||||||INDETERMINATE||CMOL/L||||LOW|NOT DONE||||INFRANATANT, SERUM|HEMOLYZED|NA|WESTERGREN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|NA|N|||NA|5||7||OPEN LABEL TREATMENT|1966-01-17|1971-02-16|||||1968-04-16||1961-09-25|U|1962-10-25
TRIAL STUDY 134XCP|LB|CAD0ED37-954A-4935-8A7E-589EC108E141|2||||DRUGSCR|DRUG SCREEN|||||||MG/H|||||||TRACE||LB||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|NON-HEMOLYZED|U|CELLULOSE TAPE|FIBROSIS 4 FORMULA||U|U|NA|Y|||U|5||7||INDUCTION TREATMENT|1965-01-20|1968-04-18|||||1961-03-09||1961-09-30|U|1969-10-10
TRIAL STUDY 134XCP|LB|BC9A31E2-100C-4AC3-8910-A04309854590|1||||FATACVLC|FATTY ACIDS, VERY LONG CHAIN|||||||10^6 ORGANISMS|||||||TRACE||PA||||ABNORMAL|NOT DONE||||CALCULUS|ROOM TEMPERATURE|Y|TRYPAN BLUE STAIN|CKD-EPI CREATININE FORMULA||N|U|Y|N|||Y|1||38||OBSERVATION|1972-02-01|1965-02-07|||||1970-09-23||1971-06-19|NA|1970-12-29
TRIAL STUDY 134XCP|LB|BC9A31E2-100C-4AC3-8910-A04309854590|2||||PAI1AG|PLASMINOGEN ACTIVATOR INHIBITOR-1 AG|||||||DPM|||||||TRACE||10^4 CFU||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|THAWED|N|PERCUSSION|FIBROSIS 4 FORMULA||U|Y|Y|NA|||NA|1||38||LONG-TERM FOLLOW-UP|1962-04-19|1961-08-30|||||1967-08-22||1966-02-21|NA|1967-11-18
TRIAL STUDY 134XCP|LB|BC9A31E2-100C-4AC3-8910-A04309854590|1||||APOE|APOLIPOPROTEIN E|||||||CYLINDER|||||||INVALID||MMOL/KG||||ABNORMAL|NOT DONE||||ISOLATE|FROZEN|NA|SECONDARY ION MASS SPECTOMETRY|GMI % FORMULA||N|N|N|N|||U|2||58||SCREENING|1965-08-05|1967-02-21|||||1961-03-03||1965-01-01|U|1973-05-24
TRIAL STUDY 134XCP|LB|BC9A31E2-100C-4AC3-8910-A04309854590|2||||ACYLCAOX|ACYL COENZYME A OXIDASE|||||||DAYS|||||||NEGATIVE||MKAT||||HIGH|NOT DONE||||GASTRIC CONTENTS|CALCIFIED|Y|CRYOSCOPY|GMI MMOL/MOL FORMULA||Y|N|U|N|||Y|2||58||INDUCTION TREATMENT|1969-05-15|1964-09-30|||||1973-08-19||1962-11-29|U|1962-09-24
TRIAL STUDY 134XCP|LB|BC9A31E2-100C-4AC3-8910-A04309854590|1||||CRDIGGAB|CARDIOLIPIN IGG ANTIBODY|||||||ECL UNIT|||||||INDETERMINATE||10^3/L||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|CONCENTRATED|U|CONTRAST ENHANCED MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|N|NA|||U|3||39||TREATMENT|1973-01-31|1970-01-15|||||1963-08-09||1964-10-24|U|1971-09-28
TRIAL STUDY 134XCP|LB|BC9A31E2-100C-4AC3-8910-A04309854590|2||||RPTLAAC|REPTILASE ACTIVITY ACTUAL/CONTROL|||||||U/KG|||||||POSITIVE||FOZ_US||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|UNEXPECTED ODOR|Y|MUGA|CKD-EPI CYSTATIN C FORMULA||Y|Y|N|Y|||NA|3||39||FOLLOW-UP|1969-06-04|1967-02-17|||||1966-08-26||1970-12-21|N|1968-11-14
TRIAL STUDY 134XCP|LB|BC9A31E2-100C-4AC3-8910-A04309854590|1||||CANNAB|CANNABINOIDS|||||||UV*SEC|||||||NEGATIVE||UMOL||||NORMAL|NOT DONE||||HAIR|SOLIDIFIED|NA|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD FORMULA||NA|Y|N|U|||N|4||88||CONTINUATION TREATMENT|1971-08-31|1968-04-21|||||1963-12-08||1965-02-16|U|1968-11-26
TRIAL STUDY 134XCP|LB|BC9A31E2-100C-4AC3-8910-A04309854590|2||||IDL|IDL CHOLESTEROL|||||||VIRTUAL PIXEL|||||||POSITIVE||ANTI-XA IU||||NORMAL|NOT DONE||||BONE|FRESH|N|FARNSWORTH-MUNSELL 100 HUE TEST|FIBROSIS 4 FORMULA||U|N|N|NA|||Y|4||88||BLINDED TREATMENT|1967-05-03|1965-05-11|||||1963-04-06||1965-04-26|U|1964-02-18
TRIAL STUDY 134XCP|LB|BC9A31E2-100C-4AC3-8910-A04309854590|1||||HSP90A|HEAT SHOCK PROTEIN 90 ALPHA|||||||MHZ|||||||BORDERLINE||LOG10 TCID 50/UL||||HIGH|NOT DONE||||NAIL|FRESH|U|HPLC/MS/MS|FIBROSIS 4 FORMULA||U|U|Y|N|||U|5||7||OPEN LABEL TREATMENT|1962-06-29|1971-06-29|||||1962-07-01||1964-02-07|NA|1965-05-12
TRIAL STUDY 134XCP|LB|BC9A31E2-100C-4AC3-8910-A04309854590|2||||DDX58|DEAD BOX PROTEIN 58|||||||V/V|||||||POSITIVE||MBQ/UL||||HIGH|NOT DONE||||STOOL|FRESH|Y|IODINE STAIN|CKD-EPI CYSTATIN C FORMULA||NA|U|N|Y|||N|5||7||CONTINUATION TREATMENT|1966-05-02|1965-01-22|||||1966-06-30||1966-04-15|N|1967-07-23
TRIAL STUDY 134XCP|LB|13A424BB-CC85-41EC-BDED-165A29532DFF|1||||NTXII|TYPE II COLLAGEN N-TELOPEPTIDES|||||||LOG10 PFU|||||||INVALID||ELISA UNIT/ML||||LOW|NOT DONE||||SWABBED MATERIAL|FROZEN|Y|GC/MS-CI|MDRD 6 VARIABLE FORMULA||Y|U|N|Y|||NA|1||38||RUN-IN|1967-08-31|1971-05-20|||||1972-03-30||1966-12-23|U|1960-10-18
TRIAL STUDY 134XCP|LB|13A424BB-CC85-41EC-BDED-165A29532DFF|2||||MIP1A|MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA|||||||BQ/KG|||||||POSITIVE||G/CAGE/WK||||ABNORMAL|NOT DONE||||RETICULOCYTES|AGGLUTINATED|NA|GC/MS/MS|NASH FIBROSURE FORMULA||NA|U|NA|Y|||Y|1||38||BLINDED TREATMENT|1969-12-27|1968-07-15|||||1961-11-27||1971-05-21|Y|1970-11-23
TRIAL STUDY 134XCP|LB|13A424BB-CC85-41EC-BDED-165A29532DFF|1||||HSP90A|HEAT SHOCK PROTEIN 90 ALPHA|||||||MG/KG/WEEK|||||||TRACE||PG/CELL||||HIGH|NOT DONE||||LYMPH|CLOTTED|U|IRON HEMATOXYLIN STAIN|FIBROMETER FORMULA||NA|NA|Y|NA|||U|2||58||CONTINUATION TREATMENT|1964-12-18|1964-11-18|||||1962-09-20||1960-05-02|U|1973-07-27
TRIAL STUDY 134XCP|LB|13A424BB-CC85-41EC-BDED-165A29532DFF|2||||ALBCREAT|ALBUMIN/CREATININE|||||||MESF|||||||TRACE||ELISA UNIT||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|N|MULTIPLE BREATH WASHOUT|FIBROTEST FORMULA||Y|U|U|Y|||N|2||58||CONTINUATION TREATMENT|1961-05-09|1970-03-10|||||1964-09-15||1964-07-28|U|1965-03-21
TRIAL STUDY 134XCP|LB|13A424BB-CC85-41EC-BDED-165A29532DFF|1||||C147281|EGG WHITE ANTIGEN IGE ANTIBODY|||||||BAG|||||||BORDERLINE||MG/M2/DAY||||LOW|NOT DONE||||EXUDATE|NON-HEMOLYZED|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|HEPASCORE FORMULA||N|NA|Y|NA|||NA|3||39||OPEN LABEL TREATMENT|1966-08-28|1971-11-19|||||1966-08-28||1964-10-09|NA|1969-08-28
TRIAL STUDY 134XCP|LB|13A424BB-CC85-41EC-BDED-165A29532DFF|2||||TRIGHDL|TRIGLYCERIDES/HDL CHOLESTEROL|||||||MONTHS|||||||BORDERLINE||10^7 CFU/ML||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|CONTAMINATED|NA|ETDRS EYE CHART|MDRD 5 VARIABLE FORMULA||NA|NA|U|U|||NA|3||39||OBSERVATION|1973-05-20|1964-07-30|||||1963-02-11||1966-09-15|N|1967-08-09
TRIAL STUDY 134XCP|LB|13A424BB-CC85-41EC-BDED-165A29532DFF|1||||MYCEPPOL|MYELOID PROLIFERATION POOL|||||||/MIN|||||||INVALID||NMOL/MOL||||NORMAL|NOT DONE||||LUNG SURFACTANT|CONCENTRATED|Y|IMPEDANCE CONDUCTIVITY|FIBROSIS 4 FORMULA||U|Y|U|Y|||Y|4||88||BASELINE|1971-07-16|1970-11-17|||||1967-08-31||1962-09-02|Y|1964-12-10
TRIAL STUDY 134XCP|LB|13A424BB-CC85-41EC-BDED-165A29532DFF|2||||INTLK8|INTERLEUKIN 8|||||||MEQ|||||||INVALID||10^5/HPF||||NORMAL|NOT DONE||||AMNIOTIC FLUID|PARAFFIN-EMBEDDED|Y|PERIODIC ACID SCHIFF STAIN|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|Y|||U|4||88||SCREENING|1962-09-29|1972-08-07|||||1973-04-03||1970-02-05|NA|1968-10-07
TRIAL STUDY 134XCP|LB|13A424BB-CC85-41EC-BDED-165A29532DFF|1||||BGTCPHRL|BETA+GAMMA TOCOPHEROL|||||||NKAT/G HB|||||||INVALID||KPA||||NORMAL|NOT DONE||||ADIPOSE TISSUE|HEMOLYZED|Y|AMSLER GRID|HEPASCORE FORMULA||N|N|N|U|||Y|5||7||FOLLOW-UP|1961-06-24|1964-04-16|||||1962-03-10||1972-03-02|NA|1968-06-13
TRIAL STUDY 134XCP|LB|13A424BB-CC85-41EC-BDED-165A29532DFF|2||||FGFBF|FIBROBLAST GROWTH FACTOR BASIC FORM|||||||LX|||||||INVALID||PLUG||||LOW|NOT DONE||||SEMINAL FLUID|FROZEN|N|CONGO RED STAIN|CKD-EPI CREATININE FORMULA||U|NA|NA|U|||N|5||7||SCREENING|1961-07-30|1969-10-04|||||1967-01-19||1965-03-03|U|1967-01-09
TRIAL STUDY 134XCP|LB|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|1||||MCPHG|MACROPHAGES|||||||/5X10^4 WBC|||||||NEGATIVE||OZ EQ||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|THAWED|Y|PET SCAN|MDRD FORMULA||Y|Y|NA|NA|||NA|1||38||CONTINUATION TREATMENT|1965-10-15|1969-04-30|||||1973-01-01||1971-02-08|Y|1968-02-13
TRIAL STUDY 134XCP|LB|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|2||||ENA78|EPITH NEUTROPHIL-ACTIVATING PEPTIDE 78|||||||PPB|||||||BORDERLINE||MG/MOL||||NORMAL|NOT DONE||||BREAST MILK|DRIED|N|REFRACTOMETRY|MDRD FORMULA||Y|NA|Y|U|||NA|1||38||WASHOUT|1971-06-16|1963-11-29|||||1967-06-06||1966-09-24|U|1969-12-03
TRIAL STUDY 134XCP|LB|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|1||||T4|THYROXINE|||||||10^3 CFU/ML|||||||INVALID||AU/ML||||NORMAL|NOT DONE||||PLATELET|UNEXPECTED ODOR|U|CRYOSCOPY|HEPASCORE FORMULA||U|N|U|Y|||U|2||58||SCREENING|1965-07-08|1967-09-20|||||1963-09-04||1972-10-25|N|1960-01-27
TRIAL STUDY 134XCP|LB|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|2||||RBCNURBC|NUCLEATED ERYTHROCYTES/ERYTHROCYTES|||||||PMOL/L/H|||||||INVALID||CYLINDER||||ABNORMAL|NOT DONE||||BILE|REFRIGERATED|NA|EPSILOMETER|CKD-EPI CYSTATIN C FORMULA||Y|Y|U|NA|||Y|2||58||INDUCTION TREATMENT|1973-05-13|1963-10-14|||||1960-02-24||1972-01-11|Y|1964-02-15
TRIAL STUDY 134XCP|LB|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|1||||MX1|INTERFERON-INDUCED PROTEIN P78|||||||UG/MOL|||||||INVALID||UG/DAY||||NORMAL|NOT DONE||||DERMAL TISSUE|CONCENTRATED|U|ACID FAST STAIN|GMI % FORMULA||NA|Y|U|Y|||NA|3||39||RUN-IN|1968-06-12|1965-09-09|||||1970-06-22||1962-07-07|U|1968-06-03
TRIAL STUDY 134XCP|LB|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|2||||CLCREAT|CHLORIDE/CREATININE|||||||ML/S|||||||INVALID||USP U||||NORMAL|NOT DONE||||SMEGMA|ICTERIC|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|NA|U|||N|3||39||BLINDED TREATMENT|1968-11-12|1968-11-26|||||1967-06-16||1966-12-28|N|1961-06-22
TRIAL STUDY 134XCP|LB|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|1||||LYMATLY|ATYPICAL LYMPHOCYTES/LYMPHOCYTES|||||||PIXELS/CM|||||||NEGATIVE||MIN||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|UNEXPECTED ODOR|NA|PET/SPECT SCAN|FIBROSIS 4 FORMULA||N|N|U|Y|||Y|4||88||OPEN LABEL TREATMENT|1967-07-08|1964-05-03|||||1969-01-20||1964-12-14|N|1970-06-26
TRIAL STUDY 134XCP|LB|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|2||||C165888|RUSSIAN THISTLE POLLEN IGE ANTIBODY|||||||10^3 CFU/G|||||||TRACE||CPM||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|FROZEN|NA|CELLULAR PROLIFERATION ASSAY|MDRD 5 VARIABLE FORMULA||N|NA|U|U|||U|4||88||FOLLOW-UP|1966-01-02|1966-08-01|||||1967-07-25||1965-11-24|N|1961-02-28
TRIAL STUDY 134XCP|LB|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|1||||ERCEMPOL|ERYTHROID MATURATION POOL|||||||VIRTUAL PIXEL|||||||INVALID||DPM/0.5 ML||||NORMAL|NOT DONE||||AMNIOTIC FLUID|PARAFFIN-EMBEDDED|NA|PAP STAIN|CKD-EPI FORMULA||N|N|Y|N|||Y|5||7||SCREENING|1968-05-26|1969-04-22|||||1972-02-25||1963-01-01|Y|1963-02-08
TRIAL STUDY 134XCP|LB|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|2||||DHEA|DEHYDROEPIANDROSTERONE|||||||U|||||||NEGATIVE||MG/G/H||||HIGH|NOT DONE||||EPITHELIAL CELL|PARAFFIN-EMBEDDED|U|PULSE OXIMETRY|FIBROSIS 4 FORMULA||U|N|U|U|||U|5||7||OBSERVATION|1962-01-08|1967-09-28|||||1973-06-14||1962-04-12|NA|1971-06-18
TRIAL STUDY 134XCP|LB|059FE504-DEE4-4E24-AA80-3C64264636BF|1||||MGB|MYOGLOBIN|||||||LENS|||||||INVALID||10^6 ORGANISMS/MG||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED|Y|WHOLE GENOME SEQUENCING|ASH FIBROSURE FORMULA||N|N|U|N|||NA|1||38||BASELINE|1967-05-21|1971-12-27|||||1963-12-14||1971-02-12|N|1965-12-18
TRIAL STUDY 134XCP|LB|059FE504-DEE4-4E24-AA80-3C64264636BF|2||||IGHG4|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 4|||||||SBE/ML|||||||POSITIVE||KBQ||||ABNORMAL|NOT DONE||||SKIN TISSUE|LACTESCENT|NA|TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA||U|Y|Y|U|||Y|1||38||BLINDED TREATMENT|1961-03-13|1962-01-24|||||1965-05-04||1973-05-21|NA|1970-07-26
TRIAL STUDY 134XCP|LB|059FE504-DEE4-4E24-AA80-3C64264636BF|1||||GLUCCLR|GLUCOSE CLEARANCE|||||||/100 WBC|||||||INVALID||G/CAGE||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|ROOM TEMPERATURE|NA|MICRONEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA||U|NA|N|NA|||Y|2||58||CONTINUATION TREATMENT|1967-08-09|1973-03-01|||||1969-11-04||1965-09-03|Y|1968-05-31
TRIAL STUDY 134XCP|LB|059FE504-DEE4-4E24-AA80-3C64264636BF|2||||CFA|COEFFICIENT OF FAT ABSORPTION|||||||MG/KG/MIN|||||||NEGATIVE||NG/MOL||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|CONCENTRATED|NA|ALCIAN BLUE STAIN|MDRD 5 VARIABLE FORMULA||NA|U|N|NA|||Y|2||58||FOLLOW-UP|1973-05-10|1968-05-04|||||1967-11-09||1971-11-13|U|1970-04-01
TRIAL STUDY 134XCP|LB|059FE504-DEE4-4E24-AA80-3C64264636BF|1||||ADSDNA|ANTI-DOUBLE STRANDED DNA|||||||CUP|||||||INDETERMINATE||OHM||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|ICTERIC|NA|MAPH|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|NA|U|||U|3||39||LONG-TERM FOLLOW-UP|1968-06-06|1971-12-19|||||1970-09-09||1962-07-16|Y|1962-05-14
TRIAL STUDY 134XCP|LB|059FE504-DEE4-4E24-AA80-3C64264636BF|2||||MERCURY|MERCURY|||||||ML/CAGE|||||||BORDERLINE||DAYS||||LOW|NOT DONE||||SEBUM|NON-HEMOLYZED|U|MICROPARTICLE ENZYME IMMUNOASSAY|MDRD ENZYMATIC FORMULA||U|NA|NA|NA|||U|3||39||FOLLOW-UP|1963-03-28|1964-04-13|||||1973-03-10||1964-11-11|NA|1960-11-05
TRIAL STUDY 134XCP|LB|059FE504-DEE4-4E24-AA80-3C64264636BF|1||||INTLK13|INTERLEUKIN 13|||||||CD*S/M2|||||||NEGATIVE||EQ||||LOW|NOT DONE||||EXPIRED AIR|PARAFFIN-EMBEDDED|NA|PET/SPECT SCAN|MDRD 5 VARIABLE FORMULA||U|NA|U|Y|||NA|4||88||RUN-IN|1960-08-29|1962-07-06|||||1967-11-01||1965-11-03|U|1966-08-17
TRIAL STUDY 134XCP|LB|059FE504-DEE4-4E24-AA80-3C64264636BF|2||||CTLPRM|CITALOPRAM|||||||CAPFUL|||||||POSITIVE||TROCHE||||NORMAL|NOT DONE||||NAIL|UNEXPECTED ODOR|Y|PHASE-CONTRAST MRI|CKD-EPI CREATININE FORMULA||U|N|U|U|||NA|4||88||CONTINUATION TREATMENT|1965-06-02|1970-03-14|||||1962-10-09||1970-06-28|NA|1966-10-22
TRIAL STUDY 134XCP|LB|059FE504-DEE4-4E24-AA80-3C64264636BF|1||||C165941|COMMON RAGWEED POLLEN IGE AB RAST SCORE|||||||ML/G/H|||||||NEGATIVE||CM/S||||LOW|NOT DONE||||MUCUS|GELLED|U|WHOLE EXOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|U|NA|||NA|5||7||RUN-IN|1969-12-18|1961-05-19|||||1968-08-08||1968-03-07|Y|1965-07-01
TRIAL STUDY 134XCP|LB|059FE504-DEE4-4E24-AA80-3C64264636BF|2||||IGG3|IMMUNOGLOBULIN G SUBCLASS 3|||||||NMOL|||||||POSITIVE||V||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|CLOTTED|NA|FLAME PHOTOMETRY|MDRD 4 VARIABLE FORMULA||U|NA|N|U|||U|5||7||WASHOUT|1960-04-23|1960-07-14|||||1970-05-22||1973-03-17|NA|1960-12-05
TRIAL STUDY 134XCP|LB|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|1||||SCL70GAB|SCL-70 IGG ANTIBODY|||||||UM/S|||||||INDETERMINATE||MILE||||LOW|NOT DONE||||MONOCYTE|NON-HEMOLYZED|U|IMMUNORADIOMETRIC ASSAY|MDRD 6 VARIABLE FORMULA||NA|N|N|N|||U|1||38||OPEN LABEL TREATMENT|1961-02-06|1961-08-26|||||1972-10-25||1965-12-18|NA|1971-08-05
TRIAL STUDY 134XCP|LB|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|2||||C165938|COW MILK PROTEIN IGE AB RAST SCORE|||||||/SEC|||||||POSITIVE||PACK YEAR||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|CONCENTRATED|Y|CLOT DETECTION|FIBROTEST FORMULA||Y|Y|U|NA|||N|1||38||OPEN LABEL TREATMENT|1968-06-02|1972-09-06|||||1970-01-20||1967-05-08|Y|1964-12-15
TRIAL STUDY 134XCP|LB|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|1||||MM2IGAB|MITOCHONDRIAL M2 IGG ANTIBODY|||||||10^11/L|||||||INDETERMINATE||MPH||||LOW|NOT DONE||||TISSUE|ROOM TEMPERATURE|Y|FLAME PHOTOMETRY|ASH FIBROSURE FORMULA||N|U|N|NA|||N|2||58||FOLLOW-UP|1967-03-29|1967-11-26|||||1967-09-02||1972-12-27|Y|1969-12-03
TRIAL STUDY 134XCP|LB|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|2||||PHADJT|PH ADJUSTED FOR BODY TEMP|||||||/4.0 ML|||||||POSITIVE||SQU/ML||||HIGH|NOT DONE||||EXPIRED AIR|DRIED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|NA|N|||N|2||58||LONG-TERM FOLLOW-UP|1967-11-11|1965-10-10|||||1970-08-20||1961-08-13|NA|1973-01-21
TRIAL STUDY 134XCP|LB|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|1||||ELA2|NEUTROPHIL ELASTASE|||||||MMOL/MIN/KPA|||||||INDETERMINATE||MEQ/KG||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|REFRIGERATED|U|REFLECTANCE SPECTROSCOPY|ASH FIBROSURE FORMULA||N|NA|Y|U|||U|3||39||BLINDED TREATMENT|1969-10-07|1965-07-20|||||1966-03-31||1962-01-04|U|1961-04-18
TRIAL STUDY 134XCP|LB|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|2||||MONOBLLE|MONOBLASTS/LEUKOCYTES|||||||MG/M2/MIN|||||||INVALID||PACKAGE||||HIGH|NOT DONE||||DIALYSIS FLUID|CONTAMINATED|U|NON-INVASIVE DIELECTRIC SENSING|MDRD FORMULA||N|U|Y|N|||Y|3||39||CONTINUATION TREATMENT|1960-10-17|1969-03-11|||||1967-06-13||1961-01-02|NA|1964-10-07
TRIAL STUDY 134XCP|LB|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|1||||ACT|ACTIVATED COAGULATION TIME|||||||MOSM/KG|||||||NEGATIVE||ML/CAGE/DAY||||ABNORMAL|NOT DONE||||SMEGMA|NON-HEMOLYZED|NA|FARNSWORTH-MUNSELL 100 HUE TEST|ASH FIBROSURE FORMULA||Y|N|U|N|||N|4||88||OPEN LABEL TREATMENT|1969-07-01|1966-08-12|||||1969-08-26||1967-06-04|NA|1972-10-24
TRIAL STUDY 134XCP|LB|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|2||||GLOBG|GAMMA GLOBULIN|||||||MOSM|||||||INDETERMINATE||MG/M2/H||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|HEMOLYZED|U|REFLECTANCE SPECTROSCOPY|FIBROMETER FORMULA||N|N|NA|Y|||Y|4||88||BASELINE|1963-09-11|1960-01-13|||||1972-06-24||1970-08-17|U|1966-09-26
TRIAL STUDY 134XCP|LB|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|1||||GAD2|GLUTAMIC ACID DECARBOXYLASE 2|||||||NCI|||||||INVALID||HZ/S||||ABNORMAL|NOT DONE||||TUMOR TISSUE|UNEXPECTED ODOR|NA|MECHANICAL CLOT DETECTION|MDRD ENZYMATIC FORMULA||Y|N|U|NA|||Y|5||7||TREATMENT|1962-10-23|1964-04-16|||||1971-02-02||1966-06-05|U|1964-01-31
TRIAL STUDY 134XCP|LB|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|2||||RBC|ERYTHROCYTES|||||||%(V/V)|||||||INVALID||SCOOPFUL||||NORMAL|NOT DONE||||LAVAGE FLUID|DRIED|NA|CLINICAL EVALUATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|Y|||NA|5||7||FOLLOW-UP|1962-08-08|1965-08-06|||||1969-08-20||1965-01-14|N|1968-09-23
TRIAL STUDY 134XCP|LB|69BCF810-6748-43AA-BDFC-64EE1536CB47|1||||C130121|SHELLFISH MIX ANTIGEN IGG ANTIBODY|||||||MG/L FEU|||||||POSITIVE||PATCH||||LOW|NOT DONE||||SPERMATOZOON|CONTAMINATED|Y|PHASE CONTRAST MICROSCOPY|MDRD FORMULA||N|U|NA|NA|||N|1||38||RUN-IN|1961-04-05|1966-01-20|||||1970-06-22||1965-11-19|N|1960-05-30
TRIAL STUDY 134XCP|LB|69BCF810-6748-43AA-BDFC-64EE1536CB47|2||||FACTXIV|FACTOR XIV|||||||ML/MIN/1.73M2|||||||INDETERMINATE||BQ/MG||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CONTAMINATED|U|FREEZING POINT DEPRESSION|MDRD 5 VARIABLE FORMULA||Y|N|N|U|||U|1||38||TREATMENT|1969-10-19|1962-08-10|||||1968-01-16||1965-08-31|Y|1972-10-20
TRIAL STUDY 134XCP|LB|69BCF810-6748-43AA-BDFC-64EE1536CB47|1||||NEUTSGLE|NEUTROPHILS, SEGMENTED/LEUKOCYTES|||||||MG/DAY|||||||POSITIVE||/500 WBC||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|ROOM TEMPERATURE|Y|MYELOPEROXIDASE STAIN|MDRD 6 VARIABLE FORMULA||U|Y|NA|NA|||Y|2||58||TREATMENT|1968-11-18|1968-03-21|||||1962-07-01||1960-10-03|NA|1966-09-07
TRIAL STUDY 134XCP|LB|69BCF810-6748-43AA-BDFC-64EE1536CB47|2||||SCHISTO|SCHISTOCYTES|||||||U/G/DAY|||||||BORDERLINE||KIU||||LOW|NOT DONE||||URINE|CLOTTED|U|SPECTROPHOTOMETRY|FIBROSIS 4 FORMULA||Y|U|U|NA|||Y|2||58||OBSERVATION|1962-03-03|1969-04-16|||||1964-05-16||1969-05-28|N|1973-03-03
TRIAL STUDY 134XCP|LB|69BCF810-6748-43AA-BDFC-64EE1536CB47|1||||TK|THYMIDINE KINASE|||||||DEG/MM|||||||NEGATIVE||WEBER||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|DRIED|NA|QUANTITATIVE COMPUTED TOMOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|NA|NA|||Y|3||39||OBSERVATION|1960-06-07|1971-09-27|||||1966-02-14||1960-09-20|N|1970-06-21
TRIAL STUDY 134XCP|LB|69BCF810-6748-43AA-BDFC-64EE1536CB47|2||||ANP|ATRIAL NATRIURETIC PEPTIDE|||||||PKAT/L|||||||NEGATIVE||PUFF||||NORMAL|NOT DONE||||VITREOUS HUMOR|UNEXPECTED ODOR|U|SPECT/CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|N|N|||NA|3||39||FOLLOW-UP|1969-06-04|1962-09-27|||||1971-05-19||1972-01-12|U|1962-07-01
TRIAL STUDY 134XCP|LB|69BCF810-6748-43AA-BDFC-64EE1536CB47|1||||LIPASEP|LIPASE, PANCREATIC|||||||TORR|||||||TRACE||ML/G/MIN||||LOW|NOT DONE||||PLEURAL FLUID|FROZEN|U|DYNAMOMETRY|HEPASCORE FORMULA||NA|N|NA|N|||Y|4||88||BLINDED TREATMENT|1967-02-23|1966-11-15|||||1963-08-11||1961-04-25|U|1963-06-10
TRIAL STUDY 134XCP|LB|69BCF810-6748-43AA-BDFC-64EE1536CB47|2||||LDHCREAT|LACTATE DEHYDROGENASE/CREATININE|||||||10^7 TCID 50/DOSE|||||||INVALID||UG/L DDU||||ABNORMAL|NOT DONE||||PERSPIRATION|CONCENTRATED|Y|ZIEHL NEELSEN ACID FAST STAIN|FIBROMETER FORMULA||Y|Y|N|N|||Y|4||88||TREATMENT|1968-10-09|1967-10-27|||||1968-01-22||1965-05-21|NA|1971-01-22
TRIAL STUDY 134XCP|LB|69BCF810-6748-43AA-BDFC-64EE1536CB47|1||||CTOT|COMPLEMENT TOTAL|||||||G/KG|||||||INVALID||SYRINGE||||LOW|NOT DONE||||PERITONEAL FLUID|HEMOLYZED|NA|TARGETED GENOME SEQUENCING|GMI MMOL/MOL FORMULA||N|Y|N|NA|||Y|5||7||FOLLOW-UP|1970-01-27|1969-07-19|||||1969-03-31||1971-06-11|U|1967-12-17
TRIAL STUDY 134XCP|LB|69BCF810-6748-43AA-BDFC-64EE1536CB47|2||||BALA|BETA ALANINE|||||||G/ANIMAL|||||||POSITIVE||VOXEL||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|PARAFFIN-EMBEDDED|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA||Y|Y|N|U|||U|5||7||SCREENING|1969-09-07|1973-05-11|||||1965-12-10||1966-04-06|Y|1970-07-13
TRIAL STUDY 134XCP|LB|DCE71DE9-8DFB-4796-BC41-21930EC21925|1||||DZPM|DIAZEPAM|||||||DAYS|||||||INVALID||NM||||NORMAL|NOT DONE||||LYMPH|GELLED|U|SMEAR|CKD-EPI FORMULA||Y|Y|N|Y|||N|1||38||CONTINUATION TREATMENT|1966-05-06|1963-11-03|||||1973-07-01||1960-06-15|Y|1963-08-06
TRIAL STUDY 134XCP|LB|DCE71DE9-8DFB-4796-BC41-21930EC21925|2||||PEPSNGA|PEPSINOGEN A|||||||USEC|||||||TRACE||10^9/G||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|LACTESCENT|U|ELISA|CKD-EPI CYSTATIN C FORMULA||N|N|N|Y|||N|1||38||OPEN LABEL TREATMENT|1961-08-03|1970-11-03|||||1960-08-24||1967-07-22|Y|1961-04-05
TRIAL STUDY 134XCP|LB|DCE71DE9-8DFB-4796-BC41-21930EC21925|1||||KLOTHO|KLOTHO|||||||PIXELS/IN|||||||POSITIVE||RNA COPIES/ML||||LOW|NOT DONE||||LYMPH|CONTAMINATED|U|TURBIDIMETRY|MDRD FORMULA||NA|N|Y|N|||NA|2||58||INDUCTION TREATMENT|1960-07-31|1963-05-29|||||1963-02-22||1963-02-20|N|1964-04-09
TRIAL STUDY 134XCP|LB|DCE71DE9-8DFB-4796-BC41-21930EC21925|2||||NEUTTOXC|NEUTROPHILIC TOXIC CHANGE|||||||10^7 CFU/ML|||||||NEGATIVE||IU/MG||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|UNEXPECTED ODOR|Y|MICROPARTICLE ENZYME IMMUNOASSAY|MDRD ENZYMATIC FORMULA||Y|U|NA|U|||N|2||58||RUN-IN|1962-03-22|1962-09-04|||||1960-01-04||1968-07-08|N|1960-12-03
TRIAL STUDY 134XCP|LB|DCE71DE9-8DFB-4796-BC41-21930EC21925|1||||PBG|PORPHOBILINOGEN|||||||ABSORBANCE U/MIN|||||||NEGATIVE||KG/CM||||ABNORMAL|NOT DONE||||TUMOR TISSUE|CONTAMINATED|N|PELLI-ROBSON EYE CHART|FIBROTEST FORMULA||U|Y|U|U|||N|3||39||TREATMENT|1961-08-29|1960-01-02|||||1962-04-04||1970-06-13|Y|1972-10-18
TRIAL STUDY 134XCP|LB|DCE71DE9-8DFB-4796-BC41-21930EC21925|2||||METANEPH|METANEPHRINE|||||||EU|||||||NEGATIVE||BOX||||HIGH|NOT DONE||||HAIR FOLLICLE|SOLIDIFIED|U|ORCHIDOMETERY|GMI MMOL/MOL FORMULA||Y|U|U|N|||N|3||39||SCREENING|1971-08-07|1972-12-04|||||1962-04-04||1965-08-14|U|1965-10-02
TRIAL STUDY 134XCP|LB|DCE71DE9-8DFB-4796-BC41-21930EC21925|1||||ICAB|ISLET CELL ANTIBODY|||||||TITER|||||||POSITIVE||AMP||||HIGH|NOT DONE||||VENOUS CORD BLOOD|AUTOLYZED|NA|RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI FORMULA||U|NA|NA|NA|||Y|4||88||OPEN LABEL TREATMENT|1973-01-22|1971-12-15|||||1967-07-31||1965-11-10|U|1970-10-13
TRIAL STUDY 134XCP|LB|DCE71DE9-8DFB-4796-BC41-21930EC21925|2||||PTHCT|PARATHYROID HORMONE, C-TERMINAL|||||||SYRINGE|||||||INVALID||U/DL||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONTAMINATED|N|NON-CONTACT SPECULAR MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|Y|U|||U|4||88||SCREENING|1961-08-16|1971-01-11|||||1965-06-03||1960-05-19|U|1966-01-15
TRIAL STUDY 134XCP|LB|DCE71DE9-8DFB-4796-BC41-21930EC21925|1||||BLYMXM|B-LYMPHOCYTE CROSSMATCH|||||||ML/H|||||||POSITIVE||G/DAY||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|REFRIGERATED|NA|PET/CT SCAN WITHOUT CONTRAST|HEPASCORE FORMULA||N|N|NA|Y|||N|5||7||BLINDED TREATMENT|1973-04-27|1972-03-23|||||1960-05-29||1963-08-11|N|1967-01-25
TRIAL STUDY 134XCP|LB|DCE71DE9-8DFB-4796-BC41-21930EC21925|2||||MIDCEF|MID CELL FRACTION|||||||MSEC|||||||POSITIVE||PFU||||HIGH|NOT DONE||||PLEURAL FLUID|UNEXPECTED ODOR|N|FLOW CYTOMETRY|CKD-EPI FORMULA||NA|N|N|Y|||U|5||7||BLINDED TREATMENT|1971-03-08|1965-05-03|||||1971-08-28||1969-05-24|NA|1972-02-14
TRIAL STUDY 134XCP|LB|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|1||||ANAG|ALPHA-N-ACETYLGLUCOSAMINIDASE|||||||GY/H|||||||INDETERMINATE||NMOL||||HIGH|NOT DONE||||AMNIOTIC FLUID|FROZEN|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|FIBROSIS 4 FORMULA||NA|Y|U|Y|||NA|1||38||BASELINE|1963-08-30|1973-01-31|||||1969-11-04||1964-02-29|Y|1964-04-22
TRIAL STUDY 134XCP|LB|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|2||||RENIN|RENIN|||||||MPL U/ML|||||||NEGATIVE||ML/CAGE/DAY||||HIGH|NOT DONE||||ISOLATE|LIPEMIC|N|POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA||Y|N|Y|N|||Y|1||38||BASELINE|1961-11-26|1967-12-20|||||1960-07-01||1962-10-06|U|1971-07-23
TRIAL STUDY 134XCP|LB|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|1||||CD161ALY|CD161A/LYMPHOCYTES|||||||PSEC|||||||POSITIVE||PIXELS/CM||||HIGH|NOT DONE||||AQUEOUS HUMOR|CONTAMINATED|U|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|U|NA|||Y|2||58||BASELINE|1961-06-27|1972-02-14|||||1970-01-21||1960-01-30|N|1966-04-26
TRIAL STUDY 134XCP|LB|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|2||||EDMAB|ENDOMYSIAL ANTIBODY|||||||UMOL/H/MMOL|||||||NEGATIVE||UG/M2/DAY||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|SOLIDIFIED|U|CELL BASED BIOASSAY|CKD-EPI CYSTATIN C FORMULA||NA|U|N|U|||U|2||58||LONG-TERM FOLLOW-UP|1973-04-23|1960-05-25|||||1970-08-18||1961-06-11|U|1966-08-13
TRIAL STUDY 134XCP|LB|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|1||||ASTCK|AST/CREATINE KINASE|||||||HOUNSFIELD UNIT|||||||INVALID||MV/SEC||||LOW|NOT DONE||||SWABBED MATERIAL|DRIED|Y|APPLANATION TONOMETRY|MDRD ENZYMATIC FORMULA||N|N|N|Y|||U|3||39||RUN-IN|1966-10-01|1969-08-02|||||1966-03-11||1969-11-12|U|1967-08-21
TRIAL STUDY 134XCP|LB|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|2||||MECONIUM|MECONIUM|||||||UL/KG/DAY|||||||INDETERMINATE||MG/DL||||NORMAL|NOT DONE||||MECONIUM|FRESH|N|HEMOCYTOMETRY|ASH FIBROSURE FORMULA||N|Y|NA|N|||NA|3||39||BASELINE|1969-04-30|1964-05-02|||||1973-09-08||1965-05-24|N|1960-02-01
TRIAL STUDY 134XCP|LB|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|1||||C1QAB|COMPLEMENT C1Q ANTIBODY|||||||CAPSULE|||||||POSITIVE||ANTI-XA IU/ML||||NORMAL|NOT DONE||||RETICULOCYTES|UNEXPECTED ODOR|N|CENTRIFUGATION|COCKCROFT-GAULT FORMULA||U|N|Y|U|||Y|4||88||OBSERVATION|1966-07-22|1970-10-29|||||1970-05-26||1960-04-18|NA|1964-07-27
TRIAL STUDY 134XCP|LB|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|2||||GSTTH|GLUTATHIONE S-TRANSFERASE, THETA|||||||KS|||||||INDETERMINATE||ANSON U||||HIGH|NOT DONE||||LOCHIA|AUTOLYZED|N|BAC ACGH|MDRD 4 VARIABLE FORMULA||N|N|NA|U|||Y|4||88||BASELINE|1963-11-18|1973-08-04|||||1967-05-30||1963-04-20|NA|1967-02-25
TRIAL STUDY 134XCP|LB|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|1||||HCHT|HYOCHOLATE|||||||MG/KG/WEEK|||||||INDETERMINATE||FRACTION OF 1||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|DRIED|U|IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD 6 VARIABLE FORMULA||NA|N|U|Y|||Y|5||7||WASHOUT|1970-12-02|1970-05-01|||||1964-09-21||1963-06-01|Y|1966-10-27
TRIAL STUDY 134XCP|LB|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|2||||ARGSAC|ARGININOSUCCINIC ACID|||||||ML/CAGE|||||||NEGATIVE||/10^3||||ABNORMAL|NOT DONE||||GASTRIC FLUID|GELLED|U|PALM METHOD|MDRD ENZYMATIC JAPANESE FORMULA||U|N|NA|N|||NA|5||7||CONTINUATION TREATMENT|1968-05-05|1965-04-18|||||1970-03-21||1965-10-09|NA|1967-07-19
TRIAL STUDY 134XCP|LB|97D06076-FE6B-4C77-BD5C-2E665F707C7A|1||||GAMBTAC|GAMMA-AMINOBUTYRIC ACID|||||||DMOL|||||||POSITIVE||ML/CM3/MIN||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|GELLED|Y|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|FIBROTEST FORMULA||Y|NA|U|U|||N|1||38||INDUCTION TREATMENT|1963-10-09|1960-08-06|||||1960-03-06||1969-01-14|NA|1960-05-13
TRIAL STUDY 134XCP|LB|97D06076-FE6B-4C77-BD5C-2E665F707C7A|2||||CPEPTIDE|C-PEPTIDE|||||||NMOL BCE/MMOL|||||||NEGATIVE||MMAL||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|THAWED|N|CT SCAN|MDRD ENZYMATIC FORMULA||U|N|N|N|||NA|1||38||TREATMENT|1966-05-21|1961-05-17|||||1962-12-20||1969-09-26|Y|1972-11-01
TRIAL STUDY 134XCP|LB|97D06076-FE6B-4C77-BD5C-2E665F707C7A|1||||CBS|CYSTATHIONINE BETA-SYNTHASE|||||||AFU|||||||TRACE||MMHG||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|ROOM TEMPERATURE|Y|MRS|MDRD 4 VARIABLE FORMULA||N|N|N|N|||Y|2||58||SCREENING|1962-07-31|1967-04-06|||||1964-06-12||1972-04-09|Y|1966-08-27
TRIAL STUDY 134XCP|LB|97D06076-FE6B-4C77-BD5C-2E665F707C7A|2||||PGF2A|PROSTAGLANDIN F2 ALPHA|||||||BISCUIT|||||||NEGATIVE||UG/CM2||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|CONTAMINATED|N|AUSCULTATION|ASH FIBROSURE FORMULA||U|U|NA|Y|||Y|2||58||TREATMENT|1971-01-07|1970-10-02|||||1968-12-30||1963-06-12|U|1964-02-22
TRIAL STUDY 134XCP|LB|97D06076-FE6B-4C77-BD5C-2E665F707C7A|1||||DDX58|DEAD BOX PROTEIN 58|||||||G/CM2|||||||NEGATIVE||TAMPON||||LOW|NOT DONE||||PLEURAL TISSUE|HEMOLYZED|Y|HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|Y|||Y|3||39||OBSERVATION|1971-06-11|1964-12-21|||||1968-08-23||1973-07-21|Y|1973-04-18
TRIAL STUDY 134XCP|LB|97D06076-FE6B-4C77-BD5C-2E665F707C7A|2||||VITC|VITAMIN C|||||||CMHG|||||||INVALID||MJOULE/CM2||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|NON-HEMOLYZED|U|CRYOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|NA|U|||N|3||39||WASHOUT|1961-09-15|1971-06-28|||||1965-08-24||1965-09-16|U|1969-07-27
TRIAL STUDY 134XCP|LB|97D06076-FE6B-4C77-BD5C-2E665F707C7A|1||||HDLPSZ|HDL PARTICLE SIZE|||||||ANTIBODY UNIT|||||||INVALID||UG/CM2||||HIGH|NOT DONE||||URINE SEDIMENT|CONCENTRATED|U|ALCIAN BLUE STAIN|FIBROSIS 4 FORMULA||N|N|U|Y|||NA|4||88||FOLLOW-UP|1963-07-27|1962-01-12|||||1971-10-18||1970-03-17|NA|1961-07-16
TRIAL STUDY 134XCP|LB|97D06076-FE6B-4C77-BD5C-2E665F707C7A|2||||PLSMCELY|MATURE PLASMA CELLS/LYMPHOCYTES|||||||UG/G/MIN|||||||POSITIVE||DIOPTER||||NORMAL|NOT DONE||||SMEGMA|THAWED|NA|RYAN BLUE STAIN|FIBROSIS 4 FORMULA||Y|Y|U|NA|||NA|4||88||INDUCTION TREATMENT|1973-03-25|1973-09-03|||||1967-10-17||1966-01-27|U|1965-10-28
TRIAL STUDY 134XCP|LB|97D06076-FE6B-4C77-BD5C-2E665F707C7A|1||||TRYPSIN|TRYPSIN|||||||%/S|||||||INVALID||10^5/L||||HIGH|NOT DONE||||MUSCLE TISSUE|SOLIDIFIED|U|URANYL ACETATE STAIN|FIBROSIS 4 FORMULA||Y|Y|N|N|||Y|5||7||LONG-TERM FOLLOW-UP|1963-02-27|1967-12-25|||||1970-06-15||1965-04-01|Y|1972-04-07
TRIAL STUDY 134XCP|LB|97D06076-FE6B-4C77-BD5C-2E665F707C7A|2||||PGE1|PROSTAGLANDIN E1|||||||10^9/DOSE|||||||BORDERLINE||10^11/L||||LOW|NOT DONE||||STOOL|SOLIDIFIED|Y|STATIC PERIMETRY|MDRD ENZYMATIC FORMULA||U|U|U|U|||Y|5||7||FOLLOW-UP|1973-02-01|1967-05-31|||||1967-02-13||1965-11-16|Y|1962-09-01
TRIAL STUDY 134XCP|LB|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|1||||CLNZPM|CLONAZEPAM|||||||NM|||||||BORDERLINE||10^9/DOSE||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED|Y|FORCED OSCILLATION TECHNIQUE|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|U|||N|1||38||TREATMENT|1967-06-19|1967-01-12|||||1964-02-06||1965-10-06|N|1968-10-17
TRIAL STUDY 134XCP|LB|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|2||||DHPG|3,4-DIHYDROXYPHENYLGLYCOL|||||||ML/DAY|||||||BORDERLINE||DMOL||||LOW|NOT DONE||||TISSUE|UNEXPECTED ODOR|NA|IMMUNORADIOMETRIC ASSAY|MDRD 4 VARIABLE FORMULA||Y|Y|U|U|||Y|1||38||RUN-IN|1972-01-21|1961-07-08|||||1960-06-12||1961-09-14|NA|1968-10-10
TRIAL STUDY 134XCP|LB|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|1||||LYMIM|IMMATURE LYMPHOCYTES|||||||10^5/HPF|||||||POSITIVE||MMOL/MIN/KPA||||HIGH|NOT DONE||||FLUID|AGGLUTINATED|U|PULSE OXIMETRY|GMI MMOL/MOL FORMULA||N|U|N|Y|||N|2||58||BASELINE|1972-08-01|1967-11-28|||||1960-07-31||1966-08-26|N|1961-04-05
TRIAL STUDY 134XCP|LB|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|2||||MPC|MEAN PLATELET COMPONENT|||||||10^6/L|||||||TRACE||MEQ/KG||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|FRESH|NA|TARGETED TRANSCRIPTOME SEQUENCING|COCKCROFT-GAULT FORMULA||Y|Y|NA|Y|||NA|2||58||INDUCTION TREATMENT|1961-12-30|1966-05-14|||||1964-12-06||1968-06-26|U|1972-04-26
TRIAL STUDY 134XCP|LB|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|1||||LDLPATT|LDL SUBTYPE PATTERN|||||||PM|||||||INDETERMINATE||UG/M2||||NORMAL|NOT DONE||||SEMINAL FLUID|HEMOLYZED|U|PYROSEQUENCING|CKD-EPI FORMULA||N|N|U|Y|||N|3||39||WASHOUT|1966-08-26|1971-11-04|||||1967-03-26||1972-10-05|U|1971-10-31
TRIAL STUDY 134XCP|LB|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|2||||T4FRIND|THYROXINE, FREE, INDIRECT|||||||ELISA UNIT|||||||TRACE||10^4 CFU/ML||||ABNORMAL|NOT DONE||||CORD SERUM|DRIED|Y|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|FIBROSIS 4 FORMULA||N|N|NA|NA|||N|3||39||OBSERVATION|1966-05-13|1963-05-24|||||1963-11-15||1973-04-05|Y|1966-06-05
TRIAL STUDY 134XCP|LB|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|1||||C130115|INDUSTRIAL MIX ANTIGEN IGG ANTIBODY|||||||10^6 CFU/G|||||||INDETERMINATE||GBQ/MG||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|CALCIFIED|U|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|ASH FIBROSURE FORMULA||N|Y|U|NA|||Y|4||88||BLINDED TREATMENT|1968-12-27|1961-02-13|||||1962-09-06||1963-07-06|U|1970-03-09
TRIAL STUDY 134XCP|LB|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|2||||AAMAPAC|ALPHA-AMINOADIPIC ACID|||||||HOURS|||||||TRACE||ML/KG/DAY||||LOW|NOT DONE||||PLATELET|CONCENTRATED|Y|POPULATION SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|N|NA|||N|4||88||BASELINE|1967-03-05|1964-01-18|||||1969-07-27||1963-07-11|N|1968-01-11
TRIAL STUDY 134XCP|LB|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|1||||TRAP|TOTAL RADICAL-TRAP ANTIOXIDANT POTENTIAL|||||||NMOL/G|||||||NEGATIVE||/5X10^4 WBC||||LOW|NOT DONE||||HAIR FOLLICLE|ROOM TEMPERATURE|Y|OPTICAL MAPPING|MDRD 6 VARIABLE FORMULA||N|NA|NA|NA|||Y|5||7||BASELINE|1972-06-22|1960-03-28|||||1961-02-15||1962-06-08|Y|1965-10-14
TRIAL STUDY 134XCP|LB|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|2||||INR|PROTHROMBIN INTL. NORMALIZED RATIO|||||||FRACTION OF 1|||||||TRACE||10^6 ORGANISMS/G||||HIGH|NOT DONE||||LEUKOCYTE|LIPEMIC|U|NUCLEAR RADIOLOGY|CKD-EPI CYSTATIN C FORMULA||NA|U|Y|Y|||Y|5||7||INDUCTION TREATMENT|1963-05-15|1968-10-31|||||1969-10-17||1967-04-23|Y|1968-04-20
TRIAL STUDY 134XCP|LB|D5A1EB38-77EA-49A5-84CA-740A83D258AF|1||||RDWRSD|RET RDW STANDARD DEVIATION|||||||V/SEC|||||||TRACE||DRAM||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|REFRIGERATED|NA|NEXT GENERATION SEQUENCING|CKD-EPI CREATININE FORMULA||N|U|Y|NA|||NA|1||38||OBSERVATION|1971-06-03|1973-07-03|||||1965-04-05||1964-08-13|NA|1961-12-08
TRIAL STUDY 134XCP|LB|D5A1EB38-77EA-49A5-84CA-740A83D258AF|2||||MPOAB|MYELOPEROXIDASE ANTIBODY|||||||S/H|||||||POSITIVE||TESLA||||HIGH|NOT DONE||||SUPERNATANT, SERUM|DRIED|U|INDIA INK STAIN|MDRD 4 VARIABLE FORMULA||NA|N|N|Y|||Y|1||38||OPEN LABEL TREATMENT|1963-02-09|1965-06-27|||||1964-11-07||1962-01-11|Y|1968-06-14
TRIAL STUDY 134XCP|LB|D5A1EB38-77EA-49A5-84CA-740A83D258AF|1||||ETPPH|ETP PEAK HEIGHT|||||||FT2|||||||POSITIVE||KEV||||LOW|NOT DONE||||LUNG SURFACTANT|PARAFFIN-EMBEDDED|NA|AUSCULTATION|MDRD ENZYMATIC FORMULA||NA|NA|U|U|||N|2||58||INDUCTION TREATMENT|1969-04-22|1970-12-21|||||1970-01-26||1973-07-09|Y|1972-10-14
TRIAL STUDY 134XCP|LB|D5A1EB38-77EA-49A5-84CA-740A83D258AF|2||||GLOBA1|ALPHA-1 GLOBULIN|||||||WEEKS|||||||NEGATIVE||KALLIKREIN INHIBITOR UNIT||||ABNORMAL|NOT DONE||||PERSPIRATION|CONTAMINATED|NA|IMPEDANCE CONDUCTIVITY|GMI % FORMULA||U|N|Y|N|||U|2||58||OBSERVATION|1964-11-19|1963-04-12|||||1962-10-28||1965-10-28|Y|1973-06-03
TRIAL STUDY 134XCP|LB|D5A1EB38-77EA-49A5-84CA-740A83D258AF|1||||TGLOB|THYROGLOBULIN|||||||NG/L|||||||NEGATIVE||MG/M2/DAY||||LOW|NOT DONE||||EMESIS|ICTERIC|U|MAGNETIC RESONANCE ANGIOGRAPHY|FIBROMETER FORMULA||U|N|N|NA|||U|3||39||BASELINE|1968-09-14|1972-10-04|||||1967-06-26||1965-04-05|Y|1963-05-14
TRIAL STUDY 134XCP|LB|D5A1EB38-77EA-49A5-84CA-740A83D258AF|2||||FACTXIA|FACTOR XI ACTIVITY|||||||NG/DL|||||||TRACE||APPLICATION||||NORMAL|NOT DONE||||LOCHIA|CLOTTED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|N|||U|3||39||FOLLOW-UP|1960-08-03|1966-01-08|||||1971-05-27||1960-04-13|Y|1969-05-12
TRIAL STUDY 134XCP|LB|D5A1EB38-77EA-49A5-84CA-740A83D258AF|1||||CYCACAR|CALCIUM CARBONATE CRYSTALS|||||||FARAD|||||||INDETERMINATE||G/M2/DAY||||HIGH|NOT DONE||||LUNG SURFACTANT|DRIED|N|MRI|HEPASCORE FORMULA||U|N|NA|U|||NA|4||88||WASHOUT|1972-01-02|1968-08-15|||||1967-12-15||1961-08-25|N|1965-08-27
TRIAL STUDY 134XCP|LB|D5A1EB38-77EA-49A5-84CA-740A83D258AF|2||||ANTHRMAG|ANTITHROMBIN ANTIGEN|||||||AGU/ML|||||||TRACE||PSI||||HIGH|NOT DONE||||BLOOD|DRIED|NA|KINYOUN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|NA|Y|||NA|4||88||FOLLOW-UP|1962-02-24|1972-07-08|||||1972-05-02||1971-08-02|Y|1972-03-04
TRIAL STUDY 134XCP|LB|D5A1EB38-77EA-49A5-84CA-740A83D258AF|1||||CONDUCTU|URINE CONDUCTIVITY|||||||DPM/MG|||||||INDETERMINATE||USP U||||LOW|NOT DONE||||LYSATE|SOLIDIFIED|Y|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|N|N|||Y|5||7||INDUCTION TREATMENT|1971-10-14|1969-08-01|||||1961-08-16||1964-12-12|U|1972-02-07
TRIAL STUDY 134XCP|LB|D5A1EB38-77EA-49A5-84CA-740A83D258AF|2||||GLOBB2|BETA-2 GLOBULIN|||||||10^3 COPIES/ML|||||||INDETERMINATE||MG/KG/H||||HIGH|NOT DONE||||BONE MARROW|ICTERIC|U|GC/FID|NASH FIBROSURE FORMULA||Y|NA|Y|U|||U|5||7||RUN-IN|1962-01-05|1970-02-18|||||1972-05-20||1964-02-13|U|1962-10-13
TRIAL STUDY 134XCP|LB|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|1||||VITB17|VITAMIN B17|||||||COPIES/UG|||||||POSITIVE||SQU/ML||||NORMAL|NOT DONE||||SOFT TISSUE|LIPEMIC|U|HIGH RESOLUTION CT|MDRD 4 VARIABLE FORMULA||U|NA|Y|Y|||N|1||38||OPEN LABEL TREATMENT|1966-10-06|1961-10-07|||||1964-12-15||1968-02-23|N|1968-12-17
TRIAL STUDY 134XCP|LB|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|2||||ECT|ECARIN CLOTTING TIME|||||||GBQ|||||||NEGATIVE||AU/ML||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|SOLIDIFIED|NA|DISK DIFFUSION|HEPASCORE FORMULA||N|U|N|Y|||N|1||38||OPEN LABEL TREATMENT|1970-04-14|1971-01-01|||||1967-10-29||1973-03-06|U|1965-09-30
TRIAL STUDY 134XCP|LB|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|1||||APOH|APOLIPOPROTEIN H|||||||LINEAR FT*LB|||||||TRACE||10^3 RNA COPIES/ML||||NORMAL|NOT DONE||||LAVAGE FLUID|PARAFFIN-EMBEDDED|Y|GC/MS-CI|MDRD 4 VARIABLE FORMULA||U|Y|U|N|||U|2||58||WASHOUT|1967-10-25|1960-09-14|||||1972-10-11||1973-07-30|N|1960-04-22
TRIAL STUDY 134XCP|LB|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|2||||HE4|HUMAN EPIDIDYMIS PROTEIN 4|||||||UL/DOSE|||||||BORDERLINE||G/CAGE/WK||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|U|FLOCCULATION, CHARCOAL ENHANCED|MDRD 6 VARIABLE FORMULA||NA|U|U|Y|||NA|2||58||BLINDED TREATMENT|1966-05-20|1965-01-17|||||1967-05-14||1961-05-07|Y|1970-09-20
TRIAL STUDY 134XCP|LB|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|1||||HBA1C|HEMOGLOBIN A1C|||||||/2000 RBC|||||||INVALID||INHALATION||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|AGGLUTINATED|Y|IRON HEMATOXYLIN STAIN|MDRD 5 VARIABLE FORMULA||Y|NA|U|NA|||N|3||39||CONTINUATION TREATMENT|1962-12-10|1970-03-15|||||1969-11-14||1960-05-29|U|1962-03-20
TRIAL STUDY 134XCP|LB|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|2||||RENINA|RENIN ACTIVITY|||||||DPM|||||||INVALID||DEG2||||LOW|NOT DONE||||INFRANATANT, SERUM|GELLED|NA|PYROSEQUENCING|CKD-EPI FORMULA||Y|N|N|U|||Y|3||39||INDUCTION TREATMENT|1971-08-14|1966-05-03|||||1969-05-21||1972-07-06|NA|1962-10-16
TRIAL STUDY 134XCP|LB|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|1||||CITCREAT|CITRATE/CREATININE|||||||PIPE|||||||INDETERMINATE||ENZYME U/L||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|SOLIDIFIED|Y|ANTIBIOTIC AGAR SCREEN|CKD-EPI CREATININE FORMULA||Y|U|NA|U|||NA|4||88||OBSERVATION|1962-04-08|1962-03-07|||||1960-04-26||1965-12-27|NA|1965-02-19
TRIAL STUDY 134XCP|LB|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|2||||VEGFD|VASCULAR ENDOTHELIAL GROWTH FACTOR D|||||||DISK|||||||INVALID||UOSM||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|CLOTTED|N|ALCIAN BLUE STAIN|CKD-EPI FORMULA||N|NA|U|Y|||U|4||88||OBSERVATION|1973-05-01|1969-08-21|||||1972-11-25||1970-07-16|U|1960-11-12
TRIAL STUDY 134XCP|LB|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|1||||MMP3|MATRIX METALLOPROTEINASE 3|||||||UKAT|||||||INVALID||UMOL/MOL||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|REFRIGERATED|U|TOLUIDINE BLUE STAIN|FIBROTEST FORMULA||NA|Y|NA|NA|||NA|5||7||SCREENING|1964-11-23|1972-04-24|||||1969-04-29||1961-04-30|N|1962-10-25
TRIAL STUDY 134XCP|LB|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|2||||NPAP|NON-PROSTATIC ACID PHOSPHATASE|||||||10^7 CFU|||||||INDETERMINATE||10^6 COPIES/ML||||LOW|NOT DONE||||PLASMA|ROOM TEMPERATURE|Y|SNELLEN EYE CHART|CKD-EPI CYSTATIN C FORMULA||N|Y|N|U|||Y|5||7||TREATMENT|1963-08-01|1968-01-22|||||1973-05-21||1967-03-07|U|1965-12-20
TRIAL STUDY 134XCP|LB|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|1||||LRZPM|LORAZEPAM|||||||MM2|||||||POSITIVE||UM2||||LOW|NOT DONE||||VENOUS PLASMA|FROZEN|U|REVERSE TRANSCRIPTASE PCR|CKD-EPI CREATININE FORMULA||NA|Y|NA|N|||U|1||38||INDUCTION TREATMENT|1968-10-20|1968-02-15|||||1962-08-30||1960-10-21|Y|1966-03-21
TRIAL STUDY 134XCP|LB|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|2||||C130118|BEE MIX ANTIGEN IGG4 ANTIBODY|||||||AMU|||||||BORDERLINE||ML/M2||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|ROOM TEMPERATURE|U|ELISA|MDRD ENZYMATIC FORMULA||N|N|NA|U|||NA|1||38||TREATMENT|1964-09-21|1967-05-08|||||1963-10-30||1962-06-17|Y|1962-09-01
TRIAL STUDY 134XCP|LB|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|1||||CYAMMBIU|AMMONIUM BIURATE CRYSTALS|||||||10^3/L|||||||INDETERMINATE||10^9 ORGANISMS/MG||||LOW|NOT DONE||||PERITONEAL FLUID|THAWED|Y|POPULATION SEQUENCING|MDRD 5 VARIABLE FORMULA||N|U|Y|U|||Y|2||58||CONTINUATION TREATMENT|1960-01-14|1968-01-28|||||1965-10-12||1967-11-17|U|1968-04-24
TRIAL STUDY 134XCP|LB|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|2||||PHNBRBTL|PHENOBARBITAL|||||||BP|||||||BORDERLINE||PA||||NORMAL|NOT DONE||||TISSUE|CALCIFIED|U|TOTAL BODY IRRADIATION|MDRD ENZYMATIC FORMULA||NA|U|N|Y|||NA|2||58||TREATMENT|1971-01-06|1968-12-25|||||1961-01-16||1960-05-19|Y|1962-01-28
TRIAL STUDY 134XCP|LB|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|1||||MMP9|MATRIX METALLOPROTEINASE 9|||||||NMOL|||||||INDETERMINATE||10^6 ORGANISMS/MG||||HIGH|NOT DONE||||TISSUE|REFRIGERATED|U|ZIEHL NEELSEN ACID FAST STAIN|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|U|NA|||Y|3||39||WASHOUT|1963-06-02|1961-03-29|||||1965-07-22||1965-03-15|N|1970-04-03
TRIAL STUDY 134XCP|LB|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|2||||STOMCY|STOMATOCYTES|||||||CP|||||||NEGATIVE||KDA||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|FRESH|U|PANENDOSCOPY|GMI % FORMULA||NA|U|N|Y|||U|3||39||WASHOUT|1961-09-18|1964-06-15|||||1973-03-20||1969-08-20|N|1972-07-06
TRIAL STUDY 134XCP|LB|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|1||||FATACVLC|FATTY ACIDS, VERY LONG CHAIN|||||||G/M2|||||||BORDERLINE||U/KG/DAY||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|CLOTTED|NA|X-RAY|CKD-EPI FORMULA||U|U|NA|NA|||U|4||88||OBSERVATION|1966-09-11|1970-04-19|||||1968-02-09||1973-06-30|Y|1973-01-19
TRIAL STUDY 134XCP|LB|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|2||||CD2|CD2|||||||UGEQ|||||||BORDERLINE||NFIU||||NORMAL|NOT DONE||||LOCHIA|THAWED|U|JAEGER EYE CHART|CKD-EPI FORMULA||Y|U|N|U|||U|4||88||OBSERVATION|1970-06-29|1967-05-03|||||1961-12-04||1970-11-19|NA|1969-08-22
TRIAL STUDY 134XCP|LB|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|1||||LTA|LYMPHOTOXIN ALPHA|||||||ML/CM|||||||NEGATIVE||DNA COPIES/ML||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH|N|MICRODENSITOMETRY|GMI MMOL/MOL FORMULA||N|NA|U|N|||U|5||7||FOLLOW-UP|1964-05-01|1962-07-17|||||1965-05-01||1968-08-06|NA|1964-04-23
TRIAL STUDY 134XCP|LB|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|2||||AG1_5|1,5-ANHYDROGLUCITOL|||||||/2500 WBC|||||||INDETERMINATE||PT_BR||||NORMAL|NOT DONE||||CORD SERUM|SOLIDIFIED|NA|RAJI CELL EIA|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|Y|N|||Y|5||7||WASHOUT|1972-09-10|1969-10-18|||||1963-09-05||1971-12-26|NA|1961-08-25
TRIAL STUDY 134XCP|LB|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|1||||AMYLOIDB|AMYLOID, BETA|||||||M2|||||||NEGATIVE||IU/ML||||LOW|NOT DONE||||WHITE MATTER TISSUE|AUTOLYZED|N|PYROSEQUENCING|FIBROMETER FORMULA||Y|Y|Y|N|||N|1||38||SCREENING|1967-07-21|1960-03-16|||||1964-11-11||1971-04-05|NA|1968-04-22
TRIAL STUDY 134XCP|LB|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|2||||PRCTC|PROSTATE CIRCULATING TUMOR CELLS|||||||MJOULE/CM2|||||||BORDERLINE||DROP||||LOW|NOT DONE||||PLATELET RICH PLASMA|LIPEMIC|U|KLEIHAUER-BETKE|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|N|NA|||U|1||38||CONTINUATION TREATMENT|1969-06-10|1962-09-13|||||1965-10-27||1965-03-10|NA|1961-01-14
TRIAL STUDY 134XCP|LB|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|1||||PCDW|PLATELET COMPONENT DISTRIBUTION WIDTH|||||||CCID 50/DOSE|||||||BORDERLINE||10^3 ORGANISMS||||ABNORMAL|NOT DONE||||HAIR|SOLIDIFIED|Y|GC/MS|CKD-EPI FORMULA||NA|N|N|NA|||U|2||58||OPEN LABEL TREATMENT|1971-02-09|1972-05-09|||||1966-02-19||1970-02-22|U|1967-02-14
TRIAL STUDY 134XCP|LB|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|2||||CD38|CD38|||||||CD*S/M2|||||||INDETERMINATE||MM2||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|PARAFFIN-EMBEDDED|N|POLYSOMNOGRAPHY|COCKCROFT-GAULT FORMULA||U|Y|U|N|||U|2||58||LONG-TERM FOLLOW-UP|1961-06-15|1961-01-01|||||1970-12-27||1966-03-18|N|1972-07-19
TRIAL STUDY 134XCP|LB|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|1||||PROGRP|PRO-GASTRIN RELEASING PEPTIDE|||||||SFC/10^6 PBMC|||||||BORDERLINE||%/MIN||||ABNORMAL|NOT DONE||||BASAL TEAR|CLOTTED|NA|LASER CAPTURE MICRODISSECTION|MDRD 5 VARIABLE FORMULA||U|N|Y|NA|||N|3||39||OPEN LABEL TREATMENT|1972-08-31|1964-03-29|||||1965-06-15||1961-05-05|N|1965-11-22
TRIAL STUDY 134XCP|LB|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|2||||C165893|WILD RYE POLLEN IGE AB RAST SCORE|||||||MG/KG/H|||||||BORDERLINE||KCAL/DAY||||NORMAL|NOT DONE||||VENOUS PLASMA|ROOM TEMPERATURE|N|DIGITAL PCR ARRAY|NASH FIBROSURE FORMULA||U|Y|Y|U|||U|3||39||LONG-TERM FOLLOW-UP|1962-06-23|1967-12-01|||||1969-10-13||1960-03-12|Y|1970-03-18
TRIAL STUDY 134XCP|LB|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|1||||CSGRAN|GRANULAR CASTS|||||||MAMP|||||||INDETERMINATE||BQ/MG||||NORMAL|NOT DONE||||BONE|CLOTTED|U|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD FORMULA||NA|NA|Y|U|||U|4||88||INDUCTION TREATMENT|1963-07-30|1961-12-02|||||1961-10-17||1970-11-11|U|1973-03-19
TRIAL STUDY 134XCP|LB|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|2||||ABNCECE|ABNORMAL CELLS/TOTAL CELLS|||||||10^3 ORGANISMS|||||||NEGATIVE||UG/KG||||LOW|NOT DONE||||SYNOVIAL FLUID|GELLED|Y|TRICHROME STAIN|FIBROSIS 4 FORMULA||Y|NA|Y|N|||N|4||88||OPEN LABEL TREATMENT|1962-12-24|1971-10-16|||||1970-02-01||1969-04-01|U|1968-09-15
TRIAL STUDY 134XCP|LB|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|1||||EOSIM|IMMATURE EOSINOPHILS|||||||NMOL/KG/DAY|||||||POSITIVE||AMOL||||HIGH|NOT DONE||||HAIR FOLLICLE|CONTAMINATED|NA|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|COCKCROFT-GAULT FORMULA||Y|Y|NA|NA|||Y|5||7||BASELINE|1973-01-07|1962-03-14|||||1973-07-18||1960-09-07|U|1969-01-27
TRIAL STUDY 134XCP|LB|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|2||||ERCEMIDX|ERYTHROID MATURATION INDEX|||||||NMOL/L|||||||INVALID||TRACE||||LOW|NOT DONE||||SERUM OR PLASMA|CLOTTED|NA|FLOCCULATION, CHARCOAL ENHANCED|CKD-EPI CREATININE FORMULA||U|NA|NA|N|||Y|5||7||BASELINE|1961-06-05|1961-04-09|||||1970-02-13||1965-02-05|NA|1967-08-04
TRIAL STUDY 134XCP|LB|640DDEF5-748A-4F92-A13D-15D1C7CE0800|1||||C165880|D. PTERONYSSINUS IGE AB RAST SCORE|||||||P|||||||TRACE||MEQ/DL||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONTAMINATED|N|CENTRIFUGATION|FIBROMETER FORMULA||N|U|NA|Y|||NA|1||38||OPEN LABEL TREATMENT|1968-09-16|1973-05-15|||||1970-03-08||1973-03-19|U|1969-05-17
TRIAL STUDY 134XCP|LB|640DDEF5-748A-4F92-A13D-15D1C7CE0800|2||||HLADRMSC|HLA-DR MISMATCH COUNT|||||||G/DAY|||||||BORDERLINE||CM H2O||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|LIPEMIC|U|PUPILLOMETRY|MDRD FORMULA||N|U|N|N|||NA|1||38||WASHOUT|1968-01-12|1968-04-24|||||1962-05-03||1965-06-22|N|1961-09-14
TRIAL STUDY 134XCP|LB|640DDEF5-748A-4F92-A13D-15D1C7CE0800|1||||VITD2425|24,25-DIHYDROXYVITAMIN D|||||||ABSORBANCE U|||||||INDETERMINATE||10^9 ORGANISMS/MG||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|Y|OSCILLOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|Y|NA|||N|2||58||OBSERVATION|1960-08-16|1961-01-04|||||1967-07-10||1961-08-08|N|1972-05-30
TRIAL STUDY 134XCP|LB|640DDEF5-748A-4F92-A13D-15D1C7CE0800|2||||ALPBS|BONE SPECIFIC ALKALINE PHOSPHATASE|||||||KCAL|||||||INDETERMINATE||ML/ANIMAL/WK||||NORMAL|NOT DONE||||AQUEOUS HUMOR|FRESH|Y|SPECT/CT SCAN|ASH FIBROSURE FORMULA||NA|N|N|NA|||N|2||58||FOLLOW-UP|1968-11-29|1961-10-31|||||1964-12-30||1973-08-02|U|1962-06-17
TRIAL STUDY 134XCP|LB|640DDEF5-748A-4F92-A13D-15D1C7CE0800|1||||MSTHCE|MESOTHELIAL CELLS|||||||ECL UNIT|||||||NEGATIVE||DEG2||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR|U|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|CKD-EPI CYSTATIN C FORMULA||U|N|Y|N|||Y|3||39||WASHOUT|1968-02-09|1971-07-13|||||1966-04-03||1967-04-02|N|1965-09-16
TRIAL STUDY 134XCP|LB|640DDEF5-748A-4F92-A13D-15D1C7CE0800|2||||MSPIKEPT|MONOCLONAL PROTEIN SPIKE/TOTAL PROTEIN|||||||BREATHS/MIN|||||||INVALID||MET*MIN||||HIGH|NOT DONE||||DERMAL TISSUE|ICTERIC|U|MOUSE PROTECTION ASSAY|ASH FIBROSURE FORMULA||Y|U|U|U|||NA|3||39||CONTINUATION TREATMENT|1966-07-16|1967-11-18|||||1965-07-13||1973-09-04|NA|1961-06-18
TRIAL STUDY 134XCP|LB|640DDEF5-748A-4F92-A13D-15D1C7CE0800|1||||B1BGLP|BETA-1B GLYCOPROTEIN|||||||IN|||||||INDETERMINATE||ANTIBODY UNIT||||LOW|NOT DONE||||HAIR FOLLICLE|DRIED|NA|RULER MEASUREMENT METHOD|FIBROSIS 4 FORMULA||NA|U|Y|NA|||Y|4||88||SCREENING|1968-08-11|1963-11-03|||||1973-01-31||1965-12-23|NA|1963-03-18
TRIAL STUDY 134XCP|LB|640DDEF5-748A-4F92-A13D-15D1C7CE0800|2||||CTXICRT|TYPE I COLLAGEN C-TELOPEPTIDES/CREAT|||||||UG/MIN|||||||TRACE||MEQ/L||||NORMAL|NOT DONE||||BONE MARROW|SOLIDIFIED|U|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||Y|N|Y|NA|||U|4||88||OBSERVATION|1971-11-19|1965-01-03|||||1962-07-08||1970-11-21|U|1964-01-23
TRIAL STUDY 134XCP|LB|640DDEF5-748A-4F92-A13D-15D1C7CE0800|1||||TNF12EXR|TNF SUPERFAMILY MEMBER 12 EXCRETION RATE|||||||JAR|||||||INDETERMINATE||/100 WBC||||HIGH|NOT DONE||||HAIR FOLLICLE|GELLED|Y|LANDOLT RING|MDRD 6 VARIABLE FORMULA||NA|N|Y|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1964-02-09|1963-05-19|||||1966-12-20||1962-12-11|U|1969-02-13
TRIAL STUDY 134XCP|LB|640DDEF5-748A-4F92-A13D-15D1C7CE0800|2||||VITD23OH|VITAMIN D2 D3 25-OH|||||||%(W/V)|||||||POSITIVE||SHOCK WAVE||||LOW|NOT DONE||||EMESIS|CONCENTRATED|U|CONTRAST ENHANCED SPIRAL CT SCAN|FIBROSIS 4 FORMULA||U|U|N|NA|||U|5||7||OPEN LABEL TREATMENT|1969-07-13|1967-09-22|||||1968-07-12||1964-02-13|U|1965-02-01
TRIAL STUDY 134XCP|LB|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|1||||CACREAT|CALCIUM/CREATININE|||||||DB|||||||POSITIVE||LOG10 TCID 50/UL||||LOW|NOT DONE||||SERUM OR PLASMA|ROOM TEMPERATURE|N|LYMPHANGIOGRAPHY|FIBROSIS 4 FORMULA||NA|U|Y|N|||U|1||38||FOLLOW-UP|1960-06-04|1968-11-18|||||1973-07-06||1971-09-07|Y|1971-10-14
TRIAL STUDY 134XCP|LB|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|2||||ACANTRBC|ACANTHOCYTES/ERYTHROCYTES|||||||PPM|||||||BORDERLINE||MMOL/MIN/KPA||||LOW|NOT DONE||||PERITONEAL FLUID|UNEXPECTED ODOR|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|N|U|||Y|1||38||OBSERVATION|1963-03-15|1963-12-14|||||1965-12-23||1973-03-27|NA|1966-01-03
TRIAL STUDY 134XCP|LB|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|1||||IFI44|INTERFERON-INDUCED PROTEIN 44|||||||BQ/UG|||||||BORDERLINE||PATCH||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|CONCENTRATED|Y|HPLC|MDRD 4 VARIABLE FORMULA||NA|N|NA|U|||Y|2||58||CONTINUATION TREATMENT|1960-09-06|1968-12-26|||||1973-06-20||1966-12-04|U|1967-02-23
TRIAL STUDY 134XCP|LB|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|2||||IGHG2|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 2|||||||PT_BR|||||||BORDERLINE||DNA COPIES/ML||||NORMAL|NOT DONE||||PROSTATIC FLUID|DRIED|N|ENZYMATIC SPECTROPHOTOMETRY|COCKCROFT-GAULT FORMULA||U|N|N|Y|||N|2||58||BASELINE|1968-09-12|1970-03-10|||||1966-07-24||1970-05-19|NA|1961-06-11
TRIAL STUDY 134XCP|LB|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|1||||ISG15|UBIQUITIN-LIKE PROTEIN ISG15|||||||NMOL/ML/MIN|||||||TRACE||MIU/L||||ABNORMAL|NOT DONE||||PUS|AUTOLYZED|U|SISH|NASH FIBROSURE FORMULA||Y|U|Y|NA|||Y|3||39||OPEN LABEL TREATMENT|1961-02-06|1963-03-06|||||1964-06-16||1964-11-07|U|1966-01-16
TRIAL STUDY 134XCP|LB|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|2||||LYMPHOTC|LYMPHOTACTIN|||||||MOSM/KG|||||||POSITIVE||CIGARETTE||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CALCIFIED|Y|FUNCTIONAL MRI|NASH FIBROSURE FORMULA||NA|U|Y|Y|||Y|3||39||TREATMENT|1965-03-18|1970-03-07|||||1962-01-03||1969-01-26|Y|1972-01-06
TRIAL STUDY 134XCP|LB|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|1||||NEUTAGR|AGRANULAR NEUTROPHILS|||||||U/KG/DAY|||||||BORDERLINE||TRANSDUCING UNIT||||HIGH|NOT DONE||||ARTERIAL BLOOD|LACTESCENT|U|RULER MEASUREMENT METHOD|HEPASCORE FORMULA||Y|Y|Y|U|||NA|4||88||SCREENING|1966-10-21|1966-08-01|||||1963-06-17||1960-08-13|U|1970-02-04
TRIAL STUDY 134XCP|LB|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|2||||CHOL|CHOLESTEROL|||||||WAFER|||||||BORDERLINE||YEARS||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CLOTTED|Y|SINGLE-SLICE SPIRAL CT|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|U|NA|||N|4||88||OPEN LABEL TREATMENT|1963-09-10|1971-09-14|||||1966-07-17||1962-03-28|U|1968-10-31
TRIAL STUDY 134XCP|LB|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|1||||MMP1|MATRIX METALLOPROTEINASE 1|||||||BU/ML|||||||BORDERLINE||LOG10 ELISA UNIT/DOSE||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|SOLIDIFIED|N|ACID FAST STAIN|MDRD FORMULA||N|Y|NA|Y|||U|5||7||CONTINUATION TREATMENT|1973-05-28|1961-09-08|||||1967-07-11||1971-10-08|N|1963-07-05
TRIAL STUDY 134XCP|LB|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|2||||CCL7|CHEMOKINE (C-C MOTIF) LIGAND 7|||||||MPS U|||||||INDETERMINATE||10^6 CFU/ML||||NORMAL|NOT DONE||||TUMOR TISSUE|NON-HEMOLYZED|Y|LYMPHANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||U|NA|Y|N|||N|5||7||TREATMENT|1960-06-04|1969-09-28|||||1971-02-05||1968-08-19|N|1967-03-16
TRIAL STUDY 134XCP|LB|EBC7BF7B-18C6-463C-8500-027B2A6966DB|1||||PRGNENLN|PREGNENOLONE|||||||10^9 ORGANISMS/G|||||||INDETERMINATE||CMOL/L||||NORMAL|NOT DONE||||CELL PELLET|CALCIFIED|Y|HEMAGGLUTINATION INHIBITION ASSAY|FIBROMETER FORMULA||U|NA|N|Y|||U|1||38||WASHOUT|1965-08-31|1960-02-08|||||1972-05-04||1960-05-12|Y|1972-09-18
TRIAL STUDY 134XCP|LB|EBC7BF7B-18C6-463C-8500-027B2A6966DB|2||||TCDCA|TAUROCHENODEOXYCHOLATE|||||||OZ|||||||POSITIVE||/2000 RBC||||NORMAL|NOT DONE||||AQUEOUS HUMOR|DRIED|NA|PULSE OXIMETRY|CKD-EPI FORMULA||Y|NA|Y|N|||N|1||38||BASELINE|1968-07-11|1970-11-26|||||1967-09-30||1972-07-26|N|1971-02-07
TRIAL STUDY 134XCP|LB|EBC7BF7B-18C6-463C-8500-027B2A6966DB|1||||PHADJT|PH ADJUSTED FOR BODY TEMP|||||||ML/G/DAY|||||||NEGATIVE||MMHG*MIN/L||||LOW|NOT DONE||||SALIVA|ICTERIC|NA|FLOW CYTOMETRY|COCKCROFT-GAULT FORMULA||N|Y|Y|Y|||U|2||58||LONG-TERM FOLLOW-UP|1960-09-20|1961-09-02|||||1965-03-18||1963-06-16|N|1963-09-04
TRIAL STUDY 134XCP|LB|EBC7BF7B-18C6-463C-8500-027B2A6966DB|2||||GLUCPE|PLASMA EQUIVALENT GLUCOSE|||||||OZ EQ|||||||TRACE||UMOL/MIN||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|CONCENTRATED|NA|RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI FORMULA||NA|N|U|NA|||NA|2||58||TREATMENT|1968-04-16|1966-04-04|||||1972-12-16||1961-09-01|Y|1961-10-23
TRIAL STUDY 134XCP|LB|EBC7BF7B-18C6-463C-8500-027B2A6966DB|1||||C130140|GERMAN COCKROACH ANTIGEN IGE ANTIBODY|||||||BOTTLE|||||||INVALID||ELISA UNIT/ML||||HIGH|NOT DONE||||TUMOR TISSUE|CONTAMINATED|U|QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROSIS 4 FORMULA||Y|U|N|U|||N|3||39||TREATMENT|1971-09-13|1963-09-13|||||1963-11-01||1963-02-19|U|1967-10-31
TRIAL STUDY 134XCP|LB|EBC7BF7B-18C6-463C-8500-027B2A6966DB|2||||APOE4|APOLIPOPROTEIN E4|||||||SUPPOSITORY|||||||BORDERLINE||UG/KG/H||||ABNORMAL|NOT DONE||||NAIL|UNEXPECTED ODOR|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA||N|N|U|N|||Y|3||39||TREATMENT|1968-03-21|1969-09-13|||||1964-11-02||1969-03-03|NA|1971-04-11
TRIAL STUDY 134XCP|LB|EBC7BF7B-18C6-463C-8500-027B2A6966DB|1||||FLUVOXAM|FLUVOXAMINE|||||||KALLIKREIN INHIBITOR UNIT|||||||INDETERMINATE||TUBERCULIN UNIT/ML||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|DRIED|N|CELL OF ORIGIN ASSAY|FIBROMETER FORMULA||N|NA|N|N|||Y|4||88||FOLLOW-UP|1966-05-03|1961-05-16|||||1964-10-16||1971-11-05|NA|1967-10-04
TRIAL STUDY 134XCP|LB|EBC7BF7B-18C6-463C-8500-027B2A6966DB|2||||CAMP|CYCLIC ADENOSINE 3,5-MONOPHOSPHATE|||||||MG/DAY|||||||POSITIVE||/MONTH||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED|NA|PERCUSSION|FIBROSIS 4 FORMULA||U|U|NA|NA|||N|4||88||CONTINUATION TREATMENT|1969-06-20|1968-01-28|||||1962-01-13||1964-01-20|N|1961-04-15
TRIAL STUDY 134XCP|LB|EBC7BF7B-18C6-463C-8500-027B2A6966DB|1||||C147279|ZEA MAYS ANTIGEN IGE ANTIBODY|||||||BOTTLE|||||||TRACE||/LPF||||HIGH|NOT DONE||||PLASMA|PARAFFIN-EMBEDDED|U|IMMUNOCHROMATOGRAPHY|MDRD FORMULA||N|NA|N|Y|||NA|5||7||CONTINUATION TREATMENT|1967-02-08|1961-07-03|||||1964-08-28||1962-03-14|NA|1973-09-02
TRIAL STUDY 134XCP|LB|EBC7BF7B-18C6-463C-8500-027B2A6966DB|2||||NEUTLE|NEUTROPHILS/LEUKOCYTES|||||||UGEQ|||||||POSITIVE||10^6/EJACULATE U||||NORMAL|NOT DONE||||BREAST MILK|PARAFFIN-EMBEDDED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA||NA|U|N|U|||U|5||7||FOLLOW-UP|1965-07-31|1960-09-02|||||1962-12-14||1962-09-21|N|1963-04-24
TRIAL STUDY 134XCP|LB|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|1||||APOA4|APOLIPOPROTEIN A4|||||||EID 50/DOSE|||||||INDETERMINATE||MU/G||||NORMAL|NOT DONE||||CAPILLARY BLOOD|THAWED|NA|PHASE CONTRAST MICROSCOPY|MDRD ENZYMATIC FORMULA||N|N|N|U|||NA|1||38||OPEN LABEL TREATMENT|1966-12-17|1963-05-18|||||1972-05-12||1965-11-30|NA|1968-06-25
TRIAL STUDY 134XCP|LB|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|2||||HIST3AB|HISTONE 3 ANTIBODY|||||||GY|||||||NEGATIVE||HZ/S||||HIGH|NOT DONE||||BUFFY COAT|CONCENTRATED|NA|ELECTROCHEMILUMINESCENCE|GMI % FORMULA||NA|N|NA|NA|||Y|1||38||OPEN LABEL TREATMENT|1971-11-16|1973-02-04|||||1969-09-13||1968-12-04|NA|1967-10-08
TRIAL STUDY 134XCP|LB|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|1||||NICOTINE|NICOTINE|||||||PKAT/L|||||||INDETERMINATE||10^6/G||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|DRIED|N|VENTILATION PERFUSION LUNG SCAN|GMI % FORMULA||NA|Y|N|NA|||Y|2||58||SCREENING|1964-05-06|1968-01-11|||||1973-01-15||1967-09-26|U|1967-01-23
TRIAL STUDY 134XCP|LB|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|2||||MONONSQE|MONOCYTES/NON-SQUAM EPI CELLS|||||||DRAM|||||||NEGATIVE||SV||||NORMAL|NOT DONE||||CAPILLARY PLASMA|SOLIDIFIED|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|ASH FIBROSURE FORMULA||NA|N|NA|Y|||Y|2||58||OPEN LABEL TREATMENT|1964-02-29|1960-01-14|||||1969-04-05||1964-08-07|Y|1967-07-26
TRIAL STUDY 134XCP|LB|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|1||||ALT|ALANINE AMINOTRANSFERASE|||||||LM|||||||BORDERLINE||PG||||HIGH|NOT DONE||||CAPILLARY PLASMA|CALCIFIED|NA|SLOAN LETTER EYE CHART 1.25%|FIBROMETER FORMULA||U|Y|U|N|||NA|3||39||WASHOUT|1962-02-17|1969-10-28|||||1970-05-21||1967-12-21|NA|1967-10-28
TRIAL STUDY 134XCP|LB|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|2||||IRON|IRON|||||||/5X10^4 WBC|||||||BORDERLINE||ML/CM3/MIN||||HIGH|NOT DONE||||SEMEN|GELLED|Y|SINGLE-MOLECULE ARRAY|FIBROTEST FORMULA||N|U|Y|N|||N|3||39||OPEN LABEL TREATMENT|1961-04-21|1967-01-31|||||1968-08-20||1966-07-14|Y|1965-12-01
TRIAL STUDY 134XCP|LB|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|1||||TK1|THYMIDINE KINASE 1|||||||POUCH|||||||TRACE||10^6 ORGANISMS||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|HEMOLYZED|U|LC-FL|FIBROSIS 4 FORMULA||U|N|U|U|||NA|4||88||FOLLOW-UP|1971-05-19|1971-05-05|||||1971-10-31||1962-03-04|U|1960-09-11
TRIAL STUDY 134XCP|LB|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|2||||RNPSMAB|RIBONUCLEOPROTEIN SMITH COMPLEX ANTIBODY|||||||MONTHS|||||||BORDERLINE||U/KG/H||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|NON-HEMOLYZED|N|LC/MS/MS|CKD-EPI FORMULA||U|N|N|Y|||Y|4||88||FOLLOW-UP|1972-08-10|1970-05-14|||||1961-01-29||1963-01-25|Y|1960-01-20
TRIAL STUDY 134XCP|LB|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|1||||LTF|LACTOFERRIN|||||||FFU|||||||TRACE||U/M2||||LOW|NOT DONE||||MECONIUM|LACTESCENT|U|HIGH RESOLUTION MELT ANALYSIS|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|NA|||N|5||7||SCREENING|1969-01-28|1970-09-04|||||1968-11-24||1967-10-11|NA|1971-10-25
TRIAL STUDY 134XCP|LB|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|2||||PFCT|PLATELET FUNCTION CLOSURE TIME|||||||UMOL/MIN|||||||INVALID||10^6 ORGANISMS/MG||||LOW|NOT DONE||||FLUID|HEMOLYZED|N|CINEANGIOGRAPHY|GMI MMOL/MOL FORMULA||U|N|Y|N|||U|5||7||BLINDED TREATMENT|1972-08-24|1970-07-30|||||1965-05-24||1962-09-26|NA|1973-06-10
TRIAL STUDY 134XCP|LB|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|1||||MASTCE|MAST CELLS|||||||%|||||||BORDERLINE||IU/DL||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|FRESH|U|NEURAMINIDASE INHIBITION ASSAY|MDRD 5 VARIABLE FORMULA||N|Y|U|Y|||NA|1||38||OPEN LABEL TREATMENT|1966-06-29|1972-08-19|||||1960-07-18||1961-07-02|U|1960-07-10
TRIAL STUDY 134XCP|LB|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|2||||SDMA|SYMMETRIC DIMETHYLARGININE|||||||UCI|||||||BORDERLINE||UG/KG/H||||HIGH|NOT DONE||||LYMPH|HEMOLYZED|N|CYSTOMETRY|MDRD 6 VARIABLE FORMULA||U|Y|U|U|||U|1||38||FOLLOW-UP|1964-08-31|1960-09-07|||||1968-10-08||1969-12-26|N|1961-10-17
TRIAL STUDY 134XCP|LB|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|1||||B2G1GMAB|BETA-2 GLYCOPROTEIN 1 IGM ANTIBODY|||||||ML/BREATH|||||||TRACE||U/KG||||NORMAL|NOT DONE||||AQUEOUS HUMOR|FRESH|N|PHOTOMETRIC CLOT DETECTION|MDRD ENZYMATIC FORMULA||U|U|NA|U|||Y|2||58||SCREENING|1971-08-09|1961-04-10|||||1965-01-14||1973-04-26|NA|1968-12-15
TRIAL STUDY 134XCP|LB|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|2||||NTRLFAT|NEUTRAL FATS|||||||L/H/M2|||||||TRACE||10^12/L||||NORMAL|NOT DONE||||SEBUM|AUTOLYZED|N|DISK DIFFUSION|FIBROSIS 4 FORMULA||Y|N|U|U|||NA|2||58||OPEN LABEL TREATMENT|1970-05-11|1963-02-06|||||1971-03-27||1970-11-05|NA|1962-11-29
TRIAL STUDY 134XCP|LB|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|1||||TCHT|TAUROCHOLATE|||||||UOSM|||||||INDETERMINATE||CFU/G||||HIGH|NOT DONE||||SEBUM|AUTOLYZED|Y|INTRAVASCULAR ULTRASOUND|GMI % FORMULA||Y|NA|NA|N|||N|3||39||FOLLOW-UP|1961-07-05|1962-11-09|||||1966-09-17||1969-02-02|N|1970-05-10
TRIAL STUDY 134XCP|LB|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|2||||HYPGST17|17-HYDROXYPROGESTERONE|||||||UG/G/MIN|||||||BORDERLINE||10^6 COPIES/ML||||NORMAL|NOT DONE||||EXUDATE|HEMOLYZED|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD ENZYMATIC FORMULA||NA|N|NA|N|||U|3||39||LONG-TERM FOLLOW-UP|1961-12-14|1967-12-08|||||1965-06-01||1960-02-17|Y|1963-05-02
TRIAL STUDY 134XCP|LB|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|1||||FATDROP|FAT DROPLET|||||||DEG2|||||||BORDERLINE||PA||||LOW|NOT DONE||||ABSCESS FLUID|CLOTTED|Y|PATHOLOGICAL EVALUATION|MDRD 6 VARIABLE FORMULA||NA|N|N|N|||U|4||88||BLINDED TREATMENT|1969-02-14|1967-01-04|||||1965-03-31||1964-09-21|NA|1967-06-15
TRIAL STUDY 134XCP|LB|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|2||||COPEP|COPEPTIN|||||||LOG10 TCID 50/DOSE|||||||INDETERMINATE||CMOL/L||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|NON-HEMOLYZED|Y|SPIRAL CT|CKD-EPI CYSTATIN C FORMULA||U|U|Y|U|||N|4||88||BASELINE|1973-09-03|1965-12-08|||||1970-12-25||1963-02-20|NA|1972-03-17
TRIAL STUDY 134XCP|LB|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|1||||PLSIMCLY|IMMATURE PLASMA CELLS/LYMPHOCYTES|||||||LOG10 COPIES/ML|||||||NEGATIVE||UG/L FEU||||NORMAL|NOT DONE||||ALVEOLAR AIR|AGGLUTINATED|N|TURBIDIMETRY|MDRD ENZYMATIC FORMULA||NA|U|N|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1964-01-29|1963-06-20|||||1960-09-16||1970-10-11|Y|1973-04-05
TRIAL STUDY 134XCP|LB|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|2||||PC3MPSAM|PCA3 MRNA/PSA MRNA|||||||10^6/EJACULATE U|||||||BORDERLINE||KALLIKREIN INHIBITOR UNIT||||NORMAL|NOT DONE||||VENOUS BLOOD|SOLIDIFIED|Y|PEAK FLOWMETRY|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|N|N|||Y|5||7||BLINDED TREATMENT|1973-08-23|1968-01-08|||||1964-03-24||1964-02-05|Y|1960-09-22
TRIAL STUDY 134XCP|LB|74741526-F925-4AA5-9BE3-F3B3884BEE68|1||||CORTFR|CORTISOL, FREE|||||||KEV|||||||INDETERMINATE||MCI||||ABNORMAL|NOT DONE||||LEUKOCYTE|UNEXPECTED ODOR|U|QUANTITATIVE ULTRASOUND|MDRD FORMULA||U|NA|NA|N|||NA|1||38||CONTINUATION TREATMENT|1965-12-08|1973-08-17|||||1967-08-19||1964-06-14|Y|1967-06-19
TRIAL STUDY 134XCP|LB|74741526-F925-4AA5-9BE3-F3B3884BEE68|2||||HGBFHGB|HEMOGLOBIN F/TOTAL HEMOGLOBIN|||||||CI/L|||||||NEGATIVE||CM/S||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|CLOTTED|N|FLUORESCEIN STAIN|CKD-EPI CREATININE FORMULA||NA|Y|U|Y|||Y|1||38||LONG-TERM FOLLOW-UP|1964-02-18|1970-03-05|||||1967-08-30||1966-09-13|NA|1967-01-26
TRIAL STUDY 134XCP|LB|74741526-F925-4AA5-9BE3-F3B3884BEE68|1||||PTHCT|PARATHYROID HORMONE, C-TERMINAL|||||||G/ANIMAL/DAY|||||||TRACE||BE/ML||||ABNORMAL|NOT DONE||||SALIVA|GELLED|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|HEPASCORE FORMULA||Y|Y|Y|U|||U|2||58||SCREENING|1968-10-30|1970-04-26|||||1970-07-18||1971-06-12|NA|1966-10-28
TRIAL STUDY 134XCP|LB|74741526-F925-4AA5-9BE3-F3B3884BEE68|2||||ELA2PMN|NEUTROPHIL ELASTASE, POLYMORPHONUCLEAR|||||||10^9 ORGANISMS/G|||||||INDETERMINATE||CCID 50/DOSE||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|ICTERIC|NA|LASER CAPTURE MICRODISSECTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|Y|||NA|2||58||TREATMENT|1968-05-28|1965-10-11|||||1961-11-20||1973-02-22|U|1971-05-19
TRIAL STUDY 134XCP|LB|74741526-F925-4AA5-9BE3-F3B3884BEE68|1||||CYSTHION|CYSTATHIONINE|||||||AG|||||||INVALID||CMH2O/ML||||NORMAL|NOT DONE||||AQUEOUS HUMOR|LACTESCENT|NA|ENZYMATIC ULTRACENTRIFUGATION|MDRD 6 VARIABLE FORMULA||U|Y|N|N|||Y|3||39||BLINDED TREATMENT|1973-03-26|1966-08-05|||||1973-04-22||1966-12-19|NA|1964-09-04
TRIAL STUDY 134XCP|LB|74741526-F925-4AA5-9BE3-F3B3884BEE68|2||||IDL|IDL CHOLESTEROL|||||||UG/G/DAY|||||||POSITIVE||CMOL||||NORMAL|NOT DONE||||ABSCESS FLUID|THAWED|U|MICROBIAL CULTURE|GMI MMOL/MOL FORMULA||NA|Y|U|Y|||NA|3||39||TREATMENT|1971-04-28|1971-03-01|||||1966-07-12||1962-12-11|Y|1968-03-13
TRIAL STUDY 134XCP|LB|74741526-F925-4AA5-9BE3-F3B3884BEE68|1||||ASTAG|ASPARTATE AMINOTRANSFERASE ANTIGEN|||||||%(W/W)|||||||BORDERLINE||PFU/ML||||ABNORMAL|NOT DONE||||SEMEN|REFRIGERATED|N|IMMUNOFIXATION ELECTROPHORESIS|FIBROTEST FORMULA||NA|NA|U|NA|||Y|4||88||TREATMENT|1973-08-27|1965-10-17|||||1972-07-11||1969-04-28|U|1964-08-30
TRIAL STUDY 134XCP|LB|74741526-F925-4AA5-9BE3-F3B3884BEE68|2||||ESTROGEN|ESTROGEN|||||||POUCH|||||||NEGATIVE||CPM||||LOW|NOT DONE||||INTERSTITIAL FLUID|CONCENTRATED|NA|CLOT DETECTION|FIBROSIS 4 FORMULA||Y|N|NA|NA|||U|4||88||FOLLOW-UP|1962-12-19|1969-12-28|||||1970-08-22||1967-05-14|U|1962-02-27
TRIAL STUDY 134XCP|LB|74741526-F925-4AA5-9BE3-F3B3884BEE68|1||||MUG|MURINOGLOBULIN|||||||KS|||||||BORDERLINE||/5X10^4 WBC||||NORMAL|NOT DONE||||TRANSUDATE|AUTOLYZED|NA|THICK SMEAR|CKD-EPI FORMULA||Y|N|N|N|||NA|5||7||LONG-TERM FOLLOW-UP|1967-03-25|1972-04-26|||||1963-05-01||1965-11-19|Y|1963-10-13
TRIAL STUDY 134XCP|LB|74741526-F925-4AA5-9BE3-F3B3884BEE68|2||||MGB|MYOGLOBIN|||||||NCI|||||||POSITIVE||L/H/M2||||LOW|NOT DONE||||KERATINOCYTE|REFRIGERATED|Y|OPTICAL COHERENCE TOMOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|N|NA|||U|5||7||BLINDED TREATMENT|1970-08-14|1963-01-26|||||1967-04-16||1967-10-07|Y|1973-02-14
TRIAL STUDY 134XCP|LB|25088C28-0FA3-4005-90C3-CCF9C6FF5851|1||||C5B9|COMPLEMENT C5B-9|||||||MEQ/UL|||||||BORDERLINE||BOX||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|REFRIGERATED|Y|LISSAMINE GREEN STAIN|ASH FIBROSURE FORMULA||Y|Y|Y|NA|||N|1||38||INDUCTION TREATMENT|1962-03-03|1971-04-10|||||1972-02-03||1968-04-28|U|1973-02-13
TRIAL STUDY 134XCP|LB|25088C28-0FA3-4005-90C3-CCF9C6FF5851|2||||PNTBRBTL|PENTOBARBITAL|||||||BAR|||||||INDETERMINATE||BEATS/MIN||||LOW|NOT DONE||||CELL PELLET|CONTAMINATED|NA|RADIAL IMMUNODIFFUSION|COCKCROFT-GAULT FORMULA||U|Y|NA|U|||Y|1||38||TREATMENT|1968-12-22|1966-01-02|||||1966-12-15||1960-04-24|N|1960-12-18
TRIAL STUDY 134XCP|LB|25088C28-0FA3-4005-90C3-CCF9C6FF5851|1||||LY6E|LYMPHOCYTE ANTIGEN 6E|||||||MEQ/UG|||||||INDETERMINATE||ML/ANIMAL/WK||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|ICTERIC|Y|IMMUNOFLUORESCENT STAIN|MDRD 6 VARIABLE FORMULA||Y|U|NA|Y|||Y|2||58||SCREENING|1966-05-28|1960-04-20|||||1961-05-12||1965-05-18|NA|1972-02-25
TRIAL STUDY 134XCP|LB|25088C28-0FA3-4005-90C3-CCF9C6FF5851|2||||PO2ADJT|PARTIAL PRESSURE OXYGEN ADJ FOR TEMP|||||||HR/DAY|||||||INDETERMINATE||/MBP||||LOW|NOT DONE||||WHITE MATTER TISSUE|CONTAMINATED|NA|MAGNETIC RESONANCE ELASTOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|N|NA|Y|||NA|2||58||OPEN LABEL TREATMENT|1973-01-25|1970-06-18|||||1962-02-07||1962-07-17|N|1961-08-13
TRIAL STUDY 134XCP|LB|25088C28-0FA3-4005-90C3-CCF9C6FF5851|1||||CCL13|CHEMOKINE (C-C MOTIF) LIGAND 13|||||||MMHG*MIN/L|||||||INVALID||KG||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|REFRIGERATED|NA|CYSTOMETRY|GMI MMOL/MOL FORMULA||Y|U|N|NA|||Y|3||39||INDUCTION TREATMENT|1961-11-13|1969-12-26|||||1960-02-14||1960-03-18|NA|1968-11-01
TRIAL STUDY 134XCP|LB|25088C28-0FA3-4005-90C3-CCF9C6FF5851|2||||TNF12EXR|TNF SUPERFAMILY MEMBER 12 EXCRETION RATE|||||||PMOL/10^10 CELLS|||||||TRACE||H*%||||NORMAL|NOT DONE||||AMNIOTIC FLUID|SOLIDIFIED|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|HEPASCORE FORMULA||NA|NA|Y|N|||N|3||39||FOLLOW-UP|1960-07-03|1965-03-03|||||1968-11-21||1969-05-01|Y|1964-11-25
TRIAL STUDY 134XCP|LB|25088C28-0FA3-4005-90C3-CCF9C6FF5851|1||||CITRTEXR|CITRATE EXCRETION RATE|||||||STEPS/MIN|||||||BORDERLINE||MG/KG/WEEK||||NORMAL|NOT DONE||||VITREOUS HUMOR|CLOTTED|Y|LINE PROBE ASSAY|CKD-EPI CREATININE FORMULA||N|Y|Y|Y|||U|4||88||TREATMENT|1971-10-09|1961-11-05|||||1961-03-20||1973-08-11|Y|1964-01-04
TRIAL STUDY 134XCP|LB|25088C28-0FA3-4005-90C3-CCF9C6FF5851|2||||CRTFREXR|CORTISOL, FREE EXCRETION RATE|||||||G/CAGE|||||||NEGATIVE||GBQ/G||||LOW|NOT DONE||||DIALYSIS FLUID|PARAFFIN-EMBEDDED|NA|CORONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|N|N|||U|4||88||TREATMENT|1971-01-09|1962-01-27|||||1967-01-01||1961-03-05|Y|1964-10-21
TRIAL STUDY 134XCP|LB|25088C28-0FA3-4005-90C3-CCF9C6FF5851|1||||LRG1|LEUCINE RICH ALPHA-2-GLYCOPROTEIN 1|||||||ML/M2/MIN|||||||INDETERMINATE||UV*SEC||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|UNEXPECTED ODOR|Y|CT SCAN|FIBROMETER FORMULA||Y|N|U|NA|||NA|5||7||RUN-IN|1968-02-17|1962-06-26|||||1964-09-27||1961-06-17|N|1970-10-25
TRIAL STUDY 134XCP|LB|25088C28-0FA3-4005-90C3-CCF9C6FF5851|2||||LDH3|LDH ISOENZYME 3|||||||DPM/ML|||||||INVALID||UL/DOSE||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|AUTOLYZED|N|KNEMOMETRY|MDRD 6 VARIABLE FORMULA||NA|NA|Y|N|||N|5||7||SCREENING|1968-05-28|1971-01-06|||||1965-12-22||1969-03-30|U|1963-11-23
TRIAL STUDY 134XCP|LB|9BF13738-0A50-46E6-A3DA-AC956A361B97|1||||VITA|VITAMIN A|||||||EIA UNIT|||||||TRACE||V/SEC||||HIGH|NOT DONE||||PLATELET|AGGLUTINATED|NA|TEMPLATE INCISION METHOD|HEPASCORE FORMULA||U|NA|NA|Y|||N|1||38||CONTINUATION TREATMENT|1968-08-08|1963-11-12|||||1970-10-23||1961-12-23|NA|1973-04-15
TRIAL STUDY 134XCP|LB|9BF13738-0A50-46E6-A3DA-AC956A361B97|2||||T4FRIDX|THYROXINE, FREE INDEX|||||||BQ/ML|||||||INDETERMINATE||DEG2||||ABNORMAL|NOT DONE||||EMESIS|GELLED|N|HIGH RESOLUTION CT|MDRD 6 VARIABLE FORMULA||NA|Y|U|NA|||U|1||38||OPEN LABEL TREATMENT|1968-06-25|1961-09-04|||||1972-09-25||1971-09-13|NA|1960-10-04
TRIAL STUDY 134XCP|LB|9BF13738-0A50-46E6-A3DA-AC956A361B97|1||||PROLYMLY|PROLYMPHOCYTES/LYMPHOCYTES|||||||CM|||||||NEGATIVE||KDA||||NORMAL|NOT DONE||||SEMEN|CONCENTRATED|N|TOTAL BODY IRRADIATION|COCKCROFT-GAULT FORMULA||N|Y|U|Y|||U|2||58||BLINDED TREATMENT|1973-03-16|1960-12-15|||||1972-09-16||1963-06-28|Y|1968-03-01
TRIAL STUDY 134XCP|LB|9BF13738-0A50-46E6-A3DA-AC956A361B97|2||||INTLK27|INTERLEUKIN 27|||||||YD|||||||POSITIVE||MHZ||||LOW|NOT DONE||||EXUDATE|PARAFFIN-EMBEDDED|NA|CELL BASED BIOASSAY|HEPASCORE FORMULA||U|NA|Y|U|||Y|2||58||WASHOUT|1967-10-16|1971-10-27|||||1960-02-22||1969-11-19|N|1961-02-14
TRIAL STUDY 134XCP|LB|9BF13738-0A50-46E6-A3DA-AC956A361B97|1||||FACTVA|FACTOR V ACTIVITY|||||||S*KPA|||||||NEGATIVE||%(V/V)||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|PARAFFIN-EMBEDDED|NA|DYNAMOMETRY|MDRD 4 VARIABLE FORMULA||Y|Y|U|Y|||N|3||39||LONG-TERM FOLLOW-UP|1966-02-19|1971-08-31|||||1971-02-11||1966-11-28|N|1964-11-07
TRIAL STUDY 134XCP|LB|9BF13738-0A50-46E6-A3DA-AC956A361B97|2||||FEMG|FRACTIONAL MAGNESIUM EXCRETION|||||||DIP|||||||INDETERMINATE||/2500 WBC||||HIGH|NOT DONE||||GASTRIC CONTENTS|ICTERIC|NA|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|FIBROSIS 4 FORMULA||N|N|N|N|||NA|3||39||FOLLOW-UP|1964-05-17|1971-06-25|||||1972-11-14||1968-05-17|N|1965-07-17
TRIAL STUDY 134XCP|LB|9BF13738-0A50-46E6-A3DA-AC956A361B97|1||||GSTAL|ALPHA GLUTATHIONE-S-TRANSFERASE|||||||ML/H|||||||INVALID||NMOL/L||||ABNORMAL|NOT DONE||||LOCHIA|NON-HEMOLYZED|Y|AUTOMATED COUNT|ASH FIBROSURE FORMULA||NA|N|Y|N|||NA|4||88||OPEN LABEL TREATMENT|1969-06-04|1969-12-05|||||1960-03-21||1968-09-19|Y|1966-03-23
TRIAL STUDY 134XCP|LB|9BF13738-0A50-46E6-A3DA-AC956A361B97|2||||C1QAB|COMPLEMENT C1Q ANTIBODY|||||||CL|||||||BORDERLINE||RNA COPIES/ML||||ABNORMAL|NOT DONE||||BREAST MILK|SOLIDIFIED|U|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|COCKCROFT-GAULT FORMULA||N|Y|U|NA|||U|4||88||TREATMENT|1965-04-22|1971-05-13|||||1966-07-13||1961-09-02|N|1967-08-09
TRIAL STUDY 134XCP|LB|9BF13738-0A50-46E6-A3DA-AC956A361B97|1||||FAT|FAT|||||||MG/M2|||||||INVALID||MMOL/MIN/KPA/L||||LOW|NOT DONE||||SMEGMA|FROZEN|NA|PHOTOGRAPHY|CKD-EPI CREATININE FORMULA||N|U|U|Y|||N|5||7||BASELINE|1971-09-11|1967-06-06|||||1968-06-16||1969-07-06|N|1966-05-15
TRIAL STUDY 134XCP|LB|9BF13738-0A50-46E6-A3DA-AC956A361B97|2||||LDH4|LDH ISOENZYME 4|||||||DAMOL/L|||||||INDETERMINATE||10^6 IU||||HIGH|NOT DONE||||PLATELET|REFRIGERATED|U|LC/MS|HEPASCORE FORMULA||Y|U|Y|NA|||Y|5||7||SCREENING|1968-06-12|1965-04-14|||||1968-06-01||1967-05-10|U|1968-08-27
TRIAL STUDY 134XCP|LB|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|1||||C130094|WESTERN RAGWEED POLLEN IGG|||||||MMOL/KG|||||||INDETERMINATE||UKAT/L||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|CONCENTRATED|U|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD 6 VARIABLE FORMULA||U|Y|NA|N|||U|1||38||OBSERVATION|1968-06-07|1961-10-01|||||1969-11-22||1971-10-23|U|1967-11-14
TRIAL STUDY 134XCP|LB|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|2||||BITECE|BITE CELLS|||||||KIT|||||||TRACE||MN||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|REFRIGERATED|NA|EIA|COCKCROFT-GAULT FORMULA||U|U|NA|Y|||Y|1||38||BLINDED TREATMENT|1966-05-09|1964-06-22|||||1963-11-14||1964-04-02|Y|1968-03-25
TRIAL STUDY 134XCP|LB|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|1||||PTSFAAC|PROTEIN S FREE ACTIVITY ACTUAL/CONTROL|||||||MEQ|||||||NEGATIVE||TUBERCULIN UNIT/ML||||HIGH|NOT DONE||||DIALYSIS FLUID|GELLED|U|FLUORESCENT SPOT TEST|ASH FIBROSURE FORMULA||U|Y|U|U|||U|2||58||WASHOUT|1963-02-11|1971-03-19|||||1963-01-06||1968-02-14|N|1967-08-27
TRIAL STUDY 134XCP|LB|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|2||||CD163S|SOLUBLE CD163|||||||PMOL/10^9 CELLS|||||||BORDERLINE||POUCH||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|LACTESCENT|NA|CENTRIFUGATION|GMI MMOL/MOL FORMULA||U|U|N|U|||NA|2||58||FOLLOW-UP|1971-07-23|1965-05-17|||||1965-12-14||1967-09-08|NA|1969-05-13
TRIAL STUDY 134XCP|LB|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|1||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||DIP|||||||INDETERMINATE||ELISA UNIT/DOSE||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|N|WRIGHT-GIEMSA STAIN|HEPASCORE FORMULA||Y|N|U|NA|||N|3||39||WASHOUT|1971-12-14|1963-06-04|||||1967-01-16||1961-08-01|NA|1960-06-08
TRIAL STUDY 134XCP|LB|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|2||||CHOLINES|CHOLINESTERASE|||||||V/SEC|||||||POSITIVE||%(W/W)||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|LACTESCENT|N|REBOUND TONOMETRY|CKD-EPI FORMULA||U|U|U|Y|||Y|3||39||WASHOUT|1967-11-08|1963-11-07|||||1968-12-26||1962-05-04|N|1968-10-14
TRIAL STUDY 134XCP|LB|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|1||||TAURCRT|TAURINE/CREATININE|||||||FEU|||||||POSITIVE||CUP||||LOW|NOT DONE||||PLATELET|CONTAMINATED|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||N|Y|N|N|||NA|4||88||BASELINE|1969-11-22|1960-04-27|||||1973-05-12||1969-02-25|Y|1961-02-26
TRIAL STUDY 134XCP|LB|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|2||||HEPCIDIN|HEPCIDIN|||||||MEQ/L|||||||TRACE||GPL U/ML||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|CALCIFIED|U|PYROSEQUENCING|COCKCROFT-GAULT FORMULA||U|N|Y|N|||N|4||88||LONG-TERM FOLLOW-UP|1965-01-06|1973-01-25|||||1972-03-07||1967-05-09|N|1966-04-27
TRIAL STUDY 134XCP|LB|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|1||||SLAIGGAB|SOLUBLE LIVER ANTIGEN IGG ANTIBODY|||||||VG/ML|||||||INVALID||MG/MIN||||HIGH|NOT DONE||||SALIVA|THAWED|Y|MAPH|MDRD 6 VARIABLE FORMULA||U|Y|Y|U|||U|5||7||OBSERVATION|1962-07-04|1968-04-29|||||1966-11-07||1965-01-07|U|1972-08-04
TRIAL STUDY 134XCP|LB|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|2||||TROPONT|TROPONIN T|||||||ABSORBANCE U|||||||TRACE||MBQ||||HIGH|NOT DONE||||GASTRIC CONTENTS|CALCIFIED|Y|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|FIBROMETER FORMULA||U|U|NA|N|||NA|5||7||OPEN LABEL TREATMENT|1965-04-20|1961-12-12|||||1965-05-31||1971-12-22|Y|1968-11-10
TRIAL STUDY 134XCP|LB|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|1||||CA242AG|CANCER ANTIGEN 242|||||||NL|||||||TRACE||CD||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|SOLIDIFIED|Y|DIFFUSION WEIGHTED MRI|MDRD 6 VARIABLE FORMULA||Y|NA|N|U|||Y|1||38||TREATMENT|1966-04-07|1971-08-08|||||1972-02-10||1969-07-05|U|1962-08-18
TRIAL STUDY 134XCP|LB|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|2||||DMG|DIMETHYLGLYCINE|||||||CI/L|||||||INVALID||MG/CM2||||HIGH|NOT DONE||||STOOL|GELLED|N|HPLC/IEX|MDRD 6 VARIABLE FORMULA||NA|U|U|U|||NA|1||38||CONTINUATION TREATMENT|1973-05-20|1963-01-03|||||1969-01-04||1962-03-04|N|1970-11-21
TRIAL STUDY 134XCP|LB|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|1||||STSA|STEROID SULFATASE ACTIVITY|||||||ML/CM3/MIN|||||||BORDERLINE||UG/CM2||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|CONCENTRATED|NA|MRI WITHOUT CONTRAST|ASH FIBROSURE FORMULA||Y|Y|N|N|||Y|2||58||WASHOUT|1963-05-21|1973-05-12|||||1961-08-09||1968-02-19|U|1968-03-11
TRIAL STUDY 134XCP|LB|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|2||||CCL23|CHEMOKINE (C-C MOTIF) LIGAND 23|||||||DNA COPIES/UG|||||||INVALID||MPH||||HIGH|NOT DONE||||MECONIUM|SOLIDIFIED|U|TRANSVAGINAL ULTRASOUND|FIBROMETER FORMULA||U|NA|Y|Y|||Y|2||58||SCREENING|1973-02-05|1962-05-28|||||1961-12-22||1968-07-20|NA|1969-11-30
TRIAL STUDY 134XCP|LB|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|1||||C165875|BERMUDA GRASS POLLEN IGE AB RAST SCORE|||||||G/M2/DAY|||||||INDETERMINATE||PIPE||||LOW|NOT DONE||||SPERMATOZOON|ICTERIC|NA|SCINTIGRAPHY|GMI % FORMULA||Y|U|Y|Y|||NA|3||39||OBSERVATION|1960-01-26|1973-08-16|||||1963-06-02||1962-10-13|U|1962-07-19
TRIAL STUDY 134XCP|LB|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|2||||EPHD|EPHEDRINE|||||||KA_U/DL|||||||NEGATIVE||NMOL/L||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|PARAFFIN-EMBEDDED|U|IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD 6 VARIABLE FORMULA||U|N|Y|U|||U|3||39||WASHOUT|1971-05-18|1966-03-05|||||1963-03-19||1960-06-12|NA|1960-08-09
TRIAL STUDY 134XCP|LB|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|1||||RPPAB|RIBOSOMAL P PROTEIN ANTIBODY|||||||FMOL/L|||||||BORDERLINE||UKAT/10^12 RBC||||ABNORMAL|NOT DONE||||LAVAGE FLUID|AGGLUTINATED|U|MICROBIAL CULTURE, SOLID|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|U|Y|||U|4||88||INDUCTION TREATMENT|1972-05-28|1973-08-24|||||1964-01-05||1964-06-05|U|1962-09-08
TRIAL STUDY 134XCP|LB|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|2||||TPAG|TISSUE POLYPEPTIDE ANTIGEN|||||||10^9/L|||||||INVALID||INHALATION||||ABNORMAL|NOT DONE||||NAIL|THAWED|N|PET SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|NA|NA|||N|4||88||INDUCTION TREATMENT|1972-03-20|1972-04-26|||||1967-11-19||1973-03-28|N|1967-09-22
TRIAL STUDY 134XCP|LB|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|1||||MASTCECE|MAST CELLS/TOTAL CELLS|||||||IN|||||||BORDERLINE||UMOL/KG/MIN||||NORMAL|NOT DONE||||SEMEN|PARAFFIN-EMBEDDED|Y|MAGNETIC RESONANCE ELASTOGRAPHY|NASH FIBROSURE FORMULA||NA|N|Y|N|||Y|5||7||BASELINE|1964-04-18|1972-05-08|||||1969-07-16||1964-06-06|N|1972-10-08
TRIAL STUDY 134XCP|LB|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|2||||ANAB|ANTI-NEUTROPHIL ANTIBODY|||||||UMOL|||||||INDETERMINATE||UG/CM2||||ABNORMAL|NOT DONE||||LEUKOCYTE|GELLED|N|CARDIAC THERMODILUTION|MDRD 6 VARIABLE FORMULA||N|U|U|N|||N|5||7||RUN-IN|1960-04-05|1962-02-03|||||1972-10-30||1969-04-21|N|1960-09-22
TRIAL STUDY 134XCP|LB|5AEA7EE9-1095-4967-B833-7665B6A71B31|1||||ALPIALP|ALK PHOS, INTESTINAL/TOTAL ALK PHOS|||||||ANTI-XA IU/ML|||||||TRACE||UM/S||||ABNORMAL|NOT DONE||||GASTRIC FLUID|FRESH|U|PET/SPECT SCAN|MDRD 5 VARIABLE FORMULA||Y|U|Y|N|||N|1||38||BASELINE|1963-08-29|1969-05-30|||||1973-01-22||1969-09-28|NA|1963-06-12
TRIAL STUDY 134XCP|LB|5AEA7EE9-1095-4967-B833-7665B6A71B31|2||||ACT|ACTIVATED COAGULATION TIME|||||||10^4/L|||||||TRACE||AFU||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|DRIED|NA|MODIFIED ACID FAST STAIN|GMI % FORMULA||NA|U|N|NA|||U|1||38||LONG-TERM FOLLOW-UP|1960-06-07|1970-06-22|||||1968-11-15||1969-12-01|Y|1970-08-14
TRIAL STUDY 134XCP|LB|5AEA7EE9-1095-4967-B833-7665B6A71B31|1||||C130087|ENGLISH PLANTAIN POLLEN IGG4|||||||H/WK|||||||INVALID||ELISA UNIT/DOSE||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|CONCENTRATED|NA|MANUAL COUNT|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|Y|U|||Y|2||58||OBSERVATION|1967-11-26|1969-01-14|||||1965-04-13||1972-03-22|Y|1967-02-22
TRIAL STUDY 134XCP|LB|5AEA7EE9-1095-4967-B833-7665B6A71B31|2||||GALM|GALACTOSE MUTAROTASE|||||||IU/DL|||||||BORDERLINE||MU/L||||NORMAL|NOT DONE||||DIALYSIS FLUID|FRESH|N|FORCED OSCILLATION TECHNIQUE|FIBROTEST FORMULA||U|NA|N|Y|||NA|2||58||OBSERVATION|1971-06-28|1963-03-07|||||1970-10-18||1969-09-05|NA|1966-02-25
TRIAL STUDY 134XCP|LB|5AEA7EE9-1095-4967-B833-7665B6A71B31|1||||VEGFA|VASCULAR ENDOTHELIAL GROWTH FACTOR A|||||||KG|||||||TRACE||UG/ML/H||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|HEMOLYZED|N|REVERSE TRANSCRIPTASE PCR|CKD-EPI FORMULA||NA|U|NA|Y|||U|3||39||OBSERVATION|1970-07-08|1964-04-21|||||1963-02-02||1973-03-19|U|1972-02-20
TRIAL STUDY 134XCP|LB|5AEA7EE9-1095-4967-B833-7665B6A71B31|2||||PDGFAA|PLATELET DERIVED GROWTH FACTOR ISOFORMAA|||||||CMOL/L|||||||BORDERLINE||WATT||||NORMAL|NOT DONE||||ISOLATE|CONCENTRATED|U|PALPATION|HEPASCORE FORMULA||Y|NA|U|U|||Y|3||39||TREATMENT|1962-09-18|1962-01-09|||||1961-06-17||1964-11-08|U|1965-06-26
TRIAL STUDY 134XCP|LB|5AEA7EE9-1095-4967-B833-7665B6A71B31|1||||INTLK32|INTERLEUKIN 32|||||||USEC|||||||TRACE||GPL U/ML||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|FROZEN|U|INFRARED SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|NA|||N|4||88||WASHOUT|1968-11-27|1963-11-08|||||1960-09-14||1973-08-07|N|1967-05-30
TRIAL STUDY 134XCP|LB|5AEA7EE9-1095-4967-B833-7665B6A71B31|2||||BETACRTN|BETA CAROTENE|||||||MMOL/MIN/KPA|||||||POSITIVE||PACK YEAR||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|N|REVERSE TRANSCRIPTASE PCR|NASH FIBROSURE FORMULA||Y|U|Y|N|||N|4||88||OPEN LABEL TREATMENT|1969-07-17|1961-09-02|||||1970-10-12||1971-04-28|N|1965-02-15
TRIAL STUDY 134XCP|LB|5AEA7EE9-1095-4967-B833-7665B6A71B31|1||||VLDL3|VLDL CHOLESTEROL SUBTYPE 3|||||||/100 HPFS|||||||TRACE||DPM/100MG||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CLOTTED|Y|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|FIBROSIS 4 FORMULA||NA|Y|U|Y|||NA|5||7||RUN-IN|1968-06-17|1966-02-09|||||1970-09-16||1969-05-26|Y|1968-03-21
TRIAL STUDY 134XCP|LB|5AEA7EE9-1095-4967-B833-7665B6A71B31|2||||ISG15|UBIQUITIN-LIKE PROTEIN ISG15|||||||10^9 CFU/G|||||||NEGATIVE||OI50||||LOW|NOT DONE||||MIXED VENOUS BLOOD|ROOM TEMPERATURE|Y|PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA||N|N|U|U|||N|5||7||WASHOUT|1968-06-16|1969-08-21|||||1961-11-15||1963-06-07|U|1963-12-19
TRIAL STUDY 134XCP|LB|241CD521-D0BD-40BB-ABA2-B8C8E500B491|1||||C130093|WESTERN RAGWEED POLLEN IGA|||||||AMPULE|||||||INDETERMINATE||10^3 ORGANISMS/ML||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|UNEXPECTED ODOR|NA|MICROARRAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|NA|N|||U|1||38||LONG-TERM FOLLOW-UP|1961-06-03|1967-04-27|||||1971-04-11||1962-04-26|N|1969-11-23
TRIAL STUDY 134XCP|LB|241CD521-D0BD-40BB-ABA2-B8C8E500B491|2||||GRANIM|IMMATURE GRANULOCYTES|||||||MCI/KG|||||||INDETERMINATE||LOG10 ELISA UNIT/DOSE||||LOW|NOT DONE||||BONE|UNEXPECTED ODOR|U|NO INFORMATION|COCKCROFT-GAULT FORMULA||NA|Y|Y|NA|||N|1||38||SCREENING|1965-03-06|1967-05-30|||||1972-08-16||1966-02-03|Y|1961-06-11
TRIAL STUDY 134XCP|LB|241CD521-D0BD-40BB-ABA2-B8C8E500B491|1||||IGF2|INSULIN-LIKE GROWTH FACTOR-2|||||||ML/MMHG/MIN/L|||||||TRACE||U/KG/MIN||||ABNORMAL|NOT DONE||||EXPIRED AIR|LACTESCENT|Y|NUCLEIC ACID HYBRIDIZATION|NASH FIBROSURE FORMULA||U|N|U|NA|||U|2||58||FOLLOW-UP|1961-02-19|1962-10-02|||||1963-02-24||1972-07-13|Y|1967-01-02
TRIAL STUDY 134XCP|LB|241CD521-D0BD-40BB-ABA2-B8C8E500B491|2||||C3|COMPLEMENT C3|||||||UM2|||||||INVALID||UG/H||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|GELLED|U|MAGNETIC RESONANCE ELASTOGRAPHY|FIBROTEST FORMULA||Y|NA|Y|U|||Y|2||58||INDUCTION TREATMENT|1965-06-01|1968-06-12|||||1968-08-12||1965-03-02|Y|1964-06-12
TRIAL STUDY 134XCP|LB|241CD521-D0BD-40BB-ABA2-B8C8E500B491|1||||FGF23C|FIBROBLAST GROWTH FACTOR 23, C-TERMINAL|||||||IU/G|||||||BORDERLINE||LOG10 IU/ML||||HIGH|NOT DONE||||EMOTIONAL TEAR|HEMOLYZED|NA|NEURAMINIDASE INHIBITION ASSAY|MDRD 6 VARIABLE FORMULA||U|U|N|NA|||Y|3||39||WASHOUT|1960-08-29|1969-08-11|||||1970-09-29||1962-02-27|N|1966-05-13
TRIAL STUDY 134XCP|LB|241CD521-D0BD-40BB-ABA2-B8C8E500B491|2||||IGG|IMMUNOGLOBULIN G|||||||SUPPOSITORY|||||||INDETERMINATE||ML/G/MIN||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED|NA|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROMETER FORMULA||U|Y|N|U|||U|3||39||WASHOUT|1967-02-04|1960-12-04|||||1972-02-18||1972-06-07|U|1968-11-20
TRIAL STUDY 134XCP|LB|241CD521-D0BD-40BB-ABA2-B8C8E500B491|1||||RETIHRTC|HIGH ABSORPTION RETIC/RETICULOCYTES|||||||DIP|||||||INDETERMINATE||NG/DAY||||HIGH|NOT DONE||||ISOLATE|REFRIGERATED|N|SPIROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|NA|NA|||NA|4||88||WASHOUT|1968-07-19|1964-01-25|||||1969-03-23||1965-04-13|U|1968-09-27
TRIAL STUDY 134XCP|LB|241CD521-D0BD-40BB-ABA2-B8C8E500B491|2||||BLAST|BLASTS|||||||BP|||||||TRACE||H*%||||NORMAL|NOT DONE||||HAIR FOLLICLE|AGGLUTINATED|N|IVY INCISION METHOD|MDRD FORMULA||U|NA|Y|U|||U|4||88||FOLLOW-UP|1964-01-05|1972-08-24|||||1972-05-21||1963-04-22|U|1966-07-05
TRIAL STUDY 134XCP|LB|241CD521-D0BD-40BB-ABA2-B8C8E500B491|1||||TROPONI2|TROPONIN I TYPE 2|||||||IU/MMOL|||||||TRACE||NMOL||||NORMAL|NOT DONE||||EMESIS|CLOTTED|N|COMPLEMENT FIXATION|CKD-EPI CREATININE FORMULA||N|Y|Y|U|||U|5||7||SCREENING|1970-09-27|1971-01-29|||||1965-02-17||1960-06-21|U|1968-03-31
TRIAL STUDY 134XCP|LB|241CD521-D0BD-40BB-ABA2-B8C8E500B491|2||||NEUTIMLE|IMMATURE NEUTROPHILS/LEUKOCYTES|||||||MPA|||||||INDETERMINATE||%||||LOW|NOT DONE||||PLATELET RICH PLASMA|NON-HEMOLYZED|Y|CLIP SEQUENCING|MDRD FORMULA||NA|NA|N|NA|||NA|5||7||FOLLOW-UP|1963-09-27|1965-02-17|||||1967-04-29||1960-03-30|Y|1960-05-31
TRIAL STUDY 134XCP|LB|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|1||||MX1|INTERFERON-INDUCED PROTEIN P78|||||||UG/L/H|||||||BORDERLINE||U||||LOW|NOT DONE||||VENOUS PLASMA|UNEXPECTED ODOR|N|ENDPOINT DILUTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|N|U|||N|1||38||TREATMENT|1962-09-28|1966-07-21|||||1970-11-01||1970-05-15|NA|1969-07-20
TRIAL STUDY 134XCP|LB|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|2||||IGE|IMMUNOGLOBULIN E|||||||FMOL/L|||||||INDETERMINATE||PL||||LOW|NOT DONE||||LEUKOCYTE|CALCIFIED|U|HPLC-UV|GMI % FORMULA||NA|Y|NA|N|||U|1||38||BLINDED TREATMENT|1973-02-26|1966-07-19|||||1967-06-10||1965-11-08|U|1971-11-07
TRIAL STUDY 134XCP|LB|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|1||||PGAG|PLATELET-GRANULOCYTE AGG|||||||UG/KG/H|||||||NEGATIVE||ECL UNIT||||ABNORMAL|NOT DONE||||LAVAGE FLUID|CONTAMINATED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|NASH FIBROSURE FORMULA||NA|NA|U|N|||N|2||58||TREATMENT|1973-07-30|1968-03-04|||||1967-07-10||1965-04-05|NA|1972-06-20
TRIAL STUDY 134XCP|LB|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|2||||ERCEPIDX|ERYTHROID PROLIFERATION INDEX|||||||MM|||||||BORDERLINE||BEAM BREAKS||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|FROZEN|U|ACCELERATOR MASS SPECTROMETRY|MDRD 5 VARIABLE FORMULA||N|Y|NA|N|||N|2||58||BASELINE|1969-11-22|1963-12-17|||||1963-01-09||1965-03-12|Y|1972-04-05
TRIAL STUDY 134XCP|LB|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|1||||PLATIM|IMMATURE PLATELETS|||||||IU/MMOL|||||||INDETERMINATE||NKAT/L||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|PARAFFIN-EMBEDDED|NA|MICRONEUTRALIZATION ASSAY|CKD-EPI CREATININE FORMULA||Y|N|Y|N|||Y|3||39||CONTINUATION TREATMENT|1962-04-22|1973-08-25|||||1963-01-09||1972-07-27|N|1962-09-06
TRIAL STUDY 134XCP|LB|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|2||||TURB|TURBIDITY|||||||JOULE|||||||POSITIVE||CGY||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|THAWED|Y|RULER MEASUREMENT METHOD|GMI % FORMULA||U|U|U|NA|||N|3||39||CONTINUATION TREATMENT|1962-02-08|1969-08-22|||||1966-06-09||1967-12-13|NA|1964-08-10
TRIAL STUDY 134XCP|LB|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|1||||BTK|BRUTON'S TYROSINE KINASE|||||||10^9/DOSE|||||||POSITIVE||CI/KG||||HIGH|NOT DONE||||AQUEOUS HUMOR|CALCIFIED|Y|IMPULSE OSCILLOMETRY|CKD-EPI CYSTATIN C FORMULA||N|NA|N|U|||Y|4||88||WASHOUT|1966-01-02|1969-06-15|||||1970-02-01||1965-12-26|U|1960-12-23
TRIAL STUDY 134XCP|LB|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|2||||GBP2|GUANYLATE BINDING PROTEIN 2|||||||MOL/G|||||||POSITIVE||NSEC||||LOW|NOT DONE||||PLATELET RICH PLASMA|GELLED|N|CALCOFLUOR WHITE STAIN|CKD-EPI CYSTATIN C FORMULA||U|N|N|N|||N|4||88||LONG-TERM FOLLOW-UP|1968-02-28|1969-03-10|||||1966-05-31||1972-01-25|Y|1969-07-10
TRIAL STUDY 134XCP|LB|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|1||||FOLHMRNA|FOLATE HYDROLASE MRNA|||||||U/KG/DAY|||||||NEGATIVE||ANSON U||||HIGH|NOT DONE||||SALIVA|AUTOLYZED|U|CLINICAL EVALUATION|NASH FIBROSURE FORMULA||U|NA|Y|Y|||N|5||7||SCREENING|1968-01-01|1972-03-01|||||1962-12-13||1961-04-02|NA|1967-04-08
TRIAL STUDY 134XCP|LB|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|2||||LIPASEG|LIPASE, GASTRIC|||||||MET*H|||||||POSITIVE||VOXEL||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CONCENTRATED|N|SINGLE-MOLECULE ARRAY|FIBROMETER FORMULA||U|N|N|U|||NA|5||7||OBSERVATION|1972-09-29|1968-09-05|||||1962-08-25||1973-02-03|Y|1966-09-11
TRIAL STUDY 134XCP|LB|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|1||||CRTCLRE|CREATININE CLEARANCE, ESTIMATED|||||||UG/MOL|||||||POSITIVE||MEQ||||LOW|NOT DONE||||SUPERNATANT, SERUM|CALCIFIED|U|CLAUSS METHOD|GMI MMOL/MOL FORMULA||N|NA|U|U|||Y|1||38||CONTINUATION TREATMENT|1964-04-15|1963-01-14|||||1962-06-11||1961-10-11|Y|1961-02-25
TRIAL STUDY 134XCP|LB|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|2||||PBGCREAT|PORPHOBILINOGEN/CREATININE|||||||FRACTION OF 1|||||||INVALID||MPL U/ML||||ABNORMAL|NOT DONE||||SEMEN|THAWED|N|SNP ARRAY|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|NA|U|||Y|1||38||LONG-TERM FOLLOW-UP|1970-06-07|1963-02-27|||||1966-06-17||1965-09-25|U|1969-12-05
TRIAL STUDY 134XCP|LB|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|1||||EOSMYL|EOSINOPHILIC MYELOCYTES|||||||UG/KG/MIN|||||||POSITIVE||MASK||||LOW|NOT DONE||||REFLEX TEAR|ICTERIC|NA|PEAK FLOWMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|NA|Y|||U|2||58||WASHOUT|1967-06-09|1967-11-22|||||1968-02-03||1968-11-29|NA|1972-07-10
TRIAL STUDY 134XCP|LB|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|2||||SFTPD|SURFACTANT PROTEIN D|||||||APL U|||||||NEGATIVE||BAU/ML||||LOW|NOT DONE||||CERUMEN|PARAFFIN-EMBEDDED|Y|MAGNETIC RESONANCE ENTEROGRAPHY|FIBROTEST FORMULA||Y|NA|NA|U|||U|2||58||WASHOUT|1966-06-03|1967-06-25|||||1968-08-17||1970-03-04|NA|1969-09-01
TRIAL STUDY 134XCP|LB|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|1||||CARNITAT|CARNITINE ACETYL TRANSFERASE|||||||VOXEL|||||||POSITIVE||IU/KG||||LOW|NOT DONE||||PLATELET RICH PLASMA|AGGLUTINATED|NA|SINGLE-SLICE SPIRAL CT|MDRD 6 VARIABLE FORMULA||Y|NA|NA|NA|||Y|3||39||CONTINUATION TREATMENT|1968-12-28|1971-12-30|||||1971-02-28||1966-11-16|Y|1961-02-11
TRIAL STUDY 134XCP|LB|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|2||||SICAM1|SOLUBLE INTERCELL ADHESION MOLECULE 1|||||||MPA|||||||BORDERLINE||ML/G/H||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|CALCIFIED|N|DARK FIELD MICROSCOPY|GMI MMOL/MOL FORMULA||Y|N|U|N|||NA|3||39||FOLLOW-UP|1966-05-09|1971-12-28|||||1972-06-05||1967-07-26|N|1969-04-18
TRIAL STUDY 134XCP|LB|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|1||||CKMM|CREATINE KINASE MM|||||||PLUG|||||||INDETERMINATE||MEQ/MMOL||||LOW|NOT DONE||||SPUTUM|SOLIDIFIED|NA|FLUORESCENT LIFETIME IMAGING MICROSCOPY|MDRD 4 VARIABLE FORMULA||Y|NA|NA|U|||U|4||88||CONTINUATION TREATMENT|1966-08-21|1972-05-12|||||1964-12-24||1964-02-26|NA|1973-01-09
TRIAL STUDY 134XCP|LB|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|2||||C165905|GRASS MIX POLLEN IGG AB RAST SCORE|||||||MCI|||||||NEGATIVE||DRAM||||ABNORMAL|NOT DONE||||SERUM|THAWED|U|SPIRAL CT|GMI % FORMULA||N|U|N|U|||Y|4||88||BLINDED TREATMENT|1970-02-10|1966-12-29|||||1966-07-23||1965-04-24|N|1960-05-29
TRIAL STUDY 134XCP|LB|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|1||||T4FRIDX|THYROXINE, FREE INDEX|||||||GLOBULE|||||||BORDERLINE||DAYS||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|AGGLUTINATED|U|DIFFUSION TENSOR MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|Y|||NA|5||7||INDUCTION TREATMENT|1963-08-10|1969-12-23|||||1967-11-13||1966-02-25|U|1972-04-06
TRIAL STUDY 134XCP|LB|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|2||||HTTP|HUNTINGTIN PROTEIN|||||||PFU/ML|||||||INVALID||PNU/ML||||NORMAL|NOT DONE||||SEMEN|CONTAMINATED|Y|RADIOIMMUNOPRECIPITATION ASSAY|GMI % FORMULA||N|U|U|U|||NA|5||7||TREATMENT|1965-10-16|1962-09-26|||||1962-11-15||1971-10-04|Y|1968-10-19
TRIAL STUDY 134XCP|LB|FD609B1C-D1E7-4349-B036-DF0126D96A52|1||||NACREAT|SODIUM/CREATININE|||||||VOXEL|||||||INVALID||UCI/KG||||HIGH|NOT DONE||||COLOSTRUM|LIPEMIC|NA|LEAD CITRATE STAIN|ASH FIBROSURE FORMULA||U|N|NA|U|||N|1||38||OPEN LABEL TREATMENT|1970-08-19|1971-12-08|||||1969-11-19||1963-08-24|Y|1967-04-15
TRIAL STUDY 134XCP|LB|FD609B1C-D1E7-4349-B036-DF0126D96A52|2||||IMMGLCFR|IMMUNOGLOBULIN LIGHT CHAINS, FREE|||||||ML/MMHG/MIN/L|||||||BORDERLINE||IU/G||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|U|IMMUNO-PET SCAN|FIBROSIS 4 FORMULA||N|Y|NA|N|||NA|1||38||RUN-IN|1960-11-23|1964-03-15|||||1968-10-20||1970-11-18|Y|1967-03-09
TRIAL STUDY 134XCP|LB|FD609B1C-D1E7-4349-B036-DF0126D96A52|1||||C130089|TIMOTHY GRASS POLLEN IGA|||||||UG/M2|||||||BORDERLINE||AMOL||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|AGGLUTINATED|N|KINETIC MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|N|||Y|2||58||INDUCTION TREATMENT|1972-07-16|1965-01-17|||||1968-01-03||1970-04-17|N|1967-12-18
TRIAL STUDY 134XCP|LB|FD609B1C-D1E7-4349-B036-DF0126D96A52|2||||AMYLOIDB|AMYLOID, BETA|||||||10^6 CFU/G|||||||BORDERLINE||COPIES/UG||||HIGH|NOT DONE||||AMNIOTIC FLUID|AUTOLYZED|Y|CLAUSS METHOD|HEPASCORE FORMULA||NA|U|N|U|||Y|2||58||LONG-TERM FOLLOW-UP|1964-01-07|1971-07-09|||||1960-12-22||1968-08-03|NA|1964-07-11
TRIAL STUDY 134XCP|LB|FD609B1C-D1E7-4349-B036-DF0126D96A52|1||||LEPTIN|LEPTIN|||||||CM2|||||||POSITIVE||MG/KG/WEEK||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|SOLIDIFIED|U|DIFFUSION TENSOR MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|U|NA|||U|3||39||TREATMENT|1962-11-12|1964-02-08|||||1966-08-12||1971-09-08|N|1965-02-14
TRIAL STUDY 134XCP|LB|FD609B1C-D1E7-4349-B036-DF0126D96A52|2||||BASOIMLE|IMMATURE BASOPHILS/LEUKOCYTES|||||||MG/DL|||||||POSITIVE||MMOL/G||||HIGH|NOT DONE||||HAIR|DRIED|N|REVERSE TRANSCRIPTASE PCR|ASH FIBROSURE FORMULA||NA|N|U|Y|||U|3||39||TREATMENT|1971-09-11|1965-02-02|||||1971-03-30||1971-08-13|NA|1960-11-18
TRIAL STUDY 134XCP|LB|FD609B1C-D1E7-4349-B036-DF0126D96A52|1||||ALPRZLM|ALPRAZOLAM|||||||TAMPON|||||||INVALID||MEQ/L||||NORMAL|NOT DONE||||COLOSTRUM|THAWED|Y|PERIODIC ACID SCHIFF STAIN|FIBROSIS 4 FORMULA||NA|NA|U|N|||N|4||88||TREATMENT|1961-11-02|1963-12-04|||||1971-10-17||1962-10-15|N|1961-02-21
TRIAL STUDY 134XCP|LB|FD609B1C-D1E7-4349-B036-DF0126D96A52|2||||PKM1|PYRUVATE KINASE ISOZYME M1|||||||NMOL/L/MIN|||||||INDETERMINATE||PMOL/G||||LOW|NOT DONE||||PLASMA|SOLIDIFIED|U|TOTAL BODY IRRADIATION|FIBROTEST FORMULA||Y|U|N|N|||NA|4||88||SCREENING|1966-07-08|1964-12-20|||||1967-09-12||1973-05-05|U|1973-08-18
TRIAL STUDY 134XCP|LB|FD609B1C-D1E7-4349-B036-DF0126D96A52|1||||HDLPL|HDL PHOSPHOLIPID|||||||MG/G/H|||||||NEGATIVE||G/DAY||||ABNORMAL|NOT DONE||||CALCULUS|AGGLUTINATED|NA|RADIOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|Y|N|N|||NA|5||7||BLINDED TREATMENT|1968-06-26|1970-03-04|||||1969-11-19||1961-06-13|U|1960-04-24
TRIAL STUDY 134XCP|LB|FD609B1C-D1E7-4349-B036-DF0126D96A52|2||||GLYCRLFR|FREE GLYCEROL|||||||NG/DL|||||||BORDERLINE||PPTR||||ABNORMAL|NOT DONE||||PLATELET POOR PLASMA|REFRIGERATED|N|CONFOCAL MICROSCOPY|FIBROSIS 4 FORMULA||NA|Y|NA|NA|||N|5||7||CONTINUATION TREATMENT|1972-02-22|1972-12-14|||||1964-08-25||1966-11-25|Y|1968-01-07
TRIAL STUDY 134XCP|LB|DEB0593B-E3FD-471C-A800-43058AC5FD86|1||||ANGTNS1|ANGIOTENSIN I|||||||CMOL/L|||||||POSITIVE||MM2||||HIGH|NOT DONE||||PERSPIRATION|CONCENTRATED|NA|DARK FIELD MICROSCOPY|NASH FIBROSURE FORMULA||Y|Y|Y|NA|||U|1||38||OPEN LABEL TREATMENT|1969-03-20|1967-05-30|||||1971-11-28||1963-02-21|N|1961-03-11
TRIAL STUDY 134XCP|LB|DEB0593B-E3FD-471C-A800-43058AC5FD86|2||||IFNG|INTERFERON GAMMA|||||||UMOL/MG/MIN|||||||BORDERLINE||10^6 IU/ML||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|NON-HEMOLYZED|NA|CLOT DETECTION|GMI % FORMULA||N|Y|Y|Y|||N|1||38||TREATMENT|1961-09-13|1966-01-31|||||1966-06-21||1973-06-25|NA|1968-09-01
TRIAL STUDY 134XCP|LB|DEB0593B-E3FD-471C-A800-43058AC5FD86|1||||RBCNURBC|NUCLEATED ERYTHROCYTES/ERYTHROCYTES|||||||CL|||||||BORDERLINE||SUPPOSITORY||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|AGGLUTINATED|U|SPIRAL CT SCAN WITHOUT CONTRAST|FIBROTEST FORMULA||U|NA|N|Y|||U|2||58||OBSERVATION|1972-11-20|1972-07-17|||||1961-06-26||1962-12-09|Y|1969-01-31
TRIAL STUDY 134XCP|LB|DEB0593B-E3FD-471C-A800-43058AC5FD86|2||||IL2R|INTERLEUKIN 2 RECEPTOR|||||||NSEC|||||||INDETERMINATE||ML/M2/MIN||||HIGH|NOT DONE||||BASAL TEAR|FROZEN|NA|DUCTOGRAPHY|FIBROMETER FORMULA||N|N|U|Y|||U|2||58||WASHOUT|1962-06-09|1971-05-28|||||1960-01-07||1960-02-21|NA|1968-07-16
TRIAL STUDY 134XCP|LB|DEB0593B-E3FD-471C-A800-43058AC5FD86|1||||C130126|CAT DANDER ANTIGEN IGA ANTIBODY|||||||MESF|||||||INVALID||10^4/L||||HIGH|NOT DONE||||CAPILLARY BLOOD|CLOTTED|Y|CONTRAST ENHANCED X-RAY|CKD-EPI CYSTATIN C FORMULA||NA|U|N|NA|||N|3||39||INDUCTION TREATMENT|1964-10-28|1967-11-06|||||1971-11-19||1960-04-23|NA|1966-08-13
TRIAL STUDY 134XCP|LB|DEB0593B-E3FD-471C-A800-43058AC5FD86|2||||SEDEXAM|SEDIMENT EXAMINATION|||||||MMOL/S|||||||POSITIVE||MEQ/UG||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|ICTERIC|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|U|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1969-03-07|1970-06-11|||||1969-12-17||1961-04-14|Y|1968-10-05
TRIAL STUDY 134XCP|LB|DEB0593B-E3FD-471C-A800-43058AC5FD86|1||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||FEU|||||||BORDERLINE||NFIU||||HIGH|NOT DONE||||PLASMA|ICTERIC|NA|PERIPHERAL ANGIOGRAPHY|GMI MMOL/MOL FORMULA||Y|N|Y|NA|||Y|4||88||TREATMENT|1961-03-14|1964-06-16|||||1970-01-14||1965-05-13|Y|1973-02-01
TRIAL STUDY 134XCP|LB|DEB0593B-E3FD-471C-A800-43058AC5FD86|2||||TIMP1CRE|TIMP1/CREATININE|||||||EID 50/ML|||||||TRACE||MPA||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|ICTERIC|N|GIEMSA STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|U|NA|N|||U|4||88||OBSERVATION|1964-12-20|1965-11-28|||||1971-12-19||1967-09-12|N|1961-01-14
TRIAL STUDY 134XCP|LB|DEB0593B-E3FD-471C-A800-43058AC5FD86|1||||CKMBCK|CREATINE KINASE MB/TOTAL CREATINE KINASE|||||||PACK YEAR|||||||INVALID||PPTH||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|NON-HEMOLYZED|U|FLUOROSCOPY|FIBROSIS 4 FORMULA||Y|U|NA|N|||Y|5||7||BASELINE|1965-03-21|1972-11-25|||||1970-09-13||1965-10-27|U|1966-04-28
TRIAL STUDY 134XCP|LB|DEB0593B-E3FD-471C-A800-43058AC5FD86|2||||MPO|MYELOPEROXIDASE|||||||10^3 CFU|||||||BORDERLINE||APL U||||ABNORMAL|NOT DONE||||LAVAGE FLUID|CLOTTED|U|LINE PROBE ASSAY|ASH FIBROSURE FORMULA||NA|Y|Y|Y|||U|5||7||BASELINE|1960-05-13|1962-01-14|||||1964-12-06||1973-04-28|N|1964-10-29
TRIAL STUDY 134XCP|LB|596BD728-2487-44E4-AFB1-8A4331EEDDF6|1||||NAK|SODIUM/POTASSIUM|||||||MEQ/DAY|||||||NEGATIVE||S^-1(%O2)^-1||||LOW|NOT DONE||||TUMOR TISSUE|CLOTTED|N|BAC ACGH|CKD-EPI FORMULA||Y|U|U|U|||Y|1||38||BLINDED TREATMENT|1965-06-16|1971-06-14|||||1967-09-30||1965-06-04|U|1963-12-20
TRIAL STUDY 134XCP|LB|596BD728-2487-44E4-AFB1-8A4331EEDDF6|2||||MKCMKBMP|MEGAKARYOCYTE AND MEGAKARYOBLAST MORPH|||||||UM/S|||||||NEGATIVE||EID 50/ML||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|ROOM TEMPERATURE|Y|PHASE-CONTRAST MRI|MDRD 6 VARIABLE FORMULA||NA|N|Y|Y|||NA|1||38||CONTINUATION TREATMENT|1971-01-11|1960-11-21|||||1968-07-08||1969-02-13|N|1969-03-12
TRIAL STUDY 134XCP|LB|596BD728-2487-44E4-AFB1-8A4331EEDDF6|1||||HTTP|HUNTINGTIN PROTEIN|||||||/MM|||||||NEGATIVE||APL U||||NORMAL|NOT DONE||||SALIVA|FRESH|NA|AURAMINE STAIN|FIBROSIS 4 FORMULA||NA|NA|N|U|||Y|2||58||FOLLOW-UP|1966-02-04|1961-07-21|||||1968-01-24||1968-10-14|NA|1971-08-02
TRIAL STUDY 134XCP|LB|596BD728-2487-44E4-AFB1-8A4331EEDDF6|2||||CHYTRYP|CHYMOTRYPSIN|||||||GBQ/G|||||||POSITIVE||MMOL/S||||NORMAL|NOT DONE||||SKIN TISSUE|CLOTTED|U|LIGHT MICROSCOPY|FIBROTEST FORMULA||Y|NA|Y|NA|||N|2||58||WASHOUT|1967-05-19|1968-09-23|||||1962-10-22||1961-12-24|Y|1968-10-22
TRIAL STUDY 134XCP|LB|596BD728-2487-44E4-AFB1-8A4331EEDDF6|1||||TNF10|TNF SUPERFAMILY MEMBER 10|||||||BU/ML|||||||POSITIVE||G/CM2||||HIGH|NOT DONE||||SOFT TISSUE|UNEXPECTED ODOR|U|TELLER ACUITY CARDS|MDRD ENZYMATIC JAPANESE FORMULA||U|N|NA|N|||Y|3||39||LONG-TERM FOLLOW-UP|1966-09-10|1969-03-22|||||1971-07-08||1961-06-09|Y|1968-04-21
TRIAL STUDY 134XCP|LB|596BD728-2487-44E4-AFB1-8A4331EEDDF6|2||||GLN|GLUTAMINE|||||||DAGU/ML|||||||INVALID||ML/G/MIN||||ABNORMAL|NOT DONE||||PLASMA|PARAFFIN-EMBEDDED|U|MACRO BROTH DILUTION|MDRD 4 VARIABLE FORMULA||Y|Y|NA|Y|||NA|3||39||OPEN LABEL TREATMENT|1966-04-04|1961-09-16|||||1964-12-14||1967-08-18|Y|1960-10-27
TRIAL STUDY 134XCP|LB|596BD728-2487-44E4-AFB1-8A4331EEDDF6|1||||BASOB|BASOPHILS BAND FORM|||||||%|||||||NEGATIVE||10^4/L||||LOW|NOT DONE||||LYSATE|LACTESCENT|N|HPLC-FL|MDRD 5 VARIABLE FORMULA||U|N|N|U|||Y|4||88||OBSERVATION|1965-01-31|1964-08-22|||||1964-05-15||1972-07-15|NA|1972-02-28
TRIAL STUDY 134XCP|LB|596BD728-2487-44E4-AFB1-8A4331EEDDF6|2||||PROMYB|PROMYELOBLASTS|||||||COULOMB|||||||POSITIVE||CP||||LOW|NOT DONE||||EPITHELIAL CELL|GELLED|N|CONGO RED STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|NA|||N|4||88||OPEN LABEL TREATMENT|1970-03-07|1971-11-13|||||1972-08-16||1963-01-06|NA|1963-01-22
TRIAL STUDY 134XCP|LB|596BD728-2487-44E4-AFB1-8A4331EEDDF6|1||||HERC5|HECT DOMAIN AND RLD 5|||||||CG|||||||INDETERMINATE||MM2||||HIGH|NOT DONE||||ISOLATE|DRIED|U|NUCLEIC ACID BASED METHOD|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|N|||N|5||7||CONTINUATION TREATMENT|1962-10-28|1970-10-23|||||1961-10-31||1970-05-24|N|1969-11-13
TRIAL STUDY 134XCP|LB|596BD728-2487-44E4-AFB1-8A4331EEDDF6|2||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||UL/ML|||||||INDETERMINATE||BAR||||LOW|NOT DONE||||AQUEOUS HUMOR|LACTESCENT|N|ACCELERATOR MASS SPECTROMETRY|GMI % FORMULA||NA|N|NA|NA|||N|5||7||BASELINE|1966-07-24|1969-11-16|||||1961-10-25||1970-09-20|Y|1971-05-24
TRIAL STUDY 134XCP|LB|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|1||||NFHP|PHOSPHORYLATED NEUROFILAMENT HEAVY CHAIN|||||||APL U/ML|||||||TRACE||DPM/MG||||HIGH|NOT DONE||||DIALYSIS FLUID|GELLED|N|BIOIMPEDANCE SPECTROSCOPY|NASH FIBROSURE FORMULA||N|Y|Y|Y|||N|1||38||RUN-IN|1960-06-28|1970-05-31|||||1971-12-20||1961-05-09|NA|1972-11-30
TRIAL STUDY 134XCP|LB|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|2||||FGF19|FIBROBLAST GROWTH FACTOR 19|||||||PELLET|||||||INDETERMINATE||/5X10^4 WBC||||LOW|NOT DONE||||VENOUS CORD BLOOD|SOLIDIFIED|U|NUCLEIC ACID AMPLIFICATION TEST|MDRD ENZYMATIC FORMULA||NA|N|NA|NA|||U|1||38||FOLLOW-UP|1969-03-13|1966-01-16|||||1967-08-05||1971-04-04|NA|1963-02-15
TRIAL STUDY 134XCP|LB|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|1||||SCCAG|SQUAMOUS CELL CARCINOMA ANTIGEN|||||||TORR|||||||INVALID||ANTI-XA IU/ML||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|ROOM TEMPERATURE|NA|PERIPHERAL ANGIOGRAPHY|MDRD FORMULA||Y|U|NA|U|||U|2||58||SCREENING|1963-04-22|1967-11-07|||||1962-11-15||1967-08-23|Y|1965-08-27
TRIAL STUDY 134XCP|LB|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|2||||MCHC|ERY. MEAN CORPUSCULAR HGB CONCENTRATION|||||||UCI/L|||||||POSITIVE||10^3 ORGANISMS||||HIGH|NOT DONE||||ALVEOLAR AIR|SOLIDIFIED|NA|NON-INVASIVE DIELECTRIC SENSING|FIBROMETER FORMULA||N|N|Y|Y|||U|2||58||SCREENING|1973-02-14|1962-01-25|||||1964-01-27||1963-10-12|Y|1972-05-27
TRIAL STUDY 134XCP|LB|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|1||||AAP|ALANINE AMINOPEPTIDASE|||||||MESF|||||||NEGATIVE||RING||||HIGH|NOT DONE||||PLEURAL TISSUE|FROZEN|Y|TRANSVAGINAL ULTRASOUND|MDRD FORMULA||N|U|Y|N|||Y|3||39||SCREENING|1973-06-08|1964-06-05|||||1960-12-20||1968-10-12|NA|1968-03-20
TRIAL STUDY 134XCP|LB|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|2||||CRBMZPN|CARBAMAZEPINE|||||||IU/MMOL|||||||POSITIVE||POINT||||NORMAL|NOT DONE||||ARTERIAL BLOOD|CALCIFIED|NA|CONTRAST ENHANCED CT SCAN|GMI MMOL/MOL FORMULA||NA|U|Y|U|||U|3||39||SCREENING|1973-04-25|1972-05-20|||||1969-03-24||1961-06-24|NA|1968-09-26
TRIAL STUDY 134XCP|LB|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|1||||PTHI|PARATHYROID HORMONE, INTACT|||||||CD|||||||INVALID||UV*SEC||||NORMAL|NOT DONE||||SEMEN|REFRIGERATED|N|IVY INCISION METHOD|NASH FIBROSURE FORMULA||N|Y|U|NA|||NA|4||88||OBSERVATION|1967-07-24|1969-05-30|||||1973-04-04||1973-03-03|NA|1966-07-01
TRIAL STUDY 134XCP|LB|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|2||||HYDROGEN|HYDROGEN|||||||MMAL|||||||TRACE||MMAL||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|FRESH|Y|SXA SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|N|U|||Y|4||88||RUN-IN|1973-04-12|1963-01-30|||||1963-11-26||1965-02-07|Y|1967-08-13
TRIAL STUDY 134XCP|LB|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|1||||GRWHRH|GROWTH HORMONE RELEASING HORMONE|||||||/4.0 ML|||||||INDETERMINATE||MEQ/G||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|GELLED|NA|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA||N|N|N|Y|||U|5||7||SCREENING|1964-07-29|1961-09-28|||||1963-02-04||1970-04-03|NA|1965-09-22
TRIAL STUDY 134XCP|LB|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|2||||B2GLYAB|BETA-2 GLYCOPROTEIN ANTIBODY|||||||ML/DOSE|||||||INVALID||ML/DAY||||NORMAL|NOT DONE||||URINE|ROOM TEMPERATURE|N|ANALYTICAL ULTRACENTRIFUGATION|CKD-EPI FORMULA||U|NA|Y|NA|||N|5||7||SCREENING|1968-01-11|1973-02-19|||||1966-02-23||1961-11-07|NA|1970-07-02
TRIAL STUDY 134XCP|LB|0365EB5F-7364-4B1F-8919-543D8D21B045|1||||GDA|GUANINE DEAMINASE|||||||MONTHS|||||||TRACE||USIEMENS||||HIGH|NOT DONE||||VENOUS PLASMA|DRIED|NA|WEBER GREEN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|N|N|||Y|1||38||INDUCTION TREATMENT|1969-12-24|1967-09-26|||||1963-12-09||1966-03-25|U|1965-08-25
TRIAL STUDY 134XCP|LB|0365EB5F-7364-4B1F-8919-543D8D21B045|2||||CCL20|CHEMOKINE (C-C MOTIF) LIGAND 20|||||||FMOL/G|||||||INVALID||GAUSS||||LOW|NOT DONE||||BONE MARROW|LACTESCENT|Y|AGAR PROPORTION|FIBROTEST FORMULA||Y|N|U|Y|||Y|1||38||INDUCTION TREATMENT|1960-11-10|1973-03-29|||||1961-06-10||1964-05-14|Y|1965-11-27
TRIAL STUDY 134XCP|LB|0365EB5F-7364-4B1F-8919-543D8D21B045|1||||NPY|NEUROPEPTIDE Y|||||||DAGU|||||||POSITIVE||PSEC||||HIGH|NOT DONE||||DISCHARGE|ICTERIC|N|GC/MS/MS|CKD-EPI CYSTATIN C FORMULA||NA|N|N|N|||U|2||58||CONTINUATION TREATMENT|1965-10-31|1973-07-29|||||1965-06-07||1972-12-23|U|1972-12-04
TRIAL STUDY 134XCP|LB|0365EB5F-7364-4B1F-8919-543D8D21B045|2||||APOB|APOLIPOPROTEIN B|||||||UV*SEC|||||||POSITIVE||L/S||||ABNORMAL|NOT DONE||||SOFT TISSUE|CONCENTRATED|NA|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|CKD-EPI CREATININE FORMULA||Y|U|NA|N|||NA|2||58||CONTINUATION TREATMENT|1968-05-30|1965-09-18|||||1963-08-13||1962-06-22|N|1967-11-14
TRIAL STUDY 134XCP|LB|0365EB5F-7364-4B1F-8919-543D8D21B045|1||||PEPSNGA|PEPSINOGEN A|||||||GY|||||||INDETERMINATE||MOSM/L||||ABNORMAL|NOT DONE||||LOCHIA|CONTAMINATED|N|THICK SMEAR|FIBROMETER FORMULA||N|Y|Y|NA|||Y|3||39||FOLLOW-UP|1969-10-03|1961-02-19|||||1961-01-25||1960-11-17|N|1968-08-27
TRIAL STUDY 134XCP|LB|0365EB5F-7364-4B1F-8919-543D8D21B045|2||||ACETONE|ACETONE|||||||ELISA UNIT|||||||NEGATIVE||MMOL||||LOW|NOT DONE||||SPERMATOZOON|FROZEN|NA|RAJI CELL EIA|CKD-EPI CYSTATIN C FORMULA||NA|Y|Y|NA|||U|3||39||BLINDED TREATMENT|1963-01-14|1968-09-04|||||1962-03-15||1972-03-14|U|1962-11-19
TRIAL STUDY 134XCP|LB|0365EB5F-7364-4B1F-8919-543D8D21B045|1||||C165896|D. PTERONYSSINUS ANTIGEN IGG4 ANTIBODY|||||||MG|||||||BORDERLINE||CI/UL||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|CLOTTED|Y|ACCELERATOR MASS SPECTROMETRY|CKD-EPI CREATININE FORMULA||N|NA|U|N|||N|4||88||RUN-IN|1971-06-13|1969-10-12|||||1970-01-31||1970-10-27|U|1963-06-18
TRIAL STUDY 134XCP|LB|0365EB5F-7364-4B1F-8919-543D8D21B045|2||||CREATCLR|CREATININE CLEARANCE|||||||ECL UNIT|||||||INVALID||UL/KG/DAY||||NORMAL|NOT DONE||||TRANSUDATE|DRIED|Y|ROMANOWSKY STAIN|CKD-EPI FORMULA||NA|U|U|NA|||Y|4||88||SCREENING|1966-09-06|1969-02-15|||||1967-03-31||1961-01-04|NA|1964-04-09
TRIAL STUDY 134XCP|LB|0365EB5F-7364-4B1F-8919-543D8D21B045|1||||IGFBP2|INSULIN-LIKE GROWTH FACTOR BINDING PROT2|||||||LOG10 ELISA UNIT|||||||TRACE||L/MIN||||ABNORMAL|NOT DONE||||SALIVA|SOLIDIFIED|Y|DUKE INCISION METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|Y|Y|||U|5||7||SCREENING|1963-04-01|1971-04-02|||||1968-07-30||1968-08-13|NA|1965-12-14
TRIAL STUDY 134XCP|LB|0365EB5F-7364-4B1F-8919-543D8D21B045|2||||BILDIRBI|DIRECT BILIRUBIN/BILIRUBIN|||||||LOG EID 50/DOSE|||||||BORDERLINE||UL/KG/DAY||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|ICTERIC|Y|COLORIMETRY|MDRD 5 VARIABLE FORMULA||Y|U|Y|U|||N|5||7||INDUCTION TREATMENT|1964-02-10|1964-06-28|||||1962-05-27||1973-05-21|Y|1960-12-10
TRIAL STUDY 134XCP|LB|364277A8-875C-4A6F-93C3-C913BB3C97CA|1||||CEIMCE|IMMATURE CELLS/TOTAL CELLS|||||||10^9 CFU/ML|||||||NEGATIVE||MIN*MG/ML||||HIGH|NOT DONE||||EPIDERMAL TISSUE|UNEXPECTED ODOR|Y|FISH|GMI MMOL/MOL FORMULA||NA|NA|Y|U|||Y|1||38||RUN-IN|1965-05-23|1972-08-25|||||1963-04-20||1968-04-25|NA|1969-06-17
TRIAL STUDY 134XCP|LB|364277A8-875C-4A6F-93C3-C913BB3C97CA|2||||CRH|CORTICOTROPIN RELEASING HORMONE|||||||IU/KG|||||||TRACE||10^3 DNA COPIES/ML||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|CONTAMINATED|N|WRIGHT-GIEMSA STAIN|GMI MMOL/MOL FORMULA||U|U|U|NA|||NA|1||38||INDUCTION TREATMENT|1972-02-19|1969-11-14|||||1960-01-20||1970-08-09|N|1964-12-08
TRIAL STUDY 134XCP|LB|364277A8-875C-4A6F-93C3-C913BB3C97CA|1||||ALPIS|INTESTINAL SPECIFIC ALKALINE PHOSPHATASE|||||||UMOL/DAY|||||||NEGATIVE||U/10^12 RBC||||LOW|NOT DONE||||ALVEOLAR AIR|SOLIDIFIED|U|PULSE OXIMETRY|MDRD 5 VARIABLE FORMULA||N|NA|Y|NA|||NA|2||58||BLINDED TREATMENT|1965-10-13|1968-06-20|||||1963-06-26||1962-07-24|U|1967-03-27
TRIAL STUDY 134XCP|LB|364277A8-875C-4A6F-93C3-C913BB3C97CA|2||||C3B|COMPLEMENT C3B|||||||MMOL/KG|||||||POSITIVE||OZ||||HIGH|NOT DONE||||HAIR|UNEXPECTED ODOR|NA|NON-INVASIVE DIELECTRIC SENSING|CKD-EPI CREATININE FORMULA||Y|NA|Y|Y|||NA|2||58||OPEN LABEL TREATMENT|1965-03-04|1965-02-23|||||1966-03-14||1967-06-10|NA|1962-05-04
TRIAL STUDY 134XCP|LB|364277A8-875C-4A6F-93C3-C913BB3C97CA|1||||RBCDIPOP|DIMORPHIC ERYTHROCYTE POPULATION|||||||/WK|||||||INVALID||GBQ||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|UNEXPECTED ODOR|Y|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||U|N|U|N|||N|3||39||WASHOUT|1971-12-14|1970-09-30|||||1962-08-07||1967-01-18|U|1970-12-04
TRIAL STUDY 134XCP|LB|364277A8-875C-4A6F-93C3-C913BB3C97CA|2||||PTF1_2|PROTHROMBIN FRAGMENTS 1 + 2|||||||BU|||||||TRACE||VG/ML||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|AUTOLYZED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|ASH FIBROSURE FORMULA||U|N|NA|U|||Y|3||39||CONTINUATION TREATMENT|1963-06-26|1966-09-16|||||1963-02-19||1971-07-23|U|1972-10-18
TRIAL STUDY 134XCP|LB|364277A8-875C-4A6F-93C3-C913BB3C97CA|1||||NMP22|NUCLEAR MATRIX PROTEIN 22|||||||G/ANIMAL|||||||NEGATIVE||10^12/L||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|CONTAMINATED|N|PERIODIC ACID SCHIFF STAIN|MDRD FORMULA||N|Y|Y|Y|||Y|4||88||OPEN LABEL TREATMENT|1960-12-27|1963-12-11|||||1967-07-05||1965-02-08|NA|1971-11-23
TRIAL STUDY 134XCP|LB|364277A8-875C-4A6F-93C3-C913BB3C97CA|2||||MONOLE|MONOCYTES/LEUKOCYTES|||||||OSM|||||||BORDERLINE||UG/DOSE||||LOW|NOT DONE||||AQUEOUS HUMOR|AGGLUTINATED|NA|GIEMSA STAIN|MDRD 5 VARIABLE FORMULA||N|NA|Y|Y|||Y|4||88||BASELINE|1965-11-03|1967-11-28|||||1960-05-02||1966-01-30|N|1960-09-12
TRIAL STUDY 134XCP|LB|364277A8-875C-4A6F-93C3-C913BB3C97CA|1||||GFRBSCUA|GFR FROM CREAT,UREAN,ALB ADJ BSA|||||||WEEKS|||||||POSITIVE||ML/KG/MIN||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|FRESH|Y|TELLER ACUITY CARDS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|U|U|||N|5||7||FOLLOW-UP|1968-04-16|1969-10-27|||||1961-10-12||1973-01-17|N|1963-08-07
TRIAL STUDY 134XCP|LB|364277A8-875C-4A6F-93C3-C913BB3C97CA|2||||WBCMORPH|LEUKOCYTE CELL MORPHOLOGY|||||||F|||||||NEGATIVE||UMOL/L/SEC||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONCENTRATED|N|INFRARED SPECTROMETRY|HEPASCORE FORMULA||N|NA|U|N|||NA|5||7||FOLLOW-UP|1967-08-29|1961-12-07|||||1964-03-02||1968-06-16|U|1965-07-28
TRIAL STUDY 134XCP|LB|B824951F-58EE-4003-A2AD-A91AADBBAC0D|1||||CRTCLRBS|CREATININE CLEARANCE ADJUSTED FOR BSA|||||||CM|||||||POSITIVE||NG/DL||||HIGH|NOT DONE||||EMOTIONAL TEAR|CONTAMINATED|N|MOUSE PROTECTION ASSAY|MDRD 6 VARIABLE FORMULA||NA|Y|N|NA|||N|1||38||BASELINE|1963-12-22|1971-07-16|||||1967-04-11||1971-04-05|Y|1963-05-25
TRIAL STUDY 134XCP|LB|B824951F-58EE-4003-A2AD-A91AADBBAC0D|2||||ACE|ANGIOTENSIN CONVERTING ENZYME|||||||USEC|||||||BORDERLINE||UMOL/L/H||||NORMAL|NOT DONE||||MECONIUM|ROOM TEMPERATURE|N|FLOW MICROSCOPY|MDRD 4 VARIABLE FORMULA||N|U|U|N|||NA|1||38||SCREENING|1962-09-12|1972-04-19|||||1972-01-17||1972-07-06|U|1965-01-09
TRIAL STUDY 134XCP|LB|B824951F-58EE-4003-A2AD-A91AADBBAC0D|1||||SPMAGGR|SPERM AGGREGATION|||||||GPL U|||||||TRACE||WEEKS||||NORMAL|NOT DONE||||SKIN TISSUE|UNEXPECTED ODOR|Y|HANSEL STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|NA|NA|||U|2||58||OPEN LABEL TREATMENT|1970-09-05|1961-06-21|||||1968-07-24||1962-10-19|NA|1962-12-12
TRIAL STUDY 134XCP|LB|B824951F-58EE-4003-A2AD-A91AADBBAC0D|2||||TESTOS|TESTOSTERONE|||||||LOG10 CCID 50/DOSE|||||||INDETERMINATE||EQ||||HIGH|NOT DONE||||SUPERNATANT, SERUM|ROOM TEMPERATURE|U|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|GMI % FORMULA||N|U|NA|U|||NA|2||58||CONTINUATION TREATMENT|1964-02-17|1963-11-16|||||1967-02-22||1964-12-05|NA|1965-09-13
TRIAL STUDY 134XCP|LB|B824951F-58EE-4003-A2AD-A91AADBBAC0D|1||||PCO2|PARTIAL PRESSURE CARBON DIOXIDE|||||||MMOL/MIN/KPA|||||||BORDERLINE||PT_US||||LOW|NOT DONE||||BREAST MILK|LACTESCENT|NA|SEQUENCING|FIBROMETER FORMULA||N|Y|NA|NA|||U|3||39||FOLLOW-UP|1969-12-30|1972-02-15|||||1961-03-19||1967-09-30|U|1963-07-23
TRIAL STUDY 134XCP|LB|B824951F-58EE-4003-A2AD-A91AADBBAC0D|2||||HLADR53A|HLA-DR53 ANTIBODY|||||||UG/KG/DAY|||||||BORDERLINE||DNA COPIES/UG||||LOW|NOT DONE||||SYNOVIAL FLUID|AUTOLYZED|Y|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD 4 VARIABLE FORMULA||U|Y|Y|U|||N|3||39||RUN-IN|1960-05-26|1971-05-24|||||1963-11-15||1973-08-16|NA|1965-01-06
TRIAL STUDY 134XCP|LB|B824951F-58EE-4003-A2AD-A91AADBBAC0D|1||||ICAM3|INTERCELLULAR ADHESION MOLECULE 3|||||||UU/DL|||||||NEGATIVE||UG/H||||NORMAL|NOT DONE||||COLOSTRUM|THAWED|N|FLUORESCENT IMMUNOASSAY|ASH FIBROSURE FORMULA||U|NA|N|N|||N|4||88||INDUCTION TREATMENT|1961-10-17|1971-01-29|||||1960-06-26||1964-06-17|NA|1961-03-12
TRIAL STUDY 134XCP|LB|B824951F-58EE-4003-A2AD-A91AADBBAC0D|2||||C147277|TRITICUM AESTIVUM ANTIGEN IGE ANTIBODY|||||||VP/DOSE|||||||BORDERLINE||MMHG/SEC||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|FRESH|N|ELECTROPHORESIS|CKD-EPI CREATININE FORMULA||U|N|Y|N|||N|4||88||TREATMENT|1969-09-19|1963-02-01|||||1964-07-14||1965-07-23|NA|1964-07-12
TRIAL STUDY 134XCP|LB|B824951F-58EE-4003-A2AD-A91AADBBAC0D|1||||MYCEMIDX|MYELOID MATURATION INDEX|||||||U/KG/DAY|||||||NEGATIVE||MU||||HIGH|NOT DONE||||BONE MARROW|CONCENTRATED|Y|SLIT LAMP|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|Y|Y|||NA|5||7||OPEN LABEL TREATMENT|1969-09-09|1962-04-27|||||1964-08-31||1972-09-02|Y|1969-07-31
TRIAL STUDY 134XCP|LB|B824951F-58EE-4003-A2AD-A91AADBBAC0D|2||||TROPONI|TROPONIN I|||||||BOWL|||||||TRACE||PIXELS/IN||||NORMAL|NOT DONE||||VENOUS BLOOD|THAWED|U|MECHANICAL CLOT DETECTION|CKD-EPI FORMULA||Y|U|NA|Y|||Y|5||7||BLINDED TREATMENT|1969-04-27|1966-01-11|||||1968-11-15||1961-06-30|U|1962-09-20
TRIAL STUDY 134XCP|LB|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|1||||FLUOXTN|FLUOXETINE|||||||DAYS/WK|||||||TRACE||NEWTON||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|CLOTTED|NA|RADIOIMMUNOPRECIPITATION ASSAY|FIBROSIS 4 FORMULA||NA|U|U|NA|||U|1||38||RUN-IN|1966-05-02|1966-05-28|||||1967-01-15||1962-09-20|Y|1960-11-21
TRIAL STUDY 134XCP|LB|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|2||||C165924|GRASS MIX POLLEN IGE AB RAST SCORE|||||||10^6 DNA COPIES/ML|||||||NEGATIVE||MG/MIN||||HIGH|NOT DONE||||COLOSTRUM|PARAFFIN-EMBEDDED|U|RADIATION DOSIMETRY|NASH FIBROSURE FORMULA||NA|N|U|N|||NA|1||38||INDUCTION TREATMENT|1968-04-20|1966-12-02|||||1963-11-08||1961-12-10|N|1971-07-03
TRIAL STUDY 134XCP|LB|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|1||||LVFBRSC|LIVER FIBROSIS SCORE|||||||10^3 COPIES/ML|||||||TRACE||LOG10 TCID 50/DOSE||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|REFRIGERATED|N|OSCILLOMETRY|ASH FIBROSURE FORMULA||Y|NA|NA|N|||N|2||58||FOLLOW-UP|1967-04-15|1961-01-02|||||1960-09-16||1972-03-24|Y|1963-02-26
TRIAL STUDY 134XCP|LB|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|2||||C130095|WESTERN RAGWEED POLLEN IGG4|||||||BEL|||||||TRACE||COPIES/UG||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|LACTESCENT|N|PELLI-ROBSON EYE CHART|ASH FIBROSURE FORMULA||U|Y|N|NA|||Y|2||58||INDUCTION TREATMENT|1962-10-14|1961-03-15|||||1961-07-12||1970-11-03|NA|1969-09-16
TRIAL STUDY 134XCP|LB|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|1||||POLYERY|POLYCHROMATOPHILIC ERYTHROBLAST|||||||/H|||||||INDETERMINATE||ATM||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONTAMINATED|Y|MICROBIAL CULTURE, SOLID|FIBROMETER FORMULA||Y|Y|N|N|||NA|3||39||INDUCTION TREATMENT|1965-12-17|1965-02-09|||||1973-09-02||1967-05-02|Y|1971-11-14
TRIAL STUDY 134XCP|LB|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|2||||RDCSUB|REDUCING SUBSTANCES|||||||ML/ANIMAL/WK|||||||INVALID||10^6 CFU/ML||||ABNORMAL|NOT DONE||||URINE SEDIMENT|UNEXPECTED ODOR|NA|HPLC-FL|HEPASCORE FORMULA||Y|NA|N|Y|||N|3||39||BLINDED TREATMENT|1965-04-27|1970-03-10|||||1962-04-24||1960-10-19|Y|1961-11-29
TRIAL STUDY 134XCP|LB|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|1||||EPINSQCE|NON-SQUAMOUS EPITHELIAL CELLS|||||||PMOL/L/H|||||||NEGATIVE||LOG10 PFU||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CALCIFIED|Y|ELLA|MDRD FORMULA||N|N|NA|Y|||N|4||88||FOLLOW-UP|1967-01-06|1967-03-12|||||1971-08-28||1973-05-27|U|1971-04-30
TRIAL STUDY 134XCP|LB|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|2||||MDZLM|MIDAZOLAM|||||||FMOL|||||||POSITIVE||PKAT/L||||LOW|NOT DONE||||SYNOVIAL FLUID|FRESH|U|LIQUID SCINTILLATION COUNTING|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|NA|NA|||N|4||88||INDUCTION TREATMENT|1968-07-03|1964-05-16|||||1963-06-18||1972-09-12|NA|1966-09-15
TRIAL STUDY 134XCP|LB|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|1||||CYTRPHOS|TRIPLE PHOSPHATE CRYSTALS|||||||DB|||||||POSITIVE||OZ||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|DRIED|U|CLINICAL EVALUATION|CKD-EPI CYSTATIN C FORMULA||NA|U|Y|U|||Y|5||7||TREATMENT|1960-05-21|1968-05-08|||||1964-01-19||1969-11-25|Y|1966-08-07
TRIAL STUDY 134XCP|LB|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|2||||IMMGLCFR|IMMUNOGLOBULIN LIGHT CHAINS, FREE|||||||U/MMOL|||||||INDETERMINATE||H*%||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED|Y|DC SHEATH FLOW|NASH FIBROSURE FORMULA||U|N|Y|N|||Y|5||7||RUN-IN|1972-01-18|1972-09-05|||||1968-11-16||1973-07-08|Y|1967-12-03
TRIAL STUDY 134XCP|LB|A108F408-906C-4320-965A-D5D295BC5C31|1||||C165935|TRITICUM AESTIVUM IGE AB RAST SCORE|||||||JAR|||||||TRACE||MG/KG/H||||HIGH|NOT DONE||||GASTRIC CONTENTS|GELLED|NA|TRIPLE-PHASE MRI SCAN|NASH FIBROSURE FORMULA||U|NA|Y|N|||NA|1||38||BASELINE|1970-06-17|1967-09-24|||||1966-08-31||1965-06-06|Y|1970-10-12
TRIAL STUDY 134XCP|LB|A108F408-906C-4320-965A-D5D295BC5C31|2||||PLATAGRN|PLATELETS, AGRANULAR|||||||L/S|||||||NEGATIVE||KPA||||HIGH|NOT DONE||||SUPERNATANT, SERUM|FRESH|Y|PET/SPECT SCAN|MDRD ENZYMATIC FORMULA||Y|Y|U|NA|||U|1||38||SCREENING|1967-08-20|1969-03-11|||||1966-05-07||1968-03-06|U|1964-08-07
TRIAL STUDY 134XCP|LB|A108F408-906C-4320-965A-D5D295BC5C31|1||||DFI|DNA FRAGMENTATION INDEX|||||||MSEC|||||||TRACE||/2500 WBC||||LOW|NOT DONE||||CORD SERUM|CONTAMINATED|Y|GC/MS-CI|FIBROTEST FORMULA||NA|Y|U|U|||N|2||58||RUN-IN|1963-01-18|1967-01-10|||||1973-06-23||1967-12-25|Y|1969-09-13
TRIAL STUDY 134XCP|LB|A108F408-906C-4320-965A-D5D295BC5C31|2||||C147281|EGG WHITE ANTIGEN IGE ANTIBODY|||||||STRIP|||||||POSITIVE||G/CAGE/WK||||NORMAL|NOT DONE||||NAIL|CONTAMINATED|NA|FLUORESCEIN STAIN|CKD-EPI CREATININE FORMULA||Y|U|Y|U|||Y|2||58||BASELINE|1971-06-05|1960-09-10|||||1965-08-17||1973-06-14|Y|1960-03-03
TRIAL STUDY 134XCP|LB|A108F408-906C-4320-965A-D5D295BC5C31|1||||PRABC|CALCULATED PANEL REACTIVE ANTIBODY|||||||CL|||||||INDETERMINATE||UMOL/MG/MIN||||LOW|NOT DONE||||LYMPH|CONTAMINATED|NA|KNEMOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|U|N|||NA|3||39||FOLLOW-UP|1969-12-19|1971-12-19|||||1963-04-29||1962-06-23|N|1960-12-09
TRIAL STUDY 134XCP|LB|A108F408-906C-4320-965A-D5D295BC5C31|2||||C5A|COMPLEMENT C5A|||||||NU/CL|||||||INDETERMINATE||ELISA UNIT/ML||||NORMAL|NOT DONE||||LYMPH|GELLED|Y|CYSTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|U|NA|||N|3||39||OPEN LABEL TREATMENT|1960-02-17|1972-04-17|||||1964-08-06||1961-06-06|NA|1967-10-13
TRIAL STUDY 134XCP|LB|A108F408-906C-4320-965A-D5D295BC5C31|1||||MCHC|ERY. MEAN CORPUSCULAR HGB CONCENTRATION|||||||ML/MMHG/MIN/L|||||||NEGATIVE||ML/M2||||ABNORMAL|NOT DONE||||VENOUS PLASMA|LACTESCENT|U|CISH|MDRD ENZYMATIC FORMULA||NA|Y|NA|N|||U|4||88||RUN-IN|1962-10-18|1970-10-13|||||1968-08-16||1967-06-21|NA|1962-05-01
TRIAL STUDY 134XCP|LB|A108F408-906C-4320-965A-D5D295BC5C31|2||||NPAP|NON-PROSTATIC ACID PHOSPHATASE|||||||UG/L DDU|||||||INDETERMINATE||UG/CM2||||ABNORMAL|NOT DONE||||EXPIRED AIR|LACTESCENT|N|CORONARY ANGIOGRAPHY|FIBROTEST FORMULA||NA|N|N|Y|||NA|4||88||OBSERVATION|1963-04-15|1967-08-24|||||1970-09-08||1961-03-19|Y|1967-01-17
TRIAL STUDY 134XCP|LB|A108F408-906C-4320-965A-D5D295BC5C31|1||||HLADRB1|HLA DR BETA1 ANTIGEN|||||||MCI/L|||||||INVALID||U/M2/DAY||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|HEMOLYZED|U|GC/MS-EI|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|U|||Y|5||7||RUN-IN|1967-10-27|1965-04-16|||||1965-03-08||1965-10-31|U|1961-09-01
TRIAL STUDY 134XCP|LB|A108F408-906C-4320-965A-D5D295BC5C31|2||||STAT3|STAT3|||||||LB|||||||TRACE||MG||||HIGH|NOT DONE||||TRANSUDATE|HEMOLYZED|U|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|U|Y|NA|||Y|5||7||SCREENING|1960-05-11|1968-08-28|||||1963-01-15||1967-02-27|NA|1967-06-29
TRIAL STUDY 134XCP|LB|8E627D27-4855-4E1B-B823-1E14368973AF|1||||COPEP|COPEPTIN|||||||/4.0 ML|||||||BORDERLINE||/2000 RBC||||LOW|NOT DONE||||PLASMA|LACTESCENT|N|AUDIOMETRY|CKD-EPI CREATININE FORMULA||U|Y|N|N|||N|1||38||BASELINE|1967-11-25|1972-11-14|||||1961-01-30||1961-01-22|N|1969-07-06
TRIAL STUDY 134XCP|LB|8E627D27-4855-4E1B-B823-1E14368973AF|2||||HYPGST17|17-HYDROXYPROGESTERONE|||||||10^6/L|||||||NEGATIVE||KG/MOL||||NORMAL|NOT DONE||||MUSCLE TISSUE|REFRIGERATED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|N|Y|||Y|1||38||WASHOUT|1960-07-08|1963-10-28|||||1960-03-17||1964-07-09|U|1970-08-25
TRIAL STUDY 134XCP|LB|8E627D27-4855-4E1B-B823-1E14368973AF|1||||GCSF|GRANULOCYTE COLONY STIMULATING FACTOR|||||||PMOL|||||||INDETERMINATE||NM||||HIGH|NOT DONE||||NAIL|NON-HEMOLYZED|N|DARK FIELD MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||U|Y|Y|N|||NA|2||58||WASHOUT|1973-04-06|1960-06-05|||||1967-12-18||1970-12-06|NA|1961-01-08
TRIAL STUDY 134XCP|LB|8E627D27-4855-4E1B-B823-1E14368973AF|2||||LDH2LDH|LDH ISOENZYME 2/LDH|||||||UU/DL|||||||INVALID||%(W/V)||||NORMAL|NOT DONE||||SYNOVIAL FLUID|ICTERIC|U|WHOLE EXOME SEQUENCING|COCKCROFT-GAULT FORMULA||U|N|N|Y|||NA|2||58||FOLLOW-UP|1968-09-09|1971-05-15|||||1972-11-26||1965-03-16|NA|1960-12-12
TRIAL STUDY 134XCP|LB|8E627D27-4855-4E1B-B823-1E14368973AF|1||||LYMPLLY|PLASMACYTOID LYMPHOCYTES/LYMPHOCYTES|||||||MG/KG/WEEK|||||||INDETERMINATE||PA||||NORMAL|NOT DONE||||RETICULOCYTES|ICTERIC|NA|SANGER SEQUENCING|MDRD 5 VARIABLE FORMULA||U|N|NA|N|||Y|3||39||LONG-TERM FOLLOW-UP|1963-05-27|1966-10-17|||||1970-07-11||1960-08-15|N|1971-03-30
TRIAL STUDY 134XCP|LB|8E627D27-4855-4E1B-B823-1E14368973AF|2||||SJSA60AB|SJOGRENS SS-A60 ANTIBODY|||||||MOSM/KG|||||||INVALID||EP U||||ABNORMAL|NOT DONE||||CORD SERUM|NON-HEMOLYZED|NA|FISH|COCKCROFT-GAULT FORMULA||N|U|N|N|||U|3||39||OBSERVATION|1961-12-26|1970-06-03|||||1961-10-16||1962-12-08|Y|1961-10-09
TRIAL STUDY 134XCP|LB|8E627D27-4855-4E1B-B823-1E14368973AF|1||||LAM|LIPOARABINOMANNAN|||||||L/H|||||||INVALID||G/KG/DAY||||HIGH|NOT DONE||||LAVAGE FLUID|CONCENTRATED|U|MULTI-SLICE SPIRAL CT|MDRD FORMULA||Y|U|NA|N|||N|4||88||BASELINE|1973-03-18|1960-04-25|||||1965-12-05||1963-09-27|NA|1971-05-03
TRIAL STUDY 134XCP|LB|8E627D27-4855-4E1B-B823-1E14368973AF|2||||C130108|WEED MIX POLLEN ANTIGEN IGA ANTIBODY|||||||ANTIBODY UNIT|||||||BORDERLINE||UU/L||||HIGH|NOT DONE||||SMEGMA|LIPEMIC|NA|SPECT SCAN|HEPASCORE FORMULA||Y|NA|NA|N|||NA|4||88||SCREENING|1966-05-11|1970-05-08|||||1967-10-15||1971-07-18|U|1966-02-12
TRIAL STUDY 134XCP|LB|8E627D27-4855-4E1B-B823-1E14368973AF|1||||IGFBP1|INSULIN-LIKE GROWTH FACTOR BINDING PROT1|||||||NMOL/KG/DAY|||||||POSITIVE||NG/L||||HIGH|NOT DONE||||BREAST MILK|THAWED|U|CELLULAR PROLIFERATION ASSAY|MDRD 5 VARIABLE FORMULA||NA|N|U|NA|||U|5||7||RUN-IN|1969-02-16|1963-05-31|||||1965-11-27||1966-12-09|Y|1967-01-14
TRIAL STUDY 134XCP|LB|8E627D27-4855-4E1B-B823-1E14368973AF|2||||HALPRZLM|HYDROXYALPRAZOLAM|||||||UG/ANIMAL|||||||BORDERLINE||BU/ML||||HIGH|NOT DONE||||SEMEN|HEMOLYZED|N|HIGH RESOLUTION MELT ANALYSIS|MDRD FORMULA||U|U|NA|Y|||NA|5||7||INDUCTION TREATMENT|1960-07-30|1972-02-02|||||1962-12-20||1961-12-30|NA|1970-09-25
TRIAL STUDY 134XCP|LB|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|1||||BTLBARTL|BUTABARBITAL|||||||MM/SEC|||||||INVALID||ML/CAGE/WK||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|GELLED|N|IHC|CKD-EPI CREATININE FORMULA||U|NA|N|NA|||U|1||38||TREATMENT|1969-07-11|1967-07-21|||||1973-07-07||1968-04-02|Y|1968-06-24
TRIAL STUDY 134XCP|LB|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|2||||CYHGBC|HEMOGLOBIN C CRYSTALS|||||||UM/S|||||||INVALID||10^3 ORGANISMS||||LOW|NOT DONE||||DERMAL TISSUE|NON-HEMOLYZED|N|LC-FL|FIBROMETER FORMULA||NA|U|NA|N|||NA|1||38||RUN-IN|1972-01-25|1962-03-27|||||1972-10-24||1967-04-09|N|1967-06-11
TRIAL STUDY 134XCP|LB|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|1||||GFRBSB2M|GFR FROM B-2 MICROGLOBULIN ADJ FOR BSA|||||||LOG EID 50/DOSE|||||||INVALID||10^3 CFU/ML||||ABNORMAL|NOT DONE||||BONE|NON-HEMOLYZED|U|MICRODENSITOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|NA|NA|||U|2||58||TREATMENT|1960-12-15|1970-10-28|||||1960-10-06||1970-08-18|Y|1965-12-26
TRIAL STUDY 134XCP|LB|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|2||||ESTFREST|ESTRADIOL, FREE/ESTRADIOL|||||||MCI/KG|||||||BORDERLINE||MMOL/S||||NORMAL|NOT DONE||||ISOLATE|LIPEMIC|Y|RAJI CELL EIA|CKD-EPI CREATININE FORMULA||N|NA|U|NA|||N|2||58||TREATMENT|1963-07-06|1965-04-13|||||1960-03-13||1970-03-05|U|1965-04-21
TRIAL STUDY 134XCP|LB|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|1||||VLDLTCT|VLDL TRIGLYCERIDE + CHYLOMICRON TRIGLYCERIDE|||||||KG/CM|||||||TRACE||BQ/UG||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|REFRIGERATED|U|MAMMOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|Y|NA|||U|3||39||TREATMENT|1972-12-04|1967-07-15|||||1964-04-30||1973-03-25|Y|1963-06-12
TRIAL STUDY 134XCP|LB|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|2||||RPA1|RENAL PAPILLARY ANTIGEN 1|||||||MG/M2/DAY|||||||NEGATIVE||UU/DL||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|CONTAMINATED|NA|LINE PROBE ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|NA|U|||U|3||39||OBSERVATION|1965-12-20|1972-09-28|||||1968-08-20||1973-09-03|U|1970-11-13
TRIAL STUDY 134XCP|LB|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|1||||RP3IGGAB|RNA POLYMERASE III IGG ANTIBODY|||||||MILE|||||||TRACE||10^9 CFU/G||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|UNEXPECTED ODOR|NA|TRIPLE-PHASE SPIRAL CT SCAN|MDRD ENZYMATIC FORMULA||Y|N|Y|Y|||Y|4||88||BLINDED TREATMENT|1969-07-13|1966-01-07|||||1969-04-15||1969-04-22|U|1966-02-19
TRIAL STUDY 134XCP|LB|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|2||||CIT|CITRULLINE|||||||COULOMB|||||||TRACE||LOG10 ELISA UNIT/DOSE||||HIGH|NOT DONE||||WHITE MATTER TISSUE|THAWED|U|OBSERVATION|MDRD 4 VARIABLE FORMULA||U|NA|N|Y|||Y|4||88||CONTINUATION TREATMENT|1968-08-04|1973-04-02|||||1966-02-14||1968-08-18|U|1973-05-30
TRIAL STUDY 134XCP|LB|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|1||||BLEEDT|BLEEDING TIME|||||||L/H/M2|||||||BORDERLINE||EJACULATE U||||ABNORMAL|NOT DONE||||SEMEN|LIPEMIC|N|GC/MS/MS|MDRD 5 VARIABLE FORMULA||N|NA|N|Y|||U|5||7||BASELINE|1973-06-13|1969-08-20|||||1969-08-17||1967-07-02|N|1965-08-02
TRIAL STUDY 134XCP|LB|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|2||||CCL2EXR|CHEMOKINE (C-C MOTIF) LIGAND 2 EXCR RATE|||||||SV|||||||TRACE||CAPLET||||HIGH|NOT DONE||||DIALYSIS FLUID, PERITONEAL|GELLED|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|U|||N|5||7||BASELINE|1964-03-02|1963-10-25|||||1960-08-05||1969-11-03|N|1969-01-17
TRIAL STUDY 134XCP|LB|483D89E1-45FD-41D4-B9E0-22FFB41D323A|1||||C130103|GRASS MIX POLLEN ANTIGEN IGE ANTIBODY|||||||EID 50/DOSE|||||||BORDERLINE||ML/MMHG/MIN/L||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|FRESH|NA|GC/MS/MS|MDRD ENZYMATIC FORMULA||NA|N|NA|N|||NA|1||38||SCREENING|1963-11-28|1962-05-22|||||1966-01-18||1971-09-29|N|1967-03-07
TRIAL STUDY 134XCP|LB|483D89E1-45FD-41D4-B9E0-22FFB41D323A|2||||ETG|ETHYL GLUCURONIDE|||||||MOL|||||||INVALID||DNA COPIES/UG||||HIGH|NOT DONE||||NAIL|DRIED|U|ENZYMATIC SPECTROPHOTOMETRY|FIBROMETER FORMULA||U|NA|Y|NA|||NA|1||38||BLINDED TREATMENT|1961-01-01|1962-05-14|||||1962-11-22||1963-04-18|Y|1962-01-12
TRIAL STUDY 134XCP|LB|483D89E1-45FD-41D4-B9E0-22FFB41D323A|1||||NPY|NEUROPEPTIDE Y|||||||S/H|||||||NEGATIVE||KA_U/DL||||LOW|NOT DONE||||EPIDERMAL TISSUE|REFRIGERATED|Y|CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE FORMULA||NA|Y|Y|Y|||NA|2||58||BLINDED TREATMENT|1963-12-06|1960-07-07|||||1961-04-14||1970-11-13|NA|1962-07-30
TRIAL STUDY 134XCP|LB|483D89E1-45FD-41D4-B9E0-22FFB41D323A|2||||ALTAST|ALT/AST|||||||L/KG|||||||TRACE||MIU/L||||HIGH|NOT DONE||||PERITONEAL FLUID|GELLED|N|AGAR DILUTION|NASH FIBROSURE FORMULA||U|NA|U|NA|||Y|2||58||BLINDED TREATMENT|1972-03-30|1970-05-08|||||1968-01-26||1966-02-02|N|1961-08-26
TRIAL STUDY 134XCP|LB|483D89E1-45FD-41D4-B9E0-22FFB41D323A|1||||C130077|SILVER BIRCH POLLEN IGA|||||||PA|||||||POSITIVE||G/MOL||||HIGH|NOT DONE||||RETICULOCYTES|LACTESCENT|NA|CALIPER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA||U|Y|NA|U|||U|3||39||BASELINE|1970-05-03|1964-01-29|||||1968-05-27||1971-04-09|N|1968-01-28
TRIAL STUDY 134XCP|LB|483D89E1-45FD-41D4-B9E0-22FFB41D323A|2||||CRP|C REACTIVE PROTEIN|||||||UL/DOSE|||||||BORDERLINE||DAGU/ML||||NORMAL|NOT DONE||||CORD SERUM|THAWED|U|RADIOGRAPHY|MDRD 4 VARIABLE FORMULA||NA|U|N|NA|||N|3||39||TREATMENT|1969-09-20|1965-08-24|||||1972-06-02||1971-08-04|N|1970-05-26
TRIAL STUDY 134XCP|LB|483D89E1-45FD-41D4-B9E0-22FFB41D323A|1||||CD45LY|CD45/LYMPHOCYTES|||||||DEG2|||||||NEGATIVE||G/G||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|UNEXPECTED ODOR|N|HILLMEN COLOR CHART|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|N|||U|4||88||RUN-IN|1961-03-23|1960-03-01|||||1966-01-12||1971-06-05|NA|1965-05-09
TRIAL STUDY 134XCP|LB|483D89E1-45FD-41D4-B9E0-22FFB41D323A|2||||AMYLOIDA|AMYLOID A|||||||DL|||||||INDETERMINATE||UG/G/H||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|N|ORCHIDOMETERY|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|Y|Y|||U|4||88||BLINDED TREATMENT|1967-03-27|1973-03-27|||||1967-03-20||1961-12-25|U|1962-12-29
TRIAL STUDY 134XCP|LB|483D89E1-45FD-41D4-B9E0-22FFB41D323A|1||||IFIT3|INTERFERON-INDUCED 60 KDA PROTEIN|||||||MIN|||||||INDETERMINATE||OD UNIT||||NORMAL|NOT DONE||||PLEURAL TISSUE|CONTAMINATED|NA|SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|NA|NA|||N|5||7||TREATMENT|1971-04-14|1961-01-23|||||1966-09-07||1962-06-27|NA|1963-11-29
TRIAL STUDY 134XCP|LB|483D89E1-45FD-41D4-B9E0-22FFB41D323A|2||||FACTVWA|VON WILLEBRAND FACTOR ACTIVITY|||||||/CMH2O|||||||INVALID||CY/CM||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|DRIED|Y|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|NA|NA|||N|5||7||TREATMENT|1971-06-15|1962-10-28|||||1969-09-13||1962-09-10|U|1965-10-13
TRIAL STUDY 134XCP|LB|2CCBED9D-5F24-4ED8-B575-8523C820A227|1||||HBBARTHB|HEMOGLOBIN BARTS/TOTAL HEMOGLOBIN|||||||KIT|||||||TRACE||DPM/100MG||||ABNORMAL|NOT DONE||||PLATELET|THAWED|N|PATHOLOGICAL EVALUATION|MDRD ENZYMATIC FORMULA||Y|U|N|NA|||NA|1||38||INDUCTION TREATMENT|1960-10-26|1962-01-22|||||1971-02-28||1966-02-24|NA|1971-03-08
TRIAL STUDY 134XCP|LB|2CCBED9D-5F24-4ED8-B575-8523C820A227|2||||C130139|AMERICAN COCKROACH ANTIGEN IGG4 ANTIBODY|||||||10^6 ORGANISMS|||||||POSITIVE||10^10/L||||NORMAL|NOT DONE||||SKIN TISSUE|CONCENTRATED|Y|DIRECT SEQUENCING|COCKCROFT-GAULT FORMULA||NA|N|NA|Y|||N|1||38||WASHOUT|1965-08-16|1972-06-14|||||1961-01-23||1967-09-10|NA|1961-06-01
TRIAL STUDY 134XCP|LB|2CCBED9D-5F24-4ED8-B575-8523C820A227|1||||KIM1|KIDNEY INJURY MOLECULE-1|||||||CONTAINER|||||||BORDERLINE||MIN/DAY||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|AUTOLYZED|Y|KINYOUN STAIN|CKD-EPI FORMULA||Y|Y|Y|U|||Y|2||58||FOLLOW-UP|1962-01-09|1971-04-15|||||1966-02-17||1966-03-23|Y|1971-12-25
TRIAL STUDY 134XCP|LB|2CCBED9D-5F24-4ED8-B575-8523C820A227|2||||ASMACT|ALPHA-SMOOTH MUSCLE ACTIN|||||||KIU|||||||NEGATIVE||%(W/W)||||ABNORMAL|NOT DONE||||CORD BLOOD|REFRIGERATED|Y|FUNCTIONAL MRI|MDRD ENZYMATIC FORMULA||NA|Y|U|N|||U|2||58||FOLLOW-UP|1970-01-08|1968-08-21|||||1961-10-25||1972-11-27|Y|1962-01-06
TRIAL STUDY 134XCP|LB|2CCBED9D-5F24-4ED8-B575-8523C820A227|1||||ESELECT|E-SELECTIN|||||||PLUG|||||||TRACE||GAUSS||||LOW|NOT DONE||||ALVEOLAR AIR|SOLIDIFIED|N|SIZE EXCLUSION CHROMATOGRAPHY|MDRD ENZYMATIC FORMULA||Y|Y|Y|N|||NA|3||39||OBSERVATION|1970-05-31|1968-05-29|||||1968-03-11||1961-09-25|NA|1964-03-21
TRIAL STUDY 134XCP|LB|2CCBED9D-5F24-4ED8-B575-8523C820A227|2||||GSTY1|GLUTATHIONE S-TRANSFERASE, Y1|||||||UIU/DL|||||||INVALID||BAU/ML||||NORMAL|NOT DONE||||NAIL|AUTOLYZED|U|IMMUNOFLUORESCENT STAIN|MDRD 5 VARIABLE FORMULA||N|N|Y|U|||Y|3||39||TREATMENT|1965-10-10|1968-12-27|||||1966-03-21||1970-06-01|U|1970-01-14
TRIAL STUDY 134XCP|LB|2CCBED9D-5F24-4ED8-B575-8523C820A227|1||||MOCYCECE|MONOCYTOID CELLS/TOTAL CELLS|||||||DL|||||||BORDERLINE||TESLA||||LOW|NOT DONE||||SUPERNATANT, PLASMA|AGGLUTINATED|NA|ELECTROGASTROGRAPHY|MDRD ENZYMATIC FORMULA||N|U|U|U|||NA|4||88||BLINDED TREATMENT|1963-08-28|1961-07-07|||||1968-07-22||1968-04-29|N|1964-02-18
TRIAL STUDY 134XCP|LB|2CCBED9D-5F24-4ED8-B575-8523C820A227|2||||PDGFAA|PLATELET DERIVED GROWTH FACTOR ISOFORMAA|||||||MU/L|||||||TRACE||MV||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CONCENTRATED|Y|PEAK FLOWMETRY|FIBROMETER FORMULA||NA|NA|N|NA|||N|4||88||LONG-TERM FOLLOW-UP|1960-04-25|1967-10-20|||||1967-02-27||1970-05-20|N|1960-12-05
TRIAL STUDY 134XCP|LB|2CCBED9D-5F24-4ED8-B575-8523C820A227|1||||CKMT2CK|CK, MACROMOLECULAR TYPE 2/TOTAL CK|||||||BOTTLE|||||||POSITIVE||JOULE||||HIGH|NOT DONE||||CAPILLARY PLASMA|THAWED|NA|PULMONARY ANGIOGRAPHY|CKD-EPI CREATININE FORMULA||U|Y|Y|NA|||U|5||7||CONTINUATION TREATMENT|1972-06-29|1970-06-14|||||1961-10-18||1964-07-26|U|1965-08-04
TRIAL STUDY 134XCP|LB|2CCBED9D-5F24-4ED8-B575-8523C820A227|2||||THROMNUC|THROMBOCYTES|||||||SUPPOSITORY|||||||BORDERLINE||SUPPOSITORY||||ABNORMAL|NOT DONE||||PLEURAL FLUID|REFRIGERATED|U|POTENTIOMETRY|FIBROMETER FORMULA||U|U|U|N|||NA|5||7||BASELINE|1962-11-08|1961-06-10|||||1965-06-26||1967-10-04|NA|1966-08-31
TRIAL STUDY 134XCP|LB|F4D6A28D-569F-4639-ACE2-10EB517128B2|1||||SMUSCGAB|SMOOTH MUSCLE IGG ANTIBODY|||||||WEBER|||||||TRACE||HPA||||LOW|NOT DONE||||COLOSTRUM|UNEXPECTED ODOR|N|CINEANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|NA|NA|||N|1||38||BASELINE|1964-01-13|1962-09-09|||||1973-07-23||1971-08-19|Y|1970-12-11
TRIAL STUDY 134XCP|LB|F4D6A28D-569F-4639-ACE2-10EB517128B2|2||||INSAAB|INSULIN AUTOANTIBODY|||||||BU|||||||TRACE||MOSM||||LOW|NOT DONE||||EPIDERMAL TISSUE|CALCIFIED|NA|PET/CT SCAN WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA||N|N|N|U|||U|1||38||TREATMENT|1967-04-21|1963-05-17|||||1966-01-25||1970-11-22|N|1962-05-20
TRIAL STUDY 134XCP|LB|F4D6A28D-569F-4639-ACE2-10EB517128B2|1||||HLAA2AB|HLA-A2 ANTIBODY|||||||M3|||||||POSITIVE||ML/M2/H||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|AUTOLYZED|Y|KINETIC MICROPARTICLE IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|N|N|||N|2||58||OPEN LABEL TREATMENT|1964-01-15|1968-04-15|||||1963-10-16||1965-05-06|N|1964-01-16
TRIAL STUDY 134XCP|LB|F4D6A28D-569F-4639-ACE2-10EB517128B2|2||||GDF11|GROWTH DIFFERENTIATION FACTOR 11|||||||UG/ANIMAL|||||||TRACE||MEQ/KG||||LOW|NOT DONE||||SOFT TISSUE|CONCENTRATED|Y|HEMOCYTOMETRY|CKD-EPI FORMULA||U|NA|U|Y|||NA|2||58||WASHOUT|1960-10-05|1970-04-15|||||1972-06-16||1971-09-04|Y|1972-08-14
TRIAL STUDY 134XCP|LB|F4D6A28D-569F-4639-ACE2-10EB517128B2|1||||RDWR|RET VOLUME DISTRIBUTION WIDTH|||||||MOL/L|||||||INDETERMINATE||BQ/MG||||LOW|NOT DONE||||SEMEN|LACTESCENT|NA|SECONDARY ION MASS SPECTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|N|N|||NA|3||39||BLINDED TREATMENT|1965-06-14|1966-02-14|||||1973-03-11||1961-01-12|Y|1962-12-29
TRIAL STUDY 134XCP|LB|F4D6A28D-569F-4639-ACE2-10EB517128B2|2||||EDTACLR|EDTA CLEARANCE|||||||VG/DOSE|||||||NEGATIVE||CY/CM||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|CLOTTED|U|DROPLET DIGITAL PCR|GMI % FORMULA||NA|U|NA|N|||N|3||39||FOLLOW-UP|1960-03-15|1972-06-17|||||1972-10-16||1966-02-12|N|1973-05-04
TRIAL STUDY 134XCP|LB|F4D6A28D-569F-4639-ACE2-10EB517128B2|1||||CYSTARCH|STARCH CRYSTALS|||||||FT2|||||||BORDERLINE||TABLET||||LOW|NOT DONE||||SPUTUM|CONCENTRATED|Y|FARNSWORTH-MUNSELL 100 HUE TEST|FIBROMETER FORMULA||N|N|Y|Y|||U|4||88||SCREENING|1968-05-21|1964-09-03|||||1963-09-21||1965-08-24|U|1971-11-12
TRIAL STUDY 134XCP|LB|F4D6A28D-569F-4639-ACE2-10EB517128B2|2||||PO2|PARTIAL PRESSURE OXYGEN|||||||CCID 50/ML|||||||BORDERLINE||PIXELS/IN||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|PARAFFIN-EMBEDDED|U|ECHOCARDIOGRAPHY|HEPASCORE FORMULA||Y|U|N|N|||NA|4||88||WASHOUT|1968-07-25|1964-06-24|||||1967-07-22||1970-11-16|U|1963-11-05
TRIAL STUDY 134XCP|LB|F4D6A28D-569F-4639-ACE2-10EB517128B2|1||||CKMBCK|CREATINE KINASE MB/TOTAL CREATINE KINASE|||||||MOL/L|||||||TRACE||IU/MG||||NORMAL|NOT DONE||||PROSTATIC FLUID|AGGLUTINATED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA||NA|N|N|N|||Y|5||7||INDUCTION TREATMENT|1973-01-05|1968-07-15|||||1967-07-28||1969-01-16|NA|1962-11-27
TRIAL STUDY 134XCP|LB|F4D6A28D-569F-4639-ACE2-10EB517128B2|2||||LEUKCRBC|LEUKS CORRECTED FOR NUCL ERYTHROCYTES|||||||LOG10 ELISA UNIT|||||||POSITIVE||KUSP||||HIGH|NOT DONE||||PLEURAL FLUID|NON-HEMOLYZED|NA|MIGET|FIBROTEST FORMULA||N|NA|N|N|||Y|5||7||INDUCTION TREATMENT|1964-12-15|1965-02-17|||||1968-01-30||1962-06-29|Y|1973-04-11
TRIAL STUDY 134XCP|LB|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|1||||ATHMBAC|ANTITHROMBIN ACTUAL/CONTROL|||||||UU/L|||||||POSITIVE||PACKET||||HIGH|NOT DONE||||ALVEOLAR AIR|PARAFFIN-EMBEDDED|Y|CONTRAST ENHANCED X-RAY|GMI MMOL/MOL FORMULA||N|N|NA|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1973-01-18|1960-05-17|||||1962-07-21||1971-02-21|N|1972-04-29
TRIAL STUDY 134XCP|LB|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|2||||TPROTFR|TAU PROTEIN, FREE|||||||PLUG|||||||TRACE||L/S/KPA||||ABNORMAL|NOT DONE||||CELL PELLET|AGGLUTINATED|Y|DOPPLER ULTRASOUND|FIBROMETER FORMULA||Y|NA|NA|U|||N|1||38||BASELINE|1972-02-17|1967-06-19|||||1968-08-28||1963-03-15|N|1972-01-11
TRIAL STUDY 134XCP|LB|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|1||||HGBEHGB|HEMOGLOBIN E/TOTAL HEMOGLOBIN|||||||LOG10 CFU/ML|||||||NEGATIVE||CM||||LOW|NOT DONE||||MIXED VENOUS BLOOD|CALCIFIED|Y|GEL ELECTROPHORESIS|MDRD 6 VARIABLE FORMULA||Y|Y|Y|N|||NA|2||58||TREATMENT|1960-06-04|1973-01-05|||||1960-05-12||1969-07-25|Y|1970-02-25
TRIAL STUDY 134XCP|LB|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|2||||A1MCREAT|ALPHA-1 MICROGLOBULIN/CREATININE|||||||ML/S/M2|||||||NEGATIVE||MG/KG/MIN||||NORMAL|NOT DONE||||BLOOD|NON-HEMOLYZED|U|CYSTOMETRY|CKD-EPI CREATININE FORMULA||Y|U|NA|Y|||NA|2||58||BLINDED TREATMENT|1966-02-14|1960-09-01|||||1963-12-02||1960-05-12|Y|1969-07-22
TRIAL STUDY 134XCP|LB|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|1||||LDH1|LDH ISOENZYME 1|||||||NMOL|||||||INVALID||FARAD||||ABNORMAL|NOT DONE||||BILE|THAWED|Y|CLIP SEQUENCING|NASH FIBROSURE FORMULA||Y|Y|N|Y|||U|3||39||TREATMENT|1971-09-06|1962-11-06|||||1967-03-19||1970-01-25|NA|1967-08-19
TRIAL STUDY 134XCP|LB|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|2||||MCV|ERY. MEAN CORPUSCULAR VOLUME|||||||GBQ/G|||||||INDETERMINATE||RATIO||||HIGH|NOT DONE||||PLASMA|FRESH|U|CALCOFLUOR WHITE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||N|N|N|Y|||NA|3||39||BASELINE|1968-07-13|1969-11-12|||||1973-08-17||1970-06-04|U|1964-02-16
TRIAL STUDY 134XCP|LB|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|1||||KEXR|POTASSIUM EXCRETION RATE|||||||S^-1(%O2)^-1|||||||BORDERLINE||L/H||||NORMAL|NOT DONE||||TUMOR TISSUE|SOLIDIFIED|N|ELECTROPHORESIS|CKD-EPI CREATININE FORMULA||U|U|N|Y|||U|4||88||FOLLOW-UP|1966-01-15|1967-10-25|||||1970-08-29||1970-09-19|NA|1973-01-04
TRIAL STUDY 134XCP|LB|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|2||||C130077|SILVER BIRCH POLLEN IGA|||||||UIU/DL|||||||INVALID||NU/CL||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|THAWED|NA|PANENDOSCOPY|FIBROSIS 4 FORMULA||Y|N|N|N|||NA|4||88||FOLLOW-UP|1963-10-15|1967-01-16|||||1971-10-31||1963-09-18|N|1962-01-28
TRIAL STUDY 134XCP|LB|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|1||||COLOR|COLOR|||||||FT2|||||||BORDERLINE||U/MMOL||||ABNORMAL|NOT DONE||||DERMAL TISSUE|ICTERIC|NA|PHOTOMETRY|NASH FIBROSURE FORMULA||NA|U|NA|N|||U|5||7||TREATMENT|1971-09-14|1964-09-01|||||1963-10-29||1963-02-23|Y|1962-03-22
TRIAL STUDY 134XCP|LB|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|2||||CAMP|CYCLIC ADENOSINE 3,5-MONOPHOSPHATE|||||||PSI|||||||INDETERMINATE||UM/S||||LOW|NOT DONE||||VENOUS PLASMA|THAWED|Y|IMMUNOBLOT|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|Y|||N|5||7||CONTINUATION TREATMENT|1969-07-19|1965-07-16|||||1969-01-16||1962-10-01|NA|1963-10-30
TRIAL STUDY 134XCP|LB|415EF35E-6D99-48F8-80A1-89A4CDC621B8|1||||HBA1C|HEMOGLOBIN A1C|||||||UG/G/DAY|||||||INDETERMINATE||%(W/W)||||LOW|NOT DONE||||MIXED VENOUS BLOOD|GELLED|U|ISHIHARA COLOR PLATES|MDRD 5 VARIABLE FORMULA||Y|U|Y|U|||N|1||38||SCREENING|1968-04-06|1971-08-27|||||1971-06-01||1962-11-28|Y|1960-06-23
TRIAL STUDY 134XCP|LB|415EF35E-6D99-48F8-80A1-89A4CDC621B8|2||||HGF|HEPATOCYTE GROWTH FACTOR|||||||M/SEC2|||||||TRACE||MG/MIN||||HIGH|NOT DONE||||EPIDERMAL TISSUE|FROZEN|NA|REFRACTOMETRY|CKD-EPI FORMULA||NA|N|U|NA|||Y|1||38||SCREENING|1961-11-20|1964-10-22|||||1962-05-14||1966-05-05|N|1963-12-31
TRIAL STUDY 134XCP|LB|415EF35E-6D99-48F8-80A1-89A4CDC621B8|1||||PTHRP|PARATHYROID HORMONE-RELATED PROTEIN|||||||M/SEC|||||||INVALID||ML/DOSE||||LOW|NOT DONE||||COLOSTRUM|ICTERIC|NA|ENZYMATIC ULTRACENTRIFUGATION|MDRD 6 VARIABLE FORMULA||NA|Y|U|Y|||NA|2||58||RUN-IN|1968-11-16|1960-03-06|||||1968-09-21||1965-06-19|Y|1964-01-06
TRIAL STUDY 134XCP|LB|415EF35E-6D99-48F8-80A1-89A4CDC621B8|2||||TMZPM|TEMAZEPAM|||||||M3|||||||POSITIVE||VP/DOSE||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|CLOTTED|NA|FLUORESCENT IMMUNOASSAY|MDRD FORMULA||NA|NA|N|Y|||U|2||58||INDUCTION TREATMENT|1965-08-17|1966-01-01|||||1960-06-11||1969-11-29|Y|1972-08-31
TRIAL STUDY 134XCP|LB|415EF35E-6D99-48F8-80A1-89A4CDC621B8|1||||CPEPTIDE|C-PEPTIDE|||||||YEARS|||||||NEGATIVE||10^9/L||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|UNEXPECTED ODOR|NA|MICROSCOPY|ASH FIBROSURE FORMULA||Y|Y|N|U|||U|3||39||LONG-TERM FOLLOW-UP|1960-04-11|1969-04-21|||||1963-01-09||1960-12-06|N|1969-09-30
TRIAL STUDY 134XCP|LB|415EF35E-6D99-48F8-80A1-89A4CDC621B8|2||||MACROBLD|MACROSCOPIC BLOOD|||||||ML/DAY|||||||INVALID||CFU/G||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|HEMOLYZED|NA|NEPHELOMETRY|MDRD ENZYMATIC FORMULA||N|N|N|U|||Y|3||39||RUN-IN|1967-02-01|1970-10-25|||||1966-10-02||1973-03-03|Y|1973-07-01
TRIAL STUDY 134XCP|LB|415EF35E-6D99-48F8-80A1-89A4CDC621B8|1||||LYMVACLE|VACUOLATED LYMPHOCYTES/LEUKOCYTES|||||||HZ|||||||TRACE||UL/DOSE||||ABNORMAL|NOT DONE||||SPERMATOZOON|LACTESCENT|Y|AUTOMATED COUNT|HEPASCORE FORMULA||U|U|Y|NA|||NA|4||88||WASHOUT|1969-06-02|1961-11-22|||||1972-11-19||1962-02-07|U|1964-07-20
TRIAL STUDY 134XCP|LB|415EF35E-6D99-48F8-80A1-89A4CDC621B8|2||||CYPHOS|PHOSPHATE CRYSTALS|||||||% INHIBITION|||||||BORDERLINE||CAPSULE||||ABNORMAL|NOT DONE||||PLASMA|CONCENTRATED|U|MS/MS|NASH FIBROSURE FORMULA||N|Y|U|NA|||NA|4||88||RUN-IN|1966-06-21|1963-10-07|||||1971-02-07||1967-03-15|Y|1968-07-05
TRIAL STUDY 134XCP|LB|415EF35E-6D99-48F8-80A1-89A4CDC621B8|1||||CXCL9|CHEMOKINE (C-X-C MOTIF) LIGAND 9|||||||KG/L|||||||INVALID||KG/M2||||ABNORMAL|NOT DONE||||PLASMA|UNEXPECTED ODOR|U|ELISA|FIBROSIS 4 FORMULA||N|NA|N|U|||NA|5||7||TREATMENT|1963-01-26|1971-05-02|||||1972-08-24||1969-06-02|NA|1965-07-01
TRIAL STUDY 134XCP|LB|415EF35E-6D99-48F8-80A1-89A4CDC621B8|2||||COCAINE|COCAINE|||||||10^7 CFU/ML|||||||POSITIVE||10^6 CFU||||HIGH|NOT DONE||||BONE|GELLED|Y|CAPILLARY ELECTROPHORESIS|MDRD 6 VARIABLE FORMULA||U|NA|Y|Y|||U|5||7||TREATMENT|1960-05-15|1963-04-09|||||1968-03-26||1963-03-08|NA|1965-01-12
TRIAL STUDY 134XCP|LB|AA0F6192-A377-43C6-8203-BDF7553AEA88|1||||FACTVWA|VON WILLEBRAND FACTOR ACTIVITY|||||||PMOL/DAY|||||||TRACE||LOG10 CCID 50/DOSE||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|ICTERIC|N|PERFUSION MRI|MDRD ENZYMATIC FORMULA||N|N|NA|N|||U|1||38||INDUCTION TREATMENT|1973-03-20|1960-06-04|||||1966-11-02||1965-10-25|U|1971-10-08
TRIAL STUDY 134XCP|LB|AA0F6192-A377-43C6-8203-BDF7553AEA88|2||||EOSMM|EOSINOPHILIC METAMYELOCYTES|||||||DROP|||||||INDETERMINATE||IU/MG||||NORMAL|NOT DONE||||TRANSUDATE|AUTOLYZED|Y|VENTILATION PERFUSION LUNG SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|Y|U|||NA|1||38||BLINDED TREATMENT|1967-07-12|1967-08-31|||||1965-10-24||1967-02-15|U|1966-07-17
TRIAL STUDY 134XCP|LB|AA0F6192-A377-43C6-8203-BDF7553AEA88|1||||A1AGLP|ALPHA-1 ACID GLYCOPROTEIN|||||||CP|||||||TRACE||LOG10 TCID 50/DOSE||||HIGH|NOT DONE||||EXPIRED AIR|AGGLUTINATED|NA|MUGA|CKD-EPI CREATININE FORMULA||Y|NA|NA|Y|||NA|2||58||OBSERVATION|1970-07-05|1969-09-08|||||1965-02-07||1961-07-08|U|1964-10-17
TRIAL STUDY 134XCP|LB|AA0F6192-A377-43C6-8203-BDF7553AEA88|2||||CABOT|CABOT RINGS|||||||AMFI|||||||INDETERMINATE||MG/MIN||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|ROOM TEMPERATURE|U|FISH|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|NA|U|||U|2||58||TREATMENT|1960-07-28|1967-08-28|||||1960-04-29||1968-08-07|NA|1964-05-06
TRIAL STUDY 134XCP|LB|AA0F6192-A377-43C6-8203-BDF7553AEA88|1||||PELGERH|PELGER HUET ANOMALY|||||||/MM|||||||INVALID||ML/CAGE/DAY||||ABNORMAL|NOT DONE||||LOCHIA|CALCIFIED|Y|DIGITAL PCR|CKD-EPI FORMULA||Y|Y|N|N|||U|3||39||LONG-TERM FOLLOW-UP|1961-05-27|1960-06-21|||||1967-08-20||1972-11-03|NA|1960-02-18
TRIAL STUDY 134XCP|LB|AA0F6192-A377-43C6-8203-BDF7553AEA88|2||||LCN2CREA|LIPOCALIN-2/CREATININE|||||||10^6 RNA COPIES/ML|||||||INDETERMINATE||CI||||NORMAL|NOT DONE||||SERUM OR PLASMA|ICTERIC|U|DNA MICROARRAY|ASH FIBROSURE FORMULA||N|N|U|NA|||Y|3||39||BASELINE|1965-08-01|1961-09-30|||||1963-10-02||1968-08-29|Y|1972-06-12
TRIAL STUDY 134XCP|LB|AA0F6192-A377-43C6-8203-BDF7553AEA88|1||||KRCYMGCE|MEGAKARYOCYTES/TOTAL CELLS|||||||MG/M2/H|||||||NEGATIVE||TCID 50/DOSE||||NORMAL|NOT DONE||||EMOTIONAL TEAR|HEMOLYZED|N|BRDU CELLULAR PROLIFERATION ASSAY|MDRD 6 VARIABLE FORMULA||NA|Y|NA|U|||U|4||88||BASELINE|1964-10-31|1960-08-04|||||1960-04-11||1972-06-30|U|1967-07-22
TRIAL STUDY 134XCP|LB|AA0F6192-A377-43C6-8203-BDF7553AEA88|2||||LTE4|LEUKOTRIENE E4|||||||CS|||||||NEGATIVE||IU/KG/H||||HIGH|NOT DONE||||MUCUS|REFRIGERATED|Y|IN SITU HYBRIDIZATION|MDRD 5 VARIABLE FORMULA||NA|N|NA|N|||N|4||88||OBSERVATION|1969-01-21|1966-12-15|||||1962-12-13||1967-01-15|NA|1964-08-20
TRIAL STUDY 134XCP|LB|AA0F6192-A377-43C6-8203-BDF7553AEA88|1||||RBCDIPOP|DIMORPHIC ERYTHROCYTE POPULATION|||||||VG/KG|||||||POSITIVE||MMHG/SEC||||HIGH|NOT DONE||||LEUKOCYTE|SOLIDIFIED|U|DIGITAL PCR ARRAY|GMI % FORMULA||U|N|N|Y|||NA|5||7||TREATMENT|1969-11-24|1966-03-19|||||1962-04-18||1972-12-28|U|1961-10-21
TRIAL STUDY 134XCP|LB|AA0F6192-A377-43C6-8203-BDF7553AEA88|2||||CARTP|COCAINE AMPHETAMINE-REG TRANSCRIPT PROT|||||||MEQ/DAY|||||||INVALID||CMH2O/ML||||NORMAL|NOT DONE||||LUNG SURFACTANT|CONTAMINATED|U|FLUORESCENT MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|Y|U|||Y|5||7||TREATMENT|1965-07-23|1960-12-03|||||1964-12-31||1961-08-28|NA|1973-01-13
TRIAL STUDY 134XCP|LB|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|1||||C165877|CAT DANDER IGE AB RAST SCORE|||||||ML/DOSE|||||||POSITIVE||FINGERTIP UNIT||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|AGGLUTINATED|U|QUANTITATIVE COMPUTED TOMOGRAPHY|NASH FIBROSURE FORMULA||N|U|U|NA|||U|1||38||RUN-IN|1967-12-13|1961-07-06|||||1963-07-24||1970-04-25|Y|1964-10-03
TRIAL STUDY 134XCP|LB|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|2||||CX3CL1|CHEMOKINE (C-X3-C MOTIF) LIGAND 1|||||||HPA|||||||NEGATIVE||AMOL||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FROZEN|Y|WRIGHT-GIEMSA STAIN|GMI MMOL/MOL FORMULA||NA|U|U|U|||NA|1||38||BLINDED TREATMENT|1966-02-12|1965-04-30|||||1970-12-26||1972-08-24|Y|1960-01-09
TRIAL STUDY 134XCP|LB|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|1||||GHB|GAMMA-HYDROXYBUTYRATE|||||||UOSM|||||||NEGATIVE||KA_U/DL||||ABNORMAL|NOT DONE||||LAVAGE FLUID|GELLED|Y|NUCLEIC ACID BASED METHOD|MDRD 4 VARIABLE FORMULA||NA|U|Y|Y|||U|2||58||BASELINE|1967-03-15|1964-09-23|||||1964-11-01||1964-04-06|N|1969-11-01
TRIAL STUDY 134XCP|LB|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|2||||TGLOB|THYROGLOBULIN|||||||/HPF|||||||TRACE||IMPLANT||||ABNORMAL|NOT DONE||||PLASMA|CONCENTRATED|Y|KINETIC CHROMOGENIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|Y|||NA|2||58||BLINDED TREATMENT|1971-12-16|1967-11-13|||||1969-09-14||1967-02-11|N|1961-12-06
TRIAL STUDY 134XCP|LB|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|1||||CHOL|CHOLESTEROL|||||||MG/KG/DAY|||||||TRACE||KM/H||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED|N|PULSE OXIMETRY|CKD-EPI CYSTATIN C FORMULA||NA|NA|NA|NA|||NA|3||39||SCREENING|1967-10-30|1969-01-30|||||1965-01-02||1962-05-24|N|1972-08-01
TRIAL STUDY 134XCP|LB|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|2||||IAPP|ISLET AMYLOID POLYPEPTIDE|||||||CMHG|||||||NEGATIVE||MMHG/SEC||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH|N|INTRAVASCULAR ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|U|NA|||U|3||39||FOLLOW-UP|1965-06-04|1964-10-25|||||1971-12-27||1965-11-04|U|1960-09-18
TRIAL STUDY 134XCP|LB|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|1||||GRANSGCE|GRANULOCYTES SEGMENTED/TOTAL CELLS|||||||ML/G/MIN|||||||INDETERMINATE||MCI/L||||HIGH|NOT DONE||||CORD SERUM|CONTAMINATED|U|GRADIENT DIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|N|NA|||NA|4||88||INDUCTION TREATMENT|1960-06-14|1965-09-15|||||1969-01-30||1960-03-04|U|1964-07-06
TRIAL STUDY 134XCP|LB|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|2||||B1BGLP|BETA-1B GLYCOPROTEIN|||||||MASK|||||||BORDERLINE||MG/L FEU||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|LIPEMIC|U|BETA LACTAMASE|CKD-EPI CREATININE FORMULA||NA|N|Y|U|||Y|4||88||SCREENING|1960-04-11|1963-07-03|||||1968-07-28||1960-02-23|N|1968-08-18
TRIAL STUDY 134XCP|LB|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|1||||PFCT|PLATELET FUNCTION CLOSURE TIME|||||||LOG10 ELISA UNIT/DOSE|||||||TRACE||FT||||ABNORMAL|NOT DONE||||CORD BLOOD|CLOTTED|N|DYNAMOMETRY|COCKCROFT-GAULT FORMULA||Y|N|Y|U|||Y|5||7||BASELINE|1969-01-26|1973-08-15|||||1972-01-19||1962-02-09|N|1963-10-12
TRIAL STUDY 134XCP|LB|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|2||||CGA|CHROMOGRANIN A|||||||CY/CM|||||||TRACE||UG/L FEU||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|UNEXPECTED ODOR|N|SISH|MDRD 6 VARIABLE FORMULA||U|NA|N|Y|||Y|5||7||LONG-TERM FOLLOW-UP|1964-01-28|1960-06-22|||||1966-06-23||1967-12-31|Y|1966-09-10
TRIAL STUDY 134XCP|LB|A848B1B5-679F-4C45-AD73-6506604C835E|1||||INSULINR|INSULIN RESISTANCE|||||||MPA|||||||POSITIVE||/200 HPFS||||HIGH|NOT DONE||||BUFFY COAT|ICTERIC|N|APPLANATION TONOMETRY|NASH FIBROSURE FORMULA||NA|N|U|N|||NA|1||38||OBSERVATION|1961-10-05|1967-06-13|||||1961-10-02||1971-01-12|NA|1962-07-12
TRIAL STUDY 134XCP|LB|A848B1B5-679F-4C45-AD73-6506604C835E|2||||CD33|CD33|||||||CMOL/L|||||||INDETERMINATE||TSP EQ||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|NON-HEMOLYZED|Y|PLETHYSMOGRAPHY|GMI % FORMULA||Y|U|U|U|||NA|1||38||BASELINE|1971-11-22|1972-11-20|||||1961-05-24||1968-01-03|NA|1963-02-11
TRIAL STUDY 134XCP|LB|A848B1B5-679F-4C45-AD73-6506604C835E|1||||CD8LY|CD8/LYMPHOCYTES|||||||KBQ|||||||TRACE||MEQ/G||||LOW|NOT DONE||||MIXED VENOUS BLOOD|CONTAMINATED|N|FLUORESCENT MICROSCOPY|CKD-EPI CREATININE FORMULA||U|N|U|NA|||NA|2||58||CONTINUATION TREATMENT|1967-01-11|1960-07-30|||||1962-01-22||1963-04-02|Y|1960-10-08
TRIAL STUDY 134XCP|LB|A848B1B5-679F-4C45-AD73-6506604C835E|2||||HIST3AB|HISTONE 3 ANTIBODY|||||||MESF|||||||NEGATIVE||MOL/DAY||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|FROZEN|N|ELLA|MDRD 5 VARIABLE FORMULA||U|NA|N|NA|||Y|2||58||BLINDED TREATMENT|1966-01-01|1962-04-19|||||1966-09-12||1969-05-22|U|1969-11-07
TRIAL STUDY 134XCP|LB|A848B1B5-679F-4C45-AD73-6506604C835E|1||||MECONIUM|MECONIUM|||||||IU|||||||INVALID||WAFER||||HIGH|NOT DONE||||SEMINAL FLUID|FRESH|N|TARGETED GENOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|NA|U|||N|3||39||TREATMENT|1964-04-24|1960-03-06|||||1969-10-25||1972-12-11|N|1969-08-25
TRIAL STUDY 134XCP|LB|A848B1B5-679F-4C45-AD73-6506604C835E|2||||IMMGLB|IMMUNOGLOBULIN|||||||MEQ/MMOL|||||||BORDERLINE||ML/CM||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|ICTERIC|U|MIGET|MDRD FORMULA||Y|NA|U|Y|||N|3||39||SCREENING|1966-02-08|1964-11-19|||||1964-10-27||1960-07-31|Y|1971-11-21
TRIAL STUDY 134XCP|LB|A848B1B5-679F-4C45-AD73-6506604C835E|1||||C165917|D. PTERONYSSINUS IGG AB RAST SCORE|||||||DYN|||||||NEGATIVE||PFU||||LOW|NOT DONE||||CEREBROSPINAL FLUID|FRESH|NA|CONGO RED STAIN|FIBROMETER FORMULA||U|U|U|NA|||N|4||88||CONTINUATION TREATMENT|1968-06-13|1960-01-07|||||1972-08-15||1963-04-24|Y|1970-01-12
TRIAL STUDY 134XCP|LB|A848B1B5-679F-4C45-AD73-6506604C835E|2||||PIVKAII|PROTEIN INDUCED BY VITAMIN K ABSENCE-II|||||||PMOL/G|||||||TRACE||10^6 CFU/ML||||LOW|NOT DONE||||SYNOVIAL FLUID|HEMOLYZED|N|QUANTITATIVE ULTRASOUND|GMI MMOL/MOL FORMULA||NA|N|U|Y|||NA|4||88||BLINDED TREATMENT|1965-06-12|1972-05-23|||||1960-04-27||1971-10-13|Y|1963-03-30
TRIAL STUDY 134XCP|LB|A848B1B5-679F-4C45-AD73-6506604C835E|1||||HGBA2HGB|HEMOGLOBIN A2/TOTAL HEMOGLOBIN|||||||STEPS/MIN|||||||INDETERMINATE||CMH2O*S2/ML||||ABNORMAL|NOT DONE||||SMEGMA|THAWED|Y|CELL BASED BIOASSAY|GMI % FORMULA||N|NA|Y|U|||NA|5||7||OBSERVATION|1962-09-23|1962-03-03|||||1963-11-15||1968-10-29|U|1960-03-31
TRIAL STUDY 134XCP|LB|A848B1B5-679F-4C45-AD73-6506604C835E|2||||APTT|ACTIVATED PARTIAL THROMBOPLASTIN TIME|||||||MM3/MM2/YEAR|||||||POSITIVE||CD*S/M2||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|LACTESCENT|Y|IMMUNOTURBIDIMETRY|MDRD 4 VARIABLE FORMULA||N|N|NA|U|||N|5||7||TREATMENT|1970-07-23|1973-08-02|||||1967-08-16||1971-12-02|NA|1972-04-12
TRIAL STUDY 134XCP|LB|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|1||||NCTD5P|5 PRIME NUCLEOTIDASE|||||||10^9/DOSE|||||||POSITIVE||KIU||||HIGH|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CALCIFIED|N|JAEGER EYE CHART|GMI MMOL/MOL FORMULA||Y|U|NA|N|||Y|1||38||SCREENING|1970-02-07|1970-08-07|||||1973-05-15||1973-02-08|NA|1967-03-24
TRIAL STUDY 134XCP|LB|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|2||||C130117|BEE MIX ANTIGEN IGG ANTIBODY|||||||UG/H|||||||INVALID||UL/DOSE||||NORMAL|NOT DONE||||PLEURAL TISSUE|LIPEMIC|NA|ACRIDINE ORANGE STAIN|NASH FIBROSURE FORMULA||NA|U|U|NA|||N|1||38||BLINDED TREATMENT|1963-07-30|1960-02-25|||||1960-04-15||1972-03-07|N|1970-09-28
TRIAL STUDY 134XCP|LB|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|1||||PRZPM|PRAZEPAM|||||||IU/ML|||||||BORDERLINE||QUANTITY SUFFICIENT||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|HEMOLYZED|Y|MICROBIAL CULTURE, SOLID|COCKCROFT-GAULT FORMULA||NA|N|U|N|||U|2||58||BASELINE|1965-01-07|1971-10-22|||||1963-08-21||1968-10-18|NA|1970-05-15
TRIAL STUDY 134XCP|LB|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|2||||PREALB|PREALBUMIN|||||||ML/DAY|||||||INVALID||KS||||NORMAL|NOT DONE||||SEBUM|HEMOLYZED|U|SNP ARRAY|MDRD ENZYMATIC FORMULA||N|NA|U|Y|||Y|2||58||OPEN LABEL TREATMENT|1961-08-26|1968-03-01|||||1962-12-03||1965-10-10|N|1962-08-31
TRIAL STUDY 134XCP|LB|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|1||||IOHEXCLR|IOHEXOL CLEARANCE|||||||UMOL/DAY|||||||BORDERLINE||UKAT||||ABNORMAL|NOT DONE||||MUCUS|REFRIGERATED|Y|SLOAN LETTER EYE CHART 1.25%|MDRD 5 VARIABLE FORMULA||N|U|U|U|||Y|3||39||LONG-TERM FOLLOW-UP|1965-10-17|1961-11-07|||||1964-03-23||1961-10-24|U|1960-03-19
TRIAL STUDY 134XCP|LB|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|2||||PBGCREAT|PORPHOBILINOGEN/CREATININE|||||||/MBP|||||||INVALID||IU/DL||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|HEMOLYZED|NA|OSCILLOMETRY|FIBROTEST FORMULA||N|Y|NA|N|||N|3||39||BLINDED TREATMENT|1969-12-05|1964-03-05|||||1962-12-06||1962-11-20|U|1963-09-01
TRIAL STUDY 134XCP|LB|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|1||||VEGFA|VASCULAR ENDOTHELIAL GROWTH FACTOR A|||||||ML/CM|||||||TRACE||/MS||||HIGH|NOT DONE||||ABSCESS FLUID|AUTOLYZED|Y|HIGH RESOLUTION MELT ANALYSIS|HEPASCORE FORMULA||N|NA|Y|NA|||Y|4||88||SCREENING|1970-12-27|1961-06-25|||||1969-12-07||1971-05-07|U|1967-12-09
TRIAL STUDY 134XCP|LB|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|2||||NCTD5P|5 PRIME NUCLEOTIDASE|||||||KM|||||||TRACE||PSI||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|HEMOLYZED|N|IMPULSE OSCILLOMETRY|MDRD 4 VARIABLE FORMULA||N|N|U|U|||U|4||88||SCREENING|1965-05-12|1969-07-01|||||1961-11-23||1965-08-01|N|1970-04-07
TRIAL STUDY 134XCP|LB|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|1||||CRBMZPN|CARBAMAZEPINE|||||||TBSP|||||||POSITIVE||MMOL/L||||HIGH|NOT DONE||||INFRANATANT, SERUM|ROOM TEMPERATURE|NA|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|GMI MMOL/MOL FORMULA||N|Y|N|U|||U|5||7||TREATMENT|1964-01-07|1972-03-21|||||1970-11-29||1965-10-30|N|1962-02-02
TRIAL STUDY 134XCP|LB|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|2||||RBCAGGLU|ERYTHROCYTE AGGLUTINATION|||||||%|||||||NEGATIVE||10^12 IU/L||||HIGH|NOT DONE||||CAPILLARY BLOOD|AUTOLYZED|N|NEPHELOMETRY|CKD-EPI CREATININE FORMULA||N|U|NA|U|||NA|5||7||TREATMENT|1970-04-22|1967-09-19|||||1967-09-03||1963-09-29|Y|1963-05-04
TRIAL STUDY 134XCP|LB|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|1||||VLDL|VLDL CHOLESTEROL|||||||UMOL/L/SEC|||||||TRACE||UG/M2||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE|NA|IMMUNODIFFUSION|COCKCROFT-GAULT FORMULA||Y|U|NA|N|||NA|1||38||SCREENING|1962-04-18|1973-07-15|||||1970-07-25||1971-12-09|Y|1960-11-01
TRIAL STUDY 134XCP|LB|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|2||||ASTAG|ASPARTATE AMINOTRANSFERASE ANTIGEN|||||||MDFI|||||||TRACE||MMOL2/L2||||LOW|NOT DONE||||DERMAL TISSUE|THAWED|N|ELECTRONEUROGRAPHY|ASH FIBROSURE FORMULA||Y|NA|Y|U|||N|1||38||CONTINUATION TREATMENT|1965-11-09|1967-01-05|||||1962-12-07||1971-05-12|U|1969-01-27
TRIAL STUDY 134XCP|LB|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|1||||ADMA|ASYMMETRIC DIMETHYLARGININE|||||||10^11/L|||||||INDETERMINATE||MIU/L||||NORMAL|NOT DONE||||AMNIOTIC FLUID|CONTAMINATED|Y|PEAK FLOWMETRY|NASH FIBROSURE FORMULA||Y|Y|U|U|||U|2||58||WASHOUT|1972-06-18|1965-11-18|||||1966-11-05||1966-04-28|NA|1962-06-08
TRIAL STUDY 134XCP|LB|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|2||||CEMORPH|CELL MORPHOLOGY|||||||BISCUIT|||||||BORDERLINE||SPRAY||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|GELLED|N|IMPULSE OSCILLOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|N|Y|||N|2||58||BLINDED TREATMENT|1960-05-12|1961-02-01|||||1965-09-28||1962-04-25|N|1964-04-24
TRIAL STUDY 134XCP|LB|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|1||||IBCU|UNSATURATED IRON BINDING CAPACITY|||||||/KG|||||||BORDERLINE||MMAL||||NORMAL|NOT DONE||||PLASMA|LIPEMIC|Y|RADIOGRAPHY|HEPASCORE FORMULA||NA|U|Y|U|||U|3||39||OBSERVATION|1969-11-07|1969-12-01|||||1962-11-28||1973-08-28|N|1972-10-03
TRIAL STUDY 134XCP|LB|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|2||||HSP70|HEAT SHOCK PROTEIN 70|||||||CMHG|||||||NEGATIVE||10^6 COPIES/ML||||LOW|NOT DONE||||LYMPH|PARAFFIN-EMBEDDED|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|NASH FIBROSURE FORMULA||Y|NA|Y|U|||Y|3||39||OBSERVATION|1967-05-11|1967-05-26|||||1962-12-23||1962-02-17|N|1965-02-23
TRIAL STUDY 134XCP|LB|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|1||||C3|COMPLEMENT C3|||||||MG/DOSE|||||||NEGATIVE||MMOL/DAY||||HIGH|NOT DONE||||ARTERIAL BLOOD|AGGLUTINATED|NA|LASER CAPTURE MICRODISSECTION|MDRD 6 VARIABLE FORMULA||Y|N|NA|Y|||N|4||88||TREATMENT|1972-12-19|1962-05-26|||||1967-08-10||1966-06-02|U|1972-09-16
TRIAL STUDY 134XCP|LB|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|2||||CAION|CALCIUM, IONIZED|||||||AG|||||||INDETERMINATE||BAR||||HIGH|NOT DONE||||SMEGMA|CLOTTED|Y|DARK FIELD MICROSCOPY|ASH FIBROSURE FORMULA||NA|N|U|NA|||U|4||88||RUN-IN|1967-04-03|1967-11-21|||||1971-04-05||1967-08-11|U|1973-08-04
TRIAL STUDY 134XCP|LB|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|1||||ARR|ALDOSTERONE/RENIN ACTIVITY|||||||CMH2O*S/ML|||||||TRACE||MG/KG/DAY||||LOW|NOT DONE||||ERYTHROCYTES|THAWED|NA|CHROMATOGRAPHY|GMI MMOL/MOL FORMULA||U|Y|Y|NA|||NA|5||7||BASELINE|1967-12-29|1961-05-23|||||1963-09-22||1973-03-08|U|1970-02-23
TRIAL STUDY 134XCP|LB|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|2||||AMH|ANTI-MULLERIAN HORMONE|||||||ELISA UNIT/ML|||||||INVALID||MANSON U/ML||||LOW|NOT DONE||||LOCHIA|LIPEMIC|N|SPIROMETRY|HEPASCORE FORMULA||N|NA|U|N|||NA|5||7||SCREENING|1967-06-28|1962-06-29|||||1973-05-18||1963-11-13|U|1968-07-05
TRIAL STUDY 134XCP|LB|FC155F37-522F-4620-BBFF-4999D37C1379|1||||HPOCROM|HYPOCHROMIA|||||||MG/M2|||||||NEGATIVE||MM/SEC||||HIGH|NOT DONE||||SERUM OR PLASMA|AGGLUTINATED|Y|WHOLE GENOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|N|||Y|1||38||LONG-TERM FOLLOW-UP|1962-04-30|1962-12-10|||||1960-06-01||1963-02-10|NA|1962-10-07
TRIAL STUDY 134XCP|LB|FC155F37-522F-4620-BBFF-4999D37C1379|2||||UNSPCE|UNSPECIFIED CELLS|||||||DRINK|||||||INVALID||ECL UNIT||||NORMAL|NOT DONE||||EMESIS|PARAFFIN-EMBEDDED|Y|CELLULAR PROLIFERATION ASSAY|HEPASCORE FORMULA||N|N|U|Y|||Y|1||38||INDUCTION TREATMENT|1967-03-05|1964-03-02|||||1971-10-29||1966-03-29|Y|1964-05-18
TRIAL STUDY 134XCP|LB|FC155F37-522F-4620-BBFF-4999D37C1379|1||||FEK|FRACTIONAL POTASSIUM EXCRETION|||||||MOL/DAY|||||||INVALID||10^3/HPF||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|CALCIFIED|N|PALPATION|FIBROSIS 4 FORMULA||U|U|U|Y|||NA|2||58||BLINDED TREATMENT|1961-01-31|1968-09-10|||||1968-09-06||1962-04-06|N|1969-02-25
TRIAL STUDY 134XCP|LB|FC155F37-522F-4620-BBFF-4999D37C1379|2||||ALBGLYCA|GLYCATED ALBUMIN|||||||UMOL/MOL|||||||BORDERLINE||MMOL/MIN/KPA||||HIGH|NOT DONE||||INTERSTITIAL FLUID|NON-HEMOLYZED|N|INFRARED SPECTROMETRY|MDRD 5 VARIABLE FORMULA||Y|Y|U|Y|||Y|2||58||OBSERVATION|1962-12-21|1971-03-10|||||1968-02-21||1971-09-26|U|1972-01-23
TRIAL STUDY 134XCP|LB|FC155F37-522F-4620-BBFF-4999D37C1379|1||||PLSIMCLY|IMMATURE PLASMA CELLS/LYMPHOCYTES|||||||/5X10^4 WBC|||||||INDETERMINATE||H/WK||||LOW|NOT DONE||||MUCUS|AGGLUTINATED|U|ORCHIDOMETERY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|N|N|||Y|3||39||BASELINE|1968-08-27|1960-05-17|||||1965-04-26||1964-01-13|Y|1972-12-05
TRIAL STUDY 134XCP|LB|FC155F37-522F-4620-BBFF-4999D37C1379|2||||VEGF|VASCULAR ENDOTHELIAL GROWTH FACTOR|||||||UU/DL|||||||INDETERMINATE||MOL/MOL||||NORMAL|NOT DONE||||PLEURAL TISSUE|CLOTTED|NA|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||NA|N|NA|U|||N|3||39||CONTINUATION TREATMENT|1963-02-05|1968-05-02|||||1962-09-15||1969-12-09|NA|1962-07-09
TRIAL STUDY 134XCP|LB|FC155F37-522F-4620-BBFF-4999D37C1379|1||||IGA|IMMUNOGLOBULIN A|||||||MG/CM2|||||||NEGATIVE||SEC||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|CONTAMINATED|U|HPLC|ASH FIBROSURE FORMULA||NA|Y|Y|U|||NA|4||88||LONG-TERM FOLLOW-UP|1964-10-07|1972-06-12|||||1969-03-30||1960-10-02|N|1969-05-27
TRIAL STUDY 134XCP|LB|FC155F37-522F-4620-BBFF-4999D37C1379|2||||LAM|LIPOARABINOMANNAN|||||||G/KG/DAY|||||||POSITIVE||TUBERCULIN UNIT/ML||||HIGH|NOT DONE||||MUCUS|UNEXPECTED ODOR|N|NUCLEIC ACID BASED METHOD|FIBROSIS 4 FORMULA||Y|N|NA|Y|||N|4||88||TREATMENT|1964-02-05|1963-08-26|||||1969-12-15||1971-12-14|NA|1970-04-08
TRIAL STUDY 134XCP|LB|FC155F37-522F-4620-BBFF-4999D37C1379|1||||ACRNCRNF|ACYLCARNITINE/CARNITINE, FREE|||||||UG/L DDU|||||||TRACE||ENZYME U||||NORMAL|NOT DONE||||DIALYSIS FLUID|CLOTTED|N|LAPAROSCOPY|HEPASCORE FORMULA||N|NA|N|U|||NA|5||7||BLINDED TREATMENT|1966-06-17|1961-05-15|||||1969-07-06||1961-07-10|NA|1964-07-21
TRIAL STUDY 134XCP|LB|FC155F37-522F-4620-BBFF-4999D37C1379|2||||CDT|CARBOHYDRATE-DEFICIENT TRANSFERRIN|||||||MOL/L|||||||NEGATIVE||MONTHS||||NORMAL|NOT DONE||||BLOOD|LIPEMIC|NA|TEST STRIP|MDRD ENZYMATIC FORMULA||NA|Y|U|Y|||U|5||7||SCREENING|1970-12-05|1963-01-31|||||1962-10-25||1970-03-25|Y|1964-08-03
TRIAL STUDY 134XCP|LB|20F817BC-4C89-4F6C-AA45-36CE786A73A8|1||||HBBARTHB|HEMOGLOBIN BARTS/TOTAL HEMOGLOBIN|||||||MMOL/MIN/KPA/L|||||||BORDERLINE||MU||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|CONCENTRATED|Y|MASS SPECTROMETRY|CKD-EPI CREATININE FORMULA||NA|Y|N|Y|||Y|1||38||INDUCTION TREATMENT|1960-03-10|1972-11-03|||||1965-08-22||1963-08-11|Y|1967-03-02
TRIAL STUDY 134XCP|LB|20F817BC-4C89-4F6C-AA45-36CE786A73A8|2||||IBCT|TOTAL IRON BINDING CAPACITY|||||||MONTHS|||||||POSITIVE||EID 50/ML||||LOW|NOT DONE||||HAIR|ROOM TEMPERATURE|NA|PANENDOSCOPY|FIBROSIS 4 FORMULA||U|NA|N|U|||U|1||38||OPEN LABEL TREATMENT|1971-05-25|1961-05-28|||||1970-12-07||1963-08-01|N|1967-12-28
TRIAL STUDY 134XCP|LB|20F817BC-4C89-4F6C-AA45-36CE786A73A8|1||||FXIVAAC|FACTOR XIV ACTIVITY ACTUAL/CONTROL|||||||DNA COPIES/UG|||||||INDETERMINATE||10^6 IU||||LOW|NOT DONE||||ADIPOSE TISSUE|GELLED|N|ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|NA|U|||U|2||58||BASELINE|1961-09-12|1964-02-05|||||1968-03-05||1962-12-16|U|1961-05-24
TRIAL STUDY 134XCP|LB|20F817BC-4C89-4F6C-AA45-36CE786A73A8|2||||EOTAXIN2|EOTAXIN-2|||||||PHERESIS UNIT|||||||BORDERLINE||STRIP||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|SOLIDIFIED|N|ARTERIAL SPIN LABELING FUNCTIONAL MRI|NASH FIBROSURE FORMULA||U|N|Y|NA|||U|2||58||OBSERVATION|1971-07-28|1962-06-15|||||1967-09-03||1964-07-16|N|1961-09-10
TRIAL STUDY 134XCP|LB|20F817BC-4C89-4F6C-AA45-36CE786A73A8|1||||LSELS|SOLUBLE L-SELECTIN|||||||10^3 ORGANISMS/G|||||||INDETERMINATE||DIP||||LOW|NOT DONE||||MONOCYTE|CONTAMINATED|U|CENTRIFUGATION|MDRD FORMULA||NA|Y|NA|NA|||Y|3||39||OPEN LABEL TREATMENT|1973-04-04|1970-02-07|||||1973-02-15||1968-08-21|U|1966-05-25
TRIAL STUDY 134XCP|LB|20F817BC-4C89-4F6C-AA45-36CE786A73A8|2||||KERAT|KERATOCYTE|||||||MG/ML/MIN|||||||INDETERMINATE||VIRTUAL PIXEL||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|REFRIGERATED|U|LC-FL|ASH FIBROSURE FORMULA||NA|U|N|N|||Y|3||39||CONTINUATION TREATMENT|1967-06-10|1963-08-19|||||1971-05-10||1969-04-06|U|1972-12-01
TRIAL STUDY 134XCP|LB|20F817BC-4C89-4F6C-AA45-36CE786A73A8|1||||IGM|IMMUNOGLOBULIN M|||||||UCI/KG|||||||INVALID||JOULE||||HIGH|NOT DONE||||BONE MARROW|SOLIDIFIED|Y|ERGOSPIROMETRY|NASH FIBROSURE FORMULA||N|Y|N|NA|||U|4||88||INDUCTION TREATMENT|1973-07-15|1964-07-08|||||1969-12-10||1965-07-04|NA|1962-02-04
TRIAL STUDY 134XCP|LB|20F817BC-4C89-4F6C-AA45-36CE786A73A8|2||||C130075|BIRCH POLLEN IGG4|||||||MOL/L|||||||INVALID||LOG10 PFU||||ABNORMAL|NOT DONE||||PERSPIRATION|ROOM TEMPERATURE|U|U-HPLC/MS/MS|MDRD 4 VARIABLE FORMULA||NA|U|U|Y|||N|4||88||BLINDED TREATMENT|1962-10-14|1962-02-26|||||1962-10-11||1964-05-08|Y|1971-08-18
TRIAL STUDY 134XCP|LB|20F817BC-4C89-4F6C-AA45-36CE786A73A8|1||||AMYLB38|AMYLOID BETA 1-38|||||||ML/G/DAY|||||||NEGATIVE||CI/G||||LOW|NOT DONE||||SPUTUM|ICTERIC|Y|FISH|COCKCROFT-GAULT FORMULA||NA|U|U|U|||NA|5||7||LONG-TERM FOLLOW-UP|1960-10-19|1971-01-18|||||1973-06-07||1961-10-22|Y|1967-05-19
TRIAL STUDY 134XCP|LB|20F817BC-4C89-4F6C-AA45-36CE786A73A8|2||||CX3CL1|CHEMOKINE (C-X3-C MOTIF) LIGAND 1|||||||UMOL/MG/MIN|||||||BORDERLINE||BQ/G||||LOW|NOT DONE||||EXUDATE|AGGLUTINATED|U|REFLECTANCE SPECTROSCOPY|COCKCROFT-GAULT FORMULA||U|Y|U|NA|||NA|5||7||CONTINUATION TREATMENT|1963-11-21|1965-11-12|||||1961-04-15||1968-05-28|U|1963-02-10
TRIAL STUDY 134XCP|LB|99058E64-9873-4CD5-BB31-28C08758A1B5|1||||RETILRTC|LOW ABSORPTION RETIC/RETICULOCYTES|||||||AFU|||||||NEGATIVE||PL||||LOW|NOT DONE||||PLATELET RICH PLASMA|GELLED|U|BRDU CELLULAR PROLIFERATION ASSAY|FIBROTEST FORMULA||Y|N|N|Y|||N|1||38||CONTINUATION TREATMENT|1969-07-13|1964-12-01|||||1969-06-18||1969-03-08|N|1972-12-12
TRIAL STUDY 134XCP|LB|99058E64-9873-4CD5-BB31-28C08758A1B5|2||||IL1R2|INTERLEUKIN 1 RECEPTOR TYPE 2|||||||/4.0 ML|||||||INVALID||L/S||||HIGH|NOT DONE||||PLATELET RICH PLASMA|PARAFFIN-EMBEDDED|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|ASH FIBROSURE FORMULA||Y|N|NA|N|||U|1||38||TREATMENT|1965-05-06|1973-04-26|||||1966-07-31||1964-09-20|NA|1962-10-13
TRIAL STUDY 134XCP|LB|99058E64-9873-4CD5-BB31-28C08758A1B5|1||||CYUNCLA|UNCLASSIFIED CRYSTALS|||||||TORR|||||||POSITIVE||U||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|NON-HEMOLYZED|U|RADIAL IMMUNODIFFUSION|CKD-EPI CREATININE FORMULA||Y|NA|N|Y|||Y|2||58||SCREENING|1962-09-25|1970-03-22|||||1963-03-29||1971-11-12|Y|1968-11-12
TRIAL STUDY 134XCP|LB|99058E64-9873-4CD5-BB31-28C08758A1B5|2||||NUCSWELL|NUCLEAR SWELLING|||||||IU/DL|||||||POSITIVE||RFU||||LOW|NOT DONE||||GASTRIC FLUID|FROZEN|Y|GC/MS-EI|CKD-EPI CYSTATIN C FORMULA||N|N|NA|Y|||U|2||58||BASELINE|1971-05-28|1970-08-29|||||1964-07-22||1962-01-11|Y|1968-06-30
TRIAL STUDY 134XCP|LB|99058E64-9873-4CD5-BB31-28C08758A1B5|1||||CORTFR|CORTISOL, FREE|||||||L|||||||INDETERMINATE||UG/DL||||LOW|NOT DONE||||LYSATE|AGGLUTINATED|Y|MOUSE PROTECTION ASSAY|MDRD 5 VARIABLE FORMULA||NA|NA|N|N|||N|3||39||OPEN LABEL TREATMENT|1965-12-20|1971-11-11|||||1973-07-16||1962-06-05|NA|1970-01-24
TRIAL STUDY 134XCP|LB|99058E64-9873-4CD5-BB31-28C08758A1B5|2||||ICAM|INTERCELLULAR ADHESION MOLECULE|||||||LOG10 ELISA UNIT/DOSE|||||||INDETERMINATE||DAGU||||LOW|NOT DONE||||PLATELET|LACTESCENT|N|CONTRAST ENHANCED CT SCAN|FIBROTEST FORMULA||N|Y|NA|N|||Y|3||39||FOLLOW-UP|1971-06-04|1966-08-19|||||1973-02-14||1968-12-09|Y|1960-07-04
TRIAL STUDY 134XCP|LB|99058E64-9873-4CD5-BB31-28C08758A1B5|1||||MDC|MACROPHAGE-DERIVED CHEMOKINE|||||||KM/H|||||||POSITIVE||OHM||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|NON-HEMOLYZED|Y|TEST STRIP|GMI MMOL/MOL FORMULA||N|N|U|Y|||Y|4||88||CONTINUATION TREATMENT|1962-03-11|1972-06-20|||||1961-03-10||1971-09-23|U|1967-07-03
TRIAL STUDY 134XCP|LB|99058E64-9873-4CD5-BB31-28C08758A1B5|2||||CAN|COEFFICIENT OF NITROGEN ABSORPTION|||||||NMOL|||||||INDETERMINATE||MEQ||||ABNORMAL|NOT DONE||||CERUMEN|LIPEMIC|Y|INDIRECT IMMUNOFLUORESCENCE|MDRD FORMULA||U|N|Y|U|||Y|4||88||FOLLOW-UP|1969-03-18|1970-02-24|||||1961-01-12||1973-06-23|NA|1960-12-27
TRIAL STUDY 134XCP|LB|99058E64-9873-4CD5-BB31-28C08758A1B5|1||||B2MCREAT|BETA-2 MICROGLOBULIN/CREATININE|||||||10^6/L|||||||INDETERMINATE||G/DL||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|FRESH|N|ELECTRICAL IMPEDANCE MYOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|N|U|||NA|5||7||BLINDED TREATMENT|1964-05-01|1960-12-11|||||1964-07-24||1972-03-22|N|1973-02-27
TRIAL STUDY 134XCP|LB|99058E64-9873-4CD5-BB31-28C08758A1B5|2||||TNFR1B|TNF RECEPTOR 1B|||||||DYN|||||||BORDERLINE||SCM||||HIGH|NOT DONE||||URINE|SOLIDIFIED|Y|PEAK FLOWMETRY|NASH FIBROSURE FORMULA||Y|NA|Y|Y|||Y|5||7||INDUCTION TREATMENT|1964-06-25|1973-08-09|||||1960-03-20||1960-08-28|U|1960-12-24
TRIAL STUDY 134XCP|LB|656B6693-1C1C-433B-84E3-77E89F0B543E|1||||IGGCREAT|IMMUNOGLOBULIN G/CREATININE|||||||UKAT/10^12 RBC|||||||BORDERLINE||TESLA||||NORMAL|NOT DONE||||SOFT TISSUE|LACTESCENT|Y|FUNDUS PHOTOGRAPHY|MDRD 4 VARIABLE FORMULA||N|N|NA|U|||NA|1||38||OBSERVATION|1973-08-08|1973-07-20|||||1967-12-17||1968-02-15|Y|1967-08-17
TRIAL STUDY 134XCP|LB|656B6693-1C1C-433B-84E3-77E89F0B543E|2||||C165893|WILD RYE POLLEN IGE AB RAST SCORE|||||||ML/M2/MIN|||||||INDETERMINATE||ML/G/MIN||||LOW|NOT DONE||||MUSCLE TISSUE|AUTOLYZED|Y|PERFUSION MRI|MDRD 5 VARIABLE FORMULA||U|Y|Y|U|||Y|1||38||CONTINUATION TREATMENT|1973-04-27|1968-04-15|||||1967-07-23||1963-05-09|U|1962-04-30
TRIAL STUDY 134XCP|LB|656B6693-1C1C-433B-84E3-77E89F0B543E|1||||ATHMBAC|ANTITHROMBIN ACTUAL/CONTROL|||||||U/L|||||||NEGATIVE||BQ/KG||||HIGH|NOT DONE||||FLUID|PARAFFIN-EMBEDDED|NA|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|COCKCROFT-GAULT FORMULA||U|NA|Y|U|||N|2||58||RUN-IN|1970-04-05|1960-07-19|||||1972-09-26||1973-06-18|N|1972-06-13
TRIAL STUDY 134XCP|LB|656B6693-1C1C-433B-84E3-77E89F0B543E|2||||FLUIDOUT|FLUID OUTPUT|||||||10^6 ORGANISMS/G|||||||INDETERMINATE||NEBULE||||LOW|NOT DONE||||VENOUS PLASMA|FROZEN|NA|DYNAMIC LIGHT SCATTERING|MDRD ENZYMATIC JAPANESE FORMULA||U|N|N|U|||U|2||58||BASELINE|1963-08-14|1972-10-30|||||1965-01-12||1969-08-20|NA|1968-07-08
TRIAL STUDY 134XCP|LB|656B6693-1C1C-433B-84E3-77E89F0B543E|1||||DPD|DEOXYPYRIDINOLINE|||||||USP U|||||||INVALID||JDF UNIT||||ABNORMAL|NOT DONE||||DERMAL TISSUE|FRESH|NA|ALCIAN BLUE STAIN|HEPASCORE FORMULA||N|NA|NA|U|||Y|3||39||OPEN LABEL TREATMENT|1963-08-26|1962-09-04|||||1960-10-20||1960-03-22|N|1969-04-13
TRIAL STUDY 134XCP|LB|656B6693-1C1C-433B-84E3-77E89F0B543E|2||||PSIGGAB|PHOSPHATIDYLSERINE IGG ANTIBODY|||||||CUP EQ|||||||BORDERLINE||GBQ/UG||||ABNORMAL|NOT DONE||||BUFFY COAT|AGGLUTINATED|U|MICROBIAL CONCENTRATION|MDRD 5 VARIABLE FORMULA||NA|NA|U|U|||U|3||39||BLINDED TREATMENT|1966-05-26|1966-05-03|||||1961-06-26||1960-06-17|U|1968-05-06
TRIAL STUDY 134XCP|LB|656B6693-1C1C-433B-84E3-77E89F0B543E|1||||C130142|GERMAN COCKROACH ANTIGEN IGG ANTIBODY|||||||IU/DAY|||||||BORDERLINE||CM2||||ABNORMAL|NOT DONE||||SOFT TISSUE|THAWED|N|IMMUNORADIOMETRIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|N|U|||NA|4||88||BLINDED TREATMENT|1965-03-08|1972-05-09|||||1972-01-20||1965-05-03|N|1960-12-16
TRIAL STUDY 134XCP|LB|656B6693-1C1C-433B-84E3-77E89F0B543E|2||||NKCE|NATURAL KILLER CELLS|||||||LOZENGE|||||||BORDERLINE||PIPE||||LOW|NOT DONE||||CAPILLARY PLASMA|AUTOLYZED|Y|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|FIBROTEST FORMULA||NA|N|NA|U|||U|4||88||BLINDED TREATMENT|1971-10-17|1972-06-15|||||1969-08-13||1973-04-11|NA|1964-03-28
TRIAL STUDY 134XCP|LB|656B6693-1C1C-433B-84E3-77E89F0B543E|1||||PLSPCELY|PRECURSOR PLASMA CELLS/LYMPHOCYTES|||||||S^-1(%O2)^-1|||||||INVALID||MAMP||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED|N|PET SCAN|HEPASCORE FORMULA||N|U|NA|N|||U|5||7||BLINDED TREATMENT|1973-01-15|1972-12-20|||||1964-07-06||1971-05-28|NA|1970-04-28
TRIAL STUDY 134XCP|LB|656B6693-1C1C-433B-84E3-77E89F0B543E|2||||CBS|CYSTATHIONINE BETA-SYNTHASE|||||||10^9/G|||||||TRACE||CMH2O*S2/ML||||HIGH|NOT DONE||||DERMAL TISSUE|CONCENTRATED|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|COCKCROFT-GAULT FORMULA||NA|Y|U|N|||NA|5||7||INDUCTION TREATMENT|1967-01-02|1962-11-21|||||1963-09-26||1961-11-25|N|1964-12-30
TRIAL STUDY 134XCP|LB|43C443F9-AB0F-44BE-B28B-63A60EE09205|1||||COCAM|COCAINE METABOLITES|||||||MS/MMHG|||||||BORDERLINE||MG/KG/MIN||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|FROZEN|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||Y|U|N|Y|||NA|1||38||SCREENING|1971-04-16|1970-12-25|||||1970-11-18||1964-02-23|Y|1973-07-26
TRIAL STUDY 134XCP|LB|43C443F9-AB0F-44BE-B28B-63A60EE09205|2||||NMP22|NUCLEAR MATRIX PROTEIN 22|||||||10^4/HPF|||||||BORDERLINE||CMHG||||ABNORMAL|NOT DONE||||CELL PELLET|LACTESCENT|NA|HEMATOXYLIN AND EOSIN STAIN|COCKCROFT-GAULT FORMULA||N|Y|NA|N|||U|1||38||OBSERVATION|1965-04-28|1962-11-23|||||1964-07-03||1972-06-04|U|1968-05-03
TRIAL STUDY 134XCP|LB|43C443F9-AB0F-44BE-B28B-63A60EE09205|1||||COL4|COLLAGEN TYPE IV|||||||AGU/ML|||||||BORDERLINE||PSI||||LOW|NOT DONE||||LYSATE|THAWED|Y|MAGNETIC RESONANCE ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA||U|N|U|N|||Y|2||58||BLINDED TREATMENT|1962-01-18|1971-02-08|||||1964-04-12||1963-02-06|NA|1971-10-19
TRIAL STUDY 134XCP|LB|43C443F9-AB0F-44BE-B28B-63A60EE09205|2||||FRFEABS|FRACTIONAL IRON ABSORPTION|||||||CS|||||||INDETERMINATE||SCM||||HIGH|NOT DONE||||BUFFY COAT|CALCIFIED|NA|PERIPHERAL ANGIOGRAPHY|COCKCROFT-GAULT FORMULA||Y|U|U|NA|||N|2||58||CONTINUATION TREATMENT|1972-01-20|1967-02-27|||||1964-04-19||1970-03-06|NA|1970-04-27
TRIAL STUDY 134XCP|LB|43C443F9-AB0F-44BE-B28B-63A60EE09205|1||||PCT|PROCALCITONIN|||||||VG/ML|||||||NEGATIVE||DEG/MM||||HIGH|NOT DONE||||GASTRIC CONTENTS|SOLIDIFIED|Y|SIZE EXCLUSION CHROMATOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|Y|U|Y|||NA|3||39||OBSERVATION|1965-03-04|1966-05-06|||||1961-08-30||1966-02-12|NA|1964-05-28
TRIAL STUDY 134XCP|LB|43C443F9-AB0F-44BE-B28B-63A60EE09205|2||||TPAG|TISSUE POLYPEPTIDE ANTIGEN|||||||NFIU|||||||TRACE||10^3 ORGANISMS||||ABNORMAL|NOT DONE||||EXUDATE|CONTAMINATED|N|MULTI-SLICE SPIRAL CT|MDRD ENZYMATIC FORMULA||NA|N|NA|N|||U|3||39||RUN-IN|1962-05-28|1973-06-13|||||1966-01-07||1964-06-26|U|1972-09-04
TRIAL STUDY 134XCP|LB|43C443F9-AB0F-44BE-B28B-63A60EE09205|1||||LYMLG|LARGE LYMPHOCYTES|||||||MOL|||||||NEGATIVE||ENZYME U/L||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|UNEXPECTED ODOR|Y|SECONDARY ION MASS SPECTOMETRY|MDRD 5 VARIABLE FORMULA||Y|N|N|Y|||U|4||88||WASHOUT|1971-02-10|1969-03-15|||||1970-01-13||1969-06-14|Y|1963-01-07
TRIAL STUDY 134XCP|LB|43C443F9-AB0F-44BE-B28B-63A60EE09205|2||||ALA|ALANINE|||||||/MM|||||||NEGATIVE||G/ANIMAL/DAY||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|GELLED|Y|SCANNING ELECTRON MICROSCOPY|MDRD 6 VARIABLE FORMULA||Y|U|U|U|||NA|4||88||CONTINUATION TREATMENT|1969-05-01|1968-01-04|||||1968-01-30||1970-10-17|NA|1964-12-26
TRIAL STUDY 134XCP|LB|43C443F9-AB0F-44BE-B28B-63A60EE09205|1||||HBHIB|HEMOGLOBIN H INCLUSION BODIES|||||||10^5/HPF|||||||BORDERLINE||V/SEC||||LOW|NOT DONE||||SWABBED MATERIAL|AUTOLYZED|N|BAC ACGH|CKD-EPI CYSTATIN C FORMULA||NA|NA|NA|Y|||U|5||7||BASELINE|1971-07-07|1970-09-22|||||1969-05-19||1968-09-01|Y|1961-07-17
TRIAL STUDY 134XCP|LB|43C443F9-AB0F-44BE-B28B-63A60EE09205|2||||PPI|INORGANIC PYROPHOSPHATE|||||||UG|||||||POSITIVE||PLUG||||LOW|NOT DONE||||ALVEOLAR AIR|LIPEMIC|U|PERIODIC ACID SCHIFF STAIN|NASH FIBROSURE FORMULA||NA|N|NA|N|||NA|5||7||OPEN LABEL TREATMENT|1970-08-22|1966-11-18|||||1973-01-06||1961-07-07|N|1967-05-07
TRIAL STUDY 134XCP|LB|37FF91B1-CE3C-4587-85CE-F76B880D40E7|1||||OXYTOCIN|OXYTOCIN|||||||HENRY|||||||INVALID||NMOL/L/H||||LOW|NOT DONE||||VITREOUS HUMOR|CONCENTRATED|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 4 VARIABLE FORMULA||N|N|N|Y|||N|1||38||INDUCTION TREATMENT|1963-12-28|1971-02-02|||||1970-02-20||1971-07-03|Y|1964-08-06
TRIAL STUDY 134XCP|LB|37FF91B1-CE3C-4587-85CE-F76B880D40E7|2||||BLSTLMLY|LEUKEMIC BLASTS/LYMPHOCYTES|||||||DPM/MG|||||||INVALID||IU||||HIGH|NOT DONE||||LYSATE|CONTAMINATED|NA|MAMMOGRAPHY|CKD-EPI FORMULA||NA|N|U|N|||U|1||38||LONG-TERM FOLLOW-UP|1963-04-16|1965-07-06|||||1969-06-16||1962-03-26|Y|1968-09-08
TRIAL STUDY 134XCP|LB|37FF91B1-CE3C-4587-85CE-F76B880D40E7|1||||PHADJT|PH ADJUSTED FOR BODY TEMP|||||||EVENTS|||||||POSITIVE||LOG10 CFU/G||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|CONTAMINATED|U|ICC|COCKCROFT-GAULT FORMULA||NA|N|U|N|||NA|2||58||SCREENING|1969-06-30|1972-02-17|||||1964-10-23||1961-09-09|N|1961-01-18
TRIAL STUDY 134XCP|LB|37FF91B1-CE3C-4587-85CE-F76B880D40E7|2||||FENA|FRACTIONAL SODIUM EXCRETION|||||||MG/ML/DAY|||||||TRACE||U/M2/DAY||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|LACTESCENT|Y|LAPAROSCOPY|GMI MMOL/MOL FORMULA||Y|NA|U|U|||Y|2||58||INDUCTION TREATMENT|1972-09-15|1963-07-08|||||1960-01-02||1973-07-05|Y|1962-10-01
TRIAL STUDY 134XCP|LB|37FF91B1-CE3C-4587-85CE-F76B880D40E7|1||||IL1R2|INTERLEUKIN 1 RECEPTOR TYPE 2|||||||COULOMB|||||||INVALID||10^3 ORGANISMS/G||||LOW|NOT DONE||||TRANSUDATE|LACTESCENT|N|MICROPARTICLE ENZYME IMMUNOASSAY|MDRD ENZYMATIC FORMULA||U|Y|U|U|||Y|3||39||WASHOUT|1962-06-27|1966-02-03|||||1965-06-01||1962-10-07|N|1968-05-09
TRIAL STUDY 134XCP|LB|37FF91B1-CE3C-4587-85CE-F76B880D40E7|2||||HLAA|HLA CLASS IA ANTIGEN|||||||MET*MIN|||||||TRACE||NMOL||||NORMAL|NOT DONE||||TRANSUDATE|FROZEN|N|ROMANOWSKY STAIN|GMI MMOL/MOL FORMULA||U|N|U|U|||U|3||39||INDUCTION TREATMENT|1963-04-16|1965-12-22|||||1968-04-18||1964-07-03|U|1970-07-10
TRIAL STUDY 134XCP|LB|37FF91B1-CE3C-4587-85CE-F76B880D40E7|1||||NEUTSG|NEUTROPHILS, SEGMENTED|||||||ANSON U|||||||BORDERLINE||/VF||||NORMAL|NOT DONE||||GASTRIC CONTENTS|CALCIFIED|N|HIGH RESOLUTION CT|MDRD 5 VARIABLE FORMULA||Y|N|Y|NA|||NA|4||88||OPEN LABEL TREATMENT|1963-01-10|1965-03-29|||||1961-12-20||1972-01-23|NA|1971-03-18
TRIAL STUDY 134XCP|LB|37FF91B1-CE3C-4587-85CE-F76B880D40E7|2||||UREANCRT|UREA NITROGEN/CREATININE|||||||ML/M2/H|||||||INDETERMINATE||MM/MIN||||ABNORMAL|NOT DONE||||TISSUE|HEMOLYZED|NA|PHOROPTER|MDRD 5 VARIABLE FORMULA||U|U|NA|N|||Y|4||88||FOLLOW-UP|1963-12-15|1971-04-10|||||1960-12-19||1967-05-03|Y|1964-09-01
TRIAL STUDY 134XCP|LB|37FF91B1-CE3C-4587-85CE-F76B880D40E7|1||||PTHRP|PARATHYROID HORMONE-RELATED PROTEIN|||||||/H|||||||INVALID||10^12/L||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|LIPEMIC|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|GMI MMOL/MOL FORMULA||Y|U|NA|N|||N|5||7||FOLLOW-UP|1970-12-21|1971-07-10|||||1961-02-17||1969-11-12|U|1971-02-20
TRIAL STUDY 134XCP|LB|37FF91B1-CE3C-4587-85CE-F76B880D40E7|2||||CYAMMOX|AMMONIUM OXALATE CRYSTALS|||||||/4.0 ML|||||||INDETERMINATE||DROP||||HIGH|NOT DONE||||INFRANATANT, PLASMA|LIPEMIC|Y|CT SCAN WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA||NA|N|N|NA|||U|5||7||OPEN LABEL TREATMENT|1963-01-16|1965-11-05|||||1970-11-23||1970-08-02|Y|1966-07-11
TRIAL STUDY 134XCP|LB|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|1||||IFNG|INTERFERON GAMMA|||||||V|||||||BORDERLINE||AFU||||NORMAL|NOT DONE||||HAIR FOLLICLE|CLOTTED|N|HPLC/MS|MDRD 6 VARIABLE FORMULA||NA|N|N|U|||N|1||38||OBSERVATION|1971-12-30|1969-01-25|||||1971-01-30||1967-07-29|U|1972-04-04
TRIAL STUDY 134XCP|LB|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|2||||CRBMZPN|CARBAMAZEPINE|||||||KCAL|||||||INVALID||VP/DOSE||||ABNORMAL|NOT DONE||||REFLEX TEAR|CONTAMINATED|NA|CLIP|FIBROTEST FORMULA||NA|N|N|U|||NA|1||38||SCREENING|1971-10-13|1969-02-21|||||1966-01-19||1964-02-04|U|1972-08-10
TRIAL STUDY 134XCP|LB|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|1||||CYAMMOX|AMMONIUM OXALATE CRYSTALS|||||||DEG2|||||||INVALID||UCI/KG||||ABNORMAL|NOT DONE||||MONOCYTE|AUTOLYZED|Y|CELLULOSE TAPE|FIBROSIS 4 FORMULA||Y|U|NA|N|||NA|2||58||SCREENING|1963-01-10|1967-01-02|||||1971-09-20||1972-12-16|N|1973-08-16
TRIAL STUDY 134XCP|LB|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|2||||STROPONI|SKELETAL TROPONIN I|||||||OZ EQ|||||||INVALID||ML/M2||||ABNORMAL|NOT DONE||||DERMAL TISSUE|CONTAMINATED|Y|INDIRECT IMMUNOFLUORESCENCE|CKD-EPI CYSTATIN C FORMULA||N|NA|NA|NA|||NA|2||58||OBSERVATION|1965-11-25|1967-01-28|||||1971-03-27||1962-06-16|N|1971-03-13
TRIAL STUDY 134XCP|LB|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|1||||WBC|LEUKOCYTES|||||||DPM/100MG|||||||BORDERLINE||TSP EQ||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|ICTERIC|U|OBSERVATION|GMI MMOL/MOL FORMULA||NA|N|Y|U|||U|3||39||CONTINUATION TREATMENT|1970-07-03|1970-06-09|||||1964-10-02||1964-05-05|Y|1964-07-20
TRIAL STUDY 134XCP|LB|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|2||||RBP|RETINOL BINDING PROTEIN|||||||TRANSDUCING UNIT/ML|||||||INVALID||MEQ/ML||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|HEMOLYZED|U|FISH|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|U|N|||NA|3||39||FOLLOW-UP|1963-02-25|1963-02-10|||||1966-07-20||1971-09-03|N|1967-01-01
TRIAL STUDY 134XCP|LB|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|1||||CTLPRM|CITALOPRAM|||||||FMOL|||||||INDETERMINATE||PG||||NORMAL|NOT DONE||||PERITONEAL FLUID|AUTOLYZED|Y|NUCLEAR RADIOLOGY|CKD-EPI FORMULA||NA|U|NA|Y|||NA|4||88||FOLLOW-UP|1967-04-22|1970-10-06|||||1965-10-16||1961-02-14|Y|1972-02-09
TRIAL STUDY 134XCP|LB|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|2||||C165899|SILVER BIRCH POLLEN IGG AB RAST SCORE|||||||ML/KG/H|||||||INDETERMINATE||UG/KG/DAY||||LOW|NOT DONE||||TUMOR TISSUE|DRIED|U|INTRAVASCULAR ULTRASOUND|CKD-EPI CREATININE FORMULA||U|U|NA|N|||N|4||88||RUN-IN|1967-02-23|1968-12-04|||||1963-06-14||1965-12-27|N|1961-08-02
TRIAL STUDY 134XCP|LB|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|1||||AMYLASEM|MACROAMYLASE|||||||MMHG/SEC|||||||TRACE||YEARS||||NORMAL|NOT DONE||||EXUDATE|FROZEN|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|Y|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1967-09-26|1970-04-22|||||1969-10-31||1970-05-27|Y|1960-06-11
TRIAL STUDY 134XCP|LB|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|2||||ALP|ALKALINE PHOSPHATASE|||||||JAR|||||||POSITIVE||GTT||||HIGH|NOT DONE||||DERMAL TISSUE|NON-HEMOLYZED|Y|DIRECT SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|NA|Y|||N|5||7||INDUCTION TREATMENT|1967-10-04|1966-03-02|||||1971-09-07||1968-03-11|Y|1964-02-05
TRIAL STUDY 134XCP|LB|49017491-2C28-4F86-BF72-CF83651052F6|1||||GLOBB1BP|BETA-1 GLOBULIN/BETA PROTEIN|||||||CI/UL|||||||BORDERLINE||BAU||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONTAMINATED|Y|POLYSOMNOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|NA|NA|NA|||U|1||38||FOLLOW-UP|1965-12-26|1970-09-30|||||1971-08-09||1969-10-15|NA|1960-04-20
TRIAL STUDY 134XCP|LB|49017491-2C28-4F86-BF72-CF83651052F6|2||||TIMP3|TISSUE INHIBITOR OF METALLOPROTEINASE 3|||||||10^3 ORGANISMS/ML|||||||TRACE||10^7 CFU/ML||||ABNORMAL|NOT DONE||||TRANSUDATE|ROOM TEMPERATURE|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|U|N|||Y|1||38||RUN-IN|1964-11-09|1969-08-06|||||1965-10-30||1964-08-22|Y|1961-11-05
TRIAL STUDY 134XCP|LB|49017491-2C28-4F86-BF72-CF83651052F6|1||||DFI|DNA FRAGMENTATION INDEX|||||||/SEC|||||||NEGATIVE||OZ EQ||||HIGH|NOT DONE||||GASTRIC CONTENTS|CONTAMINATED|N|GC/MS/MS|ASH FIBROSURE FORMULA||Y|Y|N|NA|||U|2||58||OPEN LABEL TREATMENT|1973-03-02|1967-01-29|||||1964-08-18||1965-05-13|U|1967-12-19
TRIAL STUDY 134XCP|LB|49017491-2C28-4F86-BF72-CF83651052F6|2||||MCPHGCE|MACROPHAGES/TOTAL CELLS|||||||U/G|||||||POSITIVE||BQ/UL||||NORMAL|NOT DONE||||SALIVA|HEMOLYZED|N|OPTICAL MAPPING|NASH FIBROSURE FORMULA||NA|Y|N|Y|||N|2||58||LONG-TERM FOLLOW-UP|1964-02-17|1961-08-07|||||1961-09-11||1963-09-20|NA|1972-06-30
TRIAL STUDY 134XCP|LB|49017491-2C28-4F86-BF72-CF83651052F6|1||||VOLUME|VOLUME|||||||UM2|||||||TRACE||DNA COPIES/ML||||ABNORMAL|NOT DONE||||CORD SERUM|SOLIDIFIED|U|MAGNETIC RESONANCE ELASTOGRAPHY|CKD-EPI CREATININE FORMULA||NA|U|Y|U|||N|3||39||OBSERVATION|1960-11-23|1968-06-11|||||1968-12-03||1960-09-28|N|1972-02-28
TRIAL STUDY 134XCP|LB|49017491-2C28-4F86-BF72-CF83651052F6|2||||B2MICG|BETA-2 MICROGLOBULIN|||||||/HPF|||||||INDETERMINATE||IU/KG/H||||LOW|NOT DONE||||TRANSUDATE|SOLIDIFIED|N|KINETIC MICROPARTICLE IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||N|N|U|U|||U|3||39||INDUCTION TREATMENT|1969-05-29|1965-03-10|||||1962-08-12||1967-03-14|NA|1972-05-22
TRIAL STUDY 134XCP|LB|49017491-2C28-4F86-BF72-CF83651052F6|1||||RETIMRTC|MEDIUM ABSORPTION RETIC/RETICULOCYTES|||||||STRIP|||||||POSITIVE||TUBE||||LOW|NOT DONE||||ABSCESS FLUID|NON-HEMOLYZED|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|CKD-EPI CYSTATIN C FORMULA||N|NA|Y|NA|||NA|4||88||OPEN LABEL TREATMENT|1964-04-23|1960-12-28|||||1960-04-28||1968-04-24|Y|1969-08-02
TRIAL STUDY 134XCP|LB|49017491-2C28-4F86-BF72-CF83651052F6|2||||ACYLCAOX|ACYL COENZYME A OXIDASE|||||||KUSP|||||||TRACE||10^9 CFU/ML||||NORMAL|NOT DONE||||BONE|UNEXPECTED ODOR|NA|MICROSCOPY|COCKCROFT-GAULT FORMULA||N|U|U|N|||NA|4||88||BLINDED TREATMENT|1960-09-27|1963-03-14|||||1962-02-16||1964-11-02|N|1971-04-17
TRIAL STUDY 134XCP|LB|49017491-2C28-4F86-BF72-CF83651052F6|1||||CYUNCLA|UNCLASSIFIED CRYSTALS|||||||G/ANIMAL|||||||INVALID||PMOL/G||||ABNORMAL|NOT DONE||||MONOCYTE|PARAFFIN-EMBEDDED|N|PHOTOGRAPHY|HEPASCORE FORMULA||U|Y|U|U|||Y|5||7||INDUCTION TREATMENT|1972-05-02|1966-07-23|||||1960-01-04||1963-07-22|NA|1960-07-13
TRIAL STUDY 134XCP|LB|49017491-2C28-4F86-BF72-CF83651052F6|2||||NICOTINE|NICOTINE|||||||APL U|||||||POSITIVE||U/CL||||HIGH|NOT DONE||||BLOOD|ROOM TEMPERATURE|U|SPECTROPHOTOMETRY|NASH FIBROSURE FORMULA||Y|NA|N|N|||Y|5||7||BLINDED TREATMENT|1966-10-13|1965-04-03|||||1962-08-21||1969-05-12|Y|1967-04-13
TRIAL STUDY 134XCP|LB|DAA65EE6-66ED-4354-935B-1347E1B572A5|1||||EPISCECE|SQUAMOUS EPITHELIAL CELLS/TOTAL CELLS|||||||UGEQ|||||||POSITIVE||UIU/L||||LOW|NOT DONE||||PUS|ICTERIC|U|SXA SCAN|MDRD FORMULA||Y|NA|Y|Y|||Y|1||38||INDUCTION TREATMENT|1971-03-11|1968-09-29|||||1960-01-10||1967-05-19|NA|1960-09-22
TRIAL STUDY 134XCP|LB|DAA65EE6-66ED-4354-935B-1347E1B572A5|2||||CDT|CARBOHYDRATE-DEFICIENT TRANSFERRIN|||||||GBQ/G|||||||INDETERMINATE||HPA||||LOW|NOT DONE||||BREAST MILK|PARAFFIN-EMBEDDED|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CREATININE FORMULA||N|N|Y|U|||Y|1||38||FOLLOW-UP|1966-08-10|1961-04-24|||||1967-11-03||1963-09-10|NA|1971-01-30
TRIAL STUDY 134XCP|LB|DAA65EE6-66ED-4354-935B-1347E1B572A5|1||||SCHISTO|SCHISTOCYTES|||||||UMOL/H/MMOL|||||||NEGATIVE||MN||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|LIPEMIC|NA|FUNDUS PHOTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||U|NA|Y|NA|||U|2||58||BLINDED TREATMENT|1963-12-19|1963-06-03|||||1969-02-08||1960-06-05|NA|1961-08-19
TRIAL STUDY 134XCP|LB|DAA65EE6-66ED-4354-935B-1347E1B572A5|2||||TCDCA|TAUROCHENODEOXYCHOLATE|||||||MU|||||||TRACE||KBQ/UL||||NORMAL|NOT DONE||||VENOUS PLASMA|AUTOLYZED|N|ZIEHL NEELSEN ACID FAST STAIN|MDRD 6 VARIABLE FORMULA||N|NA|Y|U|||Y|2||58||INDUCTION TREATMENT|1965-09-22|1965-12-22|||||1960-09-21||1968-02-13|NA|1970-09-25
TRIAL STUDY 134XCP|LB|DAA65EE6-66ED-4354-935B-1347E1B572A5|1||||KETONEBD|KETONE BODIES|||||||KDA|||||||POSITIVE||IU/KG||||LOW|NOT DONE||||INTERSTITIAL FLUID|DRIED|NA|SEQUENCING|CKD-EPI CYSTATIN C FORMULA||U|NA|Y|NA|||NA|3||39||OBSERVATION|1970-03-03|1966-06-24|||||1960-08-04||1960-11-24|Y|1969-06-01
TRIAL STUDY 134XCP|LB|DAA65EE6-66ED-4354-935B-1347E1B572A5|2||||HGFR|HEPATOCYTE GROWTH FACTOR RECEPTOR|||||||IU/DL|||||||INVALID||MG/MOL||||LOW|NOT DONE||||BILE|SOLIDIFIED|Y|DIRECT SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|N|Y|||NA|3||39||SCREENING|1965-12-30|1972-03-27|||||1972-10-14||1967-02-28|NA|1973-05-02
TRIAL STUDY 134XCP|LB|DAA65EE6-66ED-4354-935B-1347E1B572A5|1||||PO2ADJT|PARTIAL PRESSURE OXYGEN ADJ FOR TEMP|||||||OSM|||||||NEGATIVE||BEL||||HIGH|NOT DONE||||MENSTRUAL BLOOD|ROOM TEMPERATURE|Y|HIGH RESOLUTION MELT ANALYSIS|MDRD 5 VARIABLE FORMULA||Y|U|U|N|||Y|4||88||RUN-IN|1971-04-22|1960-09-28|||||1961-01-02||1969-08-15|NA|1965-09-03
TRIAL STUDY 134XCP|LB|DAA65EE6-66ED-4354-935B-1347E1B572A5|2||||VEGFR3S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC3|||||||UV|||||||INVALID||KAT||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|FRESH|U|DNA MICROARRAY|FIBROTEST FORMULA||U|N|Y|NA|||Y|4||88||CONTINUATION TREATMENT|1970-04-28|1971-10-25|||||1968-09-15||1960-12-27|N|1969-04-18
TRIAL STUDY 134XCP|LB|DAA65EE6-66ED-4354-935B-1347E1B572A5|1||||HDWR|RET HEMOGLOBIN DISTRIBUTION WIDTH|||||||BOWL|||||||INDETERMINATE||H/WK||||HIGH|NOT DONE||||ALVEOLAR AIR|GELLED|Y|FLUORESCENCE ANGIOGRAPHY|FIBROMETER FORMULA||U|NA|NA|NA|||N|5||7||FOLLOW-UP|1962-10-20|1964-10-29|||||1971-12-22||1966-01-08|Y|1962-02-05
TRIAL STUDY 134XCP|LB|DAA65EE6-66ED-4354-935B-1347E1B572A5|2||||C165891|WESTERN RAGWEED POLLEN IGE AB RAST SCORE|||||||/WK|||||||INDETERMINATE||U/KG/MIN||||LOW|NOT DONE||||PLEURAL FLUID|SOLIDIFIED|Y|INDIA INK STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|N|U|U|||U|5||7||SCREENING|1968-08-05|1964-08-17|||||1960-04-23||1970-01-17|NA|1967-08-20
TRIAL STUDY 134XCP|LB|A440A3E5-F87D-4306-9195-3A842F0DDE33|1||||APOA1|APOLIPOPROTEIN A1|||||||UG/ANIMAL|||||||INVALID||SCOOPFUL||||LOW|NOT DONE||||ARTERIAL BLOOD|UNEXPECTED ODOR|NA|COLORIMETRY|ASH FIBROSURE FORMULA||Y|Y|U|Y|||N|1||38||FOLLOW-UP|1972-12-30|1970-01-12|||||1972-07-26||1963-02-25|Y|1962-12-06
TRIAL STUDY 134XCP|LB|A440A3E5-F87D-4306-9195-3A842F0DDE33|2||||ANCAB|ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY|||||||/WK|||||||POSITIVE||JAR||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|CLOTTED|Y|POLYMERASE CHAIN REACTION|GMI % FORMULA||U|N|NA|Y|||NA|1||38||WASHOUT|1963-04-01|1962-01-11|||||1970-06-09||1962-04-22|U|1968-01-31
TRIAL STUDY 134XCP|LB|A440A3E5-F87D-4306-9195-3A842F0DDE33|1||||GSTCREAT|GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||UG/L DDU|||||||INVALID||/5X10^4 WBC||||NORMAL|NOT DONE||||VENOUS PLASMA|DRIED|N|ICP-MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|NA|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1967-08-30|1962-06-22|||||1969-09-22||1968-06-28|U|1965-06-25
TRIAL STUDY 134XCP|LB|A440A3E5-F87D-4306-9195-3A842F0DDE33|2||||HDLCCHOL|HDL CHOLESTEROL/TOTAL CHOLESTEROL|||||||ECL UNIT|||||||INVALID||AU/ML||||LOW|NOT DONE||||PLEURAL TISSUE|LIPEMIC|Y|DYNAMIC CONTRAST ENHANCED MRI|FIBROTEST FORMULA||N|U|U|NA|||Y|2||58||WASHOUT|1964-02-05|1969-09-11|||||1970-05-19||1962-11-02|U|1967-12-05
TRIAL STUDY 134XCP|LB|A440A3E5-F87D-4306-9195-3A842F0DDE33|1||||TFRRNSAT|TRANSFERRIN SATURATION|||||||DAYS/WK|||||||NEGATIVE||ML/DL||||LOW|NOT DONE||||SALIVA|AUTOLYZED|U|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CYSTATIN C FORMULA||N|NA|N|Y|||NA|3||39||FOLLOW-UP|1963-10-25|1961-12-14|||||1961-08-31||1969-01-16|NA|1965-12-13
TRIAL STUDY 134XCP|LB|A440A3E5-F87D-4306-9195-3A842F0DDE33|2||||ABNCELE|ABNORMAL CELLS/LEUKOCYTES|||||||UM2|||||||BORDERLINE||LM||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR|N|KNEMOMETRY|CKD-EPI FORMULA||Y|Y|NA|NA|||NA|3||39||WASHOUT|1971-06-17|1964-11-10|||||1971-10-23||1967-01-04|Y|1969-11-27
TRIAL STUDY 134XCP|LB|A440A3E5-F87D-4306-9195-3A842F0DDE33|1||||RPTLTIME|REPTILASE TIME|||||||CI|||||||INDETERMINATE||MV/SEC||||HIGH|NOT DONE||||MUSCLE TISSUE|GELLED|Y|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|ASH FIBROSURE FORMULA||N|Y|NA|U|||Y|4||88||OPEN LABEL TREATMENT|1969-06-16|1973-05-25|||||1964-06-17||1966-10-25|N|1960-06-20
TRIAL STUDY 134XCP|LB|A440A3E5-F87D-4306-9195-3A842F0DDE33|2||||RESISTIN|RESISTIN|||||||NMOL/KG/DAY|||||||TRACE||TRANSDUCING UNIT||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|THAWED|N|GC/FID|MDRD 4 VARIABLE FORMULA||Y|Y|N|N|||NA|4||88||FOLLOW-UP|1968-09-11|1970-09-12|||||1973-04-16||1966-05-03|Y|1967-11-12
TRIAL STUDY 134XCP|LB|A440A3E5-F87D-4306-9195-3A842F0DDE33|1||||FRTNHC|FERRITIN HEAVY CHAIN|||||||G|||||||TRACE||MG/ANIMAL||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|CONCENTRATED|N|NUCLEAR RADIOLOGY|MDRD 6 VARIABLE FORMULA||Y|Y|U|U|||U|5||7||CONTINUATION TREATMENT|1961-04-12|1968-04-16|||||1962-01-13||1960-09-21|NA|1969-06-22
TRIAL STUDY 134XCP|LB|A440A3E5-F87D-4306-9195-3A842F0DDE33|2||||CYAMORPH|AMORPHOUS CRYSTALS|||||||H*%|||||||TRACE||ENZYME U/L||||HIGH|NOT DONE||||INFRANATANT, SERUM|NON-HEMOLYZED|U|NUCLEIC ACID SEQUENCING|CKD-EPI CREATININE FORMULA||Y|NA|N|U|||U|5||7||RUN-IN|1963-08-06|1966-02-14|||||1961-03-03||1966-02-12|Y|1971-09-30
TRIAL STUDY 134XCP|LB|48BBE085-BD68-451A-9700-6A1AB18D84EE|1||||PSELECT|P-SELECTIN|||||||BQ/ML|||||||INVALID||KDA||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|LIPEMIC|Y|STATIC PERIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|U|||U|1||38||INDUCTION TREATMENT|1967-10-25|1966-11-21|||||1971-02-04||1964-02-14|U|1968-01-21
TRIAL STUDY 134XCP|LB|48BBE085-BD68-451A-9700-6A1AB18D84EE|2||||VEGFC|VASCULAR ENDOTHELIAL GROWTH FACTOR C|||||||MG2/DL2|||||||INDETERMINATE||MOL/ML||||NORMAL|NOT DONE||||REFLEX TEAR|GELLED|U|POLYGRAPHY|MDRD FORMULA||Y|Y|Y|Y|||NA|1||38||RUN-IN|1970-03-26|1964-01-06|||||1966-06-29||1967-02-28|N|1969-12-18
TRIAL STUDY 134XCP|LB|48BBE085-BD68-451A-9700-6A1AB18D84EE|1||||UREACRT|UREA/CREATININE|||||||NMOL/DAY|||||||TRACE||SPRAY||||LOW|NOT DONE||||PERITONEAL FLUID|THAWED|Y|CAPILLARY ELECTROPHORESIS|MDRD FORMULA||Y|NA|Y|N|||U|2||58||LONG-TERM FOLLOW-UP|1966-05-22|1969-10-29|||||1970-11-21||1969-03-25|N|1966-06-14
TRIAL STUDY 134XCP|LB|48BBE085-BD68-451A-9700-6A1AB18D84EE|2||||CELLSIM|IMMATURE CELLS|||||||UMOL/MOL|||||||BORDERLINE||M2||||HIGH|NOT DONE||||EPITHELIAL CELL|LIPEMIC|NA|MICROBIAL CULTURE|CKD-EPI CYSTATIN C FORMULA||U|U|U|U|||NA|2||58||OPEN LABEL TREATMENT|1962-04-02|1963-08-08|||||1964-06-30||1967-01-31|N|1962-05-20
TRIAL STUDY 134XCP|LB|48BBE085-BD68-451A-9700-6A1AB18D84EE|1||||BLAST|BLASTS|||||||DL|||||||BORDERLINE||PRESSOR UNITS||||NORMAL|NOT DONE||||ALVEOLAR AIR|CLOTTED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 6 VARIABLE FORMULA||Y|Y|N|U|||N|3||39||CONTINUATION TREATMENT|1963-04-14|1963-06-25|||||1973-06-09||1970-04-29|N|1967-02-21
TRIAL STUDY 134XCP|LB|48BBE085-BD68-451A-9700-6A1AB18D84EE|2||||ETPLT|ETP LAG TIME|||||||M|||||||NEGATIVE||APL U/ML||||HIGH|NOT DONE||||EXPIRED AIR|CONTAMINATED|Y|TOTAL BODY RADIOGRAPHY|CKD-EPI CREATININE FORMULA||NA|U|N|N|||U|3||39||SCREENING|1970-12-06|1966-03-15|||||1963-01-19||1967-06-18|NA|1973-01-18
TRIAL STUDY 134XCP|LB|48BBE085-BD68-451A-9700-6A1AB18D84EE|1||||NFLP|NEUROFILAMENT LIGHT CHAIN PROTEIN|||||||UG/M2/DAY|||||||INDETERMINATE||USEC||||LOW|NOT DONE||||TRANSUDATE|PARAFFIN-EMBEDDED|Y|ELISA|GMI % FORMULA||NA|Y|N|U|||NA|4||88||INDUCTION TREATMENT|1967-03-03|1968-12-22|||||1968-01-22||1967-02-13|U|1971-11-01
TRIAL STUDY 134XCP|LB|48BBE085-BD68-451A-9700-6A1AB18D84EE|2||||MCVRETIC|MCV RETICULOCYTES|||||||ML/DAY|||||||POSITIVE||CM2||||ABNORMAL|NOT DONE||||SERUM|FRESH|U|STRESS ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||N|Y|Y|N|||N|4||88||BASELINE|1964-05-07|1972-02-10|||||1962-04-19||1973-01-29|U|1969-12-28
TRIAL STUDY 134XCP|LB|48BBE085-BD68-451A-9700-6A1AB18D84EE|1||||BASOCE|BASOPHILS/TOTAL CELLS|||||||U/G/DAY|||||||INDETERMINATE||ELISA UNIT/ML||||NORMAL|NOT DONE||||BREAST MILK|CALCIFIED|NA|INFRARED SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|Y|N|||U|5||7||FOLLOW-UP|1970-07-09|1970-03-08|||||1962-11-10||1968-07-09|Y|1963-04-07
TRIAL STUDY 134XCP|LB|48BBE085-BD68-451A-9700-6A1AB18D84EE|2||||C3B|COMPLEMENT C3B|||||||MG/L|||||||BORDERLINE||KM||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CALCIFIED|U|URANYL ACETATE STAIN|NASH FIBROSURE FORMULA||Y|N|U|N|||N|5||7||SCREENING|1963-02-21|1968-06-07|||||1969-09-05||1961-07-14|NA|1965-07-11
TRIAL STUDY 134XCP|LB|F38055A2-11E2-437B-BD6A-662D81521F1D|1||||GLYCRLFR|FREE GLYCEROL|||||||MET*H|||||||INVALID||UGEQ/L||||HIGH|NOT DONE||||CALCULUS|CONCENTRATED|NA|KINETIC MICROPARTICLE IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||N|NA|NA|U|||NA|1||38||BASELINE|1969-04-25|1960-08-17|||||1963-01-27||1961-01-05|N|1971-07-06
TRIAL STUDY 134XCP|LB|F38055A2-11E2-437B-BD6A-662D81521F1D|2||||PLCGF|PLACENTAL GROWTH FACTOR|||||||IMPLANT|||||||BORDERLINE||VIRTUAL PIXEL||||HIGH|NOT DONE||||BUFFY COAT|HEMOLYZED|Y|RAJI CELL EIA|COCKCROFT-GAULT FORMULA||N|U|NA|NA|||N|1||38||BASELINE|1968-04-05|1970-12-21|||||1971-06-10||1969-02-27|Y|1966-07-28
TRIAL STUDY 134XCP|LB|F38055A2-11E2-437B-BD6A-662D81521F1D|1||||NEUTMY|NEUTROPHILIC MYELOCYTES|||||||NMOL|||||||BORDERLINE||10^6/L||||HIGH|NOT DONE||||MUSCLE TISSUE|CONTAMINATED|U|PYROSEQUENCING|GMI % FORMULA||Y|N|N|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1971-06-23|1972-08-19|||||1969-12-23||1972-11-08|Y|1964-05-13
TRIAL STUDY 134XCP|LB|F38055A2-11E2-437B-BD6A-662D81521F1D|2||||TFERRIN|TRANSFERRIN|||||||MNFI|||||||POSITIVE||ML/ANIMAL||||NORMAL|NOT DONE||||TUMOR TISSUE|AUTOLYZED|NA|STRESS ECHOCARDIOGRAPHY|FIBROMETER FORMULA||N|N|U|U|||N|2||58||SCREENING|1966-09-03|1962-04-18|||||1960-02-13||1969-02-10|U|1967-10-16
TRIAL STUDY 134XCP|LB|F38055A2-11E2-437B-BD6A-662D81521F1D|1||||HDWR|RET HEMOGLOBIN DISTRIBUTION WIDTH|||||||HPA|||||||POSITIVE||DIP||||HIGH|NOT DONE||||LEUKOCYTE|ROOM TEMPERATURE|U|MYELOPEROXIDASE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|NA|||Y|3||39||OPEN LABEL TREATMENT|1965-11-16|1964-02-22|||||1967-10-27||1970-02-02|U|1970-08-03
TRIAL STUDY 134XCP|LB|F38055A2-11E2-437B-BD6A-662D81521F1D|2||||CLRZPT|CLORAZEPATE|||||||KN/CM2|||||||NEGATIVE||MMOL/G||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CONCENTRATED|N|HIGH RESOLUTION MELT ANALYSIS|MDRD 4 VARIABLE FORMULA||NA|N|U|Y|||Y|3||39||SCREENING|1964-01-16|1973-08-17|||||1971-03-05||1965-03-28|U|1961-05-22
TRIAL STUDY 134XCP|LB|F38055A2-11E2-437B-BD6A-662D81521F1D|1||||GLOBB1|BETA-1 GLOBULIN|||||||U/G/H|||||||BORDERLINE||PACKET||||HIGH|NOT DONE||||PLATELET RICH PLASMA|CONCENTRATED|Y|TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|NA|NA|||NA|4||88||INDUCTION TREATMENT|1965-07-25|1963-06-24|||||1971-11-26||1969-12-14|Y|1963-03-21
TRIAL STUDY 134XCP|LB|F38055A2-11E2-437B-BD6A-662D81521F1D|2||||BASOSG|BASOPHILS, SEGMENTED|||||||U/KG/H|||||||INDETERMINATE||MM2||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|SOLIDIFIED|U|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROMETER FORMULA||U|Y|Y|N|||Y|4||88||WASHOUT|1961-02-25|1960-12-06|||||1962-07-14||1962-04-29|NA|1973-08-22
TRIAL STUDY 134XCP|LB|F38055A2-11E2-437B-BD6A-662D81521F1D|1||||GEC|GALACTOSE ELIMINATION CAPACITY|||||||V|||||||BORDERLINE||ML/DOSE||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR|Y|SPECULAR MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|N|N|||NA|5||7||TREATMENT|1971-03-10|1968-09-07|||||1962-03-08||1971-09-23|Y|1973-01-01
TRIAL STUDY 134XCP|LB|F38055A2-11E2-437B-BD6A-662D81521F1D|2||||IGAGM|IGG IGM IGA TOTAL|||||||G/DAY|||||||POSITIVE||/MONTH||||LOW|NOT DONE||||EXPIRED AIR|DRIED|NA|GC/MS-EI|NASH FIBROSURE FORMULA||U|U|NA|Y|||NA|5||7||OBSERVATION|1963-11-26|1965-06-02|||||1965-07-04||1970-11-30|N|1971-05-23
TRIAL STUDY 134XCP|LB|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|1||||CYSCREAT|CYSTATIN C/CREATININE|||||||DNA COPIES/ML|||||||TRACE||G/KG||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|THAWED|N|RADIAL IMMUNODIFFUSION|CKD-EPI CREATININE FORMULA||U|U|U|U|||U|1||38||LONG-TERM FOLLOW-UP|1965-09-04|1968-08-30|||||1968-06-08||1970-03-24|NA|1965-09-20
TRIAL STUDY 134XCP|LB|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|2||||C165897|BERMUDA GRASS POLLEN IGG AB RAST SCORE|||||||LX|||||||POSITIVE||UMOL/L/H||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|ROOM TEMPERATURE|NA|MACRO BROTH DILUTION|CKD-EPI FORMULA||N|Y|NA|NA|||U|1||38||INDUCTION TREATMENT|1970-07-24|1965-07-26|||||1973-06-17||1968-01-25|Y|1969-09-13
TRIAL STUDY 134XCP|LB|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|1||||PCP|PHENCYCLIDINE|||||||CM H2O|||||||INVALID||QUANTITY SUFFICIENT||||HIGH|NOT DONE||||LUNG SURFACTANT|REFRIGERATED|U|MULTIPLE BREATH WASHOUT|CKD-EPI CYSTATIN C FORMULA||Y|Y|NA|U|||U|2||58||TREATMENT|1960-02-24|1962-07-21|||||1968-09-13||1967-04-10|N|1967-10-24
TRIAL STUDY 134XCP|LB|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|2||||CABOT|CABOT RINGS|||||||P|||||||INDETERMINATE||U/KG||||ABNORMAL|NOT DONE||||STOOL|GELLED|NA|IHC|CKD-EPI CYSTATIN C FORMULA||Y|N|U|U|||Y|2||58||WASHOUT|1968-03-23|1964-03-26|||||1969-12-20||1973-05-14|Y|1960-01-06
TRIAL STUDY 134XCP|LB|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|1||||C130111|MOLD MIX ANTIGEN IGA ANTIBODY|||||||RNA COPIES/ML|||||||TRACE||/DAY||||ABNORMAL|NOT DONE||||VENOUS PLASMA|ROOM TEMPERATURE|U|LIQUID SCINTILLATION COUNTING|GMI % FORMULA||U|U|NA|NA|||N|3||39||WASHOUT|1972-03-30|1970-08-20|||||1962-01-25||1968-07-27|NA|1973-01-20
TRIAL STUDY 134XCP|LB|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|2||||VITB9|VITAMIN B9|||||||10^6 CFU/ML|||||||POSITIVE||PT_US||||NORMAL|NOT DONE||||MONOCYTE|CONTAMINATED|NA|ANTIBIOTIC AGAR SCREEN|CKD-EPI CREATININE FORMULA||N|N|N|Y|||N|3||39||CONTINUATION TREATMENT|1966-03-09|1970-03-19|||||1972-09-17||1971-01-17|Y|1967-01-25
TRIAL STUDY 134XCP|LB|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|1||||PYRUVATE|PYRUVATE|||||||MV2/HZ|||||||TRACE||IU/KG/H||||NORMAL|NOT DONE||||BONE MARROW|CLOTTED|U|DROPLET DIGITAL PCR|FIBROMETER FORMULA||N|NA|U|N|||NA|4||88||BASELINE|1960-05-03|1967-03-31|||||1969-10-28||1971-10-28|U|1965-06-24
TRIAL STUDY 134XCP|LB|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|2||||HDLCCHOL|HDL CHOLESTEROL/TOTAL CHOLESTEROL|||||||BP|||||||INVALID||MG/M2/DAY||||LOW|NOT DONE||||SERUM|AGGLUTINATED|NA|SPECT/CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|N|N|||Y|4||88||RUN-IN|1961-01-02|1967-01-01|||||1970-09-09||1962-03-21|Y|1962-08-17
TRIAL STUDY 134XCP|LB|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|1||||FERRITIN|FERRITIN|||||||MCI/L|||||||NEGATIVE||MG/M2/DAY||||HIGH|NOT DONE||||LAVAGE FLUID|CONTAMINATED|N|ZIEHL NEELSEN ACID FAST STAIN|FIBROSIS 4 FORMULA||N|NA|U|U|||U|5||7||LONG-TERM FOLLOW-UP|1968-05-15|1960-07-21|||||1961-03-09||1961-03-05|U|1964-02-16
TRIAL STUDY 134XCP|LB|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|2||||FBNCTPL|FIBRONECTIN, PLASMA|||||||CI/UG|||||||POSITIVE||DPM/MG||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|DRIED|NA|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD ENZYMATIC FORMULA||N|Y|Y|Y|||Y|5||7||RUN-IN|1966-11-01|1961-06-21|||||1961-02-19||1968-06-26|NA|1961-11-11
TRIAL STUDY 134XCP|LB|22B0F097-D571-4E65-9B58-BEF2C3482F05|1||||CYSCREAT|CYSTATIN C/CREATININE|||||||LOG10 ELISA UNIT/DOSE|||||||INVALID||H/WK||||HIGH|NOT DONE||||SERUM|CONTAMINATED|Y|U-HPLC/MS/MS|NASH FIBROSURE FORMULA||U|N|Y|Y|||N|1||38||SCREENING|1970-01-19|1972-10-02|||||1962-09-02||1969-05-14|Y|1966-04-11
TRIAL STUDY 134XCP|LB|22B0F097-D571-4E65-9B58-BEF2C3482F05|2||||NEUTVAC|VACUOLATED NEUTROPHILS|||||||/40 HPFS|||||||TRACE||UG/M2/DAY||||ABNORMAL|NOT DONE||||TUMOR TISSUE|DRIED|Y|MICROBIAL CULTURE, SOLID|COCKCROFT-GAULT FORMULA||Y|U|U|U|||U|1||38||FOLLOW-UP|1971-04-12|1970-01-03|||||1960-03-13||1964-02-11|U|1973-05-30
TRIAL STUDY 134XCP|LB|22B0F097-D571-4E65-9B58-BEF2C3482F05|1||||LYMPLLE|PLASMACYTOID LYMPHOCYTES/LEUKOCYTES|||||||NKAT|||||||INDETERMINATE||ELISA UNIT/ML||||ABNORMAL|NOT DONE||||EXUDATE|HEMOLYZED|Y|AGAR PROPORTION|NASH FIBROSURE FORMULA||U|Y|Y|NA|||Y|2||58||WASHOUT|1962-04-08|1963-01-23|||||1964-09-18||1961-08-31|Y|1965-05-14
TRIAL STUDY 134XCP|LB|22B0F097-D571-4E65-9B58-BEF2C3482F05|2||||CXCL6|CHEMOKINE (C-X-C MOTIF) LIGAND 6|||||||DIP|||||||INVALID||MCI/KG||||ABNORMAL|NOT DONE||||VENOUS PLASMA|AUTOLYZED|U|CHROMATOGRAPHY|NASH FIBROSURE FORMULA||NA|NA|Y|NA|||N|2||58||OPEN LABEL TREATMENT|1971-11-07|1966-12-07|||||1971-12-29||1960-10-30|N|1968-06-06
TRIAL STUDY 134XCP|LB|22B0F097-D571-4E65-9B58-BEF2C3482F05|1||||ORNITHIN|ORNITHINE|||||||DAYS/WK|||||||POSITIVE||EP U||||ABNORMAL|NOT DONE||||BONE|FROZEN|NA|DIGITAL PCR|ASH FIBROSURE FORMULA||N|N|N|Y|||Y|3||39||OPEN LABEL TREATMENT|1963-09-22|1961-10-06|||||1966-09-13||1961-02-03|NA|1963-03-01
TRIAL STUDY 134XCP|LB|22B0F097-D571-4E65-9B58-BEF2C3482F05|2||||EPINSQCE|NON-SQUAMOUS EPITHELIAL CELLS|||||||UG/KG/MIN|||||||INVALID||10^9 CFU/ML||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|CALCIFIED|N|ELECTROMYOGRAPHY|MDRD FORMULA||Y|U|Y|U|||NA|3||39||RUN-IN|1973-03-08|1965-12-18|||||1968-02-05||1965-09-17|N|1965-09-07
TRIAL STUDY 134XCP|LB|22B0F097-D571-4E65-9B58-BEF2C3482F05|1||||CHOLOH4B|4-BETA-HYDROXYCHOLESTEROL|||||||/KG|||||||INVALID||10^6/HPF||||HIGH|NOT DONE||||SERUM|THAWED|NA|HEMAGGLUTINATION ASSAY|NASH FIBROSURE FORMULA||U|N|U|U|||N|4||88||LONG-TERM FOLLOW-UP|1960-01-19|1965-09-07|||||1972-07-09||1973-03-08|N|1963-01-25
TRIAL STUDY 134XCP|LB|22B0F097-D571-4E65-9B58-BEF2C3482F05|2||||GLUCPE|PLASMA EQUIVALENT GLUCOSE|||||||UKAT/L|||||||INVALID||SEC||||NORMAL|NOT DONE||||LUNG SURFACTANT|AUTOLYZED|U|MICRO BROTH DILUTION|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|U|||Y|4||88||WASHOUT|1972-05-21|1966-07-26|||||1969-01-01||1963-10-14|NA|1964-12-08
TRIAL STUDY 134XCP|LB|22B0F097-D571-4E65-9B58-BEF2C3482F05|1||||WBCMORPH|LEUKOCYTE CELL MORPHOLOGY|||||||PRESSOR UNITS|||||||NEGATIVE||KG/MOL||||HIGH|NOT DONE||||SUPERNATANT, SERUM|PARAFFIN-EMBEDDED|N|NUCLEIC ACID AMPLIFICATION TEST|MDRD 6 VARIABLE FORMULA||U|N|U|Y|||NA|5||7||FOLLOW-UP|1965-11-15|1968-06-15|||||1960-11-05||1971-08-23|Y|1965-04-19
TRIAL STUDY 134XCP|LB|22B0F097-D571-4E65-9B58-BEF2C3482F05|2||||HGBFR|HEMOGLOBIN, FREE|||||||/MONTH|||||||NEGATIVE||APL U||||NORMAL|NOT DONE||||PLASMA|SOLIDIFIED|Y|TONOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|U|N|||NA|5||7||OPEN LABEL TREATMENT|1968-01-20|1972-01-22|||||1966-08-21||1962-07-23|U|1961-01-03
TRIAL STUDY 134XCP|LB|F56B6C70-0513-4032-A0BE-B961F6F2EF30|1||||TGLOBRR|THYROGLOBULIN RECOVERY RATE|||||||ANTIBODY UNIT|||||||BORDERLINE||MEQ||||ABNORMAL|NOT DONE||||SEMINAL FLUID|CALCIFIED|Y|CORONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|U|U|N|||NA|1||38||INDUCTION TREATMENT|1961-12-24|1969-06-04|||||1965-12-10||1965-09-01|N|1966-10-23
TRIAL STUDY 134XCP|LB|F56B6C70-0513-4032-A0BE-B961F6F2EF30|2||||C3|COMPLEMENT C3|||||||EU|||||||BORDERLINE||FOZ_US||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|FRESH|U|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI FORMULA||NA|N|NA|NA|||N|1||38||FOLLOW-UP|1963-07-07|1968-06-23|||||1964-10-31||1964-02-06|Y|1968-01-29
TRIAL STUDY 134XCP|LB|F56B6C70-0513-4032-A0BE-B961F6F2EF30|1||||BASOSG|BASOPHILS, SEGMENTED|||||||UG/H|||||||NEGATIVE||APL U||||NORMAL|NOT DONE||||BASAL TEAR|CONCENTRATED|NA|INDIA INK STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|Y|N|||U|2||58||TREATMENT|1966-10-05|1966-03-13|||||1968-08-01||1973-05-31|Y|1961-12-30
TRIAL STUDY 134XCP|LB|F56B6C70-0513-4032-A0BE-B961F6F2EF30|2||||DCA|DEOXYCHOLATE|||||||PPB|||||||NEGATIVE||UG/KG||||HIGH|NOT DONE||||DISCHARGE|AUTOLYZED|Y|FLUORESCENT IMMUNOASSAY|HEPASCORE FORMULA||U|NA|NA|U|||NA|2||58||INDUCTION TREATMENT|1964-05-21|1971-10-21|||||1960-09-02||1968-07-19|U|1966-02-15
TRIAL STUDY 134XCP|LB|F56B6C70-0513-4032-A0BE-B961F6F2EF30|1||||CBB|COMPLEMENT BB|||||||G/CAGE/WK|||||||BORDERLINE||LB||||LOW|NOT DONE||||SEMINAL FLUID|UNEXPECTED ODOR|N|DUCTOGRAPHY|HEPASCORE FORMULA||U|NA|U|U|||Y|3||39||BLINDED TREATMENT|1970-12-12|1970-10-18|||||1971-12-05||1963-01-13|Y|1971-11-13
TRIAL STUDY 134XCP|LB|F56B6C70-0513-4032-A0BE-B961F6F2EF30|2||||THYAB|THYROID ANTIBODIES|||||||UGEQ|||||||BORDERLINE||NG/DAY||||HIGH|NOT DONE||||EMESIS|CONCENTRATED|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||Y|U|U|NA|||N|3||39||SCREENING|1963-02-21|1961-10-10|||||1972-05-02||1962-04-05|U|1968-05-25
TRIAL STUDY 134XCP|LB|F56B6C70-0513-4032-A0BE-B961F6F2EF30|1||||CSCYL|CYLINDROID CASTS|||||||BQ/L|||||||TRACE||CCID 50/DOSE||||NORMAL|NOT DONE||||SMEGMA|CONTAMINATED|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|FIBROSIS 4 FORMULA||Y|Y|N|Y|||U|4||88||LONG-TERM FOLLOW-UP|1965-10-25|1966-12-13|||||1973-08-18||1965-05-23|U|1972-03-09
TRIAL STUDY 134XCP|LB|F56B6C70-0513-4032-A0BE-B961F6F2EF30|2||||C130116|BEE MIX ANTIGEN IGE ANTIBODY|||||||VOXEL|||||||POSITIVE||PPB||||HIGH|NOT DONE||||BREAST MILK|GELLED|U|GC/MS-CI|MDRD ENZYMATIC FORMULA||Y|N|Y|NA|||N|4||88||OBSERVATION|1962-07-26|1963-03-11|||||1970-05-17||1968-02-24|U|1972-03-11
TRIAL STUDY 134XCP|LB|F56B6C70-0513-4032-A0BE-B961F6F2EF30|1||||PTHCT|PARATHYROID HORMONE, C-TERMINAL|||||||BQ/L|||||||BORDERLINE||ML/CM3/MIN||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|ICTERIC|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|Y|NA|||NA|5||7||OPEN LABEL TREATMENT|1971-03-19|1960-04-09|||||1966-11-14||1968-06-16|N|1965-08-12
TRIAL STUDY 134XCP|LB|F56B6C70-0513-4032-A0BE-B961F6F2EF30|2||||EPHD|EPHEDRINE|||||||MU/G|||||||INVALID||PA||||LOW|NOT DONE||||INTERSTITIAL FLUID|HEMOLYZED|Y|MICROBIAL CULTURE|CKD-EPI CYSTATIN C FORMULA||Y|U|Y|U|||N|5||7||BLINDED TREATMENT|1961-04-20|1972-05-01|||||1973-01-30||1968-01-29|U|1967-05-31
TRIAL STUDY 134XCP|LB|8E385A66-25C9-417E-9298-FB87A73B661F|1||||CYUNCLA|UNCLASSIFIED CRYSTALS|||||||MMOL/MIN/KPA|||||||TRACE||GAUSS||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|FROZEN|NA|SLOAN LETTER EYE CHART 1.25%|FIBROMETER FORMULA||N|U|NA|NA|||NA|1||38||TREATMENT|1972-01-01|1973-05-30|||||1964-03-29||1972-11-11|N|1973-06-25
TRIAL STUDY 134XCP|LB|8E385A66-25C9-417E-9298-FB87A73B661F|2||||GLOBG|GAMMA GLOBULIN|||||||CAPLET|||||||BORDERLINE||MMOL/MIN/KPA||||LOW|NOT DONE||||CORD SERUM|CONTAMINATED|U|FLUORIMETRY|COCKCROFT-GAULT FORMULA||U|N|Y|Y|||N|1||38||LONG-TERM FOLLOW-UP|1970-10-25|1967-10-18|||||1961-02-23||1965-03-18|Y|1963-08-19
TRIAL STUDY 134XCP|LB|8E385A66-25C9-417E-9298-FB87A73B661F|1||||INHIBINA|INHIBIN A|||||||UGEQ/L|||||||INVALID||JDF UNIT||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|NON-HEMOLYZED|N|SXA SCAN|FIBROMETER FORMULA||NA|NA|NA|Y|||U|2||58||OPEN LABEL TREATMENT|1962-06-06|1961-02-10|||||1971-11-07||1962-11-21|N|1967-02-23
TRIAL STUDY 134XCP|LB|8E385A66-25C9-417E-9298-FB87A73B661F|2||||CACRTP|CALCIUM CORRECTED FOR TOTAL PROTEIN|||||||PMOL/10^9 CELLS|||||||INDETERMINATE||GBQ/MG||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|CONCENTRATED|NA|MAGNETIC RESONANCE ELASTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|Y|||U|2||58||OBSERVATION|1968-01-08|1971-08-12|||||1961-01-05||1962-01-20|U|1960-03-04
TRIAL STUDY 134XCP|LB|8E385A66-25C9-417E-9298-FB87A73B661F|1||||BPIAB|BACTERICIDAL/PERMEABILITY-INC PROTEIN AB|||||||LM|||||||INVALID||APPLICATION||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|FRESH|U|LISSAMINE GREEN STAIN|FIBROMETER FORMULA||NA|NA|U|Y|||Y|3||39||WASHOUT|1964-12-12|1963-05-28|||||1972-05-05||1961-05-24|Y|1963-03-27
TRIAL STUDY 134XCP|LB|8E385A66-25C9-417E-9298-FB87A73B661F|2||||GFRBSCRT|GFR FROM CREATININE ADJUSTED FOR BSA|||||||MMHG/SEC|||||||BORDERLINE||DAMOL/L||||HIGH|NOT DONE||||EXUDATE|UNEXPECTED ODOR|Y|TOLUIDINE BLUE STAIN|GMI MMOL/MOL FORMULA||N|U|NA|N|||Y|3||39||TREATMENT|1973-01-25|1960-10-11|||||1963-08-03||1972-07-04|Y|1965-03-02
TRIAL STUDY 134XCP|LB|8E385A66-25C9-417E-9298-FB87A73B661F|1||||THRCREAT|THREONINE/CREATININE|||||||IU/MMOL|||||||NEGATIVE||MG/DAY||||LOW|NOT DONE||||SMEGMA|AGGLUTINATED|Y|CONTACT SPECULAR MICROSCOPY|MDRD FORMULA||Y|N|Y|N|||U|4||88||TREATMENT|1973-09-03|1967-09-26|||||1963-05-13||1971-07-08|N|1962-02-11
TRIAL STUDY 134XCP|LB|8E385A66-25C9-417E-9298-FB87A73B661F|2||||C165880|D. PTERONYSSINUS IGE AB RAST SCORE|||||||PFU/DOSE|||||||NEGATIVE||CYLINDER||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|FROZEN|Y|OPTICAL COHERENCE TOMOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|U|U|NA|||N|4||88||FOLLOW-UP|1971-06-05|1962-12-04|||||1970-02-27||1963-08-17|Y|1962-09-29
TRIAL STUDY 134XCP|LB|8E385A66-25C9-417E-9298-FB87A73B661F|1||||CLUECE|CLUE CELLS|||||||ARBITRARY U|||||||TRACE||AMOL||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|AGGLUTINATED|NA|OPHTHALMOSCOPY|FIBROMETER FORMULA||N|NA|N|U|||Y|5||7||TREATMENT|1964-07-11|1973-01-06|||||1965-12-20||1962-10-26|NA|1971-03-17
TRIAL STUDY 134XCP|LB|8E385A66-25C9-417E-9298-FB87A73B661F|2||||HGBFHGB|HEMOGLOBIN F/TOTAL HEMOGLOBIN|||||||GENEQ/ML|||||||NEGATIVE||AG||||HIGH|NOT DONE||||SEMINAL FLUID|ROOM TEMPERATURE|NA|TRANSMISSION ELECTRON MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|NA|||NA|5||7||SCREENING|1963-06-30|1966-07-25|||||1967-04-18||1971-12-16|NA|1973-04-03
TRIAL STUDY 134XCP|LB|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|1||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||NKAT/G HB|||||||INVALID||ML/M2/MIN||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|HEMOLYZED|U|ELASTOGRAPHY|GMI % FORMULA||Y|Y|N|U|||NA|1||38||FOLLOW-UP|1971-03-07|1961-10-05|||||1963-06-22||1960-03-20|U|1961-12-19
TRIAL STUDY 134XCP|LB|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|2||||TRPCRT|TRYPTOPHAN/CREATININE|||||||10^3 ORGANISMS/ML|||||||INVALID||SPRAY||||LOW|NOT DONE||||EXUDATE|CLOTTED|NA|ELECTROGASTROGRAPHY|CKD-EPI FORMULA||NA|NA|N|N|||Y|1||38||SCREENING|1964-02-26|1969-08-15|||||1963-03-30||1963-12-11|Y|1963-09-08
TRIAL STUDY 134XCP|LB|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|1||||DKK1|DICKKOPF WNT SIGNALING PATH INHIBITOR 1|||||||AMOL|||||||TRACE||MG/DL||||LOW|NOT DONE||||EXUDATE|CONTAMINATED|NA|PULSE OXIMETRY|MDRD 5 VARIABLE FORMULA||Y|Y|U|N|||Y|2||58||WASHOUT|1968-08-03|1966-04-06|||||1966-01-21||1968-03-21|NA|1970-08-15
TRIAL STUDY 134XCP|LB|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|2||||HGBA2|HEMOGLOBIN A2|||||||PIXELS/CM|||||||TRACE||NMOL/KG/DAY||||LOW|NOT DONE||||ALVEOLAR AIR|LACTESCENT|NA|NEURAMINIDASE INHIBITION ASSAY|FIBROSIS 4 FORMULA||N|U|NA|NA|||Y|2||58||BASELINE|1964-11-23|1970-08-20|||||1969-08-19||1960-07-30|Y|1962-08-02
TRIAL STUDY 134XCP|LB|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|1||||UNSPCE|UNSPECIFIED CELLS|||||||ABSORBANCE U/MIN|||||||INVALID||PIPE||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|LIPEMIC|N|AUDIOMETRY|GMI % FORMULA||Y|Y|Y|Y|||U|3||39||INDUCTION TREATMENT|1968-08-19|1966-11-28|||||1961-08-13||1961-07-15|N|1960-10-21
TRIAL STUDY 134XCP|LB|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|2||||MCVRETIC|MCV RETICULOCYTES|||||||TUBERCULIN UNIT/ML|||||||BORDERLINE||KPA||||LOW|NOT DONE||||COLOSTRUM|UNEXPECTED ODOR|U|PLAQUE REDUCTION NEUTRALIZATION ASSAY|CKD-EPI CREATININE FORMULA||N|Y|N|N|||Y|3||39||LONG-TERM FOLLOW-UP|1960-05-20|1968-04-14|||||1961-06-24||1971-04-25|U|1966-05-22
TRIAL STUDY 134XCP|LB|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|1||||C165892|WILD RYE POLLEN IGE ANTIBODY|||||||MG/L FEU|||||||INVALID||APPLICATION||||LOW|NOT DONE||||PROSTATIC FLUID|AUTOLYZED|U|MULTIPLE BREATH WASHOUT|CKD-EPI CYSTATIN C FORMULA||NA|NA|U|N|||U|4||88||LONG-TERM FOLLOW-UP|1970-09-09|1966-03-10|||||1969-09-15||1961-11-02|Y|1963-11-21
TRIAL STUDY 134XCP|LB|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|2||||FGF23C|FIBROBLAST GROWTH FACTOR 23, C-TERMINAL|||||||G/ANIMAL/DAY|||||||INDETERMINATE||PMOL/10^9 CELLS||||HIGH|NOT DONE||||PLATELET|HEMOLYZED|NA|ELECTRONEUROGRAPHY|FIBROSIS 4 FORMULA||U|N|NA|N|||NA|4||88||BASELINE|1973-08-23|1967-02-22|||||1960-02-21||1971-10-06|NA|1972-06-04
TRIAL STUDY 134XCP|LB|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|1||||LDH5|LDH ISOENZYME 5|||||||10^12 IU/L|||||||BORDERLINE||UG/KG/H||||ABNORMAL|NOT DONE||||SEBUM|NON-HEMOLYZED|N|CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|NA|NA|||NA|5||7||WASHOUT|1960-07-19|1968-11-11|||||1964-09-30||1966-03-03|Y|1968-05-07
TRIAL STUDY 134XCP|LB|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|2||||NDMTASE|N-DEMETHYLASE|||||||DAYS|||||||NEGATIVE||UKAT/L||||NORMAL|NOT DONE||||LOCHIA|LACTESCENT|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD 4 VARIABLE FORMULA||Y|U|N|U|||N|5||7||OBSERVATION|1971-02-13|1964-09-22|||||1965-09-06||1961-04-05|U|1960-10-12
TRIAL STUDY 134XCP|LB|D0AE2069-B430-4771-9A8C-0F5442DFCECE|1||||HDLPSZ|HDL PARTICLE SIZE|||||||U/G/MIN|||||||INVALID||CAL||||NORMAL|NOT DONE||||EMESIS|AUTOLYZED|NA|FUNCTIONAL MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|U|Y|||NA|1||38||CONTINUATION TREATMENT|1962-10-31|1965-04-12|||||1965-10-13||1971-03-16|NA|1961-07-21
TRIAL STUDY 134XCP|LB|D0AE2069-B430-4771-9A8C-0F5442DFCECE|2||||TIMP1|TISSUE INHIBITOR OF METALLOPROTEINASE 1|||||||CAPFUL|||||||INDETERMINATE||IMPLANT||||ABNORMAL|NOT DONE||||RETICULOCYTES|UNEXPECTED ODOR|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|HEPASCORE FORMULA||U|U|Y|Y|||N|1||38||CONTINUATION TREATMENT|1963-11-21|1971-07-30|||||1960-01-10||1969-10-04|NA|1972-10-26
TRIAL STUDY 134XCP|LB|D0AE2069-B430-4771-9A8C-0F5442DFCECE|1||||T3|TRIIODOTHYRONINE|||||||UIU/L|||||||INDETERMINATE||IMPLANT||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|CALCIFIED|NA|SCANNING ELECTRON MICROSCOPY|GMI % FORMULA||NA|N|U|N|||NA|2||58||INDUCTION TREATMENT|1968-06-02|1963-10-06|||||1963-05-29||1961-05-29|N|1960-08-05
TRIAL STUDY 134XCP|LB|D0AE2069-B430-4771-9A8C-0F5442DFCECE|2||||CALB|CALBINDIN|||||||KG/CM2|||||||INDETERMINATE||GTT||||LOW|NOT DONE||||EPITHELIAL CELL|AUTOLYZED|U|LIQUID SCINTILLATION COUNTING|MDRD 4 VARIABLE FORMULA||NA|NA|NA|NA|||U|2||58||CONTINUATION TREATMENT|1962-11-27|1961-03-25|||||1960-03-31||1963-07-05|N|1972-01-08
TRIAL STUDY 134XCP|LB|D0AE2069-B430-4771-9A8C-0F5442DFCECE|1||||IL2RB|INTERLEUKIN 2 RECEPTOR SUBUNIT BETA|||||||MG/ANIMAL|||||||TRACE||U/L||||NORMAL|NOT DONE||||LAVAGE FLUID|HEMOLYZED|U|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|GMI % FORMULA||U|N|NA|U|||N|3||39||OPEN LABEL TREATMENT|1960-03-11|1965-11-27|||||1969-01-13||1961-10-03|N|1963-01-14
TRIAL STUDY 134XCP|LB|D0AE2069-B430-4771-9A8C-0F5442DFCECE|2||||AMMONIA|AMMONIA|||||||G/ANIMAL/WK|||||||POSITIVE||CI/G||||ABNORMAL|NOT DONE||||SPERMATOZOON|ICTERIC|U|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA||NA|U|U|N|||U|3||39||WASHOUT|1968-05-30|1960-07-04|||||1969-01-17||1963-11-14|Y|1969-11-15
TRIAL STUDY 134XCP|LB|D0AE2069-B430-4771-9A8C-0F5442DFCECE|1||||MYBLALE|MYELOBLASTS/LEUKOCYTES|||||||USEC|||||||INVALID||CAL||||ABNORMAL|NOT DONE||||DISCHARGE|FRESH|U|WESTERN BLOT|MDRD 4 VARIABLE FORMULA||N|NA|U|N|||U|4||88||OPEN LABEL TREATMENT|1972-02-15|1964-12-11|||||1965-01-08||1970-08-31|N|1968-09-15
TRIAL STUDY 134XCP|LB|D0AE2069-B430-4771-9A8C-0F5442DFCECE|2||||TGFB|TRANSFORMING GROWTH FACTOR BETA|||||||L/H/M2|||||||INDETERMINATE||G/CAGE/DAY||||LOW|NOT DONE||||SERUM|DRIED|N|CHROMOGENIC ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|U|U|||U|4||88||CONTINUATION TREATMENT|1968-08-03|1961-01-29|||||1966-12-02||1973-01-14|Y|1964-12-17
TRIAL STUDY 134XCP|LB|D0AE2069-B430-4771-9A8C-0F5442DFCECE|1||||C147279|ZEA MAYS ANTIGEN IGE ANTIBODY|||||||KCAL|||||||INDETERMINATE||LINEAR FT*LB||||LOW|NOT DONE||||BONE MARROW|CONTAMINATED|N|FREEZING POINT DEPRESSION|MDRD 5 VARIABLE FORMULA||NA|U|N|N|||N|5||7||BLINDED TREATMENT|1964-07-24|1969-01-09|||||1960-09-17||1963-10-25|NA|1960-04-20
TRIAL STUDY 134XCP|LB|D0AE2069-B430-4771-9A8C-0F5442DFCECE|2||||NEUTBLE|NEUTROPHILS BAND FORM/LEUKOCYTES|||||||KG/CM|||||||INDETERMINATE||COPIES/UL||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|U|EIA|ASH FIBROSURE FORMULA||U|Y|Y|N|||Y|5||7||LONG-TERM FOLLOW-UP|1969-03-07|1965-01-27|||||1968-04-18||1967-10-07|N|1967-03-01
TRIAL STUDY 134XCP|LB|CF214007-AC24-4760-AEDE-F78CDE3D9351|1||||ASMACT|ALPHA-SMOOTH MUSCLE ACTIN|||||||GPS U|||||||NEGATIVE||UIU/L||||HIGH|NOT DONE||||BASAL TEAR|CONCENTRATED|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NASH FIBROSURE FORMULA||NA|N|Y|N|||N|1||38||FOLLOW-UP|1961-06-14|1969-03-27|||||1962-07-07||1964-05-18|NA|1972-04-01
TRIAL STUDY 134XCP|LB|CF214007-AC24-4760-AEDE-F78CDE3D9351|2||||C165895|JOHNSON GRASS POLLEN IGG4 ANTIBODY|||||||RNA COPIES/ML|||||||INDETERMINATE||UG/MOL||||ABNORMAL|NOT DONE||||CORD BLOOD|UNEXPECTED ODOR|U|MICRO BROTH DILUTION|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|U|NA|||N|1||38||SCREENING|1969-09-28|1960-10-26|||||1964-10-16||1964-12-25|Y|1960-08-15
TRIAL STUDY 134XCP|LB|CF214007-AC24-4760-AEDE-F78CDE3D9351|1||||CBS|CYSTATHIONINE BETA-SYNTHASE|||||||MPH|||||||INVALID||LOG10 COPIES/ML||||HIGH|NOT DONE||||NAIL|AGGLUTINATED|N|TRYPAN BLUE STAIN|COCKCROFT-GAULT FORMULA||N|N|NA|Y|||NA|2||58||INDUCTION TREATMENT|1960-05-17|1968-07-16|||||1965-06-21||1962-06-02|Y|1962-02-02
TRIAL STUDY 134XCP|LB|CF214007-AC24-4760-AEDE-F78CDE3D9351|2||||C165917|D. PTERONYSSINUS IGG AB RAST SCORE|||||||NG/DL|||||||INVALID||TRANSDUCING UNIT/ML||||ABNORMAL|NOT DONE||||BILE|FROZEN|N|SLOAN LETTER EYE CHART 1.25%|MDRD FORMULA||NA|N|Y|U|||N|2||58||INDUCTION TREATMENT|1969-07-30|1970-12-31|||||1968-11-05||1965-06-06|U|1968-06-03
TRIAL STUDY 134XCP|LB|CF214007-AC24-4760-AEDE-F78CDE3D9351|1||||APTT|ACTIVATED PARTIAL THROMBOPLASTIN TIME|||||||EVENTS|||||||BORDERLINE||UM/S||||NORMAL|NOT DONE||||SKIN TISSUE|CONTAMINATED|U|COMPLEMENT FIXATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|NA|Y|||U|3||39||WASHOUT|1960-02-17|1968-03-06|||||1964-11-11||1971-10-23|NA|1970-07-28
TRIAL STUDY 134XCP|LB|CF214007-AC24-4760-AEDE-F78CDE3D9351|2||||INTLK4|INTERLEUKIN 4|||||||EIA UNIT|||||||BORDERLINE||NM||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|PARAFFIN-EMBEDDED|NA|FORCED OSCILLATION TECHNIQUE|MDRD FORMULA||Y|U|N|N|||Y|3||39||RUN-IN|1973-08-03|1969-04-12|||||1968-08-21||1973-03-28|U|1962-01-24
TRIAL STUDY 134XCP|LB|CF214007-AC24-4760-AEDE-F78CDE3D9351|1||||PRORUB|PRORUBRICYTE|||||||NMOL/L/MIN|||||||TRACE||USIEMENS||||LOW|NOT DONE||||URINE SEDIMENT|GELLED|NA|FLUORESCENT MICROSCOPY|GMI % FORMULA||U|Y|NA|Y|||N|4||88||CONTINUATION TREATMENT|1964-09-17|1965-11-23|||||1964-02-06||1968-08-30|Y|1961-12-01
TRIAL STUDY 134XCP|LB|CF214007-AC24-4760-AEDE-F78CDE3D9351|2||||C5|COMPLEMENT C5|||||||ELISA UNIT/ML|||||||POSITIVE||PNU/ML||||ABNORMAL|NOT DONE||||CORD SERUM|GELLED|N|TELLER ACUITY CARDS|GMI MMOL/MOL FORMULA||U|U|U|N|||NA|4||88||LONG-TERM FOLLOW-UP|1971-11-30|1973-01-11|||||1971-11-09||1972-12-01|N|1966-12-11
TRIAL STUDY 134XCP|LB|CF214007-AC24-4760-AEDE-F78CDE3D9351|1||||ERCEMIDX|ERYTHROID MATURATION INDEX|||||||GRAIN|||||||TRACE||ML/CM3/MIN||||ABNORMAL|NOT DONE||||EMESIS|AGGLUTINATED|U|WEBER GREEN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|N|NA|||NA|5||7||LONG-TERM FOLLOW-UP|1972-08-19|1964-12-24|||||1967-05-11||1968-04-04|Y|1961-05-01
TRIAL STUDY 134XCP|LB|CF214007-AC24-4760-AEDE-F78CDE3D9351|2||||THBD|THROMBOMODULIN|||||||LM|||||||POSITIVE||G/KG/DAY||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|UNEXPECTED ODOR|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|FIBROSIS 4 FORMULA||N|U|Y|Y|||U|5||7||WASHOUT|1969-02-11|1963-04-28|||||1962-03-07||1962-04-27|Y|1969-07-28
TRIAL STUDY 134XCP|LB|E996BE19-2824-49D3-944F-B777F3D8E746|1||||LTB4|LEUKOTRIENE B4|||||||G/CM2|||||||NEGATIVE||MG/M2/MIN||||ABNORMAL|NOT DONE||||SKIN TISSUE|CONTAMINATED|N|TRANSVAGINAL ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|NA|Y|||N|1||38||BLINDED TREATMENT|1961-07-13|1967-03-08|||||1965-08-15||1971-09-16|NA|1969-02-02
TRIAL STUDY 134XCP|LB|E996BE19-2824-49D3-944F-B777F3D8E746|2||||IFI27|INTERFERON ALPHA-INDUCIBLE PROTEIN 27|||||||10^6/HPF|||||||INDETERMINATE||ROENTGEN||||ABNORMAL|NOT DONE||||DISCHARGE|CALCIFIED|N|PALPATION|COCKCROFT-GAULT FORMULA||NA|N|Y|NA|||NA|1||38||OPEN LABEL TREATMENT|1961-01-06|1961-07-19|||||1963-06-15||1973-05-21|U|1973-05-01
TRIAL STUDY 134XCP|LB|E996BE19-2824-49D3-944F-B777F3D8E746|1||||PHENYTN|PHENYTOIN|||||||UMOL|||||||TRACE||NL||||NORMAL|NOT DONE||||ISOLATE|THAWED|U|CAPILLARY ELECTROPHORESIS|NASH FIBROSURE FORMULA||NA|N|Y|U|||Y|2||58||INDUCTION TREATMENT|1963-03-17|1971-01-15|||||1961-04-25||1961-02-17|U|1964-01-31
TRIAL STUDY 134XCP|LB|E996BE19-2824-49D3-944F-B777F3D8E746|2||||ALP|ALKALINE PHOSPHATASE|||||||G|||||||BORDERLINE||ELISA UNIT/ML||||LOW|NOT DONE||||BILE|AGGLUTINATED|Y|HPLC/MS|FIBROTEST FORMULA||N|NA|Y|N|||N|2||58||LONG-TERM FOLLOW-UP|1961-05-16|1963-10-17|||||1970-01-22||1965-11-16|NA|1961-04-01
TRIAL STUDY 134XCP|LB|E996BE19-2824-49D3-944F-B777F3D8E746|1||||HYPRLN|HYDROXYPROLINE|||||||/2000 RBC|||||||BORDERLINE||VIAL||||HIGH|NOT DONE||||PUS|CONCENTRATED|U|GEL ELECTROPHORESIS|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|Y|||N|3||39||RUN-IN|1973-04-20|1961-11-10|||||1963-02-22||1965-07-20|NA|1971-09-19
TRIAL STUDY 134XCP|LB|E996BE19-2824-49D3-944F-B777F3D8E746|2||||EOSMM|EOSINOPHILIC METAMYELOCYTES|||||||MNFI|||||||POSITIVE||UEQ/L||||NORMAL|NOT DONE||||VENOUS BLOOD|LIPEMIC|Y|ANTIBIOTIC AGAR SCREEN|COCKCROFT-GAULT FORMULA||U|NA|U|N|||NA|3||39||RUN-IN|1964-01-17|1966-03-20|||||1972-07-16||1962-11-06|U|1965-07-13
TRIAL STUDY 134XCP|LB|E996BE19-2824-49D3-944F-B777F3D8E746|1||||CLEXR|CHLORIDE EXCRETION RATE|||||||/DAY|||||||TRACE||UG/KG/H||||LOW|NOT DONE||||ALVEOLAR AIR|GELLED|Y|AGAR PROPORTION|COCKCROFT-GAULT FORMULA||NA|U|Y|U|||NA|4||88||RUN-IN|1964-10-17|1970-10-06|||||1965-04-27||1962-10-08|NA|1964-10-07
TRIAL STUDY 134XCP|LB|E996BE19-2824-49D3-944F-B777F3D8E746|2||||HLADRB1|HLA DR BETA1 ANTIGEN|||||||OI50|||||||INDETERMINATE||ML/G/MIN||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|FROZEN|Y|PHYSICAL EXAMINATION|MDRD FORMULA||NA|NA|NA|N|||U|4||88||SCREENING|1971-04-28|1961-09-14|||||1963-12-20||1963-04-01|U|1965-12-24
TRIAL STUDY 134XCP|LB|E996BE19-2824-49D3-944F-B777F3D8E746|1||||GLUCWBE|WHOLE BLOOD EQUIVALENT GLUCOSE|||||||10^9 ORGANISMS/G|||||||INVALID||UKAT||||HIGH|NOT DONE||||HAIR|CALCIFIED|N|KINETIC CHROMOGENIC ASSAY|FIBROMETER FORMULA||NA|U|NA|N|||Y|5||7||INDUCTION TREATMENT|1960-08-31|1964-02-20|||||1967-05-28||1973-06-20|NA|1972-10-23
TRIAL STUDY 134XCP|LB|E996BE19-2824-49D3-944F-B777F3D8E746|2||||ALPRZLM|ALPRAZOLAM|||||||AFU|||||||TRACE||/H||||LOW|NOT DONE||||CORD SERUM|HEMOLYZED|Y|PHOTOMETRIC CLOT DETECTION|ASH FIBROSURE FORMULA||Y|N|NA|NA|||Y|5||7||BLINDED TREATMENT|1970-07-18|1970-07-29|||||1971-01-10||1963-08-05|N|1963-04-23
TRIAL STUDY 134XCP|LB|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|1||||C147285|COMMON RAGWEED POLLEN IGE ANTIBODY|||||||JAR|||||||INVALID||UMOL/KG/MIN||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED|U|ANALYTICAL ULTRACENTRIFUGATION|MDRD 5 VARIABLE FORMULA||Y|U|N|U|||Y|1||38||OBSERVATION|1964-04-24|1960-04-24|||||1969-03-18||1964-07-07|U|1967-10-22
TRIAL STUDY 134XCP|LB|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|2||||ERCEMIDX|ERYTHROID MATURATION INDEX|||||||DPM/0.5 ML|||||||TRACE||CI/MG||||ABNORMAL|NOT DONE||||DERMAL TISSUE|CONCENTRATED|NA|PHOTOMETRIC CLOT DETECTION|GMI MMOL/MOL FORMULA||U|Y|Y|U|||U|1||38||LONG-TERM FOLLOW-UP|1960-12-26|1969-08-28|||||1960-08-26||1969-03-27|NA|1971-01-03
TRIAL STUDY 134XCP|LB|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|1||||ELA2|NEUTROPHIL ELASTASE|||||||PMOL/L/H|||||||BORDERLINE||CAN||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|AUTOLYZED|U|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD 5 VARIABLE FORMULA||N|Y|N|NA|||NA|2||58||BLINDED TREATMENT|1965-08-20|1967-01-27|||||1973-05-16||1968-03-05|NA|1960-10-31
TRIAL STUDY 134XCP|LB|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|2||||EPIN|EPINEPHRINE|||||||U/M2/DAY|||||||TRACE||ML/H||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|REFRIGERATED|Y|WEBER GREEN STAIN|CKD-EPI CREATININE FORMULA||NA|N|Y|U|||N|2||58||BLINDED TREATMENT|1962-09-29|1963-10-18|||||1962-02-12||1969-08-01|U|1963-01-12
TRIAL STUDY 134XCP|LB|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|1||||TRACP5B|TARTRATE-RESISTANT ACID PHOSPHATASE 5B|||||||BQ/G|||||||POSITIVE||TUBERCULIN UNIT/ML||||NORMAL|NOT DONE||||ISOLATE|ROOM TEMPERATURE|N|SLOAN LETTER EYE CHART 100%|GMI MMOL/MOL FORMULA||U|Y|Y|U|||U|3||39||OBSERVATION|1971-09-30|1965-08-23|||||1966-05-13||1961-06-07|NA|1967-06-07
TRIAL STUDY 134XCP|LB|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|2||||T4|THYROXINE|||||||RING|||||||TRACE||G/CAGE||||HIGH|NOT DONE||||DIALYSIS FLUID|HEMOLYZED|NA|CARDIAC THERMODILUTION|FIBROSIS 4 FORMULA||N|Y|NA|U|||N|3||39||WASHOUT|1960-06-05|1969-10-18|||||1969-01-31||1963-07-04|Y|1965-03-22
TRIAL STUDY 134XCP|LB|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|1||||CCPIGGAB|CYCLIC CITRULLINATED PEPTIDE IGG AB|||||||G/MOL|||||||NEGATIVE||GY/H||||ABNORMAL|NOT DONE||||LOCHIA|DRIED|N|AURAMINE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|U|U|||N|4||88||FOLLOW-UP|1968-04-28|1965-06-06|||||1967-03-16||1969-11-27|N|1961-10-26
TRIAL STUDY 134XCP|LB|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|2||||C130068|BERMUDA GRASS POLLEN IGE|||||||ML/(MIN*100ML)|||||||INVALID||GBQ/UG||||LOW|NOT DONE||||BUFFY COAT|FROZEN|NA|DIFFUSION TENSOR MRI|NASH FIBROSURE FORMULA||NA|U|N|NA|||Y|4||88||INDUCTION TREATMENT|1961-05-19|1964-05-22|||||1962-11-07||1972-01-29|N|1972-08-22
TRIAL STUDY 134XCP|LB|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|1||||CCL8|CHEMOKINE (C-C MOTIF) LIGAND 8|||||||CY/CM|||||||INVALID||STRIP||||HIGH|NOT DONE||||ADIPOSE TISSUE|CALCIFIED|N|ACID FAST STAIN|MDRD 5 VARIABLE FORMULA||Y|U|NA|N|||N|5||7||TREATMENT|1966-06-11|1960-12-16|||||1972-09-13||1970-06-30|NA|1970-03-09
TRIAL STUDY 134XCP|LB|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|2||||HCT|HEMATOCRIT|||||||COPIES/UL|||||||TRACE||STRIP||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|CONCENTRATED|N|IRON HEMATOXYLIN STAIN|NASH FIBROSURE FORMULA||N|NA|Y|NA|||Y|5||7||OPEN LABEL TREATMENT|1960-07-21|1965-12-02|||||1960-04-07||1961-07-05|N|1967-10-04
TRIAL STUDY 134XCP|LB|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|1||||RF|RHEUMATOID FACTOR|||||||MS2|||||||BORDERLINE||UMOL/L||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|DRIED|U|MALDI-TOF|CKD-EPI CYSTATIN C FORMULA||Y|N|U|N|||N|1||38||WASHOUT|1971-12-13|1964-06-26|||||1964-12-08||1961-11-02|Y|1967-04-28
TRIAL STUDY 134XCP|LB|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|2||||MAYHEG|MAY-HEGGLIN ANOMALY|||||||10^9/G|||||||INDETERMINATE||MG/DAY||||NORMAL|NOT DONE||||SPERMATOZOON|CONCENTRATED|Y|MAMMOGRAPHY|GMI % FORMULA||Y|U|NA|N|||NA|1||38||WASHOUT|1972-10-29|1961-09-23|||||1963-02-03||1966-11-29|Y|1966-11-30
TRIAL STUDY 134XCP|LB|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|1||||CSBACT|BACTERIAL CASTS|||||||MMHG/L/MIN|||||||POSITIVE||HR/DAY||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|AUTOLYZED|NA|ZIEHL NEELSEN ACID FAST STAIN|GMI MMOL/MOL FORMULA||NA|U|U|N|||N|2||58||RUN-IN|1971-05-26|1971-03-05|||||1967-11-18||1961-06-27|N|1968-05-11
TRIAL STUDY 134XCP|LB|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|2||||HISTAB|HISTONE ANTIBODIES|||||||TBSP|||||||INVALID||G/CAGE||||ABNORMAL|NOT DONE||||HAIR|REFRIGERATED|NA|MULTIPLE BREATH WASHOUT|GMI % FORMULA||Y|Y|NA|N|||Y|2||58||BASELINE|1961-11-14|1963-06-23|||||1962-03-19||1970-07-16|Y|1971-01-13
TRIAL STUDY 134XCP|LB|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|1||||PLSPCE|PRECURSOR PLASMA CELLS|||||||VIRTUAL PIXEL|||||||INDETERMINATE||GTT||||HIGH|NOT DONE||||TUMOR TISSUE|CONCENTRATED|NA|FREEZING POINT DEPRESSION|HEPASCORE FORMULA||Y|NA|Y|Y|||Y|3||39||OBSERVATION|1963-12-04|1970-10-20|||||1968-04-07||1962-02-03|U|1970-08-12
TRIAL STUDY 134XCP|LB|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|2||||NTRLFAT|NEUTRAL FATS|||||||M2|||||||TRACE||FMOL/L||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|PARAFFIN-EMBEDDED|NA|FLUORESCENT SPOT TEST|MDRD FORMULA||NA|N|N|N|||N|3||39||OBSERVATION|1963-11-14|1962-12-19|||||1969-10-10||1968-03-23|N|1971-07-16
TRIAL STUDY 134XCP|LB|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|1||||C4D|COMPLEMENT C4D|||||||GRAVITATIONAL UNIT|||||||INDETERMINATE||BQ/UL||||LOW|NOT DONE||||SUPERNATANT, SERUM|ICTERIC|U|CYSTOSCOPY|CKD-EPI CREATININE FORMULA||U|Y|NA|NA|||NA|4||88||OBSERVATION|1960-01-30|1964-04-19|||||1961-04-18||1962-03-31|NA|1965-10-22
TRIAL STUDY 134XCP|LB|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|2||||EPISQCE|SQUAMOUS EPITHELIAL CELLS|||||||L/S/KPA|||||||INDETERMINATE||ABSORBANCE U/MIN||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|GELLED|U|POPULATION SEQUENCING|MDRD 5 VARIABLE FORMULA||U|U|Y|U|||N|4||88||SCREENING|1968-11-06|1971-04-12|||||1962-03-18||1972-06-23|Y|1964-05-19
TRIAL STUDY 134XCP|LB|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|1||||PTSAAC|PROTEIN S ACTIVITY ACTUAL/CONTROL|||||||MBQ/UL|||||||TRACE||U/MG||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CONCENTRATED|N|PHYSICAL EXAMINATION|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|NA|N|||Y|5||7||BLINDED TREATMENT|1962-07-16|1965-11-12|||||1969-06-21||1964-03-14|U|1960-12-02
TRIAL STUDY 134XCP|LB|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|2||||MYBLAT3|TYPE III MYELOBLASTS|||||||FIU|||||||BORDERLINE||SPRAY||||HIGH|NOT DONE||||SPERMATOZOON|FRESH|NA|FUNDUS PHOTOGRAPHY|FIBROTEST FORMULA||Y|U|NA|U|||N|5||7||LONG-TERM FOLLOW-UP|1966-05-29|1969-09-22|||||1960-03-23||1973-04-24|U|1963-09-29
TRIAL STUDY 134XCP|LB|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|1||||NEUTLE|NEUTROPHILS/LEUKOCYTES|||||||G/KG|||||||INVALID||CI/L||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|UNEXPECTED ODOR|Y|FLUORIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|Y|N|||NA|1||38||SCREENING|1965-08-26|1969-06-21|||||1969-07-08||1962-03-02|Y|1960-04-29
TRIAL STUDY 134XCP|LB|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|2||||C165897|BERMUDA GRASS POLLEN IGG AB RAST SCORE|||||||MCI/KG|||||||INVALID||RATIO||||HIGH|NOT DONE||||ALVEOLAR AIR|LACTESCENT|NA|HEMOCYTOMETRY|FIBROTEST FORMULA||NA|N|NA|N|||N|1||38||OBSERVATION|1965-11-08|1963-12-25|||||1961-06-09||1966-07-27|N|1963-02-22
TRIAL STUDY 134XCP|LB|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|1||||RBCMORPH|ERYTHROCYTE CELL MORPHOLOGY|||||||FG|||||||INVALID||PNU/ML||||LOW|NOT DONE||||PERSPIRATION|UNEXPECTED ODOR|Y|LAPAROSCOPY|MDRD 5 VARIABLE FORMULA||Y|Y|U|N|||U|2||58||BASELINE|1967-06-16|1963-03-21|||||1963-08-26||1961-10-31|U|1964-07-27
TRIAL STUDY 134XCP|LB|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|2||||HCG|CHORIOGONADOTROPIN BETA|||||||S/H|||||||NEGATIVE||OD UNIT||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|PARAFFIN-EMBEDDED|N|SPIRAL CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC FORMULA||U|NA|N|NA|||Y|2||58||BASELINE|1965-06-01|1968-04-06|||||1965-01-09||1970-09-28|NA|1972-05-04
TRIAL STUDY 134XCP|LB|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|1||||CHOLOH4B|4-BETA-HYDROXYCHOLESTEROL|||||||G/G/DAY|||||||NEGATIVE||G/CAGE||||NORMAL|NOT DONE||||SOFT TISSUE|ICTERIC|NA|THICK SMEAR|CKD-EPI FORMULA||U|U|NA|N|||U|3||39||WASHOUT|1960-01-14|1970-02-06|||||1963-03-10||1969-11-08|U|1971-11-15
TRIAL STUDY 134XCP|LB|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|2||||IGG3|IMMUNOGLOBULIN G SUBCLASS 3|||||||10^6 U|||||||INVALID||CMOL/L||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|LIPEMIC|Y|NEXT GENERATION SEQUENCING|FIBROSIS 4 FORMULA||NA|N|NA|N|||N|3||39||TREATMENT|1970-07-13|1971-07-20|||||1960-06-13||1968-03-03|Y|1963-10-13
TRIAL STUDY 134XCP|LB|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|1||||CITCREAT|CITRATE/CREATININE|||||||IU/L|||||||INVALID||10^6/G||||LOW|NOT DONE||||LAVAGE FLUID|PARAFFIN-EMBEDDED|U|HIGH RESOLUTION CT|GMI MMOL/MOL FORMULA||N|Y|N|N|||NA|4||88||SCREENING|1963-07-16|1973-03-08|||||1963-01-25||1970-09-17|Y|1970-11-05
TRIAL STUDY 134XCP|LB|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|2||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||IU|||||||POSITIVE||BEL||||LOW|NOT DONE||||BASAL TEAR|THAWED|NA|MALDI-TOF|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|Y|N|||U|4||88||RUN-IN|1970-09-10|1972-06-03|||||1961-11-08||1965-09-10|U|1966-01-31
TRIAL STUDY 134XCP|LB|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|1||||BLYCECE|B-LYMPHOCYTES/TOTAL CELLS|||||||BOTTLE|||||||NEGATIVE||% INHIBITION||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|CONTAMINATED|N|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD ENZYMATIC FORMULA||Y|U|Y|NA|||N|5||7||BLINDED TREATMENT|1973-01-24|1965-03-22|||||1971-10-18||1968-01-22|NA|1973-06-13
TRIAL STUDY 134XCP|LB|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|2||||C165914|CAT DANDER IGG AB RAST SCORE|||||||L/S|||||||INDETERMINATE||FIU||||HIGH|NOT DONE||||GASTRIC FLUID|UNEXPECTED ODOR|U|KLEIHAUER-BETKE|MDRD FORMULA||Y|U|N|Y|||Y|5||7||SCREENING|1960-02-08|1965-01-18|||||1972-11-12||1968-08-08|Y|1969-06-25
TRIAL STUDY 134XCP|LB|1F75D53C-E8AA-45DA-8410-F00266080E80|1||||TLCHT|TAUROLITHOCHOLATE|||||||MG/KG/DOSE|||||||INVALID||10^6/EJACULATE U||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|LIPEMIC|U|PALPATION|ASH FIBROSURE FORMULA||NA|Y|U|Y|||Y|1||38||BASELINE|1961-12-17|1962-08-01|||||1961-09-06||1969-04-24|N|1969-09-03
TRIAL STUDY 134XCP|LB|1F75D53C-E8AA-45DA-8410-F00266080E80|2||||RBPCREAT|RETINOL BINDING PROTEIN/CREATININE|||||||BAG|||||||POSITIVE||UL/DOSE||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|LACTESCENT|U|TRIPLE-PHASE SPIRAL CT SCAN|GMI MMOL/MOL FORMULA||N|Y|NA|N|||U|1||38||CONTINUATION TREATMENT|1967-04-03|1965-06-11|||||1962-04-26||1971-01-20|U|1963-06-07
TRIAL STUDY 134XCP|LB|1F75D53C-E8AA-45DA-8410-F00266080E80|1||||KLCLLC|KAPPA LIGHT CHAIN/LAMBDA LIGHT CHAIN|||||||P|||||||TRACE||MMOL/DAY||||ABNORMAL|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|NA|DARK FIELD MICROSCOPY|CKD-EPI FORMULA||U|Y|N|N|||U|2||58||INDUCTION TREATMENT|1966-06-07|1966-03-03|||||1963-01-31||1962-08-09|N|1964-05-01
TRIAL STUDY 134XCP|LB|1F75D53C-E8AA-45DA-8410-F00266080E80|2||||MONOMA|MONOCYTES/MACROCYTES|||||||MM2|||||||INDETERMINATE||EQ||||NORMAL|NOT DONE||||URINE|DRIED|N|CT SCAN WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA||NA|Y|N|NA|||Y|2||58||RUN-IN|1968-09-14|1963-09-30|||||1964-05-12||1965-02-24|N|1964-01-17
TRIAL STUDY 134XCP|LB|1F75D53C-E8AA-45DA-8410-F00266080E80|1||||PSIGGAB|PHOSPHATIDYLSERINE IGG ANTIBODY|||||||ML/KG/MIN|||||||INVALID||TORR||||HIGH|NOT DONE||||ALVEOLAR AIR|NON-HEMOLYZED|NA|HPLC|MDRD FORMULA||NA|N|N|U|||Y|3||39||BASELINE|1972-06-12|1966-11-02|||||1972-03-16||1960-05-17|N|1961-06-09
TRIAL STUDY 134XCP|LB|1F75D53C-E8AA-45DA-8410-F00266080E80|2||||TXB2|THROMBOXANE B2|||||||ROENTGEN|||||||INDETERMINATE||IU/DL||||NORMAL|NOT DONE||||HAIR|GELLED|U|TRYPAN BLUE STAIN|FIBROMETER FORMULA||NA|U|NA|N|||N|3||39||OBSERVATION|1970-02-24|1968-02-19|||||1971-10-28||1971-02-16|NA|1971-02-09
TRIAL STUDY 134XCP|LB|1F75D53C-E8AA-45DA-8410-F00266080E80|1||||B2G1GMAB|BETA-2 GLYCOPROTEIN 1 IGM ANTIBODY|||||||CMH2O*S/ML|||||||TRACE||CI/MG||||HIGH|NOT DONE||||INTERSTITIAL FLUID|UNEXPECTED ODOR|Y|REBOUND TONOMETRY|MDRD ENZYMATIC FORMULA||U|Y|Y|Y|||NA|4||88||LONG-TERM FOLLOW-UP|1964-09-27|1971-07-30|||||1969-02-20||1968-01-28|Y|1971-04-20
TRIAL STUDY 134XCP|LB|1F75D53C-E8AA-45DA-8410-F00266080E80|2||||LGLUCLE|LARGE UNSTAINED CELLS/LEUKOCYTES|||||||MMOL2/L2|||||||TRACE||CAL||||ABNORMAL|NOT DONE||||RETICULOCYTES|SOLIDIFIED|NA|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||NA|Y|Y|NA|||N|4||88||SCREENING|1964-03-27|1963-12-15|||||1960-03-25||1968-06-29|Y|1966-04-19
TRIAL STUDY 134XCP|LB|1F75D53C-E8AA-45DA-8410-F00266080E80|1||||PHENTHZ|PHENOTHIAZINE|||||||NMOL/L|||||||BORDERLINE||LOG10 CFU/G||||NORMAL|NOT DONE||||LYMPH|CLOTTED|NA|ENDOSCOPY|CKD-EPI CREATININE FORMULA||U|U|U|U|||N|5||7||RUN-IN|1966-01-03|1966-08-31|||||1960-09-20||1967-12-08|NA|1973-02-08
TRIAL STUDY 134XCP|LB|1F75D53C-E8AA-45DA-8410-F00266080E80|2||||HYALUAC|HYALURONIC ACID|||||||MIN|||||||BORDERLINE||PG||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|CLOTTED|Y|INDIA INK STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|U|N|||N|5||7||BLINDED TREATMENT|1971-05-17|1969-10-02|||||1960-06-28||1966-12-18|NA|1965-07-12
TRIAL STUDY 134XCP|LB|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|1||||ALPRZLM|ALPRAZOLAM|||||||10^6 ORGANISMS/MG|||||||INVALID||GBQ/G||||NORMAL|NOT DONE||||VENOUS BLOOD|CALCIFIED|NA|WESTERN BLOT|HEPASCORE FORMULA||Y|N|NA|N|||Y|1||38||FOLLOW-UP|1973-05-17|1965-03-16|||||1962-09-01||1964-07-17|Y|1962-03-05
TRIAL STUDY 134XCP|LB|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|2||||KERAT|KERATOCYTE|||||||UG/H|||||||POSITIVE||L/L||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|FROZEN|N|CLIP SEQUENCING|MDRD 4 VARIABLE FORMULA||Y|U|N|U|||N|1||38||SCREENING|1962-08-22|1961-05-10|||||1966-04-23||1970-05-11|U|1968-01-05
TRIAL STUDY 134XCP|LB|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|1||||CBANH9|CARBONIC ANHYDRASE 9|||||||ML*CMH2O|||||||BORDERLINE||GPELISA UNIT/ML||||NORMAL|NOT DONE||||EXPIRED AIR|FRESH|U|ANGIOGRAPHY|FIBROMETER FORMULA||U|NA|U|NA|||NA|2||58||BASELINE|1966-02-10|1967-07-08|||||1969-05-10||1965-03-30|N|1962-05-26
TRIAL STUDY 134XCP|LB|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|2||||ASTAG|ASPARTATE AMINOTRANSFERASE ANTIGEN|||||||HOURS|||||||NEGATIVE||MG/G/H||||ABNORMAL|NOT DONE||||SMEGMA|LIPEMIC|NA|MIGET|MDRD FORMULA||Y|U|NA|NA|||U|2||58||BASELINE|1960-12-24|1966-07-21|||||1960-04-03||1960-01-23|N|1962-02-03
TRIAL STUDY 134XCP|LB|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|1||||VTRNCTN|VITRONECTIN|||||||H*%|||||||NEGATIVE||GY||||NORMAL|NOT DONE||||URINE|AGGLUTINATED|U|MICRONEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA||N|U|U|NA|||NA|3||39||INDUCTION TREATMENT|1972-08-08|1961-05-23|||||1962-07-01||1962-07-16|NA|1962-11-10
TRIAL STUDY 134XCP|LB|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|2||||ERCEPIDX|ERYTHROID PROLIFERATION INDEX|||||||CGY|||||||TRACE||MOL||||LOW|NOT DONE||||VENOUS PLASMA|REFRIGERATED|NA|PANENDOSCOPY|MDRD 4 VARIABLE FORMULA||NA|Y|Y|U|||Y|3||39||SCREENING|1971-01-29|1972-12-28|||||1972-09-05||1969-09-04|N|1964-02-24
TRIAL STUDY 134XCP|LB|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|1||||BLSTLMLY|LEUKEMIC BLASTS/LYMPHOCYTES|||||||CYCLE/MIN|||||||TRACE||/2000 RBC||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|SOLIDIFIED|NA|GC/MS-EI|MDRD 5 VARIABLE FORMULA||N|N|NA|NA|||N|4||88||INDUCTION TREATMENT|1972-10-04|1969-10-23|||||1970-04-10||1961-10-27|U|1967-07-02
TRIAL STUDY 134XCP|LB|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|2||||RF|RHEUMATOID FACTOR|||||||MMOL/MOL|||||||POSITIVE||MG/ANIMAL||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|GELLED|N|SMEAR|COCKCROFT-GAULT FORMULA||N|N|Y|N|||N|4||88||TREATMENT|1961-10-24|1964-06-14|||||1962-06-14||1969-10-03|NA|1963-07-22
TRIAL STUDY 134XCP|LB|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|1||||IL1RL1|INTERLEUKIN 1 RECEPTOR-LIKE 1|||||||S^-1(%O2)^-1|||||||INDETERMINATE||PMOL||||LOW|NOT DONE||||BONE|CONCENTRATED|N|HPLC/MS|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|Y|U|||U|5||7||LONG-TERM FOLLOW-UP|1964-08-26|1969-08-27|||||1970-04-10||1966-10-27|Y|1971-07-11
TRIAL STUDY 134XCP|LB|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|2||||TPAAG|TISSUE PLASMINOGEN ACTIVATOR ANTIGEN|||||||ELISA UNIT|||||||INVALID||ML/BEAT||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|FROZEN|Y|IHC|HEPASCORE FORMULA||U|N|N|N|||NA|5||7||TREATMENT|1970-12-18|1968-08-26|||||1967-10-25||1960-06-16|Y|1962-02-08
TRIAL STUDY 134XCP|LB|EE14E53E-19A8-4441-BF82-31444CBC8B49|1||||ABNCELE|ABNORMAL CELLS/LEUKOCYTES|||||||/500 WBC|||||||INDETERMINATE||MG/MOL||||HIGH|NOT DONE||||SEMINAL FLUID|UNEXPECTED ODOR|U|SCANNING ELECTRON MICROSCOPY|CKD-EPI CREATININE FORMULA||N|NA|N|Y|||NA|1||38||INDUCTION TREATMENT|1962-03-30|1967-07-27|||||1963-08-04||1972-06-22|Y|1961-12-14
TRIAL STUDY 134XCP|LB|EE14E53E-19A8-4441-BF82-31444CBC8B49|2||||MEPRDN|MEPERIDINE|||||||ML/KG|||||||POSITIVE||G/L||||NORMAL|NOT DONE||||PROSTATIC FLUID|DRIED|N|SLIT LAMP|GMI MMOL/MOL FORMULA||Y|Y|U|N|||U|1||38||RUN-IN|1963-12-06|1960-02-01|||||1967-05-04||1961-07-11|N|1970-03-22
TRIAL STUDY 134XCP|LB|EE14E53E-19A8-4441-BF82-31444CBC8B49|1||||APOA4|APOLIPOPROTEIN A4|||||||UEQ/L|||||||INDETERMINATE||MG/ANIMAL||||NORMAL|NOT DONE||||SPUTUM|ICTERIC|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA||Y|NA|Y|NA|||NA|2||58||OBSERVATION|1968-07-13|1965-11-12|||||1973-07-20||1971-11-08|N|1960-04-21
TRIAL STUDY 134XCP|LB|EE14E53E-19A8-4441-BF82-31444CBC8B49|2||||C130104|GRASS MIX POLLEN ANTIGEN IGG ANTIBODY|||||||MIN/DAY|||||||INVALID||AMPULE||||LOW|NOT DONE||||LYSATE|THAWED|NA|ELASTOGRAPHY|HEPASCORE FORMULA||U|Y|U|NA|||NA|2||58||LONG-TERM FOLLOW-UP|1969-10-03|1961-12-15|||||1962-07-06||1967-11-25|NA|1962-10-09
TRIAL STUDY 134XCP|LB|EE14E53E-19A8-4441-BF82-31444CBC8B49|1||||IGGCREAT|IMMUNOGLOBULIN G/CREATININE|||||||L/DAY|||||||POSITIVE||YD||||HIGH|NOT DONE||||VENOUS BLOOD|ICTERIC|N|IMMUNE REPERTOIRE DEEP SEQUENCING|COCKCROFT-GAULT FORMULA||NA|NA|Y|U|||Y|3||39||FOLLOW-UP|1962-02-07|1971-09-01|||||1962-03-07||1962-04-15|N|1972-07-20
TRIAL STUDY 134XCP|LB|EE14E53E-19A8-4441-BF82-31444CBC8B49|2||||C130074|BIRCH POLLEN IGG|||||||10^10/L|||||||TRACE||PFU||||ABNORMAL|NOT DONE||||SPUTUM|REFRIGERATED|U|TRIPLE-PHASE SPIRAL CT SCAN|NASH FIBROSURE FORMULA||N|U|Y|Y|||NA|3||39||FOLLOW-UP|1970-10-20|1972-12-30|||||1969-12-31||1970-01-02|NA|1970-12-30
TRIAL STUDY 134XCP|LB|EE14E53E-19A8-4441-BF82-31444CBC8B49|1||||COCAETH|COCAETHYLENE|||||||GPELISA UNIT/ML|||||||POSITIVE||GPS U||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|THAWED|NA|CORONARY ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|NA|Y|U|||U|4||88||WASHOUT|1964-11-24|1964-09-08|||||1968-05-12||1963-12-21|NA|1963-05-12
TRIAL STUDY 134XCP|LB|EE14E53E-19A8-4441-BF82-31444CBC8B49|2||||HYALUAC|HYALURONIC ACID|||||||UL/ML|||||||TRACE||CIGAR||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|PARAFFIN-EMBEDDED|U|ORCHIDOMETERY|GMI % FORMULA||U|NA|Y|Y|||U|4||88||INDUCTION TREATMENT|1972-05-29|1964-07-06|||||1969-06-09||1968-06-28|Y|1967-02-22
TRIAL STUDY 134XCP|LB|EE14E53E-19A8-4441-BF82-31444CBC8B49|1||||HEINZRBC|HEINZ BODIES/ERYTHROCYTES|||||||KV|||||||BORDERLINE||MPL U||||HIGH|NOT DONE||||EXPIRED AIR|CONTAMINATED|Y|MAPH|ASH FIBROSURE FORMULA||N|U|Y|NA|||U|5||7||LONG-TERM FOLLOW-UP|1969-01-15|1969-06-08|||||1972-12-19||1961-06-30|U|1961-08-30
TRIAL STUDY 134XCP|LB|EE14E53E-19A8-4441-BF82-31444CBC8B49|2||||HLAIIPRA|HLA CLASS II PANEL REACTIVE ANTIBODY|||||||MG/KG/DAY|||||||NEGATIVE||EID 50/ML||||HIGH|NOT DONE||||LYSATE|ROOM TEMPERATURE|NA|ACCELERATOR MASS SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|U|NA|||Y|5||7||CONTINUATION TREATMENT|1966-04-13|1972-01-08|||||1968-01-14||1963-05-29|U|1969-05-17
TRIAL STUDY 134XCP|LB|DAF741EF-DCCF-4E18-844B-05640A94C181|1||||CD19LY|CD19/LYMPHOCYTES|||||||TUBERCULIN UNIT/ML|||||||BORDERLINE||LOG10 PFU/ML||||ABNORMAL|NOT DONE||||BREAST MILK|NON-HEMOLYZED|NA|TRYPAN BLUE STAIN|MDRD 4 VARIABLE FORMULA||N|Y|U|U|||N|1||38||OBSERVATION|1962-12-12|1966-08-10|||||1973-05-09||1962-05-09|NA|1973-07-03
TRIAL STUDY 134XCP|LB|DAF741EF-DCCF-4E18-844B-05640A94C181|2||||AMPHETD|DEXTROAMPHETAMINE|||||||/7.5 ML|||||||INDETERMINATE||LOG10 COPIES/ML||||HIGH|NOT DONE||||PLATELET RICH PLASMA|LIPEMIC|Y|CT SCAN WITHOUT CONTRAST|GMI % FORMULA||NA|N|NA|N|||NA|1||38||FOLLOW-UP|1966-04-01|1962-12-27|||||1966-02-18||1973-02-15|Y|1966-10-14
TRIAL STUDY 134XCP|LB|DAF741EF-DCCF-4E18-844B-05640A94C181|1||||MDA|3,4-METHYLENEDIOXYAMPHETAMINE|||||||POINT|||||||TRACE||MEQ/G||||LOW|NOT DONE||||GASTRIC CONTENTS|GELLED|U|SLOAN LETTER EYE CHART 1.25%|MDRD 4 VARIABLE FORMULA||NA|U|Y|Y|||U|2||58||BLINDED TREATMENT|1963-05-25|1961-05-29|||||1962-01-22||1970-11-12|Y|1967-02-28
TRIAL STUDY 134XCP|LB|DAF741EF-DCCF-4E18-844B-05640A94C181|2||||KIM1EXR|KIDNEY INJURY MOLECULE-1 EXCRETION RATE|||||||TUBERCULIN UNIT/ML|||||||POSITIVE||MPH||||HIGH|NOT DONE||||ADIPOSE TISSUE|SOLIDIFIED|Y|CELL OF ORIGIN ASSAY|MDRD ENZYMATIC FORMULA||Y|NA|NA|U|||N|2||58||RUN-IN|1970-04-23|1965-02-19|||||1972-08-15||1960-05-15|N|1967-10-08
TRIAL STUDY 134XCP|LB|DAF741EF-DCCF-4E18-844B-05640A94C181|1||||MONO|MONOCYTES|||||||NEEDLE GAUGE|||||||POSITIVE||10^8/L||||ABNORMAL|NOT DONE||||URINE|HEMOLYZED|N|KINYOUN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|U|||N|3||39||LONG-TERM FOLLOW-UP|1970-01-15|1972-06-22|||||1962-09-28||1969-10-13|NA|1964-03-10
TRIAL STUDY 134XCP|LB|DAF741EF-DCCF-4E18-844B-05640A94C181|2||||C165935|TRITICUM AESTIVUM IGE AB RAST SCORE|||||||10^6 CFU/ML|||||||TRACE||KUSP||||LOW|NOT DONE||||TUMOR TISSUE|CALCIFIED|U|SINGLE-MOLECULE ARRAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|Y|NA|||NA|3||39||TREATMENT|1967-10-03|1972-02-15|||||1967-02-02||1963-06-26|U|1971-07-19
TRIAL STUDY 134XCP|LB|DAF741EF-DCCF-4E18-844B-05640A94C181|1||||OXACREAT|OXALATE/CREATININE|||||||PIXELS/CM|||||||INDETERMINATE||COPIES/ML||||NORMAL|NOT DONE||||TUMOR TISSUE|GELLED|U|CALCOFLUOR WHITE STAIN|NASH FIBROSURE FORMULA||N|NA|NA|Y|||N|4||88||INDUCTION TREATMENT|1960-06-29|1973-03-27|||||1972-11-26||1967-10-13|U|1969-08-06
TRIAL STUDY 134XCP|LB|DAF741EF-DCCF-4E18-844B-05640A94C181|2||||TMZPM|TEMAZEPAM|||||||/100 WBC|||||||BORDERLINE||10^9 ORGANISMS/ML||||ABNORMAL|NOT DONE||||ERYTHROCYTES|SOLIDIFIED|U|NEXT GENERATION TARGETED SEQUENCING|MDRD ENZYMATIC FORMULA||NA|Y|NA|N|||NA|4||88||BLINDED TREATMENT|1969-12-12|1962-11-06|||||1970-07-22||1973-09-06|U|1971-02-13
TRIAL STUDY 134XCP|LB|DAF741EF-DCCF-4E18-844B-05640A94C181|1||||ANISOCHR|ANISOCHROMIA|||||||10^4/L|||||||TRACE||10^4/HPF||||LOW|NOT DONE||||EPIDERMAL TISSUE|CONCENTRATED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA||NA|U|NA|Y|||U|5||7||FOLLOW-UP|1969-01-27|1960-12-04|||||1964-10-22||1966-06-30|NA|1960-09-10
TRIAL STUDY 134XCP|LB|DAF741EF-DCCF-4E18-844B-05640A94C181|2||||TURB|TURBIDITY|||||||GAUSS|||||||BORDERLINE||MM/2H||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|LIPEMIC|Y|TEMPLATE INCISION METHOD|FIBROTEST FORMULA||NA|Y|NA|Y|||NA|5||7||BASELINE|1968-04-29|1963-01-28|||||1964-04-05||1970-07-21|U|1965-03-12
TRIAL STUDY 134XCP|LB|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|1||||PSDEPHD|PSEUDOEPHEDRINE|||||||AFU|||||||INDETERMINATE||UM/DAY||||NORMAL|NOT DONE||||SEBUM|AGGLUTINATED|Y|ENZYMATIC ULTRACENTRIFUGATION|CKD-EPI FORMULA||U|Y|Y|N|||NA|1||38||FOLLOW-UP|1973-04-19|1966-11-18|||||1972-05-25||1960-11-30|N|1961-07-16
TRIAL STUDY 134XCP|LB|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|2||||HLAB27AG|HLA-B27 ANTIGEN|||||||PATCH|||||||TRACE||IU/ML||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|CONCENTRATED|NA|PERFUSION MRI|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|N|||U|1||38||TREATMENT|1972-03-01|1972-02-13|||||1968-09-06||1966-12-06|U|1968-11-01
TRIAL STUDY 134XCP|LB|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|1||||ARSENIC|ARSENIC|||||||U/G HB|||||||NEGATIVE||TORR||||ABNORMAL|NOT DONE||||SPUTUM|CLOTTED|NA|DIFFUSION WEIGHTED MRI|CKD-EPI FORMULA||NA|N|U|N|||N|2||58||TREATMENT|1967-11-22|1960-02-22|||||1969-09-27||1972-04-13|NA|1968-11-02
TRIAL STUDY 134XCP|LB|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|2||||FGF9|FIBROBLAST GROWTH FACTOR 9|||||||10^6 ORGANISMS/MG|||||||NEGATIVE||F||||NORMAL|NOT DONE||||SALIVA|CONTAMINATED|Y|FLUORIMETRY|CKD-EPI CREATININE FORMULA||U|U|N|N|||NA|2||58||TREATMENT|1963-05-15|1971-07-30|||||1960-07-10||1964-01-24|Y|1968-01-14
TRIAL STUDY 134XCP|LB|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|1||||HGBFR|HEMOGLOBIN, FREE|||||||10^6 U|||||||BORDERLINE||MEQ/ML||||HIGH|NOT DONE||||EPITHELIAL CELL|CALCIFIED|NA|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||NA|NA|Y|U|||N|3||39||LONG-TERM FOLLOW-UP|1973-07-15|1960-02-03|||||1967-06-17||1963-08-08|Y|1971-05-03
TRIAL STUDY 134XCP|LB|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|2||||BASO|BASOPHILS|||||||PG/L|||||||INVALID||PMOL/10^9 CELLS||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|AUTOLYZED|U|GIEMSA STAIN|NASH FIBROSURE FORMULA||N|U|Y|U|||U|3||39||INDUCTION TREATMENT|1973-06-12|1972-02-15|||||1967-10-26||1964-05-16|NA|1964-12-04
TRIAL STUDY 134XCP|LB|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|1||||CKBB|CREATINE KINASE BB|||||||/2000 RBC|||||||INDETERMINATE||ANSON U||||LOW|NOT DONE||||AMNIOTIC FLUID|PARAFFIN-EMBEDDED|U|MALDI-TOF|GMI MMOL/MOL FORMULA||Y|NA|N|NA|||N|4||88||TREATMENT|1967-04-17|1960-02-17|||||1969-08-17||1969-12-20|U|1963-12-19
TRIAL STUDY 134XCP|LB|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|2||||INTLK9|INTERLEUKIN 9|||||||RAD|||||||INVALID||MMHG*MIN/L||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|CLOTTED|NA|IMPEDANCE CONDUCTIVITY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|NA|N|||N|4||88||RUN-IN|1964-01-06|1966-04-16|||||1961-04-21||1969-09-14|N|1960-05-16
TRIAL STUDY 134XCP|LB|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|1||||CTXICRT|TYPE I COLLAGEN C-TELOPEPTIDES/CREAT|||||||H*%|||||||INDETERMINATE||NEWTON||||NORMAL|NOT DONE||||CAPILLARY BLOOD|AGGLUTINATED|Y|ANALYTICAL ULTRACENTRIFUGATION|MDRD FORMULA||Y|U|U|U|||Y|5||7||CONTINUATION TREATMENT|1961-12-22|1962-04-30|||||1971-05-30||1964-11-23|N|1964-09-04
TRIAL STUDY 134XCP|LB|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|2||||GLYHLACD|GLYCOCHOLIC ACID|||||||MPL U|||||||NEGATIVE||PPM||||LOW|NOT DONE||||LYSATE|NON-HEMOLYZED|NA|SECONDARY ION MASS SPECTOMETRY|CKD-EPI FORMULA||U|U|Y|N|||U|5||7||INDUCTION TREATMENT|1964-02-18|1960-07-16|||||1965-01-29||1972-12-12|Y|1962-01-04
TRIAL STUDY 134XCP|LB|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|1||||RPTLTIME|REPTILASE TIME|||||||DPM/ML|||||||POSITIVE||U/CL||||HIGH|NOT DONE||||MECONIUM|LACTESCENT|NA|MICRO BROTH DILUTION|MDRD FORMULA||Y|NA|U|N|||Y|1||38||BLINDED TREATMENT|1968-07-13|1962-04-21|||||1970-01-22||1963-06-01|U|1973-07-10
TRIAL STUDY 134XCP|LB|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|2||||SMDGCELE|SMUDGE CELLS/LEUKOCYTES|||||||CAN|||||||INDETERMINATE||MG/KG||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|PARAFFIN-EMBEDDED|Y|MRI|MDRD 4 VARIABLE FORMULA||U|Y|U|U|||U|1||38||CONTINUATION TREATMENT|1962-11-02|1970-06-13|||||1963-04-05||1960-12-26|Y|1970-01-13
TRIAL STUDY 134XCP|LB|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|1||||MDC|MACROPHAGE-DERIVED CHEMOKINE|||||||UG/G/MIN|||||||BORDERLINE||SHOCK WAVE||||HIGH|NOT DONE||||EPIDERMAL TISSUE|UNEXPECTED ODOR|U|THIN SMEAR|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|U|N|||Y|2||58||WASHOUT|1963-01-04|1964-06-16|||||1962-08-02||1960-05-25|U|1965-10-27
TRIAL STUDY 134XCP|LB|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|2||||C165904|TREE MIX POLLEN IGG AB RAST SCORE|||||||/200 HPFS|||||||BORDERLINE||DRUM||||HIGH|NOT DONE||||HAIR FOLLICLE|HEMOLYZED|Y|RYAN BLUE STAIN|HEPASCORE FORMULA||Y|U|U|Y|||U|2||58||TREATMENT|1973-07-02|1967-12-09|||||1960-07-18||1970-12-11|U|1971-05-12
TRIAL STUDY 134XCP|LB|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|1||||CYSCREAT|CYSTATIN C/CREATININE|||||||HOMEOPATHIC DILUTION|||||||TRACE||NEBULE||||LOW|NOT DONE||||INFRANATANT, SERUM|REFRIGERATED|NA|SPIRAL CT|MDRD 4 VARIABLE FORMULA||NA|N|NA|N|||Y|3||39||CONTINUATION TREATMENT|1962-12-12|1971-06-29|||||1968-01-28||1969-02-09|Y|1973-01-28
TRIAL STUDY 134XCP|LB|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|2||||CA242AG|CANCER ANTIGEN 242|||||||UMOL/KG/MIN|||||||TRACE||MS/MMHG||||ABNORMAL|NOT DONE||||PLATELET|ROOM TEMPERATURE|U|DUCTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||N|NA|Y|NA|||N|3||39||OBSERVATION|1968-12-03|1969-02-02|||||1960-02-29||1968-09-05|U|1966-12-08
TRIAL STUDY 134XCP|LB|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|1||||CACRALB|CALCIUM CORRECTED FOR ALBUMIN|||||||CI|||||||INDETERMINATE||ML/M2/DAY||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|DRIED|NA|OPTICAL MAPPING|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|Y|||Y|4||88||INDUCTION TREATMENT|1969-08-21|1972-06-06|||||1970-02-24||1971-05-04|Y|1971-01-15
TRIAL STUDY 134XCP|LB|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|2||||GRAN|GRANULOCYTES|||||||UG/KG/H|||||||BORDERLINE||MMHG/SEC||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|ICTERIC|U|ROMANOWSKY STAIN|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|NA|||Y|4||88||BASELINE|1966-08-11|1962-10-12|||||1973-01-10||1967-12-13|U|1961-06-13
TRIAL STUDY 134XCP|LB|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|1||||EOS|EOSINOPHILS|||||||PG/L|||||||INVALID||DPM/ML||||LOW|NOT DONE||||REFLEX TEAR|AUTOLYZED|N|OPHTHALMOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|U|||Y|5||7||SCREENING|1962-11-13|1963-11-20|||||1961-02-22||1972-01-06|Y|1962-06-30
TRIAL STUDY 134XCP|LB|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|2||||B2G1GAAB|BETA-2 GLYCOPROTEIN 1 IGA ANTIBODY|||||||LOG10 TCID 50/UL|||||||INVALID||ATM||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|LACTESCENT|NA|BRDU CELLULAR PROLIFERATION ASSAY|COCKCROFT-GAULT FORMULA||NA|Y|N|U|||N|5||7||SCREENING|1964-12-03|1961-04-23|||||1962-04-20||1960-05-19|NA|1963-05-10
TRIAL STUDY 134XCP|LB|CF3E1636-762F-4821-A44E-455F33F5E4CC|1||||FACTVWA|VON WILLEBRAND FACTOR ACTIVITY|||||||MASK|||||||POSITIVE||MCI/KG||||LOW|NOT DONE||||INFRANATANT, PLASMA|ICTERIC|U|NEXT GENERATION SEQUENCING|MDRD FORMULA||U|N|Y|Y|||U|1||38||INDUCTION TREATMENT|1970-01-04|1970-11-24|||||1967-05-02||1969-11-30|NA|1969-10-04
TRIAL STUDY 134XCP|LB|CF3E1636-762F-4821-A44E-455F33F5E4CC|2||||LTFAB|LACTOFERRIN ANTIBODY|||||||NG/DAY|||||||TRACE||U/G||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CLOTTED|NA|SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|Y|N|||Y|1||38||FOLLOW-UP|1973-05-02|1966-06-08|||||1964-02-08||1967-09-15|Y|1970-07-14
TRIAL STUDY 134XCP|LB|CF3E1636-762F-4821-A44E-455F33F5E4CC|1||||INTLK2|INTERLEUKIN 2|||||||CD/M2|||||||POSITIVE||CCID 50/DOSE||||LOW|NOT DONE||||CEREBROSPINAL FLUID|UNEXPECTED ODOR|NA|MS/MS|COCKCROFT-GAULT FORMULA||N|Y|U|N|||U|2||58||OPEN LABEL TREATMENT|1972-07-26|1966-10-17|||||1968-01-19||1969-03-19|NA|1964-10-03
TRIAL STUDY 134XCP|LB|CF3E1636-762F-4821-A44E-455F33F5E4CC|2||||DHEAS|DEHYDROEPIANDROSTERONE SULFATE|||||||MOL/MG|||||||POSITIVE||PM||||LOW|NOT DONE||||GASTRIC CONTENTS|LACTESCENT|U|STRESS ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|NA|N|||Y|2||58||FOLLOW-UP|1967-11-11|1969-12-20|||||1966-11-13||1968-11-26|NA|1964-06-14
TRIAL STUDY 134XCP|LB|CF3E1636-762F-4821-A44E-455F33F5E4CC|1||||CTXIICRT|TYPE II COLLAGEN C-TELOPEPTIDES/CREAT|||||||DMOL|||||||POSITIVE||CMH2O*S/ML||||NORMAL|NOT DONE||||SOFT TISSUE|LIPEMIC|Y|LAPAROSCOPY|COCKCROFT-GAULT FORMULA||NA|N|NA|N|||NA|3||39||BLINDED TREATMENT|1972-06-08|1963-06-21|||||1966-06-07||1962-04-08|Y|1962-05-11
TRIAL STUDY 134XCP|LB|CF3E1636-762F-4821-A44E-455F33F5E4CC|2||||METHAMPH|METHAMPHETAMINE|||||||UM|||||||TRACE||EU||||LOW|NOT DONE||||SPUTUM|NON-HEMOLYZED|U|PYROSEQUENCING|MDRD FORMULA||NA|Y|Y|NA|||N|3||39||WASHOUT|1963-03-11|1967-09-23|||||1969-09-26||1967-10-24|Y|1963-09-29
TRIAL STUDY 134XCP|LB|CF3E1636-762F-4821-A44E-455F33F5E4CC|1||||CSGRANF|GRANULAR FINE CASTS|||||||KG/MOL|||||||POSITIVE||LOG10 ELISA UNIT||||LOW|NOT DONE||||AMNIOTIC FLUID|AUTOLYZED|Y|POPULATION SEQUENCING|COCKCROFT-GAULT FORMULA||U|N|NA|Y|||Y|4||88||INDUCTION TREATMENT|1968-08-17|1961-03-26|||||1963-09-30||1962-06-06|Y|1966-03-02
TRIAL STUDY 134XCP|LB|CF3E1636-762F-4821-A44E-455F33F5E4CC|2||||MEPRDN|MEPERIDINE|||||||MEQ/L|||||||BORDERLINE||DB||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|LIPEMIC|Y|DIPSTICK|MDRD 4 VARIABLE FORMULA||Y|Y|NA|Y|||NA|4||88||FOLLOW-UP|1963-05-02|1972-05-23|||||1963-04-13||1972-09-27|N|1963-05-22
TRIAL STUDY 134XCP|LB|CF3E1636-762F-4821-A44E-455F33F5E4CC|1||||FACTXI|FACTOR XI|||||||ECL UNIT|||||||POSITIVE||KA_U/DL||||NORMAL|NOT DONE||||CAPILLARY BLOOD|HEMOLYZED|Y|DNA MICROARRAY|MDRD ENZYMATIC FORMULA||NA|N|N|NA|||U|5||7||LONG-TERM FOLLOW-UP|1962-11-04|1967-02-20|||||1960-10-25||1969-12-23|NA|1967-04-14
TRIAL STUDY 134XCP|LB|CF3E1636-762F-4821-A44E-455F33F5E4CC|2||||C165914|CAT DANDER IGG AB RAST SCORE|||||||MPA|||||||INDETERMINATE||DEG2||||LOW|NOT DONE||||CORD BLOOD|SOLIDIFIED|NA|PYROSEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|N|U|||Y|5||7||OPEN LABEL TREATMENT|1964-07-25|1973-06-28|||||1963-02-28||1970-08-12|NA|1962-02-19
TRIAL STUDY 134XCP|LB|3846A0A8-2D38-44C9-A579-84C66315C436|1||||FEMG|FRACTIONAL MAGNESIUM EXCRETION|||||||%(W/V)|||||||INDETERMINATE||MPH||||ABNORMAL|NOT DONE||||BASAL TEAR|FRESH|U|RAJI CELL RIA|ASH FIBROSURE FORMULA||Y|U|Y|Y|||Y|1||38||FOLLOW-UP|1969-01-17|1961-04-26|||||1963-05-06||1970-10-10|NA|1973-04-19
TRIAL STUDY 134XCP|LB|3846A0A8-2D38-44C9-A579-84C66315C436|2||||RBCAGGLU|ERYTHROCYTE AGGLUTINATION|||||||KA_U/DL|||||||POSITIVE||UMOL/DAY||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|FROZEN|NA|INDIA INK STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|U|U|||N|1||38||LONG-TERM FOLLOW-UP|1970-01-22|1965-04-15|||||1972-10-01||1973-04-15|N|1970-10-29
TRIAL STUDY 134XCP|LB|3846A0A8-2D38-44C9-A579-84C66315C436|1||||TNFSR1|SOLUBLE TNF RECEPTOR TYPE I|||||||10^11/L|||||||NEGATIVE||HENRY||||NORMAL|NOT DONE||||LUNG SURFACTANT|FROZEN|N|ELECTRONEUROGRAPHY|MDRD 6 VARIABLE FORMULA||N|N|Y|N|||U|2||58||OPEN LABEL TREATMENT|1961-12-31|1971-12-01|||||1968-10-03||1970-12-19|NA|1972-01-20
TRIAL STUDY 134XCP|LB|3846A0A8-2D38-44C9-A579-84C66315C436|2||||KYNURNN|KYNURENINE|||||||DPM/100MG|||||||INDETERMINATE||ML/DAY||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|FRESH|U|CRYOSCOPY|CKD-EPI CREATININE FORMULA||NA|U|N|Y|||Y|2||58||OPEN LABEL TREATMENT|1971-09-03|1960-07-11|||||1962-01-03||1961-12-01|Y|1961-08-07
TRIAL STUDY 134XCP|LB|3846A0A8-2D38-44C9-A579-84C66315C436|1||||CRENCE|CRENATED CELLS|||||||MEQ/UG|||||||NEGATIVE||TUBERCULIN UNIT/ML||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|DRIED|Y|ENDPOINT DILUTION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|Y|||N|3||39||OPEN LABEL TREATMENT|1965-06-23|1972-12-16|||||1962-06-18||1962-08-08|NA|1970-06-15
TRIAL STUDY 134XCP|LB|3846A0A8-2D38-44C9-A579-84C66315C436|2||||ATHMBAAC|ANTITHROMBIN ACTIVITY ACTUAL/CONTROL|||||||CD/M2|||||||POSITIVE||MEQ/DAY||||LOW|NOT DONE||||BONE|AUTOLYZED|Y|PERIPHERAL ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|NA|Y|||Y|3||39||SCREENING|1967-03-18|1963-03-02|||||1970-09-24||1968-03-29|N|1962-11-21
TRIAL STUDY 134XCP|LB|3846A0A8-2D38-44C9-A579-84C66315C436|1||||HASIGGAB|HUMAN ANTI-SHEEP IGG ANTIBODY|||||||MM/SEC|||||||POSITIVE||SV||||ABNORMAL|NOT DONE||||BONE|ROOM TEMPERATURE|N|FORCED OSCILLATION TECHNIQUE|CKD-EPI CREATININE FORMULA||N|U|Y|N|||NA|4||88||TREATMENT|1963-02-21|1965-01-21|||||1963-11-16||1971-08-12|N|1962-10-23
TRIAL STUDY 134XCP|LB|3846A0A8-2D38-44C9-A579-84C66315C436|2||||NEUTAGR|AGRANULAR NEUTROPHILS|||||||UCI/L|||||||NEGATIVE||MEQ/DL||||NORMAL|NOT DONE||||BONE|PARAFFIN-EMBEDDED|U|CINEANGIOGRAPHY|GMI MMOL/MOL FORMULA||N|U|Y|NA|||Y|4||88||FOLLOW-UP|1966-09-09|1963-05-17|||||1968-03-14||1970-07-06|Y|1966-08-10
TRIAL STUDY 134XCP|LB|3846A0A8-2D38-44C9-A579-84C66315C436|1||||PNTBRBTL|PENTOBARBITAL|||||||SCOOPFUL|||||||BORDERLINE||LM||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|AGGLUTINATED|N|ELECTROCHEMILUMINESCENCE|FIBROTEST FORMULA||Y|U|Y|NA|||U|5||7||LONG-TERM FOLLOW-UP|1965-08-15|1966-07-15|||||1967-04-03||1960-01-06|N|1969-09-17
TRIAL STUDY 134XCP|LB|3846A0A8-2D38-44C9-A579-84C66315C436|2||||CORTISOL|CORTISOL|||||||BREATHS/30S|||||||TRACE||HR/DAY||||NORMAL|NOT DONE||||CERUMEN|CALCIFIED|NA|FLOCCULATION, CHARCOAL ENHANCED|MDRD 4 VARIABLE FORMULA||U|U|NA|U|||NA|5||7||WASHOUT|1960-01-30|1960-03-16|||||1971-02-17||1970-06-03|U|1965-11-18
TRIAL STUDY 134XCP|LB|75B429C2-E173-4F72-8D4A-76F62C97F006|1||||C165893|WILD RYE POLLEN IGE AB RAST SCORE|||||||PMOL/DL|||||||POSITIVE||COULOMB||||NORMAL|NOT DONE||||CERUMEN|UNEXPECTED ODOR|N|ORCHIDOMETERY|NASH FIBROSURE FORMULA||N|N|NA|N|||Y|1||38||TREATMENT|1964-11-30|1969-10-25|||||1971-06-10||1973-02-26|N|1971-02-03
TRIAL STUDY 134XCP|LB|75B429C2-E173-4F72-8D4A-76F62C97F006|2||||CIT|CITRULLINE|||||||OD UNIT|||||||POSITIVE||UMOL/L||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|NON-HEMOLYZED|U|GIEMSA STAIN|MDRD FORMULA||Y|Y|N|Y|||Y|1||38||RUN-IN|1961-04-06|1968-04-23|||||1972-10-22||1966-08-05|U|1962-01-06
TRIAL STUDY 134XCP|LB|75B429C2-E173-4F72-8D4A-76F62C97F006|1||||CALPRO|CALPROTECTIN|||||||EP U|||||||INDETERMINATE||10^6 DNA COPIES/ML||||LOW|NOT DONE||||INTERSTITIAL FLUID|FRESH|U|RYAN BLUE STAIN|GMI MMOL/MOL FORMULA||NA|NA|U|N|||NA|2||58||RUN-IN|1966-08-17|1971-08-26|||||1967-04-27||1964-12-01|U|1969-01-28
TRIAL STUDY 134XCP|LB|75B429C2-E173-4F72-8D4A-76F62C97F006|2||||CRH|CORTICOTROPIN RELEASING HORMONE|||||||AMFI|||||||INVALID||10^3 CFU/ML||||ABNORMAL|NOT DONE||||SKIN TISSUE|LACTESCENT|U|SANGER SEQUENCING|NASH FIBROSURE FORMULA||N|N|NA|U|||Y|2||58||OPEN LABEL TREATMENT|1961-09-14|1973-03-26|||||1964-03-18||1961-06-17|Y|1966-09-30
TRIAL STUDY 134XCP|LB|75B429C2-E173-4F72-8D4A-76F62C97F006|1||||FIO2|FRACTION OF INSPIRED OXYGEN|||||||MN|||||||INDETERMINATE||/LPF||||LOW|NOT DONE||||PLATELET RICH PLASMA|CALCIFIED|U|MECHANICAL CLOT DETECTION|MDRD ENZYMATIC FORMULA||U|U|Y|N|||N|3||39||INDUCTION TREATMENT|1968-10-09|1966-12-03|||||1970-12-01||1964-05-02|N|1961-07-21
TRIAL STUDY 134XCP|LB|75B429C2-E173-4F72-8D4A-76F62C97F006|2||||GRANIMLE|IMMATURE GRANULOCYTES/LEUKOCYTES|||||||DPM/0.5 ML|||||||BORDERLINE||/HPF||||LOW|NOT DONE||||EXPIRED AIR|ROOM TEMPERATURE|U|INDIA INK STAIN|MDRD FORMULA||N|N|NA|U|||U|3||39||TREATMENT|1970-06-02|1971-04-07|||||1968-10-20||1960-06-06|NA|1971-01-19
TRIAL STUDY 134XCP|LB|75B429C2-E173-4F72-8D4A-76F62C97F006|1||||TGFB2|TRANSFORMING GROWTH FACTOR BETA 2|||||||MPL U|||||||BORDERLINE||GMFI||||HIGH|NOT DONE||||COLOSTRUM|ROOM TEMPERATURE|Y|MRI WITHOUT CONTRAST|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|N|||NA|4||88||WASHOUT|1966-01-02|1963-05-18|||||1973-04-30||1966-04-22|U|1962-09-26
TRIAL STUDY 134XCP|LB|75B429C2-E173-4F72-8D4A-76F62C97F006|2||||T4FRIND|THYROXINE, FREE, INDIRECT|||||||ML/MIN/1.73M2|||||||INVALID||10^9 CFU/G||||NORMAL|NOT DONE||||SEBUM|FROZEN|NA|SINGLE-SLICE SPIRAL CT|MDRD ENZYMATIC FORMULA||NA|N|NA|N|||Y|4||88||INDUCTION TREATMENT|1964-08-16|1965-10-09|||||1963-04-25||1962-07-29|Y|1966-01-06
TRIAL STUDY 134XCP|LB|75B429C2-E173-4F72-8D4A-76F62C97F006|1||||URATE|URATE|||||||PLUG|||||||NEGATIVE||NMOL BCE/NMOL||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|CALCIFIED|NA|SINGLE-MOLECULE ARRAY|FIBROMETER FORMULA||N|N|N|NA|||Y|5||7||BLINDED TREATMENT|1970-07-27|1965-05-29|||||1960-07-16||1965-04-22|N|1973-01-29
TRIAL STUDY 134XCP|LB|75B429C2-E173-4F72-8D4A-76F62C97F006|2||||POIKILO|POIKILOCYTES|||||||ML/G/MIN|||||||NEGATIVE||DISK||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|LACTESCENT|N|DYNAMOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|U|||NA|5||7||OBSERVATION|1962-09-20|1965-11-23|||||1963-12-12||1969-03-22|U|1964-07-30
TRIAL STUDY 134XCP|LB|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|1||||ESTRIOL|ESTRIOL|||||||AMP|||||||BORDERLINE||KM/H||||LOW|NOT DONE||||URINE|FROZEN|U|ANGIOGRAPHY|FIBROSIS 4 FORMULA||U|N|Y|N|||N|1||38||CONTINUATION TREATMENT|1970-02-08|1961-01-11|||||1970-06-16||1969-12-23|Y|1969-12-17
TRIAL STUDY 134XCP|LB|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|2||||B2MCREAT|BETA-2 MICROGLOBULIN/CREATININE|||||||DISK|||||||POSITIVE||MOL/ML||||LOW|NOT DONE||||SEMEN|PARAFFIN-EMBEDDED|NA|HIGH RESOLUTION CT|FIBROMETER FORMULA||U|Y|NA|U|||Y|1||38||BASELINE|1968-02-19|1969-12-27|||||1962-12-29||1967-03-16|N|1966-10-08
TRIAL STUDY 134XCP|LB|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|1||||CHYTRYP|CHYMOTRYPSIN|||||||ENZYME U/L|||||||BORDERLINE||10^7 CFU||||NORMAL|NOT DONE||||GASTRIC CONTENTS|REFRIGERATED|NA|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|Y|U|||N|2||58||RUN-IN|1965-04-26|1970-05-02|||||1967-01-05||1970-07-30|NA|1964-10-28
TRIAL STUDY 134XCP|LB|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|2||||RDWR|RET VOLUME DISTRIBUTION WIDTH|||||||BQ/UL|||||||BORDERLINE||BQ/ML||||NORMAL|NOT DONE||||LUNG SURFACTANT|CONTAMINATED|Y|SLIT LAMP|GMI MMOL/MOL FORMULA||NA|Y|U|NA|||Y|2||58||FOLLOW-UP|1966-05-02|1969-03-06|||||1960-06-22||1967-04-20|U|1966-02-07
TRIAL STUDY 134XCP|LB|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|1||||CASTS|CASTS|||||||FINGERTIP UNIT|||||||INVALID||UM2||||NORMAL|NOT DONE||||SKIN TISSUE|LACTESCENT|N|MAGNETIC RESONANCE ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||U|NA|NA|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1970-03-07|1960-12-05|||||1965-04-25||1960-06-08|U|1969-06-14
TRIAL STUDY 134XCP|LB|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|2||||CYCYSTIN|CYSTINE CRYSTALS|||||||FRACTION OF 1|||||||NEGATIVE||PATCH||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|LIPEMIC|N|AMSLER GRID|MDRD 4 VARIABLE FORMULA||U|Y|Y|Y|||U|3||39||OPEN LABEL TREATMENT|1968-08-22|1969-03-30|||||1960-09-09||1964-10-10|N|1973-04-16
TRIAL STUDY 134XCP|LB|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|1||||INTLK6|INTERLEUKIN 6|||||||NG/MOL|||||||TRACE||MG/KG/H||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|ROOM TEMPERATURE|N|PERIODIC ACID SCHIFF STAIN|COCKCROFT-GAULT FORMULA||NA|U|NA|U|||Y|4||88||CONTINUATION TREATMENT|1970-09-10|1968-12-17|||||1961-07-04||1971-02-24|U|1964-11-17
TRIAL STUDY 134XCP|LB|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|2||||MCPHG|MACROPHAGES|||||||SBE/ML|||||||BORDERLINE||ML/S/M2||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|HEMOLYZED|NA|CALIPER MEASUREMENT METHOD|FIBROSIS 4 FORMULA||Y|NA|Y|NA|||U|4||88||OBSERVATION|1963-09-08|1971-08-21|||||1964-06-29||1965-03-20|N|1968-12-02
TRIAL STUDY 134XCP|LB|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|1||||ETPTPR|ETP TIME TO PEAK RELATIVE|||||||MMOL|||||||POSITIVE||MG/M2||||NORMAL|NOT DONE||||EMESIS|CONTAMINATED|N|SURFACE PLASMON RESONANCE|CKD-EPI FORMULA||N|N|Y|NA|||U|5||7||TREATMENT|1972-06-08|1970-10-04|||||1967-03-02||1969-03-21|Y|1964-11-27
TRIAL STUDY 134XCP|LB|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|2||||FIXAAC|FACTOR IX ACTIVITY ACTUAL/CONTROL|||||||10^12/L|||||||TRACE||KPA||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|SOLIDIFIED|NA|DYNAMIC LIGHT SCATTERING|MDRD 4 VARIABLE FORMULA||Y|N|U|N|||Y|5||7||WASHOUT|1968-07-26|1965-09-13|||||1965-01-20||1967-09-14|Y|1962-05-22
TRIAL STUDY 134XCP|LB|8065F0B9-9183-43E4-998A-D2F096D87998|1||||RDWSD|RDW STANDARD DEVIATION|||||||DAYS/MONTH|||||||INDETERMINATE||MNFI||||HIGH|NOT DONE||||SKIN TISSUE|SOLIDIFIED|Y|IMPULSE OSCILLOMETRY|COCKCROFT-GAULT FORMULA||NA|NA|N|U|||N|1||38||OBSERVATION|1964-10-05|1967-11-03|||||1968-03-18||1963-06-26|N|1961-05-08
TRIAL STUDY 134XCP|LB|8065F0B9-9183-43E4-998A-D2F096D87998|2||||TESTOSBA|BIOAVAILABLE TESTOSTERONE|||||||AG|||||||INDETERMINATE||MV||||LOW|NOT DONE||||ERYTHROCYTES|GELLED|Y|FLUOROSCOPY|NASH FIBROSURE FORMULA||U|N|U|Y|||N|1||38||WASHOUT|1964-03-22|1969-09-18|||||1962-10-30||1968-12-15|NA|1971-06-05
TRIAL STUDY 134XCP|LB|8065F0B9-9183-43E4-998A-D2F096D87998|1||||NEUTBLE|NEUTROPHILS BAND FORM/LEUKOCYTES|||||||MG/ANIMAL|||||||BORDERLINE||SQU/ML||||HIGH|NOT DONE||||PUS|CALCIFIED|NA|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|N|||N|2||58||BLINDED TREATMENT|1960-11-26|1969-02-23|||||1972-12-22||1961-04-27|U|1963-08-14
TRIAL STUDY 134XCP|LB|8065F0B9-9183-43E4-998A-D2F096D87998|2||||IL122340|INTERLEUKIN 12+23 P40|||||||/2500 WBC|||||||BORDERLINE||PACKET||||ABNORMAL|NOT DONE||||CERUMEN|UNEXPECTED ODOR|Y|IMMUNORADIOMETRIC ASSAY|HEPASCORE FORMULA||NA|NA|NA|N|||U|2||58||SCREENING|1967-12-10|1965-09-16|||||1966-11-17||1969-06-23|N|1971-07-23
TRIAL STUDY 134XCP|LB|8065F0B9-9183-43E4-998A-D2F096D87998|1||||NEUTMY|NEUTROPHILIC MYELOCYTES|||||||U.CARR|||||||NEGATIVE||SFC/10^6 PBMC||||ABNORMAL|NOT DONE||||RETICULOCYTES|FROZEN|U|NEPHELOMETRY|MDRD FORMULA||NA|NA|NA|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1960-11-15|1966-10-31|||||1972-04-28||1968-02-05|NA|1964-10-31
TRIAL STUDY 134XCP|LB|8065F0B9-9183-43E4-998A-D2F096D87998|2||||C130093|WESTERN RAGWEED POLLEN IGA|||||||CI/KG|||||||INVALID||%(W/V)||||HIGH|NOT DONE||||PLATELET|LIPEMIC|NA|DIGITAL PCR|ASH FIBROSURE FORMULA||Y|N|Y|N|||Y|3||39||WASHOUT|1971-05-31|1966-10-21|||||1963-01-17||1964-06-05|NA|1970-12-22
TRIAL STUDY 134XCP|LB|8065F0B9-9183-43E4-998A-D2F096D87998|1||||FXAAC|FACTOR X ACTIVITY ACTUAL/CONTROL|||||||CYCLE/MIN|||||||NEGATIVE||INHALATION||||HIGH|NOT DONE||||SMEGMA|CALCIFIED|N|GC/MS-CI|HEPASCORE FORMULA||NA|N|Y|NA|||U|4||88||TREATMENT|1966-09-06|1961-01-05|||||1970-03-15||1968-12-09|U|1965-06-30
TRIAL STUDY 134XCP|LB|8065F0B9-9183-43E4-998A-D2F096D87998|2||||FLRZPM|FLURAZEPAM|||||||U/M2/H|||||||TRACE||U/G||||LOW|NOT DONE||||CELL PELLET|FROZEN|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA||N|Y|U|N|||Y|4||88||SCREENING|1972-02-06|1960-06-15|||||1961-11-23||1969-06-03|U|1964-02-27
TRIAL STUDY 134XCP|LB|8065F0B9-9183-43E4-998A-D2F096D87998|1||||LDH5|LDH ISOENZYME 5|||||||DDU|||||||INDETERMINATE||OD UNIT||||HIGH|NOT DONE||||PLATELET POOR PLASMA|REFRIGERATED|U|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD 5 VARIABLE FORMULA||Y|NA|NA|U|||NA|5||7||BLINDED TREATMENT|1965-09-06|1967-10-13|||||1960-03-28||1971-10-20|Y|1964-05-03
TRIAL STUDY 134XCP|LB|8065F0B9-9183-43E4-998A-D2F096D87998|2||||GLDIGGAB|GLIADIN IGG ANTIBODY|||||||MONTHS|||||||INDETERMINATE||1/(S*KPA)||||LOW|NOT DONE||||ABSCESS FLUID|FROZEN|NA|INTERRUPTER TECHNIQUE|MDRD 5 VARIABLE FORMULA||NA|N|NA|N|||NA|5||7||OPEN LABEL TREATMENT|1966-07-01|1965-07-15|||||1971-08-02||1968-10-23|N|1968-12-22
TRIAL STUDY 134XCP|LB|697EB3B7-5AD1-4D1D-BB53-BB0556915957|1||||DPPIVA|DIPEPTIDYL PEPTIDASE-4 ACTIVITY|||||||MBQ/UL|||||||NEGATIVE||PPM||||LOW|NOT DONE||||SALIVA|FROZEN|NA|ELECTROGASTROGRAPHY|MDRD 6 VARIABLE FORMULA||N|N|U|Y|||Y|1||38||WASHOUT|1967-05-07|1969-07-24|||||1966-03-06||1962-04-02|NA|1962-09-21
TRIAL STUDY 134XCP|LB|697EB3B7-5AD1-4D1D-BB53-BB0556915957|2||||HPOCROM|HYPOCHROMIA|||||||V/V|||||||BORDERLINE||HOUNSFIELD UNIT||||HIGH|NOT DONE||||SEBUM|CONCENTRATED|U|GC/MS/MS|MDRD 4 VARIABLE FORMULA||NA|NA|NA|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1970-07-12|1967-10-31|||||1967-03-04||1961-09-07|NA|1970-12-03
TRIAL STUDY 134XCP|LB|697EB3B7-5AD1-4D1D-BB53-BB0556915957|1||||RPTLAAC|REPTILASE ACTIVITY ACTUAL/CONTROL|||||||V/SEC|||||||POSITIVE||10^6 ORGANISMS/G||||NORMAL|NOT DONE||||CELL PELLET|CONCENTRATED|N|PHOTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|U|||N|2||58||LONG-TERM FOLLOW-UP|1968-11-06|1963-08-01|||||1963-07-14||1969-01-23|N|1969-02-10
TRIAL STUDY 134XCP|LB|697EB3B7-5AD1-4D1D-BB53-BB0556915957|2||||IL2RA|INTERLEUKIN 2 RECEPTOR SUBUNIT ALPHA|||||||DEG/MM|||||||INVALID||MMHG/L/MIN||||NORMAL|NOT DONE||||AQUEOUS HUMOR|LACTESCENT|NA|NUCLEAR RADIOLOGY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|Y|U|||NA|2||58||RUN-IN|1968-08-30|1961-12-17|||||1964-04-23||1964-05-03|NA|1962-08-25
TRIAL STUDY 134XCP|LB|697EB3B7-5AD1-4D1D-BB53-BB0556915957|1||||AST|ASPARTATE AMINOTRANSFERASE|||||||IU/KG|||||||POSITIVE||IN2||||LOW|NOT DONE||||URINE SEDIMENT|FRESH|NA|IMMUNOTURBIDIMETRY|MDRD 4 VARIABLE FORMULA||NA|U|Y|NA|||U|3||39||OPEN LABEL TREATMENT|1971-02-01|1967-11-17|||||1970-04-13||1972-12-15|U|1966-06-09
TRIAL STUDY 134XCP|LB|697EB3B7-5AD1-4D1D-BB53-BB0556915957|2||||HLADR53A|HLA-DR53 ANTIBODY|||||||CD*S/M2|||||||INVALID||/MM2||||NORMAL|NOT DONE||||MUSCLE TISSUE|FROZEN|N|CONTRAST ENHANCED CT SCAN|CKD-EPI FORMULA||U|Y|Y|NA|||N|3||39||INDUCTION TREATMENT|1965-07-14|1964-08-20|||||1967-07-18||1972-07-14|N|1965-05-10
TRIAL STUDY 134XCP|LB|697EB3B7-5AD1-4D1D-BB53-BB0556915957|1||||PGF2AI8|8-ISO-PROSTAGLANDIN F2 ALPHA|||||||L/KG|||||||POSITIVE||MOL/G||||LOW|NOT DONE||||EPITHELIAL CELL|REFRIGERATED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CREATININE FORMULA||U|U|N|Y|||U|4||88||BLINDED TREATMENT|1962-11-11|1972-01-13|||||1966-06-14||1963-06-02|N|1970-05-25
TRIAL STUDY 134XCP|LB|697EB3B7-5AD1-4D1D-BB53-BB0556915957|2||||INTLK22|INTERLEUKIN 22|||||||MCI/KG|||||||TRACE||G/MOL||||LOW|NOT DONE||||URINE SEDIMENT|SOLIDIFIED|Y|IMMUNOPRECIPITATION|FIBROTEST FORMULA||N|U|Y|Y|||N|4||88||BLINDED TREATMENT|1966-11-07|1964-04-24|||||1973-07-29||1971-04-18|U|1972-09-03
TRIAL STUDY 134XCP|LB|697EB3B7-5AD1-4D1D-BB53-BB0556915957|1||||HCT|HEMATOCRIT|||||||KAT|||||||POSITIVE||U/DL||||HIGH|NOT DONE||||NAIL|REFRIGERATED|NA|TARGETED GENOME SEQUENCING|COCKCROFT-GAULT FORMULA||Y|N|N|U|||N|5||7||WASHOUT|1970-06-22|1972-12-18|||||1962-06-13||1969-02-23|Y|1969-08-28
TRIAL STUDY 134XCP|LB|697EB3B7-5AD1-4D1D-BB53-BB0556915957|2||||KIM1S|SOLUBLE KIDNEY INJURY MOLECULE-1|||||||V/SEC|||||||INDETERMINATE||GY||||LOW|NOT DONE||||HAIR FOLLICLE|GELLED|NA|SLIT LAMP|MDRD 4 VARIABLE FORMULA||U|U|U|N|||U|5||7||TREATMENT|1969-10-23|1966-08-16|||||1964-05-28||1973-04-15|U|1971-04-30
TRIAL STUDY 134XCP|LB|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|1||||CCL19|CHEMOKINE (C-C MOTIF) LIGAND 19|||||||10^3 CFU/G|||||||BORDERLINE||CI/L||||LOW|NOT DONE||||MUSCLE TISSUE|ICTERIC|N|DUCTOGRAPHY|CKD-EPI FORMULA||U|Y|NA|NA|||N|1||38||BLINDED TREATMENT|1965-09-11|1963-08-21|||||1972-05-31||1963-10-20|Y|1962-12-28
TRIAL STUDY 134XCP|LB|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|2||||AFACTXAA|ANTI-FACTOR XA ACTIVITY|||||||M2|||||||TRACE||ML/MIN/1.73M2||||NORMAL|NOT DONE||||CERUMEN|CLOTTED|Y|MULTI-SLICE SPIRAL CT|FIBROSIS 4 FORMULA||Y|U|N|Y|||U|1||38||OPEN LABEL TREATMENT|1971-05-07|1964-06-27|||||1965-09-09||1970-12-01|Y|1960-07-30
TRIAL STUDY 134XCP|LB|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|1||||LYS|LYSINE|||||||UG/DL|||||||BORDERLINE||ML/KG/H||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|LACTESCENT|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|N|||Y|2||58||INDUCTION TREATMENT|1961-02-13|1970-10-16|||||1967-07-17||1970-05-10|Y|1962-01-07
TRIAL STUDY 134XCP|LB|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|2||||MUG|MURINOGLOBULIN|||||||IU|||||||NEGATIVE||UMOL/KG/MIN||||LOW|NOT DONE||||BLOOD|SOLIDIFIED|U|SCINTIGRAPHY|MDRD 6 VARIABLE FORMULA||N|NA|N|N|||NA|2||58||TREATMENT|1966-10-06|1968-03-17|||||1962-10-21||1966-10-22|N|1963-03-17
TRIAL STUDY 134XCP|LB|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|1||||TSHRAB|THYROTROPIN RECEPTOR ANTIBODY|||||||UM2|||||||INVALID||DNA COPIES/UG||||HIGH|NOT DONE||||LYSATE|HEMOLYZED|N|DYNAMIC LIGHT SCATTERING|FIBROSIS 4 FORMULA||N|Y|U|Y|||U|3||39||OBSERVATION|1965-03-30|1965-12-18|||||1967-09-06||1969-01-22|NA|1963-03-04
TRIAL STUDY 134XCP|LB|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|2||||TRPTRG|TRYPSIN AND TRYPSINOGEN|||||||/10^5|||||||TRACE||10^7 CFU||||NORMAL|NOT DONE||||SEMEN|CONTAMINATED|Y|HPLC-FL|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|NA|Y|||NA|3||39||BLINDED TREATMENT|1972-05-30|1968-09-26|||||1970-01-11||1972-11-05|Y|1964-01-10
TRIAL STUDY 134XCP|LB|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|1||||STAT3|STAT3|||||||U/ML|||||||TRACE||U/ANIMAL||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|CONCENTRATED|U|MS/MS|CKD-EPI FORMULA||N|Y|Y|N|||NA|4||88||LONG-TERM FOLLOW-UP|1961-06-20|1960-05-11|||||1967-09-30||1968-04-16|U|1965-12-22
TRIAL STUDY 134XCP|LB|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|2||||PROGEST|PROGESTERONE|||||||DRAM|||||||NEGATIVE||10^7 PFU||||LOW|NOT DONE||||SERUM|AUTOLYZED|N|LAPAROSCOPY|FIBROMETER FORMULA||Y|NA|U|U|||NA|4||88||BLINDED TREATMENT|1970-11-17|1962-05-12|||||1970-03-18||1962-07-23|NA|1972-08-31
TRIAL STUDY 134XCP|LB|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|1||||HDWR|RET HEMOGLOBIN DISTRIBUTION WIDTH|||||||ML/CAGE/DAY|||||||TRACE||KHZ||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|DRIED|NA|NEURAMINIDASE INHIBITION ASSAY|MDRD 4 VARIABLE FORMULA||N|N|NA|Y|||NA|5||7||FOLLOW-UP|1968-10-01|1966-05-28|||||1970-05-06||1961-02-28|NA|1970-11-08
TRIAL STUDY 134XCP|LB|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|2||||HYALUAC|HYALURONIC ACID|||||||GLOBULE|||||||TRACE||/VF||||LOW|NOT DONE||||EXUDATE|CALCIFIED|NA|PERIPHERAL ANGIOGRAPHY|HEPASCORE FORMULA||U|NA|NA|NA|||N|5||7||CONTINUATION TREATMENT|1967-01-31|1962-05-01|||||1967-01-21||1964-05-16|NA|1971-03-04
TRIAL STUDY 134XCP|LB|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|1||||ACETAMIN|ACETAMINOPHEN|||||||/HPF|||||||INVALID||UMOL/MOL||||LOW|NOT DONE||||CALCULUS|CALCIFIED|Y|FLOW MICROSCOPY|ASH FIBROSURE FORMULA||Y|NA|N|NA|||U|1||38||BASELINE|1971-04-23|1971-02-24|||||1969-09-08||1965-05-24|NA|1968-04-07
TRIAL STUDY 134XCP|LB|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|2||||TGLOB|THYROGLOBULIN|||||||UG/ML/H|||||||BORDERLINE||NL||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|AUTOLYZED|NA|CONTRAST ENHANCED MRI|GMI MMOL/MOL FORMULA||U|NA|NA|U|||Y|1||38||OBSERVATION|1972-12-15|1964-07-10|||||1961-05-01||1966-07-01|Y|1960-10-05
TRIAL STUDY 134XCP|LB|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|1||||GGTCREAT|GAMMA GLUTAMYL TRANSFERASE/CREATININE|||||||K|||||||TRACE||UM2||||ABNORMAL|NOT DONE||||PLATELET POOR PLASMA|SOLIDIFIED|U|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|Y|Y|||N|2||58||TREATMENT|1967-08-27|1962-06-04|||||1962-11-17||1964-07-18|U|1971-04-03
TRIAL STUDY 134XCP|LB|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|2||||CD40|CD40|||||||NMOL/DAY|||||||INVALID||SCM||||LOW|NOT DONE||||GASTRIC CONTENTS|GELLED|Y|DYNAMIC LIGHT SCATTERING|FIBROMETER FORMULA||U|N|N|Y|||Y|2||58||BLINDED TREATMENT|1969-02-04|1969-01-18|||||1960-09-24||1971-12-06|U|1967-08-12
TRIAL STUDY 134XCP|LB|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|1||||VITK1|VITAMIN K1|||||||TESLA|||||||TRACE||CAPFUL||||ABNORMAL|NOT DONE||||CERUMEN|PARAFFIN-EMBEDDED|Y|BAC ACGH|ASH FIBROSURE FORMULA||Y|N|N|N|||NA|3||39||BASELINE|1960-05-09|1969-07-11|||||1971-04-08||1960-05-04|U|1969-04-26
TRIAL STUDY 134XCP|LB|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|2||||ICAM3|INTERCELLULAR ADHESION MOLECULE 3|||||||/4.0 ML|||||||NEGATIVE||CUP EQ||||HIGH|NOT DONE||||ERYTHROCYTES|CALCIFIED|N|URANYL ACETATE STAIN|CKD-EPI FORMULA||Y|N|N|Y|||N|3||39||BASELINE|1969-04-24|1964-01-23|||||1965-09-30||1962-06-01|U|1967-11-03
TRIAL STUDY 134XCP|LB|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|1||||GLCHT|GLYCOLITHOCHOLATE|||||||BU|||||||BORDERLINE||KIT||||HIGH|NOT DONE||||HAIR|GELLED|N|ULTRASOUND|FIBROMETER FORMULA||N|Y|U|Y|||Y|4||88||BLINDED TREATMENT|1966-06-05|1969-08-21|||||1964-11-20||1970-12-12|NA|1965-11-10
TRIAL STUDY 134XCP|LB|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|2||||TROPONT|TROPONIN T|||||||PHERESIS UNIT|||||||NEGATIVE||/100 HPFS||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|HEMOLYZED|U|PANENDOSCOPY|CKD-EPI CYSTATIN C FORMULA||U|U|U|NA|||U|4||88||TREATMENT|1961-07-03|1968-07-19|||||1973-07-31||1971-07-29|NA|1966-03-09
TRIAL STUDY 134XCP|LB|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|1||||CHOL|CHOLESTEROL|||||||KPA|||||||TRACE||MNFI||||HIGH|NOT DONE||||EPITHELIAL CELL|NON-HEMOLYZED|Y|AUSCULTATION|MDRD 4 VARIABLE FORMULA||Y|U|U|N|||U|5||7||FOLLOW-UP|1963-04-30|1962-09-17|||||1971-03-12||1964-07-20|NA|1966-07-19
TRIAL STUDY 134XCP|LB|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|2||||NPAP|NON-PROSTATIC ACID PHOSPHATASE|||||||H*%|||||||POSITIVE||10^3 RNA COPIES/ML||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONTAMINATED|U|THIN SMEAR|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|Y|U|||NA|5||7||TREATMENT|1962-07-05|1969-06-17|||||1965-02-21||1963-01-18|U|1968-05-21
TRIAL STUDY 134XCP|LB|52EC57AA-56E4-47A8-AADA-36F62653B423|1||||B2G1GGAB|BETA-2 GLYCOPROTEIN 1 IGG ANTIBODY|||||||MG/KG/MIN|||||||BORDERLINE||DROP||||LOW|NOT DONE||||VENOUS BLOOD|CALCIFIED|U|ELECTROCHEMILUMINESCENCE|COCKCROFT-GAULT FORMULA||N|N|Y|N|||NA|1||38||OBSERVATION|1970-10-12|1970-06-22|||||1962-02-25||1966-01-24|N|1973-02-01
TRIAL STUDY 134XCP|LB|52EC57AA-56E4-47A8-AADA-36F62653B423|2||||C165936|GLYCINE MAX IGE AB RAST SCORE|||||||PMOL|||||||INDETERMINATE||L/H||||LOW|NOT DONE||||SWABBED MATERIAL|REFRIGERATED|U|THIN SMEAR|FIBROTEST FORMULA||NA|NA|U|NA|||NA|1||38||INDUCTION TREATMENT|1973-08-20|1962-11-07|||||1965-09-20||1962-04-07|NA|1968-03-06
TRIAL STUDY 134XCP|LB|52EC57AA-56E4-47A8-AADA-36F62653B423|1||||BLSTLMLY|LEUKEMIC BLASTS/LYMPHOCYTES|||||||TUBERCULIN UNIT|||||||INDETERMINATE||ML/CM3/MIN||||HIGH|NOT DONE||||CORD BLOOD|SOLIDIFIED|NA|REBOUND TONOMETRY|CKD-EPI FORMULA||Y|NA|U|Y|||N|2||58||WASHOUT|1961-12-30|1968-10-25|||||1966-02-21||1965-01-14|U|1962-04-08
TRIAL STUDY 134XCP|LB|52EC57AA-56E4-47A8-AADA-36F62653B423|2||||LIPASEP|LIPASE, PANCREATIC|||||||/VF|||||||BORDERLINE||ML/S/M2||||LOW|NOT DONE||||LUNG SURFACTANT|NON-HEMOLYZED|U|ICP-MS|MDRD ENZYMATIC FORMULA||N|Y|NA|U|||U|2||58||LONG-TERM FOLLOW-UP|1961-01-19|1971-08-12|||||1961-08-29||1972-08-25|U|1971-12-19
TRIAL STUDY 134XCP|LB|52EC57AA-56E4-47A8-AADA-36F62653B423|1||||GRANSGCE|GRANULOCYTES SEGMENTED/TOTAL CELLS|||||||HZ|||||||BORDERLINE||U/KG/H||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|ROOM TEMPERATURE|Y|ALCIAN BLUE STAIN|MDRD 5 VARIABLE FORMULA||U|NA|N|N|||Y|3||39||OBSERVATION|1964-08-15|1970-04-02|||||1967-08-21||1966-09-20|NA|1972-06-14
TRIAL STUDY 134XCP|LB|52EC57AA-56E4-47A8-AADA-36F62653B423|2||||PTHNT|PARATHYROID HORMONE, N-TERMINAL|||||||NMOL/L/MIN|||||||INDETERMINATE||HENRY||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|CONTAMINATED|Y|PULMONARY ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||U|N|Y|N|||Y|3||39||FOLLOW-UP|1968-05-24|1965-07-20|||||1971-06-27||1961-01-15|Y|1965-11-27
TRIAL STUDY 134XCP|LB|52EC57AA-56E4-47A8-AADA-36F62653B423|1||||AFPA|ALPHA FETOPROTEIN ACTIVITY|||||||LM|||||||POSITIVE||CUP EQ||||HIGH|NOT DONE||||AQUEOUS HUMOR|HEMOLYZED|NA|BAC ACGH|NASH FIBROSURE FORMULA||U|N|N|U|||NA|4||88||LONG-TERM FOLLOW-UP|1972-10-12|1967-01-28|||||1968-05-10||1966-09-09|U|1969-06-08
TRIAL STUDY 134XCP|LB|52EC57AA-56E4-47A8-AADA-36F62653B423|2||||NTXICRT|T1 COLLAGEN X-LINK N-TELOPEPTIDES/CREAT|||||||G/CAGE/DAY|||||||INVALID||MEQ/ML||||ABNORMAL|NOT DONE||||BILE|CLOTTED|N|KINYOUN STAIN|CKD-EPI FORMULA||NA|N|U|N|||Y|4||88||WASHOUT|1965-10-08|1968-04-16|||||1967-08-05||1970-10-13|NA|1971-04-03
TRIAL STUDY 134XCP|LB|52EC57AA-56E4-47A8-AADA-36F62653B423|1||||UBQN|UBIQUITIN PROTEIN|||||||/4.0 ML|||||||INVALID||KG/L||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CALCIFIED|Y|PHASE CONTRAST MICROSCOPY|CKD-EPI CREATININE FORMULA||Y|Y|U|U|||U|5||7||BASELINE|1963-05-28|1972-02-02|||||1969-03-25||1960-11-17|N|1962-01-22
TRIAL STUDY 134XCP|LB|52EC57AA-56E4-47A8-AADA-36F62653B423|2||||NEUTBNE|NEUTROPHILS BAND FORM/ NEUTROPHILS|||||||LOG10 TCID 50/DOSE|||||||NEGATIVE||P||||ABNORMAL|NOT DONE||||SKIN TISSUE|AGGLUTINATED|NA|CT SCAN|FIBROMETER FORMULA||Y|Y|N|N|||Y|5||7||CONTINUATION TREATMENT|1961-01-21|1970-10-01|||||1971-10-15||1969-11-09|NA|1962-03-19
TRIAL STUDY 134XCP|LB|F09C04A4-4F9E-4033-9115-81C6007DE8B4|1||||TGFB2|TRANSFORMING GROWTH FACTOR BETA 2|||||||IU/KG/H|||||||INVALID||PKAT/L||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|THAWED|U|IMPEDANCE CONDUCTIVITY|CKD-EPI CREATININE FORMULA||N|U|Y|NA|||NA|1||38||RUN-IN|1965-05-09|1970-10-08|||||1972-04-13||1961-01-13|Y|1967-05-04
TRIAL STUDY 134XCP|LB|F09C04A4-4F9E-4033-9115-81C6007DE8B4|2||||LYMIM|IMMATURE LYMPHOCYTES|||||||10^12 IU/L|||||||INVALID||ML/S/M2||||NORMAL|NOT DONE||||PERITONEAL FLUID|CONTAMINATED|Y|POPULATION SEQUENCING|GMI % FORMULA||Y|NA|Y|U|||Y|1||38||WASHOUT|1960-11-14|1969-09-28|||||1963-10-18||1967-12-05|U|1965-12-11
TRIAL STUDY 134XCP|LB|F09C04A4-4F9E-4033-9115-81C6007DE8B4|1||||C130130|DOG DANDER ANTIGEN IGA ANTIBODY|||||||NKAT|||||||INDETERMINATE||RFU||||LOW|NOT DONE||||CORD BLOOD|AGGLUTINATED|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||NA|NA|N|Y|||U|2||58||BLINDED TREATMENT|1964-12-12|1969-12-18|||||1962-05-29||1963-01-13|NA|1971-11-21
TRIAL STUDY 134XCP|LB|F09C04A4-4F9E-4033-9115-81C6007DE8B4|2||||HLAMSC|HLA MISMATCH COUNT|||||||IU/DL|||||||INVALID||PG/L||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|ICTERIC|NA|MUGA|GMI % FORMULA||N|Y|Y|Y|||N|2||58||WASHOUT|1968-05-29|1960-03-13|||||1963-04-10||1965-07-10|N|1962-01-05
TRIAL STUDY 134XCP|LB|F09C04A4-4F9E-4033-9115-81C6007DE8B4|1||||GLOBGPT|GAMMA GLOBULIN/TOTAL PROTEIN|||||||U/L|||||||BORDERLINE||%(V/V)||||HIGH|NOT DONE||||MENSTRUAL BLOOD|THAWED|NA|TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|NA|Y|||U|3||39||WASHOUT|1961-08-30|1966-06-29|||||1973-06-25||1972-02-14|Y|1960-08-03
TRIAL STUDY 134XCP|LB|F09C04A4-4F9E-4033-9115-81C6007DE8B4|2||||DSG1AB|DESMOGLEIN 1 ANTIBODY|||||||/100 WBC|||||||POSITIVE||MG||||NORMAL|NOT DONE||||ARTERIAL BLOOD|THAWED|Y|DIFFUSION WEIGHTED MRI|CKD-EPI CYSTATIN C FORMULA||NA|NA|Y|N|||NA|3||39||FOLLOW-UP|1967-12-05|1966-04-28|||||1971-07-03||1962-12-08|NA|1966-08-06
TRIAL STUDY 134XCP|LB|F09C04A4-4F9E-4033-9115-81C6007DE8B4|1||||C130110|MOLD MIX ANTIGEN IGG ANTIBODY|||||||DRAM|||||||INDETERMINATE||10^6 CFU/G||||NORMAL|NOT DONE||||CALCULUS|UNEXPECTED ODOR|Y|MYELOPEROXIDASE STAIN|ASH FIBROSURE FORMULA||Y|N|U|Y|||U|4||88||BASELINE|1970-02-13|1973-08-31|||||1966-11-22||1963-03-28|Y|1965-02-06
TRIAL STUDY 134XCP|LB|F09C04A4-4F9E-4033-9115-81C6007DE8B4|2||||IGFBP2|INSULIN-LIKE GROWTH FACTOR BINDING PROT2|||||||KG/CM|||||||POSITIVE||SACHET||||LOW|NOT DONE||||VENOUS CORD BLOOD|ROOM TEMPERATURE|Y|SEQUENCING|HEPASCORE FORMULA||Y|N|Y|Y|||N|4||88||FOLLOW-UP|1969-04-19|1962-05-15|||||1967-05-27||1969-06-23|U|1965-08-24
TRIAL STUDY 134XCP|LB|F09C04A4-4F9E-4033-9115-81C6007DE8B4|1||||ANDSTNDN|ANDROSTENEDIONE|||||||CL|||||||BORDERLINE||MMHG||||LOW|NOT DONE||||LOCHIA|LACTESCENT|U|AUTOMATED COUNT|MDRD FORMULA||NA|U|U|U|||U|5||7||CONTINUATION TREATMENT|1971-08-10|1964-06-13|||||1960-06-10||1971-08-02|Y|1968-10-01
TRIAL STUDY 134XCP|LB|F09C04A4-4F9E-4033-9115-81C6007DE8B4|2||||VLDL|VLDL CHOLESTEROL|||||||UL|||||||BORDERLINE||F||||HIGH|NOT DONE||||SUPERNATANT, SERUM|ROOM TEMPERATURE|Y|WESTERN BLOT|FIBROSIS 4 FORMULA||N|U|N|Y|||Y|5||7||BLINDED TREATMENT|1964-04-13|1972-05-11|||||1969-08-15||1968-11-29|Y|1969-10-21
TRIAL STUDY 134XCP|LB|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|1||||TRGTCE|TARGET CELLS|||||||OZ EQ|||||||BORDERLINE||ML/ANIMAL||||NORMAL|NOT DONE||||REFLEX TEAR|AUTOLYZED|Y|NEXT GENERATION SEQUENCING|MDRD 6 VARIABLE FORMULA||U|NA|N|NA|||NA|1||38||INDUCTION TREATMENT|1964-06-04|1972-07-30|||||1970-05-05||1971-11-15|NA|1964-04-24
TRIAL STUDY 134XCP|LB|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|2||||C165934|ARACHIS HYPOGAEA IGE AB RAST SCORE|||||||DEG/MM|||||||TRACE||BREATHS/MIN||||NORMAL|NOT DONE||||PLASMA|AUTOLYZED|N|INFRARED SPECTROMETRY|NASH FIBROSURE FORMULA||U|U|NA|U|||NA|1||38||FOLLOW-UP|1968-02-01|1972-03-17|||||1960-02-01||1961-10-02|NA|1961-04-12
TRIAL STUDY 134XCP|LB|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|1||||NEUTHYGR|HYPOGRANULAR NEUTROPHILS|||||||MOSM|||||||NEGATIVE||PA||||LOW|NOT DONE||||HAIR FOLLICLE|FROZEN|NA|ELECTRONEUROGRAPHY|CKD-EPI CREATININE FORMULA||N|U|NA|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1970-03-02|1964-09-13|||||1961-01-06||1964-01-14|U|1971-10-22
TRIAL STUDY 134XCP|LB|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|2||||C147285|COMMON RAGWEED POLLEN IGE ANTIBODY|||||||OD UNIT|||||||POSITIVE||MN||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|DRIED|Y|ETDRS EYE CHART|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|U|N|||NA|2||58||LONG-TERM FOLLOW-UP|1960-07-06|1971-09-01|||||1961-10-16||1961-03-12|Y|1965-05-11
TRIAL STUDY 134XCP|LB|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|1||||ASN|ASPARAGINE|||||||PA|||||||BORDERLINE||ML/BEAT||||LOW|NOT DONE||||DERMAL TISSUE|GELLED|N|SLOAN LETTER EYE CHART 100%|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|N|U|||U|3||39||LONG-TERM FOLLOW-UP|1970-07-01|1972-01-28|||||1970-02-22||1972-09-24|U|1962-04-29
TRIAL STUDY 134XCP|LB|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|2||||C130117|BEE MIX ANTIGEN IGG ANTIBODY|||||||FMOL/L|||||||INDETERMINATE||PA||||LOW|NOT DONE||||MONOCYTE|FRESH|NA|CYSTOMETRY|CKD-EPI FORMULA||U|NA|U|U|||U|3||39||WASHOUT|1964-08-07|1964-01-31|||||1967-08-24||1973-01-12|N|1965-07-27
TRIAL STUDY 134XCP|LB|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|1||||PSIGAAB|PHOSPHATIDYLSERINE IGA ANTIBODY|||||||COPIES/UL|||||||POSITIVE||10^6 ORGANISMS/ML||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|CONCENTRATED|Y|RIA|MDRD 5 VARIABLE FORMULA||U|N|Y|Y|||Y|4||88||CONTINUATION TREATMENT|1962-03-08|1964-03-17|||||1972-12-23||1963-04-18|Y|1971-06-19
TRIAL STUDY 134XCP|LB|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|2||||HSP70|HEAT SHOCK PROTEIN 70|||||||MHZ|||||||INVALID||CM/MIN||||HIGH|NOT DONE||||GASTRIC CONTENTS|UNEXPECTED ODOR|U|HILLMEN COLOR CHART|MDRD 4 VARIABLE FORMULA||NA|U|NA|NA|||U|4||88||WASHOUT|1967-09-01|1973-02-12|||||1966-06-24||1961-11-01|U|1969-01-27
TRIAL STUDY 134XCP|LB|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|1||||LYMPL|PLASMACYTOID LYMPHOCYTES|||||||BQ|||||||INVALID||PACKET||||HIGH|NOT DONE||||DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR|NA|SNP ARRAY|GMI % FORMULA||N|Y|N|U|||U|5||7||SCREENING|1960-04-02|1962-03-08|||||1968-12-02||1967-02-13|U|1962-02-08
TRIAL STUDY 134XCP|LB|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|2||||AMYLASEP|AMYLASE, PANCREATIC|||||||SCM|||||||INDETERMINATE||UG/M2||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|CONCENTRATED|N|EEG|MDRD FORMULA||U|U|NA|Y|||N|5||7||OPEN LABEL TREATMENT|1964-09-15|1965-08-23|||||1970-03-08||1969-10-25|NA|1960-03-01
TRIAL STUDY 134XCP|LB|4779A01C-1219-46AC-B0F7-71C9717A2B45|1||||PAI1AG|PLASMINOGEN ACTIVATOR INHIBITOR-1 AG|||||||PG/DL|||||||NEGATIVE||DEG/MM||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CLOTTED|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|FIBROTEST FORMULA||Y|U|Y|N|||N|1||38||INDUCTION TREATMENT|1961-12-19|1961-11-29|||||1972-06-04||1961-08-15|Y|1969-03-21
TRIAL STUDY 134XCP|LB|4779A01C-1219-46AC-B0F7-71C9717A2B45|2||||MCPHGCE|MACROPHAGES/TOTAL CELLS|||||||BU|||||||POSITIVE||TRANSDUCING UNIT||||ABNORMAL|NOT DONE||||VENOUS PLASMA|CONTAMINATED|NA|HILLMEN COLOR CHART|FIBROMETER FORMULA||Y|N|Y|N|||Y|1||38||BLINDED TREATMENT|1964-07-07|1968-10-26|||||1970-04-18||1966-01-28|NA|1962-06-05
TRIAL STUDY 134XCP|LB|4779A01C-1219-46AC-B0F7-71C9717A2B45|1||||PLTAGAMP|PLATELET AGGREGATION AMPLITUDE|||||||10^10/L|||||||INVALID||/2500 WBC||||NORMAL|NOT DONE||||SPERMATOZOON|ICTERIC|Y|MICRONEUTRALIZATION ASSAY|NASH FIBROSURE FORMULA||N|N|N|U|||Y|2||58||CONTINUATION TREATMENT|1967-04-04|1964-07-01|||||1963-06-05||1961-05-17|N|1964-06-21
TRIAL STUDY 134XCP|LB|4779A01C-1219-46AC-B0F7-71C9717A2B45|2||||TNF12|TNF SUPERFAMILY MEMBER 12|||||||UMOL/L/MIN|||||||INVALID||BOLUS||||LOW|NOT DONE||||MECONIUM|GELLED|U|IMMUNOTURBIDIMETRY|MDRD 4 VARIABLE FORMULA||U|NA|NA|N|||U|2||58||TREATMENT|1965-09-24|1969-11-01|||||1968-09-13||1967-12-02|NA|1970-10-09
TRIAL STUDY 134XCP|LB|4779A01C-1219-46AC-B0F7-71C9717A2B45|1||||CRYGLBSR|CRYOGLOBULIN VOLUME/SERUM VOLUME|||||||MS/MMHG|||||||INDETERMINATE||ML/KG/MIN||||ABNORMAL|NOT DONE||||EMESIS|CONTAMINATED|NA|IMMUNOPRECIPITATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|NA|U|||NA|3||39||OBSERVATION|1968-01-12|1970-06-21|||||1968-04-04||1962-02-15|Y|1964-03-15
TRIAL STUDY 134XCP|LB|4779A01C-1219-46AC-B0F7-71C9717A2B45|2||||NEUTSGB|NEUTROPHILS, SEGMENTED + BAND FORM|||||||GBQ|||||||TRACE||TABLET||||NORMAL|NOT DONE||||MECONIUM|HEMOLYZED|Y|PERIPHERAL ANGIOGRAPHY|FIBROSIS 4 FORMULA||U|NA|U|U|||Y|3||39||FOLLOW-UP|1973-01-19|1972-06-03|||||1973-05-13||1965-07-13|NA|1963-08-23
TRIAL STUDY 134XCP|LB|4779A01C-1219-46AC-B0F7-71C9717A2B45|1||||INTLK27|INTERLEUKIN 27|||||||MOL|||||||INVALID||HOUNSFIELD UNIT||||ABNORMAL|NOT DONE||||EXUDATE|CLOTTED|Y|CHROMATOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|N|NA|Y|||Y|4||88||BLINDED TREATMENT|1960-05-07|1972-07-23|||||1967-08-27||1968-04-24|NA|1961-02-22
TRIAL STUDY 134XCP|LB|4779A01C-1219-46AC-B0F7-71C9717A2B45|2||||RP3IGGAB|RNA POLYMERASE III IGG ANTIBODY|||||||MKAT|||||||POSITIVE||NMOL/DAY||||LOW|NOT DONE||||ARTERIAL BLOOD|CONTAMINATED|Y|DIRECT SEQUENCING|FIBROMETER FORMULA||NA|U|N|Y|||N|4||88||WASHOUT|1971-10-16|1972-06-19|||||1960-08-31||1966-07-27|Y|1971-03-19
TRIAL STUDY 134XCP|LB|4779A01C-1219-46AC-B0F7-71C9717A2B45|1||||GCSF|GRANULOCYTE COLONY STIMULATING FACTOR|||||||MAC50|||||||TRACE||TSP EQ||||LOW|NOT DONE||||FLUID|THAWED|N|IRON HEMATOXYLIN STAIN|MDRD 6 VARIABLE FORMULA||N|NA|Y|N|||Y|5||7||OPEN LABEL TREATMENT|1962-05-23|1967-06-23|||||1965-11-30||1965-05-20|N|1965-09-06
TRIAL STUDY 134XCP|LB|4779A01C-1219-46AC-B0F7-71C9717A2B45|2||||TT|THROMBIN TIME|||||||10^9/G|||||||POSITIVE||PACK||||LOW|NOT DONE||||VENOUS PLASMA|NON-HEMOLYZED|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|FIBROTEST FORMULA||U|N|N|U|||U|5||7||OPEN LABEL TREATMENT|1963-11-05|1961-03-16|||||1965-02-07||1968-01-30|U|1970-01-25
TRIAL STUDY 134XCP|LB|5F5C5DED-7547-40D2-9B34-77B37CCD7732|1||||YEASTHYP|YEAST HYPHAE|||||||CCID 50/ML|||||||BORDERLINE||DL||||LOW|NOT DONE||||ISOLATE|DRIED|NA|ELECTRICAL IMPEDANCE MYOGRAPHY|GMI % FORMULA||N|U|N|Y|||N|1||38||BLINDED TREATMENT|1965-03-19|1961-12-24|||||1964-07-11||1967-10-14|NA|1967-08-15
TRIAL STUDY 134XCP|LB|5F5C5DED-7547-40D2-9B34-77B37CCD7732|2||||HEPCIDIN|HEPCIDIN|||||||MU/L|||||||INDETERMINATE||MONTHS||||HIGH|NOT DONE||||SYNOVIAL FLUID|CLOTTED|Y|WHOLE TRANSCRIPTOME SEQUENCING|GMI % FORMULA||N|NA|Y|N|||NA|1||38||BASELINE|1960-10-26|1969-08-14|||||1964-06-15||1966-12-17|N|1965-02-27
TRIAL STUDY 134XCP|LB|5F5C5DED-7547-40D2-9B34-77B37CCD7732|1||||VITA|VITAMIN A|||||||U/M2/DAY|||||||INVALID||HPA||||LOW|NOT DONE||||PLATELET|CONCENTRATED|Y|STATIC PERIMETRY|FIBROSIS 4 FORMULA||U|NA|Y|Y|||NA|2||58||WASHOUT|1970-04-10|1967-09-25|||||1966-03-19||1961-08-23|NA|1971-12-03
TRIAL STUDY 134XCP|LB|5F5C5DED-7547-40D2-9B34-77B37CCD7732|2||||PKM|PYRUVATE KINASE MUSCLE ISOZYME|||||||FT|||||||BORDERLINE||ML/CAGE/DAY||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|CALCIFIED|NA|SINGLE-MOLECULE ARRAY|FIBROSIS 4 FORMULA||NA|Y|Y|NA|||N|2||58||WASHOUT|1964-03-14|1968-09-17|||||1970-01-16||1971-07-21|NA|1964-12-11
TRIAL STUDY 134XCP|LB|5F5C5DED-7547-40D2-9B34-77B37CCD7732|1||||ANA|ANTINUCLEAR ANTIBODIES|||||||FRAMES/S|||||||BORDERLINE||MG/KG/WEEK||||HIGH|NOT DONE||||ISOLATE|ROOM TEMPERATURE|U|MANUAL CLOT DETECTION|MDRD FORMULA||NA|U|NA|N|||Y|3||39||INDUCTION TREATMENT|1961-08-04|1963-07-18|||||1971-11-20||1971-08-18|U|1960-10-29
TRIAL STUDY 134XCP|LB|5F5C5DED-7547-40D2-9B34-77B37CCD7732|2||||KLK2|KALLIKREIN-2|||||||/MS|||||||POSITIVE||BE/ML||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|FROZEN|Y|CONTRAST ENHANCED SPIRAL CT SCAN|MDRD 6 VARIABLE FORMULA||Y|NA|Y|NA|||N|3||39||RUN-IN|1961-01-22|1966-04-07|||||1971-11-08||1960-04-12|N|1973-08-13
TRIAL STUDY 134XCP|LB|5F5C5DED-7547-40D2-9B34-77B37CCD7732|1||||NEUTLE|NEUTROPHILS/LEUKOCYTES|||||||MG/M2/MIN|||||||NEGATIVE||/CMH2O||||ABNORMAL|NOT DONE||||VENOUS PLASMA|FRESH|U|ORCHIDOMETERY|MDRD 5 VARIABLE FORMULA||NA|NA|N|Y|||N|4||88||FOLLOW-UP|1963-02-03|1964-07-13|||||1972-05-17||1966-09-17|Y|1971-09-26
TRIAL STUDY 134XCP|LB|5F5C5DED-7547-40D2-9B34-77B37CCD7732|2||||LYM|LYMPHOCYTES|||||||MV|||||||NEGATIVE||MKAT||||HIGH|NOT DONE||||EPITHELIAL CELL|SOLIDIFIED|U|RYAN BLUE STAIN|FIBROTEST FORMULA||Y|U|N|NA|||N|4||88||WASHOUT|1961-10-05|1972-01-16|||||1963-06-17||1961-05-11|NA|1971-07-15
TRIAL STUDY 134XCP|LB|5F5C5DED-7547-40D2-9B34-77B37CCD7732|1||||ESTFR|ESTRADIOL, FREE|||||||ML/DOSE|||||||INDETERMINATE||KV||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED|Y|HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI CREATININE FORMULA||NA|N|NA|Y|||NA|5||7||SCREENING|1973-03-16|1960-04-15|||||1970-10-10||1965-10-03|Y|1962-05-20
TRIAL STUDY 134XCP|LB|5F5C5DED-7547-40D2-9B34-77B37CCD7732|2||||CSBROAD|BROAD CASTS|||||||AMOL|||||||INDETERMINATE||G/CAGE||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|CLOTTED|NA|MICROBIAL CULTURE|MDRD 6 VARIABLE FORMULA||NA|NA|U|Y|||Y|5||7||TREATMENT|1968-07-08|1971-06-15|||||1960-04-07||1967-09-19|Y|1966-06-06
TRIAL STUDY 134XCP|LB|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|1||||TGFB|TRANSFORMING GROWTH FACTOR BETA|||||||MPL U/ML|||||||INDETERMINATE||GENEQ||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|HEMOLYZED|U|PUPILLOMETRY|MDRD 5 VARIABLE FORMULA||NA|NA|U|U|||U|1||38||LONG-TERM FOLLOW-UP|1963-01-12|1971-06-06|||||1965-06-08||1970-01-30|NA|1964-09-04
TRIAL STUDY 134XCP|LB|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|2||||APPA|AMYLOID ALPHA PRECURSOR PROTEIN|||||||CI/ML|||||||INVALID||MG/ML/DAY||||NORMAL|NOT DONE||||SPERMATOZOON|PARAFFIN-EMBEDDED|U|INTRAVASCULAR ULTRASOUND|CKD-EPI CYSTATIN C FORMULA||U|U|U|NA|||U|1||38||CONTINUATION TREATMENT|1964-03-30|1971-08-22|||||1973-04-09||1962-10-24|NA|1967-04-15
TRIAL STUDY 134XCP|LB|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|1||||PEPSNGC|PEPSINOGEN C|||||||MOL/ML|||||||NEGATIVE||UM2||||NORMAL|NOT DONE||||HAIR FOLLICLE|CLOTTED|N|SECONDARY ION MASS SPECTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|NA|N|||N|2||58||TREATMENT|1964-12-04|1961-07-31|||||1965-02-11||1960-12-05|U|1960-04-16
TRIAL STUDY 134XCP|LB|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|2||||CA2729AG|CANCER ANTIGEN 27-29|||||||ARBITRARY U|||||||BORDERLINE||NG/L||||LOW|NOT DONE||||SKIN TISSUE|FRESH|U|LIGHT SCATTERING SPECTROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|NA|||N|2||58||OBSERVATION|1969-01-20|1967-08-29|||||1962-12-21||1970-01-08|U|1961-12-17
TRIAL STUDY 134XCP|LB|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|1||||C147283|WHITE ELM POLLEN IGG ANTIBODY|||||||LOG10 TCID 50/UL|||||||BORDERLINE||VG/KG||||NORMAL|NOT DONE||||SEBUM|LIPEMIC|N|PERIODIC ACID SCHIFF STAIN|FIBROMETER FORMULA||N|NA|N|U|||NA|3||39||TREATMENT|1968-08-28|1972-03-31|||||1972-10-12||1966-02-22|N|1972-04-26
TRIAL STUDY 134XCP|LB|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|2||||VWFAC|VON WILL FACTOR ACTUAL/CONTROL|||||||GTT|||||||INDETERMINATE||MILE||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|ICTERIC|NA|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD ENZYMATIC FORMULA||U|Y|Y|NA|||Y|3||39||LONG-TERM FOLLOW-UP|1969-01-04|1970-06-17|||||1961-06-05||1967-06-09|N|1962-05-29
TRIAL STUDY 134XCP|LB|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|1||||DOPAMINE|DOPAMINE|||||||U/KG/H|||||||TRACE||PNU/ML||||LOW|NOT DONE||||WHITE MATTER TISSUE|DRIED|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|CKD-EPI CREATININE FORMULA||U|U|U|N|||U|4||88||WASHOUT|1961-08-14|1972-06-06|||||1969-05-17||1962-03-21|U|1972-06-30
TRIAL STUDY 134XCP|LB|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|2||||HER2S|SOLUBLE HER2|||||||LOG10 COPIES/ML|||||||POSITIVE||CP||||LOW|NOT DONE||||CAPILLARY PLASMA|AGGLUTINATED|N|TEMPLATE INCISION METHOD|CKD-EPI FORMULA||N|NA|U|NA|||Y|4||88||BASELINE|1973-06-19|1972-05-12|||||1966-02-15||1963-04-20|U|1971-03-20
TRIAL STUDY 134XCP|LB|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|1||||RITALAC|RITALINIC ACID|||||||CY/CM|||||||BORDERLINE||NMOL/L/H||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|NON-HEMOLYZED|Y|REFRACTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|U|U|||NA|5||7||OPEN LABEL TREATMENT|1968-12-03|1971-01-31|||||1970-07-25||1962-11-16|U|1971-03-11
TRIAL STUDY 134XCP|LB|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|2||||ANABASN|ANABASINE|||||||PIXELS/CM|||||||BORDERLINE||UEQ||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|FROZEN|N|ANTIBIOTIC AGAR SCREEN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|Y|NA|||NA|5||7||TREATMENT|1968-06-11|1972-02-17|||||1960-05-20||1971-06-06|NA|1970-04-13
TRIAL STUDY 134XCP|LB|48348DF0-33DA-457F-86C6-797FF7B32857|1||||IC512AB|ISLET CELL 512 ANTIBODY|||||||MOL/MOL|||||||POSITIVE||100 IU/ML||||HIGH|NOT DONE||||PLEURAL FLUID|CONTAMINATED|N|HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD 4 VARIABLE FORMULA||Y|NA|U|U|||U|1||38||INDUCTION TREATMENT|1969-10-10|1961-10-01|||||1964-10-19||1971-08-13|NA|1968-12-29
TRIAL STUDY 134XCP|LB|48348DF0-33DA-457F-86C6-797FF7B32857|2||||SODMEXR|SODIUM EXCRETION RATE|||||||DYN|||||||BORDERLINE||CUP||||LOW|NOT DONE||||CORD BLOOD|CALCIFIED|NA|ACRIDINE ORANGE STAIN|FIBROSIS 4 FORMULA||U|N|NA|Y|||NA|1||38||FOLLOW-UP|1961-04-22|1969-12-26|||||1967-07-18||1966-06-10|U|1963-04-19
TRIAL STUDY 134XCP|LB|48348DF0-33DA-457F-86C6-797FF7B32857|1||||GLOBGPT|GAMMA GLOBULIN/TOTAL PROTEIN|||||||HOURS|||||||NEGATIVE||NMOL||||NORMAL|NOT DONE||||NAIL|SOLIDIFIED|Y|CONTRAST ENHANCED PET/CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|N|N|||N|2||58||LONG-TERM FOLLOW-UP|1968-09-09|1961-01-15|||||1962-03-13||1970-02-18|NA|1961-03-21
TRIAL STUDY 134XCP|LB|48348DF0-33DA-457F-86C6-797FF7B32857|2||||NPAP|NON-PROSTATIC ACID PHOSPHATASE|||||||U/G/DAY|||||||BORDERLINE||MMOL/MIN/KPA||||ABNORMAL|NOT DONE||||LOCHIA|REFRIGERATED|U|LAPAROSCOPY|NASH FIBROSURE FORMULA||U|NA|Y|N|||N|2||58||FOLLOW-UP|1964-02-22|1970-09-01|||||1964-12-03||1972-12-09|N|1961-03-11
TRIAL STUDY 134XCP|LB|48348DF0-33DA-457F-86C6-797FF7B32857|1||||GLDIGGAB|GLIADIN IGG ANTIBODY|||||||MG/H|||||||TRACE||IU/MMOL||||HIGH|NOT DONE||||CERUMEN|CLOTTED|U|KLEIHAUER-BETKE|HEPASCORE FORMULA||Y|N|Y|NA|||U|3||39||OPEN LABEL TREATMENT|1968-07-27|1961-11-21|||||1968-04-16||1970-01-18|U|1970-11-06
TRIAL STUDY 134XCP|LB|48348DF0-33DA-457F-86C6-797FF7B32857|2||||YEASTBUD|YEAST BUDDING|||||||COPIES/ML|||||||TRACE||NMOL/G||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|ICTERIC|U|DNA MICROARRAY|CKD-EPI FORMULA||Y|N|NA|NA|||NA|3||39||CONTINUATION TREATMENT|1960-02-28|1969-05-17|||||1965-08-30||1970-06-19|NA|1962-09-08
TRIAL STUDY 134XCP|LB|48348DF0-33DA-457F-86C6-797FF7B32857|1||||CORTFR|CORTISOL, FREE|||||||AU/ML|||||||INVALID||UMOL/L/MIN||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|NON-HEMOLYZED|U|INTERRUPTER TECHNIQUE|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|NA|Y|||Y|4||88||FOLLOW-UP|1964-10-12|1960-07-02|||||1965-04-02||1961-03-14|Y|1967-06-11
TRIAL STUDY 134XCP|LB|48348DF0-33DA-457F-86C6-797FF7B32857|2||||PCT|PROCALCITONIN|||||||STRIP|||||||TRACE||NMOL/L/MIN||||NORMAL|NOT DONE||||ABSCESS FLUID|CALCIFIED|N|CLOT DETECTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|Y|Y|||Y|4||88||WASHOUT|1966-02-12|1971-03-22|||||1972-06-27||1966-09-16|N|1968-08-20
TRIAL STUDY 134XCP|LB|48348DF0-33DA-457F-86C6-797FF7B32857|1||||PROTPATN|PROTEIN PATTERN|||||||MGEQ|||||||NEGATIVE||MMOL/S||||NORMAL|NOT DONE||||SERUM OR PLASMA|AUTOLYZED|Y|JAFFE REACTION|ASH FIBROSURE FORMULA||NA|U|U|Y|||Y|5||7||TREATMENT|1963-11-13|1973-08-03|||||1972-05-17||1973-01-27|Y|1967-04-26
TRIAL STUDY 134XCP|LB|48348DF0-33DA-457F-86C6-797FF7B32857|2||||PUS|PUS|||||||OD UNIT|||||||INDETERMINATE||DPM/ML||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|NA|TONOMETRY|MDRD 6 VARIABLE FORMULA||Y|U|Y|N|||N|5||7||OBSERVATION|1967-03-30|1968-01-27|||||1965-09-24||1971-01-10|Y|1964-03-26
TRIAL STUDY 134XCP|LB|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|1||||C130081|ORCHARD GRASS POLLEN IGA|||||||AMOL|||||||NEGATIVE||JOULE||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|DRIED|NA|BALLPOINT PEN TECHNIQUE|MDRD ENZYMATIC FORMULA||N|NA|NA|NA|||NA|1||38||WASHOUT|1968-09-12|1962-03-17|||||1973-07-14||1968-10-21|Y|1969-08-30
TRIAL STUDY 134XCP|LB|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|2||||SOST|SCLEROSTIN|||||||10^6/L|||||||INVALID||FT2||||LOW|NOT DONE||||COLOSTRUM|ICTERIC|N|TONOMETRY|GMI MMOL/MOL FORMULA||NA|N|N|U|||NA|1||38||OBSERVATION|1971-03-30|1971-03-11|||||1960-05-25||1962-08-20|N|1972-06-07
TRIAL STUDY 134XCP|LB|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|1||||SODMEXR|SODIUM EXCRETION RATE|||||||MILE|||||||BORDERLINE||MG/DL||||LOW|NOT DONE||||CORD SERUM|FRESH|Y|MECHANICAL CLOT DETECTION|MDRD 4 VARIABLE FORMULA||N|Y|N|NA|||NA|2||58||INDUCTION TREATMENT|1964-07-12|1967-07-30|||||1970-06-05||1962-07-13|U|1968-10-07
TRIAL STUDY 134XCP|LB|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|2||||APPEAR|SPECIMEN APPEARANCE|||||||MOSM|||||||BORDERLINE||/WK||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|LIPEMIC|Y|MUGA|CKD-EPI FORMULA||U|NA|U|NA|||NA|2||58||SCREENING|1964-01-06|1968-08-31|||||1962-01-01||1964-11-24|NA|1966-01-27
TRIAL STUDY 134XCP|LB|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|1||||ICAB|ISLET CELL ANTIBODY|||||||/WK|||||||BORDERLINE||10^6 ORGANISMS/ML||||HIGH|NOT DONE||||MECONIUM|GELLED|U|MICROBIAL CULTURE|MDRD FORMULA||N|Y|NA|NA|||N|3||39||BASELINE|1960-03-17|1968-10-18|||||1961-05-04||1971-08-21|N|1970-08-23
TRIAL STUDY 134XCP|LB|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|2||||FEP|ERYTHROCYTE PROTOPORPHYRIN, FREE|||||||ML*CMH2O|||||||POSITIVE||CM/S||||LOW|NOT DONE||||LYSATE|SOLIDIFIED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|CKD-EPI CREATININE FORMULA||NA|NA|NA|NA|||N|3||39||LONG-TERM FOLLOW-UP|1962-02-21|1971-04-01|||||1964-01-29||1971-08-16|Y|1969-06-25
TRIAL STUDY 134XCP|LB|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|1||||NAGCREAT|N-ACETYL GLUCOSAMIDE/CREATININE|||||||NKAT/G HB|||||||BORDERLINE||ML/KG/DAY||||HIGH|NOT DONE||||INTERSTITIAL FLUID|FRESH|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|FIBROTEST FORMULA||N|N|Y|NA|||Y|4||88||OPEN LABEL TREATMENT|1973-06-22|1965-10-14|||||1963-07-21||1972-07-29|NA|1965-02-11
TRIAL STUDY 134XCP|LB|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|2||||INSAB|INSULIN ANTIBODY|||||||G/M2/DAY|||||||NEGATIVE||MOL/L||||HIGH|NOT DONE||||EMESIS|AUTOLYZED|Y|REVERSE TRANSCRIPTASE PCR|MDRD ENZYMATIC FORMULA||U|Y|N|NA|||NA|4||88||INDUCTION TREATMENT|1972-07-24|1960-01-16|||||1962-03-29||1965-04-25|NA|1961-05-15
TRIAL STUDY 134XCP|LB|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|1||||DALA|DELTA AMINOLEVULINATE|||||||KG/CM|||||||TRACE||ENZYME U/G HB||||NORMAL|NOT DONE||||SALIVA|PARAFFIN-EMBEDDED|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||U|N|Y|NA|||N|5||7||WASHOUT|1965-07-10|1969-11-21|||||1964-05-17||1967-11-09|U|1967-03-30
TRIAL STUDY 134XCP|LB|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|2||||VLDLPSZ|VLDL PARTICLE SIZE|||||||GLOBULE|||||||NEGATIVE||LOG10 COPIES/ML||||NORMAL|NOT DONE||||SERUM|AGGLUTINATED|N|ULTRASOUND|HEPASCORE FORMULA||N|Y|Y|U|||U|5||7||RUN-IN|1973-02-02|1970-01-18|||||1971-08-29||1960-06-19|N|1962-09-03
TRIAL STUDY 134XCP|LB|396CC122-5F23-418D-A75E-572ADF4FD6C1|1||||NPY|NEUROPEPTIDE Y|||||||10^4/L|||||||NEGATIVE||UG||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CALCIFIED|NA|IMMUNORADIOMETRIC ASSAY|CKD-EPI CREATININE FORMULA||N|U|NA|NA|||U|1||38||SCREENING|1965-11-09|1967-11-10|||||1973-03-23||1973-04-21|N|1963-06-19
TRIAL STUDY 134XCP|LB|396CC122-5F23-418D-A75E-572ADF4FD6C1|2||||C165893|WILD RYE POLLEN IGE AB RAST SCORE|||||||MEQ/UG|||||||INDETERMINATE||LOG10 CFU/G||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|PARAFFIN-EMBEDDED|Y|MODIFIED ACID FAST STAIN|FIBROSIS 4 FORMULA||NA|U|N|N|||Y|1||38||WASHOUT|1965-04-10|1967-05-27|||||1970-05-30||1971-07-27|NA|1963-10-24
TRIAL STUDY 134XCP|LB|396CC122-5F23-418D-A75E-572ADF4FD6C1|1||||ERCEMPOL|ERYTHROID MATURATION POOL|||||||GRAVITATIONAL UNIT|||||||INVALID||ENZYME U||||NORMAL|NOT DONE||||EMOTIONAL TEAR|FROZEN|U|SLIT LAMP PHOTOGRAPHY|ASH FIBROSURE FORMULA||Y|N|U|N|||N|2||58||CONTINUATION TREATMENT|1967-04-19|1961-01-26|||||1962-05-05||1965-04-01|Y|1963-05-11
TRIAL STUDY 134XCP|LB|396CC122-5F23-418D-A75E-572ADF4FD6C1|2||||C165926|MOLD MIX IGE AB RAST SCORE|||||||MONTHS|||||||POSITIVE||10^6 IU/ML||||NORMAL|NOT DONE||||CORD BLOOD|THAWED|NA|GEL ELECTROPHORESIS|MDRD 5 VARIABLE FORMULA||U|N|Y|N|||U|2||58||CONTINUATION TREATMENT|1961-06-08|1972-11-24|||||1965-04-13||1968-09-07|N|1973-01-21
TRIAL STUDY 134XCP|LB|396CC122-5F23-418D-A75E-572ADF4FD6C1|1||||EOSB|EOSINOPHILS BAND FORM|||||||NG/DAY|||||||INDETERMINATE||TRACE||||LOW|NOT DONE||||SYNOVIAL FLUID|LACTESCENT|N|AGAR PROPORTION|CKD-EPI FORMULA||N|U|Y|U|||Y|3||39||RUN-IN|1968-12-03|1972-12-09|||||1960-05-16||1968-10-14|N|1972-03-11
TRIAL STUDY 134XCP|LB|396CC122-5F23-418D-A75E-572ADF4FD6C1|2||||TGLOB|THYROGLOBULIN|||||||UCI/KG|||||||INVALID||UG/KG/MIN||||LOW|NOT DONE||||CEREBROSPINAL FLUID|ROOM TEMPERATURE|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|ASH FIBROSURE FORMULA||NA|N|NA|N|||Y|3||39||OBSERVATION|1971-11-16|1960-06-15|||||1968-01-05||1968-12-29|U|1970-06-10
TRIAL STUDY 134XCP|LB|396CC122-5F23-418D-A75E-572ADF4FD6C1|1||||CD8LY|CD8/LYMPHOCYTES|||||||10^6 IU|||||||INDETERMINATE||UV2||||HIGH|NOT DONE||||HAIR|CONCENTRATED|Y|FLUORESCEIN STAIN|MDRD ENZYMATIC FORMULA||N|NA|NA|NA|||N|4||88||FOLLOW-UP|1967-09-30|1972-03-04|||||1961-09-02||1970-02-02|Y|1968-03-30
TRIAL STUDY 134XCP|LB|396CC122-5F23-418D-A75E-572ADF4FD6C1|2||||CCL19|CHEMOKINE (C-C MOTIF) LIGAND 19|||||||NEBULE|||||||POSITIVE||RAD||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|GELLED|NA|BETA LACTAMASE|FIBROTEST FORMULA||NA|N|NA|NA|||NA|4||88||LONG-TERM FOLLOW-UP|1967-10-12|1972-01-13|||||1971-01-10||1961-10-13|NA|1965-12-26
TRIAL STUDY 134XCP|LB|396CC122-5F23-418D-A75E-572ADF4FD6C1|1||||C130123|NUT MIX ANTIGEN IGG ANTIBODY|||||||SCOOPFUL|||||||POSITIVE||PT_US||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|FROZEN|NA|FLOW CYTOMETRY|CKD-EPI CREATININE FORMULA||NA|U|NA|N|||Y|5||7||BLINDED TREATMENT|1969-11-15|1964-11-12|||||1960-06-03||1967-06-27|U|1972-08-28
TRIAL STUDY 134XCP|LB|396CC122-5F23-418D-A75E-572ADF4FD6C1|2||||METHPHEN|METHYLPHENIDATE|||||||PMOL/10^9 CELLS|||||||POSITIVE||STEPS||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|ICTERIC|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 5 VARIABLE FORMULA||NA|NA|U|N|||NA|5||7||BASELINE|1964-09-03|1970-09-30|||||1962-09-26||1965-11-10|N|1964-10-15
TRIAL STUDY 134XCP|LB|9CF3CD51-5D5B-40E6-8F13-B314911BE461|1||||C130086|ENGLISH PLANTAIN POLLEN IGG|||||||PPM|||||||INVALID||10^7 TCID 50/DOSE||||HIGH|NOT DONE||||BONE MARROW|AUTOLYZED|Y|IMMUNO-PET SCAN|COCKCROFT-GAULT FORMULA||N|NA|U|N|||N|1||38||RUN-IN|1969-07-09|1967-12-03|||||1966-05-19||1965-11-29|Y|1970-09-08
TRIAL STUDY 134XCP|LB|9CF3CD51-5D5B-40E6-8F13-B314911BE461|2||||CHRMTNAB|CHROMATIN ANTIBODIES|||||||MAMP|||||||INDETERMINATE||BP||||LOW|NOT DONE||||ALVEOLAR AIR|REFRIGERATED|NA|SANGER SEQUENCING|HEPASCORE FORMULA||NA|N|U|U|||Y|1||38||LONG-TERM FOLLOW-UP|1966-04-18|1969-05-13|||||1962-11-26||1969-04-08|NA|1969-10-11
TRIAL STUDY 134XCP|LB|9CF3CD51-5D5B-40E6-8F13-B314911BE461|1||||ANGTNS1|ANGIOTENSIN I|||||||RNA COPIES/ML|||||||BORDERLINE||U/ML||||ABNORMAL|NOT DONE||||TUMOR TISSUE|AGGLUTINATED|NA|POPULATION SEQUENCING|CKD-EPI FORMULA||N|U|NA|Y|||NA|2||58||BLINDED TREATMENT|1962-04-21|1961-08-06|||||1968-02-22||1965-08-09|N|1972-08-16
TRIAL STUDY 134XCP|LB|9CF3CD51-5D5B-40E6-8F13-B314911BE461|2||||INTLK29|INTERLEUKIN 29|||||||CAPLET|||||||INDETERMINATE||NGEQ/L||||HIGH|NOT DONE||||CELL PELLET|HEMOLYZED|NA|LASER CAPTURE MICRODISSECTION|FIBROTEST FORMULA||Y|U|NA|U|||NA|2||58||INDUCTION TREATMENT|1960-04-08|1966-08-27|||||1965-10-24||1961-07-26|U|1973-02-26
TRIAL STUDY 134XCP|LB|9CF3CD51-5D5B-40E6-8F13-B314911BE461|1||||AMYLOIDA|AMYLOID A|||||||ANTIBODY UNIT|||||||BORDERLINE||CMHG||||LOW|NOT DONE||||SWABBED MATERIAL|SOLIDIFIED|N|AUDIOMETRY|MDRD FORMULA||Y|N|NA|N|||Y|3||39||BASELINE|1963-03-24|1972-04-06|||||1963-06-04||1973-07-24|Y|1969-03-31
TRIAL STUDY 134XCP|LB|9CF3CD51-5D5B-40E6-8F13-B314911BE461|2||||MONMPHLE|MONOCYTES AND MACROPHAGES/LEUKOCYTES|||||||MEQ/ML|||||||NEGATIVE||KDA||||NORMAL|NOT DONE||||TUMOR TISSUE|CALCIFIED|NA|RIA|GMI % FORMULA||N|U|U|Y|||NA|3||39||SCREENING|1971-09-14|1960-09-19|||||1966-05-08||1961-07-18|NA|1968-05-13
TRIAL STUDY 134XCP|LB|9CF3CD51-5D5B-40E6-8F13-B314911BE461|1||||IL2SR|SOLUBLE INTERLEUKIN 2 RECEPTOR|||||||U.CARR|||||||TRACE||UG/L||||ABNORMAL|NOT DONE||||EXPIRED AIR|FRESH|Y|MODIFIED ACID FAST STAIN|GMI % FORMULA||U|Y|U|NA|||N|4||88||FOLLOW-UP|1965-11-15|1972-10-18|||||1961-11-25||1966-12-16|N|1962-08-17
TRIAL STUDY 134XCP|LB|9CF3CD51-5D5B-40E6-8F13-B314911BE461|2||||PYRIDNLN|PYRIDINOLINE|||||||MMOL/G|||||||TRACE||MG/KG/H||||LOW|NOT DONE||||CORD BLOOD|CONTAMINATED|N|GC/MS-EI|CKD-EPI FORMULA||N|NA|Y|NA|||NA|4||88||BLINDED TREATMENT|1968-08-01|1967-03-28|||||1972-04-15||1962-09-03|NA|1963-03-27
TRIAL STUDY 134XCP|LB|9CF3CD51-5D5B-40E6-8F13-B314911BE461|1||||ACYGLYCN|ACYLGLYCINE|||||||WEBER|||||||TRACE||/500 WBC||||NORMAL|NOT DONE||||URINE SEDIMENT|HEMOLYZED|Y|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|NASH FIBROSURE FORMULA||Y|NA|N|U|||NA|5||7||OPEN LABEL TREATMENT|1971-10-05|1969-03-21|||||1962-12-23||1968-05-15|NA|1963-09-15
TRIAL STUDY 134XCP|LB|9CF3CD51-5D5B-40E6-8F13-B314911BE461|2||||APOH|APOLIPOPROTEIN H|||||||UG/DOSE|||||||TRACE||GBQ/UG||||HIGH|NOT DONE||||INFRANATANT, PLASMA|THAWED|N|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD 6 VARIABLE FORMULA||NA|U|NA|N|||NA|5||7||OPEN LABEL TREATMENT|1961-10-19|1960-07-11|||||1972-11-30||1971-07-14|NA|1969-05-10
TRIAL STUDY 134XCP|LB|CB3B9054-5CDC-418D-8071-7429B1702587|1||||NCCPTN|NOCICEPTIN|||||||/4.0 ML|||||||INVALID||TAMPON||||LOW|NOT DONE||||FLUID|DRIED|Y|FLOW MICROSCOPY|MDRD 4 VARIABLE FORMULA||N|Y|N|U|||N|1||38||CONTINUATION TREATMENT|1969-09-19|1970-10-01|||||1966-08-16||1967-11-19|N|1966-03-28
TRIAL STUDY 134XCP|LB|CB3B9054-5CDC-418D-8071-7429B1702587|2||||METHANOL|METHANOL|||||||MEQ/KG|||||||INVALID||CARTRIDGE||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CONCENTRATED|U|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI FORMULA||U|N|N|NA|||NA|1||38||FOLLOW-UP|1972-02-16|1971-11-14|||||1960-10-13||1962-06-20|Y|1960-12-06
TRIAL STUDY 134XCP|LB|CB3B9054-5CDC-418D-8071-7429B1702587|1||||ANIONG4|ANION GAP 4|||||||ML/G/H|||||||BORDERLINE||EU||||NORMAL|NOT DONE||||HAIR|NON-HEMOLYZED|Y|MICROBIAL CONCENTRATION|MDRD FORMULA||N|Y|Y|NA|||Y|2||58||OPEN LABEL TREATMENT|1962-04-28|1965-05-24|||||1966-10-08||1965-03-19|NA|1960-06-27
TRIAL STUDY 134XCP|LB|CB3B9054-5CDC-418D-8071-7429B1702587|2||||ETPTPR|ETP TIME TO PEAK RELATIVE|||||||LOG10 CCID 50/DOSE|||||||POSITIVE||FMOL/G||||NORMAL|NOT DONE||||SEBUM|CALCIFIED|N|IMMUNOFIXATION ELECTROPHORESIS|MDRD FORMULA||NA|U|Y|U|||Y|2||58||BASELINE|1963-12-07|1961-08-15|||||1963-08-30||1965-04-26|Y|1968-12-03
TRIAL STUDY 134XCP|LB|CB3B9054-5CDC-418D-8071-7429B1702587|1||||APROTCRS|ACTIVATED PROTEIN C RESISTANCE|||||||U.CARR|||||||TRACE||QUANTITY SUFFICIENT||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CALCIFIED|NA|NEURAMINIDASE INHIBITION ASSAY|GMI % FORMULA||Y|NA|NA|Y|||U|3||39||BASELINE|1972-09-08|1972-09-14|||||1971-08-28||1966-07-03|NA|1972-12-07
TRIAL STUDY 134XCP|LB|CB3B9054-5CDC-418D-8071-7429B1702587|2||||PEPSNGA|PEPSINOGEN A|||||||/HPF|||||||TRACE||MBP||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|NON-HEMOLYZED|Y|TWO-COLOR MICROARRAY|FIBROMETER FORMULA||Y|U|N|Y|||U|3||39||BASELINE|1971-04-19|1964-07-07|||||1969-09-23||1962-08-20|N|1962-05-16
TRIAL STUDY 134XCP|LB|CB3B9054-5CDC-418D-8071-7429B1702587|1||||CYSTEINE|CYSTEINE|||||||BISCUIT|||||||INVALID||NMOL/ML/MIN||||ABNORMAL|NOT DONE||||TRANSUDATE|AGGLUTINATED|Y|POPULATION SEQUENCING|ASH FIBROSURE FORMULA||NA|U|NA|Y|||NA|4||88||SCREENING|1973-03-23|1969-06-03|||||1962-05-28||1968-06-08|U|1969-10-18
TRIAL STUDY 134XCP|LB|CB3B9054-5CDC-418D-8071-7429B1702587|2||||TSTFWTST|TESTOSTERONE FREE+WEAKLY BOUND/TESTOST|||||||SV|||||||INDETERMINATE||ENZYME U||||HIGH|NOT DONE||||CELL PELLET|NON-HEMOLYZED|NA|OBSERVATION|MDRD FORMULA||NA|U|U|Y|||NA|4||88||CONTINUATION TREATMENT|1969-03-12|1967-06-01|||||1965-05-24||1973-01-25|NA|1960-10-30
TRIAL STUDY 134XCP|LB|CB3B9054-5CDC-418D-8071-7429B1702587|1||||MCPHNSQE|MACROPHAGES/NON-SQUAM EPI CELLS|||||||MSEC|||||||BORDERLINE||NSEC||||ABNORMAL|NOT DONE||||PLASMA|PARAFFIN-EMBEDDED|NA|OPTICAL COHERENCE TOMOGRAPHY|FIBROTEST FORMULA||Y|NA|N|N|||NA|5||7||OBSERVATION|1963-11-21|1972-04-02|||||1966-12-11||1973-02-02|U|1966-09-29
TRIAL STUDY 134XCP|LB|CB3B9054-5CDC-418D-8071-7429B1702587|2||||BACT|BACTERIA|||||||HZ|||||||NEGATIVE||CARTRIDGE||||NORMAL|NOT DONE||||SEMEN|CLOTTED|NA|NEXT GENERATION TARGETED SEQUENCING|MDRD 4 VARIABLE FORMULA||U|Y|U|U|||NA|5||7||CONTINUATION TREATMENT|1962-09-15|1967-07-12|||||1968-08-17||1966-11-15|Y|1963-12-31
TRIAL STUDY 134XCP|LB|1AC4DE34-3486-41FB-A979-8B368912F75A|1||||T4|THYROXINE|||||||CIGAR|||||||NEGATIVE||MG/MIN||||ABNORMAL|NOT DONE||||EMESIS|HEMOLYZED|NA|PATHOLOGICAL EVALUATION|MDRD FORMULA||U|Y|N|Y|||Y|1||38||CONTINUATION TREATMENT|1960-08-29|1962-03-22|||||1960-11-20||1968-11-22|Y|1972-03-30
TRIAL STUDY 134XCP|LB|1AC4DE34-3486-41FB-A979-8B368912F75A|2||||MYCY|MYELOCYTES|||||||ML/G/MIN|||||||INVALID||IU/KG/H||||NORMAL|NOT DONE||||GASTRIC CONTENTS|GELLED|U|PH METER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA||Y|U|NA|N|||N|1||38||OBSERVATION|1968-12-10|1962-11-04|||||1970-07-03||1970-03-09|NA|1967-11-19
TRIAL STUDY 134XCP|LB|1AC4DE34-3486-41FB-A979-8B368912F75A|1||||ALPISOE|ALKALINE PHOSPHATASE ISOENZYME|||||||ML/CM|||||||TRACE||MGEQ||||NORMAL|NOT DONE||||SPERMATOZOON|SOLIDIFIED|N|FLOW CYTOMETRY|MDRD ENZYMATIC FORMULA||U|N|N|N|||NA|2||58||BLINDED TREATMENT|1963-05-06|1963-05-01|||||1970-12-25||1962-04-05|N|1960-05-20
TRIAL STUDY 134XCP|LB|1AC4DE34-3486-41FB-A979-8B368912F75A|2||||LKM1IAAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGA AB|||||||UMOL/DAY|||||||INDETERMINATE||10^9 CFU/G||||ABNORMAL|NOT DONE||||SOFT TISSUE|HEMOLYZED|NA|ICP-MS|MDRD 6 VARIABLE FORMULA||U|U|Y|U|||NA|2||58||INDUCTION TREATMENT|1960-03-18|1961-04-06|||||1965-10-05||1965-04-13|U|1963-10-21
TRIAL STUDY 134XCP|LB|1AC4DE34-3486-41FB-A979-8B368912F75A|1||||BILDIRBI|DIRECT BILIRUBIN/BILIRUBIN|||||||MANSON U/ML|||||||NEGATIVE||CIGAR||||NORMAL|NOT DONE||||BUFFY COAT|THAWED|N|CAPILLARY ELECTROPHORESIS|FIBROTEST FORMULA||U|N|U|N|||U|3||39||CONTINUATION TREATMENT|1963-05-30|1960-12-23|||||1965-04-29||1970-12-23|NA|1972-01-25
TRIAL STUDY 134XCP|LB|1AC4DE34-3486-41FB-A979-8B368912F75A|2||||MICROCY|MICROCYTES|||||||HPA|||||||INVALID||SBE/ML||||ABNORMAL|NOT DONE||||LAVAGE FLUID|FRESH|NA|NEXT GENERATION SEQUENCING|MDRD FORMULA||Y|NA|Y|U|||Y|3||39||LONG-TERM FOLLOW-UP|1965-03-07|1961-08-31|||||1962-06-24||1963-08-13|Y|1962-03-23
TRIAL STUDY 134XCP|LB|1AC4DE34-3486-41FB-A979-8B368912F75A|1||||CD33|CD33|||||||MMU/ML|||||||POSITIVE||MONTHS||||NORMAL|NOT DONE||||SEMINAL FLUID|CONCENTRATED|N|HIGH LEVEL AMINOGLYCOSIDE SCREEN|FIBROTEST FORMULA||N|NA|N|N|||N|4||88||FOLLOW-UP|1962-01-01|1966-08-18|||||1970-04-22||1965-07-09|Y|1961-05-01
TRIAL STUDY 134XCP|LB|1AC4DE34-3486-41FB-A979-8B368912F75A|2||||CD56|CD56|||||||NSEC|||||||NEGATIVE||KBQ||||ABNORMAL|NOT DONE||||PLATELET|HEMOLYZED|U|MRS|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|NA|||NA|4||88||SCREENING|1968-08-15|1961-07-24|||||1964-10-09||1961-06-04|U|1961-10-26
TRIAL STUDY 134XCP|LB|1AC4DE34-3486-41FB-A979-8B368912F75A|1||||PLTIMPLT|IMMATURE PLATELETS/TOTAL PLATELETS|||||||CAL|||||||INVALID||10^3 COPIES/ML||||LOW|NOT DONE||||BREAST MILK|AUTOLYZED|N|SLIT LAMP PHOTOGRAPHY|NASH FIBROSURE FORMULA||U|N|NA|N|||NA|5||7||BASELINE|1971-04-07|1960-07-04|||||1969-11-15||1963-09-28|Y|1971-01-03
TRIAL STUDY 134XCP|LB|1AC4DE34-3486-41FB-A979-8B368912F75A|2||||ALLOILE|ALLOISOLEUCINE|||||||DYN|||||||TRACE||U/G HB||||NORMAL|NOT DONE||||SEMEN|CONTAMINATED|N|HANSEL STAIN|MDRD ENZYMATIC FORMULA||NA|NA|U|N|||U|5||7||OPEN LABEL TREATMENT|1967-12-16|1964-11-07|||||1969-02-26||1967-06-29|Y|1966-01-22
TRIAL STUDY 134XCP|LB|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|1||||NEUTVAC|VACUOLATED NEUTROPHILS|||||||NEEDLE GAUGE|||||||INVALID||EU||||LOW|NOT DONE||||BLOOD|AGGLUTINATED|U|MANUAL CLOT DETECTION|MDRD 4 VARIABLE FORMULA||NA|U|N|N|||N|1||38||SCREENING|1967-11-05|1965-10-20|||||1970-08-07||1963-07-17|N|1966-08-19
TRIAL STUDY 134XCP|LB|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|2||||DHPG|3,4-DIHYDROXYPHENYLGLYCOL|||||||MEQ/DAY|||||||TRACE||10^4/HPF||||HIGH|NOT DONE||||TRANSUDATE|LACTESCENT|Y|FARNSWORTH-MUNSELL 100 HUE TEST|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|Y|NA|||N|1||38||OPEN LABEL TREATMENT|1962-07-21|1961-07-31|||||1960-07-08||1966-12-21|Y|1970-11-03
TRIAL STUDY 134XCP|LB|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|1||||COMP|CARTILAGE OLIGOMERIC MATRIX PROTEIN|||||||SCM|||||||NEGATIVE||GPELISA UNIT/ML||||HIGH|NOT DONE||||ARTERIAL BLOOD|CALCIFIED|U|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD ENZYMATIC FORMULA||U|N|U|U|||N|2||58||INDUCTION TREATMENT|1964-12-18|1961-07-04|||||1969-10-03||1967-02-10|N|1960-07-17
TRIAL STUDY 134XCP|LB|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|2||||C165909|INDUSTRIAL MIX IGG AB RAST SCORE|||||||MNFI|||||||BORDERLINE||10^9 ORGANISMS/G||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|NON-HEMOLYZED|NA|IODINE STAIN|GMI MMOL/MOL FORMULA||N|U|NA|N|||Y|2||58||TREATMENT|1965-04-22|1967-03-15|||||1967-12-23||1970-08-16|Y|1970-08-06
TRIAL STUDY 134XCP|LB|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|1||||SEDEXAM|SEDIMENT EXAMINATION|||||||UG/M2/H|||||||INDETERMINATE||10^6 RNA COPIES/ML||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|SOLIDIFIED|U|INDIRECT IMMUNOFLUORESCENCE|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|N|Y|||NA|3||39||CONTINUATION TREATMENT|1960-01-17|1968-04-10|||||1962-04-17||1962-03-30|NA|1965-02-03
TRIAL STUDY 134XCP|LB|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|2||||TSIAC|TSI ACTUAL/CONTROL|||||||DPM/0.5 ML|||||||BORDERLINE||% INHIBITION||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|HEMOLYZED|U|PHOTOGRAPHY|HEPASCORE FORMULA||Y|U|NA|Y|||U|3||39||OBSERVATION|1962-11-15|1962-09-01|||||1960-07-06||1968-11-13|NA|1965-04-05
TRIAL STUDY 134XCP|LB|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|1||||INTLK14|INTERLEUKIN 14|||||||DAMOL/L|||||||INVALID||UG/L DDU||||NORMAL|NOT DONE||||LUNG SURFACTANT|UNEXPECTED ODOR|Y|PET/MRI SCAN|FIBROTEST FORMULA||Y|NA|NA|NA|||N|4||88||LONG-TERM FOLLOW-UP|1969-09-05|1960-06-21|||||1973-02-09||1967-07-13|N|1968-03-07
TRIAL STUDY 134XCP|LB|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|2||||C130142|GERMAN COCKROACH ANTIGEN IGG ANTIBODY|||||||PNU/ML|||||||BORDERLINE||CS||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|HEMOLYZED|NA|VIRUS PLAQUE ASSAY|MDRD FORMULA||Y|N|N|Y|||Y|4||88||BASELINE|1971-01-09|1965-02-16|||||1964-12-12||1961-08-03|N|1963-04-24
TRIAL STUDY 134XCP|LB|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|1||||C130131|DOG DANDER ANTIGEN IGG4 ANTIBODY|||||||10^9/L|||||||TRACE||UGEQ/L||||ABNORMAL|NOT DONE||||KERATINOCYTE|CONCENTRATED|N|DROPLET DIGITAL PCR|FIBROSIS 4 FORMULA||U|U|Y|NA|||N|5||7||BLINDED TREATMENT|1965-03-07|1973-01-03|||||1967-04-20||1963-10-07|NA|1964-06-03
TRIAL STUDY 134XCP|LB|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|2||||APLSMA2A|ALPHA-2 ANTIPLASMIN ACTIVITY|||||||BEAM BREAKS|||||||TRACE||M2||||LOW|NOT DONE||||VENOUS BLOOD|ROOM TEMPERATURE|NA|GC/MS-EI|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|U|N|||U|5||7||LONG-TERM FOLLOW-UP|1966-07-22|1964-06-20|||||1968-02-22||1961-10-17|Y|1965-02-04
TRIAL STUDY 134XCP|LB|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|1||||CMPK2|CYTIDINE-URIDINE MONOPHOSPHATE KINASE 2|||||||MOL|||||||POSITIVE||STRIP||||NORMAL|NOT DONE||||EPITHELIAL CELL|PARAFFIN-EMBEDDED|N|REFLECTANCE SPECTROSCOPY|FIBROTEST FORMULA||U|NA|NA|U|||U|1||38||TREATMENT|1966-10-07|1972-06-30|||||1968-12-02||1963-08-23|Y|1960-02-16
TRIAL STUDY 134XCP|LB|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|2||||PROMYLE|PROMYELOCYTES/LEUKOCYTES|||||||GPL U/ML|||||||POSITIVE||10^6/HPF||||ABNORMAL|NOT DONE||||EXUDATE|ROOM TEMPERATURE|NA|DIGITAL PCR ARRAY|HEPASCORE FORMULA||N|NA|NA|U|||NA|1||38||OPEN LABEL TREATMENT|1972-08-25|1966-03-29|||||1971-04-15||1964-07-19|NA|1965-09-25
TRIAL STUDY 134XCP|LB|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|1||||PROPOX|PROPOXYPHENE|||||||UV*SEC|||||||POSITIVE||UMOL||||ABNORMAL|NOT DONE||||BLOOD|HEMOLYZED|N|ACRIDINE ORANGE STAIN|ASH FIBROSURE FORMULA||U|U|N|NA|||U|2||58||FOLLOW-UP|1970-02-25|1963-04-20|||||1969-03-01||1964-08-18|U|1966-01-15
TRIAL STUDY 134XCP|LB|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|2||||HBA1C|HEMOGLOBIN A1C|||||||P|||||||POSITIVE||GBQ/UG||||LOW|NOT DONE||||SALIVA|GELLED|U|RAJI CELL RIA|FIBROSIS 4 FORMULA||N|U|Y|NA|||Y|2||58||TREATMENT|1960-07-03|1964-08-14|||||1963-10-20||1969-06-12|U|1969-08-21
TRIAL STUDY 134XCP|LB|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|1||||TFRRNSAT|TRANSFERRIN SATURATION|||||||KBQ/UL|||||||TRACE||PT_US||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|AUTOLYZED|N|SPIROMETRY|MDRD 5 VARIABLE FORMULA||U|N|U|Y|||U|3||39||OPEN LABEL TREATMENT|1965-04-16|1963-05-03|||||1964-10-24||1963-07-06|N|1973-05-03
TRIAL STUDY 134XCP|LB|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|2||||EOSCE|EOSINOPHILS/TOTAL CELLS|||||||LM|||||||TRACE||F||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|CALCIFIED|N|FISH|CKD-EPI CREATININE FORMULA||Y|U|NA|N|||U|3||39||INDUCTION TREATMENT|1962-02-05|1971-06-03|||||1969-10-01||1973-06-28|N|1960-11-12
TRIAL STUDY 134XCP|LB|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|1||||APLSMA2A|ALPHA-2 ANTIPLASMIN ACTIVITY|||||||VP/DOSE|||||||TRACE||MET*H||||ABNORMAL|NOT DONE||||FLUID|THAWED|N|LEAD CITRATE STAIN|CKD-EPI FORMULA||Y|U|N|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1971-03-15|1969-07-23|||||1971-03-13||1960-04-08|Y|1969-06-21
TRIAL STUDY 134XCP|LB|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|2||||CYSTATC|CYSTATIN C|||||||L/S|||||||BORDERLINE||F||||NORMAL|NOT DONE||||BREAST MILK|CALCIFIED|U|CALCOFLUOR WHITE STAIN|CKD-EPI CYSTATIN C FORMULA||Y|Y|U|NA|||U|4||88||RUN-IN|1973-02-01|1962-07-27|||||1970-08-08||1966-12-22|N|1969-01-26
TRIAL STUDY 134XCP|LB|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|1||||CYAMPURT|AMORPHOUS URATE CRYSTALS|||||||DL|||||||INVALID||10^12/L||||ABNORMAL|NOT DONE||||LYSATE|FROZEN|Y|VENTILATION PERFUSION LUNG SCAN|FIBROMETER FORMULA||U|N|NA|N|||N|5||7||SCREENING|1972-11-13|1962-01-06|||||1961-10-18||1967-08-16|Y|1961-10-27
TRIAL STUDY 134XCP|LB|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|2||||INTLK28|INTERLEUKIN 28|||||||UG/M2/DAY|||||||TRACE||TITER||||HIGH|NOT DONE||||LYMPH|CONCENTRATED|NA|DC SHEATH FLOW|CKD-EPI FORMULA||NA|NA|NA|Y|||U|5||7||CONTINUATION TREATMENT|1967-11-01|1973-05-22|||||1964-07-16||1961-05-04|NA|1968-03-27
TRIAL STUDY 134XCP|LB|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|1||||CDT|CARBOHYDRATE-DEFICIENT TRANSFERRIN|||||||MMOL/KG|||||||TRACE||UEQ/L||||LOW|NOT DONE||||FLUID|CONCENTRATED|U|X-RAY|FIBROTEST FORMULA||NA|Y|U|N|||Y|1||38||LONG-TERM FOLLOW-UP|1961-03-11|1971-08-03|||||1963-04-01||1960-06-25|U|1972-04-28
TRIAL STUDY 134XCP|LB|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|2||||HYDCDN|HYDROCODONE|||||||CMOL|||||||INVALID||UG/L/H||||ABNORMAL|NOT DONE||||EXUDATE|CONTAMINATED|U|MIGET|CKD-EPI FORMULA||NA|U|N|Y|||N|1||38||BASELINE|1962-07-22|1970-12-23|||||1965-06-21||1962-06-06|NA|1963-02-05
TRIAL STUDY 134XCP|LB|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|1||||HLADR53A|HLA-DR53 ANTIBODY|||||||COPIES/UL|||||||BORDERLINE||SFC/10^6 PBMC||||ABNORMAL|NOT DONE||||SKIN TISSUE|CALCIFIED|N|BIOPSY|MDRD 4 VARIABLE FORMULA||N|Y|NA|U|||NA|2||58||RUN-IN|1967-08-28|1969-02-02|||||1971-03-22||1970-03-13|U|1964-08-10
TRIAL STUDY 134XCP|LB|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|2||||PROTEXR|PROTEIN EXCRETION RATE|||||||10^9 ORGANISMS/MG|||||||INVALID||ML/MMHG/MIN/L||||NORMAL|NOT DONE||||FLUID|GELLED|NA|CYSTOSCOPY|ASH FIBROSURE FORMULA||N|U|U|Y|||NA|2||58||SCREENING|1973-08-17|1967-12-06|||||1971-01-29||1971-07-13|U|1970-08-19
TRIAL STUDY 134XCP|LB|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|1||||FAS|FAS CELL SURFACE DEATH RECEPTOR|||||||G/CAGE/DAY|||||||BORDERLINE||ML/DOSE||||LOW|NOT DONE||||URINE|ICTERIC|N|MICROBIAL CULTURE, SOLID|FIBROMETER FORMULA||N|N|NA|U|||U|3||39||LONG-TERM FOLLOW-UP|1961-03-05|1967-04-29|||||1973-09-03||1963-07-03|N|1966-03-26
TRIAL STUDY 134XCP|LB|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|2||||KIM1S|SOLUBLE KIDNEY INJURY MOLECULE-1|||||||MOSM/L|||||||BORDERLINE||UMOL/MOL||||HIGH|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LACTESCENT|Y|AMSLER GRID|FIBROTEST FORMULA||U|N|U|U|||Y|3||39||SCREENING|1970-09-16|1964-05-06|||||1962-02-06||1965-06-07|NA|1966-09-12
TRIAL STUDY 134XCP|LB|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|1||||MCHC|ERY. MEAN CORPUSCULAR HGB CONCENTRATION|||||||UIU/L|||||||TRACE||/7.5 ML||||HIGH|NOT DONE||||PERITONEAL FLUID|NON-HEMOLYZED|U|FREEZING POINT DEPRESSION|NASH FIBROSURE FORMULA||U|NA|U|NA|||N|4||88||FOLLOW-UP|1970-05-02|1972-08-07|||||1966-04-28||1964-03-23|N|1961-11-16
TRIAL STUDY 134XCP|LB|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|2||||FACTVW|VON WILLEBRAND FACTOR|||||||%/S|||||||NEGATIVE||EP U||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|DRIED|N|SINGLE-MOLECULE ARRAY|MDRD ENZYMATIC FORMULA||Y|U|U|U|||NA|4||88||CONTINUATION TREATMENT|1968-01-09|1962-10-22|||||1961-02-26||1967-05-21|NA|1961-04-30
TRIAL STUDY 134XCP|LB|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|1||||MONOPTPT|MONOCLONAL PROTEIN/TOTAL PROTEIN|||||||CI/UL|||||||NEGATIVE||DAGU||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|CALCIFIED|U|DNA MICROARRAY|MDRD FORMULA||NA|U|NA|N|||NA|5||7||INDUCTION TREATMENT|1965-09-16|1971-01-07|||||1970-10-02||1965-07-22|N|1972-06-08
TRIAL STUDY 134XCP|LB|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|2||||WBCCE|LEUKOCYTES/TOTAL CELLS|||||||UIU/DL|||||||TRACE||LENS||||NORMAL|NOT DONE||||SERUM|FROZEN|N|MIGET|MDRD 4 VARIABLE FORMULA||N|U|U|Y|||NA|5||7||RUN-IN|1965-03-12|1968-12-26|||||1972-08-30||1969-02-13|NA|1967-01-01
TRIAL STUDY 134XCP|LB|0194CD2F-7ABE-4BEE-A6FC-61298880173D|1||||MDZLM|MIDAZOLAM|||||||PHERESIS UNIT|||||||INDETERMINATE||MET||||NORMAL|NOT DONE||||ADIPOSE TISSUE|CONCENTRATED|U|NUCLEIC ACID AMPLIFICATION TEST|MDRD ENZYMATIC FORMULA||Y|U|U|N|||NA|1||38||SCREENING|1966-01-26|1960-06-30|||||1960-01-30||1970-10-25|Y|1964-02-10
TRIAL STUDY 134XCP|LB|0194CD2F-7ABE-4BEE-A6FC-61298880173D|2||||PARICEAB|PARIETAL CELL ANTIBODY|||||||COAT|||||||NEGATIVE||TUBE||||HIGH|NOT DONE||||PLASMA|CONCENTRATED|Y|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||N|N|N|Y|||N|1||38||WASHOUT|1967-12-13|1973-05-24|||||1970-05-21||1962-06-04|Y|1965-06-18
TRIAL STUDY 134XCP|LB|0194CD2F-7ABE-4BEE-A6FC-61298880173D|1||||NEUTB|NEUTROPHILS BAND FORM|||||||BREATHS/30S|||||||INDETERMINATE||GPL U||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|REFRIGERATED|N|MICROARRAY|GMI MMOL/MOL FORMULA||NA|N|Y|Y|||N|2||58||SCREENING|1968-08-19|1970-11-09|||||1963-01-09||1969-05-27|Y|1967-07-18
TRIAL STUDY 134XCP|LB|0194CD2F-7ABE-4BEE-A6FC-61298880173D|2||||DRVVTSCR|DRVVT SCREEN TO CONFIRM RATIO|||||||CGY|||||||NEGATIVE||KG/M2||||ABNORMAL|NOT DONE||||CORD BLOOD|HEMOLYZED|NA|NO INFORMATION|ASH FIBROSURE FORMULA||U|Y|Y|Y|||NA|2||58||CONTINUATION TREATMENT|1962-12-05|1960-05-02|||||1973-08-21||1966-05-19|Y|1968-06-06
TRIAL STUDY 134XCP|LB|0194CD2F-7ABE-4BEE-A6FC-61298880173D|1||||C130083|ORCHARD GRASS POLLEN IGG4|||||||ABSORBANCE U|||||||NEGATIVE||GBQ/G||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|LIPEMIC|NA|SECONDARY ION MASS SPECTOMETRY|MDRD ENZYMATIC FORMULA||N|Y|U|Y|||N|3||39||BASELINE|1970-03-20|1966-04-27|||||1967-09-04||1972-01-01|U|1971-10-18
TRIAL STUDY 134XCP|LB|0194CD2F-7ABE-4BEE-A6FC-61298880173D|2||||CCL17|CHEMOKINE (C-C MOTIF) LIGAND 17|||||||L/S|||||||INVALID||ML/KG/H||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|UNEXPECTED ODOR|Y|TOLUIDINE BLUE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|NA|U|||NA|3||39||INDUCTION TREATMENT|1965-06-05|1963-01-10|||||1964-01-22||1962-09-28|NA|1973-05-27
TRIAL STUDY 134XCP|LB|0194CD2F-7ABE-4BEE-A6FC-61298880173D|1||||ADP|ADENOSINE DIPHOSPHATE|||||||IU/G|||||||NEGATIVE||MG/G/MIN||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|CONTAMINATED|N|PLETHYSMOGRAPHY|MDRD ENZYMATIC FORMULA||NA|Y|N|Y|||N|4||88||TREATMENT|1969-08-05|1961-06-11|||||1972-07-27||1967-04-10|N|1963-07-02
TRIAL STUDY 134XCP|LB|0194CD2F-7ABE-4BEE-A6FC-61298880173D|2||||C165890|TIMOTHY GRASS POLLEN IGE AB RAST SCORE|||||||10^6 RNA COPIES/ML|||||||TRACE||ELISA UNIT/ML||||ABNORMAL|NOT DONE||||SEBUM|LIPEMIC|U|FLUORESCENT IMMUNOASSAY|MDRD 4 VARIABLE FORMULA||N|NA|NA|Y|||N|4||88||OPEN LABEL TREATMENT|1967-10-20|1965-02-17|||||1966-03-18||1968-08-12|NA|1971-10-29
TRIAL STUDY 134XCP|LB|0194CD2F-7ABE-4BEE-A6FC-61298880173D|1||||C130129|DOG DANDER ANTIGEN IGG ANTIBODY|||||||CI/MG|||||||NEGATIVE||10^9/L||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|HEMOLYZED|U|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI % FORMULA||N|N|U|Y|||N|5||7||OPEN LABEL TREATMENT|1961-05-28|1960-05-31|||||1969-12-02||1971-07-16|U|1960-11-11
TRIAL STUDY 134XCP|LB|0194CD2F-7ABE-4BEE-A6FC-61298880173D|2||||LDH4|LDH ISOENZYME 4|||||||ML/M2/H|||||||NEGATIVE||MOL||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|N|N|||N|5||7||INDUCTION TREATMENT|1965-12-02|1966-06-28|||||1964-07-24||1967-07-16|NA|1962-11-23
TRIAL STUDY 134XCP|LB|A6E531C7-1BC1-402E-9B2E-03B44313487B|1||||FUNGIFIL|FUNGI, FILAMENTOUS|||||||UL|||||||INDETERMINATE||/MS||||NORMAL|NOT DONE||||SEMINAL FLUID|THAWED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|CKD-EPI FORMULA||U|U|Y|NA|||U|1||38||OPEN LABEL TREATMENT|1966-04-30|1965-06-20|||||1971-04-23||1960-08-23|NA|1967-12-28
TRIAL STUDY 134XCP|LB|A6E531C7-1BC1-402E-9B2E-03B44313487B|2||||TGLOB|THYROGLOBULIN|||||||MASK|||||||POSITIVE||DRAM||||ABNORMAL|NOT DONE||||STOOL|LIPEMIC|N|IVY INCISION METHOD|MDRD 6 VARIABLE FORMULA||NA|NA|N|N|||N|1||38||BASELINE|1967-03-23|1963-12-18|||||1970-09-18||1965-07-18|U|1968-05-20
TRIAL STUDY 134XCP|LB|A6E531C7-1BC1-402E-9B2E-03B44313487B|1||||CANNABS|CANNABINOIDS, SYNTHETIC|||||||DRUM|||||||INDETERMINATE||MU||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|CONCENTRATED|Y|WRIGHT STAIN|FIBROTEST FORMULA||Y|N|NA|N|||U|2||58||SCREENING|1966-10-27|1969-05-13|||||1968-12-31||1964-08-06|NA|1963-03-04
TRIAL STUDY 134XCP|LB|A6E531C7-1BC1-402E-9B2E-03B44313487B|2||||MOCYCE|MONOCYTOID CELLS|||||||GBQ|||||||BORDERLINE||ANTI-XA IU||||NORMAL|NOT DONE||||LAVAGE FLUID|SOLIDIFIED|U|CT SCAN WITHOUT CONTRAST|MDRD FORMULA||Y|Y|U|U|||Y|2||58||FOLLOW-UP|1969-04-12|1972-03-20|||||1961-08-02||1964-06-26|N|1969-03-01
TRIAL STUDY 134XCP|LB|A6E531C7-1BC1-402E-9B2E-03B44313487B|1||||IMMGLB|IMMUNOGLOBULIN|||||||U/G/DAY|||||||INVALID||MEQ/MMOL||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|ICTERIC|NA|GC/MS|GMI % FORMULA||U|U|Y|Y|||NA|3||39||OBSERVATION|1965-10-09|1964-02-13|||||1968-04-29||1972-10-15|Y|1970-05-24
TRIAL STUDY 134XCP|LB|A6E531C7-1BC1-402E-9B2E-03B44313487B|2||||HRYCECE|HAIRY CELLS/TOTAL CELLS|||||||MANSON U/ML|||||||TRACE||UG/G/H||||NORMAL|NOT DONE||||TRANSUDATE|FROZEN|N|ACID FAST STAIN|FIBROMETER FORMULA||N|N|NA|N|||Y|3||39||OBSERVATION|1973-05-13|1962-08-08|||||1970-04-03||1973-06-13|N|1961-10-03
TRIAL STUDY 134XCP|LB|A6E531C7-1BC1-402E-9B2E-03B44313487B|1||||NEUT|NEUTROPHILS|||||||WEBER|||||||INDETERMINATE||PFU/ML||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|SOLIDIFIED|NA|PHOTOGRAPHY|HEPASCORE FORMULA||U|NA|U|NA|||Y|4||88||RUN-IN|1965-12-30|1970-01-17|||||1969-09-23||1969-01-10|NA|1963-07-08
TRIAL STUDY 134XCP|LB|A6E531C7-1BC1-402E-9B2E-03B44313487B|2||||GGTEXR|GAMMAGLUTAMYL TRANSFERASE EXCRETION RATE|||||||LOG EID 50/DOSE|||||||POSITIVE||MSEC||||ABNORMAL|NOT DONE||||GASTRIC FLUID|CLOTTED|NA|THERMAL IONIZATION MASS SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA||Y|U|U|N|||Y|4||88||OBSERVATION|1971-02-23|1973-04-12|||||1973-03-26||1973-06-25|Y|1961-07-05
TRIAL STUDY 134XCP|LB|A6E531C7-1BC1-402E-9B2E-03B44313487B|1||||IAPP|ISLET AMYLOID POLYPEPTIDE|||||||CM2|||||||POSITIVE||SACHET||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|UNEXPECTED ODOR|Y|MAPH|CKD-EPI FORMULA||NA|NA|NA|Y|||U|5||7||LONG-TERM FOLLOW-UP|1969-02-07|1967-11-09|||||1966-09-10||1965-04-01|NA|1971-09-10
TRIAL STUDY 134XCP|LB|A6E531C7-1BC1-402E-9B2E-03B44313487B|2||||SEDEXAM|SEDIMENT EXAMINATION|||||||10^11/L|||||||POSITIVE||100 IU/ML||||HIGH|NOT DONE||||MUSCLE TISSUE|THAWED|Y|PATHOLOGICAL EVALUATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|U|N|||U|5||7||CONTINUATION TREATMENT|1970-03-05|1968-04-11|||||1973-01-09||1970-07-12|U|1962-11-09
TRIAL STUDY 134XCP|LB|47C0D833-BEAB-4BF2-B028-891808E729F1|1||||CD4|CD4|||||||UL/KG/DAY|||||||NEGATIVE||%||||LOW|NOT DONE||||RETICULOCYTES|ICTERIC|NA|IMPULSE OSCILLOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|Y|N|||NA|1||38||OBSERVATION|1966-01-21|1971-08-03|||||1963-09-22||1969-06-20|NA|1966-09-12
TRIAL STUDY 134XCP|LB|47C0D833-BEAB-4BF2-B028-891808E729F1|2||||VEGFR1S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC1|||||||APS U|||||||BORDERLINE||ML/G/DAY||||HIGH|NOT DONE||||LOCHIA|CLOTTED|NA|HEMAGGLUTINATION ASSAY|MDRD 6 VARIABLE FORMULA||NA|U|N|N|||NA|1||38||INDUCTION TREATMENT|1968-10-17|1968-03-12|||||1966-07-12||1972-06-25|Y|1969-12-12
TRIAL STUDY 134XCP|LB|47C0D833-BEAB-4BF2-B028-891808E729F1|1||||LIPASEG|LIPASE, GASTRIC|||||||CI|||||||BORDERLINE||LOG10 TCID 50/UL||||NORMAL|NOT DONE||||GASTRIC CONTENTS|ROOM TEMPERATURE|NA|NEXT GENERATION TARGETED SEQUENCING|MDRD ENZYMATIC FORMULA||Y|Y|U|Y|||Y|2||58||INDUCTION TREATMENT|1971-10-11|1962-04-16|||||1964-11-13||1972-08-26|U|1967-09-05
TRIAL STUDY 134XCP|LB|47C0D833-BEAB-4BF2-B028-891808E729F1|2||||EDTACLR|EDTA CLEARANCE|||||||QUANTITY SUFFICIENT|||||||TRACE||APL U||||HIGH|NOT DONE||||HAIR FOLLICLE|CLOTTED|Y|CAPILLARY ELECTROPHORESIS|COCKCROFT-GAULT FORMULA||Y|Y|U|NA|||NA|2||58||OBSERVATION|1962-01-28|1966-12-05|||||1970-02-24||1960-10-30|NA|1963-01-10
TRIAL STUDY 134XCP|LB|47C0D833-BEAB-4BF2-B028-891808E729F1|1||||ICTERUSI|ICTERIC INDEX|||||||UL/DOSE|||||||INDETERMINATE||UGEQ/L||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|NON-HEMOLYZED|Y|PH METER MEASUREMENT METHOD|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|N|Y|||N|3||39||CONTINUATION TREATMENT|1970-08-18|1960-02-01|||||1963-02-09||1969-10-10|Y|1967-05-05
TRIAL STUDY 134XCP|LB|47C0D833-BEAB-4BF2-B028-891808E729F1|2||||SJSSAAB|SJOGRENS SS-A ANTIBODY|||||||SCM|||||||POSITIVE||IU/DAY||||HIGH|NOT DONE||||INFRANATANT, SERUM|UNEXPECTED ODOR|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA||Y|U|Y|Y|||NA|3||39||CONTINUATION TREATMENT|1961-01-19|1971-07-27|||||1970-04-30||1969-05-03|N|1963-01-11
TRIAL STUDY 134XCP|LB|47C0D833-BEAB-4BF2-B028-891808E729F1|1||||FATDROP|FAT DROPLET|||||||U|||||||TRACE||BU||||LOW|NOT DONE||||BLOOD|PARAFFIN-EMBEDDED|U|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|HEPASCORE FORMULA||U|Y|N|U|||Y|4||88||INDUCTION TREATMENT|1972-01-30|1965-11-03|||||1966-06-11||1971-02-18|N|1963-06-14
TRIAL STUDY 134XCP|LB|47C0D833-BEAB-4BF2-B028-891808E729F1|2||||IA2AB|INSULINOMA-ASSOCIATED PROTEIN 2 ANTIBODY|||||||MET|||||||NEGATIVE||UIU/L||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|REFRIGERATED|NA|DISK DIFFUSION|FIBROSIS 4 FORMULA||U|Y|U|Y|||Y|4||88||WASHOUT|1962-07-04|1969-11-15|||||1970-04-03||1962-06-27|N|1966-10-17
TRIAL STUDY 134XCP|LB|47C0D833-BEAB-4BF2-B028-891808E729F1|1||||CXCL3|CHEMOKINE (C-X-C MOTIF) LIGAND 3|||||||DEG|||||||INVALID||PKAT||||ABNORMAL|NOT DONE||||BREAST MILK|PARAFFIN-EMBEDDED|U|HIGH RESOLUTION CT|FIBROMETER FORMULA||U|Y|NA|U|||Y|5||7||INDUCTION TREATMENT|1964-01-23|1971-06-20|||||1970-07-22||1967-09-27|Y|1964-06-12
TRIAL STUDY 134XCP|LB|47C0D833-BEAB-4BF2-B028-891808E729F1|2||||IGG2|IMMUNOGLOBULIN G SUBCLASS 2|||||||AFU|||||||NEGATIVE||MM/SEC||||LOW|NOT DONE||||BONE|CLOTTED|NA|CENTRIFUGATION|ASH FIBROSURE FORMULA||Y|U|NA|U|||U|5||7||BLINDED TREATMENT|1965-04-19|1963-11-02|||||1972-06-08||1960-03-10|U|1965-05-31
TRIAL STUDY 134XCP|LB|BA1773BD-AA89-45FC-B7C6-C5267770B197|1||||APRI|AST TO PLATELET RATIO INDEX|||||||CI|||||||NEGATIVE||G/MOL||||NORMAL|NOT DONE||||DISCHARGE|THAWED|Y|PELLI-ROBSON EYE CHART|MDRD 4 VARIABLE FORMULA||Y|U|N|N|||N|1||38||WASHOUT|1962-03-02|1973-02-16|||||1960-11-20||1960-09-07|N|1965-01-15
TRIAL STUDY 134XCP|LB|BA1773BD-AA89-45FC-B7C6-C5267770B197|2||||C165907|MOLD MIX IGG AB RAST SCORE|||||||GRAIN|||||||INVALID||V||||LOW|NOT DONE||||CAPILLARY BLOOD|DRIED|NA|PHASE-CONTRAST MRI|FIBROMETER FORMULA||NA|N|NA|N|||N|1||38||RUN-IN|1973-04-11|1970-01-09|||||1964-07-12||1969-02-03|U|1967-02-04
TRIAL STUDY 134XCP|LB|BA1773BD-AA89-45FC-B7C6-C5267770B197|1||||BCMAS|SOLUBLE B CELL MATURATION ANTIGEN|||||||CIGAR|||||||BORDERLINE||U/KG||||LOW|NOT DONE||||URINE SEDIMENT|REFRIGERATED|U|HIGH RESOLUTION MELT ANALYSIS|MDRD 6 VARIABLE FORMULA||Y|NA|NA|NA|||U|2||58||RUN-IN|1960-07-26|1967-02-26|||||1971-12-02||1968-09-30|NA|1968-01-10
TRIAL STUDY 134XCP|LB|BA1773BD-AA89-45FC-B7C6-C5267770B197|2||||MAYHEG|MAY-HEGGLIN ANOMALY|||||||KBQ/UL|||||||INDETERMINATE||MG/G/MIN||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|UNEXPECTED ODOR|N|FLOW CYTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|U|||U|2||58||LONG-TERM FOLLOW-UP|1967-06-26|1961-07-05|||||1962-06-18||1965-12-09|N|1963-04-14
TRIAL STUDY 134XCP|LB|BA1773BD-AA89-45FC-B7C6-C5267770B197|1||||PPI|INORGANIC PYROPHOSPHATE|||||||TITER|||||||INVALID||BQ/UG||||HIGH|NOT DONE||||PROSTATIC FLUID|CONCENTRATED|U|PATHOLOGICAL EVALUATION|MDRD 6 VARIABLE FORMULA||Y|N|Y|U|||U|3||39||LONG-TERM FOLLOW-UP|1965-01-19|1969-11-28|||||1973-08-09||1970-09-26|Y|1963-09-10
TRIAL STUDY 134XCP|LB|BA1773BD-AA89-45FC-B7C6-C5267770B197|2||||LIPASLAL|LIPASE, LYSOSOMAL ACID|||||||UMOL/MIN|||||||INDETERMINATE||G/U||||ABNORMAL|NOT DONE||||KERATINOCYTE|FRESH|N|NUCLEIC ACID HYBRIDIZATION|MDRD 6 VARIABLE FORMULA||U|NA|U|U|||Y|3||39||OBSERVATION|1962-07-21|1962-02-14|||||1972-08-19||1961-06-28|NA|1967-12-03
TRIAL STUDY 134XCP|LB|BA1773BD-AA89-45FC-B7C6-C5267770B197|1||||CACRALB|CALCIUM CORRECTED FOR ALBUMIN|||||||SQU/ML|||||||POSITIVE||M2||||LOW|NOT DONE||||LOCHIA|HEMOLYZED|Y|DYNAMIC CONTRAST ENHANCED MRI|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|U|N|||N|4||88||OBSERVATION|1966-06-13|1970-01-03|||||1961-06-05||1967-04-04|U|1971-09-20
TRIAL STUDY 134XCP|LB|BA1773BD-AA89-45FC-B7C6-C5267770B197|2||||HGBF|HEMOGLOBIN F|||||||TUBE|||||||BORDERLINE||ML/M2/DAY||||ABNORMAL|NOT DONE||||EXUDATE|FRESH|N|FLUORESCENCE ANGIOGRAPHY|NASH FIBROSURE FORMULA||NA|U|U|U|||NA|4||88||OBSERVATION|1970-03-22|1970-03-10|||||1970-03-18||1967-02-23|NA|1964-03-04
TRIAL STUDY 134XCP|LB|BA1773BD-AA89-45FC-B7C6-C5267770B197|1||||TIMP1|TISSUE INHIBITOR OF METALLOPROTEINASE 1|||||||UG/KG|||||||POSITIVE||CI/KG||||HIGH|NOT DONE||||PLEURAL TISSUE|AGGLUTINATED|Y|MULTIPLE BREATH WASHOUT|NASH FIBROSURE FORMULA||U|Y|N|NA|||Y|5||7||WASHOUT|1965-08-16|1972-12-10|||||1965-05-30||1965-04-06|NA|1966-02-09
TRIAL STUDY 134XCP|LB|BA1773BD-AA89-45FC-B7C6-C5267770B197|2||||MKCMKBMP|MEGAKARYOCYTE AND MEGAKARYOBLAST MORPH|||||||UL|||||||TRACE||RATIO||||NORMAL|NOT DONE||||SPUTUM|PARAFFIN-EMBEDDED|NA|REFLECTANCE SPECTROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|Y|U|||U|5||7||CONTINUATION TREATMENT|1960-11-02|1962-03-22|||||1961-04-10||1972-03-25|Y|1966-05-23
TRIAL STUDY 134XCP|LB|03D3DDC6-03FA-469A-B8A4-D504919B68F1|1||||OAS3|2-5-OLIGOADENYLATE SYNTHASE 3|||||||NG/MOL|||||||NEGATIVE||10^6 RNA COPIES/ML||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|CONCENTRATED|N|RYAN BLUE STAIN|CKD-EPI CYSTATIN C FORMULA||Y|N|U|U|||N|1||38||TREATMENT|1970-03-21|1969-11-10|||||1962-10-24||1964-01-02|N|1962-12-24
TRIAL STUDY 134XCP|LB|03D3DDC6-03FA-469A-B8A4-D504919B68F1|2||||LYMAT|LYMPHOCYTES ATYPICAL|||||||ABSORBANCE U|||||||BORDERLINE||ATM||||HIGH|NOT DONE||||MONOCYTE|UNEXPECTED ODOR|U|IN VITRO GENE EXPRESSION ASSAY|ASH FIBROSURE FORMULA||Y|N|Y|N|||Y|1||38||CONTINUATION TREATMENT|1966-02-11|1963-03-30|||||1968-02-05||1969-04-02|N|1973-07-25
TRIAL STUDY 134XCP|LB|03D3DDC6-03FA-469A-B8A4-D504919B68F1|1||||GGTCREAT|GAMMA GLUTAMYL TRANSFERASE/CREATININE|||||||UMOL/L/MIN|||||||INDETERMINATE||PT_US||||NORMAL|NOT DONE||||TRANSUDATE|GELLED|U|FLUORESCENT LIFETIME IMAGING MICROSCOPY|ASH FIBROSURE FORMULA||Y|NA|N|N|||Y|2||58||INDUCTION TREATMENT|1962-12-03|1971-10-18|||||1970-05-27||1970-10-25|U|1962-03-08
TRIAL STUDY 134XCP|LB|03D3DDC6-03FA-469A-B8A4-D504919B68F1|2||||YEASTBUD|YEAST BUDDING|||||||U/G|||||||NEGATIVE||AG||||NORMAL|NOT DONE||||LYSATE|UNEXPECTED ODOR|Y|BRDU CELLULAR PROLIFERATION ASSAY|ASH FIBROSURE FORMULA||NA|U|U|NA|||U|2||58||LONG-TERM FOLLOW-UP|1960-11-23|1969-01-19|||||1972-11-29||1964-04-05|NA|1971-12-13
TRIAL STUDY 134XCP|LB|03D3DDC6-03FA-469A-B8A4-D504919B68F1|1||||SPERMMTL|SPERM MOTILITY|||||||MM/H|||||||TRACE||PIPE||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|FROZEN|U|KINETIC CHROMOGENIC ASSAY|HEPASCORE FORMULA||NA|N|U|N|||N|3||39||RUN-IN|1964-09-04|1967-11-17|||||1961-06-22||1968-02-29|NA|1963-08-21
TRIAL STUDY 134XCP|LB|03D3DDC6-03FA-469A-B8A4-D504919B68F1|2||||TRICH|TRICHOMONAS|||||||MMOL/G|||||||BORDERLINE||MU/G||||LOW|NOT DONE||||REFLEX TEAR|AUTOLYZED|U|WRIGHT STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|NA|U|||N|3||39||INDUCTION TREATMENT|1968-12-26|1963-06-14|||||1962-05-22||1965-12-21|NA|1964-06-27
TRIAL STUDY 134XCP|LB|03D3DDC6-03FA-469A-B8A4-D504919B68F1|1||||SOMATRO|SOMATOTROPHIN|||||||VIRTUAL PIXEL|||||||INDETERMINATE||MMOL/MIN/KPA/L||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|CLOTTED|Y|RADIOIMMUNOPRECIPITATION ASSAY|MDRD 4 VARIABLE FORMULA||U|Y|NA|U|||U|4||88||OBSERVATION|1968-10-13|1961-11-29|||||1966-05-23||1964-04-14|NA|1962-07-20
TRIAL STUDY 134XCP|LB|03D3DDC6-03FA-469A-B8A4-D504919B68F1|2||||SPMMSPM|MOTILE SPERM/TOTAL SPERM|||||||PL|||||||POSITIVE||V||||LOW|NOT DONE||||SUPERNATANT, PLASMA|AGGLUTINATED|Y|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|FIBROMETER FORMULA||NA|Y|NA|Y|||U|4||88||LONG-TERM FOLLOW-UP|1971-06-22|1971-11-12|||||1968-11-09||1966-07-04|Y|1967-10-12
TRIAL STUDY 134XCP|LB|03D3DDC6-03FA-469A-B8A4-D504919B68F1|1||||C130069|BERMUDA GRASS POLLEN IGA|||||||FT|||||||POSITIVE||MOSM/L||||NORMAL|NOT DONE||||ISOLATE|HEMOLYZED|NA|STRESS ECHOCARDIOGRAPHY|FIBROMETER FORMULA||N|N|N|N|||U|5||7||TREATMENT|1967-08-04|1973-04-21|||||1961-10-18||1968-07-31|NA|1962-06-08
TRIAL STUDY 134XCP|LB|03D3DDC6-03FA-469A-B8A4-D504919B68F1|2||||APLIGMAB|ANTI-PHOSPHOLIPID IGM ANTIBODY|||||||CS|||||||INVALID||UV2||||NORMAL|NOT DONE||||PLASMA|AUTOLYZED|N|FARR ASSAY|HEPASCORE FORMULA||N|Y|NA|U|||NA|5||7||FOLLOW-UP|1963-06-04|1965-10-31|||||1960-04-19||1962-10-07|N|1969-03-12
TRIAL STUDY 134XCP|LB|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|1||||CODEINE|CODEINE|||||||ML|||||||INDETERMINATE||10^3 RNA COPIES/ML||||LOW|NOT DONE||||SYNOVIAL FLUID|GELLED|U|CELLULAR PROLIFERATION ASSAY|MDRD 4 VARIABLE FORMULA||N|NA|U|NA|||NA|1||38||WASHOUT|1972-08-28|1960-04-13|||||1971-09-02||1970-06-11|U|1963-10-13
TRIAL STUDY 134XCP|LB|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|2||||INTLK25|INTERLEUKIN 25|||||||IU/MMOL|||||||INDETERMINATE||NKAT/L||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|SOLIDIFIED|U|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|U|||U|1||38||BASELINE|1963-01-10|1971-10-12|||||1964-10-18||1970-07-09|N|1972-04-07
TRIAL STUDY 134XCP|LB|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|1||||OHDG8|8-HYDROXYDEOXYGUANOSINE|||||||TRACE|||||||TRACE||CS||||ABNORMAL|NOT DONE||||SEMINAL FLUID|LIPEMIC|NA|BIOPSY|FIBROMETER FORMULA||NA|Y|NA|Y|||Y|2||58||BASELINE|1973-04-06|1963-06-17|||||1967-11-09||1965-09-19|U|1962-03-13
TRIAL STUDY 134XCP|LB|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|2||||AFPL3AFP|A FETOPROTEIN L3/A FETOPROTEIN|||||||SCM|||||||NEGATIVE||GPL U/ML||||HIGH|NOT DONE||||PLATELET POOR PLASMA|SOLIDIFIED|U|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD FORMULA||NA|U|U|N|||N|2||58||SCREENING|1963-05-09|1968-05-25|||||1966-11-18||1971-08-03|Y|1971-11-02
TRIAL STUDY 134XCP|LB|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|1||||TEARDCY|DACRYOCYTES|||||||UV|||||||TRACE||/MIN||||LOW|NOT DONE||||VENOUS BLOOD|UNEXPECTED ODOR|N|DUKE INCISION METHOD|FIBROSIS 4 FORMULA||U|NA|Y|U|||N|3||39||INDUCTION TREATMENT|1966-11-06|1968-11-26|||||1964-11-30||1972-07-13|U|1961-10-03
TRIAL STUDY 134XCP|LB|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|2||||ETHANOL|ETHANOL|||||||MOSM/L|||||||POSITIVE||/KG||||NORMAL|NOT DONE||||SALIVA|LACTESCENT|NA|LC/MS/MS|NASH FIBROSURE FORMULA||Y|NA|N|N|||NA|3||39||BLINDED TREATMENT|1970-03-06|1968-11-20|||||1966-08-14||1964-11-10|N|1971-12-01
TRIAL STUDY 134XCP|LB|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|1||||FRTNLC|FERRITIN LIGHT CHAIN|||||||MG/M2|||||||INVALID||CM/MIN||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|THAWED|Y|CELLULAR PROLIFERATION ASSAY|GMI MMOL/MOL FORMULA||N|N|Y|U|||N|4||88||FOLLOW-UP|1966-05-08|1961-01-24|||||1966-12-02||1966-07-27|NA|1965-05-17
TRIAL STUDY 134XCP|LB|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|2||||IFI44|INTERFERON-INDUCED PROTEIN 44|||||||MNFI|||||||TRACE||KHZ||||LOW|NOT DONE||||EXPIRED AIR|FROZEN|U|TRANSMISSION ELECTRON MICROSCOPY|ASH FIBROSURE FORMULA||Y|Y|N|NA|||N|4||88||TREATMENT|1964-10-15|1968-02-20|||||1970-05-19||1963-04-20|U|1966-05-02
TRIAL STUDY 134XCP|LB|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|1||||LDH3|LDH ISOENZYME 3|||||||ML/ANIMAL/WK|||||||NEGATIVE||G/ANIMAL||||LOW|NOT DONE||||NAIL|UNEXPECTED ODOR|U|MANUAL CLOT DETECTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|U|N|||N|5||7||BASELINE|1960-12-19|1970-07-27|||||1967-05-30||1964-05-06|U|1963-06-04
TRIAL STUDY 134XCP|LB|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|2||||GAMBTAC|GAMMA-AMINOBUTYRIC ACID|||||||UG/M2/H|||||||TRACE||ANTIBODY UNIT||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|DRIED|U|HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI FORMULA||NA|NA|U|NA|||U|5||7||FOLLOW-UP|1970-03-02|1963-08-04|||||1960-11-21||1970-11-16|U|1968-11-28
TRIAL STUDY 134XCP|LB|1873D4CC-40B7-4303-9F07-8FE0E4595361|1||||ARG|ARGININE|||||||MG/L FEU|||||||TRACE||RFU||||ABNORMAL|NOT DONE||||BONE|LIPEMIC|U|MEDIASTINOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|NA|||N|1||38||BLINDED TREATMENT|1970-04-03|1969-04-03|||||1966-05-22||1967-08-04|N|1972-10-21
TRIAL STUDY 134XCP|LB|1873D4CC-40B7-4303-9F07-8FE0E4595361|2||||CRYOFBRN|CRYOFIBRINOGEN|||||||UL/DOSE|||||||INDETERMINATE||U/CL||||NORMAL|NOT DONE||||PROSTATIC FLUID|SOLIDIFIED|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NASH FIBROSURE FORMULA||U|U|U|N|||Y|1||38||OBSERVATION|1960-04-03|1960-02-09|||||1973-04-02||1963-01-27|Y|1971-05-23
TRIAL STUDY 134XCP|LB|1873D4CC-40B7-4303-9F07-8FE0E4595361|1||||CAMP|CYCLIC ADENOSINE 3,5-MONOPHOSPHATE|||||||APPLICATION|||||||TRACE||COULOMB||||HIGH|NOT DONE||||TUMOR TISSUE|CLOTTED|NA|MACRO BROTH DILUTION|ASH FIBROSURE FORMULA||N|U|N|N|||Y|2||58||BASELINE|1964-04-19|1963-10-02|||||1966-07-28||1969-02-15|U|1971-12-29
TRIAL STUDY 134XCP|LB|1873D4CC-40B7-4303-9F07-8FE0E4595361|2||||CD34|CD34|||||||CI/L|||||||INDETERMINATE||MOL/MOL||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|LACTESCENT|Y|INTERRUPTER TECHNIQUE|FIBROTEST FORMULA||U|Y|Y|U|||N|2||58||TREATMENT|1967-09-30|1970-11-12|||||1968-03-11||1968-08-26|Y|1961-01-27
TRIAL STUDY 134XCP|LB|1873D4CC-40B7-4303-9F07-8FE0E4595361|1||||LYMIM|IMMATURE LYMPHOCYTES|||||||UL/ML|||||||TRACE||RFU||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|NA|CENTRIFUGATION|CKD-EPI CREATININE FORMULA||Y|Y|N|NA|||N|3||39||LONG-TERM FOLLOW-UP|1967-03-25|1963-02-08|||||1971-11-10||1966-10-23|N|1971-03-06
TRIAL STUDY 134XCP|LB|1873D4CC-40B7-4303-9F07-8FE0E4595361|2||||WBC|LEUKOCYTES|||||||LOG10 CCID 50/DOSE|||||||INVALID||MN||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|AGGLUTINATED|N|POPULATION SEQUENCING|GMI % FORMULA||U|Y|Y|N|||N|3||39||TREATMENT|1968-07-06|1972-02-23|||||1961-09-14||1965-07-03|N|1962-07-22
TRIAL STUDY 134XCP|LB|1873D4CC-40B7-4303-9F07-8FE0E4595361|1||||ALPCREAT|ALKALINE PHOSPHATASE/CREATININE|||||||NMOL/L|||||||POSITIVE||G/ANIMAL/WK||||NORMAL|NOT DONE||||HAIR FOLLICLE|DRIED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA||U|U|NA|U|||NA|4||88||OBSERVATION|1962-06-07|1970-08-01|||||1967-11-19||1966-01-13|U|1962-10-06
TRIAL STUDY 134XCP|LB|1873D4CC-40B7-4303-9F07-8FE0E4595361|2||||C130110|MOLD MIX ANTIGEN IGG ANTIBODY|||||||MMOL|||||||BORDERLINE||ML/MMHG||||ABNORMAL|NOT DONE||||PLATELET POOR PLASMA|SOLIDIFIED|Y|FISH|MDRD FORMULA||Y|Y|NA|U|||U|4||88||OPEN LABEL TREATMENT|1964-03-15|1970-07-11|||||1971-03-25||1968-07-16|Y|1972-12-12
TRIAL STUDY 134XCP|LB|1873D4CC-40B7-4303-9F07-8FE0E4595361|1||||TCDCA|TAUROCHENODEOXYCHOLATE|||||||10^3 DNA COPIES/ML|||||||INVALID||BEAM BREAKS||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|AUTOLYZED|NA|HILLMEN COLOR CHART|FIBROSIS 4 FORMULA||N|NA|N|Y|||NA|5||7||WASHOUT|1972-10-15|1970-09-04|||||1963-05-18||1969-11-02|NA|1969-05-20
TRIAL STUDY 134XCP|LB|1873D4CC-40B7-4303-9F07-8FE0E4595361|2||||INTLK2|INTERLEUKIN 2|||||||MG/ML/MIN|||||||BORDERLINE||IU/DL||||NORMAL|NOT DONE||||ADIPOSE TISSUE|CLOTTED|Y|ANGIOGRAPHY|NASH FIBROSURE FORMULA||U|NA|U|N|||N|5||7||INDUCTION TREATMENT|1968-12-10|1971-07-27|||||1970-06-13||1969-08-07|U|1967-04-07
TRIAL STUDY 134XCP|LB|23E5569E-B324-4399-AC8A-5EC7C343C1D3|1||||FRFEABS|FRACTIONAL IRON ABSORPTION|||||||OSM|||||||POSITIVE||NMOL/MOL||||ABNORMAL|NOT DONE||||MUCUS|FROZEN|Y|DYNAMIC LIGHT SCATTERING|FIBROMETER FORMULA||U|NA|NA|U|||NA|1||38||BLINDED TREATMENT|1973-05-26|1971-06-26|||||1973-06-11||1966-01-02|NA|1968-07-01
TRIAL STUDY 134XCP|LB|23E5569E-B324-4399-AC8A-5EC7C343C1D3|2||||CRYSTALS|CRYSTALS|||||||UCI|||||||TRACE||UMOL/H/MMOL||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|CLOTTED|Y|FLUORESCENT ENZYME IMMUNOASSAY|MDRD 4 VARIABLE FORMULA||N|NA|N|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1962-02-14|1966-05-29|||||1969-09-04||1967-06-15|Y|1961-02-01
TRIAL STUDY 134XCP|LB|23E5569E-B324-4399-AC8A-5EC7C343C1D3|1||||MLIGCE|MALIGNANT CELLS, NOS|||||||MU|||||||POSITIVE||GTT||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|SOLIDIFIED|NA|ACRIDINE ORANGE STAIN|CKD-EPI FORMULA||N|N|U|Y|||N|2||58||BASELINE|1965-09-04|1961-06-10|||||1961-11-25||1963-02-24|U|1973-06-12
TRIAL STUDY 134XCP|LB|23E5569E-B324-4399-AC8A-5EC7C343C1D3|2||||ROM|REACTIVE OXYGEN METABOLITE|||||||PACKET|||||||TRACE||NEWTON||||LOW|NOT DONE||||SWABBED MATERIAL|NON-HEMOLYZED|U|POLYSOMNOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|U|U|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1967-04-22|1966-10-05|||||1961-08-14||1973-05-25|NA|1973-02-14
TRIAL STUDY 134XCP|LB|23E5569E-B324-4399-AC8A-5EC7C343C1D3|1||||BLASTIMM|IMMUNOBLASTS|||||||/500 WBC|||||||BORDERLINE||10^9 ORGANISMS/MG||||NORMAL|NOT DONE||||GASTRIC FLUID|HEMOLYZED|Y|LIGHT SCATTERING SPECTROSCOPY|MDRD 6 VARIABLE FORMULA||U|N|NA|Y|||NA|3||39||INDUCTION TREATMENT|1965-07-09|1968-01-06|||||1972-07-26||1963-11-16|U|1969-06-05
TRIAL STUDY 134XCP|LB|23E5569E-B324-4399-AC8A-5EC7C343C1D3|2||||C130084|ENGLISH PLANTAIN POLLEN IGE|||||||GPS U|||||||POSITIVE||10^6/HPF||||NORMAL|NOT DONE||||STOOL|GELLED|Y|IMMUNOFLUORESCENT STAIN|FIBROSIS 4 FORMULA||Y|Y|NA|U|||Y|3||39||OPEN LABEL TREATMENT|1963-03-29|1966-02-25|||||1973-01-17||1962-09-23|N|1970-09-10
TRIAL STUDY 134XCP|LB|23E5569E-B324-4399-AC8A-5EC7C343C1D3|1||||GLOBA1|ALPHA-1 GLOBULIN|||||||LOG EID 50/DOSE|||||||INDETERMINATE||MMOL/S||||NORMAL|NOT DONE||||BREAST MILK|CLOTTED|U|INTRAVASCULAR ULTRASOUND|HEPASCORE FORMULA||U|NA|N|NA|||U|4||88||OBSERVATION|1970-10-21|1969-02-11|||||1967-10-07||1960-07-11|U|1972-09-10
TRIAL STUDY 134XCP|LB|23E5569E-B324-4399-AC8A-5EC7C343C1D3|2||||CA1AG|CANCER ANTIGEN 1|||||||CYCLE/MIN|||||||POSITIVE||/H||||HIGH|NOT DONE||||EPITHELIAL CELL|GELLED|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD FORMULA||N|N|NA|Y|||N|4||88||FOLLOW-UP|1966-07-03|1961-07-20|||||1970-11-24||1966-09-03|N|1967-02-02
TRIAL STUDY 134XCP|LB|23E5569E-B324-4399-AC8A-5EC7C343C1D3|1||||C130083|ORCHARD GRASS POLLEN IGG4|||||||L/H|||||||POSITIVE||MIN||||NORMAL|NOT DONE||||GASTRIC CONTENTS|PARAFFIN-EMBEDDED|NA|MEDIASTINOSCOPY|CKD-EPI CYSTATIN C FORMULA||N|U|N|U|||Y|5||7||OPEN LABEL TREATMENT|1971-06-20|1966-07-28|||||1964-11-05||1973-05-19|Y|1970-09-14
TRIAL STUDY 134XCP|LB|23E5569E-B324-4399-AC8A-5EC7C343C1D3|2||||IBCT|TOTAL IRON BINDING CAPACITY|||||||KPA|||||||TRACE||TROCHE||||HIGH|NOT DONE||||ALVEOLAR AIR|UNEXPECTED ODOR|N|SECONDARY ION MASS SPECTOMETRY|MDRD FORMULA||NA|U|NA|NA|||N|5||7||OPEN LABEL TREATMENT|1967-10-30|1964-03-01|||||1962-08-12||1971-07-07|Y|1967-08-17
TRIAL STUDY 134XCP|LB|B349DD89-C41F-470E-8B54-B3589F0982FE|1||||IL1RL1|INTERLEUKIN 1 RECEPTOR-LIKE 1|||||||PMOL/L|||||||INVALID||MG/KG/WEEK||||ABNORMAL|NOT DONE||||BILE|REFRIGERATED|NA|IHC|CKD-EPI FORMULA||Y|NA|N|N|||Y|1||38||OPEN LABEL TREATMENT|1965-12-14|1967-12-15|||||1973-04-09||1966-09-05|U|1962-09-07
TRIAL STUDY 134XCP|LB|B349DD89-C41F-470E-8B54-B3589F0982FE|2||||SALCYLT|SALICYLATES|||||||ENZYME U/L|||||||POSITIVE||/5X10^4 WBC||||HIGH|NOT DONE||||ALVEOLAR AIR|LACTESCENT|N|LIGHT MICROSCOPY|FIBROMETER FORMULA||N|U|Y|N|||U|1||38||WASHOUT|1960-11-13|1966-08-15|||||1965-08-09||1960-05-31|N|1971-02-20
TRIAL STUDY 134XCP|LB|B349DD89-C41F-470E-8B54-B3589F0982FE|1||||CAN|COEFFICIENT OF NITROGEN ABSORPTION|||||||ML/ANIMAL|||||||INDETERMINATE||CG||||LOW|NOT DONE||||SWABBED MATERIAL|NON-HEMOLYZED|N|ELECTRONEUROGRAPHY|FIBROSIS 4 FORMULA||N|NA|N|U|||N|2||58||INDUCTION TREATMENT|1963-09-06|1969-04-02|||||1965-03-31||1972-07-20|U|1964-09-10
TRIAL STUDY 134XCP|LB|B349DD89-C41F-470E-8B54-B3589F0982FE|2||||SODIUM|SODIUM|||||||U/MG|||||||NEGATIVE||/MBP||||NORMAL|NOT DONE||||ABSCESS FLUID|ICTERIC|N|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD FORMULA||N|U|Y|U|||N|2||58||WASHOUT|1960-01-15|1962-06-12|||||1964-05-13||1971-04-11|U|1966-02-09
TRIAL STUDY 134XCP|LB|B349DD89-C41F-470E-8B54-B3589F0982FE|1||||C130123|NUT MIX ANTIGEN IGG ANTIBODY|||||||MMOL|||||||NEGATIVE||KPA/L/SEC||||LOW|NOT DONE||||LUNG SURFACTANT|CLOTTED|Y|IVY INCISION METHOD|NASH FIBROSURE FORMULA||N|NA|U|N|||U|3||39||SCREENING|1962-02-20|1972-10-30|||||1969-08-31||1960-01-19|Y|1970-12-31
TRIAL STUDY 134XCP|LB|B349DD89-C41F-470E-8B54-B3589F0982FE|2||||IOHEXOL|IOHEXOL|||||||BOLUS|||||||INDETERMINATE||NEBULE||||HIGH|NOT DONE||||MUSCLE TISSUE|UNEXPECTED ODOR|U|NON-INVASIVE DIELECTRIC SENSING|FIBROTEST FORMULA||Y|N|Y|Y|||Y|3||39||WASHOUT|1971-06-04|1967-09-10|||||1965-06-20||1961-01-19|NA|1962-03-08
TRIAL STUDY 134XCP|LB|B349DD89-C41F-470E-8B54-B3589F0982FE|1||||APLSMA2|ALPHA-2 ANTIPLASMIN|||||||M|||||||TRACE||MG/G/MIN||||ABNORMAL|NOT DONE||||SALIVA|THAWED|U|FLUORESCEIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|U|N|Y|||NA|4||88||CONTINUATION TREATMENT|1966-11-29|1970-03-11|||||1969-06-26||1962-05-28|N|1967-11-30
TRIAL STUDY 134XCP|LB|B349DD89-C41F-470E-8B54-B3589F0982FE|2||||PHNBRBTL|PHENOBARBITAL|||||||10^5/L|||||||INVALID||ANTI-XA IU/ML||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|HEMOLYZED|NA|TRANSCRIPTION-MEDIATED AMPLIFICATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|NA|U|||NA|4||88||BLINDED TREATMENT|1971-05-10|1972-12-31|||||1963-08-04||1963-09-12|N|1962-12-11
TRIAL STUDY 134XCP|LB|B349DD89-C41F-470E-8B54-B3589F0982FE|1||||LDLOXI|OXIDIZED LDL CHOLESTEROL|||||||IU/G|||||||NEGATIVE||MM3/MM2/YEAR||||ABNORMAL|NOT DONE||||VENOUS BLOOD|CONTAMINATED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|CKD-EPI FORMULA||N|NA|N|N|||N|5||7||BASELINE|1965-12-25|1965-11-13|||||1961-05-08||1960-02-27|N|1964-09-25
TRIAL STUDY 134XCP|LB|B349DD89-C41F-470E-8B54-B3589F0982FE|2||||CKMM|CREATINE KINASE MM|||||||APPLICATION|||||||NEGATIVE||POUCH||||NORMAL|NOT DONE||||RETICULOCYTES|CLOTTED|Y|MICROBIAL CULTURE, LIQUID|MDRD 6 VARIABLE FORMULA||U|NA|U|Y|||N|5||7||RUN-IN|1961-10-09|1966-12-02|||||1965-05-28||1960-02-04|Y|1965-03-07
TRIAL STUDY 134XCP|LB|415D178A-275A-440C-8617-154441A48F8D|1||||CSFAT|FATTY CASTS|||||||DAYS/MONTH|||||||TRACE||10^12/L||||ABNORMAL|NOT DONE||||SPERMATOZOON|GELLED|Y|GC/MS/MS|GMI MMOL/MOL FORMULA||NA|NA|Y|N|||Y|1||38||RUN-IN|1960-08-05|1963-02-07|||||1963-02-13||1963-03-10|NA|1967-05-05
TRIAL STUDY 134XCP|LB|415D178A-275A-440C-8617-154441A48F8D|2||||AFPL2|ALPHA FETOPROTEIN L2|||||||L|||||||BORDERLINE||MILE||||HIGH|NOT DONE||||PLATELET|FRESH|NA|PULSE OXIMETRY|MDRD FORMULA||NA|U|NA|U|||U|1||38||TREATMENT|1963-10-31|1970-06-24|||||1970-11-26||1963-08-19|N|1973-05-05
TRIAL STUDY 134XCP|LB|415D178A-275A-440C-8617-154441A48F8D|1||||BASOB|BASOPHILS BAND FORM|||||||FFU|||||||INVALID||MEQ/L||||HIGH|NOT DONE||||INFRANATANT, SERUM|FROZEN|U|TARGETED GENOME SEQUENCING|CKD-EPI FORMULA||Y|NA|U|U|||Y|2||58||WASHOUT|1965-03-15|1968-02-15|||||1973-02-03||1968-12-27|NA|1972-06-09
TRIAL STUDY 134XCP|LB|415D178A-275A-440C-8617-154441A48F8D|2||||AFPL3AFP|A FETOPROTEIN L3/A FETOPROTEIN|||||||BREATHS/30S|||||||INDETERMINATE||ML/M2/MIN||||LOW|NOT DONE||||CORD BLOOD|ICTERIC|Y|INTERRUPTER TECHNIQUE|FIBROTEST FORMULA||N|U|NA|NA|||NA|2||58||FOLLOW-UP|1969-05-03|1965-03-06|||||1972-08-04||1968-08-31|Y|1969-12-20
TRIAL STUDY 134XCP|LB|415D178A-275A-440C-8617-154441A48F8D|1||||GADAB|GLUTAMIC ACID DECARBOXYLASE ANTIBODY|||||||ABSORBANCE U/ML|||||||NEGATIVE||NEEDLE GAUGE||||LOW|NOT DONE||||BONE|CONCENTRATED|U|IMMUNOTURBIDIMETRY|FIBROSIS 4 FORMULA||U|Y|U|NA|||Y|3||39||BASELINE|1969-11-04|1968-11-11|||||1966-10-08||1960-01-15|U|1962-04-03
TRIAL STUDY 134XCP|LB|415D178A-275A-440C-8617-154441A48F8D|2||||G6PDRBRB|G6PD-DEFICIENT ERYTHROCYTES/ERYTHROCYTES|||||||UM2|||||||INDETERMINATE||ML/M2||||LOW|NOT DONE||||SUPERNATANT, PLASMA|HEMOLYZED|N|MUGA|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|N|Y|||N|3||39||LONG-TERM FOLLOW-UP|1973-09-06|1971-07-04|||||1960-09-25||1963-02-08|NA|1970-08-24
TRIAL STUDY 134XCP|LB|415D178A-275A-440C-8617-154441A48F8D|1||||IGFBP2|INSULIN-LIKE GROWTH FACTOR BINDING PROT2|||||||MS/MMHG|||||||TRACE||BQ/ML||||HIGH|NOT DONE||||CORD BLOOD|HEMOLYZED|U|MUGA|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|NA|NA|||Y|4||88||RUN-IN|1967-12-08|1963-02-14|||||1960-03-18||1962-09-24|U|1968-07-15
TRIAL STUDY 134XCP|LB|415D178A-275A-440C-8617-154441A48F8D|2||||NORMEEXR|NORMETANEPHRINE EXCRETION RATE|||||||PMOL/10^9 CELLS|||||||INVALID||BQ/G||||HIGH|NOT DONE||||DERMAL TISSUE|FROZEN|N|AUTOMATED COUNT|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|U|N|||Y|4||88||TREATMENT|1969-01-12|1962-08-12|||||1967-06-04||1967-02-15|Y|1964-10-03
TRIAL STUDY 134XCP|LB|415D178A-275A-440C-8617-154441A48F8D|1||||HDLCCHOL|HDL CHOLESTEROL/TOTAL CHOLESTEROL|||||||MILE|||||||INVALID||P||||LOW|NOT DONE||||VITREOUS HUMOR|ICTERIC|N|GC/MS-CI|FIBROTEST FORMULA||Y|Y|N|U|||N|5||7||OPEN LABEL TREATMENT|1967-11-12|1968-09-02|||||1966-04-22||1961-04-24|N|1969-11-08
TRIAL STUDY 134XCP|LB|415D178A-275A-440C-8617-154441A48F8D|2||||ETPLT|ETP LAG TIME|||||||MIN*MG/ML|||||||TRACE||MIN||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|REFRIGERATED|N|REFLECTANCE SPECTROSCOPY|MDRD 5 VARIABLE FORMULA||NA|NA|N|NA|||U|5||7||INDUCTION TREATMENT|1968-09-01|1960-03-06|||||1969-07-05||1962-10-18|Y|1960-04-17
TRIAL STUDY 134XCP|LB|C23917E6-6CA5-4314-A59D-A0298483BF53|1||||CLEPNSQE|COLUMNAR EPI CELLS/NON-SQUAM EPI CELLS|||||||BQ/UG|||||||NEGATIVE||HR/DAY||||ABNORMAL|NOT DONE||||SKIN TISSUE|UNEXPECTED ODOR|U|ANTIMICROBIAL COMBINATION TESTING|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|U|||N|1||38||FOLLOW-UP|1961-04-03|1972-07-11|||||1965-03-01||1962-08-01|U|1961-02-23
TRIAL STUDY 134XCP|LB|C23917E6-6CA5-4314-A59D-A0298483BF53|2||||C165918|AMERICAN COCKROACH IGG AB RAST SCORE|||||||ML/CM H2O|||||||TRACE||10^3 CFU/ML||||HIGH|NOT DONE||||TRANSUDATE|PARAFFIN-EMBEDDED|N|DROPLET DIGITAL PCR|FIBROTEST FORMULA||NA|NA|N|NA|||U|1||38||TREATMENT|1972-02-05|1971-12-19|||||1972-09-20||1973-08-20|U|1960-03-15
TRIAL STUDY 134XCP|LB|C23917E6-6CA5-4314-A59D-A0298483BF53|1||||CA1AG|CANCER ANTIGEN 1|||||||MM/H|||||||INDETERMINATE||ELISA UNIT/ML||||LOW|NOT DONE||||MIXED VENOUS BLOOD|SOLIDIFIED|NA|IRON HEMATOXYLIN STAIN|NASH FIBROSURE FORMULA||N|N|U|U|||NA|2||58||TREATMENT|1968-09-06|1964-05-23|||||1961-03-10||1970-09-09|Y|1962-12-30
TRIAL STUDY 134XCP|LB|C23917E6-6CA5-4314-A59D-A0298483BF53|2||||HELMETCE|HELMET CELLS|||||||10^3 COPIES/ML|||||||BORDERLINE||PA||||HIGH|NOT DONE||||CORD SERUM|HEMOLYZED|NA|KINETIC MICROPARTICLE IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|N|N|||N|2||58||FOLLOW-UP|1963-02-19|1961-10-12|||||1960-03-28||1963-03-03|N|1966-02-07
TRIAL STUDY 134XCP|LB|C23917E6-6CA5-4314-A59D-A0298483BF53|1||||IFI44|INTERFERON-INDUCED PROTEIN 44|||||||G/DL|||||||INDETERMINATE||MBQ||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|NON-HEMOLYZED|NA|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||U|NA|U|N|||U|3||39||SCREENING|1968-08-17|1962-05-21|||||1963-06-27||1965-04-17|NA|1960-06-01
TRIAL STUDY 134XCP|LB|C23917E6-6CA5-4314-A59D-A0298483BF53|2||||BCEFNCTN|BETA-CELL FUNCTION|||||||ML/ANIMAL/WK|||||||INVALID||ANTI-XA IU/ML||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|CONTAMINATED|Y|TRICHROME STAIN|HEPASCORE FORMULA||NA|U|Y|U|||N|3||39||OBSERVATION|1965-08-09|1963-03-24|||||1970-09-03||1971-07-10|U|1964-03-11
TRIAL STUDY 134XCP|LB|C23917E6-6CA5-4314-A59D-A0298483BF53|1||||TNFR1|TUMOR NECROSIS FACTOR RECEPTOR 1|||||||PSI|||||||INVALID||ML/SEC/1.73M2||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|PARAFFIN-EMBEDDED|N|CONGO RED STAIN|GMI % FORMULA||N|U|N|NA|||Y|4||88||OPEN LABEL TREATMENT|1961-02-04|1960-10-31|||||1961-11-15||1971-12-16|NA|1965-10-25
TRIAL STUDY 134XCP|LB|C23917E6-6CA5-4314-A59D-A0298483BF53|2||||IBCT|TOTAL IRON BINDING CAPACITY|||||||TUBE|||||||INDETERMINATE||UG/KG/H||||LOW|NOT DONE||||ABSCESS FLUID|CONCENTRATED|N|HPLC/MS/MS|CKD-EPI FORMULA||U|U|N|Y|||Y|4||88||FOLLOW-UP|1961-03-28|1970-07-30|||||1971-04-29||1965-08-05|U|1966-07-10
TRIAL STUDY 134XCP|LB|C23917E6-6CA5-4314-A59D-A0298483BF53|1||||ROUNDCE|ROUND CELLS|||||||M2|||||||POSITIVE||ML/G/H||||NORMAL|NOT DONE||||VENOUS PLASMA|AUTOLYZED|Y|CAPILLARY ELECTROPHORESIS|COCKCROFT-GAULT FORMULA||NA|N|Y|NA|||N|5||7||WASHOUT|1972-12-06|1965-01-13|||||1970-08-23||1960-08-28|Y|1970-03-30
TRIAL STUDY 134XCP|LB|C23917E6-6CA5-4314-A59D-A0298483BF53|2||||C165895|JOHNSON GRASS POLLEN IGG4 ANTIBODY|||||||MG|||||||POSITIVE||CIGAR||||ABNORMAL|NOT DONE||||DISCHARGE|LIPEMIC|NA|AUTOREFRACTION|GMI % FORMULA||NA|U|NA|N|||NA|5||7||RUN-IN|1965-10-14|1973-07-03|||||1963-02-18||1971-09-08|U|1961-05-27
TRIAL STUDY 134XCP|LB|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|1||||SALCYLT|SALICYLATES|||||||MPS U|||||||BORDERLINE||NG/DAY||||ABNORMAL|NOT DONE||||ABSCESS FLUID|FROZEN|U|DISK DIFFUSION|MDRD ENZYMATIC FORMULA||N|NA|NA|U|||Y|1||38||LONG-TERM FOLLOW-UP|1973-05-05|1962-03-06|||||1970-03-27||1963-01-28|NA|1971-06-27
TRIAL STUDY 134XCP|LB|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|2||||AMYLASE|AMYLASE|||||||NMOL/MOL|||||||INDETERMINATE||MEQ/UG||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED|NA|FLUORESCENT IMMUNOASSAY|GMI MMOL/MOL FORMULA||NA|Y|Y|U|||U|1||38||BASELINE|1970-11-22|1971-04-10|||||1967-02-20||1966-06-03|U|1965-10-08
TRIAL STUDY 134XCP|LB|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|1||||CD14|CD14|||||||10^9 ORGANISMS/ML|||||||NEGATIVE||MM||||ABNORMAL|NOT DONE||||NAIL|GELLED|Y|GEL ELECTROPHORESIS|MDRD 5 VARIABLE FORMULA||NA|U|U|NA|||Y|2||58||SCREENING|1971-12-30|1965-02-07|||||1965-02-10||1972-03-06|N|1965-10-31
TRIAL STUDY 134XCP|LB|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|2||||ANCPNCAB|NEUTROPHIL CYTOPLASMIC AB, PERINUCLEAR|||||||MG/DAY|||||||POSITIVE||PUFF||||NORMAL|NOT DONE||||SALIVA|UNEXPECTED ODOR|U|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|NASH FIBROSURE FORMULA||NA|Y|NA|NA|||N|2||58||TREATMENT|1968-09-21|1960-05-06|||||1973-04-13||1963-08-19|U|1965-02-04
TRIAL STUDY 134XCP|LB|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|1||||PHOSEXR|PHOSPHORUS EXCRETION RATE|||||||U/10^12 RBC|||||||TRACE||ML/DOSE||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|GELLED|N|ELLA|CKD-EPI CREATININE FORMULA||NA|NA|U|U|||N|3||39||SCREENING|1966-10-16|1964-01-30|||||1966-10-04||1973-07-24|U|1963-09-30
TRIAL STUDY 134XCP|LB|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|2||||GAD1|GLUTAMIC ACID DECARBOXYLASE 1|||||||BISCUIT|||||||INDETERMINATE||CI/MG||||HIGH|NOT DONE||||BONE|GELLED|N|BAC ACGH|NASH FIBROSURE FORMULA||N|N|U|Y|||Y|3||39||OPEN LABEL TREATMENT|1966-09-02|1963-02-24|||||1965-12-17||1962-06-25|N|1971-08-30
TRIAL STUDY 134XCP|LB|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|1||||SO2|SULFUR DIOXIDE|||||||GTT|||||||NEGATIVE||10^7 CFU||||NORMAL|NOT DONE||||FLUID|CLOTTED|Y|IN SITU HYBRIDIZATION|GMI MMOL/MOL FORMULA||N|NA|N|U|||NA|4||88||WASHOUT|1971-01-25|1968-05-24|||||1961-05-30||1965-07-20|N|1964-03-06
TRIAL STUDY 134XCP|LB|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|2||||UDCACM|URSODEOXYCHOLATE COMPOUNDS|||||||KEV|||||||BORDERLINE||DRAM||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|LACTESCENT|NA|KARYOTYPING|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|NA|NA|||N|4||88||TREATMENT|1961-10-06|1961-05-05|||||1971-02-16||1961-09-18|N|1962-08-21
TRIAL STUDY 134XCP|LB|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|1||||AMYLASEP|AMYLASE, PANCREATIC|||||||MV2/HZ|||||||NEGATIVE||UV2||||LOW|NOT DONE||||SYNOVIAL FLUID|LIPEMIC|N|ELECTRONEUROGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|NA|Y|NA|||N|5||7||CONTINUATION TREATMENT|1969-04-23|1969-04-30|||||1966-09-15||1965-08-27|Y|1967-05-12
TRIAL STUDY 134XCP|LB|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|2||||CARNITF|CARNITINE, FREE|||||||NMOL/L|||||||NEGATIVE||DAYS/MONTH||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|AGGLUTINATED|NA|CT SCAN|HEPASCORE FORMULA||U|U|U|U|||Y|5||7||BASELINE|1965-08-17|1971-01-18|||||1972-09-22||1960-11-02|U|1965-10-21
TRIAL STUDY 134XCP|LB|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|1||||LAG3S|SOLUBLE LYMPHOCYTE ACTIVATION GENE-3|||||||GY|||||||INVALID||SHOCK WAVE||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|LIPEMIC|NA|CT SCAN WITHOUT CONTRAST|FIBROTEST FORMULA||N|N|U|N|||N|1||38||SCREENING|1970-06-11|1968-04-25|||||1972-10-20||1971-10-20|Y|1964-06-17
TRIAL STUDY 134XCP|LB|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|2||||VITB12|VITAMIN B12|||||||UG/KG/DAY|||||||TRACE||UMOL/L||||LOW|NOT DONE||||LOCHIA|FROZEN|N|DIFFUSION TENSOR MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|NA|N|||U|1||38||WASHOUT|1966-02-14|1968-05-19|||||1970-09-05||1970-09-12|NA|1966-06-17
TRIAL STUDY 134XCP|LB|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|1||||C130116|BEE MIX ANTIGEN IGE ANTIBODY|||||||NMOL/MOL|||||||BORDERLINE||10^9 ORGANISMS||||NORMAL|NOT DONE||||PLEURAL FLUID|ICTERIC|NA|FUNCTIONAL MRI|CKD-EPI CYSTATIN C FORMULA||NA|Y|NA|N|||Y|2||58||FOLLOW-UP|1968-05-19|1967-02-25|||||1968-12-10||1960-05-12|Y|1968-12-13
TRIAL STUDY 134XCP|LB|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|2||||PNCTPP|PANCREATIC POLYPEPTIDE|||||||LOG10 PFU/ML|||||||INVALID||UV2||||NORMAL|NOT DONE||||SWABBED MATERIAL|CONTAMINATED|N|VENTILATION PERFUSION LUNG SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|NA|||N|2||58||CONTINUATION TREATMENT|1965-07-31|1972-05-16|||||1965-04-02||1972-03-08|Y|1966-06-29
TRIAL STUDY 134XCP|LB|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|1||||MERCECE|MATURING ERYTHROID CELLS/TOTAL CELLS|||||||10^6 DNA COPIES/ML|||||||NEGATIVE||PMOL/L||||ABNORMAL|NOT DONE||||BUFFY COAT|ROOM TEMPERATURE|U|NUCLEIC ACID AMPLIFICATION TEST|COCKCROFT-GAULT FORMULA||Y|N|N|U|||N|3||39||INDUCTION TREATMENT|1969-04-16|1970-10-30|||||1971-08-24||1972-04-14|U|1967-05-16
TRIAL STUDY 134XCP|LB|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|2||||TIMP3|TISSUE INHIBITOR OF METALLOPROTEINASE 3|||||||CI/G|||||||BORDERLINE||PFU/DOSE||||LOW|NOT DONE||||EPIDERMAL TISSUE|CLOTTED|U|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD ENZYMATIC FORMULA||Y|Y|NA|NA|||U|3||39||SCREENING|1972-02-03|1961-11-27|||||1961-03-21||1963-12-21|NA|1972-09-03
TRIAL STUDY 134XCP|LB|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|1||||CD5|CD5|||||||WEBER|||||||BORDERLINE||KG/MOL||||HIGH|NOT DONE||||SERUM OR PLASMA|CALCIFIED|NA|COLORIMETRY|MDRD 6 VARIABLE FORMULA||NA|Y|U|Y|||U|4||88||FOLLOW-UP|1969-10-06|1970-07-12|||||1964-03-12||1961-03-03|Y|1962-01-31
TRIAL STUDY 134XCP|LB|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|2||||CEA|CARCINOEMBRYONIC ANTIGEN|||||||MMOL/DAY|||||||NEGATIVE||WEEKS||||LOW|NOT DONE||||GASTRIC CONTENTS|HEMOLYZED|N|TRIPLE-PHASE SPIRAL CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|Y|NA|||Y|4||88||CONTINUATION TREATMENT|1967-03-25|1968-09-03|||||1964-07-19||1963-12-09|U|1966-09-13
TRIAL STUDY 134XCP|LB|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|1||||CDCA|CHENODEOXYCHOLATE|||||||CMOL/L|||||||POSITIVE||KIT||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|THAWED|NA|DC SHEATH FLOW|FIBROMETER FORMULA||Y|NA|U|N|||Y|5||7||CONTINUATION TREATMENT|1961-08-08|1968-04-23|||||1966-03-10||1965-06-01|NA|1972-11-08
TRIAL STUDY 134XCP|LB|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|2||||CBA|COMPLEMENT BA|||||||ML/ANIMAL/DAY|||||||POSITIVE||TUBERCULIN UNIT/ML||||NORMAL|NOT DONE||||SPERMATOZOON|CALCIFIED|N|NON-INVASIVE DIELECTRIC SENSING|NASH FIBROSURE FORMULA||N|NA|Y|U|||NA|5||7||BASELINE|1965-12-03|1966-12-08|||||1972-08-25||1969-04-23|Y|1967-07-04
TRIAL STUDY 134XCP|LB|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|1||||PSIGAAB|PHOSPHATIDYLSERINE IGA ANTIBODY|||||||S*KPA|||||||INDETERMINATE||/MIN||||HIGH|NOT DONE||||MUSCLE TISSUE|UNEXPECTED ODOR|Y|PERFUSION MRI|CKD-EPI CYSTATIN C FORMULA||N|N|U|Y|||Y|1||38||FOLLOW-UP|1969-12-26|1973-09-03|||||1960-10-26||1966-12-30|NA|1964-10-03
TRIAL STUDY 134XCP|LB|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|2||||AFPADJBW|ALPHA FETOPROTEIN ADJ FOR BODY WEIGHT|||||||10^5/L|||||||POSITIVE||G/ANIMAL/WK||||NORMAL|NOT DONE||||PLEURAL TISSUE|AUTOLYZED|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD 4 VARIABLE FORMULA||U|U|NA|U|||N|1||38||BLINDED TREATMENT|1967-04-04|1970-02-27|||||1972-05-10||1964-07-27|NA|1969-01-10
TRIAL STUDY 134XCP|LB|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|1||||FIBRINOF|FIBRINOGEN, FUNCTIONAL|||||||STRIP|||||||INDETERMINATE||LOG10 TCID 50/UL||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|AGGLUTINATED|N|MANUAL COUNT|CKD-EPI CYSTATIN C FORMULA||N|U|U|N|||NA|2||58||RUN-IN|1960-09-30|1967-08-29|||||1961-08-18||1966-11-25|U|1966-01-29
TRIAL STUDY 134XCP|LB|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|2||||PNTBRBTL|PENTOBARBITAL|||||||BISCUIT|||||||NEGATIVE||UG/L/H||||ABNORMAL|NOT DONE||||LEUKOCYTE|THAWED|N|SPECULAR MICROSCOPY|HEPASCORE FORMULA||N|NA|U|Y|||N|2||58||SCREENING|1961-02-07|1962-08-11|||||1972-08-05||1960-11-03|N|1973-04-13
TRIAL STUDY 134XCP|LB|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|1||||GGTEXR|GAMMAGLUTAMYL TRANSFERASE EXCRETION RATE|||||||/LPF|||||||INDETERMINATE||PIXEL||||HIGH|NOT DONE||||VENOUS CORD BLOOD|LACTESCENT|N|ETDRS EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|NA|N|||Y|3||39||RUN-IN|1970-11-14|1966-06-20|||||1963-05-13||1960-03-28|N|1962-07-09
TRIAL STUDY 134XCP|LB|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|2||||CD19LY|CD19/LYMPHOCYTES|||||||CI/UG|||||||TRACE||GPL U||||NORMAL|NOT DONE||||RETICULOCYTES|CONCENTRATED|U|TELLER ACUITY CARDS|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|N|U|||N|3||39||FOLLOW-UP|1963-03-24|1965-11-12|||||1960-12-24||1970-04-17|U|1965-04-11
TRIAL STUDY 134XCP|LB|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|1||||OLIGBAND|OLIGOCLONAL BANDS|||||||UOSM|||||||NEGATIVE||VOXEL||||LOW|NOT DONE||||CAPILLARY BLOOD|CALCIFIED|Y|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC FORMULA||U|NA|N|NA|||Y|4||88||OPEN LABEL TREATMENT|1969-06-01|1963-04-08|||||1967-06-11||1963-02-02|N|1966-04-07
TRIAL STUDY 134XCP|LB|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|2||||NEUTIMLE|IMMATURE NEUTROPHILS/LEUKOCYTES|||||||EP U|||||||INVALID||TUBERCULIN UNIT/ML||||ABNORMAL|NOT DONE||||BONE MARROW|CONTAMINATED|NA|ANALYTICAL ULTRACENTRIFUGATION|FIBROTEST FORMULA||NA|Y|U|U|||Y|4||88||OPEN LABEL TREATMENT|1963-05-13|1969-05-16|||||1962-02-13||1965-05-24|N|1964-11-19
TRIAL STUDY 134XCP|LB|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|1||||C165892|WILD RYE POLLEN IGE ANTIBODY|||||||UU/DL|||||||NEGATIVE||DRUM||||LOW|NOT DONE||||INFRANATANT, SERUM|AGGLUTINATED|NA|ELISPOT|FIBROMETER FORMULA||N|Y|N|N|||NA|5||7||FOLLOW-UP|1963-11-14|1960-05-30|||||1966-06-29||1962-12-30|N|1964-12-01
TRIAL STUDY 134XCP|LB|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|2||||MMP2|MATRIX METALLOPROTEINASE 2|||||||MOL|||||||NEGATIVE||10^3 CFU/G||||HIGH|NOT DONE||||ERYTHROCYTES|AGGLUTINATED|NA|WRIGHT STAIN|COCKCROFT-GAULT FORMULA||NA|U|U|U|||NA|5||7||OPEN LABEL TREATMENT|1966-11-24|1960-12-01|||||1962-11-26||1960-06-05|U|1969-06-27
TRIAL STUDY 134XCP|LB|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|1||||MYCEPPOL|MYELOID PROLIFERATION POOL|||||||CY/CM|||||||TRACE||MG/M2/H||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CONCENTRATED|U|ICP-MS|COCKCROFT-GAULT FORMULA||NA|NA|N|U|||N|1||38||SCREENING|1972-02-24|1971-04-21|||||1960-03-27||1962-06-13|Y|1962-08-11
TRIAL STUDY 134XCP|LB|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|2||||PICP|PROCOLLAGEN TYPE I CARBOXY TERM PEPTIDE|||||||VP/DOSE|||||||POSITIVE||10^9 ORGANISMS/MG||||ABNORMAL|NOT DONE||||VENOUS BLOOD|PARAFFIN-EMBEDDED|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|N|N|||N|1||38||BASELINE|1962-04-14|1963-01-07|||||1968-10-01||1964-04-26|Y|1961-09-12
TRIAL STUDY 134XCP|LB|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|1||||CD38|CD38|||||||MOL|||||||TRACE||PPTR||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|ICTERIC|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|U|NA|NA|||NA|2||58||RUN-IN|1967-05-06|1962-02-14|||||1965-06-03||1972-05-07|NA|1960-11-16
TRIAL STUDY 134XCP|LB|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|2||||KLOTHO|KLOTHO|||||||PMOL/DAY|||||||INVALID||PACKET||||NORMAL|NOT DONE||||SMEGMA|HEMOLYZED|U|ENZYMATIC ULTRACENTRIFUGATION|MDRD 4 VARIABLE FORMULA||U|NA|N|Y|||N|2||58||CONTINUATION TREATMENT|1971-12-06|1965-08-10|||||1971-10-15||1967-08-16|NA|1970-02-28
TRIAL STUDY 134XCP|LB|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|1||||GGTCREAT|GAMMA GLUTAMYL TRANSFERASE/CREATININE|||||||U/CL|||||||POSITIVE||YEARS||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|FROZEN|N|PULSE OXIMETRY|GMI MMOL/MOL FORMULA||U|Y|U|Y|||Y|3||39||BASELINE|1973-04-18|1973-04-18|||||1964-04-30||1964-03-22|U|1963-03-13
TRIAL STUDY 134XCP|LB|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|2||||A73OXC|7-ALPHA-HYDROXY-4-CHOLESTEN-3-ONE|||||||10^4/HPF|||||||TRACE||HR/DAY||||LOW|NOT DONE||||URINE|AUTOLYZED|U|LIQUID SCINTILLATION COUNTING|MDRD ENZYMATIC FORMULA||NA|NA|Y|N|||NA|3||39||FOLLOW-UP|1963-06-13|1971-08-09|||||1961-02-22||1965-12-17|Y|1961-11-08
TRIAL STUDY 134XCP|LB|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|1||||APOB100|APOLIPOPROTEIN B100|||||||ML/ANIMAL|||||||BORDERLINE||DNA COPIES/UG||||HIGH|NOT DONE||||PLATELET POOR PLASMA|AUTOLYZED|U|DIFFUSION WEIGHTED MRI|COCKCROFT-GAULT FORMULA||NA|Y|U|U|||Y|4||88||LONG-TERM FOLLOW-UP|1972-11-08|1966-02-28|||||1969-06-28||1973-01-25|U|1969-04-15
TRIAL STUDY 134XCP|LB|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|2||||CD40L|CD40 LIGAND|||||||PIXELS/CM|||||||POSITIVE||RING||||LOW|NOT DONE||||PERITONEAL FLUID|FROZEN|Y|PHASE-CONTRAST MRI|MDRD ENZYMATIC FORMULA||NA|NA|Y|NA|||N|4||88||WASHOUT|1965-01-30|1962-06-24|||||1964-04-24||1973-04-27|Y|1971-10-25
TRIAL STUDY 134XCP|LB|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|1||||VEGFR2|VASC ENDOTHELIAL GROWTH FACTOR REC 2|||||||MMOL/KG|||||||TRACE||DMOL||||HIGH|NOT DONE||||EMESIS|FROZEN|N|CYSTOSCOPY|FIBROSIS 4 FORMULA||NA|NA|Y|NA|||Y|5||7||TREATMENT|1964-03-12|1960-07-26|||||1963-07-21||1964-08-27|NA|1965-01-04
TRIAL STUDY 134XCP|LB|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|2||||CRTCLRBS|CREATININE CLEARANCE ADJUSTED FOR BSA|||||||/MBP|||||||INDETERMINATE||S^-1(%O2)^-1||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|GELLED|Y|ACRIDINE ORANGE STAIN|ASH FIBROSURE FORMULA||N|NA|NA|Y|||N|5||7||TREATMENT|1973-03-10|1970-05-05|||||1966-04-17||1962-04-02|U|1960-01-18
TRIAL STUDY 134XCP|LB|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|1||||APRIL|A PROLIFERATION-INDUCING LIGAND|||||||10^8 PFU|||||||INVALID||10^6 CFU/ML||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|CLOTTED|Y|GC/MS-EI|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|NA|NA|||U|1||38||OPEN LABEL TREATMENT|1969-03-02|1964-06-13|||||1972-01-14||1969-01-05|NA|1970-01-18
TRIAL STUDY 134XCP|LB|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|2||||MMP2|MATRIX METALLOPROTEINASE 2|||||||PIPE|||||||TRACE||MG/L FEU||||ABNORMAL|NOT DONE||||GASTRIC FLUID|SOLIDIFIED|N|LC/MS|FIBROTEST FORMULA||Y|NA|N|N|||U|1||38||BLINDED TREATMENT|1961-09-11|1970-03-09|||||1966-03-22||1973-01-20|U|1966-04-21
TRIAL STUDY 134XCP|LB|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|1||||A1AGLP|ALPHA-1 ACID GLYCOPROTEIN|||||||MEQ/UG|||||||BORDERLINE||BAG||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|SOLIDIFIED|NA|DIRECT SEQUENCING|MDRD 6 VARIABLE FORMULA||NA|Y|N|Y|||U|2||58||RUN-IN|1962-01-14|1963-09-05|||||1969-03-30||1971-09-18|Y|1968-03-05
TRIAL STUDY 134XCP|LB|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|2||||GSTCREAT|GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||MG|||||||INDETERMINATE||U/M2/H||||NORMAL|NOT DONE||||EMESIS|CONCENTRATED|N|CONTRAST ENHANCED X-RAY|MDRD 4 VARIABLE FORMULA||Y|N|Y|NA|||U|2||58||BASELINE|1973-06-22|1962-01-25|||||1966-03-27||1967-01-06|N|1965-05-14
TRIAL STUDY 134XCP|LB|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|1||||LKM1IMAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGM AB|||||||H*%|||||||BORDERLINE||MEQ/DAY||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|PARAFFIN-EMBEDDED|U|SINGLE-MOLECULE ARRAY|MDRD ENZYMATIC FORMULA||NA|NA|U|N|||Y|3||39||TREATMENT|1969-12-24|1969-01-14|||||1973-06-13||1971-02-13|Y|1972-01-05
TRIAL STUDY 134XCP|LB|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|2||||INTLK15|INTERLEUKIN 15|||||||CMH2O*S2/ML|||||||BORDERLINE||UL/DOSE||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|CONCENTRATED|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|GMI % FORMULA||N|N|Y|Y|||Y|3||39||RUN-IN|1970-08-28|1965-12-12|||||1962-01-24||1971-07-12|N|1961-11-28
TRIAL STUDY 134XCP|LB|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|1||||VLDL1|VLDL CHOLESTEROL SUBTYPE 1|||||||MSEC|||||||INVALID||KG/L||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|FROZEN|N|TRANSMISSION ELECTRON MICROSCOPY|MDRD 6 VARIABLE FORMULA||N|NA|NA|Y|||N|4||88||RUN-IN|1966-05-13|1960-04-05|||||1970-08-30||1963-02-20|Y|1971-11-25
TRIAL STUDY 134XCP|LB|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|2||||RNA|RIBONUCLEIC ACID|||||||MET*MIN|||||||TRACE||10^9/G||||ABNORMAL|NOT DONE||||BASAL TEAR|AGGLUTINATED|U|NUCLEIC ACID SEQUENCING|GMI MMOL/MOL FORMULA||U|N|Y|NA|||Y|4||88||RUN-IN|1972-11-12|1960-07-13|||||1962-02-24||1972-07-24|U|1969-03-08
TRIAL STUDY 134XCP|LB|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|1||||PTHI|PARATHYROID HORMONE, INTACT|||||||10^6 ORGANISMS/MG|||||||INVALID||10^4 CFU/ML||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|Y|FLUORESCEIN STAIN|MDRD 4 VARIABLE FORMULA||N|N|U|NA|||U|5||7||INDUCTION TREATMENT|1970-06-16|1963-02-16|||||1964-01-28||1968-06-14|U|1972-08-05
TRIAL STUDY 134XCP|LB|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|2||||IOHEXOL|IOHEXOL|||||||UOSM|||||||INVALID||AGU/ML||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|DRIED|N|INDIA INK STAIN|FIBROTEST FORMULA||U|Y|Y|NA|||U|5||7||WASHOUT|1969-10-24|1962-10-13|||||1967-09-11||1969-08-25|Y|1961-05-30
TRIAL STUDY 134XCP|LB|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|1||||CYPHOS|PHOSPHATE CRYSTALS|||||||MIN*MG/ML|||||||POSITIVE||G/CAGE/DAY||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|GELLED|N|AUDIOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|NA|NA|||NA|1||38||BLINDED TREATMENT|1970-10-24|1968-03-25|||||1965-01-04||1965-01-07|U|1961-05-19
TRIAL STUDY 134XCP|LB|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|2||||TROPONI3|TROPONIN I TYPE 3|||||||ML/M2/DAY|||||||NEGATIVE||UG/CM2||||HIGH|NOT DONE||||ALVEOLAR AIR|FROZEN|N|RULER MEASUREMENT METHOD|HEPASCORE FORMULA||NA|Y|N|U|||N|1||38||OPEN LABEL TREATMENT|1960-06-30|1972-02-18|||||1971-08-05||1961-11-24|Y|1967-06-21
TRIAL STUDY 134XCP|LB|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|1||||MCSF|MACROPHAGE COLONY STIMULATING FACTOR|||||||/SEC|||||||BORDERLINE||MG/DL||||NORMAL|NOT DONE||||EMOTIONAL TEAR|LIPEMIC|NA|PEAK FLOWMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|N|NA|||Y|2||58||WASHOUT|1962-10-26|1965-01-17|||||1963-12-30||1969-01-29|NA|1960-10-28
TRIAL STUDY 134XCP|LB|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|2||||INTLK7|INTERLEUKIN 7|||||||U/G/MIN|||||||BORDERLINE||MCI||||NORMAL|NOT DONE||||PUS|NON-HEMOLYZED|N|PYROSEQUENCING|MDRD 6 VARIABLE FORMULA||NA|N|N|Y|||Y|2||58||OBSERVATION|1968-09-24|1967-07-17|||||1969-11-30||1963-04-29|N|1971-03-30
TRIAL STUDY 134XCP|LB|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|1||||MDMA|3,4-METHYLENEDIOXYMETHAMPHETAMINE|||||||CMH2O/ML|||||||INVALID||MMHG/SEC||||NORMAL|NOT DONE||||GASTRIC CONTENTS|HEMOLYZED|NA|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|COCKCROFT-GAULT FORMULA||N|U|Y|NA|||N|3||39||LONG-TERM FOLLOW-UP|1967-06-16|1970-10-26|||||1971-10-29||1973-05-09|U|1963-05-30
TRIAL STUDY 134XCP|LB|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|2||||METHANOL|METHANOL|||||||PMOL/G|||||||TRACE||UM2||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|CLOTTED|Y|NUCLEIC ACID AMPLIFICATION TEST|GMI MMOL/MOL FORMULA||Y|NA|Y|N|||N|3||39||BLINDED TREATMENT|1968-10-06|1971-10-21|||||1970-02-04||1960-06-06|NA|1969-04-05
TRIAL STUDY 134XCP|LB|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|1||||FACTX|FACTOR X|||||||ML/MMHG/MIN/L|||||||INDETERMINATE||V/SEC||||LOW|NOT DONE||||FLUID|UNEXPECTED ODOR|NA|RADIATION DOSIMETRY|GMI MMOL/MOL FORMULA||U|NA|Y|N|||Y|4||88||FOLLOW-UP|1962-03-22|1971-08-29|||||1963-01-29||1965-01-18|Y|1971-03-10
TRIAL STUDY 134XCP|LB|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|2||||HCG|CHORIOGONADOTROPIN BETA|||||||DEG/MM|||||||INVALID||FFU||||LOW|NOT DONE||||SERUM OR PLASMA|UNEXPECTED ODOR|U|LC/MS|CKD-EPI CYSTATIN C FORMULA||U|U|Y|N|||U|4||88||BASELINE|1961-12-22|1966-08-29|||||1971-07-21||1960-11-06|N|1961-09-22
TRIAL STUDY 134XCP|LB|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|1||||C130074|BIRCH POLLEN IGG|||||||L/DAY|||||||POSITIVE||MMHG||||NORMAL|NOT DONE||||MONOCYTE|HEMOLYZED|N|QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROSIS 4 FORMULA||N|N|N|Y|||U|5||7||OPEN LABEL TREATMENT|1961-08-22|1973-02-27|||||1971-05-19||1970-07-16|U|1968-10-12
TRIAL STUDY 134XCP|LB|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|2||||GLOBB|BETA GLOBULIN|||||||10^9 ORGANISMS/G|||||||INVALID||/7.5 ML||||LOW|NOT DONE||||SKIN TISSUE|SOLIDIFIED|U|ALCIAN BLUE STAIN|CKD-EPI FORMULA||NA|N|N|NA|||NA|5||7||WASHOUT|1970-01-09|1963-11-30|||||1961-12-20||1966-05-31|NA|1962-03-30
TRIAL STUDY 134XCP|LB|EDB6B55B-7903-4F89-805C-32F067C2A230|1||||HLADR53A|HLA-DR53 ANTIBODY|||||||DEG/MM|||||||NEGATIVE||BAU/ML||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|REFRIGERATED|NA|IMPEDANCE CONDUCTIVITY|FIBROTEST FORMULA||U|U|NA|Y|||Y|1||38||CONTINUATION TREATMENT|1969-02-18|1967-08-13|||||1973-06-10||1964-01-14|Y|1965-10-20
TRIAL STUDY 134XCP|LB|EDB6B55B-7903-4F89-805C-32F067C2A230|2||||ETGETS|ETHYL GLUCURONIDE ETHYL SULFATE|||||||H*%|||||||INDETERMINATE||LOG10 TCID 50/UL||||ABNORMAL|NOT DONE||||BONE MARROW|AUTOLYZED|Y|ENDPOINT DILUTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|NA|N|||NA|1||38||CONTINUATION TREATMENT|1968-01-19|1964-01-11|||||1966-12-24||1963-12-22|Y|1967-10-18
TRIAL STUDY 134XCP|LB|EDB6B55B-7903-4F89-805C-32F067C2A230|1||||AFPA|ALPHA FETOPROTEIN ACTIVITY|||||||UM2|||||||BORDERLINE||LB||||ABNORMAL|NOT DONE||||LAVAGE FLUID|UNEXPECTED ODOR|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD ENZYMATIC JAPANESE FORMULA||U|U|NA|Y|||NA|2||58||BLINDED TREATMENT|1962-06-22|1968-04-30|||||1962-09-24||1973-06-11|U|1965-03-11
TRIAL STUDY 134XCP|LB|EDB6B55B-7903-4F89-805C-32F067C2A230|2||||IRON|IRON|||||||BQ/MG|||||||INVALID||MANSON U/ML||||NORMAL|NOT DONE||||MUCUS|FRESH|N|GRAM STAIN|MDRD 6 VARIABLE FORMULA||NA|N|N|N|||U|2||58||OBSERVATION|1966-02-06|1961-08-20|||||1962-08-20||1969-11-23|U|1961-07-14
TRIAL STUDY 134XCP|LB|EDB6B55B-7903-4F89-805C-32F067C2A230|1||||METARBCE|METARUBRICYTE/TOTAL CELLS|||||||100 IU/ML|||||||INVALID||TITER||||LOW|NOT DONE||||SPERMATOZOON|AUTOLYZED|Y|CONTRAST ENHANCED PET SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|U|N|||Y|3||39||BLINDED TREATMENT|1960-03-30|1960-01-25|||||1966-08-07||1973-03-17|NA|1965-02-05
TRIAL STUDY 134XCP|LB|EDB6B55B-7903-4F89-805C-32F067C2A230|2||||C165925|WEED MIX POLLEN IGE AB RAST SCORE|||||||MMOL|||||||POSITIVE||MG/G/H||||LOW|NOT DONE||||LEUKOCYTE|CALCIFIED|U|CELL BASED BIOASSAY|MDRD 6 VARIABLE FORMULA||Y|U|U|N|||NA|3||39||OPEN LABEL TREATMENT|1963-12-15|1964-11-22|||||1972-11-04||1971-08-25|U|1965-05-02
TRIAL STUDY 134XCP|LB|EDB6B55B-7903-4F89-805C-32F067C2A230|1||||TSTFWTST|TESTOSTERONE FREE+WEAKLY BOUND/TESTOST|||||||10^7 PFU|||||||BORDERLINE||S*KPA||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|FROZEN|U|IMMUNE REPERTOIRE DEEP SEQUENCING|COCKCROFT-GAULT FORMULA||U|Y|Y|Y|||N|4||88||LONG-TERM FOLLOW-UP|1960-04-19|1961-10-08|||||1971-12-05||1963-08-05|U|1966-12-15
TRIAL STUDY 134XCP|LB|EDB6B55B-7903-4F89-805C-32F067C2A230|2||||PROMONLE|PROMONOCYTES/LEUKOCYTES|||||||UIU/DL|||||||INDETERMINATE||PT_US||||HIGH|NOT DONE||||SERUM OR PLASMA|FRESH|N|NO INFORMATION|GMI % FORMULA||Y|N|U|Y|||NA|4||88||INDUCTION TREATMENT|1966-07-27|1972-03-04|||||1962-12-04||1965-07-11|N|1965-08-21
TRIAL STUDY 134XCP|LB|EDB6B55B-7903-4F89-805C-32F067C2A230|1||||ALPLALP|ALK PHOS, LIVER/TOTAL ALK PHOS|||||||RFU|||||||POSITIVE||MG/ML/DAY||||LOW|NOT DONE||||SPERMATOZOON|HEMOLYZED|U|HEMAGGLUTINATION INHIBITION ASSAY|GMI % FORMULA||NA|NA|Y|NA|||U|5||7||RUN-IN|1970-04-09|1963-11-29|||||1970-08-25||1973-08-01|Y|1972-02-18
TRIAL STUDY 134XCP|LB|EDB6B55B-7903-4F89-805C-32F067C2A230|2||||ADPNHMW|ADIPONECTIN, HIGH MOLECULAR WEIGHT|||||||U/MMOL|||||||BORDERLINE||UL/DOSE||||HIGH|NOT DONE||||LYSATE|FRESH|N|SANGER SEQUENCING|CKD-EPI CYSTATIN C FORMULA||N|Y|Y|N|||NA|5||7||SCREENING|1965-07-31|1967-07-15|||||1966-10-05||1966-10-24|NA|1972-09-08
TRIAL STUDY 134XCP|LB|8F6772DE-E4CA-4706-8754-740D3859ABDF|1||||ASTCREAT|ASPARTATE AMINOTRANSFERASE/CREATININE|||||||M|||||||NEGATIVE||/5X10^4 WBC||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|GELLED|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|NASH FIBROSURE FORMULA||Y|NA|N|U|||N|1||38||CONTINUATION TREATMENT|1966-10-13|1962-08-19|||||1971-04-06||1970-05-02|Y|1965-02-24
TRIAL STUDY 134XCP|LB|8F6772DE-E4CA-4706-8754-740D3859ABDF|2||||ACT|ACTIVATED COAGULATION TIME|||||||NMOL/KG/DAY|||||||INVALID||UG/M2/MIN||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED|NA|MALDI|NASH FIBROSURE FORMULA||Y|U|N|N|||Y|1||38||BLINDED TREATMENT|1972-05-01|1963-12-23|||||1962-11-08||1961-12-20|N|1967-04-02
TRIAL STUDY 134XCP|LB|8F6772DE-E4CA-4706-8754-740D3859ABDF|1||||CHLMCRNT|CHYLOMICRON TRIGLYCERIDE|||||||KHZ|||||||INVALID||V/V||||HIGH|NOT DONE||||AMNIOTIC FLUID|THAWED|NA|HEMOCYTOMETRY|MDRD FORMULA||U|N|Y|U|||U|2||58||OPEN LABEL TREATMENT|1963-05-17|1969-10-06|||||1963-07-28||1963-06-27|NA|1961-12-21
TRIAL STUDY 134XCP|LB|8F6772DE-E4CA-4706-8754-740D3859ABDF|2||||GCSF|GRANULOCYTE COLONY STIMULATING FACTOR|||||||MBQ|||||||TRACE||L/MIN/M2||||HIGH|NOT DONE||||FLUID|AGGLUTINATED|NA|DXA SCAN|MDRD FORMULA||U|NA|N|NA|||N|2||58||OBSERVATION|1961-12-02|1972-08-03|||||1969-12-04||1964-06-17|U|1964-11-10
TRIAL STUDY 134XCP|LB|8F6772DE-E4CA-4706-8754-740D3859ABDF|1||||TNFR1|TUMOR NECROSIS FACTOR RECEPTOR 1|||||||NMOL BCE/NMOL|||||||INDETERMINATE||GBQ/G||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|GELLED|U|MICROBIAL CULTURE, LIQUID|FIBROTEST FORMULA||U|N|N|U|||N|3||39||SCREENING|1968-04-28|1970-11-03|||||1962-05-07||1966-08-16|NA|1970-06-12
TRIAL STUDY 134XCP|LB|8F6772DE-E4CA-4706-8754-740D3859ABDF|2||||HALPRZLM|HYDROXYALPRAZOLAM|||||||POUCH|||||||INDETERMINATE||NG/MOL||||HIGH|NOT DONE||||EPITHELIAL CELL|FROZEN|NA|TARGETED TRANSCRIPTOME SEQUENCING|MDRD FORMULA||U|U|U|Y|||Y|3||39||TREATMENT|1962-04-28|1961-04-24|||||1972-12-13||1964-03-06|U|1966-01-16
TRIAL STUDY 134XCP|LB|8F6772DE-E4CA-4706-8754-740D3859ABDF|1||||DNAAB|ANTI-DNA ANTIBODIES|||||||MG/KG/WEEK|||||||TRACE||KV||||LOW|NOT DONE||||SMEGMA|DRIED|U|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD 5 VARIABLE FORMULA||U|Y|NA|N|||N|4||88||CONTINUATION TREATMENT|1967-06-08|1967-10-02|||||1970-11-10||1969-10-15|Y|1964-06-15
TRIAL STUDY 134XCP|LB|8F6772DE-E4CA-4706-8754-740D3859ABDF|2||||DHPG|3,4-DIHYDROXYPHENYLGLYCOL|||||||ML/M2/H|||||||TRACE||DDU||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|ICTERIC|N|IMPEDANCE CONDUCTIVITY|CKD-EPI FORMULA||NA|U|NA|U|||U|4||88||LONG-TERM FOLLOW-UP|1967-12-24|1966-12-10|||||1964-10-27||1969-08-06|NA|1963-05-01
TRIAL STUDY 134XCP|LB|8F6772DE-E4CA-4706-8754-740D3859ABDF|1||||GLYHLACD|GLYCOCHOLIC ACID|||||||FT2|||||||NEGATIVE||10^6/G||||LOW|NOT DONE||||CORD BLOOD|ROOM TEMPERATURE|U|PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|U|Y|||U|5||7||LONG-TERM FOLLOW-UP|1964-09-30|1963-10-26|||||1968-11-19||1969-12-31|N|1963-01-11
TRIAL STUDY 134XCP|LB|8F6772DE-E4CA-4706-8754-740D3859ABDF|2||||ECCENTCY|ECCENTROCYTES|||||||PIXELS/CM|||||||INVALID||IU/DAY||||ABNORMAL|NOT DONE||||FLUID|ROOM TEMPERATURE|N|FLAME PHOTOMETRY|MDRD 6 VARIABLE FORMULA||U|Y|NA|N|||NA|5||7||RUN-IN|1973-07-23|1964-07-02|||||1963-09-20||1966-09-25|Y|1972-10-15
TRIAL STUDY 134XCP|LB|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|1||||CMPK2|CYTIDINE-URIDINE MONOPHOSPHATE KINASE 2|||||||MS2|||||||INDETERMINATE||ML/ANIMAL/DAY||||HIGH|NOT DONE||||SWABBED MATERIAL|LACTESCENT|Y|NEXT GENERATION TARGETED SEQUENCING|FIBROSIS 4 FORMULA||N|NA|NA|Y|||Y|1||38||BASELINE|1961-10-16|1964-02-16|||||1961-12-04||1960-02-10|NA|1960-08-14
TRIAL STUDY 134XCP|LB|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|2||||HAMAB|HUMAN ANTI-MOUSE ANTIBODY|||||||/SEC|||||||POSITIVE||BAR||||LOW|NOT DONE||||CAPILLARY PLASMA|HEMOLYZED|U|TWO-COLOR MICROARRAY|FIBROTEST FORMULA||Y|U|Y|N|||N|1||38||OPEN LABEL TREATMENT|1962-03-23|1965-01-10|||||1960-11-29||1969-06-12|NA|1962-01-19
TRIAL STUDY 134XCP|LB|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|1||||C130123|NUT MIX ANTIGEN IGG ANTIBODY|||||||FT3|||||||INDETERMINATE||ML/CM3/MIN||||NORMAL|NOT DONE||||EXPIRED AIR|THAWED|N|MAMMOGRAPHY|FIBROMETER FORMULA||NA|NA|U|N|||NA|2||58||FOLLOW-UP|1960-06-30|1970-06-22|||||1964-11-23||1961-02-16|N|1964-04-30
TRIAL STUDY 134XCP|LB|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|2||||C165879|D. FARINAE IGE AB RAST SCORE|||||||AU/ML|||||||POSITIVE||KG/MOL||||HIGH|NOT DONE||||INFRANATANT, SERUM|AGGLUTINATED|NA|DISK DIFFUSION|MDRD 4 VARIABLE FORMULA||U|U|NA|NA|||Y|2||58||BASELINE|1971-09-07|1971-05-24|||||1960-09-16||1965-03-02|U|1961-03-16
TRIAL STUDY 134XCP|LB|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|1||||CCL8|CHEMOKINE (C-C MOTIF) LIGAND 8|||||||10^3 CFU/G|||||||NEGATIVE||U/G/MIN||||NORMAL|NOT DONE||||URINE SEDIMENT|GELLED|Y|AUTOMATED COUNT|ASH FIBROSURE FORMULA||NA|Y|U|Y|||NA|3||39||OPEN LABEL TREATMENT|1964-07-25|1965-06-24|||||1962-12-09||1962-01-19|NA|1973-04-20
TRIAL STUDY 134XCP|LB|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|2||||C130121|SHELLFISH MIX ANTIGEN IGG ANTIBODY|||||||MET*H|||||||NEGATIVE||MMOL2/L2||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|NA|FLUORESCENT MICROSCOPY|NASH FIBROSURE FORMULA||U|U|Y|NA|||U|3||39||RUN-IN|1973-06-05|1964-11-06|||||1966-04-10||1972-03-22|N|1964-08-05
TRIAL STUDY 134XCP|LB|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|1||||PYRUVATE|PYRUVATE|||||||ML/MMHG/MIN/L|||||||INVALID||10^9/G||||NORMAL|NOT DONE||||URINE|FROZEN|NA|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||N|N|U|U|||U|4||88||CONTINUATION TREATMENT|1960-02-25|1972-03-15|||||1962-03-13||1967-12-24|U|1963-05-08
TRIAL STUDY 134XCP|LB|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|2||||IGE|IMMUNOGLOBULIN E|||||||CL|||||||NEGATIVE||UL/KG/DAY||||HIGH|NOT DONE||||URINE|SOLIDIFIED|Y|ETDRS EYE CHART|ASH FIBROSURE FORMULA||NA|N|Y|NA|||U|4||88||BLINDED TREATMENT|1961-09-01|1964-12-26|||||1969-11-17||1962-03-14|Y|1965-10-14
TRIAL STUDY 134XCP|LB|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|1||||BLASTCE|BLASTS/TOTAL CELLS|||||||DEG/MM|||||||INVALID||IU/KG/H||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|AGGLUTINATED|Y|MECHANICAL CLOT DETECTION|MDRD FORMULA||N|Y|N|N|||N|5||7||WASHOUT|1961-04-06|1968-12-01|||||1969-12-03||1962-01-18|U|1964-04-19
TRIAL STUDY 134XCP|LB|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|2||||RITALAC|RITALINIC ACID|||||||MMOL/MIN/KPA/L|||||||POSITIVE||LOG10 CFU/ML||||HIGH|NOT DONE||||KERATINOCYTE|NON-HEMOLYZED|N|ARTERIAL SPIN LABELING FUNCTIONAL MRI|CKD-EPI CYSTATIN C FORMULA||NA|NA|NA|N|||NA|5||7||OPEN LABEL TREATMENT|1960-03-06|1968-02-26|||||1961-12-20||1960-01-31|N|1960-06-17
TRIAL STUDY 134XCP|LB|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|1||||B2MICG|BETA-2 MICROGLOBULIN|||||||UG/L/H|||||||BORDERLINE||PMOL/DAY||||LOW|NOT DONE||||EPIDERMAL TISSUE|HEMOLYZED|NA|GC/MS|FIBROMETER FORMULA||Y|U|NA|U|||N|1||38||TREATMENT|1966-03-24|1968-08-01|||||1960-04-27||1964-04-16|U|1961-07-02
TRIAL STUDY 134XCP|LB|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|2||||ANISOCHR|ANISOCHROMIA|||||||MOSM/KG|||||||BORDERLINE||MG/DAY||||ABNORMAL|NOT DONE||||SEMINAL FLUID|HEMOLYZED|U|HEMAGGLUTINATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|NA|N|||Y|1||38||FOLLOW-UP|1969-01-27|1960-10-01|||||1961-02-18||1970-08-12|U|1968-08-13
TRIAL STUDY 134XCP|LB|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|1||||APPEAR|SPECIMEN APPEARANCE|||||||PACK YEAR|||||||BORDERLINE||MET*H||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|SOLIDIFIED|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|N|Y|||NA|2||58||SCREENING|1970-07-10|1962-07-05|||||1964-03-22||1968-05-23|Y|1972-06-16
TRIAL STUDY 134XCP|LB|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|2||||C165902|TIMOTHY GRASS POLLEN IGG AB RAST SCORE|||||||ML/ANIMAL|||||||INDETERMINATE||CI/MG||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|DRIED|Y|IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|U|U|||U|2||58||OBSERVATION|1966-07-11|1965-06-22|||||1960-12-10||1962-07-27|NA|1967-05-13
TRIAL STUDY 134XCP|LB|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|1||||CKBBCK|CREATINE KINASE BB/TOTAL CREATINE KINASE|||||||MM|||||||NEGATIVE||MET*MIN||||LOW|NOT DONE||||SEMINAL FLUID|CONCENTRATED|NA|PLETHYSMOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|N|NA|NA|||Y|3||39||CONTINUATION TREATMENT|1971-06-09|1966-12-26|||||1969-07-21||1972-10-10|Y|1972-07-31
TRIAL STUDY 134XCP|LB|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|2||||PAPPEN|PAPPENHEIMER BODIES|||||||MU/G|||||||NEGATIVE||LOG10 PFU/ML||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|AGGLUTINATED|U|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD FORMULA||NA|Y|N|U|||Y|3||39||WASHOUT|1969-07-13|1961-06-14|||||1972-11-06||1963-11-06|NA|1962-11-15
TRIAL STUDY 134XCP|LB|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|1||||TRH|THYROTROPIN RELEASING HORMONE|||||||MOL/MG|||||||NEGATIVE||CM/MIN||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|ROOM TEMPERATURE|U|IMMUNOFLUORESCENT STAIN|MDRD 6 VARIABLE FORMULA||N|N|Y|U|||Y|4||88||TREATMENT|1963-07-02|1960-08-05|||||1961-12-20||1972-08-24|Y|1971-07-09
TRIAL STUDY 134XCP|LB|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|2||||CORTFR|CORTISOL, FREE|||||||CCID 50/DOSE|||||||POSITIVE||U/M2/MIN||||HIGH|NOT DONE||||ERYTHROCYTES|LIPEMIC|Y|TURBIDIMETRY|MDRD 4 VARIABLE FORMULA||N|N|U|Y|||N|4||88||TREATMENT|1966-02-28|1964-09-22|||||1968-01-21||1969-04-01|NA|1971-10-22
TRIAL STUDY 134XCP|LB|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|1||||OXYCAP|OXYGEN CAPACITY|||||||MG/KG/DAY|||||||TRACE||TAMPON||||ABNORMAL|NOT DONE||||SMEGMA|DRIED|N|LEAD CITRATE STAIN|CKD-EPI CREATININE FORMULA||NA|U|NA|N|||NA|5||7||OPEN LABEL TREATMENT|1961-02-10|1963-11-29|||||1967-12-25||1968-07-07|N|1966-09-04
TRIAL STUDY 134XCP|LB|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|2||||INTLK15|INTERLEUKIN 15|||||||GBQ/MG|||||||TRACE||MEQ/G||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|GELLED|U|ELECTROCHEMILUMINESCENCE|MDRD 6 VARIABLE FORMULA||Y|NA|N|N|||U|5||7||LONG-TERM FOLLOW-UP|1965-10-14|1964-04-02|||||1961-12-14||1965-11-23|N|1970-06-12
TRIAL STUDY 134XCP|LB|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|1||||C4D|COMPLEMENT C4D|||||||PPTR|||||||INVALID||U/KG||||HIGH|NOT DONE||||GASTRIC CONTENTS|THAWED|N|GC/MS|MDRD FORMULA||N|U|NA|Y|||N|1||38||CONTINUATION TREATMENT|1971-10-28|1966-05-30|||||1968-07-17||1969-02-10|NA|1967-12-14
TRIAL STUDY 134XCP|LB|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|2||||ALBGALB|GLYCATED ALBUMIN/ALBUMIN|||||||10^6 CFU|||||||TRACE||TUBE||||HIGH|NOT DONE||||DIALYSIS FLUID, PERITONEAL|REFRIGERATED|Y|MASS SPECTROMETRY|FIBROSIS 4 FORMULA||Y|U|N|Y|||U|1||38||INDUCTION TREATMENT|1971-09-08|1961-10-14|||||1965-03-23||1968-09-16|NA|1966-10-31
TRIAL STUDY 134XCP|LB|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|1||||PROMONLE|PROMONOCYTES/LEUKOCYTES|||||||ANSON U|||||||POSITIVE||ML/ANIMAL/WK||||LOW|NOT DONE||||BONE|AUTOLYZED|U|DIGITAL PCR|MDRD ENZYMATIC FORMULA||Y|N|U|Y|||NA|2||58||SCREENING|1972-01-09|1963-09-21|||||1961-04-12||1968-10-19|NA|1965-10-27
TRIAL STUDY 134XCP|LB|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|2||||CLNZPM|CLONAZEPAM|||||||PMOL|||||||POSITIVE||LINEAR FT*LB||||HIGH|NOT DONE||||BONE|ICTERIC|Y|ACCELERATOR MASS SPECTROMETRY|FIBROSIS 4 FORMULA||Y|Y|NA|NA|||N|2||58||BLINDED TREATMENT|1962-12-02|1963-08-15|||||1962-06-11||1970-12-26|Y|1971-08-14
TRIAL STUDY 134XCP|LB|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|1||||ABOA1|ABO A1 SUBTYPE|||||||ROENTGEN|||||||NEGATIVE||UU/DL||||ABNORMAL|NOT DONE||||SALIVA|ICTERIC|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|COCKCROFT-GAULT FORMULA||U|Y|N|N|||N|3||39||LONG-TERM FOLLOW-UP|1969-02-02|1972-04-10|||||1963-12-12||1965-08-21|NA|1968-02-27
TRIAL STUDY 134XCP|LB|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|2||||C165876|BIRCH POLLEN IGE AB RAST SCORE|||||||JOULE|||||||TRACE||UKAT||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|UNEXPECTED ODOR|N|CALIPER MEASUREMENT METHOD|MDRD 4 VARIABLE FORMULA||N|N|N|U|||Y|3||39||SCREENING|1972-05-04|1968-03-23|||||1969-08-05||1960-01-26|Y|1971-03-28
TRIAL STUDY 134XCP|LB|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|1||||TOXVAC|TOXIC VACUOLATION|||||||NU/CL|||||||INDETERMINATE||MIN/DAY||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|CALCIFIED|U|CONTRAST ENHANCED PET/CT SCAN|MDRD 4 VARIABLE FORMULA||U|N|Y|U|||N|4||88||SCREENING|1966-01-10|1966-11-18|||||1966-12-10||1970-04-09|U|1961-01-02
TRIAL STUDY 134XCP|LB|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|2||||CEIMCE|IMMATURE CELLS/TOTAL CELLS|||||||ABSORBANCE U|||||||BORDERLINE||G/ANIMAL||||NORMAL|NOT DONE||||VENOUS BLOOD|THAWED|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA||N|Y|NA|N|||U|4||88||OPEN LABEL TREATMENT|1966-11-10|1971-02-22|||||1960-08-10||1972-05-12|U|1960-11-04
TRIAL STUDY 134XCP|LB|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|1||||APLIGGAB|ANTI-PHOSPHOLIPID IGG ANTIBODY|||||||CI/ML|||||||POSITIVE||BEL||||LOW|NOT DONE||||MUSCLE TISSUE|AUTOLYZED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|Y|N|||N|5||7||TREATMENT|1961-05-10|1968-10-15|||||1967-08-05||1968-12-08|NA|1962-06-12
TRIAL STUDY 134XCP|LB|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|2||||APOJ|APOLIPOPROTEIN J|||||||UMOL/MIN|||||||TRACE||UG/ML/H||||HIGH|NOT DONE||||VENOUS PLASMA|CALCIFIED|NA|MUGA|CKD-EPI CYSTATIN C FORMULA||Y|Y|U|U|||Y|5||7||OBSERVATION|1970-01-29|1967-11-21|||||1965-06-26||1966-07-29|NA|1965-10-27
TRIAL STUDY 134XCP|LB|B3987A78-0D92-419D-A289-039C87C6C202|1||||CAN|COEFFICIENT OF NITROGEN ABSORPTION|||||||10^8/L|||||||INDETERMINATE||VG/KG||||LOW|NOT DONE||||LEUKOCYTE|CONCENTRATED|N|OPTICAL MAPPING|COCKCROFT-GAULT FORMULA||U|N|N|U|||Y|1||38||FOLLOW-UP|1972-08-12|1968-01-03|||||1973-04-02||1960-02-12|U|1962-07-31
TRIAL STUDY 134XCP|LB|B3987A78-0D92-419D-A289-039C87C6C202|2||||MMYCECE|MATURING MYELOID CELLS/TOTAL CELLS|||||||MOSM/KG|||||||POSITIVE||STEPS||||NORMAL|NOT DONE||||SMEGMA|DRIED|U|ECHOCARDIOGRAPHY|MDRD FORMULA||N|NA|N|U|||NA|1||38||RUN-IN|1963-11-04|1960-04-11|||||1961-11-18||1965-03-11|U|1965-09-26
TRIAL STUDY 134XCP|LB|B3987A78-0D92-419D-A289-039C87C6C202|1||||APAPCYS|ACETAMINOPHEN-CYSTEINE ADDUCT|||||||UMOL/L/MIN|||||||BORDERLINE||BEL||||NORMAL|NOT DONE||||VITREOUS HUMOR|REFRIGERATED|N|GIEMSA STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|Y|||NA|2||58||FOLLOW-UP|1970-03-06|1961-06-12|||||1968-11-28||1972-02-07|N|1963-01-15
TRIAL STUDY 134XCP|LB|B3987A78-0D92-419D-A289-039C87C6C202|2||||NICOTINE|NICOTINE|||||||JOULE|||||||NEGATIVE||ANTI-XA IU/ML||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|ROOM TEMPERATURE|Y|IMPULSE OSCILLOMETRY|CKD-EPI CYSTATIN C FORMULA||N|N|N|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1960-12-22|1965-06-10|||||1967-09-04||1960-04-08|Y|1972-01-14
TRIAL STUDY 134XCP|LB|B3987A78-0D92-419D-A289-039C87C6C202|1||||MYELINAB|MYELIN ANTIBODIES|||||||PRESSOR UNITS|||||||BORDERLINE||UG/G/DAY||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|LIPEMIC|Y|PHOROPTER|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|U|Y|||N|3||39||RUN-IN|1962-03-26|1966-02-12|||||1964-10-13||1965-11-15|NA|1960-02-01
TRIAL STUDY 134XCP|LB|B3987A78-0D92-419D-A289-039C87C6C202|2||||ALP|ALKALINE PHOSPHATASE|||||||CI/UG|||||||NEGATIVE||MG/KG/DAY||||NORMAL|NOT DONE||||ERYTHROCYTES|LIPEMIC|NA|CONFOCAL MICROSCOPY|GMI % FORMULA||Y|Y|Y|N|||NA|3||39||BLINDED TREATMENT|1971-04-09|1964-11-10|||||1966-11-30||1964-05-29|NA|1972-07-10
TRIAL STUDY 134XCP|LB|B3987A78-0D92-419D-A289-039C87C6C202|1||||T3UP|TRIIODOTHYRONINE UPTAKE|||||||BQ/KG|||||||NEGATIVE||NG/MOL||||NORMAL|NOT DONE||||TUMOR TISSUE|CONTAMINATED|U|MULTIPLEXED BEAD BASED IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|Y|||N|4||88||OBSERVATION|1962-09-02|1970-01-16|||||1963-02-19||1969-06-09|NA|1964-04-29
TRIAL STUDY 134XCP|LB|B3987A78-0D92-419D-A289-039C87C6C202|2||||TSTFTSTT|TESTOSTERONE, FREE/TESTOSTERONE|||||||NKAT/L|||||||INVALID||IU/DAY||||NORMAL|NOT DONE||||ERYTHROCYTES|LACTESCENT|U|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|FIBROSIS 4 FORMULA||Y|Y|Y|U|||NA|4||88||CONTINUATION TREATMENT|1973-07-26|1960-04-15|||||1960-12-13||1968-04-05|U|1964-07-08
TRIAL STUDY 134XCP|LB|B3987A78-0D92-419D-A289-039C87C6C202|1||||CD3|CD3|||||||CY/CM|||||||INDETERMINATE||EID 50/DOSE||||ABNORMAL|NOT DONE||||ISOLATE|ICTERIC|U|CELLULAR PROLIFERATION ASSAY|CKD-EPI CYSTATIN C FORMULA||N|N|NA|Y|||Y|5||7||OPEN LABEL TREATMENT|1962-08-16|1968-08-24|||||1972-04-27||1972-06-26|Y|1966-12-23
TRIAL STUDY 134XCP|LB|B3987A78-0D92-419D-A289-039C87C6C202|2||||LACTULOS|LACTULOSE|||||||BAU|||||||NEGATIVE||ML/G/H||||ABNORMAL|NOT DONE||||SOFT TISSUE|SOLIDIFIED|NA|IVY INCISION METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|N|||U|5||7||FOLLOW-UP|1967-12-01|1963-10-11|||||1970-10-30||1965-10-07|NA|1967-06-21
TRIAL STUDY 134XCP|LB|2A0D27D8-EC46-4B40-B1BB-078268E03355|1||||PYOCYTES|PYOCYTES|||||||DRAM|||||||BORDERLINE||ML/DL||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|N|CLIP SEQUENCING|ASH FIBROSURE FORMULA||Y|N|Y|Y|||N|1||38||OBSERVATION|1968-04-18|1960-05-14|||||1973-07-28||1962-10-07|U|1963-07-10
TRIAL STUDY 134XCP|LB|2A0D27D8-EC46-4B40-B1BB-078268E03355|2||||APLSMA2|ALPHA-2 ANTIPLASMIN|||||||VG/DOSE|||||||INDETERMINATE||MS2||||LOW|NOT DONE||||CORD BLOOD|THAWED|U|HEMAGGLUTINATION ASSAY|ASH FIBROSURE FORMULA||NA|NA|Y|U|||U|1||38||INDUCTION TREATMENT|1963-04-15|1972-11-20|||||1971-07-09||1968-05-10|N|1962-05-14
TRIAL STUDY 134XCP|LB|2A0D27D8-EC46-4B40-B1BB-078268E03355|1||||BDNF|BRAIN-DERIVED NEUROTROPHIC FACTOR|||||||KG/MOL|||||||POSITIVE||PPM||||ABNORMAL|NOT DONE||||CORD SERUM|LACTESCENT|Y|SIZE EXCLUSION CHROMATOGRAPHY|NASH FIBROSURE FORMULA||U|Y|U|Y|||U|2||58||CONTINUATION TREATMENT|1970-12-02|1971-03-03|||||1960-08-06||1973-07-18|NA|1961-02-11
TRIAL STUDY 134XCP|LB|2A0D27D8-EC46-4B40-B1BB-078268E03355|2||||FIBRINO|FIBRINOGEN|||||||AGU/ML|||||||BORDERLINE||/WK||||HIGH|NOT DONE||||EMESIS|FROZEN|U|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC FORMULA||N|NA|U|U|||Y|2||58||LONG-TERM FOLLOW-UP|1970-10-30|1960-03-08|||||1971-02-26||1965-06-08|N|1963-12-21
TRIAL STUDY 134XCP|LB|2A0D27D8-EC46-4B40-B1BB-078268E03355|1||||LTD4|LEUKOTRIENE D4|||||||MN|||||||INVALID||10^7 CFU/ML||||NORMAL|NOT DONE||||BASAL TEAR|LIPEMIC|Y|HPLC/MS|ASH FIBROSURE FORMULA||NA|N|Y|Y|||U|3||39||LONG-TERM FOLLOW-UP|1962-12-31|1962-11-29|||||1964-05-08||1968-01-03|Y|1972-09-24
TRIAL STUDY 134XCP|LB|2A0D27D8-EC46-4B40-B1BB-078268E03355|2||||HYALUAC|HYALURONIC ACID|||||||BLOCKS|||||||INDETERMINATE||KG/MOL||||LOW|NOT DONE||||SWABBED MATERIAL|CLOTTED|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|U|Y|||U|3||39||OBSERVATION|1971-04-05|1961-08-09|||||1963-07-13||1961-01-06|U|1971-03-13
TRIAL STUDY 134XCP|LB|2A0D27D8-EC46-4B40-B1BB-078268E03355|1||||CO2|CARBON DIOXIDE|||||||MEQ/UG|||||||BORDERLINE||UG/H||||ABNORMAL|NOT DONE||||SOFT TISSUE|LIPEMIC|U|TARGETED GENOME SEQUENCING|NASH FIBROSURE FORMULA||Y|NA|U|N|||U|4||88||OPEN LABEL TREATMENT|1968-09-28|1966-10-24|||||1968-03-07||1960-03-03|NA|1969-11-01
TRIAL STUDY 134XCP|LB|2A0D27D8-EC46-4B40-B1BB-078268E03355|2||||GRANIMLE|IMMATURE GRANULOCYTES/LEUKOCYTES|||||||MBQ|||||||BORDERLINE||/100 HPFS||||NORMAL|NOT DONE||||EXUDATE|FRESH|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||N|U|U|NA|||Y|4||88||FOLLOW-UP|1964-06-07|1972-05-10|||||1968-07-04||1970-02-22|U|1970-04-06
TRIAL STUDY 134XCP|LB|2A0D27D8-EC46-4B40-B1BB-078268E03355|1||||ABO|ABO BLOOD GROUP|||||||DIP|||||||INVALID||CIGARETTE||||LOW|NOT DONE||||ADIPOSE TISSUE|CLOTTED|U|PLAQUE REDUCTION NEUTRALIZATION ASSAY|GMI % FORMULA||N|N|Y|N|||N|5||7||CONTINUATION TREATMENT|1964-09-17|1964-05-02|||||1962-01-27||1968-03-21|Y|1961-08-17
TRIAL STUDY 134XCP|LB|2A0D27D8-EC46-4B40-B1BB-078268E03355|2||||NEUTSGNE|NEUTROPHILS, SEGMENTED/NEUTROPHILS|||||||NEWTON|||||||POSITIVE||CUP EQ||||NORMAL|NOT DONE||||BONE|ROOM TEMPERATURE|NA|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|FIBROSIS 4 FORMULA||N|N|U|NA|||Y|5||7||INDUCTION TREATMENT|1967-08-08|1972-09-28|||||1964-08-27||1961-11-20|NA|1969-09-08
TRIAL STUDY 134XCP|LB|65EBB2AF-B97A-403A-9FB5-31C1559074C4|1||||GMCSF|GRANULOCYTE MACROPHAGE COLONY STM FACTOR|||||||OHM|||||||INVALID||L/H||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|NON-HEMOLYZED|N|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD FORMULA||Y|Y|Y|N|||N|1||38||WASHOUT|1962-06-28|1971-01-26|||||1962-09-17||1967-01-27|NA|1964-08-19
TRIAL STUDY 134XCP|LB|65EBB2AF-B97A-403A-9FB5-31C1559074C4|2||||CRYSTALS|CRYSTALS|||||||10^9 ORGANISMS/ML|||||||BORDERLINE||BAU/ML||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|DRIED|NA|PELLI-ROBSON EYE CHART|GMI MMOL/MOL FORMULA||Y|Y|U|N|||U|1||38||CONTINUATION TREATMENT|1964-03-26|1972-07-18|||||1966-08-04||1964-01-16|U|1961-11-05
TRIAL STUDY 134XCP|LB|65EBB2AF-B97A-403A-9FB5-31C1559074C4|1||||FATBODOV|FAT BODIES, OVAL|||||||/MBP|||||||TRACE||10^12/L||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|ICTERIC|N|MAMMOGRAPHY|GMI % FORMULA||Y|NA|NA|NA|||U|2||58||BASELINE|1973-06-25|1966-03-21|||||1962-12-09||1965-11-15|Y|1965-11-23
TRIAL STUDY 134XCP|LB|65EBB2AF-B97A-403A-9FB5-31C1559074C4|2||||APPEAR|SPECIMEN APPEARANCE|||||||IN2|||||||POSITIVE||U/ML||||HIGH|NOT DONE||||MECONIUM|CALCIFIED|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD 6 VARIABLE FORMULA||Y|NA|NA|NA|||Y|2||58||OBSERVATION|1967-07-24|1964-09-27|||||1970-11-11||1968-03-30|NA|1963-05-17
TRIAL STUDY 134XCP|LB|65EBB2AF-B97A-403A-9FB5-31C1559074C4|1||||FATACFRS|FREE FATTY ACID, SATURATED|||||||UG/M2/MIN|||||||INDETERMINATE||DAYS||||LOW|NOT DONE||||SEBUM|AGGLUTINATED|NA|CT SCAN|FIBROMETER FORMULA||N|NA|NA|N|||Y|3||39||CONTINUATION TREATMENT|1966-03-10|1968-01-27|||||1965-05-06||1970-05-25|N|1962-02-28
TRIAL STUDY 134XCP|LB|65EBB2AF-B97A-403A-9FB5-31C1559074C4|2||||SCL70AB|SCL-70 ANTIBODY|||||||L/MIN|||||||TRACE||NSEC||||HIGH|NOT DONE||||LUNG SURFACTANT|FRESH|Y|SLIT LAMP|FIBROSIS 4 FORMULA||NA|N|Y|NA|||Y|3||39||INDUCTION TREATMENT|1960-05-15|1971-12-24|||||1965-05-16||1966-09-13|NA|1963-04-05
TRIAL STUDY 134XCP|LB|65EBB2AF-B97A-403A-9FB5-31C1559074C4|1||||C130079|SILVER BIRCH POLLEN IGG4|||||||LINEAR FT*LB|||||||BORDERLINE||IU/DAY||||LOW|NOT DONE||||CAPILLARY PLASMA|AGGLUTINATED|U|ICC|NASH FIBROSURE FORMULA||NA|Y|U|Y|||NA|4||88||WASHOUT|1965-03-04|1961-07-24|||||1967-11-17||1967-11-16|NA|1963-03-05
TRIAL STUDY 134XCP|LB|65EBB2AF-B97A-403A-9FB5-31C1559074C4|2||||C165927|ANIMAL MIX IGE AB RAST SCORE|||||||DL|||||||INVALID||CMHG||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|REFRIGERATED|NA|INFRARED SPECTROMETRY|ASH FIBROSURE FORMULA||Y|Y|N|U|||Y|4||88||WASHOUT|1968-02-10|1968-01-13|||||1971-10-20||1964-04-17|Y|1968-04-20
TRIAL STUDY 134XCP|LB|65EBB2AF-B97A-403A-9FB5-31C1559074C4|1||||CHDW|CORPUSCULAR HGB CONC DISTRIBUTION WIDTH|||||||AFU|||||||TRACE||TUBERCULIN UNIT||||HIGH|NOT DONE||||CAPILLARY PLASMA|HEMOLYZED|Y|ROMANOWSKY STAIN|GMI MMOL/MOL FORMULA||U|NA|N|N|||N|5||7||FOLLOW-UP|1966-10-20|1967-12-15|||||1960-03-21||1967-01-23|Y|1972-06-03
TRIAL STUDY 134XCP|LB|65EBB2AF-B97A-403A-9FB5-31C1559074C4|2||||PLATIM|IMMATURE PLATELETS|||||||PACK YEAR|||||||TRACE||MPA||||HIGH|NOT DONE||||BUFFY COAT|LACTESCENT|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|MDRD 4 VARIABLE FORMULA||Y|NA|Y|U|||U|5||7||SCREENING|1962-05-21|1962-06-16|||||1966-12-19||1971-07-08|N|1970-09-02
TRIAL STUDY 134XCP|LB|90892428-99C3-4E7D-B3A8-3C526812EDD2|1||||BLYMXM|B-LYMPHOCYTE CROSSMATCH|||||||PMOL/10^9 CELLS|||||||TRACE||10^9 CFU||||ABNORMAL|NOT DONE||||BONE|SOLIDIFIED|Y|EIA|NASH FIBROSURE FORMULA||NA|N|NA|NA|||NA|1||38||TREATMENT|1972-02-27|1962-04-18|||||1968-06-27||1964-06-17|N|1973-02-06
TRIAL STUDY 134XCP|LB|90892428-99C3-4E7D-B3A8-3C526812EDD2|2||||CALB|CALBINDIN|||||||DAYS|||||||INDETERMINATE||APL U/ML||||ABNORMAL|NOT DONE||||URINE SEDIMENT|LIPEMIC|N|ICC|MDRD FORMULA||U|Y|N|U|||N|1||38||RUN-IN|1970-05-24|1960-04-18|||||1961-02-12||1968-04-11|U|1965-08-25
TRIAL STUDY 134XCP|LB|90892428-99C3-4E7D-B3A8-3C526812EDD2|1||||IRF|IMMATURE RETICULOCYTE FRACTION|||||||TAMPON|||||||INVALID||KBQ||||LOW|NOT DONE||||SWABBED MATERIAL|UNEXPECTED ODOR|U|ELECTROCHEMILUMINESCENCE|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|N|N|||N|2||58||OBSERVATION|1965-02-18|1972-10-11|||||1967-02-03||1961-12-17|NA|1961-08-10
TRIAL STUDY 134XCP|LB|90892428-99C3-4E7D-B3A8-3C526812EDD2|2||||PPI|INORGANIC PYROPHOSPHATE|||||||CAPSULE|||||||POSITIVE||ENZYME U||||HIGH|NOT DONE||||AMNIOTIC FLUID|AGGLUTINATED|NA|SPIRAL CT SCAN WITHOUT CONTRAST|GMI % FORMULA||N|U|N|U|||N|2||58||OBSERVATION|1965-04-11|1964-01-24|||||1963-10-30||1967-04-13|U|1964-11-18
TRIAL STUDY 134XCP|LB|90892428-99C3-4E7D-B3A8-3C526812EDD2|1||||FUNGIFIL|FUNGI, FILAMENTOUS|||||||UG/L|||||||TRACE||DEG||||NORMAL|NOT DONE||||PERITONEAL FLUID|SOLIDIFIED|U|MULTI-SLICE SPIRAL CT|FIBROSIS 4 FORMULA||NA|Y|U|Y|||U|3||39||OBSERVATION|1962-04-29|1971-12-06|||||1963-01-30||1968-07-17|NA|1963-06-08
TRIAL STUDY 134XCP|LB|90892428-99C3-4E7D-B3A8-3C526812EDD2|2||||C165882|WHITE ELM POLLEN IGE AB RAST SCORE|||||||TESLA|||||||INDETERMINATE||SQU/ML||||HIGH|NOT DONE||||LAVAGE FLUID|CONCENTRATED|U|DIFFUSION WEIGHTED MRI|ASH FIBROSURE FORMULA||N|Y|Y|U|||NA|3||39||OPEN LABEL TREATMENT|1969-04-03|1967-09-11|||||1961-10-19||1962-06-06|N|1961-03-29
TRIAL STUDY 134XCP|LB|90892428-99C3-4E7D-B3A8-3C526812EDD2|1||||IGFBP3|INSULIN-LIKE GROWTH FACTOR BINDING PROT3|||||||ML/100G/MIN|||||||NEGATIVE||BEATS/MIN||||LOW|NOT DONE||||GASTRIC FLUID|CALCIFIED|NA|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|NASH FIBROSURE FORMULA||N|U|Y|NA|||Y|4||88||SCREENING|1970-10-22|1972-09-26|||||1964-06-03||1972-12-24|Y|1962-06-27
TRIAL STUDY 134XCP|LB|90892428-99C3-4E7D-B3A8-3C526812EDD2|2||||BLSTLMLY|LEUKEMIC BLASTS/LYMPHOCYTES|||||||COPIES/UL|||||||INVALID||/CMH2O||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CLOTTED|N|DIPSTICK|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|U|U|||Y|4||88||SCREENING|1968-07-15|1970-10-26|||||1972-11-04||1973-04-18|U|1960-09-03
TRIAL STUDY 134XCP|LB|90892428-99C3-4E7D-B3A8-3C526812EDD2|1||||NDMTASE|N-DEMETHYLASE|||||||MG/KG/MIN|||||||TRACE||10^3 ORGANISMS||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|AGGLUTINATED|NA|LANDOLT RING|NASH FIBROSURE FORMULA||Y|NA|U|N|||Y|5||7||BASELINE|1968-07-20|1964-05-29|||||1967-06-14||1960-03-13|U|1964-01-09
TRIAL STUDY 134XCP|LB|90892428-99C3-4E7D-B3A8-3C526812EDD2|2||||V25HD2|25-HYDROXYVITAMIN D2|||||||MG/DOSE|||||||POSITIVE||TCID 50/DOSE||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FRESH|N|MICROBIAL CULTURE, LIQUID|CKD-EPI FORMULA||N|U|Y|NA|||N|5||7||TREATMENT|1963-12-05|1973-04-12|||||1962-04-29||1969-07-07|Y|1963-06-10
TRIAL STUDY 134XCP|LB|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|1||||C165916|D. FARINAE IGG AB RAST SCORE|||||||MESF|||||||INDETERMINATE||MEQ/ML||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|LACTESCENT|U|TRYPAN BLUE STAIN|MDRD 4 VARIABLE FORMULA||N|Y|Y|U|||U|1||38||OPEN LABEL TREATMENT|1968-03-15|1963-12-29|||||1965-11-05||1973-07-12|Y|1969-04-09
TRIAL STUDY 134XCP|LB|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|2||||PLSIMCLY|IMMATURE PLASMA CELLS/LYMPHOCYTES|||||||U/KG|||||||POSITIVE||M2||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|CONTAMINATED|Y|LISSAMINE GREEN STAIN|NASH FIBROSURE FORMULA||Y|U|NA|U|||U|1||38||LONG-TERM FOLLOW-UP|1971-01-21|1965-11-14|||||1973-02-22||1964-08-07|NA|1964-11-11
TRIAL STUDY 134XCP|LB|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|1||||KIM1S|SOLUBLE KIDNEY INJURY MOLECULE-1|||||||DPM|||||||TRACE||PKAT/L||||NORMAL|NOT DONE||||URINE|LACTESCENT|U|LIGHT SCATTERING SPECTROSCOPY|MDRD ENZYMATIC FORMULA||NA|U|NA|NA|||N|2||58||OPEN LABEL TREATMENT|1960-09-20|1965-05-26|||||1967-01-14||1967-10-23|N|1969-09-11
TRIAL STUDY 134XCP|LB|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|2||||LIPASEG|LIPASE, GASTRIC|||||||MCI/L|||||||NEGATIVE||HENRY||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CONCENTRATED|U|OPTICAL MAPPING|ASH FIBROSURE FORMULA||N|U|NA|Y|||N|2||58||BASELINE|1962-04-02|1967-11-05|||||1962-06-25||1964-01-27|Y|1966-05-31
TRIAL STUDY 134XCP|LB|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|1||||VEGFC|VASCULAR ENDOTHELIAL GROWTH FACTOR C|||||||MCI/L|||||||BORDERLINE||ELISA UNIT/DOSE||||HIGH|NOT DONE||||BLOOD|REFRIGERATED|NA|CONTRAST ENHANCED PET/CT SCAN|COCKCROFT-GAULT FORMULA||Y|U|Y|U|||N|3||39||INDUCTION TREATMENT|1967-12-13|1971-05-17|||||1969-08-03||1971-08-08|N|1972-06-25
TRIAL STUDY 134XCP|LB|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|2||||SIXMAM|6-MONOACETYLMORPHINE|||||||NG|||||||BORDERLINE||DEG/MM||||NORMAL|NOT DONE||||HAIR|CLOTTED|U|PULMONARY ANGIOGRAPHY|FIBROMETER FORMULA||N|NA|U|Y|||U|3||39||OPEN LABEL TREATMENT|1961-07-20|1969-08-17|||||1971-02-27||1972-09-29|Y|1969-08-12
TRIAL STUDY 134XCP|LB|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|1||||ATHMBAC|ANTITHROMBIN ACTUAL/CONTROL|||||||IU/KG|||||||INDETERMINATE||CAL||||NORMAL|NOT DONE||||BONE|CONCENTRATED|N|SPECT SCAN|HEPASCORE FORMULA||N|N|U|N|||U|4||88||INDUCTION TREATMENT|1964-01-16|1961-02-03|||||1970-02-13||1963-09-20|U|1970-02-06
TRIAL STUDY 134XCP|LB|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|2||||CYAMPURT|AMORPHOUS URATE CRYSTALS|||||||UG/L/H|||||||INDETERMINATE||MM||||LOW|NOT DONE||||CERUMEN|SOLIDIFIED|U|LYMPHANGIOGRAPHY|NASH FIBROSURE FORMULA||Y|N|N|NA|||N|4||88||RUN-IN|1960-05-07|1970-12-28|||||1962-06-28||1971-03-08|Y|1962-04-15
TRIAL STUDY 134XCP|LB|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|1||||ALPLALP|ALK PHOS, LIVER/TOTAL ALK PHOS|||||||UG/DOSE|||||||BORDERLINE||KM/H||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|LACTESCENT|NA|INDIRECT IMMUNOFLUORESCENCE|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|Y|N|||U|5||7||CONTINUATION TREATMENT|1971-05-06|1964-04-24|||||1962-05-30||1960-07-12|NA|1973-02-03
TRIAL STUDY 134XCP|LB|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|2||||COLOR|COLOR|||||||IU/MG|||||||POSITIVE||MOL/ML||||HIGH|NOT DONE||||SPERMATOZOON|CONTAMINATED|U|ENDOSCOPY|CKD-EPI CREATININE FORMULA||N|NA|NA|Y|||N|5||7||BASELINE|1967-08-11|1969-04-23|||||1961-04-18||1972-09-16|NA|1970-03-31
TRIAL STUDY 134XCP|LB|2B443EEA-B98B-47D9-8D27-801582804AB5|1||||HALPRZLM|HYDROXYALPRAZOLAM|||||||10^3 ORGANISMS/ML|||||||INVALID||MOL||||HIGH|NOT DONE||||VENOUS PLASMA|ICTERIC|U|WHOLE GENOME SEQUENCING|MDRD ENZYMATIC FORMULA||U|NA|U|Y|||Y|1||38||BLINDED TREATMENT|1960-05-22|1965-05-01|||||1968-08-12||1969-10-23|NA|1971-05-11
TRIAL STUDY 134XCP|LB|2B443EEA-B98B-47D9-8D27-801582804AB5|2||||MBP|MYELIN BASIC PROTEIN|||||||LX|||||||BORDERLINE||MG/L||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|SOLIDIFIED|Y|ACCELERATOR MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA||N|U|Y|U|||Y|1||38||TREATMENT|1967-07-06|1970-04-08|||||1963-07-04||1967-08-14|N|1969-01-26
TRIAL STUDY 134XCP|LB|2B443EEA-B98B-47D9-8D27-801582804AB5|1||||ICAIGGAB|ISLET CELL CYTOPLASMIC IGG ANTIBODY|||||||NMOL/KG/DAY|||||||INDETERMINATE||10^3 CFU||||LOW|NOT DONE||||EXPIRED AIR|FRESH|N|SLIT LAMP|FIBROSIS 4 FORMULA||Y|U|U|U|||U|2||58||OPEN LABEL TREATMENT|1968-02-24|1965-05-06|||||1964-05-06||1969-04-09|NA|1962-05-23
TRIAL STUDY 134XCP|LB|2B443EEA-B98B-47D9-8D27-801582804AB5|2||||C165925|WEED MIX POLLEN IGE AB RAST SCORE|||||||PHERESIS UNIT|||||||NEGATIVE||U/ANIMAL||||LOW|NOT DONE||||CEREBROSPINAL FLUID|UNEXPECTED ODOR|NA|SEQUENCING|MDRD FORMULA||Y|U|U|N|||U|2||58||TREATMENT|1966-09-21|1965-11-16|||||1967-10-18||1971-06-17|Y|1973-07-10
TRIAL STUDY 134XCP|LB|2B443EEA-B98B-47D9-8D27-801582804AB5|1||||GFRBSA|GLOMERULAR FILTRATION RATE ADJ FOR BSA|||||||/5X10^4 WBC|||||||INDETERMINATE||GPELISA UNIT/ML||||LOW|NOT DONE||||SPERMATOZOON|CONCENTRATED|NA|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|GMI % FORMULA||NA|N|U|U|||NA|3||39||CONTINUATION TREATMENT|1964-06-19|1969-07-30|||||1965-03-11||1973-02-02|U|1961-12-25
TRIAL STUDY 134XCP|LB|2B443EEA-B98B-47D9-8D27-801582804AB5|2||||CLNZPM|CLONAZEPAM|||||||UMOL|||||||INVALID||L/S/KPA||||LOW|NOT DONE||||STOOL|CLOTTED|U|IVY INCISION METHOD|MDRD ENZYMATIC FORMULA||N|NA|NA|N|||U|3||39||SCREENING|1960-05-07|1967-02-06|||||1973-08-03||1968-10-11|Y|1972-09-23
TRIAL STUDY 134XCP|LB|2B443EEA-B98B-47D9-8D27-801582804AB5|1||||HGBF|HEMOGLOBIN F|||||||UMOL/L|||||||TRACE||RATIO||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|AUTOLYZED|N|PET SCAN|ASH FIBROSURE FORMULA||NA|U|U|Y|||NA|4||88||RUN-IN|1972-12-09|1966-10-11|||||1968-06-02||1970-07-12|Y|1962-06-04
TRIAL STUDY 134XCP|LB|2B443EEA-B98B-47D9-8D27-801582804AB5|2||||GMI|GLUCOSE MANAGEMENT INDICATOR|||||||CI/L|||||||INDETERMINATE||IN||||ABNORMAL|NOT DONE||||PLATELET|LACTESCENT|U|IN SITU HYBRIDIZATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|U|U|||NA|4||88||BASELINE|1969-07-31|1970-08-06|||||1967-06-02||1972-08-07|U|1972-10-12
TRIAL STUDY 134XCP|LB|2B443EEA-B98B-47D9-8D27-801582804AB5|1||||FACTVWA|VON WILLEBRAND FACTOR ACTIVITY|||||||KAT|||||||BORDERLINE||TBSP||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|HEMOLYZED|U|ULTRASOUND|MDRD ENZYMATIC FORMULA||U|N|NA|N|||U|5||7||FOLLOW-UP|1969-05-17|1961-05-06|||||1971-02-09||1970-04-27|N|1969-04-17
TRIAL STUDY 134XCP|LB|2B443EEA-B98B-47D9-8D27-801582804AB5|2||||LYMMCE|LYMPHOMA CELLS|||||||HZ|||||||INVALID||MM/SEC||||LOW|NOT DONE||||TRANSUDATE|UNEXPECTED ODOR|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|FIBROMETER FORMULA||N|Y|U|N|||NA|5||7||LONG-TERM FOLLOW-UP|1968-04-04|1970-02-04|||||1966-08-29||1968-01-21|NA|1966-05-01
TRIAL STUDY 134XCP|LB|0278D57A-30D6-4B7A-A45C-EB973F6686C6|1||||CKMM|CREATINE KINASE MM|||||||MEQ/DL|||||||POSITIVE||CM2||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|CONTAMINATED|Y|DUCTOGRAPHY|MDRD 4 VARIABLE FORMULA||N|N|NA|Y|||Y|1||38||OBSERVATION|1968-10-16|1968-01-01|||||1966-04-27||1963-01-28|Y|1962-04-29
TRIAL STUDY 134XCP|LB|0278D57A-30D6-4B7A-A45C-EB973F6686C6|2||||SFTPD|SURFACTANT PROTEIN D|||||||UOSM|||||||BORDERLINE||MG/L||||LOW|NOT DONE||||LYSATE|CALCIFIED|Y|MANUAL CLOT DETECTION|GMI % FORMULA||Y|U|NA|NA|||Y|1||38||OPEN LABEL TREATMENT|1960-10-30|1971-04-08|||||1972-03-02||1973-07-10|U|1961-08-04
TRIAL STUDY 134XCP|LB|0278D57A-30D6-4B7A-A45C-EB973F6686C6|1||||MPO|MYELOPEROXIDASE|||||||LOG10 COPIES/ML|||||||BORDERLINE||AFU||||LOW|NOT DONE||||INFRANATANT, PLASMA|REFRIGERATED|U|SMEAR|NASH FIBROSURE FORMULA||NA|U|U|N|||Y|2||58||INDUCTION TREATMENT|1972-11-01|1966-11-12|||||1967-01-28||1963-01-22|N|1970-11-24
TRIAL STUDY 134XCP|LB|0278D57A-30D6-4B7A-A45C-EB973F6686C6|2||||HEMOLYSI|HEMOLYTIC INDEX|||||||MIN*MG/ML|||||||POSITIVE||MEQ/G||||HIGH|NOT DONE||||SUPERNATANT, SERUM|UNEXPECTED ODOR|U|AUTOMATED COUNT|NASH FIBROSURE FORMULA||NA|N|U|N|||N|2||58||WASHOUT|1962-05-24|1960-01-04|||||1968-08-24||1970-03-08|Y|1964-09-11
TRIAL STUDY 134XCP|LB|0278D57A-30D6-4B7A-A45C-EB973F6686C6|1||||GLOBA2PT|ALPHA-2 GLOBULIN/TOTAL PROTEIN|||||||ELISA UNIT/DOSE|||||||INDETERMINATE||MSEC||||LOW|NOT DONE||||SPERMATOZOON|LACTESCENT|N|THICK SMEAR|MDRD FORMULA||Y|NA|U|N|||N|3||39||RUN-IN|1960-12-21|1972-05-14|||||1973-01-27||1968-10-04|NA|1967-11-11
TRIAL STUDY 134XCP|LB|0278D57A-30D6-4B7A-A45C-EB973F6686C6|2||||INTLK33|INTERLEUKIN 33|||||||M/SEC|||||||POSITIVE||LOG EID 50/DOSE||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|FIBROMETER FORMULA||U|Y|N|NA|||N|3||39||FOLLOW-UP|1971-02-17|1973-04-16|||||1962-03-24||1973-05-12|N|1963-10-11
TRIAL STUDY 134XCP|LB|0278D57A-30D6-4B7A-A45C-EB973F6686C6|1||||CYSTINE|CYSTINE|||||||MMHG/SEC|||||||NEGATIVE||OHM||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|SOLIDIFIED|Y|SIZE EXCLUSION CHROMATOGRAPHY|MDRD ENZYMATIC FORMULA||N|NA|U|U|||U|4||88||OPEN LABEL TREATMENT|1967-02-02|1967-07-25|||||1973-01-23||1961-03-20|NA|1971-08-30
TRIAL STUDY 134XCP|LB|0278D57A-30D6-4B7A-A45C-EB973F6686C6|2||||PROMYB|PROMYELOBLASTS|||||||ML/(MIN*100ML)|||||||INVALID||/5X10^4 WBC||||HIGH|NOT DONE||||BUFFY COAT|CONCENTRATED|N|AUDIOMETRY|CKD-EPI CREATININE FORMULA||NA|Y|Y|NA|||NA|4||88||OBSERVATION|1970-09-22|1968-09-27|||||1967-07-18||1970-01-17|U|1963-01-07
TRIAL STUDY 134XCP|LB|0278D57A-30D6-4B7A-A45C-EB973F6686C6|1||||MLR|MIXED LYMPHOCYTE REACTION|||||||MKAT|||||||INVALID||PKAT||||LOW|NOT DONE||||BONE|CONTAMINATED|N|WHOLE TRANSCRIPTOME SEQUENCING|NASH FIBROSURE FORMULA||U|Y|N|NA|||NA|5||7||BLINDED TREATMENT|1965-06-01|1972-09-04|||||1965-04-09||1961-10-26|U|1972-02-06
TRIAL STUDY 134XCP|LB|0278D57A-30D6-4B7A-A45C-EB973F6686C6|2||||THCCOOH|11-NOR-DELTA9-THC-9-CARBOXYLIC ACID|||||||MG/DAY|||||||INVALID||PPTR||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|FRESH|NA|PLAQUE REDUCTION NEUTRALIZATION ASSAY|GMI % FORMULA||Y|NA|U|Y|||NA|5||7||BLINDED TREATMENT|1965-07-27|1963-05-24|||||1962-02-02||1972-03-10|NA|1968-08-27
TRIAL STUDY 134XCP|LB|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|1||||LTB4|LEUKOTRIENE B4|||||||M2|||||||BORDERLINE||/200 HPFS||||HIGH|NOT DONE||||BONE MARROW|FROZEN|Y|JAFFE REACTION|FIBROSIS 4 FORMULA||Y|N|N|N|||NA|1||38||TREATMENT|1971-01-06|1969-01-19|||||1969-07-10||1969-02-19|Y|1960-09-11
TRIAL STUDY 134XCP|LB|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|2||||PTSFAC|PROTEIN S, FREE ACTUAL/CONTROL|||||||STEPS|||||||INDETERMINATE||MN||||ABNORMAL|NOT DONE||||FLUID|REFRIGERATED|N|PALPATION|MDRD ENZYMATIC FORMULA||NA|Y|NA|N|||Y|1||38||CONTINUATION TREATMENT|1971-01-24|1972-06-30|||||1972-03-11||1960-06-17|NA|1972-12-12
TRIAL STUDY 134XCP|LB|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|1||||ATHMBAAC|ANTITHROMBIN ACTIVITY ACTUAL/CONTROL|||||||UG/L FEU|||||||INDETERMINATE||UMOL/DAY||||NORMAL|NOT DONE||||ADIPOSE TISSUE|CONTAMINATED|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|NASH FIBROSURE FORMULA||NA|U|NA|U|||N|2||58||BLINDED TREATMENT|1972-04-08|1962-10-14|||||1973-01-01||1973-02-19|U|1960-09-19
TRIAL STUDY 134XCP|LB|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|2||||A1MCREAT|ALPHA-1 MICROGLOBULIN/CREATININE|||||||/VF|||||||INDETERMINATE||10^9 CFU||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|AUTOLYZED|NA|FLUORESCENT IMMUNOASSAY|FIBROTEST FORMULA||Y|U|NA|NA|||U|2||58||RUN-IN|1960-11-09|1964-05-12|||||1965-11-05||1971-12-23|Y|1962-09-11
TRIAL STUDY 134XCP|LB|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|1||||VITD3|VITAMIN D3|||||||UIU/DL|||||||TRACE||CI||||HIGH|NOT DONE||||CELL PELLET|CLOTTED|NA|CHROMATOGRAPHY|ASH FIBROSURE FORMULA||Y|NA|NA|NA|||N|3||39||SCREENING|1966-11-05|1973-07-10|||||1966-06-17||1967-07-30|Y|1967-05-27
TRIAL STUDY 134XCP|LB|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|2||||APOB|APOLIPOPROTEIN B|||||||V/SEC|||||||INDETERMINATE||WATT||||ABNORMAL|NOT DONE||||BUFFY COAT|THAWED|N|LISSAMINE GREEN STAIN|MDRD ENZYMATIC FORMULA||U|U|N|NA|||Y|3||39||WASHOUT|1969-03-10|1972-11-18|||||1968-11-28||1970-05-20|U|1964-07-06
TRIAL STUDY 134XCP|LB|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|1||||PT|PROTHROMBIN TIME|||||||UU/L|||||||INDETERMINATE||MM3/MM2/YEAR||||ABNORMAL|NOT DONE||||ABSCESS FLUID|CALCIFIED|Y|FLUORESCENT IMMUNOASSAY|GMI MMOL/MOL FORMULA||Y|NA|Y|NA|||U|4||88||WASHOUT|1966-09-27|1972-06-30|||||1969-06-26||1969-05-03|U|1970-03-20
TRIAL STUDY 134XCP|LB|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|2||||MCPHGLE|MACROPHAGES/LEUKOCYTES|||||||ANTIBODY UNIT|||||||POSITIVE||VIAL||||NORMAL|NOT DONE||||LUNG SURFACTANT|CONCENTRATED|NA|IODINE STAIN|CKD-EPI FORMULA||Y|NA|NA|U|||N|4||88||BLINDED TREATMENT|1970-10-10|1962-01-10|||||1966-09-17||1968-01-20|Y|1963-08-01
TRIAL STUDY 134XCP|LB|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|1||||WBCCLMP|LEUKOCYTE CELL CLUMPS|||||||MM2|||||||BORDERLINE||MPA||||LOW|NOT DONE||||STOOL|HEMOLYZED|NA|NEPHELOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|NA|Y|||Y|5||7||INDUCTION TREATMENT|1966-08-24|1966-05-14|||||1961-03-12||1968-01-29|N|1960-12-24
TRIAL STUDY 134XCP|LB|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|2||||WBC|LEUKOCYTES|||||||INHALATION|||||||NEGATIVE||CAPFUL||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|AGGLUTINATED|NA|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||N|N|U|Y|||NA|5||7||OBSERVATION|1965-01-12|1973-01-07|||||1961-02-14||1971-08-05|Y|1963-12-08
TRIAL STUDY 134XCP|LB|67D6A191-10C7-4414-BA63-DB7701998DF0|1||||C130137|AMERICAN COCKROACH ANTIGEN IGA ANTIBODY|||||||MG|||||||INVALID||TABLET||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|ICTERIC|N|BALLPOINT PEN TECHNIQUE|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|N|NA|||U|1||38||CONTINUATION TREATMENT|1969-07-12|1964-08-21|||||1961-10-05||1970-07-24|Y|1966-04-01
TRIAL STUDY 134XCP|LB|67D6A191-10C7-4414-BA63-DB7701998DF0|2||||LKM1IMAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGM AB|||||||MAC50|||||||INDETERMINATE||BISCUIT||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|NON-HEMOLYZED|N|POLYGRAPHY|FIBROMETER FORMULA||U|N|U|Y|||Y|1||38||INDUCTION TREATMENT|1963-12-27|1971-02-04|||||1964-02-14||1972-08-13|NA|1969-08-28
TRIAL STUDY 134XCP|LB|67D6A191-10C7-4414-BA63-DB7701998DF0|1||||INTLK33|INTERLEUKIN 33|||||||10^3 CFU/G|||||||BORDERLINE||PSI||||NORMAL|NOT DONE||||EPITHELIAL CELL|ROOM TEMPERATURE|N|PET SCAN|COCKCROFT-GAULT FORMULA||U|NA|Y|NA|||N|2||58||TREATMENT|1969-04-30|1962-05-11|||||1970-10-18||1968-10-26|N|1973-03-26
TRIAL STUDY 134XCP|LB|67D6A191-10C7-4414-BA63-DB7701998DF0|2||||KLK2|KALLIKREIN-2|||||||HOUNSFIELD UNIT|||||||INVALID||TUBE||||HIGH|NOT DONE||||GASTRIC FLUID|ROOM TEMPERATURE|N|DUCTOGRAPHY|GMI MMOL/MOL FORMULA||Y|N|U|U|||U|2||58||BASELINE|1962-09-27|1971-04-06|||||1962-04-08||1967-05-28|U|1962-10-05
TRIAL STUDY 134XCP|LB|67D6A191-10C7-4414-BA63-DB7701998DF0|1||||ANGLOBDR|ANTIGLOBULIN TEST, DIRECT|||||||CAPLET|||||||TRACE||MOL||||LOW|NOT DONE||||SMEGMA|GELLED|NA|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||U|NA|N|N|||NA|3||39||FOLLOW-UP|1973-02-15|1973-04-27|||||1960-10-05||1966-10-03|NA|1964-04-10
TRIAL STUDY 134XCP|LB|67D6A191-10C7-4414-BA63-DB7701998DF0|2||||NTXII|TYPE II COLLAGEN N-TELOPEPTIDES|||||||ML/ANIMAL|||||||NEGATIVE||KV||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|NON-HEMOLYZED|NA|AMSLER GRID|COCKCROFT-GAULT FORMULA||N|NA|N|U|||N|3||39||TREATMENT|1969-02-25|1969-12-31|||||1969-08-17||1963-01-10|Y|1971-03-19
TRIAL STUDY 134XCP|LB|67D6A191-10C7-4414-BA63-DB7701998DF0|1||||LYMPL|PLASMACYTOID LYMPHOCYTES|||||||CMH2O*S2/ML|||||||NEGATIVE||DYN||||NORMAL|NOT DONE||||BUFFY COAT|AUTOLYZED|U|SICKLE CELL SOLUBILITY TEST|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|U|NA|||U|4||88||RUN-IN|1963-01-18|1964-02-14|||||1963-01-02||1966-03-07|U|1965-06-28
TRIAL STUDY 134XCP|LB|67D6A191-10C7-4414-BA63-DB7701998DF0|2||||LEUKASE|LEUKOCYTE ESTERASE|||||||MMOL/DAY|||||||BORDERLINE||G/KG||||HIGH|NOT DONE||||SERUM|CALCIFIED|Y|PERCUSSION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|N|NA|||U|4||88||CONTINUATION TREATMENT|1973-09-06|1962-03-25|||||1960-05-29||1972-01-26|U|1968-04-13
TRIAL STUDY 134XCP|LB|67D6A191-10C7-4414-BA63-DB7701998DF0|1||||INTLK24|INTERLEUKIN 24|||||||10^4/L|||||||INDETERMINATE||MG/KG/MIN||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH|NA|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA||Y|NA|Y|NA|||U|5||7||CONTINUATION TREATMENT|1961-04-28|1968-09-04|||||1967-01-16||1961-02-28|U|1971-10-25
TRIAL STUDY 134XCP|LB|67D6A191-10C7-4414-BA63-DB7701998DF0|2||||MCSF|MACROPHAGE COLONY STIMULATING FACTOR|||||||U/M2/MIN|||||||NEGATIVE||BOX||||ABNORMAL|NOT DONE||||DISCHARGE|ROOM TEMPERATURE|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|FIBROTEST FORMULA||Y|Y|U|NA|||NA|5||7||BASELINE|1972-05-18|1967-11-23|||||1970-12-18||1963-10-12|Y|1960-09-14
TRIAL STUDY 134XCP|LB|499B5A47-893A-40DE-9B64-60967378C81A|1||||TPROT|TAU PROTEIN|||||||MG/MOL|||||||TRACE||UOSM||||LOW|NOT DONE||||SERUM OR PLASMA|LACTESCENT|Y|TRIPLE-PHASE MRI SCAN|CKD-EPI CREATININE FORMULA||NA|U|NA|U|||U|1||38||CONTINUATION TREATMENT|1965-05-09|1961-05-11|||||1964-09-17||1960-04-23|NA|1961-10-08
TRIAL STUDY 134XCP|LB|499B5A47-893A-40DE-9B64-60967378C81A|2||||C3DAB|COMPLEMENT C3D ANTIBODY|||||||NM|||||||POSITIVE||UG/MOL||||ABNORMAL|NOT DONE||||CERUMEN|SOLIDIFIED|Y|MICRO BROTH DILUTION|ASH FIBROSURE FORMULA||NA|NA|U|U|||Y|1||38||TREATMENT|1971-07-18|1963-03-30|||||1965-09-24||1960-10-29|Y|1961-02-24
TRIAL STUDY 134XCP|LB|499B5A47-893A-40DE-9B64-60967378C81A|1||||CXCL3|CHEMOKINE (C-X-C MOTIF) LIGAND 3|||||||MV/SEC|||||||INVALID||LOG10 CFU/G||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|CONCENTRATED|N|IMMUNODIFFUSION|MDRD 5 VARIABLE FORMULA||N|Y|NA|U|||N|2||58||BLINDED TREATMENT|1962-03-02|1965-04-09|||||1961-03-22||1963-09-23|NA|1971-08-08
TRIAL STUDY 134XCP|LB|499B5A47-893A-40DE-9B64-60967378C81A|2||||LYMPHOTC|LYMPHOTACTIN|||||||ML/MIN|||||||TRACE||INHALATION||||NORMAL|NOT DONE||||VENOUS BLOOD|CONCENTRATED|U|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|FIBROMETER FORMULA||Y|N|Y|Y|||U|2||58||SCREENING|1971-03-23|1960-05-31|||||1963-10-04||1960-12-25|Y|1968-11-14
TRIAL STUDY 134XCP|LB|499B5A47-893A-40DE-9B64-60967378C81A|1||||STAT3P|PHOSPHORYLATED STAT3|||||||PA|||||||BORDERLINE||BQ/UL||||LOW|NOT DONE||||KERATINOCYTE|LIPEMIC|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|NA|N|||U|3||39||INDUCTION TREATMENT|1965-08-19|1969-01-09|||||1963-02-01||1970-07-07|U|1961-05-29
TRIAL STUDY 134XCP|LB|499B5A47-893A-40DE-9B64-60967378C81A|2||||P1NP|PROCOLLAGEN 1 N-TERMINAL PROPEPTIDE|||||||UM|||||||NEGATIVE||G/L||||NORMAL|NOT DONE||||PROSTATIC FLUID|LIPEMIC|Y|RADIOIMMUNOPRECIPITATION ASSAY|GMI MMOL/MOL FORMULA||N|U|Y|NA|||U|3||39||INDUCTION TREATMENT|1967-11-05|1965-07-22|||||1962-03-13||1971-09-07|Y|1963-06-24
TRIAL STUDY 134XCP|LB|499B5A47-893A-40DE-9B64-60967378C81A|1||||PDW|PLATELET DISTRIBUTION WIDTH|||||||MV|||||||INDETERMINATE||K||||NORMAL|NOT DONE||||SPERMATOZOON|CALCIFIED|Y|HEMAGGLUTINATION ASSAY|FIBROMETER FORMULA||N|NA|N|N|||NA|4||88||INDUCTION TREATMENT|1970-12-16|1965-08-17|||||1963-07-03||1965-07-17|Y|1967-09-19
TRIAL STUDY 134XCP|LB|499B5A47-893A-40DE-9B64-60967378C81A|2||||INTLK9|INTERLEUKIN 9|||||||HEP|||||||NEGATIVE||/CMH2O||||ABNORMAL|NOT DONE||||SMEGMA|UNEXPECTED ODOR|Y|INCISION-INDUCED BLEEDING METHOD|MDRD 5 VARIABLE FORMULA||U|N|U|NA|||Y|4||88||RUN-IN|1968-11-26|1964-03-22|||||1971-09-25||1967-07-05|Y|1963-08-26
TRIAL STUDY 134XCP|LB|499B5A47-893A-40DE-9B64-60967378C81A|1||||THYPXDAB|THYROPEROXIDASE ANTIBODY|||||||CP|||||||INDETERMINATE||TUBE||||HIGH|NOT DONE||||BILE|HEMOLYZED|N|RAJI CELL RIA|CKD-EPI CYSTATIN C FORMULA||NA|N|N|NA|||NA|5||7||FOLLOW-UP|1964-02-07|1962-03-31|||||1965-09-25||1961-05-12|U|1964-04-19
TRIAL STUDY 134XCP|LB|499B5A47-893A-40DE-9B64-60967378C81A|2||||PTSAAC|PROTEIN S ACTIVITY ACTUAL/CONTROL|||||||TUBERCULIN UNIT|||||||INVALID||MV/SEC||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|NON-HEMOLYZED|U|OPTICAL MAPPING|ASH FIBROSURE FORMULA||NA|N|NA|NA|||N|5||7||OBSERVATION|1964-10-24|1971-10-16|||||1963-07-08||1963-04-14|Y|1969-03-29
TRIAL STUDY 134XCP|LB|984103CA-F301-4510-A9DD-4916FA858EA2|1||||HDLCLDLC|HDL CHOLESTEROL/LDL CHOLESTEROL|||||||BAU|||||||INDETERMINATE||10^4 CFU||||NORMAL|NOT DONE||||ABSCESS FLUID|AUTOLYZED|N|SECONDARY ION MASS SPECTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|U|Y|||N|1||38||SCREENING|1960-02-12|1969-10-24|||||1970-05-05||1969-01-06|N|1969-01-30
TRIAL STUDY 134XCP|LB|984103CA-F301-4510-A9DD-4916FA858EA2|2||||A1MICG|ALPHA-1 MICROGLOBULIN|||||||V/SEC|||||||INVALID||10^4 CFU||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|FRESH|NA|PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD FORMULA||NA|NA|Y|N|||N|1||38||OPEN LABEL TREATMENT|1965-12-13|1962-03-30|||||1969-09-09||1963-02-10|Y|1970-01-13
TRIAL STUDY 134XCP|LB|984103CA-F301-4510-A9DD-4916FA858EA2|1||||CYFRA18|CYTOKERATIN 18 FRAGMENT|||||||IN|||||||NEGATIVE||LOG10 IU/ML||||LOW|NOT DONE||||ISOLATE|LIPEMIC|NA|WESTERN BLOT|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|NA|||U|2||58||RUN-IN|1963-04-12|1965-11-02|||||1968-12-19||1971-05-18|NA|1960-07-18
TRIAL STUDY 134XCP|LB|984103CA-F301-4510-A9DD-4916FA858EA2|2||||C130141|GERMAN COCKROACH ANTIGEN IGA ANTIBODY|||||||MMHG/L/MIN|||||||BORDERLINE||SV||||LOW|NOT DONE||||LYMPH|FROZEN|NA|CLIP SEQUENCING|FIBROMETER FORMULA||NA|U|U|NA|||Y|2||58||INDUCTION TREATMENT|1963-07-02|1962-09-24|||||1973-04-21||1969-12-01|N|1961-07-17
TRIAL STUDY 134XCP|LB|984103CA-F301-4510-A9DD-4916FA858EA2|1||||LY6E|LYMPHOCYTE ANTIGEN 6E|||||||MET|||||||POSITIVE||L||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|PARAFFIN-EMBEDDED|NA|IMMUNOCHEMILUMINOMETRIC ASSAY|GMI MMOL/MOL FORMULA||NA|Y|NA|NA|||NA|3||39||INDUCTION TREATMENT|1970-05-14|1970-07-05|||||1964-02-19||1966-10-22|N|1972-01-22
TRIAL STUDY 134XCP|LB|984103CA-F301-4510-A9DD-4916FA858EA2|2||||INTLK14|INTERLEUKIN 14|||||||KG/CM|||||||INVALID||MG/KG/MIN||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|FROZEN|NA|SNP ARRAY|MDRD ENZYMATIC JAPANESE FORMULA||U|N|Y|N|||NA|3||39||SCREENING|1968-10-04|1973-08-02|||||1964-09-06||1971-08-15|Y|1962-05-23
TRIAL STUDY 134XCP|LB|984103CA-F301-4510-A9DD-4916FA858EA2|1||||GLUBD13|1,3-BETA-D-GLUCAN|||||||G/M2|||||||TRACE||PIXELS/CM||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|FRESH|N|TOTAL BODY IRRADIATION|GMI % FORMULA||N|NA|NA|N|||Y|4||88||RUN-IN|1968-05-16|1971-07-23|||||1963-11-07||1961-07-16|Y|1973-08-20
TRIAL STUDY 134XCP|LB|984103CA-F301-4510-A9DD-4916FA858EA2|2||||HGBMET|METHEMOGLOBIN|||||||INHALATION|||||||POSITIVE||/100 HPFS||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|DRIED|NA|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 5 VARIABLE FORMULA||N|Y|N|U|||N|4||88||BLINDED TREATMENT|1972-11-14|1968-11-30|||||1965-12-28||1968-11-09|NA|1972-07-28
TRIAL STUDY 134XCP|LB|984103CA-F301-4510-A9DD-4916FA858EA2|1||||IGM|IMMUNOGLOBULIN M|||||||KIT|||||||INDETERMINATE||RFU||||LOW|NOT DONE||||PERITONEAL FLUID|HEMOLYZED|NA|ETDRS EYE CHART|MDRD FORMULA||U|U|Y|Y|||Y|5||7||RUN-IN|1960-09-27|1973-04-26|||||1964-04-01||1969-03-06|NA|1972-07-08
TRIAL STUDY 134XCP|LB|984103CA-F301-4510-A9DD-4916FA858EA2|2||||FXAC|FACTOR X ACTUAL/CONTROL|||||||FL|||||||NEGATIVE||CARTRIDGE||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|GELLED|Y|MICROSCOPY|GMI % FORMULA||N|NA|Y|NA|||NA|5||7||BLINDED TREATMENT|1971-05-27|1968-04-25|||||1963-10-15||1965-05-14|NA|1961-10-13
TRIAL STUDY 134XCP|LB|50E626B3-9133-4A50-8907-2388DAC22AD1|1||||CATNINB|BETA CATENIN|||||||U/M2/MIN|||||||POSITIVE||CG||||NORMAL|NOT DONE||||TUMOR TISSUE|AUTOLYZED|Y|CORONARY ANGIOGRAPHY|FIBROTEST FORMULA||N|N|N|U|||N|1||38||OPEN LABEL TREATMENT|1972-11-04|1972-09-13|||||1961-03-07||1960-01-15|NA|1964-02-04
TRIAL STUDY 134XCP|LB|50E626B3-9133-4A50-8907-2388DAC22AD1|2||||INTLK3|INTERLEUKIN 3|||||||MASK|||||||POSITIVE||CARTRIDGE||||HIGH|NOT DONE||||BLOOD|ROOM TEMPERATURE|NA|RADIAL IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA||U|N|U|NA|||NA|1||38||FOLLOW-UP|1967-02-17|1963-05-02|||||1967-01-26||1968-11-05|Y|1969-01-04
TRIAL STUDY 134XCP|LB|50E626B3-9133-4A50-8907-2388DAC22AD1|1||||FATACFRU|FREE FATTY ACID, UNSATURATED|||||||10^6 ORGANISMS/ML|||||||POSITIVE||NKAT||||HIGH|NOT DONE||||BONE MARROW|FROZEN|Y|FUNCTIONAL MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|U|Y|||Y|2||58||OPEN LABEL TREATMENT|1972-01-29|1963-04-21|||||1962-03-17||1965-10-11|U|1961-03-06
TRIAL STUDY 134XCP|LB|50E626B3-9133-4A50-8907-2388DAC22AD1|2||||APTTSTND|ACTIVATED PTT/STANDARD|||||||/40 HPFS|||||||TRACE||ENZYME U||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|SOLIDIFIED|Y|ENDPOINT DILUTION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|N|N|||N|2||58||BASELINE|1960-09-23|1966-04-13|||||1969-07-21||1970-06-28|Y|1962-08-28
TRIAL STUDY 134XCP|LB|50E626B3-9133-4A50-8907-2388DAC22AD1|1||||INTLK26|INTERLEUKIN 26|||||||L/S/KPA|||||||TRACE||/10^5||||LOW|NOT DONE||||MUSCLE TISSUE|UNEXPECTED ODOR|N|GC/FID|FIBROMETER FORMULA||NA|N|U|Y|||U|3||39||LONG-TERM FOLLOW-UP|1964-01-11|1963-03-03|||||1971-12-15||1966-07-22|Y|1967-11-14
TRIAL STUDY 134XCP|LB|50E626B3-9133-4A50-8907-2388DAC22AD1|2||||C165894|D. FARINAE ANTIGEN IGG4 ANTIBODY|||||||MJOULE/CM2|||||||NEGATIVE||MG/KG||||NORMAL|NOT DONE||||MUSCLE TISSUE|GELLED|Y|CYSTOSCOPY|CKD-EPI CREATININE FORMULA||N|N|Y|U|||N|3||39||WASHOUT|1971-12-02|1963-05-04|||||1967-07-29||1964-06-29|NA|1965-04-05
TRIAL STUDY 134XCP|LB|50E626B3-9133-4A50-8907-2388DAC22AD1|1||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||10^6 CFU/G|||||||BORDERLINE||MV||||NORMAL|NOT DONE||||VITREOUS HUMOR|UNEXPECTED ODOR|U|CLOT DETECTION|COCKCROFT-GAULT FORMULA||NA|NA|N|N|||Y|4||88||FOLLOW-UP|1966-10-28|1971-11-04|||||1970-07-13||1973-04-07|U|1964-02-10
TRIAL STUDY 134XCP|LB|50E626B3-9133-4A50-8907-2388DAC22AD1|2||||AHBDH|ALPHA HYDROXYBUTYRATE DEHYDROGENASE|||||||FRACTION OF 1|||||||TRACE||10^6 ORGANISMS||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|DRIED|NA|MICROBIAL BIOCHEMICAL IDENTIFICATION|COCKCROFT-GAULT FORMULA||U|U|NA|N|||N|4||88||FOLLOW-UP|1970-08-26|1965-03-07|||||1968-01-11||1966-04-30|NA|1968-12-02
TRIAL STUDY 134XCP|LB|50E626B3-9133-4A50-8907-2388DAC22AD1|1||||TKG|T-KININOGEN|||||||/MM2|||||||TRACE||PHERESIS UNIT||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|ICTERIC|Y|NUCLEIC ACID AMPLIFICATION TEST|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|U|Y|||NA|5||7||TREATMENT|1965-10-02|1966-06-24|||||1972-08-03||1961-07-09|N|1961-04-10
TRIAL STUDY 134XCP|LB|50E626B3-9133-4A50-8907-2388DAC22AD1|2||||FAS|FAS CELL SURFACE DEATH RECEPTOR|||||||MOL/ML|||||||NEGATIVE||TUBE||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|LACTESCENT|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|CKD-EPI CREATININE FORMULA||Y|N|NA|N|||NA|5||7||OPEN LABEL TREATMENT|1967-08-17|1963-07-18|||||1967-07-30||1968-08-12|NA|1966-06-29
TRIAL STUDY 134XCP|LB|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|1||||HCHT|HYOCHOLATE|||||||MOL/DAY|||||||NEGATIVE||IU/G HB||||LOW|NOT DONE||||PLASMA|HEMOLYZED|N|INFRARED SPECTROMETRY|FIBROSIS 4 FORMULA||NA|U|NA|Y|||NA|1||38||BLINDED TREATMENT|1967-06-24|1962-10-22|||||1973-07-17||1964-03-15|N|1966-02-02
TRIAL STUDY 134XCP|LB|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|2||||ALA|ALANINE|||||||F|||||||INVALID||AMP||||ABNORMAL|NOT DONE||||MONOCYTE|NON-HEMOLYZED|N|GC/FID|MDRD 4 VARIABLE FORMULA||N|U|NA|NA|||U|1||38||OBSERVATION|1961-07-03|1965-12-21|||||1970-01-22||1972-01-07|U|1967-10-25
TRIAL STUDY 134XCP|LB|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|1||||EPISQTCE|SQUAMOUS TRANSITIONAL EPITHELIAL CELLS|||||||U/G|||||||INDETERMINATE||GLOBULE||||HIGH|NOT DONE||||BUFFY COAT|PARAFFIN-EMBEDDED|U|CT SCAN WITHOUT CONTRAST|MDRD 4 VARIABLE FORMULA||Y|Y|U|U|||U|2||58||INDUCTION TREATMENT|1973-05-07|1973-05-15|||||1965-05-15||1960-04-10|U|1964-07-02
TRIAL STUDY 134XCP|LB|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|2||||NEUTMM|NEUTROPHILIC METAMYELOCYTES|||||||DNA COPIES/ML|||||||INDETERMINATE||/5X10^4 WBC||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|HEMOLYZED|U|MICRONEUTRALIZATION ASSAY|HEPASCORE FORMULA||N|U|N|N|||N|2||58||OBSERVATION|1965-04-03|1969-06-25|||||1967-09-21||1972-02-05|U|1963-11-18
TRIAL STUDY 134XCP|LB|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|1||||VWFAC|VON WILL FACTOR ACTUAL/CONTROL|||||||UMOL/DAY|||||||INVALID||UG/L FEU||||HIGH|NOT DONE||||MENSTRUAL BLOOD|LACTESCENT|N|SPECT SCAN|COCKCROFT-GAULT FORMULA||N|NA|Y|U|||Y|3||39||OBSERVATION|1964-06-21|1962-08-31|||||1967-02-04||1961-01-23|NA|1963-01-04
TRIAL STUDY 134XCP|LB|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|2||||VLDL|VLDL CHOLESTEROL|||||||10^7/L|||||||TRACE||ENZYME U/L||||ABNORMAL|NOT DONE||||BREAST MILK|LACTESCENT|NA|TELLER ACUITY CARDS|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|NA|N|||N|3||39||FOLLOW-UP|1966-12-05|1968-10-18|||||1967-01-25||1961-05-07|NA|1965-05-29
TRIAL STUDY 134XCP|LB|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|1||||PGD2|PROSTAGLANDIN D2|||||||/LPF|||||||POSITIVE||FINGERTIP UNIT||||ABNORMAL|NOT DONE||||LYMPH|NON-HEMOLYZED|U|DYNAMIC LIGHT SCATTERING|MDRD ENZYMATIC FORMULA||U|NA|N|N|||U|4||88||RUN-IN|1966-03-18|1971-05-20|||||1973-02-10||1970-03-03|N|1971-02-18
TRIAL STUDY 134XCP|LB|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|2||||AFPADJBW|ALPHA FETOPROTEIN ADJ FOR BODY WEIGHT|||||||10^9 ORGANISMS/MG|||||||TRACE||FARAD||||NORMAL|NOT DONE||||SKIN TISSUE|ROOM TEMPERATURE|NA|IMMUNO-PET SCAN|MDRD 6 VARIABLE FORMULA||NA|N|U|NA|||Y|4||88||SCREENING|1967-08-24|1971-12-10|||||1961-08-13||1961-05-24|Y|1966-06-26
TRIAL STUDY 134XCP|LB|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|1||||CBB|COMPLEMENT BB|||||||OHM|||||||INVALID||ML/BREATH||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|CONCENTRATED|NA|JAEGER EYE CHART|CKD-EPI CREATININE FORMULA||U|U|Y|U|||U|5||7||OPEN LABEL TREATMENT|1968-08-02|1961-08-11|||||1970-08-17||1965-09-05|U|1972-10-28
TRIAL STUDY 134XCP|LB|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|2||||TCHT|TAUROCHOLATE|||||||UG/DAY|||||||POSITIVE||ML/BREATH||||HIGH|NOT DONE||||KERATINOCYTE|DRIED|Y|SLOAN LETTER EYE CHART 1.25%|GMI MMOL/MOL FORMULA||Y|N|NA|Y|||NA|5||7||INDUCTION TREATMENT|1968-06-10|1965-06-20|||||1961-03-07||1967-03-22|N|1968-12-06
TRIAL STUDY 134XCP|LB|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|1||||NACREAT|SODIUM/CREATININE|||||||NMOL/DAY|||||||POSITIVE||UL/KG/DAY||||LOW|NOT DONE||||LYSATE|FRESH|N|OPHTHALMOSCOPY|GMI % FORMULA||U|Y|U|NA|||Y|1||38||SCREENING|1962-12-16|1962-05-08|||||1961-04-24||1963-10-22|U|1965-03-16
TRIAL STUDY 134XCP|LB|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|2||||HBA1A|HEMOGLOBIN A1A|||||||GPELISA UNIT/ML|||||||BORDERLINE||U/M2||||NORMAL|NOT DONE||||AMNIOTIC FLUID|SOLIDIFIED|Y|TOTAL BODY RADIOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|N|NA|U|||Y|1||38||SCREENING|1966-09-01|1961-08-05|||||1968-08-01||1962-12-17|NA|1973-02-19
TRIAL STUDY 134XCP|LB|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|1||||WBC|LEUKOCYTES|||||||PG/CELL|||||||POSITIVE||UG/M2/DAY||||ABNORMAL|NOT DONE||||GASTRIC FLUID|AGGLUTINATED|Y|PELLI-ROBSON EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|NA|N|||N|2||58||BASELINE|1964-08-29|1970-09-09|||||1960-01-12||1969-03-20|Y|1962-07-15
TRIAL STUDY 134XCP|LB|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|2||||T3|TRIIODOTHYRONINE|||||||PFU/DOSE|||||||TRACE||MMHG||||HIGH|NOT DONE||||MENSTRUAL BLOOD|CALCIFIED|N|HANSEL STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|NA|NA|||N|2||58||BLINDED TREATMENT|1963-06-21|1972-12-20|||||1967-07-03||1968-11-09|N|1962-09-20
TRIAL STUDY 134XCP|LB|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|1||||LDH1LDH|LDH ISOENZYME 1/LDH|||||||FFU|||||||BORDERLINE||HEP||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|CALCIFIED|Y|CONTRAST ENHANCED PET/CT SCAN|GMI % FORMULA||N|Y|N|U|||Y|3||39||OBSERVATION|1971-06-26|1970-11-21|||||1961-04-25||1965-06-17|NA|1966-03-31
TRIAL STUDY 134XCP|LB|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|2||||HTTPM|HUNTINGTIN PROTEIN, MUTANT|||||||NMOL/L|||||||BORDERLINE||LENS||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED|U|PET SCAN|MDRD FORMULA||U|U|N|NA|||N|3||39||OBSERVATION|1971-05-08|1968-11-10|||||1966-05-06||1962-02-20|N|1969-05-09
TRIAL STUDY 134XCP|LB|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|1||||CGMP|CYCLIC GUANOSINE MONOPHOSPHATE|||||||SUPPOSITORY|||||||POSITIVE||APL U||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|NON-HEMOLYZED|NA|GC/MS-CI|COCKCROFT-GAULT FORMULA||Y|Y|U|Y|||U|4||88||BLINDED TREATMENT|1961-10-16|1968-01-01|||||1962-09-27||1961-03-27|N|1967-06-27
TRIAL STUDY 134XCP|LB|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|2||||CRDIGGAB|CARDIOLIPIN IGG ANTIBODY|||||||PPM|||||||INDETERMINATE||MMAL||||HIGH|NOT DONE||||EMOTIONAL TEAR|FROZEN|U|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CYSTATIN C FORMULA||U|NA|U|N|||N|4||88||SCREENING|1960-05-07|1967-10-15|||||1967-08-31||1962-01-07|NA|1972-03-02
TRIAL STUDY 134XCP|LB|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|1||||RNPAB|RIBONUCLEOPROTEIN ANTIBODY|||||||MOL/MG|||||||NEGATIVE||MG/MIN||||NORMAL|NOT DONE||||AQUEOUS HUMOR|GELLED|NA|MAPH|CKD-EPI CREATININE FORMULA||U|N|Y|N|||U|5||7||TREATMENT|1963-05-22|1972-03-06|||||1961-09-19||1963-05-27|N|1963-01-23
TRIAL STUDY 134XCP|LB|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|2||||DDNAIGAB|ANTI-DOUBLE STRANDED DNA IGG|||||||PHERESIS UNIT|||||||TRACE||DPM||||NORMAL|NOT DONE||||LUNG SURFACTANT|CALCIFIED|Y|DARK FIELD MICROSCOPY|CKD-EPI FORMULA||NA|N|U|Y|||U|5||7||OBSERVATION|1967-09-07|1960-04-16|||||1971-11-27||1961-10-28|NA|1971-03-15
TRIAL STUDY 134XCP|LB|F8F17A43-A74B-4570-8A06-D7657A4636B4|1||||BUPREN|BUPRENORPHINE|||||||PRESSOR UNITS|||||||INDETERMINATE||BE/ML||||ABNORMAL|NOT DONE||||PERSPIRATION|LACTESCENT|NA|DIFFUSION WEIGHTED MRI|ASH FIBROSURE FORMULA||N|U|U|U|||N|1||38||OBSERVATION|1963-03-19|1971-05-27|||||1966-08-30||1961-07-12|N|1967-06-05
TRIAL STUDY 134XCP|LB|F8F17A43-A74B-4570-8A06-D7657A4636B4|2||||HDWR|RET HEMOGLOBIN DISTRIBUTION WIDTH|||||||%(W/W)|||||||TRACE||DL||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|FRESH|N|TRANSVAGINAL ULTRASOUND|FIBROMETER FORMULA||U|N|NA|U|||Y|1||38||WASHOUT|1962-03-15|1968-07-09|||||1965-09-12||1970-04-20|Y|1962-06-20
TRIAL STUDY 134XCP|LB|F8F17A43-A74B-4570-8A06-D7657A4636B4|1||||SAO2FIO2|OXYGEN SATURATION/FRACTION INSPIRED O2|||||||MM/H|||||||INVALID||USEC||||LOW|NOT DONE||||PLEURAL TISSUE|LACTESCENT|Y|IMMUNOTURBIDIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|NA|NA|||N|2||58||SCREENING|1968-02-15|1972-02-17|||||1972-02-08||1971-07-05|Y|1970-07-27
TRIAL STUDY 134XCP|LB|F8F17A43-A74B-4570-8A06-D7657A4636B4|2||||AFACTXAA|ANTI-FACTOR XA ACTIVITY|||||||MEQ|||||||TRACE||10^9 ORGANISMS/G||||LOW|NOT DONE||||LAVAGE FLUID|PARAFFIN-EMBEDDED|U|CLAUSS METHOD|GMI % FORMULA||NA|U|NA|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1973-06-13|1968-04-22|||||1971-11-24||1970-05-05|U|1964-05-31
TRIAL STUDY 134XCP|LB|F8F17A43-A74B-4570-8A06-D7657A4636B4|1||||LDH2|LDH ISOENZYME 2|||||||LOG10 TCID 50/DOSE|||||||NEGATIVE||PT_BR||||NORMAL|NOT DONE||||MECONIUM|LACTESCENT|Y|IMPULSE OSCILLOMETRY|MDRD 6 VARIABLE FORMULA||N|NA|U|Y|||N|3||39||CONTINUATION TREATMENT|1964-02-17|1971-05-11|||||1966-09-19||1963-07-15|U|1969-09-09
TRIAL STUDY 134XCP|LB|F8F17A43-A74B-4570-8A06-D7657A4636B4|2||||LIPASEP|LIPASE, PANCREATIC|||||||MGEQ|||||||POSITIVE||10^6 COPIES/ML||||LOW|NOT DONE||||SPERMATOZOON|FROZEN|NA|ENZYMATIC ULTRACENTRIFUGATION|CKD-EPI FORMULA||NA|N|U|NA|||N|3||39||INDUCTION TREATMENT|1964-04-29|1966-04-18|||||1967-02-13||1973-05-06|U|1969-08-11
TRIAL STUDY 134XCP|LB|F8F17A43-A74B-4570-8A06-D7657A4636B4|1||||EPO|ERYTHROPOIETIN|||||||HR/DAY|||||||INDETERMINATE||LOZENGE||||LOW|NOT DONE||||AMNIOTIC FLUID|AGGLUTINATED|Y|SLOAN LETTER EYE CHART 2.5%|NASH FIBROSURE FORMULA||NA|NA|N|U|||Y|4||88||SCREENING|1972-11-30|1971-01-28|||||1964-08-25||1966-12-11|Y|1963-06-20
TRIAL STUDY 134XCP|LB|F8F17A43-A74B-4570-8A06-D7657A4636B4|2||||CD5|CD5|||||||MEQ/UG|||||||NEGATIVE||10^3 ORGANISMS||||NORMAL|NOT DONE||||BONE|CONTAMINATED|Y|ZIEHL NEELSEN ACID FAST STAIN|NASH FIBROSURE FORMULA||NA|Y|Y|N|||N|4||88||BLINDED TREATMENT|1969-05-12|1971-03-26|||||1963-09-14||1962-06-29|N|1970-05-18
TRIAL STUDY 134XCP|LB|F8F17A43-A74B-4570-8A06-D7657A4636B4|1||||TSTFWTST|TESTOSTERONE FREE+WEAKLY BOUND/TESTOST|||||||ARBITRARY U|||||||INVALID||M||||NORMAL|NOT DONE||||SPERMATOZOON|CLOTTED|U|RYAN BLUE STAIN|MDRD 6 VARIABLE FORMULA||NA|Y|U|NA|||NA|5||7||WASHOUT|1966-04-06|1960-04-24|||||1971-04-20||1968-06-08|U|1961-02-04
TRIAL STUDY 134XCP|LB|F8F17A43-A74B-4570-8A06-D7657A4636B4|2||||C130143|GERMAN COCKROACH ANTIGEN IGG4 ANTIBODY|||||||PL|||||||BORDERLINE||MG/MOL||||NORMAL|NOT DONE||||PLEURAL TISSUE|DRIED|Y|BIOIMPEDANCE SPECTROSCOPY|FIBROSIS 4 FORMULA||Y|Y|NA|U|||N|5||7||CONTINUATION TREATMENT|1968-09-14|1972-02-27|||||1964-01-03||1961-01-15|NA|1967-04-02
TRIAL STUDY 134XCP|LB|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|1||||CAPHOSPD|CALCIUM - PHOSPHORUS PRODUCT|||||||UG/KG|||||||INVALID||SUPPOSITORY||||LOW|NOT DONE||||AQUEOUS HUMOR|NON-HEMOLYZED|Y|REVERSE TRANSCRIPTASE PCR|MDRD 6 VARIABLE FORMULA||NA|N|Y|Y|||N|1||38||CONTINUATION TREATMENT|1965-05-29|1969-10-28|||||1965-08-28||1969-10-18|Y|1966-05-15
TRIAL STUDY 134XCP|LB|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|2||||EPICCE|EPITHELIAL CELLS/TOTAL CELLS|||||||BEL|||||||TRACE||UU/L||||HIGH|NOT DONE||||PLEURAL TISSUE|AUTOLYZED|Y|OLIGO ACGH|CKD-EPI FORMULA||Y|NA|U|NA|||Y|1||38||RUN-IN|1965-10-11|1968-04-08|||||1970-07-13||1964-07-19|U|1972-09-05
TRIAL STUDY 134XCP|LB|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|1||||NOHDLHDL|NON-HDL CHOLESTEROL/HDL CHOLESTEROL|||||||MU/L|||||||INVALID||KHZ||||HIGH|NOT DONE||||BASAL TEAR|CONTAMINATED|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|FIBROMETER FORMULA||U|U|Y|N|||NA|2||58||BASELINE|1962-01-06|1968-04-12|||||1968-01-22||1968-12-02|NA|1967-09-11
TRIAL STUDY 134XCP|LB|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|2||||LIPASEP|LIPASE, PANCREATIC|||||||GENEQ|||||||POSITIVE||MV2/HZ||||HIGH|NOT DONE||||PUS|PARAFFIN-EMBEDDED|NA|PULSE OXIMETRY|COCKCROFT-GAULT FORMULA||NA|Y|Y|U|||U|2||58||FOLLOW-UP|1969-03-26|1967-07-27|||||1971-03-28||1968-07-28|N|1964-01-19
TRIAL STUDY 134XCP|LB|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|1||||PTSAAC|PROTEIN S ACTIVITY ACTUAL/CONTROL|||||||SFC/10^6 PBMC|||||||TRACE||MPA||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|HEPASCORE FORMULA||U|Y|N|N|||U|3||39||RUN-IN|1969-11-24|1963-01-13|||||1962-07-05||1964-03-22|NA|1966-02-20
TRIAL STUDY 134XCP|LB|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|2||||GLP1AC|GLUCAGON-LIKE PEPTIDE-1, ACTIVE FORM|||||||/100 HPFS|||||||INDETERMINATE||NG/L||||HIGH|NOT DONE||||CELL PELLET|UNEXPECTED ODOR|U|LYMPHANGIOGRAPHY|CKD-EPI FORMULA||N|Y|N|N|||N|3||39||TREATMENT|1969-11-30|1962-09-12|||||1967-09-06||1963-07-01|U|1966-06-04
TRIAL STUDY 134XCP|LB|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|1||||FXAC|FACTOR X ACTUAL/CONTROL|||||||10^10/L|||||||NEGATIVE||USP U||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|ICTERIC|Y|IVY INCISION METHOD|FIBROTEST FORMULA||N|NA|NA|NA|||N|4||88||OBSERVATION|1972-06-19|1968-12-23|||||1965-05-25||1964-11-22|U|1970-01-08
TRIAL STUDY 134XCP|LB|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|2||||EUDCA|EPIMERIZED URSODEOXYCHOLATE|||||||U/G/MIN|||||||TRACE||U/M2/MIN||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|CALCIFIED|N|THIN SMEAR|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|NA|Y|||U|4||88||LONG-TERM FOLLOW-UP|1960-08-20|1964-08-27|||||1971-06-22||1960-01-08|Y|1970-04-28
TRIAL STUDY 134XCP|LB|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|1||||FACTVW|VON WILLEBRAND FACTOR|||||||FT2|||||||INVALID||NL||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|CONCENTRATED|NA|FUNDUS PHOTOGRAPHY|HEPASCORE FORMULA||N|Y|U|U|||N|5||7||BASELINE|1960-01-26|1967-12-12|||||1960-05-18||1971-05-04|NA|1973-02-03
TRIAL STUDY 134XCP|LB|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|2||||FABP3|FATTY ACID BINDING PROTEIN 3|||||||MG/H|||||||POSITIVE||FG||||NORMAL|NOT DONE||||SWABBED MATERIAL|LIPEMIC|U|IMMUNODIFFUSION|MDRD ENZYMATIC FORMULA||Y|Y|NA|U|||N|5||7||RUN-IN|1973-02-04|1973-04-20|||||1971-07-23||1966-02-14|N|1965-12-24
TRIAL STUDY 134XCP|LB|1177FD36-AAE8-4139-991A-A8C98B607565|1||||CSEPIRT|RENAL TUBULAR EPITHELIAL CASTS|||||||/H|||||||NEGATIVE||BLOCKS||||ABNORMAL|NOT DONE||||ISOLATE|LACTESCENT|Y|KNEMOMETRY|MDRD ENZYMATIC FORMULA||NA|U|N|Y|||NA|1||38||INDUCTION TREATMENT|1970-11-01|1963-03-04|||||1961-07-29||1966-04-21|N|1961-12-07
TRIAL STUDY 134XCP|LB|1177FD36-AAE8-4139-991A-A8C98B607565|2||||MONOLE|MONOCYTES/LEUKOCYTES|||||||OZ|||||||TRACE||IU/G HB||||LOW|NOT DONE||||PLATELET POOR PLASMA|REFRIGERATED|NA|HILLMEN COLOR CHART|MDRD ENZYMATIC FORMULA||Y|U|NA|N|||U|1||38||WASHOUT|1972-05-08|1967-07-02|||||1964-07-17||1964-04-21|NA|1965-07-02
TRIAL STUDY 134XCP|LB|1177FD36-AAE8-4139-991A-A8C98B607565|1||||CYUNCLA|UNCLASSIFIED CRYSTALS|||||||MAMP|||||||BORDERLINE||FT2||||ABNORMAL|NOT DONE||||DISCHARGE|FRESH|N|WRIGHT-GIEMSA STAIN|CKD-EPI CYSTATIN C FORMULA||N|NA|Y|Y|||NA|2||58||RUN-IN|1966-08-13|1964-08-20|||||1968-12-01||1963-11-24|NA|1967-08-13
TRIAL STUDY 134XCP|LB|1177FD36-AAE8-4139-991A-A8C98B607565|2||||PTF1_2|PROTHROMBIN FRAGMENTS 1 + 2|||||||KEV|||||||TRACE||CGY||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|UNEXPECTED ODOR|U|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|CKD-EPI CYSTATIN C FORMULA||U|NA|N|U|||NA|2||58||WASHOUT|1963-02-04|1967-12-18|||||1970-07-17||1973-01-21|NA|1967-02-08
TRIAL STUDY 134XCP|LB|1177FD36-AAE8-4139-991A-A8C98B607565|1||||FACTXIV|FACTOR XIV|||||||10^9 ORGANISMS/G|||||||BORDERLINE||G/G||||NORMAL|NOT DONE||||SMEGMA|FROZEN|NA|DYNAMIC CONTRAST ENHANCED MRI|NASH FIBROSURE FORMULA||NA|Y|U|U|||U|3||39||FOLLOW-UP|1970-08-16|1962-12-17|||||1971-08-28||1972-04-16|N|1970-05-11
TRIAL STUDY 134XCP|LB|1177FD36-AAE8-4139-991A-A8C98B607565|2||||PLSNCE|NEOPLASTIC PLASMA CELLS|||||||UG/H|||||||INVALID||YEARS||||NORMAL|NOT DONE||||TUMOR TISSUE|AGGLUTINATED|Y|MICRODENSITOMETRY|HEPASCORE FORMULA||Y|NA|U|U|||N|3||39||SCREENING|1962-08-16|1968-06-23|||||1961-07-14||1968-08-11|Y|1971-05-19
TRIAL STUDY 134XCP|LB|1177FD36-AAE8-4139-991A-A8C98B607565|1||||RF|RHEUMATOID FACTOR|||||||PHERESIS UNIT|||||||INVALID||MNFI||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|DRIED|Y|HANSEL STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|N|U|||U|4||88||BASELINE|1965-07-25|1970-01-21|||||1962-08-26||1970-02-20|Y|1965-03-05
TRIAL STUDY 134XCP|LB|1177FD36-AAE8-4139-991A-A8C98B607565|2||||OXMORPHN|OXYMORPHONE|||||||MOL/L|||||||POSITIVE||MMOL/MIN/KPA/L||||NORMAL|NOT DONE||||SPERMATOZOON|UNEXPECTED ODOR|U|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD 6 VARIABLE FORMULA||NA|Y|N|U|||U|4||88||LONG-TERM FOLLOW-UP|1964-09-11|1971-03-06|||||1963-01-11||1962-08-23|N|1970-02-08
TRIAL STUDY 134XCP|LB|1177FD36-AAE8-4139-991A-A8C98B607565|1||||LYMPLLE|PLASMACYTOID LYMPHOCYTES/LEUKOCYTES|||||||U/L|||||||INVALID||EU||||NORMAL|NOT DONE||||SOFT TISSUE|FROZEN|N|PHYSICAL EXAMINATION|GMI MMOL/MOL FORMULA||Y|NA|Y|Y|||Y|5||7||TREATMENT|1964-02-29|1970-01-27|||||1966-09-29||1961-07-18|U|1971-06-18
TRIAL STUDY 134XCP|LB|1177FD36-AAE8-4139-991A-A8C98B607565|2||||STBSEXCS|STANDARD BASE EXCESS|||||||MEQ/UL|||||||NEGATIVE||DEG2||||HIGH|NOT DONE||||PLATELET POOR PLASMA|CALCIFIED|U|MICROBIAL CULTURE|HEPASCORE FORMULA||NA|NA|N|NA|||U|5||7||BASELINE|1962-04-23|1969-03-15|||||1968-08-16||1960-05-03|N|1968-07-28
TRIAL STUDY 134XCP|LB|8C57F469-7CDF-493A-9839-C179D912A8A5|1||||RETIMRTC|MEDIUM ABSORPTION RETIC/RETICULOCYTES|||||||SEC|||||||POSITIVE||KIT||||NORMAL|NOT DONE||||BREAST MILK|UNEXPECTED ODOR|NA|OPTICAL MAPPING|MDRD 5 VARIABLE FORMULA||Y|U|Y|N|||NA|1||38||BASELINE|1966-02-02|1970-04-16|||||1966-12-15||1961-01-27|Y|1968-05-03
TRIAL STUDY 134XCP|LB|8C57F469-7CDF-493A-9839-C179D912A8A5|2||||ACE|ANGIOTENSIN CONVERTING ENZYME|||||||UG/CM2|||||||INDETERMINATE||LOG10 PFU||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|HEMOLYZED|NA|THERMAL IONIZATION MASS SPECTROMETRY|NASH FIBROSURE FORMULA||Y|U|NA|U|||U|1||38||CONTINUATION TREATMENT|1961-09-03|1967-07-06|||||1972-11-08||1972-03-27|Y|1965-01-30
TRIAL STUDY 134XCP|LB|8C57F469-7CDF-493A-9839-C179D912A8A5|1||||SAO2FIO2|OXYGEN SATURATION/FRACTION INSPIRED O2|||||||LB|||||||POSITIVE||LOG10 ELISA UNIT/DOSE||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|LIPEMIC|U|WHOLE GENOME SEQUENCING|NASH FIBROSURE FORMULA||N|NA|U|Y|||NA|2||58||BLINDED TREATMENT|1961-06-18|1966-08-07|||||1962-02-07||1972-09-25|U|1969-06-05
TRIAL STUDY 134XCP|LB|8C57F469-7CDF-493A-9839-C179D912A8A5|2||||CCL12|CHEMOKINE (C-C MOTIF) LIGAND 12|||||||PPTR|||||||TRACE||10^6/HPF||||ABNORMAL|NOT DONE||||STOOL|ROOM TEMPERATURE|Y|KINETIC MICROPARTICLE IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||U|U|U|NA|||NA|2||58||BLINDED TREATMENT|1972-08-09|1967-02-19|||||1965-03-11||1965-09-09|U|1963-09-15
TRIAL STUDY 134XCP|LB|8C57F469-7CDF-493A-9839-C179D912A8A5|1||||HYDMDZ1|1-HYDROXYMIDAZOLAM|||||||UMOL/MIN|||||||BORDERLINE||ML/M2||||HIGH|NOT DONE||||NAIL|FROZEN|N|HEMATOXYLIN AND EOSIN STAIN|CKD-EPI FORMULA||N|NA|NA|NA|||N|3||39||OBSERVATION|1966-05-06|1966-01-26|||||1960-06-01||1965-05-02|NA|1971-08-02
TRIAL STUDY 134XCP|LB|8C57F469-7CDF-493A-9839-C179D912A8A5|2||||FGF21|FIBROBLAST GROWTH FACTOR 21|||||||AMOL|||||||TRACE||COPIES/ML||||HIGH|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|N|KINYOUN STAIN|COCKCROFT-GAULT FORMULA||N|N|N|N|||U|3||39||OPEN LABEL TREATMENT|1964-11-03|1973-01-14|||||1962-05-06||1963-08-13|U|1970-05-14
TRIAL STUDY 134XCP|LB|8C57F469-7CDF-493A-9839-C179D912A8A5|1||||DHEA|DEHYDROEPIANDROSTERONE|||||||BAU/ML|||||||BORDERLINE||WEBER||||NORMAL|NOT DONE||||PLASMA|UNEXPECTED ODOR|Y|FLUORESCENT LIFETIME IMAGING MICROSCOPY|COCKCROFT-GAULT FORMULA||N|NA|NA|U|||Y|4||88||OBSERVATION|1969-11-01|1965-12-18|||||1963-12-30||1963-11-09|NA|1960-03-09
TRIAL STUDY 134XCP|LB|8C57F469-7CDF-493A-9839-C179D912A8A5|2||||RFIGGAB|RHEUMATOID FACTOR IGG ANTIBODY|||||||MG/DL|||||||NEGATIVE||10^9/G||||LOW|NOT DONE||||MUSCLE TISSUE|AUTOLYZED|N|INCISION-INDUCED BLEEDING METHOD|MDRD ENZYMATIC FORMULA||NA|NA|N|U|||U|4||88||BASELINE|1967-11-19|1970-07-20|||||1972-11-22||1968-11-19|U|1973-07-01
TRIAL STUDY 134XCP|LB|8C57F469-7CDF-493A-9839-C179D912A8A5|1||||PLAGGCVT|PLATELET AGGREGATION CURVE TYPE|||||||U|||||||NEGATIVE||IU/MMOL||||HIGH|NOT DONE||||EMOTIONAL TEAR|ICTERIC|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|GMI MMOL/MOL FORMULA||N|N|Y|NA|||U|5||7||OPEN LABEL TREATMENT|1971-06-23|1969-03-05|||||1965-06-25||1972-12-18|N|1968-05-10
TRIAL STUDY 134XCP|LB|8C57F469-7CDF-493A-9839-C179D912A8A5|2||||ETP|ENDOGENOUS THROMBIN POTENTIAL|||||||PFU/ANIMAL|||||||INVALID||HZ/S||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|FROZEN|U|WHOLE TRANSCRIPTOME SEQUENCING|MDRD 6 VARIABLE FORMULA||N|Y|U|Y|||U|5||7||RUN-IN|1966-02-17|1966-07-12|||||1966-05-19||1963-10-04|Y|1966-05-04
TRIAL STUDY 134XCP|LB|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|1||||RBCGHOST|ERYTHROCYTE GHOSTS|||||||FMOL/L/SEC|||||||BORDERLINE||HEP||||NORMAL|NOT DONE||||VITREOUS HUMOR|AUTOLYZED|U|MICROPARTICLE ENZYME IMMUNOASSAY|GMI MMOL/MOL FORMULA||Y|U|N|N|||N|1||38||BLINDED TREATMENT|1968-10-16|1967-09-30|||||1965-03-19||1964-06-20|N|1964-04-11
TRIAL STUDY 134XCP|LB|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|2||||VAL|VALINE|||||||ML/ANIMAL/DAY|||||||POSITIVE||NM||||NORMAL|NOT DONE||||SMEGMA|ICTERIC|NA|HPLC-FL|FIBROTEST FORMULA||NA|NA|NA|N|||N|1||38||SCREENING|1962-04-16|1970-05-27|||||1969-07-11||1962-11-22|U|1969-04-19
TRIAL STUDY 134XCP|LB|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|1||||IOHEXCLR|IOHEXOL CLEARANCE|||||||10^6/G|||||||POSITIVE||GBQ||||ABNORMAL|NOT DONE||||ERYTHROCYTES|NON-HEMOLYZED|Y|PHASE-CONTRAST MRI|MDRD 4 VARIABLE FORMULA||Y|NA|NA|Y|||Y|2||58||SCREENING|1965-07-27|1966-09-14|||||1972-01-11||1963-07-13|NA|1967-04-01
TRIAL STUDY 134XCP|LB|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|2||||MORPHINE|MORPHINE|||||||CMH2O*S2/ML|||||||TRACE||10^3 CFU/ML||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|LACTESCENT|N|PHOTOMETRIC CLOT DETECTION|CKD-EPI CREATININE FORMULA||N|U|Y|N|||U|2||58||OPEN LABEL TREATMENT|1971-11-01|1965-11-19|||||1971-12-22||1972-01-27|U|1960-05-07
TRIAL STUDY 134XCP|LB|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|1||||SCN|THIOCYANATE|||||||MMOL/KG|||||||TRACE||ELISA UNIT/DOSE||||ABNORMAL|NOT DONE||||MECONIUM|GELLED|NA|MRS|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|U|U|||U|3||39||BASELINE|1968-11-03|1973-06-24|||||1965-07-28||1970-11-24|NA|1963-10-10
TRIAL STUDY 134XCP|LB|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|2||||ETP|ENDOGENOUS THROMBIN POTENTIAL|||||||MMHG/L/MIN|||||||BORDERLINE||COPIES/UL||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|UNEXPECTED ODOR|Y|FLUORESCENCE ANGIOGRAPHY|FIBROMETER FORMULA||NA|U|U|N|||NA|3||39||OBSERVATION|1960-09-14|1960-12-26|||||1965-10-30||1964-07-15|N|1972-07-21
TRIAL STUDY 134XCP|LB|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|1||||A73OXC|7-ALPHA-HYDROXY-4-CHOLESTEN-3-ONE|||||||MET|||||||INVALID||U/G HB||||HIGH|NOT DONE||||INFRANATANT, SERUM|SOLIDIFIED|NA|WHOLE GENOME SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|Y|N|U|||U|4||88||BASELINE|1960-03-27|1964-11-13|||||1961-01-01||1963-04-18|Y|1963-09-09
TRIAL STUDY 134XCP|LB|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|2||||BLASTNCE|BLASTS/NUCLEATED CELLS|||||||% INHIBITION|||||||INVALID||BOWL||||LOW|NOT DONE||||SPUTUM|DRIED|N|IN VITRO GENE EXPRESSION ASSAY|MDRD 4 VARIABLE FORMULA||Y|N|Y|Y|||N|4||88||LONG-TERM FOLLOW-UP|1973-01-28|1966-09-16|||||1969-09-18||1965-03-02|U|1961-03-02
TRIAL STUDY 134XCP|LB|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|1||||ENDOTH1|ENDOTHELIN-1|||||||10^9 ORGANISMS/ML|||||||TRACE||BAG||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|CONCENTRATED|N|ENZYMATIC ULTRACENTRIFUGATION|MDRD ENZYMATIC JAPANESE FORMULA||U|N|Y|Y|||NA|5||7||RUN-IN|1962-11-18|1972-11-26|||||1966-05-08||1964-04-15|U|1964-03-05
TRIAL STUDY 134XCP|LB|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|2||||CD4LY|CD4/LYMPHOCYTES|||||||UG/KG/MIN|||||||NEGATIVE||PA||||ABNORMAL|NOT DONE||||MONOCYTE|LIPEMIC|NA|CONTRAST ENHANCED PET SCAN|GMI % FORMULA||NA|NA|N|NA|||Y|5||7||CONTINUATION TREATMENT|1969-02-16|1972-07-25|||||1961-10-14||1966-12-26|U|1964-02-23
TRIAL STUDY 134XCP|LB|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|1||||APTTLAS|LUPUS ANTICOAGULANT SENSITIVE APTT|||||||/4.0 ML|||||||INVALID||ENZYME U/L||||LOW|NOT DONE||||TUMOR TISSUE|ICTERIC|NA|TRYPAN BLUE STAIN|MDRD FORMULA||Y|NA|N|N|||U|1||38||BASELINE|1967-10-16|1968-04-17|||||1970-07-15||1973-07-12|U|1967-11-05
TRIAL STUDY 134XCP|LB|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|2||||RBC|ERYTHROCYTES|||||||ECL UNIT|||||||NEGATIVE||NEEDLE GAUGE||||LOW|NOT DONE||||PERITONEAL FLUID|AGGLUTINATED|Y|WRIGHT-GIEMSA STAIN|FIBROMETER FORMULA||NA|U|Y|U|||Y|1||38||BLINDED TREATMENT|1970-11-22|1960-04-28|||||1961-12-19||1966-12-17|U|1965-07-11
TRIAL STUDY 134XCP|LB|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|1||||APRI|AST TO PLATELET RATIO INDEX|||||||TUBERCULIN UNIT/ML|||||||NEGATIVE||KUSP||||ABNORMAL|NOT DONE||||LAVAGE FLUID|ROOM TEMPERATURE|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI FORMULA||U|N|U|NA|||N|2||58||WASHOUT|1965-06-15|1970-04-27|||||1964-01-28||1964-01-10|Y|1960-04-25
TRIAL STUDY 134XCP|LB|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|2||||VWFAAC|VON WILL FACTOR ACT ACTUAL/CONTROL|||||||WEEKS|||||||INVALID||PACKET||||LOW|NOT DONE||||SUPERNATANT, PLASMA|AUTOLYZED|U|HIGH RESOLUTION MELT ANALYSIS|MDRD FORMULA||U|Y|NA|NA|||N|2||58||SCREENING|1966-11-02|1973-08-23|||||1962-02-19||1973-03-30|NA|1964-11-09
TRIAL STUDY 134XCP|LB|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|1||||METHPHEN|METHYLPHENIDATE|||||||DRAM|||||||BORDERLINE||ML/KG||||ABNORMAL|NOT DONE||||SPUTUM|FROZEN|NA|INDIA INK STAIN|GMI % FORMULA||N|N|U|Y|||N|3||39||RUN-IN|1969-06-08|1970-01-01|||||1967-03-07||1965-06-23|N|1970-05-28
TRIAL STUDY 134XCP|LB|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|2||||TAP1|PEPTIDE TRANSPORTER TAP1|||||||MPL U|||||||NEGATIVE||NG/MOL||||ABNORMAL|NOT DONE||||LEUKOCYTE|DRIED|U|ELECTROCHEMILUMINESCENCE|CKD-EPI CREATININE FORMULA||NA|NA|U|N|||U|3||39||INDUCTION TREATMENT|1966-06-24|1968-10-03|||||1967-08-20||1968-08-20|NA|1970-06-19
TRIAL STUDY 134XCP|LB|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|1||||HISTAB|HISTONE ANTIBODIES|||||||TCID 50/DOSE|||||||INVALID||CM/MIN||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|THAWED|N|PET SCAN|MDRD 5 VARIABLE FORMULA||Y|N|N|N|||U|4||88||RUN-IN|1964-06-20|1969-05-05|||||1972-11-21||1972-07-27|U|1966-09-07
TRIAL STUDY 134XCP|LB|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|2||||DPDCREAT|DEOXYPYRIDINOLINE/CREATININE|||||||AG|||||||POSITIVE||10^8/L||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|UNEXPECTED ODOR|NA|CT SCAN|MDRD 6 VARIABLE FORMULA||U|U|U|NA|||NA|4||88||RUN-IN|1969-02-21|1972-03-19|||||1961-05-14||1961-12-23|Y|1964-02-07
TRIAL STUDY 134XCP|LB|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|1||||WBCCLMP|LEUKOCYTE CELL CLUMPS|||||||CM H2O|||||||TRACE||TSP||||LOW|NOT DONE||||TISSUE|UNEXPECTED ODOR|Y|ANTIMICROBIAL COMBINATION TESTING|FIBROMETER FORMULA||Y|NA|U|Y|||Y|5||7||BASELINE|1970-02-05|1970-09-01|||||1971-03-23||1971-03-29|Y|1972-05-26
TRIAL STUDY 134XCP|LB|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|2||||C147279|ZEA MAYS ANTIGEN IGE ANTIBODY|||||||U/G|||||||NEGATIVE||ML/M2/MIN||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|NON-HEMOLYZED|N|WEBER GREEN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|N|Y|||Y|5||7||TREATMENT|1961-08-31|1967-07-08|||||1960-03-17||1969-01-30|NA|1966-05-09
TRIAL STUDY 134XCP|LB|0AE36450-F37E-4F97-A250-79166011FCD7|1||||TNFSR|SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR|||||||PFU/DOSE|||||||INVALID||MG/M2/H||||ABNORMAL|NOT DONE||||CALCULUS|THAWED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|GMI % FORMULA||Y|U|Y|U|||Y|1||38||OBSERVATION|1965-10-03|1963-08-11|||||1967-09-28||1973-06-29|N|1970-09-09
TRIAL STUDY 134XCP|LB|0AE36450-F37E-4F97-A250-79166011FCD7|2||||PKM1|PYRUVATE KINASE ISOZYME M1|||||||DEG/S|||||||BORDERLINE||ML/ANIMAL/DAY||||LOW|NOT DONE||||CORD BLOOD|GELLED|Y|THIN SMEAR|MDRD FORMULA||N|N|U|Y|||Y|1||38||LONG-TERM FOLLOW-UP|1972-10-01|1966-07-13|||||1969-06-28||1960-04-30|U|1960-02-29
TRIAL STUDY 134XCP|LB|0AE36450-F37E-4F97-A250-79166011FCD7|1||||SPHERO|SPHEROCYTES|||||||KIT|||||||POSITIVE||CI/L||||HIGH|NOT DONE||||SUPERNATANT, SERUM|FROZEN|Y|EEG|FIBROTEST FORMULA||Y|N|N|NA|||U|2||58||FOLLOW-UP|1969-09-08|1968-11-23|||||1969-08-16||1969-02-08|Y|1960-05-21
TRIAL STUDY 134XCP|LB|0AE36450-F37E-4F97-A250-79166011FCD7|2||||C130077|SILVER BIRCH POLLEN IGA|||||||FL|||||||BORDERLINE||UG/L FEU||||HIGH|NOT DONE||||SYNOVIAL FLUID|THAWED|N|ELASTOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|Y|N|U|||Y|2||58||FOLLOW-UP|1960-03-16|1967-06-26|||||1972-03-11||1973-08-30|N|1965-11-26
TRIAL STUDY 134XCP|LB|0AE36450-F37E-4F97-A250-79166011FCD7|1||||FACTIXA|FACTOR IX ACTIVITY|||||||COPIES/UL|||||||NEGATIVE||10^6/EJACULATE U||||LOW|NOT DONE||||HAIR FOLLICLE|CALCIFIED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|GMI MMOL/MOL FORMULA||Y|Y|U|N|||U|3||39||SCREENING|1971-04-20|1968-05-02|||||1964-12-28||1969-12-26|N|1973-05-11
TRIAL STUDY 134XCP|LB|0AE36450-F37E-4F97-A250-79166011FCD7|2||||THC|TETRAHYDROCANNABINOL|||||||DEG|||||||TRACE||MV/SEC||||NORMAL|NOT DONE||||BUFFY COAT|REFRIGERATED|NA|TRANSVAGINAL ULTRASOUND|HEPASCORE FORMULA||N|U|Y|U|||U|3||39||WASHOUT|1973-05-15|1963-03-19|||||1961-04-04||1969-03-06|N|1973-04-11
TRIAL STUDY 134XCP|LB|0AE36450-F37E-4F97-A250-79166011FCD7|1||||HEMOLYSI|HEMOLYTIC INDEX|||||||BOWL|||||||POSITIVE||GENEQ/ML||||HIGH|NOT DONE||||SEBUM|FROZEN|N|OLIGO ACGH|MDRD 4 VARIABLE FORMULA||NA|Y|U|U|||NA|4||88||LONG-TERM FOLLOW-UP|1964-06-24|1970-09-22|||||1972-11-13||1970-09-29|Y|1967-01-21
TRIAL STUDY 134XCP|LB|0AE36450-F37E-4F97-A250-79166011FCD7|2||||EOSIMLE|IMMATURE EOSINOPHILS/LEUKOCYTES|||||||SCOOPFUL|||||||NEGATIVE||VIRTUAL PIXEL||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|UNEXPECTED ODOR|Y|IMMUNO-PET SCAN|FIBROSIS 4 FORMULA||Y|Y|U|N|||N|4||88||TREATMENT|1971-06-14|1965-09-19|||||1972-07-04||1972-11-30|NA|1971-03-02
TRIAL STUDY 134XCP|LB|0AE36450-F37E-4F97-A250-79166011FCD7|1||||LEIMLE|IMMATURE LEUKOCYTES/LEUKOCYTES|||||||IU/DAY|||||||NEGATIVE||RING||||ABNORMAL|NOT DONE||||COLOSTRUM|UNEXPECTED ODOR|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|CKD-EPI CYSTATIN C FORMULA||NA|NA|U|Y|||N|5||7||RUN-IN|1966-04-29|1967-02-07|||||1961-09-27||1970-05-03|Y|1964-05-08
TRIAL STUDY 134XCP|LB|0AE36450-F37E-4F97-A250-79166011FCD7|2||||HYPSEGCE|HYPERSEGMENTED CELLS|||||||IMPLANT|||||||INDETERMINATE||MEQ/UL||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|Y|VIRUS PLAQUE ASSAY|FIBROSIS 4 FORMULA||N|N|U|U|||Y|5||7||CONTINUATION TREATMENT|1962-09-26|1962-08-25|||||1963-11-13||1966-02-12|Y|1972-12-27
TRIAL STUDY 134XCP|LB|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|1||||CH100|COMPLEMENT CH100|||||||10^3 DNA COPIES/ML|||||||POSITIVE||PNU/ML||||LOW|NOT DONE||||SEMINAL FLUID|FROZEN|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|N|||U|1||38||RUN-IN|1963-09-18|1973-04-11|||||1972-03-11||1966-10-03|N|1973-06-18
TRIAL STUDY 134XCP|LB|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|2||||FGFBF|FIBROBLAST GROWTH FACTOR BASIC FORM|||||||ML/CAGE/DAY|||||||TRACE||PA||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|U|SLOAN LETTER EYE CHART 2.5%|CKD-EPI CYSTATIN C FORMULA||N|NA|Y|Y|||N|1||38||CONTINUATION TREATMENT|1973-05-22|1964-07-29|||||1970-01-11||1966-07-27|Y|1963-02-16
TRIAL STUDY 134XCP|LB|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|1||||BILIND|INDIRECT BILIRUBIN|||||||PMOL/G|||||||INVALID||NG/MOL||||LOW|NOT DONE||||SERUM|LACTESCENT|Y|SECONDARY ION MASS SPECTOMETRY|GMI MMOL/MOL FORMULA||NA|Y|N|NA|||NA|2||58||SCREENING|1964-01-11|1962-05-09|||||1964-01-04||1968-06-21|N|1972-08-06
TRIAL STUDY 134XCP|LB|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|2||||C147277|TRITICUM AESTIVUM ANTIGEN IGE ANTIBODY|||||||/10^3|||||||POSITIVE||MEQ/L||||ABNORMAL|NOT DONE||||DISCHARGE|THAWED|Y|NON-INVASIVE DIELECTRIC SENSING|MDRD 6 VARIABLE FORMULA||N|U|N|Y|||U|2||58||WASHOUT|1960-05-24|1970-05-22|||||1960-04-19||1962-07-02|NA|1965-08-25
TRIAL STUDY 134XCP|LB|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|1||||LCN2|LIPOCALIN-2|||||||SV|||||||BORDERLINE||10^3 COPIES/ML||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|NON-HEMOLYZED|Y|HPLC/MS|GMI % FORMULA||NA|U|N|Y|||U|3||39||CONTINUATION TREATMENT|1962-10-15|1960-05-31|||||1967-02-09||1971-09-22|Y|1973-04-07
TRIAL STUDY 134XCP|LB|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|2||||C165933|AMERICAN COCKROACH IGE AB RAST SCORE|||||||MPA|||||||NEGATIVE||DIP||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|ROOM TEMPERATURE|NA|FUNCTIONAL MRI|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|Y|NA|||NA|3||39||BASELINE|1960-12-19|1971-08-12|||||1969-01-27||1960-04-13|Y|1971-01-16
TRIAL STUDY 134XCP|LB|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|1||||KCLR|POTASSIUM CLEARANCE|||||||ML/G/H|||||||POSITIVE||FOZ_BR||||ABNORMAL|NOT DONE||||CALCULUS|SOLIDIFIED|Y|VENTILATION PERFUSION LUNG SCAN|CKD-EPI CREATININE FORMULA||NA|Y|N|N|||Y|4||88||INDUCTION TREATMENT|1970-11-17|1968-09-18|||||1965-07-15||1960-07-18|NA|1967-03-18
TRIAL STUDY 134XCP|LB|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|2||||HDWR|RET HEMOGLOBIN DISTRIBUTION WIDTH|||||||10^3/HPF|||||||INVALID||UG/L FEU||||HIGH|NOT DONE||||ADIPOSE TISSUE|FRESH|NA|KINETIC CHROMOGENIC ASSAY|MDRD 6 VARIABLE FORMULA||N|U|Y|N|||NA|4||88||LONG-TERM FOLLOW-UP|1968-05-07|1972-10-29|||||1967-04-16||1965-11-14|NA|1961-07-19
TRIAL STUDY 134XCP|LB|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|1||||PSIGMAB|PHOSPHATIDYLSERINE IGM ANTIBODY|||||||STRIP|||||||INVALID||ENZYME U||||LOW|NOT DONE||||SYNOVIAL FLUID|LIPEMIC|U|APPLANATION TONOMETRY|CKD-EPI CYSTATIN C FORMULA||U|Y|U|NA|||Y|5||7||WASHOUT|1960-10-08|1965-03-29|||||1960-08-06||1963-10-23|NA|1967-01-05
TRIAL STUDY 134XCP|LB|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|2||||APTT|ACTIVATED PARTIAL THROMBOPLASTIN TIME|||||||UGEQ|||||||BORDERLINE||PG/L||||NORMAL|NOT DONE||||SKIN TISSUE|FRESH|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|HEPASCORE FORMULA||Y|NA|Y|U|||Y|5||7||BASELINE|1965-01-24|1969-04-02|||||1962-02-25||1970-10-26|Y|1962-11-27
TRIAL STUDY 134XCP|LB|707FC46F-B8B1-456B-9E09-CABC86EA61D5|1||||CYMSU|MONOSODIUM URATE CRYSTALS|||||||FMOL/G|||||||INDETERMINATE||MBQ||||HIGH|NOT DONE||||BONE|AGGLUTINATED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|NA|Y|||Y|1||38||CONTINUATION TREATMENT|1966-07-10|1970-09-17|||||1963-12-03||1965-08-23|U|1973-01-24
TRIAL STUDY 134XCP|LB|707FC46F-B8B1-456B-9E09-CABC86EA61D5|2||||FACTVIII|FACTOR VIII|||||||CIGARETTE|||||||BORDERLINE||NFIU||||LOW|NOT DONE||||NAIL|PARAFFIN-EMBEDDED|NA|CRYOSCOPY|FIBROMETER FORMULA||N|U|Y|NA|||U|1||38||WASHOUT|1965-07-14|1966-05-21|||||1967-07-08||1960-05-02|Y|1966-06-02
TRIAL STUDY 134XCP|LB|707FC46F-B8B1-456B-9E09-CABC86EA61D5|1||||CONSIST|CONSISTENCY|||||||ML/CAGE|||||||INDETERMINATE||/H||||NORMAL|NOT DONE||||LAVAGE FLUID|LIPEMIC|U|COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD 4 VARIABLE FORMULA||U|U|U|N|||U|2||58||INDUCTION TREATMENT|1964-06-29|1966-06-25|||||1965-05-23||1970-09-18|U|1969-11-02
TRIAL STUDY 134XCP|LB|707FC46F-B8B1-456B-9E09-CABC86EA61D5|2||||CCL23|CHEMOKINE (C-C MOTIF) LIGAND 23|||||||UG/M2|||||||INDETERMINATE||MU||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|AGGLUTINATED|Y|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|FIBROSIS 4 FORMULA||Y|NA|NA|NA|||N|2||58||BLINDED TREATMENT|1966-03-03|1964-03-29|||||1968-06-06||1963-08-11|NA|1970-04-01
TRIAL STUDY 134XCP|LB|707FC46F-B8B1-456B-9E09-CABC86EA61D5|1||||EAGLUC|GLUCOSE, ESTIMATED AVERAGE|||||||CM/MIN|||||||TRACE||UMOL/DL||||HIGH|NOT DONE||||LUNG SURFACTANT|ICTERIC|Y|FREEZING POINT DEPRESSION|MDRD 4 VARIABLE FORMULA||NA|N|NA|N|||N|3||39||SCREENING|1971-08-27|1967-11-05|||||1972-01-16||1971-09-14|Y|1961-05-27
TRIAL STUDY 134XCP|LB|707FC46F-B8B1-456B-9E09-CABC86EA61D5|2||||ALBGALB|GLYCATED ALBUMIN/ALBUMIN|||||||G/U|||||||INDETERMINATE||U/G/H||||LOW|NOT DONE||||FLUID|UNEXPECTED ODOR|U|ELECTROGASTROGRAPHY|ASH FIBROSURE FORMULA||U|Y|U|Y|||Y|3||39||TREATMENT|1967-04-17|1967-07-20|||||1969-03-21||1966-05-23|U|1964-09-01
TRIAL STUDY 134XCP|LB|707FC46F-B8B1-456B-9E09-CABC86EA61D5|1||||LAG3S|SOLUBLE LYMPHOCYTE ACTIVATION GENE-3|||||||UV2|||||||TRACE||CAPFUL||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|AGGLUTINATED|Y|ACCELERATOR MASS SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|NA|N|||NA|4||88||OPEN LABEL TREATMENT|1966-12-14|1968-08-16|||||1960-10-19||1967-06-11|Y|1971-01-17
TRIAL STUDY 134XCP|LB|707FC46F-B8B1-456B-9E09-CABC86EA61D5|2||||LCHLCM|LITHOCHOLATE COMPOUNDS|||||||MKAT|||||||INDETERMINATE||G/MOL||||HIGH|NOT DONE||||PLATELET|LACTESCENT|NA|AUSCULTATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|NA|Y|||U|4||88||INDUCTION TREATMENT|1962-07-23|1962-01-03|||||1960-12-23||1963-11-25|N|1967-06-03
TRIAL STUDY 134XCP|LB|707FC46F-B8B1-456B-9E09-CABC86EA61D5|1||||NEUTSGNE|NEUTROPHILS, SEGMENTED/NEUTROPHILS|||||||PMOL/10^9 CELLS|||||||NEGATIVE||ANSON U||||HIGH|NOT DONE||||AQUEOUS HUMOR|THAWED|U|FLOCCULATION, CHARCOAL ENHANCED|HEPASCORE FORMULA||N|U|U|N|||U|5||7||CONTINUATION TREATMENT|1971-01-26|1963-08-25|||||1960-10-03||1960-09-14|N|1969-06-13
TRIAL STUDY 134XCP|LB|707FC46F-B8B1-456B-9E09-CABC86EA61D5|2||||FACTXIA|FACTOR XI ACTIVITY|||||||RING|||||||INVALID||SV||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|SOLIDIFIED|N|HEMOCYTOMETRY|CKD-EPI FORMULA||N|N|N|N|||U|5||7||INDUCTION TREATMENT|1964-05-13|1969-08-11|||||1966-01-03||1966-07-14|N|1972-05-16
TRIAL STUDY 134XCP|LB|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|1||||AMCRMRNA|AMACR MRNA|||||||TBSP|||||||TRACE||NMOL BCE/NMOL||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|ICTERIC|U|URANYL ACETATE STAIN|MDRD ENZYMATIC FORMULA||NA|N|NA|N|||N|1||38||LONG-TERM FOLLOW-UP|1969-09-17|1969-01-04|||||1961-11-03||1971-01-09|U|1972-12-01
TRIAL STUDY 134XCP|LB|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|2||||SAHOMC|S-ADENOSYLHOMOCYSTEINE|||||||UCI/L|||||||INVALID||OSM||||ABNORMAL|NOT DONE||||COLOSTRUM|FRESH|U|IMPULSE OSCILLOMETRY|FIBROTEST FORMULA||N|Y|U|U|||NA|1||38||OPEN LABEL TREATMENT|1966-08-04|1967-04-23|||||1970-06-10||1964-09-22|NA|1965-10-12
TRIAL STUDY 134XCP|LB|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|1||||PROLCTN|PROLACTIN|||||||G/L|||||||TRACE||BAU/ML||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|LIPEMIC|N|AUDIOMETRY|GMI MMOL/MOL FORMULA||Y|U|U|Y|||Y|2||58||CONTINUATION TREATMENT|1965-05-03|1970-01-17|||||1969-06-20||1965-09-19|U|1961-10-29
TRIAL STUDY 134XCP|LB|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|2||||CYHGBC|HEMOGLOBIN C CRYSTALS|||||||10^6 U|||||||INDETERMINATE||MG/ANIMAL||||ABNORMAL|NOT DONE||||RETICULOCYTES|ICTERIC|N|IMMUNOFIXATION ELECTROPHORESIS|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|N|||U|2||58||TREATMENT|1961-03-04|1968-10-01|||||1966-06-28||1965-11-28|N|1964-11-20
TRIAL STUDY 134XCP|LB|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|1||||CD79A|CD79A|||||||LOZENGE|||||||TRACE||KEV||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|ROOM TEMPERATURE|NA|IMMUNOFLUORESCENT STAIN|MDRD FORMULA||NA|N|U|NA|||NA|3||39||RUN-IN|1973-01-29|1960-09-30|||||1963-02-02||1964-11-18|Y|1969-08-23
TRIAL STUDY 134XCP|LB|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|2||||CCL12|CHEMOKINE (C-C MOTIF) LIGAND 12|||||||PMOL/10^10 CELLS|||||||INVALID||UG/M2/MIN||||NORMAL|NOT DONE||||REFLEX TEAR|LIPEMIC|NA|TRIPLE-PHASE SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA||NA|N|NA|Y|||NA|3||39||SCREENING|1964-08-06|1973-01-09|||||1965-11-05||1966-02-25|U|1962-08-13
TRIAL STUDY 134XCP|LB|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|1||||GDA|GUANINE DEAMINASE|||||||U/G/H|||||||POSITIVE||LOG10 COPIES/ML||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|THAWED|NA|IMMUNORADIOMETRIC ASSAY|MDRD 5 VARIABLE FORMULA||NA|NA|N|N|||NA|4||88||INDUCTION TREATMENT|1966-07-22|1973-05-23|||||1960-04-30||1961-09-11|U|1971-04-02
TRIAL STUDY 134XCP|LB|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|2||||MMIF|MACROPHAGE MIGRATION INHIBITORY FACTOR|||||||10^8 PFU|||||||INDETERMINATE||PT_BR||||LOW|NOT DONE||||PLATELET POOR PLASMA|LACTESCENT|NA|LAPAROSCOPY|MDRD 5 VARIABLE FORMULA||Y|N|NA|NA|||NA|4||88||LONG-TERM FOLLOW-UP|1969-06-02|1968-02-29|||||1968-06-01||1967-04-08|NA|1971-06-20
TRIAL STUDY 134XCP|LB|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|1||||FGF23C|FIBROBLAST GROWTH FACTOR 23, C-TERMINAL|||||||MS2|||||||NEGATIVE||MPL U/ML||||LOW|NOT DONE||||SEBUM|NON-HEMOLYZED|U|ULTRASONOGRAPHIC ELASTOGRAPHY|FIBROMETER FORMULA||N|Y|N|N|||N|5||7||BASELINE|1967-06-29|1965-01-12|||||1963-06-30||1969-01-29|N|1962-08-03
TRIAL STUDY 134XCP|LB|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|2||||C165941|COMMON RAGWEED POLLEN IGE AB RAST SCORE|||||||ML/G/DAY|||||||INVALID||CIGAR||||NORMAL|NOT DONE||||ABSCESS FLUID|FRESH|U|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|N|NA|||N|5||7||OPEN LABEL TREATMENT|1972-12-25|1962-10-28|||||1964-07-21||1968-04-26|Y|1969-02-24
TRIAL STUDY 134XCP|LB|70196099-5D40-4048-AABF-EB40CE345328|1||||VITB6|VITAMIN B6|||||||MASK|||||||POSITIVE||ML/G/H||||LOW|NOT DONE||||EXPIRED AIR|LACTESCENT|N|PANENDOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|Y|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1968-11-20|1965-07-25|||||1964-12-19||1962-09-15|U|1960-04-09
TRIAL STUDY 134XCP|LB|70196099-5D40-4048-AABF-EB40CE345328|2||||BACT|BACTERIA|||||||PT_BR|||||||POSITIVE||L/MIN/M2||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|REFRIGERATED|NA|PERIPHERAL ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|U|U|||N|1||38||INDUCTION TREATMENT|1960-10-03|1961-05-25|||||1964-09-19||1972-09-07|N|1960-05-17
TRIAL STUDY 134XCP|LB|70196099-5D40-4048-AABF-EB40CE345328|1||||MBP|MYELIN BASIC PROTEIN|||||||PUFF|||||||BORDERLINE||BU/ML||||HIGH|NOT DONE||||VITREOUS HUMOR|DRIED|NA|DYNAMOMETRY|CKD-EPI CYSTATIN C FORMULA||U|NA|U|Y|||Y|2||58||BLINDED TREATMENT|1970-05-20|1961-03-04|||||1969-01-08||1963-07-01|N|1960-06-06
TRIAL STUDY 134XCP|LB|70196099-5D40-4048-AABF-EB40CE345328|2||||GFRBSCRT|GFR FROM CREATININE ADJUSTED FOR BSA|||||||UM/S|||||||TRACE||MBQ||||NORMAL|NOT DONE||||SPERMATOZOON|PARAFFIN-EMBEDDED|NA|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|FIBROMETER FORMULA||Y|NA|U|NA|||U|2||58||INDUCTION TREATMENT|1968-09-15|1966-04-06|||||1967-10-08||1966-03-14|Y|1964-07-22
TRIAL STUDY 134XCP|LB|70196099-5D40-4048-AABF-EB40CE345328|1||||LACTULOS|LACTULOSE|||||||CPM|||||||POSITIVE||UMOL||||ABNORMAL|NOT DONE||||SPERMATOZOON|CONTAMINATED|N|IMPEDANCE CONDUCTIVITY|MDRD ENZYMATIC FORMULA||Y|N|U|NA|||Y|3||39||OBSERVATION|1961-03-30|1963-09-10|||||1962-04-26||1970-04-19|U|1964-10-19
TRIAL STUDY 134XCP|LB|70196099-5D40-4048-AABF-EB40CE345328|2||||PMYCECE|PROLIFERATING MYELOID CELLS/TOTAL CELLS|||||||10^9 ORGANISMS/MG|||||||BORDERLINE||COPIES/UL||||LOW|NOT DONE||||ALVEOLAR AIR|DRIED|U|WHOLE TRANSCRIPTOME SEQUENCING|GMI MMOL/MOL FORMULA||N|U|N|Y|||NA|3||39||BASELINE|1968-10-12|1969-09-26|||||1964-07-01||1962-02-11|N|1961-11-18
TRIAL STUDY 134XCP|LB|70196099-5D40-4048-AABF-EB40CE345328|1||||PECAM|PLATELET ENDOTHELIAL ADHESION MOLECULE|||||||SFC/10^6 PBMC|||||||TRACE||MM||||LOW|NOT DONE||||DISCHARGE|AUTOLYZED|N|BETA LACTAMASE|MDRD 4 VARIABLE FORMULA||N|Y|Y|U|||U|4||88||OBSERVATION|1963-11-28|1973-06-10|||||1970-02-01||1964-03-26|Y|1965-10-06
TRIAL STUDY 134XCP|LB|70196099-5D40-4048-AABF-EB40CE345328|2||||HYDCDN|HYDROCODONE|||||||/500 WBC|||||||INVALID||G/CM2||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|CONCENTRATED|U|PERFUSION MRI|MDRD 5 VARIABLE FORMULA||N|NA|NA|N|||U|4||88||FOLLOW-UP|1970-06-24|1964-01-05|||||1966-10-02||1970-11-06|U|1971-09-01
TRIAL STUDY 134XCP|LB|70196099-5D40-4048-AABF-EB40CE345328|1||||CXCL10|CHEMOKINE (C-X-C MOTIF) LIGAND 10|||||||NM|||||||INDETERMINATE||GY||||HIGH|NOT DONE||||EXUDATE|CONCENTRATED|N|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|U|NA|||N|5||7||SCREENING|1973-04-29|1964-03-25|||||1964-03-18||1972-12-27|Y|1973-06-19
TRIAL STUDY 134XCP|LB|70196099-5D40-4048-AABF-EB40CE345328|2||||C165890|TIMOTHY GRASS POLLEN IGE AB RAST SCORE|||||||ML/MMHG|||||||NEGATIVE||TBSP||||ABNORMAL|NOT DONE||||HAIR|REFRIGERATED|NA|GRAM STAIN|GMI MMOL/MOL FORMULA||Y|N|Y|U|||U|5||7||OPEN LABEL TREATMENT|1971-10-05|1964-11-06|||||1963-04-16||1966-02-18|N|1968-11-10
TRIAL STUDY 134XCP|LB|F9D4C544-F217-4676-AC40-F71CC48045AF|1||||UDCACM|URSODEOXYCHOLATE COMPOUNDS|||||||PHERESIS UNIT|||||||NEGATIVE||TORR||||LOW|NOT DONE||||ABSCESS FLUID|GELLED|Y|MALDI|HEPASCORE FORMULA||Y|Y|Y|N|||Y|1||38||RUN-IN|1969-05-04|1964-04-05|||||1960-12-11||1965-03-25|Y|1960-05-14
TRIAL STUDY 134XCP|LB|F9D4C544-F217-4676-AC40-F71CC48045AF|2||||PTF1_2|PROTHROMBIN FRAGMENTS 1 + 2|||||||ROENTGEN|||||||INDETERMINATE||MV*MIN||||ABNORMAL|NOT DONE||||MUCUS|ICTERIC|N|CLIP|CKD-EPI CREATININE FORMULA||N|N|U|U|||Y|1||38||RUN-IN|1963-06-07|1962-07-14|||||1965-07-29||1964-03-02|NA|1968-06-07
TRIAL STUDY 134XCP|LB|F9D4C544-F217-4676-AC40-F71CC48045AF|1||||C130111|MOLD MIX ANTIGEN IGA ANTIBODY|||||||ENZYME U/G HB|||||||POSITIVE||DIP||||LOW|NOT DONE||||BREAST MILK|FROZEN|U|PHOTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||U|NA|Y|Y|||N|2||58||TREATMENT|1973-02-14|1964-01-25|||||1972-09-21||1970-12-07|NA|1967-11-19
TRIAL STUDY 134XCP|LB|F9D4C544-F217-4676-AC40-F71CC48045AF|2||||GAD1|GLUTAMIC ACID DECARBOXYLASE 1|||||||PMOL/10^10 CELLS|||||||INVALID||PACKAGE||||LOW|NOT DONE||||INTERSTITIAL FLUID|LIPEMIC|NA|AURAMINE STAIN|COCKCROFT-GAULT FORMULA||N|N|N|Y|||Y|2||58||WASHOUT|1960-08-05|1972-11-21|||||1969-01-14||1962-06-23|Y|1972-09-18
TRIAL STUDY 134XCP|LB|F9D4C544-F217-4676-AC40-F71CC48045AF|1||||UROTHCE|UROTHELIAL CELLS|||||||ML/BREATH|||||||INVALID||M3||||LOW|NOT DONE||||LEUKOCYTE|CONTAMINATED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|NASH FIBROSURE FORMULA||NA|Y|N|Y|||Y|3||39||BASELINE|1964-12-04|1965-07-11|||||1967-05-27||1971-08-14|U|1969-12-12
TRIAL STUDY 134XCP|LB|F9D4C544-F217-4676-AC40-F71CC48045AF|2||||C165879|D. FARINAE IGE AB RAST SCORE|||||||DDU|||||||BORDERLINE||BOTTLE||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|REFRIGERATED|NA|MICROBIAL CULTURE|CKD-EPI CYSTATIN C FORMULA||NA|U|N|Y|||N|3||39||CONTINUATION TREATMENT|1970-05-27|1966-08-14|||||1963-06-26||1960-01-11|NA|1968-12-26
TRIAL STUDY 134XCP|LB|F9D4C544-F217-4676-AC40-F71CC48045AF|1||||ORNITHIN|ORNITHINE|||||||MM/MIN|||||||POSITIVE||MMHG||||NORMAL|NOT DONE||||PLATELET|THAWED|NA|MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI FORMULA||Y|NA|U|NA|||U|4||88||FOLLOW-UP|1969-12-13|1972-11-26|||||1961-05-23||1965-12-27|Y|1962-11-27
TRIAL STUDY 134XCP|LB|F9D4C544-F217-4676-AC40-F71CC48045AF|2||||NEUTVAC|VACUOLATED NEUTROPHILS|||||||L/KG|||||||INVALID||CAPFUL||||ABNORMAL|NOT DONE||||RETICULOCYTES|SOLIDIFIED|NA|SPECT/CT SCAN|COCKCROFT-GAULT FORMULA||U|Y|NA|N|||U|4||88||BLINDED TREATMENT|1973-08-21|1962-06-26|||||1967-09-23||1973-09-05|NA|1962-12-05
TRIAL STUDY 134XCP|LB|F9D4C544-F217-4676-AC40-F71CC48045AF|1||||DOHLE|DOHLE BODIES|||||||/2500 WBC|||||||INVALID||VIAL||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|HEMOLYZED|NA|IN SITU HYBRIDIZATION|HEPASCORE FORMULA||Y|NA|Y|N|||Y|5||7||OBSERVATION|1964-09-08|1960-12-22|||||1962-03-29||1963-12-03|U|1971-02-28
TRIAL STUDY 134XCP|LB|F9D4C544-F217-4676-AC40-F71CC48045AF|2||||CLCREAT|CHLORIDE/CREATININE|||||||%(V/V)|||||||TRACE||SFC/10^6 PBMC||||ABNORMAL|NOT DONE||||LEUKOCYTE|NON-HEMOLYZED|Y|MOUSE PROTECTION ASSAY|NASH FIBROSURE FORMULA||N|N|NA|N|||Y|5||7||FOLLOW-UP|1970-12-21|1962-04-06|||||1961-07-15||1960-12-15|Y|1968-12-24
TRIAL STUDY 134XCP|LB|E6A42133-B082-4BD7-B840-A60E49E0562B|1||||TXB2_D11|11-DEHYDRO-THROMBOXANE B2|||||||MEQ/DL|||||||POSITIVE||ML/S/M2||||NORMAL|NOT DONE||||PLEURAL TISSUE|ROOM TEMPERATURE|Y|MRS|COCKCROFT-GAULT FORMULA||N|N|Y|U|||NA|1||38||TREATMENT|1972-01-09|1964-12-12|||||1962-10-05||1960-03-23|U|1966-11-14
TRIAL STUDY 134XCP|LB|E6A42133-B082-4BD7-B840-A60E49E0562B|2||||GLDIGGAB|GLIADIN IGG ANTIBODY|||||||MEQ/DAY|||||||INDETERMINATE||UG/G/DAY||||HIGH|NOT DONE||||SEMEN|CONTAMINATED|N|JAFFE REACTION|MDRD ENZYMATIC JAPANESE FORMULA||N|U|N|NA|||N|1||38||CONTINUATION TREATMENT|1966-06-05|1966-06-21|||||1967-09-03||1962-01-20|N|1967-02-07
TRIAL STUDY 134XCP|LB|E6A42133-B082-4BD7-B840-A60E49E0562B|1||||ETPLT|ETP LAG TIME|||||||U/M2/MIN|||||||INDETERMINATE||ELISA UNIT||||NORMAL|NOT DONE||||TISSUE|SOLIDIFIED|N|MICRODENSITOMETRY|ASH FIBROSURE FORMULA||NA|U|N|NA|||N|2||58||RUN-IN|1973-06-02|1970-06-02|||||1966-06-18||1960-09-15|U|1965-07-30
TRIAL STUDY 134XCP|LB|E6A42133-B082-4BD7-B840-A60E49E0562B|2||||GFRBSCCC|GFR FROM CYSTATIN C AND CREAT ADJ BSA|||||||/SEC|||||||INVALID||MPL U||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|FROZEN|N|ISHIHARA COLOR PLATES|CKD-EPI CYSTATIN C FORMULA||U|Y|U|Y|||NA|2||58||SCREENING|1970-12-12|1969-05-29|||||1961-09-28||1968-12-08|N|1961-10-13
TRIAL STUDY 134XCP|LB|E6A42133-B082-4BD7-B840-A60E49E0562B|1||||PRAB|PANEL REACTIVE ANTIBODY|||||||USIEMENS|||||||TRACE||UG/ANIMAL||||ABNORMAL|NOT DONE||||SMEGMA|LACTESCENT|NA|HPLC/IEX|CKD-EPI CREATININE FORMULA||Y|NA|Y|U|||Y|3||39||OPEN LABEL TREATMENT|1968-07-08|1971-04-27|||||1960-03-05||1973-02-10|NA|1967-02-08
TRIAL STUDY 134XCP|LB|E6A42133-B082-4BD7-B840-A60E49E0562B|2||||BTK|BRUTON'S TYROSINE KINASE|||||||%/S|||||||NEGATIVE||NL||||HIGH|NOT DONE||||SEMINAL FLUID|HEMOLYZED|Y|DIFFUSION WEIGHTED MRI|MDRD FORMULA||U|NA|N|N|||Y|3||39||INDUCTION TREATMENT|1963-06-09|1966-12-28|||||1963-07-30||1972-07-16|Y|1960-09-08
TRIAL STUDY 134XCP|LB|E6A42133-B082-4BD7-B840-A60E49E0562B|1||||PEPSNGC|PEPSINOGEN C|||||||CMHG|||||||BORDERLINE||/100 WBC||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|CLOTTED|NA|FUNDUS PHOTOGRAPHY|COCKCROFT-GAULT FORMULA||N|NA|U|NA|||NA|4||88||TREATMENT|1965-08-12|1965-02-06|||||1968-06-23||1960-12-08|NA|1968-07-15
TRIAL STUDY 134XCP|LB|E6A42133-B082-4BD7-B840-A60E49E0562B|2||||TROPONT|TROPONIN T|||||||UG/KG|||||||INVALID||/100 WBC||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|GELLED|NA|HPLC/IEX|MDRD 6 VARIABLE FORMULA||Y|NA|NA|NA|||NA|4||88||TREATMENT|1968-11-01|1964-08-17|||||1967-10-02||1970-09-08|U|1967-09-20
TRIAL STUDY 134XCP|LB|E6A42133-B082-4BD7-B840-A60E49E0562B|1||||C165889|RUSSIAN THISTLE POLLEN IGE AB RAST SCORE|||||||UM2|||||||TRACE||KG/CM2||||ABNORMAL|NOT DONE||||KERATINOCYTE|SOLIDIFIED|NA|PHOTOMETRIC CLOT DETECTION|GMI MMOL/MOL FORMULA||N|Y|U|Y|||U|5||7||CONTINUATION TREATMENT|1964-12-25|1973-03-25|||||1960-05-19||1960-03-02|N|1970-06-03
TRIAL STUDY 134XCP|LB|E6A42133-B082-4BD7-B840-A60E49E0562B|2||||LYMNSQE|LYMPHOCYTES/NON-SQUAM EPI CELLS|||||||V|||||||POSITIVE||MMU/ML||||NORMAL|NOT DONE||||AMNIOTIC FLUID|HEMOLYZED|N|SICKLE CELL SOLUBILITY TEST|MDRD 6 VARIABLE FORMULA||NA|N|N|N|||Y|5||7||WASHOUT|1967-11-25|1962-05-01|||||1970-09-03||1966-02-11|Y|1970-10-30
TRIAL STUDY 134XCP|LB|72C9FDBC-AA86-4001-9820-90AAF5422074|1||||LDH1|LDH ISOENZYME 1|||||||YEARS|||||||INDETERMINATE||HOUNSFIELD UNIT||||LOW|NOT DONE||||SYNOVIAL FLUID|REFRIGERATED|Y|COLORIMETRY|MDRD 4 VARIABLE FORMULA||Y|Y|Y|NA|||N|1||38||OPEN LABEL TREATMENT|1967-11-30|1963-08-28|||||1967-05-23||1961-12-11|Y|1961-04-24
TRIAL STUDY 134XCP|LB|72C9FDBC-AA86-4001-9820-90AAF5422074|2||||ASTCREAT|ASPARTATE AMINOTRANSFERASE/CREATININE|||||||10^6 CFU|||||||NEGATIVE||SQU/ML||||HIGH|NOT DONE||||PERSPIRATION|AGGLUTINATED|Y|AURAMINE STAIN|ASH FIBROSURE FORMULA||N|NA|N|N|||Y|1||38||LONG-TERM FOLLOW-UP|1970-10-21|1971-03-02|||||1965-03-15||1965-09-13|Y|1965-02-22
TRIAL STUDY 134XCP|LB|72C9FDBC-AA86-4001-9820-90AAF5422074|1||||ACE|ANGIOTENSIN CONVERTING ENZYME|||||||BAR|||||||INVALID||NMOL/DAY||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|GELLED|N|NUCLEAR RADIOLOGY|FIBROTEST FORMULA||N|NA|Y|U|||NA|2||58||TREATMENT|1965-10-03|1973-04-25|||||1962-10-21||1971-05-21|N|1960-11-12
TRIAL STUDY 134XCP|LB|72C9FDBC-AA86-4001-9820-90AAF5422074|2||||KIM1EXR|KIDNEY INJURY MOLECULE-1 EXCRETION RATE|||||||GRAVITATIONAL UNIT|||||||TRACE||G/KG/DAY||||HIGH|NOT DONE||||SEMINAL FLUID|CALCIFIED|U|AUTOREFRACTION|MDRD FORMULA||Y|N|N|NA|||N|2||58||BLINDED TREATMENT|1963-06-03|1962-01-13|||||1963-10-21||1966-01-27|U|1967-11-27
TRIAL STUDY 134XCP|LB|72C9FDBC-AA86-4001-9820-90AAF5422074|1||||CD3|CD3|||||||FFU|||||||BORDERLINE||G/ANIMAL/WK||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|NON-HEMOLYZED|U|LISSAMINE GREEN STAIN|MDRD FORMULA||NA|NA|N|N|||Y|3||39||SCREENING|1966-01-25|1967-05-26|||||1963-02-26||1967-09-30|NA|1961-01-25
TRIAL STUDY 134XCP|LB|72C9FDBC-AA86-4001-9820-90AAF5422074|2||||HRYCECE|HAIRY CELLS/TOTAL CELLS|||||||/MS|||||||TRACE||MOSM/KG||||NORMAL|NOT DONE||||EMOTIONAL TEAR|AGGLUTINATED|NA|INTRAVASCULAR ULTRASOUND|MDRD 4 VARIABLE FORMULA||N|Y|Y|U|||N|3||39||OBSERVATION|1969-02-22|1971-01-22|||||1971-05-22||1961-01-01|NA|1970-01-09
TRIAL STUDY 134XCP|LB|72C9FDBC-AA86-4001-9820-90AAF5422074|1||||MYBLA|MYELOBLASTS|||||||MET*MIN|||||||INDETERMINATE||UMOL/L||||LOW|NOT DONE||||SYNOVIAL FLUID|FROZEN|N|RADIATION DOSIMETRY|MDRD 5 VARIABLE FORMULA||NA|U|U|N|||U|4||88||OBSERVATION|1960-02-20|1968-12-26|||||1967-03-27||1962-10-16|U|1962-08-21
TRIAL STUDY 134XCP|LB|72C9FDBC-AA86-4001-9820-90AAF5422074|2||||EPINSQE|EPI CELLS/NON-SQUAM EPI CELLS|||||||PNU/ML|||||||POSITIVE||MBQ/UL||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|FRESH|NA|MACRO BROTH DILUTION|FIBROMETER FORMULA||N|Y|N|U|||NA|4||88||BASELINE|1965-04-20|1963-04-08|||||1964-08-31||1962-09-02|NA|1972-10-23
TRIAL STUDY 134XCP|LB|72C9FDBC-AA86-4001-9820-90AAF5422074|1||||MLIGCE|MALIGNANT CELLS, NOS|||||||UG/M2|||||||TRACE||BQ||||HIGH|NOT DONE||||HAIR FOLLICLE|NON-HEMOLYZED|N|IMMUNOCHROMATOGRAPHY|MDRD FORMULA||Y|U|U|N|||U|5||7||FOLLOW-UP|1967-07-02|1966-05-22|||||1968-05-18||1972-11-24|Y|1964-09-23
TRIAL STUDY 134XCP|LB|72C9FDBC-AA86-4001-9820-90AAF5422074|2||||NEOPTERN|NEOPTERIN|||||||10^6 IU/ML|||||||TRACE||10^9 CFU/ML||||LOW|NOT DONE||||PLATELET|AGGLUTINATED|N|REVERSE TRANSCRIPTASE PCR|COCKCROFT-GAULT FORMULA||NA|Y|U|N|||N|5||7||BLINDED TREATMENT|1970-03-02|1973-01-31|||||1961-04-26||1967-03-11|N|1970-01-19
TRIAL STUDY 134XCP|LB|186520B9-8AAD-4063-B48F-16040EF49944|1||||APTT|ACTIVATED PARTIAL THROMBOPLASTIN TIME|||||||PFU|||||||INVALID||UMOL/L/MIN||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|DRIED|U|IMMUNE REPERTOIRE DEEP SEQUENCING|CKD-EPI FORMULA||NA|NA|NA|U|||U|1||38||SCREENING|1960-08-02|1970-04-10|||||1962-10-16||1967-03-24|Y|1961-10-06
TRIAL STUDY 134XCP|LB|186520B9-8AAD-4063-B48F-16040EF49944|2||||ACYGLYCN|ACYLGLYCINE|||||||UV|||||||NEGATIVE||CAL||||LOW|NOT DONE||||SERUM|CALCIFIED|Y|CYSTOSCOPY|COCKCROFT-GAULT FORMULA||Y|U|Y|NA|||U|1||38||INDUCTION TREATMENT|1971-04-30|1971-11-13|||||1972-08-26||1966-12-23|U|1970-04-26
TRIAL STUDY 134XCP|LB|186520B9-8AAD-4063-B48F-16040EF49944|1||||PUS|PUS|||||||ENZYME U/G HB|||||||POSITIVE||INHALATION||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|HEMOLYZED|Y|ELECTROPHORESIS|GMI MMOL/MOL FORMULA||N|N|NA|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1965-08-20|1961-11-12|||||1962-06-14||1966-07-10|Y|1961-03-11
TRIAL STUDY 134XCP|LB|186520B9-8AAD-4063-B48F-16040EF49944|2||||C130074|BIRCH POLLEN IGG|||||||UL|||||||TRACE||USEC||||HIGH|NOT DONE||||COLOSTRUM|HEMOLYZED|Y|GC/FID|CKD-EPI CYSTATIN C FORMULA||Y|U|U|NA|||NA|2||58||WASHOUT|1973-03-07|1968-08-30|||||1966-03-25||1967-07-19|N|1971-03-01
TRIAL STUDY 134XCP|LB|186520B9-8AAD-4063-B48F-16040EF49944|1||||LYMIMLE|IMMATURE LYMPHOCYTES/LEUKOCYTES|||||||MET*H|||||||BORDERLINE||G/M2/DAY||||NORMAL|NOT DONE||||ADIPOSE TISSUE|THAWED|NA|ERGOSPIROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|NA|N|||NA|3||39||OBSERVATION|1961-09-28|1972-11-18|||||1969-04-11||1968-02-14|NA|1966-10-29
TRIAL STUDY 134XCP|LB|186520B9-8AAD-4063-B48F-16040EF49944|2||||FCTVIIIA|FACTOR VIII ACTIVITY|||||||MM/SEC|||||||TRACE||U/DL||||ABNORMAL|NOT DONE||||SEBUM|CALCIFIED|U|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|COCKCROFT-GAULT FORMULA||Y|N|U|U|||Y|3||39||RUN-IN|1964-04-22|1971-10-19|||||1961-05-10||1967-11-30|Y|1966-10-24
TRIAL STUDY 134XCP|LB|186520B9-8AAD-4063-B48F-16040EF49944|1||||PNCTPP|PANCREATIC POLYPEPTIDE|||||||ML/G/DAY|||||||NEGATIVE||BEL||||HIGH|NOT DONE||||FLUID|NON-HEMOLYZED|U|ICC|GMI % FORMULA||NA|U|NA|N|||NA|4||88||OPEN LABEL TREATMENT|1970-08-29|1965-08-23|||||1970-05-11||1970-11-06|NA|1971-04-23
TRIAL STUDY 134XCP|LB|186520B9-8AAD-4063-B48F-16040EF49944|2||||LYSOZYME|LYSOZYME|||||||EID 50/DOSE|||||||BORDERLINE||G/KG||||NORMAL|NOT DONE||||LOCHIA|HEMOLYZED|N|OPTICAL DENSITY MEASUREMENT|CKD-EPI CREATININE FORMULA||N|N|U|Y|||Y|4||88||INDUCTION TREATMENT|1963-05-25|1964-01-08|||||1969-02-20||1966-05-21|N|1963-10-02
TRIAL STUDY 134XCP|LB|186520B9-8AAD-4063-B48F-16040EF49944|1||||UDCACM|URSODEOXYCHOLATE COMPOUNDS|||||||UM/S|||||||NEGATIVE||CG||||LOW|NOT DONE||||PLASMA|FRESH|U|COMPLEMENT FIXATION|GMI MMOL/MOL FORMULA||U|Y|Y|Y|||NA|5||7||SCREENING|1972-11-04|1969-03-28|||||1967-10-23||1970-11-09|N|1965-08-02
TRIAL STUDY 134XCP|LB|186520B9-8AAD-4063-B48F-16040EF49944|2||||PYK|PYRUVATE KINASE|||||||UG/DAY|||||||TRACE||AMU||||LOW|NOT DONE||||SWABBED MATERIAL|REFRIGERATED|U|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|Y|U|||NA|5||7||TREATMENT|1966-04-11|1962-09-04|||||1970-04-19||1966-04-28|Y|1971-12-20
TRIAL STUDY 134XCP|LB|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|1||||ALLOILE|ALLOISOLEUCINE|||||||FARAD|||||||INVALID||DNA COPIES/UG||||HIGH|NOT DONE||||WHITE MATTER TISSUE|HEMOLYZED|Y|VENTILATION PERFUSION LUNG SCAN|FIBROTEST FORMULA||Y|U|NA|Y|||U|1||38||OBSERVATION|1964-12-04|1970-05-21|||||1971-09-24||1971-05-13|U|1971-12-19
TRIAL STUDY 134XCP|LB|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|2||||DOPAC|3,4-DIHYDROXYPHENYLACETIC ACID|||||||PT_US|||||||POSITIVE||YEARS||||ABNORMAL|NOT DONE||||SPERMATOZOON|THAWED|N|GC/MS|GMI MMOL/MOL FORMULA||Y|N|Y|N|||Y|1||38||SCREENING|1965-10-22|1960-05-03|||||1970-08-30||1963-11-23|N|1972-07-25
TRIAL STUDY 134XCP|LB|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|1||||PAPPEN|PAPPENHEIMER BODIES|||||||10^11/L|||||||BORDERLINE||MV*MIN||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|ICTERIC|Y|TELLER ACUITY CARDS|NASH FIBROSURE FORMULA||N|NA|N|NA|||NA|2||58||OBSERVATION|1969-10-29|1971-03-10|||||1971-05-13||1962-04-16|NA|1962-09-27
TRIAL STUDY 134XCP|LB|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|2||||HCGFR|CHORIOGONADOTROPIN BETA, FREE|||||||UMOL/MG/MIN|||||||POSITIVE||U/M2/DAY||||LOW|NOT DONE||||TUMOR TISSUE|CALCIFIED|NA|CENTRIFUGATION|MDRD 6 VARIABLE FORMULA||U|Y|Y|Y|||U|2||58||OBSERVATION|1966-12-05|1963-11-27|||||1964-10-17||1962-01-17|Y|1971-06-30
TRIAL STUDY 134XCP|LB|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|1||||FACTIII|FACTOR III|||||||LOZENGE|||||||BORDERLINE||IU/DL||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED|NA|CRYOSCOPY|FIBROMETER FORMULA||Y|Y|Y|N|||N|3||39||BLINDED TREATMENT|1970-12-03|1965-11-13|||||1971-08-24||1964-03-09|N|1961-01-14
TRIAL STUDY 134XCP|LB|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|2||||PCSK9|PROPROTEIN CONVERTASE SUBTILISIN/KEXIN 9|||||||MG/M2/DAY|||||||POSITIVE||DNA COPIES/ML||||LOW|NOT DONE||||LUNG SURFACTANT|NON-HEMOLYZED|Y|CISH|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|Y|||Y|3||39||RUN-IN|1972-10-15|1967-11-17|||||1963-01-26||1971-11-14|U|1960-12-05
TRIAL STUDY 134XCP|LB|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|1||||UNSPCECE|UNSPECIFIED CELLS/TOTAL CELLS|||||||OZ EQ|||||||NEGATIVE||ELISA UNIT||||HIGH|NOT DONE||||VENOUS PLASMA|REFRIGERATED|NA|AGAR DILUTION|FIBROSIS 4 FORMULA||Y|U|NA|N|||NA|4||88||OPEN LABEL TREATMENT|1972-03-18|1966-08-26|||||1968-11-03||1969-11-27|Y|1965-08-26
TRIAL STUDY 134XCP|LB|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|2||||INTLK29|INTERLEUKIN 29|||||||NU/CL|||||||NEGATIVE||CAPLET||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|UNEXPECTED ODOR|NA|FLOW CYTOMETRY|FIBROMETER FORMULA||NA|U|NA|N|||Y|4||88||INDUCTION TREATMENT|1966-06-03|1964-04-12|||||1967-11-09||1972-03-10|U|1964-05-09
TRIAL STUDY 134XCP|LB|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|1||||TRACP5B|TARTRATE-RESISTANT ACID PHOSPHATASE 5B|||||||10^3 CFU|||||||BORDERLINE||UCI/KG||||ABNORMAL|NOT DONE||||HAIR|THAWED|N|RAJI CELL RIA|ASH FIBROSURE FORMULA||NA|NA|N|N|||U|5||7||BASELINE|1972-02-09|1963-08-28|||||1968-12-17||1964-07-03|NA|1960-04-24
TRIAL STUDY 134XCP|LB|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|2||||PORPH|PORPHYRIN|||||||IU/DL|||||||TRACE||BU||||HIGH|NOT DONE||||GASTRIC FLUID|UNEXPECTED ODOR|Y|CENTRIFUGATION|FIBROSIS 4 FORMULA||N|Y|Y|U|||NA|5||7||OBSERVATION|1963-07-29|1962-01-20|||||1972-09-28||1967-10-26|NA|1972-06-29
TRIAL STUDY 134XCP|LB|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|1||||ETPLTR|ETP LAG TIME RELATIVE|||||||LX|||||||INDETERMINATE||TUBERCULIN UNIT/ML||||ABNORMAL|NOT DONE||||LAVAGE FLUID|CONCENTRATED|U|DYNAMIC CONTRAST ENHANCED MRI|FIBROTEST FORMULA||N|NA|Y|Y|||U|1||38||WASHOUT|1972-06-04|1967-10-01|||||1962-07-13||1972-12-31|Y|1960-06-26
TRIAL STUDY 134XCP|LB|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|2||||PLAT|PLATELETS|||||||COPIES/UL|||||||TRACE||UG/CM2||||NORMAL|NOT DONE||||KERATINOCYTE|HEMOLYZED|U|TRICHROME STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|NA|NA|||NA|1||38||BASELINE|1969-12-16|1962-05-11|||||1967-06-05||1968-10-05|Y|1963-09-06
TRIAL STUDY 134XCP|LB|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|1||||C165922|MIXED ANTIGEN IGE AB RAST SCORE|||||||MG/KG/DAY|||||||BORDERLINE||UIU/L||||NORMAL|NOT DONE||||SEMINAL FLUID|PARAFFIN-EMBEDDED|N|BETA LACTAMASE|MDRD 6 VARIABLE FORMULA||N|N|Y|Y|||N|2||58||LONG-TERM FOLLOW-UP|1973-06-29|1966-03-17|||||1960-01-03||1967-02-26|U|1966-01-01
TRIAL STUDY 134XCP|LB|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|2||||HLAAAGT|HLA-A ANTIGEN TYPE|||||||KHZ|||||||INVALID||TUBERCULIN UNIT/ML||||LOW|NOT DONE||||ALVEOLAR AIR|SOLIDIFIED|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|CKD-EPI FORMULA||NA|U|N|Y|||N|2||58||RUN-IN|1969-05-08|1960-04-12|||||1968-02-16||1969-03-17|N|1960-05-21
TRIAL STUDY 134XCP|LB|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|1||||TXB2_D11|11-DEHYDRO-THROMBOXANE B2|||||||USIEMENS|||||||INVALID||U/M2/MIN||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED|Y|REFLECTANCE SPECTROSCOPY|GMI MMOL/MOL FORMULA||U|N|U|U|||Y|3||39||CONTINUATION TREATMENT|1967-09-25|1971-07-25|||||1966-11-18||1971-09-13|N|1963-04-15
TRIAL STUDY 134XCP|LB|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|2||||DOPAC|3,4-DIHYDROXYPHENYLACETIC ACID|||||||MG/G/H|||||||BORDERLINE||UG/MOL||||LOW|NOT DONE||||STOOL|GELLED|N|CLAUSS METHOD|ASH FIBROSURE FORMULA||U|U|NA|U|||U|3||39||BLINDED TREATMENT|1969-08-09|1973-04-11|||||1963-10-20||1972-10-24|NA|1970-02-14
TRIAL STUDY 134XCP|LB|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|1||||IFIT3|INTERFERON-INDUCED 60 KDA PROTEIN|||||||MG/KG/H|||||||INDETERMINATE||SCM||||ABNORMAL|NOT DONE||||CALCULUS|GELLED|N|LINE PROBE ASSAY|CKD-EPI CREATININE FORMULA||NA|U|U|NA|||Y|4||88||OPEN LABEL TREATMENT|1971-04-20|1973-09-02|||||1964-01-30||1966-09-05|NA|1960-05-07
TRIAL STUDY 134XCP|LB|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|2||||CD56|CD56|||||||DPM|||||||INVALID||10^6 COPIES/ML||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|AUTOLYZED|U|ENZYMATIC ULTRACENTRIFUGATION|GMI % FORMULA||U|N|NA|N|||NA|4||88||BASELINE|1964-08-16|1962-03-25|||||1967-02-15||1969-04-25|NA|1968-04-13
TRIAL STUDY 134XCP|LB|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|1||||GCHT|GLYCOCHOLATE|||||||UIU/L|||||||TRACE||U/G HB||||NORMAL|NOT DONE||||PERSPIRATION|REFRIGERATED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|FIBROSIS 4 FORMULA||Y|NA|Y|U|||N|5||7||BLINDED TREATMENT|1961-10-05|1969-03-17|||||1970-03-31||1962-03-20|N|1960-03-22
TRIAL STUDY 134XCP|LB|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|2||||LYS|LYSINE|||||||NMOL/KG/DAY|||||||TRACE||LM||||LOW|NOT DONE||||SERUM|REFRIGERATED|U|COLORIMETRY|CKD-EPI CYSTATIN C FORMULA||NA|N|U|Y|||N|5||7||RUN-IN|1962-05-26|1965-05-14|||||1963-06-12||1968-11-14|Y|1966-10-27
TRIAL STUDY 134XCP|LB|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|1||||MM2IGAB|MITOCHONDRIAL M2 IGG ANTIBODY|||||||KS|||||||POSITIVE||UG/M2||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|HEMOLYZED|Y|WHOLE EXOME SEQUENCING|FIBROTEST FORMULA||U|N|Y|N|||U|1||38||WASHOUT|1965-08-04|1962-10-01|||||1968-04-06||1966-09-01|U|1967-03-05
TRIAL STUDY 134XCP|LB|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|2||||TIMP3|TISSUE INHIBITOR OF METALLOPROTEINASE 3|||||||10^6 CFU/G|||||||TRACE||10^9 ORGANISMS/MG||||NORMAL|NOT DONE||||BREAST MILK|FROZEN|NA|ELECTRONEUROGRAPHY|MDRD 4 VARIABLE FORMULA||NA|N|U|Y|||Y|1||38||CONTINUATION TREATMENT|1973-06-30|1961-09-21|||||1970-05-07||1968-10-24|U|1973-04-15
TRIAL STUDY 134XCP|LB|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|1||||C130132|D. FARINAE ANTIGEN IGE ANTIBODY|||||||CONTAINER|||||||INDETERMINATE||MEQ/DL||||NORMAL|NOT DONE||||PLASMA|CLOTTED|U|INDIA INK STAIN|MDRD ENZYMATIC FORMULA||N|U|NA|Y|||Y|2||58||SCREENING|1972-04-17|1968-01-09|||||1972-04-06||1961-03-01|U|1972-10-16
TRIAL STUDY 134XCP|LB|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|2||||SPGRAV|SPECIFIC GRAVITY|||||||OI50|||||||TRACE||KUSP||||LOW|NOT DONE||||EXPIRED AIR|AUTOLYZED|U|MEDIASTINOSCOPY|GMI % FORMULA||NA|Y|NA|U|||NA|2||58||LONG-TERM FOLLOW-UP|1973-03-22|1967-03-01|||||1960-09-18||1963-05-07|U|1962-08-05
TRIAL STUDY 134XCP|LB|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|1||||OPIATE|OPIATE|||||||U/M2/DAY|||||||POSITIVE||MG/ML/DAY||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|FRESH|NA|NO INFORMATION|FIBROMETER FORMULA||N|U|Y|NA|||N|3||39||BASELINE|1967-09-18|1962-11-13|||||1961-10-04||1972-08-25|Y|1962-09-23
TRIAL STUDY 134XCP|LB|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|2||||BLASTNCE|BLASTS/NUCLEATED CELLS|||||||DNA COPIES/ML|||||||POSITIVE||MG/KG/WEEK||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|LIPEMIC|NA|FLUORESCENT MICROSCOPY|FIBROMETER FORMULA||N|N|NA|Y|||Y|3||39||CONTINUATION TREATMENT|1962-01-18|1969-07-20|||||1964-12-05||1962-07-28|Y|1966-03-16
TRIAL STUDY 134XCP|LB|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|1||||WDR26|WD REPEAT-CONTAINING PROTEIN 26|||||||MG/KG/MIN|||||||INDETERMINATE||10^3 ORGANISMS/G||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|NON-HEMOLYZED|Y|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA||U|U|NA|N|||U|4||88||SCREENING|1971-08-10|1965-12-30|||||1968-10-09||1963-09-17|NA|1965-09-16
TRIAL STUDY 134XCP|LB|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|2||||BLSTRBCE|RUBRIBLAST/TOTAL CELLS|||||||10^6 DNA COPIES/ML|||||||TRACE||10^3 ORGANISMS||||NORMAL|NOT DONE||||MECONIUM|AGGLUTINATED|Y|TARGETED TRANSCRIPTOME SEQUENCING|MDRD FORMULA||U|Y|Y|U|||Y|4||88||WASHOUT|1966-05-09|1960-05-30|||||1967-08-12||1971-03-20|Y|1972-01-15
TRIAL STUDY 134XCP|LB|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|1||||CYAMMOX|AMMONIUM OXALATE CRYSTALS|||||||CD/M2|||||||BORDERLINE||MG/M2/DAY||||HIGH|NOT DONE||||AQUEOUS HUMOR|CONTAMINATED|N|COLORIMETRY|CKD-EPI CYSTATIN C FORMULA||U|N|N|NA|||N|5||7||BASELINE|1971-10-31|1967-08-18|||||1963-09-12||1967-05-16|Y|1965-06-13
TRIAL STUDY 134XCP|LB|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|2||||VEGFA|VASCULAR ENDOTHELIAL GROWTH FACTOR A|||||||M2|||||||TRACE||MMOL/G||||LOW|NOT DONE||||PLEURAL FLUID|FROZEN|NA|PET SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|U|U|||U|5||7||RUN-IN|1969-05-21|1963-02-08|||||1969-09-26||1972-04-12|NA|1973-08-12
TRIAL STUDY 134XCP|LB|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|1||||PLSPCE|PRECURSOR PLASMA CELLS|||||||MG/KG/MIN|||||||INDETERMINATE||10^6/HPF||||ABNORMAL|NOT DONE||||BONE|NON-HEMOLYZED|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|GMI % FORMULA||N|Y|U|NA|||Y|1||38||RUN-IN|1973-04-12|1961-06-16|||||1961-06-16||1970-07-05|NA|1967-03-27
TRIAL STUDY 134XCP|LB|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|2||||APOC3|APOLIPOPROTEIN CIII|||||||10^9/G|||||||NEGATIVE||ML/KG/DAY||||LOW|NOT DONE||||MONOCYTE|THAWED|N|THICK SMEAR|GMI MMOL/MOL FORMULA||N|NA|N|Y|||Y|1||38||WASHOUT|1968-10-11|1963-12-17|||||1960-06-23||1960-06-20|N|1968-05-21
TRIAL STUDY 134XCP|LB|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|1||||C165920|WHITE ELM POLLEN IGG AB RAST SCORE|||||||PUFF|||||||TRACE||G/G||||HIGH|NOT DONE||||EMOTIONAL TEAR|ROOM TEMPERATURE|U|AGAR PROPORTION|MDRD ENZYMATIC FORMULA||U|NA|NA|N|||Y|2||58||OBSERVATION|1965-01-31|1962-03-17|||||1972-02-16||1961-04-20|U|1969-10-24
TRIAL STUDY 134XCP|LB|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|2||||NEUTMY|NEUTROPHILIC MYELOCYTES|||||||SCM|||||||NEGATIVE||H/WK||||LOW|NOT DONE||||ADIPOSE TISSUE|THAWED|NA|SXA SCAN|NASH FIBROSURE FORMULA||U|Y|N|N|||U|2||58||CONTINUATION TREATMENT|1965-02-18|1965-02-10|||||1971-02-13||1963-12-10|U|1961-10-21
TRIAL STUDY 134XCP|LB|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|1||||INTLK8|INTERLEUKIN 8|||||||GENEQ|||||||BORDERLINE||V/V||||HIGH|NOT DONE||||BILE|REFRIGERATED|Y|NUCLEIC ACID BASED METHOD|CKD-EPI CREATININE FORMULA||N|N|Y|Y|||Y|3||39||SCREENING|1960-09-02|1963-05-03|||||1967-07-02||1963-04-19|NA|1961-06-11
TRIAL STUDY 134XCP|LB|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|2||||PTHW|PARATHYROID HORMONE, WHOLE|||||||IU/MMOL|||||||INDETERMINATE||MM3/MM2/YEAR||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|AGGLUTINATED|N|MAGNETIC RESONANCE ANGIOGRAPHY|FIBROSIS 4 FORMULA||N|N|U|Y|||NA|3||39||TREATMENT|1961-04-08|1964-12-27|||||1960-12-26||1971-01-16|N|1968-12-10
TRIAL STUDY 134XCP|LB|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|1||||RBCNURBC|NUCLEATED ERYTHROCYTES/ERYTHROCYTES|||||||%(W/W)|||||||POSITIVE||MESF||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ICTERIC|U|MAMMOGRAPHY|MDRD ENZYMATIC FORMULA||N|N|NA|N|||Y|4||88||LONG-TERM FOLLOW-UP|1971-01-14|1972-12-05|||||1970-09-03||1963-09-20|N|1963-09-24
TRIAL STUDY 134XCP|LB|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|2||||CIC|CIRCULATING IMMUNE COMPLEXES|||||||BU|||||||INDETERMINATE||/MM||||ABNORMAL|NOT DONE||||TUMOR TISSUE|PARAFFIN-EMBEDDED|U|PELLI-ROBSON EYE CHART|GMI MMOL/MOL FORMULA||Y|NA|NA|NA|||N|4||88||FOLLOW-UP|1960-01-13|1968-05-07|||||1968-01-23||1972-11-22|U|1962-01-05
TRIAL STUDY 134XCP|LB|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|1||||IDLVLDL3|IDL+VLDL CHOLESTEROL SUBTYPE 3|||||||U/L|||||||BORDERLINE||BP||||ABNORMAL|NOT DONE||||SKIN TISSUE|AUTOLYZED|Y|IMMUNOPRECIPITATION|CKD-EPI CREATININE FORMULA||NA|U|NA|Y|||N|5||7||FOLLOW-UP|1961-06-14|1965-12-27|||||1961-02-17||1960-10-23|NA|1962-02-15
TRIAL STUDY 134XCP|LB|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|2||||CYSTARCH|STARCH CRYSTALS|||||||MN|||||||INVALID||VIAL||||HIGH|NOT DONE||||SMEGMA|PARAFFIN-EMBEDDED|N|HPLC/MS|GMI % FORMULA||U|Y|NA|U|||U|5||7||TREATMENT|1973-05-20|1972-08-16|||||1965-04-22||1970-06-21|U|1965-10-01
TRIAL STUDY 134XCP|LB|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|1||||PMDW|PLATELET MASS DISTRIBUTION WIDTH|||||||H/WK|||||||NEGATIVE||OZ||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FROZEN|NA|CLIP|MDRD 5 VARIABLE FORMULA||N|Y|N|NA|||U|1||38||BLINDED TREATMENT|1966-07-01|1962-08-14|||||1967-01-13||1971-01-12|NA|1973-08-01
TRIAL STUDY 134XCP|LB|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|2||||GUSA|GLUCURONIDASE, ALPHA|||||||PMOL/10^9 CELLS|||||||TRACE||KCAL||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|GELLED|U|POLYGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|N|Y|||Y|1||38||OBSERVATION|1965-07-04|1968-11-04|||||1970-02-03||1968-02-29|Y|1967-03-29
TRIAL STUDY 134XCP|LB|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|1||||IC512AG|ISLET CELL 512 ANTIGEN|||||||CMOL/L|||||||POSITIVE||MOL/DAY||||LOW|NOT DONE||||EXPIRED AIR|SOLIDIFIED|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|GMI MMOL/MOL FORMULA||N|N|N|N|||U|2||58||SCREENING|1968-11-17|1963-12-08|||||1961-08-15||1969-10-14|Y|1970-11-08
TRIAL STUDY 134XCP|LB|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|2||||RETIMRTC|MEDIUM ABSORPTION RETIC/RETICULOCYTES|||||||MG/KG/MIN|||||||INVALID||MEQ/MMOL||||NORMAL|NOT DONE||||SEMEN|PARAFFIN-EMBEDDED|Y|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|N|N|||N|2||58||BASELINE|1963-10-25|1964-12-05|||||1965-11-29||1968-07-21|U|1971-04-25
TRIAL STUDY 134XCP|LB|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|1||||C147280|COW MILK PROTEIN ANTIGEN IGE ANTIBODY|||||||KALLIKREIN INHIBITOR UNIT|||||||NEGATIVE||MOL||||ABNORMAL|NOT DONE||||VENOUS BLOOD|ICTERIC|N|HILLMEN COLOR CHART|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|Y|||N|3||39||BLINDED TREATMENT|1964-04-21|1961-02-24|||||1972-07-18||1973-08-24|N|1963-09-21
TRIAL STUDY 134XCP|LB|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|2||||UROTHCE|UROTHELIAL CELLS|||||||NFIU|||||||INVALID||UCI||||ABNORMAL|NOT DONE||||BASAL TEAR|NON-HEMOLYZED|NA|DNA MICROARRAY|MDRD 6 VARIABLE FORMULA||U|NA|Y|NA|||NA|3||39||BLINDED TREATMENT|1965-01-15|1968-05-06|||||1965-08-07||1966-08-14|N|1966-02-12
TRIAL STUDY 134XCP|LB|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|1||||ERCEPIDX|ERYTHROID PROLIFERATION INDEX|||||||MM/2H|||||||INDETERMINATE||/2000 RBC||||ABNORMAL|NOT DONE||||DISCHARGE|AGGLUTINATED|U|SEQUENCING|GMI % FORMULA||U|Y|NA|N|||N|4||88||CONTINUATION TREATMENT|1964-09-06|1960-08-18|||||1964-03-22||1964-01-21|U|1965-08-20
TRIAL STUDY 134XCP|LB|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|2||||TBG|THYROXINE BINDING GLOBULIN|||||||FMOL/L|||||||BORDERLINE||FOZ_US||||NORMAL|NOT DONE||||SPERMATOZOON|SOLIDIFIED|U|HILLMEN COLOR CHART|CKD-EPI CYSTATIN C FORMULA||U|N|NA|Y|||NA|4||88||FOLLOW-UP|1968-12-23|1969-05-17|||||1973-08-12||1969-06-03|NA|1961-02-15
TRIAL STUDY 134XCP|LB|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|1||||CSMIX|MIXED CASTS|||||||BOWL|||||||POSITIVE||ENZYME U/M2||||LOW|NOT DONE||||EPIDERMAL TISSUE|PARAFFIN-EMBEDDED|N|ANTIMICROBIAL COMBINATION TESTING|MDRD 4 VARIABLE FORMULA||Y|Y|U|NA|||U|5||7||SCREENING|1966-11-25|1971-03-23|||||1970-08-06||1962-03-17|N|1960-04-10
TRIAL STUDY 134XCP|LB|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|2||||ACHE|ACETYLCHOLINESTERASE|||||||%(W/W)|||||||TRACE||PACK YEAR||||NORMAL|NOT DONE||||CORD BLOOD|UNEXPECTED ODOR|U|FLOCCULATION, CHARCOAL ENHANCED|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|U|N|||NA|5||7||OBSERVATION|1973-07-03|1964-04-04|||||1961-05-06||1969-04-06|Y|1963-05-15
TRIAL STUDY 134XCP|LB|460486B3-B7C8-4B54-848B-21BA899EAAD6|1||||B2MICG|BETA-2 MICROGLOBULIN|||||||LB|||||||NEGATIVE||10^9 CFU/G||||LOW|NOT DONE||||EPITHELIAL CELL|AGGLUTINATED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD FORMULA||Y|U|Y|U|||NA|1||38||LONG-TERM FOLLOW-UP|1961-11-04|1965-05-30|||||1973-05-23||1971-11-15|N|1971-09-13
TRIAL STUDY 134XCP|LB|460486B3-B7C8-4B54-848B-21BA899EAAD6|2||||NPAP|NON-PROSTATIC ACID PHOSPHATASE|||||||EVENTS|||||||TRACE||DAYS/WK||||LOW|NOT DONE||||DIALYSIS FLUID|CALCIFIED|N|PHOTOMETRIC CLOT DETECTION|FIBROMETER FORMULA||U|N|NA|NA|||Y|1||38||INDUCTION TREATMENT|1967-12-07|1969-06-03|||||1963-01-21||1960-09-16|Y|1968-03-01
TRIAL STUDY 134XCP|LB|460486B3-B7C8-4B54-848B-21BA899EAAD6|1||||STAT3PS3|PHOSPHORYLATED STAT3/STAT3|||||||G/U|||||||INDETERMINATE||MEQ/G||||ABNORMAL|NOT DONE||||LYSATE|CLOTTED|NA|GIEMSA STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|U|N|||Y|2||58||RUN-IN|1961-12-22|1967-04-13|||||1968-06-27||1968-12-02|NA|1966-01-14
TRIAL STUDY 134XCP|LB|460486B3-B7C8-4B54-848B-21BA899EAAD6|2||||BLASTNCE|BLASTS/NUCLEATED CELLS|||||||KA_U/DL|||||||TRACE||BE/ML||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|GELLED|N|APPLANATION TONOMETRY|CKD-EPI CYSTATIN C FORMULA||N|Y|N|NA|||N|2||58||TREATMENT|1967-01-17|1969-01-15|||||1972-12-26||1966-10-20|NA|1972-10-01
TRIAL STUDY 134XCP|LB|460486B3-B7C8-4B54-848B-21BA899EAAD6|1||||HLAA23A|HLA-A23 ANTIBODY|||||||BQ/ML|||||||NEGATIVE||UG/MOL||||HIGH|NOT DONE||||MECONIUM|AUTOLYZED|Y|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC FORMULA||N|U|NA|U|||N|3||39||BLINDED TREATMENT|1971-12-08|1965-03-16|||||1973-05-04||1966-05-21|Y|1969-04-24
TRIAL STUDY 134XCP|LB|460486B3-B7C8-4B54-848B-21BA899EAAD6|2||||CYLEUC|LEUCINE CRYSTALS|||||||OHM|||||||TRACE||APPLICATION||||NORMAL|NOT DONE||||SERUM|GELLED|U|FISH|COCKCROFT-GAULT FORMULA||U|N|U|NA|||NA|3||39||SCREENING|1964-02-08|1965-07-09|||||1965-03-10||1966-02-23|N|1965-12-17
TRIAL STUDY 134XCP|LB|460486B3-B7C8-4B54-848B-21BA899EAAD6|1||||NPAP|NON-PROSTATIC ACID PHOSPHATASE|||||||TESLA|||||||TRACE||10^9/G||||LOW|NOT DONE||||BUFFY COAT|GELLED|U|PERFUSION MRI|MDRD ENZYMATIC FORMULA||NA|Y|N|U|||U|4||88||WASHOUT|1962-01-13|1973-03-18|||||1965-04-03||1967-06-07|N|1970-10-11
TRIAL STUDY 134XCP|LB|460486B3-B7C8-4B54-848B-21BA899EAAD6|2||||C147285|COMMON RAGWEED POLLEN IGE ANTIBODY|||||||MG/G/H|||||||BORDERLINE||MIU/L||||LOW|NOT DONE||||HAIR FOLLICLE|GELLED|NA|EPSILOMETER|COCKCROFT-GAULT FORMULA||NA|NA|NA|N|||NA|4||88||LONG-TERM FOLLOW-UP|1963-09-16|1964-04-11|||||1966-08-30||1970-11-12|U|1972-06-24
TRIAL STUDY 134XCP|LB|460486B3-B7C8-4B54-848B-21BA899EAAD6|1||||CNTIGGAB|CENTROMERE IGG ANTIBODY|||||||/4.0 ML|||||||INVALID||10^9 ORGANISMS/ML||||HIGH|NOT DONE||||STOOL|FROZEN|U|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|ASH FIBROSURE FORMULA||NA|U|N|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1969-08-01|1966-03-04|||||1966-11-10||1962-10-09|NA|1966-03-20
TRIAL STUDY 134XCP|LB|460486B3-B7C8-4B54-848B-21BA899EAAD6|2||||GLUCEXR|GLUCOSE EXCRETION RATE|||||||UGEQ/L|||||||INVALID||VG/KG||||LOW|NOT DONE||||TUMOR TISSUE|CONCENTRATED|Y|ERGOSPIROMETRY|FIBROMETER FORMULA||Y|U|NA|NA|||N|5||7||SCREENING|1963-02-16|1971-10-13|||||1972-09-29||1962-11-25|NA|1970-12-03
TRIAL STUDY 134XCP|LB|A068436F-E26E-44C5-8959-0BCBA28832D1|1||||KIM1EXR|KIDNEY INJURY MOLECULE-1 EXCRETION RATE|||||||CM/MIN|||||||INDETERMINATE||G/KG/DAY||||ABNORMAL|NOT DONE||||LYMPH|GELLED|N|ANTIMICROBIAL COMBINATION TESTING|MDRD FORMULA||U|Y|NA|NA|||U|1||38||RUN-IN|1966-06-15|1960-12-29|||||1961-03-09||1963-05-08|U|1966-08-27
TRIAL STUDY 134XCP|LB|A068436F-E26E-44C5-8959-0BCBA28832D1|2||||ACYLCAOX|ACYL COENZYME A OXIDASE|||||||KBQ|||||||POSITIVE||/H||||LOW|NOT DONE||||LYMPH|CONTAMINATED|U|LC-FL|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|NA|N|||Y|1||38||WASHOUT|1973-03-28|1966-09-09|||||1970-04-24||1964-06-24|N|1970-12-08
TRIAL STUDY 134XCP|LB|A068436F-E26E-44C5-8959-0BCBA28832D1|1||||IGG1|IMMUNOGLOBULIN G SUBCLASS 1|||||||UG/DL|||||||BORDERLINE||H/WK||||ABNORMAL|NOT DONE||||VENOUS PLASMA|REFRIGERATED|NA|SNELLEN EYE CHART|MDRD FORMULA||NA|U|U|N|||Y|2||58||WASHOUT|1972-03-28|1967-02-14|||||1960-12-22||1961-03-20|U|1967-11-06
TRIAL STUDY 134XCP|LB|A068436F-E26E-44C5-8959-0BCBA28832D1|2||||AMCRMRNA|AMACR MRNA|||||||HR/DAY|||||||BORDERLINE||10^6 ORGANISMS/ML||||ABNORMAL|NOT DONE||||SEBUM|AUTOLYZED|U|SINGLE-MOLECULE ARRAY|CKD-EPI CREATININE FORMULA||N|Y|NA|NA|||NA|2||58||BASELINE|1960-04-20|1966-11-13|||||1971-06-14||1971-07-29|Y|1961-05-02
TRIAL STUDY 134XCP|LB|A068436F-E26E-44C5-8959-0BCBA28832D1|1||||LH|LUTEINIZING HORMONE|||||||/10^5|||||||INVALID||ML/MIN||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|AGGLUTINATED|Y|MAGNETIC RESONANCE ENTEROGRAPHY|FIBROSIS 4 FORMULA||Y|NA|N|N|||U|3||39||OPEN LABEL TREATMENT|1964-01-14|1966-02-04|||||1962-08-19||1969-10-06|Y|1972-02-04
TRIAL STUDY 134XCP|LB|A068436F-E26E-44C5-8959-0BCBA28832D1|2||||KL6|KREBS VON DEN LUNGEN-6|||||||SHOCK WAVE|||||||BORDERLINE||PMOL/10^10 CELLS||||HIGH|NOT DONE||||BUFFY COAT|HEMOLYZED|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|FIBROMETER FORMULA||Y|N|U|Y|||N|3||39||BASELINE|1965-04-15|1973-02-23|||||1972-08-20||1972-02-11|U|1962-06-09
TRIAL STUDY 134XCP|LB|A068436F-E26E-44C5-8959-0BCBA28832D1|1||||IDL|IDL CHOLESTEROL|||||||UCI|||||||POSITIVE||/KG||||LOW|NOT DONE||||FLUID|SOLIDIFIED|Y|STRESS ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA||U|N|NA|N|||Y|4||88||SCREENING|1968-02-15|1960-08-04|||||1970-10-05||1969-09-17|NA|1961-12-29
TRIAL STUDY 134XCP|LB|A068436F-E26E-44C5-8959-0BCBA28832D1|2||||COCBNZEC|COCAINE BENZOYLECGONINE ECGONINE|||||||PATCH|||||||POSITIVE||BU||||HIGH|NOT DONE||||AQUEOUS HUMOR|ROOM TEMPERATURE|Y|PHOTOMETRY|MDRD FORMULA||NA|NA|NA|Y|||N|4||88||BASELINE|1970-07-17|1966-11-22|||||1962-01-12||1961-08-16|NA|1972-08-18
TRIAL STUDY 134XCP|LB|A068436F-E26E-44C5-8959-0BCBA28832D1|1||||FACTVIII|FACTOR VIII|||||||MM3/MM2/YEAR|||||||INDETERMINATE||MG/KG/H||||ABNORMAL|NOT DONE||||SPUTUM|LACTESCENT|U|ELECTROGASTROGRAPHY|MDRD 4 VARIABLE FORMULA||NA|U|NA|N|||Y|5||7||INDUCTION TREATMENT|1969-11-14|1972-12-20|||||1964-04-04||1967-02-28|N|1969-11-27
TRIAL STUDY 134XCP|LB|A068436F-E26E-44C5-8959-0BCBA28832D1|2||||ALS|ACID LABILE SUBUNIT|||||||10^3 CFU|||||||INVALID||IN||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONCENTRATED|N|QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROMETER FORMULA||Y|U|NA|N|||N|5||7||BLINDED TREATMENT|1960-12-17|1964-05-15|||||1965-04-30||1971-04-21|Y|1970-03-30
TRIAL STUDY 134XCP|LB|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|1||||ADP|ADENOSINE DIPHOSPHATE|||||||TCID 50/DOSE|||||||POSITIVE||10^9/L||||LOW|NOT DONE||||ARTERIAL BLOOD|DRIED|Y|DYNAMIC CONTRAST ENHANCED MRI|COCKCROFT-GAULT FORMULA||Y|N|U|N|||U|1||38||WASHOUT|1960-10-29|1970-11-16|||||1961-09-21||1962-02-27|NA|1960-12-01
TRIAL STUDY 134XCP|LB|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|2||||C130093|WESTERN RAGWEED POLLEN IGA|||||||CONTAINER|||||||POSITIVE||IU/KG/H||||NORMAL|NOT DONE||||KERATINOCYTE|FROZEN|NA|HPLC/MS/MS|MDRD ENZYMATIC FORMULA||N|U|U|NA|||NA|1||38||BASELINE|1960-11-16|1971-09-17|||||1972-06-11||1964-10-30|Y|1970-04-03
TRIAL STUDY 134XCP|LB|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|1||||BILI|BILIRUBIN|||||||MG/M2|||||||BORDERLINE||TESLA||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|LACTESCENT|N|ICP-MS|MDRD FORMULA||N|N|U|Y|||U|2||58||RUN-IN|1967-03-18|1973-03-29|||||1965-07-28||1969-10-03|NA|1973-08-09
TRIAL STUDY 134XCP|LB|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|2||||FIO2|FRACTION OF INSPIRED OXYGEN|||||||BISCUIT|||||||TRACE||AMU||||HIGH|NOT DONE||||VENOUS CORD BLOOD|LIPEMIC|U|BAC ACGH|MDRD ENZYMATIC JAPANESE FORMULA||U|N|NA|U|||Y|2||58||BLINDED TREATMENT|1961-03-07|1967-10-24|||||1971-01-05||1962-08-01|NA|1972-08-23
TRIAL STUDY 134XCP|LB|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|1||||C5|COMPLEMENT C5|||||||/MONTH|||||||TRACE||MMOL/L||||LOW|NOT DONE||||MECONIUM|FRESH|NA|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|CKD-EPI FORMULA||Y|NA|Y|Y|||U|3||39||LONG-TERM FOLLOW-UP|1966-02-24|1969-08-03|||||1966-10-24||1970-01-20|U|1963-12-12
TRIAL STUDY 134XCP|LB|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|2||||TGLOBRR|THYROGLOBULIN RECOVERY RATE|||||||TRACE|||||||NEGATIVE||LOG10 CFU/ML||||NORMAL|NOT DONE||||VITREOUS HUMOR|REFRIGERATED|Y|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD ENZYMATIC JAPANESE FORMULA||N|U|Y|U|||Y|3||39||WASHOUT|1964-08-08|1969-04-22|||||1962-05-24||1973-06-17|U|1963-08-16
TRIAL STUDY 134XCP|LB|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|1||||EOSCE|EOSINOPHILS/TOTAL CELLS|||||||MG/CM2|||||||INDETERMINATE||VG/DOSE||||NORMAL|NOT DONE||||URINE|LIPEMIC|NA|MICROBIAL CULTURE, SOLID|MDRD ENZYMATIC FORMULA||U|Y|NA|N|||Y|4||88||SCREENING|1964-07-07|1969-12-17|||||1969-03-05||1964-01-07|N|1962-07-17
TRIAL STUDY 134XCP|LB|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|2||||PYRUVATE|PYRUVATE|||||||ML/CM3/MIN|||||||TRACE||KCAL||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|REFRIGERATED|U|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|FIBROMETER FORMULA||N|U|U|U|||Y|4||88||RUN-IN|1962-11-15|1965-02-09|||||1961-03-04||1960-12-15|Y|1963-01-14
TRIAL STUDY 134XCP|LB|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|1||||RNPSMAB|RIBONUCLEOPROTEIN SMITH COMPLEX ANTIBODY|||||||UEQ|||||||INDETERMINATE||MDFI||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|HEMOLYZED|NA|CHROMOGENIC ASSAY|MDRD 5 VARIABLE FORMULA||NA|U|U|Y|||N|5||7||OBSERVATION|1969-01-28|1965-12-11|||||1963-12-11||1968-06-19|Y|1970-10-20
TRIAL STUDY 134XCP|LB|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|2||||C165920|WHITE ELM POLLEN IGG AB RAST SCORE|||||||NU/CL|||||||BORDERLINE||GBQ/MG||||LOW|NOT DONE||||MONOCYTE|LIPEMIC|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|GMI MMOL/MOL FORMULA||Y|NA|N|N|||NA|5||7||OBSERVATION|1972-10-15|1963-05-03|||||1967-04-30||1969-08-08|U|1963-07-03
TRIAL STUDY 134XCP|LB|E065D436-92D2-453F-86A7-27F70FE1FD03|1||||ASTCREAT|ASPARTATE AMINOTRANSFERASE/CREATININE|||||||S^-1(%O2)^-1|||||||POSITIVE||COPIES/UL||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|ICTERIC|N|HANSEL STAIN|HEPASCORE FORMULA||N|Y|N|Y|||U|1||38||WASHOUT|1964-09-11|1961-04-10|||||1965-12-04||1961-09-12|NA|1963-12-17
TRIAL STUDY 134XCP|LB|E065D436-92D2-453F-86A7-27F70FE1FD03|2||||CHRMTNAB|CHROMATIN ANTIBODIES|||||||UMOL/DL|||||||TRACE||F||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED|Y|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|ASH FIBROSURE FORMULA||N|N|Y|NA|||Y|1||38||WASHOUT|1967-09-04|1962-09-30|||||1964-02-28||1963-10-22|NA|1963-09-16
TRIAL STUDY 134XCP|LB|E065D436-92D2-453F-86A7-27F70FE1FD03|1||||NITRATE|NITRATE|||||||AFU|||||||NEGATIVE||10^6 RNA COPIES/ML||||HIGH|NOT DONE||||INFRANATANT, SERUM|CALCIFIED|Y|AGAR DILUTION|FIBROSIS 4 FORMULA||Y|U|Y|U|||N|2||58||OPEN LABEL TREATMENT|1970-06-09|1971-08-03|||||1961-02-09||1969-03-29|NA|1971-01-18
TRIAL STUDY 134XCP|LB|E065D436-92D2-453F-86A7-27F70FE1FD03|2||||BGTCPHRL|BETA+GAMMA TOCOPHEROL|||||||ECL UNIT|||||||POSITIVE||UL/KG/DAY||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|Y|SPIRAL CT|HEPASCORE FORMULA||NA|U|N|N|||N|2||58||BASELINE|1966-10-07|1964-12-28|||||1970-11-26||1961-11-10|Y|1970-08-07
TRIAL STUDY 134XCP|LB|E065D436-92D2-453F-86A7-27F70FE1FD03|1||||HGBDHGB|HEMOGLOBIN D/TOTAL HEMOGLOBIN|||||||10^6 IU/ML|||||||POSITIVE||CCID 50/DOSE||||NORMAL|NOT DONE||||PROSTATIC FLUID|THAWED|NA|OPTICAL MAPPING|CKD-EPI FORMULA||NA|N|N|N|||Y|3||39||WASHOUT|1966-10-19|1963-07-07|||||1968-11-30||1967-03-24|N|1969-02-27
TRIAL STUDY 134XCP|LB|E065D436-92D2-453F-86A7-27F70FE1FD03|2||||C147276|ARACHIS HYPOGAEA ANTIGEN IGE ANTIBODY|||||||BQ/UG|||||||INVALID||IMPLANT||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|THAWED|NA|IMMUNOFIXATION ELECTROPHORESIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|NA|||N|3||39||CONTINUATION TREATMENT|1961-08-17|1964-06-10|||||1963-07-13||1972-06-07|N|1968-05-31
TRIAL STUDY 134XCP|LB|E065D436-92D2-453F-86A7-27F70FE1FD03|1||||NEUTLE|NEUTROPHILS/LEUKOCYTES|||||||10^6 DNA COPIES/ML|||||||BORDERLINE||KG/L||||NORMAL|NOT DONE||||FLUID|FRESH|U|CT SCAN WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA||N|U|NA|U|||N|4||88||RUN-IN|1968-04-03|1968-04-20|||||1960-08-09||1971-10-07|U|1972-04-13
TRIAL STUDY 134XCP|LB|E065D436-92D2-453F-86A7-27F70FE1FD03|2||||LRZPM|LORAZEPAM|||||||GBQ/MG|||||||NEGATIVE||NMOL/L/MIN||||ABNORMAL|NOT DONE||||SOFT TISSUE|LACTESCENT|Y|RADIATION DOSIMETRY|CKD-EPI CYSTATIN C FORMULA||NA|N|N|U|||N|4||88||SCREENING|1971-01-05|1962-11-07|||||1964-09-19||1969-12-03|Y|1964-09-06
TRIAL STUDY 134XCP|LB|E065D436-92D2-453F-86A7-27F70FE1FD03|1||||C4A|COMPLEMENT C4A|||||||10^3 ORGANISMS|||||||POSITIVE||C||||LOW|NOT DONE||||MIXED VENOUS BLOOD|LIPEMIC|NA|ELECTRICAL IMPEDANCE MYOGRAPHY|CKD-EPI CYSTATIN C FORMULA||N|U|N|NA|||U|5||7||BASELINE|1962-09-04|1972-10-03|||||1965-04-20||1960-09-03|U|1960-09-11
TRIAL STUDY 134XCP|LB|E065D436-92D2-453F-86A7-27F70FE1FD03|2||||IAPP|ISLET AMYLOID POLYPEPTIDE|||||||OHM|||||||POSITIVE||UMOL/H/MMOL||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|SOLIDIFIED|U|CORONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|NA|NA|||NA|5||7||CONTINUATION TREATMENT|1968-05-08|1971-04-12|||||1965-02-19||1968-07-27|N|1964-01-07
TRIAL STUDY 134XCP|LB|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|1||||GSTALEXR|ALPHA-GST EXCRETION RATE|||||||PUFF|||||||POSITIVE||PMOL/DAY||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|CALCIFIED|U|QUANTITATIVE ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|N|U|||N|1||38||BLINDED TREATMENT|1970-01-27|1969-10-06|||||1971-08-14||1967-12-05|Y|1965-03-23
TRIAL STUDY 134XCP|LB|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|2||||HYPGST17|17-HYDROXYPROGESTERONE|||||||KDA|||||||INDETERMINATE||LOZENGE||||NORMAL|NOT DONE||||CAPILLARY BLOOD|FROZEN|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|GMI MMOL/MOL FORMULA||Y|U|Y|N|||NA|1||38||TREATMENT|1964-12-15|1973-01-09|||||1967-12-26||1973-09-02|N|1968-07-10
TRIAL STUDY 134XCP|LB|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|1||||PTSAC|PROTEIN S ACTUAL/CONTROL|||||||MG/ML/MIN|||||||POSITIVE||CI/UL||||LOW|NOT DONE||||SERUM OR PLASMA|HEMOLYZED|U|MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA||N|NA|U|NA|||N|2||58||SCREENING|1963-03-21|1963-11-29|||||1970-08-02||1966-01-04|Y|1968-05-05
TRIAL STUDY 134XCP|LB|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|2||||ANCIGAB|ANTI-NEUTROPHIL CYTOPLASMIC IGG ANTIBODY|||||||KN/CM2|||||||POSITIVE||KUSP||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|CLOTTED|NA|BIOPSY|MDRD 6 VARIABLE FORMULA||Y|NA|NA|Y|||U|2||58||OBSERVATION|1969-02-11|1961-04-13|||||1962-05-15||1968-10-09|NA|1970-10-06
TRIAL STUDY 134XCP|LB|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|1||||OXYTOCIN|OXYTOCIN|||||||UU/L|||||||TRACE||CYLINDER||||LOW|NOT DONE||||TISSUE|ICTERIC|N|GRAM STAIN|MDRD ENZYMATIC FORMULA||U|N|Y|Y|||Y|3||39||SCREENING|1961-04-30|1964-02-20|||||1967-12-05||1964-02-23|Y|1966-08-05
TRIAL STUDY 134XCP|LB|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|2||||PLATIM|IMMATURE PLATELETS|||||||MG/M2/DAY|||||||TRACE||10^3 ORGANISMS/G||||NORMAL|NOT DONE||||PLEURAL FLUID|AUTOLYZED|Y|POTENTIOMETRY|NASH FIBROSURE FORMULA||Y|NA|Y|N|||Y|3||39||SCREENING|1960-09-21|1960-06-02|||||1965-12-10||1962-11-07|NA|1972-10-19
TRIAL STUDY 134XCP|LB|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|1||||TRIG|TRIGLYCERIDES|||||||PT_US|||||||INVALID||ML/ANIMAL/WK||||LOW|NOT DONE||||SWABBED MATERIAL|SOLIDIFIED|N|SPIROMETRY|GMI % FORMULA||U|U|Y|Y|||Y|4||88||CONTINUATION TREATMENT|1970-07-15|1963-08-25|||||1966-05-01||1970-12-28|NA|1972-09-25
TRIAL STUDY 134XCP|LB|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|2||||MYBLALE|MYELOBLASTS/LEUKOCYTES|||||||BQ|||||||POSITIVE||PELLET||||HIGH|NOT DONE||||BONE MARROW|ICTERIC|Y|FLAME PHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|U|N|||N|4||88||BLINDED TREATMENT|1966-11-08|1963-03-25|||||1972-09-12||1973-06-28|NA|1962-01-26
TRIAL STUDY 134XCP|LB|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|1||||IGM|IMMUNOGLOBULIN M|||||||TAMPON|||||||BORDERLINE||LOG10 PFU||||ABNORMAL|NOT DONE||||MUCUS|REFRIGERATED|Y|HILLMEN COLOR CHART|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|Y|NA|||N|5||7||OPEN LABEL TREATMENT|1972-11-25|1967-09-14|||||1963-08-04||1960-10-18|N|1968-07-13
TRIAL STUDY 134XCP|LB|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|2||||TXB2_D11|11-DEHYDRO-THROMBOXANE B2|||||||DAYS|||||||INDETERMINATE||PPTR||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|ROOM TEMPERATURE|NA|CONTRAST ENHANCED SPIRAL CT SCAN|MDRD 4 VARIABLE FORMULA||NA|Y|U|NA|||Y|5||7||WASHOUT|1963-03-23|1966-06-21|||||1965-03-07||1964-08-04|NA|1961-08-01
TRIAL STUDY 134XCP|LB|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|1||||GFR|GLOMERULAR FILTRATION RATE|||||||CPM|||||||INVALID||K||||NORMAL|NOT DONE||||ERYTHROCYTES|CONCENTRATED|N|WESTERN BLOT|COCKCROFT-GAULT FORMULA||NA|Y|NA|NA|||NA|1||38||TREATMENT|1965-01-11|1967-12-27|||||1960-07-01||1964-05-15|Y|1971-06-23
TRIAL STUDY 134XCP|LB|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|2||||HGBMHGB|METHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||ANTI-XA IU|||||||BORDERLINE||UG/H||||NORMAL|NOT DONE||||INFRANATANT, SERUM|ICTERIC|NA|SURFACE PLASMON RESONANCE|MDRD 4 VARIABLE FORMULA||Y|U|NA|NA|||U|1||38||FOLLOW-UP|1970-03-05|1961-03-18|||||1971-12-24||1973-03-10|U|1961-10-30
TRIAL STUDY 134XCP|LB|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|1||||CYPHOS|PHOSPHATE CRYSTALS|||||||KUSP|||||||NEGATIVE||CCID 50/DOSE||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|CONCENTRATED|U|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD 6 VARIABLE FORMULA||U|N|Y|Y|||Y|2||58||INDUCTION TREATMENT|1963-11-18|1971-11-02|||||1961-11-22||1971-10-23|Y|1966-01-23
TRIAL STUDY 134XCP|LB|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|2||||RNP70AB|RIBONUCLEOPROTEIN-70 ANTIBODY|||||||PM|||||||POSITIVE||L/MIN||||LOW|NOT DONE||||DIALYSIS FLUID|REFRIGERATED|U|MRI WITHOUT CONTRAST|CKD-EPI FORMULA||NA|NA|Y|U|||N|2||58||FOLLOW-UP|1969-10-22|1967-11-22|||||1963-05-09||1972-10-10|NA|1967-09-27
TRIAL STUDY 134XCP|LB|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|1||||FACTVIII|FACTOR VIII|||||||CAPFUL|||||||BORDERLINE||UMOL/L/SEC||||HIGH|NOT DONE||||INFRANATANT, PLASMA|NON-HEMOLYZED|N|KINETIC CHROMOGENIC ASSAY|GMI MMOL/MOL FORMULA||U|NA|NA|Y|||U|3||39||BLINDED TREATMENT|1972-07-03|1964-01-25|||||1970-09-14||1966-10-21|Y|1961-06-04
TRIAL STUDY 134XCP|LB|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|2||||PLSMCELY|MATURE PLASMA CELLS/LYMPHOCYTES|||||||DEG2|||||||INVALID||MET*MIN||||LOW|NOT DONE||||PROSTATIC FLUID|THAWED|NA|CONTRAST ENHANCED MRI|FIBROSIS 4 FORMULA||U|Y|U|NA|||U|3||39||RUN-IN|1971-09-10|1969-04-17|||||1973-08-28||1971-06-27|U|1971-05-22
TRIAL STUDY 134XCP|LB|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|1||||PLATBIZ|BIZARRE PLATELETS|||||||10^6 RNA COPIES/ML|||||||INVALID||NMOL/DAY||||HIGH|NOT DONE||||LEUKOCYTE|NON-HEMOLYZED|Y|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD FORMULA||N|N|N|U|||U|4||88||BASELINE|1964-06-16|1971-12-18|||||1965-08-12||1971-12-10|U|1972-12-17
TRIAL STUDY 134XCP|LB|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|2||||LEUKCE|LEUKEMIC CELLS|||||||PKAT/L|||||||POSITIVE||FRAMES/S||||LOW|NOT DONE||||CERUMEN|FROZEN|NA|DROPLET DIGITAL PCR|MDRD 6 VARIABLE FORMULA||Y|Y|U|Y|||Y|4||88||OPEN LABEL TREATMENT|1969-10-15|1962-03-31|||||1966-04-11||1971-12-13|U|1964-04-20
TRIAL STUDY 134XCP|LB|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|1||||LIPEMIAI|LIPEMIC INDEX|||||||/H|||||||INVALID||M||||HIGH|NOT DONE||||EMOTIONAL TEAR|LIPEMIC|N|DC SHEATH FLOW|HEPASCORE FORMULA||Y|Y|U|U|||U|5||7||INDUCTION TREATMENT|1971-09-19|1962-01-28|||||1965-10-26||1970-04-27|U|1960-11-25
TRIAL STUDY 134XCP|LB|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|2||||UREANCRT|UREA NITROGEN/CREATININE|||||||MEQ|||||||TRACE||NEEDLE GAUGE||||ABNORMAL|NOT DONE||||EXPIRED AIR|ICTERIC|NA|STRESS ECHOCARDIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|NA|NA|||NA|5||7||TREATMENT|1967-12-14|1967-02-01|||||1970-07-28||1961-06-12|N|1965-08-17
TRIAL STUDY 134XCP|LB|D108D040-7177-4A14-8CA7-748D59DC5F8B|1||||ETPPH|ETP PEAK HEIGHT|||||||10^3 CFU/ML|||||||TRACE||M/SEC2||||LOW|NOT DONE||||HAIR|LIPEMIC|Y|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|GMI % FORMULA||Y|U|Y|Y|||U|1||38||SCREENING|1965-01-18|1969-01-07|||||1967-09-25||1968-03-18|U|1968-09-08
TRIAL STUDY 134XCP|LB|D108D040-7177-4A14-8CA7-748D59DC5F8B|2||||GLOBB1|BETA-1 GLOBULIN|||||||VP/DOSE|||||||INDETERMINATE||NG/DL||||HIGH|NOT DONE||||CAPILLARY BLOOD|FROZEN|N|PHASE-CONTRAST MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|NA|U|||N|1||38||BLINDED TREATMENT|1972-09-13|1971-09-19|||||1965-10-08||1960-03-17|NA|1967-06-18
TRIAL STUDY 134XCP|LB|D108D040-7177-4A14-8CA7-748D59DC5F8B|1||||PSDGLSRF|PHOSPHATIDYLGLYCEROL/LUNG SURFACTANT|||||||MG/KG/H|||||||BORDERLINE||KPA||||LOW|NOT DONE||||CAPILLARY PLASMA|LACTESCENT|Y|MULTIPLE BREATH WASHOUT|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|Y|||N|2||58||SCREENING|1969-08-16|1964-06-25|||||1970-10-07||1967-05-13|U|1971-03-29
TRIAL STUDY 134XCP|LB|D108D040-7177-4A14-8CA7-748D59DC5F8B|2||||COAGIDX|COAGULATION INDEX|||||||10^9 ORGANISMS/G|||||||INVALID||MOL/ML||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|LACTESCENT|U|MICRODENSITOMETRY|MDRD 6 VARIABLE FORMULA||U|NA|U|N|||NA|2||58||OPEN LABEL TREATMENT|1967-03-05|1968-03-19|||||1973-08-25||1960-02-08|U|1970-11-05
TRIAL STUDY 134XCP|LB|D108D040-7177-4A14-8CA7-748D59DC5F8B|1||||CARTP|COCAINE AMPHETAMINE-REG TRANSCRIPT PROT|||||||AMOL|||||||BORDERLINE||IMPLANT||||ABNORMAL|NOT DONE||||EMESIS|LIPEMIC|Y|SLIT LAMP|MDRD 6 VARIABLE FORMULA||Y|Y|N|N|||Y|3||39||SCREENING|1963-09-06|1973-03-18|||||1962-09-27||1973-07-07|Y|1961-10-17
TRIAL STUDY 134XCP|LB|D108D040-7177-4A14-8CA7-748D59DC5F8B|2||||C130114|INDUSTRIAL MIX ANTIGEN IGE ANTIBODY|||||||FT3|||||||TRACE||MU/G||||HIGH|NOT DONE||||BASAL TEAR|CLOTTED|NA|AUTOMATED COUNT|CKD-EPI CYSTATIN C FORMULA||N|NA|NA|NA|||Y|3||39||RUN-IN|1966-02-17|1967-09-23|||||1965-07-14||1966-11-27|U|1961-07-29
TRIAL STUDY 134XCP|LB|D108D040-7177-4A14-8CA7-748D59DC5F8B|1||||PRZPM|PRAZEPAM|||||||ML/M2/DAY|||||||BORDERLINE||U/L||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|LACTESCENT|Y|ICP-MS|CKD-EPI FORMULA||Y|N|NA|N|||NA|4||88||CONTINUATION TREATMENT|1964-05-22|1961-06-28|||||1972-03-29||1961-05-14|Y|1964-08-08
TRIAL STUDY 134XCP|LB|D108D040-7177-4A14-8CA7-748D59DC5F8B|2||||MGBCREAT|MYOGLOBIN/CREATININE|||||||JOULE|||||||INDETERMINATE||CM/S||||ABNORMAL|NOT DONE||||SKIN TISSUE|LIPEMIC|Y|CONTRAST ENHANCED SPIRAL CT SCAN|MDRD 6 VARIABLE FORMULA||NA|N|U|NA|||N|4||88||OPEN LABEL TREATMENT|1969-07-09|1960-03-27|||||1967-09-29||1969-12-23|NA|1961-07-21
TRIAL STUDY 134XCP|LB|D108D040-7177-4A14-8CA7-748D59DC5F8B|1||||FAS|FAS CELL SURFACE DEATH RECEPTOR|||||||LOG10 ELISA UNIT/DOSE|||||||INVALID||10^5/L||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|UNEXPECTED ODOR|NA|WESTERN BLOT|MDRD FORMULA||U|N|U|U|||Y|5||7||LONG-TERM FOLLOW-UP|1962-12-25|1972-05-05|||||1966-09-25||1968-06-22|U|1969-12-11
TRIAL STUDY 134XCP|LB|D108D040-7177-4A14-8CA7-748D59DC5F8B|2||||WBCCE|LEUKOCYTES/TOTAL CELLS|||||||UG/M2/MIN|||||||POSITIVE||MU/G||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|HEMOLYZED|NA|AUDIOMETRY|FIBROTEST FORMULA||NA|Y|U|Y|||U|5||7||RUN-IN|1960-11-26|1966-04-10|||||1962-12-09||1967-05-11|N|1963-09-23
TRIAL STUDY 134XCP|LB|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|1||||CRYOGLBN|CRYOGLOBULIN|||||||U/G HB|||||||TRACE||ML/CM3/MIN||||HIGH|NOT DONE||||INFRANATANT, SERUM|PARAFFIN-EMBEDDED|Y|CAPILLARY ELECTROPHORESIS|CKD-EPI FORMULA||U|Y|Y|Y|||U|1||38||FOLLOW-UP|1965-11-25|1965-04-01|||||1961-03-31||1968-03-14|U|1962-11-04
TRIAL STUDY 134XCP|LB|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|2||||RFIGMAB|RHEUMATOID FACTOR IGM ANTIBODY|||||||CI/ML|||||||BORDERLINE||UMOL/MG/MIN||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|NON-HEMOLYZED|U|LIQUID SCINTILLATION COUNTING|CKD-EPI FORMULA||NA|NA|NA|N|||NA|1||38||CONTINUATION TREATMENT|1971-05-23|1972-05-10|||||1965-02-18||1961-09-08|NA|1962-08-21
TRIAL STUDY 134XCP|LB|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|1||||PROGRP|PRO-GASTRIN RELEASING PEPTIDE|||||||MG/H|||||||POSITIVE||C||||LOW|NOT DONE||||BASAL TEAR|UNEXPECTED ODOR|NA|PHOTOGRAPHY|FIBROMETER FORMULA||NA|N|N|Y|||NA|2||58||INDUCTION TREATMENT|1960-11-22|1967-06-27|||||1963-09-06||1962-02-21|U|1972-01-01
TRIAL STUDY 134XCP|LB|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|2||||SLAIGGAB|SOLUBLE LIVER ANTIGEN IGG ANTIBODY|||||||CUP|||||||INVALID||PMOL/10^9 CELLS||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|THAWED|U|PET/CT SCAN WITHOUT CONTRAST|MDRD 5 VARIABLE FORMULA||Y|Y|N|U|||NA|2||58||WASHOUT|1968-08-25|1964-09-15|||||1965-11-02||1962-06-04|Y|1971-09-18
TRIAL STUDY 134XCP|LB|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|1||||IL1RL1|INTERLEUKIN 1 RECEPTOR-LIKE 1|||||||HENRY|||||||POSITIVE||SUPPOSITORY||||ABNORMAL|NOT DONE||||LYSATE|CALCIFIED|N|AUTOREFRACTION|CKD-EPI FORMULA||U|Y|Y|NA|||N|3||39||CONTINUATION TREATMENT|1967-03-09|1962-06-13|||||1967-04-06||1971-03-09|Y|1960-01-23
TRIAL STUDY 134XCP|LB|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|2||||HCG|CHORIOGONADOTROPIN BETA|||||||DEG/MM|||||||POSITIVE||ML/M2/DAY||||NORMAL|NOT DONE||||SKIN TISSUE|THAWED|NA|VENTILATION PERFUSION LUNG SCAN|GMI % FORMULA||U|Y|NA|U|||Y|3||39||TREATMENT|1962-10-26|1963-11-04|||||1969-07-19||1966-11-09|U|1970-04-05
TRIAL STUDY 134XCP|LB|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|1||||LYMPLLE|PLASMACYTOID LYMPHOCYTES/LEUKOCYTES|||||||AFU|||||||INDETERMINATE||10^12/L||||HIGH|NOT DONE||||WHITE MATTER TISSUE|UNEXPECTED ODOR|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|CKD-EPI CREATININE FORMULA||Y|U|N|N|||Y|4||88||TREATMENT|1960-09-25|1965-07-06|||||1963-06-30||1967-08-23|Y|1972-09-01
TRIAL STUDY 134XCP|LB|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|2||||GRANBCE|GRANULOCYTES BAND FORM/TOTAL CELLS|||||||LOZENGE|||||||TRACE||U||||LOW|NOT DONE||||HAIR FOLLICLE|AGGLUTINATED|U|LC/MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|NA|||U|4||88||WASHOUT|1968-04-20|1969-11-01|||||1961-12-24||1961-02-18|N|1960-03-22
TRIAL STUDY 134XCP|LB|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|1||||GHBP|GROWTH HORMONE BINDING PROTEIN|||||||%|||||||TRACE||ML/ANIMAL/WK||||LOW|NOT DONE||||PLATELET RICH PLASMA|CONTAMINATED|Y|ANALYTICAL ULTRACENTRIFUGATION|GMI MMOL/MOL FORMULA||NA|Y|Y|U|||Y|5||7||INDUCTION TREATMENT|1970-03-27|1968-01-23|||||1972-01-23||1962-06-15|NA|1971-12-24
TRIAL STUDY 134XCP|LB|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|2||||METANEPH|METANEPHRINE|||||||EIA UNIT|||||||POSITIVE||IU/G HB||||NORMAL|NOT DONE||||VENOUS BLOOD|FROZEN|NA|PHASE-CONTRAST MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|NA|||Y|5||7||WASHOUT|1966-08-31|1960-12-26|||||1965-09-27||1972-10-06|U|1967-09-26
TRIAL STUDY 134XCP|LB|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|1||||ALPLS|LIVER SPECIFIC ALKALINE PHOSPHATASE|||||||UGEQ/L|||||||INVALID||UIU/DL||||NORMAL|NOT DONE||||SPUTUM|REFRIGERATED|U|CENTRIFUGATION|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|NA|N|||Y|1||38||WASHOUT|1971-01-25|1962-08-01|||||1963-10-18||1962-11-13|U|1969-06-11
TRIAL STUDY 134XCP|LB|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|2||||APOC3|APOLIPOPROTEIN CIII|||||||GPL U|||||||INDETERMINATE||PLUG||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|N|ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI FORMULA||NA|U|U|N|||U|1||38||FOLLOW-UP|1968-12-07|1965-01-17|||||1961-07-06||1970-09-19|N|1965-05-29
TRIAL STUDY 134XCP|LB|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|1||||SHBG|SEX HORMONE BINDING GLOBULIN|||||||NMOL BCE/NMOL|||||||POSITIVE||MDFI||||HIGH|NOT DONE||||CORD SERUM|FRESH|U|AUTOREFRACTION|CKD-EPI CYSTATIN C FORMULA||U|Y|Y|NA|||Y|2||58||BLINDED TREATMENT|1970-07-05|1969-03-22|||||1970-07-10||1961-10-11|U|1967-06-22
TRIAL STUDY 134XCP|LB|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|2||||HGBDHGB|HEMOGLOBIN D/TOTAL HEMOGLOBIN|||||||MM|||||||TRACE||BQ/L||||LOW|NOT DONE||||TRANSUDATE|HEMOLYZED|Y|ENZYMATIC ULTRACENTRIFUGATION|FIBROMETER FORMULA||U|NA|Y|U|||N|2||58||TREATMENT|1965-10-31|1962-05-18|||||1972-10-26||1970-04-04|Y|1966-07-08
TRIAL STUDY 134XCP|LB|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|1||||FGF23|FIBROBLAST GROWTH FACTOR 23|||||||CAN|||||||POSITIVE||NMOL/L/MIN||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|THAWED|U|CONTRAST ENHANCED PET/CT SCAN|GMI MMOL/MOL FORMULA||N|U|NA|U|||U|3||39||TREATMENT|1973-08-17|1973-07-18|||||1970-08-24||1964-10-30|U|1972-08-29
TRIAL STUDY 134XCP|LB|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|2||||IFIT3|INTERFERON-INDUCED 60 KDA PROTEIN|||||||AGU/ML|||||||BORDERLINE||ML/MIN/1.73M2||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|GELLED|N|POPULATION SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|N|U|||U|3||39||LONG-TERM FOLLOW-UP|1971-12-17|1966-10-30|||||1966-12-30||1961-12-20|U|1969-02-12
TRIAL STUDY 134XCP|LB|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|1||||PEPSNGA|PEPSINOGEN A|||||||KN/CM2|||||||NEGATIVE||MMHG||||HIGH|NOT DONE||||ARTERIAL BLOOD|UNEXPECTED ODOR|NA|PET SCAN|MDRD 4 VARIABLE FORMULA||NA|NA|NA|Y|||N|4||88||WASHOUT|1967-04-10|1973-07-14|||||1963-06-06||1966-02-07|N|1966-10-02
TRIAL STUDY 134XCP|LB|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|2||||PAF|PLATELET ACTIVATING FACTOR|||||||S*KPA|||||||TRACE||MG/MIN||||NORMAL|NOT DONE||||SWABBED MATERIAL|REFRIGERATED|U|NEXT GENERATION TARGETED SEQUENCING|GMI % FORMULA||U|U|U|U|||Y|4||88||SCREENING|1972-06-25|1966-03-04|||||1973-05-04||1962-07-11|Y|1964-09-17
TRIAL STUDY 134XCP|LB|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|1||||C130140|GERMAN COCKROACH ANTIGEN IGE ANTIBODY|||||||BQ/MG|||||||BORDERLINE||U/MG||||LOW|NOT DONE||||ABSCESS FLUID|FRESH|U|PYROSEQUENCING|CKD-EPI CREATININE FORMULA||Y|Y|Y|NA|||N|5||7||LONG-TERM FOLLOW-UP|1973-05-13|1961-02-25|||||1972-12-03||1962-08-03|U|1964-12-28
TRIAL STUDY 134XCP|LB|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|2||||BLSTMGK|MEGAKARYOBLASTS|||||||CI/MG|||||||POSITIVE||U/MMOL||||LOW|NOT DONE||||LEUKOCYTE|UNEXPECTED ODOR|N|SNP ARRAY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|N|U|||NA|5||7||INDUCTION TREATMENT|1969-11-24|1967-01-01|||||1970-04-03||1962-10-31|U|1969-01-28
TRIAL STUDY 134XCP|LB|580CCA66-3D51-4A5C-80E1-361A90369055|1||||BLSTRBCE|RUBRIBLAST/TOTAL CELLS|||||||UKAT/L|||||||INVALID||ML/BREATH||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|LIPEMIC|U|WHOLE TRANSCRIPTOME SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|NA|N|||NA|1||38||RUN-IN|1964-04-12|1970-06-20|||||1973-04-02||1972-08-11|U|1966-04-13
TRIAL STUDY 134XCP|LB|580CCA66-3D51-4A5C-80E1-361A90369055|2||||PELGERH|PELGER HUET ANOMALY|||||||NMOL BCE/L|||||||POSITIVE||BAU/ML||||LOW|NOT DONE||||LEUKOCYTE|FRESH|N|NUCLEIC ACID HYBRIDIZATION|NASH FIBROSURE FORMULA||NA|Y|U|N|||Y|1||38||CONTINUATION TREATMENT|1972-06-22|1969-07-12|||||1965-07-13||1966-08-26|U|1961-04-12
TRIAL STUDY 134XCP|LB|580CCA66-3D51-4A5C-80E1-361A90369055|1||||PROTOSML|PROTEIN/OSMOLALITY|||||||ML|||||||POSITIVE||NMOL/G||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|CALCIFIED|NA|TURBIDIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|Y|U|||N|2||58||BASELINE|1965-05-12|1969-08-31|||||1966-06-08||1965-06-07|NA|1973-05-24
TRIAL STUDY 134XCP|LB|580CCA66-3D51-4A5C-80E1-361A90369055|2||||C165918|AMERICAN COCKROACH IGG AB RAST SCORE|||||||ML/G/MIN|||||||INDETERMINATE||KCAL||||HIGH|NOT DONE||||SOFT TISSUE|SOLIDIFIED|Y|PAP STAIN|GMI MMOL/MOL FORMULA||N|N|N|Y|||N|2||58||CONTINUATION TREATMENT|1962-04-29|1968-03-03|||||1967-04-28||1964-07-17|NA|1967-07-28
TRIAL STUDY 134XCP|LB|580CCA66-3D51-4A5C-80E1-361A90369055|1||||C130114|INDUSTRIAL MIX ANTIGEN IGE ANTIBODY|||||||CL|||||||NEGATIVE||MIN/DAY||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|SOLIDIFIED|N|IMMUNODIFFUSION|GMI % FORMULA||NA|N|U|N|||Y|3||39||INDUCTION TREATMENT|1962-10-05|1971-02-06|||||1964-10-26||1969-05-02|U|1972-02-28
TRIAL STUDY 134XCP|LB|580CCA66-3D51-4A5C-80E1-361A90369055|2||||C130138|AMERICAN COCKROACH ANTIGEN IGG ANTIBODY|||||||LOZENGE|||||||INVALID||U/MG||||ABNORMAL|NOT DONE||||SPUTUM|CLOTTED|NA|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROTEST FORMULA||N|NA|NA|N|||U|3||39||RUN-IN|1973-08-06|1970-11-05|||||1965-09-17||1960-05-07|U|1973-05-16
TRIAL STUDY 134XCP|LB|580CCA66-3D51-4A5C-80E1-361A90369055|1||||HIS|HISTIDINE|||||||MOL|||||||TRACE||FARAD||||LOW|NOT DONE||||CAPILLARY BLOOD|FRESH|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||N|N|NA|Y|||U|4||88||CONTINUATION TREATMENT|1961-01-28|1969-03-04|||||1961-11-15||1960-02-14|Y|1961-02-19
TRIAL STUDY 134XCP|LB|580CCA66-3D51-4A5C-80E1-361A90369055|2||||BLAST|BLASTS|||||||NG/L|||||||BORDERLINE||/MM2||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|THAWED|Y|INDIRECT IMMUNOFLUORESCENCE|HEPASCORE FORMULA||NA|N|N|U|||Y|4||88||BASELINE|1966-02-06|1965-07-28|||||1968-03-28||1964-09-21|NA|1961-07-24
TRIAL STUDY 134XCP|LB|580CCA66-3D51-4A5C-80E1-361A90369055|1||||FACTV|FACTOR V|||||||ML/MIN|||||||INDETERMINATE||UMOL/H/MMOL||||LOW|NOT DONE||||EPIDERMAL TISSUE|HEMOLYZED|U|FLUORESCENT SPOT TEST|CKD-EPI CYSTATIN C FORMULA||N|NA|U|NA|||Y|5||7||OBSERVATION|1962-10-02|1964-09-06|||||1960-10-27||1968-07-18|Y|1963-05-11
TRIAL STUDY 134XCP|LB|580CCA66-3D51-4A5C-80E1-361A90369055|2||||FBRTST|FIBROTEST SCORE|||||||U/G/H|||||||POSITIVE||VP/DOSE||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|CONCENTRATED|NA|SXA SCAN|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|NA|||U|5||7||LONG-TERM FOLLOW-UP|1963-09-14|1972-10-24|||||1973-06-26||1964-12-14|Y|1965-02-06
TRIAL STUDY 134XCP|LB|DAB276EB-3581-4C20-88AC-5A3D267E54D8|1||||EOSSG|EOSINOPHILS, SEGMENTED|||||||HR/DAY|||||||INVALID||CMH2O*S2/ML||||NORMAL|NOT DONE||||MONOCYTE|FROZEN|N|MICROBIAL CONCENTRATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|U|NA|||U|1||38||BLINDED TREATMENT|1970-06-09|1964-11-09|||||1968-08-05||1969-04-08|Y|1967-02-23
TRIAL STUDY 134XCP|LB|DAB276EB-3581-4C20-88AC-5A3D267E54D8|2||||CD38|CD38|||||||UKAT/L|||||||POSITIVE||F||||LOW|NOT DONE||||REFLEX TEAR|FROZEN|U|LIGHT MICROSCOPY|GMI MMOL/MOL FORMULA||U|N|N|N|||N|1||38||FOLLOW-UP|1960-01-19|1972-10-17|||||1965-07-08||1962-11-20|Y|1960-11-11
TRIAL STUDY 134XCP|LB|DAB276EB-3581-4C20-88AC-5A3D267E54D8|1||||THMBAAC|THROMBIN ACTIVITY ACTUAL/CONTROL|||||||L/DAY|||||||POSITIVE||CD||||HIGH|NOT DONE||||GASTRIC FLUID|LACTESCENT|N|PHOTOGRAPHY|CKD-EPI FORMULA||U|NA|Y|Y|||U|2||58||INDUCTION TREATMENT|1967-11-18|1966-08-11|||||1962-07-29||1967-05-25|Y|1971-07-11
TRIAL STUDY 134XCP|LB|DAB276EB-3581-4C20-88AC-5A3D267E54D8|2||||IL6SR|SOLUBLE INTERLEUKIN 6 RECEPTOR|||||||LOG10 ELISA UNIT/DOSE|||||||POSITIVE||ML/KG/H||||ABNORMAL|NOT DONE||||BONE MARROW|HEMOLYZED|NA|TWO-COLOR MICROARRAY|MDRD 6 VARIABLE FORMULA||Y|U|N|NA|||NA|2||58||WASHOUT|1962-07-15|1968-12-12|||||1972-03-14||1964-10-31|U|1964-03-10
TRIAL STUDY 134XCP|LB|DAB276EB-3581-4C20-88AC-5A3D267E54D8|1||||SCL70GAB|SCL-70 IGG ANTIBODY|||||||KBQ|||||||INVALID||NM||||NORMAL|NOT DONE||||LUNG SURFACTANT|NON-HEMOLYZED|U|CT SCAN|COCKCROFT-GAULT FORMULA||N|Y|N|Y|||U|3||39||WASHOUT|1970-02-05|1964-10-20|||||1962-01-20||1972-04-12|U|1962-03-30
TRIAL STUDY 134XCP|LB|DAB276EB-3581-4C20-88AC-5A3D267E54D8|2||||MYBLAT1|TYPE I MYELOBLASTS|||||||ROENTGEN|||||||INVALID||PSI||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|HEMOLYZED|N|ELISPOT|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|NA|Y|||Y|3||39||OBSERVATION|1972-03-21|1969-01-06|||||1972-01-28||1966-09-09|NA|1971-03-02
TRIAL STUDY 134XCP|LB|DAB276EB-3581-4C20-88AC-5A3D267E54D8|1||||FERRITIN|FERRITIN|||||||ML/MMHG|||||||BORDERLINE||BISCUIT||||NORMAL|NOT DONE||||PERITONEAL FLUID|HEMOLYZED|U|HEMAGGLUTINATION ASSAY|ASH FIBROSURE FORMULA||NA|Y|U|U|||NA|4||88||WASHOUT|1967-03-09|1971-08-19|||||1966-04-09||1968-12-08|N|1963-10-29
TRIAL STUDY 134XCP|LB|DAB276EB-3581-4C20-88AC-5A3D267E54D8|2||||APOE|APOLIPOPROTEIN E|||||||F|||||||POSITIVE||CMH2O*S2/ML||||ABNORMAL|NOT DONE||||LYMPH|THAWED|Y|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|Y|Y|||NA|4||88||OBSERVATION|1967-11-27|1960-01-26|||||1970-06-01||1963-04-13|U|1969-01-24
TRIAL STUDY 134XCP|LB|DAB276EB-3581-4C20-88AC-5A3D267E54D8|1||||KLCLLCFR|KAPPA LT CHAIN,FREE/LAMBDA LT CHAIN,FREE|||||||UMOL/L/SEC|||||||TRACE||UG/ANIMAL||||ABNORMAL|NOT DONE||||SKIN TISSUE|LACTESCENT|NA|COLORIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|N|Y|||Y|5||7||CONTINUATION TREATMENT|1968-07-25|1964-08-06|||||1970-10-18||1968-08-24|NA|1960-06-08
TRIAL STUDY 134XCP|LB|DAB276EB-3581-4C20-88AC-5A3D267E54D8|2||||THMBAAC|THROMBIN ACTIVITY ACTUAL/CONTROL|||||||HENRY|||||||BORDERLINE||L/MIN||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|GELLED|NA|CLIP SEQUENCING|MDRD ENZYMATIC FORMULA||N|N|N|U|||NA|5||7||OBSERVATION|1973-03-02|1964-02-15|||||1963-01-26||1960-12-03|NA|1973-06-15
TRIAL STUDY 134XCP|LB|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|1||||SICAM1|SOLUBLE INTERCELL ADHESION MOLECULE 1|||||||MEQ/L|||||||INDETERMINATE||10^10/L||||LOW|NOT DONE||||ALVEOLAR AIR|THAWED|U|MRS|MDRD FORMULA||Y|Y|Y|U|||N|1||38||TREATMENT|1971-04-16|1971-12-12|||||1960-03-01||1966-06-07|N|1963-08-22
TRIAL STUDY 134XCP|LB|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|2||||FACTII|FACTOR II|||||||MG/M2/DAY|||||||TRACE||U/DL||||LOW|NOT DONE||||BONE MARROW|CALCIFIED|NA|ACCELERATOR MASS SPECTROMETRY|FIBROSIS 4 FORMULA||N|Y|U|NA|||N|1||38||BLINDED TREATMENT|1961-06-08|1969-06-23|||||1967-01-29||1962-06-14|Y|1960-08-03
TRIAL STUDY 134XCP|LB|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|1||||ICAIGGAB|ISLET CELL CYTOPLASMIC IGG ANTIBODY|||||||CUP|||||||TRACE||/CMH2O||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|HEMOLYZED|U|FLUORESCENT IMMUNOASSAY|MDRD FORMULA||NA|N|U|NA|||Y|2||58||BASELINE|1965-05-09|1970-11-22|||||1964-09-22||1960-04-16|Y|1965-10-16
TRIAL STUDY 134XCP|LB|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|2||||DENSITY|DENSITY|||||||COPIES/UL|||||||INDETERMINATE||M3||||LOW|NOT DONE||||VENOUS PLASMA|UNEXPECTED ODOR|Y|NUCLEIC ACID HYBRIDIZATION|FIBROTEST FORMULA||N|Y|N|Y|||U|2||58||FOLLOW-UP|1967-09-04|1964-04-11|||||1971-08-26||1966-02-07|NA|1972-02-17
TRIAL STUDY 134XCP|LB|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|1||||C130114|INDUSTRIAL MIX ANTIGEN IGE ANTIBODY|||||||UMOL/L/H|||||||NEGATIVE||STEPS||||HIGH|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|Y|POLYGRAPHY|MDRD ENZYMATIC FORMULA||Y|Y|N|Y|||U|3||39||CONTINUATION TREATMENT|1965-01-09|1967-06-23|||||1964-06-12||1968-02-26|Y|1961-10-17
TRIAL STUDY 134XCP|LB|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|2||||T3UP|TRIIODOTHYRONINE UPTAKE|||||||DPM|||||||TRACE||UG/DOSE||||HIGH|NOT DONE||||CORD BLOOD|ICTERIC|Y|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA||NA|Y|NA|Y|||NA|3||39||SCREENING|1973-08-22|1972-03-19|||||1968-03-24||1961-02-20|NA|1964-02-08
TRIAL STUDY 134XCP|LB|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|1||||C4|COMPLEMENT C4|||||||NG/DAY|||||||TRACE||10^9/L||||ABNORMAL|NOT DONE||||RETICULOCYTES|LIPEMIC|U|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|GMI MMOL/MOL FORMULA||U|U|N|Y|||N|4||88||SCREENING|1966-01-27|1972-05-11|||||1972-10-20||1971-09-14|NA|1961-04-21
TRIAL STUDY 134XCP|LB|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|2||||TGFA|TRANSFORMING GROWTH FACTOR ALPHA|||||||MMOL/KG|||||||NEGATIVE||LOG10 CFU/G||||HIGH|NOT DONE||||PERSPIRATION|ROOM TEMPERATURE|N|LIGHT MICROSCOPY|CKD-EPI FORMULA||NA|N|U|U|||U|4||88||RUN-IN|1972-01-31|1961-12-06|||||1960-10-18||1972-05-25|NA|1962-09-14
TRIAL STUDY 134XCP|LB|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|1||||METHQLDN|METHAQUALONE|||||||DIOPTER|||||||INDETERMINATE||G/CAGE/WK||||HIGH|NOT DONE||||URINE|UNEXPECTED ODOR|Y|IN SITU HYBRIDIZATION|MDRD 4 VARIABLE FORMULA||Y|NA|NA|NA|||NA|5||7||FOLLOW-UP|1968-07-27|1965-08-22|||||1964-02-21||1970-10-20|NA|1967-11-13
TRIAL STUDY 134XCP|LB|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|2||||TRANK1|TPR-ANKYRIN REPEAT-CONTAINING PROTEIN 1|||||||EQ|||||||BORDERLINE||ML/ANIMAL/DAY||||ABNORMAL|NOT DONE||||PERSPIRATION|THAWED|U|ANTIBIOTIC AGAR SCREEN|FIBROSIS 4 FORMULA||N|U|N|U|||Y|5||7||LONG-TERM FOLLOW-UP|1967-09-29|1961-02-11|||||1962-06-22||1972-07-06|N|1965-05-15
TRIAL STUDY 134XCP|LB|5B703A43-A280-4D6A-AC40-FF5187521DB2|1||||THCCOOH|11-NOR-DELTA9-THC-9-CARBOXYLIC ACID|||||||LOG10 COPIES/ML|||||||INDETERMINATE||MG/ML/DAY||||LOW|NOT DONE||||INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|NA|SCINTIGRAPHY|FIBROTEST FORMULA||N|Y|Y|U|||Y|1||38||CONTINUATION TREATMENT|1973-06-02|1961-08-15|||||1966-09-13||1966-01-04|Y|1971-04-17
TRIAL STUDY 134XCP|LB|5B703A43-A280-4D6A-AC40-FF5187521DB2|2||||RETI|RETICULOCYTES|||||||NMOL/ML/MIN|||||||INDETERMINATE||MMU/ML||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|PARAFFIN-EMBEDDED|Y|GC/FID|FIBROTEST FORMULA||U|NA|N|Y|||NA|1||38||FOLLOW-UP|1970-04-22|1963-01-05|||||1968-01-05||1970-03-31|NA|1966-02-15
TRIAL STUDY 134XCP|LB|5B703A43-A280-4D6A-AC40-FF5187521DB2|1||||LDLPATT|LDL SUBTYPE PATTERN|||||||P|||||||BORDERLINE||ML/G/H||||NORMAL|NOT DONE||||REFLEX TEAR|ROOM TEMPERATURE|Y|MAPH|FIBROMETER FORMULA||NA|U|NA|Y|||Y|2||58||BLINDED TREATMENT|1965-08-27|1963-04-24|||||1972-07-10||1970-08-12|Y|1967-06-18
TRIAL STUDY 134XCP|LB|5B703A43-A280-4D6A-AC40-FF5187521DB2|2||||NEUTSGLE|NEUTROPHILS, SEGMENTED/LEUKOCYTES|||||||CCID 50/ML|||||||POSITIVE||MEQ/ML||||NORMAL|NOT DONE||||PLEURAL FLUID|FROZEN|Y|DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI CYSTATIN C FORMULA||U|N|Y|Y|||N|2||58||TREATMENT|1964-09-09|1960-01-10|||||1960-03-13||1960-04-25|NA|1968-02-08
TRIAL STUDY 134XCP|LB|5B703A43-A280-4D6A-AC40-FF5187521DB2|1||||ESTRONE|ESTRONE|||||||SACHET|||||||NEGATIVE||/2500 WBC||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|REFRIGERATED|U|CISH|CKD-EPI CREATININE FORMULA||U|U|Y|U|||NA|3||39||FOLLOW-UP|1961-11-13|1967-11-02|||||1966-10-24||1963-07-09|NA|1972-04-26
TRIAL STUDY 134XCP|LB|5B703A43-A280-4D6A-AC40-FF5187521DB2|2||||OCCBLD|OCCULT BLOOD|||||||ANTI-XA IU|||||||INVALID||VG/DOSE||||HIGH|NOT DONE||||VENOUS BLOOD|HEMOLYZED|N|THERMAL IONIZATION MASS SPECTROMETRY|MDRD FORMULA||U|U|Y|U|||U|3||39||SCREENING|1963-02-14|1973-08-07|||||1963-10-12||1963-05-24|Y|1969-12-03
TRIAL STUDY 134XCP|LB|5B703A43-A280-4D6A-AC40-FF5187521DB2|1||||HEMOLYSI|HEMOLYTIC INDEX|||||||10^7 CFU/ML|||||||TRACE||ARBITRARY U||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|ROOM TEMPERATURE|N|CENTRIFUGATION|GMI % FORMULA||NA|Y|NA|NA|||N|4||88||RUN-IN|1966-05-28|1963-05-04|||||1968-02-19||1966-12-26|U|1971-03-13
TRIAL STUDY 134XCP|LB|5B703A43-A280-4D6A-AC40-FF5187521DB2|2||||FLUOXTN|FLUOXETINE|||||||SIEMENS|||||||INVALID||HOUNSFIELD UNIT||||NORMAL|NOT DONE||||KERATINOCYTE|REFRIGERATED|U|FLUORESCENCE ANGIOGRAPHY|CKD-EPI CREATININE FORMULA||Y|NA|U|Y|||N|4||88||LONG-TERM FOLLOW-UP|1965-08-18|1960-04-14|||||1968-01-01||1970-01-26|Y|1962-11-17
TRIAL STUDY 134XCP|LB|5B703A43-A280-4D6A-AC40-FF5187521DB2|1||||CD8|CD8|||||||UG/M2/DAY|||||||POSITIVE||GPL U/ML||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|HEMOLYZED|U|MICROBIAL CONCENTRATION|FIBROSIS 4 FORMULA||Y|NA|N|N|||N|5||7||CONTINUATION TREATMENT|1961-11-07|1960-03-20|||||1966-08-01||1970-04-15|Y|1968-09-07
TRIAL STUDY 134XCP|LB|5B703A43-A280-4D6A-AC40-FF5187521DB2|2||||GAD2AB|GLUTAMIC ACID DECARBOXYLASE 2 ANTIBODY|||||||GY|||||||POSITIVE||MMOL/L||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LACTESCENT|NA|U-HPLC/MS/MS|MDRD 6 VARIABLE FORMULA||U|Y|U|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1965-10-30|1969-02-17|||||1963-06-26||1969-11-13|Y|1969-02-06
TRIAL STUDY 134XCP|LB|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|1||||CTXIICRT|TYPE II COLLAGEN C-TELOPEPTIDES/CREAT|||||||PMOL/G|||||||POSITIVE||MG/ML/DAY||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|CLOTTED|Y|SINGLE-MOLECULE ARRAY|MDRD FORMULA||NA|U|U|NA|||U|1||38||BASELINE|1971-08-20|1969-04-21|||||1972-06-13||1963-12-31|U|1961-12-14
TRIAL STUDY 134XCP|LB|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|2||||C165923|TREE MIX POLLEN IGE AB RAST SCORE|||||||%/S|||||||INDETERMINATE||10^6 ORGANISMS/G||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|FRESH|Y|LISSAMINE GREEN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|N|N|||N|1||38||BLINDED TREATMENT|1966-09-19|1966-02-06|||||1970-08-28||1968-04-24|Y|1973-08-23
TRIAL STUDY 134XCP|LB|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|1||||MONOIM|IMMATURE MONOCYTES|||||||CMHG|||||||NEGATIVE||PFU/DOSE||||ABNORMAL|NOT DONE||||LYMPH|LIPEMIC|NA|DYNAMIC LIGHT SCATTERING|GMI MMOL/MOL FORMULA||N|NA|U|NA|||U|2||58||INDUCTION TREATMENT|1967-12-15|1964-11-12|||||1965-04-23||1967-11-17|U|1965-09-25
TRIAL STUDY 134XCP|LB|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|2||||APOA|APOLIPOPROTEIN A|||||||DAGU|||||||INDETERMINATE||U/MMOL||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|FRESH|NA|POTENTIOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|U|U|||NA|2||58||BASELINE|1971-05-15|1966-10-27|||||1968-07-19||1962-08-29|NA|1964-05-08
TRIAL STUDY 134XCP|LB|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|1||||LYMCLF|LYMPHOCYTES, CLEFTED|||||||NMOL/G|||||||INVALID||FIU||||LOW|NOT DONE||||HAIR|THAWED|U|PAP STAIN|CKD-EPI CYSTATIN C FORMULA||NA|NA|Y|U|||Y|3||39||WASHOUT|1961-07-08|1972-05-08|||||1969-03-19||1971-01-10|N|1964-05-31
TRIAL STUDY 134XCP|LB|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|2||||DMG|DIMETHYLGLYCINE|||||||CG|||||||TRACE||UG/DOSE||||NORMAL|NOT DONE||||BLOOD|LACTESCENT|N|PELLI-ROBSON EYE CHART|MDRD ENZYMATIC FORMULA||U|NA|Y|NA|||N|3||39||INDUCTION TREATMENT|1967-11-09|1970-09-28|||||1963-06-06||1968-10-17|Y|1964-10-09
TRIAL STUDY 134XCP|LB|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|1||||WBCDIFF|LEUKOCYTE CELL DIFFERENTIAL|||||||PUFF|||||||INVALID||LOG10 ELISA UNIT||||HIGH|NOT DONE||||CELL PELLET|NON-HEMOLYZED|U|MODIFIED ACID FAST STAIN|NASH FIBROSURE FORMULA||NA|NA|Y|U|||Y|4||88||TREATMENT|1965-10-08|1966-03-20|||||1966-09-26||1963-02-09|NA|1971-04-23
TRIAL STUDY 134XCP|LB|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|2||||AMYLB42|AMYLOID BETA 1-42|||||||KG/CM2|||||||INVALID||100 IU/ML||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|U|U|||N|4||88||SCREENING|1960-07-25|1963-04-08|||||1970-08-29||1972-07-03|N|1973-03-29
TRIAL STUDY 134XCP|LB|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|1||||LKM1IAAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGA AB|||||||FFU|||||||POSITIVE||LOG10 ELISA UNIT||||HIGH|NOT DONE||||PROSTATIC FLUID|CALCIFIED|U|SISH|GMI MMOL/MOL FORMULA||N|Y|U|U|||N|5||7||SCREENING|1960-04-03|1961-07-11|||||1963-09-07||1970-09-25|Y|1961-06-28
TRIAL STUDY 134XCP|LB|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|2||||GLYHLACD|GLYCOCHOLIC ACID|||||||NEWTON|||||||NEGATIVE||KPA/L/SEC||||NORMAL|NOT DONE||||EMOTIONAL TEAR|SOLIDIFIED|U|EEG|CKD-EPI CREATININE FORMULA||NA|U|Y|NA|||N|5||7||BLINDED TREATMENT|1969-11-16|1971-11-12|||||1964-06-08||1965-10-17|N|1967-11-04
TRIAL STUDY 134XCP|LB|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|1||||CORTISOL|CORTISOL|||||||%|||||||BORDERLINE||/MS||||ABNORMAL|NOT DONE||||DISCHARGE|SOLIDIFIED|U|SINGLE-SLICE SPIRAL CT|FIBROMETER FORMULA||U|U|NA|NA|||Y|1||38||OBSERVATION|1972-12-06|1966-12-15|||||1962-12-07||1970-02-22|N|1966-01-08
TRIAL STUDY 134XCP|LB|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|2||||INSULINR|INSULIN RESISTANCE|||||||%(V/V)|||||||TRACE||MMHG/SEC||||HIGH|NOT DONE||||LOCHIA|NON-HEMOLYZED|N|WESTERN BLOT|HEPASCORE FORMULA||U|NA|N|Y|||Y|1||38||INDUCTION TREATMENT|1962-12-09|1967-01-31|||||1960-05-31||1965-07-22|N|1970-12-29
TRIAL STUDY 134XCP|LB|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|1||||PKM1|PYRUVATE KINASE ISOZYME M1|||||||DAGU/ML|||||||INVALID||GAUSS||||NORMAL|NOT DONE||||SEMINAL FLUID|CONCENTRATED|N|SURFACE PLASMON RESONANCE|FIBROMETER FORMULA||NA|NA|Y|N|||U|2||58||BLINDED TREATMENT|1966-06-20|1967-03-18|||||1969-08-14||1962-02-01|NA|1968-09-19
TRIAL STUDY 134XCP|LB|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|2||||CARNITF|CARNITINE, FREE|||||||G/M2|||||||INDETERMINATE||CAN||||LOW|NOT DONE||||SEMEN|PARAFFIN-EMBEDDED|NA|PALM METHOD|MDRD FORMULA||N|Y|NA|Y|||Y|2||58||OPEN LABEL TREATMENT|1969-03-07|1972-06-17|||||1967-08-23||1970-08-10|NA|1967-02-08
TRIAL STUDY 134XCP|LB|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|1||||HLAA|HLA CLASS IA ANTIGEN|||||||HR/DAY|||||||TRACE||FINGERTIP UNIT||||NORMAL|NOT DONE||||MONOCYTE|FROZEN|U|PLETHYSMOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|Y|N|||U|3||39||CONTINUATION TREATMENT|1965-07-31|1964-09-21|||||1973-02-09||1963-06-11|U|1963-03-03
TRIAL STUDY 134XCP|LB|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|2||||GSTMU|MU GLUTATHIONE-S-TRANSFERASE|||||||DPM|||||||TRACE||PFU/ANIMAL||||HIGH|NOT DONE||||FLUID|PARAFFIN-EMBEDDED|Y|DUCTOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|N|U|U|||Y|3||39||OPEN LABEL TREATMENT|1973-08-19|1964-07-30|||||1966-12-01||1966-02-28|N|1965-07-16
TRIAL STUDY 134XCP|LB|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|1||||FACTII|FACTOR II|||||||CS|||||||NEGATIVE||MG/DAY||||LOW|NOT DONE||||PERSPIRATION|CONTAMINATED|N|POPULATION SEQUENCING|HEPASCORE FORMULA||N|N|N|U|||NA|4||88||WASHOUT|1967-05-15|1963-04-16|||||1971-10-22||1973-04-06|NA|1966-07-06
TRIAL STUDY 134XCP|LB|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|2||||GEC|GALACTOSE ELIMINATION CAPACITY|||||||MASK|||||||TRACE||10^6 IU||||NORMAL|NOT DONE||||ADIPOSE TISSUE|PARAFFIN-EMBEDDED|U|BALLPOINT PEN TECHNIQUE|MDRD ENZYMATIC FORMULA||N|U|U|Y|||N|4||88||BLINDED TREATMENT|1972-11-17|1960-02-14|||||1971-07-23||1961-02-12|U|1968-07-29
TRIAL STUDY 134XCP|LB|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|1||||TTGIGAAB|TISSUE TRANSGLUTAMINASE IGA ANTIBODY|||||||MG/ANIMAL|||||||NEGATIVE||HOUNSFIELD UNIT||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|HEMOLYZED|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|FIBROSIS 4 FORMULA||Y|N|NA|NA|||Y|5||7||BLINDED TREATMENT|1973-04-13|1960-05-13|||||1964-05-27||1965-11-13|Y|1961-05-21
TRIAL STUDY 134XCP|LB|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|2||||HYXLYS|HYDROXYLYSINE|||||||UG/L/H|||||||BORDERLINE||/5X10^4 WBC||||NORMAL|NOT DONE||||SMEGMA|CONCENTRATED|Y|MICROBIAL CULTURE|CKD-EPI CREATININE FORMULA||N|NA|Y|U|||Y|5||7||INDUCTION TREATMENT|1972-05-25|1967-09-02|||||1968-01-29||1969-11-19|U|1965-05-18
TRIAL STUDY 134XCP|LB|51F3D3C1-3361-499F-B037-CCE8AB989989|1||||TTAC|THROMBIN TIME ACTUAL/CONTROL|||||||/MONTH|||||||TRACE||U/G/DAY||||HIGH|NOT DONE||||TRANSUDATE|ROOM TEMPERATURE|U|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|N|Y|||U|1||38||RUN-IN|1961-11-08|1965-10-28|||||1964-05-03||1963-12-30|U|1960-01-13
TRIAL STUDY 134XCP|LB|51F3D3C1-3361-499F-B037-CCE8AB989989|2||||EDMAB|ENDOMYSIAL ANTIBODY|||||||KIU|||||||INDETERMINATE||MMHG/SEC||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|DRIED|U|NUCLEAR RADIOLOGY|COCKCROFT-GAULT FORMULA||Y|U|Y|N|||N|1||38||TREATMENT|1968-05-03|1972-03-31|||||1967-03-30||1971-09-23|NA|1968-04-19
TRIAL STUDY 134XCP|LB|51F3D3C1-3361-499F-B037-CCE8AB989989|1||||FRUCT|FRUCTOSAMINE|||||||10^3 ORGANISMS/ML|||||||INDETERMINATE||MET*H||||ABNORMAL|NOT DONE||||COLOSTRUM|THAWED|Y|QUANTITATIVE COMPUTED TOMOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|NA|U|N|||U|2||58||BLINDED TREATMENT|1966-05-11|1967-04-08|||||1961-02-10||1970-05-10|U|1972-08-12
TRIAL STUDY 134XCP|LB|51F3D3C1-3361-499F-B037-CCE8AB989989|2||||C130118|BEE MIX ANTIGEN IGG4 ANTIBODY|||||||MV2/HZ|||||||NEGATIVE||LOG10 CCID 50/DOSE||||NORMAL|NOT DONE||||EXUDATE|AUTOLYZED|Y|WHOLE GENOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|Y|||NA|2||58||LONG-TERM FOLLOW-UP|1971-12-21|1963-07-22|||||1965-06-24||1970-08-30|U|1960-08-05
TRIAL STUDY 134XCP|LB|51F3D3C1-3361-499F-B037-CCE8AB989989|1||||ACHE|ACETYLCHOLINESTERASE|||||||MMHG*MIN/L|||||||POSITIVE||MASK||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|ICTERIC|N|SEQUENCING|FIBROTEST FORMULA||NA|NA|N|NA|||U|3||39||INDUCTION TREATMENT|1960-07-04|1972-07-24|||||1963-03-07||1964-11-24|NA|1960-12-31
TRIAL STUDY 134XCP|LB|51F3D3C1-3361-499F-B037-CCE8AB989989|2||||DCCARNIT|DECANOYLCARNITINE|||||||LOG10 CCID 50/DOSE|||||||POSITIVE||CONTAINER||||LOW|NOT DONE||||BILE|UNEXPECTED ODOR|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|COCKCROFT-GAULT FORMULA||U|NA|Y|Y|||U|3||39||CONTINUATION TREATMENT|1972-03-05|1966-07-07|||||1963-06-27||1973-08-30|U|1966-10-18
TRIAL STUDY 134XCP|LB|51F3D3C1-3361-499F-B037-CCE8AB989989|1||||CKMBCK|CREATINE KINASE MB/TOTAL CREATINE KINASE|||||||MU|||||||INVALID||MG/M2||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|UNEXPECTED ODOR|Y|MANUAL CLOT DETECTION|GMI % FORMULA||Y|NA|U|U|||Y|4||88||WASHOUT|1963-01-07|1968-11-19|||||1961-04-16||1973-02-18|Y|1960-03-04
TRIAL STUDY 134XCP|LB|51F3D3C1-3361-499F-B037-CCE8AB989989|2||||CETPA|CHOLESTERYL ESTER TRANSFER PROTEIN ACT|||||||CYLINDER|||||||BORDERLINE||G/L||||NORMAL|NOT DONE||||VENOUS BLOOD|CLOTTED|NA|TRICHROME STAIN|GMI % FORMULA||N|Y|U|NA|||N|4||88||RUN-IN|1963-07-08|1968-12-20|||||1963-05-19||1969-06-24|N|1967-06-15
TRIAL STUDY 134XCP|LB|51F3D3C1-3361-499F-B037-CCE8AB989989|1||||C165933|AMERICAN COCKROACH IGE AB RAST SCORE|||||||MOL/ML|||||||INDETERMINATE||UG/M2||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|AUTOLYZED|U|NEXT GENERATION SEQUENCING|MDRD ENZYMATIC FORMULA||Y|Y|N|U|||N|5||7||OPEN LABEL TREATMENT|1960-07-02|1971-01-20|||||1967-01-20||1969-07-03|N|1960-06-11
TRIAL STUDY 134XCP|LB|51F3D3C1-3361-499F-B037-CCE8AB989989|2||||HCGFR|CHORIOGONADOTROPIN BETA, FREE|||||||DAMOL/L|||||||POSITIVE||G/DL||||LOW|NOT DONE||||BUFFY COAT|REFRIGERATED|NA|SNELLEN EYE CHART|MDRD 4 VARIABLE FORMULA||NA|N|N|N|||Y|5||7||OBSERVATION|1971-10-26|1970-10-09|||||1971-12-20||1970-01-30|N|1972-12-11
TRIAL STUDY 134XCP|LB|231D401F-CA93-49E0-AC5C-C7F636343D2F|1||||CRTCLRE|CREATININE CLEARANCE, ESTIMATED|||||||UMOL/L/MIN|||||||TRACE||ECL UNIT||||ABNORMAL|NOT DONE||||ABSCESS FLUID|AUTOLYZED|U|X-RAY|MDRD FORMULA||U|Y|U|NA|||NA|1||38||SCREENING|1973-04-25|1963-07-02|||||1973-05-13||1971-10-31|N|1968-10-30
TRIAL STUDY 134XCP|LB|231D401F-CA93-49E0-AC5C-C7F636343D2F|2||||AMNOACID|AMINO ACIDS|||||||CARTRIDGE|||||||NEGATIVE||MG/M2/MIN||||NORMAL|NOT DONE||||ISOLATE|FROZEN|U|HANSEL STAIN|MDRD FORMULA||NA|U|Y|U|||N|1||38||FOLLOW-UP|1969-12-17|1966-04-12|||||1960-10-13||1969-08-31|NA|1966-11-26
TRIAL STUDY 134XCP|LB|231D401F-CA93-49E0-AC5C-C7F636343D2F|1||||C165878|GERMAN COCKROACH IGE AB RAST SCORE|||||||COAT|||||||NEGATIVE||MG/H||||ABNORMAL|NOT DONE||||COLOSTRUM|HEMOLYZED|NA|ROMANOWSKY STAIN|CKD-EPI CYSTATIN C FORMULA||U|NA|NA|Y|||N|2||58||RUN-IN|1971-10-12|1971-02-24|||||1967-04-22||1973-03-30|N|1966-01-16
TRIAL STUDY 134XCP|LB|231D401F-CA93-49E0-AC5C-C7F636343D2F|2||||ALP|ALKALINE PHOSPHATASE|||||||AGU/ML|||||||BORDERLINE||JOULE||||ABNORMAL|NOT DONE||||SMEGMA|HEMOLYZED|U|GRAM STAIN|NASH FIBROSURE FORMULA||Y|Y|N|Y|||U|2||58||BASELINE|1968-07-26|1972-05-29|||||1969-11-01||1968-06-21|NA|1960-03-01
TRIAL STUDY 134XCP|LB|231D401F-CA93-49E0-AC5C-C7F636343D2F|1||||SPMMSPM|MOTILE SPERM/TOTAL SPERM|||||||KIU|||||||TRACE||RPM||||LOW|NOT DONE||||SEMINAL FLUID|AUTOLYZED|Y|BETA LACTAMASE|CKD-EPI CYSTATIN C FORMULA||N|U|U|U|||NA|3||39||SCREENING|1965-05-22|1963-09-15|||||1970-04-24||1972-05-15|U|1963-03-15
TRIAL STUDY 134XCP|LB|231D401F-CA93-49E0-AC5C-C7F636343D2F|2||||HDLPSZ|HDL PARTICLE SIZE|||||||DPM/ML|||||||TRACE||G/ANIMAL/WK||||HIGH|NOT DONE||||PERSPIRATION|CALCIFIED|Y|TRIPLE-PHASE SPIRAL CT SCAN|CKD-EPI FORMULA||Y|N|U|Y|||Y|3||39||RUN-IN|1965-04-03|1972-08-07|||||1969-08-14||1966-04-14|N|1966-05-28
TRIAL STUDY 134XCP|LB|231D401F-CA93-49E0-AC5C-C7F636343D2F|1||||LIPEMIAI|LIPEMIC INDEX|||||||NEWTON|||||||INVALID||CONTAINER||||NORMAL|NOT DONE||||MUSCLE TISSUE|PARAFFIN-EMBEDDED|NA|LIGHT MICROSCOPY|COCKCROFT-GAULT FORMULA||NA|N|N|N|||U|4||88||CONTINUATION TREATMENT|1964-08-05|1960-11-12|||||1968-01-16||1967-11-20|Y|1971-11-10
TRIAL STUDY 134XCP|LB|231D401F-CA93-49E0-AC5C-C7F636343D2F|2||||TIMP1CRE|TIMP1/CREATININE|||||||ANTI-XA IU/ML|||||||INVALID||UCI/KG||||NORMAL|NOT DONE||||KERATINOCYTE|LIPEMIC|NA|MRS|MDRD 6 VARIABLE FORMULA||NA|N|Y|U|||U|4||88||RUN-IN|1965-12-04|1967-09-01|||||1962-08-09||1968-05-28|U|1967-08-29
TRIAL STUDY 134XCP|LB|231D401F-CA93-49E0-AC5C-C7F636343D2F|1||||RLP|RLP CHOLESTEROL|||||||ENZYME U/L|||||||TRACE||UG/CM2||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|CONCENTRATED|N|CELL BASED BIOASSAY|CKD-EPI CYSTATIN C FORMULA||NA|NA|Y|U|||NA|5||7||WASHOUT|1966-04-23|1969-10-30|||||1964-10-29||1970-06-14|NA|1963-09-19
TRIAL STUDY 134XCP|LB|231D401F-CA93-49E0-AC5C-C7F636343D2F|2||||C165919|GERMAN COCKROACH IGG AB RAST SCORE|||||||SHOCK WAVE|||||||TRACE||NMOL/G||||HIGH|NOT DONE||||LEUKOCYTE|NON-HEMOLYZED|U|ULTRASONOGRAPHIC ELASTOGRAPHY|NASH FIBROSURE FORMULA||U|N|N|Y|||NA|5||7||RUN-IN|1963-11-16|1962-05-14|||||1965-06-25||1964-03-19|NA|1962-11-14
TRIAL STUDY 134XCP|LB|2704A3C0-3345-48E5-AC9B-C00EA51AB085|1||||PLSMCE|MATURE PLASMA CELLS|||||||SV|||||||POSITIVE||10^6 CFU/ML||||LOW|NOT DONE||||TISSUE|GELLED|U|IMMUNE REPERTOIRE DEEP SEQUENCING|GMI % FORMULA||Y|U|NA|N|||Y|1||38||WASHOUT|1965-08-17|1970-04-23|||||1967-01-02||1960-02-17|Y|1964-02-26
TRIAL STUDY 134XCP|LB|2704A3C0-3345-48E5-AC9B-C00EA51AB085|2||||PCP|PHENCYCLIDINE|||||||MS2|||||||POSITIVE||MV*MIN||||LOW|NOT DONE||||LYSATE|NON-HEMOLYZED|Y|ELECTRONEUROGRAPHY|MDRD ENZYMATIC FORMULA||Y|N|U|U|||N|1||38||TREATMENT|1966-04-16|1967-08-19|||||1965-12-15||1973-03-03|Y|1970-10-23
TRIAL STUDY 134XCP|LB|2704A3C0-3345-48E5-AC9B-C00EA51AB085|1||||RBCAGGLU|ERYTHROCYTE AGGLUTINATION|||||||10^6 ORGANISMS|||||||TRACE||/LSQN||||LOW|NOT DONE||||INFRANATANT, PLASMA|NON-HEMOLYZED|NA|INTERRUPTER TECHNIQUE|CKD-EPI CREATININE FORMULA||NA|U|NA|NA|||N|2||58||TREATMENT|1973-04-07|1969-11-05|||||1972-03-11||1972-09-21|U|1972-05-13
TRIAL STUDY 134XCP|LB|2704A3C0-3345-48E5-AC9B-C00EA51AB085|2||||CTC|CIRCULATING TUMOR CELLS|||||||DL|||||||TRACE||/H||||NORMAL|NOT DONE||||SERUM|HEMOLYZED|N|CONTRAST ENHANCED CT SCAN|HEPASCORE FORMULA||U|N|N|U|||U|2||58||BASELINE|1966-12-12|1962-10-26|||||1961-01-13||1973-08-20|NA|1966-03-12
TRIAL STUDY 134XCP|LB|2704A3C0-3345-48E5-AC9B-C00EA51AB085|1||||IL2RB|INTERLEUKIN 2 RECEPTOR SUBUNIT BETA|||||||FMOL/G|||||||POSITIVE||APL U||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|THAWED|U|DIFFUSION WEIGHTED MRI|FIBROMETER FORMULA||NA|Y|N|N|||N|3||39||INDUCTION TREATMENT|1971-01-28|1970-10-24|||||1971-03-28||1971-01-01|U|1964-04-02
TRIAL STUDY 134XCP|LB|2704A3C0-3345-48E5-AC9B-C00EA51AB085|2||||PTHI|PARATHYROID HORMONE, INTACT|||||||FL|||||||BORDERLINE||LOG10 TCID 50/UL||||ABNORMAL|NOT DONE||||EXPIRED AIR|LACTESCENT|N|CYSTOMETRY|ASH FIBROSURE FORMULA||N|U|N|NA|||U|3||39||SCREENING|1972-01-31|1961-04-04|||||1971-03-25||1965-05-24|N|1969-04-01
TRIAL STUDY 134XCP|LB|2704A3C0-3345-48E5-AC9B-C00EA51AB085|1||||FCTVIIAA|FACTOR VIIA ACTIVITY|||||||IU/ML|||||||TRACE||PG/CELL||||LOW|NOT DONE||||INTERSTITIAL FLUID|REFRIGERATED|U|CLIP|CKD-EPI FORMULA||U|U|NA|NA|||Y|4||88||OBSERVATION|1968-04-08|1971-09-23|||||1964-07-27||1969-12-23|U|1964-02-11
TRIAL STUDY 134XCP|LB|2704A3C0-3345-48E5-AC9B-C00EA51AB085|2||||MGB|MYOGLOBIN|||||||NG/DL|||||||INDETERMINATE||IU/G HB||||ABNORMAL|NOT DONE||||ERYTHROCYTES|FROZEN|Y|IVY INCISION METHOD|CKD-EPI FORMULA||U|N|Y|Y|||N|4||88||TREATMENT|1969-12-02|1972-11-09|||||1962-08-26||1964-09-07|NA|1960-12-26
TRIAL STUDY 134XCP|LB|2704A3C0-3345-48E5-AC9B-C00EA51AB085|1||||PIVKAII|PROTEIN INDUCED BY VITAMIN K ABSENCE-II|||||||MCI/L|||||||INVALID||IU/KG/H||||LOW|NOT DONE||||ALVEOLAR AIR|NON-HEMOLYZED|N|DIGITAL PCR|GMI % FORMULA||N|Y|U|Y|||U|5||7||LONG-TERM FOLLOW-UP|1971-03-07|1971-07-24|||||1973-04-11||1962-09-17|Y|1969-04-28
TRIAL STUDY 134XCP|LB|2704A3C0-3345-48E5-AC9B-C00EA51AB085|2||||FUNGI|FUNGI|||||||ATM|||||||INVALID||/VF||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC|N|DUCTOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|NA|Y|N|||NA|5||7||WASHOUT|1962-03-18|1962-03-26|||||1971-11-17||1961-09-08|U|1964-06-01
TRIAL STUDY 134XCP|LB|2F636370-94FE-4BC0-9E16-DDD42D19A985|1||||BASOCE|BASOPHILS/TOTAL CELLS|||||||ML/BREATH|||||||POSITIVE||KG/CM2||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA||N|Y|Y|Y|||N|1||38||RUN-IN|1968-01-11|1964-04-15|||||1973-08-04||1968-02-14|NA|1965-03-09
TRIAL STUDY 134XCP|LB|2F636370-94FE-4BC0-9E16-DDD42D19A985|2||||MONO|MONOCYTES|||||||KA_U/DL|||||||INVALID||U/KG/MIN||||LOW|NOT DONE||||EMESIS|DRIED|U|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|GMI MMOL/MOL FORMULA||Y|NA|Y|NA|||NA|1||38||OBSERVATION|1963-09-25|1966-10-10|||||1971-11-09||1971-12-06|U|1967-11-28
TRIAL STUDY 134XCP|LB|2F636370-94FE-4BC0-9E16-DDD42D19A985|1||||ASTCK|AST/CREATINE KINASE|||||||NCI|||||||TRACE||BQ||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|ICTERIC|NA|DIGITAL PCR ARRAY|GMI MMOL/MOL FORMULA||Y|Y|U|NA|||Y|2||58||OBSERVATION|1961-10-21|1965-03-30|||||1963-03-24||1966-10-25|Y|1963-11-15
TRIAL STUDY 134XCP|LB|2F636370-94FE-4BC0-9E16-DDD42D19A985|2||||AMORPHSD|AMORPHOUS SEDIMENT|||||||MPA|||||||INDETERMINATE||NG||||LOW|NOT DONE||||CAPILLARY BLOOD|AUTOLYZED|U|MICRONEUTRALIZATION ASSAY|FIBROTEST FORMULA||NA|N|N|NA|||NA|2||58||BLINDED TREATMENT|1965-06-16|1971-12-04|||||1963-07-19||1971-04-24|Y|1966-12-15
TRIAL STUDY 134XCP|LB|2F636370-94FE-4BC0-9E16-DDD42D19A985|1||||TLYCE|T-LYMPHOCYTES|||||||UM2|||||||BORDERLINE||MNFI||||NORMAL|NOT DONE||||PERSPIRATION|PARAFFIN-EMBEDDED|N|AUDIOMETRY|GMI % FORMULA||NA|NA|NA|Y|||U|3||39||BLINDED TREATMENT|1972-10-26|1964-09-29|||||1963-11-19||1970-04-17|NA|1961-10-03
TRIAL STUDY 134XCP|LB|2F636370-94FE-4BC0-9E16-DDD42D19A985|2||||FGF21|FIBROBLAST GROWTH FACTOR 21|||||||%(V/V)|||||||POSITIVE||G/KG||||NORMAL|NOT DONE||||URINE SEDIMENT|HEMOLYZED|N|GC/MS/MS|MDRD 5 VARIABLE FORMULA||N|U|NA|NA|||NA|3||39||OPEN LABEL TREATMENT|1969-04-12|1968-05-11|||||1969-03-08||1967-11-17|NA|1961-10-15
TRIAL STUDY 134XCP|LB|2F636370-94FE-4BC0-9E16-DDD42D19A985|1||||TSTFWTST|TESTOSTERONE FREE+WEAKLY BOUND/TESTOST|||||||KG/MOL|||||||BORDERLINE||BEAM BREAKS||||HIGH|NOT DONE||||LAVAGE FLUID|DRIED|U|PHOROPTER|MDRD FORMULA||NA|N|Y|N|||NA|4||88||BLINDED TREATMENT|1969-11-27|1970-06-02|||||1969-03-21||1972-05-18|Y|1965-02-08
TRIAL STUDY 134XCP|LB|2F636370-94FE-4BC0-9E16-DDD42D19A985|2||||ETPLTR|ETP LAG TIME RELATIVE|||||||BOX|||||||INVALID||KBQ||||NORMAL|NOT DONE||||PUS|CONCENTRATED|U|PELLI-ROBSON EYE CHART|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|Y|N|||U|4||88||OPEN LABEL TREATMENT|1972-05-03|1973-07-18|||||1972-02-06||1970-09-11|N|1970-07-07
TRIAL STUDY 134XCP|LB|2F636370-94FE-4BC0-9E16-DDD42D19A985|1||||CMPK2|CYTIDINE-URIDINE MONOPHOSPHATE KINASE 2|||||||GRAVITATIONAL UNIT|||||||BORDERLINE||GPL U||||LOW|NOT DONE||||CAPILLARY BLOOD|HEMOLYZED|Y|IRON HEMATOXYLIN STAIN|CKD-EPI FORMULA||U|U|N|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1973-04-15|1962-06-01|||||1973-01-18||1960-10-21|N|1961-09-22
TRIAL STUDY 134XCP|LB|2F636370-94FE-4BC0-9E16-DDD42D19A985|2||||FECL|FRACTIONAL CHLORIDE EXCRETION|||||||COPIES/UG|||||||INVALID||DYN||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|THAWED|U|KLEIHAUER-BETKE|HEPASCORE FORMULA||NA|U|Y|U|||U|5||7||SCREENING|1966-06-10|1969-08-01|||||1962-03-29||1960-11-01|Y|1971-10-21
TRIAL STUDY 134XCP|LB|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|1||||CSAB|CATHEPSIN ANTIBODY|||||||PIXELS/IN|||||||NEGATIVE||CI/ML||||NORMAL|NOT DONE||||CELL PELLET|PARAFFIN-EMBEDDED|U|MICROARRAY|MDRD 4 VARIABLE FORMULA||NA|Y|NA|U|||N|1||38||CONTINUATION TREATMENT|1965-12-29|1964-07-10|||||1960-04-25||1961-09-13|U|1965-10-19
TRIAL STUDY 134XCP|LB|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|2||||SJSSBAB|SJOGRENS SS-B ANTIBODY|||||||CAL|||||||BORDERLINE||CS||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|FROZEN|Y|ENZYMATIC SPECTROPHOTOMETRY|GMI % FORMULA||N|Y|N|NA|||Y|1||38||OBSERVATION|1972-12-02|1965-01-21|||||1960-08-13||1965-10-27|U|1972-11-01
TRIAL STUDY 134XCP|LB|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|1||||C130109|MOLD MIX ANTIGEN IGE ANTIBODY|||||||BE/ML|||||||INDETERMINATE||UMOL/DAY||||ABNORMAL|NOT DONE||||KERATINOCYTE|GELLED|Y|ARTERIAL SPIN LABELING FUNCTIONAL MRI|CKD-EPI FORMULA||U|N|N|U|||Y|2||58||TREATMENT|1964-10-10|1967-05-29|||||1970-06-27||1968-07-18|Y|1960-12-09
TRIAL STUDY 134XCP|LB|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|2||||TROPONIN|TROPONIN|||||||10^9 ORGANISMS/G|||||||TRACE||UM||||LOW|NOT DONE||||CALCULUS|LACTESCENT|NA|LC-FL|COCKCROFT-GAULT FORMULA||U|NA|U|N|||N|2||58||OPEN LABEL TREATMENT|1965-11-03|1970-08-15|||||1969-10-06||1967-02-15|Y|1960-01-23
TRIAL STUDY 134XCP|LB|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|1||||LEUKCRBC|LEUKS CORRECTED FOR NUCL ERYTHROCYTES|||||||EIA UNIT|||||||BORDERLINE||APL U||||NORMAL|NOT DONE||||SERUM|ICTERIC|U|PERIODIC ACID SCHIFF STAIN|MDRD FORMULA||Y|U|Y|N|||U|3||39||BASELINE|1960-08-12|1963-06-17|||||1967-02-01||1965-11-14|U|1966-04-30
TRIAL STUDY 134XCP|LB|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|2||||LTD4|LEUKOTRIENE D4|||||||LOG10 CFU/G|||||||TRACE||LOG10 CFU/ML||||HIGH|NOT DONE||||REFLEX TEAR|DRIED|NA|CONTRAST ENHANCED PET/CT SCAN|FIBROSIS 4 FORMULA||U|NA|U|NA|||NA|3||39||BLINDED TREATMENT|1965-04-10|1973-03-12|||||1962-11-16||1969-05-14|NA|1960-06-08
TRIAL STUDY 134XCP|LB|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|1||||FLUVOXAM|FLUVOXAMINE|||||||UOSM|||||||INVALID||%/S||||LOW|NOT DONE||||SERUM|SOLIDIFIED|U|ACRIDINE ORANGE STAIN|MDRD 5 VARIABLE FORMULA||NA|N|U|U|||NA|4||88||BASELINE|1961-02-27|1961-02-19|||||1968-01-13||1967-01-14|N|1966-10-18
TRIAL STUDY 134XCP|LB|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|2||||CPEPTIDE|C-PEPTIDE|||||||ML/G/DAY|||||||NEGATIVE||DPM/0.5 ML||||NORMAL|NOT DONE||||PLEURAL TISSUE|THAWED|NA|CARDIAC THERMODILUTION|CKD-EPI CREATININE FORMULA||U|NA|N|Y|||N|4||88||RUN-IN|1971-03-05|1965-02-23|||||1965-06-22||1967-10-13|Y|1966-03-22
TRIAL STUDY 134XCP|LB|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|1||||PHADJT|PH ADJUSTED FOR BODY TEMP|||||||ML/ANIMAL/WK|||||||POSITIVE||DPM/ML||||HIGH|NOT DONE||||CORD SERUM|NON-HEMOLYZED|N|CONTACT SPECULAR MICROSCOPY|NASH FIBROSURE FORMULA||Y|N|U|Y|||NA|5||7||OBSERVATION|1960-04-01|1971-01-10|||||1972-07-04||1962-03-11|Y|1968-01-17
TRIAL STUDY 134XCP|LB|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|2||||C130106|WEED MIX POLLEN ANTIGEN IGE ANTIBODY|||||||DPM/0.5 ML|||||||NEGATIVE||TUBERCULIN UNIT||||LOW|NOT DONE||||EPIDERMAL TISSUE|CONCENTRATED|NA|OPHTHALMOSCOPY|FIBROTEST FORMULA||NA|U|Y|U|||NA|5||7||OBSERVATION|1972-11-04|1971-04-24|||||1964-10-14||1965-09-20|NA|1968-08-16
TRIAL STUDY 134XCP|LB|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|1||||AMYLOIDB|AMYLOID, BETA|||||||/H|||||||NEGATIVE||YD||||LOW|NOT DONE||||EPIDERMAL TISSUE|GELLED|Y|PANENDOSCOPY|CKD-EPI CYSTATIN C FORMULA||N|NA|N|N|||U|1||38||FOLLOW-UP|1972-02-14|1967-05-19|||||1969-09-29||1968-06-08|N|1963-11-29
TRIAL STUDY 134XCP|LB|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|2||||LYMATLE|LYMPHOCYTES ATYPICAL/LEUKOCYTES|||||||ML/CAGE/WK|||||||NEGATIVE||GBQ||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|ICTERIC|NA|MICROBIAL CULTURE, LIQUID|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|Y|Y|||Y|1||38||OBSERVATION|1971-03-21|1963-01-06|||||1963-10-25||1968-09-09|U|1965-11-22
TRIAL STUDY 134XCP|LB|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|1||||SCN|THIOCYANATE|||||||L/KG|||||||INVALID||UG/G/MIN||||LOW|NOT DONE||||AMNIOTIC FLUID|NON-HEMOLYZED|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|HEPASCORE FORMULA||NA|NA|Y|U|||Y|2||58||WASHOUT|1967-10-13|1960-06-24|||||1969-01-28||1965-01-18|Y|1964-10-17
TRIAL STUDY 134XCP|LB|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|2||||TGFB|TRANSFORMING GROWTH FACTOR BETA|||||||10^6 ORGANISMS/MG|||||||INVALID||ML||||HIGH|NOT DONE||||PROSTATIC FLUID|CALCIFIED|N|AUSCULTATION|MDRD FORMULA||N|U|N|N|||U|2||58||INDUCTION TREATMENT|1970-06-17|1972-05-23|||||1971-07-03||1963-04-06|NA|1963-03-25
TRIAL STUDY 134XCP|LB|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|1||||TRP1TRG1|TRYPSIN 1 AND TRYPSINOGEN 1|||||||DDU|||||||POSITIVE||G/ANIMAL/WK||||HIGH|NOT DONE||||LEUKOCYTE|CLOTTED|N|PHOROPTER|MDRD 6 VARIABLE FORMULA||Y|U|NA|N|||U|3||39||TREATMENT|1973-08-07|1970-11-23|||||1963-02-01||1973-08-26|NA|1971-05-27
TRIAL STUDY 134XCP|LB|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|2||||PSELECT|P-SELECTIN|||||||BQ|||||||INDETERMINATE||ML/DL||||ABNORMAL|NOT DONE||||CELL PELLET|CALCIFIED|NA|U-HPLC/MS/MS|FIBROMETER FORMULA||U|NA|Y|U|||U|3||39||WASHOUT|1966-06-10|1962-08-29|||||1964-08-14||1969-01-25|N|1965-06-22
TRIAL STUDY 134XCP|LB|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|1||||CXCL13|CHEMOKINE (C-X-C MOTIF) LIGAND 13|||||||AG|||||||TRACE||BAG||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|GELLED|U|BIOPSY|CKD-EPI FORMULA||N|Y|N|N|||N|4||88||CONTINUATION TREATMENT|1973-03-23|1965-06-28|||||1962-12-03||1964-12-31|NA|1967-04-30
TRIAL STUDY 134XCP|LB|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|2||||FXIVAC|FACTOR XIV ACTUAL/CONTROL|||||||MJOULE/CM2|||||||BORDERLINE||FINGERTIP UNIT||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|CALCIFIED|NA|FARNSWORTH-MUNSELL 100 HUE TEST|GMI MMOL/MOL FORMULA||NA|N|Y|U|||U|4||88||TREATMENT|1972-10-26|1962-05-05|||||1968-08-06||1969-03-02|N|1973-06-02
TRIAL STUDY 134XCP|LB|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|1||||HLADR52A|HLA-DR52 ANTIBODY|||||||U/M2/H|||||||INVALID||10^7/L||||NORMAL|NOT DONE||||VENOUS PLASMA|ROOM TEMPERATURE|U|ATOMIC ABSORPTION SPECTROMETRY|FIBROSIS 4 FORMULA||Y|Y|U|U|||U|5||7||TREATMENT|1962-12-10|1966-05-09|||||1963-07-03||1970-06-27|Y|1961-06-03
TRIAL STUDY 134XCP|LB|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|2||||INTLK28|INTERLEUKIN 28|||||||/VF|||||||NEGATIVE||VIAL||||HIGH|NOT DONE||||LOCHIA|CLOTTED|N|SPECT SCAN|NASH FIBROSURE FORMULA||U|NA|Y|NA|||U|5||7||RUN-IN|1966-07-10|1966-05-12|||||1973-04-16||1964-03-06|NA|1972-08-29
TRIAL STUDY 134XCP|LB|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|1||||RBC|ERYTHROCYTES|||||||M/SEC2|||||||INDETERMINATE||MKAT||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|THAWED|U|ULTRASONOGRAPHIC ELASTOGRAPHY|GMI % FORMULA||U|U|U|Y|||N|1||38||RUN-IN|1964-06-25|1964-07-25|||||1964-09-01||1961-02-22|Y|1969-06-16
TRIAL STUDY 134XCP|LB|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|2||||CRTFREXR|CORTISOL, FREE EXCRETION RATE|||||||TROCHE|||||||POSITIVE||NG/MOL||||NORMAL|NOT DONE||||PLEURAL TISSUE|LIPEMIC|NA|LIGHT MICROSCOPY|HEPASCORE FORMULA||N|Y|NA|NA|||NA|1||38||TREATMENT|1965-10-13|1968-12-08|||||1964-11-15||1968-04-28|N|1961-08-08
TRIAL STUDY 134XCP|LB|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|1||||SPMAGGLU|SPERM AGGLUTINATION|||||||/MS|||||||BORDERLINE||CI/UG||||ABNORMAL|NOT DONE||||LYSATE|CONTAMINATED|NA|RYAN BLUE STAIN|NASH FIBROSURE FORMULA||NA|NA|NA|U|||NA|2||58||SCREENING|1962-10-02|1964-09-01|||||1970-06-29||1968-04-22|NA|1964-11-23
TRIAL STUDY 134XCP|LB|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|2||||TT|THROMBIN TIME|||||||IU/MG|||||||INDETERMINATE||MONTHS||||NORMAL|NOT DONE||||TUMOR TISSUE|SOLIDIFIED|N|OBSERVATION|GMI % FORMULA||Y|U|NA|U|||NA|2||58||BLINDED TREATMENT|1971-02-03|1971-05-01|||||1969-01-09||1964-11-07|N|1960-12-20
TRIAL STUDY 134XCP|LB|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|1||||PAI1AG|PLASMINOGEN ACTIVATOR INHIBITOR-1 AG|||||||ML/S|||||||INDETERMINATE||CMHG||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|REFRIGERATED|Y|STRESS ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA||U|U|N|U|||U|3||39||RUN-IN|1961-11-01|1970-09-14|||||1962-01-17||1966-05-05|N|1963-11-05
TRIAL STUDY 134XCP|LB|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|2||||MOCYCE|MONOCYTOID CELLS|||||||CI/G|||||||TRACE||10^8 PFU||||ABNORMAL|NOT DONE||||SEBUM|PARAFFIN-EMBEDDED|U|MUGA|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|N|N|||U|3||39||TREATMENT|1966-08-13|1969-09-25|||||1965-10-30||1972-12-16|U|1960-03-11
TRIAL STUDY 134XCP|LB|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|1||||HTTP|HUNTINGTIN PROTEIN|||||||SCM|||||||INVALID||TAMPON||||NORMAL|NOT DONE||||BUFFY COAT|FROZEN|NA|IHC|CKD-EPI CREATININE FORMULA||Y|N|Y|NA|||N|4||88||LONG-TERM FOLLOW-UP|1964-11-27|1961-09-13|||||1969-10-17||1962-12-15|NA|1971-02-19
TRIAL STUDY 134XCP|LB|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|2||||OXYSAT|OXYGEN SATURATION|||||||10^9 ORGANISMS/MG|||||||INDETERMINATE||GY||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|FRESH|NA|AGAR PROPORTION|CKD-EPI CREATININE FORMULA||N|N|U|NA|||N|4||88||CONTINUATION TREATMENT|1970-04-28|1967-10-05|||||1969-02-08||1964-08-05|Y|1965-03-01
TRIAL STUDY 134XCP|LB|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|1||||VENLAFAX|VENLAFAXINE|||||||UMOL/KG/MIN|||||||BORDERLINE||MG/M2||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|GELLED|N|BIOIMPEDANCE SPECTROSCOPY|CKD-EPI CREATININE FORMULA||N|U|NA|N|||NA|5||7||FOLLOW-UP|1962-01-29|1973-08-24|||||1962-10-05||1963-02-15|Y|1962-05-27
TRIAL STUDY 134XCP|LB|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|2||||ESELS|SOLUBLE E-SELECTIN|||||||VIAL|||||||INVALID||KIT||||LOW|NOT DONE||||HAIR FOLLICLE|HEMOLYZED|N|ECHOCARDIOGRAPHY|ASH FIBROSURE FORMULA||N|Y|Y|U|||Y|5||7||BLINDED TREATMENT|1962-05-25|1968-08-04|||||1971-07-04||1964-11-05|Y|1969-05-24
TRIAL STUDY 134XCP|LB|A1FAB383-1757-4832-B888-90C133842EF8|1||||URATECRT|URATE/CREATININE|||||||CAPLET|||||||NEGATIVE||MG/ML/MIN||||HIGH|NOT DONE||||MECONIUM|REFRIGERATED|U|PET SCAN|FIBROMETER FORMULA||N|U|Y|NA|||N|1||38||OBSERVATION|1961-03-19|1970-05-16|||||1962-12-07||1970-04-23|U|1960-11-24
TRIAL STUDY 134XCP|LB|A1FAB383-1757-4832-B888-90C133842EF8|2||||CYTRPHOS|TRIPLE PHOSPHATE CRYSTALS|||||||UMOL/L/H|||||||NEGATIVE||G/G/DAY||||LOW|NOT DONE||||KERATINOCYTE|ICTERIC|Y|GEL ELECTROPHORESIS|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|U|||N|1||38||INDUCTION TREATMENT|1966-01-27|1973-08-26|||||1969-10-18||1970-07-05|NA|1964-09-10
TRIAL STUDY 134XCP|LB|A1FAB383-1757-4832-B888-90C133842EF8|1||||ANGPT2|ANGIOPOIETIN 2|||||||CMOL/L|||||||NEGATIVE||DRAM||||NORMAL|NOT DONE||||ADIPOSE TISSUE|ICTERIC|Y|CLOT DETECTION|FIBROSIS 4 FORMULA||U|U|N|N|||U|2||58||LONG-TERM FOLLOW-UP|1966-03-13|1962-03-18|||||1961-10-25||1970-01-03|U|1960-01-02
TRIAL STUDY 134XCP|LB|A1FAB383-1757-4832-B888-90C133842EF8|2||||PSP100AB|P100 POLYMYOSITIS-SCLERODERMA AUTOAG AB|||||||VG/DOSE|||||||POSITIVE||L/KG||||NORMAL|NOT DONE||||ISOLATE|UNEXPECTED ODOR|Y|EIA|CKD-EPI FORMULA||NA|Y|NA|N|||U|2||58||LONG-TERM FOLLOW-UP|1971-06-17|1967-08-12|||||1966-02-18||1969-05-25|NA|1968-06-02
TRIAL STUDY 134XCP|LB|A1FAB383-1757-4832-B888-90C133842EF8|1||||ALB|ALBUMIN|||||||MASK|||||||INVALID||MMOL||||LOW|NOT DONE||||NAIL|SOLIDIFIED|Y|WESTERN BLOT|FIBROMETER FORMULA||NA|U|Y|U|||Y|3||39||FOLLOW-UP|1972-11-23|1964-07-06|||||1964-03-05||1970-07-30|N|1960-04-19
TRIAL STUDY 134XCP|LB|A1FAB383-1757-4832-B888-90C133842EF8|2||||IGFBP1|INSULIN-LIKE GROWTH FACTOR BINDING PROT1|||||||PMOL/10^9 CELLS|||||||POSITIVE||LOG10 TCID 50/ML||||HIGH|NOT DONE||||AQUEOUS HUMOR|FRESH|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|Y|NA|||N|3||39||SCREENING|1968-01-26|1963-04-20|||||1973-08-07||1967-11-16|NA|1962-08-19
TRIAL STUDY 134XCP|LB|A1FAB383-1757-4832-B888-90C133842EF8|1||||CHCNT|CORPUSCULAR HEMOGLOBIN CONTENT|||||||C|||||||POSITIVE||PT_US||||NORMAL|NOT DONE||||VENOUS BLOOD|DRIED|N|MEDIASTINOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|Y|N|||U|4||88||BLINDED TREATMENT|1967-01-10|1972-08-08|||||1970-07-16||1971-02-16|N|1969-10-20
TRIAL STUDY 134XCP|LB|A1FAB383-1757-4832-B888-90C133842EF8|2||||ASSDNA|ANTI-SINGLE STRANDED DNA IGG|||||||/VF|||||||BORDERLINE||MIN*MG/ML||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|CONTAMINATED|N|KARYOTYPING|COCKCROFT-GAULT FORMULA||Y|U|Y|NA|||U|4||88||SCREENING|1964-01-28|1969-10-28|||||1968-04-24||1965-10-21|N|1964-12-14
TRIAL STUDY 134XCP|LB|A1FAB383-1757-4832-B888-90C133842EF8|1||||MG|MAGNESIUM|||||||KM/H|||||||BORDERLINE||ML/MMHG||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|THAWED|Y|HEMAGGLUTINATION ASSAY|GMI MMOL/MOL FORMULA||U|U|U|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1966-06-03|1966-04-30|||||1973-03-04||1970-04-29|NA|1960-04-01
TRIAL STUDY 134XCP|LB|A1FAB383-1757-4832-B888-90C133842EF8|2||||INSAB|INSULIN ANTIBODY|||||||M/SEC2|||||||BORDERLINE||TABLET||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|LACTESCENT|NA|QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROTEST FORMULA||NA|Y|U|U|||N|5||7||BASELINE|1970-03-30|1963-07-24|||||1970-03-21||1963-10-21|NA|1968-03-21
TRIAL STUDY 134XCP|LB|72AA1945-E676-4485-BD7F-6B969E314D83|1||||DRUGSCR|DRUG SCREEN|||||||10^6 ORGANISMS/G|||||||POSITIVE||MAMP||||LOW|NOT DONE||||GASTRIC CONTENTS|CLOTTED|N|TELLER ACUITY CARDS|GMI MMOL/MOL FORMULA||NA|N|N|U|||U|1||38||WASHOUT|1972-02-26|1967-08-17|||||1962-05-30||1963-04-02|U|1966-05-30
TRIAL STUDY 134XCP|LB|72AA1945-E676-4485-BD7F-6B969E314D83|2||||VWFAAC|VON WILL FACTOR ACT ACTUAL/CONTROL|||||||/MS|||||||BORDERLINE||TBSP||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|GELLED|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|FIBROMETER FORMULA||Y|Y|U|U|||Y|1||38||INDUCTION TREATMENT|1962-09-05|1970-08-11|||||1972-04-10||1973-06-07|N|1968-09-21
TRIAL STUDY 134XCP|LB|72AA1945-E676-4485-BD7F-6B969E314D83|1||||C165883|ORCHARD GRASS POLLEN IGE AB RAST SCORE|||||||MEQ/KG|||||||INDETERMINATE||GY||||LOW|NOT DONE||||CORD BLOOD|LIPEMIC|N|ALCIAN BLUE STAIN|COCKCROFT-GAULT FORMULA||Y|NA|U|NA|||U|2||58||BLINDED TREATMENT|1972-06-21|1963-08-19|||||1962-10-26||1961-12-12|U|1973-02-19
TRIAL STUDY 134XCP|LB|72AA1945-E676-4485-BD7F-6B969E314D83|2||||GLP1AC|GLUCAGON-LIKE PEPTIDE-1, ACTIVE FORM|||||||POUCH|||||||POSITIVE||UU/DL||||NORMAL|NOT DONE||||SEMEN|REFRIGERATED|Y|RIA|MDRD 5 VARIABLE FORMULA||Y|N|U|U|||N|2||58||OPEN LABEL TREATMENT|1970-07-22|1965-02-17|||||1968-03-05||1969-01-09|Y|1968-03-23
TRIAL STUDY 134XCP|LB|72AA1945-E676-4485-BD7F-6B969E314D83|1||||MASTCECE|MAST CELLS/TOTAL CELLS|||||||UEQ|||||||INVALID||UM/DAY||||ABNORMAL|NOT DONE||||NAIL|THAWED|U|ICC|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|Y|NA|||Y|3||39||BASELINE|1966-10-24|1972-01-29|||||1961-02-09||1967-05-16|N|1971-01-24
TRIAL STUDY 134XCP|LB|72AA1945-E676-4485-BD7F-6B969E314D83|2||||TRPTRG|TRYPSIN AND TRYPSINOGEN|||||||UG|||||||POSITIVE||PMOL||||LOW|NOT DONE||||CAPILLARY PLASMA|NON-HEMOLYZED|N|AGAR PROPORTION|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|NA|U|||U|3||39||TREATMENT|1962-08-08|1962-01-13|||||1963-03-14||1960-01-22|U|1963-04-03
TRIAL STUDY 134XCP|LB|72AA1945-E676-4485-BD7F-6B969E314D83|1||||MYCEMPOL|MYELOID MATURATION POOL|||||||10^3 ORGANISMS/G|||||||POSITIVE||PACK YEAR||||LOW|NOT DONE||||MENSTRUAL BLOOD|FROZEN|U|COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD FORMULA||Y|NA|Y|NA|||Y|4||88||INDUCTION TREATMENT|1965-08-11|1962-10-25|||||1966-02-17||1970-05-23|U|1966-12-19
TRIAL STUDY 134XCP|LB|72AA1945-E676-4485-BD7F-6B969E314D83|2||||INTLK14|INTERLEUKIN 14|||||||10^3 CFU|||||||NEGATIVE||GBQ||||LOW|NOT DONE||||SALIVA|CONTAMINATED|U|SLIT LAMP|MDRD 5 VARIABLE FORMULA||U|Y|N|U|||N|4||88||OBSERVATION|1963-04-28|1973-04-26|||||1973-02-10||1964-08-30|U|1967-06-09
TRIAL STUDY 134XCP|LB|72AA1945-E676-4485-BD7F-6B969E314D83|1||||GFRE|GLOMERULAR FILTRATION RATE, ESTIMATED|||||||/LPF|||||||BORDERLINE||/7.5 ML||||ABNORMAL|NOT DONE||||PLASMA|CONTAMINATED|U|MACRO BROTH DILUTION|CKD-EPI CREATININE FORMULA||U|NA|Y|N|||U|5||7||OBSERVATION|1966-01-11|1973-01-11|||||1970-06-13||1963-03-31|Y|1968-04-22
TRIAL STUDY 134XCP|LB|72AA1945-E676-4485-BD7F-6B969E314D83|2||||NEUTNSQE|NEUTROPHILS/NON-SQUAM EPI CELLS|||||||MG/CM2|||||||POSITIVE||CYCLE/MIN||||LOW|NOT DONE||||VENOUS CORD BLOOD|AUTOLYZED|N|PHASE-CONTRAST MRI|HEPASCORE FORMULA||NA|N|U|Y|||NA|5||7||FOLLOW-UP|1960-03-29|1971-08-12|||||1968-11-12||1961-08-05|N|1968-10-23
TRIAL STUDY 134XCP|LB|B297C689-0D99-4E36-9F27-F93D4F43E2DD|1||||NSE|NEURON SPECIFIC ENOLASE|||||||MOSM/KG|||||||NEGATIVE||MN||||ABNORMAL|NOT DONE||||LAVAGE FLUID|THAWED|U|PLAQUE REDUCTION NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA||NA|N|NA|Y|||NA|1||38||OPEN LABEL TREATMENT|1963-07-07|1972-04-30|||||1964-08-13||1968-10-21|U|1973-02-21
TRIAL STUDY 134XCP|LB|B297C689-0D99-4E36-9F27-F93D4F43E2DD|2||||PLATAGRN|PLATELETS, AGRANULAR|||||||CAPLET|||||||INDETERMINATE||HZ||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|CLOTTED|N|FLUORESCENT MICROSCOPY|HEPASCORE FORMULA||N|N|U|NA|||NA|1||38||WASHOUT|1968-03-28|1970-07-18|||||1973-04-21||1969-03-26|Y|1960-08-16
TRIAL STUDY 134XCP|LB|B297C689-0D99-4E36-9F27-F93D4F43E2DD|1||||EUDCA|EPIMERIZED URSODEOXYCHOLATE|||||||MV2/HZ|||||||BORDERLINE||10^9 ORGANISMS/MG||||NORMAL|NOT DONE||||URINE|LIPEMIC|N|NEURAMINIDASE INHIBITION ASSAY|FIBROTEST FORMULA||Y|NA|U|U|||Y|2||58||OBSERVATION|1969-03-21|1964-09-28|||||1969-06-21||1968-03-20|U|1972-09-26
TRIAL STUDY 134XCP|LB|B297C689-0D99-4E36-9F27-F93D4F43E2DD|2||||NEUTSG|NEUTROPHILS, SEGMENTED|||||||FOZ_BR|||||||INDETERMINATE||UL/ML||||LOW|NOT DONE||||BREAST MILK|CALCIFIED|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|HEPASCORE FORMULA||U|N|U|NA|||Y|2||58||FOLLOW-UP|1971-11-15|1970-08-23|||||1961-02-06||1963-08-22|Y|1961-02-01
TRIAL STUDY 134XCP|LB|B297C689-0D99-4E36-9F27-F93D4F43E2DD|1||||COCAINE|COCAINE|||||||DIP|||||||NEGATIVE||PMOL/DL||||ABNORMAL|NOT DONE||||PUS|CONCENTRATED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 6 VARIABLE FORMULA||N|U|N|Y|||U|3||39||OBSERVATION|1969-12-08|1970-06-09|||||1967-05-19||1966-03-13|NA|1971-12-04
TRIAL STUDY 134XCP|LB|B297C689-0D99-4E36-9F27-F93D4F43E2DD|2||||GRANSGCE|GRANULOCYTES SEGMENTED/TOTAL CELLS|||||||10^4/HPF|||||||TRACE||SYRINGE||||LOW|NOT DONE||||ERYTHROCYTES|ICTERIC|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI MMOL/MOL FORMULA||N|Y|Y|Y|||Y|3||39||OBSERVATION|1968-10-09|1971-05-10|||||1966-05-27||1966-02-20|NA|1964-09-13
TRIAL STUDY 134XCP|LB|B297C689-0D99-4E36-9F27-F93D4F43E2DD|1||||LMBDLC|LAMBDA LIGHT CHAIN|||||||PMOL/10^9 CELLS|||||||BORDERLINE||BAU/ML||||LOW|NOT DONE||||STOOL|GELLED|U|HANSEL STAIN|MDRD 4 VARIABLE FORMULA||U|U|NA|Y|||U|4||88||FOLLOW-UP|1971-02-02|1969-04-13|||||1968-06-28||1963-03-31|U|1962-10-25
TRIAL STUDY 134XCP|LB|B297C689-0D99-4E36-9F27-F93D4F43E2DD|2||||CD45RALY|CD45RA/LYMPHOCYTES|||||||BQ/UG|||||||INDETERMINATE||ML/ANIMAL/WK||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|REFRIGERATED|N|OPTICAL DENSITY MEASUREMENT|ASH FIBROSURE FORMULA||Y|NA|N|NA|||N|4||88||TREATMENT|1960-08-22|1970-08-31|||||1965-05-01||1965-04-05|NA|1968-06-13
TRIAL STUDY 134XCP|LB|B297C689-0D99-4E36-9F27-F93D4F43E2DD|1||||ANGTNS2|ANGIOTENSIN II|||||||RFU|||||||TRACE||PFU||||ABNORMAL|NOT DONE||||SPUTUM|CALCIFIED|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|FIBROMETER FORMULA||Y|N|NA|NA|||Y|5||7||SCREENING|1960-12-19|1971-06-16|||||1973-07-01||1965-10-12|Y|1973-07-16
TRIAL STUDY 134XCP|LB|B297C689-0D99-4E36-9F27-F93D4F43E2DD|2||||AST|ASPARTATE AMINOTRANSFERASE|||||||GBQ/UG|||||||NEGATIVE||/HPF||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|ICTERIC|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE FORMULA||NA|Y|N|NA|||NA|5||7||OPEN LABEL TREATMENT|1968-02-05|1965-10-27|||||1972-09-30||1973-08-21|Y|1967-05-25
TRIAL STUDY 134XCP|LB|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|1||||MDZLM|MIDAZOLAM|||||||ML/SEC/1.73M2|||||||NEGATIVE||PATCH||||HIGH|NOT DONE||||COLOSTRUM|AUTOLYZED|Y|DIGITAL PCR ARRAY|GMI MMOL/MOL FORMULA||Y|U|Y|U|||Y|1||38||FOLLOW-UP|1968-01-04|1968-03-23|||||1964-11-12||1966-10-01|N|1964-10-24
TRIAL STUDY 134XCP|LB|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|2||||CHYTRYP|CHYMOTRYPSIN|||||||10^9 ORGANISMS/G|||||||BORDERLINE||FMOL/L/SEC||||LOW|NOT DONE||||VENOUS BLOOD|ROOM TEMPERATURE|Y|LIGHT SCATTERING SPECTROSCOPY|MDRD 4 VARIABLE FORMULA||U|NA|U|N|||N|1||38||RUN-IN|1960-05-06|1968-06-26|||||1965-09-14||1967-02-10|N|1973-01-23
TRIAL STUDY 134XCP|LB|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|1||||C165896|D. PTERONYSSINUS ANTIGEN IGG4 ANTIBODY|||||||AMOL|||||||INVALID||EU||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CLOTTED|Y|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA||N|U|Y|NA|||N|2||58||WASHOUT|1962-10-08|1961-05-22|||||1965-11-08||1961-07-22|U|1964-04-02
TRIAL STUDY 134XCP|LB|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|2||||PPI|INORGANIC PYROPHOSPHATE|||||||SEC|||||||BORDERLINE||PT_BR||||LOW|NOT DONE||||SPERMATOZOON|ROOM TEMPERATURE|NA|PHOTOMETRY|NASH FIBROSURE FORMULA||U|NA|U|NA|||NA|2||58||FOLLOW-UP|1961-10-29|1970-04-26|||||1968-10-10||1973-04-09|N|1962-08-01
TRIAL STUDY 134XCP|LB|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|1||||HYDMRPHN|HYDROMORPHONE|||||||10^12/L|||||||INVALID||UV*SEC||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED|Y|LANDOLT RING|FIBROTEST FORMULA||NA|U|NA|Y|||N|3||39||RUN-IN|1971-02-01|1969-05-16|||||1961-02-04||1960-06-14|NA|1966-12-22
TRIAL STUDY 134XCP|LB|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|2||||COL4|COLLAGEN TYPE IV|||||||ML/DAY|||||||INVALID||CI/ML||||LOW|NOT DONE||||SEBUM|LACTESCENT|U|BALLPOINT PEN TECHNIQUE|HEPASCORE FORMULA||NA|N|U|U|||N|3||39||RUN-IN|1960-08-26|1961-04-23|||||1968-09-07||1966-08-24|Y|1969-07-01
TRIAL STUDY 134XCP|LB|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|1||||BTLBTL|BUTALBITAL|||||||UG/H|||||||BORDERLINE||KEV||||HIGH|NOT DONE||||TRANSUDATE|FRESH|Y|REFRACTOMETRY|CKD-EPI CYSTATIN C FORMULA||N|Y|Y|NA|||Y|4||88||RUN-IN|1967-06-15|1961-02-23|||||1966-10-08||1964-10-17|NA|1961-02-14
TRIAL STUDY 134XCP|LB|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|2||||RENINA|RENIN ACTIVITY|||||||MOSM/L|||||||POSITIVE||BOTTLE||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|CONTAMINATED|NA|LIGHT SCATTERING SPECTROSCOPY|CKD-EPI CREATININE FORMULA||NA|U|N|N|||U|4||88||INDUCTION TREATMENT|1970-08-24|1960-03-15|||||1966-08-02||1970-02-17|NA|1972-05-05
TRIAL STUDY 134XCP|LB|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|1||||CNTIGGAB|CENTROMERE IGG ANTIBODY|||||||WAFER|||||||INDETERMINATE||LOG10 ELISA UNIT/DOSE||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|CONTAMINATED|NA|BIOIMPEDANCE SPECTROSCOPY|NASH FIBROSURE FORMULA||Y|Y|Y|NA|||N|5||7||LONG-TERM FOLLOW-UP|1967-03-21|1968-02-06|||||1962-07-29||1961-06-18|Y|1969-10-12
TRIAL STUDY 134XCP|LB|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|2||||IAA5OH|5-HYDROXYINDOLEACETIC ACID|||||||CM|||||||BORDERLINE||DYN||||NORMAL|NOT DONE||||PLEURAL FLUID|ICTERIC|NA|ELECTRICAL IMPEDANCE MYOGRAPHY|FIBROTEST FORMULA||N|N|Y|N|||NA|5||7||CONTINUATION TREATMENT|1960-06-10|1967-11-23|||||1962-01-22||1972-03-08|U|1968-12-24
TRIAL STUDY 134XCP|LB|3F18534E-367D-45C8-BB08-C82151A0CF00|1||||PSELECTS|SOLUBLE P-SELECTIN|||||||ML/DOSE|||||||INDETERMINATE||JAR||||LOW|NOT DONE||||LUNG SURFACTANT|CONCENTRATED|N|PET/CT SCAN|CKD-EPI CYSTATIN C FORMULA||N|U|NA|Y|||N|1||38||OPEN LABEL TREATMENT|1964-06-10|1964-11-22|||||1963-05-24||1967-08-02|N|1960-10-27
TRIAL STUDY 134XCP|LB|3F18534E-367D-45C8-BB08-C82151A0CF00|2||||C130091|TIMOTHY GRASS POLLEN IGG4|||||||ML/SEC/1.73M2|||||||TRACE||MMOL/MIN/KPA||||NORMAL|NOT DONE||||BREAST MILK|ICTERIC|U|NUCLEIC ACID HYBRIDIZATION|NASH FIBROSURE FORMULA||NA|N|N|N|||U|1||38||FOLLOW-UP|1967-09-18|1970-05-02|||||1970-07-25||1968-11-21|N|1972-09-02
TRIAL STUDY 134XCP|LB|3F18534E-367D-45C8-BB08-C82151A0CF00|1||||IGF1|INSULIN-LIKE GROWTH FACTOR-1|||||||LX|||||||POSITIVE||FT3||||LOW|NOT DONE||||URINE|CONTAMINATED|N|POTENTIOMETRY|MDRD FORMULA||Y|N|U|Y|||Y|2||58||INDUCTION TREATMENT|1961-06-13|1973-02-06|||||1965-01-25||1966-08-25|Y|1961-09-08
TRIAL STUDY 134XCP|LB|3F18534E-367D-45C8-BB08-C82151A0CF00|2||||ETHANOL|ETHANOL|||||||MMAL|||||||INDETERMINATE||VP/DOSE||||LOW|NOT DONE||||GASTRIC FLUID|LACTESCENT|NA|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD 4 VARIABLE FORMULA||Y|Y|U|NA|||Y|2||58||BLINDED TREATMENT|1963-11-12|1960-08-29|||||1964-01-10||1961-10-22|NA|1962-11-03
TRIAL STUDY 134XCP|LB|3F18534E-367D-45C8-BB08-C82151A0CF00|1||||NEUTBNE|NEUTROPHILS BAND FORM/ NEUTROPHILS|||||||MG/KG/DOSE|||||||NEGATIVE||MEQ/DAY||||LOW|NOT DONE||||TISSUE|AGGLUTINATED|Y|IMMUNOTURBIDIMETRY|CKD-EPI FORMULA||N|Y|NA|U|||N|3||39||OBSERVATION|1969-11-21|1971-07-27|||||1965-01-30||1961-10-29|Y|1965-03-13
TRIAL STUDY 134XCP|LB|3F18534E-367D-45C8-BB08-C82151A0CF00|2||||APLSMA2|ALPHA-2 ANTIPLASMIN|||||||ML/ANIMAL/WK|||||||NEGATIVE||STEPS/MIN||||HIGH|NOT DONE||||SEBUM|SOLIDIFIED|Y|ERGOSPIROMETRY|CKD-EPI CYSTATIN C FORMULA||Y|Y|NA|U|||NA|3||39||INDUCTION TREATMENT|1963-02-12|1964-02-20|||||1964-03-09||1973-01-20|U|1964-08-31
TRIAL STUDY 134XCP|LB|3F18534E-367D-45C8-BB08-C82151A0CF00|1||||FXIVAAC|FACTOR XIV ACTIVITY ACTUAL/CONTROL|||||||TCID 50/DOSE|||||||POSITIVE||ML/CAGE/DAY||||NORMAL|NOT DONE||||SWABBED MATERIAL|CONCENTRATED|NA|VIRUS PLAQUE ASSAY|GMI MMOL/MOL FORMULA||U|N|U|N|||N|4||88||WASHOUT|1968-08-30|1962-04-09|||||1965-02-28||1961-02-20|N|1973-03-18
TRIAL STUDY 134XCP|LB|3F18534E-367D-45C8-BB08-C82151A0CF00|2||||CD5|CD5|||||||CAPFUL|||||||BORDERLINE||MG2/DL2||||LOW|NOT DONE||||RETICULOCYTES|UNEXPECTED ODOR|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA||N|N|Y|U|||U|4||88||WASHOUT|1962-07-23|1969-01-24|||||1968-08-27||1966-03-02|NA|1965-07-16
TRIAL STUDY 134XCP|LB|3F18534E-367D-45C8-BB08-C82151A0CF00|1||||PD1S|SOLUBLE PROGRAMMED DEATH-1|||||||10^9 ORGANISMS|||||||INVALID||% INHIBITION||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|SOLIDIFIED|NA|NUCLEIC ACID AMPLIFICATION TEST|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|N|||NA|5||7||FOLLOW-UP|1963-01-22|1965-11-28|||||1964-11-13||1968-10-12|NA|1969-07-24
TRIAL STUDY 134XCP|LB|3F18534E-367D-45C8-BB08-C82151A0CF00|2||||PTHMM|PARATHYROID HORMONE, MID-MOLECULE|||||||PM|||||||BORDERLINE||10^3 CFU||||NORMAL|NOT DONE||||URINE SEDIMENT|PARAFFIN-EMBEDDED|U|PHASE CONTRAST MICROSCOPY|GMI MMOL/MOL FORMULA||U|NA|NA|Y|||Y|5||7||BASELINE|1961-09-02|1968-12-16|||||1972-12-11||1961-07-16|U|1967-12-14
TRIAL STUDY 134XCP|LB|81C10FB0-3B47-46D8-B8B7-9C772246CA55|1||||C130080|ORCHARD GRASS POLLEN IGE|||||||MMOL/S|||||||INVALID||PPTR||||LOW|NOT DONE||||CAPILLARY PLASMA|AGGLUTINATED|N|MAGNETIC RESONANCE ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|N|U|||Y|1||38||BLINDED TREATMENT|1960-05-11|1960-01-08|||||1964-01-11||1960-07-26|NA|1964-07-23
TRIAL STUDY 134XCP|LB|81C10FB0-3B47-46D8-B8B7-9C772246CA55|2||||TNF12|TNF SUPERFAMILY MEMBER 12|||||||CM H2O|||||||NEGATIVE||UMOL/L/MIN||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LACTESCENT|N|QUANTITATIVE CORONARY ANGIOGRAPHY|GMI MMOL/MOL FORMULA||N|Y|NA|NA|||Y|1||38||BASELINE|1965-11-28|1971-09-16|||||1965-08-10||1966-12-19|NA|1968-04-04
TRIAL STUDY 134XCP|LB|81C10FB0-3B47-46D8-B8B7-9C772246CA55|1||||GLUCPED|PLASMA EQUIVALENT GLUCOSE DISTRIBUTION|||||||IU/KG/H|||||||TRACE||NMOL/MOL||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|CLOTTED|NA|PHOTOMETRIC CLOT DETECTION|FIBROMETER FORMULA||Y|NA|U|Y|||Y|2||58||BASELINE|1962-09-24|1963-10-20|||||1960-09-08||1965-10-24|Y|1967-09-11
TRIAL STUDY 134XCP|LB|81C10FB0-3B47-46D8-B8B7-9C772246CA55|2||||C165937|ZEA MAYS IGE AB RAST SCORE|||||||PIXEL|||||||TRACE||WEBER||||HIGH|NOT DONE||||VENOUS CORD BLOOD|AGGLUTINATED|N|ELECTROPHORESIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|NA|NA|||N|2||58||INDUCTION TREATMENT|1972-02-15|1963-02-17|||||1969-10-08||1973-05-04|N|1968-10-11
TRIAL STUDY 134XCP|LB|81C10FB0-3B47-46D8-B8B7-9C772246CA55|1||||GLDH|GLUTAMATE DEHYDROGENASE|||||||CGY|||||||POSITIVE||UG/DL||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED|Y|CLIP|MDRD 5 VARIABLE FORMULA||NA|U|Y|U|||NA|3||39||INDUCTION TREATMENT|1960-06-05|1972-07-11|||||1967-11-12||1972-10-13|U|1966-05-01
TRIAL STUDY 134XCP|LB|81C10FB0-3B47-46D8-B8B7-9C772246CA55|2||||CLUECE|CLUE CELLS|||||||10^3 ORGANISMS/ML|||||||BORDERLINE||KPA||||LOW|NOT DONE||||URINE|CONCENTRATED|NA|SPIRAL CT|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|Y|N|||N|3||39||CONTINUATION TREATMENT|1963-03-04|1970-09-23|||||1961-04-15||1970-10-02|Y|1963-07-14
TRIAL STUDY 134XCP|LB|81C10FB0-3B47-46D8-B8B7-9C772246CA55|1||||AMYLASEP|AMYLASE, PANCREATIC|||||||SEC|||||||NEGATIVE||MET*H||||HIGH|NOT DONE||||DERMAL TISSUE|THAWED|U|MALDI|NASH FIBROSURE FORMULA||N|Y|N|NA|||U|4||88||OPEN LABEL TREATMENT|1962-01-01|1972-01-24|||||1969-12-11||1966-03-04|N|1970-05-06
TRIAL STUDY 134XCP|LB|81C10FB0-3B47-46D8-B8B7-9C772246CA55|2||||PLATIM|IMMATURE PLATELETS|||||||UV|||||||NEGATIVE||G/M2||||LOW|NOT DONE||||MUSCLE TISSUE|FROZEN|Y|INTERRUPTER TECHNIQUE|FIBROMETER FORMULA||U|Y|Y|Y|||U|4||88||OBSERVATION|1960-01-21|1969-05-13|||||1962-11-13||1969-10-17|NA|1965-05-24
TRIAL STUDY 134XCP|LB|81C10FB0-3B47-46D8-B8B7-9C772246CA55|1||||SAA1|SERUM AMYLOID A1|||||||G/G|||||||INDETERMINATE||/100 HPFS||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|NON-HEMOLYZED|Y|PHYSICAL EXAMINATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|U|N|||N|5||7||BLINDED TREATMENT|1961-11-12|1965-10-25|||||1960-08-06||1973-05-05|U|1971-07-28
TRIAL STUDY 134XCP|LB|81C10FB0-3B47-46D8-B8B7-9C772246CA55|2||||HGFR|HEPATOCYTE GROWTH FACTOR RECEPTOR|||||||BREATHS/MIN|||||||INVALID||BQ/UG||||HIGH|NOT DONE||||SPUTUM|THAWED|NA|ROMANOWSKY STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|U|NA|||U|5||7||OBSERVATION|1960-06-29|1961-12-20|||||1965-03-06||1963-05-26|NA|1962-09-20
TRIAL STUDY 134XCP|LB|67C99F41-D839-4B8E-9220-6EC161FCD457|1||||LAP|LEUCINE AMINOPEPTIDASE|||||||FFU|||||||TRACE||ML/BREATH||||LOW|NOT DONE||||TISSUE|LIPEMIC|NA|PULMONARY ANGIOGRAPHY|GMI MMOL/MOL FORMULA||Y|U|N|NA|||NA|1||38||FOLLOW-UP|1965-05-01|1973-08-14|||||1963-10-27||1966-03-06|U|1960-07-17
TRIAL STUDY 134XCP|LB|67C99F41-D839-4B8E-9220-6EC161FCD457|2||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||MET|||||||BORDERLINE||CM/S||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|ROOM TEMPERATURE|U|QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROTEST FORMULA||U|U|NA|N|||N|1||38||INDUCTION TREATMENT|1973-06-19|1968-03-01|||||1966-04-24||1966-06-26|U|1971-09-21
TRIAL STUDY 134XCP|LB|67C99F41-D839-4B8E-9220-6EC161FCD457|1||||MX1|INTERFERON-INDUCED PROTEIN P78|||||||BOTTLE|||||||BORDERLINE||UMOL/MOL||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|HEMOLYZED|N|IMMUNOCHEMILUMINOMETRIC ASSAY|HEPASCORE FORMULA||N|U|N|Y|||NA|2||58||FOLLOW-UP|1972-05-04|1972-11-05|||||1961-07-06||1967-04-10|Y|1964-08-15
TRIAL STUDY 134XCP|LB|67C99F41-D839-4B8E-9220-6EC161FCD457|2||||TESTOSWB|TESTOSTERONE, WEAKLY BOUND|||||||UV*SEC|||||||INVALID||TESLA||||ABNORMAL|NOT DONE||||CERUMEN|THAWED|U|AUDIOMETRY|MDRD ENZYMATIC FORMULA||U|U|Y|Y|||NA|2||58||RUN-IN|1961-04-16|1966-04-01|||||1963-06-21||1963-02-24|U|1973-07-27
TRIAL STUDY 134XCP|LB|67C99F41-D839-4B8E-9220-6EC161FCD457|1||||PLATSAT|PLATELET SATELLITISM|||||||GPL U/ML|||||||INDETERMINATE||PPTH||||ABNORMAL|NOT DONE||||BUFFY COAT|REFRIGERATED|Y|ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA||Y|Y|Y|U|||N|3||39||OPEN LABEL TREATMENT|1965-11-04|1960-05-02|||||1965-09-01||1968-03-02|NA|1965-09-01
TRIAL STUDY 134XCP|LB|67C99F41-D839-4B8E-9220-6EC161FCD457|2||||BASOIM|IMMATURE BASOPHILS|||||||UMOL/MOL|||||||INDETERMINATE||TSP||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|THAWED|U|CELLULOSE TAPE|MDRD 5 VARIABLE FORMULA||N|Y|NA|NA|||Y|3||39||OPEN LABEL TREATMENT|1966-04-13|1972-08-30|||||1960-11-18||1971-04-15|U|1966-03-27
TRIAL STUDY 134XCP|LB|67C99F41-D839-4B8E-9220-6EC161FCD457|1||||PTHI|PARATHYROID HORMONE, INTACT|||||||ML/KG/DAY|||||||TRACE||PA||||HIGH|NOT DONE||||EXUDATE|LIPEMIC|Y|SURFACE PLASMON RESONANCE|GMI % FORMULA||N|Y|Y|N|||NA|4||88||OPEN LABEL TREATMENT|1968-10-06|1973-08-10|||||1962-07-31||1967-07-02|N|1972-12-19
TRIAL STUDY 134XCP|LB|67C99F41-D839-4B8E-9220-6EC161FCD457|2||||PC3MPSAM|PCA3 MRNA/PSA MRNA|||||||10^9/L|||||||NEGATIVE||V/SEC||||ABNORMAL|NOT DONE||||SEMINAL FLUID|ICTERIC|U|CLINICAL EVALUATION|HEPASCORE FORMULA||N|Y|U|N|||U|4||88||LONG-TERM FOLLOW-UP|1970-09-19|1965-05-16|||||1969-06-08||1971-09-18|NA|1969-11-04
TRIAL STUDY 134XCP|LB|67C99F41-D839-4B8E-9220-6EC161FCD457|1||||HLAIIPRA|HLA CLASS II PANEL REACTIVE ANTIBODY|||||||10^3 COPIES/ML|||||||BORDERLINE||BOTTLE||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|CALCIFIED|N|SPECT SCAN|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|Y|||N|5||7||SCREENING|1968-06-26|1965-08-13|||||1961-04-26||1964-10-06|N|1970-05-12
TRIAL STUDY 134XCP|LB|67C99F41-D839-4B8E-9220-6EC161FCD457|2||||CSEPIRT|RENAL TUBULAR EPITHELIAL CASTS|||||||KG|||||||BORDERLINE||JDF UNIT||||HIGH|NOT DONE||||GASTRIC CONTENTS|FROZEN|Y|SCANNING ELECTRON MICROSCOPY|FIBROMETER FORMULA||N|N|N|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1967-10-31|1967-10-08|||||1964-01-28||1965-09-13|Y|1960-02-19
TRIAL STUDY 134XCP|LB|76B9C25F-B418-4979-9E18-4372C8AA700C|1||||ICAIGGAB|ISLET CELL CYTOPLASMIC IGG ANTIBODY|||||||ENZYME U/M2|||||||POSITIVE||DPM/0.5 ML||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|REFRIGERATED|N|COULOMETRIC TITRATION|CKD-EPI CYSTATIN C FORMULA||U|NA|NA|U|||Y|1||38||RUN-IN|1971-01-06|1964-06-23|||||1972-04-23||1961-04-21|NA|1968-12-15
TRIAL STUDY 134XCP|LB|76B9C25F-B418-4979-9E18-4372C8AA700C|2||||VLDL2|VLDL CHOLESTEROL SUBTYPE 2|||||||UG/L|||||||INVALID||FMOL||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|REFRIGERATED|Y|BRDU CELLULAR PROLIFERATION ASSAY|COCKCROFT-GAULT FORMULA||NA|U|Y|U|||U|1||38||RUN-IN|1971-02-08|1968-07-13|||||1965-10-16||1961-05-07|N|1968-05-03
TRIAL STUDY 134XCP|LB|76B9C25F-B418-4979-9E18-4372C8AA700C|1||||FUNGI|FUNGI|||||||U/10^12 RBC|||||||INVALID||TCID 50/DOSE||||ABNORMAL|NOT DONE||||ISOLATE|SOLIDIFIED|U|FLOW CYTOMETRY|GMI % FORMULA||N|Y|NA|N|||N|2||58||TREATMENT|1967-03-26|1969-08-19|||||1965-11-21||1963-04-15|NA|1964-09-03
TRIAL STUDY 134XCP|LB|76B9C25F-B418-4979-9E18-4372C8AA700C|2||||APLSMA2|ALPHA-2 ANTIPLASMIN|||||||G/CM2|||||||NEGATIVE||10^7/L||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|FROZEN|NA|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|ASH FIBROSURE FORMULA||U|N|Y|Y|||U|2||58||TREATMENT|1962-10-22|1970-04-29|||||1968-10-07||1965-03-22|N|1963-04-23
TRIAL STUDY 134XCP|LB|76B9C25F-B418-4979-9E18-4372C8AA700C|1||||FACTVIII|FACTOR VIII|||||||PA|||||||BORDERLINE||G/MOL||||LOW|NOT DONE||||EPITHELIAL CELL|FRESH|Y|POLYSOMNOGRAPHY|MDRD 4 VARIABLE FORMULA||N|N|U|Y|||Y|3||39||SCREENING|1972-07-22|1966-10-31|||||1961-08-22||1964-01-20|NA|1971-05-13
TRIAL STUDY 134XCP|LB|76B9C25F-B418-4979-9E18-4372C8AA700C|2||||AFPL1|ALPHA FETOPROTEIN L1|||||||ANTI-XA IU|||||||INVALID||TSP||||NORMAL|NOT DONE||||PLEURAL FLUID|AUTOLYZED|Y|LC/MS/MS|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|N|Y|||Y|3||39||LONG-TERM FOLLOW-UP|1968-02-05|1967-10-12|||||1961-04-26||1965-08-17|Y|1965-07-07
TRIAL STUDY 134XCP|LB|76B9C25F-B418-4979-9E18-4372C8AA700C|1||||LYMPHOID|LYMPHOID CELLS|||||||UIU/L|||||||INDETERMINATE||BQ/MG||||NORMAL|NOT DONE||||PLEURAL FLUID|DRIED|NA|SLIT LAMP|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|Y|||Y|4||88||WASHOUT|1967-05-06|1960-11-16|||||1968-08-01||1964-08-12|U|1966-01-10
TRIAL STUDY 134XCP|LB|76B9C25F-B418-4979-9E18-4372C8AA700C|2||||ANDSTNDN|ANDROSTENEDIONE|||||||IN2|||||||BORDERLINE||EP U||||LOW|NOT DONE||||INTERSTITIAL FLUID|CALCIFIED|N|HIGH LEVEL AMINOGLYCOSIDE SCREEN|COCKCROFT-GAULT FORMULA||NA|NA|NA|U|||Y|4||88||BLINDED TREATMENT|1969-08-29|1970-01-19|||||1960-09-01||1964-05-19|N|1973-07-31
TRIAL STUDY 134XCP|LB|76B9C25F-B418-4979-9E18-4372C8AA700C|1||||POLYCHR|POLYCHROMASIA|||||||MG/L|||||||BORDERLINE||UM/DAY||||LOW|NOT DONE||||SWABBED MATERIAL|FRESH|U|MULTI-SLICE SPIRAL CT|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|N|NA|||Y|5||7||OBSERVATION|1968-04-01|1963-07-21|||||1973-06-05||1961-12-01|N|1970-01-16
TRIAL STUDY 134XCP|LB|76B9C25F-B418-4979-9E18-4372C8AA700C|2||||DDIMER|D-DIMER|||||||MIN/DAY|||||||INVALID||/500 WBC||||LOW|NOT DONE||||ABSCESS FLUID|AGGLUTINATED|N|THICK SMEAR|FIBROSIS 4 FORMULA||Y|U|Y|N|||NA|5||7||RUN-IN|1960-06-22|1966-10-25|||||1961-03-09||1963-12-04|N|1972-10-13
TRIAL STUDY 134XCP|LB|9F622B53-71F8-4362-99A5-251993E3A946|1||||ANPPRONT|N-TERMINAL PROA-TYPE NATRIURETIC PEPTIDE|||||||BEATS/MIN|||||||TRACE||TESLA||||NORMAL|NOT DONE||||LEUKOCYTE|REFRIGERATED|Y|GC/FID|MDRD 4 VARIABLE FORMULA||N|Y|U|NA|||NA|1||38||LONG-TERM FOLLOW-UP|1961-11-29|1971-03-03|||||1968-03-05||1966-08-20|U|1973-03-14
TRIAL STUDY 134XCP|LB|9F622B53-71F8-4362-99A5-251993E3A946|2||||HLADRMSC|HLA-DR MISMATCH COUNT|||||||IU|||||||POSITIVE||VP/DOSE||||ABNORMAL|NOT DONE||||SMEGMA|CALCIFIED|U|IMMUNOBLOT|MDRD FORMULA||N|N|Y|N|||Y|1||38||OBSERVATION|1962-03-25|1969-10-01|||||1969-01-01||1973-03-29|NA|1962-04-01
TRIAL STUDY 134XCP|LB|9F622B53-71F8-4362-99A5-251993E3A946|1||||TPAG|TISSUE POLYPEPTIDE ANTIGEN|||||||GTT|||||||TRACE||ML/100G/MIN||||LOW|NOT DONE||||CORD SERUM|SOLIDIFIED|N|LASER CAPTURE MICRODISSECTION|MDRD FORMULA||NA|N|Y|N|||Y|2||58||FOLLOW-UP|1971-11-20|1970-06-01|||||1960-02-06||1965-12-21|U|1962-12-24
TRIAL STUDY 134XCP|LB|9F622B53-71F8-4362-99A5-251993E3A946|2||||MONOBL|MONOBLASTS|||||||10^6 RNA COPIES/ML|||||||BORDERLINE||G/G||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|REFRIGERATED|U|PERIODIC ACID SCHIFF STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|N|NA|||U|2||58||SCREENING|1972-08-19|1960-12-03|||||1961-04-19||1963-10-12|N|1963-02-27
TRIAL STUDY 134XCP|LB|9F622B53-71F8-4362-99A5-251993E3A946|1||||IBCU|UNSATURATED IRON BINDING CAPACITY|||||||KG/CM|||||||BORDERLINE||U/CL||||NORMAL|NOT DONE||||DIALYSIS FLUID|AUTOLYZED|U|THICK SMEAR|FIBROSIS 4 FORMULA||N|N|Y|N|||NA|3||39||TREATMENT|1967-07-31|1972-02-06|||||1971-12-31||1973-05-18|NA|1968-04-08
TRIAL STUDY 134XCP|LB|9F622B53-71F8-4362-99A5-251993E3A946|2||||C165926|MOLD MIX IGE AB RAST SCORE|||||||UG/ANIMAL|||||||BORDERLINE||DL||||NORMAL|NOT DONE||||VITREOUS HUMOR|ICTERIC|N|SMEAR|MDRD 4 VARIABLE FORMULA||N|NA|Y|N|||N|3||39||TREATMENT|1973-08-20|1963-10-15|||||1966-03-26||1963-02-24|Y|1968-07-03
TRIAL STUDY 134XCP|LB|9F622B53-71F8-4362-99A5-251993E3A946|1||||NGF|NERVE GROWTH FACTOR|||||||ML/G/H|||||||NEGATIVE||MS/MMHG||||NORMAL|NOT DONE||||DERMAL TISSUE|UNEXPECTED ODOR|NA|SINGLE-SLICE SPIRAL CT|FIBROTEST FORMULA||N|Y|Y|N|||Y|4||88||BLINDED TREATMENT|1961-08-31|1963-11-04|||||1963-10-05||1962-12-04|U|1967-06-15
TRIAL STUDY 134XCP|LB|9F622B53-71F8-4362-99A5-251993E3A946|2||||MMP3|MATRIX METALLOPROTEINASE 3|||||||GPELISA UNIT/ML|||||||BORDERLINE||VG/DOSE||||ABNORMAL|NOT DONE||||RETICULOCYTES|LACTESCENT|Y|RIA|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|N|Y|||N|4||88||FOLLOW-UP|1967-08-06|1970-07-23|||||1967-05-20||1962-07-24|NA|1960-06-24
TRIAL STUDY 134XCP|LB|9F622B53-71F8-4362-99A5-251993E3A946|1||||GSTALEXR|ALPHA-GST EXCRETION RATE|||||||LM|||||||BORDERLINE||IN||||HIGH|NOT DONE||||LYSATE|NON-HEMOLYZED|N|LIGHT MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||Y|NA|NA|Y|||NA|5||7||BLINDED TREATMENT|1967-12-15|1965-05-16|||||1964-04-07||1963-02-14|Y|1973-03-18
TRIAL STUDY 134XCP|LB|9F622B53-71F8-4362-99A5-251993E3A946|2||||APOBAPA1|APOLIPOPROTEIN B/APOLIPOPROTEIN A1|||||||MEQ/KG|||||||INDETERMINATE||PKAT/L||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|UNEXPECTED ODOR|N|BETA LACTAMASE|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|NA|NA|||Y|5||7||TREATMENT|1962-10-13|1963-01-01|||||1968-01-17||1963-03-10|Y|1968-06-18
TRIAL STUDY 134XCP|LB|8F2DC6EB-0264-4112-B379-17896F4266E4|1||||CKMB|CREATINE KINASE MB|||||||MOL/MOL|||||||POSITIVE||ELISA UNIT/DOSE||||NORMAL|NOT DONE||||SWABBED MATERIAL|CLOTTED|N|GEL ELECTROPHORESIS|CKD-EPI CYSTATIN C FORMULA||NA|NA|U|U|||NA|1||38||LONG-TERM FOLLOW-UP|1969-03-08|1971-07-18|||||1962-12-03||1973-07-02|NA|1966-09-26
TRIAL STUDY 134XCP|LB|8F2DC6EB-0264-4112-B379-17896F4266E4|2||||MDC|MACROPHAGE-DERIVED CHEMOKINE|||||||PRESSOR UNITS|||||||BORDERLINE||10^6 ORGANISMS/G||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED|Y|PHOROPTER|ASH FIBROSURE FORMULA||U|N|U|Y|||U|1||38||LONG-TERM FOLLOW-UP|1965-08-28|1960-07-26|||||1973-03-02||1967-08-10|U|1960-06-15
TRIAL STUDY 134XCP|LB|8F2DC6EB-0264-4112-B379-17896F4266E4|1||||HYDCDN|HYDROCODONE|||||||ML/CM H2O|||||||INDETERMINATE||U||||LOW|NOT DONE||||LEUKOCYTE|AUTOLYZED|Y|NUCLEAR RADIOLOGY|CKD-EPI FORMULA||Y|Y|Y|N|||N|2||58||OPEN LABEL TREATMENT|1972-01-01|1962-09-20|||||1960-11-18||1967-04-17|N|1960-05-06
TRIAL STUDY 134XCP|LB|8F2DC6EB-0264-4112-B379-17896F4266E4|2||||BLASTIMM|IMMUNOBLASTS|||||||UG/KG/MIN|||||||POSITIVE||CARTRIDGE||||NORMAL|NOT DONE||||DIALYSIS FLUID|CONCENTRATED|NA|IVY INCISION METHOD|MDRD 5 VARIABLE FORMULA||NA|U|Y|NA|||N|2||58||BLINDED TREATMENT|1960-11-26|1971-08-26|||||1966-11-28||1965-07-18|NA|1961-02-14
TRIAL STUDY 134XCP|LB|8F2DC6EB-0264-4112-B379-17896F4266E4|1||||EDMAB|ENDOMYSIAL ANTIBODY|||||||ML/KG/H|||||||POSITIVE||APL U/ML||||ABNORMAL|NOT DONE||||BREAST MILK|NON-HEMOLYZED|NA|GC/MS-CI|MDRD ENZYMATIC FORMULA||N|N|Y|NA|||U|3||39||FOLLOW-UP|1961-03-22|1963-12-15|||||1963-08-18||1972-08-29|N|1962-08-10
TRIAL STUDY 134XCP|LB|8F2DC6EB-0264-4112-B379-17896F4266E4|2||||VEGFR1S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC1|||||||FINGERTIP UNIT|||||||NEGATIVE||NMOL/G||||HIGH|NOT DONE||||PLATELET|PARAFFIN-EMBEDDED|U|U-HPLC/MS/MS|GMI MMOL/MOL FORMULA||Y|Y|Y|Y|||N|3||39||LONG-TERM FOLLOW-UP|1964-06-04|1965-03-02|||||1962-10-25||1966-07-08|NA|1971-11-25
TRIAL STUDY 134XCP|LB|8F2DC6EB-0264-4112-B379-17896F4266E4|1||||KCLR|POTASSIUM CLEARANCE|||||||10^9/G|||||||NEGATIVE||PFU/ML||||HIGH|NOT DONE||||PLEURAL FLUID|REFRIGERATED|Y|AUDIOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|N|NA|||U|4||88||SCREENING|1969-04-21|1973-05-19|||||1973-05-01||1962-05-13|Y|1960-07-26
TRIAL STUDY 134XCP|LB|8F2DC6EB-0264-4112-B379-17896F4266E4|2||||SOMATRO|SOMATOTROPHIN|||||||OZ EQ|||||||TRACE||GAUSS||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|REFRIGERATED|Y|ALCIAN BLUE STAIN|MDRD 5 VARIABLE FORMULA||N|Y|N|Y|||N|4||88||LONG-TERM FOLLOW-UP|1962-07-20|1961-04-28|||||1964-03-30||1970-08-18|U|1961-03-31
TRIAL STUDY 134XCP|LB|8F2DC6EB-0264-4112-B379-17896F4266E4|1||||C165933|AMERICAN COCKROACH IGE AB RAST SCORE|||||||L/MIN|||||||TRACE||10^3 CFU/ML||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|FRESH|NA|DIGITAL PCR ARRAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|NA|N|||U|5||7||OBSERVATION|1971-07-28|1972-09-17|||||1968-10-27||1969-05-01|NA|1962-09-16
TRIAL STUDY 134XCP|LB|8F2DC6EB-0264-4112-B379-17896F4266E4|2||||TFRRNSAT|TRANSFERRIN SATURATION|||||||BISCUIT|||||||NEGATIVE||10^6 CFU||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|LACTESCENT|NA|DARK FIELD MICROSCOPY|CKD-EPI FORMULA||U|NA|Y|N|||Y|5||7||SCREENING|1970-04-28|1970-04-06|||||1964-10-08||1965-10-13|N|1968-10-26
TRIAL STUDY 134XCP|LB|448246D1-5625-4F69-B214-3A8848E86C28|1||||VCAM1|VASCULAR CELL ADHESION MOLECULE 1|||||||DEG2|||||||INDETERMINATE||UG/G/H||||LOW|NOT DONE||||BUFFY COAT|CONCENTRATED|U|TRICHROME STAIN|GMI MMOL/MOL FORMULA||N|U|U|U|||NA|1||38||RUN-IN|1962-05-28|1962-05-29|||||1963-03-20||1972-08-15|NA|1971-02-12
TRIAL STUDY 134XCP|LB|448246D1-5625-4F69-B214-3A8848E86C28|2||||PEPSNGA|PEPSINOGEN A|||||||10^5/L|||||||BORDERLINE||MG/ML/DAY||||ABNORMAL|NOT DONE||||SALIVA|DRIED|Y|MRS|MDRD ENZYMATIC FORMULA||NA|Y|NA|NA|||NA|1||38||OPEN LABEL TREATMENT|1966-12-20|1972-09-13|||||1969-05-09||1968-06-08|U|1967-11-06
TRIAL STUDY 134XCP|LB|448246D1-5625-4F69-B214-3A8848E86C28|1||||LSD|LYSERGIC ACID DIETHYLAMIDE|||||||KHZ|||||||TRACE||MIN*MG/ML||||NORMAL|NOT DONE||||SKIN TISSUE|GELLED|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA||NA|Y|N|NA|||N|2||58||LONG-TERM FOLLOW-UP|1963-03-31|1961-06-04|||||1968-04-22||1964-12-27|Y|1967-12-13
TRIAL STUDY 134XCP|LB|448246D1-5625-4F69-B214-3A8848E86C28|2||||THYPXD|THYROPEROXIDASE|||||||MANSON U/ML|||||||POSITIVE||ML/MIN||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|LACTESCENT|NA|CLINICAL EVALUATION|FIBROSIS 4 FORMULA||NA|U|N|Y|||NA|2||58||BLINDED TREATMENT|1970-07-23|1968-10-05|||||1960-09-19||1968-04-28|N|1964-12-17
TRIAL STUDY 134XCP|LB|448246D1-5625-4F69-B214-3A8848E86C28|1||||HISTAMIN|HISTAMINE|||||||10^6/HPF|||||||BORDERLINE||UMOL||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|Y|MIGET|HEPASCORE FORMULA||Y|N|N|NA|||U|3||39||OPEN LABEL TREATMENT|1969-08-12|1960-09-21|||||1964-06-02||1967-03-18|N|1970-01-29
TRIAL STUDY 134XCP|LB|448246D1-5625-4F69-B214-3A8848E86C28|2||||ASP|ASPARTIC ACID|||||||ML/G/MIN|||||||INVALID||MPH||||LOW|NOT DONE||||LYMPH|SOLIDIFIED|U|TARGETED GENOME SEQUENCING|MDRD FORMULA||NA|NA|Y|U|||Y|3||39||RUN-IN|1967-02-23|1971-04-06|||||1969-06-24||1964-11-11|Y|1972-08-08
TRIAL STUDY 134XCP|LB|448246D1-5625-4F69-B214-3A8848E86C28|1||||CHOLINES|CHOLINESTERASE|||||||U/MG|||||||BORDERLINE||DNA COPIES/ML||||HIGH|NOT DONE||||VENOUS CORD BLOOD|NON-HEMOLYZED|N|DIFFUSION WEIGHTED MRI|FIBROTEST FORMULA||NA|Y|Y|Y|||U|4||88||OBSERVATION|1960-05-26|1973-01-17|||||1971-07-05||1972-05-07|N|1965-06-10
TRIAL STUDY 134XCP|LB|448246D1-5625-4F69-B214-3A8848E86C28|2||||HGF|HEPATOCYTE GROWTH FACTOR|||||||ANTI-XA IU|||||||TRACE||10^10/L||||LOW|NOT DONE||||BILE|NON-HEMOLYZED|Y|OPTICAL DENSITY MEASUREMENT|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|N|||Y|4||88||RUN-IN|1966-01-05|1972-07-12|||||1967-11-25||1962-04-18|U|1966-08-29
TRIAL STUDY 134XCP|LB|448246D1-5625-4F69-B214-3A8848E86C28|1||||TGFB3|TRANSFORMING GROWTH FACTOR BETA 3|||||||FT3|||||||INDETERMINATE||10^6/HPF||||HIGH|NOT DONE||||EXPIRED AIR|UNEXPECTED ODOR|Y|MAGNETIC RESONANCE ANGIOGRAPHY|ASH FIBROSURE FORMULA||N|U|Y|NA|||Y|5||7||CONTINUATION TREATMENT|1967-05-19|1973-07-28|||||1961-03-06||1970-03-05|U|1966-10-11
TRIAL STUDY 134XCP|LB|448246D1-5625-4F69-B214-3A8848E86C28|2||||IAPP|ISLET AMYLOID POLYPEPTIDE|||||||S*KPA|||||||INDETERMINATE||PG/DL||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|REFRIGERATED|Y|RADIOIMMUNOPRECIPITATION ASSAY|GMI % FORMULA||N|N|Y|U|||Y|5||7||TREATMENT|1967-10-25|1971-02-01|||||1971-06-21||1961-07-31|Y|1961-12-24
TRIAL STUDY 134XCP|LB|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|1||||TGFB|TRANSFORMING GROWTH FACTOR BETA|||||||MMHG|||||||TRACE||PMOL/DL||||HIGH|NOT DONE||||PLATELET RICH PLASMA|THAWED|N|X-RAY FLUORESCENCE SPECTROMETRY|MDRD 6 VARIABLE FORMULA||NA|N|Y|N|||U|1||38||BASELINE|1962-02-24|1962-01-10|||||1961-07-16||1964-10-26|Y|1968-07-29
TRIAL STUDY 134XCP|LB|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|2||||LTA|LYMPHOTOXIN ALPHA|||||||CG|||||||NEGATIVE||IU/L||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|PARAFFIN-EMBEDDED|N|GRADIENT DIFFUSION|HEPASCORE FORMULA||N|Y|Y|N|||Y|1||38||FOLLOW-UP|1969-05-31|1969-04-20|||||1963-03-26||1964-11-13|Y|1969-12-23
TRIAL STUDY 134XCP|LB|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|1||||METHANOL|METHANOL|||||||KPA|||||||INVALID||LOG10 TCID 50/DOSE||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|HEMOLYZED|U|CALCOFLUOR WHITE STAIN|GMI MMOL/MOL FORMULA||Y|NA|N|U|||Y|2||58||SCREENING|1971-05-28|1964-10-07|||||1972-12-22||1961-12-22|N|1966-04-02
TRIAL STUDY 134XCP|LB|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|2||||CACR|CALCIUM CORRECTED|||||||CYCLE/MIN|||||||INVALID||CP||||LOW|NOT DONE||||ABSCESS FLUID|SOLIDIFIED|N|THICK SMEAR|FIBROTEST FORMULA||N|NA|N|NA|||NA|2||58||OPEN LABEL TREATMENT|1967-02-10|1967-08-10|||||1965-05-07||1972-05-29|U|1966-08-02
TRIAL STUDY 134XCP|LB|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|1||||GLOBA2|ALPHA-2 GLOBULIN|||||||UL/KG/DAY|||||||TRACE||ML/CM H2O||||NORMAL|NOT DONE||||CELL PELLET|ICTERIC|U|KNEMOMETRY|FIBROMETER FORMULA||NA|N|N|U|||U|3||39||TREATMENT|1963-08-12|1972-11-21|||||1965-07-06||1973-01-31|N|1961-03-14
TRIAL STUDY 134XCP|LB|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|2||||ATP|ADENOSINE TRIPHOSPHATE|||||||U/MG|||||||INVALID||MET*H||||LOW|NOT DONE||||GASTRIC CONTENTS|THAWED|N|SPECULAR MICROSCOPY|MDRD 4 VARIABLE FORMULA||NA|N|Y|N|||N|3||39||CONTINUATION TREATMENT|1962-02-21|1972-12-28|||||1966-03-04||1961-07-11|Y|1960-02-06
TRIAL STUDY 134XCP|LB|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|1||||WBCCLMP|LEUKOCYTE CELL CLUMPS|||||||MMHG/SEC|||||||INDETERMINATE||MIN/DAY||||ABNORMAL|NOT DONE||||SEMINAL FLUID|FRESH|Y|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|U|Y|U|||Y|4||88||OBSERVATION|1972-10-07|1968-04-06|||||1970-05-20||1962-03-16|Y|1960-09-12
TRIAL STUDY 134XCP|LB|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|2||||CIT|CITRULLINE|||||||PMOL/L/H|||||||BORDERLINE||PG/DL||||HIGH|NOT DONE||||SOFT TISSUE|LIPEMIC|NA|GC/MS|GMI % FORMULA||N|U|N|U|||Y|4||88||LONG-TERM FOLLOW-UP|1968-04-08|1960-11-26|||||1971-05-08||1964-02-24|NA|1968-07-27
TRIAL STUDY 134XCP|LB|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|1||||WBCCE|LEUKOCYTES/TOTAL CELLS|||||||/LPF|||||||INDETERMINATE||CD/M2||||NORMAL|NOT DONE||||ABSCESS FLUID|CLOTTED|NA|PHOROPTER|CKD-EPI CYSTATIN C FORMULA||U|NA|NA|NA|||Y|5||7||WASHOUT|1961-03-23|1963-03-04|||||1971-10-30||1972-12-20|N|1963-03-01
TRIAL STUDY 134XCP|LB|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|2||||PLAGGCVT|PLATELET AGGREGATION CURVE TYPE|||||||GAUSS|||||||TRACE||MMOL||||LOW|NOT DONE||||MONOCYTE|LACTESCENT|Y|HIGH RESOLUTION MELT ANALYSIS|NASH FIBROSURE FORMULA||NA|N|NA|NA|||N|5||7||LONG-TERM FOLLOW-UP|1964-04-15|1965-09-19|||||1963-03-09||1969-06-29|Y|1971-12-09
TRIAL STUDY 134XCP|LB|27DDBB16-ED11-45B6-987D-FB0D8223B993|1||||THRCREAT|THREONINE/CREATININE|||||||BAU/ML|||||||BORDERLINE||UL/KG/DAY||||NORMAL|NOT DONE||||VENOUS PLASMA|THAWED|Y|MALDI|FIBROSIS 4 FORMULA||Y|NA|N|N|||U|1||38||BLINDED TREATMENT|1968-01-17|1962-05-13|||||1960-04-28||1967-10-17|NA|1960-10-03
TRIAL STUDY 134XCP|LB|27DDBB16-ED11-45B6-987D-FB0D8223B993|2||||DIHYDCDN|DIHYDROCODEINE|||||||FINGERTIP UNIT|||||||NEGATIVE||PMOL/10^10 CELLS||||HIGH|NOT DONE||||CELL PELLET|SOLIDIFIED|Y|CONFOCAL MICROSCOPY|GMI MMOL/MOL FORMULA||N|N|N|U|||U|1||38||INDUCTION TREATMENT|1971-11-09|1965-11-19|||||1964-08-01||1961-10-20|Y|1973-01-19
TRIAL STUDY 134XCP|LB|27DDBB16-ED11-45B6-987D-FB0D8223B993|1||||KIM1|KIDNEY INJURY MOLECULE-1|||||||CMHG|||||||POSITIVE||JDF UNIT||||ABNORMAL|NOT DONE||||SEBUM|PARAFFIN-EMBEDDED|U|PALPATION|HEPASCORE FORMULA||NA|NA|NA|Y|||N|2||58||OBSERVATION|1963-10-27|1967-11-18|||||1969-07-03||1960-03-24|N|1972-06-04
TRIAL STUDY 134XCP|LB|27DDBB16-ED11-45B6-987D-FB0D8223B993|2||||INTLK25|INTERLEUKIN 25|||||||ML/BREATH|||||||TRACE||SBE/ML||||HIGH|NOT DONE||||BONE MARROW|FRESH|N|MS/MS|MDRD 5 VARIABLE FORMULA||U|N|N|Y|||Y|2||58||BLINDED TREATMENT|1972-11-03|1968-01-26|||||1965-10-05||1963-10-01|NA|1973-02-09
TRIAL STUDY 134XCP|LB|27DDBB16-ED11-45B6-987D-FB0D8223B993|1||||KLHIGMAB|KEYHOLE LIMPET HEMOCYANIN IGM ANTIBODY|||||||10^9 ORGANISMS/MG|||||||NEGATIVE||M3||||ABNORMAL|NOT DONE||||BUFFY COAT|CONTAMINATED|Y|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD 5 VARIABLE FORMULA||U|N|Y|NA|||NA|3||39||FOLLOW-UP|1962-09-14|1964-01-20|||||1965-04-06||1972-05-31|N|1973-07-27
TRIAL STUDY 134XCP|LB|27DDBB16-ED11-45B6-987D-FB0D8223B993|2||||ALTAST|ALT/AST|||||||UMOL/MIN|||||||INVALID||G/CM2||||LOW|NOT DONE||||GASTRIC FLUID|CONCENTRATED|Y|SLOAN LETTER EYE CHART 2.5%|CKD-EPI CREATININE FORMULA||N|Y|NA|NA|||U|3||39||BASELINE|1964-05-14|1973-05-03|||||1973-04-06||1970-05-10|NA|1962-09-16
TRIAL STUDY 134XCP|LB|27DDBB16-ED11-45B6-987D-FB0D8223B993|1||||FACTII|FACTOR II|||||||U/G HB|||||||INDETERMINATE||UV||||ABNORMAL|NOT DONE||||EXUDATE|ROOM TEMPERATURE|U|OPHTHALMOSCOPY|MDRD 4 VARIABLE FORMULA||U|N|N|N|||Y|4||88||BASELINE|1971-08-13|1963-08-01|||||1971-09-16||1971-11-24|NA|1970-10-28
TRIAL STUDY 134XCP|LB|27DDBB16-ED11-45B6-987D-FB0D8223B993|2||||C165909|INDUSTRIAL MIX IGG AB RAST SCORE|||||||ANTIBODY UNIT|||||||BORDERLINE||U/M2/H||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED|Y|ELISA|MDRD ENZYMATIC JAPANESE FORMULA||N|U|Y|NA|||N|4||88||WASHOUT|1962-06-10|1972-06-29|||||1965-10-08||1961-10-10|NA|1961-06-18
TRIAL STUDY 134XCP|LB|27DDBB16-ED11-45B6-987D-FB0D8223B993|1||||FENA|FRACTIONAL SODIUM EXCRETION|||||||BQ/L|||||||INDETERMINATE||TUBE||||LOW|NOT DONE||||ADIPOSE TISSUE|FROZEN|NA|CISH|FIBROMETER FORMULA||U|NA|U|NA|||NA|5||7||CONTINUATION TREATMENT|1966-09-15|1960-07-31|||||1961-09-18||1973-05-05|NA|1963-09-17
TRIAL STUDY 134XCP|LB|27DDBB16-ED11-45B6-987D-FB0D8223B993|2||||DALACRT|DELTA AMINOLEVULINATE/CREATININE|||||||UG/L FEU|||||||INDETERMINATE||KN/CM2||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|FRESH|U|ELECTROGASTROGRAPHY|COCKCROFT-GAULT FORMULA||NA|NA|Y|N|||NA|5||7||LONG-TERM FOLLOW-UP|1973-06-21|1972-06-22|||||1966-08-11||1970-10-27|U|1966-03-17
TRIAL STUDY 134XCP|LB|5545846C-F90F-4346-A075-05999641B872|1||||PEPSNGI|PEPSINOGEN I|||||||RATIO|||||||BORDERLINE||M3||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED|N|WESTERN BLOT|MDRD ENZYMATIC FORMULA||NA|U|NA|U|||NA|1||38||BASELINE|1966-03-06|1972-07-09|||||1962-02-24||1969-11-10|Y|1960-01-19
TRIAL STUDY 134XCP|LB|5545846C-F90F-4346-A075-05999641B872|2||||PSAF|PROSTATE SPECIFIC ANTIGEN, FREE|||||||G/CAGE/DAY|||||||INVALID||U/G/H||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|ICTERIC|Y|MODIFIED ACID FAST STAIN|CKD-EPI FORMULA||N|NA|Y|U|||Y|1||38||BASELINE|1968-05-23|1970-03-30|||||1971-03-31||1973-03-27|Y|1967-11-10
TRIAL STUDY 134XCP|LB|5545846C-F90F-4346-A075-05999641B872|1||||TXB2_D11|11-DEHYDRO-THROMBOXANE B2|||||||PL|||||||INVALID||BEAM BREAKS||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|REFRIGERATED|U|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 4 VARIABLE FORMULA||N|Y|Y|Y|||Y|2||58||OPEN LABEL TREATMENT|1961-05-22|1967-07-31|||||1971-01-01||1961-05-01|Y|1969-04-10
TRIAL STUDY 134XCP|LB|5545846C-F90F-4346-A075-05999641B872|2||||DPD|DEOXYPYRIDINOLINE|||||||DEG|||||||NEGATIVE||CI/ML||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|HEMOLYZED|U|MEDIASTINOSCOPY|CKD-EPI FORMULA||U|NA|U|N|||Y|2||58||LONG-TERM FOLLOW-UP|1960-10-27|1969-08-09|||||1960-06-11||1960-03-02|NA|1970-09-18
TRIAL STUDY 134XCP|LB|5545846C-F90F-4346-A075-05999641B872|1||||APLSMA2|ALPHA-2 ANTIPLASMIN|||||||MCI/KG|||||||BORDERLINE||MG/KG||||LOW|NOT DONE||||PERITONEAL FLUID|PARAFFIN-EMBEDDED|U|NUCLEAR RADIOLOGY|MDRD ENZYMATIC FORMULA||U|U|N|N|||NA|3||39||BASELINE|1968-12-25|1965-08-01|||||1969-01-08||1967-07-19|NA|1969-07-10
TRIAL STUDY 134XCP|LB|5545846C-F90F-4346-A075-05999641B872|2||||GSTCREAT|GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||GBQ/UG|||||||NEGATIVE||BEAM BREAKS||||LOW|NOT DONE||||PROSTATIC FLUID|FROZEN|N|TRANSMISSION ELECTRON MICROSCOPY|GMI % FORMULA||Y|N|Y|U|||N|3||39||SCREENING|1968-06-28|1970-07-31|||||1965-04-22||1962-05-11|Y|1970-11-08
TRIAL STUDY 134XCP|LB|5545846C-F90F-4346-A075-05999641B872|1||||RETICH|RET. CORPUSCULAR HEMOGLOBIN CONTENT|||||||UU/L|||||||TRACE||/5X10^4 WBC||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|UNEXPECTED ODOR|N|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI FORMULA||Y|N|N|U|||U|4||88||SCREENING|1968-06-03|1960-03-15|||||1970-04-22||1963-06-03|Y|1961-01-28
TRIAL STUDY 134XCP|LB|5545846C-F90F-4346-A075-05999641B872|2||||IL2RA|INTERLEUKIN 2 RECEPTOR SUBUNIT ALPHA|||||||HPA|||||||POSITIVE||10^7 PFU||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|ROOM TEMPERATURE|U|MICRODENSITOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|Y|N|||U|4||88||WASHOUT|1971-09-27|1969-10-23|||||1971-12-15||1967-08-18|N|1962-02-14
TRIAL STUDY 134XCP|LB|5545846C-F90F-4346-A075-05999641B872|1||||GSTALCRT|GLUTATHIONE S-TRANSFERASE, ALPHA/CREAT|||||||NGEQ/L|||||||INDETERMINATE||DEG/S||||HIGH|NOT DONE||||LAVAGE FLUID|CONTAMINATED|Y|ENDPOINT DILUTION ASSAY|NASH FIBROSURE FORMULA||U|N|NA|U|||Y|5||7||OPEN LABEL TREATMENT|1964-09-18|1967-10-07|||||1965-10-25||1966-03-20|Y|1973-05-06
TRIAL STUDY 134XCP|LB|5545846C-F90F-4346-A075-05999641B872|2||||HCHT|HYOCHOLATE|||||||GAUSS|||||||BORDERLINE||MCI||||ABNORMAL|NOT DONE||||BONE|AUTOLYZED|N|ELECTROGASTROGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|N|NA|||NA|5||7||OPEN LABEL TREATMENT|1970-04-20|1963-09-27|||||1970-09-17||1967-12-01|N|1963-10-04
TRIAL STUDY 134XCP|LB|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|1||||INTLK7|INTERLEUKIN 7|||||||MMHG/SEC|||||||NEGATIVE||PKAT/L||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|AUTOLYZED|U|PHYSICAL EXAMINATION|GMI MMOL/MOL FORMULA||NA|N|U|Y|||Y|1||38||TREATMENT|1965-03-12|1972-06-20|||||1968-10-05||1963-05-30|U|1971-04-11
TRIAL STUDY 134XCP|LB|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|2||||THCCOOH|11-NOR-DELTA9-THC-9-CARBOXYLIC ACID|||||||UL/DOSE|||||||POSITIVE||CAPFUL||||HIGH|NOT DONE||||HAIR FOLLICLE|CONCENTRATED|N|QUANTITATIVE ULTRASOUND|MDRD 4 VARIABLE FORMULA||N|Y|Y|NA|||U|1||38||CONTINUATION TREATMENT|1970-10-22|1970-02-16|||||1972-08-18||1963-07-01|NA|1965-11-16
TRIAL STUDY 134XCP|LB|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|1||||C130143|GERMAN COCKROACH ANTIGEN IGG4 ANTIBODY|||||||MG2/DL2|||||||POSITIVE||CI/G||||HIGH|NOT DONE||||COLOSTRUM|REFRIGERATED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI FORMULA||NA|N|N|NA|||U|2||58||OPEN LABEL TREATMENT|1963-07-04|1972-02-20|||||1972-12-23||1961-01-31|Y|1964-06-28
TRIAL STUDY 134XCP|LB|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|2||||MYCYLE|MYELOCYTES/LEUKOCYTES|||||||NU/CL|||||||NEGATIVE||CONTAINER||||HIGH|NOT DONE||||MENSTRUAL BLOOD|LIPEMIC|NA|MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA||Y|NA|U|NA|||NA|2||58||OBSERVATION|1970-07-09|1968-06-23|||||1970-02-09||1963-12-31|NA|1968-05-14
TRIAL STUDY 134XCP|LB|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|1||||PROGEST|PROGESTERONE|||||||NFIU|||||||INDETERMINATE||1/(S*KPA)||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|SOLIDIFIED|NA|EIA|NASH FIBROSURE FORMULA||N|U|NA|NA|||N|3||39||WASHOUT|1964-11-09|1967-12-22|||||1965-02-22||1960-04-24|Y|1972-08-04
TRIAL STUDY 134XCP|LB|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|2||||HGBA2HGB|HEMOGLOBIN A2/TOTAL HEMOGLOBIN|||||||ML/MMHG|||||||BORDERLINE||VG/DOSE||||LOW|NOT DONE||||BILE|NON-HEMOLYZED|NA|DIPSTICK|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|U|||N|3||39||LONG-TERM FOLLOW-UP|1966-01-30|1971-01-23|||||1964-07-12||1971-01-03|N|1960-05-26
TRIAL STUDY 134XCP|LB|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|1||||C130093|WESTERN RAGWEED POLLEN IGA|||||||CM2|||||||POSITIVE||S/H||||ABNORMAL|NOT DONE||||BLOOD|PARAFFIN-EMBEDDED|N|OPTICAL MAPPING|MDRD ENZYMATIC FORMULA||U|Y|N|NA|||NA|4||88||CONTINUATION TREATMENT|1960-04-25|1973-06-06|||||1969-11-11||1965-11-03|NA|1962-07-15
TRIAL STUDY 134XCP|LB|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|2||||MENGLCE|MENINGEAL CELLS/TOTAL CELLS|||||||/10^5|||||||INVALID||AFU||||NORMAL|NOT DONE||||DISCHARGE|PARAFFIN-EMBEDDED|Y|BIOPSY|MDRD 6 VARIABLE FORMULA||Y|N|Y|Y|||Y|4||88||CONTINUATION TREATMENT|1964-07-11|1961-03-10|||||1962-12-10||1967-05-16|N|1970-07-27
TRIAL STUDY 134XCP|LB|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|1||||INTLK3|INTERLEUKIN 3|||||||MG/ML/MIN|||||||INDETERMINATE||ML/CM H2O||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|CLOTTED|Y|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|U|U|Y|||Y|5||7||OPEN LABEL TREATMENT|1968-01-22|1968-12-31|||||1960-02-18||1960-08-29|U|1971-06-24
TRIAL STUDY 134XCP|LB|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|2||||C130143|GERMAN COCKROACH ANTIGEN IGG4 ANTIBODY|||||||10^5/L|||||||TRACE||GENEQ/ML||||LOW|NOT DONE||||BILE|UNEXPECTED ODOR|Y|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|FIBROTEST FORMULA||Y|Y|N|Y|||N|5||7||BLINDED TREATMENT|1971-07-25|1967-06-25|||||1963-04-17||1962-06-28|NA|1961-04-13
TRIAL STUDY 134XCP|LB|111541DB-D863-4C68-9E62-B8741A62401C|1||||FATLVIDX|FATTY LIVER INDEX|||||||/10^3|||||||NEGATIVE||NMOL/KG/DAY||||ABNORMAL|NOT DONE||||BUFFY COAT|REFRIGERATED|N|MICROBIAL CULTURE, LIQUID|HEPASCORE FORMULA||NA|U|Y|NA|||U|1||38||INDUCTION TREATMENT|1969-04-03|1972-06-29|||||1961-10-09||1960-12-12|U|1962-12-19
TRIAL STUDY 134XCP|LB|111541DB-D863-4C68-9E62-B8741A62401C|2||||TRPCRT|TRYPTOPHAN/CREATININE|||||||CI/L|||||||NEGATIVE||DAYS/MONTH||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|REFRIGERATED|NA|SIZE EXCLUSION CHROMATOGRAPHY|FIBROMETER FORMULA||U|Y|U|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1963-02-02|1969-08-02|||||1969-06-23||1969-08-21|N|1966-06-02
TRIAL STUDY 134XCP|LB|111541DB-D863-4C68-9E62-B8741A62401C|1||||PROGEST|PROGESTERONE|||||||UM/S|||||||NEGATIVE||MG/DOSE||||ABNORMAL|NOT DONE||||BILE|PARAFFIN-EMBEDDED|Y|DUKE INCISION METHOD|ASH FIBROSURE FORMULA||U|Y|U|U|||N|2||58||FOLLOW-UP|1969-05-20|1964-07-14|||||1970-12-30||1962-10-06|NA|1963-11-24
TRIAL STUDY 134XCP|LB|111541DB-D863-4C68-9E62-B8741A62401C|2||||TAURCRT|TAURINE/CREATININE|||||||UKAT/10^12 RBC|||||||TRACE||PIXEL||||LOW|NOT DONE||||MONOCYTE|PARAFFIN-EMBEDDED|Y|AUSCULTATION|MDRD ENZYMATIC FORMULA||N|U|NA|U|||NA|2||58||WASHOUT|1970-01-02|1963-12-14|||||1960-07-31||1960-10-22|NA|1973-06-27
TRIAL STUDY 134XCP|LB|111541DB-D863-4C68-9E62-B8741A62401C|1||||PROLYM|PROLYMPHOCYTES|||||||MEQ/MMOL|||||||INDETERMINATE||CCID 50/ML||||NORMAL|NOT DONE||||ABSCESS FLUID|FROZEN|N|ENDPOINT DILUTION ASSAY|MDRD 4 VARIABLE FORMULA||U|N|U|NA|||U|3||39||RUN-IN|1968-04-27|1971-04-14|||||1960-03-28||1972-11-10|U|1966-04-27
TRIAL STUDY 134XCP|LB|111541DB-D863-4C68-9E62-B8741A62401C|2||||IA2AB|INSULINOMA-ASSOCIATED PROTEIN 2 ANTIBODY|||||||KG|||||||BORDERLINE||TAMPON||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|AUTOLYZED|Y|X-RAY|CKD-EPI CYSTATIN C FORMULA||Y|Y|N|U|||Y|3||39||INDUCTION TREATMENT|1963-05-01|1970-03-04|||||1966-07-06||1969-04-22|N|1962-12-22
TRIAL STUDY 134XCP|LB|111541DB-D863-4C68-9E62-B8741A62401C|1||||ANTHRMAG|ANTITHROMBIN ANTIGEN|||||||LOG10 CFU/G|||||||TRACE||L/H/M2||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|THAWED|N|IMMUNE REPERTOIRE DEEP SEQUENCING|ASH FIBROSURE FORMULA||Y|NA|N|Y|||U|4||88||RUN-IN|1961-01-27|1966-10-13|||||1962-07-28||1960-11-27|U|1961-12-23
TRIAL STUDY 134XCP|LB|111541DB-D863-4C68-9E62-B8741A62401C|2||||CHCM|CORPUSCULAR HGB CONCENTRATION MEAN|||||||ANTI-XA IU/ML|||||||INDETERMINATE||U/G/H||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|LIPEMIC|N|SPIRAL CT|MDRD 5 VARIABLE FORMULA||U|N|Y|Y|||U|4||88||OBSERVATION|1963-04-01|1967-09-23|||||1970-11-12||1971-09-16|U|1970-09-12
TRIAL STUDY 134XCP|LB|111541DB-D863-4C68-9E62-B8741A62401C|1||||LTE4|LEUKOTRIENE E4|||||||10^6/G|||||||INDETERMINATE||10^11/L||||NORMAL|NOT DONE||||SMEGMA|GELLED|Y|OBSERVATION|CKD-EPI CREATININE FORMULA||Y|Y|Y|NA|||N|5||7||TREATMENT|1969-03-18|1963-03-15|||||1963-09-06||1972-10-13|U|1966-11-17
TRIAL STUDY 134XCP|LB|111541DB-D863-4C68-9E62-B8741A62401C|2||||HDLCCHOL|HDL CHOLESTEROL/TOTAL CHOLESTEROL|||||||NU/CL|||||||INDETERMINATE||MG/L FEU||||HIGH|NOT DONE||||LAVAGE FLUID|AUTOLYZED|N|TELLER ACUITY CARDS|NASH FIBROSURE FORMULA||U|Y|NA|Y|||U|5||7||RUN-IN|1965-01-01|1967-02-07|||||1968-03-31||1969-01-12|NA|1960-04-16
TRIAL STUDY 134XCP|LB|5095C113-7278-4D41-B860-0DF6B9B98738|1||||C130083|ORCHARD GRASS POLLEN IGG4|||||||MBQ|||||||TRACE||/100 HPFS||||NORMAL|NOT DONE||||GASTRIC CONTENTS|CONTAMINATED|U|BIOIMPEDANCE SPECTROSCOPY|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|N|||NA|1||38||BASELINE|1966-11-12|1962-07-23|||||1963-06-27||1961-10-21|Y|1960-02-12
TRIAL STUDY 134XCP|LB|5095C113-7278-4D41-B860-0DF6B9B98738|2||||MDZLM|MIDAZOLAM|||||||/MM|||||||NEGATIVE||RFU||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|REFRIGERATED|U|LINE PROBE ASSAY|HEPASCORE FORMULA||U|U|NA|NA|||U|1||38||OBSERVATION|1967-07-27|1961-12-06|||||1961-10-25||1969-10-17|Y|1963-02-11
TRIAL STUDY 134XCP|LB|5095C113-7278-4D41-B860-0DF6B9B98738|1||||C130091|TIMOTHY GRASS POLLEN IGG4|||||||CI/G|||||||POSITIVE||HOMEOPATHIC DILUTION||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|UNEXPECTED ODOR|NA|MICROBIAL CULTURE|FIBROTEST FORMULA||U|Y|Y|Y|||Y|2||58||SCREENING|1969-01-11|1963-02-12|||||1970-05-25||1961-06-14|NA|1963-04-05
TRIAL STUDY 134XCP|LB|5095C113-7278-4D41-B860-0DF6B9B98738|2||||RNPAB|RIBONUCLEOPROTEIN ANTIBODY|||||||GBQ|||||||INDETERMINATE||ABSORBANCE U/ML||||NORMAL|NOT DONE||||TISSUE|SOLIDIFIED|Y|MICROARRAY|NASH FIBROSURE FORMULA||N|NA|U|N|||NA|2||58||FOLLOW-UP|1972-12-11|1969-07-22|||||1961-11-21||1970-03-31|N|1967-02-19
TRIAL STUDY 134XCP|LB|5095C113-7278-4D41-B860-0DF6B9B98738|1||||C130076|SILVER BIRCH POLLEN IGE|||||||UG/MIN|||||||INDETERMINATE||10^3 DNA COPIES/ML||||HIGH|NOT DONE||||SYNOVIAL FLUID|AGGLUTINATED|NA|PEAK FLOWMETRY|COCKCROFT-GAULT FORMULA||NA|Y|N|N|||N|3||39||OBSERVATION|1970-01-08|1962-01-03|||||1970-11-09||1972-03-11|N|1963-02-20
TRIAL STUDY 134XCP|LB|5095C113-7278-4D41-B860-0DF6B9B98738|2||||TTGIGAAB|TISSUE TRANSGLUTAMINASE IGA ANTIBODY|||||||MEQ/G|||||||TRACE||10^8 PFU||||HIGH|NOT DONE||||AMNIOTIC FLUID|THAWED|NA|KINETIC CHROMOGENIC ASSAY|MDRD FORMULA||N|N|U|N|||N|3||39||INDUCTION TREATMENT|1972-10-13|1971-06-09|||||1965-11-15||1960-10-16|NA|1960-07-27
TRIAL STUDY 134XCP|LB|5095C113-7278-4D41-B860-0DF6B9B98738|1||||TGFA|TRANSFORMING GROWTH FACTOR ALPHA|||||||CFU/G|||||||POSITIVE||EU||||LOW|NOT DONE||||AMNIOTIC FLUID|SOLIDIFIED|N|HEMAGGLUTINATION INHIBITION ASSAY|ASH FIBROSURE FORMULA||N|U|U|NA|||Y|4||88||OPEN LABEL TREATMENT|1960-12-21|1964-03-08|||||1972-02-29||1969-05-06|U|1971-11-25
TRIAL STUDY 134XCP|LB|5095C113-7278-4D41-B860-0DF6B9B98738|2||||CCL23|CHEMOKINE (C-C MOTIF) LIGAND 23|||||||AGU/ML|||||||INVALID||NEWTON||||HIGH|NOT DONE||||AMNIOTIC FLUID|LIPEMIC|Y|PAP STAIN|FIBROTEST FORMULA||NA|U|N|N|||N|4||88||OBSERVATION|1964-10-31|1966-03-25|||||1971-02-06||1971-09-23|U|1967-07-13
TRIAL STUDY 134XCP|LB|5095C113-7278-4D41-B860-0DF6B9B98738|1||||CD79A|CD79A|||||||/2500 WBC|||||||POSITIVE||ML/S||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|DRIED|N|THIN SMEAR|FIBROMETER FORMULA||U|N|N|N|||U|5||7||INDUCTION TREATMENT|1966-06-19|1971-03-01|||||1969-12-15||1963-07-29|U|1967-07-15
TRIAL STUDY 134XCP|LB|5095C113-7278-4D41-B860-0DF6B9B98738|2||||LEUKCE|LEUKEMIC CELLS|||||||MEQ/UL|||||||NEGATIVE||PM||||NORMAL|NOT DONE||||EXUDATE|AUTOLYZED|NA|IRON HEMATOXYLIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|N|Y|||N|5||7||LONG-TERM FOLLOW-UP|1973-02-04|1973-06-08|||||1967-05-12||1972-08-14|N|1964-12-28
TRIAL STUDY 134XCP|LB|61319D2E-A512-425F-9301-BAD27B5F5C9B|1||||FCTXIIIA|FACTOR XIII ACTIVITY|||||||M|||||||POSITIVE||10^7 CFU/ML||||LOW|NOT DONE||||EXPIRED AIR|AUTOLYZED|N|CARDIAC THERMODILUTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|NA|N|||N|1||38||SCREENING|1961-03-27|1964-07-05|||||1963-12-14||1972-08-12|Y|1966-03-27
TRIAL STUDY 134XCP|LB|61319D2E-A512-425F-9301-BAD27B5F5C9B|2||||CLEXR|CHLORIDE EXCRETION RATE|||||||UOSM|||||||POSITIVE||MASK||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|HEMOLYZED|Y|POLYSOMNOGRAPHY|MDRD FORMULA||Y|NA|U|Y|||NA|1||38||INDUCTION TREATMENT|1960-06-29|1971-09-03|||||1966-11-08||1973-04-27|N|1961-11-17
TRIAL STUDY 134XCP|LB|61319D2E-A512-425F-9301-BAD27B5F5C9B|1||||IA5OHEXR|5-HYDROXYINDOLEACETICACID EXCRETION RATE|||||||ML/DAY|||||||INDETERMINATE||NG/MOL||||LOW|NOT DONE||||VITREOUS HUMOR|FRESH|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|HEPASCORE FORMULA||U|Y|Y|Y|||NA|2||58||INDUCTION TREATMENT|1973-01-08|1968-01-02|||||1965-05-16||1968-11-24|N|1964-10-24
TRIAL STUDY 134XCP|LB|61319D2E-A512-425F-9301-BAD27B5F5C9B|2||||OXYTOCIN|OXYTOCIN|||||||PLUG|||||||INDETERMINATE||PMOL/DAY||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|CONTAMINATED|NA|U-HPLC/MS/MS|FIBROTEST FORMULA||N|N|NA|NA|||U|2||58||OBSERVATION|1973-03-20|1969-10-13|||||1972-10-21||1965-01-26|N|1962-09-17
TRIAL STUDY 134XCP|LB|61319D2E-A512-425F-9301-BAD27B5F5C9B|1||||GST|GLUTATHIONE S-TRANSFERASE, TOTAL|||||||MOL/MOL|||||||BORDERLINE||ENZYME U||||NORMAL|NOT DONE||||BUFFY COAT|CLOTTED|NA|RADIOIMMUNOPRECIPITATION ASSAY|FIBROSIS 4 FORMULA||NA|N|U|Y|||U|3||39||BASELINE|1967-07-23|1961-01-09|||||1960-01-10||1962-12-16|N|1972-05-11
TRIAL STUDY 134XCP|LB|61319D2E-A512-425F-9301-BAD27B5F5C9B|2||||A2MACG|ALPHA-2 MACROGLOBULIN|||||||CM2|||||||BORDERLINE||NG/MOL||||HIGH|NOT DONE||||EMESIS|AGGLUTINATED|U|SLOAN LETTER EYE CHART 100%|FIBROMETER FORMULA||Y|Y|NA|U|||N|3||39||TREATMENT|1967-05-03|1969-03-08|||||1971-08-09||1972-05-14|U|1967-04-23
TRIAL STUDY 134XCP|LB|61319D2E-A512-425F-9301-BAD27B5F5C9B|1||||TBG|THYROXINE BINDING GLOBULIN|||||||PUFF|||||||INVALID||ML/ANIMAL/DAY||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|AGGLUTINATED|NA|BAC ACGH|FIBROMETER FORMULA||N|N|N|U|||NA|4||88||LONG-TERM FOLLOW-UP|1971-01-25|1963-08-30|||||1966-09-18||1964-04-22|U|1970-04-15
TRIAL STUDY 134XCP|LB|61319D2E-A512-425F-9301-BAD27B5F5C9B|2||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||STEPS/MIN|||||||INVALID||PMOL/10^10 CELLS||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|DRIED|U|PANENDOSCOPY|COCKCROFT-GAULT FORMULA||U|U|U|N|||N|4||88||LONG-TERM FOLLOW-UP|1964-10-25|1970-06-10|||||1965-10-17||1969-10-28|Y|1963-01-22
TRIAL STUDY 134XCP|LB|61319D2E-A512-425F-9301-BAD27B5F5C9B|1||||C130070|BERMUDA GRASS POLLEN IGG|||||||U/ML|||||||BORDERLINE||ML/S/M2||||ABNORMAL|NOT DONE||||PLATELET POOR PLASMA|AUTOLYZED|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|COCKCROFT-GAULT FORMULA||N|Y|NA|U|||Y|5||7||INDUCTION TREATMENT|1970-10-17|1968-05-29|||||1972-04-08||1973-07-09|Y|1964-11-20
TRIAL STUDY 134XCP|LB|61319D2E-A512-425F-9301-BAD27B5F5C9B|2||||PLATSAT|PLATELET SATELLITISM|||||||L/S/KPA|||||||POSITIVE||LOG10 TCID 50/ML||||LOW|NOT DONE||||EPIDERMAL TISSUE|PARAFFIN-EMBEDDED|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI MMOL/MOL FORMULA||NA|NA|NA|U|||NA|5||7||TREATMENT|1973-05-24|1960-10-29|||||1973-04-26||1963-07-20|Y|1963-05-16
TRIAL STUDY 134XCP|LB|3B865A8F-949B-4B64-A818-85472EABB8FB|1||||LDH4|LDH ISOENZYME 4|||||||ML*CMH2O|||||||INVALID||BQ/MG||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|FROZEN|NA|LC-FL|NASH FIBROSURE FORMULA||U|N|U|Y|||N|1||38||LONG-TERM FOLLOW-UP|1967-08-29|1964-03-15|||||1965-02-23||1970-08-27|U|1968-08-08
TRIAL STUDY 134XCP|LB|3B865A8F-949B-4B64-A818-85472EABB8FB|2||||GLOBA1|ALPHA-1 GLOBULIN|||||||10^3/L|||||||BORDERLINE||MMOL/MIN/KPA||||LOW|NOT DONE||||VENOUS PLASMA|CONTAMINATED|U|FUNDUS PHOTOGRAPHY|CKD-EPI CREATININE FORMULA||N|N|U|NA|||Y|1||38||OBSERVATION|1973-01-03|1965-12-03|||||1970-02-07||1966-12-23|N|1962-02-05
TRIAL STUDY 134XCP|LB|3B865A8F-949B-4B64-A818-85472EABB8FB|1||||ANDSTNDN|ANDROSTENEDIONE|||||||WEBER|||||||NEGATIVE||V/V||||NORMAL|NOT DONE||||VENOUS PLASMA|ICTERIC|NA|IVY INCISION METHOD|FIBROTEST FORMULA||NA|N|U|N|||Y|2||58||BASELINE|1967-09-08|1968-07-13|||||1971-04-19||1972-05-06|U|1961-02-16
TRIAL STUDY 134XCP|LB|3B865A8F-949B-4B64-A818-85472EABB8FB|2||||CXCL3|CHEMOKINE (C-X-C MOTIF) LIGAND 3|||||||MG2/DL2|||||||NEGATIVE||S/H||||LOW|NOT DONE||||SPUTUM|DRIED|N|ICP-MS|MDRD 5 VARIABLE FORMULA||Y|U|U|U|||N|2||58||CONTINUATION TREATMENT|1962-11-29|1969-08-08|||||1961-02-18||1962-01-09|NA|1969-10-03
TRIAL STUDY 134XCP|LB|3B865A8F-949B-4B64-A818-85472EABB8FB|1||||INTLK8|INTERLEUKIN 8|||||||APS U|||||||NEGATIVE||CIGARETTE||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|THAWED|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|GMI % FORMULA||Y|NA|U|U|||NA|3||39||BLINDED TREATMENT|1967-01-08|1965-11-05|||||1965-12-07||1960-07-30|U|1967-11-06
TRIAL STUDY 134XCP|LB|3B865A8F-949B-4B64-A818-85472EABB8FB|2||||GSTMU|MU GLUTATHIONE-S-TRANSFERASE|||||||LOG10 COPIES/ML|||||||POSITIVE||PELLET||||NORMAL|NOT DONE||||MUCUS|PARAFFIN-EMBEDDED|NA|SLOAN LETTER EYE CHART 2.5%|FIBROSIS 4 FORMULA||U|NA|U|N|||N|3||39||WASHOUT|1961-12-27|1964-10-15|||||1973-08-11||1966-04-01|U|1960-10-02
TRIAL STUDY 134XCP|LB|3B865A8F-949B-4B64-A818-85472EABB8FB|1||||APPEAR|SPECIMEN APPEARANCE|||||||NMOL/ML/MIN|||||||TRACE||COPIES/ML||||LOW|NOT DONE||||PLATELET|LIPEMIC|U|CONTRAST ENHANCED X-RAY|GMI % FORMULA||N|N|NA|U|||U|4||88||FOLLOW-UP|1964-11-27|1963-07-07|||||1973-02-08||1971-12-16|U|1965-10-11
TRIAL STUDY 134XCP|LB|3B865A8F-949B-4B64-A818-85472EABB8FB|2||||KL6|KREBS VON DEN LUNGEN-6|||||||PLUG|||||||NEGATIVE||BEL||||LOW|NOT DONE||||TRANSUDATE|LACTESCENT|NA|PULSE OXIMETRY|ASH FIBROSURE FORMULA||NA|Y|Y|Y|||NA|4||88||TREATMENT|1972-12-08|1960-06-26|||||1973-07-02||1973-04-07|NA|1965-11-02
TRIAL STUDY 134XCP|LB|3B865A8F-949B-4B64-A818-85472EABB8FB|1||||HALBAB|HUMAN ALBUMIN ANTIBODY|||||||U/G/H|||||||TRACE||ML/BREATH||||ABNORMAL|NOT DONE||||TISSUE|CONCENTRATED|N|SICKLE CELL SOLUBILITY TEST|NASH FIBROSURE FORMULA||N|N|Y|NA|||NA|5||7||WASHOUT|1964-07-25|1968-06-20|||||1966-10-01||1960-06-01|N|1970-09-12
TRIAL STUDY 134XCP|LB|3B865A8F-949B-4B64-A818-85472EABB8FB|2||||APRI|AST TO PLATELET RATIO INDEX|||||||G/CAGE|||||||TRACE||NMOL/MOL||||ABNORMAL|NOT DONE||||EMESIS|REFRIGERATED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NASH FIBROSURE FORMULA||NA|Y|NA|N|||U|5||7||BLINDED TREATMENT|1968-08-25|1967-11-01|||||1967-04-04||1968-09-03|N|1960-04-21
TRIAL STUDY 134XCP|LB|A6909912-22B9-4EE7-AEDF-F791F243A6B7|1||||EOSMYL|EOSINOPHILIC MYELOCYTES|||||||GRAIN|||||||TRACE||U/M2/DAY||||NORMAL|NOT DONE||||ISOLATE|CALCIFIED|N|ELECTROMYOGRAPHY|GMI MMOL/MOL FORMULA||U|Y|Y|Y|||U|1||38||BLINDED TREATMENT|1964-01-01|1967-01-14|||||1968-10-30||1969-05-01|N|1962-04-15
TRIAL STUDY 134XCP|LB|A6909912-22B9-4EE7-AEDF-F791F243A6B7|2||||NUCCE|NUCLEATED CELLS|||||||TUBERCULIN UNIT/ML|||||||INDETERMINATE||CARTRIDGE||||NORMAL|NOT DONE||||SERUM|DRIED|U|PET/MRI SCAN|ASH FIBROSURE FORMULA||N|U|U|NA|||Y|1||38||OBSERVATION|1965-09-09|1962-09-01|||||1965-06-27||1972-04-23|U|1961-07-23
TRIAL STUDY 134XCP|LB|A6909912-22B9-4EE7-AEDF-F791F243A6B7|1||||APOA4|APOLIPOPROTEIN A4|||||||10^6 ORGANISMS|||||||INVALID||M/SEC||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|Y|MRS|MDRD 6 VARIABLE FORMULA||Y|NA|U|U|||NA|2||58||RUN-IN|1970-01-02|1973-01-16|||||1962-07-22||1965-01-23|N|1963-05-18
TRIAL STUDY 134XCP|LB|A6909912-22B9-4EE7-AEDF-F791F243A6B7|2||||RPA1|RENAL PAPILLARY ANTIGEN 1|||||||10^7 TCID 50/DOSE|||||||POSITIVE||MM/H||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|THAWED|U|EIA|MDRD FORMULA||N|U|N|N|||Y|2||58||FOLLOW-UP|1969-11-08|1966-09-30|||||1964-11-22||1968-06-28|Y|1960-06-05
TRIAL STUDY 134XCP|LB|A6909912-22B9-4EE7-AEDF-F791F243A6B7|1||||GUSA|GLUCURONIDASE, ALPHA|||||||RING|||||||INVALID||LB||||HIGH|NOT DONE||||WHITE MATTER TISSUE|CLOTTED|Y|X-RAY|NASH FIBROSURE FORMULA||N|U|N|Y|||NA|3||39||INDUCTION TREATMENT|1960-03-28|1961-01-17|||||1963-01-21||1963-04-17|N|1961-04-29
TRIAL STUDY 134XCP|LB|A6909912-22B9-4EE7-AEDF-F791F243A6B7|2||||PPTDCALB|PHOSPHATIDYLCHOLINE/ALBUMIN|||||||/10^4|||||||INVALID||PG/CELL||||NORMAL|NOT DONE||||HAIR FOLLICLE|NON-HEMOLYZED|Y|ROMANOWSKY STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|U|NA|||Y|3||39||FOLLOW-UP|1971-10-22|1973-04-25|||||1970-01-23||1969-02-28|Y|1966-01-07
TRIAL STUDY 134XCP|LB|A6909912-22B9-4EE7-AEDF-F791F243A6B7|1||||OH8DXG2|8-HYDROXY-2'-DEOXYGUANOSINE|||||||MBQ/UL|||||||INDETERMINATE||KCAL/DAY||||HIGH|NOT DONE||||EXUDATE|HEMOLYZED|Y|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|GMI MMOL/MOL FORMULA||Y|U|U|Y|||Y|4||88||WASHOUT|1969-12-05|1962-09-26|||||1965-07-08||1969-12-31|NA|1969-08-15
TRIAL STUDY 134XCP|LB|A6909912-22B9-4EE7-AEDF-F791F243A6B7|2||||AMYLB42|AMYLOID BETA 1-42|||||||GPELISA UNIT/ML|||||||BORDERLINE||KA_U/DL||||LOW|NOT DONE||||VENOUS BLOOD|CONCENTRATED|U|MYELOPEROXIDASE STAIN|GMI MMOL/MOL FORMULA||Y|N|N|U|||Y|4||88||OPEN LABEL TREATMENT|1960-12-15|1968-04-06|||||1971-04-25||1971-04-08|N|1961-12-02
TRIAL STUDY 134XCP|LB|A6909912-22B9-4EE7-AEDF-F791F243A6B7|1||||NEUTBLE|NEUTROPHILS BAND FORM/LEUKOCYTES|||||||UMOL/L/H|||||||TRACE||U/CL||||HIGH|NOT DONE||||DISCHARGE|ROOM TEMPERATURE|U|MACRO BROTH DILUTION|MDRD 6 VARIABLE FORMULA||N|N|NA|Y|||NA|5||7||SCREENING|1969-08-10|1968-02-01|||||1967-03-16||1971-03-19|U|1961-08-09
TRIAL STUDY 134XCP|LB|A6909912-22B9-4EE7-AEDF-F791F243A6B7|2||||A2MACG|ALPHA-2 MACROGLOBULIN|||||||EID 50/ML|||||||INVALID||UMOL/DL||||HIGH|NOT DONE||||LYSATE|CONTAMINATED|U|HEMAGGLUTINATION INHIBITION ASSAY|MDRD 5 VARIABLE FORMULA||Y|U|N|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1968-02-07|1964-05-19|||||1964-07-29||1969-11-18|Y|1965-11-14
TRIAL STUDY 134XCP|LB|83C8AAD3-B22D-42C6-870A-D069FAC601F3|1||||C5B9S|SOLUBLE COMPLEMENT C5B-9|||||||G/G|||||||INDETERMINATE||PPB||||NORMAL|NOT DONE||||ALVEOLAR AIR|HEMOLYZED|NA|BIOIMPEDANCE SPECTROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|NA|||Y|1||38||BASELINE|1971-01-10|1960-03-12|||||1970-05-26||1969-10-21|Y|1968-03-10
TRIAL STUDY 134XCP|LB|83C8AAD3-B22D-42C6-870A-D069FAC601F3|2||||BAMBTAC|BETA-AMINOBUTYRIC ACID|||||||ELISA UNIT/DOSE|||||||INDETERMINATE||U/G/H||||LOW|NOT DONE||||PLEURAL TISSUE|ROOM TEMPERATURE|Y|CONGO RED STAIN|MDRD 5 VARIABLE FORMULA||U|N|Y|NA|||Y|1||38||WASHOUT|1967-05-28|1969-10-18|||||1967-07-22||1971-08-29|U|1965-04-12
TRIAL STUDY 134XCP|LB|83C8AAD3-B22D-42C6-870A-D069FAC601F3|1||||C130090|TIMOTHY GRASS POLLEN IGG|||||||U.CARR|||||||POSITIVE||MEQ/G||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|AUTOLYZED|N|GC/MS-CI|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|Y|||U|2||58||WASHOUT|1965-12-06|1973-04-10|||||1968-09-07||1961-05-31|U|1971-04-12
TRIAL STUDY 134XCP|LB|83C8AAD3-B22D-42C6-870A-D069FAC601F3|2||||VITB3|NIACIN|||||||MV|||||||BORDERLINE||ML/CAGE/DAY||||ABNORMAL|NOT DONE||||BONE|SOLIDIFIED|Y|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD 6 VARIABLE FORMULA||Y|N|U|Y|||Y|2||58||INDUCTION TREATMENT|1964-10-27|1965-08-01|||||1972-11-03||1964-05-31|NA|1961-11-24
TRIAL STUDY 134XCP|LB|83C8AAD3-B22D-42C6-870A-D069FAC601F3|1||||PSELECTS|SOLUBLE P-SELECTIN|||||||VIRTUAL PIXEL|||||||TRACE||BQ/UL||||ABNORMAL|NOT DONE||||SEMINAL FLUID|CONCENTRATED|U|CARDIAC THERMODILUTION|MDRD 6 VARIABLE FORMULA||U|U|U|N|||U|3||39||WASHOUT|1969-12-27|1960-07-05|||||1967-07-09||1961-09-30|NA|1965-12-14
TRIAL STUDY 134XCP|LB|83C8AAD3-B22D-42C6-870A-D069FAC601F3|2||||AMPHETD|DEXTROAMPHETAMINE|||||||NG/DAY|||||||TRACE||CUP||||ABNORMAL|NOT DONE||||SEMEN|PARAFFIN-EMBEDDED|N|IMMUNOFIXATION ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA||N|NA|U|U|||U|3||39||RUN-IN|1970-12-20|1970-11-21|||||1968-03-15||1973-03-27|NA|1969-07-09
TRIAL STUDY 134XCP|LB|83C8AAD3-B22D-42C6-870A-D069FAC601F3|1||||ANDSTNDN|ANDROSTENEDIONE|||||||MOL|||||||POSITIVE||ML/ANIMAL||||NORMAL|NOT DONE||||ISOLATE|GELLED|NA|MAMMOGRAPHY|ASH FIBROSURE FORMULA||Y|Y|NA|U|||U|4||88||CONTINUATION TREATMENT|1961-02-24|1971-04-06|||||1960-08-31||1966-10-26|Y|1966-01-19
TRIAL STUDY 134XCP|LB|83C8AAD3-B22D-42C6-870A-D069FAC601F3|2||||PTSFAC|PROTEIN S, FREE ACTUAL/CONTROL|||||||CMH2O*S2/ML|||||||NEGATIVE||HPA||||ABNORMAL|NOT DONE||||BUFFY COAT|LACTESCENT|NA|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD ENZYMATIC JAPANESE FORMULA||U|U|NA|Y|||N|4||88||WASHOUT|1961-07-30|1967-10-15|||||1963-07-09||1967-01-22|N|1963-10-27
TRIAL STUDY 134XCP|LB|83C8AAD3-B22D-42C6-870A-D069FAC601F3|1||||LDH3|LDH ISOENZYME 3|||||||/500 WBC|||||||POSITIVE||CYLINDER||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|CLOTTED|N|NON-CONTACT SPECULAR MICROSCOPY|GMI MMOL/MOL FORMULA||N|Y|Y|U|||N|5||7||CONTINUATION TREATMENT|1962-09-07|1964-08-20|||||1963-11-05||1963-03-12|N|1965-02-23
TRIAL STUDY 134XCP|LB|83C8AAD3-B22D-42C6-870A-D069FAC601F3|2||||LMBDLC|LAMBDA LIGHT CHAIN|||||||STRIP|||||||INVALID||PPM||||HIGH|NOT DONE||||LYSATE|PARAFFIN-EMBEDDED|NA|IHC|CKD-EPI CYSTATIN C FORMULA||N|U|N|Y|||NA|5||7||SCREENING|1973-08-31|1970-11-20|||||1961-02-22||1970-03-19|N|1964-09-30
TRIAL STUDY 134XCP|LB|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|1||||TRPTRG|TRYPSIN AND TRYPSINOGEN|||||||GPS U|||||||POSITIVE||10^7 CFU||||HIGH|NOT DONE||||REFLEX TEAR|PARAFFIN-EMBEDDED|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA||NA|NA|N|U|||NA|1||38||INDUCTION TREATMENT|1961-11-21|1967-12-22|||||1972-05-25||1972-09-12|N|1968-10-14
TRIAL STUDY 134XCP|LB|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|2||||INTLK1B|INTERLEUKIN 1 BETA|||||||IU/KG|||||||POSITIVE||GBQ/MG||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|NON-HEMOLYZED|Y|MAGNETIC RESONANCE ENTEROGRAPHY|MDRD 5 VARIABLE FORMULA||NA|N|Y|NA|||NA|1||38||LONG-TERM FOLLOW-UP|1963-03-17|1965-02-02|||||1968-03-10||1970-04-05|NA|1970-04-11
TRIAL STUDY 134XCP|LB|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|1||||APOA2|APOLIPOPROTEIN AII|||||||CM2|||||||BORDERLINE||AMP||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|GELLED|U|IHC|GMI MMOL/MOL FORMULA||NA|NA|U|U|||U|2||58||CONTINUATION TREATMENT|1963-12-13|1968-05-08|||||1965-01-31||1964-03-16|Y|1964-01-25
TRIAL STUDY 134XCP|LB|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|2||||NPY|NEUROPEPTIDE Y|||||||KS|||||||NEGATIVE||GPELISA UNIT/ML||||LOW|NOT DONE||||LAVAGE FLUID|CONTAMINATED|NA|LC-FL|NASH FIBROSURE FORMULA||Y|N|N|Y|||U|2||58||BLINDED TREATMENT|1964-03-24|1964-06-13|||||1961-06-21||1967-08-11|NA|1965-12-18
TRIAL STUDY 134XCP|LB|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|1||||FATACVLC|FATTY ACIDS, VERY LONG CHAIN|||||||AMU|||||||POSITIVE||ML/BREATH||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|CONTAMINATED|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD ENZYMATIC FORMULA||U|N|NA|Y|||NA|3||39||RUN-IN|1965-02-24|1968-09-26|||||1963-04-08||1966-01-15|N|1973-01-26
TRIAL STUDY 134XCP|LB|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|2||||GLUCCLR|GLUCOSE CLEARANCE|||||||10^6 ORGANISMS/G|||||||BORDERLINE||MEQ/ML||||LOW|NOT DONE||||DIALYSIS FLUID|CONCENTRATED|Y|AURAMINE STAIN|MDRD 4 VARIABLE FORMULA||N|NA|Y|U|||Y|3||39||FOLLOW-UP|1963-12-24|1973-08-30|||||1960-02-26||1961-05-03|Y|1973-07-01
TRIAL STUDY 134XCP|LB|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|1||||AZURGRAN|AZUROPHILIC GRANULES|||||||GBQ/G|||||||INDETERMINATE||L/H/M2||||ABNORMAL|NOT DONE||||PLEURAL FLUID|PARAFFIN-EMBEDDED|N|BIOPSY|FIBROTEST FORMULA||Y|N|N|N|||NA|4||88||OPEN LABEL TREATMENT|1973-03-29|1970-05-14|||||1965-05-13||1970-11-17|Y|1967-09-02
TRIAL STUDY 134XCP|LB|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|2||||OAS3|2-5-OLIGOADENYLATE SYNTHASE 3|||||||%(W/V)|||||||INVALID||MG/KG/DAY||||ABNORMAL|NOT DONE||||CALCULUS|LIPEMIC|Y|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|N|N|||NA|4||88||BASELINE|1966-12-22|1961-05-06|||||1971-02-24||1970-04-11|Y|1966-11-24
TRIAL STUDY 134XCP|LB|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|1||||DHT|DIHYDROTESTOSTERONE|||||||UMOL/MOL|||||||INDETERMINATE||MEQ/DAY||||ABNORMAL|NOT DONE||||LYSATE|LIPEMIC|Y|ETDRS EYE CHART|COCKCROFT-GAULT FORMULA||NA|N|Y|NA|||NA|5||7||LONG-TERM FOLLOW-UP|1960-01-01|1962-08-04|||||1969-12-26||1960-09-04|N|1967-04-28
TRIAL STUDY 134XCP|LB|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|2||||GLOBA1PT|ALPHA-1 GLOBULIN/TOTAL PROTEIN|||||||TUBERCULIN UNIT/ML|||||||POSITIVE||U/KG/DAY||||HIGH|NOT DONE||||SEMINAL FLUID|LIPEMIC|NA|PELLI-ROBSON EYE CHART|CKD-EPI CYSTATIN C FORMULA||Y|Y|NA|U|||Y|5||7||OPEN LABEL TREATMENT|1972-06-22|1966-06-29|||||1964-11-19||1963-09-14|Y|1967-03-31
TRIAL STUDY 134XCP|LB|937BF41A-157D-45F6-9797-2C5D19D100E6|1||||CGADJMW|CHORIOGONADOTROPIN ADJ FOR MATERNAL WT|||||||POUCH|||||||NEGATIVE||PNU/ML||||ABNORMAL|NOT DONE||||HAIR|AGGLUTINATED|U|SLIT LAMP PHOTOGRAPHY|GMI MMOL/MOL FORMULA||NA|Y|Y|NA|||N|1||38||SCREENING|1960-02-26|1967-11-12|||||1964-05-19||1968-03-22|Y|1964-03-06
TRIAL STUDY 134XCP|LB|937BF41A-157D-45F6-9797-2C5D19D100E6|2||||GLY|GLYCINE|||||||MS2|||||||INDETERMINATE||KPA/L/SEC||||NORMAL|NOT DONE||||CERUMEN|LACTESCENT|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA||Y|U|N|N|||N|1||38||INDUCTION TREATMENT|1962-07-05|1965-09-15|||||1960-10-25||1963-01-28|NA|1963-02-26
TRIAL STUDY 134XCP|LB|937BF41A-157D-45F6-9797-2C5D19D100E6|1||||CEC|CIRCULATING ENDOTHELIAL CELLS|||||||BAU/ML|||||||BORDERLINE||G/CAGE/DAY||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|ROOM TEMPERATURE|Y|TRIPLE-PHASE MRI SCAN|MDRD FORMULA||U|N|Y|N|||NA|2||58||LONG-TERM FOLLOW-UP|1972-03-16|1968-03-07|||||1963-06-11||1963-07-30|NA|1972-03-17
TRIAL STUDY 134XCP|LB|937BF41A-157D-45F6-9797-2C5D19D100E6|2||||PLTAGAMP|PLATELET AGGREGATION AMPLITUDE|||||||MG/ML/DAY|||||||POSITIVE||/100 HPFS||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|LIPEMIC|Y|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|NASH FIBROSURE FORMULA||Y|U|N|Y|||U|2||58||BLINDED TREATMENT|1972-09-10|1969-04-08|||||1967-04-03||1960-01-02|NA|1966-11-07
TRIAL STUDY 134XCP|LB|937BF41A-157D-45F6-9797-2C5D19D100E6|1||||CACRTP|CALCIUM CORRECTED FOR TOTAL PROTEIN|||||||U/M2|||||||NEGATIVE||LOG10 CFU/ML||||HIGH|NOT DONE||||NAIL|FROZEN|U|ECHOCARDIOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|N|N|NA|||N|3||39||OPEN LABEL TREATMENT|1966-06-20|1965-08-14|||||1973-02-18||1964-07-25|N|1970-02-17
TRIAL STUDY 134XCP|LB|937BF41A-157D-45F6-9797-2C5D19D100E6|2||||APLASCPD|APTT-LA SCREEN TO CONFIRM PCT DIFFERENCE|||||||MG/KG/DAY|||||||NEGATIVE||PACKET||||ABNORMAL|NOT DONE||||EXUDATE|PARAFFIN-EMBEDDED|Y|LAPAROSCOPY|CKD-EPI CYSTATIN C FORMULA||N|N|NA|Y|||Y|3||39||OBSERVATION|1961-07-20|1960-05-25|||||1966-03-25||1972-06-02|Y|1973-01-26
TRIAL STUDY 134XCP|LB|937BF41A-157D-45F6-9797-2C5D19D100E6|1||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||UKAT|||||||INDETERMINATE||CIGAR||||NORMAL|NOT DONE||||URINE SEDIMENT|CONCENTRATED|N|HEMATOXYLIN AND EOSIN STAIN|COCKCROFT-GAULT FORMULA||NA|N|NA|U|||NA|4||88||BASELINE|1964-03-18|1970-02-17|||||1961-06-12||1970-03-21|NA|1971-11-08
TRIAL STUDY 134XCP|LB|937BF41A-157D-45F6-9797-2C5D19D100E6|2||||CARNTEXR|CARNITINE EXCRETION RATE|||||||CMOL|||||||BORDERLINE||DL||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|CONCENTRATED|NA|FLOW MICROSCOPY|GMI MMOL/MOL FORMULA||N|Y|Y|N|||Y|4||88||WASHOUT|1967-12-26|1962-10-01|||||1971-09-22||1965-06-08|NA|1963-12-15
TRIAL STUDY 134XCP|LB|937BF41A-157D-45F6-9797-2C5D19D100E6|1||||TGFB|TRANSFORMING GROWTH FACTOR BETA|||||||MG|||||||POSITIVE||CD||||NORMAL|NOT DONE||||BUFFY COAT|CLOTTED|NA|MUGA|HEPASCORE FORMULA||U|U|Y|N|||Y|5||7||WASHOUT|1972-09-05|1966-01-15|||||1966-10-29||1972-03-24|U|1965-07-09
TRIAL STUDY 134XCP|LB|937BF41A-157D-45F6-9797-2C5D19D100E6|2||||OVALCY|OVALOCYTES|||||||ABSORBANCE U/MIN|||||||NEGATIVE||G/G/DAY||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|THAWED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|ASH FIBROSURE FORMULA||N|Y|Y|U|||NA|5||7||LONG-TERM FOLLOW-UP|1961-12-17|1968-04-20|||||1967-08-15||1961-10-24|NA|1963-09-17
TRIAL STUDY 134XCP|LB|1BA56D89-E536-491E-AD6A-190A07331BEA|1||||CSFIGIDX|CSF IGG INDEX|||||||L/MIN/M2|||||||INVALID||10^6 IU||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|SOLIDIFIED|U|TEMPLATE INCISION METHOD|HEPASCORE FORMULA||U|N|N|Y|||NA|1||38||BASELINE|1971-06-03|1962-05-01|||||1968-12-30||1970-06-22|U|1973-05-02
TRIAL STUDY 134XCP|LB|1BA56D89-E536-491E-AD6A-190A07331BEA|2||||TGFB1|TRANSFORMING GROWTH FACTOR BETA 1|||||||RNA COPIES/ML|||||||BORDERLINE||ML/DOSE||||LOW|NOT DONE||||MECONIUM|PARAFFIN-EMBEDDED|U|CELL OF ORIGIN ASSAY|GMI MMOL/MOL FORMULA||U|NA|U|N|||U|1||38||FOLLOW-UP|1971-04-21|1968-12-16|||||1965-04-19||1963-07-26|NA|1966-06-16
TRIAL STUDY 134XCP|LB|1BA56D89-E536-491E-AD6A-190A07331BEA|1||||EOSCE|EOSINOPHILS/TOTAL CELLS|||||||BAG|||||||NEGATIVE||G/KG||||HIGH|NOT DONE||||DISCHARGE|HEMOLYZED|NA|TOLUIDINE BLUE STAIN|CKD-EPI CYSTATIN C FORMULA||N|N|Y|U|||N|2||58||BLINDED TREATMENT|1962-09-20|1962-08-22|||||1962-07-10||1971-06-20|U|1961-04-14
TRIAL STUDY 134XCP|LB|1BA56D89-E536-491E-AD6A-190A07331BEA|2||||IL1EXR|INTERLEUKIN 1 EXCRETION RATE|||||||GY|||||||TRACE||MMOL2/L2||||NORMAL|NOT DONE||||KERATINOCYTE|SOLIDIFIED|NA|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|NASH FIBROSURE FORMULA||U|Y|NA|N|||U|2||58||BLINDED TREATMENT|1966-02-18|1969-07-18|||||1966-07-04||1972-04-04|N|1969-01-16
TRIAL STUDY 134XCP|LB|1BA56D89-E536-491E-AD6A-190A07331BEA|1||||METANEPH|METANEPHRINE|||||||UG/H|||||||NEGATIVE||NFIU||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FRESH|U|RADIATION DOSIMETRY|NASH FIBROSURE FORMULA||N|U|Y|U|||N|3||39||SCREENING|1973-04-29|1972-02-10|||||1968-11-27||1966-04-15|NA|1971-10-20
TRIAL STUDY 134XCP|LB|1BA56D89-E536-491E-AD6A-190A07331BEA|2||||HGBTET|HEMOGLOBIN TETRAMER|||||||BQ/UL|||||||BORDERLINE||COAT||||LOW|NOT DONE||||DERMAL TISSUE|REFRIGERATED|NA|CT SCAN WITHOUT CONTRAST|FIBROTEST FORMULA||Y|NA|N|Y|||Y|3||39||CONTINUATION TREATMENT|1968-01-17|1966-12-19|||||1964-12-01||1962-03-31|U|1972-02-17
TRIAL STUDY 134XCP|LB|1BA56D89-E536-491E-AD6A-190A07331BEA|1||||CD1|CD1|||||||EID 50/ML|||||||TRACE||LM||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|THAWED|NA|CISH|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|U|U|||U|4||88||FOLLOW-UP|1971-06-23|1969-05-07|||||1961-04-24||1972-09-20|N|1960-03-31
TRIAL STUDY 134XCP|LB|1BA56D89-E536-491E-AD6A-190A07331BEA|2||||CSBROAD|BROAD CASTS|||||||MOL/G|||||||TRACE||FMOL/L||||ABNORMAL|NOT DONE||||TISSUE|LACTESCENT|NA|MICROBIAL BIOCHEMICAL IDENTIFICATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|Y|NA|||N|4||88||FOLLOW-UP|1965-11-17|1971-02-05|||||1968-08-29||1969-07-24|U|1968-08-12
TRIAL STUDY 134XCP|LB|1BA56D89-E536-491E-AD6A-190A07331BEA|1||||MONONSQE|MONOCYTES/NON-SQUAM EPI CELLS|||||||/KG|||||||INVALID||LOG10 CFU/ML||||NORMAL|NOT DONE||||STOOL|HEMOLYZED|Y|HIGH RESOLUTION CT|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|N|||U|5||7||OBSERVATION|1960-09-17|1969-05-22|||||1962-12-07||1971-08-29|Y|1963-10-29
TRIAL STUDY 134XCP|LB|1BA56D89-E536-491E-AD6A-190A07331BEA|2||||RBC|ERYTHROCYTES|||||||10^5/L|||||||NEGATIVE||UG/KG/DAY||||ABNORMAL|NOT DONE||||ABSCESS FLUID|GELLED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD 4 VARIABLE FORMULA||U|Y|U|NA|||Y|5||7||SCREENING|1972-09-22|1961-07-17|||||1970-12-16||1973-07-23|U|1962-01-20
TRIAL STUDY 134XCP|LB|BE208D93-7322-427F-A8E5-1DBE5040BE8F|1||||C165939|EGG WHITE IGE AB RAST SCORE|||||||U/G/DAY|||||||NEGATIVE||KPA||||ABNORMAL|NOT DONE||||BASAL TEAR|AGGLUTINATED|N|KINETIC CHROMOGENIC ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|Y|N|||NA|1||38||WASHOUT|1968-03-27|1963-05-10|||||1965-07-21||1969-09-23|Y|1961-12-12
TRIAL STUDY 134XCP|LB|BE208D93-7322-427F-A8E5-1DBE5040BE8F|2||||HBOARBHB|HEMOGLOBIN O-ARAB/TOTAL HEMOGLOBIN|||||||UMOL|||||||INVALID||IU||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|DRIED|U|ANALYTICAL ULTRACENTRIFUGATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|U|Y|||NA|1||38||TREATMENT|1960-08-22|1969-10-03|||||1963-07-03||1972-01-31|U|1962-04-24
TRIAL STUDY 134XCP|LB|BE208D93-7322-427F-A8E5-1DBE5040BE8F|1||||ESTRIOLF|ESTRIOL, FREE|||||||UG/KG/H|||||||NEGATIVE||MG/KG||||LOW|NOT DONE||||MIXED VENOUS BLOOD|FRESH|NA|WEBER GREEN STAIN|MDRD 6 VARIABLE FORMULA||U|N|Y|N|||U|2||58||SCREENING|1970-08-26|1971-01-03|||||1971-07-08||1971-06-27|NA|1973-04-21
TRIAL STUDY 134XCP|LB|BE208D93-7322-427F-A8E5-1DBE5040BE8F|2||||C130122|NUT MIX ANTIGEN IGE ANTIBODY|||||||LENS|||||||BORDERLINE||10^3 ORGANISMS/G||||LOW|NOT DONE||||SYNOVIAL FLUID|DRIED|NA|SINGLE-SLICE SPIRAL CT|CKD-EPI FORMULA||U|NA|Y|NA|||Y|2||58||BASELINE|1972-02-07|1962-05-16|||||1966-10-11||1971-02-08|U|1964-01-30
TRIAL STUDY 134XCP|LB|BE208D93-7322-427F-A8E5-1DBE5040BE8F|1||||CD27|CD27|||||||M|||||||BORDERLINE||PMOL/DL||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT|Y|POTENTIOMETRY|MDRD ENZYMATIC FORMULA||NA|U|N|N|||U|3||39||BLINDED TREATMENT|1968-04-15|1965-01-15|||||1972-08-28||1969-06-10|N|1961-12-14
TRIAL STUDY 134XCP|LB|BE208D93-7322-427F-A8E5-1DBE5040BE8F|2||||IGGC|IGG CLEARANCE|||||||TAMPON|||||||TRACE||WEBER||||HIGH|NOT DONE||||EMESIS|ROOM TEMPERATURE|Y|IODINE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|N|||U|3||39||RUN-IN|1966-09-29|1965-12-24|||||1967-03-25||1967-08-01|U|1963-06-01
TRIAL STUDY 134XCP|LB|BE208D93-7322-427F-A8E5-1DBE5040BE8F|1||||C165886|WHITE OAK POLLEN IGE AB RAST SCORE|||||||PIPE|||||||INDETERMINATE||MG/L FEU||||LOW|NOT DONE||||VITREOUS HUMOR|GELLED|NA|DARK FIELD MICROSCOPY|NASH FIBROSURE FORMULA||NA|NA|NA|U|||Y|4||88||BLINDED TREATMENT|1968-05-14|1967-03-26|||||1961-01-01||1970-04-30|N|1964-01-30
TRIAL STUDY 134XCP|LB|BE208D93-7322-427F-A8E5-1DBE5040BE8F|2||||AMYLB42|AMYLOID BETA 1-42|||||||PG/CELL|||||||TRACE||10^6 RNA COPIES/ML||||LOW|NOT DONE||||VENOUS CORD BLOOD|DRIED|Y|MAPH|COCKCROFT-GAULT FORMULA||Y|N|N|Y|||Y|4||88||FOLLOW-UP|1964-05-27|1971-02-12|||||1960-02-08||1968-03-07|N|1968-07-15
TRIAL STUDY 134XCP|LB|BE208D93-7322-427F-A8E5-1DBE5040BE8F|1||||NEUTCYBS|CYTOPLASMIC BASOPHILIA NEUTROPHIL|||||||BOLUS|||||||BORDERLINE||U.CARR||||HIGH|NOT DONE||||ALVEOLAR AIR|AUTOLYZED|N|WHOLE GENOME SEQUENCING|GMI % FORMULA||N|U|N|NA|||NA|5||7||OBSERVATION|1973-02-03|1970-07-24|||||1960-12-23||1972-08-23|NA|1961-02-13
TRIAL STUDY 134XCP|LB|BE208D93-7322-427F-A8E5-1DBE5040BE8F|2||||FACTXI|FACTOR XI|||||||KPA/L/SEC|||||||POSITIVE||SQU/ML||||HIGH|NOT DONE||||VENOUS BLOOD|DRIED|N|PHASE CONTRAST MICROSCOPY|MDRD FORMULA||N|U|U|U|||Y|5||7||WASHOUT|1965-03-19|1961-02-11|||||1963-01-07||1962-11-21|N|1960-07-15
TRIAL STUDY 134XCP|LB|A58C5E7B-21EC-4F59-BB74-3264AC945F61|1||||CKMT1CK|CK, MACROMOLECULAR TYPE 1/TOTAL CK|||||||GENEQ|||||||NEGATIVE||ANTI-XA IU/ML||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|DRIED|N|URANYL ACETATE STAIN|MDRD 6 VARIABLE FORMULA||U|U|N|U|||NA|1||38||WASHOUT|1966-02-22|1960-11-17|||||1972-04-28||1971-11-13|Y|1965-06-01
TRIAL STUDY 134XCP|LB|A58C5E7B-21EC-4F59-BB74-3264AC945F61|2||||C130109|MOLD MIX ANTIGEN IGE ANTIBODY|||||||MMHG/L/MIN|||||||TRACE||UG/KG/H||||HIGH|NOT DONE||||STOOL|UNEXPECTED ODOR|U|AUSCULTATION|ASH FIBROSURE FORMULA||Y|Y|Y|Y|||U|1||38||INDUCTION TREATMENT|1965-04-04|1966-03-27|||||1968-09-27||1970-12-05|U|1970-04-19
TRIAL STUDY 134XCP|LB|A58C5E7B-21EC-4F59-BB74-3264AC945F61|1||||INTLK12B|INTERLEUKIN 12 BETA|||||||NL|||||||POSITIVE||IU/KG/H||||NORMAL|NOT DONE||||PLASMA|DRIED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||Y|N|NA|Y|||NA|2||58||OBSERVATION|1961-08-13|1968-02-08|||||1967-05-06||1970-05-24|N|1961-06-09
TRIAL STUDY 134XCP|LB|A58C5E7B-21EC-4F59-BB74-3264AC945F61|2||||PROGESTR|PROGESTERONE RECEPTOR|||||||MM/SEC|||||||NEGATIVE||AMOL||||NORMAL|NOT DONE||||EMESIS|AUTOLYZED|Y|WEBER GREEN STAIN|CKD-EPI CYSTATIN C FORMULA||N|U|N|N|||U|2||58||CONTINUATION TREATMENT|1972-03-21|1971-09-14|||||1968-04-07||1964-06-19|Y|1972-06-26
TRIAL STUDY 134XCP|LB|A58C5E7B-21EC-4F59-BB74-3264AC945F61|1||||ANIONG3|ANION GAP 3|||||||V|||||||INDETERMINATE||KS||||NORMAL|NOT DONE||||SWABBED MATERIAL|CONTAMINATED|N|U-HPLC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|U|NA|||U|3||39||TREATMENT|1969-03-08|1969-08-12|||||1964-11-30||1968-09-29|N|1971-08-16
TRIAL STUDY 134XCP|LB|A58C5E7B-21EC-4F59-BB74-3264AC945F61|2||||ATHMBAAC|ANTITHROMBIN ACTIVITY ACTUAL/CONTROL|||||||BOTTLE|||||||BORDERLINE||ML/BREATH||||NORMAL|NOT DONE||||CAPILLARY BLOOD|AGGLUTINATED|NA|MIGET|FIBROMETER FORMULA||U|U|Y|Y|||U|3||39||BLINDED TREATMENT|1965-08-29|1970-10-20|||||1967-08-26||1964-11-15|N|1968-03-06
TRIAL STUDY 134XCP|LB|A58C5E7B-21EC-4F59-BB74-3264AC945F61|1||||ACPHOS|ACID PHOSPHATASE|||||||UMOL|||||||INDETERMINATE||ML/CAGE/WK||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|GELLED|N|PET/SPECT SCAN|HEPASCORE FORMULA||NA|Y|NA|Y|||N|4||88||INDUCTION TREATMENT|1966-10-08|1971-02-28|||||1965-09-25||1973-02-10|U|1965-06-27
TRIAL STUDY 134XCP|LB|A58C5E7B-21EC-4F59-BB74-3264AC945F61|2||||CEMORPH|CELL MORPHOLOGY|||||||NMOL/DAY|||||||INDETERMINATE||MBP||||LOW|NOT DONE||||SYNOVIAL FLUID|FRESH|Y|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|FIBROSIS 4 FORMULA||U|N|N|Y|||U|4||88||TREATMENT|1961-06-15|1972-10-20|||||1965-04-04||1966-04-13|Y|1967-08-26
TRIAL STUDY 134XCP|LB|A58C5E7B-21EC-4F59-BB74-3264AC945F61|1||||ACHRAB|ACETYLCHOLINE RECEPTOR ANTIBODY|||||||PRESSOR UNITS|||||||INVALID||/2000 RBC||||NORMAL|NOT DONE||||PLEURAL TISSUE|LIPEMIC|U|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|FIBROSIS 4 FORMULA||Y|U|NA|NA|||NA|5||7||BLINDED TREATMENT|1971-06-25|1962-01-04|||||1966-07-30||1968-12-26|Y|1966-04-25
TRIAL STUDY 134XCP|LB|A58C5E7B-21EC-4F59-BB74-3264AC945F61|2||||APLSMA2A|ALPHA-2 ANTIPLASMIN ACTIVITY|||||||AU/ML|||||||BORDERLINE||VIAL||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CALCIFIED|U|HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD 6 VARIABLE FORMULA||Y|U|N|Y|||U|5||7||SCREENING|1971-03-12|1960-12-02|||||1962-09-01||1971-08-07|U|1968-09-03
TRIAL STUDY 134XCP|LB|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|1||||TSI|THYROID STIMULATING IMMUNOGLOBULIN|||||||MOSM|||||||BORDERLINE||/40 HPFS||||NORMAL|NOT DONE||||LAVAGE FLUID|ICTERIC|U|CONTACT SPECULAR MICROSCOPY|MDRD ENZYMATIC FORMULA||U|N|NA|N|||NA|1||38||INDUCTION TREATMENT|1967-04-20|1973-05-17|||||1969-06-10||1971-07-02|N|1964-07-13
TRIAL STUDY 134XCP|LB|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|2||||C165920|WHITE ELM POLLEN IGG AB RAST SCORE|||||||TUBERCULIN UNIT|||||||NEGATIVE||IU/G||||NORMAL|NOT DONE||||DERMAL TISSUE|LACTESCENT|U|SURFACE PLASMON RESONANCE|MDRD 4 VARIABLE FORMULA||Y|NA|U|N|||Y|1||38||LONG-TERM FOLLOW-UP|1971-01-19|1962-08-02|||||1967-12-20||1961-10-10|Y|1966-10-15
TRIAL STUDY 134XCP|LB|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|1||||A1MICG|ALPHA-1 MICROGLOBULIN|||||||ANTIBODY UNIT|||||||INDETERMINATE||MS/MMHG||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|AUTOLYZED|U|RAJI CELL EIA|FIBROSIS 4 FORMULA||U|U|Y|U|||N|2||58||CONTINUATION TREATMENT|1970-05-16|1962-06-15|||||1963-04-08||1968-07-11|Y|1962-06-28
TRIAL STUDY 134XCP|LB|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|2||||FUNGI|FUNGI|||||||/CMH2O|||||||POSITIVE||NMOL BCE/MMOL||||LOW|NOT DONE||||SEMINAL FLUID|FROZEN|NA|CLOT DETECTION|COCKCROFT-GAULT FORMULA||U|N|U|Y|||N|2||58||INDUCTION TREATMENT|1970-03-22|1965-09-25|||||1969-10-18||1960-04-15|N|1973-06-12
TRIAL STUDY 134XCP|LB|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|1||||GLOBG|GAMMA GLOBULIN|||||||PUFF|||||||NEGATIVE||BOWL||||NORMAL|NOT DONE||||ISOLATE|CALCIFIED|Y|VIRUS PLAQUE ASSAY|FIBROMETER FORMULA||NA|N|Y|Y|||N|3||39||LONG-TERM FOLLOW-UP|1960-01-06|1970-10-21|||||1971-08-12||1964-02-12|NA|1972-03-21
TRIAL STUDY 134XCP|LB|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|2||||TGLOB|THYROGLOBULIN|||||||ML/M2/DAY|||||||INDETERMINATE||/MBP||||LOW|NOT DONE||||LOCHIA|FRESH|U|ELISPOT|FIBROTEST FORMULA||U|NA|NA|NA|||NA|3||39||RUN-IN|1963-11-08|1966-12-07|||||1965-04-13||1967-05-12|U|1965-05-17
TRIAL STUDY 134XCP|LB|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|1||||CBS|CYSTATHIONINE BETA-SYNTHASE|||||||PPTH|||||||NEGATIVE||MASK||||HIGH|NOT DONE||||CAPILLARY BLOOD|LIPEMIC|Y|BETA LACTAMASE|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|U|U|||NA|4||88||SCREENING|1961-03-28|1966-10-17|||||1971-09-23||1964-07-05|U|1964-02-09
TRIAL STUDY 134XCP|LB|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|2||||CCL8|CHEMOKINE (C-C MOTIF) LIGAND 8|||||||BEATS/MIN|||||||NEGATIVE||VP/DOSE||||NORMAL|NOT DONE||||BASAL TEAR|FRESH|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|U|N|||N|4||88||BLINDED TREATMENT|1960-04-12|1973-08-25|||||1965-05-24||1968-11-22|U|1966-10-28
TRIAL STUDY 134XCP|LB|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|1||||MPM|MEAN PLATELET DRY MASS|||||||SHOCK WAVE|||||||INVALID||MG/CM2||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|CLOTTED|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|CKD-EPI CREATININE FORMULA||Y|N|Y|U|||N|5||7||RUN-IN|1960-10-09|1960-07-23|||||1963-12-14||1970-09-13|N|1960-02-27
TRIAL STUDY 134XCP|LB|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|2||||C5A|COMPLEMENT C5A|||||||UKAT|||||||NEGATIVE||ML/ANIMAL||||NORMAL|NOT DONE||||SERUM OR PLASMA|CLOTTED|NA|ORCHIDOMETERY|MDRD 4 VARIABLE FORMULA||U|U|N|Y|||Y|5||7||FOLLOW-UP|1969-06-03|1963-05-25|||||1967-06-18||1964-12-14|NA|1967-01-10
TRIAL STUDY 134XCP|LB|434B4F6A-C436-4F92-8FA5-9C2F1964098A|1||||C130084|ENGLISH PLANTAIN POLLEN IGE|||||||U/G HB|||||||BORDERLINE||LOG10 TCID 50/DOSE||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|ROOM TEMPERATURE|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|CKD-EPI CYSTATIN C FORMULA||N|NA|NA|U|||U|1||38||LONG-TERM FOLLOW-UP|1973-05-12|1971-11-01|||||1960-09-11||1968-08-07|NA|1972-07-22
TRIAL STUDY 134XCP|LB|434B4F6A-C436-4F92-8FA5-9C2F1964098A|2||||MYCEPPOL|MYELOID PROLIFERATION POOL|||||||ANTI-XA IU|||||||NEGATIVE||BREATHS/MIN||||ABNORMAL|NOT DONE||||LOCHIA|AGGLUTINATED|N|MANUAL CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|NA|N|||Y|1||38||BLINDED TREATMENT|1967-01-29|1966-05-22|||||1972-09-17||1969-02-23|N|1971-05-11
TRIAL STUDY 134XCP|LB|434B4F6A-C436-4F92-8FA5-9C2F1964098A|1||||P1NP|PROCOLLAGEN 1 N-TERMINAL PROPEPTIDE|||||||%/MIN|||||||NEGATIVE||MBQ/UL||||HIGH|NOT DONE||||SERUM OR PLASMA|NON-HEMOLYZED|Y|MAPH|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|U|N|||Y|2||58||WASHOUT|1963-08-20|1972-02-15|||||1963-05-16||1968-07-09|Y|1964-05-19
TRIAL STUDY 134XCP|LB|434B4F6A-C436-4F92-8FA5-9C2F1964098A|2||||ALPISOE|ALKALINE PHOSPHATASE ISOENZYME|||||||/MIN|||||||POSITIVE||UL/ML||||LOW|NOT DONE||||LAVAGE FLUID|GELLED|NA|BAC ACGH|FIBROSIS 4 FORMULA||Y|Y|NA|Y|||Y|2||58||WASHOUT|1960-09-06|1968-11-27|||||1965-06-25||1972-09-04|N|1965-06-25
TRIAL STUDY 134XCP|LB|434B4F6A-C436-4F92-8FA5-9C2F1964098A|1||||HGBFR|HEMOGLOBIN, FREE|||||||SQU/ML|||||||POSITIVE||TITER||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|DRIED|Y|MODIFIED ACID FAST STAIN|MDRD 4 VARIABLE FORMULA||N|U|U|Y|||NA|3||39||BASELINE|1964-12-02|1967-08-25|||||1969-10-15||1970-08-06|N|1972-12-11
TRIAL STUDY 134XCP|LB|434B4F6A-C436-4F92-8FA5-9C2F1964098A|2||||LDH1|LDH ISOENZYME 1|||||||UMOL/MIN|||||||POSITIVE||G/KG/DAY||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|SOLIDIFIED|U|TELLER ACUITY CARDS|MDRD 4 VARIABLE FORMULA||N|U|N|U|||N|3||39||LONG-TERM FOLLOW-UP|1970-11-28|1972-06-01|||||1972-05-06||1964-05-31|U|1972-10-23
TRIAL STUDY 134XCP|LB|434B4F6A-C436-4F92-8FA5-9C2F1964098A|1||||C130142|GERMAN COCKROACH ANTIGEN IGG ANTIBODY|||||||UGEQ|||||||POSITIVE||MG/M2/H||||LOW|NOT DONE||||SEMINAL FLUID|LACTESCENT|Y|MALDI|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|NA|||Y|4||88||BLINDED TREATMENT|1971-05-25|1968-08-28|||||1965-08-17||1971-01-31|Y|1962-12-12
TRIAL STUDY 134XCP|LB|434B4F6A-C436-4F92-8FA5-9C2F1964098A|2||||BLASTLE|BLASTS/LEUKOCYTES|||||||10^3 ORGANISMS/ML|||||||BORDERLINE||CM||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|PARAFFIN-EMBEDDED|Y|AGAR PROPORTION|MDRD 5 VARIABLE FORMULA||NA|Y|N|N|||Y|4||88||SCREENING|1969-04-28|1971-12-17|||||1968-04-12||1967-05-25|U|1972-05-19
TRIAL STUDY 134XCP|LB|434B4F6A-C436-4F92-8FA5-9C2F1964098A|1||||MDC|MACROPHAGE-DERIVED CHEMOKINE|||||||MG/ANIMAL|||||||NEGATIVE||APPLICATION||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|LIPEMIC|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NASH FIBROSURE FORMULA||NA|NA|N|NA|||N|5||7||INDUCTION TREATMENT|1967-05-21|1964-04-09|||||1967-10-23||1963-09-08|U|1972-02-24
TRIAL STUDY 134XCP|LB|434B4F6A-C436-4F92-8FA5-9C2F1964098A|2||||LYMATLE|LYMPHOCYTES ATYPICAL/LEUKOCYTES|||||||KN/CM2|||||||NEGATIVE||10^9 ORGANISMS/ML||||NORMAL|NOT DONE||||TRANSUDATE|HEMOLYZED|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|COCKCROFT-GAULT FORMULA||NA|N|Y|U|||NA|5||7||OBSERVATION|1964-08-15|1964-04-13|||||1965-06-19||1970-06-19|Y|1966-09-16
TRIAL STUDY 134XCP|LB|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|1||||HCGFR|CHORIOGONADOTROPIN BETA, FREE|||||||PMOL/L|||||||BORDERLINE||% INHIBITION||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|HEPASCORE FORMULA||NA|NA|U|Y|||Y|1||38||WASHOUT|1970-10-15|1973-02-23|||||1961-10-19||1965-01-02|N|1960-02-21
TRIAL STUDY 134XCP|LB|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|2||||FUNGIFIL|FUNGI, FILAMENTOUS|||||||%(W/W)|||||||BORDERLINE||SHOCK WAVE||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|SOLIDIFIED|NA|LEAD CITRATE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|NA|NA|||Y|1||38||TREATMENT|1967-09-03|1972-01-31|||||1968-08-18||1969-10-12|NA|1971-10-25
TRIAL STUDY 134XCP|LB|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|1||||C165923|TREE MIX POLLEN IGE AB RAST SCORE|||||||KPA/L/SEC|||||||BORDERLINE||CMOL/L||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|HEMOLYZED|Y|COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|NA|Y|||NA|2||58||BLINDED TREATMENT|1971-05-26|1965-04-23|||||1965-09-20||1961-06-30|NA|1966-10-11
TRIAL STUDY 134XCP|LB|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|2||||C5B9S|SOLUBLE COMPLEMENT C5B-9|||||||10^6 RNA COPIES/ML|||||||INDETERMINATE||JAR||||ABNORMAL|NOT DONE||||FLUID|FRESH|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|FIBROMETER FORMULA||Y|N|U|U|||Y|2||58||CONTINUATION TREATMENT|1972-02-15|1961-12-04|||||1970-10-05||1964-02-24|N|1960-02-08
TRIAL STUDY 134XCP|LB|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|1||||CALB|CALBINDIN|||||||ML/CAGE/WK|||||||INDETERMINATE||GY||||NORMAL|NOT DONE||||CERUMEN|NON-HEMOLYZED|U|NUCLEIC ACID SEQUENCING|COCKCROFT-GAULT FORMULA||N|NA|NA|NA|||N|3||39||CONTINUATION TREATMENT|1963-01-14|1963-10-29|||||1968-05-18||1965-12-01|Y|1962-11-27
TRIAL STUDY 134XCP|LB|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|2||||OPN|OSTEOPONTIN|||||||/MS|||||||INVALID||TORR||||LOW|NOT DONE||||SYNOVIAL FLUID|HEMOLYZED|NA|HPLC-FL|MDRD ENZYMATIC FORMULA||U|N|Y|Y|||N|3||39||RUN-IN|1965-09-30|1971-11-20|||||1965-01-15||1973-02-10|U|1973-06-25
TRIAL STUDY 134XCP|LB|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|1||||ICAM|INTERCELLULAR ADHESION MOLECULE|||||||DDU|||||||INDETERMINATE||UMOL/MOL||||LOW|NOT DONE||||ERYTHROCYTES|LIPEMIC|U|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI FORMULA||NA|U|Y|Y|||U|4||88||CONTINUATION TREATMENT|1963-12-22|1962-06-10|||||1961-05-14||1967-11-13|Y|1966-03-12
TRIAL STUDY 134XCP|LB|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|2||||CACRTP|CALCIUM CORRECTED FOR TOTAL PROTEIN|||||||MG/L FEU|||||||POSITIVE||BEL||||ABNORMAL|NOT DONE||||HAIR|AGGLUTINATED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|ASH FIBROSURE FORMULA||Y|NA|Y|NA|||U|4||88||OPEN LABEL TREATMENT|1963-10-08|1967-01-18|||||1969-12-17||1965-05-22|N|1965-07-27
TRIAL STUDY 134XCP|LB|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|1||||NTENS|NEUROTENSIN|||||||NKAT/G HB|||||||INDETERMINATE||PLUG||||LOW|NOT DONE||||DERMAL TISSUE|ROOM TEMPERATURE|NA|FORCED OSCILLATION TECHNIQUE|ASH FIBROSURE FORMULA||Y|NA|U|Y|||NA|5||7||INDUCTION TREATMENT|1970-03-20|1961-11-28|||||1967-05-17||1968-01-28|Y|1968-10-02
TRIAL STUDY 134XCP|LB|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|2||||MYCEMPOL|MYELOID MATURATION POOL|||||||TSP|||||||TRACE||UU/DL||||NORMAL|NOT DONE||||AQUEOUS HUMOR|ROOM TEMPERATURE|U|MICROARRAY|COCKCROFT-GAULT FORMULA||U|Y|U|Y|||NA|5||7||BLINDED TREATMENT|1969-05-14|1969-10-24|||||1972-08-10||1964-05-09|N|1960-12-16
TRIAL STUDY 134XCP|LB|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|1||||SPERMMTL|SPERM MOTILITY|||||||L/MIN/M2|||||||NEGATIVE||MMHG/SEC||||ABNORMAL|NOT DONE||||PERSPIRATION|DRIED|U|TRYPAN BLUE STAIN|GMI MMOL/MOL FORMULA||NA|U|Y|Y|||N|1||38||BLINDED TREATMENT|1961-12-12|1965-06-25|||||1960-05-18||1970-07-31|Y|1964-06-30
TRIAL STUDY 134XCP|LB|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|2||||TATC|THROMBIN ANTITHROMBIN COMPLEX|||||||MKAT|||||||BORDERLINE||LOG10 PFU/ML||||NORMAL|NOT DONE||||CORD SERUM|CONCENTRATED|N|HIGH RESOLUTION MELT ANALYSIS|CKD-EPI FORMULA||Y|N|U|NA|||U|1||38||INDUCTION TREATMENT|1969-09-25|1963-10-20|||||1970-10-15||1963-12-11|NA|1960-04-09
TRIAL STUDY 134XCP|LB|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|1||||HASIGMAB|HUMAN ANTI-SHEEP IGM ANTIBODY|||||||UMOL/MG/MIN|||||||INVALID||CG||||ABNORMAL|NOT DONE||||CALCULUS|FRESH|N|CONTRAST ENHANCED PET/CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|NA|Y|||U|2||58||FOLLOW-UP|1967-12-04|1967-06-13|||||1963-01-06||1962-01-13|N|1970-06-19
TRIAL STUDY 134XCP|LB|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|2||||CRTRONE|CORTICOSTERONE|||||||FT2|||||||TRACE||L/S/KPA||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|FROZEN|Y|MANUAL CLOT DETECTION|MDRD 5 VARIABLE FORMULA||Y|N|U|U|||U|2||58||SCREENING|1971-11-14|1967-02-04|||||1973-08-04||1960-06-03|NA|1968-11-29
TRIAL STUDY 134XCP|LB|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|1||||LYMPHOTC|LYMPHOTACTIN|||||||IU/DAY|||||||INVALID||MOL/L||||HIGH|NOT DONE||||PROSTATIC FLUID|CONTAMINATED|N|PERIPHERAL ANGIOGRAPHY|CKD-EPI FORMULA||NA|NA|U|U|||N|3||39||FOLLOW-UP|1961-07-26|1960-05-26|||||1965-02-20||1970-12-17|U|1965-11-04
TRIAL STUDY 134XCP|LB|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|2||||BASOMM|BASOPHILIC METAMYELOCYTES|||||||L/MIN/M2|||||||TRACE||MG/KG/WEEK||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|FROZEN|Y|DISK DIFFUSION|GMI % FORMULA||U|U|U|NA|||Y|3||39||TREATMENT|1960-06-11|1967-08-17|||||1961-05-26||1962-10-21|U|1973-03-06
TRIAL STUDY 134XCP|LB|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|1||||C130122|NUT MIX ANTIGEN IGE ANTIBODY|||||||TAMPON|||||||TRACE||UKAT/10^12 RBC||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CALCIFIED|Y|BRDU CELLULAR PROLIFERATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|N|||NA|4||88||LONG-TERM FOLLOW-UP|1970-05-06|1972-02-27|||||1970-04-15||1969-04-19|N|1962-11-06
TRIAL STUDY 134XCP|LB|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|2||||CSBROAD|BROAD CASTS|||||||PIXELS/IN|||||||POSITIVE||ECL UNIT||||ABNORMAL|NOT DONE||||SEMEN|ROOM TEMPERATURE|NA|MICRODENSITOMETRY|FIBROSIS 4 FORMULA||NA|Y|U|Y|||NA|4||88||SCREENING|1972-02-09|1962-03-28|||||1968-09-23||1960-07-30|U|1963-09-30
TRIAL STUDY 134XCP|LB|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|1||||C130106|WEED MIX POLLEN ANTIGEN IGE ANTIBODY|||||||TSP|||||||BORDERLINE||BE/ML||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|CALCIFIED|N|PET/CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|N|N|||N|5||7||RUN-IN|1971-07-27|1971-10-14|||||1964-10-24||1960-04-24|Y|1970-12-14
TRIAL STUDY 134XCP|LB|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|2||||CAMP|CYCLIC ADENOSINE 3,5-MONOPHOSPHATE|||||||MG/DAY|||||||NEGATIVE||G/CAGE/DAY||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|DRIED|U|MALDI|MDRD 5 VARIABLE FORMULA||N|Y|U|NA|||N|5||7||SCREENING|1970-12-11|1963-12-08|||||1962-03-17||1969-12-01|Y|1970-06-11
TRIAL STUDY 134XCP|LB|73C4A4D7-2177-47F3-818A-C0774F5E4A08|1||||ODMTASE|O-DEMETHYLASE|||||||MM|||||||INVALID||F||||LOW|NOT DONE||||CELL PELLET|ROOM TEMPERATURE|U|ROMANOWSKY STAIN|FIBROSIS 4 FORMULA||NA|N|U|U|||U|1||38||LONG-TERM FOLLOW-UP|1964-08-21|1971-07-12|||||1972-01-14||1973-08-20|NA|1962-04-26
TRIAL STUDY 134XCP|LB|73C4A4D7-2177-47F3-818A-C0774F5E4A08|2||||C4D|COMPLEMENT C4D|||||||10^6/EJACULATE U|||||||INDETERMINATE||JAR||||NORMAL|NOT DONE||||PROSTATIC FLUID|NON-HEMOLYZED|U|TWO-COLOR MICROARRAY|MDRD FORMULA||U|U|U|Y|||N|1||38||OBSERVATION|1970-06-10|1966-06-28|||||1963-06-03||1971-01-31|NA|1963-01-30
TRIAL STUDY 134XCP|LB|73C4A4D7-2177-47F3-818A-C0774F5E4A08|1||||MYCYCE|MYELOCYTES/TOTAL CELLS|||||||KPA|||||||POSITIVE||ML/KG/H||||HIGH|NOT DONE||||INTERSTITIAL FLUID|REFRIGERATED|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|Y|NA|||U|2||58||BLINDED TREATMENT|1971-07-11|1970-12-04|||||1964-12-27||1965-07-07|U|1970-01-05
TRIAL STUDY 134XCP|LB|73C4A4D7-2177-47F3-818A-C0774F5E4A08|2||||RBCNURBC|NUCLEATED ERYTHROCYTES/ERYTHROCYTES|||||||HOURS|||||||POSITIVE||KALLIKREIN INHIBITOR UNIT||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|GELLED|NA|LANDOLT RING|MDRD 5 VARIABLE FORMULA||U|N|NA|NA|||U|2||58||TREATMENT|1968-11-14|1964-03-13|||||1962-06-12||1972-01-25|Y|1970-05-19
TRIAL STUDY 134XCP|LB|73C4A4D7-2177-47F3-818A-C0774F5E4A08|1||||GLOBA|ALPHA GLOBULIN|||||||NFIU|||||||INDETERMINATE||10^6 CFU/G||||ABNORMAL|NOT DONE||||CORD SERUM|LACTESCENT|N|LC/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|U|U|||NA|3||39||SCREENING|1964-03-26|1972-09-28|||||1968-05-18||1969-08-08|N|1964-07-30
TRIAL STUDY 134XCP|LB|73C4A4D7-2177-47F3-818A-C0774F5E4A08|2||||PGAG|PLATELET-GRANULOCYTE AGG|||||||U|||||||TRACE||UG/ML/H||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|GELLED|N|GRADIENT DIFFUSION|GMI MMOL/MOL FORMULA||NA|Y|N|U|||Y|3||39||LONG-TERM FOLLOW-UP|1960-01-24|1972-04-26|||||1967-09-29||1964-03-05|NA|1963-05-11
TRIAL STUDY 134XCP|LB|73C4A4D7-2177-47F3-818A-C0774F5E4A08|1||||APLIGMAB|ANTI-PHOSPHOLIPID IGM ANTIBODY|||||||ML/MMHG|||||||BORDERLINE||MESF||||LOW|NOT DONE||||CAPILLARY PLASMA|AGGLUTINATED|N|SECONDARY ION MASS SPECTOMETRY|FIBROSIS 4 FORMULA||Y|NA|Y|Y|||N|4||88||RUN-IN|1967-12-18|1965-02-24|||||1970-04-26||1967-02-28|NA|1968-02-04
TRIAL STUDY 134XCP|LB|73C4A4D7-2177-47F3-818A-C0774F5E4A08|2||||IGF2|INSULIN-LIKE GROWTH FACTOR-2|||||||UEQ/L|||||||INVALID||10^4 CFU/ML||||LOW|NOT DONE||||REFLEX TEAR|UNEXPECTED ODOR|U|ENDOSCOPY|CKD-EPI CYSTATIN C FORMULA||NA|U|U|NA|||U|4||88||FOLLOW-UP|1968-12-13|1970-08-11|||||1973-03-06||1973-07-19|U|1971-09-01
TRIAL STUDY 134XCP|LB|73C4A4D7-2177-47F3-818A-C0774F5E4A08|1||||C1QAB|COMPLEMENT C1Q ANTIBODY|||||||UG/DAY|||||||INVALID||IU/KG/H||||NORMAL|NOT DONE||||TUMOR TISSUE|NON-HEMOLYZED|Y|IMMUNOFIXATION ELECTROPHORESIS|GMI MMOL/MOL FORMULA||U|U|U|NA|||N|5||7||TREATMENT|1962-03-31|1962-07-20|||||1960-12-27||1965-07-03|U|1969-03-27
TRIAL STUDY 134XCP|LB|73C4A4D7-2177-47F3-818A-C0774F5E4A08|2||||CD38|CD38|||||||BAU/ML|||||||INDETERMINATE||/40 HPFS||||HIGH|NOT DONE||||PERITONEAL FLUID|CONCENTRATED|NA|TRICHROME STAIN|MDRD FORMULA||N|U|NA|U|||N|5||7||OPEN LABEL TREATMENT|1969-07-03|1971-10-02|||||1968-12-19||1964-06-01|U|1961-02-15
TRIAL STUDY 134XCP|LB|4E3929B3-63F2-4E89-8EB4-60991E7284E1|1||||CD4|CD4|||||||DEG/S|||||||INVALID||NMOL/MOL||||HIGH|NOT DONE||||DERMAL TISSUE|AGGLUTINATED|NA|LYMPHANGIOGRAPHY|MDRD 5 VARIABLE FORMULA||U|N|U|U|||U|1||38||BASELINE|1965-01-28|1965-12-12|||||1963-08-09||1960-06-15|Y|1966-09-04
TRIAL STUDY 134XCP|LB|4E3929B3-63F2-4E89-8EB4-60991E7284E1|2||||HAIRYCE|HAIRY CELLS|||||||1/(S*KPA)|||||||NEGATIVE||ML/CM H2O||||HIGH|NOT DONE||||SWABBED MATERIAL|ICTERIC|N|MICROBIAL CONCENTRATION|ASH FIBROSURE FORMULA||NA|NA|N|N|||NA|1||38||WASHOUT|1972-12-26|1971-12-05|||||1967-04-06||1962-04-16|N|1973-02-22
TRIAL STUDY 134XCP|LB|4E3929B3-63F2-4E89-8EB4-60991E7284E1|1||||IFNA|INTERFERON ALPHA|||||||LM|||||||NEGATIVE||PLUG||||NORMAL|NOT DONE||||SKIN TISSUE|PARAFFIN-EMBEDDED|NA|HEMOCYTOMETRY|MDRD FORMULA||U|NA|Y|U|||U|2||58||OPEN LABEL TREATMENT|1969-08-08|1965-07-06|||||1968-03-16||1962-03-08|U|1966-12-03
TRIAL STUDY 134XCP|LB|4E3929B3-63F2-4E89-8EB4-60991E7284E1|2||||UNSPCECE|UNSPECIFIED CELLS/TOTAL CELLS|||||||LINEAR FT*LB|||||||BORDERLINE||10^9 ORGANISMS||||ABNORMAL|NOT DONE||||RETICULOCYTES|THAWED|N|CONTRAST ENHANCED X-RAY|HEPASCORE FORMULA||NA|NA|Y|Y|||N|2||58||BLINDED TREATMENT|1961-02-15|1964-12-21|||||1961-10-24||1965-11-28|NA|1970-01-06
TRIAL STUDY 134XCP|LB|4E3929B3-63F2-4E89-8EB4-60991E7284E1|1||||BLASTNCE|BLASTS/NUCLEATED CELLS|||||||L/L|||||||POSITIVE||NEEDLE GAUGE||||LOW|NOT DONE||||EMESIS|CONCENTRATED|N|GC/MS-CI|MDRD ENZYMATIC FORMULA||U|N|NA|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1960-03-16|1969-08-30|||||1970-07-06||1963-11-11|N|1970-11-20
TRIAL STUDY 134XCP|LB|4E3929B3-63F2-4E89-8EB4-60991E7284E1|2||||INSULIN|INSULIN|||||||MS/MMHG|||||||POSITIVE||10^9 ORGANISMS||||LOW|NOT DONE||||NAIL|GELLED|NA|AMSLER GRID|ASH FIBROSURE FORMULA||NA|U|N|Y|||N|3||39||LONG-TERM FOLLOW-UP|1962-12-16|1961-08-22|||||1966-09-22||1969-06-22|Y|1961-10-13
TRIAL STUDY 134XCP|LB|4E3929B3-63F2-4E89-8EB4-60991E7284E1|1||||EPINEXR|EPINEPHRINE EXCRETION RATE|||||||/40 HPFS|||||||POSITIVE||CI||||HIGH|NOT DONE||||URINE SEDIMENT|LIPEMIC|Y|ATOMIC ABSORPTION SPECTROMETRY|MDRD 4 VARIABLE FORMULA||U|U|Y|NA|||NA|4||88||BLINDED TREATMENT|1960-05-02|1962-11-20|||||1971-12-26||1969-12-31|Y|1961-10-16
TRIAL STUDY 134XCP|LB|4E3929B3-63F2-4E89-8EB4-60991E7284E1|2||||DHEAS|DEHYDROEPIANDROSTERONE SULFATE|||||||EID 50/DOSE|||||||INDETERMINATE||OZ EQ||||LOW|NOT DONE||||BREAST MILK|LIPEMIC|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|GMI % FORMULA||U|N|Y|N|||Y|4||88||INDUCTION TREATMENT|1961-01-29|1972-04-09|||||1971-08-02||1969-06-04|Y|1972-04-05
TRIAL STUDY 134XCP|LB|4E3929B3-63F2-4E89-8EB4-60991E7284E1|1||||VITC|VITAMIN C|||||||IU/MMOL|||||||TRACE||MG/KG/DAY||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|CONTAMINATED|NA|PHOTOMETRIC CLOT DETECTION|FIBROSIS 4 FORMULA||NA|Y|U|NA|||U|5||7||OBSERVATION|1963-09-20|1969-11-30|||||1972-03-25||1962-07-29|U|1961-05-16
TRIAL STUDY 134XCP|LB|4E3929B3-63F2-4E89-8EB4-60991E7284E1|2||||BASOMM|BASOPHILIC METAMYELOCYTES|||||||HENRY|||||||INVALID||MEQ/DAY||||ABNORMAL|NOT DONE||||BONE|DRIED|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|N|NA|||U|5||7||RUN-IN|1966-06-18|1968-04-02|||||1962-06-05||1963-10-12|Y|1965-02-11
TRIAL STUDY 134XCP|LB|F26E2F67-3F90-448C-92BB-AD60E71D5664|1||||TLCHT|TAUROLITHOCHOLATE|||||||MONTHS|||||||TRACE||COPIES/UL||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|AGGLUTINATED|N|KINETIC MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC FORMULA||U|U|U|NA|||NA|1||38||OPEN LABEL TREATMENT|1965-05-11|1961-02-15|||||1971-01-17||1962-06-12|U|1966-04-15
TRIAL STUDY 134XCP|LB|F26E2F67-3F90-448C-92BB-AD60E71D5664|2||||RDW|ERYTHROCYTES DISTRIBUTION WIDTH|||||||MPH|||||||BORDERLINE||YEARS||||NORMAL|NOT DONE||||CALCULUS|FROZEN|NA|PELLI-ROBSON EYE CHART|HEPASCORE FORMULA||N|NA|U|NA|||NA|1||38||CONTINUATION TREATMENT|1965-01-11|1970-11-06|||||1969-12-06||1968-04-28|NA|1960-12-09
TRIAL STUDY 134XCP|LB|F26E2F67-3F90-448C-92BB-AD60E71D5664|1||||CLCLR|CHLORIDE CLEARANCE|||||||CPM|||||||TRACE||/WK||||HIGH|NOT DONE||||CORD SERUM|CONCENTRATED|N|HIGH RESOLUTION CT|CKD-EPI CYSTATIN C FORMULA||NA|NA|Y|Y|||N|2||58||INDUCTION TREATMENT|1966-02-10|1965-08-17|||||1961-10-08||1973-04-23|Y|1965-11-19
TRIAL STUDY 134XCP|LB|F26E2F67-3F90-448C-92BB-AD60E71D5664|2||||CARBXHGB|CARBOXYHEMOGLOBIN|||||||MBP|||||||INVALID||HR/DAY||||HIGH|NOT DONE||||PERITONEAL FLUID|HEMOLYZED|N|SPIRAL CT SCAN WITHOUT CONTRAST|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|N|N|||N|2||58||TREATMENT|1965-11-30|1962-09-14|||||1972-11-03||1960-12-12|NA|1960-08-27
TRIAL STUDY 134XCP|LB|F26E2F67-3F90-448C-92BB-AD60E71D5664|1||||INTLK29|INTERLEUKIN 29|||||||G/G/DAY|||||||BORDERLINE||TAMPON||||HIGH|NOT DONE||||STOOL|PARAFFIN-EMBEDDED|NA|SLIT LAMP|CKD-EPI CREATININE FORMULA||U|NA|Y|U|||N|3||39||OPEN LABEL TREATMENT|1968-02-17|1971-05-03|||||1973-02-09||1961-10-25|N|1962-07-21
TRIAL STUDY 134XCP|LB|F26E2F67-3F90-448C-92BB-AD60E71D5664|2||||A1MICG|ALPHA-1 MICROGLOBULIN|||||||ML/ANIMAL/DAY|||||||POSITIVE||KHZ||||ABNORMAL|NOT DONE||||PUS|NON-HEMOLYZED|Y|BETA LACTAMASE|CKD-EPI FORMULA||N|U|U|N|||N|3||39||TREATMENT|1969-09-29|1962-04-22|||||1969-08-03||1973-04-19|N|1963-01-03
TRIAL STUDY 134XCP|LB|F26E2F67-3F90-448C-92BB-AD60E71D5664|1||||CALPRO|CALPROTECTIN|||||||MG/MOL|||||||POSITIVE||LOG10 PFU||||NORMAL|NOT DONE||||EXUDATE|AGGLUTINATED|NA|SPECT/CT SCAN|ASH FIBROSURE FORMULA||N|NA|U|N|||Y|4||88||LONG-TERM FOLLOW-UP|1963-01-21|1963-10-02|||||1964-04-23||1967-08-01|N|1962-06-06
TRIAL STUDY 134XCP|LB|F26E2F67-3F90-448C-92BB-AD60E71D5664|2||||LTF|LACTOFERRIN|||||||L/MIN/M2|||||||INDETERMINATE||EU||||NORMAL|NOT DONE||||CORD SERUM|CONTAMINATED|N|SLIT LAMP PHOTOGRAPHY|FIBROTEST FORMULA||NA|NA|Y|NA|||N|4||88||INDUCTION TREATMENT|1966-06-30|1963-10-10|||||1967-01-07||1964-12-15|NA|1960-10-22
TRIAL STUDY 134XCP|LB|F26E2F67-3F90-448C-92BB-AD60E71D5664|1||||METARUB|METARUBRICYTE|||||||ML/CAGE/WK|||||||POSITIVE||KS||||HIGH|NOT DONE||||CALCULUS|ROOM TEMPERATURE|NA|AUDIOMETRY|MDRD FORMULA||U|U|Y|NA|||NA|5||7||TREATMENT|1969-02-28|1964-12-22|||||1963-05-20||1960-07-04|U|1963-04-09
TRIAL STUDY 134XCP|LB|F26E2F67-3F90-448C-92BB-AD60E71D5664|2||||IOTCLRBS|IOTHALAMATE CLEARANCE ADJUSTED FOR BSA|||||||MN|||||||TRACE||NMOL BCE/NMOL||||LOW|NOT DONE||||GASTRIC CONTENTS|CLOTTED|N|GIEMSA STAIN|FIBROMETER FORMULA||U|NA|U|NA|||U|5||7||BLINDED TREATMENT|1968-07-25|1971-01-01|||||1970-03-13||1963-01-29|Y|1966-11-16
TRIAL STUDY 134XCP|LB|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|1||||C3A|COMPLEMENT C3A|||||||MM/H|||||||POSITIVE||NKAT||||HIGH|NOT DONE||||LYMPH|FROZEN|NA|LANDOLT RING|CKD-EPI CREATININE FORMULA||NA|Y|Y|Y|||U|1||38||FOLLOW-UP|1960-12-22|1967-11-03|||||1967-07-18||1963-12-29|N|1965-07-29
TRIAL STUDY 134XCP|LB|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|2||||HGBA|HEMOGLOBIN A|||||||UMOL/L/SEC|||||||TRACE||MOL||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|UNEXPECTED ODOR|NA|IMPEDANCE CONDUCTIVITY|FIBROSIS 4 FORMULA||U|NA|Y|Y|||Y|1||38||LONG-TERM FOLLOW-UP|1963-07-12|1965-11-02|||||1964-10-07||1973-06-15|NA|1960-04-29
TRIAL STUDY 134XCP|LB|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|1||||EPISQCE|SQUAMOUS EPITHELIAL CELLS|||||||MG/KG/DAY|||||||POSITIVE||CMH2O/ML||||HIGH|NOT DONE||||SERUM|PARAFFIN-EMBEDDED|Y|ATOMIC ABSORPTION SPECTROMETRY|FIBROMETER FORMULA||Y|Y|N|NA|||Y|2||58||OPEN LABEL TREATMENT|1967-11-21|1964-03-09|||||1964-02-02||1961-12-24|N|1971-11-30
TRIAL STUDY 134XCP|LB|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|2||||TNFR1|TUMOR NECROSIS FACTOR RECEPTOR 1|||||||SQU/ML|||||||TRACE||10^7 CFU/ML||||NORMAL|NOT DONE||||ALVEOLAR AIR|CLOTTED|NA|TRICHROME STAIN|HEPASCORE FORMULA||U|NA|Y|U|||U|2||58||INDUCTION TREATMENT|1968-03-15|1972-12-29|||||1962-11-12||1966-06-02|Y|1967-02-13
TRIAL STUDY 134XCP|LB|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|1||||IMMGLB|IMMUNOGLOBULIN|||||||DISK|||||||INVALID||CFU/G||||ABNORMAL|NOT DONE||||SOFT TISSUE|CONTAMINATED|NA|REFLECTANCE SPECTROSCOPY|GMI % FORMULA||U|U|NA|N|||Y|3||39||RUN-IN|1969-08-11|1971-08-19|||||1961-02-06||1963-11-01|NA|1963-07-10
TRIAL STUDY 134XCP|LB|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|2||||PGAG|PLATELET-GRANULOCYTE AGG|||||||LOG10 CFU/G|||||||NEGATIVE||AMFI||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FROZEN|N|MAGNETIC RESONANCE ELASTOGRAPHY|MDRD 5 VARIABLE FORMULA||U|N|U|U|||Y|3||39||TREATMENT|1964-10-31|1964-11-07|||||1964-02-18||1960-12-24|Y|1972-02-12
TRIAL STUDY 134XCP|LB|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|1||||NEUTSGNE|NEUTROPHILS, SEGMENTED/NEUTROPHILS|||||||MOSM|||||||NEGATIVE||TRANSDUCING UNIT/ML||||ABNORMAL|NOT DONE||||VENOUS PLASMA|FROZEN|Y|FLUORESCENCE ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA||N|U|N|U|||Y|4||88||CONTINUATION TREATMENT|1970-08-25|1967-04-13|||||1972-11-04||1968-08-23|Y|1966-12-31
TRIAL STUDY 134XCP|LB|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|2||||ALA|ALANINE|||||||PKAT/L|||||||INDETERMINATE||GBQ/G||||NORMAL|NOT DONE||||SEMINAL FLUID|CONTAMINATED|U|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|Y|Y|||Y|4||88||BLINDED TREATMENT|1968-02-07|1968-06-27|||||1960-10-11||1969-02-20|N|1969-02-14
TRIAL STUDY 134XCP|LB|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|1||||FACTIX|FACTOR IX|||||||1/(S*KPA)|||||||TRACE||UM||||HIGH|NOT DONE||||INFRANATANT, PLASMA|CLOTTED|NA|TRANSMISSION ELECTRON MICROSCOPY|FIBROSIS 4 FORMULA||U|N|NA|U|||NA|5||7||SCREENING|1971-05-16|1963-06-23|||||1962-09-04||1967-10-21|N|1972-08-18
TRIAL STUDY 134XCP|LB|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|2||||DENSITY|DENSITY|||||||CONTAINER|||||||NEGATIVE||APL U/ML||||NORMAL|NOT DONE||||FLUID|LIPEMIC|NA|TEST STRIP|MDRD 5 VARIABLE FORMULA||Y|N|U|Y|||U|5||7||INDUCTION TREATMENT|1969-01-25|1960-08-25|||||1969-09-24||1963-10-06|NA|1973-04-01
TRIAL STUDY 134XCP|LB|F2F1151C-F987-49CE-BC16-719DD339DBE7|1||||PHNBRBTL|PHENOBARBITAL|||||||BOX|||||||NEGATIVE||GBQ/MG||||ABNORMAL|NOT DONE||||BILE|PARAFFIN-EMBEDDED|N|HEMAGGLUTINATION INHIBITION ASSAY|FIBROSIS 4 FORMULA||Y|NA|NA|N|||NA|1||38||INDUCTION TREATMENT|1973-05-23|1968-05-30|||||1969-05-26||1972-10-02|N|1968-09-08
TRIAL STUDY 134XCP|LB|F2F1151C-F987-49CE-BC16-719DD339DBE7|2||||CYCACAR|CALCIUM CARBONATE CRYSTALS|||||||PPB|||||||NEGATIVE||DRINK||||HIGH|NOT DONE||||TISSUE|FROZEN|NA|NEPHELOMETRY|COCKCROFT-GAULT FORMULA||U|N|N|NA|||Y|1||38||OBSERVATION|1964-10-13|1968-12-25|||||1967-05-29||1971-06-29|Y|1961-07-26
TRIAL STUDY 134XCP|LB|F2F1151C-F987-49CE-BC16-719DD339DBE7|1||||G6PDA|GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACT|||||||SACHET|||||||INVALID||KIT||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|PARAFFIN-EMBEDDED|N|CALCULATION|MDRD FORMULA||U|NA|N|N|||N|2||58||WASHOUT|1968-03-09|1960-07-25|||||1973-08-22||1964-11-23|NA|1969-03-30
TRIAL STUDY 134XCP|LB|F2F1151C-F987-49CE-BC16-719DD339DBE7|2||||DSG3AB|DESMOGLEIN 3 ANTIBODY|||||||TROCHE|||||||INDETERMINATE||OZ||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|ROOM TEMPERATURE|N|PULSE OXIMETRY|FIBROSIS 4 FORMULA||U|NA|U|N|||NA|2||58||OPEN LABEL TREATMENT|1967-01-31|1960-12-15|||||1971-03-16||1963-01-09|NA|1965-08-06
TRIAL STUDY 134XCP|LB|F2F1151C-F987-49CE-BC16-719DD339DBE7|1||||PRGNENLN|PREGNENOLONE|||||||10^6 CFU|||||||TRACE||MEQ/L||||NORMAL|NOT DONE||||SPERMATOZOON|UNEXPECTED ODOR|Y|MRI WITHOUT CONTRAST|CKD-EPI FORMULA||NA|Y|U|Y|||NA|3||39||WASHOUT|1963-03-16|1960-05-03|||||1969-02-03||1961-10-27|Y|1968-01-06
TRIAL STUDY 134XCP|LB|F2F1151C-F987-49CE-BC16-719DD339DBE7|2||||LDH2LDH|LDH ISOENZYME 2/LDH|||||||BU|||||||INDETERMINATE||DB||||HIGH|NOT DONE||||MONOCYTE|AUTOLYZED|NA|COMPUTERIZED CORNEAL TOPOGRAPHY|FIBROSIS 4 FORMULA||NA|U|Y|N|||U|3||39||CONTINUATION TREATMENT|1961-02-23|1968-05-14|||||1967-10-04||1966-10-01|N|1961-03-18
TRIAL STUDY 134XCP|LB|F2F1151C-F987-49CE-BC16-719DD339DBE7|1||||SPMAGGR|SPERM AGGREGATION|||||||PACKET|||||||POSITIVE||PLUG||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|AGGLUTINATED|Y|RIA|MDRD FORMULA||U|N|N|N|||U|4||88||SCREENING|1965-07-27|1965-09-28|||||1960-08-23||1971-10-27|N|1972-06-27
TRIAL STUDY 134XCP|LB|F2F1151C-F987-49CE-BC16-719DD339DBE7|2||||PROMYLE|PROMYELOCYTES/LEUKOCYTES|||||||UCI|||||||INDETERMINATE||ML/CM||||ABNORMAL|NOT DONE||||BREAST MILK|NON-HEMOLYZED|NA|MALDI|FIBROTEST FORMULA||U|N|NA|Y|||N|4||88||LONG-TERM FOLLOW-UP|1970-07-29|1971-10-23|||||1963-01-03||1963-05-16|N|1963-05-23
TRIAL STUDY 134XCP|LB|F2F1151C-F987-49CE-BC16-719DD339DBE7|1||||VEGFR3S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC3|||||||MMOL/MOL|||||||INDETERMINATE||/MONTH||||LOW|NOT DONE||||SPERMATOZOON|THAWED|N|MULTIPLE BREATH WASHOUT|MDRD FORMULA||Y|NA|Y|NA|||N|5||7||INDUCTION TREATMENT|1970-08-28|1960-10-24|||||1960-05-03||1969-03-30|N|1965-02-12
TRIAL STUDY 134XCP|LB|F2F1151C-F987-49CE-BC16-719DD339DBE7|2||||RLP|RLP CHOLESTEROL|||||||BLOCKS|||||||NEGATIVE||DEG2||||LOW|NOT DONE||||LYMPH|DRIED|NA|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA||Y|U|Y|N|||NA|5||7||FOLLOW-UP|1963-07-16|1962-06-26|||||1964-08-06||1962-06-18|NA|1973-08-05
TRIAL STUDY 134XCP|LB|F88FCFA6-90D7-4033-86DF-223A63A6152D|1||||LPA|LIPOPROTEIN-A|||||||G/ANIMAL|||||||TRACE||/2000 RBC||||LOW|NOT DONE||||RETICULOCYTES|GELLED|Y|HEMAGGLUTINATION INHIBITION ASSAY|GMI MMOL/MOL FORMULA||U|U|U|Y|||N|1||38||SCREENING|1960-01-07|1962-02-03|||||1965-11-10||1970-09-14|NA|1961-03-18
TRIAL STUDY 134XCP|LB|F88FCFA6-90D7-4033-86DF-223A63A6152D|2||||COTININE|COTININE|||||||UV*SEC|||||||TRACE||VP/ML||||NORMAL|NOT DONE||||LYSATE|UNEXPECTED ODOR|N|SNP ARRAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|N|||Y|1||38||LONG-TERM FOLLOW-UP|1967-08-23|1969-05-02|||||1972-09-15||1971-01-21|N|1970-10-30
TRIAL STUDY 134XCP|LB|F88FCFA6-90D7-4033-86DF-223A63A6152D|1||||CRNTESTR|CARNITINE ESTERS|||||||AGU/ML|||||||INDETERMINATE||INHALATION||||NORMAL|NOT DONE||||KERATINOCYTE|LACTESCENT|N|REBOUND TONOMETRY|MDRD 4 VARIABLE FORMULA||NA|Y|U|N|||Y|2||58||RUN-IN|1971-10-19|1967-11-11|||||1968-07-18||1973-08-26|Y|1971-01-10
TRIAL STUDY 134XCP|LB|F88FCFA6-90D7-4033-86DF-223A63A6152D|2||||TGFA|TRANSFORMING GROWTH FACTOR ALPHA|||||||CM2|||||||INVALID||DAGU/ML||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|REFRIGERATED|U|FORCED OSCILLATION TECHNIQUE|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|N|U|||Y|2||58||BLINDED TREATMENT|1970-08-28|1963-11-26|||||1972-12-20||1962-12-29|N|1969-07-17
TRIAL STUDY 134XCP|LB|F88FCFA6-90D7-4033-86DF-223A63A6152D|1||||T3UP|TRIIODOTHYRONINE UPTAKE|||||||PACK|||||||INVALID||10^4 CFU/ML||||LOW|NOT DONE||||PLATELET|SOLIDIFIED|NA|BETA LACTAMASE|FIBROSIS 4 FORMULA||N|Y|N|N|||U|3||39||BASELINE|1963-01-15|1968-12-20|||||1965-03-02||1972-09-28|N|1968-12-13
TRIAL STUDY 134XCP|LB|F88FCFA6-90D7-4033-86DF-223A63A6152D|2||||ANCATYAB|NEUTROPHIL CYTOPLASMIC AB, ATYPICAL|||||||WEBER|||||||INDETERMINATE||ML/CM3/MIN||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|LACTESCENT|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CYSTATIN C FORMULA||U|U|Y|N|||NA|3||39||RUN-IN|1967-06-09|1971-10-18|||||1966-04-07||1966-02-17|U|1961-12-21
TRIAL STUDY 134XCP|LB|F88FCFA6-90D7-4033-86DF-223A63A6152D|1||||HASIGGAB|HUMAN ANTI-SHEEP IGG ANTIBODY|||||||IU/KG|||||||INVALID||KDA||||HIGH|NOT DONE||||EXPIRED AIR|HEMOLYZED|Y|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||U|Y|N|Y|||N|4||88||TREATMENT|1960-06-21|1970-03-29|||||1968-01-18||1967-12-09|NA|1963-12-22
TRIAL STUDY 134XCP|LB|F88FCFA6-90D7-4033-86DF-223A63A6152D|2||||DNASEBAB|DNASE-B ANTIBODY|||||||FFU|||||||BORDERLINE||CD/M2||||HIGH|NOT DONE||||AQUEOUS HUMOR|CONTAMINATED|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|HEPASCORE FORMULA||Y|NA|U|U|||Y|4||88||TREATMENT|1963-02-23|1962-04-06|||||1967-12-23||1962-09-29|N|1960-03-15
TRIAL STUDY 134XCP|LB|F88FCFA6-90D7-4033-86DF-223A63A6152D|1||||BTLBTL|BUTALBITAL|||||||G/G|||||||POSITIVE||AMP||||NORMAL|NOT DONE||||EXPIRED AIR|CONTAMINATED|U|NUCLEIC ACID AMPLIFICATION TEST|NASH FIBROSURE FORMULA||U|Y|U|U|||U|5||7||CONTINUATION TREATMENT|1962-01-15|1960-06-28|||||1966-11-30||1968-04-10|Y|1962-03-13
TRIAL STUDY 134XCP|LB|F88FCFA6-90D7-4033-86DF-223A63A6152D|2||||ICAIGGAB|ISLET CELL CYTOPLASMIC IGG ANTIBODY|||||||MBQ|||||||NEGATIVE||/200 HPFS||||ABNORMAL|NOT DONE||||VENOUS BLOOD|CLOTTED|N|CALIPER MEASUREMENT METHOD|MDRD FORMULA||NA|NA|N|N|||Y|5||7||BASELINE|1973-01-26|1961-09-10|||||1966-03-28||1968-07-07|Y|1968-09-16
TRIAL STUDY 134XCP|LB|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|1||||CSRBC|RBC CASTS|||||||MOL/L|||||||BORDERLINE||10^6/HPF||||LOW|NOT DONE||||SPUTUM|ROOM TEMPERATURE|NA|NON-INVASIVE DIELECTRIC SENSING|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|U|NA|||N|1||38||OBSERVATION|1963-10-06|1966-07-31|||||1966-05-05||1969-05-30|Y|1960-04-01
TRIAL STUDY 134XCP|LB|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|2||||CATNINB|BETA CATENIN|||||||MG/G/H|||||||TRACE||DROP||||LOW|NOT DONE||||EXPIRED AIR|ICTERIC|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI FORMULA||Y|U|Y|N|||Y|1||38||BLINDED TREATMENT|1965-12-01|1966-05-18|||||1968-12-12||1962-01-01|U|1967-12-10
TRIAL STUDY 134XCP|LB|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|1||||ATHPIDX|ATHEROGENIC INDEX OF PLASMA|||||||MMAL|||||||INDETERMINATE||G/CAGE/WK||||HIGH|NOT DONE||||CORD BLOOD|LIPEMIC|NA|JAFFE REACTION|CKD-EPI CREATININE FORMULA||Y|U|Y|N|||Y|2||58||WASHOUT|1971-07-07|1964-06-25|||||1966-01-09||1960-01-03|U|1972-07-10
TRIAL STUDY 134XCP|LB|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|2||||SEDEXAM|SEDIMENT EXAMINATION|||||||PATCH|||||||POSITIVE||MEQ/KG||||ABNORMAL|NOT DONE||||COLOSTRUM|AGGLUTINATED|U|IMMUNOFIXATION ELECTROPHORESIS|GMI % FORMULA||NA|NA|NA|N|||U|2||58||RUN-IN|1968-07-26|1968-04-27|||||1971-07-04||1966-06-07|U|1970-07-20
TRIAL STUDY 134XCP|LB|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|1||||HLAAMSC|HLA-A MISMATCH COUNT|||||||KPA/L/SEC|||||||INVALID||GY/MIN||||LOW|NOT DONE||||PERITONEAL FLUID|DRIED|Y|KINETIC CHROMOGENIC ASSAY|FIBROSIS 4 FORMULA||N|Y|NA|N|||N|3||39||RUN-IN|1961-06-23|1962-09-15|||||1966-06-09||1963-04-24|N|1970-12-22
TRIAL STUDY 134XCP|LB|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|2||||TLCHT|TAUROLITHOCHOLATE|||||||MG/ML/MIN|||||||NEGATIVE||PPTR||||NORMAL|NOT DONE||||GASTRIC CONTENTS|CALCIFIED|N|PYROSEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|N|Y|||Y|3||39||WASHOUT|1970-11-29|1963-03-13|||||1962-10-24||1964-01-09|NA|1968-06-23
TRIAL STUDY 134XCP|LB|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|1||||OHDG8|8-HYDROXYDEOXYGUANOSINE|||||||ML|||||||BORDERLINE||BQ||||LOW|NOT DONE||||SYNOVIAL FLUID|GELLED|NA|PALPATION|ASH FIBROSURE FORMULA||Y|NA|Y|N|||NA|4||88||WASHOUT|1966-01-11|1961-10-13|||||1973-01-11||1962-05-19|Y|1962-01-17
TRIAL STUDY 134XCP|LB|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|2||||IOTCLRBS|IOTHALAMATE CLEARANCE ADJUSTED FOR BSA|||||||10^4/L|||||||TRACE||PFU/ML||||NORMAL|NOT DONE||||BASAL TEAR|AGGLUTINATED|U|DUCTOGRAPHY|GMI MMOL/MOL FORMULA||N|Y|U|NA|||NA|4||88||WASHOUT|1964-04-16|1971-07-18|||||1966-01-04||1970-02-26|U|1968-09-07
TRIAL STUDY 134XCP|LB|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|1||||TTGIGAAB|TISSUE TRANSGLUTAMINASE IGA ANTIBODY|||||||PIXELS/CM|||||||INDETERMINATE||KG/CM2||||HIGH|NOT DONE||||SPUTUM|NON-HEMOLYZED|U|FISH|CKD-EPI FORMULA||U|U|U|N|||U|5||7||OPEN LABEL TREATMENT|1973-02-11|1961-06-14|||||1967-07-30||1961-07-28|U|1970-01-22
TRIAL STUDY 134XCP|LB|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|2||||PT|PROTHROMBIN TIME|||||||UG/DAY|||||||BORDERLINE||PPB||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|REFRIGERATED|Y|HEMOCYTOMETRY|GMI MMOL/MOL FORMULA||N|N|U|Y|||N|5||7||WASHOUT|1960-01-22|1966-09-28|||||1972-12-30||1967-11-11|NA|1973-08-28
TRIAL STUDY 134XCP|LB|7D35B2F5-7334-448B-B4E1-14671B850B6A|1||||INSULINR|INSULIN RESISTANCE|||||||PIPE|||||||BORDERLINE||U/G/MIN||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|CALCIFIED|NA|CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|N|U|||N|1||38||WASHOUT|1967-11-01|1963-07-08|||||1965-09-04||1968-10-06|N|1967-07-25
TRIAL STUDY 134XCP|LB|7D35B2F5-7334-448B-B4E1-14671B850B6A|2||||INTLK30|INTERLEUKIN 30|||||||10^7 CFU|||||||BORDERLINE||STEPS||||NORMAL|NOT DONE||||INFRANATANT, SERUM|CONTAMINATED|Y|NUCLEIC ACID BASED METHOD|FIBROSIS 4 FORMULA||U|Y|U|N|||N|1||38||WASHOUT|1967-01-01|1968-07-30|||||1964-12-19||1971-09-18|N|1970-07-07
TRIAL STUDY 134XCP|LB|7D35B2F5-7334-448B-B4E1-14671B850B6A|1||||HER2S|SOLUBLE HER2|||||||LENS|||||||NEGATIVE||UMOL||||NORMAL|NOT DONE||||DIALYSIS FLUID|SOLIDIFIED|U|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|HEPASCORE FORMULA||N|U|NA|U|||N|2||58||FOLLOW-UP|1970-12-17|1972-09-27|||||1972-05-02||1973-06-15|N|1960-06-30
TRIAL STUDY 134XCP|LB|7D35B2F5-7334-448B-B4E1-14671B850B6A|2||||EGF|EPIDERMAL GROWTH FACTOR|||||||HZ/S|||||||BORDERLINE||NMOL/G||||HIGH|NOT DONE||||ALVEOLAR AIR|PARAFFIN-EMBEDDED|N|LIGHT SCATTERING SPECTROSCOPY|CKD-EPI CYSTATIN C FORMULA||U|N|Y|U|||U|2||58||RUN-IN|1963-01-02|1960-09-15|||||1965-01-18||1967-07-11|Y|1968-07-19
TRIAL STUDY 134XCP|LB|7D35B2F5-7334-448B-B4E1-14671B850B6A|1||||CK|CREATINE KINASE|||||||BOTTLE|||||||TRACE||10^6 CFU||||HIGH|NOT DONE||||DIALYSIS FLUID|PARAFFIN-EMBEDDED|U|FLOW CYTOMETRY|NASH FIBROSURE FORMULA||Y|NA|U|U|||N|3||39||TREATMENT|1965-09-22|1970-05-07|||||1970-01-30||1971-12-01|U|1964-08-31
TRIAL STUDY 134XCP|LB|7D35B2F5-7334-448B-B4E1-14671B850B6A|2||||CRH|CORTICOTROPIN RELEASING HORMONE|||||||FOZ_US|||||||POSITIVE||ENZYME U/L||||HIGH|NOT DONE||||PLASMA|AGGLUTINATED|U|SECONDARY ION MASS SPECTOMETRY|CKD-EPI CYSTATIN C FORMULA||N|N|U|U|||U|3||39||SCREENING|1967-07-03|1962-02-15|||||1967-12-03||1967-01-18|NA|1962-08-25
TRIAL STUDY 134XCP|LB|7D35B2F5-7334-448B-B4E1-14671B850B6A|1||||GRN|PROGRANULIN|||||||CL|||||||INVALID||ML/CM||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|HEMOLYZED|N|U-HPLC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|Y|||N|4||88||SCREENING|1964-01-08|1960-12-09|||||1966-10-23||1962-07-06|Y|1966-04-09
TRIAL STUDY 134XCP|LB|7D35B2F5-7334-448B-B4E1-14671B850B6A|2||||FACTVL|FACTOR V LEIDEN|||||||MAMP|||||||NEGATIVE||MEQ/ML||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|FRESH|Y|PUPILLOMETRY|MDRD ENZYMATIC FORMULA||N|N|N|Y|||N|4||88||WASHOUT|1964-07-21|1967-11-08|||||1965-01-02||1967-12-16|N|1970-09-21
TRIAL STUDY 134XCP|LB|7D35B2F5-7334-448B-B4E1-14671B850B6A|1||||MPV|MEAN PLATELET VOLUME|||||||STRIP|||||||BORDERLINE||MEQ/UG||||LOW|NOT DONE||||SPUTUM|CALCIFIED|Y|CONTRAST ENHANCED PET SCAN|GMI % FORMULA||U|Y|N|U|||NA|5||7||CONTINUATION TREATMENT|1972-11-01|1960-06-28|||||1969-11-17||1972-05-08|NA|1961-01-04
TRIAL STUDY 134XCP|LB|7D35B2F5-7334-448B-B4E1-14671B850B6A|2||||NSPMTSPM|NORMAL SPERM/TOTAL SPERM|||||||ANTIBODY UNIT|||||||NEGATIVE||/200 HPFS||||LOW|NOT DONE||||LYMPH|FROZEN|NA|BALLPOINT PEN TECHNIQUE|GMI % FORMULA||N|U|NA|N|||NA|5||7||OPEN LABEL TREATMENT|1960-02-16|1961-03-11|||||1965-12-20||1966-06-24|Y|1966-09-10
TRIAL STUDY 134XCP|LB|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|1||||SMTHAB|SMITH ANTIBODY|||||||10^9 ORGANISMS/G|||||||INDETERMINATE||STEPS||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|CONTAMINATED|U|CORONARY ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|N|||N|1||38||LONG-TERM FOLLOW-UP|1965-04-17|1969-09-12|||||1963-05-16||1967-05-17|NA|1969-04-16
TRIAL STUDY 134XCP|LB|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|2||||HLADRAGT|HLA-DR ANTIGEN TYPE|||||||UU/DL|||||||INVALID||MOL/L||||HIGH|NOT DONE||||WHITE MATTER TISSUE|LACTESCENT|N|MECHANICAL CLOT DETECTION|ASH FIBROSURE FORMULA||NA|N|N|Y|||NA|1||38||SCREENING|1966-03-15|1969-11-27|||||1961-11-17||1972-08-17|U|1969-08-06
TRIAL STUDY 134XCP|LB|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|1||||BASOMYL|BASOPHILIC MYELOCYTES|||||||ML/M2/H|||||||INVALID||OZ||||NORMAL|NOT DONE||||CALCULUS|SOLIDIFIED|U|ELECTRONEUROGRAPHY|COCKCROFT-GAULT FORMULA||Y|U|N|Y|||N|2||58||OPEN LABEL TREATMENT|1972-06-26|1961-08-29|||||1972-01-06||1969-04-23|N|1973-07-24
TRIAL STUDY 134XCP|LB|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|2||||CHCM|CORPUSCULAR HGB CONCENTRATION MEAN|||||||TUBE|||||||NEGATIVE||10^6/G||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|UNEXPECTED ODOR|N|MEDIASTINOSCOPY|NASH FIBROSURE FORMULA||U|Y|U|U|||Y|2||58||INDUCTION TREATMENT|1972-01-28|1969-06-06|||||1969-07-28||1963-08-17|N|1965-05-23
TRIAL STUDY 134XCP|LB|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|1||||BJPROT|BENCE-JONES PROTEIN|||||||NSEC|||||||NEGATIVE||PMOL/G||||HIGH|NOT DONE||||NAIL|CALCIFIED|NA|COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI FORMULA||U|Y|NA|U|||Y|3||39||LONG-TERM FOLLOW-UP|1967-05-22|1969-07-22|||||1969-12-10||1960-11-02|N|1972-06-10
TRIAL STUDY 134XCP|LB|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|2||||MDZLM|MIDAZOLAM|||||||10^4 CFU|||||||NEGATIVE||UKAT/10^12 RBC||||LOW|NOT DONE||||PLATELET POOR PLASMA|ROOM TEMPERATURE|U|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|GMI % FORMULA||Y|NA|U|U|||NA|3||39||INDUCTION TREATMENT|1964-08-12|1968-10-14|||||1961-12-22||1973-05-30|NA|1967-12-29
TRIAL STUDY 134XCP|LB|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|1||||SEZCELY|SEZARY CELLS/LYMPHOCYTES|||||||HPA|||||||NEGATIVE||TITER||||HIGH|NOT DONE||||PROSTATIC FLUID|CLOTTED|U|TEST STRIP|GMI % FORMULA||U|N|Y|U|||NA|4||88||SCREENING|1970-10-27|1965-07-23|||||1960-05-15||1960-04-22|U|1964-10-25
TRIAL STUDY 134XCP|LB|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|2||||CTOT|COMPLEMENT TOTAL|||||||GMFI|||||||BORDERLINE||IMPLANT||||NORMAL|NOT DONE||||CAPILLARY BLOOD|LIPEMIC|NA|PHOROPTER|MDRD 4 VARIABLE FORMULA||N|Y|NA|U|||NA|4||88||TREATMENT|1965-02-17|1969-09-27|||||1961-08-28||1972-09-13|NA|1969-03-22
TRIAL STUDY 134XCP|LB|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|1||||RETIMRTC|MEDIUM ABSORPTION RETIC/RETICULOCYTES|||||||DRAM|||||||POSITIVE||NMOL BCE/L||||NORMAL|NOT DONE||||CAPILLARY BLOOD|REFRIGERATED|NA|PERFUSION MRI|MDRD 6 VARIABLE FORMULA||N|Y|U|Y|||N|5||7||SCREENING|1962-12-26|1966-10-25|||||1973-02-20||1966-10-14|NA|1962-08-15
TRIAL STUDY 134XCP|LB|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|2||||DOPAMINE|DOPAMINE|||||||10^9 CFU/G|||||||INVALID||POUCH||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|HEMOLYZED|Y|ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA||U|U|N|U|||NA|5||7||RUN-IN|1960-03-24|1964-04-17|||||1965-09-01||1962-04-05|NA|1961-08-08
TRIAL STUDY 134XCP|LB|B09D371C-2E5C-4F84-986E-5A603C0C4A28|1||||RENINA|RENIN ACTIVITY|||||||G/CAGE/WK|||||||NEGATIVE||10^4 CFU||||HIGH|NOT DONE||||ARTERIAL BLOOD|CONTAMINATED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|HEPASCORE FORMULA||Y|NA|N|NA|||N|1||38||FOLLOW-UP|1969-11-24|1971-01-26|||||1972-08-06||1969-02-04|N|1970-11-17
TRIAL STUDY 134XCP|LB|B09D371C-2E5C-4F84-986E-5A603C0C4A28|2||||CCL16|CHEMOKINE (C-C MOTIF) LIGAND 16|||||||VOXEL|||||||NEGATIVE||ML/KG/MIN||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|HEMOLYZED|N|PHYSICAL EXAMINATION|ASH FIBROSURE FORMULA||U|Y|Y|N|||NA|1||38||BASELINE|1961-03-28|1961-08-21|||||1963-11-18||1961-06-14|Y|1973-01-18
TRIAL STUDY 134XCP|LB|B09D371C-2E5C-4F84-986E-5A603C0C4A28|1||||LEU|LEUCINE|||||||KG/M2|||||||TRACE||GAUSS||||NORMAL|NOT DONE||||HAIR|AGGLUTINATED|U|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||Y|Y|N|N|||NA|2||58||OBSERVATION|1963-05-08|1969-07-07|||||1961-04-25||1965-12-20|N|1962-12-29
TRIAL STUDY 134XCP|LB|B09D371C-2E5C-4F84-986E-5A603C0C4A28|2||||C165898|BIRCH POLLEN IGG AB RAST SCORE|||||||/7.5 ML|||||||INVALID||/LSQN||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|FROZEN|Y|CONGO RED STAIN|MDRD FORMULA||NA|U|U|Y|||NA|2||58||SCREENING|1964-10-25|1963-10-07|||||1972-08-05||1966-04-14|NA|1968-10-12
TRIAL STUDY 134XCP|LB|B09D371C-2E5C-4F84-986E-5A603C0C4A28|1||||EPIN|EPINEPHRINE|||||||NMOL BCE/NMOL|||||||INVALID||KM||||ABNORMAL|NOT DONE||||COLOSTRUM|CONCENTRATED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|HEPASCORE FORMULA||NA|NA|NA|Y|||U|3||39||BASELINE|1960-01-17|1970-05-04|||||1967-12-01||1960-03-12|Y|1969-08-02
TRIAL STUDY 134XCP|LB|B09D371C-2E5C-4F84-986E-5A603C0C4A28|2||||HYDMRPHN|HYDROMORPHONE|||||||UU/L|||||||NEGATIVE||H*%||||ABNORMAL|NOT DONE||||CORD SERUM|ICTERIC|N|PULMONARY ANGIOGRAPHY|GMI MMOL/MOL FORMULA||U|NA|Y|N|||N|3||39||WASHOUT|1972-09-14|1971-07-05|||||1964-05-17||1970-06-01|N|1966-01-16
TRIAL STUDY 134XCP|LB|B09D371C-2E5C-4F84-986E-5A603C0C4A28|1||||TRIGHDL|TRIGLYCERIDES/HDL CHOLESTEROL|||||||TRANSDUCING UNIT/ML|||||||POSITIVE||CMH2O*S/ML||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|SOLIDIFIED|Y|AUDIOMETRY|MDRD FORMULA||Y|Y|U|U|||N|4||88||OPEN LABEL TREATMENT|1961-01-21|1963-04-24|||||1970-02-19||1966-10-31|U|1971-02-01
TRIAL STUDY 134XCP|LB|B09D371C-2E5C-4F84-986E-5A603C0C4A28|2||||TAURCRT|TAURINE/CREATININE|||||||LM|||||||INDETERMINATE||UG/M2/H||||HIGH|NOT DONE||||GASTRIC CONTENTS|DRIED|Y|CLIP|COCKCROFT-GAULT FORMULA||N|U|N|NA|||NA|4||88||WASHOUT|1965-12-21|1963-03-13|||||1969-12-24||1965-12-10|Y|1962-02-07
TRIAL STUDY 134XCP|LB|B09D371C-2E5C-4F84-986E-5A603C0C4A28|1||||GLY|GLYCINE|||||||TRACE|||||||INVALID||U/M2/DAY||||NORMAL|NOT DONE||||ISOLATE|ICTERIC|U|VIRUS PLAQUE ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|U|||U|5||7||WASHOUT|1964-03-19|1965-04-15|||||1972-12-29||1962-11-29|NA|1962-11-11
TRIAL STUDY 134XCP|LB|B09D371C-2E5C-4F84-986E-5A603C0C4A28|2||||EDTACLR|EDTA CLEARANCE|||||||MMHG|||||||TRACE||KG||||NORMAL|NOT DONE||||SPERMATOZOON|UNEXPECTED ODOR|U|NEXT GENERATION SEQUENCING|MDRD 4 VARIABLE FORMULA||Y|N|Y|U|||Y|5||7||OBSERVATION|1964-08-31|1961-04-15|||||1964-09-12||1961-02-17|N|1971-12-15
TRIAL STUDY 134XCP|LB|11CB653E-F113-4639-B15C-B236A2F65F47|1||||ACYLCAOX|ACYL COENZYME A OXIDASE|||||||DAMOL/L|||||||INVALID||DAYS||||NORMAL|NOT DONE||||PLASMA|THAWED|Y|HEMAGGLUTINATION ASSAY|MDRD FORMULA||N|NA|NA|NA|||N|1||38||OPEN LABEL TREATMENT|1962-07-04|1965-09-14|||||1973-04-25||1971-05-18|U|1968-04-18
TRIAL STUDY 134XCP|LB|11CB653E-F113-4639-B15C-B236A2F65F47|2||||VBCE|VIABLE CELLS|||||||G/KG|||||||BORDERLINE||U/MMOL||||HIGH|NOT DONE||||MUSCLE TISSUE|CLOTTED|Y|CLAUSS METHOD|ASH FIBROSURE FORMULA||NA|NA|NA|U|||U|1||38||OBSERVATION|1971-07-08|1962-01-09|||||1969-08-28||1970-05-07|Y|1973-06-24
TRIAL STUDY 134XCP|LB|11CB653E-F113-4639-B15C-B236A2F65F47|1||||BLASTIMM|IMMUNOBLASTS|||||||MIN|||||||INDETERMINATE||PMOL/DAY||||NORMAL|NOT DONE||||EPITHELIAL CELL|LIPEMIC|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA||NA|NA|NA|NA|||N|2||58||TREATMENT|1971-04-17|1964-05-27|||||1962-07-06||1973-06-27|U|1973-05-05
TRIAL STUDY 134XCP|LB|11CB653E-F113-4639-B15C-B236A2F65F47|2||||HEXK|HEXOKINASE|||||||CI/MG|||||||INVALID||DYN||||NORMAL|NOT DONE||||VENOUS PLASMA|HEMOLYZED|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|GMI % FORMULA||Y|Y|Y|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1973-03-14|1961-01-02|||||1960-07-19||1960-10-03|N|1963-06-24
TRIAL STUDY 134XCP|LB|11CB653E-F113-4639-B15C-B236A2F65F47|1||||TGFB|TRANSFORMING GROWTH FACTOR BETA|||||||L/DAY|||||||TRACE||FRAMES/S||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|HEMOLYZED|Y|TOLUIDINE BLUE STAIN|MDRD 4 VARIABLE FORMULA||NA|NA|U|NA|||NA|3||39||INDUCTION TREATMENT|1971-12-14|1970-02-05|||||1968-12-12||1973-04-27|Y|1971-09-19
TRIAL STUDY 134XCP|LB|11CB653E-F113-4639-B15C-B236A2F65F47|2||||IGG2|IMMUNOGLOBULIN G SUBCLASS 2|||||||BOWL|||||||INVALID||U/MG||||LOW|NOT DONE||||TRANSUDATE|DRIED|U|LC-FL|FIBROMETER FORMULA||U|Y|NA|U|||N|3||39||RUN-IN|1960-01-05|1962-05-09|||||1961-08-20||1964-04-19|Y|1968-02-29
TRIAL STUDY 134XCP|LB|11CB653E-F113-4639-B15C-B236A2F65F47|1||||BLASTLM|LEUKEMIC BLASTS|||||||BOLUS|||||||TRACE||MU/G||||NORMAL|NOT DONE||||KERATINOCYTE|UNEXPECTED ODOR|NA|DYNAMIC LIGHT SCATTERING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|NA|U|||U|4||88||OPEN LABEL TREATMENT|1963-10-25|1971-05-30|||||1966-10-31||1968-12-04|N|1972-10-08
TRIAL STUDY 134XCP|LB|11CB653E-F113-4639-B15C-B236A2F65F47|2||||CYCAPHOS|CALCIUM PHOSPHATE CRYSTALS|||||||/2500 WBC|||||||BORDERLINE||G/MOL||||ABNORMAL|NOT DONE||||BILE|FROZEN|NA|POTENTIOMETRY|COCKCROFT-GAULT FORMULA||NA|NA|NA|U|||Y|4||88||TREATMENT|1963-01-24|1971-08-14|||||1964-07-27||1969-11-10|U|1971-08-05
TRIAL STUDY 134XCP|LB|11CB653E-F113-4639-B15C-B236A2F65F47|1||||APOA2|APOLIPOPROTEIN AII|||||||U/KG/DAY|||||||NEGATIVE||ATM||||NORMAL|NOT DONE||||ADIPOSE TISSUE|FRESH|Y|NEURAMINIDASE INHIBITION ASSAY|FIBROMETER FORMULA||U|Y|U|U|||NA|5||7||FOLLOW-UP|1969-07-08|1962-07-26|||||1966-02-26||1972-10-22|Y|1963-03-20
TRIAL STUDY 134XCP|LB|11CB653E-F113-4639-B15C-B236A2F65F47|2||||C130106|WEED MIX POLLEN ANTIGEN IGE ANTIBODY|||||||TRACE|||||||NEGATIVE||10^6/HPF||||NORMAL|NOT DONE||||DIALYSIS FLUID|SOLIDIFIED|Y|IMMUNODIFFUSION|MDRD 5 VARIABLE FORMULA||Y|U|Y|N|||NA|5||7||OBSERVATION|1970-06-14|1960-08-15|||||1971-02-08||1970-01-22|N|1967-04-10
TRIAL STUDY 134XCP|LB|2AB992E7-55B7-4327-987C-47FD605B7D78|1||||PROTS|PROTEIN S|||||||GBQ/UG|||||||INDETERMINATE||UOSM||||HIGH|NOT DONE||||LYSATE|REFRIGERATED|U|DUKE INCISION METHOD|GMI % FORMULA||U|N|N|Y|||U|1||38||OPEN LABEL TREATMENT|1966-08-21|1967-11-18|||||1967-07-17||1961-08-28|N|1961-08-05
TRIAL STUDY 134XCP|LB|2AB992E7-55B7-4327-987C-47FD605B7D78|2||||HER2|HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2|||||||SACHET|||||||NEGATIVE||S*KPA||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|CONCENTRATED|U|CLIP SEQUENCING|NASH FIBROSURE FORMULA||N|Y|N|NA|||Y|1||38||TREATMENT|1962-01-20|1960-01-01|||||1965-11-03||1966-10-13|U|1973-02-10
TRIAL STUDY 134XCP|LB|2AB992E7-55B7-4327-987C-47FD605B7D78|1||||HBA1B|HEMOGLOBIN A1B|||||||S*KPA|||||||INVALID||L/H/M2||||ABNORMAL|NOT DONE||||VENOUS BLOOD|AGGLUTINATED|N|TARGETED GENOME SEQUENCING|MDRD 4 VARIABLE FORMULA||NA|NA|NA|Y|||U|2||58||TREATMENT|1962-10-08|1970-01-15|||||1964-03-01||1965-05-07|N|1971-03-15
TRIAL STUDY 134XCP|LB|2AB992E7-55B7-4327-987C-47FD605B7D78|2||||PHOSLPD|PHOSPHOLIPID|||||||M|||||||BORDERLINE||NMOL/ML/MIN||||HIGH|NOT DONE||||DISCHARGE|SOLIDIFIED|U|REFRACTOMETRY|FIBROSIS 4 FORMULA||NA|N|U|NA|||NA|2||58||OPEN LABEL TREATMENT|1962-12-07|1967-12-23|||||1972-04-06||1967-08-04|N|1962-01-24
TRIAL STUDY 134XCP|LB|2AB992E7-55B7-4327-987C-47FD605B7D78|1||||SFTPD|SURFACTANT PROTEIN D|||||||MCI/KG|||||||POSITIVE||ML/BREATH||||LOW|NOT DONE||||BUFFY COAT|AUTOLYZED|NA|CARDIAC THERMODILUTION|GMI % FORMULA||Y|NA|Y|U|||Y|3||39||SCREENING|1962-05-27|1966-07-21|||||1963-06-20||1961-03-27|N|1960-07-30
TRIAL STUDY 134XCP|LB|2AB992E7-55B7-4327-987C-47FD605B7D78|2||||ANA|ANTINUCLEAR ANTIBODIES|||||||L/MIN/M2|||||||INDETERMINATE||10^4/L||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CLOTTED|NA|OPTICAL MAPPING|ASH FIBROSURE FORMULA||Y|N|Y|N|||U|3||39||WASHOUT|1961-01-15|1961-04-02|||||1971-05-19||1963-06-19|NA|1967-03-21
TRIAL STUDY 134XCP|LB|2AB992E7-55B7-4327-987C-47FD605B7D78|1||||LDHCREAT|LACTATE DEHYDROGENASE/CREATININE|||||||GLOBULE|||||||INDETERMINATE||CI/UG||||NORMAL|NOT DONE||||RETICULOCYTES|REFRIGERATED|U|HANSEL STAIN|CKD-EPI FORMULA||NA|N|N|Y|||Y|4||88||CONTINUATION TREATMENT|1970-08-04|1970-03-30|||||1968-02-24||1969-09-05|N|1963-02-11
TRIAL STUDY 134XCP|LB|2AB992E7-55B7-4327-987C-47FD605B7D78|2||||K|POTASSIUM|||||||EIA UNIT|||||||TRACE||/2000 RBC||||HIGH|NOT DONE||||BUFFY COAT|ICTERIC|N|HPLC|FIBROSIS 4 FORMULA||Y|N|U|NA|||N|4||88||BASELINE|1972-11-05|1962-09-08|||||1970-04-13||1970-11-29|U|1971-11-17
TRIAL STUDY 134XCP|LB|2AB992E7-55B7-4327-987C-47FD605B7D78|1||||UREANCRT|UREA NITROGEN/CREATININE|||||||U/MG|||||||INDETERMINATE||HOUNSFIELD UNIT||||HIGH|NOT DONE||||LYMPH|AUTOLYZED|NA|RAJI CELL EIA|MDRD 6 VARIABLE FORMULA||NA|N|NA|Y|||NA|5||7||TREATMENT|1969-10-14|1966-02-11|||||1972-02-17||1962-04-07|N|1970-01-04
TRIAL STUDY 134XCP|LB|2AB992E7-55B7-4327-987C-47FD605B7D78|2||||MLIGCEBC|MALIGNANT CELLS, NOS/BLOOD CELLS|||||||NMOL/G|||||||POSITIVE||PSI||||NORMAL|NOT DONE||||SALIVA|NON-HEMOLYZED|Y|MECHANICAL CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|N|Y|||U|5||7||CONTINUATION TREATMENT|1967-06-16|1962-03-20|||||1962-09-12||1963-12-10|U|1965-10-29
TRIAL STUDY 134XCP|LB|6AF1B0B0-9923-459A-8629-5E628400AD00|1||||FABP1|FATTY ACID BINDING PROTEIN 1|||||||ML/M2|||||||POSITIVE||KBQ||||LOW|NOT DONE||||VENOUS CORD BLOOD|AUTOLYZED|NA|KNEMOMETRY|CKD-EPI CREATININE FORMULA||N|Y|Y|U|||NA|1||38||BASELINE|1960-08-29|1973-09-07|||||1964-04-18||1964-05-16|U|1965-07-21
TRIAL STUDY 134XCP|LB|6AF1B0B0-9923-459A-8629-5E628400AD00|2||||C130093|WESTERN RAGWEED POLLEN IGA|||||||PFU|||||||INDETERMINATE||COPIES/UG||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|CALCIFIED|N|GRAM STAIN|MDRD 6 VARIABLE FORMULA||U|U|NA|U|||Y|1||38||BLINDED TREATMENT|1973-09-05|1973-07-26|||||1963-02-14||1961-07-31|N|1966-08-03
TRIAL STUDY 134XCP|LB|6AF1B0B0-9923-459A-8629-5E628400AD00|1||||COQ10|UBIQUINONE 10|||||||ENZYME U/L|||||||BORDERLINE||NFIU||||ABNORMAL|NOT DONE||||CORD BLOOD|AGGLUTINATED|N|POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA||N|N|U|NA|||N|2||58||BASELINE|1969-12-11|1965-07-22|||||1960-09-22||1966-10-17|Y|1969-12-14
TRIAL STUDY 134XCP|LB|6AF1B0B0-9923-459A-8629-5E628400AD00|2||||RETIM|MEDIUM ABSORPTION RETICULOCYTES|||||||/MIN|||||||BORDERLINE||PRESSOR UNITS||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|LACTESCENT|U|PERCUSSION|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|NA|||NA|2||58||FOLLOW-UP|1969-01-05|1971-12-04|||||1972-09-15||1962-03-18|NA|1971-01-23
TRIAL STUDY 134XCP|LB|6AF1B0B0-9923-459A-8629-5E628400AD00|1||||NTELOP|N-TELOPEPTIDE|||||||STEPS|||||||BORDERLINE||MBQ/UL||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|FRESH|NA|FORCED OSCILLATION TECHNIQUE|CKD-EPI CREATININE FORMULA||N|U|N|NA|||U|3||39||OPEN LABEL TREATMENT|1970-03-24|1965-08-07|||||1968-03-12||1962-10-23|NA|1963-02-26
TRIAL STUDY 134XCP|LB|6AF1B0B0-9923-459A-8629-5E628400AD00|2||||DSG1AB|DESMOGLEIN 1 ANTIBODY|||||||SCOOPFUL|||||||INDETERMINATE||10^8/L||||LOW|NOT DONE||||LOCHIA|REFRIGERATED|Y|RADIOGRAPHY|FIBROMETER FORMULA||NA|NA|U|NA|||U|3||39||RUN-IN|1961-04-14|1962-11-25|||||1969-01-20||1962-01-30|Y|1960-12-23
TRIAL STUDY 134XCP|LB|6AF1B0B0-9923-459A-8629-5E628400AD00|1||||THROMNUC|THROMBOCYTES|||||||MEQ/UG|||||||BORDERLINE||/100 HPFS||||NORMAL|NOT DONE||||STOOL|HEMOLYZED|Y|SECONDARY ION MASS SPECTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|Y|N|||U|4||88||WASHOUT|1963-08-10|1971-11-07|||||1969-02-25||1966-09-10|N|1960-09-19
TRIAL STUDY 134XCP|LB|6AF1B0B0-9923-459A-8629-5E628400AD00|2||||LYMATLE|LYMPHOCYTES ATYPICAL/LEUKOCYTES|||||||10^6 ORGANISMS/G|||||||POSITIVE||RING||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|AGGLUTINATED|Y|MAPH|GMI MMOL/MOL FORMULA||U|Y|U|NA|||N|4||88||INDUCTION TREATMENT|1969-06-30|1960-02-26|||||1967-03-20||1966-02-24|NA|1970-02-26
TRIAL STUDY 134XCP|LB|6AF1B0B0-9923-459A-8629-5E628400AD00|1||||PLATAGGR|PLATELET AGGREGATION|||||||CMH2O*S2/ML|||||||POSITIVE||APPLICATION||||HIGH|NOT DONE||||HAIR|GELLED|N|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA||N|NA|Y|NA|||N|5||7||RUN-IN|1972-04-01|1966-03-21|||||1960-08-20||1968-09-18|N|1965-04-20
TRIAL STUDY 134XCP|LB|6AF1B0B0-9923-459A-8629-5E628400AD00|2||||KLOTHO|KLOTHO|||||||10^7 TCID 50/DOSE|||||||NEGATIVE||VOXEL||||HIGH|NOT DONE||||DIALYSIS FLUID|FRESH|NA|LIGHT MICROSCOPY|HEPASCORE FORMULA||Y|NA|NA|U|||N|5||7||CONTINUATION TREATMENT|1962-01-10|1961-08-09|||||1973-06-28||1968-11-04|N|1972-06-24
TRIAL STUDY 134XCP|LB|E1305E4E-DF64-4FD1-B0B2-131459AB629D|1||||MITOM2AB|MITOCHONDRIAL M2 ANTIBODY|||||||G|||||||INVALID||MAMP||||ABNORMAL|NOT DONE||||CELL PELLET|CALCIFIED|NA|ECHOCARDIOGRAPHY|FIBROTEST FORMULA||N|Y|Y|U|||U|1||38||FOLLOW-UP|1973-07-07|1960-01-21|||||1962-06-23||1971-02-02|Y|1963-05-03
TRIAL STUDY 134XCP|LB|E1305E4E-DF64-4FD1-B0B2-131459AB629D|2||||SARCOSIN|SARCOSINE|||||||MOL/L|||||||BORDERLINE||MET*H||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|NON-HEMOLYZED|U|CORONARY ANGIOGRAPHY|FIBROMETER FORMULA||N|Y|NA|N|||U|1||38||OBSERVATION|1965-12-28|1964-11-01|||||1963-08-28||1961-10-16|U|1960-07-04
TRIAL STUDY 134XCP|LB|E1305E4E-DF64-4FD1-B0B2-131459AB629D|1||||UDCACM|URSODEOXYCHOLATE COMPOUNDS|||||||ML/G/DAY|||||||INVALID||NKAT||||NORMAL|NOT DONE||||HAIR FOLLICLE|GELLED|NA|SECONDARY ION MASS SPECTOMETRY|GMI % FORMULA||NA|U|U|U|||N|2||58||SCREENING|1972-07-14|1964-09-12|||||1964-12-04||1968-11-19|U|1968-04-23
TRIAL STUDY 134XCP|LB|E1305E4E-DF64-4FD1-B0B2-131459AB629D|2||||TRYPTASE|TRYPTASE|||||||UG/L/H|||||||NEGATIVE||FEU||||LOW|NOT DONE||||DERMAL TISSUE|CLOTTED|N|HPLC-FL|GMI % FORMULA||N|U|NA|Y|||NA|2||58||BASELINE|1966-02-19|1962-10-24|||||1962-05-08||1965-03-26|U|1967-01-21
TRIAL STUDY 134XCP|LB|E1305E4E-DF64-4FD1-B0B2-131459AB629D|1||||T4FRIDX|THYROXINE, FREE INDEX|||||||ML/MIN/1.73M2|||||||INDETERMINATE||HZ||||NORMAL|NOT DONE||||SERUM OR PLASMA|ROOM TEMPERATURE|NA|DYNAMIC LIGHT SCATTERING|FIBROSIS 4 FORMULA||N|U|Y|Y|||NA|3||39||RUN-IN|1970-12-31|1970-07-09|||||1960-01-04||1969-02-19|N|1962-03-14
TRIAL STUDY 134XCP|LB|E1305E4E-DF64-4FD1-B0B2-131459AB629D|2||||CTXIICRT|TYPE II COLLAGEN C-TELOPEPTIDES/CREAT|||||||UMOL/KG/MIN|||||||TRACE||NG/DAY||||ABNORMAL|NOT DONE||||SMEGMA|NON-HEMOLYZED|NA|DIRECT SEQUENCING|NASH FIBROSURE FORMULA||NA|U|NA|NA|||U|3||39||OPEN LABEL TREATMENT|1970-05-01|1961-01-19|||||1960-09-18||1972-09-10|NA|1969-03-10
TRIAL STUDY 134XCP|LB|E1305E4E-DF64-4FD1-B0B2-131459AB629D|1||||GLUCPED|PLASMA EQUIVALENT GLUCOSE DISTRIBUTION|||||||ML/S|||||||BORDERLINE||GBQ/MG||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|AGGLUTINATED|NA|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD FORMULA||Y|N|NA|N|||NA|4||88||TREATMENT|1972-12-11|1963-01-31|||||1966-07-26||1966-01-26|NA|1963-03-01
TRIAL STUDY 134XCP|LB|E1305E4E-DF64-4FD1-B0B2-131459AB629D|2||||STROPONI|SKELETAL TROPONIN I|||||||BAG|||||||NEGATIVE||MG/KG/MIN||||LOW|NOT DONE||||MUSCLE TISSUE|AGGLUTINATED|N|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CYSTATIN C FORMULA||Y|NA|NA|NA|||NA|4||88||SCREENING|1968-09-22|1966-08-09|||||1967-10-20||1967-03-08|U|1970-08-17
TRIAL STUDY 134XCP|LB|E1305E4E-DF64-4FD1-B0B2-131459AB629D|1||||OXMORPHN|OXYMORPHONE|||||||BQ/MG|||||||NEGATIVE||DAMOL/L||||HIGH|NOT DONE||||CALCULUS|NON-HEMOLYZED|Y|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|Y|||NA|5||7||INDUCTION TREATMENT|1960-08-26|1964-05-12|||||1961-10-26||1965-05-27|N|1972-10-05
TRIAL STUDY 134XCP|LB|E1305E4E-DF64-4FD1-B0B2-131459AB629D|2||||FLUIDOUT|FLUID OUTPUT|||||||NG|||||||NEGATIVE||MCI/KG||||NORMAL|NOT DONE||||EXUDATE|UNEXPECTED ODOR|Y|PALM METHOD|CKD-EPI FORMULA||U|N|N|NA|||U|5||7||CONTINUATION TREATMENT|1964-11-21|1963-05-11|||||1960-06-27||1961-06-15|Y|1963-11-03
TRIAL STUDY 134XCP|LB|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|1||||NCCPTN|NOCICEPTIN|||||||BOWL|||||||NEGATIVE||UMOL/KG/MIN||||ABNORMAL|NOT DONE||||PUS|THAWED|Y|SPECTROPHOTOMETRY|GMI % FORMULA||N|U|U|N|||U|1||38||CONTINUATION TREATMENT|1964-04-08|1973-04-27|||||1967-03-29||1966-03-12|Y|1966-04-14
TRIAL STUDY 134XCP|LB|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|2||||GLOBB1|BETA-1 GLOBULIN|||||||NMOL/MOL|||||||POSITIVE||/4.0 ML||||LOW|NOT DONE||||VITREOUS HUMOR|AGGLUTINATED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|FIBROSIS 4 FORMULA||U|NA|NA|NA|||Y|1||38||SCREENING|1972-10-10|1963-08-02|||||1969-04-23||1972-03-08|U|1968-02-24
TRIAL STUDY 134XCP|LB|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|1||||HLAIIPRA|HLA CLASS II PANEL REACTIVE ANTIBODY|||||||MU|||||||POSITIVE||ML/G/MIN||||NORMAL|NOT DONE||||BUFFY COAT|AGGLUTINATED|U|CLOT DETECTION|CKD-EPI CYSTATIN C FORMULA||U|N|N|NA|||Y|2||58||OBSERVATION|1961-12-19|1965-08-01|||||1967-05-05||1971-05-30|U|1960-02-07
TRIAL STUDY 134XCP|LB|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|2||||PLSMCECE|MATURE PLASMA CELLS/TOTAL CELLS|||||||U/M2/DAY|||||||POSITIVE||10^3 RNA COPIES/ML||||LOW|NOT DONE||||BUFFY COAT|CONCENTRATED|U|TEMPLATE INCISION METHOD|GMI MMOL/MOL FORMULA||NA|Y|NA|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1967-06-19|1968-10-17|||||1971-03-17||1968-01-13|NA|1971-08-11
TRIAL STUDY 134XCP|LB|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|1||||HEMOLYSI|HEMOLYTIC INDEX|||||||UMOL/L|||||||INVALID||GBQ||||HIGH|NOT DONE||||COLOSTRUM|DRIED|U|PHOROPTER|ASH FIBROSURE FORMULA||NA|Y|N|Y|||Y|3||39||OPEN LABEL TREATMENT|1961-01-11|1962-12-22|||||1973-04-20||1966-12-25|NA|1965-02-22
TRIAL STUDY 134XCP|LB|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|2||||EOS|EOSINOPHILS|||||||KM|||||||INDETERMINATE||FRAMES/S||||ABNORMAL|NOT DONE||||DISCHARGE|NON-HEMOLYZED|U|ULTRASOUND|MDRD 4 VARIABLE FORMULA||N|NA|N|NA|||Y|3||39||SCREENING|1962-03-09|1973-08-17|||||1972-06-29||1967-06-21|Y|1964-09-07
TRIAL STUDY 134XCP|LB|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|1||||C165928|INDUSTRIAL MIX IGE AB RAST SCORE|||||||DB|||||||INVALID||KM/H||||HIGH|NOT DONE||||MECONIUM|DRIED|Y|MICRO BROTH DILUTION|MDRD 6 VARIABLE FORMULA||Y|U|U|NA|||NA|4||88||OBSERVATION|1963-12-02|1963-09-27|||||1965-03-26||1962-01-18|Y|1964-09-05
TRIAL STUDY 134XCP|LB|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|2||||MACROCY|MACROCYTES|||||||10^3 ORGANISMS/G|||||||TRACE||MG/G/H||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|FRESH|NA|IMMUNOFIXATION ELECTROPHORESIS|FIBROMETER FORMULA||Y|Y|Y|Y|||U|4||88||WASHOUT|1966-04-19|1970-01-18|||||1960-01-01||1973-03-17|U|1969-02-08
TRIAL STUDY 134XCP|LB|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|1||||LKM1IAAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGA AB|||||||ML/MIN/MMHG|||||||BORDERLINE||MMHG||||NORMAL|NOT DONE||||CAPILLARY PLASMA|CALCIFIED|N|MANUAL COUNT|HEPASCORE FORMULA||N|Y|N|N|||N|5||7||INDUCTION TREATMENT|1967-06-21|1970-09-16|||||1967-01-04||1960-04-21|NA|1962-10-22
TRIAL STUDY 134XCP|LB|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|2||||ACHRAB|ACETYLCHOLINE RECEPTOR ANTIBODY|||||||BOX|||||||POSITIVE||MCI||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|GELLED|N|FLUORESCENCE ANGIOGRAPHY|MDRD ENZYMATIC FORMULA||NA|U|N|NA|||Y|5||7||TREATMENT|1966-08-17|1966-04-30|||||1963-07-19||1962-06-12|Y|1969-03-04
TRIAL STUDY 134XCP|LB|0FD7F837-3D76-4A1C-B414-373B55A39506|1||||ASTAG|ASPARTATE AMINOTRANSFERASE ANTIGEN|||||||SCM|||||||POSITIVE||DEG2||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|UNEXPECTED ODOR|Y|LIQUID SCINTILLATION COUNTING|MDRD ENZYMATIC FORMULA||Y|Y|U|N|||U|1||38||INDUCTION TREATMENT|1960-03-16|1970-09-14|||||1969-10-21||1969-02-07|NA|1960-04-17
TRIAL STUDY 134XCP|LB|0FD7F837-3D76-4A1C-B414-373B55A39506|2||||C130119|DAIRY MIX ANTIGEN IGG ANTIBODY|||||||YEARS|||||||INDETERMINATE||ML/S/M2||||HIGH|NOT DONE||||MUSCLE TISSUE|CONCENTRATED|U|KINETIC MICROPARTICLE IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|U|Y|||NA|1||38||BLINDED TREATMENT|1965-10-06|1962-08-05|||||1968-12-06||1962-06-02|N|1973-04-03
TRIAL STUDY 134XCP|LB|0FD7F837-3D76-4A1C-B414-373B55A39506|1||||IL18BP|INTERLEUKIN 18 BINDING PROTEIN|||||||IU/KG|||||||POSITIVE||IU/DAY||||ABNORMAL|NOT DONE||||LYMPH|HEMOLYZED|NA|U-HPLC/MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|Y|N|||NA|2||58||RUN-IN|1965-12-26|1965-08-18|||||1971-04-25||1970-04-16|Y|1969-09-03
TRIAL STUDY 134XCP|LB|0FD7F837-3D76-4A1C-B414-373B55A39506|2||||NEUTLS|LEFT SHIFT NEUTROPHILS|||||||PFU/DOSE|||||||NEGATIVE||U/G/MIN||||HIGH|NOT DONE||||ERYTHROCYTES|CALCIFIED|NA|REFLECTANCE SPECTROSCOPY|MDRD FORMULA||N|N|NA|U|||Y|2||58||INDUCTION TREATMENT|1961-11-22|1973-06-16|||||1960-06-27||1972-05-30|Y|1963-03-05
TRIAL STUDY 134XCP|LB|0FD7F837-3D76-4A1C-B414-373B55A39506|1||||NTELOCRT|N-TELOPEPTIDE/CREATININE|||||||LX|||||||INDETERMINATE||FMOL/L||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|DRIED|Y|SXA SCAN|NASH FIBROSURE FORMULA||U|U|Y|U|||NA|3||39||INDUCTION TREATMENT|1967-08-20|1967-10-27|||||1968-11-04||1965-01-16|Y|1962-01-04
TRIAL STUDY 134XCP|LB|0FD7F837-3D76-4A1C-B414-373B55A39506|2||||SSTR2|SOMATOSTATIN RECEPTOR TYPE 2|||||||MM/H|||||||INDETERMINATE||10^7 CFU||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|FRESH|NA|OPTICAL COHERENCE TOMOGRAPHY|COCKCROFT-GAULT FORMULA||NA|Y|N|N|||Y|3||39||BLINDED TREATMENT|1973-03-04|1967-09-09|||||1968-01-24||1968-12-09|NA|1964-04-28
TRIAL STUDY 134XCP|LB|0FD7F837-3D76-4A1C-B414-373B55A39506|1||||LIPID|LIPID|||||||MS2|||||||BORDERLINE||G/KG/DAY||||ABNORMAL|NOT DONE||||BLOOD|REFRIGERATED|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD FORMULA||Y|N|U|U|||N|4||88||SCREENING|1973-09-08|1971-04-29|||||1962-10-18||1970-06-18|Y|1969-06-06
TRIAL STUDY 134XCP|LB|0FD7F837-3D76-4A1C-B414-373B55A39506|2||||HLAAMSC|HLA-A MISMATCH COUNT|||||||ML/ANIMAL/WK|||||||TRACE||MM/SEC||||ABNORMAL|NOT DONE||||CORD SERUM|LACTESCENT|U|FUNDUS PHOTOGRAPHY|CKD-EPI FORMULA||U|U|U|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1971-02-04|1967-04-23|||||1965-04-09||1972-05-25|NA|1963-04-07
TRIAL STUDY 134XCP|LB|0FD7F837-3D76-4A1C-B414-373B55A39506|1||||CCL18|CHEMOKINE (C-C MOTIF) LIGAND 18|||||||VG/DOSE|||||||POSITIVE||QUANTITY SUFFICIENT||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|AGGLUTINATED|NA|ANTIBIOTIC AGAR SCREEN|GMI % FORMULA||N|N|U|N|||N|5||7||FOLLOW-UP|1970-08-10|1966-07-03|||||1969-05-02||1965-09-07|NA|1972-02-03
TRIAL STUDY 134XCP|LB|0FD7F837-3D76-4A1C-B414-373B55A39506|2||||MPXI|MYELOPEROXIDASE INDEX|||||||NSEC|||||||NEGATIVE||/VF||||LOW|NOT DONE||||URINE SEDIMENT|REFRIGERATED|NA|GC/MS-CI|ASH FIBROSURE FORMULA||U|U|N|Y|||Y|5||7||LONG-TERM FOLLOW-UP|1962-08-30|1961-01-29|||||1971-09-15||1967-11-28|U|1964-02-08
TRIAL STUDY 134XCP|LB|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|1||||CRH|CORTICOTROPIN RELEASING HORMONE|||||||VIRTUAL PIXEL|||||||POSITIVE||10^5/HPF||||LOW|NOT DONE||||URINE SEDIMENT|LACTESCENT|Y|IHC|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|NA|Y|||NA|1||38||OPEN LABEL TREATMENT|1963-03-13|1969-07-03|||||1972-05-26||1969-11-06|U|1967-04-14
TRIAL STUDY 134XCP|LB|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|2||||C147283|WHITE ELM POLLEN IGG ANTIBODY|||||||10^3 COPIES/ML|||||||INVALID||KG/CM2||||LOW|NOT DONE||||MECONIUM|PARAFFIN-EMBEDDED|NA|ISHIHARA COLOR PLATES|HEPASCORE FORMULA||U|Y|NA|U|||N|1||38||RUN-IN|1963-03-24|1969-11-01|||||1965-08-10||1969-11-17|U|1962-12-30
TRIAL STUDY 134XCP|LB|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|1||||ERCECE|ERYTHROID CELLS/TOTAL CELLS|||||||MHZ|||||||NEGATIVE||BQ/KG||||LOW|NOT DONE||||URINE SEDIMENT|FRESH|Y|SURFACE PLASMON RESONANCE|CKD-EPI CYSTATIN C FORMULA||N|NA|NA|U|||N|2||58||INDUCTION TREATMENT|1971-01-06|1970-03-24|||||1972-01-09||1969-01-03|NA|1967-03-27
TRIAL STUDY 134XCP|LB|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|2||||MYPC|MYELOID PROGENITOR CELLS|||||||UG/M2|||||||NEGATIVE||NM||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|CONCENTRATED|N|MICROBIAL CULTURE, LIQUID|FIBROMETER FORMULA||NA|U|NA|NA|||U|2||58||OBSERVATION|1969-01-13|1970-12-13|||||1962-09-17||1972-02-01|U|1972-09-21
TRIAL STUDY 134XCP|LB|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|1||||CORCREAT|CORTISOL/CREATININE|||||||CI/ML|||||||POSITIVE||/2500 WBC||||LOW|NOT DONE||||CORD BLOOD|CONTAMINATED|NA|ELISA|GMI MMOL/MOL FORMULA||N|N|NA|N|||U|3||39||TREATMENT|1968-05-29|1964-01-24|||||1961-08-23||1972-09-03|Y|1970-03-20
TRIAL STUDY 134XCP|LB|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|2||||MPXI|MYELOPEROXIDASE INDEX|||||||IN|||||||TRACE||USEC||||HIGH|NOT DONE||||INTERSTITIAL FLUID|REFRIGERATED|N|CONFOCAL MICROSCOPY|MDRD FORMULA||U|N|U|N|||U|3||39||BASELINE|1960-11-27|1966-07-16|||||1965-06-13||1962-06-05|U|1962-01-07
TRIAL STUDY 134XCP|LB|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|1||||C165930|SHELLFISH MIX IGE AB RAST SCORE|||||||10^3 ORGANISMS/ML|||||||NEGATIVE||BEL||||LOW|NOT DONE||||EXPIRED AIR|NON-HEMOLYZED|N|IRON HEMATOXYLIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|U|N|||NA|4||88||OBSERVATION|1963-02-02|1969-03-20|||||1965-02-15||1973-01-06|U|1965-11-30
TRIAL STUDY 134XCP|LB|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|2||||PHOS|PHOSPHATE|||||||/WK|||||||BORDERLINE||MMOL/DAY||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|AGGLUTINATED|NA|IMPULSE OSCILLOMETRY|FIBROTEST FORMULA||NA|Y|NA|NA|||N|4||88||SCREENING|1962-12-06|1968-08-05|||||1970-06-02||1967-06-05|Y|1971-01-06
TRIAL STUDY 134XCP|LB|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|1||||ALTAST|ALT/AST|||||||ML/S|||||||POSITIVE||F||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|FRESH|N|IMMUNORADIOMETRIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|NA|||NA|5||7||TREATMENT|1961-06-04|1971-10-08|||||1963-06-03||1968-04-05|N|1970-05-02
TRIAL STUDY 134XCP|LB|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|2||||PROMYCE|PROMYELOCYTES/TOTAL CELLS|||||||RFU|||||||INVALID||UG/DAY||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|AUTOLYZED|U|LYMPHANGIOGRAPHY|GMI MMOL/MOL FORMULA||Y|NA|Y|N|||NA|5||7||BASELINE|1971-05-31|1962-10-27|||||1966-06-04||1971-08-21|NA|1970-09-25
TRIAL STUDY 134XCP|LB|92FB0125-67D2-41CC-9116-8C949F15614A|1||||C130088|TIMOTHY GRASS POLLEN IGE|||||||V|||||||TRACE||EID 50/DOSE||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|NA|FLUORESCENT ENZYME IMMUNOASSAY|NASH FIBROSURE FORMULA||U|Y|N|NA|||U|1||38||WASHOUT|1961-08-23|1963-09-13|||||1968-04-03||1969-11-03|U|1963-06-09
TRIAL STUDY 134XCP|LB|92FB0125-67D2-41CC-9116-8C949F15614A|2||||CORTISOL|CORTISOL|||||||ML/S/M2|||||||TRACE||/MBP||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|CONCENTRATED|Y|REVERSE TRANSCRIPTASE PCR|COCKCROFT-GAULT FORMULA||NA|NA|U|Y|||U|1||38||CONTINUATION TREATMENT|1964-09-01|1963-03-22|||||1965-12-02||1966-06-12|NA|1962-02-14
TRIAL STUDY 134XCP|LB|92FB0125-67D2-41CC-9116-8C949F15614A|1||||THYAB|THYROID ANTIBODIES|||||||USEC|||||||INDETERMINATE||KPA/L/SEC||||HIGH|NOT DONE||||INFRANATANT, PLASMA|DRIED|N|DOPPLER ULTRASOUND|FIBROTEST FORMULA||N|NA|NA|N|||Y|2||58||CONTINUATION TREATMENT|1972-04-06|1960-05-12|||||1970-04-30||1972-07-23|N|1971-03-05
TRIAL STUDY 134XCP|LB|92FB0125-67D2-41CC-9116-8C949F15614A|2||||VITB5|VITAMIN B5|||||||MEQ/G|||||||POSITIVE||UG/M2/MIN||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|THAWED|Y|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI FORMULA||Y|NA|N|U|||N|2||58||SCREENING|1963-05-05|1964-01-26|||||1964-01-08||1962-04-28|U|1971-09-08
TRIAL STUDY 134XCP|LB|92FB0125-67D2-41CC-9116-8C949F15614A|1||||IGG3|IMMUNOGLOBULIN G SUBCLASS 3|||||||BEATS/MIN|||||||INVALID||PPB||||LOW|NOT DONE||||INFRANATANT, SERUM|ICTERIC|U|BIOPSY|MDRD FORMULA||NA|U|U|N|||Y|3||39||RUN-IN|1967-04-09|1967-06-08|||||1966-10-15||1964-04-20|N|1963-08-28
TRIAL STUDY 134XCP|LB|92FB0125-67D2-41CC-9116-8C949F15614A|2||||TURB|TURBIDITY|||||||G/DL|||||||INDETERMINATE||UG/KG/DAY||||ABNORMAL|NOT DONE||||LYSATE|HEMOLYZED|N|GC/MS-EI|GMI MMOL/MOL FORMULA||N|N|U|U|||Y|3||39||OBSERVATION|1969-03-27|1961-06-27|||||1970-05-24||1969-01-06|NA|1972-11-05
TRIAL STUDY 134XCP|LB|92FB0125-67D2-41CC-9116-8C949F15614A|1||||CTC|CIRCULATING TUMOR CELLS|||||||NL|||||||INDETERMINATE||UKAT||||HIGH|NOT DONE||||SMEGMA|PARAFFIN-EMBEDDED|NA|MULTIPLE BREATH WASHOUT|MDRD 4 VARIABLE FORMULA||NA|N|NA|N|||N|4||88||RUN-IN|1964-12-07|1969-11-30|||||1968-11-30||1964-12-07|NA|1962-06-27
TRIAL STUDY 134XCP|LB|92FB0125-67D2-41CC-9116-8C949F15614A|2||||CSFIGIDX|CSF IGG INDEX|||||||10^3 ORGANISMS/ML|||||||NEGATIVE||MET||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|PARAFFIN-EMBEDDED|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|GMI % FORMULA||Y|Y|Y|Y|||U|4||88||RUN-IN|1970-12-26|1961-05-06|||||1966-08-01||1968-06-09|U|1968-04-28
TRIAL STUDY 134XCP|LB|92FB0125-67D2-41CC-9116-8C949F15614A|1||||APOJCRT|APOLIPOPROTEIN J/CREATININE|||||||LOG EID 50/DOSE|||||||INVALID||H/WK||||ABNORMAL|NOT DONE||||FLUID|UNEXPECTED ODOR|N|TRIPLE-PHASE SPIRAL CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|N|U|||U|5||7||FOLLOW-UP|1960-07-02|1967-10-31|||||1969-02-23||1960-02-15|U|1964-04-06
TRIAL STUDY 134XCP|LB|92FB0125-67D2-41CC-9116-8C949F15614A|2||||CBA|COMPLEMENT BA|||||||INHALATION|||||||BORDERLINE||ML/M2/DAY||||LOW|NOT DONE||||INFRANATANT, SERUM|FRESH|NA|ENZYMATIC SPECTROPHOTOMETRY|GMI % FORMULA||Y|Y|U|U|||Y|5||7||BLINDED TREATMENT|1971-09-23|1963-03-22|||||1971-01-22||1962-09-08|N|1968-10-19
TRIAL STUDY 134XCP|LB|7042617F-0C29-4928-B3ED-9549A53BC195|1||||INTLK15|INTERLEUKIN 15|||||||PPTH|||||||BORDERLINE||ML/MIN/MMHG||||ABNORMAL|NOT DONE||||STOOL|FRESH|U|STATIC PERIMETRY|COCKCROFT-GAULT FORMULA||U|NA|U|Y|||N|1||38||OPEN LABEL TREATMENT|1965-10-25|1961-12-18|||||1960-03-17||1960-12-21|NA|1967-09-17
TRIAL STUDY 134XCP|LB|7042617F-0C29-4928-B3ED-9549A53BC195|2||||HALLUC|HALLUCINOGEN|||||||MM/MIN|||||||INVALID||UG/G/H||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|DRIED|N|FARR ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|Y|N|||N|1||38||TREATMENT|1968-05-13|1973-02-26|||||1962-07-18||1963-02-27|N|1965-09-08
TRIAL STUDY 134XCP|LB|7042617F-0C29-4928-B3ED-9549A53BC195|1||||GHRELINA|ACTIVE GHRELIN|||||||U/KG|||||||POSITIVE||DPM||||ABNORMAL|NOT DONE||||TUMOR TISSUE|REFRIGERATED|NA|AUSCULTATION|HEPASCORE FORMULA||N|Y|Y|U|||U|2||58||LONG-TERM FOLLOW-UP|1970-02-16|1968-07-22|||||1970-10-31||1963-04-29|U|1970-08-11
TRIAL STUDY 134XCP|LB|7042617F-0C29-4928-B3ED-9549A53BC195|2||||CHOLCM|CHOLATE COMPOUNDS|||||||10^7 TCID 50/DOSE|||||||TRACE||LOG10 CFU/G||||HIGH|NOT DONE||||SEMEN|CALCIFIED|NA|MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|N|U|||Y|2||58||RUN-IN|1970-12-24|1973-04-01|||||1972-02-24||1971-12-12|NA|1969-01-22
TRIAL STUDY 134XCP|LB|7042617F-0C29-4928-B3ED-9549A53BC195|1||||CRTCLRE|CREATININE CLEARANCE, ESTIMATED|||||||/CMH2O|||||||POSITIVE||UMOL/DL||||HIGH|NOT DONE||||EPIDERMAL TISSUE|THAWED|Y|NEPHELOMETRY|GMI % FORMULA||U|NA|Y|Y|||U|3||39||OPEN LABEL TREATMENT|1973-05-02|1970-06-06|||||1964-04-29||1964-08-27|U|1972-04-16
TRIAL STUDY 134XCP|LB|7042617F-0C29-4928-B3ED-9549A53BC195|2||||PCNAG|PROLIFERATING CELL NUCLEAR ANTIGEN|||||||G/ANIMAL|||||||INVALID||PPM||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED|N|TRANSVAGINAL ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|U|U|||Y|3||39||RUN-IN|1969-12-08|1972-06-29|||||1964-11-29||1968-06-08|N|1966-11-28
TRIAL STUDY 134XCP|LB|7042617F-0C29-4928-B3ED-9549A53BC195|1||||PLSPCE|PRECURSOR PLASMA CELLS|||||||MN|||||||BORDERLINE||LOG10 TCID 50/UL||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|ICTERIC|U|IMMUNO-PET SCAN|CKD-EPI CREATININE FORMULA||NA|Y|NA|Y|||U|4||88||LONG-TERM FOLLOW-UP|1968-07-22|1966-06-14|||||1963-06-16||1960-05-23|NA|1966-06-22
TRIAL STUDY 134XCP|LB|7042617F-0C29-4928-B3ED-9549A53BC195|2||||NAK|SODIUM/POTASSIUM|||||||ML/CAGE/WK|||||||NEGATIVE||LINEAR FT*LB||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CONCENTRATED|Y|DNA MICROARRAY|ASH FIBROSURE FORMULA||U|N|NA|N|||N|4||88||OPEN LABEL TREATMENT|1971-05-10|1966-04-19|||||1972-06-23||1964-03-01|Y|1969-07-15
TRIAL STUDY 134XCP|LB|7042617F-0C29-4928-B3ED-9549A53BC195|1||||HIST4AB|HISTONE 4 ANTIBODY|||||||VP/DOSE|||||||BORDERLINE||PFU||||HIGH|NOT DONE||||CALCULUS|THAWED|N|CHROMATOGRAPHY|MDRD 4 VARIABLE FORMULA||U|N|U|N|||U|5||7||FOLLOW-UP|1970-03-15|1966-04-20|||||1960-02-05||1967-05-04|N|1972-10-22
TRIAL STUDY 134XCP|LB|7042617F-0C29-4928-B3ED-9549A53BC195|2||||APOA1|APOLIPOPROTEIN A1|||||||MASK|||||||POSITIVE||UGEQ||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|CONCENTRATED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|NA|||NA|5||7||OPEN LABEL TREATMENT|1966-09-28|1969-03-21|||||1972-05-07||1966-07-01|Y|1962-01-24
TRIAL STUDY 134XCP|LB|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|1||||LIPASEG|LIPASE, GASTRIC|||||||ML/CAGE|||||||INVALID||VP/DOSE||||NORMAL|NOT DONE||||BONE|HEMOLYZED|NA|PET SCAN|GMI % FORMULA||Y|N|U|Y|||NA|1||38||BASELINE|1965-05-22|1960-04-30|||||1962-11-04||1967-11-27|N|1968-04-25
TRIAL STUDY 134XCP|LB|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|2||||ERCECE|ERYTHROID CELLS/TOTAL CELLS|||||||UG/M2/DAY|||||||NEGATIVE||/DAY||||HIGH|NOT DONE||||ADIPOSE TISSUE|REFRIGERATED|NA|THIN SMEAR|MDRD 6 VARIABLE FORMULA||NA|Y|NA|N|||N|1||38||BLINDED TREATMENT|1969-06-25|1969-02-08|||||1969-12-29||1972-09-11|Y|1962-03-10
TRIAL STUDY 134XCP|LB|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|1||||BNPPRO|PROB-TYPE NATRIURETIC PEPTIDE|||||||/500 WBC|||||||NEGATIVE||SFC/10^6 PBMC||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|SOLIDIFIED|NA|WESTERGREN|CKD-EPI CREATININE FORMULA||NA|N|NA|NA|||Y|2||58||OPEN LABEL TREATMENT|1970-11-28|1971-04-27|||||1968-05-04||1972-11-06|NA|1961-02-21
TRIAL STUDY 134XCP|LB|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|2||||C4|COMPLEMENT C4|||||||TRANSDUCING UNIT|||||||TRACE||LOG10 TCID 50/UL||||HIGH|NOT DONE||||EPITHELIAL CELL|UNEXPECTED ODOR|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|Y|N|||Y|2||58||OPEN LABEL TREATMENT|1961-11-19|1962-08-19|||||1962-04-04||1967-08-01|Y|1962-08-11
TRIAL STUDY 134XCP|LB|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|1||||LTFAB|LACTOFERRIN ANTIBODY|||||||UKAT|||||||TRACE||UG/G/H||||HIGH|NOT DONE||||CORD BLOOD|SOLIDIFIED|N|COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD 5 VARIABLE FORMULA||N|Y|U|NA|||Y|3||39||BASELINE|1965-10-18|1961-04-06|||||1967-10-12||1969-10-12|U|1967-04-25
TRIAL STUDY 134XCP|LB|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|2||||HIST4AB|HISTONE 4 ANTIBODY|||||||/LSQN|||||||INVALID||EID 50/DOSE||||HIGH|NOT DONE||||PLATELET POOR PLASMA|CONCENTRATED|NA|SANGER SEQUENCING|CKD-EPI FORMULA||NA|Y|U|N|||N|3||39||BLINDED TREATMENT|1963-02-01|1965-02-06|||||1967-12-15||1964-01-10|Y|1968-10-03
TRIAL STUDY 134XCP|LB|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|1||||GSTMU|MU GLUTATHIONE-S-TRANSFERASE|||||||10^6 CFU|||||||INDETERMINATE||BQ/MG||||LOW|NOT DONE||||SUPERNATANT, PLASMA|DRIED|U|MAGNETIC RESONANCE ENTEROGRAPHY|MDRD 4 VARIABLE FORMULA||Y|U|U|U|||U|4||88||CONTINUATION TREATMENT|1964-01-02|1960-04-22|||||1969-10-01||1971-09-11|N|1962-08-25
TRIAL STUDY 134XCP|LB|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|2||||MYBLAT1|TYPE I MYELOBLASTS|||||||MEQ/MMOL|||||||INDETERMINATE||ML||||HIGH|NOT DONE||||SYNOVIAL FLUID|AGGLUTINATED|NA|TRYPAN BLUE STAIN|CKD-EPI FORMULA||NA|Y|Y|N|||N|4||88||BASELINE|1972-05-23|1963-11-05|||||1967-08-20||1963-06-15|N|1963-11-19
TRIAL STUDY 134XCP|LB|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|1||||C130079|SILVER BIRCH POLLEN IGG4|||||||PG/L|||||||POSITIVE||BAR||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|Y|PYROSEQUENCING|MDRD 6 VARIABLE FORMULA||U|Y|U|NA|||NA|5||7||SCREENING|1967-09-22|1968-11-10|||||1967-09-13||1971-05-24|NA|1960-09-25
TRIAL STUDY 134XCP|LB|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|2||||LDLOXAB|OXIDIZED LDL CHOLESTEROL ANTIBODY|||||||BQ/UG|||||||INDETERMINATE||LOG10 ELISA UNIT||||LOW|NOT DONE||||TRANSUDATE|CONCENTRATED|U|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|NA|NA|||Y|5||7||SCREENING|1972-07-08|1962-12-19|||||1961-08-09||1972-03-07|N|1973-05-12
TRIAL STUDY 134XCP|LB|6633CC54-D711-4780-A833-A71756D8B234|1||||RPA1|RENAL PAPILLARY ANTIGEN 1|||||||PA|||||||INDETERMINATE||M3||||NORMAL|NOT DONE||||EMOTIONAL TEAR|CLOTTED|U|ENDPOINT DILUTION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|NA|||N|1||38||FOLLOW-UP|1967-01-01|1966-09-22|||||1966-02-26||1973-02-04|U|1964-08-07
TRIAL STUDY 134XCP|LB|6633CC54-D711-4780-A833-A71756D8B234|2||||IGFBP1|INSULIN-LIKE GROWTH FACTOR BINDING PROT1|||||||MOL/DAY|||||||POSITIVE||KALLIKREIN INHIBITOR UNIT||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FRESH|NA|GC/MS-EI|ASH FIBROSURE FORMULA||NA|U|Y|N|||Y|1||38||BASELINE|1968-06-01|1960-06-22|||||1960-11-28||1971-08-14|Y|1971-06-25
TRIAL STUDY 134XCP|LB|6633CC54-D711-4780-A833-A71756D8B234|1||||IMMGLCFR|IMMUNOGLOBULIN LIGHT CHAINS, FREE|||||||MCI|||||||BORDERLINE||U/M2/H||||NORMAL|NOT DONE||||MUSCLE TISSUE|REFRIGERATED|U|ANTIMICROBIAL COMBINATION TESTING|MDRD ENZYMATIC JAPANESE FORMULA||U|U|NA|Y|||N|2||58||INDUCTION TREATMENT|1967-02-12|1965-11-20|||||1970-12-30||1963-11-11|U|1972-01-14
TRIAL STUDY 134XCP|LB|6633CC54-D711-4780-A833-A71756D8B234|2||||LYMIM|IMMATURE LYMPHOCYTES|||||||UG/G/MIN|||||||INDETERMINATE||STEPS/MIN||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|SOLIDIFIED|U|RULER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA||U|Y|N|U|||U|2||58||OBSERVATION|1961-08-11|1971-04-18|||||1960-11-01||1965-10-06|U|1965-07-11
TRIAL STUDY 134XCP|LB|6633CC54-D711-4780-A833-A71756D8B234|1||||ASSDNA|ANTI-SINGLE STRANDED DNA IGG|||||||POUCH|||||||BORDERLINE||UGEQ/L||||LOW|NOT DONE||||PLASMA|FROZEN|N|MOUSE PROTECTION ASSAY|MDRD 4 VARIABLE FORMULA||NA|Y|NA|U|||U|3||39||TREATMENT|1963-05-17|1968-06-07|||||1963-10-02||1969-05-09|Y|1968-01-04
TRIAL STUDY 134XCP|LB|6633CC54-D711-4780-A833-A71756D8B234|2||||FACTX|FACTOR X|||||||G/CAGE|||||||INDETERMINATE||KM||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONTAMINATED|NA|SLOAN LETTER EYE CHART 100%|CKD-EPI CREATININE FORMULA||U|Y|N|N|||N|3||39||SCREENING|1971-09-02|1967-01-27|||||1964-01-02||1963-11-09|NA|1960-02-10
TRIAL STUDY 134XCP|LB|6633CC54-D711-4780-A833-A71756D8B234|1||||PRORUB|PRORUBRICYTE|||||||ANTI-XA IU/ML|||||||INVALID||MBP||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|GELLED|NA|AUTOREFRACTION|FIBROMETER FORMULA||NA|Y|Y|U|||NA|4||88||SCREENING|1962-09-03|1967-01-15|||||1968-02-06||1970-08-04|Y|1968-04-29
TRIAL STUDY 134XCP|LB|6633CC54-D711-4780-A833-A71756D8B234|2||||CARBXHGB|CARBOXYHEMOGLOBIN|||||||BAR|||||||NEGATIVE||/4.0 ML||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|CALCIFIED|U|IMMUNOPRECIPITATION|HEPASCORE FORMULA||U|N|U|U|||Y|4||88||OPEN LABEL TREATMENT|1961-09-14|1966-10-18|||||1967-01-25||1972-05-26|Y|1972-11-04
TRIAL STUDY 134XCP|LB|6633CC54-D711-4780-A833-A71756D8B234|1||||C165890|TIMOTHY GRASS POLLEN IGE AB RAST SCORE|||||||UMOL/KG/MIN|||||||NEGATIVE||UEQ||||LOW|NOT DONE||||PROSTATIC FLUID|CALCIFIED|NA|CT SCAN WITHOUT CONTRAST|HEPASCORE FORMULA||N|U|N|U|||Y|5||7||WASHOUT|1964-01-23|1963-01-05|||||1960-09-20||1971-01-17|Y|1971-05-08
TRIAL STUDY 134XCP|LB|6633CC54-D711-4780-A833-A71756D8B234|2||||GHBP|GROWTH HORMONE BINDING PROTEIN|||||||STEPS|||||||INVALID||VG/KG||||HIGH|NOT DONE||||CALCULUS|CLOTTED|NA|THICK SMEAR|CKD-EPI CYSTATIN C FORMULA||N|N|U|U|||NA|5||7||OPEN LABEL TREATMENT|1964-04-25|1965-03-16|||||1961-04-17||1970-04-17|N|1973-08-19
TRIAL STUDY 134XCP|LB|84C642FE-6D84-4525-AB1C-15FAF740D63B|1||||ACTH|ADRENOCORTICOTROPIC HORMONE|||||||RATIO|||||||TRACE||NSEC||||HIGH|NOT DONE||||LYSATE|FROZEN|Y|PALM METHOD|COCKCROFT-GAULT FORMULA||N|N|N|Y|||Y|1||38||FOLLOW-UP|1965-03-22|1964-02-03|||||1971-12-07||1965-11-29|NA|1964-10-08
TRIAL STUDY 134XCP|LB|84C642FE-6D84-4525-AB1C-15FAF740D63B|2||||GLUBD13|1,3-BETA-D-GLUCAN|||||||/MM2|||||||POSITIVE||P||||LOW|NOT DONE||||VENOUS CORD BLOOD|LACTESCENT|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|U|U|||Y|1||38||INDUCTION TREATMENT|1969-07-30|1963-02-05|||||1963-12-22||1971-08-24|NA|1968-04-02
TRIAL STUDY 134XCP|LB|84C642FE-6D84-4525-AB1C-15FAF740D63B|1||||NPY|NEUROPEPTIDE Y|||||||CAPSULE|||||||TRACE||CD*S/M2||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|AGGLUTINATED|Y|DUKE INCISION METHOD|CKD-EPI FORMULA||NA|Y|N|Y|||Y|2||58||OBSERVATION|1969-08-11|1960-04-24|||||1961-06-25||1973-08-04|N|1971-12-01
TRIAL STUDY 134XCP|LB|84C642FE-6D84-4525-AB1C-15FAF740D63B|2||||C165889|RUSSIAN THISTLE POLLEN IGE AB RAST SCORE|||||||ML/H|||||||INVALID||AMU||||NORMAL|NOT DONE||||LUNG SURFACTANT|DRIED|N|HPLC-UV|CKD-EPI CYSTATIN C FORMULA||N|N|U|N|||NA|2||58||OBSERVATION|1963-10-22|1964-12-25|||||1971-07-31||1960-01-12|Y|1967-04-29
TRIAL STUDY 134XCP|LB|84C642FE-6D84-4525-AB1C-15FAF740D63B|1||||APOC3|APOLIPOPROTEIN CIII|||||||YD|||||||TRACE||UGEQ||||LOW|NOT DONE||||BILE|ROOM TEMPERATURE|NA|REVERSE TRANSCRIPTASE PCR|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|N|Y|||U|3||39||CONTINUATION TREATMENT|1964-03-30|1971-01-13|||||1962-03-22||1962-02-04|NA|1966-10-04
TRIAL STUDY 134XCP|LB|84C642FE-6D84-4525-AB1C-15FAF740D63B|2||||C130124|CAT DANDER ANTIGEN IGE ANTIBODY|||||||10^9 ORGANISMS/G|||||||TRACE||PA||||NORMAL|NOT DONE||||ABSCESS FLUID|THAWED|N|CONGO RED STAIN|MDRD FORMULA||NA|NA|NA|Y|||Y|3||39||RUN-IN|1970-04-24|1965-02-14|||||1960-08-19||1967-07-13|NA|1966-12-03
TRIAL STUDY 134XCP|LB|84C642FE-6D84-4525-AB1C-15FAF740D63B|1||||HLAIPRA|HLA CLASS I PANEL REACTIVE ANTIBODY|||||||KM/H|||||||TRACE||RPM||||NORMAL|NOT DONE||||TUMOR TISSUE|ICTERIC|U|FARR ASSAY|MDRD 4 VARIABLE FORMULA||N|N|U|NA|||U|4||88||LONG-TERM FOLLOW-UP|1960-01-06|1961-10-28|||||1972-11-19||1966-11-03|N|1973-02-06
TRIAL STUDY 134XCP|LB|84C642FE-6D84-4525-AB1C-15FAF740D63B|2||||AMCRMRNA|AMACR MRNA|||||||UV2|||||||INDETERMINATE||CI/KG||||LOW|NOT DONE||||LEUKOCYTE|CONCENTRATED|NA|MIGET|NASH FIBROSURE FORMULA||Y|Y|NA|NA|||U|4||88||CONTINUATION TREATMENT|1961-03-08|1970-04-20|||||1971-10-18||1968-11-23|N|1971-08-31
TRIAL STUDY 134XCP|LB|84C642FE-6D84-4525-AB1C-15FAF740D63B|1||||MCPROT|MONOCLONAL PROTEIN|||||||UU/DL|||||||NEGATIVE||%||||HIGH|NOT DONE||||BUFFY COAT|ICTERIC|U|BAC ACGH|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|Y|U|||U|5||7||BLINDED TREATMENT|1970-08-13|1964-06-14|||||1960-09-29||1961-05-01|NA|1970-01-24
TRIAL STUDY 134XCP|LB|84C642FE-6D84-4525-AB1C-15FAF740D63B|2||||HGBMHGB|METHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||L/DAY|||||||POSITIVE||BQ/L||||HIGH|NOT DONE||||EXUDATE|AUTOLYZED|Y|ACID FAST STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|Y|Y|||N|5||7||WASHOUT|1968-09-04|1960-12-22|||||1961-05-22||1960-02-04|U|1965-03-28
TRIAL STUDY 134XCP|LB|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|1||||ANISOCHR|ANISOCHROMIA|||||||UMOL/L/MIN|||||||POSITIVE||SV||||HIGH|NOT DONE||||VENOUS CORD BLOOD|THAWED|U|REVERSE TRANSCRIPTASE PCR|ASH FIBROSURE FORMULA||U|N|U|Y|||NA|1||38||INDUCTION TREATMENT|1967-08-25|1965-04-06|||||1965-11-27||1966-09-02|U|1960-03-28
TRIAL STUDY 134XCP|LB|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|2||||APRI|AST TO PLATELET RATIO INDEX|||||||KPA|||||||BORDERLINE||10^3 ORGANISMS/ML||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR|NA|COLORIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|N|||Y|1||38||RUN-IN|1966-06-12|1962-05-01|||||1971-07-25||1961-01-09|NA|1966-09-06
TRIAL STUDY 134XCP|LB|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|1||||APAPCYS|ACETAMINOPHEN-CYSTEINE ADDUCT|||||||MG/KG/H|||||||BORDERLINE||UCI||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|LACTESCENT|U|AUDIOMETRY|MDRD ENZYMATIC FORMULA||Y|N|U|NA|||NA|2||58||TREATMENT|1964-02-19|1963-01-29|||||1966-02-09||1973-04-11|Y|1964-09-10
TRIAL STUDY 134XCP|LB|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|2||||G6PD|GLUCOSE-6-PHOSPHATE DEHYDROGENASE|||||||KBQ/UL|||||||TRACE||KV||||LOW|NOT DONE||||BLOOD|PARAFFIN-EMBEDDED|U|SLOAN LETTER EYE CHART 1.25%|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|U|NA|||U|2||58||BLINDED TREATMENT|1961-12-29|1972-03-09|||||1973-04-01||1961-08-18|Y|1970-08-03
TRIAL STUDY 134XCP|LB|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|1||||PDW|PLATELET DISTRIBUTION WIDTH|||||||FMOL/L|||||||INVALID||IU/MG||||HIGH|NOT DONE||||PLATELET RICH PLASMA|LACTESCENT|U|LINE PROBE ASSAY|MDRD ENZYMATIC FORMULA||Y|NA|N|NA|||N|3||39||FOLLOW-UP|1972-01-28|1960-11-29|||||1960-12-06||1971-07-25|N|1965-01-20
TRIAL STUDY 134XCP|LB|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|2||||VLDLPSZ|VLDL PARTICLE SIZE|||||||/MIN|||||||BORDERLINE||UG/DL||||LOW|NOT DONE||||BILE|FROZEN|NA|TRANSMISSION ELECTRON MICROSCOPY|GMI % FORMULA||NA|NA|U|N|||N|3||39||OPEN LABEL TREATMENT|1965-04-19|1962-07-25|||||1966-07-11||1961-08-16|U|1963-04-27
TRIAL STUDY 134XCP|LB|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|1||||FBNCTPL|FIBRONECTIN, PLASMA|||||||ML/100G/MIN|||||||INVALID||L/S/KPA||||NORMAL|NOT DONE||||URINE|ROOM TEMPERATURE|Y|ACID FAST STAIN|GMI % FORMULA||U|U|N|U|||N|4||88||BASELINE|1960-01-19|1967-08-30|||||1971-03-22||1965-09-19|Y|1972-12-13
TRIAL STUDY 134XCP|LB|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|2||||PEPSNGI|PEPSINOGEN I|||||||VP/DOSE|||||||INVALID||MS/MMHG||||ABNORMAL|NOT DONE||||PERSPIRATION|THAWED|N|OBSERVATION|GMI % FORMULA||N|NA|Y|NA|||Y|4||88||BLINDED TREATMENT|1967-07-09|1964-01-31|||||1964-02-03||1968-08-07|U|1966-05-30
TRIAL STUDY 134XCP|LB|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|1||||TIMP3|TISSUE INHIBITOR OF METALLOPROTEINASE 3|||||||KG/CM|||||||TRACE||MG/KG/MIN||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CLOTTED|NA|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA||U|Y|U|Y|||Y|5||7||SCREENING|1972-07-01|1966-07-24|||||1968-09-17||1961-06-10|Y|1973-03-10
TRIAL STUDY 134XCP|LB|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|2||||SCN|THIOCYANATE|||||||QUANTITY SUFFICIENT|||||||INVALID||KG||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|GELLED|NA|DOPPLER ULTRASOUND|GMI MMOL/MOL FORMULA||U|N|U|NA|||NA|5||7||WASHOUT|1971-09-17|1966-12-05|||||1966-01-30||1961-08-18|N|1963-11-09
TRIAL STUDY 134XCP|LB|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|1||||TROPONT|TROPONIN T|||||||MS/MMHG|||||||BORDERLINE||SQU/ML||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|ICTERIC|NA|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|HEPASCORE FORMULA||NA|NA|U|U|||Y|1||38||OBSERVATION|1968-01-12|1968-03-06|||||1962-10-30||1966-07-21|N|1962-04-26
TRIAL STUDY 134XCP|LB|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|2||||CHLMCRN|CHYLOMICRONS|||||||RPM|||||||INDETERMINATE||MAMP||||NORMAL|NOT DONE||||RETICULOCYTES|CONTAMINATED|Y|FREEZING POINT DEPRESSION|MDRD ENZYMATIC FORMULA||N|NA|Y|N|||Y|1||38||OBSERVATION|1966-08-20|1971-07-22|||||1961-12-05||1965-07-12|NA|1964-12-11
TRIAL STUDY 134XCP|LB|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|1||||HLAA2AB|HLA-A2 ANTIBODY|||||||FRAMES/S|||||||INVALID||CG||||NORMAL|NOT DONE||||VENOUS BLOOD|SOLIDIFIED|U|PET/CT SCAN WITHOUT CONTRAST|HEPASCORE FORMULA||Y|U|N|NA|||U|2||58||SCREENING|1966-03-24|1973-06-14|||||1970-06-02||1961-07-11|Y|1962-03-29
TRIAL STUDY 134XCP|LB|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|2||||CEC|CIRCULATING ENDOTHELIAL CELLS|||||||CMHG|||||||BORDERLINE||/MM2||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|CONCENTRATED|Y|CENTRIFUGATION|NASH FIBROSURE FORMULA||N|N|U|N|||NA|2||58||CONTINUATION TREATMENT|1971-04-07|1969-12-08|||||1973-06-18||1964-04-26|U|1973-04-11
TRIAL STUDY 134XCP|LB|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|1||||EOSB|EOSINOPHILS BAND FORM|||||||CMOL|||||||POSITIVE||MU||||LOW|NOT DONE||||SEMEN|AGGLUTINATED|NA|CHROMATOGRAPHY|CKD-EPI FORMULA||NA|U|Y|NA|||U|3||39||OBSERVATION|1971-12-20|1965-06-21|||||1972-08-02||1964-03-10|NA|1971-03-30
TRIAL STUDY 134XCP|LB|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|2||||ALDSTRN|ALDOSTERONE|||||||OI50|||||||TRACE||MMHG/SEC||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|LIPEMIC|N|REFLECTANCE SPECTROSCOPY|MDRD 5 VARIABLE FORMULA||Y|NA|Y|Y|||NA|3||39||FOLLOW-UP|1963-11-12|1962-05-23|||||1964-04-30||1972-12-12|N|1970-08-07
TRIAL STUDY 134XCP|LB|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|1||||SICAM1|SOLUBLE INTERCELL ADHESION MOLECULE 1|||||||DEG/S|||||||TRACE||UIU/L||||ABNORMAL|NOT DONE||||BILE|AUTOLYZED|NA|X-RAY FLUORESCENCE SPECTROMETRY|CKD-EPI FORMULA||Y|U|U|NA|||U|4||88||FOLLOW-UP|1966-04-17|1967-03-19|||||1973-05-11||1965-09-03|N|1968-10-23
TRIAL STUDY 134XCP|LB|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|2||||FEPI|FRACTIONAL PHOSPHORUS EXCRETION|||||||DPM/100MG|||||||TRACE||MOSM/KG||||HIGH|NOT DONE||||PERITONEAL FLUID|HEMOLYZED|N|DIFFUSION WEIGHTED MRI|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|U|N|||N|4||88||OPEN LABEL TREATMENT|1968-05-21|1971-12-30|||||1963-09-30||1971-03-26|Y|1970-05-14
TRIAL STUDY 134XCP|LB|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|1||||CYTYRO|TYROSINE CRYSTALS|||||||PMOL|||||||NEGATIVE||PIXELS/CM||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|ROOM TEMPERATURE|Y|OPTICAL MAPPING|HEPASCORE FORMULA||Y|U|N|NA|||U|5||7||LONG-TERM FOLLOW-UP|1966-12-15|1962-01-09|||||1970-01-02||1960-08-07|Y|1963-05-28
TRIAL STUDY 134XCP|LB|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|2||||PLAGMCVT|PLATELET AGGREGATION MEAN CURVE TYPE|||||||CAPLET|||||||BORDERLINE||10^3/HPF||||LOW|NOT DONE||||SPERMATOZOON|CALCIFIED|NA|AUDIOMETRY|FIBROSIS 4 FORMULA||NA|U|Y|N|||Y|5||7||BASELINE|1968-06-09|1962-04-18|||||1971-04-26||1972-09-15|N|1971-05-05
TRIAL STUDY 134XCP|LB|A0757669-2DF6-4E78-A021-9C777BEF5697|1||||CHDW|CORPUSCULAR HGB CONC DISTRIBUTION WIDTH|||||||GPL U/ML|||||||BORDERLINE||AMOL||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|DRIED|NA|POPULATION SEQUENCING|FIBROSIS 4 FORMULA||N|NA|NA|Y|||N|1||38||LONG-TERM FOLLOW-UP|1971-12-21|1967-12-01|||||1964-04-21||1973-07-15|U|1971-06-21
TRIAL STUDY 134XCP|LB|A0757669-2DF6-4E78-A021-9C777BEF5697|2||||MMP7|MATRIX METALLOPROTEINASE 7|||||||MPH|||||||POSITIVE||MOL/G||||HIGH|NOT DONE||||STOOL|NON-HEMOLYZED|Y|EIA|MDRD 4 VARIABLE FORMULA||N|Y|NA|U|||Y|1||38||LONG-TERM FOLLOW-UP|1966-10-31|1961-09-27|||||1968-10-22||1961-01-29|NA|1968-05-19
TRIAL STUDY 134XCP|LB|A0757669-2DF6-4E78-A021-9C777BEF5697|1||||C165899|SILVER BIRCH POLLEN IGG AB RAST SCORE|||||||KG/L|||||||TRACE||10^3 COPIES/ML||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|NA|MYELOPEROXIDASE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|Y|||N|2||58||SCREENING|1968-09-29|1969-01-06|||||1966-09-04||1969-10-26|Y|1968-05-13
TRIAL STUDY 134XCP|LB|A0757669-2DF6-4E78-A021-9C777BEF5697|2||||C4A|COMPLEMENT C4A|||||||UM/DAY|||||||INDETERMINATE||AMP||||NORMAL|NOT DONE||||ERYTHROCYTES|CALCIFIED|Y|KARYOTYPING|COCKCROFT-GAULT FORMULA||NA|N|N|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1964-05-03|1963-04-24|||||1969-01-10||1970-04-23|U|1969-09-21
TRIAL STUDY 134XCP|LB|A0757669-2DF6-4E78-A021-9C777BEF5697|1||||INTLK29|INTERLEUKIN 29|||||||UMOL/DL|||||||NEGATIVE||CI/KG||||ABNORMAL|NOT DONE||||BUFFY COAT|REFRIGERATED|NA|FLUORESCENT LIFETIME IMAGING MICROSCOPY|MDRD ENZYMATIC FORMULA||U|U|NA|Y|||Y|3||39||OPEN LABEL TREATMENT|1969-02-22|1968-11-14|||||1967-06-12||1969-10-25|N|1960-08-08
TRIAL STUDY 134XCP|LB|A0757669-2DF6-4E78-A021-9C777BEF5697|2||||CREATEXR|CREATININE EXCRETION RATE|||||||CIGAR|||||||NEGATIVE||L/MIN||||HIGH|NOT DONE||||SWABBED MATERIAL|CONCENTRATED|Y|ULTRASOUND|COCKCROFT-GAULT FORMULA||N|NA|NA|U|||Y|3||39||INDUCTION TREATMENT|1963-04-08|1968-03-20|||||1973-07-28||1960-04-30|U|1962-02-03
TRIAL STUDY 134XCP|LB|A0757669-2DF6-4E78-A021-9C777BEF5697|1||||T4|THYROXINE|||||||G/DAY|||||||POSITIVE||10^11/L||||LOW|NOT DONE||||CERUMEN|REFRIGERATED|N|ELASTOGRAPHY|COCKCROFT-GAULT FORMULA||N|N|N|NA|||NA|4||88||TREATMENT|1963-09-22|1973-05-04|||||1963-07-25||1964-07-19|U|1970-12-09
TRIAL STUDY 134XCP|LB|A0757669-2DF6-4E78-A021-9C777BEF5697|2||||DPPIVA|DIPEPTIDYL PEPTIDASE-4 ACTIVITY|||||||TRANSDUCING UNIT/ML|||||||INVALID||LB||||HIGH|NOT DONE||||CORD BLOOD|CLOTTED|N|DYNAMIC CONTRAST ENHANCED MRI|MDRD 5 VARIABLE FORMULA||Y|NA|NA|U|||NA|4||88||RUN-IN|1972-02-09|1963-03-10|||||1968-01-31||1972-08-20|NA|1962-06-26
TRIAL STUDY 134XCP|LB|A0757669-2DF6-4E78-A021-9C777BEF5697|1||||FAT|FAT|||||||FT2|||||||NEGATIVE||NMOL BCE/L||||LOW|NOT DONE||||MENSTRUAL BLOOD|NON-HEMOLYZED|U|DARK FIELD MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|N|Y|||N|5||7||FOLLOW-UP|1969-08-16|1968-01-16|||||1969-01-24||1972-11-05|Y|1961-04-11
TRIAL STUDY 134XCP|LB|A0757669-2DF6-4E78-A021-9C777BEF5697|2||||TDTAG|TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE AG|||||||10^9/L|||||||POSITIVE||CCID 50/ML||||LOW|NOT DONE||||SPUTUM|SOLIDIFIED|N|IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CREATININE FORMULA||N|U|N|U|||NA|5||7||BLINDED TREATMENT|1972-11-25|1963-11-27|||||1965-07-31||1967-10-19|N|1966-08-01
TRIAL STUDY 134XCP|LB|DAF7255A-888D-43D3-97B8-5E432938747F|1||||LRG1|LEUCINE RICH ALPHA-2-GLYCOPROTEIN 1|||||||ECL UNIT|||||||NEGATIVE||10^5/L||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|AGGLUTINATED|NA|FLUORESCENT MICROSCOPY|GMI MMOL/MOL FORMULA||Y|NA|U|NA|||N|1||38||FOLLOW-UP|1969-11-02|1966-01-09|||||1966-01-18||1966-09-18|U|1962-10-16
TRIAL STUDY 134XCP|LB|DAF7255A-888D-43D3-97B8-5E432938747F|2||||HIST1AB|HISTONE 1 ANTIBODY|||||||CY/CM|||||||BORDERLINE||MG/KG/DOSE||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|LACTESCENT|NA|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|N|N|||U|1||38||INDUCTION TREATMENT|1969-01-09|1965-02-01|||||1971-11-16||1960-02-12|NA|1962-12-12
TRIAL STUDY 134XCP|LB|DAF7255A-888D-43D3-97B8-5E432938747F|1||||FRFEABS|FRACTIONAL IRON ABSORPTION|||||||MMHG*MIN/L|||||||TRACE||10^6/HPF||||NORMAL|NOT DONE||||VENOUS PLASMA|LACTESCENT|NA|SCINTIGRAPHY|MDRD ENZYMATIC FORMULA||Y|NA|NA|U|||U|2||58||LONG-TERM FOLLOW-UP|1963-05-14|1964-08-19|||||1971-02-24||1967-03-07|Y|1965-06-18
TRIAL STUDY 134XCP|LB|DAF7255A-888D-43D3-97B8-5E432938747F|2||||PLG|PLASMINOGEN|||||||KBQ/UL|||||||INDETERMINATE||ML/CAGE/DAY||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|LACTESCENT|Y|WRIGHT-GIEMSA STAIN|MDRD 4 VARIABLE FORMULA||N|N|NA|Y|||N|2||58||SCREENING|1966-12-13|1971-10-18|||||1973-06-03||1960-08-10|NA|1964-07-13
TRIAL STUDY 134XCP|LB|DAF7255A-888D-43D3-97B8-5E432938747F|1||||ANTIDPRS|ANTIDEPRESSANTS|||||||/HPF|||||||INDETERMINATE||UG/CM2||||HIGH|NOT DONE||||CELL PELLET|ICTERIC|U|QUANTITATIVE COMPUTED TOMOGRAPHY|GMI % FORMULA||N|N|Y|NA|||NA|3||39||WASHOUT|1961-10-22|1970-06-22|||||1971-12-26||1960-11-04|Y|1966-09-05
TRIAL STUDY 134XCP|LB|DAF7255A-888D-43D3-97B8-5E432938747F|2||||CALPRO|CALPROTECTIN|||||||KG/MOL|||||||TRACE||G/CAGE/WK||||LOW|NOT DONE||||LEUKOCYTE|GELLED|NA|FUNCTIONAL MRI|MDRD 6 VARIABLE FORMULA||Y|NA|NA|Y|||Y|3||39||CONTINUATION TREATMENT|1970-10-10|1972-11-13|||||1964-01-20||1968-01-02|U|1965-12-16
TRIAL STUDY 134XCP|LB|DAF7255A-888D-43D3-97B8-5E432938747F|1||||NEUTSGLE|NEUTROPHILS, SEGMENTED/LEUKOCYTES|||||||NMOL/G|||||||TRACE||MOL/ML||||HIGH|NOT DONE||||PROSTATIC FLUID|THAWED|NA|CELL BASED BIOASSAY|FIBROMETER FORMULA||NA|U|U|Y|||N|4||88||SCREENING|1972-11-09|1966-08-14|||||1969-01-31||1968-04-30|U|1971-04-03
TRIAL STUDY 134XCP|LB|DAF7255A-888D-43D3-97B8-5E432938747F|2||||C130140|GERMAN COCKROACH ANTIGEN IGE ANTIBODY|||||||NMOL/ML/MIN|||||||TRACE||NGEQ/L||||HIGH|NOT DONE||||FLUID|AUTOLYZED|NA|PHYSICAL EXAMINATION|MDRD ENZYMATIC FORMULA||NA|Y|NA|Y|||N|4||88||BLINDED TREATMENT|1966-02-01|1966-11-09|||||1964-06-11||1968-08-21|N|1967-02-19
TRIAL STUDY 134XCP|LB|DAF7255A-888D-43D3-97B8-5E432938747F|1||||ACYLCAOX|ACYL COENZYME A OXIDASE|||||||MOSM/KG|||||||NEGATIVE||MMOL/MIN/KPA||||ABNORMAL|NOT DONE||||FLUID|CONCENTRATED|Y|SPIRAL CT|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|NA|||Y|5||7||TREATMENT|1964-02-24|1968-07-26|||||1971-04-16||1972-01-05|Y|1962-04-25
TRIAL STUDY 134XCP|LB|DAF7255A-888D-43D3-97B8-5E432938747F|2||||FENA|FRACTIONAL SODIUM EXCRETION|||||||FOZ_BR|||||||TRACE||KG||||LOW|NOT DONE||||SERUM|LACTESCENT|U|INDIA INK STAIN|GMI % FORMULA||N|Y|Y|Y|||NA|5||7||FOLLOW-UP|1968-06-03|1972-08-12|||||1968-10-04||1969-12-28|U|1964-05-06
TRIAL STUDY 134XCP|LB|51989FEC-B63E-4F58-B748-2FF5E73E5D14|1||||EOSPSD|PSEUDO-EOSINOPHILS|||||||FFU|||||||POSITIVE||GY/MIN||||HIGH|NOT DONE||||GASTRIC FLUID|ROOM TEMPERATURE|NA|RAJI CELL EIA|FIBROMETER FORMULA||U|U|U|U|||NA|1||38||RUN-IN|1973-05-31|1968-08-31|||||1971-06-25||1970-02-09|NA|1968-04-09
TRIAL STUDY 134XCP|LB|51989FEC-B63E-4F58-B748-2FF5E73E5D14|2||||LPPLA2|LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2|||||||/H|||||||NEGATIVE||ML/CM3/MIN||||HIGH|NOT DONE||||URINE SEDIMENT|DRIED|Y|FLUORESCENT MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|NA|NA|||NA|1||38||CONTINUATION TREATMENT|1971-06-29|1961-10-24|||||1966-03-11||1971-11-09|Y|1960-10-29
TRIAL STUDY 134XCP|LB|51989FEC-B63E-4F58-B748-2FF5E73E5D14|1||||FGF19|FIBROBLAST GROWTH FACTOR 19|||||||LOG10 CFU/G|||||||BORDERLINE||TORR||||HIGH|NOT DONE||||VENOUS PLASMA|LIPEMIC|U|KINYOUN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|Y|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1960-04-28|1961-12-29|||||1963-06-08||1963-08-10|Y|1964-11-10
TRIAL STUDY 134XCP|LB|51989FEC-B63E-4F58-B748-2FF5E73E5D14|2||||T3FR|TRIIODOTHYRONINE, FREE|||||||PG/L|||||||BORDERLINE||TBSP||||NORMAL|NOT DONE||||SPUTUM|PARAFFIN-EMBEDDED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|N|Y|||NA|2||58||WASHOUT|1961-02-17|1960-07-23|||||1973-06-17||1965-12-10|Y|1963-10-15
TRIAL STUDY 134XCP|LB|51989FEC-B63E-4F58-B748-2FF5E73E5D14|1||||HGBMHGB|METHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||MEQ|||||||INDETERMINATE||ENZYME U/G HB||||ABNORMAL|NOT DONE||||CERUMEN|CONTAMINATED|U|DYNAMIC LIGHT SCATTERING|COCKCROFT-GAULT FORMULA||NA|U|NA|Y|||U|3||39||FOLLOW-UP|1964-09-08|1970-10-07|||||1962-05-22||1960-01-03|Y|1972-02-05
TRIAL STUDY 134XCP|LB|51989FEC-B63E-4F58-B748-2FF5E73E5D14|2||||MENGL|MENINGEAL CELLS|||||||10^9/G|||||||TRACE||MPA||||HIGH|NOT DONE||||SERUM OR PLASMA|CONTAMINATED|N|GRAM STAIN|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|NA|U|||NA|3||39||CONTINUATION TREATMENT|1964-02-11|1964-07-07|||||1970-07-06||1967-01-05|U|1968-01-27
TRIAL STUDY 134XCP|LB|51989FEC-B63E-4F58-B748-2FF5E73E5D14|1||||MLATONIN|MELATONIN|||||||FFU|||||||BORDERLINE||NMOL||||HIGH|NOT DONE||||SUPERNATANT, SERUM|CONTAMINATED|NA|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|FIBROTEST FORMULA||N|N|Y|U|||NA|4||88||BLINDED TREATMENT|1971-12-31|1969-03-30|||||1967-03-02||1966-02-10|U|1966-08-04
TRIAL STUDY 134XCP|LB|51989FEC-B63E-4F58-B748-2FF5E73E5D14|2||||MOCYCE|MONOCYTOID CELLS|||||||UL|||||||INDETERMINATE||CUP||||NORMAL|NOT DONE||||DIALYSIS FLUID|HEMOLYZED|Y|PALM METHOD|GMI % FORMULA||NA|NA|NA|U|||N|4||88||FOLLOW-UP|1963-08-20|1973-05-09|||||1966-11-26||1960-08-26|NA|1961-06-25
TRIAL STUDY 134XCP|LB|51989FEC-B63E-4F58-B748-2FF5E73E5D14|1||||NKCEFUNC|NATURAL KILLER CELL FUNCTION|||||||10^3 ORGANISMS/ML|||||||INVALID||LOG10 PFU/ML||||LOW|NOT DONE||||CALCULUS|AUTOLYZED|U|PULMONARY ANGIOGRAPHY|HEPASCORE FORMULA||Y|N|U|NA|||NA|5||7||FOLLOW-UP|1972-05-11|1968-12-25|||||1963-04-30||1972-12-23|U|1963-10-06
TRIAL STUDY 134XCP|LB|51989FEC-B63E-4F58-B748-2FF5E73E5D14|2||||C130131|DOG DANDER ANTIGEN IGG4 ANTIBODY|||||||MBQ|||||||TRACE||10^10/L||||ABNORMAL|NOT DONE||||CALCULUS|GELLED|Y|VIRUS PLAQUE ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|U|||N|5||7||BASELINE|1972-05-15|1966-08-01|||||1968-04-08||1963-12-27|N|1964-03-24
TRIAL STUDY 134XCP|LB|776299DC-1CD5-448F-82C2-C1659CEE689D|1||||CACR|CALCIUM CORRECTED|||||||UL|||||||NEGATIVE||MG/G/H||||NORMAL|NOT DONE||||AMNIOTIC FLUID|FRESH|U|MACRO BROTH DILUTION|NASH FIBROSURE FORMULA||Y|Y|Y|U|||U|1||38||OBSERVATION|1968-11-17|1973-01-03|||||1960-02-12||1965-01-13|Y|1971-07-16
TRIAL STUDY 134XCP|LB|776299DC-1CD5-448F-82C2-C1659CEE689D|2||||SAMETH|S-ADENOSYLMETHIONINE|||||||ENZYME U|||||||INVALID||GPELISA UNIT/ML||||ABNORMAL|NOT DONE||||TRANSUDATE|DRIED|Y|NEXT GENERATION SEQUENCING|GMI % FORMULA||Y|N|NA|Y|||NA|1||38||BASELINE|1962-04-02|1971-07-23|||||1961-03-28||1971-08-27|Y|1965-03-25
TRIAL STUDY 134XCP|LB|776299DC-1CD5-448F-82C2-C1659CEE689D|1||||IL2R|INTERLEUKIN 2 RECEPTOR|||||||PUFF|||||||INDETERMINATE||TSP||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|UNEXPECTED ODOR|Y|REFLECTANCE SPECTROSCOPY|MDRD FORMULA||NA|N|U|N|||NA|2||58||LONG-TERM FOLLOW-UP|1968-12-27|1971-01-02|||||1970-01-05||1964-06-14|Y|1970-12-08
TRIAL STUDY 134XCP|LB|776299DC-1CD5-448F-82C2-C1659CEE689D|2||||ETPLTR|ETP LAG TIME RELATIVE|||||||VG/ML|||||||TRACE||KM||||LOW|NOT DONE||||DISCHARGE|FRESH|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||N|N|NA|NA|||Y|2||58||INDUCTION TREATMENT|1969-07-26|1970-12-28|||||1962-09-19||1966-12-25|NA|1970-08-31
TRIAL STUDY 134XCP|LB|776299DC-1CD5-448F-82C2-C1659CEE689D|1||||BTLBTL|BUTALBITAL|||||||U/G|||||||TRACE||RFU||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|ICTERIC|U|IMMUNOFIXATION ELECTROPHORESIS|NASH FIBROSURE FORMULA||U|NA|N|U|||U|3||39||LONG-TERM FOLLOW-UP|1960-01-23|1964-04-23|||||1972-01-19||1964-12-14|N|1967-10-23
TRIAL STUDY 134XCP|LB|776299DC-1CD5-448F-82C2-C1659CEE689D|2||||IRF|IMMATURE RETICULOCYTE FRACTION|||||||MBQ|||||||BORDERLINE||ML/MMHG||||HIGH|NOT DONE||||EMOTIONAL TEAR|FRESH|U|ELECTRONEUROGRAPHY|GMI MMOL/MOL FORMULA||Y|U|N|Y|||U|3||39||OBSERVATION|1969-08-04|1961-09-14|||||1969-12-16||1973-05-17|NA|1973-06-19
TRIAL STUDY 134XCP|LB|776299DC-1CD5-448F-82C2-C1659CEE689D|1||||FATACFRU|FREE FATTY ACID, UNSATURATED|||||||MNFI|||||||INDETERMINATE||UMOL/KG/MIN||||HIGH|NOT DONE||||FLUID|UNEXPECTED ODOR|NA|AUTOREFRACTION|FIBROSIS 4 FORMULA||U|Y|N|NA|||N|4||88||OBSERVATION|1968-03-23|1962-06-27|||||1970-08-31||1969-12-24|Y|1973-04-20
TRIAL STUDY 134XCP|LB|776299DC-1CD5-448F-82C2-C1659CEE689D|2||||ESTFR|ESTRADIOL, FREE|||||||UG/ML/H|||||||INVALID||CP||||ABNORMAL|NOT DONE||||HAIR|FRESH|U|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD 4 VARIABLE FORMULA||U|N|N|N|||NA|4||88||INDUCTION TREATMENT|1970-09-06|1965-03-20|||||1966-05-28||1970-11-25|Y|1969-09-10
TRIAL STUDY 134XCP|LB|776299DC-1CD5-448F-82C2-C1659CEE689D|1||||STAT3PS3|PHOSPHORYLATED STAT3/STAT3|||||||PACKET|||||||POSITIVE||YD||||HIGH|NOT DONE||||WHITE MATTER TISSUE|LIPEMIC|Y|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD ENZYMATIC FORMULA||Y|Y|U|N|||Y|5||7||RUN-IN|1968-06-15|1962-07-24|||||1971-05-02||1968-11-13|N|1967-11-18
TRIAL STUDY 134XCP|LB|776299DC-1CD5-448F-82C2-C1659CEE689D|2||||CKMBCK|CREATINE KINASE MB/TOTAL CREATINE KINASE|||||||UG/M2|||||||INVALID||MPL U/ML||||ABNORMAL|NOT DONE||||LYSATE|UNEXPECTED ODOR|Y|COMPLEMENT FIXATION|MDRD FORMULA||U|NA|Y|Y|||U|5||7||TREATMENT|1964-10-03|1972-06-12|||||1966-08-09||1961-07-31|U|1973-01-04
TRIAL STUDY 134XCP|LB|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|1||||LPA|LIPOPROTEIN-A|||||||YEARS|||||||POSITIVE||/7.5 ML||||HIGH|NOT DONE||||BLOOD|CONCENTRATED|U|MS/MS|CKD-EPI CREATININE FORMULA||NA|Y|U|N|||NA|1||38||RUN-IN|1968-11-15|1962-06-09|||||1967-12-12||1972-05-14|U|1961-04-27
TRIAL STUDY 134XCP|LB|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|2||||C130131|DOG DANDER ANTIGEN IGG4 ANTIBODY|||||||NFIU|||||||POSITIVE||MOL/MG||||NORMAL|NOT DONE||||MECONIUM|PARAFFIN-EMBEDDED|NA|MICRODENSITOMETRY|FIBROMETER FORMULA||N|N|U|NA|||U|1||38||TREATMENT|1970-06-26|1971-11-25|||||1970-01-28||1968-07-30|Y|1961-05-15
TRIAL STUDY 134XCP|LB|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|1||||IGE|IMMUNOGLOBULIN E|||||||MG/ML/MIN|||||||INDETERMINATE||TITER||||NORMAL|NOT DONE||||HAIR|LIPEMIC|Y|LC/MS|GMI MMOL/MOL FORMULA||Y|NA|NA|U|||N|2||58||LONG-TERM FOLLOW-UP|1973-04-25|1971-10-29|||||1965-01-06||1966-10-15|N|1969-08-26
TRIAL STUDY 134XCP|LB|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|2||||C147281|EGG WHITE ANTIGEN IGE ANTIBODY|||||||UEQ/L|||||||POSITIVE||CM/MIN||||NORMAL|NOT DONE||||URINE SEDIMENT|AUTOLYZED|Y|MOUSE PROTECTION ASSAY|CKD-EPI FORMULA||N|N|Y|N|||NA|2||58||RUN-IN|1964-09-28|1967-02-14|||||1963-05-02||1965-02-12|Y|1971-08-26
TRIAL STUDY 134XCP|LB|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|1||||MASTCECE|MAST CELLS/TOTAL CELLS|||||||CONTAINER|||||||NEGATIVE||BP||||NORMAL|NOT DONE||||INFRANATANT, SERUM|ROOM TEMPERATURE|NA|CLIP SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|U|NA|||U|3||39||OBSERVATION|1968-04-03|1966-10-05|||||1967-07-12||1960-07-26|NA|1962-10-11
TRIAL STUDY 134XCP|LB|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|2||||C165888|RUSSIAN THISTLE POLLEN IGE ANTIBODY|||||||CI/UL|||||||NEGATIVE||U/ANIMAL||||NORMAL|NOT DONE||||LYMPH|SOLIDIFIED|U|DC SHEATH FLOW|COCKCROFT-GAULT FORMULA||U|U|U|N|||Y|3||39||TREATMENT|1966-12-25|1965-11-08|||||1972-12-13||1970-06-15|Y|1965-10-12
TRIAL STUDY 134XCP|LB|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|1||||C130108|WEED MIX POLLEN ANTIGEN IGA ANTIBODY|||||||UG/KG|||||||NEGATIVE||10^9 ORGANISMS/G||||ABNORMAL|NOT DONE||||SEMEN|AGGLUTINATED|N|ENZYMATIC COLORIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|U|N|||NA|4||88||WASHOUT|1966-03-24|1963-09-18|||||1963-05-08||1970-07-12|N|1965-05-11
TRIAL STUDY 134XCP|LB|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|2||||GLOBB2|BETA-2 GLOBULIN|||||||MG/DL|||||||INDETERMINATE||CCID 50/ML||||HIGH|NOT DONE||||SPUTUM|REFRIGERATED|N|KINYOUN STAIN|MDRD 4 VARIABLE FORMULA||N|Y|Y|Y|||NA|4||88||CONTINUATION TREATMENT|1966-06-07|1966-08-13|||||1970-01-27||1973-03-02|NA|1972-01-03
TRIAL STUDY 134XCP|LB|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|1||||THCCOOH|11-NOR-DELTA9-THC-9-CARBOXYLIC ACID|||||||CG|||||||POSITIVE||RPM||||ABNORMAL|NOT DONE||||MECONIUM|CLOTTED|U|MICROARRAY|FIBROMETER FORMULA||Y|N|U|U|||U|5||7||LONG-TERM FOLLOW-UP|1960-11-01|1966-10-04|||||1960-12-27||1965-10-19|N|1971-11-24
TRIAL STUDY 134XCP|LB|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|2||||ANIONG4|ANION GAP 4|||||||PFU/ML|||||||POSITIVE||MG/DAY||||LOW|NOT DONE||||PLATELET RICH PLASMA|CONCENTRATED|NA|KINYOUN STAIN|MDRD 5 VARIABLE FORMULA||NA|NA|NA|U|||NA|5||7||BLINDED TREATMENT|1960-02-25|1966-09-30|||||1964-08-30||1968-12-13|U|1969-10-04
TRIAL STUDY 134XCP|LB|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|1||||CARNITF|CARNITINE, FREE|||||||/4.0 ML|||||||POSITIVE||10^5/L||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|AUTOLYZED|Y|ACRIDINE ORANGE STAIN|MDRD 5 VARIABLE FORMULA||Y|NA|NA|Y|||Y|1||38||TREATMENT|1969-10-13|1962-10-02|||||1970-02-09||1965-01-12|Y|1964-06-15
TRIAL STUDY 134XCP|LB|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|2||||PRLYMLE|PROLYMPHOCYTES/LEUKOCYTES|||||||GRAVITATIONAL UNIT|||||||TRACE||MG/MOL||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|REFRIGERATED|Y|DIFFUSION WEIGHTED MRI|GMI MMOL/MOL FORMULA||Y|NA|NA|U|||N|1||38||OPEN LABEL TREATMENT|1967-07-28|1971-02-06|||||1967-03-15||1965-07-12|U|1964-06-05
TRIAL STUDY 134XCP|LB|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|1||||NITRITE|NITRITE|||||||MEQ/DL|||||||INVALID||MEQ/L||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|ROOM TEMPERATURE|N|FLAME PHOTOMETRY|MDRD 4 VARIABLE FORMULA||N|U|U|Y|||N|2||58||OBSERVATION|1969-11-10|1960-05-02|||||1961-12-21||1962-10-04|NA|1966-06-18
TRIAL STUDY 134XCP|LB|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|2||||PGD2|PROSTAGLANDIN D2|||||||PA|||||||TRACE||G/U||||HIGH|NOT DONE||||GASTRIC FLUID|LIPEMIC|NA|THIN SMEAR|MDRD FORMULA||N|NA|Y|NA|||Y|2||58||SCREENING|1964-07-29|1963-12-19|||||1967-04-01||1971-04-22|N|1965-10-31
TRIAL STUDY 134XCP|LB|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|1||||ESTFREST|ESTRADIOL, FREE/ESTRADIOL|||||||UG/MIN|||||||INVALID||WEEKS||||NORMAL|NOT DONE||||MECONIUM|NON-HEMOLYZED|N|HANSEL STAIN|MDRD 4 VARIABLE FORMULA||N|NA|Y|Y|||U|3||39||BLINDED TREATMENT|1969-06-25|1960-08-02|||||1970-05-22||1960-09-24|N|1965-09-21
TRIAL STUDY 134XCP|LB|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|2||||CAEXR|CALCIUM EXCRETION RATE|||||||CM/MIN|||||||TRACE||10^6 CFU/ML||||HIGH|NOT DONE||||BREAST MILK|HEMOLYZED|Y|DROPLET DIGITAL PCR|MDRD 5 VARIABLE FORMULA||NA|Y|Y|N|||Y|3||39||OPEN LABEL TREATMENT|1968-08-07|1973-01-25|||||1972-05-16||1963-12-11|U|1961-09-25
TRIAL STUDY 134XCP|LB|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|1||||VITC|VITAMIN C|||||||HOMEOPATHIC DILUTION|||||||INDETERMINATE||NGEQ/L||||LOW|NOT DONE||||PLASMA|CLOTTED|U|INDIA INK STAIN|MDRD 6 VARIABLE FORMULA||Y|Y|N|Y|||Y|4||88||FOLLOW-UP|1962-08-27|1967-02-19|||||1969-03-30||1968-06-08|NA|1968-06-06
TRIAL STUDY 134XCP|LB|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|2||||MACROBLD|MACROSCOPIC BLOOD|||||||G/CAGE|||||||INVALID||DAGU/ML||||HIGH|NOT DONE||||EMOTIONAL TEAR|FRESH|U|FLOCCULATION, CHARCOAL ENHANCED|ASH FIBROSURE FORMULA||N|U|Y|Y|||Y|4||88||BLINDED TREATMENT|1963-04-27|1970-02-18|||||1960-06-11||1967-03-21|N|1966-12-09
TRIAL STUDY 134XCP|LB|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|1||||LYMCLF|LYMPHOCYTES, CLEFTED|||||||PFU|||||||BORDERLINE||UG/M2||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|ROOM TEMPERATURE|Y|MICROBIAL CULTURE, LIQUID|MDRD FORMULA||U|U|Y|N|||NA|5||7||BLINDED TREATMENT|1960-12-16|1971-08-18|||||1973-02-24||1962-11-25|Y|1969-08-10
TRIAL STUDY 134XCP|LB|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|2||||C130123|NUT MIX ANTIGEN IGG ANTIBODY|||||||MG/DOSE|||||||TRACE||/SEC||||HIGH|NOT DONE||||EMESIS|LACTESCENT|N|PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE FORMULA||NA|NA|Y|U|||Y|5||7||TREATMENT|1965-12-21|1966-08-29|||||1970-06-15||1969-09-05|N|1969-07-10
TRIAL STUDY 134XCP|LB|054D4740-C675-4904-B912-B00A0B089F12|1||||BLSTMKCE|MEGAKARYOBLASTS/TOTAL CELLS|||||||MEQ/G|||||||INDETERMINATE||MMAL||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED|Y|FISH|NASH FIBROSURE FORMULA||Y|U|N|U|||NA|1||38||OPEN LABEL TREATMENT|1967-06-29|1972-08-19|||||1962-01-24||1971-06-27|NA|1963-07-16
TRIAL STUDY 134XCP|LB|054D4740-C675-4904-B912-B00A0B089F12|2||||C130069|BERMUDA GRASS POLLEN IGA|||||||10^12 IU/L|||||||BORDERLINE||10^6 ORGANISMS/MG||||LOW|NOT DONE||||SUPERNATANT, PLASMA|ROOM TEMPERATURE|U|MRI|MDRD 6 VARIABLE FORMULA||Y|Y|NA|Y|||NA|1||38||INDUCTION TREATMENT|1968-10-22|1962-12-20|||||1969-04-29||1969-11-10|U|1968-02-26
TRIAL STUDY 134XCP|LB|054D4740-C675-4904-B912-B00A0B089F12|1||||RETI|RETICULOCYTES|||||||PLUG|||||||INVALID||DRINK||||ABNORMAL|NOT DONE||||SEMEN|CLOTTED|Y|FLOW MICROSCOPY|MDRD FORMULA||Y|U|U|Y|||NA|2||58||RUN-IN|1969-09-05|1963-01-10|||||1966-04-15||1973-07-21|Y|1971-02-13
TRIAL STUDY 134XCP|LB|054D4740-C675-4904-B912-B00A0B089F12|2||||ERCEPIDX|ERYTHROID PROLIFERATION INDEX|||||||U.CARR|||||||BORDERLINE||CS||||HIGH|NOT DONE||||ABSCESS FLUID|LIPEMIC|Y|ACCELERATOR MASS SPECTROMETRY|FIBROSIS 4 FORMULA||N|Y|Y|N|||Y|2||58||BASELINE|1962-01-31|1963-03-29|||||1965-03-14||1965-09-17|NA|1968-09-27
TRIAL STUDY 134XCP|LB|054D4740-C675-4904-B912-B00A0B089F12|1||||FLUORIDE|FLUORIDE|||||||/4.0 ML|||||||POSITIVE||WATT||||LOW|NOT DONE||||SALIVA|SOLIDIFIED|Y|EPSILOMETER|MDRD FORMULA||Y|Y|N|N|||Y|3||39||BLINDED TREATMENT|1967-05-14|1965-07-04|||||1972-11-26||1963-02-20|NA|1962-12-15
TRIAL STUDY 134XCP|LB|054D4740-C675-4904-B912-B00A0B089F12|2||||INTLK20|INTERLEUKIN 20|||||||10^3 ORGANISMS|||||||POSITIVE||UL/KG/DAY||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|REFRIGERATED|Y|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|N|U|||N|3||39||CONTINUATION TREATMENT|1967-11-09|1962-10-10|||||1971-06-17||1972-10-28|Y|1971-08-29
TRIAL STUDY 134XCP|LB|054D4740-C675-4904-B912-B00A0B089F12|1||||RETIM|MEDIUM ABSORPTION RETICULOCYTES|||||||DISK|||||||TRACE||10^10/L||||HIGH|NOT DONE||||ERYTHROCYTES|REFRIGERATED|NA|PET/CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|U|NA|||NA|4||88||WASHOUT|1962-06-05|1960-01-26|||||1968-07-26||1960-02-26|U|1973-04-20
TRIAL STUDY 134XCP|LB|054D4740-C675-4904-B912-B00A0B089F12|2||||CYURIAC|URIC ACID CRYSTALS|||||||MG/M2/MIN|||||||NEGATIVE||PKAT/L||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|DRIED|N|ENZYMATIC SPECTROPHOTOMETRY|NASH FIBROSURE FORMULA||U|Y|NA|U|||NA|4||88||BLINDED TREATMENT|1961-11-27|1965-08-14|||||1967-10-23||1965-07-28|U|1969-12-06
TRIAL STUDY 134XCP|LB|054D4740-C675-4904-B912-B00A0B089F12|1||||DENSITY|DENSITY|||||||ML/ANIMAL/WK|||||||POSITIVE||DRINK||||NORMAL|NOT DONE||||SERUM|PARAFFIN-EMBEDDED|Y|MOUSE PROTECTION ASSAY|HEPASCORE FORMULA||Y|Y|NA|N|||NA|5||7||OPEN LABEL TREATMENT|1964-03-08|1961-05-19|||||1973-07-11||1970-12-07|NA|1973-06-07
TRIAL STUDY 134XCP|LB|054D4740-C675-4904-B912-B00A0B089F12|2||||CSWAX|WAXY CASTS|||||||/CMH2O|||||||NEGATIVE||/500 WBC||||LOW|NOT DONE||||RETICULOCYTES|SOLIDIFIED|Y|SLOAN LETTER EYE CHART 2.5%|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|N|||U|5||7||WASHOUT|1969-01-07|1961-05-15|||||1972-01-08||1968-12-31|N|1962-02-22
TRIAL STUDY 134XCP|LB|9548556E-EECF-4460-A7DD-D93F853E9EA8|1||||NORMETA|NORMETANEPHRINE|||||||KUSP|||||||INVALID||UMOL/L/H||||LOW|NOT DONE||||DISCHARGE|FROZEN|N|CALCULATION|COCKCROFT-GAULT FORMULA||NA|Y|U|NA|||N|1||38||RUN-IN|1960-07-08|1968-10-25|||||1970-04-25||1969-12-31|NA|1969-05-26
TRIAL STUDY 134XCP|LB|9548556E-EECF-4460-A7DD-D93F853E9EA8|2||||VITDAT|1, 25-DIHYDROXYVITAMIN D|||||||TUBERCULIN UNIT/ML|||||||BORDERLINE||SUPPOSITORY||||NORMAL|NOT DONE||||SPUTUM|NON-HEMOLYZED|U|GC/FID|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|Y|Y|||N|1||38||FOLLOW-UP|1971-03-23|1966-07-05|||||1960-06-25||1964-07-15|N|1964-12-29
TRIAL STUDY 134XCP|LB|9548556E-EECF-4460-A7DD-D93F853E9EA8|1||||EOSCE|EOSINOPHILS/TOTAL CELLS|||||||ML/MMHG|||||||POSITIVE||10^6 CFU/ML||||NORMAL|NOT DONE||||STOOL|THAWED|U|CONTRAST ENHANCED PET/CT SCAN|CKD-EPI FORMULA||U|N|U|U|||N|2||58||RUN-IN|1964-11-05|1964-07-19|||||1962-09-04||1964-12-18|Y|1971-05-02
TRIAL STUDY 134XCP|LB|9548556E-EECF-4460-A7DD-D93F853E9EA8|2||||PTSAC|PROTEIN S ACTUAL/CONTROL|||||||DAYS/MONTH|||||||POSITIVE||UMOL/H/MMOL||||HIGH|NOT DONE||||SOFT TISSUE|NON-HEMOLYZED|U|ULTRASOUND|CKD-EPI CREATININE FORMULA||N|N|Y|N|||Y|2||58||TREATMENT|1972-05-21|1961-03-21|||||1969-10-05||1971-07-26|NA|1966-09-02
TRIAL STUDY 134XCP|LB|9548556E-EECF-4460-A7DD-D93F853E9EA8|1||||AMYLOIDB|AMYLOID, BETA|||||||G/ANIMAL/WK|||||||INDETERMINATE||MM2||||LOW|NOT DONE||||DERMAL TISSUE|THAWED|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|CKD-EPI CREATININE FORMULA||N|NA|NA|U|||NA|3||39||CONTINUATION TREATMENT|1967-07-31|1961-07-01|||||1961-05-10||1970-01-09|Y|1971-02-10
TRIAL STUDY 134XCP|LB|9548556E-EECF-4460-A7DD-D93F853E9EA8|2||||INTLK2|INTERLEUKIN 2|||||||KPA|||||||TRACE||LOG10 ELISA UNIT/DOSE||||NORMAL|NOT DONE||||EPITHELIAL CELL|AGGLUTINATED|U|COMPLEMENT FIXATION|CKD-EPI CYSTATIN C FORMULA||NA|U|Y|N|||Y|3||39||INDUCTION TREATMENT|1964-01-03|1971-08-13|||||1965-07-01||1963-07-15|Y|1966-07-05
TRIAL STUDY 134XCP|LB|9548556E-EECF-4460-A7DD-D93F853E9EA8|1||||DCA|DEOXYCHOLATE|||||||CM2|||||||NEGATIVE||TITER||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|GELLED|U|DIFFUSION TENSOR MRI|NASH FIBROSURE FORMULA||N|NA|U|NA|||U|4||88||LONG-TERM FOLLOW-UP|1963-12-02|1960-07-25|||||1962-03-12||1964-02-11|Y|1967-11-05
TRIAL STUDY 134XCP|LB|9548556E-EECF-4460-A7DD-D93F853E9EA8|2||||HLADRB1|HLA DR BETA1 ANTIGEN|||||||M|||||||INVALID||10^4 CFU/ML||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|HEMOLYZED|N|HILLMEN COLOR CHART|GMI % FORMULA||NA|U|U|N|||NA|4||88||INDUCTION TREATMENT|1963-11-08|1964-08-05|||||1961-12-04||1967-06-18|Y|1968-02-21
TRIAL STUDY 134XCP|LB|9548556E-EECF-4460-A7DD-D93F853E9EA8|1||||ELA1|PANCREATIC ELASTASE 1|||||||SACHET|||||||POSITIVE||AMPULE||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|NON-HEMOLYZED|NA|PERCUSSION|MDRD FORMULA||Y|U|NA|N|||U|5||7||TREATMENT|1964-04-08|1969-11-23|||||1969-12-13||1966-10-01|U|1971-06-02
TRIAL STUDY 134XCP|LB|9548556E-EECF-4460-A7DD-D93F853E9EA8|2||||GFRE|GLOMERULAR FILTRATION RATE, ESTIMATED|||||||G/KG/DAY|||||||NEGATIVE||ML/G/DAY||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|NON-HEMOLYZED|N|ANALYTICAL ULTRACENTRIFUGATION|HEPASCORE FORMULA||N|NA|Y|Y|||Y|5||7||OBSERVATION|1964-04-06|1965-04-13|||||1969-03-05||1963-11-28|U|1970-08-16
TRIAL STUDY 134XCP|LB|0BCF6152-3718-402C-9333-A3EFBB3086FF|1||||INTLK27|INTERLEUKIN 27|||||||L/KG|||||||POSITIVE||MONTHS||||LOW|NOT DONE||||SUPERNATANT, PLASMA|DRIED|NA|TELLER ACUITY CARDS|FIBROSIS 4 FORMULA||NA|U|NA|NA|||U|1||38||LONG-TERM FOLLOW-UP|1960-04-17|1967-04-16|||||1964-06-10||1967-10-19|Y|1964-02-07
TRIAL STUDY 134XCP|LB|0BCF6152-3718-402C-9333-A3EFBB3086FF|2||||MONOBLLE|MONOBLASTS/LEUKOCYTES|||||||MOSM|||||||BORDERLINE||MG/KG/WEEK||||LOW|NOT DONE||||LYSATE|REFRIGERATED|Y|DUKE INCISION METHOD|MDRD ENZYMATIC FORMULA||N|NA|NA|N|||U|1||38||SCREENING|1972-12-10|1967-12-11|||||1973-05-27||1961-03-14|U|1972-06-09
TRIAL STUDY 134XCP|LB|0BCF6152-3718-402C-9333-A3EFBB3086FF|1||||CELLULAR|CELLULARITY|||||||U/KG/H|||||||TRACE||ML/M2/MIN||||LOW|NOT DONE||||COLOSTRUM|LIPEMIC|U|MICRODENSITOMETRY|MDRD FORMULA||N|Y|N|U|||NA|2||58||CONTINUATION TREATMENT|1972-07-29|1962-05-15|||||1967-02-05||1964-06-18|NA|1973-06-23
TRIAL STUDY 134XCP|LB|0BCF6152-3718-402C-9333-A3EFBB3086FF|2||||LVTRCTM|LEVETIRACETAM|||||||G/DL|||||||NEGATIVE||COPIES/UL||||HIGH|NOT DONE||||INFRANATANT, PLASMA|CALCIFIED|N|GC/MS|HEPASCORE FORMULA||NA|U|U|NA|||U|2||58||SCREENING|1971-03-07|1970-10-05|||||1963-06-26||1968-07-10|NA|1966-02-11
TRIAL STUDY 134XCP|LB|0BCF6152-3718-402C-9333-A3EFBB3086FF|1||||HLADRMSC|HLA-DR MISMATCH COUNT|||||||PIXELS/CM|||||||BORDERLINE||UM2||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|ROOM TEMPERATURE|NA|SISH|HEPASCORE FORMULA||NA|Y|Y|N|||NA|3||39||RUN-IN|1968-05-24|1961-12-12|||||1968-09-26||1967-08-18|Y|1969-01-29
TRIAL STUDY 134XCP|LB|0BCF6152-3718-402C-9333-A3EFBB3086FF|2||||PLSMCE|MATURE PLASMA CELLS|||||||GLOBULE|||||||INDETERMINATE||10^7 TCID 50/DOSE||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|PARAFFIN-EMBEDDED|Y|LIGHT SCATTERING SPECTROSCOPY|MDRD 4 VARIABLE FORMULA||U|N|NA|NA|||Y|3||39||TREATMENT|1968-11-17|1962-07-30|||||1967-09-23||1967-09-07|N|1965-05-02
TRIAL STUDY 134XCP|LB|0BCF6152-3718-402C-9333-A3EFBB3086FF|1||||C130094|WESTERN RAGWEED POLLEN IGG|||||||AFU|||||||TRACE||MOSM/KG||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|UNEXPECTED ODOR|NA|PHASE CONTRAST MICROSCOPY|MDRD 4 VARIABLE FORMULA||U|U|Y|Y|||N|4||88||INDUCTION TREATMENT|1967-06-23|1961-03-23|||||1970-09-16||1971-05-31|NA|1964-03-29
TRIAL STUDY 134XCP|LB|0BCF6152-3718-402C-9333-A3EFBB3086FF|2||||APOA5|APOLIPOPROTEIN A5|||||||DRUM|||||||TRACE||ML/G/DAY||||HIGH|NOT DONE||||DISCHARGE|ICTERIC|NA|TOLUIDINE BLUE STAIN|MDRD 6 VARIABLE FORMULA||Y|U|U|NA|||NA|4||88||RUN-IN|1973-07-05|1972-05-06|||||1970-02-13||1967-01-18|NA|1964-06-23
TRIAL STUDY 134XCP|LB|0BCF6152-3718-402C-9333-A3EFBB3086FF|1||||ALBEXR|ALBUMIN EXCRETION RATE|||||||/10^3|||||||INDETERMINATE||COPIES/UL||||LOW|NOT DONE||||BONE|GELLED|NA|FLOCCULATION|HEPASCORE FORMULA||U|U|U|NA|||N|5||7||LONG-TERM FOLLOW-UP|1961-09-22|1973-04-10|||||1961-04-24||1970-04-18|Y|1961-06-06
TRIAL STUDY 134XCP|LB|0BCF6152-3718-402C-9333-A3EFBB3086FF|2||||LVFBRSC|LIVER FIBROSIS SCORE|||||||K|||||||INDETERMINATE||KS||||NORMAL|NOT DONE||||DISCHARGE|REFRIGERATED|U|RULER MEASUREMENT METHOD|FIBROTEST FORMULA||Y|U|N|NA|||NA|5||7||SCREENING|1963-02-10|1965-09-08|||||1965-11-08||1973-04-29|N|1960-12-01
TRIAL STUDY 134XCP|LB|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|1||||PRAB|PANEL REACTIVE ANTIBODY|||||||MEQ/DL|||||||INVALID||L/L||||HIGH|NOT DONE||||EPITHELIAL CELL|THAWED|NA|TEST STRIP|FIBROSIS 4 FORMULA||NA|U|U|NA|||U|1||38||LONG-TERM FOLLOW-UP|1960-09-22|1971-01-01|||||1960-04-29||1970-12-18|U|1969-07-05
TRIAL STUDY 134XCP|LB|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|2||||C165918|AMERICAN COCKROACH IGG AB RAST SCORE|||||||MM/2H|||||||POSITIVE||WEEKS||||HIGH|NOT DONE||||EPITHELIAL CELL|CONCENTRATED|U|GC/FID|CKD-EPI CYSTATIN C FORMULA||Y|NA|U|Y|||NA|1||38||SCREENING|1966-08-05|1961-01-23|||||1967-09-05||1970-06-28|NA|1970-01-17
TRIAL STUDY 134XCP|LB|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|1||||HLADR52A|HLA-DR52 ANTIBODY|||||||BOWL|||||||INDETERMINATE||G/M2/DAY||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|LACTESCENT|Y|ELASTOGRAPHY|ASH FIBROSURE FORMULA||N|NA|N|U|||U|2||58||TREATMENT|1966-10-29|1964-09-25|||||1973-03-05||1962-02-14|N|1962-03-07
TRIAL STUDY 134XCP|LB|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|2||||RBCNURBC|NUCLEATED ERYTHROCYTES/ERYTHROCYTES|||||||LB|||||||INVALID||ML/DL||||HIGH|NOT DONE||||AQUEOUS HUMOR|FRESH|NA|OLIGO ACGH|MDRD 4 VARIABLE FORMULA||NA|N|U|N|||Y|2||58||LONG-TERM FOLLOW-UP|1972-10-11|1966-08-11|||||1967-09-29||1966-01-03|N|1962-02-07
TRIAL STUDY 134XCP|LB|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|1||||PRORUBCE|PRORUBRICYTE/TOTAL CELLS|||||||PSI|||||||POSITIVE||ENZYME U/L||||NORMAL|NOT DONE||||PLATELET|UNEXPECTED ODOR|U|SPECT/CT SCAN|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|U|||N|3||39||OPEN LABEL TREATMENT|1963-08-28|1968-07-07|||||1971-11-22||1971-07-16|NA|1969-09-22
TRIAL STUDY 134XCP|LB|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|2||||LYMMCELY|LYMPHOMA CELLS/LYMPHOCYTES|||||||LOG10 CCID 50/DOSE|||||||INDETERMINATE||PFU/ANIMAL||||LOW|NOT DONE||||VENOUS CORD BLOOD|AGGLUTINATED|U|INTERRUPTER TECHNIQUE|FIBROMETER FORMULA||N|U|U|NA|||U|3||39||SCREENING|1961-02-12|1961-04-30|||||1966-11-08||1968-09-28|U|1972-08-12
TRIAL STUDY 134XCP|LB|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|1||||MIP1A|MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA|||||||LOG10 PFU/ML|||||||INVALID||NEBULE||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR|Y|FLUORIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|Y|N|||U|4||88||INDUCTION TREATMENT|1961-04-03|1971-10-02|||||1964-06-21||1965-03-31|Y|1963-07-17
TRIAL STUDY 134XCP|LB|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|2||||EOSMM|EOSINOPHILIC METAMYELOCYTES|||||||DPM|||||||BORDERLINE||UG/M2||||HIGH|NOT DONE||||SEMEN|CLOTTED|Y|RAJI CELL EIA|GMI % FORMULA||NA|N|U|N|||N|4||88||SCREENING|1967-10-11|1973-01-27|||||1962-07-13||1961-12-21|N|1963-08-18
TRIAL STUDY 134XCP|LB|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|1||||PRORUBCE|PRORUBRICYTE/TOTAL CELLS|||||||ENZYME U/M2|||||||POSITIVE||DEG/S||||HIGH|NOT DONE||||MUSCLE TISSUE|NON-HEMOLYZED|NA|PHOTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|U|NA|||N|5||7||FOLLOW-UP|1961-03-04|1966-08-11|||||1967-07-10||1963-01-20|NA|1964-03-28
TRIAL STUDY 134XCP|LB|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|2||||ETP|ENDOGENOUS THROMBIN POTENTIAL|||||||/SEC|||||||INVALID||UG/G/DAY||||LOW|NOT DONE||||GASTRIC FLUID|CONTAMINATED|U|REBOUND TONOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|Y|Y|||U|5||7||OBSERVATION|1970-01-18|1967-06-20|||||1970-05-16||1961-07-05|Y|1962-10-26
TRIAL STUDY 134XCP|LB|EED12AC0-1CBD-4D42-8786-91834AB33A46|1||||ANTHRMAG|ANTITHROMBIN ANTIGEN|||||||MBQ|||||||INVALID||MU||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|GELLED|Y|PANENDOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|U|N|||N|1||38||SCREENING|1967-02-19|1963-08-25|||||1971-10-21||1964-12-29|N|1968-08-08
TRIAL STUDY 134XCP|LB|EED12AC0-1CBD-4D42-8786-91834AB33A46|2||||RBP|RETINOL BINDING PROTEIN|||||||10^7 PFU|||||||BORDERLINE||KM||||ABNORMAL|NOT DONE||||STOOL|NON-HEMOLYZED|U|ENZYMATIC ULTRACENTRIFUGATION|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|U|||U|1||38||WASHOUT|1971-08-21|1962-12-30|||||1966-05-24||1967-08-27|U|1965-10-30
TRIAL STUDY 134XCP|LB|EED12AC0-1CBD-4D42-8786-91834AB33A46|1||||C130119|DAIRY MIX ANTIGEN IGG ANTIBODY|||||||KG|||||||NEGATIVE||F||||HIGH|NOT DONE||||HAIR FOLLICLE|CALCIFIED|NA|GC/MS-EI|ASH FIBROSURE FORMULA||U|Y|U|Y|||N|2||58||TREATMENT|1973-07-10|1971-12-16|||||1967-04-12||1969-12-03|U|1973-02-02
TRIAL STUDY 134XCP|LB|EED12AC0-1CBD-4D42-8786-91834AB33A46|2||||RBPCREAT|RETINOL BINDING PROTEIN/CREATININE|||||||NG/L|||||||INVALID||ML/ANIMAL/DAY||||LOW|NOT DONE||||VENOUS CORD BLOOD|CONCENTRATED|U|SLOAN LETTER EYE CHART 2.5%|FIBROSIS 4 FORMULA||U|N|Y|Y|||Y|2||58||FOLLOW-UP|1969-10-08|1965-10-08|||||1960-12-23||1967-12-18|U|1960-02-25
TRIAL STUDY 134XCP|LB|EED12AC0-1CBD-4D42-8786-91834AB33A46|1||||FACTXIA|FACTOR XI ACTIVITY|||||||PA|||||||POSITIVE||G/KG/DAY||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|CONCENTRATED|NA|HILLMEN COLOR CHART|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|NA|||N|3||39||OPEN LABEL TREATMENT|1970-01-29|1969-03-04|||||1972-05-21||1964-11-04|NA|1965-05-17
TRIAL STUDY 134XCP|LB|EED12AC0-1CBD-4D42-8786-91834AB33A46|2||||INTLK22|INTERLEUKIN 22|||||||UMOL|||||||POSITIVE||UMOL/L/SEC||||LOW|NOT DONE||||NAIL|FROZEN|N|ELLA|HEPASCORE FORMULA||U|N|NA|U|||N|3||39||TREATMENT|1960-03-29|1969-01-09|||||1968-06-27||1965-04-21|Y|1968-12-06
TRIAL STUDY 134XCP|LB|EED12AC0-1CBD-4D42-8786-91834AB33A46|1||||BAMBTAC|BETA-AMINOBUTYRIC ACID|||||||/2000 RBC|||||||BORDERLINE||MOL/ML||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|UNEXPECTED ODOR|N|LIQUID SCINTILLATION COUNTING|MDRD 5 VARIABLE FORMULA||N|N|U|NA|||U|4||88||OPEN LABEL TREATMENT|1962-05-11|1968-05-25|||||1966-02-27||1962-01-09|Y|1960-03-05
TRIAL STUDY 134XCP|LB|EED12AC0-1CBD-4D42-8786-91834AB33A46|2||||ADAM8|ADAM METALLOPEPTIDASE DOMAIN 8|||||||DAYS/WK|||||||BORDERLINE||EID 50/DOSE||||HIGH|NOT DONE||||SYNOVIAL FLUID|CALCIFIED|Y|PANENDOSCOPY|NASH FIBROSURE FORMULA||U|N|U|Y|||NA|4||88||SCREENING|1973-01-07|1961-06-20|||||1964-08-23||1965-04-28|U|1971-04-15
TRIAL STUDY 134XCP|LB|EED12AC0-1CBD-4D42-8786-91834AB33A46|1||||THCCOOH|11-NOR-DELTA9-THC-9-CARBOXYLIC ACID|||||||GLOBULE|||||||INVALID||GLOBULE||||NORMAL|NOT DONE||||PLASMA|FRESH|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|N|NA|||Y|5||7||FOLLOW-UP|1960-10-12|1967-07-19|||||1962-12-24||1965-09-15|N|1970-06-18
TRIAL STUDY 134XCP|LB|EED12AC0-1CBD-4D42-8786-91834AB33A46|2||||RPTLTIME|REPTILASE TIME|||||||CYLINDER|||||||TRACE||MIN||||ABNORMAL|NOT DONE||||CALCULUS|GELLED|NA|SLIT LAMP PHOTOGRAPHY|MDRD 5 VARIABLE FORMULA||N|U|Y|U|||Y|5||7||FOLLOW-UP|1961-06-21|1970-10-29|||||1972-07-30||1966-09-09|N|1961-05-24
TRIAL STUDY 134XCP|LB|F30DC3E9-E919-4920-87FE-103CD85D89FA|1||||TRCYANDP|TRICYCLIC ANTIDEPRESSANTS|||||||10^6 ORGANISMS/ML|||||||POSITIVE||MAC50||||LOW|NOT DONE||||CAPILLARY BLOOD|LIPEMIC|U|FLUORESCENT SPOT TEST|MDRD FORMULA||U|Y|N|NA|||U|1||38||SCREENING|1970-11-28|1962-12-01|||||1964-04-27||1961-08-18|N|1960-09-16
TRIAL STUDY 134XCP|LB|F30DC3E9-E919-4920-87FE-103CD85D89FA|2||||SMDGCE|SMUDGE CELLS|||||||MG/KG/WEEK|||||||BORDERLINE||MIN||||LOW|NOT DONE||||HAIR FOLLICLE|CONTAMINATED|NA|NON-INVASIVE DIELECTRIC SENSING|GMI MMOL/MOL FORMULA||NA|U|NA|NA|||Y|1||38||CONTINUATION TREATMENT|1964-01-04|1973-01-20|||||1971-12-16||1971-06-06|U|1967-11-12
TRIAL STUDY 134XCP|LB|F30DC3E9-E919-4920-87FE-103CD85D89FA|1||||KIM1S|SOLUBLE KIDNEY INJURY MOLECULE-1|||||||GY/MIN|||||||INVALID||MG/M2/H||||NORMAL|NOT DONE||||BUFFY COAT|LIPEMIC|N|KINETIC MICROPARTICLE IMMUNOASSAY|FIBROSIS 4 FORMULA||U|Y|Y|N|||U|2||58||CONTINUATION TREATMENT|1965-07-06|1960-07-24|||||1967-07-01||1961-12-02|N|1962-04-26
TRIAL STUDY 134XCP|LB|F30DC3E9-E919-4920-87FE-103CD85D89FA|2||||NHMCELE|NONHEMATIC CELLS/LEUKOCYTES|||||||EU|||||||INDETERMINATE||/WK||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|CONCENTRATED|U|MACRO BROTH DILUTION|MDRD FORMULA||Y|Y|Y|NA|||U|2||58||BASELINE|1968-06-28|1960-12-22|||||1967-04-09||1966-05-31|NA|1970-04-14
TRIAL STUDY 134XCP|LB|F30DC3E9-E919-4920-87FE-103CD85D89FA|1||||INSLNFR|INSULIN, FREE|||||||GMFI|||||||BORDERLINE||EIA UNIT||||HIGH|NOT DONE||||PLEURAL TISSUE|SOLIDIFIED|Y|TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA||Y|U|N|U|||NA|3||39||INDUCTION TREATMENT|1966-06-13|1961-02-01|||||1963-03-16||1965-10-31|Y|1962-06-04
TRIAL STUDY 134XCP|LB|F30DC3E9-E919-4920-87FE-103CD85D89FA|2||||PHNBRBTL|PHENOBARBITAL|||||||10^3 ORGANISMS/G|||||||POSITIVE||ML/MIN||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|SOLIDIFIED|U|SLOAN LETTER EYE CHART 100%|NASH FIBROSURE FORMULA||NA|N|U|NA|||N|3||39||LONG-TERM FOLLOW-UP|1966-10-24|1973-08-11|||||1970-10-02||1968-04-23|U|1965-09-29
TRIAL STUDY 134XCP|LB|F30DC3E9-E919-4920-87FE-103CD85D89FA|1||||EOSNUCCE|EOSINOPHILS/NUCLEATED CELLS|||||||IU/ML|||||||INVALID||MIU/L||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|ROOM TEMPERATURE|U|COULOMETRIC TITRATION|MDRD ENZYMATIC FORMULA||Y|NA|Y|NA|||N|4||88||OPEN LABEL TREATMENT|1967-02-21|1968-10-03|||||1960-11-28||1964-07-04|NA|1970-05-25
TRIAL STUDY 134XCP|LB|F30DC3E9-E919-4920-87FE-103CD85D89FA|2||||ORNITHIN|ORNITHINE|||||||UEQ|||||||NEGATIVE||UG/KG||||LOW|NOT DONE||||STOOL|AUTOLYZED|Y|CHROMATOGRAPHY|CKD-EPI FORMULA||NA|Y|NA|N|||N|4||88||RUN-IN|1967-03-22|1970-09-28|||||1965-12-25||1964-06-02|Y|1964-04-21
TRIAL STUDY 134XCP|LB|F30DC3E9-E919-4920-87FE-103CD85D89FA|1||||CD11A|CD11A|||||||MG/ML/MIN|||||||NEGATIVE||BEATS/MIN||||HIGH|NOT DONE||||GASTRIC FLUID|NON-HEMOLYZED|N|ZIEHL NEELSEN ACID FAST STAIN|FIBROSIS 4 FORMULA||Y|U|U|N|||NA|5||7||LONG-TERM FOLLOW-UP|1970-03-16|1971-12-25|||||1962-08-16||1966-03-09|U|1968-10-28
TRIAL STUDY 134XCP|LB|F30DC3E9-E919-4920-87FE-103CD85D89FA|2||||HLAAAGT|HLA-A ANTIGEN TYPE|||||||/H|||||||POSITIVE||DRUM||||LOW|NOT DONE||||PLEURAL FLUID|ROOM TEMPERATURE|U|NUCLEIC ACID SEQUENCING|GMI % FORMULA||U|Y|NA|Y|||N|5||7||LONG-TERM FOLLOW-UP|1960-10-13|1968-07-07|||||1967-12-25||1965-09-22|U|1972-02-24
TRIAL STUDY 134XCP|LB|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|1||||ACANT|ACANTHOCYTES|||||||GAUSS|||||||NEGATIVE||UG/M2/DAY||||NORMAL|NOT DONE||||VENOUS BLOOD|CLOTTED|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD FORMULA||N|Y|Y|U|||NA|1||38||INDUCTION TREATMENT|1972-01-21|1960-09-09|||||1966-06-09||1965-12-27|U|1960-12-07
TRIAL STUDY 134XCP|LB|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|2||||CSFAT|FATTY CASTS|||||||MG/KG/H|||||||INDETERMINATE||COPIES/UG||||LOW|NOT DONE||||GASTRIC CONTENTS|AGGLUTINATED|NA|TOLUIDINE BLUE STAIN|CKD-EPI CREATININE FORMULA||Y|N|N|Y|||U|1||38||FOLLOW-UP|1967-03-01|1966-09-17|||||1969-03-07||1965-06-30|U|1961-09-07
TRIAL STUDY 134XCP|LB|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|1||||PLTAGAMP|PLATELET AGGREGATION AMPLITUDE|||||||RATIO|||||||BORDERLINE||GRAVITATIONAL UNIT||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|CALCIFIED|U|OPHTHALMOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|U|NA|||NA|2||58||WASHOUT|1970-09-06|1969-01-27|||||1962-06-06||1972-12-13|NA|1972-02-24
TRIAL STUDY 134XCP|LB|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|2||||ILE|ISOLEUCINE|||||||/200 HPFS|||||||NEGATIVE||BQ/L||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|PARAFFIN-EMBEDDED|U|PUPILLOMETRY|MDRD 6 VARIABLE FORMULA||Y|Y|Y|N|||Y|2||58||RUN-IN|1963-05-06|1960-10-27|||||1972-09-01||1968-03-14|Y|1962-04-09
TRIAL STUDY 134XCP|LB|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|1||||C165924|GRASS MIX POLLEN IGE AB RAST SCORE|||||||UGEQ|||||||NEGATIVE||L/MIN/M2||||ABNORMAL|NOT DONE||||ABSCESS FLUID|PARAFFIN-EMBEDDED|N|AUTOREFRACTION|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|N|Y|||N|3||39||FOLLOW-UP|1970-12-01|1960-10-03|||||1961-12-11||1967-02-09|NA|1964-10-23
TRIAL STUDY 134XCP|LB|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|2||||BALA|BETA ALANINE|||||||FARAD|||||||POSITIVE||KM/H||||NORMAL|NOT DONE||||HAIR|CALCIFIED|U|GC/FID|MDRD 4 VARIABLE FORMULA||N|NA|N|NA|||Y|3||39||BASELINE|1961-03-08|1962-09-08|||||1970-08-07||1969-11-01|NA|1968-11-02
TRIAL STUDY 134XCP|LB|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|1||||C165883|ORCHARD GRASS POLLEN IGE AB RAST SCORE|||||||BU/ML|||||||INDETERMINATE||MM2||||NORMAL|NOT DONE||||SPERMATOZOON|UNEXPECTED ODOR|U|PHOTOMETRIC CLOT DETECTION|MDRD 5 VARIABLE FORMULA||Y|Y|N|U|||N|4||88||INDUCTION TREATMENT|1961-09-09|1967-09-05|||||1962-11-25||1968-08-02|NA|1966-11-17
TRIAL STUDY 134XCP|LB|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|2||||LVFBRSC|LIVER FIBROSIS SCORE|||||||NKAT|||||||BORDERLINE||PKAT/L||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|ICTERIC|U|TWO-COLOR MICROARRAY|FIBROSIS 4 FORMULA||Y|N|U|U|||NA|4||88||FOLLOW-UP|1962-08-28|1964-01-08|||||1970-08-20||1963-03-30|U|1970-11-14
TRIAL STUDY 134XCP|LB|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|1||||KURLOFCE|KURLOFF CELLS|||||||NSEC|||||||TRACE||G/G||||ABNORMAL|NOT DONE||||DISCHARGE|DRIED|U|ISHIHARA COLOR PLATES|HEPASCORE FORMULA||N|Y|N|U|||N|5||7||BASELINE|1964-02-02|1970-02-07|||||1963-06-27||1973-03-05|U|1963-04-01
TRIAL STUDY 134XCP|LB|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|2||||C165898|BIRCH POLLEN IGG AB RAST SCORE|||||||BREATHS/MIN|||||||INVALID||MM/H||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|HEMOLYZED|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|GMI % FORMULA||N|N|NA|U|||U|5||7||FOLLOW-UP|1970-12-10|1968-07-07|||||1961-05-17||1965-08-23|NA|1971-01-12
TRIAL STUDY 134XCP|LB|729D254F-628C-4D35-8906-A1344833A610|1||||HLAB27AG|HLA-B27 ANTIGEN|||||||SPRAY|||||||INVALID||10^6 CFU||||HIGH|NOT DONE||||LYSATE|AUTOLYZED|NA|PHOTOMETRIC CLOT DETECTION|FIBROMETER FORMULA||NA|Y|Y|U|||Y|1||38||OPEN LABEL TREATMENT|1966-03-23|1960-03-20|||||1967-11-14||1970-10-23|NA|1971-03-19
TRIAL STUDY 134XCP|LB|729D254F-628C-4D35-8906-A1344833A610|2||||IOTCLRBS|IOTHALAMATE CLEARANCE ADJUSTED FOR BSA|||||||G/CAGE/WK|||||||BORDERLINE||MG/CM2||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED|NA|JAEGER EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|N|||N|1||38||BASELINE|1972-11-10|1970-05-31|||||1973-01-09||1969-08-09|N|1971-10-02
TRIAL STUDY 134XCP|LB|729D254F-628C-4D35-8906-A1344833A610|1||||INTLK1|INTERLEUKIN 1|||||||10^9 CFU/ML|||||||TRACE||10^3 ORGANISMS/G||||ABNORMAL|NOT DONE||||MONOCYTE|LIPEMIC|NA|SINGLE-MOLECULE ARRAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|NA|Y|||U|2||58||SCREENING|1968-10-24|1963-10-16|||||1966-04-04||1968-07-16|N|1963-05-11
TRIAL STUDY 134XCP|LB|729D254F-628C-4D35-8906-A1344833A610|2||||IFIT1|INTERFERON-INDUCED 56 KDA PROTEIN|||||||VG/KG|||||||INVALID||NMOL/L||||ABNORMAL|NOT DONE||||STOOL|THAWED|N|LISSAMINE GREEN STAIN|HEPASCORE FORMULA||U|Y|N|U|||Y|2||58||BLINDED TREATMENT|1966-03-17|1972-04-07|||||1961-07-20||1971-07-23|Y|1964-09-01
TRIAL STUDY 134XCP|LB|729D254F-628C-4D35-8906-A1344833A610|1||||DNA|DEOXYRIBONUCLEIC ACID|||||||UIU/DL|||||||INVALID||OHM||||LOW|NOT DONE||||MECONIUM|HEMOLYZED|N|MALDI-TOF|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|NA|||NA|3||39||OBSERVATION|1969-12-08|1969-10-31|||||1964-07-23||1969-05-03|Y|1973-03-28
TRIAL STUDY 134XCP|LB|729D254F-628C-4D35-8906-A1344833A610|2||||RBCCLMP|ERYTHROCYTE CELL CLUMPS|||||||10^4 CFU/ML|||||||BORDERLINE||BQ/UG||||LOW|NOT DONE||||INFRANATANT, SERUM|FROZEN|Y|BALLPOINT PEN TECHNIQUE|MDRD 5 VARIABLE FORMULA||U|NA|NA|N|||N|3||39||OPEN LABEL TREATMENT|1962-05-14|1960-05-14|||||1970-11-06||1971-03-27|N|1970-05-21
TRIAL STUDY 134XCP|LB|729D254F-628C-4D35-8906-A1344833A610|1||||PLATAGRN|PLATELETS, AGRANULAR|||||||GBQ/UG|||||||INVALID||RPM||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|THAWED|U|HEMOCYTOMETRY|ASH FIBROSURE FORMULA||Y|N|N|U|||Y|4||88||BLINDED TREATMENT|1966-11-23|1962-11-30|||||1969-01-08||1964-08-02|N|1968-06-29
TRIAL STUDY 134XCP|LB|729D254F-628C-4D35-8906-A1344833A610|2||||MYCEMPOL|MYELOID MATURATION POOL|||||||/VF|||||||INVALID||BQ/ML||||HIGH|NOT DONE||||AQUEOUS HUMOR|GELLED|N|RAJI CELL EIA|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|Y|NA|||Y|4||88||WASHOUT|1960-09-01|1960-06-11|||||1962-07-04||1969-03-17|NA|1965-10-04
TRIAL STUDY 134XCP|LB|729D254F-628C-4D35-8906-A1344833A610|1||||MX1|INTERFERON-INDUCED PROTEIN P78|||||||PG/L|||||||POSITIVE||CYLINDER||||LOW|NOT DONE||||EMESIS|AGGLUTINATED|N|MULTI-SLICE SPIRAL CT|MDRD FORMULA||Y|U|NA|U|||U|5||7||WASHOUT|1961-03-20|1969-11-08|||||1964-05-28||1972-12-08|N|1964-09-23
TRIAL STUDY 134XCP|LB|729D254F-628C-4D35-8906-A1344833A610|2||||MCPHNSQE|MACROPHAGES/NON-SQUAM EPI CELLS|||||||VG/DOSE|||||||NEGATIVE||10^6 RNA COPIES/ML||||ABNORMAL|NOT DONE||||BONE MARROW|FROZEN|U|PYROSEQUENCING|FIBROTEST FORMULA||U|U|N|U|||Y|5||7||BLINDED TREATMENT|1971-10-16|1971-02-06|||||1965-10-31||1966-04-11|N|1970-08-15
TRIAL STUDY 134XCP|LB|A78936A2-B8B1-4D07-8679-E324F6447EFF|1||||DDX58|DEAD BOX PROTEIN 58|||||||10^6 IU|||||||TRACE||MG/L||||HIGH|NOT DONE||||CORD SERUM|HEMOLYZED|U|IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD ENZYMATIC FORMULA||Y|NA|Y|U|||U|1||38||RUN-IN|1966-10-22|1966-03-16|||||1963-06-14||1971-07-18|NA|1969-12-05
TRIAL STUDY 134XCP|LB|A78936A2-B8B1-4D07-8679-E324F6447EFF|2||||PRLYMLE|PROLYMPHOCYTES/LEUKOCYTES|||||||MCI|||||||BORDERLINE||LOG EID 50/DOSE||||ABNORMAL|NOT DONE||||SPERMATOZOON|DRIED|U|FLUORIMETRY|COCKCROFT-GAULT FORMULA||N|NA|U|U|||Y|1||38||TREATMENT|1962-08-03|1970-11-01|||||1961-10-13||1963-08-18|Y|1962-10-15
TRIAL STUDY 134XCP|LB|A78936A2-B8B1-4D07-8679-E324F6447EFF|1||||UREA|UREA|||||||UV2|||||||NEGATIVE||FT||||LOW|NOT DONE||||ABSCESS FLUID|FRESH|N|TARGETED TRANSCRIPTOME SEQUENCING|CKD-EPI CYSTATIN C FORMULA||N|N|U|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1970-11-09|1970-04-21|||||1964-12-12||1962-02-22|U|1966-08-02
TRIAL STUDY 134XCP|LB|A78936A2-B8B1-4D07-8679-E324F6447EFF|2||||CD4LY|CD4/LYMPHOCYTES|||||||GBQ/MG|||||||INVALID||KM||||LOW|NOT DONE||||LYMPH|SOLIDIFIED|Y|IRON HEMATOXYLIN STAIN|MDRD 6 VARIABLE FORMULA||U|NA|NA|NA|||NA|2||58||LONG-TERM FOLLOW-UP|1962-10-03|1969-11-10|||||1971-02-11||1969-01-15|N|1960-09-05
TRIAL STUDY 134XCP|LB|A78936A2-B8B1-4D07-8679-E324F6447EFF|1||||NTXICRT|T1 COLLAGEN X-LINK N-TELOPEPTIDES/CREAT|||||||KUSP|||||||BORDERLINE||UM||||LOW|NOT DONE||||COLOSTRUM|THAWED|Y|MALDI-TOF|MDRD 6 VARIABLE FORMULA||U|NA|NA|Y|||NA|3||39||TREATMENT|1965-02-23|1971-01-01|||||1972-07-09||1965-05-07|U|1961-11-19
TRIAL STUDY 134XCP|LB|A78936A2-B8B1-4D07-8679-E324F6447EFF|2||||CA1AG|CANCER ANTIGEN 1|||||||HOUNSFIELD UNIT|||||||BORDERLINE||BOTTLE||||NORMAL|NOT DONE||||SKIN TISSUE|LIPEMIC|NA|FLUORESCENT ENZYME IMMUNOASSAY|FIBROTEST FORMULA||Y|U|NA|U|||U|3||39||BLINDED TREATMENT|1964-07-09|1969-04-27|||||1966-07-29||1963-03-02|NA|1967-01-26
TRIAL STUDY 134XCP|LB|A78936A2-B8B1-4D07-8679-E324F6447EFF|1||||GRANLE|GRANULOCYTES/LEUKOCYTES|||||||MEQ/UG|||||||POSITIVE||MDFI||||ABNORMAL|NOT DONE||||LAVAGE FLUID|ICTERIC|Y|HANSEL STAIN|GMI % FORMULA||N|N|U|NA|||Y|4||88||SCREENING|1972-11-13|1967-04-15|||||1969-05-12||1964-10-09|U|1960-01-28
TRIAL STUDY 134XCP|LB|A78936A2-B8B1-4D07-8679-E324F6447EFF|2||||C130071|BERMUDA GRASS POLLEN IGG4|||||||/CMH2O|||||||INDETERMINATE||10^9/L||||ABNORMAL|NOT DONE||||ISOLATE|CALCIFIED|NA|RULER MEASUREMENT METHOD|MDRD 4 VARIABLE FORMULA||N|Y|NA|N|||N|4||88||RUN-IN|1969-02-09|1969-03-19|||||1968-01-03||1970-09-05|U|1968-02-03
TRIAL STUDY 134XCP|LB|A78936A2-B8B1-4D07-8679-E324F6447EFF|1||||NEUTVAC|VACUOLATED NEUTROPHILS|||||||CAL|||||||BORDERLINE||MEQ/DL||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|AGGLUTINATED|NA|FLAME PHOTOMETRY|HEPASCORE FORMULA||N|Y|N|NA|||NA|5||7||FOLLOW-UP|1968-06-07|1968-10-26|||||1972-07-08||1971-09-27|NA|1962-01-31
TRIAL STUDY 134XCP|LB|A78936A2-B8B1-4D07-8679-E324F6447EFF|2||||PLSIMCE|IMMATURE PLASMA CELLS|||||||MANSON U/ML|||||||INDETERMINATE||MV2/HZ||||HIGH|NOT DONE||||EMOTIONAL TEAR|ICTERIC|N|FORCED OSCILLATION TECHNIQUE|CKD-EPI CREATININE FORMULA||NA|NA|U|N|||N|5||7||WASHOUT|1967-12-17|1961-09-20|||||1967-08-05||1970-07-13|U|1966-07-03
TRIAL STUDY 134XCP|LB|239B331A-08CD-41D9-BBB8-CE229480FC12|1||||C130115|INDUSTRIAL MIX ANTIGEN IGG ANTIBODY|||||||MM/SEC|||||||POSITIVE||BAU||||HIGH|NOT DONE||||PLATELET POOR PLASMA|FRESH|U|SLOAN LETTER EYE CHART 1.25%|ASH FIBROSURE FORMULA||Y|Y|NA|U|||Y|1||38||TREATMENT|1973-04-03|1972-09-07|||||1962-06-22||1965-05-03|U|1971-11-11
TRIAL STUDY 134XCP|LB|239B331A-08CD-41D9-BBB8-CE229480FC12|2||||HGBDHGB|HEMOGLOBIN D/TOTAL HEMOGLOBIN|||||||ML/KG|||||||INVALID||IU/MG||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|LIPEMIC|Y|FARR ASSAY|MDRD FORMULA||Y|NA|NA|U|||N|1||38||FOLLOW-UP|1960-07-28|1960-06-15|||||1966-04-17||1967-02-12|U|1970-03-13
TRIAL STUDY 134XCP|LB|239B331A-08CD-41D9-BBB8-CE229480FC12|1||||PKM2|PYRUVATE KINASE ISOZYME M2|||||||MM/H|||||||TRACE||MEQ/UG||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|FRESH|NA|MALDI-TOF|MDRD FORMULA||U|NA|U|Y|||Y|2||58||OPEN LABEL TREATMENT|1962-08-12|1972-09-23|||||1969-09-12||1963-06-26|U|1972-11-30
TRIAL STUDY 134XCP|LB|239B331A-08CD-41D9-BBB8-CE229480FC12|2||||INTLK1B|INTERLEUKIN 1 BETA|||||||10^3 RNA COPIES/ML|||||||INDETERMINATE||CI/G||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|PARAFFIN-EMBEDDED|N|MICRODENSITOMETRY|FIBROSIS 4 FORMULA||Y|NA|U|Y|||Y|2||58||SCREENING|1960-06-04|1971-12-25|||||1968-11-28||1973-03-05|N|1963-07-27
TRIAL STUDY 134XCP|LB|239B331A-08CD-41D9-BBB8-CE229480FC12|1||||RH|RH FACTOR|||||||MESF|||||||NEGATIVE||GPL U/ML||||ABNORMAL|NOT DONE||||NAIL|SOLIDIFIED|U|DIFFUSION TENSOR MRI|CKD-EPI CREATININE FORMULA||N|N|Y|U|||U|3||39||OBSERVATION|1967-09-14|1968-02-26|||||1972-09-16||1961-02-28|N|1969-06-17
TRIAL STUDY 134XCP|LB|239B331A-08CD-41D9-BBB8-CE229480FC12|2||||APOE|APOLIPOPROTEIN E|||||||/SEC|||||||INVALID||L/H/M2||||ABNORMAL|NOT DONE||||TISSUE|UNEXPECTED ODOR|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA||NA|U|NA|Y|||Y|3||39||OBSERVATION|1968-11-13|1973-02-22|||||1965-06-21||1962-04-29|Y|1968-02-27
TRIAL STUDY 134XCP|LB|239B331A-08CD-41D9-BBB8-CE229480FC12|1||||EPITUCE|TUBULAR EPITHELIAL CELLS|||||||VOXEL|||||||INDETERMINATE||BQ||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|GELLED|Y|CELL BASED BIOASSAY|FIBROSIS 4 FORMULA||U|Y|Y|U|||Y|4||88||OPEN LABEL TREATMENT|1961-06-27|1968-10-05|||||1962-10-28||1973-02-18|N|1962-11-16
TRIAL STUDY 134XCP|LB|239B331A-08CD-41D9-BBB8-CE229480FC12|2||||PKM1|PYRUVATE KINASE ISOZYME M1|||||||UG/G/DAY|||||||NEGATIVE||CI/L||||ABNORMAL|NOT DONE||||VENOUS BLOOD|AGGLUTINATED|Y|GIEMSA STAIN|CKD-EPI CREATININE FORMULA||U|Y|NA|N|||N|4||88||CONTINUATION TREATMENT|1964-10-05|1966-11-24|||||1965-12-02||1971-11-26|U|1968-06-05
TRIAL STUDY 134XCP|LB|239B331A-08CD-41D9-BBB8-CE229480FC12|1||||ABOA1|ABO A1 SUBTYPE|||||||COAT|||||||TRACE||10^5/HPF||||HIGH|NOT DONE||||PROSTATIC FLUID|CONCENTRATED|Y|SECONDARY ION MASS SPECTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|N|N|||N|5||7||INDUCTION TREATMENT|1960-05-25|1966-06-20|||||1968-10-28||1960-01-26|NA|1967-10-18
TRIAL STUDY 134XCP|LB|239B331A-08CD-41D9-BBB8-CE229480FC12|2||||PLATAGRN|PLATELETS, AGRANULAR|||||||DEG|||||||NEGATIVE||UEQ||||ABNORMAL|NOT DONE||||DISCHARGE|UNEXPECTED ODOR|N|FLOCCULATION, CHARCOAL ENHANCED|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|U|N|||NA|5||7||FOLLOW-UP|1962-03-12|1965-04-30|||||1970-08-10||1966-09-19|N|1961-11-20
TRIAL STUDY 134XCP|LB|958D39CD-D511-40C8-A0A6-8A138225470B|1||||DHEAS|DEHYDROEPIANDROSTERONE SULFATE|||||||G/ANIMAL/DAY|||||||POSITIVE||DAYS||||HIGH|NOT DONE||||KERATINOCYTE|NON-HEMOLYZED|U|CELL OF ORIGIN ASSAY|COCKCROFT-GAULT FORMULA||Y|Y|NA|NA|||Y|1||38||INDUCTION TREATMENT|1961-04-14|1972-05-04|||||1967-09-12||1969-10-06|NA|1961-10-13
TRIAL STUDY 134XCP|LB|958D39CD-D511-40C8-A0A6-8A138225470B|2||||PTAC|PROTHROMBIN TIME ACTUAL/CONTROL|||||||MG/DOSE|||||||BORDERLINE||MG/CM2||||ABNORMAL|NOT DONE||||URINE SEDIMENT|LIPEMIC|U|BRDU CELLULAR PROLIFERATION ASSAY|MDRD ENZYMATIC FORMULA||U|N|U|Y|||N|1||38||OBSERVATION|1968-07-15|1967-03-27|||||1966-01-04||1965-08-22|U|1965-11-08
TRIAL STUDY 134XCP|LB|958D39CD-D511-40C8-A0A6-8A138225470B|1||||CSEPIRT|RENAL TUBULAR EPITHELIAL CASTS|||||||MG/M2/DAY|||||||TRACE||CY/CM||||NORMAL|NOT DONE||||CERUMEN|DRIED|U|CLINICAL EVALUATION|HEPASCORE FORMULA||NA|Y|NA|NA|||U|2||58||RUN-IN|1970-02-04|1967-06-30|||||1970-09-17||1960-03-20|Y|1969-03-25
TRIAL STUDY 134XCP|LB|958D39CD-D511-40C8-A0A6-8A138225470B|2||||POIKRBC|POIKILOCYTES/ERYTHROCYTES|||||||DAYS/MONTH|||||||INVALID||PMOL/L/H||||ABNORMAL|NOT DONE||||CORD SERUM|ROOM TEMPERATURE|NA|NEPHELOMETRY|MDRD 5 VARIABLE FORMULA||Y|U|Y|Y|||NA|2||58||CONTINUATION TREATMENT|1970-01-19|1965-10-11|||||1973-03-06||1970-07-06|NA|1968-06-26
TRIAL STUDY 134XCP|LB|958D39CD-D511-40C8-A0A6-8A138225470B|1||||PROMY|PROMYELOCYTES|||||||PA|||||||BORDERLINE||SPRAY||||LOW|NOT DONE||||SMEGMA|NON-HEMOLYZED|U|SURFACE PLASMON RESONANCE|CKD-EPI FORMULA||Y|NA|U|Y|||Y|3||39||LONG-TERM FOLLOW-UP|1962-07-26|1970-04-19|||||1962-05-30||1970-09-25|U|1963-02-10
TRIAL STUDY 134XCP|LB|958D39CD-D511-40C8-A0A6-8A138225470B|2||||GAD2|GLUTAMIC ACID DECARBOXYLASE 2|||||||G/KG|||||||POSITIVE||KPA/L/SEC||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONCENTRATED|U|CONTRAST ENHANCED PET SCAN|ASH FIBROSURE FORMULA||U|N|NA|U|||U|3||39||LONG-TERM FOLLOW-UP|1973-05-11|1967-11-05|||||1961-05-24||1964-09-17|U|1965-05-21
TRIAL STUDY 134XCP|LB|958D39CD-D511-40C8-A0A6-8A138225470B|1||||MMIF|MACROPHAGE MIGRATION INHIBITORY FACTOR|||||||JDF UNIT|||||||TRACE||10^3 RNA COPIES/ML||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|UNEXPECTED ODOR|U|TRICHROME STAIN|FIBROMETER FORMULA||Y|U|N|N|||N|4||88||FOLLOW-UP|1960-07-31|1966-09-14|||||1960-07-31||1970-07-21|Y|1969-10-08
TRIAL STUDY 134XCP|LB|958D39CD-D511-40C8-A0A6-8A138225470B|2||||HLADRB1|HLA DR BETA1 ANTIGEN|||||||BOTTLE|||||||BORDERLINE||SUPPOSITORY||||ABNORMAL|NOT DONE||||DISCHARGE|CLOTTED|NA|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||U|U|N|NA|||Y|4||88||OBSERVATION|1970-08-11|1969-06-20|||||1965-03-06||1963-06-19|Y|1968-06-12
TRIAL STUDY 134XCP|LB|958D39CD-D511-40C8-A0A6-8A138225470B|1||||RNPAB|RIBONUCLEOPROTEIN ANTIBODY|||||||10^6/G|||||||TRACE||MNFI||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|SOLIDIFIED|Y|EEG|ASH FIBROSURE FORMULA||U|U|NA|NA|||Y|5||7||OPEN LABEL TREATMENT|1962-05-14|1970-03-19|||||1965-12-03||1972-05-08|U|1960-02-08
TRIAL STUDY 134XCP|LB|958D39CD-D511-40C8-A0A6-8A138225470B|2||||PKM1|PYRUVATE KINASE ISOZYME M1|||||||10^9 CFU|||||||INVALID||CY/CM||||LOW|NOT DONE||||EMESIS|CLOTTED|Y|REBOUND TONOMETRY|CKD-EPI FORMULA||U|Y|Y|N|||Y|5||7||OPEN LABEL TREATMENT|1968-05-30|1971-10-28|||||1970-11-11||1972-05-01|NA|1968-03-07
TRIAL STUDY 134XCP|LB|5DA21FE5-E5B9-4461-9509-94AA264B59A8|1||||MONOPTPT|MONOCLONAL PROTEIN/TOTAL PROTEIN|||||||MM|||||||BORDERLINE||KM/H||||ABNORMAL|NOT DONE||||EXPIRED AIR|REFRIGERATED|U|HEMAGGLUTINATION ASSAY|NASH FIBROSURE FORMULA||NA|N|Y|Y|||U|1||38||OBSERVATION|1964-03-31|1967-12-09|||||1972-07-11||1971-10-09|NA|1961-03-12
TRIAL STUDY 134XCP|LB|5DA21FE5-E5B9-4461-9509-94AA264B59A8|2||||MMP1|MATRIX METALLOPROTEINASE 1|||||||10^9 CFU|||||||BORDERLINE||UG/DOSE||||NORMAL|NOT DONE||||COLOSTRUM|THAWED|U|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA||NA|Y|U|NA|||U|1||38||OBSERVATION|1969-07-28|1970-05-28|||||1972-08-14||1971-07-04|Y|1961-08-17
TRIAL STUDY 134XCP|LB|5DA21FE5-E5B9-4461-9509-94AA264B59A8|1||||INTLK5|INTERLEUKIN 5|||||||PPTH|||||||TRACE||IU/DAY||||NORMAL|NOT DONE||||ERYTHROCYTES|SOLIDIFIED|NA|HEMATOXYLIN AND EOSIN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|Y|U|||U|2||58||BLINDED TREATMENT|1963-09-30|1968-03-25|||||1960-08-29||1966-11-25|Y|1963-05-01
TRIAL STUDY 134XCP|LB|5DA21FE5-E5B9-4461-9509-94AA264B59A8|2||||LEUKCRBC|LEUKS CORRECTED FOR NUCL ERYTHROCYTES|||||||CCID 50/DOSE|||||||POSITIVE||NFIU||||LOW|NOT DONE||||VENOUS BLOOD|CONTAMINATED|Y|CELL BASED BIOASSAY|HEPASCORE FORMULA||U|Y|U|NA|||NA|2||58||RUN-IN|1964-05-02|1971-12-19|||||1973-01-13||1962-08-25|NA|1973-05-26
TRIAL STUDY 134XCP|LB|5DA21FE5-E5B9-4461-9509-94AA264B59A8|1||||ALUMINUM|ALUMINUM|||||||MM/2H|||||||NEGATIVE||10^9 ORGANISMS/MG||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONTAMINATED|NA|APPLANATION TONOMETRY|COCKCROFT-GAULT FORMULA||U|U|U|Y|||U|3||39||OPEN LABEL TREATMENT|1962-12-04|1972-05-07|||||1962-12-18||1964-08-27|U|1963-11-28
TRIAL STUDY 134XCP|LB|5DA21FE5-E5B9-4461-9509-94AA264B59A8|2||||ZINC|ZINC|||||||FL|||||||TRACE||AMOL||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|SOLIDIFIED|N|LINE PROBE ASSAY|CKD-EPI FORMULA||NA|Y|NA|Y|||N|3||39||OBSERVATION|1960-11-08|1963-01-14|||||1965-10-31||1970-08-20|NA|1973-06-07
TRIAL STUDY 134XCP|LB|5DA21FE5-E5B9-4461-9509-94AA264B59A8|1||||MCPHGCE|MACROPHAGES/TOTAL CELLS|||||||10^6 ORGANISMS/G|||||||INVALID||ML||||LOW|NOT DONE||||WHITE MATTER TISSUE|CALCIFIED|U|CONGO RED STAIN|FIBROSIS 4 FORMULA||N|N|N|U|||NA|4||88||INDUCTION TREATMENT|1962-02-21|1972-07-16|||||1968-01-13||1969-03-22|Y|1970-03-09
TRIAL STUDY 134XCP|LB|5DA21FE5-E5B9-4461-9509-94AA264B59A8|2||||IDLVLDL3|IDL+VLDL CHOLESTEROL SUBTYPE 3|||||||PSI|||||||BORDERLINE||RPM||||ABNORMAL|NOT DONE||||BILE|FROZEN|Y|HIGH LEVEL AMINOGLYCOSIDE SCREEN|NASH FIBROSURE FORMULA||NA|NA|U|U|||NA|4||88||WASHOUT|1964-04-06|1970-10-03|||||1969-05-01||1964-03-12|U|1961-12-12
TRIAL STUDY 134XCP|LB|5DA21FE5-E5B9-4461-9509-94AA264B59A8|1||||TKG|T-KININOGEN|||||||BE/ML|||||||BORDERLINE||IU/KG/H||||HIGH|NOT DONE||||WHITE MATTER TISSUE|CLOTTED|U|AGAR DILUTION|MDRD 5 VARIABLE FORMULA||N|NA|Y|U|||Y|5||7||WASHOUT|1960-10-28|1963-11-03|||||1965-11-27||1962-12-27|N|1969-01-14
TRIAL STUDY 134XCP|LB|5DA21FE5-E5B9-4461-9509-94AA264B59A8|2||||BURRCE|BURR CELLS|||||||NMOL/L/MIN|||||||POSITIVE||10^6 U||||NORMAL|NOT DONE||||SKIN TISSUE|LACTESCENT|NA|QUANTITATIVE ULTRASOUND|CKD-EPI CREATININE FORMULA||Y|N|N|NA|||Y|5||7||RUN-IN|1960-04-23|1960-08-29|||||1961-01-10||1972-08-17|N|1962-06-29
TRIAL STUDY 134XCP|LB|B125DCB9-1705-430B-9982-A20E7C4CA6A8|1||||AMYLB42|AMYLOID BETA 1-42|||||||FT|||||||POSITIVE||KPA||||HIGH|NOT DONE||||LAVAGE FLUID|GELLED|NA|KNEMOMETRY|GMI MMOL/MOL FORMULA||N|N|U|N|||U|1||38||SCREENING|1964-07-30|1967-03-08|||||1963-03-12||1969-09-26|U|1960-08-18
TRIAL STUDY 134XCP|LB|B125DCB9-1705-430B-9982-A20E7C4CA6A8|2||||FRFEABS|FRACTIONAL IRON ABSORPTION|||||||DPM|||||||INVALID||CAPSULE||||HIGH|NOT DONE||||BLOOD|AGGLUTINATED|NA|DUCTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||N|N|U|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1961-05-13|1970-08-27|||||1970-03-02||1965-01-10|NA|1973-03-14
TRIAL STUDY 134XCP|LB|B125DCB9-1705-430B-9982-A20E7C4CA6A8|1||||CD11A|CD11A|||||||PMOL/L|||||||BORDERLINE||NKAT/L||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|FRESH|N|SISH|CKD-EPI FORMULA||Y|N|U|Y|||Y|2||58||RUN-IN|1965-04-14|1961-04-07|||||1972-02-25||1971-04-15|Y|1972-12-07
TRIAL STUDY 134XCP|LB|B125DCB9-1705-430B-9982-A20E7C4CA6A8|2||||IC512AB|ISLET CELL 512 ANTIBODY|||||||MG/M2|||||||INDETERMINATE||FG||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|GELLED|Y|TONOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|N|N|N|||Y|2||58||RUN-IN|1962-10-16|1967-08-21|||||1972-02-24||1964-03-22|NA|1972-07-29
TRIAL STUDY 134XCP|LB|B125DCB9-1705-430B-9982-A20E7C4CA6A8|1||||NAK|SODIUM/POTASSIUM|||||||BQ/UL|||||||TRACE||MG/KG/DOSE||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|DRIED|N|CLAUSS METHOD|COCKCROFT-GAULT FORMULA||N|NA|NA|N|||NA|3||39||LONG-TERM FOLLOW-UP|1971-11-30|1966-04-04|||||1966-06-08||1973-07-22|N|1962-05-09
TRIAL STUDY 134XCP|LB|B125DCB9-1705-430B-9982-A20E7C4CA6A8|2||||C165927|ANIMAL MIX IGE AB RAST SCORE|||||||BAG|||||||TRACE||GBQ||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|PARAFFIN-EMBEDDED|Y|LYMPHANGIOGRAPHY|MDRD FORMULA||NA|U|Y|U|||NA|3||39||RUN-IN|1968-12-02|1973-08-19|||||1965-09-28||1970-05-01|U|1971-12-05
TRIAL STUDY 134XCP|LB|B125DCB9-1705-430B-9982-A20E7C4CA6A8|1||||PHENTHZ|PHENOTHIAZINE|||||||MOSM|||||||NEGATIVE||UL/KG/DAY||||HIGH|NOT DONE||||PLEURAL FLUID|AGGLUTINATED|U|CONTRAST ENHANCED CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|NA|U|||N|4||88||WASHOUT|1963-07-04|1972-12-18|||||1966-07-26||1962-12-20|Y|1965-03-11
TRIAL STUDY 134XCP|LB|B125DCB9-1705-430B-9982-A20E7C4CA6A8|2||||CD19LY|CD19/LYMPHOCYTES|||||||MMOL/DAY|||||||TRACE||L/MIN||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|CONCENTRATED|Y|GRAM STAIN|MDRD 4 VARIABLE FORMULA||U|NA|NA|Y|||U|4||88||SCREENING|1966-06-29|1969-11-10|||||1968-03-07||1973-01-09|U|1972-10-23
TRIAL STUDY 134XCP|LB|B125DCB9-1705-430B-9982-A20E7C4CA6A8|1||||AHBDH|ALPHA HYDROXYBUTYRATE DEHYDROGENASE|||||||MANSON U/ML|||||||TRACE||OI50||||NORMAL|NOT DONE||||SALIVA|REFRIGERATED|NA|IMMUNOASSAY|MDRD ENZYMATIC FORMULA||Y|U|Y|U|||N|5||7||BASELINE|1966-05-02|1964-01-03|||||1960-06-03||1962-12-08|N|1961-08-25
TRIAL STUDY 134XCP|LB|B125DCB9-1705-430B-9982-A20E7C4CA6A8|2||||LYMCE|LYMPHOCYTES/TOTAL CELLS|||||||USP U|||||||NEGATIVE||LINEAR FT*LB||||NORMAL|NOT DONE||||LUNG SURFACTANT|NON-HEMOLYZED|NA|IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||Y|N|U|N|||Y|5||7||RUN-IN|1972-08-06|1968-03-21|||||1962-07-15||1962-12-06|U|1961-01-04
TRIAL STUDY 134XCP|LB|95C72325-301E-40D4-AA2D-49B80067FE23|1||||ADPNCTN|ADIPONECTIN|||||||L/S/KPA|||||||INDETERMINATE||MGEQ||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|CONTAMINATED|U|ELECTROMYOGRAPHY|HEPASCORE FORMULA||Y|N|U|N|||Y|1||38||CONTINUATION TREATMENT|1963-12-25|1966-04-20|||||1963-04-18||1960-05-04|U|1963-09-14
TRIAL STUDY 134XCP|LB|95C72325-301E-40D4-AA2D-49B80067FE23|2||||BLASTERY|BASOPHILIC ERYTHROBLAST|||||||CD*S/M2|||||||NEGATIVE||ML/ANIMAL/DAY||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|DRIED|U|CHROMATOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|U|N|Y|||N|1||38||TREATMENT|1965-08-23|1963-07-09|||||1968-05-24||1968-07-16|Y|1962-04-11
TRIAL STUDY 134XCP|LB|95C72325-301E-40D4-AA2D-49B80067FE23|1||||MSPIKEPT|MONOCLONAL PROTEIN SPIKE/TOTAL PROTEIN|||||||BOLUS|||||||NEGATIVE||DAMOL/L||||ABNORMAL|NOT DONE||||TRANSUDATE|PARAFFIN-EMBEDDED|N|HIGH RESOLUTION CT|FIBROMETER FORMULA||NA|N|Y|N|||N|2||58||FOLLOW-UP|1961-03-31|1966-05-11|||||1973-03-28||1965-12-31|NA|1970-01-01
TRIAL STUDY 134XCP|LB|95C72325-301E-40D4-AA2D-49B80067FE23|2||||IFI27|INTERFERON ALPHA-INDUCIBLE PROTEIN 27|||||||IU/MMOL|||||||POSITIVE||EID 50/ML||||NORMAL|NOT DONE||||PLEURAL FLUID|CONCENTRATED|U|POLYSOMNOGRAPHY|GMI % FORMULA||Y|U|N|Y|||Y|2||58||WASHOUT|1971-09-05|1964-06-21|||||1971-11-05||1969-02-22|U|1973-03-22
TRIAL STUDY 134XCP|LB|95C72325-301E-40D4-AA2D-49B80067FE23|1||||ECT|ECARIN CLOTTING TIME|||||||IU/ML|||||||POSITIVE||UKAT||||HIGH|NOT DONE||||STOOL|AUTOLYZED|N|IMMUNOCHROMATOGRAPHY|CKD-EPI CREATININE FORMULA||Y|NA|NA|N|||Y|3||39||CONTINUATION TREATMENT|1970-08-23|1964-07-11|||||1960-07-13||1960-02-09|U|1972-07-09
TRIAL STUDY 134XCP|LB|95C72325-301E-40D4-AA2D-49B80067FE23|2||||HEPCIDIN|HEPCIDIN|||||||ML/CAGE/WK|||||||INVALID||PUFF||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|LACTESCENT|Y|SPECT SCAN|MDRD ENZYMATIC FORMULA||Y|U|N|U|||NA|3||39||FOLLOW-UP|1970-02-26|1962-09-18|||||1966-02-05||1964-01-09|Y|1960-10-31
TRIAL STUDY 134XCP|LB|95C72325-301E-40D4-AA2D-49B80067FE23|1||||MONOMA|MONOCYTES/MACROCYTES|||||||UG/MOL|||||||INDETERMINATE||SFC/10^6 PBMC||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|SOLIDIFIED|N|FLUORIMETRY|HEPASCORE FORMULA||NA|Y|Y|Y|||Y|4||88||BASELINE|1970-12-14|1967-12-17|||||1969-11-21||1966-09-11|N|1960-11-20
TRIAL STUDY 134XCP|LB|95C72325-301E-40D4-AA2D-49B80067FE23|2||||MCPHGLE|MACROPHAGES/LEUKOCYTES|||||||INHALATION|||||||NEGATIVE||/4.0 ML||||LOW|NOT DONE||||ISOLATE|FROZEN|Y|WRIGHT-GIEMSA STAIN|MDRD ENZYMATIC FORMULA||U|N|NA|U|||U|4||88||SCREENING|1963-04-10|1964-02-29|||||1972-12-16||1972-01-15|NA|1960-07-23
TRIAL STUDY 134XCP|LB|95C72325-301E-40D4-AA2D-49B80067FE23|1||||OAS2|2-5-OLIGOADENYLATE SYNTHASE 2|||||||MMOL/L|||||||TRACE||ML/G/DAY||||HIGH|NOT DONE||||SWABBED MATERIAL|THAWED|NA|SPECT SCAN|CKD-EPI FORMULA||N|U|Y|U|||NA|5||7||BLINDED TREATMENT|1963-07-02|1962-01-15|||||1971-08-03||1962-03-20|NA|1973-05-04
TRIAL STUDY 134XCP|LB|95C72325-301E-40D4-AA2D-49B80067FE23|2||||METARBLE|METARUBRICYTES/LEUKOCYTES|||||||NG/MOL|||||||BORDERLINE||ML/DAY||||LOW|NOT DONE||||SERUM OR PLASMA|DRIED|NA|NEXT GENERATION SEQUENCING|NASH FIBROSURE FORMULA||NA|U|N|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1963-09-20|1967-09-13|||||1972-11-15||1960-03-21|NA|1960-11-11
TRIAL STUDY 134XCP|LB|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|1||||PDL1S|SOLUBLE PROGRAMMED DEATH LIGAND 1|||||||MONTHS|||||||POSITIVE||UCI||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|GELLED|N|HIGH RESOLUTION MELT ANALYSIS|GMI MMOL/MOL FORMULA||Y|NA|N|U|||N|1||38||OBSERVATION|1963-11-26|1971-07-12|||||1966-07-04||1961-07-12|Y|1972-02-06
TRIAL STUDY 134XCP|LB|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|2||||C165926|MOLD MIX IGE AB RAST SCORE|||||||NMOL/G|||||||INDETERMINATE||PT_BR||||HIGH|NOT DONE||||EXPIRED AIR|THAWED|NA|MASS SPECTROMETRY|NASH FIBROSURE FORMULA||N|Y|Y|U|||N|1||38||BLINDED TREATMENT|1972-10-22|1963-07-17|||||1960-06-09||1963-12-25|Y|1966-09-17
TRIAL STUDY 134XCP|LB|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|1||||ESTFREST|ESTRADIOL, FREE/ESTRADIOL|||||||TORR|||||||BORDERLINE||%||||ABNORMAL|NOT DONE||||ABSCESS FLUID|LACTESCENT|N|CISH|CKD-EPI CREATININE FORMULA||N|Y|NA|U|||NA|2||58||RUN-IN|1971-03-06|1968-09-05|||||1961-06-23||1963-07-19|Y|1963-12-15
TRIAL STUDY 134XCP|LB|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|2||||C130130|DOG DANDER ANTIGEN IGA ANTIBODY|||||||MM/2H|||||||NEGATIVE||ML/KG||||NORMAL|NOT DONE||||CAPILLARY PLASMA|FRESH|U|HILLMEN COLOR CHART|ASH FIBROSURE FORMULA||U|NA|U|Y|||Y|2||58||CONTINUATION TREATMENT|1972-04-24|1972-02-01|||||1967-11-30||1964-10-30|Y|1969-10-08
TRIAL STUDY 134XCP|LB|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|1||||INTLK17|INTERLEUKIN 17|||||||FT2|||||||NEGATIVE||MG2/DL2||||HIGH|NOT DONE||||NAIL|LACTESCENT|NA|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||Y|NA|NA|NA|||NA|3||39||OBSERVATION|1971-02-15|1973-06-25|||||1961-04-11||1973-07-26|N|1973-08-23
TRIAL STUDY 134XCP|LB|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|2||||GLOBB1|BETA-1 GLOBULIN|||||||/CMH2O|||||||INVALID||KG/CM2||||LOW|NOT DONE||||GASTRIC FLUID|DRIED|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|U|U|||N|3||39||TREATMENT|1965-04-23|1968-07-19|||||1971-05-12||1971-06-29|Y|1971-03-26
TRIAL STUDY 134XCP|LB|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|1||||CL|CHLORIDE|||||||CM/S|||||||NEGATIVE||MPL U||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|CLOTTED|Y|ELECTROGASTROGRAPHY|NASH FIBROSURE FORMULA||Y|Y|U|NA|||U|4||88||SCREENING|1960-03-23|1961-08-30|||||1960-01-19||1972-10-31|U|1971-04-25
TRIAL STUDY 134XCP|LB|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|2||||GMCSF|GRANULOCYTE MACROPHAGE COLONY STM FACTOR|||||||GENEQ|||||||TRACE||S*KPA||||LOW|NOT DONE||||LYSATE|ICTERIC|U|CELL OF ORIGIN ASSAY|MDRD 5 VARIABLE FORMULA||NA|N|NA|U|||Y|4||88||WASHOUT|1971-10-29|1961-02-10|||||1964-01-18||1962-04-09|U|1970-06-18
TRIAL STUDY 134XCP|LB|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|1||||INTLK21|INTERLEUKIN 21|||||||S*KPA|||||||TRACE||CI/KG||||LOW|NOT DONE||||LYMPH|AGGLUTINATED|Y|SANGER SEQUENCING|NASH FIBROSURE FORMULA||U|U|U|N|||NA|5||7||RUN-IN|1972-10-10|1963-12-13|||||1972-04-07||1960-01-26|N|1966-07-09
TRIAL STUDY 134XCP|LB|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|2||||ENA78|EPITH NEUTROPHIL-ACTIVATING PEPTIDE 78|||||||ML/KG/H|||||||INDETERMINATE||10^4/L||||HIGH|NOT DONE||||SPERMATOZOON|AGGLUTINATED|NA|THICK SMEAR|NASH FIBROSURE FORMULA||N|NA|NA|Y|||N|5||7||INDUCTION TREATMENT|1960-06-14|1973-06-23|||||1966-08-21||1971-04-25|NA|1961-09-21
TRIAL STUDY 134XCP|LB|7DF25CA4-0846-4180-9356-F53C704F0233|1||||PLATHCT|PLATELET HEMATOCRIT|||||||MG/ML/MIN|||||||BORDERLINE||NMOL/ML/MIN||||NORMAL|NOT DONE||||FLUID|UNEXPECTED ODOR|N|PALPATION|HEPASCORE FORMULA||Y|NA|N|N|||Y|1||38||TREATMENT|1960-10-18|1962-09-02|||||1964-12-24||1961-12-14|N|1970-03-18
TRIAL STUDY 134XCP|LB|7DF25CA4-0846-4180-9356-F53C704F0233|2||||IOHEXCLR|IOHEXOL CLEARANCE|||||||AFU|||||||NEGATIVE||U/CL||||LOW|NOT DONE||||BASAL TEAR|FROZEN|NA|LYMPHANGIOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|Y|U|Y|||NA|1||38||SCREENING|1961-11-09|1965-01-25|||||1964-09-23||1965-12-29|N|1966-05-19
TRIAL STUDY 134XCP|LB|7DF25CA4-0846-4180-9356-F53C704F0233|1||||C165881|WHITE ELM POLLEN IGE ANTIBODY|||||||NU/CL|||||||BORDERLINE||CIGARETTE||||LOW|NOT DONE||||GASTRIC FLUID|CONTAMINATED|N|CLIP|HEPASCORE FORMULA||Y|U|Y|Y|||U|2||58||WASHOUT|1962-02-05|1970-08-27|||||1973-06-30||1972-04-06|Y|1966-12-06
TRIAL STUDY 134XCP|LB|7DF25CA4-0846-4180-9356-F53C704F0233|2||||NUCSWELL|NUCLEAR SWELLING|||||||ML/KG/H|||||||TRACE||COPIES/ML||||LOW|NOT DONE||||VENOUS BLOOD|SOLIDIFIED|NA|WESTERN BLOT|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|U|||NA|2||58||INDUCTION TREATMENT|1964-09-11|1971-01-23|||||1970-12-22||1960-08-09|Y|1961-02-08
TRIAL STUDY 134XCP|LB|7DF25CA4-0846-4180-9356-F53C704F0233|1||||PROTPATN|PROTEIN PATTERN|||||||IN2|||||||INVALID||U/CL||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|SOLIDIFIED|N|ULTRASOUND|ASH FIBROSURE FORMULA||U|N|U|NA|||N|3||39||LONG-TERM FOLLOW-UP|1972-11-24|1971-11-26|||||1973-03-03||1965-01-24|U|1964-05-01
TRIAL STUDY 134XCP|LB|7DF25CA4-0846-4180-9356-F53C704F0233|2||||METAMYCE|METAMYELOCYTES/TOTAL CELLS|||||||UMOL/H/MMOL|||||||INDETERMINATE||BQ/KG||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|FROZEN|N|ULTRASOUND|MDRD ENZYMATIC FORMULA||NA|Y|Y|N|||NA|3||39||OPEN LABEL TREATMENT|1964-06-08|1973-01-07|||||1973-07-03||1963-05-30|Y|1969-11-10
TRIAL STUDY 134XCP|LB|7DF25CA4-0846-4180-9356-F53C704F0233|1||||PROLYMLY|PROLYMPHOCYTES/LYMPHOCYTES|||||||NMOL BCE/L|||||||NEGATIVE||PMOL||||LOW|NOT DONE||||CELL PELLET|SOLIDIFIED|NA|POLYGRAPHY|GMI MMOL/MOL FORMULA||N|U|NA|Y|||NA|4||88||INDUCTION TREATMENT|1963-01-28|1968-08-19|||||1963-04-27||1963-06-08|U|1969-06-30
TRIAL STUDY 134XCP|LB|7DF25CA4-0846-4180-9356-F53C704F0233|2||||GSTAL|ALPHA GLUTATHIONE-S-TRANSFERASE|||||||ML/ANIMAL|||||||INDETERMINATE||CMOL||||HIGH|NOT DONE||||SPERMATOZOON|REFRIGERATED|N|IRON HEMATOXYLIN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|NA|||Y|4||88||CONTINUATION TREATMENT|1968-03-11|1963-10-03|||||1970-04-01||1966-11-24|NA|1970-10-18
TRIAL STUDY 134XCP|LB|7DF25CA4-0846-4180-9356-F53C704F0233|1||||AMMONIA|AMMONIA|||||||CUP|||||||POSITIVE||KPA||||ABNORMAL|NOT DONE||||PUS|DRIED|Y|IMMUNOPRECIPITATION|MDRD 6 VARIABLE FORMULA||Y|U|U|NA|||Y|5||7||CONTINUATION TREATMENT|1969-07-13|1969-10-18|||||1963-12-12||1968-02-27|Y|1960-06-18
TRIAL STUDY 134XCP|LB|7DF25CA4-0846-4180-9356-F53C704F0233|2||||ALPCREAT|ALKALINE PHOSPHATASE/CREATININE|||||||UG/DAY|||||||POSITIVE||M/SEC2||||NORMAL|NOT DONE||||CERUMEN|REFRIGERATED|U|IMMUNOFIXATION ELECTROPHORESIS|FIBROMETER FORMULA||N|N|N|U|||NA|5||7||CONTINUATION TREATMENT|1962-11-23|1963-10-01|||||1962-04-20||1969-05-25|N|1973-01-21
TRIAL STUDY 134XCP|LB|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|1||||C130131|DOG DANDER ANTIGEN IGG4 ANTIBODY|||||||USIEMENS|||||||INVALID||G/KG/DAY||||HIGH|NOT DONE||||LUNG SURFACTANT|CALCIFIED|NA|HIGH RESOLUTION CT|ASH FIBROSURE FORMULA||U|Y|U|Y|||N|1||38||RUN-IN|1973-09-04|1960-06-10|||||1961-09-02||1968-10-03|U|1964-11-16
TRIAL STUDY 134XCP|LB|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|2||||VITB9|VITAMIN B9|||||||G/CM2|||||||INDETERMINATE||DAGU/ML||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CONTAMINATED|N|SCANNING ELECTRON MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|Y|||N|1||38||OPEN LABEL TREATMENT|1962-10-17|1962-09-06|||||1972-12-19||1962-02-09|N|1963-07-20
TRIAL STUDY 134XCP|LB|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|1||||PLATGNT|GIANT PLATELETS|||||||MIN*MG/ML|||||||INDETERMINATE||ML/M2/H||||LOW|NOT DONE||||MONOCYTE|NON-HEMOLYZED|NA|NEXT GENERATION SEQUENCING|GMI MMOL/MOL FORMULA||NA|U|NA|NA|||Y|2||58||RUN-IN|1964-09-12|1972-06-08|||||1967-07-17||1972-06-05|NA|1972-10-28
TRIAL STUDY 134XCP|LB|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|2||||DNPSEPHD|D-NORPSEUDOEPHEDRINE|||||||KG/M2|||||||BORDERLINE||DEG||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|CONCENTRATED|N|IMMUNOTURBIDIMETRY|CKD-EPI CYSTATIN C FORMULA||U|NA|Y|NA|||NA|2||58||RUN-IN|1965-07-12|1960-07-08|||||1965-09-02||1960-12-19|NA|1961-11-14
TRIAL STUDY 134XCP|LB|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|1||||TAT|THROMBIN/ANTITHROMBIN|||||||YEARS|||||||INVALID||U/G HB||||ABNORMAL|NOT DONE||||RETICULOCYTES|AUTOLYZED|U|ISHIHARA COLOR PLATES|COCKCROFT-GAULT FORMULA||U|N|NA|U|||NA|3||39||OPEN LABEL TREATMENT|1972-06-13|1962-12-07|||||1967-08-04||1965-01-20|U|1960-07-19
TRIAL STUDY 134XCP|LB|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|2||||MYPCERPC|MYELOID/ERYTHROID RATIO|||||||UG/MIN|||||||TRACE||AG||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|DRIED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|GMI MMOL/MOL FORMULA||NA|Y|NA|N|||U|3||39||RUN-IN|1961-06-29|1972-12-03|||||1962-07-08||1965-01-28|Y|1972-12-06
TRIAL STUDY 134XCP|LB|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|1||||CYCYSTIN|CYSTINE CRYSTALS|||||||MV/SEC|||||||POSITIVE||MPS U||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|LACTESCENT|NA|ANTIMICROBIAL COMBINATION TESTING|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|U|||NA|4||88||TREATMENT|1967-04-07|1972-04-03|||||1966-03-17||1970-01-16|Y|1965-03-09
TRIAL STUDY 134XCP|LB|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|2||||INSAAB|INSULIN AUTOANTIBODY|||||||10^9 CFU|||||||POSITIVE||DROP||||NORMAL|NOT DONE||||LOCHIA|ICTERIC|Y|CT SCAN|MDRD 5 VARIABLE FORMULA||NA|N|N|N|||N|4||88||WASHOUT|1961-05-23|1967-08-31|||||1961-12-10||1960-09-22|U|1960-10-14
TRIAL STUDY 134XCP|LB|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|1||||C130074|BIRCH POLLEN IGG|||||||BQ/L|||||||TRACE||DIP||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|FRESH|N|CYSTOMETRY|MDRD 5 VARIABLE FORMULA||U|U|U|N|||U|5||7||RUN-IN|1960-08-03|1960-02-01|||||1965-02-12||1973-05-06|U|1963-02-01
TRIAL STUDY 134XCP|LB|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|2||||APOA5|APOLIPOPROTEIN A5|||||||10^9/G|||||||INDETERMINATE||BQ/MG||||LOW|NOT DONE||||VITREOUS HUMOR|UNEXPECTED ODOR|N|PHASE-CONTRAST MRI|MDRD 5 VARIABLE FORMULA||U|NA|U|NA|||N|5||7||CONTINUATION TREATMENT|1966-02-23|1960-06-16|||||1972-01-14||1962-02-07|U|1962-05-30
TRIAL STUDY 134XCP|LB|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|1||||NRDZPM|NORDAZEPAM|||||||1/(S*KPA)|||||||BORDERLINE||UMOL/L/MIN||||HIGH|NOT DONE||||EPITHELIAL CELL|LACTESCENT|U|ENDPOINT DILUTION ASSAY|MDRD ENZYMATIC FORMULA||U|N|NA|N|||N|1||38||SCREENING|1966-11-19|1966-11-07|||||1960-03-16||1961-12-17|N|1968-06-23
TRIAL STUDY 134XCP|LB|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|2||||CLRDZPXD|CHLORDIAZEPOXIDE|||||||MIN/DAY|||||||INVALID||PIXELS/CM||||ABNORMAL|NOT DONE||||SPUTUM|CALCIFIED|NA|CONFOCAL MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|N|Y|||N|1||38||OPEN LABEL TREATMENT|1969-11-02|1970-07-20|||||1962-06-04||1972-01-06|Y|1963-06-16
TRIAL STUDY 134XCP|LB|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|1||||GLOBA1PT|ALPHA-1 GLOBULIN/TOTAL PROTEIN|||||||WEEKS|||||||INVALID||BOLUS||||NORMAL|NOT DONE||||SWABBED MATERIAL|CONTAMINATED|Y|MULTI-SLICE SPIRAL CT|MDRD 6 VARIABLE FORMULA||N|N|Y|Y|||U|2||58||RUN-IN|1963-12-24|1962-03-29|||||1962-05-20||1964-03-21|Y|1961-12-31
TRIAL STUDY 134XCP|LB|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|2||||ADAM8|ADAM METALLOPEPTIDASE DOMAIN 8|||||||PMOL/G|||||||NEGATIVE||10^9/L||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|UNEXPECTED ODOR|U|ENDPOINT DILUTION ASSAY|MDRD 4 VARIABLE FORMULA||N|Y|Y|NA|||N|2||58||FOLLOW-UP|1964-10-23|1964-12-29|||||1962-10-31||1966-06-19|N|1962-01-20
TRIAL STUDY 134XCP|LB|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|1||||MIP1G|MACROPHAGE INFLAMMATORY PROTEIN 1 GAMMA|||||||CIGARETTE|||||||BORDERLINE||TRANSDUCING UNIT||||HIGH|NOT DONE||||DERMAL TISSUE|LIPEMIC|U|DROPLET DIGITAL PCR|MDRD ENZYMATIC FORMULA||N|N|NA|Y|||N|3||39||WASHOUT|1962-08-29|1970-05-11|||||1967-12-20||1969-07-04|U|1961-04-01
TRIAL STUDY 134XCP|LB|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|2||||GLUBD13|1,3-BETA-D-GLUCAN|||||||MMHG|||||||INDETERMINATE||%/S||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|FROZEN|NA|MICROARRAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|N|U|||N|3||39||RUN-IN|1961-06-21|1961-04-21|||||1961-02-24||1963-07-02|NA|1968-11-22
TRIAL STUDY 134XCP|LB|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|1||||T3|TRIIODOTHYRONINE|||||||HOURS|||||||NEGATIVE||EIA UNIT||||NORMAL|NOT DONE||||SYNOVIAL FLUID|GELLED|Y|POLYSOMNOGRAPHY|MDRD 5 VARIABLE FORMULA||N|Y|N|N|||U|4||88||WASHOUT|1963-09-19|1965-07-09|||||1965-09-05||1970-06-12|U|1971-11-09
TRIAL STUDY 134XCP|LB|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|2||||ANPPROMR|MID-REG PRO-ATRIAL NATRIURETIC PEPTIDE|||||||GPELISA UNIT/ML|||||||BORDERLINE||NMOL/MOL||||LOW|NOT DONE||||BREAST MILK|DRIED|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA||U|N|Y|Y|||NA|4||88||OBSERVATION|1963-10-04|1968-04-13|||||1963-10-28||1968-01-18|N|1971-01-24
TRIAL STUDY 134XCP|LB|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|1||||IL2RA|INTERLEUKIN 2 RECEPTOR SUBUNIT ALPHA|||||||L/L|||||||TRACE||MASK||||ABNORMAL|NOT DONE||||EXUDATE|LIPEMIC|U|FLOCCULATION, CHARCOAL ENHANCED|FIBROMETER FORMULA||NA|U|N|Y|||N|5||7||RUN-IN|1971-06-07|1960-02-20|||||1963-01-16||1973-07-20|N|1964-04-06
TRIAL STUDY 134XCP|LB|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|2||||MDZPM|MEDAZEPAM|||||||QUANTITY SUFFICIENT|||||||POSITIVE||KM||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|CONTAMINATED|U|PELLI-ROBSON EYE CHART|MDRD 5 VARIABLE FORMULA||N|N|NA|Y|||NA|5||7||CONTINUATION TREATMENT|1973-01-29|1961-08-24|||||1968-10-17||1967-03-18|Y|1966-04-09
TRIAL STUDY 134XCP|LB|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|1||||FIXAAC|FACTOR IX ACTIVITY ACTUAL/CONTROL|||||||ENZYME U/L|||||||TRACE||UG/M2||||LOW|NOT DONE||||BREAST MILK|DRIED|N|TOLUIDINE BLUE STAIN|MDRD ENZYMATIC FORMULA||N|U|Y|NA|||Y|1||38||FOLLOW-UP|1961-02-03|1966-03-10|||||1968-12-14||1961-04-05|Y|1969-03-27
TRIAL STUDY 134XCP|LB|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|2||||TGFB2|TRANSFORMING GROWTH FACTOR BETA 2|||||||U/L|||||||INDETERMINATE||UMOL/MG/MIN||||HIGH|NOT DONE||||ADIPOSE TISSUE|DRIED|NA|MAGNETIC RESONANCE ANGIOGRAPHY|MDRD ENZYMATIC FORMULA||NA|N|NA|U|||U|1||38||FOLLOW-UP|1961-01-22|1970-10-11|||||1969-01-21||1964-09-20|U|1965-06-09
TRIAL STUDY 134XCP|LB|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|1||||LVFBRSC|LIVER FIBROSIS SCORE|||||||YD|||||||INDETERMINATE||COPIES/UG||||NORMAL|NOT DONE||||BONE|LIPEMIC|U|ERGOSPIROMETRY|GMI % FORMULA||N|U|Y|U|||U|2||58||WASHOUT|1966-12-20|1971-09-30|||||1965-11-21||1966-04-17|N|1966-10-25
TRIAL STUDY 134XCP|LB|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|2||||CAPHOS|CALCIUM/PHOSPHORUS|||||||UKAT|||||||POSITIVE||STEPS/MIN||||ABNORMAL|NOT DONE||||ABSCESS FLUID|NON-HEMOLYZED|Y|MECHANICAL CLOT DETECTION|FIBROTEST FORMULA||NA|N|N|N|||Y|2||58||OBSERVATION|1969-05-24|1962-01-18|||||1967-07-25||1967-09-22|NA|1960-10-04
TRIAL STUDY 134XCP|LB|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|1||||DDNAIGAB|ANTI-DOUBLE STRANDED DNA IGG|||||||UU/DL|||||||POSITIVE||BU/ML||||LOW|NOT DONE||||EPITHELIAL CELL|ROOM TEMPERATURE|Y|DIFFUSION TENSOR MRI|CKD-EPI CYSTATIN C FORMULA||U|U|NA|NA|||U|3||39||CONTINUATION TREATMENT|1969-01-12|1971-05-19|||||1965-01-14||1964-01-23|U|1972-06-09
TRIAL STUDY 134XCP|LB|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|2||||HCGFR|CHORIOGONADOTROPIN BETA, FREE|||||||DPM/MG|||||||TRACE||NEEDLE GAUGE||||NORMAL|NOT DONE||||ALVEOLAR AIR|CLOTTED|NA|GIEMSA STAIN|NASH FIBROSURE FORMULA||U|N|NA|NA|||N|3||39||BASELINE|1962-07-20|1967-11-07|||||1972-07-31||1969-01-04|U|1964-10-14
TRIAL STUDY 134XCP|LB|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|1||||CGA|CHROMOGRANIN A|||||||CM|||||||TRACE||HENRY||||HIGH|NOT DONE||||INTERSTITIAL FLUID|GELLED|NA|PALM METHOD|NASH FIBROSURE FORMULA||N|N|U|NA|||U|4||88||WASHOUT|1965-04-14|1961-12-08|||||1965-08-12||1970-11-28|Y|1971-08-10
TRIAL STUDY 134XCP|LB|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|2||||GFRBSCCC|GFR FROM CYSTATIN C AND CREAT ADJ BSA|||||||UMOL/H/MMOL|||||||TRACE||GRAIN||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|NON-HEMOLYZED|NA|CONTRAST ENHANCED PET/CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|U|N|||Y|4||88||SCREENING|1964-02-21|1973-06-19|||||1961-11-12||1968-09-18|Y|1960-09-11
TRIAL STUDY 134XCP|LB|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|1||||ERCEMIDX|ERYTHROID MATURATION INDEX|||||||ENZYME U/M2|||||||POSITIVE||PFU/DOSE||||LOW|NOT DONE||||BREAST MILK|GELLED|N|PET/CT SCAN WITHOUT CONTRAST|FIBROTEST FORMULA||N|Y|U|U|||Y|5||7||BASELINE|1972-01-01|1962-05-03|||||1970-10-11||1961-02-18|NA|1972-11-02
TRIAL STUDY 134XCP|LB|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|2||||CYP2C9|CYTOCHROME P450 2C9|||||||ECL UNIT|||||||TRACE||BQ/MG||||ABNORMAL|NOT DONE||||PERSPIRATION|LIPEMIC|Y|IHC|NASH FIBROSURE FORMULA||U|U|Y|N|||NA|5||7||OBSERVATION|1970-03-01|1964-11-28|||||1971-05-25||1964-09-25|Y|1960-09-24
TRIAL STUDY 134XCP|LB|2C15756E-1096-403B-989D-D2C3D31396A9|1||||MONOBL|MONOBLASTS|||||||ELISA UNIT|||||||TRACE||PACK||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|CLOTTED|N|TRIPLE-PHASE SPIRAL CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|NA|U|||Y|1||38||OBSERVATION|1964-03-14|1964-12-23|||||1960-06-19||1966-04-24|U|1971-04-26
TRIAL STUDY 134XCP|LB|2C15756E-1096-403B-989D-D2C3D31396A9|2||||MSPIKEXR|MONOCLONAL PROTEIN SPIKE EXCRETION RATE|||||||PLUG|||||||POSITIVE||UG/G/H||||NORMAL|NOT DONE||||SOFT TISSUE|REFRIGERATED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|U|NA|||U|1||38||BLINDED TREATMENT|1960-06-10|1961-05-10|||||1973-05-27||1964-03-16|NA|1968-01-23
TRIAL STUDY 134XCP|LB|2C15756E-1096-403B-989D-D2C3D31396A9|1||||TFRRNSAT|TRANSFERRIN SATURATION|||||||HOMEOPATHIC DILUTION|||||||BORDERLINE||ML||||LOW|NOT DONE||||WHITE MATTER TISSUE|ROOM TEMPERATURE|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|NASH FIBROSURE FORMULA||NA|U|U|N|||NA|2||58||OPEN LABEL TREATMENT|1967-06-02|1970-03-27|||||1963-10-14||1962-08-27|Y|1966-01-09
TRIAL STUDY 134XCP|LB|2C15756E-1096-403B-989D-D2C3D31396A9|2||||CKMT2CK|CK, MACROMOLECULAR TYPE 2/TOTAL CK|||||||10^9/DOSE|||||||INVALID||MEQ/KG||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|SOLIDIFIED|N|DIGITAL PCR|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|Y|Y|||N|2||58||INDUCTION TREATMENT|1971-08-03|1965-08-15|||||1966-08-23||1963-04-27|Y|1966-08-07
TRIAL STUDY 134XCP|LB|2C15756E-1096-403B-989D-D2C3D31396A9|1||||NEUTB|NEUTROPHILS BAND FORM|||||||S^-1(%O2)^-1|||||||INVALID||PA||||ABNORMAL|NOT DONE||||LOCHIA|NON-HEMOLYZED|NA|SMEAR|MDRD 4 VARIABLE FORMULA||Y|N|Y|U|||Y|3||39||RUN-IN|1969-06-15|1963-09-29|||||1971-06-15||1963-11-12|Y|1968-10-03
TRIAL STUDY 134XCP|LB|2C15756E-1096-403B-989D-D2C3D31396A9|2||||GSTAL|ALPHA GLUTATHIONE-S-TRANSFERASE|||||||NMOL BCE/NMOL|||||||INDETERMINATE||%/S||||LOW|NOT DONE||||EPIDERMAL TISSUE|AUTOLYZED|Y|CONTRAST ENHANCED PET SCAN|CKD-EPI FORMULA||NA|Y|NA|NA|||NA|3||39||OPEN LABEL TREATMENT|1969-09-12|1965-03-03|||||1963-02-13||1960-02-22|U|1971-02-01
TRIAL STUDY 134XCP|LB|2C15756E-1096-403B-989D-D2C3D31396A9|1||||APRI|AST TO PLATELET RATIO INDEX|||||||MILE|||||||NEGATIVE||SCOOPFUL||||ABNORMAL|NOT DONE||||KERATINOCYTE|PARAFFIN-EMBEDDED|NA|AUDIOMETRY|FIBROMETER FORMULA||N|U|N|NA|||U|4||88||SCREENING|1967-09-09|1964-05-07|||||1962-11-16||1962-03-14|Y|1962-11-07
TRIAL STUDY 134XCP|LB|2C15756E-1096-403B-989D-D2C3D31396A9|2||||HDWR|RET HEMOGLOBIN DISTRIBUTION WIDTH|||||||BISCUIT|||||||INDETERMINATE||KM||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|LACTESCENT|N|ELECTROPHORESIS|FIBROTEST FORMULA||N|NA|U|N|||N|4||88||RUN-IN|1972-08-05|1969-01-09|||||1973-05-20||1973-06-14|U|1973-07-13
TRIAL STUDY 134XCP|LB|2C15756E-1096-403B-989D-D2C3D31396A9|1||||ANDSTNDL|ANDROSTENEDIOL|||||||TRANSDUCING UNIT|||||||BORDERLINE||TRACE||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|FRESH|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD 5 VARIABLE FORMULA||N|NA|N|NA|||Y|5||7||TREATMENT|1961-08-03|1968-02-03|||||1962-09-01||1962-09-27|N|1962-04-16
TRIAL STUDY 134XCP|LB|2C15756E-1096-403B-989D-D2C3D31396A9|2||||IL122340|INTERLEUKIN 12+23 P40|||||||MMHG|||||||NEGATIVE||UIU/DL||||LOW|NOT DONE||||INFRANATANT, SERUM|AUTOLYZED|N|HILLMEN COLOR CHART|MDRD ENZYMATIC FORMULA||NA|N|U|N|||N|5||7||BLINDED TREATMENT|1961-04-03|1967-06-22|||||1962-05-16||1965-07-25|N|1961-04-24
TRIAL STUDY 134XCP|LB|CD103276-37FC-4E40-A0C8-8D1300D21AE1|1||||STOMCY|STOMATOCYTES|||||||ML/ANIMAL/DAY|||||||INVALID||CI/G||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|SOLIDIFIED|N|DUKE INCISION METHOD|MDRD ENZYMATIC FORMULA||Y|NA|U|N|||NA|1||38||LONG-TERM FOLLOW-UP|1969-02-21|1966-03-20|||||1969-10-28||1969-10-29|U|1960-07-11
TRIAL STUDY 134XCP|LB|CD103276-37FC-4E40-A0C8-8D1300D21AE1|2||||MOCYCECE|MONOCYTOID CELLS/TOTAL CELLS|||||||U/KG/MIN|||||||POSITIVE||DAYS/MONTH||||HIGH|NOT DONE||||MUCUS|CALCIFIED|U|WRIGHT-GIEMSA STAIN|GMI % FORMULA||Y|N|N|NA|||N|1||38||SCREENING|1965-08-27|1967-08-18|||||1966-09-24||1961-08-29|Y|1972-07-18
TRIAL STUDY 134XCP|LB|CD103276-37FC-4E40-A0C8-8D1300D21AE1|1||||HEPARIN|HEPARIN|||||||10^7 CFU/ML|||||||TRACE||MGEQ||||HIGH|NOT DONE||||PROSTATIC FLUID|CONCENTRATED|Y|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD 5 VARIABLE FORMULA||NA|NA|NA|Y|||NA|2||58||CONTINUATION TREATMENT|1963-01-03|1962-08-21|||||1963-04-04||1960-03-15|NA|1971-11-01
TRIAL STUDY 134XCP|LB|CD103276-37FC-4E40-A0C8-8D1300D21AE1|2||||MUCTHR|MUCOUS THREADS|||||||UEQ/L|||||||INDETERMINATE||BE/ML||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|CALCIFIED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|HEPASCORE FORMULA||U|U|Y|Y|||U|2||58||BLINDED TREATMENT|1965-04-02|1972-02-06|||||1967-10-26||1969-03-25|N|1962-12-03
TRIAL STUDY 134XCP|LB|CD103276-37FC-4E40-A0C8-8D1300D21AE1|1||||METARUB|METARUBRICYTE|||||||ML/CAGE/DAY|||||||INDETERMINATE||FFU||||NORMAL|NOT DONE||||TISSUE|LACTESCENT|NA|WEBER GREEN STAIN|CKD-EPI CREATININE FORMULA||NA|Y|U|NA|||Y|3||39||CONTINUATION TREATMENT|1970-07-26|1969-03-02|||||1962-09-22||1966-02-15|U|1961-02-18
TRIAL STUDY 134XCP|LB|CD103276-37FC-4E40-A0C8-8D1300D21AE1|2||||HLAA23A|HLA-A23 ANTIBODY|||||||UG/M2/MIN|||||||INVALID||QUANTITY SUFFICIENT||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|GELLED|NA|HPLC|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|N|||U|3||39||RUN-IN|1971-05-18|1968-10-08|||||1965-06-28||1961-11-18|N|1960-10-15
TRIAL STUDY 134XCP|LB|CD103276-37FC-4E40-A0C8-8D1300D21AE1|1||||CD3|CD3|||||||CS|||||||TRACE||MMHG/L/MIN||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|CLOTTED|N|ELECTROPHORESIS|MDRD ENZYMATIC FORMULA||NA|NA|Y|N|||NA|4||88||BLINDED TREATMENT|1964-09-27|1966-02-06|||||1970-06-24||1963-10-12|U|1971-02-22
TRIAL STUDY 134XCP|LB|CD103276-37FC-4E40-A0C8-8D1300D21AE1|2||||FAI|FREE ANDROGEN INDEX|||||||UGEQ/L|||||||INDETERMINATE||UCI||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|ICTERIC|Y|MICROSCOPY|MDRD 4 VARIABLE FORMULA||N|U|NA|N|||NA|4||88||OPEN LABEL TREATMENT|1967-08-19|1972-02-01|||||1965-06-02||1971-10-29|NA|1962-06-02
TRIAL STUDY 134XCP|LB|CD103276-37FC-4E40-A0C8-8D1300D21AE1|1||||VLDL1|VLDL CHOLESTEROL SUBTYPE 1|||||||ML/MIN/1.73M2|||||||BORDERLINE||LOG10 COPIES/ML||||LOW|NOT DONE||||SUPERNATANT, SERUM|DRIED|U|WRIGHT STAIN|CKD-EPI CREATININE FORMULA||NA|NA|N|Y|||U|5||7||WASHOUT|1969-10-27|1973-07-24|||||1963-04-06||1964-12-31|Y|1963-09-10
TRIAL STUDY 134XCP|LB|CD103276-37FC-4E40-A0C8-8D1300D21AE1|2||||A2MACG|ALPHA-2 MACROGLOBULIN|||||||UMOL/KG/MIN|||||||NEGATIVE||G/MOL||||NORMAL|NOT DONE||||SALIVA|CLOTTED|U|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|U|Y|||Y|5||7||TREATMENT|1961-09-05|1967-08-14|||||1968-09-27||1970-02-06|NA|1964-07-14
TRIAL STUDY 134XCP|LB|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|1||||HLAAMSC|HLA-A MISMATCH COUNT|||||||MOSM/L|||||||INVALID||AMOL||||ABNORMAL|NOT DONE||||GASTRIC FLUID|CALCIFIED|NA|MICROSCOPY|FIBROSIS 4 FORMULA||NA|Y|N|NA|||Y|1||38||WASHOUT|1967-01-17|1963-11-21|||||1960-11-27||1969-05-04|NA|1972-06-02
TRIAL STUDY 134XCP|LB|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|2||||RDCSUG|REDUCING SUGARS|||||||10^8/L|||||||POSITIVE||U/G/H||||NORMAL|NOT DONE||||LEUKOCYTE|HEMOLYZED|U|FLUORESCENT MICROSCOPY|FIBROSIS 4 FORMULA||NA|Y|NA|Y|||N|1||38||FOLLOW-UP|1962-10-02|1961-11-03|||||1964-03-22||1964-04-07|U|1962-07-13
TRIAL STUDY 134XCP|LB|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|1||||ELA1|PANCREATIC ELASTASE 1|||||||%|||||||POSITIVE||NMOL/KG/DAY||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|FROZEN|NA|RADIOGRAPHY|NASH FIBROSURE FORMULA||N|U|N|N|||NA|2||58||TREATMENT|1968-08-25|1963-10-19|||||1966-12-10||1963-09-19|NA|1960-11-09
TRIAL STUDY 134XCP|LB|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|2||||GHBP|GROWTH HORMONE BINDING PROTEIN|||||||GPS U|||||||BORDERLINE||RNA COPIES/ML||||NORMAL|NOT DONE||||EXPIRED AIR|UNEXPECTED ODOR|N|CENTRIFUGATION|GMI % FORMULA||N|N|NA|N|||Y|2||58||RUN-IN|1968-11-05|1960-12-04|||||1963-09-29||1966-05-01|N|1971-07-14
TRIAL STUDY 134XCP|LB|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|1||||STAT3PS3|PHOSPHORYLATED STAT3/STAT3|||||||BAU|||||||NEGATIVE||ML/CM3/MIN||||HIGH|NOT DONE||||PLEURAL TISSUE|REFRIGERATED|NA|MICROSCOPY|MDRD 6 VARIABLE FORMULA||U|NA|NA|Y|||N|3||39||WASHOUT|1967-10-15|1964-11-03|||||1966-09-20||1972-07-25|N|1968-09-19
TRIAL STUDY 134XCP|LB|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|2||||PIVKAII|PROTEIN INDUCED BY VITAMIN K ABSENCE-II|||||||10^6 COPIES/ML|||||||POSITIVE||MMHG*MIN/L||||LOW|NOT DONE||||TISSUE|PARAFFIN-EMBEDDED|Y|EEG|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|U|||Y|3||39||RUN-IN|1972-11-20|1973-03-10|||||1965-08-14||1964-03-29|N|1968-04-13
TRIAL STUDY 134XCP|LB|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|1||||LAG3S|SOLUBLE LYMPHOCYTE ACTIVATION GENE-3|||||||CM2|||||||INVALID||ML/ANIMAL/DAY||||ABNORMAL|NOT DONE||||URINE SEDIMENT|GELLED|U|ENZYMATIC SPECTROPHOTOMETRY|MDRD 5 VARIABLE FORMULA||U|NA|Y|NA|||Y|4||88||SCREENING|1963-05-27|1967-08-07|||||1961-03-29||1966-10-04|Y|1962-06-11
TRIAL STUDY 134XCP|LB|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|2||||CH100|COMPLEMENT CH100|||||||ML/(MIN*100ML)|||||||BORDERLINE||TSP EQ||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|ICTERIC|Y|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|ASH FIBROSURE FORMULA||Y|Y|NA|N|||Y|4||88||RUN-IN|1968-01-15|1963-09-06|||||1973-04-30||1972-12-23|N|1969-11-24
TRIAL STUDY 134XCP|LB|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|1||||PLATGNT|GIANT PLATELETS|||||||ML*CMH2O|||||||TRACE||G/ANIMAL/DAY||||LOW|NOT DONE||||ALVEOLAR AIR|SOLIDIFIED|N|AGAR PROPORTION|COCKCROFT-GAULT FORMULA||NA|NA|U|U|||Y|5||7||BASELINE|1970-12-14|1970-04-21|||||1972-05-13||1964-02-02|N|1972-06-18
TRIAL STUDY 134XCP|LB|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|2||||NAGASEXR|NAGASE EXCRETION RATE|||||||MG/KG|||||||INDETERMINATE||CGY||||HIGH|NOT DONE||||AMNIOTIC FLUID|AGGLUTINATED|N|TOTAL BODY IRRADIATION|FIBROTEST FORMULA||Y|Y|U|U|||Y|5||7||WASHOUT|1960-02-23|1970-03-08|||||1965-07-15||1963-04-28|U|1971-10-10
TRIAL STUDY 134XCP|LB|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|1||||BNP|BRAIN NATRIURETIC PEPTIDE|||||||KCAL/DAY|||||||TRACE||KM||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED|Y|FARNSWORTH-MUNSELL 100 HUE TEST|NASH FIBROSURE FORMULA||U|NA|U|U|||N|1||38||FOLLOW-UP|1964-04-29|1963-11-12|||||1972-12-08||1969-09-11|U|1960-06-16
TRIAL STUDY 134XCP|LB|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|2||||HLAIIAB|HLA CLASS II ANTIBODY|||||||MMHG/SEC|||||||NEGATIVE||DAYS/WK||||NORMAL|NOT DONE||||SEBUM|DRIED|U|CONTRAST ENHANCED PET SCAN|FIBROSIS 4 FORMULA||N|NA|U|U|||Y|1||38||RUN-IN|1966-10-05|1963-10-10|||||1967-05-01||1960-11-01|Y|1973-05-24
TRIAL STUDY 134XCP|LB|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|1||||TSTFTSTT|TESTOSTERONE, FREE/TESTOSTERONE|||||||GENEQ|||||||INDETERMINATE||NG/MOL||||LOW|NOT DONE||||LYSATE|HEMOLYZED|U|PULMONARY ANGIOGRAPHY|GMI MMOL/MOL FORMULA||U|NA|N|U|||Y|2||58||BLINDED TREATMENT|1968-09-03|1963-08-10|||||1967-05-18||1962-08-18|Y|1964-10-12
TRIAL STUDY 134XCP|LB|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|2||||FVIIIAAC|FACTOR VIII ACTIVITY ACTUAL/CONTROL|||||||MEQ/L|||||||INDETERMINATE||YEARS||||LOW|NOT DONE||||ADIPOSE TISSUE|HEMOLYZED|NA|ALCIAN BLUE STAIN|GMI MMOL/MOL FORMULA||U|U|NA|NA|||U|2||58||OBSERVATION|1968-11-12|1967-11-27|||||1965-05-17||1961-05-04|Y|1973-06-24
TRIAL STUDY 134XCP|LB|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|1||||PEPSNGC|PEPSINOGEN C|||||||GBQ|||||||INVALID||OD UNIT||||LOW|NOT DONE||||HAIR FOLLICLE|CALCIFIED|N|CLINICAL EVALUATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|N|NA|||Y|3||39||CONTINUATION TREATMENT|1972-02-26|1966-09-16|||||1970-01-08||1964-02-16|U|1970-10-04
TRIAL STUDY 134XCP|LB|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|2||||MPC|MEAN PLATELET COMPONENT|||||||CY/CM|||||||INVALID||ML/CM H2O||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|GMI % FORMULA||NA|U|N|U|||N|3||39||INDUCTION TREATMENT|1972-01-25|1967-03-02|||||1966-06-11||1969-05-05|NA|1965-11-14
TRIAL STUDY 134XCP|LB|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|1||||GRANLE|GRANULOCYTES/LEUKOCYTES|||||||UMOL/L/H|||||||NEGATIVE||ANSON U||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|CALCIFIED|N|VIRUS PLAQUE ASSAY|FIBROTEST FORMULA||NA|Y|NA|Y|||Y|4||88||OPEN LABEL TREATMENT|1968-12-23|1962-02-06|||||1967-02-12||1970-12-04|U|1960-01-03
TRIAL STUDY 134XCP|LB|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|2||||TRIM21|TRIPARTITE MOTIF CONTAINING PROTEIN 21|||||||BAU/ML|||||||BORDERLINE||MASK||||HIGH|NOT DONE||||CAPILLARY PLASMA|SOLIDIFIED|U|BETA LACTAMASE|FIBROTEST FORMULA||N|U|NA|NA|||U|4||88||FOLLOW-UP|1973-06-30|1971-11-04|||||1961-10-05||1973-08-26|Y|1972-01-26
TRIAL STUDY 134XCP|LB|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|1||||C130143|GERMAN COCKROACH ANTIGEN IGG4 ANTIBODY|||||||ABSORBANCE U/MIN|||||||INVALID||PMOL/L||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|PARAFFIN-EMBEDDED|U|TRIPLE-PHASE MRI SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|N|Y|||Y|5||7||TREATMENT|1962-09-26|1967-05-26|||||1962-10-22||1961-12-13|NA|1962-06-11
TRIAL STUDY 134XCP|LB|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|2||||CSGRANC|GRANULAR COARSE CASTS|||||||NKAT|||||||INVALID||MET||||HIGH|NOT DONE||||PLATELET|ROOM TEMPERATURE|U|CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE FORMULA||NA|NA|N|U|||U|5||7||OBSERVATION|1969-02-21|1968-01-08|||||1965-10-26||1968-10-21|NA|1963-07-17
TRIAL STUDY 134XCP|LB|7B583F10-E460-4B25-8A6B-530A154442CD|1||||TTAC|THROMBIN TIME ACTUAL/CONTROL|||||||ANTI-XA IU/ML|||||||POSITIVE||ELISA UNIT/DOSE||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|GELLED|NA|CONTRAST ENHANCED PET/CT SCAN|MDRD 5 VARIABLE FORMULA||U|NA|U|NA|||U|1||38||RUN-IN|1968-05-11|1972-11-29|||||1972-05-28||1965-09-27|N|1963-12-29
TRIAL STUDY 134XCP|LB|7B583F10-E460-4B25-8A6B-530A154442CD|2||||INTLK33|INTERLEUKIN 33|||||||MEQ/DAY|||||||INDETERMINATE||EID 50/ML||||NORMAL|NOT DONE||||BILE|GELLED|U|MAMMOGRAPHY|ASH FIBROSURE FORMULA||NA|U|Y|NA|||U|1||38||OPEN LABEL TREATMENT|1969-04-13|1969-12-27|||||1970-07-14||1961-06-15|Y|1962-07-27
TRIAL STUDY 134XCP|LB|7B583F10-E460-4B25-8A6B-530A154442CD|1||||ALBGLYCA|GLYCATED ALBUMIN|||||||MG/ANIMAL|||||||INDETERMINATE||DISK||||HIGH|NOT DONE||||PLATELET RICH PLASMA|SOLIDIFIED|Y|OPTICAL COHERENCE TOMOGRAPHY|MDRD ENZYMATIC FORMULA||Y|U|N|NA|||NA|2||58||OBSERVATION|1971-04-04|1962-07-13|||||1969-11-22||1966-05-27|N|1960-02-24
TRIAL STUDY 134XCP|LB|7B583F10-E460-4B25-8A6B-530A154442CD|2||||MONO|MONOCYTES|||||||MEQ/G|||||||BORDERLINE||NEBULE||||HIGH|NOT DONE||||CERUMEN|NON-HEMOLYZED|N|MULTI-SLICE SPIRAL CT|COCKCROFT-GAULT FORMULA||U|N|Y|N|||U|2||58||CONTINUATION TREATMENT|1965-02-09|1963-01-24|||||1971-07-08||1962-08-11|U|1961-09-09
TRIAL STUDY 134XCP|LB|7B583F10-E460-4B25-8A6B-530A154442CD|1||||NKINA|NEUROKININ A|||||||COPIES/ML|||||||POSITIVE||UG/M2||||NORMAL|NOT DONE||||GASTRIC CONTENTS|AGGLUTINATED|Y|PH METER MEASUREMENT METHOD|CKD-EPI CYSTATIN C FORMULA||N|Y|U|U|||N|3||39||TREATMENT|1972-08-14|1964-04-28|||||1969-04-03||1967-09-13|U|1960-07-08
TRIAL STUDY 134XCP|LB|7B583F10-E460-4B25-8A6B-530A154442CD|2||||GNRH|GONADOTROPIN RELEASING HORMONE|||||||VOXEL|||||||POSITIVE||L/H/M2||||NORMAL|NOT DONE||||LYMPH|FRESH|NA|CT SCAN WITHOUT CONTRAST|GMI % FORMULA||Y|Y|N|N|||U|3||39||OBSERVATION|1960-11-16|1962-06-11|||||1968-01-25||1961-12-20|U|1973-05-10
TRIAL STUDY 134XCP|LB|7B583F10-E460-4B25-8A6B-530A154442CD|1||||C165892|WILD RYE POLLEN IGE ANTIBODY|||||||G/U|||||||POSITIVE||CI||||LOW|NOT DONE||||COLOSTRUM|CALCIFIED|N|DYNAMIC LIGHT SCATTERING|GMI % FORMULA||NA|Y|U|U|||NA|4||88||WASHOUT|1962-10-18|1968-04-04|||||1973-07-07||1972-01-27|N|1962-10-11
TRIAL STUDY 134XCP|LB|7B583F10-E460-4B25-8A6B-530A154442CD|2||||CARNITF|CARNITINE, FREE|||||||MOL/MG|||||||BORDERLINE||DEG/MM||||LOW|NOT DONE||||BLOOD|HEMOLYZED|U|IN VITRO GENE EXPRESSION ASSAY|MDRD 4 VARIABLE FORMULA||Y|N|N|NA|||U|4||88||RUN-IN|1968-03-14|1967-11-04|||||1972-10-25||1972-01-11|U|1966-09-30
TRIAL STUDY 134XCP|LB|7B583F10-E460-4B25-8A6B-530A154442CD|1||||GLUCWBE|WHOLE BLOOD EQUIVALENT GLUCOSE|||||||LOG10 CCID 50/DOSE|||||||INVALID||10^8/L||||LOW|NOT DONE||||EXUDATE|CONCENTRATED|NA|MEDIASTINOSCOPY|CKD-EPI CREATININE FORMULA||N|U|Y|NA|||N|5||7||WASHOUT|1960-12-06|1969-01-01|||||1965-05-06||1964-09-07|Y|1972-12-23
TRIAL STUDY 134XCP|LB|7B583F10-E460-4B25-8A6B-530A154442CD|2||||C130140|GERMAN COCKROACH ANTIGEN IGE ANTIBODY|||||||ENZYME U/G HB|||||||BORDERLINE||U/M2/H||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|PARAFFIN-EMBEDDED|NA|PLAQUE REDUCTION NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA||U|U|U|NA|||Y|5||7||BASELINE|1970-03-13|1969-12-07|||||1965-10-12||1960-12-21|Y|1964-03-25
TRIAL STUDY 134XCP|LB|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|1||||HGBTET|HEMOGLOBIN TETRAMER|||||||UG/M2/H|||||||POSITIVE||CFU/G||||ABNORMAL|NOT DONE||||ABSCESS FLUID|LIPEMIC|U|OSCILLOMETRY|FIBROSIS 4 FORMULA||N|N|Y|Y|||Y|1||38||WASHOUT|1961-11-26|1973-08-05|||||1964-04-24||1965-07-28|N|1966-06-27
TRIAL STUDY 134XCP|LB|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|2||||PRZPM|PRAZEPAM|||||||U/10^12 RBC|||||||INDETERMINATE||MOL/MOL||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|PARAFFIN-EMBEDDED|Y|GIEMSA STAIN|CKD-EPI FORMULA||U|U|Y|NA|||N|1||38||FOLLOW-UP|1963-06-15|1967-12-17|||||1967-08-16||1968-07-04|N|1971-07-06
TRIAL STUDY 134XCP|LB|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|1||||LEPTIN|LEPTIN|||||||AMP|||||||INVALID||MG/MOL||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|LACTESCENT|N|PYROSEQUENCING|FIBROSIS 4 FORMULA||N|U|Y|NA|||N|2||58||WASHOUT|1963-06-05|1963-03-13|||||1973-03-11||1965-03-11|Y|1968-06-14
TRIAL STUDY 134XCP|LB|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|2||||IRF|IMMATURE RETICULOCYTE FRACTION|||||||ML/M2/DAY|||||||POSITIVE||UL||||HIGH|NOT DONE||||TISSUE|FROZEN|NA|LYMPHANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|U|NA|||N|2||58||WASHOUT|1967-04-01|1968-02-10|||||1961-06-02||1968-03-22|N|1967-06-20
TRIAL STUDY 134XCP|LB|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|1||||T4FR|THYROXINE, FREE|||||||CONTAINER|||||||INDETERMINATE||/7.5 ML||||HIGH|NOT DONE||||MENSTRUAL BLOOD|LIPEMIC|NA|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|N|N|||Y|3||39||SCREENING|1969-03-20|1968-08-05|||||1966-09-05||1969-11-30|Y|1962-04-27
TRIAL STUDY 134XCP|LB|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|2||||C130115|INDUSTRIAL MIX ANTIGEN IGG ANTIBODY|||||||% INHIBITION|||||||NEGATIVE||CMH2O*S/ML||||LOW|NOT DONE||||DERMAL TISSUE|UNEXPECTED ODOR|U|GC/MS|CKD-EPI CREATININE FORMULA||U|U|N|N|||U|3||39||OPEN LABEL TREATMENT|1971-02-01|1960-05-08|||||1966-01-08||1973-05-19|Y|1973-02-05
TRIAL STUDY 134XCP|LB|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|1||||B2G1GGAB|BETA-2 GLYCOPROTEIN 1 IGG ANTIBODY|||||||LOG10 TCID 50/ML|||||||BORDERLINE||/MM2||||HIGH|NOT DONE||||GASTRIC FLUID|CONCENTRATED|Y|EIA|MDRD 4 VARIABLE FORMULA||U|N|U|NA|||N|4||88||RUN-IN|1966-02-28|1969-06-08|||||1971-06-21||1968-03-02|NA|1963-04-18
TRIAL STUDY 134XCP|LB|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|2||||PRAB|PANEL REACTIVE ANTIBODY|||||||KIT|||||||POSITIVE||ML/CM3/MIN||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|HEMOLYZED|NA|CT SCAN WITHOUT CONTRAST|HEPASCORE FORMULA||N|NA|Y|NA|||N|4||88||FOLLOW-UP|1971-07-14|1965-06-04|||||1972-02-12||1971-05-28|N|1972-10-13
TRIAL STUDY 134XCP|LB|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|1||||BTLBTL|BUTALBITAL|||||||ML/KG/DAY|||||||INDETERMINATE||PMOL/10^10 CELLS||||HIGH|NOT DONE||||COLOSTRUM|HEMOLYZED|U|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|CKD-EPI CREATININE FORMULA||U|Y|NA|N|||N|5||7||SCREENING|1972-04-22|1971-10-03|||||1968-11-16||1972-05-30|NA|1968-03-19
TRIAL STUDY 134XCP|LB|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|2||||TRIG|TRIGLYCERIDES|||||||UMOL/L/SEC|||||||BORDERLINE||CFU/ML||||NORMAL|NOT DONE||||COLOSTRUM|UNEXPECTED ODOR|U|WRIGHT-GIEMSA STAIN|FIBROSIS 4 FORMULA||Y|U|N|NA|||U|5||7||LONG-TERM FOLLOW-UP|1969-04-04|1969-10-02|||||1970-01-08||1961-02-20|N|1968-03-31
TRIAL STUDY 134XCP|LB|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|1||||C130086|ENGLISH PLANTAIN POLLEN IGG|||||||NFIU|||||||POSITIVE||HENRY||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|UNEXPECTED ODOR|U|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD 5 VARIABLE FORMULA||N|NA|NA|N|||N|1||38||OBSERVATION|1968-03-22|1963-08-18|||||1971-01-08||1969-08-22|Y|1962-07-11
TRIAL STUDY 134XCP|LB|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|2||||TROPONI|TROPONIN I|||||||MOL/MOL|||||||TRACE||UIU/L||||NORMAL|NOT DONE||||BREAST MILK|FRESH|U|U-HPLC/MS/MS|MDRD 4 VARIABLE FORMULA||Y|NA|NA|U|||U|1||38||RUN-IN|1966-12-30|1964-07-01|||||1969-07-27||1967-01-07|U|1972-06-25
TRIAL STUDY 134XCP|LB|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|1||||NGF|NERVE GROWTH FACTOR|||||||UMOL/MIN|||||||INDETERMINATE||UG/M2/MIN||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD 5 VARIABLE FORMULA||N|Y|U|N|||N|2||58||SCREENING|1962-02-16|1963-09-12|||||1960-02-26||1962-04-20|Y|1962-01-25
TRIAL STUDY 134XCP|LB|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|2||||EOTAXIN3|EOTAXIN-3|||||||DAGU/ML|||||||POSITIVE||GBQ/MG||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|SOLIDIFIED|NA|PERFUSION MRI|CKD-EPI FORMULA||NA|N|NA|Y|||NA|2||58||RUN-IN|1967-05-14|1967-01-01|||||1967-08-25||1960-04-25|U|1969-10-05
TRIAL STUDY 134XCP|LB|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|1||||B2MCREAT|BETA-2 MICROGLOBULIN/CREATININE|||||||MM/MIN|||||||INVALID||G/U||||LOW|NOT DONE||||MUSCLE TISSUE|FROZEN|NA|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|NASH FIBROSURE FORMULA||N|Y|Y|Y|||NA|3||39||RUN-IN|1973-08-20|1963-07-21|||||1963-10-04||1960-12-16|NA|1968-11-19
TRIAL STUDY 134XCP|LB|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|2||||FATACVLC|FATTY ACIDS, VERY LONG CHAIN|||||||P|||||||INDETERMINATE||APL U/ML||||HIGH|NOT DONE||||ADIPOSE TISSUE|FROZEN|NA|TOTAL BODY IRRADIATION|ASH FIBROSURE FORMULA||U|N|NA|U|||Y|3||39||WASHOUT|1969-12-01|1960-05-16|||||1969-06-08||1963-05-23|U|1961-08-22
TRIAL STUDY 134XCP|LB|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|1||||GRN|PROGRANULIN|||||||10^3 CFU/ML|||||||POSITIVE||/HPF||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|UNEXPECTED ODOR|Y|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC FORMULA||Y|NA|U|N|||Y|4||88||RUN-IN|1969-02-09|1970-01-17|||||1972-09-22||1962-06-13|Y|1962-05-03
TRIAL STUDY 134XCP|LB|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|2||||SH2D1A|SH2 DOMAIN CONTAINING 1A PROTEIN|||||||MM/SEC|||||||NEGATIVE||PMOL/G||||NORMAL|NOT DONE||||NAIL|LIPEMIC|Y|DROPLET DIGITAL PCR|GMI MMOL/MOL FORMULA||N|N|U|Y|||NA|4||88||OPEN LABEL TREATMENT|1965-12-19|1964-06-06|||||1973-04-24||1964-10-15|N|1964-11-08
TRIAL STUDY 134XCP|LB|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|1||||INULIN|INULIN|||||||L/MIN|||||||TRACE||GPELISA UNIT/ML||||LOW|NOT DONE||||GASTRIC CONTENTS|SOLIDIFIED|Y|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROTEST FORMULA||N|Y|N|NA|||Y|5||7||TREATMENT|1967-09-14|1962-02-13|||||1961-07-30||1969-07-30|Y|1968-01-11
TRIAL STUDY 134XCP|LB|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|2||||EUDCA|EPIMERIZED URSODEOXYCHOLATE|||||||VIAL|||||||POSITIVE||MET||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|NON-HEMOLYZED|U|IMMUNOTURBIDIMETRY|FIBROTEST FORMULA||Y|NA|NA|Y|||Y|5||7||FOLLOW-UP|1971-11-25|1961-01-03|||||1966-04-15||1967-12-18|NA|1962-08-09
TRIAL STUDY 134XCP|LB|51FE575E-2161-414B-B772-9F1888E7C5CC|1||||PEPSNGII|PEPSINOGEN II|||||||10^9 CFU/ML|||||||INDETERMINATE||SCOOPFUL||||HIGH|NOT DONE||||PLEURAL FLUID|DRIED|N|ENZYMATIC COLORIMETRY|GMI % FORMULA||N|N|N|U|||N|1||38||SCREENING|1973-03-02|1970-08-16|||||1963-01-04||1965-07-02|N|1966-07-15
TRIAL STUDY 134XCP|LB|51FE575E-2161-414B-B772-9F1888E7C5CC|2||||APLSMA2A|ALPHA-2 ANTIPLASMIN ACTIVITY|||||||MCI/L|||||||BORDERLINE||SV||||LOW|NOT DONE||||EXUDATE|CONTAMINATED|Y|PALPATION|GMI % FORMULA||Y|U|NA|N|||NA|1||38||OBSERVATION|1966-08-17|1962-03-23|||||1971-02-03||1964-11-24|NA|1963-04-22
TRIAL STUDY 134XCP|LB|51FE575E-2161-414B-B772-9F1888E7C5CC|1||||CD79A|CD79A|||||||/HPF|||||||INVALID||IU/MG||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|CONCENTRATED|Y|IVY INCISION METHOD|CKD-EPI CYSTATIN C FORMULA||NA|N|NA|N|||NA|2||58||SCREENING|1965-10-26|1966-11-22|||||1972-10-30||1968-12-08|Y|1967-09-28
TRIAL STUDY 134XCP|LB|51FE575E-2161-414B-B772-9F1888E7C5CC|2||||ASTALT|AST/ALT|||||||MV*MIN|||||||POSITIVE||10^9 CFU||||ABNORMAL|NOT DONE||||DISCHARGE|LACTESCENT|N|NUCLEIC ACID BASED METHOD|FIBROSIS 4 FORMULA||NA|Y|NA|Y|||Y|2||58||FOLLOW-UP|1970-10-27|1965-04-27|||||1963-11-28||1962-05-18|Y|1960-03-26
TRIAL STUDY 134XCP|LB|51FE575E-2161-414B-B772-9F1888E7C5CC|1||||FACTXIA|FACTOR XI ACTIVITY|||||||UCI/L|||||||POSITIVE||PNU/ML||||NORMAL|NOT DONE||||BONE MARROW|ROOM TEMPERATURE|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||U|Y|NA|NA|||Y|3||39||OBSERVATION|1968-04-22|1962-02-16|||||1966-03-11||1970-01-19|U|1972-04-25
TRIAL STUDY 134XCP|LB|51FE575E-2161-414B-B772-9F1888E7C5CC|2||||CYAMMBIU|AMMONIUM BIURATE CRYSTALS|||||||/500 WBC|||||||BORDERLINE||/MIN||||HIGH|NOT DONE||||SYNOVIAL FLUID|GELLED|N|CINEANGIOGRAPHY|MDRD ENZYMATIC FORMULA||Y|NA|NA|N|||N|3||39||INDUCTION TREATMENT|1962-03-01|1965-07-21|||||1963-03-25||1965-06-23|N|1960-05-19
TRIAL STUDY 134XCP|LB|51FE575E-2161-414B-B772-9F1888E7C5CC|1||||INTLK3|INTERLEUKIN 3|||||||VP/DOSE|||||||INDETERMINATE||KAT||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|HEMOLYZED|Y|OSCILLOMETRY|MDRD 4 VARIABLE FORMULA||NA|U|N|NA|||N|4||88||RUN-IN|1960-01-20|1968-01-18|||||1960-10-26||1971-03-06|U|1964-11-26
TRIAL STUDY 134XCP|LB|51FE575E-2161-414B-B772-9F1888E7C5CC|2||||INTLK18|INTERLEUKIN 18|||||||PT_US|||||||POSITIVE||10^7 PFU||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|HEMOLYZED|Y|NUCLEIC ACID HYBRIDIZATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|U|N|||NA|4||88||INDUCTION TREATMENT|1965-09-03|1962-07-28|||||1973-04-27||1966-07-08|N|1971-07-12
TRIAL STUDY 134XCP|LB|51FE575E-2161-414B-B772-9F1888E7C5CC|1||||FABP3|FATTY ACID BINDING PROTEIN 3|||||||10^9/L|||||||TRACE||ANTIBODY UNIT||||HIGH|NOT DONE||||SMEGMA|ROOM TEMPERATURE|NA|PERIPHERAL ANGIOGRAPHY|GMI MMOL/MOL FORMULA||U|U|N|N|||U|5||7||INDUCTION TREATMENT|1972-06-05|1968-06-03|||||1965-08-27||1967-04-15|N|1966-04-16
TRIAL STUDY 134XCP|LB|51FE575E-2161-414B-B772-9F1888E7C5CC|2||||APTTLAS|LUPUS ANTICOAGULANT SENSITIVE APTT|||||||CMH2O*S2/ML|||||||POSITIVE||NEBULE||||ABNORMAL|NOT DONE||||BONE MARROW|CONCENTRATED|U|ELECTRICAL IMPEDANCE MYOGRAPHY|CKD-EPI FORMULA||N|NA|N|U|||Y|5||7||INDUCTION TREATMENT|1966-09-07|1970-10-23|||||1967-06-16||1967-12-28|N|1963-07-24
TRIAL STUDY 134XCP|LB|991C72FC-777F-4CED-824B-A4DECA57BE99|1||||ALPBS|BONE SPECIFIC ALKALINE PHOSPHATASE|||||||ML/M2/H|||||||INVALID||MMOL||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|FRESH|Y|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|HEPASCORE FORMULA||U|N|N|NA|||Y|1||38||INDUCTION TREATMENT|1963-09-17|1963-12-02|||||1968-03-15||1961-06-04|NA|1970-12-04
TRIAL STUDY 134XCP|LB|991C72FC-777F-4CED-824B-A4DECA57BE99|2||||DOPAMINE|DOPAMINE|||||||KG/L|||||||INVALID||DPM/0.5 ML||||NORMAL|NOT DONE||||VENOUS BLOOD|SOLIDIFIED|N|ROMANOWSKY STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|N|U|||N|1||38||WASHOUT|1966-08-28|1971-08-06|||||1963-09-11||1966-11-23|NA|1967-06-13
TRIAL STUDY 134XCP|LB|991C72FC-777F-4CED-824B-A4DECA57BE99|1||||ACPHOS|ACID PHOSPHATASE|||||||MGEQ|||||||POSITIVE||GY/H||||ABNORMAL|NOT DONE||||TUMOR TISSUE|CONTAMINATED|U|RIA|GMI % FORMULA||NA|U|Y|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1964-03-31|1968-07-13|||||1962-01-10||1972-09-28|NA|1968-10-24
TRIAL STUDY 134XCP|LB|991C72FC-777F-4CED-824B-A4DECA57BE99|2||||DHPG|3,4-DIHYDROXYPHENYLGLYCOL|||||||SV|||||||BORDERLINE||M2||||LOW|NOT DONE||||SPUTUM|FROZEN|Y|COMPUTERIZED CORNEAL TOPOGRAPHY|GMI MMOL/MOL FORMULA||N|N|NA|N|||Y|2||58||OPEN LABEL TREATMENT|1966-03-07|1968-05-15|||||1962-02-16||1968-03-04|NA|1963-08-15
TRIAL STUDY 134XCP|LB|991C72FC-777F-4CED-824B-A4DECA57BE99|1||||FRUMCRTP|FRUCTOSAMINE CORRECTED FOR TOTAL PROTEIN|||||||MDFI|||||||INDETERMINATE||CUP EQ||||LOW|NOT DONE||||SOFT TISSUE|LACTESCENT|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|N|U|||U|3||39||BASELINE|1972-02-19|1969-03-04|||||1961-08-28||1965-05-01|Y|1962-09-11
TRIAL STUDY 134XCP|LB|991C72FC-777F-4CED-824B-A4DECA57BE99|2||||S100B|S100 CALCIUM-BINDING PROTEIN B|||||||KAT|||||||INVALID||SV||||HIGH|NOT DONE||||LOCHIA|ICTERIC|N|CALCULATION|MDRD FORMULA||N|N|U|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1966-03-28|1972-07-08|||||1964-09-23||1970-03-19|U|1969-07-27
TRIAL STUDY 134XCP|LB|991C72FC-777F-4CED-824B-A4DECA57BE99|1||||IGG3|IMMUNOGLOBULIN G SUBCLASS 3|||||||BOX|||||||POSITIVE||DAYS/WK||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED|U|PHOTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|U|N|||NA|4||88||OBSERVATION|1971-04-13|1962-05-10|||||1960-06-24||1966-02-15|NA|1971-01-04
TRIAL STUDY 134XCP|LB|991C72FC-777F-4CED-824B-A4DECA57BE99|2||||MIP1G|MACROPHAGE INFLAMMATORY PROTEIN 1 GAMMA|||||||ML/G/MIN|||||||POSITIVE||UG/KG/H||||LOW|NOT DONE||||LUNG SURFACTANT|FRESH|NA|DYNAMIC LIGHT SCATTERING|FIBROTEST FORMULA||U|U|U|Y|||Y|4||88||BASELINE|1961-03-28|1961-08-03|||||1965-09-03||1967-07-18|N|1966-10-12
TRIAL STUDY 134XCP|LB|991C72FC-777F-4CED-824B-A4DECA57BE99|1||||IGFBP3|INSULIN-LIKE GROWTH FACTOR BINDING PROT3|||||||10^9/G|||||||POSITIVE||KM||||HIGH|NOT DONE||||ABSCESS FLUID|NON-HEMOLYZED|N|ELECTRONEUROGRAPHY|MDRD 6 VARIABLE FORMULA||U|U|Y|U|||U|5||7||LONG-TERM FOLLOW-UP|1969-04-02|1966-01-31|||||1969-11-10||1971-11-16|NA|1973-01-01
TRIAL STUDY 134XCP|LB|991C72FC-777F-4CED-824B-A4DECA57BE99|2||||LYMVAC|VACUOLATED LYMPHOCYTES|||||||WAFER|||||||NEGATIVE||CARTRIDGE||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|U|ELISPOT|CKD-EPI CREATININE FORMULA||N|Y|Y|N|||Y|5||7||CONTINUATION TREATMENT|1973-08-23|1961-02-24|||||1968-07-03||1972-06-11|NA|1966-08-08
TRIAL STUDY 134XCP|LB|FFECA538-8D16-421C-ACA2-4A769BC15D7D|1||||IL2RB|INTERLEUKIN 2 RECEPTOR SUBUNIT BETA|||||||/200 HPFS|||||||POSITIVE||LOG10 TCID 50/UL||||HIGH|NOT DONE||||COLOSTRUM|ICTERIC|N|PHOTOMETRIC CLOT DETECTION|MDRD 4 VARIABLE FORMULA||NA|U|NA|Y|||N|1||38||WASHOUT|1961-03-03|1965-12-13|||||1962-01-05||1971-12-20|NA|1968-09-27
TRIAL STUDY 134XCP|LB|FFECA538-8D16-421C-ACA2-4A769BC15D7D|2||||GLOBA|ALPHA GLOBULIN|||||||KM|||||||NEGATIVE||ML/CAGE/DAY||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|DRIED|N|ELECTROPHORESIS|GMI MMOL/MOL FORMULA||U|U|NA|NA|||NA|1||38||SCREENING|1973-03-16|1961-09-05|||||1963-11-14||1968-08-29|Y|1969-11-22
TRIAL STUDY 134XCP|LB|FFECA538-8D16-421C-ACA2-4A769BC15D7D|1||||C130082|ORCHARD GRASS POLLEN IGG|||||||IMPLANT|||||||POSITIVE||CFU/ML||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|REFRIGERATED|Y|CLAUSS METHOD|MDRD FORMULA||N|U|N|Y|||U|2||58||OBSERVATION|1970-08-24|1970-12-30|||||1973-01-17||1970-04-15|Y|1965-01-26
TRIAL STUDY 134XCP|LB|FFECA538-8D16-421C-ACA2-4A769BC15D7D|2||||SECRETIN|SECRETIN|||||||MOSM/KG|||||||INVALID||G/L||||ABNORMAL|NOT DONE||||BLOOD|SOLIDIFIED|Y|ULTRASONOGRAPHIC ELASTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|Y|U|||N|2||58||LONG-TERM FOLLOW-UP|1965-03-02|1964-09-01|||||1969-07-02||1972-10-19|N|1965-06-07
TRIAL STUDY 134XCP|LB|FFECA538-8D16-421C-ACA2-4A769BC15D7D|1||||HLAAAGT|HLA-A ANTIGEN TYPE|||||||PELLET|||||||NEGATIVE||AMU||||ABNORMAL|NOT DONE||||BLOOD|CONTAMINATED|N|CONTRAST ENHANCED X-RAY|CKD-EPI CYSTATIN C FORMULA||N|U|NA|U|||U|3||39||SCREENING|1966-07-11|1969-02-08|||||1961-02-23||1965-06-13|U|1963-04-26
TRIAL STUDY 134XCP|LB|FFECA538-8D16-421C-ACA2-4A769BC15D7D|2||||HGBA2|HEMOGLOBIN A2|||||||DIP|||||||NEGATIVE||MV||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|AUTOLYZED|N|LIGHT SCATTERING SPECTROSCOPY|HEPASCORE FORMULA||N|N|NA|NA|||U|3||39||WASHOUT|1964-03-28|1971-06-12|||||1962-10-25||1972-01-10|U|1972-10-02
TRIAL STUDY 134XCP|LB|FFECA538-8D16-421C-ACA2-4A769BC15D7D|1||||HDW|HEMOGLOBIN DISTRIBUTION WIDTH|||||||BREATHS/30S|||||||POSITIVE||MEQ/ML||||HIGH|NOT DONE||||HAIR|THAWED|N|HPLC/MS|HEPASCORE FORMULA||N|NA|U|Y|||Y|4||88||RUN-IN|1960-10-16|1963-07-30|||||1967-06-12||1960-09-18|Y|1965-06-08
TRIAL STUDY 134XCP|LB|FFECA538-8D16-421C-ACA2-4A769BC15D7D|2||||UREA|UREA|||||||L|||||||INVALID||MG2/DL2||||HIGH|NOT DONE||||VENOUS BLOOD|LACTESCENT|U|IMMUNORADIOMETRIC ASSAY|MDRD 6 VARIABLE FORMULA||U|N|NA|NA|||NA|4||88||CONTINUATION TREATMENT|1968-05-05|1969-10-12|||||1962-07-01||1972-05-05|Y|1972-01-06
TRIAL STUDY 134XCP|LB|FFECA538-8D16-421C-ACA2-4A769BC15D7D|1||||INTLK10|INTERLEUKIN 10|||||||LOG10 PFU|||||||INVALID||MCI/L||||LOW|NOT DONE||||GASTRIC CONTENTS|ROOM TEMPERATURE|Y|IMPEDANCE CONDUCTIVITY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|Y|Y|||U|5||7||BLINDED TREATMENT|1962-06-15|1961-01-07|||||1971-02-06||1965-08-04|Y|1960-03-05
TRIAL STUDY 134XCP|LB|FFECA538-8D16-421C-ACA2-4A769BC15D7D|2||||GLUCPE|PLASMA EQUIVALENT GLUCOSE|||||||MMHG|||||||TRACE||MG/KG/DOSE||||HIGH|NOT DONE||||SOFT TISSUE|AGGLUTINATED|Y|IMPEDANCE CONDUCTIVITY|MDRD ENZYMATIC FORMULA||Y|NA|Y|U|||U|5||7||TREATMENT|1961-02-21|1967-10-18|||||1965-03-14||1963-04-14|NA|1962-09-19
TRIAL STUDY 134XCP|LB|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|1||||C130129|DOG DANDER ANTIGEN IGG ANTIBODY|||||||MEQ/DL|||||||TRACE||M2||||NORMAL|NOT DONE||||SERUM OR PLASMA|CALCIFIED|NA|ENZYMATIC ULTRACENTRIFUGATION|MDRD 5 VARIABLE FORMULA||NA|Y|NA|NA|||N|1||38||OPEN LABEL TREATMENT|1964-11-12|1969-10-03|||||1968-08-08||1966-04-30|Y|1961-01-07
TRIAL STUDY 134XCP|LB|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|2||||CD56|CD56|||||||ML/DAY|||||||INDETERMINATE||10^9 ORGANISMS/MG||||LOW|NOT DONE||||DISCHARGE|LIPEMIC|U|MICROBIAL CULTURE, LIQUID|NASH FIBROSURE FORMULA||NA|Y|Y|NA|||U|1||38||OBSERVATION|1961-08-05|1963-05-15|||||1961-06-19||1969-10-08|N|1964-11-22
TRIAL STUDY 134XCP|LB|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|1||||CARNIT|CARNITINE|||||||BLOCKS|||||||INVALID||V/SEC||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|LIPEMIC|U|ORCHIDOMETERY|CKD-EPI FORMULA||NA|Y|Y|U|||Y|2||58||INDUCTION TREATMENT|1970-02-26|1960-07-23|||||1969-06-03||1963-11-02|U|1970-03-09
TRIAL STUDY 134XCP|LB|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|2||||BASOMM|BASOPHILIC METAMYELOCYTES|||||||G/DAY|||||||TRACE||TRANSDUCING UNIT||||NORMAL|NOT DONE||||SKIN TISSUE|AUTOLYZED|N|ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|NA|NA|Y|||N|2||58||LONG-TERM FOLLOW-UP|1961-07-20|1961-10-21|||||1969-07-21||1960-09-11|N|1972-10-06
TRIAL STUDY 134XCP|LB|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|1||||APPB|AMYLOID BETA PRECURSOR PROTEIN|||||||BLOCKS|||||||TRACE||DEG2||||ABNORMAL|NOT DONE||||BONE|CALCIFIED|Y|POTENTIOMETRY|MDRD 6 VARIABLE FORMULA||Y|N|U|NA|||Y|3||39||WASHOUT|1965-05-30|1965-08-06|||||1969-03-25||1971-05-12|U|1968-02-14
TRIAL STUDY 134XCP|LB|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|2||||OAS1|2-5-OLIGOADENYLATE SYNTHASE 1|||||||MEQ|||||||INVALID||FMOL||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|LACTESCENT|Y|DOPPLER ULTRASOUND|MDRD 6 VARIABLE FORMULA||Y|NA|Y|Y|||NA|3||39||BLINDED TREATMENT|1971-02-01|1964-02-23|||||1965-05-08||1960-06-20|Y|1969-04-29
TRIAL STUDY 134XCP|LB|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|1||||IGFBP1|INSULIN-LIKE GROWTH FACTOR BINDING PROT1|||||||U/G/MIN|||||||BORDERLINE||UG/ML/H||||NORMAL|NOT DONE||||SERUM|CONCENTRATED|Y|COULOMETRIC TITRATION|GMI MMOL/MOL FORMULA||N|Y|U|NA|||N|4||88||INDUCTION TREATMENT|1961-06-03|1963-01-07|||||1965-12-11||1972-04-25|NA|1962-11-21
TRIAL STUDY 134XCP|LB|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|2||||HGBF|HEMOGLOBIN F|||||||M/SEC|||||||INDETERMINATE||10^7 CFU||||ABNORMAL|NOT DONE||||SALIVA|UNEXPECTED ODOR|NA|LANDOLT RING|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|NA|Y|||Y|4||88||CONTINUATION TREATMENT|1970-08-26|1969-01-11|||||1960-09-08||1960-12-12|Y|1966-09-09
TRIAL STUDY 134XCP|LB|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|1||||PROMYCE|PROMYELOCYTES/TOTAL CELLS|||||||IU/MG|||||||TRACE||KG/CM2||||LOW|NOT DONE||||LYMPH|ROOM TEMPERATURE|NA|LYMPHANGIOGRAPHY|CKD-EPI CREATININE FORMULA||N|N|N|N|||N|5||7||BLINDED TREATMENT|1964-05-20|1970-03-09|||||1969-11-17||1963-06-21|NA|1969-08-27
TRIAL STUDY 134XCP|LB|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|2||||CSCYL|CYLINDROID CASTS|||||||KDA|||||||BORDERLINE||USEC||||HIGH|NOT DONE||||WHITE MATTER TISSUE|THAWED|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|N|Y|NA|||NA|5||7||WASHOUT|1969-01-15|1966-12-23|||||1964-09-30||1965-01-23|NA|1966-06-25
TRIAL STUDY 134XCP|LB|54507F00-0C16-4F35-A762-104B47390283|1||||BLYCELE|B-LYMPHOCYTES/LEUKOCYTES|||||||UMOL/L/SEC|||||||INVALID||OZ||||HIGH|NOT DONE||||PLEURAL TISSUE|DRIED|U|TELLER ACUITY CARDS|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|Y|Y|||NA|1||38||RUN-IN|1968-08-27|1962-01-08|||||1961-04-17||1973-06-21|U|1966-05-30
TRIAL STUDY 134XCP|LB|54507F00-0C16-4F35-A762-104B47390283|2||||CXCL1|CHEMOKINE (C-X-C MOTIF) LIGAND 1|||||||U/M2/MIN|||||||TRACE||DEG||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|AUTOLYZED|U|PLAQUE REDUCTION NEUTRALIZATION ASSAY|GMI MMOL/MOL FORMULA||Y|NA|NA|NA|||NA|1||38||INDUCTION TREATMENT|1962-01-08|1973-07-16|||||1965-08-28||1973-01-13|N|1961-10-28
TRIAL STUDY 134XCP|LB|54507F00-0C16-4F35-A762-104B47390283|1||||DCCARNIT|DECANOYLCARNITINE|||||||PPB|||||||TRACE||UG/KG/H||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|FROZEN|U|ENDOSCOPY|CKD-EPI CREATININE FORMULA||N|NA|Y|U|||N|2||58||INDUCTION TREATMENT|1966-09-25|1960-06-17|||||1960-05-08||1967-07-17|Y|1969-04-25
TRIAL STUDY 134XCP|LB|54507F00-0C16-4F35-A762-104B47390283|2||||A1MCREAT|ALPHA-1 MICROGLOBULIN/CREATININE|||||||MG/MOL|||||||INVALID||ML/ANIMAL/WK||||LOW|NOT DONE||||SEMEN|HEMOLYZED|U|PAP STAIN|COCKCROFT-GAULT FORMULA||N|U|Y|Y|||Y|2||58||BASELINE|1972-02-08|1963-01-26|||||1968-11-27||1969-05-12|Y|1960-11-03
TRIAL STUDY 134XCP|LB|54507F00-0C16-4F35-A762-104B47390283|1||||SPMMSPM|MOTILE SPERM/TOTAL SPERM|||||||LOG10 CCID 50/DOSE|||||||INDETERMINATE||/5X10^4 WBC||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|FRESH|N|ENDOSCOPY|FIBROTEST FORMULA||U|NA|N|U|||Y|3||39||CONTINUATION TREATMENT|1968-12-30|1967-01-01|||||1965-02-05||1968-06-05|N|1963-01-13
TRIAL STUDY 134XCP|LB|54507F00-0C16-4F35-A762-104B47390283|2||||CD2LY|CD2/LYMPHOCYTES|||||||M|||||||BORDERLINE||G/ANIMAL/DAY||||NORMAL|NOT DONE||||URINE SEDIMENT|LIPEMIC|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD FORMULA||N|NA|NA|N|||U|3||39||RUN-IN|1962-01-20|1961-07-31|||||1960-04-18||1967-01-07|U|1967-10-16
TRIAL STUDY 134XCP|LB|54507F00-0C16-4F35-A762-104B47390283|1||||MYPC|MYELOID PROGENITOR CELLS|||||||BU|||||||INDETERMINATE||KEV||||NORMAL|NOT DONE||||FLUID|CONTAMINATED|Y|WESTERN BLOT|FIBROTEST FORMULA||U|U|NA|NA|||N|4||88||CONTINUATION TREATMENT|1971-05-30|1967-06-12|||||1973-08-21||1966-07-26|NA|1967-01-20
TRIAL STUDY 134XCP|LB|54507F00-0C16-4F35-A762-104B47390283|2||||CLCTONN|CALCITONIN|||||||KG|||||||NEGATIVE||ML/M2/H||||LOW|NOT DONE||||REFLEX TEAR|REFRIGERATED|Y|TOTAL BODY RADIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|U|||NA|4||88||WASHOUT|1970-11-13|1971-01-30|||||1960-03-19||1970-03-25|NA|1968-11-14
TRIAL STUDY 134XCP|LB|54507F00-0C16-4F35-A762-104B47390283|1||||LSD|LYSERGIC ACID DIETHYLAMIDE|||||||MG/MIN|||||||INVALID||KV||||HIGH|NOT DONE||||GASTRIC CONTENTS|FRESH|N|STRESS ECHOCARDIOGRAPHY|FIBROTEST FORMULA||N|Y|N|Y|||Y|5||7||BASELINE|1962-02-10|1969-10-15|||||1971-02-12||1971-09-10|N|1967-04-09
TRIAL STUDY 134XCP|LB|54507F00-0C16-4F35-A762-104B47390283|2||||EOTAXIN2|EOTAXIN-2|||||||%(W/V)|||||||BORDERLINE||DYN||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|REFRIGERATED|NA|MUGA|FIBROSIS 4 FORMULA||Y|N|N|Y|||U|5||7||WASHOUT|1967-02-26|1962-05-14|||||1963-02-11||1963-04-28|NA|1968-01-04
TRIAL STUDY 134XCP|LB|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|1||||C165899|SILVER BIRCH POLLEN IGG AB RAST SCORE|||||||MPA|||||||INVALID||ML/DL||||ABNORMAL|NOT DONE||||EMESIS|AUTOLYZED|U|SIZE EXCLUSION CHROMATOGRAPHY|GMI % FORMULA||U|NA|NA|N|||NA|1||38||CONTINUATION TREATMENT|1971-11-16|1966-01-22|||||1968-12-13||1960-03-27|Y|1972-04-11
TRIAL STUDY 134XCP|LB|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|2||||MDA|3,4-METHYLENEDIOXYAMPHETAMINE|||||||ML/MIN/1.73M2|||||||INDETERMINATE||10^6 COPIES/ML||||LOW|NOT DONE||||DERMAL TISSUE|UNEXPECTED ODOR|U|MAPH|MDRD 5 VARIABLE FORMULA||NA|Y|Y|N|||U|1||38||RUN-IN|1973-02-22|1968-07-04|||||1970-10-12||1971-03-27|NA|1962-10-01
TRIAL STUDY 134XCP|LB|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|1||||V25HD2|25-HYDROXYVITAMIN D2|||||||USEC|||||||NEGATIVE||WEBER||||HIGH|NOT DONE||||PLATELET POOR PLASMA|REFRIGERATED|U|HIGH RESOLUTION CT|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|N|NA|||N|2||58||WASHOUT|1967-06-11|1971-03-17|||||1970-01-22||1960-01-23|U|1961-08-12
TRIAL STUDY 134XCP|LB|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|2||||HASIGGAB|HUMAN ANTI-SHEEP IGG ANTIBODY|||||||BREATHS/30S|||||||POSITIVE||10^8 PFU||||LOW|NOT DONE||||BILE|HEMOLYZED|N|FLOCCULATION|GMI MMOL/MOL FORMULA||NA|N|NA|Y|||U|2||58||WASHOUT|1970-11-07|1968-12-20|||||1967-03-12||1960-09-30|U|1967-06-30
TRIAL STUDY 134XCP|LB|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|1||||MEPRDN|MEPERIDINE|||||||CIGARETTE|||||||TRACE||LOG10 TCID 50/ML||||NORMAL|NOT DONE||||BREAST MILK|REFRIGERATED|U|THERMAL IONIZATION MASS SPECTROMETRY|ASH FIBROSURE FORMULA||Y|U|NA|U|||Y|3||39||SCREENING|1964-12-04|1969-01-22|||||1965-02-16||1969-10-10|NA|1960-10-24
TRIAL STUDY 134XCP|LB|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|2||||VITB5|VITAMIN B5|||||||PIXELS/CM|||||||INDETERMINATE||L/KG||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|CLOTTED|Y|ACRIDINE ORANGE STAIN|CKD-EPI CREATININE FORMULA||Y|Y|N|U|||Y|3||39||RUN-IN|1966-01-27|1960-06-07|||||1971-03-16||1969-05-18|Y|1961-06-07
TRIAL STUDY 134XCP|LB|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|1||||AMPEA|ALPHA-METHYLPHENETHYLAMINE|||||||CMH2O*S2/ML|||||||BORDERLINE||G/CM2||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|CONTAMINATED|NA|CONTRAST ENHANCED CT SCAN|CKD-EPI FORMULA||N|U|N|NA|||NA|4||88||OBSERVATION|1961-01-05|1962-08-17|||||1964-03-31||1973-05-03|N|1971-06-14
TRIAL STUDY 134XCP|LB|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|2||||HYDROGEN|HYDROGEN|||||||NSEC|||||||POSITIVE||SPRAY||||LOW|NOT DONE||||SMEGMA|THAWED|NA|QUANTITATIVE COMPUTED TOMOGRAPHY|CKD-EPI CREATININE FORMULA||N|N|Y|Y|||N|4||88||RUN-IN|1963-11-25|1966-02-18|||||1971-02-22||1964-11-06|U|1967-02-03
TRIAL STUDY 134XCP|LB|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|1||||CYDCPHOS|DICALCIUM PHOSPHATE CRYSTALS|||||||/DAY|||||||INDETERMINATE||ML/DOSE||||LOW|NOT DONE||||HAIR|SOLIDIFIED|N|CLIP|GMI MMOL/MOL FORMULA||N|N|Y|Y|||NA|5||7||FOLLOW-UP|1962-02-11|1960-08-06|||||1969-04-07||1964-03-31|Y|1963-07-29
TRIAL STUDY 134XCP|LB|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|2||||VITDBP|VITAMIN D BINDING PROTEIN|||||||VIRTUAL PIXEL|||||||NEGATIVE||L/S/KPA||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|THAWED|NA|NO INFORMATION|HEPASCORE FORMULA||Y|Y|Y|U|||N|5||7||OPEN LABEL TREATMENT|1968-07-19|1968-03-07|||||1967-01-31||1967-08-17|NA|1961-10-17
TRIAL STUDY 134XCP|LB|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|1||||EPSTI1|EPITHELIAL STROMAL INTERACTION PROTEIN 1|||||||UMOL/L/MIN|||||||TRACE||DRINK||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|AGGLUTINATED|Y|SECONDARY ION MASS SPECTOMETRY|NASH FIBROSURE FORMULA||U|NA|U|NA|||U|1||38||INDUCTION TREATMENT|1965-04-08|1960-02-28|||||1966-04-26||1968-07-30|NA|1960-08-19
TRIAL STUDY 134XCP|LB|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|2||||BLASTLM|LEUKEMIC BLASTS|||||||NG/DAY|||||||TRACE||YD||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONCENTRATED|NA|ANTIBIOTIC AGAR SCREEN|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|N|||N|1||38||FOLLOW-UP|1962-04-19|1973-08-07|||||1964-08-26||1963-07-22|U|1963-03-07
TRIAL STUDY 134XCP|LB|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|1||||MPXI|MYELOPEROXIDASE INDEX|||||||ANSON U|||||||INVALID||PRESSOR UNITS||||LOW|NOT DONE||||ARTERIAL BLOOD|CONCENTRATED|U|MICRODENSITOMETRY|FIBROMETER FORMULA||NA|Y|Y|N|||U|2||58||BASELINE|1972-01-18|1963-01-02|||||1971-01-25||1965-09-18|N|1963-08-17
TRIAL STUDY 134XCP|LB|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|2||||ARR|ALDOSTERONE/RENIN ACTIVITY|||||||MMU/ML|||||||POSITIVE||10^7 PFU||||LOW|NOT DONE||||AMNIOTIC FLUID|CLOTTED|NA|CELL OF ORIGIN ASSAY|GMI MMOL/MOL FORMULA||Y|Y|N|U|||Y|2||58||OBSERVATION|1962-03-14|1970-11-17|||||1973-06-28||1967-07-18|N|1970-07-11
TRIAL STUDY 134XCP|LB|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|1||||BLSTMBCE|MYELOBLASTS/TOTAL CELLS|||||||SPRAY|||||||POSITIVE||10^6 ORGANISMS||||LOW|NOT DONE||||CALCULUS|CONCENTRATED|N|HEMOCYTOMETRY|CKD-EPI FORMULA||N|NA|Y|U|||N|3||39||SCREENING|1962-04-23|1966-02-15|||||1966-11-30||1969-05-27|NA|1962-01-07
TRIAL STUDY 134XCP|LB|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|2||||FGF9|FIBROBLAST GROWTH FACTOR 9|||||||CI/MG|||||||INVALID||/MONTH||||NORMAL|NOT DONE||||CAPILLARY PLASMA|CLOTTED|NA|BAC ACGH|CKD-EPI FORMULA||Y|N|U|NA|||Y|3||39||WASHOUT|1961-07-09|1964-08-30|||||1967-10-09||1961-02-03|NA|1968-09-04
TRIAL STUDY 134XCP|LB|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|1||||TTAC|THROMBIN TIME ACTUAL/CONTROL|||||||GY|||||||POSITIVE||KS||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|FROZEN|NA|ANTIBIOTIC AGAR SCREEN|CKD-EPI FORMULA||Y|Y|NA|Y|||N|4||88||WASHOUT|1961-01-23|1961-07-05|||||1969-05-22||1969-08-12|N|1963-03-12
TRIAL STUDY 134XCP|LB|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|2||||TGLOBRR|THYROGLOBULIN RECOVERY RATE|||||||CM2|||||||POSITIVE||KBQ||||NORMAL|NOT DONE||||PLEURAL TISSUE|UNEXPECTED ODOR|Y|DIFFUSION TENSOR MRI|CKD-EPI CREATININE FORMULA||U|U|N|Y|||NA|4||88||INDUCTION TREATMENT|1960-02-06|1962-04-23|||||1961-01-31||1970-08-25|N|1972-07-19
TRIAL STUDY 134XCP|LB|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|1||||C165929|BEE MIX IGE AB RAST SCORE|||||||10^6 IU|||||||INVALID||M2||||NORMAL|NOT DONE||||CELL PELLET|CALCIFIED|N|DROPLET DIGITAL PCR|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|Y|N|||NA|5||7||BASELINE|1965-07-05|1964-08-17|||||1966-12-07||1966-01-19|NA|1970-08-28
TRIAL STUDY 134XCP|LB|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|2||||C130125|CAT DANDER ANTIGEN IGG ANTIBODY|||||||H*%|||||||BORDERLINE||CM H2O||||LOW|NOT DONE||||EMOTIONAL TEAR|CALCIFIED|N|POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|N|NA|||U|5||7||BLINDED TREATMENT|1964-03-24|1969-12-16|||||1960-09-23||1960-01-15|NA|1963-02-05
TRIAL STUDY 134XCP|LB|CF8F9036-3380-4A0B-B17A-7EF814B02700|1||||RPPAB|RIBOSOMAL P PROTEIN ANTIBODY|||||||GY/MIN|||||||NEGATIVE||SFC/10^6 PBMC||||LOW|NOT DONE||||BLOOD|CLOTTED|NA|MICROBIAL BIOCHEMICAL IDENTIFICATION|FIBROMETER FORMULA||U|U|N|N|||N|1||38||RUN-IN|1964-11-29|1971-10-25|||||1971-12-09||1965-03-06|Y|1963-01-30
TRIAL STUDY 134XCP|LB|CF8F9036-3380-4A0B-B17A-7EF814B02700|2||||SAMETH|S-ADENOSYLMETHIONINE|||||||TABLET|||||||POSITIVE||ENZYME U/G HB||||ABNORMAL|NOT DONE||||CORD SERUM|REFRIGERATED|N|OPTICAL DENSITY MEASUREMENT|NASH FIBROSURE FORMULA||U|U|N|U|||N|1||38||INDUCTION TREATMENT|1965-03-25|1960-04-11|||||1967-12-31||1968-12-02|N|1963-08-23
TRIAL STUDY 134XCP|LB|CF8F9036-3380-4A0B-B17A-7EF814B02700|1||||CYTYRO|TYROSINE CRYSTALS|||||||GBQ|||||||INDETERMINATE||U/G/DAY||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|ICTERIC|NA|HIGH LEVEL AMINOGLYCOSIDE SCREEN|CKD-EPI CREATININE FORMULA||Y|NA|U|Y|||N|2||58||TREATMENT|1970-07-01|1966-01-01|||||1967-01-26||1963-06-03|U|1962-01-19
TRIAL STUDY 134XCP|LB|CF8F9036-3380-4A0B-B17A-7EF814B02700|2||||CKBBCK|CREATINE KINASE BB/TOTAL CREATINE KINASE|||||||PA|||||||POSITIVE||10^4 CFU||||NORMAL|NOT DONE||||CERUMEN|AUTOLYZED|Y|SINGLE-MOLECULE ARRAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|Y|||Y|2||58||INDUCTION TREATMENT|1970-05-05|1969-09-04|||||1967-02-13||1969-07-26|U|1970-09-08
TRIAL STUDY 134XCP|LB|CF8F9036-3380-4A0B-B17A-7EF814B02700|1||||AG1_5|1,5-ANHYDROGLUCITOL|||||||PPM|||||||TRACE||/HPF||||HIGH|NOT DONE||||PLEURAL FLUID|CLOTTED|N|ETDRS EYE CHART|CKD-EPI CYSTATIN C FORMULA||Y|U|Y|U|||U|3||39||OBSERVATION|1969-04-21|1962-03-27|||||1964-04-12||1963-06-19|U|1964-07-21
TRIAL STUDY 134XCP|LB|CF8F9036-3380-4A0B-B17A-7EF814B02700|2||||NEUTGT|GIANT NEUTROPHILS|||||||U/KG/H|||||||BORDERLINE||WEBER||||LOW|NOT DONE||||PUS|NON-HEMOLYZED|U|IMMUNOPRECIPITATION|FIBROMETER FORMULA||U|N|Y|N|||NA|3||39||BLINDED TREATMENT|1973-04-19|1972-04-12|||||1969-06-06||1962-12-18|U|1963-08-21
TRIAL STUDY 134XCP|LB|CF8F9036-3380-4A0B-B17A-7EF814B02700|1||||RDW|ERYTHROCYTES DISTRIBUTION WIDTH|||||||/LPF|||||||POSITIVE||UMOL/KG/MIN||||NORMAL|NOT DONE||||MECONIUM|THAWED|N|THERMAL IONIZATION MASS SPECTROMETRY|HEPASCORE FORMULA||U|N|Y|U|||N|4||88||BASELINE|1960-11-09|1962-09-25|||||1967-05-09||1960-05-15|Y|1972-08-19
TRIAL STUDY 134XCP|LB|CF8F9036-3380-4A0B-B17A-7EF814B02700|2||||FBRTST|FIBROTEST SCORE|||||||VIRTUAL PIXEL|||||||POSITIVE||UV2||||ABNORMAL|NOT DONE||||KERATINOCYTE|CONCENTRATED|U|CLAUSS METHOD|MDRD FORMULA||Y|Y|Y|U|||NA|4||88||CONTINUATION TREATMENT|1968-12-20|1971-10-14|||||1970-03-13||1970-07-28|NA|1966-10-29
TRIAL STUDY 134XCP|LB|CF8F9036-3380-4A0B-B17A-7EF814B02700|1||||MPC|MEAN PLATELET COMPONENT|||||||MIN*MG/ML|||||||BORDERLINE||MG/M2||||LOW|NOT DONE||||INFRANATANT, SERUM|AUTOLYZED|Y|TOTAL BODY RADIOGRAPHY|MDRD 6 VARIABLE FORMULA||U|Y|N|Y|||NA|5||7||BLINDED TREATMENT|1960-03-16|1967-09-03|||||1968-12-14||1963-05-15|N|1961-04-15
TRIAL STUDY 134XCP|LB|CF8F9036-3380-4A0B-B17A-7EF814B02700|2||||TIMM10|TRANSLOCASE INNER MITOCHONDRIAL MEMBR 10|||||||DEG/S|||||||INDETERMINATE||IU/MG||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|REFRIGERATED|Y|DIRECT SEQUENCING|GMI MMOL/MOL FORMULA||N|U|Y|Y|||N|5||7||BASELINE|1962-11-20|1971-08-23|||||1969-01-19||1972-09-02|Y|1962-01-29
TRIAL STUDY 134XCP|LB|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|1||||HAIRYCE|HAIRY CELLS|||||||LOG10 ELISA UNIT|||||||BORDERLINE||/2500 WBC||||ABNORMAL|NOT DONE||||HAIR|GELLED|NA|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|HEPASCORE FORMULA||N|Y|NA|N|||U|1||38||OPEN LABEL TREATMENT|1969-03-31|1972-02-05|||||1972-03-09||1969-02-04|N|1969-08-07
TRIAL STUDY 134XCP|LB|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|2||||ESTRCPT|ESTROGEN RECEPTOR|||||||G/MOL|||||||INVALID||HEP||||LOW|NOT DONE||||INFRANATANT, SERUM|CONTAMINATED|N|ICC|FIBROMETER FORMULA||Y|N|N|N|||NA|1||38||SCREENING|1972-07-21|1960-11-03|||||1962-11-15||1960-07-28|U|1965-11-01
TRIAL STUDY 134XCP|LB|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|1||||ALBGLOB|ALBUMIN/GLOBULIN|||||||MEQ/DL|||||||NEGATIVE||UG/H||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CLOTTED|Y|ERGOSPIROMETRY|FIBROTEST FORMULA||N|N|NA|NA|||NA|2||58||RUN-IN|1961-09-02|1962-09-15|||||1968-07-22||1961-10-13|U|1964-08-25
TRIAL STUDY 134XCP|LB|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|2||||CCL7|CHEMOKINE (C-C MOTIF) LIGAND 7|||||||/5X10^4 WBC|||||||TRACE||PUFF||||NORMAL|NOT DONE||||CAPILLARY BLOOD|UNEXPECTED ODOR|N|IN SITU HYBRIDIZATION|FIBROMETER FORMULA||NA|NA|U|U|||U|2||58||BLINDED TREATMENT|1972-05-12|1964-08-03|||||1971-07-10||1968-12-05|U|1962-08-24
TRIAL STUDY 134XCP|LB|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|1||||FATDROP|FAT DROPLET|||||||NMOL|||||||NEGATIVE||COAT||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|FROZEN|N|DYNAMOMETRY|FIBROMETER FORMULA||NA|N|U|Y|||NA|3||39||FOLLOW-UP|1963-12-30|1968-10-02|||||1969-11-26||1962-12-07|U|1970-01-21
TRIAL STUDY 134XCP|LB|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|2||||ANP|ATRIAL NATRIURETIC PEPTIDE|||||||UM|||||||BORDERLINE||MET||||HIGH|NOT DONE||||PROSTATIC FLUID|NON-HEMOLYZED|N|INDIA INK STAIN|MDRD 5 VARIABLE FORMULA||Y|U|NA|NA|||N|3||39||SCREENING|1972-11-27|1965-12-11|||||1962-12-11||1969-12-01|U|1962-09-05
TRIAL STUDY 134XCP|LB|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|1||||IGHG4|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 4|||||||BOWL|||||||BORDERLINE||UV2||||LOW|NOT DONE||||DIALYSIS FLUID|AUTOLYZED|Y|CLAUSS METHOD|MDRD 6 VARIABLE FORMULA||U|U|N|U|||U|4||88||LONG-TERM FOLLOW-UP|1961-03-21|1964-01-29|||||1972-04-11||1960-10-31|U|1972-06-18
TRIAL STUDY 134XCP|LB|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|2||||LYMPL|PLASMACYTOID LYMPHOCYTES|||||||IU/DAY|||||||NEGATIVE||ML/ANIMAL/DAY||||NORMAL|NOT DONE||||KERATINOCYTE|CALCIFIED|Y|LIGHT SCATTERING SPECTROSCOPY|FIBROTEST FORMULA||NA|U|N|NA|||N|4||88||INDUCTION TREATMENT|1960-03-12|1964-11-08|||||1960-07-29||1969-06-16|Y|1964-01-12
TRIAL STUDY 134XCP|LB|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|1||||TCHT|TAUROCHOLATE|||||||USP U|||||||NEGATIVE||VG/ML||||NORMAL|NOT DONE||||NAIL|CONTAMINATED|NA|HPLC|FIBROSIS 4 FORMULA||NA|N|NA|NA|||N|5||7||INDUCTION TREATMENT|1965-05-22|1966-01-07|||||1969-04-19||1960-02-07|NA|1972-06-21
TRIAL STUDY 134XCP|LB|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|2||||BLSTLY|LYMPHOBLASTS|||||||G/U|||||||POSITIVE||MOL/G||||HIGH|NOT DONE||||PUS|LACTESCENT|N|WESTERN BLOT|GMI MMOL/MOL FORMULA||N|NA|N|Y|||N|5||7||OPEN LABEL TREATMENT|1972-05-15|1969-04-20|||||1968-07-05||1965-02-26|Y|1961-01-02
TRIAL STUDY 134XCP|LB|58360390-F6AB-41D7-9A0D-1039E795403E|1||||SOST|SCLEROSTIN|||||||PG/CELL|||||||POSITIVE||G/ANIMAL/DAY||||HIGH|NOT DONE||||DISCHARGE|GELLED|N|IMMUNOFLUORESCENT STAIN|MDRD ENZYMATIC FORMULA||Y|Y|NA|Y|||Y|1||38||OBSERVATION|1972-09-26|1972-02-17|||||1970-01-21||1964-09-04|NA|1969-01-04
TRIAL STUDY 134XCP|LB|58360390-F6AB-41D7-9A0D-1039E795403E|2||||RETIL|LOW ABSORPTION RETICULOCYTES|||||||ML/CAGE/DAY|||||||NEGATIVE||MS/MMHG||||NORMAL|NOT DONE||||SEMINAL FLUID|SOLIDIFIED|NA|CONTRAST ENHANCED PET/CT SCAN|CKD-EPI CREATININE FORMULA||NA|U|NA|Y|||Y|1||38||FOLLOW-UP|1960-12-10|1963-02-18|||||1960-05-05||1970-04-23|U|1972-10-30
TRIAL STUDY 134XCP|LB|58360390-F6AB-41D7-9A0D-1039E795403E|1||||CYAMMOX|AMMONIUM OXALATE CRYSTALS|||||||MEQ/G|||||||TRACE||1/(S*KPA)||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|ROOM TEMPERATURE|NA|SICKLE CELL SOLUBILITY TEST|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|Y|N|||NA|2||58||TREATMENT|1963-06-22|1966-12-23|||||1971-05-03||1965-08-01|NA|1970-11-22
TRIAL STUDY 134XCP|LB|58360390-F6AB-41D7-9A0D-1039E795403E|2||||TTGIGGAB|TISSUE TRANSGLUTAMINASE IGG ANTIBODY|||||||BQ/MG|||||||BORDERLINE||EIA UNIT||||ABNORMAL|NOT DONE||||STOOL|FROZEN|NA|ELECTROMYOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|U|NA|||N|2||58||INDUCTION TREATMENT|1961-03-12|1971-07-20|||||1973-06-18||1973-09-08|Y|1969-06-16
TRIAL STUDY 134XCP|LB|58360390-F6AB-41D7-9A0D-1039E795403E|1||||ACT|ACTIVATED COAGULATION TIME|||||||CCID 50/ML|||||||TRACE||HPA||||HIGH|NOT DONE||||WHITE MATTER TISSUE|AUTOLYZED|Y|KINYOUN STAIN|MDRD FORMULA||U|Y|U|N|||N|3||39||INDUCTION TREATMENT|1972-04-07|1971-03-19|||||1968-06-29||1971-11-08|U|1966-10-04
TRIAL STUDY 134XCP|LB|58360390-F6AB-41D7-9A0D-1039E795403E|2||||FATLVIDX|FATTY LIVER INDEX|||||||UGEQ|||||||INDETERMINATE||UG/L DDU||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|N|EIA|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|NA|Y|||U|3||39||OBSERVATION|1960-12-29|1971-06-13|||||1967-09-14||1962-09-19|N|1968-05-11
TRIAL STUDY 134XCP|LB|58360390-F6AB-41D7-9A0D-1039E795403E|1||||AMYLOIDP|AMYLOID P|||||||U|||||||NEGATIVE||10^8/L||||NORMAL|NOT DONE||||HAIR FOLLICLE|PARAFFIN-EMBEDDED|U|LINE PROBE ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|U|N|||NA|4||88||CONTINUATION TREATMENT|1972-04-24|1960-05-24|||||1965-01-13||1967-05-23|N|1973-05-29
TRIAL STUDY 134XCP|LB|58360390-F6AB-41D7-9A0D-1039E795403E|2||||NTELOCRT|N-TELOPEPTIDE/CREATININE|||||||UGEQ|||||||NEGATIVE||MM/SEC||||ABNORMAL|NOT DONE||||MONOCYTE|THAWED|Y|PHASE-CONTRAST MRI|FIBROTEST FORMULA||NA|N|Y|Y|||Y|4||88||OPEN LABEL TREATMENT|1973-01-23|1962-02-12|||||1960-02-03||1971-01-04|Y|1964-11-18
TRIAL STUDY 134XCP|LB|58360390-F6AB-41D7-9A0D-1039E795403E|1||||MPXI|MYELOPEROXIDASE INDEX|||||||LOG10 IU/ML|||||||POSITIVE||MM/H||||LOW|NOT DONE||||BONE MARROW|CONTAMINATED|N|WHOLE EXOME SEQUENCING|FIBROMETER FORMULA||N|U|NA|NA|||N|5||7||INDUCTION TREATMENT|1970-05-28|1966-09-01|||||1960-12-11||1969-08-08|N|1966-12-30
TRIAL STUDY 134XCP|LB|58360390-F6AB-41D7-9A0D-1039E795403E|2||||BASOB|BASOPHILS BAND FORM|||||||PFU/ANIMAL|||||||INVALID||CONTAINER||||ABNORMAL|NOT DONE||||GASTRIC FLUID|CLOTTED|U|CALIPER MEASUREMENT METHOD|MDRD ENZYMATIC FORMULA||U|N|U|U|||NA|5||7||RUN-IN|1965-01-21|1963-07-13|||||1960-11-18||1965-04-07|Y|1961-10-30
TRIAL STUDY 134XCP|LB|61B02780-0C99-47F8-93B2-CA839876604E|1||||ANGLBIND|ANTIGLOBULIN TEST, INDIRECT|||||||UL|||||||INDETERMINATE||UIU/L||||NORMAL|NOT DONE||||HAIR FOLLICLE|LACTESCENT|Y|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD ENZYMATIC FORMULA||NA|Y|U|Y|||NA|1||38||INDUCTION TREATMENT|1971-07-29|1962-10-23|||||1967-12-05||1961-05-03|NA|1968-11-22
TRIAL STUDY 134XCP|LB|61B02780-0C99-47F8-93B2-CA839876604E|2||||CA|CALCIUM|||||||F|||||||BORDERLINE||ML*CMH2O||||NORMAL|NOT DONE||||SPUTUM|UNEXPECTED ODOR|N|GC/MS/MS|ASH FIBROSURE FORMULA||Y|NA|NA|NA|||U|1||38||INDUCTION TREATMENT|1961-05-15|1967-10-03|||||1963-08-05||1964-03-08|U|1960-08-13
TRIAL STUDY 134XCP|LB|61B02780-0C99-47F8-93B2-CA839876604E|1||||COPPER|COPPER|||||||%/MIN|||||||TRACE||HOMEOPATHIC DILUTION||||LOW|NOT DONE||||BLOOD|PARAFFIN-EMBEDDED|Y|MICROBIAL CONCENTRATION|GMI % FORMULA||U|N|NA|Y|||N|2||58||FOLLOW-UP|1961-12-15|1965-08-13|||||1966-02-18||1960-06-02|U|1971-08-20
TRIAL STUDY 134XCP|LB|61B02780-0C99-47F8-93B2-CA839876604E|2||||C130102|TREE MIX POLLEN ANTIGEN IGG ANTIBODY|||||||NMOL/L/H|||||||TRACE||/H||||ABNORMAL|NOT DONE||||BONE MARROW|ICTERIC|Y|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|NASH FIBROSURE FORMULA||NA|U|U|N|||U|2||58||CONTINUATION TREATMENT|1968-04-21|1968-11-23|||||1969-01-30||1972-03-05|NA|1964-08-17
TRIAL STUDY 134XCP|LB|61B02780-0C99-47F8-93B2-CA839876604E|1||||IGF1|INSULIN-LIKE GROWTH FACTOR-1|||||||COAT|||||||BORDERLINE||IMPLANT||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|CONCENTRATED|U|IMMUNOTURBIDIMETRY|MDRD FORMULA||U|N|NA|N|||NA|3||39||TREATMENT|1968-12-15|1972-07-20|||||1969-06-25||1960-10-13|Y|1962-04-21
TRIAL STUDY 134XCP|LB|61B02780-0C99-47F8-93B2-CA839876604E|2||||KL6|KREBS VON DEN LUNGEN-6|||||||K|||||||POSITIVE||MEQ/DAY||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|AGGLUTINATED|N|PHOROPTER|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|U|N|||NA|3||39||FOLLOW-UP|1964-11-12|1968-11-13|||||1961-06-30||1961-07-24|U|1960-07-15
TRIAL STUDY 134XCP|LB|61B02780-0C99-47F8-93B2-CA839876604E|1||||PTAUAB42|PHOSPHORYLATED TAU PROT/AMYLOID BETA1-42|||||||MG/L|||||||POSITIVE||NMOL/KG/DAY||||ABNORMAL|NOT DONE||||PLATELET|ROOM TEMPERATURE|Y|ELISA|MDRD ENZYMATIC FORMULA||Y|U|U|U|||U|4||88||OPEN LABEL TREATMENT|1962-11-14|1968-01-09|||||1973-04-23||1963-08-03|NA|1970-03-12
TRIAL STUDY 134XCP|LB|61B02780-0C99-47F8-93B2-CA839876604E|2||||TGFB1|TRANSFORMING GROWTH FACTOR BETA 1|||||||UG/ML/H|||||||BORDERLINE||UG/M2/MIN||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|FROZEN|U|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|U|Y|NA|||U|4||88||BASELINE|1965-05-22|1963-03-27|||||1970-05-07||1965-08-03|U|1968-11-12
TRIAL STUDY 134XCP|LB|61B02780-0C99-47F8-93B2-CA839876604E|1||||PLATSAT|PLATELET SATELLITISM|||||||UG/G/DAY|||||||INDETERMINATE||G/U||||ABNORMAL|NOT DONE||||LEUKOCYTE|CONTAMINATED|NA|WHOLE EXOME SEQUENCING|FIBROSIS 4 FORMULA||N|U|NA|Y|||U|5||7||OPEN LABEL TREATMENT|1961-01-23|1970-05-17|||||1973-06-14||1973-05-22|U|1965-02-06
TRIAL STUDY 134XCP|LB|61B02780-0C99-47F8-93B2-CA839876604E|2||||AMYLASEP|AMYLASE, PANCREATIC|||||||/MM2|||||||NEGATIVE||EP U||||NORMAL|NOT DONE||||INFRANATANT, SERUM|LACTESCENT|U|DIFFUSION TENSOR MRI|COCKCROFT-GAULT FORMULA||NA|NA|NA|Y|||Y|5||7||CONTINUATION TREATMENT|1971-06-25|1972-03-14|||||1972-11-02||1967-09-23|U|1966-09-14
TRIAL STUDY 134XCP|LB|1381458A-D702-467D-ADCA-984EE7BD894D|1||||NGF|NERVE GROWTH FACTOR|||||||BOLUS|||||||NEGATIVE||UG/DL||||NORMAL|NOT DONE||||SPUTUM|PARAFFIN-EMBEDDED|Y|TEMPLATE INCISION METHOD|CKD-EPI CREATININE FORMULA||NA|N|Y|U|||N|1||38||SCREENING|1972-10-20|1961-06-03|||||1973-04-06||1970-05-20|U|1960-01-13
TRIAL STUDY 134XCP|LB|1381458A-D702-467D-ADCA-984EE7BD894D|2||||DKK1|DICKKOPF WNT SIGNALING PATH INHIBITOR 1|||||||SHOCK WAVE|||||||INVALID||PIPE||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|CALCIFIED|Y|TONOMETRY|CKD-EPI CYSTATIN C FORMULA||N|NA|NA|Y|||N|1||38||INDUCTION TREATMENT|1960-06-09|1967-04-30|||||1965-03-14||1963-06-25|Y|1967-05-08
TRIAL STUDY 134XCP|LB|1381458A-D702-467D-ADCA-984EE7BD894D|1||||GUDCA|GLYCOURSODEOXYCHOLATE|||||||CM/S|||||||INVALID||1/(S*KPA)||||HIGH|NOT DONE||||LEUKOCYTE|NON-HEMOLYZED|N|ELASTOGRAPHY|NASH FIBROSURE FORMULA||U|NA|N|U|||U|2||58||OPEN LABEL TREATMENT|1969-04-24|1961-05-24|||||1972-08-10||1963-09-10|Y|1965-02-22
TRIAL STUDY 134XCP|LB|1381458A-D702-467D-ADCA-984EE7BD894D|2||||IDL|IDL CHOLESTEROL|||||||IU/G HB|||||||TRACE||ML/M2/MIN||||NORMAL|NOT DONE||||VENOUS BLOOD|CALCIFIED|Y|SLOAN LETTER EYE CHART 1.25%|FIBROMETER FORMULA||N|Y|U|NA|||U|2||58||INDUCTION TREATMENT|1961-08-13|1966-01-03|||||1965-04-17||1967-10-31|NA|1967-08-09
TRIAL STUDY 134XCP|LB|1381458A-D702-467D-ADCA-984EE7BD894D|1||||MGB|MYOGLOBIN|||||||BQ/ML|||||||POSITIVE||G/ANIMAL/DAY||||ABNORMAL|NOT DONE||||SPERMATOZOON|HEMOLYZED|Y|IMMUNOFLUORESCENT STAIN|FIBROMETER FORMULA||N|Y|Y|N|||U|3||39||WASHOUT|1971-01-10|1960-05-28|||||1967-11-19||1972-03-07|Y|1970-08-19
TRIAL STUDY 134XCP|LB|1381458A-D702-467D-ADCA-984EE7BD894D|2||||LDH|LACTATE DEHYDROGENASE|||||||MIN/DAY|||||||INDETERMINATE||UIU/DL||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|CALCIFIED|Y|THIN SMEAR|MDRD FORMULA||Y|N|N|U|||Y|3||39||CONTINUATION TREATMENT|1966-02-28|1970-03-24|||||1960-07-20||1970-06-24|N|1961-05-05
TRIAL STUDY 134XCP|LB|1381458A-D702-467D-ADCA-984EE7BD894D|1||||BTKFR|BRUTON'S TYROSINE KINASE, FREE|||||||10^3 CFU/ML|||||||POSITIVE||BQ/ML||||LOW|NOT DONE||||MUCUS|AGGLUTINATED|NA|WEBER GREEN STAIN|MDRD 6 VARIABLE FORMULA||NA|NA|Y|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1972-02-01|1963-12-24|||||1965-06-20||1966-01-04|Y|1964-10-09
TRIAL STUDY 134XCP|LB|1381458A-D702-467D-ADCA-984EE7BD894D|2||||NEUTAGR|AGRANULAR NEUTROPHILS|||||||K|||||||NEGATIVE||MOL/MG||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|FROZEN|U|MODIFIED ACID FAST STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|Y|||NA|4||88||INDUCTION TREATMENT|1971-02-16|1963-04-05|||||1965-01-10||1972-01-30|N|1965-05-06
TRIAL STUDY 134XCP|LB|1381458A-D702-467D-ADCA-984EE7BD894D|1||||ALB|ALBUMIN|||||||RATIO|||||||POSITIVE||TBSP||||HIGH|NOT DONE||||KERATINOCYTE|HEMOLYZED|U|IMMUNOASSAY|MDRD ENZYMATIC FORMULA||U|N|U|Y|||NA|5||7||RUN-IN|1973-03-11|1966-07-01|||||1972-04-11||1966-04-26|U|1972-08-25
TRIAL STUDY 134XCP|LB|1381458A-D702-467D-ADCA-984EE7BD894D|2||||TAURCRT|TAURINE/CREATININE|||||||MM/MIN|||||||INVALID||PMOL/10^10 CELLS||||HIGH|NOT DONE||||BLOOD|GELLED|Y|TRANSVAGINAL ULTRASOUND|FIBROSIS 4 FORMULA||U|NA|U|NA|||U|5||7||OPEN LABEL TREATMENT|1960-12-08|1967-03-24|||||1967-06-01||1971-01-19|NA|1970-02-20
TRIAL STUDY 134XCP|LB|04211DA3-CFD5-4750-9D61-C91FF7BC338A|1||||VITD2425|24,25-DIHYDROXYVITAMIN D|||||||UG/M2|||||||POSITIVE||UU/DL||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|ROOM TEMPERATURE|N|PET/SPECT SCAN|MDRD 4 VARIABLE FORMULA||N|U|N|NA|||N|1||38||BLINDED TREATMENT|1972-01-17|1967-05-27|||||1969-11-02||1962-03-05|U|1966-11-08
TRIAL STUDY 134XCP|LB|04211DA3-CFD5-4750-9D61-C91FF7BC338A|2||||VITDAT|1, 25-DIHYDROXYVITAMIN D|||||||10^6 ORGANISMS|||||||TRACE||DAMOL/L||||HIGH|NOT DONE||||DIALYSIS FLUID|AUTOLYZED|Y|REFRACTOMETRY|CKD-EPI CYSTATIN C FORMULA||NA|NA|N|NA|||U|1||38||OPEN LABEL TREATMENT|1968-09-25|1962-12-07|||||1972-03-21||1964-10-19|Y|1970-10-08
TRIAL STUDY 134XCP|LB|04211DA3-CFD5-4750-9D61-C91FF7BC338A|1||||CTXIICRT|TYPE II COLLAGEN C-TELOPEPTIDES/CREAT|||||||IU/KG/H|||||||POSITIVE||M||||ABNORMAL|NOT DONE||||CORD SERUM|LACTESCENT|U|PET/CT SCAN WITHOUT CONTRAST|ASH FIBROSURE FORMULA||NA|U|NA|Y|||Y|2||58||CONTINUATION TREATMENT|1967-03-04|1963-04-15|||||1964-12-26||1972-12-16|U|1969-07-01
TRIAL STUDY 134XCP|LB|04211DA3-CFD5-4750-9D61-C91FF7BC338A|2||||NHMCE|NONHEMATIC CELLS|||||||NMOL BCE/NMOL|||||||TRACE||10^6 CFU||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|UNEXPECTED ODOR|Y|ARTERIAL SPIN LABELING FUNCTIONAL MRI|FIBROSIS 4 FORMULA||NA|U|N|N|||NA|2||58||RUN-IN|1965-07-10|1964-07-08|||||1972-08-03||1962-09-09|U|1965-02-19
TRIAL STUDY 134XCP|LB|04211DA3-CFD5-4750-9D61-C91FF7BC338A|1||||PLTMORPH|PLATELET MORPHOLOGY|||||||CFU/G|||||||POSITIVE||DPM/100MG||||HIGH|NOT DONE||||ABSCESS FLUID|CALCIFIED|N|ATOMIC ABSORPTION SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA||U|N|N|NA|||U|3||39||OBSERVATION|1967-10-09|1966-10-22|||||1973-01-25||1968-06-09|NA|1962-10-12
TRIAL STUDY 134XCP|LB|04211DA3-CFD5-4750-9D61-C91FF7BC338A|2||||LDHEXR|LACTATE DEHYDROGENASE EXCRETION RATE|||||||10^4 CFU|||||||BORDERLINE||ABSORBANCE U/ML||||NORMAL|NOT DONE||||SKIN TISSUE|FRESH|Y|DNA MICROARRAY|NASH FIBROSURE FORMULA||NA|Y|U|U|||NA|3||39||BLINDED TREATMENT|1968-01-18|1972-05-13|||||1960-07-15||1964-07-27|Y|1968-06-25
TRIAL STUDY 134XCP|LB|04211DA3-CFD5-4750-9D61-C91FF7BC338A|1||||PROMYB|PROMYELOBLASTS|||||||ML/KG/DAY|||||||BORDERLINE||ABSORBANCE U||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|FROZEN|Y|IMMUNOFIXATION ELECTROPHORESIS|GMI MMOL/MOL FORMULA||Y|NA|N|N|||Y|4||88||BLINDED TREATMENT|1961-10-02|1961-03-13|||||1966-03-01||1971-07-08|NA|1962-08-03
TRIAL STUDY 134XCP|LB|04211DA3-CFD5-4750-9D61-C91FF7BC338A|2||||ERCEMIDX|ERYTHROID MATURATION INDEX|||||||PMOL/G|||||||INDETERMINATE||AMP||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|DRIED|U|GC/MS-EI|FIBROTEST FORMULA||NA|U|U|NA|||N|4||88||OBSERVATION|1964-05-08|1962-07-17|||||1964-12-27||1971-09-29|N|1961-06-23
TRIAL STUDY 134XCP|LB|04211DA3-CFD5-4750-9D61-C91FF7BC338A|1||||FATBODOV|FAT BODIES, OVAL|||||||G/CAGE/WK|||||||POSITIVE||10^6 ORGANISMS/G||||ABNORMAL|NOT DONE||||ERYTHROCYTES|AGGLUTINATED|Y|INDIRECT IMMUNOFLUORESCENCE|CKD-EPI CREATININE FORMULA||N|N|Y|Y|||Y|5||7||FOLLOW-UP|1972-04-03|1966-06-20|||||1968-12-28||1963-12-24|U|1968-01-31
TRIAL STUDY 134XCP|LB|04211DA3-CFD5-4750-9D61-C91FF7BC338A|2||||TPAAG|TISSUE PLASMINOGEN ACTIVATOR ANTIGEN|||||||PNU/ML|||||||INDETERMINATE||MG/DAY||||NORMAL|NOT DONE||||INFRANATANT, SERUM|PARAFFIN-EMBEDDED|N|MICROBIAL CULTURE, SOLID|CKD-EPI FORMULA||Y|N|N|NA|||U|5||7||FOLLOW-UP|1960-04-22|1960-09-18|||||1969-05-04||1969-05-01|Y|1968-08-30
TRIAL STUDY 134XCP|LB|EF707A48-6FAD-47C0-913A-5CBCACA539E0|1||||C165903|WESTERN RAGWEED POLLEN IGG AB RAST SCORE|||||||ML/MIN/1.73M2|||||||BORDERLINE||UGEQ/L||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|DRIED|U|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD 6 VARIABLE FORMULA||U|NA|N|U|||NA|1||38||OPEN LABEL TREATMENT|1972-05-07|1969-11-06|||||1972-11-12||1966-08-04|N|1967-03-17
TRIAL STUDY 134XCP|LB|EF707A48-6FAD-47C0-913A-5CBCACA539E0|2||||FLUIDOUT|FLUID OUTPUT|||||||PACK YEAR|||||||BORDERLINE||DYN||||NORMAL|NOT DONE||||PLEURAL FLUID|CALCIFIED|U|MACRO BROTH DILUTION|FIBROTEST FORMULA||NA|Y|U|U|||U|1||38||BLINDED TREATMENT|1965-10-20|1968-01-28|||||1966-03-02||1963-06-13|Y|1964-10-12
TRIAL STUDY 134XCP|LB|EF707A48-6FAD-47C0-913A-5CBCACA539E0|1||||TGFB3|TRANSFORMING GROWTH FACTOR BETA 3|||||||10^9/DOSE|||||||INVALID||LOZENGE||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|UNEXPECTED ODOR|N|RADIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|U|||N|2||58||LONG-TERM FOLLOW-UP|1962-08-16|1963-01-14|||||1965-08-06||1964-05-20|Y|1964-10-26
TRIAL STUDY 134XCP|LB|EF707A48-6FAD-47C0-913A-5CBCACA539E0|2||||MIP1|MACROPHAGE INFLAMMATORY PROTEIN 1|||||||U/M2/DAY|||||||BORDERLINE||U/KG/DAY||||NORMAL|NOT DONE||||MUCUS|CLOTTED|N|MRI WITHOUT CONTRAST|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|N|N|||NA|2||58||CONTINUATION TREATMENT|1962-04-06|1971-11-13|||||1973-06-09||1968-07-18|U|1968-12-25
TRIAL STUDY 134XCP|LB|EF707A48-6FAD-47C0-913A-5CBCACA539E0|1||||CH100|COMPLEMENT CH100|||||||V/V|||||||BORDERLINE||IU/MMOL||||LOW|NOT DONE||||MIXED VENOUS BLOOD|ICTERIC|U|HEMATOXYLIN AND EOSIN STAIN|HEPASCORE FORMULA||N|U|U|U|||N|3||39||SCREENING|1973-02-12|1973-03-18|||||1972-09-20||1961-04-10|NA|1973-01-17
TRIAL STUDY 134XCP|LB|EF707A48-6FAD-47C0-913A-5CBCACA539E0|2||||VITB6|VITAMIN B6|||||||BAR|||||||NEGATIVE||UV2||||ABNORMAL|NOT DONE||||BUFFY COAT|HEMOLYZED|U|MAGNETIC RESONANCE ELASTOGRAPHY|FIBROMETER FORMULA||Y|NA|NA|Y|||Y|3||39||CONTINUATION TREATMENT|1968-08-31|1967-03-09|||||1961-04-11||1966-10-21|N|1964-12-12
TRIAL STUDY 134XCP|LB|EF707A48-6FAD-47C0-913A-5CBCACA539E0|1||||CYSTATC|CYSTATIN C|||||||UG/H|||||||POSITIVE||G/DL||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|HEMOLYZED|NA|LEAD CITRATE STAIN|CKD-EPI CYSTATIN C FORMULA||Y|Y|U|NA|||NA|4||88||OPEN LABEL TREATMENT|1971-05-04|1965-07-16|||||1964-02-09||1966-06-12|Y|1969-01-04
TRIAL STUDY 134XCP|LB|EF707A48-6FAD-47C0-913A-5CBCACA539E0|2||||ALA|ALANINE|||||||10^3 COPIES/ML|||||||POSITIVE||U/MG||||HIGH|NOT DONE||||BREAST MILK|CONTAMINATED|N|MEDIASTINOSCOPY|MDRD ENZYMATIC FORMULA||Y|N|U|N|||NA|4||88||OPEN LABEL TREATMENT|1966-04-23|1962-11-12|||||1969-12-19||1972-06-10|Y|1967-08-03
TRIAL STUDY 134XCP|LB|EF707A48-6FAD-47C0-913A-5CBCACA539E0|1||||HLADR53A|HLA-DR53 ANTIBODY|||||||MU/G|||||||INDETERMINATE||MOSM/KG||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|FRESH|Y|CONGO RED STAIN|FIBROMETER FORMULA||NA|Y|NA|N|||N|5||7||BLINDED TREATMENT|1960-09-08|1973-03-02|||||1967-02-27||1960-06-25|N|1967-08-30
TRIAL STUDY 134XCP|LB|EF707A48-6FAD-47C0-913A-5CBCACA539E0|2||||CALPRO|CALPROTECTIN|||||||NMOL|||||||BORDERLINE||MOSM/KG||||LOW|NOT DONE||||CALCULUS|PARAFFIN-EMBEDDED|Y|WRIGHT-GIEMSA STAIN|GMI MMOL/MOL FORMULA||N|U|N|Y|||NA|5||7||SCREENING|1969-12-26|1973-01-11|||||1972-12-20||1970-05-17|N|1968-12-15
TRIAL STUDY 134XCP|LB|C896767E-2418-4226-A8AE-D875DA40F9FB|1||||IL2RB|INTERLEUKIN 2 RECEPTOR SUBUNIT BETA|||||||% INHIBITION|||||||INDETERMINATE||KV||||LOW|NOT DONE||||CELL PELLET|CONTAMINATED|U|CARDIAC THERMODILUTION|MDRD 5 VARIABLE FORMULA||Y|NA|NA|N|||Y|1||38||OBSERVATION|1963-01-07|1967-07-31|||||1971-04-05||1965-08-30|U|1973-06-16
TRIAL STUDY 134XCP|LB|C896767E-2418-4226-A8AE-D875DA40F9FB|2||||PHNBRBTL|PHENOBARBITAL|||||||UMOL/L/H|||||||POSITIVE||10^6/HPF||||HIGH|NOT DONE||||EXUDATE|AGGLUTINATED|NA|PHOTOMETRY|HEPASCORE FORMULA||N|U|N|N|||Y|1||38||OBSERVATION|1965-10-19|1971-03-16|||||1963-11-29||1961-05-05|NA|1966-03-26
TRIAL STUDY 134XCP|LB|C896767E-2418-4226-A8AE-D875DA40F9FB|1||||TAT|THROMBIN/ANTITHROMBIN|||||||MS/MMHG|||||||TRACE||USIEMENS||||LOW|NOT DONE||||GASTRIC CONTENTS|UNEXPECTED ODOR|N|OPTICAL DENSITY MEASUREMENT|FIBROTEST FORMULA||Y|Y|NA|N|||NA|2||58||TREATMENT|1963-01-05|1968-02-07|||||1960-11-23||1969-09-26|NA|1968-04-25
TRIAL STUDY 134XCP|LB|C896767E-2418-4226-A8AE-D875DA40F9FB|2||||LYMPHOID|LYMPHOID CELLS|||||||G/G|||||||BORDERLINE||MG/KG/DAY||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|AGGLUTINATED|NA|WESTERN BLOT|MDRD 4 VARIABLE FORMULA||U|U|Y|NA|||Y|2||58||INDUCTION TREATMENT|1971-03-20|1960-02-19|||||1963-01-11||1962-01-10|NA|1965-01-07
TRIAL STUDY 134XCP|LB|C896767E-2418-4226-A8AE-D875DA40F9FB|1||||ODMTASE|O-DEMETHYLASE|||||||ML/M2/H|||||||NEGATIVE||SIEMENS||||ABNORMAL|NOT DONE||||SEBUM|REFRIGERATED|N|U-HPLC/MS/MS|MDRD 5 VARIABLE FORMULA||NA|NA|N|Y|||Y|3||39||CONTINUATION TREATMENT|1963-02-09|1960-03-30|||||1972-11-26||1972-02-03|NA|1968-01-06
TRIAL STUDY 134XCP|LB|C896767E-2418-4226-A8AE-D875DA40F9FB|2||||RDWR|RET VOLUME DISTRIBUTION WIDTH|||||||UL|||||||INVALID||FRACTION OF 1||||ABNORMAL|NOT DONE||||TRANSUDATE|UNEXPECTED ODOR|NA|TRYPAN BLUE STAIN|MDRD FORMULA||U|Y|U|NA|||Y|3||39||LONG-TERM FOLLOW-UP|1964-12-29|1972-04-24|||||1971-07-26||1963-03-09|N|1966-03-03
TRIAL STUDY 134XCP|LB|C896767E-2418-4226-A8AE-D875DA40F9FB|1||||INTLK28|INTERLEUKIN 28|||||||BOTTLE|||||||INDETERMINATE||CIGARETTE||||LOW|NOT DONE||||EMOTIONAL TEAR|THAWED|Y|IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|N|Y|||N|4||88||CONTINUATION TREATMENT|1966-08-14|1972-12-31|||||1961-02-18||1966-07-14|Y|1964-12-17
TRIAL STUDY 134XCP|LB|C896767E-2418-4226-A8AE-D875DA40F9FB|2||||IL1RL1|INTERLEUKIN 1 RECEPTOR-LIKE 1|||||||UG/H|||||||INVALID||FG||||NORMAL|NOT DONE||||PUS|AGGLUTINATED|N|INDIA INK STAIN|CKD-EPI CREATININE FORMULA||Y|N|NA|Y|||U|4||88||RUN-IN|1972-01-22|1963-02-19|||||1967-10-16||1970-01-21|Y|1961-01-20
TRIAL STUDY 134XCP|LB|C896767E-2418-4226-A8AE-D875DA40F9FB|1||||UNSPCECE|UNSPECIFIED CELLS/TOTAL CELLS|||||||ANTI-XA IU/ML|||||||BORDERLINE||DPM/MG||||HIGH|NOT DONE||||SWABBED MATERIAL|CALCIFIED|Y|MRI WITHOUT CONTRAST|MDRD ENZYMATIC FORMULA||U|NA|U|N|||NA|5||7||WASHOUT|1963-09-26|1961-05-08|||||1966-07-22||1967-12-26|N|1969-06-06
TRIAL STUDY 134XCP|LB|C896767E-2418-4226-A8AE-D875DA40F9FB|2||||KCREAT|POTASSIUM/CREATININE|||||||COPIES/UG|||||||POSITIVE||AU/ML||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|AUTOLYZED|Y|ELECTROMYOGRAPHY|CKD-EPI FORMULA||NA|NA|U|N|||N|5||7||TREATMENT|1973-08-18|1972-03-01|||||1973-01-19||1961-12-31|U|1971-10-01
TRIAL STUDY 134XCP|LB|666BC019-B828-4DB4-BD2F-973BA689C9E7|1||||TFERRIN|TRANSFERRIN|||||||KN/CM2|||||||TRACE||MSEC||||ABNORMAL|NOT DONE||||KERATINOCYTE|CLOTTED|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|ASH FIBROSURE FORMULA||U|N|N|Y|||Y|1||38||OPEN LABEL TREATMENT|1970-03-27|1969-06-02|||||1960-07-06||1965-06-26|N|1968-09-25
TRIAL STUDY 134XCP|LB|666BC019-B828-4DB4-BD2F-973BA689C9E7|2||||PERCECE|PROLIFERATING ERYTHROID/TOTAL CELLS|||||||TORR|||||||BORDERLINE||UM/DAY||||LOW|NOT DONE||||MIXED VENOUS BLOOD|AUTOLYZED|U|MANUAL COUNT|CKD-EPI FORMULA||N|Y|N|U|||Y|1||38||WASHOUT|1960-11-28|1971-09-08|||||1963-10-14||1965-01-23|NA|1969-04-12
TRIAL STUDY 134XCP|LB|666BC019-B828-4DB4-BD2F-973BA689C9E7|1||||CKMMCK|CREATINE KINASE MM/TOTAL CREATINE KINASE|||||||UMOL/KG/MIN|||||||INVALID||FT3||||NORMAL|NOT DONE||||RETICULOCYTES|CLOTTED|U|GC/MS|CKD-EPI FORMULA||U|N|U|NA|||N|2||58||OPEN LABEL TREATMENT|1970-09-24|1973-08-20|||||1965-10-18||1967-12-13|U|1971-09-23
TRIAL STUDY 134XCP|LB|666BC019-B828-4DB4-BD2F-973BA689C9E7|2||||ADSDNA|ANTI-DOUBLE STRANDED DNA|||||||NEBULE|||||||INDETERMINATE||SBE/ML||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|CONTAMINATED|N|KINYOUN STAIN|GMI % FORMULA||N|N|NA|Y|||U|2||58||TREATMENT|1963-11-22|1971-05-20|||||1960-08-07||1972-11-09|N|1970-06-04
TRIAL STUDY 134XCP|LB|666BC019-B828-4DB4-BD2F-973BA689C9E7|1||||HDLPL|HDL PHOSPHOLIPID|||||||MOSM/L|||||||BORDERLINE||MCI/KG||||ABNORMAL|NOT DONE||||SKIN TISSUE|NON-HEMOLYZED|U|NON-CONTACT SPECULAR MICROSCOPY|CKD-EPI CREATININE FORMULA||NA|U|NA|Y|||Y|3||39||CONTINUATION TREATMENT|1960-07-30|1971-09-19|||||1970-12-26||1967-01-10|U|1965-10-23
TRIAL STUDY 134XCP|LB|666BC019-B828-4DB4-BD2F-973BA689C9E7|2||||CD14|CD14|||||||ML/KG/MIN|||||||NEGATIVE||10^3 CFU/G||||NORMAL|NOT DONE||||SWABBED MATERIAL|ROOM TEMPERATURE|Y|PHASE-CONTRAST MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|N|||U|3||39||TREATMENT|1969-11-01|1962-11-08|||||1963-10-11||1971-11-25|N|1968-05-06
TRIAL STUDY 134XCP|LB|666BC019-B828-4DB4-BD2F-973BA689C9E7|1||||TRIG|TRIGLYCERIDES|||||||10^6/HPF|||||||INVALID||MET*H||||LOW|NOT DONE||||DERMAL TISSUE|ICTERIC|N|NEPHELOMETRY|MDRD ENZYMATIC FORMULA||NA|NA|NA|U|||U|4||88||INDUCTION TREATMENT|1961-04-28|1960-01-11|||||1971-10-09||1966-12-02|U|1973-05-14
TRIAL STUDY 134XCP|LB|666BC019-B828-4DB4-BD2F-973BA689C9E7|2||||C130120|SHELLFISH MIX ANTIGEN IGE ANTIBODY|||||||TUBE|||||||POSITIVE||NKAT/G HB||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|CONCENTRATED|Y|CHROMOGENIC ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|N|N|||NA|4||88||OPEN LABEL TREATMENT|1966-08-28|1973-01-10|||||1961-03-15||1971-07-08|N|1960-10-09
TRIAL STUDY 134XCP|LB|666BC019-B828-4DB4-BD2F-973BA689C9E7|1||||C130116|BEE MIX ANTIGEN IGE ANTIBODY|||||||GPELISA UNIT/ML|||||||POSITIVE||HENRY||||LOW|NOT DONE||||AMNIOTIC FLUID|REFRIGERATED|U|CLIP|COCKCROFT-GAULT FORMULA||Y|NA|Y|Y|||U|5||7||BASELINE|1970-02-19|1965-12-10|||||1972-03-31||1961-12-23|N|1964-04-24
TRIAL STUDY 134XCP|LB|666BC019-B828-4DB4-BD2F-973BA689C9E7|2||||ACYGLYCN|ACYLGLYCINE|||||||ML/M2|||||||INDETERMINATE||G/ANIMAL||||NORMAL|NOT DONE||||ARTERIAL BLOOD|PARAFFIN-EMBEDDED|U|ELECTROPHORESIS|MDRD 6 VARIABLE FORMULA||N|U|Y|Y|||N|5||7||BASELINE|1973-05-19|1963-06-29|||||1966-07-31||1963-12-15|N|1964-03-10
TRIAL STUDY 134XCP|LB|91282D87-4943-4527-8F33-27A5C153951C|1||||PBGCREAT|PORPHOBILINOGEN/CREATININE|||||||TORR|||||||INDETERMINATE||BQ||||ABNORMAL|NOT DONE||||LYMPH|ICTERIC|NA|MULTIPLE BREATH WASHOUT|NASH FIBROSURE FORMULA||NA|U|U|NA|||U|1||38||FOLLOW-UP|1967-12-02|1968-03-02|||||1966-10-26||1971-07-16|N|1964-04-08
TRIAL STUDY 134XCP|LB|91282D87-4943-4527-8F33-27A5C153951C|2||||PTSAC|PROTEIN S ACTUAL/CONTROL|||||||10^6 CFU|||||||TRACE||KG/MOL||||HIGH|NOT DONE||||PROSTATIC FLUID|ICTERIC|Y|RIA|NASH FIBROSURE FORMULA||NA|Y|NA|U|||U|1||38||BASELINE|1966-02-28|1973-03-23|||||1969-08-08||1973-06-04|U|1965-10-24
TRIAL STUDY 134XCP|LB|91282D87-4943-4527-8F33-27A5C153951C|1||||KEXR|POTASSIUM EXCRETION RATE|||||||DEG2|||||||NEGATIVE||MEQ||||NORMAL|NOT DONE||||CALCULUS|LACTESCENT|N|HPLC/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|U|N|||N|2||58||OBSERVATION|1961-03-23|1961-11-28|||||1968-08-12||1969-05-28|U|1968-03-29
TRIAL STUDY 134XCP|LB|91282D87-4943-4527-8F33-27A5C153951C|2||||CLEXR|CHLORIDE EXCRETION RATE|||||||MMOL/KG|||||||INDETERMINATE||/MM2||||HIGH|NOT DONE||||PLEURAL TISSUE|ROOM TEMPERATURE|Y|EPSILOMETER|MDRD 6 VARIABLE FORMULA||U|NA|Y|N|||N|2||58||OBSERVATION|1960-12-25|1970-07-03|||||1960-03-18||1964-04-02|NA|1961-10-06
TRIAL STUDY 134XCP|LB|91282D87-4943-4527-8F33-27A5C153951C|1||||KLK2|KALLIKREIN-2|||||||MOSM/KG|||||||POSITIVE||AGU/ML||||HIGH|NOT DONE||||MONOCYTE|LIPEMIC|N|REVERSE TRANSCRIPTASE PCR|NASH FIBROSURE FORMULA||Y|NA|N|NA|||N|3||39||SCREENING|1970-07-19|1965-11-22|||||1967-09-23||1968-08-02|U|1970-12-27
TRIAL STUDY 134XCP|LB|91282D87-4943-4527-8F33-27A5C153951C|2||||C130101|TREE MIX POLLEN ANTIGEN IGE ANTIBODY|||||||UG/CM2|||||||NEGATIVE||MNFI||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|CONCENTRATED|N|LEAD CITRATE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|N|||Y|3||39||TREATMENT|1971-02-21|1970-08-22|||||1973-02-15||1964-10-03|Y|1968-11-16
TRIAL STUDY 134XCP|LB|91282D87-4943-4527-8F33-27A5C153951C|1||||BLSTMKCE|MEGAKARYOBLASTS/TOTAL CELLS|||||||STEPS|||||||INVALID||1/(S*KPA)||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|LIPEMIC|NA|VIRUS PLAQUE ASSAY|NASH FIBROSURE FORMULA||N|U|Y|Y|||U|4||88||BASELINE|1965-08-06|1968-04-28|||||1969-11-17||1971-03-23|U|1969-01-24
TRIAL STUDY 134XCP|LB|91282D87-4943-4527-8F33-27A5C153951C|2||||WBC|LEUKOCYTES|||||||MG/L|||||||TRACE||/MM2||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|CALCIFIED|NA|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA||Y|N|N|NA|||NA|4||88||TREATMENT|1966-01-17|1969-05-12|||||1969-08-09||1970-09-03|NA|1969-07-04
TRIAL STUDY 134XCP|LB|91282D87-4943-4527-8F33-27A5C153951C|1||||PLCGF|PLACENTAL GROWTH FACTOR|||||||ML/100G/MIN|||||||INVALID||MEQ||||NORMAL|NOT DONE||||DISCHARGE|HEMOLYZED|U|DYNAMOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|U|NA|||Y|5||7||BLINDED TREATMENT|1971-06-25|1965-09-26|||||1968-09-18||1968-02-22|NA|1963-11-19
TRIAL STUDY 134XCP|LB|91282D87-4943-4527-8F33-27A5C153951C|2||||NITRICOX|NITRIC OXIDE|||||||INHALATION|||||||NEGATIVE||M3||||HIGH|NOT DONE||||PLATELET RICH PLASMA|LIPEMIC|NA|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD 6 VARIABLE FORMULA||U|Y|Y|U|||U|5||7||RUN-IN|1967-06-14|1972-08-07|||||1973-03-21||1966-11-26|U|1969-08-19
TRIAL STUDY 134XCP|LB|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|1||||SO2|SULFUR DIOXIDE|||||||CGY|||||||TRACE||ML/M2/DAY||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|REFRIGERATED|Y|IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|U|U|||Y|1||38||BLINDED TREATMENT|1972-02-21|1963-10-07|||||1962-06-22||1963-01-22|Y|1967-09-03
TRIAL STUDY 134XCP|LB|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|2||||LDH4LDH|LDH ISOENZYME 4/LDH|||||||JOULE|||||||NEGATIVE||NG/DL||||NORMAL|NOT DONE||||TISSUE|AUTOLYZED|U|MAMMOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|U|NA|||NA|1||38||TREATMENT|1968-01-08|1970-04-16|||||1962-05-31||1969-12-19|U|1963-12-12
TRIAL STUDY 134XCP|LB|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|1||||BACT|BACTERIA|||||||MOSM/L|||||||TRACE||UIU/DL||||HIGH|NOT DONE||||ABSCESS FLUID|CONTAMINATED|N|PERIPHERAL ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|U|Y|||NA|2||58||SCREENING|1972-06-06|1960-04-05|||||1965-09-08||1972-09-30|NA|1963-11-20
TRIAL STUDY 134XCP|LB|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|2||||DPD|DEOXYPYRIDINOLINE|||||||10^9 ORGANISMS/ML|||||||TRACE||LOZENGE||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|CLOTTED|NA|DC SHEATH FLOW|GMI MMOL/MOL FORMULA||NA|Y|Y|N|||Y|2||58||LONG-TERM FOLLOW-UP|1962-04-23|1967-02-14|||||1961-06-07||1973-03-14|U|1970-01-07
TRIAL STUDY 134XCP|LB|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|1||||C165922|MIXED ANTIGEN IGE AB RAST SCORE|||||||PACKAGE|||||||INVALID||TCID 50/DOSE||||LOW|NOT DONE||||GASTRIC CONTENTS|CONCENTRATED|U|MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|NA|N|||U|3||39||RUN-IN|1962-11-10|1966-03-27|||||1970-07-14||1964-12-08|U|1964-03-19
TRIAL STUDY 134XCP|LB|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|2||||PROLCTN|PROLACTIN|||||||LENS|||||||NEGATIVE||CAPLET||||LOW|NOT DONE||||CELL PELLET|GELLED|N|PAP STAIN|CKD-EPI CREATININE FORMULA||NA|Y|Y|Y|||U|3||39||INDUCTION TREATMENT|1968-11-05|1969-12-12|||||1963-12-27||1967-01-13|Y|1964-11-06
TRIAL STUDY 134XCP|LB|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|1||||OAS3|2-5-OLIGOADENYLATE SYNTHASE 3|||||||FRAMES/S|||||||TRACE||ELISA UNIT||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|GELLED|N|POPULATION SEQUENCING|MDRD 6 VARIABLE FORMULA||N|U|N|U|||U|4||88||TREATMENT|1964-09-11|1971-05-13|||||1972-05-06||1969-09-18|NA|1965-06-17
TRIAL STUDY 134XCP|LB|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|2||||PYY|PEPTIDE YY|||||||ML/100G/MIN|||||||POSITIVE||BAR||||HIGH|NOT DONE||||INFRANATANT, PLASMA|FRESH|NA|THIN SMEAR|CKD-EPI CREATININE FORMULA||NA|N|NA|N|||U|4||88||BASELINE|1966-08-13|1960-06-13|||||1972-05-15||1963-02-10|N|1972-03-26
TRIAL STUDY 134XCP|LB|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|1||||EOSPSDLE|PSEUDO-EOSINOPHILS/LEUKOCYTES|||||||LOG10 TCID 50/UL|||||||INDETERMINATE||CD/M2||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|ROOM TEMPERATURE|U|PHOTOGRAPHY|CKD-EPI CREATININE FORMULA||N|Y|N|U|||Y|5||7||LONG-TERM FOLLOW-UP|1968-10-12|1967-11-15|||||1967-11-24||1962-05-11|NA|1964-12-30
TRIAL STUDY 134XCP|LB|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|2||||C147276|ARACHIS HYPOGAEA ANTIGEN IGE ANTIBODY|||||||UMOL/MIN|||||||INVALID||FIU||||HIGH|NOT DONE||||RETICULOCYTES|REFRIGERATED|NA|DYNAMOMETRY|GMI MMOL/MOL FORMULA||Y|NA|U|N|||N|5||7||LONG-TERM FOLLOW-UP|1963-12-10|1965-02-25|||||1970-11-03||1963-09-16|NA|1971-01-07
TRIAL STUDY 134XCP|LB|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|1||||PLCGF|PLACENTAL GROWTH FACTOR|||||||G/CAGE/DAY|||||||POSITIVE||GY/MIN||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|THAWED|Y|DUCTOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|N|Y|U|||U|1||38||SCREENING|1963-08-28|1966-06-29|||||1971-12-27||1973-02-09|NA|1968-07-11
TRIAL STUDY 134XCP|LB|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|2||||VLDL3|VLDL CHOLESTEROL SUBTYPE 3|||||||/MS|||||||INVALID||MU/L||||LOW|NOT DONE||||DIALYSIS FLUID|PARAFFIN-EMBEDDED|NA|PERIODIC ACID SCHIFF STAIN|CKD-EPI CYSTATIN C FORMULA||N|Y|Y|Y|||NA|1||38||OPEN LABEL TREATMENT|1966-07-31|1960-05-13|||||1965-07-02||1961-10-15|N|1971-03-25
TRIAL STUDY 134XCP|LB|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|1||||OHDG8|8-HYDROXYDEOXYGUANOSINE|||||||APPLICATION|||||||INVALID||TABLET||||HIGH|NOT DONE||||EPIDERMAL TISSUE|PARAFFIN-EMBEDDED|U|NEPHELOMETRY|FIBROTEST FORMULA||N|NA|Y|U|||N|2||58||RUN-IN|1967-12-23|1967-04-06|||||1967-03-16||1971-01-29|NA|1965-03-07
TRIAL STUDY 134XCP|LB|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|2||||ALTAST|ALT/AST|||||||PMOL|||||||NEGATIVE||MG/MIN||||NORMAL|NOT DONE||||BLOOD|LACTESCENT|U|LEAD CITRATE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|NA|Y|||NA|2||58||FOLLOW-UP|1968-07-16|1963-04-11|||||1964-04-28||1961-03-17|N|1970-12-16
TRIAL STUDY 134XCP|LB|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|1||||HYPERCHR|HYPERCHROMIA|||||||KCAL|||||||INVALID||MG/M2/DAY||||ABNORMAL|NOT DONE||||SPUTUM|GELLED|U|SNELLEN EYE CHART|MDRD FORMULA||N|N|NA|N|||U|3||39||OBSERVATION|1960-05-19|1967-04-19|||||1968-09-09||1963-03-06|U|1962-10-08
TRIAL STUDY 134XCP|LB|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|2||||NTXICRT|T1 COLLAGEN X-LINK N-TELOPEPTIDES/CREAT|||||||GLOBULE|||||||BORDERLINE||MG/M2/DAY||||HIGH|NOT DONE||||REFLEX TEAR|CONCENTRATED|NA|EEG|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|NA|||NA|3||39||WASHOUT|1969-11-23|1966-05-12|||||1967-06-14||1966-05-22|N|1966-03-23
TRIAL STUDY 134XCP|LB|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|1||||TESTOSWB|TESTOSTERONE, WEAKLY BOUND|||||||10^6/G|||||||TRACE||CP||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|CLOTTED|U|BAC ACGH|CKD-EPI CREATININE FORMULA||U|Y|N|Y|||U|4||88||BLINDED TREATMENT|1970-07-15|1960-09-24|||||1965-09-13||1971-12-27|U|1970-06-28
TRIAL STUDY 134XCP|LB|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|2||||ROULEAUX|ROULEAUX FORMATION|||||||NU/CL|||||||INDETERMINATE||PIXELS/CM||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|CLOTTED|U|STRESS ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA||N|U|Y|NA|||Y|4||88||FOLLOW-UP|1969-03-28|1964-10-07|||||1971-03-05||1968-10-08|NA|1960-07-16
TRIAL STUDY 134XCP|LB|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|1||||DHEAS|DEHYDROEPIANDROSTERONE SULFATE|||||||MEQ/UL|||||||TRACE||LOG10 ELISA UNIT/DOSE||||HIGH|NOT DONE||||EXPIRED AIR|CLOTTED|U|ENZYMATIC SPECTROPHOTOMETRY|MDRD ENZYMATIC FORMULA||NA|N|NA|Y|||Y|5||7||TREATMENT|1960-10-09|1964-09-02|||||1962-03-30||1969-11-20|NA|1962-02-25
TRIAL STUDY 134XCP|LB|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|2||||INHIBINB|INHIBIN B|||||||/10^3|||||||TRACE||RNA COPIES/ML||||ABNORMAL|NOT DONE||||PLASMA|SOLIDIFIED|NA|TRIPLE-PHASE SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA||NA|NA|U|U|||N|5||7||LONG-TERM FOLLOW-UP|1968-10-16|1968-10-06|||||1969-09-02||1968-03-03|NA|1965-07-19
TRIAL STUDY 134XCP|LB|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|1||||FXAAC|FACTOR X ACTIVITY ACTUAL/CONTROL|||||||CI/MG|||||||INDETERMINATE||MPS U||||NORMAL|NOT DONE||||AQUEOUS HUMOR|CONCENTRATED|Y|OBSERVATION|NASH FIBROSURE FORMULA||N|Y|NA|Y|||N|1||38||SCREENING|1967-01-10|1968-04-19|||||1962-03-22||1964-01-21|N|1962-04-13
TRIAL STUDY 134XCP|LB|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|2||||GLUCPE|PLASMA EQUIVALENT GLUCOSE|||||||DMOL|||||||BORDERLINE||LOG10 TCID 50/ML||||HIGH|NOT DONE||||ARTERIAL BLOOD|LACTESCENT|U|BIOPSY|FIBROMETER FORMULA||NA|U|U|N|||NA|1||38||TREATMENT|1969-08-26|1972-01-11|||||1962-10-07||1966-12-19|N|1962-04-26
TRIAL STUDY 134XCP|LB|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|1||||C130105|GRASS MIX POLLEN ANTIGEN IGA ANTIBODY|||||||NMOL/G|||||||BORDERLINE||MMOL||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|FRESH|NA|IMPEDANCE CONDUCTIVITY|GMI % FORMULA||N|NA|U|U|||NA|2||58||WASHOUT|1970-01-13|1962-12-28|||||1963-07-16||1964-03-14|Y|1967-01-06
TRIAL STUDY 134XCP|LB|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|2||||MIP1A|MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA|||||||SHOCK WAVE|||||||INDETERMINATE||NFIU||||ABNORMAL|NOT DONE||||PLEURAL FLUID|FRESH|U|FLAME PHOTOMETRY|MDRD 6 VARIABLE FORMULA||Y|N|NA|N|||Y|2||58||OBSERVATION|1966-10-14|1971-09-09|||||1967-10-08||1969-04-07|Y|1962-12-08
TRIAL STUDY 134XCP|LB|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|1||||METARBCE|METARUBRICYTE/TOTAL CELLS|||||||FMOL/G|||||||NEGATIVE||MJOULE/CM2||||HIGH|NOT DONE||||SEBUM|CALCIFIED|N|NUCLEIC ACID AMPLIFICATION TEST|MDRD FORMULA||N|Y|NA|NA|||U|3||39||TREATMENT|1962-03-21|1971-11-04|||||1968-02-10||1967-07-16|NA|1971-01-21
TRIAL STUDY 134XCP|LB|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|2||||RBCGHOST|ERYTHROCYTE GHOSTS|||||||MMOL/S|||||||INDETERMINATE||SFC/10^6 PBMC||||NORMAL|NOT DONE||||SEMEN|NON-HEMOLYZED|N|HIGH LEVEL AMINOGLYCOSIDE SCREEN|FIBROSIS 4 FORMULA||Y|NA|N|Y|||Y|3||39||CONTINUATION TREATMENT|1971-09-04|1965-09-02|||||1970-10-17||1973-03-02|N|1973-05-27
TRIAL STUDY 134XCP|LB|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|1||||LDLOXI|OXIDIZED LDL CHOLESTEROL|||||||APPLICATION|||||||POSITIVE||MG/MIN||||LOW|NOT DONE||||AMNIOTIC FLUID|CONCENTRATED|NA|HILLMEN COLOR CHART|COCKCROFT-GAULT FORMULA||NA|U|N|U|||N|4||88||BASELINE|1962-06-07|1964-02-10|||||1972-03-20||1960-03-15|U|1963-03-27
TRIAL STUDY 134XCP|LB|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|2||||TTAC|THROMBIN TIME ACTUAL/CONTROL|||||||MPS U|||||||NEGATIVE||MOSM/L||||NORMAL|NOT DONE||||LAVAGE FLUID|CLOTTED|Y|REBOUND TONOMETRY|ASH FIBROSURE FORMULA||Y|Y|Y|NA|||N|4||88||FOLLOW-UP|1960-05-04|1970-06-19|||||1962-07-01||1973-04-18|NA|1962-08-22
TRIAL STUDY 134XCP|LB|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|1||||ERCEMPOL|ERYTHROID MATURATION POOL|||||||CI/L|||||||INDETERMINATE||APL U/ML||||ABNORMAL|NOT DONE||||MONOCYTE|REFRIGERATED|N|PALM METHOD|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|NA|Y|||NA|5||7||CONTINUATION TREATMENT|1966-06-13|1961-10-12|||||1963-12-27||1970-11-16|N|1966-07-26
TRIAL STUDY 134XCP|LB|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|2||||DKK1|DICKKOPF WNT SIGNALING PATH INHIBITOR 1|||||||MG2/DL2|||||||NEGATIVE||10^7/L||||NORMAL|NOT DONE||||VENOUS PLASMA|DRIED|N|FLUORESCENCE ANGIOGRAPHY|NASH FIBROSURE FORMULA||N|NA|NA|U|||Y|5||7||SCREENING|1968-03-22|1968-10-18|||||1970-04-13||1973-08-21|N|1961-11-19
TRIAL STUDY 134XCP|LB|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|1||||C165895|JOHNSON GRASS POLLEN IGG4 ANTIBODY|||||||C|||||||NEGATIVE||NFIU||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|LACTESCENT|U|PELLI-ROBSON EYE CHART|CKD-EPI FORMULA||Y|U|Y|Y|||NA|1||38||WASHOUT|1962-02-04|1967-09-02|||||1962-08-07||1969-04-09|Y|1969-08-18
TRIAL STUDY 134XCP|LB|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|2||||HGBDHGB|HEMOGLOBIN D/TOTAL HEMOGLOBIN|||||||S/H|||||||BORDERLINE||S^-1(%O2)^-1||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|REFRIGERATED|N|DC SHEATH FLOW|HEPASCORE FORMULA||Y|Y|NA|NA|||N|1||38||SCREENING|1970-04-19|1968-07-09|||||1968-05-24||1970-04-23|NA|1971-06-15
TRIAL STUDY 134XCP|LB|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|1||||FVAAC|FACTOR V ACTIVITY ACTUAL/CONTROL|||||||10^6 CFU|||||||BORDERLINE||LX||||NORMAL|NOT DONE||||BREAST MILK|NON-HEMOLYZED|N|WESTERGREN|FIBROMETER FORMULA||N|U|N|N|||U|2||58||SCREENING|1970-08-22|1967-10-16|||||1973-07-04||1967-11-18|NA|1960-06-03
TRIAL STUDY 134XCP|LB|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|2||||EOSIMLE|IMMATURE EOSINOPHILS/LEUKOCYTES|||||||DIOPTER|||||||INVALID||ELISA UNIT||||ABNORMAL|NOT DONE||||KERATINOCYTE|LACTESCENT|U|REBOUND TONOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|Y|||N|2||58||SCREENING|1964-09-08|1966-02-01|||||1961-09-03||1968-10-14|N|1961-05-05
TRIAL STUDY 134XCP|LB|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|1||||BLYCECE|B-LYMPHOCYTES/TOTAL CELLS|||||||PFU|||||||POSITIVE||MKAT||||HIGH|NOT DONE||||PLATELET RICH PLASMA|CONCENTRATED|N|TARGETED GENOME SEQUENCING|CKD-EPI FORMULA||Y|U|N|N|||NA|3||39||WASHOUT|1963-03-02|1973-04-20|||||1960-08-19||1964-03-02|N|1972-10-23
TRIAL STUDY 134XCP|LB|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|2||||VITA|VITAMIN A|||||||VG/DOSE|||||||TRACE||DB||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|CONCENTRATED|Y|FISH|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|Y|N|||U|3||39||FOLLOW-UP|1962-10-17|1969-02-10|||||1970-09-17||1960-11-21|Y|1973-03-03
TRIAL STUDY 134XCP|LB|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|1||||MCH|ERY. MEAN CORPUSCULAR HEMOGLOBIN|||||||NMOL BCE/MMOL|||||||BORDERLINE||ML*CMH2O||||HIGH|NOT DONE||||INTERSTITIAL FLUID|ROOM TEMPERATURE|U|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|FIBROSIS 4 FORMULA||N|NA|U|Y|||N|4||88||SCREENING|1969-04-26|1965-10-14|||||1963-06-19||1964-05-25|N|1969-03-31
TRIAL STUDY 134XCP|LB|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|2||||PDGFAA|PLATELET DERIVED GROWTH FACTOR ISOFORMAA|||||||/MS|||||||BORDERLINE||IN||||NORMAL|NOT DONE||||SKIN TISSUE|GELLED|U|URANYL ACETATE STAIN|COCKCROFT-GAULT FORMULA||U|Y|Y|NA|||N|4||88||BLINDED TREATMENT|1972-02-26|1972-11-04|||||1973-03-01||1965-02-01|N|1968-05-18
TRIAL STUDY 134XCP|LB|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|1||||ESTRONE|ESTRONE|||||||ML/M2/H|||||||BORDERLINE||KM||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|Y|DYNAMIC CONTRAST ENHANCED MRI|FIBROTEST FORMULA||N|NA|U|Y|||U|5||7||RUN-IN|1965-02-21|1966-04-12|||||1971-04-30||1968-08-29|Y|1972-07-24
TRIAL STUDY 134XCP|LB|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|2||||PAP|PROSTATIC ACID PHOSPHATASE|||||||BAG|||||||POSITIVE||NKAT/L||||HIGH|NOT DONE||||AMNIOTIC FLUID|ICTERIC|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA||U|U|U|U|||U|5||7||OPEN LABEL TREATMENT|1967-03-03|1968-03-06|||||1967-03-25||1962-08-10|U|1968-01-10
TRIAL STUDY 134XCP|LB|0320460C-3770-486A-85EB-ECD133AE6EFA|1||||NAGASEXR|NAGASE EXCRETION RATE|||||||AGU/ML|||||||NEGATIVE||CIGAR||||ABNORMAL|NOT DONE||||SPUTUM|CALCIFIED|N|REFLECTANCE SPECTROSCOPY|MDRD 6 VARIABLE FORMULA||Y|U|NA|NA|||NA|1||38||SCREENING|1970-05-03|1965-06-26|||||1965-11-18||1972-10-08|U|1964-06-16
TRIAL STUDY 134XCP|LB|0320460C-3770-486A-85EB-ECD133AE6EFA|2||||TUDCA|TAUROURSODEOXYCHOLATE|||||||MOL/MG|||||||INVALID||MASK||||NORMAL|NOT DONE||||MONOCYTE|GELLED|NA|FLOCCULATION|MDRD 5 VARIABLE FORMULA||Y|N|N|U|||NA|1||38||BASELINE|1964-08-13|1968-10-25|||||1968-06-09||1961-02-24|N|1961-04-08
TRIAL STUDY 134XCP|LB|0320460C-3770-486A-85EB-ECD133AE6EFA|1||||PLAGMCVT|PLATELET AGGREGATION MEAN CURVE TYPE|||||||L/MIN|||||||INDETERMINATE||MMOL/G||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|FRESH|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||N|NA|U|Y|||U|2||58||FOLLOW-UP|1961-10-26|1966-10-28|||||1967-08-22||1960-03-27|NA|1969-04-12
TRIAL STUDY 134XCP|LB|0320460C-3770-486A-85EB-ECD133AE6EFA|2||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||SCOOPFUL|||||||POSITIVE||NG/L||||NORMAL|NOT DONE||||ALVEOLAR AIR|GELLED|U|WHOLE GENOME SEQUENCING|MDRD 5 VARIABLE FORMULA||U|U|U|Y|||Y|2||58||INDUCTION TREATMENT|1965-11-08|1971-11-25|||||1969-07-22||1965-02-17|NA|1966-07-02
TRIAL STUDY 134XCP|LB|0320460C-3770-486A-85EB-ECD133AE6EFA|1||||ALBGALB|GLYCATED ALBUMIN/ALBUMIN|||||||FEU|||||||TRACE||PMOL||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|ROOM TEMPERATURE|NA|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|U|Y|||N|3||39||BASELINE|1961-07-23|1961-08-27|||||1967-06-30||1966-06-21|NA|1962-04-09
TRIAL STUDY 134XCP|LB|0320460C-3770-486A-85EB-ECD133AE6EFA|2||||KLCLLCFR|KAPPA LT CHAIN,FREE/LAMBDA LT CHAIN,FREE|||||||%/MIN|||||||POSITIVE||FOZ_BR||||ABNORMAL|NOT DONE||||CALCULUS|HEMOLYZED|NA|MAMMOGRAPHY|NASH FIBROSURE FORMULA||Y|N|NA|NA|||U|3||39||INDUCTION TREATMENT|1960-08-20|1968-10-09|||||1961-07-05||1972-03-24|N|1968-05-16
TRIAL STUDY 134XCP|LB|0320460C-3770-486A-85EB-ECD133AE6EFA|1||||CCPAB|CYCLIC CITRULLINATED PEPTIDE ANTIBODY|||||||CD/M2|||||||INVALID||BQ||||LOW|NOT DONE||||SEBUM|REFRIGERATED|NA|DARK FIELD MICROSCOPY|MDRD 5 VARIABLE FORMULA||U|U|Y|U|||Y|4||88||TREATMENT|1960-11-29|1973-02-12|||||1973-06-26||1961-03-28|U|1973-01-14
TRIAL STUDY 134XCP|LB|0320460C-3770-486A-85EB-ECD133AE6EFA|2||||VITB7|VITAMIN B7|||||||10^7 CFU/ML|||||||NEGATIVE||KV||||LOW|NOT DONE||||STOOL|FRESH|Y|DYNAMIC LIGHT SCATTERING|CKD-EPI CREATININE FORMULA||Y|NA|Y|Y|||N|4||88||LONG-TERM FOLLOW-UP|1964-09-28|1962-12-01|||||1968-01-30||1967-07-01|Y|1969-01-24
TRIAL STUDY 134XCP|LB|0320460C-3770-486A-85EB-ECD133AE6EFA|1||||KRCYMG|MEGAKARYOCYTES|||||||USIEMENS|||||||POSITIVE||AMFI||||HIGH|NOT DONE||||ERYTHROCYTES|NON-HEMOLYZED|U|CISH|COCKCROFT-GAULT FORMULA||N|Y|NA|Y|||NA|5||7||FOLLOW-UP|1966-11-12|1971-10-22|||||1973-08-07||1965-05-05|U|1971-12-15
TRIAL STUDY 134XCP|LB|0320460C-3770-486A-85EB-ECD133AE6EFA|2||||ALDSTRN|ALDOSTERONE|||||||MG/G/MIN|||||||INVALID||P||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|FROZEN|Y|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|N|||Y|5||7||LONG-TERM FOLLOW-UP|1964-07-23|1960-08-16|||||1961-10-21||1966-07-12|Y|1963-08-02
TRIAL STUDY 134XCP|LB|810B0B08-9236-41EC-8879-924661FA224E|1||||AMNOACID|AMINO ACIDS|||||||ENZYME U/M2|||||||POSITIVE||UG/ML/H||||ABNORMAL|NOT DONE||||DERMAL TISSUE|FROZEN|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|FIBROMETER FORMULA||N|N|N|U|||NA|1||38||LONG-TERM FOLLOW-UP|1969-09-27|1972-05-26|||||1971-04-01||1968-07-07|U|1973-01-26
TRIAL STUDY 134XCP|LB|810B0B08-9236-41EC-8879-924661FA224E|2||||GLUCAGON|GLUCAGON|||||||CGY|||||||INVALID||MAMP||||HIGH|NOT DONE||||SEMEN|CLOTTED|N|CELL OF ORIGIN ASSAY|CKD-EPI CREATININE FORMULA||N|U|Y|N|||N|1||38||CONTINUATION TREATMENT|1962-09-14|1962-05-03|||||1966-03-16||1973-04-15|U|1966-06-10
TRIAL STUDY 134XCP|LB|810B0B08-9236-41EC-8879-924661FA224E|1||||SCHISTO|SCHISTOCYTES|||||||MG/KG/WEEK|||||||INVALID||/MBP||||ABNORMAL|NOT DONE||||CELL PELLET|FROZEN|N|MAGNETIC RESONANCE ANGIOGRAPHY|COCKCROFT-GAULT FORMULA||U|N|N|N|||U|2||58||WASHOUT|1965-02-14|1971-02-28|||||1962-02-15||1961-09-15|NA|1965-08-22
TRIAL STUDY 134XCP|LB|810B0B08-9236-41EC-8879-924661FA224E|2||||RETCRRBC|HCT CORRECTED RETICULOCYTES/ERYTHROCYTES|||||||ML/ANIMAL/DAY|||||||POSITIVE||U/10^12 RBC||||NORMAL|NOT DONE||||CORD BLOOD|CALCIFIED|N|ICC|FIBROSIS 4 FORMULA||NA|N|Y|U|||NA|2||58||FOLLOW-UP|1960-05-27|1971-04-12|||||1973-01-29||1960-10-27|U|1967-03-06
TRIAL STUDY 134XCP|LB|810B0B08-9236-41EC-8879-924661FA224E|1||||C130140|GERMAN COCKROACH ANTIGEN IGE ANTIBODY|||||||HOUNSFIELD UNIT|||||||INVALID||EP U||||NORMAL|NOT DONE||||CALCULUS|CLOTTED|Y|OPTICAL COHERENCE TOMOGRAPHY|CKD-EPI FORMULA||NA|NA|Y|N|||NA|3||39||WASHOUT|1971-09-04|1972-07-15|||||1967-07-18||1960-03-25|N|1961-02-15
TRIAL STUDY 134XCP|LB|810B0B08-9236-41EC-8879-924661FA224E|2||||POIKRBC|POIKILOCYTES/ERYTHROCYTES|||||||U/G/MIN|||||||POSITIVE||CP||||NORMAL|NOT DONE||||ALVEOLAR AIR|ICTERIC|NA|CLINICAL EVALUATION|MDRD 4 VARIABLE FORMULA||NA|U|N|U|||NA|3||39||FOLLOW-UP|1969-04-21|1964-11-15|||||1963-09-23||1965-05-22|U|1966-06-13
TRIAL STUDY 134XCP|LB|810B0B08-9236-41EC-8879-924661FA224E|1||||GBP2|GUANYLATE BINDING PROTEIN 2|||||||SBE/ML|||||||POSITIVE||MG/KG/DOSE||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|GELLED|Y|CLOT DETECTION|CKD-EPI FORMULA||NA|NA|N|N|||N|4||88||RUN-IN|1960-04-19|1967-01-23|||||1973-04-15||1966-06-18|U|1965-03-16
TRIAL STUDY 134XCP|LB|810B0B08-9236-41EC-8879-924661FA224E|2||||LYMPLLY|PLASMACYTOID LYMPHOCYTES/LYMPHOCYTES|||||||PKAT|||||||INDETERMINATE||MOSM||||ABNORMAL|NOT DONE||||SOFT TISSUE|AGGLUTINATED|Y|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|NA|NA|||U|4||88||TREATMENT|1965-06-29|1961-05-04|||||1965-01-08||1962-02-14|N|1964-09-23
TRIAL STUDY 134XCP|LB|810B0B08-9236-41EC-8879-924661FA224E|1||||CITRTEXR|CITRATE EXCRETION RATE|||||||MOSM/KG|||||||NEGATIVE||10^5/HPF||||NORMAL|NOT DONE||||DISCHARGE|FRESH|NA|HANSEL STAIN|CKD-EPI CYSTATIN C FORMULA||U|Y|N|NA|||NA|5||7||WASHOUT|1962-07-17|1969-05-12|||||1973-07-22||1966-02-22|NA|1970-03-20
TRIAL STUDY 134XCP|LB|810B0B08-9236-41EC-8879-924661FA224E|2||||VITB5|VITAMIN B5|||||||CD/M2|||||||POSITIVE||PPM||||ABNORMAL|NOT DONE||||LYSATE|AUTOLYZED|NA|IRON HEMATOXYLIN STAIN|GMI MMOL/MOL FORMULA||NA|U|N|Y|||Y|5||7||OPEN LABEL TREATMENT|1966-11-15|1964-07-10|||||1961-04-26||1964-12-24|NA|1966-07-17
TRIAL STUDY 134XCP|LB|BA3B0D91-DC95-4916-8ACA-71451447BE81|1||||CLEXR|CHLORIDE EXCRETION RATE|||||||MMOL|||||||POSITIVE||TBSP||||LOW|NOT DONE||||CAPILLARY BLOOD|UNEXPECTED ODOR|N|BETA LACTAMASE|FIBROSIS 4 FORMULA||U|NA|U|U|||N|1||38||OBSERVATION|1963-02-19|1973-08-02|||||1961-12-24||1969-03-18|U|1962-09-02
TRIAL STUDY 134XCP|LB|BA3B0D91-DC95-4916-8ACA-71451447BE81|2||||CREATEXR|CREATININE EXCRETION RATE|||||||PPB|||||||BORDERLINE||CI||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|THAWED|Y|EIA|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|N|U|||NA|1||38||RUN-IN|1966-02-12|1967-11-21|||||1965-11-17||1964-05-19|NA|1961-09-21
TRIAL STUDY 134XCP|LB|BA3B0D91-DC95-4916-8ACA-71451447BE81|1||||NEUTHYGR|HYPOGRANULAR NEUTROPHILS|||||||UMOL/MIN|||||||TRACE||10^4 CFU/ML||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|LIPEMIC|U|SISH|NASH FIBROSURE FORMULA||U|Y|N|NA|||N|2||58||FOLLOW-UP|1965-04-27|1972-06-13|||||1973-02-20||1969-01-14|NA|1967-04-23
TRIAL STUDY 134XCP|LB|BA3B0D91-DC95-4916-8ACA-71451447BE81|2||||FGF23|FIBROBLAST GROWTH FACTOR 23|||||||KG/CM|||||||INVALID||SFC/10^6 PBMC||||HIGH|NOT DONE||||MUCUS|LACTESCENT|Y|INCISION-INDUCED BLEEDING METHOD|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|Y|N|||NA|2||58||BLINDED TREATMENT|1964-12-29|1969-11-25|||||1972-04-22||1969-03-08|NA|1972-02-05
TRIAL STUDY 134XCP|LB|BA3B0D91-DC95-4916-8ACA-71451447BE81|1||||NUCCE|NUCLEATED CELLS|||||||/HPF|||||||BORDERLINE||PRESSOR UNITS||||ABNORMAL|NOT DONE||||FLUID|THAWED|Y|PH METER MEASUREMENT METHOD|FIBROTEST FORMULA||U|Y|NA|N|||N|3||39||INDUCTION TREATMENT|1964-09-21|1966-06-18|||||1972-05-14||1961-05-14|Y|1971-12-16
TRIAL STUDY 134XCP|LB|BA3B0D91-DC95-4916-8ACA-71451447BE81|2||||CXCR3|CHEMOKINE (C-X-C MOTIF) RECEPTOR 3|||||||L/H/M2|||||||BORDERLINE||LOG10 CFU/G||||ABNORMAL|NOT DONE||||SPUTUM|AGGLUTINATED|N|WHOLE EXOME SEQUENCING|CKD-EPI CREATININE FORMULA||N|NA|N|N|||NA|3||39||INDUCTION TREATMENT|1962-07-19|1964-01-21|||||1972-09-29||1963-03-29|N|1972-03-22
TRIAL STUDY 134XCP|LB|BA3B0D91-DC95-4916-8ACA-71451447BE81|1||||PSP100AB|P100 POLYMYOSITIS-SCLERODERMA AUTOAG AB|||||||/10^5|||||||INVALID||MG/ML/DAY||||NORMAL|NOT DONE||||SERUM|LIPEMIC|NA|SLOAN LETTER EYE CHART 2.5%|CKD-EPI CYSTATIN C FORMULA||NA|NA|N|Y|||NA|4||88||CONTINUATION TREATMENT|1961-04-15|1961-10-29|||||1965-02-22||1965-05-04|U|1966-01-10
TRIAL STUDY 134XCP|LB|BA3B0D91-DC95-4916-8ACA-71451447BE81|2||||PLP|PYRIDOXAL PHOSPHATE|||||||/7.5 ML|||||||NEGATIVE||TUBE||||LOW|NOT DONE||||SYNOVIAL FLUID|LIPEMIC|N|GC/MS/MS|MDRD FORMULA||N|NA|NA|NA|||N|4||88||FOLLOW-UP|1967-10-24|1968-07-08|||||1970-02-05||1965-10-08|NA|1967-08-08
TRIAL STUDY 134XCP|LB|BA3B0D91-DC95-4916-8ACA-71451447BE81|1||||LEUKASE|LEUKOCYTE ESTERASE|||||||ML/MIN/1.73M2|||||||INVALID||AU/ML||||ABNORMAL|NOT DONE||||BILE|NON-HEMOLYZED|N|ETDRS EYE CHART|CKD-EPI CYSTATIN C FORMULA||N|N|Y|U|||N|5||7||BASELINE|1969-01-10|1973-08-18|||||1967-08-27||1965-10-25|NA|1966-06-29
TRIAL STUDY 134XCP|LB|BA3B0D91-DC95-4916-8ACA-71451447BE81|2||||NKCE|NATURAL KILLER CELLS|||||||ANTI-XA IU/ML|||||||INVALID||%/S||||LOW|NOT DONE||||AMNIOTIC FLUID|FROZEN|NA|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||Y|N|Y|Y|||NA|5||7||WASHOUT|1962-09-28|1964-10-28|||||1967-07-10||1972-03-31|NA|1966-07-14
TRIAL STUDY 134XCP|LB|DE385129-5FB9-43C3-9FB1-005886674C9B|1||||LYMCE|LYMPHOCYTES/TOTAL CELLS|||||||MMHG/L/MIN|||||||BORDERLINE||EID 50/DOSE||||ABNORMAL|NOT DONE||||NAIL|CLOTTED|NA|SICKLE CELL SOLUBILITY TEST|ASH FIBROSURE FORMULA||U|U|N|Y|||U|1||38||LONG-TERM FOLLOW-UP|1972-07-07|1973-02-04|||||1970-08-13||1960-07-24|N|1960-06-22
TRIAL STUDY 134XCP|LB|DE385129-5FB9-43C3-9FB1-005886674C9B|2||||CD22|CD22|||||||RAD|||||||BORDERLINE||IN2||||HIGH|NOT DONE||||VENOUS BLOOD|THAWED|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|N|Y|||U|1||38||LONG-TERM FOLLOW-UP|1960-11-15|1966-02-21|||||1964-07-05||1961-12-06|Y|1973-05-30
TRIAL STUDY 134XCP|LB|DE385129-5FB9-43C3-9FB1-005886674C9B|1||||APOE|APOLIPOPROTEIN E|||||||MMHG/L/MIN|||||||INVALID||PMOL/DAY||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|CONCENTRATED|Y|MICROBIAL CONCENTRATION|FIBROTEST FORMULA||Y|NA|U|NA|||U|2||58||SCREENING|1971-06-24|1970-07-29|||||1962-11-13||1964-05-03|U|1965-12-26
TRIAL STUDY 134XCP|LB|DE385129-5FB9-43C3-9FB1-005886674C9B|2||||METANEPH|METANEPHRINE|||||||MG/G/H|||||||INVALID||PM||||NORMAL|NOT DONE||||HAIR|SOLIDIFIED|Y|PHASE CONTRAST MICROSCOPY|FIBROMETER FORMULA||Y|U|Y|N|||NA|2||58||RUN-IN|1971-01-03|1961-10-18|||||1965-10-10||1963-07-28|NA|1972-09-11
TRIAL STUDY 134XCP|LB|DE385129-5FB9-43C3-9FB1-005886674C9B|1||||FBRTST|FIBROTEST SCORE|||||||TCID 50/DOSE|||||||TRACE||YEARS||||HIGH|NOT DONE||||MENSTRUAL BLOOD|LACTESCENT|NA|DIPSTICK|MDRD 6 VARIABLE FORMULA||NA|Y|N|N|||N|3||39||BASELINE|1971-08-26|1960-01-09|||||1960-06-18||1971-03-28|U|1965-12-16
TRIAL STUDY 134XCP|LB|DE385129-5FB9-43C3-9FB1-005886674C9B|2||||RETIRBC|RETICULOCYTES/ERYTHROCYTES|||||||SACHET|||||||POSITIVE||MMOL2/L2||||HIGH|NOT DONE||||CERUMEN|CALCIFIED|Y|CLIP|MDRD 5 VARIABLE FORMULA||Y|N|U|U|||N|3||39||FOLLOW-UP|1969-12-09|1965-07-16|||||1969-04-02||1964-08-30|U|1970-03-12
TRIAL STUDY 134XCP|LB|DE385129-5FB9-43C3-9FB1-005886674C9B|1||||BLASTNCE|BLASTS/NUCLEATED CELLS|||||||ML/CAGE|||||||POSITIVE||G/M2||||NORMAL|NOT DONE||||URINE SEDIMENT|PARAFFIN-EMBEDDED|Y|MUGA|GMI % FORMULA||NA|N|U|U|||Y|4||88||BASELINE|1965-01-07|1967-08-26|||||1971-10-28||1960-04-28|Y|1970-01-15
TRIAL STUDY 134XCP|LB|DE385129-5FB9-43C3-9FB1-005886674C9B|2||||EDTACLR|EDTA CLEARANCE|||||||NMOL/DAY|||||||NEGATIVE||OD UNIT||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|CONTAMINATED|Y|EIA|MDRD 5 VARIABLE FORMULA||Y|Y|NA|N|||Y|4||88||OBSERVATION|1969-01-15|1966-05-11|||||1965-07-19||1972-01-29|U|1967-10-29
TRIAL STUDY 134XCP|LB|DE385129-5FB9-43C3-9FB1-005886674C9B|1||||ANAB|ANTI-NEUTROPHIL ANTIBODY|||||||/7.5 ML|||||||INVALID||MOL/DAY||||NORMAL|NOT DONE||||CORD BLOOD|ROOM TEMPERATURE|NA|RADIAL IMMUNODIFFUSION|GMI % FORMULA||NA|NA|NA|U|||U|5||7||LONG-TERM FOLLOW-UP|1973-04-06|1971-12-23|||||1960-10-10||1965-02-07|N|1969-09-01
TRIAL STUDY 134XCP|LB|DE385129-5FB9-43C3-9FB1-005886674C9B|2||||CTC|CIRCULATING TUMOR CELLS|||||||10^8 PFU|||||||POSITIVE||DYN||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|FRESH|N|BRDU CELLULAR PROLIFERATION ASSAY|COCKCROFT-GAULT FORMULA||NA|Y|N|NA|||Y|5||7||BASELINE|1969-10-25|1961-10-28|||||1969-04-08||1964-07-27|N|1969-07-23
TRIAL STUDY 134XCP|LB|8AE8077F-A13C-4593-B012-213A5EBE0A1D|1||||MICROCY|MICROCYTES|||||||ML/G/DAY|||||||INVALID||MG/DAY||||NORMAL|NOT DONE||||URINE SEDIMENT|AGGLUTINATED|U|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NASH FIBROSURE FORMULA||N|U|N|NA|||Y|1||38||CONTINUATION TREATMENT|1966-06-29|1962-07-25|||||1966-12-28||1973-04-10|U|1973-04-21
TRIAL STUDY 134XCP|LB|8AE8077F-A13C-4593-B012-213A5EBE0A1D|2||||GUSA|GLUCURONIDASE, ALPHA|||||||/MS|||||||INDETERMINATE||CG||||NORMAL|NOT DONE||||FLUID|ROOM TEMPERATURE|U|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|FIBROTEST FORMULA||U|Y|N|N|||N|1||38||LONG-TERM FOLLOW-UP|1963-05-22|1969-03-05|||||1969-01-16||1972-11-19|N|1971-01-18
TRIAL STUDY 134XCP|LB|8AE8077F-A13C-4593-B012-213A5EBE0A1D|1||||ZPP|ZINC PROTOPORPHYRIN|||||||MU|||||||INDETERMINATE||CCID 50/DOSE||||NORMAL|NOT DONE||||SPERMATOZOON|GELLED|U|LIQUID SCINTILLATION COUNTING|MDRD 5 VARIABLE FORMULA||U|U|N|N|||NA|2||58||BASELINE|1972-12-18|1968-04-18|||||1968-01-02||1963-04-23|N|1961-05-27
TRIAL STUDY 134XCP|LB|8AE8077F-A13C-4593-B012-213A5EBE0A1D|2||||INCLBRBC|ERYTHROCYTE INCLUSION BODIES|||||||ML/100G/MIN|||||||INVALID||MG/ML/DAY||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|HEMOLYZED|U|SLIT LAMP|GMI % FORMULA||U|NA|N|Y|||U|2||58||RUN-IN|1972-10-01|1971-11-18|||||1970-05-18||1970-03-23|N|1967-01-19
TRIAL STUDY 134XCP|LB|8AE8077F-A13C-4593-B012-213A5EBE0A1D|1||||GRANIMLE|IMMATURE GRANULOCYTES/LEUKOCYTES|||||||TUBERCULIN UNIT/ML|||||||INVALID||MV2/HZ||||LOW|NOT DONE||||INFRANATANT, PLASMA|UNEXPECTED ODOR|Y|APPLANATION TONOMETRY|FIBROTEST FORMULA||Y|N|NA|Y|||U|3||39||SCREENING|1968-08-24|1964-10-16|||||1963-12-03||1968-12-26|Y|1966-11-21
TRIAL STUDY 134XCP|LB|8AE8077F-A13C-4593-B012-213A5EBE0A1D|2||||RPTLAAC|REPTILASE ACTIVITY ACTUAL/CONTROL|||||||BAR|||||||POSITIVE||MET*H||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|LIPEMIC|Y|LINE PROBE ASSAY|FIBROSIS 4 FORMULA||NA|N|Y|NA|||Y|3||39||SCREENING|1971-06-09|1968-02-07|||||1961-05-16||1970-03-11|NA|1969-12-15
TRIAL STUDY 134XCP|LB|8AE8077F-A13C-4593-B012-213A5EBE0A1D|1||||CEC|CIRCULATING ENDOTHELIAL CELLS|||||||UKAT|||||||INDETERMINATE||%/S||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|LACTESCENT|U|GIEMSA STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|NA|Y|||N|4||88||TREATMENT|1969-05-10|1968-05-03|||||1967-02-21||1961-01-12|NA|1971-08-31
TRIAL STUDY 134XCP|LB|8AE8077F-A13C-4593-B012-213A5EBE0A1D|2||||BTK|BRUTON'S TYROSINE KINASE|||||||MOL/ML|||||||BORDERLINE||%/S||||HIGH|NOT DONE||||GASTRIC FLUID|CLOTTED|Y|RIA|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|Y|Y|||N|4||88||LONG-TERM FOLLOW-UP|1970-08-13|1971-10-09|||||1960-06-17||1966-12-31|U|1971-02-10
TRIAL STUDY 134XCP|LB|8AE8077F-A13C-4593-B012-213A5EBE0A1D|1||||CAMP|CYCLIC ADENOSINE 3,5-MONOPHOSPHATE|||||||MM2|||||||NEGATIVE||10^6 CFU/ML||||NORMAL|NOT DONE||||MECONIUM|AGGLUTINATED|Y|NON-CONTACT SPECULAR MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||NA|NA|U|Y|||NA|5||7||CONTINUATION TREATMENT|1970-04-08|1968-04-12|||||1965-12-26||1971-11-27|U|1960-03-08
TRIAL STUDY 134XCP|LB|8AE8077F-A13C-4593-B012-213A5EBE0A1D|2||||MOCYCELE|MONOCYTOID CELLS/LEUKOCYTES|||||||APPLICATION|||||||NEGATIVE||UV||||LOW|NOT DONE||||EPIDERMAL TISSUE|LIPEMIC|NA|CARDIAC THERMODILUTION|MDRD FORMULA||N|U|N|Y|||Y|5||7||OBSERVATION|1960-02-28|1970-08-30|||||1962-01-05||1964-01-27|N|1973-05-20
TRIAL STUDY 134XCP|LB|72FCE18B-B3D6-45AC-993F-9883E4D11313|1||||NITRITE|NITRITE|||||||NMOL/L/MIN|||||||INVALID||LOG10 ELISA UNIT/DOSE||||NORMAL|NOT DONE||||SPUTUM|CLOTTED|U|PLETHYSMOGRAPHY|MDRD ENZYMATIC FORMULA||N|Y|U|N|||U|1||38||BLINDED TREATMENT|1973-05-16|1963-05-10|||||1967-06-09||1972-10-07|U|1960-11-22
TRIAL STUDY 134XCP|LB|72FCE18B-B3D6-45AC-993F-9883E4D11313|2||||SCKCERBC|SICKLE CELLS/ERYTHROCYTES|||||||KEV|||||||TRACE||PMOL/10^9 CELLS||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|ICTERIC|NA|WHOLE EXOME SEQUENCING|HEPASCORE FORMULA||N|Y|N|U|||N|1||38||FOLLOW-UP|1970-10-05|1961-02-14|||||1963-12-25||1970-08-04|N|1973-03-06
TRIAL STUDY 134XCP|LB|72FCE18B-B3D6-45AC-993F-9883E4D11313|1||||FACTVIIA|FACTOR VII ACTIVITY|||||||/H|||||||POSITIVE||10^6 IU/ML||||NORMAL|NOT DONE||||SALIVA|UNEXPECTED ODOR|NA|CONTACT SPECULAR MICROSCOPY|CKD-EPI CREATININE FORMULA||U|NA|U|U|||NA|2||58||BLINDED TREATMENT|1965-04-30|1971-10-24|||||1961-06-22||1968-08-06|Y|1962-04-30
TRIAL STUDY 134XCP|LB|72FCE18B-B3D6-45AC-993F-9883E4D11313|2||||MYBLAT2|TYPE II MYELOBLASTS|||||||SIEMENS|||||||INVALID||LOG10 TCID 50/DOSE||||ABNORMAL|NOT DONE||||BASAL TEAR|FROZEN|Y|PHOTOMETRY|CKD-EPI CREATININE FORMULA||Y|N|Y|N|||NA|2||58||WASHOUT|1967-03-30|1964-04-27|||||1960-04-03||1971-10-02|N|1965-10-25
TRIAL STUDY 134XCP|LB|72FCE18B-B3D6-45AC-993F-9883E4D11313|1||||COLOR|COLOR|||||||UG/L/H|||||||INDETERMINATE||HENRY||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|NON-HEMOLYZED|U|INTERRUPTER TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|Y|NA|||NA|3||39||OPEN LABEL TREATMENT|1969-10-10|1969-10-28|||||1973-04-13||1965-03-17|N|1970-08-25
TRIAL STUDY 134XCP|LB|72FCE18B-B3D6-45AC-993F-9883E4D11313|2||||ERCEMIDX|ERYTHROID MATURATION INDEX|||||||MBQ/UL|||||||TRACE||ML/S/M2||||NORMAL|NOT DONE||||DERMAL TISSUE|CONTAMINATED|N|GC/MS-CI|FIBROMETER FORMULA||U|U|U|U|||Y|3||39||INDUCTION TREATMENT|1964-05-16|1964-04-08|||||1972-12-22||1962-09-01|N|1963-10-12
TRIAL STUDY 134XCP|LB|72FCE18B-B3D6-45AC-993F-9883E4D11313|1||||PNCTPP|PANCREATIC POLYPEPTIDE|||||||RING|||||||INVALID||MV/SEC||||LOW|NOT DONE||||URINE|PARAFFIN-EMBEDDED|N|WHOLE EXOME SEQUENCING|CKD-EPI FORMULA||U|Y|N|Y|||N|4||88||INDUCTION TREATMENT|1964-07-11|1973-05-24|||||1962-10-30||1962-03-05|N|1972-09-29
TRIAL STUDY 134XCP|LB|72FCE18B-B3D6-45AC-993F-9883E4D11313|2||||C165884|OLIVE TREE POLLEN IGE ANTIBODY|||||||G/ANIMAL/WK|||||||NEGATIVE||/VF||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED|NA|KINETIC MICROPARTICLE IMMUNOASSAY|GMI MMOL/MOL FORMULA||U|NA|NA|NA|||Y|4||88||BASELINE|1973-05-14|1971-04-20|||||1963-03-10||1972-09-21|NA|1966-01-23
TRIAL STUDY 134XCP|LB|72FCE18B-B3D6-45AC-993F-9883E4D11313|1||||KCLR|POTASSIUM CLEARANCE|||||||GRAVITATIONAL UNIT|||||||BORDERLINE||HPA||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|REFRIGERATED|NA|CELLULOSE TAPE|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|Y|||NA|5||7||RUN-IN|1970-11-11|1964-10-22|||||1964-03-20||1969-01-11|U|1967-07-27
TRIAL STUDY 134XCP|LB|72FCE18B-B3D6-45AC-993F-9883E4D11313|2||||IGE|IMMUNOGLOBULIN E|||||||JDF UNIT|||||||INVALID||10^3 RNA COPIES/ML||||NORMAL|NOT DONE||||DERMAL TISSUE|CALCIFIED|N|CONTRAST ENHANCED SPIRAL CT SCAN|MDRD 4 VARIABLE FORMULA||NA|U|NA|U|||N|5||7||FOLLOW-UP|1973-05-12|1962-08-14|||||1964-05-04||1970-12-17|NA|1964-12-09
TRIAL STUDY 134XCP|LB|1123F894-0821-41DF-9C28-ED6BC4A7098C|1||||V25HD2|25-HYDROXYVITAMIN D2|||||||MCI|||||||INDETERMINATE||HZ||||LOW|NOT DONE||||PERSPIRATION|AGGLUTINATED|NA|APPLANATION TONOMETRY|MDRD ENZYMATIC FORMULA||Y|NA|NA|N|||NA|1||38||WASHOUT|1969-09-25|1968-12-27|||||1971-11-24||1967-12-06|N|1969-12-21
TRIAL STUDY 134XCP|LB|1123F894-0821-41DF-9C28-ED6BC4A7098C|2||||C165894|D. FARINAE ANTIGEN IGG4 ANTIBODY|||||||PFU/ANIMAL|||||||BORDERLINE||DIP||||LOW|NOT DONE||||AQUEOUS HUMOR|FROZEN|U|ELLA|MDRD 4 VARIABLE FORMULA||Y|Y|NA|NA|||N|1||38||RUN-IN|1960-06-27|1962-10-12|||||1970-05-15||1969-07-28|NA|1961-06-07
TRIAL STUDY 134XCP|LB|1123F894-0821-41DF-9C28-ED6BC4A7098C|1||||IRON|IRON|||||||CD*S/M2|||||||INDETERMINATE||ML/BEAT||||LOW|NOT DONE||||SEBUM|GELLED|N|CARDIAC THERMODILUTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|N|Y|||N|2||58||INDUCTION TREATMENT|1969-10-28|1962-05-30|||||1968-02-28||1969-09-09|Y|1960-10-20
TRIAL STUDY 134XCP|LB|1123F894-0821-41DF-9C28-ED6BC4A7098C|2||||SCBRBTL|SECOBARBITAL|||||||KG/M2|||||||POSITIVE||ELISA UNIT/DOSE||||HIGH|NOT DONE||||REFLEX TEAR|CALCIFIED|N|COMPLEMENT FIXATION|NASH FIBROSURE FORMULA||U|U|NA|U|||Y|2||58||OBSERVATION|1973-03-05|1973-08-29|||||1968-07-12||1972-07-27|U|1973-05-04
TRIAL STUDY 134XCP|LB|1123F894-0821-41DF-9C28-ED6BC4A7098C|1||||C130132|D. FARINAE ANTIGEN IGE ANTIBODY|||||||CAPSULE|||||||INDETERMINATE||10^3 CFU||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|HEMOLYZED|N|CORONARY ANGIOGRAPHY|HEPASCORE FORMULA||Y|N|N|NA|||NA|3||39||CONTINUATION TREATMENT|1963-06-29|1964-01-31|||||1972-10-11||1966-06-25|U|1970-10-25
TRIAL STUDY 134XCP|LB|1123F894-0821-41DF-9C28-ED6BC4A7098C|2||||FCTVIIIA|FACTOR VIII ACTIVITY|||||||CMOL/L|||||||TRACE||MV/SEC||||LOW|NOT DONE||||VENOUS BLOOD|AUTOLYZED|Y|INDIA INK STAIN|GMI MMOL/MOL FORMULA||N|NA|Y|N|||Y|3||39||OPEN LABEL TREATMENT|1967-02-05|1964-05-27|||||1960-03-14||1963-04-05|Y|1960-03-31
TRIAL STUDY 134XCP|LB|1123F894-0821-41DF-9C28-ED6BC4A7098C|1||||TGLOB|THYROGLOBULIN|||||||IU/DL|||||||TRACE||ML/G/DAY||||ABNORMAL|NOT DONE||||SOFT TISSUE|CLOTTED|Y|KNEMOMETRY|FIBROTEST FORMULA||NA|NA|U|NA|||U|4||88||CONTINUATION TREATMENT|1971-08-19|1962-07-16|||||1968-12-30||1962-09-01|U|1971-10-20
TRIAL STUDY 134XCP|LB|1123F894-0821-41DF-9C28-ED6BC4A7098C|2||||VITK|VITAMIN K|||||||%/MIN|||||||BORDERLINE||BQ/KG||||LOW|NOT DONE||||DERMAL TISSUE|ROOM TEMPERATURE|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|NASH FIBROSURE FORMULA||U|U|N|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1973-05-24|1973-02-04|||||1972-05-20||1967-07-30|U|1961-07-29
TRIAL STUDY 134XCP|LB|1123F894-0821-41DF-9C28-ED6BC4A7098C|1||||TYR|TYROSINE|||||||TITER|||||||INDETERMINATE||ML/KG||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|AGGLUTINATED|U|TOTAL BODY RADIOGRAPHY|MDRD 4 VARIABLE FORMULA||N|Y|U|U|||Y|5||7||CONTINUATION TREATMENT|1963-07-16|1969-10-02|||||1968-08-03||1961-05-14|Y|1970-06-25
TRIAL STUDY 134XCP|LB|1123F894-0821-41DF-9C28-ED6BC4A7098C|2||||METHPHEN|METHYLPHENIDATE|||||||CCID 50/DOSE|||||||NEGATIVE||ELISA UNIT/ML||||LOW|NOT DONE||||RETICULOCYTES|LACTESCENT|N|JAFFE REACTION|FIBROMETER FORMULA||N|Y|U|N|||U|5||7||RUN-IN|1963-12-22|1964-08-25|||||1966-11-08||1968-09-06|Y|1961-06-04
TRIAL STUDY 134XCP|LB|42DD827A-E788-4E61-8E9F-421136A16166|1||||ACHE|ACETYLCHOLINESTERASE|||||||CFU/ML|||||||TRACE||MAMP||||HIGH|NOT DONE||||EMESIS|THAWED|NA|IMMUNOASSAY|GMI MMOL/MOL FORMULA||U|N|Y|N|||Y|1||38||CONTINUATION TREATMENT|1967-05-18|1966-05-26|||||1970-06-15||1972-10-19|N|1973-03-06
TRIAL STUDY 134XCP|LB|42DD827A-E788-4E61-8E9F-421136A16166|2||||IGGCALBC|IGG CLEARANCE/ALBUMIN CLEARANCE|||||||DRINK|||||||INDETERMINATE||IMPLANT||||LOW|NOT DONE||||PLEURAL TISSUE|CONTAMINATED|N|COULOMETRIC TITRATION|MDRD 4 VARIABLE FORMULA||Y|N|Y|NA|||U|1||38||BLINDED TREATMENT|1964-05-27|1973-01-13|||||1966-12-14||1969-07-23|NA|1966-10-31
TRIAL STUDY 134XCP|LB|42DD827A-E788-4E61-8E9F-421136A16166|1||||JO1AB|JO-1 ANTIBODY|||||||/LPF|||||||TRACE||LB||||NORMAL|NOT DONE||||LYMPH|DRIED|U|IMMUNOBLOT|MDRD 4 VARIABLE FORMULA||N|NA|N|N|||Y|2||58||TREATMENT|1968-04-30|1965-06-13|||||1964-09-25||1972-10-28|N|1964-01-12
TRIAL STUDY 134XCP|LB|42DD827A-E788-4E61-8E9F-421136A16166|2||||GOLD|GOLD|||||||MM3/MM2/YEAR|||||||TRACE||MMOL/L||||LOW|NOT DONE||||BUFFY COAT|UNEXPECTED ODOR|N|FISH|NASH FIBROSURE FORMULA||N|NA|U|Y|||Y|2||58||OPEN LABEL TREATMENT|1966-11-26|1973-01-14|||||1960-11-21||1970-06-21|N|1973-02-05
TRIAL STUDY 134XCP|LB|42DD827A-E788-4E61-8E9F-421136A16166|1||||C147278|GLYCINE MAX ANTIGEN IGE ANTIBODY|||||||MG/L FEU|||||||NEGATIVE||IU/ML||||NORMAL|NOT DONE||||MONOCYTE|LACTESCENT|Y|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|Y|||N|3||39||TREATMENT|1968-03-28|1963-04-14|||||1970-04-18||1962-03-05|Y|1960-10-31
TRIAL STUDY 134XCP|LB|42DD827A-E788-4E61-8E9F-421136A16166|2||||HYPGST17|17-HYDROXYPROGESTERONE|||||||10^6 CFU|||||||TRACE||KPA/L/SEC||||ABNORMAL|NOT DONE||||TUMOR TISSUE|UNEXPECTED ODOR|NA|PATHOLOGICAL EVALUATION|MDRD ENZYMATIC FORMULA||NA|N|Y|N|||U|3||39||TREATMENT|1965-04-04|1973-05-09|||||1960-02-07||1972-04-28|NA|1969-02-18
TRIAL STUDY 134XCP|LB|42DD827A-E788-4E61-8E9F-421136A16166|1||||HYDCDN|HYDROCODONE|||||||PIXELS/CM|||||||INDETERMINATE||ML/SEC/1.73M2||||HIGH|NOT DONE||||PLEURAL FLUID|AUTOLYZED|U|IMMUNOPRECIPITATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|U|U|||NA|4||88||FOLLOW-UP|1964-03-07|1969-12-24|||||1973-07-30||1973-09-08|Y|1973-06-28
TRIAL STUDY 134XCP|LB|42DD827A-E788-4E61-8E9F-421136A16166|2||||MCPHGLE|MACROPHAGES/LEUKOCYTES|||||||ELISA UNIT|||||||INVALID||DAMOL/L||||NORMAL|NOT DONE||||VENOUS PLASMA|CALCIFIED|N|GEL ELECTROPHORESIS|GMI MMOL/MOL FORMULA||U|Y|Y|N|||N|4||88||WASHOUT|1964-04-07|1964-07-16|||||1960-05-30||1967-12-02|NA|1970-08-21
TRIAL STUDY 134XCP|LB|42DD827A-E788-4E61-8E9F-421136A16166|1||||GRANSGCE|GRANULOCYTES SEGMENTED/TOTAL CELLS|||||||NMOL BCE/MMOL|||||||BORDERLINE||IU/KG||||LOW|NOT DONE||||WHITE MATTER TISSUE|CONCENTRATED|U|MRI|MDRD ENZYMATIC FORMULA||U|Y|U|NA|||U|5||7||OPEN LABEL TREATMENT|1961-04-07|1970-02-03|||||1960-06-11||1965-11-09|N|1965-03-13
TRIAL STUDY 134XCP|LB|42DD827A-E788-4E61-8E9F-421136A16166|2||||CD3|CD3|||||||UG/L/H|||||||INVALID||PMOL/L/H||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|CLOTTED|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|FIBROTEST FORMULA||N|NA|NA|NA|||U|5||7||OPEN LABEL TREATMENT|1972-11-30|1966-11-05|||||1971-02-20||1971-07-12|N|1961-01-21
TRIAL STUDY 134XCP|LB|CC1E2338-4454-4CBA-8848-0B994C459F05|1||||CD45RALY|CD45RA/LYMPHOCYTES|||||||/100 HPFS|||||||NEGATIVE||HENRY||||ABNORMAL|NOT DONE||||CORD SERUM|GELLED|Y|SPIRAL CT SCAN WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA||U|NA|NA|Y|||U|1||38||TREATMENT|1971-11-20|1965-04-02|||||1962-03-28||1962-05-08|U|1969-07-26
TRIAL STUDY 134XCP|LB|CC1E2338-4454-4CBA-8848-0B994C459F05|2||||NAGASE|N-ACETYL-BETA-D-GLUCOSAMINIDASE|||||||HPA|||||||POSITIVE||DAMOL/L||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|AUTOLYZED|NA|HANSEL STAIN|CKD-EPI CYSTATIN C FORMULA||N|Y|N|U|||Y|1||38||OBSERVATION|1962-05-30|1966-01-05|||||1967-01-01||1972-08-22|U|1971-01-11
TRIAL STUDY 134XCP|LB|CC1E2338-4454-4CBA-8848-0B994C459F05|1||||CTLPRM|CITALOPRAM|||||||HEP|||||||BORDERLINE||DRAM||||LOW|NOT DONE||||EXUDATE|NON-HEMOLYZED|N|IRON HEMATOXYLIN STAIN|HEPASCORE FORMULA||N|U|N|U|||Y|2||58||BLINDED TREATMENT|1961-08-05|1973-07-15|||||1962-02-12||1964-01-05|NA|1960-09-21
TRIAL STUDY 134XCP|LB|CC1E2338-4454-4CBA-8848-0B994C459F05|2||||CLCTRIOL|CALCITRIOL|||||||MS/MMHG|||||||POSITIVE||LOG10 COPIES/ML||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|NA|FLOCCULATION, CHARCOAL ENHANCED|FIBROTEST FORMULA||N|NA|N|N|||NA|2||58||RUN-IN|1971-04-13|1960-04-11|||||1967-09-24||1967-09-03|Y|1965-06-11
TRIAL STUDY 134XCP|LB|CC1E2338-4454-4CBA-8848-0B994C459F05|1||||PROMYLE|PROMYELOCYTES/LEUKOCYTES|||||||ML/DOSE|||||||NEGATIVE||RAD||||LOW|NOT DONE||||KERATINOCYTE|DRIED|NA|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD ENZYMATIC FORMULA||N|U|N|U|||NA|3||39||RUN-IN|1962-11-10|1969-06-16|||||1968-11-14||1961-10-17|Y|1960-01-29
TRIAL STUDY 134XCP|LB|CC1E2338-4454-4CBA-8848-0B994C459F05|2||||C130140|GERMAN COCKROACH ANTIGEN IGE ANTIBODY|||||||HENRY|||||||TRACE||G/CAGE||||NORMAL|NOT DONE||||BLOOD|UNEXPECTED ODOR|Y|IMMUNO-PET SCAN|MDRD ENZYMATIC FORMULA||N|NA|NA|U|||N|3||39||WASHOUT|1967-03-02|1973-03-19|||||1969-10-19||1962-03-11|N|1961-09-10
TRIAL STUDY 134XCP|LB|CC1E2338-4454-4CBA-8848-0B994C459F05|1||||LKM1IMAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGM AB|||||||VG/KG|||||||NEGATIVE||G/ANIMAL/WK||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|UNEXPECTED ODOR|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 4 VARIABLE FORMULA||N|U|U|U|||Y|4||88||FOLLOW-UP|1962-05-25|1969-07-09|||||1963-06-05||1965-03-03|NA|1966-08-16
TRIAL STUDY 134XCP|LB|CC1E2338-4454-4CBA-8848-0B994C459F05|2||||THBD|THROMBOMODULIN|||||||UM2|||||||INDETERMINATE||IU/MMOL||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|CONTAMINATED|U|CISH|MDRD FORMULA||Y|Y|NA|U|||NA|4||88||CONTINUATION TREATMENT|1967-06-12|1972-06-28|||||1965-08-31||1967-10-27|U|1965-04-02
TRIAL STUDY 134XCP|LB|CC1E2338-4454-4CBA-8848-0B994C459F05|1||||CSBACT|BACTERIAL CASTS|||||||OHM|||||||INDETERMINATE||MMU/ML||||LOW|NOT DONE||||ARTERIAL BLOOD|REFRIGERATED|Y|INDIRECT IMMUNOFLUORESCENCE|NASH FIBROSURE FORMULA||NA|N|NA|Y|||Y|5||7||OBSERVATION|1962-10-10|1965-01-04|||||1964-04-30||1968-01-08|Y|1965-05-16
TRIAL STUDY 134XCP|LB|CC1E2338-4454-4CBA-8848-0B994C459F05|2||||C3M|COLLAGEN III NEO-PEPTIDE C3M|||||||ML/MIN|||||||TRACE||IU/G||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED|U|GRAM STAIN|FIBROSIS 4 FORMULA||Y|Y|U|N|||N|5||7||OPEN LABEL TREATMENT|1965-06-08|1962-12-22|||||1969-08-16||1973-01-16|NA|1970-05-29
TRIAL STUDY 134XCP|LB|ED04E60D-256A-4DB9-9290-4EFD0602A130|1||||ATHMBAAC|ANTITHROMBIN ACTIVITY ACTUAL/CONTROL|||||||/MBP|||||||BORDERLINE||ELISA UNIT/ML||||HIGH|NOT DONE||||ABSCESS FLUID|AGGLUTINATED|Y|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|NA|||NA|1||38||BASELINE|1972-07-02|1965-05-17|||||1968-05-21||1972-11-25|NA|1967-06-08
TRIAL STUDY 134XCP|LB|ED04E60D-256A-4DB9-9290-4EFD0602A130|2||||RMNTLP|REMNANT LIPOPROTEIN|||||||UCI/L|||||||INDETERMINATE||KCAL/DAY||||HIGH|NOT DONE||||INFRANATANT, PLASMA|THAWED|NA|PLAQUE REDUCTION NEUTRALIZATION ASSAY|NASH FIBROSURE FORMULA||U|NA|NA|NA|||Y|1||38||OBSERVATION|1964-06-01|1966-10-09|||||1969-02-28||1968-11-25|U|1966-02-06
TRIAL STUDY 134XCP|LB|ED04E60D-256A-4DB9-9290-4EFD0602A130|1||||ELA2PMN|NEUTROPHIL ELASTASE, POLYMORPHONUCLEAR|||||||TUBERCULIN UNIT|||||||POSITIVE||OZ||||LOW|NOT DONE||||AMNIOTIC FLUID|HEMOLYZED|U|INTRAVASCULAR ULTRASOUND|MDRD 4 VARIABLE FORMULA||N|NA|NA|U|||NA|2||58||SCREENING|1960-08-09|1966-08-02|||||1961-05-22||1960-01-17|N|1965-05-17
TRIAL STUDY 134XCP|LB|ED04E60D-256A-4DB9-9290-4EFD0602A130|2||||TNF12EXR|TNF SUPERFAMILY MEMBER 12 EXCRETION RATE|||||||NMOL/DAY|||||||BORDERLINE||U/ML||||ABNORMAL|NOT DONE||||BREAST MILK|CALCIFIED|U|NUCLEIC ACID BASED METHOD|MDRD 5 VARIABLE FORMULA||Y|U|Y|NA|||Y|2||58||BASELINE|1971-11-28|1972-08-27|||||1961-10-25||1970-06-09|N|1966-03-29
TRIAL STUDY 134XCP|LB|ED04E60D-256A-4DB9-9290-4EFD0602A130|1||||ALBPROT|ALBUMIN/TOTAL PROTEIN|||||||CD*S/M2|||||||INVALID||FINGERTIP UNIT||||HIGH|NOT DONE||||SWABBED MATERIAL|HEMOLYZED|Y|CLOT DETECTION|MDRD FORMULA||NA|N|Y|N|||NA|3||39||SCREENING|1967-09-01|1962-05-25|||||1964-04-10||1960-01-21|U|1970-04-21
TRIAL STUDY 134XCP|LB|ED04E60D-256A-4DB9-9290-4EFD0602A130|2||||HDL|HDL CHOLESTEROL|||||||COPIES/ML|||||||POSITIVE||KEV||||NORMAL|NOT DONE||||MUCUS|LIPEMIC|Y|PALM METHOD|MDRD 5 VARIABLE FORMULA||Y|Y|NA|Y|||NA|3||39||BLINDED TREATMENT|1968-02-16|1968-07-18|||||1964-07-07||1972-02-09|N|1971-02-07
TRIAL STUDY 134XCP|LB|ED04E60D-256A-4DB9-9290-4EFD0602A130|1||||RFIGMAB|RHEUMATOID FACTOR IGM ANTIBODY|||||||MV|||||||POSITIVE||UMOL/L||||HIGH|NOT DONE||||AQUEOUS HUMOR|SOLIDIFIED|N|MANUAL CLOT DETECTION|CKD-EPI CYSTATIN C FORMULA||N|NA|Y|NA|||U|4||88||FOLLOW-UP|1965-10-29|1970-02-02|||||1969-11-03||1961-12-11|N|1965-08-01
TRIAL STUDY 134XCP|LB|ED04E60D-256A-4DB9-9290-4EFD0602A130|2||||SLXAG|SIALYL SSEA-1 ANTIGEN|||||||LOG10 COPIES/ML|||||||INVALID||MV||||HIGH|NOT DONE||||MENSTRUAL BLOOD|PARAFFIN-EMBEDDED|N|IMPULSE OSCILLOMETRY|COCKCROFT-GAULT FORMULA||NA|U|N|U|||NA|4||88||TREATMENT|1972-09-19|1961-07-12|||||1973-06-30||1964-04-23|U|1968-09-11
TRIAL STUDY 134XCP|LB|ED04E60D-256A-4DB9-9290-4EFD0602A130|1||||TMZPM|TEMAZEPAM|||||||GBQ/G|||||||NEGATIVE||G/M2||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|CALCIFIED|NA|ATOMIC ABSORPTION SPECTROMETRY|GMI MMOL/MOL FORMULA||NA|N|N|NA|||NA|5||7||OPEN LABEL TREATMENT|1961-01-07|1969-12-19|||||1971-09-06||1965-08-28|N|1962-12-02
TRIAL STUDY 134XCP|LB|ED04E60D-256A-4DB9-9290-4EFD0602A130|2||||HALPRZLM|HYDROXYALPRAZOLAM|||||||FT2|||||||NEGATIVE||ENZYME U||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|NA|MUGA|ASH FIBROSURE FORMULA||Y|NA|U|NA|||Y|5||7||FOLLOW-UP|1962-07-14|1963-11-18|||||1971-01-24||1971-04-14|NA|1963-11-02
TRIAL STUDY 134XCP|LB|C70F82F6-3280-429D-9657-CDFBA6B7F626|1||||INTLK33|INTERLEUKIN 33|||||||UEQ|||||||INDETERMINATE||ML/G/DAY||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED|N|MASS SPECTROMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|U|Y|||Y|1||38||OPEN LABEL TREATMENT|1964-03-30|1969-07-16|||||1971-03-10||1967-08-01|NA|1963-07-11
TRIAL STUDY 134XCP|LB|C70F82F6-3280-429D-9657-CDFBA6B7F626|2||||MIP1A|MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA|||||||PRESSOR UNITS|||||||INVALID||DEG/MM||||NORMAL|NOT DONE||||SOFT TISSUE|AGGLUTINATED|N|DIGITAL PCR|FIBROTEST FORMULA||NA|Y|NA|NA|||U|1||38||INDUCTION TREATMENT|1968-12-09|1966-03-23|||||1966-05-22||1961-04-15|Y|1969-05-14
TRIAL STUDY 134XCP|LB|C70F82F6-3280-429D-9657-CDFBA6B7F626|1||||TRICH|TRICHOMONAS|||||||MMOL/S|||||||TRACE||UG/KG||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|LIPEMIC|N|FLUORESCENT SPOT TEST|CKD-EPI FORMULA||Y|NA|N|U|||N|2||58||OPEN LABEL TREATMENT|1962-05-09|1961-12-15|||||1963-02-08||1968-05-29|N|1962-03-09
TRIAL STUDY 134XCP|LB|C70F82F6-3280-429D-9657-CDFBA6B7F626|2||||LKM1IMAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGM AB|||||||CYCLE/MIN|||||||BORDERLINE||MG/DOSE||||LOW|NOT DONE||||INFRANATANT, PLASMA|FROZEN|N|AUSCULTATION|FIBROTEST FORMULA||N|Y|Y|Y|||NA|2||58||INDUCTION TREATMENT|1972-09-14|1971-12-21|||||1963-06-28||1961-02-01|N|1963-08-15
TRIAL STUDY 134XCP|LB|C70F82F6-3280-429D-9657-CDFBA6B7F626|1||||LAM|LIPOARABINOMANNAN|||||||10^6/EJACULATE U|||||||NEGATIVE||BQ/UL||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|AUTOLYZED|NA|MICROBIAL CULTURE|GMI % FORMULA||N|Y|Y|Y|||NA|3||39||CONTINUATION TREATMENT|1970-07-25|1973-05-02|||||1964-09-25||1960-01-19|NA|1966-01-22
TRIAL STUDY 134XCP|LB|C70F82F6-3280-429D-9657-CDFBA6B7F626|2||||PC3MPSAM|PCA3 MRNA/PSA MRNA|||||||10^6 CFU/ML|||||||BORDERLINE||MOL/DAY||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|CONCENTRATED|U|WEBER GREEN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|Y|||N|3||39||WASHOUT|1970-06-02|1967-12-31|||||1965-07-11||1972-06-12|N|1973-02-03
TRIAL STUDY 134XCP|LB|C70F82F6-3280-429D-9657-CDFBA6B7F626|1||||HDLCLDLC|HDL CHOLESTEROL/LDL CHOLESTEROL|||||||GPELISA UNIT/ML|||||||POSITIVE||ABSORBANCE U/MIN||||ABNORMAL|NOT DONE||||PERSPIRATION|THAWED|NA|SPECTROPHOTOMETRY|CKD-EPI FORMULA||Y|Y|Y|NA|||N|4||88||OPEN LABEL TREATMENT|1962-10-11|1962-05-28|||||1963-11-12||1970-10-04|NA|1969-09-20
TRIAL STUDY 134XCP|LB|C70F82F6-3280-429D-9657-CDFBA6B7F626|2||||C130072|BIRCH POLLEN IGE|||||||MMOL/S|||||||TRACE||NEWTON||||HIGH|NOT DONE||||SERUM OR PLASMA|FRESH|Y|ENZYMATIC COLORIMETRY|GMI MMOL/MOL FORMULA||N|N|NA|N|||N|4||88||WASHOUT|1966-02-19|1970-08-28|||||1973-08-27||1960-10-24|NA|1961-02-28
TRIAL STUDY 134XCP|LB|C70F82F6-3280-429D-9657-CDFBA6B7F626|1||||PTSFAAC|PROTEIN S FREE ACTIVITY ACTUAL/CONTROL|||||||MG/DL|||||||NEGATIVE||DROP||||NORMAL|NOT DONE||||ADIPOSE TISSUE|AGGLUTINATED|U|NON-CONTACT SPECULAR MICROSCOPY|GMI % FORMULA||N|Y|U|NA|||Y|5||7||BASELINE|1965-04-18|1966-11-16|||||1961-05-14||1964-01-24|NA|1964-03-30
TRIAL STUDY 134XCP|LB|C70F82F6-3280-429D-9657-CDFBA6B7F626|2||||BLSTLYLE|LYMPHOBLASTS/LEUKOCYTES|||||||ROENTGEN|||||||NEGATIVE||ML/M2/H||||ABNORMAL|NOT DONE||||BASAL TEAR|CLOTTED|NA|AUTOMATED COUNT|HEPASCORE FORMULA||NA|U|Y|NA|||Y|5||7||WASHOUT|1964-08-23|1972-04-26|||||1961-12-19||1969-04-10|NA|1963-01-29
TRIAL STUDY 134XCP|LB|D735D137-2C27-4F27-BA18-9A0F7FF0B145|1||||CAFFEINE|CAFFEINE|||||||GPL U|||||||INDETERMINATE||L/MIN/M2||||LOW|NOT DONE||||ERYTHROCYTES|DRIED|U|MANUAL CLOT DETECTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|N|N|||U|1||38||SCREENING|1965-07-30|1962-03-17|||||1972-02-17||1972-05-04|NA|1971-08-01
TRIAL STUDY 134XCP|LB|D735D137-2C27-4F27-BA18-9A0F7FF0B145|2||||PSAF|PROSTATE SPECIFIC ANTIGEN, FREE|||||||LOG10 CFU/G|||||||INVALID||CI/L||||LOW|NOT DONE||||CAPILLARY BLOOD|CLOTTED|NA|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|Y|Y|||U|1||38||BASELINE|1962-05-16|1968-05-17|||||1962-06-20||1971-05-21|N|1972-08-31
TRIAL STUDY 134XCP|LB|D735D137-2C27-4F27-BA18-9A0F7FF0B145|1||||NEUTSGLE|NEUTROPHILS, SEGMENTED/LEUKOCYTES|||||||10^6/G|||||||TRACE||10^7 TCID 50/DOSE||||ABNORMAL|NOT DONE||||CELL PELLET|NON-HEMOLYZED|Y|MANUAL COUNT|COCKCROFT-GAULT FORMULA||U|Y|U|U|||NA|2||58||OPEN LABEL TREATMENT|1967-04-06|1967-07-31|||||1965-05-11||1973-07-24|NA|1965-02-22
TRIAL STUDY 134XCP|LB|D735D137-2C27-4F27-BA18-9A0F7FF0B145|2||||HGBCHGB|HEMOGLOBIN C/TOTAL HEMOGLOBIN|||||||PG/CELL|||||||BORDERLINE||CIGAR||||LOW|NOT DONE||||RETICULOCYTES|HEMOLYZED|N|PULSE OXIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|Y|Y|||NA|2||58||SCREENING|1964-07-20|1971-06-18|||||1968-12-18||1962-05-12|U|1972-10-18
TRIAL STUDY 134XCP|LB|D735D137-2C27-4F27-BA18-9A0F7FF0B145|1||||VAL|VALINE|||||||MEQ/UL|||||||INVALID||FRACTION OF 1||||LOW|NOT DONE||||CEREBROSPINAL FLUID|FRESH|U|PELLI-ROBSON EYE CHART|CKD-EPI CREATININE FORMULA||U|Y|N|Y|||N|3||39||RUN-IN|1963-05-13|1965-01-31|||||1965-03-06||1964-08-22|N|1968-09-05
TRIAL STUDY 134XCP|LB|D735D137-2C27-4F27-BA18-9A0F7FF0B145|2||||NACLR|SODIUM CLEARANCE|||||||KPA|||||||TRACE||HZ||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|AUTOLYZED|Y|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|FIBROMETER FORMULA||N|U|NA|N|||NA|3||39||INDUCTION TREATMENT|1972-10-14|1962-12-18|||||1969-05-30||1966-11-30|Y|1961-12-24
TRIAL STUDY 134XCP|LB|D735D137-2C27-4F27-BA18-9A0F7FF0B145|1||||RLP|RLP CHOLESTEROL|||||||CI/UG|||||||NEGATIVE||GY||||ABNORMAL|NOT DONE||||CALCULUS|FROZEN|U|CELL BASED BIOASSAY|FIBROMETER FORMULA||Y|NA|Y|U|||U|4||88||OPEN LABEL TREATMENT|1968-03-31|1968-10-27|||||1973-05-03||1964-10-05|U|1967-09-22
TRIAL STUDY 134XCP|LB|D735D137-2C27-4F27-BA18-9A0F7FF0B145|2||||TESTOSWB|TESTOSTERONE, WEAKLY BOUND|||||||VIAL|||||||INDETERMINATE||CI/KG||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|NON-HEMOLYZED|NA|IMMUNOPRECIPITATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|NA|N|||U|4||88||SCREENING|1960-01-18|1968-12-08|||||1968-06-12||1963-10-06|N|1968-03-28
TRIAL STUDY 134XCP|LB|D735D137-2C27-4F27-BA18-9A0F7FF0B145|1||||CAPHOSPD|CALCIUM - PHOSPHORUS PRODUCT|||||||OZ EQ|||||||NEGATIVE||ML/KG/H||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|AGGLUTINATED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|FIBROTEST FORMULA||N|Y|Y|U|||Y|5||7||SCREENING|1972-09-21|1970-01-26|||||1972-08-19||1964-12-19|NA|1960-08-15
TRIAL STUDY 134XCP|LB|D735D137-2C27-4F27-BA18-9A0F7FF0B145|2||||IGFBP1|INSULIN-LIKE GROWTH FACTOR BINDING PROT1|||||||%(W/W)|||||||TRACE||FIU||||HIGH|NOT DONE||||MUCUS|FROZEN|N|MAPH|CKD-EPI CYSTATIN C FORMULA||U|Y|N|N|||N|5||7||LONG-TERM FOLLOW-UP|1960-06-13|1970-11-07|||||1969-03-25||1971-12-15|NA|1967-02-17
TRIAL STUDY 134XCP|LB|B00194E0-0E85-46DD-86C3-CD9048535986|1||||NEUTLS|LEFT SHIFT NEUTROPHILS|||||||/MBP|||||||TRACE||ML/BEAT||||HIGH|NOT DONE||||ABSCESS FLUID|GELLED|U|WHOLE EXOME SEQUENCING|NASH FIBROSURE FORMULA||U|Y|N|U|||NA|1||38||OPEN LABEL TREATMENT|1960-02-10|1971-01-12|||||1972-10-23||1960-11-14|NA|1965-04-21
TRIAL STUDY 134XCP|LB|B00194E0-0E85-46DD-86C3-CD9048535986|2||||C165875|BERMUDA GRASS POLLEN IGE AB RAST SCORE|||||||KN/CM2|||||||INDETERMINATE||MMHG/L/MIN||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|FROZEN|N|SISH|NASH FIBROSURE FORMULA||U|Y|Y|NA|||N|1||38||OBSERVATION|1970-10-14|1973-05-15|||||1960-10-14||1961-10-04|NA|1963-09-05
TRIAL STUDY 134XCP|LB|B00194E0-0E85-46DD-86C3-CD9048535986|1||||CHDWR|RET CORPUSCULAR HGB CONC DISTR WIDTH|||||||MG/MIN|||||||NEGATIVE||PELLET||||HIGH|NOT DONE||||URINE SEDIMENT|AUTOLYZED|Y|BIOIMPEDANCE SPECTROSCOPY|FIBROMETER FORMULA||U|Y|U|U|||NA|2||58||BASELINE|1969-08-23|1973-02-27|||||1968-02-02||1968-01-03|U|1972-12-23
TRIAL STUDY 134XCP|LB|B00194E0-0E85-46DD-86C3-CD9048535986|2||||APOC1|APOLIPOPROTEIN CI|||||||ML/KG/DAY|||||||NEGATIVE||LX||||HIGH|NOT DONE||||ERYTHROCYTES|FROZEN|U|REVERSE TRANSCRIPTASE PCR|MDRD FORMULA||U|Y|N|N|||U|2||58||BLINDED TREATMENT|1960-04-22|1972-03-24|||||1966-05-06||1971-04-01|Y|1965-09-16
TRIAL STUDY 134XCP|LB|B00194E0-0E85-46DD-86C3-CD9048535986|1||||INTLK8|INTERLEUKIN 8|||||||LOG10 TCID 50/ML|||||||BORDERLINE||/VF||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|ROOM TEMPERATURE|N|PHOROPTER|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|N|Y|||N|3||39||OPEN LABEL TREATMENT|1962-03-17|1968-12-05|||||1969-12-31||1963-01-06|U|1973-07-16
TRIAL STUDY 134XCP|LB|B00194E0-0E85-46DD-86C3-CD9048535986|2||||IL2SRA|SOLUBLE INTERLEUKIN 2 RECEPTOR ACTIVITY|||||||GLOBULE|||||||NEGATIVE||CI/L||||ABNORMAL|NOT DONE||||DERMAL TISSUE|FROZEN|Y|HPLC-UV|HEPASCORE FORMULA||NA|Y|NA|Y|||U|3||39||BASELINE|1973-03-22|1962-03-04|||||1967-03-13||1961-03-01|Y|1960-09-23
TRIAL STUDY 134XCP|LB|B00194E0-0E85-46DD-86C3-CD9048535986|1||||BETAINES|BETAINES|||||||UMOL/MIN|||||||INVALID||GTT||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|DRIED|N|STATIC PERIMETRY|CKD-EPI CREATININE FORMULA||NA|NA|N|U|||N|4||88||LONG-TERM FOLLOW-UP|1963-05-03|1965-07-22|||||1960-01-31||1964-07-26|Y|1963-04-13
TRIAL STUDY 134XCP|LB|B00194E0-0E85-46DD-86C3-CD9048535986|2||||HGBTET|HEMOGLOBIN TETRAMER|||||||100 IU/ML|||||||TRACE||ML/BREATH||||NORMAL|NOT DONE||||BASAL TEAR|LIPEMIC|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD FORMULA||N|Y|NA|N|||U|4||88||RUN-IN|1965-06-25|1960-05-13|||||1967-03-25||1970-01-26|NA|1971-04-16
TRIAL STUDY 134XCP|LB|B00194E0-0E85-46DD-86C3-CD9048535986|1||||SPLA2II|TYPE II SECRETORY PHOSPHOLIPASE A2|||||||ECL UNIT|||||||TRACE||10^6 RNA COPIES/ML||||ABNORMAL|NOT DONE||||PLATELET|DRIED|Y|VIRUS PLAQUE ASSAY|ASH FIBROSURE FORMULA||N|Y|NA|Y|||Y|5||7||OPEN LABEL TREATMENT|1966-06-10|1971-02-10|||||1966-04-29||1964-10-07|NA|1961-06-06
TRIAL STUDY 134XCP|LB|B00194E0-0E85-46DD-86C3-CD9048535986|2||||MICROCY|MICROCYTES|||||||UMOL/L/H|||||||BORDERLINE||FINGERTIP UNIT||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|CLOTTED|Y|MICROBIAL BIOCHEMICAL IDENTIFICATION|NASH FIBROSURE FORMULA||Y|U|N|N|||U|5||7||OBSERVATION|1968-07-22|1962-10-22|||||1966-10-03||1963-05-14|NA|1964-06-18
TRIAL STUDY 134XCP|LB|B4F372E9-C461-414A-95B4-93CA0221D396|1||||BLEEDT|BLEEDING TIME|||||||10^6 ORGANISMS/ML|||||||POSITIVE||10^6 ORGANISMS||||HIGH|NOT DONE||||MENSTRUAL BLOOD|UNEXPECTED ODOR|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|CKD-EPI CREATININE FORMULA||U|NA|U|NA|||N|1||38||FOLLOW-UP|1969-03-29|1971-06-07|||||1960-07-07||1971-07-28|NA|1963-01-09
TRIAL STUDY 134XCP|LB|B4F372E9-C461-414A-95B4-93CA0221D396|2||||NORMBASO|BASOPHILIC NORMOBLAST|||||||LB|||||||INVALID||UMOL/L||||ABNORMAL|NOT DONE||||KERATINOCYTE|GELLED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD 6 VARIABLE FORMULA||NA|N|NA|U|||Y|1||38||LONG-TERM FOLLOW-UP|1971-06-16|1965-10-08|||||1964-12-24||1968-10-21|U|1960-06-08
TRIAL STUDY 134XCP|LB|B4F372E9-C461-414A-95B4-93CA0221D396|1||||MPC|MEAN PLATELET COMPONENT|||||||KG|||||||BORDERLINE||PMOL/L||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|GELLED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 5 VARIABLE FORMULA||U|Y|U|U|||U|2||58||INDUCTION TREATMENT|1966-07-03|1960-11-23|||||1971-07-06||1966-05-23|U|1961-08-04
TRIAL STUDY 134XCP|LB|B4F372E9-C461-414A-95B4-93CA0221D396|2||||C3A|COMPLEMENT C3A|||||||KN/CM2|||||||INVALID||EP U||||LOW|NOT DONE||||SEMEN|LACTESCENT|NA|SISH|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|U|NA|||N|2||58||WASHOUT|1972-03-07|1972-04-23|||||1970-03-31||1964-07-18|Y|1963-12-14
TRIAL STUDY 134XCP|LB|B4F372E9-C461-414A-95B4-93CA0221D396|1||||PROMYB|PROMYELOBLASTS|||||||KG/CM2|||||||INDETERMINATE||NGEQ/L||||ABNORMAL|NOT DONE||||SEMEN|REFRIGERATED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|NA|N|||N|3||39||LONG-TERM FOLLOW-UP|1960-04-25|1966-01-29|||||1963-02-25||1973-04-26|N|1963-02-26
TRIAL STUDY 134XCP|LB|B4F372E9-C461-414A-95B4-93CA0221D396|2||||FXAAC|FACTOR X ACTIVITY ACTUAL/CONTROL|||||||PFU/ANIMAL|||||||NEGATIVE||ML/M2/MIN||||NORMAL|NOT DONE||||HAIR FOLLICLE|FRESH|Y|MICRODENSITOMETRY|HEPASCORE FORMULA||U|U|Y|N|||N|3||39||TREATMENT|1962-04-01|1960-12-24|||||1960-12-08||1966-12-31|NA|1963-09-07
TRIAL STUDY 134XCP|LB|B4F372E9-C461-414A-95B4-93CA0221D396|1||||SPGRAV|SPECIFIC GRAVITY|||||||PIXEL|||||||TRACE||COPIES/UG||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|UNEXPECTED ODOR|U|ELECTRONEUROGRAPHY|MDRD 5 VARIABLE FORMULA||NA|NA|U|U|||N|4||88||RUN-IN|1960-06-06|1972-06-04|||||1960-10-30||1970-07-30|N|1961-10-16
TRIAL STUDY 134XCP|LB|B4F372E9-C461-414A-95B4-93CA0221D396|2||||EDMAB|ENDOMYSIAL ANTIBODY|||||||NG/DAY|||||||NEGATIVE||GPS U||||NORMAL|NOT DONE||||CELL PELLET|REFRIGERATED|Y|DYNAMIC LIGHT SCATTERING|CKD-EPI CREATININE FORMULA||U|N|NA|NA|||N|4||88||LONG-TERM FOLLOW-UP|1972-01-13|1970-03-25|||||1968-12-13||1968-05-28|N|1961-05-29
TRIAL STUDY 134XCP|LB|B4F372E9-C461-414A-95B4-93CA0221D396|1||||MEPRDN|MEPERIDINE|||||||ML*CMH2O|||||||POSITIVE||CPM||||LOW|NOT DONE||||BILE|HEMOLYZED|NA|IMPULSE OSCILLOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|Y|N|||U|5||7||CONTINUATION TREATMENT|1965-10-03|1970-07-24|||||1963-11-05||1970-06-21|NA|1960-02-09
TRIAL STUDY 134XCP|LB|B4F372E9-C461-414A-95B4-93CA0221D396|2||||HYDMDZ1|1-HYDROXYMIDAZOLAM|||||||AFU|||||||INVALID||/KG||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|SOLIDIFIED|NA|TRANSTHORACIC ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||U|Y|Y|U|||U|5||7||CONTINUATION TREATMENT|1966-04-21|1961-06-21|||||1963-11-13||1970-09-04|Y|1967-04-14
TRIAL STUDY 134XCP|LB|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|1||||RF|RHEUMATOID FACTOR|||||||10^3 CFU/G|||||||POSITIVE||MMOL||||ABNORMAL|NOT DONE||||CORD SERUM|AGGLUTINATED|Y|POLYSOMNOGRAPHY|CKD-EPI CYSTATIN C FORMULA||U|N|N|Y|||N|1||38||CONTINUATION TREATMENT|1960-12-24|1968-09-03|||||1966-08-25||1970-02-04|NA|1960-05-12
TRIAL STUDY 134XCP|LB|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|2||||CHOLINES|CHOLINESTERASE|||||||MMHG/SEC|||||||INDETERMINATE||MG/DL||||NORMAL|NOT DONE||||LAVAGE FLUID|NON-HEMOLYZED|Y|FARR ASSAY|MDRD 5 VARIABLE FORMULA||NA|Y|N|NA|||NA|1||38||BLINDED TREATMENT|1968-07-22|1966-09-20|||||1960-12-27||1972-08-20|Y|1960-03-30
TRIAL STUDY 134XCP|LB|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|1||||C4|COMPLEMENT C4|||||||GPL U|||||||INDETERMINATE||ENZYME U/L||||LOW|NOT DONE||||AMNIOTIC FLUID|CLOTTED|NA|MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI FORMULA||N|U|N|Y|||Y|2||58||INDUCTION TREATMENT|1969-09-26|1965-11-20|||||1973-02-22||1960-04-27|N|1970-05-20
TRIAL STUDY 134XCP|LB|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|2||||CCL25|CHEMOKINE (C-C MOTIF) LIGAND 25|||||||10^3 ORGANISMS/ML|||||||TRACE||NMOL||||HIGH|NOT DONE||||CORD BLOOD|SOLIDIFIED|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI FORMULA||N|NA|NA|U|||U|2||58||RUN-IN|1971-11-03|1965-02-22|||||1968-09-18||1972-05-03|NA|1972-05-17
TRIAL STUDY 134XCP|LB|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|1||||ETGETS|ETHYL GLUCURONIDE ETHYL SULFATE|||||||MET*MIN|||||||NEGATIVE||C||||NORMAL|NOT DONE||||TUMOR TISSUE|HEMOLYZED|Y|STATIC PERIMETRY|CKD-EPI FORMULA||U|NA|U|Y|||Y|3||39||WASHOUT|1965-11-12|1970-06-16|||||1965-04-05||1966-02-24|Y|1969-12-30
TRIAL STUDY 134XCP|LB|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|2||||SIXMAM|6-MONOACETYLMORPHINE|||||||RFU|||||||NEGATIVE||LOZENGE||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|FRESH|Y|RADIAL IMMUNODIFFUSION|COCKCROFT-GAULT FORMULA||N|Y|NA|N|||U|3||39||OPEN LABEL TREATMENT|1972-12-25|1969-09-29|||||1962-01-21||1964-08-12|U|1968-06-06
TRIAL STUDY 134XCP|LB|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|1||||ATP|ADENOSINE TRIPHOSPHATE|||||||RFU|||||||INDETERMINATE||CP||||LOW|NOT DONE||||CEREBROSPINAL FLUID|FROZEN|U|GC/MS-CI|CKD-EPI CREATININE FORMULA||N|NA|Y|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1961-03-24|1961-07-30|||||1968-04-30||1973-03-11|N|1964-07-27
TRIAL STUDY 134XCP|LB|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|2||||CYFRA18|CYTOKERATIN 18 FRAGMENT|||||||10^9/L|||||||NEGATIVE||CGY||||LOW|NOT DONE||||SMEGMA|ICTERIC|N|AUSCULTATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|NA|NA|||N|4||88||FOLLOW-UP|1967-12-30|1969-10-15|||||1960-08-27||1961-12-06|U|1962-11-04
TRIAL STUDY 134XCP|LB|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|1||||WBCMORPH|LEUKOCYTE CELL MORPHOLOGY|||||||CYCLE/MIN|||||||TRACE||LINEAR FT*LB||||NORMAL|NOT DONE||||SWABBED MATERIAL|REFRIGERATED|U|X-RAY|GMI MMOL/MOL FORMULA||U|N|NA|U|||NA|5||7||BASELINE|1966-08-22|1966-03-30|||||1973-02-09||1972-11-03|N|1965-07-22
TRIAL STUDY 134XCP|LB|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|2||||CRBMZPN|CARBAMAZEPINE|||||||FMOL/L|||||||INVALID||FOZ_BR||||HIGH|NOT DONE||||PLEURAL TISSUE|LACTESCENT|N|MULTIPLE BREATH WASHOUT|MDRD FORMULA||N|NA|N|N|||N|5||7||FOLLOW-UP|1968-10-04|1961-05-01|||||1963-06-15||1961-02-12|N|1973-01-22
TRIAL STUDY 134XCP|LB|E43169E4-8B57-47D7-9C91-D42E40DD579B|1||||TSHRAB|THYROTROPIN RECEPTOR ANTIBODY|||||||NMOL BCE/L|||||||INVALID||10^3 DNA COPIES/ML||||ABNORMAL|NOT DONE||||LOCHIA|HEMOLYZED|NA|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|FIBROMETER FORMULA||N|N|NA|Y|||NA|1||38||OBSERVATION|1960-01-31|1967-05-23|||||1968-08-22||1960-01-28|Y|1968-04-20
TRIAL STUDY 134XCP|LB|E43169E4-8B57-47D7-9C91-D42E40DD579B|2||||PEPSNGII|PEPSINOGEN II|||||||GAUSS|||||||INDETERMINATE||WAFER||||LOW|NOT DONE||||GASTRIC CONTENTS|PARAFFIN-EMBEDDED|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|FIBROSIS 4 FORMULA||NA|N|U|U|||U|1||38||LONG-TERM FOLLOW-UP|1963-06-30|1961-02-02|||||1966-07-06||1968-12-03|Y|1963-03-13
TRIAL STUDY 134XCP|LB|E43169E4-8B57-47D7-9C91-D42E40DD579B|1||||NITRITE|NITRITE|||||||ML/KG|||||||INDETERMINATE||MG/H||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|DRIED|Y|SMEAR|FIBROSIS 4 FORMULA||Y|N|U|U|||N|2||58||TREATMENT|1969-02-24|1969-05-27|||||1963-05-14||1960-06-01|N|1968-12-20
TRIAL STUDY 134XCP|LB|E43169E4-8B57-47D7-9C91-D42E40DD579B|2||||BTK|BRUTON'S TYROSINE KINASE|||||||TUBERCULIN UNIT|||||||INDETERMINATE||MMOL/MIN/KPA/L||||HIGH|NOT DONE||||PLEURAL TISSUE|CALCIFIED|Y|DISK DIFFUSION|FIBROSIS 4 FORMULA||NA|U|U|U|||Y|2||58||CONTINUATION TREATMENT|1970-10-02|1963-10-31|||||1963-10-16||1960-08-01|N|1970-03-18
TRIAL STUDY 134XCP|LB|E43169E4-8B57-47D7-9C91-D42E40DD579B|1||||CREAT|CREATININE|||||||UMOL/MOL|||||||TRACE||PMOL/DL||||HIGH|NOT DONE||||DERMAL TISSUE|AUTOLYZED|U|FLAME PHOTOMETRY|NASH FIBROSURE FORMULA||N|N|NA|U|||Y|3||39||SCREENING|1962-10-23|1966-01-12|||||1968-10-16||1961-07-21|NA|1962-12-11
TRIAL STUDY 134XCP|LB|E43169E4-8B57-47D7-9C91-D42E40DD579B|2||||TMZPM|TEMAZEPAM|||||||MV2/HZ|||||||TRACE||DDU||||ABNORMAL|NOT DONE||||CERUMEN|PARAFFIN-EMBEDDED|N|SPIRAL CT SCAN WITHOUT CONTRAST|FIBROTEST FORMULA||U|U|NA|U|||U|3||39||BASELINE|1968-03-16|1963-04-01|||||1960-12-14||1972-07-07|Y|1968-02-28
TRIAL STUDY 134XCP|LB|E43169E4-8B57-47D7-9C91-D42E40DD579B|1||||BTKFR|BRUTON'S TYROSINE KINASE, FREE|||||||MM/MIN|||||||TRACE||UG/G/MIN||||ABNORMAL|NOT DONE||||SEMEN|AUTOLYZED|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA||NA|U|NA|NA|||U|4||88||TREATMENT|1972-04-23|1967-06-21|||||1968-06-08||1971-07-09|U|1963-04-10
TRIAL STUDY 134XCP|LB|E43169E4-8B57-47D7-9C91-D42E40DD579B|2||||ETPLTR|ETP LAG TIME RELATIVE|||||||MEQ/G|||||||INVALID||NG/DAY||||ABNORMAL|NOT DONE||||SEBUM|HEMOLYZED|Y|IMMUNOFLUORESCENT STAIN|CKD-EPI FORMULA||Y|N|Y|NA|||U|4||88||RUN-IN|1965-10-12|1968-08-11|||||1962-05-25||1968-11-03|N|1971-04-19
TRIAL STUDY 134XCP|LB|E43169E4-8B57-47D7-9C91-D42E40DD579B|1||||CLUECE|CLUE CELLS|||||||KA_U/DL|||||||BORDERLINE||BREATHS/MIN||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|HEMOLYZED|Y|ELISPOT|HEPASCORE FORMULA||N|U|Y|Y|||N|5||7||SCREENING|1969-01-13|1965-06-28|||||1961-12-16||1962-02-25|U|1963-08-15
TRIAL STUDY 134XCP|LB|E43169E4-8B57-47D7-9C91-D42E40DD579B|2||||INTLK30|INTERLEUKIN 30|||||||VG/DOSE|||||||TRACE||CM2||||NORMAL|NOT DONE||||PLEURAL TISSUE|REFRIGERATED|NA|MASS SPECTROMETRY|NASH FIBROSURE FORMULA||N|Y|NA|U|||U|5||7||FOLLOW-UP|1969-04-16|1971-01-05|||||1965-09-16||1967-05-14|U|1970-04-26
TRIAL STUDY 134XCP|LB|066393EE-D112-41DD-AF8F-65EF57A4415B|1||||CORCREAT|CORTISOL/CREATININE|||||||NMOL/KG/DAY|||||||POSITIVE||UG/CM2||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|PARAFFIN-EMBEDDED|Y|REBOUND TONOMETRY|CKD-EPI CREATININE FORMULA||N|N|NA|Y|||Y|1||38||BASELINE|1962-12-01|1969-06-22|||||1960-09-09||1963-06-03|NA|1967-05-08
TRIAL STUDY 134XCP|LB|066393EE-D112-41DD-AF8F-65EF57A4415B|2||||CACLR|CALCIUM CLEARANCE|||||||CI/ML|||||||POSITIVE||LOG10 CCID 50/DOSE||||HIGH|NOT DONE||||DERMAL TISSUE|GELLED|U|LISSAMINE GREEN STAIN|FIBROMETER FORMULA||U|NA|U|N|||Y|1||38||BASELINE|1962-04-22|1964-06-13|||||1960-04-15||1966-10-11|U|1968-01-16
TRIAL STUDY 134XCP|LB|066393EE-D112-41DD-AF8F-65EF57A4415B|1||||ACYCRNTN|ACYLCARNITINE|||||||IU/L|||||||INVALID||CARTRIDGE||||NORMAL|NOT DONE||||PROSTATIC FLUID|HEMOLYZED|NA|INTRAVASCULAR ULTRASOUND|CKD-EPI CREATININE FORMULA||N|NA|U|N|||U|2||58||INDUCTION TREATMENT|1963-01-31|1961-05-31|||||1972-04-12||1970-01-13|N|1970-08-28
TRIAL STUDY 134XCP|LB|066393EE-D112-41DD-AF8F-65EF57A4415B|2||||KL6|KREBS VON DEN LUNGEN-6|||||||IU/KG/H|||||||POSITIVE||MOSM||||ABNORMAL|NOT DONE||||KERATINOCYTE|UNEXPECTED ODOR|U|PHASE CONTRAST MICROSCOPY|CKD-EPI CREATININE FORMULA||U|U|NA|NA|||N|2||58||FOLLOW-UP|1963-01-20|1960-07-21|||||1969-04-07||1970-09-09|N|1967-01-04
TRIAL STUDY 134XCP|LB|066393EE-D112-41DD-AF8F-65EF57A4415B|1||||RBCMORPH|ERYTHROCYTE CELL MORPHOLOGY|||||||BISCUIT|||||||BORDERLINE||PMOL||||NORMAL|NOT DONE||||CALCULUS|CLOTTED|N|FLOCCULATION, CHARCOAL ENHANCED|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|Y|U|||N|3||39||CONTINUATION TREATMENT|1964-10-05|1972-10-10|||||1972-12-04||1965-01-31|NA|1962-05-19
TRIAL STUDY 134XCP|LB|066393EE-D112-41DD-AF8F-65EF57A4415B|2||||HMOSIDRN|HEMOSIDERIN|||||||IN2|||||||TRACE||MILE||||NORMAL|NOT DONE||||MONOCYTE|AUTOLYZED|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI CYSTATIN C FORMULA||U|Y|U|U|||NA|3||39||FOLLOW-UP|1965-08-01|1961-11-30|||||1968-02-29||1971-06-28|N|1968-11-12
TRIAL STUDY 134XCP|LB|066393EE-D112-41DD-AF8F-65EF57A4415B|1||||KIM1|KIDNEY INJURY MOLECULE-1|||||||GY/H|||||||INDETERMINATE||LOG10 ELISA UNIT/DOSE||||HIGH|NOT DONE||||EXPIRED AIR|ICTERIC|N|FLUORIMETRY|MDRD FORMULA||N|Y|NA|U|||NA|4||88||WASHOUT|1963-03-18|1962-07-11|||||1969-02-24||1969-09-29|N|1965-12-26
TRIAL STUDY 134XCP|LB|066393EE-D112-41DD-AF8F-65EF57A4415B|2||||LDH2LDH|LDH ISOENZYME 2/LDH|||||||10^3 COPIES/ML|||||||INDETERMINATE||HOURS||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|ROOM TEMPERATURE|Y|FLAME PHOTOMETRY|MDRD 6 VARIABLE FORMULA||U|U|U|Y|||N|4||88||WASHOUT|1971-09-02|1965-04-06|||||1961-12-22||1968-01-19|N|1962-11-01
TRIAL STUDY 134XCP|LB|066393EE-D112-41DD-AF8F-65EF57A4415B|1||||ETPPH|ETP PEAK HEIGHT|||||||KN/CM2|||||||INVALID||10^3 RNA COPIES/ML||||LOW|NOT DONE||||GASTRIC FLUID|LACTESCENT|Y|ANTIMICROBIAL COMBINATION TESTING|FIBROSIS 4 FORMULA||U|U|NA|N|||Y|5||7||INDUCTION TREATMENT|1964-10-08|1967-03-08|||||1964-09-22||1963-09-27|NA|1972-11-10
TRIAL STUDY 134XCP|LB|066393EE-D112-41DD-AF8F-65EF57A4415B|2||||CCPIGGAB|CYCLIC CITRULLINATED PEPTIDE IGG AB|||||||FOZ_US|||||||INVALID||MNFI||||NORMAL|NOT DONE||||PROSTATIC FLUID|LIPEMIC|NA|MS/MS|FIBROMETER FORMULA||Y|Y|Y|NA|||N|5||7||SCREENING|1968-01-11|1961-12-06|||||1964-03-11||1971-11-07|NA|1966-02-03
TRIAL STUDY 134XCP|LB|573C9228-D341-491C-9D66-0D0435E2C631|1||||TRP|TRYPTOPHAN|||||||JDF UNIT|||||||TRACE||MMOL/MIN/KPA||||HIGH|NOT DONE||||SPUTUM|CALCIFIED|U|MRI WITHOUT CONTRAST|CKD-EPI FORMULA||N|Y|Y|NA|||NA|1||38||SCREENING|1971-12-18|1962-01-16|||||1965-12-02||1962-04-07|Y|1969-09-24
TRIAL STUDY 134XCP|LB|573C9228-D341-491C-9D66-0D0435E2C631|2||||NONHDL|NON-HDL CHOLESTEROL|||||||ML/M2/H|||||||BORDERLINE||RATIO||||ABNORMAL|NOT DONE||||SALIVA|FRESH|U|KINYOUN STAIN|FIBROSIS 4 FORMULA||NA|NA|NA|N|||N|1||38||RUN-IN|1969-05-30|1971-04-16|||||1969-01-08||1965-08-02|NA|1966-11-04
TRIAL STUDY 134XCP|LB|573C9228-D341-491C-9D66-0D0435E2C631|1||||MENGL|MENINGEAL CELLS|||||||YEARS|||||||INVALID||/200 HPFS||||ABNORMAL|NOT DONE||||HAIR|LIPEMIC|U|SICKLE CELL SOLUBILITY TEST|CKD-EPI CYSTATIN C FORMULA||Y|U|Y|Y|||U|2||58||INDUCTION TREATMENT|1971-02-15|1961-10-03|||||1962-01-08||1963-04-01|U|1970-07-08
TRIAL STUDY 134XCP|LB|573C9228-D341-491C-9D66-0D0435E2C631|2||||HLZPM|HALAZEPAM|||||||AMFI|||||||INDETERMINATE||%(V/V)||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|Y|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|CKD-EPI CREATININE FORMULA||U|U|U|NA|||U|2||58||BASELINE|1971-01-08|1970-11-17|||||1961-09-17||1960-10-06|N|1965-09-19
TRIAL STUDY 134XCP|LB|573C9228-D341-491C-9D66-0D0435E2C631|1||||MCP1|MONOCYTE CHEMOTACTIC PROTEIN 1|||||||FINGERTIP UNIT|||||||INVALID||U/G HB||||NORMAL|NOT DONE||||PLEURAL FLUID|AGGLUTINATED|U|CELL BASED BIOASSAY|MDRD 4 VARIABLE FORMULA||NA|NA|Y|N|||U|3||39||WASHOUT|1968-03-14|1971-05-10|||||1963-10-31||1964-03-29|U|1972-09-12
TRIAL STUDY 134XCP|LB|573C9228-D341-491C-9D66-0D0435E2C631|2||||PKM1|PYRUVATE KINASE ISOZYME M1|||||||RAD|||||||NEGATIVE||CI||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|CONTAMINATED|N|SECONDARY ION MASS SPECTOMETRY|COCKCROFT-GAULT FORMULA||N|NA|NA|NA|||NA|3||39||OPEN LABEL TREATMENT|1973-07-21|1963-07-16|||||1963-12-15||1964-05-02|NA|1963-07-04
TRIAL STUDY 134XCP|LB|573C9228-D341-491C-9D66-0D0435E2C631|1||||FACTXIA|FACTOR XI ACTIVITY|||||||BQ/MG|||||||BORDERLINE||CIGARETTE||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|GELLED|N|TWO-COLOR MICROARRAY|FIBROMETER FORMULA||NA|U|NA|U|||Y|4||88||FOLLOW-UP|1970-02-25|1966-03-20|||||1971-06-27||1973-07-09|Y|1967-07-31
TRIAL STUDY 134XCP|LB|573C9228-D341-491C-9D66-0D0435E2C631|2||||KERAT|KERATOCYTE|||||||RATIO|||||||INVALID||JDF UNIT||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|CALCIFIED|Y|SINGLE-MOLECULE ARRAY|ASH FIBROSURE FORMULA||U|NA|Y|U|||Y|4||88||INDUCTION TREATMENT|1972-06-18|1969-06-04|||||1972-12-12||1961-11-14|Y|1973-08-03
TRIAL STUDY 134XCP|LB|573C9228-D341-491C-9D66-0D0435E2C631|1||||MONOPTPT|MONOCLONAL PROTEIN/TOTAL PROTEIN|||||||UG/G/MIN|||||||POSITIVE||MEQ/L||||HIGH|NOT DONE||||PERSPIRATION|SOLIDIFIED|N|AUTOREFRACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1967-01-07|1963-04-15|||||1965-10-28||1966-12-02|NA|1965-05-25
TRIAL STUDY 134XCP|LB|573C9228-D341-491C-9D66-0D0435E2C631|2||||FATBODOV|FAT BODIES, OVAL|||||||RAD|||||||TRACE||CCID 50/ML||||LOW|NOT DONE||||SUPERNATANT, PLASMA|CONTAMINATED|NA|COMPUTERIZED CORNEAL TOPOGRAPHY|GMI MMOL/MOL FORMULA||N|Y|N|N|||U|5||7||FOLLOW-UP|1973-08-03|1960-06-28|||||1961-01-01||1968-07-07|NA|1967-02-09
TRIAL STUDY 134XCP|LB|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|1||||CCL7|CHEMOKINE (C-C MOTIF) LIGAND 7|||||||VIRTUAL PIXEL|||||||NEGATIVE||UKAT/10^12 RBC||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|CLOTTED|U|RULER MEASUREMENT METHOD|CKD-EPI FORMULA||N|N|NA|N|||U|1||38||BASELINE|1964-08-05|1972-12-27|||||1966-04-17||1962-06-07|N|1971-06-03
TRIAL STUDY 134XCP|LB|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|2||||PECAM|PLATELET ENDOTHELIAL ADHESION MOLECULE|||||||GPS U|||||||NEGATIVE||LOG10 TCID 50/UL||||LOW|NOT DONE||||EXUDATE|THAWED|N|ANTIMICROBIAL COMBINATION TESTING|ASH FIBROSURE FORMULA||Y|U|U|Y|||NA|1||38||BASELINE|1970-01-21|1961-11-17|||||1962-03-08||1960-10-29|Y|1960-05-29
TRIAL STUDY 134XCP|LB|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|1||||SODMEXR|SODIUM EXCRETION RATE|||||||NMOL/L/MIN|||||||POSITIVE||MOL/L||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|CONTAMINATED|N|CELL BASED BIOASSAY|HEPASCORE FORMULA||N|NA|Y|NA|||U|2||58||OPEN LABEL TREATMENT|1971-03-02|1967-07-12|||||1963-02-07||1971-11-26|NA|1969-04-16
TRIAL STUDY 134XCP|LB|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|2||||CYAMMOX|AMMONIUM OXALATE CRYSTALS|||||||KG/CM|||||||INVALID||TORR||||ABNORMAL|NOT DONE||||HAIR|REFRIGERATED|NA|CONFOCAL MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||NA|NA|Y|NA|||NA|2||58||BLINDED TREATMENT|1964-08-08|1962-06-01|||||1960-10-10||1971-12-01|Y|1971-04-07
TRIAL STUDY 134XCP|LB|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|1||||OCCBLD|OCCULT BLOOD|||||||UG|||||||NEGATIVE||MMOL/KG||||HIGH|NOT DONE||||MUCUS|LIPEMIC|N|POPULATION SEQUENCING|MDRD ENZYMATIC FORMULA||Y|N|U|NA|||N|3||39||INDUCTION TREATMENT|1961-01-12|1963-07-04|||||1966-12-22||1964-04-11|N|1967-07-09
TRIAL STUDY 134XCP|LB|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|2||||RESISTIN|RESISTIN|||||||MMHG|||||||BORDERLINE||%(V/V)||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|CLOTTED|NA|OLIGO ACGH|CKD-EPI FORMULA||N|Y|NA|NA|||N|3||39||OPEN LABEL TREATMENT|1964-10-25|1960-10-16|||||1960-08-25||1967-10-28|Y|1967-04-08
TRIAL STUDY 134XCP|LB|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|1||||FPP|PROTOPORPHYRIN, FREE|||||||ML/(MIN*100ML)|||||||INDETERMINATE||10^9/G||||NORMAL|NOT DONE||||LUNG SURFACTANT|GELLED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD 6 VARIABLE FORMULA||Y|Y|U|Y|||Y|4||88||OPEN LABEL TREATMENT|1964-09-23|1961-08-03|||||1970-07-07||1968-03-04|N|1966-11-06
TRIAL STUDY 134XCP|LB|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|2||||EPINEXR|EPINEPHRINE EXCRETION RATE|||||||10^9/G|||||||BORDERLINE||GRAVITATIONAL UNIT||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|AUTOLYZED|Y|NEXT GENERATION TARGETED SEQUENCING|MDRD 5 VARIABLE FORMULA||U|N|U|Y|||U|4||88||OBSERVATION|1961-04-04|1962-07-20|||||1962-08-16||1969-06-12|U|1960-03-07
TRIAL STUDY 134XCP|LB|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|1||||ALDOLASE|ALDOLASE|||||||MMU/ML|||||||INVALID||UV||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|N|NEURAMINIDASE INHIBITION ASSAY|FIBROSIS 4 FORMULA||U|NA|NA|U|||U|5||7||RUN-IN|1968-12-13|1965-12-08|||||1972-08-02||1970-05-15|U|1966-11-05
TRIAL STUDY 134XCP|LB|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|2||||PHADJT|PH ADJUSTED FOR BODY TEMP|||||||MG/M2/DAY|||||||TRACE||DEG||||HIGH|NOT DONE||||SPERMATOZOON|FRESH|Y|WHOLE EXOME SEQUENCING|MDRD 6 VARIABLE FORMULA||NA|N|U|U|||Y|5||7||RUN-IN|1961-10-17|1967-05-29|||||1967-05-01||1963-04-30|U|1970-12-19
TRIAL STUDY 134XCP|LB|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|1||||PC3MPSAM|PCA3 MRNA/PSA MRNA|||||||DAGU/ML|||||||NEGATIVE||FL||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|NA|Y|||U|1||38||RUN-IN|1971-08-25|1968-08-07|||||1968-05-18||1969-01-18|N|1970-12-02
TRIAL STUDY 134XCP|LB|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|2||||CA1AG|CANCER ANTIGEN 1|||||||GTT|||||||POSITIVE||U/CL||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|SOLIDIFIED|Y|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|NA|NA|||NA|1||38||FOLLOW-UP|1969-06-14|1970-06-18|||||1973-04-19||1972-08-04|N|1961-03-22
TRIAL STUDY 134XCP|LB|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|1||||ETPTPR|ETP TIME TO PEAK RELATIVE|||||||DEG/S|||||||TRACE||MU/L||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|GELLED|NA|DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI FORMULA||Y|U|Y|N|||U|2||58||BASELINE|1966-11-21|1961-09-10|||||1968-07-04||1969-08-06|U|1960-09-28
TRIAL STUDY 134XCP|LB|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|2||||RH|RH FACTOR|||||||DNA COPIES/ML|||||||BORDERLINE||SQU/ML||||LOW|NOT DONE||||MUCUS|ROOM TEMPERATURE|NA|WESTERN BLOT|CKD-EPI CREATININE FORMULA||N|N|U|U|||Y|2||58||RUN-IN|1962-04-25|1968-12-06|||||1970-12-11||1969-02-21|U|1965-01-05
TRIAL STUDY 134XCP|LB|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|1||||PGAG|PLATELET-GRANULOCYTE AGG|||||||UG/KG/H|||||||BORDERLINE||UMOL/L/SEC||||HIGH|NOT DONE||||ERYTHROCYTES|ICTERIC|Y|TURBIDIMETRY|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|NA|||Y|3||39||INDUCTION TREATMENT|1969-12-22|1962-10-19|||||1965-12-25||1969-12-25|NA|1966-01-23
TRIAL STUDY 134XCP|LB|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|2||||CCK|CHOLECYSTOKININ|||||||BAR|||||||POSITIVE||ML/KG/H||||HIGH|NOT DONE||||DERMAL TISSUE|FRESH|Y|AMSLER GRID|MDRD ENZYMATIC JAPANESE FORMULA||N|N|U|Y|||U|3||39||OPEN LABEL TREATMENT|1964-05-07|1969-03-24|||||1972-12-22||1967-12-30|U|1967-09-05
TRIAL STUDY 134XCP|LB|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|1||||UROBIL|UROBILINOGEN|||||||KS|||||||BORDERLINE||/H||||HIGH|NOT DONE||||EPIDERMAL TISSUE|UNEXPECTED ODOR|U|MANUAL CLOT DETECTION|MDRD ENZYMATIC JAPANESE FORMULA||U|N|N|N|||N|4||88||TREATMENT|1967-02-14|1973-01-27|||||1964-02-17||1967-11-18|U|1971-04-21
TRIAL STUDY 134XCP|LB|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|2||||THEOPHYL|THEOPHYLLINE|||||||PG/DL|||||||TRACE||ML/KG||||ABNORMAL|NOT DONE||||SKIN TISSUE|ICTERIC|N|ERGOSPIROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|Y|N|||NA|4||88||WASHOUT|1963-11-20|1972-05-20|||||1964-08-16||1965-08-29|Y|1963-03-24
TRIAL STUDY 134XCP|LB|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|1||||APTTLAS|LUPUS ANTICOAGULANT SENSITIVE APTT|||||||ML/ANIMAL/DAY|||||||INDETERMINATE||MG/H||||ABNORMAL|NOT DONE||||BILE|GELLED|NA|CONTRAST ENHANCED SPIRAL CT SCAN|ASH FIBROSURE FORMULA||N|N|Y|U|||U|5||7||WASHOUT|1973-04-28|1961-10-30|||||1969-02-21||1968-08-23|U|1963-08-15
TRIAL STUDY 134XCP|LB|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|2||||GLP1IAC|GLUCAGON-LIKE PEPTIDE-1, INACTIVE FORM|||||||BU|||||||INDETERMINATE||MOL/MG||||NORMAL|NOT DONE||||SYNOVIAL FLUID|HEMOLYZED|Y|DYNAMOMETRY|CKD-EPI CREATININE FORMULA||NA|NA|N|N|||U|5||7||OBSERVATION|1962-08-14|1973-05-08|||||1969-12-01||1966-03-04|NA|1960-08-05
TRIAL STUDY 134XCP|LB|61C75130-5C1A-4B8D-804C-92D3288B55D2|1||||BLYCELE|B-LYMPHOCYTES/LEUKOCYTES|||||||IU/ML|||||||NEGATIVE||NMOL||||ABNORMAL|NOT DONE||||CORD BLOOD|LIPEMIC|NA|IN SITU HYBRIDIZATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|NA|U|||Y|1||38||BASELINE|1972-04-27|1963-03-05|||||1963-12-30||1970-08-03|U|1966-07-15
TRIAL STUDY 134XCP|LB|61C75130-5C1A-4B8D-804C-92D3288B55D2|2||||PTAC|PROTHROMBIN TIME ACTUAL/CONTROL|||||||MV*MIN|||||||INDETERMINATE||TUBERCULIN UNIT/ML||||ABNORMAL|NOT DONE||||SEBUM|CLOTTED|Y|GEL ELECTROPHORESIS|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|Y|||U|1||38||FOLLOW-UP|1966-08-24|1963-09-29|||||1973-06-27||1967-09-19|N|1968-10-26
TRIAL STUDY 134XCP|LB|61C75130-5C1A-4B8D-804C-92D3288B55D2|1||||HYPRLN|HYDROXYPROLINE|||||||10^4 CFU/ML|||||||POSITIVE||L/MIN/M2||||HIGH|NOT DONE||||VITREOUS HUMOR|PARAFFIN-EMBEDDED|U|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD FORMULA||NA|N|NA|U|||NA|2||58||OPEN LABEL TREATMENT|1961-05-24|1964-10-21|||||1966-07-05||1963-01-06|NA|1972-07-12
TRIAL STUDY 134XCP|LB|61C75130-5C1A-4B8D-804C-92D3288B55D2|2||||KRCYMGCE|MEGAKARYOCYTES/TOTAL CELLS|||||||MG/H|||||||NEGATIVE||TESLA||||NORMAL|NOT DONE||||SYNOVIAL FLUID|LACTESCENT|NA|MALDI-TOF|GMI MMOL/MOL FORMULA||N|N|Y|Y|||N|2||58||LONG-TERM FOLLOW-UP|1964-08-26|1963-07-16|||||1971-06-11||1968-10-19|Y|1966-11-28
TRIAL STUDY 134XCP|LB|61C75130-5C1A-4B8D-804C-92D3288B55D2|1||||C165917|D. PTERONYSSINUS IGG AB RAST SCORE|||||||EP U|||||||BORDERLINE||BOTTLE||||ABNORMAL|NOT DONE||||TUMOR TISSUE|ROOM TEMPERATURE|U|ELECTRONEUROGRAPHY|FIBROTEST FORMULA||Y|N|N|NA|||NA|3||39||CONTINUATION TREATMENT|1964-10-17|1970-01-30|||||1961-09-17||1961-04-18|NA|1966-03-04
TRIAL STUDY 134XCP|LB|61C75130-5C1A-4B8D-804C-92D3288B55D2|2||||CYSTARCH|STARCH CRYSTALS|||||||EIA UNIT|||||||POSITIVE||KA_U/DL||||ABNORMAL|NOT DONE||||KERATINOCYTE|CONCENTRATED|NA|LC/MS|FIBROSIS 4 FORMULA||U|U|N|Y|||U|3||39||SCREENING|1962-09-06|1964-11-24|||||1964-10-27||1966-06-10|U|1971-05-09
TRIAL STUDY 134XCP|LB|61C75130-5C1A-4B8D-804C-92D3288B55D2|1||||UREANCRT|UREA NITROGEN/CREATININE|||||||KG/M2|||||||POSITIVE||UG/M2/DAY||||HIGH|NOT DONE||||LUNG SURFACTANT|LACTESCENT|NA|TRIPLE-PHASE SPIRAL CT SCAN|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|U|||U|4||88||OPEN LABEL TREATMENT|1961-01-20|1962-05-02|||||1960-01-05||1962-12-24|N|1960-11-07
TRIAL STUDY 134XCP|LB|61C75130-5C1A-4B8D-804C-92D3288B55D2|2||||CSGRANF|GRANULAR FINE CASTS|||||||OZ EQ|||||||INVALID||FINGERTIP UNIT||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|LIPEMIC|NA|PHOTOMETRIC CLOT DETECTION|MDRD ENZYMATIC FORMULA||Y|NA|Y|N|||N|4||88||INDUCTION TREATMENT|1966-10-22|1960-01-25|||||1968-12-20||1966-06-22|Y|1973-04-23
TRIAL STUDY 134XCP|LB|61C75130-5C1A-4B8D-804C-92D3288B55D2|1||||CSWBC|WBC CASTS|||||||UG/KG/MIN|||||||INDETERMINATE||U/MG||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|HEMOLYZED|Y|COLORIMETRY|MDRD 5 VARIABLE FORMULA||NA|Y|NA|NA|||U|5||7||LONG-TERM FOLLOW-UP|1971-10-31|1964-05-02|||||1965-09-16||1971-11-09|U|1973-08-08
TRIAL STUDY 134XCP|LB|61C75130-5C1A-4B8D-804C-92D3288B55D2|2||||C165924|GRASS MIX POLLEN IGE AB RAST SCORE|||||||MPL U/ML|||||||TRACE||MMHG||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|AGGLUTINATED|N|ENDOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|NA|N|||N|5||7||LONG-TERM FOLLOW-UP|1970-12-21|1961-04-27|||||1973-04-07||1972-02-22|N|1972-06-08
TRIAL STUDY 134XCP|LB|90AFB57A-125C-4C08-AE92-061F66FC2DAC|1||||A1AGLP|ALPHA-1 ACID GLYCOPROTEIN|||||||10^5/L|||||||TRACE||SCM||||NORMAL|NOT DONE||||PUS|CALCIFIED|U|PHOTOMETRY|FIBROMETER FORMULA||N|N|Y|NA|||U|1||38||CONTINUATION TREATMENT|1968-12-01|1968-06-15|||||1971-10-03||1964-02-22|U|1969-05-26
TRIAL STUDY 134XCP|LB|90AFB57A-125C-4C08-AE92-061F66FC2DAC|2||||ACH|ACETYLCHOLINE|||||||MET*H|||||||INDETERMINATE||NEBULE||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|NA|NUCLEIC ACID AMPLIFICATION TEST|NASH FIBROSURE FORMULA||Y|N|Y|U|||U|1||38||LONG-TERM FOLLOW-UP|1971-02-26|1966-09-30|||||1969-09-06||1960-07-16|Y|1972-03-13
TRIAL STUDY 134XCP|LB|90AFB57A-125C-4C08-AE92-061F66FC2DAC|1||||TESTOS|TESTOSTERONE|||||||MMHG/L/MIN|||||||BORDERLINE||HOUNSFIELD UNIT||||HIGH|NOT DONE||||VITREOUS HUMOR|AUTOLYZED|N|MICROPARTICLE ENZYME IMMUNOASSAY|MDRD FORMULA||N|U|Y|Y|||U|2||58||BLINDED TREATMENT|1960-02-13|1965-04-04|||||1972-04-25||1970-12-21|U|1973-02-20
TRIAL STUDY 134XCP|LB|90AFB57A-125C-4C08-AE92-061F66FC2DAC|2||||T3UP|TRIIODOTHYRONINE UPTAKE|||||||ML/ANIMAL|||||||POSITIVE||BOTTLE||||HIGH|NOT DONE||||PERITONEAL FLUID|CONCENTRATED|U|CONTRAST ENHANCED PET SCAN|GMI MMOL/MOL FORMULA||U|Y|NA|U|||N|2||58||OPEN LABEL TREATMENT|1971-04-29|1963-03-15|||||1967-08-07||1962-02-15|U|1971-12-29
TRIAL STUDY 134XCP|LB|90AFB57A-125C-4C08-AE92-061F66FC2DAC|1||||BTLBTL|BUTALBITAL|||||||FRAMES/S|||||||BORDERLINE||FIU||||LOW|NOT DONE||||CERUMEN|AUTOLYZED|U|DUKE INCISION METHOD|ASH FIBROSURE FORMULA||N|Y|NA|Y|||Y|3||39||OPEN LABEL TREATMENT|1969-11-07|1964-07-09|||||1963-09-30||1964-06-30|Y|1967-08-18
TRIAL STUDY 134XCP|LB|90AFB57A-125C-4C08-AE92-061F66FC2DAC|2||||CARBXHGB|CARBOXYHEMOGLOBIN|||||||/MM|||||||TRACE||10^3/L||||ABNORMAL|NOT DONE||||CELL PELLET|CONTAMINATED|U|JAFFE REACTION|MDRD ENZYMATIC FORMULA||U|NA|N|Y|||Y|3||39||BLINDED TREATMENT|1967-03-20|1964-05-25|||||1960-04-22||1966-03-15|N|1969-12-12
TRIAL STUDY 134XCP|LB|90AFB57A-125C-4C08-AE92-061F66FC2DAC|1||||ANGLOBDR|ANTIGLOBULIN TEST, DIRECT|||||||MG/KG/DAY|||||||POSITIVE||10^7 TCID 50/DOSE||||NORMAL|NOT DONE||||EMOTIONAL TEAR|CONTAMINATED|NA|RYAN BLUE STAIN|MDRD 4 VARIABLE FORMULA||NA|Y|N|Y|||N|4||88||OPEN LABEL TREATMENT|1963-02-20|1965-11-27|||||1962-04-23||1963-03-09|NA|1962-04-08
TRIAL STUDY 134XCP|LB|90AFB57A-125C-4C08-AE92-061F66FC2DAC|2||||AUERRODS|AUER RODS|||||||UG/G/DAY|||||||INDETERMINATE||IU/MMOL||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|REFRIGERATED|N|RIA|NASH FIBROSURE FORMULA||U|Y|NA|NA|||U|4||88||BASELINE|1972-07-13|1963-12-12|||||1973-02-15||1968-02-15|NA|1969-07-24
TRIAL STUDY 134XCP|LB|90AFB57A-125C-4C08-AE92-061F66FC2DAC|1||||CYSTATC|CYSTATIN C|||||||10^9 ORGANISMS/MG|||||||TRACE||GENEQ||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|THAWED|U|WEBER GREEN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|Y|U|||N|5||7||CONTINUATION TREATMENT|1961-11-10|1966-09-18|||||1964-05-16||1972-01-14|U|1970-08-24
TRIAL STUDY 134XCP|LB|90AFB57A-125C-4C08-AE92-061F66FC2DAC|2||||NRDZPM|NORDAZEPAM|||||||ELISA UNIT|||||||TRACE||ML/MIN||||LOW|NOT DONE||||GASTRIC FLUID|SOLIDIFIED|N|TWO-COLOR MICROARRAY|CKD-EPI FORMULA||Y|U|NA|U|||N|5||7||OBSERVATION|1973-06-30|1965-05-14|||||1963-07-31||1964-07-23|NA|1973-01-09
TRIAL STUDY 134XCP|LB|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|1||||GRANULIN|GRANULIN|||||||/KG|||||||NEGATIVE||COAT||||LOW|NOT DONE||||SEMINAL FLUID|CONCENTRATED|Y|TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|Y|U|U|||N|1||38||SCREENING|1968-06-09|1967-03-30|||||1970-02-26||1960-07-22|U|1970-10-26
TRIAL STUDY 134XCP|LB|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|2||||NITRATE|NITRATE|||||||ML/MMHG/MIN/L|||||||INVALID||PKAT/L||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|NA|DYNAMOMETRY|HEPASCORE FORMULA||N|Y|Y|NA|||N|1||38||OPEN LABEL TREATMENT|1962-01-28|1964-07-22|||||1965-01-02||1966-07-11|NA|1973-08-26
TRIAL STUDY 134XCP|LB|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|1||||CD23|CD23|||||||IU/ML|||||||NEGATIVE||BU||||NORMAL|NOT DONE||||DISCHARGE|LIPEMIC|NA|INCISION-INDUCED BLEEDING METHOD|CKD-EPI CREATININE FORMULA||Y|U|U|U|||U|2||58||SCREENING|1970-10-10|1972-11-05|||||1970-06-27||1969-03-21|N|1963-03-07
TRIAL STUDY 134XCP|LB|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|2||||PLTAGAMP|PLATELET AGGREGATION AMPLITUDE|||||||ML/MIN/1.73M2|||||||INDETERMINATE||UOSM||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|LIPEMIC|NA|CT SCAN|MDRD 6 VARIABLE FORMULA||N|Y|Y|U|||U|2||58||RUN-IN|1964-07-02|1964-07-15|||||1973-01-03||1962-08-17|NA|1968-09-09
TRIAL STUDY 134XCP|LB|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|1||||HASIGMAB|HUMAN ANTI-SHEEP IGM ANTIBODY|||||||CI/G|||||||INDETERMINATE||10^6 IU||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|AUTOLYZED|U|LC-FL|MDRD FORMULA||N|U|Y|N|||U|3||39||TREATMENT|1965-01-26|1963-09-11|||||1966-06-13||1964-12-18|Y|1963-03-04
TRIAL STUDY 134XCP|LB|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|2||||GLOBB1BP|BETA-1 GLOBULIN/BETA PROTEIN|||||||100 IU/ML|||||||BORDERLINE||MG/KG||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|CALCIFIED|NA|SPIROMETRY|MDRD 5 VARIABLE FORMULA||Y|N|U|U|||NA|3||39||OBSERVATION|1969-02-02|1968-01-24|||||1960-01-03||1964-09-21|N|1962-02-02
TRIAL STUDY 134XCP|LB|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|1||||SPHERO|SPHEROCYTES|||||||/200 HPFS|||||||BORDERLINE||UMOL/L/SEC||||NORMAL|NOT DONE||||RETICULOCYTES|SOLIDIFIED|N|MRS|GMI % FORMULA||N|Y|Y|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1964-07-01|1966-04-05|||||1966-05-22||1961-04-02|NA|1966-02-09
TRIAL STUDY 134XCP|LB|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|2||||G6PD|GLUCOSE-6-PHOSPHATE DEHYDROGENASE|||||||KCAL/DAY|||||||NEGATIVE||U/G HB||||HIGH|NOT DONE||||SMEGMA|AUTOLYZED|NA|DIPSTICK|CKD-EPI FORMULA||Y|U|NA|U|||N|4||88||WASHOUT|1968-09-02|1972-03-03|||||1962-03-18||1966-09-16|U|1968-09-12
TRIAL STUDY 134XCP|LB|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|1||||HALPRZLM|HYDROXYALPRAZOLAM|||||||FIU|||||||POSITIVE||10^4 CFU/ML||||HIGH|NOT DONE||||EMESIS|HEMOLYZED|N|SINGLE-MOLECULE ARRAY|MDRD 6 VARIABLE FORMULA||U|U|U|U|||U|5||7||WASHOUT|1966-01-15|1963-04-02|||||1972-01-06||1966-05-05|U|1968-08-07
TRIAL STUDY 134XCP|LB|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|2||||SAHOMC|S-ADENOSYLHOMOCYSTEINE|||||||10^9 ORGANISMS/G|||||||TRACE||ML/M2||||NORMAL|NOT DONE||||FLUID|GELLED|N|CLINICAL EVALUATION|FIBROMETER FORMULA||N|N|NA|N|||U|5||7||RUN-IN|1970-12-11|1970-07-05|||||1971-08-19||1960-01-30|NA|1962-04-14
TRIAL STUDY 134XCP|LB|01A42FAE-1EE2-4203-A62E-E368F31434F7|1||||LDLPSZ|LDL PARTICLE SIZE|||||||/MM2|||||||INVALID||M/SEC||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|PARAFFIN-EMBEDDED|U|X-RAY|ASH FIBROSURE FORMULA||U|NA|N|NA|||NA|1||38||CONTINUATION TREATMENT|1970-10-28|1968-08-24|||||1966-10-28||1967-02-03|Y|1963-06-24
TRIAL STUDY 134XCP|LB|01A42FAE-1EE2-4203-A62E-E368F31434F7|2||||EPO|ERYTHROPOIETIN|||||||ML/KG|||||||INDETERMINATE||100 IU/ML||||LOW|NOT DONE||||STOOL|FRESH|Y|CRYOSCOPY|MDRD 6 VARIABLE FORMULA||Y|Y|N|N|||N|1||38||RUN-IN|1967-02-15|1969-07-03|||||1960-08-18||1968-05-13|N|1970-09-16
TRIAL STUDY 134XCP|LB|01A42FAE-1EE2-4203-A62E-E368F31434F7|1||||VTD2D3IT|25-HYDROXYVIT D2 + 25-HYDROXYVIT D3|||||||UEQ|||||||INDETERMINATE||S/H||||ABNORMAL|NOT DONE||||KERATINOCYTE|SOLIDIFIED|N|ERGOSPIROMETRY|NASH FIBROSURE FORMULA||U|N|N|NA|||NA|2||58||BLINDED TREATMENT|1965-05-30|1960-11-27|||||1965-06-18||1960-07-29|N|1972-10-15
TRIAL STUDY 134XCP|LB|01A42FAE-1EE2-4203-A62E-E368F31434F7|2||||IGHG2|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 2|||||||TITER|||||||TRACE||BAG||||LOW|NOT DONE||||SPERMATOZOON|THAWED|NA|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|GMI MMOL/MOL FORMULA||N|NA|NA|Y|||NA|2||58||RUN-IN|1971-10-12|1971-05-29|||||1967-10-18||1963-12-04|NA|1972-04-28
TRIAL STUDY 134XCP|LB|01A42FAE-1EE2-4203-A62E-E368F31434F7|1||||FACTXII|FACTOR XII|||||||G/ANIMAL/DAY|||||||TRACE||JAR||||LOW|NOT DONE||||VENOUS PLASMA|AUTOLYZED|N|IMPEDANCE CONDUCTIVITY|FIBROTEST FORMULA||Y|N|Y|N|||U|3||39||RUN-IN|1970-03-29|1971-04-21|||||1969-01-15||1963-12-24|U|1963-05-26
TRIAL STUDY 134XCP|LB|01A42FAE-1EE2-4203-A62E-E368F31434F7|2||||HAPTOG|HAPTOGLOBIN|||||||UMOL/H/MMOL|||||||TRACE||CM||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|THAWED|Y|CARDIAC THERMODILUTION|CKD-EPI FORMULA||NA|Y|N|N|||Y|3||39||SCREENING|1969-04-30|1967-06-20|||||1965-10-12||1971-11-06|N|1966-02-10
TRIAL STUDY 134XCP|LB|01A42FAE-1EE2-4203-A62E-E368F31434F7|1||||LYMPHOID|LYMPHOID CELLS|||||||L/S|||||||NEGATIVE||DIP||||LOW|NOT DONE||||PLEURAL TISSUE|REFRIGERATED|U|SPIRAL CT SCAN WITHOUT CONTRAST|MDRD FORMULA||N|U|NA|U|||NA|4||88||BLINDED TREATMENT|1962-01-18|1962-07-17|||||1961-11-02||1972-08-03|NA|1972-04-15
TRIAL STUDY 134XCP|LB|01A42FAE-1EE2-4203-A62E-E368F31434F7|2||||LDL|LDL CHOLESTEROL|||||||FT|||||||TRACE||KM||||HIGH|NOT DONE||||BONE MARROW|REFRIGERATED|U|DNA MICROARRAY|CKD-EPI CREATININE FORMULA||N|N|Y|N|||NA|4||88||RUN-IN|1962-11-16|1965-09-03|||||1961-08-12||1973-02-05|Y|1973-02-02
TRIAL STUDY 134XCP|LB|01A42FAE-1EE2-4203-A62E-E368F31434F7|1||||HYDMDZ1|1-HYDROXYMIDAZOLAM|||||||ML/CAGE|||||||POSITIVE||ANTIBODY UNIT||||NORMAL|NOT DONE||||SEMINAL FLUID|CONTAMINATED|U|AMSLER GRID|CKD-EPI FORMULA||NA|Y|Y|Y|||U|5||7||OPEN LABEL TREATMENT|1973-01-24|1968-03-05|||||1968-06-30||1961-01-23|NA|1970-01-23
TRIAL STUDY 134XCP|LB|01A42FAE-1EE2-4203-A62E-E368F31434F7|2||||PRORUB|PRORUBRICYTE|||||||KG/CM2|||||||BORDERLINE||/100 HPFS||||HIGH|NOT DONE||||CAPILLARY PLASMA|LIPEMIC|U|PALM METHOD|MDRD ENZYMATIC FORMULA||U|NA|N|Y|||U|5||7||FOLLOW-UP|1970-06-11|1960-12-02|||||1965-11-17||1970-11-10|Y|1972-05-11
TRIAL STUDY 134XCP|LB|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|1||||METHQLDN|METHAQUALONE|||||||WAFER|||||||TRACE||G/U||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|HEMOLYZED|U|RADIOIMMUNOPRECIPITATION ASSAY|GMI % FORMULA||Y|N|U|Y|||N|1||38||INDUCTION TREATMENT|1963-11-01|1967-01-11|||||1960-08-11||1966-12-19|Y|1961-05-18
TRIAL STUDY 134XCP|LB|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|2||||COCAM|COCAINE METABOLITES|||||||10^4/L|||||||INVALID||ML/BREATH||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|ICTERIC|U|PEAK FLOWMETRY|MDRD 4 VARIABLE FORMULA||Y|U|U|NA|||NA|1||38||WASHOUT|1967-08-23|1971-08-22|||||1961-08-31||1966-11-11|N|1970-03-27
TRIAL STUDY 134XCP|LB|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|1||||BCMAS|SOLUBLE B CELL MATURATION ANTIGEN|||||||TSP|||||||NEGATIVE||GENEQ||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FRESH|Y|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|NA|NA|||U|2||58||SCREENING|1962-12-26|1960-11-04|||||1961-08-27||1969-12-30|NA|1960-05-30
TRIAL STUDY 134XCP|LB|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|2||||AAP|ALANINE AMINOPEPTIDASE|||||||PFU|||||||NEGATIVE||%/MIN||||NORMAL|NOT DONE||||VENOUS PLASMA|HEMOLYZED|NA|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|COCKCROFT-GAULT FORMULA||Y|NA|U|NA|||U|2||58||BLINDED TREATMENT|1961-12-15|1964-04-03|||||1967-09-14||1973-03-12|N|1970-04-30
TRIAL STUDY 134XCP|LB|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|1||||EPINSQCE|NON-SQUAMOUS EPITHELIAL CELLS|||||||DPM/ML|||||||NEGATIVE||MG/L FEU||||HIGH|NOT DONE||||PROSTATIC FLUID|UNEXPECTED ODOR|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA||N|NA|NA|N|||N|3||39||FOLLOW-UP|1963-01-06|1968-12-18|||||1971-09-19||1969-09-06|U|1964-10-07
TRIAL STUDY 134XCP|LB|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|2||||LYMCE|LYMPHOCYTES/TOTAL CELLS|||||||MG/G/H|||||||INDETERMINATE||CUP||||LOW|NOT DONE||||ARTERIAL BLOOD|FROZEN|NA|PHASE CONTRAST MICROSCOPY|CKD-EPI FORMULA||N|U|Y|NA|||Y|3||39||OPEN LABEL TREATMENT|1962-02-09|1964-07-25|||||1964-07-04||1965-11-28|NA|1963-10-27
TRIAL STUDY 134XCP|LB|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|1||||EOS|EOSINOPHILS|||||||MEQ/UL|||||||NEGATIVE||FT||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONTAMINATED|Y|TRICHROME STAIN|MDRD 5 VARIABLE FORMULA||Y|N|U|Y|||NA|4||88||BLINDED TREATMENT|1969-08-04|1962-09-15|||||1971-11-01||1967-01-06|NA|1968-05-29
TRIAL STUDY 134XCP|LB|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|2||||ELA2|NEUTROPHIL ELASTASE|||||||10^9 CFU/ML|||||||NEGATIVE||KALLIKREIN INHIBITOR UNIT||||NORMAL|NOT DONE||||VENOUS BLOOD|CONTAMINATED|NA|TRANSMISSION ELECTRON MICROSCOPY|MDRD 6 VARIABLE FORMULA||Y|NA|Y|NA|||U|4||88||OPEN LABEL TREATMENT|1966-01-13|1960-07-24|||||1961-05-27||1965-06-17|U|1963-02-01
TRIAL STUDY 134XCP|LB|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|1||||RHD|RHD FACTOR|||||||EJACULATE U|||||||TRACE||BLOCKS||||NORMAL|NOT DONE||||ARTERIAL BLOOD|PARAFFIN-EMBEDDED|Y|SPECT SCAN|GMI % FORMULA||N|Y|N|N|||Y|5||7||WASHOUT|1963-11-06|1966-01-29|||||1968-12-10||1960-09-18|NA|1972-07-27
TRIAL STUDY 134XCP|LB|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|2||||C3M|COLLAGEN III NEO-PEPTIDE C3M|||||||MDFI|||||||BORDERLINE||PPTR||||HIGH|NOT DONE||||EMOTIONAL TEAR|GELLED|U|SPIROMETRY|FIBROMETER FORMULA||Y|U|Y|U|||N|5||7||INDUCTION TREATMENT|1973-04-11|1965-09-24|||||1960-06-14||1967-08-08|N|1960-09-27
TRIAL STUDY 134XCP|LB|92232C8B-0D28-4E2A-AA56-BA938429CCBF|1||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||KPA/L/SEC|||||||NEGATIVE||GBQ/G||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR|U|POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||U|Y|Y|NA|||U|1||38||LONG-TERM FOLLOW-UP|1967-12-27|1965-01-16|||||1972-03-07||1970-04-14|N|1970-05-14
TRIAL STUDY 134XCP|LB|92232C8B-0D28-4E2A-AA56-BA938429CCBF|2||||VTRNCTN|VITRONECTIN|||||||MOSM/KG|||||||INVALID||TSP||||ABNORMAL|NOT DONE||||HAIR|LACTESCENT|Y|CINEANGIOGRAPHY|CKD-EPI FORMULA||N|N|NA|NA|||NA|1||38||OBSERVATION|1971-09-15|1965-03-31|||||1960-12-15||1971-12-02|N|1965-10-31
TRIAL STUDY 134XCP|LB|92232C8B-0D28-4E2A-AA56-BA938429CCBF|1||||CASTS|CASTS|||||||U.CARR|||||||INDETERMINATE||UG/ANIMAL||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|CALCIFIED|Y|COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI FORMULA||NA|N|N|N|||NA|2||58||OBSERVATION|1966-02-12|1966-05-25|||||1971-10-06||1964-10-25|Y|1972-05-24
TRIAL STUDY 134XCP|LB|92232C8B-0D28-4E2A-AA56-BA938429CCBF|2||||GASTRIN|GASTRIN|||||||CARTRIDGE|||||||BORDERLINE||DAGU||||ABNORMAL|NOT DONE||||EXUDATE|PARAFFIN-EMBEDDED|U|LANDOLT RING|MDRD ENZYMATIC JAPANESE FORMULA||U|N|U|Y|||U|2||58||INDUCTION TREATMENT|1961-08-15|1965-07-20|||||1965-03-08||1970-10-11|N|1960-11-03
TRIAL STUDY 134XCP|LB|92232C8B-0D28-4E2A-AA56-BA938429CCBF|1||||CYDCPHOS|DICALCIUM PHOSPHATE CRYSTALS|||||||BQ/G|||||||INVALID||MCI/L||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|CONTAMINATED|Y|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROMETER FORMULA||NA|Y|N|U|||NA|3||39||BLINDED TREATMENT|1968-05-13|1968-04-08|||||1964-07-10||1966-02-06|Y|1965-02-11
TRIAL STUDY 134XCP|LB|92232C8B-0D28-4E2A-AA56-BA938429CCBF|2||||CRTCLRBS|CREATININE CLEARANCE ADJUSTED FOR BSA|||||||NMOL/MOL|||||||BORDERLINE||ML/DAY||||HIGH|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|U|NEURAMINIDASE INHIBITION ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|U|||U|3||39||WASHOUT|1961-11-27|1970-11-05|||||1971-06-26||1963-04-13|N|1962-10-05
TRIAL STUDY 134XCP|LB|92232C8B-0D28-4E2A-AA56-BA938429CCBF|1||||ERCEMPOL|ERYTHROID MATURATION POOL|||||||GBQ/G|||||||POSITIVE||MET||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONTAMINATED|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|Y|||NA|4||88||SCREENING|1968-06-27|1965-04-05|||||1969-03-01||1963-10-14|NA|1964-07-31
TRIAL STUDY 134XCP|LB|92232C8B-0D28-4E2A-AA56-BA938429CCBF|2||||LYMMCELE|LYMPHOMA CELLS/LEUKOCYTES|||||||/5X10^4 WBC|||||||TRACE||10^6 IU||||ABNORMAL|NOT DONE||||EXPIRED AIR|DRIED|NA|CARDIAC THERMODILUTION|FIBROTEST FORMULA||N|U|N|NA|||U|4||88||FOLLOW-UP|1966-10-21|1960-12-25|||||1971-09-27||1967-12-13|Y|1966-03-02
TRIAL STUDY 134XCP|LB|92232C8B-0D28-4E2A-AA56-BA938429CCBF|1||||CYAMPURT|AMORPHOUS URATE CRYSTALS|||||||G/M2/DAY|||||||NEGATIVE||%||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED|U|KINETIC MICROPARTICLE IMMUNOASSAY|GMI MMOL/MOL FORMULA||NA|N|U|N|||N|5||7||SCREENING|1969-08-23|1973-07-24|||||1968-08-26||1960-04-26|NA|1968-11-02
TRIAL STUDY 134XCP|LB|92232C8B-0D28-4E2A-AA56-BA938429CCBF|2||||CXCL4|CHEMOKINE (C-X-C MOTIF) LIGAND 4|||||||10^9 ORGANISMS/G|||||||NEGATIVE||U/ML||||HIGH|NOT DONE||||PLATELET|UNEXPECTED ODOR|N|FLUORESCENT ENZYME IMMUNOASSAY|MDRD ENZYMATIC FORMULA||U|Y|NA|Y|||NA|5||7||BLINDED TREATMENT|1961-08-01|1970-10-19|||||1965-11-11||1966-02-11|N|1961-08-23
TRIAL STUDY 134XCP|LB|F4F12AAA-E825-45D7-B414-A06F2D20381A|1||||CD40|CD40|||||||10^6/EJACULATE U|||||||BORDERLINE||USEC||||LOW|NOT DONE||||SEMINAL FLUID|LIPEMIC|NA|CLAUSS METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|Y|NA|||N|1||38||CONTINUATION TREATMENT|1969-10-29|1964-07-30|||||1962-09-04||1973-03-22|Y|1967-07-03
TRIAL STUDY 134XCP|LB|F4F12AAA-E825-45D7-B414-A06F2D20381A|2||||DFI|DNA FRAGMENTATION INDEX|||||||G/CM2|||||||INDETERMINATE||MEQ/G||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|AUTOLYZED|N|MICROBIAL CONCENTRATION|GMI MMOL/MOL FORMULA||NA|Y|Y|NA|||Y|1||38||RUN-IN|1963-11-18|1963-11-28|||||1970-12-06||1961-07-23|NA|1965-06-12
TRIAL STUDY 134XCP|LB|F4F12AAA-E825-45D7-B414-A06F2D20381A|1||||SARCOSIN|SARCOSINE|||||||USP U|||||||INVALID||IMPLANT||||ABNORMAL|NOT DONE||||HAIR|REFRIGERATED|U|IMMUNOFIXATION ELECTROPHORESIS|MDRD FORMULA||NA|N|N|NA|||NA|2||58||BASELINE|1965-09-30|1972-08-26|||||1967-07-31||1962-06-10|Y|1966-03-19
TRIAL STUDY 134XCP|LB|F4F12AAA-E825-45D7-B414-A06F2D20381A|2||||CBA|COMPLEMENT BA|||||||H*%|||||||NEGATIVE||FOZ_US||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|LIPEMIC|Y|CISH|COCKCROFT-GAULT FORMULA||U|N|Y|NA|||Y|2||58||INDUCTION TREATMENT|1960-01-26|1972-10-11|||||1964-03-23||1967-06-10|Y|1971-09-08
TRIAL STUDY 134XCP|LB|F4F12AAA-E825-45D7-B414-A06F2D20381A|1||||OPG|OSTEOPROTEGERIN|||||||EP U|||||||TRACE||10^6 ORGANISMS||||HIGH|NOT DONE||||BONE MARROW|NON-HEMOLYZED|U|SISH|FIBROSIS 4 FORMULA||NA|N|NA|U|||NA|3||39||INDUCTION TREATMENT|1972-06-11|1970-01-16|||||1971-10-04||1960-01-12|NA|1960-01-07
TRIAL STUDY 134XCP|LB|F4F12AAA-E825-45D7-B414-A06F2D20381A|2||||LYMA|LYMPHOCYTES ACTIVATED|||||||GPELISA UNIT/ML|||||||INDETERMINATE||RFU||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|CALCIFIED|U|IMMUNOFIXATION ELECTROPHORESIS|NASH FIBROSURE FORMULA||N|Y|U|NA|||N|3||39||CONTINUATION TREATMENT|1972-08-25|1969-12-02|||||1965-03-03||1965-09-25|U|1973-02-03
TRIAL STUDY 134XCP|LB|F4F12AAA-E825-45D7-B414-A06F2D20381A|1||||PPA|PHENYLPROPANOLAMINE|||||||NKAT|||||||INVALID||/4.0 ML||||LOW|NOT DONE||||CELL PELLET|CONCENTRATED|Y|FLUORIMETRY|FIBROSIS 4 FORMULA||N|NA|U|U|||U|4||88||OPEN LABEL TREATMENT|1969-02-16|1961-02-26|||||1970-05-01||1960-03-26|Y|1961-07-27
TRIAL STUDY 134XCP|LB|F4F12AAA-E825-45D7-B414-A06F2D20381A|2||||C165913|NUT MIX IGG AB RAST SCORE|||||||BQ|||||||TRACE||M||||HIGH|NOT DONE||||ERYTHROCYTES|LIPEMIC|NA|GC/MS|FIBROTEST FORMULA||N|U|U|U|||NA|4||88||BLINDED TREATMENT|1968-09-09|1965-10-21|||||1963-08-29||1966-10-28|U|1972-09-13
TRIAL STUDY 134XCP|LB|F4F12AAA-E825-45D7-B414-A06F2D20381A|1||||C130125|CAT DANDER ANTIGEN IGG ANTIBODY|||||||DAYS/MONTH|||||||INDETERMINATE||BQ/KG||||HIGH|NOT DONE||||SERUM|NON-HEMOLYZED|Y|PET/SPECT SCAN|CKD-EPI FORMULA||NA|U|NA|Y|||U|5||7||INDUCTION TREATMENT|1966-02-23|1961-05-03|||||1960-01-30||1961-10-09|Y|1966-04-20
TRIAL STUDY 134XCP|LB|F4F12AAA-E825-45D7-B414-A06F2D20381A|2||||ENRAGE|EXTRACELL NEWLY IDENT RAGE BIND PROTEIN|||||||ML/(MIN*100ML)|||||||INVALID||MOL/ML||||HIGH|NOT DONE||||SKIN TISSUE|AUTOLYZED|Y|SPECT/CT SCAN|MDRD 6 VARIABLE FORMULA||N|N|NA|N|||N|5||7||SCREENING|1973-08-04|1969-07-12|||||1968-09-21||1960-11-30|NA|1968-07-26
TRIAL STUDY 134XCP|LB|6CF611F2-686E-4AE9-B491-32157710F46D|1||||CRBMZPN|CARBAMAZEPINE|||||||NKAT|||||||INVALID||MKAT||||NORMAL|NOT DONE||||RETICULOCYTES|UNEXPECTED ODOR|NA|MRI WITHOUT CONTRAST|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|NA|NA|||NA|1||38||OBSERVATION|1964-03-09|1973-07-15|||||1971-09-16||1965-01-05|NA|1969-08-02
TRIAL STUDY 134XCP|LB|6CF611F2-686E-4AE9-B491-32157710F46D|2||||TNFR5S|SOLUBLE TNF RECEPTOR SUPERFAMILY MEM 5|||||||G|||||||INDETERMINATE||KALLIKREIN INHIBITOR UNIT||||HIGH|NOT DONE||||SKIN TISSUE|FRESH|NA|VIRUS PLAQUE ASSAY|CKD-EPI CYSTATIN C FORMULA||NA|N|Y|Y|||N|1||38||OBSERVATION|1968-08-06|1962-04-29|||||1968-03-07||1972-03-31|U|1964-06-03
TRIAL STUDY 134XCP|LB|6CF611F2-686E-4AE9-B491-32157710F46D|1||||BNPPRONT|N-TERMINAL PROB-TYPE NATRIURETIC PEPTIDE|||||||ML/ANIMAL/DAY|||||||INDETERMINATE||ML/(MIN*100ML)||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|AGGLUTINATED|NA|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD ENZYMATIC FORMULA||N|U|N|N|||Y|2||58||FOLLOW-UP|1962-06-27|1963-07-03|||||1965-02-17||1967-02-02|U|1972-09-16
TRIAL STUDY 134XCP|LB|6CF611F2-686E-4AE9-B491-32157710F46D|2||||MENGLCE|MENINGEAL CELLS/TOTAL CELLS|||||||PMOL|||||||NEGATIVE||KIT||||HIGH|NOT DONE||||LYMPH|GELLED|U|TEMPLATE INCISION METHOD|MDRD ENZYMATIC JAPANESE FORMULA||U|N|NA|NA|||Y|2||58||INDUCTION TREATMENT|1966-04-15|1969-12-03|||||1972-01-29||1960-07-21|N|1969-12-04
TRIAL STUDY 134XCP|LB|6CF611F2-686E-4AE9-B491-32157710F46D|1||||EOTAXIN2|EOTAXIN-2|||||||PMOL/10^10 CELLS|||||||INDETERMINATE||BLOCKS||||HIGH|NOT DONE||||PLATELET RICH PLASMA|LACTESCENT|NA|KINETIC MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|NA|U|||U|3||39||INDUCTION TREATMENT|1966-05-14|1970-07-19|||||1961-02-23||1972-01-14|N|1968-09-19
TRIAL STUDY 134XCP|LB|6CF611F2-686E-4AE9-B491-32157710F46D|2||||INTLK19|INTERLEUKIN 19|||||||PKAT|||||||NEGATIVE||G/M2/DAY||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|CLOTTED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA||N|N|Y|NA|||N|3||39||BLINDED TREATMENT|1967-05-28|1961-11-27|||||1964-04-18||1968-10-16|U|1961-07-12
TRIAL STUDY 134XCP|LB|6CF611F2-686E-4AE9-B491-32157710F46D|1||||HETRPHLE|HETEROPHILS/LEUKOCYTES|||||||NG/DAY|||||||POSITIVE||10^6 ORGANISMS||||LOW|NOT DONE||||PERITONEAL FLUID|DRIED|Y|CLOT DETECTION|COCKCROFT-GAULT FORMULA||Y|N|NA|N|||Y|4||88||OBSERVATION|1973-08-23|1969-04-03|||||1962-10-22||1965-05-12|NA|1972-12-24
TRIAL STUDY 134XCP|LB|6CF611F2-686E-4AE9-B491-32157710F46D|2||||HLAIPRA|HLA CLASS I PANEL REACTIVE ANTIBODY|||||||COPIES/UG|||||||BORDERLINE||10^9 ORGANISMS||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|CONCENTRATED|NA|STRESS ECHOCARDIOGRAPHY|MDRD FORMULA||Y|U|U|Y|||NA|4||88||TREATMENT|1968-01-18|1967-03-22|||||1965-09-11||1967-11-18|NA|1970-05-11
TRIAL STUDY 134XCP|LB|6CF611F2-686E-4AE9-B491-32157710F46D|1||||MYPC|MYELOID PROGENITOR CELLS|||||||NG/DL|||||||BORDERLINE||FOZ_BR||||HIGH|NOT DONE||||CALCULUS|NON-HEMOLYZED|U|PHOROPTER|MDRD 6 VARIABLE FORMULA||Y|NA|U|U|||N|5||7||TREATMENT|1960-09-26|1967-04-05|||||1971-01-16||1968-09-16|N|1966-09-03
TRIAL STUDY 134XCP|LB|6CF611F2-686E-4AE9-B491-32157710F46D|2||||NACLR|SODIUM CLEARANCE|||||||UMOL/DL|||||||TRACE||MG/M2/DAY||||ABNORMAL|NOT DONE||||EMESIS|CALCIFIED|NA|MAMMOGRAPHY|FIBROMETER FORMULA||N|NA|U|U|||U|5||7||CONTINUATION TREATMENT|1963-02-01|1960-09-11|||||1965-04-25||1964-08-09|NA|1962-10-09
TRIAL STUDY 134XCP|LB|417DBC64-7BF9-4EB8-A14B-C5F63541F826|1||||RBCNURBC|NUCLEATED ERYTHROCYTES/ERYTHROCYTES|||||||BU/ML|||||||BORDERLINE||DRUM||||LOW|NOT DONE||||EXUDATE|LIPEMIC|Y|SANGER SEQUENCING|NASH FIBROSURE FORMULA||NA|Y|N|N|||U|1||38||BASELINE|1970-01-30|1966-09-11|||||1963-04-07||1971-04-27|NA|1961-12-27
TRIAL STUDY 134XCP|LB|417DBC64-7BF9-4EB8-A14B-C5F63541F826|2||||HEXK|HEXOKINASE|||||||ML/ANIMAL/DAY|||||||POSITIVE||PATCH||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|REFRIGERATED|U|CLIP SEQUENCING|MDRD 6 VARIABLE FORMULA||Y|Y|Y|NA|||U|1||38||TREATMENT|1968-03-10|1973-05-15|||||1961-12-18||1966-01-03|Y|1960-06-24
TRIAL STUDY 134XCP|LB|417DBC64-7BF9-4EB8-A14B-C5F63541F826|1||||KRCYMGCE|MEGAKARYOCYTES/TOTAL CELLS|||||||PG|||||||INDETERMINATE||V||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|HEMOLYZED|Y|IMMUNOFIXATION ELECTROPHORESIS|CKD-EPI CREATININE FORMULA||U|N|N|U|||U|2||58||INDUCTION TREATMENT|1972-05-16|1971-01-22|||||1968-07-28||1967-12-11|NA|1964-06-17
TRIAL STUDY 134XCP|LB|417DBC64-7BF9-4EB8-A14B-C5F63541F826|2||||CD4CD8|CD4/CD8|||||||IU/MMOL|||||||POSITIVE||G/CM2||||HIGH|NOT DONE||||LEUKOCYTE|CONCENTRATED|Y|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD ENZYMATIC FORMULA||U|U|NA|N|||N|2||58||RUN-IN|1973-03-21|1963-04-28|||||1962-06-04||1960-11-30|U|1972-11-16
TRIAL STUDY 134XCP|LB|417DBC64-7BF9-4EB8-A14B-C5F63541F826|1||||BLSTMBCE|MYELOBLASTS/TOTAL CELLS|||||||MG/KG/WEEK|||||||POSITIVE||MAMP||||NORMAL|NOT DONE||||NAIL|CONCENTRATED|Y|PALM METHOD|CKD-EPI CYSTATIN C FORMULA||U|Y|Y|N|||Y|3||39||BASELINE|1970-08-10|1968-08-31|||||1963-01-06||1960-06-12|U|1965-06-28
TRIAL STUDY 134XCP|LB|417DBC64-7BF9-4EB8-A14B-C5F63541F826|2||||PLATAGGR|PLATELET AGGREGATION|||||||PL|||||||INDETERMINATE||MG/KG/MIN||||HIGH|NOT DONE||||BUFFY COAT|CONCENTRATED|NA|OSCILLOMETRY|MDRD FORMULA||U|N|NA|N|||NA|3||39||WASHOUT|1962-04-26|1966-06-23|||||1964-02-24||1971-09-22|N|1972-05-28
TRIAL STUDY 134XCP|LB|417DBC64-7BF9-4EB8-A14B-C5F63541F826|1||||PHOS|PHOSPHATE|||||||UG/M2/H|||||||INVALID||DPM/MG||||LOW|NOT DONE||||PERITONEAL FLUID|NON-HEMOLYZED|U|GRADIENT DIFFUSION|CKD-EPI FORMULA||U|Y|Y|Y|||N|4||88||BASELINE|1970-06-13|1964-04-07|||||1969-06-04||1961-12-10|N|1973-05-29
TRIAL STUDY 134XCP|LB|417DBC64-7BF9-4EB8-A14B-C5F63541F826|2||||INHIBINA|INHIBIN A|||||||PMOL/DL|||||||POSITIVE||10^3 COPIES/ML||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|DRIED|Y|HPLC|MDRD 6 VARIABLE FORMULA||Y|N|Y|NA|||U|4||88||SCREENING|1965-12-14|1970-02-20|||||1970-02-05||1962-05-18|N|1966-08-27
TRIAL STUDY 134XCP|LB|417DBC64-7BF9-4EB8-A14B-C5F63541F826|1||||ABNCECE|ABNORMAL CELLS/TOTAL CELLS|||||||POUCH|||||||BORDERLINE||UIU/L||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|FROZEN|U|DUKE INCISION METHOD|MDRD 4 VARIABLE FORMULA||U|U|N|NA|||N|5||7||RUN-IN|1960-12-21|1960-09-20|||||1962-05-25||1964-10-26|NA|1971-08-11
TRIAL STUDY 134XCP|LB|417DBC64-7BF9-4EB8-A14B-C5F63541F826|2||||GUSB|GLUCURONIDASE, BETA|||||||TRANSDUCING UNIT/ML|||||||BORDERLINE||ML/BREATH||||NORMAL|NOT DONE||||RETICULOCYTES|FROZEN|Y|MAMMOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|U|NA|U|||NA|5||7||WASHOUT|1971-09-15|1969-09-02|||||1963-10-08||1965-06-22|N|1971-02-28
TRIAL STUDY 134XCP|LB|C3EF644E-25DC-4E0D-9073-735AED77EFAF|1||||HYDCDN|HYDROCODONE|||||||10^8 PFU|||||||INDETERMINATE||HEP||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|DRIED|NA|LINE PROBE ASSAY|CKD-EPI CYSTATIN C FORMULA||NA|U|N|NA|||U|1||38||OBSERVATION|1971-12-11|1961-11-20|||||1970-06-30||1972-05-27|Y|1972-12-03
TRIAL STUDY 134XCP|LB|C3EF644E-25DC-4E0D-9073-735AED77EFAF|2||||CORTFR|CORTISOL, FREE|||||||ELISA UNIT|||||||NEGATIVE||OHM||||HIGH|NOT DONE||||BASAL TEAR|NON-HEMOLYZED|Y|DOUBLE IMMUNODIFFUSION|FIBROSIS 4 FORMULA||N|U|N|N|||N|1||38||BASELINE|1963-02-01|1971-06-23|||||1972-09-27||1970-06-05|N|1971-07-06
TRIAL STUDY 134XCP|LB|C3EF644E-25DC-4E0D-9073-735AED77EFAF|1||||IL2R|INTERLEUKIN 2 RECEPTOR|||||||UG/KG/H|||||||NEGATIVE||10^6 RNA COPIES/ML||||HIGH|NOT DONE||||MONOCYTE|ROOM TEMPERATURE|N|CYSTOSCOPY|GMI MMOL/MOL FORMULA||Y|N|Y|N|||U|2||58||CONTINUATION TREATMENT|1966-07-09|1962-05-27|||||1972-03-13||1972-03-29|U|1966-04-16
TRIAL STUDY 134XCP|LB|C3EF644E-25DC-4E0D-9073-735AED77EFAF|2||||IGG2|IMMUNOGLOBULIN G SUBCLASS 2|||||||10^12/L|||||||TRACE||MEQ/ML||||ABNORMAL|NOT DONE||||EXPIRED AIR|AUTOLYZED|N|CONTRAST ENHANCED PET SCAN|MDRD 6 VARIABLE FORMULA||Y|NA|NA|N|||Y|2||58||RUN-IN|1960-02-08|1972-12-09|||||1969-04-16||1960-02-26|U|1960-06-24
TRIAL STUDY 134XCP|LB|C3EF644E-25DC-4E0D-9073-735AED77EFAF|1||||CSGRAN|GRANULAR CASTS|||||||HZ|||||||INDETERMINATE||VG/DOSE||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|SOLIDIFIED|U|NUCLEIC ACID HYBRIDIZATION|GMI % FORMULA||N|U|Y|U|||NA|3||39||SCREENING|1968-08-20|1972-04-30|||||1968-08-16||1972-05-14|N|1972-01-31
TRIAL STUDY 134XCP|LB|C3EF644E-25DC-4E0D-9073-735AED77EFAF|2||||HLADR53A|HLA-DR53 ANTIBODY|||||||% INHIBITION|||||||INDETERMINATE||UCI/KG||||LOW|NOT DONE||||PUS|GELLED|N|IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA||Y|U|U|NA|||NA|3||39||CONTINUATION TREATMENT|1963-03-11|1961-05-06|||||1969-11-25||1966-12-07|NA|1965-01-26
TRIAL STUDY 134XCP|LB|C3EF644E-25DC-4E0D-9073-735AED77EFAF|1||||METARUB|METARUBRICYTE|||||||UMOL/H/MMOL|||||||INDETERMINATE||LOG10 PFU/ML||||LOW|NOT DONE||||PUS|PARAFFIN-EMBEDDED|Y|NON-CONTACT SPECULAR MICROSCOPY|MDRD ENZYMATIC FORMULA||N|N|Y|U|||NA|4||88||OBSERVATION|1972-07-18|1964-01-21|||||1966-01-30||1964-09-26|U|1972-04-17
TRIAL STUDY 134XCP|LB|C3EF644E-25DC-4E0D-9073-735AED77EFAF|2||||ALB|ALBUMIN|||||||AMFI|||||||INDETERMINATE||GY/MIN||||ABNORMAL|NOT DONE||||BLOOD|FROZEN|N|OPTICAL COHERENCE TOMOGRAPHY|MDRD 5 VARIABLE FORMULA||N|NA|U|Y|||N|4||88||BASELINE|1961-11-04|1969-03-19|||||1972-01-02||1961-03-15|Y|1968-04-08
TRIAL STUDY 134XCP|LB|C3EF644E-25DC-4E0D-9073-735AED77EFAF|1||||MUG|MURINOGLOBULIN|||||||/H|||||||POSITIVE||10^7/L||||LOW|NOT DONE||||CORD BLOOD|FROZEN|U|DYNAMIC LIGHT SCATTERING|COCKCROFT-GAULT FORMULA||U|U|U|Y|||N|5||7||LONG-TERM FOLLOW-UP|1971-09-12|1966-05-31|||||1966-04-10||1971-03-23|Y|1972-08-26
TRIAL STUDY 134XCP|LB|C3EF644E-25DC-4E0D-9073-735AED77EFAF|2||||PT|PROTHROMBIN TIME|||||||G/ANIMAL|||||||POSITIVE||UG/M2||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|SOLIDIFIED|N|SLIT LAMP|GMI % FORMULA||Y|N|U|Y|||Y|5||7||BASELINE|1969-07-06|1961-08-18|||||1970-09-04||1960-12-19|NA|1961-10-11
TRIAL STUDY 134XCP|LB|CAE5F41C-0560-4782-BA27-E314BF7E66B6|1||||NEUTSGNE|NEUTROPHILS, SEGMENTED/NEUTROPHILS|||||||MG/ANIMAL|||||||INDETERMINATE||MG/M2||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|FROZEN|Y|WESTERGREN|FIBROMETER FORMULA||N|NA|Y|Y|||U|1||38||OPEN LABEL TREATMENT|1967-06-01|1968-10-12|||||1968-11-28||1962-10-25|U|1965-09-12
TRIAL STUDY 134XCP|LB|CAE5F41C-0560-4782-BA27-E314BF7E66B6|2||||MYBLAT3|TYPE III MYELOBLASTS|||||||BEL|||||||INVALID||CYCLE/MIN||||LOW|NOT DONE||||LYMPH|GELLED|Y|PERIODIC ACID SCHIFF STAIN|CKD-EPI CYSTATIN C FORMULA||Y|U|U|U|||N|1||38||BLINDED TREATMENT|1972-06-15|1967-12-05|||||1966-07-12||1962-01-19|U|1971-12-14
TRIAL STUDY 134XCP|LB|CAE5F41C-0560-4782-BA27-E314BF7E66B6|1||||CYTRPHOS|TRIPLE PHOSPHATE CRYSTALS|||||||/VF|||||||INDETERMINATE||GY||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|NON-HEMOLYZED|U|LASER CAPTURE MICRODISSECTION|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|N|U|||NA|2||58||WASHOUT|1964-01-09|1967-07-12|||||1972-09-07||1968-05-01|NA|1973-02-12
TRIAL STUDY 134XCP|LB|CAE5F41C-0560-4782-BA27-E314BF7E66B6|2||||INTLK1|INTERLEUKIN 1|||||||UG/G/MIN|||||||INVALID||UCI||||ABNORMAL|NOT DONE||||DISCHARGE|PARAFFIN-EMBEDDED|U|SPIROMETRY|NASH FIBROSURE FORMULA||NA|NA|Y|U|||U|2||58||BLINDED TREATMENT|1971-08-10|1968-02-07|||||1966-02-04||1961-11-26|U|1966-11-07
TRIAL STUDY 134XCP|LB|CAE5F41C-0560-4782-BA27-E314BF7E66B6|1||||C165904|TREE MIX POLLEN IGG AB RAST SCORE|||||||APL U|||||||INVALID||ATM||||LOW|NOT DONE||||GASTRIC CONTENTS|AUTOLYZED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|U|Y|||U|3||39||BLINDED TREATMENT|1967-12-05|1964-08-16|||||1968-04-12||1966-04-06|Y|1960-05-13
TRIAL STUDY 134XCP|LB|CAE5F41C-0560-4782-BA27-E314BF7E66B6|2||||RITALAC|RITALINIC ACID|||||||G/CAGE/WK|||||||INVALID||DEG||||NORMAL|NOT DONE||||MUCUS|HEMOLYZED|N|REVERSE TRANSCRIPTASE PCR|FIBROSIS 4 FORMULA||Y|Y|N|NA|||U|3||39||WASHOUT|1961-08-04|1971-02-13|||||1966-07-20||1964-08-29|NA|1964-12-21
TRIAL STUDY 134XCP|LB|CAE5F41C-0560-4782-BA27-E314BF7E66B6|1||||AUERRODS|AUER RODS|||||||MG/ML/DAY|||||||INVALID||UG/KG/DAY||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|AGGLUTINATED|NA|SNP ARRAY|ASH FIBROSURE FORMULA||N|U|U|NA|||Y|4||88||OBSERVATION|1972-04-08|1966-01-26|||||1966-07-04||1963-08-20|U|1962-11-19
TRIAL STUDY 134XCP|LB|CAE5F41C-0560-4782-BA27-E314BF7E66B6|2||||BCMAS|SOLUBLE B CELL MATURATION ANTIGEN|||||||MEQ/KG|||||||TRACE||ELISA UNIT/DOSE||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|SOLIDIFIED|U|MALDI|COCKCROFT-GAULT FORMULA||NA|U|N|N|||NA|4||88||BASELINE|1968-05-31|1967-01-11|||||1960-10-19||1967-12-03|U|1966-04-30
TRIAL STUDY 134XCP|LB|CAE5F41C-0560-4782-BA27-E314BF7E66B6|1||||ETP|ENDOGENOUS THROMBIN POTENTIAL|||||||FOZ_BR|||||||NEGATIVE||UEQ||||LOW|NOT DONE||||BONE MARROW|FRESH|N|CLINICAL EVALUATION|ASH FIBROSURE FORMULA||Y|NA|Y|N|||U|5||7||FOLLOW-UP|1961-08-03|1963-08-13|||||1970-12-31||1962-12-09|NA|1968-07-03
TRIAL STUDY 134XCP|LB|CAE5F41C-0560-4782-BA27-E314BF7E66B6|2||||FACTVW|VON WILLEBRAND FACTOR|||||||100 IU/ML|||||||TRACE||CONTAINER||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|SOLIDIFIED|U|REFRACTOMETRY|NASH FIBROSURE FORMULA||Y|Y|N|U|||U|5||7||LONG-TERM FOLLOW-UP|1961-10-30|1963-06-13|||||1964-11-15||1962-01-24|U|1963-08-11
TRIAL STUDY 134XCP|LB|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|1||||RF|RHEUMATOID FACTOR|||||||/100 WBC|||||||NEGATIVE||MN||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|CONTAMINATED|Y|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|N|U|||U|1||38||OBSERVATION|1968-04-26|1964-09-17|||||1970-01-02||1960-09-20|NA|1965-01-27
TRIAL STUDY 134XCP|LB|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|2||||PLATGNT|GIANT PLATELETS|||||||USP U|||||||BORDERLINE||KEV||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|NON-HEMOLYZED|N|DYNAMIC CONTRAST ENHANCED MRI|GMI % FORMULA||Y|U|Y|U|||N|1||38||RUN-IN|1961-10-07|1972-11-26|||||1969-09-14||1965-01-02|U|1963-12-07
TRIAL STUDY 134XCP|LB|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|1||||DRVVTSCR|DRVVT SCREEN TO CONFIRM RATIO|||||||G/G|||||||INDETERMINATE||BQ/L||||NORMAL|NOT DONE||||CORD SERUM|NON-HEMOLYZED|U|REVERSE TRANSCRIPTASE PCR|GMI MMOL/MOL FORMULA||N|NA|N|NA|||U|2||58||BLINDED TREATMENT|1962-04-29|1972-12-31|||||1963-02-10||1966-08-14|NA|1963-01-11
TRIAL STUDY 134XCP|LB|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|2||||HDL3|HDL-CHOLESTEROL SUBCLASS 3|||||||TUBE|||||||POSITIVE||ML/G/H||||LOW|NOT DONE||||EPIDERMAL TISSUE|FROZEN|NA|CISH|FIBROSIS 4 FORMULA||N|U|U|NA|||Y|2||58||CONTINUATION TREATMENT|1963-08-30|1964-10-20|||||1966-03-03||1973-02-24|U|1964-08-03
TRIAL STUDY 134XCP|LB|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|1||||EOSIM|IMMATURE EOSINOPHILS|||||||UG/M2/MIN|||||||INDETERMINATE||AMOL||||HIGH|NOT DONE||||DISCHARGE|CLOTTED|U|PULSE OXIMETRY|COCKCROFT-GAULT FORMULA||Y|N|U|N|||U|3||39||LONG-TERM FOLLOW-UP|1964-01-02|1963-02-08|||||1973-06-17||1970-01-06|NA|1963-11-20
TRIAL STUDY 134XCP|LB|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|2||||KRCYMG|MEGAKARYOCYTES|||||||%/S|||||||INDETERMINATE||U/M2/DAY||||HIGH|NOT DONE||||EXUDATE|HEMOLYZED|Y|IN VITRO GENE EXPRESSION ASSAY|MDRD FORMULA||U|NA|Y|Y|||U|3||39||BASELINE|1965-11-15|1970-12-06|||||1960-04-01||1970-01-02|NA|1967-08-27
TRIAL STUDY 134XCP|LB|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|1||||VITC|VITAMIN C|||||||10^9/DOSE|||||||INVALID||PPTH||||HIGH|NOT DONE||||EXPIRED AIR|FRESH|U|DUCTOGRAPHY|CKD-EPI CREATININE FORMULA||U|N|N|Y|||NA|4||88||CONTINUATION TREATMENT|1961-10-02|1964-11-06|||||1971-04-13||1971-05-30|Y|1973-01-22
TRIAL STUDY 134XCP|LB|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|2||||ENAAB|EXTRACTABLE NUCLEAR ANTIGEN ANTIBODY|||||||U/KG|||||||INVALID||FMOL/G||||ABNORMAL|NOT DONE||||PLASMA|FROZEN|NA|MS/MS|NASH FIBROSURE FORMULA||N|NA|U|U|||NA|4||88||OPEN LABEL TREATMENT|1966-08-07|1966-10-29|||||1972-03-25||1960-07-02|N|1960-05-20
TRIAL STUDY 134XCP|LB|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|1||||VEGFR2|VASC ENDOTHELIAL GROWTH FACTOR REC 2|||||||EU|||||||NEGATIVE||DPM/100MG||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|CLOTTED|NA|KARYOTYPING|MDRD FORMULA||Y|U|N|N|||N|5||7||RUN-IN|1970-03-26|1969-06-05|||||1968-02-27||1970-12-22|U|1962-12-25
TRIAL STUDY 134XCP|LB|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|2||||OXALATE|OXALATE|||||||PKAT|||||||BORDERLINE||RATIO||||HIGH|NOT DONE||||ABSCESS FLUID|NON-HEMOLYZED|NA|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA||Y|U|U|U|||Y|5||7||FOLLOW-UP|1972-08-01|1973-04-01|||||1970-01-18||1964-10-07|Y|1962-08-19
TRIAL STUDY 134XCP|LB|F34E7DCC-8637-463D-88E6-28AEBF495E9B|1||||PHTRMN|PHENTERMINE|||||||TSP|||||||INDETERMINATE||ML/KG/DAY||||NORMAL|NOT DONE||||CORD BLOOD|CLOTTED|NA|PHASE-CONTRAST MRI|NASH FIBROSURE FORMULA||U|N|U|NA|||U|1||38||WASHOUT|1963-05-19|1960-05-13|||||1960-07-19||1962-10-28|U|1968-09-16
TRIAL STUDY 134XCP|LB|F34E7DCC-8637-463D-88E6-28AEBF495E9B|2||||BLASTLE|BLASTS/LEUKOCYTES|||||||/LPF|||||||BORDERLINE||UMOL/L||||ABNORMAL|NOT DONE||||BASAL TEAR|FROZEN|NA|FARR ASSAY|HEPASCORE FORMULA||Y|Y|N|U|||NA|1||38||WASHOUT|1965-10-08|1970-10-23|||||1973-07-07||1963-10-02|Y|1973-06-08
TRIAL STUDY 134XCP|LB|F34E7DCC-8637-463D-88E6-28AEBF495E9B|1||||ROUNDCE|ROUND CELLS|||||||VG/DOSE|||||||TRACE||PHERESIS UNIT||||NORMAL|NOT DONE||||VENOUS PLASMA|GELLED|N|MICRO BROTH DILUTION|ASH FIBROSURE FORMULA||Y|U|Y|N|||NA|2||58||INDUCTION TREATMENT|1971-10-01|1971-09-28|||||1972-01-20||1962-04-23|Y|1969-09-25
TRIAL STUDY 134XCP|LB|F34E7DCC-8637-463D-88E6-28AEBF495E9B|2||||RDWR|RET VOLUME DISTRIBUTION WIDTH|||||||ML/ANIMAL|||||||POSITIVE||U/M2/DAY||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|FROZEN|U|TRANSVAGINAL ULTRASOUND|GMI % FORMULA||N|N|N|Y|||Y|2||58||RUN-IN|1961-12-05|1965-07-14|||||1965-08-22||1965-10-11|Y|1963-10-16
TRIAL STUDY 134XCP|LB|F34E7DCC-8637-463D-88E6-28AEBF495E9B|1||||POLYNORM|POLYCHROMATOPHILIC NORMOBLAST|||||||BQ/MG|||||||TRACE||AMU||||LOW|NOT DONE||||VENOUS PLASMA|AUTOLYZED|N|MS/MS|MDRD ENZYMATIC FORMULA||U|N|Y|N|||N|3||39||BLINDED TREATMENT|1965-06-06|1970-04-23|||||1970-03-17||1965-08-19|U|1960-05-31
TRIAL STUDY 134XCP|LB|F34E7DCC-8637-463D-88E6-28AEBF495E9B|2||||PLATSAT|PLATELET SATELLITISM|||||||CUP|||||||POSITIVE||NMOL/L/H||||HIGH|NOT DONE||||WHITE MATTER TISSUE|GELLED|N|REVERSE TRANSCRIPTASE PCR|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|NA|N|||NA|3||39||LONG-TERM FOLLOW-UP|1972-02-04|1971-05-01|||||1972-11-21||1970-08-14|U|1960-04-28
TRIAL STUDY 134XCP|LB|F34E7DCC-8637-463D-88E6-28AEBF495E9B|1||||LDH5LDH|LDH ISOENZYME 5/LDH|||||||IU/DAY|||||||INVALID||SFC/10^6 PBMC||||HIGH|NOT DONE||||MENSTRUAL BLOOD|CALCIFIED|U|FORCED OSCILLATION TECHNIQUE|CKD-EPI FORMULA||N|Y|NA|U|||N|4||88||RUN-IN|1968-08-25|1964-10-10|||||1966-02-28||1973-02-19|U|1971-07-22
TRIAL STUDY 134XCP|LB|F34E7DCC-8637-463D-88E6-28AEBF495E9B|2||||TK2|THYMIDINE KINASE 2|||||||MPS U|||||||INVALID||LENS||||LOW|NOT DONE||||SPERMATOZOON|CALCIFIED|N|CONTRAST ENHANCED MRI|MDRD ENZYMATIC FORMULA||N|N|U|N|||N|4||88||CONTINUATION TREATMENT|1961-02-26|1970-11-21|||||1962-07-23||1973-04-01|Y|1973-07-08
TRIAL STUDY 134XCP|LB|F34E7DCC-8637-463D-88E6-28AEBF495E9B|1||||LYMMCE|LYMPHOMA CELLS|||||||BAU/ML|||||||NEGATIVE||/MM||||LOW|NOT DONE||||SUPERNATANT, PLASMA|CONTAMINATED|N|PET/MRI SCAN|MDRD ENZYMATIC FORMULA||NA|U|U|NA|||U|5||7||FOLLOW-UP|1960-06-30|1962-11-10|||||1970-09-25||1970-03-18|Y|1961-04-04
TRIAL STUDY 134XCP|LB|F34E7DCC-8637-463D-88E6-28AEBF495E9B|2||||TSTFWTST|TESTOSTERONE FREE+WEAKLY BOUND/TESTOST|||||||TBSP|||||||INVALID||ML/(MIN*100ML)||||LOW|NOT DONE||||EMOTIONAL TEAR|CLOTTED|N|SLIT LAMP|FIBROTEST FORMULA||NA|Y|U|N|||NA|5||7||CONTINUATION TREATMENT|1964-07-23|1964-03-06|||||1960-08-28||1966-04-14|N|1967-10-19
TRIAL STUDY 134XCP|LB|69530FE0-6896-4585-8B20-29AE90DB91F5|1||||VEGFR2S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC2|||||||FINGERTIP UNIT|||||||POSITIVE||LOG10 TCID 50/ML||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|SOLIDIFIED|N|MANUAL COUNT|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|N|N|||NA|1||38||LONG-TERM FOLLOW-UP|1965-12-31|1970-08-17|||||1968-07-23||1960-12-03|NA|1962-12-12
TRIAL STUDY 134XCP|LB|69530FE0-6896-4585-8B20-29AE90DB91F5|2||||MSTHCELE|MESOTHELIAL CELLS/LEUKOCYTES|||||||UG/M2/MIN|||||||POSITIVE||L/H||||NORMAL|NOT DONE||||CERUMEN|CALCIFIED|N|KINETIC CHROMOGENIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|Y|N|||NA|1||38||WASHOUT|1962-03-16|1969-09-12|||||1960-07-09||1962-03-22|NA|1961-12-14
TRIAL STUDY 134XCP|LB|69530FE0-6896-4585-8B20-29AE90DB91F5|1||||TIMP3|TISSUE INHIBITOR OF METALLOPROTEINASE 3|||||||KCAL|||||||INVALID||10^6 CFU||||LOW|NOT DONE||||SWABBED MATERIAL|LACTESCENT|N|HPLC|CKD-EPI CYSTATIN C FORMULA||Y|N|NA|U|||N|2||58||CONTINUATION TREATMENT|1973-06-26|1969-04-28|||||1969-04-12||1961-12-13|N|1970-02-14
TRIAL STUDY 134XCP|LB|69530FE0-6896-4585-8B20-29AE90DB91F5|2||||PAI1AG|PLASMINOGEN ACTIVATOR INHIBITOR-1 AG|||||||ML/SEC/1.73M2|||||||POSITIVE||IN||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CLOTTED|Y|LANDOLT RING|CKD-EPI CREATININE FORMULA||Y|N|NA|Y|||Y|2||58||CONTINUATION TREATMENT|1962-03-25|1969-11-27|||||1960-09-10||1972-07-12|N|1962-03-22
TRIAL STUDY 134XCP|LB|69530FE0-6896-4585-8B20-29AE90DB91F5|1||||CHOL|CHOLESTEROL|||||||/DAY|||||||NEGATIVE||ML/CM||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|LACTESCENT|U|FISH|GMI MMOL/MOL FORMULA||N|Y|N|NA|||N|3||39||RUN-IN|1965-09-25|1967-11-12|||||1961-08-10||1961-01-24|U|1971-11-15
TRIAL STUDY 134XCP|LB|69530FE0-6896-4585-8B20-29AE90DB91F5|2||||CYSCREAT|CYSTATIN C/CREATININE|||||||U/KG/DAY|||||||NEGATIVE||BQ/G||||NORMAL|NOT DONE||||VENOUS PLASMA|ROOM TEMPERATURE|U|HEMAGGLUTINATION INHIBITION ASSAY|ASH FIBROSURE FORMULA||NA|U|NA|N|||U|3||39||OBSERVATION|1971-03-21|1972-06-23|||||1970-09-15||1960-10-21|Y|1966-03-13
TRIAL STUDY 134XCP|LB|69530FE0-6896-4585-8B20-29AE90DB91F5|1||||C165889|RUSSIAN THISTLE POLLEN IGE AB RAST SCORE|||||||MET*H|||||||INDETERMINATE||CM||||ABNORMAL|NOT DONE||||URINE SEDIMENT|CONCENTRATED|Y|LANDOLT RING|FIBROTEST FORMULA||Y|Y|NA|N|||U|4||88||CONTINUATION TREATMENT|1973-03-02|1965-10-10|||||1972-12-12||1973-02-09|NA|1972-04-20
TRIAL STUDY 134XCP|LB|69530FE0-6896-4585-8B20-29AE90DB91F5|2||||VITC|VITAMIN C|||||||CI/KG|||||||TRACE||DAMOL/L||||NORMAL|NOT DONE||||PERITONEAL FLUID|NON-HEMOLYZED|NA|MASS SPECTROMETRY|FIBROTEST FORMULA||NA|NA|Y|U|||U|4||88||BLINDED TREATMENT|1965-10-27|1964-08-30|||||1963-08-28||1964-04-07|NA|1967-06-01
TRIAL STUDY 134XCP|LB|69530FE0-6896-4585-8B20-29AE90DB91F5|1||||MBP|MYELIN BASIC PROTEIN|||||||VIRTUAL PIXEL|||||||POSITIVE||ML/G/DAY||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|REFRIGERATED|Y|IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA||N|NA|NA|NA|||N|5||7||INDUCTION TREATMENT|1964-12-05|1964-08-08|||||1961-01-08||1969-09-27|Y|1970-05-18
TRIAL STUDY 134XCP|LB|69530FE0-6896-4585-8B20-29AE90DB91F5|2||||RFIGMAB|RHEUMATOID FACTOR IGM ANTIBODY|||||||MG/KG/MIN|||||||NEGATIVE||10^3/L||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|THAWED|N|CALCOFLUOR WHITE STAIN|GMI MMOL/MOL FORMULA||U|U|U|NA|||NA|5||7||TREATMENT|1963-03-16|1965-11-10|||||1965-02-25||1964-12-07|N|1970-08-04
TRIAL STUDY 134XCP|LB|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|1||||C165912|SHELLFISH MIX IGG AB RAST SCORE|||||||CI/UL|||||||NEGATIVE||KV||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|UNEXPECTED ODOR|U|POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||Y|Y|N|N|||Y|1||38||CONTINUATION TREATMENT|1969-05-25|1972-07-10|||||1965-08-04||1962-09-29|Y|1962-06-30
TRIAL STUDY 134XCP|LB|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|2||||PBG|PORPHOBILINOGEN|||||||CM|||||||BORDERLINE||ARBITRARY U||||LOW|NOT DONE||||SUPERNATANT, SERUM|ICTERIC|Y|CELLULOSE TAPE|CKD-EPI FORMULA||N|Y|Y|Y|||N|1||38||RUN-IN|1963-06-30|1968-06-14|||||1966-02-28||1969-09-13|U|1971-06-06
TRIAL STUDY 134XCP|LB|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|1||||TMZPM|TEMAZEPAM|||||||ML/KG/DAY|||||||TRACE||PIXELS/IN||||HIGH|NOT DONE||||EPIDERMAL TISSUE|REFRIGERATED|N|CRYOSCOPY|CKD-EPI CREATININE FORMULA||NA|Y|NA|N|||Y|2||58||SCREENING|1960-06-20|1962-12-17|||||1969-12-02||1965-03-27|U|1966-08-03
TRIAL STUDY 134XCP|LB|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|2||||HBCOHGB|CARBOXYHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||MMOL/DAY|||||||TRACE||KM/H||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|CONTAMINATED|NA|FLAME PHOTOMETRY|FIBROMETER FORMULA||Y|NA|NA|U|||N|2||58||OPEN LABEL TREATMENT|1961-04-26|1973-06-03|||||1966-12-10||1964-07-22|N|1961-05-16
TRIAL STUDY 134XCP|LB|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|1||||G6PDRBRB|G6PD-DEFICIENT ERYTHROCYTES/ERYTHROCYTES|||||||CI/KG|||||||BORDERLINE||APL U/ML||||HIGH|NOT DONE||||PERITONEAL FLUID|ICTERIC|U|FLUORIMETRY|ASH FIBROSURE FORMULA||NA|Y|NA|N|||Y|3||39||FOLLOW-UP|1969-11-17|1963-11-22|||||1972-04-23||1963-08-20|NA|1966-03-13
TRIAL STUDY 134XCP|LB|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|2||||CEC|CIRCULATING ENDOTHELIAL CELLS|||||||RPM|||||||NEGATIVE||MM/H||||NORMAL|NOT DONE||||SALIVA|PARAFFIN-EMBEDDED|Y|PULSE OXIMETRY|HEPASCORE FORMULA||NA|N|N|NA|||NA|3||39||CONTINUATION TREATMENT|1966-02-14|1962-05-30|||||1961-10-13||1967-08-01|Y|1971-04-02
TRIAL STUDY 134XCP|LB|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|1||||VLDL3|VLDL CHOLESTEROL SUBTYPE 3|||||||U/G HB|||||||POSITIVE||10^9/L||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|PARAFFIN-EMBEDDED|NA|LIQUID SCINTILLATION COUNTING|GMI MMOL/MOL FORMULA||N|U|U|U|||U|4||88||TREATMENT|1969-01-07|1970-10-05|||||1965-12-29||1961-10-27|U|1960-04-08
TRIAL STUDY 134XCP|LB|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|2||||TLCHT|TAUROLITHOCHOLATE|||||||ECL UNIT|||||||NEGATIVE||ML/M2/DAY||||ABNORMAL|NOT DONE||||URINE|NON-HEMOLYZED|U|MICRODENSITOMETRY|FIBROMETER FORMULA||U|N|U|N|||N|4||88||TREATMENT|1966-08-31|1972-01-30|||||1967-09-29||1968-05-15|NA|1962-07-20
TRIAL STUDY 134XCP|LB|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|1||||GLOBA2|ALPHA-2 GLOBULIN|||||||LM|||||||BORDERLINE||SIEMENS||||ABNORMAL|NOT DONE||||VENOUS BLOOD|GELLED|NA|NEURAMINIDASE INHIBITION ASSAY|FIBROTEST FORMULA||NA|U|Y|U|||N|5||7||OBSERVATION|1971-06-08|1965-11-30|||||1961-07-25||1960-06-20|N|1961-09-24
TRIAL STUDY 134XCP|LB|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|2||||CETP|CHOLESTERYL ESTER TRANSFER PROTEIN|||||||MEQ/KG|||||||NEGATIVE||BEL||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|LIPEMIC|NA|MAGNETIC RESONANCE ELASTOGRAPHY|FIBROMETER FORMULA||Y|Y|N|N|||U|5||7||CONTINUATION TREATMENT|1967-05-20|1973-05-08|||||1972-07-15||1965-06-30|Y|1967-03-12
TRIAL STUDY 134XCP|LB|F1EF928C-B819-4620-8991-ABDC4E182217|1||||CYUNCLA|UNCLASSIFIED CRYSTALS|||||||UMOL/MOL|||||||BORDERLINE||MOL/MOL||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC|Y|MICROBIAL BIOCHEMICAL IDENTIFICATION|FIBROTEST FORMULA||Y|NA|NA|U|||N|1||38||BLINDED TREATMENT|1965-05-16|1972-02-14|||||1963-09-28||1963-06-02|NA|1969-05-08
TRIAL STUDY 134XCP|LB|F1EF928C-B819-4620-8991-ABDC4E182217|2||||BDNF|BRAIN-DERIVED NEUROTROPHIC FACTOR|||||||UG/L DDU|||||||INDETERMINATE||MG/CM2||||ABNORMAL|NOT DONE||||SEMEN|DRIED|NA|CENTRIFUGATION|FIBROSIS 4 FORMULA||Y|NA|N|N|||N|1||38||CONTINUATION TREATMENT|1968-07-23|1969-02-28|||||1966-05-12||1963-09-10|U|1963-01-30
TRIAL STUDY 134XCP|LB|F1EF928C-B819-4620-8991-ABDC4E182217|1||||C165920|WHITE ELM POLLEN IGG AB RAST SCORE|||||||PELLET|||||||BORDERLINE||CAPLET||||ABNORMAL|NOT DONE||||TRANSUDATE|LIPEMIC|NA|DIRECT SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|Y|U|||U|2||58||WASHOUT|1964-03-28|1963-08-14|||||1966-01-25||1963-07-19|Y|1961-06-22
TRIAL STUDY 134XCP|LB|F1EF928C-B819-4620-8991-ABDC4E182217|2||||CYHGBC|HEMOGLOBIN C CRYSTALS|||||||UG/ANIMAL|||||||INDETERMINATE||TBSP||||HIGH|NOT DONE||||EXPIRED AIR|ICTERIC|N|WRIGHT-GIEMSA STAIN|GMI % FORMULA||NA|Y|N|Y|||NA|2||58||BLINDED TREATMENT|1961-02-18|1970-12-29|||||1965-02-09||1967-08-15|NA|1970-10-12
TRIAL STUDY 134XCP|LB|F1EF928C-B819-4620-8991-ABDC4E182217|1||||HAHA|HUMAN ANTI-HUMAN ANTIBODY|||||||MMHG*MIN/L|||||||INVALID||S^-1(%O2)^-1||||LOW|NOT DONE||||LOCHIA|CONTAMINATED|N|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROTEST FORMULA||N|U|Y|U|||U|3||39||TREATMENT|1970-04-06|1967-01-21|||||1960-08-14||1972-07-20|U|1968-11-24
TRIAL STUDY 134XCP|LB|F1EF928C-B819-4620-8991-ABDC4E182217|2||||TAP1|PEPTIDE TRANSPORTER TAP1|||||||%|||||||TRACE||G/CAGE/WK||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|GELLED|NA|PET/CT SCAN|ASH FIBROSURE FORMULA||N|NA|NA|Y|||Y|3||39||WASHOUT|1964-06-10|1960-12-06|||||1960-05-09||1971-10-22|Y|1963-10-22
TRIAL STUDY 134XCP|LB|F1EF928C-B819-4620-8991-ABDC4E182217|1||||AMYLB42|AMYLOID BETA 1-42|||||||POUCH|||||||TRACE||CI/KG||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|FROZEN|Y|PERCUSSION|MDRD 4 VARIABLE FORMULA||NA|NA|U|N|||Y|4||88||RUN-IN|1970-04-12|1968-08-11|||||1967-09-07||1969-12-25|Y|1960-09-08
TRIAL STUDY 134XCP|LB|F1EF928C-B819-4620-8991-ABDC4E182217|2||||C130101|TREE MIX POLLEN ANTIGEN IGE ANTIBODY|||||||NEBULE|||||||INDETERMINATE||U/CL||||ABNORMAL|NOT DONE||||NAIL|HEMOLYZED|U|ENZYMATIC SPECTROPHOTOMETRY|MDRD ENZYMATIC FORMULA||Y|U|NA|Y|||NA|4||88||BASELINE|1964-04-05|1961-10-06|||||1966-10-12||1961-10-24|N|1966-03-31
TRIAL STUDY 134XCP|LB|F1EF928C-B819-4620-8991-ABDC4E182217|1||||EOSPSDLE|PSEUDO-EOSINOPHILS/LEUKOCYTES|||||||MMOL/KG|||||||INVALID||BLOCKS||||HIGH|NOT DONE||||HAIR FOLLICLE|PARAFFIN-EMBEDDED|N|ICC|MDRD 4 VARIABLE FORMULA||Y|N|Y|N|||NA|5||7||SCREENING|1960-07-27|1965-12-23|||||1972-10-22||1966-09-09|NA|1961-05-20
TRIAL STUDY 134XCP|LB|F1EF928C-B819-4620-8991-ABDC4E182217|2||||GALANIN|GALANIN|||||||JAR|||||||POSITIVE||GBQ/MG||||ABNORMAL|NOT DONE||||DISCHARGE|FROZEN|U|GRADIENT DIFFUSION|HEPASCORE FORMULA||U|U|U|N|||N|5||7||RUN-IN|1964-06-29|1963-12-22|||||1972-07-07||1968-12-23|Y|1960-12-14
TRIAL STUDY 134XCP|LB|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|1||||FOLHMRNA|FOLATE HYDROLASE MRNA|||||||GAUSS|||||||NEGATIVE||IU/ML||||HIGH|NOT DONE||||EPIDERMAL TISSUE|CONTAMINATED|N|WESTERN BLOT|ASH FIBROSURE FORMULA||U|NA|NA|U|||Y|1||38||BLINDED TREATMENT|1963-11-25|1970-01-09|||||1964-08-27||1962-11-12|N|1966-01-15
TRIAL STUDY 134XCP|LB|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|2||||GUSA|GLUCURONIDASE, ALPHA|||||||KS|||||||NEGATIVE||ML||||ABNORMAL|NOT DONE||||FLUID|GELLED|NA|DIFFUSION WEIGHTED MRI|FIBROMETER FORMULA||NA|NA|U|N|||N|1||38||BASELINE|1964-02-17|1962-05-16|||||1971-12-13||1962-01-18|NA|1962-02-05
TRIAL STUDY 134XCP|LB|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|1||||LEPTO|LEPTOCYTES|||||||10^6 ORGANISMS/MG|||||||BORDERLINE||UMOL/MIN||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONTAMINATED|U|SNP ARRAY|CKD-EPI FORMULA||NA|Y|NA|NA|||NA|2||58||CONTINUATION TREATMENT|1972-07-05|1965-06-13|||||1960-08-24||1962-06-14|Y|1966-06-18
TRIAL STUDY 134XCP|LB|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|2||||RENINA|RENIN ACTIVITY|||||||FMOL|||||||INDETERMINATE||S/H||||HIGH|NOT DONE||||CELL PELLET|AGGLUTINATED|U|TELLER ACUITY CARDS|FIBROMETER FORMULA||N|U|N|NA|||N|2||58||TREATMENT|1968-08-18|1966-02-07|||||1971-01-13||1973-06-13|N|1962-06-07
TRIAL STUDY 134XCP|LB|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|1||||T3FR|TRIIODOTHYRONINE, FREE|||||||L/L|||||||INVALID||BU/ML||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|CONTAMINATED|NA|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|U|||NA|3||39||OPEN LABEL TREATMENT|1964-04-13|1966-07-23|||||1961-12-11||1970-12-24|NA|1964-09-25
TRIAL STUDY 134XCP|LB|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|2||||CYHIPPAC|HIPPURIC ACID CRYSTALS|||||||MG/KG|||||||NEGATIVE||ML/M2/MIN||||LOW|NOT DONE||||SEMEN|AGGLUTINATED|U|HEMAGGLUTINATION ASSAY|CKD-EPI CREATININE FORMULA||U|U|Y|Y|||U|3||39||TREATMENT|1960-09-22|1963-09-11|||||1962-06-08||1969-06-15|Y|1967-04-26
TRIAL STUDY 134XCP|LB|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|1||||GLOBB1PT|BETA-1 GLOBULIN/TOTAL PROTEIN|||||||ML/MMHG|||||||POSITIVE||ML/ANIMAL||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|HEMOLYZED|Y|HANSEL STAIN|GMI MMOL/MOL FORMULA||NA|U|N|N|||NA|4||88||SCREENING|1971-09-10|1972-12-12|||||1969-10-30||1964-12-18|Y|1964-12-02
TRIAL STUDY 134XCP|LB|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|2||||MYBLA|MYELOBLASTS|||||||KPA|||||||NEGATIVE||L/DAY||||ABNORMAL|NOT DONE||||URINE|CALCIFIED|N|WHOLE GENOME SEQUENCING|MDRD 6 VARIABLE FORMULA||N|N|U|Y|||U|4||88||FOLLOW-UP|1967-07-29|1965-04-22|||||1971-10-13||1960-10-10|N|1967-06-12
TRIAL STUDY 134XCP|LB|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|1||||CD5|CD5|||||||CD/M2|||||||NEGATIVE||YEARS||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|LIPEMIC|NA|NUCLEIC ACID HYBRIDIZATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|Y|N|||Y|5||7||OBSERVATION|1960-06-10|1967-08-17|||||1960-09-22||1966-10-26|N|1972-10-24
TRIAL STUDY 134XCP|LB|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|2||||IOHEXOL|IOHEXOL|||||||CM|||||||BORDERLINE||LOG10 TCID 50/ML||||NORMAL|NOT DONE||||SPUTUM|LACTESCENT|NA|DIFFUSION TENSOR MRI|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|N|U|||Y|5||7||INDUCTION TREATMENT|1972-02-14|1961-12-24|||||1960-10-09||1963-10-08|NA|1972-04-13
TRIAL STUDY 134XCP|LB|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|1||||APOB48|APOLIPOPROTEIN B48|||||||PG/DL|||||||INVALID||CONTAINER||||NORMAL|NOT DONE||||PUS|ROOM TEMPERATURE|NA|KINETIC MICROPARTICLE IMMUNOASSAY|COCKCROFT-GAULT FORMULA||NA|NA|Y|N|||NA|1||38||LONG-TERM FOLLOW-UP|1968-11-15|1967-12-28|||||1967-10-09||1968-04-06|N|1961-03-25
TRIAL STUDY 134XCP|LB|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|2||||CEIMCE|IMMATURE CELLS/TOTAL CELLS|||||||MM/MIN|||||||INDETERMINATE||NMOL/DAY||||ABNORMAL|NOT DONE||||ERYTHROCYTES|ICTERIC|Y|HPLC/IEX|MDRD ENZYMATIC FORMULA||N|Y|U|NA|||U|1||38||TREATMENT|1968-08-04|1971-01-09|||||1967-02-14||1964-10-12|Y|1970-08-21
TRIAL STUDY 134XCP|LB|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|1||||CHOLINES|CHOLINESTERASE|||||||PM|||||||POSITIVE||/MIN||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|FROZEN|Y|CONTRAST ENHANCED CT SCAN|FIBROTEST FORMULA||NA|NA|N|NA|||NA|2||58||TREATMENT|1960-05-11|1972-08-27|||||1967-12-14||1961-06-02|U|1963-12-30
TRIAL STUDY 134XCP|LB|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|2||||PSDGLSRF|PHOSPHATIDYLGLYCEROL/LUNG SURFACTANT|||||||ML/ANIMAL/WK|||||||TRACE||NG/MOL||||ABNORMAL|NOT DONE||||CORD BLOOD|NON-HEMOLYZED|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD 5 VARIABLE FORMULA||Y|U|Y|U|||NA|2||58||FOLLOW-UP|1962-07-04|1962-04-04|||||1966-12-27||1962-10-14|U|1966-11-28
TRIAL STUDY 134XCP|LB|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|1||||SFTPD|SURFACTANT PROTEIN D|||||||MM/2H|||||||INVALID||UG/MIN||||ABNORMAL|NOT DONE||||URINE SEDIMENT|GELLED|Y|DYNAMIC LIGHT SCATTERING|MDRD FORMULA||NA|N|U|N|||NA|3||39||FOLLOW-UP|1964-09-24|1960-10-28|||||1965-10-01||1973-03-08|N|1964-06-30
TRIAL STUDY 134XCP|LB|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|2||||PSP100AB|P100 POLYMYOSITIS-SCLERODERMA AUTOAG AB|||||||MEQ/DL|||||||BORDERLINE||PPTH||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|ICTERIC|Y|PELLI-ROBSON EYE CHART|GMI MMOL/MOL FORMULA||U|U|NA|U|||U|3||39||FOLLOW-UP|1964-06-26|1969-05-19|||||1971-10-06||1962-08-17|U|1967-07-09
TRIAL STUDY 134XCP|LB|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|1||||C165935|TRITICUM AESTIVUM IGE AB RAST SCORE|||||||ENZYME U/M2|||||||INDETERMINATE||U/CL||||HIGH|NOT DONE||||TISSUE|ICTERIC|NA|SNP ARRAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|U|NA|||NA|4||88||WASHOUT|1966-02-02|1962-08-21|||||1961-10-29||1968-08-08|N|1970-09-14
TRIAL STUDY 134XCP|LB|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|2||||ESTRONE|ESTRONE|||||||KG/L|||||||NEGATIVE||KPA/L/SEC||||NORMAL|NOT DONE||||PERSPIRATION|FRESH|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|N|U|Y|||NA|4||88||BLINDED TREATMENT|1970-11-29|1970-07-08|||||1970-02-15||1962-01-25|Y|1969-01-18
TRIAL STUDY 134XCP|LB|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|1||||HBLEPRHB|HEMOGLOBIN LEPORE/TOTAL HEMOGLOBIN|||||||GTT|||||||BORDERLINE||MHZ||||LOW|NOT DONE||||SPUTUM|REFRIGERATED|Y|RADIOIMMUNOPRECIPITATION ASSAY|FIBROSIS 4 FORMULA||NA|Y|Y|U|||U|5||7||CONTINUATION TREATMENT|1967-10-11|1961-01-09|||||1965-01-20||1971-09-20|NA|1966-09-28
TRIAL STUDY 134XCP|LB|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|2||||CITCREAT|CITRATE/CREATININE|||||||NMOL/KG/DAY|||||||NEGATIVE||U/KG/H||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|HEMOLYZED|NA|INFRARED SPECTROMETRY|MDRD 6 VARIABLE FORMULA||U|Y|U|N|||U|5||7||OBSERVATION|1960-12-15|1971-06-15|||||1965-08-24||1965-10-01|U|1971-07-03
TRIAL STUDY 134XCP|LB|27D5690D-BCB3-4FEC-988C-666C29D5239A|1||||TRIM21|TRIPARTITE MOTIF CONTAINING PROTEIN 21|||||||10^7 TCID 50/DOSE|||||||BORDERLINE||NMOL||||NORMAL|NOT DONE||||DERMAL TISSUE|CALCIFIED|N|VENTILATION PERFUSION LUNG SCAN|MDRD 5 VARIABLE FORMULA||Y|U|NA|N|||Y|1||38||INDUCTION TREATMENT|1960-04-07|1972-12-09|||||1970-03-20||1971-08-16|N|1963-12-17
TRIAL STUDY 134XCP|LB|27D5690D-BCB3-4FEC-988C-666C29D5239A|2||||PROMYB|PROMYELOBLASTS|||||||BISCUIT|||||||INVALID||GBQ/G||||NORMAL|NOT DONE||||BONE MARROW|NON-HEMOLYZED|Y|MICROBIAL CULTURE, SOLID|COCKCROFT-GAULT FORMULA||N|Y|N|N|||N|1||38||FOLLOW-UP|1970-05-19|1960-06-12|||||1968-02-28||1968-07-27|NA|1969-07-08
TRIAL STUDY 134XCP|LB|27D5690D-BCB3-4FEC-988C-666C29D5239A|1||||NEUTBLE|NEUTROPHILS BAND FORM/LEUKOCYTES|||||||10^3/HPF|||||||BORDERLINE||10^6 ORGANISMS/MG||||LOW|NOT DONE||||EXPIRED AIR|SOLIDIFIED|U|ENZYMATIC SPECTROPHOTOMETRY|FIBROSIS 4 FORMULA||U|N|Y|U|||U|2||58||CONTINUATION TREATMENT|1969-10-15|1960-04-13|||||1969-06-06||1969-02-20|U|1965-11-13
TRIAL STUDY 134XCP|LB|27D5690D-BCB3-4FEC-988C-666C29D5239A|2||||C165899|SILVER BIRCH POLLEN IGG AB RAST SCORE|||||||L/MIN|||||||INDETERMINATE||10^3 CFU/ML||||HIGH|NOT DONE||||HAIR|LACTESCENT|NA|ACID FAST STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|N|NA|||U|2||58||WASHOUT|1968-05-15|1971-01-16|||||1962-10-12||1963-10-07|NA|1964-11-17
TRIAL STUDY 134XCP|LB|27D5690D-BCB3-4FEC-988C-666C29D5239A|1||||ANCAB|ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY|||||||LOG10 CFU/G|||||||BORDERLINE||10^6 CFU||||NORMAL|NOT DONE||||MECONIUM|THAWED|N|FREEZING POINT DEPRESSION|FIBROMETER FORMULA||Y|N|NA|N|||Y|3||39||OPEN LABEL TREATMENT|1971-10-31|1965-08-21|||||1966-02-11||1964-09-01|N|1965-10-08
TRIAL STUDY 134XCP|LB|27D5690D-BCB3-4FEC-988C-666C29D5239A|2||||ANGTNSGN|ANGIOTENSINOGEN|||||||MG/ANIMAL|||||||TRACE||IU/ML||||ABNORMAL|NOT DONE||||VENOUS BLOOD|AUTOLYZED|NA|IMMUNOBLOT|MDRD 4 VARIABLE FORMULA||U|N|U|Y|||Y|3||39||BLINDED TREATMENT|1963-04-24|1965-10-07|||||1965-07-15||1970-10-30|N|1960-07-06
TRIAL STUDY 134XCP|LB|27D5690D-BCB3-4FEC-988C-666C29D5239A|1||||CL|CHLORIDE|||||||BQ/KG|||||||BORDERLINE||PATCH||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|SOLIDIFIED|U|PET/CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|U|U|||Y|4||88||BLINDED TREATMENT|1971-03-04|1968-09-19|||||1968-02-11||1965-06-19|U|1973-04-28
TRIAL STUDY 134XCP|LB|27D5690D-BCB3-4FEC-988C-666C29D5239A|2||||PCP|PHENCYCLIDINE|||||||10^7 CFU|||||||POSITIVE||GPS U||||ABNORMAL|NOT DONE||||RETICULOCYTES|LACTESCENT|U|TARGETED GENOME SEQUENCING|ASH FIBROSURE FORMULA||NA|N|N|U|||Y|4||88||BASELINE|1969-07-01|1967-09-30|||||1966-04-28||1968-01-10|NA|1971-03-28
TRIAL STUDY 134XCP|LB|27D5690D-BCB3-4FEC-988C-666C29D5239A|1||||FABP1|FATTY ACID BINDING PROTEIN 1|||||||CGY|||||||BORDERLINE||U/10^12 RBC||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CLOTTED|N|IMMUNO-PET SCAN|CKD-EPI CREATININE FORMULA||U|Y|U|Y|||U|5||7||CONTINUATION TREATMENT|1964-03-28|1967-06-13|||||1970-12-07||1961-08-27|N|1964-11-28
TRIAL STUDY 134XCP|LB|27D5690D-BCB3-4FEC-988C-666C29D5239A|2||||HAMAB|HUMAN ANTI-MOUSE ANTIBODY|||||||MOL/MOL|||||||NEGATIVE||G/CM2||||HIGH|NOT DONE||||CORD BLOOD|ROOM TEMPERATURE|U|FISH|GMI MMOL/MOL FORMULA||NA|NA|U|N|||Y|5||7||TREATMENT|1970-10-19|1971-07-17|||||1968-03-28||1971-04-16|Y|1960-02-01
TRIAL STUDY 134XCP|LB|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|1||||COPPER|COPPER|||||||LOG10 PFU/ML|||||||INVALID||MG/DL||||LOW|NOT DONE||||SEMEN|CLOTTED|U|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI FORMULA||N|U|N|Y|||Y|1||38||OPEN LABEL TREATMENT|1962-09-05|1968-11-12|||||1967-10-25||1965-11-03|NA|1965-11-13
TRIAL STUDY 134XCP|LB|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|2||||HLZPM|HALAZEPAM|||||||/MM|||||||TRACE||10^3 CFU/ML||||HIGH|NOT DONE||||MONOCYTE|THAWED|N|OPTICAL DENSITY MEASUREMENT|MDRD FORMULA||Y|U|N|N|||U|1||38||BLINDED TREATMENT|1962-09-05|1967-05-21|||||1964-06-15||1963-06-15|U|1965-02-28
TRIAL STUDY 134XCP|LB|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|1||||HLAIIAB|HLA CLASS II ANTIBODY|||||||/KG|||||||POSITIVE||BREATHS/30S||||NORMAL|NOT DONE||||VENOUS BLOOD|THAWED|U|RIA|MDRD 4 VARIABLE FORMULA||Y|U|NA|NA|||N|2||58||SCREENING|1969-05-27|1973-06-05|||||1969-08-06||1961-05-18|Y|1971-10-03
TRIAL STUDY 134XCP|LB|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|2||||NEUTTOXC|NEUTROPHILIC TOXIC CHANGE|||||||DPM/ML|||||||NEGATIVE||/DAY||||HIGH|NOT DONE||||BASAL TEAR|ICTERIC|U|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD 4 VARIABLE FORMULA||U|Y|U|N|||U|2||58||RUN-IN|1964-07-01|1966-10-21|||||1963-06-25||1967-08-11|Y|1968-02-19
TRIAL STUDY 134XCP|LB|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|1||||CACRALB|CALCIUM CORRECTED FOR ALBUMIN|||||||NEEDLE GAUGE|||||||INDETERMINATE||NEWTON||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LACTESCENT|N|IMMUNOTURBIDIMETRY|GMI % FORMULA||U|Y|N|U|||N|3||39||RUN-IN|1963-05-31|1965-01-02|||||1966-06-12||1970-02-02|U|1965-05-17
TRIAL STUDY 134XCP|LB|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|2||||LAP|LEUCINE AMINOPEPTIDASE|||||||FMOL/L|||||||BORDERLINE||H*%||||ABNORMAL|NOT DONE||||PLASMA|UNEXPECTED ODOR|NA|TARGETED GENOME SEQUENCING|MDRD ENZYMATIC FORMULA||Y|Y|U|NA|||NA|3||39||OPEN LABEL TREATMENT|1961-11-23|1972-08-11|||||1969-01-20||1969-06-14|NA|1961-10-07
TRIAL STUDY 134XCP|LB|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|1||||MYBLAT2|TYPE II MYELOBLASTS|||||||DISK|||||||POSITIVE||MG/ML/MIN||||ABNORMAL|NOT DONE||||LOCHIA|AGGLUTINATED|U|CYSTOMETRY|NASH FIBROSURE FORMULA||N|NA|U|Y|||NA|4||88||OBSERVATION|1960-03-01|1962-05-08|||||1973-05-27||1965-02-09|Y|1970-12-14
TRIAL STUDY 134XCP|LB|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|2||||ANABASN|ANABASINE|||||||MG/M2/H|||||||TRACE||MMOL/DAY||||LOW|NOT DONE||||DERMAL TISSUE|AUTOLYZED|Y|MICRONEUTRALIZATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|U|||Y|4||88||SCREENING|1964-02-25|1970-02-19|||||1963-08-08||1962-05-28|NA|1963-08-08
TRIAL STUDY 134XCP|LB|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|1||||FATACFR|FREE FATTY ACID|||||||PPTH|||||||INDETERMINATE||S^-1(%O2)^-1||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|DRIED|Y|MICROBIAL CONCENTRATION|MDRD 5 VARIABLE FORMULA||U|U|N|NA|||N|5||7||BLINDED TREATMENT|1960-11-07|1966-08-13|||||1963-07-19||1969-06-11|N|1961-03-04
TRIAL STUDY 134XCP|LB|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|2||||ANAG|ALPHA-N-ACETYLGLUCOSAMINIDASE|||||||MG/H|||||||POSITIVE||MU||||HIGH|NOT DONE||||VENOUS BLOOD|AGGLUTINATED|U|PHOROPTER|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|N|N|||NA|5||7||FOLLOW-UP|1970-06-02|1962-02-13|||||1968-09-29||1972-11-10|N|1971-07-18
TRIAL STUDY 134XCP|LB|8E25F21F-A565-40CB-B0D7-6CC496171293|1||||IFNA|INTERFERON ALPHA|||||||KEV|||||||INDETERMINATE||PFU/DOSE||||HIGH|NOT DONE||||BLOOD|LIPEMIC|Y|CLIP|ASH FIBROSURE FORMULA||NA|NA|N|NA|||U|1||38||BLINDED TREATMENT|1962-04-20|1968-11-04|||||1962-01-23||1972-02-09|U|1963-10-27
TRIAL STUDY 134XCP|LB|8E25F21F-A565-40CB-B0D7-6CC496171293|2||||CYAMORPH|AMORPHOUS CRYSTALS|||||||DYN|||||||POSITIVE||MOL/L||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|THAWED|U|HIGH RESOLUTION MELT ANALYSIS|GMI MMOL/MOL FORMULA||N|N|Y|N|||N|1||38||BLINDED TREATMENT|1961-05-08|1960-06-01|||||1967-07-22||1971-07-10|N|1971-03-08
TRIAL STUDY 134XCP|LB|8E25F21F-A565-40CB-B0D7-6CC496171293|1||||KIM1EXR|KIDNEY INJURY MOLECULE-1 EXCRETION RATE|||||||10^6 CFU/G|||||||POSITIVE||HOURS||||HIGH|NOT DONE||||AMNIOTIC FLUID|ICTERIC|NA|HEMATOXYLIN AND EOSIN STAIN|MDRD ENZYMATIC FORMULA||Y|U|Y|N|||NA|2||58||INDUCTION TREATMENT|1960-08-08|1968-11-25|||||1966-03-30||1963-12-20|U|1964-05-27
TRIAL STUDY 134XCP|LB|8E25F21F-A565-40CB-B0D7-6CC496171293|2||||APLIGMAB|ANTI-PHOSPHOLIPID IGM ANTIBODY|||||||DRUM|||||||POSITIVE||UMOL/L/MIN||||LOW|NOT DONE||||SWABBED MATERIAL|LACTESCENT|Y|HPLC/IEX|CKD-EPI CYSTATIN C FORMULA||N|NA|NA|U|||N|2||58||OPEN LABEL TREATMENT|1972-05-23|1971-08-29|||||1972-11-05||1969-07-28|U|1962-12-25
TRIAL STUDY 134XCP|LB|8E25F21F-A565-40CB-B0D7-6CC496171293|1||||C165884|OLIVE TREE POLLEN IGE ANTIBODY|||||||V/SEC|||||||NEGATIVE||RAD||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|GELLED|Y|WRIGHT-GIEMSA STAIN|FIBROTEST FORMULA||Y|N|Y|N|||U|3||39||FOLLOW-UP|1960-10-22|1969-06-16|||||1972-02-27||1964-03-09|NA|1966-09-25
TRIAL STUDY 134XCP|LB|8E25F21F-A565-40CB-B0D7-6CC496171293|2||||RLP|RLP CHOLESTEROL|||||||EJACULATE U|||||||TRACE||MG/G/MIN||||ABNORMAL|NOT DONE||||BONE MARROW|AUTOLYZED|N|CYSTOSCOPY|MDRD FORMULA||Y|NA|N|Y|||Y|3||39||SCREENING|1964-08-03|1966-03-07|||||1970-02-18||1965-01-31|U|1967-09-06
TRIAL STUDY 134XCP|LB|8E25F21F-A565-40CB-B0D7-6CC496171293|1||||PAPPEN|PAPPENHEIMER BODIES|||||||KG/CM2|||||||INDETERMINATE||ML/MIN/1.73M2||||HIGH|NOT DONE||||NAIL|HEMOLYZED|NA|FLOW MICROSCOPY|HEPASCORE FORMULA||NA|U|U|NA|||NA|4||88||BASELINE|1962-07-22|1963-06-07|||||1960-08-29||1972-10-10|N|1972-05-11
TRIAL STUDY 134XCP|LB|8E25F21F-A565-40CB-B0D7-6CC496171293|2||||DDNAIGAB|ANTI-DOUBLE STRANDED DNA IGG|||||||MS/MMHG|||||||POSITIVE||HZ/S||||LOW|NOT DONE||||LOCHIA|SOLIDIFIED|N|CHROMATOGRAPHY|NASH FIBROSURE FORMULA||Y|U|N|NA|||U|4||88||FOLLOW-UP|1964-11-08|1962-03-20|||||1967-09-29||1969-09-04|Y|1973-02-15
TRIAL STUDY 134XCP|LB|8E25F21F-A565-40CB-B0D7-6CC496171293|1||||HGBEHGB|HEMOGLOBIN E/TOTAL HEMOGLOBIN|||||||KBQ/UL|||||||NEGATIVE||ML/ANIMAL/WK||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|AGGLUTINATED|N|ULTRASOUND|FIBROTEST FORMULA||Y|NA|U|NA|||N|5||7||OPEN LABEL TREATMENT|1962-04-01|1960-01-10|||||1961-09-18||1966-12-04|U|1962-10-10
TRIAL STUDY 134XCP|LB|8E25F21F-A565-40CB-B0D7-6CC496171293|2||||GSTMUCRT|MU GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||/DAY|||||||POSITIVE||GPL U||||NORMAL|NOT DONE||||EPITHELIAL CELL|CONCENTRATED|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|HEPASCORE FORMULA||N|N|N|U|||NA|5||7||INDUCTION TREATMENT|1967-03-13|1966-07-01|||||1962-10-18||1964-02-04|Y|1967-09-07
TRIAL STUDY 134XCP|LB|8CDD2247-485D-495C-9186-FF4CA3FFC32E|1||||C165919|GERMAN COCKROACH IGG AB RAST SCORE|||||||%(W/V)|||||||TRACE||UG/G/DAY||||NORMAL|NOT DONE||||EXUDATE|PARAFFIN-EMBEDDED|NA|FLUORIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|NA|NA|||NA|1||38||WASHOUT|1969-01-15|1960-12-08|||||1960-02-17||1967-11-19|NA|1963-04-16
TRIAL STUDY 134XCP|LB|8CDD2247-485D-495C-9186-FF4CA3FFC32E|2||||PSDGLSRF|PHOSPHATIDYLGLYCEROL/LUNG SURFACTANT|||||||LOG10 CCID 50/DOSE|||||||TRACE||10^6/L||||HIGH|NOT DONE||||HAIR|CLOTTED|U|RULER MEASUREMENT METHOD|FIBROTEST FORMULA||U|NA|U|U|||Y|1||38||OBSERVATION|1964-10-15|1963-12-15|||||1973-07-07||1971-12-10|Y|1964-06-08
TRIAL STUDY 134XCP|LB|8CDD2247-485D-495C-9186-FF4CA3FFC32E|1||||GLP1AC|GLUCAGON-LIKE PEPTIDE-1, ACTIVE FORM|||||||IU|||||||POSITIVE||L/DAY||||LOW|NOT DONE||||EXPIRED AIR|AUTOLYZED|Y|MANUAL CLOT DETECTION|GMI % FORMULA||N|NA|U|NA|||NA|2||58||BLINDED TREATMENT|1962-04-09|1967-03-05|||||1961-03-30||1960-09-23|NA|1972-08-23
TRIAL STUDY 134XCP|LB|8CDD2247-485D-495C-9186-FF4CA3FFC32E|2||||DCA|DEOXYCHOLATE|||||||10^8 PFU|||||||POSITIVE||S^-1(%O2)^-1||||LOW|NOT DONE||||VENOUS PLASMA|FRESH|N|PHOTOMETRIC CLOT DETECTION|CKD-EPI CREATININE FORMULA||NA|U|U|Y|||Y|2||58||WASHOUT|1966-03-25|1967-07-19|||||1969-12-13||1973-06-11|N|1963-07-06
TRIAL STUDY 134XCP|LB|8CDD2247-485D-495C-9186-FF4CA3FFC32E|1||||PKM2|PYRUVATE KINASE ISOZYME M2|||||||NSEC|||||||TRACE||10^5/L||||LOW|NOT DONE||||LUNG SURFACTANT|NON-HEMOLYZED|Y|HPLC|FIBROTEST FORMULA||Y|NA|Y|NA|||Y|3||39||INDUCTION TREATMENT|1973-04-09|1969-04-16|||||1964-03-02||1973-05-18|N|1965-06-15
TRIAL STUDY 134XCP|LB|8CDD2247-485D-495C-9186-FF4CA3FFC32E|2||||IL2SR|SOLUBLE INTERLEUKIN 2 RECEPTOR|||||||BU|||||||POSITIVE||H/WK||||HIGH|NOT DONE||||FLUID|THAWED|U|PEAK FLOWMETRY|FIBROMETER FORMULA||N|U|N|U|||N|3||39||SCREENING|1970-02-04|1963-01-18|||||1967-06-21||1969-09-25|NA|1970-10-15
TRIAL STUDY 134XCP|LB|8CDD2247-485D-495C-9186-FF4CA3FFC32E|1||||GLP1|GLUCAGON-LIKE PEPTIDE-1|||||||PHERESIS UNIT|||||||TRACE||APL U/ML||||HIGH|NOT DONE||||SUPERNATANT, SERUM|ICTERIC|N|IMMUNOFIXATION ELECTROPHORESIS|FIBROSIS 4 FORMULA||N|U|Y|N|||NA|4||88||LONG-TERM FOLLOW-UP|1971-04-14|1964-05-13|||||1968-02-23||1965-05-15|NA|1962-07-31
TRIAL STUDY 134XCP|LB|8CDD2247-485D-495C-9186-FF4CA3FFC32E|2||||C5B9|COMPLEMENT C5B-9|||||||TRANSDUCING UNIT/ML|||||||INDETERMINATE||HOMEOPATHIC DILUTION||||HIGH|NOT DONE||||URINE SEDIMENT|CLOTTED|N|FARR ASSAY|MDRD 6 VARIABLE FORMULA||NA|Y|NA|U|||NA|4||88||SCREENING|1967-11-28|1963-05-26|||||1972-07-17||1969-09-15|Y|1972-11-02
TRIAL STUDY 134XCP|LB|8CDD2247-485D-495C-9186-FF4CA3FFC32E|1||||KAPPALC|KAPPA LIGHT CHAIN|||||||UMOL|||||||TRACE||SCM||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|NON-HEMOLYZED|N|BAC ACGH|FIBROMETER FORMULA||U|N|N|U|||N|5||7||INDUCTION TREATMENT|1960-11-25|1972-09-29|||||1973-04-29||1969-06-07|NA|1971-05-11
TRIAL STUDY 134XCP|LB|8CDD2247-485D-495C-9186-FF4CA3FFC32E|2||||TGFA|TRANSFORMING GROWTH FACTOR ALPHA|||||||KG/CM2|||||||TRACE||10^3 ORGANISMS/G||||ABNORMAL|NOT DONE||||GASTRIC FLUID|PARAFFIN-EMBEDDED|Y|DIPSTICK|FIBROSIS 4 FORMULA||N|Y|Y|NA|||Y|5||7||FOLLOW-UP|1960-11-29|1969-05-20|||||1963-02-20||1973-07-25|Y|1960-06-21
TRIAL STUDY 134XCP|LB|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|1||||TSIAC|TSI ACTUAL/CONTROL|||||||BREATHS/MIN|||||||INVALID||USP U||||HIGH|NOT DONE||||SMEGMA|FRESH|U|FLOW CYTOMETRY|COCKCROFT-GAULT FORMULA||U|N|N|N|||NA|1||38||TREATMENT|1972-02-12|1969-03-26|||||1960-04-12||1973-05-02|Y|1969-08-08
TRIAL STUDY 134XCP|LB|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|2||||MLR|MIXED LYMPHOCYTE REACTION|||||||UMOL/MG/MIN|||||||POSITIVE||H*%||||HIGH|NOT DONE||||BONE MARROW|REFRIGERATED|N|SPIRAL CT SCAN WITHOUT CONTRAST|ASH FIBROSURE FORMULA||N|NA|N|Y|||N|1||38||WASHOUT|1973-08-09|1968-06-27|||||1961-02-24||1960-10-28|Y|1971-01-28
TRIAL STUDY 134XCP|LB|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|1||||CKMM|CREATINE KINASE MM|||||||10^5/L|||||||TRACE||UMOL/DAY||||ABNORMAL|NOT DONE||||CELL PELLET|HEMOLYZED|Y|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|ASH FIBROSURE FORMULA||U|Y|Y|U|||N|2||58||LONG-TERM FOLLOW-UP|1973-04-06|1962-07-31|||||1968-01-08||1973-07-25|NA|1972-03-11
TRIAL STUDY 134XCP|LB|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|2||||METANEXR|METANEPHRINE EXCRETION RATE|||||||MMU/ML|||||||BORDERLINE||MBQ/UL||||NORMAL|NOT DONE||||VITREOUS HUMOR|FRESH|U|CELL OF ORIGIN ASSAY|FIBROMETER FORMULA||Y|NA|Y|Y|||N|2||58||RUN-IN|1968-09-24|1966-04-09|||||1969-03-04||1969-03-01|NA|1962-01-15
TRIAL STUDY 134XCP|LB|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|1||||PHNBRBTL|PHENOBARBITAL|||||||BOWL|||||||NEGATIVE||MV2/HZ||||ABNORMAL|NOT DONE||||LYSATE|LIPEMIC|N|GC/FID|GMI % FORMULA||NA|N|N|Y|||U|3||39||INDUCTION TREATMENT|1969-06-20|1970-04-24|||||1972-10-24||1966-08-21|Y|1969-12-29
TRIAL STUDY 134XCP|LB|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|2||||C130129|DOG DANDER ANTIGEN IGG ANTIBODY|||||||KCAL|||||||TRACE||G/M2/DAY||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED|NA|URANYL ACETATE STAIN|FIBROSIS 4 FORMULA||Y|N|N|N|||N|3||39||OPEN LABEL TREATMENT|1962-11-30|1963-07-08|||||1967-12-08||1972-05-11|U|1960-12-13
TRIAL STUDY 134XCP|LB|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|1||||STAT3P|PHOSPHORYLATED STAT3|||||||WEEKS|||||||BORDERLINE||PA||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|LACTESCENT|U|TRIPLE-PHASE SPIRAL CT SCAN|GMI MMOL/MOL FORMULA||NA|N|N|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1965-08-10|1962-09-14|||||1964-05-31||1960-04-02|NA|1971-05-14
TRIAL STUDY 134XCP|LB|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|2||||C130088|TIMOTHY GRASS POLLEN IGE|||||||10^7 PFU|||||||INVALID||TABLET||||LOW|NOT DONE||||SKIN TISSUE|UNEXPECTED ODOR|U|DUCTOGRAPHY|FIBROSIS 4 FORMULA||NA|Y|Y|N|||NA|4||88||LONG-TERM FOLLOW-UP|1966-02-08|1973-05-17|||||1962-10-06||1970-12-03|Y|1961-10-04
TRIAL STUDY 134XCP|LB|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|1||||RETIH|HIGH ABSORPTION RETICULOCYTES|||||||ML/M2/H|||||||TRACE||ML/KG||||HIGH|NOT DONE||||AMNIOTIC FLUID|ICTERIC|Y|INDIRECT IMMUNOFLUORESCENCE|COCKCROFT-GAULT FORMULA||N|N|NA|NA|||NA|5||7||SCREENING|1966-02-12|1973-01-13|||||1972-11-24||1972-08-10|NA|1964-05-25
TRIAL STUDY 134XCP|LB|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|2||||C165920|WHITE ELM POLLEN IGG AB RAST SCORE|||||||FRACTION OF 1|||||||NEGATIVE||MOL/L||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|CALCIFIED|U|LYMPHANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|U|Y|Y|||Y|5||7||OBSERVATION|1961-05-28|1961-08-25|||||1969-01-24||1968-03-05|N|1968-06-08
TRIAL STUDY 134XCP|LB|C004A8EB-220F-4FC5-A150-B5159DCA84D9|1||||MONONSQE|MONOCYTES/NON-SQUAM EPI CELLS|||||||EU|||||||INDETERMINATE||L/KG||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|UNEXPECTED ODOR|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||Y|Y|N|NA|||Y|1||38||OBSERVATION|1971-07-16|1972-04-03|||||1971-08-31||1973-02-18|NA|1967-01-22
TRIAL STUDY 134XCP|LB|C004A8EB-220F-4FC5-A150-B5159DCA84D9|2||||HIST2AAB|HISTONE 2A ANTIBODY|||||||MM2|||||||BORDERLINE||MG/M2||||HIGH|NOT DONE||||EPITHELIAL CELL|HEMOLYZED|NA|BIOIMPEDANCE SPECTROSCOPY|FIBROMETER FORMULA||NA|NA|Y|U|||NA|1||38||OPEN LABEL TREATMENT|1972-04-28|1971-09-18|||||1973-05-08||1965-08-14|Y|1961-04-15
TRIAL STUDY 134XCP|LB|C004A8EB-220F-4FC5-A150-B5159DCA84D9|1||||VAL|VALINE|||||||EP U|||||||INDETERMINATE||UM||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED|U|LC-FL|GMI MMOL/MOL FORMULA||NA|U|N|Y|||U|2||58||OPEN LABEL TREATMENT|1973-06-08|1972-05-31|||||1970-08-03||1960-05-22|NA|1970-12-08
TRIAL STUDY 134XCP|LB|C004A8EB-220F-4FC5-A150-B5159DCA84D9|2||||LYMA|LYMPHOCYTES ACTIVATED|||||||M3|||||||NEGATIVE||10^3 ORGANISMS/ML||||NORMAL|NOT DONE||||LYSATE|AUTOLYZED|NA|AGAR PROPORTION|FIBROSIS 4 FORMULA||NA|N|Y|N|||N|2||58||TREATMENT|1970-06-19|1970-01-11|||||1962-01-12||1968-11-06|Y|1960-03-10
TRIAL STUDY 134XCP|LB|C004A8EB-220F-4FC5-A150-B5159DCA84D9|1||||INTLK27|INTERLEUKIN 27|||||||LOG10 TCID 50/UL|||||||INVALID||10^6 COPIES/ML||||HIGH|NOT DONE||||KERATINOCYTE|FRESH|NA|URANYL ACETATE STAIN|CKD-EPI CYSTATIN C FORMULA||NA|U|Y|U|||NA|3||39||BASELINE|1967-10-15|1965-02-17|||||1962-03-22||1972-10-04|Y|1970-11-30
TRIAL STUDY 134XCP|LB|C004A8EB-220F-4FC5-A150-B5159DCA84D9|2||||INTLK14|INTERLEUKIN 14|||||||GAUSS|||||||INDETERMINATE||FEU||||HIGH|NOT DONE||||VENOUS BLOOD|CALCIFIED|NA|TARGETED TRANSCRIPTOME SEQUENCING|CKD-EPI CYSTATIN C FORMULA||N|NA|Y|NA|||NA|3||39||RUN-IN|1972-12-20|1966-02-24|||||1960-04-08||1972-05-27|NA|1960-08-20
TRIAL STUDY 134XCP|LB|C004A8EB-220F-4FC5-A150-B5159DCA84D9|1||||G6PDA|GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACT|||||||RATIO|||||||POSITIVE||MMOL/MIN/KPA/L||||ABNORMAL|NOT DONE||||SERUM|PARAFFIN-EMBEDDED|Y|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|COCKCROFT-GAULT FORMULA||NA|N|NA|N|||NA|4||88||OBSERVATION|1963-08-15|1963-06-04|||||1972-08-15||1971-06-17|U|1970-03-07
TRIAL STUDY 134XCP|LB|C004A8EB-220F-4FC5-A150-B5159DCA84D9|2||||CALB|CALBINDIN|||||||LOG EID 50/DOSE|||||||NEGATIVE||SV||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|REFRIGERATED|Y|DYNAMIC LIGHT SCATTERING|HEPASCORE FORMULA||N|NA|Y|N|||N|4||88||RUN-IN|1961-12-17|1972-09-15|||||1960-07-19||1962-11-01|Y|1964-09-26
TRIAL STUDY 134XCP|LB|C004A8EB-220F-4FC5-A150-B5159DCA84D9|1||||C130113|ANIMAL MIX ANTIGEN IGG ANTIBODY|||||||ML/CAGE/DAY|||||||INVALID||U/G/MIN||||LOW|NOT DONE||||SWABBED MATERIAL|CONTAMINATED|NA|LEAD CITRATE STAIN|FIBROMETER FORMULA||NA|N|NA|U|||U|5||7||FOLLOW-UP|1963-02-09|1967-01-17|||||1973-08-23||1969-07-17|U|1969-01-15
TRIAL STUDY 134XCP|LB|C004A8EB-220F-4FC5-A150-B5159DCA84D9|2||||C165922|MIXED ANTIGEN IGE AB RAST SCORE|||||||UKAT/10^12 RBC|||||||INDETERMINATE||ML/KG/H||||HIGH|NOT DONE||||SOFT TISSUE|SOLIDIFIED|U|X-RAY|HEPASCORE FORMULA||U|N|NA|Y|||N|5||7||BLINDED TREATMENT|1961-06-18|1963-03-22|||||1961-10-29||1960-08-16|U|1961-10-21
TRIAL STUDY 134XCP|LB|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|1||||LDHCREAT|LACTATE DEHYDROGENASE/CREATININE|||||||AGU/ML|||||||NEGATIVE||10^4 CFU/ML||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|LIPEMIC|NA|SMEAR|HEPASCORE FORMULA||NA|Y|N|N|||U|1||38||SCREENING|1967-06-10|1972-12-19|||||1961-11-07||1972-01-29|U|1965-10-02
TRIAL STUDY 134XCP|LB|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|2||||CRH|CORTICOTROPIN RELEASING HORMONE|||||||U/M2/DAY|||||||TRACE||LOG EID 50/DOSE||||NORMAL|NOT DONE||||DISCHARGE|ICTERIC|NA|MACRO BROTH DILUTION|GMI MMOL/MOL FORMULA||U|U|U|NA|||U|1||38||RUN-IN|1973-03-29|1973-05-07|||||1972-12-04||1966-02-17|U|1969-04-13
TRIAL STUDY 134XCP|LB|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|1||||CAEXR|CALCIUM EXCRETION RATE|||||||MAC50|||||||TRACE||PFU/ANIMAL||||HIGH|NOT DONE||||EXPIRED AIR|NON-HEMOLYZED|U|FARNSWORTH-MUNSELL 100 HUE TEST|HEPASCORE FORMULA||U|N|Y|N|||NA|2||58||RUN-IN|1961-05-26|1967-10-13|||||1962-09-19||1967-09-18|NA|1971-01-06
TRIAL STUDY 134XCP|LB|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|2||||APTTLAAC|APTT-LA ACTUAL/CONTROL|||||||/VF|||||||POSITIVE||MOL||||NORMAL|NOT DONE||||SYNOVIAL FLUID|PARAFFIN-EMBEDDED|NA|CENTRIFUGATION|NASH FIBROSURE FORMULA||Y|N|N|N|||NA|2||58||TREATMENT|1973-05-23|1973-06-12|||||1963-12-26||1963-03-31|U|1961-11-28
TRIAL STUDY 134XCP|LB|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|1||||UREANEXR|UREA NITROGEN EXCRETION RATE|||||||MEQ/MMOL|||||||TRACE||V||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|PARAFFIN-EMBEDDED|Y|DISK DIFFUSION|MDRD 4 VARIABLE FORMULA||NA|NA|N|N|||U|3||39||FOLLOW-UP|1969-09-17|1965-08-09|||||1966-04-25||1969-08-25|NA|1967-11-11
TRIAL STUDY 134XCP|LB|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|2||||FACTVII|FACTOR VII|||||||MM/SEC|||||||POSITIVE||TUBE||||LOW|NOT DONE||||CAPILLARY PLASMA|HEMOLYZED|U|MAGNETIC RESONANCE ENTEROGRAPHY|FIBROSIS 4 FORMULA||Y|N|NA|Y|||N|3||39||FOLLOW-UP|1962-02-20|1971-06-15|||||1964-06-09||1973-03-02|NA|1967-11-24
TRIAL STUDY 134XCP|LB|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|1||||FATACFRS|FREE FATTY ACID, SATURATED|||||||KA_U/DL|||||||POSITIVE||BREATHS/MIN||||LOW|NOT DONE||||BREAST MILK|UNEXPECTED ODOR|Y|COULOMETRIC TITRATION|MDRD 4 VARIABLE FORMULA||NA|U|U|N|||Y|4||88||LONG-TERM FOLLOW-UP|1973-02-12|1972-05-25|||||1969-04-26||1969-06-14|N|1964-10-18
TRIAL STUDY 134XCP|LB|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|2||||LYMMCELY|LYMPHOMA CELLS/LYMPHOCYTES|||||||NKAT/G HB|||||||INVALID||SUPPOSITORY||||NORMAL|NOT DONE||||ERYTHROCYTES|DRIED|Y|MICROARRAY|MDRD 5 VARIABLE FORMULA||NA|U|U|U|||NA|4||88||RUN-IN|1965-06-10|1967-03-20|||||1963-09-19||1960-03-17|U|1972-08-19
TRIAL STUDY 134XCP|LB|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|1||||KRCYMGLE|MEGAKARYOCYTES/LEUKOCYTES|||||||CUP EQ|||||||INVALID||RATIO||||NORMAL|NOT DONE||||AQUEOUS HUMOR|UNEXPECTED ODOR|NA|LISSAMINE GREEN STAIN|COCKCROFT-GAULT FORMULA||Y|NA|N|Y|||Y|5||7||WASHOUT|1963-03-09|1961-11-06|||||1966-03-09||1963-11-22|N|1969-02-17
TRIAL STUDY 134XCP|LB|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|2||||GUSA|GLUCURONIDASE, ALPHA|||||||V|||||||NEGATIVE||HEP||||ABNORMAL|NOT DONE||||TISSUE|ICTERIC|NA|URANYL ACETATE STAIN|FIBROTEST FORMULA||U|U|Y|NA|||NA|5||7||WASHOUT|1962-09-15|1969-01-23|||||1973-07-26||1970-05-07|N|1962-05-09
TRIAL STUDY 134XCP|LB|AE127EDD-D708-4B1A-95F7-176A541A9584|1||||HDL3|HDL-CHOLESTEROL SUBCLASS 3|||||||IU/MG|||||||POSITIVE||/10^5||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|AGGLUTINATED|Y|OSCILLOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|N|NA|||NA|1||38||FOLLOW-UP|1965-02-01|1971-05-29|||||1961-07-21||1970-11-30|N|1961-05-23
TRIAL STUDY 134XCP|LB|AE127EDD-D708-4B1A-95F7-176A541A9584|2||||TOXVAC|TOXIC VACUOLATION|||||||CUP EQ|||||||INVALID||DB||||NORMAL|NOT DONE||||PLEURAL FLUID|SOLIDIFIED|Y|ICP-MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|NA|NA|||U|1||38||FOLLOW-UP|1971-06-13|1962-10-14|||||1968-07-20||1970-08-22|NA|1965-04-09
TRIAL STUDY 134XCP|LB|AE127EDD-D708-4B1A-95F7-176A541A9584|1||||HGBC|HEMOGLOBIN C|||||||DAYS|||||||TRACE||10^6 COPIES/ML||||ABNORMAL|NOT DONE||||SERUM|CONCENTRATED|Y|LIQUID SCINTILLATION COUNTING|GMI % FORMULA||U|N|NA|N|||U|2||58||BASELINE|1960-10-17|1966-09-25|||||1961-12-29||1965-09-14|N|1969-11-11
TRIAL STUDY 134XCP|LB|AE127EDD-D708-4B1A-95F7-176A541A9584|2||||C147285|COMMON RAGWEED POLLEN IGE ANTIBODY|||||||NMOL/KG/DAY|||||||INDETERMINATE||LENS||||NORMAL|NOT DONE||||AMNIOTIC FLUID|LACTESCENT|NA|PERCUSSION|FIBROSIS 4 FORMULA||NA|N|NA|Y|||NA|2||58||RUN-IN|1972-12-02|1972-03-22|||||1962-09-11||1961-01-19|N|1969-04-01
TRIAL STUDY 134XCP|LB|AE127EDD-D708-4B1A-95F7-176A541A9584|1||||HYPGST17|17-HYDROXYPROGESTERONE|||||||BOX|||||||BORDERLINE||PFU/ANIMAL||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|CONTAMINATED|NA|MRI WITHOUT CONTRAST|MDRD 4 VARIABLE FORMULA||Y|Y|Y|Y|||N|3||39||OBSERVATION|1966-09-12|1961-08-25|||||1963-01-06||1963-09-02|NA|1963-02-10
TRIAL STUDY 134XCP|LB|AE127EDD-D708-4B1A-95F7-176A541A9584|2||||LTB4|LEUKOTRIENE B4|||||||BU/ML|||||||INVALID||VP/DOSE||||NORMAL|NOT DONE||||BASAL TEAR|CONCENTRATED|Y|MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|U|U|U|||NA|3||39||WASHOUT|1960-05-07|1971-02-20|||||1965-12-24||1971-06-28|NA|1968-06-01
TRIAL STUDY 134XCP|LB|AE127EDD-D708-4B1A-95F7-176A541A9584|1||||VOLUME|VOLUME|||||||MOL/ML|||||||NEGATIVE||PMOL/DL||||ABNORMAL|NOT DONE||||EXPIRED AIR|FRESH|Y|FISH|NASH FIBROSURE FORMULA||U|Y|N|NA|||U|4||88||CONTINUATION TREATMENT|1963-06-25|1963-01-11|||||1968-01-26||1971-07-18|U|1971-07-16
TRIAL STUDY 134XCP|LB|AE127EDD-D708-4B1A-95F7-176A541A9584|2||||C165938|COW MILK PROTEIN IGE AB RAST SCORE|||||||ML/CAGE|||||||BORDERLINE||UG/H||||NORMAL|NOT DONE||||ISOLATE|UNEXPECTED ODOR|Y|SLOAN LETTER EYE CHART 100%|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|NA|Y|||Y|4||88||OPEN LABEL TREATMENT|1970-05-28|1967-11-07|||||1965-11-06||1973-05-02|NA|1973-02-07
TRIAL STUDY 134XCP|LB|AE127EDD-D708-4B1A-95F7-176A541A9584|1||||O2CT|OXYGEN CONTENT|||||||UG/L FEU|||||||POSITIVE||STEPS/MIN||||NORMAL|NOT DONE||||LYSATE|LACTESCENT|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|FIBROMETER FORMULA||N|Y|Y|U|||U|5||7||INDUCTION TREATMENT|1967-08-05|1968-06-09|||||1964-02-07||1965-07-17|U|1971-02-13
TRIAL STUDY 134XCP|LB|AE127EDD-D708-4B1A-95F7-176A541A9584|2||||LEPTIN|LEPTIN|||||||S*KPA|||||||NEGATIVE||/500 WBC||||NORMAL|NOT DONE||||HAIR FOLLICLE|DRIED|U|SPECT/CT SCAN|MDRD FORMULA||U|Y|U|N|||NA|5||7||OPEN LABEL TREATMENT|1964-10-01|1964-05-08|||||1968-03-09||1969-02-05|U|1961-12-29
TRIAL STUDY 134XCP|LB|F642D4A0-A67F-4A10-BB21-E4644E963D45|1||||LDH|LACTATE DEHYDROGENASE|||||||MEQ/UG|||||||BORDERLINE||L/L||||ABNORMAL|NOT DONE||||MECONIUM|UNEXPECTED ODOR|N|WRIGHT STAIN|CKD-EPI CYSTATIN C FORMULA||NA|U|N|NA|||N|1||38||WASHOUT|1964-06-05|1968-05-05|||||1973-05-14||1966-01-31|Y|1960-08-25
TRIAL STUDY 134XCP|LB|F642D4A0-A67F-4A10-BB21-E4644E963D45|2||||LIPASEG|LIPASE, GASTRIC|||||||MM/MIN|||||||POSITIVE||UG/H||||NORMAL|NOT DONE||||SMEGMA|UNEXPECTED ODOR|N|MOUSE PROTECTION ASSAY|COCKCROFT-GAULT FORMULA||N|Y|Y|Y|||U|1||38||TREATMENT|1961-11-09|1960-09-15|||||1968-11-27||1962-04-07|U|1961-09-24
TRIAL STUDY 134XCP|LB|F642D4A0-A67F-4A10-BB21-E4644E963D45|1||||LDLP|LDL PARTICLES|||||||/MM2|||||||POSITIVE||U/G/DAY||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE|NA|SISH|MDRD 4 VARIABLE FORMULA||NA|Y|NA|NA|||N|2||58||RUN-IN|1963-05-20|1962-11-28|||||1961-12-13||1971-02-04|Y|1973-01-18
TRIAL STUDY 134XCP|LB|F642D4A0-A67F-4A10-BB21-E4644E963D45|2||||PLSMCE|MATURE PLASMA CELLS|||||||PG|||||||NEGATIVE||AGU/ML||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|REFRIGERATED|NA|BRDU CELLULAR PROLIFERATION ASSAY|MDRD FORMULA||N|NA|U|N|||U|2||58||RUN-IN|1964-10-02|1970-03-22|||||1965-11-04||1968-02-28|NA|1961-11-27
TRIAL STUDY 134XCP|LB|F642D4A0-A67F-4A10-BB21-E4644E963D45|1||||OXZPM|OXAZEPAM|||||||KM/H|||||||BORDERLINE||/KG||||HIGH|NOT DONE||||SERUM|LACTESCENT|U|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|FIBROTEST FORMULA||N|Y|NA|Y|||Y|3||39||OPEN LABEL TREATMENT|1960-08-13|1968-02-04|||||1966-10-06||1970-02-11|Y|1972-02-08
TRIAL STUDY 134XCP|LB|F642D4A0-A67F-4A10-BB21-E4644E963D45|2||||PARICEAB|PARIETAL CELL ANTIBODY|||||||10^9/G|||||||INVALID||CI/KG||||NORMAL|NOT DONE||||DIALYSIS FLUID|LIPEMIC|U|SANGER SEQUENCING|CKD-EPI FORMULA||N|NA|N|Y|||N|3||39||SCREENING|1962-01-28|1972-03-25|||||1960-09-02||1972-02-27|Y|1970-09-13
TRIAL STUDY 134XCP|LB|F642D4A0-A67F-4A10-BB21-E4644E963D45|1||||IMMGLB|IMMUNOGLOBULIN|||||||TRANSDUCING UNIT/ML|||||||POSITIVE||KPA/L/SEC||||LOW|NOT DONE||||CORD BLOOD|AUTOLYZED|N|DYNAMOMETRY|CKD-EPI CYSTATIN C FORMULA||U|U|U|Y|||N|4||88||FOLLOW-UP|1966-02-11|1964-09-07|||||1970-02-02||1965-05-07|Y|1966-03-27
TRIAL STUDY 134XCP|LB|F642D4A0-A67F-4A10-BB21-E4644E963D45|2||||HDL3|HDL-CHOLESTEROL SUBCLASS 3|||||||POINT|||||||INVALID||MDFI||||ABNORMAL|NOT DONE||||BONE|LACTESCENT|NA|RADIOIMMUNOPRECIPITATION ASSAY|MDRD 5 VARIABLE FORMULA||N|N|U|NA|||U|4||88||LONG-TERM FOLLOW-UP|1961-04-29|1965-05-16|||||1971-09-29||1973-06-24|NA|1960-11-01
TRIAL STUDY 134XCP|LB|F642D4A0-A67F-4A10-BB21-E4644E963D45|1||||ETHANOL|ETHANOL|||||||/5X10^4 WBC|||||||TRACE||MG/G/H||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|GELLED|U|IMMUNORADIOMETRIC ASSAY|FIBROMETER FORMULA||N|NA|U|N|||Y|5||7||RUN-IN|1965-03-13|1967-12-20|||||1962-07-31||1973-03-05|N|1965-08-16
TRIAL STUDY 134XCP|LB|F642D4A0-A67F-4A10-BB21-E4644E963D45|2||||HGBS|HEMOGLOBIN S|||||||CI/L|||||||INDETERMINATE||DPM/ML||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|THAWED|Y|FLOW CYTOMETRY|MDRD 4 VARIABLE FORMULA||NA|Y|U|NA|||Y|5||7||RUN-IN|1961-10-18|1971-04-11|||||1966-01-02||1968-05-16|N|1971-07-01
TRIAL STUDY 134XCP|LB|933A6DFF-D519-46F4-AB52-78E6A898E4A1|1||||E1S|ESTRONE SULFATE|||||||G/CAGE/DAY|||||||NEGATIVE||NGEQ/L||||HIGH|NOT DONE||||MECONIUM|ICTERIC|U|PERFUSION MRI|GMI MMOL/MOL FORMULA||NA|NA|Y|N|||Y|1||38||RUN-IN|1968-05-17|1972-10-15|||||1965-08-26||1970-12-27|U|1968-09-22
TRIAL STUDY 134XCP|LB|933A6DFF-D519-46F4-AB52-78E6A898E4A1|2||||HGF|HEPATOCYTE GROWTH FACTOR|||||||MM3/MM2/YEAR|||||||NEGATIVE||MOSM/KG||||NORMAL|NOT DONE||||PLASMA|FRESH|Y|PULSE OXIMETRY|MDRD 6 VARIABLE FORMULA||NA|N|Y|Y|||Y|1||38||SCREENING|1971-06-06|1971-03-29|||||1960-04-14||1965-02-09|Y|1960-11-25
TRIAL STUDY 134XCP|LB|933A6DFF-D519-46F4-AB52-78E6A898E4A1|1||||HCGNDI|CHORIOGONADOTROPIN, INTACT|||||||MM/H|||||||NEGATIVE||FT||||NORMAL|NOT DONE||||COLOSTRUM|FROZEN|U|HEMOCYTOMETRY|GMI MMOL/MOL FORMULA||NA|N|Y|Y|||U|2||58||INDUCTION TREATMENT|1969-05-22|1972-04-04|||||1970-10-30||1960-12-30|NA|1972-07-26
TRIAL STUDY 134XCP|LB|933A6DFF-D519-46F4-AB52-78E6A898E4A1|2||||PLAGMAMP|PLATELET AGGREGATION MEAN AMPLITUDE|||||||TABLET|||||||BORDERLINE||PMOL||||NORMAL|NOT DONE||||CAPILLARY PLASMA|REFRIGERATED|U|REBOUND TONOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|U|N|||N|2||58||FOLLOW-UP|1971-12-09|1971-04-23|||||1965-08-09||1962-10-25|U|1967-03-05
TRIAL STUDY 134XCP|LB|933A6DFF-D519-46F4-AB52-78E6A898E4A1|1||||APPA|AMYLOID ALPHA PRECURSOR PROTEIN|||||||G/M2|||||||INVALID||10^4/L||||LOW|NOT DONE||||ARTERIAL BLOOD|FRESH|Y|FUNDUS PHOTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|N|U|||N|3||39||LONG-TERM FOLLOW-UP|1969-09-27|1973-07-12|||||1962-08-23||1961-06-07|U|1966-11-19
TRIAL STUDY 134XCP|LB|933A6DFF-D519-46F4-AB52-78E6A898E4A1|2||||PDL1S|SOLUBLE PROGRAMMED DEATH LIGAND 1|||||||ML/CAGE/DAY|||||||NEGATIVE||ML/DL||||LOW|NOT DONE||||DISCHARGE|NON-HEMOLYZED|U|IMPULSE OSCILLOMETRY|MDRD 5 VARIABLE FORMULA||NA|U|U|N|||U|3||39||LONG-TERM FOLLOW-UP|1971-10-01|1963-08-05|||||1972-02-29||1966-04-16|U|1969-02-22
TRIAL STUDY 134XCP|LB|933A6DFF-D519-46F4-AB52-78E6A898E4A1|1||||C165937|ZEA MAYS IGE AB RAST SCORE|||||||UG/MIN|||||||INVALID||10^8 PFU||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|UNEXPECTED ODOR|U|FLUORESCENT MICROSCOPY|MDRD ENZYMATIC FORMULA||N|NA|N|NA|||U|4||88||FOLLOW-UP|1973-05-16|1961-01-04|||||1964-07-20||1969-09-21|Y|1961-09-29
TRIAL STUDY 134XCP|LB|933A6DFF-D519-46F4-AB52-78E6A898E4A1|2||||BHYXBTR|BETA-HYDROXYBUTYRATE|||||||U/ML|||||||INVALID||ELISA UNIT/ML||||NORMAL|NOT DONE||||BONE MARROW|LACTESCENT|N|SNP ARRAY|CKD-EPI FORMULA||U|Y|NA|N|||NA|4||88||WASHOUT|1964-05-19|1969-11-14|||||1967-03-01||1966-12-29|NA|1966-11-10
TRIAL STUDY 134XCP|LB|933A6DFF-D519-46F4-AB52-78E6A898E4A1|1||||SEZCELY|SEZARY CELLS/LYMPHOCYTES|||||||10^3 ORGANISMS/ML|||||||TRACE||G/U||||HIGH|NOT DONE||||CORD BLOOD|ROOM TEMPERATURE|NA|SNP ARRAY|MDRD 4 VARIABLE FORMULA||Y|NA|NA|U|||N|5||7||SCREENING|1965-04-14|1961-01-23|||||1970-04-29||1970-08-09|NA|1962-02-03
TRIAL STUDY 134XCP|LB|933A6DFF-D519-46F4-AB52-78E6A898E4A1|2||||HGBOXY|OXYHEMOGLOBIN|||||||G/KG/DAY|||||||INDETERMINATE||RATIO||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED|N|SCANNING ELECTRON MICROSCOPY|MDRD ENZYMATIC FORMULA||N|U|N|Y|||Y|5||7||BLINDED TREATMENT|1967-11-03|1973-02-09|||||1961-01-18||1968-03-16|U|1964-01-04
TRIAL STUDY 134XCP|LB|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|1||||CTXIICRT|TYPE II COLLAGEN C-TELOPEPTIDES/CREAT|||||||10^6 ORGANISMS/ML|||||||TRACE||OZ EQ||||NORMAL|NOT DONE||||DERMAL TISSUE|NON-HEMOLYZED|Y|TOTAL BODY RADIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|NA|N|||U|1||38||OPEN LABEL TREATMENT|1968-02-15|1964-07-15|||||1965-06-29||1970-11-20|N|1968-09-26
TRIAL STUDY 134XCP|LB|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|2||||C165894|D. FARINAE ANTIGEN IGG4 ANTIBODY|||||||UM/DAY|||||||BORDERLINE||UG/M2/H||||NORMAL|NOT DONE||||PUS|GELLED|N|TARGETED TRANSCRIPTOME SEQUENCING|HEPASCORE FORMULA||NA|U|N|Y|||N|1||38||WASHOUT|1969-09-22|1967-03-28|||||1964-02-02||1963-11-02|Y|1965-10-24
TRIAL STUDY 134XCP|LB|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|1||||HGBAHGB|HEMOGLOBIN A/TOTAL HEMOGLOBIN|||||||MG/KG/H|||||||BORDERLINE||AMOL||||ABNORMAL|NOT DONE||||PLATELET|DRIED|NA|SECONDARY ION MASS SPECTOMETRY|MDRD ENZYMATIC FORMULA||N|NA|NA|U|||N|2||58||SCREENING|1967-03-13|1963-09-03|||||1962-06-11||1970-10-11|Y|1970-07-09
TRIAL STUDY 134XCP|LB|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|2||||DECORIN|DECORIN|||||||MJOULE/CM2|||||||BORDERLINE||MMOL/MOL||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|FROZEN|NA|HPLC-FL|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|N|Y|||U|2||58||BASELINE|1966-08-21|1962-03-31|||||1963-04-06||1964-10-28|Y|1970-10-20
TRIAL STUDY 134XCP|LB|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|1||||LIPASLAL|LIPASE, LYSOSOMAL ACID|||||||KIU|||||||TRACE||MIN*MG/ML||||LOW|NOT DONE||||LEUKOCYTE|LIPEMIC|N|IN VITRO GENE EXPRESSION ASSAY|ASH FIBROSURE FORMULA||NA|NA|Y|N|||U|3||39||CONTINUATION TREATMENT|1961-02-04|1969-02-12|||||1969-08-19||1966-03-07|N|1966-04-07
TRIAL STUDY 134XCP|LB|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|2||||PLATBIZ|BIZARRE PLATELETS|||||||MPL U|||||||POSITIVE||TUBE||||NORMAL|NOT DONE||||FLUID|SOLIDIFIED|N|MACRO BROTH DILUTION|ASH FIBROSURE FORMULA||U|Y|U|NA|||N|3||39||CONTINUATION TREATMENT|1962-05-10|1967-03-17|||||1970-08-28||1964-11-20|N|1965-03-03
TRIAL STUDY 134XCP|LB|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|1||||IGSOL|SOLUBLE IMMUNOGLOBULIN|||||||/10^5|||||||TRACE||CIGARETTE||||LOW|NOT DONE||||TRANSUDATE|REFRIGERATED|U|MULTIPLEXED BEAD BASED IMMUNOASSAY|FIBROTEST FORMULA||NA|NA|NA|U|||N|4||88||BASELINE|1971-01-24|1965-04-15|||||1962-11-19||1973-07-30|U|1961-04-27
TRIAL STUDY 134XCP|LB|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|2||||SPMPSPM|SPERMATOZOA, PROGRESSIVE/SPERMATOZOA|||||||CI/ML|||||||INVALID||KIT||||HIGH|NOT DONE||||CERUMEN|UNEXPECTED ODOR|U|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|FIBROTEST FORMULA||N|Y|NA|NA|||Y|4||88||FOLLOW-UP|1962-05-03|1964-07-21|||||1965-11-30||1972-12-03|Y|1967-06-04
TRIAL STUDY 134XCP|LB|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|1||||ICAM|INTERCELLULAR ADHESION MOLECULE|||||||COPIES/UG|||||||NEGATIVE||NKAT/L||||NORMAL|NOT DONE||||NAIL|NON-HEMOLYZED|U|PULSE OXIMETRY|COCKCROFT-GAULT FORMULA||Y|NA|NA|Y|||NA|5||7||OPEN LABEL TREATMENT|1968-11-21|1970-08-26|||||1972-11-06||1965-08-15|U|1965-04-19
TRIAL STUDY 134XCP|LB|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|2||||BLSTMGK|MEGAKARYOBLASTS|||||||OZ EQ|||||||NEGATIVE||BREATHS/30S||||HIGH|NOT DONE||||REFLEX TEAR|PARAFFIN-EMBEDDED|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD ENZYMATIC FORMULA||N|U|NA|Y|||U|5||7||TREATMENT|1963-10-09|1964-12-02|||||1965-05-25||1966-04-03|NA|1971-09-08
TRIAL STUDY 134XCP|LB|38E177D4-1A58-4E78-90B7-85F76BF66826|1||||INTLK24|INTERLEUKIN 24|||||||ML/G/DAY|||||||INVALID||UG/DAY||||HIGH|NOT DONE||||SPERMATOZOON|PARAFFIN-EMBEDDED|N|MRI WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA||U|U|NA|U|||Y|1||38||BASELINE|1963-05-18|1972-04-04|||||1971-05-26||1962-06-16|NA|1969-12-15
TRIAL STUDY 134XCP|LB|38E177D4-1A58-4E78-90B7-85F76BF66826|2||||PHNBRBTL|PHENOBARBITAL|||||||G/U|||||||INDETERMINATE||MOL/G||||NORMAL|NOT DONE||||LYSATE|CONTAMINATED|NA|ANALYTICAL ULTRACENTRIFUGATION|MDRD FORMULA||N|Y|N|NA|||U|1||38||LONG-TERM FOLLOW-UP|1965-03-14|1968-09-12|||||1973-05-29||1970-07-11|NA|1964-04-17
TRIAL STUDY 134XCP|LB|38E177D4-1A58-4E78-90B7-85F76BF66826|1||||FENTANYL|FENTANYL|||||||YEARS|||||||TRACE||DIOPTER||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|LIPEMIC|U|NUCLEIC ACID HYBRIDIZATION|MDRD 4 VARIABLE FORMULA||N|Y|NA|U|||Y|2||58||TREATMENT|1965-11-10|1961-09-15|||||1961-10-26||1964-12-14|U|1969-01-30
TRIAL STUDY 134XCP|LB|38E177D4-1A58-4E78-90B7-85F76BF66826|2||||HALLUC|HALLUCINOGEN|||||||GAUSS|||||||BORDERLINE||CFU/ML||||NORMAL|NOT DONE||||GASTRIC FLUID|THAWED|U|FLUORIMETRY|MDRD 4 VARIABLE FORMULA||N|Y|N|U|||N|2||58||TREATMENT|1961-05-24|1972-05-09|||||1966-03-22||1971-09-27|Y|1970-08-05
TRIAL STUDY 134XCP|LB|38E177D4-1A58-4E78-90B7-85F76BF66826|1||||HDLCLDLC|HDL CHOLESTEROL/LDL CHOLESTEROL|||||||IN2|||||||TRACE||%||||LOW|NOT DONE||||RETICULOCYTES|AUTOLYZED|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD 6 VARIABLE FORMULA||U|U|NA|N|||N|3||39||INDUCTION TREATMENT|1965-12-23|1962-06-10|||||1968-11-10||1971-05-27|U|1964-06-07
TRIAL STUDY 134XCP|LB|38E177D4-1A58-4E78-90B7-85F76BF66826|2||||BACT|BACTERIA|||||||RPM|||||||INDETERMINATE||AMPULE||||ABNORMAL|NOT DONE||||SOFT TISSUE|CALCIFIED|NA|SCANNING ELECTRON MICROSCOPY|MDRD ENZYMATIC FORMULA||U|U|U|N|||NA|3||39||TREATMENT|1968-05-30|1970-11-26|||||1971-11-25||1969-01-19|Y|1967-03-20
TRIAL STUDY 134XCP|LB|38E177D4-1A58-4E78-90B7-85F76BF66826|1||||EPISQTCE|SQUAMOUS TRANSITIONAL EPITHELIAL CELLS|||||||10^3 ORGANISMS/ML|||||||BORDERLINE||ML/ANIMAL/DAY||||HIGH|NOT DONE||||SEBUM|CALCIFIED|Y|APPLANATION TONOMETRY|GMI MMOL/MOL FORMULA||N|N|NA|NA|||Y|4||88||FOLLOW-UP|1968-04-03|1963-09-22|||||1966-06-16||1964-08-22|NA|1967-08-29
TRIAL STUDY 134XCP|LB|38E177D4-1A58-4E78-90B7-85F76BF66826|2||||GSTMU|MU GLUTATHIONE-S-TRANSFERASE|||||||NMOL BCE/NMOL|||||||TRACE||U/M2/DAY||||LOW|NOT DONE||||COLOSTRUM|CONTAMINATED|U|CHROMATOGRAPHY|MDRD 5 VARIABLE FORMULA||U|NA|NA|NA|||Y|4||88||FOLLOW-UP|1972-08-06|1972-01-23|||||1972-12-25||1966-05-15|N|1960-08-31
TRIAL STUDY 134XCP|LB|38E177D4-1A58-4E78-90B7-85F76BF66826|1||||SODMEXR|SODIUM EXCRETION RATE|||||||PMOL|||||||TRACE||SBE/ML||||LOW|NOT DONE||||BUFFY COAT|AUTOLYZED|U|GC/MS/MS|NASH FIBROSURE FORMULA||N|U|N|Y|||N|5||7||WASHOUT|1961-12-01|1963-11-22|||||1961-10-09||1965-05-23|Y|1970-03-07
TRIAL STUDY 134XCP|LB|38E177D4-1A58-4E78-90B7-85F76BF66826|2||||NEUTGT|GIANT NEUTROPHILS|||||||DEG/S|||||||POSITIVE||/VF||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|CONCENTRATED|U|SURFACE PLASMON RESONANCE|ASH FIBROSURE FORMULA||Y|NA|N|N|||Y|5||7||SCREENING|1967-07-15|1964-11-09|||||1971-09-20||1963-11-04|Y|1963-06-06
TRIAL STUDY 134XCP|LB|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|1||||DRUGSCR|DRUG SCREEN|||||||10^7 CFU|||||||INVALID||FMOL/L/SEC||||NORMAL|NOT DONE||||DIALYSIS FLUID|AUTOLYZED|U|PYROSEQUENCING|GMI MMOL/MOL FORMULA||U|N|U|N|||U|1||38||INDUCTION TREATMENT|1962-03-20|1960-06-07|||||1961-05-18||1972-09-05|U|1973-06-03
TRIAL STUDY 134XCP|LB|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|2||||CD8LY|CD8/LYMPHOCYTES|||||||L/S/KPA|||||||BORDERLINE||DPM/0.5 ML||||LOW|NOT DONE||||SKIN TISSUE|SOLIDIFIED|N|MICROBIAL CULTURE, LIQUID|HEPASCORE FORMULA||N|N|Y|U|||N|1||38||CONTINUATION TREATMENT|1968-06-11|1967-11-22|||||1965-01-26||1968-06-22|U|1962-06-27
TRIAL STUDY 134XCP|LB|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|1||||C4D|COMPLEMENT C4D|||||||KALLIKREIN INHIBITOR UNIT|||||||NEGATIVE||10^11/L||||HIGH|NOT DONE||||PLATELET POOR PLASMA|ROOM TEMPERATURE|N|FARNSWORTH-MUNSELL 100 HUE TEST|HEPASCORE FORMULA||U|N|U|N|||N|2||58||INDUCTION TREATMENT|1964-10-28|1973-03-01|||||1971-05-20||1961-10-09|U|1961-05-27
TRIAL STUDY 134XCP|LB|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|2||||CXCR3|CHEMOKINE (C-X-C MOTIF) RECEPTOR 3|||||||MU/G|||||||TRACE||OD UNIT||||ABNORMAL|NOT DONE||||URINE|LIPEMIC|Y|LC-FL|CKD-EPI FORMULA||Y|N|Y|NA|||Y|2||58||INDUCTION TREATMENT|1964-02-26|1960-01-18|||||1972-01-11||1962-04-13|Y|1972-06-11
TRIAL STUDY 134XCP|LB|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|1||||GAD1|GLUTAMIC ACID DECARBOXYLASE 1|||||||U/MMOL|||||||BORDERLINE||DEG||||LOW|NOT DONE||||LEUKOCYTE|REFRIGERATED|N|NEXT GENERATION TARGETED SEQUENCING|MDRD 6 VARIABLE FORMULA||NA|NA|U|U|||U|3||39||BASELINE|1963-09-25|1964-03-08|||||1964-09-16||1961-11-21|N|1968-03-16
TRIAL STUDY 134XCP|LB|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|2||||CORCREAT|CORTISOL/CREATININE|||||||CS|||||||NEGATIVE||PLUG||||NORMAL|NOT DONE||||GASTRIC FLUID|DRIED|Y|HPLC/MS|GMI % FORMULA||U|NA|Y|Y|||Y|3||39||BASELINE|1962-11-10|1960-05-02|||||1960-08-04||1966-06-04|N|1964-09-07
TRIAL STUDY 134XCP|LB|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|1||||SCBRBTL|SECOBARBITAL|||||||MU/G|||||||INVALID||/MM2||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|LIPEMIC|N|MICROBIAL CULTURE, LIQUID|NASH FIBROSURE FORMULA||Y|NA|N|NA|||NA|4||88||WASHOUT|1965-08-11|1964-08-23|||||1960-07-06||1962-08-03|U|1967-02-16
TRIAL STUDY 134XCP|LB|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|2||||PAPPEN|PAPPENHEIMER BODIES|||||||UMOL/L|||||||INDETERMINATE||MG2/DL2||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|HEMOLYZED|N|PEAK FLOWMETRY|FIBROSIS 4 FORMULA||Y|Y|NA|N|||U|4||88||LONG-TERM FOLLOW-UP|1960-08-11|1968-05-29|||||1960-11-11||1970-03-25|U|1973-06-08
TRIAL STUDY 134XCP|LB|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|1||||CYSCREAT|CYSTATIN C/CREATININE|||||||MG/KG/MIN|||||||INDETERMINATE||ML/DAY||||HIGH|NOT DONE||||SKIN TISSUE|FROZEN|NA|CARDIAC THERMODILUTION|MDRD 6 VARIABLE FORMULA||NA|U|N|U|||Y|5||7||FOLLOW-UP|1972-01-18|1969-06-24|||||1972-08-30||1967-05-21|N|1970-03-11
TRIAL STUDY 134XCP|LB|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|2||||CYCHOL|CHOLESTEROL CRYSTALS|||||||%(W/W)|||||||INVALID||NMOL/G||||HIGH|NOT DONE||||SERUM OR PLASMA|ICTERIC|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|COCKCROFT-GAULT FORMULA||Y|U|U|Y|||Y|5||7||OBSERVATION|1969-12-17|1968-07-29|||||1966-04-08||1966-01-12|Y|1968-08-23
TRIAL STUDY 134XCP|LB|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|1||||ESTRIOLF|ESTRIOL, FREE|||||||10^6 ORGANISMS/ML|||||||INVALID||LOG10 ELISA UNIT/DOSE||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|FROZEN|Y|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|CKD-EPI FORMULA||NA|N|N|Y|||Y|1||38||BLINDED TREATMENT|1968-11-28|1968-06-28|||||1963-03-01||1960-06-18|U|1966-09-01
TRIAL STUDY 134XCP|LB|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|2||||IFI27|INTERFERON ALPHA-INDUCIBLE PROTEIN 27|||||||KG/CM|||||||BORDERLINE||CG||||LOW|NOT DONE||||VITREOUS HUMOR|GELLED|NA|VIRUS PLAQUE ASSAY|MDRD FORMULA||N|U|N|U|||Y|1||38||WASHOUT|1968-08-20|1965-10-25|||||1963-08-01||1962-06-10|N|1961-08-21
TRIAL STUDY 134XCP|LB|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|1||||CSRBC|RBC CASTS|||||||TRANSDUCING UNIT/ML|||||||NEGATIVE||TUBE||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|REFRIGERATED|NA|IMMUNO-PET SCAN|FIBROSIS 4 FORMULA||U|N|U|U|||U|2||58||CONTINUATION TREATMENT|1972-01-22|1965-05-13|||||1960-12-19||1961-09-16|N|1970-07-11
TRIAL STUDY 134XCP|LB|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|2||||HYDMRPHN|HYDROMORPHONE|||||||EQ|||||||POSITIVE||FFU||||NORMAL|NOT DONE||||ISOLATE|CONTAMINATED|Y|DIRECT SEQUENCING|GMI MMOL/MOL FORMULA||NA|N|Y|N|||N|2||58||RUN-IN|1967-03-11|1963-03-20|||||1969-03-14||1972-05-24|N|1973-03-02
TRIAL STUDY 134XCP|LB|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|1||||LDH2LDH|LDH ISOENZYME 2/LDH|||||||UG/L/H|||||||BORDERLINE||MMOL2/L2||||NORMAL|NOT DONE||||BONE|CLOTTED|N|REFLECTANCE SPECTROSCOPY|MDRD 5 VARIABLE FORMULA||N|U|N|Y|||Y|3||39||OBSERVATION|1966-09-02|1963-05-16|||||1973-01-31||1972-10-04|U|1971-03-05
TRIAL STUDY 134XCP|LB|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|2||||BLSTMBCE|MYELOBLASTS/TOTAL CELLS|||||||BQ/L|||||||INDETERMINATE||CPM||||HIGH|NOT DONE||||INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|NA|EPSILOMETER|GMI MMOL/MOL FORMULA||N|NA|N|U|||N|3||39||CONTINUATION TREATMENT|1969-11-21|1965-10-25|||||1966-04-07||1964-02-03|N|1963-12-22
TRIAL STUDY 134XCP|LB|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|1||||ALPLALP|ALK PHOS, LIVER/TOTAL ALK PHOS|||||||TSP EQ|||||||TRACE||P||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA||NA|NA|U|U|||U|4||88||OPEN LABEL TREATMENT|1960-01-14|1964-04-20|||||1964-12-31||1963-07-19|U|1967-04-03
TRIAL STUDY 134XCP|LB|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|2||||ACYGLYCN|ACYLGLYCINE|||||||L/H/M2|||||||TRACE||% INHIBITION||||HIGH|NOT DONE||||LUNG SURFACTANT|CALCIFIED|U|RAJI CELL RIA|FIBROMETER FORMULA||N|Y|NA|NA|||U|4||88||WASHOUT|1971-09-23|1972-12-19|||||1970-04-24||1962-09-20|U|1969-07-12
TRIAL STUDY 134XCP|LB|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|1||||PMDW|PLATELET MASS DISTRIBUTION WIDTH|||||||UG/M2/MIN|||||||INVALID||CAN||||HIGH|NOT DONE||||ISOLATE|SOLIDIFIED|N|PEAK FLOWMETRY|FIBROMETER FORMULA||Y|U|NA|U|||NA|5||7||WASHOUT|1971-03-15|1966-09-29|||||1963-11-02||1964-10-30|N|1962-09-29
TRIAL STUDY 134XCP|LB|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|2||||STIPBASO|BASOPHILIC STIPPLING|||||||CAPLET|||||||TRACE||MEQ||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|NA|POLYGRAPHY|FIBROMETER FORMULA||N|Y|Y|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1968-03-18|1960-01-30|||||1964-06-13||1965-03-19|N|1965-12-07
TRIAL STUDY 134XCP|LB|50CFC814-7135-4356-BAC2-3F975B9F6AE3|1||||DSG1AB|DESMOGLEIN 1 ANTIBODY|||||||10^11/L|||||||POSITIVE||BOWL||||HIGH|NOT DONE||||DERMAL TISSUE|ICTERIC|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|FIBROMETER FORMULA||NA|U|U|Y|||NA|1||38||INDUCTION TREATMENT|1960-11-09|1965-10-09|||||1962-10-07||1968-11-12|Y|1967-09-30
TRIAL STUDY 134XCP|LB|50CFC814-7135-4356-BAC2-3F975B9F6AE3|2||||MIP1B|MACROPHAGE INFLAMMATORY PROTEIN 1 BETA|||||||CI|||||||TRACE||LOG10 TCID 50/DOSE||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|CONTAMINATED|U|OLIGO ACGH|CKD-EPI CREATININE FORMULA||NA|U|NA|NA|||NA|1||38||OBSERVATION|1973-05-23|1960-06-07|||||1971-05-12||1962-04-08|N|1964-08-30
TRIAL STUDY 134XCP|LB|50CFC814-7135-4356-BAC2-3F975B9F6AE3|1||||HIS|HISTIDINE|||||||U/M2|||||||POSITIVE||MG/G/H||||NORMAL|NOT DONE||||HAIR|CALCIFIED|Y|SPECTROPHOTOMETRY|MDRD 6 VARIABLE FORMULA||N|NA|U|Y|||NA|2||58||INDUCTION TREATMENT|1960-06-25|1961-12-29|||||1966-07-08||1970-09-13|N|1964-11-12
TRIAL STUDY 134XCP|LB|50CFC814-7135-4356-BAC2-3F975B9F6AE3|2||||P1NP|PROCOLLAGEN 1 N-TERMINAL PROPEPTIDE|||||||LOG10 CCID 50/DOSE|||||||POSITIVE||CFU/G||||ABNORMAL|NOT DONE||||MUCUS|REFRIGERATED|NA|MICROBIAL CONCENTRATION|MDRD 4 VARIABLE FORMULA||N|U|U|U|||U|2||58||INDUCTION TREATMENT|1972-04-25|1962-06-13|||||1966-08-31||1962-11-10|U|1968-05-05
TRIAL STUDY 134XCP|LB|50CFC814-7135-4356-BAC2-3F975B9F6AE3|1||||ANGTNS2|ANGIOTENSIN II|||||||MG/ML/MIN|||||||TRACE||ML/MIN||||HIGH|NOT DONE||||LYMPH|GELLED|N|CALIPER MEASUREMENT METHOD|CKD-EPI FORMULA||Y|U|U|U|||N|3||39||FOLLOW-UP|1962-08-14|1968-04-27|||||1968-07-22||1965-12-12|Y|1962-10-21
TRIAL STUDY 134XCP|LB|50CFC814-7135-4356-BAC2-3F975B9F6AE3|2||||C130110|MOLD MIX ANTIGEN IGG ANTIBODY|||||||CARTRIDGE|||||||NEGATIVE||10^6/EJACULATE U||||NORMAL|NOT DONE||||BILE|NON-HEMOLYZED|N|OSCILLOMETRY|COCKCROFT-GAULT FORMULA||NA|Y|U|Y|||NA|3||39||WASHOUT|1962-12-10|1964-11-23|||||1972-08-09||1962-01-28|NA|1965-11-18
TRIAL STUDY 134XCP|LB|50CFC814-7135-4356-BAC2-3F975B9F6AE3|1||||CX3CL1|CHEMOKINE (C-X3-C MOTIF) LIGAND 1|||||||MG/KG/H|||||||INDETERMINATE||UG/L DDU||||HIGH|NOT DONE||||NAIL|CALCIFIED|NA|GC/MS-EI|COCKCROFT-GAULT FORMULA||N|NA|U|U|||U|4||88||BASELINE|1961-06-25|1960-05-25|||||1966-01-25||1973-03-15|Y|1973-01-30
TRIAL STUDY 134XCP|LB|50CFC814-7135-4356-BAC2-3F975B9F6AE3|2||||ASMACT|ALPHA-SMOOTH MUSCLE ACTIN|||||||MMHG/L/MIN|||||||INVALID||UL/KG/DAY||||NORMAL|NOT DONE||||TRANSUDATE|LACTESCENT|Y|CINEANGIOGRAPHY|FIBROTEST FORMULA||NA|N|N|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1968-09-24|1971-07-24|||||1967-07-14||1966-06-17|N|1960-05-16
TRIAL STUDY 134XCP|LB|50CFC814-7135-4356-BAC2-3F975B9F6AE3|1||||IFIT3|INTERFERON-INDUCED 60 KDA PROTEIN|||||||SYRINGE|||||||TRACE||/MM||||LOW|NOT DONE||||CAPILLARY BLOOD|ICTERIC|Y|TONOMETRY|MDRD 5 VARIABLE FORMULA||Y|Y|NA|N|||NA|5||7||CONTINUATION TREATMENT|1969-04-08|1968-07-20|||||1967-05-17||1972-08-25|U|1970-02-10
TRIAL STUDY 134XCP|LB|50CFC814-7135-4356-BAC2-3F975B9F6AE3|2||||CHCMR|RET. CORPUSCULAR HGB CONCENTRATION MEAN|||||||U/G HB|||||||INVALID||ANTIBODY UNIT||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|HEMOLYZED|U|FLUORESCENT IMMUNOASSAY|CKD-EPI CREATININE FORMULA||U|N|Y|Y|||Y|5||7||SCREENING|1960-12-07|1966-04-21|||||1970-07-30||1963-08-28|U|1963-10-28
TRIAL STUDY 134XCP|LB|8A639816-D878-4FD7-AF28-CF9EA2236462|1||||ACANT|ACANTHOCYTES|||||||FIU|||||||INDETERMINATE||10^3 ORGANISMS/ML||||HIGH|NOT DONE||||CORD SERUM|CALCIFIED|U|FORCED OSCILLATION TECHNIQUE|CKD-EPI CREATININE FORMULA||U|U|Y|U|||U|1||38||OBSERVATION|1971-10-25|1962-07-16|||||1969-06-08||1961-11-08|U|1960-08-10
TRIAL STUDY 134XCP|LB|8A639816-D878-4FD7-AF28-CF9EA2236462|2||||PHOSCRT|PHOSPHATE/CREATININE|||||||MS2|||||||NEGATIVE||STEPS||||HIGH|NOT DONE||||INTERSTITIAL FLUID|FRESH|U|JAFFE REACTION|GMI MMOL/MOL FORMULA||NA|NA|N|NA|||N|1||38||FOLLOW-UP|1967-12-25|1964-08-17|||||1968-05-23||1970-05-10|Y|1962-08-24
TRIAL STUDY 134XCP|LB|8A639816-D878-4FD7-AF28-CF9EA2236462|1||||CTOT|COMPLEMENT TOTAL|||||||UG/L DDU|||||||NEGATIVE||ABSORBANCE U||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|ROOM TEMPERATURE|Y|STATIC PERIMETRY|HEPASCORE FORMULA||Y|N|Y|Y|||Y|2||58||CONTINUATION TREATMENT|1965-02-10|1965-12-20|||||1968-08-01||1962-02-20|U|1964-03-07
TRIAL STUDY 134XCP|LB|8A639816-D878-4FD7-AF28-CF9EA2236462|2||||MYPCERPC|MYELOID/ERYTHROID RATIO|||||||RATIO|||||||INDETERMINATE||BAR||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED|NA|TURBIDIMETRY|GMI % FORMULA||NA|Y|Y|NA|||Y|2||58||BLINDED TREATMENT|1968-05-17|1973-03-26|||||1962-09-23||1968-07-05|Y|1969-04-24
TRIAL STUDY 134XCP|LB|8A639816-D878-4FD7-AF28-CF9EA2236462|1||||METAMY|METAMYELOCYTES|||||||NMOL BCE/NMOL|||||||TRACE||MS/MMHG||||LOW|NOT DONE||||EMESIS|HEMOLYZED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|MDRD FORMULA||N|N|Y|NA|||Y|3||39||SCREENING|1971-07-11|1969-12-24|||||1972-01-15||1967-09-18|NA|1964-08-20
TRIAL STUDY 134XCP|LB|8A639816-D878-4FD7-AF28-CF9EA2236462|2||||PRZPM|PRAZEPAM|||||||KBQ|||||||INDETERMINATE||KIT||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|FROZEN|U|JAEGER EYE CHART|COCKCROFT-GAULT FORMULA||Y|U|Y|U|||U|3||39||LONG-TERM FOLLOW-UP|1970-11-27|1968-01-13|||||1964-07-10||1966-05-25|Y|1963-08-27
TRIAL STUDY 134XCP|LB|8A639816-D878-4FD7-AF28-CF9EA2236462|1||||BNZDZPN|BENZODIAZEPINE|||||||RATIO|||||||POSITIVE||YEARS||||LOW|NOT DONE||||EMESIS|GELLED|U|CHROMATOGRAPHY|CKD-EPI FORMULA||U|NA|NA|U|||U|4||88||LONG-TERM FOLLOW-UP|1969-10-13|1970-05-21|||||1973-03-29||1964-03-01|NA|1961-08-14
TRIAL STUDY 134XCP|LB|8A639816-D878-4FD7-AF28-CF9EA2236462|2||||ZPP|ZINC PROTOPORPHYRIN|||||||MG/M2|||||||INDETERMINATE||ELISA UNIT/ML||||HIGH|NOT DONE||||ALVEOLAR AIR|LACTESCENT|N|LEAD CITRATE STAIN|FIBROTEST FORMULA||U|Y|Y|NA|||Y|4||88||RUN-IN|1966-05-16|1965-05-02|||||1969-06-28||1972-08-06|N|1963-04-29
TRIAL STUDY 134XCP|LB|8A639816-D878-4FD7-AF28-CF9EA2236462|1||||EOSBLE|EOSINOPHILS BAND FORM/LEUKOCYTES|||||||IU/KG|||||||INDETERMINATE||10^3 CFU/ML||||NORMAL|NOT DONE||||ISOLATE|ICTERIC|U|COMPLEMENT FIXATION|MDRD FORMULA||N|Y|N|N|||Y|5||7||BASELINE|1973-03-11|1964-03-12|||||1972-03-08||1964-08-25|U|1966-04-30
TRIAL STUDY 134XCP|LB|8A639816-D878-4FD7-AF28-CF9EA2236462|2||||TOXVAC|TOXIC VACUOLATION|||||||NMOL/L/H|||||||BORDERLINE||MBQ/UL||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|AGGLUTINATED|U|WHOLE GENOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|U|||U|5||7||FOLLOW-UP|1960-09-11|1972-11-18|||||1960-10-22||1966-05-23|N|1972-06-16
TRIAL STUDY 134XCP|LB|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|1||||MCPHG|MACROPHAGES|||||||CAPFUL|||||||INDETERMINATE||ML/CM3/MIN||||ABNORMAL|NOT DONE||||REFLEX TEAR|REFRIGERATED|Y|IMPULSE OSCILLOMETRY|GMI MMOL/MOL FORMULA||U|NA|NA|NA|||N|1||38||WASHOUT|1969-01-04|1963-09-06|||||1973-04-26||1972-01-26|N|1969-07-04
TRIAL STUDY 134XCP|LB|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|2||||VEGFR3S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC3|||||||HPA|||||||POSITIVE||TSP||||ABNORMAL|NOT DONE||||REFLEX TEAR|PARAFFIN-EMBEDDED|N|MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|N|Y|||U|1||38||OBSERVATION|1972-12-17|1968-08-06|||||1960-10-23||1967-02-09|U|1961-07-29
TRIAL STUDY 134XCP|LB|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|1||||B2G1GAAB|BETA-2 GLYCOPROTEIN 1 IGA ANTIBODY|||||||INHALATION|||||||INVALID||MG/G/H||||HIGH|NOT DONE||||GASTRIC CONTENTS|ICTERIC|N|SISH|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|N|NA|||N|2||58||OPEN LABEL TREATMENT|1961-03-15|1965-03-01|||||1971-12-02||1968-03-09|Y|1970-06-06
TRIAL STUDY 134XCP|LB|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|2||||EOSB|EOSINOPHILS BAND FORM|||||||U/MG|||||||POSITIVE||LOG10 CCID 50/DOSE||||LOW|NOT DONE||||MUCUS|AUTOLYZED|NA|IN VITRO GENE EXPRESSION ASSAY|MDRD 4 VARIABLE FORMULA||Y|U|NA|NA|||N|2||58||CONTINUATION TREATMENT|1973-04-09|1972-10-03|||||1971-01-20||1960-10-24|Y|1969-11-07
TRIAL STUDY 134XCP|LB|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|1||||FIBRINOF|FIBRINOGEN, FUNCTIONAL|||||||CG|||||||TRACE||G/KG||||NORMAL|NOT DONE||||REFLEX TEAR|ROOM TEMPERATURE|Y|INCISION-INDUCED BLEEDING METHOD|GMI MMOL/MOL FORMULA||N|N|Y|Y|||N|3||39||FOLLOW-UP|1970-02-16|1966-07-31|||||1969-08-25||1960-08-28|Y|1971-07-07
TRIAL STUDY 134XCP|LB|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|2||||APOA2|APOLIPOPROTEIN AII|||||||10^5/L|||||||TRACE||U/10^12 RBC||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|CONCENTRATED|NA|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA||Y|U|N|U|||Y|3||39||FOLLOW-UP|1967-12-24|1969-10-08|||||1962-03-16||1964-10-24|N|1962-03-02
TRIAL STUDY 134XCP|LB|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|1||||HBBARTHB|HEMOGLOBIN BARTS/TOTAL HEMOGLOBIN|||||||WAFER|||||||POSITIVE||DAGU/ML||||ABNORMAL|NOT DONE||||PLASMA|CLOTTED|Y|PLETHYSMOGRAPHY|GMI % FORMULA||NA|Y|N|N|||NA|4||88||CONTINUATION TREATMENT|1966-06-24|1965-04-22|||||1965-06-29||1972-07-28|N|1960-08-25
TRIAL STUDY 134XCP|LB|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|2||||CLEPNSQE|COLUMNAR EPI CELLS/NON-SQUAM EPI CELLS|||||||GPELISA UNIT/ML|||||||INDETERMINATE||CMOL||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|UNEXPECTED ODOR|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|GMI MMOL/MOL FORMULA||NA|N|Y|Y|||N|4||88||BASELINE|1965-01-12|1968-04-08|||||1966-10-20||1970-07-27|U|1960-12-22
TRIAL STUDY 134XCP|LB|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|1||||ESTROGEN|ESTROGEN|||||||UMOL/DAY|||||||BORDERLINE||L/DAY||||NORMAL|NOT DONE||||SALIVA|AUTOLYZED|U|NUCLEIC ACID HYBRIDIZATION|CKD-EPI CYSTATIN C FORMULA||U|NA|Y|Y|||NA|5||7||OBSERVATION|1963-05-30|1967-01-04|||||1972-12-20||1960-01-27|Y|1971-05-26
TRIAL STUDY 134XCP|LB|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|2||||DFI|DNA FRAGMENTATION INDEX|||||||ML/KG/MIN|||||||NEGATIVE||RAD||||NORMAL|NOT DONE||||NAIL|SOLIDIFIED|U|DISK DIFFUSION|ASH FIBROSURE FORMULA||N|U|Y|N|||Y|5||7||TREATMENT|1970-03-27|1960-12-15|||||1965-10-08||1970-10-26|NA|1965-10-28
TRIAL STUDY 134XCP|LB|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|1||||BLYCELY|B-LYMPHOCYTES/LYMPHOCYTES|||||||MU|||||||NEGATIVE||ANTIBODY UNIT||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|CALCIFIED|Y|RADIATION DOSIMETRY|CKD-EPI FORMULA||NA|N|Y|NA|||N|1||38||RUN-IN|1972-07-02|1970-12-24|||||1960-06-21||1968-03-31|N|1972-08-22
TRIAL STUDY 134XCP|LB|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|2||||VEGFR3S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC3|||||||MEQ/G|||||||NEGATIVE||BREATHS/30S||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|LIPEMIC|U|MANUAL CLOT DETECTION|MDRD ENZYMATIC FORMULA||N|NA|Y|Y|||N|1||38||BASELINE|1962-11-19|1966-01-29|||||1962-06-18||1964-03-31|Y|1964-10-28
TRIAL STUDY 134XCP|LB|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|1||||CYSTHION|CYSTATHIONINE|||||||MESF|||||||TRACE||SPRAY||||LOW|NOT DONE||||URINE|CONCENTRATED|N|SLOAN LETTER EYE CHART 100%|MDRD 5 VARIABLE FORMULA||Y|N|Y|U|||NA|2||58||BASELINE|1962-05-28|1964-10-26|||||1972-03-18||1970-05-15|NA|1965-04-06
TRIAL STUDY 134XCP|LB|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|2||||EPIC|EPITHELIAL CELLS|||||||KBQ/UL|||||||NEGATIVE||APL U||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|AGGLUTINATED|N|CLIP|MDRD FORMULA||U|N|NA|Y|||U|2||58||RUN-IN|1967-06-24|1967-01-01|||||1965-12-21||1968-11-20|NA|1966-05-05
TRIAL STUDY 134XCP|LB|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|1||||ESR|ERYTHROCYTE SEDIMENTATION RATE|||||||DEG|||||||NEGATIVE||MG/KG/H||||HIGH|NOT DONE||||TISSUE|NON-HEMOLYZED|U|JAEGER EYE CHART|FIBROSIS 4 FORMULA||Y|Y|U|NA|||NA|3||39||FOLLOW-UP|1961-01-03|1970-06-15|||||1967-08-03||1966-09-06|N|1963-02-16
TRIAL STUDY 134XCP|LB|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|2||||C165940|BOXELDER POLLEN IGE AB RAST SCORE|||||||%/MIN|||||||NEGATIVE||EVENTS||||NORMAL|NOT DONE||||ARTERIAL BLOOD|DRIED|Y|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROMETER FORMULA||Y|U|Y|Y|||N|3||39||FOLLOW-UP|1961-06-06|1973-06-28|||||1969-05-03||1967-04-27|N|1968-09-16
TRIAL STUDY 134XCP|LB|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|1||||A1ANTRYP|ALPHA-1 ANTITRYPSIN|||||||UIU/DL|||||||POSITIVE||TSP EQ||||NORMAL|NOT DONE||||COLOSTRUM|REFRIGERATED|N|CONFOCAL MICROSCOPY|FIBROSIS 4 FORMULA||U|N|Y|N|||NA|4||88||TREATMENT|1968-11-16|1962-12-24|||||1962-09-26||1968-09-05|U|1967-08-23
TRIAL STUDY 134XCP|LB|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|2||||DRUGSCR|DRUG SCREEN|||||||OD UNIT|||||||INVALID||PELLET||||LOW|NOT DONE||||HAIR|AUTOLYZED|U|POTENTIOMETRY|HEPASCORE FORMULA||N|Y|NA|U|||Y|4||88||BLINDED TREATMENT|1966-07-16|1973-03-14|||||1968-03-10||1970-10-26|NA|1961-12-20
TRIAL STUDY 134XCP|LB|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|1||||PO2|PARTIAL PRESSURE OXYGEN|||||||MCI/KG|||||||POSITIVE||MNFI||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|ICTERIC|NA|FLOCCULATION|GMI % FORMULA||NA|Y|N|U|||N|5||7||FOLLOW-UP|1965-05-23|1968-04-15|||||1961-05-03||1973-03-26|NA|1960-05-09
TRIAL STUDY 134XCP|LB|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|2||||HDW|HEMOGLOBIN DISTRIBUTION WIDTH|||||||/HPF|||||||POSITIVE||10^6 CFU/ML||||HIGH|NOT DONE||||TRANSUDATE|NON-HEMOLYZED|NA|HIGH RESOLUTION MELT ANALYSIS|MDRD 5 VARIABLE FORMULA||Y|NA|Y|N|||N|5||7||INDUCTION TREATMENT|1960-08-16|1965-04-03|||||1972-07-10||1960-09-25|N|1968-11-25
TRIAL STUDY 134XCP|LB|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|1||||LEU|LEUCINE|||||||GLOBULE|||||||NEGATIVE||G/DL||||HIGH|NOT DONE||||TISSUE|UNEXPECTED ODOR|Y|IMPEDANCE CONDUCTIVITY|CKD-EPI CYSTATIN C FORMULA||Y|Y|N|Y|||Y|1||38||BLINDED TREATMENT|1961-12-27|1972-05-06|||||1965-08-27||1967-12-06|NA|1963-07-16
TRIAL STUDY 134XCP|LB|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|2||||IFNG|INTERFERON GAMMA|||||||AMPULE|||||||POSITIVE||ML/G/MIN||||ABNORMAL|NOT DONE||||BUFFY COAT|ROOM TEMPERATURE|Y|TELLER ACUITY CARDS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|N|N|||Y|1||38||FOLLOW-UP|1970-05-12|1961-11-05|||||1972-08-06||1963-01-14|Y|1967-02-18
TRIAL STUDY 134XCP|LB|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|1||||GLOBB1BP|BETA-1 GLOBULIN/BETA PROTEIN|||||||DNA COPIES/ML|||||||NEGATIVE||CARTRIDGE||||HIGH|NOT DONE||||SALIVA|GELLED|Y|REFRACTOMETRY|MDRD FORMULA||NA|N|U|U|||Y|2||58||WASHOUT|1961-01-13|1964-06-22|||||1960-07-25||1971-08-04|N|1967-03-14
TRIAL STUDY 134XCP|LB|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|2||||INTLK31|INTERLEUKIN 31|||||||CP|||||||POSITIVE||UEQ||||HIGH|NOT DONE||||BONE|CONCENTRATED|U|MODIFIED ACID FAST STAIN|FIBROSIS 4 FORMULA||NA|NA|Y|N|||NA|2||58||BASELINE|1972-01-06|1972-01-10|||||1960-12-15||1964-02-20|N|1964-02-21
TRIAL STUDY 134XCP|LB|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|1||||INDICAN|INDICAN|||||||IN|||||||INVALID||MMAL||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|CALCIFIED|N|TARGETED GENOME SEQUENCING|ASH FIBROSURE FORMULA||N|Y|NA|Y|||N|3||39||BASELINE|1964-05-01|1969-11-24|||||1966-10-19||1965-04-29|U|1969-03-14
TRIAL STUDY 134XCP|LB|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|2||||CSBACT|BACTERIAL CASTS|||||||/VF|||||||INDETERMINATE||TBSP||||HIGH|NOT DONE||||WHITE MATTER TISSUE|THAWED|Y|FISH|MDRD FORMULA||Y|U|U|Y|||U|3||39||TREATMENT|1962-02-09|1963-06-28|||||1962-12-21||1972-04-03|U|1973-08-31
TRIAL STUDY 134XCP|LB|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|1||||TRAP|TOTAL RADICAL-TRAP ANTIOXIDANT POTENTIAL|||||||UMOL/DAY|||||||NEGATIVE||BOTTLE||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|CALCIFIED|U|ANTIBIOTIC AGAR SCREEN|GMI % FORMULA||NA|N|NA|NA|||Y|4||88||INDUCTION TREATMENT|1971-01-30|1967-08-13|||||1961-03-15||1961-11-14|N|1963-04-21
TRIAL STUDY 134XCP|LB|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|2||||VOLUME|VOLUME|||||||UCI|||||||TRACE||GPELISA UNIT/ML||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|SOLIDIFIED|Y|MICRONEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA||NA|N|Y|N|||NA|4||88||CONTINUATION TREATMENT|1964-01-13|1966-04-06|||||1966-10-03||1972-02-11|NA|1966-03-17
TRIAL STUDY 134XCP|LB|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|1||||IGGCREAT|IMMUNOGLOBULIN G/CREATININE|||||||U/10^12 RBC|||||||POSITIVE||AMPULE||||LOW|NOT DONE||||TUMOR TISSUE|CALCIFIED|Y|LINE PROBE ASSAY|COCKCROFT-GAULT FORMULA||N|NA|NA|N|||Y|5||7||CONTINUATION TREATMENT|1962-12-07|1965-12-09|||||1966-03-22||1973-08-25|Y|1962-04-19
TRIAL STUDY 134XCP|LB|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|2||||SMUSCGAB|SMOOTH MUSCLE IGG ANTIBODY|||||||CM2|||||||NEGATIVE||BQ/ML||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED|Y|AGAR DILUTION|MDRD 6 VARIABLE FORMULA||U|N|NA|U|||N|5||7||BLINDED TREATMENT|1968-06-29|1967-03-02|||||1961-05-15||1973-07-16|Y|1962-10-03
TRIAL STUDY 134XCP|LB|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|1||||RDCSUB|REDUCING SUBSTANCES|||||||IU/DAY|||||||INVALID||MG/G/MIN||||LOW|NOT DONE||||SUPERNATANT, SERUM|GELLED|N|LIGHT MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||NA|U|U|Y|||Y|1||38||BASELINE|1963-12-18|1967-05-07|||||1973-06-27||1971-07-19|N|1967-06-06
TRIAL STUDY 134XCP|LB|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|2||||HERC5|HECT DOMAIN AND RLD 5|||||||MG/KG/DOSE|||||||BORDERLINE||UKAT||||ABNORMAL|NOT DONE||||PERSPIRATION|HEMOLYZED|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|GMI % FORMULA||N|NA|N|Y|||NA|1||38||OPEN LABEL TREATMENT|1971-09-24|1972-08-13|||||1965-08-28||1972-02-26|NA|1970-09-10
TRIAL STUDY 134XCP|LB|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|1||||TRACP5B|TARTRATE-RESISTANT ACID PHOSPHATASE 5B|||||||KIT|||||||INVALID||OSM||||HIGH|NOT DONE||||PLEURAL FLUID|CONTAMINATED|N|FLUOROSCOPY|CKD-EPI CYSTATIN C FORMULA||Y|U|N|NA|||N|2||58||LONG-TERM FOLLOW-UP|1961-03-17|1970-10-12|||||1972-08-09||1971-07-18|N|1965-02-01
TRIAL STUDY 134XCP|LB|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|2||||TESTOSWB|TESTOSTERONE, WEAKLY BOUND|||||||CGY|||||||TRACE||DNA COPIES/UG||||NORMAL|NOT DONE||||VITREOUS HUMOR|FROZEN|NA|CONTRAST ENHANCED SPIRAL CT SCAN|NASH FIBROSURE FORMULA||N|NA|Y|U|||U|2||58||SCREENING|1968-03-02|1965-04-17|||||1971-12-10||1968-01-10|Y|1968-01-07
TRIAL STUDY 134XCP|LB|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|1||||EOSCE|EOSINOPHILS/TOTAL CELLS|||||||CS|||||||INDETERMINATE||ML/CAGE/WK||||NORMAL|NOT DONE||||CALCULUS|CONCENTRATED|Y|MODIFIED ACID FAST STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|Y|Y|||Y|3||39||FOLLOW-UP|1967-01-04|1960-04-10|||||1965-07-07||1967-02-18|N|1969-02-03
TRIAL STUDY 134XCP|LB|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|2||||BLYCECE|B-LYMPHOCYTES/TOTAL CELLS|||||||10^3 CFU/ML|||||||TRACE||MG/M2/H||||LOW|NOT DONE||||ABSCESS FLUID|ICTERIC|NA|BAC ACGH|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|Y|U|||U|3||39||INDUCTION TREATMENT|1962-08-18|1962-01-28|||||1971-08-25||1971-03-19|Y|1962-12-25
TRIAL STUDY 134XCP|LB|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|1||||PGD2|PROSTAGLANDIN D2|||||||WATT|||||||POSITIVE||FINGERTIP UNIT||||HIGH|NOT DONE||||VENOUS CORD BLOOD|CONCENTRATED|U|QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROSIS 4 FORMULA||N|U|NA|NA|||NA|4||88||SCREENING|1966-09-14|1960-11-28|||||1965-04-29||1962-05-14|Y|1967-05-03
TRIAL STUDY 134XCP|LB|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|2||||INTLK25|INTERLEUKIN 25|||||||MMHG/L/MIN|||||||TRACE||KHZ||||LOW|NOT DONE||||AMNIOTIC FLUID|AGGLUTINATED|N|FREEZING POINT DEPRESSION|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|N|Y|||N|4||88||OBSERVATION|1963-11-30|1963-10-09|||||1970-04-02||1966-06-17|Y|1970-11-18
TRIAL STUDY 134XCP|LB|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|1||||EPINSQCE|NON-SQUAMOUS EPITHELIAL CELLS|||||||/4.0 ML|||||||BORDERLINE||G||||HIGH|NOT DONE||||SYNOVIAL FLUID|THAWED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|COCKCROFT-GAULT FORMULA||Y|U|Y|U|||Y|5||7||CONTINUATION TREATMENT|1970-06-16|1961-10-10|||||1966-06-30||1966-06-05|NA|1966-03-09
TRIAL STUDY 134XCP|LB|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|2||||BTECERBC|BITE CELLS/ERYTHROCYTES|||||||MEQ/G|||||||INVALID||KUSP||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|FRESH|Y|RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI FORMULA||NA|N|Y|Y|||Y|5||7||CONTINUATION TREATMENT|1963-08-25|1967-12-03|||||1967-05-27||1968-06-23|NA|1971-03-01
TRIAL STUDY 134XCP|LB|30419F44-B519-488C-A505-F23D88A46024|1||||GALANIN|GALANIN|||||||PMOL/DAY|||||||NEGATIVE||ML/CM||||HIGH|NOT DONE||||TRANSUDATE|DRIED|N|IMMUNODIFFUSION|COCKCROFT-GAULT FORMULA||U|Y|NA|U|||N|1||38||WASHOUT|1968-02-02|1960-04-17|||||1964-08-16||1962-12-15|NA|1970-11-13
TRIAL STUDY 134XCP|LB|30419F44-B519-488C-A505-F23D88A46024|2||||MIDCEF|MID CELL FRACTION|||||||%(V/V)|||||||INVALID||UG/KG/DAY||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|N|SINGLE-MOLECULE ARRAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|NA|N|||Y|1||38||BLINDED TREATMENT|1966-03-07|1964-05-24|||||1973-06-13||1972-05-07|Y|1969-07-22
TRIAL STUDY 134XCP|LB|30419F44-B519-488C-A505-F23D88A46024|1||||FACTVW|VON WILLEBRAND FACTOR|||||||BQ/ML|||||||NEGATIVE||10^5/L||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|Y|MICRONEUTRALIZATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|N|||U|2||58||FOLLOW-UP|1962-11-27|1972-02-29|||||1966-05-23||1963-12-04|NA|1967-02-04
TRIAL STUDY 134XCP|LB|30419F44-B519-488C-A505-F23D88A46024|2||||PRO|PROLINE|||||||MG/L|||||||INVALID||GENEQ/ML||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|NON-HEMOLYZED|U|IMMUNOPRECIPITATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|U|NA|||NA|2||58||INDUCTION TREATMENT|1973-05-26|1965-03-11|||||1970-12-24||1960-10-31|U|1971-08-03
TRIAL STUDY 134XCP|LB|30419F44-B519-488C-A505-F23D88A46024|1||||INTLK12|INTERLEUKIN 12|||||||MBQ|||||||TRACE||MPL U||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CONTAMINATED|U|POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA||Y|NA|Y|Y|||Y|3||39||BLINDED TREATMENT|1963-10-04|1964-05-03|||||1963-09-23||1972-08-31|Y|1965-11-01
TRIAL STUDY 134XCP|LB|30419F44-B519-488C-A505-F23D88A46024|2||||DDNAIGAB|ANTI-DOUBLE STRANDED DNA IGG|||||||VIRTUAL PIXEL|||||||TRACE||G/CAGE||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CALCIFIED|Y|GEL ELECTROPHORESIS|GMI MMOL/MOL FORMULA||N|Y|N|U|||Y|3||39||BLINDED TREATMENT|1971-09-25|1967-06-11|||||1970-07-03||1971-03-12|NA|1968-01-20
TRIAL STUDY 134XCP|LB|30419F44-B519-488C-A505-F23D88A46024|1||||AMPHET|AMPHETAMINE|||||||/2000 RBC|||||||POSITIVE||SQU/ML||||NORMAL|NOT DONE||||REFLEX TEAR|PARAFFIN-EMBEDDED|N|ANGIOGRAPHY|HEPASCORE FORMULA||NA|U|N|Y|||NA|4||88||BASELINE|1969-04-08|1964-05-18|||||1967-01-22||1966-03-17|N|1970-01-02
TRIAL STUDY 134XCP|LB|30419F44-B519-488C-A505-F23D88A46024|2||||C165900|ORCHARD GRASS POLLEN IGG AB RAST SCORE|||||||CARTRIDGE|||||||NEGATIVE||IU/DAY||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|ROOM TEMPERATURE|NA|DOUBLE IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA||Y|U|Y|NA|||NA|4||88||OPEN LABEL TREATMENT|1970-07-08|1963-11-09|||||1963-08-13||1960-07-26|NA|1961-05-04
TRIAL STUDY 134XCP|LB|30419F44-B519-488C-A505-F23D88A46024|1||||CSHYGR|HYALOGRANULAR CASTS|||||||10^8/L|||||||INVALID||U/10^12 RBC||||LOW|NOT DONE||||SMEGMA|UNEXPECTED ODOR|Y|PHOTOMETRIC CLOT DETECTION|MDRD FORMULA||N|N|U|NA|||Y|5||7||OPEN LABEL TREATMENT|1965-05-27|1963-11-04|||||1964-05-16||1962-09-25|NA|1965-01-20
TRIAL STUDY 134XCP|LB|30419F44-B519-488C-A505-F23D88A46024|2||||PHADJT|PH ADJUSTED FOR BODY TEMP|||||||MG/L FEU|||||||INVALID||10^7 TCID 50/DOSE||||NORMAL|NOT DONE||||CAPILLARY PLASMA|CLOTTED|U|SPIROMETRY|MDRD 6 VARIABLE FORMULA||NA|U|NA|N|||Y|5||7||FOLLOW-UP|1960-12-30|1970-07-15|||||1971-05-26||1960-10-02|N|1967-09-03
TRIAL STUDY 134XCP|LB|2AF06F66-5E51-4AC9-AF62-A34329724F7D|1||||VITD3|VITAMIN D3|||||||NG/DAY|||||||INVALID||GTT||||ABNORMAL|NOT DONE||||PERSPIRATION|SOLIDIFIED|U|MRS|NASH FIBROSURE FORMULA||Y|NA|Y|U|||N|1||38||RUN-IN|1965-06-04|1968-08-02|||||1962-07-26||1970-11-22|U|1962-06-13
TRIAL STUDY 134XCP|LB|2AF06F66-5E51-4AC9-AF62-A34329724F7D|2||||HALPRZLM|HYDROXYALPRAZOLAM|||||||KBQ/UL|||||||BORDERLINE||PSEC||||LOW|NOT DONE||||GASTRIC FLUID|DRIED|N|DIRECT SEQUENCING|GMI MMOL/MOL FORMULA||NA|NA|U|NA|||N|1||38||BASELINE|1970-01-25|1960-03-28|||||1968-03-13||1972-11-28|U|1962-11-25
TRIAL STUDY 134XCP|LB|2AF06F66-5E51-4AC9-AF62-A34329724F7D|1||||FPP|PROTOPORPHYRIN, FREE|||||||10^3 ORGANISMS/ML|||||||POSITIVE||KG/L||||HIGH|NOT DONE||||PERSPIRATION|HEMOLYZED|NA|ACCELERATOR MASS SPECTROMETRY|MDRD 4 VARIABLE FORMULA||U|U|Y|Y|||N|2||58||FOLLOW-UP|1962-04-23|1971-03-15|||||1972-08-26||1966-08-09|Y|1972-06-17
TRIAL STUDY 134XCP|LB|2AF06F66-5E51-4AC9-AF62-A34329724F7D|2||||EPINSQCE|NON-SQUAMOUS EPITHELIAL CELLS|||||||/LSQN|||||||INDETERMINATE||LOG10 ELISA UNIT/DOSE||||HIGH|NOT DONE||||FLUID|NON-HEMOLYZED|Y|COMPLEMENT FIXATION|MDRD ENZYMATIC FORMULA||NA|Y|NA|NA|||NA|2||58||OBSERVATION|1971-09-05|1961-11-01|||||1965-08-27||1962-06-27|N|1967-02-01
TRIAL STUDY 134XCP|LB|2AF06F66-5E51-4AC9-AF62-A34329724F7D|1||||C130089|TIMOTHY GRASS POLLEN IGA|||||||G/KG|||||||NEGATIVE||IU||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|CLOTTED|NA|PERIPHERAL ANGIOGRAPHY|CKD-EPI CREATININE FORMULA||N|Y|Y|N|||U|3||39||LONG-TERM FOLLOW-UP|1960-03-10|1960-10-13|||||1967-05-23||1961-08-11|Y|1971-12-27
TRIAL STUDY 134XCP|LB|2AF06F66-5E51-4AC9-AF62-A34329724F7D|2||||VITD|VITAMIN D|||||||FT3|||||||POSITIVE||KIT||||HIGH|NOT DONE||||SMEGMA|UNEXPECTED ODOR|N|SCINTIGRAPHY|MDRD 5 VARIABLE FORMULA||U|N|U|NA|||N|3||39||BLINDED TREATMENT|1970-03-20|1960-05-05|||||1961-01-19||1972-07-18|NA|1963-09-14
TRIAL STUDY 134XCP|LB|2AF06F66-5E51-4AC9-AF62-A34329724F7D|1||||IGF2|INSULIN-LIKE GROWTH FACTOR-2|||||||OSM|||||||TRACE||U/M2||||ABNORMAL|NOT DONE||||ISOLATE|DRIED|NA|DUKE INCISION METHOD|MDRD 5 VARIABLE FORMULA||NA|N|NA|Y|||N|4||88||RUN-IN|1965-04-16|1970-02-23|||||1960-03-27||1962-05-25|Y|1969-02-26
TRIAL STUDY 134XCP|LB|2AF06F66-5E51-4AC9-AF62-A34329724F7D|2||||CETPA|CHOLESTERYL ESTER TRANSFER PROTEIN ACT|||||||CM/S|||||||POSITIVE||ANSON U||||HIGH|NOT DONE||||AMNIOTIC FLUID|UNEXPECTED ODOR|N|NEURAMINIDASE INHIBITION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|N|N|||NA|4||88||OPEN LABEL TREATMENT|1961-08-11|1967-04-09|||||1963-09-06||1965-04-11|NA|1973-06-04
TRIAL STUDY 134XCP|LB|2AF06F66-5E51-4AC9-AF62-A34329724F7D|1||||ANISOCHR|ANISOCHROMIA|||||||UG/G/H|||||||TRACE||JOULE||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED|NA|ANALYTICAL ULTRACENTRIFUGATION|GMI % FORMULA||U|U|U|NA|||U|5||7||BLINDED TREATMENT|1969-09-30|1962-04-06|||||1960-06-01||1967-11-26|Y|1960-03-18
TRIAL STUDY 134XCP|LB|2AF06F66-5E51-4AC9-AF62-A34329724F7D|2||||PLTAGAMP|PLATELET AGGREGATION AMPLITUDE|||||||UG/M2/MIN|||||||INVALID||MM3/MM2/YEAR||||NORMAL|NOT DONE||||KERATINOCYTE|REFRIGERATED|U|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|Y|||Y|5||7||BASELINE|1963-10-11|1973-08-23|||||1970-11-06||1962-09-14|Y|1960-08-28
TRIAL STUDY 134XCP|LB|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|1||||CSWBC|WBC CASTS|||||||NFIU|||||||BORDERLINE||MESF||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|U|MULTIPLE BREATH WASHOUT|NASH FIBROSURE FORMULA||N|N|Y|NA|||NA|1||38||FOLLOW-UP|1967-03-19|1968-04-30|||||1963-04-01||1969-01-27|U|1965-09-02
TRIAL STUDY 134XCP|LB|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|2||||C130076|SILVER BIRCH POLLEN IGE|||||||10^3 CFU/ML|||||||POSITIVE||10^6 ORGANISMS/MG||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|CONCENTRATED|U|ACRIDINE ORANGE STAIN|CKD-EPI CYSTATIN C FORMULA||N|Y|N|N|||NA|1||38||BLINDED TREATMENT|1962-02-10|1960-02-29|||||1966-04-19||1971-03-28|Y|1965-07-23
TRIAL STUDY 134XCP|LB|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|1||||NEUTLS|LEFT SHIFT NEUTROPHILS|||||||KG|||||||TRACE||10^6/HPF||||HIGH|NOT DONE||||PLATELET|THAWED|Y|ANALYTICAL ULTRACENTRIFUGATION|CKD-EPI CREATININE FORMULA||N|U|NA|U|||Y|2||58||OBSERVATION|1960-06-16|1961-07-21|||||1968-04-06||1969-07-31|Y|1965-02-23
TRIAL STUDY 134XCP|LB|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|2||||IDLVLDL3|IDL+VLDL CHOLESTEROL SUBTYPE 3|||||||HR/DAY|||||||BORDERLINE||PA||||HIGH|NOT DONE||||WHITE MATTER TISSUE|FRESH|N|CHROMATOGRAPHY|MDRD FORMULA||U|U|Y|U|||U|2||58||OBSERVATION|1961-12-12|1961-12-27|||||1966-05-23||1961-08-05|N|1961-10-13
TRIAL STUDY 134XCP|LB|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|1||||RBCDIPOP|DIMORPHIC ERYTHROCYTE POPULATION|||||||U/G HB|||||||NEGATIVE||ML/S||||NORMAL|NOT DONE||||DISCHARGE|REFRIGERATED|NA|FLUORIMETRY|COCKCROFT-GAULT FORMULA||NA|U|U|Y|||U|3||39||FOLLOW-UP|1961-06-21|1972-02-23|||||1964-01-06||1963-08-26|Y|1965-07-15
TRIAL STUDY 134XCP|LB|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|2||||APOA4|APOLIPOPROTEIN A4|||||||FMOL/G|||||||TRACE||DEG/MM||||NORMAL|NOT DONE||||TISSUE|FRESH|U|ALCIAN BLUE STAIN|MDRD FORMULA||N|Y|Y|NA|||U|3||39||RUN-IN|1964-05-03|1973-05-23|||||1972-05-14||1968-02-24|N|1970-03-05
TRIAL STUDY 134XCP|LB|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|1||||MMP7|MATRIX METALLOPROTEINASE 7|||||||MMOL/G|||||||INVALID||/SEC||||ABNORMAL|NOT DONE||||EXUDATE|UNEXPECTED ODOR|NA|TOTAL BODY IRRADIATION|FIBROSIS 4 FORMULA||NA|Y|NA|Y|||N|4||88||CONTINUATION TREATMENT|1962-06-09|1960-12-02|||||1962-01-27||1967-12-24|N|1972-11-12
TRIAL STUDY 134XCP|LB|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|2||||FATDROP|FAT DROPLET|||||||DEG|||||||NEGATIVE||10^3/L||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|FRESH|U|IMMUNOFLUORESCENT STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|N|NA|||NA|4||88||BLINDED TREATMENT|1967-10-06|1967-12-10|||||1973-02-04||1960-08-08|U|1962-04-06
TRIAL STUDY 134XCP|LB|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|1||||C165930|SHELLFISH MIX IGE AB RAST SCORE|||||||ML/S/M2|||||||INDETERMINATE||MG/M2/H||||HIGH|NOT DONE||||PLATELET POOR PLASMA|ROOM TEMPERATURE|Y|THICK SMEAR|CKD-EPI FORMULA||Y|NA|U|NA|||N|5||7||INDUCTION TREATMENT|1969-05-31|1966-11-08|||||1973-06-08||1971-01-17|Y|1964-10-09
TRIAL STUDY 134XCP|LB|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|2||||TRIG|TRIGLYCERIDES|||||||1/(S*KPA)|||||||POSITIVE||APL U||||LOW|NOT DONE||||TRANSUDATE|GELLED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD 4 VARIABLE FORMULA||Y|Y|NA|U|||U|5||7||INDUCTION TREATMENT|1960-09-13|1960-12-29|||||1973-04-05||1968-12-29|Y|1967-09-06
TRIAL STUDY 134XCP|LB|94F4C997-3114-4444-BF89-E762226AAC89|1||||PIVKAII|PROTEIN INDUCED BY VITAMIN K ABSENCE-II|||||||10^6 CFU/G|||||||BORDERLINE||TAMPON||||LOW|NOT DONE||||HAIR FOLLICLE|LACTESCENT|U|MICROBIAL BIOCHEMICAL IDENTIFICATION|GMI % FORMULA||NA|U|Y|U|||U|1||38||LONG-TERM FOLLOW-UP|1967-11-11|1960-10-31|||||1966-09-12||1966-08-30|N|1966-01-09
TRIAL STUDY 134XCP|LB|94F4C997-3114-4444-BF89-E762226AAC89|2||||HBA1A|HEMOGLOBIN A1A|||||||% INHIBITION|||||||POSITIVE||BQ/L||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|HEMOLYZED|U|PH METER MEASUREMENT METHOD|MDRD ENZYMATIC JAPANESE FORMULA||U|U|Y|U|||N|1||38||TREATMENT|1972-10-06|1965-10-03|||||1970-02-27||1964-08-03|U|1966-04-11
TRIAL STUDY 134XCP|LB|94F4C997-3114-4444-BF89-E762226AAC89|1||||PRORUBCE|PRORUBRICYTE/TOTAL CELLS|||||||BEAM BREAKS|||||||TRACE||NMOL/G||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|AUTOLYZED|Y|CLIP SEQUENCING|GMI MMOL/MOL FORMULA||NA|NA|Y|Y|||U|2||58||FOLLOW-UP|1972-08-07|1969-07-16|||||1970-01-15||1965-11-12|NA|1971-03-11
TRIAL STUDY 134XCP|LB|94F4C997-3114-4444-BF89-E762226AAC89|2||||BASOSG|BASOPHILS, SEGMENTED|||||||KALLIKREIN INHIBITOR UNIT|||||||INVALID||UGEQ/L||||ABNORMAL|NOT DONE||||MONOCYTE|GELLED|Y|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|COCKCROFT-GAULT FORMULA||Y|U|Y|N|||NA|2||58||LONG-TERM FOLLOW-UP|1972-08-24|1969-02-23|||||1960-03-22||1971-07-25|U|1973-04-18
TRIAL STUDY 134XCP|LB|94F4C997-3114-4444-BF89-E762226AAC89|1||||EPSTI1|EPITHELIAL STROMAL INTERACTION PROTEIN 1|||||||MOL/DAY|||||||TRACE||UMOL/DAY||||LOW|NOT DONE||||EXPIRED AIR|REFRIGERATED|N|COULOMETRIC TITRATION|CKD-EPI CYSTATIN C FORMULA||N|NA|NA|Y|||N|3||39||OBSERVATION|1967-01-11|1968-09-30|||||1962-11-13||1971-04-25|N|1972-07-21
TRIAL STUDY 134XCP|LB|94F4C997-3114-4444-BF89-E762226AAC89|2||||HBGCHTHB|HEMOGLOBIN G COUSHATTA/TOTAL HEMOGLOBIN|||||||ML/CAGE/WK|||||||INDETERMINATE||IU/L||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|FRESH|NA|IMMUNOTURBIDIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|U|N|||NA|3||39||BASELINE|1967-07-29|1968-05-26|||||1966-11-16||1962-02-15|Y|1968-11-21
TRIAL STUDY 134XCP|LB|94F4C997-3114-4444-BF89-E762226AAC89|1||||IL2RB|INTERLEUKIN 2 RECEPTOR SUBUNIT BETA|||||||L/L|||||||NEGATIVE||%(W/V)||||LOW|NOT DONE||||CERUMEN|AGGLUTINATED|NA|GRADIENT DIFFUSION|NASH FIBROSURE FORMULA||NA|Y|U|U|||Y|4||88||RUN-IN|1972-12-21|1966-03-30|||||1971-11-02||1970-09-09|N|1965-06-06
TRIAL STUDY 134XCP|LB|94F4C997-3114-4444-BF89-E762226AAC89|2||||SER|SERINE|||||||BAG|||||||NEGATIVE||MG/L||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|LACTESCENT|N|CONGO RED STAIN|FIBROTEST FORMULA||N|U|U|N|||U|4||88||LONG-TERM FOLLOW-UP|1972-07-27|1965-09-14|||||1971-02-16||1963-12-07|U|1963-04-17
TRIAL STUDY 134XCP|LB|94F4C997-3114-4444-BF89-E762226AAC89|1||||MACROBLD|MACROSCOPIC BLOOD|||||||UKAT/10^12 RBC|||||||TRACE||JOULE||||ABNORMAL|NOT DONE||||TUMOR TISSUE|SOLIDIFIED|Y|MRS|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|U|||N|5||7||BASELINE|1963-10-29|1973-06-29|||||1971-03-31||1960-06-16|N|1963-07-17
TRIAL STUDY 134XCP|LB|94F4C997-3114-4444-BF89-E762226AAC89|2||||HLAB|HLA CLASS IB ANTIGEN|||||||/H|||||||BORDERLINE||PRESSOR UNITS||||LOW|NOT DONE||||CORD SERUM|CONTAMINATED|NA|DIFFUSION TENSOR MRI|ASH FIBROSURE FORMULA||N|Y|U|Y|||Y|5||7||TREATMENT|1973-07-27|1972-05-18|||||1971-05-02||1962-02-21|Y|1971-10-09
TRIAL STUDY 134XCP|LB|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|1||||GFRBSCYC|GFR FROM CYSTATIN C ADJUSTED FOR BSA|||||||MG/CM2|||||||POSITIVE||10^6 ORGANISMS/MG||||HIGH|NOT DONE||||SERUM OR PLASMA|UNEXPECTED ODOR|N|DNA MICROARRAY|NASH FIBROSURE FORMULA||NA|NA|N|Y|||N|1||38||WASHOUT|1963-02-26|1966-05-15|||||1972-12-30||1965-12-08|U|1962-08-20
TRIAL STUDY 134XCP|LB|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|2||||GLP1IAC|GLUCAGON-LIKE PEPTIDE-1, INACTIVE FORM|||||||/WK|||||||TRACE||MMHG*MIN/L||||ABNORMAL|NOT DONE||||CORD BLOOD|CLOTTED|NA|SCANNING ELECTRON MICROSCOPY|MDRD 6 VARIABLE FORMULA||N|NA|U|Y|||U|1||38||CONTINUATION TREATMENT|1964-05-28|1960-10-23|||||1962-04-27||1964-10-24|U|1971-11-28
TRIAL STUDY 134XCP|LB|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|1||||CA2729AG|CANCER ANTIGEN 27-29|||||||ML/ANIMAL|||||||POSITIVE||KV||||NORMAL|NOT DONE||||FLUID|HEMOLYZED|U|IMMUNOBLOT|MDRD 6 VARIABLE FORMULA||NA|NA|N|U|||U|2||58||SCREENING|1971-01-27|1960-11-20|||||1973-06-27||1970-07-13|NA|1970-07-16
TRIAL STUDY 134XCP|LB|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|2||||PGES|PROSTAGLANDIN E SYNTHASE|||||||MOSM/L|||||||POSITIVE||DEG/S||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|CONCENTRATED|U|CELLULOSE TAPE|MDRD 5 VARIABLE FORMULA||U|U|Y|N|||U|2||58||BASELINE|1971-03-05|1967-04-29|||||1962-03-17||1962-06-03|NA|1972-11-07
TRIAL STUDY 134XCP|LB|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|1||||CYSTHION|CYSTATHIONINE|||||||RAD|||||||POSITIVE||ML/MIN||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|SOLIDIFIED|NA|RAJI CELL EIA|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|NA|U|||N|3||39||FOLLOW-UP|1963-08-11|1960-12-13|||||1960-11-27||1961-04-24|N|1961-10-14
TRIAL STUDY 134XCP|LB|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|2||||TROPONIN|TROPONIN|||||||UG/M2/MIN|||||||INVALID||MOSM/KG||||HIGH|NOT DONE||||SMEGMA|FRESH|Y|GEL ELECTROPHORESIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|NA|U|||Y|3||39||FOLLOW-UP|1963-10-17|1966-04-30|||||1972-02-06||1970-10-28|NA|1962-09-16
TRIAL STUDY 134XCP|LB|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|1||||IOTCLRBS|IOTHALAMATE CLEARANCE ADJUSTED FOR BSA|||||||MG/MOL|||||||TRACE||BOWL||||HIGH|NOT DONE||||DISCHARGE|ROOM TEMPERATURE|U|GC/FID|CKD-EPI FORMULA||NA|U|U|N|||N|4||88||OBSERVATION|1971-02-08|1966-08-23|||||1967-01-10||1967-01-08|Y|1973-03-30
TRIAL STUDY 134XCP|LB|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|2||||PLSMCE|MATURE PLASMA CELLS|||||||MMU/ML|||||||POSITIVE||G/G/DAY||||LOW|NOT DONE||||CORD SERUM|AUTOLYZED|NA|ENZYMATIC ULTRACENTRIFUGATION|MDRD FORMULA||U|N|U|NA|||N|4||88||CONTINUATION TREATMENT|1970-09-25|1967-07-11|||||1973-01-11||1967-11-27|NA|1970-04-20
TRIAL STUDY 134XCP|LB|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|1||||AMMONIA|AMMONIA|||||||UM2|||||||INVALID||U/G HB||||LOW|NOT DONE||||AQUEOUS HUMOR|CALCIFIED|NA|REFLECTANCE SPECTROSCOPY|GMI MMOL/MOL FORMULA||NA|NA|Y|Y|||Y|5||7||BASELINE|1965-10-27|1966-11-29|||||1961-12-15||1972-01-15|N|1966-12-29
TRIAL STUDY 134XCP|LB|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|2||||A1MCREAT|ALPHA-1 MICROGLOBULIN/CREATININE|||||||ML/G/DAY|||||||TRACE||UMOL/KG/MIN||||ABNORMAL|NOT DONE||||BONE|GELLED|NA|ENDPOINT DILUTION ASSAY|COCKCROFT-GAULT FORMULA||U|U|N|NA|||U|5||7||BLINDED TREATMENT|1973-08-05|1972-08-27|||||1961-05-27||1972-07-17|Y|1970-07-14
TRIAL STUDY 134XCP|LB|D20DE6F0-DA30-4453-8F80-61093BF046A6|1||||C130101|TREE MIX POLLEN ANTIGEN IGE ANTIBODY|||||||GY/H|||||||TRACE||MG/H||||NORMAL|NOT DONE||||LAVAGE FLUID|DRIED|Y|PULMONARY ANGIOGRAPHY|NASH FIBROSURE FORMULA||N|U|NA|U|||Y|1||38||RUN-IN|1966-02-09|1965-09-07|||||1970-10-22||1967-06-14|N|1969-07-04
TRIAL STUDY 134XCP|LB|D20DE6F0-DA30-4453-8F80-61093BF046A6|2||||MIDCEF|MID CELL FRACTION|||||||PT_US|||||||NEGATIVE||UG/KG||||ABNORMAL|NOT DONE||||SPERMATOZOON|PARAFFIN-EMBEDDED|NA|TOTAL BODY IRRADIATION|MDRD FORMULA||NA|Y|U|Y|||U|1||38||FOLLOW-UP|1969-05-24|1969-01-18|||||1968-10-27||1972-07-16|Y|1966-09-18
TRIAL STUDY 134XCP|LB|D20DE6F0-DA30-4453-8F80-61093BF046A6|1||||GSTPI|GLUTATHIONE S-TRANSFERASE, PI|||||||JAR|||||||INDETERMINATE||FRAMES/S||||NORMAL|NOT DONE||||REFLEX TEAR|AUTOLYZED|N|TOTAL BODY RADIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|NA|||U|2||58||OPEN LABEL TREATMENT|1961-06-05|1967-05-21|||||1971-04-04||1972-02-28|Y|1969-05-23
TRIAL STUDY 134XCP|LB|D20DE6F0-DA30-4453-8F80-61093BF046A6|2||||LIPASEP|LIPASE, PANCREATIC|||||||S*KPA|||||||BORDERLINE||BEAM BREAKS||||HIGH|NOT DONE||||BREAST MILK|GELLED|U|ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|N|||U|2||58||INDUCTION TREATMENT|1970-07-07|1963-03-08|||||1973-06-23||1961-08-31|Y|1963-02-03
TRIAL STUDY 134XCP|LB|D20DE6F0-DA30-4453-8F80-61093BF046A6|1||||C165916|D. FARINAE IGG AB RAST SCORE|||||||10^6 ORGANISMS/ML|||||||NEGATIVE||JDF UNIT||||LOW|NOT DONE||||CORD SERUM|REFRIGERATED|U|MEDIASTINOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|N|Y|||U|3||39||SCREENING|1967-04-07|1970-11-29|||||1962-02-21||1960-04-12|U|1965-08-02
TRIAL STUDY 134XCP|LB|D20DE6F0-DA30-4453-8F80-61093BF046A6|2||||NEUTLS|LEFT SHIFT NEUTROPHILS|||||||10^5/L|||||||TRACE||KEV||||ABNORMAL|NOT DONE||||DERMAL TISSUE|ICTERIC|Y|SLIT LAMP PHOTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||N|Y|Y|U|||Y|3||39||SCREENING|1963-11-18|1962-08-28|||||1962-04-21||1963-11-01|Y|1973-04-25
TRIAL STUDY 134XCP|LB|D20DE6F0-DA30-4453-8F80-61093BF046A6|1||||NOREPEXR|NOREPINEPHRINE EXCRETION RATE|||||||CAPSULE|||||||NEGATIVE||KN/CM2||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|REFRIGERATED|N|SNP ARRAY|MDRD ENZYMATIC FORMULA||N|N|NA|U|||Y|4||88||LONG-TERM FOLLOW-UP|1970-01-06|1971-08-13|||||1969-09-13||1969-04-12|N|1964-02-21
TRIAL STUDY 134XCP|LB|D20DE6F0-DA30-4453-8F80-61093BF046A6|2||||C165879|D. FARINAE IGE AB RAST SCORE|||||||10^6 IU|||||||INVALID||10^6 IU/ML||||LOW|NOT DONE||||ARTERIAL BLOOD|LIPEMIC|U|MICROBIAL CULTURE, SOLID|FIBROMETER FORMULA||Y|NA|Y|N|||U|4||88||WASHOUT|1961-04-11|1969-09-03|||||1962-12-19||1973-04-16|U|1968-06-06
TRIAL STUDY 134XCP|LB|D20DE6F0-DA30-4453-8F80-61093BF046A6|1||||GSTAL|ALPHA GLUTATHIONE-S-TRANSFERASE|||||||/MM2|||||||INVALID||10^3 ORGANISMS/ML||||LOW|NOT DONE||||CORD BLOOD|THAWED|NA|TOTAL BODY RADIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||N|N|U|U|||U|5||7||BLINDED TREATMENT|1968-07-12|1968-02-23|||||1961-06-02||1963-11-08|NA|1967-09-28
TRIAL STUDY 134XCP|LB|D20DE6F0-DA30-4453-8F80-61093BF046A6|2||||TEARDCY|DACRYOCYTES|||||||EU|||||||INDETERMINATE||SIEMENS||||ABNORMAL|NOT DONE||||DERMAL TISSUE|CALCIFIED|Y|PUPILLOMETRY|GMI % FORMULA||Y|U|U|NA|||U|5||7||OBSERVATION|1960-08-20|1969-01-03|||||1967-04-22||1971-01-04|NA|1966-01-01
TRIAL STUDY 134XCP|LB|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|1||||MPV|MEAN PLATELET VOLUME|||||||DIP|||||||POSITIVE||ECL UNIT||||HIGH|NOT DONE||||MUCUS|THAWED|N|COMPLEMENT FIXATION|MDRD 6 VARIABLE FORMULA||U|NA|NA|Y|||Y|1||38||FOLLOW-UP|1972-05-14|1960-03-14|||||1965-06-12||1968-04-28|N|1960-05-21
TRIAL STUDY 134XCP|LB|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|2||||INTLK12B|INTERLEUKIN 12 BETA|||||||L/L|||||||NEGATIVE||GPS U||||NORMAL|NOT DONE||||SOFT TISSUE|FROZEN|U|AUSCULTATION|MDRD 6 VARIABLE FORMULA||U|NA|N|U|||NA|1||38||BLINDED TREATMENT|1967-04-23|1962-07-10|||||1972-02-20||1966-07-12|U|1967-04-01
TRIAL STUDY 134XCP|LB|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|1||||PLTLPLT|LARGE PLATELETS/TOTAL PLATELETS|||||||10^7 CFU|||||||BORDERLINE||KV||||LOW|NOT DONE||||EPIDERMAL TISSUE|THAWED|NA|SISH|CKD-EPI CREATININE FORMULA||U|NA|Y|U|||N|2||58||OPEN LABEL TREATMENT|1965-12-14|1967-08-21|||||1973-08-10||1966-01-04|NA|1961-03-13
TRIAL STUDY 134XCP|LB|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|2||||CPEPTIDE|C-PEPTIDE|||||||10^6/L|||||||POSITIVE||U.CARR||||HIGH|NOT DONE||||PLATELET POOR PLASMA|REFRIGERATED|N|ANTIBIOTIC AGAR SCREEN|MDRD 5 VARIABLE FORMULA||Y|U|U|N|||Y|2||58||WASHOUT|1964-10-13|1965-09-13|||||1970-08-06||1971-04-25|N|1970-06-03
TRIAL STUDY 134XCP|LB|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|1||||MYPCERPC|MYELOID/ERYTHROID RATIO|||||||CY/CM|||||||POSITIVE||UKAT/10^12 RBC||||LOW|NOT DONE||||MECONIUM|DRIED|N|SINGLE-MOLECULE ARRAY|FIBROTEST FORMULA||NA|NA|NA|Y|||N|3||39||INDUCTION TREATMENT|1962-12-25|1971-12-22|||||1965-10-06||1967-10-28|Y|1969-10-13
TRIAL STUDY 134XCP|LB|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|2||||BLSTMKCE|MEGAKARYOBLASTS/TOTAL CELLS|||||||GY|||||||NEGATIVE||IU/G HB||||HIGH|NOT DONE||||PROSTATIC FLUID|HEMOLYZED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|HEPASCORE FORMULA||NA|U|Y|Y|||N|3||39||LONG-TERM FOLLOW-UP|1966-12-20|1969-09-16|||||1973-06-19||1961-02-17|U|1972-11-14
TRIAL STUDY 134XCP|LB|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|1||||BUCHE|BUTYRYLCHOLINESTERASE|||||||S/H|||||||NEGATIVE||GMFI||||NORMAL|NOT DONE||||SALIVA|LIPEMIC|N|POPULATION SEQUENCING|GMI % FORMULA||NA|NA|Y|N|||N|4||88||BLINDED TREATMENT|1969-02-25|1967-01-04|||||1973-07-26||1962-11-09|N|1960-11-28
TRIAL STUDY 134XCP|LB|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|2||||GRN|PROGRANULIN|||||||NMOL/L|||||||INVALID||RAD||||NORMAL|NOT DONE||||TISSUE|CONCENTRATED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|GMI % FORMULA||U|Y|U|NA|||Y|4||88||FOLLOW-UP|1970-12-22|1970-03-16|||||1964-05-09||1964-11-06|N|1970-09-07
TRIAL STUDY 134XCP|LB|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|1||||CAFFEINE|CAFFEINE|||||||KG/L|||||||TRACE||MMOL/S||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|DRIED|NA|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||Y|N|NA|NA|||U|5||7||FOLLOW-UP|1969-05-14|1966-04-07|||||1966-03-18||1966-11-24|N|1963-05-19
TRIAL STUDY 134XCP|LB|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|2||||CX3CL1|CHEMOKINE (C-X3-C MOTIF) LIGAND 1|||||||SACHET|||||||BORDERLINE||L/DAY||||ABNORMAL|NOT DONE||||TISSUE|ROOM TEMPERATURE|U|IMMUNOFLUORESCENT STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|NA|U|||U|5||7||OPEN LABEL TREATMENT|1972-12-07|1962-02-25|||||1964-05-10||1964-08-04|N|1960-08-19
TRIAL STUDY 134XCP|LB|F20939CF-C668-4514-A2CF-63723560FA46|1||||CD163S|SOLUBLE CD163|||||||GENEQ/ML|||||||INDETERMINATE||OHM||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|FRESH|Y|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD ENZYMATIC JAPANESE FORMULA||N|N|NA|Y|||N|1||38||BLINDED TREATMENT|1966-12-30|1969-01-13|||||1973-02-23||1962-10-02|U|1969-05-02
TRIAL STUDY 134XCP|LB|F20939CF-C668-4514-A2CF-63723560FA46|2||||BILIND|INDIRECT BILIRUBIN|||||||ML/G/MIN|||||||NEGATIVE||GPL U||||LOW|NOT DONE||||MECONIUM|FROZEN|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|GMI % FORMULA||Y|N|Y|N|||NA|1||38||LONG-TERM FOLLOW-UP|1961-02-15|1960-08-23|||||1970-03-19||1961-07-29|Y|1962-07-24
TRIAL STUDY 134XCP|LB|F20939CF-C668-4514-A2CF-63723560FA46|1||||B2MCREAT|BETA-2 MICROGLOBULIN/CREATININE|||||||GY|||||||POSITIVE||ENZYME U/L||||HIGH|NOT DONE||||PLATELET|CALCIFIED|NA|HANSEL STAIN|HEPASCORE FORMULA||N|Y|U|N|||Y|2||58||INDUCTION TREATMENT|1967-05-03|1971-11-08|||||1965-10-17||1970-09-05|Y|1964-09-30
TRIAL STUDY 134XCP|LB|F20939CF-C668-4514-A2CF-63723560FA46|2||||CHOLATE|CHOLATE|||||||CMHG|||||||TRACE||PPTH||||HIGH|NOT DONE||||SPUTUM|ICTERIC|NA|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|FIBROSIS 4 FORMULA||Y|NA|N|U|||N|2||58||INDUCTION TREATMENT|1972-02-12|1966-12-23|||||1969-10-13||1960-10-31|N|1962-04-26
TRIAL STUDY 134XCP|LB|F20939CF-C668-4514-A2CF-63723560FA46|1||||TK2|THYMIDINE KINASE 2|||||||MG/M2/DAY|||||||BORDERLINE||ANTI-XA IU/ML||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CALCIFIED|Y|PALPATION|GMI % FORMULA||N|NA|U|NA|||N|3||39||SCREENING|1961-08-28|1971-06-07|||||1969-05-07||1971-04-04|Y|1965-05-12
TRIAL STUDY 134XCP|LB|F20939CF-C668-4514-A2CF-63723560FA46|2||||AFPL1|ALPHA FETOPROTEIN L1|||||||KDA|||||||POSITIVE||PG/CELL||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|AUTOLYZED|NA|MRI WITHOUT CONTRAST|GMI % FORMULA||NA|NA|U|Y|||U|3||39||OBSERVATION|1972-09-22|1966-04-30|||||1965-12-06||1960-06-13|Y|1961-08-27
TRIAL STUDY 134XCP|LB|F20939CF-C668-4514-A2CF-63723560FA46|1||||ETPLT|ETP LAG TIME|||||||10^6/HPF|||||||POSITIVE||CPM||||LOW|NOT DONE||||SWABBED MATERIAL|CALCIFIED|N|ELLA|MDRD 6 VARIABLE FORMULA||NA|N|U|U|||Y|4||88||OBSERVATION|1968-01-18|1968-01-21|||||1968-09-21||1965-09-12|NA|1968-09-16
TRIAL STUDY 134XCP|LB|F20939CF-C668-4514-A2CF-63723560FA46|2||||SCKLCE|SICKLE CELLS|||||||LOG10 ELISA UNIT/DOSE|||||||BORDERLINE||LOG10 PFU||||ABNORMAL|NOT DONE||||PLASMA|THAWED|Y|CLINICAL EVALUATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|N|Y|||Y|4||88||SCREENING|1970-12-15|1963-01-06|||||1972-04-30||1966-03-18|Y|1964-04-05
TRIAL STUDY 134XCP|LB|F20939CF-C668-4514-A2CF-63723560FA46|1||||PLAGMAMP|PLATELET AGGREGATION MEAN AMPLITUDE|||||||PIXELS/IN|||||||POSITIVE||DL||||ABNORMAL|NOT DONE||||SEBUM|LACTESCENT|U|KLEIHAUER-BETKE|GMI % FORMULA||N|Y|U|NA|||N|5||7||LONG-TERM FOLLOW-UP|1966-08-04|1967-02-11|||||1967-11-24||1967-11-05|Y|1966-03-06
TRIAL STUDY 134XCP|LB|F20939CF-C668-4514-A2CF-63723560FA46|2||||ENDOSTN|ENDOSTATIN|||||||PACKET|||||||TRACE||UG/G/MIN||||NORMAL|NOT DONE||||PLASMA|LACTESCENT|Y|PET/CT SCAN WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA||N|U|U|Y|||N|5||7||CONTINUATION TREATMENT|1972-02-25|1967-08-22|||||1967-09-30||1970-06-16|NA|1972-05-21
TRIAL STUDY 134XCP|LB|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|1||||VLDL1|VLDL CHOLESTEROL SUBTYPE 1|||||||CIGARETTE|||||||POSITIVE||UG/M2/H||||HIGH|NOT DONE||||FLUID|THAWED|NA|SNP ARRAY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|N|NA|||NA|1||38||RUN-IN|1962-09-03|1972-12-09|||||1970-10-31||1973-07-17|N|1966-05-07
TRIAL STUDY 134XCP|LB|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|2||||C130143|GERMAN COCKROACH ANTIGEN IGG4 ANTIBODY|||||||BQ/ML|||||||TRACE||BEL||||LOW|NOT DONE||||BREAST MILK|GELLED|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|MDRD 5 VARIABLE FORMULA||U|N|U|Y|||Y|1||38||OPEN LABEL TREATMENT|1973-06-08|1973-03-14|||||1971-01-05||1963-02-11|U|1972-12-02
TRIAL STUDY 134XCP|LB|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|1||||ALUMINUM|ALUMINUM|||||||UMOL|||||||TRACE||NGEQ/L||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|AUTOLYZED|Y|CONTRAST ENHANCED SPIRAL CT SCAN|FIBROTEST FORMULA||N|NA|U|U|||Y|2||58||TREATMENT|1969-05-25|1966-07-21|||||1966-12-12||1961-08-10|N|1963-10-17
TRIAL STUDY 134XCP|LB|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|2||||IDL|IDL CHOLESTEROL|||||||MET|||||||BORDERLINE||DAGU||||ABNORMAL|NOT DONE||||LOCHIA|FROZEN|U|IMMUNOFIXATION ELECTROPHORESIS|MDRD ENZYMATIC FORMULA||Y|Y|U|NA|||NA|2||58||CONTINUATION TREATMENT|1964-12-22|1963-01-07|||||1965-06-03||1965-09-30|N|1961-06-04
TRIAL STUDY 134XCP|LB|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|1||||CSEPI846|AGGRECAN CHONDROITIN SULFATE EPITOPE 846|||||||MNFI|||||||BORDERLINE||KN/CM2||||LOW|NOT DONE||||SALIVA|NON-HEMOLYZED|Y|JAEGER EYE CHART|MDRD 5 VARIABLE FORMULA||Y|U|NA|Y|||U|3||39||WASHOUT|1965-11-17|1961-09-23|||||1970-02-18||1962-06-09|NA|1960-06-07
TRIAL STUDY 134XCP|LB|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|2||||THCCOOH|11-NOR-DELTA9-THC-9-CARBOXYLIC ACID|||||||S/H|||||||POSITIVE||ANSON U||||HIGH|NOT DONE||||EPITHELIAL CELL|AUTOLYZED|Y|IHC|CKD-EPI CYSTATIN C FORMULA||NA|N|U|U|||NA|3||39||OBSERVATION|1969-12-26|1972-04-14|||||1966-06-17||1969-04-01|NA|1961-04-14
TRIAL STUDY 134XCP|LB|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|1||||UNSPCELE|UNSPECIFIED CELLS/LEUKOCYTES|||||||10^6 DNA COPIES/ML|||||||POSITIVE||CMH2O/ML||||HIGH|NOT DONE||||REFLEX TEAR|GELLED|Y|MICRONEUTRALIZATION ASSAY|CKD-EPI FORMULA||Y|N|Y|N|||N|4||88||OBSERVATION|1971-11-16|1963-10-18|||||1973-02-07||1971-01-05|NA|1971-09-30
TRIAL STUDY 134XCP|LB|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|2||||C165936|GLYCINE MAX IGE AB RAST SCORE|||||||DL|||||||INVALID||L/MIN/M2||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|N|SPECULAR MICROSCOPY|FIBROTEST FORMULA||NA|Y|NA|Y|||N|4||88||CONTINUATION TREATMENT|1972-07-29|1969-04-29|||||1969-04-21||1970-03-06|NA|1966-12-24
TRIAL STUDY 134XCP|LB|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|1||||HBLEPRHB|HEMOGLOBIN LEPORE/TOTAL HEMOGLOBIN|||||||UMOL/L/MIN|||||||INVALID||G/G/DAY||||HIGH|NOT DONE||||EXUDATE|FRESH|Y|MICROARRAY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|Y|U|||N|5||7||CONTINUATION TREATMENT|1972-10-13|1968-10-15|||||1970-08-23||1962-10-26|NA|1969-01-18
TRIAL STUDY 134XCP|LB|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|2||||CD4|CD4|||||||ML/MIN/MMHG|||||||INVALID||MMHG/L/MIN||||LOW|NOT DONE||||CORD BLOOD|HEMOLYZED|N|ULTRASOUND|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|U|NA|||N|5||7||OBSERVATION|1968-12-18|1967-12-20|||||1973-03-09||1964-05-08|Y|1965-04-12
TRIAL STUDY 134XCP|LB|9A60A414-54A0-4A7F-84EE-FCB8246D2477|1||||PLTAGAMP|PLATELET AGGREGATION AMPLITUDE|||||||MEQ/KG|||||||NEGATIVE||MG/MOL||||LOW|NOT DONE||||LAVAGE FLUID|PARAFFIN-EMBEDDED|U|LANDOLT RING|MDRD 4 VARIABLE FORMULA||N|Y|NA|Y|||NA|1||38||OBSERVATION|1969-11-22|1972-05-18|||||1963-09-23||1970-05-20|U|1968-09-17
TRIAL STUDY 134XCP|LB|9A60A414-54A0-4A7F-84EE-FCB8246D2477|2||||HALBAB|HUMAN ALBUMIN ANTIBODY|||||||MS/MMHG|||||||BORDERLINE||ML/DOSE||||ABNORMAL|NOT DONE||||DISCHARGE|AGGLUTINATED|U|PET SCAN|CKD-EPI CYSTATIN C FORMULA||N|N|NA|U|||Y|1||38||LONG-TERM FOLLOW-UP|1969-10-19|1966-12-26|||||1973-03-21||1967-01-08|N|1961-06-29
TRIAL STUDY 134XCP|LB|9A60A414-54A0-4A7F-84EE-FCB8246D2477|1||||C130090|TIMOTHY GRASS POLLEN IGG|||||||CM/MIN|||||||INDETERMINATE||GENEQ||||HIGH|NOT DONE||||INFRANATANT, SERUM|LACTESCENT|NA|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|CKD-EPI CREATININE FORMULA||NA|U|N|Y|||N|2||58||INDUCTION TREATMENT|1967-10-12|1963-12-04|||||1969-02-18||1960-11-29|U|1964-11-15
TRIAL STUDY 134XCP|LB|9A60A414-54A0-4A7F-84EE-FCB8246D2477|2||||PHTRMN|PHENTERMINE|||||||CCID 50/ML|||||||INDETERMINATE||G/CAGE||||LOW|NOT DONE||||CAPILLARY PLASMA|AUTOLYZED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|Y|NA|||U|2||58||CONTINUATION TREATMENT|1966-01-03|1961-07-08|||||1968-06-16||1963-03-17|N|1969-05-19
TRIAL STUDY 134XCP|LB|9A60A414-54A0-4A7F-84EE-FCB8246D2477|1||||INDICAN|INDICAN|||||||MPL U|||||||INDETERMINATE||MAMP||||HIGH|NOT DONE||||SERUM|THAWED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|NA|U|||N|3||39||TREATMENT|1969-11-22|1967-07-11|||||1963-12-17||1970-10-30|N|1965-05-09
TRIAL STUDY 134XCP|LB|9A60A414-54A0-4A7F-84EE-FCB8246D2477|2||||T3UP|TRIIODOTHYRONINE UPTAKE|||||||10^8/L|||||||POSITIVE||PACK||||LOW|NOT DONE||||SUPERNATANT, SERUM|CONCENTRATED|U|COULOMETRIC TITRATION|MDRD ENZYMATIC FORMULA||Y|NA|Y|NA|||NA|3||39||OPEN LABEL TREATMENT|1969-05-22|1968-12-17|||||1966-01-20||1973-05-05|U|1963-04-15
TRIAL STUDY 134XCP|LB|9A60A414-54A0-4A7F-84EE-FCB8246D2477|1||||ARGSAC|ARGININOSUCCINIC ACID|||||||MIN*MG/ML|||||||POSITIVE||PPM||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|ROOM TEMPERATURE|NA|FLUORESCENT IMMUNOASSAY|CKD-EPI FORMULA||NA|Y|Y|U|||U|4||88||BLINDED TREATMENT|1965-03-31|1965-03-18|||||1971-04-09||1973-04-03|Y|1966-06-12
TRIAL STUDY 134XCP|LB|9A60A414-54A0-4A7F-84EE-FCB8246D2477|2||||STBSEXCS|STANDARD BASE EXCESS|||||||ML/DOSE|||||||NEGATIVE||FOZ_US||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|ICTERIC|N|LC-FL|COCKCROFT-GAULT FORMULA||NA|NA|Y|Y|||NA|4||88||CONTINUATION TREATMENT|1968-08-09|1960-10-06|||||1962-09-24||1971-07-15|NA|1968-09-06
TRIAL STUDY 134XCP|LB|9A60A414-54A0-4A7F-84EE-FCB8246D2477|1||||PKM2|PYRUVATE KINASE ISOZYME M2|||||||DIP|||||||INVALID||PFU/ML||||LOW|NOT DONE||||EXUDATE|NON-HEMOLYZED|U|FARNSWORTH-MUNSELL 100 HUE TEST|MDRD ENZYMATIC FORMULA||NA|Y|U|N|||N|5||7||SCREENING|1968-08-30|1970-01-09|||||1963-11-26||1972-11-07|N|1966-06-20
TRIAL STUDY 134XCP|LB|9A60A414-54A0-4A7F-84EE-FCB8246D2477|2||||T4FRIND|THYROXINE, FREE, INDIRECT|||||||QUANTITY SUFFICIENT|||||||POSITIVE||GENEQ||||ABNORMAL|NOT DONE||||KERATINOCYTE|HEMOLYZED|Y|MICROBIAL CULTURE, LIQUID|GMI MMOL/MOL FORMULA||Y|N|NA|U|||N|5||7||WASHOUT|1961-12-25|1962-02-24|||||1971-09-30||1961-02-04|U|1972-11-10
TRIAL STUDY 134XCP|LB|8D546F1C-E719-4C03-A66A-9916EFF2A144|1||||LDHEXR|LACTATE DEHYDROGENASE EXCRETION RATE|||||||GPS U|||||||BORDERLINE||VP/DOSE||||LOW|NOT DONE||||PROSTATIC FLUID|LACTESCENT|U|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|Y|||NA|1||38||FOLLOW-UP|1961-07-03|1965-02-11|||||1960-12-30||1966-05-22|NA|1971-11-03
TRIAL STUDY 134XCP|LB|8D546F1C-E719-4C03-A66A-9916EFF2A144|2||||PSA|PROSTATE SPECIFIC ANTIGEN|||||||UIU/DL|||||||INVALID||MASK||||HIGH|NOT DONE||||WHITE MATTER TISSUE|PARAFFIN-EMBEDDED|N|ELECTROGASTROGRAPHY|MDRD 5 VARIABLE FORMULA||Y|NA|N|N|||N|1||38||TREATMENT|1961-05-15|1970-03-01|||||1965-07-25||1967-08-18|N|1965-05-22
TRIAL STUDY 134XCP|LB|8D546F1C-E719-4C03-A66A-9916EFF2A144|1||||CD3|CD3|||||||NKAT/G HB|||||||NEGATIVE||MPA||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE|NA|PERFUSION MRI|MDRD ENZYMATIC FORMULA||NA|N|N|N|||Y|2||58||INDUCTION TREATMENT|1961-05-02|1963-12-11|||||1964-02-16||1960-06-11|NA|1961-04-24
TRIAL STUDY 134XCP|LB|8D546F1C-E719-4C03-A66A-9916EFF2A144|2||||C130084|ENGLISH PLANTAIN POLLEN IGE|||||||VG/KG|||||||NEGATIVE||MESF||||HIGH|NOT DONE||||NAIL|REFRIGERATED|Y|ENZYMATIC ULTRACENTRIFUGATION|MDRD 5 VARIABLE FORMULA||U|Y|N|U|||U|2||58||BLINDED TREATMENT|1968-12-30|1972-08-27|||||1970-06-13||1963-09-21|U|1965-01-31
TRIAL STUDY 134XCP|LB|8D546F1C-E719-4C03-A66A-9916EFF2A144|1||||MSTHCELE|MESOTHELIAL CELLS/LEUKOCYTES|||||||NMOL|||||||INDETERMINATE||DRAM||||NORMAL|NOT DONE||||BONE|AGGLUTINATED|Y|CONFOCAL MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||NA|Y|NA|U|||U|3||39||INDUCTION TREATMENT|1971-07-28|1966-08-13|||||1964-07-16||1963-07-09|NA|1967-07-18
TRIAL STUDY 134XCP|LB|8D546F1C-E719-4C03-A66A-9916EFF2A144|2||||CCPAB|CYCLIC CITRULLINATED PEPTIDE ANTIBODY|||||||NL|||||||TRACE||U/ML||||LOW|NOT DONE||||ALVEOLAR AIR|THAWED|N|URANYL ACETATE STAIN|MDRD 5 VARIABLE FORMULA||N|U|U|U|||NA|3||39||TREATMENT|1960-06-12|1967-12-17|||||1961-07-04||1971-02-20|N|1962-01-15
TRIAL STUDY 134XCP|LB|8D546F1C-E719-4C03-A66A-9916EFF2A144|1||||PLATGNT|GIANT PLATELETS|||||||MPS U|||||||INDETERMINATE||MOL/MOL||||LOW|NOT DONE||||SYNOVIAL FLUID|REFRIGERATED|Y|SISH|CKD-EPI FORMULA||Y|N|NA|Y|||Y|4||88||BASELINE|1964-03-20|1964-10-29|||||1964-10-19||1969-11-03|U|1963-07-08
TRIAL STUDY 134XCP|LB|8D546F1C-E719-4C03-A66A-9916EFF2A144|2||||BASOBLE|BASOPHILS BAND FORM/LEUKOCYTES|||||||KM|||||||INDETERMINATE||MG/ML/MIN||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|LIPEMIC|U|MICROARRAY|CKD-EPI FORMULA||Y|U|N|Y|||N|4||88||INDUCTION TREATMENT|1965-02-14|1964-01-12|||||1968-01-17||1973-04-16|N|1965-08-03
TRIAL STUDY 134XCP|LB|8D546F1C-E719-4C03-A66A-9916EFF2A144|1||||LVTRCTM|LEVETIRACETAM|||||||UMOL/L|||||||INVALID||F||||NORMAL|NOT DONE||||KERATINOCYTE|CLOTTED|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC FORMULA||Y|NA|NA|Y|||Y|5||7||INDUCTION TREATMENT|1966-09-08|1970-11-09|||||1971-08-19||1969-07-16|Y|1968-12-24
TRIAL STUDY 134XCP|LB|8D546F1C-E719-4C03-A66A-9916EFF2A144|2||||FAI|FREE ANDROGEN INDEX|||||||MBQ/UL|||||||INVALID||UMOL/L/MIN||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|CONCENTRATED|U|IMPEDANCE CONDUCTIVITY|NASH FIBROSURE FORMULA||NA|Y|N|Y|||Y|5||7||OPEN LABEL TREATMENT|1971-08-25|1962-01-28|||||1968-02-06||1962-12-16|Y|1967-10-20
TRIAL STUDY 134XCP|LB|B998085D-F227-46C8-B2D8-37E97BA799D2|1||||CREAT|CREATININE|||||||EU|||||||NEGATIVE||F||||ABNORMAL|NOT DONE||||PLATELET|AUTOLYZED|Y|SEQUENCING|FIBROTEST FORMULA||NA|U|NA|Y|||Y|1||38||LONG-TERM FOLLOW-UP|1965-05-15|1971-06-29|||||1960-11-29||1971-02-16|NA|1973-03-09
TRIAL STUDY 134XCP|LB|B998085D-F227-46C8-B2D8-37E97BA799D2|2||||PLSTCE|TOTAL PLASMA CELLS|||||||KN/CM2|||||||INDETERMINATE||LOG10 PFU||||LOW|NOT DONE||||HAIR|NON-HEMOLYZED|Y|PATHOLOGICAL EVALUATION|MDRD 4 VARIABLE FORMULA||N|Y|N|NA|||NA|1||38||BASELINE|1971-08-12|1972-12-14|||||1966-05-10||1967-09-03|U|1972-07-18
TRIAL STUDY 134XCP|LB|B998085D-F227-46C8-B2D8-37E97BA799D2|1||||TNF10|TNF SUPERFAMILY MEMBER 10|||||||UMOL/L|||||||POSITIVE||MV/SEC||||LOW|NOT DONE||||LAVAGE FLUID|ROOM TEMPERATURE|NA|MICROBIAL CONCENTRATION|FIBROTEST FORMULA||N|N|Y|N|||Y|2||58||OPEN LABEL TREATMENT|1964-01-26|1964-10-18|||||1961-08-18||1966-08-27|Y|1970-07-10
TRIAL STUDY 134XCP|LB|B998085D-F227-46C8-B2D8-37E97BA799D2|2||||RDWRCV|RET RDW COEFFICIENT OF VARIATION|||||||SYRINGE|||||||NEGATIVE||UG/L FEU||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|ROOM TEMPERATURE|N|INTERRUPTER TECHNIQUE|MDRD FORMULA||Y|N|Y|Y|||N|2||58||TREATMENT|1972-02-22|1965-12-14|||||1961-09-12||1962-11-12|NA|1969-04-17
TRIAL STUDY 134XCP|LB|B998085D-F227-46C8-B2D8-37E97BA799D2|1||||CARBXHGB|CARBOXYHEMOGLOBIN|||||||BQ/KG|||||||NEGATIVE||NMOL BCE/L||||HIGH|NOT DONE||||PROSTATIC FLUID|PARAFFIN-EMBEDDED|N|SPECT/CT SCAN|GMI MMOL/MOL FORMULA||N|Y|N|NA|||NA|3||39||TREATMENT|1962-12-17|1972-11-05|||||1966-10-09||1966-06-15|Y|1962-10-14
TRIAL STUDY 134XCP|LB|B998085D-F227-46C8-B2D8-37E97BA799D2|2||||C165895|JOHNSON GRASS POLLEN IGG4 ANTIBODY|||||||/VF|||||||POSITIVE||CG||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|SOLIDIFIED|Y|SPIRAL CT SCAN WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA||U|U|NA|NA|||Y|3||39||BASELINE|1964-06-04|1971-07-25|||||1967-10-11||1968-01-03|N|1966-12-14
TRIAL STUDY 134XCP|LB|B998085D-F227-46C8-B2D8-37E97BA799D2|1||||CYTRPHOS|TRIPLE PHOSPHATE CRYSTALS|||||||ML/M2/DAY|||||||BORDERLINE||10^6 IU/ML||||HIGH|NOT DONE||||PERSPIRATION|ROOM TEMPERATURE|N|ACCELERATOR MASS SPECTROMETRY|FIBROTEST FORMULA||N|NA|NA|U|||Y|4||88||CONTINUATION TREATMENT|1963-08-11|1971-11-23|||||1961-07-23||1971-12-15|Y|1972-07-24
TRIAL STUDY 134XCP|LB|B998085D-F227-46C8-B2D8-37E97BA799D2|2||||PSELECT|P-SELECTIN|||||||UL/ML|||||||BORDERLINE||MOSM/KG||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|CALCIFIED|U|MECHANICAL CLOT DETECTION|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|Y|N|||NA|4||88||RUN-IN|1960-10-14|1960-04-11|||||1973-07-27||1968-08-25|NA|1972-04-14
TRIAL STUDY 134XCP|LB|B998085D-F227-46C8-B2D8-37E97BA799D2|1||||CARTP|COCAINE AMPHETAMINE-REG TRANSCRIPT PROT|||||||MMOL/MIN/KPA|||||||INVALID||L/L||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|ICTERIC|Y|AGAR DILUTION|FIBROTEST FORMULA||Y|Y|U|N|||N|5||7||OPEN LABEL TREATMENT|1968-03-02|1960-05-13|||||1964-10-31||1960-11-09|Y|1967-08-23
TRIAL STUDY 134XCP|LB|B998085D-F227-46C8-B2D8-37E97BA799D2|2||||ERCECE|ERYTHROID CELLS/TOTAL CELLS|||||||LB|||||||INDETERMINATE||DPM/0.5 ML||||LOW|NOT DONE||||LYMPH|AGGLUTINATED|NA|INCISION-INDUCED BLEEDING METHOD|MDRD 4 VARIABLE FORMULA||NA|N|U|N|||Y|5||7||CONTINUATION TREATMENT|1962-06-16|1971-11-24|||||1965-02-18||1973-07-25|NA|1963-06-16
TRIAL STUDY 134XCP|LB|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|1||||FBRTST|FIBROTEST SCORE|||||||CFU/ML|||||||NEGATIVE||FOZ_BR||||ABNORMAL|NOT DONE||||BUFFY COAT|SOLIDIFIED|U|PULSE OXIMETRY|MDRD 5 VARIABLE FORMULA||Y|Y|N|U|||U|1||38||CONTINUATION TREATMENT|1973-08-17|1963-05-13|||||1962-07-18||1964-02-10|Y|1967-11-05
TRIAL STUDY 134XCP|LB|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|2||||CD3|CD3|||||||ML/CM3/MIN|||||||TRACE||COPIES/UG||||NORMAL|NOT DONE||||ARTERIAL BLOOD|HEMOLYZED|NA|CELL BASED BIOASSAY|ASH FIBROSURE FORMULA||Y|N|Y|U|||U|1||38||RUN-IN|1969-06-04|1969-09-20|||||1970-02-19||1966-04-29|U|1971-07-22
TRIAL STUDY 134XCP|LB|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|1||||CCPAB|CYCLIC CITRULLINATED PEPTIDE ANTIBODY|||||||UV2|||||||NEGATIVE||GPS U||||NORMAL|NOT DONE||||VITREOUS HUMOR|AGGLUTINATED|NA|OPTICAL DENSITY MEASUREMENT|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|NA|NA|||N|2||58||SCREENING|1973-01-22|1961-08-29|||||1961-06-17||1963-09-23|N|1970-04-05
TRIAL STUDY 134XCP|LB|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|2||||TSP1|THROMBOSPONDIN 1|||||||/HPF|||||||TRACE||M2||||LOW|NOT DONE||||VENOUS PLASMA|UNEXPECTED ODOR|NA|WRIGHT STAIN|MDRD 6 VARIABLE FORMULA||NA|U|NA|U|||N|2||58||OPEN LABEL TREATMENT|1966-08-15|1963-03-11|||||1973-03-27||1961-06-24|U|1963-10-15
TRIAL STUDY 134XCP|LB|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|1||||HDLCLDLC|HDL CHOLESTEROL/LDL CHOLESTEROL|||||||CL|||||||INDETERMINATE||WATT||||LOW|NOT DONE||||ARTERIAL BLOOD|LACTESCENT|U|CRYOSCOPY|MDRD 4 VARIABLE FORMULA||N|N|N|U|||N|3||39||RUN-IN|1973-04-11|1972-10-07|||||1963-10-03||1965-06-13|NA|1967-10-22
TRIAL STUDY 134XCP|LB|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|2||||BNP|BRAIN NATRIURETIC PEPTIDE|||||||10^4 CFU|||||||NEGATIVE||NM||||LOW|NOT DONE||||CORD SERUM|CONCENTRATED|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|NASH FIBROSURE FORMULA||Y|NA|Y|N|||N|3||39||RUN-IN|1964-07-10|1961-04-13|||||1968-05-05||1971-07-21|Y|1963-05-30
TRIAL STUDY 134XCP|LB|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|1||||OXYSAT|OXYGEN SATURATION|||||||GBQ/MG|||||||BORDERLINE||HENRY||||LOW|NOT DONE||||EPIDERMAL TISSUE|DRIED|NA|IN VITRO GENE EXPRESSION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|NA|N|||U|4||88||BASELINE|1962-01-20|1963-03-21|||||1966-05-05||1973-05-26|NA|1965-11-19
TRIAL STUDY 134XCP|LB|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|2||||NITRICOX|NITRIC OXIDE|||||||COPIES/UL|||||||TRACE||/MIN||||ABNORMAL|NOT DONE||||DERMAL TISSUE|REFRIGERATED|NA|DIGITAL PCR|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|U|NA|||N|4||88||OBSERVATION|1966-05-28|1961-04-01|||||1970-07-21||1966-05-28|NA|1972-09-19
TRIAL STUDY 134XCP|LB|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|1||||CAPHOSPD|CALCIUM - PHOSPHORUS PRODUCT|||||||VOXEL|||||||NEGATIVE||ML/M2/DAY||||HIGH|NOT DONE||||PLEURAL TISSUE|THAWED|NA|TRANSVAGINAL ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|NA|U|||NA|5||7||BLINDED TREATMENT|1973-08-13|1966-09-17|||||1968-04-24||1967-11-11|NA|1962-07-16
TRIAL STUDY 134XCP|LB|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|2||||NAGASECR|N-ACETYL-B-D-GLUCOSAMINIDASE/CREATININE|||||||OZ|||||||NEGATIVE||PIXELS/IN||||HIGH|NOT DONE||||DERMAL TISSUE|ICTERIC|NA|JAFFE REACTION|MDRD 4 VARIABLE FORMULA||NA|N|Y|N|||Y|5||7||LONG-TERM FOLLOW-UP|1972-06-29|1963-12-15|||||1963-02-26||1964-03-17|U|1963-08-07
TRIAL STUDY 134XCP|LB|537CE647-EA58-430C-B37B-F56BF20B5AF0|1||||MX1|INTERFERON-INDUCED PROTEIN P78|||||||KDA|||||||TRACE||BQ/MG||||NORMAL|NOT DONE||||BONE|REFRIGERATED|NA|CELLULAR PROLIFERATION ASSAY|MDRD 6 VARIABLE FORMULA||NA|U|N|U|||Y|1||38||SCREENING|1972-07-03|1970-11-13|||||1968-09-28||1967-10-21|Y|1965-03-05
TRIAL STUDY 134XCP|LB|537CE647-EA58-430C-B37B-F56BF20B5AF0|2||||RANKL|RECEPTOR ACTIVATOR NUCLEAR KAPPAB LIGAND|||||||GPL U|||||||INDETERMINATE||U/G/H||||LOW|NOT DONE||||CAPILLARY BLOOD|AGGLUTINATED|NA|SXA SCAN|FIBROTEST FORMULA||Y|Y|U|Y|||N|1||38||TREATMENT|1960-10-24|1973-08-04|||||1960-10-22||1972-01-22|U|1967-05-31
TRIAL STUDY 134XCP|LB|537CE647-EA58-430C-B37B-F56BF20B5AF0|1||||MIP1G|MACROPHAGE INFLAMMATORY PROTEIN 1 GAMMA|||||||IU/KG/H|||||||INDETERMINATE||U.CARR||||ABNORMAL|NOT DONE||||PLATELET POOR PLASMA|LIPEMIC|Y|NEXT GENERATION SEQUENCING|CKD-EPI CYSTATIN C FORMULA||Y|NA|NA|NA|||Y|2||58||OPEN LABEL TREATMENT|1961-02-23|1961-03-28|||||1972-02-26||1966-02-27|Y|1968-10-07
TRIAL STUDY 134XCP|LB|537CE647-EA58-430C-B37B-F56BF20B5AF0|2||||INR|PROTHROMBIN INTL. NORMALIZED RATIO|||||||G/CAGE/DAY|||||||INDETERMINATE||GMFI||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|THAWED|U|TARGETED TRANSCRIPTOME SEQUENCING|CKD-EPI CREATININE FORMULA||N|U|U|N|||Y|2||58||WASHOUT|1969-08-27|1972-10-28|||||1963-04-22||1968-09-26|N|1969-07-14
TRIAL STUDY 134XCP|LB|537CE647-EA58-430C-B37B-F56BF20B5AF0|1||||SJSSAAB|SJOGRENS SS-A ANTIBODY|||||||MMOL/G|||||||NEGATIVE||MOL/DAY||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|ROOM TEMPERATURE|Y|ELISPOT|FIBROTEST FORMULA||Y|NA|NA|N|||N|3||39||TREATMENT|1964-08-22|1960-06-21|||||1973-07-17||1968-01-22|NA|1960-10-26
TRIAL STUDY 134XCP|LB|537CE647-EA58-430C-B37B-F56BF20B5AF0|2||||C130081|ORCHARD GRASS POLLEN IGA|||||||COPIES/UL|||||||INDETERMINATE||OSM||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|CONTAMINATED|N|PERCUSSION|FIBROSIS 4 FORMULA||U|U|U|N|||N|3||39||RUN-IN|1971-12-10|1971-03-18|||||1968-03-23||1960-07-25|Y|1962-05-14
TRIAL STUDY 134XCP|LB|537CE647-EA58-430C-B37B-F56BF20B5AF0|1||||PLSCR1|PHOSPHOLIPID SCRAMBLASE 1|||||||AFU|||||||INDETERMINATE||OSM||||NORMAL|NOT DONE||||AQUEOUS HUMOR|CONCENTRATED|N|SPIROMETRY|HEPASCORE FORMULA||N|N|N|N|||NA|4||88||OBSERVATION|1965-01-24|1971-05-20|||||1969-07-05||1966-03-29|Y|1970-10-28
TRIAL STUDY 134XCP|LB|537CE647-EA58-430C-B37B-F56BF20B5AF0|2||||FIBRINOF|FIBRINOGEN, FUNCTIONAL|||||||MG/H|||||||BORDERLINE||KA_U/DL||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CONCENTRATED|N|FARNSWORTH-MUNSELL 100 HUE TEST|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|N|Y|||Y|4||88||BASELINE|1973-05-16|1966-01-09|||||1968-06-11||1964-06-07|N|1960-01-22
TRIAL STUDY 134XCP|LB|537CE647-EA58-430C-B37B-F56BF20B5AF0|1||||PLAGMAMP|PLATELET AGGREGATION MEAN AMPLITUDE|||||||U/KG/DAY|||||||POSITIVE||ML/M2/MIN||||NORMAL|NOT DONE||||URINE SEDIMENT|AGGLUTINATED|N|PH METER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA||N|N|NA|NA|||Y|5||7||WASHOUT|1966-04-25|1962-11-08|||||1962-01-08||1963-09-25|U|1964-06-29
TRIAL STUDY 134XCP|LB|537CE647-EA58-430C-B37B-F56BF20B5AF0|2||||ENA78|EPITH NEUTROPHIL-ACTIVATING PEPTIDE 78|||||||UGEQ|||||||NEGATIVE||CMH2O/ML||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|AGGLUTINATED|U|ELISA|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|U|Y|||N|5||7||BASELINE|1960-03-12|1963-03-05|||||1962-02-18||1973-06-16|U|1967-05-29
TRIAL STUDY 134XCP|LB|3464201C-9704-40B6-B3B3-2BADE02BD58F|1||||TGFB1|TRANSFORMING GROWTH FACTOR BETA 1|||||||CFU/G|||||||INDETERMINATE||MMOL2/L2||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|FRESH|NA|THICK SMEAR|CKD-EPI CREATININE FORMULA||U|NA|NA|NA|||N|1||38||INDUCTION TREATMENT|1966-05-06|1962-11-11|||||1962-01-05||1968-11-02|N|1966-09-29
TRIAL STUDY 134XCP|LB|3464201C-9704-40B6-B3B3-2BADE02BD58F|2||||GRANBCE|GRANULOCYTES BAND FORM/TOTAL CELLS|||||||CAL|||||||INVALID||/500 WBC||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|LIPEMIC|NA|DUKE INCISION METHOD|MDRD 4 VARIABLE FORMULA||NA|NA|N|Y|||N|1||38||OPEN LABEL TREATMENT|1971-07-26|1972-12-25|||||1961-06-30||1969-10-30|U|1965-03-06
TRIAL STUDY 134XCP|LB|3464201C-9704-40B6-B3B3-2BADE02BD58F|1||||CYAMORPH|AMORPHOUS CRYSTALS|||||||KA_U/DL|||||||TRACE||UG/CM2||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|LIPEMIC|Y|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD 6 VARIABLE FORMULA||N|N|U|U|||N|2||58||TREATMENT|1971-05-22|1960-11-06|||||1970-05-24||1968-11-16|NA|1972-03-24
TRIAL STUDY 134XCP|LB|3464201C-9704-40B6-B3B3-2BADE02BD58F|2||||IL1RL1|INTERLEUKIN 1 RECEPTOR-LIKE 1|||||||NMOL/G|||||||BORDERLINE||TUBERCULIN UNIT||||NORMAL|NOT DONE||||PLEURAL FLUID|GELLED|NA|HEMAGGLUTINATION INHIBITION ASSAY|HEPASCORE FORMULA||N|U|N|NA|||N|2||58||BASELINE|1968-12-13|1963-05-29|||||1961-05-13||1966-05-03|U|1967-09-16
TRIAL STUDY 134XCP|LB|3464201C-9704-40B6-B3B3-2BADE02BD58F|1||||PEMAB|PEMPHIGOID ANTIBODIES|||||||10^9 ORGANISMS/MG|||||||INDETERMINATE||GMFI||||LOW|NOT DONE||||INFRANATANT, PLASMA|FROZEN|NA|MAGNETIC RESONANCE ENTEROGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|N|||NA|3||39||WASHOUT|1963-06-19|1970-06-21|||||1966-09-17||1962-12-19|Y|1970-10-16
TRIAL STUDY 134XCP|LB|3464201C-9704-40B6-B3B3-2BADE02BD58F|2||||RDWRSD|RET RDW STANDARD DEVIATION|||||||UL/ML|||||||POSITIVE||KS||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|REFRIGERATED|U|CONTRAST ENHANCED PET SCAN|MDRD FORMULA||N|U|Y|U|||N|3||39||BLINDED TREATMENT|1962-02-07|1960-05-08|||||1973-03-14||1971-12-23|NA|1969-09-06
TRIAL STUDY 134XCP|LB|3464201C-9704-40B6-B3B3-2BADE02BD58F|1||||ACETOAC|ACETOACETIC ACID|||||||CM/S|||||||INVALID||ML/KG||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|UNEXPECTED ODOR|U|CALCOFLUOR WHITE STAIN|HEPASCORE FORMULA||NA|N|NA|NA|||N|4||88||OPEN LABEL TREATMENT|1960-10-03|1970-07-15|||||1969-06-15||1961-03-12|N|1960-10-10
TRIAL STUDY 134XCP|LB|3464201C-9704-40B6-B3B3-2BADE02BD58F|2||||SHBG|SEX HORMONE BINDING GLOBULIN|||||||L/S/KPA|||||||NEGATIVE||KDA||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|UNEXPECTED ODOR|U|KINETIC CHROMOGENIC ASSAY|NASH FIBROSURE FORMULA||U|NA|NA|N|||NA|4||88||RUN-IN|1972-01-02|1968-04-07|||||1970-09-26||1963-11-17|NA|1966-11-04
TRIAL STUDY 134XCP|LB|3464201C-9704-40B6-B3B3-2BADE02BD58F|1||||MASTCE|MAST CELLS|||||||UG/MOL|||||||BORDERLINE||M/SEC2||||NORMAL|NOT DONE||||ARTERIAL BLOOD|DRIED|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 4 VARIABLE FORMULA||N|N|NA|NA|||Y|5||7||OBSERVATION|1961-08-11|1960-06-08|||||1968-12-22||1965-11-04|Y|1963-01-20
TRIAL STUDY 134XCP|LB|3464201C-9704-40B6-B3B3-2BADE02BD58F|2||||EPISCECE|SQUAMOUS EPITHELIAL CELLS/TOTAL CELLS|||||||U/CL|||||||BORDERLINE||L/H/M2||||HIGH|NOT DONE||||COLOSTRUM|CLOTTED|NA|NUCLEIC ACID SEQUENCING|ASH FIBROSURE FORMULA||U|N|NA|N|||N|5||7||SCREENING|1965-10-09|1962-10-17|||||1972-06-16||1963-01-30|NA|1969-05-14
TRIAL STUDY 134XCP|LB|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|1||||GLUC|GLUCOSE|||||||PL|||||||NEGATIVE||KG/M2||||HIGH|NOT DONE||||PLATELET RICH PLASMA|ICTERIC|U|DIGITAL PCR ARRAY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|NA|Y|||NA|1||38||SCREENING|1969-07-31|1972-10-15|||||1960-11-25||1971-03-06|NA|1963-06-21
TRIAL STUDY 134XCP|LB|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|2||||CEIMCE|IMMATURE CELLS/TOTAL CELLS|||||||PL|||||||INDETERMINATE||UV*SEC||||HIGH|NOT DONE||||BILE|FROZEN|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|HEPASCORE FORMULA||NA|U|NA|N|||N|1||38||BASELINE|1971-03-31|1965-07-13|||||1969-05-25||1965-07-12|Y|1963-02-19
TRIAL STUDY 134XCP|LB|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|1||||NHMCE|NONHEMATIC CELLS|||||||G/ANIMAL/DAY|||||||INDETERMINATE||/200 HPFS||||ABNORMAL|NOT DONE||||ABSCESS FLUID|DRIED|U|DOPPLER ULTRASOUND|COCKCROFT-GAULT FORMULA||Y|U|U|Y|||Y|2||58||BASELINE|1967-02-24|1968-06-16|||||1971-07-24||1972-10-12|Y|1968-03-18
TRIAL STUDY 134XCP|LB|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|2||||C3DAB|COMPLEMENT C3D ANTIBODY|||||||OZ EQ|||||||TRACE||MGEQ||||HIGH|NOT DONE||||MUCUS|LACTESCENT|U|SLOAN LETTER EYE CHART 2.5%|FIBROSIS 4 FORMULA||U|Y|N|NA|||N|2||58||OBSERVATION|1972-09-24|1965-11-10|||||1968-12-08||1973-08-04|NA|1964-08-30
TRIAL STUDY 134XCP|LB|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|1||||HBOARBHB|HEMOGLOBIN O-ARAB/TOTAL HEMOGLOBIN|||||||10^9/DOSE|||||||TRACE||VIAL||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|SOLIDIFIED|NA|MICROBIAL CULTURE, LIQUID|COCKCROFT-GAULT FORMULA||N|U|Y|Y|||NA|3||39||OPEN LABEL TREATMENT|1966-06-23|1970-10-07|||||1961-05-30||1969-08-11|NA|1962-04-26
TRIAL STUDY 134XCP|LB|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|2||||CA2729AG|CANCER ANTIGEN 27-29|||||||MIN|||||||BORDERLINE||L/KG||||HIGH|NOT DONE||||PERITONEAL FLUID|ICTERIC|NA|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NASH FIBROSURE FORMULA||U|NA|N|NA|||N|3||39||OPEN LABEL TREATMENT|1973-07-31|1965-04-12|||||1972-12-18||1965-04-14|N|1972-02-27
TRIAL STUDY 134XCP|LB|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|1||||NEUTCYBS|CYTOPLASMIC BASOPHILIA NEUTROPHIL|||||||G/ANIMAL|||||||BORDERLINE||MEQ/G||||ABNORMAL|NOT DONE||||TUMOR TISSUE|NON-HEMOLYZED|NA|POLYMERASE CHAIN REACTION|GMI % FORMULA||Y|N|NA|U|||U|4||88||SCREENING|1965-11-27|1972-09-06|||||1963-02-23||1961-09-17|NA|1967-11-11
TRIAL STUDY 134XCP|LB|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|2||||HELMOV10|HELICASE MOV-10 PROTEIN|||||||U/KG/H|||||||NEGATIVE||KM/H||||HIGH|NOT DONE||||BLOOD|SOLIDIFIED|Y|ICC|FIBROSIS 4 FORMULA||U|N|N|NA|||U|4||88||INDUCTION TREATMENT|1963-12-29|1963-12-21|||||1961-04-08||1968-07-15|N|1963-03-09
TRIAL STUDY 134XCP|LB|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|1||||C130089|TIMOTHY GRASS POLLEN IGA|||||||ANTIBODY UNIT|||||||BORDERLINE||10^6 CFU||||NORMAL|NOT DONE||||LEUKOCYTE|CONTAMINATED|U|TRANSMISSION ELECTRON MICROSCOPY|CKD-EPI FORMULA||U|U|Y|U|||U|5||7||CONTINUATION TREATMENT|1960-01-05|1966-08-27|||||1965-03-13||1963-07-19|NA|1961-04-10
TRIAL STUDY 134XCP|LB|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|2||||C130139|AMERICAN COCKROACH ANTIGEN IGG4 ANTIBODY|||||||PFU/DOSE|||||||INDETERMINATE||BISCUIT||||NORMAL|NOT DONE||||HAIR|AGGLUTINATED|NA|IHC|MDRD ENZYMATIC JAPANESE FORMULA||U|N|Y|Y|||NA|5||7||RUN-IN|1968-02-16|1971-07-15|||||1964-06-12||1961-11-21|Y|1971-04-25
TRIAL STUDY 134XCP|LB|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|1||||CNTIGGAB|CENTROMERE IGG ANTIBODY|||||||U/G HB|||||||BORDERLINE||10^3 COPIES/ML||||LOW|NOT DONE||||BUFFY COAT|DRIED|NA|CALIPER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA||N|N|NA|N|||U|1||38||BASELINE|1960-06-19|1962-12-01|||||1962-12-14||1962-04-14|U|1972-01-27
TRIAL STUDY 134XCP|LB|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|2||||CYSULFA|SULFA CRYSTALS|||||||/VF|||||||POSITIVE||SCOOPFUL||||HIGH|NOT DONE||||LOCHIA|HEMOLYZED|U|DIRECT SEQUENCING|COCKCROFT-GAULT FORMULA||Y|U|U|U|||NA|1||38||INDUCTION TREATMENT|1969-12-22|1971-12-24|||||1962-10-10||1962-05-03|U|1971-01-02
TRIAL STUDY 134XCP|LB|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|1||||ETGETS|ETHYL GLUCURONIDE ETHYL SULFATE|||||||MBQ|||||||POSITIVE||UG/H||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|AUTOLYZED|N|DC SHEATH FLOW|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|N|U|||NA|2||58||BLINDED TREATMENT|1970-06-25|1971-08-03|||||1966-11-06||1962-09-17|N|1973-01-17
TRIAL STUDY 134XCP|LB|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|2||||EPISQTCE|SQUAMOUS TRANSITIONAL EPITHELIAL CELLS|||||||FEU|||||||NEGATIVE||RNA COPIES/ML||||LOW|NOT DONE||||SUPERNATANT, SERUM|GELLED|Y|PEAK FLOWMETRY|MDRD FORMULA||Y|U|Y|Y|||Y|2||58||OPEN LABEL TREATMENT|1967-07-02|1971-09-30|||||1968-06-19||1966-11-01|Y|1969-10-19
TRIAL STUDY 134XCP|LB|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|1||||HLAIAB|HLA CLASS I ANTIBODY|||||||KA_U/DL|||||||TRACE||10^3 CFU||||LOW|NOT DONE||||CERUMEN|THAWED|U|SPIROMETRY|COCKCROFT-GAULT FORMULA||N|NA|NA|Y|||Y|3||39||BASELINE|1966-07-07|1966-10-14|||||1967-10-31||1963-07-31|NA|1967-12-21
TRIAL STUDY 134XCP|LB|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|2||||GNRH|GONADOTROPIN RELEASING HORMONE|||||||ABSORBANCE U|||||||BORDERLINE||RATIO||||HIGH|NOT DONE||||ABSCESS FLUID|CONCENTRATED|NA|X-RAY FLUORESCENCE SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|N|N|||Y|3||39||FOLLOW-UP|1966-10-13|1970-09-10|||||1965-02-15||1966-05-29|NA|1970-06-13
TRIAL STUDY 134XCP|LB|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|1||||CONSIST|CONSISTENCY|||||||EQ|||||||INVALID||UMOL/H/MMOL||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|DRIED|N|QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROTEST FORMULA||Y|U|Y|N|||U|4||88||LONG-TERM FOLLOW-UP|1965-09-02|1967-12-31|||||1972-12-16||1973-05-30|U|1962-07-18
TRIAL STUDY 134XCP|LB|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|2||||ALBEXR|ALBUMIN EXCRETION RATE|||||||MG/M2|||||||NEGATIVE||LOG10 TCID 50/ML||||NORMAL|NOT DONE||||LOCHIA|GELLED|Y|APPLANATION TONOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|N|Y|||NA|4||88||RUN-IN|1968-09-12|1968-02-18|||||1972-11-13||1962-01-29|NA|1970-01-28
TRIAL STUDY 134XCP|LB|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|1||||DALACRT|DELTA AMINOLEVULINATE/CREATININE|||||||DYN|||||||BORDERLINE||VIRTUAL PIXEL||||HIGH|NOT DONE||||HAIR|HEMOLYZED|NA|GC/MS/MS|CKD-EPI FORMULA||Y|U|U|NA|||U|5||7||OPEN LABEL TREATMENT|1971-08-11|1966-03-17|||||1973-05-22||1973-01-10|Y|1961-03-09
TRIAL STUDY 134XCP|LB|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|2||||C130137|AMERICAN COCKROACH ANTIGEN IGA ANTIBODY|||||||ML/MIN|||||||INVALID||PIXELS/IN||||NORMAL|NOT DONE||||SPERMATOZOON|AGGLUTINATED|U|AUTOMATED COUNT|FIBROMETER FORMULA||N|Y|N|U|||N|5||7||FOLLOW-UP|1966-08-15|1969-06-01|||||1970-08-06||1963-01-31|U|1971-07-25
TRIAL STUDY 134XCP|LB|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|1||||DALA|DELTA AMINOLEVULINATE|||||||COPIES/UL|||||||NEGATIVE||MDFI||||LOW|NOT DONE||||CEREBROSPINAL FLUID|GELLED|Y|ALCIAN BLUE STAIN|MDRD 5 VARIABLE FORMULA||U|NA|N|U|||NA|1||38||BASELINE|1973-02-09|1960-11-07|||||1968-12-09||1960-03-13|Y|1969-08-28
TRIAL STUDY 134XCP|LB|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|2||||LEIMLE|IMMATURE LEUKOCYTES/LEUKOCYTES|||||||KUSP|||||||INDETERMINATE||IU/MMOL||||NORMAL|NOT DONE||||PUS|ICTERIC|NA|CELL OF ORIGIN ASSAY|FIBROMETER FORMULA||Y|Y|U|NA|||U|1||38||INDUCTION TREATMENT|1966-12-31|1972-02-05|||||1963-03-07||1960-11-29|NA|1961-08-01
TRIAL STUDY 134XCP|LB|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|1||||AMH|ANTI-MULLERIAN HORMONE|||||||PIXELS/CM|||||||BORDERLINE||APPLICATION||||NORMAL|NOT DONE||||CELL PELLET|DRIED|U|DOPPLER ULTRASOUND|GMI % FORMULA||Y|Y|Y|N|||NA|2||58||LONG-TERM FOLLOW-UP|1964-07-29|1970-10-03|||||1966-05-10||1969-07-12|U|1971-06-30
TRIAL STUDY 134XCP|LB|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|2||||C130131|DOG DANDER ANTIGEN IGG4 ANTIBODY|||||||TITER|||||||POSITIVE||MG/L||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|HEMOLYZED|U|MECHANICAL CLOT DETECTION|HEPASCORE FORMULA||N|N|U|NA|||Y|2||58||WASHOUT|1964-03-27|1964-11-20|||||1965-03-30||1969-02-25|U|1971-10-19
TRIAL STUDY 134XCP|LB|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|1||||C165886|WHITE OAK POLLEN IGE AB RAST SCORE|||||||ML/DAY|||||||POSITIVE||PMOL/10^10 CELLS||||NORMAL|NOT DONE||||PLATELET|AUTOLYZED|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|FIBROMETER FORMULA||N|U|N|Y|||NA|3||39||TREATMENT|1968-05-04|1970-01-13|||||1962-01-21||1960-09-21|N|1968-08-19
TRIAL STUDY 134XCP|LB|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|2||||CHOLHDL|CHOLESTEROL/HDL-CHOLESTEROL|||||||CG|||||||INVALID||FFU||||HIGH|NOT DONE||||LUNG SURFACTANT|FROZEN|N|FLUORESCEIN STAIN|MDRD ENZYMATIC FORMULA||U|Y|Y|N|||N|3||39||LONG-TERM FOLLOW-UP|1960-10-25|1969-08-11|||||1972-05-18||1970-10-14|NA|1966-09-19
TRIAL STUDY 134XCP|LB|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|1||||TNFSR|SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR|||||||BEAM BREAKS|||||||TRACE||VG/ML||||HIGH|NOT DONE||||CELL PELLET|FRESH|U|CYSTOMETRY|FIBROTEST FORMULA||U|Y|NA|N|||U|4||88||FOLLOW-UP|1969-11-28|1962-02-24|||||1967-04-08||1969-07-20|U|1962-04-26
TRIAL STUDY 134XCP|LB|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|2||||ALPISOE|ALKALINE PHOSPHATASE ISOENZYME|||||||UG/KG|||||||BORDERLINE||LENS||||LOW|NOT DONE||||CALCULUS|UNEXPECTED ODOR|NA|SNELLEN EYE CHART|MDRD 4 VARIABLE FORMULA||NA|N|U|U|||NA|4||88||LONG-TERM FOLLOW-UP|1966-11-28|1960-07-19|||||1968-11-30||1968-10-28|NA|1972-01-13
TRIAL STUDY 134XCP|LB|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|1||||GBP2|GUANYLATE BINDING PROTEIN 2|||||||GRAIN|||||||INVALID||LENS||||LOW|NOT DONE||||ADIPOSE TISSUE|CONTAMINATED|N|MICROARRAY|FIBROTEST FORMULA||NA|U|Y|N|||NA|5||7||WASHOUT|1971-05-20|1967-01-20|||||1963-05-26||1962-12-26|Y|1970-07-28
TRIAL STUDY 134XCP|LB|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|2||||OXYSAT|OXYGEN SATURATION|||||||TROCHE|||||||TRACE||UU/L||||ABNORMAL|NOT DONE||||REFLEX TEAR|NON-HEMOLYZED|NA|MRS|CKD-EPI CREATININE FORMULA||U|U|N|NA|||NA|5||7||OPEN LABEL TREATMENT|1972-06-05|1969-04-11|||||1973-03-05||1961-08-17|U|1973-03-07
TRIAL STUDY 134XCP|LB|11A6144A-895B-4143-85D2-69952C6D452C|1||||SLXAG|SIALYL SSEA-1 ANTIGEN|||||||/MBP|||||||INVALID||ML/CAGE/DAY||||LOW|NOT DONE||||BUFFY COAT|FRESH|NA|URANYL ACETATE STAIN|MDRD FORMULA||Y|NA|Y|NA|||N|1||38||BASELINE|1972-08-03|1966-09-23|||||1960-02-17||1960-03-28|Y|1965-02-08
TRIAL STUDY 134XCP|LB|11A6144A-895B-4143-85D2-69952C6D452C|2||||CD163S|SOLUBLE CD163|||||||MEQ/ML|||||||BORDERLINE||10^3/HPF||||LOW|NOT DONE||||SERUM OR PLASMA|DRIED|N|WHOLE EXOME SEQUENCING|GMI MMOL/MOL FORMULA||U|U|N|N|||Y|1||38||OBSERVATION|1966-06-26|1963-04-18|||||1971-02-27||1964-10-03|NA|1970-10-22
TRIAL STUDY 134XCP|LB|11A6144A-895B-4143-85D2-69952C6D452C|1||||C165913|NUT MIX IGG AB RAST SCORE|||||||OZ EQ|||||||INVALID||G/ANIMAL/DAY||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|SOLIDIFIED|NA|COMPLEMENT FIXATION|FIBROMETER FORMULA||N|NA|NA|U|||NA|2||58||SCREENING|1968-03-30|1966-02-10|||||1960-06-18||1964-12-27|U|1970-10-20
TRIAL STUDY 134XCP|LB|11A6144A-895B-4143-85D2-69952C6D452C|2||||PCNAG|PROLIFERATING CELL NUCLEAR ANTIGEN|||||||UL|||||||BORDERLINE||FIU||||LOW|NOT DONE||||TUMOR TISSUE|PARAFFIN-EMBEDDED|NA|IMMUNOTURBIDIMETRY|MDRD 6 VARIABLE FORMULA||NA|NA|N|NA|||Y|2||58||TREATMENT|1964-11-09|1960-10-23|||||1971-11-20||1960-07-07|N|1965-12-03
TRIAL STUDY 134XCP|LB|11A6144A-895B-4143-85D2-69952C6D452C|1||||TNF5S|SOLUBLE TNF SUPERFAMILY MEMBER 5|||||||OI50|||||||BORDERLINE||MEQ/L||||LOW|NOT DONE||||VITREOUS HUMOR|REFRIGERATED|N|PALPATION|COCKCROFT-GAULT FORMULA||U|Y|NA|U|||U|3||39||BLINDED TREATMENT|1972-11-15|1961-01-09|||||1971-07-06||1964-04-09|Y|1973-03-21
TRIAL STUDY 134XCP|LB|11A6144A-895B-4143-85D2-69952C6D452C|2||||TGLOBRR|THYROGLOBULIN RECOVERY RATE|||||||MG/H|||||||POSITIVE||KALLIKREIN INHIBITOR UNIT||||HIGH|NOT DONE||||INTERSTITIAL FLUID|DRIED|N|MACRO BROTH DILUTION|ASH FIBROSURE FORMULA||U|N|Y|NA|||N|3||39||BASELINE|1963-05-19|1968-06-19|||||1967-04-13||1962-10-18|U|1966-03-04
TRIAL STUDY 134XCP|LB|11A6144A-895B-4143-85D2-69952C6D452C|1||||OXYCDN|OXYCODONE|||||||ML/S|||||||BORDERLINE||CP||||NORMAL|NOT DONE||||SPERMATOZOON|GELLED|U|ICC|FIBROTEST FORMULA||U|NA|N|Y|||U|4||88||WASHOUT|1973-01-21|1962-09-01|||||1964-01-08||1962-12-02|NA|1970-03-15
TRIAL STUDY 134XCP|LB|11A6144A-895B-4143-85D2-69952C6D452C|2||||PFCT|PLATELET FUNCTION CLOSURE TIME|||||||BOX|||||||INVALID||MOL/L||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|CLOTTED|N|IMMUNOCHROMATOGRAPHY|FIBROTEST FORMULA||Y|N|N|U|||Y|4||88||TREATMENT|1965-04-20|1970-05-14|||||1969-06-10||1967-06-27|Y|1970-07-23
TRIAL STUDY 134XCP|LB|11A6144A-895B-4143-85D2-69952C6D452C|1||||BASEEXCS|BASE EXCESS|||||||GENEQ|||||||TRACE||MOSM||||HIGH|NOT DONE||||TUMOR TISSUE|CALCIFIED|U|VENTILATION PERFUSION LUNG SCAN|CKD-EPI CYSTATIN C FORMULA||NA|Y|U|N|||NA|5||7||LONG-TERM FOLLOW-UP|1962-03-29|1970-06-23|||||1960-01-08||1970-02-09|U|1971-12-23
TRIAL STUDY 134XCP|LB|11A6144A-895B-4143-85D2-69952C6D452C|2||||RDWR|RET VOLUME DISTRIBUTION WIDTH|||||||CUP|||||||TRACE||LOG10 TCID 50/UL||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|FRESH|NA|TRIPLE-PHASE MRI SCAN|CKD-EPI FORMULA||N|U|U|Y|||Y|5||7||BASELINE|1965-05-25|1962-01-16|||||1969-04-07||1963-04-14|Y|1970-09-05
TRIAL STUDY 134XCP|LB|8958D35E-F685-4542-AE01-625133F1EF7D|1||||CCL19|CHEMOKINE (C-C MOTIF) LIGAND 19|||||||NG/MOL|||||||INDETERMINATE||BAG||||ABNORMAL|NOT DONE||||PLATELET|GELLED|U|MIGET|FIBROTEST FORMULA||U|N|U|N|||NA|1||38||OBSERVATION|1961-04-22|1965-12-21|||||1967-05-27||1972-02-16|U|1960-08-22
TRIAL STUDY 134XCP|LB|8958D35E-F685-4542-AE01-625133F1EF7D|2||||BLSTMGK|MEGAKARYOBLASTS|||||||FL|||||||INDETERMINATE||KM||||LOW|NOT DONE||||CORD SERUM|THAWED|Y|SPIROMETRY|FIBROSIS 4 FORMULA||N|U|U|NA|||U|1||38||CONTINUATION TREATMENT|1964-03-22|1971-05-08|||||1964-10-25||1970-12-26|N|1970-11-12
TRIAL STUDY 134XCP|LB|8958D35E-F685-4542-AE01-625133F1EF7D|1||||DDIMER|D-DIMER|||||||TSP EQ|||||||INDETERMINATE||U/G/DAY||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|LIPEMIC|N|EPSILOMETER|FIBROTEST FORMULA||NA|U|N|U|||NA|2||58||WASHOUT|1966-07-19|1965-12-29|||||1972-11-26||1965-07-09|Y|1968-05-05
TRIAL STUDY 134XCP|LB|8958D35E-F685-4542-AE01-625133F1EF7D|2||||CD13|CD13|||||||/DAY|||||||POSITIVE||HENRY||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|N|CISH|GMI MMOL/MOL FORMULA||NA|Y|Y|N|||Y|2||58||CONTINUATION TREATMENT|1971-02-14|1960-12-26|||||1969-12-27||1962-02-07|NA|1970-12-11
TRIAL STUDY 134XCP|LB|8958D35E-F685-4542-AE01-625133F1EF7D|1||||FXIVAC|FACTOR XIV ACTUAL/CONTROL|||||||CAN|||||||NEGATIVE||TCID 50/DOSE||||ABNORMAL|NOT DONE||||SEMEN|CONCENTRATED|N|FLUORESCEIN STAIN|MDRD ENZYMATIC FORMULA||Y|N|N|N|||U|3||39||RUN-IN|1973-08-08|1971-02-22|||||1960-09-13||1968-12-08|U|1966-01-05
TRIAL STUDY 134XCP|LB|8958D35E-F685-4542-AE01-625133F1EF7D|2||||PROTOSML|PROTEIN/OSMOLALITY|||||||CI/L|||||||NEGATIVE||ML/H||||HIGH|NOT DONE||||SEMINAL FLUID|NON-HEMOLYZED|U|HPLC-FL|CKD-EPI FORMULA||N|NA|Y|Y|||Y|3||39||INDUCTION TREATMENT|1962-04-23|1964-07-21|||||1972-05-23||1973-07-23|N|1963-02-13
TRIAL STUDY 134XCP|LB|8958D35E-F685-4542-AE01-625133F1EF7D|1||||VWFAC|VON WILL FACTOR ACTUAL/CONTROL|||||||POUCH|||||||BORDERLINE||KIT||||NORMAL|NOT DONE||||RETICULOCYTES|UNEXPECTED ODOR|N|SLOAN LETTER EYE CHART 2.5%|NASH FIBROSURE FORMULA||U|N|N|NA|||NA|4||88||OPEN LABEL TREATMENT|1973-06-15|1972-11-08|||||1960-02-26||1971-04-18|N|1961-08-22
TRIAL STUDY 134XCP|LB|8958D35E-F685-4542-AE01-625133F1EF7D|2||||EPINEXR|EPINEPHRINE EXCRETION RATE|||||||CAPSULE|||||||INDETERMINATE||BOWL||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|DRIED|NA|FLOW CYTOMETRY|NASH FIBROSURE FORMULA||Y|Y|U|Y|||N|4||88||WASHOUT|1965-03-17|1964-04-23|||||1967-11-23||1963-06-20|U|1973-08-11
TRIAL STUDY 134XCP|LB|8958D35E-F685-4542-AE01-625133F1EF7D|1||||GLOBGPT|GAMMA GLOBULIN/TOTAL PROTEIN|||||||ML/ANIMAL/WK|||||||TRACE||L/S/KPA||||HIGH|NOT DONE||||CAPILLARY PLASMA|REFRIGERATED|U|CONTACT SPECULAR MICROSCOPY|HEPASCORE FORMULA||Y|U|N|NA|||Y|5||7||INDUCTION TREATMENT|1967-04-29|1973-07-27|||||1971-12-20||1960-11-06|U|1969-04-16
TRIAL STUDY 134XCP|LB|8958D35E-F685-4542-AE01-625133F1EF7D|2||||CKMT1CK|CK, MACROMOLECULAR TYPE 1/TOTAL CK|||||||10^7 CFU|||||||INDETERMINATE||ELISA UNIT/ML||||ABNORMAL|NOT DONE||||DISCHARGE|CLOTTED|NA|ZIEHL NEELSEN ACID FAST STAIN|MDRD 5 VARIABLE FORMULA||NA|Y|N|U|||NA|5||7||INDUCTION TREATMENT|1971-05-06|1964-12-13|||||1969-01-13||1971-04-29|N|1960-06-26
TRIAL STUDY 134XCP|LB|00982640-C826-4CD4-B927-A311227E63CC|1||||GLOBGPT|GAMMA GLOBULIN/TOTAL PROTEIN|||||||/4.0 ML|||||||BORDERLINE||OHM||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|THAWED|Y|HPLC/MS/MS|GMI % FORMULA||N|NA|U|NA|||N|1||38||WASHOUT|1970-01-23|1971-02-19|||||1964-07-20||1964-11-29|Y|1967-03-31
TRIAL STUDY 134XCP|LB|00982640-C826-4CD4-B927-A311227E63CC|2||||EOSLE|EOSINOPHILS/LEUKOCYTES|||||||U/CL|||||||NEGATIVE||NG/DAY||||LOW|NOT DONE||||ERYTHROCYTES|ICTERIC|Y|NUCLEIC ACID HYBRIDIZATION|MDRD 6 VARIABLE FORMULA||Y|U|N|Y|||Y|1||38||OBSERVATION|1970-10-28|1964-10-13|||||1964-03-27||1969-02-02|NA|1961-12-31
TRIAL STUDY 134XCP|LB|00982640-C826-4CD4-B927-A311227E63CC|1||||MORPHINE|MORPHINE|||||||10^10/L|||||||INDETERMINATE||MG/DAY||||ABNORMAL|NOT DONE||||BASAL TEAR|PARAFFIN-EMBEDDED|U|PERIPHERAL ANGIOGRAPHY|FIBROMETER FORMULA||NA|Y|N|Y|||N|2||58||WASHOUT|1972-07-22|1967-05-20|||||1967-09-01||1973-08-09|NA|1972-12-24
TRIAL STUDY 134XCP|LB|00982640-C826-4CD4-B927-A311227E63CC|2||||MMIF|MACROPHAGE MIGRATION INHIBITORY FACTOR|||||||EIA UNIT|||||||NEGATIVE||G/ANIMAL||||HIGH|NOT DONE||||SEMINAL FLUID|FRESH|NA|DUKE INCISION METHOD|FIBROSIS 4 FORMULA||N|N|N|Y|||Y|2||58||BLINDED TREATMENT|1966-04-29|1969-10-10|||||1971-02-28||1967-09-09|U|1969-10-12
TRIAL STUDY 134XCP|LB|00982640-C826-4CD4-B927-A311227E63CC|1||||NTELOCRT|N-TELOPEPTIDE/CREATININE|||||||U/G/MIN|||||||INVALID||MM3/MM2/YEAR||||ABNORMAL|NOT DONE||||LYMPH|FRESH|N|PUPILLOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|U|||NA|3||39||TREATMENT|1970-03-25|1963-08-05|||||1962-01-24||1973-08-25|Y|1969-11-22
TRIAL STUDY 134XCP|LB|00982640-C826-4CD4-B927-A311227E63CC|2||||GCDCA|GLYCOCHENODEOXYCHOLATE|||||||MMOL/MOL|||||||TRACE||DL||||NORMAL|NOT DONE||||BONE|CLOTTED|Y|REVERSE TRANSCRIPTASE PCR|MDRD 6 VARIABLE FORMULA||U|NA|N|Y|||N|3||39||OPEN LABEL TREATMENT|1962-01-11|1969-05-23|||||1961-03-14||1962-03-09|U|1973-08-08
TRIAL STUDY 134XCP|LB|00982640-C826-4CD4-B927-A311227E63CC|1||||MICA|MHC CLASS I CHAIN RELATED PROTEIN A|||||||TORR|||||||TRACE||DPM/0.5 ML||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED|N|ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD ENZYMATIC FORMULA||NA|Y|Y|Y|||U|4||88||OBSERVATION|1968-09-06|1969-07-24|||||1972-10-29||1969-03-26|U|1962-12-27
TRIAL STUDY 134XCP|LB|00982640-C826-4CD4-B927-A311227E63CC|2||||NAGASECR|N-ACETYL-B-D-GLUCOSAMINIDASE/CREATININE|||||||IU/MMOL|||||||BORDERLINE||MEQ/L||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|REFRIGERATED|U|FLUORESCENCE ANGIOGRAPHY|COCKCROFT-GAULT FORMULA||Y|NA|N|Y|||NA|4||88||WASHOUT|1963-09-01|1962-06-15|||||1970-12-25||1965-10-14|N|1967-08-27
TRIAL STUDY 134XCP|LB|00982640-C826-4CD4-B927-A311227E63CC|1||||GAD2AB|GLUTAMIC ACID DECARBOXYLASE 2 ANTIBODY|||||||BU/ML|||||||NEGATIVE||G/CAGE/WK||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|Y|SPECT/CT SCAN|MDRD ENZYMATIC FORMULA||NA|Y|NA|N|||NA|5||7||SCREENING|1968-05-04|1972-09-04|||||1964-10-30||1961-07-03|U|1968-11-12
TRIAL STUDY 134XCP|LB|00982640-C826-4CD4-B927-A311227E63CC|2||||KETONES|KETONES|||||||MG/ANIMAL|||||||BORDERLINE||NG/MOL||||HIGH|NOT DONE||||CALCULUS|ICTERIC|Y|MOUSE PROTECTION ASSAY|ASH FIBROSURE FORMULA||Y|NA|Y|NA|||Y|5||7||OBSERVATION|1971-07-14|1973-01-13|||||1965-03-15||1966-04-11|NA|1960-05-18
TRIAL STUDY 134XCP|LB|C213CAA8-2FAC-402C-A19E-11A60708A71A|1||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||V/V|||||||BORDERLINE||G/DL||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|REFRIGERATED|Y|SLOAN LETTER EYE CHART 1.25%|GMI MMOL/MOL FORMULA||NA|U|N|Y|||NA|1||38||OBSERVATION|1969-06-25|1965-01-24|||||1964-05-11||1972-07-01|N|1966-05-17
TRIAL STUDY 134XCP|LB|C213CAA8-2FAC-402C-A19E-11A60708A71A|2||||ANGTNS1|ANGIOTENSIN I|||||||UL/KG/DAY|||||||INDETERMINATE||10^5/L||||NORMAL|NOT DONE||||MUSCLE TISSUE|THAWED|NA|FLOW CYTOMETRY|GMI MMOL/MOL FORMULA||Y|N|NA|NA|||Y|1||38||OBSERVATION|1970-08-28|1966-12-03|||||1962-11-01||1969-07-02|NA|1965-10-20
TRIAL STUDY 134XCP|LB|C213CAA8-2FAC-402C-A19E-11A60708A71A|1||||CCL12|CHEMOKINE (C-C MOTIF) LIGAND 12|||||||IN|||||||BORDERLINE||COPIES/ML||||ABNORMAL|NOT DONE||||ABSCESS FLUID|CONCENTRATED|N|POPULATION SEQUENCING|HEPASCORE FORMULA||U|N|U|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1969-11-20|1971-06-16|||||1969-05-16||1963-05-17|N|1968-11-11
TRIAL STUDY 134XCP|LB|C213CAA8-2FAC-402C-A19E-11A60708A71A|2||||NTXICRT|T1 COLLAGEN X-LINK N-TELOPEPTIDES/CREAT|||||||UV*SEC|||||||INDETERMINATE||FIU||||LOW|NOT DONE||||PLEURAL FLUID|LACTESCENT|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|NA|NA|||N|2||58||FOLLOW-UP|1969-11-28|1966-04-17|||||1961-08-20||1971-10-09|Y|1960-08-25
TRIAL STUDY 134XCP|LB|C213CAA8-2FAC-402C-A19E-11A60708A71A|1||||FATDROP|FAT DROPLET|||||||G/U|||||||INVALID||G/MOL||||NORMAL|NOT DONE||||LYSATE|REFRIGERATED|Y|LEAD CITRATE STAIN|MDRD 6 VARIABLE FORMULA||NA|N|Y|U|||NA|3||39||SCREENING|1964-05-22|1971-02-16|||||1972-03-17||1972-08-14|NA|1971-06-22
TRIAL STUDY 134XCP|LB|C213CAA8-2FAC-402C-A19E-11A60708A71A|2||||BNPPRONT|N-TERMINAL PROB-TYPE NATRIURETIC PEPTIDE|||||||L/MIN|||||||BORDERLINE||BQ||||HIGH|NOT DONE||||LAVAGE FLUID|HEMOLYZED|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD ENZYMATIC FORMULA||U|U|N|Y|||N|3||39||INDUCTION TREATMENT|1965-12-02|1973-08-24|||||1968-02-10||1972-04-06|Y|1965-01-04
TRIAL STUDY 134XCP|LB|C213CAA8-2FAC-402C-A19E-11A60708A71A|1||||C165885|OLIVE TREE POLLEN IGE AB RAST SCORE|||||||U/ANIMAL|||||||INVALID||10^4/HPF||||ABNORMAL|NOT DONE||||BONE|CALCIFIED|NA|POTENTIOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|NA|U|||U|4||88||SCREENING|1971-11-24|1960-12-01|||||1967-02-27||1972-12-10|N|1972-09-03
TRIAL STUDY 134XCP|LB|C213CAA8-2FAC-402C-A19E-11A60708A71A|2||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||10^6 RNA COPIES/ML|||||||NEGATIVE||10^3/HPF||||LOW|NOT DONE||||EXPIRED AIR|CONCENTRATED|NA|PERFUSION MRI|GMI % FORMULA||N|U|NA|NA|||NA|4||88||TREATMENT|1972-05-01|1960-10-22|||||1971-05-21||1968-09-10|U|1962-10-15
TRIAL STUDY 134XCP|LB|C213CAA8-2FAC-402C-A19E-11A60708A71A|1||||AAP|ALANINE AMINOPEPTIDASE|||||||10^6 DNA COPIES/ML|||||||POSITIVE||CMOL||||NORMAL|NOT DONE||||SEMINAL FLUID|NON-HEMOLYZED|NA|LIQUID SCINTILLATION COUNTING|FIBROTEST FORMULA||N|U|NA|U|||N|5||7||BASELINE|1966-06-17|1964-04-19|||||1967-01-24||1971-12-25|U|1965-06-21
TRIAL STUDY 134XCP|LB|C213CAA8-2FAC-402C-A19E-11A60708A71A|2||||PEPSNGC|PEPSINOGEN C|||||||S*KPA|||||||INVALID||OD UNIT||||LOW|NOT DONE||||SPERMATOZOON|REFRIGERATED|U|MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CYSTATIN C FORMULA||N|U|U|U|||NA|5||7||LONG-TERM FOLLOW-UP|1963-12-22|1967-09-07|||||1964-05-08||1962-06-25|Y|1972-08-25
TRIAL STUDY 134XCP|LB|F0559682-CD36-4ED0-8082-A54D40305512|1||||CLARITY|CLARITY|||||||MEQ/L|||||||TRACE||KG/CM2||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|SOLIDIFIED|N|SICKLE CELL SOLUBILITY TEST|FIBROMETER FORMULA||N|N|Y|N|||Y|1||38||WASHOUT|1965-07-29|1965-05-25|||||1973-08-21||1962-11-01|N|1971-08-07
TRIAL STUDY 134XCP|LB|F0559682-CD36-4ED0-8082-A54D40305512|2||||CA15_3AG|CANCER ANTIGEN 15-3|||||||LOG10 CCID 50/DOSE|||||||TRACE||10^3 CFU/G||||HIGH|NOT DONE||||EPITHELIAL CELL|DRIED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||N|Y|Y|Y|||N|1||38||BLINDED TREATMENT|1968-04-01|1972-04-24|||||1973-06-14||1961-01-16|U|1964-05-13
TRIAL STUDY 134XCP|LB|F0559682-CD36-4ED0-8082-A54D40305512|1||||APRIL|A PROLIFERATION-INDUCING LIGAND|||||||CI/UG|||||||NEGATIVE||VP/DOSE||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|U|ACID FAST STAIN|NASH FIBROSURE FORMULA||NA|Y|NA|N|||U|2||58||INDUCTION TREATMENT|1963-09-01|1965-01-08|||||1972-04-05||1962-03-31|U|1961-02-10
TRIAL STUDY 134XCP|LB|F0559682-CD36-4ED0-8082-A54D40305512|2||||LDH3LDH|LDH ISOENZYME 3/LDH|||||||MIU/L|||||||TRACE||BQ/UG||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|LACTESCENT|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI CREATININE FORMULA||Y|N|U|NA|||Y|2||58||CONTINUATION TREATMENT|1967-08-24|1969-11-27|||||1973-03-18||1970-08-05|U|1964-12-11
TRIAL STUDY 134XCP|LB|F0559682-CD36-4ED0-8082-A54D40305512|1||||NEUTGT|GIANT NEUTROPHILS|||||||U/L|||||||TRACE||DRAM||||NORMAL|NOT DONE||||MUCUS|FRESH|N|ENZYMATIC COLORIMETRY|MDRD 4 VARIABLE FORMULA||NA|NA|Y|N|||N|3||39||TREATMENT|1969-08-22|1960-04-16|||||1969-08-09||1963-07-27|Y|1969-12-03
TRIAL STUDY 134XCP|LB|F0559682-CD36-4ED0-8082-A54D40305512|2||||CXCL3|CHEMOKINE (C-X-C MOTIF) LIGAND 3|||||||BOTTLE|||||||INDETERMINATE||ML/S/M2||||NORMAL|NOT DONE||||FLUID|HEMOLYZED|N|DXA SCAN|FIBROTEST FORMULA||NA|N|NA|N|||U|3||39||INDUCTION TREATMENT|1969-12-18|1970-06-29|||||1964-01-15||1966-10-28|N|1966-04-29
TRIAL STUDY 134XCP|LB|F0559682-CD36-4ED0-8082-A54D40305512|1||||TNFSR|SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR|||||||PPM|||||||INVALID||MG/DL||||HIGH|NOT DONE||||EPIDERMAL TISSUE|HEMOLYZED|Y|FARR ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|NA|U|||Y|4||88||RUN-IN|1971-02-05|1969-12-06|||||1970-12-14||1964-07-27|NA|1960-04-25
TRIAL STUDY 134XCP|LB|F0559682-CD36-4ED0-8082-A54D40305512|2||||CYFRA211|CYTOKERATIN 19 FRAGMENT 21-1|||||||PIXEL|||||||TRACE||/2000 RBC||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|CONTAMINATED|NA|NEPHELOMETRY|FIBROMETER FORMULA||N|N|U|U|||U|4||88||INDUCTION TREATMENT|1966-02-08|1966-11-25|||||1971-01-13||1969-09-01|Y|1966-01-13
TRIAL STUDY 134XCP|LB|F0559682-CD36-4ED0-8082-A54D40305512|1||||ELA1|PANCREATIC ELASTASE 1|||||||10^4/HPF|||||||NEGATIVE||MANSON U/ML||||LOW|NOT DONE||||PROSTATIC FLUID|ICTERIC|NA|SPIRAL CT SCAN WITHOUT CONTRAST|ASH FIBROSURE FORMULA||NA|NA|NA|NA|||NA|5||7||OPEN LABEL TREATMENT|1966-09-01|1965-07-23|||||1965-11-04||1965-01-22|U|1973-08-14
TRIAL STUDY 134XCP|LB|F0559682-CD36-4ED0-8082-A54D40305512|2||||METHANOL|METHANOL|||||||MPL U/ML|||||||BORDERLINE||NMOL BCE/L||||LOW|NOT DONE||||INFRANATANT, PLASMA|AGGLUTINATED|NA|U-HPLC/MS/MS|COCKCROFT-GAULT FORMULA||U|U|NA|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1962-09-17|1973-03-19|||||1961-08-20||1962-06-26|N|1972-10-14
TRIAL STUDY 134XCP|LB|C004A4D5-DBD0-4967-9597-8C1653AB8298|1||||CFA|COEFFICIENT OF FAT ABSORPTION|||||||U/M2/MIN|||||||NEGATIVE||UL/ML||||LOW|NOT DONE||||SYNOVIAL FLUID|AUTOLYZED|Y|HPLC/MS/MS|ASH FIBROSURE FORMULA||Y|NA|N|Y|||Y|1||38||INDUCTION TREATMENT|1968-07-09|1965-05-05|||||1969-04-28||1967-06-09|U|1973-04-17
TRIAL STUDY 134XCP|LB|C004A4D5-DBD0-4967-9597-8C1653AB8298|2||||CRTCREAT|CORTICOSTERONE/CREATININE|||||||MILE|||||||TRACE||G/G/DAY||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|FROZEN|NA|FLUORESCENT MICROSCOPY|NASH FIBROSURE FORMULA||NA|N|Y|Y|||U|1||38||OPEN LABEL TREATMENT|1969-01-17|1966-03-25|||||1960-04-23||1965-08-01|N|1969-05-28
TRIAL STUDY 134XCP|LB|C004A4D5-DBD0-4967-9597-8C1653AB8298|1||||CITCREAT|CITRATE/CREATININE|||||||ML/DAY|||||||BORDERLINE||UL||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|ICTERIC|U|DIGITAL PCR ARRAY|NASH FIBROSURE FORMULA||U|NA|NA|U|||NA|2||58||INDUCTION TREATMENT|1961-04-01|1963-02-01|||||1966-02-25||1973-05-19|U|1967-11-09
TRIAL STUDY 134XCP|LB|C004A4D5-DBD0-4967-9597-8C1653AB8298|2||||IGGALB|IMMUNOGLOBULIN G/ALBUMIN|||||||UEQ/L|||||||POSITIVE||CY/CM||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|ROOM TEMPERATURE|U|CENTRIFUGATION|MDRD 5 VARIABLE FORMULA||N|U|U|NA|||NA|2||58||SCREENING|1971-11-04|1966-04-21|||||1971-06-24||1962-03-25|U|1973-03-24
TRIAL STUDY 134XCP|LB|C004A4D5-DBD0-4967-9597-8C1653AB8298|1||||CD4CD8|CD4/CD8|||||||10^7 PFU|||||||NEGATIVE||ML/CAGE||||HIGH|NOT DONE||||PLEURAL FLUID|CLOTTED|U|JAFFE REACTION|ASH FIBROSURE FORMULA||Y|N|NA|Y|||Y|3||39||WASHOUT|1963-04-20|1970-10-22|||||1964-09-09||1963-05-11|NA|1965-12-20
TRIAL STUDY 134XCP|LB|C004A4D5-DBD0-4967-9597-8C1653AB8298|2||||LYMNSQE|LYMPHOCYTES/NON-SQUAM EPI CELLS|||||||PHERESIS UNIT|||||||INVALID||10^4/L||||HIGH|NOT DONE||||SERUM|DRIED|U|MALDI-TOF|FIBROSIS 4 FORMULA||Y|Y|Y|Y|||NA|3||39||OPEN LABEL TREATMENT|1972-03-21|1967-11-26|||||1966-03-22||1966-11-26|U|1969-05-07
TRIAL STUDY 134XCP|LB|C004A4D5-DBD0-4967-9597-8C1653AB8298|1||||APTTLAS|LUPUS ANTICOAGULANT SENSITIVE APTT|||||||MMOL/MIN/KPA|||||||BORDERLINE||CD*S/M2||||ABNORMAL|NOT DONE||||FLUID|CALCIFIED|Y|BIOPSY|MDRD 6 VARIABLE FORMULA||NA|U|Y|NA|||U|4||88||OBSERVATION|1963-09-29|1960-08-07|||||1970-01-28||1969-03-11|Y|1962-08-29
TRIAL STUDY 134XCP|LB|C004A4D5-DBD0-4967-9597-8C1653AB8298|2||||ANUAB|ANTI-NUCLEOSOME ANTIBODY|||||||FEU|||||||NEGATIVE||YEARS||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|AUTOLYZED|U|CENTRIFUGATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|U|NA|||Y|4||88||BLINDED TREATMENT|1964-10-29|1965-11-13|||||1961-05-30||1963-08-11|N|1969-06-09
TRIAL STUDY 134XCP|LB|C004A4D5-DBD0-4967-9597-8C1653AB8298|1||||IMMGLC|IMMUNOGLOBULIN LIGHT CHAINS|||||||MEQ/DL|||||||BORDERLINE||KBQ/UL||||NORMAL|NOT DONE||||SWABBED MATERIAL|PARAFFIN-EMBEDDED|NA|VENTILATION PERFUSION LUNG SCAN|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|N|U|||NA|5||7||OBSERVATION|1961-05-31|1961-04-23|||||1963-01-16||1964-08-18|U|1967-12-29
TRIAL STUDY 134XCP|LB|C004A4D5-DBD0-4967-9597-8C1653AB8298|2||||CSMIX|MIXED CASTS|||||||MS2|||||||POSITIVE||TAMPON||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|NA|MULTI-SLICE SPIRAL CT|COCKCROFT-GAULT FORMULA||Y|N|Y|NA|||NA|5||7||CONTINUATION TREATMENT|1965-09-24|1961-10-10|||||1965-12-13||1971-08-14|Y|1971-10-26
TRIAL STUDY 134XCP|LB|ABB838A1-2387-471E-8F50-1F48205BC8EE|1||||C165913|NUT MIX IGG AB RAST SCORE|||||||ABSORBANCE U/MIN|||||||INDETERMINATE||NKAT/G HB||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|FROZEN|U|DIGITAL PCR ARRAY|ASH FIBROSURE FORMULA||N|U|U|Y|||Y|1||38||OPEN LABEL TREATMENT|1966-05-26|1969-09-17|||||1968-05-18||1962-12-10|NA|1963-03-11
TRIAL STUDY 134XCP|LB|ABB838A1-2387-471E-8F50-1F48205BC8EE|2||||EOSIM|IMMATURE EOSINOPHILS|||||||UG/M2|||||||INDETERMINATE||MG/KG/DOSE||||NORMAL|NOT DONE||||ARTERIAL BLOOD|SOLIDIFIED|Y|MALDI-TOF|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|NA|||N|1||38||CONTINUATION TREATMENT|1968-09-17|1971-07-28|||||1966-04-25||1965-03-26|N|1969-11-01
TRIAL STUDY 134XCP|LB|ABB838A1-2387-471E-8F50-1F48205BC8EE|1||||ALPBS|BONE SPECIFIC ALKALINE PHOSPHATASE|||||||RATIO|||||||INVALID||NMOL||||HIGH|NOT DONE||||PLEURAL TISSUE|DRIED|U|FLOCCULATION|MDRD ENZYMATIC FORMULA||NA|N|Y|U|||U|2||58||BASELINE|1965-08-05|1967-10-11|||||1964-01-02||1972-11-29|NA|1963-09-07
TRIAL STUDY 134XCP|LB|ABB838A1-2387-471E-8F50-1F48205BC8EE|2||||VITD2425|24,25-DIHYDROXYVITAMIN D|||||||BQ/UL|||||||POSITIVE||MV2/HZ||||NORMAL|NOT DONE||||LYMPH|DRIED|NA|IMMUNO-PET SCAN|GMI % FORMULA||Y|N|NA|Y|||Y|2||58||SCREENING|1961-03-24|1968-05-20|||||1972-11-28||1961-10-28|NA|1966-12-29
TRIAL STUDY 134XCP|LB|ABB838A1-2387-471E-8F50-1F48205BC8EE|1||||B2MICG|BETA-2 MICROGLOBULIN|||||||M2|||||||NEGATIVE||%||||NORMAL|NOT DONE||||URINE|PARAFFIN-EMBEDDED|N|ERGOSPIROMETRY|MDRD 5 VARIABLE FORMULA||Y|U|N|U|||NA|3||39||FOLLOW-UP|1971-08-28|1967-06-05|||||1973-07-14||1965-05-23|U|1963-04-18
TRIAL STUDY 134XCP|LB|ABB838A1-2387-471E-8F50-1F48205BC8EE|2||||C165888|RUSSIAN THISTLE POLLEN IGE ANTIBODY|||||||BISCUIT|||||||TRACE||MDFI||||NORMAL|NOT DONE||||DISCHARGE|CALCIFIED|NA|ANTIMICROBIAL COMBINATION TESTING|CKD-EPI FORMULA||U|U|U|N|||U|3||39||LONG-TERM FOLLOW-UP|1961-05-21|1973-03-24|||||1965-12-16||1972-10-19|U|1966-05-05
TRIAL STUDY 134XCP|LB|ABB838A1-2387-471E-8F50-1F48205BC8EE|1||||PTHI|PARATHYROID HORMONE, INTACT|||||||NMOL/ML/MIN|||||||BORDERLINE||TCID 50/DOSE||||NORMAL|NOT DONE||||MECONIUM|ICTERIC|U|CONTACT SPECULAR MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|NA|U|||N|4||88||TREATMENT|1963-10-21|1972-07-23|||||1970-05-04||1970-09-25|U|1967-02-14
TRIAL STUDY 134XCP|LB|ABB838A1-2387-471E-8F50-1F48205BC8EE|2||||V25HD2|25-HYDROXYVITAMIN D2|||||||RING|||||||NEGATIVE||L/S/KPA||||LOW|NOT DONE||||LEUKOCYTE|REFRIGERATED|Y|FLOCCULATION, CHARCOAL ENHANCED|MDRD 4 VARIABLE FORMULA||Y|NA|N|NA|||U|4||88||LONG-TERM FOLLOW-UP|1960-02-15|1965-11-18|||||1966-11-04||1960-09-07|NA|1966-03-30
TRIAL STUDY 134XCP|LB|ABB838A1-2387-471E-8F50-1F48205BC8EE|1||||CASULPH|CALCIUM SULPHATE|||||||10^7 TCID 50/DOSE|||||||NEGATIVE||MOSM/KG||||NORMAL|NOT DONE||||ARTERIAL BLOOD|PARAFFIN-EMBEDDED|Y|KARYOTYPING|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|NA|NA|||U|5||7||LONG-TERM FOLLOW-UP|1963-05-29|1962-01-29|||||1967-10-28||1968-08-31|NA|1964-06-03
TRIAL STUDY 134XCP|LB|ABB838A1-2387-471E-8F50-1F48205BC8EE|2||||CLCTRIOL|CALCITRIOL|||||||G/M2/DAY|||||||INDETERMINATE||MM2||||HIGH|NOT DONE||||NAIL|AUTOLYZED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA||N|U|Y|U|||N|5||7||LONG-TERM FOLLOW-UP|1963-07-16|1966-09-10|||||1961-07-25||1971-03-11|NA|1971-04-30
TRIAL STUDY 134XCP|LB|88126417-8564-4659-AA60-63642067113D|1||||OAS1|2-5-OLIGOADENYLATE SYNTHASE 1|||||||GENEQ/ML|||||||POSITIVE||U/M2/H||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|NON-HEMOLYZED|Y|THIN SMEAR|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|U|||NA|1||38||FOLLOW-UP|1967-07-25|1962-07-17|||||1968-11-09||1964-08-19|N|1961-10-10
TRIAL STUDY 134XCP|LB|88126417-8564-4659-AA60-63642067113D|2||||IMMGLC|IMMUNOGLOBULIN LIGHT CHAINS|||||||G/DL|||||||TRACE||IU/G HB||||NORMAL|NOT DONE||||BUFFY COAT|LACTESCENT|Y|OSCILLOMETRY|GMI MMOL/MOL FORMULA||U|Y|U|U|||N|1||38||SCREENING|1962-12-24|1970-01-03|||||1962-05-29||1972-04-15|U|1969-06-21
TRIAL STUDY 134XCP|LB|88126417-8564-4659-AA60-63642067113D|1||||BLASTIMM|IMMUNOBLASTS|||||||NEBULE|||||||TRACE||CM H2O||||LOW|NOT DONE||||TISSUE|CONCENTRATED|N|HIGH RESOLUTION MELT ANALYSIS|FIBROMETER FORMULA||NA|NA|N|U|||N|2||58||BLINDED TREATMENT|1962-10-16|1969-08-23|||||1967-12-23||1961-07-10|U|1962-06-03
TRIAL STUDY 134XCP|LB|88126417-8564-4659-AA60-63642067113D|2||||IGFBP2|INSULIN-LIKE GROWTH FACTOR BINDING PROT2|||||||MMOL/L|||||||INVALID||GENEQ||||HIGH|NOT DONE||||GASTRIC FLUID|FROZEN|N|CALCULATION|COCKCROFT-GAULT FORMULA||NA|NA|U|Y|||NA|2||58||WASHOUT|1961-04-29|1972-12-21|||||1971-06-14||1967-10-06|N|1966-04-13
TRIAL STUDY 134XCP|LB|88126417-8564-4659-AA60-63642067113D|1||||C165927|ANIMAL MIX IGE AB RAST SCORE|||||||ML/S|||||||TRACE||DL||||NORMAL|NOT DONE||||LYMPH|UNEXPECTED ODOR|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||NA|Y|N|NA|||Y|3||39||BLINDED TREATMENT|1967-11-30|1963-05-30|||||1969-07-10||1972-08-17|Y|1964-12-08
TRIAL STUDY 134XCP|LB|88126417-8564-4659-AA60-63642067113D|2||||KETONEBD|KETONE BODIES|||||||JAR|||||||NEGATIVE||MEQ/KG||||ABNORMAL|NOT DONE||||KERATINOCYTE|CLOTTED|N|PLETHYSMOGRAPHY|MDRD FORMULA||Y|NA|NA|U|||U|3||39||INDUCTION TREATMENT|1968-07-11|1965-07-14|||||1960-10-24||1963-02-14|N|1971-08-19
TRIAL STUDY 134XCP|LB|88126417-8564-4659-AA60-63642067113D|1||||GLOBBPT|BETA GLOBULIN/TOTAL PROTEIN|||||||MEQ|||||||NEGATIVE||GY/H||||HIGH|NOT DONE||||PLEURAL TISSUE|HEMOLYZED|N|REVERSE TRANSCRIPTASE PCR|HEPASCORE FORMULA||N|N|N|Y|||Y|4||88||TREATMENT|1973-04-15|1961-06-25|||||1970-11-11||1964-02-28|Y|1970-04-28
TRIAL STUDY 134XCP|LB|88126417-8564-4659-AA60-63642067113D|2||||PLCGF|PLACENTAL GROWTH FACTOR|||||||10^8 PFU|||||||BORDERLINE||PSI||||HIGH|NOT DONE||||MUSCLE TISSUE|PARAFFIN-EMBEDDED|NA|IMMUNOFLUORESCENT STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|N|N|||Y|4||88||BLINDED TREATMENT|1967-12-07|1960-03-26|||||1970-06-22||1973-04-17|U|1967-01-13
TRIAL STUDY 134XCP|LB|88126417-8564-4659-AA60-63642067113D|1||||FACTVWA|VON WILLEBRAND FACTOR ACTIVITY|||||||AGU/ML|||||||TRACE||NG||||HIGH|NOT DONE||||LUNG SURFACTANT|NON-HEMOLYZED|NA|SMEAR|FIBROSIS 4 FORMULA||U|Y|Y|NA|||U|5||7||CONTINUATION TREATMENT|1970-07-15|1969-06-02|||||1971-05-03||1967-08-15|Y|1965-10-14
TRIAL STUDY 134XCP|LB|88126417-8564-4659-AA60-63642067113D|2||||IBCT|TOTAL IRON BINDING CAPACITY|||||||/HPF|||||||POSITIVE||AG||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|LACTESCENT|N|SLOAN LETTER EYE CHART 2.5%|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|Y|U|||NA|5||7||INDUCTION TREATMENT|1973-02-12|1967-07-21|||||1972-12-31||1962-12-13|U|1960-11-12
TRIAL STUDY 134XCP|LB|6ADA444E-F1B4-4E59-9F2D-26DC78845397|1||||APOC2|APOLIPOPROTEIN C2|||||||HOUNSFIELD UNIT|||||||BORDERLINE||MM/H||||ABNORMAL|NOT DONE||||SEMEN|CONCENTRATED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|ASH FIBROSURE FORMULA||N|U|N|U|||NA|1||38||BASELINE|1972-03-30|1962-02-04|||||1963-03-23||1969-02-16|N|1966-03-19
TRIAL STUDY 134XCP|LB|6ADA444E-F1B4-4E59-9F2D-26DC78845397|2||||HLABAGT|HLA-B ANTIGEN TYPE|||||||TSP|||||||NEGATIVE||DAYS/WK||||HIGH|NOT DONE||||SOFT TISSUE|LACTESCENT|U|TURBIDIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|NA|||Y|1||38||WASHOUT|1973-07-04|1962-10-16|||||1960-09-22||1967-02-28|Y|1962-01-01
TRIAL STUDY 134XCP|LB|6ADA444E-F1B4-4E59-9F2D-26DC78845397|1||||CIT|CITRULLINE|||||||G/CAGE/WK|||||||INVALID||VOXEL||||NORMAL|NOT DONE||||URINE|AUTOLYZED|NA|ENZYMATIC SPECTROPHOTOMETRY|FIBROSIS 4 FORMULA||Y|NA|U|Y|||NA|2||58||SCREENING|1965-06-09|1968-12-09|||||1965-07-02||1961-02-12|NA|1967-05-13
TRIAL STUDY 134XCP|LB|6ADA444E-F1B4-4E59-9F2D-26DC78845397|2||||BAFF|B-CELL ACTIVATING FACTOR|||||||MG/KG/MIN|||||||INDETERMINATE||UMOL/MOL||||HIGH|NOT DONE||||SEMEN|SOLIDIFIED|U|OBSERVATION|CKD-EPI CYSTATIN C FORMULA||N|N|N|Y|||Y|2||58||INDUCTION TREATMENT|1966-03-29|1963-10-23|||||1963-07-21||1966-10-16|N|1970-02-09
TRIAL STUDY 134XCP|LB|6ADA444E-F1B4-4E59-9F2D-26DC78845397|1||||VITB3|NIACIN|||||||ML/ANIMAL/WK|||||||POSITIVE||PSEC||||LOW|NOT DONE||||TISSUE|AUTOLYZED|NA|PET SCAN|MDRD FORMULA||U|Y|U|U|||NA|3||39||FOLLOW-UP|1963-10-20|1971-04-24|||||1969-08-14||1972-06-19|NA|1962-04-21
TRIAL STUDY 134XCP|LB|6ADA444E-F1B4-4E59-9F2D-26DC78845397|2||||FLUDOUTE|FLUID OUTPUT, ESTIMATED|||||||ML/CAGE/DAY|||||||POSITIVE||MAMP||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|ICTERIC|N|GEL ELECTROPHORESIS|MDRD ENZYMATIC FORMULA||U|N|Y|NA|||U|3||39||BASELINE|1965-09-17|1965-04-05|||||1969-03-09||1971-08-01|N|1961-10-19
TRIAL STUDY 134XCP|LB|6ADA444E-F1B4-4E59-9F2D-26DC78845397|1||||ELLIPCY|ELLIPTOCYTES|||||||G/U|||||||BORDERLINE||TCID 50/DOSE||||NORMAL|NOT DONE||||URINE|FRESH|Y|ELECTROPHORESIS|HEPASCORE FORMULA||U|N|Y|U|||U|4||88||RUN-IN|1968-04-12|1972-12-13|||||1972-08-03||1964-05-09|U|1968-12-02
TRIAL STUDY 134XCP|LB|6ADA444E-F1B4-4E59-9F2D-26DC78845397|2||||T4FRIDX|THYROXINE, FREE INDEX|||||||HZ/S|||||||INVALID||MU||||HIGH|NOT DONE||||CALCULUS|SOLIDIFIED|NA|CONTRAST ENHANCED X-RAY|FIBROSIS 4 FORMULA||N|Y|U|Y|||NA|4||88||SCREENING|1961-06-24|1964-05-08|||||1960-12-29||1968-03-30|U|1967-07-12
TRIAL STUDY 134XCP|LB|6ADA444E-F1B4-4E59-9F2D-26DC78845397|1||||IFI27|INTERFERON ALPHA-INDUCIBLE PROTEIN 27|||||||BOWL|||||||INVALID||EIA UNIT||||NORMAL|NOT DONE||||CALCULUS|GELLED|N|ZIEHL NEELSEN ACID FAST STAIN|MDRD 5 VARIABLE FORMULA||Y|N|NA|N|||N|5||7||OBSERVATION|1973-03-29|1964-04-12|||||1967-05-03||1960-06-19|U|1967-02-15
TRIAL STUDY 134XCP|LB|6ADA444E-F1B4-4E59-9F2D-26DC78845397|2||||FAS|FAS CELL SURFACE DEATH RECEPTOR|||||||G/DL|||||||NEGATIVE||EQ||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|CONCENTRATED|N|CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE FORMULA||U|NA|Y|N|||N|5||7||CONTINUATION TREATMENT|1960-01-24|1960-08-20|||||1966-03-16||1961-08-16|NA|1969-08-09
TRIAL STUDY 134XCP|LB|85060A90-92F7-4440-AD1C-62A70C2FD5CB|1||||CA1AG|CANCER ANTIGEN 1|||||||ABSORBANCE U/MIN|||||||INVALID||CM2||||ABNORMAL|NOT DONE||||BILE|AUTOLYZED|NA|SPIRAL CT SCAN WITHOUT CONTRAST|MDRD 4 VARIABLE FORMULA||N|N|NA|U|||NA|1||38||INDUCTION TREATMENT|1968-05-23|1965-01-14|||||1972-01-16||1960-12-17|U|1973-04-28
TRIAL STUDY 134XCP|LB|85060A90-92F7-4440-AD1C-62A70C2FD5CB|2||||CHOLHDL|CHOLESTEROL/HDL-CHOLESTEROL|||||||BAG|||||||INDETERMINATE||ML/CM H2O||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|FRESH|Y|TRYPAN BLUE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|N|U|||NA|1||38||OPEN LABEL TREATMENT|1961-04-19|1962-02-11|||||1961-11-09||1963-03-19|NA|1966-07-06
TRIAL STUDY 134XCP|LB|85060A90-92F7-4440-AD1C-62A70C2FD5CB|1||||EPHD|EPHEDRINE|||||||10^9 CFU/G|||||||TRACE||USEC||||HIGH|NOT DONE||||ISOLATE|GELLED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|GMI % FORMULA||U|N|N|U|||Y|2||58||OBSERVATION|1960-03-15|1967-11-26|||||1969-04-24||1964-09-28|N|1973-06-25
TRIAL STUDY 134XCP|LB|85060A90-92F7-4440-AD1C-62A70C2FD5CB|2||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||S/H|||||||NEGATIVE||PKAT/L||||HIGH|NOT DONE||||DIALYSIS FLUID|NON-HEMOLYZED|NA|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|NASH FIBROSURE FORMULA||U|U|N|NA|||Y|2||58||BLINDED TREATMENT|1968-10-29|1967-06-10|||||1968-05-25||1968-02-22|Y|1968-12-08
TRIAL STUDY 134XCP|LB|85060A90-92F7-4440-AD1C-62A70C2FD5CB|1||||MAYHEG|MAY-HEGGLIN ANOMALY|||||||DNA COPIES/ML|||||||BORDERLINE||GBQ/MG||||ABNORMAL|NOT DONE||||LOCHIA|DRIED|U|PULSE OXIMETRY|COCKCROFT-GAULT FORMULA||N|N|NA|N|||N|3||39||BASELINE|1970-07-30|1964-09-29|||||1972-04-02||1964-09-25|NA|1973-08-31
TRIAL STUDY 134XCP|LB|85060A90-92F7-4440-AD1C-62A70C2FD5CB|2||||IFNB|INTERFERON BETA|||||||GPS U|||||||NEGATIVE||/LSQN||||NORMAL|NOT DONE||||SEMINAL FLUID|DRIED|U|MEDIASTINOSCOPY|MDRD 5 VARIABLE FORMULA||Y|NA|N|U|||U|3||39||INDUCTION TREATMENT|1962-07-06|1969-10-06|||||1973-03-02||1961-01-20|NA|1961-08-03
TRIAL STUDY 134XCP|LB|85060A90-92F7-4440-AD1C-62A70C2FD5CB|1||||APLAB|ANTIPHOSPHOLIPID ANTIBODIES|||||||10^6/EJACULATE U|||||||INDETERMINATE||HR/DAY||||NORMAL|NOT DONE||||NAIL|AGGLUTINATED|Y|CRYOSCOPY|NASH FIBROSURE FORMULA||NA|NA|NA|N|||NA|4||88||BLINDED TREATMENT|1971-04-20|1960-10-13|||||1963-02-28||1970-02-16|Y|1963-10-03
TRIAL STUDY 134XCP|LB|85060A90-92F7-4440-AD1C-62A70C2FD5CB|2||||ANAB|ANTI-NEUTROPHIL ANTIBODY|||||||CG|||||||BORDERLINE||10^6 ORGANISMS/G||||NORMAL|NOT DONE||||KERATINOCYTE|UNEXPECTED ODOR|N|TEST STRIP|FIBROSIS 4 FORMULA||U|U|N|NA|||N|4||88||OPEN LABEL TREATMENT|1969-06-05|1962-10-17|||||1968-11-28||1962-08-25|N|1963-02-08
TRIAL STUDY 134XCP|LB|85060A90-92F7-4440-AD1C-62A70C2FD5CB|1||||CDCACM|CHENODEOXYCHOLATE COMPOUNDS|||||||PHERESIS UNIT|||||||TRACE||/4.0 ML||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|REFRIGERATED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 4 VARIABLE FORMULA||NA|U|Y|U|||NA|5||7||LONG-TERM FOLLOW-UP|1971-08-01|1960-01-02|||||1973-09-06||1961-01-16|NA|1965-11-28
TRIAL STUDY 134XCP|LB|85060A90-92F7-4440-AD1C-62A70C2FD5CB|2||||NEUTIM|IMMATURE NEUTROPHILS|||||||ENZYME U|||||||POSITIVE||IMPLANT||||LOW|NOT DONE||||HAIR|ICTERIC|N|COMPLEMENT FIXATION|GMI % FORMULA||N|NA|U|U|||U|5||7||BASELINE|1972-06-15|1967-02-15|||||1960-09-15||1970-07-22|NA|1966-11-15
TRIAL STUDY 134XCP|LB|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|1||||POIKRBC|POIKILOCYTES/ERYTHROCYTES|||||||10^4/L|||||||TRACE||UEQ/L||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|AGGLUTINATED|Y|NEPHELOMETRY|HEPASCORE FORMULA||Y|Y|U|U|||U|1||38||TREATMENT|1972-06-26|1960-11-21|||||1963-01-05||1971-10-18|U|1972-02-21
TRIAL STUDY 134XCP|LB|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|2||||FECA|FRACTIONAL CALCIUM EXCRETION|||||||MDFI|||||||NEGATIVE||NMOL/KG/DAY||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|CLOTTED|Y|RAJI CELL EIA|ASH FIBROSURE FORMULA||NA|NA|Y|N|||NA|1||38||FOLLOW-UP|1973-02-03|1970-02-07|||||1965-04-24||1973-06-09|U|1965-08-19
TRIAL STUDY 134XCP|LB|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|1||||VITD|VITAMIN D|||||||EIA UNIT|||||||POSITIVE||ML/MIN/MMHG||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|LIPEMIC|NA|ELECTRONEUROGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|U|N|||U|2||58||RUN-IN|1960-12-25|1971-01-25|||||1969-10-29||1963-02-10|U|1968-11-18
TRIAL STUDY 134XCP|LB|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|2||||SOMATRO|SOMATOTROPHIN|||||||BREATHS/30S|||||||POSITIVE||V/V||||LOW|NOT DONE||||SPUTUM|DRIED|U|IMMUNOFIXATION ELECTROPHORESIS|FIBROTEST FORMULA||NA|N|N|Y|||U|2||58||OPEN LABEL TREATMENT|1969-01-06|1962-02-07|||||1966-10-28||1966-02-27|N|1961-06-19
TRIAL STUDY 134XCP|LB|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|1||||LYMMCE|LYMPHOMA CELLS|||||||MOL/L|||||||NEGATIVE||MM3/MM2/YEAR||||LOW|NOT DONE||||LOCHIA|CONCENTRATED|N|GRADIENT DIFFUSION|HEPASCORE FORMULA||Y|N|Y|N|||Y|3||39||SCREENING|1964-05-03|1965-10-12|||||1966-09-22||1967-01-07|Y|1960-09-27
TRIAL STUDY 134XCP|LB|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|2||||ATHMBAAC|ANTITHROMBIN ACTIVITY ACTUAL/CONTROL|||||||G/G|||||||POSITIVE||PA||||HIGH|NOT DONE||||ABSCESS FLUID|REFRIGERATED|N|MIGET|MDRD ENZYMATIC FORMULA||Y|Y|N|NA|||Y|3||39||SCREENING|1966-09-27|1973-05-06|||||1963-11-16||1968-10-24|NA|1972-02-10
TRIAL STUDY 134XCP|LB|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|1||||VITD2425|24,25-DIHYDROXYVITAMIN D|||||||SCOOPFUL|||||||NEGATIVE||PRESSOR UNITS||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|CONCENTRATED|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|FIBROMETER FORMULA||NA|NA|NA|NA|||NA|4||88||RUN-IN|1960-07-14|1967-08-27|||||1964-10-12||1963-07-20|N|1964-09-28
TRIAL STUDY 134XCP|LB|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|2||||TSI|THYROID STIMULATING IMMUNOGLOBULIN|||||||/MM2|||||||TRACE||PACK||||ABNORMAL|NOT DONE||||LEUKOCYTE|UNEXPECTED ODOR|NA|FLOW MICROSCOPY|GMI MMOL/MOL FORMULA||Y|Y|N|Y|||U|4||88||OBSERVATION|1973-07-05|1973-07-11|||||1969-05-14||1973-02-18|Y|1964-12-29
TRIAL STUDY 134XCP|LB|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|1||||NORMEEXR|NORMETANEPHRINE EXCRETION RATE|||||||GPS U|||||||POSITIVE||MMHG||||ABNORMAL|NOT DONE||||PLEURAL FLUID|THAWED|NA|HEMAGGLUTINATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|NA|U|||NA|5||7||FOLLOW-UP|1971-08-04|1968-09-04|||||1968-08-16||1968-08-23|N|1971-11-02
TRIAL STUDY 134XCP|LB|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|2||||TRGTCE|TARGET CELLS|||||||G/G|||||||NEGATIVE||10^5/HPF||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|THAWED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|GMI MMOL/MOL FORMULA||NA|Y|NA|NA|||NA|5||7||OPEN LABEL TREATMENT|1967-04-05|1968-10-17|||||1972-10-05||1962-10-27|U|1972-09-10
TRIAL STUDY 134XCP|LB|170052E6-031C-48EF-9CE4-CA84ED6B77FF|1||||TT|THROMBIN TIME|||||||G/KG/DAY|||||||INDETERMINATE||10^9 ORGANISMS/ML||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|PARAFFIN-EMBEDDED|U|MALDI|ASH FIBROSURE FORMULA||N|U|N|NA|||U|1||38||TREATMENT|1964-10-26|1972-05-04|||||1967-03-30||1961-01-16|Y|1970-11-02
TRIAL STUDY 134XCP|LB|170052E6-031C-48EF-9CE4-CA84ED6B77FF|2||||CD38|CD38|||||||STEPS|||||||INVALID||MG/CM2||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|DRIED|U|TRYPAN BLUE STAIN|FIBROTEST FORMULA||U|N|N|N|||N|1||38||BLINDED TREATMENT|1968-10-24|1960-11-12|||||1962-05-18||1967-01-10|N|1972-10-11
TRIAL STUDY 134XCP|LB|170052E6-031C-48EF-9CE4-CA84ED6B77FF|1||||MASTCECE|MAST CELLS/TOTAL CELLS|||||||HOURS|||||||INVALID||10^11/L||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|LACTESCENT|U|DIGITAL PCR|FIBROSIS 4 FORMULA||Y|NA|Y|U|||N|2||58||BASELINE|1970-11-25|1971-05-31|||||1963-06-22||1971-09-01|Y|1969-04-17
TRIAL STUDY 134XCP|LB|170052E6-031C-48EF-9CE4-CA84ED6B77FF|2||||URATEEXR|URATE EXCRETION RATE|||||||UL/ML|||||||NEGATIVE||MG/G/MIN||||LOW|NOT DONE||||MUCUS|CONCENTRATED|U|GC/MS/MS|CKD-EPI CYSTATIN C FORMULA||U|N|N|Y|||NA|2||58||FOLLOW-UP|1968-08-16|1972-03-23|||||1967-06-10||1972-10-09|U|1960-04-23
TRIAL STUDY 134XCP|LB|170052E6-031C-48EF-9CE4-CA84ED6B77FF|1||||LCN2|LIPOCALIN-2|||||||ROENTGEN|||||||INVALID||UG/ML/H||||NORMAL|NOT DONE||||ARTERIAL BLOOD|PARAFFIN-EMBEDDED|Y|TOTAL BODY IRRADIATION|FIBROSIS 4 FORMULA||Y|U|N|NA|||N|3||39||BLINDED TREATMENT|1960-12-04|1966-08-30|||||1963-09-06||1971-02-02|N|1970-06-19
TRIAL STUDY 134XCP|LB|170052E6-031C-48EF-9CE4-CA84ED6B77FF|2||||PROTOSML|PROTEIN/OSMOLALITY|||||||M/SEC2|||||||BORDERLINE||DEG/MM||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|LACTESCENT|NA|MASS SPECTROMETRY|MDRD FORMULA||N|Y|N|U|||N|3||39||BLINDED TREATMENT|1961-08-08|1960-11-10|||||1971-07-13||1962-03-22|U|1961-08-20
TRIAL STUDY 134XCP|LB|170052E6-031C-48EF-9CE4-CA84ED6B77FF|1||||NEUTSGLE|NEUTROPHILS, SEGMENTED/LEUKOCYTES|||||||GY/H|||||||POSITIVE||EJACULATE U||||HIGH|NOT DONE||||TISSUE|CLOTTED|Y|PET/CT SCAN|CKD-EPI CREATININE FORMULA||NA|Y|N|Y|||NA|4||88||CONTINUATION TREATMENT|1960-01-21|1969-07-04|||||1972-11-15||1971-03-30|NA|1962-11-13
TRIAL STUDY 134XCP|LB|170052E6-031C-48EF-9CE4-CA84ED6B77FF|2||||CHRMTNAB|CHROMATIN ANTIBODIES|||||||LX|||||||NEGATIVE||K||||HIGH|NOT DONE||||LEUKOCYTE|AUTOLYZED|U|CENTRIFUGATION|NASH FIBROSURE FORMULA||NA|U|Y|Y|||NA|4||88||SCREENING|1972-01-08|1970-04-04|||||1969-06-13||1960-12-19|Y|1966-05-27
TRIAL STUDY 134XCP|LB|170052E6-031C-48EF-9CE4-CA84ED6B77FF|1||||C165902|TIMOTHY GRASS POLLEN IGG AB RAST SCORE|||||||CMHG|||||||INVALID||LOG10 ELISA UNIT||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|LIPEMIC|U|LEAD CITRATE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|NA|Y|||U|5||7||OPEN LABEL TREATMENT|1966-03-22|1965-12-12|||||1968-12-06||1963-08-31|NA|1961-04-10
TRIAL STUDY 134XCP|LB|170052E6-031C-48EF-9CE4-CA84ED6B77FF|2||||LDH3LDH|LDH ISOENZYME 3/LDH|||||||U/DL|||||||BORDERLINE||10^7 TCID 50/DOSE||||NORMAL|NOT DONE||||VENOUS PLASMA|AUTOLYZED|NA|IHC|MDRD FORMULA||N|U|N|U|||U|5||7||FOLLOW-UP|1962-01-24|1970-10-06|||||1970-12-06||1971-09-04|NA|1973-05-30
TRIAL STUDY 134XCP|LB|D3F628DE-8358-4C2C-B474-763E48719E5E|1||||PLATAGRN|PLATELETS, AGRANULAR|||||||10^6/HPF|||||||INDETERMINATE||MBQ/UL||||LOW|NOT DONE||||SEMEN|LIPEMIC|U|ALCIAN BLUE STAIN|GMI % FORMULA||NA|Y|U|Y|||U|1||38||FOLLOW-UP|1967-05-19|1963-12-19|||||1962-05-26||1963-12-26|NA|1969-03-01
TRIAL STUDY 134XCP|LB|D3F628DE-8358-4C2C-B474-763E48719E5E|2||||IGHG4|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 4|||||||MPA|||||||BORDERLINE||UV*SEC||||ABNORMAL|NOT DONE||||DISCHARGE|THAWED|Y|X-RAY FLUORESCENCE SPECTROMETRY|CKD-EPI CREATININE FORMULA||NA|Y|N|Y|||NA|1||38||TREATMENT|1961-02-28|1970-08-20|||||1963-04-05||1961-06-14|Y|1971-04-15
TRIAL STUDY 134XCP|LB|D3F628DE-8358-4C2C-B474-763E48719E5E|1||||HOWJOL|HOWELL-JOLLY BODIES|||||||UIU/L|||||||INVALID||GY/H||||NORMAL|NOT DONE||||EXPIRED AIR|PARAFFIN-EMBEDDED|N|RAJI CELL RIA|MDRD ENZYMATIC FORMULA||N|NA|NA|NA|||Y|2||58||SCREENING|1970-01-09|1961-12-08|||||1961-06-04||1961-10-18|N|1967-12-26
TRIAL STUDY 134XCP|LB|D3F628DE-8358-4C2C-B474-763E48719E5E|2||||VENLAFAX|VENLAFAXINE|||||||10^12 IU/L|||||||BORDERLINE||ML/S||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|LIPEMIC|N|BETA LACTAMASE|FIBROTEST FORMULA||Y|U|U|Y|||Y|2||58||FOLLOW-UP|1964-04-08|1962-12-24|||||1964-06-12||1973-02-04|Y|1973-01-12
TRIAL STUDY 134XCP|LB|D3F628DE-8358-4C2C-B474-763E48719E5E|1||||C130107|WEED MIX POLLEN ANTIGEN IGG ANTIBODY|||||||UMOL|||||||BORDERLINE||/LSQN||||HIGH|NOT DONE||||SEMEN|FRESH|N|WESTERGREN|MDRD 4 VARIABLE FORMULA||NA|N|N|NA|||NA|3||39||INDUCTION TREATMENT|1965-02-24|1972-01-10|||||1972-07-04||1969-04-21|U|1963-08-27
TRIAL STUDY 134XCP|LB|D3F628DE-8358-4C2C-B474-763E48719E5E|2||||COQ10|UBIQUINONE 10|||||||UCI/KG|||||||NEGATIVE||U/MMOL||||NORMAL|NOT DONE||||PLEURAL FLUID|CALCIFIED|U|CYSTOMETRY|MDRD 5 VARIABLE FORMULA||NA|NA|Y|NA|||U|3||39||INDUCTION TREATMENT|1972-11-16|1963-08-17|||||1967-07-04||1970-02-19|Y|1970-01-09
TRIAL STUDY 134XCP|LB|D3F628DE-8358-4C2C-B474-763E48719E5E|1||||SPERMMTL|SPERM MOTILITY|||||||MG/G/MIN|||||||INDETERMINATE||S^-1(%O2)^-1||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|FRESH|U|IMMUNOCHROMATOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|Y|Y|U|||N|4||88||BASELINE|1965-01-14|1966-03-18|||||1971-12-13||1972-06-17|U|1969-12-30
TRIAL STUDY 134XCP|LB|D3F628DE-8358-4C2C-B474-763E48719E5E|2||||ETS|ETHYL SULFATE|||||||ENZYME U|||||||INDETERMINATE||U/MG||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|ROOM TEMPERATURE|N|AUTOREFRACTION|GMI % FORMULA||Y|N|NA|U|||U|4||88||BLINDED TREATMENT|1964-04-05|1961-09-07|||||1967-01-23||1970-11-07|Y|1961-09-26
TRIAL STUDY 134XCP|LB|D3F628DE-8358-4C2C-B474-763E48719E5E|1||||PSP100AB|P100 POLYMYOSITIS-SCLERODERMA AUTOAG AB|||||||QUANTITY SUFFICIENT|||||||POSITIVE||DAGU/ML||||ABNORMAL|NOT DONE||||CELL PELLET|AGGLUTINATED|N|ACCELERATOR MASS SPECTROMETRY|ASH FIBROSURE FORMULA||NA|NA|NA|N|||NA|5||7||WASHOUT|1966-09-12|1964-11-28|||||1966-09-21||1970-07-21|U|1965-09-19
TRIAL STUDY 134XCP|LB|D3F628DE-8358-4C2C-B474-763E48719E5E|2||||ESTRDIOL|ESTRADIOL|||||||U/MG|||||||TRACE||TUBERCULIN UNIT/ML||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|DRIED|N|MASS SPECTROMETRY|CKD-EPI CREATININE FORMULA||N|U|U|N|||N|5||7||TREATMENT|1961-10-05|1965-01-02|||||1962-10-02||1969-06-11|N|1967-04-30
TRIAL STUDY 134XCP|LB|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|1||||RBCNUC|NUCLEATED ERYTHROCYTES|||||||/H|||||||INDETERMINATE||CIGAR||||HIGH|NOT DONE||||BASAL TEAR|CONCENTRATED|NA|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD ENZYMATIC FORMULA||U|NA|Y|N|||Y|1||38||OPEN LABEL TREATMENT|1972-12-22|1964-12-06|||||1960-03-12||1971-03-16|NA|1960-09-05
TRIAL STUDY 134XCP|LB|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|2||||OXAEXR|OXALATE EXCRETION RATE|||||||MV*MIN|||||||TRACE||CUP EQ||||ABNORMAL|NOT DONE||||SEMEN|HEMOLYZED|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA||Y|Y|NA|U|||U|1||38||LONG-TERM FOLLOW-UP|1964-03-29|1972-06-10|||||1962-03-09||1962-11-07|Y|1972-12-21
TRIAL STUDY 134XCP|LB|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|1||||BASEEXCS|BASE EXCESS|||||||MG/KG|||||||BORDERLINE||KA_U/DL||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|CLOTTED|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|HEPASCORE FORMULA||U|Y|U|U|||N|2||58||BASELINE|1967-07-23|1965-04-01|||||1968-10-20||1961-06-17|N|1961-09-14
TRIAL STUDY 134XCP|LB|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|2||||HCGNDI|CHORIOGONADOTROPIN, INTACT|||||||WEEKS|||||||INVALID||10^3 ORGANISMS/G||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|U|CHROMATOGRAPHY|GMI % FORMULA||Y|NA|NA|U|||N|2||58||BASELINE|1965-07-16|1968-10-02|||||1973-02-01||1965-02-28|NA|1969-10-05
TRIAL STUDY 134XCP|LB|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|1||||NITRATE|NITRATE|||||||WEBER|||||||POSITIVE||IU/KG||||ABNORMAL|NOT DONE||||SEMEN|LACTESCENT|NA|IMMUNOCHROMATOGRAPHY|NASH FIBROSURE FORMULA||NA|NA|NA|U|||N|3||39||OBSERVATION|1965-06-13|1962-01-03|||||1965-03-22||1966-09-11|NA|1961-10-04
TRIAL STUDY 134XCP|LB|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|2||||IAA5OHCR|5-HYDROXYINDOLEACETIC ACID/CREATININE|||||||L/S|||||||INVALID||GENEQ/ML||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|NA|FUNDUS PHOTOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|NA|N|NA|||N|3||39||LONG-TERM FOLLOW-UP|1960-11-13|1970-09-07|||||1969-12-06||1960-04-04|U|1967-01-08
TRIAL STUDY 134XCP|LB|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|1||||INTLK12B|INTERLEUKIN 12 BETA|||||||CYCLE/MIN|||||||NEGATIVE||10^7/L||||NORMAL|NOT DONE||||EMESIS|AGGLUTINATED|Y|TRANSVAGINAL ULTRASOUND|NASH FIBROSURE FORMULA||Y|NA|U|NA|||N|4||88||BLINDED TREATMENT|1970-12-29|1967-11-03|||||1971-11-16||1963-09-29|NA|1964-02-14
TRIAL STUDY 134XCP|LB|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|2||||CD1|CD1|||||||KG/M2|||||||TRACE||PG/L||||LOW|NOT DONE||||EPITHELIAL CELL|THAWED|U|CALCOFLUOR WHITE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|NA|NA|||Y|4||88||WASHOUT|1966-08-11|1963-12-25|||||1969-03-16||1964-12-13|Y|1963-11-13
TRIAL STUDY 134XCP|LB|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|1||||PSAFPSAT|PSA, FREE/PSA|||||||10^4 CFU/ML|||||||NEGATIVE||GPS U||||NORMAL|NOT DONE||||ARTERIAL BLOOD|FROZEN|Y|FLUORIMETRY|FIBROMETER FORMULA||Y|NA|Y|N|||U|5||7||RUN-IN|1971-03-05|1969-07-01|||||1970-08-14||1971-02-16|N|1966-07-11
TRIAL STUDY 134XCP|LB|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|2||||HLAB|HLA CLASS IB ANTIGEN|||||||CP|||||||POSITIVE||GAUSS||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|GELLED|U|DARK FIELD MICROSCOPY|MDRD 6 VARIABLE FORMULA||N|Y|NA|Y|||Y|5||7||TREATMENT|1967-11-06|1964-09-08|||||1969-07-16||1973-05-07|U|1970-05-19
TRIAL STUDY 134XCP|LB|4395486D-C521-4478-9442-68CF0344C6FB|1||||APOB48|APOLIPOPROTEIN B48|||||||SYRINGE|||||||NEGATIVE||UV*SEC||||LOW|NOT DONE||||SYNOVIAL FLUID|GELLED|U|LINE PROBE ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|U|||N|1||38||CONTINUATION TREATMENT|1969-04-06|1970-09-17|||||1965-09-05||1966-03-01|N|1968-06-26
TRIAL STUDY 134XCP|LB|4395486D-C521-4478-9442-68CF0344C6FB|2||||KL6|KREBS VON DEN LUNGEN-6|||||||IU/MMOL|||||||POSITIVE||HENRY||||LOW|NOT DONE||||SEBUM|CONCENTRATED|U|SLIT LAMP|GMI MMOL/MOL FORMULA||NA|Y|NA|U|||NA|1||38||TREATMENT|1972-03-10|1965-09-16|||||1971-12-21||1970-12-05|N|1970-07-24
TRIAL STUDY 134XCP|LB|4395486D-C521-4478-9442-68CF0344C6FB|1||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||BEL|||||||BORDERLINE||MG||||ABNORMAL|NOT DONE||||KERATINOCYTE|CALCIFIED|U|DXA SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|NA|||Y|2||58||WASHOUT|1963-10-13|1970-07-20|||||1970-05-15||1973-05-06|NA|1972-09-25
TRIAL STUDY 134XCP|LB|4395486D-C521-4478-9442-68CF0344C6FB|2||||LDH1|LDH ISOENZYME 1|||||||MU/L|||||||INVALID||PPB||||LOW|NOT DONE||||CALCULUS|CALCIFIED|U|ANALYTICAL ULTRACENTRIFUGATION|GMI % FORMULA||U|Y|NA|Y|||NA|2||58||TREATMENT|1967-01-22|1962-01-05|||||1961-02-24||1968-02-16|U|1969-03-20
TRIAL STUDY 134XCP|LB|4395486D-C521-4478-9442-68CF0344C6FB|1||||ETPTPR|ETP TIME TO PEAK RELATIVE|||||||UEQ|||||||BORDERLINE||MILE||||LOW|NOT DONE||||ADIPOSE TISSUE|AUTOLYZED|Y|MULTIPLE BREATH WASHOUT|CKD-EPI CREATININE FORMULA||U|Y|U|Y|||N|3||39||BASELINE|1971-12-01|1970-01-29|||||1968-12-16||1971-03-24|N|1971-05-08
TRIAL STUDY 134XCP|LB|4395486D-C521-4478-9442-68CF0344C6FB|2||||HYXLYS|HYDROXYLYSINE|||||||/LPF|||||||TRACE||MCI||||HIGH|NOT DONE||||EPIDERMAL TISSUE|CONCENTRATED|N|CT SCAN|FIBROSIS 4 FORMULA||U|U|Y|Y|||U|3||39||INDUCTION TREATMENT|1965-01-28|1966-01-13|||||1973-01-21||1964-09-21|N|1969-12-31
TRIAL STUDY 134XCP|LB|4395486D-C521-4478-9442-68CF0344C6FB|1||||CD8LY|CD8/LYMPHOCYTES|||||||G/DL|||||||TRACE||UG/M2||||ABNORMAL|NOT DONE||||PLEURAL FLUID|THAWED|Y|CELL OF ORIGIN ASSAY|MDRD ENZYMATIC FORMULA||NA|U|Y|U|||U|4||88||BASELINE|1960-10-13|1971-04-28|||||1963-07-08||1960-07-31|NA|1963-03-29
TRIAL STUDY 134XCP|LB|4395486D-C521-4478-9442-68CF0344C6FB|2||||MASTCECE|MAST CELLS/TOTAL CELLS|||||||MNFI|||||||INVALID||U/10^12 RBC||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|GELLED|NA|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|HEPASCORE FORMULA||Y|Y|Y|U|||U|4||88||TREATMENT|1962-09-20|1967-06-05|||||1962-12-18||1966-01-18|Y|1972-12-24
TRIAL STUDY 134XCP|LB|4395486D-C521-4478-9442-68CF0344C6FB|1||||TSIAC|TSI ACTUAL/CONTROL|||||||UU/L|||||||POSITIVE||MMOL/S||||NORMAL|NOT DONE||||FLUID|REFRIGERATED|U|MANUAL CLOT DETECTION|MDRD 5 VARIABLE FORMULA||U|Y|U|Y|||Y|5||7||OBSERVATION|1964-02-09|1966-05-05|||||1971-09-02||1962-01-10|Y|1964-01-16
TRIAL STUDY 134XCP|LB|4395486D-C521-4478-9442-68CF0344C6FB|2||||NHMCE|NONHEMATIC CELLS|||||||HPA|||||||TRACE||10^6/L||||LOW|NOT DONE||||LOCHIA|REFRIGERATED|N|BALLPOINT PEN TECHNIQUE|MDRD FORMULA||Y|U|Y|U|||NA|5||7||BASELINE|1960-06-19|1962-02-15|||||1970-11-23||1965-08-14|U|1970-05-17
TRIAL STUDY 134XCP|LB|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|1||||FAS|FAS CELL SURFACE DEATH RECEPTOR|||||||/10^3|||||||BORDERLINE||UG/ML/H||||LOW|NOT DONE||||KERATINOCYTE|UNEXPECTED ODOR|Y|MICROBIAL CULTURE|MDRD 4 VARIABLE FORMULA||N|NA|Y|Y|||U|1||38||INDUCTION TREATMENT|1963-05-05|1968-02-08|||||1966-11-18||1973-01-28|NA|1964-05-30
TRIAL STUDY 134XCP|LB|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|2||||MYPC|MYELOID PROGENITOR CELLS|||||||NMOL/MOL|||||||TRACE||MG/M2/MIN||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|LIPEMIC|N|U-HPLC/MS/MS|FIBROTEST FORMULA||Y|NA|N|U|||U|1||38||TREATMENT|1973-05-04|1970-02-14|||||1963-09-08||1960-09-28|U|1965-05-31
TRIAL STUDY 134XCP|LB|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|1||||A1AGLP|ALPHA-1 ACID GLYCOPROTEIN|||||||USIEMENS|||||||BORDERLINE||ELISA UNIT/DOSE||||HIGH|NOT DONE||||ARTERIAL BLOOD|FROZEN|U|FLUORESCENT ENZYME IMMUNOASSAY|GMI % FORMULA||Y|U|Y|NA|||N|2||58||SCREENING|1967-05-21|1970-01-06|||||1969-06-23||1972-05-21|NA|1970-06-30
TRIAL STUDY 134XCP|LB|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|2||||HYALUAC|HYALURONIC ACID|||||||BREATHS/MIN|||||||NEGATIVE||DIP||||ABNORMAL|NOT DONE||||DERMAL TISSUE|FROZEN|U|TONOMETRY|MDRD 4 VARIABLE FORMULA||N|U|N|N|||NA|2||58||INDUCTION TREATMENT|1971-05-11|1961-08-06|||||1972-01-16||1961-10-08|U|1967-01-04
TRIAL STUDY 134XCP|LB|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|1||||C130133|D. FARINAE ANTIGEN IGG ANTIBODY|||||||GLOBULE|||||||BORDERLINE||PG/DL||||LOW|NOT DONE||||SUPERNATANT, SERUM|REFRIGERATED|U|CYSTOMETRY|MDRD 5 VARIABLE FORMULA||Y|N|U|U|||N|3||39||BLINDED TREATMENT|1969-02-03|1960-09-26|||||1961-01-14||1961-05-01|Y|1972-10-30
TRIAL STUDY 134XCP|LB|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|2||||ALPIS|INTESTINAL SPECIFIC ALKALINE PHOSPHATASE|||||||MG/KG/DOSE|||||||BORDERLINE||ML/MIN||||HIGH|NOT DONE||||BONE|DRIED|NA|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA||N|U|Y|U|||U|3||39||SCREENING|1965-04-22|1971-07-02|||||1967-09-15||1962-07-07|N|1973-07-12
TRIAL STUDY 134XCP|LB|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|1||||AMYLB40|AMYLOID BETA 1-40|||||||ENZYME U/L|||||||TRACE||PMOL/DL||||HIGH|NOT DONE||||BILE|UNEXPECTED ODOR|NA|PANENDOSCOPY|COCKCROFT-GAULT FORMULA||U|NA|U|N|||N|4||88||OBSERVATION|1971-04-11|1964-01-01|||||1961-10-04||1969-05-10|NA|1967-12-11
TRIAL STUDY 134XCP|LB|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|2||||C147282|WHITE OAK POLLEN IGE ANTIBODY|||||||10^6 RNA COPIES/ML|||||||INDETERMINATE||MOL/ML||||LOW|NOT DONE||||PLATELET|ROOM TEMPERATURE|Y|MAGNETIC RESONANCE ANGIOGRAPHY|GMI MMOL/MOL FORMULA||NA|U|NA|Y|||U|4||88||SCREENING|1961-01-01|1960-04-29|||||1972-05-05||1971-09-24|Y|1960-11-11
TRIAL STUDY 134XCP|LB|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|1||||NAGASECR|N-ACETYL-B-D-GLUCOSAMINIDASE/CREATININE|||||||MU|||||||NEGATIVE||POUCH||||HIGH|NOT DONE||||BONE MARROW|FROZEN|NA|FLUORIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|N|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1960-11-29|1960-04-03|||||1960-06-11||1973-08-07|Y|1970-10-18
TRIAL STUDY 134XCP|LB|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|2||||C165927|ANIMAL MIX IGE AB RAST SCORE|||||||RFU|||||||TRACE||GENEQ/ML||||HIGH|NOT DONE||||PLEURAL FLUID|NON-HEMOLYZED|N|IODINE STAIN|MDRD 6 VARIABLE FORMULA||Y|Y|U|U|||N|5||7||FOLLOW-UP|1971-07-30|1964-02-13|||||1960-05-01||1969-08-14|Y|1960-05-20
TRIAL STUDY 134XCP|LB|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|1||||TGLOB|THYROGLOBULIN|||||||RFU|||||||INDETERMINATE||VG/DOSE||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|REFRIGERATED|Y|ELISPOT|NASH FIBROSURE FORMULA||Y|Y|Y|Y|||Y|1||38||OPEN LABEL TREATMENT|1969-02-25|1961-06-12|||||1966-06-22||1960-04-29|Y|1965-12-11
TRIAL STUDY 134XCP|LB|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|2||||C130079|SILVER BIRCH POLLEN IGG4|||||||PSEC|||||||BORDERLINE||LOG10 ELISA UNIT/DOSE||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|FRESH|N|LC-FL|GMI % FORMULA||U|U|Y|Y|||U|1||38||CONTINUATION TREATMENT|1972-06-27|1973-06-03|||||1960-07-26||1961-05-08|U|1963-01-16
TRIAL STUDY 134XCP|LB|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|1||||APOA5|APOLIPOPROTEIN A5|||||||SFC/10^6 PBMC|||||||POSITIVE||U/DL||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|UNEXPECTED ODOR|NA|INDIRECT IMMUNOFLUORESCENCE|GMI % FORMULA||NA|Y|NA|N|||N|2||58||INDUCTION TREATMENT|1971-01-31|1961-02-14|||||1961-09-02||1964-12-22|U|1971-11-22
TRIAL STUDY 134XCP|LB|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|2||||LYMMCE|LYMPHOMA CELLS|||||||VG/KG|||||||INVALID||ECL UNIT||||LOW|NOT DONE||||MECONIUM|UNEXPECTED ODOR|Y|CLOT DETECTION|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|U|N|||U|2||58||WASHOUT|1963-05-20|1963-02-14|||||1972-05-07||1972-04-11|N|1963-04-24
TRIAL STUDY 134XCP|LB|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|1||||IGHG2|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 2|||||||KIU|||||||BORDERLINE||MPL U||||HIGH|NOT DONE||||MENSTRUAL BLOOD|AGGLUTINATED|NA|DNA MICROARRAY|GMI % FORMULA||U|Y|Y|Y|||NA|3||39||OBSERVATION|1960-12-31|1961-10-12|||||1962-11-13||1970-10-26|Y|1962-11-02
TRIAL STUDY 134XCP|LB|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|2||||LYMCLF|LYMPHOCYTES, CLEFTED|||||||UIU/DL|||||||TRACE||CMHG||||HIGH|NOT DONE||||CERUMEN|REFRIGERATED|U|X-RAY FLUORESCENCE SPECTROMETRY|GMI % FORMULA||NA|Y|N|U|||NA|3||39||INDUCTION TREATMENT|1962-06-21|1969-10-20|||||1967-12-01||1965-11-05|Y|1971-08-30
TRIAL STUDY 134XCP|LB|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|1||||PKM|PYRUVATE KINASE MUSCLE ISOZYME|||||||10^9/L|||||||TRACE||UL/DOSE||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|GELLED|Y|ENZYMATIC COLORIMETRY|GMI MMOL/MOL FORMULA||N|NA|Y|N|||Y|4||88||FOLLOW-UP|1964-05-16|1965-12-09|||||1965-04-11||1960-05-24|NA|1966-01-28
TRIAL STUDY 134XCP|LB|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|2||||ABNCELE|ABNORMAL CELLS/LEUKOCYTES|||||||MV/SEC|||||||TRACE||EQ||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|LIPEMIC|Y|OPHTHALMOSCOPY|CKD-EPI FORMULA||N|U|Y|U|||NA|4||88||SCREENING|1972-08-03|1962-02-20|||||1968-06-09||1968-04-10|N|1972-03-11
TRIAL STUDY 134XCP|LB|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|1||||PLATHCT|PLATELET HEMATOCRIT|||||||EP U|||||||TRACE||ATM||||ABNORMAL|NOT DONE||||SEMINAL FLUID|AGGLUTINATED|N|SLIT LAMP PHOTOGRAPHY|GMI % FORMULA||NA|U|NA|NA|||NA|5||7||SCREENING|1968-02-15|1964-03-05|||||1960-01-22||1965-03-15|U|1964-12-11
TRIAL STUDY 134XCP|LB|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|2||||HIS|HISTIDINE|||||||10^4 CFU|||||||BORDERLINE||U/10^12 RBC||||LOW|NOT DONE||||EPITHELIAL CELL|CLOTTED|NA|FLUORIMETRY|HEPASCORE FORMULA||Y|N|N|Y|||U|5||7||WASHOUT|1972-02-24|1968-08-08|||||1962-08-25||1970-11-04|N|1966-07-21
TRIAL STUDY 134XCP|LB|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|1||||CXCL6|CHEMOKINE (C-X-C MOTIF) LIGAND 6|||||||BAU|||||||INVALID||10^6 CFU/G||||HIGH|NOT DONE||||KERATINOCYTE|CALCIFIED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|GMI MMOL/MOL FORMULA||N|Y|NA|Y|||U|1||38||RUN-IN|1967-09-20|1964-01-27|||||1972-10-04||1967-06-29|U|1960-08-24
TRIAL STUDY 134XCP|LB|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|2||||PO2ADJT|PARTIAL PRESSURE OXYGEN ADJ FOR TEMP|||||||MM/MIN|||||||BORDERLINE||10^3 CFU/G||||HIGH|NOT DONE||||VENOUS BLOOD|ICTERIC|N|CHROMOGENIC ASSAY|MDRD FORMULA||Y|Y|N|N|||U|1||38||RUN-IN|1968-11-17|1967-12-01|||||1972-07-11||1968-05-29|Y|1971-09-14
TRIAL STUDY 134XCP|LB|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|1||||AMA|ANTIMITOCHONDRIAL ANTIBODIES|||||||BOTTLE|||||||POSITIVE||ANSON U||||ABNORMAL|NOT DONE||||BLOOD|CONCENTRATED|U|INTERRUPTER TECHNIQUE|COCKCROFT-GAULT FORMULA||N|N|N|Y|||U|2||58||INDUCTION TREATMENT|1967-03-29|1967-02-05|||||1969-09-15||1970-08-15|U|1967-03-03
TRIAL STUDY 134XCP|LB|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|2||||SMDGCELE|SMUDGE CELLS/LEUKOCYTES|||||||MOL/DAY|||||||NEGATIVE||/MS||||LOW|NOT DONE||||PLATELET RICH PLASMA|CONTAMINATED|U|MICRO BROTH DILUTION|FIBROTEST FORMULA||N|U|N|Y|||NA|2||58||FOLLOW-UP|1972-04-25|1967-09-05|||||1966-07-07||1964-02-13|NA|1968-04-29
TRIAL STUDY 134XCP|LB|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|1||||NORMBASO|BASOPHILIC NORMOBLAST|||||||COULOMB|||||||NEGATIVE||VG/DOSE||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|GELLED|Y|SNP ARRAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|Y|U|||N|3||39||INDUCTION TREATMENT|1971-01-04|1963-11-28|||||1960-03-27||1970-08-15|NA|1963-03-21
TRIAL STUDY 134XCP|LB|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|2||||LEUKCE|LEUKEMIC CELLS|||||||CPM|||||||TRACE||/HPF||||HIGH|NOT DONE||||EMOTIONAL TEAR|LIPEMIC|U|ULTRASOUND|FIBROTEST FORMULA||N|Y|NA|U|||N|3||39||LONG-TERM FOLLOW-UP|1962-09-13|1971-09-01|||||1973-03-21||1965-11-08|N|1967-11-14
TRIAL STUDY 134XCP|LB|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|1||||CCPAB|CYCLIC CITRULLINATED PEPTIDE ANTIBODY|||||||ROENTGEN|||||||BORDERLINE||NMOL/DAY||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|DRIED|Y|ULTRASOUND|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|N|NA|||U|4||88||INDUCTION TREATMENT|1960-07-02|1965-09-16|||||1964-10-25||1965-11-24|N|1966-07-06
TRIAL STUDY 134XCP|LB|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|2||||NORMEEXR|NORMETANEPHRINE EXCRETION RATE|||||||UG/H|||||||INDETERMINATE||CAL||||HIGH|NOT DONE||||URINE|GELLED|N|CONTRAST ENHANCED X-RAY|FIBROTEST FORMULA||N|U|Y|U|||NA|4||88||RUN-IN|1968-07-04|1970-07-23|||||1964-10-03||1971-04-15|NA|1972-04-01
TRIAL STUDY 134XCP|LB|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|1||||CYHGBC|HEMOGLOBIN C CRYSTALS|||||||CM/MIN|||||||INDETERMINATE||CFU/G||||HIGH|NOT DONE||||DIALYSIS FLUID, PERITONEAL|GELLED|U|IMMUNOPRECIPITATION|GMI % FORMULA||NA|NA|N|U|||Y|5||7||BLINDED TREATMENT|1969-09-20|1971-05-17|||||1968-12-17||1970-10-03|Y|1966-06-04
TRIAL STUDY 134XCP|LB|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|2||||CD13|CD13|||||||UL/DOSE|||||||TRACE||MMU/ML||||ABNORMAL|NOT DONE||||BILE|AGGLUTINATED|N|DARK FIELD MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|N|N|||U|5||7||RUN-IN|1971-11-04|1971-10-05|||||1965-07-25||1972-02-18|U|1973-02-13
TRIAL STUDY 134XCP|LB|19394300-46A6-484F-AE02-50BDD39096E3|1||||MONOBLLE|MONOBLASTS/LEUKOCYTES|||||||MMOL/DAY|||||||INDETERMINATE||10^3 COPIES/ML||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|LIPEMIC|N|APPLANATION TONOMETRY|FIBROMETER FORMULA||Y|NA|U|U|||N|1||38||SCREENING|1972-03-13|1963-01-02|||||1969-08-22||1964-05-30|NA|1960-09-25
TRIAL STUDY 134XCP|LB|19394300-46A6-484F-AE02-50BDD39096E3|2||||FVIIAAC|FACTOR VII ACTIVITY ACTUAL/CONTROL|||||||UIU/DL|||||||POSITIVE||COPIES/UG||||LOW|NOT DONE||||PLASMA|PARAFFIN-EMBEDDED|NA|AMSLER GRID|MDRD 5 VARIABLE FORMULA||Y|Y|NA|U|||U|1||38||OPEN LABEL TREATMENT|1965-01-19|1964-05-09|||||1969-03-31||1961-02-18|Y|1962-07-17
TRIAL STUDY 134XCP|LB|19394300-46A6-484F-AE02-50BDD39096E3|1||||IOTCLRBS|IOTHALAMATE CLEARANCE ADJUSTED FOR BSA|||||||CM|||||||TRACE||10^12/L||||HIGH|NOT DONE||||AMNIOTIC FLUID|DRIED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA||Y|Y|NA|N|||U|2||58||TREATMENT|1971-03-27|1962-04-19|||||1972-12-02||1967-05-01|NA|1961-05-30
TRIAL STUDY 134XCP|LB|19394300-46A6-484F-AE02-50BDD39096E3|2||||KLCLLCFR|KAPPA LT CHAIN,FREE/LAMBDA LT CHAIN,FREE|||||||POINT|||||||POSITIVE||BEATS/MIN||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|NON-HEMOLYZED|N|ELECTROGASTROGRAPHY|GMI % FORMULA||U|NA|U|N|||N|2||58||WASHOUT|1964-07-02|1970-10-24|||||1969-04-29||1968-10-10|Y|1973-01-23
TRIAL STUDY 134XCP|LB|19394300-46A6-484F-AE02-50BDD39096E3|1||||RETCRRBC|HCT CORRECTED RETICULOCYTES/ERYTHROCYTES|||||||10^6/EJACULATE U|||||||INVALID||UMOL||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|DRIED|NA|IMMUNORADIOMETRIC ASSAY|HEPASCORE FORMULA||NA|NA|NA|Y|||N|3||39||RUN-IN|1963-07-05|1967-07-13|||||1969-12-26||1967-12-22|N|1966-05-15
TRIAL STUDY 134XCP|LB|19394300-46A6-484F-AE02-50BDD39096E3|2||||GSTY1|GLUTATHIONE S-TRANSFERASE, Y1|||||||F|||||||NEGATIVE||IU/ML||||LOW|NOT DONE||||CAPILLARY BLOOD|PARAFFIN-EMBEDDED|NA|NUCLEIC ACID SEQUENCING|GMI % FORMULA||Y|NA|Y|U|||NA|3||39||SCREENING|1972-06-06|1963-04-15|||||1967-07-17||1961-05-25|NA|1966-10-28
TRIAL STUDY 134XCP|LB|19394300-46A6-484F-AE02-50BDD39096E3|1||||ESTFREST|ESTRADIOL, FREE/ESTRADIOL|||||||FMOL/L/SEC|||||||BORDERLINE||MM/SEC||||ABNORMAL|NOT DONE||||BONE|REFRIGERATED|NA|ERGOSPIROMETRY|NASH FIBROSURE FORMULA||Y|U|Y|U|||U|4||88||TREATMENT|1962-01-18|1960-03-06|||||1966-06-04||1964-03-04|Y|1967-11-13
TRIAL STUDY 134XCP|LB|19394300-46A6-484F-AE02-50BDD39096E3|2||||UNSPCECE|UNSPECIFIED CELLS/TOTAL CELLS|||||||UL/DOSE|||||||INVALID||ML/KG/DAY||||LOW|NOT DONE||||MIXED VENOUS BLOOD|CALCIFIED|Y|ICC|CKD-EPI CREATININE FORMULA||NA|U|U|NA|||U|4||88||RUN-IN|1968-08-07|1961-12-31|||||1968-02-07||1960-10-24|N|1967-02-15
TRIAL STUDY 134XCP|LB|19394300-46A6-484F-AE02-50BDD39096E3|1||||CANNABS|CANNABINOIDS, SYNTHETIC|||||||NEEDLE GAUGE|||||||NEGATIVE||UM2||||LOW|NOT DONE||||GASTRIC CONTENTS|CLOTTED|Y|DIFFUSION WEIGHTED MRI|MDRD 5 VARIABLE FORMULA||N|U|N|Y|||U|5||7||BLINDED TREATMENT|1969-12-22|1972-01-13|||||1961-04-07||1973-05-02|N|1960-01-18
TRIAL STUDY 134XCP|LB|19394300-46A6-484F-AE02-50BDD39096E3|2||||T4FRIDX|THYROXINE, FREE INDEX|||||||MCI/L|||||||TRACE||ML/MMHG||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|REFRIGERATED|U|EPSILOMETER|MDRD 6 VARIABLE FORMULA||NA|NA|Y|NA|||U|5||7||WASHOUT|1964-05-10|1960-01-13|||||1971-10-23||1969-03-15|U|1973-08-18
TRIAL STUDY 134XCP|LB|8C89BD60-3504-4F8B-8F33-7F0C949DB407|1||||HLADRAGT|HLA-DR ANTIGEN TYPE|||||||10^11/L|||||||INVALID||MU/G||||HIGH|NOT DONE||||LOCHIA|AUTOLYZED|N|CALCOFLUOR WHITE STAIN|CKD-EPI CREATININE FORMULA||Y|Y|NA|U|||U|1||38||BASELINE|1961-09-29|1972-01-19|||||1965-05-31||1960-05-28|N|1967-06-19
TRIAL STUDY 134XCP|LB|8C89BD60-3504-4F8B-8F33-7F0C949DB407|2||||EDMIGAAB|ENDOMYSIAL IGA ANTIBODY|||||||VIAL|||||||BORDERLINE||MS/MMHG||||NORMAL|NOT DONE||||AQUEOUS HUMOR|NON-HEMOLYZED|N|LINE PROBE ASSAY|CKD-EPI CREATININE FORMULA||N|Y|U|N|||U|1||38||RUN-IN|1963-03-29|1964-07-16|||||1966-12-27||1969-02-07|N|1961-05-21
TRIAL STUDY 134XCP|LB|8C89BD60-3504-4F8B-8F33-7F0C949DB407|1||||MMP3|MATRIX METALLOPROTEINASE 3|||||||ROENTGEN|||||||INDETERMINATE||UIU/L||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|AGGLUTINATED|Y|MODIFIED ACID FAST STAIN|FIBROMETER FORMULA||Y|NA|U|NA|||Y|2||58||BASELINE|1965-10-29|1962-12-25|||||1961-08-29||1967-03-06|N|1964-08-09
TRIAL STUDY 134XCP|LB|8C89BD60-3504-4F8B-8F33-7F0C949DB407|2||||RDCSUG|REDUCING SUGARS|||||||PMOL/L/H|||||||NEGATIVE||G/CAGE/WK||||HIGH|NOT DONE||||MUSCLE TISSUE|ROOM TEMPERATURE|N|MICRONEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA||U|N|NA|U|||N|2||58||LONG-TERM FOLLOW-UP|1961-09-26|1972-02-29|||||1961-03-31||1966-05-23|N|1960-11-09
TRIAL STUDY 134XCP|LB|8C89BD60-3504-4F8B-8F33-7F0C949DB407|1||||MYBLALE|MYELOBLASTS/LEUKOCYTES|||||||FEU|||||||BORDERLINE||LOG10 PFU/ML||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|GELLED|U|LC/MS/MS|CKD-EPI CREATININE FORMULA||U|NA|NA|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1963-12-22|1968-02-14|||||1971-06-15||1964-12-23|N|1969-06-18
TRIAL STUDY 134XCP|LB|8C89BD60-3504-4F8B-8F33-7F0C949DB407|2||||EPINSQE|EPI CELLS/NON-SQUAM EPI CELLS|||||||NMOL/KG/DAY|||||||NEGATIVE||UGEQ/L||||NORMAL|NOT DONE||||KERATINOCYTE|FROZEN|N|CAPILLARY ELECTROPHORESIS|FIBROTEST FORMULA||N|NA|NA|Y|||Y|3||39||OPEN LABEL TREATMENT|1965-07-06|1969-03-26|||||1962-05-28||1971-01-31|NA|1968-07-30
TRIAL STUDY 134XCP|LB|8C89BD60-3504-4F8B-8F33-7F0C949DB407|1||||GRN|PROGRANULIN|||||||ML/DL|||||||TRACE||PG/L||||LOW|NOT DONE||||ADIPOSE TISSUE|ICTERIC|Y|NUCLEIC ACID BASED METHOD|NASH FIBROSURE FORMULA||U|N|NA|U|||N|4||88||WASHOUT|1971-07-08|1965-12-18|||||1961-07-26||1962-01-20|Y|1966-09-12
TRIAL STUDY 134XCP|LB|8C89BD60-3504-4F8B-8F33-7F0C949DB407|2||||PLTLPLT|LARGE PLATELETS/TOTAL PLATELETS|||||||BE/ML|||||||INVALID||/40 HPFS||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|CONTAMINATED|N|LASER CAPTURE MICRODISSECTION|FIBROTEST FORMULA||Y|U|U|N|||NA|4||88||CONTINUATION TREATMENT|1964-07-20|1973-06-05|||||1972-02-27||1964-12-25|NA|1963-02-11
TRIAL STUDY 134XCP|LB|8C89BD60-3504-4F8B-8F33-7F0C949DB407|1||||G6PD|GLUCOSE-6-PHOSPHATE DEHYDROGENASE|||||||PELLET|||||||TRACE||PIXELS/CM||||LOW|NOT DONE||||SOFT TISSUE|REFRIGERATED|NA|CONGO RED STAIN|CKD-EPI CYSTATIN C FORMULA||N|Y|N|U|||NA|5||7||RUN-IN|1965-01-05|1962-03-18|||||1971-12-28||1962-10-15|U|1965-01-12
TRIAL STUDY 134XCP|LB|8C89BD60-3504-4F8B-8F33-7F0C949DB407|2||||ETPPH|ETP PEAK HEIGHT|||||||MG/G/MIN|||||||INDETERMINATE||/10^3||||LOW|NOT DONE||||SERUM|LACTESCENT|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD FORMULA||U|NA|NA|NA|||N|5||7||LONG-TERM FOLLOW-UP|1964-01-04|1971-01-09|||||1968-03-29||1972-12-02|Y|1960-10-20
TRIAL STUDY 134XCP|LB|4746A481-011E-4376-9D2F-5E57F560A6DE|1||||PLAGMAMP|PLATELET AGGREGATION MEAN AMPLITUDE|||||||RNA COPIES/ML|||||||BORDERLINE||NG/MOL||||NORMAL|NOT DONE||||SYNOVIAL FLUID|AUTOLYZED|U|MICROARRAY|ASH FIBROSURE FORMULA||N|U|U|U|||U|1||38||LONG-TERM FOLLOW-UP|1966-12-26|1964-09-16|||||1971-02-06||1966-09-29|U|1963-06-06
TRIAL STUDY 134XCP|LB|4746A481-011E-4376-9D2F-5E57F560A6DE|2||||C130118|BEE MIX ANTIGEN IGG4 ANTIBODY|||||||/500 WBC|||||||BORDERLINE||10^6 ORGANISMS||||LOW|NOT DONE||||EXPIRED AIR|CLOTTED|NA|HEMATOXYLIN AND EOSIN STAIN|CKD-EPI CYSTATIN C FORMULA||Y|N|N|U|||Y|1||38||TREATMENT|1964-02-14|1960-06-10|||||1967-11-08||1962-02-25|Y|1970-01-27
TRIAL STUDY 134XCP|LB|4746A481-011E-4376-9D2F-5E57F560A6DE|1||||GFRBSB2M|GFR FROM B-2 MICROGLOBULIN ADJ FOR BSA|||||||MM|||||||BORDERLINE||/5X10^4 WBC||||HIGH|NOT DONE||||BILE|LACTESCENT|U|POLYSOMNOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|U|NA|N|||Y|2||58||SCREENING|1971-10-15|1971-02-28|||||1966-08-18||1970-07-08|NA|1966-01-24
TRIAL STUDY 134XCP|LB|4746A481-011E-4376-9D2F-5E57F560A6DE|2||||CKMT2CK|CK, MACROMOLECULAR TYPE 2/TOTAL CK|||||||AFU|||||||TRACE||UG/G/DAY||||NORMAL|NOT DONE||||SMEGMA|DRIED|Y|IMPULSE OSCILLOMETRY|GMI MMOL/MOL FORMULA||N|N|NA|U|||U|2||58||TREATMENT|1964-11-10|1969-11-24|||||1970-01-29||1963-10-07|NA|1961-12-21
TRIAL STUDY 134XCP|LB|4746A481-011E-4376-9D2F-5E57F560A6DE|1||||COMP|CARTILAGE OLIGOMERIC MATRIX PROTEIN|||||||10^3/HPF|||||||POSITIVE||GENEQ||||LOW|NOT DONE||||SEMEN|ROOM TEMPERATURE|U|GIEMSA STAIN|MDRD 5 VARIABLE FORMULA||N|N|N|Y|||Y|3||39||BLINDED TREATMENT|1965-09-03|1962-09-14|||||1960-05-02||1972-04-27|Y|1971-04-11
TRIAL STUDY 134XCP|LB|4746A481-011E-4376-9D2F-5E57F560A6DE|2||||FIBRINOF|FIBRINOGEN, FUNCTIONAL|||||||LOG10 CFU/G|||||||POSITIVE||U/CL||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|NON-HEMOLYZED|N|INDIA INK STAIN|CKD-EPI FORMULA||N|N|U|N|||U|3||39||BASELINE|1965-11-04|1964-12-17|||||1961-11-13||1969-06-05|N|1963-03-26
TRIAL STUDY 134XCP|LB|4746A481-011E-4376-9D2F-5E57F560A6DE|1||||PSAFPSAT|PSA, FREE/PSA|||||||DEG2|||||||BORDERLINE||UG/G/DAY||||LOW|NOT DONE||||ISOLATE|CONCENTRATED|N|MRI WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA||Y|Y|N|Y|||N|4||88||CONTINUATION TREATMENT|1963-06-23|1965-09-13|||||1965-07-30||1963-06-17|U|1961-07-31
TRIAL STUDY 134XCP|LB|4746A481-011E-4376-9D2F-5E57F560A6DE|2||||INULIN|INULIN|||||||GLOBULE|||||||BORDERLINE||UMOL/L/H||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|NON-HEMOLYZED|Y|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|NA|U|||NA|4||88||LONG-TERM FOLLOW-UP|1964-10-12|1971-01-08|||||1966-03-03||1964-05-06|U|1962-12-21
TRIAL STUDY 134XCP|LB|4746A481-011E-4376-9D2F-5E57F560A6DE|1||||FSH|FOLLICLE STIMULATING HORMONE|||||||/WK|||||||BORDERLINE||CARTRIDGE||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|FROZEN|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||U|N|N|NA|||U|5||7||SCREENING|1960-04-05|1967-05-27|||||1965-08-18||1960-12-17|N|1971-07-13
TRIAL STUDY 134XCP|LB|4746A481-011E-4376-9D2F-5E57F560A6DE|2||||SPHERO|SPHEROCYTES|||||||/MM|||||||BORDERLINE||MOL/DAY||||LOW|NOT DONE||||ABSCESS FLUID|CALCIFIED|NA|TOTAL BODY RADIOGRAPHY|MDRD ENZYMATIC FORMULA||U|U|U|NA|||Y|5||7||TREATMENT|1964-04-09|1961-05-23|||||1963-01-18||1973-07-10|N|1962-07-14
TRIAL STUDY 134XCP|LB|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|1||||CTXICRT|TYPE I COLLAGEN C-TELOPEPTIDES/CREAT|||||||MOL/MG|||||||NEGATIVE||FARAD||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|GELLED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|HEPASCORE FORMULA||Y|N|Y|Y|||Y|1||38||RUN-IN|1972-05-09|1960-11-03|||||1966-08-19||1963-10-03|NA|1971-10-23
TRIAL STUDY 134XCP|LB|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|2||||ANTIDPRS|ANTIDEPRESSANTS|||||||BQ|||||||NEGATIVE||TAMPON||||ABNORMAL|NOT DONE||||VENOUS PLASMA|HEMOLYZED|Y|DYNAMIC LIGHT SCATTERING|GMI % FORMULA||N|U|U|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1963-11-09|1966-04-10|||||1962-05-21||1971-07-13|U|1968-03-31
TRIAL STUDY 134XCP|LB|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|1||||SJSA52AB|SJOGRENS SS-A52 ANTIBODY|||||||G/CAGE/DAY|||||||INDETERMINATE||U/M2/MIN||||HIGH|NOT DONE||||LYMPH|LIPEMIC|N|FLUORESCENCE ANGIOGRAPHY|GMI MMOL/MOL FORMULA||N|N|N|U|||N|2||58||SCREENING|1965-09-28|1973-04-06|||||1971-12-24||1964-12-27|Y|1961-02-09
TRIAL STUDY 134XCP|LB|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|2||||TGFB1|TRANSFORMING GROWTH FACTOR BETA 1|||||||BAU/ML|||||||INDETERMINATE||CD*S/M2||||HIGH|NOT DONE||||ISOLATE|CONTAMINATED|N|CALIPER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA||N|U|N|N|||N|2||58||LONG-TERM FOLLOW-UP|1970-09-02|1970-06-15|||||1967-09-09||1961-09-16|U|1963-04-10
TRIAL STUDY 134XCP|LB|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|1||||RDWSD|RDW STANDARD DEVIATION|||||||MJOULE/CM2|||||||NEGATIVE||ROENTGEN||||HIGH|NOT DONE||||KERATINOCYTE|PARAFFIN-EMBEDDED|NA|IODINE STAIN|MDRD 5 VARIABLE FORMULA||N|N|Y|NA|||Y|3||39||BLINDED TREATMENT|1960-01-09|1961-03-02|||||1965-08-01||1963-05-13|Y|1968-11-15
TRIAL STUDY 134XCP|LB|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|2||||BARB|BARBITURATES|||||||EQ|||||||NEGATIVE||NMOL BCE/NMOL||||LOW|NOT DONE||||INTERSTITIAL FLUID|FROZEN|Y|HANSEL STAIN|GMI % FORMULA||Y|N|NA|U|||N|3||39||CONTINUATION TREATMENT|1969-05-14|1961-12-20|||||1960-05-08||1971-01-30|NA|1969-07-15
TRIAL STUDY 134XCP|LB|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|1||||INTLK11|INTERLEUKIN 11|||||||OSM|||||||POSITIVE||MEQ||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|FRESH|Y|FLUORESCENT IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||Y|NA|Y|U|||NA|4||88||TREATMENT|1973-04-23|1972-08-02|||||1963-11-28||1968-01-09|NA|1969-02-01
TRIAL STUDY 134XCP|LB|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|2||||RBCCLMP|ERYTHROCYTE CELL CLUMPS|||||||GRAIN|||||||INDETERMINATE||KG||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED|NA|LC/MS|HEPASCORE FORMULA||Y|N|Y|U|||Y|4||88||WASHOUT|1963-04-05|1965-01-31|||||1965-02-08||1966-03-27|U|1973-04-25
TRIAL STUDY 134XCP|LB|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|1||||GFRBSCRT|GFR FROM CREATININE ADJUSTED FOR BSA|||||||CCID 50/ML|||||||NEGATIVE||HOUNSFIELD UNIT||||NORMAL|NOT DONE||||CERUMEN|DRIED|Y|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||Y|N|U|NA|||NA|5||7||OPEN LABEL TREATMENT|1967-01-25|1973-06-18|||||1966-07-21||1973-05-14|U|1960-05-31
TRIAL STUDY 134XCP|LB|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|2||||ACH|ACETYLCHOLINE|||||||MMU/ML|||||||INVALID||/4.0 ML||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|ICTERIC|U|ELISA|COCKCROFT-GAULT FORMULA||NA|N|NA|U|||NA|5||7||BLINDED TREATMENT|1972-01-15|1972-03-09|||||1969-10-12||1964-10-25|N|1971-06-20
TRIAL STUDY 134XCP|LB|04F5220E-7A8C-4982-9379-496306612E33|1||||METARUB|METARUBRICYTE|||||||IU/MG|||||||BORDERLINE||MOSM/KG||||HIGH|NOT DONE||||SEMEN|ICTERIC|U|SLIT LAMP|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|NA|U|||N|1||38||SCREENING|1972-03-19|1968-12-25|||||1973-03-03||1960-11-23|NA|1961-04-01
TRIAL STUDY 134XCP|LB|04F5220E-7A8C-4982-9379-496306612E33|2||||CELLULAR|CELLULARITY|||||||NG/MOL|||||||POSITIVE||MMOL/G||||LOW|NOT DONE||||SKIN TISSUE|CLOTTED|Y|RADIATION DOSIMETRY|ASH FIBROSURE FORMULA||Y|NA|N|Y|||U|1||38||INDUCTION TREATMENT|1972-01-06|1969-02-07|||||1962-05-12||1960-03-09|U|1960-10-13
TRIAL STUDY 134XCP|LB|04F5220E-7A8C-4982-9379-496306612E33|1||||ATHMBAAC|ANTITHROMBIN ACTIVITY ACTUAL/CONTROL|||||||CIGAR|||||||TRACE||/WK||||LOW|NOT DONE||||MUSCLE TISSUE|GELLED|NA|CONTRAST ENHANCED X-RAY|CKD-EPI FORMULA||U|Y|NA|NA|||Y|2||58||WASHOUT|1965-08-23|1972-10-20|||||1971-06-16||1967-11-28|NA|1970-02-01
TRIAL STUDY 134XCP|LB|04F5220E-7A8C-4982-9379-496306612E33|2||||GMCSF|GRANULOCYTE MACROPHAGE COLONY STM FACTOR|||||||/500 WBC|||||||INDETERMINATE||DPM/ML||||HIGH|NOT DONE||||ISOLATE|CALCIFIED|N|WHOLE TRANSCRIPTOME SEQUENCING|ASH FIBROSURE FORMULA||U|N|NA|Y|||U|2||58||OBSERVATION|1969-07-15|1971-04-24|||||1963-12-24||1967-11-14|U|1971-10-07
TRIAL STUDY 134XCP|LB|04F5220E-7A8C-4982-9379-496306612E33|1||||C165884|OLIVE TREE POLLEN IGE ANTIBODY|||||||MEQ|||||||POSITIVE||10^6/EJACULATE U||||NORMAL|NOT DONE||||VITREOUS HUMOR|CALCIFIED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||N|U|Y|U|||U|3||39||FOLLOW-UP|1962-08-02|1964-05-02|||||1963-04-24||1973-01-18|U|1969-08-17
TRIAL STUDY 134XCP|LB|04F5220E-7A8C-4982-9379-496306612E33|2||||FGF23|FIBROBLAST GROWTH FACTOR 23|||||||10^3 RNA COPIES/ML|||||||NEGATIVE||NMOL/DAY||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|ICTERIC|N|PERCUSSION|GMI % FORMULA||NA|U|NA|NA|||Y|3||39||CONTINUATION TREATMENT|1968-04-19|1963-04-21|||||1972-01-17||1968-02-01|N|1961-12-20
TRIAL STUDY 134XCP|LB|04F5220E-7A8C-4982-9379-496306612E33|1||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||IU/L|||||||POSITIVE||TAMPON||||HIGH|NOT DONE||||STOOL|NON-HEMOLYZED|Y|MULTI-SLICE SPIRAL CT|MDRD ENZYMATIC FORMULA||N|NA|N|Y|||N|4||88||OBSERVATION|1968-03-27|1967-10-15|||||1962-09-26||1970-10-25|U|1964-01-15
TRIAL STUDY 134XCP|LB|04F5220E-7A8C-4982-9379-496306612E33|2||||IFI6|INTERFERON ALPHA-INDUCIBLE PROTEIN 6|||||||AMU|||||||NEGATIVE||EU||||LOW|NOT DONE||||AQUEOUS HUMOR|FROZEN|U|VENTILATION PERFUSION LUNG SCAN|CKD-EPI FORMULA||N|U|N|U|||NA|4||88||BASELINE|1972-10-02|1968-03-15|||||1960-07-17||1965-08-29|Y|1967-12-19
TRIAL STUDY 134XCP|LB|04F5220E-7A8C-4982-9379-496306612E33|1||||TBG|THYROXINE BINDING GLOBULIN|||||||TRACE|||||||BORDERLINE||MG/MOL||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ICTERIC|NA|CLAUSS METHOD|NASH FIBROSURE FORMULA||U|NA|NA|U|||NA|5||7||BASELINE|1960-08-26|1968-02-23|||||1960-07-23||1963-02-03|N|1965-03-26
TRIAL STUDY 134XCP|LB|04F5220E-7A8C-4982-9379-496306612E33|2||||PRZPM|PRAZEPAM|||||||AGU/ML|||||||TRACE||UG/M2/MIN||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|REFRIGERATED|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA||NA|Y|Y|N|||N|5||7||BASELINE|1970-08-26|1965-01-29|||||1963-11-12||1962-05-17|N|1969-10-04
TRIAL STUDY 134XCP|LB|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|1||||EPIC|EPITHELIAL CELLS|||||||UG/G/MIN|||||||BORDERLINE||10^9 ORGANISMS/G||||LOW|NOT DONE||||SKIN TISSUE|FRESH|U|HEMAGGLUTINATION ASSAY|NASH FIBROSURE FORMULA||U|N|N|U|||Y|1||38||CONTINUATION TREATMENT|1966-06-30|1967-03-25|||||1968-06-08||1970-05-17|N|1965-10-02
TRIAL STUDY 134XCP|LB|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|2||||TESTOSBA|BIOAVAILABLE TESTOSTERONE|||||||AMP|||||||TRACE||MEQ/DL||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|LACTESCENT|N|ELASTOGRAPHY|COCKCROFT-GAULT FORMULA||NA|NA|N|N|||NA|1||38||INDUCTION TREATMENT|1970-10-14|1972-10-02|||||1971-12-22||1968-09-25|U|1967-04-30
TRIAL STUDY 134XCP|LB|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|1||||EOS|EOSINOPHILS|||||||MOL/DAY|||||||BORDERLINE||10^6 ORGANISMS/G||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|SOLIDIFIED|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|HEPASCORE FORMULA||N|NA|N|NA|||U|2||58||WASHOUT|1961-02-02|1961-07-19|||||1962-04-19||1961-10-04|N|1962-12-19
TRIAL STUDY 134XCP|LB|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|2||||AXL|AXL RECEPTOR TYROSINE KINASE|||||||PFU/DOSE|||||||INDETERMINATE||GBQ/MG||||HIGH|NOT DONE||||CORD SERUM|FROZEN|NA|DNA MICROARRAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|Y|N|||U|2||58||OPEN LABEL TREATMENT|1960-08-10|1969-04-08|||||1970-01-05||1966-11-28|U|1962-12-28
TRIAL STUDY 134XCP|LB|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|1||||HLADR51A|HLA-DR51 ANTIBODY|||||||UG/KG/MIN|||||||INDETERMINATE||POUCH||||LOW|NOT DONE||||GASTRIC CONTENTS|ICTERIC|Y|MICROPARTICLE ENZYME IMMUNOASSAY|GMI MMOL/MOL FORMULA||U|N|Y|NA|||U|3||39||OPEN LABEL TREATMENT|1966-05-22|1970-01-17|||||1967-09-03||1968-04-10|NA|1972-01-26
TRIAL STUDY 134XCP|LB|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|2||||IA5OHEXR|5-HYDROXYINDOLEACETICACID EXCRETION RATE|||||||DDU|||||||TRACE||MEQ/L||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|FRESH|Y|ACID FAST STAIN|GMI MMOL/MOL FORMULA||Y|N|NA|Y|||Y|3||39||FOLLOW-UP|1963-05-20|1961-06-23|||||1973-07-03||1970-03-27|U|1973-02-02
TRIAL STUDY 134XCP|LB|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|1||||ABNCELE|ABNORMAL CELLS/LEUKOCYTES|||||||CP|||||||INVALID||PMOL/L/H||||NORMAL|NOT DONE||||MUSCLE TISSUE|LACTESCENT|NA|MANUAL CLOT DETECTION|GMI % FORMULA||U|NA|NA|Y|||Y|4||88||BLINDED TREATMENT|1971-09-20|1973-03-21|||||1965-12-18||1973-07-19|Y|1963-07-12
TRIAL STUDY 134XCP|LB|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|2||||RBC|ERYTHROCYTES|||||||KG/CM2|||||||TRACE||UG/KG||||HIGH|NOT DONE||||LAVAGE FLUID|CLOTTED|Y|CLIP|COCKCROFT-GAULT FORMULA||N|NA|U|U|||N|4||88||RUN-IN|1968-05-04|1973-02-20|||||1967-12-05||1963-10-17|Y|1960-11-25
TRIAL STUDY 134XCP|LB|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|1||||FBNCTCE|FIBRONECTIN, CELLULAR|||||||10^3 CFU/ML|||||||POSITIVE||ABSORBANCE U||||ABNORMAL|NOT DONE||||EMESIS|NON-HEMOLYZED|U|OBSERVATION|FIBROMETER FORMULA||Y|Y|NA|N|||NA|5||7||CONTINUATION TREATMENT|1969-02-27|1971-08-03|||||1963-12-02||1962-11-25|Y|1965-01-19
TRIAL STUDY 134XCP|LB|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|2||||CA72_4AG|CANCER ANTIGEN 72-4|||||||MG/KG|||||||INDETERMINATE||KN/CM2||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|CONCENTRATED|Y|DOPPLER ULTRASOUND|CKD-EPI FORMULA||NA|U|NA|NA|||Y|5||7||INDUCTION TREATMENT|1969-04-01|1967-08-27|||||1966-04-17||1962-07-11|U|1963-10-26
TRIAL STUDY 134XCP|LB|73BDFAA2-6260-4E1D-8039-7523F0C52873|1||||APLIGGAB|ANTI-PHOSPHOLIPID IGG ANTIBODY|||||||NMOL/MOL|||||||INDETERMINATE||%/S||||NORMAL|NOT DONE||||BILE|LIPEMIC|N|AUDIOMETRY|FIBROTEST FORMULA||Y|N|U|NA|||U|1||38||INDUCTION TREATMENT|1960-03-10|1969-04-10|||||1971-09-02||1960-03-01|U|1970-07-08
TRIAL STUDY 134XCP|LB|73BDFAA2-6260-4E1D-8039-7523F0C52873|2||||INTLK12B|INTERLEUKIN 12 BETA|||||||/WK|||||||INDETERMINATE||ML/KG/H||||NORMAL|NOT DONE||||SKIN TISSUE|ICTERIC|Y|CONTRAST ENHANCED CT SCAN|MDRD 4 VARIABLE FORMULA||NA|U|Y|Y|||U|1||38||CONTINUATION TREATMENT|1970-03-13|1965-05-30|||||1960-01-13||1961-12-19|N|1962-06-20
TRIAL STUDY 134XCP|LB|73BDFAA2-6260-4E1D-8039-7523F0C52873|1||||TRANK1|TPR-ANKYRIN REPEAT-CONTAINING PROTEIN 1|||||||TRANSDUCING UNIT/ML|||||||INVALID||10^10/L||||HIGH|NOT DONE||||RETICULOCYTES|LIPEMIC|NA|DOUBLE IMMUNODIFFUSION|COCKCROFT-GAULT FORMULA||U|Y|NA|Y|||NA|2||58||OBSERVATION|1973-01-12|1964-12-24|||||1962-09-17||1960-10-15|NA|1964-05-01
TRIAL STUDY 134XCP|LB|73BDFAA2-6260-4E1D-8039-7523F0C52873|2||||NORMBASO|BASOPHILIC NORMOBLAST|||||||/LSQN|||||||INVALID||OZ||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|CONTAMINATED|NA|MOUSE PROTECTION ASSAY|CKD-EPI FORMULA||N|NA|NA|N|||NA|2||58||TREATMENT|1972-07-03|1966-05-28|||||1971-11-23||1961-02-21|N|1972-08-26
TRIAL STUDY 134XCP|LB|73BDFAA2-6260-4E1D-8039-7523F0C52873|1||||IRF|IMMATURE RETICULOCYTE FRACTION|||||||CGY|||||||INVALID||G/CAGE/DAY||||HIGH|NOT DONE||||CALCULUS|HEMOLYZED|Y|TOLUIDINE BLUE STAIN|MDRD ENZYMATIC FORMULA||Y|Y|U|N|||N|3||39||FOLLOW-UP|1968-03-05|1960-07-03|||||1961-10-12||1967-06-14|U|1966-09-07
TRIAL STUDY 134XCP|LB|73BDFAA2-6260-4E1D-8039-7523F0C52873|2||||TRIG|TRIGLYCERIDES|||||||TABLET|||||||INVALID||HZ||||LOW|NOT DONE||||LOCHIA|THAWED|N|ALCIAN BLUE STAIN|CKD-EPI FORMULA||U|NA|Y|N|||U|3||39||LONG-TERM FOLLOW-UP|1962-12-13|1972-06-28|||||1971-04-24||1960-10-30|Y|1963-12-13
TRIAL STUDY 134XCP|LB|73BDFAA2-6260-4E1D-8039-7523F0C52873|1||||PROGESTR|PROGESTERONE RECEPTOR|||||||CUP EQ|||||||TRACE||KPA/L/SEC||||ABNORMAL|NOT DONE||||EXUDATE|FROZEN|N|DROPLET DIGITAL PCR|MDRD ENZYMATIC FORMULA||NA|Y|N|U|||U|4||88||FOLLOW-UP|1969-04-26|1964-02-10|||||1972-07-19||1963-01-20|NA|1964-05-13
TRIAL STUDY 134XCP|LB|73BDFAA2-6260-4E1D-8039-7523F0C52873|2||||IGFBP7|INSULIN-LIKE GROWTH FACTOR BINDING PROT7|||||||NMOL/L/H|||||||POSITIVE||LM||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|PARAFFIN-EMBEDDED|U|REBOUND TONOMETRY|COCKCROFT-GAULT FORMULA||NA|NA|NA|N|||N|4||88||INDUCTION TREATMENT|1967-09-28|1964-12-05|||||1968-01-07||1971-04-17|Y|1971-02-27
TRIAL STUDY 134XCP|LB|73BDFAA2-6260-4E1D-8039-7523F0C52873|1||||CSWBC|WBC CASTS|||||||10^3/L|||||||INVALID||/500 WBC||||ABNORMAL|NOT DONE||||MONOCYTE|ROOM TEMPERATURE|U|IVY INCISION METHOD|GMI % FORMULA||N|Y|U|U|||N|5||7||BASELINE|1970-10-28|1961-01-03|||||1970-12-15||1972-03-31|N|1970-06-17
TRIAL STUDY 134XCP|LB|73BDFAA2-6260-4E1D-8039-7523F0C52873|2||||GRAN|GRANULOCYTES|||||||UG/ML/H|||||||NEGATIVE||/100 HPFS||||NORMAL|NOT DONE||||MONOCYTE|ICTERIC|Y|ULTRASOUND|MDRD FORMULA||U|NA|N|Y|||U|5||7||RUN-IN|1972-11-23|1969-07-08|||||1966-01-03||1967-05-27|Y|1960-03-19
TRIAL STUDY 134XCP|LB|147C2E77-A2C5-4219-9BB5-D209813E563B|1||||C130141|GERMAN COCKROACH ANTIGEN IGA ANTIBODY|||||||MCI/L|||||||INVALID||CI/UG||||LOW|NOT DONE||||AQUEOUS HUMOR|DRIED|U|PET/SPECT SCAN|FIBROMETER FORMULA||Y|NA|N|U|||N|1||38||OPEN LABEL TREATMENT|1962-07-28|1973-06-28|||||1963-12-22||1968-03-09|N|1963-09-30
TRIAL STUDY 134XCP|LB|147C2E77-A2C5-4219-9BB5-D209813E563B|2||||HYPGST17|17-HYDROXYPROGESTERONE|||||||FMOL/L/SEC|||||||NEGATIVE||NMOL/KG/DAY||||HIGH|NOT DONE||||RETICULOCYTES|PARAFFIN-EMBEDDED|N|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|FIBROTEST FORMULA||NA|Y|NA|NA|||Y|1||38||SCREENING|1972-10-30|1966-09-24|||||1968-07-01||1970-03-10|NA|1961-11-02
TRIAL STUDY 134XCP|LB|147C2E77-A2C5-4219-9BB5-D209813E563B|1||||SJSA60AB|SJOGRENS SS-A60 ANTIBODY|||||||BISCUIT|||||||INVALID||% INHIBITION||||ABNORMAL|NOT DONE||||PLEURAL FLUID|AUTOLYZED|U|WRIGHT STAIN|GMI MMOL/MOL FORMULA||N|Y|NA|U|||NA|2||58||FOLLOW-UP|1967-04-21|1966-10-10|||||1962-03-13||1967-03-20|N|1972-09-05
TRIAL STUDY 134XCP|LB|147C2E77-A2C5-4219-9BB5-D209813E563B|2||||CCL16|CHEMOKINE (C-C MOTIF) LIGAND 16|||||||MET*H|||||||BORDERLINE||10^6 CFU/ML||||ABNORMAL|NOT DONE||||TISSUE|ICTERIC|U|GRADIENT DIFFUSION|MDRD 6 VARIABLE FORMULA||Y|U|N|N|||Y|2||58||INDUCTION TREATMENT|1960-11-18|1970-08-02|||||1964-11-25||1961-10-28|Y|1972-06-03
TRIAL STUDY 134XCP|LB|147C2E77-A2C5-4219-9BB5-D209813E563B|1||||FLUIDOUT|FLUID OUTPUT|||||||ML/SEC/1.73M2|||||||BORDERLINE||MG/ML/DAY||||HIGH|NOT DONE||||ADIPOSE TISSUE|UNEXPECTED ODOR|U|ICP-MS|COCKCROFT-GAULT FORMULA||N|N|N|Y|||U|3||39||RUN-IN|1969-12-10|1969-08-08|||||1961-01-23||1963-11-04|N|1963-03-12
TRIAL STUDY 134XCP|LB|147C2E77-A2C5-4219-9BB5-D209813E563B|2||||WDR26|WD REPEAT-CONTAINING PROTEIN 26|||||||UG/DOSE|||||||POSITIVE||DPM||||HIGH|NOT DONE||||MENSTRUAL BLOOD|THAWED|N|IMMUNOCHROMATOGRAPHY|MDRD FORMULA||NA|Y|Y|Y|||NA|3||39||TREATMENT|1962-05-23|1963-05-15|||||1965-04-10||1964-12-26|Y|1968-03-13
TRIAL STUDY 134XCP|LB|147C2E77-A2C5-4219-9BB5-D209813E563B|1||||TK2|THYMIDINE KINASE 2|||||||TUBERCULIN UNIT/ML|||||||POSITIVE||MOL/MG||||HIGH|NOT DONE||||TISSUE|LACTESCENT|N|PHYSICAL EXAMINATION|GMI % FORMULA||U|U|N|NA|||N|4||88||BASELINE|1968-09-18|1971-04-29|||||1968-03-11||1961-11-20|Y|1968-08-10
TRIAL STUDY 134XCP|LB|147C2E77-A2C5-4219-9BB5-D209813E563B|2||||BASEDEF|BASE DEFICIT|||||||S^-1(%O2)^-1|||||||TRACE||G/CM2||||ABNORMAL|NOT DONE||||PERSPIRATION|DRIED|U|DISK DIFFUSION|GMI % FORMULA||U|Y|Y|NA|||U|4||88||SCREENING|1962-04-28|1962-09-06|||||1964-05-12||1963-01-19|N|1963-07-04
TRIAL STUDY 134XCP|LB|147C2E77-A2C5-4219-9BB5-D209813E563B|1||||IFIT1|INTERFERON-INDUCED 56 KDA PROTEIN|||||||10^4/L|||||||INVALID||10^9 ORGANISMS/ML||||HIGH|NOT DONE||||LEUKOCYTE|FROZEN|NA|CYSTOSCOPY|GMI MMOL/MOL FORMULA||N|N|N|Y|||NA|5||7||SCREENING|1966-08-14|1965-01-03|||||1964-05-02||1966-08-05|NA|1964-05-16
TRIAL STUDY 134XCP|LB|147C2E77-A2C5-4219-9BB5-D209813E563B|2||||LYMIM|IMMATURE LYMPHOCYTES|||||||DPM/0.5 ML|||||||BORDERLINE||BQ/UL||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|THAWED|NA|INTERRUPTER TECHNIQUE|MDRD FORMULA||U|U|N|N|||N|5||7||SCREENING|1965-07-25|1964-03-17|||||1964-05-24||1965-01-14|NA|1962-02-04
TRIAL STUDY 134XCP|LB|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|1||||DRUGSCR|DRUG SCREEN|||||||U.CARR|||||||NEGATIVE||ML/KG/DAY||||LOW|NOT DONE||||ARTERIAL BLOOD|UNEXPECTED ODOR|N|OPTICAL MAPPING|FIBROTEST FORMULA||N|Y|NA|NA|||U|1||38||OBSERVATION|1972-01-28|1970-05-21|||||1972-11-11||1970-08-11|Y|1965-01-31
TRIAL STUDY 134XCP|LB|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|2||||ANABASN|ANABASINE|||||||U/G|||||||TRACE||IU||||LOW|NOT DONE||||INTERSTITIAL FLUID|UNEXPECTED ODOR|U|SLIT LAMP PHOTOGRAPHY|CKD-EPI CREATININE FORMULA||U|NA|NA|U|||N|1||38||FOLLOW-UP|1963-12-16|1965-03-18|||||1960-03-28||1963-10-27|U|1965-05-26
TRIAL STUDY 134XCP|LB|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|1||||SOST|SCLEROSTIN|||||||MOL/DAY|||||||TRACE||KN/CM2||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|ICTERIC|N|PALM METHOD|MDRD FORMULA||N|N|U|U|||U|2||58||LONG-TERM FOLLOW-UP|1960-03-29|1966-12-18|||||1969-05-31||1966-05-12|Y|1961-09-30
TRIAL STUDY 134XCP|LB|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|2||||RITALAC|RITALINIC ACID|||||||NKAT|||||||BORDERLINE||KIT||||HIGH|NOT DONE||||EPITHELIAL CELL|ROOM TEMPERATURE|Y|CONTACT SPECULAR MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||N|Y|Y|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1972-11-26|1972-01-06|||||1972-12-30||1961-11-24|Y|1967-03-27
TRIAL STUDY 134XCP|LB|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|1||||LAP|LEUCINE AMINOPEPTIDASE|||||||VIAL|||||||INVALID||UV2||||ABNORMAL|NOT DONE||||REFLEX TEAR|PARAFFIN-EMBEDDED|N|ICP-MS|HEPASCORE FORMULA||U|N|U|N|||Y|3||39||WASHOUT|1966-06-20|1973-04-06|||||1969-10-03||1972-02-19|NA|1966-06-07
TRIAL STUDY 134XCP|LB|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|2||||INTLK4|INTERLEUKIN 4|||||||G/CM2|||||||NEGATIVE||PPB||||LOW|NOT DONE||||BONE MARROW|HEMOLYZED|NA|SPECTROPHOTOMETRY|CKD-EPI CYSTATIN C FORMULA||Y|Y|N|NA|||Y|3||39||TREATMENT|1969-07-07|1967-11-04|||||1971-04-10||1966-06-22|N|1960-05-08
TRIAL STUDY 134XCP|LB|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|1||||LDL|LDL CHOLESTEROL|||||||GPELISA UNIT/ML|||||||INVALID||MG/KG/WEEK||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|DRIED|U|HILLMEN COLOR CHART|MDRD 4 VARIABLE FORMULA||U|Y|NA|U|||Y|4||88||WASHOUT|1973-02-16|1963-07-03|||||1970-05-14||1968-02-05|NA|1961-07-17
TRIAL STUDY 134XCP|LB|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|2||||THC|TETRAHYDROCANNABINOL|||||||MG/H|||||||NEGATIVE||MM3/MM2/YEAR||||ABNORMAL|NOT DONE||||FLUID|PARAFFIN-EMBEDDED|N|EPSILOMETER|COCKCROFT-GAULT FORMULA||U|Y|U|N|||N|4||88||WASHOUT|1972-08-12|1970-12-25|||||1964-04-09||1968-05-19|U|1971-03-09
TRIAL STUDY 134XCP|LB|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|1||||VMAEXR|VANILLYL MANDELIC ACID EXCRETION RATE|||||||MCI/KG|||||||INVALID||VG/DOSE||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|LIPEMIC|U|SCINTIGRAPHY|FIBROMETER FORMULA||Y|N|Y|Y|||NA|5||7||CONTINUATION TREATMENT|1972-09-07|1972-05-11|||||1966-11-10||1964-12-06|NA|1972-03-21
TRIAL STUDY 134XCP|LB|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|2||||CRDIGMAB|CARDIOLIPIN IGM ANTIBODY|||||||/10^5|||||||BORDERLINE||10^3 CFU||||HIGH|NOT DONE||||PROSTATIC FLUID|SOLIDIFIED|Y|CONTACT SPECULAR MICROSCOPY|NASH FIBROSURE FORMULA||N|Y|N|Y|||NA|5||7||OPEN LABEL TREATMENT|1960-08-14|1972-10-17|||||1972-06-18||1966-01-09|NA|1973-06-16
TRIAL STUDY 134XCP|LB|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|1||||LYMCLF|LYMPHOCYTES, CLEFTED|||||||UMOL|||||||INVALID||AMU||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|CALCIFIED|U|MICROBIAL CULTURE|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|NA|Y|||Y|1||38||CONTINUATION TREATMENT|1962-10-19|1970-11-14|||||1967-10-26||1962-03-23|U|1970-04-18
TRIAL STUDY 134XCP|LB|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|2||||GATCPHRL|GAMMA TOCOPHEROL|||||||BU|||||||INDETERMINATE||MN||||LOW|NOT DONE||||ADIPOSE TISSUE|CONTAMINATED|Y|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|NA|N|||NA|1||38||OBSERVATION|1970-09-15|1962-04-30|||||1961-05-26||1968-01-04|N|1972-11-03
TRIAL STUDY 134XCP|LB|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|1||||HLZPM|HALAZEPAM|||||||SQU/ML|||||||POSITIVE||MPA||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|LACTESCENT|N|PLETHYSMOGRAPHY|GMI % FORMULA||NA|U|NA|NA|||Y|2||58||INDUCTION TREATMENT|1967-08-04|1970-07-11|||||1967-05-23||1970-02-04|NA|1965-05-16
TRIAL STUDY 134XCP|LB|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|2||||IGFBP1|INSULIN-LIKE GROWTH FACTOR BINDING PROT1|||||||TITER|||||||INVALID||MOSM/KG||||HIGH|NOT DONE||||HAIR FOLLICLE|AUTOLYZED|NA|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|GMI MMOL/MOL FORMULA||Y|U|NA|NA|||NA|2||58||OBSERVATION|1969-01-27|1968-01-01|||||1971-02-26||1962-01-17|Y|1960-12-04
TRIAL STUDY 134XCP|LB|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|1||||EDMAB|ENDOMYSIAL ANTIBODY|||||||10^7 PFU|||||||BORDERLINE||MEQ/DL||||LOW|NOT DONE||||VITREOUS HUMOR|SOLIDIFIED|N|TRANSMISSION ELECTRON MICROSCOPY|FIBROMETER FORMULA||NA|U|Y|N|||U|3||39||BLINDED TREATMENT|1970-01-24|1972-05-24|||||1973-08-19||1962-08-07|U|1972-01-16
TRIAL STUDY 134XCP|LB|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|2||||PLAGMCVT|PLATELET AGGREGATION MEAN CURVE TYPE|||||||PMOL/DAY|||||||POSITIVE||MG/KG/WEEK||||LOW|NOT DONE||||DERMAL TISSUE|REFRIGERATED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 6 VARIABLE FORMULA||NA|N|N|Y|||N|3||39||BLINDED TREATMENT|1961-11-15|1972-06-04|||||1969-03-02||1962-04-16|U|1967-05-06
TRIAL STUDY 134XCP|LB|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|1||||AST|ASPARTATE AMINOTRANSFERASE|||||||MOL|||||||BORDERLINE||ML/MIN/MMHG||||ABNORMAL|NOT DONE||||CERUMEN|CONCENTRATED|U|ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI CREATININE FORMULA||N|N|N|N|||N|4||88||BASELINE|1960-12-10|1971-10-11|||||1965-07-17||1962-05-11|NA|1970-10-16
TRIAL STUDY 134XCP|LB|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|2||||SECRETIN|SECRETIN|||||||10^7 TCID 50/DOSE|||||||INDETERMINATE||10^6/G||||LOW|NOT DONE||||MONOCYTE|AUTOLYZED|Y|POLYGRAPHY|FIBROTEST FORMULA||NA|NA|NA|NA|||U|4||88||BASELINE|1964-10-27|1963-06-20|||||1965-08-17||1970-02-14|NA|1964-03-13
TRIAL STUDY 134XCP|LB|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|1||||LTE4|LEUKOTRIENE E4|||||||PFU/ML|||||||TRACE||G/KG/DAY||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|AUTOLYZED|N|OPTICAL COHERENCE TOMOGRAPHY|CKD-EPI CREATININE FORMULA||Y|U|NA|N|||U|5||7||BLINDED TREATMENT|1961-06-30|1973-01-26|||||1963-05-17||1972-07-11|N|1966-05-21
TRIAL STUDY 134XCP|LB|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|2||||SPERM|SPERMATOZOA|||||||POINT|||||||BORDERLINE||MV*MIN||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|U|QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROSIS 4 FORMULA||NA|NA|NA|NA|||N|5||7||BASELINE|1971-06-13|1969-07-12|||||1972-11-20||1966-05-16|NA|1971-01-23
TRIAL STUDY 134XCP|LB|25E17A89-8A2F-4870-B076-1D32634F5620|1||||HRYCELE|HAIRY CELLS/LEUKOCYTES|||||||KIT|||||||POSITIVE||CM/S||||HIGH|NOT DONE||||SYNOVIAL FLUID|NON-HEMOLYZED|Y|FLUOROSCOPY|FIBROSIS 4 FORMULA||U|NA|NA|U|||U|1||38||SCREENING|1961-12-11|1963-03-31|||||1961-11-26||1967-03-08|Y|1972-03-01
TRIAL STUDY 134XCP|LB|25E17A89-8A2F-4870-B076-1D32634F5620|2||||PNCTPP|PANCREATIC POLYPEPTIDE|||||||CMH2O*S2/ML|||||||NEGATIVE||IU||||ABNORMAL|NOT DONE||||REFLEX TEAR|REFRIGERATED|Y|SPECT/CT SCAN|FIBROTEST FORMULA||NA|Y|U|Y|||N|1||38||OPEN LABEL TREATMENT|1961-04-25|1965-08-14|||||1967-03-11||1963-08-13|U|1965-02-27
TRIAL STUDY 134XCP|LB|25E17A89-8A2F-4870-B076-1D32634F5620|1||||HALPRZLM|HYDROXYALPRAZOLAM|||||||IU/G HB|||||||TRACE||10^9 ORGANISMS/G||||HIGH|NOT DONE||||SPUTUM|HEMOLYZED|U|NEURAMINIDASE INHIBITION ASSAY|MDRD 4 VARIABLE FORMULA||Y|Y|Y|NA|||N|2||58||SCREENING|1960-03-22|1967-06-11|||||1968-04-16||1964-05-25|N|1964-07-16
TRIAL STUDY 134XCP|LB|25E17A89-8A2F-4870-B076-1D32634F5620|2||||NORMBASO|BASOPHILIC NORMOBLAST|||||||BQ/MG|||||||TRACE||U/G HB||||NORMAL|NOT DONE||||REFLEX TEAR|AGGLUTINATED|U|FLAME PHOTOMETRY|FIBROMETER FORMULA||U|NA|N|Y|||Y|2||58||BASELINE|1962-11-24|1971-01-07|||||1960-08-18||1973-02-24|N|1973-06-08
TRIAL STUDY 134XCP|LB|25E17A89-8A2F-4870-B076-1D32634F5620|1||||S100B|S100 CALCIUM-BINDING PROTEIN B|||||||%/MIN|||||||POSITIVE||V/V||||ABNORMAL|NOT DONE||||SALIVA|THAWED|U|U-HPLC/MS/MS|CKD-EPI CREATININE FORMULA||N|N|U|U|||NA|3||39||CONTINUATION TREATMENT|1973-01-15|1966-01-08|||||1967-05-24||1965-07-21|NA|1969-08-30
TRIAL STUDY 134XCP|LB|25E17A89-8A2F-4870-B076-1D32634F5620|2||||ETPAUC|ETP AREA UNDER CURVE|||||||G/DAY|||||||BORDERLINE||MG/G/H||||HIGH|NOT DONE||||EPITHELIAL CELL|FRESH|U|CLIP SEQUENCING|MDRD 5 VARIABLE FORMULA||NA|N|U|U|||U|3||39||RUN-IN|1970-12-12|1969-03-21|||||1973-04-04||1960-01-25|N|1966-05-30
TRIAL STUDY 134XCP|LB|25E17A89-8A2F-4870-B076-1D32634F5620|1||||DOHLE|DOHLE BODIES|||||||NCI|||||||INDETERMINATE||MG/ANIMAL||||LOW|NOT DONE||||VENOUS BLOOD|HEMOLYZED|Y|IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CYSTATIN C FORMULA||U|N|Y|Y|||U|4||88||BASELINE|1960-04-23|1973-02-14|||||1972-03-24||1968-08-29|NA|1964-04-06
TRIAL STUDY 134XCP|LB|25E17A89-8A2F-4870-B076-1D32634F5620|2||||PHE|PHENYLALANINE|||||||PA|||||||INDETERMINATE||IN2||||NORMAL|NOT DONE||||EXUDATE|CLOTTED|U|TRICHROME STAIN|GMI MMOL/MOL FORMULA||N|NA|Y|NA|||N|4||88||TREATMENT|1972-12-23|1972-12-26|||||1960-01-30||1973-08-05|NA|1963-05-20
TRIAL STUDY 134XCP|LB|25E17A89-8A2F-4870-B076-1D32634F5620|1||||IGGCALBC|IGG CLEARANCE/ALBUMIN CLEARANCE|||||||FT2|||||||TRACE||COULOMB||||NORMAL|NOT DONE||||AQUEOUS HUMOR|AUTOLYZED|NA|URANYL ACETATE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|U|Y|||N|5||7||WASHOUT|1970-06-24|1966-08-25|||||1969-04-16||1962-04-02|Y|1971-12-11
TRIAL STUDY 134XCP|LB|25E17A89-8A2F-4870-B076-1D32634F5620|2||||PLG|PLASMINOGEN|||||||L/MIN|||||||NEGATIVE||10^9/DOSE||||NORMAL|NOT DONE||||SERUM|CONTAMINATED|U|SLIT LAMP|ASH FIBROSURE FORMULA||U|Y|U|Y|||U|5||7||BASELINE|1966-05-09|1969-05-07|||||1971-08-29||1965-05-08|N|1970-09-03
TRIAL STUDY 134XCP|LB|B7B67C06-0802-4E69-A5A1-469213BE7E48|1||||B2G1GMAB|BETA-2 GLYCOPROTEIN 1 IGM ANTIBODY|||||||ML/100G/MIN|||||||POSITIVE||COULOMB||||LOW|NOT DONE||||MUCUS|DRIED|NA|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|NA|NA|||N|1||38||TREATMENT|1960-11-01|1969-12-24|||||1970-05-21||1967-12-02|NA|1960-02-12
TRIAL STUDY 134XCP|LB|B7B67C06-0802-4E69-A5A1-469213BE7E48|2||||INHIBINA|INHIBIN A|||||||ML/S|||||||POSITIVE||PFU||||NORMAL|NOT DONE||||BUFFY COAT|FRESH|N|CYSTOMETRY|CKD-EPI CREATININE FORMULA||NA|Y|N|Y|||Y|1||38||TREATMENT|1960-07-10|1964-02-13|||||1964-02-27||1969-12-24|Y|1971-04-10
TRIAL STUDY 134XCP|LB|B7B67C06-0802-4E69-A5A1-469213BE7E48|1||||C165928|INDUSTRIAL MIX IGE AB RAST SCORE|||||||GAUSS|||||||TRACE||ML/KG/MIN||||LOW|NOT DONE||||AQUEOUS HUMOR|SOLIDIFIED|N|FLAME PHOTOMETRY|CKD-EPI CREATININE FORMULA||NA|U|U|U|||N|2||58||BASELINE|1964-05-10|1971-10-12|||||1973-05-14||1968-12-25|U|1970-12-14
TRIAL STUDY 134XCP|LB|B7B67C06-0802-4E69-A5A1-469213BE7E48|2||||CHDWR|RET CORPUSCULAR HGB CONC DISTR WIDTH|||||||MG/KG/H|||||||INDETERMINATE||UG/H||||HIGH|NOT DONE||||ADIPOSE TISSUE|FRESH|U|LIGHT SCATTERING SPECTROSCOPY|MDRD FORMULA||N|N|Y|N|||Y|2||58||OBSERVATION|1973-05-12|1966-11-09|||||1962-10-23||1966-06-19|U|1971-10-08
TRIAL STUDY 134XCP|LB|B7B67C06-0802-4E69-A5A1-469213BE7E48|1||||VLDL|VLDL CHOLESTEROL|||||||M3|||||||POSITIVE||HENRY||||LOW|NOT DONE||||CAPILLARY PLASMA|AUTOLYZED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|FIBROSIS 4 FORMULA||NA|NA|U|NA|||N|3||39||INDUCTION TREATMENT|1963-08-29|1970-12-24|||||1963-03-17||1972-12-11|U|1970-08-02
TRIAL STUDY 134XCP|LB|B7B67C06-0802-4E69-A5A1-469213BE7E48|2||||ADMA|ASYMMETRIC DIMETHYLARGININE|||||||UGEQ/L|||||||BORDERLINE||10^6 DNA COPIES/ML||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|ROOM TEMPERATURE|Y|ANGIOGRAPHY|CKD-EPI CREATININE FORMULA||Y|Y|U|U|||U|3||39||LONG-TERM FOLLOW-UP|1972-01-10|1964-10-22|||||1972-10-07||1968-09-30|NA|1961-10-02
TRIAL STUDY 134XCP|LB|B7B67C06-0802-4E69-A5A1-469213BE7E48|1||||PGF2A|PROSTAGLANDIN F2 ALPHA|||||||TESLA|||||||INVALID||STEPS||||NORMAL|NOT DONE||||EMOTIONAL TEAR|FROZEN|U|CELLULOSE TAPE|FIBROMETER FORMULA||N|U|NA|U|||N|4||88||INDUCTION TREATMENT|1968-03-06|1966-12-12|||||1962-05-22||1965-02-10|U|1964-12-04
TRIAL STUDY 134XCP|LB|B7B67C06-0802-4E69-A5A1-469213BE7E48|2||||B2GLYAB|BETA-2 GLYCOPROTEIN ANTIBODY|||||||USIEMENS|||||||TRACE||C||||LOW|NOT DONE||||PLATELET|HEMOLYZED|U|FLOW MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|U|N|||Y|4||88||TREATMENT|1971-04-11|1960-04-08|||||1960-10-14||1969-05-31|N|1960-04-07
TRIAL STUDY 134XCP|LB|B7B67C06-0802-4E69-A5A1-469213BE7E48|1||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||ML/H|||||||TRACE||FOZ_BR||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|LACTESCENT|Y|CELLULOSE TAPE|FIBROMETER FORMULA||Y|NA|NA|Y|||Y|5||7||TREATMENT|1967-08-13|1972-01-25|||||1965-08-31||1969-04-24|NA|1961-09-03
TRIAL STUDY 134XCP|LB|B7B67C06-0802-4E69-A5A1-469213BE7E48|2||||HCGNDI|CHORIOGONADOTROPIN, INTACT|||||||HEP|||||||INVALID||MG/KG||||ABNORMAL|NOT DONE||||STOOL|REFRIGERATED|U|REVERSE TRANSCRIPTASE PCR|NASH FIBROSURE FORMULA||N|Y|N|N|||N|5||7||TREATMENT|1961-02-12|1964-08-27|||||1961-09-23||1972-06-11|N|1962-01-15
TRIAL STUDY 134XCP|LB|626E3EA7-423B-434F-89E4-CA076A39B8DB|1||||CEIMCE|IMMATURE CELLS/TOTAL CELLS|||||||BREATHS/MIN|||||||BORDERLINE||UEQ/L||||NORMAL|NOT DONE||||VENOUS PLASMA|UNEXPECTED ODOR|NA|PET/CT SCAN|MDRD 5 VARIABLE FORMULA||N|Y|U|NA|||Y|1||38||OPEN LABEL TREATMENT|1968-11-18|1969-06-20|||||1963-10-01||1960-12-21|U|1971-12-06
TRIAL STUDY 134XCP|LB|626E3EA7-423B-434F-89E4-CA076A39B8DB|2||||WBCMORPH|LEUKOCYTE CELL MORPHOLOGY|||||||TRANSDUCING UNIT|||||||NEGATIVE||MCI||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|LIPEMIC|NA|GC/MS-CI|HEPASCORE FORMULA||NA|NA|NA|U|||NA|1||38||CONTINUATION TREATMENT|1961-05-30|1971-01-08|||||1971-04-18||1973-04-21|NA|1971-09-06
TRIAL STUDY 134XCP|LB|626E3EA7-423B-434F-89E4-CA076A39B8DB|1||||TPROTP|PHOSPHORYLATED TAU PROTEIN|||||||UGEQ|||||||POSITIVE||LOG10 ELISA UNIT/DOSE||||NORMAL|NOT DONE||||ALVEOLAR AIR|CONCENTRATED|Y|MALDI-TOF|FIBROTEST FORMULA||U|U|Y|NA|||N|2||58||FOLLOW-UP|1961-06-30|1972-11-13|||||1972-02-21||1965-11-30|U|1968-07-07
TRIAL STUDY 134XCP|LB|626E3EA7-423B-434F-89E4-CA076A39B8DB|2||||LYMLE|LYMPHOCYTES/LEUKOCYTES|||||||SCM|||||||NEGATIVE||/KG||||LOW|NOT DONE||||BONE MARROW|SOLIDIFIED|NA|AURAMINE STAIN|MDRD 5 VARIABLE FORMULA||NA|NA|NA|NA|||U|2||58||LONG-TERM FOLLOW-UP|1971-09-22|1961-09-23|||||1960-05-06||1961-04-10|U|1963-08-01
TRIAL STUDY 134XCP|LB|626E3EA7-423B-434F-89E4-CA076A39B8DB|1||||BLEEDT|BLEEDING TIME|||||||MEQ|||||||INDETERMINATE||CFU/ML||||HIGH|NOT DONE||||INTERSTITIAL FLUID|REFRIGERATED|U|FUNCTIONAL MRI|HEPASCORE FORMULA||U|NA|N|N|||N|3||39||OPEN LABEL TREATMENT|1965-12-28|1973-08-16|||||1966-01-14||1969-06-13|Y|1967-09-12
TRIAL STUDY 134XCP|LB|626E3EA7-423B-434F-89E4-CA076A39B8DB|2||||APOC2|APOLIPOPROTEIN C2|||||||ML/MIN|||||||INDETERMINATE||10^3 ORGANISMS/ML||||LOW|NOT DONE||||PLEURAL TISSUE|SOLIDIFIED|NA|TRANSVAGINAL ULTRASOUND|COCKCROFT-GAULT FORMULA||Y|U|NA|Y|||NA|3||39||OPEN LABEL TREATMENT|1964-09-15|1970-09-30|||||1972-09-05||1972-12-21|NA|1966-11-27
TRIAL STUDY 134XCP|LB|626E3EA7-423B-434F-89E4-CA076A39B8DB|1||||VITB7|VITAMIN B7|||||||MOL/ML|||||||INDETERMINATE||PL||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|REFRIGERATED|U|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 6 VARIABLE FORMULA||N|N|U|N|||U|4||88||FOLLOW-UP|1960-04-14|1967-08-14|||||1967-09-26||1966-07-15|Y|1965-02-16
TRIAL STUDY 134XCP|LB|626E3EA7-423B-434F-89E4-CA076A39B8DB|2||||CSEPIRT|RENAL TUBULAR EPITHELIAL CASTS|||||||PM|||||||NEGATIVE||PMOL/10^9 CELLS||||HIGH|NOT DONE||||BILE|AUTOLYZED|N|SURFACE PLASMON RESONANCE|CKD-EPI FORMULA||Y|N|U|Y|||Y|4||88||OBSERVATION|1968-02-28|1962-05-02|||||1963-06-15||1964-01-12|NA|1966-05-19
TRIAL STUDY 134XCP|LB|626E3EA7-423B-434F-89E4-CA076A39B8DB|1||||FABP3|FATTY ACID BINDING PROTEIN 3|||||||MOL/G|||||||INVALID||MIN/DAY||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|DRIED|U|DOPPLER ULTRASOUND|GMI MMOL/MOL FORMULA||U|NA|Y|Y|||U|5||7||SCREENING|1972-06-20|1966-04-15|||||1971-02-19||1969-11-21|U|1960-01-19
TRIAL STUDY 134XCP|LB|626E3EA7-423B-434F-89E4-CA076A39B8DB|2||||CRYOGLBN|CRYOGLOBULIN|||||||K|||||||POSITIVE||/4.0 ML||||HIGH|NOT DONE||||COLOSTRUM|GELLED|N|URANYL ACETATE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|U|N|||U|5||7||SCREENING|1960-04-27|1964-09-05|||||1965-07-06||1964-12-12|Y|1963-08-30
TRIAL STUDY 134XCP|LB|98ED3A38-1E74-470E-BF45-0D1E905BEF36|1||||GCHT|GLYCOCHOLATE|||||||MEQ/L|||||||TRACE||L/H||||ABNORMAL|NOT DONE||||STOOL|NON-HEMOLYZED|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD 6 VARIABLE FORMULA||Y|Y|NA|NA|||NA|1||38||BLINDED TREATMENT|1965-11-26|1968-08-22|||||1967-10-15||1964-02-19|U|1963-05-08
TRIAL STUDY 134XCP|LB|98ED3A38-1E74-470E-BF45-0D1E905BEF36|2||||HLAIIAB|HLA CLASS II ANTIBODY|||||||10^6/L|||||||BORDERLINE||NKAT/L||||HIGH|NOT DONE||||BUFFY COAT|AGGLUTINATED|NA|DYNAMIC CONTRAST ENHANCED MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|N|N|||NA|1||38||OBSERVATION|1968-10-19|1965-09-04|||||1971-10-04||1967-02-19|NA|1971-12-02
TRIAL STUDY 134XCP|LB|98ED3A38-1E74-470E-BF45-0D1E905BEF36|1||||PROTSFR|PROTEIN S, FREE|||||||KN/CM2|||||||BORDERLINE||NGEQ/L||||ABNORMAL|NOT DONE||||PLASMA|REFRIGERATED|N|PET/MRI SCAN|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|Y|U|||Y|2||58||FOLLOW-UP|1967-09-19|1970-03-13|||||1972-09-28||1968-03-03|N|1967-06-13
TRIAL STUDY 134XCP|LB|98ED3A38-1E74-470E-BF45-0D1E905BEF36|2||||EPINSQCE|NON-SQUAMOUS EPITHELIAL CELLS|||||||L/DAY|||||||INDETERMINATE||IU/L||||LOW|NOT DONE||||AMNIOTIC FLUID|FRESH|Y|OBSERVATION|MDRD ENZYMATIC JAPANESE FORMULA||U|N|NA|NA|||NA|2||58||SCREENING|1965-05-08|1966-01-07|||||1966-06-28||1973-03-11|N|1963-07-09
TRIAL STUDY 134XCP|LB|98ED3A38-1E74-470E-BF45-0D1E905BEF36|1||||GRANBCE|GRANULOCYTES BAND FORM/TOTAL CELLS|||||||U/ANIMAL|||||||INDETERMINATE||PACKET||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|CLOTTED|Y|LANDOLT RING|FIBROSIS 4 FORMULA||U|NA|N|Y|||N|3||39||SCREENING|1965-01-30|1965-03-20|||||1972-08-25||1963-04-24|N|1972-09-10
TRIAL STUDY 134XCP|LB|98ED3A38-1E74-470E-BF45-0D1E905BEF36|2||||DCA|DEOXYCHOLATE|||||||EP U|||||||POSITIVE||CUP||||LOW|NOT DONE||||RETICULOCYTES|GELLED|NA|ENZYMATIC ULTRACENTRIFUGATION|FIBROSIS 4 FORMULA||NA|Y|U|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1963-07-18|1963-01-04|||||1962-07-06||1961-09-22|Y|1964-09-13
TRIAL STUDY 134XCP|LB|98ED3A38-1E74-470E-BF45-0D1E905BEF36|1||||TUDCA|TAUROURSODEOXYCHOLATE|||||||UCI|||||||POSITIVE||ML/M2/H||||LOW|NOT DONE||||EPITHELIAL CELL|CONCENTRATED|Y|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA||U|NA|NA|N|||N|4||88||TREATMENT|1961-10-11|1968-01-05|||||1961-04-03||1964-08-20|N|1968-08-16
TRIAL STUDY 134XCP|LB|98ED3A38-1E74-470E-BF45-0D1E905BEF36|2||||METHPHEN|METHYLPHENIDATE|||||||L/S|||||||NEGATIVE||UG/M2||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|LACTESCENT|N|JAFFE REACTION|CKD-EPI CREATININE FORMULA||NA|Y|U|NA|||U|4||88||BASELINE|1967-04-03|1966-01-15|||||1962-11-13||1970-05-07|U|1968-09-04
TRIAL STUDY 134XCP|LB|98ED3A38-1E74-470E-BF45-0D1E905BEF36|1||||C130075|BIRCH POLLEN IGG4|||||||UG/ANIMAL|||||||INDETERMINATE||% INHIBITION||||LOW|NOT DONE||||CORD BLOOD|FRESH|U|TEST STRIP|NASH FIBROSURE FORMULA||Y|Y|NA|NA|||NA|5||7||CONTINUATION TREATMENT|1961-02-01|1962-07-23|||||1965-04-15||1963-06-18|Y|1962-10-20
TRIAL STUDY 134XCP|LB|98ED3A38-1E74-470E-BF45-0D1E905BEF36|2||||MLATONIN|MELATONIN|||||||BEL|||||||POSITIVE||LOG10 COPIES/ML||||ABNORMAL|NOT DONE||||COLOSTRUM|NON-HEMOLYZED|Y|MALDI-TOF|ASH FIBROSURE FORMULA||N|U|N|NA|||N|5||7||TREATMENT|1967-05-19|1967-06-20|||||1963-09-24||1963-09-02|N|1964-07-25
TRIAL STUDY 134XCP|LB|99DF7819-987E-4E55-89FD-FF49E7C02A5A|1||||PROT|PROTEIN|||||||KPA/L/SEC|||||||BORDERLINE||ML/BREATH||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|AUTOLYZED|N|EPSILOMETER|HEPASCORE FORMULA||U|U|N|NA|||Y|1||38||BLINDED TREATMENT|1960-09-15|1973-01-09|||||1961-01-17||1961-02-14|NA|1973-02-19
TRIAL STUDY 134XCP|LB|99DF7819-987E-4E55-89FD-FF49E7C02A5A|2||||CYSTARCH|STARCH CRYSTALS|||||||L/MIN/M2|||||||POSITIVE||ML/BEAT||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|HEMOLYZED|N|SXA SCAN|FIBROTEST FORMULA||Y|N|U|U|||NA|1||38||LONG-TERM FOLLOW-UP|1973-01-29|1964-01-22|||||1970-02-13||1960-12-09|Y|1963-03-10
TRIAL STUDY 134XCP|LB|99DF7819-987E-4E55-89FD-FF49E7C02A5A|1||||CARNITF|CARNITINE, FREE|||||||10^7 TCID 50/DOSE|||||||INVALID||LOZENGE||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|LIPEMIC|Y|SISH|GMI % FORMULA||NA|Y|U|Y|||NA|2||58||OBSERVATION|1968-12-12|1962-03-22|||||1969-06-20||1970-11-14|NA|1962-12-21
TRIAL STUDY 134XCP|LB|99DF7819-987E-4E55-89FD-FF49E7C02A5A|2||||CEMORPH|CELL MORPHOLOGY|||||||UM|||||||INVALID||UG/DL||||NORMAL|NOT DONE||||LUNG SURFACTANT|HEMOLYZED|NA|SPIRAL CT|MDRD 4 VARIABLE FORMULA||N|Y|Y|NA|||Y|2||58||WASHOUT|1967-05-19|1966-11-02|||||1968-01-08||1969-04-22|U|1968-08-12
TRIAL STUDY 134XCP|LB|99DF7819-987E-4E55-89FD-FF49E7C02A5A|1||||ALPLS|LIVER SPECIFIC ALKALINE PHOSPHATASE|||||||10^6 RNA COPIES/ML|||||||BORDERLINE||FMOL/G||||NORMAL|NOT DONE||||PERSPIRATION|CONTAMINATED|NA|TOLUIDINE BLUE STAIN|FIBROSIS 4 FORMULA||N|NA|N|Y|||N|3||39||SCREENING|1967-09-27|1963-10-15|||||1964-05-15||1962-12-17|NA|1969-06-07
TRIAL STUDY 134XCP|LB|99DF7819-987E-4E55-89FD-FF49E7C02A5A|2||||FACTXA|FACTOR X ACTIVITY|||||||AG|||||||POSITIVE||G/KG||||LOW|NOT DONE||||BASAL TEAR|CONTAMINATED|U|MICROSCOPY|GMI MMOL/MOL FORMULA||N|NA|N|U|||U|3||39||RUN-IN|1969-05-28|1960-03-18|||||1969-12-08||1968-02-01|NA|1971-11-17
TRIAL STUDY 134XCP|LB|99DF7819-987E-4E55-89FD-FF49E7C02A5A|1||||EOSMM|EOSINOPHILIC METAMYELOCYTES|||||||SIEMENS|||||||NEGATIVE||L/S||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|REFRIGERATED|NA|ELECTRONEUROGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|NA|Y|||NA|4||88||TREATMENT|1969-08-29|1965-02-15|||||1961-05-31||1968-10-11|NA|1972-03-27
TRIAL STUDY 134XCP|LB|99DF7819-987E-4E55-89FD-FF49E7C02A5A|2||||FAI|FREE ANDROGEN INDEX|||||||ML/DL|||||||POSITIVE||CMH2O*S/ML||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED|NA|ELECTRICAL IMPEDANCE MYOGRAPHY|ASH FIBROSURE FORMULA||NA|N|NA|N|||N|4||88||SCREENING|1964-11-27|1971-04-26|||||1965-10-03||1963-02-26|Y|1960-09-28
TRIAL STUDY 134XCP|LB|99DF7819-987E-4E55-89FD-FF49E7C02A5A|1||||TNF10|TNF SUPERFAMILY MEMBER 10|||||||KBQ|||||||NEGATIVE||10^3 ORGANISMS/G||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|PARAFFIN-EMBEDDED|N|LYMPHANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|NA|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1968-02-28|1972-05-06|||||1969-11-19||1972-03-04|U|1969-08-09
TRIAL STUDY 134XCP|LB|99DF7819-987E-4E55-89FD-FF49E7C02A5A|2||||ESTRONE|ESTRONE|||||||MG/CM2|||||||NEGATIVE||MSEC||||HIGH|NOT DONE||||REFLEX TEAR|HEMOLYZED|U|IMMUNOCHEMILUMINOMETRIC ASSAY|ASH FIBROSURE FORMULA||NA|Y|Y|Y|||U|5||7||OPEN LABEL TREATMENT|1966-11-08|1971-08-01|||||1961-07-25||1969-06-08|NA|1973-08-06
TRIAL STUDY 134XCP|LB|05481BE7-9309-4356-B46E-9C2525D2C54E|1||||BALA|BETA ALANINE|||||||L/L|||||||POSITIVE||IU/DAY||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH|U|WESTERN BLOT|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|N|U|||Y|1||38||WASHOUT|1969-12-27|1972-07-07|||||1962-05-18||1966-04-10|U|1969-08-27
TRIAL STUDY 134XCP|LB|05481BE7-9309-4356-B46E-9C2525D2C54E|2||||CXCL12|CHEMOKINE (C-X-C MOTIF) LIGAND 12|||||||GY/H|||||||NEGATIVE||/MM2||||LOW|NOT DONE||||MECONIUM|AGGLUTINATED|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|CKD-EPI FORMULA||U|N|NA|Y|||N|1||38||OBSERVATION|1966-02-04|1964-04-17|||||1971-09-12||1967-01-31|N|1960-02-05
TRIAL STUDY 134XCP|LB|05481BE7-9309-4356-B46E-9C2525D2C54E|1||||CD56|CD56|||||||BLOCKS|||||||INDETERMINATE||CL||||NORMAL|NOT DONE||||GASTRIC FLUID|CONTAMINATED|Y|ELECTROGASTROGRAPHY|CKD-EPI FORMULA||U|U|N|U|||U|2||58||OPEN LABEL TREATMENT|1962-09-29|1964-07-14|||||1960-03-21||1965-05-27|N|1964-11-18
TRIAL STUDY 134XCP|LB|05481BE7-9309-4356-B46E-9C2525D2C54E|2||||TROPONT|TROPONIN T|||||||NMOL/DAY|||||||INVALID||L/KG||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|DRIED|U|PET/MRI SCAN|MDRD 6 VARIABLE FORMULA||U|U|N|N|||Y|2||58||RUN-IN|1961-09-28|1968-01-30|||||1967-08-02||1964-08-29|Y|1960-04-16
TRIAL STUDY 134XCP|LB|05481BE7-9309-4356-B46E-9C2525D2C54E|1||||AZURGRAN|AZUROPHILIC GRANULES|||||||EVENTS|||||||BORDERLINE||KG/L||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|THAWED|U|LYMPHANGIOGRAPHY|COCKCROFT-GAULT FORMULA||Y|N|NA|N|||U|3||39||OBSERVATION|1965-12-30|1965-10-13|||||1972-11-07||1967-09-26|N|1966-08-16
TRIAL STUDY 134XCP|LB|05481BE7-9309-4356-B46E-9C2525D2C54E|2||||C165927|ANIMAL MIX IGE AB RAST SCORE|||||||ML/KG/H|||||||INVALID||ABSORBANCE U/ML||||NORMAL|NOT DONE||||DERMAL TISSUE|UNEXPECTED ODOR|NA|CALCOFLUOR WHITE STAIN|GMI MMOL/MOL FORMULA||NA|U|U|Y|||N|3||39||RUN-IN|1967-04-26|1960-04-06|||||1968-05-17||1970-10-25|NA|1964-07-21
TRIAL STUDY 134XCP|LB|05481BE7-9309-4356-B46E-9C2525D2C54E|1||||NEUTTOXC|NEUTROPHILIC TOXIC CHANGE|||||||HEP|||||||INDETERMINATE||TAMPON||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|GELLED|U|THIN SMEAR|MDRD 4 VARIABLE FORMULA||NA|N|Y|N|||N|4||88||BLINDED TREATMENT|1963-06-07|1962-03-07|||||1965-07-27||1969-07-13|N|1964-04-02
TRIAL STUDY 134XCP|LB|05481BE7-9309-4356-B46E-9C2525D2C54E|2||||COCAM|COCAINE METABOLITES|||||||GMFI|||||||INDETERMINATE||HENRY||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|FROZEN|Y|IMMUNOASSAY|HEPASCORE FORMULA||N|U|NA|NA|||N|4||88||RUN-IN|1969-03-02|1963-10-20|||||1965-12-19||1960-06-11|N|1968-12-15
TRIAL STUDY 134XCP|LB|05481BE7-9309-4356-B46E-9C2525D2C54E|1||||A1MICG|ALPHA-1 MICROGLOBULIN|||||||M2|||||||INDETERMINATE||MG||||NORMAL|NOT DONE||||SERUM|PARAFFIN-EMBEDDED|U|MANUAL CLOT DETECTION|GMI % FORMULA||Y|Y|NA|Y|||Y|5||7||SCREENING|1971-06-13|1967-07-11|||||1967-10-08||1963-01-10|N|1970-05-21
TRIAL STUDY 134XCP|LB|05481BE7-9309-4356-B46E-9C2525D2C54E|2||||HIS|HISTIDINE|||||||MM3/MM2/YEAR|||||||INVALID||10^7 PFU||||NORMAL|NOT DONE||||KERATINOCYTE|LIPEMIC|NA|SPIROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|U|U|||Y|5||7||RUN-IN|1967-02-20|1971-09-19|||||1970-11-14||1960-02-24|N|1971-06-09
TRIAL STUDY 134XCP|LB|2F49D512-0A23-4D2D-959B-A1756991E817|1||||MCPHNSQE|MACROPHAGES/NON-SQUAM EPI CELLS|||||||DNA COPIES/UG|||||||INDETERMINATE||L/H/M2||||LOW|NOT DONE||||SEBUM|UNEXPECTED ODOR|U|CARDIAC THERMODILUTION|ASH FIBROSURE FORMULA||NA|U|N|Y|||U|1||38||RUN-IN|1969-10-31|1967-03-02|||||1972-06-13||1965-05-28|N|1969-01-10
TRIAL STUDY 134XCP|LB|2F49D512-0A23-4D2D-959B-A1756991E817|2||||RBCNUC|NUCLEATED ERYTHROCYTES|||||||SEC|||||||BORDERLINE||GPS U||||HIGH|NOT DONE||||EPITHELIAL CELL|FROZEN|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|HEPASCORE FORMULA||N|Y|Y|N|||Y|1||38||LONG-TERM FOLLOW-UP|1965-10-12|1972-06-13|||||1965-09-04||1961-10-09|NA|1969-02-25
TRIAL STUDY 134XCP|LB|2F49D512-0A23-4D2D-959B-A1756991E817|1||||SVCAM1|SOLUBLE VASC CELL ADHESION MOLECULE 1|||||||M|||||||NEGATIVE||HZ||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CLOTTED|Y|TONOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|U|NA|||N|2||58||WASHOUT|1960-05-10|1971-02-01|||||1961-11-03||1970-12-21|Y|1973-06-04
TRIAL STUDY 134XCP|LB|2F49D512-0A23-4D2D-959B-A1756991E817|2||||A1ANTRYP|ALPHA-1 ANTITRYPSIN|||||||EID 50/ML|||||||INDETERMINATE||ML/M2||||NORMAL|NOT DONE||||GASTRIC FLUID|ROOM TEMPERATURE|N|FLOCCULATION, CHARCOAL ENHANCED|MDRD ENZYMATIC FORMULA||Y|N|Y|N|||NA|2||58||LONG-TERM FOLLOW-UP|1965-05-13|1961-01-29|||||1967-12-05||1964-03-09|Y|1965-07-20
TRIAL STUDY 134XCP|LB|2F49D512-0A23-4D2D-959B-A1756991E817|1||||IOHEXCLR|IOHEXOL CLEARANCE|||||||GAUSS|||||||POSITIVE||DEG||||HIGH|NOT DONE||||LUNG SURFACTANT|GELLED|Y|OPTICAL COHERENCE TOMOGRAPHY|NASH FIBROSURE FORMULA||U|Y|NA|Y|||Y|3||39||CONTINUATION TREATMENT|1963-03-04|1960-04-19|||||1968-02-25||1962-12-05|Y|1964-07-10
TRIAL STUDY 134XCP|LB|2F49D512-0A23-4D2D-959B-A1756991E817|2||||TRP1TRG1|TRYPSIN 1 AND TRYPSINOGEN 1|||||||U/M2/MIN|||||||TRACE||10^3 ORGANISMS/G||||NORMAL|NOT DONE||||BLOOD|FRESH|NA|STRESS ECHOCARDIOGRAPHY|FIBROMETER FORMULA||Y|N|Y|Y|||N|3||39||LONG-TERM FOLLOW-UP|1962-02-08|1963-10-09|||||1963-09-18||1960-06-06|U|1968-11-12
TRIAL STUDY 134XCP|LB|2F49D512-0A23-4D2D-959B-A1756991E817|1||||HRYCECE|HAIRY CELLS/TOTAL CELLS|||||||AFU|||||||INVALID||MG2/DL2||||LOW|NOT DONE||||CORD BLOOD|CONCENTRATED|U|RAJI CELL RIA|CKD-EPI FORMULA||Y|Y|N|N|||N|4||88||CONTINUATION TREATMENT|1967-04-10|1966-07-24|||||1968-04-24||1971-11-11|U|1962-04-15
TRIAL STUDY 134XCP|LB|2F49D512-0A23-4D2D-959B-A1756991E817|2||||GFRBSCU|GFR FROM CREAT AND UREAN ADJ BSA|||||||/10^3|||||||INDETERMINATE||PMOL/G||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|CONTAMINATED|Y|RADIAL IMMUNODIFFUSION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|U|NA|||NA|4||88||CONTINUATION TREATMENT|1972-08-08|1961-03-09|||||1972-08-15||1970-11-27|NA|1969-04-23
TRIAL STUDY 134XCP|LB|2F49D512-0A23-4D2D-959B-A1756991E817|1||||IC512AB|ISLET CELL 512 ANTIBODY|||||||UG/KG/H|||||||TRACE||U/KG/MIN||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|NON-HEMOLYZED|Y|PALPATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|NA|NA|||U|5||7||INDUCTION TREATMENT|1971-09-24|1972-04-07|||||1969-07-12||1962-03-17|U|1972-08-13
TRIAL STUDY 134XCP|LB|2F49D512-0A23-4D2D-959B-A1756991E817|2||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||FFU|||||||NEGATIVE||ML/M2||||HIGH|NOT DONE||||INTERSTITIAL FLUID|FROZEN|N|ENZYMATIC SPECTROPHOTOMETRY|NASH FIBROSURE FORMULA||U|NA|N|NA|||U|5||7||OPEN LABEL TREATMENT|1964-02-12|1966-05-23|||||1968-11-03||1966-08-19|Y|1964-10-23
TRIAL STUDY 134XCP|LB|E884C56C-1612-49CC-A594-B65E7B354842|1||||TT|THROMBIN TIME|||||||BREATHS/30S|||||||INDETERMINATE||ML/G/DAY||||NORMAL|NOT DONE||||EMOTIONAL TEAR|HEMOLYZED|N|POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||Y|Y|Y|N|||NA|1||38||RUN-IN|1964-04-01|1973-03-03|||||1969-01-23||1962-11-22|Y|1960-03-02
TRIAL STUDY 134XCP|LB|E884C56C-1612-49CC-A594-B65E7B354842|2||||KCREAT|POTASSIUM/CREATININE|||||||ROENTGEN|||||||NEGATIVE||/10^3||||ABNORMAL|NOT DONE||||GASTRIC FLUID|CALCIFIED|U|SURFACE PLASMON RESONANCE|FIBROMETER FORMULA||N|NA|U|NA|||NA|1||38||INDUCTION TREATMENT|1967-10-29|1964-11-18|||||1973-01-14||1972-03-08|Y|1966-12-01
TRIAL STUDY 134XCP|LB|E884C56C-1612-49CC-A594-B65E7B354842|1||||CD161LY|CD161/LYMPHOCYTES|||||||LOG10 CFU/G|||||||BORDERLINE||/2000 RBC||||LOW|NOT DONE||||SWABBED MATERIAL|AGGLUTINATED|U|RADIATION DOSIMETRY|GMI MMOL/MOL FORMULA||U|NA|Y|N|||Y|2||58||WASHOUT|1972-01-02|1963-03-03|||||1961-03-15||1967-11-07|NA|1972-04-08
TRIAL STUDY 134XCP|LB|E884C56C-1612-49CC-A594-B65E7B354842|2||||GLOBA1PT|ALPHA-1 GLOBULIN/TOTAL PROTEIN|||||||10^6/EJACULATE U|||||||POSITIVE||PMOL/10^10 CELLS||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|NA|ELECTROGASTROGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|NA|Y|||U|2||58||TREATMENT|1963-12-09|1971-08-01|||||1964-10-24||1970-07-05|U|1973-02-15
TRIAL STUDY 134XCP|LB|E884C56C-1612-49CC-A594-B65E7B354842|1||||LVTRCTM|LEVETIRACETAM|||||||MMHG/L/MIN|||||||POSITIVE||BOTTLE||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|LIPEMIC|U|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|Y|N|||N|3||39||OPEN LABEL TREATMENT|1961-04-12|1972-08-12|||||1967-10-27||1968-11-10|N|1966-10-10
TRIAL STUDY 134XCP|LB|E884C56C-1612-49CC-A594-B65E7B354842|2||||CD2LY|CD2/LYMPHOCYTES|||||||MG/KG/H|||||||POSITIVE||PNU/ML||||LOW|NOT DONE||||LAVAGE FLUID|THAWED|U|ELISA|COCKCROFT-GAULT FORMULA||NA|N|N|NA|||Y|3||39||SCREENING|1964-04-05|1972-07-18|||||1973-07-08||1972-06-25|Y|1966-10-20
TRIAL STUDY 134XCP|LB|E884C56C-1612-49CC-A594-B65E7B354842|1||||CAION|CALCIUM, IONIZED|||||||MMOL/DAY|||||||INVALID||PUFF||||HIGH|NOT DONE||||CORD SERUM|LIPEMIC|Y|NUCLEIC ACID AMPLIFICATION TEST|MDRD 6 VARIABLE FORMULA||U|NA|N|NA|||U|4||88||BASELINE|1973-07-22|1967-01-11|||||1970-12-25||1969-07-15|Y|1971-09-02
TRIAL STUDY 134XCP|LB|E884C56C-1612-49CC-A594-B65E7B354842|2||||TRPTRG|TRYPSIN AND TRYPSINOGEN|||||||10^6 COPIES/ML|||||||BORDERLINE||MIN||||HIGH|NOT DONE||||PLASMA|DRIED|Y|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA||N|U|Y|N|||NA|4||88||SCREENING|1966-04-23|1969-07-08|||||1968-07-09||1961-12-03|NA|1971-11-09
TRIAL STUDY 134XCP|LB|E884C56C-1612-49CC-A594-B65E7B354842|1||||TROPONIN|TROPONIN|||||||CI/UL|||||||BORDERLINE||10^8 PFU||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|HEMOLYZED|NA|MIGET|FIBROTEST FORMULA||Y|N|Y|U|||Y|5||7||OBSERVATION|1972-06-06|1966-10-06|||||1971-05-05||1968-05-19|NA|1961-10-14
TRIAL STUDY 134XCP|LB|E884C56C-1612-49CC-A594-B65E7B354842|2||||C130095|WESTERN RAGWEED POLLEN IGG4|||||||ML/M2/DAY|||||||POSITIVE||U/CL||||NORMAL|NOT DONE||||BONE|LIPEMIC|Y|ATOMIC ABSORPTION SPECTROMETRY|MDRD FORMULA||Y|N|NA|U|||NA|5||7||BASELINE|1967-12-04|1972-05-12|||||1967-10-15||1966-09-02|U|1971-10-10
TRIAL STUDY 134XCP|LB|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|1||||HYALUAC|HYALURONIC ACID|||||||KCAL/DAY|||||||INDETERMINATE||GPL U||||LOW|NOT DONE||||EXPIRED AIR|NON-HEMOLYZED|NA|INTERRUPTER TECHNIQUE|MDRD FORMULA||Y|NA|N|NA|||Y|1||38||CONTINUATION TREATMENT|1964-05-31|1960-05-31|||||1971-12-25||1971-03-22|NA|1971-11-04
TRIAL STUDY 134XCP|LB|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|2||||CYHIPPAC|HIPPURIC ACID CRYSTALS|||||||ML/KG/MIN|||||||POSITIVE||FMOL/L/SEC||||LOW|NOT DONE||||GASTRIC FLUID|AGGLUTINATED|Y|FLUORESCENT MICROSCOPY|GMI MMOL/MOL FORMULA||NA|N|U|U|||Y|1||38||INDUCTION TREATMENT|1973-08-16|1965-08-27|||||1962-10-20||1963-01-30|N|1961-12-26
TRIAL STUDY 134XCP|LB|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|1||||MSPIKEXR|MONOCLONAL PROTEIN SPIKE EXCRETION RATE|||||||/KG|||||||NEGATIVE||VG/ML||||ABNORMAL|NOT DONE||||EXUDATE|LACTESCENT|U|PET/CT SCAN WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA||NA|U|Y|Y|||NA|2||58||BLINDED TREATMENT|1963-07-09|1964-08-20|||||1968-04-07||1963-03-06|NA|1973-05-17
TRIAL STUDY 134XCP|LB|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|2||||IFI44|INTERFERON-INDUCED PROTEIN 44|||||||MEQ/DAY|||||||NEGATIVE||RPM||||LOW|NOT DONE||||URINE SEDIMENT|LACTESCENT|Y|AGAR DILUTION|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|U|||Y|2||58||TREATMENT|1969-03-26|1960-06-07|||||1962-05-02||1973-08-21|U|1963-01-27
TRIAL STUDY 134XCP|LB|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|1||||EPITUCE|TUBULAR EPITHELIAL CELLS|||||||BREATHS/30S|||||||INVALID||STEPS/MIN||||ABNORMAL|NOT DONE||||PLATELET|GELLED|NA|FARR ASSAY|GMI MMOL/MOL FORMULA||N|NA|NA|N|||U|3||39||OPEN LABEL TREATMENT|1972-02-01|1968-11-12|||||1973-01-14||1962-08-06|U|1964-10-12
TRIAL STUDY 134XCP|LB|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|2||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||GLOBULE|||||||TRACE||DAGU||||NORMAL|NOT DONE||||LAVAGE FLUID|CONCENTRATED|NA|MAPH|ASH FIBROSURE FORMULA||NA|Y|NA|U|||N|3||39||BLINDED TREATMENT|1972-12-23|1971-07-19|||||1966-01-07||1968-06-21|Y|1969-10-16
TRIAL STUDY 134XCP|LB|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|1||||PREALB|PREALBUMIN|||||||QUANTITY SUFFICIENT|||||||INVALID||UL/DOSE||||ABNORMAL|NOT DONE||||SMEGMA|CLOTTED|U|HPLC-UV|FIBROTEST FORMULA||U|Y|Y|U|||N|4||88||LONG-TERM FOLLOW-UP|1971-04-11|1965-09-26|||||1963-08-05||1964-12-12|Y|1960-12-30
TRIAL STUDY 134XCP|LB|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|2||||C130077|SILVER BIRCH POLLEN IGA|||||||COPIES/UG|||||||INVALID||L||||ABNORMAL|NOT DONE||||DERMAL TISSUE|THAWED|Y|URANYL ACETATE STAIN|MDRD ENZYMATIC FORMULA||U|Y|U|NA|||N|4||88||TREATMENT|1963-09-15|1963-08-11|||||1970-07-26||1961-07-27|N|1971-02-25
TRIAL STUDY 134XCP|LB|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|1||||A1ANTRYP|ALPHA-1 ANTITRYPSIN|||||||UL/DOSE|||||||INDETERMINATE||UL||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CONCENTRATED|U|IMMUNOFLUORESCENT STAIN|FIBROSIS 4 FORMULA||Y|N|NA|N|||Y|5||7||BLINDED TREATMENT|1972-07-05|1969-12-21|||||1965-12-01||1970-01-30|Y|1960-03-18
TRIAL STUDY 134XCP|LB|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|2||||ANABASN|ANABASINE|||||||KCAL|||||||TRACE||MS/MMHG||||LOW|NOT DONE||||FLUID|ROOM TEMPERATURE|N|INCISION-INDUCED BLEEDING METHOD|CKD-EPI CREATININE FORMULA||N|N|Y|NA|||Y|5||7||BLINDED TREATMENT|1972-05-01|1967-03-29|||||1971-03-23||1971-04-16|N|1964-10-02
TRIAL STUDY 134XCP|LB|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|1||||HBOXHGB|OXYHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||MG|||||||INVALID||PA||||ABNORMAL|NOT DONE||||ERYTHROCYTES|CONCENTRATED|Y|ICC|MDRD 6 VARIABLE FORMULA||U|U|N|N|||N|1||38||RUN-IN|1960-02-18|1964-12-03|||||1968-12-06||1960-03-08|U|1962-05-03
TRIAL STUDY 134XCP|LB|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|2||||EDMAB|ENDOMYSIAL ANTIBODY|||||||MV/SEC|||||||INDETERMINATE||10^6/HPF||||LOW|NOT DONE||||CAPILLARY BLOOD|CONCENTRATED|Y|SECONDARY ION MASS SPECTOMETRY|FIBROMETER FORMULA||U|NA|U|NA|||N|1||38||FOLLOW-UP|1967-06-19|1969-05-27|||||1961-05-03||1971-05-02|U|1971-06-30
TRIAL STUDY 134XCP|LB|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|1||||OXYCAP|OXYGEN CAPACITY|||||||MOL/ML|||||||BORDERLINE||BAR||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|GELLED|Y|RYAN BLUE STAIN|NASH FIBROSURE FORMULA||N|Y|U|U|||NA|2||58||FOLLOW-UP|1964-08-08|1967-04-11|||||1973-01-04||1960-10-04|NA|1960-03-11
TRIAL STUDY 134XCP|LB|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|2||||GFRBSCYC|GFR FROM CYSTATIN C ADJUSTED FOR BSA|||||||MONTHS|||||||BORDERLINE||M||||ABNORMAL|NOT DONE||||SOFT TISSUE|LACTESCENT|U|ELECTROMYOGRAPHY|CKD-EPI FORMULA||U|N|Y|N|||U|2||58||BLINDED TREATMENT|1968-07-14|1964-09-13|||||1969-05-21||1970-04-03|U|1962-05-30
TRIAL STUDY 134XCP|LB|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|1||||ACT|ACTIVATED COAGULATION TIME|||||||KIU|||||||INVALID||KM||||NORMAL|NOT DONE||||BLOOD|AUTOLYZED|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|GMI MMOL/MOL FORMULA||NA|N|U|U|||Y|3||39||SCREENING|1973-07-22|1961-11-12|||||1966-07-07||1964-10-08|N|1973-03-11
TRIAL STUDY 134XCP|LB|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|2||||INCLBOD|INCLUSION BODIES|||||||MMHG/L/MIN|||||||NEGATIVE||KPA||||HIGH|NOT DONE||||EPITHELIAL CELL|DRIED|U|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|HEPASCORE FORMULA||U|NA|Y|N|||Y|3||39||CONTINUATION TREATMENT|1969-05-15|1970-12-10|||||1962-04-19||1962-02-23|NA|1960-06-16
TRIAL STUDY 134XCP|LB|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|1||||PHENYTN|PHENYTOIN|||||||KIU|||||||TRACE||NEEDLE GAUGE||||LOW|NOT DONE||||SMEGMA|AGGLUTINATED|NA|URANYL ACETATE STAIN|GMI MMOL/MOL FORMULA||Y|NA|N|Y|||N|4||88||OPEN LABEL TREATMENT|1963-02-28|1973-01-20|||||1973-02-11||1969-08-22|U|1964-02-11
TRIAL STUDY 134XCP|LB|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|2||||BLAST|BLASTS|||||||MEQ/UL|||||||POSITIVE||LINEAR FT*LB||||HIGH|NOT DONE||||DIALYSIS FLUID|AGGLUTINATED|U|FLOW CYTOMETRY|MDRD 5 VARIABLE FORMULA||N|N|U|Y|||N|4||88||SCREENING|1965-11-01|1970-02-12|||||1965-05-17||1965-12-31|U|1972-06-29
TRIAL STUDY 134XCP|LB|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|1||||ACANT|ACANTHOCYTES|||||||MIN/DAY|||||||INVALID||DAGU/ML||||NORMAL|NOT DONE||||SEMINAL FLUID|CALCIFIED|N|TRIPLE-PHASE MRI SCAN|NASH FIBROSURE FORMULA||NA|U|NA|N|||NA|5||7||LONG-TERM FOLLOW-UP|1965-11-27|1961-09-18|||||1968-05-02||1969-05-04|U|1965-01-04
TRIAL STUDY 134XCP|LB|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|2||||TCHT|TAUROCHOLATE|||||||BQ|||||||INDETERMINATE||MASK||||LOW|NOT DONE||||CORD SERUM|UNEXPECTED ODOR|NA|TRANSCRIPTION-MEDIATED AMPLIFICATION|GMI MMOL/MOL FORMULA||U|NA|NA|Y|||NA|5||7||CONTINUATION TREATMENT|1968-05-22|1965-05-31|||||1961-07-30||1962-09-23|Y|1965-05-20
TRIAL STUDY 134XCP|LB|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|1||||HBHIB|HEMOGLOBIN H INCLUSION BODIES|||||||10^6/EJACULATE U|||||||INDETERMINATE||10^3 ORGANISMS/ML||||LOW|NOT DONE||||GASTRIC CONTENTS|LIPEMIC|NA|TURBIDIMETRY|MDRD 4 VARIABLE FORMULA||NA|NA|Y|NA|||N|1||38||OPEN LABEL TREATMENT|1971-03-08|1967-10-24|||||1972-12-15||1961-11-18|N|1966-05-29
TRIAL STUDY 134XCP|LB|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|2||||NICOTINE|NICOTINE|||||||10^6/EJACULATE U|||||||BORDERLINE||L/MIN||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|LIPEMIC|Y|SEQUENCING|FIBROTEST FORMULA||NA|Y|N|U|||Y|1||38||BLINDED TREATMENT|1965-10-02|1960-03-10|||||1965-08-13||1966-11-30|U|1962-01-18
TRIAL STUDY 134XCP|LB|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|1||||C130077|SILVER BIRCH POLLEN IGA|||||||H*%|||||||BORDERLINE||10^6/EJACULATE U||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED|U|PET/CT SCAN|CKD-EPI CREATININE FORMULA||U|Y|N|N|||Y|2||58||SCREENING|1963-09-10|1967-05-16|||||1960-01-25||1960-01-30|U|1972-09-02
TRIAL STUDY 134XCP|LB|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|2||||TRICH|TRICHOMONAS|||||||U/G HB|||||||BORDERLINE||DPM||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|U|HANSEL STAIN|MDRD ENZYMATIC FORMULA||N|N|Y|U|||NA|2||58||TREATMENT|1962-08-22|1972-11-17|||||1968-12-24||1971-02-24|NA|1968-01-11
TRIAL STUDY 134XCP|LB|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|1||||CARBXHGB|CARBOXYHEMOGLOBIN|||||||SQU/ML|||||||POSITIVE||BQ/UL||||HIGH|NOT DONE||||PLEURAL TISSUE|ICTERIC|Y|ROMANOWSKY STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|U|N|||Y|3||39||CONTINUATION TREATMENT|1970-12-30|1967-10-18|||||1971-01-07||1965-06-20|N|1969-04-06
TRIAL STUDY 134XCP|LB|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|2||||C130110|MOLD MIX ANTIGEN IGG ANTIBODY|||||||10^6 CFU/ML|||||||POSITIVE||MG/G/MIN||||LOW|NOT DONE||||CEREBROSPINAL FLUID|REFRIGERATED|NA|PHOTOGRAPHY|MDRD 4 VARIABLE FORMULA||N|Y|U|NA|||Y|3||39||BLINDED TREATMENT|1967-08-16|1961-01-28|||||1969-07-23||1972-04-23|N|1965-06-25
TRIAL STUDY 134XCP|LB|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|1||||DPD|DEOXYPYRIDINOLINE|||||||GPS U|||||||INVALID||ML/BEAT||||LOW|NOT DONE||||PLASMA|HEMOLYZED|Y|SNELLEN EYE CHART|MDRD ENZYMATIC FORMULA||NA|U|U|Y|||U|4||88||OPEN LABEL TREATMENT|1964-11-04|1966-04-15|||||1964-12-29||1966-08-16|Y|1965-03-26
TRIAL STUDY 134XCP|LB|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|2||||VITB3|NIACIN|||||||UL/ML|||||||TRACE||NMOL/L||||NORMAL|NOT DONE||||CELL PELLET|LIPEMIC|Y|SURFACE PLASMON RESONANCE|MDRD ENZYMATIC FORMULA||N|N|N|N|||NA|4||88||LONG-TERM FOLLOW-UP|1967-08-16|1961-09-15|||||1968-05-18||1961-03-12|Y|1960-01-03
TRIAL STUDY 134XCP|LB|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|1||||ETPAUC|ETP AREA UNDER CURVE|||||||UEQ/L|||||||INVALID||/4.0 ML||||ABNORMAL|NOT DONE||||PLASMA|HEMOLYZED|U|LYMPHANGIOGRAPHY|FIBROMETER FORMULA||N|NA|NA|NA|||U|5||7||SCREENING|1967-09-17|1961-01-25|||||1961-10-14||1966-08-18|N|1964-06-28
TRIAL STUDY 134XCP|LB|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|2||||HYPERCHR|HYPERCHROMIA|||||||PIXEL|||||||TRACE||DPM/ML||||NORMAL|NOT DONE||||ERYTHROCYTES|THAWED|Y|FARNSWORTH-MUNSELL 100 HUE TEST|GMI % FORMULA||U|U|NA|N|||NA|5||7||OBSERVATION|1965-04-28|1963-04-05|||||1963-10-19||1962-11-25|U|1961-05-28
TRIAL STUDY 134XCP|LB|0B140787-9458-4F66-B7E9-1FAFF239085E|1||||CALPRO|CALPROTECTIN|||||||BQ/UL|||||||INVALID||IMPLANT||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|NON-HEMOLYZED|NA|MICROARRAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|N|||N|1||38||OPEN LABEL TREATMENT|1960-10-27|1970-02-16|||||1960-04-26||1971-08-16|NA|1970-03-04
TRIAL STUDY 134XCP|LB|0B140787-9458-4F66-B7E9-1FAFF239085E|2||||SCHISTO|SCHISTOCYTES|||||||M/SEC2|||||||INVALID||MU/L||||HIGH|NOT DONE||||SWABBED MATERIAL|LACTESCENT|U|GC/MS|CKD-EPI CREATININE FORMULA||Y|NA|U|N|||U|1||38||BLINDED TREATMENT|1967-02-21|1964-07-05|||||1961-08-05||1960-02-17|N|1972-09-17
TRIAL STUDY 134XCP|LB|0B140787-9458-4F66-B7E9-1FAFF239085E|1||||HBBARTHB|HEMOGLOBIN BARTS/TOTAL HEMOGLOBIN|||||||ARBITRARY U|||||||BORDERLINE||UMOL/H/MMOL||||ABNORMAL|NOT DONE||||PERSPIRATION|GELLED|N|PET/SPECT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|N|N|||N|2||58||OPEN LABEL TREATMENT|1963-01-11|1965-07-27|||||1968-06-17||1966-06-30|N|1967-06-13
TRIAL STUDY 134XCP|LB|0B140787-9458-4F66-B7E9-1FAFF239085E|2||||FLNTRZPM|FLUNITRAZEPAM|||||||KIU|||||||POSITIVE||LOZENGE||||NORMAL|NOT DONE||||BASAL TEAR|UNEXPECTED ODOR|NA|CENTRIFUGATION|FIBROTEST FORMULA||U|Y|Y|Y|||NA|2||58||BLINDED TREATMENT|1969-01-26|1966-06-04|||||1961-07-12||1972-06-26|NA|1970-03-28
TRIAL STUDY 134XCP|LB|0B140787-9458-4F66-B7E9-1FAFF239085E|1||||MAYHEG|MAY-HEGGLIN ANOMALY|||||||APPLICATION|||||||BORDERLINE||CL||||LOW|NOT DONE||||EXPIRED AIR|FRESH|N|CONFOCAL MICROSCOPY|FIBROMETER FORMULA||NA|Y|Y|NA|||NA|3||39||SCREENING|1970-03-03|1962-05-14|||||1966-02-13||1963-09-08|U|1971-12-15
TRIAL STUDY 134XCP|LB|0B140787-9458-4F66-B7E9-1FAFF239085E|2||||VITDIT|25-HYDROXYVITAMIN D|||||||PMOL/10^9 CELLS|||||||INDETERMINATE||EQ||||LOW|NOT DONE||||MENSTRUAL BLOOD|SOLIDIFIED|N|CT SCAN|GMI MMOL/MOL FORMULA||N|U|U|NA|||Y|3||39||BLINDED TREATMENT|1967-01-28|1972-02-24|||||1973-02-15||1965-04-29|NA|1960-02-24
TRIAL STUDY 134XCP|LB|0B140787-9458-4F66-B7E9-1FAFF239085E|1||||MBP|MYELIN BASIC PROTEIN|||||||10^6 CFU|||||||INDETERMINATE||S*KPA||||NORMAL|NOT DONE||||SERUM OR PLASMA|CALCIFIED|N|HPLC/IEX|COCKCROFT-GAULT FORMULA||NA|Y|Y|N|||N|4||88||WASHOUT|1973-03-23|1962-01-24|||||1966-12-13||1960-09-06|Y|1964-10-15
TRIAL STUDY 134XCP|LB|0B140787-9458-4F66-B7E9-1FAFF239085E|2||||MPOAB|MYELOPEROXIDASE ANTIBODY|||||||U/G/H|||||||POSITIVE||PIXELS/IN||||NORMAL|NOT DONE||||RETICULOCYTES|FROZEN|NA|IVY INCISION METHOD|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|U|||Y|4||88||BASELINE|1965-05-12|1962-06-30|||||1970-05-19||1973-04-16|NA|1971-09-21
TRIAL STUDY 134XCP|LB|0B140787-9458-4F66-B7E9-1FAFF239085E|1||||CRYOGLBN|CRYOGLOBULIN|||||||10^3 CFU|||||||INVALID||PMOL/DAY||||NORMAL|NOT DONE||||EMESIS|REFRIGERATED|U|QUANTITATIVE ULTRASOUND|FIBROMETER FORMULA||Y|U|N|U|||Y|5||7||INDUCTION TREATMENT|1973-06-18|1972-11-30|||||1968-04-26||1960-08-21|N|1965-08-07
TRIAL STUDY 134XCP|LB|0B140787-9458-4F66-B7E9-1FAFF239085E|2||||THR|THREONINE|||||||AMPULE|||||||BORDERLINE||PIXEL||||NORMAL|NOT DONE||||PERSPIRATION|LACTESCENT|NA|POPULATION SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|NA|U|N|||U|5||7||CONTINUATION TREATMENT|1962-06-08|1967-08-06|||||1970-02-07||1968-02-13|N|1970-12-25
TRIAL STUDY 134XCP|LB|FB91BADF-308B-4F6A-90D0-032E93E20C4A|1||||ZINC|ZINC|||||||MOL/ML|||||||TRACE||GRAVITATIONAL UNIT||||NORMAL|NOT DONE||||ARTERIAL BLOOD|REFRIGERATED|N|GC/FID|CKD-EPI CREATININE FORMULA||N|U|U|N|||N|1||38||LONG-TERM FOLLOW-UP|1973-05-23|1965-03-18|||||1965-09-12||1967-11-01|U|1964-06-17
TRIAL STUDY 134XCP|LB|FB91BADF-308B-4F6A-90D0-032E93E20C4A|2||||FEK|FRACTIONAL POTASSIUM EXCRETION|||||||NMOL/ML/MIN|||||||POSITIVE||YEARS||||LOW|NOT DONE||||SPUTUM|CALCIFIED|Y|IMPULSE OSCILLOMETRY|COCKCROFT-GAULT FORMULA||U|U|Y|Y|||NA|1||38||BASELINE|1962-03-12|1967-08-10|||||1972-10-09||1962-02-24|NA|1965-03-17
TRIAL STUDY 134XCP|LB|FB91BADF-308B-4F6A-90D0-032E93E20C4A|1||||INTLK11|INTERLEUKIN 11|||||||10^12/L|||||||NEGATIVE||MS2||||NORMAL|NOT DONE||||ISOLATE|FRESH|U|SINGLE-SLICE SPIRAL CT|NASH FIBROSURE FORMULA||N|U|N|U|||N|2||58||OPEN LABEL TREATMENT|1972-06-18|1966-03-20|||||1972-12-25||1962-04-11|NA|1960-11-18
TRIAL STUDY 134XCP|LB|FB91BADF-308B-4F6A-90D0-032E93E20C4A|2||||ANISOCHR|ANISOCHROMIA|||||||POUCH|||||||INVALID||PRESSOR UNITS||||LOW|NOT DONE||||CORD BLOOD|THAWED|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA||Y|Y|U|U|||N|2||58||SCREENING|1961-09-29|1971-09-03|||||1964-11-03||1962-06-11|Y|1970-04-29
TRIAL STUDY 134XCP|LB|FB91BADF-308B-4F6A-90D0-032E93E20C4A|1||||CXCL6|CHEMOKINE (C-X-C MOTIF) LIGAND 6|||||||BQ/G|||||||INVALID||FINGERTIP UNIT||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|ICTERIC|U|U-HPLC/MS/MS|HEPASCORE FORMULA||U|Y|N|NA|||Y|3||39||TREATMENT|1970-03-03|1972-09-17|||||1965-04-24||1973-06-06|N|1972-01-19
TRIAL STUDY 134XCP|LB|FB91BADF-308B-4F6A-90D0-032E93E20C4A|2||||HER2S|SOLUBLE HER2|||||||DNA COPIES/ML|||||||POSITIVE||PPM||||ABNORMAL|NOT DONE||||SERUM|FRESH|U|TRIPLE-PHASE SPIRAL CT SCAN|GMI MMOL/MOL FORMULA||U|Y|NA|N|||Y|3||39||SCREENING|1964-11-04|1968-03-10|||||1967-03-21||1966-05-30|Y|1961-04-04
TRIAL STUDY 134XCP|LB|FB91BADF-308B-4F6A-90D0-032E93E20C4A|1||||DPD|DEOXYPYRIDINOLINE|||||||BP|||||||NEGATIVE||UMOL||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONCENTRATED|Y|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|FIBROSIS 4 FORMULA||Y|Y|Y|NA|||N|4||88||SCREENING|1965-01-31|1967-12-18|||||1963-10-01||1962-04-07|U|1960-03-27
TRIAL STUDY 134XCP|LB|FB91BADF-308B-4F6A-90D0-032E93E20C4A|2||||STROPONI|SKELETAL TROPONIN I|||||||PPM|||||||INVALID||BOTTLE||||HIGH|NOT DONE||||CAPILLARY BLOOD|SOLIDIFIED|Y|SEQUENCING|CKD-EPI CREATININE FORMULA||N|Y|NA|NA|||N|4||88||WASHOUT|1971-01-22|1967-12-29|||||1968-02-27||1970-01-22|Y|1964-10-29
TRIAL STUDY 134XCP|LB|FB91BADF-308B-4F6A-90D0-032E93E20C4A|1||||GLTRCE|GLITTER CELLS|||||||UKAT/L|||||||NEGATIVE||ML/KG||||LOW|NOT DONE||||MECONIUM|THAWED|U|IMPEDANCE CONDUCTIVITY|MDRD 5 VARIABLE FORMULA||U|NA|N|Y|||Y|5||7||LONG-TERM FOLLOW-UP|1960-02-14|1972-12-02|||||1968-09-25||1967-12-26|U|1971-02-01
TRIAL STUDY 134XCP|LB|FB91BADF-308B-4F6A-90D0-032E93E20C4A|2||||RETIMRTC|MEDIUM ABSORPTION RETIC/RETICULOCYTES|||||||L/L|||||||TRACE||POINT||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|LACTESCENT|NA|OPTICAL DENSITY MEASUREMENT|MDRD 4 VARIABLE FORMULA||Y|Y|U|N|||N|5||7||BLINDED TREATMENT|1961-08-20|1967-05-02|||||1972-05-03||1967-01-29|U|1964-12-22
TRIAL STUDY 134XCP|LB|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|1||||INTLK15|INTERLEUKIN 15|||||||/2000 RBC|||||||TRACE||/MM||||HIGH|NOT DONE||||EMESIS|SOLIDIFIED|Y|CONTRAST ENHANCED X-RAY|FIBROSIS 4 FORMULA||U|Y|NA|Y|||U|1||38||SCREENING|1970-10-06|1973-05-02|||||1970-11-09||1965-07-23|NA|1964-04-05
TRIAL STUDY 134XCP|LB|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|2||||G6PDRBRB|G6PD-DEFICIENT ERYTHROCYTES/ERYTHROCYTES|||||||USP U|||||||INVALID||10^4 CFU/ML||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|HEMOLYZED|NA|PET/CT SCAN|CKD-EPI CYSTATIN C FORMULA||Y|N|NA|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1970-07-08|1961-04-24|||||1970-03-07||1962-08-23|N|1966-09-12
TRIAL STUDY 134XCP|LB|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|1||||HCGFR|CHORIOGONADOTROPIN BETA, FREE|||||||G/KG|||||||BORDERLINE||USP U||||NORMAL|NOT DONE||||ARTERIAL BLOOD|UNEXPECTED ODOR|U|PELLI-ROBSON EYE CHART|COCKCROFT-GAULT FORMULA||N|U|Y|Y|||U|2||58||BASELINE|1972-11-27|1972-08-10|||||1969-10-20||1960-09-09|U|1969-02-01
TRIAL STUDY 134XCP|LB|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|2||||PMDW|PLATELET MASS DISTRIBUTION WIDTH|||||||LENS|||||||INDETERMINATE||UEQ/L||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|REFRIGERATED|U|CLINICAL EVALUATION|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|Y|Y|||U|2||58||BASELINE|1970-04-21|1967-05-20|||||1964-04-09||1961-02-21|NA|1967-10-08
TRIAL STUDY 134XCP|LB|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|1||||RBCDIPOP|DIMORPHIC ERYTHROCYTE POPULATION|||||||LX|||||||BORDERLINE||PSEC||||ABNORMAL|NOT DONE||||LOCHIA|FRESH|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|NA|Y|||U|3||39||CONTINUATION TREATMENT|1965-07-29|1971-04-16|||||1960-02-06||1960-05-14|N|1964-06-16
TRIAL STUDY 134XCP|LB|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|2||||C165914|CAT DANDER IGG AB RAST SCORE|||||||L/S/KPA|||||||BORDERLINE||10^6 IU/ML||||HIGH|NOT DONE||||CALCULUS|FROZEN|N|MRS|MDRD 4 VARIABLE FORMULA||NA|Y|Y|NA|||N|3||39||TREATMENT|1962-08-01|1973-01-21|||||1971-02-11||1966-09-26|N|1965-04-27
TRIAL STUDY 134XCP|LB|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|1||||TK1|THYMIDINE KINASE 1|||||||BQ/KG|||||||INDETERMINATE||NEEDLE GAUGE||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|SOLIDIFIED|Y|TRANSVAGINAL ULTRASOUND|MDRD 5 VARIABLE FORMULA||NA|Y|N|NA|||N|4||88||WASHOUT|1968-10-04|1968-07-24|||||1960-09-14||1964-12-20|NA|1961-07-30
TRIAL STUDY 134XCP|LB|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|2||||VITB9|VITAMIN B9|||||||CUP EQ|||||||NEGATIVE||FT||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|CONTAMINATED|NA|PERCUSSION|FIBROSIS 4 FORMULA||U|N|NA|Y|||U|4||88||FOLLOW-UP|1964-09-22|1969-02-15|||||1971-11-13||1961-06-30|U|1964-03-22
TRIAL STUDY 134XCP|LB|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|1||||PRZPM|PRAZEPAM|||||||10^11/L|||||||NEGATIVE||UMOL/MG/MIN||||HIGH|NOT DONE||||RETICULOCYTES|CALCIFIED|N|MICROBIAL CULTURE, SOLID|FIBROSIS 4 FORMULA||U|U|U|NA|||U|5||7||CONTINUATION TREATMENT|1961-11-06|1961-02-19|||||1962-05-02||1961-12-21|Y|1973-02-05
TRIAL STUDY 134XCP|LB|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|2||||HVA|HOMOVANILLIC ACID|||||||DNA COPIES/ML|||||||TRACE||BQ/L||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR|N|RADIOGRAPHY|COCKCROFT-GAULT FORMULA||U|N|NA|Y|||N|5||7||WASHOUT|1968-09-13|1972-10-15|||||1971-09-04||1964-01-10|NA|1965-07-14
TRIAL STUDY 134XCP|LB|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|1||||SERTRAL|SERTRALINE|||||||UMOL|||||||NEGATIVE||CAL||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|AUTOLYZED|N|DYNAMIC CONTRAST ENHANCED MRI|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|NA|N|||N|1||38||BASELINE|1960-04-20|1970-09-28|||||1965-04-05||1966-12-27|N|1964-06-23
TRIAL STUDY 134XCP|LB|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|2||||CSCYL|CYLINDROID CASTS|||||||/H|||||||POSITIVE||MM2||||LOW|NOT DONE||||PUS|DRIED|U|FARNSWORTH-MUNSELL 100 HUE TEST|GMI MMOL/MOL FORMULA||Y|NA|Y|NA|||N|1||38||WASHOUT|1966-12-24|1964-02-23|||||1965-10-31||1969-05-14|N|1960-12-18
TRIAL STUDY 134XCP|LB|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|1||||GSTALEXR|ALPHA-GST EXCRETION RATE|||||||CI/L|||||||POSITIVE||UG/G/H||||LOW|NOT DONE||||CEREBROSPINAL FLUID|LIPEMIC|Y|PHOTOGRAPHY|CKD-EPI CREATININE FORMULA||NA|U|N|NA|||NA|2||58||LONG-TERM FOLLOW-UP|1973-07-06|1968-10-30|||||1967-04-03||1966-10-06|Y|1970-02-14
TRIAL STUDY 134XCP|LB|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|2||||IDLP|IDL PARTICLES|||||||/KG|||||||TRACE||10^6 CFU||||ABNORMAL|NOT DONE||||STOOL|FROZEN|N|PH METER MEASUREMENT METHOD|FIBROMETER FORMULA||Y|N|NA|U|||NA|2||58||WASHOUT|1971-07-06|1964-08-08|||||1962-10-12||1965-12-14|N|1963-02-28
TRIAL STUDY 134XCP|LB|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|1||||DKK1|DICKKOPF WNT SIGNALING PATH INHIBITOR 1|||||||IN2|||||||POSITIVE||NMOL/MOL||||NORMAL|NOT DONE||||LEUKOCYTE|REFRIGERATED|Y|CALIPER MEASUREMENT METHOD|MDRD FORMULA||Y|U|N|N|||U|3||39||INDUCTION TREATMENT|1961-05-18|1968-07-24|||||1966-04-05||1972-12-17|N|1964-03-18
TRIAL STUDY 134XCP|LB|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|2||||LYMATLY|ATYPICAL LYMPHOCYTES/LYMPHOCYTES|||||||U/M2/MIN|||||||TRACE||IMPLANT||||NORMAL|NOT DONE||||PERITONEAL FLUID|SOLIDIFIED|Y|IMMUNOBLOT|MDRD 5 VARIABLE FORMULA||U|U|N|N|||NA|3||39||LONG-TERM FOLLOW-UP|1967-05-25|1961-02-17|||||1971-03-07||1960-11-10|N|1967-06-20
TRIAL STUDY 134XCP|LB|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|1||||GGTEXR|GAMMAGLUTAMYL TRANSFERASE EXCRETION RATE|||||||PA|||||||POSITIVE||/VF||||HIGH|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|Y|ENZYMATIC ULTRACENTRIFUGATION|FIBROMETER FORMULA||Y|N|Y|Y|||Y|4||88||LONG-TERM FOLLOW-UP|1963-12-15|1970-02-14|||||1963-03-07||1960-07-17|NA|1965-02-08
TRIAL STUDY 134XCP|LB|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|2||||CD13|CD13|||||||POUCH|||||||INDETERMINATE||LB||||NORMAL|NOT DONE||||PLASMA|ICTERIC|NA|X-RAY FLUORESCENCE SPECTROMETRY|MDRD 5 VARIABLE FORMULA||NA|U|N|U|||N|4||88||BASELINE|1970-05-02|1967-01-09|||||1963-03-30||1965-04-20|N|1969-09-24
TRIAL STUDY 134XCP|LB|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|1||||BLYCELE|B-LYMPHOCYTES/LEUKOCYTES|||||||PFU/ML|||||||INVALID||10^4 CFU/ML||||HIGH|NOT DONE||||REFLEX TEAR|CLOTTED|Y|APPLANATION TONOMETRY|MDRD 5 VARIABLE FORMULA||U|U|NA|U|||U|5||7||FOLLOW-UP|1962-01-08|1972-12-22|||||1971-06-02||1963-12-16|U|1969-12-01
TRIAL STUDY 134XCP|LB|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|2||||CCL12|CHEMOKINE (C-C MOTIF) LIGAND 12|||||||AMOL|||||||NEGATIVE||CUP EQ||||NORMAL|NOT DONE||||HAIR FOLLICLE|FRESH|NA|LC/MS/MS|MDRD 4 VARIABLE FORMULA||U|NA|NA|N|||NA|5||7||SCREENING|1971-06-11|1962-04-13|||||1970-04-14||1971-12-26|U|1966-07-02
TRIAL STUDY 134XCP|LB|3B583022-3A2C-4387-80A5-035E3FD111BD|1||||C147280|COW MILK PROTEIN ANTIGEN IGE ANTIBODY|||||||PL|||||||TRACE||AMFI||||LOW|NOT DONE||||GASTRIC CONTENTS|FRESH|U|MS/MS|HEPASCORE FORMULA||Y|Y|NA|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1972-09-20|1971-07-19|||||1967-02-17||1961-10-03|NA|1971-04-16
TRIAL STUDY 134XCP|LB|3B583022-3A2C-4387-80A5-035E3FD111BD|2||||C130104|GRASS MIX POLLEN ANTIGEN IGG ANTIBODY|||||||BOTTLE|||||||NEGATIVE||%/S||||HIGH|NOT DONE||||DISCHARGE|NON-HEMOLYZED|NA|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|CKD-EPI CREATININE FORMULA||NA|NA|Y|N|||N|1||38||TREATMENT|1970-06-14|1960-05-01|||||1973-01-04||1969-11-16|Y|1962-12-25
TRIAL STUDY 134XCP|LB|3B583022-3A2C-4387-80A5-035E3FD111BD|1||||CRYSTALS|CRYSTALS|||||||UV*SEC|||||||NEGATIVE||10^3/L||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|CONTAMINATED|Y|PLAQUE REDUCTION NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA||NA|NA|Y|N|||NA|2||58||BLINDED TREATMENT|1964-09-08|1969-06-25|||||1965-04-29||1969-02-05|Y|1967-12-06
TRIAL STUDY 134XCP|LB|3B583022-3A2C-4387-80A5-035E3FD111BD|2||||C130077|SILVER BIRCH POLLEN IGA|||||||DEG2|||||||NEGATIVE||BU/ML||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|SOLIDIFIED|U|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||N|U|N|NA|||N|2||58||FOLLOW-UP|1971-09-28|1965-02-04|||||1967-06-24||1966-01-05|Y|1960-10-25
TRIAL STUDY 134XCP|LB|3B583022-3A2C-4387-80A5-035E3FD111BD|1||||ESELECT|E-SELECTIN|||||||UCI/KG|||||||TRACE||NMOL/DAY||||NORMAL|NOT DONE||||ISOLATE|LIPEMIC|N|TELLER ACUITY CARDS|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|U|N|||N|3||39||OPEN LABEL TREATMENT|1960-08-06|1969-08-19|||||1970-04-11||1963-01-27|N|1971-07-25
TRIAL STUDY 134XCP|LB|3B583022-3A2C-4387-80A5-035E3FD111BD|2||||NEUTBLE|NEUTROPHILS BAND FORM/LEUKOCYTES|||||||IU/DAY|||||||INVALID||FEU||||HIGH|NOT DONE||||SERUM OR PLASMA|PARAFFIN-EMBEDDED|Y|LIQUID SCINTILLATION COUNTING|FIBROSIS 4 FORMULA||Y|Y|U|NA|||NA|3||39||OPEN LABEL TREATMENT|1969-02-17|1968-10-01|||||1967-11-16||1961-01-12|N|1969-11-11
TRIAL STUDY 134XCP|LB|3B583022-3A2C-4387-80A5-035E3FD111BD|1||||CATNINB|BETA CATENIN|||||||UIU/DL|||||||TRACE||MIU/L||||NORMAL|NOT DONE||||TUMOR TISSUE|DRIED|NA|SINGLE-MOLECULE ARRAY|MDRD FORMULA||U|NA|N|NA|||U|4||88||WASHOUT|1963-03-05|1961-12-23|||||1961-09-25||1961-07-29|NA|1965-09-14
TRIAL STUDY 134XCP|LB|3B583022-3A2C-4387-80A5-035E3FD111BD|2||||HLADPB1|HLA DP BETA1 ANTIGEN|||||||MU/L|||||||INDETERMINATE||OZ||||HIGH|NOT DONE||||SEBUM|THAWED|N|PERIODIC ACID SCHIFF STAIN|MDRD 4 VARIABLE FORMULA||Y|U|U|N|||U|4||88||RUN-IN|1963-02-23|1960-12-06|||||1972-05-21||1969-05-18|Y|1960-08-13
TRIAL STUDY 134XCP|LB|3B583022-3A2C-4387-80A5-035E3FD111BD|1||||C4D|COMPLEMENT C4D|||||||CM2|||||||INVALID||MG/KG/WEEK||||NORMAL|NOT DONE||||SEBUM|SOLIDIFIED|U|RADIOIMMUNOPRECIPITATION ASSAY|MDRD ENZYMATIC FORMULA||Y|N|NA|Y|||Y|5||7||SCREENING|1972-09-11|1960-07-28|||||1968-07-03||1962-02-04|NA|1960-02-17
TRIAL STUDY 134XCP|LB|3B583022-3A2C-4387-80A5-035E3FD111BD|2||||ETGETS|ETHYL GLUCURONIDE ETHYL SULFATE|||||||MIN|||||||INDETERMINATE||G/KG/DAY||||NORMAL|NOT DONE||||ARTERIAL BLOOD|ROOM TEMPERATURE|U|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 6 VARIABLE FORMULA||NA|Y|Y|U|||Y|5||7||RUN-IN|1970-06-25|1971-01-21|||||1973-08-03||1963-01-24|Y|1971-05-04
TRIAL STUDY 134XCP|LB|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|1||||C130138|AMERICAN COCKROACH ANTIGEN IGG ANTIBODY|||||||UG/G/H|||||||TRACE||AMP||||ABNORMAL|NOT DONE||||PUS|LACTESCENT|N|PLETHYSMOGRAPHY|CKD-EPI FORMULA||NA|N|Y|U|||NA|1||38||WASHOUT|1967-08-24|1973-07-11|||||1972-01-09||1971-03-18|Y|1962-08-02
TRIAL STUDY 134XCP|LB|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|2||||MMP3|MATRIX METALLOPROTEINASE 3|||||||/10^3|||||||POSITIVE||CD*S/M2||||ABNORMAL|NOT DONE||||MECONIUM|NON-HEMOLYZED|NA|IMMUNOASSAY|GMI MMOL/MOL FORMULA||NA|NA|Y|NA|||U|1||38||LONG-TERM FOLLOW-UP|1964-04-26|1963-05-19|||||1972-12-11||1964-02-14|N|1968-10-23
TRIAL STUDY 134XCP|LB|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|1||||OXACREAT|OXALATE/CREATININE|||||||U/MG|||||||INVALID||G/CM2||||LOW|NOT DONE||||SERUM|CLOTTED|N|LEAD CITRATE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|NA|||U|2||58||LONG-TERM FOLLOW-UP|1963-09-05|1966-05-09|||||1969-01-07||1970-06-28|U|1968-11-28
TRIAL STUDY 134XCP|LB|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|2||||HETRPH|HETEROPHILS|||||||LM|||||||NEGATIVE||CMH2O*S2/ML||||ABNORMAL|NOT DONE||||GASTRIC FLUID|CLOTTED|NA|LC/MS/MS|COCKCROFT-GAULT FORMULA||NA|N|Y|Y|||NA|2||58||SCREENING|1966-11-29|1962-04-15|||||1964-09-28||1972-02-14|U|1968-04-25
TRIAL STUDY 134XCP|LB|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|1||||LYMLG|LARGE LYMPHOCYTES|||||||KPA/L/SEC|||||||INVALID||UG/KG/DAY||||NORMAL|NOT DONE||||SERUM|FRESH|N|FLUORESCENT SPOT TEST|MDRD ENZYMATIC FORMULA||Y|Y|Y|N|||NA|3||39||FOLLOW-UP|1961-11-20|1960-02-25|||||1965-12-14||1967-07-05|U|1965-05-17
TRIAL STUDY 134XCP|LB|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|2||||CRDIGGAB|CARDIOLIPIN IGG ANTIBODY|||||||BAG|||||||BORDERLINE||PKAT/L||||HIGH|NOT DONE||||SEMEN|FRESH|Y|PHASE-CONTRAST MRI|FIBROMETER FORMULA||U|NA|N|U|||NA|3||39||RUN-IN|1973-05-24|1963-09-05|||||1967-10-11||1960-09-08|Y|1968-06-27
TRIAL STUDY 134XCP|LB|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|1||||PMDW|PLATELET MASS DISTRIBUTION WIDTH|||||||CAPFUL|||||||BORDERLINE||LM||||HIGH|NOT DONE||||ABSCESS FLUID|CONCENTRATED|U|HIGH RESOLUTION CT|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|U|NA|||U|4||88||BASELINE|1963-12-04|1972-11-28|||||1971-12-15||1969-05-09|N|1961-10-10
TRIAL STUDY 134XCP|LB|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|2||||THCCOOH|11-NOR-DELTA9-THC-9-CARBOXYLIC ACID|||||||KG/L|||||||BORDERLINE||NMOL/L||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|SOLIDIFIED|U|CELLULAR PROLIFERATION ASSAY|MDRD 6 VARIABLE FORMULA||Y|NA|NA|N|||Y|4||88||INDUCTION TREATMENT|1967-01-26|1962-06-07|||||1963-02-10||1960-10-25|NA|1967-05-07
TRIAL STUDY 134XCP|LB|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|1||||C130133|D. FARINAE ANTIGEN IGG ANTIBODY|||||||CI/ML|||||||INDETERMINATE||10^6/L||||NORMAL|NOT DONE||||VITREOUS HUMOR|GELLED|U|HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI FORMULA||U|U|Y|N|||Y|5||7||RUN-IN|1971-01-10|1969-04-21|||||1973-05-06||1966-11-14|N|1964-08-25
TRIAL STUDY 134XCP|LB|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|2||||IFI44|INTERFERON-INDUCED PROTEIN 44|||||||BE/ML|||||||INVALID||NMOL/KG/DAY||||LOW|NOT DONE||||VITREOUS HUMOR|PARAFFIN-EMBEDDED|Y|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||U|N|U|U|||N|5||7||TREATMENT|1960-09-11|1966-11-25|||||1963-07-21||1963-05-21|Y|1968-01-16
TRIAL STUDY 134XCP|LB|B5370AC4-3185-48DC-B1BC-A00AE8496783|1||||PLSMCECE|MATURE PLASMA CELLS/TOTAL CELLS|||||||G/G/DAY|||||||TRACE||PPM||||LOW|NOT DONE||||SOFT TISSUE|LACTESCENT|NA|CALCULATION|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|N|||NA|1||38||RUN-IN|1966-08-29|1965-02-20|||||1962-06-25||1964-01-14|Y|1972-02-21
TRIAL STUDY 134XCP|LB|B5370AC4-3185-48DC-B1BC-A00AE8496783|2||||APOC3|APOLIPOPROTEIN CIII|||||||MV2/HZ|||||||POSITIVE||S/H||||NORMAL|NOT DONE||||CORD BLOOD|CALCIFIED|U|RYAN BLUE STAIN|CKD-EPI CYSTATIN C FORMULA||Y|NA|N|NA|||U|1||38||RUN-IN|1962-05-31|1962-01-25|||||1966-03-31||1963-10-03|N|1971-10-05
TRIAL STUDY 134XCP|LB|B5370AC4-3185-48DC-B1BC-A00AE8496783|1||||FRFEABS|FRACTIONAL IRON ABSORPTION|||||||PHERESIS UNIT|||||||POSITIVE||U/CL||||NORMAL|NOT DONE||||LYMPH|PARAFFIN-EMBEDDED|U|IMPULSE OSCILLOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|NA|U|||NA|2||58||LONG-TERM FOLLOW-UP|1968-08-01|1965-02-22|||||1969-06-22||1967-10-09|N|1960-07-15
TRIAL STUDY 134XCP|LB|B5370AC4-3185-48DC-B1BC-A00AE8496783|2||||POLYCHR|POLYCHROMASIA|||||||IU/MMOL|||||||INVALID||MOSM||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|FROZEN|N|IMMUNOBLOT|CKD-EPI CYSTATIN C FORMULA||Y|N|U|Y|||Y|2||58||OBSERVATION|1973-07-23|1970-12-18|||||1969-06-01||1972-05-12|N|1960-11-22
TRIAL STUDY 134XCP|LB|B5370AC4-3185-48DC-B1BC-A00AE8496783|1||||MTNEPHFR|METANEPHRINE, FREE|||||||10^6 U|||||||INVALID||UG/L/H||||ABNORMAL|NOT DONE||||MUCUS|LACTESCENT|Y|CT SCAN|GMI % FORMULA||N|N|Y|Y|||Y|3||39||WASHOUT|1970-01-11|1968-08-31|||||1966-06-08||1961-04-22|N|1964-07-20
TRIAL STUDY 134XCP|LB|B5370AC4-3185-48DC-B1BC-A00AE8496783|2||||C130095|WESTERN RAGWEED POLLEN IGG4|||||||10^5/L|||||||NEGATIVE||ML/KG/MIN||||NORMAL|NOT DONE||||SEMEN|THAWED|N|SICKLE CELL SOLUBILITY TEST|MDRD 4 VARIABLE FORMULA||U|Y|Y|N|||NA|3||39||BLINDED TREATMENT|1969-12-05|1961-10-10|||||1962-07-14||1965-02-10|NA|1970-02-27
TRIAL STUDY 134XCP|LB|B5370AC4-3185-48DC-B1BC-A00AE8496783|1||||COCAINE|COCAINE|||||||PPTR|||||||INDETERMINATE||MG/L||||ABNORMAL|NOT DONE||||PUS|ROOM TEMPERATURE|Y|CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|N|NA|||N|4||88||WASHOUT|1969-10-20|1969-02-09|||||1961-06-18||1967-10-30|NA|1963-10-15
TRIAL STUDY 134XCP|LB|B5370AC4-3185-48DC-B1BC-A00AE8496783|2||||ALBEXR|ALBUMIN EXCRETION RATE|||||||CG|||||||INDETERMINATE||ML/CAGE||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|ICTERIC|N|MULTIPLE BREATH WASHOUT|MDRD 4 VARIABLE FORMULA||Y|Y|NA|NA|||U|4||88||WASHOUT|1966-09-21|1966-02-18|||||1966-02-15||1966-06-23|NA|1969-08-31
TRIAL STUDY 134XCP|LB|B5370AC4-3185-48DC-B1BC-A00AE8496783|1||||HCGNDI|CHORIOGONADOTROPIN, INTACT|||||||H/WK|||||||INDETERMINATE||CI/L||||ABNORMAL|NOT DONE||||NAIL|REFRIGERATED|NA|IMPULSE OSCILLOMETRY|GMI MMOL/MOL FORMULA||U|NA|N|U|||Y|5||7||OBSERVATION|1963-09-07|1964-07-14|||||1967-01-08||1965-03-25|N|1965-06-16
TRIAL STUDY 134XCP|LB|B5370AC4-3185-48DC-B1BC-A00AE8496783|2||||TGFB1|TRANSFORMING GROWTH FACTOR BETA 1|||||||LOG10 TCID 50/ML|||||||TRACE||10^7 CFU/ML||||HIGH|NOT DONE||||GASTRIC FLUID|FRESH|Y|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROSIS 4 FORMULA||N|NA|NA|Y|||U|5||7||RUN-IN|1960-11-10|1962-04-30|||||1970-09-15||1963-07-03|U|1967-05-19
TRIAL STUDY 134XCP|LB|1112A903-1F2A-4583-BB9A-41DD206D5B4A|1||||UROTHCE|UROTHELIAL CELLS|||||||CI/KG|||||||BORDERLINE||PNU/ML||||LOW|NOT DONE||||VITREOUS HUMOR|HEMOLYZED|N|ELECTRICAL IMPEDANCE MYOGRAPHY|CKD-EPI CREATININE FORMULA||NA|U|N|U|||Y|1||38||CONTINUATION TREATMENT|1969-07-23|1965-02-19|||||1964-09-19||1969-03-27|U|1967-07-24
TRIAL STUDY 134XCP|LB|1112A903-1F2A-4583-BB9A-41DD206D5B4A|2||||GHRELIN|GHRELIN|||||||UCI/L|||||||NEGATIVE||GY/MIN||||LOW|NOT DONE||||SEBUM|CALCIFIED|NA|TWO-COLOR MICROARRAY|GMI MMOL/MOL FORMULA||NA|Y|U|NA|||NA|1||38||TREATMENT|1972-07-30|1965-03-19|||||1968-10-26||1968-07-15|N|1969-11-28
TRIAL STUDY 134XCP|LB|1112A903-1F2A-4583-BB9A-41DD206D5B4A|1||||NHMCE|NONHEMATIC CELLS|||||||ML/CM3/MIN|||||||POSITIVE||10^6 CFU/ML||||NORMAL|NOT DONE||||DIALYSIS FLUID|CONTAMINATED|Y|HIGH RESOLUTION CT|NASH FIBROSURE FORMULA||U|NA|N|N|||U|2||58||RUN-IN|1969-08-11|1973-06-18|||||1966-04-06||1965-03-22|U|1965-10-12
TRIAL STUDY 134XCP|LB|1112A903-1F2A-4583-BB9A-41DD206D5B4A|2||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||MMOL/KG|||||||INVALID||/CMH2O||||LOW|NOT DONE||||INFRANATANT, PLASMA|ROOM TEMPERATURE|U|SURFACE PLASMON RESONANCE|FIBROTEST FORMULA||NA|N|NA|N|||Y|2||58||LONG-TERM FOLLOW-UP|1967-09-17|1964-03-17|||||1961-08-25||1969-11-09|U|1961-08-09
TRIAL STUDY 134XCP|LB|1112A903-1F2A-4583-BB9A-41DD206D5B4A|1||||TIMP1CRE|TIMP1/CREATININE|||||||UKAT/L|||||||NEGATIVE||KUSP||||LOW|NOT DONE||||BLOOD|CONCENTRATED|NA|FLUORESCENCE ANGIOGRAPHY|FIBROSIS 4 FORMULA||Y|U|NA|U|||Y|3||39||BLINDED TREATMENT|1973-07-22|1964-02-28|||||1971-08-17||1961-06-29|N|1971-07-16
TRIAL STUDY 134XCP|LB|1112A903-1F2A-4583-BB9A-41DD206D5B4A|2||||APPEAR|SPECIMEN APPEARANCE|||||||OI50|||||||TRACE||UMOL/MOL||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|FROZEN|U|DYNAMOMETRY|FIBROSIS 4 FORMULA||U|NA|NA|Y|||N|3||39||TREATMENT|1961-01-20|1962-09-19|||||1968-11-28||1969-09-12|U|1972-04-26
TRIAL STUDY 134XCP|LB|1112A903-1F2A-4583-BB9A-41DD206D5B4A|1||||TPAAG|TISSUE PLASMINOGEN ACTIVATOR ANTIGEN|||||||IMPLANT|||||||NEGATIVE||UG/L||||NORMAL|NOT DONE||||GASTRIC CONTENTS|REFRIGERATED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|Y|||Y|4||88||BASELINE|1963-08-29|1966-01-21|||||1970-05-18||1965-03-27|U|1962-09-09
TRIAL STUDY 134XCP|LB|1112A903-1F2A-4583-BB9A-41DD206D5B4A|2||||RBCDYSM|DYSMORPHIC ERYTHROCYTES|||||||MEQ/UG|||||||INVALID||CM/MIN||||LOW|NOT DONE||||BASAL TEAR|DRIED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 4 VARIABLE FORMULA||Y|U|U|Y|||U|4||88||CONTINUATION TREATMENT|1971-01-18|1962-04-24|||||1971-03-27||1963-07-17|N|1961-07-03
TRIAL STUDY 134XCP|LB|1112A903-1F2A-4583-BB9A-41DD206D5B4A|1||||C130102|TREE MIX POLLEN ANTIGEN IGG ANTIBODY|||||||CI/KG|||||||TRACE||CAL||||LOW|NOT DONE||||BASAL TEAR|LACTESCENT|N|HEMAGGLUTINATION ASSAY|COCKCROFT-GAULT FORMULA||N|N|Y|U|||U|5||7||OPEN LABEL TREATMENT|1965-08-11|1961-08-14|||||1963-01-02||1966-08-01|U|1962-04-05
TRIAL STUDY 134XCP|LB|1112A903-1F2A-4583-BB9A-41DD206D5B4A|2||||FVAAC|FACTOR V ACTIVITY ACTUAL/CONTROL|||||||NCI|||||||INDETERMINATE||IU/MG||||ABNORMAL|NOT DONE||||SOFT TISSUE|DRIED|N|BRDU CELLULAR PROLIFERATION ASSAY|GMI % FORMULA||N|NA|N|Y|||Y|5||7||WASHOUT|1961-12-19|1970-09-13|||||1963-07-08||1960-02-14|U|1962-10-15
TRIAL STUDY 134XCP|LB|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|1||||FVIIAAC|FACTOR VII ACTIVITY ACTUAL/CONTROL|||||||/HPF|||||||BORDERLINE||GAUSS||||NORMAL|NOT DONE||||CAPILLARY PLASMA|CONTAMINATED|N|MODIFIED ACID FAST STAIN|MDRD 5 VARIABLE FORMULA||U|U|NA|N|||Y|1||38||CONTINUATION TREATMENT|1965-12-12|1966-11-17|||||1965-10-26||1964-02-03|Y|1962-10-24
TRIAL STUDY 134XCP|LB|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|2||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||/40 HPFS|||||||POSITIVE||TRANSDUCING UNIT/ML||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|CONTAMINATED|U|ICP-MS|CKD-EPI CYSTATIN C FORMULA||N|Y|N|N|||U|1||38||INDUCTION TREATMENT|1970-11-17|1960-12-07|||||1971-07-03||1967-03-20|N|1962-02-06
TRIAL STUDY 134XCP|LB|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|1||||ASMACT|ALPHA-SMOOTH MUSCLE ACTIN|||||||100 IU/ML|||||||NEGATIVE||NMOL/G||||LOW|NOT DONE||||SEBUM|CONCENTRATED|Y|LC/MS|GMI MMOL/MOL FORMULA||N|U|N|U|||Y|2||58||SCREENING|1961-09-28|1963-03-27|||||1962-06-14||1960-01-14|N|1970-09-19
TRIAL STUDY 134XCP|LB|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|2||||CSHYAL|HYALINE CASTS|||||||FG|||||||NEGATIVE||FMOL||||HIGH|NOT DONE||||SERUM|AUTOLYZED|N|SCINTIGRAPHY|NASH FIBROSURE FORMULA||Y|N|N|N|||N|2||58||CONTINUATION TREATMENT|1972-02-05|1973-05-18|||||1970-06-27||1970-05-15|Y|1960-06-23
TRIAL STUDY 134XCP|LB|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|1||||FEP|ERYTHROCYTE PROTOPORPHYRIN, FREE|||||||PA|||||||INDETERMINATE||USIEMENS||||LOW|NOT DONE||||LOCHIA|AUTOLYZED|U|MEDIASTINOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|N|Y|||N|3||39||INDUCTION TREATMENT|1962-08-07|1967-10-24|||||1964-10-02||1960-08-30|N|1963-02-07
TRIAL STUDY 134XCP|LB|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|2||||BLAST|BLASTS|||||||10^10/L|||||||INVALID||KG/M2||||HIGH|NOT DONE||||PUS|FROZEN|U|RADIOGRAPHY|CKD-EPI CREATININE FORMULA||U|Y|Y|U|||U|3||39||BLINDED TREATMENT|1966-02-16|1972-05-27|||||1964-11-04||1962-05-21|U|1960-12-01
TRIAL STUDY 134XCP|LB|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|1||||FRTNLC|FERRITIN LIGHT CHAIN|||||||IU/L|||||||INVALID||ANTIBODY UNIT||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|REFRIGERATED|Y|PHOTOGRAPHY|MDRD 4 VARIABLE FORMULA||N|N|U|U|||NA|4||88||OPEN LABEL TREATMENT|1965-03-15|1965-02-16|||||1969-02-16||1970-07-24|NA|1962-02-24
TRIAL STUDY 134XCP|LB|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|2||||T4FRIDX|THYROXINE, FREE INDEX|||||||/HPF|||||||BORDERLINE||BAR||||HIGH|NOT DONE||||EXPIRED AIR|AUTOLYZED|Y|ELECTROMYOGRAPHY|ASH FIBROSURE FORMULA||N|NA|Y|NA|||N|4||88||LONG-TERM FOLLOW-UP|1964-08-15|1964-09-06|||||1967-05-21||1971-11-02|NA|1971-12-20
TRIAL STUDY 134XCP|LB|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|1||||STAT3PS3|PHOSPHORYLATED STAT3/STAT3|||||||PMOL/DL|||||||TRACE||10^3 CFU/G||||LOW|NOT DONE||||CORD SERUM|PARAFFIN-EMBEDDED|NA|TELLER ACUITY CARDS|ASH FIBROSURE FORMULA||NA|U|U|N|||NA|5||7||OPEN LABEL TREATMENT|1972-05-18|1969-01-26|||||1964-08-03||1964-11-20|U|1963-08-26
TRIAL STUDY 134XCP|LB|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|2||||LKM1IGAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGG AB|||||||PMOL/DL|||||||NEGATIVE||KG/CM||||NORMAL|NOT DONE||||SERUM OR PLASMA|ROOM TEMPERATURE|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|GMI MMOL/MOL FORMULA||Y|U|U|N|||Y|5||7||SCREENING|1966-05-09|1964-08-13|||||1972-01-29||1961-06-15|U|1962-02-02
TRIAL STUDY 134XCP|LB|D09F047E-E380-453B-875D-FF3C8C5EA839|1||||C165904|TREE MIX POLLEN IGG AB RAST SCORE|||||||10^3 ORGANISMS/ML|||||||INDETERMINATE||KG/CM2||||ABNORMAL|NOT DONE||||MONOCYTE|DRIED|U|NUCLEIC ACID HYBRIDIZATION|CKD-EPI CREATININE FORMULA||N|Y|U|N|||U|1||38||BLINDED TREATMENT|1964-12-10|1972-09-09|||||1966-01-18||1962-05-03|NA|1969-11-27
TRIAL STUDY 134XCP|LB|D09F047E-E380-453B-875D-FF3C8C5EA839|2||||HCG|CHORIOGONADOTROPIN BETA|||||||MM/H|||||||TRACE||LOG10 TCID 50/UL||||NORMAL|NOT DONE||||CERUMEN|AGGLUTINATED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|FIBROMETER FORMULA||N|NA|N|U|||N|1||38||BASELINE|1969-05-05|1963-05-05|||||1963-10-21||1969-06-10|U|1968-07-13
TRIAL STUDY 134XCP|LB|D09F047E-E380-453B-875D-FF3C8C5EA839|1||||BLEEDT|BLEEDING TIME|||||||MG2/DL2|||||||TRACE||USIEMENS||||LOW|NOT DONE||||INFRANATANT, SERUM|ROOM TEMPERATURE|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD FORMULA||N|U|Y|Y|||N|2||58||WASHOUT|1972-07-08|1961-03-25|||||1966-09-16||1961-12-07|N|1971-12-04
TRIAL STUDY 134XCP|LB|D09F047E-E380-453B-875D-FF3C8C5EA839|2||||PRORUBCE|PRORUBRICYTE/TOTAL CELLS|||||||ABSORBANCE U/MIN|||||||TRACE||NMOL/L||||NORMAL|NOT DONE||||DIALYSIS FLUID|LACTESCENT|U|CONTRAST ENHANCED X-RAY|FIBROTEST FORMULA||U|U|NA|U|||N|2||58||SCREENING|1963-07-05|1969-05-18|||||1973-05-20||1963-04-30|NA|1961-11-06
TRIAL STUDY 134XCP|LB|D09F047E-E380-453B-875D-FF3C8C5EA839|1||||HDL2|HDL-CHOLESTEROL SUBCLASS 2|||||||10^6 DNA COPIES/ML|||||||TRACE||DEG/S||||HIGH|NOT DONE||||SPUTUM|UNEXPECTED ODOR|Y|AUTOMATED COUNT|ASH FIBROSURE FORMULA||Y|NA|N|N|||NA|3||39||RUN-IN|1960-07-31|1964-02-18|||||1960-12-19||1963-06-01|Y|1970-07-06
TRIAL STUDY 134XCP|LB|D09F047E-E380-453B-875D-FF3C8C5EA839|2||||GOLD|GOLD|||||||ANTI-XA IU/ML|||||||BORDERLINE||NG/MOL||||LOW|NOT DONE||||AMNIOTIC FLUID|FRESH|Y|HIGH RESOLUTION CT|CKD-EPI FORMULA||NA|U|Y|U|||U|3||39||BLINDED TREATMENT|1964-05-22|1962-08-30|||||1973-04-09||1967-09-09|Y|1962-03-19
TRIAL STUDY 134XCP|LB|D09F047E-E380-453B-875D-FF3C8C5EA839|1||||COPEP|COPEPTIN|||||||10^3 RNA COPIES/ML|||||||POSITIVE||UG/L FEU||||HIGH|NOT DONE||||LAVAGE FLUID|LIPEMIC|U|ELISA|MDRD ENZYMATIC FORMULA||Y|N|NA|Y|||U|4||88||BLINDED TREATMENT|1965-08-15|1972-11-16|||||1965-07-31||1960-07-08|NA|1960-04-16
TRIAL STUDY 134XCP|LB|D09F047E-E380-453B-875D-FF3C8C5EA839|2||||LYMVACLE|VACUOLATED LYMPHOCYTES/LEUKOCYTES|||||||/MONTH|||||||NEGATIVE||10^6 CFU/G||||LOW|NOT DONE||||SWABBED MATERIAL|THAWED|U|TWO-COLOR MICROARRAY|MDRD FORMULA||U|Y|Y|U|||Y|4||88||SCREENING|1963-09-11|1970-01-21|||||1966-06-27||1970-12-09|Y|1970-01-09
TRIAL STUDY 134XCP|LB|D09F047E-E380-453B-875D-FF3C8C5EA839|1||||EPINEXR|EPINEPHRINE EXCRETION RATE|||||||MMOL/MIN/KPA/L|||||||NEGATIVE||10^5/HPF||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|REFRIGERATED|Y|ULTRASONOGRAPHIC ELASTOGRAPHY|NASH FIBROSURE FORMULA||Y|NA|Y|U|||Y|5||7||CONTINUATION TREATMENT|1963-08-04|1967-02-17|||||1968-10-31||1971-12-26|N|1970-10-18
TRIAL STUDY 134XCP|LB|D09F047E-E380-453B-875D-FF3C8C5EA839|2||||CCL7|CHEMOKINE (C-C MOTIF) LIGAND 7|||||||BP|||||||INDETERMINATE||SFC/10^6 PBMC||||ABNORMAL|NOT DONE||||HAIR|AUTOLYZED|U|FORCED OSCILLATION TECHNIQUE|GMI MMOL/MOL FORMULA||U|NA|Y|U|||NA|5||7||TREATMENT|1967-12-15|1972-08-07|||||1970-02-01||1962-01-26|N|1970-06-03
TRIAL STUDY 134XCP|LB|E1B16559-B9CA-4B14-A77A-4AD546EF5262|1||||PH|PH|||||||UG/MIN|||||||INDETERMINATE||BREATHS/30S||||NORMAL|NOT DONE||||SKIN TISSUE|REFRIGERATED|U|LC-FL|MDRD 5 VARIABLE FORMULA||N|U|Y|N|||Y|1||38||FOLLOW-UP|1970-11-27|1971-06-12|||||1966-02-01||1972-09-07|Y|1972-07-29
TRIAL STUDY 134XCP|LB|E1B16559-B9CA-4B14-A77A-4AD546EF5262|2||||KRCYMG|MEGAKARYOCYTES|||||||PPM|||||||INDETERMINATE||UL/ML||||ABNORMAL|NOT DONE||||LEUKOCYTE|CALCIFIED|N|TOTAL BODY IRRADIATION|MDRD 6 VARIABLE FORMULA||U|Y|NA|Y|||Y|1||38||LONG-TERM FOLLOW-UP|1963-01-15|1960-02-06|||||1960-04-28||1972-03-03|U|1968-07-23
TRIAL STUDY 134XCP|LB|E1B16559-B9CA-4B14-A77A-4AD546EF5262|1||||SSTR2|SOMATOSTATIN RECEPTOR TYPE 2|||||||ML/MIN|||||||INVALID||LOG10 CFU/G||||ABNORMAL|NOT DONE||||REFLEX TEAR|FROZEN|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||U|Y|NA|Y|||NA|2||58||OPEN LABEL TREATMENT|1967-01-22|1971-08-24|||||1968-09-20||1971-10-19|U|1960-12-27
TRIAL STUDY 134XCP|LB|E1B16559-B9CA-4B14-A77A-4AD546EF5262|2||||CD8|CD8|||||||SUPPOSITORY|||||||NEGATIVE||NEEDLE GAUGE||||NORMAL|NOT DONE||||REFLEX TEAR|CALCIFIED|N|DIFFUSION TENSOR MRI|MDRD 4 VARIABLE FORMULA||U|NA|NA|NA|||Y|2||58||OPEN LABEL TREATMENT|1972-07-29|1961-02-27|||||1964-12-12||1970-03-24|N|1965-10-06
TRIAL STUDY 134XCP|LB|E1B16559-B9CA-4B14-A77A-4AD546EF5262|1||||TLYMXM|T-LYMPHOCYTE CROSSMATCH|||||||MG/G/MIN|||||||NEGATIVE||SBE/ML||||ABNORMAL|NOT DONE||||TISSUE|AUTOLYZED|NA|JAFFE REACTION|MDRD ENZYMATIC FORMULA||N|U|N|Y|||U|3||39||CONTINUATION TREATMENT|1970-11-29|1960-02-11|||||1961-02-22||1961-06-19|NA|1962-12-21
TRIAL STUDY 134XCP|LB|E1B16559-B9CA-4B14-A77A-4AD546EF5262|2||||VITDBP|VITAMIN D BINDING PROTEIN|||||||ML/MMHG/MIN/L|||||||NEGATIVE||GPS U||||HIGH|NOT DONE||||DISCHARGE|FRESH|U|REFLECTANCE SPECTROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|N|Y|||NA|3||39||BLINDED TREATMENT|1965-05-07|1964-04-04|||||1971-06-18||1969-04-10|Y|1963-08-01
TRIAL STUDY 134XCP|LB|E1B16559-B9CA-4B14-A77A-4AD546EF5262|1||||MYCYCE|MYELOCYTES/TOTAL CELLS|||||||UCI|||||||NEGATIVE||/100 HPFS||||NORMAL|NOT DONE||||ISOLATE|DRIED|U|TRANSVAGINAL ULTRASOUND|MDRD 4 VARIABLE FORMULA||U|N|N|Y|||U|4||88||OBSERVATION|1972-04-07|1964-05-23|||||1964-09-25||1968-08-01|NA|1963-03-21
TRIAL STUDY 134XCP|LB|E1B16559-B9CA-4B14-A77A-4AD546EF5262|2||||ALPRZLM|ALPRAZOLAM|||||||PELLET|||||||INDETERMINATE||CUP EQ||||HIGH|NOT DONE||||NAIL|DRIED|U|LEAD CITRATE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|U|N|||NA|4||88||WASHOUT|1966-11-27|1962-08-30|||||1961-11-12||1968-10-30|N|1972-11-09
TRIAL STUDY 134XCP|LB|E1B16559-B9CA-4B14-A77A-4AD546EF5262|1||||FXAAC|FACTOR X ACTIVITY ACTUAL/CONTROL|||||||KN/CM2|||||||NEGATIVE||UM||||HIGH|NOT DONE||||BASAL TEAR|ICTERIC|U|MULTI-SLICE SPIRAL CT|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|Y|NA|||Y|5||7||TREATMENT|1973-01-12|1962-03-10|||||1961-01-08||1965-01-30|U|1969-12-26
TRIAL STUDY 134XCP|LB|E1B16559-B9CA-4B14-A77A-4AD546EF5262|2||||ETPAUC|ETP AREA UNDER CURVE|||||||ML/KG/MIN|||||||POSITIVE||PUFF||||HIGH|NOT DONE||||EXUDATE|LACTESCENT|Y|TURBIDIMETRY|FIBROMETER FORMULA||N|U|NA|U|||N|5||7||BLINDED TREATMENT|1963-06-15|1965-01-05|||||1970-02-28||1968-06-04|Y|1962-01-19
TRIAL STUDY 134XCP|LB|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|1||||LCN2CREA|LIPOCALIN-2/CREATININE|||||||TRANSDUCING UNIT/ML|||||||POSITIVE||UU/DL||||LOW|NOT DONE||||ERYTHROCYTES|FRESH|U|INCISION-INDUCED BLEEDING METHOD|MDRD ENZYMATIC JAPANESE FORMULA||U|U|N|N|||Y|1||38||BLINDED TREATMENT|1966-02-01|1960-05-18|||||1964-11-10||1970-01-17|U|1967-08-08
TRIAL STUDY 134XCP|LB|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|2||||SVCAM1|SOLUBLE VASC CELL ADHESION MOLECULE 1|||||||NMOL/G|||||||POSITIVE||SPRAY||||NORMAL|NOT DONE||||CORD SERUM|UNEXPECTED ODOR|NA|IMMUNORADIOMETRIC ASSAY|MDRD ENZYMATIC FORMULA||N|N|N|NA|||Y|1||38||OBSERVATION|1962-04-25|1961-07-21|||||1971-10-26||1970-05-26|NA|1973-06-26
TRIAL STUDY 134XCP|LB|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|1||||HYPERCHR|HYPERCHROMIA|||||||DAGU|||||||TRACE||NMOL/DAY||||ABNORMAL|NOT DONE||||DERMAL TISSUE|LACTESCENT|NA|HEMATOXYLIN AND EOSIN STAIN|CKD-EPI CYSTATIN C FORMULA||N|U|Y|N|||Y|2||58||LONG-TERM FOLLOW-UP|1962-10-25|1971-03-04|||||1965-07-13||1966-02-27|Y|1963-12-29
TRIAL STUDY 134XCP|LB|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|2||||CYBILI|BILIRUBIN CRYSTALS|||||||APL U|||||||TRACE||CMOL||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|UNEXPECTED ODOR|Y|IMMUNE REPERTOIRE DEEP SEQUENCING|FIBROSIS 4 FORMULA||N|N|NA|U|||Y|2||58||OPEN LABEL TREATMENT|1964-03-13|1968-12-01|||||1964-05-25||1965-08-09|U|1961-12-20
TRIAL STUDY 134XCP|LB|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|1||||IGA|IMMUNOGLOBULIN A|||||||G/G/DAY|||||||INDETERMINATE||G/DL||||HIGH|NOT DONE||||BUFFY COAT|ICTERIC|U|FLOCCULATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|U|||NA|3||39||BLINDED TREATMENT|1970-12-04|1968-06-01|||||1970-09-07||1966-02-10|N|1966-04-04
TRIAL STUDY 134XCP|LB|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|2||||ALBGALB|GLYCATED ALBUMIN/ALBUMIN|||||||10^3 DNA COPIES/ML|||||||NEGATIVE||ML/M2/H||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|ROOM TEMPERATURE|Y|POLYSOMNOGRAPHY|NASH FIBROSURE FORMULA||N|U|N|N|||N|3||39||SCREENING|1963-12-02|1960-11-16|||||1970-12-16||1971-04-04|U|1964-01-07
TRIAL STUDY 134XCP|LB|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|1||||NACLR|SODIUM CLEARANCE|||||||UU/DL|||||||TRACE||VOXEL||||HIGH|NOT DONE||||LUNG SURFACTANT|ROOM TEMPERATURE|NA|CELLULOSE TAPE|MDRD 6 VARIABLE FORMULA||U|N|NA|NA|||N|4||88||FOLLOW-UP|1967-07-04|1971-10-21|||||1972-11-02||1973-04-16|NA|1960-06-17
TRIAL STUDY 134XCP|LB|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|2||||MPV|MEAN PLATELET VOLUME|||||||NG/DAY|||||||INDETERMINATE||10^12 IU/L||||LOW|NOT DONE||||EXPIRED AIR|AGGLUTINATED|N|NUCLEAR RADIOLOGY|FIBROTEST FORMULA||U|Y|N|NA|||N|4||88||SCREENING|1963-05-01|1961-01-16|||||1970-07-26||1962-09-18|N|1971-06-23
TRIAL STUDY 134XCP|LB|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|1||||IGFBP1|INSULIN-LIKE GROWTH FACTOR BINDING PROT1|||||||CUP EQ|||||||BORDERLINE||NMOL/G||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|CALCIFIED|NA|IMMUNORADIOMETRIC ASSAY|CKD-EPI FORMULA||U|NA|N|U|||N|5||7||SCREENING|1971-06-12|1973-05-31|||||1968-04-19||1971-07-17|U|1960-01-20
TRIAL STUDY 134XCP|LB|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|2||||SHBG|SEX HORMONE BINDING GLOBULIN|||||||OI50|||||||POSITIVE||NMOL/L||||NORMAL|NOT DONE||||VENOUS BLOOD|REFRIGERATED|N|MANUAL CLOT DETECTION|ASH FIBROSURE FORMULA||Y|Y|N|Y|||Y|5||7||FOLLOW-UP|1968-01-29|1973-01-09|||||1960-05-28||1966-01-05|NA|1964-05-16
TRIAL STUDY 134XCP|LB|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|1||||PROGRP|PRO-GASTRIN RELEASING PEPTIDE|||||||KEV|||||||BORDERLINE||UMOL/L/SEC||||HIGH|NOT DONE||||GASTRIC CONTENTS|NON-HEMOLYZED|U|HANSEL STAIN|NASH FIBROSURE FORMULA||NA|U|U|NA|||U|1||38||SCREENING|1969-11-26|1967-05-23|||||1963-06-10||1970-04-11|U|1968-02-04
TRIAL STUDY 134XCP|LB|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|2||||LDH1|LDH ISOENZYME 1|||||||VP/ML|||||||NEGATIVE||/H||||NORMAL|NOT DONE||||VENOUS PLASMA|AGGLUTINATED|N|BAC ACGH|MDRD 5 VARIABLE FORMULA||N|U|N|U|||Y|1||38||CONTINUATION TREATMENT|1963-01-08|1960-10-08|||||1963-05-25||1961-06-03|NA|1966-06-24
TRIAL STUDY 134XCP|LB|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|1||||B1BGLP|BETA-1B GLYCOPROTEIN|||||||MG/CM2|||||||NEGATIVE||TRANSDUCING UNIT/ML||||NORMAL|NOT DONE||||PLASMA|FROZEN|Y|ETDRS EYE CHART|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|Y|NA|||N|2||58||FOLLOW-UP|1960-08-29|1961-02-28|||||1966-01-22||1970-01-26|NA|1961-10-08
TRIAL STUDY 134XCP|LB|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|2||||MDA|3,4-METHYLENEDIOXYAMPHETAMINE|||||||CMOL/L|||||||POSITIVE||MIN/DAY||||HIGH|NOT DONE||||BREAST MILK|DRIED|N|AUTOREFRACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|NA|NA|||N|2||58||INDUCTION TREATMENT|1971-04-16|1970-05-26|||||1969-07-15||1960-04-21|NA|1968-10-27
TRIAL STUDY 134XCP|LB|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|1||||VCAM1|VASCULAR CELL ADHESION MOLECULE 1|||||||MOSM/KG|||||||BORDERLINE||KG/CM||||HIGH|NOT DONE||||SUPERNATANT, SERUM|UNEXPECTED ODOR|N|IMMUNO-PET SCAN|MDRD 6 VARIABLE FORMULA||Y|U|NA|U|||Y|3||39||RUN-IN|1969-10-19|1969-06-18|||||1970-12-07||1966-11-03|NA|1960-11-21
TRIAL STUDY 134XCP|LB|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|2||||CLCTONN|CALCITONIN|||||||% INHIBITION|||||||BORDERLINE||ML/G/MIN||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|AGGLUTINATED|U|CAPILLARY ELECTROPHORESIS|GMI MMOL/MOL FORMULA||U|U|NA|N|||N|3||39||SCREENING|1970-12-18|1960-09-02|||||1964-11-20||1967-07-07|U|1969-09-30
TRIAL STUDY 134XCP|LB|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|1||||VITB2|RIBOFLAVIN|||||||DRUM|||||||POSITIVE||BISCUIT||||LOW|NOT DONE||||BUFFY COAT|SOLIDIFIED|NA|LEAD CITRATE STAIN|ASH FIBROSURE FORMULA||N|NA|U|Y|||U|4||88||BLINDED TREATMENT|1965-02-02|1969-04-13|||||1963-09-06||1960-10-27|NA|1972-02-12
TRIAL STUDY 134XCP|LB|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|2||||OHF6B|6 BETA-HYDROXYCORTISOL|||||||MIN/DAY|||||||NEGATIVE||LOG10 ELISA UNIT||||LOW|NOT DONE||||PLASMA|NON-HEMOLYZED|N|TARGETED TRANSCRIPTOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|NA|Y|||NA|4||88||CONTINUATION TREATMENT|1964-04-27|1970-11-26|||||1961-07-23||1966-11-20|N|1962-06-13
TRIAL STUDY 134XCP|LB|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|1||||C130113|ANIMAL MIX ANTIGEN IGG ANTIBODY|||||||UL/KG/DAY|||||||NEGATIVE||GPS U||||LOW|NOT DONE||||URINE SEDIMENT|NON-HEMOLYZED|NA|TRANSVAGINAL ULTRASOUND|GMI % FORMULA||U|NA|Y|N|||U|5||7||CONTINUATION TREATMENT|1964-04-04|1972-12-09|||||1969-10-02||1970-04-26|Y|1966-08-10
TRIAL STUDY 134XCP|LB|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|2||||CD3|CD3|||||||DPM/MG|||||||INDETERMINATE||WAFER||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|HEMOLYZED|Y|MAMMOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|NA|Y|NA|||N|5||7||OBSERVATION|1960-07-21|1970-02-07|||||1964-03-11||1961-03-07|NA|1960-12-21
TRIAL STUDY 134XCP|LB|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|1||||STSA|STEROID SULFATASE ACTIVITY|||||||G|||||||TRACE||MM||||NORMAL|NOT DONE||||SYNOVIAL FLUID|FROZEN|NA|FLUORESCENT IMMUNOASSAY|CKD-EPI FORMULA||N|NA|U|N|||N|1||38||CONTINUATION TREATMENT|1960-06-13|1973-02-11|||||1973-04-24||1965-08-15|Y|1968-12-12
TRIAL STUDY 134XCP|LB|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|2||||FGF21|FIBROBLAST GROWTH FACTOR 21|||||||PG|||||||NEGATIVE||KIU||||LOW|NOT DONE||||SUPERNATANT, PLASMA|FROZEN|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|ASH FIBROSURE FORMULA||N|U|NA|Y|||NA|1||38||SCREENING|1967-04-01|1972-07-06|||||1964-04-11||1960-06-21|Y|1960-11-03
TRIAL STUDY 134XCP|LB|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|1||||INTLK26|INTERLEUKIN 26|||||||LOG10 TCID 50/DOSE|||||||TRACE||FT2||||HIGH|NOT DONE||||PLATELET|CALCIFIED|NA|SINGLE-SLICE SPIRAL CT|COCKCROFT-GAULT FORMULA||NA|Y|NA|U|||N|2||58||SCREENING|1971-08-06|1961-08-10|||||1973-08-07||1973-08-27|N|1969-09-05
TRIAL STUDY 134XCP|LB|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|2||||FGF23C|FIBROBLAST GROWTH FACTOR 23, C-TERMINAL|||||||10^9 ORGANISMS/G|||||||INVALID||STRIP||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|HEMOLYZED|NA|PHOROPTER|CKD-EPI FORMULA||U|NA|NA|NA|||N|2||58||BLINDED TREATMENT|1960-10-24|1973-04-22|||||1967-11-04||1969-11-20|U|1967-08-13
TRIAL STUDY 134XCP|LB|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|1||||METAMY|METAMYELOCYTES|||||||MEQ/L|||||||NEGATIVE||KEV||||HIGH|NOT DONE||||REFLEX TEAR|PARAFFIN-EMBEDDED|Y|QUANTITATIVE ULTRASOUND|FIBROMETER FORMULA||N|NA|Y|NA|||N|3||39||CONTINUATION TREATMENT|1966-11-14|1971-08-22|||||1967-08-16||1964-04-05|NA|1961-02-22
TRIAL STUDY 134XCP|LB|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|2||||MYCEPPOL|MYELOID PROLIFERATION POOL|||||||FEU|||||||NEGATIVE||DAYS/MONTH||||LOW|NOT DONE||||MIXED VENOUS BLOOD|GELLED|NA|FUNCTIONAL MRI|GMI MMOL/MOL FORMULA||U|N|NA|N|||NA|3||39||INDUCTION TREATMENT|1966-04-08|1963-09-28|||||1971-08-04||1969-05-23|Y|1963-08-10
TRIAL STUDY 134XCP|LB|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|1||||MITOM2AB|MITOCHONDRIAL M2 ANTIBODY|||||||MMAL|||||||TRACE||LOG10 PFU/ML||||LOW|NOT DONE||||EPIDERMAL TISSUE|LACTESCENT|N|PHOTOGRAPHY|FIBROTEST FORMULA||Y|N|N|Y|||U|4||88||CONTINUATION TREATMENT|1961-01-26|1961-08-14|||||1967-02-22||1969-12-18|NA|1967-04-04
TRIAL STUDY 134XCP|LB|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|2||||EDTACLR|EDTA CLEARANCE|||||||UV*SEC|||||||NEGATIVE||MU||||HIGH|NOT DONE||||MECONIUM|CONCENTRATED|NA|CLOT DETECTION|MDRD FORMULA||N|U|NA|N|||Y|4||88||OPEN LABEL TREATMENT|1972-01-07|1971-01-11|||||1966-06-11||1962-01-29|NA|1970-06-27
TRIAL STUDY 134XCP|LB|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|1||||APPA|AMYLOID ALPHA PRECURSOR PROTEIN|||||||MBQ|||||||TRACE||U||||HIGH|NOT DONE||||SKIN TISSUE|ICTERIC|NA|WEBER GREEN STAIN|FIBROMETER FORMULA||Y|N|N|Y|||U|5||7||OBSERVATION|1972-10-07|1965-03-31|||||1973-02-04||1970-05-14|NA|1971-12-11
TRIAL STUDY 134XCP|LB|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|2||||VITD23OH|VITAMIN D2 D3 25-OH|||||||ABSORBANCE U/MIN|||||||NEGATIVE||ML/MMHG/MIN/L||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|SOLIDIFIED|N|AMSLER GRID|NASH FIBROSURE FORMULA||NA|U|U|Y|||U|5||7||INDUCTION TREATMENT|1961-12-19|1966-12-19|||||1971-10-14||1961-02-02|U|1963-07-25
TRIAL STUDY 134XCP|LB|44199000-F1B7-4187-9E5A-AA5F69E831C3|1||||ADMA|ASYMMETRIC DIMETHYLARGININE|||||||MIN|||||||INVALID||CM H2O||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|AUTOLYZED|N|MIGET|HEPASCORE FORMULA||U|N|U|N|||NA|1||38||WASHOUT|1971-10-09|1964-04-03|||||1963-07-23||1971-05-21|N|1973-04-09
TRIAL STUDY 134XCP|LB|44199000-F1B7-4187-9E5A-AA5F69E831C3|2||||CREATCLR|CREATININE CLEARANCE|||||||EU|||||||INVALID||YEARS||||HIGH|NOT DONE||||TUMOR TISSUE|ROOM TEMPERATURE|U|DC SHEATH FLOW|MDRD FORMULA||U|Y|NA|N|||N|1||38||INDUCTION TREATMENT|1970-06-28|1968-07-31|||||1969-05-30||1961-02-18|U|1962-11-14
TRIAL STUDY 134XCP|LB|44199000-F1B7-4187-9E5A-AA5F69E831C3|1||||CSCELL|CELLULAR CASTS|||||||UG/KG/DAY|||||||BORDERLINE||CFU/G||||NORMAL|NOT DONE||||SKIN TISSUE|THAWED|Y|FARR ASSAY|HEPASCORE FORMULA||N|NA|U|U|||N|2||58||FOLLOW-UP|1972-07-18|1967-01-15|||||1967-10-17||1961-07-24|Y|1971-02-21
TRIAL STUDY 134XCP|LB|44199000-F1B7-4187-9E5A-AA5F69E831C3|2||||THEOPHYL|THEOPHYLLINE|||||||BOWL|||||||NEGATIVE||ML/CAGE/WK||||LOW|NOT DONE||||VENOUS CORD BLOOD|HEMOLYZED|N|PHOROPTER|MDRD FORMULA||N|NA|Y|U|||Y|2||58||FOLLOW-UP|1962-11-11|1972-04-11|||||1961-12-03||1970-07-10|U|1961-10-26
TRIAL STUDY 134XCP|LB|44199000-F1B7-4187-9E5A-AA5F69E831C3|1||||CSWBC|WBC CASTS|||||||10^9 CFU/ML|||||||INVALID||KS||||LOW|NOT DONE||||MENSTRUAL BLOOD|THAWED|Y|SIZE EXCLUSION CHROMATOGRAPHY|NASH FIBROSURE FORMULA||U|NA|NA|Y|||NA|3||39||OBSERVATION|1972-04-21|1973-02-12|||||1968-11-29||1965-09-22|NA|1970-04-17
TRIAL STUDY 134XCP|LB|44199000-F1B7-4187-9E5A-AA5F69E831C3|2||||T4FR|THYROXINE, FREE|||||||APS U|||||||NEGATIVE||UMOL/L/H||||LOW|NOT DONE||||TUMOR TISSUE|DRIED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||NA|Y|NA|U|||NA|3||39||BLINDED TREATMENT|1965-08-23|1960-03-19|||||1966-05-05||1960-10-20|NA|1963-08-08
TRIAL STUDY 134XCP|LB|44199000-F1B7-4187-9E5A-AA5F69E831C3|1||||PO2FIO2|PP ARTERIAL O2/FRACTION INSPIRED O2|||||||CD*S/M2|||||||INVALID||SFC/10^6 PBMC||||HIGH|NOT DONE||||EXPIRED AIR|DRIED|N|SLOAN LETTER EYE CHART 1.25%|FIBROSIS 4 FORMULA||NA|U|U|N|||U|4||88||TREATMENT|1972-10-09|1967-12-18|||||1971-08-28||1963-09-11|Y|1964-09-08
TRIAL STUDY 134XCP|LB|44199000-F1B7-4187-9E5A-AA5F69E831C3|2||||CALPRO|CALPROTECTIN|||||||NMOL BCE/NMOL|||||||POSITIVE||%/MIN||||NORMAL|NOT DONE||||CERUMEN|SOLIDIFIED|NA|KLEIHAUER-BETKE|CKD-EPI CYSTATIN C FORMULA||NA|NA|U|NA|||NA|4||88||OPEN LABEL TREATMENT|1972-02-20|1960-02-25|||||1960-05-27||1972-07-31|N|1971-07-03
TRIAL STUDY 134XCP|LB|44199000-F1B7-4187-9E5A-AA5F69E831C3|1||||CELLULAR|CELLULARITY|||||||10^5/HPF|||||||INDETERMINATE||UIU/DL||||NORMAL|NOT DONE||||RETICULOCYTES|CALCIFIED|NA|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD FORMULA||NA|N|NA|U|||U|5||7||OPEN LABEL TREATMENT|1968-03-06|1973-02-05|||||1964-11-26||1963-07-05|NA|1960-09-04
TRIAL STUDY 134XCP|LB|44199000-F1B7-4187-9E5A-AA5F69E831C3|2||||THMBAAC|THROMBIN ACTIVITY ACTUAL/CONTROL|||||||M/SEC2|||||||INVALID||MM/H||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED|NA|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROSIS 4 FORMULA||NA|N|N|Y|||N|5||7||WASHOUT|1968-08-26|1969-01-10|||||1969-01-28||1972-07-29|N|1970-09-11
TRIAL STUDY 134XCP|LB|1D487F49-92DB-4132-BD95-1B8797594DE7|1||||CHRMTNAB|CHROMATIN ANTIBODIES|||||||SACHET|||||||INDETERMINATE||NM||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|LIPEMIC|U|TARGETED GENOME SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|U|U|U|||NA|1||38||BLINDED TREATMENT|1961-01-24|1963-04-17|||||1972-10-25||1967-07-24|N|1962-05-24
TRIAL STUDY 134XCP|LB|1D487F49-92DB-4132-BD95-1B8797594DE7|2||||LPPLA2|LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2|||||||UMOL/H/MMOL|||||||TRACE||EJACULATE U||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|FRESH|N|SLOAN LETTER EYE CHART 2.5%|GMI % FORMULA||U|U|NA|NA|||U|1||38||BLINDED TREATMENT|1965-03-25|1972-04-09|||||1973-01-31||1966-10-03|NA|1968-06-25
TRIAL STUDY 134XCP|LB|1D487F49-92DB-4132-BD95-1B8797594DE7|1||||ETPPHR|ETP PEAK HEIGHT RELATIVE|||||||G|||||||INDETERMINATE||BEATS/MIN||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|LIPEMIC|N|SPIROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|U|||U|2||58||OPEN LABEL TREATMENT|1964-10-04|1967-07-10|||||1961-03-23||1969-06-15|NA|1968-09-03
TRIAL STUDY 134XCP|LB|1D487F49-92DB-4132-BD95-1B8797594DE7|2||||FATBODOV|FAT BODIES, OVAL|||||||MPL U/ML|||||||INVALID||FRACTION OF 1||||HIGH|NOT DONE||||URINE|CLOTTED|Y|HPLC/IEX|HEPASCORE FORMULA||Y|Y|NA|U|||N|2||58||LONG-TERM FOLLOW-UP|1969-04-09|1968-09-18|||||1960-06-09||1960-06-15|U|1964-01-26
TRIAL STUDY 134XCP|LB|1D487F49-92DB-4132-BD95-1B8797594DE7|1||||C130105|GRASS MIX POLLEN ANTIGEN IGA ANTIBODY|||||||MMHG/SEC|||||||TRACE||FFU||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|NON-HEMOLYZED|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|FIBROMETER FORMULA||U|U|NA|U|||Y|3||39||INDUCTION TREATMENT|1972-01-21|1969-10-24|||||1972-05-05||1972-12-17|Y|1964-07-08
TRIAL STUDY 134XCP|LB|1D487F49-92DB-4132-BD95-1B8797594DE7|2||||MKCMKBMP|MEGAKARYOCYTE AND MEGAKARYOBLAST MORPH|||||||M/SEC2|||||||POSITIVE||MU||||LOW|NOT DONE||||CAPILLARY BLOOD|FRESH|N|NUCLEAR RADIOLOGY|FIBROSIS 4 FORMULA||NA|N|Y|Y|||NA|3||39||FOLLOW-UP|1972-06-13|1968-02-25|||||1967-02-26||1968-10-24|U|1970-12-26
TRIAL STUDY 134XCP|LB|1D487F49-92DB-4132-BD95-1B8797594DE7|1||||TNF10|TNF SUPERFAMILY MEMBER 10|||||||KPA|||||||POSITIVE||MG/KG/H||||HIGH|NOT DONE||||SYNOVIAL FLUID|CLOTTED|Y|IN SITU HYBRIDIZATION|CKD-EPI CYSTATIN C FORMULA||NA|U|NA|Y|||U|4||88||BASELINE|1965-10-14|1964-09-17|||||1972-02-06||1967-07-08|NA|1967-10-03
TRIAL STUDY 134XCP|LB|1D487F49-92DB-4132-BD95-1B8797594DE7|2||||MYBLAT1|TYPE I MYELOBLASTS|||||||MV|||||||INDETERMINATE||MEQ/KG||||HIGH|NOT DONE||||HAIR|AGGLUTINATED|U|PERCUSSION|COCKCROFT-GAULT FORMULA||N|Y|NA|NA|||Y|4||88||TREATMENT|1972-11-02|1971-06-18|||||1963-08-28||1964-03-25|NA|1969-01-28
TRIAL STUDY 134XCP|LB|1D487F49-92DB-4132-BD95-1B8797594DE7|1||||INGAPAB|ISLET NEOGENESIS ASSOC PROTEIN ANTIBODY|||||||IU/KG|||||||INVALID||MMHG/L/MIN||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|AUTOLYZED|Y|HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI FORMULA||N|N|N|U|||Y|5||7||INDUCTION TREATMENT|1960-10-11|1971-08-20|||||1960-06-23||1962-07-12|N|1970-11-11
TRIAL STUDY 134XCP|LB|1D487F49-92DB-4132-BD95-1B8797594DE7|2||||BASOIM|IMMATURE BASOPHILS|||||||CMH2O/ML|||||||POSITIVE||VIRTUAL PIXEL||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|LIPEMIC|NA|SURFACE PLASMON RESONANCE|MDRD 5 VARIABLE FORMULA||Y|NA|N|U|||Y|5||7||SCREENING|1971-10-15|1964-03-10|||||1960-11-28||1961-03-12|NA|1971-06-02
TRIAL STUDY 134XCP|LB|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|1||||MUG|MURINOGLOBULIN|||||||BREATHS/MIN|||||||POSITIVE||YD||||ABNORMAL|NOT DONE||||BREAST MILK|CALCIFIED|U|SXA SCAN|CKD-EPI CREATININE FORMULA||N|N|U|U|||NA|1||38||OPEN LABEL TREATMENT|1964-05-02|1970-01-16|||||1961-07-13||1968-09-28|Y|1965-02-28
TRIAL STUDY 134XCP|LB|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|2||||EOSNUCCE|EOSINOPHILS/NUCLEATED CELLS|||||||ANTI-XA IU|||||||TRACE||MPS U||||ABNORMAL|NOT DONE||||SALIVA|ROOM TEMPERATURE|N|CONTACT SPECULAR MICROSCOPY|COCKCROFT-GAULT FORMULA||Y|U|U|U|||Y|1||38||LONG-TERM FOLLOW-UP|1963-02-23|1960-02-26|||||1969-11-03||1961-02-01|Y|1965-05-03
TRIAL STUDY 134XCP|LB|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|1||||MM2IGAB|MITOCHONDRIAL M2 IGG ANTIBODY|||||||MG/ML/DAY|||||||TRACE||KPA||||HIGH|NOT DONE||||VENOUS PLASMA|LACTESCENT|N|DYNAMIC LIGHT SCATTERING|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|NA|N|||Y|2||58||FOLLOW-UP|1969-09-25|1970-11-13|||||1962-02-08||1961-11-11|NA|1961-06-27
TRIAL STUDY 134XCP|LB|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|2||||CKBBCK|CREATINE KINASE BB/TOTAL CREATINE KINASE|||||||DAYS|||||||TRACE||10^12/L||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|HEMOLYZED|N|SICKLE CELL SOLUBILITY TEST|MDRD 5 VARIABLE FORMULA||NA|N|N|Y|||NA|2||58||FOLLOW-UP|1960-07-05|1967-02-28|||||1963-02-10||1969-07-16|N|1972-01-16
TRIAL STUDY 134XCP|LB|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|1||||BLYCE|B-LYMPHOCYTES|||||||DEG/MM|||||||INVALID||SCM||||ABNORMAL|NOT DONE||||ERYTHROCYTES|PARAFFIN-EMBEDDED|U|CHROMATOGRAPHY|MDRD 5 VARIABLE FORMULA||U|Y|U|Y|||N|3||39||RUN-IN|1970-01-01|1961-06-13|||||1961-01-22||1967-05-25|N|1969-10-24
TRIAL STUDY 134XCP|LB|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|2||||C3|COMPLEMENT C3|||||||NMOL BCE/NMOL|||||||INVALID||APL U||||HIGH|NOT DONE||||BONE|AGGLUTINATED|NA|INCISION-INDUCED BLEEDING METHOD|MDRD 6 VARIABLE FORMULA||N|Y|U|N|||NA|3||39||SCREENING|1965-07-19|1972-09-09|||||1965-01-24||1970-05-31|N|1970-05-26
TRIAL STUDY 134XCP|LB|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|1||||ANGPT2|ANGIOPOIETIN 2|||||||MMOL/DAY|||||||TRACE||HZ||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|ICTERIC|Y|TRYPAN BLUE STAIN|FIBROTEST FORMULA||U|U|U|Y|||Y|4||88||LONG-TERM FOLLOW-UP|1972-06-13|1971-06-25|||||1972-03-08||1967-10-24|N|1965-10-30
TRIAL STUDY 134XCP|LB|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|2||||NPAP|NON-PROSTATIC ACID PHOSPHATASE|||||||CI/ML|||||||INVALID||UMOL/DL||||NORMAL|NOT DONE||||CORD BLOOD|UNEXPECTED ODOR|N|IMPEDANCE CONDUCTIVITY|GMI MMOL/MOL FORMULA||Y|N|U|Y|||NA|4||88||OPEN LABEL TREATMENT|1972-06-03|1961-05-31|||||1964-05-03||1960-09-11|U|1967-04-20
TRIAL STUDY 134XCP|LB|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|1||||VITK1|VITAMIN K1|||||||MMU/ML|||||||POSITIVE||VG/DOSE||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|REFRIGERATED|U|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|NA|Y|||Y|5||7||WASHOUT|1966-11-10|1965-04-01|||||1968-09-03||1967-12-14|NA|1973-06-19
TRIAL STUDY 134XCP|LB|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|2||||GUSB|GLUCURONIDASE, BETA|||||||MMOL/KG|||||||BORDERLINE||FARAD||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|CONTAMINATED|N|TELLER ACUITY CARDS|FIBROSIS 4 FORMULA||U|Y|N|U|||N|5||7||OBSERVATION|1970-12-06|1966-11-10|||||1960-04-09||1961-01-02|Y|1961-07-22
TRIAL STUDY 134XCP|LB|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|1||||CONSIST|CONSISTENCY|||||||VP/ML|||||||INVALID||MBQ||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|REFRIGERATED|NA|ELECTROPHORESIS|CKD-EPI FORMULA||U|Y|N|Y|||NA|1||38||TREATMENT|1962-07-30|1962-01-05|||||1968-12-21||1960-04-03|NA|1967-01-11
TRIAL STUDY 134XCP|LB|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|2||||NRP1|NEUROPILIN-1|||||||VG/DOSE|||||||POSITIVE||MU||||NORMAL|NOT DONE||||BILE|PARAFFIN-EMBEDDED|U|SANGER SEQUENCING|CKD-EPI CREATININE FORMULA||U|U|NA|N|||Y|1||38||BLINDED TREATMENT|1970-11-16|1968-06-06|||||1970-11-29||1963-09-03|U|1961-01-05
TRIAL STUDY 134XCP|LB|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|1||||UROBIL|UROBILINOGEN|||||||WATT|||||||POSITIVE||UM2||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|UNEXPECTED ODOR|NA|RAJI CELL EIA|FIBROSIS 4 FORMULA||N|U|Y|N|||U|2||58||OBSERVATION|1973-01-21|1961-04-11|||||1964-06-22||1969-07-18|U|1964-04-07
TRIAL STUDY 134XCP|LB|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|2||||CCL25|CHEMOKINE (C-C MOTIF) LIGAND 25|||||||NM|||||||BORDERLINE||MMOL/MIN/KPA||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|ICTERIC|N|THICK SMEAR|ASH FIBROSURE FORMULA||U|Y|NA|N|||N|2||58||INDUCTION TREATMENT|1960-06-25|1963-01-08|||||1965-01-15||1961-06-05|N|1971-05-30
TRIAL STUDY 134XCP|LB|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|1||||T4FRIND|THYROXINE, FREE, INDIRECT|||||||ENZYME U/G HB|||||||INDETERMINATE||KCAL/DAY||||NORMAL|NOT DONE||||PLEURAL TISSUE|GELLED|N|SNP ARRAY|GMI MMOL/MOL FORMULA||U|N|NA|N|||U|3||39||RUN-IN|1960-10-04|1961-02-09|||||1967-07-30||1966-09-06|U|1973-02-16
TRIAL STUDY 134XCP|LB|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|2||||APRIL|A PROLIFERATION-INDUCING LIGAND|||||||TRANSDUCING UNIT|||||||NEGATIVE||%/S||||ABNORMAL|NOT DONE||||LAVAGE FLUID|HEMOLYZED|NA|PHASE CONTRAST MICROSCOPY|MDRD ENZYMATIC FORMULA||U|Y|U|Y|||U|3||39||SCREENING|1972-05-22|1966-10-13|||||1968-01-19||1964-10-07|U|1966-06-11
TRIAL STUDY 134XCP|LB|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|1||||GSTCREAT|GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||MEQ/DAY|||||||NEGATIVE||MMOL/G||||LOW|NOT DONE||||SMEGMA|ROOM TEMPERATURE|Y|IMMUNORADIOMETRIC ASSAY|GMI % FORMULA||U|NA|Y|U|||N|4||88||BLINDED TREATMENT|1961-02-07|1966-06-17|||||1964-02-09||1970-10-10|U|1968-06-15
TRIAL STUDY 134XCP|LB|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|2||||BNZLCGN|BENZOYLECGONINE|||||||NMOL/KG/DAY|||||||INVALID||NMOL/L/MIN||||LOW|NOT DONE||||VENOUS CORD BLOOD|NON-HEMOLYZED|U|TRYPAN BLUE STAIN|MDRD 5 VARIABLE FORMULA||Y|NA|Y|U|||U|4||88||WASHOUT|1962-12-08|1964-04-14|||||1965-01-02||1972-01-21|NA|1972-05-13
TRIAL STUDY 134XCP|LB|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|1||||CTXIICRT|TYPE II COLLAGEN C-TELOPEPTIDES/CREAT|||||||MCI|||||||BORDERLINE||KUSP||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|CALCIFIED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CYSTATIN C FORMULA||U|Y|U|N|||Y|5||7||OPEN LABEL TREATMENT|1966-06-17|1963-07-02|||||1965-01-31||1963-05-15|U|1969-03-14
TRIAL STUDY 134XCP|LB|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|2||||KYNURNN|KYNURENINE|||||||MSEC|||||||INVALID||UMOL/KG/MIN||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|ROOM TEMPERATURE|N|COULOMETRIC TITRATION|CKD-EPI FORMULA||U|Y|N|NA|||U|5||7||BASELINE|1970-03-23|1966-01-20|||||1965-05-08||1968-08-27|U|1967-11-01
TRIAL STUDY 134XCP|LB|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|1||||LYMCLF|LYMPHOCYTES, CLEFTED|||||||UEQ|||||||NEGATIVE||10^3 ORGANISMS/ML||||HIGH|NOT DONE||||SEBUM|DRIED|U|HIGH RESOLUTION CT|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|N|Y|||Y|1||38||TREATMENT|1963-12-12|1970-09-13|||||1970-10-08||1962-05-29|N|1965-01-07
TRIAL STUDY 134XCP|LB|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|2||||LIPASLAL|LIPASE, LYSOSOMAL ACID|||||||FFU|||||||BORDERLINE||UG/M2/MIN||||HIGH|NOT DONE||||EPITHELIAL CELL|ROOM TEMPERATURE|NA|COMPLEMENT FIXATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|N|NA|||U|1||38||OBSERVATION|1969-12-30|1967-10-23|||||1960-03-30||1960-11-12|U|1965-02-24
TRIAL STUDY 134XCP|LB|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|1||||MCPROT|MONOCLONAL PROTEIN|||||||MILE|||||||TRACE||UGEQ||||LOW|NOT DONE||||SERUM OR PLASMA|FRESH|NA|STRESS ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|NA|U|||NA|2||58||OPEN LABEL TREATMENT|1971-02-21|1965-01-15|||||1968-08-03||1961-07-16|Y|1968-06-13
TRIAL STUDY 134XCP|LB|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|2||||LTD4|LEUKOTRIENE D4|||||||MG/CM2|||||||INDETERMINATE||GMFI||||LOW|NOT DONE||||EPITHELIAL CELL|ICTERIC|Y|REBOUND TONOMETRY|CKD-EPI FORMULA||Y|U|Y|U|||Y|2||58||OPEN LABEL TREATMENT|1969-02-15|1968-02-01|||||1961-06-10||1965-01-15|U|1967-03-15
TRIAL STUDY 134XCP|LB|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|1||||HIST1AB|HISTONE 1 ANTIBODY|||||||UKAT|||||||INDETERMINATE||SEC||||ABNORMAL|NOT DONE||||SERUM|AGGLUTINATED|U|MRI|HEPASCORE FORMULA||NA|Y|Y|Y|||N|3||39||RUN-IN|1971-11-05|1969-04-02|||||1972-08-10||1969-07-28|N|1964-08-19
TRIAL STUDY 134XCP|LB|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|2||||HYDROGEN|HYDROGEN|||||||BU/ML|||||||INDETERMINATE||CYCLE/MIN||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|FRESH|Y|INCISION-INDUCED BLEEDING METHOD|GMI MMOL/MOL FORMULA||Y|U|N|Y|||U|3||39||TREATMENT|1965-07-07|1973-03-21|||||1966-02-16||1964-02-29|Y|1962-04-05
TRIAL STUDY 134XCP|LB|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|1||||TXB2|THROMBOXANE B2|||||||CL|||||||INDETERMINATE||U/ML||||ABNORMAL|NOT DONE||||SKIN TISSUE|SOLIDIFIED|U|PET/CT SCAN WITHOUT CONTRAST|GMI % FORMULA||U|Y|N|N|||N|4||88||CONTINUATION TREATMENT|1960-09-16|1970-01-28|||||1972-10-22||1972-04-10|U|1969-03-22
TRIAL STUDY 134XCP|LB|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|2||||APOE|APOLIPOPROTEIN E|||||||PATCH|||||||TRACE||TABLET||||ABNORMAL|NOT DONE||||RETICULOCYTES|HEMOLYZED|U|BAC ACGH|CKD-EPI CREATININE FORMULA||Y|U|N|Y|||U|4||88||FOLLOW-UP|1971-01-04|1968-08-23|||||1970-10-29||1969-11-18|NA|1960-05-16
TRIAL STUDY 134XCP|LB|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|1||||APOE4|APOLIPOPROTEIN E4|||||||UG/ML/H|||||||POSITIVE||/VF||||HIGH|NOT DONE||||VENOUS BLOOD|UNEXPECTED ODOR|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|Y|||Y|5||7||FOLLOW-UP|1973-03-31|1963-06-07|||||1968-12-16||1973-01-25|N|1967-01-24
TRIAL STUDY 134XCP|LB|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|2||||GLOBUL|GLOBULIN|||||||/40 HPFS|||||||TRACE||10^12 IU/L||||ABNORMAL|NOT DONE||||SPERMATOZOON|SOLIDIFIED|Y|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA||U|Y|N|NA|||NA|5||7||WASHOUT|1966-07-06|1972-10-29|||||1971-06-15||1963-01-13|U|1970-08-06
TRIAL STUDY 134XCP|LB|33233744-4E16-437D-852B-B5F2CCC94B1A|1||||BLASTNCE|BLASTS/NUCLEATED CELLS|||||||PPTR|||||||POSITIVE||10^3 COPIES/ML||||NORMAL|NOT DONE||||CALCULUS|CLOTTED|U|WHOLE TRANSCRIPTOME SEQUENCING|GMI % FORMULA||Y|N|U|U|||Y|1||38||BLINDED TREATMENT|1972-02-10|1965-05-03|||||1967-03-22||1966-08-15|NA|1973-02-05
TRIAL STUDY 134XCP|LB|33233744-4E16-437D-852B-B5F2CCC94B1A|2||||ICAM3|INTERCELLULAR ADHESION MOLECULE 3|||||||NMOL/MOL|||||||POSITIVE||ML/KG/DAY||||NORMAL|NOT DONE||||AMNIOTIC FLUID|UNEXPECTED ODOR|Y|IVY INCISION METHOD|GMI % FORMULA||U|U|N|U|||U|1||38||BASELINE|1968-01-19|1969-03-13|||||1961-12-15||1967-06-18|NA|1966-02-20
TRIAL STUDY 134XCP|LB|33233744-4E16-437D-852B-B5F2CCC94B1A|1||||SCKCERBC|SICKLE CELLS/ERYTHROCYTES|||||||ML/S|||||||INVALID||PMOL/DAY||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|HEMOLYZED|U|PH METER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA||Y|U|N|Y|||Y|2||58||RUN-IN|1968-06-01|1963-06-08|||||1962-06-11||1966-06-02|U|1965-05-12
TRIAL STUDY 134XCP|LB|33233744-4E16-437D-852B-B5F2CCC94B1A|2||||CLCTRIOL|CALCITRIOL|||||||NMOL/L|||||||NEGATIVE||APL U||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|NON-HEMOLYZED|Y|MICROBIAL CULTURE, SOLID|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|Y|||N|2||58||FOLLOW-UP|1965-01-19|1968-04-25|||||1973-07-24||1964-03-26|U|1969-11-13
TRIAL STUDY 134XCP|LB|33233744-4E16-437D-852B-B5F2CCC94B1A|1||||OCCBLD|OCCULT BLOOD|||||||FT|||||||INDETERMINATE||L/MIN/M2||||ABNORMAL|NOT DONE||||LYMPH|AUTOLYZED|N|EPSILOMETER|MDRD ENZYMATIC JAPANESE FORMULA||N|U|Y|U|||NA|3||39||RUN-IN|1969-12-31|1967-06-14|||||1965-02-03||1962-09-01|NA|1967-04-03
TRIAL STUDY 134XCP|LB|33233744-4E16-437D-852B-B5F2CCC94B1A|2||||CAIONPH|CALCIUM, IONIZED PH ADJUSTED|||||||TUBERCULIN UNIT|||||||POSITIVE||UV||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CLOTTED|NA|OSCILLOMETRY|COCKCROFT-GAULT FORMULA||Y|N|Y|N|||Y|3||39||LONG-TERM FOLLOW-UP|1972-05-28|1968-03-20|||||1963-12-13||1968-05-14|U|1971-11-17
TRIAL STUDY 134XCP|LB|33233744-4E16-437D-852B-B5F2CCC94B1A|1||||BNZLCGN|BENZOYLECGONINE|||||||IU/MG|||||||INDETERMINATE||LOG10 PFU||||HIGH|NOT DONE||||SWABBED MATERIAL|REFRIGERATED|Y|VENTILATION PERFUSION LUNG SCAN|COCKCROFT-GAULT FORMULA||Y|NA|Y|U|||NA|4||88||BLINDED TREATMENT|1969-05-02|1969-04-11|||||1968-12-14||1964-03-04|U|1961-02-23
TRIAL STUDY 134XCP|LB|33233744-4E16-437D-852B-B5F2CCC94B1A|2||||HCG|CHORIOGONADOTROPIN BETA|||||||LOG10 PFU|||||||TRACE||10^9 CFU||||HIGH|NOT DONE||||BONE MARROW|NON-HEMOLYZED|Y|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD FORMULA||U|U|NA|NA|||U|4||88||LONG-TERM FOLLOW-UP|1970-01-12|1970-09-09|||||1966-05-19||1971-06-24|Y|1968-04-08
TRIAL STUDY 134XCP|LB|33233744-4E16-437D-852B-B5F2CCC94B1A|1||||GLTRCE|GLITTER CELLS|||||||USIEMENS|||||||TRACE||NMOL/L/MIN||||HIGH|NOT DONE||||KERATINOCYTE|NON-HEMOLYZED|NA|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROTEST FORMULA||NA|Y|NA|Y|||Y|5||7||SCREENING|1972-02-03|1969-06-01|||||1972-06-05||1968-07-26|Y|1961-07-13
TRIAL STUDY 134XCP|LB|33233744-4E16-437D-852B-B5F2CCC94B1A|2||||CSFAT|FATTY CASTS|||||||CMH2O*S2/ML|||||||INVALID||G/CAGE/DAY||||ABNORMAL|NOT DONE||||URINE SEDIMENT|CLOTTED|N|RAJI CELL EIA|COCKCROFT-GAULT FORMULA||N|NA|Y|U|||Y|5||7||BLINDED TREATMENT|1966-02-16|1961-01-14|||||1968-04-14||1970-11-25|U|1963-03-23
TRIAL STUDY 134XCP|LB|B27DC754-F6E2-41E3-9804-0F92AE0006B4|1||||C130111|MOLD MIX ANTIGEN IGA ANTIBODY|||||||PFU/ML|||||||BORDERLINE||V/SEC||||HIGH|NOT DONE||||LAVAGE FLUID|DRIED|NA|PHYSICAL EXAMINATION|FIBROSIS 4 FORMULA||U|N|NA|N|||U|1||38||WASHOUT|1966-09-21|1962-08-02|||||1964-01-02||1966-10-17|Y|1962-01-09
TRIAL STUDY 134XCP|LB|B27DC754-F6E2-41E3-9804-0F92AE0006B4|2||||APOA|APOLIPOPROTEIN A|||||||PACK YEAR|||||||INDETERMINATE||CD*S/M2||||NORMAL|NOT DONE||||DISCHARGE|FRESH|NA|MALDI-TOF|COCKCROFT-GAULT FORMULA||Y|U|Y|Y|||Y|1||38||TREATMENT|1968-03-22|1962-09-04|||||1963-04-12||1971-08-06|N|1963-02-03
TRIAL STUDY 134XCP|LB|B27DC754-F6E2-41E3-9804-0F92AE0006B4|1||||CSHYGR|HYALOGRANULAR CASTS|||||||10^6 RNA COPIES/ML|||||||TRACE||KA_U/DL||||HIGH|NOT DONE||||CERUMEN|AUTOLYZED|Y|PATHOLOGICAL EVALUATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|Y|U|||N|2||58||SCREENING|1960-12-04|1963-10-23|||||1967-12-23||1969-05-09|NA|1962-04-20
TRIAL STUDY 134XCP|LB|B27DC754-F6E2-41E3-9804-0F92AE0006B4|2||||HALPRZLM|HYDROXYALPRAZOLAM|||||||UMOL/MG/MIN|||||||NEGATIVE||SHOCK WAVE||||NORMAL|NOT DONE||||SERUM OR PLASMA|ICTERIC|U|MRI|NASH FIBROSURE FORMULA||U|U|U|N|||NA|2||58||RUN-IN|1963-01-20|1966-08-04|||||1961-10-08||1960-05-30|Y|1966-03-26
TRIAL STUDY 134XCP|LB|B27DC754-F6E2-41E3-9804-0F92AE0006B4|1||||GRANCE|GRANULOCYTES/TOTAL CELLS|||||||UMOL/L|||||||POSITIVE||U/G/MIN||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|UNEXPECTED ODOR|Y|HEMATOXYLIN AND EOSIN STAIN|CKD-EPI FORMULA||NA|U|NA|Y|||N|3||39||BLINDED TREATMENT|1966-03-31|1964-07-09|||||1963-12-10||1969-10-08|Y|1965-01-10
TRIAL STUDY 134XCP|LB|B27DC754-F6E2-41E3-9804-0F92AE0006B4|2||||PRGNENLN|PREGNENOLONE|||||||DAYS/WK|||||||INVALID||PUFF||||HIGH|NOT DONE||||REFLEX TEAR|HEMOLYZED|N|SANGER SEQUENCING|CKD-EPI FORMULA||Y|U|U|NA|||NA|3||39||OPEN LABEL TREATMENT|1969-07-01|1964-12-04|||||1965-11-05||1961-04-13|Y|1972-06-26
TRIAL STUDY 134XCP|LB|B27DC754-F6E2-41E3-9804-0F92AE0006B4|1||||OPIATE|OPIATE|||||||ANSON U|||||||NEGATIVE||HZ||||ABNORMAL|NOT DONE||||CORD BLOOD|CALCIFIED|N|CELLULAR PROLIFERATION ASSAY|MDRD 5 VARIABLE FORMULA||U|U|Y|U|||U|4||88||BLINDED TREATMENT|1962-07-31|1966-04-05|||||1969-06-29||1967-03-14|N|1968-04-08
TRIAL STUDY 134XCP|LB|B27DC754-F6E2-41E3-9804-0F92AE0006B4|2||||AMYLB42|AMYLOID BETA 1-42|||||||YEARS|||||||NEGATIVE||MG/DOSE||||ABNORMAL|NOT DONE||||VENOUS PLASMA|DRIED|U|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|FIBROSIS 4 FORMULA||U|Y|Y|Y|||NA|4||88||FOLLOW-UP|1970-06-21|1960-03-19|||||1971-04-02||1972-03-02|NA|1961-03-27
TRIAL STUDY 134XCP|LB|B27DC754-F6E2-41E3-9804-0F92AE0006B4|1||||LYMPLLE|PLASMACYTOID LYMPHOCYTES/LEUKOCYTES|||||||SYRINGE|||||||BORDERLINE||/HPF||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|LACTESCENT|NA|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|CKD-EPI CYSTATIN C FORMULA||N|N|NA|Y|||Y|5||7||OPEN LABEL TREATMENT|1970-06-17|1965-09-22|||||1971-07-02||1967-07-29|Y|1963-02-22
TRIAL STUDY 134XCP|LB|B27DC754-F6E2-41E3-9804-0F92AE0006B4|2||||CYAMPPH|AMORPHOUS PHOSPHATE CRYSTALS|||||||DPM|||||||INDETERMINATE||MMOL/DAY||||HIGH|NOT DONE||||VENOUS CORD BLOOD|GELLED|Y|COLORIMETRY|NASH FIBROSURE FORMULA||NA|U|U|Y|||Y|5||7||BLINDED TREATMENT|1970-10-13|1961-12-28|||||1966-02-06||1973-05-24|Y|1971-01-28
TRIAL STUDY 134XCP|LB|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|1||||BLYCE|B-LYMPHOCYTES|||||||M/SEC|||||||NEGATIVE||F||||ABNORMAL|NOT DONE||||PLATELET|NON-HEMOLYZED|NA|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD ENZYMATIC FORMULA||Y|N|NA|NA|||Y|1||38||BLINDED TREATMENT|1973-04-17|1968-01-04|||||1966-03-04||1964-12-16|Y|1960-11-15
TRIAL STUDY 134XCP|LB|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|2||||IL6SR|SOLUBLE INTERLEUKIN 6 RECEPTOR|||||||MMOL/MOL|||||||INVALID||MMOL/L||||HIGH|NOT DONE||||CAPILLARY BLOOD|CONCENTRATED|NA|CHROMATOGRAPHY|COCKCROFT-GAULT FORMULA||NA|N|U|Y|||U|1||38||RUN-IN|1971-05-30|1965-03-12|||||1972-11-27||1961-10-05|Y|1968-05-20
TRIAL STUDY 134XCP|LB|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|1||||CTXI|TYPE I COLLAGEN C-TELOPEPTIDES|||||||PMOL/G|||||||BORDERLINE||TRANSDUCING UNIT||||LOW|NOT DONE||||URINE|CONCENTRATED|U|RULER MEASUREMENT METHOD|CKD-EPI FORMULA||NA|U|U|U|||NA|2||58||FOLLOW-UP|1970-12-27|1961-12-11|||||1968-05-07||1969-12-13|U|1966-12-26
TRIAL STUDY 134XCP|LB|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|2||||ETPLTR|ETP LAG TIME RELATIVE|||||||UM2|||||||POSITIVE||ENZYME U/M2||||LOW|NOT DONE||||LUNG SURFACTANT|CONCENTRATED|U|PHOTOMETRIC CLOT DETECTION|GMI % FORMULA||U|Y|Y|U|||Y|2||58||BASELINE|1963-02-08|1961-08-06|||||1964-04-07||1972-07-17|U|1961-05-03
TRIAL STUDY 134XCP|LB|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|1||||PLATSAT|PLATELET SATELLITISM|||||||USEC|||||||BORDERLINE||MG/MOL||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|UNEXPECTED ODOR|Y|IMMUNOCHROMATOGRAPHY|CKD-EPI FORMULA||Y|Y|N|U|||U|3||39||RUN-IN|1962-10-08|1971-05-20|||||1961-09-12||1962-04-19|U|1972-02-28
TRIAL STUDY 134XCP|LB|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|2||||ANTHRMAG|ANTITHROMBIN ANTIGEN|||||||MEQ/MMOL|||||||INVALID||/MIN||||LOW|NOT DONE||||ALVEOLAR AIR|PARAFFIN-EMBEDDED|Y|LEAD CITRATE STAIN|MDRD FORMULA||N|N|U|Y|||Y|3||39||INDUCTION TREATMENT|1969-07-12|1972-12-14|||||1964-09-13||1966-08-08|NA|1964-09-07
TRIAL STUDY 134XCP|LB|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|1||||MONOIM|IMMATURE MONOCYTES|||||||PMOL/DAY|||||||BORDERLINE||V||||NORMAL|NOT DONE||||SEMEN|AUTOLYZED|U|NEXT GENERATION TARGETED SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|Y|U|||U|4||88||LONG-TERM FOLLOW-UP|1963-12-21|1961-11-18|||||1968-01-28||1969-08-09|NA|1964-02-03
TRIAL STUDY 134XCP|LB|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|2||||CYSULFA|SULFA CRYSTALS|||||||GY|||||||INVALID||LOG10 PFU/ML||||ABNORMAL|NOT DONE||||SEBUM|AGGLUTINATED|NA|SICKLE CELL SOLUBILITY TEST|NASH FIBROSURE FORMULA||N|U|NA|N|||N|4||88||BASELINE|1972-10-31|1964-02-03|||||1970-08-15||1960-11-15|U|1961-05-25
TRIAL STUDY 134XCP|LB|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|1||||PIVKAII|PROTEIN INDUCED BY VITAMIN K ABSENCE-II|||||||G|||||||INVALID||PA||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|CONCENTRATED|Y|HPLC-FL|MDRD ENZYMATIC JAPANESE FORMULA||N|U|Y|N|||N|5||7||OBSERVATION|1966-09-15|1969-02-04|||||1972-10-31||1967-12-02|U|1968-12-26
TRIAL STUDY 134XCP|LB|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|2||||FRTNLC|FERRITIN LIGHT CHAIN|||||||MPS U|||||||NEGATIVE||RING||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|HEMOLYZED|NA|MICROBIAL CULTURE|FIBROTEST FORMULA||N|N|NA|N|||NA|5||7||INDUCTION TREATMENT|1961-09-21|1966-07-29|||||1972-03-01||1966-02-03|N|1963-01-09
TRIAL STUDY 134XCP|LB|BDE843D8-2F69-4542-BC47-D52302FD4898|1||||HGBA1HGB|HEMOGLOBIN A1/TOTAL HEMOGLOBIN|||||||ML/H|||||||TRACE||ANTI-XA IU/ML||||HIGH|NOT DONE||||SERUM OR PLASMA|NON-HEMOLYZED|Y|DUKE INCISION METHOD|FIBROSIS 4 FORMULA||U|U|U|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1965-07-07|1968-05-02|||||1965-09-18||1967-07-16|N|1968-06-02
TRIAL STUDY 134XCP|LB|BDE843D8-2F69-4542-BC47-D52302FD4898|2||||HLAIPRA|HLA CLASS I PANEL REACTIVE ANTIBODY|||||||GRAVITATIONAL UNIT|||||||NEGATIVE||S^-1(%O2)^-1||||LOW|NOT DONE||||CEREBROSPINAL FLUID|CONCENTRATED|Y|PHOROPTER|ASH FIBROSURE FORMULA||N|N|U|N|||N|1||38||FOLLOW-UP|1968-03-25|1964-04-02|||||1963-07-18||1969-09-19|U|1972-11-28
TRIAL STUDY 134XCP|LB|BDE843D8-2F69-4542-BC47-D52302FD4898|1||||C5FR|COMPLEMENT C5, FREE|||||||ML/100G/MIN|||||||INVALID||CMOL/L||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|DRIED|N|TEST STRIP|GMI MMOL/MOL FORMULA||U|N|N|N|||NA|2||58||OPEN LABEL TREATMENT|1969-12-23|1961-11-27|||||1973-06-14||1969-08-21|Y|1961-04-29
TRIAL STUDY 134XCP|LB|BDE843D8-2F69-4542-BC47-D52302FD4898|2||||FSH|FOLLICLE STIMULATING HORMONE|||||||10^3 ORGANISMS/G|||||||INDETERMINATE||APPLICATION||||NORMAL|NOT DONE||||PUS|DRIED|NA|PHOTOMETRIC CLOT DETECTION|MDRD 5 VARIABLE FORMULA||NA|NA|N|N|||Y|2||58||SCREENING|1960-03-20|1966-06-16|||||1966-04-27||1961-11-25|NA|1971-05-06
TRIAL STUDY 134XCP|LB|BDE843D8-2F69-4542-BC47-D52302FD4898|1||||PCDW|PLATELET COMPONENT DISTRIBUTION WIDTH|||||||COPIES/ML|||||||POSITIVE||MPL U||||NORMAL|NOT DONE||||VITREOUS HUMOR|ICTERIC|Y|PLAQUE REDUCTION NEUTRALIZATION ASSAY|FIBROTEST FORMULA||U|Y|Y|N|||NA|3||39||OPEN LABEL TREATMENT|1968-06-25|1965-04-20|||||1964-08-09||1967-07-31|Y|1967-07-02
TRIAL STUDY 134XCP|LB|BDE843D8-2F69-4542-BC47-D52302FD4898|2||||C130136|AMERICAN COCKROACH ANTIGEN IGE ANTIBODY|||||||KM|||||||INDETERMINATE||RING||||ABNORMAL|NOT DONE||||CORD BLOOD|ROOM TEMPERATURE|N|IMMUNOCHROMATOGRAPHY|CKD-EPI CREATININE FORMULA||N|NA|NA|U|||NA|3||39||RUN-IN|1961-01-20|1967-11-25|||||1962-08-29||1966-05-29|U|1968-05-27
TRIAL STUDY 134XCP|LB|BDE843D8-2F69-4542-BC47-D52302FD4898|1||||CONDUCTU|URINE CONDUCTIVITY|||||||K|||||||INDETERMINATE||PIXELS/IN||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|GELLED|N|MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|U|U|||U|4||88||INDUCTION TREATMENT|1961-10-28|1961-05-20|||||1969-01-04||1968-09-22|U|1963-04-21
TRIAL STUDY 134XCP|LB|BDE843D8-2F69-4542-BC47-D52302FD4898|2||||SPERM|SPERMATOZOA|||||||V/V|||||||POSITIVE||VIRTUAL PIXEL||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|LACTESCENT|U|ELECTROPHORESIS|CKD-EPI FORMULA||N|N|NA|U|||Y|4||88||INDUCTION TREATMENT|1962-01-21|1972-01-19|||||1962-01-30||1962-04-15|Y|1972-03-29
TRIAL STUDY 134XCP|LB|BDE843D8-2F69-4542-BC47-D52302FD4898|1||||CAPHOSPD|CALCIUM - PHOSPHORUS PRODUCT|||||||YD|||||||POSITIVE||10^3 RNA COPIES/ML||||HIGH|NOT DONE||||SALIVA|CALCIFIED|U|CONTRAST ENHANCED SPIRAL CT SCAN|FIBROSIS 4 FORMULA||NA|NA|N|NA|||N|5||7||BLINDED TREATMENT|1962-11-15|1962-03-07|||||1967-07-18||1973-07-09|U|1971-09-03
TRIAL STUDY 134XCP|LB|BDE843D8-2F69-4542-BC47-D52302FD4898|2||||CRLPLSMN|CERULOPLASMIN|||||||PRESSOR UNITS|||||||INDETERMINATE||UM||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED|Y|SEQUENCING|FIBROTEST FORMULA||U|NA|Y|Y|||NA|5||7||OBSERVATION|1964-03-27|1966-09-16|||||1971-11-28||1965-11-25|Y|1972-03-17
TRIAL STUDY 134XCP|LB|A8C8CB0C-C575-414C-BF1C-846361DB03BC|1||||CD161LY|CD161/LYMPHOCYTES|||||||PMOL/DAY|||||||BORDERLINE||FEU||||NORMAL|NOT DONE||||PERSPIRATION|CLOTTED|U|PHOTOMETRY|CKD-EPI CREATININE FORMULA||Y|N|Y|U|||U|1||38||BASELINE|1968-11-16|1973-07-30|||||1973-09-01||1963-12-04|U|1966-12-06
TRIAL STUDY 134XCP|LB|A8C8CB0C-C575-414C-BF1C-846361DB03BC|2||||CLCREAT|CHLORIDE/CREATININE|||||||TITER|||||||INDETERMINATE||MEQ/UG||||HIGH|NOT DONE||||SEBUM|PARAFFIN-EMBEDDED|U|CONTRAST ENHANCED PET SCAN|FIBROSIS 4 FORMULA||U|N|N|Y|||U|1||38||RUN-IN|1969-12-15|1970-09-06|||||1973-04-15||1970-10-09|N|1963-05-20
TRIAL STUDY 134XCP|LB|A8C8CB0C-C575-414C-BF1C-846361DB03BC|1||||CYAMPPH|AMORPHOUS PHOSPHATE CRYSTALS|||||||DRAM|||||||NEGATIVE||PT_BR||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|FRESH|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|FIBROMETER FORMULA||U|NA|NA|U|||N|2||58||LONG-TERM FOLLOW-UP|1961-05-22|1969-03-26|||||1965-02-15||1960-05-11|N|1969-05-23
TRIAL STUDY 134XCP|LB|A8C8CB0C-C575-414C-BF1C-846361DB03BC|2||||APPEAR|SPECIMEN APPEARANCE|||||||NMOL/ML/MIN|||||||TRACE||NMOL/KG/DAY||||LOW|NOT DONE||||SERUM|GELLED|NA|LIGHT SCATTERING SPECTROSCOPY|CKD-EPI CREATININE FORMULA||U|N|Y|NA|||U|2||58||WASHOUT|1965-08-14|1970-07-16|||||1968-12-09||1972-11-27|U|1973-03-01
TRIAL STUDY 134XCP|LB|A8C8CB0C-C575-414C-BF1C-846361DB03BC|1||||VEGFD|VASCULAR ENDOTHELIAL GROWTH FACTOR D|||||||PRESSOR UNITS|||||||TRACE||LM||||NORMAL|NOT DONE||||KERATINOCYTE|LACTESCENT|N|HPLC/MS|GMI MMOL/MOL FORMULA||Y|U|U|Y|||Y|3||39||OBSERVATION|1973-01-08|1968-08-16|||||1971-07-08||1967-03-08|NA|1960-03-12
TRIAL STUDY 134XCP|LB|A8C8CB0C-C575-414C-BF1C-846361DB03BC|2||||MICA|MHC CLASS I CHAIN RELATED PROTEIN A|||||||MM3/MM2/YEAR|||||||BORDERLINE||U||||HIGH|NOT DONE||||PERITONEAL FLUID|NON-HEMOLYZED|Y|DIFFUSION TENSOR MRI|FIBROSIS 4 FORMULA||Y|Y|N|N|||U|3||39||LONG-TERM FOLLOW-UP|1970-08-22|1962-01-24|||||1965-10-30||1968-06-13|Y|1970-01-19
TRIAL STUDY 134XCP|LB|A8C8CB0C-C575-414C-BF1C-846361DB03BC|1||||LPL|LIPOPROTEIN LIPASE|||||||LX|||||||INDETERMINATE||ML/G/DAY||||ABNORMAL|NOT DONE||||TISSUE|CONTAMINATED|N|IN VITRO GENE EXPRESSION ASSAY|GMI MMOL/MOL FORMULA||Y|Y|Y|U|||N|4||88||OBSERVATION|1968-07-06|1966-04-19|||||1972-05-25||1969-11-02|U|1966-07-15
TRIAL STUDY 134XCP|LB|A8C8CB0C-C575-414C-BF1C-846361DB03BC|2||||GLDIGAAB|GLIADIN IGA ANTIBODY|||||||FG|||||||POSITIVE||MMOL2/L2||||HIGH|NOT DONE||||SWABBED MATERIAL|UNEXPECTED ODOR|Y|SPECULAR MICROSCOPY|NASH FIBROSURE FORMULA||U|Y|U|U|||U|4||88||OBSERVATION|1969-02-14|1965-01-24|||||1964-06-12||1963-03-11|U|1965-08-04
TRIAL STUDY 134XCP|LB|A8C8CB0C-C575-414C-BF1C-846361DB03BC|1||||CHOLINES|CHOLINESTERASE|||||||KG/MOL|||||||INDETERMINATE||DEG/S||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|HEMOLYZED|U|TRIPLE-PHASE SPIRAL CT SCAN|FIBROTEST FORMULA||N|N|U|NA|||N|5||7||RUN-IN|1963-03-15|1972-07-22|||||1962-03-21||1969-12-27|N|1965-03-29
TRIAL STUDY 134XCP|LB|A8C8CB0C-C575-414C-BF1C-846361DB03BC|2||||TRCYANDP|TRICYCLIC ANTIDEPRESSANTS|||||||DAYS|||||||NEGATIVE||GPL U||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|CONCENTRATED|NA|NUCLEAR RADIOLOGY|CKD-EPI CYSTATIN C FORMULA||NA|U|U|U|||NA|5||7||INDUCTION TREATMENT|1971-12-30|1964-07-26|||||1961-08-04||1968-06-07|Y|1966-10-06
TRIAL STUDY 134XCP|LB|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|1||||MONOBLLE|MONOBLASTS/LEUKOCYTES|||||||UKAT/10^12 RBC|||||||INVALID||UG/L/H||||ABNORMAL|NOT DONE||||PUS|CONCENTRATED|U|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|ASH FIBROSURE FORMULA||NA|Y|N|NA|||N|1||38||TREATMENT|1970-11-12|1961-01-29|||||1972-08-24||1964-08-02|U|1970-04-05
TRIAL STUDY 134XCP|LB|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|2||||RETIRBC|RETICULOCYTES/ERYTHROCYTES|||||||UG/G/H|||||||BORDERLINE||MOSM||||HIGH|NOT DONE||||INFRANATANT, PLASMA|PARAFFIN-EMBEDDED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|FIBROMETER FORMULA||N|U|N|U|||U|1||38||INDUCTION TREATMENT|1967-08-18|1964-07-26|||||1965-02-28||1973-05-24|U|1965-02-04
TRIAL STUDY 134XCP|LB|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|1||||EOSMM|EOSINOPHILIC METAMYELOCYTES|||||||/2000 RBC|||||||POSITIVE||PIXELS/IN||||ABNORMAL|NOT DONE||||MONOCYTE|NON-HEMOLYZED|NA|INCISION-INDUCED BLEEDING METHOD|FIBROTEST FORMULA||Y|NA|U|N|||Y|2||58||SCREENING|1963-07-02|1963-05-25|||||1969-12-03||1960-12-02|NA|1971-03-12
TRIAL STUDY 134XCP|LB|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|2||||PLAGMAMP|PLATELET AGGREGATION MEAN AMPLITUDE|||||||ML/SEC/1.73M2|||||||POSITIVE||/MIN||||HIGH|NOT DONE||||SEBUM|CALCIFIED|NA|SPECT/CT SCAN|FIBROSIS 4 FORMULA||U|U|U|Y|||N|2||58||FOLLOW-UP|1972-08-21|1962-04-12|||||1969-09-21||1963-07-11|U|1965-02-07
TRIAL STUDY 134XCP|LB|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|1||||INTLK1A|INTERLEUKIN 1 ALPHA|||||||MMOL2/L2|||||||POSITIVE||ML/MIN||||HIGH|NOT DONE||||LYSATE|AUTOLYZED|U|GIEMSA STAIN|GMI % FORMULA||N|Y|Y|NA|||U|3||39||FOLLOW-UP|1968-02-16|1969-06-02|||||1960-03-27||1962-09-14|N|1961-01-05
TRIAL STUDY 134XCP|LB|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|2||||C165893|WILD RYE POLLEN IGE AB RAST SCORE|||||||ML/G/MIN|||||||TRACE||MGEQ||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|ROOM TEMPERATURE|Y|RAJI CELL EIA|MDRD 4 VARIABLE FORMULA||NA|NA|U|Y|||N|3||39||CONTINUATION TREATMENT|1970-04-08|1961-01-15|||||1970-07-07||1968-07-16|N|1967-09-24
TRIAL STUDY 134XCP|LB|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|1||||HLADPB1|HLA DP BETA1 ANTIGEN|||||||FT|||||||BORDERLINE||G/G||||LOW|NOT DONE||||SEBUM|PARAFFIN-EMBEDDED|Y|TARGETED GENOME SEQUENCING|MDRD 6 VARIABLE FORMULA||N|Y|Y|N|||Y|4||88||WASHOUT|1973-07-24|1964-01-10|||||1965-04-08||1962-09-01|Y|1963-02-20
TRIAL STUDY 134XCP|LB|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|2||||CCK|CHOLECYSTOKININ|||||||UMOL/KG/MIN|||||||INDETERMINATE||APS U||||LOW|NOT DONE||||WHITE MATTER TISSUE|FRESH|U|GC/MS|NASH FIBROSURE FORMULA||N|N|U|NA|||NA|4||88||FOLLOW-UP|1965-03-06|1973-04-16|||||1964-05-19||1962-08-21|NA|1969-04-21
TRIAL STUDY 134XCP|LB|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|1||||PRZPM|PRAZEPAM|||||||RAD|||||||POSITIVE||MMOL/G||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|DRIED|U|MS/MS|HEPASCORE FORMULA||U|Y|NA|Y|||NA|5||7||OPEN LABEL TREATMENT|1968-11-01|1962-02-12|||||1967-06-19||1969-05-06|NA|1967-06-15
TRIAL STUDY 134XCP|LB|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|2||||IRF|IMMATURE RETICULOCYTE FRACTION|||||||RPM|||||||INDETERMINATE||PATCH||||LOW|NOT DONE||||DIALYSIS FLUID|FRESH|N|ULTRASOUND|MDRD ENZYMATIC FORMULA||NA|N|NA|Y|||Y|5||7||SCREENING|1973-03-30|1963-08-07|||||1971-12-18||1973-07-05|U|1962-05-10
TRIAL STUDY 134XCP|LB|86198851-0F45-45E0-A0CE-C50FEC078456|1||||PTHCT|PARATHYROID HORMONE, C-TERMINAL|||||||10^5/L|||||||TRACE||100 IU/ML||||NORMAL|NOT DONE||||EXUDATE|PARAFFIN-EMBEDDED|NA|APPLANATION TONOMETRY|GMI MMOL/MOL FORMULA||U|NA|NA|N|||NA|1||38||FOLLOW-UP|1963-03-25|1960-07-02|||||1966-04-26||1972-05-04|NA|1969-04-30
TRIAL STUDY 134XCP|LB|86198851-0F45-45E0-A0CE-C50FEC078456|2||||FATDROP|FAT DROPLET|||||||HENRY|||||||POSITIVE||GPL U||||NORMAL|NOT DONE||||STOOL|LIPEMIC|N|SCANNING ELECTRON MICROSCOPY|FIBROSIS 4 FORMULA||Y|N|Y|NA|||U|1||38||WASHOUT|1963-04-13|1972-02-05|||||1971-04-12||1968-10-11|Y|1963-07-31
TRIAL STUDY 134XCP|LB|86198851-0F45-45E0-A0CE-C50FEC078456|1||||HLAAAGT|HLA-A ANTIGEN TYPE|||||||MOSM/L|||||||INVALID||ENZYME U/M2||||HIGH|NOT DONE||||GASTRIC FLUID|REFRIGERATED|U|HPLC/IEX|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|N|NA|||N|2||58||BASELINE|1968-01-21|1963-11-11|||||1962-07-28||1960-02-23|N|1972-08-24
TRIAL STUDY 134XCP|LB|86198851-0F45-45E0-A0CE-C50FEC078456|2||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||EIA UNIT|||||||POSITIVE||H*%||||NORMAL|NOT DONE||||ERYTHROCYTES|NON-HEMOLYZED|NA|SPIROMETRY|HEPASCORE FORMULA||NA|Y|NA|NA|||U|2||58||SCREENING|1961-04-30|1964-02-13|||||1967-12-28||1971-12-24|NA|1965-10-27
TRIAL STUDY 134XCP|LB|86198851-0F45-45E0-A0CE-C50FEC078456|1||||S100B|S100 CALCIUM-BINDING PROTEIN B|||||||MGEQ|||||||TRACE||APL U/ML||||NORMAL|NOT DONE||||PERITONEAL FLUID|HEMOLYZED|Y|DISK DIFFUSION|MDRD 4 VARIABLE FORMULA||Y|U|N|Y|||U|3||39||BLINDED TREATMENT|1969-10-16|1968-04-15|||||1972-01-09||1964-08-13|U|1966-09-22
TRIAL STUDY 134XCP|LB|86198851-0F45-45E0-A0CE-C50FEC078456|2||||ETPPHR|ETP PEAK HEIGHT RELATIVE|||||||PATCH|||||||INVALID||EIA UNIT||||HIGH|NOT DONE||||DIALYSIS FLUID|HEMOLYZED|NA|TOTAL BODY IRRADIATION|HEPASCORE FORMULA||N|U|NA|Y|||U|3||39||FOLLOW-UP|1964-01-09|1968-09-23|||||1960-12-10||1971-03-11|Y|1972-07-31
TRIAL STUDY 134XCP|LB|86198851-0F45-45E0-A0CE-C50FEC078456|1||||CD10|CD10|||||||UG/L/H|||||||INDETERMINATE||ML/MMHG/MIN/L||||LOW|NOT DONE||||GASTRIC CONTENTS|ICTERIC|N|DIRECT SEQUENCING|MDRD FORMULA||U|NA|N|N|||NA|4||88||BLINDED TREATMENT|1964-03-05|1969-04-01|||||1969-09-29||1966-08-12|Y|1960-06-13
TRIAL STUDY 134XCP|LB|86198851-0F45-45E0-A0CE-C50FEC078456|2||||IOTCLR|IOTHALAMATE CLEARANCE|||||||PFU|||||||POSITIVE||G/KG||||NORMAL|NOT DONE||||EXUDATE|FROZEN|U|IVY INCISION METHOD|CKD-EPI CREATININE FORMULA||NA|NA|U|N|||Y|4||88||LONG-TERM FOLLOW-UP|1971-07-22|1964-09-01|||||1967-03-31||1973-03-22|NA|1963-04-02
TRIAL STUDY 134XCP|LB|86198851-0F45-45E0-A0CE-C50FEC078456|1||||ALP|ALKALINE PHOSPHATASE|||||||NSEC|||||||BORDERLINE||G/MOL||||ABNORMAL|NOT DONE||||PLASMA|THAWED|Y|MIGET|GMI % FORMULA||NA|N|N|NA|||U|5||7||BLINDED TREATMENT|1971-07-26|1965-01-18|||||1972-04-26||1968-01-20|Y|1966-05-07
TRIAL STUDY 134XCP|LB|86198851-0F45-45E0-A0CE-C50FEC078456|2||||VWFAAC|VON WILL FACTOR ACT ACTUAL/CONTROL|||||||INHALATION|||||||POSITIVE||ATM||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|UNEXPECTED ODOR|U|LC/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|N|N|||U|5||7||FOLLOW-UP|1963-03-01|1965-08-26|||||1962-05-12||1961-09-04|NA|1962-04-15
TRIAL STUDY 134XCP|LB|9CD28016-BED9-4159-9C1B-60821D74615B|1||||STOMCY|STOMATOCYTES|||||||/VF|||||||INDETERMINATE||LOG10 CFU/G||||HIGH|NOT DONE||||BILE|AUTOLYZED|N|MODIFIED ACID FAST STAIN|HEPASCORE FORMULA||U|U|NA|U|||Y|1||38||BLINDED TREATMENT|1968-08-24|1967-04-23|||||1964-03-06||1965-08-23|Y|1966-04-07
TRIAL STUDY 134XCP|LB|9CD28016-BED9-4159-9C1B-60821D74615B|2||||DHT|DIHYDROTESTOSTERONE|||||||FRACTION OF 1|||||||TRACE||ABSORBANCE U||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|CONTAMINATED|U|EPSILOMETER|MDRD ENZYMATIC FORMULA||NA|Y|N|Y|||N|1||38||RUN-IN|1960-08-04|1964-01-18|||||1969-12-25||1970-06-09|U|1973-01-20
TRIAL STUDY 134XCP|LB|9CD28016-BED9-4159-9C1B-60821D74615B|1||||APTTLAAC|APTT-LA ACTUAL/CONTROL|||||||NG/DAY|||||||TRACE||ENZYME U||||LOW|NOT DONE||||CERUMEN|NON-HEMOLYZED|U|FUNDUS PHOTOGRAPHY|FIBROTEST FORMULA||U|N|Y|U|||U|2||58||OBSERVATION|1972-07-26|1970-01-24|||||1961-12-08||1966-07-17|NA|1963-01-10
TRIAL STUDY 134XCP|LB|9CD28016-BED9-4159-9C1B-60821D74615B|2||||CKMB|CREATINE KINASE MB|||||||QUANTITY SUFFICIENT|||||||INDETERMINATE||MMOL/L||||LOW|NOT DONE||||EXUDATE|LACTESCENT|Y|AUTOMATED COUNT|MDRD 6 VARIABLE FORMULA||NA|NA|NA|NA|||N|2||58||WASHOUT|1966-06-21|1961-07-31|||||1965-12-23||1971-04-28|Y|1970-05-29
TRIAL STUDY 134XCP|LB|9CD28016-BED9-4159-9C1B-60821D74615B|1||||APTTLAAC|APTT-LA ACTUAL/CONTROL|||||||MONTHS|||||||TRACE||MEQ/DAY||||NORMAL|NOT DONE||||EMESIS|SOLIDIFIED|N|MICROBIAL CULTURE, LIQUID|COCKCROFT-GAULT FORMULA||N|N|NA|NA|||NA|3||39||TREATMENT|1960-02-15|1973-07-01|||||1961-09-01||1968-03-03|U|1966-07-05
TRIAL STUDY 134XCP|LB|9CD28016-BED9-4159-9C1B-60821D74615B|2||||EPIC|EPITHELIAL CELLS|||||||ML/MMHG|||||||POSITIVE||PKAT/L||||HIGH|NOT DONE||||EPITHELIAL CELL|SOLIDIFIED|NA|IMMUNOFIXATION ELECTROPHORESIS|ASH FIBROSURE FORMULA||U|N|NA|N|||N|3||39||TREATMENT|1965-07-22|1964-10-27|||||1963-11-13||1962-11-06|NA|1963-01-21
TRIAL STUDY 134XCP|LB|9CD28016-BED9-4159-9C1B-60821D74615B|1||||PPI|INORGANIC PYROPHOSPHATE|||||||10^6 CFU/ML|||||||POSITIVE||/10^3||||ABNORMAL|NOT DONE||||SPERMATOZOON|DRIED|U|TRANSVAGINAL ULTRASOUND|CKD-EPI CYSTATIN C FORMULA||N|N|NA|U|||Y|4||88||OPEN LABEL TREATMENT|1962-07-27|1967-11-03|||||1960-05-31||1962-01-15|Y|1971-01-06
TRIAL STUDY 134XCP|LB|9CD28016-BED9-4159-9C1B-60821D74615B|2||||FACTVA|FACTOR V ACTIVITY|||||||NG/DL|||||||POSITIVE||ML/CAGE/WK||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|LACTESCENT|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI CREATININE FORMULA||N|NA|N|Y|||N|4||88||TREATMENT|1972-01-28|1960-02-09|||||1970-03-12||1962-06-04|N|1972-09-25
TRIAL STUDY 134XCP|LB|9CD28016-BED9-4159-9C1B-60821D74615B|1||||GCHT|GLYCOCHOLATE|||||||MPH|||||||BORDERLINE||CYCLE/MIN||||ABNORMAL|NOT DONE||||SOFT TISSUE|FROZEN|Y|IMMUNOCHROMATOGRAPHY|CKD-EPI CREATININE FORMULA||N|Y|Y|NA|||U|5||7||LONG-TERM FOLLOW-UP|1965-01-20|1970-02-07|||||1973-05-01||1964-08-31|U|1968-11-08
TRIAL STUDY 134XCP|LB|9CD28016-BED9-4159-9C1B-60821D74615B|2||||RDCSUG|REDUCING SUGARS|||||||HOMEOPATHIC DILUTION|||||||POSITIVE||10^12 IU/L||||LOW|NOT DONE||||AQUEOUS HUMOR|ROOM TEMPERATURE|U|SEQUENCING|CKD-EPI FORMULA||Y|N|Y|Y|||NA|5||7||FOLLOW-UP|1965-07-28|1966-05-15|||||1969-12-18||1968-12-10|Y|1973-01-13
TRIAL STUDY 134XCP|LB|BE578D25-C23E-416F-8A57-C901F7B58596|1||||SCL70AB|SCL-70 ANTIBODY|||||||10^9 CFU/G|||||||NEGATIVE||UKAT/L||||ABNORMAL|NOT DONE||||ERYTHROCYTES|DRIED|NA|IN VITRO GENE EXPRESSION ASSAY|ASH FIBROSURE FORMULA||U|Y|Y|Y|||U|1||38||INDUCTION TREATMENT|1961-02-01|1966-02-22|||||1968-10-04||1964-05-06|Y|1965-12-15
TRIAL STUDY 134XCP|LB|BE578D25-C23E-416F-8A57-C901F7B58596|2||||THR|THREONINE|||||||AMU|||||||TRACE||PATCH||||ABNORMAL|NOT DONE||||REFLEX TEAR|FROZEN|Y|MAGNETIC RESONANCE ENTEROGRAPHY|MDRD 6 VARIABLE FORMULA||NA|N|NA|NA|||Y|1||38||RUN-IN|1970-12-22|1972-02-22|||||1965-10-01||1970-11-10|U|1968-08-05
TRIAL STUDY 134XCP|LB|BE578D25-C23E-416F-8A57-C901F7B58596|1||||EPICCE|EPITHELIAL CELLS/TOTAL CELLS|||||||KG/CM|||||||BORDERLINE||MET*H||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|AUTOLYZED|N|FARNSWORTH-MUNSELL 100 HUE TEST|COCKCROFT-GAULT FORMULA||Y|U|N|NA|||N|2||58||FOLLOW-UP|1961-01-04|1972-05-10|||||1971-10-10||1971-05-19|Y|1969-11-02
TRIAL STUDY 134XCP|LB|BE578D25-C23E-416F-8A57-C901F7B58596|2||||PRABC|CALCULATED PANEL REACTIVE ANTIBODY|||||||VIAL|||||||TRACE||PG/CELL||||ABNORMAL|NOT DONE||||EMESIS|CONTAMINATED|NA|PH METER MEASUREMENT METHOD|MDRD 6 VARIABLE FORMULA||U|N|Y|U|||N|2||58||BASELINE|1966-03-14|1965-05-28|||||1969-06-25||1961-12-20|N|1972-06-06
TRIAL STUDY 134XCP|LB|BE578D25-C23E-416F-8A57-C901F7B58596|1||||STSA|STEROID SULFATASE ACTIVITY|||||||G/ANIMAL/WK|||||||NEGATIVE||U/G/DAY||||NORMAL|NOT DONE||||EXPIRED AIR|UNEXPECTED ODOR|U|REFLECTANCE SPECTROSCOPY|MDRD 4 VARIABLE FORMULA||Y|N|NA|NA|||NA|3||39||SCREENING|1960-07-30|1965-01-27|||||1963-02-04||1972-11-29|Y|1960-10-08
TRIAL STUDY 134XCP|LB|BE578D25-C23E-416F-8A57-C901F7B58596|2||||MOCYCE|MONOCYTOID CELLS|||||||UOSM|||||||INDETERMINATE||MPH||||LOW|NOT DONE||||AQUEOUS HUMOR|DRIED|NA|SLOAN LETTER EYE CHART 100%|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|Y|||NA|3||39||RUN-IN|1965-08-02|1967-09-30|||||1963-11-18||1967-12-03|N|1962-07-14
TRIAL STUDY 134XCP|LB|BE578D25-C23E-416F-8A57-C901F7B58596|1||||ANDSTNDN|ANDROSTENEDIONE|||||||CI/ML|||||||TRACE||ML/M2/MIN||||HIGH|NOT DONE||||SERUM OR PLASMA|ICTERIC|U|GEL ELECTROPHORESIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|N|||NA|4||88||RUN-IN|1966-02-23|1968-02-04|||||1969-06-27||1963-06-15|U|1964-03-10
TRIAL STUDY 134XCP|LB|BE578D25-C23E-416F-8A57-C901F7B58596|2||||AMNOACID|AMINO ACIDS|||||||IU/G|||||||NEGATIVE||10^9/DOSE||||NORMAL|NOT DONE||||LYSATE|CLOTTED|Y|AMSLER GRID|MDRD 6 VARIABLE FORMULA||U|N|Y|U|||U|4||88||RUN-IN|1963-08-08|1970-05-16|||||1971-11-15||1968-05-28|N|1972-12-02
TRIAL STUDY 134XCP|LB|BE578D25-C23E-416F-8A57-C901F7B58596|1||||C130101|TREE MIX POLLEN ANTIGEN IGE ANTIBODY|||||||CM2|||||||POSITIVE||KM/H||||LOW|NOT DONE||||SERUM|REFRIGERATED|N|THERMAL IONIZATION MASS SPECTROMETRY|COCKCROFT-GAULT FORMULA||U|U|Y|NA|||Y|5||7||TREATMENT|1964-02-03|1967-02-11|||||1962-06-07||1962-04-05|U|1961-06-10
TRIAL STUDY 134XCP|LB|BE578D25-C23E-416F-8A57-C901F7B58596|2||||BLAST|BLASTS|||||||AU/ML|||||||INDETERMINATE||MM/H||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|REFRIGERATED|Y|MANUAL COUNT|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|Y|Y|||Y|5||7||LONG-TERM FOLLOW-UP|1969-07-02|1966-06-19|||||1965-10-19||1960-05-12|Y|1970-03-04
TRIAL STUDY 134XCP|LB|A60D5FE6-26BA-487D-98E0-5F464305924C|1||||TRYPSIN|TRYPSIN|||||||MBP|||||||TRACE||APL U||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|NON-HEMOLYZED|U|SINGLE-MOLECULE ARRAY|ASH FIBROSURE FORMULA||NA|N|U|N|||Y|1||38||OPEN LABEL TREATMENT|1968-11-11|1960-06-04|||||1965-07-15||1961-11-11|Y|1972-10-06
TRIAL STUDY 134XCP|LB|A60D5FE6-26BA-487D-98E0-5F464305924C|2||||ERCEPPOL|ERYTHROID PROLIFERATION POOL|||||||NMOL BCE/L|||||||INVALID||G/DAY||||LOW|NOT DONE||||TRANSUDATE|ROOM TEMPERATURE|N|NON-CONTACT SPECULAR MICROSCOPY|CKD-EPI FORMULA||U|N|N|N|||N|1||38||SCREENING|1960-07-13|1970-08-13|||||1970-04-27||1971-06-10|NA|1962-08-29
TRIAL STUDY 134XCP|LB|A60D5FE6-26BA-487D-98E0-5F464305924C|1||||LDLPSZ|LDL PARTICLE SIZE|||||||HOUNSFIELD UNIT|||||||BORDERLINE||NMOL/DAY||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|GELLED|NA|MICRO BROTH DILUTION|FIBROSIS 4 FORMULA||Y|U|Y|Y|||U|2||58||BLINDED TREATMENT|1969-05-05|1968-01-31|||||1966-10-11||1961-01-05|NA|1965-04-13
TRIAL STUDY 134XCP|LB|A60D5FE6-26BA-487D-98E0-5F464305924C|2||||PSP100AB|P100 POLYMYOSITIS-SCLERODERMA AUTOAG AB|||||||10^7/L|||||||TRACE||UMOL/DAY||||NORMAL|NOT DONE||||EXUDATE|CONTAMINATED|NA|HIGH RESOLUTION CT|MDRD 6 VARIABLE FORMULA||NA|U|Y|Y|||Y|2||58||OPEN LABEL TREATMENT|1967-03-15|1960-12-30|||||1960-01-27||1961-10-01|Y|1971-09-02
TRIAL STUDY 134XCP|LB|A60D5FE6-26BA-487D-98E0-5F464305924C|1||||V25HD2|25-HYDROXYVITAMIN D2|||||||PIXEL|||||||INVALID||G/ANIMAL/DAY||||LOW|NOT DONE||||GASTRIC CONTENTS|NON-HEMOLYZED|N|CENTRIFUGATION|NASH FIBROSURE FORMULA||NA|N|NA|NA|||Y|3||39||FOLLOW-UP|1960-01-18|1970-08-15|||||1963-07-25||1961-04-24|N|1963-08-02
TRIAL STUDY 134XCP|LB|A60D5FE6-26BA-487D-98E0-5F464305924C|2||||GUSB|GLUCURONIDASE, BETA|||||||PACKAGE|||||||INVALID||FT||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|NON-HEMOLYZED|NA|BRDU CELLULAR PROLIFERATION ASSAY|GMI % FORMULA||NA|Y|U|NA|||NA|3||39||INDUCTION TREATMENT|1961-08-04|1973-07-21|||||1960-12-29||1964-02-28|Y|1961-07-09
TRIAL STUDY 134XCP|LB|A60D5FE6-26BA-487D-98E0-5F464305924C|1||||GLOBA1PT|ALPHA-1 GLOBULIN/TOTAL PROTEIN|||||||ML/G/H|||||||NEGATIVE||MM/SEC||||LOW|NOT DONE||||MIXED VENOUS BLOOD|DRIED|NA|CYSTOSCOPY|GMI % FORMULA||U|U|NA|NA|||Y|4||88||BLINDED TREATMENT|1961-08-31|1963-04-23|||||1972-06-14||1972-09-19|N|1967-09-17
TRIAL STUDY 134XCP|LB|A60D5FE6-26BA-487D-98E0-5F464305924C|2||||THC|TETRAHYDROCANNABINOL|||||||UG/DOSE|||||||NEGATIVE||TRANSDUCING UNIT||||HIGH|NOT DONE||||PLEURAL FLUID|CALCIFIED|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|NA|Y|||Y|4||88||FOLLOW-UP|1966-07-03|1966-05-04|||||1963-12-10||1965-10-29|U|1970-09-28
TRIAL STUDY 134XCP|LB|A60D5FE6-26BA-487D-98E0-5F464305924C|1||||IL2RA|INTERLEUKIN 2 RECEPTOR SUBUNIT ALPHA|||||||G/G/DAY|||||||INDETERMINATE||ML/CAGE/DAY||||LOW|NOT DONE||||BONE|CONTAMINATED|Y|ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI CREATININE FORMULA||NA|Y|N|NA|||Y|5||7||INDUCTION TREATMENT|1973-04-19|1972-05-03|||||1963-07-30||1971-08-10|NA|1960-02-04
TRIAL STUDY 134XCP|LB|A60D5FE6-26BA-487D-98E0-5F464305924C|2||||TXB2|THROMBOXANE B2|||||||BU/ML|||||||BORDERLINE||BQ/KG||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|THAWED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA||N|Y|NA|U|||U|5||7||LONG-TERM FOLLOW-UP|1965-04-29|1969-03-17|||||1969-03-17||1964-08-27|N|1965-12-10
TRIAL STUDY 134XCP|LB|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|1||||FCTVIIIA|FACTOR VIII ACTIVITY|||||||PPM|||||||INDETERMINATE||MOL/ML||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|NON-HEMOLYZED|Y|RYAN BLUE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|U|U|||Y|1||38||FOLLOW-UP|1967-09-14|1970-05-23|||||1960-12-15||1964-05-20|N|1967-04-02
TRIAL STUDY 134XCP|LB|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|2||||PROMYCE|PROMYELOCYTES/TOTAL CELLS|||||||COPIES/UL|||||||INDETERMINATE||ELISA UNIT/ML||||LOW|NOT DONE||||EPITHELIAL CELL|NON-HEMOLYZED|U|CELL BASED BIOASSAY|GMI MMOL/MOL FORMULA||Y|U|NA|Y|||N|1||38||LONG-TERM FOLLOW-UP|1973-04-03|1965-09-25|||||1967-05-26||1961-08-03|N|1964-03-20
TRIAL STUDY 134XCP|LB|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|1||||GLYCRL|GLYCEROL|||||||SEC|||||||NEGATIVE||MS2||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|LACTESCENT|NA|TURBIDIMETRY|CKD-EPI FORMULA||Y|U|Y|U|||Y|2||58||OBSERVATION|1964-11-02|1962-03-21|||||1962-04-15||1960-11-03|N|1964-10-31
TRIAL STUDY 134XCP|LB|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|2||||HIS|HISTIDINE|||||||G/M2|||||||POSITIVE||ML/G/H||||NORMAL|NOT DONE||||MUCUS|LIPEMIC|Y|ENZYMATIC COLORIMETRY|COCKCROFT-GAULT FORMULA||N|N|NA|Y|||NA|2||58||BASELINE|1960-08-14|1970-02-24|||||1964-08-17||1968-04-01|N|1962-08-27
TRIAL STUDY 134XCP|LB|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|1||||GLYCRL|GLYCEROL|||||||SFC/10^6 PBMC|||||||NEGATIVE||MET*H||||ABNORMAL|NOT DONE||||MECONIUM|CLOTTED|N|MICRODENSITOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|N|N|||Y|3||39||WASHOUT|1963-08-07|1968-12-06|||||1961-09-26||1965-10-12|U|1962-10-21
TRIAL STUDY 134XCP|LB|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|2||||FGF21|FIBROBLAST GROWTH FACTOR 21|||||||EID 50/DOSE|||||||INDETERMINATE||UG/KG/H||||NORMAL|NOT DONE||||CORD SERUM|UNEXPECTED ODOR|Y|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|GMI % FORMULA||N|NA|Y|NA|||N|3||39||WASHOUT|1971-11-26|1964-02-23|||||1960-12-21||1971-09-10|N|1971-08-26
TRIAL STUDY 134XCP|LB|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|1||||IGG4|IMMUNOGLOBULIN G SUBCLASS 4|||||||INHALATION|||||||INDETERMINATE||H/WK||||HIGH|NOT DONE||||SMEGMA|DRIED|NA|BAC ACGH|FIBROMETER FORMULA||N|N|NA|Y|||U|4||88||OBSERVATION|1969-04-11|1970-08-18|||||1961-10-16||1968-05-02|NA|1973-02-03
TRIAL STUDY 134XCP|LB|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|2||||INSULINS|INSULIN SENSITIVITY|||||||LM|||||||INVALID||10^6 ORGANISMS||||LOW|NOT DONE||||TRANSUDATE|CONCENTRATED|Y|FUNDUS PHOTOGRAPHY|FIBROMETER FORMULA||U|Y|U|Y|||Y|4||88||RUN-IN|1967-04-08|1966-05-25|||||1973-08-11||1964-12-10|NA|1970-01-28
TRIAL STUDY 134XCP|LB|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|1||||KETONES|KETONES|||||||UV2|||||||POSITIVE||/MM||||NORMAL|NOT DONE||||NAIL|CONTAMINATED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|N|||U|5||7||CONTINUATION TREATMENT|1962-02-19|1972-10-19|||||1964-07-15||1966-04-24|NA|1972-07-27
TRIAL STUDY 134XCP|LB|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|2||||NUCCE|NUCLEATED CELLS|||||||IU/DL|||||||NEGATIVE||MEQ/UG||||LOW|NOT DONE||||PUS|AUTOLYZED|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|ASH FIBROSURE FORMULA||NA|N|N|U|||NA|5||7||LONG-TERM FOLLOW-UP|1972-02-27|1965-06-04|||||1969-08-11||1963-11-23|U|1966-01-02
TRIAL STUDY 134XCP|LB|89739AE0-A8B9-44DE-970E-9D679ED58C4F|1||||LYMVAC|VACUOLATED LYMPHOCYTES|||||||MOSM|||||||BORDERLINE||BQ/KG||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|LIPEMIC|Y|STRESS ECHOCARDIOGRAPHY|MDRD FORMULA||N|NA|Y|U|||U|1||38||INDUCTION TREATMENT|1972-04-18|1972-04-29|||||1966-05-23||1964-05-11|NA|1969-10-17
TRIAL STUDY 134XCP|LB|89739AE0-A8B9-44DE-970E-9D679ED58C4F|2||||HLAB27AG|HLA-B27 ANTIGEN|||||||CFU/ML|||||||INVALID||10^3 RNA COPIES/ML||||HIGH|NOT DONE||||ADIPOSE TISSUE|CONCENTRATED|U|U-HPLC/MS/MS|MDRD 5 VARIABLE FORMULA||Y|N|NA|NA|||NA|1||38||INDUCTION TREATMENT|1968-07-18|1966-04-30|||||1966-07-25||1969-09-03|NA|1962-10-28
TRIAL STUDY 134XCP|LB|89739AE0-A8B9-44DE-970E-9D679ED58C4F|1||||CEC|CIRCULATING ENDOTHELIAL CELLS|||||||UM|||||||INVALID||10^9 CFU/G||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|FRESH|NA|ISHIHARA COLOR PLATES|FIBROSIS 4 FORMULA||Y|U|NA|NA|||U|2||58||FOLLOW-UP|1970-07-10|1971-02-03|||||1971-02-23||1972-02-28|NA|1965-11-04
TRIAL STUDY 134XCP|LB|89739AE0-A8B9-44DE-970E-9D679ED58C4F|2||||C165911|DAIRY MIX IGG AB RAST SCORE|||||||/2500 WBC|||||||TRACE||CIGARETTE||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CLOTTED|NA|MEDIASTINOSCOPY|GMI MMOL/MOL FORMULA||U|Y|NA|Y|||U|2||58||OBSERVATION|1970-06-24|1962-10-26|||||1973-03-02||1973-01-13|N|1960-03-17
TRIAL STUDY 134XCP|LB|89739AE0-A8B9-44DE-970E-9D679ED58C4F|1||||RFIGMAB|RHEUMATOID FACTOR IGM ANTIBODY|||||||KPA|||||||BORDERLINE||FT2||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|REFRIGERATED|N|DC SHEATH FLOW|CKD-EPI FORMULA||U|NA|U|NA|||Y|3||39||BASELINE|1970-02-06|1965-07-25|||||1971-10-30||1966-10-17|Y|1973-04-19
TRIAL STUDY 134XCP|LB|89739AE0-A8B9-44DE-970E-9D679ED58C4F|2||||HSP90A|HEAT SHOCK PROTEIN 90 ALPHA|||||||ML/CM|||||||NEGATIVE||RATIO||||HIGH|NOT DONE||||DIALYSIS FLUID|PARAFFIN-EMBEDDED|NA|HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD ENZYMATIC FORMULA||Y|Y|NA|Y|||NA|3||39||OPEN LABEL TREATMENT|1972-01-29|1961-03-24|||||1960-02-21||1961-07-29|NA|1967-09-21
TRIAL STUDY 134XCP|LB|89739AE0-A8B9-44DE-970E-9D679ED58C4F|1||||BASOSG|BASOPHILS, SEGMENTED|||||||IMPLANT|||||||BORDERLINE||LOG EID 50/DOSE||||LOW|NOT DONE||||CELL PELLET|LACTESCENT|NA|PERCUSSION|COCKCROFT-GAULT FORMULA||NA|Y|U|NA|||N|4||88||RUN-IN|1963-12-29|1964-04-11|||||1963-07-29||1961-11-06|NA|1961-01-31
TRIAL STUDY 134XCP|LB|89739AE0-A8B9-44DE-970E-9D679ED58C4F|2||||PORPH|PORPHYRIN|||||||10^3/L|||||||NEGATIVE||ML/DL||||ABNORMAL|NOT DONE||||LYSATE|NON-HEMOLYZED|U|ELECTROPHORESIS|FIBROSIS 4 FORMULA||Y|NA|U|NA|||NA|4||88||TREATMENT|1965-02-03|1968-06-10|||||1964-06-08||1973-04-30|U|1972-11-01
TRIAL STUDY 134XCP|LB|89739AE0-A8B9-44DE-970E-9D679ED58C4F|1||||GLCHT|GLYCOLITHOCHOLATE|||||||BQ/UL|||||||INDETERMINATE||SV||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|HEMOLYZED|Y|NUCLEIC ACID AMPLIFICATION TEST|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|N|||U|5||7||LONG-TERM FOLLOW-UP|1963-05-23|1968-04-24|||||1962-06-13||1962-12-30|U|1972-10-05
TRIAL STUDY 134XCP|LB|89739AE0-A8B9-44DE-970E-9D679ED58C4F|2||||STBSEXCS|STANDARD BASE EXCESS|||||||NMOL/G|||||||BORDERLINE||%/S||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|SOLIDIFIED|NA|ACRIDINE ORANGE STAIN|CKD-EPI CREATININE FORMULA||NA|N|Y|N|||U|5||7||TREATMENT|1966-10-10|1963-09-01|||||1972-05-19||1968-11-10|N|1962-07-23
TRIAL STUDY 134XCP|LB|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|1||||APOA5|APOLIPOPROTEIN A5|||||||MMOL/MIN/KPA/L|||||||INDETERMINATE||EJACULATE U||||HIGH|NOT DONE||||BILE|THAWED|NA|ENZYMATIC SPECTROPHOTOMETRY|FIBROMETER FORMULA||NA|N|U|Y|||N|1||38||OPEN LABEL TREATMENT|1961-04-29|1960-07-24|||||1961-01-01||1971-09-07|N|1971-03-24
TRIAL STUDY 134XCP|LB|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|2||||IL2SRA|SOLUBLE INTERLEUKIN 2 RECEPTOR ACTIVITY|||||||PIXEL|||||||TRACE||PMOL/DL||||NORMAL|NOT DONE||||LUNG SURFACTANT|LIPEMIC|U|BRDU CELLULAR PROLIFERATION ASSAY|FIBROSIS 4 FORMULA||N|U|N|N|||Y|1||38||OBSERVATION|1961-02-22|1965-07-28|||||1966-12-18||1969-12-31|NA|1966-06-24
TRIAL STUDY 134XCP|LB|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|1||||C165889|RUSSIAN THISTLE POLLEN IGE AB RAST SCORE|||||||PMOL/L/H|||||||POSITIVE||QUANTITY SUFFICIENT||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|FRESH|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|NA|NA|N|||NA|2||58||CONTINUATION TREATMENT|1969-04-18|1964-05-01|||||1968-03-25||1966-07-29|NA|1972-01-03
TRIAL STUDY 134XCP|LB|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|2||||CLUECE|CLUE CELLS|||||||MG/MIN|||||||TRACE||PKAT/L||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|LACTESCENT|Y|TRANSVAGINAL ULTRASOUND|FIBROMETER FORMULA||Y|N|Y|Y|||Y|2||58||BLINDED TREATMENT|1967-02-09|1964-12-27|||||1967-07-06||1966-02-01|U|1972-03-23
TRIAL STUDY 134XCP|LB|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|1||||PTHFG|PARATHYROID HORMONE, FRAGMENTED|||||||UG/ANIMAL|||||||BORDERLINE||NMOL/KG/DAY||||NORMAL|NOT DONE||||ISOLATE|FRESH|U|POLYGRAPHY|MDRD 5 VARIABLE FORMULA||U|Y|N|U|||NA|3||39||INDUCTION TREATMENT|1968-05-24|1971-01-02|||||1963-10-18||1962-11-09|NA|1960-08-15
TRIAL STUDY 134XCP|LB|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|2||||HLAA|HLA CLASS IA ANTIGEN|||||||ML/(MIN*100ML)|||||||NEGATIVE||CONTAINER||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|GELLED|N|OBSERVATION|MDRD 5 VARIABLE FORMULA||N|U|Y|N|||U|3||39||LONG-TERM FOLLOW-UP|1965-09-12|1967-10-29|||||1965-09-04||1968-09-26|U|1961-04-17
TRIAL STUDY 134XCP|LB|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|1||||APTTLAAC|APTT-LA ACTUAL/CONTROL|||||||MIN/DAY|||||||POSITIVE||USP U||||LOW|NOT DONE||||LEUKOCYTE|CALCIFIED|Y|THIN SMEAR|FIBROMETER FORMULA||Y|U|N|Y|||N|4||88||CONTINUATION TREATMENT|1963-10-27|1969-06-07|||||1964-03-28||1966-07-22|N|1972-02-27
TRIAL STUDY 134XCP|LB|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|2||||PROINSUL|PROINSULIN|||||||EU|||||||INVALID||TRANSDUCING UNIT/ML||||HIGH|NOT DONE||||PLATELET POOR PLASMA|DRIED|N|WESTERGREN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|NA|Y|||N|4||88||LONG-TERM FOLLOW-UP|1961-07-07|1968-04-06|||||1965-02-19||1969-04-03|N|1973-06-01
TRIAL STUDY 134XCP|LB|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|1||||CANNABS|CANNABINOIDS, SYNTHETIC|||||||TBSP|||||||BORDERLINE||NCI||||LOW|NOT DONE||||CELL PELLET|AGGLUTINATED|Y|FUNCTIONAL MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|N|Y|||NA|5||7||CONTINUATION TREATMENT|1971-06-15|1968-08-12|||||1971-11-23||1973-05-27|NA|1967-03-05
TRIAL STUDY 134XCP|LB|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|2||||KLK2|KALLIKREIN-2|||||||SIEMENS|||||||INVALID||HOURS||||ABNORMAL|NOT DONE||||MONOCYTE|CLOTTED|NA|FARR ASSAY|GMI MMOL/MOL FORMULA||U|Y|NA|Y|||NA|5||7||SCREENING|1966-06-19|1971-06-19|||||1967-06-15||1971-09-21|NA|1965-03-25
TRIAL STUDY 134XCP|LB|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|1||||RSAD2|CYTOMEGALOVIRUS-INDUCED GENE 5 PROTEIN|||||||U/M2/H|||||||NEGATIVE||CGY||||HIGH|NOT DONE||||ARTERIAL BLOOD|CONTAMINATED|Y|STATIC PERIMETRY|MDRD 5 VARIABLE FORMULA||N|Y|N|NA|||N|1||38||SCREENING|1960-03-04|1971-10-24|||||1964-08-18||1965-06-29|N|1961-05-07
TRIAL STUDY 134XCP|LB|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|2||||CREATEXR|CREATININE EXCRETION RATE|||||||NEBULE|||||||TRACE||UMOL/KG/MIN||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|HEMOLYZED|N|JAFFE REACTION|MDRD 5 VARIABLE FORMULA||Y|Y|NA|U|||NA|1||38||TREATMENT|1970-01-24|1969-08-29|||||1960-05-10||1963-03-25|N|1967-07-13
TRIAL STUDY 134XCP|LB|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|1||||ANCIGAB|ANTI-NEUTROPHIL CYTOPLASMIC IGG ANTIBODY|||||||PA|||||||INDETERMINATE||TBSP||||HIGH|NOT DONE||||PUS|NON-HEMOLYZED|NA|SICKLE CELL SOLUBILITY TEST|GMI % FORMULA||NA|NA|U|U|||NA|2||58||OPEN LABEL TREATMENT|1961-02-22|1965-10-17|||||1972-11-30||1967-06-20|N|1968-07-22
TRIAL STUDY 134XCP|LB|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|2||||LYM|LYMPHOCYTES|||||||BE/ML|||||||INDETERMINATE||TROCHE||||HIGH|NOT DONE||||TRANSUDATE|LIPEMIC|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA||U|N|NA|NA|||NA|2||58||BLINDED TREATMENT|1969-05-22|1969-11-27|||||1960-07-27||1961-05-18|U|1964-06-07
TRIAL STUDY 134XCP|LB|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|1||||THRCREAT|THREONINE/CREATININE|||||||POUCH|||||||NEGATIVE||JOULE||||NORMAL|NOT DONE||||SEMEN|SOLIDIFIED|NA|CLIP|CKD-EPI FORMULA||U|NA|U|NA|||U|3||39||WASHOUT|1972-03-19|1968-02-29|||||1968-12-04||1971-01-27|N|1972-11-02
TRIAL STUDY 134XCP|LB|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|2||||MONOIMLE|IMMATURE MONOCYTES/LEUKOCYTES|||||||MCI/L|||||||BORDERLINE||ML/DOSE||||LOW|NOT DONE||||BONE|CONCENTRATED|Y|TRIPLE-PHASE SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA||N|U|NA|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1962-02-21|1973-09-07|||||1965-09-29||1961-06-14|NA|1961-09-21
TRIAL STUDY 134XCP|LB|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|1||||RDWRCV|RET RDW COEFFICIENT OF VARIATION|||||||MPA|||||||INVALID||BP||||ABNORMAL|NOT DONE||||COLOSTRUM|NON-HEMOLYZED|N|EPSILOMETER|CKD-EPI FORMULA||Y|Y|N|N|||N|4||88||LONG-TERM FOLLOW-UP|1968-05-24|1964-08-20|||||1970-04-14||1965-09-15|U|1966-11-09
TRIAL STUDY 134XCP|LB|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|2||||NOREPIN|NOREPINEPHRINE|||||||DDU|||||||POSITIVE||U/MMOL||||LOW|NOT DONE||||KERATINOCYTE|SOLIDIFIED|N|CLIP SEQUENCING|NASH FIBROSURE FORMULA||NA|U|NA|U|||U|4||88||WASHOUT|1964-05-04|1968-08-24|||||1965-08-13||1971-04-07|U|1961-07-13
TRIAL STUDY 134XCP|LB|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|1||||TRH|THYROTROPIN RELEASING HORMONE|||||||UG/KG/H|||||||NEGATIVE||ML/CM3/MIN||||HIGH|NOT DONE||||VENOUS CORD BLOOD|CONTAMINATED|N|RADIAL IMMUNODIFFUSION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|Y|NA|||Y|5||7||BASELINE|1962-07-23|1961-11-29|||||1970-08-05||1968-11-05|U|1965-12-21
TRIAL STUDY 134XCP|LB|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|2||||CHCMR|RET. CORPUSCULAR HGB CONCENTRATION MEAN|||||||PG/DL|||||||NEGATIVE||G/G/DAY||||LOW|NOT DONE||||NAIL|ICTERIC|NA|SNELLEN EYE CHART|COCKCROFT-GAULT FORMULA||U|U|U|N|||Y|5||7||INDUCTION TREATMENT|1967-11-21|1968-05-26|||||1961-11-20||1966-07-10|Y|1961-11-26
TRIAL STUDY 134XCP|LB|CED88848-769E-41C1-9ACD-99E45766D27B|1||||UNSPCE|UNSPECIFIED CELLS|||||||COPIES/UL|||||||NEGATIVE||PFU/DOSE||||NORMAL|NOT DONE||||LUNG SURFACTANT|UNEXPECTED ODOR|Y|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD ENZYMATIC FORMULA||Y|NA|U|Y|||N|1||38||RUN-IN|1969-12-22|1972-06-09|||||1972-03-13||1960-02-03|Y|1965-04-05
TRIAL STUDY 134XCP|LB|CED88848-769E-41C1-9ACD-99E45766D27B|2||||ICAM|INTERCELLULAR ADHESION MOLECULE|||||||HZ|||||||INDETERMINATE||PFU||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|ICTERIC|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|GMI % FORMULA||Y|NA|Y|N|||N|1||38||OPEN LABEL TREATMENT|1964-03-25|1972-01-07|||||1968-05-28||1963-10-21|U|1968-04-02
TRIAL STUDY 134XCP|LB|CED88848-769E-41C1-9ACD-99E45766D27B|1||||PEPSNGA|PEPSINOGEN A|||||||/40 HPFS|||||||INVALID||10^12 IU/L||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|CLOTTED|N|MICRO BROTH DILUTION|FIBROMETER FORMULA||U|NA|Y|Y|||N|2||58||TREATMENT|1960-08-19|1967-05-31|||||1965-08-15||1962-12-14|N|1960-03-13
TRIAL STUDY 134XCP|LB|CED88848-769E-41C1-9ACD-99E45766D27B|2||||EOS|EOSINOPHILS|||||||MIN|||||||INDETERMINATE||KAT||||ABNORMAL|NOT DONE||||PLEURAL FLUID|ICTERIC|Y|GIEMSA STAIN|GMI MMOL/MOL FORMULA||NA|U|U|Y|||U|2||58||FOLLOW-UP|1962-12-20|1962-05-18|||||1970-05-11||1964-08-03|U|1972-11-09
TRIAL STUDY 134XCP|LB|CED88848-769E-41C1-9ACD-99E45766D27B|1||||PTAC|PROTHROMBIN TIME ACTUAL/CONTROL|||||||10^9 ORGANISMS/G|||||||POSITIVE||MMHG/L/MIN||||ABNORMAL|NOT DONE||||ABSCESS FLUID|FROZEN|N|TWO-COLOR MICROARRAY|GMI MMOL/MOL FORMULA||U|Y|NA|Y|||NA|3||39||FOLLOW-UP|1961-10-03|1964-07-02|||||1971-03-18||1970-01-08|U|1969-01-31
TRIAL STUDY 134XCP|LB|CED88848-769E-41C1-9ACD-99E45766D27B|2||||CSBROAD|BROAD CASTS|||||||VG/KG|||||||INVALID||/2500 WBC||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|LIPEMIC|N|DUKE INCISION METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|NA|Y|||Y|3||39||FOLLOW-UP|1960-06-23|1963-03-20|||||1972-01-05||1973-02-27|Y|1966-12-16
TRIAL STUDY 134XCP|LB|CED88848-769E-41C1-9ACD-99E45766D27B|1||||CYMSU|MONOSODIUM URATE CRYSTALS|||||||NG/DL|||||||POSITIVE||SPRAY||||NORMAL|NOT DONE||||SERUM|GELLED|N|ETDRS EYE CHART|FIBROTEST FORMULA||NA|N|U|N|||NA|4||88||FOLLOW-UP|1973-08-02|1968-03-05|||||1961-08-02||1964-03-10|U|1973-08-16
TRIAL STUDY 134XCP|LB|CED88848-769E-41C1-9ACD-99E45766D27B|2||||KRCYMG|MEGAKARYOCYTES|||||||MET*H|||||||POSITIVE||PRESSOR UNITS||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|PARAFFIN-EMBEDDED|Y|FLOCCULATION, CHARCOAL ENHANCED|MDRD 4 VARIABLE FORMULA||Y|N|Y|NA|||U|4||88||WASHOUT|1962-01-03|1967-07-20|||||1961-04-16||1969-08-02|U|1963-04-26
TRIAL STUDY 134XCP|LB|CED88848-769E-41C1-9ACD-99E45766D27B|1||||CYTRPHOS|TRIPLE PHOSPHATE CRYSTALS|||||||OD UNIT|||||||BORDERLINE||NU/CL||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|CONTAMINATED|N|CT SCAN|GMI % FORMULA||N|NA|N|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1964-07-08|1960-09-30|||||1961-07-01||1970-05-17|Y|1963-06-07
TRIAL STUDY 134XCP|LB|CED88848-769E-41C1-9ACD-99E45766D27B|2||||BASOSG|BASOPHILS, SEGMENTED|||||||DAYS/MONTH|||||||NEGATIVE||GPELISA UNIT/ML||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|HEMOLYZED|N|MICROPARTICLE ENZYME IMMUNOASSAY|HEPASCORE FORMULA||Y|U|N|U|||NA|5||7||FOLLOW-UP|1965-06-22|1970-01-30|||||1965-07-13||1970-02-01|NA|1964-02-17
TRIAL STUDY 134XCP|LB|E7958F8B-D987-4929-993A-8960EB30A309|1||||APOE|APOLIPOPROTEIN E|||||||FL|||||||NEGATIVE||NEBULE||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|LACTESCENT|NA|MICRONEUTRALIZATION ASSAY|HEPASCORE FORMULA||N|U|U|Y|||NA|1||38||TREATMENT|1965-02-12|1968-02-27|||||1966-07-20||1964-10-26|Y|1973-07-10
TRIAL STUDY 134XCP|LB|E7958F8B-D987-4929-993A-8960EB30A309|2||||C165889|RUSSIAN THISTLE POLLEN IGE AB RAST SCORE|||||||/100 HPFS|||||||NEGATIVE||UM||||HIGH|NOT DONE||||LOCHIA|CONCENTRATED|N|CYSTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|Y|Y|||Y|1||38||CONTINUATION TREATMENT|1973-07-20|1966-02-24|||||1972-05-16||1970-07-25|NA|1971-01-23
TRIAL STUDY 134XCP|LB|E7958F8B-D987-4929-993A-8960EB30A309|1||||NEUTSGLE|NEUTROPHILS, SEGMENTED/LEUKOCYTES|||||||ARBITRARY U|||||||NEGATIVE||/LPF||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|FRESH|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|GMI % FORMULA||N|U|N|Y|||NA|2||58||WASHOUT|1966-05-16|1973-07-10|||||1967-05-16||1969-07-16|Y|1962-10-04
TRIAL STUDY 134XCP|LB|E7958F8B-D987-4929-993A-8960EB30A309|2||||CD40|CD40|||||||/10^5|||||||BORDERLINE||/500 WBC||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|CLOTTED|NA|PANENDOSCOPY|GMI MMOL/MOL FORMULA||Y|N|NA|N|||Y|2||58||OPEN LABEL TREATMENT|1961-11-17|1960-06-04|||||1964-05-13||1967-06-27|Y|1966-12-28
TRIAL STUDY 134XCP|LB|E7958F8B-D987-4929-993A-8960EB30A309|1||||CANNAB|CANNABINOIDS|||||||U/G|||||||INVALID||10^9/L||||HIGH|NOT DONE||||FLUID|PARAFFIN-EMBEDDED|N|ANGIOGRAPHY|MDRD ENZYMATIC FORMULA||N|U|Y|U|||NA|3||39||TREATMENT|1963-05-01|1965-06-22|||||1969-03-08||1971-09-26|N|1961-05-13
TRIAL STUDY 134XCP|LB|E7958F8B-D987-4929-993A-8960EB30A309|2||||ANGLBIND|ANTIGLOBULIN TEST, INDIRECT|||||||L|||||||NEGATIVE||MG/KG/WEEK||||NORMAL|NOT DONE||||EMOTIONAL TEAR|GELLED|U|MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|NA|U|||N|3||39||OPEN LABEL TREATMENT|1962-06-07|1960-02-27|||||1960-07-05||1967-11-06|N|1965-10-13
TRIAL STUDY 134XCP|LB|E7958F8B-D987-4929-993A-8960EB30A309|1||||GFRBSCYC|GFR FROM CYSTATIN C ADJUSTED FOR BSA|||||||CMHG|||||||NEGATIVE||HR/DAY||||LOW|NOT DONE||||EXUDATE|NON-HEMOLYZED|Y|MRI WITHOUT CONTRAST|HEPASCORE FORMULA||N|NA|NA|N|||NA|4||88||SCREENING|1961-04-23|1964-05-20|||||1962-01-21||1964-02-05|NA|1962-12-07
TRIAL STUDY 134XCP|LB|E7958F8B-D987-4929-993A-8960EB30A309|2||||PLTMORPH|PLATELET MORPHOLOGY|||||||%/S|||||||INDETERMINATE||VIRTUAL PIXEL||||NORMAL|NOT DONE||||BASAL TEAR|LIPEMIC|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI % FORMULA||Y|Y|U|N|||U|4||88||LONG-TERM FOLLOW-UP|1964-04-20|1971-09-30|||||1968-02-28||1961-10-15|Y|1962-08-19
TRIAL STUDY 134XCP|LB|E7958F8B-D987-4929-993A-8960EB30A309|1||||INSAAB|INSULIN AUTOANTIBODY|||||||UM2|||||||NEGATIVE||ML/H||||LOW|NOT DONE||||SKIN TISSUE|LACTESCENT|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|CKD-EPI CREATININE FORMULA||NA|Y|U|U|||U|5||7||RUN-IN|1963-07-27|1960-04-20|||||1966-11-25||1961-04-16|N|1968-04-07
TRIAL STUDY 134XCP|LB|E7958F8B-D987-4929-993A-8960EB30A309|2||||PEMAB|PEMPHIGOID ANTIBODIES|||||||/40 HPFS|||||||TRACE||10^6/G||||HIGH|NOT DONE||||MUSCLE TISSUE|CALCIFIED|Y|GEL ELECTROPHORESIS|HEPASCORE FORMULA||NA|U|N|U|||U|5||7||FOLLOW-UP|1966-08-19|1964-11-24|||||1970-06-04||1965-06-01|Y|1970-03-03
TRIAL STUDY 134XCP|LB|A633D973-B611-4014-A43E-C8C2D21DBFC2|1||||HDLCCHOL|HDL CHOLESTEROL/TOTAL CHOLESTEROL|||||||LOG10 PFU|||||||NEGATIVE||S/H||||NORMAL|NOT DONE||||ADIPOSE TISSUE|CALCIFIED|N|PEAK FLOWMETRY|CKD-EPI FORMULA||Y|Y|U|U|||NA|1||38||INDUCTION TREATMENT|1963-06-26|1966-10-14|||||1960-07-19||1962-02-14|U|1972-11-15
TRIAL STUDY 134XCP|LB|A633D973-B611-4014-A43E-C8C2D21DBFC2|2||||CCL16|CHEMOKINE (C-C MOTIF) LIGAND 16|||||||UG/G/H|||||||POSITIVE||ML||||NORMAL|NOT DONE||||CERUMEN|CALCIFIED|U|NO INFORMATION|MDRD FORMULA||U|N|Y|NA|||Y|1||38||WASHOUT|1968-10-13|1968-04-22|||||1971-11-18||1968-03-23|NA|1965-06-30
TRIAL STUDY 134XCP|LB|A633D973-B611-4014-A43E-C8C2D21DBFC2|1||||MYBLAT3|TYPE III MYELOBLASTS|||||||%|||||||POSITIVE||KDA||||NORMAL|NOT DONE||||SEMINAL FLUID|AUTOLYZED|U|SPIRAL CT|FIBROSIS 4 FORMULA||N|Y|NA|N|||NA|2||58||CONTINUATION TREATMENT|1969-04-30|1961-09-20|||||1970-08-26||1970-06-25|N|1972-11-07
TRIAL STUDY 134XCP|LB|A633D973-B611-4014-A43E-C8C2D21DBFC2|2||||PLATCLMP|PLATELET CLUMPS|||||||TSP|||||||INVALID||BOWL||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|REFRIGERATED|U|WHOLE EXOME SEQUENCING|NASH FIBROSURE FORMULA||NA|NA|Y|NA|||NA|2||58||LONG-TERM FOLLOW-UP|1960-04-12|1962-01-19|||||1969-04-25||1960-07-25|NA|1970-02-19
TRIAL STUDY 134XCP|LB|A633D973-B611-4014-A43E-C8C2D21DBFC2|1||||CSFIGIDX|CSF IGG INDEX|||||||UKAT/L|||||||BORDERLINE||KCAL||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|FROZEN|U|NON-INVASIVE DIELECTRIC SENSING|COCKCROFT-GAULT FORMULA||NA|Y|U|N|||Y|3||39||BLINDED TREATMENT|1973-07-23|1971-10-17|||||1972-12-10||1972-09-20|NA|1967-12-16
TRIAL STUDY 134XCP|LB|A633D973-B611-4014-A43E-C8C2D21DBFC2|2||||APROTCRS|ACTIVATED PROTEIN C RESISTANCE|||||||BU/ML|||||||INDETERMINATE||MCI/L||||NORMAL|NOT DONE||||SERUM|FRESH|U|WHOLE EXOME SEQUENCING|CKD-EPI FORMULA||NA|Y|Y|Y|||NA|3||39||OBSERVATION|1960-03-21|1969-10-26|||||1961-01-21||1968-01-12|NA|1973-06-20
TRIAL STUDY 134XCP|LB|A633D973-B611-4014-A43E-C8C2D21DBFC2|1||||PLSIMCCE|IMMATURE PLASMA CELLS/TOTAL CELLS|||||||SHOCK WAVE|||||||INDETERMINATE||UMOL/MIN||||LOW|NOT DONE||||AQUEOUS HUMOR|LIPEMIC|N|DYNAMOMETRY|GMI % FORMULA||NA|U|N|Y|||U|4||88||INDUCTION TREATMENT|1968-03-19|1971-10-10|||||1965-03-21||1965-08-19|Y|1968-10-24
TRIAL STUDY 134XCP|LB|A633D973-B611-4014-A43E-C8C2D21DBFC2|2||||STBSEXCS|STANDARD BASE EXCESS|||||||KG/MOL|||||||POSITIVE||MAMP||||HIGH|NOT DONE||||AMNIOTIC FLUID|SOLIDIFIED|U|POLYMERASE CHAIN REACTION|FIBROTEST FORMULA||U|Y|NA|Y|||N|4||88||LONG-TERM FOLLOW-UP|1972-12-02|1962-05-29|||||1964-07-14||1966-07-28|Y|1971-06-15
TRIAL STUDY 134XCP|LB|A633D973-B611-4014-A43E-C8C2D21DBFC2|1||||VITB6|VITAMIN B6|||||||MV/SEC|||||||BORDERLINE||UG/MIN||||ABNORMAL|NOT DONE||||PLASMA|ROOM TEMPERATURE|N|GC/MS|MDRD ENZYMATIC FORMULA||N|U|N|N|||U|5||7||OBSERVATION|1969-03-14|1971-02-18|||||1966-11-15||1970-03-06|U|1971-08-19
TRIAL STUDY 134XCP|LB|A633D973-B611-4014-A43E-C8C2D21DBFC2|2||||AFPL3AFP|A FETOPROTEIN L3/A FETOPROTEIN|||||||L/MIN|||||||NEGATIVE||MG/KG/H||||ABNORMAL|NOT DONE||||VENOUS PLASMA|CLOTTED|U|PET SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|N|||N|5||7||OPEN LABEL TREATMENT|1972-05-18|1972-06-20|||||1971-12-07||1967-05-02|U|1967-10-03
TRIAL STUDY 134XCP|LB|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|1||||HLAIIPRA|HLA CLASS II PANEL REACTIVE ANTIBODY|||||||G/DAY|||||||TRACE||POUCH||||HIGH|NOT DONE||||BASAL TEAR|ROOM TEMPERATURE|Y|SPIROMETRY|GMI MMOL/MOL FORMULA||NA|NA|NA|Y|||U|1||38||INDUCTION TREATMENT|1967-07-25|1961-03-02|||||1961-04-24||1965-04-03|U|1971-04-02
TRIAL STUDY 134XCP|LB|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|2||||BLSTRSID|RINGED SIDEROBLASTS|||||||S/H|||||||NEGATIVE||10^3 DNA COPIES/ML||||NORMAL|NOT DONE||||DERMAL TISSUE|THAWED|Y|MEDIASTINOSCOPY|COCKCROFT-GAULT FORMULA||NA|U|Y|Y|||N|1||38||LONG-TERM FOLLOW-UP|1967-01-03|1960-02-20|||||1961-06-30||1962-01-05|NA|1962-07-09
TRIAL STUDY 134XCP|LB|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|1||||VITB12|VITAMIN B12|||||||10^6/HPF|||||||NEGATIVE||C||||NORMAL|NOT DONE||||HAIR FOLLICLE|LIPEMIC|Y|ELECTROMYOGRAPHY|FIBROSIS 4 FORMULA||Y|Y|Y|N|||NA|2||58||INDUCTION TREATMENT|1967-02-18|1973-08-22|||||1971-03-15||1971-12-05|NA|1969-08-19
TRIAL STUDY 134XCP|LB|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|2||||ALDOLASE|ALDOLASE|||||||IU/DAY|||||||POSITIVE||AMOL||||HIGH|NOT DONE||||STOOL|DRIED|U|IMMUNOASSAY|FIBROMETER FORMULA||N|Y|Y|NA|||U|2||58||FOLLOW-UP|1969-07-21|1962-10-30|||||1964-01-25||1960-05-24|Y|1972-09-24
TRIAL STUDY 134XCP|LB|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|1||||FACTXA|FACTOR X ACTIVITY|||||||10^6 COPIES/ML|||||||INVALID||EP U||||NORMAL|NOT DONE||||BILE|CALCIFIED|Y|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CYSTATIN C FORMULA||U|NA|U|NA|||N|3||39||OBSERVATION|1969-03-25|1963-06-04|||||1973-05-19||1972-05-27|Y|1967-04-22
TRIAL STUDY 134XCP|LB|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|2||||HGBA1HGB|HEMOGLOBIN A1/TOTAL HEMOGLOBIN|||||||AMU|||||||INVALID||10^4 CFU/ML||||LOW|NOT DONE||||SMEGMA|LIPEMIC|NA|WRIGHT STAIN|MDRD ENZYMATIC FORMULA||NA|U|N|U|||N|3||39||RUN-IN|1960-09-06|1969-05-12|||||1971-11-19||1966-05-29|N|1966-07-02
TRIAL STUDY 134XCP|LB|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|1||||INTLK8|INTERLEUKIN 8|||||||/CMH2O|||||||POSITIVE||DRUM||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|LACTESCENT|U|IMMUNODIFFUSION|MDRD 5 VARIABLE FORMULA||N|NA|Y|NA|||NA|4||88||OPEN LABEL TREATMENT|1971-05-21|1962-12-03|||||1963-03-13||1960-11-20|N|1969-10-05
TRIAL STUDY 134XCP|LB|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|2||||UROTHCE|UROTHELIAL CELLS|||||||10^6 ORGANISMS/G|||||||INDETERMINATE||ML/CAGE||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|PARAFFIN-EMBEDDED|NA|EPSILOMETER|MDRD FORMULA||N|U|U|NA|||N|4||88||LONG-TERM FOLLOW-UP|1968-03-15|1963-12-27|||||1973-02-10||1972-07-12|U|1961-09-29
TRIAL STUDY 134XCP|LB|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|1||||PTAC|PROTHROMBIN TIME ACTUAL/CONTROL|||||||UG/MOL|||||||POSITIVE||NMOL/G||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|Y|PET/CT SCAN|MDRD ENZYMATIC FORMULA||N|N|N|NA|||U|5||7||OPEN LABEL TREATMENT|1965-04-27|1961-05-04|||||1973-05-29||1967-10-06|U|1972-10-13
TRIAL STUDY 134XCP|LB|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|2||||NRP1|NEUROPILIN-1|||||||S^-1(%O2)^-1|||||||POSITIVE||DRAM||||LOW|NOT DONE||||SEMEN|NON-HEMOLYZED|NA|PET SCAN|FIBROTEST FORMULA||N|NA|N|N|||NA|5||7||BLINDED TREATMENT|1967-07-27|1968-01-26|||||1972-01-29||1963-07-02|U|1969-07-20
TRIAL STUDY 134XCP|LB|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|1||||IDLVLDL3|IDL+VLDL CHOLESTEROL SUBTYPE 3|||||||KEV|||||||TRACE||MBQ/UL||||ABNORMAL|NOT DONE||||KERATINOCYTE|CLOTTED|U|PANENDOSCOPY|FIBROSIS 4 FORMULA||N|N|U|Y|||N|1||38||RUN-IN|1972-01-01|1967-08-10|||||1969-11-02||1960-02-23|Y|1970-10-31
TRIAL STUDY 134XCP|LB|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|2||||PROMONLE|PROMONOCYTES/LEUKOCYTES|||||||MCI/L|||||||NEGATIVE||OSM||||NORMAL|NOT DONE||||STOOL|CONCENTRATED|U|DC SHEATH FLOW|MDRD ENZYMATIC FORMULA||N|N|N|NA|||NA|1||38||RUN-IN|1967-11-19|1966-04-02|||||1966-09-28||1970-07-14|N|1972-06-30
TRIAL STUDY 134XCP|LB|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|1||||CREATCLR|CREATININE CLEARANCE|||||||ML/MIN/1.73M2|||||||POSITIVE||DAGU/ML||||HIGH|NOT DONE||||EXPIRED AIR|AGGLUTINATED|N|X-RAY FLUORESCENCE SPECTROMETRY|MDRD 5 VARIABLE FORMULA||N|U|U|NA|||N|2||58||TREATMENT|1969-08-20|1967-07-24|||||1960-03-03||1960-04-11|N|1961-06-27
TRIAL STUDY 134XCP|LB|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|2||||IGGC|IGG CLEARANCE|||||||CYLINDER|||||||TRACE||FT3||||NORMAL|NOT DONE||||ARTERIAL BLOOD|CONTAMINATED|NA|PUPILLOMETRY|FIBROTEST FORMULA||NA|Y|Y|N|||U|2||58||BLINDED TREATMENT|1968-01-25|1966-11-23|||||1962-08-06||1972-10-26|NA|1966-04-13
TRIAL STUDY 134XCP|LB|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|1||||FVIIIAAC|FACTOR VIII ACTIVITY ACTUAL/CONTROL|||||||CD|||||||TRACE||NKAT/G HB||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR|N|GC/MS-EI|CKD-EPI CREATININE FORMULA||NA|Y|NA|Y|||Y|3||39||LONG-TERM FOLLOW-UP|1964-01-05|1966-08-15|||||1973-04-06||1962-01-13|NA|1963-09-26
TRIAL STUDY 134XCP|LB|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|2||||TNFR1|TUMOR NECROSIS FACTOR RECEPTOR 1|||||||PRESSOR UNITS|||||||BORDERLINE||GPL U/ML||||ABNORMAL|NOT DONE||||EXUDATE|PARAFFIN-EMBEDDED|U|ORCHIDOMETERY|MDRD ENZYMATIC FORMULA||NA|N|Y|N|||U|3||39||OBSERVATION|1967-12-23|1970-06-15|||||1972-09-30||1969-03-02|N|1960-05-20
TRIAL STUDY 134XCP|LB|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|1||||TPROTFR|TAU PROTEIN, FREE|||||||MMOL/MIN/KPA|||||||INDETERMINATE||KIT||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|CALCIFIED|U|ETDRS EYE CHART|COCKCROFT-GAULT FORMULA||NA|N|NA|Y|||N|4||88||FOLLOW-UP|1966-07-13|1966-02-19|||||1972-06-09||1972-08-21|NA|1973-06-14
TRIAL STUDY 134XCP|LB|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|2||||C130122|NUT MIX ANTIGEN IGE ANTIBODY|||||||MU/L|||||||POSITIVE||DIP||||LOW|NOT DONE||||PUS|DRIED|NA|ICP-MS|CKD-EPI CYSTATIN C FORMULA||U|NA|Y|Y|||N|4||88||SCREENING|1964-08-28|1970-02-18|||||1969-06-14||1967-07-30|U|1968-09-21
TRIAL STUDY 134XCP|LB|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|1||||B2G1GMAB|BETA-2 GLYCOPROTEIN 1 IGM ANTIBODY|||||||ML/KG|||||||BORDERLINE||TUBE||||LOW|NOT DONE||||BONE|FRESH|NA|TOTAL BODY RADIOGRAPHY|ASH FIBROSURE FORMULA||NA|N|NA|NA|||N|5||7||TREATMENT|1967-09-12|1960-12-16|||||1966-08-21||1972-11-02|U|1972-07-12
TRIAL STUDY 134XCP|LB|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|2||||FENTANYL|FENTANYL|||||||K|||||||NEGATIVE||PIXELS/CM||||ABNORMAL|NOT DONE||||BONE|LIPEMIC|NA|DNA MICROARRAY|MDRD FORMULA||N|U|Y|Y|||U|5||7||INDUCTION TREATMENT|1973-01-07|1966-11-18|||||1970-02-14||1971-08-16|Y|1971-01-17
TRIAL STUDY 134XCP|LB|264AA652-A25E-43CE-A54F-6FEB54AB62F3|1||||B2G1GAAB|BETA-2 GLYCOPROTEIN 1 IGA ANTIBODY|||||||VOXEL|||||||TRACE||PT_BR||||NORMAL|NOT DONE||||SEBUM|FROZEN|Y|BALLPOINT PEN TECHNIQUE|MDRD FORMULA||U|N|NA|NA|||U|1||38||WASHOUT|1962-04-10|1961-01-02|||||1964-06-07||1970-11-27|Y|1967-04-27
TRIAL STUDY 134XCP|LB|264AA652-A25E-43CE-A54F-6FEB54AB62F3|2||||HDL3|HDL-CHOLESTEROL SUBCLASS 3|||||||UMOL/MG/MIN|||||||POSITIVE||PPM||||NORMAL|NOT DONE||||GASTRIC CONTENTS|AUTOLYZED|Y|CALIPER MEASUREMENT METHOD|CKD-EPI FORMULA||Y|Y|N|Y|||NA|1||38||CONTINUATION TREATMENT|1972-08-09|1969-02-24|||||1967-01-12||1961-01-06|NA|1962-09-08
TRIAL STUDY 134XCP|LB|264AA652-A25E-43CE-A54F-6FEB54AB62F3|1||||ISG15|UBIQUITIN-LIKE PROTEIN ISG15|||||||UGEQ|||||||TRACE||ML/DL||||HIGH|NOT DONE||||LEUKOCYTE|NON-HEMOLYZED|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD 4 VARIABLE FORMULA||U|Y|N|U|||NA|2||58||LONG-TERM FOLLOW-UP|1970-08-25|1967-09-22|||||1963-12-09||1964-10-04|U|1967-06-13
TRIAL STUDY 134XCP|LB|264AA652-A25E-43CE-A54F-6FEB54AB62F3|2||||RANKL|RECEPTOR ACTIVATOR NUCLEAR KAPPAB LIGAND|||||||10^9 CFU/G|||||||INVALID||ML/MIN||||NORMAL|NOT DONE||||URINE SEDIMENT|DRIED|NA|PHOTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|Y|NA|||Y|2||58||BASELINE|1970-09-13|1971-11-13|||||1973-01-13||1967-03-12|N|1969-04-05
TRIAL STUDY 134XCP|LB|264AA652-A25E-43CE-A54F-6FEB54AB62F3|1||||SODMEXR|SODIUM EXCRETION RATE|||||||DPM|||||||POSITIVE||MPH||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|DRIED|N|ANGIOGRAPHY|ASH FIBROSURE FORMULA||N|U|Y|Y|||NA|3||39||CONTINUATION TREATMENT|1963-01-05|1963-10-22|||||1971-05-04||1969-10-11|Y|1960-08-15
TRIAL STUDY 134XCP|LB|264AA652-A25E-43CE-A54F-6FEB54AB62F3|2||||MONOPTPT|MONOCLONAL PROTEIN/TOTAL PROTEIN|||||||EQ|||||||NEGATIVE||INHALATION||||NORMAL|NOT DONE||||KERATINOCYTE|CONCENTRATED|Y|LC-FL|FIBROTEST FORMULA||NA|N|NA|NA|||N|3||39||TREATMENT|1962-11-06|1960-01-13|||||1969-01-03||1970-01-16|Y|1971-07-18
TRIAL STUDY 134XCP|LB|264AA652-A25E-43CE-A54F-6FEB54AB62F3|1||||TPAAG|TISSUE PLASMINOGEN ACTIVATOR ANTIGEN|||||||ML/CM|||||||BORDERLINE||MG2/DL2||||NORMAL|NOT DONE||||PERITONEAL FLUID|REFRIGERATED|Y|MICROARRAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|U|NA|||U|4||88||CONTINUATION TREATMENT|1970-05-20|1965-03-19|||||1972-02-07||1962-01-06|N|1968-09-20
TRIAL STUDY 134XCP|LB|264AA652-A25E-43CE-A54F-6FEB54AB62F3|2||||SAMETH|S-ADENOSYLMETHIONINE|||||||10^6 ORGANISMS/ML|||||||POSITIVE||/500 WBC||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|PARAFFIN-EMBEDDED|Y|MRI|MDRD ENZYMATIC JAPANESE FORMULA||U|N|N|Y|||Y|4||88||RUN-IN|1972-12-07|1966-07-14|||||1973-05-11||1971-09-14|U|1964-08-10
TRIAL STUDY 134XCP|LB|264AA652-A25E-43CE-A54F-6FEB54AB62F3|1||||BLSTRSID|RINGED SIDEROBLASTS|||||||BQ/KG|||||||NEGATIVE||CYLINDER||||HIGH|NOT DONE||||HAIR|CALCIFIED|Y|WRIGHT-GIEMSA STAIN|FIBROTEST FORMULA||Y|U|U|U|||NA|5||7||OPEN LABEL TREATMENT|1971-08-23|1969-11-19|||||1965-02-27||1961-11-01|Y|1967-01-13
TRIAL STUDY 134XCP|LB|264AA652-A25E-43CE-A54F-6FEB54AB62F3|2||||THRMPTN|THROMBOPOIETIN|||||||ML/M2/MIN|||||||BORDERLINE||M3||||NORMAL|NOT DONE||||HAIR|DRIED|NA|ELECTROCHEMILUMINESCENCE|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|U|||U|5||7||OPEN LABEL TREATMENT|1960-06-15|1971-09-11|||||1971-07-09||1966-08-27|N|1967-03-13
TRIAL STUDY 134XCP|LB|4DE042DC-2F1E-425C-BA36-F64A3493CE76|1||||PGD2S|PROSTAGLANDIN D2 SYNTHASE|||||||PACKET|||||||BORDERLINE||L/H||||LOW|NOT DONE||||HAIR|LACTESCENT|NA|KLEIHAUER-BETKE|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|U|||N|1||38||TREATMENT|1969-02-25|1969-03-16|||||1966-05-27||1962-03-02|Y|1967-02-02
TRIAL STUDY 134XCP|LB|4DE042DC-2F1E-425C-BA36-F64A3493CE76|2||||HER2|HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2|||||||UMOL|||||||INVALID||U/G/MIN||||LOW|NOT DONE||||MONOCYTE|CALCIFIED|Y|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE FORMULA||NA|N|N|NA|||Y|1||38||WASHOUT|1963-03-31|1962-05-28|||||1962-11-25||1965-12-26|NA|1962-11-05
TRIAL STUDY 134XCP|LB|4DE042DC-2F1E-425C-BA36-F64A3493CE76|1||||APOE4|APOLIPOPROTEIN E4|||||||SYRINGE|||||||TRACE||10^5/HPF||||ABNORMAL|NOT DONE||||COLOSTRUM|ROOM TEMPERATURE|U|SLIT LAMP|FIBROTEST FORMULA||N|U|U|N|||U|2||58||FOLLOW-UP|1969-07-26|1971-03-16|||||1961-07-14||1962-08-02|N|1968-10-14
TRIAL STUDY 134XCP|LB|4DE042DC-2F1E-425C-BA36-F64A3493CE76|2||||C147277|TRITICUM AESTIVUM ANTIGEN IGE ANTIBODY|||||||G/DL|||||||BORDERLINE||AU/ML||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|N|CT SCAN|MDRD 5 VARIABLE FORMULA||Y|N|NA|N|||U|2||58||SCREENING|1961-10-29|1967-11-09|||||1965-04-10||1970-09-15|U|1968-06-20
TRIAL STUDY 134XCP|LB|4DE042DC-2F1E-425C-BA36-F64A3493CE76|1||||PTSFAAC|PROTEIN S FREE ACTIVITY ACTUAL/CONTROL|||||||OZ EQ|||||||INVALID||BQ/L||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|CALCIFIED|Y|SINGLE-MOLECULE ARRAY|MDRD ENZYMATIC FORMULA||N|NA|U|U|||U|3||39||BLINDED TREATMENT|1966-04-19|1969-12-25|||||1965-06-13||1971-09-30|N|1972-06-12
TRIAL STUDY 134XCP|LB|4DE042DC-2F1E-425C-BA36-F64A3493CE76|2||||OXYCDN|OXYCODONE|||||||L/S/KPA|||||||POSITIVE||LM||||ABNORMAL|NOT DONE||||NAIL|GELLED|U|CYSTOMETRY|FIBROSIS 4 FORMULA||NA|NA|NA|NA|||N|3||39||TREATMENT|1963-07-07|1962-04-23|||||1961-10-19||1970-08-27|NA|1961-06-13
TRIAL STUDY 134XCP|LB|4DE042DC-2F1E-425C-BA36-F64A3493CE76|1||||CHLMCRNT|CHYLOMICRON TRIGLYCERIDE|||||||M/SEC2|||||||BORDERLINE||UMOL/L/SEC||||LOW|NOT DONE||||CERUMEN|GELLED|U|NUCLEAR RADIOLOGY|GMI % FORMULA||U|NA|Y|NA|||NA|4||88||LONG-TERM FOLLOW-UP|1968-07-05|1961-12-10|||||1969-07-30||1964-04-07|Y|1967-01-18
TRIAL STUDY 134XCP|LB|4DE042DC-2F1E-425C-BA36-F64A3493CE76|2||||TSHRAB|THYROTROPIN RECEPTOR ANTIBODY|||||||WEEKS|||||||INVALID||CUP||||HIGH|NOT DONE||||STOOL|AUTOLYZED|NA|GC/MS-CI|HEPASCORE FORMULA||NA|U|NA|U|||N|4||88||CONTINUATION TREATMENT|1961-12-01|1960-02-22|||||1962-09-25||1970-04-30|Y|1971-11-11
TRIAL STUDY 134XCP|LB|4DE042DC-2F1E-425C-BA36-F64A3493CE76|1||||C130116|BEE MIX ANTIGEN IGE ANTIBODY|||||||PA|||||||NEGATIVE||/2500 WBC||||HIGH|NOT DONE||||PROSTATIC FLUID|NON-HEMOLYZED|Y|CONTRAST ENHANCED PET SCAN|MDRD 6 VARIABLE FORMULA||NA|Y|NA|N|||N|5||7||OPEN LABEL TREATMENT|1960-09-18|1966-03-26|||||1970-10-31||1965-12-20|Y|1968-04-11
TRIAL STUDY 134XCP|LB|4DE042DC-2F1E-425C-BA36-F64A3493CE76|2||||C130123|NUT MIX ANTIGEN IGG ANTIBODY|||||||PG/L|||||||NEGATIVE||U/M2||||LOW|NOT DONE||||PLATELET|AGGLUTINATED|U|IHC|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|U|Y|||NA|5||7||CONTINUATION TREATMENT|1965-12-29|1961-12-11|||||1961-03-09||1962-12-29|U|1967-10-10
TRIAL STUDY 134XCP|LB|872942E9-A575-4929-9B21-D30DE51B367B|1||||MONMPHLE|MONOCYTES AND MACROPHAGES/LEUKOCYTES|||||||/100 HPFS|||||||INDETERMINATE||FIU||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|LACTESCENT|U|X-RAY FLUORESCENCE SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|Y|||NA|1||38||RUN-IN|1963-12-03|1961-06-20|||||1962-12-23||1965-02-12|Y|1969-03-04
TRIAL STUDY 134XCP|LB|872942E9-A575-4929-9B21-D30DE51B367B|2||||NORMBASO|BASOPHILIC NORMOBLAST|||||||10^3 RNA COPIES/ML|||||||INDETERMINATE||DPM/ML||||ABNORMAL|NOT DONE||||BASAL TEAR|FROZEN|Y|SLIT LAMP PHOTOGRAPHY|FIBROMETER FORMULA||Y|Y|NA|NA|||U|1||38||FOLLOW-UP|1971-05-03|1961-01-08|||||1969-05-13||1966-02-12|U|1973-01-23
TRIAL STUDY 134XCP|LB|872942E9-A575-4929-9B21-D30DE51B367B|1||||FXIVAC|FACTOR XIV ACTUAL/CONTROL|||||||FFU|||||||NEGATIVE||10^8 PFU||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|LACTESCENT|NA|LISSAMINE GREEN STAIN|ASH FIBROSURE FORMULA||Y|Y|U|Y|||N|2||58||WASHOUT|1964-07-10|1960-11-04|||||1969-03-29||1968-07-09|N|1960-04-02
TRIAL STUDY 134XCP|LB|872942E9-A575-4929-9B21-D30DE51B367B|2||||PIVKAII|PROTEIN INDUCED BY VITAMIN K ABSENCE-II|||||||TUBERCULIN UNIT|||||||POSITIVE||RING||||ABNORMAL|NOT DONE||||EXUDATE|CALCIFIED|NA|POTENTIOMETRY|MDRD ENZYMATIC FORMULA||NA|N|Y|NA|||U|2||58||RUN-IN|1963-05-23|1962-07-31|||||1967-08-23||1969-12-13|Y|1962-11-10
TRIAL STUDY 134XCP|LB|872942E9-A575-4929-9B21-D30DE51B367B|1||||CH100|COMPLEMENT CH100|||||||MMOL/L|||||||BORDERLINE||NG/DAY||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|CONTAMINATED|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CREATININE FORMULA||NA|N|Y|NA|||Y|3||39||FOLLOW-UP|1968-12-09|1963-05-07|||||1964-12-18||1962-03-29|NA|1961-09-25
TRIAL STUDY 134XCP|LB|872942E9-A575-4929-9B21-D30DE51B367B|2||||IAA5OH|5-HYDROXYINDOLEACETIC ACID|||||||COULOMB|||||||BORDERLINE||UG/L||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|GELLED|N|JAFFE REACTION|MDRD FORMULA||Y|N|U|N|||NA|3||39||LONG-TERM FOLLOW-UP|1964-07-06|1967-12-14|||||1968-09-18||1966-12-23|Y|1973-02-28
TRIAL STUDY 134XCP|LB|872942E9-A575-4929-9B21-D30DE51B367B|1||||C165877|CAT DANDER IGE AB RAST SCORE|||||||MG/DOSE|||||||INVALID||OHM||||LOW|NOT DONE||||ADIPOSE TISSUE|AUTOLYZED|Y|PET/MRI SCAN|FIBROSIS 4 FORMULA||N|Y|U|NA|||U|4||88||OBSERVATION|1968-02-26|1960-09-10|||||1963-01-15||1963-10-10|Y|1972-05-25
TRIAL STUDY 134XCP|LB|872942E9-A575-4929-9B21-D30DE51B367B|2||||CHDWR|RET CORPUSCULAR HGB CONC DISTR WIDTH|||||||10^11/L|||||||NEGATIVE||MV||||HIGH|NOT DONE||||PLATELET|NON-HEMOLYZED|U|DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|N|N|||N|4||88||BLINDED TREATMENT|1963-08-10|1964-11-07|||||1966-11-06||1971-09-16|Y|1967-11-16
TRIAL STUDY 134XCP|LB|872942E9-A575-4929-9B21-D30DE51B367B|1||||MPC|MEAN PLATELET COMPONENT|||||||RING|||||||TRACE||TRANSDUCING UNIT/ML||||LOW|NOT DONE||||LOCHIA|DRIED|NA|POLYSOMNOGRAPHY|CKD-EPI CREATININE FORMULA||NA|N|Y|Y|||N|5||7||LONG-TERM FOLLOW-UP|1964-02-28|1969-10-24|||||1964-07-18||1965-08-24|Y|1968-11-07
TRIAL STUDY 134XCP|LB|872942E9-A575-4929-9B21-D30DE51B367B|2||||INTLK3|INTERLEUKIN 3|||||||COAT|||||||BORDERLINE||ML/M2/H||||HIGH|NOT DONE||||ISOLATE|LIPEMIC|U|CONTRAST ENHANCED CT SCAN|FIBROMETER FORMULA||N|Y|Y|Y|||NA|5||7||BLINDED TREATMENT|1972-04-09|1970-01-01|||||1963-07-18||1960-07-30|Y|1970-11-22
TRIAL STUDY 134XCP|LB|628822F3-4983-44F8-B98D-7A35AAFF2962|1||||NITRITE|NITRITE|||||||NSEC|||||||NEGATIVE||10^9 ORGANISMS/ML||||ABNORMAL|NOT DONE||||TISSUE|HEMOLYZED|NA|INFRARED SPECTROMETRY|FIBROSIS 4 FORMULA||N|NA|U|U|||U|1||38||SCREENING|1961-09-28|1966-01-13|||||1969-08-14||1966-06-26|NA|1966-08-18
TRIAL STUDY 134XCP|LB|628822F3-4983-44F8-B98D-7A35AAFF2962|2||||SERTRAL|SERTRALINE|||||||CONTAINER|||||||NEGATIVE||MDFI||||NORMAL|NOT DONE||||MUCUS|CONCENTRATED|U|SINGLE-SLICE SPIRAL CT|FIBROTEST FORMULA||NA|U|Y|Y|||Y|1||38||INDUCTION TREATMENT|1973-04-18|1962-09-14|||||1963-02-13||1964-08-18|N|1963-05-31
TRIAL STUDY 134XCP|LB|628822F3-4983-44F8-B98D-7A35AAFF2962|1||||NTENS|NEUROTENSIN|||||||10^3/L|||||||INDETERMINATE||/MM2||||HIGH|NOT DONE||||CERUMEN|THAWED|N|BAC ACGH|FIBROMETER FORMULA||Y|U|U|N|||U|2||58||RUN-IN|1969-06-05|1966-06-10|||||1963-12-01||1967-04-06|U|1961-07-17
TRIAL STUDY 134XCP|LB|628822F3-4983-44F8-B98D-7A35AAFF2962|2||||C130123|NUT MIX ANTIGEN IGG ANTIBODY|||||||LOG10 CFU/G|||||||INDETERMINATE||UM/S||||LOW|NOT DONE||||TRANSUDATE|REFRIGERATED|Y|HILLMEN COLOR CHART|MDRD ENZYMATIC FORMULA||NA|NA|Y|U|||N|2||58||BASELINE|1964-04-29|1971-06-05|||||1972-07-07||1972-01-06|N|1971-11-17
TRIAL STUDY 134XCP|LB|628822F3-4983-44F8-B98D-7A35AAFF2962|1||||OVALCY|OVALOCYTES|||||||MMOL/MOL|||||||INVALID||KDA||||HIGH|NOT DONE||||BLOOD|GELLED|U|TWO-COLOR MICROARRAY|CKD-EPI CREATININE FORMULA||NA|NA|Y|NA|||N|3||39||INDUCTION TREATMENT|1962-03-28|1967-06-29|||||1966-08-17||1964-11-14|NA|1961-09-20
TRIAL STUDY 134XCP|LB|628822F3-4983-44F8-B98D-7A35AAFF2962|2||||LYMVAC|VACUOLATED LYMPHOCYTES|||||||MOL/L|||||||INDETERMINATE||MS2||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|CLOTTED|N|IMMUNOTURBIDIMETRY|HEPASCORE FORMULA||NA|N|Y|U|||Y|3||39||LONG-TERM FOLLOW-UP|1965-11-28|1973-01-12|||||1967-06-17||1970-07-15|Y|1966-07-03
TRIAL STUDY 134XCP|LB|628822F3-4983-44F8-B98D-7A35AAFF2962|1||||ESELS|SOLUBLE E-SELECTIN|||||||U.CARR|||||||NEGATIVE||STEPS||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|THAWED|N|ELECTROPHORESIS|HEPASCORE FORMULA||N|N|N|N|||N|4||88||INDUCTION TREATMENT|1971-04-09|1973-02-25|||||1969-05-14||1968-12-07|N|1969-04-17
TRIAL STUDY 134XCP|LB|628822F3-4983-44F8-B98D-7A35AAFF2962|2||||IDLVLDL3|IDL+VLDL CHOLESTEROL SUBTYPE 3|||||||PM|||||||INDETERMINATE||S*KPA||||ABNORMAL|NOT DONE||||PERSPIRATION|GELLED|NA|FARR ASSAY|NASH FIBROSURE FORMULA||N|U|NA|NA|||NA|4||88||LONG-TERM FOLLOW-UP|1971-06-25|1965-05-15|||||1961-03-27||1972-03-28|N|1963-02-17
TRIAL STUDY 134XCP|LB|628822F3-4983-44F8-B98D-7A35AAFF2962|1||||GDIGA1|GALACTOSE-DEFICIENT IGA1|||||||MESF|||||||TRACE||K||||NORMAL|NOT DONE||||MUSCLE TISSUE|UNEXPECTED ODOR|N|MAMMOGRAPHY|CKD-EPI CREATININE FORMULA||N|U|NA|U|||U|5||7||BLINDED TREATMENT|1969-09-04|1968-04-09|||||1972-10-09||1963-07-12|U|1964-02-20
TRIAL STUDY 134XCP|LB|628822F3-4983-44F8-B98D-7A35AAFF2962|2||||LYMCE|LYMPHOCYTES/TOTAL CELLS|||||||GPS U|||||||BORDERLINE||/500 WBC||||LOW|NOT DONE||||CELL PELLET|GELLED|Y|ISHIHARA COLOR PLATES|MDRD 4 VARIABLE FORMULA||U|Y|Y|U|||U|5||7||BLINDED TREATMENT|1968-11-21|1967-11-07|||||1966-12-29||1962-12-04|NA|1968-08-19
TRIAL STUDY 134XCP|LB|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|1||||HRYCECE|HAIRY CELLS/TOTAL CELLS|||||||CARTRIDGE|||||||INDETERMINATE||CARTRIDGE||||HIGH|NOT DONE||||VENOUS CORD BLOOD|ROOM TEMPERATURE|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|NA|Y|||Y|1||38||RUN-IN|1971-01-04|1964-10-21|||||1967-07-29||1973-06-26|N|1960-05-30
TRIAL STUDY 134XCP|LB|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|2||||PROPOX|PROPOXYPHENE|||||||POINT|||||||BORDERLINE||U/M2/MIN||||ABNORMAL|NOT DONE||||CORD SERUM|GELLED|Y|TARGETED TRANSCRIPTOME SEQUENCING|MDRD FORMULA||NA|N|N|N|||U|1||38||LONG-TERM FOLLOW-UP|1963-09-20|1965-11-24|||||1967-02-05||1969-04-25|NA|1961-09-29
TRIAL STUDY 134XCP|LB|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|1||||PRZPM|PRAZEPAM|||||||IU/KG|||||||BORDERLINE||BAU||||LOW|NOT DONE||||DERMAL TISSUE|LIPEMIC|U|ENDPOINT DILUTION ASSAY|GMI MMOL/MOL FORMULA||U|NA|Y|NA|||N|2||58||OPEN LABEL TREATMENT|1963-07-03|1972-04-21|||||1961-12-24||1972-02-23|Y|1964-08-24
TRIAL STUDY 134XCP|LB|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|2||||NEUTIMLE|IMMATURE NEUTROPHILS/LEUKOCYTES|||||||UG/ANIMAL|||||||NEGATIVE||LOG10 TCID 50/UL||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR|N|FLAME PHOTOMETRY|FIBROTEST FORMULA||NA|N|N|N|||NA|2||58||FOLLOW-UP|1967-08-23|1970-12-14|||||1970-07-29||1961-07-10|N|1966-01-03
TRIAL STUDY 134XCP|LB|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|1||||HAPTOG|HAPTOGLOBIN|||||||APS U|||||||BORDERLINE||/10^5||||ABNORMAL|NOT DONE||||COLOSTRUM|FRESH|NA|LC/MS/MS|MDRD ENZYMATIC FORMULA||N|Y|Y|N|||NA|3||39||INDUCTION TREATMENT|1969-01-03|1969-04-21|||||1960-04-01||1964-03-14|N|1966-05-06
TRIAL STUDY 134XCP|LB|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|2||||ALA|ALANINE|||||||MG/DAY|||||||INDETERMINATE||CM2||||NORMAL|NOT DONE||||SWABBED MATERIAL|AUTOLYZED|Y|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA||U|N|NA|Y|||U|3||39||WASHOUT|1960-10-22|1968-12-18|||||1968-03-16||1970-07-05|NA|1960-03-07
TRIAL STUDY 134XCP|LB|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|1||||TRANK1|TPR-ANKYRIN REPEAT-CONTAINING PROTEIN 1|||||||NSEC|||||||INVALID||L||||LOW|NOT DONE||||SEMINAL FLUID|REFRIGERATED|Y|PYROSEQUENCING|MDRD FORMULA||Y|N|N|N|||NA|4||88||BLINDED TREATMENT|1972-03-24|1968-07-06|||||1966-06-24||1970-05-16|NA|1973-08-13
TRIAL STUDY 134XCP|LB|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|2||||SODMEXR|SODIUM EXCRETION RATE|||||||UMOL/DL|||||||INDETERMINATE||DRAM||||HIGH|NOT DONE||||SWABBED MATERIAL|FROZEN|N|ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||NA|NA|NA|U|||Y|4||88||TREATMENT|1961-03-22|1973-03-29|||||1963-05-20||1960-01-13|Y|1971-01-16
TRIAL STUDY 134XCP|LB|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|1||||LYMA|LYMPHOCYTES ACTIVATED|||||||UGEQ/L|||||||NEGATIVE||MG/M2/DAY||||LOW|NOT DONE||||REFLEX TEAR|FROZEN|NA|SURFACE PLASMON RESONANCE|CKD-EPI CYSTATIN C FORMULA||Y|N|NA|Y|||N|5||7||FOLLOW-UP|1963-06-28|1962-06-27|||||1965-06-15||1970-12-08|N|1961-05-03
TRIAL STUDY 134XCP|LB|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|2||||HLAMSC|HLA MISMATCH COUNT|||||||ML/CAGE/DAY|||||||NEGATIVE||AG||||ABNORMAL|NOT DONE||||URINE SEDIMENT|HEMOLYZED|N|CONFOCAL MICROSCOPY|NASH FIBROSURE FORMULA||U|U|U|Y|||N|5||7||SCREENING|1968-01-04|1967-11-30|||||1968-03-12||1961-01-05|U|1964-09-11
TRIAL STUDY 134XCP|LB|6045DFAB-0734-4E6D-A492-34BD613EC783|1||||CELLSIM|IMMATURE CELLS|||||||NCI|||||||INDETERMINATE||G/ANIMAL||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|LACTESCENT|NA|FLUORESCENT ENZYME IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||U|U|Y|Y|||Y|1||38||INDUCTION TREATMENT|1961-04-15|1968-03-01|||||1971-10-29||1970-10-03|Y|1960-10-03
TRIAL STUDY 134XCP|LB|6045DFAB-0734-4E6D-A492-34BD613EC783|2||||RLP|RLP CHOLESTEROL|||||||UV2|||||||NEGATIVE||/40 HPFS||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|FRESH|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA||U|Y|U|NA|||N|1||38||BASELINE|1966-11-23|1970-06-29|||||1967-10-31||1972-01-23|NA|1962-10-22
TRIAL STUDY 134XCP|LB|6045DFAB-0734-4E6D-A492-34BD613EC783|1||||EOTAXIN1|EOTAXIN-1|||||||STEPS/MIN|||||||NEGATIVE||MET*MIN||||NORMAL|NOT DONE||||CAPILLARY PLASMA|GELLED|Y|LIGHT SCATTERING SPECTROSCOPY|FIBROSIS 4 FORMULA||U|NA|Y|NA|||NA|2||58||OBSERVATION|1965-01-20|1964-03-26|||||1961-05-15||1966-06-29|Y|1968-10-31
TRIAL STUDY 134XCP|LB|6045DFAB-0734-4E6D-A492-34BD613EC783|2||||TXB2D11R|11-DEHYDRO-THROMBOXANE B2 EXCRETION RATE|||||||SYRINGE|||||||NEGATIVE||CYCLE/MIN||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|LACTESCENT|U|ELECTROMYOGRAPHY|GMI % FORMULA||U|Y|NA|Y|||NA|2||58||SCREENING|1969-06-26|1966-10-09|||||1960-03-06||1968-08-19|U|1962-07-01
TRIAL STUDY 134XCP|LB|6045DFAB-0734-4E6D-A492-34BD613EC783|1||||ERCEPPOL|ERYTHROID PROLIFERATION POOL|||||||CM H2O|||||||TRACE||PIXELS/IN||||ABNORMAL|NOT DONE||||SEMINAL FLUID|GELLED|N|SPECT/CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|U|NA|||U|3||39||LONG-TERM FOLLOW-UP|1966-03-11|1972-04-02|||||1960-05-22||1971-07-04|NA|1968-02-06
TRIAL STUDY 134XCP|LB|6045DFAB-0734-4E6D-A492-34BD613EC783|2||||BETAINES|BETAINES|||||||10^6 IU|||||||NEGATIVE||AMFI||||LOW|NOT DONE||||LYSATE|ICTERIC|NA|IMMUNOBLOT|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|Y|NA|||Y|3||39||OPEN LABEL TREATMENT|1962-03-05|1963-12-19|||||1964-12-22||1967-08-31|Y|1960-01-01
TRIAL STUDY 134XCP|LB|6045DFAB-0734-4E6D-A492-34BD613EC783|1||||COCAM|COCAINE METABOLITES|||||||UG/DAY|||||||POSITIVE||C||||ABNORMAL|NOT DONE||||MECONIUM|AGGLUTINATED|NA|IN SITU HYBRIDIZATION|CKD-EPI CYSTATIN C FORMULA||N|Y|NA|U|||U|4||88||CONTINUATION TREATMENT|1969-01-31|1971-01-02|||||1960-04-27||1962-01-16|N|1960-04-24
TRIAL STUDY 134XCP|LB|6045DFAB-0734-4E6D-A492-34BD613EC783|2||||LDH2LDH|LDH ISOENZYME 2/LDH|||||||BQ/UG|||||||NEGATIVE||VIRTUAL PIXEL||||HIGH|NOT DONE||||MONOCYTE|NON-HEMOLYZED|N|CELL OF ORIGIN ASSAY|CKD-EPI FORMULA||U|U|N|N|||Y|4||88||LONG-TERM FOLLOW-UP|1963-09-24|1970-01-28|||||1973-08-10||1963-07-13|NA|1962-04-12
TRIAL STUDY 134XCP|LB|6045DFAB-0734-4E6D-A492-34BD613EC783|1||||ACE|ANGIOTENSIN CONVERTING ENZYME|||||||C|||||||POSITIVE||UG/L/H||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|HEMOLYZED|N|IN VITRO GENE EXPRESSION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|N|NA|||N|5||7||WASHOUT|1965-01-24|1962-07-29|||||1968-08-22||1965-09-19|NA|1963-12-02
TRIAL STUDY 134XCP|LB|6045DFAB-0734-4E6D-A492-34BD613EC783|2||||PSA|PROSTATE SPECIFIC ANTIGEN|||||||BE/ML|||||||NEGATIVE||GPL U/ML||||LOW|NOT DONE||||HAIR|THAWED|Y|SXA SCAN|MDRD 5 VARIABLE FORMULA||Y|NA|NA|N|||Y|5||7||BASELINE|1972-09-21|1972-07-15|||||1971-06-20||1962-02-22|N|1971-09-19
TRIAL STUDY 134XCP|LB|482F0519-E738-46DE-A5C4-4AC76B6E7011|1||||ANGPT1|ANGIOPOIETIN 1|||||||LOG10 ELISA UNIT|||||||TRACE||FARAD||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONCENTRATED|Y|PULSE OXIMETRY|FIBROMETER FORMULA||Y|N|NA|U|||NA|1||38||BLINDED TREATMENT|1972-03-13|1967-12-31|||||1969-03-07||1964-05-08|U|1966-05-24
TRIAL STUDY 134XCP|LB|482F0519-E738-46DE-A5C4-4AC76B6E7011|2||||OXZPM|OXAZEPAM|||||||UMOL/MIN|||||||INVALID||HOMEOPATHIC DILUTION||||HIGH|NOT DONE||||ARTERIAL BLOOD|CONTAMINATED|Y|PET SCAN|CKD-EPI FORMULA||U|NA|Y|U|||U|1||38||INDUCTION TREATMENT|1960-08-09|1965-11-28|||||1973-06-10||1969-02-02|Y|1961-06-18
TRIAL STUDY 134XCP|LB|482F0519-E738-46DE-A5C4-4AC76B6E7011|1||||TDTAG|TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE AG|||||||MNFI|||||||TRACE||MMOL/KG||||LOW|NOT DONE||||VENOUS BLOOD|FROZEN|NA|ATOMIC ABSORPTION SPECTROMETRY|GMI MMOL/MOL FORMULA||U|NA|Y|U|||U|2||58||SCREENING|1961-03-26|1971-08-22|||||1964-11-14||1966-10-12|NA|1971-07-18
TRIAL STUDY 134XCP|LB|482F0519-E738-46DE-A5C4-4AC76B6E7011|2||||FACTIII|FACTOR III|||||||U/L|||||||TRACE||MCI/L||||NORMAL|NOT DONE||||MECONIUM|CALCIFIED|NA|DYNAMOMETRY|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1972-06-30|1964-09-01|||||1972-04-20||1972-11-10|NA|1961-12-27
TRIAL STUDY 134XCP|LB|482F0519-E738-46DE-A5C4-4AC76B6E7011|1||||CREATCLR|CREATININE CLEARANCE|||||||/MM|||||||TRACE||10^6 ORGANISMS||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|CLOTTED|U|MRI WITHOUT CONTRAST|NASH FIBROSURE FORMULA||N|N|NA|Y|||N|3||39||OBSERVATION|1972-05-06|1973-06-03|||||1960-06-19||1964-02-06|U|1965-07-25
TRIAL STUDY 134XCP|LB|482F0519-E738-46DE-A5C4-4AC76B6E7011|2||||HBBARTHB|HEMOGLOBIN BARTS/TOTAL HEMOGLOBIN|||||||UKAT|||||||POSITIVE||CYCLE/MIN||||NORMAL|NOT DONE||||EXPIRED AIR|GELLED|Y|AGAR DILUTION|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|NA|U|||N|3||39||TREATMENT|1967-07-20|1962-06-10|||||1960-10-26||1969-12-16|N|1966-01-27
TRIAL STUDY 134XCP|LB|482F0519-E738-46DE-A5C4-4AC76B6E7011|1||||ESR|ERYTHROCYTE SEDIMENTATION RATE|||||||GMFI|||||||POSITIVE||PRESSOR UNITS||||ABNORMAL|NOT DONE||||CELL PELLET|AUTOLYZED|Y|ENZYMATIC ULTRACENTRIFUGATION|HEPASCORE FORMULA||Y|Y|Y|NA|||NA|4||88||BLINDED TREATMENT|1970-03-03|1972-12-27|||||1962-05-25||1969-06-18|Y|1963-03-13
TRIAL STUDY 134XCP|LB|482F0519-E738-46DE-A5C4-4AC76B6E7011|2||||HDLCCHOL|HDL CHOLESTEROL/TOTAL CHOLESTEROL|||||||ANTI-XA IU|||||||NEGATIVE||MPL U/ML||||LOW|NOT DONE||||SALIVA|NON-HEMOLYZED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CYSTATIN C FORMULA||NA|NA|NA|NA|||N|4||88||TREATMENT|1965-10-09|1960-01-18|||||1967-09-26||1972-04-23|U|1968-09-08
TRIAL STUDY 134XCP|LB|482F0519-E738-46DE-A5C4-4AC76B6E7011|1||||MIP1B|MACROPHAGE INFLAMMATORY PROTEIN 1 BETA|||||||PELLET|||||||POSITIVE||ML/CAGE/WK||||NORMAL|NOT DONE||||PLASMA|PARAFFIN-EMBEDDED|N|CELL OF ORIGIN ASSAY|FIBROMETER FORMULA||U|Y|NA|N|||NA|5||7||FOLLOW-UP|1971-08-22|1967-05-03|||||1961-01-30||1967-09-18|NA|1973-03-13
TRIAL STUDY 134XCP|LB|482F0519-E738-46DE-A5C4-4AC76B6E7011|2||||BLSTSID|SIDEROBLAST|||||||10^3 COPIES/ML|||||||INDETERMINATE||MG/ML/MIN||||NORMAL|NOT DONE||||ISOLATE|REFRIGERATED|NA|PHOTOMETRIC CLOT DETECTION|FIBROMETER FORMULA||NA|U|Y|U|||Y|5||7||FOLLOW-UP|1969-11-25|1962-01-08|||||1966-02-07||1973-02-22|N|1967-11-20
TRIAL STUDY 134XCP|LB|DFDD42F5-749C-4AF0-8351-780DB9614F61|1||||B2G1GMAB|BETA-2 GLYCOPROTEIN 1 IGM ANTIBODY|||||||VIRTUAL PIXEL|||||||INVALID||PPM||||HIGH|NOT DONE||||PLASMA|SOLIDIFIED|N|MICROBIAL CULTURE, LIQUID|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|U|Y|||N|1||38||CONTINUATION TREATMENT|1965-02-17|1962-09-28|||||1967-04-15||1963-03-16|U|1967-02-04
TRIAL STUDY 134XCP|LB|DFDD42F5-749C-4AF0-8351-780DB9614F61|2||||PLATAGRN|PLATELETS, AGRANULAR|||||||NU/CL|||||||POSITIVE||10^7 CFU/ML||||NORMAL|NOT DONE||||SPUTUM|UNEXPECTED ODOR|U|AUSCULTATION|FIBROTEST FORMULA||Y|NA|Y|NA|||N|1||38||INDUCTION TREATMENT|1972-02-02|1962-12-15|||||1966-03-23||1962-07-12|U|1969-11-10
TRIAL STUDY 134XCP|LB|DFDD42F5-749C-4AF0-8351-780DB9614F61|1||||RBCDYSM|DYSMORPHIC ERYTHROCYTES|||||||G/MOL|||||||POSITIVE||MCI/KG||||HIGH|NOT DONE||||SYNOVIAL FLUID|ICTERIC|Y|HIGH RESOLUTION MELT ANALYSIS|GMI MMOL/MOL FORMULA||Y|U|NA|Y|||NA|2||58||BASELINE|1964-04-07|1969-01-12|||||1968-07-28||1964-01-05|U|1961-06-08
TRIAL STUDY 134XCP|LB|DFDD42F5-749C-4AF0-8351-780DB9614F61|2||||NKINA|NEUROKININ A|||||||GPELISA UNIT/ML|||||||INVALID||EVENTS||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|HEMOLYZED|N|TRIPLE-PHASE SPIRAL CT SCAN|HEPASCORE FORMULA||NA|Y|U|N|||NA|2||58||OPEN LABEL TREATMENT|1960-09-07|1963-08-29|||||1965-10-03||1964-11-28|NA|1963-09-20
TRIAL STUDY 134XCP|LB|DFDD42F5-749C-4AF0-8351-780DB9614F61|1||||MOCYCECE|MONOCYTOID CELLS/TOTAL CELLS|||||||MG/KG/WEEK|||||||NEGATIVE||ML/CAGE/DAY||||LOW|NOT DONE||||CORD BLOOD|FRESH|U|SCANNING ELECTRON MICROSCOPY|FIBROSIS 4 FORMULA||U|Y|N|N|||NA|3||39||FOLLOW-UP|1968-05-27|1970-10-15|||||1969-03-13||1968-12-12|U|1968-03-27
TRIAL STUDY 134XCP|LB|DFDD42F5-749C-4AF0-8351-780DB9614F61|2||||C130129|DOG DANDER ANTIGEN IGG ANTIBODY|||||||MM2|||||||BORDERLINE||V/SEC||||NORMAL|NOT DONE||||COLOSTRUM|CALCIFIED|NA|VIRUS PLAQUE ASSAY|CKD-EPI CREATININE FORMULA||NA|U|NA|Y|||Y|3||39||CONTINUATION TREATMENT|1970-01-05|1961-07-13|||||1970-05-28||1967-06-08|Y|1965-06-25
TRIAL STUDY 134XCP|LB|DFDD42F5-749C-4AF0-8351-780DB9614F61|1||||PORPH|PORPHYRIN|||||||KPA/L/SEC|||||||POSITIVE||NL||||HIGH|NOT DONE||||HAIR FOLLICLE|PARAFFIN-EMBEDDED|NA|THERMAL IONIZATION MASS SPECTROMETRY|MDRD 5 VARIABLE FORMULA||U|Y|N|U|||Y|4||88||BLINDED TREATMENT|1965-02-26|1961-10-10|||||1968-02-26||1971-07-19|NA|1973-01-13
TRIAL STUDY 134XCP|LB|DFDD42F5-749C-4AF0-8351-780DB9614F61|2||||SEZCELE|SEZARY CELLS/LEUKOCYTES|||||||NMOL/L|||||||INVALID||MG/H||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|FROZEN|N|MACRO BROTH DILUTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|N|NA|||U|4||88||OPEN LABEL TREATMENT|1963-09-06|1963-07-21|||||1961-05-16||1966-12-24|NA|1967-07-02
TRIAL STUDY 134XCP|LB|DFDD42F5-749C-4AF0-8351-780DB9614F61|1||||ORNITHIN|ORNITHINE|||||||SBE/ML|||||||TRACE||PPTR||||NORMAL|NOT DONE||||MUSCLE TISSUE|FRESH|U|CAPILLARY ELECTROPHORESIS|COCKCROFT-GAULT FORMULA||U|Y|NA|N|||NA|5||7||OBSERVATION|1967-12-02|1971-05-03|||||1967-03-04||1962-06-09|NA|1965-01-11
TRIAL STUDY 134XCP|LB|DFDD42F5-749C-4AF0-8351-780DB9614F61|2||||HDLCCHOL|HDL CHOLESTEROL/TOTAL CHOLESTEROL|||||||MPH|||||||BORDERLINE||MG/KG/DAY||||NORMAL|NOT DONE||||EMOTIONAL TEAR|GELLED|NA|OPHTHALMOSCOPY|HEPASCORE FORMULA||U|N|N|N|||U|5||7||INDUCTION TREATMENT|1970-03-15|1961-12-17|||||1970-10-01||1970-09-11|N|1962-03-20
TRIAL STUDY 134XCP|LB|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|1||||IA5OHEXR|5-HYDROXYINDOLEACETICACID EXCRETION RATE|||||||UG/L/H|||||||BORDERLINE||CM H2O||||NORMAL|NOT DONE||||AMNIOTIC FLUID|PARAFFIN-EMBEDDED|N|DOPPLER ULTRASOUND|NASH FIBROSURE FORMULA||U|U|N|U|||U|1||38||OBSERVATION|1961-12-03|1965-06-07|||||1972-02-23||1965-05-24|NA|1962-05-07
TRIAL STUDY 134XCP|LB|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|2||||VWFAAC|VON WILL FACTOR ACT ACTUAL/CONTROL|||||||/HPF|||||||INDETERMINATE||F||||NORMAL|NOT DONE||||SPERMATOZOON|FROZEN|N|KINYOUN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|N|U|||U|1||38||WASHOUT|1970-07-23|1960-03-31|||||1971-01-26||1961-05-01|NA|1966-07-09
TRIAL STUDY 134XCP|LB|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|1||||HALPRZLM|HYDROXYALPRAZOLAM|||||||10^3 ORGANISMS|||||||NEGATIVE||RPM||||LOW|NOT DONE||||PLATELET|UNEXPECTED ODOR|Y|INDIA INK STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|Y|NA|||Y|2||58||BLINDED TREATMENT|1972-03-01|1967-06-02|||||1972-12-21||1972-05-24|N|1962-05-08
TRIAL STUDY 134XCP|LB|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|2||||C130117|BEE MIX ANTIGEN IGG ANTIBODY|||||||CM|||||||INDETERMINATE||QUANTITY SUFFICIENT||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|AUTOLYZED|NA|IN VITRO GENE EXPRESSION ASSAY|MDRD 5 VARIABLE FORMULA||U|N|Y|Y|||N|2||58||WASHOUT|1970-09-05|1960-06-06|||||1965-12-09||1969-04-20|N|1963-04-06
TRIAL STUDY 134XCP|LB|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|1||||SPHERO|SPHEROCYTES|||||||10^3/L|||||||INDETERMINATE||LOG10 IU/ML||||LOW|NOT DONE||||LYMPH|ICTERIC|N|LINE PROBE ASSAY|CKD-EPI CREATININE FORMULA||N|N|N|U|||N|3||39||BLINDED TREATMENT|1973-06-14|1970-04-04|||||1967-09-28||1966-02-04|Y|1972-02-26
TRIAL STUDY 134XCP|LB|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|2||||CCL16|CHEMOKINE (C-C MOTIF) LIGAND 16|||||||NMOL/ML/MIN|||||||INVALID||MOL/G||||NORMAL|NOT DONE||||SERUM|LACTESCENT|N|DXA SCAN|FIBROTEST FORMULA||Y|NA|N|NA|||N|3||39||SCREENING|1968-10-04|1964-04-07|||||1966-03-31||1971-06-08|NA|1966-08-21
TRIAL STUDY 134XCP|LB|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|1||||BURRCE|BURR CELLS|||||||KIU|||||||POSITIVE||GRAIN||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|LACTESCENT|U|REFLECTANCE SPECTROSCOPY|GMI % FORMULA||Y|NA|Y|U|||Y|4||88||RUN-IN|1963-01-03|1972-01-12|||||1968-11-13||1960-11-28|Y|1961-11-09
TRIAL STUDY 134XCP|LB|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|2||||RBCFRAG|ERYTHROCYTE FRAGMENT|||||||DAYS|||||||NEGATIVE||DAGU||||LOW|NOT DONE||||CAPILLARY BLOOD|HEMOLYZED|Y|MS/MS|GMI MMOL/MOL FORMULA||NA|Y|Y|NA|||N|4||88||TREATMENT|1970-10-19|1968-03-20|||||1965-11-09||1968-08-19|U|1960-10-30
TRIAL STUDY 134XCP|LB|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|1||||C147280|COW MILK PROTEIN ANTIGEN IGE ANTIBODY|||||||DB|||||||TRACE||KG||||ABNORMAL|NOT DONE||||SERUM|CALCIFIED|Y|IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CREATININE FORMULA||Y|U|U|U|||U|5||7||INDUCTION TREATMENT|1966-02-12|1967-06-11|||||1966-02-03||1962-07-12|Y|1966-11-04
TRIAL STUDY 134XCP|LB|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|2||||TRAMADOL|TRAMADOL|||||||U/DL|||||||BORDERLINE||NFIU||||NORMAL|NOT DONE||||LUNG SURFACTANT|FRESH|Y|NUCLEIC ACID BASED METHOD|CKD-EPI CREATININE FORMULA||NA|Y|NA|NA|||N|5||7||BLINDED TREATMENT|1965-10-04|1971-01-25|||||1960-04-20||1966-02-03|U|1969-03-09
TRIAL STUDY 134XCP|LB|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|1||||IC512AB|ISLET CELL 512 ANTIBODY|||||||NKAT/G HB|||||||NEGATIVE||MEQ/DL||||LOW|NOT DONE||||CALCULUS|DRIED|N|TARGETED GENOME SEQUENCING|GMI % FORMULA||NA|NA|U|U|||Y|1||38||INDUCTION TREATMENT|1973-02-02|1971-08-08|||||1965-05-16||1960-01-25|N|1963-11-10
TRIAL STUDY 134XCP|LB|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|2||||PPTDCALB|PHOSPHATIDYLCHOLINE/ALBUMIN|||||||ML/KG/MIN|||||||BORDERLINE||KBQ/UL||||NORMAL|NOT DONE||||TUMOR TISSUE|LIPEMIC|Y|GC/MS-EI|MDRD ENZYMATIC FORMULA||N|U|U|Y|||N|1||38||WASHOUT|1972-08-28|1971-05-10|||||1966-05-29||1968-01-09|Y|1963-10-18
TRIAL STUDY 134XCP|LB|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|1||||CD11A|CD11A|||||||MG/MIN|||||||INDETERMINATE||SEC||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|FRESH|U|CALIPER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA||NA|N|U|NA|||U|2||58||TREATMENT|1960-12-15|1967-05-17|||||1963-02-17||1968-06-14|NA|1966-04-29
TRIAL STUDY 134XCP|LB|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|2||||MIP1G|MACROPHAGE INFLAMMATORY PROTEIN 1 GAMMA|||||||G/DL|||||||INDETERMINATE||10^4/L||||LOW|NOT DONE||||LEUKOCYTE|UNEXPECTED ODOR|N|VIRUS PLAQUE ASSAY|MDRD 5 VARIABLE FORMULA||N|Y|Y|U|||N|2||58||SCREENING|1970-06-03|1971-01-04|||||1971-10-22||1966-03-01|NA|1969-11-28
TRIAL STUDY 134XCP|LB|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|1||||TIMP1CRE|TIMP1/CREATININE|||||||MV*MIN|||||||POSITIVE||10^3 COPIES/ML||||NORMAL|NOT DONE||||MUSCLE TISSUE|SOLIDIFIED|N|FLOCCULATION|MDRD ENZYMATIC FORMULA||U|NA|Y|U|||N|3||39||BLINDED TREATMENT|1971-01-17|1969-09-17|||||1963-02-23||1971-04-09|U|1968-05-05
TRIAL STUDY 134XCP|LB|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|2||||TROPONI3|TROPONIN I TYPE 3|||||||10^6 CFU|||||||TRACE||C||||LOW|NOT DONE||||CORD SERUM|CALCIFIED|Y|HIGH RESOLUTION MELT ANALYSIS|HEPASCORE FORMULA||U|NA|Y|N|||NA|3||39||WASHOUT|1964-12-19|1965-07-07|||||1968-08-07||1963-12-08|Y|1971-09-19
TRIAL STUDY 134XCP|LB|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|1||||SDMA|SYMMETRIC DIMETHYLARGININE|||||||DRAM|||||||INDETERMINATE||HZ/S||||HIGH|NOT DONE||||MECONIUM|LACTESCENT|U|BIOIMPEDANCE SPECTROSCOPY|CKD-EPI CREATININE FORMULA||U|Y|N|Y|||NA|4||88||TREATMENT|1969-05-20|1963-07-20|||||1967-01-11||1960-10-31|N|1961-02-05
TRIAL STUDY 134XCP|LB|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|2||||PKM1|PYRUVATE KINASE ISOZYME M1|||||||IU/DL|||||||NEGATIVE||MIN||||HIGH|NOT DONE||||NAIL|SOLIDIFIED|Y|CHROMATOGRAPHY|MDRD ENZYMATIC FORMULA||Y|Y|NA|U|||NA|4||88||RUN-IN|1968-02-06|1970-04-17|||||1973-03-22||1965-04-29|NA|1964-10-08
TRIAL STUDY 134XCP|LB|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|1||||ASMACT|ALPHA-SMOOTH MUSCLE ACTIN|||||||DPM/0.5 ML|||||||INVALID||M||||NORMAL|NOT DONE||||URINE|CLOTTED|U|SXA SCAN|MDRD FORMULA||U|Y|N|N|||N|5||7||TREATMENT|1964-04-05|1970-08-18|||||1962-02-10||1971-10-24|Y|1971-11-03
TRIAL STUDY 134XCP|LB|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|2||||HCGFR|CHORIOGONADOTROPIN BETA, FREE|||||||%(W/W)|||||||BORDERLINE||NMOL/L/H||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR|NA|POTENTIOMETRY|FIBROSIS 4 FORMULA||NA|NA|NA|Y|||NA|5||7||TREATMENT|1969-09-08|1973-05-17|||||1970-01-04||1973-05-06|N|1963-12-31
TRIAL STUDY 134XCP|LB|E0434C66-0F59-476F-9913-55766C4AED1B|1||||ICAM1|INTERCELLULAR ADHESION MOLECULE 1|||||||/MS|||||||TRACE||TITER||||LOW|NOT DONE||||CORD SERUM|PARAFFIN-EMBEDDED|N|MASS SPECTROMETRY|GMI MMOL/MOL FORMULA||Y|Y|NA|Y|||NA|1||38||BLINDED TREATMENT|1961-02-07|1970-04-25|||||1969-01-30||1966-05-02|U|1965-07-10
TRIAL STUDY 134XCP|LB|E0434C66-0F59-476F-9913-55766C4AED1B|2||||NAGASEXR|NAGASE EXCRETION RATE|||||||EU|||||||BORDERLINE||MCI/KG||||ABNORMAL|NOT DONE||||DERMAL TISSUE|HEMOLYZED|N|FLUORESCENT SPOT TEST|MDRD 6 VARIABLE FORMULA||Y|U|Y|NA|||NA|1||38||CONTINUATION TREATMENT|1969-12-23|1963-12-12|||||1973-07-15||1972-08-27|Y|1971-10-04
TRIAL STUDY 134XCP|LB|E0434C66-0F59-476F-9913-55766C4AED1B|1||||GOLD|GOLD|||||||FMOL/G|||||||INDETERMINATE||UMOL/MIN||||NORMAL|NOT DONE||||MONOCYTE|AGGLUTINATED|Y|ATOMIC ABSORPTION SPECTROMETRY|FIBROMETER FORMULA||U|N|U|U|||Y|2||58||BASELINE|1965-12-02|1969-06-02|||||1968-08-07||1969-11-03|NA|1964-07-24
TRIAL STUDY 134XCP|LB|E0434C66-0F59-476F-9913-55766C4AED1B|2||||PLSIMCE|IMMATURE PLASMA CELLS|||||||MG/M2/MIN|||||||POSITIVE||ML/MMHG||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|CALCIFIED|Y|TOTAL BODY RADIOGRAPHY|CKD-EPI FORMULA||Y|Y|NA|N|||Y|2||58||FOLLOW-UP|1969-02-12|1965-04-03|||||1964-03-21||1972-07-10|N|1964-01-12
TRIAL STUDY 134XCP|LB|E0434C66-0F59-476F-9913-55766C4AED1B|1||||TK2|THYMIDINE KINASE 2|||||||FRACTION OF 1|||||||NEGATIVE||10^6/EJACULATE U||||LOW|NOT DONE||||BASAL TEAR|UNEXPECTED ODOR|NA|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|NA|N|||Y|3||39||BASELINE|1963-07-28|1964-05-03|||||1962-11-12||1961-05-09|NA|1971-02-15
TRIAL STUDY 134XCP|LB|E0434C66-0F59-476F-9913-55766C4AED1B|2||||VISC|VISCOSITY|||||||U/L|||||||INDETERMINATE||CAPFUL||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|CONTAMINATED|U|DARK FIELD MICROSCOPY|CKD-EPI CREATININE FORMULA||N|N|Y|NA|||Y|3||39||OPEN LABEL TREATMENT|1965-06-04|1965-08-28|||||1964-02-26||1969-03-23|NA|1965-04-01
TRIAL STUDY 134XCP|LB|E0434C66-0F59-476F-9913-55766C4AED1B|1||||CLCTONN|CALCITONIN|||||||UG/G/MIN|||||||NEGATIVE||GENEQ||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|CONCENTRATED|N|INTERRUPTER TECHNIQUE|CKD-EPI CREATININE FORMULA||NA|N|Y|NA|||U|4||88||OBSERVATION|1965-07-12|1967-03-26|||||1972-09-07||1962-01-10|U|1961-09-21
TRIAL STUDY 134XCP|LB|E0434C66-0F59-476F-9913-55766C4AED1B|2||||HLADRB1|HLA DR BETA1 ANTIGEN|||||||CMH2O/ML|||||||INDETERMINATE||AG||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|NON-HEMOLYZED|U|NUCLEIC ACID AMPLIFICATION TEST|COCKCROFT-GAULT FORMULA||Y|Y|N|N|||NA|4||88||SCREENING|1962-08-28|1960-05-24|||||1964-12-07||1961-08-04|U|1968-05-03
TRIAL STUDY 134XCP|LB|E0434C66-0F59-476F-9913-55766C4AED1B|1||||EOSNUCCE|EOSINOPHILS/NUCLEATED CELLS|||||||MMOL/S|||||||INDETERMINATE||F||||HIGH|NOT DONE||||SALIVA|DRIED|Y|TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA||N|Y|Y|Y|||U|5||7||CONTINUATION TREATMENT|1969-05-03|1971-12-23|||||1965-10-14||1961-09-20|N|1969-02-10
TRIAL STUDY 134XCP|LB|E0434C66-0F59-476F-9913-55766C4AED1B|2||||FLNTRZPM|FLUNITRAZEPAM|||||||MG/G/MIN|||||||INVALID||KALLIKREIN INHIBITOR UNIT||||LOW|NOT DONE||||SERUM|GELLED|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|U|Y|||N|5||7||FOLLOW-UP|1964-03-04|1960-07-11|||||1963-02-17||1963-09-17|NA|1963-04-22
TRIAL STUDY 134XCP|LB|60B57F98-61FF-4322-8084-7A536964F60A|1||||FCTVIIAA|FACTOR VIIA ACTIVITY|||||||CMOL|||||||NEGATIVE||BQ/MG||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED|N|NUCLEIC ACID SEQUENCING|GMI MMOL/MOL FORMULA||Y|N|N|U|||NA|1||38||BASELINE|1971-11-16|1968-07-05|||||1966-04-14||1965-10-06|U|1966-10-01
TRIAL STUDY 134XCP|LB|60B57F98-61FF-4322-8084-7A536964F60A|2||||TPROT|TAU PROTEIN|||||||PIXELS/CM|||||||NEGATIVE||CD||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|GELLED|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||N|NA|Y|N|||U|1||38||RUN-IN|1970-11-11|1972-11-17|||||1969-04-05||1960-06-09|N|1973-04-05
TRIAL STUDY 134XCP|LB|60B57F98-61FF-4322-8084-7A536964F60A|1||||FRTNHC|FERRITIN HEAVY CHAIN|||||||KIT|||||||INDETERMINATE||HOUNSFIELD UNIT||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|DRIED|Y|CELL BASED BIOASSAY|MDRD ENZYMATIC FORMULA||N|U|NA|N|||Y|2||58||OBSERVATION|1967-01-03|1966-09-10|||||1973-07-12||1962-08-01|NA|1963-02-03
TRIAL STUDY 134XCP|LB|60B57F98-61FF-4322-8084-7A536964F60A|2||||BASOSG|BASOPHILS, SEGMENTED|||||||10^9 ORGANISMS/G|||||||BORDERLINE||CM||||HIGH|NOT DONE||||LYMPH|CONCENTRATED|Y|PET/CT SCAN WITHOUT CONTRAST|COCKCROFT-GAULT FORMULA||U|N|U|N|||Y|2||58||OPEN LABEL TREATMENT|1965-03-23|1972-06-07|||||1968-12-27||1965-10-30|N|1972-06-01
TRIAL STUDY 134XCP|LB|60B57F98-61FF-4322-8084-7A536964F60A|1||||IGGCALBC|IGG CLEARANCE/ALBUMIN CLEARANCE|||||||EID 50/ML|||||||NEGATIVE||PACK||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|DRIED|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|FIBROMETER FORMULA||N|NA|N|U|||NA|3||39||OBSERVATION|1967-07-09|1969-09-03|||||1965-01-01||1968-11-19|U|1973-06-27
TRIAL STUDY 134XCP|LB|60B57F98-61FF-4322-8084-7A536964F60A|2||||CASTS|CASTS|||||||CY/CM|||||||NEGATIVE||MMOL/MIN/KPA||||ABNORMAL|NOT DONE||||SMEGMA|HEMOLYZED|U|ELECTRICAL IMPEDANCE MYOGRAPHY|GMI MMOL/MOL FORMULA||NA|Y|NA|N|||U|3||39||TREATMENT|1965-05-03|1972-02-25|||||1971-05-30||1961-01-05|U|1960-12-11
TRIAL STUDY 134XCP|LB|60B57F98-61FF-4322-8084-7A536964F60A|1||||MONOIM|IMMATURE MONOCYTES|||||||DEG|||||||BORDERLINE||MG/DAY||||ABNORMAL|NOT DONE||||TUMOR TISSUE|SOLIDIFIED|NA|SECONDARY ION MASS SPECTOMETRY|MDRD 4 VARIABLE FORMULA||N|Y|Y|U|||NA|4||88||BLINDED TREATMENT|1972-03-24|1969-05-19|||||1961-10-02||1970-08-08|N|1970-03-08
TRIAL STUDY 134XCP|LB|60B57F98-61FF-4322-8084-7A536964F60A|2||||FATACFRS|FREE FATTY ACID, SATURATED|||||||/VF|||||||TRACE||MPL U||||ABNORMAL|NOT DONE||||SEMINAL FLUID|THAWED|NA|CAPILLARY ELECTROPHORESIS|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|NA|NA|||U|4||88||BASELINE|1961-04-14|1967-02-06|||||1965-12-30||1965-08-25|Y|1962-12-15
TRIAL STUDY 134XCP|LB|60B57F98-61FF-4322-8084-7A536964F60A|1||||C165940|BOXELDER POLLEN IGE AB RAST SCORE|||||||ML/MIN|||||||BORDERLINE||TABLET||||LOW|NOT DONE||||LUNG SURFACTANT|AUTOLYZED|U|MUGA|ASH FIBROSURE FORMULA||Y|N|U|NA|||U|5||7||INDUCTION TREATMENT|1963-03-07|1971-12-22|||||1968-08-23||1966-10-07|NA|1961-04-13
TRIAL STUDY 134XCP|LB|60B57F98-61FF-4322-8084-7A536964F60A|2||||MYCYCE|MYELOCYTES/TOTAL CELLS|||||||ARBITRARY U|||||||NEGATIVE||MG/ANIMAL||||NORMAL|NOT DONE||||PUS|FROZEN|N|TELLER ACUITY CARDS|MDRD ENZYMATIC FORMULA||N|Y|NA|U|||NA|5||7||BLINDED TREATMENT|1962-01-23|1968-03-22|||||1965-03-29||1964-11-29|Y|1972-01-23
TRIAL STUDY 134XCP|LB|C79CA198-24E2-4A76-8C32-F3AA973EA41E|1||||TYR|TYROSINE|||||||UCI/L|||||||BORDERLINE||TAMPON||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|THAWED|U|HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|U|||Y|1||38||SCREENING|1963-12-04|1971-06-07|||||1964-10-29||1969-08-06|N|1967-02-20
TRIAL STUDY 134XCP|LB|C79CA198-24E2-4A76-8C32-F3AA973EA41E|2||||C130112|ANIMAL MIX ANTIGEN IGE ANTIBODY|||||||ML/KG|||||||NEGATIVE||PSEC||||LOW|NOT DONE||||MECONIUM|REFRIGERATED|NA|ISHIHARA COLOR PLATES|HEPASCORE FORMULA||Y|U|NA|NA|||N|1||38||OBSERVATION|1973-01-24|1965-05-24|||||1965-11-15||1965-12-19|NA|1970-07-13
TRIAL STUDY 134XCP|LB|C79CA198-24E2-4A76-8C32-F3AA973EA41E|1||||C5B9|COMPLEMENT C5B-9|||||||LOG10 PFU|||||||INDETERMINATE||U/DL||||HIGH|NOT DONE||||ALVEOLAR AIR|PARAFFIN-EMBEDDED|Y|QUANTITATIVE CORONARY ANGIOGRAPHY|COCKCROFT-GAULT FORMULA||U|N|U|NA|||N|2||58||INDUCTION TREATMENT|1968-10-19|1962-02-23|||||1961-04-14||1970-02-15|Y|1964-01-13
TRIAL STUDY 134XCP|LB|C79CA198-24E2-4A76-8C32-F3AA973EA41E|2||||LYSOZYME|LYSOZYME|||||||MOL/ML|||||||INDETERMINATE||CAPSULE||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|SOLIDIFIED|Y|LEAD CITRATE STAIN|CKD-EPI FORMULA||NA|N|U|N|||U|2||58||LONG-TERM FOLLOW-UP|1964-02-13|1965-06-16|||||1968-05-22||1972-05-16|Y|1963-06-03
TRIAL STUDY 134XCP|LB|C79CA198-24E2-4A76-8C32-F3AA973EA41E|1||||CCL21|CHEMOKINE (C-C MOTIF) LIGAND 21|||||||ML/ANIMAL|||||||TRACE||G/L||||NORMAL|NOT DONE||||VENOUS BLOOD|CLOTTED|Y|IMPEDANCE CONDUCTIVITY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|U|Y|||NA|3||39||WASHOUT|1967-04-20|1967-09-17|||||1960-01-03||1967-11-18|U|1969-07-18
TRIAL STUDY 134XCP|LB|C79CA198-24E2-4A76-8C32-F3AA973EA41E|2||||CSEPIRT|RENAL TUBULAR EPITHELIAL CASTS|||||||10^5/HPF|||||||POSITIVE||LX||||LOW|NOT DONE||||SMEGMA|HEMOLYZED|NA|SCANNING ELECTRON MICROSCOPY|GMI MMOL/MOL FORMULA||Y|U|NA|NA|||NA|3||39||WASHOUT|1971-05-04|1969-12-08|||||1969-06-14||1960-12-06|NA|1970-11-06
TRIAL STUDY 134XCP|LB|C79CA198-24E2-4A76-8C32-F3AA973EA41E|1||||EPINSQE|EPI CELLS/NON-SQUAM EPI CELLS|||||||LOG10 TCID 50/ML|||||||POSITIVE||FINGERTIP UNIT||||ABNORMAL|NOT DONE||||SERUM|DRIED|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|N|NA|N|||Y|4||88||BLINDED TREATMENT|1971-01-09|1973-01-08|||||1965-03-21||1970-08-12|N|1961-07-20
TRIAL STUDY 134XCP|LB|C79CA198-24E2-4A76-8C32-F3AA973EA41E|2||||HETRPHLE|HETEROPHILS/LEUKOCYTES|||||||RAD|||||||INDETERMINATE||EU||||HIGH|NOT DONE||||PROSTATIC FLUID|DRIED|U|NEPHELOMETRY|FIBROMETER FORMULA||U|N|Y|N|||U|4||88||SCREENING|1969-08-31|1971-01-14|||||1963-10-16||1962-12-03|N|1965-01-20
TRIAL STUDY 134XCP|LB|C79CA198-24E2-4A76-8C32-F3AA973EA41E|1||||PSP100AB|P100 POLYMYOSITIS-SCLERODERMA AUTOAG AB|||||||LOG10 CFU/ML|||||||INVALID||NMOL/L||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|HEMOLYZED|NA|ZIEHL NEELSEN ACID FAST STAIN|GMI % FORMULA||U|NA|NA|N|||NA|5||7||OBSERVATION|1966-12-23|1962-05-31|||||1961-02-23||1961-09-15|NA|1969-08-15
TRIAL STUDY 134XCP|LB|C79CA198-24E2-4A76-8C32-F3AA973EA41E|2||||BARB|BARBITURATES|||||||BEATS/MIN|||||||NEGATIVE||U/M2||||NORMAL|NOT DONE||||PERITONEAL FLUID|FROZEN|Y|ENZYMATIC COLORIMETRY|NASH FIBROSURE FORMULA||U|N|NA|Y|||Y|5||7||BLINDED TREATMENT|1971-01-27|1960-11-16|||||1972-07-19||1960-05-30|N|1966-03-07
TRIAL STUDY 134XCP|LB|D250194D-9BBD-40D3-A13B-BBCEB53DB450|1||||YEASTBUD|YEAST BUDDING|||||||UIU/L|||||||INVALID||EJACULATE U||||NORMAL|NOT DONE||||BASAL TEAR|CONCENTRATED|Y|RADIATION DOSIMETRY|FIBROSIS 4 FORMULA||U|Y|U|NA|||NA|1||38||FOLLOW-UP|1964-10-20|1960-04-24|||||1964-04-12||1961-01-25|U|1963-12-20
TRIAL STUDY 134XCP|LB|D250194D-9BBD-40D3-A13B-BBCEB53DB450|2||||FDP|FIBRIN DEGRADATION PRODUCTS|||||||G/G|||||||NEGATIVE||TITER||||ABNORMAL|NOT DONE||||LYSATE|PARAFFIN-EMBEDDED|N|GC/FID|HEPASCORE FORMULA||N|U|NA|U|||U|1||38||BLINDED TREATMENT|1962-04-05|1969-07-24|||||1972-03-22||1961-08-07|Y|1972-04-11
TRIAL STUDY 134XCP|LB|D250194D-9BBD-40D3-A13B-BBCEB53DB450|1||||HGBMHGB|METHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||/MBP|||||||BORDERLINE||10^7 CFU||||LOW|NOT DONE||||ABSCESS FLUID|NON-HEMOLYZED|U|AGAR PROPORTION|MDRD ENZYMATIC FORMULA||U|U|Y|NA|||NA|2||58||OBSERVATION|1965-12-20|1961-08-07|||||1968-11-15||1960-11-01|U|1971-02-26
TRIAL STUDY 134XCP|LB|D250194D-9BBD-40D3-A13B-BBCEB53DB450|2||||HIST1AB|HISTONE 1 ANTIBODY|||||||MOL/DAY|||||||TRACE||ABSORBANCE U/MIN||||HIGH|NOT DONE||||VENOUS PLASMA|REFRIGERATED|Y|COMPLEMENT FIXATION|ASH FIBROSURE FORMULA||U|N|N|Y|||U|2||58||BLINDED TREATMENT|1973-08-16|1973-04-15|||||1964-05-28||1963-06-23|NA|1973-01-25
TRIAL STUDY 134XCP|LB|D250194D-9BBD-40D3-A13B-BBCEB53DB450|1||||IA2AB|INSULINOMA-ASSOCIATED PROTEIN 2 ANTIBODY|||||||DIP|||||||TRACE||JOULE||||HIGH|NOT DONE||||PLEURAL TISSUE|CONTAMINATED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI CYSTATIN C FORMULA||U|N|N|U|||Y|3||39||INDUCTION TREATMENT|1973-02-16|1966-12-27|||||1965-10-06||1960-11-16|Y|1968-09-10
TRIAL STUDY 134XCP|LB|D250194D-9BBD-40D3-A13B-BBCEB53DB450|2||||G6PDRBC|G6PD-DEFICIENT ERYTHROCYTES|||||||FINGERTIP UNIT|||||||INDETERMINATE||ML/CM3/MIN||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|CALCIFIED|NA|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA||U|U|U|N|||U|3||39||BASELINE|1967-01-23|1968-07-21|||||1967-06-01||1965-07-14|NA|1969-08-17
TRIAL STUDY 134XCP|LB|D250194D-9BBD-40D3-A13B-BBCEB53DB450|1||||C165928|INDUSTRIAL MIX IGE AB RAST SCORE|||||||STEPS/MIN|||||||INVALID||KG/M2||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|PARAFFIN-EMBEDDED|Y|FLUORESCENT MICROSCOPY|NASH FIBROSURE FORMULA||U|NA|N|Y|||NA|4||88||BLINDED TREATMENT|1963-03-19|1965-08-21|||||1968-07-09||1963-05-15|Y|1965-02-10
TRIAL STUDY 134XCP|LB|D250194D-9BBD-40D3-A13B-BBCEB53DB450|2||||C165886|WHITE OAK POLLEN IGE AB RAST SCORE|||||||MCI|||||||TRACE||IU/MG||||NORMAL|NOT DONE||||SOFT TISSUE|HEMOLYZED|U|NEURAMINIDASE INHIBITION ASSAY|ASH FIBROSURE FORMULA||NA|N|NA|NA|||N|4||88||RUN-IN|1973-03-02|1969-04-03|||||1965-11-02||1967-12-18|U|1960-07-07
TRIAL STUDY 134XCP|LB|D250194D-9BBD-40D3-A13B-BBCEB53DB450|1||||NORMETA|NORMETANEPHRINE|||||||MG/DL|||||||POSITIVE||/7.5 ML||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|CONCENTRATED|U|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI CREATININE FORMULA||U|N|NA|U|||NA|5||7||BLINDED TREATMENT|1966-12-11|1967-09-22|||||1972-10-07||1967-08-18|NA|1971-07-02
TRIAL STUDY 134XCP|LB|D250194D-9BBD-40D3-A13B-BBCEB53DB450|2||||T4FRIND|THYROXINE, FREE, INDIRECT|||||||TESLA|||||||TRACE||10^9 ORGANISMS/MG||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|THAWED|N|IMPEDANCE CONDUCTIVITY|MDRD FORMULA||Y|N|U|U|||U|5||7||FOLLOW-UP|1960-04-03|1962-04-21|||||1969-09-15||1971-03-09|NA|1972-11-09
TRIAL STUDY 134XCP|LB|369AE0AF-8693-4363-9A6E-CD30567BD614|1||||CENTROAB|CENTROMERE B ANTIBODIES|||||||MCI|||||||NEGATIVE||CARTRIDGE||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|REFRIGERATED|Y|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|N|N|||NA|1||38||OPEN LABEL TREATMENT|1963-08-11|1963-03-27|||||1970-09-04||1966-01-05|NA|1971-03-24
TRIAL STUDY 134XCP|LB|369AE0AF-8693-4363-9A6E-CD30567BD614|2||||FVAAC|FACTOR V ACTIVITY ACTUAL/CONTROL|||||||CCID 50/DOSE|||||||POSITIVE||MET*H||||LOW|NOT DONE||||AMNIOTIC FLUID|PARAFFIN-EMBEDDED|U|ENDPOINT DILUTION ASSAY|ASH FIBROSURE FORMULA||N|Y|U|NA|||U|1||38||BLINDED TREATMENT|1960-02-25|1970-08-16|||||1961-09-11||1966-12-03|N|1960-01-12
TRIAL STUDY 134XCP|LB|369AE0AF-8693-4363-9A6E-CD30567BD614|1||||MYCEPPOL|MYELOID PROLIFERATION POOL|||||||UL/ML|||||||BORDERLINE||LX||||HIGH|NOT DONE||||TISSUE|LACTESCENT|N|PET/MRI SCAN|COCKCROFT-GAULT FORMULA||NA|NA|U|NA|||Y|2||58||OBSERVATION|1971-06-13|1966-07-08|||||1968-09-19||1961-02-04|NA|1968-12-19
TRIAL STUDY 134XCP|LB|369AE0AF-8693-4363-9A6E-CD30567BD614|2||||DSVLFXN|DESVENLAFAXINE|||||||G/CAGE/DAY|||||||TRACE||GAUSS||||LOW|NOT DONE||||TUMOR TISSUE|AGGLUTINATED|U|TURBIDIMETRY|MDRD ENZYMATIC FORMULA||Y|N|Y|U|||N|2||58||LONG-TERM FOLLOW-UP|1971-11-19|1962-06-27|||||1963-09-20||1962-08-24|NA|1971-07-17
TRIAL STUDY 134XCP|LB|369AE0AF-8693-4363-9A6E-CD30567BD614|1||||AMACR|ALPHA-METHYLACYL COENZYME A RACEMASE|||||||BQ|||||||BORDERLINE||U/M2||||LOW|NOT DONE||||REFLEX TEAR|FRESH|Y|LIQUID SCINTILLATION COUNTING|MDRD 4 VARIABLE FORMULA||N|NA|U|NA|||U|3||39||CONTINUATION TREATMENT|1967-04-28|1965-12-14|||||1969-11-16||1968-11-24|Y|1970-08-04
TRIAL STUDY 134XCP|LB|369AE0AF-8693-4363-9A6E-CD30567BD614|2||||TRIM21|TRIPARTITE MOTIF CONTAINING PROTEIN 21|||||||SFC/10^6 PBMC|||||||BORDERLINE||10^3 CFU/G||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|LACTESCENT|Y|MANUAL CLOT DETECTION|CKD-EPI CYSTATIN C FORMULA||NA|Y|N|N|||U|3||39||OPEN LABEL TREATMENT|1964-03-11|1962-03-03|||||1966-06-29||1970-01-22|Y|1970-09-28
TRIAL STUDY 134XCP|LB|369AE0AF-8693-4363-9A6E-CD30567BD614|1||||C165899|SILVER BIRCH POLLEN IGG AB RAST SCORE|||||||/10^5|||||||POSITIVE||PRESSOR UNITS||||NORMAL|NOT DONE||||ISOLATE|DRIED|U|DROPLET DIGITAL PCR|MDRD 5 VARIABLE FORMULA||U|N|Y|N|||N|4||88||BLINDED TREATMENT|1960-03-06|1966-03-16|||||1965-02-06||1963-11-02|U|1969-05-26
TRIAL STUDY 134XCP|LB|369AE0AF-8693-4363-9A6E-CD30567BD614|2||||GRANBCE|GRANULOCYTES BAND FORM/TOTAL CELLS|||||||NU/CL|||||||INVALID||DRUM||||HIGH|NOT DONE||||MUCUS|PARAFFIN-EMBEDDED|N|MIGET|ASH FIBROSURE FORMULA||Y|U|U|U|||NA|4||88||OPEN LABEL TREATMENT|1968-03-01|1971-04-30|||||1970-10-25||1972-10-07|Y|1969-10-21
TRIAL STUDY 134XCP|LB|369AE0AF-8693-4363-9A6E-CD30567BD614|1||||NKCE|NATURAL KILLER CELLS|||||||MOSM/KG|||||||INDETERMINATE||ABSORBANCE U/MIN||||HIGH|NOT DONE||||GASTRIC FLUID|FRESH|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA||Y|NA|N|U|||U|5||7||FOLLOW-UP|1968-11-10|1970-03-24|||||1969-01-17||1971-01-02|NA|1962-10-03
TRIAL STUDY 134XCP|LB|369AE0AF-8693-4363-9A6E-CD30567BD614|2||||LGLUCLE|LARGE UNSTAINED CELLS/LEUKOCYTES|||||||OHM|||||||NEGATIVE||OZ||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|SOLIDIFIED|N|SINGLE-SLICE SPIRAL CT|CKD-EPI CYSTATIN C FORMULA||NA|NA|U|NA|||N|5||7||FOLLOW-UP|1971-08-13|1961-08-20|||||1964-10-23||1971-07-28|N|1963-05-30
TRIAL STUDY 134XCP|LB|4497DB94-5B91-4169-9D73-73EE5C1D9B76|1||||CD34|CD34|||||||HEP|||||||INDETERMINATE||NMOL BCE/MMOL||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|CALCIFIED|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA||U|U|Y|NA|||N|1||38||RUN-IN|1968-12-27|1972-02-18|||||1970-04-20||1973-01-06|Y|1967-04-01
TRIAL STUDY 134XCP|LB|4497DB94-5B91-4169-9D73-73EE5C1D9B76|2||||GRANIM|IMMATURE GRANULOCYTES|||||||LM|||||||INDETERMINATE||KN/CM2||||HIGH|NOT DONE||||CERUMEN|FROZEN|Y|PET/CT SCAN|MDRD ENZYMATIC FORMULA||N|U|NA|NA|||NA|1||38||RUN-IN|1971-04-30|1967-01-20|||||1970-05-29||1972-12-19|Y|1972-05-08
TRIAL STUDY 134XCP|LB|4497DB94-5B91-4169-9D73-73EE5C1D9B76|1||||VOLUME|VOLUME|||||||VIAL|||||||INDETERMINATE||PACKAGE||||NORMAL|NOT DONE||||STOOL|THAWED|U|MODIFIED ACID FAST STAIN|MDRD 4 VARIABLE FORMULA||NA|U|Y|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1969-01-01|1971-05-28|||||1960-01-21||1971-01-29|Y|1973-08-21
TRIAL STUDY 134XCP|LB|4497DB94-5B91-4169-9D73-73EE5C1D9B76|2||||PLSTCE|TOTAL PLASMA CELLS|||||||MPH|||||||BORDERLINE||V||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR|N|EPSILOMETER|MDRD 4 VARIABLE FORMULA||U|NA|N|Y|||Y|2||58||BLINDED TREATMENT|1965-08-26|1968-10-25|||||1968-01-02||1964-06-25|Y|1969-10-15
TRIAL STUDY 134XCP|LB|4497DB94-5B91-4169-9D73-73EE5C1D9B76|1||||CIT|CITRULLINE|||||||L|||||||INVALID||L/S/KPA||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|CONCENTRATED|U|SPECTROPHOTOMETRY|GMI MMOL/MOL FORMULA||N|U|NA|NA|||U|3||39||INDUCTION TREATMENT|1964-11-15|1962-06-16|||||1973-05-13||1961-08-18|NA|1962-10-28
TRIAL STUDY 134XCP|LB|4497DB94-5B91-4169-9D73-73EE5C1D9B76|2||||THCCOOH|11-NOR-DELTA9-THC-9-CARBOXYLIC ACID|||||||ABSORBANCE U|||||||POSITIVE||CUP EQ||||LOW|NOT DONE||||LEUKOCYTE|LIPEMIC|U|SPIROMETRY|GMI % FORMULA||N|Y|U|U|||NA|3||39||WASHOUT|1969-07-19|1962-12-25|||||1962-05-01||1960-08-04|U|1961-06-09
TRIAL STUDY 134XCP|LB|4497DB94-5B91-4169-9D73-73EE5C1D9B76|1||||GLDAB|GLIADIN ANTIBODY|||||||MV*MIN|||||||INVALID||/10^4||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|Y|TARGETED GENOME SEQUENCING|HEPASCORE FORMULA||NA|N|N|Y|||N|4||88||CONTINUATION TREATMENT|1965-08-18|1971-11-23|||||1973-06-05||1973-04-22|Y|1967-03-07
TRIAL STUDY 134XCP|LB|4497DB94-5B91-4169-9D73-73EE5C1D9B76|2||||C165916|D. FARINAE IGG AB RAST SCORE|||||||G/KG|||||||NEGATIVE||IU/L||||HIGH|NOT DONE||||CORD SERUM|CALCIFIED|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD FORMULA||U|U|U|NA|||Y|4||88||BLINDED TREATMENT|1966-09-05|1960-01-07|||||1970-03-08||1963-04-23|N|1967-05-18
TRIAL STUDY 134XCP|LB|4497DB94-5B91-4169-9D73-73EE5C1D9B76|1||||HEINZ|HEINZ BODIES|||||||MG/DOSE|||||||POSITIVE||VIAL||||ABNORMAL|NOT DONE||||URINE SEDIMENT|AGGLUTINATED|NA|CALCULATION|FIBROSIS 4 FORMULA||NA|Y|N|U|||Y|5||7||FOLLOW-UP|1965-11-12|1972-05-31|||||1972-07-01||1971-11-14|N|1971-09-03
TRIAL STUDY 134XCP|LB|4497DB94-5B91-4169-9D73-73EE5C1D9B76|2||||LDH4|LDH ISOENZYME 4|||||||U/KG/DAY|||||||NEGATIVE||PL||||LOW|NOT DONE||||TUMOR TISSUE|DRIED|U|REVERSE TRANSCRIPTASE PCR|ASH FIBROSURE FORMULA||U|U|N|NA|||Y|5||7||INDUCTION TREATMENT|1960-09-01|1967-02-05|||||1963-10-15||1963-11-28|U|1962-06-11
TRIAL STUDY 134XCP|LB|487D7E2D-6E7E-4A5E-ADC7-72B888746263|1||||TRICH|TRICHOMONAS|||||||KG/L|||||||BORDERLINE||ATM||||ABNORMAL|NOT DONE||||SOFT TISSUE|LIPEMIC|Y|MICROARRAY|CKD-EPI CREATININE FORMULA||Y|NA|Y|NA|||N|1||38||OPEN LABEL TREATMENT|1960-07-30|1966-06-24|||||1963-01-25||1971-03-03|NA|1961-12-17
TRIAL STUDY 134XCP|LB|487D7E2D-6E7E-4A5E-ADC7-72B888746263|2||||ALDOLASE|ALDOLASE|||||||UV2|||||||INDETERMINATE||VG/DOSE||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|ICTERIC|Y|TONOMETRY|MDRD 5 VARIABLE FORMULA||Y|NA|NA|N|||U|1||38||BASELINE|1962-06-06|1972-05-08|||||1965-12-19||1970-08-01|Y|1971-07-28
TRIAL STUDY 134XCP|LB|487D7E2D-6E7E-4A5E-ADC7-72B888746263|1||||FXIVAAC|FACTOR XIV ACTIVITY ACTUAL/CONTROL|||||||PMOL|||||||INVALID||DIP||||NORMAL|NOT DONE||||SEMINAL FLUID|REFRIGERATED|N|SPECT SCAN|FIBROTEST FORMULA||U|U|NA|Y|||N|2||58||SCREENING|1963-03-18|1972-03-06|||||1971-08-27||1971-06-06|NA|1970-03-13
TRIAL STUDY 134XCP|LB|487D7E2D-6E7E-4A5E-ADC7-72B888746263|2||||PSIGMAB|PHOSPHATIDYLSERINE IGM ANTIBODY|||||||LOG10 PFU/ML|||||||TRACE||/40 HPFS||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|CALCIFIED|U|WHOLE TRANSCRIPTOME SEQUENCING|NASH FIBROSURE FORMULA||NA|U|Y|NA|||U|2||58||RUN-IN|1965-03-13|1965-09-05|||||1967-08-02||1973-04-07|N|1960-10-02
TRIAL STUDY 134XCP|LB|487D7E2D-6E7E-4A5E-ADC7-72B888746263|1||||C165939|EGG WHITE IGE AB RAST SCORE|||||||10^6 CFU|||||||INDETERMINATE||ML/DOSE||||LOW|NOT DONE||||PLATELET POOR PLASMA|FROZEN|U|MODIFIED ACID FAST STAIN|MDRD 6 VARIABLE FORMULA||NA|NA|N|Y|||N|3||39||WASHOUT|1969-12-07|1969-06-02|||||1968-05-28||1969-09-03|N|1973-04-25
TRIAL STUDY 134XCP|LB|487D7E2D-6E7E-4A5E-ADC7-72B888746263|2||||PFCT|PLATELET FUNCTION CLOSURE TIME|||||||PFU|||||||BORDERLINE||ML*CMH2O||||HIGH|NOT DONE||||SEMEN|FRESH|Y|PYROSEQUENCING|MDRD 4 VARIABLE FORMULA||NA|U|NA|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1966-05-22|1961-05-14|||||1965-11-29||1960-04-20|Y|1970-11-23
TRIAL STUDY 134XCP|LB|487D7E2D-6E7E-4A5E-ADC7-72B888746263|1||||HGFR|HEPATOCYTE GROWTH FACTOR RECEPTOR|||||||ML/M2/MIN|||||||NEGATIVE||10^6/HPF||||NORMAL|NOT DONE||||DIALYSIS FLUID|PARAFFIN-EMBEDDED|NA|PATHOLOGICAL EVALUATION|MDRD 5 VARIABLE FORMULA||U|NA|NA|N|||Y|4||88||BASELINE|1964-01-17|1961-08-22|||||1970-06-05||1966-11-05|NA|1963-07-24
TRIAL STUDY 134XCP|LB|487D7E2D-6E7E-4A5E-ADC7-72B888746263|2||||ERCEMIDX|ERYTHROID MATURATION INDEX|||||||U/KG/MIN|||||||POSITIVE||L/DAY||||HIGH|NOT DONE||||SWABBED MATERIAL|NON-HEMOLYZED|Y|FLUOROSCOPY|MDRD FORMULA||Y|N|U|Y|||U|4||88||TREATMENT|1969-06-03|1970-06-26|||||1966-08-27||1961-05-08|NA|1970-03-08
TRIAL STUDY 134XCP|LB|487D7E2D-6E7E-4A5E-ADC7-72B888746263|1||||MYL3|MYOSIN LIGHT CHAIN 3|||||||MOL/MOL|||||||INVALID||ARBITRARY U||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|CONCENTRATED|U|ENZYMATIC SPECTROPHOTOMETRY|HEPASCORE FORMULA||Y|Y|Y|N|||NA|5||7||SCREENING|1969-05-21|1961-05-08|||||1973-03-29||1969-04-26|U|1962-12-14
TRIAL STUDY 134XCP|LB|487D7E2D-6E7E-4A5E-ADC7-72B888746263|2||||FACTVWA|VON WILLEBRAND FACTOR ACTIVITY|||||||U/DL|||||||INVALID||HOUNSFIELD UNIT||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|PARAFFIN-EMBEDDED|U|DROPLET DIGITAL PCR|HEPASCORE FORMULA||NA|U|U|NA|||NA|5||7||WASHOUT|1966-09-13|1961-12-25|||||1968-03-30||1961-02-22|N|1968-09-25
TRIAL STUDY 134XCP|LB|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|1||||UNSPCE|UNSPECIFIED CELLS|||||||JAR|||||||NEGATIVE||%/MIN||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|LIPEMIC|N|TRANSTHORACIC ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|N|N|||U|1||38||OPEN LABEL TREATMENT|1969-05-25|1969-02-26|||||1964-02-27||1966-04-22|N|1971-02-13
TRIAL STUDY 134XCP|LB|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|2||||HLAA2AB|HLA-A2 ANTIBODY|||||||10^6 RNA COPIES/ML|||||||INDETERMINATE||PUFF||||HIGH|NOT DONE||||AMNIOTIC FLUID|ROOM TEMPERATURE|N|MECHANICAL CLOT DETECTION|MDRD ENZYMATIC FORMULA||N|U|Y|U|||Y|1||38||OPEN LABEL TREATMENT|1964-09-07|1962-12-03|||||1967-11-21||1965-05-12|Y|1968-04-27
TRIAL STUDY 134XCP|LB|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|1||||CEACAM1|CEA CELL ADHESION MOLECULE 1|||||||UG/DOSE|||||||INVALID||/40 HPFS||||HIGH|NOT DONE||||LYMPH|HEMOLYZED|Y|CLINICAL EVALUATION|FIBROTEST FORMULA||NA|Y|U|Y|||N|2||58||CONTINUATION TREATMENT|1964-01-28|1966-09-21|||||1971-02-20||1970-10-15|N|1971-07-25
TRIAL STUDY 134XCP|LB|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|2||||NCCPTN|NOCICEPTIN|||||||ML/MIN/MMHG|||||||BORDERLINE||MEQ/MMOL||||LOW|NOT DONE||||SKIN TISSUE|CONTAMINATED|U|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|FIBROSIS 4 FORMULA||Y|Y|N|NA|||N|2||58||CONTINUATION TREATMENT|1970-04-25|1962-04-27|||||1970-08-22||1971-02-04|U|1963-02-06
TRIAL STUDY 134XCP|LB|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|1||||HYDMRPHN|HYDROMORPHONE|||||||BP|||||||INDETERMINATE||PRESSOR UNITS||||HIGH|NOT DONE||||CALCULUS|FRESH|N|MULTI-SLICE SPIRAL CT|FIBROMETER FORMULA||NA|U|Y|N|||U|3||39||RUN-IN|1965-02-13|1964-05-24|||||1962-03-26||1972-09-06|NA|1964-12-10
TRIAL STUDY 134XCP|LB|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|2||||MYCEMPOL|MYELOID MATURATION POOL|||||||FL|||||||TRACE||/2000 RBC||||LOW|NOT DONE||||SUPERNATANT, SERUM|GELLED|NA|COLORIMETRY|MDRD 4 VARIABLE FORMULA||Y|N|Y|NA|||Y|3||39||INDUCTION TREATMENT|1966-09-02|1965-02-05|||||1960-02-03||1966-04-24|N|1960-11-16
TRIAL STUDY 134XCP|LB|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|1||||CSRBC|RBC CASTS|||||||TUBERCULIN UNIT|||||||BORDERLINE||MG/L||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|PARAFFIN-EMBEDDED|NA|AMSLER GRID|MDRD 4 VARIABLE FORMULA||NA|Y|NA|U|||NA|4||88||WASHOUT|1966-04-23|1963-12-24|||||1960-06-19||1968-01-17|U|1970-02-28
TRIAL STUDY 134XCP|LB|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|2||||GLUCAGON|GLUCAGON|||||||LOG10 ELISA UNIT/DOSE|||||||BORDERLINE||UG/ML/H||||LOW|NOT DONE||||CORD SERUM|NON-HEMOLYZED|N|DNA MICROARRAY|CKD-EPI CYSTATIN C FORMULA||Y|Y|N|N|||Y|4||88||SCREENING|1961-05-25|1968-02-21|||||1967-12-13||1964-02-02|U|1960-02-07
TRIAL STUDY 134XCP|LB|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|1||||VLDL3|VLDL CHOLESTEROL SUBTYPE 3|||||||PMOL/DL|||||||NEGATIVE||NMOL/L||||ABNORMAL|NOT DONE||||SERUM|FROZEN|Y|MICROBIAL CULTURE, SOLID|MDRD 5 VARIABLE FORMULA||N|NA|NA|NA|||Y|5||7||WASHOUT|1965-11-08|1962-12-17|||||1971-10-23||1972-08-19|Y|1970-04-12
TRIAL STUDY 134XCP|LB|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|2||||TK2|THYMIDINE KINASE 2|||||||PELLET|||||||BORDERLINE||ML/M2/H||||NORMAL|NOT DONE||||EXPIRED AIR|FROZEN|N|PHASE-CONTRAST MRI|CKD-EPI CYSTATIN C FORMULA||NA|NA|U|Y|||N|5||7||LONG-TERM FOLLOW-UP|1967-07-17|1968-05-14|||||1973-03-25||1964-07-08|U|1963-03-05
TRIAL STUDY 134XCP|LB|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|1||||ERCEMIDX|ERYTHROID MATURATION INDEX|||||||10^3 ORGANISMS/ML|||||||BORDERLINE||G/M2/DAY||||NORMAL|NOT DONE||||ADIPOSE TISSUE|THAWED|U|HANSEL STAIN|COCKCROFT-GAULT FORMULA||NA|U|NA|NA|||N|1||38||SCREENING|1960-02-15|1963-12-21|||||1960-02-24||1960-11-12|N|1972-01-23
TRIAL STUDY 134XCP|LB|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|2||||PYOCYTES|PYOCYTES|||||||TRANSDUCING UNIT/ML|||||||INDETERMINATE||ML/CAGE/DAY||||LOW|NOT DONE||||KERATINOCYTE|CONCENTRATED|N|IHC|CKD-EPI FORMULA||U|NA|N|NA|||N|1||38||OBSERVATION|1969-05-24|1965-01-11|||||1965-11-18||1969-12-14|Y|1970-08-19
TRIAL STUDY 134XCP|LB|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|1||||RBC|ERYTHROCYTES|||||||U/DL|||||||INDETERMINATE||M/SEC||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED|Y|MECHANICAL CLOT DETECTION|MDRD FORMULA||Y|Y|NA|NA|||U|2||58||BLINDED TREATMENT|1967-03-31|1967-06-18|||||1967-01-13||1965-08-31|U|1966-12-01
TRIAL STUDY 134XCP|LB|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|2||||IFNA|INTERFERON ALPHA|||||||L/DAY|||||||INVALID||FOZ_BR||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|FRESH|N|IMMUNOPRECIPITATION|FIBROMETER FORMULA||Y|Y|NA|U|||U|2||58||WASHOUT|1964-11-15|1971-11-03|||||1971-09-26||1970-08-16|N|1973-05-13
TRIAL STUDY 134XCP|LB|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|1||||GLOBBPT|BETA GLOBULIN/TOTAL PROTEIN|||||||MPS U|||||||NEGATIVE||MMOL/S||||HIGH|NOT DONE||||VENOUS PLASMA|LACTESCENT|U|ANTIMICROBIAL COMBINATION TESTING|CKD-EPI CREATININE FORMULA||N|Y|N|Y|||NA|3||39||WASHOUT|1970-12-20|1967-05-12|||||1967-11-07||1961-03-24|NA|1964-09-11
TRIAL STUDY 134XCP|LB|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|2||||SODIUM|SODIUM|||||||10^9 CFU|||||||INVALID||UL/ML||||HIGH|NOT DONE||||TUMOR TISSUE|CLOTTED|NA|IHC|MDRD 6 VARIABLE FORMULA||N|N|N|U|||NA|3||39||BASELINE|1963-10-20|1964-04-15|||||1960-12-29||1965-07-06|NA|1963-09-11
TRIAL STUDY 134XCP|LB|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|1||||GATCPHRL|GAMMA TOCOPHEROL|||||||ML/ANIMAL/DAY|||||||INVALID||BU||||LOW|NOT DONE||||ADIPOSE TISSUE|GELLED|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|FIBROMETER FORMULA||U|Y|U|U|||NA|4||88||TREATMENT|1962-06-16|1963-10-22|||||1967-06-23||1965-08-24|Y|1971-04-16
TRIAL STUDY 134XCP|LB|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|2||||C130117|BEE MIX ANTIGEN IGG ANTIBODY|||||||SEC|||||||TRACE||KAT||||HIGH|NOT DONE||||RETICULOCYTES|GELLED|Y|WRIGHT-GIEMSA STAIN|COCKCROFT-GAULT FORMULA||N|N|NA|NA|||NA|4||88||WASHOUT|1972-01-31|1969-08-29|||||1972-11-28||1967-12-31|U|1972-04-01
TRIAL STUDY 134XCP|LB|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|1||||VMAEXR|VANILLYL MANDELIC ACID EXCRETION RATE|||||||CI|||||||NEGATIVE||SFC/10^6 PBMC||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|FRESH|Y|CARDIAC THERMODILUTION|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|NA|||NA|5||7||CONTINUATION TREATMENT|1973-07-10|1973-06-11|||||1961-11-09||1964-05-08|U|1961-08-16
TRIAL STUDY 134XCP|LB|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|2||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||USEC|||||||INDETERMINATE||GY/MIN||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|CONTAMINATED|U|CELLULOSE TAPE|FIBROSIS 4 FORMULA||U|Y|N|Y|||N|5||7||TREATMENT|1973-01-26|1966-01-09|||||1964-08-27||1964-06-16|N|1969-05-10
TRIAL STUDY 134XCP|LB|8BF6E538-2F39-48E4-B115-AE1693843BBC|1||||CHDW|CORPUSCULAR HGB CONC DISTRIBUTION WIDTH|||||||EID 50/DOSE|||||||POSITIVE||U/G||||NORMAL|NOT DONE||||LEUKOCYTE|HEMOLYZED|N|FLOCCULATION, CHARCOAL ENHANCED|CKD-EPI CYSTATIN C FORMULA||Y|U|U|U|||Y|1||38||BLINDED TREATMENT|1971-03-12|1969-05-25|||||1967-11-15||1970-12-15|NA|1972-04-14
TRIAL STUDY 134XCP|LB|8BF6E538-2F39-48E4-B115-AE1693843BBC|2||||BNPPRONT|N-TERMINAL PROB-TYPE NATRIURETIC PEPTIDE|||||||BQ|||||||INVALID||KG/L||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|AGGLUTINATED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|GMI MMOL/MOL FORMULA||U|U|U|NA|||N|1||38||OBSERVATION|1964-10-26|1968-11-22|||||1973-03-07||1966-06-02|N|1971-12-25
TRIAL STUDY 134XCP|LB|8BF6E538-2F39-48E4-B115-AE1693843BBC|1||||TGFB3|TRANSFORMING GROWTH FACTOR BETA 3|||||||UV2|||||||BORDERLINE||/10^3||||HIGH|NOT DONE||||BONE|FRESH|Y|IHC|MDRD 5 VARIABLE FORMULA||Y|NA|NA|NA|||NA|2||58||INDUCTION TREATMENT|1972-10-23|1968-06-06|||||1971-02-06||1965-05-27|Y|1962-03-10
TRIAL STUDY 134XCP|LB|8BF6E538-2F39-48E4-B115-AE1693843BBC|2||||AMYLASEP|AMYLASE, PANCREATIC|||||||10^6 CFU|||||||BORDERLINE||U/KG/MIN||||LOW|NOT DONE||||FLUID|SOLIDIFIED|NA|ISHIHARA COLOR PLATES|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|U|NA|||NA|2||58||INDUCTION TREATMENT|1970-03-01|1967-01-24|||||1964-01-04||1961-09-20|U|1966-06-09
TRIAL STUDY 134XCP|LB|8BF6E538-2F39-48E4-B115-AE1693843BBC|1||||VITB7|VITAMIN B7|||||||TORR|||||||INDETERMINATE||CCID 50/ML||||LOW|NOT DONE||||SYNOVIAL FLUID|PARAFFIN-EMBEDDED|U|GRAM STAIN|HEPASCORE FORMULA||Y|U|N|NA|||U|3||39||CONTINUATION TREATMENT|1966-06-29|1970-07-09|||||1967-07-17||1966-07-30|NA|1963-06-12
TRIAL STUDY 134XCP|LB|8BF6E538-2F39-48E4-B115-AE1693843BBC|2||||IFIT3|INTERFERON-INDUCED 60 KDA PROTEIN|||||||FEU|||||||INVALID||ENZYME U/M2||||HIGH|NOT DONE||||HAIR|THAWED|U|CONTACT SPECULAR MICROSCOPY|FIBROSIS 4 FORMULA||U|U|Y|NA|||N|3||39||CONTINUATION TREATMENT|1969-12-17|1971-06-11|||||1967-11-27||1967-08-20|Y|1972-10-23
TRIAL STUDY 134XCP|LB|8BF6E538-2F39-48E4-B115-AE1693843BBC|1||||MCV|ERY. MEAN CORPUSCULAR VOLUME|||||||APPLICATION|||||||NEGATIVE||K||||HIGH|NOT DONE||||LOCHIA|AGGLUTINATED|U|DC SHEATH FLOW|GMI % FORMULA||Y|N|U|NA|||NA|4||88||INDUCTION TREATMENT|1970-01-04|1971-02-01|||||1972-08-13||1965-08-19|N|1961-05-05
TRIAL STUDY 134XCP|LB|8BF6E538-2F39-48E4-B115-AE1693843BBC|2||||VLDL2|VLDL CHOLESTEROL SUBTYPE 2|||||||UL/KG/DAY|||||||TRACE||PMOL/L/H||||HIGH|NOT DONE||||DIALYSIS FLUID|AUTOLYZED|Y|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|NASH FIBROSURE FORMULA||U|N|Y|U|||N|4||88||BLINDED TREATMENT|1965-08-15|1973-02-01|||||1967-08-30||1962-02-08|N|1973-08-22
TRIAL STUDY 134XCP|LB|8BF6E538-2F39-48E4-B115-AE1693843BBC|1||||ANGPT1|ANGIOPOIETIN 1|||||||MMU/ML|||||||BORDERLINE||10^6 IU||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|REFRIGERATED|NA|OPTICAL MAPPING|MDRD ENZYMATIC FORMULA||NA|U|Y|NA|||Y|5||7||CONTINUATION TREATMENT|1961-10-27|1967-08-30|||||1965-12-19||1969-06-30|N|1971-01-12
TRIAL STUDY 134XCP|LB|8BF6E538-2F39-48E4-B115-AE1693843BBC|2||||MBP|MYELIN BASIC PROTEIN|||||||ENZYME U/G HB|||||||NEGATIVE||MG/KG/WEEK||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|CONTAMINATED|Y|ENDPOINT DILUTION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|NA|U|||Y|5||7||FOLLOW-UP|1970-04-20|1973-06-28|||||1968-01-22||1960-10-25|N|1967-05-28
TRIAL STUDY 134XCP|LB|57F001BC-36EB-44AF-9487-373FA31B7311|1||||GLYCREAT|GLYCINE/CREATININE|||||||ML/CAGE/DAY|||||||NEGATIVE||U/MMOL||||NORMAL|NOT DONE||||EXPIRED AIR|LIPEMIC|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||N|N|N|U|||Y|1||38||TREATMENT|1965-03-06|1966-05-18|||||1972-01-29||1960-08-07|N|1970-04-21
TRIAL STUDY 134XCP|LB|57F001BC-36EB-44AF-9487-373FA31B7311|2||||C147283|WHITE ELM POLLEN IGG ANTIBODY|||||||PPTR|||||||POSITIVE||UEQ||||HIGH|NOT DONE||||SALIVA|CONTAMINATED|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD 4 VARIABLE FORMULA||Y|NA|N|N|||Y|1||38||OBSERVATION|1973-06-17|1962-02-16|||||1973-07-04||1965-05-04|Y|1965-07-13
TRIAL STUDY 134XCP|LB|57F001BC-36EB-44AF-9487-373FA31B7311|1||||INTLK2|INTERLEUKIN 2|||||||FG|||||||NEGATIVE||MET*H||||HIGH|NOT DONE||||REFLEX TEAR|ICTERIC|Y|ARTERIAL SPIN LABELING FUNCTIONAL MRI|FIBROSIS 4 FORMULA||Y|U|NA|N|||Y|2||58||OBSERVATION|1971-05-21|1967-03-13|||||1967-11-17||1961-04-24|N|1963-07-24
TRIAL STUDY 134XCP|LB|57F001BC-36EB-44AF-9487-373FA31B7311|2||||ALBCREAT|ALBUMIN/CREATININE|||||||ML/DOSE|||||||TRACE||UMOL/KG/MIN||||NORMAL|NOT DONE||||FLUID|AGGLUTINATED|Y|PHYSICAL EXAMINATION|COCKCROFT-GAULT FORMULA||U|Y|U|NA|||N|2||58||BLINDED TREATMENT|1968-11-02|1968-09-06|||||1967-03-07||1963-03-15|Y|1962-10-25
TRIAL STUDY 134XCP|LB|57F001BC-36EB-44AF-9487-373FA31B7311|1||||RETIM|MEDIUM ABSORPTION RETICULOCYTES|||||||IN2|||||||NEGATIVE||/CMH2O||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|SOLIDIFIED|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 4 VARIABLE FORMULA||Y|NA|N|N|||N|3||39||CONTINUATION TREATMENT|1960-09-09|1970-09-09|||||1972-02-12||1965-05-05|N|1963-03-14
TRIAL STUDY 134XCP|LB|57F001BC-36EB-44AF-9487-373FA31B7311|2||||CHLMCRNT|CHYLOMICRON TRIGLYCERIDE|||||||MU|||||||INVALID||ML/BEAT||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|THAWED|N|ULTRASOUND|MDRD 4 VARIABLE FORMULA||U|Y|N|NA|||NA|3||39||RUN-IN|1973-07-02|1972-06-27|||||1961-01-01||1968-04-15|U|1960-11-29
TRIAL STUDY 134XCP|LB|57F001BC-36EB-44AF-9487-373FA31B7311|1||||ANISOCHR|ANISOCHROMIA|||||||MET*H|||||||INVALID||V||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|CALCIFIED|N|NEXT GENERATION SEQUENCING|HEPASCORE FORMULA||N|NA|U|NA|||Y|4||88||TREATMENT|1967-03-05|1966-03-02|||||1961-05-18||1961-10-17|U|1972-03-01
TRIAL STUDY 134XCP|LB|57F001BC-36EB-44AF-9487-373FA31B7311|2||||HELMOV10|HELICASE MOV-10 PROTEIN|||||||NMOL/DAY|||||||TRACE||OSM||||LOW|NOT DONE||||TISSUE|GELLED|NA|MICROPARTICLE ENZYME IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|N|NA|||N|4||88||SCREENING|1968-10-13|1964-10-31|||||1962-07-28||1971-04-26|NA|1964-10-23
TRIAL STUDY 134XCP|LB|57F001BC-36EB-44AF-9487-373FA31B7311|1||||A1MICG|ALPHA-1 MICROGLOBULIN|||||||UG/MOL|||||||INVALID||CI/ML||||HIGH|NOT DONE||||REFLEX TEAR|REFRIGERATED|U|CINEANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||U|Y|N|NA|||U|5||7||BLINDED TREATMENT|1968-07-02|1971-06-05|||||1973-04-12||1961-12-13|N|1961-09-10
TRIAL STUDY 134XCP|LB|57F001BC-36EB-44AF-9487-373FA31B7311|2||||PAH|P-AMINOHIPPURATE SODIUM|||||||TRANSDUCING UNIT|||||||INDETERMINATE||BISCUIT||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|LIPEMIC|N|TRANSMISSION ELECTRON MICROSCOPY|MDRD 6 VARIABLE FORMULA||N|Y|Y|NA|||Y|5||7||BLINDED TREATMENT|1970-09-29|1962-10-25|||||1961-02-07||1965-12-25|Y|1969-07-25
TRIAL STUDY 134XCP|LB|3FBDC961-EB02-4B28-8672-2A0A0A33529E|1||||C165881|WHITE ELM POLLEN IGE ANTIBODY|||||||JOULE|||||||POSITIVE||U/KG/H||||LOW|NOT DONE||||SERUM OR PLASMA|UNEXPECTED ODOR|NA|CLIP|MDRD 6 VARIABLE FORMULA||N|NA|N|NA|||N|1||38||TREATMENT|1971-04-13|1966-11-20|||||1970-10-30||1970-04-11|N|1961-01-06
TRIAL STUDY 134XCP|LB|3FBDC961-EB02-4B28-8672-2A0A0A33529E|2||||MM2IGAB|MITOCHONDRIAL M2 IGG ANTIBODY|||||||MOL/DAY|||||||TRACE||CY/CM||||ABNORMAL|NOT DONE||||CERUMEN|FRESH|U|CLINICAL EVALUATION|GMI % FORMULA||N|U|N|Y|||N|1||38||RUN-IN|1971-10-25|1964-10-16|||||1964-07-07||1966-05-19|N|1966-07-03
TRIAL STUDY 134XCP|LB|3FBDC961-EB02-4B28-8672-2A0A0A33529E|1||||AFP|ALPHA FETOPROTEIN|||||||ML/KG/MIN|||||||NEGATIVE||DNA COPIES/ML||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR|U|ENZYMATIC SPECTROPHOTOMETRY|HEPASCORE FORMULA||U|Y|NA|NA|||Y|2||58||OPEN LABEL TREATMENT|1962-06-27|1964-12-02|||||1970-10-28||1965-11-02|NA|1971-07-04
TRIAL STUDY 134XCP|LB|3FBDC961-EB02-4B28-8672-2A0A0A33529E|2||||ANCIGAB|ANTI-NEUTROPHIL CYTOPLASMIC IGG ANTIBODY|||||||UG/G/H|||||||TRACE||MCI/KG||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|AUTOLYZED|NA|FLUORESCEIN STAIN|FIBROSIS 4 FORMULA||N|N|U|U|||Y|2||58||TREATMENT|1970-02-09|1972-09-23|||||1962-05-18||1971-04-20|N|1969-12-27
TRIAL STUDY 134XCP|LB|3FBDC961-EB02-4B28-8672-2A0A0A33529E|1||||BASOSG|BASOPHILS, SEGMENTED|||||||UG/G/H|||||||INVALID||10^6 RNA COPIES/ML||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|FROZEN|N|SLIT LAMP|MDRD ENZYMATIC JAPANESE FORMULA||U|N|N|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1967-05-26|1972-01-29|||||1973-03-24||1961-11-22|NA|1968-03-27
TRIAL STUDY 134XCP|LB|3FBDC961-EB02-4B28-8672-2A0A0A33529E|2||||MANNITOL|MANNITOL|||||||10^9 CFU/ML|||||||BORDERLINE||CMH2O/ML||||LOW|NOT DONE||||STOOL|SOLIDIFIED|U|PERIODIC ACID SCHIFF STAIN|MDRD 6 VARIABLE FORMULA||N|N|Y|Y|||NA|3||39||SCREENING|1961-06-13|1961-02-03|||||1961-04-13||1963-08-17|NA|1970-04-11
TRIAL STUDY 134XCP|LB|3FBDC961-EB02-4B28-8672-2A0A0A33529E|1||||SCHISTO|SCHISTOCYTES|||||||PIXEL|||||||INVALID||ENZYME U/M2||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|NON-HEMOLYZED|N|MICRONEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|N|||N|4||88||WASHOUT|1963-01-13|1961-12-06|||||1973-07-28||1972-05-10|U|1960-06-28
TRIAL STUDY 134XCP|LB|3FBDC961-EB02-4B28-8672-2A0A0A33529E|2||||HEMOLYSI|HEMOLYTIC INDEX|||||||EU|||||||NEGATIVE||ML/M2/MIN||||LOW|NOT DONE||||BASAL TEAR|CONTAMINATED|Y|WHOLE EXOME SEQUENCING|ASH FIBROSURE FORMULA||NA|Y|Y|U|||U|4||88||OPEN LABEL TREATMENT|1962-06-02|1962-01-29|||||1966-01-04||1968-11-13|N|1970-02-09
TRIAL STUDY 134XCP|LB|3FBDC961-EB02-4B28-8672-2A0A0A33529E|1||||EOSMM|EOSINOPHILIC METAMYELOCYTES|||||||NGEQ/L|||||||INDETERMINATE||PT_BR||||LOW|NOT DONE||||AMNIOTIC FLUID|ICTERIC|NA|CELL BASED BIOASSAY|GMI MMOL/MOL FORMULA||Y|Y|U|N|||U|5||7||RUN-IN|1972-10-17|1971-11-27|||||1965-12-09||1972-12-17|NA|1962-05-12
TRIAL STUDY 134XCP|LB|3FBDC961-EB02-4B28-8672-2A0A0A33529E|2||||BLSTIMLY|IMMUNOBLASTS/LYMPHOCYTES|||||||KM/H|||||||INVALID||CM H2O||||HIGH|NOT DONE||||ERYTHROCYTES|AGGLUTINATED|N|IMMUNO-PET SCAN|GMI MMOL/MOL FORMULA||U|NA|N|N|||Y|5||7||RUN-IN|1966-06-15|1963-10-14|||||1971-11-29||1962-10-08|NA|1965-10-09
TRIAL STUDY 134XCP|LB|1B524FC4-365B-4A16-A4D7-ED818C6E6086|1||||FCT8INH|FACTOR VIII INHIBITOR|||||||10^9/G|||||||NEGATIVE||UCI||||NORMAL|NOT DONE||||LYSATE|GELLED|U|TRIPLE-PHASE MRI SCAN|MDRD 4 VARIABLE FORMULA||NA|NA|Y|Y|||Y|1||38||BASELINE|1965-02-18|1966-09-02|||||1971-11-12||1971-07-13|NA|1972-09-15
TRIAL STUDY 134XCP|LB|1B524FC4-365B-4A16-A4D7-ED818C6E6086|2||||CRDIGGAB|CARDIOLIPIN IGG ANTIBODY|||||||SCOOPFUL|||||||POSITIVE||UKAT||||ABNORMAL|NOT DONE||||COLOSTRUM|CALCIFIED|U|ENDOSCOPY|GMI MMOL/MOL FORMULA||N|U|U|N|||Y|1||38||BASELINE|1972-02-05|1967-07-02|||||1966-02-19||1970-07-07|Y|1970-04-08
TRIAL STUDY 134XCP|LB|1B524FC4-365B-4A16-A4D7-ED818C6E6086|1||||C165890|TIMOTHY GRASS POLLEN IGE AB RAST SCORE|||||||UCI/KG|||||||BORDERLINE||TORR||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|LACTESCENT|NA|WEBER GREEN STAIN|FIBROSIS 4 FORMULA||N|U|Y|U|||N|2||58||BASELINE|1969-01-06|1971-09-10|||||1967-08-30||1962-02-24|Y|1962-07-15
TRIAL STUDY 134XCP|LB|1B524FC4-365B-4A16-A4D7-ED818C6E6086|2||||C147280|COW MILK PROTEIN ANTIGEN IGE ANTIBODY|||||||ANTIBODY UNIT|||||||INVALID||TSP EQ||||ABNORMAL|NOT DONE||||SALIVA|CLOTTED|U|IMPEDANCE CONDUCTIVITY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|N|Y|||U|2||58||INDUCTION TREATMENT|1971-01-28|1967-11-28|||||1966-11-17||1973-05-27|NA|1973-05-03
TRIAL STUDY 134XCP|LB|1B524FC4-365B-4A16-A4D7-ED818C6E6086|1||||HLABMSC|HLA-B MISMATCH COUNT|||||||CI/G|||||||TRACE||BE/ML||||ABNORMAL|NOT DONE||||BONE MARROW|ICTERIC|NA|SNELLEN EYE CHART|MDRD 4 VARIABLE FORMULA||NA|NA|U|U|||N|3||39||FOLLOW-UP|1972-12-20|1969-11-24|||||1962-08-27||1960-05-30|NA|1968-03-05
TRIAL STUDY 134XCP|LB|1B524FC4-365B-4A16-A4D7-ED818C6E6086|2||||C165885|OLIVE TREE POLLEN IGE AB RAST SCORE|||||||10^7 CFU|||||||INVALID||PNU/ML||||ABNORMAL|NOT DONE||||LYSATE|SOLIDIFIED|Y|FLUOROSCOPY|ASH FIBROSURE FORMULA||Y|NA|Y|Y|||NA|3||39||CONTINUATION TREATMENT|1961-06-27|1973-09-08|||||1963-08-26||1969-07-13|N|1966-09-26
TRIAL STUDY 134XCP|LB|1B524FC4-365B-4A16-A4D7-ED818C6E6086|1||||FBNCTFT|FIBRONECTIN, FETAL|||||||EID 50/ML|||||||POSITIVE||MMHG*MIN/L||||LOW|NOT DONE||||URINE|PARAFFIN-EMBEDDED|Y|LIQUID SCINTILLATION COUNTING|HEPASCORE FORMULA||U|U|NA|Y|||Y|4||88||BLINDED TREATMENT|1973-01-16|1970-11-23|||||1971-10-13||1972-12-29|Y|1972-09-30
TRIAL STUDY 134XCP|LB|1B524FC4-365B-4A16-A4D7-ED818C6E6086|2||||POLYERY|POLYCHROMATOPHILIC ERYTHROBLAST|||||||HOUNSFIELD UNIT|||||||INVALID||GPL U||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|DRIED|NA|FORCED OSCILLATION TECHNIQUE|FIBROSIS 4 FORMULA||N|N|NA|U|||NA|4||88||CONTINUATION TREATMENT|1972-09-13|1963-01-28|||||1962-06-24||1970-12-31|N|1968-05-18
TRIAL STUDY 134XCP|LB|1B524FC4-365B-4A16-A4D7-ED818C6E6086|1||||FAT|FAT|||||||LINEAR FT*LB|||||||POSITIVE||KAT||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|DRIED|U|SLOAN LETTER EYE CHART 1.25%|MDRD 4 VARIABLE FORMULA||Y|N|NA|Y|||N|5||7||CONTINUATION TREATMENT|1964-06-19|1965-12-15|||||1963-10-20||1962-06-09|Y|1969-01-26
TRIAL STUDY 134XCP|LB|1B524FC4-365B-4A16-A4D7-ED818C6E6086|2||||LH|LUTEINIZING HORMONE|||||||UCI/L|||||||INVALID||NKAT||||LOW|NOT DONE||||LYSATE|AUTOLYZED|N|TWO-COLOR MICROARRAY|FIBROMETER FORMULA||Y|U|Y|Y|||Y|5||7||INDUCTION TREATMENT|1969-09-27|1965-10-28|||||1972-04-21||1966-07-17|NA|1972-01-22
TRIAL STUDY 134XCP|LB|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|1||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||10^5/HPF|||||||INVALID||PELLET||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|AGGLUTINATED|Y|LC/MS/MS|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|U|NA|||Y|1||38||BLINDED TREATMENT|1971-09-10|1961-03-27|||||1971-08-27||1969-04-10|U|1973-03-12
TRIAL STUDY 134XCP|LB|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|2||||P1NP|PROCOLLAGEN 1 N-TERMINAL PROPEPTIDE|||||||CM|||||||INDETERMINATE||U/ML||||LOW|NOT DONE||||NAIL|ICTERIC|NA|SANGER SEQUENCING|ASH FIBROSURE FORMULA||U|NA|NA|Y|||Y|1||38||SCREENING|1965-08-29|1962-02-09|||||1964-08-20||1972-03-31|N|1961-02-23
TRIAL STUDY 134XCP|LB|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|1||||PO2|PARTIAL PRESSURE OXYGEN|||||||ML/CM3/MIN|||||||POSITIVE||BEL||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|CALCIFIED|U|HPLC/MS|MDRD ENZYMATIC FORMULA||NA|N|Y|U|||N|2||58||TREATMENT|1964-08-16|1967-01-06|||||1965-09-22||1966-12-23|NA|1966-01-30
TRIAL STUDY 134XCP|LB|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|2||||PDGFAB|PLATELET DERIVED GROWTH FACTOR ISOFORMAB|||||||DL|||||||POSITIVE||UG/KG/DAY||||ABNORMAL|NOT DONE||||LEUKOCYTE|CONTAMINATED|U|NUCLEIC ACID BASED METHOD|COCKCROFT-GAULT FORMULA||NA|N|NA|U|||NA|2||58||TREATMENT|1970-06-10|1970-09-08|||||1960-04-28||1972-08-12|N|1964-05-27
TRIAL STUDY 134XCP|LB|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|1||||PPI|INORGANIC PYROPHOSPHATE|||||||UMOL/DL|||||||BORDERLINE||MPA||||LOW|NOT DONE||||EXUDATE|AGGLUTINATED|Y|MASS SPECTROMETRY|MDRD 5 VARIABLE FORMULA||N|Y|NA|NA|||Y|3||39||TREATMENT|1965-09-12|1971-04-16|||||1963-02-03||1963-06-08|N|1965-05-20
TRIAL STUDY 134XCP|LB|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|2||||RENIN|RENIN|||||||UG/M2/H|||||||POSITIVE||10^12 IU/L||||NORMAL|NOT DONE||||MONOCYTE|PARAFFIN-EMBEDDED|U|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD 4 VARIABLE FORMULA||Y|NA|Y|NA|||N|3||39||TREATMENT|1962-10-03|1971-09-20|||||1972-04-15||1966-08-04|Y|1964-06-26
TRIAL STUDY 134XCP|LB|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|1||||SPERMP|SPERMATOZOA, PROGRESSIVE|||||||L/MIN/M2|||||||TRACE||EP U||||LOW|NOT DONE||||DERMAL TISSUE|AGGLUTINATED|NA|ELLA|COCKCROFT-GAULT FORMULA||NA|Y|U|N|||U|4||88||BLINDED TREATMENT|1963-05-19|1964-03-28|||||1965-03-23||1968-07-07|NA|1970-10-29
TRIAL STUDY 134XCP|LB|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|2||||EOTAXIN1|EOTAXIN-1|||||||IU/KG/H|||||||INDETERMINATE||HPA||||LOW|NOT DONE||||VENOUS CORD BLOOD|THAWED|U|CONTRAST ENHANCED MRI|MDRD FORMULA||N|U|N|Y|||NA|4||88||OBSERVATION|1967-05-09|1967-07-22|||||1961-03-23||1966-05-23|U|1969-08-14
TRIAL STUDY 134XCP|LB|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|1||||CAPHOS|CALCIUM/PHOSPHORUS|||||||CD/M2|||||||NEGATIVE||LOG10 PFU/ML||||NORMAL|NOT DONE||||NAIL|ROOM TEMPERATURE|NA|COULOMETRIC TITRATION|MDRD 6 VARIABLE FORMULA||U|U|Y|Y|||Y|5||7||RUN-IN|1960-05-12|1971-06-17|||||1960-09-20||1967-11-27|U|1961-07-02
TRIAL STUDY 134XCP|LB|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|2||||FAT|FAT|||||||GPELISA UNIT/ML|||||||INDETERMINATE||10^6 U||||HIGH|NOT DONE||||INFRANATANT, PLASMA|DRIED|Y|MULTI-SLICE SPIRAL CT|HEPASCORE FORMULA||Y|Y|U|N|||U|5||7||OBSERVATION|1966-07-28|1960-10-09|||||1972-01-18||1972-11-11|U|1961-05-29
TRIAL STUDY 134XCP|LB|27671577-2C6D-429F-BED9-0EDAB15CCB33|1||||CRDIGGAB|CARDIOLIPIN IGG ANTIBODY|||||||PELLET|||||||POSITIVE||PRESSOR UNITS||||HIGH|NOT DONE||||REFLEX TEAR|HEMOLYZED|NA|RADIOGRAPHY|FIBROTEST FORMULA||N|U|N|Y|||NA|1||38||BASELINE|1963-08-22|1972-05-05|||||1965-02-15||1963-08-14|Y|1972-04-04
TRIAL STUDY 134XCP|LB|27671577-2C6D-429F-BED9-0EDAB15CCB33|2||||MIP1B|MACROPHAGE INFLAMMATORY PROTEIN 1 BETA|||||||TRANSDUCING UNIT/ML|||||||BORDERLINE||KG/CM2||||NORMAL|NOT DONE||||URINE SEDIMENT|PARAFFIN-EMBEDDED|U|GIEMSA STAIN|MDRD 4 VARIABLE FORMULA||Y|NA|Y|NA|||Y|1||38||INDUCTION TREATMENT|1961-06-24|1968-05-31|||||1960-06-17||1970-03-27|U|1962-07-19
TRIAL STUDY 134XCP|LB|27671577-2C6D-429F-BED9-0EDAB15CCB33|1||||APOB100|APOLIPOPROTEIN B100|||||||NMOL/G|||||||INVALID||BQ||||ABNORMAL|NOT DONE||||TISSUE|PARAFFIN-EMBEDDED|N|LC/MS/MS|FIBROTEST FORMULA||NA|U|N|NA|||NA|2||58||BLINDED TREATMENT|1965-04-25|1972-09-14|||||1965-03-12||1971-11-01|N|1963-08-03
TRIAL STUDY 134XCP|LB|27671577-2C6D-429F-BED9-0EDAB15CCB33|2||||CYCAPHOS|CALCIUM PHOSPHATE CRYSTALS|||||||PATCH|||||||INVALID||G/ANIMAL/DAY||||HIGH|NOT DONE||||SMEGMA|CALCIFIED|U|FORCED OSCILLATION TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|N|Y|||Y|2||58||WASHOUT|1968-03-18|1968-05-01|||||1961-01-08||1960-11-13|NA|1962-07-07
TRIAL STUDY 134XCP|LB|27671577-2C6D-429F-BED9-0EDAB15CCB33|1||||CLARITY|CLARITY|||||||MPL U|||||||POSITIVE||UMOL/L||||ABNORMAL|NOT DONE||||SMEGMA|ROOM TEMPERATURE|N|DIFFUSION WEIGHTED MRI|CKD-EPI CYSTATIN C FORMULA||NA|NA|NA|NA|||Y|3||39||LONG-TERM FOLLOW-UP|1964-03-23|1972-10-15|||||1964-03-04||1962-08-23|NA|1965-03-25
TRIAL STUDY 134XCP|LB|27671577-2C6D-429F-BED9-0EDAB15CCB33|2||||EOSMM|EOSINOPHILIC METAMYELOCYTES|||||||MEQ|||||||BORDERLINE||DAMOL/L||||LOW|NOT DONE||||CERUMEN|ICTERIC|U|LIQUID SCINTILLATION COUNTING|NASH FIBROSURE FORMULA||Y|NA|Y|Y|||U|3||39||CONTINUATION TREATMENT|1973-07-02|1960-09-26|||||1968-12-11||1972-01-30|NA|1960-02-08
TRIAL STUDY 134XCP|LB|27671577-2C6D-429F-BED9-0EDAB15CCB33|1||||CRH|CORTICOTROPIN RELEASING HORMONE|||||||CG|||||||BORDERLINE||MIN||||NORMAL|NOT DONE||||CORD SERUM|NON-HEMOLYZED|N|ANTIMICROBIAL COMBINATION TESTING|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|N|N|||U|4||88||LONG-TERM FOLLOW-UP|1963-05-17|1961-08-28|||||1971-06-12||1962-08-07|Y|1968-03-04
TRIAL STUDY 134XCP|LB|27671577-2C6D-429F-BED9-0EDAB15CCB33|2||||A1MCREAT|ALPHA-1 MICROGLOBULIN/CREATININE|||||||CM/MIN|||||||INVALID||JAR||||NORMAL|NOT DONE||||DISCHARGE|CONTAMINATED|N|THERMAL IONIZATION MASS SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA||N|Y|U|N|||U|4||88||OBSERVATION|1969-11-01|1964-10-28|||||1972-12-18||1967-08-01|U|1965-09-01
TRIAL STUDY 134XCP|LB|27671577-2C6D-429F-BED9-0EDAB15CCB33|1||||RBCDIPOP|DIMORPHIC ERYTHROCYTE POPULATION|||||||MIN*MG/ML|||||||POSITIVE||PT_BR||||LOW|NOT DONE||||BONE MARROW|NON-HEMOLYZED|NA|IHC|CKD-EPI FORMULA||NA|U|N|Y|||N|5||7||CONTINUATION TREATMENT|1970-11-28|1973-06-26|||||1969-07-20||1970-08-22|U|1967-01-13
TRIAL STUDY 134XCP|LB|27671577-2C6D-429F-BED9-0EDAB15CCB33|2||||C130137|AMERICAN COCKROACH ANTIGEN IGA ANTIBODY|||||||BQ/UG|||||||TRACE||GY/H||||NORMAL|NOT DONE||||SERUM|SOLIDIFIED|NA|SPECULAR MICROSCOPY|GMI % FORMULA||N|Y|N|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1969-09-13|1969-02-04|||||1970-09-09||1966-01-27|NA|1969-04-19
TRIAL STUDY 134XCP|LB|CD69750D-957B-405C-A397-AFA331D30535|1||||PSDGLSRF|PHOSPHATIDYLGLYCEROL/LUNG SURFACTANT|||||||SIEMENS|||||||BORDERLINE||GPS U||||LOW|NOT DONE||||SWABBED MATERIAL|HEMOLYZED|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|FIBROTEST FORMULA||Y|N|N|N|||Y|1||38||RUN-IN|1970-02-09|1964-12-13|||||1966-01-21||1960-12-08|Y|1960-10-09
TRIAL STUDY 134XCP|LB|CD69750D-957B-405C-A397-AFA331D30535|2||||TLYCE|T-LYMPHOCYTES|||||||MOL/MG|||||||INDETERMINATE||TUBERCULIN UNIT/ML||||NORMAL|NOT DONE||||LUNG SURFACTANT|GELLED|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|FIBROMETER FORMULA||N|U|N|NA|||NA|1||38||INDUCTION TREATMENT|1961-11-12|1972-04-16|||||1970-10-16||1968-11-20|N|1964-05-21
TRIAL STUDY 134XCP|LB|CD69750D-957B-405C-A397-AFA331D30535|1||||BASOLE|BASOPHILS/LEUKOCYTES|||||||MSEC|||||||INVALID||DNA COPIES/ML||||ABNORMAL|NOT DONE||||URINE SEDIMENT|SOLIDIFIED|Y|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|N|Y|||N|2||58||BASELINE|1971-11-20|1968-08-23|||||1969-04-12||1973-03-27|U|1968-05-31
TRIAL STUDY 134XCP|LB|CD69750D-957B-405C-A397-AFA331D30535|2||||ALB|ALBUMIN|||||||GRAVITATIONAL UNIT|||||||TRACE||BOWL||||NORMAL|NOT DONE||||MUSCLE TISSUE|ROOM TEMPERATURE|Y|MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI FORMULA||U|Y|U|U|||Y|2||58||OPEN LABEL TREATMENT|1971-11-27|1970-07-04|||||1966-01-13||1967-10-09|NA|1972-10-14
TRIAL STUDY 134XCP|LB|CD69750D-957B-405C-A397-AFA331D30535|1||||IGG4|IMMUNOGLOBULIN G SUBCLASS 4|||||||MG/DAY|||||||INDETERMINATE||KG/MOL||||HIGH|NOT DONE||||EMOTIONAL TEAR|LACTESCENT|Y|RULER MEASUREMENT METHOD|GMI MMOL/MOL FORMULA||NA|Y|N|U|||Y|3||39||OPEN LABEL TREATMENT|1964-02-07|1967-07-16|||||1966-04-29||1962-08-27|N|1973-08-10
TRIAL STUDY 134XCP|LB|CD69750D-957B-405C-A397-AFA331D30535|2||||IGD|IMMUNOGLOBULIN D|||||||DEG2|||||||TRACE||10^11/L||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|FRESH|U|PYROSEQUENCING|NASH FIBROSURE FORMULA||NA|NA|U|N|||N|3||39||BLINDED TREATMENT|1969-03-21|1968-12-14|||||1969-04-25||1965-09-01|U|1972-06-30
TRIAL STUDY 134XCP|LB|CD69750D-957B-405C-A397-AFA331D30535|1||||LKM1AB|LIVER KIDNEY MICROSOMAL TYPE 1 ANTIBODY|||||||PG|||||||BORDERLINE||TSP EQ||||HIGH|NOT DONE||||EXPIRED AIR|SOLIDIFIED|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|CKD-EPI CYSTATIN C FORMULA||N|Y|Y|Y|||U|4||88||BLINDED TREATMENT|1963-09-06|1970-01-22|||||1967-03-22||1968-09-26|Y|1961-03-30
TRIAL STUDY 134XCP|LB|CD69750D-957B-405C-A397-AFA331D30535|2||||PLSIMCCE|IMMATURE PLASMA CELLS/TOTAL CELLS|||||||L/L|||||||INVALID||ML/ANIMAL/DAY||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|ICTERIC|U|CONTRAST ENHANCED PET SCAN|GMI % FORMULA||Y|Y|U|U|||Y|4||88||RUN-IN|1960-04-17|1971-09-06|||||1966-09-20||1961-11-15|N|1967-03-10
TRIAL STUDY 134XCP|LB|CD69750D-957B-405C-A397-AFA331D30535|1||||C165933|AMERICAN COCKROACH IGE AB RAST SCORE|||||||GPS U|||||||INVALID||FT||||NORMAL|NOT DONE||||MONOCYTE|UNEXPECTED ODOR|N|TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|U|Y|NA|||U|5||7||INDUCTION TREATMENT|1963-11-05|1971-01-01|||||1964-05-08||1967-02-21|N|1967-11-03
TRIAL STUDY 134XCP|LB|CD69750D-957B-405C-A397-AFA331D30535|2||||GLBCREAT|GLOBULIN/CREATININE|||||||CMHG|||||||INDETERMINATE||COULOMB||||LOW|NOT DONE||||INFRANATANT, SERUM|SOLIDIFIED|N|PH METER MEASUREMENT METHOD|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|NA|NA|||N|5||7||INDUCTION TREATMENT|1972-01-03|1960-05-12|||||1968-06-24||1971-03-30|Y|1960-08-26
TRIAL STUDY 134XCP|LB|5BFDDFC2-7D15-4B01-8140-62376D160EF0|1||||PLATEST|PLATELETS, ESTIMATED|||||||MOL|||||||TRACE||GPL U||||LOW|NOT DONE||||KERATINOCYTE|CLOTTED|N|HANSEL STAIN|FIBROSIS 4 FORMULA||N|N|N|N|||U|1||38||WASHOUT|1960-08-03|1969-04-08|||||1967-03-07||1968-10-21|U|1970-07-13
TRIAL STUDY 134XCP|LB|5BFDDFC2-7D15-4B01-8140-62376D160EF0|2||||TRAMADOL|TRAMADOL|||||||FMOL/L|||||||POSITIVE||G/DL||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CLOTTED|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|ASH FIBROSURE FORMULA||NA|NA|N|N|||Y|1||38||WASHOUT|1966-12-23|1961-10-27|||||1967-12-28||1962-03-07|NA|1963-10-10
TRIAL STUDY 134XCP|LB|5BFDDFC2-7D15-4B01-8140-62376D160EF0|1||||BITECE|BITE CELLS|||||||LX|||||||BORDERLINE||G/L||||ABNORMAL|NOT DONE||||SEMEN|ICTERIC|U|MICROBIAL CULTURE, SOLID|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|NA|U|||NA|2||58||WASHOUT|1962-10-28|1961-12-12|||||1966-09-27||1969-04-26|N|1961-11-13
TRIAL STUDY 134XCP|LB|5BFDDFC2-7D15-4B01-8140-62376D160EF0|2||||PEPSNGA|PEPSINOGEN A|||||||LENS|||||||INDETERMINATE||CMHG||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED|NA|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|N|||Y|2||58||WASHOUT|1972-06-27|1968-06-26|||||1971-03-21||1967-05-17|NA|1964-07-19
TRIAL STUDY 134XCP|LB|5BFDDFC2-7D15-4B01-8140-62376D160EF0|1||||BILEAC|BILE ACID|||||||MG/KG/MIN|||||||TRACE||GBQ/MG||||HIGH|NOT DONE||||BREAST MILK|CALCIFIED|NA|SANGER SEQUENCING|ASH FIBROSURE FORMULA||NA|U|Y|Y|||N|3||39||OBSERVATION|1973-03-27|1963-11-29|||||1965-03-01||1962-10-09|NA|1965-11-26
TRIAL STUDY 134XCP|LB|5BFDDFC2-7D15-4B01-8140-62376D160EF0|2||||DRUGSCR|DRUG SCREEN|||||||GAUSS|||||||INDETERMINATE||BE/ML||||HIGH|NOT DONE||||PROSTATIC FLUID|REFRIGERATED|U|ICP-MS|FIBROSIS 4 FORMULA||U|N|N|U|||U|3||39||CONTINUATION TREATMENT|1962-05-31|1971-08-13|||||1966-04-02||1970-07-11|Y|1973-07-20
TRIAL STUDY 134XCP|LB|5BFDDFC2-7D15-4B01-8140-62376D160EF0|1||||PLSPCE|PRECURSOR PLASMA CELLS|||||||10^5/L|||||||INDETERMINATE||WEBER||||ABNORMAL|NOT DONE||||LAVAGE FLUID|UNEXPECTED ODOR|N|X-RAY FLUORESCENCE SPECTROMETRY|MDRD ENZYMATIC FORMULA||N|N|N|Y|||Y|4||88||CONTINUATION TREATMENT|1962-09-04|1968-11-06|||||1962-06-26||1969-09-11|NA|1963-08-15
TRIAL STUDY 134XCP|LB|5BFDDFC2-7D15-4B01-8140-62376D160EF0|2||||BD2|BETA-DEFENSIN 2|||||||NU/CL|||||||POSITIVE||10^6 COPIES/ML||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|AUTOLYZED|N|REBOUND TONOMETRY|MDRD FORMULA||U|N|U|U|||U|4||88||BLINDED TREATMENT|1965-01-10|1971-07-06|||||1973-01-30||1960-01-24|N|1968-07-12
TRIAL STUDY 134XCP|LB|5BFDDFC2-7D15-4B01-8140-62376D160EF0|1||||CSGRAN|GRANULAR CASTS|||||||UG/MIN|||||||TRACE||EVENTS||||ABNORMAL|NOT DONE||||LYSATE|ROOM TEMPERATURE|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||NA|N|Y|Y|||Y|5||7||SCREENING|1961-03-03|1960-01-19|||||1965-08-01||1971-01-08|Y|1968-07-29
TRIAL STUDY 134XCP|LB|5BFDDFC2-7D15-4B01-8140-62376D160EF0|2||||APOC2|APOLIPOPROTEIN C2|||||||10^6 IU/ML|||||||BORDERLINE||MMOL/MOL||||LOW|NOT DONE||||SKIN TISSUE|THAWED|NA|ETDRS EYE CHART|FIBROTEST FORMULA||NA|U|N|U|||NA|5||7||WASHOUT|1965-12-10|1967-04-13|||||1963-10-30||1968-07-05|NA|1969-07-04
TRIAL STUDY 134XCP|LB|DEA8E573-2709-41F9-AB0D-8C39F5169B48|1||||BALA|BETA ALANINE|||||||UU/DL|||||||NEGATIVE||CAPFUL||||NORMAL|NOT DONE||||GASTRIC FLUID|THAWED|U|ELECTROCHEMILUMINESCENCE|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|Y|Y|||NA|1||38||OBSERVATION|1972-05-06|1960-06-07|||||1960-10-26||1966-10-16|N|1969-02-22
TRIAL STUDY 134XCP|LB|DEA8E573-2709-41F9-AB0D-8C39F5169B48|2||||PROGESTR|PROGESTERONE RECEPTOR|||||||TABLET|||||||NEGATIVE||MG/M2/H||||HIGH|NOT DONE||||EXPIRED AIR|NON-HEMOLYZED|U|PELLI-ROBSON EYE CHART|GMI MMOL/MOL FORMULA||NA|N|U|U|||NA|1||38||CONTINUATION TREATMENT|1966-01-09|1965-08-15|||||1970-01-05||1971-04-19|U|1965-12-24
TRIAL STUDY 134XCP|LB|DEA8E573-2709-41F9-AB0D-8C39F5169B48|1||||ALLOILE|ALLOISOLEUCINE|||||||10^9/DOSE|||||||INDETERMINATE||M||||ABNORMAL|NOT DONE||||FLUID|NON-HEMOLYZED|U|AUTOMATED COUNT|GMI % FORMULA||N|Y|U|N|||U|2||58||RUN-IN|1968-07-11|1961-03-02|||||1970-05-30||1964-07-14|U|1963-10-03
TRIAL STUDY 134XCP|LB|DEA8E573-2709-41F9-AB0D-8C39F5169B48|2||||LEPTIN|LEPTIN|||||||U/G|||||||BORDERLINE||10^6 ORGANISMS||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|ICTERIC|NA|PHOTOGRAPHY|CKD-EPI CREATININE FORMULA||N|Y|N|U|||NA|2||58||CONTINUATION TREATMENT|1963-05-20|1965-10-22|||||1965-12-26||1963-03-01|N|1962-08-19
TRIAL STUDY 134XCP|LB|DEA8E573-2709-41F9-AB0D-8C39F5169B48|1||||CEACAM1|CEA CELL ADHESION MOLECULE 1|||||||MET*MIN|||||||BORDERLINE||AGU/ML||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|FRESH|U|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|N|U|||Y|3||39||CONTINUATION TREATMENT|1965-02-24|1973-02-07|||||1964-12-20||1965-09-11|U|1962-07-21
TRIAL STUDY 134XCP|LB|DEA8E573-2709-41F9-AB0D-8C39F5169B48|2||||GAD1|GLUTAMIC ACID DECARBOXYLASE 1|||||||10^9 ORGANISMS/ML|||||||INDETERMINATE||GENEQ||||ABNORMAL|NOT DONE||||LYMPH|REFRIGERATED|N|MICROARRAY|MDRD 4 VARIABLE FORMULA||N|NA|Y|N|||U|3||39||SCREENING|1971-03-29|1967-11-04|||||1969-09-15||1967-04-08|U|1973-04-27
TRIAL STUDY 134XCP|LB|DEA8E573-2709-41F9-AB0D-8C39F5169B48|1||||RDWRSD|RET RDW STANDARD DEVIATION|||||||M/SEC|||||||BORDERLINE||MMOL/S||||LOW|NOT DONE||||ALVEOLAR AIR|AUTOLYZED|NA|IN VITRO GENE EXPRESSION ASSAY|MDRD FORMULA||NA|N|N|NA|||N|4||88||OBSERVATION|1969-01-04|1964-01-15|||||1969-08-07||1961-12-25|Y|1962-06-30
TRIAL STUDY 134XCP|LB|DEA8E573-2709-41F9-AB0D-8C39F5169B48|2||||THMBAAC|THROMBIN ACTIVITY ACTUAL/CONTROL|||||||MU/L|||||||BORDERLINE||COPIES/UL||||NORMAL|NOT DONE||||GASTRIC FLUID|HEMOLYZED|U|HEMOCYTOMETRY|MDRD 6 VARIABLE FORMULA||Y|NA|U|U|||U|4||88||FOLLOW-UP|1964-03-22|1969-01-31|||||1971-07-14||1969-08-15|U|1961-08-06
TRIAL STUDY 134XCP|LB|DEA8E573-2709-41F9-AB0D-8C39F5169B48|1||||PSDGLSRF|PHOSPHATIDYLGLYCEROL/LUNG SURFACTANT|||||||MG/ANIMAL|||||||INDETERMINATE||10^6 ORGANISMS||||HIGH|NOT DONE||||PLATELET RICH PLASMA|LIPEMIC|Y|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|GMI MMOL/MOL FORMULA||NA|U|N|N|||Y|5||7||FOLLOW-UP|1964-10-26|1972-09-27|||||1968-11-13||1965-05-15|U|1972-04-12
TRIAL STUDY 134XCP|LB|DEA8E573-2709-41F9-AB0D-8C39F5169B48|2||||HYDCDN|HYDROCODONE|||||||MDFI|||||||NEGATIVE||CYCLE/MIN||||ABNORMAL|NOT DONE||||CERUMEN|FROZEN|Y|INTERRUPTER TECHNIQUE|CKD-EPI FORMULA||U|NA|Y|Y|||Y|5||7||BLINDED TREATMENT|1971-11-10|1972-01-29|||||1968-03-16||1962-07-26|NA|1973-06-25
TRIAL STUDY 134XCP|LB|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|1||||LYMIM|IMMATURE LYMPHOCYTES|||||||LOG10 TCID 50/ML|||||||INVALID||MPL U||||NORMAL|NOT DONE||||CORD BLOOD|CONCENTRATED|N|CRYOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|NA|U|||Y|1||38||RUN-IN|1970-01-25|1961-06-29|||||1969-08-09||1970-08-03|NA|1970-03-01
TRIAL STUDY 134XCP|LB|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|2||||C130100|MIXED ANTIGEN IGE ANTIBODY|||||||MOL/L|||||||BORDERLINE||MESF||||NORMAL|NOT DONE||||BONE|GELLED|N|SECONDARY ION MASS SPECTOMETRY|FIBROSIS 4 FORMULA||U|Y|Y|Y|||U|1||38||BLINDED TREATMENT|1970-07-08|1963-03-11|||||1967-01-02||1967-07-03|U|1960-06-02
TRIAL STUDY 134XCP|LB|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|1||||HAPTOG|HAPTOGLOBIN|||||||ENZYME U/G HB|||||||NEGATIVE||GBQ/MG||||NORMAL|NOT DONE||||EMESIS|SOLIDIFIED|NA|MICROBIAL CULTURE|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|U|||U|2||58||BLINDED TREATMENT|1965-04-18|1963-10-01|||||1963-01-30||1973-06-07|U|1966-07-19
TRIAL STUDY 134XCP|LB|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|2||||INTLK32|INTERLEUKIN 32|||||||M/SEC2|||||||INVALID||K||||LOW|NOT DONE||||BLOOD|UNEXPECTED ODOR|Y|ULTRASONOGRAPHIC ELASTOGRAPHY|GMI MMOL/MOL FORMULA||U|N|Y|N|||Y|2||58||CONTINUATION TREATMENT|1973-03-11|1962-11-12|||||1966-01-05||1972-12-30|NA|1971-08-06
TRIAL STUDY 134XCP|LB|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|1||||NMH|N-METHYLHISTAMINE|||||||NEEDLE GAUGE|||||||POSITIVE||UIU/DL||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ICTERIC|U|CARDIAC THERMODILUTION|CKD-EPI CREATININE FORMULA||N|U|U|Y|||U|3||39||OPEN LABEL TREATMENT|1961-12-15|1967-01-08|||||1970-06-19||1960-01-26|NA|1964-08-14
TRIAL STUDY 134XCP|LB|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|2||||EOS|EOSINOPHILS|||||||10^4 CFU|||||||INDETERMINATE||GPL U||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC|Y|TARGETED GENOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|Y|||U|3||39||WASHOUT|1969-12-23|1970-02-27|||||1962-03-27||1961-09-28|NA|1962-01-15
TRIAL STUDY 134XCP|LB|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|1||||ESTFREST|ESTRADIOL, FREE/ESTRADIOL|||||||DAYS|||||||INVALID||KCAL/DAY||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|AGGLUTINATED|U|OLIGO ACGH|GMI MMOL/MOL FORMULA||NA|NA|Y|N|||U|4||88||OBSERVATION|1971-07-29|1968-06-24|||||1965-02-06||1962-04-03|U|1961-12-21
TRIAL STUDY 134XCP|LB|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|2||||LVTRCTM|LEVETIRACETAM|||||||LOG10 ELISA UNIT|||||||TRACE||LOG10 PFU/ML||||HIGH|NOT DONE||||MECONIUM|CONTAMINATED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|CKD-EPI FORMULA||Y|Y|NA|Y|||N|4||88||FOLLOW-UP|1966-04-30|1970-09-15|||||1970-12-10||1968-07-08|N|1960-02-01
TRIAL STUDY 134XCP|LB|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|1||||ALPIALP|ALK PHOS, INTESTINAL/TOTAL ALK PHOS|||||||USIEMENS|||||||INVALID||MEQ/DL||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|CALCIFIED|NA|CONTRAST ENHANCED PET/CT SCAN|CKD-EPI CYSTATIN C FORMULA||U|N|N|NA|||N|5||7||BLINDED TREATMENT|1964-06-24|1969-05-26|||||1963-04-09||1965-03-20|U|1972-02-15
TRIAL STUDY 134XCP|LB|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|2||||BNPPRO|PROB-TYPE NATRIURETIC PEPTIDE|||||||EQ|||||||INDETERMINATE||S/H||||NORMAL|NOT DONE||||LOCHIA|LACTESCENT|NA|MODIFIED ACID FAST STAIN|GMI MMOL/MOL FORMULA||NA|Y|NA|N|||Y|5||7||OPEN LABEL TREATMENT|1968-05-26|1969-12-02|||||1960-10-02||1971-01-05|U|1965-03-17
TRIAL STUDY 134XCP|LB|77CF8795-CFF5-40C6-A811-624972806A38|1||||FCT8INH|FACTOR VIII INHIBITOR|||||||DIP|||||||POSITIVE||CMH2O*S/ML||||ABNORMAL|NOT DONE||||FLUID|DRIED|NA|POPULATION SEQUENCING|HEPASCORE FORMULA||Y|NA|Y|Y|||N|1||38||CONTINUATION TREATMENT|1969-08-29|1961-01-11|||||1965-07-29||1960-10-24|U|1961-04-04
TRIAL STUDY 134XCP|LB|77CF8795-CFF5-40C6-A811-624972806A38|2||||STSA|STEROID SULFATASE ACTIVITY|||||||NMOL/G|||||||NEGATIVE||ENZYME U/L||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|AGGLUTINATED|N|SINGLE-MOLECULE ARRAY|NASH FIBROSURE FORMULA||N|NA|U|NA|||N|1||38||BLINDED TREATMENT|1971-03-28|1966-07-10|||||1962-12-20||1967-02-09|N|1963-02-03
TRIAL STUDY 134XCP|LB|77CF8795-CFF5-40C6-A811-624972806A38|1||||BCEFNCTN|BETA-CELL FUNCTION|||||||ARBITRARY U|||||||BORDERLINE||/100 WBC||||HIGH|NOT DONE||||SALIVA|SOLIDIFIED|Y|MANUAL CLOT DETECTION|MDRD ENZYMATIC FORMULA||N|U|U|N|||N|2||58||INDUCTION TREATMENT|1972-10-06|1961-01-28|||||1970-12-24||1960-08-22|Y|1965-08-22
TRIAL STUDY 134XCP|LB|77CF8795-CFF5-40C6-A811-624972806A38|2||||CBS|CYSTATHIONINE BETA-SYNTHASE|||||||MEQ/ML|||||||INVALID||TUBE||||LOW|NOT DONE||||EMOTIONAL TEAR|AGGLUTINATED|N|LC-FL|GMI % FORMULA||N|N|Y|Y|||Y|2||58||BLINDED TREATMENT|1972-07-01|1963-03-31|||||1967-02-26||1960-12-25|NA|1971-04-15
TRIAL STUDY 134XCP|LB|77CF8795-CFF5-40C6-A811-624972806A38|1||||PLSMCECE|MATURE PLASMA CELLS/TOTAL CELLS|||||||/10^4|||||||POSITIVE||DEG||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|REFRIGERATED|Y|AUTOREFRACTION|ASH FIBROSURE FORMULA||Y|NA|Y|Y|||Y|3||39||SCREENING|1970-01-01|1963-05-26|||||1966-07-04||1969-10-09|N|1967-06-30
TRIAL STUDY 134XCP|LB|77CF8795-CFF5-40C6-A811-624972806A38|2||||CCPIGGAB|CYCLIC CITRULLINATED PEPTIDE IGG AB|||||||10^9/DOSE|||||||TRACE||ML/ANIMAL||||ABNORMAL|NOT DONE||||MONOCYTE|SOLIDIFIED|Y|AUDIOMETRY|MDRD 6 VARIABLE FORMULA||Y|N|NA|Y|||N|3||39||BLINDED TREATMENT|1968-12-23|1964-10-17|||||1965-01-01||1971-04-15|Y|1963-04-19
TRIAL STUDY 134XCP|LB|77CF8795-CFF5-40C6-A811-624972806A38|1||||TRP|TRYPTOPHAN|||||||UG/CM2|||||||NEGATIVE||C||||LOW|NOT DONE||||MUCUS|ICTERIC|U|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|COCKCROFT-GAULT FORMULA||N|U|NA|Y|||Y|4||88||WASHOUT|1964-11-30|1968-01-19|||||1965-04-22||1970-01-11|N|1969-12-05
TRIAL STUDY 134XCP|LB|77CF8795-CFF5-40C6-A811-624972806A38|2||||C165885|OLIVE TREE POLLEN IGE AB RAST SCORE|||||||S*KPA|||||||INDETERMINATE||PPM||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CONTAMINATED|N|FUNCTIONAL MRI|CKD-EPI FORMULA||N|NA|Y|N|||Y|4||88||LONG-TERM FOLLOW-UP|1968-07-29|1970-05-14|||||1964-04-09||1967-11-06|N|1965-09-07
TRIAL STUDY 134XCP|LB|77CF8795-CFF5-40C6-A811-624972806A38|1||||ALTCPHRL|ALPHA TOCOPHEROL|||||||CMH2O*S2/ML|||||||TRACE||UG/MIN||||HIGH|NOT DONE||||SYNOVIAL FLUID|UNEXPECTED ODOR|NA|ENDOSCOPY|MDRD 5 VARIABLE FORMULA||Y|N|U|Y|||Y|5||7||CONTINUATION TREATMENT|1964-07-01|1969-11-01|||||1970-04-17||1963-08-02|NA|1965-12-08
TRIAL STUDY 134XCP|LB|77CF8795-CFF5-40C6-A811-624972806A38|2||||SEZCELE|SEZARY CELLS/LEUKOCYTES|||||||MG/M2/H|||||||INDETERMINATE||10^4 CFU/ML||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|UNEXPECTED ODOR|NA|LIGHT MICROSCOPY|MDRD 5 VARIABLE FORMULA||NA|NA|Y|NA|||N|5||7||BASELINE|1970-11-24|1963-08-18|||||1970-12-08||1966-12-02|U|1967-05-30
TRIAL STUDY 134XCP|LB|D43B827C-D393-41D4-81C5-AACB1A7673A1|1||||HYDCDN|HYDROCODONE|||||||CCID 50/ML|||||||TRACE||10^9 ORGANISMS/G||||LOW|NOT DONE||||REFLEX TEAR|FRESH|NA|ELECTROCHEMILUMINESCENCE|MDRD FORMULA||Y|NA|N|Y|||N|1||38||BLINDED TREATMENT|1966-10-18|1960-04-04|||||1967-12-16||1968-02-01|U|1971-12-21
TRIAL STUDY 134XCP|LB|D43B827C-D393-41D4-81C5-AACB1A7673A1|2||||CIC|CIRCULATING IMMUNE COMPLEXES|||||||ML/S|||||||POSITIVE||BEATS/MIN||||LOW|NOT DONE||||INFRANATANT, SERUM|FROZEN|U|IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|N|N|||Y|1||38||BLINDED TREATMENT|1967-09-17|1973-08-07|||||1963-12-13||1965-02-22|NA|1964-01-05
TRIAL STUDY 134XCP|LB|D43B827C-D393-41D4-81C5-AACB1A7673A1|1||||NGF|NERVE GROWTH FACTOR|||||||GRAIN|||||||NEGATIVE||MV2/HZ||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|REFRIGERATED|N|RADIOIMMUNOPRECIPITATION ASSAY|GMI % FORMULA||Y|NA|Y|U|||N|2||58||OBSERVATION|1970-02-19|1961-08-09|||||1965-10-11||1964-01-16|Y|1971-07-25
TRIAL STUDY 134XCP|LB|D43B827C-D393-41D4-81C5-AACB1A7673A1|2||||FENA|FRACTIONAL SODIUM EXCRETION|||||||GPELISA UNIT/ML|||||||INDETERMINATE||NMOL BCE/NMOL||||HIGH|NOT DONE||||GASTRIC CONTENTS|PARAFFIN-EMBEDDED|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 6 VARIABLE FORMULA||Y|NA|N|N|||NA|2||58||BASELINE|1970-06-22|1964-10-14|||||1966-02-10||1969-05-16|U|1973-08-01
TRIAL STUDY 134XCP|LB|D43B827C-D393-41D4-81C5-AACB1A7673A1|1||||HTTPM|HUNTINGTIN PROTEIN, MUTANT|||||||OSM|||||||TRACE||MMOL/DAY||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|CONCENTRATED|NA|MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|U|U|||NA|3||39||BASELINE|1966-03-07|1972-06-04|||||1961-05-17||1967-12-14|U|1968-06-12
TRIAL STUDY 134XCP|LB|D43B827C-D393-41D4-81C5-AACB1A7673A1|2||||NITRITE|NITRITE|||||||MG/MOL|||||||INDETERMINATE||10^7 PFU||||ABNORMAL|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|U|ELLA|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|N|||N|3||39||FOLLOW-UP|1970-09-04|1960-05-03|||||1960-06-04||1970-03-15|U|1963-12-01
TRIAL STUDY 134XCP|LB|D43B827C-D393-41D4-81C5-AACB1A7673A1|1||||SLTFRNRC|SOLUBLE TRANSFERRIN RECEPTOR|||||||MEQ|||||||BORDERLINE||10^4/HPF||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|FROZEN|N|ELECTRICAL IMPEDANCE MYOGRAPHY|COCKCROFT-GAULT FORMULA||Y|U|Y|NA|||U|4||88||WASHOUT|1971-10-30|1966-10-12|||||1961-04-29||1969-04-29|N|1961-11-05
TRIAL STUDY 134XCP|LB|D43B827C-D393-41D4-81C5-AACB1A7673A1|2||||SCN|THIOCYANATE|||||||RING|||||||INVALID||10^3 CFU||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|AUTOLYZED|U|PANENDOSCOPY|NASH FIBROSURE FORMULA||U|U|Y|N|||Y|4||88||SCREENING|1966-03-29|1964-04-16|||||1961-04-30||1966-09-24|Y|1963-07-01
TRIAL STUDY 134XCP|LB|D43B827C-D393-41D4-81C5-AACB1A7673A1|1||||TRACP5B|TARTRATE-RESISTANT ACID PHOSPHATASE 5B|||||||PMOL/G|||||||BORDERLINE||G/U||||LOW|NOT DONE||||SALIVA|FROZEN|NA|DIPSTICK|MDRD FORMULA||N|U|Y|NA|||NA|5||7||BLINDED TREATMENT|1965-12-27|1972-10-28|||||1971-05-24||1966-09-03|N|1971-03-07
TRIAL STUDY 134XCP|LB|D43B827C-D393-41D4-81C5-AACB1A7673A1|2||||CSAB|CATHEPSIN ANTIBODY|||||||MM|||||||INDETERMINATE||UGEQ||||LOW|NOT DONE||||DERMAL TISSUE|CLOTTED|NA|FLUOROSCOPY|HEPASCORE FORMULA||N|N|Y|U|||U|5||7||CONTINUATION TREATMENT|1971-04-11|1962-07-18|||||1962-06-19||1967-02-18|NA|1972-12-23
TRIAL STUDY 134XCP|LB|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|1||||ALAALB|APOLIPOPROTEIN A/APOLIPOPROTEIN B|||||||MBQ/UL|||||||TRACE||U/DL||||NORMAL|NOT DONE||||SALIVA|AGGLUTINATED|U|CORONARY ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|NA|U|||Y|1||38||OPEN LABEL TREATMENT|1964-04-13|1968-12-31|||||1972-03-04||1967-07-10|NA|1963-01-03
TRIAL STUDY 134XCP|LB|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|2||||FACTVA|FACTOR V ACTIVITY|||||||U/KG/MIN|||||||TRACE||UCI/KG||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|AUTOLYZED|NA|ENZYMATIC ULTRACENTRIFUGATION|CKD-EPI CREATININE FORMULA||Y|NA|N|U|||U|1||38||TREATMENT|1961-08-08|1970-07-28|||||1968-04-29||1960-07-30|N|1967-04-18
TRIAL STUDY 134XCP|LB|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|1||||VEGF|VASCULAR ENDOTHELIAL GROWTH FACTOR|||||||UMOL/KG/MIN|||||||NEGATIVE||RAD||||LOW|NOT DONE||||SPUTUM|LACTESCENT|U|FLOW CYTOMETRY|CKD-EPI FORMULA||Y|Y|N|Y|||N|2||58||FOLLOW-UP|1965-03-15|1960-07-05|||||1967-06-27||1965-05-21|Y|1960-11-30
TRIAL STUDY 134XCP|LB|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|2||||K|POTASSIUM|||||||BQ/ML|||||||INDETERMINATE||V/V||||NORMAL|NOT DONE||||SERUM|ICTERIC|NA|LAPAROSCOPY|CKD-EPI FORMULA||NA|N|Y|U|||U|2||58||BLINDED TREATMENT|1960-09-07|1961-02-03|||||1969-07-03||1968-09-14|Y|1966-01-31
TRIAL STUDY 134XCP|LB|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|1||||NSE|NEURON SPECIFIC ENOLASE|||||||SCM|||||||INDETERMINATE||NU/CL||||HIGH|NOT DONE||||LUNG SURFACTANT|ICTERIC|N|HPLC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|U|N|||N|3||39||OBSERVATION|1960-07-15|1970-05-12|||||1970-06-01||1973-03-31|U|1971-12-08
TRIAL STUDY 134XCP|LB|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|2||||HGBFR|HEMOGLOBIN, FREE|||||||/100 HPFS|||||||NEGATIVE||ELISA UNIT/DOSE||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|FROZEN|U|IMPULSE OSCILLOMETRY|NASH FIBROSURE FORMULA||NA|NA|U|N|||Y|3||39||LONG-TERM FOLLOW-UP|1969-03-26|1970-03-15|||||1971-08-17||1961-05-10|N|1964-12-13
TRIAL STUDY 134XCP|LB|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|1||||CONSIST|CONSISTENCY|||||||UG/MIN|||||||NEGATIVE||10^9 CFU/ML||||ABNORMAL|NOT DONE||||REFLEX TEAR|UNEXPECTED ODOR|NA|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROSIS 4 FORMULA||Y|N|N|Y|||Y|4||88||SCREENING|1960-05-15|1963-07-17|||||1967-09-02||1971-10-05|NA|1965-11-21
TRIAL STUDY 134XCP|LB|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|2||||ANISOCHR|ANISOCHROMIA|||||||MASK|||||||BORDERLINE||KG/L||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|LIPEMIC|NA|PALM METHOD|MDRD FORMULA||N|N|U|Y|||Y|4||88||OBSERVATION|1970-02-11|1964-08-26|||||1965-08-09||1969-07-28|N|1963-12-25
TRIAL STUDY 134XCP|LB|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|1||||HDL2|HDL-CHOLESTEROL SUBCLASS 2|||||||OZ EQ|||||||INDETERMINATE||BOLUS||||LOW|NOT DONE||||SPERMATOZOON|DRIED|U|FLUORESCENT SPOT TEST|GMI % FORMULA||Y|U|U|U|||U|5||7||BASELINE|1964-09-03|1962-12-01|||||1971-06-07||1971-07-27|NA|1965-07-01
TRIAL STUDY 134XCP|LB|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|2||||TNFR1B|TNF RECEPTOR 1B|||||||G/DAY|||||||TRACE||BREATHS/30S||||LOW|NOT DONE||||BILE|FRESH|N|THICK SMEAR|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|NA|N|||Y|5||7||SCREENING|1971-04-03|1964-04-23|||||1969-09-06||1960-05-19|Y|1961-01-15
TRIAL STUDY 134XCP|LB|0671FB62-42B8-4882-93ED-0E11CFE07DE9|1||||BLSTLY|LYMPHOBLASTS|||||||UG/MIN|||||||INDETERMINATE||SEC||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|HEMOLYZED|Y|DUKE INCISION METHOD|MDRD FORMULA||Y|Y|U|U|||U|1||38||CONTINUATION TREATMENT|1960-12-13|1960-11-11|||||1967-01-17||1961-04-04|NA|1971-07-13
TRIAL STUDY 134XCP|LB|0671FB62-42B8-4882-93ED-0E11CFE07DE9|2||||FLRZPM|FLURAZEPAM|||||||KM|||||||BORDERLINE||MG/M2/DAY||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CALCIFIED|U|AUSCULTATION|GMI MMOL/MOL FORMULA||N|N|Y|Y|||N|1||38||FOLLOW-UP|1967-05-22|1973-05-08|||||1966-08-12||1964-02-27|NA|1967-12-24
TRIAL STUDY 134XCP|LB|0671FB62-42B8-4882-93ED-0E11CFE07DE9|1||||VITK|VITAMIN K|||||||CL|||||||NEGATIVE||10^3 ORGANISMS/G||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|REFRIGERATED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD FORMULA||NA|N|U|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1965-12-25|1963-05-07|||||1965-10-12||1963-01-22|NA|1967-07-25
TRIAL STUDY 134XCP|LB|0671FB62-42B8-4882-93ED-0E11CFE07DE9|2||||DNA|DEOXYRIBONUCLEIC ACID|||||||UMOL/L|||||||INVALID||EID 50/ML||||ABNORMAL|NOT DONE||||CERUMEN|CONCENTRATED|NA|IMMUNORADIOMETRIC ASSAY|CKD-EPI CYSTATIN C FORMULA||U|NA|NA|N|||U|2||58||TREATMENT|1962-08-06|1968-05-07|||||1965-07-24||1966-09-09|Y|1969-06-22
TRIAL STUDY 134XCP|LB|0671FB62-42B8-4882-93ED-0E11CFE07DE9|1||||CYPHOS|PHOSPHATE CRYSTALS|||||||MOSM/L|||||||INDETERMINATE||L||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR|NA|DC SHEATH FLOW|HEPASCORE FORMULA||N|N|NA|N|||U|3||39||SCREENING|1962-04-30|1973-06-19|||||1973-04-17||1973-05-27|U|1962-01-14
TRIAL STUDY 134XCP|LB|0671FB62-42B8-4882-93ED-0E11CFE07DE9|2||||PHOSLPD|PHOSPHOLIPID|||||||LOG10 CFU/ML|||||||INVALID||CI/ML||||NORMAL|NOT DONE||||SERUM OR PLASMA|LIPEMIC|Y|PET SCAN|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|Y|Y|||U|3||39||RUN-IN|1972-10-30|1972-09-13|||||1960-11-04||1966-10-22|U|1966-04-03
TRIAL STUDY 134XCP|LB|0671FB62-42B8-4882-93ED-0E11CFE07DE9|1||||APOE4|APOLIPOPROTEIN E4|||||||IU/DAY|||||||NEGATIVE||10^9 ORGANISMS/G||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|DRIED|Y|CLINICAL EVALUATION|GMI % FORMULA||NA|U|U|NA|||U|4||88||INDUCTION TREATMENT|1962-12-28|1971-11-21|||||1968-11-01||1963-02-01|NA|1969-01-02
TRIAL STUDY 134XCP|LB|0671FB62-42B8-4882-93ED-0E11CFE07DE9|2||||MCPHGLE|MACROPHAGES/LEUKOCYTES|||||||EIA UNIT|||||||BORDERLINE||CMHG||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONCENTRATED|Y|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|Y|N|||U|4||88||OBSERVATION|1960-06-22|1965-10-09|||||1967-07-18||1969-09-28|N|1968-02-14
TRIAL STUDY 134XCP|LB|0671FB62-42B8-4882-93ED-0E11CFE07DE9|1||||ANIONG4|ANION GAP 4|||||||GY/MIN|||||||INDETERMINATE||/HPF||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|DRIED|U|ERGOSPIROMETRY|CKD-EPI CYSTATIN C FORMULA||NA|NA|N|NA|||NA|5||7||CONTINUATION TREATMENT|1971-05-06|1965-09-07|||||1961-03-09||1968-08-31|NA|1971-12-20
TRIAL STUDY 134XCP|LB|0671FB62-42B8-4882-93ED-0E11CFE07DE9|2||||CYCACAR|CALCIUM CARBONATE CRYSTALS|||||||EU|||||||NEGATIVE||G/DAY||||HIGH|NOT DONE||||SEBUM|LIPEMIC|NA|KARYOTYPING|MDRD 5 VARIABLE FORMULA||Y|U|U|Y|||N|5||7||WASHOUT|1962-11-14|1966-02-05|||||1965-06-24||1965-03-15|N|1961-11-15
TRIAL STUDY 134XCP|LB|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|1||||FIO2|FRACTION OF INSPIRED OXYGEN|||||||NG|||||||INDETERMINATE||DIP||||NORMAL|NOT DONE||||RETICULOCYTES|LIPEMIC|NA|RIA|MDRD 4 VARIABLE FORMULA||Y|Y|N|U|||N|1||38||FOLLOW-UP|1964-06-29|1972-09-07|||||1970-02-05||1968-04-02|N|1965-04-14
TRIAL STUDY 134XCP|LB|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|2||||EPINSQE|EPI CELLS/NON-SQUAM EPI CELLS|||||||EJACULATE U|||||||POSITIVE||DEG/MM||||NORMAL|NOT DONE||||LEUKOCYTE|ROOM TEMPERATURE|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|HEPASCORE FORMULA||U|Y|U|Y|||N|1||38||TREATMENT|1964-08-05|1968-06-11|||||1964-11-29||1962-09-24|U|1970-11-03
TRIAL STUDY 134XCP|LB|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|1||||GLOBB1BP|BETA-1 GLOBULIN/BETA PROTEIN|||||||JAR|||||||INDETERMINATE||/7.5 ML||||HIGH|NOT DONE||||PLATELET POOR PLASMA|DRIED|Y|OLIGO ACGH|MDRD 5 VARIABLE FORMULA||Y|N|U|N|||NA|2||58||BLINDED TREATMENT|1973-07-08|1965-11-17|||||1972-05-05||1967-08-31|U|1960-03-21
TRIAL STUDY 134XCP|LB|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|2||||MPC|MEAN PLATELET COMPONENT|||||||WEBER|||||||TRACE||SCM||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|REFRIGERATED|Y|CLINICAL EVALUATION|MDRD 5 VARIABLE FORMULA||Y|Y|N|N|||NA|2||58||CONTINUATION TREATMENT|1968-08-29|1971-04-09|||||1969-02-24||1971-11-06|U|1967-08-28
TRIAL STUDY 134XCP|LB|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|1||||HLADRMSC|HLA-DR MISMATCH COUNT|||||||UKAT/10^12 RBC|||||||BORDERLINE||NKAT||||NORMAL|NOT DONE||||HAIR|ROOM TEMPERATURE|N|X-RAY FLUORESCENCE SPECTROMETRY|MDRD FORMULA||N|U|Y|NA|||Y|3||39||CONTINUATION TREATMENT|1960-02-15|1962-03-26|||||1971-11-24||1972-04-28|NA|1969-07-31
TRIAL STUDY 134XCP|LB|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|2||||RETI|RETICULOCYTES|||||||ANSON U|||||||NEGATIVE||HOURS||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|REFRIGERATED|N|ICP-MS|CKD-EPI FORMULA||N|Y|N|U|||U|3||39||OBSERVATION|1964-01-07|1961-08-28|||||1966-06-04||1968-07-06|NA|1963-03-09
TRIAL STUDY 134XCP|LB|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|1||||INULIN|INULIN|||||||10^3 RNA COPIES/ML|||||||POSITIVE||10^6/HPF||||ABNORMAL|NOT DONE||||NAIL|DRIED|U|RIA|FIBROSIS 4 FORMULA||N|U|N|U|||U|4||88||INDUCTION TREATMENT|1965-01-04|1971-02-08|||||1963-10-14||1967-01-08|N|1961-09-18
TRIAL STUDY 134XCP|LB|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|2||||C130100|MIXED ANTIGEN IGE ANTIBODY|||||||UKAT|||||||TRACE||UIU/DL||||ABNORMAL|NOT DONE||||PLATELET|SOLIDIFIED|NA|INDIA INK STAIN|MDRD 6 VARIABLE FORMULA||N|U|Y|Y|||NA|4||88||LONG-TERM FOLLOW-UP|1964-04-15|1971-07-29|||||1972-09-03||1965-04-21|Y|1961-03-28
TRIAL STUDY 134XCP|LB|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|1||||FRUCT|FRUCTOSAMINE|||||||ML/KG|||||||TRACE||KV||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|SOLIDIFIED|U|DIPSTICK|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|Y|NA|||NA|5||7||BLINDED TREATMENT|1966-10-04|1968-05-12|||||1961-04-29||1961-05-12|U|1964-07-10
TRIAL STUDY 134XCP|LB|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|2||||LYMCLF|LYMPHOCYTES, CLEFTED|||||||ML/G/MIN|||||||INVALID||DIP||||LOW|NOT DONE||||STOOL|FROZEN|NA|MAPH|MDRD 6 VARIABLE FORMULA||U|U|N|Y|||N|5||7||INDUCTION TREATMENT|1970-07-15|1972-09-08|||||1972-03-08||1967-02-28|Y|1962-08-20
TRIAL STUDY 134XCP|LB|E9161164-3B91-4855-AFBA-12C6BD93F95F|1||||RUB|RUBRICYTE|||||||MCI/KG|||||||NEGATIVE||IU/L||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|HEMOLYZED|NA|CONFOCAL MICROSCOPY|MDRD 5 VARIABLE FORMULA||NA|NA|Y|Y|||U|1||38||CONTINUATION TREATMENT|1968-02-05|1963-12-17|||||1969-12-08||1964-05-03|Y|1969-12-28
TRIAL STUDY 134XCP|LB|E9161164-3B91-4855-AFBA-12C6BD93F95F|2||||COLOR|COLOR|||||||UL|||||||NEGATIVE||MM/MIN||||ABNORMAL|NOT DONE||||BREAST MILK|NON-HEMOLYZED|U|TARGETED TRANSCRIPTOME SEQUENCING|MDRD 4 VARIABLE FORMULA||U|U|U|NA|||U|1||38||OBSERVATION|1972-09-20|1972-04-02|||||1971-11-09||1964-07-04|N|1962-02-11
TRIAL STUDY 134XCP|LB|E9161164-3B91-4855-AFBA-12C6BD93F95F|1||||LDH3LDH|LDH ISOENZYME 3/LDH|||||||PMOL/G|||||||TRACE||MCI/L||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|CONTAMINATED|U|DOUBLE IMMUNODIFFUSION|CKD-EPI CREATININE FORMULA||NA|Y|Y|U|||U|2||58||OPEN LABEL TREATMENT|1965-08-14|1970-03-08|||||1964-03-10||1960-11-29|U|1964-07-16
TRIAL STUDY 134XCP|LB|E9161164-3B91-4855-AFBA-12C6BD93F95F|2||||PLP|PYRIDOXAL PHOSPHATE|||||||TRACE|||||||INDETERMINATE||ML/100G/MIN||||NORMAL|NOT DONE||||SMEGMA|THAWED|N|JAEGER EYE CHART|COCKCROFT-GAULT FORMULA||N|U|U|NA|||U|2||58||BLINDED TREATMENT|1969-08-23|1962-07-04|||||1961-06-01||1968-06-20|U|1960-11-04
TRIAL STUDY 134XCP|LB|E9161164-3B91-4855-AFBA-12C6BD93F95F|1||||LDLOXI|OXIDIZED LDL CHOLESTEROL|||||||UG/G/DAY|||||||TRACE||/HPF||||ABNORMAL|NOT DONE||||BUFFY COAT|FROZEN|Y|TELLER ACUITY CARDS|FIBROMETER FORMULA||NA|N|U|U|||Y|3||39||TREATMENT|1965-12-16|1969-04-21|||||1965-03-13||1971-07-10|Y|1967-04-10
TRIAL STUDY 134XCP|LB|E9161164-3B91-4855-AFBA-12C6BD93F95F|2||||EPIROCE|ROUND EPITHELIAL CELLS|||||||DNA COPIES/UG|||||||NEGATIVE||PACKET||||LOW|NOT DONE||||CEREBROSPINAL FLUID|UNEXPECTED ODOR|Y|BAC ACGH|CKD-EPI FORMULA||N|N|Y|NA|||NA|3||39||SCREENING|1973-09-02|1966-05-14|||||1968-11-02||1967-09-20|NA|1968-10-22
TRIAL STUDY 134XCP|LB|E9161164-3B91-4855-AFBA-12C6BD93F95F|1||||ANGLBIND|ANTIGLOBULIN TEST, INDIRECT|||||||MEQ/DL|||||||POSITIVE||MEQ/UG||||HIGH|NOT DONE||||RETICULOCYTES|CLOTTED|U|IRON HEMATOXYLIN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|Y|NA|||Y|4||88||BASELINE|1963-09-28|1961-08-25|||||1963-05-05||1962-12-20|N|1972-01-04
TRIAL STUDY 134XCP|LB|E9161164-3B91-4855-AFBA-12C6BD93F95F|2||||CSEPIRT|RENAL TUBULAR EPITHELIAL CASTS|||||||U/M2/MIN|||||||POSITIVE||L/S/KPA||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|AGGLUTINATED|U|ICP-MS|ASH FIBROSURE FORMULA||NA|U|Y|N|||N|4||88||OBSERVATION|1968-05-28|1972-11-25|||||1961-02-14||1971-08-08|N|1962-12-17
TRIAL STUDY 134XCP|LB|E9161164-3B91-4855-AFBA-12C6BD93F95F|1||||BASOMM|BASOPHILIC METAMYELOCYTES|||||||MG/ML/MIN|||||||INDETERMINATE||WATT||||LOW|NOT DONE||||BREAST MILK|CONTAMINATED|U|SPIROMETRY|MDRD 5 VARIABLE FORMULA||Y|N|N|U|||NA|5||7||LONG-TERM FOLLOW-UP|1961-10-05|1967-10-11|||||1961-01-08||1969-04-01|Y|1968-02-12
TRIAL STUDY 134XCP|LB|E9161164-3B91-4855-AFBA-12C6BD93F95F|2||||GFRBSCUA|GFR FROM CREAT,UREAN,ALB ADJ BSA|||||||SPRAY|||||||POSITIVE||DAGU||||HIGH|NOT DONE||||AMNIOTIC FLUID|AUTOLYZED|Y|WRIGHT STAIN|MDRD 4 VARIABLE FORMULA||Y|U|U|NA|||N|5||7||SCREENING|1973-03-25|1967-10-13|||||1971-10-09||1969-07-08|NA|1969-09-17
TRIAL STUDY 134XCP|LB|FBB66C13-05F5-4337-B34A-9900EB5F50F3|1||||NEUTIM|IMMATURE NEUTROPHILS|||||||SBE/ML|||||||NEGATIVE||U/10^12 RBC||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|PARAFFIN-EMBEDDED|NA|SPECULAR MICROSCOPY|FIBROTEST FORMULA||U|U|Y|U|||N|1||38||TREATMENT|1963-06-10|1962-06-07|||||1969-07-21||1967-12-25|N|1967-04-07
TRIAL STUDY 134XCP|LB|FBB66C13-05F5-4337-B34A-9900EB5F50F3|2||||GALM|GALACTOSE MUTAROTASE|||||||MOL/ML|||||||NEGATIVE||10^4 CFU||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|CALCIFIED|Y|REFLECTANCE SPECTROSCOPY|MDRD 5 VARIABLE FORMULA||Y|N|U|Y|||U|1||38||SCREENING|1967-01-26|1966-06-04|||||1971-04-23||1962-04-13|Y|1967-12-05
TRIAL STUDY 134XCP|LB|FBB66C13-05F5-4337-B34A-9900EB5F50F3|1||||PCA3MRNA|PROSTATE CANCER ANTIGEN 3 MRNA|||||||MG/M2/H|||||||NEGATIVE||ELISA UNIT||||NORMAL|NOT DONE||||ALVEOLAR AIR|GELLED|U|ACCELERATOR MASS SPECTROMETRY|GMI MMOL/MOL FORMULA||N|N|U|NA|||Y|2||58||BLINDED TREATMENT|1970-12-27|1969-11-25|||||1963-09-29||1971-03-25|NA|1967-03-25
TRIAL STUDY 134XCP|LB|FBB66C13-05F5-4337-B34A-9900EB5F50F3|2||||MDA|3,4-METHYLENEDIOXYAMPHETAMINE|||||||MG/M2/DAY|||||||TRACE||10^9 ORGANISMS/ML||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|DRIED|NA|HIGH LEVEL AMINOGLYCOSIDE SCREEN|GMI MMOL/MOL FORMULA||NA|NA|Y|NA|||U|2||58||INDUCTION TREATMENT|1973-03-24|1967-08-03|||||1963-12-23||1969-11-26|U|1964-02-11
TRIAL STUDY 134XCP|LB|FBB66C13-05F5-4337-B34A-9900EB5F50F3|1||||TROPONI|TROPONIN I|||||||10^6 CFU|||||||INDETERMINATE||EID 50/ML||||NORMAL|NOT DONE||||AMNIOTIC FLUID|LACTESCENT|NA|SLIT LAMP|CKD-EPI FORMULA||Y|N|U|N|||N|3||39||FOLLOW-UP|1967-05-15|1963-04-26|||||1972-08-02||1971-09-13|NA|1960-05-14
TRIAL STUDY 134XCP|LB|FBB66C13-05F5-4337-B34A-9900EB5F50F3|2||||DOPAMEXR|DOPAMINE EXCRETION RATE|||||||PKAT/L|||||||NEGATIVE||UMOL/MIN||||LOW|NOT DONE||||MUCUS|CALCIFIED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||N|N|NA|N|||U|3||39||BLINDED TREATMENT|1962-06-21|1966-11-22|||||1960-12-09||1973-03-19|N|1961-02-20
TRIAL STUDY 134XCP|LB|FBB66C13-05F5-4337-B34A-9900EB5F50F3|1||||PLATGNT|GIANT PLATELETS|||||||H*%|||||||INDETERMINATE||CI/ML||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|NON-HEMOLYZED|N|KINETIC CHROMOGENIC ASSAY|HEPASCORE FORMULA||U|U|NA|NA|||NA|4||88||BLINDED TREATMENT|1972-05-26|1961-10-15|||||1972-12-21||1964-06-17|Y|1969-08-18
TRIAL STUDY 134XCP|LB|FBB66C13-05F5-4337-B34A-9900EB5F50F3|2||||C3M|COLLAGEN III NEO-PEPTIDE C3M|||||||/5X10^4 WBC|||||||NEGATIVE||FEU||||NORMAL|NOT DONE||||CAPILLARY PLASMA|THAWED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||N|NA|U|U|||NA|4||88||RUN-IN|1970-05-12|1965-09-24|||||1964-03-08||1970-08-30|N|1968-09-04
TRIAL STUDY 134XCP|LB|FBB66C13-05F5-4337-B34A-9900EB5F50F3|1||||CREATCLR|CREATININE CLEARANCE|||||||ML/M2/DAY|||||||POSITIVE||MASK||||LOW|NOT DONE||||CERUMEN|CONCENTRATED|Y|MOUSE PROTECTION ASSAY|FIBROTEST FORMULA||U|N|N|Y|||N|5||7||BLINDED TREATMENT|1966-03-05|1968-03-02|||||1962-03-30||1961-04-12|N|1968-10-16
TRIAL STUDY 134XCP|LB|FBB66C13-05F5-4337-B34A-9900EB5F50F3|2||||IL122340|INTERLEUKIN 12+23 P40|||||||MM2|||||||INDETERMINATE||FOZ_US||||HIGH|NOT DONE||||MUCUS|AGGLUTINATED|N|PH METER MEASUREMENT METHOD|FIBROSIS 4 FORMULA||N|N|NA|NA|||Y|5||7||OBSERVATION|1962-11-19|1964-09-15|||||1970-02-21||1961-10-02|Y|1963-06-27
TRIAL STUDY 134XCP|LB|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|1||||GLUCCLR|GLUCOSE CLEARANCE|||||||GENEQ|||||||INDETERMINATE||NMOL/L/MIN||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|THAWED|N|NON-CONTACT SPECULAR MICROSCOPY|FIBROTEST FORMULA||U|NA|N|Y|||Y|1||38||SCREENING|1963-03-01|1969-01-19|||||1963-12-08||1970-06-07|N|1971-02-20
TRIAL STUDY 134XCP|LB|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|2||||BLASTCE|BLASTS/TOTAL CELLS|||||||H*%|||||||INDETERMINATE||NG/MOL||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|GELLED|N|WRIGHT STAIN|MDRD 5 VARIABLE FORMULA||Y|NA|Y|NA|||Y|1||38||SCREENING|1967-12-14|1969-08-28|||||1973-04-30||1970-09-23|U|1964-06-20
TRIAL STUDY 134XCP|LB|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|1||||MIP1A|MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA|||||||L/H/M2|||||||INDETERMINATE||U/G HB||||ABNORMAL|NOT DONE||||BONE MARROW|HEMOLYZED|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|U|U|||U|2||58||OPEN LABEL TREATMENT|1971-06-13|1961-01-30|||||1961-05-31||1962-07-30|NA|1967-12-02
TRIAL STUDY 134XCP|LB|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|2||||PMDW|PLATELET MASS DISTRIBUTION WIDTH|||||||MEQ|||||||TRACE||ARBITRARY U||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|FRESH|N|SPIROMETRY|GMI MMOL/MOL FORMULA||Y|N|N|U|||N|2||58||CONTINUATION TREATMENT|1962-07-04|1969-07-01|||||1963-04-18||1969-01-08|NA|1965-10-09
TRIAL STUDY 134XCP|LB|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|1||||APPB|AMYLOID BETA PRECURSOR PROTEIN|||||||SQU/ML|||||||INDETERMINATE||MASK||||HIGH|NOT DONE||||SOFT TISSUE|SOLIDIFIED|Y|FLUORESCENT SPOT TEST|ASH FIBROSURE FORMULA||N|U|Y|U|||N|3||39||BLINDED TREATMENT|1960-11-16|1970-10-16|||||1965-08-19||1964-05-29|Y|1968-02-28
TRIAL STUDY 134XCP|LB|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|2||||PLTMORPH|PLATELET MORPHOLOGY|||||||TUBERCULIN UNIT|||||||INDETERMINATE||TESLA||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|SOLIDIFIED|N|THIN SMEAR|FIBROSIS 4 FORMULA||N|U|U|U|||N|3||39||CONTINUATION TREATMENT|1971-06-09|1960-06-25|||||1967-03-28||1960-09-13|U|1967-06-28
TRIAL STUDY 134XCP|LB|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|1||||TFRRNSAT|TRANSFERRIN SATURATION|||||||FIU|||||||INDETERMINATE||MMOL/L||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|THAWED|NA|PHASE-CONTRAST MRI|MDRD 6 VARIABLE FORMULA||N|N|Y|NA|||Y|4||88||CONTINUATION TREATMENT|1969-12-03|1960-10-24|||||1966-10-22||1968-04-04|N|1967-03-07
TRIAL STUDY 134XCP|LB|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|2||||PLATSAT|PLATELET SATELLITISM|||||||M/SEC|||||||NEGATIVE||L/DAY||||ABNORMAL|NOT DONE||||EMESIS|REFRIGERATED|N|SINGLE-SLICE SPIRAL CT|ASH FIBROSURE FORMULA||U|Y|U|N|||N|4||88||RUN-IN|1968-01-13|1968-12-20|||||1967-10-23||1965-05-25|NA|1967-09-03
TRIAL STUDY 134XCP|LB|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|1||||PICP|PROCOLLAGEN TYPE I CARBOXY TERM PEPTIDE|||||||BOWL|||||||NEGATIVE||APL U||||ABNORMAL|NOT DONE||||STOOL|NON-HEMOLYZED|U|WHOLE EXOME SEQUENCING|COCKCROFT-GAULT FORMULA||N|NA|U|Y|||N|5||7||LONG-TERM FOLLOW-UP|1968-02-01|1972-04-12|||||1966-12-27||1970-12-16|U|1968-04-23
TRIAL STUDY 134XCP|LB|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|2||||AMYLB38|AMYLOID BETA 1-38|||||||P|||||||BORDERLINE||BOWL||||HIGH|NOT DONE||||PROSTATIC FLUID|HEMOLYZED|NA|CLOT DETECTION|MDRD ENZYMATIC FORMULA||NA|U|Y|NA|||N|5||7||BASELINE|1967-11-27|1971-10-21|||||1966-07-08||1961-01-14|Y|1969-06-04
TRIAL STUDY 134XCP|LB|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|1||||C130142|GERMAN COCKROACH ANTIGEN IGG ANTIBODY|||||||MG/KG/H|||||||INVALID||DAYS/WK||||HIGH|NOT DONE||||SPERMATOZOON|DRIED|NA|JAFFE REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|U|||U|1||38||FOLLOW-UP|1971-01-05|1970-02-20|||||1970-07-24||1967-04-21|NA|1964-02-20
TRIAL STUDY 134XCP|LB|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|2||||DRVVTSCR|DRVVT SCREEN TO CONFIRM RATIO|||||||ML*CMH2O|||||||BORDERLINE||WEBER||||HIGH|NOT DONE||||HAIR FOLLICLE|GELLED|Y|PATHOLOGICAL EVALUATION|FIBROSIS 4 FORMULA||Y|Y|Y|Y|||Y|1||38||INDUCTION TREATMENT|1972-03-27|1968-11-05|||||1969-11-11||1968-06-17|N|1965-03-13
TRIAL STUDY 134XCP|LB|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|1||||LEIMLE|IMMATURE LEUKOCYTES/LEUKOCYTES|||||||/LPF|||||||NEGATIVE||TUBERCULIN UNIT||||NORMAL|NOT DONE||||EXPIRED AIR|FROZEN|Y|EEG|CKD-EPI CREATININE FORMULA||U|U|NA|N|||NA|2||58||LONG-TERM FOLLOW-UP|1960-06-02|1965-02-21|||||1968-08-02||1970-01-08|U|1973-08-31
TRIAL STUDY 134XCP|LB|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|2||||AMPHET|AMPHETAMINE|||||||MU|||||||BORDERLINE||/5X10^4 WBC||||ABNORMAL|NOT DONE||||TUMOR TISSUE|CONTAMINATED|U|WRIGHT STAIN|COCKCROFT-GAULT FORMULA||Y|N|U|Y|||U|2||58||TREATMENT|1961-12-05|1963-12-02|||||1963-08-14||1964-04-12|NA|1971-04-18
TRIAL STUDY 134XCP|LB|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|1||||NOREPEXR|NOREPINEPHRINE EXCRETION RATE|||||||BREATHS/30S|||||||INDETERMINATE||U/G||||HIGH|NOT DONE||||INFRANATANT, SERUM|ICTERIC|N|X-RAY|FIBROMETER FORMULA||Y|NA|U|U|||NA|3||39||SCREENING|1969-03-01|1966-10-17|||||1963-10-11||1970-09-12|U|1967-02-09
TRIAL STUDY 134XCP|LB|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|2||||GLUCEXR|GLUCOSE EXCRETION RATE|||||||MOL|||||||BORDERLINE||UG/DL||||NORMAL|NOT DONE||||BILE|GELLED|Y|LAPAROSCOPY|COCKCROFT-GAULT FORMULA||U|NA|Y|Y|||Y|3||39||OBSERVATION|1973-02-10|1972-09-17|||||1963-07-18||1970-11-13|NA|1972-03-23
TRIAL STUDY 134XCP|LB|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|1||||C165894|D. FARINAE ANTIGEN IGG4 ANTIBODY|||||||COULOMB|||||||INVALID||CY/CM||||ABNORMAL|NOT DONE||||SOFT TISSUE|HEMOLYZED|NA|INDIRECT IMMUNOFLUORESCENCE|MDRD ENZYMATIC FORMULA||NA|Y|N|Y|||N|4||88||BLINDED TREATMENT|1969-07-30|1969-02-06|||||1967-12-18||1970-07-07|Y|1968-02-29
TRIAL STUDY 134XCP|LB|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|2||||INTLK19|INTERLEUKIN 19|||||||10^3 RNA COPIES/ML|||||||NEGATIVE||MG/ML/DAY||||NORMAL|NOT DONE||||GASTRIC FLUID|UNEXPECTED ODOR|U|DUCTOGRAPHY|COCKCROFT-GAULT FORMULA||NA|NA|Y|N|||N|4||88||WASHOUT|1964-07-02|1967-03-02|||||1969-10-20||1972-11-23|Y|1965-05-15
TRIAL STUDY 134XCP|LB|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|1||||CD22|CD22|||||||BOTTLE|||||||POSITIVE||ML||||HIGH|NOT DONE||||ISOLATE|DRIED|N|MULTI-SLICE SPIRAL CT|MDRD 6 VARIABLE FORMULA||NA|U|Y|U|||N|5||7||TREATMENT|1969-07-08|1960-10-05|||||1967-12-12||1961-12-20|Y|1963-11-05
TRIAL STUDY 134XCP|LB|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|2||||CYP2C9|CYTOCHROME P450 2C9|||||||MEQ/G|||||||POSITIVE||USIEMENS||||HIGH|NOT DONE||||PROSTATIC FLUID|GELLED|NA|KLEIHAUER-BETKE|CKD-EPI FORMULA||N|Y|NA|U|||U|5||7||BLINDED TREATMENT|1965-08-28|1962-07-04|||||1969-04-12||1973-02-18|U|1972-06-10
TRIAL STUDY 134XCP|LB|21223189-5527-4B3F-AFD5-21F77AC0DEBE|1||||GRANSGCE|GRANULOCYTES SEGMENTED/TOTAL CELLS|||||||UG/G/H|||||||NEGATIVE||IU/KG/H||||ABNORMAL|NOT DONE||||EXPIRED AIR|GELLED|NA|SURFACE PLASMON RESONANCE|GMI % FORMULA||N|N|Y|NA|||Y|1||38||CONTINUATION TREATMENT|1968-03-25|1966-04-02|||||1967-05-11||1967-09-05|N|1961-09-27
TRIAL STUDY 134XCP|LB|21223189-5527-4B3F-AFD5-21F77AC0DEBE|2||||COCAINE|COCAINE|||||||/MM2|||||||INVALID||PMOL/10^10 CELLS||||NORMAL|NOT DONE||||CALCULUS|HEMOLYZED|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|NA|||N|1||38||OPEN LABEL TREATMENT|1967-09-21|1961-03-01|||||1960-03-21||1972-07-22|U|1961-12-29
TRIAL STUDY 134XCP|LB|21223189-5527-4B3F-AFD5-21F77AC0DEBE|1||||CSMIX|MIXED CASTS|||||||SFC/10^6 PBMC|||||||POSITIVE||MKAT||||HIGH|NOT DONE||||RETICULOCYTES|HEMOLYZED|NA|PERCUSSION|GMI % FORMULA||N|Y|U|N|||U|2||58||RUN-IN|1964-06-26|1973-02-02|||||1967-06-24||1963-09-15|Y|1962-11-11
TRIAL STUDY 134XCP|LB|21223189-5527-4B3F-AFD5-21F77AC0DEBE|2||||HDWR|RET HEMOGLOBIN DISTRIBUTION WIDTH|||||||%(W/V)|||||||BORDERLINE||MG/CM2||||HIGH|NOT DONE||||VITREOUS HUMOR|FROZEN|Y|ENZYMATIC COLORIMETRY|GMI MMOL/MOL FORMULA||U|N|N|Y|||N|2||58||BASELINE|1963-01-30|1972-01-08|||||1968-09-02||1961-11-12|N|1969-12-13
TRIAL STUDY 134XCP|LB|21223189-5527-4B3F-AFD5-21F77AC0DEBE|1||||C3ADARG|COMPLEMENT C3A DESARG|||||||UMOL/H/MMOL|||||||BORDERLINE||EIA UNIT||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|REFRIGERATED|U|WRIGHT-GIEMSA STAIN|FIBROSIS 4 FORMULA||NA|Y|Y|NA|||Y|3||39||FOLLOW-UP|1970-09-25|1964-12-21|||||1968-05-31||1969-05-25|Y|1970-11-04
TRIAL STUDY 134XCP|LB|21223189-5527-4B3F-AFD5-21F77AC0DEBE|2||||DALACRT|DELTA AMINOLEVULINATE/CREATININE|||||||NKAT/L|||||||POSITIVE||MMHG/SEC||||NORMAL|NOT DONE||||AQUEOUS HUMOR|HEMOLYZED|NA|DOPPLER ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|U|NA|||NA|3||39||FOLLOW-UP|1962-05-29|1961-11-08|||||1971-04-21||1962-09-13|NA|1968-09-24
TRIAL STUDY 134XCP|LB|21223189-5527-4B3F-AFD5-21F77AC0DEBE|1||||COLOR|COLOR|||||||GRAVITATIONAL UNIT|||||||INDETERMINATE||EVENTS||||HIGH|NOT DONE||||STOOL|CALCIFIED|NA|PET/MRI SCAN|GMI MMOL/MOL FORMULA||N|Y|U|Y|||NA|4||88||RUN-IN|1961-07-17|1966-11-06|||||1970-11-12||1965-08-24|Y|1963-08-13
TRIAL STUDY 134XCP|LB|21223189-5527-4B3F-AFD5-21F77AC0DEBE|2||||NAGASE|N-ACETYL-BETA-D-GLUCOSAMINIDASE|||||||MOL/ML|||||||TRACE||MG/M2||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|SOLIDIFIED|N|POTENTIOMETRY|GMI % FORMULA||N|N|N|U|||NA|4||88||INDUCTION TREATMENT|1965-09-12|1962-07-25|||||1960-04-05||1965-01-17|NA|1967-02-08
TRIAL STUDY 134XCP|LB|21223189-5527-4B3F-AFD5-21F77AC0DEBE|1||||CSEPI846|AGGRECAN CHONDROITIN SULFATE EPITOPE 846|||||||MMU/ML|||||||TRACE||10^7 TCID 50/DOSE||||LOW|NOT DONE||||SKIN TISSUE|UNEXPECTED ODOR|Y|FLUORIMETRY|FIBROMETER FORMULA||N|N|Y|N|||N|5||7||BASELINE|1960-01-16|1968-01-12|||||1964-09-18||1963-06-01|Y|1962-06-23
TRIAL STUDY 134XCP|LB|21223189-5527-4B3F-AFD5-21F77AC0DEBE|2||||MONOIM|IMMATURE MONOCYTES|||||||MV2/HZ|||||||INDETERMINATE||MPS U||||ABNORMAL|NOT DONE||||REFLEX TEAR|NON-HEMOLYZED|Y|CAPILLARY ELECTROPHORESIS|CKD-EPI CREATININE FORMULA||Y|NA|NA|U|||N|5||7||LONG-TERM FOLLOW-UP|1970-12-08|1963-11-09|||||1972-05-04||1969-02-13|U|1967-07-28
TRIAL STUDY 134XCP|LB|CA6ECC17-3E3B-435C-A485-8612C267E52B|1||||UROBIL|UROBILINOGEN|||||||BAU/ML|||||||INVALID||MOL||||ABNORMAL|NOT DONE||||SMEGMA|CLOTTED|Y|FLUORESCENCE ANGIOGRAPHY|FIBROTEST FORMULA||Y|NA|Y|U|||NA|1||38||CONTINUATION TREATMENT|1972-06-20|1962-04-03|||||1966-07-08||1967-03-16|U|1970-06-20
TRIAL STUDY 134XCP|LB|CA6ECC17-3E3B-435C-A485-8612C267E52B|2||||KLHIGMAB|KEYHOLE LIMPET HEMOCYANIN IGM ANTIBODY|||||||LB|||||||POSITIVE||SUPPOSITORY||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|REFRIGERATED|Y|WRIGHT STAIN|MDRD FORMULA||U|NA|N|NA|||U|1||38||LONG-TERM FOLLOW-UP|1973-05-19|1971-01-28|||||1962-03-05||1971-02-15|N|1971-12-24
TRIAL STUDY 134XCP|LB|CA6ECC17-3E3B-435C-A485-8612C267E52B|1||||C130131|DOG DANDER ANTIGEN IGG4 ANTIBODY|||||||JDF UNIT|||||||INDETERMINATE||KG/CM2||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|NA|CHROMATOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|Y|U|U|||Y|2||58||OPEN LABEL TREATMENT|1963-03-27|1964-05-22|||||1960-05-31||1968-07-02|N|1962-10-13
TRIAL STUDY 134XCP|LB|CA6ECC17-3E3B-435C-A485-8612C267E52B|2||||YEASTHYP|YEAST HYPHAE|||||||10^3 DNA COPIES/ML|||||||POSITIVE||BLOCKS||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR|U|LASER CAPTURE MICRODISSECTION|MDRD ENZYMATIC FORMULA||N|U|Y|N|||Y|2||58||LONG-TERM FOLLOW-UP|1970-04-16|1969-03-07|||||1964-01-01||1970-06-04|Y|1960-08-07
TRIAL STUDY 134XCP|LB|CA6ECC17-3E3B-435C-A485-8612C267E52B|1||||CD23|CD23|||||||10^3 ORGANISMS/G|||||||TRACE||M3||||HIGH|NOT DONE||||ALVEOLAR AIR|THAWED|N|ANALYTICAL ULTRACENTRIFUGATION|FIBROSIS 4 FORMULA||U|NA|Y|Y|||N|3||39||FOLLOW-UP|1968-03-05|1970-12-10|||||1971-11-20||1964-10-02|U|1963-08-19
TRIAL STUDY 134XCP|LB|CA6ECC17-3E3B-435C-A485-8612C267E52B|2||||JO1AB|JO-1 ANTIBODY|||||||/VF|||||||POSITIVE||ELISA UNIT/ML||||HIGH|NOT DONE||||BILE|CONTAMINATED|U|IVY INCISION METHOD|MDRD 6 VARIABLE FORMULA||NA|U|U|N|||U|3||39||BLINDED TREATMENT|1967-04-28|1972-02-28|||||1969-11-24||1968-07-11|Y|1961-07-03
TRIAL STUDY 134XCP|LB|CA6ECC17-3E3B-435C-A485-8612C267E52B|1||||MPXI|MYELOPEROXIDASE INDEX|||||||WAFER|||||||TRACE||MPH||||ABNORMAL|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|NA|JAEGER EYE CHART|GMI MMOL/MOL FORMULA||NA|U|N|Y|||NA|4||88||TREATMENT|1972-06-30|1970-03-03|||||1967-08-27||1971-12-11|N|1964-07-31
TRIAL STUDY 134XCP|LB|CA6ECC17-3E3B-435C-A485-8612C267E52B|2||||GSTY1|GLUTATHIONE S-TRANSFERASE, Y1|||||||MSEC|||||||TRACE||ML/CAGE/WK||||NORMAL|NOT DONE||||PLEURAL TISSUE|REFRIGERATED|NA|WHOLE TRANSCRIPTOME SEQUENCING|MDRD 5 VARIABLE FORMULA||NA|Y|Y|NA|||Y|4||88||SCREENING|1967-12-06|1964-12-08|||||1972-07-16||1967-02-05|U|1962-04-01
TRIAL STUDY 134XCP|LB|CA6ECC17-3E3B-435C-A485-8612C267E52B|1||||C130121|SHELLFISH MIX ANTIGEN IGG ANTIBODY|||||||10^7 CFU|||||||NEGATIVE||BQ/UL||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|FRESH|U|ENDPOINT DILUTION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|U|NA|||NA|5||7||OBSERVATION|1961-08-31|1962-06-02|||||1963-03-20||1962-11-21|NA|1965-11-06
TRIAL STUDY 134XCP|LB|CA6ECC17-3E3B-435C-A485-8612C267E52B|2||||AMCRMRNA|AMACR MRNA|||||||MG/ML/DAY|||||||NEGATIVE||ROENTGEN||||HIGH|NOT DONE||||BILE|SOLIDIFIED|NA|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA||N|NA|Y|U|||NA|5||7||OPEN LABEL TREATMENT|1967-06-28|1968-11-10|||||1965-05-17||1969-05-16|U|1962-11-13
TRIAL STUDY 134XCP|LB|BCB41507-87B3-4773-B1E5-AE039853DED0|1||||RBCDIPOP|DIMORPHIC ERYTHROCYTE POPULATION|||||||CM|||||||POSITIVE||ELISA UNIT/DOSE||||HIGH|NOT DONE||||AQUEOUS HUMOR|SOLIDIFIED|Y|IMMUNOBLOT|CKD-EPI CREATININE FORMULA||Y|Y|Y|NA|||N|1||38||OBSERVATION|1963-11-20|1964-02-17|||||1969-07-24||1972-01-22|NA|1970-12-13
TRIAL STUDY 134XCP|LB|BCB41507-87B3-4773-B1E5-AE039853DED0|2||||TSIAC|TSI ACTUAL/CONTROL|||||||MPA|||||||INVALID||UMOL/L/SEC||||LOW|NOT DONE||||BONE|AUTOLYZED|NA|DIGITAL PCR|MDRD FORMULA||N|NA|Y|Y|||U|1||38||SCREENING|1960-05-08|1968-02-18|||||1971-09-13||1972-08-24|NA|1971-06-12
TRIAL STUDY 134XCP|LB|BCB41507-87B3-4773-B1E5-AE039853DED0|1||||LDL|LDL CHOLESTEROL|||||||UG/L|||||||NEGATIVE||KCAL||||ABNORMAL|NOT DONE||||SOFT TISSUE|FROZEN|NA|WESTERN BLOT|COCKCROFT-GAULT FORMULA||N|N|Y|N|||U|2||58||WASHOUT|1965-01-28|1963-07-11|||||1966-03-15||1961-07-12|N|1965-05-30
TRIAL STUDY 134XCP|LB|BCB41507-87B3-4773-B1E5-AE039853DED0|2||||SIXMAM|6-MONOACETYLMORPHINE|||||||BEAM BREAKS|||||||NEGATIVE||PUFF||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|DRIED|N|KARYOTYPING|FIBROSIS 4 FORMULA||U|Y|N|N|||N|2||58||LONG-TERM FOLLOW-UP|1963-11-25|1967-08-23|||||1965-11-14||1972-03-09|U|1966-02-01
TRIAL STUDY 134XCP|LB|BCB41507-87B3-4773-B1E5-AE039853DED0|1||||FUNGI|FUNGI|||||||CI/L|||||||BORDERLINE||MPL U/ML||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|THAWED|U|NEXT GENERATION SEQUENCING|NASH FIBROSURE FORMULA||U|U|N|N|||NA|3||39||BASELINE|1962-07-19|1970-03-13|||||1972-06-30||1965-06-15|N|1966-12-07
TRIAL STUDY 134XCP|LB|BCB41507-87B3-4773-B1E5-AE039853DED0|2||||T4|THYROXINE|||||||G/CAGE|||||||POSITIVE||FEU||||NORMAL|NOT DONE||||DIALYSIS FLUID|DRIED|N|OPTICAL COHERENCE TOMOGRAPHY|MDRD FORMULA||Y|U|NA|NA|||U|3||39||OPEN LABEL TREATMENT|1969-03-06|1969-10-05|||||1964-07-03||1972-08-17|N|1965-05-10
TRIAL STUDY 134XCP|LB|BCB41507-87B3-4773-B1E5-AE039853DED0|1||||HCT|HEMATOCRIT|||||||RING|||||||INDETERMINATE||FT2||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|N|CLIP|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|N|Y|||N|4||88||RUN-IN|1960-04-06|1961-04-08|||||1970-08-22||1961-01-11|NA|1969-03-28
TRIAL STUDY 134XCP|LB|BCB41507-87B3-4773-B1E5-AE039853DED0|2||||PAF|PLATELET ACTIVATING FACTOR|||||||S^-1(%O2)^-1|||||||BORDERLINE||TSP EQ||||NORMAL|NOT DONE||||HAIR FOLLICLE|HEMOLYZED|N|CALIPER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA||NA|NA|N|Y|||U|4||88||BASELINE|1964-11-30|1970-12-09|||||1966-06-28||1961-09-21|NA|1970-12-18
TRIAL STUDY 134XCP|LB|BCB41507-87B3-4773-B1E5-AE039853DED0|1||||MUG|MURINOGLOBULIN|||||||FT3|||||||TRACE||V||||HIGH|NOT DONE||||MUSCLE TISSUE|HEMOLYZED|NA|ENZYMATIC COLORIMETRY|CKD-EPI CYSTATIN C FORMULA||U|Y|N|N|||NA|5||7||BLINDED TREATMENT|1963-03-14|1960-10-29|||||1965-03-08||1964-04-13|Y|1971-01-25
TRIAL STUDY 134XCP|LB|BCB41507-87B3-4773-B1E5-AE039853DED0|2||||ANUAB|ANTI-NUCLEOSOME ANTIBODY|||||||VP/DOSE|||||||INVALID||GPL U/ML||||LOW|NOT DONE||||SOFT TISSUE|REFRIGERATED|U|TOLUIDINE BLUE STAIN|MDRD FORMULA||U|N|NA|U|||U|5||7||RUN-IN|1969-07-03|1967-04-13|||||1961-05-30||1970-03-16|U|1972-11-29
TRIAL STUDY 134XCP|LB|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|1||||FACTIXA|FACTOR IX ACTIVITY|||||||CY/CM|||||||BORDERLINE||/MIN||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|ASH FIBROSURE FORMULA||N|NA|U|U|||U|1||38||OBSERVATION|1970-09-10|1970-03-31|||||1961-09-17||1962-03-22|NA|1972-07-23
TRIAL STUDY 134XCP|LB|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|2||||ANGTNS2|ANGIOTENSIN II|||||||MASK|||||||NEGATIVE||TRANSDUCING UNIT||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|NA|RADIOIMMUNOPRECIPITATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|NA|N|||Y|1||38||RUN-IN|1963-09-04|1968-12-12|||||1962-02-11||1973-01-15|U|1963-07-01
TRIAL STUDY 134XCP|LB|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|1||||NOREPIN|NOREPINEPHRINE|||||||10^6 RNA COPIES/ML|||||||BORDERLINE||MEQ/ML||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|SOLIDIFIED|U|PHASE-CONTRAST MRI|ASH FIBROSURE FORMULA||N|Y|NA|Y|||N|2||58||OPEN LABEL TREATMENT|1967-12-14|1961-10-02|||||1962-03-22||1963-09-07|U|1968-01-17
TRIAL STUDY 134XCP|LB|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|2||||KLOTHO|KLOTHO|||||||%|||||||INVALID||SCOOPFUL||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|FRESH|N|CLAUSS METHOD|COCKCROFT-GAULT FORMULA||N|U|NA|N|||Y|2||58||OPEN LABEL TREATMENT|1973-03-17|1973-08-17|||||1964-11-16||1972-12-09|Y|1963-02-20
TRIAL STUDY 134XCP|LB|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|1||||CTC|CIRCULATING TUMOR CELLS|||||||BOWL|||||||INVALID||L/KG||||LOW|NOT DONE||||BONE|CONCENTRATED|Y|WHOLE EXOME SEQUENCING|COCKCROFT-GAULT FORMULA||U|U|N|NA|||N|3||39||TREATMENT|1965-10-14|1964-04-12|||||1968-09-01||1963-08-20|U|1973-07-26
TRIAL STUDY 134XCP|LB|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|2||||SER|SERINE|||||||NMOL/DAY|||||||INDETERMINATE||RATIO||||HIGH|NOT DONE||||ARTERIAL BLOOD|DRIED|NA|KINETIC MICROPARTICLE IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|U|Y|||NA|3||39||BLINDED TREATMENT|1973-03-14|1969-09-04|||||1969-07-13||1961-04-19|NA|1965-06-17
TRIAL STUDY 134XCP|LB|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|1||||TROPONI|TROPONIN I|||||||OI50|||||||BORDERLINE||UG/MIN||||HIGH|NOT DONE||||PERSPIRATION|FRESH|Y|IMMUNOFIXATION ELECTROPHORESIS|CKD-EPI CYSTATIN C FORMULA||NA|Y|U|U|||Y|4||88||OBSERVATION|1970-09-02|1967-09-18|||||1970-07-20||1972-11-16|NA|1967-01-03
TRIAL STUDY 134XCP|LB|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|2||||BETAINES|BETAINES|||||||ABSORBANCE U|||||||POSITIVE||L/DAY||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|CLOTTED|U|AMSLER GRID|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|U|U|||NA|4||88||FOLLOW-UP|1971-12-22|1966-05-05|||||1960-05-17||1973-05-08|NA|1967-04-26
TRIAL STUDY 134XCP|LB|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|1||||CLCTONN|CALCITONIN|||||||MG/KG/WEEK|||||||NEGATIVE||MEQ/ML||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|AUTOLYZED|N|MAMMOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|NA|N|||NA|5||7||SCREENING|1968-02-25|1967-06-25|||||1962-02-10||1969-05-05|N|1965-04-09
TRIAL STUDY 134XCP|LB|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|2||||EGFR|EPIDERMAL GROWTH FACTOR RECEPTOR|||||||V|||||||INDETERMINATE||RPM||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|HEMOLYZED|NA|MICRODENSITOMETRY|COCKCROFT-GAULT FORMULA||N|U|NA|N|||U|5||7||OPEN LABEL TREATMENT|1961-08-23|1963-02-28|||||1973-05-07||1960-11-25|NA|1972-02-09
TRIAL STUDY 134XCP|LB|EC726B09-0B0F-4933-94F4-8941DF68EDE6|1||||MERCECE|MATURING ERYTHROID CELLS/TOTAL CELLS|||||||UG/DAY|||||||NEGATIVE||TCID 50/DOSE||||ABNORMAL|NOT DONE||||CERUMEN|AGGLUTINATED|Y|PALM METHOD|MDRD 4 VARIABLE FORMULA||U|NA|N|U|||NA|1||38||TREATMENT|1971-08-18|1961-07-12|||||1961-03-31||1970-07-06|Y|1964-10-07
TRIAL STUDY 134XCP|LB|EC726B09-0B0F-4933-94F4-8941DF68EDE6|2||||EPSTI1|EPITHELIAL STROMAL INTERACTION PROTEIN 1|||||||ML/MMHG|||||||NEGATIVE||CMOL||||LOW|NOT DONE||||MECONIUM|DRIED|Y|FLOW CYTOMETRY|FIBROMETER FORMULA||NA|N|Y|N|||Y|1||38||LONG-TERM FOLLOW-UP|1963-06-10|1972-03-31|||||1962-02-19||1968-03-28|Y|1972-08-03
TRIAL STUDY 134XCP|LB|EC726B09-0B0F-4933-94F4-8941DF68EDE6|1||||INTLK9|INTERLEUKIN 9|||||||MDFI|||||||BORDERLINE||LOG10 PFU||||NORMAL|NOT DONE||||CALCULUS|SOLIDIFIED|Y|ANTIBIOTIC AGAR SCREEN|NASH FIBROSURE FORMULA||N|U|NA|NA|||N|2||58||TREATMENT|1963-09-02|1973-04-28|||||1960-11-10||1969-04-23|Y|1970-08-25
TRIAL STUDY 134XCP|LB|EC726B09-0B0F-4933-94F4-8941DF68EDE6|2||||ALP|ALKALINE PHOSPHATASE|||||||QUANTITY SUFFICIENT|||||||TRACE||U||||HIGH|NOT DONE||||MENSTRUAL BLOOD|GELLED|U|SURFACE PLASMON RESONANCE|MDRD 6 VARIABLE FORMULA||U|N|N|Y|||U|2||58||LONG-TERM FOLLOW-UP|1967-03-13|1960-09-03|||||1968-09-15||1968-11-09|Y|1973-01-14
TRIAL STUDY 134XCP|LB|EC726B09-0B0F-4933-94F4-8941DF68EDE6|1||||HASIGGAB|HUMAN ANTI-SHEEP IGG ANTIBODY|||||||10^6 IU/ML|||||||NEGATIVE||LOG10 PFU||||HIGH|NOT DONE||||SOFT TISSUE|ROOM TEMPERATURE|NA|MAGNETIC RESONANCE ANGIOGRAPHY|FIBROSIS 4 FORMULA||NA|N|Y|U|||NA|3||39||TREATMENT|1960-10-13|1963-12-21|||||1967-07-19||1966-04-19|U|1965-03-11
TRIAL STUDY 134XCP|LB|EC726B09-0B0F-4933-94F4-8941DF68EDE6|2||||FATLVIDX|FATTY LIVER INDEX|||||||UM/S|||||||NEGATIVE||UMOL/MIN||||HIGH|NOT DONE||||CERUMEN|HEMOLYZED|NA|MACRO BROTH DILUTION|COCKCROFT-GAULT FORMULA||NA|U|U|N|||NA|3||39||BASELINE|1963-08-31|1970-12-17|||||1972-02-01||1966-02-19|N|1967-08-30
TRIAL STUDY 134XCP|LB|EC726B09-0B0F-4933-94F4-8941DF68EDE6|1||||CYCAOXA|CALCIUM OXALATE CRYSTALS|||||||MCI/L|||||||POSITIVE||MMOL||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|CLOTTED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD ENZYMATIC FORMULA||U|Y|Y|NA|||Y|4||88||SCREENING|1968-07-08|1963-07-11|||||1961-12-26||1968-03-23|N|1973-06-05
TRIAL STUDY 134XCP|LB|EC726B09-0B0F-4933-94F4-8941DF68EDE6|2||||PG|PROSTAGLANDIN|||||||PLUG|||||||INVALID||UMOL/MIN||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|NA|ELECTROMYOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|N|Y|||Y|4||88||INDUCTION TREATMENT|1968-02-28|1965-06-07|||||1969-08-16||1964-12-05|NA|1972-09-12
TRIAL STUDY 134XCP|LB|EC726B09-0B0F-4933-94F4-8941DF68EDE6|1||||VITD3|VITAMIN D3|||||||GENEQ/ML|||||||INVALID||L/H||||HIGH|NOT DONE||||SEMINAL FLUID|CONCENTRATED|NA|GC/MS/MS|MDRD 6 VARIABLE FORMULA||N|Y|Y|NA|||NA|5||7||LONG-TERM FOLLOW-UP|1970-06-09|1963-05-24|||||1961-02-17||1971-06-27|U|1960-08-15
TRIAL STUDY 134XCP|LB|EC726B09-0B0F-4933-94F4-8941DF68EDE6|2||||CSEPIR|RENAL EPITHELIAL CASTS|||||||10^5/HPF|||||||BORDERLINE||DDU||||ABNORMAL|NOT DONE||||URINE SEDIMENT|FRESH|Y|CONTRAST ENHANCED PET SCAN|MDRD ENZYMATIC FORMULA||Y|N|NA|NA|||Y|5||7||RUN-IN|1973-08-21|1972-07-30|||||1968-02-28||1968-11-21|N|1966-08-10
TRIAL STUDY 134XCP|LB|9F703096-9152-422E-AEAB-AD22F00863ED|1||||AAMBTAC|ALPHA-AMINOBUTYRIC ACID|||||||CPM|||||||INVALID||ML||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|AUTOLYZED|NA|CINEANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|U|NA|||NA|1||38||BLINDED TREATMENT|1968-05-12|1967-03-10|||||1960-12-16||1972-06-20|U|1969-07-20
TRIAL STUDY 134XCP|LB|9F703096-9152-422E-AEAB-AD22F00863ED|2||||CSWAX|WAXY CASTS|||||||MG/DAY|||||||INDETERMINATE||MPA||||LOW|NOT DONE||||INFRANATANT, PLASMA|CALCIFIED|U|COLORIMETRY|FIBROMETER FORMULA||Y|NA|N|U|||Y|1||38||OPEN LABEL TREATMENT|1969-03-26|1972-11-20|||||1966-10-15||1964-03-07|N|1960-10-04
TRIAL STUDY 134XCP|LB|9F703096-9152-422E-AEAB-AD22F00863ED|1||||C3M|COLLAGEN III NEO-PEPTIDE C3M|||||||STEPS|||||||NEGATIVE||MG/KG/DAY||||ABNORMAL|NOT DONE||||BONE MARROW|CLOTTED|U|SPIROMETRY|FIBROSIS 4 FORMULA||NA|NA|Y|U|||NA|2||58||OBSERVATION|1960-12-29|1968-06-29|||||1963-11-06||1961-04-21|Y|1963-06-23
TRIAL STUDY 134XCP|LB|9F703096-9152-422E-AEAB-AD22F00863ED|2||||HTTPM|HUNTINGTIN PROTEIN, MUTANT|||||||CAPFUL|||||||INDETERMINATE||U.CARR||||HIGH|NOT DONE||||BASAL TEAR|CLOTTED|Y|TRIPLE-PHASE SPIRAL CT SCAN|NASH FIBROSURE FORMULA||U|N|Y|NA|||U|2||58||BASELINE|1966-12-10|1970-07-10|||||1966-06-23||1964-08-28|Y|1970-06-03
TRIAL STUDY 134XCP|LB|9F703096-9152-422E-AEAB-AD22F00863ED|1||||LYMMCELY|LYMPHOMA CELLS/LYMPHOCYTES|||||||DAGU|||||||TRACE||IU/DAY||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|ROOM TEMPERATURE|NA|INTRAVASCULAR ULTRASOUND|ASH FIBROSURE FORMULA||U|NA|N|N|||U|3||39||LONG-TERM FOLLOW-UP|1960-01-31|1970-08-02|||||1967-10-28||1970-10-17|N|1963-10-07
TRIAL STUDY 134XCP|LB|9F703096-9152-422E-AEAB-AD22F00863ED|2||||IL1SR1|SOLUBLE INTERLEUKIN-1 RECEPTOR TYPE I|||||||L|||||||INVALID||CUP EQ||||LOW|NOT DONE||||PLASMA|HEMOLYZED|Y|BAC ACGH|MDRD 6 VARIABLE FORMULA||N|N|U|N|||U|3||39||TREATMENT|1964-01-09|1961-04-24|||||1969-10-14||1968-07-25|NA|1970-08-25
TRIAL STUDY 134XCP|LB|9F703096-9152-422E-AEAB-AD22F00863ED|1||||CL|CHLORIDE|||||||BQ/UL|||||||TRACE||PPTR||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|DRIED|NA|CALCOFLUOR WHITE STAIN|NASH FIBROSURE FORMULA||U|Y|Y|NA|||Y|4||88||TREATMENT|1966-12-12|1963-07-29|||||1970-09-22||1970-01-25|N|1961-05-06
TRIAL STUDY 134XCP|LB|9F703096-9152-422E-AEAB-AD22F00863ED|2||||HIST3AB|HISTONE 3 ANTIBODY|||||||NG/MOL|||||||INVALID||1/(S*KPA)||||LOW|NOT DONE||||PLATELET POOR PLASMA|FROZEN|Y|EPSILOMETER|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|U|Y|||NA|4||88||RUN-IN|1967-06-03|1973-03-19|||||1960-01-03||1969-10-20|N|1961-12-20
TRIAL STUDY 134XCP|LB|9F703096-9152-422E-AEAB-AD22F00863ED|1||||ASTCREAT|ASPARTATE AMINOTRANSFERASE/CREATININE|||||||U/DL|||||||TRACE||VG/KG||||LOW|NOT DONE||||VENOUS BLOOD|NON-HEMOLYZED|U|FLAME PHOTOMETRY|GMI % FORMULA||U|U|Y|NA|||N|5||7||OPEN LABEL TREATMENT|1969-02-23|1963-11-07|||||1969-04-16||1963-02-08|NA|1968-08-26
TRIAL STUDY 134XCP|LB|9F703096-9152-422E-AEAB-AD22F00863ED|2||||LYMMCELY|LYMPHOMA CELLS/LYMPHOCYTES|||||||TBSP|||||||NEGATIVE||MG/ANIMAL||||HIGH|NOT DONE||||TUMOR TISSUE|FROZEN|NA|CLAUSS METHOD|MDRD 5 VARIABLE FORMULA||U|N|Y|U|||N|5||7||OBSERVATION|1973-03-20|1960-01-16|||||1962-11-29||1961-01-27|U|1969-01-17
TRIAL STUDY 134XCP|LB|57455593-8872-4B17-8B3F-8A02FE855290|1||||TGFB2|TRANSFORMING GROWTH FACTOR BETA 2|||||||AMPULE|||||||INVALID||MG/ML/MIN||||LOW|NOT DONE||||URINE|HEMOLYZED|Y|MOUSE PROTECTION ASSAY|MDRD 5 VARIABLE FORMULA||N|Y|NA|NA|||Y|1||38||RUN-IN|1961-01-14|1972-09-02|||||1962-08-11||1963-06-07|N|1965-08-15
TRIAL STUDY 134XCP|LB|57455593-8872-4B17-8B3F-8A02FE855290|2||||PO2ADJT|PARTIAL PRESSURE OXYGEN ADJ FOR TEMP|||||||PLUG|||||||INVALID||COPIES/UL||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|ROOM TEMPERATURE|N|FLOCCULATION, CHARCOAL ENHANCED|FIBROSIS 4 FORMULA||NA|N|Y|U|||U|1||38||WASHOUT|1962-08-05|1968-09-06|||||1967-01-17||1971-10-15|U|1964-11-02
TRIAL STUDY 134XCP|LB|57455593-8872-4B17-8B3F-8A02FE855290|1||||HSP70|HEAT SHOCK PROTEIN 70|||||||ECL UNIT|||||||TRACE||MMU/ML||||LOW|NOT DONE||||BONE MARROW|CONCENTRATED|Y|FLUORESCEIN STAIN|COCKCROFT-GAULT FORMULA||Y|N|U|N|||Y|2||58||LONG-TERM FOLLOW-UP|1969-07-30|1971-03-24|||||1964-06-15||1962-03-06|N|1965-04-08
TRIAL STUDY 134XCP|LB|57455593-8872-4B17-8B3F-8A02FE855290|2||||CREATCLR|CREATININE CLEARANCE|||||||EVENTS|||||||NEGATIVE||U/MMOL||||ABNORMAL|NOT DONE||||MONOCYTE|UNEXPECTED ODOR|NA|TEST STRIP|MDRD ENZYMATIC FORMULA||N|Y|Y|Y|||U|2||58||BASELINE|1971-03-24|1961-12-09|||||1965-05-30||1964-03-10|N|1972-08-23
TRIAL STUDY 134XCP|LB|57455593-8872-4B17-8B3F-8A02FE855290|1||||MYCYLE|MYELOCYTES/LEUKOCYTES|||||||MMOL/MIN/KPA/L|||||||INDETERMINATE||VIAL||||NORMAL|NOT DONE||||LEUKOCYTE|NON-HEMOLYZED|Y|TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|N|N|NA|||NA|3||39||RUN-IN|1962-01-28|1969-11-26|||||1970-04-07||1972-03-31|N|1960-03-19
TRIAL STUDY 134XCP|LB|57455593-8872-4B17-8B3F-8A02FE855290|2||||OXMORPHN|OXYMORPHONE|||||||% INHIBITION|||||||BORDERLINE||CARTRIDGE||||ABNORMAL|NOT DONE||||EXUDATE|FRESH|NA|SLOAN LETTER EYE CHART 1.25%|MDRD 6 VARIABLE FORMULA||Y|Y|Y|U|||NA|3||39||BLINDED TREATMENT|1961-02-25|1968-07-17|||||1960-08-17||1967-12-19|N|1971-07-22
TRIAL STUDY 134XCP|LB|57455593-8872-4B17-8B3F-8A02FE855290|1||||VITB5|VITAMIN B5|||||||10^5/HPF|||||||INDETERMINATE||CY/CM||||HIGH|NOT DONE||||MONOCYTE|AUTOLYZED|NA|POLYGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|NA|N|||U|4||88||OPEN LABEL TREATMENT|1968-04-01|1964-08-18|||||1966-11-02||1971-07-24|U|1964-04-27
TRIAL STUDY 134XCP|LB|57455593-8872-4B17-8B3F-8A02FE855290|2||||BASOCE|BASOPHILS/TOTAL CELLS|||||||MG/L FEU|||||||BORDERLINE||MMHG*MIN/L||||LOW|NOT DONE||||SALIVA|LACTESCENT|NA|ARTERIAL SPIN LABELING FUNCTIONAL MRI|GMI % FORMULA||NA|NA|NA|U|||N|4||88||CONTINUATION TREATMENT|1960-01-09|1972-11-05|||||1965-10-26||1964-09-23|Y|1970-06-07
TRIAL STUDY 134XCP|LB|57455593-8872-4B17-8B3F-8A02FE855290|1||||PYK|PYRUVATE KINASE|||||||IN|||||||INDETERMINATE||U/ML||||LOW|NOT DONE||||EPITHELIAL CELL|GELLED|Y|PERIODIC ACID SCHIFF STAIN|ASH FIBROSURE FORMULA||U|N|U|Y|||U|5||7||SCREENING|1968-12-22|1966-03-30|||||1964-04-16||1967-10-17|Y|1960-06-28
TRIAL STUDY 134XCP|LB|57455593-8872-4B17-8B3F-8A02FE855290|2||||C147283|WHITE ELM POLLEN IGG ANTIBODY|||||||10^6 DNA COPIES/ML|||||||TRACE||MG/KG/DOSE||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|PARAFFIN-EMBEDDED|U|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|FIBROSIS 4 FORMULA||N|U|Y|NA|||Y|5||7||CONTINUATION TREATMENT|1970-04-16|1965-12-11|||||1964-09-11||1972-08-17|N|1962-07-10
TRIAL STUDY 134XCP|LB|97F58005-7367-49DC-967B-FAD681B55DF8|1||||PREALB|PREALBUMIN|||||||%(W/V)|||||||INVALID||KG/CM2||||LOW|NOT DONE||||VITREOUS HUMOR|FROZEN|NA|MAGNETIC RESONANCE ENTEROGRAPHY|GMI MMOL/MOL FORMULA||NA|Y|N|U|||Y|1||38||BASELINE|1972-11-06|1965-04-01|||||1970-08-05||1963-07-19|Y|1972-09-07
TRIAL STUDY 134XCP|LB|97F58005-7367-49DC-967B-FAD681B55DF8|2||||LDLOXAB|OXIDIZED LDL CHOLESTEROL ANTIBODY|||||||ML/G/H|||||||NEGATIVE||GLOBULE||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|DRIED|U|CLIP SEQUENCING|ASH FIBROSURE FORMULA||N|U|NA|N|||NA|1||38||OPEN LABEL TREATMENT|1964-11-16|1970-04-02|||||1963-10-25||1961-03-29|N|1966-04-05
TRIAL STUDY 134XCP|LB|97F58005-7367-49DC-967B-FAD681B55DF8|1||||PERCECE|PROLIFERATING ERYTHROID/TOTAL CELLS|||||||UL/KG/DAY|||||||INDETERMINATE||F||||LOW|NOT DONE||||COLOSTRUM|HEMOLYZED|NA|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CYSTATIN C FORMULA||Y|N|N|Y|||Y|2||58||OPEN LABEL TREATMENT|1969-10-11|1963-03-30|||||1961-01-21||1964-12-23|N|1966-09-02
TRIAL STUDY 134XCP|LB|97F58005-7367-49DC-967B-FAD681B55DF8|2||||GAD2AB|GLUTAMIC ACID DECARBOXYLASE 2 ANTIBODY|||||||K|||||||INDETERMINATE||MV||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|CALCIFIED|Y|SCANNING ELECTRON MICROSCOPY|MDRD 5 VARIABLE FORMULA||U|Y|N|Y|||NA|2||58||INDUCTION TREATMENT|1973-06-13|1962-09-24|||||1962-08-29||1970-06-19|NA|1966-02-19
TRIAL STUDY 134XCP|LB|97F58005-7367-49DC-967B-FAD681B55DF8|1||||CA2729AG|CANCER ANTIGEN 27-29|||||||KS|||||||BORDERLINE||ML/CAGE||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|NA|MICROBIAL CULTURE, SOLID|MDRD ENZYMATIC FORMULA||N|NA|NA|N|||U|3||39||SCREENING|1967-05-31|1972-08-25|||||1969-11-23||1966-11-25|N|1966-03-29
TRIAL STUDY 134XCP|LB|97F58005-7367-49DC-967B-FAD681B55DF8|2||||PKM1|PYRUVATE KINASE ISOZYME M1|||||||MCI/L|||||||INDETERMINATE||NU/CL||||LOW|NOT DONE||||LOCHIA|DRIED|Y|POTENTIOMETRY|FIBROMETER FORMULA||NA|N|N|Y|||Y|3||39||WASHOUT|1966-08-09|1961-03-16|||||1963-06-01||1964-07-15|U|1964-12-19
TRIAL STUDY 134XCP|LB|97F58005-7367-49DC-967B-FAD681B55DF8|1||||A1AGLP|ALPHA-1 ACID GLYCOPROTEIN|||||||APL U|||||||POSITIVE||AMP||||LOW|NOT DONE||||TISSUE|FROZEN|Y|MAPH|FIBROMETER FORMULA||NA|N|NA|Y|||U|4||88||LONG-TERM FOLLOW-UP|1965-04-05|1971-02-20|||||1965-07-29||1969-06-05|U|1966-09-21
TRIAL STUDY 134XCP|LB|97F58005-7367-49DC-967B-FAD681B55DF8|2||||SJSSAAB|SJOGRENS SS-A ANTIBODY|||||||CMOL|||||||BORDERLINE||CL||||LOW|NOT DONE||||TISSUE|THAWED|N|SMEAR|MDRD 5 VARIABLE FORMULA||Y|NA|Y|Y|||NA|4||88||TREATMENT|1971-11-08|1967-12-08|||||1971-10-24||1971-03-05|NA|1970-10-18
TRIAL STUDY 134XCP|LB|97F58005-7367-49DC-967B-FAD681B55DF8|1||||KRCYMGCE|MEGAKARYOCYTES/TOTAL CELLS|||||||G|||||||INDETERMINATE||SPRAY||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|AGGLUTINATED|Y|NO INFORMATION|NASH FIBROSURE FORMULA||N|N|Y|Y|||NA|5||7||BASELINE|1969-08-22|1973-02-28|||||1968-10-22||1966-10-20|U|1963-08-07
TRIAL STUDY 134XCP|LB|97F58005-7367-49DC-967B-FAD681B55DF8|2||||HGBA2HGB|HEMOGLOBIN A2/TOTAL HEMOGLOBIN|||||||MMU/ML|||||||BORDERLINE||PFU||||HIGH|NOT DONE||||CALCULUS|DRIED|N|FLOCCULATION, CHARCOAL ENHANCED|FIBROMETER FORMULA||U|NA|U|Y|||U|5||7||CONTINUATION TREATMENT|1964-06-06|1960-05-28|||||1962-04-23||1968-05-10|Y|1960-02-06
TRIAL STUDY 134XCP|LB|83AC0828-3C22-4F7C-9D22-F044BB5B630D|1||||CKMMCK|CREATINE KINASE MM/TOTAL CREATINE KINASE|||||||10^6/L|||||||INVALID||LOG10 PFU||||LOW|NOT DONE||||VENOUS CORD BLOOD|THAWED|Y|FLUORESCENT SPOT TEST|MDRD ENZYMATIC FORMULA||Y|U|U|Y|||N|1||38||TREATMENT|1966-01-03|1966-01-30|||||1971-12-12||1968-01-06|U|1962-04-12
TRIAL STUDY 134XCP|LB|83AC0828-3C22-4F7C-9D22-F044BB5B630D|2||||GST|GLUTATHIONE S-TRANSFERASE, TOTAL|||||||KG|||||||NEGATIVE||UOSM||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|AUTOLYZED|NA|ALCIAN BLUE STAIN|CKD-EPI CYSTATIN C FORMULA||N|Y|U|N|||U|1||38||OBSERVATION|1963-06-15|1971-12-16|||||1972-03-31||1972-10-02|Y|1961-12-07
TRIAL STUDY 134XCP|LB|83AC0828-3C22-4F7C-9D22-F044BB5B630D|1||||PPI|INORGANIC PYROPHOSPHATE|||||||MG/L|||||||NEGATIVE||TITER||||HIGH|NOT DONE||||MECONIUM|ICTERIC|U|CONGO RED STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|N|N|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1971-10-13|1966-11-02|||||1971-06-02||1967-04-16|NA|1972-10-23
TRIAL STUDY 134XCP|LB|83AC0828-3C22-4F7C-9D22-F044BB5B630D|2||||ANIONG3|ANION GAP 3|||||||SACHET|||||||BORDERLINE||UG/CM2||||NORMAL|NOT DONE||||PROSTATIC FLUID|PARAFFIN-EMBEDDED|Y|NUCLEIC ACID AMPLIFICATION TEST|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|N|Y|||Y|2||58||BLINDED TREATMENT|1961-04-15|1972-02-29|||||1969-01-02||1970-06-24|N|1970-12-30
TRIAL STUDY 134XCP|LB|83AC0828-3C22-4F7C-9D22-F044BB5B630D|1||||GSTMU|MU GLUTATHIONE-S-TRANSFERASE|||||||UG/CM2|||||||INDETERMINATE||NG/L||||NORMAL|NOT DONE||||CERUMEN|FRESH|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|U|U|||U|3||39||CONTINUATION TREATMENT|1968-05-05|1972-05-05|||||1966-04-17||1966-08-17|U|1962-03-11
TRIAL STUDY 134XCP|LB|83AC0828-3C22-4F7C-9D22-F044BB5B630D|2||||RETIM|MEDIUM ABSORPTION RETICULOCYTES|||||||CAN|||||||INVALID||UG||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|CALCIFIED|N|PERCUSSION|MDRD 5 VARIABLE FORMULA||U|NA|U|N|||N|3||39||RUN-IN|1969-10-25|1962-02-09|||||1966-09-21||1960-12-24|NA|1961-03-06
TRIAL STUDY 134XCP|LB|83AC0828-3C22-4F7C-9D22-F044BB5B630D|1||||CORTISOL|CORTISOL|||||||F|||||||TRACE||10^11/L||||NORMAL|NOT DONE||||LYSATE|PARAFFIN-EMBEDDED|U|REFLECTANCE SPECTROSCOPY|ASH FIBROSURE FORMULA||NA|N|Y|U|||NA|4||88||CONTINUATION TREATMENT|1971-04-09|1965-06-27|||||1972-10-02||1964-11-02|NA|1964-01-21
TRIAL STUDY 134XCP|LB|83AC0828-3C22-4F7C-9D22-F044BB5B630D|2||||HLABAGT|HLA-B ANTIGEN TYPE|||||||VP/DOSE|||||||TRACE||APS U||||ABNORMAL|NOT DONE||||SERUM|FROZEN|N|CHROMOGENIC ASSAY|MDRD 6 VARIABLE FORMULA||NA|N|U|Y|||NA|4||88||OPEN LABEL TREATMENT|1970-05-02|1972-07-05|||||1971-04-15||1963-04-23|N|1971-12-21
TRIAL STUDY 134XCP|LB|83AC0828-3C22-4F7C-9D22-F044BB5B630D|1||||PTHI|PARATHYROID HORMONE, INTACT|||||||UG/H|||||||NEGATIVE||PHERESIS UNIT||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|AUTOLYZED|Y|PET/SPECT SCAN|CKD-EPI CREATININE FORMULA||NA|U|NA|NA|||N|5||7||FOLLOW-UP|1967-10-31|1965-11-26|||||1970-01-15||1960-12-08|Y|1968-03-11
TRIAL STUDY 134XCP|LB|83AC0828-3C22-4F7C-9D22-F044BB5B630D|2||||IL2RB|INTERLEUKIN 2 RECEPTOR SUBUNIT BETA|||||||CD*S/M2|||||||INDETERMINATE||G/CAGE||||HIGH|NOT DONE||||URINE|THAWED|NA|BETA LACTAMASE|COCKCROFT-GAULT FORMULA||U|U|N|U|||Y|5||7||CONTINUATION TREATMENT|1965-01-24|1970-11-26|||||1966-09-04||1971-09-20|U|1966-05-31
TRIAL STUDY 134XCP|LB|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|1||||HIST1AB|HISTONE 1 ANTIBODY|||||||EID 50/DOSE|||||||INVALID||10^9/G||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|SOLIDIFIED|Y|PET/CT SCAN|FIBROMETER FORMULA||N|Y|NA|N|||NA|1||38||CONTINUATION TREATMENT|1962-02-12|1973-07-01|||||1971-01-29||1971-06-05|N|1964-11-05
TRIAL STUDY 134XCP|LB|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|2||||CSEPI846|AGGRECAN CHONDROITIN SULFATE EPITOPE 846|||||||VOXEL|||||||TRACE||10^3 DNA COPIES/ML||||ABNORMAL|NOT DONE||||CORD BLOOD|REFRIGERATED|Y|RADIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|NA|NA|||N|1||38||INDUCTION TREATMENT|1971-07-29|1973-08-22|||||1964-04-04||1963-06-28|N|1960-07-21
TRIAL STUDY 134XCP|LB|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|1||||CHOLHDL|CHOLESTEROL/HDL-CHOLESTEROL|||||||FEU|||||||BORDERLINE||UGEQ||||ABNORMAL|NOT DONE||||URINE SEDIMENT|SOLIDIFIED|U|LYMPHANGIOGRAPHY|CKD-EPI CREATININE FORMULA||Y|Y|Y|U|||U|2||58||BASELINE|1965-03-15|1961-09-27|||||1960-06-27||1965-08-16|N|1971-12-05
TRIAL STUDY 134XCP|LB|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|2||||FLNTRZPM|FLUNITRAZEPAM|||||||NMOL/L/H|||||||BORDERLINE||AMPULE||||LOW|NOT DONE||||SERUM OR PLASMA|SOLIDIFIED|N|SANGER SEQUENCING|ASH FIBROSURE FORMULA||Y|Y|U|U|||Y|2||58||CONTINUATION TREATMENT|1967-05-01|1970-01-02|||||1971-07-05||1970-02-23|NA|1969-09-28
TRIAL STUDY 134XCP|LB|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|1||||CYAMORPH|AMORPHOUS CRYSTALS|||||||ELISA UNIT|||||||INDETERMINATE||%||||HIGH|NOT DONE||||RETICULOCYTES|CALCIFIED|NA|SLOAN LETTER EYE CHART 2.5%|NASH FIBROSURE FORMULA||N|NA|Y|U|||Y|3||39||OPEN LABEL TREATMENT|1964-03-05|1967-10-13|||||1961-06-07||1966-02-03|Y|1972-09-22
TRIAL STUDY 134XCP|LB|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|2||||HGBMHGB|METHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||LX|||||||NEGATIVE||GBQ/G||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|NON-HEMOLYZED|Y|RULER MEASUREMENT METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|NA|NA|||N|3||39||OBSERVATION|1963-03-10|1968-10-31|||||1968-11-23||1970-10-24|Y|1968-02-03
TRIAL STUDY 134XCP|LB|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|1||||ILE|ISOLEUCINE|||||||DEG|||||||BORDERLINE||BEL||||HIGH|NOT DONE||||AQUEOUS HUMOR|PARAFFIN-EMBEDDED|Y|STRESS ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|U|Y|||U|4||88||SCREENING|1966-08-28|1973-08-22|||||1969-04-18||1971-06-19|U|1960-11-11
TRIAL STUDY 134XCP|LB|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|2||||MLATONIN|MELATONIN|||||||10^3/HPF|||||||BORDERLINE||SIEMENS||||LOW|NOT DONE||||CORD SERUM|PARAFFIN-EMBEDDED|Y|MANUAL CLOT DETECTION|MDRD FORMULA||U|NA|Y|NA|||U|4||88||OPEN LABEL TREATMENT|1967-07-01|1966-10-26|||||1965-06-19||1969-09-19|N|1967-01-05
TRIAL STUDY 134XCP|LB|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|1||||AUERRODS|AUER RODS|||||||OSM|||||||INDETERMINATE||G/DL||||NORMAL|NOT DONE||||BREAST MILK|SOLIDIFIED|NA|SECONDARY ION MASS SPECTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|NA|N|||Y|5||7||OBSERVATION|1973-09-04|1971-08-30|||||1972-09-08||1971-02-21|Y|1962-04-09
TRIAL STUDY 134XCP|LB|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|2||||CCPIGGAB|CYCLIC CITRULLINATED PEPTIDE IGG AB|||||||G/G|||||||POSITIVE||NKAT/L||||NORMAL|NOT DONE||||SOFT TISSUE|FROZEN|Y|IMMUNO-PET SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|U|||U|5||7||BASELINE|1961-12-02|1969-11-03|||||1966-11-05||1962-07-14|N|1971-04-06
TRIAL STUDY 134XCP|LB|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|1||||CD13|CD13|||||||FL|||||||INDETERMINATE||CAPFUL||||HIGH|NOT DONE||||EXPIRED AIR|LIPEMIC|NA|MUGA|MDRD ENZYMATIC FORMULA||NA|NA|U|U|||Y|1||38||BASELINE|1962-06-27|1964-05-25|||||1962-11-06||1962-11-27|U|1962-06-19
TRIAL STUDY 134XCP|LB|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|2||||MYCEMIDX|MYELOID MATURATION INDEX|||||||COPIES/UL|||||||INVALID||LOG10 CCID 50/DOSE||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|UNEXPECTED ODOR|U|MACRO BROTH DILUTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|N|U|||N|1||38||INDUCTION TREATMENT|1969-12-16|1963-06-21|||||1966-05-19||1963-07-25|Y|1961-10-19
TRIAL STUDY 134XCP|LB|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|1||||FEP|ERYTHROCYTE PROTOPORPHYRIN, FREE|||||||EQ|||||||POSITIVE||COULOMB||||ABNORMAL|NOT DONE||||CERUMEN|FROZEN|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|FIBROSIS 4 FORMULA||U|U|U|N|||U|2||58||BASELINE|1963-03-27|1973-02-02|||||1968-03-01||1970-09-07|NA|1960-09-01
TRIAL STUDY 134XCP|LB|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|2||||GGTCREAT|GAMMA GLUTAMYL TRANSFERASE/CREATININE|||||||UMOL/DL|||||||NEGATIVE||10^6 ORGANISMS||||HIGH|NOT DONE||||SEMEN|FRESH|N|VENTILATION PERFUSION LUNG SCAN|FIBROTEST FORMULA||Y|Y|U|Y|||NA|2||58||BASELINE|1967-02-09|1961-03-18|||||1972-06-18||1972-05-10|NA|1972-05-10
TRIAL STUDY 134XCP|LB|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|1||||ETS|ETHYL SULFATE|||||||PELLET|||||||TRACE||UG/KG||||ABNORMAL|NOT DONE||||SEBUM|UNEXPECTED ODOR|NA|PET/MRI SCAN|HEPASCORE FORMULA||NA|NA|NA|NA|||N|3||39||TREATMENT|1968-03-17|1969-06-06|||||1960-12-20||1966-01-05|Y|1960-08-13
TRIAL STUDY 134XCP|LB|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|2||||PD1S|SOLUBLE PROGRAMMED DEATH-1|||||||APS U|||||||TRACE||PA||||NORMAL|NOT DONE||||ISOLATE|HEMOLYZED|NA|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA||N|Y|U|N|||N|3||39||SCREENING|1966-05-19|1969-01-08|||||1961-12-15||1961-09-20|NA|1962-06-28
TRIAL STUDY 134XCP|LB|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|1||||ALPBS|BONE SPECIFIC ALKALINE PHOSPHATASE|||||||CAN|||||||POSITIVE||LINEAR FT*LB||||HIGH|NOT DONE||||EMOTIONAL TEAR|HEMOLYZED|U|BALLPOINT PEN TECHNIQUE|CKD-EPI FORMULA||N|U|U|NA|||Y|4||88||CONTINUATION TREATMENT|1960-01-01|1966-01-26|||||1963-06-03||1967-11-19|NA|1967-01-19
TRIAL STUDY 134XCP|LB|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|2||||NTENS|NEUROTENSIN|||||||/500 WBC|||||||POSITIVE||RFU||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|SOLIDIFIED|Y|SICKLE CELL SOLUBILITY TEST|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|Y|U|||NA|4||88||SCREENING|1968-08-08|1969-12-06|||||1973-07-26||1964-08-06|N|1963-02-02
TRIAL STUDY 134XCP|LB|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|1||||KLK2|KALLIKREIN-2|||||||/100 HPFS|||||||BORDERLINE||UG/L/H||||HIGH|NOT DONE||||LOCHIA|FRESH|N|SNP ARRAY|NASH FIBROSURE FORMULA||Y|NA|NA|NA|||N|5||7||WASHOUT|1965-05-24|1960-01-01|||||1965-05-24||1969-05-19|NA|1971-03-15
TRIAL STUDY 134XCP|LB|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|2||||C130076|SILVER BIRCH POLLEN IGE|||||||BQ/G|||||||NEGATIVE||CD||||NORMAL|NOT DONE||||PLEURAL TISSUE|PARAFFIN-EMBEDDED|N|NEXT GENERATION SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|Y|U|||Y|5||7||WASHOUT|1972-05-04|1962-01-06|||||1960-11-25||1960-06-30|NA|1965-01-08
TRIAL STUDY 134XCP|LB|B386B813-1175-4421-9C86-F9AB597877FA|1||||ELA2PMN|NEUTROPHIL ELASTASE, POLYMORPHONUCLEAR|||||||UMOL/L/H|||||||INVALID||ML/M2||||NORMAL|NOT DONE||||DIALYSIS FLUID|HEMOLYZED|NA|HANSEL STAIN|CKD-EPI CREATININE FORMULA||Y|NA|NA|NA|||U|1||38||TREATMENT|1965-07-24|1965-01-19|||||1972-10-05||1970-08-12|NA|1969-03-14
TRIAL STUDY 134XCP|LB|B386B813-1175-4421-9C86-F9AB597877FA|2||||BLAST|BLASTS|||||||HENRY|||||||BORDERLINE||IU/KG/H||||HIGH|NOT DONE||||ARTERIAL BLOOD|SOLIDIFIED|N|KNEMOMETRY|NASH FIBROSURE FORMULA||NA|U|U|U|||N|1||38||INDUCTION TREATMENT|1972-03-22|1964-06-15|||||1973-06-12||1969-04-23|N|1970-08-24
TRIAL STUDY 134XCP|LB|B386B813-1175-4421-9C86-F9AB597877FA|1||||INTLK27|INTERLEUKIN 27|||||||DNA COPIES/UG|||||||BORDERLINE||UMOL/H/MMOL||||ABNORMAL|NOT DONE||||CERUMEN|UNEXPECTED ODOR|Y|DC SHEATH FLOW|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|Y|U|||Y|2||58||TREATMENT|1968-10-24|1971-12-31|||||1971-02-21||1961-03-31|U|1966-07-05
TRIAL STUDY 134XCP|LB|B386B813-1175-4421-9C86-F9AB597877FA|2||||SDH|SORBITOL DEHYDROGENASE|||||||U/G HB|||||||INVALID||/LPF||||LOW|NOT DONE||||PERITONEAL FLUID|REFRIGERATED|Y|CONTACT SPECULAR MICROSCOPY|MDRD FORMULA||N|U|NA|N|||NA|2||58||INDUCTION TREATMENT|1971-11-06|1970-02-13|||||1968-01-01||1962-02-27|Y|1964-11-02
TRIAL STUDY 134XCP|LB|B386B813-1175-4421-9C86-F9AB597877FA|1||||LYMATLE|LYMPHOCYTES ATYPICAL/LEUKOCYTES|||||||VOXEL|||||||INVALID||WATT||||LOW|NOT DONE||||CERUMEN|AUTOLYZED|N|AURAMINE STAIN|MDRD 6 VARIABLE FORMULA||N|U|U|Y|||Y|3||39||BLINDED TREATMENT|1960-09-22|1972-08-28|||||1963-08-23||1960-09-18|NA|1962-05-13
TRIAL STUDY 134XCP|LB|B386B813-1175-4421-9C86-F9AB597877FA|2||||WBCMORPH|LEUKOCYTE CELL MORPHOLOGY|||||||NEBULE|||||||TRACE||/LPF||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CONCENTRATED|N|CAPILLARY ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA||U|N|NA|NA|||N|3||39||OPEN LABEL TREATMENT|1966-03-02|1963-02-12|||||1963-09-07||1966-06-17|U|1973-05-21
TRIAL STUDY 134XCP|LB|B386B813-1175-4421-9C86-F9AB597877FA|1||||NPY|NEUROPEPTIDE Y|||||||NMOL|||||||BORDERLINE||10^5/L||||NORMAL|NOT DONE||||KERATINOCYTE|CONTAMINATED|N|INTRAVASCULAR ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|N|N|||N|4||88||INDUCTION TREATMENT|1963-06-30|1961-01-29|||||1968-01-20||1972-05-19|N|1960-10-19
TRIAL STUDY 134XCP|LB|B386B813-1175-4421-9C86-F9AB597877FA|2||||CCPAB|CYCLIC CITRULLINATED PEPTIDE ANTIBODY|||||||/100 HPFS|||||||BORDERLINE||MKAT||||LOW|NOT DONE||||HAIR FOLLICLE|GELLED|NA|LINE PROBE ASSAY|MDRD FORMULA||Y|NA|Y|N|||N|4||88||OPEN LABEL TREATMENT|1972-12-03|1963-04-08|||||1971-07-15||1969-04-29|NA|1972-07-18
TRIAL STUDY 134XCP|LB|B386B813-1175-4421-9C86-F9AB597877FA|1||||MONOBL|MONOBLASTS|||||||UG/G/MIN|||||||TRACE||VOXEL||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|DRIED|Y|TRYPAN BLUE STAIN|MDRD 5 VARIABLE FORMULA||N|NA|U|Y|||N|5||7||BASELINE|1960-05-06|1973-07-01|||||1973-05-23||1970-10-12|U|1961-09-25
TRIAL STUDY 134XCP|LB|B386B813-1175-4421-9C86-F9AB597877FA|2||||HALBAB|HUMAN ALBUMIN ANTIBODY|||||||PMOL/L|||||||POSITIVE||MAMP||||HIGH|NOT DONE||||ABSCESS FLUID|SOLIDIFIED|NA|HANSEL STAIN|FIBROMETER FORMULA||U|U|N|NA|||Y|5||7||BASELINE|1966-03-16|1967-06-07|||||1969-01-03||1967-06-23|U|1971-10-13
TRIAL STUDY 134XCP|LB|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|1||||CENTROAB|CENTROMERE B ANTIBODIES|||||||MMOL/L|||||||TRACE||U.CARR||||LOW|NOT DONE||||SUPERNATANT, SERUM|CALCIFIED|Y|APPLANATION TONOMETRY|GMI MMOL/MOL FORMULA||U|N|N|N|||Y|1||38||LONG-TERM FOLLOW-UP|1962-03-25|1964-01-23|||||1967-09-17||1967-11-05|Y|1962-04-27
TRIAL STUDY 134XCP|LB|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|2||||LY6E|LYMPHOCYTE ANTIGEN 6E|||||||MV2/HZ|||||||INDETERMINATE||FG||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|LACTESCENT|NA|CYSTOMETRY|MDRD FORMULA||N|NA|Y|NA|||Y|1||38||BASELINE|1961-05-28|1965-12-09|||||1969-03-04||1972-09-20|NA|1960-04-12
TRIAL STUDY 134XCP|LB|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|1||||MSPIKEPT|MONOCLONAL PROTEIN SPIKE/TOTAL PROTEIN|||||||MMAL|||||||BORDERLINE||/5X10^4 WBC||||NORMAL|NOT DONE||||SERUM OR PLASMA|LIPEMIC|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||U|NA|NA|U|||N|2||58||OPEN LABEL TREATMENT|1969-08-06|1967-04-16|||||1972-03-03||1966-05-12|NA|1972-04-05
TRIAL STUDY 134XCP|LB|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|2||||IFIT1|INTERFERON-INDUCED 56 KDA PROTEIN|||||||10^3 CFU/ML|||||||NEGATIVE||10^3 DNA COPIES/ML||||ABNORMAL|NOT DONE||||LOCHIA|PARAFFIN-EMBEDDED|U|REVERSE TRANSCRIPTASE PCR|GMI % FORMULA||NA|NA|Y|Y|||U|2||58||RUN-IN|1969-07-02|1967-03-02|||||1970-11-21||1964-10-27|NA|1973-04-15
TRIAL STUDY 134XCP|LB|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|1||||C130087|ENGLISH PLANTAIN POLLEN IGG4|||||||CM H2O|||||||INVALID||ML/CM3/MIN||||NORMAL|NOT DONE||||HAIR|FROZEN|Y|NUCLEIC ACID HYBRIDIZATION|MDRD FORMULA||NA|NA|Y|U|||Y|3||39||FOLLOW-UP|1972-07-03|1961-04-11|||||1966-07-09||1965-07-19|U|1972-04-24
TRIAL STUDY 134XCP|LB|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|2||||SIXMAM|6-MONOACETYLMORPHINE|||||||MU|||||||NEGATIVE||ABSORBANCE U||||NORMAL|NOT DONE||||BLOOD|UNEXPECTED ODOR|U|HIGH RESOLUTION MELT ANALYSIS|COCKCROFT-GAULT FORMULA||U|Y|N|Y|||Y|3||39||INDUCTION TREATMENT|1968-03-14|1960-12-19|||||1961-06-29||1969-06-28|N|1967-11-08
TRIAL STUDY 134XCP|LB|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|1||||CYDCPHOS|DICALCIUM PHOSPHATE CRYSTALS|||||||PSI|||||||NEGATIVE||KBQ/UL||||ABNORMAL|NOT DONE||||LYSATE|SOLIDIFIED|N|PET/SPECT SCAN|MDRD 4 VARIABLE FORMULA||N|Y|N|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1969-02-06|1964-02-11|||||1963-08-01||1965-10-03|NA|1971-08-26
TRIAL STUDY 134XCP|LB|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|2||||FRUCTOSE|FRUCTOSE|||||||IU/KG|||||||BORDERLINE||MG/ANIMAL||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|AUTOLYZED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||U|Y|U|N|||N|4||88||FOLLOW-UP|1969-02-27|1973-02-13|||||1969-12-27||1972-03-15|U|1967-08-17
TRIAL STUDY 134XCP|LB|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|1||||C130072|BIRCH POLLEN IGE|||||||UCI/KG|||||||NEGATIVE||10^7 PFU||||LOW|NOT DONE||||BREAST MILK|ICTERIC|N|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA||U|U|U|NA|||U|5||7||LONG-TERM FOLLOW-UP|1972-06-30|1966-09-20|||||1968-07-10||1962-02-13|U|1973-02-28
TRIAL STUDY 134XCP|LB|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|2||||BLSTMBCE|MYELOBLASTS/TOTAL CELLS|||||||L/S/KPA|||||||NEGATIVE||NCI||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|CALCIFIED|U|WESTERN BLOT|ASH FIBROSURE FORMULA||Y|N|U|Y|||NA|5||7||INDUCTION TREATMENT|1965-02-28|1965-07-28|||||1972-10-19||1973-01-17|U|1968-12-13
TRIAL STUDY 134XCP|LB|7B33775D-1DFF-49A6-820E-7981F5C16AFF|1||||INTLK26|INTERLEUKIN 26|||||||EIA UNIT|||||||POSITIVE||PIXELS/CM||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|ICTERIC|U|CONTRAST ENHANCED X-RAY|NASH FIBROSURE FORMULA||U|NA|Y|NA|||NA|1||38||RUN-IN|1970-01-03|1972-12-31|||||1967-11-13||1967-02-12|Y|1962-01-11
TRIAL STUDY 134XCP|LB|7B33775D-1DFF-49A6-820E-7981F5C16AFF|2||||HGBCHGB|HEMOGLOBIN C/TOTAL HEMOGLOBIN|||||||CI/UG|||||||INVALID||10^6 CFU/ML||||HIGH|NOT DONE||||SALIVA|CONCENTRATED|NA|DUCTOGRAPHY|GMI % FORMULA||Y|N|Y|Y|||U|1||38||BASELINE|1967-05-23|1969-05-09|||||1971-07-18||1966-07-06|N|1964-01-13
TRIAL STUDY 134XCP|LB|7B33775D-1DFF-49A6-820E-7981F5C16AFF|1||||EOSMM|EOSINOPHILIC METAMYELOCYTES|||||||10^3 ORGANISMS|||||||NEGATIVE||FT2||||HIGH|NOT DONE||||SWABBED MATERIAL|HEMOLYZED|N|ICC|FIBROSIS 4 FORMULA||NA|N|NA|NA|||N|2||58||OBSERVATION|1971-01-02|1972-05-23|||||1963-07-03||1964-06-25|Y|1961-02-18
TRIAL STUDY 134XCP|LB|7B33775D-1DFF-49A6-820E-7981F5C16AFF|2||||THR|THREONINE|||||||S^-1(%O2)^-1|||||||BORDERLINE||CCID 50/DOSE||||HIGH|NOT DONE||||HAIR FOLLICLE|CLOTTED|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|FIBROMETER FORMULA||Y|NA|N|NA|||U|2||58||OPEN LABEL TREATMENT|1961-02-02|1972-07-12|||||1964-01-01||1969-12-23|NA|1969-02-28
TRIAL STUDY 134XCP|LB|7B33775D-1DFF-49A6-820E-7981F5C16AFF|1||||CAPHOSPD|CALCIUM - PHOSPHORUS PRODUCT|||||||DDU|||||||INVALID||DROP||||NORMAL|NOT DONE||||TRANSUDATE|AUTOLYZED|U|PAP STAIN|MDRD FORMULA||NA|NA|NA|Y|||Y|3||39||TREATMENT|1970-03-24|1961-07-19|||||1960-01-29||1961-04-15|N|1967-10-17
TRIAL STUDY 134XCP|LB|7B33775D-1DFF-49A6-820E-7981F5C16AFF|2||||GAD2|GLUTAMIC ACID DECARBOXYLASE 2|||||||U/G/MIN|||||||BORDERLINE||TRACE||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|REFRIGERATED|U|SECONDARY ION MASS SPECTOMETRY|CKD-EPI CREATININE FORMULA||NA|NA|U|N|||NA|3||39||INDUCTION TREATMENT|1972-05-21|1969-05-15|||||1969-03-02||1964-09-24|N|1970-12-27
TRIAL STUDY 134XCP|LB|7B33775D-1DFF-49A6-820E-7981F5C16AFF|1||||GGTEXR|GAMMAGLUTAMYL TRANSFERASE EXCRETION RATE|||||||ANTI-XA IU|||||||INVALID||VP/ML||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|AUTOLYZED|N|PERIODIC ACID SCHIFF STAIN|MDRD 5 VARIABLE FORMULA||N|Y|U|U|||N|4||88||CONTINUATION TREATMENT|1971-12-12|1961-09-11|||||1962-04-22||1962-11-20|Y|1973-06-29
TRIAL STUDY 134XCP|LB|7B33775D-1DFF-49A6-820E-7981F5C16AFF|2||||UNSPCECE|UNSPECIFIED CELLS/TOTAL CELLS|||||||U/CL|||||||INDETERMINATE||MEQ/DAY||||ABNORMAL|NOT DONE||||DERMAL TISSUE|HEMOLYZED|Y|SECONDARY ION MASS SPECTOMETRY|NASH FIBROSURE FORMULA||N|U|NA|Y|||U|4||88||LONG-TERM FOLLOW-UP|1968-07-12|1961-04-10|||||1969-11-09||1966-01-09|NA|1969-08-31
TRIAL STUDY 134XCP|LB|7B33775D-1DFF-49A6-820E-7981F5C16AFF|1||||ATHPIDX|ATHEROGENIC INDEX OF PLASMA|||||||10^9/L|||||||BORDERLINE||CAN||||LOW|NOT DONE||||CELL PELLET|AUTOLYZED|NA|WHOLE TRANSCRIPTOME SEQUENCING|HEPASCORE FORMULA||N|N|NA|NA|||NA|5||7||CONTINUATION TREATMENT|1961-12-28|1962-05-19|||||1972-09-05||1964-04-02|Y|1972-10-26
TRIAL STUDY 134XCP|LB|7B33775D-1DFF-49A6-820E-7981F5C16AFF|2||||FGF23C|FIBROBLAST GROWTH FACTOR 23, C-TERMINAL|||||||L/MIN|||||||BORDERLINE||PMOL/10^10 CELLS||||NORMAL|NOT DONE||||EMOTIONAL TEAR|FROZEN|N|MAMMOGRAPHY|FIBROMETER FORMULA||N|N|N|U|||Y|5||7||TREATMENT|1969-02-21|1966-02-21|||||1962-05-16||1965-01-13|U|1965-07-27
TRIAL STUDY 134XCP|LB|DC48DD03-B87E-422D-A2EE-D87342260E19|1||||G6PD|GLUCOSE-6-PHOSPHATE DEHYDROGENASE|||||||GTT|||||||INVALID||UU/DL||||ABNORMAL|NOT DONE||||CELL PELLET|HEMOLYZED|U|ATOMIC ABSORPTION SPECTROMETRY|NASH FIBROSURE FORMULA||N|N|NA|U|||U|1||38||SCREENING|1961-01-07|1960-04-03|||||1965-07-18||1966-01-20|N|1970-07-05
TRIAL STUDY 134XCP|LB|DC48DD03-B87E-422D-A2EE-D87342260E19|2||||IGGCREAT|IMMUNOGLOBULIN G/CREATININE|||||||DEG/MM|||||||NEGATIVE||CM/MIN||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|SOLIDIFIED|N|RADIOGRAPHY|FIBROSIS 4 FORMULA||NA|U|N|U|||N|1||38||BLINDED TREATMENT|1962-11-08|1968-03-01|||||1969-07-29||1966-12-13|N|1973-01-24
TRIAL STUDY 134XCP|LB|DC48DD03-B87E-422D-A2EE-D87342260E19|1||||RNA|RIBONUCLEIC ACID|||||||NEBULE|||||||INVALID||ML/CAGE/DAY||||HIGH|NOT DONE||||DERMAL TISSUE|HEMOLYZED|Y|ULTRASOUND|MDRD FORMULA||U|NA|N|U|||U|2||58||BASELINE|1966-04-24|1973-02-17|||||1960-11-16||1971-11-05|Y|1961-11-08
TRIAL STUDY 134XCP|LB|DC48DD03-B87E-422D-A2EE-D87342260E19|2||||GMI|GLUCOSE MANAGEMENT INDICATOR|||||||UMOL/MIN|||||||BORDERLINE||MMHG||||ABNORMAL|NOT DONE||||BUFFY COAT|SOLIDIFIED|N|AUTOMATED COUNT|MDRD 5 VARIABLE FORMULA||U|N|N|N|||Y|2||58||SCREENING|1960-08-03|1971-02-28|||||1960-06-11||1962-11-03|NA|1965-10-02
TRIAL STUDY 134XCP|LB|DC48DD03-B87E-422D-A2EE-D87342260E19|1||||PAI1AG|PLASMINOGEN ACTIVATOR INHIBITOR-1 AG|||||||DPM|||||||BORDERLINE||MIU/L||||NORMAL|NOT DONE||||CAPILLARY BLOOD|HEMOLYZED|U|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|HEPASCORE FORMULA||NA|Y|NA|Y|||U|3||39||FOLLOW-UP|1966-04-11|1965-07-13|||||1964-03-19||1968-07-12|Y|1961-02-10
TRIAL STUDY 134XCP|LB|DC48DD03-B87E-422D-A2EE-D87342260E19|2||||TROPONI3|TROPONIN I TYPE 3|||||||L/KG|||||||INVALID||ECL UNIT||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|FRESH|NA|HEMAGGLUTINATION ASSAY|COCKCROFT-GAULT FORMULA||NA|N|U|U|||Y|3||39||LONG-TERM FOLLOW-UP|1960-05-17|1963-06-03|||||1963-05-25||1971-08-24|NA|1973-07-28
TRIAL STUDY 134XCP|LB|DC48DD03-B87E-422D-A2EE-D87342260E19|1||||INTLK12|INTERLEUKIN 12|||||||CM/MIN|||||||INDETERMINATE||/LPF||||ABNORMAL|NOT DONE||||LAVAGE FLUID|REFRIGERATED|U|INFRARED SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|Y|Y|||NA|4||88||TREATMENT|1968-03-20|1969-02-21|||||1961-11-06||1962-10-14|NA|1963-10-09
TRIAL STUDY 134XCP|LB|DC48DD03-B87E-422D-A2EE-D87342260E19|2||||BLASTIMM|IMMUNOBLASTS|||||||CCID 50/ML|||||||TRACE||TUBE||||ABNORMAL|NOT DONE||||SEMEN|AUTOLYZED|Y|FUNDUS PHOTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|NA|||U|4||88||LONG-TERM FOLLOW-UP|1971-05-01|1968-11-22|||||1961-03-13||1963-07-21|Y|1965-09-26
TRIAL STUDY 134XCP|LB|DC48DD03-B87E-422D-A2EE-D87342260E19|1||||AMBRBTL|AMOBARBITAL|||||||PNU/ML|||||||TRACE||MG/DOSE||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|ROOM TEMPERATURE|U|LC/MS/MS|FIBROTEST FORMULA||N|N|NA|Y|||N|5||7||TREATMENT|1966-10-31|1962-10-31|||||1967-12-15||1966-07-21|Y|1971-08-08
TRIAL STUDY 134XCP|LB|DC48DD03-B87E-422D-A2EE-D87342260E19|2||||VTRNCTN|VITRONECTIN|||||||10^7 CFU/ML|||||||BORDERLINE||NG/DAY||||LOW|NOT DONE||||REFLEX TEAR|CALCIFIED|NA|SPIROMETRY|FIBROTEST FORMULA||U|U|N|Y|||U|5||7||WASHOUT|1969-05-27|1960-01-03|||||1962-10-25||1973-02-12|U|1965-10-14
TRIAL STUDY 134XCP|LB|2E084441-61A3-4B8B-9050-A5D7B38CA978|1||||HIS|HISTIDINE|||||||MAMP|||||||INVALID||MMOL/L||||NORMAL|NOT DONE||||PLEURAL FLUID|FRESH|NA|QUANTITATIVE ULTRASOUND|ASH FIBROSURE FORMULA||Y|U|N|N|||U|1||38||OBSERVATION|1970-10-23|1964-08-16|||||1961-01-27||1965-03-10|Y|1964-02-26
TRIAL STUDY 134XCP|LB|2E084441-61A3-4B8B-9050-A5D7B38CA978|2||||VTD2D3IT|25-HYDROXYVIT D2 + 25-HYDROXYVIT D3|||||||MN|||||||NEGATIVE||10^6 IU||||LOW|NOT DONE||||SALIVA|AUTOLYZED|N|OPTICAL COHERENCE TOMOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|N|N|N|||U|1||38||FOLLOW-UP|1962-03-23|1965-01-19|||||1971-12-02||1973-07-14|Y|1962-08-25
TRIAL STUDY 134XCP|LB|2E084441-61A3-4B8B-9050-A5D7B38CA978|1||||ADP|ADENOSINE DIPHOSPHATE|||||||ML/ANIMAL/DAY|||||||INVALID||MG/DAY||||ABNORMAL|NOT DONE||||TUMOR TISSUE|NON-HEMOLYZED|Y|FREEZING POINT DEPRESSION|ASH FIBROSURE FORMULA||U|U|NA|U|||Y|2||58||BASELINE|1966-07-18|1973-03-09|||||1967-09-21||1964-05-25|NA|1963-07-14
TRIAL STUDY 134XCP|LB|2E084441-61A3-4B8B-9050-A5D7B38CA978|2||||FGF19|FIBROBLAST GROWTH FACTOR 19|||||||PIXELS/IN|||||||TRACE||OI50||||ABNORMAL|NOT DONE||||FLUID|CALCIFIED|NA|MULTI-SLICE SPIRAL CT|MDRD ENZYMATIC FORMULA||Y|U|N|NA|||NA|2||58||OPEN LABEL TREATMENT|1965-04-04|1964-07-31|||||1962-04-07||1970-01-25|U|1969-12-11
TRIAL STUDY 134XCP|LB|2E084441-61A3-4B8B-9050-A5D7B38CA978|1||||IL1RL1|INTERLEUKIN 1 RECEPTOR-LIKE 1|||||||H*%|||||||TRACE||FMOL/L/SEC||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|Y|PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC FORMULA||NA|U|N|NA|||NA|3||39||BLINDED TREATMENT|1961-05-21|1961-01-30|||||1964-06-11||1966-07-06|Y|1969-04-22
TRIAL STUDY 134XCP|LB|2E084441-61A3-4B8B-9050-A5D7B38CA978|2||||FCTVIIIA|FACTOR VIII ACTIVITY|||||||MU/G|||||||INVALID||BE/ML||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|HEMOLYZED|Y|SPECT/CT SCAN|FIBROTEST FORMULA||NA|N|U|NA|||U|3||39||RUN-IN|1968-12-25|1961-10-03|||||1960-05-09||1961-05-27|N|1963-05-13
TRIAL STUDY 134XCP|LB|2E084441-61A3-4B8B-9050-A5D7B38CA978|1||||RBPCREAT|RETINOL BINDING PROTEIN/CREATININE|||||||DDU|||||||INDETERMINATE||PMOL/L/H||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|CONTAMINATED|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA||N|NA|NA|U|||Y|4||88||RUN-IN|1969-10-26|1963-09-22|||||1962-06-09||1962-09-27|U|1961-05-27
TRIAL STUDY 134XCP|LB|2E084441-61A3-4B8B-9050-A5D7B38CA978|2||||INTLK1RA|INTERLEUKIN 1 RECEPTOR ANTAGONIST|||||||10^7 CFU|||||||TRACE||10^6 U||||LOW|NOT DONE||||PLATELET POOR PLASMA|ICTERIC|Y|CONTRAST ENHANCED CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|N|||Y|4||88||FOLLOW-UP|1963-08-28|1966-06-27|||||1972-08-13||1967-01-19|N|1969-08-31
TRIAL STUDY 134XCP|LB|2E084441-61A3-4B8B-9050-A5D7B38CA978|1||||HYPSEGCE|HYPERSEGMENTED CELLS|||||||MM/H|||||||BORDERLINE||NCI||||HIGH|NOT DONE||||VENOUS PLASMA|UNEXPECTED ODOR|Y|SXA SCAN|CKD-EPI FORMULA||NA|N|N|N|||N|5||7||FOLLOW-UP|1962-01-03|1970-01-13|||||1963-09-17||1971-12-31|Y|1965-12-28
TRIAL STUDY 134XCP|LB|2E084441-61A3-4B8B-9050-A5D7B38CA978|2||||C165891|WESTERN RAGWEED POLLEN IGE AB RAST SCORE|||||||ML/ANIMAL|||||||INVALID||DNA COPIES/UG||||LOW|NOT DONE||||ISOLATE|AUTOLYZED|NA|DIRECT SEQUENCING|FIBROMETER FORMULA||Y|Y|Y|N|||N|5||7||CONTINUATION TREATMENT|1962-05-25|1960-12-05|||||1969-02-03||1972-10-01|U|1969-04-11
TRIAL STUDY 134XCP|LB|601D563B-AA21-4859-A87E-B2068C1E3F53|1||||HYDMDZ4|4-HYDROXYMIDAZOLAM|||||||10^6 RNA COPIES/ML|||||||BORDERLINE||KPA||||NORMAL|NOT DONE||||BONE|CONCENTRATED|U|MICRODENSITOMETRY|FIBROSIS 4 FORMULA||NA|N|Y|NA|||N|1||38||CONTINUATION TREATMENT|1961-11-05|1970-10-05|||||1961-08-15||1963-04-04|Y|1964-08-18
TRIAL STUDY 134XCP|LB|601D563B-AA21-4859-A87E-B2068C1E3F53|2||||HBBARTHB|HEMOGLOBIN BARTS/TOTAL HEMOGLOBIN|||||||CD|||||||NEGATIVE||FG||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|LIPEMIC|N|RADIAL IMMUNODIFFUSION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|N|NA|||Y|1||38||CONTINUATION TREATMENT|1968-08-31|1965-10-09|||||1965-08-13||1966-12-19|Y|1970-03-18
TRIAL STUDY 134XCP|LB|601D563B-AA21-4859-A87E-B2068C1E3F53|1||||SER|SERINE|||||||PACKET|||||||INVALID||FEU||||NORMAL|NOT DONE||||CORD SERUM|UNEXPECTED ODOR|N|IMMUNOASSAY|ASH FIBROSURE FORMULA||N|U|N|Y|||Y|2||58||OBSERVATION|1964-06-11|1969-06-11|||||1971-09-01||1972-07-18|N|1970-07-08
TRIAL STUDY 134XCP|LB|601D563B-AA21-4859-A87E-B2068C1E3F53|2||||PO2ADJT|PARTIAL PRESSURE OXYGEN ADJ FOR TEMP|||||||UG/M2/H|||||||NEGATIVE||UMOL/L||||HIGH|NOT DONE||||VENOUS BLOOD|DRIED|N|IODINE STAIN|CKD-EPI CYSTATIN C FORMULA||Y|N|U|NA|||NA|2||58||SCREENING|1963-03-06|1960-11-01|||||1962-10-09||1962-11-25|N|1968-08-07
TRIAL STUDY 134XCP|LB|601D563B-AA21-4859-A87E-B2068C1E3F53|1||||MASTCE|MAST CELLS|||||||10^9 ORGANISMS|||||||NEGATIVE||IU/DAY||||HIGH|NOT DONE||||BONE|NON-HEMOLYZED|NA|FORCED OSCILLATION TECHNIQUE|MDRD 6 VARIABLE FORMULA||Y|Y|NA|Y|||NA|3||39||TREATMENT|1964-12-30|1972-11-18|||||1961-04-11||1963-03-30|U|1971-03-22
TRIAL STUDY 134XCP|LB|601D563B-AA21-4859-A87E-B2068C1E3F53|2||||CYFRA18|CYTOKERATIN 18 FRAGMENT|||||||EU|||||||POSITIVE||TROCHE||||ABNORMAL|NOT DONE||||BLOOD|UNEXPECTED ODOR|U|MICROBIAL CONCENTRATION|HEPASCORE FORMULA||N|U|Y|NA|||NA|3||39||BASELINE|1970-05-09|1966-11-27|||||1972-02-19||1971-11-01|Y|1969-10-06
TRIAL STUDY 134XCP|LB|601D563B-AA21-4859-A87E-B2068C1E3F53|1||||CYFRA211|CYTOKERATIN 19 FRAGMENT 21-1|||||||VP/DOSE|||||||NEGATIVE||HR/DAY||||LOW|NOT DONE||||MECONIUM|AUTOLYZED|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA||N|Y|NA|NA|||U|4||88||BLINDED TREATMENT|1971-11-27|1962-06-29|||||1966-09-27||1968-03-29|N|1971-06-24
TRIAL STUDY 134XCP|LB|601D563B-AA21-4859-A87E-B2068C1E3F53|2||||GCDCA|GLYCOCHENODEOXYCHOLATE|||||||MMOL/L|||||||INVALID||ANTI-XA IU||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|AGGLUTINATED|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|N|Y|||Y|4||88||FOLLOW-UP|1972-10-21|1970-07-29|||||1962-08-02||1971-04-18|N|1962-05-12
TRIAL STUDY 134XCP|LB|601D563B-AA21-4859-A87E-B2068C1E3F53|1||||VITK1|VITAMIN K1|||||||UG/H|||||||TRACE||MG/DL||||ABNORMAL|NOT DONE||||URINE|SOLIDIFIED|U|DYNAMIC LIGHT SCATTERING|MDRD ENZYMATIC FORMULA||N|U|N|NA|||NA|5||7||TREATMENT|1961-12-04|1961-07-31|||||1970-08-26||1969-02-03|N|1968-03-25
TRIAL STUDY 134XCP|LB|601D563B-AA21-4859-A87E-B2068C1E3F53|2||||EPITUCE|TUBULAR EPITHELIAL CELLS|||||||VIAL|||||||BORDERLINE||FOZ_US||||HIGH|NOT DONE||||HAIR FOLLICLE|CLOTTED|U|TONOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|N|Y|||U|5||7||SCREENING|1973-06-08|1968-08-07|||||1966-05-20||1964-03-09|NA|1963-08-03
TRIAL STUDY 134XCP|LB|D8FE5979-24C7-478F-8612-0102F28F5ADE|1||||SPWEIGHT|SPECIMEN WEIGHT|||||||DRUM|||||||POSITIVE||CL||||NORMAL|NOT DONE||||LYSATE|AUTOLYZED|N|TRICHROME STAIN|MDRD ENZYMATIC FORMULA||Y|N|N|Y|||N|1||38||RUN-IN|1967-04-20|1965-09-04|||||1965-12-24||1970-09-06|NA|1966-11-14
TRIAL STUDY 134XCP|LB|D8FE5979-24C7-478F-8612-0102F28F5ADE|2||||GDA|GUANINE DEAMINASE|||||||UG/L/H|||||||BORDERLINE||MOL/ML||||NORMAL|NOT DONE||||EMESIS|UNEXPECTED ODOR|U|ENZYMATIC COLORIMETRY|ASH FIBROSURE FORMULA||NA|Y|U|NA|||U|1||38||FOLLOW-UP|1972-09-29|1965-12-27|||||1963-07-04||1962-03-25|Y|1970-07-10
TRIAL STUDY 134XCP|LB|D8FE5979-24C7-478F-8612-0102F28F5ADE|1||||CYAMPPH|AMORPHOUS PHOSPHATE CRYSTALS|||||||UMOL/MG/MIN|||||||TRACE||PPM||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|NON-HEMOLYZED|N|FLUORESCENT SPOT TEST|COCKCROFT-GAULT FORMULA||NA|N|U|N|||U|2||58||TREATMENT|1971-12-01|1965-08-02|||||1962-01-01||1963-01-06|NA|1966-02-22
TRIAL STUDY 134XCP|LB|D8FE5979-24C7-478F-8612-0102F28F5ADE|2||||DPPIVA|DIPEPTIDYL PEPTIDASE-4 ACTIVITY|||||||KG/L|||||||BORDERLINE||CM/MIN||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|UNEXPECTED ODOR|Y|INTERRUPTER TECHNIQUE|MDRD FORMULA||U|Y|N|U|||U|2||58||FOLLOW-UP|1970-04-06|1965-08-31|||||1972-07-03||1960-02-29|NA|1966-06-14
TRIAL STUDY 134XCP|LB|D8FE5979-24C7-478F-8612-0102F28F5ADE|1||||INTLK4|INTERLEUKIN 4|||||||CUP EQ|||||||BORDERLINE||PMOL/10^9 CELLS||||NORMAL|NOT DONE||||ISOLATE|AUTOLYZED|N|URANYL ACETATE STAIN|CKD-EPI FORMULA||Y|N|Y|NA|||NA|3||39||INDUCTION TREATMENT|1972-05-11|1969-02-02|||||1973-06-11||1972-12-06|U|1964-12-16
TRIAL STUDY 134XCP|LB|D8FE5979-24C7-478F-8612-0102F28F5ADE|2||||APOA|APOLIPOPROTEIN A|||||||NGEQ/L|||||||NEGATIVE||MASK||||HIGH|NOT DONE||||INFRANATANT, PLASMA|CONCENTRATED|N|LEAD CITRATE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|NA|NA|||Y|3||39||CONTINUATION TREATMENT|1968-09-16|1970-07-16|||||1964-12-22||1968-08-12|NA|1960-05-08
TRIAL STUDY 134XCP|LB|D8FE5979-24C7-478F-8612-0102F28F5ADE|1||||CRENCE|CRENATED CELLS|||||||MEQ/MMOL|||||||BORDERLINE||UMOL/L||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|HEMOLYZED|U|COULOMETRIC TITRATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|U|N|||Y|4||88||CONTINUATION TREATMENT|1967-10-31|1970-04-18|||||1966-01-24||1969-10-21|NA|1965-03-04
TRIAL STUDY 134XCP|LB|D8FE5979-24C7-478F-8612-0102F28F5ADE|2||||ENAAB|EXTRACTABLE NUCLEAR ANTIGEN ANTIBODY|||||||HEP|||||||BORDERLINE||LOG10 IU/ML||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|ICTERIC|NA|MEDIASTINOSCOPY|HEPASCORE FORMULA||NA|U|U|U|||N|4||88||TREATMENT|1965-02-03|1965-03-04|||||1968-05-13||1970-04-22|Y|1970-09-13
TRIAL STUDY 134XCP|LB|D8FE5979-24C7-478F-8612-0102F28F5ADE|1||||IA5OHEXR|5-HYDROXYINDOLEACETICACID EXCRETION RATE|||||||DRINK|||||||INDETERMINATE||DIOPTER||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|FRESH|Y|APPLANATION TONOMETRY|HEPASCORE FORMULA||Y|Y|Y|Y|||Y|5||7||SCREENING|1963-03-27|1963-10-20|||||1973-07-25||1967-06-02|NA|1961-01-15
TRIAL STUDY 134XCP|LB|D8FE5979-24C7-478F-8612-0102F28F5ADE|2||||MYL3|MYOSIN LIGHT CHAIN 3|||||||L/MIN/M2|||||||TRACE||/SEC||||HIGH|NOT DONE||||LOCHIA|FRESH|N|FUNDUS PHOTOGRAPHY|HEPASCORE FORMULA||Y|NA|NA|U|||Y|5||7||FOLLOW-UP|1963-04-29|1972-10-27|||||1965-12-01||1962-05-28|U|1965-12-15
TRIAL STUDY 134XCP|LB|D275315F-D3C5-4260-8BD6-37DDB67262B0|1||||C130105|GRASS MIX POLLEN ANTIGEN IGA ANTIBODY|||||||AMP|||||||BORDERLINE||PMOL/10^10 CELLS||||HIGH|NOT DONE||||INFRANATANT, SERUM|REFRIGERATED|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|NASH FIBROSURE FORMULA||N|N|Y|Y|||N|1||38||TREATMENT|1969-10-08|1968-08-20|||||1961-09-24||1961-08-06|Y|1973-04-02
TRIAL STUDY 134XCP|LB|D275315F-D3C5-4260-8BD6-37DDB67262B0|2||||C147283|WHITE ELM POLLEN IGG ANTIBODY|||||||U|||||||NEGATIVE||UIU/DL||||HIGH|NOT DONE||||CALCULUS|CONCENTRATED|NA|CONTRAST ENHANCED MRI|MDRD ENZYMATIC FORMULA||N|N|U|N|||U|1||38||WASHOUT|1973-08-22|1965-08-13|||||1973-09-08||1960-03-24|U|1968-02-26
TRIAL STUDY 134XCP|LB|D275315F-D3C5-4260-8BD6-37DDB67262B0|1||||HBA1A|HEMOGLOBIN A1A|||||||CUP EQ|||||||BORDERLINE||MG/KG/MIN||||LOW|NOT DONE||||EMESIS|CALCIFIED|NA|AGAR PROPORTION|MDRD 6 VARIABLE FORMULA||NA|Y|NA|U|||Y|2||58||RUN-IN|1967-01-03|1969-10-24|||||1963-06-02||1967-10-07|U|1963-05-14
TRIAL STUDY 134XCP|LB|D275315F-D3C5-4260-8BD6-37DDB67262B0|2||||HGBFHGB|HEMOGLOBIN F/TOTAL HEMOGLOBIN|||||||NGEQ/L|||||||INVALID||MOL/ML||||NORMAL|NOT DONE||||DIALYSIS FLUID|CALCIFIED|NA|CISH|MDRD 6 VARIABLE FORMULA||U|Y|NA|Y|||U|2||58||INDUCTION TREATMENT|1963-04-29|1973-04-25|||||1964-02-04||1972-06-28|N|1971-01-16
TRIAL STUDY 134XCP|LB|D275315F-D3C5-4260-8BD6-37DDB67262B0|1||||CTXI|TYPE I COLLAGEN C-TELOPEPTIDES|||||||L/MIN|||||||POSITIVE||KA_U/DL||||NORMAL|NOT DONE||||PLASMA|ROOM TEMPERATURE|N|INTERRUPTER TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|NA|||Y|3||39||TREATMENT|1962-02-17|1967-09-13|||||1965-09-17||1966-07-21|N|1967-07-06
TRIAL STUDY 134XCP|LB|D275315F-D3C5-4260-8BD6-37DDB67262B0|2||||CBB|COMPLEMENT BB|||||||IU/KG|||||||INVALID||MET*H||||HIGH|NOT DONE||||MUCUS|ICTERIC|N|IMMUNOFIXATION ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA||N|Y|N|U|||Y|3||39||CONTINUATION TREATMENT|1969-07-24|1967-01-12|||||1964-11-21||1973-05-05|U|1960-11-08
TRIAL STUDY 134XCP|LB|D275315F-D3C5-4260-8BD6-37DDB67262B0|1||||NEUTGT|GIANT NEUTROPHILS|||||||KDA|||||||INDETERMINATE||UG/G/MIN||||NORMAL|NOT DONE||||HAIR FOLLICLE|AGGLUTINATED|U|WRIGHT STAIN|MDRD 4 VARIABLE FORMULA||Y|NA|Y|U|||Y|4||88||TREATMENT|1969-08-24|1960-06-23|||||1973-01-25||1968-09-23|NA|1969-06-20
TRIAL STUDY 134XCP|LB|D275315F-D3C5-4260-8BD6-37DDB67262B0|2||||INTLK1A|INTERLEUKIN 1 ALPHA|||||||ABSORBANCE U/MIN|||||||INDETERMINATE||IU/DL||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|AGGLUTINATED|NA|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|FIBROMETER FORMULA||NA|NA|N|Y|||Y|4||88||CONTINUATION TREATMENT|1964-11-25|1961-01-30|||||1971-11-27||1965-08-04|U|1962-10-31
TRIAL STUDY 134XCP|LB|D275315F-D3C5-4260-8BD6-37DDB67262B0|1||||PSIGGAB|PHOSPHATIDYLSERINE IGG ANTIBODY|||||||PPTR|||||||NEGATIVE||G/CAGE/WK||||ABNORMAL|NOT DONE||||MONOCYTE|REFRIGERATED|Y|BALLPOINT PEN TECHNIQUE|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|Y|U|||N|5||7||OBSERVATION|1970-04-28|1962-01-07|||||1967-06-06||1964-10-06|NA|1969-02-01
TRIAL STUDY 134XCP|LB|D275315F-D3C5-4260-8BD6-37DDB67262B0|2||||B2GLYAB|BETA-2 GLYCOPROTEIN ANTIBODY|||||||10^6 IU/ML|||||||POSITIVE||DDU||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|FRESH|N|MYELOPEROXIDASE STAIN|FIBROTEST FORMULA||NA|U|Y|NA|||N|5||7||SCREENING|1969-02-08|1972-02-10|||||1967-01-14||1961-08-07|Y|1968-01-25
TRIAL STUDY 134XCP|LB|34127CD2-378B-4335-AD4B-F305D0A21AF4|1||||PTAUAB42|PHOSPHORYLATED TAU PROT/AMYLOID BETA1-42|||||||10^9 CFU/G|||||||INDETERMINATE||LOG10 TCID 50/ML||||HIGH|NOT DONE||||DERMAL TISSUE|LIPEMIC|U|SLOAN LETTER EYE CHART 1.25%|ASH FIBROSURE FORMULA||Y|Y|Y|U|||Y|1||38||WASHOUT|1965-07-25|1972-05-05|||||1970-09-09||1960-11-12|N|1967-04-22
TRIAL STUDY 134XCP|LB|34127CD2-378B-4335-AD4B-F305D0A21AF4|2||||VEGFR3S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC3|||||||DAYS|||||||NEGATIVE||ENZYME U||||LOW|NOT DONE||||BONE MARROW|LIPEMIC|Y|DXA SCAN|NASH FIBROSURE FORMULA||Y|U|NA|NA|||Y|1||38||RUN-IN|1963-02-19|1970-11-04|||||1973-01-12||1971-03-26|U|1970-11-16
TRIAL STUDY 134XCP|LB|34127CD2-378B-4335-AD4B-F305D0A21AF4|1||||THROMNUC|THROMBOCYTES|||||||GY|||||||TRACE||DAYS/WK||||LOW|NOT DONE||||SPUTUM|LIPEMIC|Y|LC/MS|FIBROMETER FORMULA||NA|U|NA|N|||N|2||58||LONG-TERM FOLLOW-UP|1970-03-24|1970-05-13|||||1963-04-24||1964-05-02|N|1972-06-21
TRIAL STUDY 134XCP|LB|34127CD2-378B-4335-AD4B-F305D0A21AF4|2||||BASOMM|BASOPHILIC METAMYELOCYTES|||||||AMPULE|||||||INVALID||UEQ/L||||ABNORMAL|NOT DONE||||CALCULUS|ROOM TEMPERATURE|Y|SNELLEN EYE CHART|FIBROSIS 4 FORMULA||N|N|Y|Y|||Y|2||58||CONTINUATION TREATMENT|1960-01-17|1969-08-01|||||1963-09-14||1971-11-11|N|1964-11-11
TRIAL STUDY 134XCP|LB|34127CD2-378B-4335-AD4B-F305D0A21AF4|1||||CIT|CITRULLINE|||||||CL|||||||POSITIVE||ARBITRARY U||||LOW|NOT DONE||||INFRANATANT, SERUM|FROZEN|Y|BETA LACTAMASE|MDRD 5 VARIABLE FORMULA||U|Y|NA|Y|||U|3||39||FOLLOW-UP|1960-05-31|1970-08-03|||||1962-06-21||1973-06-08|NA|1961-10-21
TRIAL STUDY 134XCP|LB|34127CD2-378B-4335-AD4B-F305D0A21AF4|2||||BLSTMGK|MEGAKARYOBLASTS|||||||PFU/ML|||||||INVALID||F||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|DRIED|N|INTRAVASCULAR ULTRASOUND|ASH FIBROSURE FORMULA||U|Y|Y|NA|||N|3||39||CONTINUATION TREATMENT|1964-03-13|1969-09-14|||||1970-04-01||1969-02-26|N|1967-10-17
TRIAL STUDY 134XCP|LB|34127CD2-378B-4335-AD4B-F305D0A21AF4|1||||BD2|BETA-DEFENSIN 2|||||||MG/ML/DAY|||||||INVALID||UMOL/H/MMOL||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED|Y|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|FIBROTEST FORMULA||Y|N|N|Y|||NA|4||88||LONG-TERM FOLLOW-UP|1960-04-19|1972-07-06|||||1969-10-14||1973-07-27|N|1962-01-08
TRIAL STUDY 134XCP|LB|34127CD2-378B-4335-AD4B-F305D0A21AF4|2||||EGF|EPIDERMAL GROWTH FACTOR|||||||U/KG|||||||POSITIVE||IU/ML||||ABNORMAL|NOT DONE||||BASAL TEAR|PARAFFIN-EMBEDDED|NA|KARYOTYPING|COCKCROFT-GAULT FORMULA||NA|NA|Y|Y|||N|4||88||SCREENING|1961-04-18|1968-10-27|||||1960-05-18||1961-05-28|Y|1972-12-17
TRIAL STUDY 134XCP|LB|34127CD2-378B-4335-AD4B-F305D0A21AF4|1||||GLOBG|GAMMA GLOBULIN|||||||BOWL|||||||INVALID||MPS U||||LOW|NOT DONE||||ALVEOLAR AIR|CLOTTED|U|NEXT GENERATION TARGETED SEQUENCING|MDRD FORMULA||N|U|Y|Y|||U|5||7||OBSERVATION|1971-03-05|1966-06-22|||||1972-12-09||1972-08-03|U|1962-03-13
TRIAL STUDY 134XCP|LB|34127CD2-378B-4335-AD4B-F305D0A21AF4|2||||EPISQTCE|SQUAMOUS TRANSITIONAL EPITHELIAL CELLS|||||||CM H2O|||||||POSITIVE||MJOULE/CM2||||HIGH|NOT DONE||||WHITE MATTER TISSUE|UNEXPECTED ODOR|U|PH METER MEASUREMENT METHOD|FIBROMETER FORMULA||U|NA|Y|Y|||U|5||7||OPEN LABEL TREATMENT|1973-04-04|1961-07-19|||||1962-07-12||1966-03-22|U|1961-05-19
TRIAL STUDY 134XCP|LB|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|1||||PLSNCE|NEOPLASTIC PLASMA CELLS|||||||PELLET|||||||BORDERLINE||NG/DL||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED|Y|MICROSCOPY|MDRD ENZYMATIC FORMULA||N|N|Y|NA|||Y|1||38||WASHOUT|1971-03-31|1969-06-09|||||1967-10-13||1967-05-02|N|1963-04-01
TRIAL STUDY 134XCP|LB|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|2||||ATHMBAC|ANTITHROMBIN ACTUAL/CONTROL|||||||APL U/ML|||||||BORDERLINE||TROCHE||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|PARAFFIN-EMBEDDED|Y|OPTICAL DENSITY MEASUREMENT|MDRD ENZYMATIC FORMULA||N|Y|NA|U|||N|1||38||OPEN LABEL TREATMENT|1962-01-27|1960-11-08|||||1969-06-13||1972-05-01|Y|1960-11-09
TRIAL STUDY 134XCP|LB|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|1||||C165902|TIMOTHY GRASS POLLEN IGG AB RAST SCORE|||||||LB|||||||NEGATIVE||EVENTS||||NORMAL|NOT DONE||||CAPILLARY PLASMA|LACTESCENT|U|MAPH|MDRD 6 VARIABLE FORMULA||N|U|NA|Y|||NA|2||58||OBSERVATION|1969-05-02|1964-02-10|||||1966-02-21||1961-05-25|NA|1968-03-27
TRIAL STUDY 134XCP|LB|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|2||||GFRBSA|GLOMERULAR FILTRATION RATE ADJ FOR BSA|||||||ML/MIN|||||||BORDERLINE||ML/DOSE||||HIGH|NOT DONE||||LUNG SURFACTANT|AUTOLYZED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD FORMULA||N|Y|NA|N|||NA|2||58||TREATMENT|1973-03-01|1968-04-18|||||1967-10-20||1961-02-09|NA|1972-12-11
TRIAL STUDY 134XCP|LB|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|1||||CO2|CARBON DIOXIDE|||||||U/DL|||||||INVALID||FRAMES/S||||HIGH|NOT DONE||||TISSUE|REFRIGERATED|Y|MICROBIAL CULTURE, LIQUID|ASH FIBROSURE FORMULA||N|NA|NA|N|||NA|3||39||CONTINUATION TREATMENT|1972-04-15|1971-05-25|||||1964-06-02||1970-02-13|NA|1964-12-05
TRIAL STUDY 134XCP|LB|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|2||||ALPIS|INTESTINAL SPECIFIC ALKALINE PHOSPHATASE|||||||/HPF|||||||INDETERMINATE||PM||||LOW|NOT DONE||||SKIN TISSUE|REFRIGERATED|NA|FLUOROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|U|U|||Y|3||39||SCREENING|1965-09-09|1971-10-22|||||1964-06-24||1961-06-07|U|1967-07-02
TRIAL STUDY 134XCP|LB|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|1||||G6PDRBC|G6PD-DEFICIENT ERYTHROCYTES|||||||GPS U|||||||NEGATIVE||ANSON U||||NORMAL|NOT DONE||||LUNG SURFACTANT|ICTERIC|U|DISK DIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA||U|U|NA|N|||N|4||88||BASELINE|1965-06-16|1966-09-23|||||1970-01-11||1971-10-02|NA|1969-10-17
TRIAL STUDY 134XCP|LB|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|2||||ICAIGGAB|ISLET CELL CYTOPLASMIC IGG ANTIBODY|||||||ML/DAY|||||||NEGATIVE||HENRY||||LOW|NOT DONE||||SMEGMA|LACTESCENT|NA|MANUAL COUNT|MDRD FORMULA||N|Y|NA|Y|||N|4||88||CONTINUATION TREATMENT|1961-12-09|1970-10-19|||||1965-02-13||1963-09-12|N|1967-10-20
TRIAL STUDY 134XCP|LB|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|1||||FACTVIII|FACTOR VIII|||||||MM/SEC|||||||BORDERLINE||OZ EQ||||NORMAL|NOT DONE||||ARTERIAL BLOOD|SOLIDIFIED|Y|SURFACE PLASMON RESONANCE|FIBROMETER FORMULA||Y|U|U|Y|||Y|5||7||OPEN LABEL TREATMENT|1967-05-06|1962-04-26|||||1972-09-18||1968-10-28|Y|1962-02-07
TRIAL STUDY 134XCP|LB|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|2||||CEC|CIRCULATING ENDOTHELIAL CELLS|||||||MV/SEC|||||||BORDERLINE||SV||||NORMAL|NOT DONE||||CELL PELLET|CONTAMINATED|Y|FLUORIMETRY|FIBROMETER FORMULA||U|Y|U|N|||U|5||7||OBSERVATION|1973-03-24|1962-05-25|||||1961-02-07||1966-02-14|N|1972-04-10
TRIAL STUDY 134XCP|LB|6EE04A90-681B-439E-9783-04B40A4AF240|1||||NAGCREAT|N-ACETYL GLUCOSAMIDE/CREATININE|||||||MEQ/MMOL|||||||INVALID||TORR||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|LIPEMIC|Y|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|NA|Y|||NA|1||38||RUN-IN|1961-10-16|1973-07-26|||||1961-11-17||1969-02-12|Y|1961-05-07
TRIAL STUDY 134XCP|LB|6EE04A90-681B-439E-9783-04B40A4AF240|2||||DDNAIGAB|ANTI-DOUBLE STRANDED DNA IGG|||||||MET*H|||||||NEGATIVE||UGEQ||||HIGH|NOT DONE||||CORD BLOOD|ICTERIC|Y|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|FIBROSIS 4 FORMULA||NA|NA|U|N|||U|1||38||BASELINE|1972-05-21|1970-05-08|||||1972-01-03||1966-11-19|N|1960-01-05
TRIAL STUDY 134XCP|LB|6EE04A90-681B-439E-9783-04B40A4AF240|1||||GUDCA|GLYCOURSODEOXYCHOLATE|||||||MEQ/DL|||||||POSITIVE||FARAD||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|SOLIDIFIED|U|REFRACTOMETRY|CKD-EPI FORMULA||N|NA|NA|NA|||U|2||58||OBSERVATION|1967-11-23|1971-04-22|||||1961-11-27||1962-01-03|N|1973-02-19
TRIAL STUDY 134XCP|LB|6EE04A90-681B-439E-9783-04B40A4AF240|2||||DZPM|DIAZEPAM|||||||MG/ANIMAL|||||||TRACE||UG/KG||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|GELLED|U|SXA SCAN|FIBROSIS 4 FORMULA||Y|U|Y|N|||Y|2||58||FOLLOW-UP|1963-11-03|1962-12-25|||||1966-09-29||1967-07-16|Y|1967-09-29
TRIAL STUDY 134XCP|LB|6EE04A90-681B-439E-9783-04B40A4AF240|1||||MYL3|MYOSIN LIGHT CHAIN 3|||||||APL U/ML|||||||BORDERLINE||MET*MIN||||ABNORMAL|NOT DONE||||URINE|SOLIDIFIED|Y|CENTRIFUGATION|MDRD ENZYMATIC FORMULA||NA|NA|U|U|||U|3||39||SCREENING|1962-03-31|1968-04-30|||||1969-07-05||1972-08-04|U|1966-07-13
TRIAL STUDY 134XCP|LB|6EE04A90-681B-439E-9783-04B40A4AF240|2||||CANNABS|CANNABINOIDS, SYNTHETIC|||||||10^7 CFU|||||||INVALID||G/ANIMAL/DAY||||LOW|NOT DONE||||GASTRIC FLUID|REFRIGERATED|Y|PHOTOMETRY|FIBROMETER FORMULA||N|U|N|N|||N|3||39||INDUCTION TREATMENT|1968-10-24|1970-08-12|||||1962-05-22||1965-11-18|N|1960-02-22
TRIAL STUDY 134XCP|LB|6EE04A90-681B-439E-9783-04B40A4AF240|1||||SODIUM|SODIUM|||||||UV*SEC|||||||INVALID||ATM||||NORMAL|NOT DONE||||LYSATE|CONTAMINATED|N|CLAUSS METHOD|GMI MMOL/MOL FORMULA||U|U|Y|N|||U|4||88||LONG-TERM FOLLOW-UP|1969-04-02|1963-05-01|||||1960-08-12||1973-08-24|NA|1961-12-06
TRIAL STUDY 134XCP|LB|6EE04A90-681B-439E-9783-04B40A4AF240|2||||PPTDCALB|PHOSPHATIDYLCHOLINE/ALBUMIN|||||||MOL/DAY|||||||NEGATIVE||UMOL/MOL||||NORMAL|NOT DONE||||CAPILLARY BLOOD|AGGLUTINATED|Y|SINGLE-MOLECULE ARRAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|NA|N|||NA|4||88||SCREENING|1960-07-15|1961-12-28|||||1965-05-08||1960-02-03|U|1968-05-30
TRIAL STUDY 134XCP|LB|6EE04A90-681B-439E-9783-04B40A4AF240|1||||RANTES|REG UPON ACT NORMAL T-CELL EXPRD SECRTD|||||||MV|||||||TRACE||MMOL/KG||||NORMAL|NOT DONE||||HAIR|CALCIFIED|NA|KNEMOMETRY|MDRD 5 VARIABLE FORMULA||Y|Y|NA|Y|||Y|5||7||WASHOUT|1962-08-09|1968-10-08|||||1965-11-22||1971-10-18|Y|1966-05-01
TRIAL STUDY 134XCP|LB|6EE04A90-681B-439E-9783-04B40A4AF240|2||||FATACFRS|FREE FATTY ACID, SATURATED|||||||/LSQN|||||||NEGATIVE||G/KG/DAY||||ABNORMAL|NOT DONE||||PLASMA|LIPEMIC|NA|CONTRAST ENHANCED PET SCAN|MDRD FORMULA||U|NA|N|N|||NA|5||7||SCREENING|1973-04-02|1972-04-15|||||1963-09-06||1962-08-04|Y|1964-01-11
TRIAL STUDY 134XCP|LB|A5C0B034-1226-40EE-87E3-D46A7342B550|1||||CSCELL|CELLULAR CASTS|||||||U/CL|||||||POSITIVE||GPL U||||LOW|NOT DONE||||BUFFY COAT|THAWED|N|MIGET|MDRD 4 VARIABLE FORMULA||N|NA|N|Y|||N|1||38||OPEN LABEL TREATMENT|1965-01-18|1970-12-21|||||1963-09-27||1967-11-06|U|1966-09-22
TRIAL STUDY 134XCP|LB|A5C0B034-1226-40EE-87E3-D46A7342B550|2||||CBA|COMPLEMENT BA|||||||APL U|||||||NEGATIVE||10^6 CFU||||ABNORMAL|NOT DONE||||KERATINOCYTE|DRIED|Y|PAP STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|N|NA|||U|1||38||BLINDED TREATMENT|1968-08-14|1966-03-28|||||1969-03-09||1971-11-04|N|1971-11-17
TRIAL STUDY 134XCP|LB|A5C0B034-1226-40EE-87E3-D46A7342B550|1||||HASIGEAB|HUMAN ANTI-SHEEP IGE ANTIBODY|||||||UMOL|||||||TRACE||DPM/ML||||ABNORMAL|NOT DONE||||CORD SERUM|CLOTTED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||NA|U|N|N|||N|2||58||TREATMENT|1969-12-29|1970-02-27|||||1963-06-25||1966-07-23|NA|1965-05-30
TRIAL STUDY 134XCP|LB|A5C0B034-1226-40EE-87E3-D46A7342B550|2||||GFRBSCCC|GFR FROM CYSTATIN C AND CREAT ADJ BSA|||||||OI50|||||||POSITIVE||10^4/L||||NORMAL|NOT DONE||||CAPILLARY BLOOD|PARAFFIN-EMBEDDED|Y|MECHANICAL CLOT DETECTION|MDRD 6 VARIABLE FORMULA||N|NA|NA|N|||U|2||58||RUN-IN|1971-08-19|1965-09-13|||||1966-07-17||1967-01-12|Y|1968-03-11
TRIAL STUDY 134XCP|LB|A5C0B034-1226-40EE-87E3-D46A7342B550|1||||MONOMA|MONOCYTES/MACROCYTES|||||||L/MIN/M2|||||||NEGATIVE||10^9 ORGANISMS/ML||||LOW|NOT DONE||||MONOCYTE|CLOTTED|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROTEST FORMULA||N|N|Y|Y|||U|3||39||RUN-IN|1973-01-22|1972-07-11|||||1962-07-02||1972-01-10|NA|1963-05-10
TRIAL STUDY 134XCP|LB|A5C0B034-1226-40EE-87E3-D46A7342B550|2||||VTRNCTN|VITRONECTIN|||||||MOL/MG|||||||BORDERLINE||MMOL||||NORMAL|NOT DONE||||SEBUM|GELLED|Y|MRS|CKD-EPI CREATININE FORMULA||U|Y|Y|NA|||Y|3||39||FOLLOW-UP|1966-04-30|1968-04-10|||||1963-09-24||1965-02-23|U|1967-05-07
TRIAL STUDY 134XCP|LB|A5C0B034-1226-40EE-87E3-D46A7342B550|1||||S100A8|S100 CALCIUM BINDING PROTEIN A8|||||||L/S/KPA|||||||BORDERLINE||/500 WBC||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|PARAFFIN-EMBEDDED|U|MASS SPECTROMETRY|NASH FIBROSURE FORMULA||NA|NA|Y|NA|||NA|4||88||CONTINUATION TREATMENT|1971-08-18|1962-01-06|||||1970-09-24||1961-06-11|Y|1960-07-25
TRIAL STUDY 134XCP|LB|A5C0B034-1226-40EE-87E3-D46A7342B550|2||||SICAM1|SOLUBLE INTERCELL ADHESION MOLECULE 1|||||||ML/ANIMAL/WK|||||||TRACE||GMFI||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|LIPEMIC|U|INTERRUPTER TECHNIQUE|NASH FIBROSURE FORMULA||U|N|N|U|||U|4||88||OPEN LABEL TREATMENT|1969-08-17|1967-08-22|||||1973-03-29||1962-03-12|Y|1966-01-10
TRIAL STUDY 134XCP|LB|A5C0B034-1226-40EE-87E3-D46A7342B550|1||||FUNGYLK|FUNGI, YEAST-LIKE|||||||U/M2/MIN|||||||INVALID||GBQ/G||||NORMAL|NOT DONE||||PLATELET|DRIED|NA|MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI FORMULA||NA|N|NA|Y|||N|5||7||SCREENING|1971-07-21|1967-10-10|||||1965-08-12||1971-10-29|NA|1964-02-15
TRIAL STUDY 134XCP|LB|A5C0B034-1226-40EE-87E3-D46A7342B550|2||||BLSTSID|SIDEROBLAST|||||||MM2|||||||POSITIVE||COULOMB||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|ICTERIC|NA|MS/MS|FIBROMETER FORMULA||N|U|N|NA|||U|5||7||WASHOUT|1960-08-24|1971-03-31|||||1967-07-27||1965-07-26|U|1965-12-16
TRIAL STUDY 134XCP|LB|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|1||||MERCECE|MATURING ERYTHROID CELLS/TOTAL CELLS|||||||IU|||||||BORDERLINE||L/L||||ABNORMAL|NOT DONE||||SALIVA|LACTESCENT|N|LASER CAPTURE MICRODISSECTION|GMI % FORMULA||N|NA|NA|N|||NA|1||38||TREATMENT|1964-02-25|1963-05-10|||||1960-05-13||1963-06-12|N|1965-02-19
TRIAL STUDY 134XCP|LB|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|2||||FGF23|FIBROBLAST GROWTH FACTOR 23|||||||LOG10 TCID 50/UL|||||||INDETERMINATE||/VF||||HIGH|NOT DONE||||CORD BLOOD|LIPEMIC|Y|LEAD CITRATE STAIN|MDRD 6 VARIABLE FORMULA||U|N|N|U|||U|1||38||TREATMENT|1970-09-30|1967-01-17|||||1966-12-04||1968-06-21|U|1969-11-11
TRIAL STUDY 134XCP|LB|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|1||||ICAM|INTERCELLULAR ADHESION MOLECULE|||||||L/S/KPA|||||||TRACE||MEQ/DAY||||LOW|NOT DONE||||AMNIOTIC FLUID|HEMOLYZED|N|LC/MS|GMI % FORMULA||Y|U|NA|U|||U|2||58||LONG-TERM FOLLOW-UP|1963-06-04|1965-05-24|||||1973-03-08||1960-07-30|N|1970-02-01
TRIAL STUDY 134XCP|LB|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|2||||BDNF|BRAIN-DERIVED NEUROTROPHIC FACTOR|||||||MM|||||||TRACE||FL||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|GELLED|Y|CONGO RED STAIN|GMI % FORMULA||NA|N|U|NA|||NA|2||58||RUN-IN|1971-07-05|1966-11-23|||||1972-06-08||1971-02-28|N|1967-10-05
TRIAL STUDY 134XCP|LB|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|1||||CCL7|CHEMOKINE (C-C MOTIF) LIGAND 7|||||||NG/DAY|||||||BORDERLINE||GY/H||||ABNORMAL|NOT DONE||||ABSCESS FLUID|ICTERIC|N|CT SCAN|MDRD FORMULA||U|NA|Y|N|||N|3||39||OBSERVATION|1964-09-10|1970-01-24|||||1965-08-17||1969-12-07|NA|1962-08-23
TRIAL STUDY 134XCP|LB|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|2||||MCH|ERY. MEAN CORPUSCULAR HEMOGLOBIN|||||||LOG10 CCID 50/DOSE|||||||INDETERMINATE||GTT||||ABNORMAL|NOT DONE||||SKIN TISSUE|AUTOLYZED|Y|KINETIC MICROPARTICLE IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|Y|N|||N|3||39||OPEN LABEL TREATMENT|1969-02-20|1972-10-13|||||1962-07-30||1968-09-22|Y|1963-02-19
TRIAL STUDY 134XCP|LB|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|1||||CLARITY|CLARITY|||||||U/KG/MIN|||||||TRACE||COPIES/ML||||LOW|NOT DONE||||KERATINOCYTE|THAWED|N|ORCHIDOMETERY|MDRD FORMULA||N|NA|U|NA|||N|4||88||OBSERVATION|1970-05-31|1962-07-26|||||1965-07-10||1961-10-28|NA|1962-03-23
TRIAL STUDY 134XCP|LB|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|2||||CMPK2|CYTIDINE-URIDINE MONOPHOSPHATE KINASE 2|||||||KG/MOL|||||||NEGATIVE||G/U||||HIGH|NOT DONE||||ISOLATE|ROOM TEMPERATURE|NA|HEMATOXYLIN AND EOSIN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|NA|U|||N|4||88||CONTINUATION TREATMENT|1961-05-27|1967-10-30|||||1964-04-21||1968-05-08|U|1963-02-21
TRIAL STUDY 134XCP|LB|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|1||||HDWR|RET HEMOGLOBIN DISTRIBUTION WIDTH|||||||ATM|||||||INVALID||10^6 ORGANISMS||||NORMAL|NOT DONE||||SERUM|ICTERIC|N|SLOAN LETTER EYE CHART 100%|MDRD 4 VARIABLE FORMULA||N|NA|Y|Y|||N|5||7||FOLLOW-UP|1968-04-13|1972-09-17|||||1963-11-14||1967-01-21|Y|1969-03-19
TRIAL STUDY 134XCP|LB|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|2||||NEUTBNE|NEUTROPHILS BAND FORM/ NEUTROPHILS|||||||OD UNIT|||||||BORDERLINE||EVENTS||||HIGH|NOT DONE||||EPITHELIAL CELL|PARAFFIN-EMBEDDED|NA|VENTILATION PERFUSION LUNG SCAN|MDRD 6 VARIABLE FORMULA||Y|NA|N|NA|||NA|5||7||INDUCTION TREATMENT|1970-10-07|1960-01-22|||||1967-07-16||1964-04-13|U|1966-06-20
TRIAL STUDY 134XCP|LB|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|1||||LDH|LACTATE DEHYDROGENASE|||||||G/M2|||||||POSITIVE||POINT||||LOW|NOT DONE||||MIXED VENOUS BLOOD|SOLIDIFIED|NA|HEMATOXYLIN AND EOSIN STAIN|MDRD 6 VARIABLE FORMULA||U|Y|Y|NA|||Y|1||38||BASELINE|1972-10-02|1964-04-15|||||1962-08-21||1961-06-19|N|1962-07-07
TRIAL STUDY 134XCP|LB|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|2||||HGBA|HEMOGLOBIN A|||||||CI/KG|||||||BORDERLINE||DRAM||||HIGH|NOT DONE||||STOOL|LIPEMIC|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|N|U|N|||NA|1||38||INDUCTION TREATMENT|1964-11-23|1964-12-22|||||1965-09-21||1962-08-02|Y|1966-01-16
TRIAL STUDY 134XCP|LB|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|1||||LDH1|LDH ISOENZYME 1|||||||10^3 ORGANISMS|||||||INVALID||% INHIBITION||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|PARAFFIN-EMBEDDED|U|IMMUNOCHEMILUMINOMETRIC ASSAY|FIBROTEST FORMULA||N|N|Y|NA|||NA|2||58||TREATMENT|1970-01-23|1961-02-15|||||1966-01-24||1968-12-15|N|1970-03-02
TRIAL STUDY 134XCP|LB|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|2||||CD33|CD33|||||||CFU/ML|||||||INVALID||GY||||LOW|NOT DONE||||ERYTHROCYTES|CONCENTRATED|Y|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD 5 VARIABLE FORMULA||U|U|U|Y|||Y|2||58||FOLLOW-UP|1972-06-09|1971-08-23|||||1966-03-20||1967-06-09|NA|1966-04-27
TRIAL STUDY 134XCP|LB|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|1||||OAS1|2-5-OLIGOADENYLATE SYNTHASE 1|||||||TORR|||||||POSITIVE||CI/UG||||LOW|NOT DONE||||PROSTATIC FLUID|CLOTTED|NA|TARGETED GENOME SEQUENCING|CKD-EPI CYSTATIN C FORMULA||NA|NA|NA|NA|||Y|3||39||LONG-TERM FOLLOW-UP|1962-01-14|1964-05-01|||||1964-03-31||1967-09-23|Y|1964-10-12
TRIAL STUDY 134XCP|LB|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|2||||INSULINR|INSULIN RESISTANCE|||||||10^6/EJACULATE U|||||||POSITIVE||GRAIN||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|PARAFFIN-EMBEDDED|NA|X-RAY FLUORESCENCE SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|NA|Y|||U|3||39||LONG-TERM FOLLOW-UP|1972-02-24|1967-09-21|||||1965-02-10||1963-11-04|NA|1962-05-03
TRIAL STUDY 134XCP|LB|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|1||||FACTV|FACTOR V|||||||SUPPOSITORY|||||||NEGATIVE||CPM||||ABNORMAL|NOT DONE||||PUS|CALCIFIED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|Y|Y|||NA|4||88||TREATMENT|1973-04-25|1963-12-06|||||1972-08-11||1962-11-14|U|1971-12-03
TRIAL STUDY 134XCP|LB|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|2||||CD4LY|CD4/LYMPHOCYTES|||||||EQ|||||||INVALID||10^3 COPIES/ML||||LOW|NOT DONE||||LAVAGE FLUID|PARAFFIN-EMBEDDED|Y|HIGH LEVEL AMINOGLYCOSIDE SCREEN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|Y|NA|||U|4||88||FOLLOW-UP|1972-07-12|1970-01-31|||||1970-04-23||1960-11-22|NA|1968-05-15
TRIAL STUDY 134XCP|LB|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|1||||LAP|LEUCINE AMINOPEPTIDASE|||||||BQ/MG|||||||BORDERLINE||FMOL/G||||NORMAL|NOT DONE||||MONOCYTE|REFRIGERATED|Y|TWO-COLOR MICROARRAY|MDRD 6 VARIABLE FORMULA||U|U|N|N|||Y|5||7||WASHOUT|1970-02-23|1961-06-01|||||1970-05-14||1960-02-27|N|1967-01-08
TRIAL STUDY 134XCP|LB|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|2||||FCTVIIIA|FACTOR VIII ACTIVITY|||||||10^9 ORGANISMS|||||||NEGATIVE||U/CL||||HIGH|NOT DONE||||PLEURAL TISSUE|AUTOLYZED|N|EIA|GMI MMOL/MOL FORMULA||U|U|N|Y|||N|5||7||BASELINE|1968-11-18|1970-07-02|||||1972-03-28||1962-10-29|NA|1968-04-25
TRIAL STUDY 134XCP|LB|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|1||||ERCEMIDX|ERYTHROID MATURATION INDEX|||||||ARBITRARY U|||||||NEGATIVE||COULOMB||||LOW|NOT DONE||||SUPERNATANT, PLASMA|THAWED|Y|LASER CAPTURE MICRODISSECTION|HEPASCORE FORMULA||Y|N|N|U|||U|1||38||BLINDED TREATMENT|1972-03-29|1969-01-11|||||1972-11-20||1966-03-10|N|1966-02-20
TRIAL STUDY 134XCP|LB|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|2||||PTHMM|PARATHYROID HORMONE, MID-MOLECULE|||||||UG/G/MIN|||||||INVALID||VOXEL||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|FRESH|U|PERIODIC ACID SCHIFF STAIN|HEPASCORE FORMULA||N|NA|NA|U|||Y|1||38||BASELINE|1960-05-27|1961-08-01|||||1963-08-03||1965-05-05|Y|1963-06-03
TRIAL STUDY 134XCP|LB|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|1||||HLAAMSC|HLA-A MISMATCH COUNT|||||||ML/MIN/MMHG|||||||INVALID||RING||||HIGH|NOT DONE||||PLEURAL FLUID|FROZEN|N|ACCELERATOR MASS SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|N|Y|||U|2||58||OBSERVATION|1963-09-21|1967-10-05|||||1967-02-14||1962-06-05|NA|1967-08-20
TRIAL STUDY 134XCP|LB|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|2||||THR|THREONINE|||||||GBQ/MG|||||||BORDERLINE||MOL/DAY||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|CONTAMINATED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 6 VARIABLE FORMULA||N|N|U|Y|||N|2||58||BASELINE|1973-06-27|1965-01-15|||||1967-10-04||1972-07-04|N|1971-06-09
TRIAL STUDY 134XCP|LB|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|1||||CD13|CD13|||||||MU/L|||||||NEGATIVE||KM||||ABNORMAL|NOT DONE||||LOCHIA|UNEXPECTED ODOR|N|PERCUSSION|MDRD ENZYMATIC FORMULA||NA|Y|N|NA|||NA|3||39||BLINDED TREATMENT|1973-02-28|1969-03-27|||||1962-04-12||1964-07-08|Y|1966-01-21
TRIAL STUDY 134XCP|LB|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|2||||PAPPA|PREGNANCY-ASSOCIATED PLASMA PROTEIN-A|||||||/VF|||||||INDETERMINATE||CM/MIN||||HIGH|NOT DONE||||MUCUS|UNEXPECTED ODOR|U|MYELOPEROXIDASE STAIN|MDRD ENZYMATIC FORMULA||N|NA|U|N|||U|3||39||BASELINE|1962-05-05|1960-09-24|||||1967-11-18||1963-09-04|N|1961-11-30
TRIAL STUDY 134XCP|LB|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|1||||CTXII|TYPE II COLLAGEN C-TELOPEPTIDES|||||||UG/KG|||||||BORDERLINE||QUANTITY SUFFICIENT||||HIGH|NOT DONE||||REFLEX TEAR|PARAFFIN-EMBEDDED|U|ALCIAN BLUE STAIN|ASH FIBROSURE FORMULA||NA|N|NA|N|||N|4||88||SCREENING|1968-04-22|1963-03-10|||||1969-05-07||1962-07-07|Y|1964-05-05
TRIAL STUDY 134XCP|LB|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|2||||ANAIGGAB|ANTINUCLEAR IGG ANTIBODY|||||||GPL U/ML|||||||BORDERLINE||UMOL/L/MIN||||LOW|NOT DONE||||SEMINAL FLUID|ICTERIC|NA|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|Y|NA|||U|4||88||OBSERVATION|1964-07-27|1972-06-13|||||1970-05-21||1960-11-18|U|1961-10-16
TRIAL STUDY 134XCP|LB|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|1||||APLIGMAB|ANTI-PHOSPHOLIPID IGM ANTIBODY|||||||10^6 COPIES/ML|||||||NEGATIVE||BAU/ML||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|HEMOLYZED|Y|ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|U|||Y|5||7||LONG-TERM FOLLOW-UP|1963-03-17|1972-07-25|||||1966-01-27||1968-01-24|NA|1969-08-25
TRIAL STUDY 134XCP|LB|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|2||||CRTCLRBS|CREATININE CLEARANCE ADJUSTED FOR BSA|||||||JAR|||||||INDETERMINATE||CD/M2||||LOW|NOT DONE||||ARTERIAL BLOOD|ICTERIC|NA|SLOAN LETTER EYE CHART 1.25%|ASH FIBROSURE FORMULA||Y|U|N|U|||Y|5||7||FOLLOW-UP|1973-06-11|1972-12-03|||||1962-09-24||1964-11-02|Y|1963-01-16
TRIAL STUDY 134XCP|LB|D58A8C37-6659-4B00-8BED-256E8754F93C|1||||B2GLYAB|BETA-2 GLYCOPROTEIN ANTIBODY|||||||HOUNSFIELD UNIT|||||||INDETERMINATE||UG/KG/DAY||||HIGH|NOT DONE||||BONE MARROW|HEMOLYZED|Y|HIGH RESOLUTION CT|COCKCROFT-GAULT FORMULA||Y|NA|N|N|||U|1||38||FOLLOW-UP|1968-02-01|1961-03-19|||||1962-01-28||1961-12-03|NA|1965-06-28
TRIAL STUDY 134XCP|LB|D58A8C37-6659-4B00-8BED-256E8754F93C|2||||LDH2|LDH ISOENZYME 2|||||||CUP EQ|||||||TRACE||LB||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|DRIED|N|NUCLEIC ACID AMPLIFICATION TEST|MDRD FORMULA||U|N|N|N|||N|1||38||SCREENING|1967-07-19|1965-01-10|||||1960-05-05||1960-11-29|Y|1965-01-07
TRIAL STUDY 134XCP|LB|D58A8C37-6659-4B00-8BED-256E8754F93C|1||||PHOSLPD|PHOSPHOLIPID|||||||UG/ML/H|||||||BORDERLINE||BQ/L||||ABNORMAL|NOT DONE||||DISCHARGE|SOLIDIFIED|Y|CLOT DETECTION|MDRD ENZYMATIC JAPANESE FORMULA||N|U|Y|U|||N|2||58||LONG-TERM FOLLOW-UP|1964-06-10|1961-03-28|||||1967-03-05||1968-08-30|Y|1964-04-02
TRIAL STUDY 134XCP|LB|D58A8C37-6659-4B00-8BED-256E8754F93C|2||||SLXAG|SIALYL SSEA-1 ANTIGEN|||||||GMFI|||||||INDETERMINATE||G/CAGE/WK||||NORMAL|NOT DONE||||INFRANATANT, SERUM|THAWED|NA|ELISA|FIBROMETER FORMULA||Y|NA|N|U|||U|2||58||RUN-IN|1966-06-13|1963-05-30|||||1966-09-28||1965-03-31|U|1960-06-18
TRIAL STUDY 134XCP|LB|D58A8C37-6659-4B00-8BED-256E8754F93C|1||||INTLK31|INTERLEUKIN 31|||||||IU/MG|||||||TRACE||U/DL||||NORMAL|NOT DONE||||AMNIOTIC FLUID|UNEXPECTED ODOR|N|TURBIDIMETRY|FIBROSIS 4 FORMULA||U|U|U|U|||NA|3||39||LONG-TERM FOLLOW-UP|1970-12-24|1962-12-18|||||1961-01-10||1969-03-04|Y|1971-09-08
TRIAL STUDY 134XCP|LB|D58A8C37-6659-4B00-8BED-256E8754F93C|2||||HBOARBHB|HEMOGLOBIN O-ARAB/TOTAL HEMOGLOBIN|||||||ML/CM|||||||POSITIVE||MMOL/KG||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED|Y|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|N|NA|||Y|3||39||SCREENING|1966-05-10|1967-05-05|||||1966-08-15||1965-12-17|N|1961-03-07
TRIAL STUDY 134XCP|LB|D58A8C37-6659-4B00-8BED-256E8754F93C|1||||DZPM|DIAZEPAM|||||||LOG EID 50/DOSE|||||||POSITIVE||BOX||||HIGH|NOT DONE||||AMNIOTIC FLUID|SOLIDIFIED|Y|DOPPLER ULTRASOUND|MDRD 4 VARIABLE FORMULA||U|U|N|U|||N|4||88||LONG-TERM FOLLOW-UP|1961-01-06|1971-09-24|||||1968-04-22||1971-06-10|NA|1964-03-23
TRIAL STUDY 134XCP|LB|D58A8C37-6659-4B00-8BED-256E8754F93C|2||||KL6|KREBS VON DEN LUNGEN-6|||||||10^5/HPF|||||||NEGATIVE||ML/MIN/MMHG||||NORMAL|NOT DONE||||PLEURAL FLUID|NON-HEMOLYZED|N|MULTI-SLICE SPIRAL CT|GMI % FORMULA||U|N|N|U|||NA|4||88||CONTINUATION TREATMENT|1972-03-24|1972-09-17|||||1964-09-05||1963-02-02|NA|1960-11-17
TRIAL STUDY 134XCP|LB|D58A8C37-6659-4B00-8BED-256E8754F93C|1||||TGFB3|TRANSFORMING GROWTH FACTOR BETA 3|||||||DEG2|||||||POSITIVE||NEEDLE GAUGE||||NORMAL|NOT DONE||||ERYTHROCYTES|HEMOLYZED|U|RULER MEASUREMENT METHOD|GMI % FORMULA||NA|NA|U|NA|||NA|5||7||RUN-IN|1970-09-01|1961-01-11|||||1970-10-31||1966-09-11|U|1962-11-24
TRIAL STUDY 134XCP|LB|D58A8C37-6659-4B00-8BED-256E8754F93C|2||||INTLK1RA|INTERLEUKIN 1 RECEPTOR ANTAGONIST|||||||MG/M2/DAY|||||||INDETERMINATE||MG/KG/DOSE||||NORMAL|NOT DONE||||SYNOVIAL FLUID|AGGLUTINATED|U|DIRECT SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|N|U|||U|5||7||RUN-IN|1961-12-15|1965-12-18|||||1967-08-08||1972-09-05|N|1972-11-06
TRIAL STUDY 134XCP|LB|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|1||||IGSOL|SOLUBLE IMMUNOGLOBULIN|||||||BAG|||||||TRACE||LENS||||HIGH|NOT DONE||||INFRANATANT, PLASMA|FROZEN|N|CELL BASED BIOASSAY|GMI MMOL/MOL FORMULA||U|NA|N|Y|||N|1||38||TREATMENT|1967-02-26|1960-02-04|||||1960-06-27||1972-02-14|N|1964-11-21
TRIAL STUDY 134XCP|LB|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|2||||HLZPM|HALAZEPAM|||||||10^6 CFU/G|||||||INVALID||PIXELS/CM||||HIGH|NOT DONE||||URINE SEDIMENT|GELLED|Y|FREEZING POINT DEPRESSION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|N|N|||U|1||38||WASHOUT|1966-06-21|1962-03-06|||||1963-05-17||1966-04-03|Y|1969-06-21
TRIAL STUDY 134XCP|LB|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|1||||OXYSAT|OXYGEN SATURATION|||||||10^7 TCID 50/DOSE|||||||POSITIVE||USEC||||NORMAL|NOT DONE||||AQUEOUS HUMOR|CLOTTED|Y|PELLI-ROBSON EYE CHART|FIBROMETER FORMULA||Y|N|N|N|||U|2||58||WASHOUT|1967-01-12|1960-05-20|||||1966-06-06||1962-05-05|U|1963-02-13
TRIAL STUDY 134XCP|LB|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|2||||APRIL|A PROLIFERATION-INDUCING LIGAND|||||||TSP EQ|||||||POSITIVE||M3||||ABNORMAL|NOT DONE||||URINE SEDIMENT|PARAFFIN-EMBEDDED|N|U-HPLC/MS/MS|FIBROMETER FORMULA||U|U|Y|Y|||Y|2||58||BLINDED TREATMENT|1966-10-06|1973-05-26|||||1973-08-28||1967-12-21|U|1960-01-13
TRIAL STUDY 134XCP|LB|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|1||||TPRONP|NON-PHOSPHORYLATED TAU PROTEIN|||||||EVENTS|||||||TRACE||CP||||HIGH|NOT DONE||||CORD BLOOD|AUTOLYZED|N|MAMMOGRAPHY|FIBROTEST FORMULA||NA|NA|Y|U|||NA|3||39||OBSERVATION|1969-12-19|1973-08-24|||||1968-01-09||1962-07-10|NA|1970-07-18
TRIAL STUDY 134XCP|LB|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|2||||PLAT|PLATELETS|||||||ML/BREATH|||||||POSITIVE||ATM||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|CALCIFIED|U|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|COCKCROFT-GAULT FORMULA||Y|Y|N|Y|||U|3||39||INDUCTION TREATMENT|1963-07-25|1961-01-01|||||1969-12-29||1970-07-28|U|1968-03-10
TRIAL STUDY 134XCP|LB|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|1||||IA2AB|INSULINOMA-ASSOCIATED PROTEIN 2 ANTIBODY|||||||BOX|||||||BORDERLINE||AMU||||ABNORMAL|NOT DONE||||SERUM|UNEXPECTED ODOR|U|REBOUND TONOMETRY|MDRD 5 VARIABLE FORMULA||U|N|Y|N|||NA|4||88||WASHOUT|1972-12-05|1969-11-22|||||1973-04-27||1969-10-02|Y|1966-07-07
TRIAL STUDY 134XCP|LB|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|2||||BNP|BRAIN NATRIURETIC PEPTIDE|||||||SHOCK WAVE|||||||NEGATIVE||EU||||LOW|NOT DONE||||WHITE MATTER TISSUE|NON-HEMOLYZED|U|KINYOUN STAIN|MDRD 6 VARIABLE FORMULA||NA|NA|N|U|||U|4||88||RUN-IN|1967-05-05|1961-03-04|||||1971-05-09||1966-04-25|Y|1969-12-30
TRIAL STUDY 134XCP|LB|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|1||||CSGRANF|GRANULAR FINE CASTS|||||||KCAL|||||||INVALID||ML/KG/H||||LOW|NOT DONE||||RETICULOCYTES|HEMOLYZED|U|OBSERVATION|CKD-EPI CREATININE FORMULA||U|U|NA|NA|||Y|5||7||OBSERVATION|1968-09-23|1960-02-18|||||1971-05-08||1961-10-31|NA|1961-04-16
TRIAL STUDY 134XCP|LB|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|2||||CCL25|CHEMOKINE (C-C MOTIF) LIGAND 25|||||||CD|||||||BORDERLINE||FT3||||LOW|NOT DONE||||SYNOVIAL FLUID|DRIED|Y|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA||NA|N|NA|Y|||Y|5||7||LONG-TERM FOLLOW-UP|1963-01-15|1967-08-17|||||1964-05-22||1967-03-09|U|1962-06-10
TRIAL STUDY 134XCP|LB|5440F45F-C220-46E7-8354-6AF34A003E5E|1||||NMP22|NUCLEAR MATRIX PROTEIN 22|||||||ENZYME U/G HB|||||||NEGATIVE||IU/DL||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|ICTERIC|Y|FARNSWORTH-MUNSELL 100 HUE TEST|COCKCROFT-GAULT FORMULA||Y|Y|Y|U|||U|1||38||CONTINUATION TREATMENT|1972-05-13|1961-05-11|||||1962-04-13||1966-01-25|U|1972-05-18
TRIAL STUDY 134XCP|LB|5440F45F-C220-46E7-8354-6AF34A003E5E|2||||A1AGLP|ALPHA-1 ACID GLYCOPROTEIN|||||||ML*CMH2O|||||||NEGATIVE||BP||||NORMAL|NOT DONE||||BREAST MILK|THAWED|NA|NUCLEAR RADIOLOGY|FIBROMETER FORMULA||N|Y|NA|N|||N|1||38||BLINDED TREATMENT|1961-07-16|1963-12-03|||||1963-10-16||1969-04-17|N|1971-10-20
TRIAL STUDY 134XCP|LB|5440F45F-C220-46E7-8354-6AF34A003E5E|1||||LIPASEG|LIPASE, GASTRIC|||||||CM/MIN|||||||POSITIVE||BEL||||NORMAL|NOT DONE||||INFRANATANT, SERUM|ICTERIC|U|FLUOROSCOPY|MDRD 6 VARIABLE FORMULA||NA|N|N|N|||Y|2||58||CONTINUATION TREATMENT|1969-09-28|1970-11-28|||||1960-08-20||1962-07-15|Y|1963-10-12
TRIAL STUDY 134XCP|LB|5440F45F-C220-46E7-8354-6AF34A003E5E|2||||PYK|PYRUVATE KINASE|||||||SHOCK WAVE|||||||INDETERMINATE||DMOL||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|CALCIFIED|NA|TRANSMISSION ELECTRON MICROSCOPY|FIBROMETER FORMULA||Y|NA|NA|NA|||Y|2||58||TREATMENT|1970-07-11|1970-10-20|||||1967-04-07||1965-09-07|NA|1963-06-13
TRIAL STUDY 134XCP|LB|5440F45F-C220-46E7-8354-6AF34A003E5E|1||||AMYLOIDB|AMYLOID, BETA|||||||PM|||||||BORDERLINE||MMAL||||ABNORMAL|NOT DONE||||BONE|SOLIDIFIED|N|LYMPHANGIOGRAPHY|NASH FIBROSURE FORMULA||Y|NA|U|N|||N|3||39||OBSERVATION|1971-04-09|1963-08-25|||||1972-09-05||1973-05-19|Y|1972-03-17
TRIAL STUDY 134XCP|LB|5440F45F-C220-46E7-8354-6AF34A003E5E|2||||CD3LY|CD3/LYMPHOCYTES|||||||HOURS|||||||NEGATIVE||PPM||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|DRIED|U|CELLULOSE TAPE|GMI MMOL/MOL FORMULA||NA|NA|NA|U|||Y|3||39||FOLLOW-UP|1965-06-11|1964-08-09|||||1972-10-21||1961-03-22|N|1964-10-31
TRIAL STUDY 134XCP|LB|5440F45F-C220-46E7-8354-6AF34A003E5E|1||||OXACREAT|OXALATE/CREATININE|||||||MEQ/UG|||||||NEGATIVE||TCID 50/DOSE||||ABNORMAL|NOT DONE||||PERSPIRATION|AUTOLYZED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||N|N|Y|NA|||NA|4||88||FOLLOW-UP|1968-11-27|1972-12-07|||||1962-02-22||1971-06-12|NA|1968-05-28
TRIAL STUDY 134XCP|LB|5440F45F-C220-46E7-8354-6AF34A003E5E|2||||LDLPSZ|LDL PARTICLE SIZE|||||||U.CARR|||||||BORDERLINE||NMOL/MOL||||HIGH|NOT DONE||||PLEURAL TISSUE|CALCIFIED|Y|IMMUNOFLUORESCENT STAIN|MDRD ENZYMATIC FORMULA||NA|Y|Y|Y|||U|4||88||WASHOUT|1961-07-08|1962-07-11|||||1962-12-23||1961-03-20|N|1965-01-29
TRIAL STUDY 134XCP|LB|5440F45F-C220-46E7-8354-6AF34A003E5E|1||||FLT3L|FMS-LIKE TYROSINE KINASE 3 LIGAND|||||||ML/M2/H|||||||INVALID||NU/CL||||HIGH|NOT DONE||||EMOTIONAL TEAR|CLOTTED|NA|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|NA|Y|||NA|5||7||CONTINUATION TREATMENT|1971-01-25|1966-08-20|||||1970-05-21||1973-02-05|NA|1971-11-09
TRIAL STUDY 134XCP|LB|5440F45F-C220-46E7-8354-6AF34A003E5E|2||||C165905|GRASS MIX POLLEN IGG AB RAST SCORE|||||||TSP|||||||TRACE||DB||||HIGH|NOT DONE||||VENOUS PLASMA|AUTOLYZED|NA|MICROARRAY|ASH FIBROSURE FORMULA||U|NA|U|U|||NA|5||7||BLINDED TREATMENT|1967-05-05|1970-08-17|||||1967-05-14||1963-04-05|N|1963-04-10
TRIAL STUDY 134XCP|LB|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|1||||AUERRODS|AUER RODS|||||||MU|||||||INDETERMINATE||NM||||HIGH|NOT DONE||||RETICULOCYTES|SOLIDIFIED|U|REVERSE TRANSCRIPTASE PCR|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|U|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1970-04-22|1963-08-15|||||1973-02-15||1962-12-24|N|1970-02-04
TRIAL STUDY 134XCP|LB|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|2||||ANGLOBDR|ANTIGLOBULIN TEST, DIRECT|||||||FMOL/L/SEC|||||||NEGATIVE||10^4/HPF||||HIGH|NOT DONE||||TRANSUDATE|ICTERIC|U|MAPH|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|NA|Y|||Y|1||38||WASHOUT|1965-08-27|1971-05-27|||||1972-11-24||1967-08-09|NA|1967-02-16
TRIAL STUDY 134XCP|LB|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|1||||MPXI|MYELOPEROXIDASE INDEX|||||||10^3/HPF|||||||BORDERLINE||UMOL/L/H||||LOW|NOT DONE||||BILE|GELLED|U|HEMOCYTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|U|N|||Y|2||58||BASELINE|1961-05-24|1967-06-22|||||1973-06-14||1966-09-08|N|1961-07-09
TRIAL STUDY 134XCP|LB|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|2||||APLIGMAB|ANTI-PHOSPHOLIPID IGM ANTIBODY|||||||BQ/MG|||||||INDETERMINATE||NKAT||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|CONCENTRATED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|FIBROSIS 4 FORMULA||NA|N|Y|U|||Y|2||58||OBSERVATION|1966-11-18|1965-11-07|||||1962-10-09||1961-01-04|NA|1968-05-17
TRIAL STUDY 134XCP|LB|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|1||||FATDROP|FAT DROPLET|||||||FIU|||||||NEGATIVE||PACK YEAR||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|ROOM TEMPERATURE|Y|PERFUSION MRI|FIBROSIS 4 FORMULA||U|NA|U|Y|||N|3||39||SCREENING|1973-01-13|1960-07-18|||||1965-03-22||1963-11-05|NA|1971-06-11
TRIAL STUDY 134XCP|LB|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|2||||CRTCREAT|CORTICOSTERONE/CREATININE|||||||CARTRIDGE|||||||BORDERLINE||BAR||||NORMAL|NOT DONE||||NAIL|ICTERIC|Y|ENDOSCOPY|FIBROTEST FORMULA||Y|U|U|U|||U|3||39||OBSERVATION|1963-05-24|1968-04-04|||||1960-12-07||1966-12-10|U|1966-08-19
TRIAL STUDY 134XCP|LB|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|1||||BACT|BACTERIA|||||||ANTIBODY UNIT|||||||INVALID||UL/DOSE||||HIGH|NOT DONE||||SPERMATOZOON|CALCIFIED|N|ISHIHARA COLOR PLATES|MDRD 5 VARIABLE FORMULA||Y|U|NA|N|||NA|4||88||OBSERVATION|1972-03-02|1972-08-30|||||1972-08-19||1966-04-27|U|1961-08-10
TRIAL STUDY 134XCP|LB|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|2||||CD4CD8|CD4/CD8|||||||FRACTION OF 1|||||||INDETERMINATE||U/KG/H||||LOW|NOT DONE||||CORD SERUM|CLOTTED|U|CONTACT SPECULAR MICROSCOPY|ASH FIBROSURE FORMULA||NA|U|NA|N|||NA|4||88||BASELINE|1964-10-31|1969-11-15|||||1970-11-18||1971-02-10|N|1961-11-15
TRIAL STUDY 134XCP|LB|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|1||||BASOMM|BASOPHILIC METAMYELOCYTES|||||||L/S/KPA|||||||NEGATIVE||CI/UG||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|AGGLUTINATED|NA|HPLC/MS|CKD-EPI CREATININE FORMULA||U|N|NA|Y|||N|5||7||CONTINUATION TREATMENT|1960-07-08|1972-04-03|||||1966-04-11||1960-05-16|N|1961-05-17
TRIAL STUDY 134XCP|LB|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|2||||TNFR1B|TNF RECEPTOR 1B|||||||ML/KG|||||||POSITIVE||NL||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|LIPEMIC|U|CRYOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|NA|U|||Y|5||7||OPEN LABEL TREATMENT|1964-08-19|1967-08-21|||||1964-09-18||1971-04-16|NA|1970-12-14
TRIAL STUDY 134XCP|LB|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|1||||METHQLDN|METHAQUALONE|||||||AGU/ML|||||||INVALID||U/10^12 RBC||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|UNEXPECTED ODOR|U|DUKE INCISION METHOD|MDRD ENZYMATIC FORMULA||NA|U|Y|U|||NA|1||38||LONG-TERM FOLLOW-UP|1965-02-10|1971-08-11|||||1973-06-15||1970-09-23|N|1968-05-31
TRIAL STUDY 134XCP|LB|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|2||||MYCEPIDX|MYELOID PROLIFERATION INDEX|||||||MMOL/MIN/KPA|||||||INVALID||UG/G/DAY||||LOW|NOT DONE||||HAIR|LACTESCENT|NA|DC SHEATH FLOW|MDRD 6 VARIABLE FORMULA||N|NA|Y|N|||NA|1||38||INDUCTION TREATMENT|1964-08-30|1973-06-13|||||1960-06-30||1964-01-13|U|1970-09-28
TRIAL STUDY 134XCP|LB|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|1||||MLATONIN|MELATONIN|||||||MMOL/KG|||||||TRACE||MG/ANIMAL||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|LIPEMIC|NA|INFRARED SPECTROMETRY|MDRD FORMULA||NA|N|U|N|||NA|2||58||SCREENING|1962-02-21|1971-07-14|||||1967-08-27||1960-05-02|U|1969-03-23
TRIAL STUDY 134XCP|LB|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|2||||GLDAB|GLIADIN ANTIBODY|||||||NKAT|||||||BORDERLINE||IU/L||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|DRIED|U|ETDRS EYE CHART|NASH FIBROSURE FORMULA||Y|U|Y|N|||N|2||58||RUN-IN|1964-08-27|1963-01-28|||||1962-12-29||1964-07-16|N|1972-10-21
TRIAL STUDY 134XCP|LB|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|1||||CALB|CALBINDIN|||||||NMOL/KG/DAY|||||||INVALID||STRIP||||HIGH|NOT DONE||||ABSCESS FLUID|NON-HEMOLYZED|N|IMMUNO-PET SCAN|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|U|NA|||Y|3||39||BASELINE|1966-07-01|1967-07-12|||||1960-05-06||1967-09-01|Y|1971-10-24
TRIAL STUDY 134XCP|LB|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|2||||ALDEPX|ALDRIN EPOXIDASE|||||||CMH2O*S2/ML|||||||INVALID||10^9 ORGANISMS||||HIGH|NOT DONE||||VENOUS BLOOD|CONCENTRATED|Y|HPLC/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|U|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1970-07-12|1964-06-21|||||1966-08-09||1962-10-07|N|1966-09-15
TRIAL STUDY 134XCP|LB|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|1||||LH|LUTEINIZING HORMONE|||||||IU/MMOL|||||||POSITIVE||MEQ/DAY||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|NA|FLOW CYTOMETRY|MDRD 6 VARIABLE FORMULA||Y|NA|Y|NA|||U|4||88||TREATMENT|1972-04-09|1970-08-02|||||1971-04-15||1973-01-03|U|1963-04-12
TRIAL STUDY 134XCP|LB|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|2||||HLAB|HLA CLASS IB ANTIGEN|||||||SACHET|||||||POSITIVE||10^3 ORGANISMS||||LOW|NOT DONE||||SEBUM|REFRIGERATED|Y|DOPPLER ULTRASOUND|MDRD 6 VARIABLE FORMULA||NA|N|NA|NA|||Y|4||88||WASHOUT|1962-10-12|1973-07-01|||||1961-03-10||1969-10-19|NA|1970-08-01
TRIAL STUDY 134XCP|LB|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|1||||CDCA|CHENODEOXYCHOLATE|||||||BQ/MG|||||||BORDERLINE||DB||||ABNORMAL|NOT DONE||||SMEGMA|PARAFFIN-EMBEDDED|U|ELECTRONEUROGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|NA|N|||U|5||7||WASHOUT|1960-01-01|1961-08-08|||||1970-08-25||1967-12-26|NA|1962-05-31
TRIAL STUDY 134XCP|LB|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|2||||HLAAMSC|HLA-A MISMATCH COUNT|||||||LX|||||||INDETERMINATE||IN2||||NORMAL|NOT DONE||||ISOLATE|ICTERIC|Y|ATOMIC ABSORPTION SPECTROMETRY|NASH FIBROSURE FORMULA||Y|NA|NA|N|||U|5||7||LONG-TERM FOLLOW-UP|1964-01-01|1971-01-22|||||1970-12-10||1969-11-04|Y|1961-01-23
TRIAL STUDY 134XCP|LB|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|1||||ANGTNSGN|ANGIOTENSINOGEN|||||||NM|||||||BORDERLINE||MOL/DAY||||LOW|NOT DONE||||LAVAGE FLUID|UNEXPECTED ODOR|Y|PERCUSSION|GMI % FORMULA||U|Y|N|U|||U|1||38||INDUCTION TREATMENT|1961-02-04|1969-08-02|||||1964-07-19||1961-02-02|NA|1965-12-03
TRIAL STUDY 134XCP|LB|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|2||||CSGRANC|GRANULAR COARSE CASTS|||||||MN|||||||NEGATIVE||UMOL/MOL||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|HEMOLYZED|NA|MICROPARTICLE ENZYME IMMUNOASSAY|GMI % FORMULA||Y|N|Y|NA|||NA|1||38||RUN-IN|1973-01-23|1966-02-22|||||1964-12-09||1967-07-18|N|1963-04-02
TRIAL STUDY 134XCP|LB|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|1||||CLCLR|CHLORIDE CLEARANCE|||||||DPM|||||||POSITIVE||%(W/W)||||HIGH|NOT DONE||||BONE|CALCIFIED|Y|ANTIBIOTIC AGAR SCREEN|MDRD 6 VARIABLE FORMULA||N|N|Y|NA|||Y|2||58||INDUCTION TREATMENT|1960-11-05|1962-06-25|||||1971-04-04||1966-05-31|N|1963-02-17
TRIAL STUDY 134XCP|LB|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|2||||ALTAST|ALT/AST|||||||BQ/MG|||||||BORDERLINE||10^6 ORGANISMS/ML||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|CONCENTRATED|Y|SNELLEN EYE CHART|HEPASCORE FORMULA||NA|NA|NA|U|||N|2||58||FOLLOW-UP|1961-09-05|1965-05-23|||||1964-03-24||1966-07-19|NA|1967-12-16
TRIAL STUDY 134XCP|LB|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|1||||C130143|GERMAN COCKROACH ANTIGEN IGG4 ANTIBODY|||||||DEG2|||||||POSITIVE||ML/BREATH||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|ICTERIC|Y|NON-INVASIVE DIELECTRIC SENSING|CKD-EPI CREATININE FORMULA||NA|U|Y|U|||U|3||39||LONG-TERM FOLLOW-UP|1973-02-11|1966-11-26|||||1969-06-19||1968-04-26|Y|1966-04-18
TRIAL STUDY 134XCP|LB|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|2||||ACHRAB|ACETYLCHOLINE RECEPTOR ANTIBODY|||||||SPRAY|||||||POSITIVE||OD UNIT||||LOW|NOT DONE||||PLATELET POOR PLASMA|ICTERIC|N|NUCLEIC ACID HYBRIDIZATION|NASH FIBROSURE FORMULA||NA|NA|N|Y|||Y|3||39||FOLLOW-UP|1962-12-25|1971-01-02|||||1961-11-18||1971-09-04|U|1965-04-09
TRIAL STUDY 134XCP|LB|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|1||||CGMP|CYCLIC GUANOSINE MONOPHOSPHATE|||||||MU/L|||||||TRACE||ML/CAGE/DAY||||ABNORMAL|NOT DONE||||STOOL|DRIED|Y|MALDI|MDRD FORMULA||U|Y|NA|U|||U|4||88||TREATMENT|1972-05-18|1968-07-18|||||1972-03-28||1970-05-29|Y|1972-01-04
TRIAL STUDY 134XCP|LB|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|2||||GHBP|GROWTH HORMONE BINDING PROTEIN|||||||GLOBULE|||||||POSITIVE||ENZYME U/L||||LOW|NOT DONE||||BILE|FRESH|NA|LAPAROSCOPY|CKD-EPI CREATININE FORMULA||NA|Y|NA|NA|||Y|4||88||FOLLOW-UP|1971-04-23|1972-06-09|||||1961-03-16||1973-04-03|NA|1966-05-15
TRIAL STUDY 134XCP|LB|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|1||||T3|TRIIODOTHYRONINE|||||||UM|||||||INVALID||HOUNSFIELD UNIT||||HIGH|NOT DONE||||FLUID|PARAFFIN-EMBEDDED|Y|FLAME PHOTOMETRY|CKD-EPI CREATININE FORMULA||U|Y|N|NA|||NA|5||7||TREATMENT|1969-05-20|1967-12-22|||||1966-10-19||1970-02-22|U|1961-01-06
TRIAL STUDY 134XCP|LB|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|2||||LYMAT|LYMPHOCYTES ATYPICAL|||||||GRAIN|||||||INVALID||UL/KG/DAY||||LOW|NOT DONE||||ABSCESS FLUID|LIPEMIC|Y|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|U|NA|||NA|5||7||SCREENING|1961-06-19|1962-10-29|||||1960-02-26||1972-11-16|Y|1973-04-09
TRIAL STUDY 134XCP|LB|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|1||||MCH|ERY. MEAN CORPUSCULAR HEMOGLOBIN|||||||NEEDLE GAUGE|||||||POSITIVE||CM2||||ABNORMAL|NOT DONE||||LOCHIA|DRIED|U|INCISION-INDUCED BLEEDING METHOD|MDRD 6 VARIABLE FORMULA||Y|U|U|U|||Y|1||38||BASELINE|1970-06-09|1973-03-21|||||1972-02-20||1962-07-09|Y|1973-07-06
TRIAL STUDY 134XCP|LB|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|2||||CH50|COMPLEMENT CH50|||||||ML/M2/MIN|||||||INDETERMINATE||IU/MG||||ABNORMAL|NOT DONE||||TRANSUDATE|AUTOLYZED|N|BAC ACGH|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|NA|||NA|1||38||BLINDED TREATMENT|1962-10-08|1972-05-29|||||1973-05-28||1970-09-02|U|1970-07-25
TRIAL STUDY 134XCP|LB|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|1||||K|POTASSIUM|||||||/10^4|||||||NEGATIVE||COULOMB||||HIGH|NOT DONE||||SEMEN|CONTAMINATED|NA|INDIA INK STAIN|MDRD 6 VARIABLE FORMULA||U|N|N|N|||U|2||58||SCREENING|1963-04-29|1967-06-13|||||1961-08-26||1968-05-26|Y|1964-11-06
TRIAL STUDY 134XCP|LB|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|2||||CIC|CIRCULATING IMMUNE COMPLEXES|||||||UMOL/DL|||||||INVALID||G/CM2||||ABNORMAL|NOT DONE||||SALIVA|FRESH|U|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD FORMULA||U|N|N|N|||U|2||58||WASHOUT|1961-03-14|1963-07-07|||||1961-02-22||1966-09-20|N|1966-01-23
TRIAL STUDY 134XCP|LB|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|1||||APLIGGAB|ANTI-PHOSPHOLIPID IGG ANTIBODY|||||||10^6 DNA COPIES/ML|||||||BORDERLINE||MG/G/MIN||||HIGH|NOT DONE||||VITREOUS HUMOR|PARAFFIN-EMBEDDED|NA|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|NA|N|||U|3||39||SCREENING|1969-07-09|1965-09-10|||||1972-11-11||1964-06-26|N|1968-02-29
TRIAL STUDY 134XCP|LB|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|2||||RBCDYSM|DYSMORPHIC ERYTHROCYTES|||||||KCAL/DAY|||||||INVALID||MDFI||||LOW|NOT DONE||||INFRANATANT, PLASMA|UNEXPECTED ODOR|U|MICRO BROTH DILUTION|CKD-EPI CREATININE FORMULA||Y|N|N|N|||N|3||39||WASHOUT|1965-04-20|1961-10-09|||||1973-06-27||1970-12-03|N|1963-12-17
TRIAL STUDY 134XCP|LB|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|1||||CSGRAN|GRANULAR CASTS|||||||JOULE|||||||INVALID||PM||||ABNORMAL|NOT DONE||||PLATELET|HEMOLYZED|NA|HPLC|GMI % FORMULA||N|U|Y|U|||NA|4||88||BASELINE|1963-01-22|1969-01-24|||||1961-08-20||1962-07-09|N|1962-10-27
TRIAL STUDY 134XCP|LB|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|2||||C130102|TREE MIX POLLEN ANTIGEN IGG ANTIBODY|||||||KA_U/DL|||||||TRACE||COULOMB||||NORMAL|NOT DONE||||EXUDATE|LACTESCENT|U|DYNAMIC LIGHT SCATTERING|GMI MMOL/MOL FORMULA||N|NA|Y|Y|||U|4||88||FOLLOW-UP|1969-07-06|1961-05-24|||||1973-06-29||1960-08-01|N|1964-11-16
TRIAL STUDY 134XCP|LB|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|1||||THEOPHYL|THEOPHYLLINE|||||||%/S|||||||BORDERLINE||DRAM||||HIGH|NOT DONE||||PLATELET|ICTERIC|N|REFRACTOMETRY|FIBROSIS 4 FORMULA||Y|N|NA|U|||N|5||7||INDUCTION TREATMENT|1960-07-09|1964-03-17|||||1973-06-23||1972-09-28|U|1969-08-11
TRIAL STUDY 134XCP|LB|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|2||||MASTCE|MAST CELLS|||||||UG/G/MIN|||||||NEGATIVE||PA||||LOW|NOT DONE||||STOOL|CLOTTED|U|SXA SCAN|FIBROMETER FORMULA||Y|Y|N|NA|||U|5||7||TREATMENT|1971-06-01|1960-07-25|||||1971-07-06||1960-01-22|N|1970-05-05
TRIAL STUDY 134XCP|LB|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|1||||CANNABS|CANNABINOIDS, SYNTHETIC|||||||COPIES/ML|||||||TRACE||CGY||||LOW|NOT DONE||||DERMAL TISSUE|LACTESCENT|U|NEXT GENERATION TARGETED SEQUENCING|NASH FIBROSURE FORMULA||NA|N|Y|Y|||Y|1||38||LONG-TERM FOLLOW-UP|1963-08-15|1963-01-31|||||1969-12-01||1973-07-10|U|1966-02-02
TRIAL STUDY 134XCP|LB|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|2||||C165889|RUSSIAN THISTLE POLLEN IGE AB RAST SCORE|||||||DAGU/ML|||||||INDETERMINATE||VP/ML||||HIGH|NOT DONE||||ISOLATE|HEMOLYZED|NA|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD 5 VARIABLE FORMULA||U|NA|N|Y|||N|1||38||OBSERVATION|1967-02-27|1969-11-26|||||1961-09-14||1968-02-12|Y|1966-12-05
TRIAL STUDY 134XCP|LB|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|1||||A73OXC|7-ALPHA-HYDROXY-4-CHOLESTEN-3-ONE|||||||/VF|||||||INVALID||FARAD||||LOW|NOT DONE||||LEUKOCYTE|CALCIFIED|NA|CELLULOSE TAPE|GMI MMOL/MOL FORMULA||N|U|Y|U|||Y|2||58||RUN-IN|1963-04-07|1968-01-13|||||1972-06-09||1973-06-07|NA|1973-06-13
TRIAL STUDY 134XCP|LB|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|2||||IOHEXOL|IOHEXOL|||||||NG/L|||||||INVALID||/SEC||||HIGH|NOT DONE||||INFRANATANT, SERUM|ICTERIC|U|ZIEHL NEELSEN ACID FAST STAIN|MDRD 4 VARIABLE FORMULA||Y|N|U|Y|||U|2||58||LONG-TERM FOLLOW-UP|1969-04-18|1970-05-31|||||1964-02-05||1970-09-09|N|1969-10-06
TRIAL STUDY 134XCP|LB|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|1||||BLASTLM|LEUKEMIC BLASTS|||||||UG/M2/H|||||||BORDERLINE||EP U||||ABNORMAL|NOT DONE||||CORD SERUM|NON-HEMOLYZED|NA|ANTIBIOTIC AGAR SCREEN|CKD-EPI CREATININE FORMULA||N|U|U|N|||NA|3||39||LONG-TERM FOLLOW-UP|1967-03-08|1970-10-14|||||1972-08-01||1971-03-08|Y|1961-09-25
TRIAL STUDY 134XCP|LB|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|2||||CD3LY|CD3/LYMPHOCYTES|||||||CONTAINER|||||||NEGATIVE||DAMOL/L||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|U|FLUORESCENT LIFETIME IMAGING MICROSCOPY|GMI MMOL/MOL FORMULA||N|NA|NA|N|||N|3||39||OBSERVATION|1962-10-19|1967-06-23|||||1966-12-18||1960-05-08|U|1973-03-09
TRIAL STUDY 134XCP|LB|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|1||||HEINZRBC|HEINZ BODIES/ERYTHROCYTES|||||||CMH2O*S2/ML|||||||NEGATIVE||NCI||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|FROZEN|NA|SLOAN LETTER EYE CHART 100%|ASH FIBROSURE FORMULA||Y|Y|Y|Y|||N|4||88||BLINDED TREATMENT|1968-06-25|1969-09-21|||||1962-08-25||1960-09-24|U|1972-02-16
TRIAL STUDY 134XCP|LB|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|2||||CITCREAT|CITRATE/CREATININE|||||||PA|||||||INVALID||NG/L||||HIGH|NOT DONE||||LEUKOCYTE|CLOTTED|N|SLIT LAMP|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|N|U|||N|4||88||SCREENING|1963-05-26|1964-04-03|||||1962-07-23||1962-10-14|U|1963-03-01
TRIAL STUDY 134XCP|LB|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|1||||GRANLE|GRANULOCYTES/LEUKOCYTES|||||||DAYS/MONTH|||||||POSITIVE||UMOL/MIN||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|PARAFFIN-EMBEDDED|NA|FORCED OSCILLATION TECHNIQUE|MDRD 4 VARIABLE FORMULA||U|U|N|U|||U|5||7||RUN-IN|1972-04-20|1964-08-23|||||1965-10-21||1971-06-11|Y|1970-11-26
TRIAL STUDY 134XCP|LB|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|2||||GATCPHRL|GAMMA TOCOPHEROL|||||||/5X10^4 WBC|||||||INVALID||KPA/L/SEC||||LOW|NOT DONE||||BUFFY COAT|LACTESCENT|U|NEPHELOMETRY|MDRD FORMULA||U|Y|U|Y|||NA|5||7||WASHOUT|1972-11-02|1966-08-28|||||1967-02-06||1960-03-11|N|1972-12-27
TRIAL STUDY 134XCP|LB|1E9C7E41-8565-4C60-9EEB-814914081596|1||||SPERM|SPERMATOZOA|||||||MEQ/UG|||||||TRACE||10^9/DOSE||||LOW|NOT DONE||||MUSCLE TISSUE|FROZEN|NA|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD 5 VARIABLE FORMULA||N|Y|N|NA|||NA|1||38||WASHOUT|1967-11-28|1967-11-15|||||1963-05-04||1969-12-20|N|1968-04-11
TRIAL STUDY 134XCP|LB|1E9C7E41-8565-4C60-9EEB-814914081596|2||||IAPP|ISLET AMYLOID POLYPEPTIDE|||||||UG/L|||||||POSITIVE||NGEQ/L||||HIGH|NOT DONE||||PLATELET RICH PLASMA|REFRIGERATED|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|GMI MMOL/MOL FORMULA||Y|NA|U|NA|||Y|1||38||FOLLOW-UP|1970-03-01|1966-03-29|||||1973-01-02||1969-10-13|NA|1967-11-05
TRIAL STUDY 134XCP|LB|1E9C7E41-8565-4C60-9EEB-814914081596|1||||FBNCTFT|FIBRONECTIN, FETAL|||||||CD*S/M2|||||||INDETERMINATE||LOG10 CCID 50/DOSE||||LOW|NOT DONE||||STOOL|CALCIFIED|NA|HPLC/IEX|FIBROSIS 4 FORMULA||N|NA|NA|Y|||NA|2||58||FOLLOW-UP|1960-06-03|1969-04-03|||||1968-03-22||1970-06-01|Y|1969-06-11
TRIAL STUDY 134XCP|LB|1E9C7E41-8565-4C60-9EEB-814914081596|2||||PHNKET|PHENYLKETONES|||||||MEQ/DL|||||||POSITIVE||ML/KG/DAY||||LOW|NOT DONE||||CEREBROSPINAL FLUID|CLOTTED|U|CLAUSS METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|NA|N|||Y|2||58||WASHOUT|1971-01-06|1970-08-06|||||1966-02-13||1966-07-30|NA|1965-05-27
TRIAL STUDY 134XCP|LB|1E9C7E41-8565-4C60-9EEB-814914081596|1||||WBC|LEUKOCYTES|||||||BAR|||||||BORDERLINE||DRAM||||LOW|NOT DONE||||RETICULOCYTES|ICTERIC|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|U|NA|||U|3||39||OPEN LABEL TREATMENT|1970-12-06|1962-10-11|||||1962-01-14||1963-09-12|N|1966-01-09
TRIAL STUDY 134XCP|LB|1E9C7E41-8565-4C60-9EEB-814914081596|2||||BURRCE|BURR CELLS|||||||MU|||||||INVALID||CM/S||||NORMAL|NOT DONE||||ALVEOLAR AIR|AUTOLYZED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|U|N|||Y|3||39||RUN-IN|1963-10-28|1972-07-20|||||1973-01-30||1960-07-26|NA|1972-10-05
TRIAL STUDY 134XCP|LB|1E9C7E41-8565-4C60-9EEB-814914081596|1||||RNPSMAB|RIBONUCLEOPROTEIN SMITH COMPLEX ANTIBODY|||||||UG/MIN|||||||NEGATIVE||MMOL/MIN/KPA/L||||NORMAL|NOT DONE||||EMESIS|CALCIFIED|NA|ENZYMATIC ULTRACENTRIFUGATION|FIBROSIS 4 FORMULA||N|Y|Y|NA|||U|4||88||TREATMENT|1963-10-13|1963-09-23|||||1972-11-19||1972-03-08|U|1961-02-05
TRIAL STUDY 134XCP|LB|1E9C7E41-8565-4C60-9EEB-814914081596|2||||PTA|PROTHROMBIN ACTIVITY|||||||/HPF|||||||BORDERLINE||MOSM/L||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|REFRIGERATED|Y|DOUBLE IMMUNODIFFUSION|FIBROMETER FORMULA||N|NA|U|N|||U|4||88||BLINDED TREATMENT|1962-06-22|1960-11-13|||||1961-07-15||1961-12-01|U|1967-02-02
TRIAL STUDY 134XCP|LB|1E9C7E41-8565-4C60-9EEB-814914081596|1||||BLYCELE|B-LYMPHOCYTES/LEUKOCYTES|||||||U/M2/H|||||||POSITIVE||MG/ML/DAY||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|DRIED|Y|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|Y|Y|||Y|5||7||OPEN LABEL TREATMENT|1971-06-20|1963-03-10|||||1970-06-15||1966-12-26|N|1971-10-27
TRIAL STUDY 134XCP|LB|1E9C7E41-8565-4C60-9EEB-814914081596|2||||OHF6B|6 BETA-HYDROXYCORTISOL|||||||UL/KG/DAY|||||||BORDERLINE||FMOL||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|AUTOLYZED|U|CALCOFLUOR WHITE STAIN|MDRD FORMULA||Y|Y|U|U|||N|5||7||SCREENING|1960-10-28|1964-11-09|||||1965-08-08||1966-05-02|U|1971-05-22
TRIAL STUDY 134XCP|LB|D7A008CF-5990-4D74-934A-A4DD3180EBD4|1||||NTENS|NEUROTENSIN|||||||PLUG|||||||TRACE||LOZENGE||||NORMAL|NOT DONE||||LEUKOCYTE|PARAFFIN-EMBEDDED|U|FLUORESCENT LIFETIME IMAGING MICROSCOPY|NASH FIBROSURE FORMULA||U|U|N|U|||U|1||38||SCREENING|1971-06-21|1971-10-28|||||1964-03-25||1968-05-27|NA|1961-05-08
TRIAL STUDY 134XCP|LB|D7A008CF-5990-4D74-934A-A4DD3180EBD4|2||||MYBLAT2|TYPE II MYELOBLASTS|||||||G/ANIMAL|||||||POSITIVE||UM2||||NORMAL|NOT DONE||||LUNG SURFACTANT|NON-HEMOLYZED|NA|RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|Y|U|||N|1||38||CONTINUATION TREATMENT|1970-01-18|1966-10-12|||||1969-07-31||1971-05-14|N|1961-05-23
TRIAL STUDY 134XCP|LB|D7A008CF-5990-4D74-934A-A4DD3180EBD4|1||||VTD2D3IT|25-HYDROXYVIT D2 + 25-HYDROXYVIT D3|||||||10^6/HPF|||||||POSITIVE||MCI||||NORMAL|NOT DONE||||MUSCLE TISSUE|SOLIDIFIED|U|CONFOCAL MICROSCOPY|ASH FIBROSURE FORMULA||N|Y|N|NA|||U|2||58||CONTINUATION TREATMENT|1973-06-16|1964-05-01|||||1963-12-24||1970-01-02|U|1964-12-25
TRIAL STUDY 134XCP|LB|D7A008CF-5990-4D74-934A-A4DD3180EBD4|2||||TRPCRT|TRYPTOPHAN/CREATININE|||||||UG/M2|||||||INDETERMINATE||V/V||||ABNORMAL|NOT DONE||||VENOUS BLOOD|CONTAMINATED|NA|SMEAR|MDRD FORMULA||Y|U|U|U|||NA|2||58||RUN-IN|1973-01-05|1963-06-07|||||1966-07-18||1962-11-07|N|1973-01-25
TRIAL STUDY 134XCP|LB|D7A008CF-5990-4D74-934A-A4DD3180EBD4|1||||MMP9|MATRIX METALLOPROTEINASE 9|||||||TESLA|||||||INDETERMINATE||NMOL/G||||NORMAL|NOT DONE||||SPERMATOZOON|FRESH|Y|INTRAVASCULAR ULTRASOUND|CKD-EPI CREATININE FORMULA||NA|NA|U|U|||NA|3||39||FOLLOW-UP|1970-02-04|1973-05-20|||||1973-06-07||1963-07-28|NA|1970-05-29
TRIAL STUDY 134XCP|LB|D7A008CF-5990-4D74-934A-A4DD3180EBD4|2||||CALB|CALBINDIN|||||||BREATHS/MIN|||||||NEGATIVE||C||||LOW|NOT DONE||||ADIPOSE TISSUE|GELLED|Y|OPTICAL MAPPING|GMI MMOL/MOL FORMULA||NA|N|Y|U|||Y|3||39||CONTINUATION TREATMENT|1972-06-25|1971-06-01|||||1962-06-21||1968-12-08|NA|1963-08-12
TRIAL STUDY 134XCP|LB|D7A008CF-5990-4D74-934A-A4DD3180EBD4|1||||VLDLTCT|VLDL TRIGLYCERIDE + CHYLOMICRON TRIGLYCERIDE|||||||FMOL/G|||||||BORDERLINE||10^3 CFU||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|LIPEMIC|Y|MANUAL CLOT DETECTION|GMI MMOL/MOL FORMULA||N|N|U|U|||Y|4||88||SCREENING|1963-09-29|1969-11-08|||||1962-02-23||1964-10-23|NA|1969-08-04
TRIAL STUDY 134XCP|LB|D7A008CF-5990-4D74-934A-A4DD3180EBD4|2||||VLDL2|VLDL CHOLESTEROL SUBTYPE 2|||||||10^6/HPF|||||||INDETERMINATE||/CMH2O||||HIGH|NOT DONE||||INFRANATANT, SERUM|LIPEMIC|Y|NEXT GENERATION TARGETED SEQUENCING|FIBROSIS 4 FORMULA||NA|U|NA|NA|||NA|4||88||INDUCTION TREATMENT|1963-04-06|1964-04-27|||||1968-10-28||1972-04-13|U|1961-05-18
TRIAL STUDY 134XCP|LB|D7A008CF-5990-4D74-934A-A4DD3180EBD4|1||||PKM1|PYRUVATE KINASE ISOZYME M1|||||||L/H/M2|||||||NEGATIVE||MM/MIN||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|FROZEN|U|SECONDARY ION MASS SPECTOMETRY|CKD-EPI CYSTATIN C FORMULA||N|N|Y|Y|||NA|5||7||SCREENING|1968-05-12|1973-06-15|||||1972-08-11||1968-06-21|NA|1962-07-26
TRIAL STUDY 134XCP|LB|D7A008CF-5990-4D74-934A-A4DD3180EBD4|2||||PRAB|PANEL REACTIVE ANTIBODY|||||||PPM|||||||POSITIVE||KIT||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|THAWED|N|RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|Y|Y|||N|5||7||FOLLOW-UP|1963-11-17|1960-09-11|||||1966-05-16||1968-09-08|N|1967-04-02
TRIAL STUDY 134XCP|LB|C168FA23-40EE-46D8-9A56-8B80490A0EFB|1||||OSMRTY|OSMOLARITY|||||||G/CM2|||||||TRACE||GY||||NORMAL|NOT DONE||||EXUDATE|CALCIFIED|U|CLAUSS METHOD|FIBROSIS 4 FORMULA||NA|Y|N|N|||NA|1||38||WASHOUT|1962-06-18|1971-10-03|||||1961-07-21||1961-12-05|U|1960-03-31
TRIAL STUDY 134XCP|LB|C168FA23-40EE-46D8-9A56-8B80490A0EFB|2||||COCBNZEC|COCAINE BENZOYLECGONINE ECGONINE|||||||EIA UNIT|||||||POSITIVE||MV/SEC||||NORMAL|NOT DONE||||BASAL TEAR|DRIED|Y|ACCELERATOR MASS SPECTROMETRY|MDRD FORMULA||Y|Y|Y|N|||U|1||38||OBSERVATION|1962-06-05|1972-10-23|||||1962-11-23||1973-01-15|Y|1961-11-05
TRIAL STUDY 134XCP|LB|C168FA23-40EE-46D8-9A56-8B80490A0EFB|1||||INTLK1RA|INTERLEUKIN 1 RECEPTOR ANTAGONIST|||||||MEQ/G|||||||NEGATIVE||UG/KG/MIN||||LOW|NOT DONE||||REFLEX TEAR|AGGLUTINATED|NA|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|N|U|||NA|2||58||CONTINUATION TREATMENT|1972-05-09|1962-01-18|||||1970-06-10||1972-06-03|N|1963-09-07
TRIAL STUDY 134XCP|LB|C168FA23-40EE-46D8-9A56-8B80490A0EFB|2||||C130101|TREE MIX POLLEN ANTIGEN IGE ANTIBODY|||||||UG/MOL|||||||INDETERMINATE||MM3/MM2/YEAR||||HIGH|NOT DONE||||SEBUM|THAWED|U|ULTRASOUND|FIBROMETER FORMULA||NA|N|Y|NA|||U|2||58||BLINDED TREATMENT|1972-09-05|1962-04-21|||||1969-12-02||1967-05-16|N|1964-07-10
TRIAL STUDY 134XCP|LB|C168FA23-40EE-46D8-9A56-8B80490A0EFB|1||||MCSF|MACROPHAGE COLONY STIMULATING FACTOR|||||||MOSM/L|||||||INDETERMINATE||UMOL/L||||HIGH|NOT DONE||||ISOLATE|NON-HEMOLYZED|U|PLETHYSMOGRAPHY|CKD-EPI FORMULA||U|N|Y|Y|||NA|3||39||OPEN LABEL TREATMENT|1964-08-01|1971-05-23|||||1971-01-29||1960-01-15|N|1967-03-16
TRIAL STUDY 134XCP|LB|C168FA23-40EE-46D8-9A56-8B80490A0EFB|2||||LGUNSCE|LARGE UNSTAINED CELLS|||||||M2|||||||TRACE||UG/G/MIN||||LOW|NOT DONE||||VENOUS BLOOD|DRIED|NA|MRS|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|Y|U|||NA|3||39||FOLLOW-UP|1967-04-06|1966-07-25|||||1968-06-26||1967-08-11|N|1960-06-07
TRIAL STUDY 134XCP|LB|C168FA23-40EE-46D8-9A56-8B80490A0EFB|1||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||BOTTLE|||||||TRACE||LOG EID 50/DOSE||||ABNORMAL|NOT DONE||||VENOUS PLASMA|REFRIGERATED|NA|REFRACTOMETRY|FIBROTEST FORMULA||N|NA|N|Y|||NA|4||88||WASHOUT|1964-12-05|1967-04-10|||||1970-05-05||1971-09-18|N|1972-03-30
TRIAL STUDY 134XCP|LB|C168FA23-40EE-46D8-9A56-8B80490A0EFB|2||||ACANT|ACANTHOCYTES|||||||NMOL/L/H|||||||POSITIVE||TRANSDUCING UNIT/ML||||NORMAL|NOT DONE||||ISOLATE|CALCIFIED|U|BALLPOINT PEN TECHNIQUE|ASH FIBROSURE FORMULA||N|Y|N|N|||NA|4||88||TREATMENT|1969-05-19|1973-01-27|||||1966-05-03||1966-08-29|N|1968-07-29
TRIAL STUDY 134XCP|LB|C168FA23-40EE-46D8-9A56-8B80490A0EFB|1||||HGBMHGB|METHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||G/ANIMAL/WK|||||||INVALID||KBQ||||LOW|NOT DONE||||PERSPIRATION|FRESH|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|MDRD FORMULA||Y|NA|Y|U|||Y|5||7||LONG-TERM FOLLOW-UP|1965-08-28|1960-03-02|||||1962-04-14||1973-01-24|N|1965-01-30
TRIAL STUDY 134XCP|LB|C168FA23-40EE-46D8-9A56-8B80490A0EFB|2||||VITB6|VITAMIN B6|||||||OHM|||||||INDETERMINATE||WEEKS||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|GELLED|N|LANDOLT RING|FIBROTEST FORMULA||N|Y|Y|Y|||N|5||7||BLINDED TREATMENT|1966-01-01|1968-11-22|||||1969-05-12||1967-10-05|NA|1973-01-06
TRIAL STUDY 134XCP|LB|215E4E69-70C3-493C-9D67-F717363E8138|1||||VEGFC|VASCULAR ENDOTHELIAL GROWTH FACTOR C|||||||U/MMOL|||||||INDETERMINATE||CPM||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|FROZEN|N|REVERSE TRANSCRIPTASE PCR|COCKCROFT-GAULT FORMULA||N|NA|U|Y|||Y|1||38||TREATMENT|1961-05-04|1964-10-03|||||1972-07-11||1969-12-14|NA|1966-10-25
TRIAL STUDY 134XCP|LB|215E4E69-70C3-493C-9D67-F717363E8138|2||||CDT|CARBOHYDRATE-DEFICIENT TRANSFERRIN|||||||C|||||||INVALID||IU/DL||||LOW|NOT DONE||||SYNOVIAL FLUID|NON-HEMOLYZED|NA|LYMPHANGIOGRAPHY|FIBROMETER FORMULA||Y|N|Y|N|||Y|1||38||CONTINUATION TREATMENT|1960-07-18|1971-10-09|||||1970-06-19||1973-08-21|U|1967-09-09
TRIAL STUDY 134XCP|LB|215E4E69-70C3-493C-9D67-F717363E8138|1||||APOB100|APOLIPOPROTEIN B100|||||||BOTTLE|||||||TRACE||MV/SEC||||LOW|NOT DONE||||COLOSTRUM|PARAFFIN-EMBEDDED|U|COULOMETRIC TITRATION|FIBROSIS 4 FORMULA||NA|NA|N|Y|||Y|2||58||OBSERVATION|1967-04-16|1967-10-30|||||1972-04-30||1963-04-23|NA|1960-11-14
TRIAL STUDY 134XCP|LB|215E4E69-70C3-493C-9D67-F717363E8138|2||||COLOR|COLOR|||||||/10^5|||||||INDETERMINATE||/HPF||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|FROZEN|U|SINGLE-SLICE SPIRAL CT|MDRD 6 VARIABLE FORMULA||Y|N|N|Y|||Y|2||58||CONTINUATION TREATMENT|1967-05-28|1969-07-28|||||1972-04-18||1960-07-21|NA|1961-12-28
TRIAL STUDY 134XCP|LB|215E4E69-70C3-493C-9D67-F717363E8138|1||||C130135|D. PTERONYSSINUS ANTIGEN IGG ANTIBODY|||||||TORR|||||||INVALID||HENRY||||LOW|NOT DONE||||SOFT TISSUE|UNEXPECTED ODOR|NA|PYROSEQUENCING|NASH FIBROSURE FORMULA||U|N|U|U|||U|3||39||FOLLOW-UP|1961-12-28|1966-03-27|||||1972-12-17||1971-01-18|NA|1972-10-26
TRIAL STUDY 134XCP|LB|215E4E69-70C3-493C-9D67-F717363E8138|2||||ICAM|INTERCELLULAR ADHESION MOLECULE|||||||MOSM/L|||||||INVALID||MOSM/L||||HIGH|NOT DONE||||PLEURAL TISSUE|ICTERIC|NA|INDIRECT IMMUNOFLUORESCENCE|COCKCROFT-GAULT FORMULA||NA|U|NA|U|||NA|3||39||BASELINE|1968-12-23|1970-01-21|||||1969-08-19||1964-04-25|N|1970-03-08
TRIAL STUDY 134XCP|LB|215E4E69-70C3-493C-9D67-F717363E8138|1||||GLUCCLR|GLUCOSE CLEARANCE|||||||DEG/MM|||||||INVALID||NG/DL||||LOW|NOT DONE||||EMESIS|ICTERIC|NA|OPTICAL DENSITY MEASUREMENT|FIBROTEST FORMULA||Y|NA|Y|NA|||NA|4||88||OPEN LABEL TREATMENT|1971-11-09|1961-09-20|||||1961-05-27||1970-07-27|Y|1973-06-18
TRIAL STUDY 134XCP|LB|215E4E69-70C3-493C-9D67-F717363E8138|2||||TGFB1|TRANSFORMING GROWTH FACTOR BETA 1|||||||BEATS/MIN|||||||TRACE||ANTI-XA IU||||ABNORMAL|NOT DONE||||PLATELET POOR PLASMA|SOLIDIFIED|Y|MUGA|CKD-EPI FORMULA||N|NA|U|N|||U|4||88||INDUCTION TREATMENT|1965-05-27|1963-11-01|||||1972-09-21||1961-06-29|NA|1972-02-04
TRIAL STUDY 134XCP|LB|215E4E69-70C3-493C-9D67-F717363E8138|1||||LTE4|LEUKOTRIENE E4|||||||CI/ML|||||||TRACE||BREATHS/MIN||||NORMAL|NOT DONE||||RETICULOCYTES|LACTESCENT|N|HEMAGGLUTINATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|U|U|||N|5||7||RUN-IN|1965-09-03|1968-06-25|||||1969-12-10||1968-04-21|NA|1971-08-03
TRIAL STUDY 134XCP|LB|215E4E69-70C3-493C-9D67-F717363E8138|2||||MYPCERPC|MYELOID/ERYTHROID RATIO|||||||BQ/MG|||||||TRACE||U/KG/DAY||||ABNORMAL|NOT DONE||||VENOUS BLOOD|CONCENTRATED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI % FORMULA||N|NA|U|NA|||U|5||7||WASHOUT|1966-05-06|1972-03-03|||||1966-07-10||1969-08-20|U|1971-10-09
TRIAL STUDY 134XCP|LB|962CD4CA-AF22-42FB-ADB5-85F76850CA81|1||||OSTEOC|OSTEOCALCIN|||||||MN|||||||NEGATIVE||10^9/G||||HIGH|NOT DONE||||PROSTATIC FLUID|AUTOLYZED|Y|ICP-MS|ASH FIBROSURE FORMULA||Y|Y|N|Y|||U|1||38||RUN-IN|1965-06-25|1964-07-22|||||1969-08-23||1969-08-05|N|1966-12-06
TRIAL STUDY 134XCP|LB|962CD4CA-AF22-42FB-ADB5-85F76850CA81|2||||CD34|CD34|||||||MAC50|||||||INDETERMINATE||H*%||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|FROZEN|U|PET/CT SCAN WITHOUT CONTRAST|MDRD FORMULA||Y|Y|Y|N|||NA|1||38||INDUCTION TREATMENT|1961-05-01|1973-01-06|||||1962-10-30||1964-03-11|NA|1972-12-24
TRIAL STUDY 134XCP|LB|962CD4CA-AF22-42FB-ADB5-85F76850CA81|1||||PCP|PHENCYCLIDINE|||||||/10^4|||||||POSITIVE||UG/M2||||NORMAL|NOT DONE||||SALIVA|GELLED|U|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|NASH FIBROSURE FORMULA||U|NA|N|U|||N|2||58||FOLLOW-UP|1962-09-11|1961-12-01|||||1963-03-10||1963-09-13|NA|1973-08-22
TRIAL STUDY 134XCP|LB|962CD4CA-AF22-42FB-ADB5-85F76850CA81|2||||BASOMYL|BASOPHILIC MYELOCYTES|||||||NMOL/DAY|||||||INVALID||SPRAY||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|LIPEMIC|N|ELECTRONEUROGRAPHY|MDRD 4 VARIABLE FORMULA||N|U|NA|N|||N|2||58||LONG-TERM FOLLOW-UP|1972-02-08|1969-11-16|||||1972-02-25||1970-09-28|N|1969-06-15
TRIAL STUDY 134XCP|LB|962CD4CA-AF22-42FB-ADB5-85F76850CA81|1||||GFRBSBTP|GFR FROM BETA-TRACE PROTEIN ADJ FOR BSA|||||||ML/G/H|||||||INDETERMINATE||MPH||||LOW|NOT DONE||||PLATELET RICH PLASMA|ICTERIC|Y|DIRECT SEQUENCING|GMI MMOL/MOL FORMULA||Y|Y|Y|Y|||N|3||39||OBSERVATION|1969-10-26|1961-03-17|||||1972-03-19||1968-09-15|U|1965-03-03
TRIAL STUDY 134XCP|LB|962CD4CA-AF22-42FB-ADB5-85F76850CA81|2||||MSPIKE|MONOCLONAL PROTEIN SPIKE|||||||OI50|||||||INVALID||STEPS||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|CONTAMINATED|N|OSCILLOMETRY|FIBROSIS 4 FORMULA||U|Y|NA|NA|||N|3||39||BASELINE|1973-03-05|1965-03-01|||||1966-06-18||1969-04-23|U|1967-08-15
TRIAL STUDY 134XCP|LB|962CD4CA-AF22-42FB-ADB5-85F76850CA81|1||||P50OXYGN|P50 OXYGEN|||||||EQ|||||||POSITIVE||AU/ML||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|ROOM TEMPERATURE|U|DC SHEATH FLOW|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|U|NA|||N|4||88||CONTINUATION TREATMENT|1964-04-09|1960-08-10|||||1964-01-05||1962-06-10|N|1972-07-13
TRIAL STUDY 134XCP|LB|962CD4CA-AF22-42FB-ADB5-85F76850CA81|2||||OPG|OSTEOPROTEGERIN|||||||TBSP|||||||NEGATIVE||PSEC||||ABNORMAL|NOT DONE||||PLASMA|FROZEN|U|ANTIMICROBIAL COMBINATION TESTING|GMI % FORMULA||Y|U|NA|NA|||U|4||88||WASHOUT|1965-02-19|1965-08-14|||||1960-11-28||1960-11-06|U|1967-08-18
TRIAL STUDY 134XCP|LB|962CD4CA-AF22-42FB-ADB5-85F76850CA81|1||||C165934|ARACHIS HYPOGAEA IGE AB RAST SCORE|||||||NMOL/ML/MIN|||||||BORDERLINE||TRANSDUCING UNIT/ML||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|AGGLUTINATED|N|AMSLER GRID|MDRD 4 VARIABLE FORMULA||NA|NA|N|U|||NA|5||7||WASHOUT|1969-03-01|1963-07-28|||||1966-12-31||1963-08-08|NA|1969-12-30
TRIAL STUDY 134XCP|LB|962CD4CA-AF22-42FB-ADB5-85F76850CA81|2||||RDWR|RET VOLUME DISTRIBUTION WIDTH|||||||/100 WBC|||||||POSITIVE||HZ||||NORMAL|NOT DONE||||TUMOR TISSUE|CALCIFIED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|NASH FIBROSURE FORMULA||U|U|NA|U|||N|5||7||FOLLOW-UP|1964-01-29|1966-08-31|||||1968-10-13||1967-04-24|Y|1970-10-11
TRIAL STUDY 134XCP|LB|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|1||||CIT|CITRULLINE|||||||EQ|||||||BORDERLINE||DB||||NORMAL|NOT DONE||||EMESIS|FRESH|N|ELECTRONEUROGRAPHY|FIBROSIS 4 FORMULA||N|U|U|Y|||NA|1||38||OBSERVATION|1969-08-09|1972-06-24|||||1960-08-26||1968-04-15|NA|1973-01-28
TRIAL STUDY 134XCP|LB|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|2||||RDCSUB|REDUCING SUBSTANCES|||||||L/S|||||||BORDERLINE||MMOL/MIN/KPA||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|ROOM TEMPERATURE|U|GIEMSA STAIN|NASH FIBROSURE FORMULA||N|N|N|N|||NA|1||38||SCREENING|1972-08-06|1969-11-26|||||1967-10-23||1971-07-18|NA|1971-07-20
TRIAL STUDY 134XCP|LB|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|1||||XNTHCHR|XANTHOCHROMIA|||||||NMOL/DAY|||||||TRACE||GY/H||||HIGH|NOT DONE||||CAPILLARY BLOOD|FROZEN|NA|HIGH RESOLUTION MELT ANALYSIS|CKD-EPI CREATININE FORMULA||N|Y|Y|NA|||NA|2||58||RUN-IN|1965-09-26|1972-02-15|||||1962-02-04||1968-11-05|U|1968-05-08
TRIAL STUDY 134XCP|LB|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|2||||HYALUAC|HYALURONIC ACID|||||||KG/MOL|||||||INVALID||IU/G HB||||HIGH|NOT DONE||||SMEGMA|FROZEN|NA|ANGIOGRAPHY|ASH FIBROSURE FORMULA||N|N|U|NA|||U|2||58||OPEN LABEL TREATMENT|1966-10-19|1971-07-02|||||1965-04-20||1968-04-04|NA|1961-10-20
TRIAL STUDY 134XCP|LB|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|1||||VITD2425|24,25-DIHYDROXYVITAMIN D|||||||FFU|||||||NEGATIVE||U/G/DAY||||NORMAL|NOT DONE||||TRANSUDATE|FROZEN|U|SISH|FIBROSIS 4 FORMULA||Y|Y|Y|Y|||N|3||39||FOLLOW-UP|1971-02-23|1972-07-29|||||1965-11-24||1964-12-31|U|1960-07-28
TRIAL STUDY 134XCP|LB|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|2||||CH100|COMPLEMENT CH100|||||||G/CAGE/WK|||||||INDETERMINATE||MG/KG/H||||LOW|NOT DONE||||DERMAL TISSUE|GELLED|NA|HILLMEN COLOR CHART|CKD-EPI CYSTATIN C FORMULA||Y|NA|U|NA|||NA|3||39||RUN-IN|1965-03-18|1970-03-30|||||1966-02-07||1965-08-02|U|1963-06-08
TRIAL STUDY 134XCP|LB|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|1||||C130109|MOLD MIX ANTIGEN IGE ANTIBODY|||||||MPA|||||||TRACE||ML/CAGE||||ABNORMAL|NOT DONE||||ABSCESS FLUID|AGGLUTINATED|U|PERIPHERAL ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|Y|||NA|4||88||BASELINE|1971-04-10|1966-03-23|||||1971-11-11||1960-04-12|NA|1962-03-24
TRIAL STUDY 134XCP|LB|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|2||||B2G1GMAB|BETA-2 GLYCOPROTEIN 1 IGM ANTIBODY|||||||MG/M2/H|||||||INVALID||KG/CM2||||NORMAL|NOT DONE||||VITREOUS HUMOR|AUTOLYZED|NA|GRAM STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|NA|U|||N|4||88||BLINDED TREATMENT|1966-11-03|1964-11-12|||||1969-02-01||1973-02-19|N|1961-11-24
TRIAL STUDY 134XCP|LB|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|1||||NEUTLE|NEUTROPHILS/LEUKOCYTES|||||||LOG10 CCID 50/DOSE|||||||NEGATIVE||10^6/HPF||||HIGH|NOT DONE||||NAIL|LACTESCENT|N|HPLC|MDRD 5 VARIABLE FORMULA||NA|Y|U|N|||NA|5||7||LONG-TERM FOLLOW-UP|1966-05-03|1964-07-16|||||1965-08-28||1967-06-19|NA|1967-04-05
TRIAL STUDY 134XCP|LB|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|2||||NPAP|NON-PROSTATIC ACID PHOSPHATASE|||||||BQ/KG|||||||TRACE||UMOL/KG/MIN||||NORMAL|NOT DONE||||SWABBED MATERIAL|GELLED|U|ANTIBIOTIC AGAR SCREEN|NASH FIBROSURE FORMULA||NA|NA|NA|N|||Y|5||7||SCREENING|1965-11-18|1961-10-15|||||1963-12-05||1967-04-17|NA|1963-08-27
TRIAL STUDY 134XCP|LB|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|1||||NUCCE|NUCLEATED CELLS|||||||10^3 ORGANISMS/G|||||||INVALID||JDF UNIT||||LOW|NOT DONE||||LYMPH|REFRIGERATED|Y|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROMETER FORMULA||NA|N|NA|U|||N|1||38||OBSERVATION|1964-01-08|1960-02-04|||||1968-11-28||1968-10-18|N|1960-03-14
TRIAL STUDY 134XCP|LB|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|2||||VITB3|NIACIN|||||||UG/L|||||||INDETERMINATE||CMOL/L||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|DRIED|NA|SCANNING ELECTRON MICROSCOPY|FIBROMETER FORMULA||U|N|NA|U|||NA|1||38||LONG-TERM FOLLOW-UP|1962-10-30|1961-05-08|||||1965-02-27||1966-03-25|Y|1963-07-03
TRIAL STUDY 134XCP|LB|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|1||||TRP|TRYPTOPHAN|||||||PUFF|||||||TRACE||KG/L||||LOW|NOT DONE||||SKIN TISSUE|HEMOLYZED|NA|FLUORESCEIN STAIN|MDRD 5 VARIABLE FORMULA||Y|NA|N|U|||Y|2||58||OPEN LABEL TREATMENT|1972-04-15|1960-03-27|||||1960-02-09||1970-05-17|NA|1968-11-03
TRIAL STUDY 134XCP|LB|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|2||||RNPAB|RIBONUCLEOPROTEIN ANTIBODY|||||||KALLIKREIN INHIBITOR UNIT|||||||INVALID||HEP||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|ICTERIC|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|FIBROMETER FORMULA||N|N|N|Y|||NA|2||58||RUN-IN|1963-06-30|1967-02-01|||||1962-06-28||1973-05-19|Y|1964-12-18
TRIAL STUDY 134XCP|LB|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|1||||CACRALB|CALCIUM CORRECTED FOR ALBUMIN|||||||UG/G/H|||||||TRACE||PM||||ABNORMAL|NOT DONE||||EXUDATE|THAWED|NA|PEAK FLOWMETRY|FIBROTEST FORMULA||N|NA|N|Y|||Y|3||39||WASHOUT|1968-06-10|1972-12-24|||||1968-11-02||1967-11-23|N|1964-12-04
TRIAL STUDY 134XCP|LB|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|2||||PLSMCE|MATURE PLASMA CELLS|||||||/WK|||||||TRACE||VG/DOSE||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|FRESH|N|CONTRAST ENHANCED X-RAY|MDRD 5 VARIABLE FORMULA||U|N|N|NA|||Y|3||39||WASHOUT|1971-02-05|1966-02-07|||||1965-10-02||1969-03-10|Y|1960-09-11
TRIAL STUDY 134XCP|LB|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|1||||RBCNURBC|NUCLEATED ERYTHROCYTES/ERYTHROCYTES|||||||10^5/HPF|||||||NEGATIVE||NEEDLE GAUGE||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|FRESH|NA|RADIOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|U|U|U|||Y|4||88||TREATMENT|1970-06-10|1964-06-07|||||1969-10-13||1963-01-19|U|1961-08-28
TRIAL STUDY 134XCP|LB|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|2||||C1QAB|COMPLEMENT C1Q ANTIBODY|||||||FIU|||||||BORDERLINE||10^4/L||||LOW|NOT DONE||||PERITONEAL FLUID|FROZEN|NA|DC SHEATH FLOW|GMI MMOL/MOL FORMULA||U|N|Y|U|||NA|4||88||SCREENING|1962-05-12|1967-07-08|||||1968-07-06||1965-01-07|N|1970-02-19
TRIAL STUDY 134XCP|LB|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|1||||MSPIKER|MONOCLONAL PROTEIN SPIKE REGION|||||||MMOL/MIN/KPA/L|||||||BORDERLINE||VG/DOSE||||ABNORMAL|NOT DONE||||PUS|FRESH|Y|LASER CAPTURE MICRODISSECTION|CKD-EPI CYSTATIN C FORMULA||N|Y|N|Y|||N|5||7||OPEN LABEL TREATMENT|1971-12-31|1973-05-03|||||1960-05-06||1968-04-27|N|1960-05-27
TRIAL STUDY 134XCP|LB|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|2||||PTSAC|PROTEIN S ACTUAL/CONTROL|||||||TITER|||||||INDETERMINATE||CUP||||ABNORMAL|NOT DONE||||LEUKOCYTE|SOLIDIFIED|Y|DIPSTICK|MDRD FORMULA||U|N|N|N|||Y|5||7||WASHOUT|1963-03-04|1962-09-03|||||1967-06-12||1966-08-04|NA|1966-09-05
TRIAL STUDY 134XCP|LB|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|1||||SCCAG|SQUAMOUS CELL CARCINOMA ANTIGEN|||||||/4.0 ML|||||||INVALID||UM/S||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED|Y|HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|Y|Y|||U|1||38||TREATMENT|1970-06-11|1961-09-04|||||1969-05-18||1972-06-30|N|1964-08-09
TRIAL STUDY 134XCP|LB|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|2||||TRAP|TOTAL RADICAL-TRAP ANTIOXIDANT POTENTIAL|||||||MET*MIN|||||||NEGATIVE||L/MIN/M2||||NORMAL|NOT DONE||||ADIPOSE TISSUE|LACTESCENT|Y|WHOLE GENOME SEQUENCING|CKD-EPI CYSTATIN C FORMULA||Y|NA|U|N|||N|1||38||FOLLOW-UP|1972-12-03|1962-09-08|||||1965-07-19||1973-04-12|N|1960-09-15
TRIAL STUDY 134XCP|LB|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|1||||HGBDOXY|DEOXYHEMOGLOBIN|||||||PLUG|||||||TRACE||TSP EQ||||LOW|NOT DONE||||BASAL TEAR|FROZEN|NA|SANGER SEQUENCING|GMI % FORMULA||NA|NA|U|N|||Y|2||58||SCREENING|1964-10-20|1963-08-05|||||1972-03-09||1969-11-10|N|1967-11-18
TRIAL STUDY 134XCP|LB|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|2||||LDH2|LDH ISOENZYME 2|||||||GPS U|||||||INDETERMINATE||AU/ML||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|CONTAMINATED|N|MRI WITHOUT CONTRAST|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|U|Y|||Y|2||58||OPEN LABEL TREATMENT|1969-10-30|1969-12-17|||||1971-11-22||1969-06-30|Y|1973-08-26
TRIAL STUDY 134XCP|LB|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|1||||UNSPCE|UNSPECIFIED CELLS|||||||G/CAGE/DAY|||||||TRACE||CM||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|THAWED|N|MUGA|GMI % FORMULA||NA|N|Y|N|||U|3||39||OBSERVATION|1967-11-04|1967-05-23|||||1969-10-19||1969-09-13|N|1973-08-17
TRIAL STUDY 134XCP|LB|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|2||||NACREAT|SODIUM/CREATININE|||||||MET*MIN|||||||NEGATIVE||ML/G/DAY||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|AGGLUTINATED|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA||NA|N|U|U|||U|3||39||WASHOUT|1964-05-10|1963-07-29|||||1970-06-05||1969-02-16|N|1963-05-01
TRIAL STUDY 134XCP|LB|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|1||||CD19|CD19|||||||SFC/10^6 PBMC|||||||INDETERMINATE||APL U||||NORMAL|NOT DONE||||LOCHIA|ICTERIC|N|DROPLET DIGITAL PCR|CKD-EPI FORMULA||U|NA|Y|N|||U|4||88||WASHOUT|1966-11-06|1971-11-05|||||1972-09-30||1969-07-17|U|1963-01-11
TRIAL STUDY 134XCP|LB|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|2||||RETILRTC|LOW ABSORPTION RETIC/RETICULOCYTES|||||||V|||||||BORDERLINE||MOSM/KG||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|N|TRIPLE-PHASE SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA||U|NA|U|U|||N|4||88||SCREENING|1964-10-05|1971-02-21|||||1966-09-22||1971-11-11|Y|1972-04-24
TRIAL STUDY 134XCP|LB|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|1||||CYAMMBIU|AMMONIUM BIURATE CRYSTALS|||||||GPL U/ML|||||||POSITIVE||UM2||||LOW|NOT DONE||||MIXED VENOUS BLOOD|FRESH|NA|PYROSEQUENCING|NASH FIBROSURE FORMULA||Y|NA|U|NA|||U|5||7||OBSERVATION|1961-02-20|1966-06-20|||||1961-09-29||1970-02-16|Y|1963-05-05
TRIAL STUDY 134XCP|LB|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|2||||DDX58|DEAD BOX PROTEIN 58|||||||SUPPOSITORY|||||||NEGATIVE||FIU||||NORMAL|NOT DONE||||DERMAL TISSUE|FRESH|U|SLIT LAMP PHOTOGRAPHY|ASH FIBROSURE FORMULA||Y|N|NA|NA|||N|5||7||INDUCTION TREATMENT|1971-10-22|1970-11-04|||||1964-07-10||1966-06-07|N|1962-09-22
TRIAL STUDY 134XCP|LB|4A5A02C2-F875-4146-B58D-9E0E4F00527D|1||||TPROTFR|TAU PROTEIN, FREE|||||||10^12 IU/L|||||||NEGATIVE||U/G/MIN||||HIGH|NOT DONE||||CAPILLARY PLASMA|LIPEMIC|NA|IRON HEMATOXYLIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|U|N|||Y|1||38||BASELINE|1970-01-05|1969-11-03|||||1964-01-22||1964-12-09|N|1970-05-12
TRIAL STUDY 134XCP|LB|4A5A02C2-F875-4146-B58D-9E0E4F00527D|2||||C130137|AMERICAN COCKROACH ANTIGEN IGA ANTIBODY|||||||/100 HPFS|||||||POSITIVE||ANTIBODY UNIT||||HIGH|NOT DONE||||PLATELET POOR PLASMA|THAWED|N|AUDIOMETRY|MDRD 6 VARIABLE FORMULA||NA|NA|N|N|||N|1||38||SCREENING|1971-05-17|1973-02-04|||||1967-08-20||1968-12-15|U|1965-03-18
TRIAL STUDY 134XCP|LB|4A5A02C2-F875-4146-B58D-9E0E4F00527D|1||||RENIN|RENIN|||||||PELLET|||||||POSITIVE||10^9 ORGANISMS||||NORMAL|NOT DONE||||EMOTIONAL TEAR|SOLIDIFIED|N|GC/MS-EI|NASH FIBROSURE FORMULA||N|NA|Y|NA|||N|2||58||SCREENING|1967-05-18|1968-12-16|||||1965-05-05||1970-06-23|Y|1967-02-11
TRIAL STUDY 134XCP|LB|4A5A02C2-F875-4146-B58D-9E0E4F00527D|2||||AFPADJBW|ALPHA FETOPROTEIN ADJ FOR BODY WEIGHT|||||||GBQ/UG|||||||POSITIVE||GY||||NORMAL|NOT DONE||||SEMINAL FLUID|FROZEN|Y|CONTRAST ENHANCED CT SCAN|COCKCROFT-GAULT FORMULA||N|U|Y|N|||Y|2||58||CONTINUATION TREATMENT|1960-09-09|1966-02-27|||||1961-11-25||1961-04-18|N|1962-03-16
TRIAL STUDY 134XCP|LB|4A5A02C2-F875-4146-B58D-9E0E4F00527D|1||||FACTII|FACTOR II|||||||LOG EID 50/DOSE|||||||BORDERLINE||LINEAR FT*LB||||NORMAL|NOT DONE||||CAPILLARY BLOOD|CALCIFIED|N|PHOTOMETRY|GMI % FORMULA||U|NA|U|U|||Y|3||39||WASHOUT|1968-01-13|1963-12-01|||||1965-03-04||1967-02-23|Y|1970-04-25
TRIAL STUDY 134XCP|LB|4A5A02C2-F875-4146-B58D-9E0E4F00527D|2||||INTLK12B|INTERLEUKIN 12 BETA|||||||DAYS/WK|||||||INDETERMINATE||/KG||||LOW|NOT DONE||||WHITE MATTER TISSUE|AUTOLYZED|Y|ISHIHARA COLOR PLATES|MDRD FORMULA||NA|Y|NA|U|||N|3||39||CONTINUATION TREATMENT|1969-04-16|1966-09-28|||||1963-06-23||1962-03-29|Y|1967-02-11
TRIAL STUDY 134XCP|LB|4A5A02C2-F875-4146-B58D-9E0E4F00527D|1||||C130084|ENGLISH PLANTAIN POLLEN IGE|||||||HPA|||||||TRACE||ML/M2||||LOW|NOT DONE||||CORD SERUM|CALCIFIED|Y|FLOCCULATION|FIBROTEST FORMULA||Y|Y|N|N|||U|4||88||LONG-TERM FOLLOW-UP|1971-11-02|1970-12-31|||||1961-06-04||1961-03-28|Y|1967-03-22
TRIAL STUDY 134XCP|LB|4A5A02C2-F875-4146-B58D-9E0E4F00527D|2||||CYLEUC|LEUCINE CRYSTALS|||||||CYCLE/MIN|||||||TRACE||IU||||LOW|NOT DONE||||PLEURAL FLUID|CONTAMINATED|N|WEBER GREEN STAIN|HEPASCORE FORMULA||U|Y|NA|Y|||Y|4||88||RUN-IN|1963-01-24|1966-05-10|||||1966-09-08||1966-04-28|U|1963-11-07
TRIAL STUDY 134XCP|LB|4A5A02C2-F875-4146-B58D-9E0E4F00527D|1||||NEUTSGLE|NEUTROPHILS, SEGMENTED/LEUKOCYTES|||||||MM3/MM2/YEAR|||||||POSITIVE||MV2/HZ||||ABNORMAL|NOT DONE||||BILE|REFRIGERATED|NA|FLAME PHOTOMETRY|COCKCROFT-GAULT FORMULA||N|U|U|Y|||NA|5||7||SCREENING|1964-06-14|1965-02-16|||||1964-11-02||1963-06-25|NA|1969-05-25
TRIAL STUDY 134XCP|LB|4A5A02C2-F875-4146-B58D-9E0E4F00527D|2||||C165894|D. FARINAE ANTIGEN IGG4 ANTIBODY|||||||DAGU/ML|||||||BORDERLINE||AMOL||||LOW|NOT DONE||||PERITONEAL FLUID|CLOTTED|U|CHROMATOGRAPHY|CKD-EPI CREATININE FORMULA||U|U|Y|NA|||Y|5||7||OBSERVATION|1971-07-05|1960-05-17|||||1961-02-09||1962-08-14|NA|1965-09-12
TRIAL STUDY 134XCP|LB|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|1||||APPT|TOTAL AMYLOID PRECURSOR PROTEIN|||||||BAU/ML|||||||INVALID||PIXEL||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE|Y|EPSILOMETER|MDRD 6 VARIABLE FORMULA||Y|N|NA|N|||NA|1||38||BASELINE|1966-09-11|1968-03-28|||||1964-07-03||1962-12-02|NA|1968-12-21
TRIAL STUDY 134XCP|LB|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|2||||SPHERO|SPHEROCYTES|||||||MGEQ|||||||NEGATIVE||ECL UNIT||||NORMAL|NOT DONE||||PLEURAL TISSUE|ROOM TEMPERATURE|N|TEMPLATE INCISION METHOD|MDRD 4 VARIABLE FORMULA||N|U|NA|U|||NA|1||38||BLINDED TREATMENT|1968-06-02|1968-03-11|||||1960-05-14||1971-07-24|N|1965-06-03
TRIAL STUDY 134XCP|LB|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|1||||SALCYLT|SALICYLATES|||||||PA|||||||POSITIVE||10^9 CFU/G||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|AUTOLYZED|N|ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA||U|U|U|NA|||NA|2||58||CONTINUATION TREATMENT|1960-06-05|1962-07-31|||||1972-11-01||1968-10-11|N|1961-09-28
TRIAL STUDY 134XCP|LB|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|2||||HGB|HEMOGLOBIN|||||||CD|||||||TRACE||UCI/KG||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|PARAFFIN-EMBEDDED|NA|HPLC-FL|ASH FIBROSURE FORMULA||Y|U|Y|U|||U|2||58||OPEN LABEL TREATMENT|1961-12-30|1964-03-02|||||1963-05-18||1971-03-28|NA|1962-11-17
TRIAL STUDY 134XCP|LB|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|1||||SALCYLT|SALICYLATES|||||||BEL|||||||INDETERMINATE||% INHIBITION||||NORMAL|NOT DONE||||CERUMEN|LACTESCENT|NA|RULER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA||U|Y|NA|Y|||U|3||39||OBSERVATION|1973-02-17|1967-06-07|||||1972-05-17||1966-10-26|U|1970-11-26
TRIAL STUDY 134XCP|LB|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|2||||BASEDEF|BASE DEFICIT|||||||U/MG|||||||INVALID||MPH||||HIGH|NOT DONE||||SYNOVIAL FLUID|ROOM TEMPERATURE|Y|HPLC-UV|CKD-EPI FORMULA||N|Y|N|NA|||U|3||39||BLINDED TREATMENT|1972-02-09|1967-01-09|||||1971-09-16||1965-03-14|U|1968-07-29
TRIAL STUDY 134XCP|LB|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|1||||HLADRB1|HLA DR BETA1 ANTIGEN|||||||SCOOPFUL|||||||NEGATIVE||NMOL/G||||LOW|NOT DONE||||CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|N|MANUAL CLOT DETECTION|CKD-EPI CYSTATIN C FORMULA||NA|NA|Y|Y|||Y|4||88||WASHOUT|1973-03-30|1967-07-14|||||1964-12-01||1972-03-06|N|1965-02-26
TRIAL STUDY 134XCP|LB|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|2||||VBCE|VIABLE CELLS|||||||HENRY|||||||INVALID||AG||||ABNORMAL|NOT DONE||||REFLEX TEAR|FRESH|NA|BETA LACTAMASE|GMI % FORMULA||U|N|Y|U|||N|4||88||RUN-IN|1972-10-18|1969-05-09|||||1971-06-09||1961-05-01|Y|1962-05-27
TRIAL STUDY 134XCP|LB|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|1||||AMCRMRNA|AMACR MRNA|||||||ML/SEC/1.73M2|||||||BORDERLINE||DYN||||LOW|NOT DONE||||SKIN TISSUE|SOLIDIFIED|N|HPLC-FL|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|Y|N|||Y|5||7||WASHOUT|1972-03-15|1962-09-02|||||1970-10-01||1962-03-03|N|1966-05-23
TRIAL STUDY 134XCP|LB|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|2||||SPERM|SPERMATOZOA|||||||10^6 CFU|||||||INVALID||NMOL BCE/L||||NORMAL|NOT DONE||||BUFFY COAT|CLOTTED|U|ENZYMATIC SPECTROPHOTOMETRY|NASH FIBROSURE FORMULA||N|NA|NA|U|||NA|5||7||OBSERVATION|1970-06-26|1960-10-15|||||1971-12-27||1966-04-07|U|1965-11-12
TRIAL STUDY 134XCP|LB|859D9297-58D0-4740-899D-E7BEC931D419|1||||IGHG2|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 2|||||||G/L|||||||INVALID||DIOPTER||||NORMAL|NOT DONE||||URINE SEDIMENT|FROZEN|U|MULTI-SLICE SPIRAL CT|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|N|||Y|1||38||BLINDED TREATMENT|1971-07-21|1963-06-16|||||1966-04-26||1973-02-17|N|1971-02-03
TRIAL STUDY 134XCP|LB|859D9297-58D0-4740-899D-E7BEC931D419|2||||SALCYLT|SALICYLATES|||||||/4.0 ML|||||||INVALID||ML/CAGE/DAY||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|LIPEMIC|N|FLUORESCENT ENZYME IMMUNOASSAY|MDRD 4 VARIABLE FORMULA||U|U|N|N|||NA|1||38||CONTINUATION TREATMENT|1972-04-18|1962-08-30|||||1971-02-23||1972-02-11|N|1964-08-16
TRIAL STUDY 134XCP|LB|859D9297-58D0-4740-899D-E7BEC931D419|1||||VITD2|VITAMIN D2|||||||LOG10 PFU/ML|||||||TRACE||KG/CM||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|CLOTTED|N|IMMUNOTURBIDIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|N|N|||Y|2||58||SCREENING|1964-05-03|1969-08-01|||||1965-01-05||1961-12-24|N|1961-03-18
TRIAL STUDY 134XCP|LB|859D9297-58D0-4740-899D-E7BEC931D419|2||||TRP|TRYPTOPHAN|||||||%(W/V)|||||||TRACE||DNA COPIES/UG||||LOW|NOT DONE||||SWABBED MATERIAL|CONCENTRATED|Y|WRIGHT-GIEMSA STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|Y|||N|2||58||BASELINE|1962-06-27|1964-04-23|||||1962-02-05||1968-11-09|Y|1971-01-19
TRIAL STUDY 134XCP|LB|859D9297-58D0-4740-899D-E7BEC931D419|1||||MCPROT|MONOCLONAL PROTEIN|||||||MG/G/MIN|||||||NEGATIVE||KA_U/DL||||ABNORMAL|NOT DONE||||COLOSTRUM|CALCIFIED|N|U-HPLC/MS/MS|NASH FIBROSURE FORMULA||U|NA|U|N|||N|3||39||SCREENING|1971-10-25|1961-10-22|||||1963-02-08||1973-03-16|Y|1971-03-15
TRIAL STUDY 134XCP|LB|859D9297-58D0-4740-899D-E7BEC931D419|2||||RP3IGGAB|RNA POLYMERASE III IGG ANTIBODY|||||||KM|||||||INDETERMINATE||U/KG||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|DRIED|U|MODIFIED ACID FAST STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|NA|NA|||NA|3||39||OBSERVATION|1960-12-29|1967-08-23|||||1969-01-07||1967-07-15|N|1969-03-09
TRIAL STUDY 134XCP|LB|859D9297-58D0-4740-899D-E7BEC931D419|1||||C130142|GERMAN COCKROACH ANTIGEN IGG ANTIBODY|||||||VG/ML|||||||INDETERMINATE||U/KG/H||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|CONCENTRATED|NA|RADIOIMMUNOPRECIPITATION ASSAY|FIBROTEST FORMULA||Y|N|NA|N|||NA|4||88||OBSERVATION|1967-11-11|1972-12-09|||||1968-07-07||1972-10-16|Y|1971-11-16
TRIAL STUDY 134XCP|LB|859D9297-58D0-4740-899D-E7BEC931D419|2||||VLDL1|VLDL CHOLESTEROL SUBTYPE 1|||||||LOG10 TCID 50/UL|||||||TRACE||MEQ/UG||||NORMAL|NOT DONE||||PUS|AUTOLYZED|NA|LC-FL|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|N|N|||N|4||88||CONTINUATION TREATMENT|1967-06-23|1966-02-18|||||1970-10-15||1963-08-02|Y|1969-11-18
TRIAL STUDY 134XCP|LB|859D9297-58D0-4740-899D-E7BEC931D419|1||||CD5|CD5|||||||F|||||||TRACE||DEG/S||||NORMAL|NOT DONE||||SYNOVIAL FLUID|ROOM TEMPERATURE|Y|CONFOCAL MICROSCOPY|MDRD ENZYMATIC FORMULA||U|N|NA|NA|||N|5||7||FOLLOW-UP|1965-05-03|1971-09-21|||||1963-10-26||1962-10-16|NA|1964-06-06
TRIAL STUDY 134XCP|LB|859D9297-58D0-4740-899D-E7BEC931D419|2||||TRH|THYROTROPIN RELEASING HORMONE|||||||10^6/EJACULATE U|||||||INDETERMINATE||CD||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|LIPEMIC|Y|MRI WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|NA|NA|||N|5||7||TREATMENT|1966-06-01|1961-07-28|||||1961-08-25||1971-06-08|U|1961-12-04
TRIAL STUDY 134XCP|LB|A1E34C29-91C2-4C2B-942E-84CD6A10A056|1||||HLAA2AB|HLA-A2 ANTIBODY|||||||10^9 ORGANISMS/G|||||||INDETERMINATE||MM/2H||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|HEMOLYZED|Y|STRESS ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA||NA|NA|N|NA|||NA|1||38||WASHOUT|1967-11-10|1970-10-07|||||1963-06-04||1965-04-22|NA|1973-03-12
TRIAL STUDY 134XCP|LB|A1E34C29-91C2-4C2B-942E-84CD6A10A056|2||||C130124|CAT DANDER ANTIGEN IGE ANTIBODY|||||||MG/KG/DAY|||||||NEGATIVE||UMOL/L/H||||HIGH|NOT DONE||||URINE SEDIMENT|REFRIGERATED|NA|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|N|NA|||N|1||38||BLINDED TREATMENT|1970-06-16|1970-09-19|||||1971-09-23||1967-12-28|N|1973-04-15
TRIAL STUDY 134XCP|LB|A1E34C29-91C2-4C2B-942E-84CD6A10A056|1||||HOMOCY|HOMOCYSTEINE|||||||%(V/V)|||||||INDETERMINATE||UL||||NORMAL|NOT DONE||||CELL PELLET|CALCIFIED|U|PET SCAN|GMI MMOL/MOL FORMULA||Y|NA|NA|U|||Y|2||58||OPEN LABEL TREATMENT|1962-12-15|1972-04-17|||||1966-07-03||1962-07-25|NA|1969-08-26
TRIAL STUDY 134XCP|LB|A1E34C29-91C2-4C2B-942E-84CD6A10A056|2||||PLSMCELY|MATURE PLASMA CELLS/LYMPHOCYTES|||||||CS|||||||BORDERLINE||POUCH||||NORMAL|NOT DONE||||REFLEX TEAR|DRIED|Y|CONTACT SPECULAR MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|N|Y|||N|2||58||OPEN LABEL TREATMENT|1962-04-13|1962-07-25|||||1962-07-21||1963-05-06|U|1971-12-03
TRIAL STUDY 134XCP|LB|A1E34C29-91C2-4C2B-942E-84CD6A10A056|1||||C165912|SHELLFISH MIX IGG AB RAST SCORE|||||||TROCHE|||||||INVALID||IU/L||||ABNORMAL|NOT DONE||||LYMPH|CONCENTRATED|NA|AMSLER GRID|MDRD 4 VARIABLE FORMULA||U|U|U|Y|||U|3||39||WASHOUT|1961-06-20|1964-11-11|||||1960-09-14||1973-07-02|NA|1970-01-10
TRIAL STUDY 134XCP|LB|A1E34C29-91C2-4C2B-942E-84CD6A10A056|2||||GLOBUL|GLOBULIN|||||||NMOL/G|||||||INVALID||NMOL/L/H||||ABNORMAL|NOT DONE||||MUCUS|FROZEN|U|TRICHROME STAIN|ASH FIBROSURE FORMULA||NA|U|N|N|||U|3||39||LONG-TERM FOLLOW-UP|1970-02-01|1961-01-16|||||1971-03-04||1963-12-30|N|1967-12-27
TRIAL STUDY 134XCP|LB|A1E34C29-91C2-4C2B-942E-84CD6A10A056|1||||FACTXIIA|FACTOR XII ACTIVITY|||||||UKAT/L|||||||NEGATIVE||H*%||||ABNORMAL|NOT DONE||||LAVAGE FLUID|THAWED|N|DYNAMOMETRY|HEPASCORE FORMULA||U|NA|Y|U|||U|4||88||LONG-TERM FOLLOW-UP|1968-09-21|1965-11-06|||||1971-04-16||1962-06-24|N|1964-05-15
TRIAL STUDY 134XCP|LB|A1E34C29-91C2-4C2B-942E-84CD6A10A056|2||||C130073|BIRCH POLLEN IGA|||||||10^3 RNA COPIES/ML|||||||TRACE||PG/DL||||NORMAL|NOT DONE||||MECONIUM|REFRIGERATED|N|CLIP SEQUENCING|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|Y|||U|4||88||BASELINE|1970-09-15|1966-03-20|||||1969-02-03||1970-01-27|NA|1965-12-04
TRIAL STUDY 134XCP|LB|A1E34C29-91C2-4C2B-942E-84CD6A10A056|1||||KYNURNN|KYNURENINE|||||||G|||||||TRACE||/MONTH||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|LIPEMIC|N|MECHANICAL CLOT DETECTION|FIBROTEST FORMULA||NA|N|N|U|||Y|5||7||OBSERVATION|1961-04-20|1968-02-21|||||1969-03-08||1967-06-19|N|1968-07-12
TRIAL STUDY 134XCP|LB|A1E34C29-91C2-4C2B-942E-84CD6A10A056|2||||GSTPIEXR|PI-GST EXCRETION RATE|||||||10^9/L|||||||POSITIVE||USP U||||ABNORMAL|NOT DONE||||SMEGMA|CLOTTED|NA|KINETIC CHROMOGENIC ASSAY|NASH FIBROSURE FORMULA||NA|U|N|N|||NA|5||7||INDUCTION TREATMENT|1963-06-10|1973-08-13|||||1963-11-26||1969-03-09|N|1972-02-24
TRIAL STUDY 134XCP|LB|4E5FF284-E15A-421D-BC13-94655EEFE540|1||||MCPHGCE|MACROPHAGES/TOTAL CELLS|||||||TITER|||||||TRACE||COPIES/ML||||ABNORMAL|NOT DONE||||DERMAL TISSUE|LIPEMIC|U|FLOCCULATION, CHARCOAL ENHANCED|MDRD 6 VARIABLE FORMULA||U|NA|NA|N|||Y|1||38||OPEN LABEL TREATMENT|1966-02-09|1972-10-09|||||1963-10-10||1960-02-01|N|1967-11-07
TRIAL STUDY 134XCP|LB|4E5FF284-E15A-421D-BC13-94655EEFE540|2||||FRUCTOSE|FRUCTOSE|||||||ANSON U|||||||INDETERMINATE||BAR||||LOW|NOT DONE||||SERUM|REFRIGERATED|U|PET/MRI SCAN|GMI MMOL/MOL FORMULA||U|Y|N|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1970-09-24|1966-07-06|||||1963-05-09||1967-11-12|U|1965-04-22
TRIAL STUDY 134XCP|LB|4E5FF284-E15A-421D-BC13-94655EEFE540|1||||PHENTHZ|PHENOTHIAZINE|||||||BOWL|||||||TRACE||UMOL||||LOW|NOT DONE||||VITREOUS HUMOR|LACTESCENT|U|OLIGO ACGH|NASH FIBROSURE FORMULA||N|N|U|NA|||U|2||58||BASELINE|1966-06-01|1969-03-27|||||1970-03-15||1963-12-19|NA|1966-05-06
TRIAL STUDY 134XCP|LB|4E5FF284-E15A-421D-BC13-94655EEFE540|2||||A1MCREAT|ALPHA-1 MICROGLOBULIN/CREATININE|||||||GTT|||||||INVALID||NM||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|PARAFFIN-EMBEDDED|U|ANTIMICROBIAL COMBINATION TESTING|FIBROTEST FORMULA||N|NA|U|Y|||U|2||58||TREATMENT|1969-12-06|1967-01-25|||||1965-04-04||1968-07-29|Y|1968-03-30
TRIAL STUDY 134XCP|LB|4E5FF284-E15A-421D-BC13-94655EEFE540|1||||LYMLG|LARGE LYMPHOCYTES|||||||MEQ/UG|||||||INVALID||10^3 CFU/ML||||LOW|NOT DONE||||TUMOR TISSUE|LACTESCENT|N|MACRO BROTH DILUTION|FIBROMETER FORMULA||N|N|NA|Y|||N|3||39||TREATMENT|1963-09-29|1961-09-14|||||1962-10-10||1973-03-27|Y|1965-09-25
TRIAL STUDY 134XCP|LB|4E5FF284-E15A-421D-BC13-94655EEFE540|2||||PIVKAII|PROTEIN INDUCED BY VITAMIN K ABSENCE-II|||||||ML/H|||||||TRACE||10^6 DNA COPIES/ML||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|NON-HEMOLYZED|U|FLUORESCENCE ANGIOGRAPHY|MDRD FORMULA||N|U|U|N|||U|3||39||LONG-TERM FOLLOW-UP|1966-03-29|1960-04-16|||||1962-10-12||1963-03-13|Y|1970-07-01
TRIAL STUDY 134XCP|LB|4E5FF284-E15A-421D-BC13-94655EEFE540|1||||RETIHRTC|HIGH ABSORPTION RETIC/RETICULOCYTES|||||||%(W/V)|||||||NEGATIVE||DAMOL/L||||NORMAL|NOT DONE||||URINE SEDIMENT|DRIED|N|DISK DIFFUSION|MDRD 5 VARIABLE FORMULA||N|N|U|U|||NA|4||88||CONTINUATION TREATMENT|1969-10-22|1967-04-07|||||1972-10-11||1972-03-21|NA|1968-08-03
TRIAL STUDY 134XCP|LB|4E5FF284-E15A-421D-BC13-94655EEFE540|2||||CBB|COMPLEMENT BB|||||||%(W/V)|||||||NEGATIVE||PACK YEAR||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|ICTERIC|NA|FLUORESCENT LIFETIME IMAGING MICROSCOPY|NASH FIBROSURE FORMULA||NA|U|N|U|||N|4||88||BASELINE|1967-06-10|1967-08-20|||||1965-06-14||1960-06-29|NA|1968-04-11
TRIAL STUDY 134XCP|LB|4E5FF284-E15A-421D-BC13-94655EEFE540|1||||PSDGLSRF|PHOSPHATIDYLGLYCEROL/LUNG SURFACTANT|||||||CMHG|||||||NEGATIVE||CAL||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|LIPEMIC|Y|AGAR DILUTION|ASH FIBROSURE FORMULA||Y|NA|U|U|||NA|5||7||FOLLOW-UP|1962-10-17|1966-12-06|||||1964-06-22||1968-09-29|N|1970-10-23
TRIAL STUDY 134XCP|LB|4E5FF284-E15A-421D-BC13-94655EEFE540|2||||YEAST|YEAST CELLS|||||||PPB|||||||POSITIVE||/MBP||||HIGH|NOT DONE||||REFLEX TEAR|REFRIGERATED|N|WRIGHT STAIN|FIBROSIS 4 FORMULA||N|NA|U|Y|||U|5||7||BASELINE|1971-08-02|1961-02-08|||||1970-08-29||1966-12-12|Y|1963-10-15
TRIAL STUDY 134XCP|LB|30BAB760-662A-41DF-9599-CBE0BC3A57D9|1||||ETP|ENDOGENOUS THROMBIN POTENTIAL|||||||G/CM2|||||||POSITIVE||10^9 ORGANISMS/MG||||NORMAL|NOT DONE||||ADIPOSE TISSUE|CONCENTRATED|N|CONGO RED STAIN|FIBROMETER FORMULA||N|U|U|U|||U|1||38||BASELINE|1960-06-01|1963-06-20|||||1968-08-31||1968-04-19|U|1964-06-15
TRIAL STUDY 134XCP|LB|30BAB760-662A-41DF-9599-CBE0BC3A57D9|2||||MENGL|MENINGEAL CELLS|||||||/HPF|||||||POSITIVE||DPM/MG||||LOW|NOT DONE||||HAIR|CONCENTRATED|U|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|NASH FIBROSURE FORMULA||NA|U|NA|NA|||U|1||38||OPEN LABEL TREATMENT|1963-06-02|1961-06-13|||||1964-09-15||1964-01-31|U|1963-07-28
TRIAL STUDY 134XCP|LB|30BAB760-662A-41DF-9599-CBE0BC3A57D9|1||||C130121|SHELLFISH MIX ANTIGEN IGG ANTIBODY|||||||APL U/ML|||||||BORDERLINE||FARAD||||HIGH|NOT DONE||||SWABBED MATERIAL|ROOM TEMPERATURE|Y|CHROMATOGRAPHY|ASH FIBROSURE FORMULA||Y|U|NA|Y|||N|2||58||WASHOUT|1961-07-01|1968-05-05|||||1963-08-11||1969-10-05|N|1972-03-15
TRIAL STUDY 134XCP|LB|30BAB760-662A-41DF-9599-CBE0BC3A57D9|2||||APOH|APOLIPOPROTEIN H|||||||GY/MIN|||||||TRACE||ML/CAGE/WK||||NORMAL|NOT DONE||||SEMEN|ICTERIC|N|MRI WITHOUT CONTRAST|FIBROTEST FORMULA||U|N|U|N|||U|2||58||BASELINE|1971-01-30|1967-08-06|||||1971-05-25||1972-12-06|Y|1970-04-20
TRIAL STUDY 134XCP|LB|30BAB760-662A-41DF-9599-CBE0BC3A57D9|1||||P1NP|PROCOLLAGEN 1 N-TERMINAL PROPEPTIDE|||||||MOSM/L|||||||TRACE||ML/MMHG/MIN/L||||LOW|NOT DONE||||ISOLATE|ROOM TEMPERATURE|N|SPECT SCAN|FIBROTEST FORMULA||N|N|N|N|||U|3||39||OPEN LABEL TREATMENT|1960-10-13|1973-08-22|||||1964-03-05||1968-12-13|Y|1965-04-05
TRIAL STUDY 134XCP|LB|30BAB760-662A-41DF-9599-CBE0BC3A57D9|2||||NRP1|NEUROPILIN-1|||||||NG/L|||||||INVALID||ML/G/DAY||||HIGH|NOT DONE||||SPERMATOZOON|GELLED|Y|SINGLE-MOLECULE ARRAY|CKD-EPI CYSTATIN C FORMULA||NA|U|U|N|||U|3||39||CONTINUATION TREATMENT|1963-02-20|1966-09-28|||||1963-12-15||1960-03-24|Y|1967-08-24
TRIAL STUDY 134XCP|LB|30BAB760-662A-41DF-9599-CBE0BC3A57D9|1||||INSULIN|INSULIN|||||||H/WK|||||||INDETERMINATE||MEQ/L||||LOW|NOT DONE||||COLOSTRUM|UNEXPECTED ODOR|N|ICC|CKD-EPI CREATININE FORMULA||U|Y|NA|Y|||Y|4||88||LONG-TERM FOLLOW-UP|1973-02-24|1971-03-16|||||1961-07-04||1960-10-08|N|1971-05-03
TRIAL STUDY 134XCP|LB|30BAB760-662A-41DF-9599-CBE0BC3A57D9|2||||HYDCDN|HYDROCODONE|||||||ML/M2/DAY|||||||TRACE||NEWTON||||LOW|NOT DONE||||VITREOUS HUMOR|FROZEN|N|HPLC|MDRD 6 VARIABLE FORMULA||NA|N|Y|U|||U|4||88||FOLLOW-UP|1967-10-11|1964-07-24|||||1962-08-11||1965-11-14|NA|1962-06-04
TRIAL STUDY 134XCP|LB|30BAB760-662A-41DF-9599-CBE0BC3A57D9|1||||UREACRT|UREA/CREATININE|||||||NMOL/MOL|||||||BORDERLINE||NMOL/L||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|THAWED|U|SPECT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|NA|N|||N|5||7||INDUCTION TREATMENT|1973-08-27|1961-12-28|||||1961-01-25||1973-08-11|U|1960-07-17
TRIAL STUDY 134XCP|LB|30BAB760-662A-41DF-9599-CBE0BC3A57D9|2||||SICAM1|SOLUBLE INTERCELL ADHESION MOLECULE 1|||||||CONTAINER|||||||INDETERMINATE||BQ/L||||NORMAL|NOT DONE||||AMNIOTIC FLUID|FROZEN|Y|CONTRAST ENHANCED CT SCAN|CKD-EPI CYSTATIN C FORMULA||NA|N|N|NA|||NA|5||7||BASELINE|1963-12-15|1963-09-13|||||1961-02-22||1960-04-04|U|1971-07-21
TRIAL STUDY 134XCP|LB|8747C2AB-18EB-430B-8E89-CF9183DBF322|1||||CELLULAR|CELLULARITY|||||||UKAT|||||||BORDERLINE||%(W/V)||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|SOLIDIFIED|U|SISH|CKD-EPI CYSTATIN C FORMULA||Y|NA|U|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1960-07-08|1963-10-19|||||1967-06-19||1971-02-05|U|1972-02-06
TRIAL STUDY 134XCP|LB|8747C2AB-18EB-430B-8E89-CF9183DBF322|2||||PLG|PLASMINOGEN|||||||P|||||||INVALID||NMOL/DAY||||NORMAL|NOT DONE||||CORD SERUM|THAWED|NA|NUCLEIC ACID BASED METHOD|FIBROTEST FORMULA||NA|NA|N|NA|||N|1||38||RUN-IN|1960-08-03|1973-09-05|||||1972-01-18||1967-09-23|N|1972-12-13
TRIAL STUDY 134XCP|LB|8747C2AB-18EB-430B-8E89-CF9183DBF322|1||||ALPLS|LIVER SPECIFIC ALKALINE PHOSPHATASE|||||||MMOL2/L2|||||||INDETERMINATE||%||||LOW|NOT DONE||||PERSPIRATION|LACTESCENT|NA|CT SCAN WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|N|||NA|2||58||BASELINE|1960-04-04|1961-02-13|||||1967-10-06||1966-05-01|Y|1964-12-29
TRIAL STUDY 134XCP|LB|8747C2AB-18EB-430B-8E89-CF9183DBF322|2||||GLOBUL|GLOBULIN|||||||10^3 CFU|||||||NEGATIVE||SBE/ML||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|UNEXPECTED ODOR|NA|DNA MICROARRAY|CKD-EPI CREATININE FORMULA||U|U|N|U|||U|2||58||BLINDED TREATMENT|1966-04-27|1972-02-20|||||1964-05-25||1969-03-01|NA|1971-01-05
TRIAL STUDY 134XCP|LB|8747C2AB-18EB-430B-8E89-CF9183DBF322|1||||C5FR|COMPLEMENT C5, FREE|||||||DDU|||||||BORDERLINE||MAC50||||NORMAL|NOT DONE||||ISOLATE|ROOM TEMPERATURE|N|IN VITRO GENE EXPRESSION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|NA|U|||N|3||39||CONTINUATION TREATMENT|1964-03-03|1968-09-07|||||1960-09-23||1963-03-02|NA|1962-07-24
TRIAL STUDY 134XCP|LB|8747C2AB-18EB-430B-8E89-CF9183DBF322|2||||OXALATE|OXALATE|||||||ANTIBODY UNIT|||||||BORDERLINE||10^6/EJACULATE U||||NORMAL|NOT DONE||||PROSTATIC FLUID|DRIED|NA|ICP-MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|U|NA|||NA|3||39||CONTINUATION TREATMENT|1971-02-20|1965-04-04|||||1967-05-28||1972-03-19|N|1961-05-25
TRIAL STUDY 134XCP|LB|8747C2AB-18EB-430B-8E89-CF9183DBF322|1||||TDTAG|TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE AG|||||||LOG10 CFU/G|||||||INVALID||HENRY||||HIGH|NOT DONE||||VENOUS CORD BLOOD|CLOTTED|U|HPLC/MS/MS|GMI MMOL/MOL FORMULA||U|Y|U|U|||NA|4||88||CONTINUATION TREATMENT|1966-01-18|1969-05-06|||||1965-10-28||1968-04-17|Y|1963-01-07
TRIAL STUDY 134XCP|LB|8747C2AB-18EB-430B-8E89-CF9183DBF322|2||||INTLK25|INTERLEUKIN 25|||||||NG/DAY|||||||POSITIVE||MEQ||||HIGH|NOT DONE||||SEMEN|NON-HEMOLYZED|U|DIRECT SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|N|N|||U|4||88||LONG-TERM FOLLOW-UP|1965-04-27|1962-09-17|||||1970-02-03||1968-02-02|NA|1969-09-10
TRIAL STUDY 134XCP|LB|8747C2AB-18EB-430B-8E89-CF9183DBF322|1||||GDA|GUANINE DEAMINASE|||||||ML/100G/MIN|||||||INDETERMINATE||LOG10 IU/ML||||ABNORMAL|NOT DONE||||SPUTUM|CONCENTRATED|NA|PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC FORMULA||U|U|U|NA|||U|5||7||FOLLOW-UP|1973-08-13|1963-02-08|||||1970-08-04||1969-05-29|N|1973-01-26
TRIAL STUDY 134XCP|LB|8747C2AB-18EB-430B-8E89-CF9183DBF322|2||||C165914|CAT DANDER IGG AB RAST SCORE|||||||H/WK|||||||TRACE||IU/DAY||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|NON-HEMOLYZED|NA|BRDU CELLULAR PROLIFERATION ASSAY|HEPASCORE FORMULA||N|N|NA|NA|||NA|5||7||TREATMENT|1972-12-13|1961-02-01|||||1964-03-31||1967-09-21|N|1970-12-07
TRIAL STUDY 134XCP|LB|5A0FF15D-E779-47BA-8D3C-247A0FA57854|1||||EPIRCE|RENAL EPITHELIAL CELLS|||||||PELLET|||||||INVALID||DAMOL/L||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|LIPEMIC|N|IMMUNO-PET SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|Y|NA|||NA|1||38||FOLLOW-UP|1967-12-17|1968-07-21|||||1964-06-14||1960-03-24|NA|1964-10-12
TRIAL STUDY 134XCP|LB|5A0FF15D-E779-47BA-8D3C-247A0FA57854|2||||C165897|BERMUDA GRASS POLLEN IGG AB RAST SCORE|||||||NU/CL|||||||INVALID||MEQ||||HIGH|NOT DONE||||BONE|DRIED|NA|ACRIDINE ORANGE STAIN|COCKCROFT-GAULT FORMULA||Y|NA|N|NA|||N|1||38||TREATMENT|1967-07-04|1963-05-23|||||1963-09-16||1965-01-25|NA|1973-08-03
TRIAL STUDY 134XCP|LB|5A0FF15D-E779-47BA-8D3C-247A0FA57854|1||||BLSTLY|LYMPHOBLASTS|||||||UCI|||||||BORDERLINE||KA_U/DL||||ABNORMAL|NOT DONE||||FLUID|AGGLUTINATED|NA|RADIATION DOSIMETRY|NASH FIBROSURE FORMULA||U|U|Y|Y|||NA|2||58||BLINDED TREATMENT|1968-07-22|1961-03-14|||||1970-01-28||1962-10-09|U|1960-07-05
TRIAL STUDY 134XCP|LB|5A0FF15D-E779-47BA-8D3C-247A0FA57854|2||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||SYRINGE|||||||INDETERMINATE||/VF||||HIGH|NOT DONE||||SEBUM|CALCIFIED|Y|ELECTROMYOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|NA|N|||Y|2||58||LONG-TERM FOLLOW-UP|1968-08-08|1969-07-01|||||1968-02-26||1968-07-05|Y|1971-10-19
TRIAL STUDY 134XCP|LB|5A0FF15D-E779-47BA-8D3C-247A0FA57854|1||||HETRPH|HETEROPHILS|||||||AFU|||||||TRACE||PFU/ANIMAL||||HIGH|NOT DONE||||SUPERNATANT, SERUM|NON-HEMOLYZED|NA|FLOW CYTOMETRY|MDRD FORMULA||NA|U|Y|U|||Y|3||39||LONG-TERM FOLLOW-UP|1966-02-24|1971-10-27|||||1963-07-19||1970-07-25|NA|1973-08-27
TRIAL STUDY 134XCP|LB|5A0FF15D-E779-47BA-8D3C-247A0FA57854|2||||MYCEPPOL|MYELOID PROLIFERATION POOL|||||||NMOL/DAY|||||||BORDERLINE||DROP||||HIGH|NOT DONE||||LYSATE|GELLED|Y|PHOTOMETRIC CLOT DETECTION|MDRD ENZYMATIC JAPANESE FORMULA||U|U|Y|NA|||N|3||39||LONG-TERM FOLLOW-UP|1965-03-29|1970-12-29|||||1970-10-10||1967-07-28|U|1961-08-24
TRIAL STUDY 134XCP|LB|5A0FF15D-E779-47BA-8D3C-247A0FA57854|1||||VEGFA|VASCULAR ENDOTHELIAL GROWTH FACTOR A|||||||U/KG/DAY|||||||INVALID||/5X10^4 WBC||||LOW|NOT DONE||||EMOTIONAL TEAR|REFRIGERATED|N|WHOLE TRANSCRIPTOME SEQUENCING|FIBROTEST FORMULA||NA|U|Y|N|||NA|4||88||BLINDED TREATMENT|1961-09-06|1964-04-15|||||1969-09-08||1964-01-12|Y|1973-08-19
TRIAL STUDY 134XCP|LB|5A0FF15D-E779-47BA-8D3C-247A0FA57854|2||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||/100 WBC|||||||INDETERMINATE||NMOL/DAY||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|DRIED|N|FUNDUS PHOTOGRAPHY|HEPASCORE FORMULA||Y|N|N|NA|||U|4||88||OBSERVATION|1965-05-23|1970-02-11|||||1967-09-25||1966-03-06|Y|1971-07-14
TRIAL STUDY 134XCP|LB|5A0FF15D-E779-47BA-8D3C-247A0FA57854|1||||LEUKASE|LEUKOCYTE ESTERASE|||||||UG/G/DAY|||||||NEGATIVE||U/10^12 RBC||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|REFRIGERATED|U|MICRO BROTH DILUTION|MDRD 5 VARIABLE FORMULA||U|Y|Y|N|||U|5||7||LONG-TERM FOLLOW-UP|1965-06-22|1962-12-06|||||1968-06-18||1971-10-20|N|1971-06-05
TRIAL STUDY 134XCP|LB|5A0FF15D-E779-47BA-8D3C-247A0FA57854|2||||C165902|TIMOTHY GRASS POLLEN IGG AB RAST SCORE|||||||U/G/DAY|||||||TRACE||MET*MIN||||ABNORMAL|NOT DONE||||TISSUE|AUTOLYZED|Y|BALLPOINT PEN TECHNIQUE|CKD-EPI FORMULA||N|N|NA|NA|||U|5||7||BLINDED TREATMENT|1963-12-12|1970-10-11|||||1961-06-26||1970-08-12|N|1961-04-30
TRIAL STUDY 134XCP|LB|73260E60-6ADB-44DA-9A45-776B91F8B453|1||||RBCDYSM|DYSMORPHIC ERYTHROCYTES|||||||UV2|||||||BORDERLINE||NM||||NORMAL|NOT DONE||||ISOLATE|CONTAMINATED|Y|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA||N|Y|Y|Y|||NA|1||38||RUN-IN|1963-04-17|1963-04-13|||||1969-09-18||1972-12-10|Y|1962-05-03
TRIAL STUDY 134XCP|LB|73260E60-6ADB-44DA-9A45-776B91F8B453|2||||LIPASET|LIPASE|||||||MMOL/KG|||||||BORDERLINE||HZ/S||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED|Y|FUNCTIONAL MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|N|N|||Y|1||38||OBSERVATION|1963-01-06|1962-09-10|||||1960-06-12||1971-11-16|U|1962-01-15
TRIAL STUDY 134XCP|LB|73260E60-6ADB-44DA-9A45-776B91F8B453|1||||APOJCRT|APOLIPOPROTEIN J/CREATININE|||||||EU|||||||BORDERLINE||FEU||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|REFRIGERATED|U|SCANNING ELECTRON MICROSCOPY|MDRD 4 VARIABLE FORMULA||N|U|Y|NA|||U|2||58||TREATMENT|1962-09-02|1968-02-22|||||1962-10-05||1964-01-05|N|1965-06-21
TRIAL STUDY 134XCP|LB|73260E60-6ADB-44DA-9A45-776B91F8B453|2||||NEUTCE|NEUTROPHILS/TOTAL CELLS|||||||KBQ/UL|||||||BORDERLINE||MGEQ||||NORMAL|NOT DONE||||SMEGMA|AGGLUTINATED|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE FORMULA||Y|Y|Y|NA|||NA|2||58||BASELINE|1960-09-16|1962-11-21|||||1972-10-28||1965-11-01|N|1967-10-11
TRIAL STUDY 134XCP|LB|73260E60-6ADB-44DA-9A45-776B91F8B453|1||||C147276|ARACHIS HYPOGAEA ANTIGEN IGE ANTIBODY|||||||/5X10^4 WBC|||||||TRACE||ML/DOSE||||LOW|NOT DONE||||VITREOUS HUMOR|NON-HEMOLYZED|Y|CYSTOMETRY|CKD-EPI CREATININE FORMULA||N|N|U|Y|||U|3||39||CONTINUATION TREATMENT|1963-04-20|1961-03-04|||||1972-05-05||1963-11-03|U|1960-06-16
TRIAL STUDY 134XCP|LB|73260E60-6ADB-44DA-9A45-776B91F8B453|2||||AFP|ALPHA FETOPROTEIN|||||||RFU|||||||NEGATIVE||U/ML||||LOW|NOT DONE||||SPERMATOZOON|LACTESCENT|NA|FORCED OSCILLATION TECHNIQUE|COCKCROFT-GAULT FORMULA||NA|N|N|NA|||N|3||39||SCREENING|1971-09-22|1960-12-30|||||1960-05-06||1972-01-23|NA|1963-02-08
TRIAL STUDY 134XCP|LB|73260E60-6ADB-44DA-9A45-776B91F8B453|1||||GEC|GALACTOSE ELIMINATION CAPACITY|||||||VG/ML|||||||BORDERLINE||MMOL/MOL||||ABNORMAL|NOT DONE||||KERATINOCYTE|LIPEMIC|N|CELL OF ORIGIN ASSAY|FIBROMETER FORMULA||N|NA|NA|Y|||N|4||88||FOLLOW-UP|1965-06-12|1973-04-12|||||1961-12-21||1969-03-13|NA|1967-04-03
TRIAL STUDY 134XCP|LB|73260E60-6ADB-44DA-9A45-776B91F8B453|2||||PCT|PROCALCITONIN|||||||MG/L FEU|||||||TRACE||ECL UNIT||||NORMAL|NOT DONE||||SEBUM|GELLED|U|RYAN BLUE STAIN|GMI MMOL/MOL FORMULA||Y|Y|U|N|||N|4||88||OBSERVATION|1960-10-19|1972-11-08|||||1971-05-24||1965-02-13|Y|1960-01-27
TRIAL STUDY 134XCP|LB|73260E60-6ADB-44DA-9A45-776B91F8B453|1||||GFRBSCU|GFR FROM CREAT AND UREAN ADJ BSA|||||||10^3 COPIES/ML|||||||TRACE||SV||||HIGH|NOT DONE||||TUMOR TISSUE|LACTESCENT|NA|DYNAMIC CONTRAST ENHANCED MRI|FIBROTEST FORMULA||NA|NA|NA|NA|||Y|5||7||BLINDED TREATMENT|1972-06-06|1970-07-12|||||1968-03-11||1961-06-17|U|1962-03-07
TRIAL STUDY 134XCP|LB|73260E60-6ADB-44DA-9A45-776B91F8B453|2||||GGT|GAMMA GLUTAMYL TRANSFERASE|||||||10^9 CFU|||||||INDETERMINATE||U/MMOL||||HIGH|NOT DONE||||INFRANATANT, PLASMA|AGGLUTINATED|NA|X-RAY FLUORESCENCE SPECTROMETRY|MDRD 4 VARIABLE FORMULA||U|N|U|U|||N|5||7||INDUCTION TREATMENT|1967-09-11|1964-11-07|||||1963-12-21||1966-04-09|NA|1971-05-08
TRIAL STUDY 134XCP|LB|7B64252E-9A08-4177-BFA9-45B0C0E53097|1||||AAMAPAC|ALPHA-AMINOADIPIC ACID|||||||IU/MMOL|||||||TRACE||UMOL/L/SEC||||HIGH|NOT DONE||||ADIPOSE TISSUE|FROZEN|U|CALIPER MEASUREMENT METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|N|U|||NA|1||38||SCREENING|1968-09-24|1968-06-06|||||1972-12-30||1970-09-04|U|1970-01-22
TRIAL STUDY 134XCP|LB|7B64252E-9A08-4177-BFA9-45B0C0E53097|2||||ESR|ERYTHROCYTE SEDIMENTATION RATE|||||||ML/M2|||||||NEGATIVE||POUCH||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|FROZEN|NA|FUNDUS PHOTOGRAPHY|HEPASCORE FORMULA||NA|NA|NA|U|||Y|1||38||BLINDED TREATMENT|1972-07-20|1972-07-25|||||1961-01-16||1968-11-02|N|1961-08-17
TRIAL STUDY 134XCP|LB|7B64252E-9A08-4177-BFA9-45B0C0E53097|1||||CD161LY|CD161/LYMPHOCYTES|||||||G/CAGE|||||||TRACE||10^3 CFU/G||||HIGH|NOT DONE||||ERYTHROCYTES|SOLIDIFIED|N|OLIGO ACGH|ASH FIBROSURE FORMULA||NA|Y|Y|U|||NA|2||58||CONTINUATION TREATMENT|1966-05-15|1964-11-10|||||1965-09-05||1973-08-19|NA|1969-07-17
TRIAL STUDY 134XCP|LB|7B64252E-9A08-4177-BFA9-45B0C0E53097|2||||MONOBLLE|MONOBLASTS/LEUKOCYTES|||||||MILE|||||||BORDERLINE||MMOL/KG||||NORMAL|NOT DONE||||SERUM OR PLASMA|LACTESCENT|N|DIFFUSION WEIGHTED MRI|NASH FIBROSURE FORMULA||U|N|U|Y|||U|2||58||CONTINUATION TREATMENT|1961-07-25|1973-06-01|||||1968-09-22||1970-10-17|N|1971-11-18
TRIAL STUDY 134XCP|LB|7B64252E-9A08-4177-BFA9-45B0C0E53097|1||||PLSPCE|PRECURSOR PLASMA CELLS|||||||KG/CM2|||||||TRACE||SCM||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CONCENTRATED|N|HEMAGGLUTINATION INHIBITION ASSAY|MDRD FORMULA||N|NA|N|N|||Y|3||39||CONTINUATION TREATMENT|1961-07-31|1967-05-29|||||1969-01-25||1968-01-19|Y|1965-11-11
TRIAL STUDY 134XCP|LB|7B64252E-9A08-4177-BFA9-45B0C0E53097|2||||PTHI|PARATHYROID HORMONE, INTACT|||||||10^3 ORGANISMS|||||||INVALID||UL/DOSE||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|AUTOLYZED|Y|TEST STRIP|MDRD 5 VARIABLE FORMULA||Y|NA|N|Y|||NA|3||39||RUN-IN|1969-03-13|1961-09-02|||||1966-08-17||1961-12-24|N|1967-10-23
TRIAL STUDY 134XCP|LB|7B64252E-9A08-4177-BFA9-45B0C0E53097|1||||MDZLM|MIDAZOLAM|||||||FMOL/L|||||||NEGATIVE||SQU/ML||||ABNORMAL|NOT DONE||||REFLEX TEAR|UNEXPECTED ODOR|NA|ELECTRONEUROGRAPHY|FIBROMETER FORMULA||U|N|NA|Y|||U|4||88||WASHOUT|1968-12-29|1962-05-16|||||1969-06-27||1968-12-04|U|1973-01-29
TRIAL STUDY 134XCP|LB|7B64252E-9A08-4177-BFA9-45B0C0E53097|2||||FXAAC|FACTOR X ACTIVITY ACTUAL/CONTROL|||||||UG/L/H|||||||BORDERLINE||10^3 CFU/G||||ABNORMAL|NOT DONE||||SKIN TISSUE|ROOM TEMPERATURE|N|ULTRASONOGRAPHIC ELASTOGRAPHY|FIBROMETER FORMULA||Y|NA|Y|U|||N|4||88||CONTINUATION TREATMENT|1971-06-17|1968-08-15|||||1969-12-13||1972-07-21|Y|1972-01-23
TRIAL STUDY 134XCP|LB|7B64252E-9A08-4177-BFA9-45B0C0E53097|1||||LLCFR|LAMBDA LIGHT CHAIN, FREE|||||||ML/CM|||||||TRACE||GBQ/MG||||LOW|NOT DONE||||GASTRIC FLUID|NON-HEMOLYZED|NA|TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD 6 VARIABLE FORMULA||Y|NA|U|N|||NA|5||7||OBSERVATION|1966-12-31|1972-08-27|||||1960-02-28||1970-05-08|Y|1960-08-12
TRIAL STUDY 134XCP|LB|7B64252E-9A08-4177-BFA9-45B0C0E53097|2||||APOC2|APOLIPOPROTEIN C2|||||||UG/KG/MIN|||||||NEGATIVE||MEQ/DL||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|LIPEMIC|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI CREATININE FORMULA||N|N|N|NA|||N|5||7||SCREENING|1972-11-28|1972-03-19|||||1966-10-04||1965-03-22|NA|1972-02-11
TRIAL STUDY 134XCP|LB|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|1||||PICP|PROCOLLAGEN TYPE I CARBOXY TERM PEPTIDE|||||||10^9/L|||||||INDETERMINATE||%/S||||NORMAL|NOT DONE||||DERMAL TISSUE|UNEXPECTED ODOR|NA|MAPH|COCKCROFT-GAULT FORMULA||Y|N|U|N|||Y|1||38||CONTINUATION TREATMENT|1965-04-03|1967-02-16|||||1969-04-22||1960-10-15|Y|1972-07-13
TRIAL STUDY 134XCP|LB|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|2||||LDLOXI|OXIDIZED LDL CHOLESTEROL|||||||G/KG/DAY|||||||INVALID||ML/M2/H||||NORMAL|NOT DONE||||SPUTUM|AUTOLYZED|NA|NUCLEIC ACID HYBRIDIZATION|FIBROSIS 4 FORMULA||U|U|U|Y|||N|1||38||WASHOUT|1961-11-19|1969-01-04|||||1961-07-01||1967-05-17|U|1965-08-14
TRIAL STUDY 134XCP|LB|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|1||||INTLK17|INTERLEUKIN 17|||||||UM/S|||||||BORDERLINE||DAYS/WK||||NORMAL|NOT DONE||||ARTERIAL BLOOD|ROOM TEMPERATURE|U|URANYL ACETATE STAIN|COCKCROFT-GAULT FORMULA||NA|Y|NA|U|||NA|2||58||OBSERVATION|1969-09-14|1968-10-07|||||1964-04-27||1962-03-29|Y|1967-02-06
TRIAL STUDY 134XCP|LB|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|2||||LDLPATT|LDL SUBTYPE PATTERN|||||||ML/100G/MIN|||||||NEGATIVE||RNA COPIES/ML||||NORMAL|NOT DONE||||TISSUE|THAWED|Y|REFRACTOMETRY|GMI MMOL/MOL FORMULA||N|U|NA|N|||N|2||58||TREATMENT|1963-03-02|1967-01-19|||||1964-09-28||1970-06-25|Y|1964-07-03
TRIAL STUDY 134XCP|LB|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|1||||UNSPCECE|UNSPECIFIED CELLS/TOTAL CELLS|||||||UG/DAY|||||||TRACE||ML/M2/H||||NORMAL|NOT DONE||||GASTRIC FLUID|CONCENTRATED|N|TRIPLE-PHASE SPIRAL CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|NA|||U|3||39||TREATMENT|1962-11-11|1962-03-20|||||1963-05-22||1968-06-10|N|1968-11-14
TRIAL STUDY 134XCP|LB|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|2||||UREANCRT|UREA NITROGEN/CREATININE|||||||CM|||||||TRACE||MU/L||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|LACTESCENT|N|IVY INCISION METHOD|COCKCROFT-GAULT FORMULA||NA|U|U|N|||N|3||39||BLINDED TREATMENT|1967-09-02|1969-04-10|||||1964-11-10||1966-04-03|N|1963-09-04
TRIAL STUDY 134XCP|LB|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|1||||MONONSQE|MONOCYTES/NON-SQUAM EPI CELLS|||||||NEBULE|||||||NEGATIVE||ML/BREATH||||ABNORMAL|NOT DONE||||BONE MARROW|LIPEMIC|N|HIGH LEVEL AMINOGLYCOSIDE SCREEN|GMI % FORMULA||U|NA|N|N|||NA|4||88||WASHOUT|1965-09-17|1962-06-26|||||1968-06-01||1968-07-12|U|1968-01-07
TRIAL STUDY 134XCP|LB|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|2||||SPMAGGR|SPERM AGGREGATION|||||||10^6 COPIES/ML|||||||INVALID||HOUNSFIELD UNIT||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|FRESH|NA|SNP ARRAY|CKD-EPI FORMULA||N|Y|N|N|||NA|4||88||WASHOUT|1967-02-06|1962-01-10|||||1964-11-19||1969-01-28|Y|1966-05-30
TRIAL STUDY 134XCP|LB|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|1||||C130095|WESTERN RAGWEED POLLEN IGG4|||||||%/MIN|||||||TRACE||PELLET||||HIGH|NOT DONE||||VENOUS CORD BLOOD|REFRIGERATED|U|OPTICAL DENSITY MEASUREMENT|CKD-EPI CYSTATIN C FORMULA||U|N|N|U|||NA|5||7||TREATMENT|1967-04-04|1973-02-08|||||1961-07-23||1966-05-22|U|1961-06-21
TRIAL STUDY 134XCP|LB|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|2||||NONHDL|NON-HDL CHOLESTEROL|||||||UG|||||||INVALID||U/L||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|ROOM TEMPERATURE|Y|WRIGHT-GIEMSA STAIN|ASH FIBROSURE FORMULA||Y|N|Y|U|||Y|5||7||RUN-IN|1966-04-16|1960-04-11|||||1971-12-17||1970-04-06|NA|1970-03-26
TRIAL STUDY 134XCP|LB|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|1||||NTXII|TYPE II COLLAGEN N-TELOPEPTIDES|||||||/MIN|||||||BORDERLINE||MU||||LOW|NOT DONE||||SWABBED MATERIAL|CONTAMINATED|NA|POLYMERASE CHAIN REACTION|FIBROTEST FORMULA||U|NA|N|N|||Y|1||38||OBSERVATION|1970-07-10|1966-11-12|||||1967-12-26||1962-11-13|NA|1972-07-20
TRIAL STUDY 134XCP|LB|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|2||||SULFATE|SULFATE|||||||DEG2|||||||POSITIVE||ARBITRARY U||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|AUTOLYZED|U|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|GMI % FORMULA||U|Y|Y|Y|||N|1||38||TREATMENT|1960-06-21|1971-03-01|||||1967-07-23||1967-04-28|Y|1966-09-28
TRIAL STUDY 134XCP|LB|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|1||||RDCSUG|REDUCING SUGARS|||||||G/CAGE|||||||NEGATIVE||UKAT/10^12 RBC||||LOW|NOT DONE||||DIALYSIS FLUID|HEMOLYZED|Y|DIRECT SEQUENCING|CKD-EPI CREATININE FORMULA||U|NA|Y|U|||N|2||58||BLINDED TREATMENT|1973-06-07|1965-01-29|||||1964-12-31||1967-04-13|Y|1962-05-20
TRIAL STUDY 134XCP|LB|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|2||||GIPI|GLUCOSE-DEP INSULINOTROPIC PEP, INTACT|||||||10^6 DNA COPIES/ML|||||||INDETERMINATE||DMOL||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|HEMOLYZED|U|SPECT SCAN|COCKCROFT-GAULT FORMULA||Y|N|U|N|||N|2||58||BLINDED TREATMENT|1963-06-27|1963-10-11|||||1971-06-01||1967-02-26|N|1964-10-03
TRIAL STUDY 134XCP|LB|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|1||||ALBC|ALBUMIN CLEARANCE|||||||ML/M2/H|||||||INVALID||MOL/L||||HIGH|NOT DONE||||TUMOR TISSUE|LACTESCENT|NA|ELECTRONEUROGRAPHY|ASH FIBROSURE FORMULA||Y|NA|NA|N|||U|3||39||FOLLOW-UP|1965-03-07|1964-04-24|||||1968-10-07||1962-03-05|N|1962-06-25
TRIAL STUDY 134XCP|LB|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|2||||PROC6|PRO-C6|||||||UM/DAY|||||||TRACE||DNA COPIES/UG||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|CALCIFIED|Y|DIFFUSION TENSOR MRI|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|N|Y|||NA|3||39||RUN-IN|1961-04-20|1970-12-25|||||1962-11-10||1964-05-21|NA|1964-09-24
TRIAL STUDY 134XCP|LB|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|1||||LEUKASE|LEUKOCYTE ESTERASE|||||||U/G/MIN|||||||INVALID||PSI||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|SOLIDIFIED|N|APPLANATION TONOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|NA|N|||U|4||88||FOLLOW-UP|1962-09-11|1962-07-07|||||1963-12-10||1966-03-10|U|1961-06-13
TRIAL STUDY 134XCP|LB|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|2||||NITRICOX|NITRIC OXIDE|||||||BREATHS/MIN|||||||INDETERMINATE||L/KG||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|AUTOLYZED|U|RADIOGRAPHY|GMI MMOL/MOL FORMULA||U|NA|U|NA|||NA|4||88||SCREENING|1964-01-25|1971-07-20|||||1970-06-06||1969-10-08|U|1971-11-09
TRIAL STUDY 134XCP|LB|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|1||||LTD4|LEUKOTRIENE D4|||||||BQ/UL|||||||BORDERLINE||ML/MMHG/MIN/L||||ABNORMAL|NOT DONE||||LYSATE|HEMOLYZED|N|CONGO RED STAIN|MDRD 5 VARIABLE FORMULA||U|N|Y|U|||N|5||7||CONTINUATION TREATMENT|1960-10-20|1965-09-21|||||1960-09-23||1970-05-27|NA|1964-03-13
TRIAL STUDY 134XCP|LB|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|2||||C165926|MOLD MIX IGE AB RAST SCORE|||||||MOL/L|||||||TRACE||BOLUS||||HIGH|NOT DONE||||ERYTHROCYTES|PARAFFIN-EMBEDDED|NA|NUCLEIC ACID HYBRIDIZATION|GMI % FORMULA||Y|NA|Y|Y|||NA|5||7||RUN-IN|1966-07-29|1962-01-07|||||1972-03-13||1971-02-03|U|1965-07-27
TRIAL STUDY 134XCP|LB|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|1||||SAA1|SERUM AMYLOID A1|||||||VP/DOSE|||||||TRACE||HOUNSFIELD UNIT||||NORMAL|NOT DONE||||SALIVA|REFRIGERATED|NA|LIGHT SCATTERING SPECTROSCOPY|MDRD ENZYMATIC FORMULA||U|NA|U|U|||Y|1||38||FOLLOW-UP|1966-03-31|1969-10-04|||||1963-07-04||1967-11-12|U|1962-07-24
TRIAL STUDY 134XCP|LB|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|2||||MPOAB|MYELOPEROXIDASE ANTIBODY|||||||BQ/KG|||||||BORDERLINE||ML/100G/MIN||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|CLOTTED|Y|AGAR PROPORTION|ASH FIBROSURE FORMULA||N|NA|Y|N|||U|1||38||BASELINE|1967-03-13|1972-08-26|||||1964-06-29||1961-08-20|Y|1972-11-18
TRIAL STUDY 134XCP|LB|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|1||||ALA|ALANINE|||||||U/KG/H|||||||BORDERLINE||WEEKS||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|FROZEN|NA|RYAN BLUE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|U|N|||Y|2||58||BASELINE|1971-09-13|1960-03-08|||||1968-11-19||1972-05-31|NA|1971-07-04
TRIAL STUDY 134XCP|LB|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|2||||PGD2|PROSTAGLANDIN D2|||||||SUPPOSITORY|||||||POSITIVE||UEQ||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|SOLIDIFIED|U|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD FORMULA||N|U|N|N|||NA|2||58||SCREENING|1961-06-13|1971-02-15|||||1972-06-03||1971-08-19|Y|1967-07-15
TRIAL STUDY 134XCP|LB|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|1||||GHRELINA|ACTIVE GHRELIN|||||||PPB|||||||NEGATIVE||C||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|REFRIGERATED|N|AGAR PROPORTION|COCKCROFT-GAULT FORMULA||U|U|NA|U|||NA|3||39||LONG-TERM FOLLOW-UP|1960-02-26|1960-11-08|||||1971-09-01||1969-01-29|N|1964-05-14
TRIAL STUDY 134XCP|LB|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|2||||ADP|ADENOSINE DIPHOSPHATE|||||||ML/S/M2|||||||INDETERMINATE||MEQ/DAY||||ABNORMAL|NOT DONE||||CORD SERUM|LIPEMIC|U|ENZYMATIC SPECTROPHOTOMETRY|NASH FIBROSURE FORMULA||U|NA|Y|NA|||U|3||39||INDUCTION TREATMENT|1962-03-15|1968-08-13|||||1964-10-18||1962-05-16|U|1960-11-01
TRIAL STUDY 134XCP|LB|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|1||||C147283|WHITE ELM POLLEN IGG ANTIBODY|||||||PMOL|||||||NEGATIVE||MG/MIN||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|CALCIFIED|NA|SLOAN LETTER EYE CHART 1.25%|MDRD 5 VARIABLE FORMULA||N|U|Y|U|||N|4||88||RUN-IN|1962-09-18|1972-06-02|||||1967-03-30||1965-01-28|Y|1971-12-14
TRIAL STUDY 134XCP|LB|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|2||||PROPOX|PROPOXYPHENE|||||||PFU/DOSE|||||||NEGATIVE||MOL/G||||ABNORMAL|NOT DONE||||BONE|ICTERIC|Y|HEMOCYTOMETRY|CKD-EPI FORMULA||Y|N|U|N|||Y|4||88||BLINDED TREATMENT|1961-02-24|1971-01-11|||||1972-04-29||1971-09-29|Y|1960-08-25
TRIAL STUDY 134XCP|LB|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|1||||C130138|AMERICAN COCKROACH ANTIGEN IGG ANTIBODY|||||||HENRY|||||||POSITIVE||SUPPOSITORY||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|AUTOLYZED|NA|ERGOSPIROMETRY|FIBROSIS 4 FORMULA||Y|Y|NA|N|||U|5||7||WASHOUT|1967-04-14|1964-01-25|||||1961-02-27||1965-05-22|U|1964-07-27
TRIAL STUDY 134XCP|LB|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|2||||INTLK2|INTERLEUKIN 2|||||||MU|||||||BORDERLINE||KM/H||||NORMAL|NOT DONE||||TUMOR TISSUE|UNEXPECTED ODOR|N|PERIPHERAL ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|U|Y|Y|||N|5||7||OBSERVATION|1963-04-24|1963-01-26|||||1967-08-08||1965-10-31|N|1961-02-02
TRIAL STUDY 134XCP|LB|1B0EE182-6729-4333-BB9B-5561CAB31D26|1||||HIST2AAB|HISTONE 2A ANTIBODY|||||||ML/MMHG|||||||INVALID||KG/CM||||NORMAL|NOT DONE||||CALCULUS|DRIED|Y|POLYSOMNOGRAPHY|NASH FIBROSURE FORMULA||U|U|N|N|||U|1||38||INDUCTION TREATMENT|1972-05-02|1962-03-28|||||1973-07-27||1960-01-11|NA|1972-03-22
TRIAL STUDY 134XCP|LB|1B0EE182-6729-4333-BB9B-5561CAB31D26|2||||KLCLLCFR|KAPPA LT CHAIN,FREE/LAMBDA LT CHAIN,FREE|||||||MEQ|||||||TRACE||IU/L||||NORMAL|NOT DONE||||CALCULUS|ICTERIC|N|ORCHIDOMETERY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|NA|||NA|1||38||FOLLOW-UP|1972-12-21|1960-07-02|||||1964-11-06||1969-03-12|U|1967-12-16
TRIAL STUDY 134XCP|LB|1B0EE182-6729-4333-BB9B-5561CAB31D26|1||||GSTMUCRT|MU GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||FMOL|||||||INVALID||PMOL||||LOW|NOT DONE||||NAIL|ROOM TEMPERATURE|N|SLOAN LETTER EYE CHART 2.5%|FIBROSIS 4 FORMULA||NA|N|U|U|||N|2||58||INDUCTION TREATMENT|1964-08-23|1963-06-26|||||1966-09-17||1969-07-22|NA|1962-02-08
TRIAL STUDY 134XCP|LB|1B0EE182-6729-4333-BB9B-5561CAB31D26|2||||IA5OHEXR|5-HYDROXYINDOLEACETICACID EXCRETION RATE|||||||ANSON U|||||||INDETERMINATE||DIOPTER||||HIGH|NOT DONE||||SERUM OR PLASMA|CONCENTRATED|NA|PYROSEQUENCING|MDRD 4 VARIABLE FORMULA||U|N|Y|NA|||Y|2||58||INDUCTION TREATMENT|1962-08-17|1965-01-30|||||1968-06-30||1966-01-11|Y|1966-05-26
TRIAL STUDY 134XCP|LB|1B0EE182-6729-4333-BB9B-5561CAB31D26|1||||VLDLPSZ|VLDL PARTICLE SIZE|||||||MILE|||||||NEGATIVE||UMOL/MG/MIN||||NORMAL|NOT DONE||||GASTRIC FLUID|GELLED|U|MICROARRAY|MDRD 5 VARIABLE FORMULA||Y|N|N|N|||N|3||39||SCREENING|1967-04-12|1963-02-14|||||1968-04-15||1960-03-25|N|1972-07-13
TRIAL STUDY 134XCP|LB|1B0EE182-6729-4333-BB9B-5561CAB31D26|2||||NSPMTSPM|NORMAL SPERM/TOTAL SPERM|||||||CMH2O/ML|||||||INVALID||10^11/L||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|THAWED|N|ELISPOT|GMI % FORMULA||NA|Y|Y|NA|||Y|3||39||OBSERVATION|1967-12-07|1961-08-12|||||1965-11-01||1968-07-23|NA|1972-10-31
TRIAL STUDY 134XCP|LB|1B0EE182-6729-4333-BB9B-5561CAB31D26|1||||IRONEXR|IRON EXCRETION RATE|||||||PHERESIS UNIT|||||||NEGATIVE||UM/DAY||||ABNORMAL|NOT DONE||||SEMINAL FLUID|CONTAMINATED|U|PAP STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|U|||Y|4||88||FOLLOW-UP|1970-03-17|1970-07-26|||||1960-12-28||1961-01-01|NA|1962-12-06
TRIAL STUDY 134XCP|LB|1B0EE182-6729-4333-BB9B-5561CAB31D26|2||||FACTVII|FACTOR VII|||||||UMOL/DL|||||||INDETERMINATE||NMOL BCE/NMOL||||HIGH|NOT DONE||||SALIVA|AUTOLYZED|U|NON-INVASIVE DIELECTRIC SENSING|COCKCROFT-GAULT FORMULA||U|U|U|N|||N|4||88||BASELINE|1968-12-29|1971-02-27|||||1972-02-15||1965-01-02|N|1972-02-10
TRIAL STUDY 134XCP|LB|1B0EE182-6729-4333-BB9B-5561CAB31D26|1||||C130135|D. PTERONYSSINUS ANTIGEN IGG ANTIBODY|||||||MET*H|||||||BORDERLINE||MONTHS||||HIGH|NOT DONE||||BREAST MILK|LIPEMIC|NA|POLYSOMNOGRAPHY|HEPASCORE FORMULA||Y|N|U|U|||NA|5||7||INDUCTION TREATMENT|1972-10-26|1966-12-15|||||1973-02-05||1966-07-31|NA|1965-08-25
TRIAL STUDY 134XCP|LB|1B0EE182-6729-4333-BB9B-5561CAB31D26|2||||HLABAGT|HLA-B ANTIGEN TYPE|||||||UMOL/DL|||||||BORDERLINE||UG/L DDU||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|CONTAMINATED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA||Y|N|Y|Y|||NA|5||7||TREATMENT|1968-06-03|1965-09-15|||||1967-10-30||1971-07-28|NA|1968-06-07
TRIAL STUDY 134XCP|LB|1F3AD620-4B16-4EFF-8F5A-45105841BE02|1||||DPD|DEOXYPYRIDINOLINE|||||||LOG10 CFU/ML|||||||NEGATIVE||/7.5 ML||||NORMAL|NOT DONE||||EXUDATE|GELLED|NA|STRESS ECHOCARDIOGRAPHY|GMI % FORMULA||U|NA|U|Y|||N|1||38||BLINDED TREATMENT|1971-12-12|1963-05-18|||||1962-05-14||1965-04-18|U|1969-02-23
TRIAL STUDY 134XCP|LB|1F3AD620-4B16-4EFF-8F5A-45105841BE02|2||||MSPIKER|MONOCLONAL PROTEIN SPIKE REGION|||||||BOWL|||||||NEGATIVE||G/M2||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|CALCIFIED|NA|PET/CT SCAN|MDRD FORMULA||N|U|U|NA|||Y|1||38||RUN-IN|1966-01-03|1960-07-23|||||1965-12-02||1968-12-29|NA|1961-09-28
TRIAL STUDY 134XCP|LB|1F3AD620-4B16-4EFF-8F5A-45105841BE02|1||||RANKL|RECEPTOR ACTIVATOR NUCLEAR KAPPAB LIGAND|||||||ML/KG/MIN|||||||POSITIVE||JOULE||||LOW|NOT DONE||||SPERMATOZOON|CONCENTRATED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD FORMULA||NA|U|Y|NA|||Y|2||58||RUN-IN|1964-07-12|1969-02-23|||||1967-01-16||1965-06-26|N|1972-09-16
TRIAL STUDY 134XCP|LB|1F3AD620-4B16-4EFF-8F5A-45105841BE02|2||||CITCREAT|CITRATE/CREATININE|||||||EQ|||||||BORDERLINE||NMOL/ML/MIN||||HIGH|NOT DONE||||CALCULUS|GELLED|N|ENDOSCOPY|CKD-EPI FORMULA||Y|NA|NA|N|||Y|2||58||CONTINUATION TREATMENT|1972-12-26|1965-11-21|||||1960-11-09||1967-04-20|Y|1960-10-21
TRIAL STUDY 134XCP|LB|1F3AD620-4B16-4EFF-8F5A-45105841BE02|1||||B2MICG|BETA-2 MICROGLOBULIN|||||||MM/MIN|||||||INVALID||FL||||HIGH|NOT DONE||||CORD SERUM|ROOM TEMPERATURE|N|WESTERN BLOT|MDRD 4 VARIABLE FORMULA||Y|NA|Y|NA|||N|3||39||LONG-TERM FOLLOW-UP|1963-06-10|1965-11-11|||||1968-02-22||1970-06-04|U|1972-11-29
TRIAL STUDY 134XCP|LB|1F3AD620-4B16-4EFF-8F5A-45105841BE02|2||||WDR26|WD REPEAT-CONTAINING PROTEIN 26|||||||10^7/L|||||||INDETERMINATE||10^9 ORGANISMS/ML||||NORMAL|NOT DONE||||BLOOD|CLOTTED|U|IN SITU HYBRIDIZATION|MDRD FORMULA||NA|Y|N|NA|||U|3||39||OPEN LABEL TREATMENT|1963-11-20|1960-04-24|||||1970-05-03||1965-06-21|U|1965-11-04
TRIAL STUDY 134XCP|LB|1F3AD620-4B16-4EFF-8F5A-45105841BE02|1||||GLY|GLYCINE|||||||DL|||||||BORDERLINE||LOG10 IU/ML||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|GELLED|NA|PET SCAN|GMI MMOL/MOL FORMULA||NA|N|N|Y|||U|4||88||OBSERVATION|1960-03-26|1969-11-05|||||1966-07-31||1966-08-26|N|1968-09-14
TRIAL STUDY 134XCP|LB|1F3AD620-4B16-4EFF-8F5A-45105841BE02|2||||RNPAB|RIBONUCLEOPROTEIN ANTIBODY|||||||CAPLET|||||||NEGATIVE||MG/H||||ABNORMAL|NOT DONE||||TUMOR TISSUE|REFRIGERATED|NA|MAPH|GMI MMOL/MOL FORMULA||N|N|N|Y|||U|4||88||CONTINUATION TREATMENT|1965-06-01|1972-08-25|||||1964-04-04||1963-05-21|Y|1972-11-18
TRIAL STUDY 134XCP|LB|1F3AD620-4B16-4EFF-8F5A-45105841BE02|1||||VEGFR1S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC1|||||||HEP|||||||NEGATIVE||NMOL/L/H||||HIGH|NOT DONE||||URINE|NON-HEMOLYZED|N|MAGNETIC RESONANCE ENTEROGRAPHY|MDRD ENZYMATIC FORMULA||Y|NA|NA|U|||Y|5||7||OBSERVATION|1972-12-12|1961-01-12|||||1972-12-04||1966-03-16|NA|1973-02-24
TRIAL STUDY 134XCP|LB|1F3AD620-4B16-4EFF-8F5A-45105841BE02|2||||ANIONG|ANION GAP|||||||GPS U|||||||POSITIVE||AGU/ML||||LOW|NOT DONE||||EXPIRED AIR|ICTERIC|U|TRIPLE-PHASE MRI SCAN|FIBROSIS 4 FORMULA||Y|Y|NA|N|||U|5||7||TREATMENT|1971-08-22|1964-11-07|||||1970-01-22||1964-06-16|N|1963-05-19
TRIAL STUDY 134XCP|LB|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|1||||CYDCPHOS|DICALCIUM PHOSPHATE CRYSTALS|||||||10^9 CFU|||||||POSITIVE||GLOBULE||||LOW|NOT DONE||||REFLEX TEAR|AGGLUTINATED|Y|RAJI CELL RIA|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|NA|N|||Y|1||38||INDUCTION TREATMENT|1960-08-31|1970-04-17|||||1964-09-09||1966-11-12|Y|1967-12-07
TRIAL STUDY 134XCP|LB|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|2||||C130077|SILVER BIRCH POLLEN IGA|||||||/CMH2O|||||||INDETERMINATE||UG/KG||||HIGH|NOT DONE||||MONOCYTE|ICTERIC|Y|TRICHROME STAIN|CKD-EPI CYSTATIN C FORMULA||U|N|U|U|||U|1||38||BASELINE|1961-05-02|1970-07-25|||||1966-04-17||1971-12-11|N|1973-05-09
TRIAL STUDY 134XCP|LB|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|1||||IRON|IRON|||||||V/V|||||||BORDERLINE||MPL U/ML||||HIGH|NOT DONE||||HAIR FOLLICLE|PARAFFIN-EMBEDDED|N|RULER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA||NA|N|N|Y|||NA|2||58||WASHOUT|1964-09-30|1970-02-25|||||1967-11-26||1969-10-15|Y|1970-10-06
TRIAL STUDY 134XCP|LB|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|2||||METANEXR|METANEPHRINE EXCRETION RATE|||||||UL/KG/DAY|||||||INVALID||M||||ABNORMAL|NOT DONE||||SERUM|CONTAMINATED|U|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI MMOL/MOL FORMULA||Y|NA|U|N|||U|2||58||BLINDED TREATMENT|1961-03-11|1970-01-13|||||1973-04-21||1965-04-19|U|1968-08-21
TRIAL STUDY 134XCP|LB|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|1||||BASO|BASOPHILS|||||||MPA|||||||POSITIVE||DEG2||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|AGGLUTINATED|NA|PET SCAN|CKD-EPI CYSTATIN C FORMULA||N|N|N|N|||Y|3||39||LONG-TERM FOLLOW-UP|1962-06-01|1972-12-15|||||1961-10-10||1963-02-03|U|1965-06-29
TRIAL STUDY 134XCP|LB|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|2||||TSTFTSTT|TESTOSTERONE, FREE/TESTOSTERONE|||||||CMH2O*S2/ML|||||||INDETERMINATE||IU/G HB||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|ICTERIC|N|THICK SMEAR|MDRD 4 VARIABLE FORMULA||U|N|Y|U|||N|3||39||BASELINE|1970-04-09|1970-09-25|||||1970-05-24||1962-10-07|N|1967-02-06
TRIAL STUDY 134XCP|LB|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|1||||LSD|LYSERGIC ACID DIETHYLAMIDE|||||||G/CM2|||||||NEGATIVE||CI/UL||||LOW|NOT DONE||||MONOCYTE|THAWED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|COCKCROFT-GAULT FORMULA||N|U|U|NA|||NA|4||88||LONG-TERM FOLLOW-UP|1960-06-22|1965-03-27|||||1970-06-17||1965-04-04|Y|1963-01-22
TRIAL STUDY 134XCP|LB|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|2||||C165877|CAT DANDER IGE AB RAST SCORE|||||||CAPSULE|||||||NEGATIVE||M/SEC2||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|AUTOLYZED|U|TRIPLE-PHASE MRI SCAN|GMI % FORMULA||NA|N|Y|NA|||NA|4||88||CONTINUATION TREATMENT|1960-06-17|1970-04-24|||||1963-11-03||1968-09-17|U|1966-12-15
TRIAL STUDY 134XCP|LB|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|1||||NEUTAGR|AGRANULAR NEUTROPHILS|||||||PNU/ML|||||||BORDERLINE||PPTR||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|HEMOLYZED|NA|SICKLE CELL SOLUBILITY TEST|GMI % FORMULA||NA|N|U|NA|||Y|5||7||SCREENING|1970-01-29|1969-10-31|||||1972-04-02||1970-09-22|NA|1973-09-06
TRIAL STUDY 134XCP|LB|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|2||||C130143|GERMAN COCKROACH ANTIGEN IGG4 ANTIBODY|||||||FG|||||||BORDERLINE||UG/ML/H||||ABNORMAL|NOT DONE||||SEBUM|CONTAMINATED|Y|X-RAY|MDRD 6 VARIABLE FORMULA||N|U|NA|N|||NA|5||7||FOLLOW-UP|1969-09-25|1971-02-07|||||1966-04-03||1965-03-30|N|1969-07-13
TRIAL STUDY 134XCP|LB|152147B0-6EAD-4124-8E1A-BD7707850B60|1||||TGLOBRR|THYROGLOBULIN RECOVERY RATE|||||||PMOL/DL|||||||INVALID||CAPLET||||HIGH|NOT DONE||||SPUTUM|AGGLUTINATED|Y|STRESS ECHOCARDIOGRAPHY|GMI % FORMULA||N|Y|Y|N|||NA|1||38||SCREENING|1965-03-11|1971-12-01|||||1967-06-01||1962-09-15|U|1960-04-13
TRIAL STUDY 134XCP|LB|152147B0-6EAD-4124-8E1A-BD7707850B60|2||||C165909|INDUSTRIAL MIX IGG AB RAST SCORE|||||||BEAM BREAKS|||||||BORDERLINE||AMU||||HIGH|NOT DONE||||PLATELET POOR PLASMA|CALCIFIED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI FORMULA||N|U|Y|U|||U|1||38||TREATMENT|1963-01-25|1963-04-04|||||1970-01-13||1969-01-09|N|1962-02-25
TRIAL STUDY 134XCP|LB|152147B0-6EAD-4124-8E1A-BD7707850B60|1||||APLIGMAB|ANTI-PHOSPHOLIPID IGM ANTIBODY|||||||U/KG/H|||||||POSITIVE||UMOL/MOL||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|CLOTTED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|NASH FIBROSURE FORMULA||Y|U|NA|Y|||Y|2||58||BLINDED TREATMENT|1960-06-04|1960-12-22|||||1960-12-06||1964-03-10|N|1961-09-17
TRIAL STUDY 134XCP|LB|152147B0-6EAD-4124-8E1A-BD7707850B60|2||||CSBROAD|BROAD CASTS|||||||L/KG|||||||INVALID||SACHET||||LOW|NOT DONE||||LUNG SURFACTANT|REFRIGERATED|U|GIEMSA STAIN|CKD-EPI CREATININE FORMULA||Y|U|NA|NA|||Y|2||58||INDUCTION TREATMENT|1971-05-03|1966-07-16|||||1964-01-25||1969-11-23|U|1963-03-18
TRIAL STUDY 134XCP|LB|152147B0-6EAD-4124-8E1A-BD7707850B60|1||||C130120|SHELLFISH MIX ANTIGEN IGE ANTIBODY|||||||SUPPOSITORY|||||||INVALID||/4.0 ML||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|NON-HEMOLYZED|U|CELL BASED BIOASSAY|CKD-EPI FORMULA||NA|U|NA|NA|||Y|3||39||BLINDED TREATMENT|1964-04-06|1964-12-25|||||1972-10-02||1970-04-12|Y|1970-03-09
TRIAL STUDY 134XCP|LB|152147B0-6EAD-4124-8E1A-BD7707850B60|2||||NEUTMY|NEUTROPHILIC MYELOCYTES|||||||CAPLET|||||||NEGATIVE||ANTI-XA IU||||NORMAL|NOT DONE||||MECONIUM|CONTAMINATED|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROSIS 4 FORMULA||NA|Y|Y|Y|||Y|3||39||RUN-IN|1961-02-21|1970-12-07|||||1961-03-06||1970-04-06|NA|1970-01-03
TRIAL STUDY 134XCP|LB|152147B0-6EAD-4124-8E1A-BD7707850B60|1||||ANGLBIND|ANTIGLOBULIN TEST, INDIRECT|||||||UG/H|||||||NEGATIVE||NU/CL||||NORMAL|NOT DONE||||VENOUS PLASMA|DRIED|U|CYSTOSCOPY|GMI MMOL/MOL FORMULA||U|U|U|U|||U|4||88||FOLLOW-UP|1969-10-15|1964-10-06|||||1971-05-21||1972-02-06|NA|1961-04-11
TRIAL STUDY 134XCP|LB|152147B0-6EAD-4124-8E1A-BD7707850B60|2||||IL2SR|SOLUBLE INTERLEUKIN 2 RECEPTOR|||||||NEEDLE GAUGE|||||||INDETERMINATE||MG/DAY||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|GELLED|Y|DYNAMOMETRY|FIBROSIS 4 FORMULA||U|N|NA|Y|||N|4||88||RUN-IN|1966-10-29|1966-03-12|||||1968-01-13||1970-04-02|NA|1970-11-17
TRIAL STUDY 134XCP|LB|152147B0-6EAD-4124-8E1A-BD7707850B60|1||||LYMCE|LYMPHOCYTES/TOTAL CELLS|||||||L/L|||||||BORDERLINE||MU/L||||LOW|NOT DONE||||ALVEOLAR AIR|THAWED|U|RIA|CKD-EPI CREATININE FORMULA||NA|N|NA|N|||U|5||7||WASHOUT|1961-05-18|1971-03-09|||||1967-06-18||1969-08-10|NA|1967-03-19
TRIAL STUDY 134XCP|LB|152147B0-6EAD-4124-8E1A-BD7707850B60|2||||ANGPT2|ANGIOPOIETIN 2|||||||UM2|||||||NEGATIVE||FEU||||HIGH|NOT DONE||||ARTERIAL BLOOD|SOLIDIFIED|U|IVY INCISION METHOD|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|U|N|||NA|5||7||BASELINE|1964-03-14|1964-01-29|||||1963-04-15||1961-09-26|Y|1966-01-12
TRIAL STUDY 134XCP|LB|3CCF019C-5663-4670-B2D1-EC01D6B58D06|1||||ABOA1|ABO A1 SUBTYPE|||||||10^9 ORGANISMS/ML|||||||POSITIVE||UMOL/DAY||||HIGH|NOT DONE||||PLASMA|SOLIDIFIED|U|STATIC PERIMETRY|HEPASCORE FORMULA||NA|NA|Y|U|||N|1||38||BLINDED TREATMENT|1969-01-12|1969-03-14|||||1967-09-28||1965-12-25|Y|1970-08-26
TRIAL STUDY 134XCP|LB|3CCF019C-5663-4670-B2D1-EC01D6B58D06|2||||CKMBCK|CREATINE KINASE MB/TOTAL CREATINE KINASE|||||||LOG10 PFU/ML|||||||TRACE||MMOL2/L2||||LOW|NOT DONE||||REFLEX TEAR|UNEXPECTED ODOR|NA|PALPATION|MDRD 4 VARIABLE FORMULA||Y|Y|U|N|||U|1||38||BLINDED TREATMENT|1961-02-24|1966-07-15|||||1972-11-16||1965-07-22|Y|1963-05-15
TRIAL STUDY 134XCP|LB|3CCF019C-5663-4670-B2D1-EC01D6B58D06|1||||PLSTCELE|TOTAL PLASMA CELLS/LEUKOCYTES|||||||U/ML|||||||POSITIVE||ML/G/DAY||||ABNORMAL|NOT DONE||||SERUM|DRIED|U|LEAD CITRATE STAIN|FIBROTEST FORMULA||U|N|Y|U|||NA|2||58||BLINDED TREATMENT|1973-06-23|1963-03-28|||||1961-01-12||1970-03-09|NA|1968-02-08
TRIAL STUDY 134XCP|LB|3CCF019C-5663-4670-B2D1-EC01D6B58D06|2||||PBG|PORPHOBILINOGEN|||||||APPLICATION|||||||NEGATIVE||U/M2||||HIGH|NOT DONE||||RETICULOCYTES|DRIED|NA|SPECTROPHOTOMETRY|MDRD 6 VARIABLE FORMULA||NA|NA|U|NA|||N|2||58||CONTINUATION TREATMENT|1961-12-01|1962-09-04|||||1973-05-28||1962-10-28|N|1973-03-04
TRIAL STUDY 134XCP|LB|3CCF019C-5663-4670-B2D1-EC01D6B58D06|1||||PLAGGCVT|PLATELET AGGREGATION CURVE TYPE|||||||MMHG/SEC|||||||TRACE||ML/CM3/MIN||||LOW|NOT DONE||||CORD SERUM|LACTESCENT|N|INTRAVASCULAR ULTRASOUND|MDRD FORMULA||N|U|NA|Y|||U|3||39||SCREENING|1971-08-19|1965-09-05|||||1963-10-10||1971-07-10|NA|1968-09-22
TRIAL STUDY 134XCP|LB|3CCF019C-5663-4670-B2D1-EC01D6B58D06|2||||TEARDCY|DACRYOCYTES|||||||10^6 IU/ML|||||||INDETERMINATE||10^10/L||||LOW|NOT DONE||||EMESIS|CONTAMINATED|Y|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|GMI MMOL/MOL FORMULA||N|NA|Y|Y|||NA|3||39||BASELINE|1963-11-14|1971-06-01|||||1966-12-03||1966-11-05|N|1961-09-11
TRIAL STUDY 134XCP|LB|3CCF019C-5663-4670-B2D1-EC01D6B58D06|1||||NPY|NEUROPEPTIDE Y|||||||TAMPON|||||||INVALID||DMOL||||NORMAL|NOT DONE||||COLOSTRUM|FRESH|Y|KARYOTYPING|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|U|Y|||NA|4||88||CONTINUATION TREATMENT|1964-03-19|1961-10-05|||||1969-02-22||1966-03-03|NA|1972-11-06
TRIAL STUDY 134XCP|LB|3CCF019C-5663-4670-B2D1-EC01D6B58D06|2||||SODMEXR|SODIUM EXCRETION RATE|||||||MV/SEC|||||||INVALID||10^6 ORGANISMS/G||||ABNORMAL|NOT DONE||||COLOSTRUM|SOLIDIFIED|U|CAPILLARY ELECTROPHORESIS|GMI MMOL/MOL FORMULA||NA|U|U|Y|||U|4||88||FOLLOW-UP|1960-03-20|1964-07-30|||||1969-06-30||1962-01-24|U|1961-05-13
TRIAL STUDY 134XCP|LB|3CCF019C-5663-4670-B2D1-EC01D6B58D06|1||||MECONIUM|MECONIUM|||||||%/S|||||||INDETERMINATE||10^4/HPF||||LOW|NOT DONE||||EPITHELIAL CELL|SOLIDIFIED|Y|POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||N|NA|U|U|||NA|5||7||WASHOUT|1962-08-23|1968-07-17|||||1960-11-18||1961-10-28|Y|1973-08-18
TRIAL STUDY 134XCP|LB|3CCF019C-5663-4670-B2D1-EC01D6B58D06|2||||HCGNDI|CHORIOGONADOTROPIN, INTACT|||||||UKAT/L|||||||INDETERMINATE||FRACTION OF 1||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|ROOM TEMPERATURE|NA|CELLULOSE TAPE|FIBROMETER FORMULA||Y|NA|N|NA|||N|5||7||WASHOUT|1973-02-03|1960-11-20|||||1972-02-10||1971-05-16|NA|1961-03-15
TRIAL STUDY 134XCP|LB|6599D082-A8A0-412D-BBDF-CD786C581905|1||||MORPHINE|MORPHINE|||||||10^6 CFU/G|||||||INVALID||UMOL/MIN||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|DRIED|NA|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|CKD-EPI CREATININE FORMULA||Y|N|Y|Y|||N|1||38||WASHOUT|1973-07-18|1960-05-22|||||1962-12-11||1969-04-21|Y|1962-09-28
TRIAL STUDY 134XCP|LB|6599D082-A8A0-412D-BBDF-CD786C581905|2||||ANAIGGAB|ANTINUCLEAR IGG ANTIBODY|||||||KV|||||||BORDERLINE||M||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|GELLED|U|PHOTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|N|U|||U|1||38||SCREENING|1961-05-14|1966-01-18|||||1960-04-09||1971-08-21|Y|1967-05-26
TRIAL STUDY 134XCP|LB|6599D082-A8A0-412D-BBDF-CD786C581905|1||||ALUMINUM|ALUMINUM|||||||MEQ/ML|||||||INVALID||SQU/ML||||NORMAL|NOT DONE||||CAPILLARY PLASMA|CLOTTED|U|DIFFUSION WEIGHTED MRI|MDRD 4 VARIABLE FORMULA||N|NA|U|NA|||U|2||58||BASELINE|1972-04-07|1960-09-04|||||1967-10-17||1965-05-12|N|1972-01-19
TRIAL STUDY 134XCP|LB|6599D082-A8A0-412D-BBDF-CD786C581905|2||||HCGND|CHORIOGONADOTROPIN|||||||MEQ/KG|||||||INVALID||10^9 ORGANISMS/MG||||HIGH|NOT DONE||||BONE|PARAFFIN-EMBEDDED|Y|ELECTROGASTROGRAPHY|MDRD 4 VARIABLE FORMULA||U|NA|N|U|||NA|2||58||FOLLOW-UP|1968-06-25|1969-04-06|||||1973-02-26||1969-06-11|NA|1966-11-18
TRIAL STUDY 134XCP|LB|6599D082-A8A0-412D-BBDF-CD786C581905|1||||C165889|RUSSIAN THISTLE POLLEN IGE AB RAST SCORE|||||||ML/MMHG/MIN/L|||||||INVALID||/10^3||||ABNORMAL|NOT DONE||||TISSUE|DRIED|NA|SPIROMETRY|MDRD ENZYMATIC FORMULA||U|Y|U|Y|||N|3||39||CONTINUATION TREATMENT|1968-07-12|1968-08-29|||||1969-08-16||1968-01-09|NA|1961-07-24
TRIAL STUDY 134XCP|LB|6599D082-A8A0-412D-BBDF-CD786C581905|2||||LTFAB|LACTOFERRIN ANTIBODY|||||||EU|||||||INVALID||BQ/UL||||HIGH|NOT DONE||||EXPIRED AIR|FRESH|U|DIRECT SEQUENCING|MDRD 4 VARIABLE FORMULA||U|NA|N|NA|||U|3||39||LONG-TERM FOLLOW-UP|1963-12-22|1967-11-12|||||1968-01-18||1969-11-08|N|1972-03-09
TRIAL STUDY 134XCP|LB|6599D082-A8A0-412D-BBDF-CD786C581905|1||||TNFSR2|SOLUBLE TNF RECEPTOR TYPE II|||||||NG|||||||TRACE||HENRY||||HIGH|NOT DONE||||VENOUS CORD BLOOD|LACTESCENT|NA|RAJI CELL EIA|GMI % FORMULA||NA|N|Y|NA|||N|4||88||FOLLOW-UP|1971-09-28|1962-09-30|||||1965-06-02||1962-07-14|U|1963-06-08
TRIAL STUDY 134XCP|LB|6599D082-A8A0-412D-BBDF-CD786C581905|2||||AMPEA|ALPHA-METHYLPHENETHYLAMINE|||||||CMOL/L|||||||BORDERLINE||10^6 CFU/ML||||HIGH|NOT DONE||||MENSTRUAL BLOOD|CONCENTRATED|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|U|U|||Y|4||88||RUN-IN|1972-05-14|1969-10-04|||||1971-08-17||1969-06-16|NA|1964-05-02
TRIAL STUDY 134XCP|LB|6599D082-A8A0-412D-BBDF-CD786C581905|1||||ORNITHIN|ORNITHINE|||||||PT_US|||||||POSITIVE||ML/DL||||ABNORMAL|NOT DONE||||RETICULOCYTES|REFRIGERATED|NA|WRIGHT STAIN|MDRD ENZYMATIC FORMULA||N|U|U|N|||Y|5||7||BASELINE|1965-09-27|1963-01-07|||||1964-07-19||1967-07-22|U|1967-02-01
TRIAL STUDY 134XCP|LB|6599D082-A8A0-412D-BBDF-CD786C581905|2||||LDLPSZ|LDL PARTICLE SIZE|||||||HOURS|||||||INVALID||MEQ||||NORMAL|NOT DONE||||SOFT TISSUE|ICTERIC|U|NUCLEIC ACID BASED METHOD|ASH FIBROSURE FORMULA||NA|U|U|Y|||U|5||7||INDUCTION TREATMENT|1966-01-21|1973-02-20|||||1967-09-29||1969-11-27|U|1963-01-25
TRIAL STUDY 134XCP|LB|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|1||||ADSDNA|ANTI-DOUBLE STRANDED DNA|||||||HOMEOPATHIC DILUTION|||||||INVALID||CM/S||||ABNORMAL|NOT DONE||||MONOCYTE|THAWED|Y|WESTERN BLOT|COCKCROFT-GAULT FORMULA||N|U|U|Y|||N|1||38||OPEN LABEL TREATMENT|1966-04-19|1960-08-30|||||1973-03-07||1968-03-29|U|1964-07-04
TRIAL STUDY 134XCP|LB|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|2||||BASOLE|BASOPHILS/LEUKOCYTES|||||||PMOL/10^10 CELLS|||||||INVALID||MCI||||NORMAL|NOT DONE||||SERUM|FROZEN|NA|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|N|U|U|||U|1||38||BLINDED TREATMENT|1971-11-20|1971-07-27|||||1961-10-12||1971-08-28|U|1964-11-13
TRIAL STUDY 134XCP|LB|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|1||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||COPIES/UL|||||||BORDERLINE||DPM/MG||||NORMAL|NOT DONE||||ALVEOLAR AIR|ICTERIC|U|AGAR PROPORTION|HEPASCORE FORMULA||Y|U|NA|N|||N|2||58||LONG-TERM FOLLOW-UP|1968-01-12|1970-10-31|||||1965-05-08||1968-01-14|N|1969-07-01
TRIAL STUDY 134XCP|LB|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|2||||CSCELL|CELLULAR CASTS|||||||UL/DOSE|||||||INDETERMINATE||OZ EQ||||LOW|NOT DONE||||COLOSTRUM|DRIED|Y|ELECTRONEUROGRAPHY|MDRD 5 VARIABLE FORMULA||U|U|N|U|||Y|2||58||BASELINE|1971-03-27|1967-06-27|||||1962-07-13||1967-06-30|Y|1960-05-21
TRIAL STUDY 134XCP|LB|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|1||||NKCEFUNC|NATURAL KILLER CELL FUNCTION|||||||UG/G/DAY|||||||BORDERLINE||MG/ML/DAY||||NORMAL|NOT DONE||||NAIL|NON-HEMOLYZED|NA|IMPULSE OSCILLOMETRY|CKD-EPI FORMULA||Y|U|U|NA|||N|3||39||CONTINUATION TREATMENT|1961-11-09|1966-10-28|||||1970-04-04||1963-10-30|U|1969-12-14
TRIAL STUDY 134XCP|LB|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|2||||CSMIX|MIXED CASTS|||||||/MS|||||||NEGATIVE||GPL U/ML||||HIGH|NOT DONE||||PLEURAL FLUID|SOLIDIFIED|U|HIGH LEVEL AMINOGLYCOSIDE SCREEN|GMI MMOL/MOL FORMULA||U|NA|U|Y|||NA|3||39||BLINDED TREATMENT|1972-03-08|1962-11-04|||||1966-11-13||1963-12-20|U|1965-02-14
TRIAL STUDY 134XCP|LB|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|1||||LDHEXR|LACTATE DEHYDROGENASE EXCRETION RATE|||||||SFC/10^6 PBMC|||||||POSITIVE||HZ||||HIGH|NOT DONE||||LYSATE|HEMOLYZED|Y|PHASE CONTRAST MICROSCOPY|FIBROTEST FORMULA||U|N|U|Y|||Y|4||88||LONG-TERM FOLLOW-UP|1963-03-25|1965-07-12|||||1960-09-18||1965-11-26|Y|1972-04-11
TRIAL STUDY 134XCP|LB|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|2||||FLUOXTN|FLUOXETINE|||||||MG/M2/MIN|||||||POSITIVE||MM3/MM2/YEAR||||NORMAL|NOT DONE||||KERATINOCYTE|DRIED|N|MASS SPECTROMETRY|NASH FIBROSURE FORMULA||Y|Y|N|N|||U|4||88||LONG-TERM FOLLOW-UP|1971-10-31|1973-04-07|||||1962-08-13||1963-01-30|Y|1962-08-13
TRIAL STUDY 134XCP|LB|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|1||||C130072|BIRCH POLLEN IGE|||||||UMOL/DAY|||||||INDETERMINATE||U/G/DAY||||LOW|NOT DONE||||ADIPOSE TISSUE|GELLED|Y|SXA SCAN|MDRD ENZYMATIC JAPANESE FORMULA||N|N|Y|U|||N|5||7||LONG-TERM FOLLOW-UP|1961-11-08|1962-07-29|||||1969-06-25||1967-10-25|Y|1972-08-04
TRIAL STUDY 134XCP|LB|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|2||||LEU|LEUCINE|||||||KBQ/UL|||||||INVALID||MEQ/UL||||ABNORMAL|NOT DONE||||URINE SEDIMENT|FROZEN|U|IMMUNOFLUORESCENT STAIN|FIBROTEST FORMULA||NA|NA|NA|N|||NA|5||7||CONTINUATION TREATMENT|1962-07-31|1968-11-14|||||1964-05-11||1960-11-08|N|1970-06-29
TRIAL STUDY 134XCP|LB|AAC3113C-793D-43F4-87E9-111246E03003|1||||HLADPB1|HLA DP BETA1 ANTIGEN|||||||MV2/HZ|||||||POSITIVE||RAD||||NORMAL|NOT DONE||||LUNG SURFACTANT|LIPEMIC|U|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI % FORMULA||N|NA|Y|NA|||NA|1||38||BASELINE|1966-05-28|1970-05-24|||||1967-04-01||1966-11-23|N|1972-08-10
TRIAL STUDY 134XCP|LB|AAC3113C-793D-43F4-87E9-111246E03003|2||||MMP2|MATRIX METALLOPROTEINASE 2|||||||MG/M2/MIN|||||||BORDERLINE||RNA COPIES/ML||||LOW|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|U|OPTICAL COHERENCE TOMOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|Y|NA|Y|||Y|1||38||LONG-TERM FOLLOW-UP|1961-05-22|1971-07-17|||||1966-10-22||1970-07-26|NA|1971-10-01
TRIAL STUDY 134XCP|LB|AAC3113C-793D-43F4-87E9-111246E03003|1||||INTLK23|INTERLEUKIN 23|||||||MMOL/S|||||||POSITIVE||10^3/HPF||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|SOLIDIFIED|Y|INTERRUPTER TECHNIQUE|GMI MMOL/MOL FORMULA||Y|Y|N|N|||N|2||58||CONTINUATION TREATMENT|1962-05-12|1973-04-06|||||1964-11-08||1961-08-19|Y|1968-12-27
TRIAL STUDY 134XCP|LB|AAC3113C-793D-43F4-87E9-111246E03003|2||||TGFB2|TRANSFORMING GROWTH FACTOR BETA 2|||||||10^5/L|||||||INDETERMINATE||ML/BREATH||||NORMAL|NOT DONE||||HAIR FOLLICLE|LIPEMIC|N|ZIEHL NEELSEN ACID FAST STAIN|MDRD 4 VARIABLE FORMULA||U|NA|N|Y|||NA|2||58||WASHOUT|1964-09-09|1970-03-05|||||1966-10-12||1963-04-20|U|1961-09-22
TRIAL STUDY 134XCP|LB|AAC3113C-793D-43F4-87E9-111246E03003|1||||TRANK1|TPR-ANKYRIN REPEAT-CONTAINING PROTEIN 1|||||||PA|||||||INVALID||ML/100G/MIN||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH|N|MICROSCOPY|FIBROMETER FORMULA||U|Y|N|NA|||NA|3||39||FOLLOW-UP|1970-05-17|1965-01-13|||||1971-01-07||1962-06-04|Y|1960-09-25
TRIAL STUDY 134XCP|LB|AAC3113C-793D-43F4-87E9-111246E03003|2||||TRCYANDP|TRICYCLIC ANTIDEPRESSANTS|||||||10^7 PFU|||||||TRACE||JOULE||||LOW|NOT DONE||||LUNG SURFACTANT|CALCIFIED|Y|TRANSMISSION ELECTRON MICROSCOPY|CKD-EPI CREATININE FORMULA||U|Y|Y|N|||U|3||39||FOLLOW-UP|1970-06-13|1971-03-21|||||1961-09-23||1962-09-06|N|1960-12-07
TRIAL STUDY 134XCP|LB|AAC3113C-793D-43F4-87E9-111246E03003|1||||HGBA2|HEMOGLOBIN A2|||||||ML/CAGE|||||||NEGATIVE||SQU/ML||||NORMAL|NOT DONE||||URINE|THAWED|NA|GC/MS/MS|CKD-EPI CYSTATIN C FORMULA||Y|NA|U|NA|||NA|4||88||LONG-TERM FOLLOW-UP|1961-01-02|1973-08-02|||||1964-08-21||1972-10-21|U|1968-04-15
TRIAL STUDY 134XCP|LB|AAC3113C-793D-43F4-87E9-111246E03003|2||||SFTPD|SURFACTANT PROTEIN D|||||||NMOL/L/MIN|||||||TRACE||TESLA||||NORMAL|NOT DONE||||MUSCLE TISSUE|LACTESCENT|N|SPECT/CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|Y|U|||U|4||88||RUN-IN|1963-04-29|1963-02-08|||||1973-06-05||1962-08-23|U|1961-11-19
TRIAL STUDY 134XCP|LB|AAC3113C-793D-43F4-87E9-111246E03003|1||||HLAB27AG|HLA-B27 ANTIGEN|||||||CMH2O/ML|||||||BORDERLINE||ML/CAGE/DAY||||HIGH|NOT DONE||||LUNG SURFACTANT|UNEXPECTED ODOR|N|CONTACT SPECULAR MICROSCOPY|NASH FIBROSURE FORMULA||Y|U|NA|NA|||NA|5||7||BASELINE|1964-01-18|1968-09-28|||||1968-05-18||1971-12-29|U|1972-09-30
TRIAL STUDY 134XCP|LB|AAC3113C-793D-43F4-87E9-111246E03003|2||||GFR|GLOMERULAR FILTRATION RATE|||||||IMPLANT|||||||POSITIVE||10^6/HPF||||LOW|NOT DONE||||NAIL|DRIED|N|CONTRAST ENHANCED CT SCAN|COCKCROFT-GAULT FORMULA||N|U|U|NA|||Y|5||7||OPEN LABEL TREATMENT|1968-10-10|1966-07-10|||||1963-06-13||1969-05-19|N|1962-12-15
TRIAL STUDY 134XCP|LB|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|1||||NRP1|NEUROPILIN-1|||||||LOG10 IU/ML|||||||TRACE||MIU/L||||NORMAL|NOT DONE||||BASAL TEAR|HEMOLYZED|Y|ANTIMICROBIAL COMBINATION TESTING|GMI MMOL/MOL FORMULA||NA|N|N|NA|||U|1||38||WASHOUT|1973-01-05|1968-09-05|||||1964-01-09||1970-11-17|N|1966-11-24
TRIAL STUDY 134XCP|LB|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|2||||HBLEPRHB|HEMOGLOBIN LEPORE/TOTAL HEMOGLOBIN|||||||10^3 RNA COPIES/ML|||||||INVALID||SIEMENS||||ABNORMAL|NOT DONE||||ERYTHROCYTES|UNEXPECTED ODOR|U|REVERSE TRANSCRIPTASE PCR|FIBROTEST FORMULA||NA|U|Y|U|||NA|1||38||CONTINUATION TREATMENT|1962-01-17|1973-09-07|||||1960-09-24||1971-12-06|Y|1969-12-04
TRIAL STUDY 134XCP|LB|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|1||||GLOBBPT|BETA GLOBULIN/TOTAL PROTEIN|||||||TUBERCULIN UNIT/ML|||||||POSITIVE||UG/L||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|CONCENTRATED|NA|RAJI CELL EIA|MDRD 6 VARIABLE FORMULA||N|U|U|N|||Y|2||58||OBSERVATION|1966-11-20|1963-11-12|||||1963-10-24||1971-12-22|Y|1967-11-03
TRIAL STUDY 134XCP|LB|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|2||||C3ADARG|COMPLEMENT C3A DESARG|||||||/CMH2O|||||||TRACE||PHERESIS UNIT||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|GELLED|U|OLIGO ACGH|FIBROMETER FORMULA||NA|U|U|Y|||NA|2||58||TREATMENT|1968-05-05|1960-08-18|||||1967-10-15||1966-01-04|Y|1965-01-02
TRIAL STUDY 134XCP|LB|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|1||||SSTR2|SOMATOSTATIN RECEPTOR TYPE 2|||||||CMOL/L|||||||NEGATIVE||ELISA UNIT||||ABNORMAL|NOT DONE||||CORD SERUM|REFRIGERATED|N|COMPUTERIZED CORNEAL TOPOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|NA|||Y|3||39||WASHOUT|1966-09-06|1968-02-08|||||1972-10-20||1961-07-08|NA|1968-04-19
TRIAL STUDY 134XCP|LB|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|2||||GSTCREAT|GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||10^8/L|||||||POSITIVE||KG/M2||||ABNORMAL|NOT DONE||||BONE MARROW|ICTERIC|N|COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD ENZYMATIC FORMULA||U|Y|NA|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1965-10-19|1968-04-10|||||1961-11-11||1964-09-22|N|1961-05-10
TRIAL STUDY 134XCP|LB|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|1||||BLASTIMM|IMMUNOBLASTS|||||||ML/CAGE/WK|||||||INDETERMINATE||FFU||||LOW|NOT DONE||||ADIPOSE TISSUE|CALCIFIED|NA|MAGNETIC RESONANCE ELASTOGRAPHY|CKD-EPI FORMULA||NA|Y|U|U|||NA|4||88||OPEN LABEL TREATMENT|1967-07-09|1960-01-17|||||1961-12-15||1971-07-17|U|1971-01-27
TRIAL STUDY 134XCP|LB|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|2||||PTSFAC|PROTEIN S, FREE ACTUAL/CONTROL|||||||U/KG/MIN|||||||INDETERMINATE||BEATS/MIN||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|PARAFFIN-EMBEDDED|NA|HEMOCYTOMETRY|FIBROTEST FORMULA||Y|NA|N|N|||Y|4||88||LONG-TERM FOLLOW-UP|1964-08-12|1966-08-18|||||1971-03-15||1973-08-29|NA|1966-09-10
TRIAL STUDY 134XCP|LB|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|1||||PDGFAB|PLATELET DERIVED GROWTH FACTOR ISOFORMAB|||||||/7.5 ML|||||||NEGATIVE||UCI||||ABNORMAL|NOT DONE||||CERUMEN|THAWED|N|IN SITU HYBRIDIZATION|NASH FIBROSURE FORMULA||NA|N|N|NA|||U|5||7||WASHOUT|1965-02-22|1967-02-17|||||1966-11-20||1964-10-12|Y|1971-03-19
TRIAL STUDY 134XCP|LB|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|2||||GLYCRL|GLYCEROL|||||||AMOL|||||||NEGATIVE||IU/G HB||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|HEMOLYZED|N|DIFFUSION TENSOR MRI|ASH FIBROSURE FORMULA||NA|N|NA|NA|||U|5||7||LONG-TERM FOLLOW-UP|1961-02-13|1967-10-17|||||1963-06-20||1972-09-16|N|1968-06-21
TRIAL STUDY 134XCP|LB|941A9CF9-872C-42CF-A409-129BE5A88520|1||||LYMPHOID|LYMPHOID CELLS|||||||SHOCK WAVE|||||||BORDERLINE||CI/UG||||LOW|NOT DONE||||BREAST MILK|LIPEMIC|N|TRIPLE-PHASE MRI SCAN|CKD-EPI FORMULA||N|NA|U|NA|||N|1||38||LONG-TERM FOLLOW-UP|1967-08-23|1969-09-21|||||1967-03-20||1962-04-23|U|1964-04-20
TRIAL STUDY 134XCP|LB|941A9CF9-872C-42CF-A409-129BE5A88520|2||||SDMA|SYMMETRIC DIMETHYLARGININE|||||||ML/ANIMAL/DAY|||||||BORDERLINE||MEQ/KG||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR|Y|MULTIPLE BREATH WASHOUT|CKD-EPI FORMULA||Y|Y|NA|N|||U|1||38||RUN-IN|1963-03-20|1971-01-24|||||1964-11-05||1961-12-27|NA|1968-12-27
TRIAL STUDY 134XCP|LB|941A9CF9-872C-42CF-A409-129BE5A88520|1||||LDH|LACTATE DEHYDROGENASE|||||||V/SEC|||||||POSITIVE||/100 WBC||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED|NA|NUCLEAR RADIOLOGY|CKD-EPI CYSTATIN C FORMULA||NA|Y|U|Y|||U|2||58||BASELINE|1964-04-17|1966-11-18|||||1960-02-16||1963-03-29|N|1972-01-04
TRIAL STUDY 134XCP|LB|941A9CF9-872C-42CF-A409-129BE5A88520|2||||C1INH|COMPLEMENT C1 ESTERASE INHIBITOR|||||||G/KG|||||||INVALID||QUANTITY SUFFICIENT||||NORMAL|NOT DONE||||SPUTUM|CONCENTRATED|N|GC/MS-EI|ASH FIBROSURE FORMULA||N|N|Y|Y|||N|2||58||LONG-TERM FOLLOW-UP|1964-11-24|1964-10-11|||||1967-04-03||1973-08-22|N|1971-11-21
TRIAL STUDY 134XCP|LB|941A9CF9-872C-42CF-A409-129BE5A88520|1||||CCL20|CHEMOKINE (C-C MOTIF) LIGAND 20|||||||AMFI|||||||BORDERLINE||MU/G||||ABNORMAL|NOT DONE||||BLOOD|UNEXPECTED ODOR|Y|SLIT LAMP|FIBROSIS 4 FORMULA||U|U|N|N|||Y|3||39||WASHOUT|1963-08-30|1970-02-18|||||1972-01-23||1962-03-18|N|1971-06-06
TRIAL STUDY 134XCP|LB|941A9CF9-872C-42CF-A409-129BE5A88520|2||||NRDZPM|NORDAZEPAM|||||||BQ/G|||||||TRACE||KN/CM2||||LOW|NOT DONE||||CALCULUS|AGGLUTINATED|Y|HPLC/MS|ASH FIBROSURE FORMULA||N|U|N|Y|||N|3||39||OBSERVATION|1973-02-27|1966-11-03|||||1972-03-15||1968-11-02|U|1960-07-04
TRIAL STUDY 134XCP|LB|941A9CF9-872C-42CF-A409-129BE5A88520|1||||CA15_3AG|CANCER ANTIGEN 15-3|||||||ENZYME U/G HB|||||||TRACE||ENZYME U||||NORMAL|NOT DONE||||SYNOVIAL FLUID|ICTERIC|N|FLOW MICROSCOPY|GMI MMOL/MOL FORMULA||U|NA|N|Y|||NA|4||88||OPEN LABEL TREATMENT|1964-09-19|1962-11-07|||||1968-11-04||1972-06-19|N|1964-12-31
TRIAL STUDY 134XCP|LB|941A9CF9-872C-42CF-A409-129BE5A88520|2||||COCAETH|COCAETHYLENE|||||||FG|||||||INDETERMINATE||M2||||NORMAL|NOT DONE||||FLUID|FRESH|NA|AURAMINE STAIN|ASH FIBROSURE FORMULA||Y|N|NA|Y|||U|4||88||WASHOUT|1968-06-02|1967-03-24|||||1968-05-19||1967-09-28|N|1964-02-26
TRIAL STUDY 134XCP|LB|941A9CF9-872C-42CF-A409-129BE5A88520|1||||BNP|BRAIN NATRIURETIC PEPTIDE|||||||ML/BREATH|||||||NEGATIVE||KG/MOL||||LOW|NOT DONE||||MONOCYTE|AUTOLYZED|N|U-HPLC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|N|U|||NA|5||7||SCREENING|1971-04-06|1973-06-07|||||1965-10-16||1972-06-22|NA|1966-03-07
TRIAL STUDY 134XCP|LB|941A9CF9-872C-42CF-A409-129BE5A88520|2||||IGM|IMMUNOGLOBULIN M|||||||TRANSDUCING UNIT|||||||POSITIVE||G/G/DAY||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|GELLED|Y|HIGH RESOLUTION MELT ANALYSIS|FIBROMETER FORMULA||U|NA|U|N|||Y|5||7||CONTINUATION TREATMENT|1962-10-03|1972-03-07|||||1971-12-14||1963-05-02|NA|1965-09-23
TRIAL STUDY 134XCP|LB|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|1||||C130088|TIMOTHY GRASS POLLEN IGE|||||||PG/CELL|||||||INVALID||LOG10 TCID 50/ML||||HIGH|NOT DONE||||GASTRIC CONTENTS|LIPEMIC|U|INTERRUPTER TECHNIQUE|MDRD ENZYMATIC FORMULA||U|N|U|Y|||N|1||38||BASELINE|1965-01-09|1962-06-05|||||1964-09-11||1971-01-08|NA|1970-06-22
TRIAL STUDY 134XCP|LB|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|2||||C130071|BERMUDA GRASS POLLEN IGG4|||||||ML/KG/MIN|||||||BORDERLINE||10^3 CFU/G||||HIGH|NOT DONE||||CAPILLARY PLASMA|NON-HEMOLYZED|Y|GC/FID|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|N|U|||N|1||38||FOLLOW-UP|1970-09-28|1971-09-09|||||1973-05-16||1972-03-19|N|1965-10-09
TRIAL STUDY 134XCP|LB|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|1||||MACROCY|MACROCYTES|||||||TSP|||||||TRACE||UGEQ/L||||HIGH|NOT DONE||||ARTERIAL BLOOD|THAWED|NA|KINETIC MICROPARTICLE IMMUNOASSAY|COCKCROFT-GAULT FORMULA||Y|N|NA|Y|||N|2||58||SCREENING|1968-06-07|1968-06-07|||||1969-03-27||1964-02-27|Y|1967-08-06
TRIAL STUDY 134XCP|LB|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|2||||C165905|GRASS MIX POLLEN IGG AB RAST SCORE|||||||G/KG/DAY|||||||INDETERMINATE||NM||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|REFRIGERATED|N|RIA|GMI MMOL/MOL FORMULA||Y|Y|Y|U|||NA|2||58||BLINDED TREATMENT|1965-12-27|1965-10-26|||||1966-08-05||1966-05-12|U|1960-08-18
TRIAL STUDY 134XCP|LB|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|1||||HASIGGAB|HUMAN ANTI-SHEEP IGG ANTIBODY|||||||MMHG*MIN/L|||||||BORDERLINE||UMOL/L/H||||LOW|NOT DONE||||ALVEOLAR AIR|DRIED|NA|GC/MS|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|U|||U|3||39||TREATMENT|1971-09-16|1963-05-14|||||1961-01-28||1967-11-19|U|1972-03-01
TRIAL STUDY 134XCP|LB|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|2||||MSPIKER|MONOCLONAL PROTEIN SPIKE REGION|||||||CAPSULE|||||||BORDERLINE||RPM||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|SOLIDIFIED|NA|NEPHELOMETRY|FIBROTEST FORMULA||U|Y|U|NA|||N|3||39||RUN-IN|1970-10-24|1970-05-28|||||1964-05-21||1973-01-12|Y|1967-02-26
TRIAL STUDY 134XCP|LB|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|1||||GSTTH|GLUTATHIONE S-TRANSFERASE, THETA|||||||MMU/ML|||||||INVALID||UG/M2/H||||HIGH|NOT DONE||||MONOCYTE|UNEXPECTED ODOR|Y|PH METER MEASUREMENT METHOD|MDRD ENZYMATIC JAPANESE FORMULA||U|N|Y|Y|||U|4||88||INDUCTION TREATMENT|1965-03-05|1967-11-24|||||1961-07-14||1964-10-04|Y|1967-07-06
TRIAL STUDY 134XCP|LB|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|2||||IL2R|INTERLEUKIN 2 RECEPTOR|||||||CI|||||||INVALID||UG||||HIGH|NOT DONE||||URINE|GELLED|N|LC-FL|NASH FIBROSURE FORMULA||Y|Y|N|U|||Y|4||88||SCREENING|1967-02-24|1967-07-31|||||1970-01-29||1970-12-16|NA|1972-11-17
TRIAL STUDY 134XCP|LB|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|1||||TSHRAB|THYROTROPIN RECEPTOR ANTIBODY|||||||MMAL|||||||BORDERLINE||NEWTON||||NORMAL|NOT DONE||||LYSATE|CALCIFIED|NA|COMPLEMENT FIXATION|FIBROTEST FORMULA||N|U|U|NA|||Y|5||7||RUN-IN|1970-01-10|1971-12-06|||||1969-12-27||1965-09-16|U|1969-02-21
TRIAL STUDY 134XCP|LB|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|2||||PLAGGCVT|PLATELET AGGREGATION CURVE TYPE|||||||DAGU|||||||INVALID||LB||||HIGH|NOT DONE||||EPIDERMAL TISSUE|PARAFFIN-EMBEDDED|U|LIQUID SCINTILLATION COUNTING|FIBROMETER FORMULA||U|U|NA|Y|||N|5||7||INDUCTION TREATMENT|1964-08-24|1972-06-28|||||1965-11-23||1971-12-27|NA|1966-12-01
TRIAL STUDY 134XCP|LB|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|1||||IGF1|INSULIN-LIKE GROWTH FACTOR-1|||||||LOG10 ELISA UNIT/DOSE|||||||TRACE||LM||||LOW|NOT DONE||||VENOUS CORD BLOOD|REFRIGERATED|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD FORMULA||U|Y|NA|Y|||U|1||38||LONG-TERM FOLLOW-UP|1965-07-04|1973-05-29|||||1966-04-16||1964-12-09|NA|1963-01-12
TRIAL STUDY 134XCP|LB|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|2||||ASTCK|AST/CREATINE KINASE|||||||PSEC|||||||BORDERLINE||LOG10 COPIES/ML||||LOW|NOT DONE||||AMNIOTIC FLUID|LIPEMIC|NA|HIGH RESOLUTION CT|FIBROMETER FORMULA||Y|U|NA|NA|||NA|1||38||BLINDED TREATMENT|1972-11-24|1966-04-29|||||1965-08-17||1964-04-02|U|1963-05-28
TRIAL STUDY 134XCP|LB|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|1||||BJPROT|BENCE-JONES PROTEIN|||||||MDFI|||||||BORDERLINE||/MS||||NORMAL|NOT DONE||||URINE|NON-HEMOLYZED|Y|MS/MS|CKD-EPI CYSTATIN C FORMULA||N|Y|N|NA|||N|2||58||LONG-TERM FOLLOW-UP|1973-02-19|1969-06-18|||||1970-08-13||1971-06-07|NA|1963-02-28
TRIAL STUDY 134XCP|LB|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|2||||IGFBP2|INSULIN-LIKE GROWTH FACTOR BINDING PROT2|||||||/WK|||||||POSITIVE||%(W/V)||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|N|REFRACTOMETRY|GMI MMOL/MOL FORMULA||NA|Y|U|U|||Y|2||58||CONTINUATION TREATMENT|1961-12-24|1964-10-29|||||1961-01-15||1961-11-08|Y|1964-03-26
TRIAL STUDY 134XCP|LB|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|1||||APROTCRS|ACTIVATED PROTEIN C RESISTANCE|||||||MMHG*MIN/L|||||||POSITIVE||MIN||||ABNORMAL|NOT DONE||||SEBUM|THAWED|N|MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|U|Y|||U|3||39||LONG-TERM FOLLOW-UP|1968-08-26|1968-11-09|||||1962-12-22||1961-04-04|U|1969-01-08
TRIAL STUDY 134XCP|LB|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|2||||CRNTESTR|CARNITINE ESTERS|||||||SIEMENS|||||||TRACE||PMOL/DL||||HIGH|NOT DONE||||LAVAGE FLUID|FRESH|U|MECHANICAL CLOT DETECTION|MDRD 5 VARIABLE FORMULA||NA|N|NA|U|||Y|3||39||INDUCTION TREATMENT|1962-04-15|1960-09-28|||||1972-06-22||1971-11-21|Y|1971-05-30
TRIAL STUDY 134XCP|LB|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|1||||SAMETH|S-ADENOSYLMETHIONINE|||||||1/(S*KPA)|||||||NEGATIVE||KS||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|CONTAMINATED|NA|AGAR DILUTION|MDRD ENZYMATIC FORMULA||NA|Y|U|N|||Y|4||88||BLINDED TREATMENT|1967-11-23|1968-06-13|||||1969-09-16||1963-06-26|U|1973-06-15
TRIAL STUDY 134XCP|LB|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|2||||EOSB|EOSINOPHILS BAND FORM|||||||GBQ|||||||INVALID||NG/MOL||||LOW|NOT DONE||||URINE SEDIMENT|CONCENTRATED|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 4 VARIABLE FORMULA||N|N|Y|U|||NA|4||88||BASELINE|1971-11-14|1962-08-28|||||1960-01-27||1962-12-28|NA|1961-03-30
TRIAL STUDY 134XCP|LB|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|1||||PROGESTR|PROGESTERONE RECEPTOR|||||||AMFI|||||||BORDERLINE||LOG EID 50/DOSE||||HIGH|NOT DONE||||EXPIRED AIR|CLOTTED|U|TRICHROME STAIN|GMI MMOL/MOL FORMULA||U|U|Y|N|||N|5||7||SCREENING|1968-03-15|1966-03-28|||||1967-01-21||1970-07-24|N|1963-05-05
TRIAL STUDY 134XCP|LB|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|2||||MMA|METHYLMALONIC ACID|||||||CPM|||||||INDETERMINATE||BU||||NORMAL|NOT DONE||||GASTRIC FLUID|DRIED|U|TEST STRIP|MDRD 4 VARIABLE FORMULA||Y|U|N|NA|||U|5||7||CONTINUATION TREATMENT|1971-04-13|1965-10-12|||||1969-06-01||1963-05-09|NA|1965-08-14
TRIAL STUDY 134XCP|LB|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|1||||PAH|P-AMINOHIPPURATE SODIUM|||||||PMOL/DL|||||||NEGATIVE||MPS U||||NORMAL|NOT DONE||||PERSPIRATION|HEMOLYZED|Y|CELL OF ORIGIN ASSAY|MDRD FORMULA||U|Y|U|U|||Y|1||38||INDUCTION TREATMENT|1968-08-06|1969-12-07|||||1971-08-22||1966-07-30|NA|1962-02-20
TRIAL STUDY 134XCP|LB|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|2||||HBCOHGB|CARBOXYHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||PPB|||||||INDETERMINATE||TROCHE||||ABNORMAL|NOT DONE||||SPUTUM|NON-HEMOLYZED|NA|DOUBLE IMMUNODIFFUSION|GMI % FORMULA||Y|Y|N|N|||NA|1||38||SCREENING|1961-04-17|1973-06-28|||||1963-06-03||1963-03-13|Y|1972-03-15
TRIAL STUDY 134XCP|LB|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|1||||VLDL|VLDL CHOLESTEROL|||||||G/CM2|||||||BORDERLINE||U/L||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|LIPEMIC|U|STATIC PERIMETRY|HEPASCORE FORMULA||Y|Y|U|U|||NA|2||58||OBSERVATION|1965-03-28|1970-08-15|||||1966-10-24||1962-11-08|N|1961-01-10
TRIAL STUDY 134XCP|LB|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|2||||LYMAT|LYMPHOCYTES ATYPICAL|||||||10^7 TCID 50/DOSE|||||||POSITIVE||CD||||LOW|NOT DONE||||MECONIUM|CONCENTRATED|NA|RIA|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|U|U|||U|2||58||SCREENING|1973-07-29|1972-05-01|||||1971-07-21||1960-12-15|NA|1970-02-17
TRIAL STUDY 134XCP|LB|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|1||||C165897|BERMUDA GRASS POLLEN IGG AB RAST SCORE|||||||CI/UG|||||||NEGATIVE||MG/MIN||||HIGH|NOT DONE||||PLATELET RICH PLASMA|PARAFFIN-EMBEDDED|U|LC/MS/MS|MDRD ENZYMATIC FORMULA||U|N|N|U|||U|3||39||OPEN LABEL TREATMENT|1973-06-21|1969-03-20|||||1972-02-01||1963-07-17|NA|1973-06-20
TRIAL STUDY 134XCP|LB|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|2||||NEUTB|NEUTROPHILS BAND FORM|||||||BREATHS/30S|||||||TRACE||EID 50/ML||||NORMAL|NOT DONE||||SPUTUM|GELLED|NA|DIPSTICK|MDRD 6 VARIABLE FORMULA||NA|U|NA|Y|||Y|3||39||CONTINUATION TREATMENT|1967-07-13|1968-11-03|||||1972-10-24||1964-02-16|NA|1963-06-20
TRIAL STUDY 134XCP|LB|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|1||||NEUTLS|LEFT SHIFT NEUTROPHILS|||||||G/G/DAY|||||||TRACE||DAGU/ML||||LOW|NOT DONE||||BONE|AUTOLYZED|N|REBOUND TONOMETRY|COCKCROFT-GAULT FORMULA||U|NA|NA|NA|||Y|4||88||FOLLOW-UP|1970-10-14|1967-09-05|||||1960-06-10||1971-07-25|NA|1972-03-30
TRIAL STUDY 134XCP|LB|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|2||||PSP100AB|P100 POLYMYOSITIS-SCLERODERMA AUTOAG AB|||||||MONTHS|||||||INDETERMINATE||AMFI||||HIGH|NOT DONE||||PLATELET|SOLIDIFIED|NA|CRYOSCOPY|MDRD 5 VARIABLE FORMULA||NA|U|U|NA|||NA|4||88||INDUCTION TREATMENT|1966-12-27|1967-08-30|||||1965-01-26||1965-08-30|Y|1964-10-03
TRIAL STUDY 134XCP|LB|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|1||||SJSSBAB|SJOGRENS SS-B ANTIBODY|||||||KV|||||||NEGATIVE||PMOL||||LOW|NOT DONE||||PLATELET POOR PLASMA|CALCIFIED|N|MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|U|N|U|||U|5||7||FOLLOW-UP|1973-05-27|1973-01-13|||||1963-01-31||1969-07-30|NA|1960-09-14
TRIAL STUDY 134XCP|LB|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|2||||CGMP|CYCLIC GUANOSINE MONOPHOSPHATE|||||||OHM|||||||INVALID||/7.5 ML||||LOW|NOT DONE||||ARTERIAL BLOOD|LIPEMIC|Y|ETDRS EYE CHART|MDRD 5 VARIABLE FORMULA||NA|U|U|U|||N|5||7||LONG-TERM FOLLOW-UP|1965-10-27|1964-04-10|||||1961-03-30||1968-09-20|U|1968-02-09
TRIAL STUDY 134XCP|LB|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|1||||PNTBRBTL|PENTOBARBITAL|||||||CP|||||||POSITIVE||GBQ||||LOW|NOT DONE||||ERYTHROCYTES|GELLED|U|VIRUS PLAQUE ASSAY|MDRD 6 VARIABLE FORMULA||NA|NA|U|Y|||Y|1||38||BASELINE|1962-08-30|1973-09-03|||||1966-04-12||1973-02-28|NA|1967-05-22
TRIAL STUDY 134XCP|LB|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|2||||PUS|PUS|||||||PRESSOR UNITS|||||||POSITIVE||ML/CM3/MIN||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|ICTERIC|Y|LIGHT SCATTERING SPECTROSCOPY|CKD-EPI CYSTATIN C FORMULA||NA|NA|N|Y|||U|1||38||LONG-TERM FOLLOW-UP|1967-07-20|1970-12-28|||||1970-04-26||1971-06-11|U|1970-08-22
TRIAL STUDY 134XCP|LB|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|1||||LEPTIN|LEPTIN|||||||10^6 U|||||||BORDERLINE||CG||||LOW|NOT DONE||||CALCULUS|ICTERIC|N|PERCUSSION|CKD-EPI CREATININE FORMULA||NA|U|Y|Y|||Y|2||58||WASHOUT|1968-08-14|1964-10-15|||||1961-01-04||1963-04-23|Y|1961-11-13
TRIAL STUDY 134XCP|LB|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|2||||HLADRB1|HLA DR BETA1 ANTIGEN|||||||UG/H|||||||BORDERLINE||CY/CM||||ABNORMAL|NOT DONE||||PLATELET|THAWED|NA|SLIT LAMP PHOTOGRAPHY|GMI MMOL/MOL FORMULA||NA|Y|Y|NA|||U|2||58||RUN-IN|1967-07-07|1960-11-07|||||1968-03-12||1963-09-22|Y|1968-09-27
TRIAL STUDY 134XCP|LB|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|1||||AFPL3AFP|A FETOPROTEIN L3/A FETOPROTEIN|||||||NMOL/G|||||||INDETERMINATE||/VF||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|CALCIFIED|U|ACRIDINE ORANGE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|NA|NA|||Y|3||39||RUN-IN|1963-02-20|1970-09-03|||||1969-06-29||1965-01-29|NA|1962-10-01
TRIAL STUDY 134XCP|LB|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|2||||CYSTATC|CYSTATIN C|||||||TAMPON|||||||INVALID||ML/G/MIN||||NORMAL|NOT DONE||||ERYTHROCYTES|PARAFFIN-EMBEDDED|U|POTENTIOMETRY|ASH FIBROSURE FORMULA||NA|NA|U|N|||N|3||39||OBSERVATION|1965-10-29|1970-02-17|||||1961-05-29||1968-03-26|Y|1962-10-26
TRIAL STUDY 134XCP|LB|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|1||||PLATLRG|LARGE PLATELETS|||||||MV/SEC|||||||INVALID||LOG EID 50/DOSE||||ABNORMAL|NOT DONE||||LAVAGE FLUID|UNEXPECTED ODOR|Y|SMEAR|FIBROSIS 4 FORMULA||N|U|NA|NA|||U|4||88||TREATMENT|1968-08-05|1966-02-15|||||1966-05-02||1967-02-13|N|1972-02-19
TRIAL STUDY 134XCP|LB|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|2||||APOC3|APOLIPOPROTEIN CIII|||||||PL|||||||POSITIVE||GPS U||||HIGH|NOT DONE||||SMEGMA|NON-HEMOLYZED|NA|PHASE-CONTRAST MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|Y|Y|||Y|4||88||INDUCTION TREATMENT|1964-05-04|1969-06-27|||||1960-09-07||1971-06-06|N|1962-09-13
TRIAL STUDY 134XCP|LB|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|1||||APOB48|APOLIPOPROTEIN B48|||||||LB|||||||INVALID||KS||||NORMAL|NOT DONE||||BILE|AUTOLYZED|N|DYNAMIC LIGHT SCATTERING|MDRD 5 VARIABLE FORMULA||Y|U|U|Y|||N|5||7||OBSERVATION|1960-07-11|1972-05-15|||||1961-08-31||1963-04-02|Y|1962-11-24
TRIAL STUDY 134XCP|LB|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|2||||ETP|ENDOGENOUS THROMBIN POTENTIAL|||||||NL|||||||BORDERLINE||ENZYME U/L||||LOW|NOT DONE||||PLEURAL TISSUE|CALCIFIED|Y|CONTRAST ENHANCED SPIRAL CT SCAN|FIBROSIS 4 FORMULA||U|N|U|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1961-10-29|1960-01-12|||||1971-11-19||1971-08-29|Y|1971-09-20
TRIAL STUDY 134XCP|LB|A4A5E66A-E65C-4234-8858-E69D04AB1593|1||||ROM|REACTIVE OXYGEN METABOLITE|||||||G/U|||||||INDETERMINATE||RAD||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|FRESH|NA|DOPPLER ULTRASOUND|FIBROSIS 4 FORMULA||NA|NA|NA|NA|||U|1||38||INDUCTION TREATMENT|1960-05-16|1962-06-29|||||1969-04-29||1963-07-04|Y|1970-02-06
TRIAL STUDY 134XCP|LB|A4A5E66A-E65C-4234-8858-E69D04AB1593|2||||FBNCTPL|FIBRONECTIN, PLASMA|||||||MV*MIN|||||||TRACE||UG/M2||||HIGH|NOT DONE||||FLUID|PARAFFIN-EMBEDDED|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|FIBROTEST FORMULA||Y|N|N|U|||NA|1||38||OBSERVATION|1966-02-06|1962-08-28|||||1973-04-03||1967-05-14|U|1963-03-31
TRIAL STUDY 134XCP|LB|A4A5E66A-E65C-4234-8858-E69D04AB1593|1||||PROMY|PROMYELOCYTES|||||||G/DAY|||||||BORDERLINE||WAFER||||HIGH|NOT DONE||||EXPIRED AIR|LIPEMIC|NA|REBOUND TONOMETRY|GMI % FORMULA||U|N|NA|U|||N|2||58||BASELINE|1961-09-08|1963-07-03|||||1960-08-15||1963-02-19|NA|1962-08-13
TRIAL STUDY 134XCP|LB|A4A5E66A-E65C-4234-8858-E69D04AB1593|2||||CYLEUC|LEUCINE CRYSTALS|||||||BE/ML|||||||TRACE||LOG10 CFU/G||||NORMAL|NOT DONE||||VENOUS PLASMA|AUTOLYZED|Y|JAEGER EYE CHART|CKD-EPI CYSTATIN C FORMULA||Y|N|NA|U|||NA|2||58||BASELINE|1964-10-19|1973-01-19|||||1962-04-08||1971-03-05|NA|1967-12-13
TRIAL STUDY 134XCP|LB|A4A5E66A-E65C-4234-8858-E69D04AB1593|1||||MDZPM|MEDAZEPAM|||||||UL|||||||BORDERLINE||KCAL||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|AGGLUTINATED|U|QUANTITATIVE COMPUTED TOMOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|Y|U|N|||N|3||39||INDUCTION TREATMENT|1962-02-11|1965-08-18|||||1972-03-30||1972-07-19|Y|1972-01-18
TRIAL STUDY 134XCP|LB|A4A5E66A-E65C-4234-8858-E69D04AB1593|2||||EOTAXIN1|EOTAXIN-1|||||||U/10^12 RBC|||||||BORDERLINE||NMOL/G||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|HEMOLYZED|NA|ENZYMATIC COLORIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1961-08-24|1964-06-16|||||1960-06-28||1968-01-31|Y|1960-06-18
TRIAL STUDY 134XCP|LB|A4A5E66A-E65C-4234-8858-E69D04AB1593|1||||STBSEXCS|STANDARD BASE EXCESS|||||||NCI|||||||POSITIVE||UV2||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|PARAFFIN-EMBEDDED|Y|DNA MICROARRAY|MDRD ENZYMATIC FORMULA||U|N|U|NA|||NA|4||88||RUN-IN|1967-08-11|1970-01-29|||||1965-08-21||1964-06-04|Y|1961-08-06
TRIAL STUDY 134XCP|LB|A4A5E66A-E65C-4234-8858-E69D04AB1593|2||||SAHOMC|S-ADENOSYLHOMOCYSTEINE|||||||MEQ/L|||||||BORDERLINE||OHM||||HIGH|NOT DONE||||HAIR FOLLICLE|CONCENTRATED|NA|HIGH RESOLUTION CT|MDRD 6 VARIABLE FORMULA||U|Y|U|NA|||N|4||88||RUN-IN|1964-04-23|1970-05-10|||||1973-09-01||1962-09-26|U|1965-06-25
TRIAL STUDY 134XCP|LB|A4A5E66A-E65C-4234-8858-E69D04AB1593|1||||A1MCREAT|ALPHA-1 MICROGLOBULIN/CREATININE|||||||10^9/DOSE|||||||POSITIVE||MG/MIN||||HIGH|NOT DONE||||SEMEN|CALCIFIED|N|SANGER SEQUENCING|CKD-EPI CYSTATIN C FORMULA||U|NA|Y|Y|||NA|5||7||TREATMENT|1960-05-03|1963-03-21|||||1972-10-24||1963-01-02|NA|1961-11-15
TRIAL STUDY 134XCP|LB|A4A5E66A-E65C-4234-8858-E69D04AB1593|2||||ASYNP|ALPHA SYNUCLEIN PROTEIN|||||||%(W/V)|||||||BORDERLINE||IU/G||||NORMAL|NOT DONE||||DIALYSIS FLUID|ICTERIC|U|LASER CAPTURE MICRODISSECTION|FIBROMETER FORMULA||N|NA|Y|N|||N|5||7||TREATMENT|1967-03-04|1972-09-27|||||1960-08-28||1970-04-24|NA|1963-03-28
TRIAL STUDY 134XCP|LB|0EA46DA5-4291-4585-9745-08BFA60BED3F|1||||LIPASET|LIPASE|||||||DEG|||||||TRACE||/10^4||||LOW|NOT DONE||||TUMOR TISSUE|CALCIFIED|Y|PULMONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|Y|NA|||Y|1||38||TREATMENT|1966-07-18|1967-07-17|||||1966-02-25||1963-10-10|NA|1961-08-02
TRIAL STUDY 134XCP|LB|0EA46DA5-4291-4585-9745-08BFA60BED3F|2||||CD8LY|CD8/LYMPHOCYTES|||||||UG/ML/H|||||||BORDERLINE||/40 HPFS||||HIGH|NOT DONE||||ADIPOSE TISSUE|HEMOLYZED|NA|DXA SCAN|FIBROMETER FORMULA||U|Y|N|Y|||N|1||38||SCREENING|1963-07-15|1967-01-16|||||1971-12-11||1970-06-24|Y|1968-12-24
TRIAL STUDY 134XCP|LB|0EA46DA5-4291-4585-9745-08BFA60BED3F|1||||RETICH|RET. CORPUSCULAR HEMOGLOBIN CONTENT|||||||10^8 PFU|||||||INDETERMINATE||RING||||HIGH|NOT DONE||||EPITHELIAL CELL|PARAFFIN-EMBEDDED|N|INCISION-INDUCED BLEEDING METHOD|CKD-EPI CREATININE FORMULA||U|N|N|U|||U|2||58||RUN-IN|1966-09-08|1971-11-29|||||1968-09-25||1963-06-26|U|1962-05-08
TRIAL STUDY 134XCP|LB|0EA46DA5-4291-4585-9745-08BFA60BED3F|2||||PLSTCELE|TOTAL PLASMA CELLS/LEUKOCYTES|||||||L/KG|||||||INDETERMINATE||C||||NORMAL|NOT DONE||||BLOOD|FROZEN|U|ELISPOT|GMI % FORMULA||U|Y|U|N|||NA|2||58||BLINDED TREATMENT|1973-05-24|1963-10-28|||||1966-01-21||1968-11-14|Y|1964-10-02
TRIAL STUDY 134XCP|LB|0EA46DA5-4291-4585-9745-08BFA60BED3F|1||||LDHCREAT|LACTATE DEHYDROGENASE/CREATININE|||||||L/H|||||||TRACE||MPS U||||ABNORMAL|NOT DONE||||EXUDATE|ROOM TEMPERATURE|NA|SCINTIGRAPHY|HEPASCORE FORMULA||N|Y|Y|NA|||N|3||39||OPEN LABEL TREATMENT|1963-08-20|1969-08-05|||||1973-08-28||1969-11-20|NA|1960-05-18
TRIAL STUDY 134XCP|LB|0EA46DA5-4291-4585-9745-08BFA60BED3F|2||||PLTAGAMP|PLATELET AGGREGATION AMPLITUDE|||||||10^12 IU/L|||||||POSITIVE||GRAVITATIONAL UNIT||||LOW|NOT DONE||||SPUTUM|CALCIFIED|Y|PALPATION|MDRD ENZYMATIC FORMULA||U|NA|N|U|||N|3||39||BASELINE|1968-10-01|1970-02-12|||||1962-07-02||1961-08-14|N|1964-12-10
TRIAL STUDY 134XCP|LB|0EA46DA5-4291-4585-9745-08BFA60BED3F|1||||MYCEPIDX|MYELOID PROLIFERATION INDEX|||||||DYN|||||||BORDERLINE||/4.0 ML||||LOW|NOT DONE||||VENOUS BLOOD|CALCIFIED|N|CONTACT SPECULAR MICROSCOPY|FIBROTEST FORMULA||NA|N|N|NA|||NA|4||88||RUN-IN|1961-07-13|1972-10-25|||||1967-02-02||1962-05-01|Y|1972-09-03
TRIAL STUDY 134XCP|LB|0EA46DA5-4291-4585-9745-08BFA60BED3F|2||||KIM1S|SOLUBLE KIDNEY INJURY MOLECULE-1|||||||PSI|||||||BORDERLINE||%||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|CLOTTED|Y|TOLUIDINE BLUE STAIN|NASH FIBROSURE FORMULA||U|NA|N|U|||U|4||88||OPEN LABEL TREATMENT|1966-10-24|1970-05-07|||||1966-05-31||1962-02-07|Y|1967-01-26
TRIAL STUDY 134XCP|LB|0EA46DA5-4291-4585-9745-08BFA60BED3F|1||||MERCURY|MERCURY|||||||UGEQ/L|||||||BORDERLINE||DPM/MG||||HIGH|NOT DONE||||REFLEX TEAR|FROZEN|Y|IRON HEMATOXYLIN STAIN|MDRD 5 VARIABLE FORMULA||N|NA|U|NA|||NA|5||7||BASELINE|1966-02-01|1965-10-31|||||1972-01-29||1962-12-01|Y|1970-03-30
TRIAL STUDY 134XCP|LB|0EA46DA5-4291-4585-9745-08BFA60BED3F|2||||OSTEOC|OSTEOCALCIN|||||||KEV|||||||POSITIVE||UU/DL||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|DRIED|Y|DOUBLE IMMUNODIFFUSION|CKD-EPI CYSTATIN C FORMULA||N|N|Y|N|||U|5||7||OBSERVATION|1971-02-18|1963-09-07|||||1962-07-01||1966-02-14|N|1968-01-28
TRIAL STUDY 134XCP|LB|F54E494F-7EC2-41E7-A969-DF7151EA08E9|1||||SO2|SULFUR DIOXIDE|||||||10^3 DNA COPIES/ML|||||||NEGATIVE||MMHG||||LOW|NOT DONE||||LUNG SURFACTANT|LIPEMIC|Y|CONTRAST ENHANCED PET/CT SCAN|FIBROMETER FORMULA||U|NA|U|Y|||U|1||38||WASHOUT|1971-11-04|1972-11-02|||||1973-06-06||1971-01-03|U|1963-11-05
TRIAL STUDY 134XCP|LB|F54E494F-7EC2-41E7-A969-DF7151EA08E9|2||||PAROXET|PAROXETINE|||||||/KG|||||||INDETERMINATE||UG||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|LIPEMIC|U|OPTICAL DENSITY MEASUREMENT|CKD-EPI CREATININE FORMULA||NA|U|N|U|||NA|1||38||WASHOUT|1962-09-14|1965-11-15|||||1972-11-03||1962-04-17|N|1965-12-15
TRIAL STUDY 134XCP|LB|F54E494F-7EC2-41E7-A969-DF7151EA08E9|1||||CSRBC|RBC CASTS|||||||IU/DAY|||||||NEGATIVE||UMOL/L/H||||HIGH|NOT DONE||||BLOOD|GELLED|N|MRI WITHOUT CONTRAST|GMI % FORMULA||N|NA|N|U|||NA|2||58||BLINDED TREATMENT|1969-03-25|1972-01-31|||||1962-12-10||1970-01-22|NA|1966-01-24
TRIAL STUDY 134XCP|LB|F54E494F-7EC2-41E7-A969-DF7151EA08E9|2||||HASIGEAB|HUMAN ANTI-SHEEP IGE ANTIBODY|||||||RAD|||||||INVALID||MBP||||NORMAL|NOT DONE||||COLOSTRUM|ICTERIC|N|DIPSTICK|FIBROTEST FORMULA||Y|U|N|NA|||Y|2||58||TREATMENT|1972-10-09|1966-05-22|||||1970-11-05||1973-03-17|U|1964-07-13
TRIAL STUDY 134XCP|LB|F54E494F-7EC2-41E7-A969-DF7151EA08E9|1||||CASTS|CASTS|||||||G/CAGE/WK|||||||POSITIVE||AMPULE||||HIGH|NOT DONE||||INFRANATANT, SERUM|CLOTTED|NA|MAPH|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|N|NA|||Y|3||39||FOLLOW-UP|1966-07-27|1971-05-11|||||1963-06-14||1965-02-11|U|1964-05-11
TRIAL STUDY 134XCP|LB|F54E494F-7EC2-41E7-A969-DF7151EA08E9|2||||GDF8|GROWTH DIFFERENTIATION FACTOR 8|||||||/WK|||||||BORDERLINE||U/L||||HIGH|NOT DONE||||SUPERNATANT, SERUM|PARAFFIN-EMBEDDED|NA|GC/MS-CI|COCKCROFT-GAULT FORMULA||Y|Y|U|N|||NA|3||39||OBSERVATION|1973-03-02|1962-03-27|||||1965-05-26||1967-04-26|Y|1961-10-16
TRIAL STUDY 134XCP|LB|F54E494F-7EC2-41E7-A969-DF7151EA08E9|1||||CSGRANC|GRANULAR COARSE CASTS|||||||VP/DOSE|||||||INVALID||NMOL/L/H||||ABNORMAL|NOT DONE||||TRANSUDATE|CLOTTED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||NA|N|NA|NA|||Y|4||88||WASHOUT|1971-11-14|1971-05-06|||||1966-11-04||1963-05-08|Y|1973-08-08
TRIAL STUDY 134XCP|LB|F54E494F-7EC2-41E7-A969-DF7151EA08E9|2||||SEZCELE|SEZARY CELLS/LEUKOCYTES|||||||MET*MIN|||||||NEGATIVE||CAL||||NORMAL|NOT DONE||||SALIVA|GELLED|U|ELLA|CKD-EPI CREATININE FORMULA||NA|U|NA|NA|||N|4||88||TREATMENT|1968-01-27|1968-03-15|||||1965-09-11||1961-12-24|N|1973-04-18
TRIAL STUDY 134XCP|LB|F54E494F-7EC2-41E7-A969-DF7151EA08E9|1||||PTHW|PARATHYROID HORMONE, WHOLE|||||||MG|||||||TRACE||ML/DL||||ABNORMAL|NOT DONE||||BILE|CLOTTED|N|DIFFUSION WEIGHTED MRI|MDRD FORMULA||NA|NA|N|N|||Y|5||7||OBSERVATION|1970-01-20|1963-10-10|||||1969-03-16||1960-03-02|Y|1963-03-04
TRIAL STUDY 134XCP|LB|F54E494F-7EC2-41E7-A969-DF7151EA08E9|2||||UDCACM|URSODEOXYCHOLATE COMPOUNDS|||||||10^7 TCID 50/DOSE|||||||INVALID||RNA COPIES/ML||||ABNORMAL|NOT DONE||||LOCHIA|CLOTTED|NA|CONFOCAL MICROSCOPY|CKD-EPI FORMULA||NA|Y|U|U|||NA|5||7||CONTINUATION TREATMENT|1972-08-20|1970-06-08|||||1966-01-21||1963-06-02|U|1961-03-28
TRIAL STUDY 134XCP|LB|3C4215F7-A7FA-4177-8B84-FD26FEB43039|1||||IL1EXR|INTERLEUKIN 1 EXCRETION RATE|||||||MG/KG/MIN|||||||TRACE||/200 HPFS||||NORMAL|NOT DONE||||DERMAL TISSUE|LIPEMIC|U|IMPULSE OSCILLOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|Y|N|||NA|1||38||OPEN LABEL TREATMENT|1967-11-16|1963-07-23|||||1971-12-15||1963-05-15|N|1968-09-29
TRIAL STUDY 134XCP|LB|3C4215F7-A7FA-4177-8B84-FD26FEB43039|2||||CGA|CHROMOGRANIN A|||||||ML/MIN|||||||INVALID||HOUNSFIELD UNIT||||HIGH|NOT DONE||||PLATELET RICH PLASMA|ROOM TEMPERATURE|Y|DIPSTICK|MDRD 4 VARIABLE FORMULA||Y|Y|U|NA|||N|1||38||SCREENING|1971-05-27|1972-11-03|||||1960-07-18||1965-08-11|Y|1970-12-01
TRIAL STUDY 134XCP|LB|3C4215F7-A7FA-4177-8B84-FD26FEB43039|1||||OSTEOC|OSTEOCALCIN|||||||NKAT/G HB|||||||POSITIVE||MMHG||||HIGH|NOT DONE||||CAPILLARY BLOOD|HEMOLYZED|Y|OPTICAL MAPPING|FIBROTEST FORMULA||U|N|Y|U|||N|2||58||LONG-TERM FOLLOW-UP|1965-12-26|1970-11-03|||||1962-04-16||1967-10-29|NA|1966-07-15
TRIAL STUDY 134XCP|LB|3C4215F7-A7FA-4177-8B84-FD26FEB43039|2||||THR|THREONINE|||||||U/G HB|||||||POSITIVE||MSEC||||NORMAL|NOT DONE||||AQUEOUS HUMOR|NON-HEMOLYZED|N|CHROMATOGRAPHY|HEPASCORE FORMULA||NA|NA|NA|Y|||NA|2||58||LONG-TERM FOLLOW-UP|1964-05-24|1971-12-07|||||1961-04-12||1966-08-07|N|1964-07-23
TRIAL STUDY 134XCP|LB|3C4215F7-A7FA-4177-8B84-FD26FEB43039|1||||BLASTIMM|IMMUNOBLASTS|||||||PMOL/10^10 CELLS|||||||POSITIVE||UG/M2/DAY||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|CLOTTED|Y|COULOMETRIC TITRATION|FIBROSIS 4 FORMULA||Y|NA|N|NA|||NA|3||39||OBSERVATION|1969-04-01|1967-12-10|||||1960-05-19||1968-01-03|NA|1967-01-02
TRIAL STUDY 134XCP|LB|3C4215F7-A7FA-4177-8B84-FD26FEB43039|2||||PRZPM|PRAZEPAM|||||||ML*CMH2O|||||||INDETERMINATE||NG/DAY||||HIGH|NOT DONE||||PLATELET POOR PLASMA|SOLIDIFIED|Y|SPECT/CT SCAN|NASH FIBROSURE FORMULA||Y|Y|N|U|||Y|3||39||SCREENING|1969-09-01|1973-02-17|||||1966-04-16||1963-10-23|Y|1971-09-28
TRIAL STUDY 134XCP|LB|3C4215F7-A7FA-4177-8B84-FD26FEB43039|1||||CA242AG|CANCER ANTIGEN 242|||||||NKAT/L|||||||BORDERLINE||UGEQ/L||||LOW|NOT DONE||||EMOTIONAL TEAR|FROZEN|Y|THIN SMEAR|MDRD 5 VARIABLE FORMULA||NA|N|N|U|||U|4||88||CONTINUATION TREATMENT|1973-04-11|1971-05-30|||||1968-08-21||1969-10-07|Y|1966-09-22
TRIAL STUDY 134XCP|LB|3C4215F7-A7FA-4177-8B84-FD26FEB43039|2||||COCAAOM|COCAINE AND/OR METABOLITES|||||||MG/CM2|||||||BORDERLINE||KCAL/DAY||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|AGGLUTINATED|U|WEBER GREEN STAIN|MDRD 4 VARIABLE FORMULA||U|NA|NA|Y|||U|4||88||WASHOUT|1962-07-24|1965-08-20|||||1965-10-05||1973-01-23|NA|1972-07-07
TRIAL STUDY 134XCP|LB|3C4215F7-A7FA-4177-8B84-FD26FEB43039|1||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||TSP EQ|||||||INDETERMINATE||PMOL||||NORMAL|NOT DONE||||LOCHIA|CONCENTRATED|Y|JAFFE REACTION|COCKCROFT-GAULT FORMULA||Y|N|N|Y|||Y|5||7||OBSERVATION|1968-08-02|1972-12-24|||||1971-10-16||1964-01-15|Y|1969-09-16
TRIAL STUDY 134XCP|LB|3C4215F7-A7FA-4177-8B84-FD26FEB43039|2||||KLCLLCFR|KAPPA LT CHAIN,FREE/LAMBDA LT CHAIN,FREE|||||||LOG10 TCID 50/UL|||||||INDETERMINATE||10^6 ORGANISMS/G||||HIGH|NOT DONE||||MONOCYTE|CALCIFIED|U|WESTERN BLOT|FIBROMETER FORMULA||N|N|U|NA|||U|5||7||FOLLOW-UP|1971-11-17|1968-11-13|||||1963-12-16||1961-05-21|N|1971-07-06
TRIAL STUDY 134XCP|LB|797C71A3-375E-466E-BDA8-A2828C9C45BB|1||||AMABARAB|ACH RECEPTOR MODULATN AB/ACH RECEPTOR AB|||||||KDA|||||||BORDERLINE||PACK||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|LIPEMIC|NA|HEMAGGLUTINATION ASSAY|GMI MMOL/MOL FORMULA||Y|N|NA|N|||NA|1||38||BASELINE|1961-04-22|1970-11-12|||||1961-03-02||1961-01-28|U|1961-11-16
TRIAL STUDY 134XCP|LB|797C71A3-375E-466E-BDA8-A2828C9C45BB|2||||CETPA|CHOLESTERYL ESTER TRANSFER PROTEIN ACT|||||||PPB|||||||POSITIVE||MM/2H||||LOW|NOT DONE||||INFRANATANT, SERUM|THAWED|U|RADIOIMMUNOPRECIPITATION ASSAY|COCKCROFT-GAULT FORMULA||U|N|NA|Y|||NA|1||38||FOLLOW-UP|1972-07-23|1973-04-02|||||1973-01-28||1970-08-24|U|1960-03-07
TRIAL STUDY 134XCP|LB|797C71A3-375E-466E-BDA8-A2828C9C45BB|1||||HETRPH|HETEROPHILS|||||||AG|||||||POSITIVE||PMOL/G||||HIGH|NOT DONE||||MONOCYTE|AGGLUTINATED|Y|SLOAN LETTER EYE CHART 2.5%|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|N|N|||U|2||58||FOLLOW-UP|1971-02-07|1965-01-24|||||1964-10-17||1969-06-12|U|1972-05-10
TRIAL STUDY 134XCP|LB|797C71A3-375E-466E-BDA8-A2828C9C45BB|2||||CXCL6|CHEMOKINE (C-X-C MOTIF) LIGAND 6|||||||GBQ/MG|||||||POSITIVE||COPIES/ML||||LOW|NOT DONE||||SWABBED MATERIAL|AGGLUTINATED|U|REFLECTANCE SPECTROSCOPY|HEPASCORE FORMULA||Y|U|NA|N|||N|2||58||SCREENING|1970-03-22|1966-07-20|||||1969-09-13||1967-04-10|U|1969-09-27
TRIAL STUDY 134XCP|LB|797C71A3-375E-466E-BDA8-A2828C9C45BB|1||||ACPHOS|ACID PHOSPHATASE|||||||CPM|||||||NEGATIVE||MG/H||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|NON-HEMOLYZED|U|ZIEHL NEELSEN ACID FAST STAIN|MDRD ENZYMATIC FORMULA||N|NA|NA|NA|||U|3||39||CONTINUATION TREATMENT|1973-02-21|1962-07-06|||||1962-05-01||1961-08-04|NA|1966-11-28
TRIAL STUDY 134XCP|LB|797C71A3-375E-466E-BDA8-A2828C9C45BB|2||||HDLCLDLC|HDL CHOLESTEROL/LDL CHOLESTEROL|||||||10^6 IU/ML|||||||INVALID||G/MOL||||HIGH|NOT DONE||||INTERSTITIAL FLUID|LIPEMIC|Y|DYNAMIC CONTRAST ENHANCED MRI|MDRD 4 VARIABLE FORMULA||U|U|Y|N|||Y|3||39||FOLLOW-UP|1972-09-05|1972-04-21|||||1967-09-27||1968-02-23|U|1960-05-16
TRIAL STUDY 134XCP|LB|797C71A3-375E-466E-BDA8-A2828C9C45BB|1||||CRYOGLBN|CRYOGLOBULIN|||||||CMH2O/ML|||||||NEGATIVE||PPM||||LOW|NOT DONE||||SUPERNATANT, SERUM|HEMOLYZED|U|PHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|N|U|U|||U|4||88||OBSERVATION|1963-10-10|1963-12-22|||||1960-06-27||1967-06-19|Y|1960-11-04
TRIAL STUDY 134XCP|LB|797C71A3-375E-466E-BDA8-A2828C9C45BB|2||||CELLS|CELLS|||||||LOG10 IU/ML|||||||INDETERMINATE||G/KG/DAY||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|PARAFFIN-EMBEDDED|NA|TEST STRIP|MDRD 5 VARIABLE FORMULA||U|Y|NA|U|||NA|4||88||OPEN LABEL TREATMENT|1967-06-26|1964-09-12|||||1972-01-17||1968-12-04|N|1967-01-30
TRIAL STUDY 134XCP|LB|797C71A3-375E-466E-BDA8-A2828C9C45BB|1||||C130086|ENGLISH PLANTAIN POLLEN IGG|||||||RNA COPIES/ML|||||||INDETERMINATE||CUP||||LOW|NOT DONE||||SERUM OR PLASMA|AUTOLYZED|NA|HIGH LEVEL AMINOGLYCOSIDE SCREEN|ASH FIBROSURE FORMULA||N|N|N|N|||U|5||7||FOLLOW-UP|1960-06-19|1968-11-29|||||1962-06-09||1972-10-29|N|1964-04-20
TRIAL STUDY 134XCP|LB|797C71A3-375E-466E-BDA8-A2828C9C45BB|2||||HSP90A|HEAT SHOCK PROTEIN 90 ALPHA|||||||P|||||||POSITIVE||DEG/MM||||NORMAL|NOT DONE||||MECONIUM|SOLIDIFIED|NA|PULSE OXIMETRY|CKD-EPI FORMULA||NA|NA|NA|N|||N|5||7||LONG-TERM FOLLOW-UP|1972-06-08|1963-12-28|||||1961-07-02||1968-10-09|U|1964-04-10
TRIAL STUDY 134XCP|LB|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|1||||CXCL11|CHEMOKINE (C-X-C MOTIF) LIGAND 11|||||||SUPPOSITORY|||||||INVALID||MHZ||||LOW|NOT DONE||||CAPILLARY PLASMA|REFRIGERATED|N|MYELOPEROXIDASE STAIN|FIBROSIS 4 FORMULA||U|Y|NA|U|||N|1||38||BASELINE|1964-01-12|1960-06-17|||||1965-11-08||1972-07-12|Y|1960-11-01
TRIAL STUDY 134XCP|LB|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|2||||INTLK33|INTERLEUKIN 33|||||||DEG2|||||||INDETERMINATE||UG/CM2||||NORMAL|NOT DONE||||LYSATE|PARAFFIN-EMBEDDED|N|DYNAMOMETRY|FIBROTEST FORMULA||U|U|U|N|||NA|1||38||OBSERVATION|1973-09-02|1968-01-27|||||1962-08-03||1972-08-18|NA|1973-07-24
TRIAL STUDY 134XCP|LB|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|1||||C130084|ENGLISH PLANTAIN POLLEN IGE|||||||DAGU/ML|||||||INDETERMINATE||MMHG/L/MIN||||HIGH|NOT DONE||||LYSATE|REFRIGERATED|Y|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|N|U|||U|2||58||BASELINE|1962-12-18|1961-10-04|||||1968-12-28||1964-04-14|NA|1969-08-20
TRIAL STUDY 134XCP|LB|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|2||||CXCL10|CHEMOKINE (C-X-C MOTIF) LIGAND 10|||||||UG/CM2|||||||BORDERLINE||MAC50||||NORMAL|NOT DONE||||EMESIS|SOLIDIFIED|NA|POLYGRAPHY|MDRD 5 VARIABLE FORMULA||N|NA|NA|N|||U|2||58||CONTINUATION TREATMENT|1964-08-03|1967-08-20|||||1966-09-10||1964-07-26|N|1970-08-01
TRIAL STUDY 134XCP|LB|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|1||||PYRIDNLN|PYRIDINOLINE|||||||PMOL/G|||||||POSITIVE||ML/G/DAY||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|SOLIDIFIED|N|HPLC/MS|MDRD 6 VARIABLE FORMULA||N|N|N|NA|||N|3||39||BLINDED TREATMENT|1968-10-05|1967-03-21|||||1970-05-27||1960-06-27|U|1962-05-22
TRIAL STUDY 134XCP|LB|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|2||||HDL3|HDL-CHOLESTEROL SUBCLASS 3|||||||CMH2O*S/ML|||||||INDETERMINATE||10^6 IU/ML||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED|Y|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROTEST FORMULA||Y|U|U|Y|||Y|3||39||SCREENING|1966-01-05|1962-05-01|||||1970-09-11||1961-12-30|U|1970-05-10
TRIAL STUDY 134XCP|LB|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|1||||V25HD2|25-HYDROXYVITAMIN D2|||||||NMOL BCE/L|||||||INVALID||PMOL||||NORMAL|NOT DONE||||PLATELET|ROOM TEMPERATURE|NA|PHYSICAL EXAMINATION|ASH FIBROSURE FORMULA||NA|N|N|U|||Y|4||88||OPEN LABEL TREATMENT|1967-10-07|1969-05-01|||||1969-02-18||1971-02-17|U|1962-07-21
TRIAL STUDY 134XCP|LB|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|2||||HRYCELY|HAIRY CELLS/LYMPHOCYTES|||||||U/KG/MIN|||||||NEGATIVE||NMOL/G||||LOW|NOT DONE||||EXUDATE|NON-HEMOLYZED|Y|NUCLEAR RADIOLOGY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|Y|||Y|4||88||WASHOUT|1969-02-27|1969-09-05|||||1964-07-25||1971-06-18|Y|1961-11-11
TRIAL STUDY 134XCP|LB|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|1||||HLAA2AB|HLA-A2 ANTIBODY|||||||10^9 ORGANISMS/G|||||||NEGATIVE||WEEKS||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|REFRIGERATED|U|TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD FORMULA||U|U|NA|Y|||NA|5||7||FOLLOW-UP|1960-01-05|1961-08-27|||||1968-09-30||1966-04-07|N|1965-05-19
TRIAL STUDY 134XCP|LB|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|2||||FLNTRZPM|FLUNITRAZEPAM|||||||U/KG|||||||INVALID||OHM||||NORMAL|NOT DONE||||VENOUS PLASMA|UNEXPECTED ODOR|U|PHASE-CONTRAST MRI|MDRD ENZYMATIC FORMULA||N|Y|N|NA|||NA|5||7||WASHOUT|1963-11-13|1965-10-27|||||1967-07-13||1973-06-11|Y|1965-01-02
TRIAL STUDY 134XCP|LB|5617A5B9-AEE0-4118-9113-3755ED8E961A|1||||CCPAB|CYCLIC CITRULLINATED PEPTIDE ANTIBODY|||||||MPL U|||||||NEGATIVE||G/MOL||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CONTAMINATED|NA|ATOMIC ABSORPTION SPECTROMETRY|MDRD 4 VARIABLE FORMULA||N|U|U|Y|||NA|1||38||RUN-IN|1965-07-23|1960-05-04|||||1967-12-01||1965-04-09|NA|1960-08-18
TRIAL STUDY 134XCP|LB|5617A5B9-AEE0-4118-9113-3755ED8E961A|2||||CYAMPPH|AMORPHOUS PHOSPHATE CRYSTALS|||||||FMOL/L|||||||POSITIVE||WEBER||||ABNORMAL|NOT DONE||||SERUM|HEMOLYZED|N|ENZYMATIC ULTRACENTRIFUGATION|COCKCROFT-GAULT FORMULA||N|U|NA|Y|||Y|1||38||TREATMENT|1962-07-11|1962-08-15|||||1967-05-09||1972-12-15|NA|1967-08-01
TRIAL STUDY 134XCP|LB|5617A5B9-AEE0-4118-9113-3755ED8E961A|1||||LAM|LIPOARABINOMANNAN|||||||SACHET|||||||TRACE||MG/M2||||HIGH|NOT DONE||||FLUID|GELLED|Y|FLUORESCENT SPOT TEST|ASH FIBROSURE FORMULA||N|U|NA|NA|||N|2||58||SCREENING|1970-08-18|1973-01-17|||||1961-08-06||1960-02-07|NA|1960-08-09
TRIAL STUDY 134XCP|LB|5617A5B9-AEE0-4118-9113-3755ED8E961A|2||||MSTHCE|MESOTHELIAL CELLS|||||||PG/L|||||||INVALID||NEWTON||||HIGH|NOT DONE||||ISOLATE|CONCENTRATED|NA|FLUORESCENT MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|NA|||U|2||58||OBSERVATION|1964-01-13|1972-02-09|||||1972-07-01||1969-11-12|N|1973-01-27
TRIAL STUDY 134XCP|LB|5617A5B9-AEE0-4118-9113-3755ED8E961A|1||||EPO|ERYTHROPOIETIN|||||||KHZ|||||||INVALID||EID 50/DOSE||||HIGH|NOT DONE||||EMOTIONAL TEAR|SOLIDIFIED|U|DUCTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|N|NA|N|||U|3||39||LONG-TERM FOLLOW-UP|1970-05-20|1965-08-26|||||1966-10-06||1966-06-14|NA|1966-12-29
TRIAL STUDY 134XCP|LB|5617A5B9-AEE0-4118-9113-3755ED8E961A|2||||CD2LY|CD2/LYMPHOCYTES|||||||PIXEL|||||||POSITIVE||EIA UNIT||||ABNORMAL|NOT DONE||||CALCULUS|LACTESCENT|NA|CONFOCAL MICROSCOPY|GMI % FORMULA||NA|U|Y|N|||U|3||39||CONTINUATION TREATMENT|1968-07-27|1961-11-07|||||1967-03-14||1973-05-27|Y|1963-01-31
TRIAL STUDY 134XCP|LB|5617A5B9-AEE0-4118-9113-3755ED8E961A|1||||LIPASEG|LIPASE, GASTRIC|||||||UG/G/MIN|||||||TRACE||ML/H||||NORMAL|NOT DONE||||LUNG SURFACTANT|SOLIDIFIED|Y|INTRAVASCULAR ULTRASOUND|ASH FIBROSURE FORMULA||NA|NA|NA|N|||Y|4||88||BASELINE|1968-09-17|1968-03-06|||||1969-05-19||1966-11-28|U|1971-11-14
TRIAL STUDY 134XCP|LB|5617A5B9-AEE0-4118-9113-3755ED8E961A|2||||C130127|CAT DANDER ANTIGEN IGG4 ANTIBODY|||||||UG/L DDU|||||||TRACE||LOG10 ELISA UNIT/DOSE||||ABNORMAL|NOT DONE||||COLOSTRUM|GELLED|NA|BRDU CELLULAR PROLIFERATION ASSAY|MDRD ENZYMATIC FORMULA||N|U|NA|NA|||Y|4||88||SCREENING|1962-02-06|1972-05-05|||||1967-02-15||1965-02-03|NA|1967-06-22
TRIAL STUDY 134XCP|LB|5617A5B9-AEE0-4118-9113-3755ED8E961A|1||||TAURCRT|TAURINE/CREATININE|||||||SUPPOSITORY|||||||TRACE||G/CM2||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|LIPEMIC|U|GC/MS-CI|FIBROSIS 4 FORMULA||N|Y|N|N|||Y|5||7||CONTINUATION TREATMENT|1968-09-20|1967-08-31|||||1968-07-17||1966-05-12|NA|1963-05-07
TRIAL STUDY 134XCP|LB|5617A5B9-AEE0-4118-9113-3755ED8E961A|2||||PROTS|PROTEIN S|||||||10^6 CFU/G|||||||INVALID||KG/M2||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|ROOM TEMPERATURE|NA|SLIT LAMP PHOTOGRAPHY|CKD-EPI FORMULA||Y|NA|U|U|||U|5||7||CONTINUATION TREATMENT|1962-02-23|1963-10-16|||||1973-04-15||1970-03-12|Y|1969-06-29
TRIAL STUDY 134XCP|LB|7ECE0F95-910A-4FB3-9435-73805E498415|1||||HGBSHGB|HEMOGLOBIN S/TOTAL HEMOGLOBIN|||||||OZ EQ|||||||POSITIVE||ROENTGEN||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|AUTOLYZED|Y|SLOAN LETTER EYE CHART 1.25%|HEPASCORE FORMULA||N|NA|Y|NA|||N|1||38||FOLLOW-UP|1966-05-17|1960-06-19|||||1962-08-10||1961-09-14|NA|1968-05-23
TRIAL STUDY 134XCP|LB|7ECE0F95-910A-4FB3-9435-73805E498415|2||||HLAAMSC|HLA-A MISMATCH COUNT|||||||10^6 DNA COPIES/ML|||||||TRACE||CUP||||HIGH|NOT DONE||||EMOTIONAL TEAR|PARAFFIN-EMBEDDED|Y|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|ASH FIBROSURE FORMULA||N|NA|Y|U|||Y|1||38||RUN-IN|1965-07-05|1963-09-14|||||1963-12-05||1970-05-22|Y|1968-05-08
TRIAL STUDY 134XCP|LB|7ECE0F95-910A-4FB3-9435-73805E498415|1||||BASOMM|BASOPHILIC METAMYELOCYTES|||||||CM/MIN|||||||NEGATIVE||IU/DL||||HIGH|NOT DONE||||REFLEX TEAR|FRESH|U|POLYSOMNOGRAPHY|GMI % FORMULA||N|N|NA|NA|||NA|2||58||TREATMENT|1965-08-06|1972-01-14|||||1972-09-10||1960-03-02|N|1966-10-07
TRIAL STUDY 134XCP|LB|7ECE0F95-910A-4FB3-9435-73805E498415|2||||EOSPSDLE|PSEUDO-EOSINOPHILS/LEUKOCYTES|||||||IU/G HB|||||||NEGATIVE||10^4 CFU||||HIGH|NOT DONE||||URINE SEDIMENT|PARAFFIN-EMBEDDED|NA|NUCLEIC ACID AMPLIFICATION TEST|GMI MMOL/MOL FORMULA||N|N|NA|Y|||N|2||58||FOLLOW-UP|1969-05-03|1961-05-28|||||1968-11-25||1961-01-09|NA|1962-05-15
TRIAL STUDY 134XCP|LB|7ECE0F95-910A-4FB3-9435-73805E498415|1||||MYCY|MYELOCYTES|||||||KEV|||||||INDETERMINATE||MG/G/MIN||||ABNORMAL|NOT DONE||||TISSUE|AUTOLYZED|Y|SPIRAL CT|CKD-EPI CYSTATIN C FORMULA||Y|U|N|Y|||N|3||39||OBSERVATION|1968-02-20|1966-09-28|||||1965-08-01||1964-12-26|NA|1966-02-22
TRIAL STUDY 134XCP|LB|7ECE0F95-910A-4FB3-9435-73805E498415|2||||BILDIRBI|DIRECT BILIRUBIN/BILIRUBIN|||||||MG/KG/MIN|||||||NEGATIVE||U.CARR||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|ROOM TEMPERATURE|N|OPTICAL DENSITY MEASUREMENT|GMI MMOL/MOL FORMULA||N|U|Y|NA|||NA|3||39||BLINDED TREATMENT|1971-06-24|1966-11-21|||||1971-03-04||1972-07-27|U|1971-10-07
TRIAL STUDY 134XCP|LB|7ECE0F95-910A-4FB3-9435-73805E498415|1||||DRUGSCR|DRUG SCREEN|||||||/LPF|||||||NEGATIVE||/100 HPFS||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|CONTAMINATED|N|DC SHEATH FLOW|CKD-EPI CREATININE FORMULA||NA|Y|U|NA|||U|4||88||WASHOUT|1963-01-26|1966-09-01|||||1972-05-25||1960-07-17|Y|1961-09-19
TRIAL STUDY 134XCP|LB|7ECE0F95-910A-4FB3-9435-73805E498415|2||||SPERM|SPERMATOZOA|||||||DRINK|||||||POSITIVE||MIU/L||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|THAWED|U|IN VITRO GENE EXPRESSION ASSAY|MDRD 4 VARIABLE FORMULA||NA|N|U|Y|||NA|4||88||OPEN LABEL TREATMENT|1971-03-14|1967-03-14|||||1971-02-17||1969-03-30|N|1962-02-18
TRIAL STUDY 134XCP|LB|7ECE0F95-910A-4FB3-9435-73805E498415|1||||CHOLATE|CHOLATE|||||||ECL UNIT|||||||TRACE||L||||HIGH|NOT DONE||||BILE|GELLED|U|SECONDARY ION MASS SPECTOMETRY|FIBROTEST FORMULA||U|N|NA|NA|||NA|5||7||CONTINUATION TREATMENT|1968-08-23|1963-04-22|||||1965-04-11||1970-12-31|U|1965-09-15
TRIAL STUDY 134XCP|LB|7ECE0F95-910A-4FB3-9435-73805E498415|2||||KRCYMGLE|MEGAKARYOCYTES/LEUKOCYTES|||||||MG/DL|||||||BORDERLINE||PG/CELL||||LOW|NOT DONE||||BONE|DRIED|U|ANTIBIOTIC AGAR SCREEN|MDRD 6 VARIABLE FORMULA||Y|N|NA|N|||U|5||7||FOLLOW-UP|1962-09-07|1964-07-28|||||1971-03-03||1972-01-09|N|1972-10-17
TRIAL STUDY 134XCP|LB|83EDB0FE-728D-453F-8DB2-7D44202EEB43|1||||COMP|CARTILAGE OLIGOMERIC MATRIX PROTEIN|||||||PATCH|||||||TRACE||UG/CM2||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|ICTERIC|U|ENZYMATIC ULTRACENTRIFUGATION|MDRD 5 VARIABLE FORMULA||N|Y|N|N|||Y|1||38||OPEN LABEL TREATMENT|1964-01-14|1965-10-30|||||1962-05-24||1967-02-28|N|1966-04-16
TRIAL STUDY 134XCP|LB|83EDB0FE-728D-453F-8DB2-7D44202EEB43|2||||CYHGBC|HEMOGLOBIN C CRYSTALS|||||||UG|||||||INDETERMINATE||MG/G/MIN||||HIGH|NOT DONE||||DERMAL TISSUE|REFRIGERATED|Y|MAGNETIC RESONANCE ELASTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|N|N|||Y|1||38||TREATMENT|1962-04-13|1970-07-16|||||1968-03-28||1966-06-13|Y|1971-05-17
TRIAL STUDY 134XCP|LB|83EDB0FE-728D-453F-8DB2-7D44202EEB43|1||||AMYLASES|AMYLASE, SALIVARY|||||||MEQ/DAY|||||||TRACE||LENS||||HIGH|NOT DONE||||FLUID|THAWED|Y|NEXT GENERATION SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|Y|||NA|2||58||CONTINUATION TREATMENT|1965-12-17|1969-10-09|||||1969-06-06||1963-03-28|Y|1970-12-14
TRIAL STUDY 134XCP|LB|83EDB0FE-728D-453F-8DB2-7D44202EEB43|2||||LGUNSCE|LARGE UNSTAINED CELLS|||||||MMHG/L/MIN|||||||INVALID||CL||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|GELLED|NA|DIGITAL PCR|ASH FIBROSURE FORMULA||N|U|N|Y|||NA|2||58||CONTINUATION TREATMENT|1965-05-02|1969-03-03|||||1961-11-30||1961-05-13|N|1971-01-24
TRIAL STUDY 134XCP|LB|83EDB0FE-728D-453F-8DB2-7D44202EEB43|1||||TGFB|TRANSFORMING GROWTH FACTOR BETA|||||||U/CL|||||||INDETERMINATE||10^11/L||||NORMAL|NOT DONE||||DISCHARGE|DRIED|N|IMMUNOBLOT|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|Y|NA|||U|3||39||WASHOUT|1970-04-30|1972-11-14|||||1969-11-05||1960-12-29|Y|1968-06-21
TRIAL STUDY 134XCP|LB|83EDB0FE-728D-453F-8DB2-7D44202EEB43|2||||GAMBTAC|GAMMA-AMINOBUTYRIC ACID|||||||U/G/DAY|||||||BORDERLINE||L/H/M2||||NORMAL|NOT DONE||||STOOL|THAWED|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD 4 VARIABLE FORMULA||Y|Y|NA|N|||Y|3||39||SCREENING|1970-11-19|1971-03-14|||||1960-07-10||1972-10-09|U|1961-05-20
TRIAL STUDY 134XCP|LB|83EDB0FE-728D-453F-8DB2-7D44202EEB43|1||||ALPBS|BONE SPECIFIC ALKALINE PHOSPHATASE|||||||RAD|||||||TRACE||OSM||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|REFRIGERATED|NA|MICROBIAL CULTURE, LIQUID|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|U|U|||NA|4||88||BASELINE|1969-03-27|1970-08-24|||||1970-06-03||1960-04-12|N|1966-07-03
TRIAL STUDY 134XCP|LB|83EDB0FE-728D-453F-8DB2-7D44202EEB43|2||||MCVRETIC|MCV RETICULOCYTES|||||||TRACE|||||||INVALID||ATM||||HIGH|NOT DONE||||DIALYSIS FLUID|CLOTTED|Y|DYNAMOMETRY|MDRD 5 VARIABLE FORMULA||NA|N|Y|U|||U|4||88||OPEN LABEL TREATMENT|1964-08-17|1960-05-09|||||1966-11-21||1961-01-24|NA|1963-10-23
TRIAL STUDY 134XCP|LB|83EDB0FE-728D-453F-8DB2-7D44202EEB43|1||||AAP|ALANINE AMINOPEPTIDASE|||||||QUANTITY SUFFICIENT|||||||INVALID||CAPLET||||LOW|NOT DONE||||URINE|FROZEN|U|CLINICAL EVALUATION|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|NA|Y|||N|5||7||OPEN LABEL TREATMENT|1962-09-08|1966-09-24|||||1968-09-01||1961-01-11|U|1972-08-24
TRIAL STUDY 134XCP|LB|83EDB0FE-728D-453F-8DB2-7D44202EEB43|2||||EPIRCE|RENAL EPITHELIAL CELLS|||||||/HPF|||||||INVALID||MM/SEC||||NORMAL|NOT DONE||||NAIL|LACTESCENT|U|IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD FORMULA||NA|U|Y|N|||Y|5||7||WASHOUT|1962-02-15|1964-08-04|||||1960-10-05||1967-11-12|N|1972-11-30
TRIAL STUDY 134XCP|LB|35589D89-B019-4C5E-8A4B-BFA58E894A9C|1||||RANTES|REG UPON ACT NORMAL T-CELL EXPRD SECRTD|||||||MESF|||||||INDETERMINATE||MEQ/DAY||||NORMAL|NOT DONE||||GASTRIC FLUID|THAWED|N|MASS SPECTROMETRY|MDRD 4 VARIABLE FORMULA||Y|NA|Y|U|||Y|1||38||OBSERVATION|1964-08-19|1969-02-09|||||1963-05-05||1965-04-12|NA|1962-09-02
TRIAL STUDY 134XCP|LB|35589D89-B019-4C5E-8A4B-BFA58E894A9C|2||||TROPONI1|TROPONIN I TYPE 1|||||||OZ|||||||INDETERMINATE||GBQ/MG||||HIGH|NOT DONE||||REFLEX TEAR|FROZEN|U|ELISA|COCKCROFT-GAULT FORMULA||U|U|NA|NA|||U|1||38||TREATMENT|1973-08-04|1960-02-29|||||1972-05-14||1960-09-13|N|1966-08-26
TRIAL STUDY 134XCP|LB|35589D89-B019-4C5E-8A4B-BFA58E894A9C|1||||C130130|DOG DANDER ANTIGEN IGA ANTIBODY|||||||SEC|||||||INVALID||SACHET||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED|Y|PULSE OXIMETRY|CKD-EPI FORMULA||NA|N|Y|U|||Y|2||58||INDUCTION TREATMENT|1967-12-10|1964-10-15|||||1965-12-23||1970-10-25|NA|1963-06-14
TRIAL STUDY 134XCP|LB|35589D89-B019-4C5E-8A4B-BFA58E894A9C|2||||UNSPCECE|UNSPECIFIED CELLS/TOTAL CELLS|||||||ML/M2|||||||POSITIVE||DAGU/ML||||LOW|NOT DONE||||LAVAGE FLUID|CLOTTED|NA|OBSERVATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|Y|NA|||N|2||58||TREATMENT|1962-08-14|1963-01-30|||||1960-09-10||1960-07-26|Y|1973-08-13
TRIAL STUDY 134XCP|LB|35589D89-B019-4C5E-8A4B-BFA58E894A9C|1||||NOREPEXR|NOREPINEPHRINE EXCRETION RATE|||||||MMOL/MIN/KPA|||||||BORDERLINE||AGU/ML||||HIGH|NOT DONE||||LYMPH|ICTERIC|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD FORMULA||N|U|N|N|||U|3||39||BLINDED TREATMENT|1972-04-30|1966-06-23|||||1961-08-16||1964-03-21|U|1971-12-13
TRIAL STUDY 134XCP|LB|35589D89-B019-4C5E-8A4B-BFA58E894A9C|2||||PNTBRBTL|PENTOBARBITAL|||||||10^6/HPF|||||||POSITIVE||EJACULATE U||||HIGH|NOT DONE||||BASAL TEAR|ICTERIC|U|SPECULAR MICROSCOPY|GMI MMOL/MOL FORMULA||Y|Y|NA|Y|||N|3||39||RUN-IN|1967-08-16|1965-05-24|||||1966-11-29||1968-06-24|U|1973-07-18
TRIAL STUDY 134XCP|LB|35589D89-B019-4C5E-8A4B-BFA58E894A9C|1||||KCREAT|POTASSIUM/CREATININE|||||||TABLET|||||||TRACE||DIOPTER||||NORMAL|NOT DONE||||BUFFY COAT|DRIED|NA|OSCILLOMETRY|CKD-EPI CREATININE FORMULA||Y|U|U|NA|||Y|4||88||RUN-IN|1971-10-30|1960-10-21|||||1967-12-24||1969-08-06|Y|1972-08-09
TRIAL STUDY 134XCP|LB|35589D89-B019-4C5E-8A4B-BFA58E894A9C|2||||CH50|COMPLEMENT CH50|||||||GBQ|||||||NEGATIVE||FOZ_US||||ABNORMAL|NOT DONE||||TISSUE|LACTESCENT|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|NASH FIBROSURE FORMULA||Y|Y|U|N|||N|4||88||WASHOUT|1965-08-09|1969-12-11|||||1966-07-24||1970-06-14|Y|1971-10-31
TRIAL STUDY 134XCP|LB|35589D89-B019-4C5E-8A4B-BFA58E894A9C|1||||BASOMM|BASOPHILIC METAMYELOCYTES|||||||/2500 WBC|||||||NEGATIVE||NKAT||||LOW|NOT DONE||||EMESIS|SOLIDIFIED|U|PHASE-CONTRAST MRI|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|U|||Y|5||7||OBSERVATION|1963-03-10|1962-10-24|||||1965-05-19||1967-06-10|Y|1970-09-08
TRIAL STUDY 134XCP|LB|35589D89-B019-4C5E-8A4B-BFA58E894A9C|2||||HLABMSC|HLA-B MISMATCH COUNT|||||||UG/M2/MIN|||||||BORDERLINE||PIXEL||||HIGH|NOT DONE||||DISCHARGE|THAWED|N|HPLC/MS/MS|FIBROSIS 4 FORMULA||N|N|N|NA|||N|5||7||RUN-IN|1966-07-05|1965-01-19|||||1972-05-29||1967-11-01|NA|1967-07-20
TRIAL STUDY 134XCP|LB|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|1||||APOA5|APOLIPOPROTEIN A5|||||||L/MIN/M2|||||||TRACE||BQ/UG||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|THAWED|NA|MAGNETIC RESONANCE ELASTOGRAPHY|MDRD 4 VARIABLE FORMULA||U|Y|N|U|||Y|1||38||CONTINUATION TREATMENT|1972-11-04|1969-10-19|||||1971-08-06||1968-09-24|Y|1968-05-22
TRIAL STUDY 134XCP|LB|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|2||||LDH5LDH|LDH ISOENZYME 5/LDH|||||||EJACULATE U|||||||BORDERLINE||10^3 CFU||||LOW|NOT DONE||||ISOLATE|ICTERIC|NA|TRYPAN BLUE STAIN|FIBROTEST FORMULA||Y|N|N|NA|||Y|1||38||OBSERVATION|1965-06-04|1966-05-26|||||1973-08-15||1967-02-19|NA|1972-12-31
TRIAL STUDY 134XCP|LB|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|1||||PSIGMAB|PHOSPHATIDYLSERINE IGM ANTIBODY|||||||UMOL/H/MMOL|||||||NEGATIVE||PA||||NORMAL|NOT DONE||||ARTERIAL BLOOD|REFRIGERATED|N|DISK DIFFUSION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|N|N|||U|2||58||WASHOUT|1962-04-03|1966-04-02|||||1968-03-31||1963-10-23|Y|1961-04-14
TRIAL STUDY 134XCP|LB|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|2||||GRANBCE|GRANULOCYTES BAND FORM/TOTAL CELLS|||||||UG/DAY|||||||INDETERMINATE||MMHG/L/MIN||||NORMAL|NOT DONE||||SPERMATOZOON|GELLED|Y|LANDOLT RING|FIBROSIS 4 FORMULA||U|N|Y|U|||NA|2||58||OPEN LABEL TREATMENT|1968-08-10|1963-11-21|||||1964-04-10||1967-05-31|N|1967-09-20
TRIAL STUDY 134XCP|LB|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|1||||PDGFAA|PLATELET DERIVED GROWTH FACTOR ISOFORMAA|||||||MMOL/DAY|||||||INVALID||U/G/MIN||||LOW|NOT DONE||||BONE MARROW|SOLIDIFIED|N|DOPPLER ULTRASOUND|MDRD ENZYMATIC FORMULA||N|NA|Y|U|||NA|3||39||FOLLOW-UP|1964-05-19|1972-04-30|||||1971-10-25||1972-01-26|U|1964-09-01
TRIAL STUDY 134XCP|LB|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|2||||INLCLR|INULIN CLEARANCE|||||||GLOBULE|||||||POSITIVE||G/DL||||LOW|NOT DONE||||BONE MARROW|PARAFFIN-EMBEDDED|U|MAMMOGRAPHY|FIBROTEST FORMULA||N|U|Y|U|||N|3||39||INDUCTION TREATMENT|1969-09-11|1962-01-13|||||1965-10-10||1969-06-14|N|1971-02-21
TRIAL STUDY 134XCP|LB|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|1||||SALCYLT|SALICYLATES|||||||DMOL|||||||INDETERMINATE||L/L||||LOW|NOT DONE||||PROSTATIC FLUID|CLOTTED|Y|MRI WITHOUT CONTRAST|GMI % FORMULA||U|Y|U|Y|||NA|4||88||OPEN LABEL TREATMENT|1964-03-24|1969-12-12|||||1972-09-24||1973-07-10|U|1964-12-13
TRIAL STUDY 134XCP|LB|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|2||||C165882|WHITE ELM POLLEN IGE AB RAST SCORE|||||||PT_BR|||||||BORDERLINE||UU/DL||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|AGGLUTINATED|NA|PLAQUE REDUCTION NEUTRALIZATION ASSAY|CKD-EPI FORMULA||U|NA|U|N|||Y|4||88||OPEN LABEL TREATMENT|1973-07-23|1965-07-05|||||1965-11-10||1971-11-12|Y|1962-06-03
TRIAL STUDY 134XCP|LB|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|1||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||10^6 DNA COPIES/ML|||||||TRACE||SBE/ML||||NORMAL|NOT DONE||||CORD SERUM|ICTERIC|U|PHOROPTER|COCKCROFT-GAULT FORMULA||N|U|Y|Y|||Y|5||7||LONG-TERM FOLLOW-UP|1960-12-31|1971-04-04|||||1972-06-17||1973-08-04|U|1963-10-10
TRIAL STUDY 134XCP|LB|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|2||||GLOBB1BP|BETA-1 GLOBULIN/BETA PROTEIN|||||||/MM|||||||NEGATIVE||MS/MMHG||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|ICTERIC|NA|KNEMOMETRY|NASH FIBROSURE FORMULA||NA|Y|Y|NA|||N|5||7||SCREENING|1966-03-10|1966-09-25|||||1964-02-24||1970-04-16|U|1971-08-24
TRIAL STUDY 134XCP|LB|21934F6E-8333-413B-931C-DF115519F394|1||||TCDCA|TAUROCHENODEOXYCHOLATE|||||||10^4/HPF|||||||INDETERMINATE||UCI/L||||HIGH|NOT DONE||||KERATINOCYTE|AGGLUTINATED|U|CELLULAR PROLIFERATION ASSAY|CKD-EPI FORMULA||N|U|N|N|||U|1||38||LONG-TERM FOLLOW-UP|1964-10-17|1962-07-17|||||1971-11-22||1969-06-23|N|1962-12-10
TRIAL STUDY 134XCP|LB|21934F6E-8333-413B-931C-DF115519F394|2||||TK1|THYMIDINE KINASE 1|||||||IU/L|||||||BORDERLINE||MG/DOSE||||HIGH|NOT DONE||||VITREOUS HUMOR|UNEXPECTED ODOR|NA|TEMPLATE INCISION METHOD|FIBROTEST FORMULA||U|NA|NA|N|||N|1||38||TREATMENT|1973-03-06|1969-05-27|||||1961-02-21||1967-12-28|U|1962-01-21
TRIAL STUDY 134XCP|LB|21934F6E-8333-413B-931C-DF115519F394|1||||LDH3|LDH ISOENZYME 3|||||||BQ|||||||BORDERLINE||10^6 IU/ML||||LOW|NOT DONE||||ARTERIAL BLOOD|ICTERIC|N|CENTRIFUGATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|Y|NA|||Y|2||58||FOLLOW-UP|1961-12-22|1961-09-05|||||1968-06-19||1972-11-04|N|1966-04-01
TRIAL STUDY 134XCP|LB|21934F6E-8333-413B-931C-DF115519F394|2||||BLASTRUB|RUBRIBLAST|||||||NKAT/G HB|||||||INDETERMINATE||10^7/L||||NORMAL|NOT DONE||||DISCHARGE|CALCIFIED|Y|COMPUTERIZED CORNEAL TOPOGRAPHY|FIBROSIS 4 FORMULA||U|N|Y|Y|||NA|2||58||BLINDED TREATMENT|1973-06-18|1963-08-04|||||1960-09-03||1965-03-30|Y|1960-03-25
TRIAL STUDY 134XCP|LB|21934F6E-8333-413B-931C-DF115519F394|1||||PLATSAT|PLATELET SATELLITISM|||||||CMH2O/ML|||||||INDETERMINATE||BOTTLE||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|GELLED|NA|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI FORMULA||Y|U|Y|Y|||NA|3||39||SCREENING|1973-04-17|1960-09-07|||||1964-09-24||1965-04-20|Y|1972-09-21
TRIAL STUDY 134XCP|LB|21934F6E-8333-413B-931C-DF115519F394|2||||POLYERY|POLYCHROMATOPHILIC ERYTHROBLAST|||||||10^9 ORGANISMS/ML|||||||POSITIVE||MMOL/G||||HIGH|NOT DONE||||ARTERIAL BLOOD|FROZEN|N|DOUBLE IMMUNODIFFUSION|CKD-EPI CREATININE FORMULA||N|N|N|NA|||NA|3||39||OPEN LABEL TREATMENT|1967-06-15|1965-10-04|||||1970-08-18||1960-03-24|N|1963-03-29
TRIAL STUDY 134XCP|LB|21934F6E-8333-413B-931C-DF115519F394|1||||TNFR5S|SOLUBLE TNF RECEPTOR SUPERFAMILY MEM 5|||||||EQ|||||||TRACE||UG/MOL||||HIGH|NOT DONE||||STOOL|PARAFFIN-EMBEDDED|U|MICROARRAY|MDRD 6 VARIABLE FORMULA||U|NA|U|U|||NA|4||88||RUN-IN|1973-04-10|1966-06-20|||||1968-05-15||1973-05-18|NA|1961-08-25
TRIAL STUDY 134XCP|LB|21934F6E-8333-413B-931C-DF115519F394|2||||T4FRIND|THYROXINE, FREE, INDIRECT|||||||MG/KG/WEEK|||||||BORDERLINE||MHZ||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|NA|HANSEL STAIN|CKD-EPI CREATININE FORMULA||NA|U|NA|N|||U|4||88||FOLLOW-UP|1968-09-16|1962-09-08|||||1967-07-27||1965-10-19|U|1962-11-04
TRIAL STUDY 134XCP|LB|21934F6E-8333-413B-931C-DF115519F394|1||||MORPHINE|MORPHINE|||||||P|||||||POSITIVE||ML/MMHG/MIN/L||||ABNORMAL|NOT DONE||||COLOSTRUM|AUTOLYZED|U|TURBIDIMETRY|MDRD ENZYMATIC FORMULA||Y|N|N|Y|||U|5||7||TREATMENT|1963-03-03|1960-02-14|||||1965-08-06||1971-11-15|N|1964-11-22
TRIAL STUDY 134XCP|LB|21934F6E-8333-413B-931C-DF115519F394|2||||ESELS|SOLUBLE E-SELECTIN|||||||MEQ/ML|||||||NEGATIVE||IU/DL||||HIGH|NOT DONE||||BLOOD|ICTERIC|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|FIBROTEST FORMULA||N|N|NA|U|||N|5||7||OPEN LABEL TREATMENT|1967-09-26|1964-01-01|||||1960-07-16||1965-12-25|Y|1961-07-20
TRIAL STUDY 134XCP|LB|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|1||||ALP|ALKALINE PHOSPHATASE|||||||HPA|||||||NEGATIVE||G/G||||HIGH|NOT DONE||||EXUDATE|REFRIGERATED|N|CONTRAST ENHANCED PET/CT SCAN|FIBROSIS 4 FORMULA||NA|NA|N|Y|||Y|1||38||FOLLOW-UP|1972-02-07|1966-11-10|||||1965-11-06||1963-04-14|U|1960-02-07
TRIAL STUDY 134XCP|LB|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|2||||APROTCRS|ACTIVATED PROTEIN C RESISTANCE|||||||H/WK|||||||INVALID||/VF||||HIGH|NOT DONE||||BILE|SOLIDIFIED|NA|MICROSCOPY|FIBROSIS 4 FORMULA||Y|N|N|NA|||NA|1||38||BLINDED TREATMENT|1967-06-19|1960-06-04|||||1963-03-20||1973-01-10|Y|1970-08-12
TRIAL STUDY 134XCP|LB|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|1||||ECCENTCY|ECCENTROCYTES|||||||DPM|||||||NEGATIVE||10^9/L||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|AGGLUTINATED|NA|NUCLEIC ACID SEQUENCING|MDRD FORMULA||NA|N|Y|NA|||N|2||58||WASHOUT|1965-06-02|1967-09-22|||||1971-10-02||1960-05-13|NA|1970-03-03
TRIAL STUDY 134XCP|LB|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|2||||C165915|DOG DANDER IGG AB RAST SCORE|||||||BAU/ML|||||||TRACE||GBQ/UG||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|NON-HEMOLYZED|U|TURBIDIMETRY|COCKCROFT-GAULT FORMULA||NA|N|U|U|||N|2||58||FOLLOW-UP|1965-07-14|1970-06-09|||||1972-12-16||1970-07-07|U|1963-04-14
TRIAL STUDY 134XCP|LB|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|1||||VITD|VITAMIN D|||||||10^10/L|||||||INVALID||CPM||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|LIPEMIC|NA|RADIOGRAPHY|CKD-EPI FORMULA||NA|N|Y|Y|||NA|3||39||BASELINE|1967-11-08|1960-09-19|||||1968-02-13||1970-03-21|Y|1973-03-13
TRIAL STUDY 134XCP|LB|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|2||||TFERRIN|TRANSFERRIN|||||||LOG10 TCID 50/ML|||||||POSITIVE||/40 HPFS||||LOW|NOT DONE||||CERUMEN|UNEXPECTED ODOR|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD 6 VARIABLE FORMULA||Y|NA|N|Y|||NA|3||39||CONTINUATION TREATMENT|1970-06-11|1969-06-28|||||1969-08-03||1973-08-19|Y|1970-07-26
TRIAL STUDY 134XCP|LB|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|1||||HEPCIDIN|HEPCIDIN|||||||EIA UNIT|||||||BORDERLINE||UCI/KG||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|DRIED|Y|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|COCKCROFT-GAULT FORMULA||N|NA|NA|U|||Y|4||88||SCREENING|1960-04-10|1962-01-14|||||1970-02-13||1972-06-15|NA|1966-10-26
TRIAL STUDY 134XCP|LB|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|2||||C165912|SHELLFISH MIX IGG AB RAST SCORE|||||||NMOL/L/MIN|||||||INVALID||ABSORBANCE U||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|LIPEMIC|N|REFRACTOMETRY|GMI % FORMULA||N|N|N|N|||N|4||88||LONG-TERM FOLLOW-UP|1963-09-06|1967-12-20|||||1973-08-08||1966-09-27|U|1966-05-27
TRIAL STUDY 134XCP|LB|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|1||||THBD|THROMBOMODULIN|||||||UM2|||||||POSITIVE||NG/DAY||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|THAWED|N|INDIRECT IMMUNOFLUORESCENCE|ASH FIBROSURE FORMULA||NA|N|Y|U|||U|5||7||INDUCTION TREATMENT|1970-09-17|1968-06-12|||||1970-07-19||1968-04-25|NA|1969-06-21
TRIAL STUDY 134XCP|LB|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|2||||BASOIM|IMMATURE BASOPHILS|||||||L/KG|||||||INDETERMINATE||UG/ANIMAL||||LOW|NOT DONE||||PLEURAL TISSUE|LACTESCENT|N|MULTIPLE BREATH WASHOUT|CKD-EPI CYSTATIN C FORMULA||NA|U|N|N|||N|5||7||WASHOUT|1969-09-10|1968-06-22|||||1972-10-31||1971-02-24|N|1964-02-29
TRIAL STUDY 134XCP|LB|E31F3DEB-BCA2-4660-935D-BAEBC4238866|1||||GSTALCRT|GLUTATHIONE S-TRANSFERASE, ALPHA/CREAT|||||||10^6 IU|||||||INDETERMINATE||UG/DL||||ABNORMAL|NOT DONE||||BONE|ROOM TEMPERATURE|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD FORMULA||Y|U|NA|U|||N|1||38||OPEN LABEL TREATMENT|1972-06-27|1970-04-07|||||1966-03-18||1962-02-08|NA|1966-01-15
TRIAL STUDY 134XCP|LB|E31F3DEB-BCA2-4660-935D-BAEBC4238866|2||||NORMEEXR|NORMETANEPHRINE EXCRETION RATE|||||||L/MIN|||||||TRACE||IU/G HB||||LOW|NOT DONE||||PLATELET|CALCIFIED|N|INFRARED SPECTROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|NA|N|||NA|1||38||CONTINUATION TREATMENT|1969-07-06|1967-04-05|||||1969-07-22||1963-10-29|NA|1971-08-24
TRIAL STUDY 134XCP|LB|E31F3DEB-BCA2-4660-935D-BAEBC4238866|1||||APRI|AST TO PLATELET RATIO INDEX|||||||UU/DL|||||||TRACE||MG/ML/DAY||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CLOTTED|U|INDIA INK STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|U|||NA|2||58||SCREENING|1968-04-14|1963-12-28|||||1973-01-11||1963-05-23|U|1971-10-12
TRIAL STUDY 134XCP|LB|E31F3DEB-BCA2-4660-935D-BAEBC4238866|2||||SPERMP|SPERMATOZOA, PROGRESSIVE|||||||UG/ML/H|||||||NEGATIVE||/2500 WBC||||HIGH|NOT DONE||||FLUID|THAWED|NA|SECONDARY ION MASS SPECTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|N|NA|U|||U|2||58||LONG-TERM FOLLOW-UP|1970-05-17|1970-01-09|||||1970-06-05||1963-01-17|U|1962-02-27
TRIAL STUDY 134XCP|LB|E31F3DEB-BCA2-4660-935D-BAEBC4238866|1||||HBOXHGB|OXYHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||UG/ANIMAL|||||||NEGATIVE||DEG||||LOW|NOT DONE||||COLOSTRUM|PARAFFIN-EMBEDDED|U|POPULATION SEQUENCING|MDRD 6 VARIABLE FORMULA||NA|U|Y|U|||Y|3||39||INDUCTION TREATMENT|1964-04-04|1967-01-26|||||1966-07-26||1964-11-18|N|1972-03-01
TRIAL STUDY 134XCP|LB|E31F3DEB-BCA2-4660-935D-BAEBC4238866|2||||LEUKASE|LEUKOCYTE ESTERASE|||||||PMOL/10^10 CELLS|||||||POSITIVE||CUP||||LOW|NOT DONE||||SERUM OR PLASMA|NON-HEMOLYZED|U|PET/MRI SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|Y|U|||NA|3||39||RUN-IN|1969-10-21|1960-01-08|||||1961-03-27||1963-10-29|U|1961-08-06
TRIAL STUDY 134XCP|LB|E31F3DEB-BCA2-4660-935D-BAEBC4238866|1||||UREA|UREA|||||||MEQ|||||||BORDERLINE||ML/S||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|LIPEMIC|NA|SPECT SCAN|MDRD 4 VARIABLE FORMULA||U|NA|NA|N|||N|4||88||BASELINE|1972-03-17|1963-03-15|||||1967-03-04||1966-04-22|U|1960-05-22
TRIAL STUDY 134XCP|LB|E31F3DEB-BCA2-4660-935D-BAEBC4238866|2||||FGF23|FIBROBLAST GROWTH FACTOR 23|||||||KN/CM2|||||||POSITIVE||/100 HPFS||||HIGH|NOT DONE||||CAPILLARY BLOOD|DRIED|NA|MAGNETIC RESONANCE ELASTOGRAPHY|FIBROSIS 4 FORMULA||NA|U|U|N|||NA|4||88||RUN-IN|1967-04-20|1968-08-07|||||1965-09-07||1965-09-25|Y|1972-02-20
TRIAL STUDY 134XCP|LB|E31F3DEB-BCA2-4660-935D-BAEBC4238866|1||||CPEPCRT|C-PEPTIDE/CREATININE|||||||G/ANIMAL|||||||TRACE||SEC||||ABNORMAL|NOT DONE||||EXPIRED AIR|PARAFFIN-EMBEDDED|U|ULTRASOUND|FIBROTEST FORMULA||N|U|NA|N|||N|5||7||CONTINUATION TREATMENT|1965-08-11|1967-04-01|||||1970-04-04||1971-08-25|U|1961-12-07
TRIAL STUDY 134XCP|LB|E31F3DEB-BCA2-4660-935D-BAEBC4238866|2||||GRANIMLE|IMMATURE GRANULOCYTES/LEUKOCYTES|||||||U/MG|||||||INVALID||ML/M2/H||||ABNORMAL|NOT DONE||||CELL PELLET|AUTOLYZED|N|REFLECTANCE SPECTROSCOPY|ASH FIBROSURE FORMULA||U|N|U|Y|||N|5||7||FOLLOW-UP|1964-05-23|1968-12-30|||||1966-04-22||1965-09-05|U|1967-11-03
TRIAL STUDY 134XCP|LB|8310989D-82CC-456C-965A-E38AC9EA073F|1||||ANIONG4|ANION GAP 4|||||||UMOL/MOL|||||||INVALID||PPM||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|DRIED|U|ICP-MS|CKD-EPI FORMULA||Y|U|NA|N|||NA|1||38||FOLLOW-UP|1973-07-16|1966-11-02|||||1969-11-03||1965-12-31|U|1972-03-10
TRIAL STUDY 134XCP|LB|8310989D-82CC-456C-965A-E38AC9EA073F|2||||BASOMYL|BASOPHILIC MYELOCYTES|||||||ROENTGEN|||||||NEGATIVE||MG/DL||||LOW|NOT DONE||||SPUTUM|REFRIGERATED|NA|REBOUND TONOMETRY|ASH FIBROSURE FORMULA||U|N|NA|Y|||NA|1||38||RUN-IN|1967-01-07|1966-04-23|||||1969-08-04||1960-12-28|U|1963-04-06
TRIAL STUDY 134XCP|LB|8310989D-82CC-456C-965A-E38AC9EA073F|1||||TNFSR1|SOLUBLE TNF RECEPTOR TYPE I|||||||TRANSDUCING UNIT/ML|||||||INDETERMINATE||HR/DAY||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|N|PANENDOSCOPY|FIBROSIS 4 FORMULA||NA|U|NA|NA|||N|2||58||TREATMENT|1962-09-12|1965-02-14|||||1966-04-23||1967-08-21|Y|1965-08-29
TRIAL STUDY 134XCP|LB|8310989D-82CC-456C-965A-E38AC9EA073F|2||||MYBLA|MYELOBLASTS|||||||APPLICATION|||||||INVALID||KUSP||||HIGH|NOT DONE||||AQUEOUS HUMOR|AUTOLYZED|U|DNA MICROARRAY|CKD-EPI CREATININE FORMULA||U|NA|NA|NA|||U|2||58||TREATMENT|1971-09-27|1960-03-24|||||1968-04-21||1971-04-12|Y|1967-09-23
TRIAL STUDY 134XCP|LB|8310989D-82CC-456C-965A-E38AC9EA073F|1||||NEUTTOXC|NEUTROPHILIC TOXIC CHANGE|||||||DRAM|||||||POSITIVE||UG/KG/DAY||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|FRESH|U|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|NA|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1966-02-02|1969-08-05|||||1971-10-01||1973-09-05|NA|1973-06-06
TRIAL STUDY 134XCP|LB|8310989D-82CC-456C-965A-E38AC9EA073F|2||||HGBAHGB|HEMOGLOBIN A/TOTAL HEMOGLOBIN|||||||MONTHS|||||||INVALID||PRESSOR UNITS||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|UNEXPECTED ODOR|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI FORMULA||Y|Y|NA|N|||N|3||39||BASELINE|1969-10-13|1970-09-07|||||1970-09-19||1962-08-17|N|1969-10-20
TRIAL STUDY 134XCP|LB|8310989D-82CC-456C-965A-E38AC9EA073F|1||||THC|TETRAHYDROCANNABINOL|||||||FIU|||||||POSITIVE||/LPF||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|CONCENTRATED|N|AUSCULTATION|FIBROMETER FORMULA||Y|NA|Y|N|||N|4||88||LONG-TERM FOLLOW-UP|1972-12-25|1961-07-05|||||1972-11-11||1962-12-19|NA|1965-08-24
TRIAL STUDY 134XCP|LB|8310989D-82CC-456C-965A-E38AC9EA073F|2||||TXB2_D11|11-DEHYDRO-THROMBOXANE B2|||||||USEC|||||||POSITIVE||NGEQ/L||||LOW|NOT DONE||||BASAL TEAR|UNEXPECTED ODOR|Y|PALM METHOD|FIBROSIS 4 FORMULA||N|N|U|N|||U|4||88||INDUCTION TREATMENT|1973-05-11|1970-01-25|||||1967-04-05||1963-10-26|N|1962-01-15
TRIAL STUDY 134XCP|LB|8310989D-82CC-456C-965A-E38AC9EA073F|1||||CHOLINES|CHOLINESTERASE|||||||MEQ/UL|||||||INVALID||DRAM||||LOW|NOT DONE||||SPERMATOZOON|LIPEMIC|U|HPLC-FL|MDRD 4 VARIABLE FORMULA||N|N|U|Y|||Y|5||7||OPEN LABEL TREATMENT|1964-05-03|1967-08-01|||||1962-02-19||1962-12-13|Y|1963-08-14
TRIAL STUDY 134XCP|LB|8310989D-82CC-456C-965A-E38AC9EA073F|2||||CKMB|CREATINE KINASE MB|||||||GY/H|||||||NEGATIVE||ROENTGEN||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|SOLIDIFIED|NA|FISH|FIBROTEST FORMULA||Y|U|NA|N|||Y|5||7||TREATMENT|1971-04-19|1971-11-14|||||1972-11-07||1968-08-11|NA|1967-07-15
TRIAL STUDY 134XCP|LB|826D8DC2-E407-481C-93D8-5169DBDF99C4|1||||PLSIMCCE|IMMATURE PLASMA CELLS/TOTAL CELLS|||||||ELISA UNIT/ML|||||||POSITIVE||NMOL/MOL||||NORMAL|NOT DONE||||SMEGMA|DRIED|U|KNEMOMETRY|NASH FIBROSURE FORMULA||U|Y|Y|NA|||Y|1||38||TREATMENT|1962-07-11|1966-09-18|||||1960-05-09||1961-08-27|U|1969-05-21
TRIAL STUDY 134XCP|LB|826D8DC2-E407-481C-93D8-5169DBDF99C4|2||||VWFAAC|VON WILL FACTOR ACT ACTUAL/CONTROL|||||||KALLIKREIN INHIBITOR UNIT|||||||NEGATIVE||S/H||||HIGH|NOT DONE||||LUNG SURFACTANT|FROZEN|NA|TEMPLATE INCISION METHOD|CKD-EPI FORMULA||U|Y|NA|U|||Y|1||38||CONTINUATION TREATMENT|1970-03-26|1966-03-02|||||1970-09-30||1965-02-26|NA|1961-10-23
TRIAL STUDY 134XCP|LB|826D8DC2-E407-481C-93D8-5169DBDF99C4|1||||PRCTC|PROSTATE CIRCULATING TUMOR CELLS|||||||EIA UNIT|||||||TRACE||CMH2O*S2/ML||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|SOLIDIFIED|NA|CYSTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|Y|NA|||NA|2||58||TREATMENT|1964-11-22|1961-03-20|||||1966-12-24||1968-06-01|N|1967-05-15
TRIAL STUDY 134XCP|LB|826D8DC2-E407-481C-93D8-5169DBDF99C4|2||||ABNCELE|ABNORMAL CELLS/LEUKOCYTES|||||||CM|||||||INVALID||KM/H||||HIGH|NOT DONE||||CALCULUS|CALCIFIED|Y|KNEMOMETRY|MDRD 6 VARIABLE FORMULA||N|Y|N|NA|||U|2||58||OPEN LABEL TREATMENT|1969-12-15|1962-04-11|||||1971-07-26||1966-03-01|U|1969-03-06
TRIAL STUDY 134XCP|LB|826D8DC2-E407-481C-93D8-5169DBDF99C4|1||||CBB|COMPLEMENT BB|||||||BAG|||||||BORDERLINE||MESF||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|THAWED|N|CONTRAST ENHANCED SPIRAL CT SCAN|GMI MMOL/MOL FORMULA||N|NA|N|N|||NA|3||39||CONTINUATION TREATMENT|1973-03-29|1967-12-07|||||1965-05-31||1971-11-27|N|1965-08-01
TRIAL STUDY 134XCP|LB|826D8DC2-E407-481C-93D8-5169DBDF99C4|2||||INTLK14|INTERLEUKIN 14|||||||CMH2O/ML|||||||POSITIVE||PACKET||||NORMAL|NOT DONE||||BUFFY COAT|LIPEMIC|N|LC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|Y|Y|||U|3||39||INDUCTION TREATMENT|1971-04-26|1973-07-18|||||1963-11-11||1963-10-21|Y|1963-06-21
TRIAL STUDY 134XCP|LB|826D8DC2-E407-481C-93D8-5169DBDF99C4|1||||HGBA2|HEMOGLOBIN A2|||||||MEQ/KG|||||||TRACE||PSEC||||ABNORMAL|NOT DONE||||TRANSUDATE|HEMOLYZED|NA|AUTOREFRACTION|CKD-EPI CYSTATIN C FORMULA||N|U|Y|N|||NA|4||88||OBSERVATION|1971-05-26|1965-07-12|||||1972-07-07||1967-12-06|U|1972-02-20
TRIAL STUDY 134XCP|LB|826D8DC2-E407-481C-93D8-5169DBDF99C4|2||||ESELS|SOLUBLE E-SELECTIN|||||||UG/G/DAY|||||||TRACE||UM||||NORMAL|NOT DONE||||AQUEOUS HUMOR|REFRIGERATED|U|COLORIMETRY|MDRD ENZYMATIC FORMULA||NA|Y|NA|N|||NA|4||88||OBSERVATION|1964-01-25|1963-08-31|||||1969-05-03||1970-11-30|NA|1961-09-03
TRIAL STUDY 134XCP|LB|826D8DC2-E407-481C-93D8-5169DBDF99C4|1||||NEUTCYBS|CYTOPLASMIC BASOPHILIA NEUTROPHIL|||||||G/G/DAY|||||||INDETERMINATE||MIN||||ABNORMAL|NOT DONE||||CORD SERUM|REFRIGERATED|Y|NUCLEIC ACID BASED METHOD|MDRD FORMULA||N|U|Y|N|||Y|5||7||LONG-TERM FOLLOW-UP|1964-01-14|1973-08-29|||||1965-05-14||1961-09-10|N|1973-09-07
TRIAL STUDY 134XCP|LB|826D8DC2-E407-481C-93D8-5169DBDF99C4|2||||C165882|WHITE ELM POLLEN IGE AB RAST SCORE|||||||ABSORBANCE U/MIN|||||||NEGATIVE||KPA||||LOW|NOT DONE||||EXPIRED AIR|NON-HEMOLYZED|N|CELLULOSE TAPE|CKD-EPI CYSTATIN C FORMULA||U|N|NA|U|||U|5||7||TREATMENT|1962-05-19|1972-10-02|||||1970-02-09||1967-04-28|N|1962-12-01
TRIAL STUDY 134XCP|LB|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|1||||LDLPSZ|LDL PARTICLE SIZE|||||||JDF UNIT|||||||BORDERLINE||GMFI||||HIGH|NOT DONE||||DISCHARGE|ROOM TEMPERATURE|Y|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD ENZYMATIC FORMULA||U|N|N|Y|||NA|1||38||BLINDED TREATMENT|1969-01-03|1964-05-25|||||1969-11-11||1969-01-30|U|1961-08-29
TRIAL STUDY 134XCP|LB|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|2||||TOXVAC|TOXIC VACUOLATION|||||||FMOL|||||||NEGATIVE||DRAM||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|ICTERIC|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|COCKCROFT-GAULT FORMULA||N|NA|NA|N|||Y|1||38||INDUCTION TREATMENT|1971-11-18|1966-10-17|||||1970-02-08||1963-08-16|N|1973-03-08
TRIAL STUDY 134XCP|LB|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|1||||BLYCECE|B-LYMPHOCYTES/TOTAL CELLS|||||||U/M2/H|||||||INDETERMINATE||MMOL/MIN/KPA/L||||LOW|NOT DONE||||DISCHARGE|CLOTTED|U|ELISPOT|CKD-EPI FORMULA||N|U|Y|U|||N|2||58||RUN-IN|1972-03-24|1971-05-13|||||1966-02-01||1966-04-20|N|1965-08-18
TRIAL STUDY 134XCP|LB|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|2||||NSE|NEURON SPECIFIC ENOLASE|||||||MG/KG/MIN|||||||BORDERLINE||/MBP||||NORMAL|NOT DONE||||PUS|CALCIFIED|NA|ERGOSPIROMETRY|FIBROMETER FORMULA||Y|NA|U|N|||U|2||58||CONTINUATION TREATMENT|1961-02-07|1960-04-24|||||1966-01-19||1971-08-05|N|1965-08-12
TRIAL STUDY 134XCP|LB|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|1||||BLSTRBCE|RUBRIBLAST/TOTAL CELLS|||||||TROCHE|||||||BORDERLINE||UCI||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CONCENTRATED|U|RADIOIMMUNOPRECIPITATION ASSAY|GMI % FORMULA||NA|Y|U|N|||NA|3||39||FOLLOW-UP|1960-09-15|1970-02-06|||||1971-09-29||1961-06-03|Y|1963-06-11
TRIAL STUDY 134XCP|LB|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|2||||CBS|CYSTATHIONINE BETA-SYNTHASE|||||||CI/UG|||||||INVALID||10^7 CFU||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|NA|GC/MS/MS|CKD-EPI CREATININE FORMULA||N|Y|Y|NA|||NA|3||39||OBSERVATION|1964-06-17|1972-03-19|||||1972-11-17||1963-07-30|N|1971-10-16
TRIAL STUDY 134XCP|LB|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|1||||C165933|AMERICAN COCKROACH IGE AB RAST SCORE|||||||FMOL/G|||||||INVALID||PACK||||HIGH|NOT DONE||||URINE SEDIMENT|AUTOLYZED|NA|STATIC PERIMETRY|COCKCROFT-GAULT FORMULA||Y|U|NA|NA|||U|4||88||LONG-TERM FOLLOW-UP|1968-06-30|1963-12-07|||||1964-09-08||1968-08-02|NA|1970-05-16
TRIAL STUDY 134XCP|LB|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|2||||ACRNCRNF|ACYLCARNITINE/CARNITINE, FREE|||||||FT3|||||||INVALID||APPLICATION||||LOW|NOT DONE||||KERATINOCYTE|CONTAMINATED|N|ROMANOWSKY STAIN|ASH FIBROSURE FORMULA||Y|NA|Y|N|||N|4||88||CONTINUATION TREATMENT|1964-11-24|1960-05-12|||||1971-06-21||1967-08-07|NA|1971-03-19
TRIAL STUDY 134XCP|LB|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|1||||PROT|PROTEIN|||||||PMOL/10^9 CELLS|||||||INDETERMINATE||TROCHE||||NORMAL|NOT DONE||||DIALYSIS FLUID|CLOTTED|N|WESTERGREN|NASH FIBROSURE FORMULA||NA|Y|Y|U|||NA|5||7||WASHOUT|1968-01-27|1964-03-28|||||1963-06-29||1961-11-24|U|1969-04-01
TRIAL STUDY 134XCP|LB|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|2||||LYMA|LYMPHOCYTES ACTIVATED|||||||MV*MIN|||||||NEGATIVE||ML/MIN/1.73M2||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|CALCIFIED|Y|PERFUSION MRI|GMI MMOL/MOL FORMULA||NA|N|U|NA|||U|5||7||WASHOUT|1967-08-31|1967-11-16|||||1968-06-01||1966-10-20|Y|1967-03-17
TRIAL STUDY 134XCP|LB|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|1||||C165902|TIMOTHY GRASS POLLEN IGG AB RAST SCORE|||||||10^3 RNA COPIES/ML|||||||BORDERLINE||CAPFUL||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|ROOM TEMPERATURE|U|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC FORMULA||N|Y|N|N|||N|1||38||CONTINUATION TREATMENT|1961-12-12|1962-04-06|||||1963-09-10||1964-12-13|N|1970-01-01
TRIAL STUDY 134XCP|LB|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|2||||VEGFD|VASCULAR ENDOTHELIAL GROWTH FACTOR D|||||||PG|||||||POSITIVE||ML/KG/H||||HIGH|NOT DONE||||LYMPH|CONCENTRATED|N|JAEGER EYE CHART|COCKCROFT-GAULT FORMULA||Y|U|N|NA|||U|1||38||CONTINUATION TREATMENT|1962-01-29|1963-12-09|||||1970-07-06||1962-11-26|Y|1966-07-22
TRIAL STUDY 134XCP|LB|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|1||||PSP100AB|P100 POLYMYOSITIS-SCLERODERMA AUTOAG AB|||||||V|||||||TRACE||10^3 DNA COPIES/ML||||LOW|NOT DONE||||HAIR FOLLICLE|ROOM TEMPERATURE|N|IMMUNORADIOMETRIC ASSAY|CKD-EPI FORMULA||U|N|U|Y|||NA|2||58||INDUCTION TREATMENT|1970-04-02|1960-07-31|||||1969-10-03||1963-06-20|Y|1966-11-27
TRIAL STUDY 134XCP|LB|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|2||||METHANOL|METHANOL|||||||CYCLE/MIN|||||||NEGATIVE||CD*S/M2||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|PARAFFIN-EMBEDDED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|COCKCROFT-GAULT FORMULA||Y|Y|U|N|||Y|2||58||FOLLOW-UP|1971-08-07|1963-09-24|||||1972-08-17||1964-05-06|N|1961-12-27
TRIAL STUDY 134XCP|LB|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|1||||DHPG|3,4-DIHYDROXYPHENYLGLYCOL|||||||FMOL/L/SEC|||||||BORDERLINE||DRAM||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|SOLIDIFIED|U|LIGHT SCATTERING SPECTROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|U|U|||Y|3||39||CONTINUATION TREATMENT|1966-03-17|1960-08-05|||||1965-11-25||1969-06-08|N|1965-09-17
TRIAL STUDY 134XCP|LB|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|2||||BJPROT|BENCE-JONES PROTEIN|||||||MM2|||||||INVALID||S/H||||HIGH|NOT DONE||||AQUEOUS HUMOR|ICTERIC|U|IMMUNOFLUORESCENT STAIN|NASH FIBROSURE FORMULA||Y|NA|N|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1973-05-24|1968-05-17|||||1970-12-17||1970-10-02|NA|1972-08-16
TRIAL STUDY 134XCP|LB|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|1||||APOA4|APOLIPOPROTEIN A4|||||||PG/DL|||||||TRACE||DEG/S||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|HEMOLYZED|NA|ACRIDINE ORANGE STAIN|MDRD ENZYMATIC FORMULA||NA|U|Y|NA|||NA|4||88||WASHOUT|1973-01-18|1962-04-26|||||1960-06-17||1973-03-12|U|1972-12-31
TRIAL STUDY 134XCP|LB|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|2||||TFRRNSAT|TRANSFERRIN SATURATION|||||||/VF|||||||POSITIVE||BQ/G||||LOW|NOT DONE||||EPIDERMAL TISSUE|ROOM TEMPERATURE|NA|KNEMOMETRY|FIBROTEST FORMULA||N|N|U|Y|||U|4||88||LONG-TERM FOLLOW-UP|1960-01-20|1960-11-28|||||1971-11-20||1971-07-15|Y|1961-12-18
TRIAL STUDY 134XCP|LB|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|1||||IRON|IRON|||||||PMOL|||||||BORDERLINE||IU/KG/H||||NORMAL|NOT DONE||||VENOUS BLOOD|REFRIGERATED|U|X-RAY|MDRD 5 VARIABLE FORMULA||U|N|N|U|||U|5||7||RUN-IN|1965-08-20|1966-10-14|||||1972-06-08||1960-01-05|NA|1966-06-12
TRIAL STUDY 134XCP|LB|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|2||||C130104|GRASS MIX POLLEN ANTIGEN IGG ANTIBODY|||||||C|||||||INVALID||AMPULE||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|REFRIGERATED|U|MALDI-TOF|CKD-EPI CYSTATIN C FORMULA||U|Y|Y|U|||N|5||7||CONTINUATION TREATMENT|1970-07-20|1964-08-18|||||1968-10-20||1970-11-02|U|1960-11-24
TRIAL STUDY 134XCP|LB|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|1||||INULIN|INULIN|||||||UMOL/L/H|||||||INDETERMINATE||UEQ||||LOW|NOT DONE||||AQUEOUS HUMOR|HEMOLYZED|U|GIEMSA STAIN|MDRD ENZYMATIC FORMULA||Y|NA|Y|NA|||U|1||38||TREATMENT|1962-09-02|1968-10-08|||||1972-08-04||1960-07-01|Y|1970-05-03
TRIAL STUDY 134XCP|LB|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|2||||CACLR|CALCIUM CLEARANCE|||||||IU/L|||||||POSITIVE||MPA||||NORMAL|NOT DONE||||PERITONEAL FLUID|ROOM TEMPERATURE|N|PH METER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA||Y|N|Y|NA|||U|1||38||RUN-IN|1969-04-14|1962-01-19|||||1971-09-07||1969-01-30|U|1960-10-26
TRIAL STUDY 134XCP|LB|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|1||||COPPER|COPPER|||||||ML/MIN/MMHG|||||||INDETERMINATE||AMP||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|NA|DIRECT SEQUENCING|CKD-EPI FORMULA||NA|U|N|NA|||NA|2||58||INDUCTION TREATMENT|1969-06-17|1972-02-06|||||1964-12-30||1960-03-05|NA|1964-05-05
TRIAL STUDY 134XCP|LB|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|2||||PRAB|PANEL REACTIVE ANTIBODY|||||||GENEQ|||||||BORDERLINE||PFU/DOSE||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|HEMOLYZED|NA|NUCLEAR RADIOLOGY|FIBROTEST FORMULA||U|N|Y|U|||N|2||58||BLINDED TREATMENT|1968-09-17|1970-04-12|||||1971-03-21||1971-09-14|N|1971-04-06
TRIAL STUDY 134XCP|LB|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|1||||TSTSFRPT|TESTOSTERONE, FREE/TOTAL PROTEIN|||||||10^3 ORGANISMS|||||||INVALID||V/V||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|CONCENTRATED|NA|MICRONEUTRALIZATION ASSAY|FIBROTEST FORMULA||U|U|Y|N|||U|3||39||RUN-IN|1964-02-02|1963-07-23|||||1966-05-18||1961-04-20|N|1967-07-22
TRIAL STUDY 134XCP|LB|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|2||||IFNB|INTERFERON BETA|||||||NEEDLE GAUGE|||||||INDETERMINATE||ML/SEC/1.73M2||||ABNORMAL|NOT DONE||||FLUID|THAWED|N|THIN SMEAR|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|NA|Y|||Y|3||39||WASHOUT|1973-04-28|1961-03-09|||||1972-02-05||1965-06-27|U|1972-11-07
TRIAL STUDY 134XCP|LB|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|1||||CBA|COMPLEMENT BA|||||||10^3 ORGANISMS|||||||BORDERLINE||10^6 ORGANISMS||||HIGH|NOT DONE||||EPIDERMAL TISSUE|THAWED|N|IN VITRO GENE EXPRESSION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|NA|N|||N|4||88||FOLLOW-UP|1965-07-14|1961-08-18|||||1972-05-24||1964-04-14|NA|1973-04-22
TRIAL STUDY 134XCP|LB|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|2||||HRYCELY|HAIRY CELLS/LYMPHOCYTES|||||||VIAL|||||||INVALID||10^8 PFU||||NORMAL|NOT DONE||||INFRANATANT, SERUM|AUTOLYZED|Y|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|NA|Y|||NA|4||88||RUN-IN|1960-10-06|1962-11-01|||||1968-05-28||1973-05-13|NA|1965-11-27
TRIAL STUDY 134XCP|LB|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|1||||RDW|ERYTHROCYTES DISTRIBUTION WIDTH|||||||MG/MIN|||||||TRACE||MMOL/MOL||||HIGH|NOT DONE||||SERUM OR PLASMA|FRESH|N|HPLC-FL|MDRD FORMULA||U|NA|N|Y|||N|5||7||SCREENING|1962-08-25|1973-05-24|||||1963-05-13||1961-12-14|U|1961-04-16
TRIAL STUDY 134XCP|LB|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|2||||CLCLR|CHLORIDE CLEARANCE|||||||L/S|||||||INVALID||U/ANIMAL||||HIGH|NOT DONE||||REFLEX TEAR|PARAFFIN-EMBEDDED|NA|LIGHT SCATTERING SPECTROSCOPY|CKD-EPI CREATININE FORMULA||N|NA|NA|U|||Y|5||7||LONG-TERM FOLLOW-UP|1962-10-17|1969-05-09|||||1970-04-07||1964-02-27|U|1972-09-22
TRIAL STUDY 134XCP|LB|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|1||||BNPPRONT|N-TERMINAL PROB-TYPE NATRIURETIC PEPTIDE|||||||UG/L|||||||NEGATIVE||PIXELS/CM||||LOW|NOT DONE||||SERUM OR PLASMA|REFRIGERATED|U|INCISION-INDUCED BLEEDING METHOD|MDRD 5 VARIABLE FORMULA||U|Y|U|U|||Y|1||38||CONTINUATION TREATMENT|1962-11-09|1970-03-17|||||1969-02-13||1960-09-25|Y|1960-10-22
TRIAL STUDY 134XCP|LB|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|2||||IL1R2|INTERLEUKIN 1 RECEPTOR TYPE 2|||||||ANTI-XA IU/ML|||||||POSITIVE||10^5/HPF||||NORMAL|NOT DONE||||SEBUM|ROOM TEMPERATURE|U|FLOW MICROSCOPY|ASH FIBROSURE FORMULA||NA|NA|NA|U|||N|1||38||RUN-IN|1967-06-18|1963-01-07|||||1973-07-06||1971-07-09|U|1962-01-27
TRIAL STUDY 134XCP|LB|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|1||||GLOBB1BP|BETA-1 GLOBULIN/BETA PROTEIN|||||||EQ|||||||INVALID||KG||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|SOLIDIFIED|N|PHOROPTER|MDRD FORMULA||U|N|Y|Y|||U|2||58||WASHOUT|1971-03-03|1970-03-10|||||1963-01-15||1970-03-19|N|1971-03-18
TRIAL STUDY 134XCP|LB|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|2||||INTLK18|INTERLEUKIN 18|||||||PMOL/10^9 CELLS|||||||INVALID||MPL U/ML||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|AGGLUTINATED|N|KNEMOMETRY|MDRD FORMULA||Y|NA|NA|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1961-04-17|1968-12-10|||||1968-09-26||1971-04-21|N|1970-12-18
TRIAL STUDY 134XCP|LB|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|1||||INSLNFR|INSULIN, FREE|||||||FRACTION OF 1|||||||POSITIVE||L/H/M2||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|LIPEMIC|Y|NO INFORMATION|GMI MMOL/MOL FORMULA||U|N|NA|N|||U|3||39||FOLLOW-UP|1972-03-11|1972-12-19|||||1971-06-29||1962-09-24|N|1971-08-13
TRIAL STUDY 134XCP|LB|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|2||||ABO|ABO BLOOD GROUP|||||||10^4 CFU|||||||INDETERMINATE||BREATHS/30S||||HIGH|NOT DONE||||CALCULUS|CLOTTED|NA|PEAK FLOWMETRY|MDRD 4 VARIABLE FORMULA||N|NA|Y|N|||Y|3||39||SCREENING|1962-05-04|1963-02-14|||||1960-11-18||1961-10-29|Y|1963-05-31
TRIAL STUDY 134XCP|LB|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|1||||PAF|PLATELET ACTIVATING FACTOR|||||||MMHG|||||||INVALID||DPM/0.5 ML||||LOW|NOT DONE||||FLUID|REFRIGERATED|Y|IMMUNORADIOMETRIC ASSAY|HEPASCORE FORMULA||Y|Y|NA|U|||N|4||88||BASELINE|1963-02-08|1972-08-25|||||1961-12-31||1972-08-14|U|1968-07-07
TRIAL STUDY 134XCP|LB|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|2||||TRH|THYROTROPIN RELEASING HORMONE|||||||/100 HPFS|||||||POSITIVE||FARAD||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CALCIFIED|U|IMMUNOTURBIDIMETRY|MDRD ENZYMATIC FORMULA||Y|NA|U|NA|||U|4||88||OBSERVATION|1971-10-11|1966-01-05|||||1965-09-03||1965-08-18|NA|1970-07-02
TRIAL STUDY 134XCP|LB|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|1||||FUNGI|FUNGI|||||||MV|||||||POSITIVE||ML/CM3/MIN||||LOW|NOT DONE||||HAIR FOLLICLE|LACTESCENT|N|GC/FID|FIBROSIS 4 FORMULA||Y|N|U|Y|||NA|5||7||WASHOUT|1972-08-07|1973-05-22|||||1968-02-11||1964-07-11|Y|1963-07-02
TRIAL STUDY 134XCP|LB|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|2||||ALPBALP|ALK PHOS, BONE/TOTAL ALK PHOS|||||||SEC|||||||NEGATIVE||MBQ/UL||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT|U|ICP-MS|GMI MMOL/MOL FORMULA||U|Y|Y|U|||NA|5||7||OBSERVATION|1972-10-04|1963-03-16|||||1968-09-28||1960-02-10|N|1971-12-30
TRIAL STUDY 134XCP|LB|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|1||||BAMBTAC|BETA-AMINOBUTYRIC ACID|||||||PKAT/L|||||||INDETERMINATE||BQ/MG||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|FRESH|N|LISSAMINE GREEN STAIN|MDRD FORMULA||NA|NA|N|Y|||U|1||38||OBSERVATION|1972-09-12|1963-04-13|||||1972-07-02||1969-05-30|NA|1962-08-03
TRIAL STUDY 134XCP|LB|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|2||||ATP|ADENOSINE TRIPHOSPHATE|||||||PPB|||||||INVALID||RATIO||||ABNORMAL|NOT DONE||||NAIL|CALCIFIED|Y|TOLUIDINE BLUE STAIN|MDRD 5 VARIABLE FORMULA||NA|N|U|N|||NA|1||38||SCREENING|1962-03-04|1968-11-24|||||1962-06-02||1963-10-18|N|1967-06-17
TRIAL STUDY 134XCP|LB|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|1||||GSTTH|GLUTATHIONE S-TRANSFERASE, THETA|||||||U/M2|||||||NEGATIVE||MOL/L||||NORMAL|NOT DONE||||SALIVA|ROOM TEMPERATURE|Y|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|NASH FIBROSURE FORMULA||Y|N|Y|NA|||NA|2||58||SCREENING|1961-05-06|1971-08-22|||||1967-04-08||1964-03-24|N|1973-01-04
TRIAL STUDY 134XCP|LB|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|2||||VEGFR2|VASC ENDOTHELIAL GROWTH FACTOR REC 2|||||||MG2/DL2|||||||NEGATIVE||ML/MIN||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|REFRIGERATED|N|DYNAMIC LIGHT SCATTERING|MDRD ENZYMATIC JAPANESE FORMULA||N|U|N|Y|||NA|2||58||FOLLOW-UP|1970-10-16|1969-02-23|||||1965-01-11||1966-10-26|N|1964-06-05
TRIAL STUDY 134XCP|LB|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|1||||BILDIR|DIRECT BILIRUBIN|||||||KIU|||||||NEGATIVE||RING||||LOW|NOT DONE||||INFRANATANT, PLASMA|FROZEN|Y|FLUORESCENT LIFETIME IMAGING MICROSCOPY|MDRD ENZYMATIC FORMULA||N|Y|Y|U|||Y|3||39||TREATMENT|1967-11-02|1960-10-14|||||1962-02-04||1971-01-03|NA|1967-11-03
TRIAL STUDY 134XCP|LB|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|2||||TRICH|TRICHOMONAS|||||||10^9/L|||||||TRACE||MIN||||HIGH|NOT DONE||||SEMINAL FLUID|FROZEN|U|WRIGHT-GIEMSA STAIN|FIBROTEST FORMULA||U|N|N|Y|||U|3||39||BLINDED TREATMENT|1967-08-18|1973-04-15|||||1967-01-20||1970-12-17|Y|1969-06-02
TRIAL STUDY 134XCP|LB|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|1||||EOSPSDLE|PSEUDO-EOSINOPHILS/LEUKOCYTES|||||||ANSON U|||||||INVALID||MIU/L||||ABNORMAL|NOT DONE||||PLATELET|FROZEN|U|OPTICAL MAPPING|COCKCROFT-GAULT FORMULA||Y|NA|N|NA|||Y|4||88||TREATMENT|1961-09-09|1967-11-08|||||1966-02-05||1960-07-13|N|1965-03-01
TRIAL STUDY 134XCP|LB|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|2||||APLAB|ANTIPHOSPHOLIPID ANTIBODIES|||||||PIXELS/CM|||||||INDETERMINATE||MIN||||LOW|NOT DONE||||PLATELET|LIPEMIC|N|ACRIDINE ORANGE STAIN|MDRD 6 VARIABLE FORMULA||Y|U|U|N|||U|4||88||INDUCTION TREATMENT|1966-10-04|1969-09-20|||||1970-01-04||1963-04-04|NA|1966-10-12
TRIAL STUDY 134XCP|LB|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|1||||GALM|GALACTOSE MUTAROTASE|||||||C|||||||INVALID||G/ANIMAL||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|DRIED|U|POLYGRAPHY|MDRD 5 VARIABLE FORMULA||U|Y|U|NA|||N|5||7||LONG-TERM FOLLOW-UP|1972-07-10|1970-10-29|||||1965-09-19||1960-03-07|NA|1964-10-14
TRIAL STUDY 134XCP|LB|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|2||||AMYLASE|AMYLASE|||||||FT2|||||||BORDERLINE||CMH2O*S/ML||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|NON-HEMOLYZED|U|ACID FAST STAIN|FIBROMETER FORMULA||N|NA|NA|Y|||N|5||7||INDUCTION TREATMENT|1961-05-01|1973-08-01|||||1973-04-25||1966-08-14|NA|1967-11-14
TRIAL STUDY 134XCP|LB|B396F12E-7BF5-47CC-AFD1-1B679066B106|1||||ARG|ARGININE|||||||UMOL/MOL|||||||INVALID||WAFER||||NORMAL|NOT DONE||||SEMEN|FROZEN|N|SLOAN LETTER EYE CHART 2.5%|HEPASCORE FORMULA||U|N|U|N|||N|1||38||TREATMENT|1971-03-17|1970-11-09|||||1972-12-27||1968-05-07|Y|1973-02-11
TRIAL STUDY 134XCP|LB|B396F12E-7BF5-47CC-AFD1-1B679066B106|2||||APPA|AMYLOID ALPHA PRECURSOR PROTEIN|||||||KPA|||||||INVALID||UG/M2/MIN||||LOW|NOT DONE||||SMEGMA|SOLIDIFIED|NA|GRADIENT DIFFUSION|FIBROTEST FORMULA||U|Y|N|NA|||NA|1||38||WASHOUT|1971-06-13|1968-02-17|||||1963-09-29||1963-01-18|N|1970-07-18
TRIAL STUDY 134XCP|LB|B396F12E-7BF5-47CC-AFD1-1B679066B106|1||||IL1RL1|INTERLEUKIN 1 RECEPTOR-LIKE 1|||||||MG/G/MIN|||||||INDETERMINATE||NMOL/G||||LOW|NOT DONE||||PLATELET RICH PLASMA|THAWED|Y|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROTEST FORMULA||Y|Y|N|Y|||Y|2||58||BASELINE|1968-04-25|1968-06-21|||||1968-01-31||1967-08-01|N|1965-07-15
TRIAL STUDY 134XCP|LB|B396F12E-7BF5-47CC-AFD1-1B679066B106|2||||TRP1TRG1|TRYPSIN 1 AND TRYPSINOGEN 1|||||||/DAY|||||||BORDERLINE||VG/DOSE||||NORMAL|NOT DONE||||EMOTIONAL TEAR|PARAFFIN-EMBEDDED|U|FREEZING POINT DEPRESSION|CKD-EPI CREATININE FORMULA||NA|N|Y|NA|||Y|2||58||SCREENING|1972-08-12|1962-03-03|||||1972-11-25||1961-11-23|U|1962-11-08
TRIAL STUDY 134XCP|LB|B396F12E-7BF5-47CC-AFD1-1B679066B106|1||||HLAB|HLA CLASS IB ANTIGEN|||||||PUFF|||||||INDETERMINATE||10^7 CFU/ML||||HIGH|NOT DONE||||NAIL|AGGLUTINATED|U|X-RAY FLUORESCENCE SPECTROMETRY|HEPASCORE FORMULA||N|U|N|N|||N|3||39||FOLLOW-UP|1967-11-13|1969-10-18|||||1970-11-03||1969-07-10|U|1970-08-03
TRIAL STUDY 134XCP|LB|B396F12E-7BF5-47CC-AFD1-1B679066B106|2||||G6PDRBRB|G6PD-DEFICIENT ERYTHROCYTES/ERYTHROCYTES|||||||/100 HPFS|||||||INDETERMINATE||UG/KG/DAY||||HIGH|NOT DONE||||NAIL|UNEXPECTED ODOR|NA|IMMUNOCHEMILUMINOMETRIC ASSAY|CKD-EPI CYSTATIN C FORMULA||N|U|Y|U|||NA|3||39||BLINDED TREATMENT|1969-06-01|1967-04-24|||||1972-12-03||1964-03-21|N|1970-01-18
TRIAL STUDY 134XCP|LB|B396F12E-7BF5-47CC-AFD1-1B679066B106|1||||PCDW|PLATELET COMPONENT DISTRIBUTION WIDTH|||||||MMAL|||||||BORDERLINE||10^9 ORGANISMS/ML||||HIGH|NOT DONE||||LYSATE|SOLIDIFIED|N|NUCLEAR RADIOLOGY|MDRD 5 VARIABLE FORMULA||Y|U|N|NA|||NA|4||88||OBSERVATION|1960-03-09|1962-12-08|||||1964-03-23||1969-04-10|Y|1964-08-20
TRIAL STUDY 134XCP|LB|B396F12E-7BF5-47CC-AFD1-1B679066B106|2||||CXCL6|CHEMOKINE (C-X-C MOTIF) LIGAND 6|||||||MET*MIN|||||||TRACE||ENZYME U/M2||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|ICTERIC|NA|DOPPLER ULTRASOUND|NASH FIBROSURE FORMULA||N|Y|NA|U|||N|4||88||SCREENING|1971-11-07|1968-10-20|||||1964-12-27||1960-07-20|N|1966-08-06
TRIAL STUDY 134XCP|LB|B396F12E-7BF5-47CC-AFD1-1B679066B106|1||||APTT|ACTIVATED PARTIAL THROMBOPLASTIN TIME|||||||UG/MIN|||||||INDETERMINATE||UKAT||||NORMAL|NOT DONE||||VENOUS PLASMA|HEMOLYZED|NA|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|MDRD 6 VARIABLE FORMULA||NA|Y|Y|NA|||NA|5||7||LONG-TERM FOLLOW-UP|1970-05-06|1962-03-09|||||1962-02-10||1972-09-28|N|1972-07-16
TRIAL STUDY 134XCP|LB|B396F12E-7BF5-47CC-AFD1-1B679066B106|2||||KLCLLC|KAPPA LIGHT CHAIN/LAMBDA LIGHT CHAIN|||||||%(V/V)|||||||INVALID||KDA||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED|Y|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|HEPASCORE FORMULA||N|N|U|NA|||U|5||7||BASELINE|1965-12-16|1963-01-22|||||1972-05-29||1972-03-21|U|1969-07-15
TRIAL STUDY 134XCP|LB|2936B26A-9A8D-4C28-90A7-6131837F255F|1||||YKL40P|YKL-40 PROTEIN|||||||FOZ_US|||||||NEGATIVE||GRAIN||||HIGH|NOT DONE||||TISSUE|CONTAMINATED|NA|PULMONARY ANGIOGRAPHY|MDRD 5 VARIABLE FORMULA||N|U|Y|Y|||Y|1||38||TREATMENT|1960-01-18|1972-09-22|||||1968-10-08||1960-03-15|Y|1971-03-09
TRIAL STUDY 134XCP|LB|2936B26A-9A8D-4C28-90A7-6131837F255F|2||||FLUIDOUT|FLUID OUTPUT|||||||MG/DOSE|||||||BORDERLINE||KG/M2||||LOW|NOT DONE||||PLASMA|NON-HEMOLYZED|NA|SCANNING ELECTRON MICROSCOPY|FIBROSIS 4 FORMULA||N|N|N|N|||NA|1||38||OBSERVATION|1967-11-17|1972-01-04|||||1969-04-22||1964-07-03|U|1962-12-27
TRIAL STUDY 134XCP|LB|2936B26A-9A8D-4C28-90A7-6131837F255F|1||||AXL|AXL RECEPTOR TYROSINE KINASE|||||||UG/L FEU|||||||INVALID||TCID 50/DOSE||||HIGH|NOT DONE||||ADIPOSE TISSUE|GELLED|N|FLAME PHOTOMETRY|NASH FIBROSURE FORMULA||NA|N|NA|NA|||N|2||58||CONTINUATION TREATMENT|1965-03-07|1966-12-30|||||1963-03-31||1967-12-20|N|1970-03-14
TRIAL STUDY 134XCP|LB|2936B26A-9A8D-4C28-90A7-6131837F255F|2||||CCL25|CHEMOKINE (C-C MOTIF) LIGAND 25|||||||10^7 PFU|||||||POSITIVE||UMOL/L/SEC||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|CALCIFIED|NA|MUGA|CKD-EPI CYSTATIN C FORMULA||Y|N|U|Y|||Y|2||58||BLINDED TREATMENT|1968-06-18|1971-04-13|||||1968-08-29||1960-06-21|N|1971-12-18
TRIAL STUDY 134XCP|LB|2936B26A-9A8D-4C28-90A7-6131837F255F|1||||UDCA|URSODEOXYCHOLATE|||||||10^3 CFU/ML|||||||INDETERMINATE||UV*SEC||||HIGH|NOT DONE||||EPIDERMAL TISSUE|NON-HEMOLYZED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA||U|NA|U|NA|||Y|3||39||FOLLOW-UP|1973-02-28|1970-09-30|||||1961-07-31||1961-11-25|U|1963-04-22
TRIAL STUDY 134XCP|LB|2936B26A-9A8D-4C28-90A7-6131837F255F|2||||RNP70AB|RIBONUCLEOPROTEIN-70 ANTIBODY|||||||MOSM/L|||||||TRACE||AFU||||NORMAL|NOT DONE||||BASAL TEAR|THAWED|Y|TOTAL BODY RADIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|N|U|||U|3||39||SCREENING|1969-08-06|1964-09-25|||||1961-06-17||1967-09-18|U|1969-08-09
TRIAL STUDY 134XCP|LB|2936B26A-9A8D-4C28-90A7-6131837F255F|1||||TRIG|TRIGLYCERIDES|||||||UG/MOL|||||||INVALID||CUP EQ||||LOW|NOT DONE||||TISSUE|AGGLUTINATED|N|FLUORIMETRY|CKD-EPI FORMULA||N|Y|NA|NA|||U|4||88||FOLLOW-UP|1968-10-21|1964-10-06|||||1962-09-13||1963-01-06|NA|1968-11-11
TRIAL STUDY 134XCP|LB|2936B26A-9A8D-4C28-90A7-6131837F255F|2||||METHANOL|METHANOL|||||||M2|||||||POSITIVE||BQ/UG||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|THAWED|Y|HPLC-UV|NASH FIBROSURE FORMULA||NA|Y|N|NA|||NA|4||88||OBSERVATION|1970-07-16|1971-03-28|||||1966-04-17||1973-01-11|N|1964-06-19
TRIAL STUDY 134XCP|LB|2936B26A-9A8D-4C28-90A7-6131837F255F|1||||GLUCEXR|GLUCOSE EXCRETION RATE|||||||ML/ANIMAL/WK|||||||POSITIVE||STEPS||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|THAWED|N|RAJI CELL RIA|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|N|U|||N|5||7||LONG-TERM FOLLOW-UP|1968-08-18|1968-05-25|||||1969-02-28||1971-05-12|Y|1967-07-29
TRIAL STUDY 134XCP|LB|2936B26A-9A8D-4C28-90A7-6131837F255F|2||||LGLUCLE|LARGE UNSTAINED CELLS/LEUKOCYTES|||||||MMOL/L|||||||INVALID||FMOL||||LOW|NOT DONE||||ARTERIAL BLOOD|CONCENTRATED|N|JAEGER EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|U|N|||NA|5||7||CONTINUATION TREATMENT|1966-03-22|1969-08-08|||||1962-01-24||1960-06-17|N|1965-09-06
TRIAL STUDY 134XCP|LB|901A91DC-9EF3-4A20-A35D-9C426A5C640B|1||||PLSIMCLY|IMMATURE PLASMA CELLS/LYMPHOCYTES|||||||% INHIBITION|||||||INDETERMINATE||10^3 ORGANISMS/ML||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|GELLED|NA|HPLC/MS|CKD-EPI FORMULA||U|N|Y|NA|||NA|1||38||OBSERVATION|1969-10-01|1963-06-29|||||1970-09-16||1970-11-07|U|1961-06-17
TRIAL STUDY 134XCP|LB|901A91DC-9EF3-4A20-A35D-9C426A5C640B|2||||GLUC|GLUCOSE|||||||PG/L|||||||INDETERMINATE||UMOL/DL||||NORMAL|NOT DONE||||BONE MARROW|CLOTTED|Y|PH METER MEASUREMENT METHOD|GMI % FORMULA||N|NA|N|Y|||U|1||38||TREATMENT|1967-05-27|1964-11-01|||||1966-10-04||1967-06-27|NA|1972-07-15
TRIAL STUDY 134XCP|LB|901A91DC-9EF3-4A20-A35D-9C426A5C640B|1||||MX1|INTERFERON-INDUCED PROTEIN P78|||||||RFU|||||||INDETERMINATE||/LSQN||||LOW|NOT DONE||||LUNG SURFACTANT|NON-HEMOLYZED|N|PLETHYSMOGRAPHY|HEPASCORE FORMULA||U|U|N|Y|||N|2||58||BASELINE|1967-06-10|1970-10-17|||||1967-05-24||1969-07-29|NA|1971-03-18
TRIAL STUDY 134XCP|LB|901A91DC-9EF3-4A20-A35D-9C426A5C640B|2||||SAMETH|S-ADENOSYLMETHIONINE|||||||DAGU|||||||INVALID||/100 HPFS||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|GELLED|NA|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|U|N|||U|2||58||FOLLOW-UP|1972-08-09|1966-05-13|||||1964-07-14||1965-07-07|U|1973-07-31
TRIAL STUDY 134XCP|LB|901A91DC-9EF3-4A20-A35D-9C426A5C640B|1||||C130100|MIXED ANTIGEN IGE ANTIBODY|||||||PACKAGE|||||||BORDERLINE||DPM/MG||||LOW|NOT DONE||||INFRANATANT, SERUM|THAWED|NA|FARNSWORTH-MUNSELL 100 HUE TEST|ASH FIBROSURE FORMULA||U|U|NA|NA|||Y|3||39||BASELINE|1970-10-13|1972-03-12|||||1971-06-17||1964-09-29|Y|1966-03-13
TRIAL STUDY 134XCP|LB|901A91DC-9EF3-4A20-A35D-9C426A5C640B|2||||SAHOMC|S-ADENOSYLHOMOCYSTEINE|||||||MG/M2/H|||||||TRACE||10^6 CFU/G||||ABNORMAL|NOT DONE||||ERYTHROCYTES|AGGLUTINATED|Y|URANYL ACETATE STAIN|MDRD 5 VARIABLE FORMULA||NA|N|U|N|||N|3||39||SCREENING|1960-11-20|1971-01-17|||||1966-01-10||1962-08-31|NA|1960-07-31
TRIAL STUDY 134XCP|LB|901A91DC-9EF3-4A20-A35D-9C426A5C640B|1||||ARA|ARACHIDONIC ACID|||||||NGEQ/L|||||||TRACE||MEQ||||ABNORMAL|NOT DONE||||SEMEN|UNEXPECTED ODOR|N|HPLC/MS|FIBROMETER FORMULA||N|N|N|N|||Y|4||88||SCREENING|1966-02-23|1960-07-17|||||1971-12-24||1962-02-01|N|1970-01-10
TRIAL STUDY 134XCP|LB|901A91DC-9EF3-4A20-A35D-9C426A5C640B|2||||TMZPM|TEMAZEPAM|||||||MG/ML/MIN|||||||NEGATIVE||UG/ML/H||||NORMAL|NOT DONE||||INFRANATANT, SERUM|CLOTTED|U|BAC ACGH|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|Y|NA|||U|4||88||INDUCTION TREATMENT|1961-11-17|1973-06-15|||||1962-01-04||1962-04-06|N|1965-02-06
TRIAL STUDY 134XCP|LB|901A91DC-9EF3-4A20-A35D-9C426A5C640B|1||||FUNGYLK|FUNGI, YEAST-LIKE|||||||MG/KG/WEEK|||||||INDETERMINATE||DAGU/ML||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|NA|MICRONEUTRALIZATION ASSAY|MDRD 5 VARIABLE FORMULA||NA|Y|U|Y|||U|5||7||BLINDED TREATMENT|1971-05-23|1963-09-14|||||1970-03-09||1962-05-20|NA|1965-11-29
TRIAL STUDY 134XCP|LB|901A91DC-9EF3-4A20-A35D-9C426A5C640B|2||||PERIOSTN|PERIOSTIN|||||||U.CARR|||||||TRACE||MG/MIN||||HIGH|NOT DONE||||AMNIOTIC FLUID|ICTERIC|NA|SPIRAL CT SCAN WITHOUT CONTRAST|GMI MMOL/MOL FORMULA||U|Y|Y|Y|||N|5||7||BASELINE|1966-01-25|1962-01-26|||||1966-04-22||1965-02-23|Y|1972-02-28
TRIAL STUDY 134XCP|LB|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|1||||LDLP|LDL PARTICLES|||||||L/MIN|||||||BORDERLINE||GRAVITATIONAL UNIT||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|CONCENTRATED|U|IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD 5 VARIABLE FORMULA||U|NA|U|NA|||Y|1||38||RUN-IN|1969-10-05|1961-06-02|||||1961-01-23||1965-08-14|N|1964-05-29
TRIAL STUDY 134XCP|LB|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|2||||RETIL|LOW ABSORPTION RETICULOCYTES|||||||ML/BEAT|||||||BORDERLINE||BEAM BREAKS||||ABNORMAL|NOT DONE||||TISSUE|CONTAMINATED|N|FLOW MICROSCOPY|CKD-EPI FORMULA||N|Y|NA|NA|||U|1||38||OBSERVATION|1969-02-09|1968-12-26|||||1960-05-17||1963-01-26|U|1967-05-19
TRIAL STUDY 134XCP|LB|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|1||||CLEXR|CHLORIDE EXCRETION RATE|||||||TCID 50/DOSE|||||||INDETERMINATE||G||||NORMAL|NOT DONE||||EXPIRED AIR|ROOM TEMPERATURE|NA|QUANTITATIVE CORONARY ANGIOGRAPHY|ASH FIBROSURE FORMULA||NA|N|N|Y|||NA|2||58||WASHOUT|1960-10-13|1969-02-07|||||1971-01-14||1972-09-14|U|1961-12-01
TRIAL STUDY 134XCP|LB|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|2||||DSG3AB|DESMOGLEIN 3 ANTIBODY|||||||%|||||||POSITIVE||MG2/DL2||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|CONTAMINATED|Y|MALDI|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|N|N|||U|2||58||OPEN LABEL TREATMENT|1969-03-31|1961-10-05|||||1960-09-18||1971-10-18|N|1966-08-07
TRIAL STUDY 134XCP|LB|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|1||||APRI|AST TO PLATELET RATIO INDEX|||||||GBQ/MG|||||||INDETERMINATE||/100 HPFS||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|CALCIFIED|U|IN SITU HYBRIDIZATION|ASH FIBROSURE FORMULA||N|NA|Y|NA|||U|3||39||WASHOUT|1961-04-01|1967-02-17|||||1968-09-12||1970-11-25|Y|1962-03-23
TRIAL STUDY 134XCP|LB|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|2||||FRFEABS|FRACTIONAL IRON ABSORPTION|||||||PL|||||||INVALID||10^3 COPIES/ML||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|LIPEMIC|Y|MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CREATININE FORMULA||NA|Y|U|N|||N|3||39||CONTINUATION TREATMENT|1970-11-21|1964-03-22|||||1967-10-12||1968-05-22|Y|1966-06-27
TRIAL STUDY 134XCP|LB|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|1||||C165911|DAIRY MIX IGG AB RAST SCORE|||||||L/H/M2|||||||BORDERLINE||U/M2/H||||ABNORMAL|NOT DONE||||PLATELET|FRESH|Y|CINEANGIOGRAPHY|CKD-EPI CREATININE FORMULA||U|NA|NA|Y|||U|4||88||BLINDED TREATMENT|1972-09-21|1970-09-08|||||1973-05-01||1960-11-11|NA|1964-06-30
TRIAL STUDY 134XCP|LB|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|2||||TROPONT|TROPONIN T|||||||GMFI|||||||INDETERMINATE||DL||||NORMAL|NOT DONE||||EMOTIONAL TEAR|HEMOLYZED|U|IMMUNO-PET SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|NA|NA|||N|4||88||WASHOUT|1971-09-24|1972-12-22|||||1968-09-05||1965-03-24|NA|1969-06-02
TRIAL STUDY 134XCP|LB|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|1||||CYSTHION|CYSTATHIONINE|||||||FMOL/L/SEC|||||||BORDERLINE||10^6 DNA COPIES/ML||||LOW|NOT DONE||||CAPILLARY PLASMA|LIPEMIC|Y|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||Y|Y|Y|N|||Y|5||7||RUN-IN|1966-11-06|1967-04-18|||||1969-06-17||1966-02-21|Y|1961-09-21
TRIAL STUDY 134XCP|LB|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|2||||APOE4|APOLIPOPROTEIN E4|||||||MILE|||||||BORDERLINE||UG/L/H||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|FROZEN|U|LIQUID SCINTILLATION COUNTING|FIBROTEST FORMULA||NA|NA|U|N|||Y|5||7||CONTINUATION TREATMENT|1972-01-16|1964-02-12|||||1965-05-09||1971-10-08|NA|1973-03-28
TRIAL STUDY 134XCP|LB|5A7F2C89-5398-4119-8EA0-B432FF8942A4|1||||BASEEXCS|BASE EXCESS|||||||K|||||||POSITIVE||U/G/DAY||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|DRIED|Y|LYMPHANGIOGRAPHY|MDRD FORMULA||Y|N|U|Y|||N|1||38||TREATMENT|1973-05-18|1962-11-17|||||1973-02-04||1971-10-22|NA|1971-07-23
TRIAL STUDY 134XCP|LB|5A7F2C89-5398-4119-8EA0-B432FF8942A4|2||||GSTPIEXR|PI-GST EXCRETION RATE|||||||MPS U|||||||TRACE||LOG10 TCID 50/DOSE||||NORMAL|NOT DONE||||EMESIS|ICTERIC|U|HPLC/IEX|HEPASCORE FORMULA||N|U|N|U|||Y|1||38||CONTINUATION TREATMENT|1962-07-21|1970-01-02|||||1970-12-10||1971-02-15|Y|1969-03-09
TRIAL STUDY 134XCP|LB|5A7F2C89-5398-4119-8EA0-B432FF8942A4|1||||BLSTMKCE|MEGAKARYOBLASTS/TOTAL CELLS|||||||/HPF|||||||INVALID||10^6/G||||ABNORMAL|NOT DONE||||SMEGMA|CALCIFIED|NA|X-RAY FLUORESCENCE SPECTROMETRY|MDRD FORMULA||Y|Y|N|U|||NA|2||58||RUN-IN|1971-02-27|1962-05-08|||||1971-08-18||1965-12-27|N|1969-12-09
TRIAL STUDY 134XCP|LB|5A7F2C89-5398-4119-8EA0-B432FF8942A4|2||||LPA|LIPOPROTEIN-A|||||||MM/MIN|||||||INVALID||MG/L FEU||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|NA|ORCHIDOMETERY|MDRD 6 VARIABLE FORMULA||Y|N|U|U|||NA|2||58||BASELINE|1968-05-31|1961-11-26|||||1964-06-30||1972-10-24|NA|1960-07-16
TRIAL STUDY 134XCP|LB|5A7F2C89-5398-4119-8EA0-B432FF8942A4|1||||NEUTB|NEUTROPHILS BAND FORM|||||||/2500 WBC|||||||INDETERMINATE||MCI/L||||HIGH|NOT DONE||||SYNOVIAL FLUID|AUTOLYZED|U|TRICHROME STAIN|MDRD 6 VARIABLE FORMULA||N|U|Y|NA|||Y|3||39||OPEN LABEL TREATMENT|1968-07-23|1971-08-28|||||1960-03-31||1969-02-08|U|1969-02-24
TRIAL STUDY 134XCP|LB|5A7F2C89-5398-4119-8EA0-B432FF8942A4|2||||RBCCLMP|ERYTHROCYTE CELL CLUMPS|||||||TSP EQ|||||||TRACE||/SEC||||ABNORMAL|NOT DONE||||REFLEX TEAR|FRESH|NA|LC-FL|CKD-EPI FORMULA||Y|Y|U|U|||NA|3||39||OPEN LABEL TREATMENT|1961-01-01|1973-07-07|||||1972-07-03||1964-06-16|NA|1962-03-11
TRIAL STUDY 134XCP|LB|5A7F2C89-5398-4119-8EA0-B432FF8942A4|1||||MACROCY|MACROCYTES|||||||DRUM|||||||BORDERLINE||ML/M2/MIN||||LOW|NOT DONE||||SERUM|CALCIFIED|U|SPIRAL CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC FORMULA||NA|Y|N|N|||U|4||88||CONTINUATION TREATMENT|1971-08-31|1969-12-18|||||1963-08-08||1973-07-18|NA|1962-02-23
TRIAL STUDY 134XCP|LB|5A7F2C89-5398-4119-8EA0-B432FF8942A4|2||||AMYLOIDP|AMYLOID P|||||||MBQ/UL|||||||INDETERMINATE||MEQ/L||||LOW|NOT DONE||||HAIR|AUTOLYZED|Y|COULOMETRIC TITRATION|MDRD 6 VARIABLE FORMULA||U|NA|NA|U|||Y|4||88||INDUCTION TREATMENT|1972-07-09|1962-08-22|||||1972-05-02||1973-05-23|U|1969-11-28
TRIAL STUDY 134XCP|LB|5A7F2C89-5398-4119-8EA0-B432FF8942A4|1||||AMH|ANTI-MULLERIAN HORMONE|||||||COPIES/UG|||||||INVALID||YEARS||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|CALCIFIED|Y|PET SCAN|CKD-EPI CREATININE FORMULA||NA|U|U|U|||U|5||7||LONG-TERM FOLLOW-UP|1966-04-16|1967-05-09|||||1965-06-22||1964-05-06|U|1961-12-05
TRIAL STUDY 134XCP|LB|5A7F2C89-5398-4119-8EA0-B432FF8942A4|2||||B1BGLP|BETA-1B GLYCOPROTEIN|||||||NL|||||||TRACE||PACK YEAR||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|FROZEN|N|CYSTOMETRY|NASH FIBROSURE FORMULA||U|Y|Y|N|||U|5||7||WASHOUT|1973-04-14|1961-12-10|||||1966-09-16||1965-12-12|Y|1967-02-02
TRIAL STUDY 134XCP|LB|898FB78B-63D1-4ECE-B6B8-34750E958D93|1||||CD40|CD40|||||||10^12 IU/L|||||||BORDERLINE||U/ML||||HIGH|NOT DONE||||VITREOUS HUMOR|DRIED|NA|ANTIBIOTIC AGAR SCREEN|CKD-EPI CREATININE FORMULA||U|U|NA|U|||N|1||38||OBSERVATION|1967-02-09|1968-07-15|||||1965-05-17||1964-08-29|U|1963-12-08
TRIAL STUDY 134XCP|LB|898FB78B-63D1-4ECE-B6B8-34750E958D93|2||||CD161LY|CD161/LYMPHOCYTES|||||||EID 50/DOSE|||||||TRACE||ML/CAGE/WK||||LOW|NOT DONE||||BONE MARROW|NON-HEMOLYZED|N|HEMAGGLUTINATION INHIBITION ASSAY|NASH FIBROSURE FORMULA||U|Y|NA|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1972-12-24|1968-06-02|||||1967-05-06||1966-05-06|N|1972-05-02
TRIAL STUDY 134XCP|LB|898FB78B-63D1-4ECE-B6B8-34750E958D93|1||||NOREPEXR|NOREPINEPHRINE EXCRETION RATE|||||||U/M2/H|||||||INDETERMINATE||PATCH||||HIGH|NOT DONE||||ALVEOLAR AIR|AGGLUTINATED|N|GC/FID|MDRD 5 VARIABLE FORMULA||Y|U|Y|U|||U|2||58||FOLLOW-UP|1967-07-12|1963-07-12|||||1960-10-22||1971-03-28|U|1971-05-13
TRIAL STUDY 134XCP|LB|898FB78B-63D1-4ECE-B6B8-34750E958D93|2||||TESTOSFR|TESTOSTERONE, FREE|||||||VIRTUAL PIXEL|||||||INDETERMINATE||MG/ANIMAL||||LOW|NOT DONE||||SALIVA|LACTESCENT|N|MICRO BROTH DILUTION|MDRD ENZYMATIC FORMULA||Y|NA|Y|NA|||U|2||58||LONG-TERM FOLLOW-UP|1970-08-10|1972-08-22|||||1972-04-14||1969-03-20|Y|1969-02-13
TRIAL STUDY 134XCP|LB|898FB78B-63D1-4ECE-B6B8-34750E958D93|1||||CCK|CHOLECYSTOKININ|||||||DNA COPIES/ML|||||||BORDERLINE||VG/ML||||HIGH|NOT DONE||||SERUM OR PLASMA|FROZEN|NA|IN SITU HYBRIDIZATION|MDRD 5 VARIABLE FORMULA||Y|U|N|NA|||N|3||39||BLINDED TREATMENT|1963-06-23|1973-06-28|||||1966-11-12||1960-12-08|N|1960-11-04
TRIAL STUDY 134XCP|LB|898FB78B-63D1-4ECE-B6B8-34750E958D93|2||||MCVRETIC|MCV RETICULOCYTES|||||||BQ/KG|||||||INDETERMINATE||KIT||||LOW|NOT DONE||||WHITE MATTER TISSUE|CONCENTRATED|NA|SPIROMETRY|MDRD ENZYMATIC FORMULA||U|Y|NA|N|||NA|3||39||CONTINUATION TREATMENT|1963-07-18|1971-04-23|||||1962-12-06||1968-11-21|N|1968-08-06
TRIAL STUDY 134XCP|LB|898FB78B-63D1-4ECE-B6B8-34750E958D93|1||||C130068|BERMUDA GRASS POLLEN IGE|||||||CYCLE/MIN|||||||TRACE||PMOL/L/H||||LOW|NOT DONE||||EPITHELIAL CELL|CALCIFIED|U|MRS|FIBROSIS 4 FORMULA||Y|N|U|Y|||Y|4||88||OPEN LABEL TREATMENT|1960-04-02|1967-01-08|||||1961-06-18||1968-08-05|NA|1964-10-14
TRIAL STUDY 134XCP|LB|898FB78B-63D1-4ECE-B6B8-34750E958D93|2||||CKBB|CREATINE KINASE BB|||||||MPA|||||||INVALID||L||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|LACTESCENT|Y|CLAUSS METHOD|HEPASCORE FORMULA||Y|U|NA|Y|||Y|4||88||BASELINE|1961-01-17|1962-11-25|||||1973-02-13||1966-07-04|Y|1965-11-01
TRIAL STUDY 134XCP|LB|898FB78B-63D1-4ECE-B6B8-34750E958D93|1||||LDLPSZ|LDL PARTICLE SIZE|||||||CPM|||||||INVALID||TUBE||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|HEMOLYZED|Y|RYAN BLUE STAIN|CKD-EPI FORMULA||U|NA|N|Y|||Y|5||7||BASELINE|1960-08-31|1971-04-22|||||1970-05-17||1972-01-30|U|1966-06-02
TRIAL STUDY 134XCP|LB|898FB78B-63D1-4ECE-B6B8-34750E958D93|2||||INTLK19|INTERLEUKIN 19|||||||U/G HB|||||||BORDERLINE||CI/UL||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|ROOM TEMPERATURE|N|HIGH RESOLUTION MELT ANALYSIS|FIBROTEST FORMULA||U|N|U|NA|||Y|5||7||CONTINUATION TREATMENT|1960-03-29|1972-07-22|||||1964-02-08||1962-08-21|NA|1965-11-09
TRIAL STUDY 134XCP|LB|AF1E7141-5390-4928-9F49-94E1C7464A63|1||||PF2AI8CR|8-ISO-PGF2ALPHA/CREATININE|||||||G/DL|||||||TRACE||HENRY||||ABNORMAL|NOT DONE||||TUMOR TISSUE|CLOTTED|Y|SPIRAL CT|CKD-EPI FORMULA||U|U|Y|U|||NA|1||38||TREATMENT|1972-03-25|1963-03-26|||||1969-03-13||1966-04-02|U|1971-08-08
TRIAL STUDY 134XCP|LB|AF1E7141-5390-4928-9F49-94E1C7464A63|2||||TUDCA|TAUROURSODEOXYCHOLATE|||||||10^9 CFU/ML|||||||INVALID||TRANSDUCING UNIT/ML||||NORMAL|NOT DONE||||INFRANATANT, SERUM|DRIED|N|CLOT DETECTION|MDRD FORMULA||Y|Y|U|U|||NA|1||38||RUN-IN|1966-10-12|1961-05-12|||||1962-02-17||1962-09-03|U|1960-10-08
TRIAL STUDY 134XCP|LB|AF1E7141-5390-4928-9F49-94E1C7464A63|1||||APOC2|APOLIPOPROTEIN C2|||||||GY/MIN|||||||BORDERLINE||10^3 CFU||||LOW|NOT DONE||||EMOTIONAL TEAR|REFRIGERATED|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|N|U|||U|2||58||TREATMENT|1969-04-05|1963-10-01|||||1972-06-22||1961-02-20|N|1966-01-25
TRIAL STUDY 134XCP|LB|AF1E7141-5390-4928-9F49-94E1C7464A63|2||||ALPBS|BONE SPECIFIC ALKALINE PHOSPHATASE|||||||GBQ/UG|||||||BORDERLINE||RNA COPIES/ML||||LOW|NOT DONE||||BASAL TEAR|AUTOLYZED|U|AGAR PROPORTION|MDRD FORMULA||N|Y|NA|NA|||U|2||58||LONG-TERM FOLLOW-UP|1965-05-12|1968-07-06|||||1967-10-13||1964-10-19|U|1962-06-05
TRIAL STUDY 134XCP|LB|AF1E7141-5390-4928-9F49-94E1C7464A63|1||||APROTCRS|ACTIVATED PROTEIN C RESISTANCE|||||||UG/L FEU|||||||BORDERLINE||GBQ/MG||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR|NA|EPSILOMETER|COCKCROFT-GAULT FORMULA||N|Y|NA|NA|||U|3||39||LONG-TERM FOLLOW-UP|1970-06-06|1973-05-22|||||1973-03-08||1968-07-29|N|1970-07-06
TRIAL STUDY 134XCP|LB|AF1E7141-5390-4928-9F49-94E1C7464A63|2||||LYMCLFLE|LYMPHOCYTES, CLEFTED/LEUKOCYTES|||||||10^12/L|||||||BORDERLINE||/500 WBC||||ABNORMAL|NOT DONE||||PLATELET|LIPEMIC|N|HPLC/MS|MDRD FORMULA||N|NA|N|U|||Y|3||39||SCREENING|1969-01-07|1965-04-23|||||1973-02-17||1963-01-06|N|1968-04-18
TRIAL STUDY 134XCP|LB|AF1E7141-5390-4928-9F49-94E1C7464A63|1||||G6PDA|GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACT|||||||ML/G/MIN|||||||POSITIVE||M3||||LOW|NOT DONE||||TISSUE|LACTESCENT|U|SECONDARY ION MASS SPECTOMETRY|GMI % FORMULA||U|Y|Y|N|||Y|4||88||OPEN LABEL TREATMENT|1968-01-07|1973-06-11|||||1965-06-12||1971-06-14|N|1973-08-18
TRIAL STUDY 134XCP|LB|AF1E7141-5390-4928-9F49-94E1C7464A63|2||||GLOBG|GAMMA GLOBULIN|||||||CI/ML|||||||INDETERMINATE||G/DL||||NORMAL|NOT DONE||||VENOUS PLASMA|AUTOLYZED|N|WRIGHT STAIN|FIBROMETER FORMULA||N|NA|Y|Y|||Y|4||88||BASELINE|1962-11-24|1968-09-30|||||1966-04-13||1963-12-29|NA|1965-04-05
TRIAL STUDY 134XCP|LB|AF1E7141-5390-4928-9F49-94E1C7464A63|1||||FRUCTOSE|FRUCTOSE|||||||10^9 CFU/G|||||||POSITIVE||IU/G||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|UNEXPECTED ODOR|NA|VIRUS PLAQUE ASSAY|FIBROTEST FORMULA||Y|N|U|Y|||NA|5||7||INDUCTION TREATMENT|1971-05-12|1972-07-22|||||1965-06-05||1968-11-19|U|1969-06-10
TRIAL STUDY 134XCP|LB|AF1E7141-5390-4928-9F49-94E1C7464A63|2||||PAPPEN|PAPPENHEIMER BODIES|||||||STEPS|||||||TRACE||BQ/KG||||LOW|NOT DONE||||INTERSTITIAL FLUID|GELLED|Y|SLOAN LETTER EYE CHART 1.25%|CKD-EPI CYSTATIN C FORMULA||Y|N|N|NA|||U|5||7||CONTINUATION TREATMENT|1973-03-03|1967-12-10|||||1961-08-15||1970-04-19|U|1968-01-11
TRIAL STUDY 134XCP|LB|2188CADE-EE6F-4F14-8049-5EDD72020185|1||||MENGLCE|MENINGEAL CELLS/TOTAL CELLS|||||||GMFI|||||||POSITIVE||CGY||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|THAWED|Y|LINE PROBE ASSAY|FIBROSIS 4 FORMULA||Y|Y|Y|NA|||Y|1||38||BLINDED TREATMENT|1971-01-21|1968-08-12|||||1969-10-11||1960-01-26|N|1971-11-26
TRIAL STUDY 134XCP|LB|2188CADE-EE6F-4F14-8049-5EDD72020185|2||||IGG|IMMUNOGLOBULIN G|||||||UL/KG/DAY|||||||BORDERLINE||BQ/ML||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|AUTOLYZED|NA|KNEMOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|Y|NA|||NA|1||38||WASHOUT|1973-08-15|1969-07-18|||||1962-04-26||1968-12-02|N|1966-12-27
TRIAL STUDY 134XCP|LB|2188CADE-EE6F-4F14-8049-5EDD72020185|1||||ERCEMPOL|ERYTHROID MATURATION POOL|||||||MM/MIN|||||||NEGATIVE||BOX||||NORMAL|NOT DONE||||INFRANATANT, SERUM|UNEXPECTED ODOR|N|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||U|NA|Y|Y|||U|2||58||CONTINUATION TREATMENT|1967-04-07|1962-10-23|||||1970-02-03||1961-02-18|Y|1962-09-29
TRIAL STUDY 134XCP|LB|2188CADE-EE6F-4F14-8049-5EDD72020185|2||||FCTVIIIA|FACTOR VIII ACTIVITY|||||||MG/KG/WEEK|||||||BORDERLINE||10^9 ORGANISMS||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|THAWED|NA|NON-INVASIVE DIELECTRIC SENSING|COCKCROFT-GAULT FORMULA||U|N|Y|NA|||N|2||58||OBSERVATION|1960-02-13|1972-10-30|||||1962-12-11||1966-09-09|U|1960-02-04
TRIAL STUDY 134XCP|LB|2188CADE-EE6F-4F14-8049-5EDD72020185|1||||PRINSINS|PROINSULIN/INSULIN RATIO|||||||ML/(MIN*100ML)|||||||POSITIVE||PPB||||LOW|NOT DONE||||BREAST MILK|HEMOLYZED|U|CALCULATION|FIBROTEST FORMULA||Y|NA|U|NA|||Y|3||39||TREATMENT|1963-02-04|1965-04-07|||||1965-07-16||1969-09-08|N|1964-03-11
TRIAL STUDY 134XCP|LB|2188CADE-EE6F-4F14-8049-5EDD72020185|2||||GLOBUL|GLOBULIN|||||||U/L|||||||INVALID||ML/G/MIN||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|FROZEN|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 4 VARIABLE FORMULA||U|Y|NA|N|||NA|3||39||OBSERVATION|1972-05-26|1963-03-15|||||1965-12-24||1964-04-16|Y|1965-02-26
TRIAL STUDY 134XCP|LB|2188CADE-EE6F-4F14-8049-5EDD72020185|1||||LTFAB|LACTOFERRIN ANTIBODY|||||||MV2/HZ|||||||NEGATIVE||UG/M2/MIN||||ABNORMAL|NOT DONE||||EXUDATE|FROZEN|NA|TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROMETER FORMULA||N|Y|Y|U|||U|4||88||FOLLOW-UP|1960-02-07|1968-09-30|||||1968-07-17||1968-09-17|N|1965-02-18
TRIAL STUDY 134XCP|LB|2188CADE-EE6F-4F14-8049-5EDD72020185|2||||TUDCA|TAUROURSODEOXYCHOLATE|||||||MV/SEC|||||||TRACE||LOG10 ELISA UNIT/DOSE||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|SOLIDIFIED|Y|CALCOFLUOR WHITE STAIN|CKD-EPI CREATININE FORMULA||U|U|U|NA|||NA|4||88||CONTINUATION TREATMENT|1972-07-08|1969-04-17|||||1967-02-11||1961-09-24|N|1961-09-14
TRIAL STUDY 134XCP|LB|2188CADE-EE6F-4F14-8049-5EDD72020185|1||||FACTII|FACTOR II|||||||COPIES/UL|||||||TRACE||COPIES/UL||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|UNEXPECTED ODOR|N|CHROMATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|N|U|||Y|5||7||CONTINUATION TREATMENT|1972-07-03|1971-12-14|||||1970-12-11||1963-10-26|NA|1965-07-19
TRIAL STUDY 134XCP|LB|2188CADE-EE6F-4F14-8049-5EDD72020185|2||||PLATSAT|PLATELET SATELLITISM|||||||MG/M2/H|||||||NEGATIVE||FL||||NORMAL|NOT DONE||||INFRANATANT, SERUM|DRIED|NA|RADIAL IMMUNODIFFUSION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|U|Y|||U|5||7||WASHOUT|1970-02-08|1962-05-01|||||1961-07-10||1971-08-01|N|1964-04-04
TRIAL STUDY 134XCP|LB|DFF30783-4496-4134-8201-67C727683A7D|1||||GCHT|GLYCOCHOLATE|||||||ML/100G/MIN|||||||INDETERMINATE||PG/L||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|FRESH|NA|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|U|Y|||U|1||38||LONG-TERM FOLLOW-UP|1965-04-13|1961-08-28|||||1973-08-03||1973-07-28|N|1963-05-22
TRIAL STUDY 134XCP|LB|DFF30783-4496-4134-8201-67C727683A7D|2||||GFR|GLOMERULAR FILTRATION RATE|||||||UG/M2/DAY|||||||TRACE||UV2||||ABNORMAL|NOT DONE||||LYMPH|ROOM TEMPERATURE|U|HILLMEN COLOR CHART|MDRD ENZYMATIC FORMULA||NA|U|N|NA|||U|1||38||CONTINUATION TREATMENT|1964-01-07|1966-05-27|||||1960-08-21||1962-03-31|U|1966-04-09
TRIAL STUDY 134XCP|LB|DFF30783-4496-4134-8201-67C727683A7D|1||||FDP|FIBRIN DEGRADATION PRODUCTS|||||||PIXEL|||||||POSITIVE||NKAT/G HB||||HIGH|NOT DONE||||GASTRIC CONTENTS|AGGLUTINATED|Y|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA||N|N|Y|N|||NA|2||58||FOLLOW-UP|1962-07-05|1970-12-05|||||1965-04-22||1966-09-18|U|1973-04-23
TRIAL STUDY 134XCP|LB|DFF30783-4496-4134-8201-67C727683A7D|2||||IFIT1|INTERFERON-INDUCED 56 KDA PROTEIN|||||||KM/H|||||||INVALID||NMOL/MOL||||ABNORMAL|NOT DONE||||SPUTUM|ICTERIC|NA|CYSTOSCOPY|CKD-EPI FORMULA||N|N|Y|U|||U|2||58||OPEN LABEL TREATMENT|1971-01-18|1970-06-21|||||1960-03-10||1969-03-24|Y|1965-07-19
TRIAL STUDY 134XCP|LB|DFF30783-4496-4134-8201-67C727683A7D|1||||EDMAB|ENDOMYSIAL ANTIBODY|||||||PPTH|||||||INDETERMINATE||UM2||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CLOTTED|U|TEST STRIP|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|U|N|||N|3||39||WASHOUT|1964-08-22|1970-01-22|||||1969-12-16||1963-02-26|U|1972-05-21
TRIAL STUDY 134XCP|LB|DFF30783-4496-4134-8201-67C727683A7D|2||||HLAA|HLA CLASS IA ANTIGEN|||||||10^6 ORGANISMS|||||||INVALID||10^3 CFU/G||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|ROOM TEMPERATURE|Y|MODIFIED ACID FAST STAIN|GMI MMOL/MOL FORMULA||N|N|N|Y|||N|3||39||BLINDED TREATMENT|1972-05-26|1968-09-07|||||1965-12-01||1970-02-13|NA|1962-10-24
TRIAL STUDY 134XCP|LB|DFF30783-4496-4134-8201-67C727683A7D|1||||BASO|BASOPHILS|||||||CONTAINER|||||||BORDERLINE||DIP||||LOW|NOT DONE||||LYSATE|THAWED|NA|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|FIBROMETER FORMULA||NA|N|NA|Y|||N|4||88||TREATMENT|1966-07-23|1971-10-07|||||1961-05-31||1967-03-29|NA|1968-12-13
TRIAL STUDY 134XCP|LB|DFF30783-4496-4134-8201-67C727683A7D|2||||COLOR|COLOR|||||||KS|||||||BORDERLINE||GPL U||||NORMAL|NOT DONE||||COLOSTRUM|CONCENTRATED|Y|DIRECT SEQUENCING|MDRD 6 VARIABLE FORMULA||Y|U|Y|Y|||NA|4||88||BLINDED TREATMENT|1960-03-04|1969-11-17|||||1966-10-23||1970-04-23|N|1969-06-14
TRIAL STUDY 134XCP|LB|DFF30783-4496-4134-8201-67C727683A7D|1||||MOCYCE|MONOCYTOID CELLS|||||||/7.5 ML|||||||NEGATIVE||CM2||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|CONCENTRATED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||U|N|Y|U|||U|5||7||WASHOUT|1973-03-25|1970-10-09|||||1963-05-21||1964-09-13|U|1969-04-21
TRIAL STUDY 134XCP|LB|DFF30783-4496-4134-8201-67C727683A7D|2||||MLIGCEBC|MALIGNANT CELLS, NOS/BLOOD CELLS|||||||10^9 CFU/G|||||||BORDERLINE||G/ANIMAL||||NORMAL|NOT DONE||||LEUKOCYTE|CONTAMINATED|NA|AUTOREFRACTION|CKD-EPI FORMULA||U|N|Y|U|||NA|5||7||RUN-IN|1962-11-07|1968-06-25|||||1964-05-09||1970-01-26|N|1960-11-27
TRIAL STUDY 134XCP|LB|970170C0-8FF0-4D24-84E8-1195272D55C0|1||||MYBLA|MYELOBLASTS|||||||PATCH|||||||BORDERLINE||MOSM/KG||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|UNEXPECTED ODOR|NA|TURBIDIMETRY|COCKCROFT-GAULT FORMULA||NA|NA|NA|Y|||U|1||38||OPEN LABEL TREATMENT|1973-08-05|1963-06-02|||||1962-07-29||1970-12-27|N|1970-01-07
TRIAL STUDY 134XCP|LB|970170C0-8FF0-4D24-84E8-1195272D55C0|2||||LY6E|LYMPHOCYTE ANTIGEN 6E|||||||MG/KG/H|||||||POSITIVE||UG/DL||||LOW|NOT DONE||||BLOOD|LACTESCENT|N|SLOAN LETTER EYE CHART 100%|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|Y|N|||U|1||38||WASHOUT|1966-03-16|1965-12-12|||||1963-01-14||1960-06-25|U|1962-12-04
TRIAL STUDY 134XCP|LB|970170C0-8FF0-4D24-84E8-1195272D55C0|1||||C165933|AMERICAN COCKROACH IGE AB RAST SCORE|||||||G/KG|||||||NEGATIVE||DPM/ML||||HIGH|NOT DONE||||VENOUS CORD BLOOD|THAWED|Y|NUCLEIC ACID SEQUENCING|CKD-EPI CREATININE FORMULA||Y|Y|NA|NA|||NA|2||58||SCREENING|1962-03-01|1969-11-30|||||1965-08-22||1964-08-04|Y|1965-11-03
TRIAL STUDY 134XCP|LB|970170C0-8FF0-4D24-84E8-1195272D55C0|2||||WBCCLMP|LEUKOCYTE CELL CLUMPS|||||||SCOOPFUL|||||||INVALID||PG/L||||ABNORMAL|NOT DONE||||DERMAL TISSUE|SOLIDIFIED|N|HIGH RESOLUTION CT|FIBROSIS 4 FORMULA||N|N|N|NA|||U|2||58||FOLLOW-UP|1963-02-14|1971-05-25|||||1968-01-01||1961-03-24|U|1962-07-17
TRIAL STUDY 134XCP|LB|970170C0-8FF0-4D24-84E8-1195272D55C0|1||||NEUTSG|NEUTROPHILS, SEGMENTED|||||||NMOL/MOL|||||||NEGATIVE||FG||||LOW|NOT DONE||||VITREOUS HUMOR|AUTOLYZED|NA|NUCLEIC ACID AMPLIFICATION TEST|FIBROSIS 4 FORMULA||U|Y|N|U|||Y|3||39||RUN-IN|1972-07-23|1971-04-19|||||1961-01-26||1960-05-27|NA|1965-09-18
TRIAL STUDY 134XCP|LB|970170C0-8FF0-4D24-84E8-1195272D55C0|2||||ALTCPHRL|ALPHA TOCOPHEROL|||||||BISCUIT|||||||INDETERMINATE||ELISA UNIT||||HIGH|NOT DONE||||SERUM|AGGLUTINATED|U|POLYGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|N|U|||U|3||39||TREATMENT|1965-08-20|1969-01-29|||||1973-03-27||1966-10-22|Y|1972-12-30
TRIAL STUDY 134XCP|LB|970170C0-8FF0-4D24-84E8-1195272D55C0|1||||ADSDNA|ANTI-DOUBLE STRANDED DNA|||||||10^6 CFU/G|||||||INDETERMINATE||U/ML||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|FRESH|NA|NEPHELOMETRY|MDRD 4 VARIABLE FORMULA||U|N|U|NA|||NA|4||88||RUN-IN|1961-01-04|1973-02-24|||||1961-01-26||1966-04-30|U|1960-08-26
TRIAL STUDY 134XCP|LB|970170C0-8FF0-4D24-84E8-1195272D55C0|2||||C130074|BIRCH POLLEN IGG|||||||V/SEC|||||||NEGATIVE||MG/M2/DAY||||LOW|NOT DONE||||CORD SERUM|PARAFFIN-EMBEDDED|Y|TELLER ACUITY CARDS|MDRD 5 VARIABLE FORMULA||Y|NA|N|U|||N|4||88||INDUCTION TREATMENT|1967-08-22|1967-04-09|||||1966-01-31||1966-08-23|NA|1960-10-07
TRIAL STUDY 134XCP|LB|970170C0-8FF0-4D24-84E8-1195272D55C0|1||||FUNGI|FUNGI|||||||MOSM|||||||NEGATIVE||IU/L||||LOW|NOT DONE||||PLATELET POOR PLASMA|AUTOLYZED|Y|JAFFE REACTION|CKD-EPI FORMULA||NA|U|Y|Y|||Y|5||7||BASELINE|1973-07-20|1962-10-19|||||1972-11-15||1964-05-05|N|1965-11-11
TRIAL STUDY 134XCP|LB|970170C0-8FF0-4D24-84E8-1195272D55C0|2||||ICAIGGAB|ISLET CELL CYTOPLASMIC IGG ANTIBODY|||||||HOURS|||||||INDETERMINATE||UG||||HIGH|NOT DONE||||EXPIRED AIR|AGGLUTINATED|Y|EPSILOMETER|MDRD 5 VARIABLE FORMULA||N|NA|NA|Y|||Y|5||7||OBSERVATION|1970-08-10|1960-08-03|||||1961-04-20||1961-02-28|Y|1967-03-02
TRIAL STUDY 134XCP|LB|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|1||||NEUTLE|NEUTROPHILS/LEUKOCYTES|||||||DDU|||||||BORDERLINE||DPM/0.5 ML||||HIGH|NOT DONE||||MUSCLE TISSUE|UNEXPECTED ODOR|Y|NUCLEIC ACID HYBRIDIZATION|HEPASCORE FORMULA||Y|Y|U|NA|||NA|1||38||OPEN LABEL TREATMENT|1971-11-16|1964-05-27|||||1968-07-31||1964-03-11|Y|1973-07-11
TRIAL STUDY 134XCP|LB|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|2||||CTXIICRT|TYPE II COLLAGEN C-TELOPEPTIDES/CREAT|||||||TUBERCULIN UNIT|||||||TRACE||UL/KG/DAY||||HIGH|NOT DONE||||BASAL TEAR|CLOTTED|Y|TRYPAN BLUE STAIN|COCKCROFT-GAULT FORMULA||U|U|N|NA|||Y|1||38||FOLLOW-UP|1964-07-13|1967-05-18|||||1972-04-18||1965-04-05|N|1960-10-06
TRIAL STUDY 134XCP|LB|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|1||||GGT|GAMMA GLUTAMYL TRANSFERASE|||||||APPLICATION|||||||POSITIVE||KHZ||||LOW|NOT DONE||||SEMEN|LIPEMIC|U|MAPH|FIBROTEST FORMULA||U|U|Y|Y|||Y|2||58||INDUCTION TREATMENT|1964-10-30|1964-01-08|||||1972-04-14||1972-12-07|NA|1962-01-14
TRIAL STUDY 134XCP|LB|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|2||||NTXI|TYPE I COLLAGEN N-TELOPEPTIDES|||||||ML/KG/MIN|||||||INVALID||G/CM2||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|CLOTTED|U|INTERRUPTER TECHNIQUE|GMI MMOL/MOL FORMULA||Y|U|N|NA|||U|2||58||LONG-TERM FOLLOW-UP|1960-12-20|1960-12-15|||||1960-12-15||1967-08-14|NA|1971-10-16
TRIAL STUDY 134XCP|LB|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|1||||CTLPRM|CITALOPRAM|||||||CM/S|||||||POSITIVE||G/ANIMAL||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|PARAFFIN-EMBEDDED|N|MODIFIED ACID FAST STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|U|NA|||N|3||39||INDUCTION TREATMENT|1961-02-26|1962-12-10|||||1961-05-09||1966-04-19|U|1968-05-26
TRIAL STUDY 134XCP|LB|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|2||||CD38|CD38|||||||UG/M2/DAY|||||||BORDERLINE||CD/M2||||ABNORMAL|NOT DONE||||SALIVA|GELLED|NA|OPTICAL DENSITY MEASUREMENT|COCKCROFT-GAULT FORMULA||Y|U|NA|Y|||U|3||39||BLINDED TREATMENT|1966-10-11|1969-11-15|||||1965-01-13||1962-11-15|N|1972-11-08
TRIAL STUDY 134XCP|LB|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|1||||C165889|RUSSIAN THISTLE POLLEN IGE AB RAST SCORE|||||||MU/G|||||||INDETERMINATE||MIN*MG/ML||||LOW|NOT DONE||||EXPIRED AIR|LIPEMIC|U|PULMONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|N|N|||Y|4||88||WASHOUT|1960-02-20|1961-02-18|||||1963-03-23||1971-11-14|N|1965-06-01
TRIAL STUDY 134XCP|LB|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|2||||HEXK|HEXOKINASE|||||||10^9/L|||||||INVALID||SQU/ML||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CALCIFIED|U|IMMUNO-PET SCAN|MDRD 4 VARIABLE FORMULA||U|Y|U|N|||N|4||88||OPEN LABEL TREATMENT|1962-05-25|1961-02-15|||||1969-02-23||1960-04-17|Y|1960-05-28
TRIAL STUDY 134XCP|LB|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|1||||C165910|BEE MIX IGG AB RAST SCORE|||||||PKAT|||||||BORDERLINE||GENEQ||||LOW|NOT DONE||||MUCUS|ROOM TEMPERATURE|Y|HPLC-UV|MDRD ENZYMATIC FORMULA||Y|N|U|U|||Y|5||7||SCREENING|1961-04-06|1961-08-09|||||1964-07-26||1967-05-21|U|1971-11-02
TRIAL STUDY 134XCP|LB|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|2||||CSEPI|EPITHELIAL CASTS|||||||ML/MIN|||||||POSITIVE||UG/KG||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|CONCENTRATED|N|SLOAN LETTER EYE CHART 100%|CKD-EPI CYSTATIN C FORMULA||NA|Y|N|Y|||Y|5||7||SCREENING|1966-01-15|1972-01-30|||||1963-07-31||1965-04-26|U|1960-09-01
TRIAL STUDY 134XCP|LB|69CC47A3-DA90-4919-889E-E0008ED689FA|1||||BLSTSID|SIDEROBLAST|||||||10^6/HPF|||||||TRACE||MOSM/L||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|SOLIDIFIED|U|FLAME PHOTOMETRY|GMI % FORMULA||NA|NA|NA|U|||Y|1||38||SCREENING|1969-08-24|1971-05-19|||||1972-04-09||1973-05-23|NA|1964-09-01
TRIAL STUDY 134XCP|LB|69CC47A3-DA90-4919-889E-E0008ED689FA|2||||HBOXHGB|OXYHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||NKAT|||||||INDETERMINATE||OHM||||NORMAL|NOT DONE||||TRANSUDATE|SOLIDIFIED|Y|WEBER GREEN STAIN|MDRD 6 VARIABLE FORMULA||N|NA|U|N|||U|1||38||TREATMENT|1970-02-27|1969-10-18|||||1963-06-12||1962-01-30|U|1963-10-24
TRIAL STUDY 134XCP|LB|69CC47A3-DA90-4919-889E-E0008ED689FA|1||||LIPASEG|LIPASE, GASTRIC|||||||CMH2O*S/ML|||||||BORDERLINE||KIU||||NORMAL|NOT DONE||||SEMEN|AUTOLYZED|Y|FLUORESCENT MICROSCOPY|FIBROSIS 4 FORMULA||Y|NA|Y|U|||Y|2||58||CONTINUATION TREATMENT|1964-02-14|1972-11-29|||||1961-05-13||1960-03-09|Y|1969-08-27
TRIAL STUDY 134XCP|LB|69CC47A3-DA90-4919-889E-E0008ED689FA|2||||HCGND|CHORIOGONADOTROPIN|||||||ML/MMHG/MIN/L|||||||NEGATIVE||MMOL/KG||||LOW|NOT DONE||||LEUKOCYTE|FROZEN|U|FLOW CYTOMETRY|CKD-EPI CREATININE FORMULA||N|NA|NA|NA|||Y|2||58||INDUCTION TREATMENT|1970-11-04|1965-12-25|||||1969-11-09||1971-08-11|U|1960-11-01
TRIAL STUDY 134XCP|LB|69CC47A3-DA90-4919-889E-E0008ED689FA|1||||PYRUVATE|PYRUVATE|||||||10^6 IU/ML|||||||INVALID||KG/CM2||||HIGH|NOT DONE||||SMEGMA|CONTAMINATED|U|IMPEDANCE CONDUCTIVITY|FIBROTEST FORMULA||NA|Y|NA|U|||Y|3||39||LONG-TERM FOLLOW-UP|1969-12-01|1971-08-28|||||1965-12-01||1965-12-04|U|1971-05-23
TRIAL STUDY 134XCP|LB|69CC47A3-DA90-4919-889E-E0008ED689FA|2||||FERRITIN|FERRITIN|||||||APPLICATION|||||||INDETERMINATE||UG/L FEU||||HIGH|NOT DONE||||CERUMEN|DRIED|U|KNEMOMETRY|MDRD ENZYMATIC FORMULA||N|NA|NA|U|||NA|3||39||RUN-IN|1962-01-31|1973-02-11|||||1961-07-30||1965-11-23|NA|1966-12-27
TRIAL STUDY 134XCP|LB|69CC47A3-DA90-4919-889E-E0008ED689FA|1||||LYMLG|LARGE LYMPHOCYTES|||||||SQU/ML|||||||TRACE||VIAL||||HIGH|NOT DONE||||REFLEX TEAR|UNEXPECTED ODOR|N|TRYPAN BLUE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|NA|U|||N|4||88||INDUCTION TREATMENT|1969-12-14|1973-03-19|||||1965-05-13||1962-01-02|U|1966-08-26
TRIAL STUDY 134XCP|LB|69CC47A3-DA90-4919-889E-E0008ED689FA|2||||MGB|MYOGLOBIN|||||||CFU/ML|||||||INDETERMINATE||ANTIBODY UNIT||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|HEMOLYZED|U|WRIGHT-GIEMSA STAIN|MDRD 6 VARIABLE FORMULA||N|NA|NA|U|||N|4||88||RUN-IN|1969-06-03|1960-09-24|||||1966-12-11||1968-08-03|N|1973-02-08
TRIAL STUDY 134XCP|LB|69CC47A3-DA90-4919-889E-E0008ED689FA|1||||KRCYMGCE|MEGAKARYOCYTES/TOTAL CELLS|||||||UG/L DDU|||||||INDETERMINATE||10^9/L||||HIGH|NOT DONE||||BLOOD|FROZEN|U|MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||N|N|U|Y|||U|5||7||OBSERVATION|1965-10-29|1971-04-26|||||1960-10-29||1969-10-08|N|1971-01-03
TRIAL STUDY 134XCP|LB|69CC47A3-DA90-4919-889E-E0008ED689FA|2||||ENA78|EPITH NEUTROPHIL-ACTIVATING PEPTIDE 78|||||||GMFI|||||||POSITIVE||SBE/ML||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|LACTESCENT|Y|DIFFUSION TENSOR MRI|MDRD 5 VARIABLE FORMULA||N|U|U|Y|||NA|5||7||SCREENING|1964-07-20|1969-08-11|||||1965-09-20||1962-09-04|Y|1971-07-10
TRIAL STUDY 134XCP|LB|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|1||||PTAC|PROTHROMBIN TIME ACTUAL/CONTROL|||||||TABLET|||||||POSITIVE||MSEC||||LOW|NOT DONE||||SUPERNATANT, SERUM|HEMOLYZED|U|ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|Y|NA|||Y|1||38||WASHOUT|1970-05-07|1972-01-09|||||1964-06-12||1973-06-25|U|1964-11-16
TRIAL STUDY 134XCP|LB|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|2||||C3B|COMPLEMENT C3B|||||||U/10^12 RBC|||||||POSITIVE||AMOL||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|FRESH|N|SLOAN LETTER EYE CHART 2.5%|CKD-EPI CYSTATIN C FORMULA||U|Y|N|U|||Y|1||38||OPEN LABEL TREATMENT|1971-05-28|1973-05-05|||||1969-09-11||1966-03-18|Y|1972-11-24
TRIAL STUDY 134XCP|LB|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|1||||FXIVAAC|FACTOR XIV ACTIVITY ACTUAL/CONTROL|||||||PG/DL|||||||BORDERLINE||COPIES/UG||||NORMAL|NOT DONE||||PERITONEAL FLUID|GELLED|U|POPULATION SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|U|U|||NA|2||58||CONTINUATION TREATMENT|1960-05-24|1968-05-02|||||1961-10-12||1966-06-26|N|1968-06-26
TRIAL STUDY 134XCP|LB|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|2||||ANCCLSAB|NEUTROPHIL CYTOPLASMIC AB, CLASSIC|||||||MEQ|||||||TRACE||CMH2O/ML||||NORMAL|NOT DONE||||SKIN TISSUE|FRESH|NA|IMMUNO-PET SCAN|MDRD 6 VARIABLE FORMULA||NA|N|N|N|||U|2||58||WASHOUT|1963-10-11|1969-03-06|||||1964-12-07||1969-12-01|N|1970-01-09
TRIAL STUDY 134XCP|LB|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|1||||ANCIGAB|ANTI-NEUTROPHIL CYTOPLASMIC IGG ANTIBODY|||||||/LPF|||||||BORDERLINE||U/KG/MIN||||HIGH|NOT DONE||||VENOUS BLOOD|UNEXPECTED ODOR|N|QUANTITATIVE ULTRASOUND|CKD-EPI FORMULA||NA|Y|U|NA|||Y|3||39||SCREENING|1969-12-27|1966-09-25|||||1973-06-21||1969-01-19|U|1961-03-13
TRIAL STUDY 134XCP|LB|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|2||||VITA|VITAMIN A|||||||UM/DAY|||||||POSITIVE||HR/DAY||||NORMAL|NOT DONE||||EMESIS|HEMOLYZED|Y|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|Y|N|||N|3||39||TREATMENT|1970-10-29|1965-06-26|||||1973-01-27||1965-12-17|NA|1972-05-19
TRIAL STUDY 134XCP|LB|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|1||||NTELOCRT|N-TELOPEPTIDE/CREATININE|||||||10^12 IU/L|||||||INDETERMINATE||DB||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|UNEXPECTED ODOR|NA|WRIGHT STAIN|CKD-EPI CYSTATIN C FORMULA||N|Y|Y|N|||Y|4||88||OPEN LABEL TREATMENT|1972-03-17|1970-03-26|||||1966-06-22||1963-08-24|NA|1963-01-24
TRIAL STUDY 134XCP|LB|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|2||||CCL23|CHEMOKINE (C-C MOTIF) LIGAND 23|||||||IU/DAY|||||||INDETERMINATE||MET*MIN||||LOW|NOT DONE||||PERSPIRATION|DRIED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|COCKCROFT-GAULT FORMULA||N|N|U|N|||N|4||88||LONG-TERM FOLLOW-UP|1967-06-13|1961-01-02|||||1973-07-12||1964-03-09|N|1962-06-30
TRIAL STUDY 134XCP|LB|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|1||||HLAA23A|HLA-A23 ANTIBODY|||||||10^6 RNA COPIES/ML|||||||INVALID||JOULE||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|AGGLUTINATED|N|NUCLEIC ACID HYBRIDIZATION|MDRD 5 VARIABLE FORMULA||NA|Y|U|U|||U|5||7||BASELINE|1962-01-12|1962-11-15|||||1969-05-28||1967-05-01|N|1964-01-14
TRIAL STUDY 134XCP|LB|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|2||||G6PDA|GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACT|||||||KV|||||||TRACE||APL U||||LOW|NOT DONE||||DERMAL TISSUE|ICTERIC|NA|DUKE INCISION METHOD|MDRD 5 VARIABLE FORMULA||NA|NA|N|Y|||N|5||7||INDUCTION TREATMENT|1963-03-12|1970-04-20|||||1968-01-01||1960-08-22|NA|1964-02-01
TRIAL STUDY 134XCP|LB|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|1||||PHTRMN|PHENTERMINE|||||||L|||||||BORDERLINE||GY/H||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FRESH|NA|DIGITAL PCR|FIBROTEST FORMULA||Y|NA|NA|U|||U|1||38||OPEN LABEL TREATMENT|1965-07-30|1970-11-17|||||1968-10-01||1972-03-18|U|1960-01-08
TRIAL STUDY 134XCP|LB|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|2||||PTSFAC|PROTEIN S, FREE ACTUAL/CONTROL|||||||PG|||||||POSITIVE||KIU||||LOW|NOT DONE||||BILE|LIPEMIC|N|ENDPOINT DILUTION ASSAY|CKD-EPI CYSTATIN C FORMULA||N|U|Y|U|||U|1||38||CONTINUATION TREATMENT|1961-06-26|1963-09-11|||||1966-08-06||1961-07-18|Y|1968-03-21
TRIAL STUDY 134XCP|LB|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|1||||ALBEXR|ALBUMIN EXCRETION RATE|||||||CM/S|||||||TRACE||10^6 ORGANISMS/ML||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CLOTTED|Y|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROMETER FORMULA||NA|U|Y|N|||N|2||58||LONG-TERM FOLLOW-UP|1961-09-15|1967-11-09|||||1964-10-21||1971-11-14|N|1962-01-13
TRIAL STUDY 134XCP|LB|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|2||||PRORUBCE|PRORUBRICYTE/TOTAL CELLS|||||||TUBERCULIN UNIT|||||||BORDERLINE||KPA/L/SEC||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|DRIED|U|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|CKD-EPI FORMULA||U|N|U|Y|||Y|2||58||BLINDED TREATMENT|1962-12-14|1966-02-25|||||1965-02-28||1971-08-25|NA|1962-06-15
TRIAL STUDY 134XCP|LB|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|1||||NSPMTSPM|NORMAL SPERM/TOTAL SPERM|||||||TUBERCULIN UNIT|||||||NEGATIVE||ML/G/DAY||||HIGH|NOT DONE||||BUFFY COAT|LACTESCENT|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD ENZYMATIC FORMULA||NA|Y|U|NA|||NA|3||39||WASHOUT|1966-06-17|1971-06-30|||||1963-09-29||1963-08-14|NA|1961-01-23
TRIAL STUDY 134XCP|LB|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|2||||CA72_4AG|CANCER ANTIGEN 72-4|||||||10^6 CFU/ML|||||||INVALID||ML/BREATH||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|LIPEMIC|NA|MANUAL CLOT DETECTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|U|N|||Y|3||39||BASELINE|1966-03-07|1965-10-15|||||1970-08-19||1966-11-21|Y|1962-04-22
TRIAL STUDY 134XCP|LB|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|1||||MENGL|MENINGEAL CELLS|||||||DL|||||||NEGATIVE||CMOL/L||||NORMAL|NOT DONE||||MECONIUM|SOLIDIFIED|U|CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI CREATININE FORMULA||Y|N|N|N|||U|4||88||WASHOUT|1968-12-30|1971-08-24|||||1965-01-01||1970-03-24|N|1968-05-26
TRIAL STUDY 134XCP|LB|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|2||||ABO|ABO BLOOD GROUP|||||||MMOL|||||||BORDERLINE||SACHET||||LOW|NOT DONE||||DERMAL TISSUE|THAWED|NA|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NASH FIBROSURE FORMULA||U|U|Y|U|||Y|4||88||BLINDED TREATMENT|1961-06-13|1973-02-22|||||1973-09-03||1961-09-13|NA|1968-05-31
TRIAL STUDY 134XCP|LB|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|1||||C165889|RUSSIAN THISTLE POLLEN IGE AB RAST SCORE|||||||NSEC|||||||NEGATIVE||MV||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FROZEN|U|U-HPLC/MS/MS|MDRD FORMULA||N|Y|U|Y|||NA|5||7||TREATMENT|1968-02-08|1969-05-13|||||1961-10-20||1972-11-07|NA|1962-12-07
TRIAL STUDY 134XCP|LB|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|2||||OAS2|2-5-OLIGOADENYLATE SYNTHASE 2|||||||MANSON U/ML|||||||INVALID||L/S/KPA||||HIGH|NOT DONE||||SMEGMA|HEMOLYZED|Y|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|FIBROTEST FORMULA||N|N|N|N|||N|5||7||TREATMENT|1961-02-16|1965-04-12|||||1965-07-18||1962-11-30|NA|1967-11-16
TRIAL STUDY 134XCP|LB|0281E055-F419-4BA2-89CE-23EC7428CDA0|1||||CCL17|CHEMOKINE (C-C MOTIF) LIGAND 17|||||||MPH|||||||POSITIVE||DAYS/MONTH||||LOW|NOT DONE||||ADIPOSE TISSUE|SOLIDIFIED|U|DXA SCAN|CKD-EPI CYSTATIN C FORMULA||NA|N|NA|Y|||U|1||38||OBSERVATION|1963-03-18|1966-03-04|||||1961-04-02||1963-12-23|N|1962-08-30
TRIAL STUDY 134XCP|LB|0281E055-F419-4BA2-89CE-23EC7428CDA0|2||||GLOBB1|BETA-1 GLOBULIN|||||||TRANSDUCING UNIT|||||||INDETERMINATE||ML/KG/H||||NORMAL|NOT DONE||||SPERMATOZOON|CALCIFIED|N|FREEZING POINT DEPRESSION|FIBROSIS 4 FORMULA||N|N|U|Y|||NA|1||38||WASHOUT|1971-06-10|1965-09-11|||||1964-06-21||1969-03-25|Y|1973-07-02
TRIAL STUDY 134XCP|LB|0281E055-F419-4BA2-89CE-23EC7428CDA0|1||||SODMEXR|SODIUM EXCRETION RATE|||||||NEWTON|||||||POSITIVE||MASK||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|ICTERIC|U|RYAN BLUE STAIN|FIBROMETER FORMULA||U|NA|NA|N|||NA|2||58||OPEN LABEL TREATMENT|1969-09-02|1964-09-04|||||1969-11-04||1960-03-11|NA|1966-05-19
TRIAL STUDY 134XCP|LB|0281E055-F419-4BA2-89CE-23EC7428CDA0|2||||C4|COMPLEMENT C4|||||||10^4 CFU|||||||INDETERMINATE||UG/M2/DAY||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|CONTAMINATED|Y|FLOW CYTOMETRY|MDRD 5 VARIABLE FORMULA||N|U|U|N|||N|2||58||CONTINUATION TREATMENT|1965-10-10|1964-12-06|||||1971-08-24||1971-02-14|Y|1969-01-23
TRIAL STUDY 134XCP|LB|0281E055-F419-4BA2-89CE-23EC7428CDA0|1||||BASOIMLE|IMMATURE BASOPHILS/LEUKOCYTES|||||||/MBP|||||||INVALID||ML/MIN||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED|U|PERIPHERAL ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|U|Y|||NA|3||39||OBSERVATION|1960-05-20|1968-08-31|||||1973-04-16||1968-08-01|U|1971-04-11
TRIAL STUDY 134XCP|LB|0281E055-F419-4BA2-89CE-23EC7428CDA0|2||||TTGIGGAB|TISSUE TRANSGLUTAMINASE IGG ANTIBODY|||||||BREATHS/30S|||||||NEGATIVE||LOG10 IU/ML||||NORMAL|NOT DONE||||PLASMA|ROOM TEMPERATURE|NA|CYSTOSCOPY|FIBROMETER FORMULA||U|NA|U|U|||Y|3||39||BLINDED TREATMENT|1973-07-17|1967-04-09|||||1972-03-16||1964-03-26|U|1966-10-02
TRIAL STUDY 134XCP|LB|0281E055-F419-4BA2-89CE-23EC7428CDA0|1||||VITDAT|1, 25-DIHYDROXYVITAMIN D|||||||STEPS/MIN|||||||POSITIVE||FMOL/L/SEC||||HIGH|NOT DONE||||SEMINAL FLUID|AGGLUTINATED|Y|VIRUS PLAQUE ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|NA|Y|||Y|4||88||INDUCTION TREATMENT|1961-05-03|1972-09-04|||||1968-05-19||1960-02-14|NA|1964-12-19
TRIAL STUDY 134XCP|LB|0281E055-F419-4BA2-89CE-23EC7428CDA0|2||||FEP|ERYTHROCYTE PROTOPORPHYRIN, FREE|||||||BQ|||||||POSITIVE||BEAM BREAKS||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|THAWED|U|POTENTIOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|U|N|||NA|4||88||BASELINE|1966-12-06|1973-04-23|||||1966-07-27||1973-04-01|U|1970-09-29
TRIAL STUDY 134XCP|LB|0281E055-F419-4BA2-89CE-23EC7428CDA0|1||||DHEA|DEHYDROEPIANDROSTERONE|||||||PSEC|||||||BORDERLINE||MOSM/L||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|FROZEN|NA|COMPLEMENT FIXATION|MDRD ENZYMATIC FORMULA||Y|Y|NA|U|||Y|5||7||SCREENING|1964-04-09|1965-02-26|||||1968-10-11||1971-12-03|Y|1971-01-11
TRIAL STUDY 134XCP|LB|0281E055-F419-4BA2-89CE-23EC7428CDA0|2||||PROLCTN|PROLACTIN|||||||U/KG/DAY|||||||BORDERLINE||ML/BREATH||||HIGH|NOT DONE||||DISCHARGE|FROZEN|U|ISHIHARA COLOR PLATES|GMI MMOL/MOL FORMULA||U|U|U|NA|||U|5||7||TREATMENT|1964-10-31|1965-12-02|||||1972-03-25||1962-09-25|U|1970-12-13
TRIAL STUDY 134XCP|LB|23CE1310-DBB3-4135-8E11-2A870CE42D50|1||||PAI1AG|PLASMINOGEN ACTIVATOR INHIBITOR-1 AG|||||||NEEDLE GAUGE|||||||NEGATIVE||ECL UNIT||||HIGH|NOT DONE||||LYSATE|SOLIDIFIED|N|FORCED OSCILLATION TECHNIQUE|MDRD 5 VARIABLE FORMULA||Y|N|N|Y|||NA|1||38||RUN-IN|1972-12-31|1967-01-01|||||1971-10-12||1964-12-04|U|1961-07-20
TRIAL STUDY 134XCP|LB|23CE1310-DBB3-4135-8E11-2A870CE42D50|2||||C165916|D. FARINAE IGG AB RAST SCORE|||||||10^9/DOSE|||||||TRACE||SBE/ML||||ABNORMAL|NOT DONE||||SEBUM|CLOTTED|N|BALLPOINT PEN TECHNIQUE|CKD-EPI FORMULA||NA|N|NA|NA|||U|1||38||WASHOUT|1966-02-11|1960-03-22|||||1971-03-01||1966-09-25|N|1960-01-16
TRIAL STUDY 134XCP|LB|23CE1310-DBB3-4135-8E11-2A870CE42D50|1||||LDLPATT|LDL SUBTYPE PATTERN|||||||PT_US|||||||POSITIVE||ELISA UNIT||||HIGH|NOT DONE||||ADIPOSE TISSUE|AUTOLYZED|Y|FLUOROSCOPY|MDRD ENZYMATIC FORMULA||N|NA|U|Y|||N|2||58||OBSERVATION|1972-07-24|1971-03-18|||||1967-04-02||1966-05-19|N|1970-04-28
TRIAL STUDY 134XCP|LB|23CE1310-DBB3-4135-8E11-2A870CE42D50|2||||SPERM|SPERMATOZOA|||||||CI/UG|||||||NEGATIVE||ANSON U||||HIGH|NOT DONE||||WHITE MATTER TISSUE|LIPEMIC|NA|INDIRECT IMMUNOFLUORESCENCE|MDRD 4 VARIABLE FORMULA||NA|U|Y|N|||NA|2||58||RUN-IN|1969-12-20|1965-06-25|||||1971-09-10||1960-02-23|NA|1970-04-27
TRIAL STUDY 134XCP|LB|23CE1310-DBB3-4135-8E11-2A870CE42D50|1||||TGFB|TRANSFORMING GROWTH FACTOR BETA|||||||EIA UNIT|||||||BORDERLINE||AMFI||||NORMAL|NOT DONE||||ALVEOLAR AIR|FRESH|Y|IMMUNOFIXATION ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA||NA|NA|U|NA|||N|3||39||CONTINUATION TREATMENT|1967-05-25|1973-07-30|||||1960-04-23||1964-07-31|N|1970-01-16
TRIAL STUDY 134XCP|LB|23CE1310-DBB3-4135-8E11-2A870CE42D50|2||||FDP|FIBRIN DEGRADATION PRODUCTS|||||||NMOL/MOL|||||||TRACE||10^6/G||||NORMAL|NOT DONE||||EXUDATE|NON-HEMOLYZED|NA|IMPEDANCE CONDUCTIVITY|FIBROSIS 4 FORMULA||Y|Y|NA|NA|||U|3||39||FOLLOW-UP|1968-12-24|1968-12-06|||||1968-12-20||1961-02-14|U|1966-04-12
TRIAL STUDY 134XCP|LB|23CE1310-DBB3-4135-8E11-2A870CE42D50|1||||RETIHRTC|HIGH ABSORPTION RETIC/RETICULOCYTES|||||||NKAT/G HB|||||||TRACE||10^6 CFU||||LOW|NOT DONE||||BLOOD|FRESH|NA|FUNCTIONAL MRI|GMI MMOL/MOL FORMULA||Y|N|Y|Y|||Y|4||88||RUN-IN|1970-04-07|1963-11-11|||||1968-06-08||1965-04-04|NA|1966-01-18
TRIAL STUDY 134XCP|LB|23CE1310-DBB3-4135-8E11-2A870CE42D50|2||||CHOLHDL|CHOLESTEROL/HDL-CHOLESTEROL|||||||CM/S|||||||TRACE||DRINK||||LOW|NOT DONE||||LYMPH|CALCIFIED|N|ATOMIC ABSORPTION SPECTROMETRY|FIBROTEST FORMULA||Y|Y|N|N|||U|4||88||BLINDED TREATMENT|1972-11-07|1962-07-17|||||1960-01-28||1964-01-10|NA|1966-10-12
TRIAL STUDY 134XCP|LB|23CE1310-DBB3-4135-8E11-2A870CE42D50|1||||CETP|CHOLESTERYL ESTER TRANSFER PROTEIN|||||||STEPS/MIN|||||||TRACE||KBQ/UL||||LOW|NOT DONE||||ERYTHROCYTES|PARAFFIN-EMBEDDED|N|POLYSOMNOGRAPHY|COCKCROFT-GAULT FORMULA||U|N|NA|N|||U|5||7||TREATMENT|1967-08-11|1961-08-19|||||1964-03-06||1964-02-09|Y|1962-05-27
TRIAL STUDY 134XCP|LB|23CE1310-DBB3-4135-8E11-2A870CE42D50|2||||AMORPHSD|AMORPHOUS SEDIMENT|||||||PACK|||||||BORDERLINE||MOSM||||HIGH|NOT DONE||||SMEGMA|CALCIFIED|U|DIPSTICK|CKD-EPI CREATININE FORMULA||NA|N|Y|U|||N|5||7||BLINDED TREATMENT|1960-02-15|1962-09-01|||||1966-03-13||1965-09-29|U|1962-02-22
TRIAL STUDY 134XCP|LB|CC80D8A2-7D71-428B-9599-C0D0312B8691|1||||C165887|ENGLISHPLANTAIN POLLEN IGE AB RAST SCORE|||||||BAR|||||||NEGATIVE||TSP EQ||||HIGH|NOT DONE||||RETICULOCYTES|HEMOLYZED|Y|PLETHYSMOGRAPHY|FIBROSIS 4 FORMULA||Y|U|Y|U|||Y|1||38||FOLLOW-UP|1960-05-04|1964-04-05|||||1965-05-07||1965-12-26|N|1965-09-21
TRIAL STUDY 134XCP|LB|CC80D8A2-7D71-428B-9599-C0D0312B8691|2||||MEPRDN|MEPERIDINE|||||||KCAL|||||||INDETERMINATE||KCAL/DAY||||HIGH|NOT DONE||||SUPERNATANT, SERUM|UNEXPECTED ODOR|U|SLOAN LETTER EYE CHART 1.25%|MDRD 5 VARIABLE FORMULA||Y|Y|N|N|||N|1||38||WASHOUT|1963-12-09|1961-03-10|||||1963-01-05||1962-02-20|NA|1967-05-24
TRIAL STUDY 134XCP|LB|CC80D8A2-7D71-428B-9599-C0D0312B8691|1||||VLDL|VLDL CHOLESTEROL|||||||PMOL/L/H|||||||INDETERMINATE||BQ/KG||||LOW|NOT DONE||||SPUTUM|SOLIDIFIED|N|ELISPOT|MDRD ENZYMATIC FORMULA||U|Y|NA|N|||N|2||58||BASELINE|1960-04-20|1969-10-23|||||1962-04-04||1970-06-28|Y|1965-09-22
TRIAL STUDY 134XCP|LB|CC80D8A2-7D71-428B-9599-C0D0312B8691|2||||NITRATE|NITRATE|||||||MU/G|||||||POSITIVE||10^9 CFU/ML||||LOW|NOT DONE||||BASAL TEAR|GELLED|Y|PET SCAN|MDRD FORMULA||N|N|NA|U|||NA|2||58||TREATMENT|1966-01-24|1968-12-26|||||1973-01-01||1972-04-28|NA|1963-01-23
TRIAL STUDY 134XCP|LB|CC80D8A2-7D71-428B-9599-C0D0312B8691|1||||C130114|INDUSTRIAL MIX ANTIGEN IGE ANTIBODY|||||||MONTHS|||||||POSITIVE||BQ/KG||||NORMAL|NOT DONE||||CORD BLOOD|CONTAMINATED|U|ELLA|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|NA|Y|||NA|3||39||OBSERVATION|1962-01-12|1971-02-08|||||1963-01-28||1960-10-06|Y|1960-03-08
TRIAL STUDY 134XCP|LB|CC80D8A2-7D71-428B-9599-C0D0312B8691|2||||CRNTESTR|CARNITINE ESTERS|||||||EIA UNIT|||||||TRACE||EID 50/DOSE||||LOW|NOT DONE||||MUCUS|GELLED|NA|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||U|Y|U|N|||N|3||39||LONG-TERM FOLLOW-UP|1971-06-06|1960-06-19|||||1966-10-03||1964-06-01|U|1968-06-02
TRIAL STUDY 134XCP|LB|CC80D8A2-7D71-428B-9599-C0D0312B8691|1||||THBD|THROMBOMODULIN|||||||L/MIN|||||||BORDERLINE||DL||||HIGH|NOT DONE||||TISSUE|AUTOLYZED|U|PHOTOMETRY|MDRD 4 VARIABLE FORMULA||Y|U|NA|Y|||N|4||88||RUN-IN|1973-07-07|1972-05-09|||||1960-06-30||1964-11-13|N|1971-07-03
TRIAL STUDY 134XCP|LB|CC80D8A2-7D71-428B-9599-C0D0312B8691|2||||TSTSFRPT|TESTOSTERONE, FREE/TOTAL PROTEIN|||||||PG/CELL|||||||BORDERLINE||CYLINDER||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|CLOTTED|Y|FLOW MICROSCOPY|HEPASCORE FORMULA||Y|NA|N|U|||Y|4||88||INDUCTION TREATMENT|1962-06-06|1969-06-30|||||1961-06-07||1968-08-01|U|1972-09-16
TRIAL STUDY 134XCP|LB|CC80D8A2-7D71-428B-9599-C0D0312B8691|1||||MONOIM|IMMATURE MONOCYTES|||||||NL|||||||INVALID||UU/L||||LOW|NOT DONE||||SOFT TISSUE|GELLED|NA|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|MDRD FORMULA||U|U|NA|U|||U|5||7||OBSERVATION|1972-01-11|1969-07-15|||||1962-01-29||1966-04-02|U|1972-12-16
TRIAL STUDY 134XCP|LB|CC80D8A2-7D71-428B-9599-C0D0312B8691|2||||PSIGMAB|PHOSPHATIDYLSERINE IGM ANTIBODY|||||||VP/ML|||||||INDETERMINATE||TSP EQ||||HIGH|NOT DONE||||SERUM|AGGLUTINATED|Y|AMSLER GRID|FIBROSIS 4 FORMULA||U|NA|N|N|||NA|5||7||RUN-IN|1964-07-08|1967-04-21|||||1968-12-03||1970-03-21|U|1961-01-27
TRIAL STUDY 134XCP|LB|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|1||||RUB|RUBRICYTE|||||||YEARS|||||||BORDERLINE||ANSON U||||NORMAL|NOT DONE||||LYSATE|CONTAMINATED|U|GRADIENT DIFFUSION|FIBROMETER FORMULA||NA|U|N|N|||NA|1||38||TREATMENT|1964-09-14|1962-06-14|||||1970-10-12||1966-05-24|Y|1973-06-10
TRIAL STUDY 134XCP|LB|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|2||||IGG3|IMMUNOGLOBULIN G SUBCLASS 3|||||||IU/G|||||||INDETERMINATE||CAN||||HIGH|NOT DONE||||ABSCESS FLUID|GELLED|U|ALCIAN BLUE STAIN|ASH FIBROSURE FORMULA||N|NA|NA|Y|||U|1||38||BLINDED TREATMENT|1968-12-03|1965-08-04|||||1966-02-02||1973-05-18|U|1966-10-18
TRIAL STUDY 134XCP|LB|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|1||||ANGTNSGN|ANGIOTENSINOGEN|||||||MONTHS|||||||INVALID||SYRINGE||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONCENTRATED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||U|Y|U|Y|||U|2||58||FOLLOW-UP|1971-04-26|1970-01-10|||||1964-01-04||1967-08-18|NA|1972-11-11
TRIAL STUDY 134XCP|LB|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|2||||CD56|CD56|||||||KA_U/DL|||||||NEGATIVE||IU/KG||||HIGH|NOT DONE||||BASAL TEAR|ICTERIC|U|GC/MS|MDRD 6 VARIABLE FORMULA||Y|Y|Y|Y|||U|2||58||SCREENING|1971-12-02|1970-04-16|||||1964-12-18||1966-11-10|N|1972-05-22
TRIAL STUDY 134XCP|LB|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|1||||HER2S|SOLUBLE HER2|||||||PNU/ML|||||||BORDERLINE||MM/H||||LOW|NOT DONE||||VITREOUS HUMOR|CONTAMINATED|NA|MICROARRAY|MDRD 5 VARIABLE FORMULA||NA|Y|NA|NA|||N|3||39||BASELINE|1966-10-26|1960-04-27|||||1965-09-11||1961-05-03|N|1965-02-12
TRIAL STUDY 134XCP|LB|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|2||||TPROT|TAU PROTEIN|||||||AU/ML|||||||INVALID||UKAT||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|CONCENTRATED|N|PET/CT SCAN WITHOUT CONTRAST|FIBROSIS 4 FORMULA||U|U|U|Y|||NA|3||39||BLINDED TREATMENT|1964-09-29|1961-10-14|||||1967-01-24||1971-07-01|Y|1972-01-19
TRIAL STUDY 134XCP|LB|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|1||||C130093|WESTERN RAGWEED POLLEN IGA|||||||MG/KG/DOSE|||||||INVALID||%/S||||HIGH|NOT DONE||||CORD BLOOD|NON-HEMOLYZED|Y|SCANNING ELECTRON MICROSCOPY|CKD-EPI FORMULA||N|NA|N|N|||NA|4||88||RUN-IN|1971-12-10|1972-01-25|||||1965-09-08||1972-04-03|NA|1966-02-05
TRIAL STUDY 134XCP|LB|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|2||||FIBRINOF|FIBRINOGEN, FUNCTIONAL|||||||U/ANIMAL|||||||INVALID||SUPPOSITORY||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED|NA|WHOLE GENOME SEQUENCING|HEPASCORE FORMULA||Y|N|NA|U|||U|4||88||BASELINE|1963-01-05|1965-07-17|||||1970-03-25||1965-10-17|NA|1964-12-08
TRIAL STUDY 134XCP|LB|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|1||||CD40L|CD40 LIGAND|||||||NG/DL|||||||NEGATIVE||MMHG||||NORMAL|NOT DONE||||CAPILLARY BLOOD|ICTERIC|U|LC/MS|GMI MMOL/MOL FORMULA||N|NA|U|U|||U|5||7||RUN-IN|1966-02-12|1961-09-11|||||1967-11-18||1962-12-25|N|1961-06-17
TRIAL STUDY 134XCP|LB|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|2||||PLATBIZ|BIZARRE PLATELETS|||||||PA|||||||NEGATIVE||PG||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|AUTOLYZED|N|EEG|MDRD 5 VARIABLE FORMULA||Y|N|U|Y|||N|5||7||OPEN LABEL TREATMENT|1961-10-23|1966-10-12|||||1970-10-23||1966-06-29|U|1971-07-02
TRIAL STUDY 134XCP|LB|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|1||||SH2D1A|SH2 DOMAIN CONTAINING 1A PROTEIN|||||||FRAMES/S|||||||TRACE||PATCH||||NORMAL|NOT DONE||||AMNIOTIC FLUID|ROOM TEMPERATURE|N|RYAN BLUE STAIN|MDRD 6 VARIABLE FORMULA||U|NA|U|Y|||N|1||38||INDUCTION TREATMENT|1966-06-09|1961-02-01|||||1961-03-03||1967-07-31|U|1966-03-14
TRIAL STUDY 134XCP|LB|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|2||||MDA|3,4-METHYLENEDIOXYAMPHETAMINE|||||||NKAT|||||||TRACE||MEQ/KG||||ABNORMAL|NOT DONE||||LEUKOCYTE|AUTOLYZED|Y|DYNAMIC LIGHT SCATTERING|MDRD 4 VARIABLE FORMULA||Y|N|NA|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1969-09-22|1962-08-22|||||1964-04-16||1964-08-12|U|1973-05-16
TRIAL STUDY 134XCP|LB|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|1||||IL2R|INTERLEUKIN 2 RECEPTOR|||||||PPM|||||||BORDERLINE||MG/ANIMAL||||HIGH|NOT DONE||||PERITONEAL FLUID|CALCIFIED|U|IMPULSE OSCILLOMETRY|MDRD 6 VARIABLE FORMULA||U|Y|U|Y|||NA|2||58||FOLLOW-UP|1967-09-02|1970-10-20|||||1969-05-02||1960-11-07|Y|1970-04-21
TRIAL STUDY 134XCP|LB|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|2||||GFRBSA|GLOMERULAR FILTRATION RATE ADJ FOR BSA|||||||PIXELS/CM|||||||TRACE||/MONTH||||ABNORMAL|NOT DONE||||SKIN TISSUE|PARAFFIN-EMBEDDED|Y|REFRACTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|Y|U|||Y|2||58||RUN-IN|1962-03-02|1970-09-03|||||1970-12-06||1967-03-12|U|1970-05-08
TRIAL STUDY 134XCP|LB|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|1||||BASEDEF|BASE DEFICIT|||||||CAL|||||||BORDERLINE||GPL U||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|FRESH|Y|HEMOCYTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|N|||Y|3||39||BASELINE|1973-08-06|1960-03-13|||||1966-10-02||1970-12-30|U|1966-08-06
TRIAL STUDY 134XCP|LB|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|2||||WBCCLMP|LEUKOCYTE CELL CLUMPS|||||||IU/KG|||||||TRACE||ML/KG/MIN||||NORMAL|NOT DONE||||GASTRIC FLUID|LIPEMIC|Y|DIFFUSION WEIGHTED MRI|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|N|N|||NA|3||39||LONG-TERM FOLLOW-UP|1960-07-31|1968-03-12|||||1968-03-22||1963-04-19|NA|1970-04-30
TRIAL STUDY 134XCP|LB|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|1||||LVTRCTM|LEVETIRACETAM|||||||MG/G/H|||||||INDETERMINATE||OD UNIT||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|SOLIDIFIED|U|NON-INVASIVE DIELECTRIC SENSING|MDRD 6 VARIABLE FORMULA||Y|NA|Y|NA|||Y|4||88||FOLLOW-UP|1960-02-18|1961-04-01|||||1971-11-10||1970-02-27|Y|1968-07-29
TRIAL STUDY 134XCP|LB|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|2||||OXMORPHN|OXYMORPHONE|||||||LOG10 CFU/ML|||||||TRACE||FRACTION OF 1||||HIGH|NOT DONE||||SPUTUM|UNEXPECTED ODOR|NA|PLETHYSMOGRAPHY|MDRD FORMULA||NA|N|Y|N|||Y|4||88||SCREENING|1970-01-04|1961-06-25|||||1965-09-19||1971-02-15|Y|1968-12-24
TRIAL STUDY 134XCP|LB|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|1||||TRYPSIN|TRYPSIN|||||||MM/SEC|||||||POSITIVE||/4.0 ML||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|ROOM TEMPERATURE|N|PET/MRI SCAN|CKD-EPI CYSTATIN C FORMULA||NA|Y|Y|Y|||N|5||7||OPEN LABEL TREATMENT|1966-11-09|1968-01-11|||||1965-02-07||1965-01-30|Y|1968-11-24
TRIAL STUDY 134XCP|LB|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|2||||INTLK33|INTERLEUKIN 33|||||||CD|||||||TRACE||LB||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|REFRIGERATED|U|WEBER GREEN STAIN|MDRD FORMULA||N|N|NA|N|||U|5||7||TREATMENT|1971-07-09|1968-11-14|||||1961-03-29||1961-12-16|NA|1970-04-01
TRIAL STUDY 134XCP|LB|3D25A735-6298-4AF4-91CC-AE8D481DF552|1||||C165882|WHITE ELM POLLEN IGE AB RAST SCORE|||||||NG/L|||||||INDETERMINATE||CGY||||LOW|NOT DONE||||MIXED VENOUS BLOOD|GELLED|NA|CONTRAST ENHANCED PET SCAN|COCKCROFT-GAULT FORMULA||U|Y|U|N|||U|1||38||LONG-TERM FOLLOW-UP|1965-02-23|1973-08-28|||||1964-12-22||1965-11-12|U|1970-05-07
TRIAL STUDY 134XCP|LB|3D25A735-6298-4AF4-91CC-AE8D481DF552|2||||CD27|CD27|||||||APL U/ML|||||||INVALID||CGY||||HIGH|NOT DONE||||TUMOR TISSUE|CONCENTRATED|U|SXA SCAN|ASH FIBROSURE FORMULA||NA|N|N|U|||U|1||38||CONTINUATION TREATMENT|1968-05-15|1971-06-10|||||1960-12-15||1962-12-25|N|1962-03-25
TRIAL STUDY 134XCP|LB|3D25A735-6298-4AF4-91CC-AE8D481DF552|1||||IGFBP7|INSULIN-LIKE GROWTH FACTOR BINDING PROT7|||||||CMHG|||||||BORDERLINE||MASK||||LOW|NOT DONE||||CAPILLARY PLASMA|HEMOLYZED|U|WEBER GREEN STAIN|GMI % FORMULA||N|U|NA|N|||NA|2||58||RUN-IN|1971-06-03|1961-08-11|||||1963-02-18||1970-02-21|U|1966-03-10
TRIAL STUDY 134XCP|LB|3D25A735-6298-4AF4-91CC-AE8D481DF552|2||||CD27|CD27|||||||ML/100G/MIN|||||||NEGATIVE||G/ANIMAL/DAY||||LOW|NOT DONE||||ARTERIAL BLOOD|SOLIDIFIED|U|PULMONARY ANGIOGRAPHY|HEPASCORE FORMULA||N|U|Y|NA|||NA|2||58||BASELINE|1963-02-11|1972-12-02|||||1969-02-02||1971-01-14|N|1972-01-20
TRIAL STUDY 134XCP|LB|3D25A735-6298-4AF4-91CC-AE8D481DF552|1||||HLAAAGT|HLA-A ANTIGEN TYPE|||||||TORR|||||||NEGATIVE||10^3 ORGANISMS||||NORMAL|NOT DONE||||SERUM OR PLASMA|ROOM TEMPERATURE|NA|RAJI CELL RIA|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|N|N|||Y|3||39||OPEN LABEL TREATMENT|1973-01-17|1966-12-24|||||1966-01-18||1970-06-24|Y|1967-02-28
TRIAL STUDY 134XCP|LB|3D25A735-6298-4AF4-91CC-AE8D481DF552|2||||HDLPSZ|HDL PARTICLE SIZE|||||||CM|||||||INVALID||PMOL/10^10 CELLS||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|ROOM TEMPERATURE|Y|HPLC|HEPASCORE FORMULA||NA|N|Y|Y|||U|3||39||BASELINE|1972-10-23|1964-12-01|||||1968-08-09||1968-08-26|NA|1973-05-21
TRIAL STUDY 134XCP|LB|3D25A735-6298-4AF4-91CC-AE8D481DF552|1||||PRCTC|PROSTATE CIRCULATING TUMOR CELLS|||||||HOURS|||||||INVALID||CM/MIN||||ABNORMAL|NOT DONE||||BUFFY COAT|AUTOLYZED|N|MAGNETIC RESONANCE ANGIOGRAPHY|FIBROTEST FORMULA||N|N|U|N|||Y|4||88||RUN-IN|1971-09-28|1968-08-02|||||1969-02-16||1966-03-07|Y|1967-05-29
TRIAL STUDY 134XCP|LB|3D25A735-6298-4AF4-91CC-AE8D481DF552|2||||GHBP|GROWTH HORMONE BINDING PROTEIN|||||||MAC50|||||||INVALID||HZ/S||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|CONTAMINATED|U|IMMUNOCHROMATOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|U|N|N|||N|4||88||BASELINE|1965-04-27|1970-02-26|||||1965-11-15||1973-04-23|Y|1964-01-08
TRIAL STUDY 134XCP|LB|3D25A735-6298-4AF4-91CC-AE8D481DF552|1||||GLUCCRT|GLUCOSE/CREATININE|||||||BAG|||||||POSITIVE||AMPULE||||LOW|NOT DONE||||PLATELET|CONTAMINATED|NA|MRI|NASH FIBROSURE FORMULA||NA|N|NA|Y|||NA|5||7||BLINDED TREATMENT|1970-04-07|1969-07-07|||||1965-11-27||1972-02-15|N|1968-01-03
TRIAL STUDY 134XCP|LB|3D25A735-6298-4AF4-91CC-AE8D481DF552|2||||CXCL10|CHEMOKINE (C-X-C MOTIF) LIGAND 10|||||||CD*S/M2|||||||INDETERMINATE||L/KG||||NORMAL|NOT DONE||||SMEGMA|ROOM TEMPERATURE|N|JAFFE REACTION|MDRD ENZYMATIC FORMULA||NA|Y|NA|Y|||N|5||7||TREATMENT|1960-11-22|1968-04-11|||||1966-07-20||1972-11-12|NA|1971-12-06
TRIAL STUDY 134XCP|LB|C249E38B-B454-47D9-8D8B-E2F6A434BA21|1||||NPAP|NON-PROSTATIC ACID PHOSPHATASE|||||||EIA UNIT|||||||INDETERMINATE||ML/MMHG||||LOW|NOT DONE||||BLOOD|CALCIFIED|N|MRI WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|U|N|||NA|1||38||WASHOUT|1964-09-28|1966-04-24|||||1967-03-22||1962-11-30|NA|1960-04-29
TRIAL STUDY 134XCP|LB|C249E38B-B454-47D9-8D8B-E2F6A434BA21|2||||PAH|P-AMINOHIPPURATE SODIUM|||||||JOULE|||||||INVALID||UG/KG/DAY||||LOW|NOT DONE||||INFRANATANT, SERUM|AGGLUTINATED|NA|CLOT DETECTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|NA|U|||Y|1||38||OPEN LABEL TREATMENT|1962-01-02|1960-10-19|||||1964-04-27||1972-03-19|U|1965-08-05
TRIAL STUDY 134XCP|LB|C249E38B-B454-47D9-8D8B-E2F6A434BA21|1||||TTAC|THROMBIN TIME ACTUAL/CONTROL|||||||FT|||||||NEGATIVE||10^5/L||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LACTESCENT|Y|LIQUID SCINTILLATION COUNTING|HEPASCORE FORMULA||U|NA|N|U|||N|2||58||FOLLOW-UP|1962-09-09|1965-02-12|||||1972-04-21||1960-01-18|NA|1960-03-24
TRIAL STUDY 134XCP|LB|C249E38B-B454-47D9-8D8B-E2F6A434BA21|2||||LCHT|LITHOCHOLATE|||||||NFIU|||||||NEGATIVE||10^3 DNA COPIES/ML||||HIGH|NOT DONE||||SUPERNATANT, SERUM|HEMOLYZED|U|MECHANICAL CLOT DETECTION|MDRD ENZYMATIC FORMULA||NA|Y|U|Y|||U|2||58||BASELINE|1969-09-13|1972-05-12|||||1966-07-01||1965-09-05|U|1965-07-17
TRIAL STUDY 134XCP|LB|C249E38B-B454-47D9-8D8B-E2F6A434BA21|1||||PTHNT|PARATHYROID HORMONE, N-TERMINAL|||||||PPTH|||||||POSITIVE||ENZYME U||||LOW|NOT DONE||||ABSCESS FLUID|SOLIDIFIED|Y|SPECULAR MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|NA|N|||U|3||39||TREATMENT|1966-02-22|1961-01-10|||||1967-01-23||1965-09-01|Y|1970-05-03
TRIAL STUDY 134XCP|LB|C249E38B-B454-47D9-8D8B-E2F6A434BA21|2||||IGGSYNRT|IGG SYNTHESIS RATE|||||||PIXELS/CM|||||||TRACE||GENEQ/ML||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|DRIED|Y|CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC FORMULA||NA|Y|N|NA|||N|3||39||FOLLOW-UP|1972-10-30|1971-09-25|||||1970-04-25||1966-07-10|N|1969-03-26
TRIAL STUDY 134XCP|LB|C249E38B-B454-47D9-8D8B-E2F6A434BA21|1||||LTA|LYMPHOTOXIN ALPHA|||||||LX|||||||NEGATIVE||BU||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|CLOTTED|U|BAC ACGH|FIBROTEST FORMULA||Y|U|Y|U|||NA|4||88||FOLLOW-UP|1971-02-26|1972-03-27|||||1961-08-28||1967-08-28|Y|1967-01-31
TRIAL STUDY 134XCP|LB|C249E38B-B454-47D9-8D8B-E2F6A434BA21|2||||LDH5LDH|LDH ISOENZYME 5/LDH|||||||UMOL|||||||BORDERLINE||WEEKS||||NORMAL|NOT DONE||||PUS|THAWED|N|ROMANOWSKY STAIN|COCKCROFT-GAULT FORMULA||Y|U|Y|N|||N|4||88||WASHOUT|1972-03-09|1961-11-17|||||1970-10-04||1965-04-26|NA|1963-05-09
TRIAL STUDY 134XCP|LB|C249E38B-B454-47D9-8D8B-E2F6A434BA21|1||||INTLK6|INTERLEUKIN 6|||||||UU/DL|||||||INVALID||MG/DOSE||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|REFRIGERATED|U|FREEZING POINT DEPRESSION|COCKCROFT-GAULT FORMULA||N|N|Y|NA|||U|5||7||BLINDED TREATMENT|1960-07-13|1967-09-28|||||1969-09-13||1960-01-27|N|1969-05-21
TRIAL STUDY 134XCP|LB|C249E38B-B454-47D9-8D8B-E2F6A434BA21|2||||ETHANOL|ETHANOL|||||||10^6 ORGANISMS/MG|||||||NEGATIVE||GY/MIN||||ABNORMAL|NOT DONE||||LOCHIA|CALCIFIED|NA|HPLC-UV|HEPASCORE FORMULA||Y|Y|Y|N|||NA|5||7||OPEN LABEL TREATMENT|1960-07-10|1960-08-26|||||1972-05-10||1966-02-25|Y|1969-07-17
TRIAL STUDY 134XCP|LB|4540D569-1DD0-4984-89DB-6F9A391397FE|1||||CRYSTALS|CRYSTALS|||||||PACK|||||||BORDERLINE||CYLINDER||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|HEMOLYZED|Y|THERMAL IONIZATION MASS SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|U|N|||N|1||38||FOLLOW-UP|1964-05-02|1960-04-23|||||1965-09-13||1960-08-24|U|1963-08-11
TRIAL STUDY 134XCP|LB|4540D569-1DD0-4984-89DB-6F9A391397FE|2||||VITB2|RIBOFLAVIN|||||||APL U/ML|||||||INVALID||ML/CM H2O||||NORMAL|NOT DONE||||MUCUS|UNEXPECTED ODOR|NA|U-HPLC/MS/MS|MDRD ENZYMATIC FORMULA||NA|Y|Y|U|||U|1||38||SCREENING|1961-05-24|1964-10-06|||||1966-07-23||1967-07-22|N|1962-06-29
TRIAL STUDY 134XCP|LB|4540D569-1DD0-4984-89DB-6F9A391397FE|1||||DENSITY|DENSITY|||||||UG/L DDU|||||||TRACE||MOL/L||||HIGH|NOT DONE||||CELL PELLET|AUTOLYZED|NA|LC/MS|MDRD FORMULA||Y|Y|N|N|||Y|2||58||RUN-IN|1966-05-27|1970-12-04|||||1972-12-29||1962-10-19|U|1963-04-19
TRIAL STUDY 134XCP|LB|4540D569-1DD0-4984-89DB-6F9A391397FE|2||||KCREAT|POTASSIUM/CREATININE|||||||V/V|||||||POSITIVE||BAR||||LOW|NOT DONE||||CORD BLOOD|SOLIDIFIED|U|ATOMIC ABSORPTION SPECTROMETRY|COCKCROFT-GAULT FORMULA||NA|Y|Y|U|||NA|2||58||SCREENING|1971-04-13|1964-10-19|||||1961-11-09||1966-02-01|N|1970-02-11
TRIAL STUDY 134XCP|LB|4540D569-1DD0-4984-89DB-6F9A391397FE|1||||C165921|SILVER BIRCH POLLEN IGE AB RAST SCORE|||||||DPM/0.5 ML|||||||POSITIVE||GPS U||||HIGH|NOT DONE||||MECONIUM|CALCIFIED|NA|FREEZING POINT DEPRESSION|FIBROSIS 4 FORMULA||NA|Y|U|Y|||NA|3||39||SCREENING|1966-12-11|1971-03-22|||||1963-03-25||1967-12-02|U|1969-05-27
TRIAL STUDY 134XCP|LB|4540D569-1DD0-4984-89DB-6F9A391397FE|2||||ALBGALB|GLYCATED ALBUMIN/ALBUMIN|||||||L/S|||||||TRACE||10^4/L||||NORMAL|NOT DONE||||SERUM OR PLASMA|CONCENTRATED|N|IN SITU HYBRIDIZATION|NASH FIBROSURE FORMULA||U|NA|U|N|||Y|3||39||LONG-TERM FOLLOW-UP|1970-07-24|1971-10-30|||||1970-07-15||1961-04-03|U|1969-04-24
TRIAL STUDY 134XCP|LB|4540D569-1DD0-4984-89DB-6F9A391397FE|1||||TNF10|TNF SUPERFAMILY MEMBER 10|||||||TCID 50/DOSE|||||||POSITIVE||CI/UL||||NORMAL|NOT DONE||||EPITHELIAL CELL|CLOTTED|Y|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|NASH FIBROSURE FORMULA||U|Y|N|Y|||N|4||88||RUN-IN|1962-08-16|1966-12-03|||||1963-04-28||1960-02-18|U|1972-01-24
TRIAL STUDY 134XCP|LB|4540D569-1DD0-4984-89DB-6F9A391397FE|2||||CCL8|CHEMOKINE (C-C MOTIF) LIGAND 8|||||||MG|||||||POSITIVE||BOLUS||||HIGH|NOT DONE||||SMEGMA|CALCIFIED|Y|MIGET|CKD-EPI CYSTATIN C FORMULA||N|Y|NA|N|||U|4||88||TREATMENT|1966-12-25|1960-09-08|||||1963-03-14||1963-05-18|Y|1967-09-05
TRIAL STUDY 134XCP|LB|4540D569-1DD0-4984-89DB-6F9A391397FE|1||||C5A|COMPLEMENT C5A|||||||SPRAY|||||||NEGATIVE||DEG2||||NORMAL|NOT DONE||||KERATINOCYTE|CONCENTRATED|U|X-RAY|ASH FIBROSURE FORMULA||N|NA|Y|NA|||NA|5||7||FOLLOW-UP|1963-08-05|1966-03-14|||||1962-03-31||1971-04-12|U|1967-10-17
TRIAL STUDY 134XCP|LB|4540D569-1DD0-4984-89DB-6F9A391397FE|2||||HBA2PHB|HEMOGLOBIN A2 PRIME/TOTAL HEMOGLOBIN|||||||10^6 RNA COPIES/ML|||||||POSITIVE||M3||||ABNORMAL|NOT DONE||||CALCULUS|ROOM TEMPERATURE|NA|FORCED OSCILLATION TECHNIQUE|MDRD 5 VARIABLE FORMULA||Y|NA|N|Y|||NA|5||7||OPEN LABEL TREATMENT|1970-04-19|1967-02-19|||||1963-01-20||1962-07-17|N|1969-04-17
TRIAL STUDY 134XCP|LB|DC1D666E-4920-4B60-A520-D183BCDE0E85|1||||OLIGBAND|OLIGOCLONAL BANDS|||||||FMOL/G|||||||TRACE||NMOL BCE/L||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|REFRIGERATED|N|MASS SPECTROMETRY|GMI % FORMULA||Y|N|NA|U|||U|1||38||BLINDED TREATMENT|1961-11-25|1963-11-09|||||1972-07-11||1965-12-02|U|1969-01-15
TRIAL STUDY 134XCP|LB|DC1D666E-4920-4B60-A520-D183BCDE0E85|2||||C130112|ANIMAL MIX ANTIGEN IGE ANTIBODY|||||||ENZYME U/L|||||||INVALID||STEPS||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|SOLIDIFIED|Y|BIOIMPEDANCE SPECTROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|NA|Y|||Y|1||38||OBSERVATION|1966-10-07|1969-03-04|||||1966-06-24||1960-01-15|U|1969-11-17
TRIAL STUDY 134XCP|LB|DC1D666E-4920-4B60-A520-D183BCDE0E85|1||||BLAST|BLASTS|||||||STRIP|||||||NEGATIVE||CI/ML||||ABNORMAL|NOT DONE||||SPERMATOZOON|SOLIDIFIED|Y|HPLC-UV|CKD-EPI FORMULA||U|NA|U|N|||Y|2||58||WASHOUT|1971-01-02|1963-11-06|||||1965-04-22||1962-04-30|NA|1967-12-25
TRIAL STUDY 134XCP|LB|DC1D666E-4920-4B60-A520-D183BCDE0E85|2||||GBP1|GUANYLATE BINDING PROTEIN 1|||||||GPS U|||||||POSITIVE||RATIO||||NORMAL|NOT DONE||||BASAL TEAR|ICTERIC|U|SNELLEN EYE CHART|GMI % FORMULA||Y|Y|Y|U|||Y|2||58||OBSERVATION|1967-12-15|1973-09-02|||||1965-01-11||1968-07-02|N|1969-11-22
TRIAL STUDY 134XCP|LB|DC1D666E-4920-4B60-A520-D183BCDE0E85|1||||SPMAGGLU|SPERM AGGLUTINATION|||||||CMOL/L|||||||INDETERMINATE||ML/SEC/1.73M2||||HIGH|NOT DONE||||TUMOR TISSUE|ROOM TEMPERATURE|Y|POLYSOMNOGRAPHY|CKD-EPI FORMULA||U|Y|N|U|||NA|3||39||BLINDED TREATMENT|1970-06-15|1964-12-20|||||1970-09-11||1960-04-22|NA|1969-01-23
TRIAL STUDY 134XCP|LB|DC1D666E-4920-4B60-A520-D183BCDE0E85|2||||GAMBTAC|GAMMA-AMINOBUTYRIC ACID|||||||ML/M2|||||||BORDERLINE||WAFER||||LOW|NOT DONE||||ERYTHROCYTES|GELLED|N|POTENTIOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|U|U|||N|3||39||CONTINUATION TREATMENT|1960-01-03|1964-01-06|||||1968-03-08||1967-12-21|Y|1970-08-28
TRIAL STUDY 134XCP|LB|DC1D666E-4920-4B60-A520-D183BCDE0E85|1||||SPMAGGR|SPERM AGGREGATION|||||||KG|||||||INDETERMINATE||UG/CM2||||HIGH|NOT DONE||||LAVAGE FLUID|REFRIGERATED|NA|ANTIMICROBIAL COMBINATION TESTING|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|U|N|||U|4||88||OPEN LABEL TREATMENT|1961-05-25|1966-02-05|||||1973-08-21||1962-05-29|NA|1970-06-02
TRIAL STUDY 134XCP|LB|DC1D666E-4920-4B60-A520-D183BCDE0E85|2||||FEPI|FRACTIONAL PHOSPHORUS EXCRETION|||||||L/H|||||||INDETERMINATE||CD/M2||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CLOTTED|N|RULER MEASUREMENT METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|U|||NA|4||88||WASHOUT|1960-10-11|1962-11-23|||||1971-03-24||1972-11-03|U|1970-08-26
TRIAL STUDY 134XCP|LB|DC1D666E-4920-4B60-A520-D183BCDE0E85|1||||HRYCECE|HAIRY CELLS/TOTAL CELLS|||||||ML/DL|||||||TRACE||HEP||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|ROOM TEMPERATURE|U|SXA SCAN|MDRD 4 VARIABLE FORMULA||Y|N|U|U|||NA|5||7||LONG-TERM FOLLOW-UP|1961-12-16|1960-05-01|||||1968-03-24||1973-01-22|N|1969-09-08
TRIAL STUDY 134XCP|LB|DC1D666E-4920-4B60-A520-D183BCDE0E85|2||||HLAIPRA|HLA CLASS I PANEL REACTIVE ANTIBODY|||||||LOG10 ELISA UNIT/DOSE|||||||POSITIVE||%/MIN||||ABNORMAL|NOT DONE||||BASAL TEAR|SOLIDIFIED|Y|FLOW CYTOMETRY|MDRD 6 VARIABLE FORMULA||Y|Y|Y|NA|||Y|5||7||OBSERVATION|1961-02-02|1968-12-07|||||1969-06-19||1961-03-02|Y|1967-07-25
TRIAL STUDY 134XCP|LB|A015D12B-C03B-4371-8D1F-F03D60542BA7|1||||CSUNCLA|UNCLASSIFIED CASTS|||||||MS2|||||||BORDERLINE||/KG||||HIGH|NOT DONE||||SALIVA|AUTOLYZED|Y|LC-FL|MDRD 6 VARIABLE FORMULA||Y|Y|NA|NA|||Y|1||38||SCREENING|1967-04-16|1962-11-13|||||1960-03-29||1967-12-29|N|1967-06-15
TRIAL STUDY 134XCP|LB|A015D12B-C03B-4371-8D1F-F03D60542BA7|2||||HALBAB|HUMAN ALBUMIN ANTIBODY|||||||PMOL/G|||||||BORDERLINE||KPA||||LOW|NOT DONE||||SEBUM|FROZEN|N|INDIA INK STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|U|Y|Y|||NA|1||38||TREATMENT|1969-07-20|1964-10-27|||||1961-03-25||1971-11-12|N|1970-10-10
TRIAL STUDY 134XCP|LB|A015D12B-C03B-4371-8D1F-F03D60542BA7|1||||IRON|IRON|||||||VIAL|||||||NEGATIVE||NG/MOL||||HIGH|NOT DONE||||PERITONEAL FLUID|FRESH|U|CONTRAST ENHANCED PET/CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|N|Y|||U|2||58||OPEN LABEL TREATMENT|1968-08-08|1960-11-04|||||1971-02-07||1966-05-22|U|1973-06-13
TRIAL STUDY 134XCP|LB|A015D12B-C03B-4371-8D1F-F03D60542BA7|2||||TK2|THYMIDINE KINASE 2|||||||PATCH|||||||INVALID||EID 50/DOSE||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|ICTERIC|N|DARK FIELD MICROSCOPY|HEPASCORE FORMULA||NA|NA|U|NA|||U|2||58||OPEN LABEL TREATMENT|1968-02-12|1962-01-07|||||1967-06-15||1960-08-29|U|1973-02-07
TRIAL STUDY 134XCP|LB|A015D12B-C03B-4371-8D1F-F03D60542BA7|1||||CHCNT|CORPUSCULAR HEMOGLOBIN CONTENT|||||||UG/MOL|||||||NEGATIVE||KUSP||||NORMAL|NOT DONE||||BONE MARROW|CALCIFIED|N|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|GMI % FORMULA||N|U|Y|U|||U|3||39||BASELINE|1963-03-26|1961-11-29|||||1968-05-29||1972-03-28|NA|1970-01-07
TRIAL STUDY 134XCP|LB|A015D12B-C03B-4371-8D1F-F03D60542BA7|2||||HLAB|HLA CLASS IB ANTIGEN|||||||MOSM/L|||||||BORDERLINE||MU||||LOW|NOT DONE||||PLATELET POOR PLASMA|UNEXPECTED ODOR|Y|QUANTITATIVE ULTRASOUND|MDRD ENZYMATIC JAPANESE FORMULA||U|N|Y|Y|||NA|3||39||WASHOUT|1960-12-05|1973-06-06|||||1969-08-24||1966-09-07|N|1965-12-23
TRIAL STUDY 134XCP|LB|A015D12B-C03B-4371-8D1F-F03D60542BA7|1||||TURB|TURBIDITY|||||||G/M2|||||||BORDERLINE||UL/KG/DAY||||NORMAL|NOT DONE||||BUFFY COAT|THAWED|N|HPLC-FL|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|NA|||U|4||88||SCREENING|1962-06-03|1964-11-08|||||1968-04-07||1967-06-13|N|1962-07-09
TRIAL STUDY 134XCP|LB|A015D12B-C03B-4371-8D1F-F03D60542BA7|2||||EDMAB|ENDOMYSIAL ANTIBODY|||||||LOG10 ELISA UNIT/DOSE|||||||POSITIVE||RPM||||ABNORMAL|NOT DONE||||PLEURAL FLUID|AUTOLYZED|NA|MECHANICAL CLOT DETECTION|MDRD FORMULA||U|Y|U|N|||NA|4||88||TREATMENT|1966-05-16|1973-07-28|||||1964-05-05||1971-02-14|N|1963-12-18
TRIAL STUDY 134XCP|LB|A015D12B-C03B-4371-8D1F-F03D60542BA7|1||||NAGASECR|N-ACETYL-B-D-GLUCOSAMINIDASE/CREATININE|||||||LOG10 PFU|||||||NEGATIVE||MAC50||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|U|IMMUNOASSAY|GMI MMOL/MOL FORMULA||U|U|Y|NA|||N|5||7||SCREENING|1972-12-06|1962-05-24|||||1968-02-13||1966-07-28|N|1962-09-02
TRIAL STUDY 134XCP|LB|A015D12B-C03B-4371-8D1F-F03D60542BA7|2||||FACTII|FACTOR II|||||||FT2|||||||TRACE||S/H||||LOW|NOT DONE||||SERUM OR PLASMA|REFRIGERATED|NA|IMMUNOTURBIDIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|Y|||NA|5||7||BLINDED TREATMENT|1968-05-18|1966-12-22|||||1966-07-04||1962-12-20|NA|1972-01-25
TRIAL STUDY 134XCP|LB|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|1||||THRMPTN|THROMBOPOIETIN|||||||TAMPON|||||||TRACE||WEBER||||HIGH|NOT DONE||||PUS|THAWED|U|MAMMOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|Y|U|||U|1||38||CONTINUATION TREATMENT|1967-06-05|1966-02-22|||||1970-11-21||1972-08-15|U|1969-03-11
TRIAL STUDY 134XCP|LB|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|2||||V25HD2|25-HYDROXYVITAMIN D2|||||||CL|||||||INVALID||CI/UG||||NORMAL|NOT DONE||||SPERMATOZOON|PARAFFIN-EMBEDDED|NA|ENZYMATIC ULTRACENTRIFUGATION|GMI % FORMULA||NA|U|N|U|||U|1||38||TREATMENT|1970-12-09|1968-09-29|||||1968-04-13||1963-03-05|N|1963-05-20
TRIAL STUDY 134XCP|LB|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|1||||CHCMR|RET. CORPUSCULAR HGB CONCENTRATION MEAN|||||||DPM/0.5 ML|||||||TRACE||U/M2/MIN||||NORMAL|NOT DONE||||ALVEOLAR AIR|HEMOLYZED|U|BETA LACTAMASE|GMI % FORMULA||U|Y|NA|Y|||NA|2||58||BASELINE|1965-07-29|1963-01-08|||||1965-12-08||1969-08-17|N|1962-01-12
TRIAL STUDY 134XCP|LB|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|2||||NKCEFUNC|NATURAL KILLER CELL FUNCTION|||||||IU/KG/H|||||||INVALID||KEV||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|SOLIDIFIED|U|TEMPLATE INCISION METHOD|CKD-EPI CREATININE FORMULA||N|U|NA|N|||U|2||58||SCREENING|1970-02-27|1969-11-29|||||1960-11-13||1969-11-17|N|1971-04-16
TRIAL STUDY 134XCP|LB|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|1||||NORMBASO|BASOPHILIC NORMOBLAST|||||||UG/CM2|||||||INDETERMINATE||CI/ML||||NORMAL|NOT DONE||||ALVEOLAR AIR|AGGLUTINATED|N|SISH|FIBROTEST FORMULA||N|NA|NA|Y|||Y|3||39||OBSERVATION|1966-08-08|1969-11-09|||||1973-01-08||1969-05-12|NA|1969-11-06
TRIAL STUDY 134XCP|LB|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|2||||INTLK11|INTERLEUKIN 11|||||||ML/G/MIN|||||||TRACE||UM/S||||NORMAL|NOT DONE||||LEUKOCYTE|CLOTTED|N|PUPILLOMETRY|MDRD 5 VARIABLE FORMULA||Y|NA|NA|NA|||NA|3||39||RUN-IN|1971-09-26|1973-01-20|||||1968-04-04||1970-01-02|N|1967-03-09
TRIAL STUDY 134XCP|LB|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|1||||TESTOS|TESTOSTERONE|||||||/VF|||||||TRACE||AMPULE||||LOW|NOT DONE||||PLEURAL TISSUE|LACTESCENT|U|REVERSE TRANSCRIPTASE PCR|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|N|NA|||N|4||88||FOLLOW-UP|1965-01-11|1973-03-01|||||1969-12-31||1969-03-16|N|1968-12-14
TRIAL STUDY 134XCP|LB|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|2||||POLYCHR|POLYCHROMASIA|||||||LOG10 CFU/G|||||||BORDERLINE||ENZYME U||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|U|CONGO RED STAIN|GMI MMOL/MOL FORMULA||N|N|U|Y|||NA|4||88||WASHOUT|1966-03-25|1965-01-20|||||1965-08-18||1961-06-05|U|1971-06-06
TRIAL STUDY 134XCP|LB|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|1||||ACHE|ACETYLCHOLINESTERASE|||||||CAPSULE|||||||INDETERMINATE||10^8/L||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|CLOTTED|U|MAGNETIC RESONANCE ELASTOGRAPHY|NASH FIBROSURE FORMULA||Y|N|U|N|||N|5||7||FOLLOW-UP|1969-08-03|1967-08-28|||||1963-12-28||1961-09-13|Y|1961-08-13
TRIAL STUDY 134XCP|LB|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|2||||LGLUCLE|LARGE UNSTAINED CELLS/LEUKOCYTES|||||||TESLA|||||||INVALID||CONTAINER||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|NON-HEMOLYZED|N|ULTRASONOGRAPHIC ELASTOGRAPHY|COCKCROFT-GAULT FORMULA||NA|U|N|NA|||N|5||7||BLINDED TREATMENT|1971-07-31|1961-11-23|||||1962-01-12||1964-02-04|Y|1968-05-03
TRIAL STUDY 134XCP|LB|34AC7973-686F-45A2-999A-1A36C7874F91|1||||RBCNUC|NUCLEATED ERYTHROCYTES|||||||10^9 ORGANISMS|||||||BORDERLINE||/SEC||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|REFRIGERATED|N|LC/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|N|Y|||N|1||38||INDUCTION TREATMENT|1965-09-18|1962-01-02|||||1962-11-14||1968-01-11|NA|1964-10-17
TRIAL STUDY 134XCP|LB|34AC7973-686F-45A2-999A-1A36C7874F91|2||||GLCHT|GLYCOLITHOCHOLATE|||||||L/DAY|||||||NEGATIVE||CI/UL||||LOW|NOT DONE||||MONOCYTE|ICTERIC|N|CALIPER MEASUREMENT METHOD|HEPASCORE FORMULA||Y|Y|U|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1971-08-11|1967-07-05|||||1968-03-29||1962-02-14|U|1961-05-28
TRIAL STUDY 134XCP|LB|34AC7973-686F-45A2-999A-1A36C7874F91|1||||C165933|AMERICAN COCKROACH IGE AB RAST SCORE|||||||M2|||||||TRACE||PMOL/L/H||||LOW|NOT DONE||||INFRANATANT, PLASMA|DRIED|Y|ORCHIDOMETERY|COCKCROFT-GAULT FORMULA||Y|Y|U|Y|||NA|2||58||SCREENING|1971-05-17|1962-12-27|||||1966-08-14||1971-10-01|N|1965-09-28
TRIAL STUDY 134XCP|LB|34AC7973-686F-45A2-999A-1A36C7874F91|2||||PROC6|PRO-C6|||||||MKAT|||||||POSITIVE||USIEMENS||||ABNORMAL|NOT DONE||||EXPIRED AIR|DRIED|Y|APPLANATION TONOMETRY|MDRD FORMULA||NA|NA|NA|Y|||NA|2||58||OPEN LABEL TREATMENT|1972-01-15|1968-11-11|||||1967-01-12||1966-01-30|N|1961-11-05
TRIAL STUDY 134XCP|LB|34AC7973-686F-45A2-999A-1A36C7874F91|1||||FCTXIIIA|FACTOR XIII ACTIVITY|||||||10^6 COPIES/ML|||||||INDETERMINATE||BQ/UG||||HIGH|NOT DONE||||LOCHIA|LACTESCENT|N|PATHOLOGICAL EVALUATION|FIBROMETER FORMULA||Y|N|N|N|||Y|3||39||OPEN LABEL TREATMENT|1966-03-14|1972-05-12|||||1960-04-23||1964-12-26|Y|1972-07-28
TRIAL STUDY 134XCP|LB|34AC7973-686F-45A2-999A-1A36C7874F91|2||||COTININE|COTININE|||||||OHM|||||||INDETERMINATE||MILE||||ABNORMAL|NOT DONE||||REFLEX TEAR|CALCIFIED|N|ELECTRONEUROGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|N|N|||U|3||39||RUN-IN|1960-09-06|1967-10-04|||||1962-02-08||1969-06-14|NA|1968-07-16
TRIAL STUDY 134XCP|LB|34AC7973-686F-45A2-999A-1A36C7874F91|1||||GBP1|GUANYLATE BINDING PROTEIN 1|||||||UG/CM2|||||||INDETERMINATE||10^6/EJACULATE U||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|DRIED|N|CT SCAN WITHOUT CONTRAST|HEPASCORE FORMULA||U|N|U|U|||NA|4||88||LONG-TERM FOLLOW-UP|1960-09-04|1967-06-01|||||1966-06-21||1965-10-22|NA|1964-10-23
TRIAL STUDY 134XCP|LB|34AC7973-686F-45A2-999A-1A36C7874F91|2||||ACETONE|ACETONE|||||||G/U|||||||INDETERMINATE||UEQ/L||||NORMAL|NOT DONE||||ADIPOSE TISSUE|ICTERIC|U|MAGNETIC RESONANCE ENTEROGRAPHY|MDRD FORMULA||NA|NA|NA|Y|||N|4||88||WASHOUT|1962-06-05|1961-10-30|||||1961-11-01||1973-01-13|U|1971-09-09
TRIAL STUDY 134XCP|LB|34AC7973-686F-45A2-999A-1A36C7874F91|1||||TRIM21|TRIPARTITE MOTIF CONTAINING PROTEIN 21|||||||ML/DAY|||||||NEGATIVE||/10^5||||LOW|NOT DONE||||LAVAGE FLUID|AGGLUTINATED|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|GMI MMOL/MOL FORMULA||NA|U|N|U|||U|5||7||BASELINE|1970-06-18|1964-09-02|||||1961-12-20||1970-05-29|NA|1963-03-28
TRIAL STUDY 134XCP|LB|34AC7973-686F-45A2-999A-1A36C7874F91|2||||HBA1A|HEMOGLOBIN A1A|||||||/200 HPFS|||||||BORDERLINE||HOMEOPATHIC DILUTION||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|FRESH|N|IMMUNOPRECIPITATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|U|Y|||N|5||7||OPEN LABEL TREATMENT|1966-06-23|1970-07-25|||||1972-03-29||1961-12-19|N|1967-02-10
TRIAL STUDY 134XCP|LB|5AE66AC0-ECB6-49A2-859F-871B9A15E624|1||||AMACR|ALPHA-METHYLACYL COENZYME A RACEMASE|||||||L/H/M2|||||||TRACE||CMHG||||LOW|NOT DONE||||SPUTUM|AGGLUTINATED|NA|MICRODENSITOMETRY|HEPASCORE FORMULA||Y|N|Y|N|||NA|1||38||INDUCTION TREATMENT|1960-10-10|1972-03-22|||||1970-01-07||1960-09-07|NA|1960-01-23
TRIAL STUDY 134XCP|LB|5AE66AC0-ECB6-49A2-859F-871B9A15E624|2||||C130113|ANIMAL MIX ANTIGEN IGG ANTIBODY|||||||MNFI|||||||NEGATIVE||/200 HPFS||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|GELLED|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|NASH FIBROSURE FORMULA||U|N|Y|Y|||U|1||38||CONTINUATION TREATMENT|1972-04-24|1964-10-12|||||1962-09-09||1970-10-29|Y|1966-11-30
TRIAL STUDY 134XCP|LB|5AE66AC0-ECB6-49A2-859F-871B9A15E624|1||||BASEEXCS|BASE EXCESS|||||||KG/MOL|||||||INVALID||SUPPOSITORY||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|FROZEN|NA|DROPLET DIGITAL PCR|MDRD 6 VARIABLE FORMULA||N|Y|Y|NA|||NA|2||58||OPEN LABEL TREATMENT|1963-05-16|1970-02-14|||||1966-03-25||1972-10-24|U|1963-10-28
TRIAL STUDY 134XCP|LB|5AE66AC0-ECB6-49A2-859F-871B9A15E624|2||||SFTPD|SURFACTANT PROTEIN D|||||||U/M2|||||||TRACE||BAU/ML||||LOW|NOT DONE||||SERUM OR PLASMA|DRIED|Y|TONOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|Y|N|||N|2||58||FOLLOW-UP|1970-09-09|1970-04-09|||||1969-07-11||1966-04-19|Y|1965-05-25
TRIAL STUDY 134XCP|LB|5AE66AC0-ECB6-49A2-859F-871B9A15E624|1||||PYRIDNLN|PYRIDINOLINE|||||||KPA|||||||NEGATIVE||CAPSULE||||LOW|NOT DONE||||SEBUM|CONCENTRATED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|HEPASCORE FORMULA||NA|Y|Y|NA|||N|3||39||CONTINUATION TREATMENT|1968-05-30|1970-07-25|||||1969-03-31||1972-09-21|N|1965-07-30
TRIAL STUDY 134XCP|LB|5AE66AC0-ECB6-49A2-859F-871B9A15E624|2||||DHEAS|DEHYDROEPIANDROSTERONE SULFATE|||||||MG/M2/MIN|||||||TRACE||FMOL/L||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|CLOTTED|U|CELL BASED BIOASSAY|MDRD 4 VARIABLE FORMULA||U|N|U|N|||N|3||39||SCREENING|1973-05-19|1968-11-29|||||1960-10-20||1967-06-23|Y|1972-05-08
TRIAL STUDY 134XCP|LB|5AE66AC0-ECB6-49A2-859F-871B9A15E624|1||||CPEPTIDE|C-PEPTIDE|||||||EJACULATE U|||||||TRACE||S*KPA||||ABNORMAL|NOT DONE||||MECONIUM|CONCENTRATED|Y|CONTRAST ENHANCED CT SCAN|CKD-EPI FORMULA||Y|NA|NA|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1965-04-26|1967-10-03|||||1964-07-15||1965-02-05|Y|1972-12-01
TRIAL STUDY 134XCP|LB|5AE66AC0-ECB6-49A2-859F-871B9A15E624|2||||INSULIN|INSULIN|||||||BU/ML|||||||INDETERMINATE||OZ||||HIGH|NOT DONE||||BILE|THAWED|NA|TRANSMISSION ELECTRON MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|N|||NA|4||88||BASELINE|1967-03-12|1962-07-05|||||1969-01-07||1971-05-20|Y|1961-10-12
TRIAL STUDY 134XCP|LB|5AE66AC0-ECB6-49A2-859F-871B9A15E624|1||||PYRIDNLN|PYRIDINOLINE|||||||CY/CM|||||||BORDERLINE||KV||||LOW|NOT DONE||||CORD BLOOD|CONTAMINATED|NA|VIRUS PLAQUE ASSAY|CKD-EPI CYSTATIN C FORMULA||NA|Y|NA|Y|||NA|5||7||SCREENING|1960-02-14|1967-12-02|||||1964-12-24||1968-03-06|N|1967-12-31
TRIAL STUDY 134XCP|LB|5AE66AC0-ECB6-49A2-859F-871B9A15E624|2||||ASTAG|ASPARTATE AMINOTRANSFERASE ANTIGEN|||||||UMOL/MIN|||||||INVALID||L||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|LACTESCENT|Y|AGAR DILUTION|FIBROSIS 4 FORMULA||Y|N|NA|NA|||N|5||7||CONTINUATION TREATMENT|1966-07-20|1972-08-18|||||1961-01-18||1961-11-04|Y|1960-05-03
TRIAL STUDY 134XCP|LB|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|1||||C130130|DOG DANDER ANTIGEN IGA ANTIBODY|||||||KIU|||||||BORDERLINE||PPB||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|GELLED|Y|CALIPER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA||N|Y|N|Y|||Y|1||38||OBSERVATION|1960-06-16|1963-10-23|||||1968-01-01||1962-06-29|N|1968-09-28
TRIAL STUDY 134XCP|LB|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|2||||HYXLYS|HYDROXYLYSINE|||||||BQ/G|||||||TRACE||MMU/ML||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|UNEXPECTED ODOR|N|NEPHELOMETRY|FIBROMETER FORMULA||Y|NA|Y|N|||NA|1||38||TREATMENT|1965-11-27|1970-07-14|||||1962-07-12||1963-10-03|Y|1960-06-12
TRIAL STUDY 134XCP|LB|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|1||||VITB5|VITAMIN B5|||||||PT_BR|||||||TRACE||VIAL||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|CLOTTED|U|OPTICAL MAPPING|FIBROSIS 4 FORMULA||N|NA|Y|Y|||U|2||58||FOLLOW-UP|1969-03-06|1965-09-02|||||1962-06-26||1971-09-09|NA|1960-08-04
TRIAL STUDY 134XCP|LB|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|2||||FACTXII|FACTOR XII|||||||WAFER|||||||NEGATIVE||10^6/G||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|UNEXPECTED ODOR|N|ANTIMICROBIAL COMBINATION TESTING|FIBROMETER FORMULA||Y|N|NA|Y|||NA|2||58||TREATMENT|1963-12-03|1971-04-08|||||1967-03-12||1965-11-18|U|1969-04-23
TRIAL STUDY 134XCP|LB|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|1||||PPTDCALB|PHOSPHATIDYLCHOLINE/ALBUMIN|||||||CI|||||||BORDERLINE||KCAL/DAY||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|N|VIRUS PLAQUE ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|NA|||N|3||39||OPEN LABEL TREATMENT|1960-09-03|1966-09-11|||||1964-05-26||1972-01-27|Y|1971-05-23
TRIAL STUDY 134XCP|LB|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|2||||PDW|PLATELET DISTRIBUTION WIDTH|||||||FIU|||||||POSITIVE||CY/CM||||ABNORMAL|NOT DONE||||NAIL|ICTERIC|U|ROMANOWSKY STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|U|N|||NA|3||39||BASELINE|1961-09-10|1973-07-13|||||1972-03-14||1964-05-29|Y|1961-05-30
TRIAL STUDY 134XCP|LB|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|1||||E1S|ESTRONE SULFATE|||||||PIXEL|||||||INVALID||V||||LOW|NOT DONE||||ABSCESS FLUID|THAWED|N|LC/MS|CKD-EPI CREATININE FORMULA||N|U|U|Y|||Y|4||88||OPEN LABEL TREATMENT|1968-09-16|1969-12-17|||||1964-10-22||1963-01-26|NA|1972-02-15
TRIAL STUDY 134XCP|LB|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|2||||PLAGMAMP|PLATELET AGGREGATION MEAN AMPLITUDE|||||||H*%|||||||INVALID||NMOL/MOL||||NORMAL|NOT DONE||||HAIR FOLLICLE|AGGLUTINATED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|NASH FIBROSURE FORMULA||N|Y|U|U|||U|4||88||INDUCTION TREATMENT|1965-04-28|1962-01-30|||||1960-08-10||1969-11-12|NA|1968-03-05
TRIAL STUDY 134XCP|LB|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|1||||INTLK32|INTERLEUKIN 32|||||||USIEMENS|||||||INDETERMINATE||LOG10 PFU/ML||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|ROOM TEMPERATURE|N|TRYPAN BLUE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|N|N|||N|5||7||SCREENING|1967-10-14|1972-09-07|||||1973-08-08||1962-07-31|U|1963-03-14
TRIAL STUDY 134XCP|LB|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|2||||ENRAGE|EXTRACELL NEWLY IDENT RAGE BIND PROTEIN|||||||MG/MOL|||||||NEGATIVE||U/M2/MIN||||HIGH|NOT DONE||||AMNIOTIC FLUID|FROZEN|Y|TRANSMISSION ELECTRON MICROSCOPY|FIBROSIS 4 FORMULA||Y|N|NA|N|||NA|5||7||LONG-TERM FOLLOW-UP|1960-01-18|1960-10-27|||||1967-02-01||1971-12-15|NA|1965-01-07
TRIAL STUDY 134XCP|LB|59A9826F-4C2F-482A-8888-F649544318BE|1||||PREALB|PREALBUMIN|||||||GY|||||||INVALID||BQ/UG||||HIGH|NOT DONE||||SPERMATOZOON|FRESH|N|ENDPOINT DILUTION ASSAY|HEPASCORE FORMULA||NA|Y|Y|U|||Y|1||38||CONTINUATION TREATMENT|1970-03-21|1961-09-03|||||1967-12-16||1961-02-23|U|1969-09-28
TRIAL STUDY 134XCP|LB|59A9826F-4C2F-482A-8888-F649544318BE|2||||BLASTLE|BLASTS/LEUKOCYTES|||||||NSEC|||||||NEGATIVE||U/KG/DAY||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|THAWED|U|CAPILLARY ELECTROPHORESIS|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|NA|||NA|1||38||OBSERVATION|1972-04-26|1973-03-04|||||1965-03-19||1962-12-08|U|1971-06-26
TRIAL STUDY 134XCP|LB|59A9826F-4C2F-482A-8888-F649544318BE|1||||INTLK25|INTERLEUKIN 25|||||||KEV|||||||POSITIVE||UG/M2/H||||LOW|NOT DONE||||ARTERIAL BLOOD|HEMOLYZED|Y|CALCOFLUOR WHITE STAIN|CKD-EPI CYSTATIN C FORMULA||NA|U|N|N|||N|2||58||SCREENING|1972-01-09|1965-03-02|||||1971-11-21||1972-10-13|NA|1973-01-04
TRIAL STUDY 134XCP|LB|59A9826F-4C2F-482A-8888-F649544318BE|2||||TK|THYMIDINE KINASE|||||||CIGAR|||||||TRACE||MNFI||||ABNORMAL|NOT DONE||||ERYTHROCYTES|CONTAMINATED|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|FIBROSIS 4 FORMULA||NA|NA|N|U|||U|2||58||OBSERVATION|1966-09-25|1961-08-17|||||1965-11-28||1960-12-26|U|1966-03-11
TRIAL STUDY 134XCP|LB|59A9826F-4C2F-482A-8888-F649544318BE|1||||CELLULAR|CELLULARITY|||||||10^6/HPF|||||||POSITIVE||IU/KG/H||||NORMAL|NOT DONE||||SEMEN|LIPEMIC|NA|MULTIPLE BREATH WASHOUT|CKD-EPI CYSTATIN C FORMULA||NA|Y|NA|Y|||N|3||39||BLINDED TREATMENT|1966-08-20|1969-11-01|||||1968-02-15||1962-09-22|Y|1971-06-28
TRIAL STUDY 134XCP|LB|59A9826F-4C2F-482A-8888-F649544318BE|2||||CD3|CD3|||||||YD|||||||INDETERMINATE||DEG||||NORMAL|NOT DONE||||SKIN TISSUE|SOLIDIFIED|N|MULTIPLE BREATH WASHOUT|CKD-EPI CYSTATIN C FORMULA||N|N|U|U|||Y|3||39||INDUCTION TREATMENT|1962-06-01|1972-09-27|||||1970-11-03||1971-08-15|N|1971-12-01
TRIAL STUDY 134XCP|LB|59A9826F-4C2F-482A-8888-F649544318BE|1||||HOMOCIT|HOMOCITRULLINE|||||||/MIN|||||||NEGATIVE||10^3 CFU||||HIGH|NOT DONE||||SPUTUM|ROOM TEMPERATURE|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|Y|||U|4||88||CONTINUATION TREATMENT|1972-11-14|1961-08-12|||||1964-10-10||1965-03-19|Y|1969-10-07
TRIAL STUDY 134XCP|LB|59A9826F-4C2F-482A-8888-F649544318BE|2||||CYDCPHOS|DICALCIUM PHOSPHATE CRYSTALS|||||||ML/M2/MIN|||||||INVALID||SCOOPFUL||||LOW|NOT DONE||||INFRANATANT, PLASMA|SOLIDIFIED|NA|DYNAMOMETRY|CKD-EPI CYSTATIN C FORMULA||N|N|NA|Y|||U|4||88||CONTINUATION TREATMENT|1963-05-05|1973-05-29|||||1961-01-27||1972-05-20|U|1961-05-18
TRIAL STUDY 134XCP|LB|59A9826F-4C2F-482A-8888-F649544318BE|1||||CCPIGGAB|CYCLIC CITRULLINATED PEPTIDE IGG AB|||||||UEQ/L|||||||TRACE||L/S/KPA||||NORMAL|NOT DONE||||BASAL TEAR|FRESH|U|NUCLEIC ACID SEQUENCING|FIBROTEST FORMULA||N|NA|Y|U|||Y|5||7||OBSERVATION|1972-02-13|1968-12-14|||||1965-03-10||1966-09-15|N|1963-02-28
TRIAL STUDY 134XCP|LB|59A9826F-4C2F-482A-8888-F649544318BE|2||||CRDIGMAB|CARDIOLIPIN IGM ANTIBODY|||||||CM/S|||||||TRACE||POINT||||HIGH|NOT DONE||||ABSCESS FLUID|GELLED|NA|FARR ASSAY|GMI % FORMULA||Y|NA|U|U|||NA|5||7||LONG-TERM FOLLOW-UP|1967-05-03|1965-09-02|||||1964-08-12||1973-01-11|U|1967-11-21
TRIAL STUDY 134XCP|LB|B6E55A62-CF0B-4BC6-84DC-038F29518909|1||||NONHDL|NON-HDL CHOLESTEROL|||||||10^6 ORGANISMS/G|||||||NEGATIVE||10^12/L||||LOW|NOT DONE||||VENOUS CORD BLOOD|SOLIDIFIED|Y|IMMUNOTURBIDIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|U|U|||U|1||38||INDUCTION TREATMENT|1969-06-07|1968-11-29|||||1967-05-24||1970-08-07|Y|1972-06-24
TRIAL STUDY 134XCP|LB|B6E55A62-CF0B-4BC6-84DC-038F29518909|2||||INLCLR|INULIN CLEARANCE|||||||V|||||||NEGATIVE||MG/KG/MIN||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|SOLIDIFIED|U|MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|N|NA|||NA|1||38||WASHOUT|1965-08-30|1968-06-14|||||1971-11-07||1963-01-01|U|1968-01-23
TRIAL STUDY 134XCP|LB|B6E55A62-CF0B-4BC6-84DC-038F29518909|1||||C130105|GRASS MIX POLLEN ANTIGEN IGA ANTIBODY|||||||MG/KG/DOSE|||||||INVALID||H*%||||LOW|NOT DONE||||EXPIRED AIR|CALCIFIED|NA|FISH|COCKCROFT-GAULT FORMULA||U|U|Y|U|||NA|2||58||SCREENING|1969-11-02|1961-08-12|||||1970-04-25||1972-09-22|Y|1966-07-22
TRIAL STUDY 134XCP|LB|B6E55A62-CF0B-4BC6-84DC-038F29518909|2||||INTLK30|INTERLEUKIN 30|||||||NU/CL|||||||INVALID||UM2||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|CLOTTED|U|OPTICAL MAPPING|HEPASCORE FORMULA||NA|U|NA|Y|||U|2||58||LONG-TERM FOLLOW-UP|1970-08-22|1961-09-24|||||1964-01-08||1965-11-19|Y|1969-12-26
TRIAL STUDY 134XCP|LB|B6E55A62-CF0B-4BC6-84DC-038F29518909|1||||HLADR52A|HLA-DR52 ANTIBODY|||||||ARBITRARY U|||||||INVALID||MMOL2/L2||||NORMAL|NOT DONE||||STOOL|CLOTTED|NA|FLUORESCENT MICROSCOPY|CKD-EPI CREATININE FORMULA||N|N|N|N|||U|3||39||SCREENING|1972-09-09|1969-07-31|||||1973-09-01||1961-01-28|Y|1967-03-07
TRIAL STUDY 134XCP|LB|B6E55A62-CF0B-4BC6-84DC-038F29518909|2||||VITD2|VITAMIN D2|||||||/H|||||||POSITIVE||UG/MIN||||HIGH|NOT DONE||||MECONIUM|CONTAMINATED|N|NEURAMINIDASE INHIBITION ASSAY|FIBROTEST FORMULA||Y|U|NA|N|||Y|3||39||BLINDED TREATMENT|1965-07-19|1962-07-20|||||1963-09-23||1969-01-08|Y|1971-10-10
TRIAL STUDY 134XCP|LB|B6E55A62-CF0B-4BC6-84DC-038F29518909|1||||PLTMORPH|PLATELET MORPHOLOGY|||||||FOZ_US|||||||BORDERLINE||APPLICATION||||HIGH|NOT DONE||||LUNG SURFACTANT|CLOTTED|N|MRI WITHOUT CONTRAST|MDRD ENZYMATIC JAPANESE FORMULA||U|N|U|Y|||Y|4||88||LONG-TERM FOLLOW-UP|1971-04-03|1972-07-17|||||1961-04-07||1971-10-20|U|1967-03-22
TRIAL STUDY 134XCP|LB|B6E55A62-CF0B-4BC6-84DC-038F29518909|2||||FACTVWA|VON WILLEBRAND FACTOR ACTIVITY|||||||ML/M2/DAY|||||||BORDERLINE||PACKET||||NORMAL|NOT DONE||||GASTRIC CONTENTS|GELLED|Y|CHROMOGENIC ASSAY|ASH FIBROSURE FORMULA||N|Y|NA|U|||N|4||88||LONG-TERM FOLLOW-UP|1970-11-30|1971-02-24|||||1970-02-01||1969-05-30|Y|1960-09-02
TRIAL STUDY 134XCP|LB|B6E55A62-CF0B-4BC6-84DC-038F29518909|1||||HBA1CHGB|HEMOGLOBIN A1C/HEMOGLOBIN|||||||MIN|||||||POSITIVE||GENEQ/ML||||ABNORMAL|NOT DONE||||EXPIRED AIR|LIPEMIC|NA|PATHOLOGICAL EVALUATION|FIBROTEST FORMULA||Y|NA|Y|NA|||N|5||7||BLINDED TREATMENT|1967-10-31|1972-05-30|||||1964-02-16||1967-10-10|NA|1968-11-10
TRIAL STUDY 134XCP|LB|B6E55A62-CF0B-4BC6-84DC-038F29518909|2||||INGAPAB|ISLET NEOGENESIS ASSOC PROTEIN ANTIBODY|||||||%/S|||||||NEGATIVE||MG/KG/H||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|DRIED|N|REVERSE TRANSCRIPTASE PCR|ASH FIBROSURE FORMULA||U|U|NA|NA|||Y|5||7||INDUCTION TREATMENT|1970-02-22|1961-02-13|||||1961-02-22||1963-01-19|U|1964-08-16
TRIAL STUDY 134XCP|LB|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|1||||EOSIM|IMMATURE EOSINOPHILS|||||||U/G|||||||NEGATIVE||VG/ML||||LOW|NOT DONE||||BLOOD|LIPEMIC|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||N|NA|NA|U|||NA|1||38||CONTINUATION TREATMENT|1965-06-09|1971-03-28|||||1968-02-21||1961-09-19|N|1964-08-06
TRIAL STUDY 134XCP|LB|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|2||||CD34|CD34|||||||NCI|||||||POSITIVE||L/MIN||||NORMAL|NOT DONE||||MUCUS|CLOTTED|Y|LISSAMINE GREEN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|N|N|||U|1||38||RUN-IN|1972-10-14|1968-07-30|||||1969-11-15||1968-06-20|NA|1967-04-15
TRIAL STUDY 134XCP|LB|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|1||||GLOBUL|GLOBULIN|||||||PMOL/10^9 CELLS|||||||NEGATIVE||YEARS||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|LIPEMIC|NA|NEURAMINIDASE INHIBITION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|U|Y|||Y|2||58||TREATMENT|1962-01-17|1972-02-24|||||1971-08-07||1972-06-23|NA|1968-03-19
TRIAL STUDY 134XCP|LB|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|2||||GLUBD13|1,3-BETA-D-GLUCAN|||||||AMOL|||||||POSITIVE||10^6/HPF||||HIGH|NOT DONE||||BILE|ICTERIC|N|FLOW CYTOMETRY|CKD-EPI CYSTATIN C FORMULA||U|N|Y|N|||U|2||58||RUN-IN|1971-08-04|1966-02-07|||||1963-07-30||1968-03-30|N|1961-05-24
TRIAL STUDY 134XCP|LB|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|1||||RLP|RLP CHOLESTEROL|||||||G/G|||||||NEGATIVE||UV*SEC||||NORMAL|NOT DONE||||TISSUE|LACTESCENT|Y|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|GMI MMOL/MOL FORMULA||Y|Y|Y|Y|||NA|3||39||CONTINUATION TREATMENT|1961-03-08|1960-02-23|||||1961-04-03||1970-02-09|Y|1970-03-18
TRIAL STUDY 134XCP|LB|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|2||||THYPXD|THYROPEROXIDASE|||||||MG/M2|||||||POSITIVE||CM/MIN||||HIGH|NOT DONE||||TRANSUDATE|LACTESCENT|Y|BIOPSY|GMI % FORMULA||N|U|NA|U|||NA|3||39||INDUCTION TREATMENT|1967-08-07|1961-05-16|||||1961-11-17||1966-10-05|N|1965-11-24
TRIAL STUDY 134XCP|LB|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|1||||ASTCREAT|ASPARTATE AMINOTRANSFERASE/CREATININE|||||||G/CAGE/DAY|||||||INDETERMINATE||MAC50||||LOW|NOT DONE||||DISCHARGE|GELLED|NA|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|GMI MMOL/MOL FORMULA||Y|U|NA|N|||NA|4||88||INDUCTION TREATMENT|1970-04-16|1966-03-24|||||1962-03-23||1963-05-23|U|1972-04-30
TRIAL STUDY 134XCP|LB|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|2||||PAP|PROSTATIC ACID PHOSPHATASE|||||||GBQ/G|||||||POSITIVE||MMOL/S||||LOW|NOT DONE||||LOCHIA|HEMOLYZED|N|ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|Y|||N|4||88||OBSERVATION|1973-06-29|1971-01-04|||||1972-06-03||1963-11-15|Y|1967-04-23
TRIAL STUDY 134XCP|LB|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|1||||INTLK1RA|INTERLEUKIN 1 RECEPTOR ANTAGONIST|||||||10^5/L|||||||TRACE||HENRY||||LOW|NOT DONE||||SYNOVIAL FLUID|DRIED|Y|CONTRAST ENHANCED CT SCAN|FIBROSIS 4 FORMULA||NA|NA|Y|NA|||N|5||7||FOLLOW-UP|1967-01-14|1965-12-13|||||1960-09-25||1960-02-12|NA|1963-01-16
TRIAL STUDY 134XCP|LB|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|2||||PROTCRT|PROTEIN/CREATININE|||||||NG/MOL|||||||TRACE||MM2||||NORMAL|NOT DONE||||SERUM OR PLASMA|NON-HEMOLYZED|U|ELECTROMYOGRAPHY|FIBROTEST FORMULA||U|N|U|NA|||N|5||7||LONG-TERM FOLLOW-UP|1971-12-06|1962-11-06|||||1962-11-20||1967-12-19|N|1961-09-25
TRIAL STUDY 134XCP|LB|5577E914-C90D-4CC4-A7A8-D919C29A61D1|1||||LTB4|LEUKOTRIENE B4|||||||/MBP|||||||POSITIVE||10^7 PFU||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED|NA|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA||U|N|Y|Y|||U|1||38||BLINDED TREATMENT|1965-02-09|1961-02-28|||||1960-02-24||1969-12-24|NA|1963-09-05
TRIAL STUDY 134XCP|LB|5577E914-C90D-4CC4-A7A8-D919C29A61D1|2||||BNZLCGN|BENZOYLECGONINE|||||||NG/DL|||||||INVALID||DNA COPIES/UG||||LOW|NOT DONE||||SWABBED MATERIAL|LIPEMIC|N|PAP STAIN|FIBROTEST FORMULA||NA|NA|U|NA|||Y|1||38||WASHOUT|1968-12-07|1968-04-28|||||1964-07-25||1965-08-20|NA|1963-05-09
TRIAL STUDY 134XCP|LB|5577E914-C90D-4CC4-A7A8-D919C29A61D1|1||||ZPP|ZINC PROTOPORPHYRIN|||||||U|||||||TRACE||MOL||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|ICTERIC|Y|CYSTOSCOPY|HEPASCORE FORMULA||U|NA|N|U|||NA|2||58||INDUCTION TREATMENT|1970-05-20|1972-07-20|||||1964-01-06||1965-07-10|Y|1964-11-27
TRIAL STUDY 134XCP|LB|5577E914-C90D-4CC4-A7A8-D919C29A61D1|2||||AMBRBTL|AMOBARBITAL|||||||MG/G/H|||||||BORDERLINE||ML/BREATH||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|GELLED|NA|MODIFIED ACID FAST STAIN|FIBROMETER FORMULA||U|N|Y|N|||N|2||58||OBSERVATION|1963-08-27|1970-05-01|||||1973-06-18||1962-10-04|U|1966-01-27
TRIAL STUDY 134XCP|LB|5577E914-C90D-4CC4-A7A8-D919C29A61D1|1||||TFERRIN|TRANSFERRIN|||||||KAT|||||||INVALID||UMOL/L/SEC||||HIGH|NOT DONE||||PLATELET POOR PLASMA|ROOM TEMPERATURE|U|CAPILLARY ELECTROPHORESIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|Y|U|||NA|3||39||CONTINUATION TREATMENT|1972-09-17|1960-06-09|||||1972-05-30||1969-02-16|Y|1971-11-20
TRIAL STUDY 134XCP|LB|5577E914-C90D-4CC4-A7A8-D919C29A61D1|2||||ALPCREAT|ALKALINE PHOSPHATASE/CREATININE|||||||10^9 ORGANISMS/MG|||||||NEGATIVE||ML/BREATH||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|HEMOLYZED|Y|FREEZING POINT DEPRESSION|MDRD ENZYMATIC FORMULA||N|U|Y|NA|||U|3||39||WASHOUT|1963-01-02|1961-07-27|||||1967-12-16||1960-01-07|NA|1969-01-04
TRIAL STUDY 134XCP|LB|5577E914-C90D-4CC4-A7A8-D919C29A61D1|1||||INTLK11|INTERLEUKIN 11|||||||CMH2O*S/ML|||||||NEGATIVE||IN2||||NORMAL|NOT DONE||||BILE|AUTOLYZED|N|LC/MS|NASH FIBROSURE FORMULA||N|N|N|NA|||U|4||88||LONG-TERM FOLLOW-UP|1969-04-26|1964-09-30|||||1973-06-04||1961-06-30|Y|1973-01-14
TRIAL STUDY 134XCP|LB|5577E914-C90D-4CC4-A7A8-D919C29A61D1|2||||CCL12|CHEMOKINE (C-C MOTIF) LIGAND 12|||||||G|||||||POSITIVE||UM/DAY||||HIGH|NOT DONE||||SOFT TISSUE|AUTOLYZED|Y|CLIP|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|U|Y|||U|4||88||RUN-IN|1971-10-02|1968-02-08|||||1960-05-14||1970-10-24|N|1961-07-06
TRIAL STUDY 134XCP|LB|5577E914-C90D-4CC4-A7A8-D919C29A61D1|1||||PLSNCE|NEOPLASTIC PLASMA CELLS|||||||KIU|||||||INDETERMINATE||MG/KG/MIN||||HIGH|NOT DONE||||ABSCESS FLUID|NON-HEMOLYZED|U|NEXT GENERATION TARGETED SEQUENCING|GMI % FORMULA||NA|Y|U|NA|||N|5||7||BASELINE|1965-06-08|1963-08-16|||||1972-10-31||1962-12-10|N|1971-12-14
TRIAL STUDY 134XCP|LB|5577E914-C90D-4CC4-A7A8-D919C29A61D1|2||||VITE|VITAMIN E|||||||UMOL/L/MIN|||||||POSITIVE||NEBULE||||HIGH|NOT DONE||||EXUDATE|HEMOLYZED|U|MRS|COCKCROFT-GAULT FORMULA||U|NA|U|N|||N|5||7||RUN-IN|1963-11-22|1966-06-23|||||1969-11-10||1973-03-12|N|1969-02-11
TRIAL STUDY 134XCP|LB|2DBA8940-F59E-4A0D-8858-408D71DD9753|1||||ETGETS|ETHYL GLUCURONIDE ETHYL SULFATE|||||||PNU/ML|||||||BORDERLINE||K||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED|N|SECONDARY ION MASS SPECTOMETRY|FIBROTEST FORMULA||Y|U|N|N|||NA|1||38||FOLLOW-UP|1964-02-04|1961-01-18|||||1964-06-12||1965-11-10|U|1966-07-13
TRIAL STUDY 134XCP|LB|2DBA8940-F59E-4A0D-8858-408D71DD9753|2||||FLUOXTN|FLUOXETINE|||||||MMHG/L/MIN|||||||POSITIVE||MU/L||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|FRESH|U|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|CKD-EPI FORMULA||U|N|NA|N|||N|1||38||OBSERVATION|1972-07-17|1973-07-24|||||1962-12-24||1972-10-28|N|1964-01-14
TRIAL STUDY 134XCP|LB|2DBA8940-F59E-4A0D-8858-408D71DD9753|1||||DOPAC|3,4-DIHYDROXYPHENYLACETIC ACID|||||||U.CARR|||||||POSITIVE||UEQ/L||||ABNORMAL|NOT DONE||||SALIVA|AUTOLYZED|NA|TWO-COLOR MICROARRAY|CKD-EPI CREATININE FORMULA||U|Y|Y|U|||N|2||58||BLINDED TREATMENT|1967-12-17|1972-04-18|||||1973-08-03||1965-11-08|U|1960-07-16
TRIAL STUDY 134XCP|LB|2DBA8940-F59E-4A0D-8858-408D71DD9753|2||||APOA2|APOLIPOPROTEIN AII|||||||DPM/ML|||||||POSITIVE||10^4/HPF||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|CONCENTRATED|N|LC/MS/MS|CKD-EPI CREATININE FORMULA||NA|Y|N|U|||N|2||58||FOLLOW-UP|1967-08-25|1966-11-11|||||1962-01-13||1967-08-07|N|1966-11-14
TRIAL STUDY 134XCP|LB|2DBA8940-F59E-4A0D-8858-408D71DD9753|1||||C130092|WESTERN RAGWEED POLLEN IGE|||||||UG/L/H|||||||INVALID||FOZ_US||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|AGGLUTINATED|NA|TARGETED GENOME SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||N|U|N|N|||Y|3||39||BASELINE|1963-08-15|1962-11-04|||||1961-01-17||1973-08-28|NA|1961-04-24
TRIAL STUDY 134XCP|LB|2DBA8940-F59E-4A0D-8858-408D71DD9753|2||||NOHDLHDL|NON-HDL CHOLESTEROL/HDL CHOLESTEROL|||||||H/WK|||||||INDETERMINATE||JAR||||NORMAL|NOT DONE||||CORD BLOOD|SOLIDIFIED|Y|MACRO BROTH DILUTION|MDRD 6 VARIABLE FORMULA||U|U|N|NA|||Y|3||39||LONG-TERM FOLLOW-UP|1973-04-26|1964-01-31|||||1964-08-20||1960-06-24|N|1972-02-22
TRIAL STUDY 134XCP|LB|2DBA8940-F59E-4A0D-8858-408D71DD9753|1||||TMZPM|TEMAZEPAM|||||||U/G|||||||TRACE||CONTAINER||||NORMAL|NOT DONE||||VENOUS PLASMA|UNEXPECTED ODOR|U|MECHANICAL CLOT DETECTION|HEPASCORE FORMULA||NA|U|U|Y|||NA|4||88||WASHOUT|1967-12-25|1972-04-04|||||1963-05-04||1964-12-04|U|1962-12-29
TRIAL STUDY 134XCP|LB|2DBA8940-F59E-4A0D-8858-408D71DD9753|2||||INTLK6|INTERLEUKIN 6|||||||KDA|||||||NEGATIVE||U/10^12 RBC||||NORMAL|NOT DONE||||ALVEOLAR AIR|THAWED|N|POPULATION SEQUENCING|MDRD 5 VARIABLE FORMULA||U|U|NA|U|||NA|4||88||BLINDED TREATMENT|1969-07-31|1966-05-11|||||1968-06-01||1970-08-27|N|1973-03-21
TRIAL STUDY 134XCP|LB|2DBA8940-F59E-4A0D-8858-408D71DD9753|1||||TEARDCY|DACRYOCYTES|||||||MV*MIN|||||||INVALID||MPS U||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|ICTERIC|Y|TRIPLE-PHASE MRI SCAN|FIBROMETER FORMULA||N|U|U|N|||NA|5||7||WASHOUT|1960-09-07|1962-11-10|||||1973-03-21||1960-10-29|Y|1968-02-16
TRIAL STUDY 134XCP|LB|2DBA8940-F59E-4A0D-8858-408D71DD9753|2||||PLATCLMP|PLATELET CLUMPS|||||||CMH2O/ML|||||||TRACE||UMOL/MOL||||LOW|NOT DONE||||LOCHIA|ICTERIC|NA|MAPH|MDRD FORMULA||Y|NA|NA|N|||U|5||7||FOLLOW-UP|1969-05-09|1967-01-13|||||1966-04-18||1966-04-11|Y|1969-08-28
TRIAL STUDY 134XCP|LB|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|1||||ALBGLYCA|GLYCATED ALBUMIN|||||||10^8 PFU|||||||INVALID||GPL U||||HIGH|NOT DONE||||SALIVA|HEMOLYZED|N|KINETIC CHROMOGENIC ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|Y|NA|||NA|1||38||LONG-TERM FOLLOW-UP|1963-06-17|1960-11-07|||||1972-10-07||1973-04-10|N|1966-06-26
TRIAL STUDY 134XCP|LB|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|2||||MIP1A|MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA|||||||UMOL/DL|||||||TRACE||/MBP||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|SOLIDIFIED|NA|IMMUNOTURBIDIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|Y|U|||U|1||38||RUN-IN|1967-03-21|1973-08-22|||||1965-04-28||1962-04-01|Y|1963-12-23
TRIAL STUDY 134XCP|LB|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|1||||C130100|MIXED ANTIGEN IGE ANTIBODY|||||||BU/ML|||||||NEGATIVE||G/G/DAY||||LOW|NOT DONE||||BLOOD|UNEXPECTED ODOR|NA|COLORIMETRY|GMI MMOL/MOL FORMULA||U|NA|NA|U|||U|2||58||BLINDED TREATMENT|1963-10-09|1963-06-20|||||1966-01-21||1961-05-09|Y|1962-03-24
TRIAL STUDY 134XCP|LB|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|2||||ASSDNA|ANTI-SINGLE STRANDED DNA IGG|||||||LOG10 TCID 50/DOSE|||||||NEGATIVE||10^8 PFU||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONTAMINATED|NA|MULTIPLE BREATH WASHOUT|COCKCROFT-GAULT FORMULA||N|U|U|Y|||NA|2||58||SCREENING|1961-10-13|1968-10-31|||||1971-12-24||1973-07-19|Y|1971-07-12
TRIAL STUDY 134XCP|LB|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|1||||NUCCE|NUCLEATED CELLS|||||||AMP|||||||POSITIVE||KG/L||||ABNORMAL|NOT DONE||||DERMAL TISSUE|HEMOLYZED|N|RAJI CELL EIA|ASH FIBROSURE FORMULA||U|U|U|NA|||NA|3||39||RUN-IN|1963-07-29|1968-02-09|||||1963-01-04||1965-05-20|Y|1961-12-31
TRIAL STUDY 134XCP|LB|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|2||||APOB48|APOLIPOPROTEIN B48|||||||AMPULE|||||||BORDERLINE||BOTTLE||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|SOLIDIFIED|NA|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||U|U|N|N|||NA|3||39||BLINDED TREATMENT|1972-06-02|1972-12-02|||||1969-08-08||1970-08-17|N|1961-03-16
TRIAL STUDY 134XCP|LB|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|1||||CTXII|TYPE II COLLAGEN C-TELOPEPTIDES|||||||MM|||||||INVALID||G/M2||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|FROZEN|U|ISHIHARA COLOR PLATES|GMI % FORMULA||NA|N|Y|Y|||U|4||88||LONG-TERM FOLLOW-UP|1961-05-22|1971-12-23|||||1960-01-07||1973-06-04|Y|1971-03-09
TRIAL STUDY 134XCP|LB|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|2||||HAMAB|HUMAN ANTI-MOUSE ANTIBODY|||||||/LPF|||||||INDETERMINATE||COULOMB||||ABNORMAL|NOT DONE||||CERUMEN|CONTAMINATED|N|SLOAN LETTER EYE CHART 100%|COCKCROFT-GAULT FORMULA||N|U|N|NA|||N|4||88||LONG-TERM FOLLOW-UP|1973-04-08|1964-02-20|||||1962-05-06||1965-04-24|U|1971-02-24
TRIAL STUDY 134XCP|LB|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|1||||IGGC|IGG CLEARANCE|||||||KV|||||||POSITIVE||ML/H||||HIGH|NOT DONE||||INTERSTITIAL FLUID|DRIED|Y|CYSTOMETRY|CKD-EPI CREATININE FORMULA||U|U|Y|Y|||N|5||7||WASHOUT|1969-03-28|1973-04-11|||||1964-02-08||1969-05-19|Y|1973-04-19
TRIAL STUDY 134XCP|LB|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|2||||C130129|DOG DANDER ANTIGEN IGG ANTIBODY|||||||NGEQ/L|||||||INVALID||10^6 DNA COPIES/ML||||NORMAL|NOT DONE||||SYNOVIAL FLUID|CLOTTED|U|PEAK FLOWMETRY|MDRD 6 VARIABLE FORMULA||N|N|U|NA|||NA|5||7||BLINDED TREATMENT|1963-11-05|1968-10-06|||||1962-04-07||1962-12-15|U|1965-12-22
TRIAL STUDY 134XCP|LB|0250EC5D-B08F-4010-9653-95E20EDD0CCA|1||||DKK1|DICKKOPF WNT SIGNALING PATH INHIBITOR 1|||||||OD UNIT|||||||BORDERLINE||MMOL/MIN/KPA/L||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONCENTRATED|Y|SLOAN LETTER EYE CHART 100%|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|Y|Y|||U|1||38||BASELINE|1973-04-25|1966-05-09|||||1970-11-24||1971-11-05|NA|1969-03-05
TRIAL STUDY 134XCP|LB|0250EC5D-B08F-4010-9653-95E20EDD0CCA|2||||ATHPIDX|ATHEROGENIC INDEX OF PLASMA|||||||CI/UL|||||||TRACE||/7.5 ML||||LOW|NOT DONE||||MONOCYTE|PARAFFIN-EMBEDDED|U|ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|NA|NA|NA|||Y|1||38||WASHOUT|1967-08-19|1963-11-04|||||1962-01-22||1965-11-20|U|1970-11-29
TRIAL STUDY 134XCP|LB|0250EC5D-B08F-4010-9653-95E20EDD0CCA|1||||CSEPIR|RENAL EPITHELIAL CASTS|||||||KPA|||||||BORDERLINE||MIN/DAY||||ABNORMAL|NOT DONE||||SERUM|CALCIFIED|U|JAFFE REACTION|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|U|N|||Y|2||58||OPEN LABEL TREATMENT|1966-01-27|1970-07-16|||||1962-04-23||1966-02-03|U|1960-02-16
TRIAL STUDY 134XCP|LB|0250EC5D-B08F-4010-9653-95E20EDD0CCA|2||||TPRONP|NON-PHOSPHORYLATED TAU PROTEIN|||||||UEQ/L|||||||NEGATIVE||10^12 IU/L||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|CALCIFIED|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC FORMULA||U|N|N|Y|||NA|2||58||TREATMENT|1965-10-04|1964-02-27|||||1965-04-29||1973-02-15|Y|1962-10-07
TRIAL STUDY 134XCP|LB|0250EC5D-B08F-4010-9653-95E20EDD0CCA|1||||VITD3|VITAMIN D3|||||||CMH2O/ML|||||||NEGATIVE||H*%||||HIGH|NOT DONE||||BILE|CONTAMINATED|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|HEPASCORE FORMULA||U|N|N|U|||N|3||39||FOLLOW-UP|1963-10-13|1970-03-04|||||1960-03-11||1961-11-21|U|1967-08-09
TRIAL STUDY 134XCP|LB|0250EC5D-B08F-4010-9653-95E20EDD0CCA|2||||FACTXIII|FACTOR XIII|||||||ML/KG/H|||||||TRACE||UG/MIN||||NORMAL|NOT DONE||||MECONIUM|AGGLUTINATED|Y|SNELLEN EYE CHART|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|Y|||NA|3||39||OBSERVATION|1963-02-23|1967-09-22|||||1962-07-13||1964-10-23|N|1966-05-13
TRIAL STUDY 134XCP|LB|0250EC5D-B08F-4010-9653-95E20EDD0CCA|1||||AMH|ANTI-MULLERIAN HORMONE|||||||LM|||||||POSITIVE||ML/M2||||NORMAL|NOT DONE||||TISSUE|FROZEN|N|PET/CT SCAN WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA||U|Y|U|N|||N|4||88||CONTINUATION TREATMENT|1960-12-16|1971-10-05|||||1967-11-27||1973-03-12|N|1960-03-03
TRIAL STUDY 134XCP|LB|0250EC5D-B08F-4010-9653-95E20EDD0CCA|2||||ACETONE|ACETONE|||||||ATM|||||||INDETERMINATE||10^3 CFU/ML||||HIGH|NOT DONE||||PERSPIRATION|SOLIDIFIED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|Y|NA|||NA|4||88||SCREENING|1963-09-07|1967-03-19|||||1973-03-26||1962-05-30|N|1965-09-18
TRIAL STUDY 134XCP|LB|0250EC5D-B08F-4010-9653-95E20EDD0CCA|1||||CEC|CIRCULATING ENDOTHELIAL CELLS|||||||CM/MIN|||||||POSITIVE||/MM2||||ABNORMAL|NOT DONE||||COLOSTRUM|PARAFFIN-EMBEDDED|Y|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD FORMULA||U|N|U|N|||N|5||7||BASELINE|1966-05-23|1972-06-10|||||1966-11-26||1963-06-12|N|1971-06-09
TRIAL STUDY 134XCP|LB|0250EC5D-B08F-4010-9653-95E20EDD0CCA|2||||HGBAHGB|HEMOGLOBIN A/TOTAL HEMOGLOBIN|||||||MEQ/KG|||||||BORDERLINE||LOG10 IU/ML||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|SOLIDIFIED|N|ORCHIDOMETERY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|NA|N|||NA|5||7||CONTINUATION TREATMENT|1962-09-09|1962-12-13|||||1967-09-15||1964-07-12|U|1973-06-09
TRIAL STUDY 134XCP|LB|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|1||||PTSFAC|PROTEIN S, FREE ACTUAL/CONTROL|||||||HEP|||||||INDETERMINATE||GY/H||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|THAWED|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|HEPASCORE FORMULA||NA|N|U|N|||N|1||38||LONG-TERM FOLLOW-UP|1965-05-23|1960-06-05|||||1971-04-29||1963-07-07|N|1971-01-15
TRIAL STUDY 134XCP|LB|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|2||||BTK|BRUTON'S TYROSINE KINASE|||||||MDFI|||||||TRACE||NMOL/KG/DAY||||HIGH|NOT DONE||||LYMPH|AUTOLYZED|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD ENZYMATIC FORMULA||N|N|Y|NA|||NA|1||38||LONG-TERM FOLLOW-UP|1972-08-06|1963-09-16|||||1970-07-05||1967-01-05|Y|1973-06-06
TRIAL STUDY 134XCP|LB|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|1||||CBS|CYSTATHIONINE BETA-SYNTHASE|||||||CCID 50/DOSE|||||||BORDERLINE||UM||||LOW|NOT DONE||||CALCULUS|CONCENTRATED|U|SLOAN LETTER EYE CHART 2.5%|MDRD ENZYMATIC FORMULA||NA|NA|Y|N|||NA|2||58||TREATMENT|1963-01-04|1973-05-16|||||1970-03-17||1971-05-15|N|1963-05-07
TRIAL STUDY 134XCP|LB|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|2||||HVA|HOMOVANILLIC ACID|||||||UMOL/L|||||||TRACE||FG||||NORMAL|NOT DONE||||TUMOR TISSUE|FROZEN|U|AUTOREFRACTION|FIBROTEST FORMULA||N|NA|U|N|||NA|2||58||BASELINE|1964-02-11|1966-05-11|||||1963-03-08||1964-11-28|U|1968-11-22
TRIAL STUDY 134XCP|LB|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|1||||FVAAC|FACTOR V ACTIVITY ACTUAL/CONTROL|||||||L/MIN/M2|||||||INDETERMINATE||ATM||||NORMAL|NOT DONE||||DIALYSIS FLUID|PARAFFIN-EMBEDDED|N|CONTRAST ENHANCED X-RAY|GMI MMOL/MOL FORMULA||Y|U|Y|Y|||Y|3||39||OBSERVATION|1969-07-22|1964-05-13|||||1970-10-29||1970-01-08|NA|1964-05-29
TRIAL STUDY 134XCP|LB|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|2||||ETPLT|ETP LAG TIME|||||||EID 50/DOSE|||||||INVALID||TUBE||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|UNEXPECTED ODOR|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 5 VARIABLE FORMULA||N|NA|N|U|||U|3||39||FOLLOW-UP|1966-07-28|1962-03-30|||||1962-04-02||1960-05-02|N|1964-09-25
TRIAL STUDY 134XCP|LB|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|1||||EPO|ERYTHROPOIETIN|||||||KS|||||||INVALID||MOL/DAY||||NORMAL|NOT DONE||||LEUKOCYTE|REFRIGERATED|N|TRANSVAGINAL ULTRASOUND|MDRD 4 VARIABLE FORMULA||U|Y|N|Y|||U|4||88||RUN-IN|1967-08-29|1972-01-16|||||1965-02-21||1964-06-23|N|1960-01-02
TRIAL STUDY 134XCP|LB|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|2||||LGUNSCE|LARGE UNSTAINED CELLS|||||||ML/MMHG/MIN/L|||||||INVALID||10^8 PFU||||ABNORMAL|NOT DONE||||PUS|HEMOLYZED|N|DNA MICROARRAY|FIBROMETER FORMULA||N|Y|N|Y|||Y|4||88||BLINDED TREATMENT|1971-06-19|1968-01-05|||||1970-08-11||1973-06-06|U|1963-12-03
TRIAL STUDY 134XCP|LB|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|1||||NCCPTN|NOCICEPTIN|||||||L/H/M2|||||||TRACE||PM||||HIGH|NOT DONE||||BLOOD|HEMOLYZED|Y|SLIT LAMP PHOTOGRAPHY|MDRD FORMULA||N|Y|NA|Y|||U|5||7||INDUCTION TREATMENT|1966-06-22|1969-09-28|||||1964-06-10||1972-02-27|NA|1960-04-16
TRIAL STUDY 134XCP|LB|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|2||||KI67|KI-67|||||||DRUM|||||||NEGATIVE||FT2||||HIGH|NOT DONE||||MECONIUM|FROZEN|N|DYNAMIC LIGHT SCATTERING|CKD-EPI CREATININE FORMULA||Y|N|U|Y|||N|5||7||OPEN LABEL TREATMENT|1964-08-23|1969-07-31|||||1966-06-20||1964-09-13|U|1968-03-16
TRIAL STUDY 134XCP|LB|140FFC83-72C9-4BD4-AA44-C98CA42147F3|1||||C130076|SILVER BIRCH POLLEN IGE|||||||MCI/L|||||||TRACE||IU/MMOL||||NORMAL|NOT DONE||||GASTRIC FLUID|PARAFFIN-EMBEDDED|NA|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC FORMULA||N|U|U|NA|||NA|1||38||WASHOUT|1971-04-30|1962-06-08|||||1972-05-13||1967-08-08|NA|1961-02-23
TRIAL STUDY 134XCP|LB|140FFC83-72C9-4BD4-AA44-C98CA42147F3|2||||IGHG2|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 2|||||||10^6 ORGANISMS/MG|||||||TRACE||10^9 CFU||||HIGH|NOT DONE||||SERUM OR PLASMA|GELLED|U|LISSAMINE GREEN STAIN|GMI % FORMULA||Y|Y|Y|Y|||Y|1||38||CONTINUATION TREATMENT|1966-04-16|1971-07-04|||||1972-04-14||1967-06-24|Y|1966-01-30
TRIAL STUDY 134XCP|LB|140FFC83-72C9-4BD4-AA44-C98CA42147F3|1||||C165930|SHELLFISH MIX IGE AB RAST SCORE|||||||10^9/G|||||||TRACE||UMOL/L/MIN||||LOW|NOT DONE||||AQUEOUS HUMOR|AGGLUTINATED|N|DUCTOGRAPHY|FIBROSIS 4 FORMULA||NA|NA|U|U|||N|2||58||WASHOUT|1968-04-05|1964-07-17|||||1964-02-11||1960-09-03|N|1972-07-04
TRIAL STUDY 134XCP|LB|140FFC83-72C9-4BD4-AA44-C98CA42147F3|2||||TIMM10|TRANSLOCASE INNER MITOCHONDRIAL MEMBR 10|||||||NGEQ/L|||||||INVALID||ML/SEC/1.73M2||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|ICTERIC|NA|OPTICAL COHERENCE TOMOGRAPHY|FIBROSIS 4 FORMULA||U|Y|N|N|||N|2||58||CONTINUATION TREATMENT|1973-01-16|1961-11-09|||||1968-08-15||1960-03-04|Y|1969-12-30
TRIAL STUDY 134XCP|LB|140FFC83-72C9-4BD4-AA44-C98CA42147F3|1||||METARUB|METARUBRICYTE|||||||TRANSDUCING UNIT|||||||BORDERLINE||CCID 50/ML||||HIGH|NOT DONE||||URINE|LACTESCENT|Y|SCANNING ELECTRON MICROSCOPY|GMI MMOL/MOL FORMULA||NA|N|NA|N|||NA|3||39||OPEN LABEL TREATMENT|1968-09-07|1968-11-03|||||1961-10-24||1971-03-14|Y|1968-06-24
TRIAL STUDY 134XCP|LB|140FFC83-72C9-4BD4-AA44-C98CA42147F3|2||||LDLOXAB|OXIDIZED LDL CHOLESTEROL ANTIBODY|||||||S/H|||||||TRACE||FMOL/L||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|NON-HEMOLYZED|Y|BETA LACTAMASE|CKD-EPI FORMULA||Y|Y|N|U|||N|3||39||RUN-IN|1965-04-11|1966-09-05|||||1965-09-21||1972-03-24|Y|1960-08-06
TRIAL STUDY 134XCP|LB|140FFC83-72C9-4BD4-AA44-C98CA42147F3|1||||CLEXR|CHLORIDE EXCRETION RATE|||||||CP|||||||BORDERLINE||LOG10 IU/ML||||NORMAL|NOT DONE||||URINE SEDIMENT|DRIED|U|GC/MS/MS|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|U|||Y|4||88||OBSERVATION|1962-06-15|1963-09-05|||||1960-05-03||1971-02-18|NA|1964-12-12
TRIAL STUDY 134XCP|LB|140FFC83-72C9-4BD4-AA44-C98CA42147F3|2||||PSDGLSRF|PHOSPHATIDYLGLYCEROL/LUNG SURFACTANT|||||||DIOPTER|||||||INDETERMINATE||STRIP||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|THAWED|N|ELECTROPHORESIS|MDRD ENZYMATIC FORMULA||U|N|U|U|||N|4||88||INDUCTION TREATMENT|1969-08-27|1971-10-04|||||1972-01-28||1960-08-22|N|1968-05-06
TRIAL STUDY 134XCP|LB|140FFC83-72C9-4BD4-AA44-C98CA42147F3|1||||PGF2A|PROSTAGLANDIN F2 ALPHA|||||||OD UNIT|||||||BORDERLINE||YD||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|DRIED|U|INTERRUPTER TECHNIQUE|MDRD FORMULA||NA|U|Y|NA|||U|5||7||WASHOUT|1971-08-24|1960-02-26|||||1968-08-23||1969-10-04|NA|1969-08-24
TRIAL STUDY 134XCP|LB|140FFC83-72C9-4BD4-AA44-C98CA42147F3|2||||BASO|BASOPHILS|||||||/200 HPFS|||||||POSITIVE||/MIN||||LOW|NOT DONE||||CAPILLARY PLASMA|LACTESCENT|Y|NEXT GENERATION SEQUENCING|MDRD 4 VARIABLE FORMULA||U|Y|N|NA|||NA|5||7||BASELINE|1973-04-03|1972-10-10|||||1961-05-08||1967-02-25|NA|1969-03-29
TRIAL STUDY 134XCP|LB|7BAC399A-0523-476E-A294-C57309E573AF|1||||GLP1|GLUCAGON-LIKE PEPTIDE-1|||||||QUANTITY SUFFICIENT|||||||NEGATIVE||CCID 50/ML||||NORMAL|NOT DONE||||URINE SEDIMENT|CONTAMINATED|N|IN VITRO GENE EXPRESSION ASSAY|MDRD 5 VARIABLE FORMULA||Y|U|N|Y|||NA|1||38||OPEN LABEL TREATMENT|1961-03-31|1963-06-06|||||1967-09-11||1969-04-03|Y|1969-04-19
TRIAL STUDY 134XCP|LB|7BAC399A-0523-476E-A294-C57309E573AF|2||||HDL3|HDL-CHOLESTEROL SUBCLASS 3|||||||10^6/HPF|||||||BORDERLINE||KG/M2||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|AGGLUTINATED|NA|HEMATOXYLIN AND EOSIN STAIN|FIBROMETER FORMULA||Y|NA|N|N|||Y|1||38||OPEN LABEL TREATMENT|1967-09-24|1964-08-06|||||1967-09-14||1967-01-31|Y|1963-11-20
TRIAL STUDY 134XCP|LB|7BAC399A-0523-476E-A294-C57309E573AF|1||||PSELECT|P-SELECTIN|||||||MEQ/UG|||||||BORDERLINE||ML/CAGE/WK||||ABNORMAL|NOT DONE||||STOOL|LACTESCENT|Y|PET/SPECT SCAN|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|N|||Y|2||58||WASHOUT|1964-07-10|1960-03-22|||||1967-12-23||1967-07-17|U|1964-09-28
TRIAL STUDY 134XCP|LB|7BAC399A-0523-476E-A294-C57309E573AF|2||||C165928|INDUSTRIAL MIX IGE AB RAST SCORE|||||||KM|||||||NEGATIVE||10^3 CFU||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|GELLED|N|TEST STRIP|GMI MMOL/MOL FORMULA||N|NA|N|N|||U|2||58||INDUCTION TREATMENT|1966-09-30|1972-04-10|||||1973-08-27||1960-06-24|Y|1968-07-25
TRIAL STUDY 134XCP|LB|7BAC399A-0523-476E-A294-C57309E573AF|1||||OHF6B|6 BETA-HYDROXYCORTISOL|||||||CAPFUL|||||||POSITIVE||/MM2||||HIGH|NOT DONE||||INFRANATANT, PLASMA|CLOTTED|N|CORONARY ANGIOGRAPHY|MDRD FORMULA||U|NA|N|NA|||N|3||39||INDUCTION TREATMENT|1965-11-13|1965-09-17|||||1964-03-31||1968-12-09|NA|1968-08-11
TRIAL STUDY 134XCP|LB|7BAC399A-0523-476E-A294-C57309E573AF|2||||PKM|PYRUVATE KINASE MUSCLE ISOZYME|||||||EID 50/DOSE|||||||BORDERLINE||/CMH2O||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|CONTAMINATED|N|BRDU CELLULAR PROLIFERATION ASSAY|FIBROSIS 4 FORMULA||U|N|N|N|||Y|3||39||WASHOUT|1972-08-14|1963-07-07|||||1973-05-06||1971-11-16|U|1970-12-19
TRIAL STUDY 134XCP|LB|7BAC399A-0523-476E-A294-C57309E573AF|1||||GLOBB|BETA GLOBULIN|||||||BP|||||||INDETERMINATE||10^9 CFU||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|ROOM TEMPERATURE|N|FREEZING POINT DEPRESSION|MDRD 6 VARIABLE FORMULA||N|NA|N|Y|||N|4||88||SCREENING|1965-04-18|1960-03-21|||||1962-04-26||1972-03-23|NA|1970-08-29
TRIAL STUDY 134XCP|LB|7BAC399A-0523-476E-A294-C57309E573AF|2||||IGGALB|IMMUNOGLOBULIN G/ALBUMIN|||||||UCI/KG|||||||POSITIVE||10^6 RNA COPIES/ML||||ABNORMAL|NOT DONE||||ISOLATE|THAWED|Y|EIA|ASH FIBROSURE FORMULA||Y|N|Y|N|||N|4||88||OBSERVATION|1963-10-02|1969-06-01|||||1966-11-04||1968-11-27|NA|1961-06-28
TRIAL STUDY 134XCP|LB|7BAC399A-0523-476E-A294-C57309E573AF|1||||RENIN|RENIN|||||||ANTI-XA IU/ML|||||||TRACE||IU/DL||||LOW|NOT DONE||||URINE SEDIMENT|ROOM TEMPERATURE|U|EEG|CKD-EPI CREATININE FORMULA||Y|N|Y|U|||N|5||7||BASELINE|1973-07-21|1972-12-12|||||1963-01-10||1961-09-21|NA|1961-11-11
TRIAL STUDY 134XCP|LB|7BAC399A-0523-476E-A294-C57309E573AF|2||||LDLOXI|OXIDIZED LDL CHOLESTEROL|||||||IU/G HB|||||||NEGATIVE||JAR||||HIGH|NOT DONE||||INTERSTITIAL FLUID|CONTAMINATED|N|FARNSWORTH-MUNSELL 100 HUE TEST|GMI % FORMULA||NA|NA|U|U|||U|5||7||FOLLOW-UP|1969-04-27|1970-06-12|||||1967-08-30||1960-01-20|U|1970-07-06
TRIAL STUDY 134XCP|LB|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|1||||PSELECT|P-SELECTIN|||||||MEQ/G|||||||BORDERLINE||GPELISA UNIT/ML||||LOW|NOT DONE||||SMEGMA|ICTERIC|N|INCISION-INDUCED BLEEDING METHOD|CKD-EPI FORMULA||Y|NA|U|NA|||Y|1||38||SCREENING|1973-05-23|1969-01-04|||||1970-07-23||1969-06-08|U|1963-06-25
TRIAL STUDY 134XCP|LB|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|2||||NEUTLS|LEFT SHIFT NEUTROPHILS|||||||% INHIBITION|||||||NEGATIVE||NGEQ/L||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|CONCENTRATED|N|FUNDUS PHOTOGRAPHY|GMI % FORMULA||N|NA|U|N|||NA|1||38||TREATMENT|1964-06-11|1970-05-12|||||1964-10-06||1965-11-13|U|1963-01-29
TRIAL STUDY 134XCP|LB|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|1||||NORMBASO|BASOPHILIC NORMOBLAST|||||||PACKET|||||||NEGATIVE||10^9 CFU/G||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|LACTESCENT|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD FORMULA||U|U|U|U|||N|2||58||WASHOUT|1972-11-08|1962-05-09|||||1969-12-05||1965-05-12|N|1969-09-06
TRIAL STUDY 134XCP|LB|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|2||||PYDCREAT|PYRIDINOLINE/CREATININE|||||||GBQ/G|||||||INVALID||10^4/L||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|CLOTTED|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|GMI % FORMULA||NA|N|U|U|||Y|2||58||CONTINUATION TREATMENT|1967-05-15|1968-09-26|||||1965-01-11||1968-07-28|N|1963-02-20
TRIAL STUDY 134XCP|LB|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|1||||SO2|SULFUR DIOXIDE|||||||MG/KG|||||||BORDERLINE||PPM||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|GELLED|Y|PHOTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||N|NA|Y|N|||NA|3||39||OBSERVATION|1970-01-20|1971-07-28|||||1960-12-30||1962-05-13|NA|1968-06-01
TRIAL STUDY 134XCP|LB|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|2||||PTAC|PROTHROMBIN TIME ACTUAL/CONTROL|||||||IMPLANT|||||||POSITIVE||10^10/L||||LOW|NOT DONE||||COLOSTRUM|HEMOLYZED|Y|MAPH|FIBROMETER FORMULA||N|Y|Y|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1967-11-14|1969-02-04|||||1963-09-27||1969-01-23|Y|1963-02-01
TRIAL STUDY 134XCP|LB|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|1||||C5FR|COMPLEMENT C5, FREE|||||||NCI|||||||NEGATIVE||MEQ/DAY||||HIGH|NOT DONE||||LAVAGE FLUID|CONCENTRATED|NA|ANTIBIOTIC AGAR SCREEN|HEPASCORE FORMULA||U|U|Y|N|||N|4||88||RUN-IN|1971-01-08|1968-03-27|||||1969-11-19||1971-07-08|NA|1970-09-21
TRIAL STUDY 134XCP|LB|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|2||||CD13|CD13|||||||ROENTGEN|||||||NEGATIVE||10^6 ORGANISMS/G||||LOW|NOT DONE||||LUNG SURFACTANT|THAWED|N|CLAUSS METHOD|COCKCROFT-GAULT FORMULA||U|U|U|N|||U|4||88||CONTINUATION TREATMENT|1962-03-17|1967-01-18|||||1960-04-27||1960-01-03|U|1961-09-09
TRIAL STUDY 134XCP|LB|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|1||||OXALATE|OXALATE|||||||ML/S/M2|||||||POSITIVE||COPIES/ML||||NORMAL|NOT DONE||||BONE MARROW|THAWED|NA|HPLC-FL|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|U|||N|5||7||RUN-IN|1963-06-20|1973-04-10|||||1968-04-12||1960-04-09|NA|1973-04-25
TRIAL STUDY 134XCP|LB|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|2||||PROLYMLY|PROLYMPHOCYTES/LYMPHOCYTES|||||||PPB|||||||BORDERLINE||/4.0 ML||||HIGH|NOT DONE||||ADIPOSE TISSUE|NON-HEMOLYZED|NA|EEG|NASH FIBROSURE FORMULA||U|Y|Y|NA|||NA|5||7||BLINDED TREATMENT|1962-09-27|1970-04-02|||||1970-04-12||1961-04-24|N|1961-04-04
TRIAL STUDY 134XCP|LB|0F180E62-F840-490F-8EB3-F7DDB7132401|1||||T4FRIND|THYROXINE, FREE, INDIRECT|||||||/10^5|||||||INVALID||DYN||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|REFRIGERATED|N|IVY INCISION METHOD|MDRD ENZYMATIC FORMULA||U|NA|N|U|||N|1||38||WASHOUT|1972-06-22|1960-12-08|||||1968-10-19||1962-06-04|Y|1969-02-23
TRIAL STUDY 134XCP|LB|0F180E62-F840-490F-8EB3-F7DDB7132401|2||||IL18EXR|INTERLEUKIN 18 EXCRETION RATE|||||||FEU|||||||INVALID||UG/DL||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|FIBROMETER FORMULA||U|N|N|NA|||NA|1||38||OPEN LABEL TREATMENT|1967-07-24|1960-03-11|||||1967-11-16||1963-05-02|NA|1961-03-05
TRIAL STUDY 134XCP|LB|0F180E62-F840-490F-8EB3-F7DDB7132401|1||||CKMM|CREATINE KINASE MM|||||||ML/MMHG/MIN/L|||||||TRACE||CM||||NORMAL|NOT DONE||||TRANSUDATE|FROZEN|Y|HANSEL STAIN|MDRD 4 VARIABLE FORMULA||U|U|NA|U|||Y|2||58||OPEN LABEL TREATMENT|1967-07-24|1960-08-07|||||1967-11-15||1965-02-27|U|1965-01-10
TRIAL STUDY 134XCP|LB|0F180E62-F840-490F-8EB3-F7DDB7132401|2||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||TITER|||||||BORDERLINE||MBQ||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|GMI % FORMULA||N|U|U|Y|||N|2||58||OBSERVATION|1970-04-17|1961-03-01|||||1964-07-05||1964-07-22|NA|1961-01-14
TRIAL STUDY 134XCP|LB|0F180E62-F840-490F-8EB3-F7DDB7132401|1||||HBOARBHB|HEMOGLOBIN O-ARAB/TOTAL HEMOGLOBIN|||||||MM2|||||||NEGATIVE||MV*MIN||||LOW|NOT DONE||||INTERSTITIAL FLUID|DRIED|NA|PET SCAN|HEPASCORE FORMULA||Y|U|U|Y|||Y|3||39||SCREENING|1969-10-03|1963-06-15|||||1960-08-10||1965-09-28|Y|1965-09-20
TRIAL STUDY 134XCP|LB|0F180E62-F840-490F-8EB3-F7DDB7132401|2||||G6PDRBRB|G6PD-DEFICIENT ERYTHROCYTES/ERYTHROCYTES|||||||MV*MIN|||||||NEGATIVE||MMOL/MOL||||ABNORMAL|NOT DONE||||COLOSTRUM|LIPEMIC|U|MICROBIAL CONCENTRATION|MDRD ENZYMATIC FORMULA||NA|U|N|NA|||N|3||39||RUN-IN|1967-12-17|1972-08-01|||||1971-09-01||1973-04-12|Y|1967-03-21
TRIAL STUDY 134XCP|LB|0F180E62-F840-490F-8EB3-F7DDB7132401|1||||PLAGMCVT|PLATELET AGGREGATION MEAN CURVE TYPE|||||||HOMEOPATHIC DILUTION|||||||TRACE||10^3 ORGANISMS||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|CALCIFIED|U|MICROPARTICLE ENZYME IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||Y|NA|N|NA|||NA|4||88||OBSERVATION|1966-06-08|1960-05-28|||||1973-02-22||1960-12-07|U|1961-04-01
TRIAL STUDY 134XCP|LB|0F180E62-F840-490F-8EB3-F7DDB7132401|2||||C165940|BOXELDER POLLEN IGE AB RAST SCORE|||||||CMH2O/ML|||||||INDETERMINATE||RNA COPIES/ML||||LOW|NOT DONE||||SMEGMA|THAWED|NA|PET/CT SCAN|FIBROSIS 4 FORMULA||NA|U|U|U|||Y|4||88||SCREENING|1969-08-04|1973-03-11|||||1962-03-09||1966-10-31|Y|1960-03-26
TRIAL STUDY 134XCP|LB|0F180E62-F840-490F-8EB3-F7DDB7132401|1||||LDH4LDH|LDH ISOENZYME 4/LDH|||||||MMOL2/L2|||||||INVALID||UG/ML/H||||HIGH|NOT DONE||||ARTERIAL BLOOD|FROZEN|U|FLOW MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|N|N|||N|5||7||TREATMENT|1972-11-22|1972-11-08|||||1965-09-16||1965-08-23|U|1966-10-18
TRIAL STUDY 134XCP|LB|0F180E62-F840-490F-8EB3-F7DDB7132401|2||||NTENS|NEUROTENSIN|||||||UEQ/L|||||||POSITIVE||CS||||NORMAL|NOT DONE||||MUSCLE TISSUE|ROOM TEMPERATURE|Y|NUCLEIC ACID AMPLIFICATION TEST|MDRD ENZYMATIC FORMULA||U|NA|Y|NA|||U|5||7||OPEN LABEL TREATMENT|1965-08-25|1972-05-20|||||1961-05-03||1961-01-09|NA|1971-02-04
TRIAL STUDY 134XCP|LB|80E7A428-CDDE-453F-B7D1-1B282A1835BF|1||||TIMP1CRE|TIMP1/CREATININE|||||||UG/M2|||||||NEGATIVE||MNFI||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|SOLIDIFIED|N|HEMOCYTOMETRY|CKD-EPI CYSTATIN C FORMULA||N|Y|NA|Y|||U|1||38||INDUCTION TREATMENT|1969-01-07|1966-08-30|||||1965-08-18||1972-05-25|N|1962-07-05
TRIAL STUDY 134XCP|LB|80E7A428-CDDE-453F-B7D1-1B282A1835BF|2||||TRANK1|TPR-ANKYRIN REPEAT-CONTAINING PROTEIN 1|||||||PMOL/L|||||||BORDERLINE||DAMOL/L||||ABNORMAL|NOT DONE||||PLEURAL FLUID|LACTESCENT|N|WHOLE GENOME SEQUENCING|FIBROSIS 4 FORMULA||NA|Y|Y|NA|||U|1||38||INDUCTION TREATMENT|1964-04-30|1967-06-26|||||1965-09-23||1961-09-16|NA|1961-03-31
TRIAL STUDY 134XCP|LB|80E7A428-CDDE-453F-B7D1-1B282A1835BF|1||||ALP|ALKALINE PHOSPHATASE|||||||ML/CAGE/WK|||||||POSITIVE||KG/CM2||||NORMAL|NOT DONE||||CAPILLARY PLASMA|FRESH|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD FORMULA||Y|NA|NA|N|||Y|2||58||TREATMENT|1969-07-01|1973-01-09|||||1962-02-21||1960-04-24|Y|1972-03-07
TRIAL STUDY 134XCP|LB|80E7A428-CDDE-453F-B7D1-1B282A1835BF|2||||THYPXDAB|THYROPEROXIDASE ANTIBODY|||||||PACK YEAR|||||||BORDERLINE||MET*MIN||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|DRIED|NA|MACRO BROTH DILUTION|CKD-EPI CYSTATIN C FORMULA||U|Y|Y|Y|||NA|2||58||OPEN LABEL TREATMENT|1961-11-07|1971-04-13|||||1965-08-26||1965-07-10|Y|1964-03-12
TRIAL STUDY 134XCP|LB|80E7A428-CDDE-453F-B7D1-1B282A1835BF|1||||KI67|KI-67|||||||NM|||||||INVALID||QUANTITY SUFFICIENT||||HIGH|NOT DONE||||PLATELET RICH PLASMA|UNEXPECTED ODOR|Y|GRADIENT DIFFUSION|HEPASCORE FORMULA||Y|NA|NA|U|||N|3||39||TREATMENT|1964-11-12|1962-05-14|||||1965-08-23||1961-02-05|NA|1965-12-01
TRIAL STUDY 134XCP|LB|80E7A428-CDDE-453F-B7D1-1B282A1835BF|2||||APLASCPD|APTT-LA SCREEN TO CONFIRM PCT DIFFERENCE|||||||MM/2H|||||||NEGATIVE||PMOL/10^9 CELLS||||HIGH|NOT DONE||||BLOOD|FRESH|N|NUCLEIC ACID BASED METHOD|FIBROTEST FORMULA||N|NA|Y|Y|||U|3||39||OBSERVATION|1968-08-08|1970-09-03|||||1962-09-01||1968-09-25|Y|1972-01-16
TRIAL STUDY 134XCP|LB|80E7A428-CDDE-453F-B7D1-1B282A1835BF|1||||APTT|ACTIVATED PARTIAL THROMBOPLASTIN TIME|||||||WEBER|||||||POSITIVE||HR/DAY||||HIGH|NOT DONE||||BREAST MILK|UNEXPECTED ODOR|NA|TRANSVAGINAL ULTRASOUND|FIBROTEST FORMULA||NA|N|N|NA|||Y|4||88||CONTINUATION TREATMENT|1960-11-08|1968-05-18|||||1964-12-13||1962-09-03|U|1967-03-26
TRIAL STUDY 134XCP|LB|80E7A428-CDDE-453F-B7D1-1B282A1835BF|2||||CYSTATC|CYSTATIN C|||||||PFU/DOSE|||||||NEGATIVE||MEQ/DAY||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED|NA|MICRO BROTH DILUTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|U|Y|||Y|4||88||INDUCTION TREATMENT|1964-10-12|1964-07-29|||||1973-03-21||1960-06-03|U|1971-11-15
TRIAL STUDY 134XCP|LB|80E7A428-CDDE-453F-B7D1-1B282A1835BF|1||||GLOBB1|BETA-1 GLOBULIN|||||||MIN/DAY|||||||INDETERMINATE||10^9 ORGANISMS/ML||||NORMAL|NOT DONE||||CERUMEN|REFRIGERATED|Y|AURAMINE STAIN|ASH FIBROSURE FORMULA||Y|Y|Y|N|||N|5||7||OPEN LABEL TREATMENT|1967-02-25|1964-01-15|||||1965-02-15||1971-10-05|Y|1968-07-02
TRIAL STUDY 134XCP|LB|80E7A428-CDDE-453F-B7D1-1B282A1835BF|2||||IL2RB|INTERLEUKIN 2 RECEPTOR SUBUNIT BETA|||||||KG|||||||NEGATIVE||BU/ML||||ABNORMAL|NOT DONE||||EXPIRED AIR|HEMOLYZED|U|CLINICAL EVALUATION|ASH FIBROSURE FORMULA||N|NA|N|Y|||N|5||7||WASHOUT|1961-03-30|1961-03-14|||||1971-03-04||1970-04-25|N|1972-05-02
TRIAL STUDY 134XCP|LB|F1D265C4-B975-4E74-9545-122A10FE100F|1||||APOA4|APOLIPOPROTEIN A4|||||||UU/DL|||||||POSITIVE||ML/S/M2||||LOW|NOT DONE||||HAIR|LIPEMIC|Y|SIZE EXCLUSION CHROMATOGRAPHY|MDRD 4 VARIABLE FORMULA||U|N|Y|Y|||NA|1||38||FOLLOW-UP|1964-06-08|1972-04-11|||||1972-01-18||1967-01-22|N|1968-12-03
TRIAL STUDY 134XCP|LB|F1D265C4-B975-4E74-9545-122A10FE100F|2||||BASOLE|BASOPHILS/LEUKOCYTES|||||||MM/MIN|||||||BORDERLINE||PFU/ML||||LOW|NOT DONE||||SPUTUM|HEMOLYZED|Y|MICROBIAL CONCENTRATION|MDRD FORMULA||Y|N|NA|U|||NA|1||38||SCREENING|1965-11-29|1969-05-07|||||1968-06-16||1969-02-16|NA|1963-10-06
TRIAL STUDY 134XCP|LB|F1D265C4-B975-4E74-9545-122A10FE100F|1||||FGFBF|FIBROBLAST GROWTH FACTOR BASIC FORM|||||||/HPF|||||||POSITIVE||GTT||||LOW|NOT DONE||||URINE|CONTAMINATED|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|NASH FIBROSURE FORMULA||NA|NA|N|NA|||N|2||58||OPEN LABEL TREATMENT|1967-10-03|1968-09-03|||||1973-08-01||1970-08-16|N|1964-12-10
TRIAL STUDY 134XCP|LB|F1D265C4-B975-4E74-9545-122A10FE100F|2||||ANABASN|ANABASINE|||||||PT_US|||||||INDETERMINATE||NEBULE||||LOW|NOT DONE||||CALCULUS|CONTAMINATED|Y|CALCULATION|CKD-EPI FORMULA||N|N|U|N|||Y|2||58||BLINDED TREATMENT|1970-01-19|1971-12-18|||||1963-11-04||1970-03-20|NA|1966-04-30
TRIAL STUDY 134XCP|LB|F1D265C4-B975-4E74-9545-122A10FE100F|1||||KIM1|KIDNEY INJURY MOLECULE-1|||||||DEG/MM|||||||NEGATIVE||G/G||||NORMAL|NOT DONE||||SEBUM|HEMOLYZED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|GMI MMOL/MOL FORMULA||Y|NA|N|N|||Y|3||39||BLINDED TREATMENT|1971-04-22|1968-11-11|||||1967-12-11||1965-01-30|U|1962-06-17
TRIAL STUDY 134XCP|LB|F1D265C4-B975-4E74-9545-122A10FE100F|2||||C130143|GERMAN COCKROACH ANTIGEN IGG4 ANTIBODY|||||||PKAT/L|||||||INDETERMINATE||MPL U/ML||||ABNORMAL|NOT DONE||||COLOSTRUM|FRESH|Y|FLOW CYTOMETRY|HEPASCORE FORMULA||U|Y|Y|N|||N|3||39||SCREENING|1964-04-29|1970-05-08|||||1968-03-03||1969-04-09|Y|1968-07-22
TRIAL STUDY 134XCP|LB|F1D265C4-B975-4E74-9545-122A10FE100F|1||||LYMCLF|LYMPHOCYTES, CLEFTED|||||||MG/KG/H|||||||TRACE||PRESSOR UNITS||||NORMAL|NOT DONE||||PROSTATIC FLUID|HEMOLYZED|U|AGAR DILUTION|CKD-EPI CYSTATIN C FORMULA||NA|N|N|NA|||U|4||88||SCREENING|1970-12-08|1963-09-26|||||1960-04-12||1969-05-08|U|1968-09-01
TRIAL STUDY 134XCP|LB|F1D265C4-B975-4E74-9545-122A10FE100F|2||||DRVVTSCR|DRVVT SCREEN TO CONFIRM RATIO|||||||MU/L|||||||BORDERLINE||USEC||||LOW|NOT DONE||||DISCHARGE|NON-HEMOLYZED|U|MAGNETIC RESONANCE ANGIOGRAPHY|MDRD FORMULA||Y|NA|N|U|||N|4||88||LONG-TERM FOLLOW-UP|1970-12-13|1962-03-15|||||1967-10-19||1969-07-14|NA|1972-09-20
TRIAL STUDY 134XCP|LB|F1D265C4-B975-4E74-9545-122A10FE100F|1||||XNTHCHR|XANTHOCHROMIA|||||||CD|||||||INVALID||IN||||HIGH|NOT DONE||||SERUM OR PLASMA|LACTESCENT|U|CONTRAST ENHANCED PET SCAN|CKD-EPI CYSTATIN C FORMULA||NA|N|NA|NA|||Y|5||7||BASELINE|1960-06-12|1966-12-07|||||1965-07-24||1964-07-22|U|1970-07-15
TRIAL STUDY 134XCP|LB|F1D265C4-B975-4E74-9545-122A10FE100F|2||||COTININE|COTININE|||||||U/G|||||||INVALID||ENZYME U/M2||||HIGH|NOT DONE||||DISCHARGE|CALCIFIED|U|STATIC PERIMETRY|FIBROMETER FORMULA||NA|NA|NA|Y|||Y|5||7||OBSERVATION|1970-06-04|1964-12-04|||||1966-10-24||1969-07-13|NA|1967-10-14
TRIAL STUDY 134XCP|LB|7A272C35-DB2C-429D-AF31-CC7386DC8F07|1||||DCA|DEOXYCHOLATE|||||||MEQ/UL|||||||TRACE||SHOCK WAVE||||NORMAL|NOT DONE||||HAIR FOLLICLE|FROZEN|NA|PELLI-ROBSON EYE CHART|FIBROTEST FORMULA||N|Y|N|NA|||Y|1||38||CONTINUATION TREATMENT|1969-04-14|1962-09-11|||||1967-12-31||1973-08-09|U|1961-04-24
TRIAL STUDY 134XCP|LB|7A272C35-DB2C-429D-AF31-CC7386DC8F07|2||||ABO|ABO BLOOD GROUP|||||||DAYS/WK|||||||BORDERLINE||FEU||||ABNORMAL|NOT DONE||||SKIN TISSUE|REFRIGERATED|N|WESTERGREN|GMI MMOL/MOL FORMULA||N|NA|Y|N|||U|1||38||BLINDED TREATMENT|1969-09-25|1963-08-02|||||1971-03-15||1972-06-22|U|1968-02-18
TRIAL STUDY 134XCP|LB|7A272C35-DB2C-429D-AF31-CC7386DC8F07|1||||OHDG8|8-HYDROXYDEOXYGUANOSINE|||||||10^9 ORGANISMS/G|||||||INDETERMINATE||HOMEOPATHIC DILUTION||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|UNEXPECTED ODOR|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD 6 VARIABLE FORMULA||U|N|NA|N|||NA|2||58||WASHOUT|1966-03-23|1968-05-03|||||1972-01-19||1964-10-10|Y|1966-09-07
TRIAL STUDY 134XCP|LB|7A272C35-DB2C-429D-AF31-CC7386DC8F07|2||||HOWJOL|HOWELL-JOLLY BODIES|||||||V/SEC|||||||TRACE||ML/S/M2||||HIGH|NOT DONE||||HAIR FOLLICLE|NON-HEMOLYZED|NA|OPTICAL MAPPING|COCKCROFT-GAULT FORMULA||U|N|N|NA|||Y|2||58||OPEN LABEL TREATMENT|1965-12-10|1973-01-06|||||1964-06-28||1964-06-04|N|1963-02-13
TRIAL STUDY 134XCP|LB|7A272C35-DB2C-429D-AF31-CC7386DC8F07|1||||HGBFHGB|HEMOGLOBIN F/TOTAL HEMOGLOBIN|||||||UCI/KG|||||||TRACE||U/KG/H||||NORMAL|NOT DONE||||SERUM|LIPEMIC|Y|NUCLEIC ACID HYBRIDIZATION|NASH FIBROSURE FORMULA||NA|N|N|N|||U|3||39||LONG-TERM FOLLOW-UP|1973-02-27|1962-11-17|||||1967-02-16||1969-11-16|Y|1968-11-11
TRIAL STUDY 134XCP|LB|7A272C35-DB2C-429D-AF31-CC7386DC8F07|2||||CH100|COMPLEMENT CH100|||||||BQ/G|||||||BORDERLINE||MM/MIN||||HIGH|NOT DONE||||CALCULUS|NON-HEMOLYZED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD 4 VARIABLE FORMULA||N|Y|U|N|||Y|3||39||TREATMENT|1963-08-24|1961-01-05|||||1962-08-30||1972-03-15|Y|1970-09-16
TRIAL STUDY 134XCP|LB|7A272C35-DB2C-429D-AF31-CC7386DC8F07|1||||EPINSQCE|NON-SQUAMOUS EPITHELIAL CELLS|||||||KG/MOL|||||||TRACE||DMOL||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|ROOM TEMPERATURE|Y|AMSLER GRID|COCKCROFT-GAULT FORMULA||N|N|N|Y|||Y|4||88||TREATMENT|1961-08-14|1971-03-11|||||1965-04-29||1972-08-11|U|1965-06-27
TRIAL STUDY 134XCP|LB|7A272C35-DB2C-429D-AF31-CC7386DC8F07|2||||FEK|FRACTIONAL POTASSIUM EXCRETION|||||||ECL UNIT|||||||BORDERLINE||HZ||||LOW|NOT DONE||||AQUEOUS HUMOR|LACTESCENT|N|NUCLEIC ACID BASED METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|N|N|||Y|4||88||BASELINE|1968-03-02|1965-08-27|||||1967-10-18||1965-10-14|U|1960-02-23
TRIAL STUDY 134XCP|LB|7A272C35-DB2C-429D-AF31-CC7386DC8F07|1||||VLDLT|VLDL TRIGLYCERIDE|||||||MSEC|||||||POSITIVE||NGEQ/L||||LOW|NOT DONE||||BONE MARROW|AUTOLYZED|Y|CT SCAN WITHOUT CONTRAST|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|Y|U|||U|5||7||OBSERVATION|1968-12-05|1964-08-23|||||1970-07-26||1967-03-02|N|1967-06-03
TRIAL STUDY 134XCP|LB|7A272C35-DB2C-429D-AF31-CC7386DC8F07|2||||AMYLOIDB|AMYLOID, BETA|||||||UM|||||||TRACE||ARBITRARY U||||ABNORMAL|NOT DONE||||BASAL TEAR|THAWED|Y|DISK DIFFUSION|FIBROTEST FORMULA||Y|U|U|N|||Y|5||7||INDUCTION TREATMENT|1962-07-21|1966-07-24|||||1960-01-15||1968-08-01|Y|1971-03-25
TRIAL STUDY 134XCP|LB|FBF95CF9-933D-406A-8D67-B1F643C5F554|1||||CSCELL|CELLULAR CASTS|||||||/VF|||||||TRACE||%(V/V)||||LOW|NOT DONE||||EXPIRED AIR|UNEXPECTED ODOR|NA|DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|Y|U|||NA|1||38||TREATMENT|1960-03-21|1962-12-31|||||1962-03-12||1972-02-01|N|1969-07-19
TRIAL STUDY 134XCP|LB|FBF95CF9-933D-406A-8D67-B1F643C5F554|2||||CSWBC|WBC CASTS|||||||SYRINGE|||||||INDETERMINATE||10^6 CFU||||ABNORMAL|NOT DONE||||SMEGMA|CONTAMINATED|N|ISHIHARA COLOR PLATES|MDRD ENZYMATIC FORMULA||Y|NA|Y|Y|||U|1||38||TREATMENT|1972-03-25|1970-01-05|||||1972-07-16||1972-03-03|U|1967-04-29
TRIAL STUDY 134XCP|LB|FBF95CF9-933D-406A-8D67-B1F643C5F554|1||||C130095|WESTERN RAGWEED POLLEN IGG4|||||||MMOL/MIN/KPA/L|||||||INVALID||COPIES/UG||||HIGH|NOT DONE||||URINE|LIPEMIC|Y|NEURAMINIDASE INHIBITION ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|Y|NA|N|||U|2||58||RUN-IN|1968-01-12|1967-09-25|||||1961-10-23||1961-03-02|N|1964-09-12
TRIAL STUDY 134XCP|LB|FBF95CF9-933D-406A-8D67-B1F643C5F554|2||||FATLVIDX|FATTY LIVER INDEX|||||||PIXELS/IN|||||||BORDERLINE||BQ||||NORMAL|NOT DONE||||CAPILLARY BLOOD|FROZEN|N|DOPPLER ULTRASOUND|MDRD 4 VARIABLE FORMULA||NA|Y|N|N|||N|2||58||SCREENING|1966-05-08|1962-09-26|||||1971-12-30||1971-11-30|NA|1963-04-20
TRIAL STUDY 134XCP|LB|FBF95CF9-933D-406A-8D67-B1F643C5F554|1||||IL2RB|INTERLEUKIN 2 RECEPTOR SUBUNIT BETA|||||||10^3 RNA COPIES/ML|||||||POSITIVE||FFU||||NORMAL|NOT DONE||||MONOCYTE|CONCENTRATED|U|MIGET|CKD-EPI FORMULA||Y|NA|U|N|||U|3||39||SCREENING|1968-11-13|1970-09-05|||||1962-11-29||1973-05-14|NA|1966-08-30
TRIAL STUDY 134XCP|LB|FBF95CF9-933D-406A-8D67-B1F643C5F554|2||||CYHGBC|HEMOGLOBIN C CRYSTALS|||||||PM|||||||POSITIVE||NEEDLE GAUGE||||ABNORMAL|NOT DONE||||SOFT TISSUE|PARAFFIN-EMBEDDED|NA|CALIPER MEASUREMENT METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|U|N|||N|3||39||OPEN LABEL TREATMENT|1964-01-06|1964-08-28|||||1967-06-13||1967-04-03|Y|1965-09-26
TRIAL STUDY 134XCP|LB|FBF95CF9-933D-406A-8D67-B1F643C5F554|1||||TNF|TUMOR NECROSIS FACTOR|||||||MBP|||||||BORDERLINE||G/MOL||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|PARAFFIN-EMBEDDED|U|X-RAY|ASH FIBROSURE FORMULA||Y|Y|U|U|||U|4||88||WASHOUT|1962-05-11|1962-10-07|||||1968-01-05||1972-06-02|NA|1964-08-16
TRIAL STUDY 134XCP|LB|FBF95CF9-933D-406A-8D67-B1F643C5F554|2||||PEMAB|PEMPHIGOID ANTIBODIES|||||||MG/MIN|||||||INDETERMINATE||EVENTS||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|AGGLUTINATED|N|NUCLEIC ACID AMPLIFICATION TEST|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|N|||U|4||88||FOLLOW-UP|1968-03-13|1965-04-11|||||1966-10-23||1960-11-13|U|1967-03-15
TRIAL STUDY 134XCP|LB|FBF95CF9-933D-406A-8D67-B1F643C5F554|1||||CSWAX|WAXY CASTS|||||||10^3 CFU/G|||||||TRACE||U/ML||||ABNORMAL|NOT DONE||||REFLEX TEAR|AGGLUTINATED|U|PHOTOMETRY|ASH FIBROSURE FORMULA||U|Y|N|Y|||U|5||7||TREATMENT|1966-02-28|1965-06-03|||||1961-11-17||1961-12-17|NA|1960-11-12
TRIAL STUDY 134XCP|LB|FBF95CF9-933D-406A-8D67-B1F643C5F554|2||||FECA|FRACTIONAL CALCIUM EXCRETION|||||||CMOL|||||||TRACE||1/(S*KPA)||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|PARAFFIN-EMBEDDED|U|DISK DIFFUSION|COCKCROFT-GAULT FORMULA||NA|N|Y|NA|||U|5||7||INDUCTION TREATMENT|1967-12-08|1966-01-20|||||1967-05-26||1964-06-03|U|1969-09-12
TRIAL STUDY 134XCP|LB|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|1||||MACROCY|MACROCYTES|||||||10^3/HPF|||||||INVALID||KG/CM2||||NORMAL|NOT DONE||||CALCULUS|AGGLUTINATED|NA|OPHTHALMOSCOPY|COCKCROFT-GAULT FORMULA||U|Y|NA|NA|||Y|1||38||SCREENING|1969-11-30|1963-01-08|||||1965-12-01||1967-01-04|N|1969-09-30
TRIAL STUDY 134XCP|LB|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|2||||FACTVWMU|VON WILLEBRAND FACTOR MULTIMERS|||||||UIU/L|||||||INDETERMINATE||UG/DOSE||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|LACTESCENT|NA|IMMUNOCHEMILUMINOMETRIC ASSAY|COCKCROFT-GAULT FORMULA||N|Y|NA|N|||U|1||38||INDUCTION TREATMENT|1966-03-12|1970-11-06|||||1962-09-20||1967-06-23|NA|1963-01-05
TRIAL STUDY 134XCP|LB|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|1||||TIMP3|TISSUE INHIBITOR OF METALLOPROTEINASE 3|||||||BU/ML|||||||INDETERMINATE||U/CL||||LOW|NOT DONE||||ALVEOLAR AIR|SOLIDIFIED|NA|MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI FORMULA||U|Y|N|N|||U|2||58||FOLLOW-UP|1965-02-28|1961-11-08|||||1964-01-29||1970-06-26|NA|1969-01-20
TRIAL STUDY 134XCP|LB|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|2||||EPISQCE|SQUAMOUS EPITHELIAL CELLS|||||||IU/MMOL|||||||INVALID||NEEDLE GAUGE||||ABNORMAL|NOT DONE||||CELL PELLET|ROOM TEMPERATURE|Y|OPTICAL MAPPING|MDRD 6 VARIABLE FORMULA||U|N|U|N|||Y|2||58||BASELINE|1966-04-27|1966-04-03|||||1966-08-18||1967-05-22|Y|1966-12-15
TRIAL STUDY 134XCP|LB|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|1||||GSTPI|GLUTATHIONE S-TRANSFERASE, PI|||||||APL U|||||||INVALID||MESF||||HIGH|NOT DONE||||SYNOVIAL FLUID|THAWED|N|CLIP SEQUENCING|MDRD 4 VARIABLE FORMULA||U|U|Y|N|||NA|3||39||INDUCTION TREATMENT|1969-09-10|1961-09-18|||||1968-10-26||1972-01-25|N|1965-09-17
TRIAL STUDY 134XCP|LB|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|2||||CTOT|COMPLEMENT TOTAL|||||||ML/BREATH|||||||POSITIVE||BQ||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|ROOM TEMPERATURE|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|FIBROSIS 4 FORMULA||N|NA|NA|U|||U|3||39||OPEN LABEL TREATMENT|1968-09-16|1962-11-21|||||1966-01-04||1966-10-06|U|1965-12-13
TRIAL STUDY 134XCP|LB|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|1||||HLAB27AG|HLA-B27 ANTIGEN|||||||IU/MG|||||||INDETERMINATE||G/DAY||||ABNORMAL|NOT DONE||||MONOCYTE|CONCENTRATED|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA||N|U|NA|Y|||N|4||88||OBSERVATION|1971-09-05|1968-12-01|||||1966-05-29||1966-08-10|U|1963-03-18
TRIAL STUDY 134XCP|LB|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|2||||C5B9|COMPLEMENT C5B-9|||||||MG/ANIMAL|||||||INVALID||POINT||||LOW|NOT DONE||||SERUM OR PLASMA|AGGLUTINATED|Y|REVERSE TRANSCRIPTASE PCR|MDRD FORMULA||Y|U|NA|NA|||U|4||88||OPEN LABEL TREATMENT|1969-07-19|1968-03-14|||||1971-08-06||1960-09-08|Y|1964-04-21
TRIAL STUDY 134XCP|LB|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|1||||TRAP|TOTAL RADICAL-TRAP ANTIOXIDANT POTENTIAL|||||||LENS|||||||NEGATIVE||MG/MIN||||NORMAL|NOT DONE||||ALVEOLAR AIR|LIPEMIC|N|AGAR PROPORTION|GMI % FORMULA||U|Y|Y|N|||NA|5||7||BLINDED TREATMENT|1968-12-18|1962-05-11|||||1963-03-15||1961-06-03|Y|1973-05-04
TRIAL STUDY 134XCP|LB|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|2||||ALP|ALKALINE PHOSPHATASE|||||||PMOL|||||||INVALID||ML/CAGE||||NORMAL|NOT DONE||||EMESIS|SOLIDIFIED|N|WHOLE EXOME SEQUENCING|CKD-EPI CYSTATIN C FORMULA||Y|N|U|U|||N|5||7||WASHOUT|1967-10-12|1971-08-28|||||1960-03-05||1972-01-11|N|1970-03-26
TRIAL STUDY 134XCP|LB|391D2418-5359-457B-AEC5-6A48DE04DAFD|1||||MONOPTPT|MONOCLONAL PROTEIN/TOTAL PROTEIN|||||||UMOL/DAY|||||||INVALID||NL||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|N|RADIOIMMUNOPRECIPITATION ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|N|||Y|1||38||TREATMENT|1964-02-12|1970-11-10|||||1966-11-23||1966-01-03|NA|1966-02-27
TRIAL STUDY 134XCP|LB|391D2418-5359-457B-AEC5-6A48DE04DAFD|2||||SPMPSPM|SPERMATOZOA, PROGRESSIVE/SPERMATOZOA|||||||LX|||||||INVALID||DAYS/MONTH||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|LIPEMIC|N|HPLC|NASH FIBROSURE FORMULA||N|NA|N|Y|||NA|1||38||RUN-IN|1973-07-21|1968-03-16|||||1962-10-18||1968-01-17|NA|1963-07-01
TRIAL STUDY 134XCP|LB|391D2418-5359-457B-AEC5-6A48DE04DAFD|1||||C130110|MOLD MIX ANTIGEN IGG ANTIBODY|||||||10^7 CFU/ML|||||||INVALID||MU/G||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|NON-HEMOLYZED|N|FLUOROSCOPY|MDRD ENZYMATIC FORMULA||NA|N|Y|NA|||Y|2||58||CONTINUATION TREATMENT|1960-07-22|1966-08-08|||||1968-05-22||1972-06-11|U|1960-10-12
TRIAL STUDY 134XCP|LB|391D2418-5359-457B-AEC5-6A48DE04DAFD|2||||MSTHCELE|MESOTHELIAL CELLS/LEUKOCYTES|||||||ARBITRARY U|||||||POSITIVE||10^6 ORGANISMS||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|HEMOLYZED|Y|EEG|FIBROTEST FORMULA||U|Y|N|N|||U|2||58||TREATMENT|1962-02-27|1966-11-16|||||1963-08-19||1964-08-13|N|1962-04-10
TRIAL STUDY 134XCP|LB|391D2418-5359-457B-AEC5-6A48DE04DAFD|1||||AZURGRAN|AZUROPHILIC GRANULES|||||||U/KG/MIN|||||||POSITIVE||PKAT/L||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|UNEXPECTED ODOR|U|RULER MEASUREMENT METHOD|FIBROMETER FORMULA||U|NA|Y|N|||Y|3||39||CONTINUATION TREATMENT|1963-08-27|1969-04-03|||||1972-07-14||1961-07-04|Y|1963-07-26
TRIAL STUDY 134XCP|LB|391D2418-5359-457B-AEC5-6A48DE04DAFD|2||||LIPID|LIPID|||||||TCID 50/DOSE|||||||NEGATIVE||UEQ/L||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CLOTTED|NA|ACRIDINE ORANGE STAIN|MDRD FORMULA||N|U|U|N|||NA|3||39||OPEN LABEL TREATMENT|1973-08-23|1971-04-20|||||1961-11-15||1964-04-10|N|1960-02-07
TRIAL STUDY 134XCP|LB|391D2418-5359-457B-AEC5-6A48DE04DAFD|1||||APTT|ACTIVATED PARTIAL THROMBOPLASTIN TIME|||||||DDU|||||||BORDERLINE||ATM||||LOW|NOT DONE||||BREAST MILK|CONCENTRATED|N|ELECTROMYOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|N|U|||Y|4||88||LONG-TERM FOLLOW-UP|1973-01-25|1965-07-06|||||1971-01-26||1961-10-12|NA|1969-11-25
TRIAL STUDY 134XCP|LB|391D2418-5359-457B-AEC5-6A48DE04DAFD|2||||INTLK28|INTERLEUKIN 28|||||||PATCH|||||||TRACE||ANTIBODY UNIT||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|FROZEN|U|PHASE-CONTRAST MRI|HEPASCORE FORMULA||Y|N|N|NA|||N|4||88||INDUCTION TREATMENT|1964-12-06|1973-09-03|||||1964-11-27||1970-05-23|NA|1966-10-02
TRIAL STUDY 134XCP|LB|391D2418-5359-457B-AEC5-6A48DE04DAFD|1||||RENIN|RENIN|||||||G/M2|||||||POSITIVE||ANTI-XA IU/ML||||ABNORMAL|NOT DONE||||BASAL TEAR|AUTOLYZED|Y|ELISA|MDRD FORMULA||N|Y|Y|Y|||Y|5||7||CONTINUATION TREATMENT|1972-12-20|1962-11-15|||||1972-01-20||1973-01-05|N|1965-12-08
TRIAL STUDY 134XCP|LB|391D2418-5359-457B-AEC5-6A48DE04DAFD|2||||BILEAC|BILE ACID|||||||UM|||||||BORDERLINE||NEWTON||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|GELLED|U|WESTERGREN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|NA|||N|5||7||BLINDED TREATMENT|1964-06-14|1969-05-08|||||1967-05-03||1965-03-24|NA|1960-06-25
TRIAL STUDY 134XCP|LB|68F706F0-2F0B-4D50-B15C-2DFDD186112E|1||||LYSOZYME|LYSOZYME|||||||OZ EQ|||||||TRACE||UMOL/MG/MIN||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|THAWED|Y|ELECTROMYOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|N|NA|||NA|1||38||TREATMENT|1965-11-15|1964-07-26|||||1960-12-06||1962-07-31|NA|1970-08-29
TRIAL STUDY 134XCP|LB|68F706F0-2F0B-4D50-B15C-2DFDD186112E|2||||FCT8INH|FACTOR VIII INHIBITOR|||||||10^6 ORGANISMS/MG|||||||INDETERMINATE||ML/CAGE/DAY||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|THAWED|NA|LC-FL|MDRD FORMULA||N|U|U|U|||Y|1||38||RUN-IN|1964-05-23|1968-04-04|||||1963-11-23||1972-09-10|N|1973-06-16
TRIAL STUDY 134XCP|LB|68F706F0-2F0B-4D50-B15C-2DFDD186112E|1||||LDH|LACTATE DEHYDROGENASE|||||||PSEC|||||||INDETERMINATE||LOG10 TCID 50/ML||||HIGH|NOT DONE||||SERUM|ROOM TEMPERATURE|U|NEXT GENERATION SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|U|Y|||NA|2||58||CONTINUATION TREATMENT|1964-02-25|1966-10-03|||||1965-05-12||1965-11-12|NA|1967-04-08
TRIAL STUDY 134XCP|LB|68F706F0-2F0B-4D50-B15C-2DFDD186112E|2||||B2MCREAT|BETA-2 MICROGLOBULIN/CREATININE|||||||UG/L|||||||BORDERLINE||GPL U||||ABNORMAL|NOT DONE||||COLOSTRUM|LIPEMIC|N|CELL BASED BIOASSAY|MDRD ENZYMATIC FORMULA||Y|NA|N|NA|||U|2||58||RUN-IN|1972-06-16|1961-04-01|||||1968-04-19||1965-06-11|NA|1968-02-23
TRIAL STUDY 134XCP|LB|68F706F0-2F0B-4D50-B15C-2DFDD186112E|1||||LYMPLLY|PLASMACYTOID LYMPHOCYTES/LYMPHOCYTES|||||||100 IU/ML|||||||TRACE||UIU/DL||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED|U|CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC FORMULA||U|Y|U|N|||Y|3||39||TREATMENT|1966-12-29|1968-04-21|||||1971-03-30||1965-02-14|N|1971-07-12
TRIAL STUDY 134XCP|LB|68F706F0-2F0B-4D50-B15C-2DFDD186112E|2||||FACTVWA|VON WILLEBRAND FACTOR ACTIVITY|||||||MMOL/KG|||||||INVALID||LOG10 ELISA UNIT||||NORMAL|NOT DONE||||VENOUS BLOOD|LIPEMIC|N|SLOAN LETTER EYE CHART 2.5%|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|U|U|||N|3||39||CONTINUATION TREATMENT|1971-10-22|1969-11-24|||||1973-01-02||1968-05-26|Y|1970-02-26
TRIAL STUDY 134XCP|LB|68F706F0-2F0B-4D50-B15C-2DFDD186112E|1||||CYSCREAT|CYSTATIN C/CREATININE|||||||UG/L/H|||||||INVALID||CI/MG||||NORMAL|NOT DONE||||KERATINOCYTE|LACTESCENT|Y|PALPATION|MDRD 6 VARIABLE FORMULA||NA|Y|NA|Y|||U|4||88||BASELINE|1967-09-06|1963-05-31|||||1970-02-04||1964-05-14|U|1971-02-15
TRIAL STUDY 134XCP|LB|68F706F0-2F0B-4D50-B15C-2DFDD186112E|2||||EPIRCE|RENAL EPITHELIAL CELLS|||||||RING|||||||BORDERLINE||CYCLE/MIN||||LOW|NOT DONE||||EMESIS|FRESH|NA|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|GMI MMOL/MOL FORMULA||N|Y|Y|N|||N|4||88||CONTINUATION TREATMENT|1965-07-30|1972-09-25|||||1960-03-29||1960-12-18|N|1971-05-30
TRIAL STUDY 134XCP|LB|68F706F0-2F0B-4D50-B15C-2DFDD186112E|1||||MTNEPHFR|METANEPHRINE, FREE|||||||BQ/L|||||||INDETERMINATE||FEU||||LOW|NOT DONE||||LYMPH|LACTESCENT|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|FIBROMETER FORMULA||U|N|NA|N|||NA|5||7||WASHOUT|1967-07-10|1961-05-08|||||1971-07-18||1970-07-13|Y|1968-12-26
TRIAL STUDY 134XCP|LB|68F706F0-2F0B-4D50-B15C-2DFDD186112E|2||||CTXIICRT|TYPE II COLLAGEN C-TELOPEPTIDES/CREAT|||||||CPM|||||||POSITIVE||MMOL/L||||LOW|NOT DONE||||MONOCYTE|CALCIFIED|Y|SISH|MDRD 6 VARIABLE FORMULA||N|NA|U|U|||NA|5||7||OBSERVATION|1961-04-21|1960-05-12|||||1965-09-05||1962-01-17|N|1961-03-23
TRIAL STUDY 134XCP|LB|E8D4AACE-0832-482D-8266-96B7423F9459|1||||PPI|INORGANIC PYROPHOSPHATE|||||||10^6 COPIES/ML|||||||INDETERMINATE||10^9/DOSE||||NORMAL|NOT DONE||||PLEURAL TISSUE|ICTERIC|Y|PERCUSSION|COCKCROFT-GAULT FORMULA||U|U|Y|NA|||NA|1||38||RUN-IN|1973-02-05|1973-05-20|||||1966-02-23||1973-04-05|Y|1960-04-18
TRIAL STUDY 134XCP|LB|E8D4AACE-0832-482D-8266-96B7423F9459|2||||CHOLHDL|CHOLESTEROL/HDL-CHOLESTEROL|||||||ELISA UNIT/ML|||||||POSITIVE||PFU/ANIMAL||||HIGH|NOT DONE||||FLUID|AGGLUTINATED|NA|MALDI-TOF|GMI % FORMULA||N|Y|Y|U|||Y|1||38||OPEN LABEL TREATMENT|1967-03-23|1960-08-14|||||1963-02-09||1969-03-20|NA|1973-02-21
TRIAL STUDY 134XCP|LB|E8D4AACE-0832-482D-8266-96B7423F9459|1||||RNPAB|RIBONUCLEOPROTEIN ANTIBODY|||||||M3|||||||NEGATIVE||% INHIBITION||||LOW|NOT DONE||||AMNIOTIC FLUID|SOLIDIFIED|N|SPECT SCAN|ASH FIBROSURE FORMULA||NA|U|NA|NA|||U|2||58||RUN-IN|1966-03-17|1961-07-25|||||1969-03-11||1964-08-29|N|1967-10-28
TRIAL STUDY 134XCP|LB|E8D4AACE-0832-482D-8266-96B7423F9459|2||||OXYCAP|OXYGEN CAPACITY|||||||10^8/L|||||||BORDERLINE||PELLET||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|CONCENTRATED|N|MIGET|GMI % FORMULA||NA|NA|Y|NA|||N|2||58||BLINDED TREATMENT|1968-02-06|1962-07-18|||||1970-05-30||1967-04-08|N|1962-04-11
TRIAL STUDY 134XCP|LB|E8D4AACE-0832-482D-8266-96B7423F9459|1||||HLAC|HLA CLASS IC ANTIGEN|||||||IU/KG/H|||||||INDETERMINATE||ML||||LOW|NOT DONE||||ERYTHROCYTES|FROZEN|N|AUTOREFRACTION|GMI % FORMULA||U|NA|N|N|||Y|3||39||RUN-IN|1971-06-07|1971-10-24|||||1969-07-07||1961-03-07|Y|1964-11-17
TRIAL STUDY 134XCP|LB|E8D4AACE-0832-482D-8266-96B7423F9459|2||||MASTCECE|MAST CELLS/TOTAL CELLS|||||||IU|||||||POSITIVE||/VF||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|ICTERIC|U|MICROBIAL CULTURE, LIQUID|MDRD 4 VARIABLE FORMULA||N|U|Y|Y|||NA|3||39||SCREENING|1962-10-19|1960-08-12|||||1969-04-01||1969-09-28|U|1967-08-17
TRIAL STUDY 134XCP|LB|E8D4AACE-0832-482D-8266-96B7423F9459|1||||NEUTMY|NEUTROPHILIC MYELOCYTES|||||||10^7/L|||||||BORDERLINE||10^3 ORGANISMS/G||||ABNORMAL|NOT DONE||||SEMEN|LACTESCENT|NA|MULTIPLE BREATH WASHOUT|FIBROSIS 4 FORMULA||U|NA|N|Y|||Y|4||88||SCREENING|1968-02-04|1968-01-06|||||1964-04-26||1966-08-03|NA|1964-07-10
TRIAL STUDY 134XCP|LB|E8D4AACE-0832-482D-8266-96B7423F9459|2||||LIQUFT|LIQUEFACTION TIME|||||||CMH2O/ML|||||||INDETERMINATE||UMOL||||LOW|NOT DONE||||HAIR|CALCIFIED|U|THICK SMEAR|NASH FIBROSURE FORMULA||NA|N|Y|NA|||Y|4||88||OBSERVATION|1963-08-13|1966-11-24|||||1963-12-03||1969-01-22|NA|1963-10-25
TRIAL STUDY 134XCP|LB|E8D4AACE-0832-482D-8266-96B7423F9459|1||||VITDBP|VITAMIN D BINDING PROTEIN|||||||DRUM|||||||TRACE||KBQ/UL||||HIGH|NOT DONE||||LYMPH|FROZEN|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|GMI MMOL/MOL FORMULA||N|N|U|NA|||N|5||7||INDUCTION TREATMENT|1960-10-13|1966-03-07|||||1972-11-29||1970-10-27|Y|1968-07-08
TRIAL STUDY 134XCP|LB|E8D4AACE-0832-482D-8266-96B7423F9459|2||||RETILRTC|LOW ABSORPTION RETIC/RETICULOCYTES|||||||G/DL|||||||POSITIVE||COPIES/UL||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH|U|PET/CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|Y|N|||Y|5||7||OBSERVATION|1969-05-29|1972-08-09|||||1962-04-23||1969-09-18|N|1962-09-29
TRIAL STUDY 134XCP|LB|F358E69F-9B9A-4637-9063-B8FECFF000B2|1||||PROMYB|PROMYELOBLASTS|||||||EJACULATE U|||||||INVALID||U/M2/DAY||||HIGH|NOT DONE||||PLASMA|THAWED|NA|AUDIOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|NA|||N|1||38||BLINDED TREATMENT|1960-12-21|1963-03-24|||||1962-01-16||1973-06-14|U|1962-12-01
TRIAL STUDY 134XCP|LB|F358E69F-9B9A-4637-9063-B8FECFF000B2|2||||CD8LY|CD8/LYMPHOCYTES|||||||USIEMENS|||||||POSITIVE||10^6 ORGANISMS/G||||LOW|NOT DONE||||PERSPIRATION|NON-HEMOLYZED|NA|SXA SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|Y|U|||NA|1||38||LONG-TERM FOLLOW-UP|1968-06-19|1965-01-02|||||1963-11-27||1968-05-12|Y|1968-08-28
TRIAL STUDY 134XCP|LB|F358E69F-9B9A-4637-9063-B8FECFF000B2|1||||ACYCRNTN|ACYLCARNITINE|||||||G/KG|||||||TRACE||ECL UNIT||||LOW|NOT DONE||||PLATELET POOR PLASMA|ROOM TEMPERATURE|NA|DUCTOGRAPHY|FIBROSIS 4 FORMULA||NA|Y|NA|U|||Y|2||58||BASELINE|1970-10-30|1960-06-02|||||1961-04-03||1965-01-06|N|1970-02-01
TRIAL STUDY 134XCP|LB|F358E69F-9B9A-4637-9063-B8FECFF000B2|2||||AMYLOIDA|AMYLOID A|||||||MG/L FEU|||||||NEGATIVE||NG/L||||LOW|NOT DONE||||AMNIOTIC FLUID|PARAFFIN-EMBEDDED|U|FLUORESCENT IMMUNOASSAY|CKD-EPI CREATININE FORMULA||U|U|N|N|||Y|2||58||FOLLOW-UP|1972-02-24|1964-08-07|||||1962-09-03||1973-05-18|NA|1963-12-21
TRIAL STUDY 134XCP|LB|F358E69F-9B9A-4637-9063-B8FECFF000B2|1||||MGCREAT|MAGNESIUM/CREATININE|||||||ANTIBODY UNIT|||||||POSITIVE||CAPSULE||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|CONTAMINATED|U|CAPILLARY ELECTROPHORESIS|FIBROMETER FORMULA||N|Y|U|NA|||N|3||39||WASHOUT|1970-09-01|1966-03-23|||||1968-01-16||1960-12-05|U|1964-01-04
TRIAL STUDY 134XCP|LB|F358E69F-9B9A-4637-9063-B8FECFF000B2|2||||ADPNHMW|ADIPONECTIN, HIGH MOLECULAR WEIGHT|||||||MMHG/SEC|||||||INVALID||MBQ||||NORMAL|NOT DONE||||LYSATE|LIPEMIC|U|MICROBIAL CULTURE, LIQUID|ASH FIBROSURE FORMULA||NA|N|Y|NA|||Y|3||39||CONTINUATION TREATMENT|1965-04-26|1970-02-02|||||1964-06-28||1968-07-05|Y|1968-08-02
TRIAL STUDY 134XCP|LB|F358E69F-9B9A-4637-9063-B8FECFF000B2|1||||ASSDNA|ANTI-SINGLE STRANDED DNA IGG|||||||AMP|||||||NEGATIVE||UMOL/H/MMOL||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|LIPEMIC|U|TARGETED GENOME SEQUENCING|MDRD FORMULA||N|N|N|N|||Y|4||88||OPEN LABEL TREATMENT|1966-10-13|1968-01-16|||||1969-04-09||1963-12-26|Y|1962-11-05
TRIAL STUDY 134XCP|LB|F358E69F-9B9A-4637-9063-B8FECFF000B2|2||||APOC1|APOLIPOPROTEIN CI|||||||G/DL|||||||POSITIVE||BQ/MG||||NORMAL|NOT DONE||||EXPIRED AIR|ICTERIC|NA|REBOUND TONOMETRY|HEPASCORE FORMULA||N|N|N|Y|||Y|4||88||TREATMENT|1960-03-13|1961-11-26|||||1960-04-01||1962-08-20|NA|1968-01-26
TRIAL STUDY 134XCP|LB|F358E69F-9B9A-4637-9063-B8FECFF000B2|1||||MNC|MONONUCLEAR CELLS|||||||EJACULATE U|||||||INVALID||MM/SEC||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|GELLED|N|AGAR DILUTION|FIBROTEST FORMULA||N|NA|N|N|||Y|5||7||RUN-IN|1967-01-11|1965-08-13|||||1971-04-20||1962-06-11|N|1962-06-02
TRIAL STUDY 134XCP|LB|F358E69F-9B9A-4637-9063-B8FECFF000B2|2||||APTTSTND|ACTIVATED PTT/STANDARD|||||||VIAL|||||||NEGATIVE||MS2||||NORMAL|NOT DONE||||SOFT TISSUE|LIPEMIC|NA|BAC ACGH|NASH FIBROSURE FORMULA||Y|NA|U|NA|||N|5||7||BLINDED TREATMENT|1973-03-17|1967-01-02|||||1964-12-26||1973-06-25|U|1960-03-23
TRIAL STUDY 134XCP|LB|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|1||||LDHCREAT|LACTATE DEHYDROGENASE/CREATININE|||||||MEQ/DL|||||||NEGATIVE||MOL||||LOW|NOT DONE||||DIALYSIS FLUID|CLOTTED|U|IODINE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|N|Y|||Y|1||38||SCREENING|1968-04-18|1972-10-29|||||1960-01-07||1972-08-06|N|1969-08-21
TRIAL STUDY 134XCP|LB|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|2||||NOREPEXR|NOREPINEPHRINE EXCRETION RATE|||||||MG/KG/DAY|||||||INDETERMINATE||U||||LOW|NOT DONE||||AMNIOTIC FLUID|LACTESCENT|U|FARNSWORTH-MUNSELL 100 HUE TEST|MDRD 4 VARIABLE FORMULA||N|N|U|NA|||Y|1||38||SCREENING|1968-07-13|1960-03-03|||||1965-10-29||1970-12-25|Y|1963-10-20
TRIAL STUDY 134XCP|LB|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|1||||BLASTCE|BLASTS/TOTAL CELLS|||||||10^3 ORGANISMS/ML|||||||POSITIVE||BQ/UG||||LOW|NOT DONE||||SALIVA|HEMOLYZED|NA|QUANTITATIVE ULTRASOUND|COCKCROFT-GAULT FORMULA||Y|Y|N|NA|||U|2||58||BLINDED TREATMENT|1969-04-11|1972-04-14|||||1961-04-16||1965-06-16|NA|1972-05-31
TRIAL STUDY 134XCP|LB|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|2||||PLSCR1|PHOSPHOLIPID SCRAMBLASE 1|||||||KCAL|||||||INVALID||KCAL/DAY||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|NA|JAFFE REACTION|FIBROMETER FORMULA||NA|NA|Y|Y|||NA|2||58||BLINDED TREATMENT|1971-11-06|1967-07-04|||||1964-12-01||1967-11-01|N|1967-01-26
TRIAL STUDY 134XCP|LB|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|1||||BTLBTL|BUTALBITAL|||||||UG/KG/DAY|||||||POSITIVE||U/M2/H||||LOW|NOT DONE||||LYMPH|NON-HEMOLYZED|Y|KINETIC CHROMOGENIC ASSAY|CKD-EPI FORMULA||Y|N|Y|U|||Y|3||39||BASELINE|1969-01-19|1966-05-13|||||1966-11-27||1966-03-19|N|1965-01-26
TRIAL STUDY 134XCP|LB|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|2||||PLSMCELY|MATURE PLASMA CELLS/LYMPHOCYTES|||||||10^6 COPIES/ML|||||||INVALID||CI/ML||||HIGH|NOT DONE||||MENSTRUAL BLOOD|GELLED|N|TEMPLATE INCISION METHOD|MDRD 6 VARIABLE FORMULA||NA|NA|U|U|||U|3||39||TREATMENT|1973-01-17|1969-11-20|||||1971-03-17||1960-02-05|Y|1972-03-19
TRIAL STUDY 134XCP|LB|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|1||||TXB2D11R|11-DEHYDRO-THROMBOXANE B2 EXCRETION RATE|||||||TCID 50/DOSE|||||||TRACE||UL/DOSE||||ABNORMAL|NOT DONE||||PLATELET POOR PLASMA|FRESH|N|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA||N|U|NA|NA|||N|4||88||OBSERVATION|1961-01-04|1963-05-04|||||1968-09-16||1962-12-28|U|1971-02-06
TRIAL STUDY 134XCP|LB|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|2||||EPITUCE|TUBULAR EPITHELIAL CELLS|||||||IN2|||||||INVALID||ABSORBANCE U/MIN||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|SOLIDIFIED|N|PULMONARY ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|Y|N|||U|4||88||INDUCTION TREATMENT|1961-09-16|1967-11-11|||||1965-03-17||1961-06-09|N|1963-08-30
TRIAL STUDY 134XCP|LB|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|1||||NEUTLE|NEUTROPHILS/LEUKOCYTES|||||||PG|||||||TRACE||SCOOPFUL||||NORMAL|NOT DONE||||TRANSUDATE|CONCENTRATED|U|GIEMSA STAIN|FIBROTEST FORMULA||N|U|U|NA|||N|5||7||WASHOUT|1962-10-27|1972-03-04|||||1967-12-24||1962-01-04|N|1963-09-28
TRIAL STUDY 134XCP|LB|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|2||||PROMYLE|PROMYELOCYTES/LEUKOCYTES|||||||COPIES/ML|||||||TRACE||UG/L DDU||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|LIPEMIC|NA|GC/MS-EI|MDRD FORMULA||NA|Y|Y|NA|||Y|5||7||WASHOUT|1969-09-26|1960-08-30|||||1962-04-26||1969-07-30|NA|1966-05-30
TRIAL STUDY 134XCP|LB|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|1||||THBD|THROMBOMODULIN|||||||LOG10 TCID 50/DOSE|||||||POSITIVE||IN||||HIGH|NOT DONE||||SMEGMA|CONCENTRATED|NA|RADIAL IMMUNODIFFUSION|ASH FIBROSURE FORMULA||Y|NA|N|U|||N|1||38||BASELINE|1964-08-31|1968-10-12|||||1969-09-19||1969-08-30|Y|1960-07-03
TRIAL STUDY 134XCP|LB|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|2||||COTININE|COTININE|||||||ELISA UNIT/ML|||||||INDETERMINATE||MMOL||||LOW|NOT DONE||||INTERSTITIAL FLUID|FROZEN|N|PATHOLOGICAL EVALUATION|FIBROTEST FORMULA||N|U|Y|Y|||U|1||38||OPEN LABEL TREATMENT|1972-09-30|1963-09-06|||||1963-11-16||1967-12-23|U|1964-09-09
TRIAL STUDY 134XCP|LB|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|1||||INTLK29|INTERLEUKIN 29|||||||ELISA UNIT/DOSE|||||||BORDERLINE||10^6 RNA COPIES/ML||||LOW|NOT DONE||||NAIL|UNEXPECTED ODOR|U|ENZYMATIC ULTRACENTRIFUGATION|HEPASCORE FORMULA||NA|U|N|U|||U|2||58||INDUCTION TREATMENT|1961-05-30|1970-03-01|||||1964-04-24||1961-02-18|U|1961-03-16
TRIAL STUDY 134XCP|LB|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|2||||FVAAC|FACTOR V ACTIVITY ACTUAL/CONTROL|||||||BE/ML|||||||POSITIVE||MONTHS||||NORMAL|NOT DONE||||LAVAGE FLUID|DRIED|N|KLEIHAUER-BETKE|FIBROSIS 4 FORMULA||N|Y|Y|N|||Y|2||58||INDUCTION TREATMENT|1961-05-05|1971-05-16|||||1966-04-29||1961-04-26|N|1971-03-07
TRIAL STUDY 134XCP|LB|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|1||||C165884|OLIVE TREE POLLEN IGE ANTIBODY|||||||NU/CL|||||||INVALID||EVENTS||||LOW|NOT DONE||||SUPERNATANT, SERUM|CALCIFIED|NA|FLUORESCEIN STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|Y|||Y|3||39||OPEN LABEL TREATMENT|1967-03-17|1972-06-14|||||1966-08-10||1968-10-12|Y|1970-07-15
TRIAL STUDY 134XCP|LB|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|2||||INTLK12|INTERLEUKIN 12|||||||ML/G/MIN|||||||TRACE||MMHG/SEC||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|FROZEN|U|DXA SCAN|GMI % FORMULA||N|U|Y|NA|||NA|3||39||OBSERVATION|1963-04-26|1966-11-30|||||1971-08-08||1965-07-24|NA|1961-07-21
TRIAL STUDY 134XCP|LB|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|1||||GDF8|GROWTH DIFFERENTIATION FACTOR 8|||||||%(V/V)|||||||INDETERMINATE||DYN||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|AUTOLYZED|NA|COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD 4 VARIABLE FORMULA||N|NA|U|U|||NA|4||88||FOLLOW-UP|1961-08-06|1964-11-11|||||1962-10-29||1970-05-25|Y|1962-06-10
TRIAL STUDY 134XCP|LB|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|2||||CXCL4|CHEMOKINE (C-X-C MOTIF) LIGAND 4|||||||MAMP|||||||BORDERLINE||MONTHS||||LOW|NOT DONE||||BONE|UNEXPECTED ODOR|N|LIGHT SCATTERING SPECTROSCOPY|MDRD FORMULA||U|NA|NA|NA|||Y|4||88||CONTINUATION TREATMENT|1970-03-10|1962-05-13|||||1970-08-20||1969-03-10|Y|1970-06-20
TRIAL STUDY 134XCP|LB|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|1||||SPLA2II|TYPE II SECRETORY PHOSPHOLIPASE A2|||||||KDA|||||||TRACE||G||||NORMAL|NOT DONE||||SERUM OR PLASMA|THAWED|U|IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA||U|Y|N|Y|||N|5||7||LONG-TERM FOLLOW-UP|1968-07-26|1972-09-04|||||1972-09-10||1962-03-30|NA|1967-07-23
TRIAL STUDY 134XCP|LB|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|2||||CHOLATE|CHOLATE|||||||/H|||||||BORDERLINE||ML/MMHG||||NORMAL|NOT DONE||||AMNIOTIC FLUID|LIPEMIC|NA|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|GMI % FORMULA||N|U|Y|Y|||Y|5||7||INDUCTION TREATMENT|1964-06-28|1960-10-06|||||1972-07-16||1968-12-18|Y|1968-02-27
TRIAL STUDY 134XCP|LB|586B4529-9808-4205-B3D6-5C4A1DAFA922|1||||FATACFR|FREE FATTY ACID|||||||MMOL/MIN/KPA|||||||TRACE||TAMPON||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|REFRIGERATED|N|INCISION-INDUCED BLEEDING METHOD|FIBROSIS 4 FORMULA||U|NA|N|NA|||N|1||38||OPEN LABEL TREATMENT|1971-11-03|1961-01-10|||||1971-12-22||1972-02-09|Y|1971-09-04
TRIAL STUDY 134XCP|LB|586B4529-9808-4205-B3D6-5C4A1DAFA922|2||||FACTIXA|FACTOR IX ACTIVITY|||||||10^7 CFU|||||||INDETERMINATE||PELLET||||ABNORMAL|NOT DONE||||BREAST MILK|FRESH|NA|CLOT DETECTION|HEPASCORE FORMULA||NA|U|U|NA|||NA|1||38||OBSERVATION|1969-05-25|1964-02-29|||||1965-01-31||1967-02-12|U|1972-05-12
TRIAL STUDY 134XCP|LB|586B4529-9808-4205-B3D6-5C4A1DAFA922|1||||IL1R2|INTERLEUKIN 1 RECEPTOR TYPE 2|||||||MN|||||||TRACE||FT||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|REFRIGERATED|U|FLUORESCENT SPOT TEST|CKD-EPI CREATININE FORMULA||Y|NA|Y|Y|||U|2||58||INDUCTION TREATMENT|1969-02-28|1967-03-29|||||1969-01-11||1964-06-30|U|1961-08-29
TRIAL STUDY 134XCP|LB|586B4529-9808-4205-B3D6-5C4A1DAFA922|2||||ANGLBIND|ANTIGLOBULIN TEST, INDIRECT|||||||/10^4|||||||NEGATIVE||L/H/M2||||NORMAL|NOT DONE||||BILE|LIPEMIC|U|SANGER SEQUENCING|CKD-EPI FORMULA||N|NA|NA|Y|||U|2||58||OPEN LABEL TREATMENT|1963-03-06|1968-02-25|||||1966-03-13||1967-06-16|N|1961-07-28
TRIAL STUDY 134XCP|LB|586B4529-9808-4205-B3D6-5C4A1DAFA922|1||||RBPCREAT|RETINOL BINDING PROTEIN/CREATININE|||||||SPRAY|||||||NEGATIVE||CS||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|DRIED|U|ENZYMATIC COLORIMETRY|CKD-EPI CREATININE FORMULA||U|Y|U|N|||NA|3||39||BLINDED TREATMENT|1967-10-19|1965-03-12|||||1972-01-15||1960-11-16|NA|1960-12-15
TRIAL STUDY 134XCP|LB|586B4529-9808-4205-B3D6-5C4A1DAFA922|2||||C130124|CAT DANDER ANTIGEN IGE ANTIBODY|||||||G/M2/DAY|||||||BORDERLINE||MV/SEC||||ABNORMAL|NOT DONE||||DERMAL TISSUE|CONCENTRATED|N|ICP-MS|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|Y|||N|3||39||INDUCTION TREATMENT|1970-12-03|1964-07-08|||||1972-05-18||1961-11-21|NA|1971-06-06
TRIAL STUDY 134XCP|LB|586B4529-9808-4205-B3D6-5C4A1DAFA922|1||||INTLK23|INTERLEUKIN 23|||||||CYLINDER|||||||POSITIVE||KN/CM2||||LOW|NOT DONE||||SERUM|HEMOLYZED|NA|TELLER ACUITY CARDS|FIBROSIS 4 FORMULA||U|Y|NA|N|||U|4||88||INDUCTION TREATMENT|1965-10-02|1961-07-18|||||1964-10-07||1972-06-08|N|1960-05-04
TRIAL STUDY 134XCP|LB|586B4529-9808-4205-B3D6-5C4A1DAFA922|2||||LIF|LEUKEMIA INHIBITORY FACTOR|||||||U/G/DAY|||||||INVALID||TABLET||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|CLOTTED|U|MAGNETIC RESONANCE ELASTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|Y|N|||U|4||88||RUN-IN|1960-03-22|1965-05-06|||||1961-10-12||1965-11-18|U|1966-11-11
TRIAL STUDY 134XCP|LB|586B4529-9808-4205-B3D6-5C4A1DAFA922|1||||TFRRNSAT|TRANSFERRIN SATURATION|||||||MM2|||||||INDETERMINATE||TRACE||||ABNORMAL|NOT DONE||||GASTRIC FLUID|LACTESCENT|U|SPIRAL CT SCAN WITHOUT CONTRAST|ASH FIBROSURE FORMULA||Y|NA|U|N|||Y|5||7||BASELINE|1960-09-18|1970-03-20|||||1963-01-24||1972-08-18|Y|1972-10-15
TRIAL STUDY 134XCP|LB|586B4529-9808-4205-B3D6-5C4A1DAFA922|2||||C165938|COW MILK PROTEIN IGE AB RAST SCORE|||||||GAUSS|||||||NEGATIVE||DRINK||||NORMAL|NOT DONE||||URINE|NON-HEMOLYZED|N|IMMUNOPRECIPITATION|ASH FIBROSURE FORMULA||NA|Y|Y|N|||U|5||7||SCREENING|1964-09-23|1973-03-25|||||1968-01-30||1972-08-07|N|1963-12-21
TRIAL STUDY 134XCP|LB|54685EFC-EE92-4591-B059-24145A3E6D69|1||||CCL12|CHEMOKINE (C-C MOTIF) LIGAND 12|||||||PT_US|||||||POSITIVE||DL||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|ICTERIC|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|FIBROTEST FORMULA||NA|N|N|Y|||U|1||38||SCREENING|1970-04-06|1971-02-05|||||1966-10-13||1960-04-20|N|1963-09-01
TRIAL STUDY 134XCP|LB|54685EFC-EE92-4591-B059-24145A3E6D69|2||||BLASTLM|LEUKEMIC BLASTS|||||||ENZYME U/L|||||||INDETERMINATE||JDF UNIT||||LOW|NOT DONE||||SUPERNATANT, PLASMA|LACTESCENT|N|FLOW CYTOMETRY|FIBROTEST FORMULA||U|U|N|U|||U|1||38||SCREENING|1968-03-04|1961-10-14|||||1972-10-30||1970-10-24|N|1963-02-23
TRIAL STUDY 134XCP|LB|54685EFC-EE92-4591-B059-24145A3E6D69|1||||PG|PROSTAGLANDIN|||||||ML/MMHG|||||||INVALID||NG/DL||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|FRESH|N|PAP STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|U|N|||NA|2||58||RUN-IN|1972-03-29|1968-02-05|||||1968-11-05||1972-04-16|U|1965-04-28
TRIAL STUDY 134XCP|LB|54685EFC-EE92-4591-B059-24145A3E6D69|2||||ALPCREAT|ALKALINE PHOSPHATASE/CREATININE|||||||USEC|||||||POSITIVE||PFU/ML||||HIGH|NOT DONE||||REFLEX TEAR|CONCENTRATED|Y|PHOROPTER|MDRD 4 VARIABLE FORMULA||N|U|Y|N|||U|2||58||BLINDED TREATMENT|1960-07-01|1966-03-04|||||1961-04-20||1968-10-21|N|1961-03-15
TRIAL STUDY 134XCP|LB|54685EFC-EE92-4591-B059-24145A3E6D69|1||||CARBXHGB|CARBOXYHEMOGLOBIN|||||||KG/MOL|||||||INVALID||U/10^12 RBC||||LOW|NOT DONE||||SYNOVIAL FLUID|PARAFFIN-EMBEDDED|Y|SINGLE-SLICE SPIRAL CT|CKD-EPI CYSTATIN C FORMULA||N|N|NA|Y|||N|3||39||INDUCTION TREATMENT|1973-08-05|1972-05-23|||||1964-04-10||1969-07-15|Y|1972-11-05
TRIAL STUDY 134XCP|LB|54685EFC-EE92-4591-B059-24145A3E6D69|2||||ELA1|PANCREATIC ELASTASE 1|||||||PA|||||||NEGATIVE||S/H||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|UNEXPECTED ODOR|U|CLINICAL EVALUATION|MDRD 4 VARIABLE FORMULA||NA|U|NA|NA|||NA|3||39||TREATMENT|1973-08-23|1972-05-13|||||1971-11-24||1970-08-09|N|1969-05-26
TRIAL STUDY 134XCP|LB|54685EFC-EE92-4591-B059-24145A3E6D69|1||||ANGTNSGN|ANGIOTENSINOGEN|||||||MOL/DAY|||||||INDETERMINATE||BLOCKS||||HIGH|NOT DONE||||SEMEN|AUTOLYZED|N|MICRODENSITOMETRY|NASH FIBROSURE FORMULA||U|N|U|NA|||N|4||88||WASHOUT|1969-01-28|1972-10-11|||||1964-12-08||1970-01-15|Y|1967-03-10
TRIAL STUDY 134XCP|LB|54685EFC-EE92-4591-B059-24145A3E6D69|2||||KERAT|KERATOCYTE|||||||UG/CM2|||||||TRACE||ABSORBANCE U/ML||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|SOLIDIFIED|NA|WRIGHT-GIEMSA STAIN|HEPASCORE FORMULA||N|NA|NA|U|||Y|4||88||FOLLOW-UP|1965-01-28|1963-10-29|||||1968-05-25||1972-10-28|NA|1967-10-20
TRIAL STUDY 134XCP|LB|54685EFC-EE92-4591-B059-24145A3E6D69|1||||EOTAXIN2|EOTAXIN-2|||||||G/CAGE/WK|||||||TRACE||UMOL/MG/MIN||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|LIPEMIC|N|GEL ELECTROPHORESIS|HEPASCORE FORMULA||NA|U|N|Y|||N|5||7||WASHOUT|1965-10-14|1960-10-30|||||1971-10-29||1960-02-25|N|1966-05-07
TRIAL STUDY 134XCP|LB|54685EFC-EE92-4591-B059-24145A3E6D69|2||||VLDLTCT|VLDL TRIGLYCERIDE + CHYLOMICRON TRIGLYCERIDE|||||||NU/CL|||||||BORDERLINE||UEQ/L||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|FROZEN|Y|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|CKD-EPI CREATININE FORMULA||N|U|Y|U|||Y|5||7||SCREENING|1968-06-27|1962-08-04|||||1971-12-11||1966-09-14|Y|1965-02-17
TRIAL STUDY 134XCP|LB|7BD32505-61D5-4862-8896-B3E41D3EE779|1||||FABP3|FATTY ACID BINDING PROTEIN 3|||||||/MBP|||||||BORDERLINE||DPM||||HIGH|NOT DONE||||PLATELET RICH PLASMA|FRESH|Y|COMPLEMENT FIXATION|MDRD ENZYMATIC FORMULA||U|U|Y|U|||N|1||38||INDUCTION TREATMENT|1961-07-12|1964-08-15|||||1964-11-02||1962-08-05|NA|1972-09-27
TRIAL STUDY 134XCP|LB|7BD32505-61D5-4862-8896-B3E41D3EE779|2||||HBA2PHB|HEMOGLOBIN A2 PRIME/TOTAL HEMOGLOBIN|||||||BQ/ML|||||||BORDERLINE||CI/UL||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|CLOTTED|NA|CONTRAST ENHANCED CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|N|||N|1||38||RUN-IN|1971-04-05|1967-07-31|||||1963-07-29||1971-06-02|N|1964-04-13
TRIAL STUDY 134XCP|LB|7BD32505-61D5-4862-8896-B3E41D3EE779|1||||ETPLTR|ETP LAG TIME RELATIVE|||||||MG/KG/WEEK|||||||POSITIVE||UG/L||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|DRIED|N|SINGLE-SLICE SPIRAL CT|COCKCROFT-GAULT FORMULA||Y|Y|N|NA|||Y|2||58||WASHOUT|1960-01-19|1966-02-04|||||1962-05-08||1971-02-01|NA|1960-09-03
TRIAL STUDY 134XCP|LB|7BD32505-61D5-4862-8896-B3E41D3EE779|2||||TNF|TUMOR NECROSIS FACTOR|||||||L/S|||||||INDETERMINATE||L/L||||HIGH|NOT DONE||||HAIR|DRIED|N|ICP-MS|FIBROTEST FORMULA||NA|N|U|NA|||Y|2||58||OPEN LABEL TREATMENT|1968-07-22|1962-08-03|||||1972-11-04||1971-09-20|N|1969-03-15
TRIAL STUDY 134XCP|LB|7BD32505-61D5-4862-8896-B3E41D3EE779|1||||C130095|WESTERN RAGWEED POLLEN IGG4|||||||PATCH|||||||POSITIVE||MET*MIN||||ABNORMAL|NOT DONE||||BLOOD|AUTOLYZED|NA|DIGITAL PCR ARRAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|NA|Y|||U|3||39||RUN-IN|1960-10-31|1970-07-06|||||1970-02-12||1967-01-18|NA|1973-06-11
TRIAL STUDY 134XCP|LB|7BD32505-61D5-4862-8896-B3E41D3EE779|2||||VITA|VITAMIN A|||||||MMOL/DAY|||||||TRACE||BREATHS/MIN||||NORMAL|NOT DONE||||DERMAL TISSUE|GELLED|N|ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA||U|U|Y|U|||Y|3||39||SCREENING|1973-09-04|1960-12-25|||||1961-07-13||1961-04-21|U|1971-04-29
TRIAL STUDY 134XCP|LB|7BD32505-61D5-4862-8896-B3E41D3EE779|1||||TRIG|TRIGLYCERIDES|||||||MG/KG/WEEK|||||||BORDERLINE||MBQ/UL||||LOW|NOT DONE||||CAPILLARY PLASMA|UNEXPECTED ODOR|N|COULOMETRIC TITRATION|MDRD 4 VARIABLE FORMULA||NA|U|Y|U|||N|4||88||BASELINE|1965-10-20|1965-11-01|||||1970-05-28||1963-05-08|U|1968-04-03
TRIAL STUDY 134XCP|LB|7BD32505-61D5-4862-8896-B3E41D3EE779|2||||MYPCERPC|MYELOID/ERYTHROID RATIO|||||||UGEQ/L|||||||POSITIVE||RATIO||||NORMAL|NOT DONE||||MUCUS|PARAFFIN-EMBEDDED|Y|TWO-COLOR MICROARRAY|GMI MMOL/MOL FORMULA||N|Y|Y|Y|||N|4||88||LONG-TERM FOLLOW-UP|1963-12-04|1970-02-09|||||1967-05-23||1961-05-27|Y|1964-02-20
TRIAL STUDY 134XCP|LB|7BD32505-61D5-4862-8896-B3E41D3EE779|1||||MMP2|MATRIX METALLOPROTEINASE 2|||||||NMOL/L|||||||INVALID||VG/ML||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|DRIED|N|FUNCTIONAL MRI|CKD-EPI CREATININE FORMULA||U|U|U|U|||NA|5||7||OBSERVATION|1966-01-21|1960-12-19|||||1966-05-04||1964-10-22|NA|1971-06-13
TRIAL STUDY 134XCP|LB|7BD32505-61D5-4862-8896-B3E41D3EE779|2||||RETIRBC|RETICULOCYTES/ERYTHROCYTES|||||||EID 50/DOSE|||||||INVALID||AMFI||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|GELLED|Y|WESTERN BLOT|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|N|U|||NA|5||7||OBSERVATION|1966-11-09|1965-10-18|||||1970-10-21||1972-04-18|NA|1966-10-09
TRIAL STUDY 134XCP|LB|3461C227-E30F-482B-B404-026FE0CA3549|1||||IL6SR|SOLUBLE INTERLEUKIN 6 RECEPTOR|||||||UKAT|||||||INVALID||PIXELS/CM||||HIGH|NOT DONE||||BLOOD|CONCENTRATED|NA|DUCTOGRAPHY|ASH FIBROSURE FORMULA||N|Y|U|U|||U|1||38||RUN-IN|1969-07-09|1967-07-08|||||1971-08-11||1965-11-02|NA|1965-03-19
TRIAL STUDY 134XCP|LB|3461C227-E30F-482B-B404-026FE0CA3549|2||||FEPI|FRACTIONAL PHOSPHORUS EXCRETION|||||||10^9 ORGANISMS/G|||||||TRACE||MG/M2/DAY||||HIGH|NOT DONE||||SPERMATOZOON|CLOTTED|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|CKD-EPI CREATININE FORMULA||Y|N|N|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1961-09-04|1973-08-24|||||1972-10-17||1972-12-10|U|1966-04-22
TRIAL STUDY 134XCP|LB|3461C227-E30F-482B-B404-026FE0CA3549|1||||AMORPHSD|AMORPHOUS SEDIMENT|||||||NKAT/G HB|||||||INDETERMINATE||BOLUS||||LOW|NOT DONE||||EXPIRED AIR|LACTESCENT|N|MAPH|MDRD ENZYMATIC FORMULA||NA|Y|NA|U|||NA|2||58||SCREENING|1967-08-02|1972-05-01|||||1971-11-03||1960-08-15|Y|1961-03-09
TRIAL STUDY 134XCP|LB|3461C227-E30F-482B-B404-026FE0CA3549|2||||ALUMINUM|ALUMINUM|||||||FRAMES/S|||||||INVALID||MU/G||||ABNORMAL|NOT DONE||||SALIVA|LACTESCENT|NA|DIFFUSION TENSOR MRI|CKD-EPI CREATININE FORMULA||NA|U|Y|Y|||NA|2||58||CONTINUATION TREATMENT|1970-07-24|1971-01-26|||||1964-11-28||1963-04-28|Y|1964-09-17
TRIAL STUDY 134XCP|LB|3461C227-E30F-482B-B404-026FE0CA3549|1||||IGE|IMMUNOGLOBULIN E|||||||CAPLET|||||||TRACE||PATCH||||HIGH|NOT DONE||||BILE|SOLIDIFIED|N|ERGOSPIROMETRY|HEPASCORE FORMULA||Y|N|U|Y|||U|3||39||OPEN LABEL TREATMENT|1964-02-11|1966-08-15|||||1968-10-06||1966-11-15|Y|1965-10-18
TRIAL STUDY 134XCP|LB|3461C227-E30F-482B-B404-026FE0CA3549|2||||B2G1GMAB|BETA-2 GLYCOPROTEIN 1 IGM ANTIBODY|||||||MDFI|||||||TRACE||ML/KG/H||||HIGH|NOT DONE||||URINE|LACTESCENT|NA|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|ASH FIBROSURE FORMULA||N|NA|N|NA|||NA|3||39||RUN-IN|1962-02-14|1967-04-10|||||1970-11-17||1963-02-01|U|1969-09-02
TRIAL STUDY 134XCP|LB|3461C227-E30F-482B-B404-026FE0CA3549|1||||NDMTASE|N-DEMETHYLASE|||||||DEG2|||||||BORDERLINE||CMHG||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|LIPEMIC|U|AUSCULTATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|U|NA|||N|4||88||WASHOUT|1972-05-11|1972-04-09|||||1966-10-20||1961-08-23|U|1970-03-10
TRIAL STUDY 134XCP|LB|3461C227-E30F-482B-B404-026FE0CA3549|2||||LDH2|LDH ISOENZYME 2|||||||PMOL/G|||||||INVALID||CL||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED|NA|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROTEST FORMULA||U|Y|N|NA|||Y|4||88||INDUCTION TREATMENT|1960-11-05|1962-10-13|||||1965-04-02||1960-01-08|NA|1963-10-30
TRIAL STUDY 134XCP|LB|3461C227-E30F-482B-B404-026FE0CA3549|1||||AAP|ALANINE AMINOPEPTIDASE|||||||UG/DL|||||||POSITIVE||CAN||||NORMAL|NOT DONE||||SEMEN|REFRIGERATED|N|PLETHYSMOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|N|N|Y|||Y|5||7||BLINDED TREATMENT|1967-04-03|1969-12-20|||||1965-10-27||1963-09-19|U|1969-02-25
TRIAL STUDY 134XCP|LB|3461C227-E30F-482B-B404-026FE0CA3549|2||||CTC|CIRCULATING TUMOR CELLS|||||||EVENTS|||||||TRACE||/MM||||HIGH|NOT DONE||||TISSUE|LACTESCENT|N|MALDI-TOF|CKD-EPI FORMULA||Y|Y|Y|N|||NA|5||7||RUN-IN|1970-02-15|1962-06-03|||||1969-08-16||1960-04-16|Y|1963-07-12
TRIAL STUDY 134XCP|LB|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|1||||GADAB|GLUTAMIC ACID DECARBOXYLASE ANTIBODY|||||||CONTAINER|||||||INVALID||KG/CM||||LOW|NOT DONE||||BUFFY COAT|LACTESCENT|Y|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD ENZYMATIC FORMULA||Y|U|NA|U|||Y|1||38||FOLLOW-UP|1969-10-25|1971-07-28|||||1971-01-14||1968-06-07|Y|1969-09-13
TRIAL STUDY 134XCP|LB|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|2||||B2MCREAT|BETA-2 MICROGLOBULIN/CREATININE|||||||%(W/V)|||||||POSITIVE||TRANSDUCING UNIT||||LOW|NOT DONE||||PERITONEAL FLUID|AUTOLYZED|NA|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|GMI MMOL/MOL FORMULA||N|NA|U|N|||NA|1||38||OPEN LABEL TREATMENT|1971-02-28|1968-05-08|||||1963-02-04||1967-09-18|NA|1961-09-06
TRIAL STUDY 134XCP|LB|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|1||||VITB7|VITAMIN B7|||||||UIU/DL|||||||POSITIVE||MG/ML/MIN||||ABNORMAL|NOT DONE||||BUFFY COAT|HEMOLYZED|NA|CT SCAN|NASH FIBROSURE FORMULA||NA|U|NA|Y|||N|2||58||CONTINUATION TREATMENT|1970-07-25|1970-01-12|||||1968-12-28||1970-09-29|Y|1960-01-05
TRIAL STUDY 134XCP|LB|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|2||||C130117|BEE MIX ANTIGEN IGG ANTIBODY|||||||BP|||||||TRACE||RAD||||LOW|NOT DONE||||PLASMA|NON-HEMOLYZED|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||N|Y|U|NA|||NA|2||58||LONG-TERM FOLLOW-UP|1970-05-26|1965-06-10|||||1970-09-08||1972-10-22|NA|1968-08-05
TRIAL STUDY 134XCP|LB|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|1||||OXACREAT|OXALATE/CREATININE|||||||NEBULE|||||||TRACE||UG/L DDU||||ABNORMAL|NOT DONE||||CORD BLOOD|FROZEN|Y|DUKE INCISION METHOD|CKD-EPI FORMULA||U|NA|NA|N|||Y|3||39||FOLLOW-UP|1962-01-20|1963-04-26|||||1968-11-25||1973-07-25|N|1960-09-18
TRIAL STUDY 134XCP|LB|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|2||||HLZPM|HALAZEPAM|||||||NM|||||||BORDERLINE||MMOL/G||||ABNORMAL|NOT DONE||||SEBUM|CONTAMINATED|Y|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD 5 VARIABLE FORMULA||NA|NA|U|Y|||NA|3||39||FOLLOW-UP|1960-05-10|1964-04-03|||||1965-11-14||1968-06-02|N|1969-06-08
TRIAL STUDY 134XCP|LB|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|1||||CCL21|CHEMOKINE (C-C MOTIF) LIGAND 21|||||||MM/2H|||||||INDETERMINATE||MS/MMHG||||LOW|NOT DONE||||ADIPOSE TISSUE|UNEXPECTED ODOR|NA|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|GMI % FORMULA||N|NA|NA|N|||Y|4||88||CONTINUATION TREATMENT|1960-11-09|1963-08-30|||||1964-02-28||1966-07-21|U|1969-05-13
TRIAL STUDY 134XCP|LB|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|2||||ETPAUC|ETP AREA UNDER CURVE|||||||U/10^12 RBC|||||||INVALID||MPA||||NORMAL|NOT DONE||||COLOSTRUM|REFRIGERATED|N|MALDI|MDRD ENZYMATIC FORMULA||U|NA|N|Y|||N|4||88||BASELINE|1962-10-30|1970-01-26|||||1967-04-10||1963-02-01|U|1961-07-31
TRIAL STUDY 134XCP|LB|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|1||||C130079|SILVER BIRCH POLLEN IGG4|||||||OD UNIT|||||||BORDERLINE||PACKET||||NORMAL|NOT DONE||||VITREOUS HUMOR|NON-HEMOLYZED|U|DOUBLE IMMUNODIFFUSION|GMI % FORMULA||Y|U|NA|U|||Y|5||7||WASHOUT|1972-05-15|1960-03-08|||||1969-06-13||1969-12-31|U|1963-07-18
TRIAL STUDY 134XCP|LB|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|2||||GADAB|GLUTAMIC ACID DECARBOXYLASE ANTIBODY|||||||CUP|||||||INDETERMINATE||LOG EID 50/DOSE||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|REFRIGERATED|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|HEPASCORE FORMULA||N|Y|N|U|||U|5||7||TREATMENT|1963-03-23|1960-04-20|||||1966-06-13||1964-06-28|Y|1963-06-27
TRIAL STUDY 134XCP|LB|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|1||||FUNGYLK|FUNGI, YEAST-LIKE|||||||USEC|||||||TRACE||G/U||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|AUTOLYZED|Y|BAC ACGH|HEPASCORE FORMULA||Y|Y|NA|N|||Y|1||38||OBSERVATION|1961-08-20|1969-05-27|||||1970-05-10||1971-09-16|N|1964-11-05
TRIAL STUDY 134XCP|LB|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|2||||AMORPHSD|AMORPHOUS SEDIMENT|||||||TITER|||||||NEGATIVE||DRUM||||NORMAL|NOT DONE||||CAPILLARY PLASMA|THAWED|NA|DYNAMOMETRY|HEPASCORE FORMULA||NA|U|Y|NA|||NA|1||38||OPEN LABEL TREATMENT|1960-11-09|1961-08-28|||||1961-03-13||1960-11-06|U|1963-07-31
TRIAL STUDY 134XCP|LB|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|1||||GLOBA|ALPHA GLOBULIN|||||||CM2|||||||POSITIVE||UCI/L||||LOW|NOT DONE||||INFRANATANT, PLASMA|AGGLUTINATED|Y|CONTRAST ENHANCED CT SCAN|FIBROMETER FORMULA||Y|Y|U|NA|||Y|2||58||OPEN LABEL TREATMENT|1971-06-11|1960-09-18|||||1972-06-20||1971-02-01|Y|1960-10-24
TRIAL STUDY 134XCP|LB|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|2||||CPEPTIDE|C-PEPTIDE|||||||IU/MMOL|||||||POSITIVE||PG/L||||ABNORMAL|NOT DONE||||SALIVA|FROZEN|U|SEQUENCING|FIBROSIS 4 FORMULA||U|Y|NA|Y|||NA|2||58||BLINDED TREATMENT|1963-09-12|1969-10-20|||||1971-03-17||1962-02-26|N|1967-06-05
TRIAL STUDY 134XCP|LB|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|1||||CD22|CD22|||||||G/DAY|||||||TRACE||KM||||LOW|NOT DONE||||CEREBROSPINAL FLUID|HEMOLYZED|Y|ANTIBIOTIC AGAR SCREEN|CKD-EPI CYSTATIN C FORMULA||NA|Y|N|U|||NA|3||39||BLINDED TREATMENT|1962-04-20|1964-07-10|||||1971-07-19||1968-03-12|U|1966-02-07
TRIAL STUDY 134XCP|LB|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|2||||DALA|DELTA AMINOLEVULINATE|||||||MG/MIN|||||||POSITIVE||NMOL/L||||ABNORMAL|NOT DONE||||SKIN TISSUE|CLOTTED|N|REFRACTOMETRY|GMI % FORMULA||NA|N|NA|Y|||U|3||39||OPEN LABEL TREATMENT|1960-06-16|1962-07-26|||||1967-05-28||1964-06-02|U|1971-01-16
TRIAL STUDY 134XCP|LB|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|1||||P50OXYGN|P50 OXYGEN|||||||UL/KG/DAY|||||||BORDERLINE||FRACTION OF 1||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|CLOTTED|NA|ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|NA|U|||N|4||88||TREATMENT|1962-07-16|1973-09-05|||||1968-08-04||1967-09-30|N|1966-07-25
TRIAL STUDY 134XCP|LB|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|2||||BD2|BETA-DEFENSIN 2|||||||USIEMENS|||||||TRACE||PSEC||||ABNORMAL|NOT DONE||||BLOOD|LIPEMIC|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|ASH FIBROSURE FORMULA||Y|Y|N|N|||U|4||88||SCREENING|1961-09-29|1969-07-23|||||1962-07-12||1969-05-30|Y|1960-06-29
TRIAL STUDY 134XCP|LB|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|1||||TROPONI3|TROPONIN I TYPE 3|||||||%(W/W)|||||||BORDERLINE||/VF||||HIGH|NOT DONE||||MUCUS|AUTOLYZED|Y|DIFFUSION TENSOR MRI|HEPASCORE FORMULA||Y|Y|NA|U|||U|5||7||SCREENING|1968-01-06|1969-01-12|||||1971-10-24||1970-12-19|U|1964-11-01
TRIAL STUDY 134XCP|LB|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|2||||DHEAS|DEHYDROEPIANDROSTERONE SULFATE|||||||UG/G/MIN|||||||POSITIVE||ML/MMHG/MIN/L||||NORMAL|NOT DONE||||BILE|LACTESCENT|NA|MECHANICAL CLOT DETECTION|ASH FIBROSURE FORMULA||N|NA|N|N|||N|5||7||TREATMENT|1961-02-18|1969-03-11|||||1968-05-16||1966-09-05|Y|1965-09-14
TRIAL STUDY 134XCP|LB|C7C91F63-87B7-4E62-B5F3-39979F74E955|1||||HEPCIDIN|HEPCIDIN|||||||UCI/L|||||||NEGATIVE||DAYS/WK||||NORMAL|NOT DONE||||CELL PELLET|FRESH|NA|BRDU CELLULAR PROLIFERATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|Y|N|||Y|1||38||BLINDED TREATMENT|1960-08-28|1968-08-07|||||1970-09-20||1960-10-21|NA|1961-04-20
TRIAL STUDY 134XCP|LB|C7C91F63-87B7-4E62-B5F3-39979F74E955|2||||FXIVAAC|FACTOR XIV ACTIVITY ACTUAL/CONTROL|||||||PFU/ML|||||||INDETERMINATE||MEQ/L||||LOW|NOT DONE||||BILE|LACTESCENT|U|MICROBIAL CULTURE, SOLID|MDRD 5 VARIABLE FORMULA||Y|U|U|NA|||N|1||38||CONTINUATION TREATMENT|1966-09-15|1971-01-08|||||1972-06-30||1971-10-05|Y|1965-09-21
TRIAL STUDY 134XCP|LB|C7C91F63-87B7-4E62-B5F3-39979F74E955|1||||MMP1|MATRIX METALLOPROTEINASE 1|||||||MESF|||||||BORDERLINE||CI/MG||||LOW|NOT DONE||||CEREBROSPINAL FLUID|LACTESCENT|U|CALCULATION|CKD-EPI FORMULA||U|N|U|U|||N|2||58||OBSERVATION|1970-10-04|1965-01-04|||||1966-01-17||1969-04-11|N|1963-01-13
TRIAL STUDY 134XCP|LB|C7C91F63-87B7-4E62-B5F3-39979F74E955|2||||GLCTN3|GALECTIN-3|||||||TORR|||||||INDETERMINATE||CI/KG||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|HEMOLYZED|Y|ORCHIDOMETERY|HEPASCORE FORMULA||N|NA|NA|N|||U|2||58||LONG-TERM FOLLOW-UP|1969-10-03|1965-02-12|||||1971-08-14||1970-01-16|U|1973-01-18
TRIAL STUDY 134XCP|LB|C7C91F63-87B7-4E62-B5F3-39979F74E955|1||||CKMB|CREATINE KINASE MB|||||||ML/SEC/1.73M2|||||||POSITIVE||ML/H||||HIGH|NOT DONE||||PERSPIRATION|AGGLUTINATED|Y|NUCLEIC ACID SEQUENCING|GMI % FORMULA||Y|NA|U|NA|||Y|3||39||WASHOUT|1971-09-30|1967-08-03|||||1962-08-15||1963-03-02|Y|1961-02-10
TRIAL STUDY 134XCP|LB|C7C91F63-87B7-4E62-B5F3-39979F74E955|2||||NORMETA|NORMETANEPHRINE|||||||/2500 WBC|||||||NEGATIVE||DISK||||ABNORMAL|NOT DONE||||BASAL TEAR|CONCENTRATED|Y|MUGA|MDRD 5 VARIABLE FORMULA||Y|Y|NA|U|||U|3||39||INDUCTION TREATMENT|1973-05-12|1961-05-14|||||1967-10-18||1962-05-15|NA|1969-01-02
TRIAL STUDY 134XCP|LB|C7C91F63-87B7-4E62-B5F3-39979F74E955|1||||CASULPH|CALCIUM SULPHATE|||||||10^3 CFU/G|||||||INDETERMINATE||UL/KG/DAY||||LOW|NOT DONE||||BREAST MILK|ROOM TEMPERATURE|Y|GC/MS-EI|MDRD 4 VARIABLE FORMULA||NA|Y|Y|N|||NA|4||88||BLINDED TREATMENT|1962-10-16|1967-05-16|||||1963-06-06||1966-07-17|Y|1968-06-14
TRIAL STUDY 134XCP|LB|C7C91F63-87B7-4E62-B5F3-39979F74E955|2||||GSTY1|GLUTATHIONE S-TRANSFERASE, Y1|||||||LOG10 ELISA UNIT|||||||NEGATIVE||KM/H||||ABNORMAL|NOT DONE||||TUMOR TISSUE|AUTOLYZED|Y|LANDOLT RING|NASH FIBROSURE FORMULA||Y|Y|NA|U|||U|4||88||FOLLOW-UP|1960-12-22|1972-12-26|||||1965-06-30||1967-03-03|N|1967-07-29
TRIAL STUDY 134XCP|LB|C7C91F63-87B7-4E62-B5F3-39979F74E955|1||||MYCEPPOL|MYELOID PROLIFERATION POOL|||||||S*KPA|||||||INDETERMINATE||CD||||HIGH|NOT DONE||||BUFFY COAT|SOLIDIFIED|NA|RAJI CELL EIA|NASH FIBROSURE FORMULA||N|U|N|N|||N|5||7||BASELINE|1968-03-13|1968-05-09|||||1967-07-27||1970-07-09|NA|1972-12-16
TRIAL STUDY 134XCP|LB|C7C91F63-87B7-4E62-B5F3-39979F74E955|2||||APPT|TOTAL AMYLOID PRECURSOR PROTEIN|||||||LOG EID 50/DOSE|||||||INVALID||ML/G/MIN||||HIGH|NOT DONE||||RETICULOCYTES|CLOTTED|Y|IMMUNOPRECIPITATION|MDRD ENZYMATIC FORMULA||NA|NA|N|NA|||Y|5||7||TREATMENT|1972-12-05|1963-12-04|||||1969-08-11||1961-12-19|U|1970-03-01
TRIAL STUDY 134XCP|LB|D6659F53-6DF6-4F88-BF9A-160E2D057028|1||||COMP|CARTILAGE OLIGOMERIC MATRIX PROTEIN|||||||VIRTUAL PIXEL|||||||POSITIVE||MS2||||LOW|NOT DONE||||LUNG SURFACTANT|AUTOLYZED|NA|MICRODENSITOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|Y|NA|||NA|1||38||OBSERVATION|1968-11-29|1961-02-23|||||1968-01-06||1969-11-28|N|1965-07-20
TRIAL STUDY 134XCP|LB|D6659F53-6DF6-4F88-BF9A-160E2D057028|2||||GASTRIN|GASTRIN|||||||MMOL|||||||TRACE||MMOL/MOL||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|AUTOLYZED|N|MIGET|COCKCROFT-GAULT FORMULA||Y|N|Y|U|||U|1||38||FOLLOW-UP|1962-11-02|1963-07-05|||||1969-10-17||1965-08-18|Y|1973-05-29
TRIAL STUDY 134XCP|LB|D6659F53-6DF6-4F88-BF9A-160E2D057028|1||||OXYCAP|OXYGEN CAPACITY|||||||UV*SEC|||||||NEGATIVE||KG/CM2||||LOW|NOT DONE||||EXUDATE|FRESH|N|LINE PROBE ASSAY|MDRD ENZYMATIC FORMULA||NA|N|NA|N|||NA|2||58||LONG-TERM FOLLOW-UP|1971-10-28|1963-06-29|||||1967-12-26||1970-04-09|U|1971-12-17
TRIAL STUDY 134XCP|LB|D6659F53-6DF6-4F88-BF9A-160E2D057028|2||||CELLS|CELLS|||||||KN/CM2|||||||INDETERMINATE||10^6/G||||HIGH|NOT DONE||||ADIPOSE TISSUE|LIPEMIC|NA|TEMPLATE INCISION METHOD|MDRD 5 VARIABLE FORMULA||NA|Y|Y|U|||U|2||58||FOLLOW-UP|1967-04-17|1964-11-19|||||1971-11-14||1960-11-15|N|1968-02-12
TRIAL STUDY 134XCP|LB|D6659F53-6DF6-4F88-BF9A-160E2D057028|1||||FACTV|FACTOR V|||||||10^4/L|||||||TRACE||/10^3||||LOW|NOT DONE||||BUFFY COAT|AUTOLYZED|NA|DOPPLER ULTRASOUND|MDRD ENZYMATIC FORMULA||NA|U|NA|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1971-02-07|1960-10-02|||||1966-03-27||1971-02-23|U|1970-01-12
TRIAL STUDY 134XCP|LB|D6659F53-6DF6-4F88-BF9A-160E2D057028|2||||GAD2|GLUTAMIC ACID DECARBOXYLASE 2|||||||AMFI|||||||INDETERMINATE||BOX||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|DRIED|U|AUSCULTATION|CKD-EPI CREATININE FORMULA||N|U|NA|NA|||N|3||39||BASELINE|1973-07-02|1965-04-28|||||1968-10-08||1969-12-01|NA|1963-03-20
TRIAL STUDY 134XCP|LB|D6659F53-6DF6-4F88-BF9A-160E2D057028|1||||PAI1AG|PLASMINOGEN ACTIVATOR INHIBITOR-1 AG|||||||MMOL/S|||||||POSITIVE||G/G||||HIGH|NOT DONE||||PERSPIRATION|CALCIFIED|NA|POLYMERASE CHAIN REACTION|FIBROMETER FORMULA||NA|U|NA|NA|||U|4||88||LONG-TERM FOLLOW-UP|1972-10-21|1972-10-26|||||1970-09-01||1972-06-06|NA|1965-03-26
TRIAL STUDY 134XCP|LB|D6659F53-6DF6-4F88-BF9A-160E2D057028|2||||IGG3|IMMUNOGLOBULIN G SUBCLASS 3|||||||BEATS/MIN|||||||NEGATIVE||UM2||||HIGH|NOT DONE||||LAVAGE FLUID|FROZEN|U|GC/MS-EI|MDRD 5 VARIABLE FORMULA||Y|N|Y|Y|||N|4||88||FOLLOW-UP|1962-01-12|1971-07-03|||||1972-05-30||1970-10-11|N|1969-12-31
TRIAL STUDY 134XCP|LB|D6659F53-6DF6-4F88-BF9A-160E2D057028|1||||BHYXBTR|BETA-HYDROXYBUTYRATE|||||||FRAMES/S|||||||INDETERMINATE||G/CAGE/WK||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|FRESH|NA|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||Y|Y|NA|U|||NA|5||7||OBSERVATION|1973-07-23|1962-04-18|||||1972-06-13||1964-04-19|NA|1968-09-18
TRIAL STUDY 134XCP|LB|D6659F53-6DF6-4F88-BF9A-160E2D057028|2||||CANNABS|CANNABINOIDS, SYNTHETIC|||||||KHZ|||||||INVALID||GPL U||||ABNORMAL|NOT DONE||||SKIN TISSUE|FRESH|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|HEPASCORE FORMULA||NA|N|NA|N|||U|5||7||OPEN LABEL TREATMENT|1967-03-09|1973-02-07|||||1967-04-07||1964-08-09|U|1960-10-21
TRIAL STUDY 134XCP|LB|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|1||||CYFRA211|CYTOKERATIN 19 FRAGMENT 21-1|||||||ML/CAGE/WK|||||||NEGATIVE||KUSP||||LOW|NOT DONE||||CORD SERUM|AGGLUTINATED|U|KINETIC MICROPARTICLE IMMUNOASSAY|FIBROMETER FORMULA||U|U|N|Y|||NA|1||38||BLINDED TREATMENT|1960-01-17|1961-12-13|||||1971-06-26||1962-07-23|N|1961-05-06
TRIAL STUDY 134XCP|LB|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|2||||LTB4|LEUKOTRIENE B4|||||||/MIN|||||||INDETERMINATE||10^3 CFU||||HIGH|NOT DONE||||INFRANATANT, PLASMA|PARAFFIN-EMBEDDED|NA|OPTICAL MAPPING|MDRD 5 VARIABLE FORMULA||U|U|N|Y|||N|1||38||LONG-TERM FOLLOW-UP|1971-05-29|1960-10-15|||||1973-07-22||1969-02-17|NA|1969-11-04
TRIAL STUDY 134XCP|LB|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|1||||CSFAT|FATTY CASTS|||||||ML/CAGE/DAY|||||||POSITIVE||MG||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT|NA|PULSE OXIMETRY|MDRD ENZYMATIC FORMULA||N|Y|U|Y|||Y|2||58||BLINDED TREATMENT|1961-04-19|1964-05-13|||||1973-04-29||1972-03-28|N|1960-11-02
TRIAL STUDY 134XCP|LB|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|2||||SAO2FIO2|OXYGEN SATURATION/FRACTION INSPIRED O2|||||||BQ/L|||||||BORDERLINE||10^9/L||||LOW|NOT DONE||||VENOUS CORD BLOOD|ICTERIC|U|IMMUNOFIXATION ELECTROPHORESIS|MDRD 5 VARIABLE FORMULA||Y|U|U|Y|||Y|2||58||FOLLOW-UP|1972-05-30|1967-05-06|||||1962-01-30||1964-12-06|N|1969-05-12
TRIAL STUDY 134XCP|LB|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|1||||TXB2|THROMBOXANE B2|||||||MBQ|||||||INVALID||OZ EQ||||LOW|NOT DONE||||ADIPOSE TISSUE|SOLIDIFIED|Y|SCANNING ELECTRON MICROSCOPY|FIBROMETER FORMULA||NA|U|NA|Y|||Y|3||39||TREATMENT|1970-01-08|1963-03-17|||||1972-04-13||1973-05-17|Y|1965-12-02
TRIAL STUDY 134XCP|LB|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|2||||SRTONIN|SEROTONIN|||||||JDF UNIT|||||||INDETERMINATE||F||||LOW|NOT DONE||||LUNG SURFACTANT|SOLIDIFIED|U|CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI FORMULA||U|Y|U|N|||Y|3||39||RUN-IN|1971-10-06|1968-09-18|||||1962-01-30||1972-01-01|Y|1963-11-13
TRIAL STUDY 134XCP|LB|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|1||||PTSAAC|PROTEIN S ACTIVITY ACTUAL/CONTROL|||||||10^3 CFU/G|||||||BORDERLINE||S/H||||HIGH|NOT DONE||||CORD BLOOD|FRESH|U|HEMAGGLUTINATION INHIBITION ASSAY|ASH FIBROSURE FORMULA||N|Y|N|NA|||N|4||88||FOLLOW-UP|1966-08-29|1972-08-23|||||1969-05-29||1963-08-14|N|1962-08-22
TRIAL STUDY 134XCP|LB|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|2||||CCL17|CHEMOKINE (C-C MOTIF) LIGAND 17|||||||10^9 CFU/G|||||||POSITIVE||FOZ_US||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|NON-HEMOLYZED|Y|AGAR PROPORTION|CKD-EPI CREATININE FORMULA||NA|Y|Y|N|||NA|4||88||RUN-IN|1968-11-17|1966-02-06|||||1967-06-24||1966-07-22|N|1962-01-14
TRIAL STUDY 134XCP|LB|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|1||||CD161LY|CD161/LYMPHOCYTES|||||||MMAL|||||||TRACE||CMOL||||HIGH|NOT DONE||||CAPILLARY PLASMA|LIPEMIC|Y|FLUORIMETRY|FIBROMETER FORMULA||NA|U|Y|NA|||N|5||7||BLINDED TREATMENT|1961-12-04|1967-06-01|||||1960-12-20||1967-02-17|Y|1970-10-17
TRIAL STUDY 134XCP|LB|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|2||||LRZPM|LORAZEPAM|||||||MOSM|||||||INVALID||IMPLANT||||HIGH|NOT DONE||||HAIR FOLLICLE|THAWED|NA|LANDOLT RING|MDRD 5 VARIABLE FORMULA||Y|NA|N|Y|||NA|5||7||INDUCTION TREATMENT|1967-09-30|1970-10-09|||||1970-09-29||1968-02-18|N|1966-05-02
TRIAL STUDY 134XCP|LB|91B36C93-3ADF-4570-B355-BC81B097EEFC|1||||PSIGAAB|PHOSPHATIDYLSERINE IGA ANTIBODY|||||||NG/DL|||||||INDETERMINATE||CD*S/M2||||LOW|NOT DONE||||RETICULOCYTES|UNEXPECTED ODOR|N|REFLECTANCE SPECTROSCOPY|FIBROMETER FORMULA||Y|U|NA|NA|||N|1||38||CONTINUATION TREATMENT|1964-05-24|1971-09-28|||||1964-01-05||1970-01-06|U|1968-05-20
TRIAL STUDY 134XCP|LB|91B36C93-3ADF-4570-B355-BC81B097EEFC|2||||C147277|TRITICUM AESTIVUM ANTIGEN IGE ANTIBODY|||||||MG/M2/DAY|||||||TRACE||NL||||HIGH|NOT DONE||||HAIR|NON-HEMOLYZED|NA|PLETHYSMOGRAPHY|FIBROTEST FORMULA||U|N|Y|U|||U|1||38||WASHOUT|1968-01-06|1968-09-07|||||1961-03-02||1969-11-29|Y|1970-10-03
TRIAL STUDY 134XCP|LB|91B36C93-3ADF-4570-B355-BC81B097EEFC|1||||MEPRDN|MEPERIDINE|||||||MMHG|||||||BORDERLINE||BOX||||HIGH|NOT DONE||||LAVAGE FLUID|AGGLUTINATED|Y|APPLANATION TONOMETRY|CKD-EPI CYSTATIN C FORMULA||NA|Y|U|NA|||U|2||58||BLINDED TREATMENT|1968-05-04|1971-01-27|||||1972-05-24||1969-06-06|U|1970-10-04
TRIAL STUDY 134XCP|LB|91B36C93-3ADF-4570-B355-BC81B097EEFC|2||||SCL70GAB|SCL-70 IGG ANTIBODY|||||||UG/G/DAY|||||||INVALID||IN2||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|SOLIDIFIED|N|SCINTIGRAPHY|ASH FIBROSURE FORMULA||U|Y|Y|Y|||NA|2||58||OPEN LABEL TREATMENT|1961-03-12|1972-08-03|||||1961-03-23||1965-01-17|N|1973-05-11
TRIAL STUDY 134XCP|LB|91B36C93-3ADF-4570-B355-BC81B097EEFC|1||||NEUTGT|GIANT NEUTROPHILS|||||||POINT|||||||INDETERMINATE||/500 WBC||||ABNORMAL|NOT DONE||||SEMEN|FRESH|U|SXA SCAN|MDRD FORMULA||NA|NA|NA|Y|||Y|3||39||BLINDED TREATMENT|1967-03-23|1961-04-04|||||1971-08-07||1965-06-03|U|1965-10-28
TRIAL STUDY 134XCP|LB|91B36C93-3ADF-4570-B355-BC81B097EEFC|2||||VITDAT|1, 25-DIHYDROXYVITAMIN D|||||||BP|||||||POSITIVE||G/CAGE/DAY||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|DRIED|Y|BRDU CELLULAR PROLIFERATION ASSAY|ASH FIBROSURE FORMULA||NA|Y|N|N|||U|3||39||CONTINUATION TREATMENT|1965-09-12|1960-03-09|||||1968-02-13||1972-02-23|U|1973-05-09
TRIAL STUDY 134XCP|LB|91B36C93-3ADF-4570-B355-BC81B097EEFC|1||||HLAB|HLA CLASS IB ANTIGEN|||||||10^6 ORGANISMS|||||||TRACE||CAL||||HIGH|NOT DONE||||EPIDERMAL TISSUE|NON-HEMOLYZED|N|ALCIAN BLUE STAIN|MDRD 4 VARIABLE FORMULA||NA|N|Y|Y|||U|4||88||BLINDED TREATMENT|1968-11-11|1971-02-11|||||1968-05-20||1963-07-01|U|1965-11-25
TRIAL STUDY 134XCP|LB|91B36C93-3ADF-4570-B355-BC81B097EEFC|2||||GSTPI|GLUTATHIONE S-TRANSFERASE, PI|||||||S^-1(%O2)^-1|||||||BORDERLINE||PMOL/10^9 CELLS||||HIGH|NOT DONE||||VITREOUS HUMOR|SOLIDIFIED|N|SLOAN LETTER EYE CHART 100%|MDRD FORMULA||Y|U|U|NA|||U|4||88||TREATMENT|1965-01-03|1971-04-13|||||1964-08-28||1969-04-18|Y|1967-03-18
TRIAL STUDY 134XCP|LB|91B36C93-3ADF-4570-B355-BC81B097EEFC|1||||C165935|TRITICUM AESTIVUM IGE AB RAST SCORE|||||||CY/CM|||||||TRACE||L/S/KPA||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|FRESH|NA|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD FORMULA||NA|N|NA|U|||U|5||7||SCREENING|1961-11-25|1967-03-02|||||1968-08-31||1968-03-14|Y|1972-08-11
TRIAL STUDY 134XCP|LB|91B36C93-3ADF-4570-B355-BC81B097EEFC|2||||HASIGGAB|HUMAN ANTI-SHEEP IGG ANTIBODY|||||||PFU|||||||POSITIVE||10^6/HPF||||NORMAL|NOT DONE||||RETICULOCYTES|GELLED|N|NUCLEIC ACID AMPLIFICATION TEST|FIBROMETER FORMULA||U|Y|Y|NA|||U|5||7||BASELINE|1970-06-08|1961-08-30|||||1961-12-28||1963-07-23|NA|1966-10-21
TRIAL STUDY 134XCP|LB|ADD0DDE5-166F-4C20-B3C3-31B131509771|1||||CA2729AG|CANCER ANTIGEN 27-29|||||||UMOL/KG/MIN|||||||TRACE||KBQ/UL||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|FRESH|Y|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI CREATININE FORMULA||Y|Y|N|NA|||N|1||38||BLINDED TREATMENT|1965-04-24|1968-04-24|||||1969-07-05||1965-08-22|U|1961-06-08
TRIAL STUDY 134XCP|LB|ADD0DDE5-166F-4C20-B3C3-31B131509771|2||||HGBSHGB|HEMOGLOBIN S/TOTAL HEMOGLOBIN|||||||10^9/L|||||||BORDERLINE||KG/CM2||||LOW|NOT DONE||||DERMAL TISSUE|CONTAMINATED|NA|IMPULSE OSCILLOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|Y|U|||U|1||38||CONTINUATION TREATMENT|1972-10-01|1969-03-10|||||1972-06-17||1972-04-20|Y|1969-11-20
TRIAL STUDY 134XCP|LB|ADD0DDE5-166F-4C20-B3C3-31B131509771|1||||AST|ASPARTATE AMINOTRANSFERASE|||||||BQ/KG|||||||POSITIVE||/WK||||NORMAL|NOT DONE||||SWABBED MATERIAL|GELLED|NA|BAC ACGH|MDRD 6 VARIABLE FORMULA||N|U|U|N|||U|2||58||OPEN LABEL TREATMENT|1971-12-25|1962-12-11|||||1961-10-21||1964-01-07|N|1966-09-02
TRIAL STUDY 134XCP|LB|ADD0DDE5-166F-4C20-B3C3-31B131509771|2||||C130104|GRASS MIX POLLEN ANTIGEN IGG ANTIBODY|||||||CAL|||||||NEGATIVE||MG||||HIGH|NOT DONE||||STOOL|AUTOLYZED|NA|MODIFIED ACID FAST STAIN|FIBROTEST FORMULA||N|NA|Y|N|||Y|2||58||RUN-IN|1971-12-28|1964-07-14|||||1965-09-08||1962-03-16|NA|1969-02-16
TRIAL STUDY 134XCP|LB|ADD0DDE5-166F-4C20-B3C3-31B131509771|1||||ZPP|ZINC PROTOPORPHYRIN|||||||MM/SEC|||||||INVALID||%/MIN||||NORMAL|NOT DONE||||ALVEOLAR AIR|AGGLUTINATED|NA|ANGIOGRAPHY|NASH FIBROSURE FORMULA||Y|Y|U|Y|||Y|3||39||INDUCTION TREATMENT|1971-08-30|1967-06-05|||||1973-08-31||1963-04-16|NA|1960-12-16
TRIAL STUDY 134XCP|LB|ADD0DDE5-166F-4C20-B3C3-31B131509771|2||||CD45RALY|CD45RA/LYMPHOCYTES|||||||ML/KG/DAY|||||||INVALID||10^12/L||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|FROZEN|Y|CONTRAST ENHANCED X-RAY|CKD-EPI CREATININE FORMULA||NA|Y|N|U|||NA|3||39||WASHOUT|1969-12-24|1973-06-15|||||1964-02-04||1968-06-23|Y|1967-04-21
TRIAL STUDY 134XCP|LB|ADD0DDE5-166F-4C20-B3C3-31B131509771|1||||NORMETA|NORMETANEPHRINE|||||||CM/MIN|||||||NEGATIVE||MOL/ML||||LOW|NOT DONE||||LEUKOCYTE|LACTESCENT|NA|NUCLEIC ACID AMPLIFICATION TEST|MDRD FORMULA||N|Y|NA|Y|||N|4||88||OPEN LABEL TREATMENT|1965-06-11|1963-03-31|||||1969-05-05||1964-01-28|N|1964-12-11
TRIAL STUDY 134XCP|LB|ADD0DDE5-166F-4C20-B3C3-31B131509771|2||||RETIHCR|HEMATOCRIT CORRECTED RETICULOCYTES|||||||G/DAY|||||||INVALID||APS U||||LOW|NOT DONE||||VENOUS CORD BLOOD|NON-HEMOLYZED|NA|IMPULSE OSCILLOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|Y|N|||U|4||88||WASHOUT|1966-09-17|1972-10-16|||||1970-02-18||1968-04-24|N|1973-01-06
TRIAL STUDY 134XCP|LB|ADD0DDE5-166F-4C20-B3C3-31B131509771|1||||AMYLASES|AMYLASE, SALIVARY|||||||BQ/UG|||||||INVALID||MEQ||||ABNORMAL|NOT DONE||||BLOOD|AGGLUTINATED|NA|SPIRAL CT SCAN WITHOUT CONTRAST|MDRD 4 VARIABLE FORMULA||U|Y|Y|U|||U|5||7||INDUCTION TREATMENT|1968-08-10|1970-04-18|||||1962-06-24||1972-07-14|Y|1970-05-28
TRIAL STUDY 134XCP|LB|ADD0DDE5-166F-4C20-B3C3-31B131509771|2||||MYBLA|MYELOBLASTS|||||||/2000 RBC|||||||NEGATIVE||BOTTLE||||HIGH|NOT DONE||||DERMAL TISSUE|NON-HEMOLYZED|U|MODIFIED ACID FAST STAIN|CKD-EPI CREATININE FORMULA||N|U|NA|N|||U|5||7||TREATMENT|1971-07-31|1965-12-02|||||1963-11-19||1965-01-26|NA|1973-03-07
TRIAL STUDY 134XCP|LB|4265CC9E-26AF-4A14-B9AA-04A246E2523C|1||||NCCPTN|NOCICEPTIN|||||||DYN|||||||BORDERLINE||MPH||||HIGH|NOT DONE||||BUFFY COAT|CALCIFIED|NA|IMMUNOFLUORESCENT STAIN|ASH FIBROSURE FORMULA||U|U|N|U|||U|1||38||CONTINUATION TREATMENT|1963-04-07|1960-02-03|||||1961-08-28||1963-11-20|Y|1963-12-08
TRIAL STUDY 134XCP|LB|4265CC9E-26AF-4A14-B9AA-04A246E2523C|2||||METANEXR|METANEPHRINE EXCRETION RATE|||||||U/G/MIN|||||||INDETERMINATE||EID 50/ML||||LOW|NOT DONE||||VENOUS CORD BLOOD|CONTAMINATED|U|ALCIAN BLUE STAIN|FIBROTEST FORMULA||U|N|U|N|||U|1||38||OBSERVATION|1970-03-26|1973-01-24|||||1966-07-14||1962-03-09|Y|1966-12-26
TRIAL STUDY 134XCP|LB|4265CC9E-26AF-4A14-B9AA-04A246E2523C|1||||ANUAB|ANTI-NUCLEOSOME ANTIBODY|||||||GBQ/UG|||||||INDETERMINATE||UKAT/L||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|LACTESCENT|NA|INDIRECT IMMUNOFLUORESCENCE|MDRD ENZYMATIC FORMULA||N|Y|Y|N|||U|2||58||INDUCTION TREATMENT|1970-01-14|1968-04-20|||||1961-02-15||1970-11-17|U|1964-05-29
TRIAL STUDY 134XCP|LB|4265CC9E-26AF-4A14-B9AA-04A246E2523C|2||||GFRBSCRT|GFR FROM CREATININE ADJUSTED FOR BSA|||||||MMOL/G|||||||POSITIVE||LOG10 PFU/ML||||HIGH|NOT DONE||||ADIPOSE TISSUE|REFRIGERATED|Y|IN SITU HYBRIDIZATION|MDRD ENZYMATIC FORMULA||Y|N|U|Y|||N|2||58||FOLLOW-UP|1963-07-03|1966-08-03|||||1963-12-08||1972-10-03|NA|1970-01-27
TRIAL STUDY 134XCP|LB|4265CC9E-26AF-4A14-B9AA-04A246E2523C|1||||GLDIGAAB|GLIADIN IGA ANTIBODY|||||||WEBER|||||||INDETERMINATE||ML/KG/MIN||||NORMAL|NOT DONE||||GASTRIC CONTENTS|ICTERIC|Y|TURBIDIMETRY|CKD-EPI CREATININE FORMULA||U|Y|U|Y|||NA|3||39||BASELINE|1964-07-05|1970-11-27|||||1966-03-08||1967-01-07|NA|1964-09-20
TRIAL STUDY 134XCP|LB|4265CC9E-26AF-4A14-B9AA-04A246E2523C|2||||ODMTASE|O-DEMETHYLASE|||||||PHERESIS UNIT|||||||POSITIVE||MG/H||||NORMAL|NOT DONE||||SERUM OR PLASMA|PARAFFIN-EMBEDDED|U|WRIGHT-GIEMSA STAIN|FIBROTEST FORMULA||Y|NA|N|U|||Y|3||39||WASHOUT|1965-10-05|1963-12-01|||||1969-08-11||1973-05-06|N|1970-08-09
TRIAL STUDY 134XCP|LB|4265CC9E-26AF-4A14-B9AA-04A246E2523C|1||||CD161ALY|CD161A/LYMPHOCYTES|||||||OZ EQ|||||||TRACE||CMHG||||NORMAL|NOT DONE||||EXPIRED AIR|ICTERIC|N|NEXT GENERATION SEQUENCING|GMI MMOL/MOL FORMULA||N|Y|NA|Y|||Y|4||88||CONTINUATION TREATMENT|1972-06-30|1972-10-06|||||1962-05-30||1970-01-29|NA|1969-01-16
TRIAL STUDY 134XCP|LB|4265CC9E-26AF-4A14-B9AA-04A246E2523C|2||||CELLSIM|IMMATURE CELLS|||||||TUBERCULIN UNIT|||||||INDETERMINATE||ML/SEC/1.73M2||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|FROZEN|N|ATOMIC ABSORPTION SPECTROMETRY|GMI % FORMULA||NA|Y|U|U|||Y|4||88||OPEN LABEL TREATMENT|1971-08-11|1972-04-23|||||1963-10-01||1964-12-24|NA|1964-01-19
TRIAL STUDY 134XCP|LB|4265CC9E-26AF-4A14-B9AA-04A246E2523C|1||||C165908|ANIMAL MIX IGG AB RAST SCORE|||||||MM/SEC|||||||INDETERMINATE||APL U||||HIGH|NOT DONE||||SOFT TISSUE|DRIED|U|POTENTIOMETRY|CKD-EPI FORMULA||U|U|U|N|||U|5||7||TREATMENT|1971-12-02|1972-05-04|||||1972-12-14||1969-08-05|Y|1967-08-09
TRIAL STUDY 134XCP|LB|4265CC9E-26AF-4A14-B9AA-04A246E2523C|2||||NEUTSGBP|NEUTROPHILS, SEG + BAND FORM + PRECURSOR|||||||KDA|||||||INDETERMINATE||G/M2||||LOW|NOT DONE||||COLOSTRUM|CALCIFIED|U|MULTIPLE BREATH WASHOUT|CKD-EPI FORMULA||U|Y|Y|Y|||U|5||7||RUN-IN|1971-07-26|1972-03-15|||||1967-06-25||1970-11-22|N|1962-03-17
TRIAL STUDY 134XCP|LB|96F268D3-7441-415C-95C9-A6B70C1718D5|1||||C165892|WILD RYE POLLEN IGE ANTIBODY|||||||MM3/MM2/YEAR|||||||NEGATIVE||NSEC||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|CALCIFIED|U|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|FIBROSIS 4 FORMULA||Y|N|U|U|||N|1||38||SCREENING|1961-06-17|1971-08-26|||||1964-12-03||1972-01-24|N|1962-06-05
TRIAL STUDY 134XCP|LB|96F268D3-7441-415C-95C9-A6B70C1718D5|2||||C165934|ARACHIS HYPOGAEA IGE AB RAST SCORE|||||||GTT|||||||NEGATIVE||MMHG/L/MIN||||LOW|NOT DONE||||PERSPIRATION|CLOTTED|NA|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|FIBROMETER FORMULA||NA|NA|U|N|||N|1||38||FOLLOW-UP|1972-09-07|1972-11-08|||||1962-08-19||1962-09-03|Y|1970-05-05
TRIAL STUDY 134XCP|LB|96F268D3-7441-415C-95C9-A6B70C1718D5|1||||FVAAC|FACTOR V ACTIVITY ACTUAL/CONTROL|||||||KHZ|||||||POSITIVE||MG/L||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|NON-HEMOLYZED|U|CONTRAST ENHANCED PET/CT SCAN|ASH FIBROSURE FORMULA||U|Y|N|N|||N|2||58||LONG-TERM FOLLOW-UP|1961-11-07|1968-08-11|||||1969-09-10||1966-10-08|U|1968-06-09
TRIAL STUDY 134XCP|LB|96F268D3-7441-415C-95C9-A6B70C1718D5|2||||CXCL1|CHEMOKINE (C-X-C MOTIF) LIGAND 1|||||||MOSM/KG|||||||INVALID||CONTAINER||||LOW|NOT DONE||||ERYTHROCYTES|FRESH|N|SNP ARRAY|HEPASCORE FORMULA||U|U|N|U|||NA|2||58||BASELINE|1964-12-11|1961-03-23|||||1969-01-17||1970-07-09|NA|1965-06-03
TRIAL STUDY 134XCP|LB|96F268D3-7441-415C-95C9-A6B70C1718D5|1||||CPB2|CARBOXYPEPTIDASE B2|||||||MMHG/SEC|||||||INVALID||L/MIN/M2||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|LIPEMIC|U|AGAR DILUTION|HEPASCORE FORMULA||NA|NA|NA|N|||Y|3||39||CONTINUATION TREATMENT|1967-05-08|1963-09-16|||||1962-11-27||1963-09-07|Y|1964-07-27
TRIAL STUDY 134XCP|LB|96F268D3-7441-415C-95C9-A6B70C1718D5|2||||PMYCECE|PROLIFERATING MYELOID CELLS/TOTAL CELLS|||||||PATCH|||||||POSITIVE||CMOL||||HIGH|NOT DONE||||URINE SEDIMENT|CONCENTRATED|NA|WESTERN BLOT|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|N|||U|3||39||CONTINUATION TREATMENT|1968-08-06|1971-08-03|||||1965-10-27||1960-05-05|N|1961-05-06
TRIAL STUDY 134XCP|LB|96F268D3-7441-415C-95C9-A6B70C1718D5|1||||DALA|DELTA AMINOLEVULINATE|||||||MU/L|||||||TRACE||UG/CM2||||NORMAL|NOT DONE||||CAPILLARY PLASMA|FRESH|U|PHOTOMETRY|COCKCROFT-GAULT FORMULA||Y|NA|NA|N|||N|4||88||TREATMENT|1971-08-22|1960-11-30|||||1968-07-05||1973-02-21|N|1965-07-22
TRIAL STUDY 134XCP|LB|96F268D3-7441-415C-95C9-A6B70C1718D5|2||||MYCEMPOL|MYELOID MATURATION POOL|||||||L/MIN/M2|||||||NEGATIVE||RPM||||HIGH|NOT DONE||||SWABBED MATERIAL|GELLED|NA|SPIROMETRY|GMI % FORMULA||NA|U|N|NA|||Y|4||88||RUN-IN|1960-12-04|1972-07-26|||||1969-03-31||1960-04-26|U|1960-02-25
TRIAL STUDY 134XCP|LB|96F268D3-7441-415C-95C9-A6B70C1718D5|1||||FACTVIII|FACTOR VIII|||||||PA|||||||TRACE||UG/G/DAY||||HIGH|NOT DONE||||BONE|CLOTTED|U|NON-INVASIVE DIELECTRIC SENSING|GMI % FORMULA||U|N|N|NA|||N|5||7||RUN-IN|1972-04-21|1961-12-07|||||1962-09-11||1969-04-09|Y|1969-03-24
TRIAL STUDY 134XCP|LB|96F268D3-7441-415C-95C9-A6B70C1718D5|2||||C130139|AMERICAN COCKROACH ANTIGEN IGG4 ANTIBODY|||||||/HPF|||||||BORDERLINE||BQ/KG||||LOW|NOT DONE||||BASAL TEAR|CONCENTRATED|U|CELLULAR PROLIFERATION ASSAY|COCKCROFT-GAULT FORMULA||N|N|Y|U|||N|5||7||LONG-TERM FOLLOW-UP|1963-02-23|1972-04-16|||||1963-12-01||1965-01-23|NA|1970-04-18
TRIAL STUDY 134XCP|LB|15D32D1F-AEE2-474C-956E-461FB087D7B0|1||||TRYPSIN|TRYPSIN|||||||PELLET|||||||TRACE||MS2||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED|U|PEAK FLOWMETRY|NASH FIBROSURE FORMULA||NA|Y|NA|U|||Y|1||38||INDUCTION TREATMENT|1972-07-29|1969-06-18|||||1970-08-19||1961-08-03|Y|1973-03-12
TRIAL STUDY 134XCP|LB|15D32D1F-AEE2-474C-956E-461FB087D7B0|2||||DZPM|DIAZEPAM|||||||UOSM|||||||BORDERLINE||UG/L/H||||NORMAL|NOT DONE||||SYNOVIAL FLUID|DRIED|N|ELASTOGRAPHY|COCKCROFT-GAULT FORMULA||N|NA|U|U|||NA|1||38||LONG-TERM FOLLOW-UP|1963-12-10|1971-03-28|||||1965-05-03||1973-04-17|U|1960-08-11
TRIAL STUDY 134XCP|LB|15D32D1F-AEE2-474C-956E-461FB087D7B0|1||||SODMEXR|SODIUM EXCRETION RATE|||||||BAU|||||||NEGATIVE||WEBER||||LOW|NOT DONE||||EXPIRED AIR|AGGLUTINATED|Y|ROMANOWSKY STAIN|MDRD FORMULA||N|NA|N|N|||Y|2||58||OPEN LABEL TREATMENT|1968-06-06|1962-05-24|||||1972-09-27||1973-03-07|Y|1973-02-22
TRIAL STUDY 134XCP|LB|15D32D1F-AEE2-474C-956E-461FB087D7B0|2||||GFRBSA|GLOMERULAR FILTRATION RATE ADJ FOR BSA|||||||FL|||||||NEGATIVE||LOG10 TCID 50/DOSE||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|FROZEN|N|MICRODENSITOMETRY|NASH FIBROSURE FORMULA||Y|NA|NA|NA|||N|2||58||RUN-IN|1963-10-12|1967-11-05|||||1969-12-17||1966-04-20|N|1965-09-04
TRIAL STUDY 134XCP|LB|15D32D1F-AEE2-474C-956E-461FB087D7B0|1||||C147276|ARACHIS HYPOGAEA ANTIGEN IGE ANTIBODY|||||||L|||||||INDETERMINATE||GRAVITATIONAL UNIT||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|CONTAMINATED|N|BIOIMPEDANCE SPECTROSCOPY|COCKCROFT-GAULT FORMULA||Y|Y|U|N|||N|3||39||TREATMENT|1965-11-06|1969-09-04|||||1973-03-07||1969-01-01|Y|1968-03-31
TRIAL STUDY 134XCP|LB|15D32D1F-AEE2-474C-956E-461FB087D7B0|2||||INTLK3|INTERLEUKIN 3|||||||UIU/L|||||||INVALID||STEPS||||HIGH|NOT DONE||||PLATELET|DRIED|Y|ELECTROGASTROGRAPHY|FIBROSIS 4 FORMULA||U|NA|Y|Y|||Y|3||39||OPEN LABEL TREATMENT|1961-04-20|1964-10-31|||||1969-03-17||1972-12-11|U|1969-12-24
TRIAL STUDY 134XCP|LB|15D32D1F-AEE2-474C-956E-461FB087D7B0|1||||C130070|BERMUDA GRASS POLLEN IGG|||||||UGEQ/L|||||||TRACE||VG/KG||||NORMAL|NOT DONE||||AMNIOTIC FLUID|CONCENTRATED|NA|ULTRASOUND|CKD-EPI FORMULA||Y|NA|NA|NA|||Y|4||88||FOLLOW-UP|1971-03-04|1962-03-11|||||1964-01-30||1961-11-01|N|1960-02-18
TRIAL STUDY 134XCP|LB|15D32D1F-AEE2-474C-956E-461FB087D7B0|2||||ALS|ACID LABILE SUBUNIT|||||||TRANSDUCING UNIT/ML|||||||INDETERMINATE||/40 HPFS||||HIGH|NOT DONE||||SERUM OR PLASMA|HEMOLYZED|Y|MICROBIAL CULTURE, SOLID|COCKCROFT-GAULT FORMULA||Y|NA|N|N|||Y|4||88||OBSERVATION|1971-08-19|1970-12-22|||||1968-10-04||1967-04-06|Y|1967-06-01
TRIAL STUDY 134XCP|LB|15D32D1F-AEE2-474C-956E-461FB087D7B0|1||||SECRETIN|SECRETIN|||||||BQ|||||||INVALID||NSEC||||HIGH|NOT DONE||||VENOUS PLASMA|FROZEN|N|SINGLE-MOLECULE ARRAY|FIBROSIS 4 FORMULA||U|Y|N|Y|||Y|5||7||CONTINUATION TREATMENT|1963-08-12|1972-03-14|||||1971-12-25||1964-10-13|U|1970-09-08
TRIAL STUDY 134XCP|LB|15D32D1F-AEE2-474C-956E-461FB087D7B0|2||||ALTCPHRL|ALPHA TOCOPHEROL|||||||CP|||||||POSITIVE||DB||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|DRIED|U|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||N|NA|NA|NA|||Y|5||7||SCREENING|1971-12-30|1965-02-03|||||1963-06-16||1961-10-16|Y|1962-03-21
TRIAL STUDY 134XCP|LB|DB42C81A-D644-455D-9D95-42131EF2BFE5|1||||AAMBTAC|ALPHA-AMINOBUTYRIC ACID|||||||UM/S|||||||INVALID||/SEC||||LOW|NOT DONE||||INFRANATANT, SERUM|AGGLUTINATED|NA|RAJI CELL RIA|MDRD 5 VARIABLE FORMULA||NA|N|U|NA|||N|1||38||OBSERVATION|1960-04-07|1967-10-17|||||1962-08-11||1966-03-28|U|1962-10-05
TRIAL STUDY 134XCP|LB|DB42C81A-D644-455D-9D95-42131EF2BFE5|2||||S6PHS|PHOS-S6 RIBOSOMAL PROTEIN|||||||U/G/MIN|||||||INVALID||DISK||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|NON-HEMOLYZED|N|KINETIC CHROMOGENIC ASSAY|CKD-EPI FORMULA||N|NA|Y|NA|||N|1||38||RUN-IN|1970-01-21|1967-07-01|||||1968-09-08||1963-11-30|U|1962-08-29
TRIAL STUDY 134XCP|LB|DB42C81A-D644-455D-9D95-42131EF2BFE5|1||||GLDH|GLUTAMATE DEHYDROGENASE|||||||UMOL/L/MIN|||||||TRACE||NMOL/L/H||||NORMAL|NOT DONE||||PUS|PARAFFIN-EMBEDDED|Y|ELASTOGRAPHY|MDRD 5 VARIABLE FORMULA||U|N|N|U|||U|2||58||SCREENING|1971-01-19|1973-08-03|||||1966-03-06||1967-03-28|U|1964-04-22
TRIAL STUDY 134XCP|LB|DB42C81A-D644-455D-9D95-42131EF2BFE5|2||||ERCENC|ERYTHROID CELLS/NUCLEATED CELLS|||||||MG/M2|||||||INVALID||KS||||LOW|NOT DONE||||INFRANATANT, PLASMA|PARAFFIN-EMBEDDED|U|COMPLEMENT FIXATION|MDRD 4 VARIABLE FORMULA||N|N|U|NA|||N|2||58||CONTINUATION TREATMENT|1966-08-28|1965-07-28|||||1961-04-30||1972-07-12|N|1968-03-05
TRIAL STUDY 134XCP|LB|DB42C81A-D644-455D-9D95-42131EF2BFE5|1||||C130068|BERMUDA GRASS POLLEN IGE|||||||KUSP|||||||NEGATIVE||UG/KG/MIN||||LOW|NOT DONE||||PERITONEAL FLUID|HEMOLYZED|Y|QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROMETER FORMULA||N|Y|U|Y|||NA|3||39||FOLLOW-UP|1973-03-20|1960-04-13|||||1964-11-22||1965-02-19|N|1968-10-21
TRIAL STUDY 134XCP|LB|DB42C81A-D644-455D-9D95-42131EF2BFE5|2||||CACRALB|CALCIUM CORRECTED FOR ALBUMIN|||||||GRAVITATIONAL UNIT|||||||INDETERMINATE||CPM||||LOW|NOT DONE||||DIALYSIS FLUID|CONTAMINATED|NA|IMMUNOASSAY|CKD-EPI CREATININE FORMULA||N|Y|U|N|||N|3||39||BASELINE|1967-03-28|1967-11-11|||||1972-09-20||1961-12-28|Y|1970-04-23
TRIAL STUDY 134XCP|LB|DB42C81A-D644-455D-9D95-42131EF2BFE5|1||||GDIGA1|GALACTOSE-DEFICIENT IGA1|||||||10^9 ORGANISMS/G|||||||POSITIVE||UL/KG/DAY||||LOW|NOT DONE||||MECONIUM|PARAFFIN-EMBEDDED|N|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|FIBROMETER FORMULA||N|NA|NA|Y|||Y|4||88||LONG-TERM FOLLOW-UP|1961-03-04|1961-09-14|||||1971-11-09||1964-11-01|Y|1967-05-09
TRIAL STUDY 134XCP|LB|DB42C81A-D644-455D-9D95-42131EF2BFE5|2||||VEGFD|VASCULAR ENDOTHELIAL GROWTH FACTOR D|||||||UG/M2/DAY|||||||NEGATIVE||WEEKS||||ABNORMAL|NOT DONE||||SPUTUM|SOLIDIFIED|U|PYROSEQUENCING|NASH FIBROSURE FORMULA||N|NA|Y|U|||NA|4||88||SCREENING|1961-03-30|1971-08-11|||||1962-08-24||1963-09-13|Y|1961-04-23
TRIAL STUDY 134XCP|LB|DB42C81A-D644-455D-9D95-42131EF2BFE5|1||||NOREPIN|NOREPINEPHRINE|||||||HEP|||||||INDETERMINATE||MIN||||HIGH|NOT DONE||||CAPILLARY BLOOD|ICTERIC|N|COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD FORMULA||Y|NA|NA|N|||N|5||7||OPEN LABEL TREATMENT|1970-09-01|1971-07-22|||||1972-04-18||1965-03-31|U|1967-02-09
TRIAL STUDY 134XCP|LB|DB42C81A-D644-455D-9D95-42131EF2BFE5|2||||CD163S|SOLUBLE CD163|||||||G/CAGE|||||||TRACE||10^3 CFU/G||||LOW|NOT DONE||||BILE|CLOTTED|Y|HPLC-UV|MDRD 6 VARIABLE FORMULA||U|NA|NA|NA|||NA|5||7||OBSERVATION|1966-10-01|1965-04-10|||||1966-09-25||1963-01-04|N|1961-01-25
TRIAL STUDY 134XCP|LB|4B01CC59-51D3-4499-9AB1-DF446006CB8D|1||||GRANCE|GRANULOCYTES/TOTAL CELLS|||||||AMPULE|||||||NEGATIVE||10^4 CFU/ML||||NORMAL|NOT DONE||||NAIL|FROZEN|N|HANSEL STAIN|FIBROSIS 4 FORMULA||N|U|NA|NA|||NA|1||38||TREATMENT|1964-05-22|1964-02-29|||||1962-04-09||1968-08-31|Y|1972-07-06
TRIAL STUDY 134XCP|LB|4B01CC59-51D3-4499-9AB1-DF446006CB8D|2||||IC512AG|ISLET CELL 512 ANTIGEN|||||||CY/CM|||||||BORDERLINE||KG/MOL||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|CONTAMINATED|N|LC-FL|CKD-EPI CREATININE FORMULA||Y|U|N|N|||N|1||38||FOLLOW-UP|1970-09-23|1965-08-01|||||1973-09-07||1966-01-14|U|1963-03-17
TRIAL STUDY 134XCP|LB|4B01CC59-51D3-4499-9AB1-DF446006CB8D|1||||GLBCREAT|GLOBULIN/CREATININE|||||||U/G/DAY|||||||INVALID||NEBULE||||HIGH|NOT DONE||||SEBUM|CLOTTED|N|KINETIC MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|Y|N|||U|2||58||OBSERVATION|1971-01-31|1969-02-03|||||1973-08-28||1972-10-18|U|1968-02-09
TRIAL STUDY 134XCP|LB|4B01CC59-51D3-4499-9AB1-DF446006CB8D|2||||CD8LY|CD8/LYMPHOCYTES|||||||10^6 CFU|||||||POSITIVE||G/M2/DAY||||HIGH|NOT DONE||||FLUID|ROOM TEMPERATURE|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|U|U|||NA|2||58||RUN-IN|1966-09-08|1966-05-07|||||1963-12-21||1966-02-24|Y|1960-08-07
TRIAL STUDY 134XCP|LB|4B01CC59-51D3-4499-9AB1-DF446006CB8D|1||||FLUVOXAM|FLUVOXAMINE|||||||CUP EQ|||||||INDETERMINATE||BOX||||HIGH|NOT DONE||||CORD BLOOD|CLOTTED|U|TEMPLATE INCISION METHOD|CKD-EPI FORMULA||N|N|Y|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1972-02-01|1973-08-26|||||1965-09-08||1970-04-11|Y|1963-05-03
TRIAL STUDY 134XCP|LB|4B01CC59-51D3-4499-9AB1-DF446006CB8D|2||||TPROTP|PHOSPHORYLATED TAU PROTEIN|||||||ECL UNIT|||||||NEGATIVE||ELISA UNIT/DOSE||||NORMAL|NOT DONE||||TUMOR TISSUE|CALCIFIED|NA|DIRECT SEQUENCING|CKD-EPI CYSTATIN C FORMULA||N|N|U|N|||Y|3||39||BASELINE|1972-07-14|1963-12-05|||||1966-09-15||1971-07-10|N|1965-04-15
TRIAL STUDY 134XCP|LB|4B01CC59-51D3-4499-9AB1-DF446006CB8D|1||||CD8|CD8|||||||NL|||||||TRACE||UGEQ/L||||ABNORMAL|NOT DONE||||VENOUS PLASMA|AUTOLYZED|NA|APPLANATION TONOMETRY|GMI MMOL/MOL FORMULA||Y|NA|NA|Y|||N|4||88||WASHOUT|1971-03-18|1971-04-01|||||1967-09-27||1971-08-03|Y|1973-03-23
TRIAL STUDY 134XCP|LB|4B01CC59-51D3-4499-9AB1-DF446006CB8D|2||||TGLOB|THYROGLOBULIN|||||||SCM|||||||INDETERMINATE||UG/M2/MIN||||HIGH|NOT DONE||||HAIR FOLLICLE|CALCIFIED|U|OSCILLOMETRY|NASH FIBROSURE FORMULA||U|Y|U|U|||N|4||88||BLINDED TREATMENT|1967-02-16|1972-04-29|||||1967-04-11||1962-11-21|N|1968-09-04
TRIAL STUDY 134XCP|LB|4B01CC59-51D3-4499-9AB1-DF446006CB8D|1||||LSELS|SOLUBLE L-SELECTIN|||||||10^3 ORGANISMS/ML|||||||POSITIVE||%/S||||HIGH|NOT DONE||||BREAST MILK|AGGLUTINATED|N|MUGA|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|Y|||U|5||7||RUN-IN|1960-09-06|1972-11-20|||||1964-02-21||1970-01-05|Y|1969-03-20
TRIAL STUDY 134XCP|LB|4B01CC59-51D3-4499-9AB1-DF446006CB8D|2||||HISTAMIN|HISTAMINE|||||||MU|||||||INVALID||/100 HPFS||||ABNORMAL|NOT DONE||||SPUTUM|LIPEMIC|NA|ENZYMATIC ULTRACENTRIFUGATION|MDRD FORMULA||N|N|NA|N|||NA|5||7||OPEN LABEL TREATMENT|1967-03-14|1960-09-22|||||1962-01-24||1965-02-10|NA|1972-10-26
TRIAL STUDY 134XCP|LB|B69774FC-1151-45DD-B329-6C21C2F29603|1||||VLDLPSZ|VLDL PARTICLE SIZE|||||||EID 50/ML|||||||POSITIVE||MG/M2||||LOW|NOT DONE||||EPIDERMAL TISSUE|SOLIDIFIED|Y|SCANNING ELECTRON MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|NA|Y|||NA|1||38||OBSERVATION|1972-04-10|1967-10-23|||||1964-07-19||1962-09-15|N|1961-12-04
TRIAL STUDY 134XCP|LB|B69774FC-1151-45DD-B329-6C21C2F29603|2||||INTLK1A|INTERLEUKIN 1 ALPHA|||||||LOG10 CCID 50/DOSE|||||||POSITIVE||UV||||ABNORMAL|NOT DONE||||REFLEX TEAR|UNEXPECTED ODOR|U|TEMPLATE INCISION METHOD|CKD-EPI FORMULA||NA|U|N|NA|||Y|1||38||FOLLOW-UP|1965-02-26|1960-03-11|||||1972-03-06||1968-04-19|Y|1969-05-13
TRIAL STUDY 134XCP|LB|B69774FC-1151-45DD-B329-6C21C2F29603|1||||C130135|D. PTERONYSSINUS ANTIGEN IGG ANTIBODY|||||||UV*SEC|||||||INVALID||ML/G/MIN||||LOW|NOT DONE||||PUS|CONTAMINATED|N|DARK FIELD MICROSCOPY|ASH FIBROSURE FORMULA||Y|N|NA|Y|||NA|2||58||TREATMENT|1970-07-21|1971-12-26|||||1967-11-13||1972-02-12|U|1962-02-22
TRIAL STUDY 134XCP|LB|B69774FC-1151-45DD-B329-6C21C2F29603|2||||MPO|MYELOPEROXIDASE|||||||/100 WBC|||||||TRACE||MKAT||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|PARAFFIN-EMBEDDED|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|FIBROSIS 4 FORMULA||U|NA|Y|NA|||U|2||58||CONTINUATION TREATMENT|1972-04-11|1971-07-30|||||1967-08-29||1967-01-09|N|1964-04-23
TRIAL STUDY 134XCP|LB|B69774FC-1151-45DD-B329-6C21C2F29603|1||||LTF|LACTOFERRIN|||||||MESF|||||||POSITIVE||DNA COPIES/ML||||LOW|NOT DONE||||PLATELET POOR PLASMA|LACTESCENT|Y|QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROTEST FORMULA||NA|N|N|N|||NA|3||39||BASELINE|1965-12-28|1962-03-20|||||1962-01-21||1971-01-14|Y|1970-10-07
TRIAL STUDY 134XCP|LB|B69774FC-1151-45DD-B329-6C21C2F29603|2||||MGB|MYOGLOBIN|||||||/DAY|||||||BORDERLINE||/KG||||NORMAL|NOT DONE||||VITREOUS HUMOR|NON-HEMOLYZED|NA|SNELLEN EYE CHART|CKD-EPI FORMULA||Y|Y|NA|Y|||Y|3||39||TREATMENT|1965-07-22|1965-12-14|||||1970-06-22||1968-10-23|NA|1966-12-16
TRIAL STUDY 134XCP|LB|B69774FC-1151-45DD-B329-6C21C2F29603|1||||CXCL12|CHEMOKINE (C-X-C MOTIF) LIGAND 12|||||||CFU/ML|||||||TRACE||CFU/ML||||NORMAL|NOT DONE||||DERMAL TISSUE|HEMOLYZED|Y|MICROARRAY|ASH FIBROSURE FORMULA||Y|Y|NA|NA|||NA|4||88||SCREENING|1960-05-11|1965-10-10|||||1962-09-26||1962-12-05|U|1968-10-12
TRIAL STUDY 134XCP|LB|B69774FC-1151-45DD-B329-6C21C2F29603|2||||NEUTSG|NEUTROPHILS, SEGMENTED|||||||10^6/L|||||||NEGATIVE||BREATHS/MIN||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|AUTOLYZED|N|CELLULAR PROLIFERATION ASSAY|FIBROMETER FORMULA||Y|NA|U|NA|||U|4||88||TREATMENT|1967-08-17|1963-01-21|||||1962-05-29||1972-09-20|N|1968-09-16
TRIAL STUDY 134XCP|LB|B69774FC-1151-45DD-B329-6C21C2F29603|1||||NDMTASE|N-DEMETHYLASE|||||||OI50|||||||NEGATIVE||KUSP||||NORMAL|NOT DONE||||BONE|AGGLUTINATED|N|KLEIHAUER-BETKE|NASH FIBROSURE FORMULA||N|N|NA|NA|||NA|5||7||FOLLOW-UP|1964-09-26|1963-05-26|||||1962-05-28||1971-05-07|N|1960-03-15
TRIAL STUDY 134XCP|LB|B69774FC-1151-45DD-B329-6C21C2F29603|2||||MMP7|MATRIX METALLOPROTEINASE 7|||||||MOL/ML|||||||TRACE||NMOL/MOL||||ABNORMAL|NOT DONE||||PLATELET|FRESH|Y|KINETIC MICROPARTICLE IMMUNOASSAY|HEPASCORE FORMULA||NA|Y|U|N|||NA|5||7||INDUCTION TREATMENT|1973-08-11|1969-11-23|||||1963-10-15||1965-02-15|Y|1970-08-23
TRIAL STUDY 134XCP|LB|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|1||||ANDSTNDL|ANDROSTENEDIOL|||||||MOL/ML|||||||INDETERMINATE||ELISA UNIT/ML||||LOW|NOT DONE||||CEREBROSPINAL FLUID|REFRIGERATED|N|NEURAMINIDASE INHIBITION ASSAY|FIBROTEST FORMULA||Y|NA|Y|Y|||Y|1||38||LONG-TERM FOLLOW-UP|1961-01-22|1970-08-09|||||1973-07-13||1973-04-12|NA|1971-06-08
TRIAL STUDY 134XCP|LB|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|2||||PERIOSTN|PERIOSTIN|||||||FRACTION OF 1|||||||TRACE||DEG/S||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|ICTERIC|Y|RIA|MDRD 4 VARIABLE FORMULA||N|N|NA|Y|||Y|1||38||SCREENING|1963-06-22|1972-07-03|||||1969-02-16||1961-10-17|Y|1960-03-02
TRIAL STUDY 134XCP|LB|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|1||||MYCEPIDX|MYELOID PROLIFERATION INDEX|||||||ML/CM H2O|||||||INVALID||DYN||||HIGH|NOT DONE||||KERATINOCYTE|LACTESCENT|U|CARDIAC THERMODILUTION|GMI MMOL/MOL FORMULA||NA|NA|U|Y|||U|2||58||OPEN LABEL TREATMENT|1969-02-08|1964-08-30|||||1971-08-03||1960-10-30|U|1963-10-19
TRIAL STUDY 134XCP|LB|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|2||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||10^3 ORGANISMS/ML|||||||NEGATIVE||MV||||NORMAL|NOT DONE||||NAIL|CONTAMINATED|NA|CONTRAST ENHANCED CT SCAN|MDRD 5 VARIABLE FORMULA||NA|U|U|Y|||N|2||58||OPEN LABEL TREATMENT|1973-02-05|1960-06-22|||||1965-05-09||1970-08-23|Y|1971-09-30
TRIAL STUDY 134XCP|LB|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|1||||MCPHGLE|MACROPHAGES/LEUKOCYTES|||||||DNA COPIES/UG|||||||INDETERMINATE||UEQ/L||||LOW|NOT DONE||||CAPILLARY PLASMA|FROZEN|U|IMMUNOCHROMATOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|U|||N|3||39||OPEN LABEL TREATMENT|1967-04-09|1964-09-03|||||1969-07-25||1964-06-22|Y|1968-12-21
TRIAL STUDY 134XCP|LB|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|2||||BICARB|BICARBONATE|||||||ARBITRARY U|||||||BORDERLINE||10^3 RNA COPIES/ML||||NORMAL|NOT DONE||||EXUDATE|ICTERIC|NA|MANUAL CLOT DETECTION|COCKCROFT-GAULT FORMULA||N|NA|NA|Y|||Y|3||39||INDUCTION TREATMENT|1962-07-28|1962-04-25|||||1972-06-10||1972-02-22|U|1970-09-30
TRIAL STUDY 134XCP|LB|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|1||||EOSIMLE|IMMATURE EOSINOPHILS/LEUKOCYTES|||||||BREATHS/30S|||||||BORDERLINE||/SEC||||HIGH|NOT DONE||||BONE|HEMOLYZED|Y|ELECTRONEUROGRAPHY|MDRD 4 VARIABLE FORMULA||N|Y|NA|N|||NA|4||88||SCREENING|1971-08-21|1965-06-21|||||1963-05-10||1960-06-04|NA|1960-02-08
TRIAL STUDY 134XCP|LB|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|2||||C130077|SILVER BIRCH POLLEN IGA|||||||PPTH|||||||INVALID||ML/M2||||HIGH|NOT DONE||||LOCHIA|HEMOLYZED|N|GC/MS-CI|MDRD 4 VARIABLE FORMULA||U|NA|U|U|||U|4||88||TREATMENT|1970-02-23|1968-08-08|||||1960-04-26||1969-12-06|Y|1973-09-07
TRIAL STUDY 134XCP|LB|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|1||||FLT3L|FMS-LIKE TYROSINE KINASE 3 LIGAND|||||||BEL|||||||NEGATIVE||AFU||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|HEMOLYZED|Y|CONTRAST ENHANCED CT SCAN|MDRD FORMULA||NA|U|NA|NA|||Y|5||7||BLINDED TREATMENT|1963-09-07|1969-02-23|||||1970-09-15||1963-11-28|Y|1961-07-27
TRIAL STUDY 134XCP|LB|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|2||||BLSTRSID|RINGED SIDEROBLASTS|||||||KPA/L/SEC|||||||BORDERLINE||WAFER||||LOW|NOT DONE||||EXUDATE|CONCENTRATED|U|NO INFORMATION|MDRD 6 VARIABLE FORMULA||NA|Y|NA|Y|||Y|5||7||INDUCTION TREATMENT|1972-02-24|1970-10-30|||||1962-11-23||1960-10-27|Y|1960-03-08
TRIAL STUDY 134XCP|LB|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|1||||C165876|BIRCH POLLEN IGE AB RAST SCORE|||||||CMH2O*S/ML|||||||TRACE||TORR||||NORMAL|NOT DONE||||DISCHARGE|CALCIFIED|U|ELECTROPHORESIS|NASH FIBROSURE FORMULA||N|N|N|NA|||N|1||38||BASELINE|1966-10-25|1973-02-22|||||1963-04-13||1971-10-10|Y|1971-06-27
TRIAL STUDY 134XCP|LB|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|2||||C165893|WILD RYE POLLEN IGE AB RAST SCORE|||||||USIEMENS|||||||TRACE||OI50||||HIGH|NOT DONE||||EXPIRED AIR|AGGLUTINATED|N|SINGLE-MOLECULE ARRAY|FIBROMETER FORMULA||N|U|U|Y|||U|1||38||BASELINE|1960-12-18|1961-01-08|||||1973-03-09||1970-07-25|U|1966-11-12
TRIAL STUDY 134XCP|LB|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|1||||UREAN|UREA NITROGEN|||||||KG/CM|||||||BORDERLINE||MG/L||||HIGH|NOT DONE||||DERMAL TISSUE|PARAFFIN-EMBEDDED|N|ETDRS EYE CHART|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|U|N|||Y|2||58||TREATMENT|1972-01-18|1968-02-22|||||1960-03-11||1970-07-11|Y|1963-10-17
TRIAL STUDY 134XCP|LB|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|2||||TFERRIN|TRANSFERRIN|||||||ML/M2/DAY|||||||NEGATIVE||MMHG||||HIGH|NOT DONE||||TISSUE|ICTERIC|N|GC/MS|MDRD 6 VARIABLE FORMULA||NA|NA|Y|Y|||NA|2||58||BLINDED TREATMENT|1968-07-10|1971-08-16|||||1968-01-19||1968-10-17|Y|1964-06-25
TRIAL STUDY 134XCP|LB|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|1||||TNFSR|SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR|||||||MET|||||||INDETERMINATE||%(V/V)||||HIGH|NOT DONE||||INFRANATANT, SERUM|DRIED|NA|HPLC-UV|MDRD 4 VARIABLE FORMULA||N|N|Y|Y|||U|3||39||RUN-IN|1966-08-25|1970-08-06|||||1966-09-21||1964-05-06|NA|1962-11-19
TRIAL STUDY 134XCP|LB|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|2||||KERAT|KERATOCYTE|||||||PHERESIS UNIT|||||||NEGATIVE||MMOL/L||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|HEMOLYZED|N|FORCED OSCILLATION TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|NA|NA|||U|3||39||INDUCTION TREATMENT|1970-09-10|1963-06-25|||||1964-09-26||1968-11-13|NA|1973-04-16
TRIAL STUDY 134XCP|LB|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|1||||FACTX|FACTOR X|||||||PIXELS/CM|||||||INDETERMINATE||UG/M2||||LOW|NOT DONE||||COLOSTRUM|AUTOLYZED|N|FREEZING POINT DEPRESSION|HEPASCORE FORMULA||U|N|NA|Y|||U|4||88||FOLLOW-UP|1961-12-03|1968-03-03|||||1963-04-27||1961-10-13|Y|1969-08-20
TRIAL STUDY 134XCP|LB|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|2||||TESTOSWB|TESTOSTERONE, WEAKLY BOUND|||||||ROENTGEN|||||||TRACE||U/KG/H||||HIGH|NOT DONE||||ARTERIAL BLOOD|CALCIFIED|Y|MUGA|FIBROMETER FORMULA||U|U|NA|U|||U|4||88||WASHOUT|1971-02-06|1961-07-27|||||1961-01-16||1968-11-26|NA|1968-10-02
TRIAL STUDY 134XCP|LB|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|1||||PLAGGCVT|PLATELET AGGREGATION CURVE TYPE|||||||MG/DOSE|||||||TRACE||CYLINDER||||ABNORMAL|NOT DONE||||HAIR|CONCENTRATED|U|LYMPHANGIOGRAPHY|NASH FIBROSURE FORMULA||N|NA|Y|Y|||N|5||7||INDUCTION TREATMENT|1970-03-20|1967-06-18|||||1968-12-18||1962-01-17|NA|1972-03-17
TRIAL STUDY 134XCP|LB|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|2||||HEINZRBC|HEINZ BODIES/ERYTHROCYTES|||||||PG/CELL|||||||INDETERMINATE||MMAL||||LOW|NOT DONE||||VENOUS PLASMA|LIPEMIC|U|MRI|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|Y|N|||NA|5||7||SCREENING|1971-04-26|1972-12-30|||||1964-11-07||1969-11-26|Y|1960-12-02
TRIAL STUDY 134XCP|LB|674B4474-6D52-4DE2-8342-EDB28F577BB5|1||||C130137|AMERICAN COCKROACH ANTIGEN IGA ANTIBODY|||||||KIT|||||||INDETERMINATE||MET||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|HEMOLYZED|U|MAGNETIC RESONANCE ENTEROGRAPHY|ASH FIBROSURE FORMULA||Y|U|N|NA|||U|1||38||WASHOUT|1972-08-27|1971-05-31|||||1962-07-18||1967-07-19|NA|1964-10-14
TRIAL STUDY 134XCP|LB|674B4474-6D52-4DE2-8342-EDB28F577BB5|2||||FRFEABS|FRACTIONAL IRON ABSORPTION|||||||MN|||||||INVALID||NCI||||ABNORMAL|NOT DONE||||LEUKOCYTE|REFRIGERATED|NA|RYAN BLUE STAIN|MDRD FORMULA||N|U|U|NA|||N|1||38||CONTINUATION TREATMENT|1971-05-03|1968-10-23|||||1966-12-07||1965-09-03|U|1968-10-22
TRIAL STUDY 134XCP|LB|674B4474-6D52-4DE2-8342-EDB28F577BB5|1||||PROTS|PROTEIN S|||||||PRESSOR UNITS|||||||INVALID||KS||||NORMAL|NOT DONE||||LAVAGE FLUID|SOLIDIFIED|Y|RADIAL IMMUNODIFFUSION|MDRD FORMULA||NA|U|NA|NA|||U|2||58||INDUCTION TREATMENT|1967-04-08|1963-02-07|||||1963-04-29||1970-06-10|U|1964-07-08
TRIAL STUDY 134XCP|LB|674B4474-6D52-4DE2-8342-EDB28F577BB5|2||||RBCDYSM|DYSMORPHIC ERYTHROCYTES|||||||10^6 ORGANISMS/G|||||||INVALID||BAR||||NORMAL|NOT DONE||||SWABBED MATERIAL|NON-HEMOLYZED|N|IMMUNOFLUORESCENT STAIN|MDRD 5 VARIABLE FORMULA||NA|U|U|N|||N|2||58||SCREENING|1970-02-19|1967-03-24|||||1962-06-11||1969-03-14|U|1966-12-09
TRIAL STUDY 134XCP|LB|674B4474-6D52-4DE2-8342-EDB28F577BB5|1||||TRACP5B|TARTRATE-RESISTANT ACID PHOSPHATASE 5B|||||||NG/MOL|||||||INDETERMINATE||PMOL||||HIGH|NOT DONE||||HAIR FOLLICLE|LIPEMIC|U|KARYOTYPING|MDRD FORMULA||N|NA|U|NA|||Y|3||39||RUN-IN|1969-07-05|1972-09-17|||||1970-04-07||1962-08-21|U|1966-01-31
TRIAL STUDY 134XCP|LB|674B4474-6D52-4DE2-8342-EDB28F577BB5|2||||HALLUC|HALLUCINOGEN|||||||UGEQ/L|||||||NEGATIVE||FEU||||NORMAL|NOT DONE||||LYSATE|CONCENTRATED|NA|BIOIMPEDANCE SPECTROSCOPY|FIBROMETER FORMULA||N|NA|U|N|||NA|3||39||OBSERVATION|1973-04-30|1962-07-13|||||1964-04-12||1967-06-11|NA|1962-01-28
TRIAL STUDY 134XCP|LB|674B4474-6D52-4DE2-8342-EDB28F577BB5|1||||PHNBRBTL|PHENOBARBITAL|||||||BE/ML|||||||NEGATIVE||KPA||||ABNORMAL|NOT DONE||||BASAL TEAR|PARAFFIN-EMBEDDED|U|CLIP|MDRD 4 VARIABLE FORMULA||Y|N|N|N|||U|4||88||LONG-TERM FOLLOW-UP|1960-03-22|1961-09-29|||||1971-03-15||1970-05-14|N|1968-06-24
TRIAL STUDY 134XCP|LB|674B4474-6D52-4DE2-8342-EDB28F577BB5|2||||RBP|RETINOL BINDING PROTEIN|||||||LOG10 IU/ML|||||||NEGATIVE||VIAL||||NORMAL|NOT DONE||||SPUTUM|PARAFFIN-EMBEDDED|N|GC/MS-EI|MDRD 4 VARIABLE FORMULA||NA|U|U|N|||Y|4||88||FOLLOW-UP|1964-06-04|1960-06-05|||||1968-08-20||1968-09-17|NA|1961-10-15
TRIAL STUDY 134XCP|LB|674B4474-6D52-4DE2-8342-EDB28F577BB5|1||||DFI|DNA FRAGMENTATION INDEX|||||||SCOOPFUL|||||||TRACE||KG/CM2||||NORMAL|NOT DONE||||LAVAGE FLUID|LIPEMIC|N|TRICHROME STAIN|GMI MMOL/MOL FORMULA||N|Y|Y|NA|||NA|5||7||SCREENING|1960-05-02|1966-03-21|||||1962-05-20||1966-05-15|NA|1962-01-23
TRIAL STUDY 134XCP|LB|674B4474-6D52-4DE2-8342-EDB28F577BB5|2||||MMP2|MATRIX METALLOPROTEINASE 2|||||||ML/KG/H|||||||NEGATIVE||WATT||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|REFRIGERATED|U|WRIGHT STAIN|COCKCROFT-GAULT FORMULA||Y|N|Y|NA|||Y|5||7||FOLLOW-UP|1963-04-15|1968-05-04|||||1965-08-23||1963-12-20|NA|1963-02-25
TRIAL STUDY 134XCP|LB|AF634AD4-086A-47EE-A5DB-A4B6833356C7|1||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||TSP EQ|||||||INDETERMINATE||HOMEOPATHIC DILUTION||||LOW|NOT DONE||||EXPIRED AIR|CONCENTRATED|U|SPIRAL CT|FIBROTEST FORMULA||U|U|NA|Y|||N|1||38||OBSERVATION|1961-06-10|1961-05-13|||||1967-08-08||1969-12-16|NA|1968-02-15
TRIAL STUDY 134XCP|LB|AF634AD4-086A-47EE-A5DB-A4B6833356C7|2||||FXIVAAC|FACTOR XIV ACTIVITY ACTUAL/CONTROL|||||||GY|||||||TRACE||PUFF||||LOW|NOT DONE||||SOFT TISSUE|CALCIFIED|NA|KINETIC CHROMOGENIC ASSAY|CKD-EPI CYSTATIN C FORMULA||U|N|N|U|||Y|1||38||SCREENING|1964-11-12|1967-12-08|||||1972-05-18||1970-07-30|Y|1960-01-08
TRIAL STUDY 134XCP|LB|AF634AD4-086A-47EE-A5DB-A4B6833356C7|1||||ALBGLOB|ALBUMIN/GLOBULIN|||||||LOG10 PFU|||||||INDETERMINATE||MG/ML/DAY||||ABNORMAL|NOT DONE||||RETICULOCYTES|SOLIDIFIED|U|PULMONARY ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||NA|Y|NA|NA|||U|2||58||OBSERVATION|1964-10-28|1967-12-16|||||1960-08-22||1972-12-16|Y|1972-07-03
TRIAL STUDY 134XCP|LB|AF634AD4-086A-47EE-A5DB-A4B6833356C7|2||||HER2|HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2|||||||MEQ/DL|||||||INVALID||UL/ML||||HIGH|NOT DONE||||CELL PELLET|FRESH|N|BIOIMPEDANCE SPECTROSCOPY|FIBROSIS 4 FORMULA||U|NA|U|U|||N|2||58||INDUCTION TREATMENT|1962-07-23|1971-09-03|||||1965-11-08||1970-03-04|Y|1964-12-27
TRIAL STUDY 134XCP|LB|AF634AD4-086A-47EE-A5DB-A4B6833356C7|1||||C130085|ENGLISH PLANTAIN POLLEN IGA|||||||RAD|||||||NEGATIVE||CM2||||ABNORMAL|NOT DONE||||GASTRIC FLUID|ROOM TEMPERATURE|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|FIBROTEST FORMULA||N|Y|Y|NA|||NA|3||39||SCREENING|1964-10-28|1966-11-09|||||1967-04-16||1964-10-16|Y|1967-03-12
TRIAL STUDY 134XCP|LB|AF634AD4-086A-47EE-A5DB-A4B6833356C7|2||||NTELOP|N-TELOPEPTIDE|||||||UKAT/10^12 RBC|||||||BORDERLINE||CFU/ML||||LOW|NOT DONE||||SWABBED MATERIAL|NON-HEMOLYZED|Y|IMMUNOBLOT|MDRD FORMULA||NA|N|Y|Y|||U|3||39||CONTINUATION TREATMENT|1961-10-20|1971-03-27|||||1960-08-01||1965-03-06|Y|1966-07-07
TRIAL STUDY 134XCP|LB|AF634AD4-086A-47EE-A5DB-A4B6833356C7|1||||PAPPEN|PAPPENHEIMER BODIES|||||||IU|||||||INVALID||UM/DAY||||ABNORMAL|NOT DONE||||SPERMATOZOON|NON-HEMOLYZED|U|PHASE-CONTRAST MRI|MDRD 5 VARIABLE FORMULA||NA|Y|NA|U|||N|4||88||BLINDED TREATMENT|1971-04-12|1966-11-11|||||1967-12-26||1967-03-15|Y|1964-02-03
TRIAL STUDY 134XCP|LB|AF634AD4-086A-47EE-A5DB-A4B6833356C7|2||||SDH|SORBITOL DEHYDROGENASE|||||||ML/KG/H|||||||BORDERLINE||/5X10^4 WBC||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|REFRIGERATED|NA|POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|NA|||N|4||88||INDUCTION TREATMENT|1968-09-07|1970-11-25|||||1973-01-05||1971-01-21|Y|1969-05-10
TRIAL STUDY 134XCP|LB|AF634AD4-086A-47EE-A5DB-A4B6833356C7|1||||HAHA|HUMAN ANTI-HUMAN ANTIBODY|||||||ML/ANIMAL|||||||TRACE||MDFI||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|AGGLUTINATED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|FIBROSIS 4 FORMULA||Y|N|N|N|||NA|5||7||RUN-IN|1961-09-28|1968-05-16|||||1966-08-22||1965-07-31|N|1972-11-02
TRIAL STUDY 134XCP|LB|AF634AD4-086A-47EE-A5DB-A4B6833356C7|2||||AFPL1|ALPHA FETOPROTEIN L1|||||||U/M2/H|||||||INDETERMINATE||10^9/G||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|CONTAMINATED|N|SNELLEN EYE CHART|CKD-EPI CYSTATIN C FORMULA||Y|Y|NA|U|||N|5||7||FOLLOW-UP|1969-11-14|1968-06-23|||||1968-05-03||1967-08-05|Y|1968-07-23
TRIAL STUDY 134XCP|LB|89298058-EB86-4892-97D6-1B87277DF7FC|1||||HBA2PHB|HEMOGLOBIN A2 PRIME/TOTAL HEMOGLOBIN|||||||UV2|||||||INDETERMINATE||CMH2O*S/ML||||HIGH|NOT DONE||||LEUKOCYTE|CALCIFIED|N|GIEMSA STAIN|MDRD 6 VARIABLE FORMULA||Y|N|N|Y|||U|1||38||RUN-IN|1973-05-18|1964-01-11|||||1960-03-30||1963-03-13|N|1965-01-19
TRIAL STUDY 134XCP|LB|89298058-EB86-4892-97D6-1B87277DF7FC|2||||ADPNHMW|ADIPONECTIN, HIGH MOLECULAR WEIGHT|||||||LB|||||||INDETERMINATE||FT2||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|SOLIDIFIED|NA|CONTRAST ENHANCED PET SCAN|MDRD 5 VARIABLE FORMULA||NA|Y|N|Y|||U|1||38||CONTINUATION TREATMENT|1962-06-11|1970-10-21|||||1972-12-23||1962-09-27|U|1970-03-23
TRIAL STUDY 134XCP|LB|89298058-EB86-4892-97D6-1B87277DF7FC|1||||PSDEPHD|PSEUDOEPHEDRINE|||||||UG/KG/H|||||||NEGATIVE||KPA||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|AUTOLYZED|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||U|N|N|NA|||U|2||58||BASELINE|1966-03-22|1967-12-22|||||1970-02-06||1961-08-23|Y|1960-11-02
TRIAL STUDY 134XCP|LB|89298058-EB86-4892-97D6-1B87277DF7FC|2||||LYMIMLE|IMMATURE LYMPHOCYTES/LEUKOCYTES|||||||10^12 IU/L|||||||NEGATIVE||NMOL/ML/MIN||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|FROZEN|N|MAGNETIC RESONANCE ANGIOGRAPHY|GMI % FORMULA||NA|NA|U|Y|||U|2||58||TREATMENT|1964-01-27|1961-09-17|||||1960-08-27||1962-03-03|U|1966-04-26
TRIAL STUDY 134XCP|LB|89298058-EB86-4892-97D6-1B87277DF7FC|1||||TRH|THYROTROPIN RELEASING HORMONE|||||||COPIES/ML|||||||BORDERLINE||L||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CONCENTRATED|NA|BRDU CELLULAR PROLIFERATION ASSAY|FIBROSIS 4 FORMULA||Y|Y|U|Y|||Y|3||39||BLINDED TREATMENT|1968-09-16|1963-04-27|||||1968-06-15||1967-02-09|NA|1960-04-30
TRIAL STUDY 134XCP|LB|89298058-EB86-4892-97D6-1B87277DF7FC|2||||LDLPATT|LDL SUBTYPE PATTERN|||||||10^6 ORGANISMS/G|||||||NEGATIVE||SCM||||HIGH|NOT DONE||||SEMEN|ICTERIC|NA|ZIEHL NEELSEN ACID FAST STAIN|FIBROMETER FORMULA||U|N|U|N|||NA|3||39||RUN-IN|1969-03-15|1964-05-20|||||1962-12-07||1969-09-07|NA|1963-11-03
TRIAL STUDY 134XCP|LB|89298058-EB86-4892-97D6-1B87277DF7FC|1||||UREANCRT|UREA NITROGEN/CREATININE|||||||ML/BEAT|||||||INDETERMINATE||ML/DOSE||||ABNORMAL|NOT DONE||||SEMEN|CLOTTED|NA|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1967-04-02|1970-04-16|||||1962-01-31||1966-10-13|N|1967-12-01
TRIAL STUDY 134XCP|LB|89298058-EB86-4892-97D6-1B87277DF7FC|2||||TRAP|TOTAL RADICAL-TRAP ANTIOXIDANT POTENTIAL|||||||U/M2/DAY|||||||INVALID||MOL/G||||LOW|NOT DONE||||SERUM|FROZEN|NA|ELECTROMYOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|U|||U|4||88||BLINDED TREATMENT|1972-11-04|1966-11-16|||||1972-07-04||1969-06-07|N|1961-11-14
TRIAL STUDY 134XCP|LB|89298058-EB86-4892-97D6-1B87277DF7FC|1||||GSTCREAT|GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||UG/ML/H|||||||INDETERMINATE||DAMOL/L||||HIGH|NOT DONE||||BONE MARROW|NON-HEMOLYZED|N|MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|NA|N|||Y|5||7||TREATMENT|1966-04-13|1969-04-24|||||1967-01-24||1970-03-25|NA|1973-02-04
TRIAL STUDY 134XCP|LB|89298058-EB86-4892-97D6-1B87277DF7FC|2||||CCL8|CHEMOKINE (C-C MOTIF) LIGAND 8|||||||/SEC|||||||POSITIVE||PMOL/10^10 CELLS||||HIGH|NOT DONE||||WHITE MATTER TISSUE|DRIED|Y|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CREATININE FORMULA||U|NA|N|U|||NA|5||7||INDUCTION TREATMENT|1971-05-20|1960-01-01|||||1972-05-27||1973-06-09|NA|1969-05-24
TRIAL STUDY 134XCP|LB|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|1||||PTHRP|PARATHYROID HORMONE-RELATED PROTEIN|||||||DB|||||||NEGATIVE||G/CM2||||ABNORMAL|NOT DONE||||ABSCESS FLUID|PARAFFIN-EMBEDDED|U|ANTIMICROBIAL COMBINATION TESTING|CKD-EPI CYSTATIN C FORMULA||U|U|N|NA|||N|1||38||FOLLOW-UP|1962-09-23|1972-12-13|||||1971-05-15||1967-06-29|N|1970-06-28
TRIAL STUDY 134XCP|LB|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|2||||C130084|ENGLISH PLANTAIN POLLEN IGE|||||||PKAT/L|||||||BORDERLINE||UG/MOL||||LOW|NOT DONE||||AQUEOUS HUMOR|ROOM TEMPERATURE|Y|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA||N|U|N|Y|||U|1||38||RUN-IN|1965-07-12|1963-12-20|||||1967-08-18||1972-02-09|NA|1968-09-07
TRIAL STUDY 134XCP|LB|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|1||||C130082|ORCHARD GRASS POLLEN IGG|||||||/H|||||||TRACE||IMPLANT||||HIGH|NOT DONE||||LEUKOCYTE|LACTESCENT|Y|DIGITAL PCR ARRAY|HEPASCORE FORMULA||Y|U|NA|U|||Y|2||58||FOLLOW-UP|1960-04-29|1966-09-30|||||1966-03-25||1966-10-08|U|1960-07-07
TRIAL STUDY 134XCP|LB|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|2||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||10^3/HPF|||||||INVALID||ENZYME U||||HIGH|NOT DONE||||DERMAL TISSUE|LIPEMIC|U|ISHIHARA COLOR PLATES|MDRD FORMULA||N|N|Y|N|||Y|2||58||FOLLOW-UP|1967-02-18|1969-06-14|||||1968-11-21||1966-06-11|NA|1969-05-09
TRIAL STUDY 134XCP|LB|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|1||||C130101|TREE MIX POLLEN ANTIGEN IGE ANTIBODY|||||||MG/G/MIN|||||||BORDERLINE||TUBE||||LOW|NOT DONE||||ABSCESS FLUID|THAWED|Y|ELECTROCHEMILUMINESCENCE|FIBROTEST FORMULA||Y|Y|Y|Y|||U|3||39||WASHOUT|1963-05-22|1961-04-03|||||1961-08-21||1962-01-15|Y|1970-08-06
TRIAL STUDY 134XCP|LB|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|2||||DALACRT|DELTA AMINOLEVULINATE/CREATININE|||||||AMU|||||||INVALID||PELLET||||ABNORMAL|NOT DONE||||PLASMA|LACTESCENT|Y|IMMUNO-PET SCAN|MDRD 6 VARIABLE FORMULA||Y|NA|N|U|||N|3||39||TREATMENT|1973-04-17|1965-10-19|||||1965-05-17||1969-08-05|Y|1961-08-05
TRIAL STUDY 134XCP|LB|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|1||||SPLA2II|TYPE II SECRETORY PHOSPHOLIPASE A2|||||||NG|||||||POSITIVE||ML/KG/H||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|CALCIFIED|NA|CONTRAST ENHANCED X-RAY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|NA|U|||Y|4||88||RUN-IN|1972-03-20|1967-07-11|||||1969-11-01||1967-08-29|N|1964-01-03
TRIAL STUDY 134XCP|LB|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|2||||FGFBF|FIBROBLAST GROWTH FACTOR BASIC FORM|||||||ML/MMHG/MIN/L|||||||INDETERMINATE||ML/KG/H||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|FRESH|U|NEPHELOMETRY|MDRD FORMULA||NA|Y|NA|U|||N|4||88||INDUCTION TREATMENT|1968-09-02|1967-03-24|||||1964-07-01||1966-11-14|N|1970-08-23
TRIAL STUDY 134XCP|LB|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|1||||CD79A|CD79A|||||||MG/G/H|||||||NEGATIVE||ANTI-XA IU||||ABNORMAL|NOT DONE||||DERMAL TISSUE|AUTOLYZED|NA|FLAME PHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|Y|||U|5||7||RUN-IN|1966-06-10|1968-04-26|||||1972-04-12||1965-10-28|U|1968-12-21
TRIAL STUDY 134XCP|LB|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|2||||C130116|BEE MIX ANTIGEN IGE ANTIBODY|||||||PNU/ML|||||||INDETERMINATE||BREATHS/30S||||HIGH|NOT DONE||||BONE MARROW|CALCIFIED|N|CLINICAL EVALUATION|CKD-EPI CREATININE FORMULA||U|NA|N|U|||U|5||7||RUN-IN|1962-09-26|1970-11-20|||||1961-05-31||1970-06-01|N|1966-05-18
TRIAL STUDY 134XCP|LB|D5235188-810B-431F-A6EF-E50DAA57F5E7|1||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||S/H|||||||NEGATIVE||UL/DOSE||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|CONTAMINATED|Y|CALIPER MEASUREMENT METHOD|HEPASCORE FORMULA||NA|NA|Y|NA|||N|1||38||TREATMENT|1962-12-26|1962-04-27|||||1966-06-21||1969-04-22|N|1967-04-25
TRIAL STUDY 134XCP|LB|D5235188-810B-431F-A6EF-E50DAA57F5E7|2||||APTTLAS|LUPUS ANTICOAGULANT SENSITIVE APTT|||||||L/MIN/M2|||||||INVALID||CAPFUL||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|GELLED|Y|NUCLEIC ACID AMPLIFICATION TEST|MDRD FORMULA||N|N|N|N|||N|1||38||WASHOUT|1966-12-08|1961-11-25|||||1968-04-23||1969-10-19|U|1972-04-17
TRIAL STUDY 134XCP|LB|D5235188-810B-431F-A6EF-E50DAA57F5E7|1||||C130140|GERMAN COCKROACH ANTIGEN IGE ANTIBODY|||||||AG|||||||INVALID||EIA UNIT||||HIGH|NOT DONE||||SYNOVIAL FLUID|CONCENTRATED|N|PUPILLOMETRY|FIBROSIS 4 FORMULA||Y|Y|N|NA|||Y|2||58||TREATMENT|1967-04-20|1973-01-08|||||1960-08-03||1964-07-29|N|1971-05-04
TRIAL STUDY 134XCP|LB|D5235188-810B-431F-A6EF-E50DAA57F5E7|2||||PKM|PYRUVATE KINASE MUSCLE ISOZYME|||||||CY/CM|||||||TRACE||MEQ/ML||||ABNORMAL|NOT DONE||||FLUID|FROZEN|U|WRIGHT STAIN|CKD-EPI CYSTATIN C FORMULA||U|Y|U|NA|||N|2||58||CONTINUATION TREATMENT|1970-04-11|1970-06-11|||||1962-08-06||1961-11-07|U|1968-10-28
TRIAL STUDY 134XCP|LB|D5235188-810B-431F-A6EF-E50DAA57F5E7|1||||TROPONT|TROPONIN T|||||||ENZYME U|||||||INDETERMINATE||MG/L FEU||||LOW|NOT DONE||||EXPIRED AIR|DRIED|U|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI FORMULA||Y|N|Y|Y|||Y|3||39||TREATMENT|1971-03-09|1964-01-07|||||1971-03-21||1971-03-11|U|1970-10-16
TRIAL STUDY 134XCP|LB|D5235188-810B-431F-A6EF-E50DAA57F5E7|2||||FPP|PROTOPORPHYRIN, FREE|||||||UG/G/MIN|||||||TRACE||MG||||LOW|NOT DONE||||SYNOVIAL FLUID|GELLED|NA|STRESS ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA||U|U|U|N|||N|3||39||CONTINUATION TREATMENT|1965-07-11|1964-02-17|||||1963-11-19||1970-05-27|N|1962-02-18
TRIAL STUDY 134XCP|LB|D5235188-810B-431F-A6EF-E50DAA57F5E7|1||||PTSFAC|PROTEIN S, FREE ACTUAL/CONTROL|||||||/LSQN|||||||POSITIVE||L/L||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|REFRIGERATED|N|BAC ACGH|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|NA|NA|||Y|4||88||CONTINUATION TREATMENT|1970-06-01|1970-01-06|||||1967-10-04||1973-03-08|N|1960-11-07
TRIAL STUDY 134XCP|LB|D5235188-810B-431F-A6EF-E50DAA57F5E7|2||||ETPTPR|ETP TIME TO PEAK RELATIVE|||||||PKAT|||||||INVALID||ML/100G/MIN||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CALCIFIED|Y|VIRUS PLAQUE ASSAY|NASH FIBROSURE FORMULA||Y|NA|U|Y|||NA|4||88||BLINDED TREATMENT|1963-01-03|1972-12-13|||||1970-01-01||1960-12-27|N|1970-01-19
TRIAL STUDY 134XCP|LB|D5235188-810B-431F-A6EF-E50DAA57F5E7|1||||PSAFPSAT|PSA, FREE/PSA|||||||MG/G/H|||||||INVALID||/2000 RBC||||ABNORMAL|NOT DONE||||DERMAL TISSUE|CONTAMINATED|Y|MIGET|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|N|U|||NA|5||7||OPEN LABEL TREATMENT|1968-08-24|1967-10-21|||||1960-05-01||1968-12-24|NA|1960-03-02
TRIAL STUDY 134XCP|LB|D5235188-810B-431F-A6EF-E50DAA57F5E7|2||||VITB1|THIAMINE|||||||ML/DOSE|||||||BORDERLINE||AFU||||NORMAL|NOT DONE||||ADIPOSE TISSUE|REFRIGERATED|NA|ACRIDINE ORANGE STAIN|MDRD 6 VARIABLE FORMULA||NA|NA|NA|U|||N|5||7||TREATMENT|1971-05-19|1962-07-17|||||1966-02-11||1963-02-17|N|1963-04-04
TRIAL STUDY 134XCP|LB|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|1||||HLADRAGT|HLA-DR ANTIGEN TYPE|||||||CAL|||||||INVALID||CI/MG||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED|NA|TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|Y|N|||NA|1||38||WASHOUT|1968-09-03|1962-03-27|||||1971-11-19||1972-04-09|NA|1967-11-10
TRIAL STUDY 134XCP|LB|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|2||||SJSSBAB|SJOGRENS SS-B ANTIBODY|||||||FT3|||||||INVALID||GY/MIN||||LOW|NOT DONE||||DERMAL TISSUE|ROOM TEMPERATURE|U|BETA LACTAMASE|MDRD FORMULA||Y|NA|U|Y|||U|1||38||BLINDED TREATMENT|1969-03-29|1967-07-27|||||1960-05-15||1971-10-28|NA|1973-08-11
TRIAL STUDY 134XCP|LB|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|1||||LRZPM|LORAZEPAM|||||||PG/L|||||||BORDERLINE||CM H2O||||HIGH|NOT DONE||||DISCHARGE|UNEXPECTED ODOR|NA|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|GMI % FORMULA||U|NA|Y|NA|||U|2||58||INDUCTION TREATMENT|1971-03-08|1961-05-15|||||1968-05-23||1967-10-04|N|1964-08-17
TRIAL STUDY 134XCP|LB|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|2||||C130094|WESTERN RAGWEED POLLEN IGG|||||||SEC|||||||POSITIVE||MG/KG/H||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|CONTAMINATED|Y|PALPATION|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|U|||Y|2||58||OPEN LABEL TREATMENT|1967-10-23|1962-11-19|||||1971-04-05||1961-09-03|N|1970-11-03
TRIAL STUDY 134XCP|LB|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|1||||APOJCRT|APOLIPOPROTEIN J/CREATININE|||||||10^6 RNA COPIES/ML|||||||INDETERMINATE||10^6 DNA COPIES/ML||||ABNORMAL|NOT DONE||||MECONIUM|SOLIDIFIED|NA|CYSTOMETRY|MDRD ENZYMATIC FORMULA||Y|U|NA|U|||Y|3||39||INDUCTION TREATMENT|1962-04-23|1967-09-30|||||1963-10-29||1971-06-11|N|1969-03-10
TRIAL STUDY 134XCP|LB|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|2||||BUPREN|BUPRENORPHINE|||||||NEBULE|||||||NEGATIVE||BQ/MG||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|FROZEN|Y|SPECT SCAN|NASH FIBROSURE FORMULA||NA|Y|U|N|||U|3||39||LONG-TERM FOLLOW-UP|1960-11-26|1967-01-13|||||1965-10-01||1970-12-20|Y|1969-12-29
TRIAL STUDY 134XCP|LB|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|1||||UREA|UREA|||||||L/MIN|||||||INVALID||BISCUIT||||NORMAL|NOT DONE||||DISCHARGE|AUTOLYZED|N|X-RAY FLUORESCENCE SPECTROMETRY|FIBROSIS 4 FORMULA||Y|Y|U|NA|||Y|4||88||BLINDED TREATMENT|1973-01-27|1966-05-23|||||1961-03-04||1970-04-12|Y|1964-08-14
TRIAL STUDY 134XCP|LB|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|2||||B1BGLP|BETA-1B GLYCOPROTEIN|||||||TSP EQ|||||||POSITIVE||RNA COPIES/ML||||LOW|NOT DONE||||WHITE MATTER TISSUE|DRIED|U|IMMUNE REPERTOIRE DEEP SEQUENCING|FIBROMETER FORMULA||NA|U|U|N|||Y|4||88||CONTINUATION TREATMENT|1973-05-03|1971-09-06|||||1971-08-05||1969-12-06|N|1972-06-08
TRIAL STUDY 134XCP|LB|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|1||||TESTOSFR|TESTOSTERONE, FREE|||||||10^6 ORGANISMS|||||||INDETERMINATE||10^3 RNA COPIES/ML||||HIGH|NOT DONE||||WHITE MATTER TISSUE|FROZEN|Y|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|Y|NA|||U|5||7||BASELINE|1963-08-20|1961-02-02|||||1962-07-11||1963-05-08|Y|1970-01-31
TRIAL STUDY 134XCP|LB|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|2||||CABOT|CABOT RINGS|||||||ENZYME U/M2|||||||TRACE||10^10/L||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|THAWED|Y|MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|Y|Y|||Y|5||7||SCREENING|1961-10-27|1968-01-21|||||1964-02-15||1968-09-12|N|1972-10-07
TRIAL STUDY 134XCP|LB|E3BB136E-0913-43FB-B760-CBE939F0C4D2|1||||HRYCELE|HAIRY CELLS/LEUKOCYTES|||||||PL|||||||NEGATIVE||HENRY||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|CLOTTED|U|CARDIAC THERMODILUTION|MDRD FORMULA||U|Y|Y|Y|||Y|1||38||INDUCTION TREATMENT|1970-11-20|1971-11-11|||||1961-09-15||1965-08-21|NA|1971-11-14
TRIAL STUDY 134XCP|LB|E3BB136E-0913-43FB-B760-CBE939F0C4D2|2||||VITB5|VITAMIN B5|||||||EVENTS|||||||TRACE||DPM/100MG||||ABNORMAL|NOT DONE||||CELL PELLET|CLOTTED|U|CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI FORMULA||Y|U|U|N|||Y|1||38||RUN-IN|1971-08-23|1968-08-13|||||1971-09-15||1961-07-19|NA|1970-08-31
TRIAL STUDY 134XCP|LB|E3BB136E-0913-43FB-B760-CBE939F0C4D2|1||||PTHW|PARATHYROID HORMONE, WHOLE|||||||KBQ/UL|||||||INDETERMINATE||ML/MIN/MMHG||||ABNORMAL|NOT DONE||||DISCHARGE|NON-HEMOLYZED|Y|CONTACT SPECULAR MICROSCOPY|HEPASCORE FORMULA||N|U|N|NA|||Y|2||58||CONTINUATION TREATMENT|1962-08-10|1970-03-20|||||1972-07-30||1961-05-19|U|1967-12-02
TRIAL STUDY 134XCP|LB|E3BB136E-0913-43FB-B760-CBE939F0C4D2|2||||PYRIDNLN|PYRIDINOLINE|||||||PUFF|||||||NEGATIVE||COPIES/ML||||HIGH|NOT DONE||||AQUEOUS HUMOR|ROOM TEMPERATURE|U|SPECT/CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|N|U|||U|2||58||LONG-TERM FOLLOW-UP|1962-08-30|1971-11-03|||||1964-11-06||1964-04-21|U|1966-12-24
TRIAL STUDY 134XCP|LB|E3BB136E-0913-43FB-B760-CBE939F0C4D2|1||||WBC|LEUKOCYTES|||||||DPM|||||||INDETERMINATE||NMOL||||NORMAL|NOT DONE||||SPERMATOZOON|THAWED|U|FLUORESCEIN STAIN|ASH FIBROSURE FORMULA||Y|N|N|U|||Y|3||39||OBSERVATION|1961-05-25|1961-02-10|||||1973-06-17||1968-10-14|N|1970-09-10
TRIAL STUDY 134XCP|LB|E3BB136E-0913-43FB-B760-CBE939F0C4D2|2||||C165931|NUT MIX IGE AB RAST SCORE|||||||JDF UNIT|||||||POSITIVE||SQU/ML||||HIGH|NOT DONE||||DISCHARGE|ROOM TEMPERATURE|Y|CELL OF ORIGIN ASSAY|CKD-EPI CYSTATIN C FORMULA||NA|U|N|Y|||NA|3||39||OPEN LABEL TREATMENT|1960-09-25|1972-07-06|||||1966-01-17||1970-09-23|Y|1967-05-16
TRIAL STUDY 134XCP|LB|E3BB136E-0913-43FB-B760-CBE939F0C4D2|1||||PLSIMCE|IMMATURE PLASMA CELLS|||||||KN/CM2|||||||TRACE||VG/ML||||HIGH|NOT DONE||||HAIR FOLLICLE|CONTAMINATED|U|LINE PROBE ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|U|Y|||NA|4||88||SCREENING|1968-06-30|1970-08-01|||||1970-05-11||1971-12-06|U|1971-09-19
TRIAL STUDY 134XCP|LB|E3BB136E-0913-43FB-B760-CBE939F0C4D2|2||||HDL3|HDL-CHOLESTEROL SUBCLASS 3|||||||DAYS/WK|||||||NEGATIVE||SEC||||HIGH|NOT DONE||||SYNOVIAL FLUID|SOLIDIFIED|NA|EPSILOMETER|MDRD FORMULA||N|NA|NA|NA|||U|4||88||LONG-TERM FOLLOW-UP|1968-09-28|1962-07-06|||||1965-02-28||1973-04-20|Y|1962-10-17
TRIAL STUDY 134XCP|LB|E3BB136E-0913-43FB-B760-CBE939F0C4D2|1||||CXCL4|CHEMOKINE (C-X-C MOTIF) LIGAND 4|||||||UMOL/L/H|||||||POSITIVE||10^6 CFU||||HIGH|NOT DONE||||TRANSUDATE|FROZEN|NA|OSCILLOMETRY|COCKCROFT-GAULT FORMULA||N|NA|Y|U|||NA|5||7||FOLLOW-UP|1961-04-14|1972-03-02|||||1963-02-12||1966-05-17|U|1963-04-28
TRIAL STUDY 134XCP|LB|E3BB136E-0913-43FB-B760-CBE939F0C4D2|2||||GLYCRL|GLYCEROL|||||||ML/G/DAY|||||||POSITIVE||TAMPON||||ABNORMAL|NOT DONE||||ISOLATE|GELLED|NA|NO INFORMATION|CKD-EPI CYSTATIN C FORMULA||NA|U|Y|U|||N|5||7||TREATMENT|1967-03-04|1960-05-10|||||1966-11-11||1972-09-22|N|1965-12-31
TRIAL STUDY 134XCP|LB|60C25341-42CE-4532-8F99-25B8305C4ED5|1||||CA19_9AG|CANCER ANTIGEN 19-9|||||||LOG10 TCID 50/ML|||||||INVALID||PL||||NORMAL|NOT DONE||||SWABBED MATERIAL|LACTESCENT|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|GMI MMOL/MOL FORMULA||Y|U|U|N|||N|1||38||CONTINUATION TREATMENT|1968-05-30|1970-08-13|||||1968-06-27||1966-07-31|NA|1962-12-21
TRIAL STUDY 134XCP|LB|60C25341-42CE-4532-8F99-25B8305C4ED5|2||||CD11A|CD11A|||||||UMOL|||||||POSITIVE||ML/M2/DAY||||LOW|NOT DONE||||BUFFY COAT|FROZEN|U|SLOAN LETTER EYE CHART 100%|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|Y|||Y|1||38||BASELINE|1964-08-19|1970-07-28|||||1971-02-21||1965-12-09|U|1963-09-27
TRIAL STUDY 134XCP|LB|60C25341-42CE-4532-8F99-25B8305C4ED5|1||||PGF1A|PROSTAGLANDIN F1 ALPHA|||||||IU/ML|||||||POSITIVE||CI/L||||LOW|NOT DONE||||HAIR|ICTERIC|N|POLYGRAPHY|CKD-EPI FORMULA||NA|N|N|NA|||N|2||58||CONTINUATION TREATMENT|1973-07-04|1964-07-01|||||1967-08-03||1964-02-03|N|1972-08-27
TRIAL STUDY 134XCP|LB|60C25341-42CE-4532-8F99-25B8305C4ED5|2||||ALBPROT|ALBUMIN/TOTAL PROTEIN|||||||UM/DAY|||||||TRACE||MG/G/H||||LOW|NOT DONE||||PLATELET POOR PLASMA|ICTERIC|N|GC/MS/MS|CKD-EPI FORMULA||NA|N|U|Y|||NA|2||58||OBSERVATION|1968-10-28|1970-10-15|||||1962-03-24||1966-10-17|NA|1965-08-10
TRIAL STUDY 134XCP|LB|60C25341-42CE-4532-8F99-25B8305C4ED5|1||||DPD|DEOXYPYRIDINOLINE|||||||U/M2/H|||||||BORDERLINE||POUCH||||HIGH|NOT DONE||||GASTRIC CONTENTS|THAWED|N|EPSILOMETER|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|U|||Y|3||39||RUN-IN|1960-07-27|1969-05-28|||||1964-12-02||1962-05-19|Y|1970-10-13
TRIAL STUDY 134XCP|LB|60C25341-42CE-4532-8F99-25B8305C4ED5|2||||ACETONE|ACETONE|||||||BREATHS/MIN|||||||NEGATIVE||PKAT||||LOW|NOT DONE||||PERSPIRATION|FRESH|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|U|||Y|3||39||INDUCTION TREATMENT|1963-06-20|1961-04-06|||||1972-11-11||1963-08-14|Y|1968-05-20
TRIAL STUDY 134XCP|LB|60C25341-42CE-4532-8F99-25B8305C4ED5|1||||PSAMRNA|PROSTATE SPECIFIC ANTIGEN MRNA|||||||DAGU/ML|||||||INDETERMINATE||NMOL BCE/NMOL||||LOW|NOT DONE||||PLATELET RICH PLASMA|NON-HEMOLYZED|Y|LYMPHANGIOGRAPHY|COCKCROFT-GAULT FORMULA||Y|Y|U|U|||N|4||88||OPEN LABEL TREATMENT|1966-02-03|1961-11-29|||||1969-12-24||1965-03-14|Y|1968-05-15
TRIAL STUDY 134XCP|LB|60C25341-42CE-4532-8F99-25B8305C4ED5|2||||CCPAB|CYCLIC CITRULLINATED PEPTIDE ANTIBODY|||||||TABLET|||||||INVALID||RFU||||LOW|NOT DONE||||ADIPOSE TISSUE|NON-HEMOLYZED|U|X-RAY|HEPASCORE FORMULA||N|U|NA|U|||NA|4||88||RUN-IN|1963-03-08|1961-05-18|||||1965-03-15||1967-06-06|N|1960-06-09
TRIAL STUDY 134XCP|LB|60C25341-42CE-4532-8F99-25B8305C4ED5|1||||ERCEPIDX|ERYTHROID PROLIFERATION INDEX|||||||USIEMENS|||||||TRACE||DROP||||NORMAL|NOT DONE||||HAIR FOLLICLE|CONCENTRATED|N|VIRUS PLAQUE ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|U|U|||U|5||7||WASHOUT|1960-03-09|1965-07-19|||||1972-08-17||1960-08-02|U|1964-10-17
TRIAL STUDY 134XCP|LB|60C25341-42CE-4532-8F99-25B8305C4ED5|2||||BASOMM|BASOPHILIC METAMYELOCYTES|||||||10^4 CFU/ML|||||||BORDERLINE||10^9 ORGANISMS/MG||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|ICTERIC|Y|CONFOCAL MICROSCOPY|CKD-EPI CREATININE FORMULA||Y|NA|Y|NA|||N|5||7||OPEN LABEL TREATMENT|1972-04-28|1972-01-21|||||1960-08-06||1969-12-10|Y|1971-09-20
TRIAL STUDY 134XCP|LB|42B54D88-E5B5-4828-958B-4B64F07E34B3|1||||C130122|NUT MIX ANTIGEN IGE ANTIBODY|||||||C|||||||NEGATIVE||MG/MIN||||LOW|NOT DONE||||SERUM OR PLASMA|FROZEN|NA|ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|N|Y|||Y|1||38||RUN-IN|1960-03-24|1972-01-05|||||1973-01-19||1960-08-29|Y|1971-01-04
TRIAL STUDY 134XCP|LB|42B54D88-E5B5-4828-958B-4B64F07E34B3|2||||V25HD3|25-HYDROXYVITAMIN D3|||||||UEQ/L|||||||POSITIVE||MV*MIN||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|CALCIFIED|NA|BAC ACGH|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|Y|||N|1||38||BASELINE|1965-04-24|1962-07-25|||||1968-04-06||1973-08-04|U|1963-04-17
TRIAL STUDY 134XCP|LB|42B54D88-E5B5-4828-958B-4B64F07E34B3|1||||CPEPCRT|C-PEPTIDE/CREATININE|||||||ANTI-XA IU/ML|||||||INDETERMINATE||CI/G||||LOW|NOT DONE||||CORD BLOOD|FROZEN|NA|MACRO BROTH DILUTION|MDRD 6 VARIABLE FORMULA||N|NA|NA|U|||Y|2||58||OPEN LABEL TREATMENT|1961-08-19|1969-06-12|||||1961-09-17||1962-11-24|NA|1972-07-26
TRIAL STUDY 134XCP|LB|42B54D88-E5B5-4828-958B-4B64F07E34B3|2||||GFRBSCU|GFR FROM CREAT AND UREAN ADJ BSA|||||||PSEC|||||||TRACE||MOSM/L||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|GELLED|NA|BETA LACTAMASE|GMI MMOL/MOL FORMULA||NA|NA|U|N|||Y|2||58||RUN-IN|1970-06-04|1968-05-03|||||1966-10-27||1967-02-16|U|1973-04-15
TRIAL STUDY 134XCP|LB|42B54D88-E5B5-4828-958B-4B64F07E34B3|1||||C1QAB|COMPLEMENT C1Q ANTIBODY|||||||HEP|||||||INVALID||ML/MIN/MMHG||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|NON-HEMOLYZED|NA|CHROMATOGRAPHY|NASH FIBROSURE FORMULA||Y|U|NA|U|||N|3||39||RUN-IN|1966-01-28|1969-12-02|||||1968-05-26||1961-04-24|N|1967-03-31
TRIAL STUDY 134XCP|LB|42B54D88-E5B5-4828-958B-4B64F07E34B3|2||||CD45RALY|CD45RA/LYMPHOCYTES|||||||FOZ_BR|||||||INDETERMINATE||DNA COPIES/ML||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|CLOTTED|U|PET/CT SCAN WITHOUT CONTRAST|MDRD FORMULA||Y|N|N|U|||N|3||39||OPEN LABEL TREATMENT|1972-03-08|1966-09-02|||||1973-05-04||1970-10-28|NA|1965-02-12
TRIAL STUDY 134XCP|LB|42B54D88-E5B5-4828-958B-4B64F07E34B3|1||||BACT|BACTERIA|||||||/200 HPFS|||||||INDETERMINATE||%/MIN||||ABNORMAL|NOT DONE||||ISOLATE|NON-HEMOLYZED|NA|NEXT GENERATION TARGETED SEQUENCING|FIBROSIS 4 FORMULA||N|Y|Y|NA|||Y|4||88||OPEN LABEL TREATMENT|1969-01-26|1969-04-10|||||1961-04-16||1963-10-09|U|1964-07-14
TRIAL STUDY 134XCP|LB|42B54D88-E5B5-4828-958B-4B64F07E34B3|2||||C165895|JOHNSON GRASS POLLEN IGG4 ANTIBODY|||||||MV/SEC|||||||BORDERLINE||G/L||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|CONTAMINATED|NA|MALDI-TOF|GMI % FORMULA||U|Y|Y|N|||N|4||88||OPEN LABEL TREATMENT|1973-03-07|1963-06-19|||||1973-02-02||1965-10-16|U|1966-10-07
TRIAL STUDY 134XCP|LB|42B54D88-E5B5-4828-958B-4B64F07E34B3|1||||DRVTSCPD|DRVVT SCREEN TO CONFIRM PCT DIFFERENCE|||||||IU/G|||||||POSITIVE||IU/MG||||LOW|NOT DONE||||SEBUM|CONCENTRATED|NA|QUANTITATIVE ULTRASOUND|MDRD ENZYMATIC FORMULA||U|NA|NA|N|||Y|5||7||TREATMENT|1968-11-22|1972-07-23|||||1972-02-23||1973-07-27|N|1971-11-19
TRIAL STUDY 134XCP|LB|42B54D88-E5B5-4828-958B-4B64F07E34B3|2||||DRVVTRT|DILUTE RUSSELL'S VIPER VENOM TIME RATIO|||||||ML/DL|||||||POSITIVE||MG/MIN||||HIGH|NOT DONE||||LAVAGE FLUID|LACTESCENT|U|AGAR PROPORTION|MDRD 4 VARIABLE FORMULA||Y|NA|Y|NA|||NA|5||7||INDUCTION TREATMENT|1972-09-14|1960-11-09|||||1963-02-27||1962-03-04|NA|1964-01-04
TRIAL STUDY 134XCP|LB|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|1||||THRCREAT|THREONINE/CREATININE|||||||MG/KG/DOSE|||||||BORDERLINE||UMOL||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|LIPEMIC|U|AGAR DILUTION|MDRD FORMULA||Y|NA|Y|U|||N|1||38||INDUCTION TREATMENT|1964-09-22|1968-03-13|||||1973-04-29||1961-08-29|N|1970-01-18
TRIAL STUDY 134XCP|LB|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|2||||C165879|D. FARINAE IGE AB RAST SCORE|||||||JOULE|||||||INDETERMINATE||JOULE||||LOW|NOT DONE||||PLATELET RICH PLASMA|HEMOLYZED|U|LANDOLT RING|MDRD 5 VARIABLE FORMULA||Y|U|U|U|||U|1||38||BASELINE|1961-05-05|1961-04-15|||||1971-08-10||1968-08-07|U|1969-11-29
TRIAL STUDY 134XCP|LB|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|1||||TNF5S|SOLUBLE TNF SUPERFAMILY MEMBER 5|||||||G/KG/DAY|||||||BORDERLINE||FFU||||NORMAL|NOT DONE||||TRANSUDATE|FRESH|NA|POLYSOMNOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|N|N|||NA|2||58||SCREENING|1960-01-13|1967-07-17|||||1961-12-01||1962-07-26|NA|1972-12-14
TRIAL STUDY 134XCP|LB|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|2||||CALPRO|CALPROTECTIN|||||||MAC50|||||||NEGATIVE||MV/SEC||||NORMAL|NOT DONE||||SERUM OR PLASMA|PARAFFIN-EMBEDDED|NA|BIOPSY|CKD-EPI CYSTATIN C FORMULA||U|Y|N|U|||N|2||58||CONTINUATION TREATMENT|1963-11-23|1962-09-24|||||1971-03-24||1964-01-28|N|1971-09-01
TRIAL STUDY 134XCP|LB|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|1||||PLSIMCLY|IMMATURE PLASMA CELLS/LYMPHOCYTES|||||||HZ/S|||||||POSITIVE||PKAT||||NORMAL|NOT DONE||||COLOSTRUM|THAWED|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|ASH FIBROSURE FORMULA||Y|U|NA|N|||Y|3||39||FOLLOW-UP|1973-07-12|1973-03-22|||||1964-04-18||1964-09-03|Y|1973-07-03
TRIAL STUDY 134XCP|LB|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|2||||C130122|NUT MIX ANTIGEN IGE ANTIBODY|||||||CARTRIDGE|||||||BORDERLINE||TBSP||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|AUTOLYZED|U|KINETIC MICROPARTICLE IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|NA|Y|||N|3||39||FOLLOW-UP|1970-08-26|1961-05-02|||||1972-03-27||1967-07-10|Y|1961-05-29
TRIAL STUDY 134XCP|LB|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|1||||C165920|WHITE ELM POLLEN IGG AB RAST SCORE|||||||MANSON U/ML|||||||TRACE||JAR||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|ICTERIC|N|HPLC/MS|MDRD 6 VARIABLE FORMULA||Y|U|Y|N|||NA|4||88||LONG-TERM FOLLOW-UP|1964-12-20|1973-05-13|||||1968-12-04||1960-06-04|NA|1970-12-06
TRIAL STUDY 134XCP|LB|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|2||||CBANH9|CARBONIC ANHYDRASE 9|||||||LOG10 CCID 50/DOSE|||||||BORDERLINE||/2000 RBC||||LOW|NOT DONE||||EPITHELIAL CELL|UNEXPECTED ODOR|Y|ENZYMATIC COLORIMETRY|HEPASCORE FORMULA||NA|Y|Y|Y|||NA|4||88||INDUCTION TREATMENT|1964-08-07|1960-02-22|||||1966-02-23||1967-07-12|N|1967-08-14
TRIAL STUDY 134XCP|LB|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|1||||INULIN|INULIN|||||||UG/CM2|||||||TRACE||10^6 DNA COPIES/ML||||LOW|NOT DONE||||PLEURAL TISSUE|ICTERIC|Y|SICKLE CELL SOLUBILITY TEST|FIBROMETER FORMULA||Y|N|NA|N|||NA|5||7||CONTINUATION TREATMENT|1970-07-09|1972-11-24|||||1972-07-21||1961-02-13|Y|1964-06-12
TRIAL STUDY 134XCP|LB|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|2||||ANIONG4|ANION GAP 4|||||||APL U/ML|||||||INVALID||MCI/L||||HIGH|NOT DONE||||SWABBED MATERIAL|UNEXPECTED ODOR|N|CRYOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|N|Y|||NA|5||7||WASHOUT|1972-03-13|1962-01-14|||||1971-01-12||1967-11-27|N|1963-04-02
TRIAL STUDY 134XCP|LB|1FD985ED-A573-4A00-8902-214A7F182F28|1||||APOA2|APOLIPOPROTEIN AII|||||||NU/CL|||||||BORDERLINE||10^7 TCID 50/DOSE||||NORMAL|NOT DONE||||CERUMEN|GELLED|U|MASS SPECTROMETRY|CKD-EPI CREATININE FORMULA||Y|N|U|Y|||N|1||38||TREATMENT|1962-11-10|1973-02-22|||||1962-05-29||1963-04-04|U|1962-08-09
TRIAL STUDY 134XCP|LB|1FD985ED-A573-4A00-8902-214A7F182F28|2||||BLASTNCE|BLASTS/NUCLEATED CELLS|||||||UKAT/10^12 RBC|||||||BORDERLINE||CIGARETTE||||HIGH|NOT DONE||||ISOLATE|THAWED|NA|TRIPLE-PHASE MRI SCAN|MDRD 6 VARIABLE FORMULA||NA|NA|Y|U|||N|1||38||BASELINE|1961-04-25|1973-08-01|||||1969-04-16||1971-02-26|N|1968-05-20
TRIAL STUDY 134XCP|LB|1FD985ED-A573-4A00-8902-214A7F182F28|1||||THMBAAC|THROMBIN ACTIVITY ACTUAL/CONTROL|||||||CCID 50/ML|||||||NEGATIVE||MG/KG/DAY||||HIGH|NOT DONE||||BASAL TEAR|AUTOLYZED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD 6 VARIABLE FORMULA||NA|U|NA|N|||U|2||58||FOLLOW-UP|1970-11-09|1970-09-02|||||1971-03-26||1962-07-01|NA|1972-06-19
TRIAL STUDY 134XCP|LB|1FD985ED-A573-4A00-8902-214A7F182F28|2||||ANCPNCAB|NEUTROPHIL CYTOPLASMIC AB, PERINUCLEAR|||||||KM/H|||||||TRACE||NEBULE||||LOW|NOT DONE||||FLUID|FRESH|U|STATIC PERIMETRY|FIBROSIS 4 FORMULA||U|Y|U|N|||U|2||58||BASELINE|1970-01-25|1961-09-10|||||1969-03-22||1969-07-22|N|1969-12-18
TRIAL STUDY 134XCP|LB|1FD985ED-A573-4A00-8902-214A7F182F28|1||||HIST3AB|HISTONE 3 ANTIBODY|||||||AU/ML|||||||BORDERLINE||CUP EQ||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|SOLIDIFIED|N|ENDOSCOPY|CKD-EPI CYSTATIN C FORMULA||N|N|U|N|||NA|3||39||OBSERVATION|1967-01-22|1970-04-06|||||1964-10-25||1972-01-11|NA|1969-08-14
TRIAL STUDY 134XCP|LB|1FD985ED-A573-4A00-8902-214A7F182F28|2||||APOB100|APOLIPOPROTEIN B100|||||||HR/DAY|||||||BORDERLINE||JAR||||HIGH|NOT DONE||||BASAL TEAR|LACTESCENT|NA|FLUORESCENT SPOT TEST|CKD-EPI CYSTATIN C FORMULA||Y|N|N|U|||NA|3||39||CONTINUATION TREATMENT|1963-12-06|1966-09-05|||||1963-07-21||1962-07-04|U|1968-01-16
TRIAL STUDY 134XCP|LB|1FD985ED-A573-4A00-8902-214A7F182F28|1||||AAP|ALANINE AMINOPEPTIDASE|||||||BOX|||||||INDETERMINATE||ENZYME U||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|ROOM TEMPERATURE|NA|FLUORESCENT MICROSCOPY|ASH FIBROSURE FORMULA||Y|NA|Y|N|||N|4||88||OPEN LABEL TREATMENT|1963-06-08|1970-03-26|||||1968-10-01||1965-06-16|N|1961-03-22
TRIAL STUDY 134XCP|LB|1FD985ED-A573-4A00-8902-214A7F182F28|2||||INLCLR|INULIN CLEARANCE|||||||CAL|||||||NEGATIVE||CMH2O/ML||||HIGH|NOT DONE||||SEMINAL FLUID|CONTAMINATED|Y|MICRODENSITOMETRY|FIBROTEST FORMULA||N|U|NA|N|||Y|4||88||TREATMENT|1963-12-17|1966-03-06|||||1966-12-25||1971-05-18|NA|1960-05-02
TRIAL STUDY 134XCP|LB|1FD985ED-A573-4A00-8902-214A7F182F28|1||||CYDRUG|DRUG CRYSTALS|||||||GPL U|||||||INVALID||U/KG/H||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|Y|PHOTOGRAPHY|ASH FIBROSURE FORMULA||U|N|NA|U|||Y|5||7||FOLLOW-UP|1967-06-08|1963-01-08|||||1963-09-08||1964-10-10|NA|1962-12-15
TRIAL STUDY 134XCP|LB|1FD985ED-A573-4A00-8902-214A7F182F28|2||||ACETOAC|ACETOACETIC ACID|||||||DYN|||||||INDETERMINATE||AMFI||||LOW|NOT DONE||||STOOL|PARAFFIN-EMBEDDED|U|SLOAN LETTER EYE CHART 100%|CKD-EPI CREATININE FORMULA||Y|N|Y|U|||U|5||7||OPEN LABEL TREATMENT|1969-07-21|1971-11-13|||||1962-05-03||1960-12-12|Y|1968-02-18
TRIAL STUDY 134XCP|LB|A2FD338A-F994-4399-BD02-99CB299F768E|1||||SEZCELE|SEZARY CELLS/LEUKOCYTES|||||||DIP|||||||POSITIVE||UMOL/KG/MIN||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CLOTTED|N|EIA|MDRD ENZYMATIC FORMULA||NA|Y|U|N|||Y|1||38||OPEN LABEL TREATMENT|1966-01-09|1968-10-04|||||1962-06-19||1962-08-08|U|1968-07-25
TRIAL STUDY 134XCP|LB|A2FD338A-F994-4399-BD02-99CB299F768E|2||||HOMOCY|HOMOCYSTEINE|||||||PACK YEAR|||||||NEGATIVE||MMHG/SEC||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|FROZEN|Y|MICROBIAL CULTURE, SOLID|CKD-EPI CREATININE FORMULA||NA|Y|NA|Y|||Y|1||38||RUN-IN|1964-02-26|1967-09-20|||||1969-01-05||1971-07-15|U|1962-02-21
TRIAL STUDY 134XCP|LB|A2FD338A-F994-4399-BD02-99CB299F768E|1||||BASOIMLE|IMMATURE BASOPHILS/LEUKOCYTES|||||||ENZYME U/M2|||||||POSITIVE||BQ/MG||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CLOTTED|NA|CELL OF ORIGIN ASSAY|MDRD 4 VARIABLE FORMULA||Y|U|Y|U|||U|2||58||BLINDED TREATMENT|1971-09-18|1972-10-11|||||1968-03-08||1960-11-14|Y|1960-11-20
TRIAL STUDY 134XCP|LB|A2FD338A-F994-4399-BD02-99CB299F768E|2||||PRCTC|PROSTATE CIRCULATING TUMOR CELLS|||||||RNA COPIES/ML|||||||POSITIVE||K||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|CALCIFIED|N|IMMUNOCHROMATOGRAPHY|COCKCROFT-GAULT FORMULA||N|N|Y|Y|||NA|2||58||INDUCTION TREATMENT|1971-11-09|1970-05-31|||||1972-08-25||1968-12-19|N|1963-11-11
TRIAL STUDY 134XCP|LB|A2FD338A-F994-4399-BD02-99CB299F768E|1||||GEC|GALACTOSE ELIMINATION CAPACITY|||||||ML/ANIMAL/WK|||||||INVALID||KG||||HIGH|NOT DONE||||SPUTUM|NON-HEMOLYZED|Y|MICRODENSITOMETRY|CKD-EPI CYSTATIN C FORMULA||NA|U|U|U|||NA|3||39||OPEN LABEL TREATMENT|1969-01-12|1971-03-18|||||1968-10-01||1973-06-17|NA|1961-02-28
TRIAL STUDY 134XCP|LB|A2FD338A-F994-4399-BD02-99CB299F768E|2||||C165881|WHITE ELM POLLEN IGE ANTIBODY|||||||ML/BREATH|||||||POSITIVE||ML/G/DAY||||HIGH|NOT DONE||||RETICULOCYTES|ROOM TEMPERATURE|N|BALLPOINT PEN TECHNIQUE|NASH FIBROSURE FORMULA||NA|U|N|U|||U|3||39||BLINDED TREATMENT|1970-01-18|1971-05-20|||||1972-11-27||1966-07-24|NA|1963-04-05
TRIAL STUDY 134XCP|LB|A2FD338A-F994-4399-BD02-99CB299F768E|1||||C130068|BERMUDA GRASS POLLEN IGE|||||||UKAT/10^12 RBC|||||||INVALID||MG/KG/WEEK||||ABNORMAL|NOT DONE||||SEMINAL FLUID|FRESH|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|GMI MMOL/MOL FORMULA||N|U|U|Y|||NA|4||88||SCREENING|1966-11-17|1970-02-01|||||1968-02-17||1961-04-09|NA|1973-04-01
TRIAL STUDY 134XCP|LB|A2FD338A-F994-4399-BD02-99CB299F768E|2||||APROTCRS|ACTIVATED PROTEIN C RESISTANCE|||||||10^6 ORGANISMS/G|||||||BORDERLINE||MG/KG/MIN||||LOW|NOT DONE||||DIALYSIS FLUID|SOLIDIFIED|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|NA|U|N|||NA|4||88||SCREENING|1968-02-03|1973-06-29|||||1968-01-20||1962-03-01|U|1972-03-19
TRIAL STUDY 134XCP|LB|A2FD338A-F994-4399-BD02-99CB299F768E|1||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||UOSM|||||||TRACE||10^9 ORGANISMS/MG||||NORMAL|NOT DONE||||BILE|PARAFFIN-EMBEDDED|U|SPECT/CT SCAN|FIBROSIS 4 FORMULA||U|U|Y|N|||NA|5||7||INDUCTION TREATMENT|1967-02-06|1964-11-13|||||1964-08-22||1972-12-13|N|1961-08-18
TRIAL STUDY 134XCP|LB|A2FD338A-F994-4399-BD02-99CB299F768E|2||||PREALB|PREALBUMIN|||||||MCI/KG|||||||TRACE||UKAT||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|LACTESCENT|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|U|NA|||N|5||7||CONTINUATION TREATMENT|1963-05-20|1962-04-07|||||1968-08-17||1963-01-05|Y|1964-03-18
TRIAL STUDY 134XCP|LB|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|1||||CSBACT|BACTERIAL CASTS|||||||UIU/L|||||||TRACE||NKAT||||LOW|NOT DONE||||CORD SERUM|THAWED|U|NEURAMINIDASE INHIBITION ASSAY|MDRD ENZYMATIC FORMULA||Y|Y|N|N|||Y|1||38||RUN-IN|1966-02-08|1963-03-20|||||1962-08-23||1971-09-04|Y|1972-07-22
TRIAL STUDY 134XCP|LB|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|2||||ELLIPCY|ELLIPTOCYTES|||||||ML/ANIMAL|||||||BORDERLINE||CM H2O||||LOW|NOT DONE||||GASTRIC FLUID|ROOM TEMPERATURE|U|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|Y|Y|||U|1||38||BLINDED TREATMENT|1965-12-15|1972-09-12|||||1960-06-08||1966-09-16|Y|1973-02-10
TRIAL STUDY 134XCP|LB|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|1||||MYBLA|MYELOBLASTS|||||||ANTIBODY UNIT|||||||TRACE||ML/M2/DAY||||HIGH|NOT DONE||||MECONIUM|HEMOLYZED|Y|CONTRAST ENHANCED SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA||Y|NA|NA|N|||N|2||58||BLINDED TREATMENT|1970-10-17|1967-06-19|||||1973-08-20||1968-11-02|N|1969-08-30
TRIAL STUDY 134XCP|LB|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|2||||LDH4LDH|LDH ISOENZYME 4/LDH|||||||LX|||||||BORDERLINE||BP||||LOW|NOT DONE||||BUFFY COAT|SOLIDIFIED|Y|GIEMSA STAIN|NASH FIBROSURE FORMULA||N|NA|Y|Y|||N|2||58||RUN-IN|1970-05-10|1969-08-13|||||1964-04-18||1963-10-31|U|1961-11-27
TRIAL STUDY 134XCP|LB|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|1||||MASTCE|MAST CELLS|||||||%/S|||||||BORDERLINE||MM/2H||||LOW|NOT DONE||||BREAST MILK|CONCENTRATED|U|PET/CT SCAN|CKD-EPI CREATININE FORMULA||U|NA|U|NA|||U|3||39||FOLLOW-UP|1972-04-10|1961-02-05|||||1972-01-10||1966-08-12|U|1967-11-30
TRIAL STUDY 134XCP|LB|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|2||||PTAUAB42|PHOSPHORYLATED TAU PROT/AMYLOID BETA1-42|||||||ANTI-XA IU|||||||BORDERLINE||KDA||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|FROZEN|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD ENZYMATIC FORMULA||Y|Y|Y|U|||NA|3||39||BLINDED TREATMENT|1961-09-07|1969-07-08|||||1964-07-16||1966-01-08|U|1971-05-02
TRIAL STUDY 134XCP|LB|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|1||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||L/DAY|||||||INVALID||APS U||||HIGH|NOT DONE||||PLATELET RICH PLASMA|NON-HEMOLYZED|Y|ELECTROMYOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|U|N|N|||N|4||88||OBSERVATION|1963-10-28|1961-05-08|||||1968-08-09||1971-08-22|NA|1969-04-25
TRIAL STUDY 134XCP|LB|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|2||||PRORUBCE|PRORUBRICYTE/TOTAL CELLS|||||||PM|||||||NEGATIVE||FRACTION OF 1||||HIGH|NOT DONE||||NAIL|LACTESCENT|Y|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|NASH FIBROSURE FORMULA||Y|U|Y|NA|||NA|4||88||BLINDED TREATMENT|1972-10-08|1960-02-27|||||1962-11-06||1961-11-03|N|1963-03-21
TRIAL STUDY 134XCP|LB|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|1||||CCL25|CHEMOKINE (C-C MOTIF) LIGAND 25|||||||MEQ/L|||||||POSITIVE||CMH2O/ML||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|LIPEMIC|U|EEG|MDRD 4 VARIABLE FORMULA||NA|N|Y|N|||U|5||7||OBSERVATION|1972-08-18|1967-12-12|||||1968-08-19||1967-08-13|N|1969-08-29
TRIAL STUDY 134XCP|LB|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|2||||RBCDYSM|DYSMORPHIC ERYTHROCYTES|||||||EQ|||||||BORDERLINE||G/DAY||||HIGH|NOT DONE||||ABSCESS FLUID|FRESH|U|SPIRAL CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|N|U|||NA|5||7||SCREENING|1962-01-01|1962-08-16|||||1967-06-15||1970-03-17|N|1962-02-26
TRIAL STUDY 134XCP|LB|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|1||||PEPSNG|PEPSINOGEN|||||||IU/DL|||||||POSITIVE||UG/G/MIN||||LOW|NOT DONE||||BUFFY COAT|FROZEN|N|GRADIENT DIFFUSION|CKD-EPI FORMULA||U|N|NA|Y|||U|1||38||INDUCTION TREATMENT|1971-12-16|1969-07-14|||||1965-10-05||1968-08-24|N|1972-12-31
TRIAL STUDY 134XCP|LB|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|2||||AAMAPAC|ALPHA-AMINOADIPIC ACID|||||||WEEKS|||||||TRACE||10^8/L||||NORMAL|NOT DONE||||ABSCESS FLUID|LACTESCENT|NA|HEMATOXYLIN AND EOSIN STAIN|CKD-EPI FORMULA||Y|Y|N|NA|||NA|1||38||CONTINUATION TREATMENT|1965-07-13|1966-03-13|||||1961-06-29||1965-10-24|NA|1969-08-11
TRIAL STUDY 134XCP|LB|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|1||||C165940|BOXELDER POLLEN IGE AB RAST SCORE|||||||S^-1(%O2)^-1|||||||POSITIVE||CG||||NORMAL|NOT DONE||||STOOL|CALCIFIED|U|KINETIC MICROPARTICLE IMMUNOASSAY|FIBROMETER FORMULA||NA|U|Y|U|||U|2||58||FOLLOW-UP|1967-02-19|1960-09-19|||||1967-08-02||1970-10-22|N|1962-03-12
TRIAL STUDY 134XCP|LB|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|2||||GLUTAM|GLUTAMATE|||||||CAPSULE|||||||TRACE||NG/L||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|DRIED|N|OPTICAL MAPPING|FIBROMETER FORMULA||NA|Y|NA|Y|||U|2||58||CONTINUATION TREATMENT|1973-04-25|1968-08-07|||||1961-11-20||1961-02-07|Y|1963-08-11
TRIAL STUDY 134XCP|LB|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|1||||PGE2|PROSTAGLANDIN E2|||||||ML/BREATH|||||||TRACE||UL/ML||||ABNORMAL|NOT DONE||||PERSPIRATION|NON-HEMOLYZED|U|LEAD CITRATE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|N|N|||Y|3||39||INDUCTION TREATMENT|1970-11-06|1961-04-13|||||1972-05-26||1967-02-22|NA|1963-07-17
TRIAL STUDY 134XCP|LB|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|2||||OXAEXR|OXALATE EXCRETION RATE|||||||STEPS|||||||POSITIVE||PRESSOR UNITS||||LOW|NOT DONE||||INFRANATANT, PLASMA|LACTESCENT|N|FLUORESCENT IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|U|U|||N|3||39||BASELINE|1971-04-11|1967-08-25|||||1968-04-01||1964-11-13|N|1966-07-09
TRIAL STUDY 134XCP|LB|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|1||||HISTAMIN|HISTAMINE|||||||NG/MOL|||||||INVALID||CIGARETTE||||NORMAL|NOT DONE||||FLUID|ROOM TEMPERATURE|Y|CONTRAST ENHANCED MRI|MDRD ENZYMATIC FORMULA||Y|U|U|NA|||Y|4||88||BASELINE|1964-03-29|1964-02-23|||||1961-02-20||1962-01-22|U|1960-01-28
TRIAL STUDY 134XCP|LB|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|2||||EUDCA|EPIMERIZED URSODEOXYCHOLATE|||||||DPM|||||||TRACE||EP U||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|THAWED|N|SISH|MDRD FORMULA||Y|U|NA|Y|||N|4||88||OPEN LABEL TREATMENT|1969-02-16|1967-04-23|||||1969-04-25||1962-02-26|Y|1967-04-30
TRIAL STUDY 134XCP|LB|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|1||||HIST2AAB|HISTONE 2A ANTIBODY|||||||UU/DL|||||||TRACE||PMOL/10^9 CELLS||||NORMAL|NOT DONE||||TUMOR TISSUE|CLOTTED|N|AURAMINE STAIN|HEPASCORE FORMULA||N|N|Y|NA|||U|5||7||OBSERVATION|1968-05-06|1966-11-06|||||1965-10-29||1970-03-07|N|1972-05-16
TRIAL STUDY 134XCP|LB|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|2||||HELMOV10|HELICASE MOV-10 PROTEIN|||||||CM/S|||||||BORDERLINE||NG/DAY||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|SOLIDIFIED|NA|IHC|FIBROSIS 4 FORMULA||NA|NA|U|N|||N|5||7||BLINDED TREATMENT|1967-07-25|1966-06-07|||||1972-10-13||1966-10-09|NA|1966-10-07
TRIAL STUDY 134XCP|LB|A8821AEE-49EB-4687-BB63-361BC3B8B182|1||||MIDCEF|MID CELL FRACTION|||||||10^9 ORGANISMS/G|||||||TRACE||ROENTGEN||||NORMAL|NOT DONE||||AQUEOUS HUMOR|AUTOLYZED|NA|INTRAVASCULAR ULTRASOUND|COCKCROFT-GAULT FORMULA||Y|Y|N|N|||N|1||38||OBSERVATION|1973-01-07|1969-02-18|||||1968-01-19||1966-04-03|N|1962-04-03
TRIAL STUDY 134XCP|LB|A8821AEE-49EB-4687-BB63-361BC3B8B182|2||||OHF6B|6 BETA-HYDROXYCORTISOL|||||||NMOL BCE/NMOL|||||||TRACE||NMOL||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|CONCENTRATED|N|SXA SCAN|HEPASCORE FORMULA||Y|Y|N|NA|||U|1||38||INDUCTION TREATMENT|1969-07-04|1972-03-09|||||1972-04-21||1964-01-04|NA|1966-10-14
TRIAL STUDY 134XCP|LB|A8821AEE-49EB-4687-BB63-361BC3B8B182|1||||C165934|ARACHIS HYPOGAEA IGE AB RAST SCORE|||||||FG|||||||INVALID||MNFI||||LOW|NOT DONE||||LOCHIA|AGGLUTINATED|NA|FARNSWORTH-MUNSELL 100 HUE TEST|MDRD 6 VARIABLE FORMULA||N|NA|Y|N|||NA|2||58||RUN-IN|1971-01-17|1961-10-06|||||1960-04-26||1968-06-21|U|1968-04-02
TRIAL STUDY 134XCP|LB|A8821AEE-49EB-4687-BB63-361BC3B8B182|2||||ERCEPPOL|ERYTHROID PROLIFERATION POOL|||||||AMU|||||||POSITIVE||PMOL/DAY||||LOW|NOT DONE||||SPUTUM|LACTESCENT|Y|MALDI-TOF|CKD-EPI FORMULA||Y|N|Y|Y|||U|2||58||BASELINE|1962-12-25|1965-12-09|||||1969-06-21||1964-02-29|U|1972-06-17
TRIAL STUDY 134XCP|LB|A8821AEE-49EB-4687-BB63-361BC3B8B182|1||||PHNKET|PHENYLKETONES|||||||GTT|||||||INVALID||10^5/HPF||||HIGH|NOT DONE||||CELL PELLET|REFRIGERATED|NA|PET/CT SCAN WITHOUT CONTRAST|MDRD 5 VARIABLE FORMULA||U|N|Y|Y|||NA|3||39||TREATMENT|1961-06-15|1972-01-01|||||1973-05-30||1962-08-25|N|1961-07-23
TRIAL STUDY 134XCP|LB|A8821AEE-49EB-4687-BB63-361BC3B8B182|2||||HYDROGEN|HYDROGEN|||||||MG/MOL|||||||TRACE||IU/MMOL||||NORMAL|NOT DONE||||CERUMEN|SOLIDIFIED|N|TOTAL BODY RADIOGRAPHY|HEPASCORE FORMULA||N|U|N|U|||N|3||39||SCREENING|1961-09-26|1962-07-18|||||1970-01-15||1960-02-08|NA|1963-05-21
TRIAL STUDY 134XCP|LB|A8821AEE-49EB-4687-BB63-361BC3B8B182|1||||AMYLASEM|MACROAMYLASE|||||||10^3 COPIES/ML|||||||BORDERLINE||MS/MMHG||||HIGH|NOT DONE||||BREAST MILK|PARAFFIN-EMBEDDED|Y|LEAD CITRATE STAIN|CKD-EPI CYSTATIN C FORMULA||U|N|U|NA|||Y|4||88||OBSERVATION|1964-12-24|1960-12-20|||||1963-07-27||1964-11-01|NA|1969-04-10
TRIAL STUDY 134XCP|LB|A8821AEE-49EB-4687-BB63-361BC3B8B182|2||||BTLBARTL|BUTABARBITAL|||||||MG/ML/MIN|||||||BORDERLINE||FG||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|Y|KNEMOMETRY|CKD-EPI FORMULA||U|Y|NA|NA|||NA|4||88||BASELINE|1973-04-05|1963-07-05|||||1966-03-18||1969-02-01|Y|1960-09-19
TRIAL STUDY 134XCP|LB|A8821AEE-49EB-4687-BB63-361BC3B8B182|1||||INTLK20|INTERLEUKIN 20|||||||L/S/KPA|||||||TRACE||UGEQ/L||||HIGH|NOT DONE||||PLEURAL FLUID|GELLED|Y|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CREATININE FORMULA||U|NA|Y|NA|||U|5||7||WASHOUT|1962-05-23|1971-05-24|||||1970-05-10||1963-01-11|NA|1967-08-25
TRIAL STUDY 134XCP|LB|A8821AEE-49EB-4687-BB63-361BC3B8B182|2||||HAIRYCE|HAIRY CELLS|||||||UG/KG/H|||||||INVALID||LOG10 ELISA UNIT/DOSE||||NORMAL|NOT DONE||||REFLEX TEAR|FRESH|NA|LIGHT MICROSCOPY|FIBROSIS 4 FORMULA||NA|U|Y|Y|||U|5||7||BASELINE|1971-05-31|1963-02-10|||||1961-06-20||1971-12-06|U|1966-02-20
TRIAL STUDY 134XCP|LB|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|1||||C165881|WHITE ELM POLLEN IGE ANTIBODY|||||||CFU/G|||||||INVALID||DAMOL/L||||LOW|NOT DONE||||MECONIUM|REFRIGERATED|U|WESTERN BLOT|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|N|U|||U|1||38||FOLLOW-UP|1960-03-27|1960-07-11|||||1966-09-30||1961-10-03|NA|1968-03-28
TRIAL STUDY 134XCP|LB|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|2||||HBOARBHB|HEMOGLOBIN O-ARAB/TOTAL HEMOGLOBIN|||||||10^3 DNA COPIES/ML|||||||BORDERLINE||G||||ABNORMAL|NOT DONE||||BONE|FROZEN|U|LC-FL|MDRD ENZYMATIC JAPANESE FORMULA||N|N|NA|N|||Y|1||38||WASHOUT|1967-10-21|1960-03-16|||||1965-05-15||1968-06-28|U|1961-02-24
TRIAL STUDY 134XCP|LB|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|1||||GRWHRH|GROWTH HORMONE RELEASING HORMONE|||||||UG/DAY|||||||NEGATIVE||PIXELS/CM||||HIGH|NOT DONE||||HAIR|ICTERIC|U|HPLC/IEX|FIBROMETER FORMULA||NA|Y|NA|U|||Y|2||58||TREATMENT|1967-07-27|1961-10-02|||||1965-10-05||1965-01-22|N|1967-03-29
TRIAL STUDY 134XCP|LB|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|2||||VLDL1|VLDL CHOLESTEROL SUBTYPE 1|||||||SIEMENS|||||||NEGATIVE||MPA||||LOW|NOT DONE||||TUMOR TISSUE|CONCENTRATED|Y|CLAUSS METHOD|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|Y|NA|||NA|2||58||OBSERVATION|1965-07-18|1963-06-30|||||1970-06-23||1960-11-06|N|1968-03-28
TRIAL STUDY 134XCP|LB|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|1||||FXAAC|FACTOR X ACTIVITY ACTUAL/CONTROL|||||||GRAVITATIONAL UNIT|||||||TRACE||UG||||NORMAL|NOT DONE||||SPUTUM|HEMOLYZED|NA|KLEIHAUER-BETKE|ASH FIBROSURE FORMULA||U|Y|Y|N|||N|3||39||SCREENING|1968-12-25|1973-04-18|||||1964-05-20||1964-12-07|NA|1972-02-12
TRIAL STUDY 134XCP|LB|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|2||||C130095|WESTERN RAGWEED POLLEN IGG4|||||||PM|||||||POSITIVE||JOULE||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|ROOM TEMPERATURE|U|CHROMATOGRAPHY|GMI % FORMULA||U|U|NA|U|||Y|3||39||BLINDED TREATMENT|1965-01-30|1966-01-08|||||1967-08-23||1964-07-03|Y|1964-06-07
TRIAL STUDY 134XCP|LB|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|1||||UDCA|URSODEOXYCHOLATE|||||||MEQ|||||||INVALID||U/L||||NORMAL|NOT DONE||||EXUDATE|SOLIDIFIED|N|IMMUNOCHEMILUMINOMETRIC ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|U|||Y|4||88||BLINDED TREATMENT|1960-02-21|1960-11-14|||||1967-09-18||1972-08-28|NA|1963-10-06
TRIAL STUDY 134XCP|LB|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|2||||BLSTRSID|RINGED SIDEROBLASTS|||||||MMOL|||||||TRACE||MPL U/ML||||NORMAL|NOT DONE||||LYSATE|HEMOLYZED|NA|MICROBIAL CULTURE, SOLID|COCKCROFT-GAULT FORMULA||U|NA|U|Y|||U|4||88||RUN-IN|1971-11-08|1973-07-26|||||1970-07-01||1962-09-10|Y|1967-05-29
TRIAL STUDY 134XCP|LB|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|1||||APOC2|APOLIPOPROTEIN C2|||||||10^9/L|||||||INDETERMINATE||/7.5 ML||||LOW|NOT DONE||||SUPERNATANT, PLASMA|THAWED|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|ASH FIBROSURE FORMULA||N|N|Y|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1963-01-09|1966-09-09|||||1964-10-14||1961-12-12|Y|1963-11-05
TRIAL STUDY 134XCP|LB|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|2||||MEPRDN|MEPERIDINE|||||||PELLET|||||||INDETERMINATE||CD||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|CONTAMINATED|N|POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||N|Y|Y|N|||U|5||7||SCREENING|1961-01-27|1973-04-20|||||1972-05-14||1969-12-24|Y|1960-04-11
TRIAL STUDY 134XCP|LB|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|1||||PLP|PYRIDOXAL PHOSPHATE|||||||/MONTH|||||||BORDERLINE||ML/S/M2||||LOW|NOT DONE||||URINE SEDIMENT|HEMOLYZED|N|CONFOCAL MICROSCOPY|CKD-EPI FORMULA||U|NA|U|Y|||N|1||38||BLINDED TREATMENT|1962-12-27|1963-08-27|||||1963-09-16||1961-06-29|Y|1970-01-01
TRIAL STUDY 134XCP|LB|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|2||||C130119|DAIRY MIX ANTIGEN IGG ANTIBODY|||||||10^6/L|||||||BORDERLINE||PMOL/L||||NORMAL|NOT DONE||||URINE|UNEXPECTED ODOR|U|TARGETED GENOME SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|Y|N|N|||U|1||38||OBSERVATION|1970-03-20|1968-04-09|||||1964-12-20||1963-11-07|NA|1962-12-21
TRIAL STUDY 134XCP|LB|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|1||||C165901|ENGLISHPLANTAIN POLLEN IGG AB RAST SCORE|||||||10^7 TCID 50/DOSE|||||||POSITIVE||BU/ML||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|CLOTTED|NA|MICROBIAL CULTURE, SOLID|NASH FIBROSURE FORMULA||U|N|U|Y|||NA|2||58||CONTINUATION TREATMENT|1970-05-17|1966-06-25|||||1964-05-08||1968-05-03|U|1962-05-28
TRIAL STUDY 134XCP|LB|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|2||||NTXII|TYPE II COLLAGEN N-TELOPEPTIDES|||||||KIT|||||||NEGATIVE||UG/KG/DAY||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|FROZEN|Y|IVY INCISION METHOD|ASH FIBROSURE FORMULA||Y|Y|Y|N|||N|2||58||BLINDED TREATMENT|1961-10-30|1961-02-22|||||1970-01-06||1966-08-26|N|1966-08-31
TRIAL STUDY 134XCP|LB|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|1||||INTLK30|INTERLEUKIN 30|||||||/MM2|||||||POSITIVE||NMOL/L/H||||HIGH|NOT DONE||||SERUM OR PLASMA|NON-HEMOLYZED|NA|LINE PROBE ASSAY|HEPASCORE FORMULA||N|U|Y|U|||N|3||39||OBSERVATION|1963-04-17|1969-10-28|||||1968-11-14||1972-01-23|Y|1964-12-13
TRIAL STUDY 134XCP|LB|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|2||||C130101|TREE MIX POLLEN ANTIGEN IGE ANTIBODY|||||||UG/M2/H|||||||NEGATIVE||SYRINGE||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|FRESH|NA|SPECT SCAN|NASH FIBROSURE FORMULA||U|N|Y|NA|||U|3||39||WASHOUT|1968-04-30|1965-01-18|||||1965-07-05||1965-05-02|NA|1966-07-02
TRIAL STUDY 134XCP|LB|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|1||||HAHA|HUMAN ANTI-HUMAN ANTIBODY|||||||PMOL/10^10 CELLS|||||||NEGATIVE||L/H||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|UNEXPECTED ODOR|N|CONTRAST ENHANCED PET/CT SCAN|COCKCROFT-GAULT FORMULA||N|NA|U|Y|||N|4||88||INDUCTION TREATMENT|1960-05-28|1963-11-14|||||1972-07-28||1964-09-02|U|1968-09-03
TRIAL STUDY 134XCP|LB|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|2||||HCHT|HYOCHOLATE|||||||NFIU|||||||BORDERLINE||DAYS||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|ROOM TEMPERATURE|N|ATOMIC ABSORPTION SPECTROMETRY|FIBROMETER FORMULA||NA|U|U|NA|||Y|4||88||SCREENING|1961-01-06|1968-05-19|||||1961-12-19||1973-01-27|U|1966-11-05
TRIAL STUDY 134XCP|LB|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|1||||COL4|COLLAGEN TYPE IV|||||||100 IU/ML|||||||INDETERMINATE||U/G/DAY||||LOW|NOT DONE||||GASTRIC CONTENTS|ICTERIC|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|FIBROTEST FORMULA||Y|N|N|N|||N|5||7||WASHOUT|1971-03-02|1960-05-15|||||1967-03-19||1969-05-22|NA|1970-04-09
TRIAL STUDY 134XCP|LB|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|2||||C165906|WEED MIX POLLEN IGG AB RAST SCORE|||||||DEG|||||||NEGATIVE||ML/S||||LOW|NOT DONE||||PLEURAL TISSUE|REFRIGERATED|N|RIA|MDRD ENZYMATIC FORMULA||Y|Y|U|U|||NA|5||7||WASHOUT|1963-12-09|1960-03-09|||||1961-08-09||1970-05-30|N|1960-12-05
TRIAL STUDY 134XCP|LB|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|1||||INTLK19|INTERLEUKIN 19|||||||ML/CAGE/DAY|||||||POSITIVE||MG/ANIMAL||||NORMAL|NOT DONE||||PERSPIRATION|CALCIFIED|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|CKD-EPI FORMULA||U|N|NA|N|||N|1||38||INDUCTION TREATMENT|1965-08-22|1965-11-04|||||1970-03-03||1966-07-02|U|1969-11-13
TRIAL STUDY 134XCP|LB|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|2||||FENTANYL|FENTANYL|||||||MMHG*MIN/L|||||||TRACE||PELLET||||NORMAL|NOT DONE||||CAPILLARY PLASMA|DRIED|N|LEAD CITRATE STAIN|FIBROMETER FORMULA||U|NA|U|U|||Y|1||38||FOLLOW-UP|1973-04-02|1964-08-18|||||1969-08-28||1968-05-24|U|1972-06-22
TRIAL STUDY 134XCP|LB|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|1||||LEU|LEUCINE|||||||POINT|||||||TRACE||L/S||||LOW|NOT DONE||||PERSPIRATION|LIPEMIC|U|CISH|ASH FIBROSURE FORMULA||NA|Y|N|NA|||NA|2||58||RUN-IN|1963-03-16|1969-07-17|||||1969-05-21||1963-07-11|Y|1961-11-22
TRIAL STUDY 134XCP|LB|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|2||||CYP2C9|CYTOCHROME P450 2C9|||||||G|||||||NEGATIVE||NG/DL||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|THAWED|U|BAC ACGH|FIBROTEST FORMULA||NA|NA|N|Y|||N|2||58||FOLLOW-UP|1966-05-18|1963-10-25|||||1970-01-09||1960-07-05|U|1960-01-10
TRIAL STUDY 134XCP|LB|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|1||||S100B|S100 CALCIUM-BINDING PROTEIN B|||||||IU/KG/H|||||||INDETERMINATE||MOL/G||||NORMAL|NOT DONE||||PLEURAL FLUID|ROOM TEMPERATURE|Y|ECHOCARDIOGRAPHY|ASH FIBROSURE FORMULA||NA|N|U|Y|||N|3||39||SCREENING|1969-05-05|1964-10-20|||||1970-06-07||1970-10-20|U|1961-07-02
TRIAL STUDY 134XCP|LB|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|2||||FAT|FAT|||||||L/S|||||||BORDERLINE||/10^4||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|CALCIFIED|N|MACRO BROTH DILUTION|CKD-EPI FORMULA||Y|N|NA|U|||Y|3||39||BLINDED TREATMENT|1962-11-26|1960-07-15|||||1960-07-05||1963-10-25|N|1964-08-30
TRIAL STUDY 134XCP|LB|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|1||||ODMTASE|O-DEMETHYLASE|||||||KEV|||||||INVALID||10^9 ORGANISMS/MG||||ABNORMAL|NOT DONE||||MUCUS|REFRIGERATED|NA|ATOMIC ABSORPTION SPECTROMETRY|GMI MMOL/MOL FORMULA||NA|NA|Y|Y|||Y|4||88||LONG-TERM FOLLOW-UP|1964-08-24|1961-11-18|||||1970-07-20||1968-06-23|Y|1962-04-05
TRIAL STUDY 134XCP|LB|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|2||||LDH5LDH|LDH ISOENZYME 5/LDH|||||||FG|||||||TRACE||IU/G HB||||NORMAL|NOT DONE||||REFLEX TEAR|FRESH|U|DUCTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|Y|NA|||N|4||88||LONG-TERM FOLLOW-UP|1967-09-29|1969-07-08|||||1970-11-11||1964-09-20|N|1971-01-18
TRIAL STUDY 134XCP|LB|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|1||||FLUOXTN|FLUOXETINE|||||||GBQ/G|||||||BORDERLINE||IMPLANT||||LOW|NOT DONE||||SUPERNATANT, PLASMA|ROOM TEMPERATURE|NA|ICC|MDRD ENZYMATIC FORMULA||Y|U|N|N|||N|5||7||TREATMENT|1966-05-30|1964-12-04|||||1968-02-16||1964-08-19|U|1970-03-18
TRIAL STUDY 134XCP|LB|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|2||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||APPLICATION|||||||INDETERMINATE||UMOL/KG/MIN||||NORMAL|NOT DONE||||PROSTATIC FLUID|FRESH|N|AURAMINE STAIN|FIBROSIS 4 FORMULA||Y|NA|Y|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1967-08-09|1972-08-09|||||1966-02-08||1971-11-07|NA|1966-02-10
TRIAL STUDY 134XCP|LB|E711C534-E58F-4B41-95CC-24E938D89B61|1||||CYDRUG|DRUG CRYSTALS|||||||10^9/G|||||||POSITIVE||MET*H||||HIGH|NOT DONE||||SKIN TISSUE|CONTAMINATED|N|PHOROPTER|FIBROMETER FORMULA||U|N|NA|N|||N|1||38||LONG-TERM FOLLOW-UP|1970-08-24|1962-03-04|||||1960-03-01||1972-04-28|NA|1971-09-08
TRIAL STUDY 134XCP|LB|E711C534-E58F-4B41-95CC-24E938D89B61|2||||PRZPM|PRAZEPAM|||||||FMOL|||||||TRACE||MOL||||HIGH|NOT DONE||||COLOSTRUM|PARAFFIN-EMBEDDED|N|SLIT LAMP PHOTOGRAPHY|GMI MMOL/MOL FORMULA||U|U|Y|Y|||U|1||38||SCREENING|1970-08-29|1965-06-03|||||1972-12-18||1968-02-26|U|1967-05-25
TRIAL STUDY 134XCP|LB|E711C534-E58F-4B41-95CC-24E938D89B61|1||||LYMATLE|LYMPHOCYTES ATYPICAL/LEUKOCYTES|||||||%/S|||||||NEGATIVE||10^8/L||||LOW|NOT DONE||||EMESIS|AGGLUTINATED|NA|TRYPAN BLUE STAIN|MDRD ENZYMATIC FORMULA||Y|NA|NA|Y|||N|2||58||SCREENING|1963-05-10|1960-04-24|||||1965-04-13||1973-08-03|N|1963-10-30
TRIAL STUDY 134XCP|LB|E711C534-E58F-4B41-95CC-24E938D89B61|2||||CHOLCM|CHOLATE COMPOUNDS|||||||MIN*MG/ML|||||||INVALID||MEQ/MMOL||||HIGH|NOT DONE||||BREAST MILK|CONCENTRATED|Y|PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC FORMULA||Y|NA|NA|Y|||U|2||58||WASHOUT|1969-09-20|1961-05-24|||||1967-05-06||1960-10-02|Y|1973-04-24
TRIAL STUDY 134XCP|LB|E711C534-E58F-4B41-95CC-24E938D89B61|1||||ABNCE|ABNORMAL CELLS|||||||S^-1(%O2)^-1|||||||INDETERMINATE||/10^5||||LOW|NOT DONE||||NAIL|CONCENTRATED|NA|GRAM STAIN|GMI % FORMULA||NA|Y|Y|NA|||N|3||39||LONG-TERM FOLLOW-UP|1962-10-31|1971-06-19|||||1967-04-13||1972-08-01|Y|1964-07-07
TRIAL STUDY 134XCP|LB|E711C534-E58F-4B41-95CC-24E938D89B61|2||||APOC2|APOLIPOPROTEIN C2|||||||ML/BEAT|||||||INDETERMINATE||MMOL/DAY||||ABNORMAL|NOT DONE||||VENOUS BLOOD|REFRIGERATED|U|CYSTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|Y|N|||U|3||39||LONG-TERM FOLLOW-UP|1967-06-11|1965-05-24|||||1966-10-07||1966-06-11|N|1970-08-11
TRIAL STUDY 134XCP|LB|E711C534-E58F-4B41-95CC-24E938D89B61|1||||LDH1LDH|LDH ISOENZYME 1/LDH|||||||G/ANIMAL|||||||TRACE||VP/ML||||ABNORMAL|NOT DONE||||PLEURAL FLUID|HEMOLYZED|NA|LIGHT SCATTERING SPECTROSCOPY|GMI MMOL/MOL FORMULA||N|N|Y|NA|||N|4||88||LONG-TERM FOLLOW-UP|1964-11-08|1968-07-18|||||1962-10-16||1968-07-22|U|1964-07-26
TRIAL STUDY 134XCP|LB|E711C534-E58F-4B41-95CC-24E938D89B61|2||||HRYCELE|HAIRY CELLS/LEUKOCYTES|||||||MCI|||||||INVALID||SPRAY||||ABNORMAL|NOT DONE||||CALCULUS|SOLIDIFIED|U|NEXT GENERATION TARGETED SEQUENCING|FIBROTEST FORMULA||NA|NA|N|NA|||Y|4||88||FOLLOW-UP|1971-02-03|1961-06-18|||||1962-02-16||1971-01-06|U|1961-05-31
TRIAL STUDY 134XCP|LB|E711C534-E58F-4B41-95CC-24E938D89B61|1||||PGE2|PROSTAGLANDIN E2|||||||COPIES/ML|||||||POSITIVE||PMOL/G||||NORMAL|NOT DONE||||SWABBED MATERIAL|GELLED|U|SPECULAR MICROSCOPY|ASH FIBROSURE FORMULA||Y|Y|N|Y|||N|5||7||CONTINUATION TREATMENT|1963-07-01|1961-04-13|||||1967-01-20||1967-09-18|NA|1964-09-02
TRIAL STUDY 134XCP|LB|E711C534-E58F-4B41-95CC-24E938D89B61|2||||HOWJOL|HOWELL-JOLLY BODIES|||||||OZ EQ|||||||BORDERLINE||10^9 CFU/G||||NORMAL|NOT DONE||||AQUEOUS HUMOR|REFRIGERATED|N|INTERRUPTER TECHNIQUE|CKD-EPI CYSTATIN C FORMULA||NA|NA|N|N|||NA|5||7||OBSERVATION|1972-03-11|1962-10-02|||||1963-08-04||1970-04-21|U|1970-02-02
TRIAL STUDY 134XCP|LB|83938342-C01F-491A-84A7-F85D327F112D|1||||CCPIGGAB|CYCLIC CITRULLINATED PEPTIDE IGG AB|||||||LOG10 TCID 50/DOSE|||||||INVALID||10^8/L||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|PARAFFIN-EMBEDDED|NA|DXA SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|NA|Y|||Y|1||38||BASELINE|1968-03-28|1960-08-15|||||1966-02-26||1971-05-18|Y|1961-03-24
TRIAL STUDY 134XCP|LB|83938342-C01F-491A-84A7-F85D327F112D|2||||B2GLYAB|BETA-2 GLYCOPROTEIN ANTIBODY|||||||MOSM/KG|||||||POSITIVE||UMOL/MOL||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|DRIED|N|REVERSE TRANSCRIPTASE PCR|HEPASCORE FORMULA||Y|Y|N|Y|||U|1||38||RUN-IN|1966-12-01|1969-09-24|||||1968-06-17||1961-06-05|N|1968-12-16
TRIAL STUDY 134XCP|LB|83938342-C01F-491A-84A7-F85D327F112D|1||||ACYGLYCN|ACYLGLYCINE|||||||MMOL/MIN/KPA|||||||BORDERLINE||U/G||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED|N|IODINE STAIN|CKD-EPI CYSTATIN C FORMULA||U|N|Y|N|||NA|2||58||INDUCTION TREATMENT|1966-05-27|1966-05-29|||||1964-01-08||1962-06-14|U|1968-03-07
TRIAL STUDY 134XCP|LB|83938342-C01F-491A-84A7-F85D327F112D|2||||CD14|CD14|||||||BOWL|||||||INVALID||V||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|CONTAMINATED|U|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|FIBROSIS 4 FORMULA||U|NA|NA|N|||N|2||58||LONG-TERM FOLLOW-UP|1973-01-11|1967-05-31|||||1972-10-01||1965-06-02|Y|1964-09-05
TRIAL STUDY 134XCP|LB|83938342-C01F-491A-84A7-F85D327F112D|1||||C165914|CAT DANDER IGG AB RAST SCORE|||||||MASK|||||||TRACE||UIU/DL||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|HEMOLYZED|N|PHYSICAL EXAMINATION|GMI % FORMULA||NA|NA|N|N|||N|3||39||CONTINUATION TREATMENT|1961-12-19|1972-01-30|||||1966-10-23||1964-06-12|N|1962-10-30
TRIAL STUDY 134XCP|LB|83938342-C01F-491A-84A7-F85D327F112D|2||||INSULINS|INSULIN SENSITIVITY|||||||M2|||||||INDETERMINATE||10^6 RNA COPIES/ML||||ABNORMAL|NOT DONE||||LOCHIA|CONTAMINATED|U|MICROSCOPY|FIBROSIS 4 FORMULA||U|N|Y|Y|||NA|3||39||RUN-IN|1970-11-20|1971-02-21|||||1971-08-27||1970-09-27|N|1968-05-16
TRIAL STUDY 134XCP|LB|83938342-C01F-491A-84A7-F85D327F112D|1||||BLSTMKCE|MEGAKARYOBLASTS/TOTAL CELLS|||||||DISK|||||||INDETERMINATE||TITER||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|GELLED|N|CALCOFLUOR WHITE STAIN|CKD-EPI FORMULA||U|N|Y|NA|||NA|4||88||SCREENING|1962-02-25|1972-08-27|||||1963-05-14||1966-02-05|Y|1969-10-28
TRIAL STUDY 134XCP|LB|83938342-C01F-491A-84A7-F85D327F112D|2||||BLYCELE|B-LYMPHOCYTES/LEUKOCYTES|||||||DEG/S|||||||INDETERMINATE||CM/S||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|HEMOLYZED|Y|FUNCTIONAL MRI|HEPASCORE FORMULA||U|N|Y|Y|||NA|4||88||OPEN LABEL TREATMENT|1967-02-16|1966-01-07|||||1970-07-11||1968-08-18|Y|1966-02-05
TRIAL STUDY 134XCP|LB|83938342-C01F-491A-84A7-F85D327F112D|1||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||AFU|||||||BORDERLINE||10^3 CFU/G||||HIGH|NOT DONE||||PERITONEAL FLUID|PARAFFIN-EMBEDDED|NA|THICK SMEAR|CKD-EPI CREATININE FORMULA||NA|N|Y|N|||U|5||7||LONG-TERM FOLLOW-UP|1968-08-26|1961-05-16|||||1965-12-21||1972-05-24|NA|1960-11-03
TRIAL STUDY 134XCP|LB|83938342-C01F-491A-84A7-F85D327F112D|2||||MPC|MEAN PLATELET COMPONENT|||||||MOSM/L|||||||TRACE||OD UNIT||||HIGH|NOT DONE||||MUCUS|GELLED|NA|PULSE OXIMETRY|CKD-EPI FORMULA||Y|Y|N|N|||N|5||7||CONTINUATION TREATMENT|1968-02-16|1965-12-20|||||1966-01-26||1965-01-28|NA|1962-09-10
TRIAL STUDY 134XCP|LB|731665AB-4418-4943-BFC5-D78F03C8D423|1||||C165929|BEE MIX IGE AB RAST SCORE|||||||MEQ/MMOL|||||||POSITIVE||U/G/DAY||||HIGH|NOT DONE||||SEMEN|FRESH|Y|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|CKD-EPI CYSTATIN C FORMULA||U|NA|U|U|||N|1||38||BLINDED TREATMENT|1969-04-16|1963-08-07|||||1973-01-04||1971-05-05|N|1960-02-18
TRIAL STUDY 134XCP|LB|731665AB-4418-4943-BFC5-D78F03C8D423|2||||RETIL|LOW ABSORPTION RETICULOCYTES|||||||MMHG/L/MIN|||||||NEGATIVE||BQ/UG||||HIGH|NOT DONE||||DIALYSIS FLUID|LIPEMIC|U|PH METER MEASUREMENT METHOD|MDRD 5 VARIABLE FORMULA||Y|U|N|NA|||Y|1||38||WASHOUT|1962-06-27|1966-01-11|||||1961-08-24||1965-09-14|Y|1971-12-08
TRIAL STUDY 134XCP|LB|731665AB-4418-4943-BFC5-D78F03C8D423|1||||ERCEPIDX|ERYTHROID PROLIFERATION INDEX|||||||DL|||||||INDETERMINATE||MU/L||||LOW|NOT DONE||||BUFFY COAT|FROZEN|U|PALPATION|MDRD 5 VARIABLE FORMULA||N|N|Y|N|||N|2||58||LONG-TERM FOLLOW-UP|1970-08-22|1968-06-21|||||1967-07-09||1968-08-11|Y|1971-01-10
TRIAL STUDY 134XCP|LB|731665AB-4418-4943-BFC5-D78F03C8D423|2||||EPISQTCE|SQUAMOUS TRANSITIONAL EPITHELIAL CELLS|||||||UG/DAY|||||||INDETERMINATE||CI/ML||||NORMAL|NOT DONE||||SEMEN|ICTERIC|Y|MICROPARTICLE ENZYME IMMUNOASSAY|FIBROTEST FORMULA||N|Y|U|U|||Y|2||58||TREATMENT|1964-06-21|1972-12-02|||||1967-11-20||1971-12-01|Y|1971-01-24
TRIAL STUDY 134XCP|LB|731665AB-4418-4943-BFC5-D78F03C8D423|1||||ALPIS|INTESTINAL SPECIFIC ALKALINE PHOSPHATASE|||||||MIN/DAY|||||||TRACE||LM||||NORMAL|NOT DONE||||BREAST MILK|AGGLUTINATED|NA|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|ASH FIBROSURE FORMULA||Y|N|NA|NA|||U|3||39||RUN-IN|1968-01-31|1962-11-01|||||1973-07-18||1964-12-12|NA|1964-03-22
TRIAL STUDY 134XCP|LB|731665AB-4418-4943-BFC5-D78F03C8D423|2||||FENA|FRACTIONAL SODIUM EXCRETION|||||||% INHIBITION|||||||TRACE||/MIN||||NORMAL|NOT DONE||||ADIPOSE TISSUE|SOLIDIFIED|U|COMPLEMENT FIXATION|MDRD 6 VARIABLE FORMULA||NA|Y|U|N|||NA|3||39||TREATMENT|1965-10-26|1965-05-12|||||1966-10-15||1968-05-24|Y|1962-04-23
TRIAL STUDY 134XCP|LB|731665AB-4418-4943-BFC5-D78F03C8D423|1||||SPMMSPM|MOTILE SPERM/TOTAL SPERM|||||||S/H|||||||BORDERLINE||FMOL||||ABNORMAL|NOT DONE||||DISCHARGE|THAWED|Y|CHROMOGENIC ASSAY|GMI MMOL/MOL FORMULA||N|N|Y|U|||U|4||88||RUN-IN|1971-01-16|1964-02-22|||||1967-03-12||1969-11-29|NA|1964-01-12
TRIAL STUDY 134XCP|LB|731665AB-4418-4943-BFC5-D78F03C8D423|2||||FEK|FRACTIONAL POTASSIUM EXCRETION|||||||CI/L|||||||TRACE||FRAMES/S||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|CLOTTED|NA|CELLULOSE TAPE|MDRD FORMULA||N|Y|Y|Y|||NA|4||88||OPEN LABEL TREATMENT|1966-07-09|1968-06-24|||||1970-10-20||1972-08-06|Y|1960-10-01
TRIAL STUDY 134XCP|LB|731665AB-4418-4943-BFC5-D78F03C8D423|1||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||/10^3|||||||INDETERMINATE||MG/KG/DOSE||||ABNORMAL|NOT DONE||||MUCUS|FRESH|N|DYNAMIC CONTRAST ENHANCED MRI|MDRD ENZYMATIC FORMULA||U|NA|Y|Y|||NA|5||7||BASELINE|1963-09-02|1965-12-12|||||1967-10-19||1961-03-23|NA|1968-07-26
TRIAL STUDY 134XCP|LB|731665AB-4418-4943-BFC5-D78F03C8D423|2||||PHTRMN|PHENTERMINE|||||||UEQ/L|||||||POSITIVE||KBQ||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|FRESH|N|U-HPLC/MS/MS|HEPASCORE FORMULA||U|Y|N|U|||NA|5||7||INDUCTION TREATMENT|1963-01-16|1969-12-09|||||1962-11-07||1966-01-10|N|1969-05-25
TRIAL STUDY 134XCP|LB|3E337B9F-D718-4FE6-83D8-E05BC77CA872|1||||ACYGLYCN|ACYLGLYCINE|||||||MCI/L|||||||POSITIVE||GBQ/MG||||LOW|NOT DONE||||LYSATE|AGGLUTINATED|NA|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|U|N|||NA|1||38||TREATMENT|1961-05-30|1963-07-30|||||1966-03-31||1965-03-08|U|1968-09-29
TRIAL STUDY 134XCP|LB|3E337B9F-D718-4FE6-83D8-E05BC77CA872|2||||DSVLFXN|DESVENLAFAXINE|||||||GAUSS|||||||INVALID||MIN||||LOW|NOT DONE||||SERUM|FROZEN|U|SURFACE PLASMON RESONANCE|GMI % FORMULA||N|NA|U|Y|||Y|1||38||SCREENING|1969-03-01|1960-12-11|||||1968-08-26||1961-07-13|NA|1960-09-16
TRIAL STUDY 134XCP|LB|3E337B9F-D718-4FE6-83D8-E05BC77CA872|1||||DNA|DEOXYRIBONUCLEIC ACID|||||||MPL U|||||||TRACE||GPL U||||ABNORMAL|NOT DONE||||BONE MARROW|FRESH|U|ELECTROPHORESIS|FIBROSIS 4 FORMULA||NA|N|N|NA|||N|2||58||LONG-TERM FOLLOW-UP|1965-09-07|1965-09-04|||||1971-10-28||1964-10-22|Y|1973-08-09
TRIAL STUDY 134XCP|LB|3E337B9F-D718-4FE6-83D8-E05BC77CA872|2||||EDMAB|ENDOMYSIAL ANTIBODY|||||||NG|||||||BORDERLINE||C||||HIGH|NOT DONE||||CELL PELLET|CLOTTED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA||NA|N|Y|NA|||Y|2||58||CONTINUATION TREATMENT|1969-09-06|1972-12-08|||||1966-08-08||1966-03-09|N|1966-12-01
TRIAL STUDY 134XCP|LB|3E337B9F-D718-4FE6-83D8-E05BC77CA872|1||||MCSF|MACROPHAGE COLONY STIMULATING FACTOR|||||||SEC|||||||INDETERMINATE||10^6 ORGANISMS/MG||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|SOLIDIFIED|N|PULSE OXIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|Y|||N|3||39||OBSERVATION|1971-05-16|1972-07-21|||||1968-06-05||1971-08-15|U|1963-07-29
TRIAL STUDY 134XCP|LB|3E337B9F-D718-4FE6-83D8-E05BC77CA872|2||||LSELS|SOLUBLE L-SELECTIN|||||||MMOL2/L2|||||||POSITIVE||DEG/S||||LOW|NOT DONE||||CEREBROSPINAL FLUID|NON-HEMOLYZED|Y|CONTACT SPECULAR MICROSCOPY|MDRD 6 VARIABLE FORMULA||Y|Y|Y|U|||Y|3||39||CONTINUATION TREATMENT|1970-05-14|1963-02-11|||||1966-12-11||1973-09-04|Y|1972-07-22
TRIAL STUDY 134XCP|LB|3E337B9F-D718-4FE6-83D8-E05BC77CA872|1||||GRWHIH|GROWTH HORMONE INHIBITING HORMONE|||||||MDFI|||||||BORDERLINE||M3||||NORMAL|NOT DONE||||AQUEOUS HUMOR|DRIED|N|FUNDUS PHOTOGRAPHY|GMI MMOL/MOL FORMULA||Y|NA|NA|Y|||U|4||88||SCREENING|1967-12-19|1964-04-14|||||1971-05-29||1961-07-11|NA|1962-11-02
TRIAL STUDY 134XCP|LB|3E337B9F-D718-4FE6-83D8-E05BC77CA872|2||||C130118|BEE MIX ANTIGEN IGG4 ANTIBODY|||||||U/G HB|||||||INDETERMINATE||PPTH||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|LACTESCENT|NA|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI FORMULA||NA|N|N|Y|||Y|4||88||BASELINE|1966-02-12|1966-03-27|||||1971-11-26||1967-08-30|Y|1967-05-20
TRIAL STUDY 134XCP|LB|3E337B9F-D718-4FE6-83D8-E05BC77CA872|1||||CCPIGGAB|CYCLIC CITRULLINATED PEPTIDE IGG AB|||||||MBQ|||||||NEGATIVE||GBQ/MG||||NORMAL|NOT DONE||||KERATINOCYTE|LIPEMIC|NA|CLAUSS METHOD|COCKCROFT-GAULT FORMULA||Y|U|Y|U|||N|5||7||CONTINUATION TREATMENT|1961-07-28|1972-05-31|||||1967-05-17||1962-07-12|NA|1968-08-19
TRIAL STUDY 134XCP|LB|3E337B9F-D718-4FE6-83D8-E05BC77CA872|2||||HSP90A|HEAT SHOCK PROTEIN 90 ALPHA|||||||TRANSDUCING UNIT/ML|||||||INDETERMINATE||UU/L||||NORMAL|NOT DONE||||SEBUM|CONCENTRATED|U|DNA MICROARRAY|MDRD ENZYMATIC FORMULA||NA|N|U|Y|||NA|5||7||INDUCTION TREATMENT|1962-08-12|1972-04-11|||||1967-09-03||1960-08-18|Y|1963-05-14
TRIAL STUDY 134XCP|LB|D5243E6E-2521-4331-ABFB-75112D06F771|1||||C165888|RUSSIAN THISTLE POLLEN IGE ANTIBODY|||||||ML/ANIMAL|||||||INDETERMINATE||MONTHS||||NORMAL|NOT DONE||||PLATELET|HEMOLYZED|N|PALPATION|NASH FIBROSURE FORMULA||N|Y|Y|NA|||NA|1||38||LONG-TERM FOLLOW-UP|1963-07-03|1962-11-09|||||1969-11-22||1967-08-02|U|1962-07-27
TRIAL STUDY 134XCP|LB|D5243E6E-2521-4331-ABFB-75112D06F771|2||||PGE1|PROSTAGLANDIN E1|||||||10^6 IU/ML|||||||INVALID||DRUM||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|U|||U|1||38||INDUCTION TREATMENT|1965-06-24|1966-07-06|||||1969-11-30||1968-11-24|NA|1968-07-04
TRIAL STUDY 134XCP|LB|D5243E6E-2521-4331-ABFB-75112D06F771|1||||CRTCLRBS|CREATININE CLEARANCE ADJUSTED FOR BSA|||||||ML/MMHG/MIN/L|||||||NEGATIVE||HOMEOPATHIC DILUTION||||NORMAL|NOT DONE||||GASTRIC FLUID|UNEXPECTED ODOR|Y|PET/MRI SCAN|MDRD ENZYMATIC FORMULA||N|NA|Y|NA|||Y|2||58||OBSERVATION|1965-03-02|1971-01-23|||||1966-06-18||1968-05-11|Y|1969-06-21
TRIAL STUDY 134XCP|LB|D5243E6E-2521-4331-ABFB-75112D06F771|2||||INGAPAB|ISLET NEOGENESIS ASSOC PROTEIN ANTIBODY|||||||ML/G/H|||||||INDETERMINATE||UKAT/L||||NORMAL|NOT DONE||||CERUMEN|ICTERIC|N|AUTOREFRACTION|ASH FIBROSURE FORMULA||U|N|Y|N|||Y|2||58||BLINDED TREATMENT|1972-07-15|1972-05-03|||||1964-03-27||1973-05-17|NA|1965-01-20
TRIAL STUDY 134XCP|LB|D5243E6E-2521-4331-ABFB-75112D06F771|1||||GLOBB|BETA GLOBULIN|||||||10^8/L|||||||INDETERMINATE||UG/M2/DAY||||ABNORMAL|NOT DONE||||LOCHIA|GELLED|Y|DYNAMIC LIGHT SCATTERING|GMI % FORMULA||NA|N|Y|N|||N|3||39||TREATMENT|1965-11-16|1971-01-07|||||1969-08-04||1972-08-04|NA|1967-03-25
TRIAL STUDY 134XCP|LB|D5243E6E-2521-4331-ABFB-75112D06F771|2||||HGBFPATN|HEMOGLOBIN FRACTION PATTERN|||||||UCI/L|||||||TRACE||MMOL/KG||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|N|FLUORESCEIN STAIN|ASH FIBROSURE FORMULA||NA|U|Y|U|||N|3||39||SCREENING|1967-02-28|1965-03-14|||||1961-06-24||1960-12-29|U|1970-10-13
TRIAL STUDY 134XCP|LB|D5243E6E-2521-4331-ABFB-75112D06F771|1||||UNSPCELE|UNSPECIFIED CELLS/LEUKOCYTES|||||||U/L|||||||BORDERLINE||ML/BREATH||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|AUTOLYZED|N|PERIPHERAL ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|N|U|Y|||N|4||88||LONG-TERM FOLLOW-UP|1960-12-14|1962-09-15|||||1964-08-21||1962-08-13|U|1964-06-27
TRIAL STUDY 134XCP|LB|D5243E6E-2521-4331-ABFB-75112D06F771|2||||C165897|BERMUDA GRASS POLLEN IGG AB RAST SCORE|||||||KAT|||||||NEGATIVE||CPM||||LOW|NOT DONE||||GASTRIC FLUID|FRESH|N|SURFACE PLASMON RESONANCE|CKD-EPI CYSTATIN C FORMULA||NA|U|U|N|||N|4||88||INDUCTION TREATMENT|1968-09-02|1971-12-07|||||1962-10-14||1967-07-27|NA|1970-08-03
TRIAL STUDY 134XCP|LB|D5243E6E-2521-4331-ABFB-75112D06F771|1||||PYRIDNLN|PYRIDINOLINE|||||||MMHG|||||||NEGATIVE||10^6 DNA COPIES/ML||||ABNORMAL|NOT DONE||||SEMEN|DRIED|NA|REFLECTANCE SPECTROSCOPY|MDRD 4 VARIABLE FORMULA||Y|NA|NA|N|||U|5||7||BLINDED TREATMENT|1963-03-29|1965-11-12|||||1973-03-18||1963-07-20|Y|1961-06-15
TRIAL STUDY 134XCP|LB|D5243E6E-2521-4331-ABFB-75112D06F771|2||||NHMCE|NONHEMATIC CELLS|||||||FMOL/G|||||||POSITIVE||MM/H||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|THAWED|NA|PATHOLOGICAL EVALUATION|CKD-EPI CREATININE FORMULA||Y|N|U|U|||U|5||7||BLINDED TREATMENT|1960-02-01|1963-07-05|||||1971-03-07||1966-01-03|N|1973-04-23
TRIAL STUDY 134XCP|LB|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|1||||TNFR5S|SOLUBLE TNF RECEPTOR SUPERFAMILY MEM 5|||||||GBQ|||||||POSITIVE||KBQ||||HIGH|NOT DONE||||URINE|NON-HEMOLYZED|Y|TEST STRIP|CKD-EPI CREATININE FORMULA||Y|N|NA|Y|||Y|1||38||BLINDED TREATMENT|1965-09-27|1968-10-17|||||1962-05-31||1971-01-24|U|1964-12-06
TRIAL STUDY 134XCP|LB|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|2||||MMP1|MATRIX METALLOPROTEINASE 1|||||||BEAM BREAKS|||||||BORDERLINE||ML/CM H2O||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|FRESH|U|HPLC/IEX|GMI % FORMULA||N|U|Y|Y|||Y|1||38||SCREENING|1971-07-26|1973-09-02|||||1966-12-05||1967-08-28|U|1961-07-11
TRIAL STUDY 134XCP|LB|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|1||||CXCL9|CHEMOKINE (C-X-C MOTIF) LIGAND 9|||||||10^6/EJACULATE U|||||||INDETERMINATE||L/MIN||||HIGH|NOT DONE||||RETICULOCYTES|NON-HEMOLYZED|U|SICKLE CELL SOLUBILITY TEST|MDRD ENZYMATIC FORMULA||N|U|N|NA|||N|2||58||FOLLOW-UP|1962-04-19|1961-03-10|||||1969-05-01||1973-02-27|Y|1961-12-16
TRIAL STUDY 134XCP|LB|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|2||||CARTP|COCAINE AMPHETAMINE-REG TRANSCRIPT PROT|||||||MG/ML/DAY|||||||NEGATIVE||BE/ML||||LOW|NOT DONE||||VITREOUS HUMOR|GELLED|NA|REFRACTOMETRY|MDRD ENZYMATIC FORMULA||Y|N|Y|NA|||U|2||58||RUN-IN|1966-12-11|1965-01-03|||||1967-12-09||1968-11-03|N|1969-08-17
TRIAL STUDY 134XCP|LB|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|1||||TK|THYMIDINE KINASE|||||||/100 HPFS|||||||BORDERLINE||MHZ||||NORMAL|NOT DONE||||MONOCYTE|FROZEN|N|HPLC/MS/MS|MDRD ENZYMATIC FORMULA||NA|NA|NA|N|||NA|3||39||OBSERVATION|1969-06-03|1960-03-13|||||1961-12-07||1967-02-18|N|1963-03-13
TRIAL STUDY 134XCP|LB|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|2||||BASOMYL|BASOPHILIC MYELOCYTES|||||||10^12/L|||||||INVALID||NMOL/KG/DAY||||LOW|NOT DONE||||VENOUS PLASMA|THAWED|Y|ELISPOT|COCKCROFT-GAULT FORMULA||NA|U|Y|U|||U|3||39||WASHOUT|1966-07-16|1973-07-11|||||1966-09-29||1973-07-20|NA|1971-08-23
TRIAL STUDY 134XCP|LB|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|1||||BLASTRUB|RUBRIBLAST|||||||UEQ|||||||TRACE||AMU||||LOW|NOT DONE||||CAPILLARY BLOOD|AUTOLYZED|NA|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|NASH FIBROSURE FORMULA||Y|N|NA|NA|||U|4||88||BASELINE|1960-09-13|1964-08-06|||||1961-06-24||1961-07-14|U|1971-10-04
TRIAL STUDY 134XCP|LB|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|2||||SJSSBAB|SJOGRENS SS-B ANTIBODY|||||||CAPFUL|||||||INVALID||ML/CM H2O||||NORMAL|NOT DONE||||KERATINOCYTE|THAWED|NA|DOPPLER ULTRASOUND|CKD-EPI FORMULA||N|Y|NA|N|||U|4||88||OBSERVATION|1968-05-21|1965-10-30|||||1960-09-08||1972-12-09|NA|1964-07-16
TRIAL STUDY 134XCP|LB|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|1||||TAT|THROMBIN/ANTITHROMBIN|||||||IU/KG|||||||POSITIVE||DIOPTER||||HIGH|NOT DONE||||PERITONEAL FLUID|SOLIDIFIED|Y|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||U|U|U|NA|||U|5||7||INDUCTION TREATMENT|1970-10-13|1962-09-15|||||1966-03-26||1963-11-14|Y|1968-12-06
TRIAL STUDY 134XCP|LB|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|2||||IL1EXR|INTERLEUKIN 1 EXCRETION RATE|||||||L/H|||||||NEGATIVE||WAFER||||ABNORMAL|NOT DONE||||EXPIRED AIR|CONCENTRATED|Y|OPTICAL DENSITY MEASUREMENT|CKD-EPI FORMULA||Y|Y|U|N|||NA|5||7||SCREENING|1972-02-26|1968-07-20|||||1963-07-25||1965-12-23|N|1971-10-07
TRIAL STUDY 134XCP|LB|5B3E406E-F2A5-4F25-8271-DC1FABA40138|1||||FACTXIVA|FACTOR XIV ACTIVITY|||||||ML/MMHG|||||||INVALID||MMOL/KG||||LOW|NOT DONE||||PERSPIRATION|UNEXPECTED ODOR|N|RADIOGRAPHY|ASH FIBROSURE FORMULA||NA|N|U|N|||N|1||38||CONTINUATION TREATMENT|1960-05-25|1967-05-24|||||1963-12-26||1973-04-25|Y|1968-10-04
TRIAL STUDY 134XCP|LB|5B3E406E-F2A5-4F25-8271-DC1FABA40138|2||||BLYCELE|B-LYMPHOCYTES/LEUKOCYTES|||||||MONTHS|||||||INVALID||NMOL/L/H||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|DRIED|NA|MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CYSTATIN C FORMULA||U|NA|N|N|||N|1||38||WASHOUT|1960-12-22|1967-09-13|||||1960-05-05||1966-10-08|N|1969-05-20
TRIAL STUDY 134XCP|LB|5B3E406E-F2A5-4F25-8271-DC1FABA40138|1||||BILIND|INDIRECT BILIRUBIN|||||||/10^4|||||||INDETERMINATE||10^3 CFU||||LOW|NOT DONE||||ADIPOSE TISSUE|REFRIGERATED|N|BALLPOINT PEN TECHNIQUE|MDRD FORMULA||Y|N|U|U|||Y|2||58||CONTINUATION TREATMENT|1969-10-25|1966-05-10|||||1963-08-26||1966-04-20|Y|1972-08-13
TRIAL STUDY 134XCP|LB|5B3E406E-F2A5-4F25-8271-DC1FABA40138|2||||NEUTB|NEUTROPHILS BAND FORM|||||||CI/L|||||||INDETERMINATE||MG/ML/MIN||||NORMAL|NOT DONE||||INFRANATANT, SERUM|THAWED|Y|CLOT DETECTION|MDRD FORMULA||N|U|NA|Y|||N|2||58||TREATMENT|1964-08-29|1972-04-30|||||1966-03-28||1968-09-10|NA|1960-12-08
TRIAL STUDY 134XCP|LB|5B3E406E-F2A5-4F25-8271-DC1FABA40138|1||||CSEPIR|RENAL EPITHELIAL CASTS|||||||U/ANIMAL|||||||INVALID||MCI/KG||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|CONCENTRATED|N|THERMAL IONIZATION MASS SPECTROMETRY|MDRD 6 VARIABLE FORMULA||Y|NA|NA|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1969-11-22|1969-12-28|||||1965-06-05||1962-03-15|U|1966-09-29
TRIAL STUDY 134XCP|LB|5B3E406E-F2A5-4F25-8271-DC1FABA40138|2||||TOXVAC|TOXIC VACUOLATION|||||||U/M2/H|||||||POSITIVE||NKAT/G HB||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|CONTAMINATED|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|GMI % FORMULA||NA|NA|NA|U|||Y|3||39||CONTINUATION TREATMENT|1970-04-16|1972-05-27|||||1973-07-06||1967-01-16|U|1970-08-04
TRIAL STUDY 134XCP|LB|5B3E406E-F2A5-4F25-8271-DC1FABA40138|1||||EUDCA|EPIMERIZED URSODEOXYCHOLATE|||||||CG|||||||BORDERLINE||SBE/ML||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|THAWED|NA|EEG|MDRD 6 VARIABLE FORMULA||N|Y|U|NA|||NA|4||88||WASHOUT|1964-02-22|1968-06-21|||||1964-07-03||1972-06-13|N|1963-02-02
TRIAL STUDY 134XCP|LB|5B3E406E-F2A5-4F25-8271-DC1FABA40138|2||||BACT|BACTERIA|||||||ANTIBODY UNIT|||||||INVALID||CD||||NORMAL|NOT DONE||||SERUM|ICTERIC|Y|POLYSOMNOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|NA|Y|||U|4||88||FOLLOW-UP|1971-06-24|1972-01-26|||||1966-07-21||1973-01-29|Y|1961-11-09
TRIAL STUDY 134XCP|LB|5B3E406E-F2A5-4F25-8271-DC1FABA40138|1||||LEPTIN|LEPTIN|||||||CM|||||||NEGATIVE||DAYS/MONTH||||HIGH|NOT DONE||||SWABBED MATERIAL|GELLED|N|FLUORESCENT MICROSCOPY|NASH FIBROSURE FORMULA||Y|NA|U|NA|||NA|5||7||CONTINUATION TREATMENT|1963-11-24|1973-01-07|||||1960-10-06||1968-08-25|NA|1973-03-13
TRIAL STUDY 134XCP|LB|5B3E406E-F2A5-4F25-8271-DC1FABA40138|2||||PLSPCELY|PRECURSOR PLASMA CELLS/LYMPHOCYTES|||||||U/M2|||||||NEGATIVE||UGEQ||||LOW|NOT DONE||||BILE|FROZEN|N|CONGO RED STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|U|NA|N|||N|5||7||CONTINUATION TREATMENT|1969-08-17|1971-09-18|||||1972-09-12||1971-11-07|NA|1966-11-15
TRIAL STUDY 134XCP|LB|D5262627-52D7-42F5-B4BA-D7E6FA243959|1||||GLYCRL|GLYCEROL|||||||ML/CAGE|||||||BORDERLINE||CI||||ABNORMAL|NOT DONE||||BONE|CLOTTED|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|CKD-EPI CREATININE FORMULA||U|N|NA|U|||U|1||38||LONG-TERM FOLLOW-UP|1968-06-25|1973-04-17|||||1964-07-18||1963-08-13|NA|1960-01-01
TRIAL STUDY 134XCP|LB|D5262627-52D7-42F5-B4BA-D7E6FA243959|2||||BUCHE|BUTYRYLCHOLINESTERASE|||||||HR/DAY|||||||BORDERLINE||UG/M2/MIN||||HIGH|NOT DONE||||AMNIOTIC FLUID|NON-HEMOLYZED|U|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|NASH FIBROSURE FORMULA||Y|U|NA|NA|||N|1||38||OPEN LABEL TREATMENT|1973-08-22|1964-07-26|||||1964-11-15||1966-09-30|N|1968-09-02
TRIAL STUDY 134XCP|LB|D5262627-52D7-42F5-B4BA-D7E6FA243959|1||||OAS3|2-5-OLIGOADENYLATE SYNTHASE 3|||||||G/CAGE/WK|||||||INVALID||GMFI||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CONTAMINATED|U|MICRONEUTRALIZATION ASSAY|CKD-EPI CREATININE FORMULA||NA|U|U|N|||N|2||58||FOLLOW-UP|1972-02-24|1961-11-09|||||1972-08-16||1970-11-27|Y|1967-10-02
TRIAL STUDY 134XCP|LB|D5262627-52D7-42F5-B4BA-D7E6FA243959|2||||HAIRYCE|HAIRY CELLS|||||||G/CAGE/DAY|||||||NEGATIVE||MMOL/MOL||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|CALCIFIED|Y|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 6 VARIABLE FORMULA||Y|NA|Y|N|||NA|2||58||INDUCTION TREATMENT|1963-03-26|1962-06-25|||||1967-10-04||1966-12-03|N|1960-07-21
TRIAL STUDY 134XCP|LB|D5262627-52D7-42F5-B4BA-D7E6FA243959|1||||LSD|LYSERGIC ACID DIETHYLAMIDE|||||||ABSORBANCE U|||||||INDETERMINATE||HEP||||HIGH|NOT DONE||||ALVEOLAR AIR|CONCENTRATED|N|PHASE CONTRAST MICROSCOPY|GMI MMOL/MOL FORMULA||U|U|N|NA|||NA|3||39||OPEN LABEL TREATMENT|1972-03-13|1960-09-16|||||1969-12-16||1960-07-12|NA|1969-03-07
TRIAL STUDY 134XCP|LB|D5262627-52D7-42F5-B4BA-D7E6FA243959|2||||MUCTHR|MUCOUS THREADS|||||||FMOL/G|||||||TRACE||CMH2O/ML||||NORMAL|NOT DONE||||TISSUE|THAWED|NA|CT SCAN WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA||Y|NA|U|NA|||NA|3||39||SCREENING|1970-10-19|1969-11-28|||||1961-02-07||1967-04-15|U|1970-11-24
TRIAL STUDY 134XCP|LB|D5262627-52D7-42F5-B4BA-D7E6FA243959|1||||AMACR|ALPHA-METHYLACYL COENZYME A RACEMASE|||||||IU/MG|||||||NEGATIVE||ML/DL||||LOW|NOT DONE||||SYNOVIAL FLUID|AUTOLYZED|NA|MRI|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|U|||N|4||88||BLINDED TREATMENT|1964-07-11|1960-03-14|||||1962-08-04||1970-02-12|N|1968-05-20
TRIAL STUDY 134XCP|LB|D5262627-52D7-42F5-B4BA-D7E6FA243959|2||||LACTICAC|LACTIC ACID|||||||/2000 RBC|||||||INVALID||UG/CM2||||NORMAL|NOT DONE||||RETICULOCYTES|CONCENTRATED|U|OPHTHALMOSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|N|NA|||Y|4||88||TREATMENT|1965-08-05|1964-06-11|||||1968-08-24||1965-02-28|NA|1962-06-04
TRIAL STUDY 134XCP|LB|D5262627-52D7-42F5-B4BA-D7E6FA243959|1||||AMYLB40|AMYLOID BETA 1-40|||||||UG/L|||||||TRACE||ENZYME U/M2||||HIGH|NOT DONE||||PLASMA|LIPEMIC|NA|CELLULOSE TAPE|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|NA|N|||Y|5||7||RUN-IN|1966-07-12|1961-05-14|||||1962-12-03||1965-10-18|NA|1963-08-04
TRIAL STUDY 134XCP|LB|D5262627-52D7-42F5-B4BA-D7E6FA243959|2||||PLSIMCLY|IMMATURE PLASMA CELLS/LYMPHOCYTES|||||||OSM|||||||INDETERMINATE||KCAL/DAY||||LOW|NOT DONE||||PLEURAL FLUID|THAWED|Y|OSCILLOMETRY|FIBROSIS 4 FORMULA||N|N|N|U|||NA|5||7||FOLLOW-UP|1971-02-18|1962-08-03|||||1970-03-19||1960-08-09|N|1964-10-31
TRIAL STUDY 134XCP|LB|C550278D-F171-42D0-8C34-D60824A3FE98|1||||IBCU|UNSATURATED IRON BINDING CAPACITY|||||||MCI/KG|||||||INDETERMINATE||LOG10 ELISA UNIT/DOSE||||NORMAL|NOT DONE||||SEBUM|HEMOLYZED|Y|DYNAMOMETRY|CKD-EPI CREATININE FORMULA||NA|Y|NA|U|||U|1||38||TREATMENT|1962-09-17|1963-06-12|||||1969-04-02||1966-07-30|Y|1964-10-28
TRIAL STUDY 134XCP|LB|C550278D-F171-42D0-8C34-D60824A3FE98|2||||GRANLE|GRANULOCYTES/LEUKOCYTES|||||||/MS|||||||INVALID||PG/L||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED|N|GC/FID|GMI % FORMULA||N|N|U|N|||Y|1||38||SCREENING|1973-05-09|1962-02-03|||||1965-07-29||1968-03-18|Y|1961-11-23
TRIAL STUDY 134XCP|LB|C550278D-F171-42D0-8C34-D60824A3FE98|1||||CSGRAN|GRANULAR CASTS|||||||UG/DOSE|||||||BORDERLINE||SPRAY||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|UNEXPECTED ODOR|N|COLORIMETRY|NASH FIBROSURE FORMULA||N|Y|U|Y|||N|2||58||CONTINUATION TREATMENT|1967-09-27|1971-08-16|||||1965-11-01||1969-10-30|Y|1960-04-02
TRIAL STUDY 134XCP|LB|C550278D-F171-42D0-8C34-D60824A3FE98|2||||ATPVITE|ALPHA TOCOPHEROL/VITAMIN E|||||||AMU|||||||NEGATIVE||FMOL||||HIGH|NOT DONE||||URINE|REFRIGERATED|Y|NON-INVASIVE DIELECTRIC SENSING|CKD-EPI CREATININE FORMULA||U|NA|N|NA|||N|2||58||SCREENING|1971-08-19|1960-10-24|||||1973-03-09||1968-08-11|Y|1961-02-13
TRIAL STUDY 134XCP|LB|C550278D-F171-42D0-8C34-D60824A3FE98|1||||ANGTNS2|ANGIOTENSIN II|||||||10^8 PFU|||||||POSITIVE||UKAT/L||||LOW|NOT DONE||||SEMINAL FLUID|HEMOLYZED|NA|HPLC/IEX|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|U|NA|||NA|3||39||OBSERVATION|1960-10-09|1973-08-29|||||1962-06-08||1969-10-29|Y|1964-06-12
TRIAL STUDY 134XCP|LB|C550278D-F171-42D0-8C34-D60824A3FE98|2||||MENGL|MENINGEAL CELLS|||||||FFU|||||||NEGATIVE||RATIO||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|N|CALCULATION|MDRD FORMULA||NA|Y|Y|NA|||Y|3||39||OPEN LABEL TREATMENT|1972-12-25|1970-10-14|||||1971-04-30||1966-12-26|U|1966-11-06
TRIAL STUDY 134XCP|LB|C550278D-F171-42D0-8C34-D60824A3FE98|1||||PYK|PYRUVATE KINASE|||||||PIXELS/CM|||||||INDETERMINATE||VP/DOSE||||HIGH|NOT DONE||||VENOUS BLOOD|LIPEMIC|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|ASH FIBROSURE FORMULA||NA|NA|Y|N|||N|4||88||CONTINUATION TREATMENT|1965-12-21|1973-05-16|||||1971-03-01||1961-04-30|NA|1970-03-15
TRIAL STUDY 134XCP|LB|C550278D-F171-42D0-8C34-D60824A3FE98|2||||TTGIGGAB|TISSUE TRANSGLUTAMINASE IGG ANTIBODY|||||||MESF|||||||INVALID||10^6/HPF||||ABNORMAL|NOT DONE||||SALIVA|CLOTTED|U|FLOW MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|NA|||U|4||88||OPEN LABEL TREATMENT|1966-08-21|1971-04-29|||||1965-11-09||1962-11-24|Y|1967-11-10
TRIAL STUDY 134XCP|LB|C550278D-F171-42D0-8C34-D60824A3FE98|1||||INTLK5|INTERLEUKIN 5|||||||VIRTUAL PIXEL|||||||TRACE||L/KG||||HIGH|NOT DONE||||MENSTRUAL BLOOD|UNEXPECTED ODOR|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|NA|U|||Y|5||7||OPEN LABEL TREATMENT|1970-11-13|1960-04-18|||||1964-07-11||1966-01-22|N|1969-03-26
TRIAL STUDY 134XCP|LB|C550278D-F171-42D0-8C34-D60824A3FE98|2||||HLADR52A|HLA-DR52 ANTIBODY|||||||10^3 COPIES/ML|||||||TRACE||MAMP||||LOW|NOT DONE||||SERUM|UNEXPECTED ODOR|U|PATHOLOGICAL EVALUATION|FIBROMETER FORMULA||NA|N|Y|N|||Y|5||7||RUN-IN|1968-03-19|1964-04-12|||||1971-06-13||1973-06-17|U|1966-11-18
TRIAL STUDY 134XCP|LB|5E76262E-FE1E-40C9-B147-3C792F768F48|1||||AMYLASES|AMYLASE, SALIVARY|||||||GBQ/UG|||||||INDETERMINATE||HR/DAY||||LOW|NOT DONE||||LEUKOCYTE|LIPEMIC|N|SXA SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|NA|N|||Y|1||38||LONG-TERM FOLLOW-UP|1969-06-27|1965-08-19|||||1964-07-24||1965-12-13|NA|1968-07-24
TRIAL STUDY 134XCP|LB|5E76262E-FE1E-40C9-B147-3C792F768F48|2||||ADPNHMW|ADIPONECTIN, HIGH MOLECULAR WEIGHT|||||||ABSORBANCE U|||||||POSITIVE||MEQ/L||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|CALCIFIED|U|PHOROPTER|GMI % FORMULA||U|N|Y|U|||N|1||38||CONTINUATION TREATMENT|1965-03-29|1967-07-27|||||1966-01-12||1961-04-11|Y|1973-07-20
TRIAL STUDY 134XCP|LB|5E76262E-FE1E-40C9-B147-3C792F768F48|1||||CX3CL1|CHEMOKINE (C-X3-C MOTIF) LIGAND 1|||||||PMOL/L|||||||TRACE||UMOL/DAY||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|GELLED|N|ANALYTICAL ULTRACENTRIFUGATION|GMI % FORMULA||NA|N|U|NA|||N|2||58||BASELINE|1967-03-13|1965-07-22|||||1967-01-08||1963-12-17|Y|1963-03-11
TRIAL STUDY 134XCP|LB|5E76262E-FE1E-40C9-B147-3C792F768F48|2||||AMYLASEM|MACROAMYLASE|||||||K|||||||TRACE||FARAD||||LOW|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|Y|PHOTOGRAPHY|MDRD 5 VARIABLE FORMULA||U|N|N|N|||NA|2||58||RUN-IN|1964-04-09|1962-01-28|||||1969-09-16||1961-10-29|Y|1970-11-07
TRIAL STUDY 134XCP|LB|5E76262E-FE1E-40C9-B147-3C792F768F48|1||||PLSTCELE|TOTAL PLASMA CELLS/LEUKOCYTES|||||||MG/ML/DAY|||||||NEGATIVE||NMOL/ML/MIN||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|CONCENTRATED|U|GC/MS-CI|CKD-EPI CREATININE FORMULA||U|N|U|Y|||U|3||39||OPEN LABEL TREATMENT|1972-10-11|1971-02-12|||||1969-06-07||1963-02-12|U|1964-06-17
TRIAL STUDY 134XCP|LB|5E76262E-FE1E-40C9-B147-3C792F768F48|2||||POLYERY|POLYCHROMATOPHILIC ERYTHROBLAST|||||||IU/DL|||||||POSITIVE||BQ||||LOW|NOT DONE||||URINE SEDIMENT|AUTOLYZED|N|TRIPLE-PHASE MRI SCAN|CKD-EPI CYSTATIN C FORMULA||NA|Y|U|Y|||U|3||39||INDUCTION TREATMENT|1969-11-25|1963-03-07|||||1970-08-31||1961-11-12|Y|1971-04-28
TRIAL STUDY 134XCP|LB|5E76262E-FE1E-40C9-B147-3C792F768F48|1||||TPRONP|NON-PHOSPHORYLATED TAU PROTEIN|||||||/100 WBC|||||||INVALID||MHZ||||HIGH|NOT DONE||||SKIN TISSUE|GELLED|Y|IN SITU HYBRIDIZATION|HEPASCORE FORMULA||U|N|N|U|||U|4||88||RUN-IN|1970-07-02|1962-04-25|||||1969-04-14||1960-11-15|U|1968-07-14
TRIAL STUDY 134XCP|LB|5E76262E-FE1E-40C9-B147-3C792F768F48|2||||MLR|MIXED LYMPHOCYTE REACTION|||||||MG/KG/MIN|||||||POSITIVE||USIEMENS||||NORMAL|NOT DONE||||LYMPH|CONTAMINATED|NA|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA||N|NA|NA|Y|||Y|4||88||OPEN LABEL TREATMENT|1971-11-02|1963-03-06|||||1967-12-12||1973-06-10|U|1965-05-26
TRIAL STUDY 134XCP|LB|5E76262E-FE1E-40C9-B147-3C792F768F48|1||||TNFAPIA|TNF-A PRODUCTION INHIBITORY ACTIVITY|||||||ML/H|||||||POSITIVE||S/H||||LOW|NOT DONE||||HAIR FOLLICLE|REFRIGERATED|Y|ACRIDINE ORANGE STAIN|GMI MMOL/MOL FORMULA||NA|U|NA|Y|||N|5||7||WASHOUT|1964-04-11|1963-05-16|||||1964-01-07||1961-03-12|Y|1960-02-18
TRIAL STUDY 134XCP|LB|5E76262E-FE1E-40C9-B147-3C792F768F48|2||||HGBC|HEMOGLOBIN C|||||||G/G|||||||INDETERMINATE||IN||||LOW|NOT DONE||||MIXED VENOUS BLOOD|CONCENTRATED|Y|MICRODENSITOMETRY|FIBROSIS 4 FORMULA||N|NA|NA|NA|||Y|5||7||OBSERVATION|1965-04-07|1964-10-26|||||1963-09-10||1967-08-07|NA|1971-12-09
TRIAL STUDY 134XCP|LB|2F21921D-D18C-43EE-A39E-91A93B262B8C|1||||TAP1|PEPTIDE TRANSPORTER TAP1|||||||10^9/DOSE|||||||TRACE||MMOL||||NORMAL|NOT DONE||||HAIR|LIPEMIC|N|ETDRS EYE CHART|HEPASCORE FORMULA||NA|NA|NA|NA|||Y|1||38||WASHOUT|1966-01-05|1972-07-05|||||1965-05-30||1962-06-07|NA|1965-10-11
TRIAL STUDY 134XCP|LB|2F21921D-D18C-43EE-A39E-91A93B262B8C|2||||ODMTASE|O-DEMETHYLASE|||||||NMOL/G|||||||INDETERMINATE||PATCH||||NORMAL|NOT DONE||||URINE SEDIMENT|LACTESCENT|NA|LC/MS/MS|NASH FIBROSURE FORMULA||U|N|Y|U|||Y|1||38||LONG-TERM FOLLOW-UP|1971-09-29|1968-05-15|||||1967-11-26||1963-01-02|U|1969-06-17
TRIAL STUDY 134XCP|LB|2F21921D-D18C-43EE-A39E-91A93B262B8C|1||||LEU|LEUCINE|||||||CIGARETTE|||||||INVALID||PLUG||||LOW|NOT DONE||||SUPERNATANT, SERUM|NON-HEMOLYZED|NA|ISHIHARA COLOR PLATES|MDRD ENZYMATIC FORMULA||NA|N|Y|U|||N|2||58||SCREENING|1971-08-12|1966-03-14|||||1969-01-18||1967-05-11|U|1962-04-19
TRIAL STUDY 134XCP|LB|2F21921D-D18C-43EE-A39E-91A93B262B8C|2||||BJPROT|BENCE-JONES PROTEIN|||||||GTT|||||||TRACE||MESF||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|CLOTTED|Y|ALCIAN BLUE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|N|U|||N|2||58||LONG-TERM FOLLOW-UP|1967-09-28|1960-03-11|||||1973-02-19||1968-06-07|N|1962-05-16
TRIAL STUDY 134XCP|LB|2F21921D-D18C-43EE-A39E-91A93B262B8C|1||||RDCSUB|REDUCING SUBSTANCES|||||||KUSP|||||||TRACE||SFC/10^6 PBMC||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|SOLIDIFIED|N|SIZE EXCLUSION CHROMATOGRAPHY|FIBROSIS 4 FORMULA||U|N|N|Y|||N|3||39||OBSERVATION|1972-04-21|1970-03-28|||||1965-09-14||1962-10-16|Y|1963-06-01
TRIAL STUDY 134XCP|LB|2F21921D-D18C-43EE-A39E-91A93B262B8C|2||||APOB100|APOLIPOPROTEIN B100|||||||S/H|||||||NEGATIVE||ML/MIN||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|LACTESCENT|N|KINYOUN STAIN|MDRD 4 VARIABLE FORMULA||U|N|Y|N|||U|3||39||WASHOUT|1970-01-04|1972-10-02|||||1966-10-16||1964-07-18|U|1965-08-18
TRIAL STUDY 134XCP|LB|2F21921D-D18C-43EE-A39E-91A93B262B8C|1||||CGA|CHROMOGRANIN A|||||||MEQ/DAY|||||||TRACE||PG/CELL||||HIGH|NOT DONE||||SALIVA|CALCIFIED|NA|CLIP|HEPASCORE FORMULA||Y|NA|N|N|||U|4||88||INDUCTION TREATMENT|1962-01-29|1961-11-30|||||1965-09-26||1968-11-09|NA|1964-04-23
TRIAL STUDY 134XCP|LB|2F21921D-D18C-43EE-A39E-91A93B262B8C|2||||ACETOAC|ACETOACETIC ACID|||||||/VF|||||||INDETERMINATE||G/L||||HIGH|NOT DONE||||MENSTRUAL BLOOD|CALCIFIED|NA|TRIPLE-PHASE SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA||NA|Y|U|U|||U|4||88||OBSERVATION|1971-03-19|1964-10-14|||||1966-04-08||1963-03-15|N|1968-02-16
TRIAL STUDY 134XCP|LB|2F21921D-D18C-43EE-A39E-91A93B262B8C|1||||IGG2|IMMUNOGLOBULIN G SUBCLASS 2|||||||HOMEOPATHIC DILUTION|||||||NEGATIVE||1/(S*KPA)||||ABNORMAL|NOT DONE||||VENOUS BLOOD|CONTAMINATED|NA|KNEMOMETRY|FIBROMETER FORMULA||N|U|U|NA|||NA|5||7||BASELINE|1973-02-13|1970-02-28|||||1964-11-30||1962-02-13|NA|1969-01-11
TRIAL STUDY 134XCP|LB|2F21921D-D18C-43EE-A39E-91A93B262B8C|2||||HYDROGEN|HYDROGEN|||||||HZ|||||||INVALID||MG/G/H||||NORMAL|NOT DONE||||NAIL|AGGLUTINATED|U|RYAN BLUE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|NA|Y|||N|5||7||FOLLOW-UP|1966-03-14|1968-09-25|||||1960-10-12||1969-12-16|N|1967-10-13
TRIAL STUDY 134XCP|LB|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|1||||PTHNT|PARATHYROID HORMONE, N-TERMINAL|||||||TAMPON|||||||INDETERMINATE||PKAT/L||||LOW|NOT DONE||||PLATELET POOR PLASMA|FROZEN|NA|GC/MS-CI|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|U|||NA|1||38||OPEN LABEL TREATMENT|1966-12-19|1966-02-10|||||1960-07-19||1961-09-12|N|1969-01-22
TRIAL STUDY 134XCP|LB|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|2||||BLASTRUB|RUBRIBLAST|||||||MAC50|||||||NEGATIVE||KG/MOL||||LOW|NOT DONE||||INTERSTITIAL FLUID|GELLED|U|ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|N|N|N|||U|1||38||OBSERVATION|1967-06-05|1966-11-12|||||1960-07-20||1972-11-29|Y|1963-04-10
TRIAL STUDY 134XCP|LB|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|1||||C165895|JOHNSON GRASS POLLEN IGG4 ANTIBODY|||||||UCI|||||||POSITIVE||MG/ML/MIN||||HIGH|NOT DONE||||SEMEN|DRIED|U|PULSE OXIMETRY|CKD-EPI CYSTATIN C FORMULA||N|NA|Y|N|||U|2||58||BLINDED TREATMENT|1963-02-16|1972-06-12|||||1966-02-01||1968-02-29|U|1965-02-16
TRIAL STUDY 134XCP|LB|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|2||||FSH|FOLLICLE STIMULATING HORMONE|||||||UL/KG/DAY|||||||TRACE||PELLET||||ABNORMAL|NOT DONE||||URINE SEDIMENT|ROOM TEMPERATURE|NA|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||Y|U|U|NA|||Y|2||58||TREATMENT|1970-02-14|1967-10-30|||||1964-12-11||1962-08-29|N|1969-08-12
TRIAL STUDY 134XCP|LB|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|1||||NRDZPM|NORDAZEPAM|||||||10^9 ORGANISMS/ML|||||||INVALID||MANSON U/ML||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|DRIED|N|DARK FIELD MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|N|Y|||Y|3||39||INDUCTION TREATMENT|1971-06-14|1972-11-01|||||1966-07-30||1968-07-13|N|1961-12-07
TRIAL STUDY 134XCP|LB|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|2||||CSEPI846|AGGRECAN CHONDROITIN SULFATE EPITOPE 846|||||||MPL U/ML|||||||INDETERMINATE||MDFI||||ABNORMAL|NOT DONE||||GASTRIC FLUID|ICTERIC|Y|CRYOSCOPY|FIBROMETER FORMULA||N|N|N|Y|||NA|3||39||INDUCTION TREATMENT|1960-09-22|1962-10-07|||||1973-03-02||1970-09-04|N|1967-07-15
TRIAL STUDY 134XCP|LB|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|1||||METHDN|METHADONE|||||||10^3 CFU/G|||||||INVALID||10^7/L||||NORMAL|NOT DONE||||CORD BLOOD|ROOM TEMPERATURE|N|MANUAL CLOT DETECTION|MDRD 6 VARIABLE FORMULA||Y|Y|N|N|||NA|4||88||BLINDED TREATMENT|1966-11-29|1961-12-18|||||1968-03-11||1963-06-28|NA|1970-06-14
TRIAL STUDY 134XCP|LB|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|2||||CEMORPH|CELL MORPHOLOGY|||||||10^3 DNA COPIES/ML|||||||POSITIVE||G/MOL||||LOW|NOT DONE||||STOOL|CONCENTRATED|Y|DC SHEATH FLOW|CKD-EPI CREATININE FORMULA||Y|Y|N|Y|||Y|4||88||TREATMENT|1966-06-11|1972-02-08|||||1964-04-04||1965-05-04|NA|1972-08-16
TRIAL STUDY 134XCP|LB|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|1||||HLADR51A|HLA-DR51 ANTIBODY|||||||MG/DL|||||||BORDERLINE||ML/100G/MIN||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|U|TWO-COLOR MICROARRAY|MDRD FORMULA||NA|N|NA|U|||U|5||7||RUN-IN|1962-05-28|1963-06-10|||||1972-11-16||1961-08-02|NA|1961-11-23
TRIAL STUDY 134XCP|LB|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|2||||MCPHGLE|MACROPHAGES/LEUKOCYTES|||||||UU/L|||||||INDETERMINATE||CI||||LOW|NOT DONE||||PROSTATIC FLUID|CONTAMINATED|U|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD ENZYMATIC FORMULA||U|Y|N|Y|||U|5||7||FOLLOW-UP|1962-08-30|1967-02-08|||||1971-08-04||1966-08-08|NA|1971-06-06
TRIAL STUDY 134XCP|LB|55985646-0224-4442-90C5-EFEDF990E88C|1||||KLCFR|KAPPA LIGHT CHAIN, FREE|||||||ML/KG/H|||||||POSITIVE||UG/M2/DAY||||LOW|NOT DONE||||ADIPOSE TISSUE|LIPEMIC|Y|MACRO BROTH DILUTION|MDRD ENZYMATIC FORMULA||N|N|NA|NA|||N|1||38||LONG-TERM FOLLOW-UP|1966-02-02|1971-10-23|||||1968-09-29||1961-01-29|U|1967-05-14
TRIAL STUDY 134XCP|LB|55985646-0224-4442-90C5-EFEDF990E88C|2||||HGBS|HEMOGLOBIN S|||||||G/M2|||||||INDETERMINATE||FMOL/L/SEC||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|LIPEMIC|N|BRDU CELLULAR PROLIFERATION ASSAY|MDRD 6 VARIABLE FORMULA||U|N|Y|NA|||N|1||38||TREATMENT|1964-04-20|1973-06-10|||||1969-11-27||1962-10-01|U|1968-04-21
TRIAL STUDY 134XCP|LB|55985646-0224-4442-90C5-EFEDF990E88C|1||||HETRPHLE|HETEROPHILS/LEUKOCYTES|||||||MCI/L|||||||NEGATIVE||MDFI||||LOW|NOT DONE||||MUCUS|GELLED|NA|IMMUNOFLUORESCENT STAIN|CKD-EPI CREATININE FORMULA||Y|Y|Y|N|||Y|2||58||FOLLOW-UP|1972-06-01|1971-02-22|||||1964-05-13||1966-01-15|U|1961-10-11
TRIAL STUDY 134XCP|LB|55985646-0224-4442-90C5-EFEDF990E88C|2||||CPB2|CARBOXYPEPTIDASE B2|||||||MG/KG/DAY|||||||POSITIVE||FMOL/G||||NORMAL|NOT DONE||||COLOSTRUM|CONCENTRATED|N|SLOAN LETTER EYE CHART 2.5%|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|NA|N|||U|2||58||FOLLOW-UP|1966-11-09|1968-05-02|||||1967-07-31||1964-11-03|N|1967-08-12
TRIAL STUDY 134XCP|LB|55985646-0224-4442-90C5-EFEDF990E88C|1||||C165919|GERMAN COCKROACH IGG AB RAST SCORE|||||||%|||||||TRACE||TRACE||||HIGH|NOT DONE||||VENOUS PLASMA|AGGLUTINATED|Y|MICROBIAL CULTURE, SOLID|GMI MMOL/MOL FORMULA||Y|Y|NA|U|||Y|3||39||SCREENING|1960-04-23|1970-03-30|||||1964-07-14||1969-12-22|Y|1962-05-13
TRIAL STUDY 134XCP|LB|55985646-0224-4442-90C5-EFEDF990E88C|2||||ASTCK|AST/CREATINE KINASE|||||||CI/KG|||||||BORDERLINE||MS2||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|FRESH|N|ANTIBIOTIC AGAR SCREEN|HEPASCORE FORMULA||Y|U|Y|Y|||N|3||39||LONG-TERM FOLLOW-UP|1965-06-13|1963-09-04|||||1961-04-04||1960-09-12|U|1965-03-05
TRIAL STUDY 134XCP|LB|55985646-0224-4442-90C5-EFEDF990E88C|1||||ZPP|ZINC PROTOPORPHYRIN|||||||DEG|||||||TRACE||10^8 PFU||||NORMAL|NOT DONE||||BLOOD|THAWED|U|KINETIC MICROPARTICLE IMMUNOASSAY|CKD-EPI CREATININE FORMULA||NA|N|Y|N|||NA|4||88||WASHOUT|1972-03-01|1973-02-12|||||1972-08-15||1971-08-26|Y|1971-07-31
TRIAL STUDY 134XCP|LB|55985646-0224-4442-90C5-EFEDF990E88C|2||||CGA|CHROMOGRANIN A|||||||UG/G/H|||||||POSITIVE||ML*CMH2O||||HIGH|NOT DONE||||KERATINOCYTE|LACTESCENT|Y|BIOPSY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|U|U|||NA|4||88||RUN-IN|1961-01-30|1970-06-02|||||1968-12-11||1967-09-16|Y|1962-12-27
TRIAL STUDY 134XCP|LB|55985646-0224-4442-90C5-EFEDF990E88C|1||||INSULINS|INSULIN SENSITIVITY|||||||PFU/ANIMAL|||||||INDETERMINATE||10^3 CFU/ML||||HIGH|NOT DONE||||SUPERNATANT, SERUM|CONTAMINATED|N|ELECTROCHEMILUMINESCENCE|CKD-EPI FORMULA||Y|Y|Y|U|||Y|5||7||OPEN LABEL TREATMENT|1968-07-10|1969-12-11|||||1967-05-02||1960-02-12|Y|1965-08-08
TRIAL STUDY 134XCP|LB|55985646-0224-4442-90C5-EFEDF990E88C|2||||COQ10|UBIQUINONE 10|||||||/KG|||||||TRACE||RFU||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONTAMINATED|U|SMEAR|ASH FIBROSURE FORMULA||NA|N|N|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1961-04-22|1973-07-30|||||1961-06-07||1968-01-13|NA|1972-04-05
TRIAL STUDY 134XCP|LB|86509C90-3C57-4755-A06F-79C620779371|1||||GASTRIN|GASTRIN|||||||ML/KG|||||||POSITIVE||10^7/L||||NORMAL|NOT DONE||||ERYTHROCYTES|GELLED|N|PET/CT SCAN WITHOUT CONTRAST|MDRD 4 VARIABLE FORMULA||Y|N|N|N|||Y|1||38||SCREENING|1962-07-19|1973-08-01|||||1960-09-16||1966-08-09|N|1962-01-09
TRIAL STUDY 134XCP|LB|86509C90-3C57-4755-A06F-79C620779371|2||||AMYLOIDA|AMYLOID A|||||||NMOL|||||||TRACE||L/MIN/M2||||LOW|NOT DONE||||MUCUS|AUTOLYZED|NA|CELLULOSE TAPE|MDRD ENZYMATIC FORMULA||NA|U|U|U|||U|1||38||FOLLOW-UP|1968-12-23|1968-06-19|||||1973-05-24||1971-04-11|N|1961-09-17
TRIAL STUDY 134XCP|LB|86509C90-3C57-4755-A06F-79C620779371|1||||TNF10|TNF SUPERFAMILY MEMBER 10|||||||/40 HPFS|||||||BORDERLINE||10^6 ORGANISMS/G||||ABNORMAL|NOT DONE||||LYSATE|THAWED|U|FLUORESCENCE ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||N|NA|NA|N|||U|2||58||INDUCTION TREATMENT|1966-03-13|1966-09-10|||||1970-08-18||1961-12-26|NA|1963-02-01
TRIAL STUDY 134XCP|LB|86509C90-3C57-4755-A06F-79C620779371|2||||PLATLRG|LARGE PLATELETS|||||||MPL U|||||||INVALID||10^5/L||||NORMAL|NOT DONE||||PUS|ROOM TEMPERATURE|Y|FLAME PHOTOMETRY|CKD-EPI FORMULA||Y|NA|U|U|||N|2||58||OPEN LABEL TREATMENT|1962-07-08|1968-04-13|||||1970-06-27||1965-01-16|N|1961-11-23
TRIAL STUDY 134XCP|LB|86509C90-3C57-4755-A06F-79C620779371|1||||CCPIGGAB|CYCLIC CITRULLINATED PEPTIDE IGG AB|||||||10^4 CFU|||||||BORDERLINE||TUBERCULIN UNIT||||NORMAL|NOT DONE||||CORD SERUM|FRESH|Y|CHROMOGENIC ASSAY|MDRD 6 VARIABLE FORMULA||NA|N|NA|N|||N|3||39||WASHOUT|1965-01-10|1969-08-16|||||1971-05-08||1964-08-09|N|1968-09-26
TRIAL STUDY 134XCP|LB|86509C90-3C57-4755-A06F-79C620779371|2||||HLAIPRA|HLA CLASS I PANEL REACTIVE ANTIBODY|||||||PFU|||||||INVALID||/HPF||||HIGH|NOT DONE||||PROSTATIC FLUID|GELLED|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|N|U|||Y|3||39||WASHOUT|1963-06-21|1969-06-06|||||1962-04-21||1968-12-19|NA|1960-09-08
TRIAL STUDY 134XCP|LB|86509C90-3C57-4755-A06F-79C620779371|1||||DPDCREAT|DEOXYPYRIDINOLINE/CREATININE|||||||CM H2O|||||||INVALID||MOSM/L||||LOW|NOT DONE||||PUS|GELLED|N|IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD 6 VARIABLE FORMULA||N|Y|NA|Y|||U|4||88||TREATMENT|1967-03-02|1972-06-16|||||1970-04-02||1965-05-27|Y|1968-05-11
TRIAL STUDY 134XCP|LB|86509C90-3C57-4755-A06F-79C620779371|2||||COL4|COLLAGEN TYPE IV|||||||V/SEC|||||||TRACE||MG/KG/MIN||||ABNORMAL|NOT DONE||||BONE|AUTOLYZED|U|NEURAMINIDASE INHIBITION ASSAY|HEPASCORE FORMULA||NA|NA|U|Y|||N|4||88||RUN-IN|1962-04-26|1961-09-01|||||1972-12-30||1965-06-26|Y|1960-07-28
TRIAL STUDY 134XCP|LB|86509C90-3C57-4755-A06F-79C620779371|1||||ACETAMIN|ACETAMINOPHEN|||||||BU/ML|||||||INVALID||PFU/ANIMAL||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|CONCENTRATED|NA|NUCLEIC ACID AMPLIFICATION TEST|MDRD 6 VARIABLE FORMULA||U|NA|N|Y|||N|5||7||CONTINUATION TREATMENT|1965-12-11|1963-06-29|||||1970-01-08||1967-05-07|N|1965-09-20
TRIAL STUDY 134XCP|LB|86509C90-3C57-4755-A06F-79C620779371|2||||GLUTAM|GLUTAMATE|||||||10^3 ORGANISMS/ML|||||||BORDERLINE||CAPSULE||||ABNORMAL|NOT DONE||||PLASMA|AUTOLYZED|Y|CINEANGIOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|NA|U|N|||NA|5||7||TREATMENT|1965-12-27|1964-09-10|||||1961-02-02||1972-08-29|Y|1965-04-18
TRIAL STUDY 134XCP|LB|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|1||||AMH|ANTI-MULLERIAN HORMONE|||||||PFU/ANIMAL|||||||TRACE||10^6 DNA COPIES/ML||||HIGH|NOT DONE||||SEMINAL FLUID|CONTAMINATED|N|IMMUNOPRECIPITATION|MDRD 4 VARIABLE FORMULA||Y|Y|U|Y|||Y|1||38||INDUCTION TREATMENT|1962-08-20|1973-01-20|||||1968-06-22||1961-01-30|Y|1972-05-27
TRIAL STUDY 134XCP|LB|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|2||||MTNEPHFR|METANEPHRINE, FREE|||||||BREATHS/MIN|||||||POSITIVE||VG/ML||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|SOLIDIFIED|NA|PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|N|N|||NA|1||38||LONG-TERM FOLLOW-UP|1962-07-06|1971-08-31|||||1972-08-20||1960-01-12|U|1971-01-14
TRIAL STUDY 134XCP|LB|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|1||||GRN|PROGRANULIN|||||||FMOL/L/SEC|||||||NEGATIVE||CS||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CALCIFIED|NA|EPSILOMETER|HEPASCORE FORMULA||Y|NA|NA|Y|||NA|2||58||TREATMENT|1971-06-25|1964-05-21|||||1970-05-15||1971-12-01|NA|1960-07-22
TRIAL STUDY 134XCP|LB|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|2||||GRANULIN|GRANULIN|||||||10^6 IU/ML|||||||NEGATIVE||MU||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|FROZEN|NA|CYSTOSCOPY|MDRD 6 VARIABLE FORMULA||N|U|NA|Y|||U|2||58||BLINDED TREATMENT|1971-06-13|1970-08-21|||||1963-12-30||1961-06-07|N|1967-07-25
TRIAL STUDY 134XCP|LB|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|1||||LYMA|LYMPHOCYTES ACTIVATED|||||||MHZ|||||||POSITIVE||MCI/KG||||NORMAL|NOT DONE||||KERATINOCYTE|GELLED|NA|OPTICAL MAPPING|MDRD 6 VARIABLE FORMULA||U|N|N|N|||N|3||39||CONTINUATION TREATMENT|1973-05-26|1966-03-11|||||1968-02-25||1966-06-14|U|1968-01-20
TRIAL STUDY 134XCP|LB|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|2||||ANCATYAB|NEUTROPHIL CYTOPLASMIC AB, ATYPICAL|||||||DNA COPIES/ML|||||||INDETERMINATE||SPRAY||||HIGH|NOT DONE||||MENSTRUAL BLOOD|FROZEN|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|ASH FIBROSURE FORMULA||N|N|N|Y|||N|3||39||OBSERVATION|1962-08-25|1969-05-01|||||1962-05-21||1961-11-24|U|1971-08-29
TRIAL STUDY 134XCP|LB|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|1||||CYCYSTIN|CYSTINE CRYSTALS|||||||U/G/H|||||||INVALID||LOG10 CFU/G||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|FRESH|N|LC/MS|MDRD FORMULA||NA|NA|U|NA|||NA|4||88||SCREENING|1961-08-28|1972-03-23|||||1972-12-13||1969-06-29|Y|1970-02-25
TRIAL STUDY 134XCP|LB|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|2||||HIST4AB|HISTONE 4 ANTIBODY|||||||ELISA UNIT/ML|||||||POSITIVE||%(W/V)||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|DRIED|Y|COMPLEMENT FIXATION|ASH FIBROSURE FORMULA||Y|U|U|NA|||Y|4||88||FOLLOW-UP|1969-01-18|1972-06-26|||||1969-05-08||1973-08-22|NA|1972-01-19
TRIAL STUDY 134XCP|LB|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|1||||HEMOLYSI|HEMOLYTIC INDEX|||||||UG/ANIMAL|||||||TRACE||GRAVITATIONAL UNIT||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|REFRIGERATED|NA|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 4 VARIABLE FORMULA||N|U|NA|Y|||U|5||7||BLINDED TREATMENT|1962-09-23|1961-07-18|||||1973-07-10||1962-10-06|N|1968-11-14
TRIAL STUDY 134XCP|LB|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|2||||ANCPNCAB|NEUTROPHIL CYTOPLASMIC AB, PERINUCLEAR|||||||ML/(MIN*100ML)|||||||INVALID||FT2||||HIGH|NOT DONE||||ISOLATE|THAWED|Y|X-RAY FLUORESCENCE SPECTROMETRY|FIBROSIS 4 FORMULA||NA|Y|U|Y|||Y|5||7||BLINDED TREATMENT|1965-02-28|1970-03-24|||||1963-05-01||1972-12-18|NA|1964-02-15
TRIAL STUDY 134XCP|LB|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|1||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||10^9 CFU/ML|||||||INVALID||MNFI||||NORMAL|NOT DONE||||PLASMA|DRIED|Y|IRON HEMATOXYLIN STAIN|MDRD ENZYMATIC FORMULA||Y|U|Y|Y|||U|1||38||WASHOUT|1970-09-01|1972-11-27|||||1967-04-26||1964-10-16|NA|1968-08-12
TRIAL STUDY 134XCP|LB|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|2||||NKCE|NATURAL KILLER CELLS|||||||UG/G/DAY|||||||NEGATIVE||DPM||||HIGH|NOT DONE||||SKIN TISSUE|SOLIDIFIED|U|HEMOCYTOMETRY|GMI % FORMULA||Y|N|Y|U|||U|1||38||BLINDED TREATMENT|1960-01-01|1971-01-07|||||1965-05-19||1962-07-21|N|1973-01-25
TRIAL STUDY 134XCP|LB|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|1||||PLATEST|PLATELETS, ESTIMATED|||||||BQ/UL|||||||BORDERLINE||BQ||||HIGH|NOT DONE||||INFRANATANT, PLASMA|FROZEN|U|ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||N|U|Y|Y|||N|2||58||SCREENING|1970-07-31|1965-02-03|||||1972-09-28||1967-03-28|Y|1965-05-08
TRIAL STUDY 134XCP|LB|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|2||||CHOLOH4B|4-BETA-HYDROXYCHOLESTEROL|||||||OI50|||||||NEGATIVE||MM/H||||LOW|NOT DONE||||CERUMEN|GELLED|N|RAJI CELL EIA|MDRD 4 VARIABLE FORMULA||NA|N|U|N|||NA|2||58||BASELINE|1972-06-09|1965-01-17|||||1960-07-25||1964-08-16|Y|1960-11-15
TRIAL STUDY 134XCP|LB|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|1||||FENTANYL|FENTANYL|||||||MNFI|||||||INVALID||JOULE||||NORMAL|NOT DONE||||NAIL|LIPEMIC|N|MAGNETIC RESONANCE ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||NA|U|U|U|||NA|3||39||OBSERVATION|1963-11-15|1961-03-20|||||1967-03-31||1961-05-09|NA|1970-12-09
TRIAL STUDY 134XCP|LB|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|2||||GALANIN|GALANIN|||||||MEQ/KG|||||||TRACE||UG/KG/MIN||||LOW|NOT DONE||||ALVEOLAR AIR|LIPEMIC|NA|LISSAMINE GREEN STAIN|MDRD 5 VARIABLE FORMULA||NA|U|U|Y|||Y|3||39||OPEN LABEL TREATMENT|1960-06-28|1970-09-30|||||1964-11-25||1968-10-12|NA|1969-01-04
TRIAL STUDY 134XCP|LB|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|1||||TIMP3|TISSUE INHIBITOR OF METALLOPROTEINASE 3|||||||ML/M2/H|||||||BORDERLINE||CPM||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|HEMOLYZED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|N|NA|||N|4||88||OPEN LABEL TREATMENT|1960-10-30|1971-09-09|||||1962-01-07||1970-01-25|Y|1962-01-12
TRIAL STUDY 134XCP|LB|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|2||||C165896|D. PTERONYSSINUS ANTIGEN IGG4 ANTIBODY|||||||PMOL/10^10 CELLS|||||||NEGATIVE||CM H2O||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|U|MULTIPLE BREATH WASHOUT|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|N|U|||Y|4||88||WASHOUT|1964-12-01|1962-12-12|||||1968-02-17||1970-08-30|Y|1960-07-07
TRIAL STUDY 134XCP|LB|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|1||||FACTVIII|FACTOR VIII|||||||%(W/W)|||||||POSITIVE||RATIO||||ABNORMAL|NOT DONE||||CORD BLOOD|CONTAMINATED|N|MRI WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|N|NA|||NA|5||7||BLINDED TREATMENT|1967-10-11|1972-05-31|||||1960-10-26||1962-01-21|Y|1962-11-13
TRIAL STUDY 134XCP|LB|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|2||||PLSMCELY|MATURE PLASMA CELLS/LYMPHOCYTES|||||||MAMP|||||||INVALID||U/ANIMAL||||HIGH|NOT DONE||||INFRANATANT, PLASMA|CONCENTRATED|U|NO INFORMATION|MDRD 5 VARIABLE FORMULA||U|NA|Y|N|||Y|5||7||INDUCTION TREATMENT|1963-07-27|1963-01-05|||||1969-05-12||1966-11-24|U|1963-04-05
TRIAL STUDY 134XCP|LB|0FFBFF7C-7C64-411E-8D07-C959F0886023|1||||APOE4|APOLIPOPROTEIN E4|||||||U/ANIMAL|||||||NEGATIVE||MCI/KG||||HIGH|NOT DONE||||BONE MARROW|UNEXPECTED ODOR|Y|CYSTOMETRY|FIBROTEST FORMULA||U|U|U|Y|||Y|1||38||BASELINE|1971-07-26|1970-01-13|||||1971-01-21||1960-01-01|NA|1968-02-06
TRIAL STUDY 134XCP|LB|0FFBFF7C-7C64-411E-8D07-C959F0886023|2||||THYPXDAB|THYROPEROXIDASE ANTIBODY|||||||U/KG/H|||||||NEGATIVE||IU/DAY||||LOW|NOT DONE||||PLEURAL TISSUE|ICTERIC|U|KINYOUN STAIN|FIBROSIS 4 FORMULA||Y|N|U|NA|||NA|1||38||TREATMENT|1968-12-23|1972-01-02|||||1965-07-14||1961-08-21|U|1970-01-11
TRIAL STUDY 134XCP|LB|0FFBFF7C-7C64-411E-8D07-C959F0886023|1||||C165909|INDUSTRIAL MIX IGG AB RAST SCORE|||||||MG/G/MIN|||||||TRACE||JAR||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ICTERIC|NA|IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|U|N|||N|2||58||CONTINUATION TREATMENT|1963-06-25|1962-09-25|||||1967-10-30||1970-08-08|NA|1968-10-04
TRIAL STUDY 134XCP|LB|0FFBFF7C-7C64-411E-8D07-C959F0886023|2||||ESELECT|E-SELECTIN|||||||/2500 WBC|||||||INVALID||GRAIN||||LOW|NOT DONE||||GASTRIC FLUID|REFRIGERATED|NA|DIFFUSION WEIGHTED MRI|GMI MMOL/MOL FORMULA||N|NA|U|Y|||Y|2||58||CONTINUATION TREATMENT|1965-10-03|1969-05-22|||||1970-10-18||1966-03-18|NA|1963-05-25
TRIAL STUDY 134XCP|LB|0FFBFF7C-7C64-411E-8D07-C959F0886023|1||||FACTVII|FACTOR VII|||||||GRAVITATIONAL UNIT|||||||POSITIVE||%(W/W)||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR|Y|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|Y|Y|||NA|3||39||OPEN LABEL TREATMENT|1960-04-20|1966-08-02|||||1968-02-07||1965-10-10|NA|1970-03-01
TRIAL STUDY 134XCP|LB|0FFBFF7C-7C64-411E-8D07-C959F0886023|2||||CD4|CD4|||||||RNA COPIES/ML|||||||INDETERMINATE||ML/KG/MIN||||HIGH|NOT DONE||||SEMINAL FLUID|HEMOLYZED|NA|CENTRIFUGATION|CKD-EPI CYSTATIN C FORMULA||NA|N|NA|Y|||NA|3||39||OBSERVATION|1960-05-27|1971-02-15|||||1965-10-03||1960-08-07|N|1963-10-02
TRIAL STUDY 134XCP|LB|0FFBFF7C-7C64-411E-8D07-C959F0886023|1||||RNPSMAB|RIBONUCLEOPROTEIN SMITH COMPLEX ANTIBODY|||||||U/G HB|||||||INVALID||DAYS/WK||||LOW|NOT DONE||||GASTRIC FLUID|PARAFFIN-EMBEDDED|N|IMMUNOPRECIPITATION|FIBROSIS 4 FORMULA||NA|Y|NA|N|||Y|4||88||INDUCTION TREATMENT|1961-03-29|1969-02-28|||||1960-07-03||1969-04-14|NA|1971-11-23
TRIAL STUDY 134XCP|LB|0FFBFF7C-7C64-411E-8D07-C959F0886023|2||||AMYLASES|AMYLASE, SALIVARY|||||||ML/DL|||||||NEGATIVE||DPM/100MG||||HIGH|NOT DONE||||SALIVA|CONTAMINATED|N|LAPAROSCOPY|COCKCROFT-GAULT FORMULA||N|Y|U|U|||NA|4||88||LONG-TERM FOLLOW-UP|1960-04-09|1962-11-07|||||1961-11-06||1960-07-31|NA|1968-02-24
TRIAL STUDY 134XCP|LB|0FFBFF7C-7C64-411E-8D07-C959F0886023|1||||BPIAB|BACTERICIDAL/PERMEABILITY-INC PROTEIN AB|||||||FMOL|||||||BORDERLINE||U/10^12 RBC||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|DRIED|NA|INTRAVASCULAR ULTRASOUND|MDRD 5 VARIABLE FORMULA||U|Y|NA|NA|||N|5||7||SCREENING|1968-03-29|1965-03-22|||||1971-10-30||1964-10-15|N|1965-04-24
TRIAL STUDY 134XCP|LB|0FFBFF7C-7C64-411E-8D07-C959F0886023|2||||NEUTIM|IMMATURE NEUTROPHILS|||||||ANTIBODY UNIT|||||||BORDERLINE||BQ/G||||HIGH|NOT DONE||||DIALYSIS FLUID|CLOTTED|U|FLUORIMETRY|COCKCROFT-GAULT FORMULA||Y|N|NA|Y|||N|5||7||INDUCTION TREATMENT|1973-03-06|1961-09-18|||||1970-12-12||1973-05-31|Y|1967-06-20
TRIAL STUDY 134XCP|LB|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|1||||EPICCE|EPITHELIAL CELLS/TOTAL CELLS|||||||PIXELS/CM|||||||POSITIVE||BISCUIT||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|CLOTTED|Y|HEMOCYTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|Y|U|||NA|1||38||CONTINUATION TREATMENT|1969-12-13|1961-09-13|||||1963-01-11||1973-03-09|N|1961-06-08
TRIAL STUDY 134XCP|LB|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|2||||HLAA|HLA CLASS IA ANTIGEN|||||||ENZYME U/L|||||||POSITIVE||BAU/ML||||HIGH|NOT DONE||||SUPERNATANT, SERUM|NON-HEMOLYZED|NA|ORCHIDOMETERY|MDRD FORMULA||Y|U|U|N|||NA|1||38||LONG-TERM FOLLOW-UP|1969-04-30|1960-05-05|||||1960-11-03||1971-06-17|NA|1961-11-01
TRIAL STUDY 134XCP|LB|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|1||||EOSCE|EOSINOPHILS/TOTAL CELLS|||||||BQ/KG|||||||TRACE||G/ANIMAL/WK||||LOW|NOT DONE||||EPITHELIAL CELL|CONCENTRATED|NA|ROMANOWSKY STAIN|CKD-EPI CYSTATIN C FORMULA||U|NA|Y|N|||Y|2||58||CONTINUATION TREATMENT|1966-01-16|1968-03-19|||||1960-10-21||1968-03-22|N|1965-12-05
TRIAL STUDY 134XCP|LB|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|2||||RAGE|RECEPTOR ADVANCED GLYCATION ENDPRODUCTS|||||||ML/CAGE/WK|||||||INDETERMINATE||MG/H||||HIGH|NOT DONE||||SEMINAL FLUID|FRESH|NA|STRESS ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA||U|U|U|Y|||NA|2||58||SCREENING|1962-10-17|1970-09-14|||||1970-11-14||1961-04-26|N|1968-04-06
TRIAL STUDY 134XCP|LB|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|1||||SO2|SULFUR DIOXIDE|||||||MET*MIN|||||||POSITIVE||TUBE||||ABNORMAL|NOT DONE||||MUCUS|HEMOLYZED|N|CONGO RED STAIN|FIBROMETER FORMULA||NA|NA|N|Y|||N|3||39||BLINDED TREATMENT|1968-05-31|1964-02-02|||||1973-08-18||1961-12-31|U|1971-04-12
TRIAL STUDY 134XCP|LB|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|2||||C165936|GLYCINE MAX IGE AB RAST SCORE|||||||HOUNSFIELD UNIT|||||||INVALID||CI/ML||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|SOLIDIFIED|Y|TRICHROME STAIN|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|N|||NA|3||39||INDUCTION TREATMENT|1972-06-10|1964-11-05|||||1966-04-08||1965-07-21|U|1972-10-01
TRIAL STUDY 134XCP|LB|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|1||||OXYCDN|OXYCODONE|||||||IU/MG|||||||NEGATIVE||RFU||||HIGH|NOT DONE||||TRANSUDATE|FROZEN|U|PHASE-CONTRAST MRI|GMI % FORMULA||N|U|N|N|||NA|4||88||INDUCTION TREATMENT|1967-12-25|1964-07-10|||||1962-10-07||1965-07-13|Y|1960-01-20
TRIAL STUDY 134XCP|LB|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|2||||GHB|GAMMA-HYDROXYBUTYRATE|||||||UG/ML/H|||||||BORDERLINE||USEC||||ABNORMAL|NOT DONE||||REFLEX TEAR|HEMOLYZED|NA|FARNSWORTH-MUNSELL 100 HUE TEST|HEPASCORE FORMULA||U|Y|NA|Y|||NA|4||88||BASELINE|1966-03-04|1965-10-28|||||1964-01-18||1961-11-21|N|1971-07-20
TRIAL STUDY 134XCP|LB|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|1||||CRH|CORTICOTROPIN RELEASING HORMONE|||||||G/MOL|||||||TRACE||G/M2||||NORMAL|NOT DONE||||DIALYSIS FLUID|THAWED|Y|ERGOSPIROMETRY|FIBROTEST FORMULA||Y|U|NA|U|||Y|5||7||RUN-IN|1960-01-22|1963-10-09|||||1969-04-27||1967-09-16|Y|1969-07-17
TRIAL STUDY 134XCP|LB|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|2||||MSPIKEPT|MONOCLONAL PROTEIN SPIKE/TOTAL PROTEIN|||||||NG/L|||||||BORDERLINE||GBQ/UG||||ABNORMAL|NOT DONE||||BILE|NON-HEMOLYZED|N|KARYOTYPING|ASH FIBROSURE FORMULA||U|N|N|U|||Y|5||7||CONTINUATION TREATMENT|1961-10-21|1969-02-14|||||1971-08-07||1972-10-18|N|1970-02-01
TRIAL STUDY 134XCP|LB|5DC5F780-264A-4EB1-BEA5-28209D416FEB|1||||TAT|THROMBIN/ANTITHROMBIN|||||||KBQ/UL|||||||INVALID||10^3 CFU||||ABNORMAL|NOT DONE||||BASAL TEAR|UNEXPECTED ODOR|Y|ANALYTICAL ULTRACENTRIFUGATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|NA|Y|||N|1||38||LONG-TERM FOLLOW-UP|1973-05-08|1965-01-19|||||1972-10-04||1973-02-25|N|1964-10-02
TRIAL STUDY 134XCP|LB|5DC5F780-264A-4EB1-BEA5-28209D416FEB|2||||CSEPI|EPITHELIAL CASTS|||||||%|||||||BORDERLINE||PPM||||HIGH|NOT DONE||||ISOLATE|DRIED|Y|HPLC/MS/MS|FIBROMETER FORMULA||N|U|U|Y|||NA|1||38||BLINDED TREATMENT|1961-06-01|1971-09-18|||||1960-08-13||1971-12-24|NA|1972-02-11
TRIAL STUDY 134XCP|LB|5DC5F780-264A-4EB1-BEA5-28209D416FEB|1||||PO2ADJT|PARTIAL PRESSURE OXYGEN ADJ FOR TEMP|||||||RAD|||||||BORDERLINE||UCI/KG||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|CONCENTRATED|N|PALPATION|MDRD 6 VARIABLE FORMULA||N|N|Y|Y|||NA|2||58||LONG-TERM FOLLOW-UP|1961-03-06|1969-07-07|||||1966-04-19||1972-07-21|Y|1971-01-04
TRIAL STUDY 134XCP|LB|5DC5F780-264A-4EB1-BEA5-28209D416FEB|2||||FENTANYL|FENTANYL|||||||ML/M2|||||||TRACE||KG/CM||||HIGH|NOT DONE||||PLEURAL TISSUE|FROZEN|Y|SINGLE-MOLECULE ARRAY|CKD-EPI CYSTATIN C FORMULA||NA|N|Y|NA|||U|2||58||FOLLOW-UP|1962-07-03|1971-09-12|||||1969-02-25||1969-10-08|Y|1962-02-05
TRIAL STUDY 134XCP|LB|5DC5F780-264A-4EB1-BEA5-28209D416FEB|1||||SCKCERBC|SICKLE CELLS/ERYTHROCYTES|||||||KALLIKREIN INHIBITOR UNIT|||||||INDETERMINATE||NMOL BCE/MMOL||||NORMAL|NOT DONE||||SEMINAL FLUID|LIPEMIC|N|WHOLE GENOME SEQUENCING|CKD-EPI FORMULA||NA|NA|Y|Y|||NA|3||39||SCREENING|1960-11-01|1962-06-13|||||1973-06-08||1973-04-02|U|1960-12-22
TRIAL STUDY 134XCP|LB|5DC5F780-264A-4EB1-BEA5-28209D416FEB|2||||KCLR|POTASSIUM CLEARANCE|||||||ML/M2|||||||INVALID||CAPSULE||||ABNORMAL|NOT DONE||||MUCUS|CLOTTED|U|NUCLEIC ACID HYBRIDIZATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|N|Y|||N|3||39||SCREENING|1962-01-12|1968-09-21|||||1962-11-11||1970-06-19|U|1963-03-01
TRIAL STUDY 134XCP|LB|5DC5F780-264A-4EB1-BEA5-28209D416FEB|1||||FACTVIIA|FACTOR VII ACTIVITY|||||||EP U|||||||BORDERLINE||ENZYME U/L||||LOW|NOT DONE||||SEBUM|LIPEMIC|U|MOUSE PROTECTION ASSAY|GMI % FORMULA||NA|NA|NA|NA|||Y|4||88||BLINDED TREATMENT|1961-09-22|1973-01-21|||||1968-08-13||1960-01-09|U|1967-12-29
TRIAL STUDY 134XCP|LB|5DC5F780-264A-4EB1-BEA5-28209D416FEB|2||||PARICEAB|PARIETAL CELL ANTIBODY|||||||10^6 DNA COPIES/ML|||||||INVALID||MM/H||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|ICTERIC|U|ANGIOGRAPHY|MDRD ENZYMATIC FORMULA||U|N|U|N|||U|4||88||OPEN LABEL TREATMENT|1961-08-16|1968-10-30|||||1964-11-09||1965-03-30|N|1962-11-07
TRIAL STUDY 134XCP|LB|5DC5F780-264A-4EB1-BEA5-28209D416FEB|1||||CTXI|TYPE I COLLAGEN C-TELOPEPTIDES|||||||GPELISA UNIT/ML|||||||INDETERMINATE||SEC||||LOW|NOT DONE||||BONE|FRESH|U|PHOTOMETRY|HEPASCORE FORMULA||U|U|U|NA|||N|5||7||LONG-TERM FOLLOW-UP|1967-07-10|1965-09-24|||||1963-04-20||1961-04-27|NA|1964-09-09
TRIAL STUDY 134XCP|LB|5DC5F780-264A-4EB1-BEA5-28209D416FEB|2||||CD27|CD27|||||||G/M2|||||||NEGATIVE||EVENTS||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|ICTERIC|U|DISK DIFFUSION|MDRD FORMULA||NA|U|NA|Y|||NA|5||7||WASHOUT|1972-07-08|1969-01-11|||||1968-08-31||1967-12-21|N|1962-08-12
TRIAL STUDY 134XCP|LB|DDBCA084-DD05-4FA0-9083-7CD31CECA420|1||||SECRETIN|SECRETIN|||||||OZ|||||||INVALID||ML/G/H||||LOW|NOT DONE||||SUPERNATANT, SERUM|ICTERIC|N|X-RAY FLUORESCENCE SPECTROMETRY|NASH FIBROSURE FORMULA||U|Y|Y|U|||Y|1||38||FOLLOW-UP|1960-05-06|1970-10-05|||||1968-09-17||1962-12-30|Y|1972-04-15
TRIAL STUDY 134XCP|LB|DDBCA084-DD05-4FA0-9083-7CD31CECA420|2||||NAG|N-ACETYL GLUCOSAMIDE|||||||U/L|||||||INDETERMINATE||10^4 CFU||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|CONCENTRATED|Y|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CYSTATIN C FORMULA||Y|Y|N|NA|||Y|1||38||FOLLOW-UP|1961-08-12|1963-06-21|||||1962-01-17||1968-08-25|NA|1972-07-23
TRIAL STUDY 134XCP|LB|DDBCA084-DD05-4FA0-9083-7CD31CECA420|1||||FUNGI|FUNGI|||||||MESF|||||||INDETERMINATE||PHERESIS UNIT||||NORMAL|NOT DONE||||FLUID|CONTAMINATED|U|ANALYTICAL ULTRACENTRIFUGATION|MDRD FORMULA||Y|NA|Y|U|||N|2||58||CONTINUATION TREATMENT|1964-03-27|1965-09-19|||||1972-08-15||1960-03-19|N|1965-09-14
TRIAL STUDY 134XCP|LB|DDBCA084-DD05-4FA0-9083-7CD31CECA420|2||||C147281|EGG WHITE ANTIGEN IGE ANTIBODY|||||||10^7 PFU|||||||POSITIVE||YD||||ABNORMAL|NOT DONE||||ERYTHROCYTES|ROOM TEMPERATURE|Y|MODIFIED ACID FAST STAIN|FIBROTEST FORMULA||NA|U|U|U|||N|2||58||LONG-TERM FOLLOW-UP|1966-03-04|1967-09-07|||||1965-10-17||1969-05-01|Y|1970-11-19
TRIAL STUDY 134XCP|LB|DDBCA084-DD05-4FA0-9083-7CD31CECA420|1||||KURLOFCE|KURLOFF CELLS|||||||UCI/KG|||||||NEGATIVE||NL||||LOW|NOT DONE||||CORD SERUM|AGGLUTINATED|U|MUGA|MDRD 5 VARIABLE FORMULA||U|U|NA|Y|||U|3||39||INDUCTION TREATMENT|1962-10-24|1961-03-10|||||1966-02-21||1963-03-15|NA|1963-05-05
TRIAL STUDY 134XCP|LB|DDBCA084-DD05-4FA0-9083-7CD31CECA420|2||||C165910|BEE MIX IGG AB RAST SCORE|||||||UG/M2/H|||||||NEGATIVE||VOXEL||||HIGH|NOT DONE||||WHITE MATTER TISSUE|HEMOLYZED|Y|POTENTIOMETRY|MDRD 6 VARIABLE FORMULA||NA|N|U|N|||U|3||39||OPEN LABEL TREATMENT|1961-06-18|1960-04-22|||||1971-01-09||1964-09-18|U|1964-05-26
TRIAL STUDY 134XCP|LB|DDBCA084-DD05-4FA0-9083-7CD31CECA420|1||||HISTAMIN|HISTAMINE|||||||/10^4|||||||INDETERMINATE||DRUM||||NORMAL|NOT DONE||||BONE|ICTERIC|Y|CONTRAST ENHANCED MRI|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|Y|Y|||Y|4||88||BASELINE|1960-02-25|1963-06-23|||||1960-11-03||1960-08-03|Y|1970-09-30
TRIAL STUDY 134XCP|LB|DDBCA084-DD05-4FA0-9083-7CD31CECA420|2||||EPIN|EPINEPHRINE|||||||UG/M2/MIN|||||||BORDERLINE||ML/BREATH||||HIGH|NOT DONE||||MUCUS|DRIED|Y|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD FORMULA||U|N|Y|U|||U|4||88||INDUCTION TREATMENT|1962-05-19|1966-10-03|||||1966-12-15||1963-03-10|N|1963-03-10
TRIAL STUDY 134XCP|LB|DDBCA084-DD05-4FA0-9083-7CD31CECA420|1||||FATACFR|FREE FATTY ACID|||||||UG/M2|||||||NEGATIVE||CMH2O*S2/ML||||LOW|NOT DONE||||SMEGMA|FROZEN|NA|FLUORESCENT SPOT TEST|CKD-EPI CYSTATIN C FORMULA||NA|N|N|Y|||Y|5||7||BLINDED TREATMENT|1960-06-11|1970-01-03|||||1973-01-27||1966-07-27|Y|1961-02-15
TRIAL STUDY 134XCP|LB|DDBCA084-DD05-4FA0-9083-7CD31CECA420|2||||CYSTHION|CYSTATHIONINE|||||||FOZ_BR|||||||NEGATIVE||10^3 CFU/G||||LOW|NOT DONE||||EPITHELIAL CELL|REFRIGERATED|NA|MANUAL CLOT DETECTION|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|N|NA|||NA|5||7||TREATMENT|1968-06-12|1970-01-29|||||1961-11-09||1967-06-24|Y|1967-03-26
TRIAL STUDY 134XCP|LB|65A5AAA6-A817-45F8-9BA8-584E9627AB26|1||||HGB|HEMOGLOBIN|||||||MS/MMHG|||||||NEGATIVE||UG/L||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|PARAFFIN-EMBEDDED|Y|CT SCAN WITHOUT CONTRAST|ASH FIBROSURE FORMULA||U|U|N|U|||Y|1||38||INDUCTION TREATMENT|1968-12-28|1972-12-05|||||1966-07-28||1967-04-01|NA|1969-12-19
TRIAL STUDY 134XCP|LB|65A5AAA6-A817-45F8-9BA8-584E9627AB26|2||||APOA2|APOLIPOPROTEIN AII|||||||BOLUS|||||||NEGATIVE||LOG10 IU/ML||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|PARAFFIN-EMBEDDED|N|ALCIAN BLUE STAIN|HEPASCORE FORMULA||NA|U|U|N|||N|1||38||FOLLOW-UP|1972-08-27|1968-05-23|||||1969-10-19||1962-03-02|Y|1965-07-09
TRIAL STUDY 134XCP|LB|65A5AAA6-A817-45F8-9BA8-584E9627AB26|1||||C130140|GERMAN COCKROACH ANTIGEN IGE ANTIBODY|||||||ANTI-XA IU/ML|||||||INDETERMINATE||GENEQ||||LOW|NOT DONE||||BONE|CONCENTRATED|Y|KINYOUN STAIN|NASH FIBROSURE FORMULA||U|NA|NA|Y|||NA|2||58||RUN-IN|1965-02-28|1970-04-02|||||1961-05-27||1962-12-25|N|1972-02-27
TRIAL STUDY 134XCP|LB|65A5AAA6-A817-45F8-9BA8-584E9627AB26|2||||GRANULIN|GRANULIN|||||||OZ EQ|||||||INDETERMINATE||MPH||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|HEMOLYZED|NA|CLOT DETECTION|NASH FIBROSURE FORMULA||U|Y|NA|U|||NA|2||58||RUN-IN|1968-12-11|1960-07-26|||||1964-06-30||1968-04-17|U|1963-11-24
TRIAL STUDY 134XCP|LB|65A5AAA6-A817-45F8-9BA8-584E9627AB26|1||||HLABAGT|HLA-B ANTIGEN TYPE|||||||/200 HPFS|||||||INDETERMINATE||FARAD||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|CALCIFIED|U|HILLMEN COLOR CHART|MDRD 6 VARIABLE FORMULA||Y|U|U|NA|||U|3||39||WASHOUT|1961-02-06|1964-02-06|||||1962-04-16||1963-05-25|NA|1972-10-30
TRIAL STUDY 134XCP|LB|65A5AAA6-A817-45F8-9BA8-584E9627AB26|2||||ENDOSTN|ENDOSTATIN|||||||PKAT|||||||POSITIVE||10^3 ORGANISMS||||LOW|NOT DONE||||HAIR FOLLICLE|AGGLUTINATED|NA|CRYOSCOPY|COCKCROFT-GAULT FORMULA||N|Y|Y|Y|||N|3||39||OBSERVATION|1972-08-23|1961-05-30|||||1972-04-17||1970-03-20|Y|1973-08-01
TRIAL STUDY 134XCP|LB|65A5AAA6-A817-45F8-9BA8-584E9627AB26|1||||HIST2AAB|HISTONE 2A ANTIBODY|||||||GBQ/MG|||||||TRACE||KN/CM2||||HIGH|NOT DONE||||SMEGMA|FROZEN|N|REFLECTANCE SPECTROSCOPY|GMI % FORMULA||N|Y|NA|U|||NA|4||88||INDUCTION TREATMENT|1973-08-26|1971-08-10|||||1961-03-14||1960-06-22|Y|1968-03-11
TRIAL STUDY 134XCP|LB|65A5AAA6-A817-45F8-9BA8-584E9627AB26|2||||BASOLE|BASOPHILS/LEUKOCYTES|||||||GPL U|||||||NEGATIVE||MJOULE/CM2||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|LIPEMIC|NA|PH METER MEASUREMENT METHOD|FIBROSIS 4 FORMULA||U|Y|N|Y|||N|4||88||LONG-TERM FOLLOW-UP|1963-11-10|1964-05-18|||||1961-08-28||1961-05-21|N|1971-08-15
TRIAL STUDY 134XCP|LB|65A5AAA6-A817-45F8-9BA8-584E9627AB26|1||||CBANH9|CARBONIC ANHYDRASE 9|||||||10^3/L|||||||INVALID||UGEQ/L||||HIGH|NOT DONE||||LYSATE|THAWED|Y|IMPEDANCE CONDUCTIVITY|MDRD FORMULA||U|Y|Y|NA|||U|5||7||WASHOUT|1964-05-06|1965-09-16|||||1973-08-05||1971-12-16|Y|1972-04-06
TRIAL STUDY 134XCP|LB|65A5AAA6-A817-45F8-9BA8-584E9627AB26|2||||CYTYRO|TYROSINE CRYSTALS|||||||/2000 RBC|||||||POSITIVE||INHALATION||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|SOLIDIFIED|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|Y|||NA|5||7||BLINDED TREATMENT|1973-07-15|1964-05-04|||||1963-04-11||1970-02-20|NA|1970-12-12
TRIAL STUDY 134XCP|LB|854AD9A5-A869-41C7-9AF0-43383CE64B86|1||||TRGTCE|TARGET CELLS|||||||BQ/ML|||||||INDETERMINATE||MG/M2/DAY||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|CLOTTED|U|TWO-COLOR MICROARRAY|MDRD 5 VARIABLE FORMULA||U|Y|N|U|||NA|1||38||TREATMENT|1970-08-17|1966-02-10|||||1963-07-16||1961-01-13|NA|1960-11-11
TRIAL STUDY 134XCP|LB|854AD9A5-A869-41C7-9AF0-43383CE64B86|2||||C130134|D. PTERONYSSINUS ANTIGEN IGE ANTIBODY|||||||JOULE|||||||INVALID||BOLUS||||LOW|NOT DONE||||HAIR|REFRIGERATED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA||N|U|NA|NA|||U|1||38||TREATMENT|1965-08-03|1970-03-13|||||1967-04-02||1973-05-28|Y|1964-08-23
TRIAL STUDY 134XCP|LB|854AD9A5-A869-41C7-9AF0-43383CE64B86|1||||CMONOX|CARBON MONOXIDE|||||||TCID 50/DOSE|||||||NEGATIVE||/10^5||||LOW|NOT DONE||||LAVAGE FLUID|REFRIGERATED|NA|PALPATION|NASH FIBROSURE FORMULA||N|Y|U|NA|||Y|2||58||TREATMENT|1961-10-18|1967-12-18|||||1963-12-19||1965-07-19|N|1962-09-20
TRIAL STUDY 134XCP|LB|854AD9A5-A869-41C7-9AF0-43383CE64B86|2||||PARICEAB|PARIETAL CELL ANTIBODY|||||||KALLIKREIN INHIBITOR UNIT|||||||INDETERMINATE||10^4/HPF||||ABNORMAL|NOT DONE||||DERMAL TISSUE|ICTERIC|NA|GC/MS/MS|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|NA|U|||NA|2||58||CONTINUATION TREATMENT|1966-09-29|1967-03-18|||||1972-10-11||1972-06-04|NA|1966-10-25
TRIAL STUDY 134XCP|LB|854AD9A5-A869-41C7-9AF0-43383CE64B86|1||||MYBLALE|MYELOBLASTS/LEUKOCYTES|||||||DAYS/WK|||||||TRACE||RFU||||NORMAL|NOT DONE||||SWABBED MATERIAL|CLOTTED|NA|QUANTITATIVE COMPUTED TOMOGRAPHY|GMI % FORMULA||U|Y|NA|N|||U|3||39||OBSERVATION|1961-07-21|1962-08-30|||||1970-05-10||1964-11-15|U|1964-10-06
TRIAL STUDY 134XCP|LB|854AD9A5-A869-41C7-9AF0-43383CE64B86|2||||PLATBIZ|BIZARRE PLATELETS|||||||MMOL/L|||||||NEGATIVE||CG||||NORMAL|NOT DONE||||INFRANATANT, SERUM|CONTAMINATED|NA|CISH|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|N|NA|||Y|3||39||BLINDED TREATMENT|1971-02-08|1972-11-02|||||1967-11-12||1972-09-26|Y|1969-02-01
TRIAL STUDY 134XCP|LB|854AD9A5-A869-41C7-9AF0-43383CE64B86|1||||CHOLINES|CHOLINESTERASE|||||||CP|||||||TRACE||L/MIN||||NORMAL|NOT DONE||||URINE|CLOTTED|N|NEXT GENERATION TARGETED SEQUENCING|GMI MMOL/MOL FORMULA||U|N|N|U|||U|4||88||FOLLOW-UP|1968-06-25|1960-08-20|||||1968-01-02||1960-04-12|N|1965-07-17
TRIAL STUDY 134XCP|LB|854AD9A5-A869-41C7-9AF0-43383CE64B86|2||||CASTS|CASTS|||||||TESLA|||||||NEGATIVE||%(W/W)||||LOW|NOT DONE||||CAPILLARY PLASMA|SOLIDIFIED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||N|N|N|U|||N|4||88||INDUCTION TREATMENT|1961-01-29|1964-06-13|||||1962-01-14||1964-08-23|Y|1966-02-23
TRIAL STUDY 134XCP|LB|854AD9A5-A869-41C7-9AF0-43383CE64B86|1||||HLAMSC|HLA MISMATCH COUNT|||||||KBQ/UL|||||||BORDERLINE||ML/H||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|CONTAMINATED|U|PERCUSSION|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|N|||Y|5||7||OPEN LABEL TREATMENT|1971-12-30|1961-03-27|||||1964-11-04||1963-04-07|U|1965-09-06
TRIAL STUDY 134XCP|LB|854AD9A5-A869-41C7-9AF0-43383CE64B86|2||||IL2RB|INTERLEUKIN 2 RECEPTOR SUBUNIT BETA|||||||VIRTUAL PIXEL|||||||NEGATIVE||CM H2O||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR|NA|ZIEHL NEELSEN ACID FAST STAIN|CKD-EPI CYSTATIN C FORMULA||NA|N|Y|Y|||U|5||7||LONG-TERM FOLLOW-UP|1965-01-19|1963-11-05|||||1960-12-04||1972-10-01|NA|1960-09-30
TRIAL STUDY 134XCP|LB|008F02C8-B28A-490E-A77A-F32584DA06FA|1||||BILEAC|BILE ACID|||||||GPL U/ML|||||||TRACE||/MM||||LOW|NOT DONE||||AQUEOUS HUMOR|UNEXPECTED ODOR|NA|PYROSEQUENCING|FIBROTEST FORMULA||U|Y|Y|Y|||U|1||38||BASELINE|1969-06-04|1970-09-12|||||1964-06-02||1973-03-11|Y|1961-08-30
TRIAL STUDY 134XCP|LB|008F02C8-B28A-490E-A77A-F32584DA06FA|2||||BASOIM|IMMATURE BASOPHILS|||||||GY|||||||INVALID||LM||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CONCENTRATED|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|ASH FIBROSURE FORMULA||U|NA|U|Y|||NA|1||38||CONTINUATION TREATMENT|1964-05-31|1960-08-04|||||1968-09-14||1961-09-25|U|1966-10-30
TRIAL STUDY 134XCP|LB|008F02C8-B28A-490E-A77A-F32584DA06FA|1||||CONDUCTU|URINE CONDUCTIVITY|||||||UG/MIN|||||||INVALID||MET||||NORMAL|NOT DONE||||SMEGMA|CALCIFIED|U|SPIROMETRY|CKD-EPI CYSTATIN C FORMULA||Y|U|N|Y|||U|2||58||LONG-TERM FOLLOW-UP|1966-01-03|1972-09-02|||||1967-09-30||1964-12-03|N|1966-08-05
TRIAL STUDY 134XCP|LB|008F02C8-B28A-490E-A77A-F32584DA06FA|2||||PROTS|PROTEIN S|||||||U/M2|||||||TRACE||U/CL||||NORMAL|NOT DONE||||LYSATE|LACTESCENT|Y|ICC|MDRD 5 VARIABLE FORMULA||U|N|NA|Y|||NA|2||58||RUN-IN|1962-08-11|1961-01-14|||||1961-10-04||1963-04-12|N|1965-04-12
TRIAL STUDY 134XCP|LB|008F02C8-B28A-490E-A77A-F32584DA06FA|1||||CRNTESTR|CARNITINE ESTERS|||||||IU/ML|||||||INDETERMINATE||NEWTON||||HIGH|NOT DONE||||TUMOR TISSUE|ROOM TEMPERATURE|NA|LC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|U|U|||U|3||39||CONTINUATION TREATMENT|1968-07-25|1963-11-05|||||1969-07-29||1960-12-25|Y|1963-10-14
TRIAL STUDY 134XCP|LB|008F02C8-B28A-490E-A77A-F32584DA06FA|2||||NRDZPM|NORDAZEPAM|||||||%/MIN|||||||NEGATIVE||MMHG/L/MIN||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|AGGLUTINATED|U|DUKE INCISION METHOD|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|N|N|||N|3||39||BLINDED TREATMENT|1968-06-27|1967-01-11|||||1960-12-12||1963-04-26|NA|1961-05-14
TRIAL STUDY 134XCP|LB|008F02C8-B28A-490E-A77A-F32584DA06FA|1||||ACYLCAOX|ACYL COENZYME A OXIDASE|||||||UG/KG/MIN|||||||INDETERMINATE||GPS U||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|CLOTTED|Y|SPECT SCAN|MDRD ENZYMATIC JAPANESE FORMULA||U|N|U|U|||U|4||88||RUN-IN|1961-05-18|1960-07-20|||||1968-09-10||1973-03-13|U|1964-11-03
TRIAL STUDY 134XCP|LB|008F02C8-B28A-490E-A77A-F32584DA06FA|2||||LCN2CREA|LIPOCALIN-2/CREATININE|||||||CS|||||||POSITIVE||UG/MIN||||NORMAL|NOT DONE||||MUSCLE TISSUE|CLOTTED|U|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 6 VARIABLE FORMULA||Y|NA|Y|N|||NA|4||88||WASHOUT|1972-07-09|1971-09-07|||||1960-01-08||1960-10-10|Y|1961-09-04
TRIAL STUDY 134XCP|LB|008F02C8-B28A-490E-A77A-F32584DA06FA|1||||COCAINE|COCAINE|||||||GBQ|||||||INDETERMINATE||CD/M2||||LOW|NOT DONE||||LUNG SURFACTANT|CALCIFIED|NA|HPLC/MS|HEPASCORE FORMULA||U|Y|NA|Y|||N|5||7||WASHOUT|1967-04-03|1969-07-31|||||1967-12-07||1962-06-10|U|1961-04-14
TRIAL STUDY 134XCP|LB|008F02C8-B28A-490E-A77A-F32584DA06FA|2||||LSD|LYSERGIC ACID DIETHYLAMIDE|||||||10^6 ORGANISMS/ML|||||||INDETERMINATE||U/KG/H||||NORMAL|NOT DONE||||BLOOD|AUTOLYZED|Y|IN SITU HYBRIDIZATION|CKD-EPI FORMULA||U|NA|NA|NA|||Y|5||7||INDUCTION TREATMENT|1972-09-26|1967-08-08|||||1966-09-03||1968-05-10|U|1968-08-03
TRIAL STUDY 134XCP|LB|7C06549D-596C-4C47-BD0B-119DF6CD67AC|1||||INTLK3|INTERLEUKIN 3|||||||BU|||||||NEGATIVE||ML/KG||||NORMAL|NOT DONE||||KERATINOCYTE|CONTAMINATED|N|OPTICAL MAPPING|MDRD ENZYMATIC FORMULA||U|N|Y|Y|||Y|1||38||INDUCTION TREATMENT|1972-07-21|1962-05-14|||||1962-04-29||1963-07-24|Y|1969-03-26
TRIAL STUDY 134XCP|LB|7C06549D-596C-4C47-BD0B-119DF6CD67AC|2||||CASULPH|CALCIUM SULPHATE|||||||M|||||||NEGATIVE||TRANSDUCING UNIT/ML||||HIGH|NOT DONE||||CALCULUS|NON-HEMOLYZED|Y|CALCOFLUOR WHITE STAIN|ASH FIBROSURE FORMULA||N|Y|NA|N|||N|1||38||OPEN LABEL TREATMENT|1960-02-28|1969-06-25|||||1972-06-03||1967-11-19|N|1961-08-23
TRIAL STUDY 134XCP|LB|7C06549D-596C-4C47-BD0B-119DF6CD67AC|1||||HDLPL|HDL PHOSPHOLIPID|||||||10^6 ORGANISMS/MG|||||||INDETERMINATE||V/V||||NORMAL|NOT DONE||||TRANSUDATE|CONCENTRATED|U|IMMUNOFIXATION ELECTROPHORESIS|COCKCROFT-GAULT FORMULA||N|Y|N|N|||U|2||58||SCREENING|1970-12-10|1963-12-02|||||1969-06-09||1970-08-25|N|1965-09-24
TRIAL STUDY 134XCP|LB|7C06549D-596C-4C47-BD0B-119DF6CD67AC|2||||POIKRBC|POIKILOCYTES/ERYTHROCYTES|||||||CAPSULE|||||||INDETERMINATE||LOG10 TCID 50/UL||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|FROZEN|N|SECONDARY ION MASS SPECTOMETRY|MDRD FORMULA||Y|U|U|N|||N|2||58||OBSERVATION|1967-01-06|1967-03-31|||||1964-11-17||1970-05-13|NA|1967-04-10
TRIAL STUDY 134XCP|LB|7C06549D-596C-4C47-BD0B-119DF6CD67AC|1||||GUSA|GLUCURONIDASE, ALPHA|||||||LB|||||||BORDERLINE||U/G/H||||LOW|NOT DONE||||CORD SERUM|AUTOLYZED|N|IMMUNOTURBIDIMETRY|FIBROTEST FORMULA||Y|Y|N|N|||NA|3||39||INDUCTION TREATMENT|1961-06-27|1966-06-03|||||1968-09-06||1961-08-23|NA|1971-12-15
TRIAL STUDY 134XCP|LB|7C06549D-596C-4C47-BD0B-119DF6CD67AC|2||||HBA1CHGB|HEMOGLOBIN A1C/HEMOGLOBIN|||||||ENZYME U/L|||||||TRACE||L/S||||LOW|NOT DONE||||SEMEN|NON-HEMOLYZED|NA|FLOCCULATION, CHARCOAL ENHANCED|CKD-EPI CREATININE FORMULA||U|NA|Y|N|||NA|3||39||FOLLOW-UP|1972-08-03|1966-07-03|||||1971-04-24||1960-09-25|N|1962-12-15
TRIAL STUDY 134XCP|LB|7C06549D-596C-4C47-BD0B-119DF6CD67AC|1||||FCT8INH|FACTOR VIII INHIBITOR|||||||KDA|||||||TRACE||SCM||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|FROZEN|NA|DYNAMIC LIGHT SCATTERING|NASH FIBROSURE FORMULA||NA|NA|Y|N|||N|4||88||WASHOUT|1966-12-08|1961-10-23|||||1965-03-09||1961-07-17|N|1966-08-14
TRIAL STUDY 134XCP|LB|7C06549D-596C-4C47-BD0B-119DF6CD67AC|2||||BILI|BILIRUBIN|||||||KS|||||||TRACE||L/S/KPA||||HIGH|NOT DONE||||ISOLATE|AGGLUTINATED|Y|ACID FAST STAIN|HEPASCORE FORMULA||NA|U|NA|N|||Y|4||88||BLINDED TREATMENT|1970-10-27|1968-05-06|||||1966-06-16||1967-02-18|U|1962-03-17
TRIAL STUDY 134XCP|LB|7C06549D-596C-4C47-BD0B-119DF6CD67AC|1||||IGG3|IMMUNOGLOBULIN G SUBCLASS 3|||||||UG/CM2|||||||INVALID||NMOL||||NORMAL|NOT DONE||||COLOSTRUM|DRIED|N|POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||U|N|N|Y|||N|5||7||BLINDED TREATMENT|1964-08-24|1973-08-28|||||1971-06-26||1961-06-14|N|1966-03-10
TRIAL STUDY 134XCP|LB|7C06549D-596C-4C47-BD0B-119DF6CD67AC|2||||PD1S|SOLUBLE PROGRAMMED DEATH-1|||||||FG|||||||INDETERMINATE||EVENTS||||HIGH|NOT DONE||||EPIDERMAL TISSUE|ICTERIC|Y|DIPSTICK|GMI % FORMULA||N|NA|Y|U|||NA|5||7||BASELINE|1967-09-18|1964-08-08|||||1970-04-11||1969-04-15|N|1964-10-12
TRIAL STUDY 134XCP|LB|39A00D93-61B9-44C5-9672-005A1F9A93EB|1||||T3UP|TRIIODOTHYRONINE UPTAKE|||||||MOL/DAY|||||||NEGATIVE||ML/100G/MIN||||LOW|NOT DONE||||BONE|HEMOLYZED|U|HPLC-UV|MDRD 5 VARIABLE FORMULA||Y|Y|Y|U|||NA|1||38||OPEN LABEL TREATMENT|1969-09-04|1966-02-13|||||1968-07-25||1965-03-27|N|1968-01-30
TRIAL STUDY 134XCP|LB|39A00D93-61B9-44C5-9672-005A1F9A93EB|2||||CANNABS|CANNABINOIDS, SYNTHETIC|||||||CM|||||||INDETERMINATE||CFU/ML||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|UNEXPECTED ODOR|Y|OSCILLOMETRY|MDRD 6 VARIABLE FORMULA||N|NA|NA|Y|||Y|1||38||INDUCTION TREATMENT|1963-04-08|1965-11-08|||||1965-02-03||1966-08-23|N|1964-12-01
TRIAL STUDY 134XCP|LB|39A00D93-61B9-44C5-9672-005A1F9A93EB|1||||A73OXC|7-ALPHA-HYDROXY-4-CHOLESTEN-3-ONE|||||||CMH2O/ML|||||||NEGATIVE||MMOL||||ABNORMAL|NOT DONE||||SEMEN|CALCIFIED|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CREATININE FORMULA||U|NA|U|U|||U|2||58||WASHOUT|1970-01-30|1972-12-03|||||1967-01-30||1971-05-11|U|1965-12-01
TRIAL STUDY 134XCP|LB|39A00D93-61B9-44C5-9672-005A1F9A93EB|2||||MDEA|3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE|||||||UG/DOSE|||||||BORDERLINE||G/M2/DAY||||LOW|NOT DONE||||PROSTATIC FLUID|CONCENTRATED|U|CELL OF ORIGIN ASSAY|MDRD 4 VARIABLE FORMULA||NA|N|U|NA|||N|2||58||WASHOUT|1970-12-13|1962-02-02|||||1964-05-25||1967-05-11|N|1969-10-03
TRIAL STUDY 134XCP|LB|39A00D93-61B9-44C5-9672-005A1F9A93EB|1||||PROT|PROTEIN|||||||TABLET|||||||INDETERMINATE||TUBE||||LOW|NOT DONE||||INFRANATANT, PLASMA|PARAFFIN-EMBEDDED|N|STRESS ECHOCARDIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|N|Y|||Y|3||39||CONTINUATION TREATMENT|1964-07-04|1963-05-08|||||1972-04-28||1960-01-04|NA|1962-07-07
TRIAL STUDY 134XCP|LB|39A00D93-61B9-44C5-9672-005A1F9A93EB|2||||FECA|FRACTIONAL CALCIUM EXCRETION|||||||VIAL|||||||TRACE||MDFI||||NORMAL|NOT DONE||||VENOUS PLASMA|LACTESCENT|U|ROMANOWSKY STAIN|MDRD 5 VARIABLE FORMULA||Y|U|Y|Y|||N|3||39||TREATMENT|1961-09-01|1964-05-19|||||1968-03-05||1971-09-29|NA|1971-11-11
TRIAL STUDY 134XCP|LB|39A00D93-61B9-44C5-9672-005A1F9A93EB|1||||TESTOSBA|BIOAVAILABLE TESTOSTERONE|||||||MG/KG/DAY|||||||POSITIVE||LX||||ABNORMAL|NOT DONE||||SEBUM|NON-HEMOLYZED|Y|IMPULSE OSCILLOMETRY|GMI MMOL/MOL FORMULA||U|N|Y|NA|||N|4||88||TREATMENT|1961-08-19|1964-10-02|||||1971-08-30||1969-09-09|U|1970-08-11
TRIAL STUDY 134XCP|LB|39A00D93-61B9-44C5-9672-005A1F9A93EB|2||||VITB7|VITAMIN B7|||||||ABSORBANCE U/ML|||||||INDETERMINATE||SPRAY||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|CONTAMINATED|NA|TOTAL BODY IRRADIATION|FIBROTEST FORMULA||NA|Y|U|NA|||U|4||88||LONG-TERM FOLLOW-UP|1969-08-15|1966-08-18|||||1961-01-04||1963-04-04|NA|1970-09-10
TRIAL STUDY 134XCP|LB|39A00D93-61B9-44C5-9672-005A1F9A93EB|1||||CCL8|CHEMOKINE (C-C MOTIF) LIGAND 8|||||||MG/DAY|||||||TRACE||UMOL/MIN||||HIGH|NOT DONE||||CAPILLARY BLOOD|AUTOLYZED|U|PEAK FLOWMETRY|COCKCROFT-GAULT FORMULA||U|U|Y|U|||N|5||7||FOLLOW-UP|1961-01-02|1960-06-20|||||1961-10-23||1965-09-22|Y|1972-02-19
TRIAL STUDY 134XCP|LB|39A00D93-61B9-44C5-9672-005A1F9A93EB|2||||BNZLCGN|BENZOYLECGONINE|||||||/7.5 ML|||||||INDETERMINATE||S^-1(%O2)^-1||||NORMAL|NOT DONE||||ABSCESS FLUID|LACTESCENT|N|HEMAGGLUTINATION INHIBITION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|Y|U|||U|5||7||OBSERVATION|1963-07-31|1965-03-07|||||1967-11-24||1971-03-25|NA|1961-09-11
TRIAL STUDY 134XCP|LB|71B78EFA-AE7A-4248-9A59-63885131F1D1|1||||MONOCE|MONOCYTES/TOTAL CELLS|||||||BQ/G|||||||INVALID||DIOPTER||||ABNORMAL|NOT DONE||||URINE|CONCENTRATED|N|SXA SCAN|FIBROMETER FORMULA||N|Y|NA|N|||Y|1||38||OPEN LABEL TREATMENT|1972-12-26|1962-07-04|||||1964-10-14||1967-11-15|U|1973-05-15
TRIAL STUDY 134XCP|LB|71B78EFA-AE7A-4248-9A59-63885131F1D1|2||||GLOBG|GAMMA GLOBULIN|||||||G/G|||||||INVALID||MMHG/SEC||||ABNORMAL|NOT DONE||||VENOUS BLOOD|ICTERIC|NA|CONTRAST ENHANCED SPIRAL CT SCAN|COCKCROFT-GAULT FORMULA||U|N|Y|Y|||Y|1||38||INDUCTION TREATMENT|1966-12-31|1972-12-07|||||1972-12-25||1960-05-03|NA|1973-02-13
TRIAL STUDY 134XCP|LB|71B78EFA-AE7A-4248-9A59-63885131F1D1|1||||SFTPD|SURFACTANT PROTEIN D|||||||JOULE|||||||INVALID||/5X10^4 WBC||||LOW|NOT DONE||||PLATELET POOR PLASMA|THAWED|U|PET/MRI SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|Y|NA|||U|2||58||OPEN LABEL TREATMENT|1966-08-10|1972-01-10|||||1971-06-10||1962-02-06|N|1972-03-15
TRIAL STUDY 134XCP|LB|71B78EFA-AE7A-4248-9A59-63885131F1D1|2||||PLATLRG|LARGE PLATELETS|||||||CD/M2|||||||BORDERLINE||DISK||||HIGH|NOT DONE||||MECONIUM|CLOTTED|Y|MANUAL CLOT DETECTION|NASH FIBROSURE FORMULA||N|U|Y|Y|||NA|2||58||FOLLOW-UP|1972-06-08|1960-05-05|||||1969-08-12||1962-08-19|N|1962-02-03
TRIAL STUDY 134XCP|LB|71B78EFA-AE7A-4248-9A59-63885131F1D1|1||||RENIN|RENIN|||||||MG/DAY|||||||NEGATIVE||TROCHE||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|HEMOLYZED|N|ENZYMATIC COLORIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|NA|NA|||U|3||39||OPEN LABEL TREATMENT|1964-12-26|1960-08-04|||||1961-04-02||1968-03-20|N|1961-12-31
TRIAL STUDY 134XCP|LB|71B78EFA-AE7A-4248-9A59-63885131F1D1|2||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||RAD|||||||INDETERMINATE||KG||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|THAWED|U|MOUSE PROTECTION ASSAY|FIBROSIS 4 FORMULA||NA|Y|N|U|||Y|3||39||OPEN LABEL TREATMENT|1973-07-21|1971-10-20|||||1971-12-31||1963-03-08|Y|1962-07-04
TRIAL STUDY 134XCP|LB|71B78EFA-AE7A-4248-9A59-63885131F1D1|1||||HLZPM|HALAZEPAM|||||||LOG10 PFU/ML|||||||INDETERMINATE||UL/DOSE||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|LACTESCENT|Y|TONOMETRY|FIBROMETER FORMULA||N|U|Y|U|||N|4||88||OBSERVATION|1970-08-28|1970-05-05|||||1968-01-10||1967-07-16|NA|1973-07-05
TRIAL STUDY 134XCP|LB|71B78EFA-AE7A-4248-9A59-63885131F1D1|2||||LYMVAC|VACUOLATED LYMPHOCYTES|||||||AMU|||||||POSITIVE||U/ANIMAL||||LOW|NOT DONE||||BASAL TEAR|CLOTTED|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|ASH FIBROSURE FORMULA||NA|N|N|N|||U|4||88||FOLLOW-UP|1964-04-04|1960-04-03|||||1969-12-24||1971-10-10|Y|1965-08-20
TRIAL STUDY 134XCP|LB|71B78EFA-AE7A-4248-9A59-63885131F1D1|1||||ADSDNA|ANTI-DOUBLE STRANDED DNA|||||||U/KG/H|||||||BORDERLINE||ML/KG||||NORMAL|NOT DONE||||GASTRIC CONTENTS|FROZEN|N|TRIPLE-PHASE MRI SCAN|GMI MMOL/MOL FORMULA||N|NA|U|U|||U|5||7||OBSERVATION|1960-08-16|1960-03-16|||||1968-09-16||1967-11-20|Y|1972-02-25
TRIAL STUDY 134XCP|LB|71B78EFA-AE7A-4248-9A59-63885131F1D1|2||||HYPSEGCE|HYPERSEGMENTED CELLS|||||||NG/L|||||||INDETERMINATE||SYRINGE||||ABNORMAL|NOT DONE||||TRANSUDATE|DRIED|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD 6 VARIABLE FORMULA||Y|U|U|Y|||N|5||7||TREATMENT|1963-01-15|1961-05-15|||||1971-02-17||1967-02-08|Y|1968-04-25
TRIAL STUDY 134XCP|LB|CE28B885-422E-471D-895C-DE8F41CD9FE9|1||||INGAPAB|ISLET NEOGENESIS ASSOC PROTEIN ANTIBODY|||||||PACK YEAR|||||||INDETERMINATE||SV||||ABNORMAL|NOT DONE||||PLEURAL FLUID|AGGLUTINATED|NA|PYROSEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|NA|U|||Y|1||38||OBSERVATION|1965-12-03|1966-10-26|||||1972-04-19||1963-10-03|N|1965-06-23
TRIAL STUDY 134XCP|LB|CE28B885-422E-471D-895C-DE8F41CD9FE9|2||||GNRH|GONADOTROPIN RELEASING HORMONE|||||||STRIP|||||||TRACE||LOG10 TCID 50/ML||||LOW|NOT DONE||||SERUM|ROOM TEMPERATURE|NA|DIRECT SEQUENCING|GMI % FORMULA||U|NA|Y|N|||Y|1||38||CONTINUATION TREATMENT|1960-11-29|1969-03-31|||||1969-11-11||1960-07-21|U|1969-12-03
TRIAL STUDY 134XCP|LB|CE28B885-422E-471D-895C-DE8F41CD9FE9|1||||IAA5OHCR|5-HYDROXYINDOLEACETIC ACID/CREATININE|||||||ML/DAY|||||||INDETERMINATE||GENEQ/ML||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|REFRIGERATED|Y|ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|NA|NA|N|||N|2||58||TREATMENT|1964-09-28|1966-09-18|||||1973-06-14||1966-08-21|N|1963-06-24
TRIAL STUDY 134XCP|LB|CE28B885-422E-471D-895C-DE8F41CD9FE9|2||||MONMPHLE|MONOCYTES AND MACROPHAGES/LEUKOCYTES|||||||MM/H|||||||INVALID||IU/DL||||NORMAL|NOT DONE||||MUCUS|NON-HEMOLYZED|N|TWO-COLOR MICROARRAY|FIBROMETER FORMULA||Y|Y|NA|N|||N|2||58||OPEN LABEL TREATMENT|1966-11-07|1962-10-24|||||1962-02-03||1964-12-10|NA|1961-12-21
TRIAL STUDY 134XCP|LB|CE28B885-422E-471D-895C-DE8F41CD9FE9|1||||SPGRAV|SPECIFIC GRAVITY|||||||10^6 ORGANISMS/MG|||||||NEGATIVE||/100 HPFS||||ABNORMAL|NOT DONE||||LEUKOCYTE|LACTESCENT|Y|CELLULOSE TAPE|FIBROMETER FORMULA||NA|U|U|U|||Y|3||39||SCREENING|1963-04-23|1972-12-04|||||1973-04-09||1972-01-17|N|1969-06-05
TRIAL STUDY 134XCP|LB|CE28B885-422E-471D-895C-DE8F41CD9FE9|2||||CCL2EXR|CHEMOKINE (C-C MOTIF) LIGAND 2 EXCR RATE|||||||PIXELS/IN|||||||TRACE||RFU||||LOW|NOT DONE||||TRANSUDATE|CLOTTED|NA|SISH|CKD-EPI FORMULA||U|N|N|NA|||N|3||39||TREATMENT|1966-01-04|1970-02-06|||||1962-08-01||1962-12-07|Y|1971-05-01
TRIAL STUDY 134XCP|LB|CE28B885-422E-471D-895C-DE8F41CD9FE9|1||||ELA2PMN|NEUTROPHIL ELASTASE, POLYMORPHONUCLEAR|||||||PT_US|||||||NEGATIVE||YEARS||||LOW|NOT DONE||||EPITHELIAL CELL|GELLED|Y|DOUBLE IMMUNODIFFUSION|MDRD 5 VARIABLE FORMULA||N|NA|N|U|||U|4||88||FOLLOW-UP|1962-11-08|1962-11-13|||||1968-03-24||1963-08-29|U|1968-12-10
TRIAL STUDY 134XCP|LB|CE28B885-422E-471D-895C-DE8F41CD9FE9|2||||CIT|CITRULLINE|||||||IU|||||||TRACE||SYRINGE||||LOW|NOT DONE||||SPERMATOZOON|REFRIGERATED|N|SECONDARY ION MASS SPECTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|NA|N|||NA|4||88||SCREENING|1961-06-04|1963-08-17|||||1967-05-18||1960-01-22|Y|1966-03-01
TRIAL STUDY 134XCP|LB|CE28B885-422E-471D-895C-DE8F41CD9FE9|1||||BASOLE|BASOPHILS/LEUKOCYTES|||||||DRINK|||||||INDETERMINATE||AU/ML||||LOW|NOT DONE||||WHITE MATTER TISSUE|AGGLUTINATED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|N|||NA|5||7||INDUCTION TREATMENT|1967-05-09|1968-10-23|||||1971-07-17||1963-06-30|NA|1971-02-28
TRIAL STUDY 134XCP|LB|CE28B885-422E-471D-895C-DE8F41CD9FE9|2||||LCHLCM|LITHOCHOLATE COMPOUNDS|||||||10^6/G|||||||NEGATIVE||BAG||||LOW|NOT DONE||||VITREOUS HUMOR|PARAFFIN-EMBEDDED|Y|ACID FAST STAIN|MDRD ENZYMATIC FORMULA||U|N|NA|U|||NA|5||7||CONTINUATION TREATMENT|1960-01-31|1971-10-15|||||1960-05-29||1964-10-26|Y|1966-10-24
TRIAL STUDY 134XCP|LB|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|1||||C130123|NUT MIX ANTIGEN IGG ANTIBODY|||||||MANSON U/ML|||||||TRACE||MMHG*MIN/L||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|GELLED|Y|MIGET|GMI MMOL/MOL FORMULA||Y|NA|Y|NA|||N|1||38||OPEN LABEL TREATMENT|1972-09-01|1960-01-11|||||1964-01-18||1969-02-08|U|1973-01-18
TRIAL STUDY 134XCP|LB|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|2||||TLYCE|T-LYMPHOCYTES|||||||IU/DAY|||||||BORDERLINE||ML/DOSE||||HIGH|NOT DONE||||MENSTRUAL BLOOD|DRIED|N|DIFFUSION TENSOR MRI|FIBROSIS 4 FORMULA||U|NA|NA|NA|||NA|1||38||CONTINUATION TREATMENT|1972-12-28|1963-03-06|||||1965-06-12||1964-08-24|NA|1960-10-12
TRIAL STUDY 134XCP|LB|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|1||||METHQLDN|METHAQUALONE|||||||PELLET|||||||INDETERMINATE||10^3 COPIES/ML||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|SOLIDIFIED|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|HEPASCORE FORMULA||NA|NA|NA|U|||NA|2||58||RUN-IN|1967-05-22|1960-01-17|||||1961-04-02||1967-09-08|N|1967-05-04
TRIAL STUDY 134XCP|LB|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|2||||CPEPTIDE|C-PEPTIDE|||||||10^3 CFU|||||||INDETERMINATE||SUPPOSITORY||||HIGH|NOT DONE||||EPIDERMAL TISSUE|AUTOLYZED|U|SPIROMETRY|NASH FIBROSURE FORMULA||N|NA|U|Y|||Y|2||58||CONTINUATION TREATMENT|1966-12-12|1970-10-14|||||1970-07-07||1960-01-23|NA|1963-07-25
TRIAL STUDY 134XCP|LB|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|1||||KLCLLCFR|KAPPA LT CHAIN,FREE/LAMBDA LT CHAIN,FREE|||||||U.CARR|||||||NEGATIVE||INHALATION||||NORMAL|NOT DONE||||LEUKOCYTE|HEMOLYZED|U|CONTRAST ENHANCED MRI|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|U|||Y|3||39||CONTINUATION TREATMENT|1967-09-14|1971-12-11|||||1968-04-15||1962-01-08|NA|1966-07-06
TRIAL STUDY 134XCP|LB|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|2||||ALP|ALKALINE PHOSPHATASE|||||||UG/KG/DAY|||||||NEGATIVE||PPM||||HIGH|NOT DONE||||URINE|AGGLUTINATED|Y|ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||U|U|U|N|||NA|3||39||BASELINE|1963-08-07|1966-04-26|||||1960-06-08||1968-11-21|NA|1961-10-19
TRIAL STUDY 134XCP|LB|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|1||||COTININE|COTININE|||||||KM/H|||||||POSITIVE||DEG||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|FROZEN|N|TRIPLE-PHASE MRI SCAN|GMI MMOL/MOL FORMULA||Y|N|Y|N|||Y|4||88||OBSERVATION|1967-07-11|1961-02-24|||||1970-08-24||1965-08-15|N|1960-10-06
TRIAL STUDY 134XCP|LB|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|2||||UROTHCE|UROTHELIAL CELLS|||||||1/(S*KPA)|||||||BORDERLINE||MG/KG||||NORMAL|NOT DONE||||BONE MARROW|SOLIDIFIED|U|LINE PROBE ASSAY|FIBROMETER FORMULA||N|U|NA|Y|||NA|4||88||FOLLOW-UP|1972-04-12|1965-01-07|||||1964-11-05||1963-03-11|Y|1970-02-13
TRIAL STUDY 134XCP|LB|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|1||||LYMVAC|VACUOLATED LYMPHOCYTES|||||||UIU/L|||||||INVALID||M2||||LOW|NOT DONE||||ARTERIAL BLOOD|HEMOLYZED|N|WHOLE GENOME SEQUENCING|MDRD ENZYMATIC FORMULA||Y|NA|N|Y|||Y|5||7||FOLLOW-UP|1964-04-07|1965-06-28|||||1973-01-05||1964-01-20|N|1970-07-11
TRIAL STUDY 134XCP|LB|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|2||||NTRLFAT|NEUTRAL FATS|||||||DAYS/MONTH|||||||BORDERLINE||U/MG||||NORMAL|NOT DONE||||PLEURAL FLUID|HEMOLYZED|N|NON-INVASIVE DIELECTRIC SENSING|MDRD FORMULA||NA|N|Y|U|||N|5||7||OBSERVATION|1968-04-15|1962-03-20|||||1969-06-17||1968-01-15|NA|1961-08-10
TRIAL STUDY 134XCP|LB|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|1||||IL2SRA|SOLUBLE INTERLEUKIN 2 RECEPTOR ACTIVITY|||||||PRESSOR UNITS|||||||NEGATIVE||KHZ||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|CONTAMINATED|N|SPIROMETRY|CKD-EPI FORMULA||Y|Y|U|NA|||Y|1||38||OPEN LABEL TREATMENT|1960-01-07|1960-09-18|||||1962-08-30||1969-11-07|NA|1962-06-01
TRIAL STUDY 134XCP|LB|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|2||||C165884|OLIVE TREE POLLEN IGE ANTIBODY|||||||ML/100G/MIN|||||||TRACE||TUBERCULIN UNIT/ML||||ABNORMAL|NOT DONE||||SMEGMA|SOLIDIFIED|NA|EEG|NASH FIBROSURE FORMULA||Y|NA|NA|N|||N|1||38||LONG-TERM FOLLOW-UP|1967-01-11|1962-02-23|||||1971-02-05||1972-01-11|U|1967-12-23
TRIAL STUDY 134XCP|LB|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|1||||CYDCPHOS|DICALCIUM PHOSPHATE CRYSTALS|||||||NMOL/DAY|||||||INDETERMINATE||MG/KG/H||||LOW|NOT DONE||||EXPIRED AIR|CLOTTED|Y|CLIP SEQUENCING|MDRD FORMULA||U|U|NA|N|||N|2||58||FOLLOW-UP|1971-01-08|1969-07-05|||||1972-10-11||1970-01-01|NA|1972-12-24
TRIAL STUDY 134XCP|LB|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|2||||CDT|CARBOHYDRATE-DEFICIENT TRANSFERRIN|||||||BLOCKS|||||||TRACE||/CMH2O||||LOW|NOT DONE||||WHITE MATTER TISSUE|AUTOLYZED|U|TRANSMISSION ELECTRON MICROSCOPY|MDRD FORMULA||NA|NA|NA|N|||NA|2||58||TREATMENT|1963-02-28|1972-09-10|||||1969-03-26||1967-12-23|N|1970-04-30
TRIAL STUDY 134XCP|LB|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|1||||VLDLPSZ|VLDL PARTICLE SIZE|||||||MDFI|||||||BORDERLINE||KAT||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|DRIED|NA|U-HPLC/MS/MS|ASH FIBROSURE FORMULA||N|NA|Y|U|||U|3||39||CONTINUATION TREATMENT|1967-05-03|1962-03-03|||||1967-09-09||1968-10-31|N|1962-06-17
TRIAL STUDY 134XCP|LB|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|2||||HCGND|CHORIOGONADOTROPIN|||||||CI/ML|||||||INVALID||UMOL/DL||||NORMAL|NOT DONE||||PERITONEAL FLUID|CONTAMINATED|Y|SIZE EXCLUSION CHROMATOGRAPHY|FIBROTEST FORMULA||NA|N|NA|NA|||NA|3||39||TREATMENT|1973-08-27|1968-10-15|||||1960-03-22||1967-01-16|Y|1972-08-20
TRIAL STUDY 134XCP|LB|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|1||||CONSIST|CONSISTENCY|||||||CMHG|||||||TRACE||/H||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|AUTOLYZED|U|QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROMETER FORMULA||U|U|NA|NA|||Y|4||88||SCREENING|1970-01-22|1970-05-22|||||1969-02-17||1965-07-03|N|1962-11-21
TRIAL STUDY 134XCP|LB|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|2||||HLAIIPRA|HLA CLASS II PANEL REACTIVE ANTIBODY|||||||UV*SEC|||||||INDETERMINATE||MG||||LOW|NOT DONE||||EMESIS|HEMOLYZED|N|NEXT GENERATION TARGETED SEQUENCING|GMI % FORMULA||N|N|U|NA|||U|4||88||OPEN LABEL TREATMENT|1961-10-24|1969-08-03|||||1965-08-18||1968-09-22|NA|1973-01-20
TRIAL STUDY 134XCP|LB|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|1||||C165881|WHITE ELM POLLEN IGE ANTIBODY|||||||MG/H|||||||POSITIVE||MAC50||||ABNORMAL|NOT DONE||||GASTRIC FLUID|DRIED|U|TARGETED GENOME SEQUENCING|COCKCROFT-GAULT FORMULA||N|N|N|U|||U|5||7||CONTINUATION TREATMENT|1967-09-13|1968-12-11|||||1965-10-30||1973-01-02|N|1965-12-26
TRIAL STUDY 134XCP|LB|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|2||||SLXAG|SIALYL SSEA-1 ANTIGEN|||||||MG/DAY|||||||INDETERMINATE||PPM||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|FROZEN|N|NUCLEIC ACID HYBRIDIZATION|MDRD 5 VARIABLE FORMULA||Y|U|NA|Y|||U|5||7||INDUCTION TREATMENT|1964-10-23|1972-05-23|||||1960-07-25||1965-04-11|NA|1965-08-17
TRIAL STUDY 134XCP|LB|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|1||||LYMCE|LYMPHOCYTES/TOTAL CELLS|||||||BQ|||||||POSITIVE||10^9 CFU/ML||||ABNORMAL|NOT DONE||||BONE MARROW|AGGLUTINATED|N|GC/MS-EI|FIBROTEST FORMULA||NA|NA|N|U|||NA|1||38||BASELINE|1966-10-22|1961-11-05|||||1966-03-22||1962-02-07|U|1960-03-20
TRIAL STUDY 134XCP|LB|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|2||||C130109|MOLD MIX ANTIGEN IGE ANTIBODY|||||||10^7 PFU|||||||INDETERMINATE||BEL||||HIGH|NOT DONE||||CORD BLOOD|ROOM TEMPERATURE|Y|ATOMIC ABSORPTION SPECTROMETRY|FIBROTEST FORMULA||Y|U|N|U|||U|1||38||FOLLOW-UP|1967-06-05|1967-07-18|||||1972-09-08||1967-09-05|U|1973-09-01
TRIAL STUDY 134XCP|LB|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|1||||MCPHG|MACROPHAGES|||||||U/KG/H|||||||BORDERLINE||FT3||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|GELLED|NA|PULSE OXIMETRY|MDRD 4 VARIABLE FORMULA||U|U|N|NA|||NA|2||58||LONG-TERM FOLLOW-UP|1973-09-07|1968-12-26|||||1966-02-26||1961-09-14|Y|1961-08-14
TRIAL STUDY 134XCP|LB|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|2||||CCL18|CHEMOKINE (C-C MOTIF) LIGAND 18|||||||U.CARR|||||||POSITIVE||TSP EQ||||LOW|NOT DONE||||EPIDERMAL TISSUE|AUTOLYZED|NA|FLUORESCENT LIFETIME IMAGING MICROSCOPY|MDRD 6 VARIABLE FORMULA||Y|NA|N|NA|||NA|2||58||OPEN LABEL TREATMENT|1970-08-24|1963-08-04|||||1961-04-03||1965-04-11|Y|1968-06-10
TRIAL STUDY 134XCP|LB|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|1||||MSTHCE|MESOTHELIAL CELLS|||||||NMOL/L/MIN|||||||INVALID||MV/SEC||||NORMAL|NOT DONE||||STOOL|LIPEMIC|Y|CONTRAST ENHANCED PET/CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|Y|U|||N|3||39||LONG-TERM FOLLOW-UP|1961-02-16|1971-05-10|||||1964-09-07||1970-07-05|Y|1969-09-29
TRIAL STUDY 134XCP|LB|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|2||||MYL3|MYOSIN LIGHT CHAIN 3|||||||MG/ANIMAL|||||||POSITIVE||MCI/KG||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|AGGLUTINATED|NA|CARDIAC THERMODILUTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|Y|NA|||NA|3||39||INDUCTION TREATMENT|1972-10-26|1972-05-03|||||1971-01-21||1970-11-06|Y|1973-08-29
TRIAL STUDY 134XCP|LB|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|1||||MMYCECE|MATURING MYELOID CELLS/TOTAL CELLS|||||||UKAT/10^12 RBC|||||||INDETERMINATE||UMOL/L||||NORMAL|NOT DONE||||VITREOUS HUMOR|HEMOLYZED|U|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 6 VARIABLE FORMULA||N|N|NA|U|||Y|4||88||RUN-IN|1970-05-30|1960-06-14|||||1969-10-12||1961-12-11|U|1969-12-28
TRIAL STUDY 134XCP|LB|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|2||||KYNURNN|KYNURENINE|||||||G/ANIMAL/WK|||||||NEGATIVE||UIU/L||||LOW|NOT DONE||||SPUTUM|SOLIDIFIED|NA|SINGLE-SLICE SPIRAL CT|ASH FIBROSURE FORMULA||NA|N|NA|U|||U|4||88||OPEN LABEL TREATMENT|1970-08-27|1962-09-04|||||1961-09-25||1973-01-25|NA|1971-09-11
TRIAL STUDY 134XCP|LB|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|1||||FAT|FAT|||||||UG/MOL|||||||POSITIVE||M2||||ABNORMAL|NOT DONE||||LYSATE|LACTESCENT|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|CKD-EPI CYSTATIN C FORMULA||U|N|NA|U|||Y|5||7||FOLLOW-UP|1966-01-06|1966-07-17|||||1971-02-06||1967-12-03|U|1966-06-24
TRIAL STUDY 134XCP|LB|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|2||||CCL23|CHEMOKINE (C-C MOTIF) LIGAND 23|||||||COAT|||||||BORDERLINE||EJACULATE U||||NORMAL|NOT DONE||||EXUDATE|LIPEMIC|U|IMPULSE OSCILLOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|N|NA|||NA|5||7||OPEN LABEL TREATMENT|1969-03-14|1964-07-26|||||1973-05-08||1968-11-11|Y|1969-03-01
TRIAL STUDY 134XCP|LB|3AA56307-0D09-4C82-91B6-717A7C503EFE|1||||MUCTHR|MUCOUS THREADS|||||||MKAT|||||||POSITIVE||CCID 50/ML||||ABNORMAL|NOT DONE||||KERATINOCYTE|SOLIDIFIED|NA|ANGIOGRAPHY|MDRD FORMULA||Y|N|N|U|||N|1||38||OBSERVATION|1965-08-31|1971-11-16|||||1968-06-02||1968-04-25|NA|1965-05-08
TRIAL STUDY 134XCP|LB|3AA56307-0D09-4C82-91B6-717A7C503EFE|2||||VWFAAC|VON WILL FACTOR ACT ACTUAL/CONTROL|||||||S/H|||||||POSITIVE||10^6 RNA COPIES/ML||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|CALCIFIED|NA|SINGLE-SLICE SPIRAL CT|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|Y|N|||N|1||38||WASHOUT|1966-06-26|1962-07-27|||||1964-02-19||1971-05-07|NA|1969-02-01
TRIAL STUDY 134XCP|LB|3AA56307-0D09-4C82-91B6-717A7C503EFE|1||||AST|ASPARTATE AMINOTRANSFERASE|||||||S^-1(%O2)^-1|||||||INDETERMINATE||CYLINDER||||LOW|NOT DONE||||HAIR FOLLICLE|THAWED|Y|MICROBIAL CULTURE, SOLID|HEPASCORE FORMULA||Y|Y|N|NA|||NA|2||58||INDUCTION TREATMENT|1960-01-31|1961-11-11|||||1964-07-09||1966-12-27|U|1961-05-29
TRIAL STUDY 134XCP|LB|3AA56307-0D09-4C82-91B6-717A7C503EFE|2||||PGD2S|PROSTAGLANDIN D2 SYNTHASE|||||||MEQ/DAY|||||||INDETERMINATE||ML/100G/MIN||||LOW|NOT DONE||||VITREOUS HUMOR|CLOTTED|U|NUCLEAR RADIOLOGY|FIBROMETER FORMULA||Y|NA|NA|NA|||U|2||58||RUN-IN|1960-12-01|1964-09-12|||||1967-02-28||1960-05-18|Y|1973-06-28
TRIAL STUDY 134XCP|LB|3AA56307-0D09-4C82-91B6-717A7C503EFE|1||||INTLK24|INTERLEUKIN 24|||||||DEG2|||||||POSITIVE||10^6/G||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|REFRIGERATED|NA|ELECTRONEUROGRAPHY|MDRD 6 VARIABLE FORMULA||Y|NA|U|N|||NA|3||39||LONG-TERM FOLLOW-UP|1972-07-26|1968-01-02|||||1972-05-05||1964-09-02|N|1973-03-19
TRIAL STUDY 134XCP|LB|3AA56307-0D09-4C82-91B6-717A7C503EFE|2||||NRDZPM|NORDAZEPAM|||||||NEEDLE GAUGE|||||||INDETERMINATE||GBQ/UG||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|REFRIGERATED|N|TOLUIDINE BLUE STAIN|FIBROTEST FORMULA||NA|U|NA|N|||NA|3||39||OBSERVATION|1972-05-14|1972-05-05|||||1969-06-27||1968-04-21|U|1966-11-26
TRIAL STUDY 134XCP|LB|3AA56307-0D09-4C82-91B6-717A7C503EFE|1||||NACLR|SODIUM CLEARANCE|||||||1/(S*KPA)|||||||POSITIVE||NG/DAY||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|AGGLUTINATED|N|GC/MS|HEPASCORE FORMULA||NA|U|NA|Y|||Y|4||88||TREATMENT|1965-09-10|1966-06-25|||||1972-06-20||1967-08-22|U|1960-08-22
TRIAL STUDY 134XCP|LB|3AA56307-0D09-4C82-91B6-717A7C503EFE|2||||GSTPIEXR|PI-GST EXCRETION RATE|||||||10^6/HPF|||||||INDETERMINATE||IU/DAY||||HIGH|NOT DONE||||EXPIRED AIR|CONCENTRATED|NA|RAJI CELL EIA|MDRD 5 VARIABLE FORMULA||N|U|Y|U|||U|4||88||OPEN LABEL TREATMENT|1964-04-03|1968-01-06|||||1971-02-24||1969-07-22|NA|1965-01-27
TRIAL STUDY 134XCP|LB|3AA56307-0D09-4C82-91B6-717A7C503EFE|1||||CETP|CHOLESTERYL ESTER TRANSFER PROTEIN|||||||GBQ/MG|||||||INVALID||LOG10 TCID 50/ML||||NORMAL|NOT DONE||||CALCULUS|DRIED|Y|CYSTOSCOPY|CKD-EPI CREATININE FORMULA||Y|NA|NA|Y|||Y|5||7||INDUCTION TREATMENT|1969-03-22|1960-05-24|||||1968-07-08||1971-12-17|Y|1966-12-30
TRIAL STUDY 134XCP|LB|3AA56307-0D09-4C82-91B6-717A7C503EFE|2||||APLIGGAB|ANTI-PHOSPHOLIPID IGG ANTIBODY|||||||L/H|||||||TRACE||PM||||HIGH|NOT DONE||||AQUEOUS HUMOR|UNEXPECTED ODOR|U|RADIATION DOSIMETRY|MDRD ENZYMATIC FORMULA||Y|NA|N|Y|||N|5||7||SCREENING|1973-05-20|1966-07-17|||||1968-02-06||1962-04-21|N|1966-08-10
TRIAL STUDY 134XCP|LB|811AE318-625A-4913-8B18-2D318AF04EAC|1||||FACTII|FACTOR II|||||||ABSORBANCE U|||||||NEGATIVE||% INHIBITION||||NORMAL|NOT DONE||||KERATINOCYTE|CONTAMINATED|Y|RIA|COCKCROFT-GAULT FORMULA||Y|Y|U|Y|||U|1||38||INDUCTION TREATMENT|1969-04-06|1961-08-08|||||1973-02-10||1964-12-11|NA|1966-12-31
TRIAL STUDY 134XCP|LB|811AE318-625A-4913-8B18-2D318AF04EAC|2||||C165935|TRITICUM AESTIVUM IGE AB RAST SCORE|||||||S*KPA|||||||POSITIVE||10^3 COPIES/ML||||HIGH|NOT DONE||||PERSPIRATION|FRESH|NA|FLUORESCENT ENZYME IMMUNOASSAY|GMI MMOL/MOL FORMULA||N|N|NA|N|||N|1||38||OPEN LABEL TREATMENT|1965-10-25|1969-09-19|||||1966-05-20||1970-07-14|Y|1966-03-17
TRIAL STUDY 134XCP|LB|811AE318-625A-4913-8B18-2D318AF04EAC|1||||IFI44L|INTERFERON-INDUCED PROTEIN 44-LIKE|||||||10^9 CFU/ML|||||||INDETERMINATE||ML/CM3/MIN||||LOW|NOT DONE||||PLATELET POOR PLASMA|UNEXPECTED ODOR|U|PHOROPTER|COCKCROFT-GAULT FORMULA||U|N|NA|NA|||N|2||58||CONTINUATION TREATMENT|1962-11-15|1961-07-19|||||1965-03-19||1962-06-16|U|1961-03-27
TRIAL STUDY 134XCP|LB|811AE318-625A-4913-8B18-2D318AF04EAC|2||||PAPPA|PREGNANCY-ASSOCIATED PLASMA PROTEIN-A|||||||G/CAGE/DAY|||||||NEGATIVE||DAYS||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|FROZEN|NA|HEMAGGLUTINATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|Y|||N|2||58||BASELINE|1964-09-15|1970-05-08|||||1968-08-06||1971-11-14|N|1968-01-18
TRIAL STUDY 134XCP|LB|811AE318-625A-4913-8B18-2D318AF04EAC|1||||C165911|DAIRY MIX IGG AB RAST SCORE|||||||MV2/HZ|||||||INVALID||MMHG*MIN/L||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|THAWED|N|LINE PROBE ASSAY|MDRD 5 VARIABLE FORMULA||Y|N|U|N|||Y|3||39||FOLLOW-UP|1969-07-25|1971-05-26|||||1962-05-12||1960-04-27|U|1967-08-26
TRIAL STUDY 134XCP|LB|811AE318-625A-4913-8B18-2D318AF04EAC|2||||ALTCPHRL|ALPHA TOCOPHEROL|||||||QUANTITY SUFFICIENT|||||||INVALID||CONTAINER||||LOW|NOT DONE||||VENOUS PLASMA|SOLIDIFIED|U|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|HEPASCORE FORMULA||N|U|NA|Y|||N|3||39||BLINDED TREATMENT|1961-05-31|1970-07-05|||||1972-11-16||1962-08-05|Y|1972-05-16
TRIAL STUDY 134XCP|LB|811AE318-625A-4913-8B18-2D318AF04EAC|1||||CYSCREAT|CYSTATIN C/CREATININE|||||||ELISA UNIT/ML|||||||INDETERMINATE||ML/M2/H||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|FROZEN|N|CONTRAST ENHANCED PET SCAN|HEPASCORE FORMULA||N|U|Y|N|||NA|4||88||RUN-IN|1964-12-02|1962-10-20|||||1971-03-18||1963-02-17|Y|1972-05-25
TRIAL STUDY 134XCP|LB|811AE318-625A-4913-8B18-2D318AF04EAC|2||||FECL|FRACTIONAL CHLORIDE EXCRETION|||||||ML/CM3/MIN|||||||INDETERMINATE||ML/G/H||||LOW|NOT DONE||||CORD SERUM|CALCIFIED|NA|PHYSICAL EXAMINATION|MDRD 6 VARIABLE FORMULA||NA|N|N|NA|||NA|4||88||FOLLOW-UP|1972-01-11|1967-12-12|||||1968-01-30||1965-02-11|N|1972-06-17
TRIAL STUDY 134XCP|LB|811AE318-625A-4913-8B18-2D318AF04EAC|1||||HAMAB|HUMAN ANTI-MOUSE ANTIBODY|||||||UM|||||||INVALID||IU/G||||HIGH|NOT DONE||||REFLEX TEAR|CONTAMINATED|U|SINGLE-MOLECULE ARRAY|MDRD 4 VARIABLE FORMULA||U|NA|Y|N|||Y|5||7||BASELINE|1964-05-13|1963-10-12|||||1968-10-07||1969-03-15|NA|1961-07-26
TRIAL STUDY 134XCP|LB|811AE318-625A-4913-8B18-2D318AF04EAC|2||||APLSMA2A|ALPHA-2 ANTIPLASMIN ACTIVITY|||||||NSEC|||||||BORDERLINE||10^3 CFU||||HIGH|NOT DONE||||WHITE MATTER TISSUE|THAWED|NA|CONTRAST ENHANCED PET SCAN|HEPASCORE FORMULA||NA|NA|U|NA|||U|5||7||TREATMENT|1972-06-07|1963-08-24|||||1962-02-02||1964-08-29|N|1969-12-30
TRIAL STUDY 134XCP|LB|E8F0AF72-5DB4-41D5-814E-5E280A027E94|1||||VITB17|VITAMIN B17|||||||RPM|||||||INDETERMINATE||MG/ANIMAL||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|GELLED|N|DOUBLE IMMUNODIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|N|N|||Y|1||38||INDUCTION TREATMENT|1968-05-30|1962-11-29|||||1965-09-02||1964-10-08|Y|1969-05-15
TRIAL STUDY 134XCP|LB|E8F0AF72-5DB4-41D5-814E-5E280A027E94|2||||LYMPHOID|LYMPHOID CELLS|||||||10^3 CFU/G|||||||INDETERMINATE||MG/KG/DOSE||||ABNORMAL|NOT DONE||||KERATINOCYTE|FRESH|N|OPHTHALMOSCOPY|HEPASCORE FORMULA||N|N|N|U|||N|1||38||RUN-IN|1968-04-21|1966-12-26|||||1971-06-12||1970-10-15|NA|1960-11-16
TRIAL STUDY 134XCP|LB|E8F0AF72-5DB4-41D5-814E-5E280A027E94|1||||MSPIKEXR|MONOCLONAL PROTEIN SPIKE EXCRETION RATE|||||||AMU|||||||INVALID||SIEMENS||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|GELLED|U|NUCLEIC ACID AMPLIFICATION TEST|CKD-EPI CYSTATIN C FORMULA||U|U|Y|N|||U|2||58||OBSERVATION|1962-07-26|1966-02-02|||||1965-06-09||1968-09-18|NA|1961-03-22
TRIAL STUDY 134XCP|LB|E8F0AF72-5DB4-41D5-814E-5E280A027E94|2||||KLCLLCFR|KAPPA LT CHAIN,FREE/LAMBDA LT CHAIN,FREE|||||||ML/S|||||||NEGATIVE||S/H||||LOW|NOT DONE||||INTERSTITIAL FLUID|CONCENTRATED|N|FLUORESCENT ENZYME IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|Y|N|||N|2||58||FOLLOW-UP|1973-07-14|1964-10-18|||||1965-03-03||1962-12-20|U|1960-03-26
TRIAL STUDY 134XCP|LB|E8F0AF72-5DB4-41D5-814E-5E280A027E94|1||||ASP|ASPARTIC ACID|||||||TORR|||||||INDETERMINATE||UG/DL||||NORMAL|NOT DONE||||KERATINOCYTE|CLOTTED|Y|MICRO BROTH DILUTION|MDRD 4 VARIABLE FORMULA||N|U|U|U|||U|3||39||WASHOUT|1973-07-26|1972-03-28|||||1970-05-01||1967-02-25|NA|1963-08-08
TRIAL STUDY 134XCP|LB|E8F0AF72-5DB4-41D5-814E-5E280A027E94|2||||C165889|RUSSIAN THISTLE POLLEN IGE AB RAST SCORE|||||||ML/KG|||||||NEGATIVE||TUBERCULIN UNIT||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|AGGLUTINATED|Y|ULTRASONOGRAPHIC ELASTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|U|||N|3||39||OPEN LABEL TREATMENT|1966-06-22|1970-04-27|||||1966-12-09||1963-10-10|N|1970-08-13
TRIAL STUDY 134XCP|LB|E8F0AF72-5DB4-41D5-814E-5E280A027E94|1||||ALDOLASE|ALDOLASE|||||||F|||||||NEGATIVE||PA||||HIGH|NOT DONE||||LEUKOCYTE|THAWED|Y|ELLA|MDRD 6 VARIABLE FORMULA||NA|N|Y|U|||N|4||88||BASELINE|1961-06-15|1968-11-27|||||1973-04-18||1965-10-30|Y|1966-07-16
TRIAL STUDY 134XCP|LB|E8F0AF72-5DB4-41D5-814E-5E280A027E94|2||||MAYHEG|MAY-HEGGLIN ANOMALY|||||||UKAT|||||||INVALID||BOTTLE||||NORMAL|NOT DONE||||COLOSTRUM|AGGLUTINATED|NA|CONTRAST ENHANCED X-RAY|ASH FIBROSURE FORMULA||Y|U|Y|U|||U|4||88||RUN-IN|1965-12-16|1962-05-28|||||1972-09-07||1963-02-02|NA|1968-07-03
TRIAL STUDY 134XCP|LB|E8F0AF72-5DB4-41D5-814E-5E280A027E94|1||||VEGF|VASCULAR ENDOTHELIAL GROWTH FACTOR|||||||GY/MIN|||||||NEGATIVE||VP/DOSE||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|CALCIFIED|NA|HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|N|N|||N|5||7||INDUCTION TREATMENT|1965-07-02|1971-09-29|||||1964-04-30||1969-02-26|U|1965-05-06
TRIAL STUDY 134XCP|LB|E8F0AF72-5DB4-41D5-814E-5E280A027E94|2||||LKM1IAAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGA AB|||||||ANTI-XA IU/ML|||||||TRACE||MG/KG/DOSE||||NORMAL|NOT DONE||||RETICULOCYTES|CONCENTRATED|U|ELECTROCHEMILUMINESCENCE|GMI % FORMULA||N|NA|U|N|||Y|5||7||WASHOUT|1973-01-20|1960-11-22|||||1967-09-20||1969-10-04|N|1964-07-26
TRIAL STUDY 134XCP|LB|3B726736-01B3-4A69-ABFB-C6255E341E69|1||||AAP|ALANINE AMINOPEPTIDASE|||||||CGY|||||||BORDERLINE||/CMH2O||||HIGH|NOT DONE||||ALVEOLAR AIR|CALCIFIED|NA|FUNDUS PHOTOGRAPHY|FIBROTEST FORMULA||N|Y|Y|Y|||NA|1||38||BASELINE|1961-07-08|1971-07-11|||||1964-10-17||1969-03-15|U|1962-07-07
TRIAL STUDY 134XCP|LB|3B726736-01B3-4A69-ABFB-C6255E341E69|2||||MMIF|MACROPHAGE MIGRATION INHIBITORY FACTOR|||||||CI/KG|||||||POSITIVE||MG/DOSE||||ABNORMAL|NOT DONE||||LEUKOCYTE|CLOTTED|Y|CONTRAST ENHANCED PET/CT SCAN|NASH FIBROSURE FORMULA||NA|Y|Y|Y|||Y|1||38||TREATMENT|1962-09-12|1971-07-20|||||1971-11-14||1963-07-09|Y|1972-01-27
TRIAL STUDY 134XCP|LB|3B726736-01B3-4A69-ABFB-C6255E341E69|1||||WBCMORPH|LEUKOCYTE CELL MORPHOLOGY|||||||10^6 IU/ML|||||||INDETERMINATE||MIN||||LOW|NOT DONE||||BILE|HEMOLYZED|NA|NEXT GENERATION SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||U|N|NA|U|||N|2||58||FOLLOW-UP|1963-11-09|1960-11-14|||||1967-10-01||1962-03-05|Y|1961-04-22
TRIAL STUDY 134XCP|LB|3B726736-01B3-4A69-ABFB-C6255E341E69|2||||IL2SR|SOLUBLE INTERLEUKIN 2 RECEPTOR|||||||MESF|||||||NEGATIVE||UG/ML/H||||LOW|NOT DONE||||SALIVA|PARAFFIN-EMBEDDED|U|GRADIENT DIFFUSION|GMI % FORMULA||U|U|U|NA|||Y|2||58||BASELINE|1970-02-21|1962-05-16|||||1961-01-05||1961-03-16|NA|1965-06-15
TRIAL STUDY 134XCP|LB|3B726736-01B3-4A69-ABFB-C6255E341E69|1||||HLAIIPRA|HLA CLASS II PANEL REACTIVE ANTIBODY|||||||CCID 50/DOSE|||||||POSITIVE||/5X10^4 WBC||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|NON-HEMOLYZED|N|ZIEHL NEELSEN ACID FAST STAIN|NASH FIBROSURE FORMULA||N|Y|N|Y|||N|3||39||OBSERVATION|1970-07-22|1970-08-24|||||1970-07-03||1972-06-26|U|1961-12-03
TRIAL STUDY 134XCP|LB|3B726736-01B3-4A69-ABFB-C6255E341E69|2||||ASMACT|ALPHA-SMOOTH MUSCLE ACTIN|||||||LOG EID 50/DOSE|||||||NEGATIVE||10^6/HPF||||ABNORMAL|NOT DONE||||HAIR|NON-HEMOLYZED|U|SPECT/CT SCAN|NASH FIBROSURE FORMULA||N|U|N|Y|||U|3||39||OPEN LABEL TREATMENT|1963-04-26|1970-05-08|||||1960-07-03||1966-11-27|Y|1971-05-03
TRIAL STUDY 134XCP|LB|3B726736-01B3-4A69-ABFB-C6255E341E69|1||||PTAUAB42|PHOSPHORYLATED TAU PROT/AMYLOID BETA1-42|||||||F|||||||INDETERMINATE||MOL||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|REFRIGERATED|Y|SICKLE CELL SOLUBILITY TEST|MDRD 4 VARIABLE FORMULA||N|NA|N|U|||Y|4||88||BASELINE|1962-10-17|1968-09-13|||||1972-01-26||1973-08-03|Y|1964-05-18
TRIAL STUDY 134XCP|LB|3B726736-01B3-4A69-ABFB-C6255E341E69|2||||DOPAMINE|DOPAMINE|||||||MG/KG|||||||INVALID||CI/UL||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|REFRIGERATED|NA|CLIP|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|U|U|||Y|4||88||TREATMENT|1961-01-17|1965-04-03|||||1965-07-17||1965-02-02|N|1961-08-03
TRIAL STUDY 134XCP|LB|3B726736-01B3-4A69-ABFB-C6255E341E69|1||||HLAIIAB|HLA CLASS II ANTIBODY|||||||AG|||||||INVALID||PLUG||||LOW|NOT DONE||||VENOUS PLASMA|AUTOLYZED|Y|SISH|NASH FIBROSURE FORMULA||N|U|U|Y|||NA|5||7||INDUCTION TREATMENT|1964-09-28|1966-05-03|||||1968-05-06||1966-01-28|N|1967-04-22
TRIAL STUDY 134XCP|LB|3B726736-01B3-4A69-ABFB-C6255E341E69|2||||MYPC|MYELOID PROGENITOR CELLS|||||||U/M2|||||||BORDERLINE||CP||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|PARAFFIN-EMBEDDED|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|FIBROSIS 4 FORMULA||N|U|U|Y|||N|5||7||OPEN LABEL TREATMENT|1972-04-13|1970-07-28|||||1967-05-14||1962-05-17|Y|1966-09-12
TRIAL STUDY 134XCP|LB|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|1||||BLSTSID|SIDEROBLAST|||||||KCAL|||||||BORDERLINE||S*KPA||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|SOLIDIFIED|N|PHOROPTER|CKD-EPI FORMULA||Y|Y|NA|N|||U|1||38||INDUCTION TREATMENT|1967-02-20|1970-06-25|||||1966-09-06||1961-05-19|NA|1969-10-03
TRIAL STUDY 134XCP|LB|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|2||||AMYLASEM|MACROAMYLASE|||||||IU/G|||||||BORDERLINE||10^6 ORGANISMS/G||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED|U|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROMETER FORMULA||U|Y|NA|N|||NA|1||38||TREATMENT|1960-05-15|1963-03-09|||||1971-12-28||1962-12-26|NA|1963-03-30
TRIAL STUDY 134XCP|LB|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|1||||S100A8|S100 CALCIUM BINDING PROTEIN A8|||||||UL|||||||NEGATIVE||LINEAR FT*LB||||NORMAL|NOT DONE||||REFLEX TEAR|AGGLUTINATED|U|PYROSEQUENCING|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|U|||U|2||58||OBSERVATION|1967-07-04|1965-07-13|||||1966-12-08||1967-08-19|U|1967-04-07
TRIAL STUDY 134XCP|LB|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|2||||TRIGHDL|TRIGLYCERIDES/HDL CHOLESTEROL|||||||10^6 IU/ML|||||||TRACE||G/KG||||HIGH|NOT DONE||||DIALYSIS FLUID|SOLIDIFIED|U|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA||U|Y|NA|N|||U|2||58||OBSERVATION|1963-09-15|1963-02-26|||||1970-12-16||1960-11-30|Y|1973-04-17
TRIAL STUDY 134XCP|LB|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|1||||FRFEABS|FRACTIONAL IRON ABSORPTION|||||||TBSP|||||||POSITIVE||CD/M2||||HIGH|NOT DONE||||FLUID|FRESH|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD ENZYMATIC FORMULA||Y|N|Y|N|||N|3||39||SCREENING|1969-08-19|1962-01-22|||||1960-12-20||1961-09-06|NA|1968-10-14
TRIAL STUDY 134XCP|LB|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|2||||CO2|CARBON DIOXIDE|||||||G/CAGE|||||||BORDERLINE||NG/DL||||ABNORMAL|NOT DONE||||CORD BLOOD|HEMOLYZED|Y|PET/MRI SCAN|NASH FIBROSURE FORMULA||U|N|N|U|||N|3||39||BASELINE|1966-12-08|1966-01-11|||||1973-01-16||1963-05-20|N|1969-03-30
TRIAL STUDY 134XCP|LB|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|1||||INTLK28|INTERLEUKIN 28|||||||10^6 RNA COPIES/ML|||||||INVALID||/5X10^4 WBC||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|CLOTTED|NA|PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA||U|U|U|NA|||N|4||88||FOLLOW-UP|1963-06-02|1963-11-05|||||1972-07-20||1967-03-07|NA|1961-02-15
TRIAL STUDY 134XCP|LB|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|2||||FACTXIII|FACTOR XIII|||||||U/KG/MIN|||||||POSITIVE||CGY||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|CONTAMINATED|U|IHC|MDRD 5 VARIABLE FORMULA||Y|N|N|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1964-08-22|1973-07-08|||||1968-11-23||1969-09-17|U|1965-07-10
TRIAL STUDY 134XCP|LB|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|1||||NGF|NERVE GROWTH FACTOR|||||||U/G/MIN|||||||POSITIVE||POINT||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|CONTAMINATED|U|POLYGRAPHY|NASH FIBROSURE FORMULA||U|N|N|NA|||Y|5||7||OPEN LABEL TREATMENT|1973-02-10|1964-03-26|||||1970-05-15||1972-02-25|Y|1962-01-10
TRIAL STUDY 134XCP|LB|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|2||||C165887|ENGLISHPLANTAIN POLLEN IGE AB RAST SCORE|||||||ML/CM|||||||NEGATIVE||MESF||||LOW|NOT DONE||||PLEURAL TISSUE|GELLED|U|CELL BASED BIOASSAY|CKD-EPI FORMULA||N|NA|NA|NA|||NA|5||7||WASHOUT|1960-03-15|1972-03-27|||||1963-08-26||1971-03-31|N|1963-02-26
TRIAL STUDY 134XCP|LB|0535EF31-5388-4CC0-8567-44F4C20975EC|1||||MPV|MEAN PLATELET VOLUME|||||||NEBULE|||||||INDETERMINATE||BREATHS/MIN||||ABNORMAL|NOT DONE||||GASTRIC FLUID|FRESH|NA|TONOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|NA|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1973-01-19|1970-11-26|||||1965-12-08||1966-04-21|Y|1960-09-24
TRIAL STUDY 134XCP|LB|0535EF31-5388-4CC0-8567-44F4C20975EC|2||||TGFB3|TRANSFORMING GROWTH FACTOR BETA 3|||||||UG/CM2|||||||TRACE||MG2/DL2||||HIGH|NOT DONE||||GASTRIC FLUID|NON-HEMOLYZED|Y|IMMUNOPRECIPITATION|HEPASCORE FORMULA||NA|U|NA|U|||N|1||38||LONG-TERM FOLLOW-UP|1973-01-14|1968-01-02|||||1970-06-21||1971-12-10|Y|1962-05-28
TRIAL STUDY 134XCP|LB|0535EF31-5388-4CC0-8567-44F4C20975EC|1||||INTLK18|INTERLEUKIN 18|||||||ML/MMHG/MIN/L|||||||NEGATIVE||10^6 ORGANISMS/MG||||LOW|NOT DONE||||SPUTUM|CONCENTRATED|NA|MAGNETIC RESONANCE ANGIOGRAPHY|ASH FIBROSURE FORMULA||NA|Y|NA|N|||N|2||58||OBSERVATION|1968-12-11|1968-10-29|||||1969-04-25||1963-08-14|NA|1969-12-11
TRIAL STUDY 134XCP|LB|0535EF31-5388-4CC0-8567-44F4C20975EC|2||||PLSMCELY|MATURE PLASMA CELLS/LYMPHOCYTES|||||||NCI|||||||NEGATIVE||HOUNSFIELD UNIT||||NORMAL|NOT DONE||||SKIN TISSUE|REFRIGERATED|NA|EPSILOMETER|FIBROSIS 4 FORMULA||U|Y|U|Y|||N|2||58||OBSERVATION|1964-07-02|1967-09-28|||||1969-04-04||1972-03-15|U|1965-04-23
TRIAL STUDY 134XCP|LB|0535EF31-5388-4CC0-8567-44F4C20975EC|1||||GRANIM|IMMATURE GRANULOCYTES|||||||DISK|||||||POSITIVE||FFU||||NORMAL|NOT DONE||||SPUTUM|FRESH|U|PHOTOMETRIC CLOT DETECTION|MDRD ENZYMATIC FORMULA||U|N|U|Y|||U|3||39||LONG-TERM FOLLOW-UP|1961-11-15|1971-06-20|||||1967-12-27||1965-07-07|U|1967-01-01
TRIAL STUDY 134XCP|LB|0535EF31-5388-4CC0-8567-44F4C20975EC|2||||TNF12|TNF SUPERFAMILY MEMBER 12|||||||UG/M2/DAY|||||||POSITIVE||FT2||||LOW|NOT DONE||||AMNIOTIC FLUID|CLOTTED|Y|RADIOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|N|N|U|||U|3||39||LONG-TERM FOLLOW-UP|1968-06-29|1963-12-12|||||1961-05-24||1971-01-26|NA|1966-09-14
TRIAL STUDY 134XCP|LB|0535EF31-5388-4CC0-8567-44F4C20975EC|1||||INTLK12B|INTERLEUKIN 12 BETA|||||||PFU|||||||BORDERLINE||PUFF||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|DRIED|Y|TRICHROME STAIN|NASH FIBROSURE FORMULA||Y|NA|Y|NA|||N|4||88||TREATMENT|1963-03-20|1965-06-19|||||1972-07-20||1960-08-16|U|1971-01-02
TRIAL STUDY 134XCP|LB|0535EF31-5388-4CC0-8567-44F4C20975EC|2||||EPO|ERYTHROPOIETIN|||||||FARAD|||||||TRACE||PMOL||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE|U|LEAD CITRATE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|NA|||N|4||88||BASELINE|1967-02-03|1969-10-28|||||1961-01-22||1966-01-12|Y|1963-02-09
TRIAL STUDY 134XCP|LB|0535EF31-5388-4CC0-8567-44F4C20975EC|1||||C165891|WESTERN RAGWEED POLLEN IGE AB RAST SCORE|||||||NKAT/L|||||||INVALID||10^12 IU/L||||HIGH|NOT DONE||||PLATELET RICH PLASMA|THAWED|U|CLAUSS METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|U|Y|||U|5||7||SCREENING|1966-04-06|1971-11-23|||||1970-11-08||1967-04-02|N|1969-06-04
TRIAL STUDY 134XCP|LB|0535EF31-5388-4CC0-8567-44F4C20975EC|2||||MYBLALE|MYELOBLASTS/LEUKOCYTES|||||||RNA COPIES/ML|||||||BORDERLINE||AMPULE||||LOW|NOT DONE||||ABSCESS FLUID|LIPEMIC|N|CLIP|FIBROMETER FORMULA||Y|N|N|U|||N|5||7||BLINDED TREATMENT|1972-08-12|1970-01-01|||||1960-10-14||1967-04-16|Y|1964-07-18
TRIAL STUDY 134XCP|LB|F149BD98-0802-4C18-8599-426C5258D513|1||||APTTSTND|ACTIVATED PTT/STANDARD|||||||EU|||||||INVALID||UU/L||||LOW|NOT DONE||||CAPILLARY BLOOD|SOLIDIFIED|N|CT SCAN|CKD-EPI FORMULA||NA|N|Y|N|||Y|1||38||WASHOUT|1960-06-08|1962-08-27|||||1970-10-24||1966-12-18|N|1960-08-29
TRIAL STUDY 134XCP|LB|F149BD98-0802-4C18-8599-426C5258D513|2||||CA1AG|CANCER ANTIGEN 1|||||||LOG10 CFU/G|||||||TRACE||/MS||||HIGH|NOT DONE||||VENOUS CORD BLOOD|SOLIDIFIED|N|MUGA|CKD-EPI FORMULA||U|NA|Y|U|||U|1||38||BLINDED TREATMENT|1970-05-16|1961-10-19|||||1971-07-06||1960-05-27|NA|1964-02-08
TRIAL STUDY 134XCP|LB|F149BD98-0802-4C18-8599-426C5258D513|1||||B2MCREAT|BETA-2 MICROGLOBULIN/CREATININE|||||||FT3|||||||INDETERMINATE||RATIO||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|CONTAMINATED|Y|ELECTROCHEMILUMINESCENCE|COCKCROFT-GAULT FORMULA||N|N|Y|Y|||NA|2||58||CONTINUATION TREATMENT|1968-09-21|1964-11-13|||||1970-01-10||1973-05-24|N|1969-01-10
TRIAL STUDY 134XCP|LB|F149BD98-0802-4C18-8599-426C5258D513|2||||IAPP|ISLET AMYLOID POLYPEPTIDE|||||||WATT|||||||NEGATIVE||NMOL/G||||LOW|NOT DONE||||BUFFY COAT|THAWED|N|ULTRASONOGRAPHIC ELASTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|NA|N|NA|||Y|2||58||INDUCTION TREATMENT|1964-09-18|1964-10-17|||||1973-04-14||1964-09-08|U|1961-06-03
TRIAL STUDY 134XCP|LB|F149BD98-0802-4C18-8599-426C5258D513|1||||INCLBRBC|ERYTHROCYTE INCLUSION BODIES|||||||PMOL/10^9 CELLS|||||||BORDERLINE||DMOL||||NORMAL|NOT DONE||||LEUKOCYTE|LIPEMIC|U|RADIATION DOSIMETRY|CKD-EPI FORMULA||Y|U|Y|N|||U|3||39||LONG-TERM FOLLOW-UP|1967-06-22|1972-03-26|||||1966-07-26||1970-04-14|U|1963-07-12
TRIAL STUDY 134XCP|LB|F149BD98-0802-4C18-8599-426C5258D513|2||||BLSTLMLY|LEUKEMIC BLASTS/LYMPHOCYTES|||||||ML/CM H2O|||||||POSITIVE||BREATHS/MIN||||LOW|NOT DONE||||CAPILLARY PLASMA|FRESH|Y|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE FORMULA||N|N|NA|NA|||N|3||39||BLINDED TREATMENT|1966-01-03|1969-10-03|||||1961-10-08||1960-04-25|N|1960-06-09
TRIAL STUDY 134XCP|LB|F149BD98-0802-4C18-8599-426C5258D513|1||||AAMBTAC|ALPHA-AMINOBUTYRIC ACID|||||||UEQ/L|||||||INDETERMINATE||GRAVITATIONAL UNIT||||LOW|NOT DONE||||EMESIS|HEMOLYZED|NA|WRIGHT STAIN|CKD-EPI FORMULA||U|N|N|NA|||NA|4||88||TREATMENT|1963-10-08|1967-05-22|||||1972-10-16||1970-07-13|N|1967-06-29
TRIAL STUDY 134XCP|LB|F149BD98-0802-4C18-8599-426C5258D513|2||||FOLHMRNA|FOLATE HYDROLASE MRNA|||||||KA_U/DL|||||||POSITIVE||V||||ABNORMAL|NOT DONE||||CORD SERUM|CONTAMINATED|N|MICRONEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA||N|NA|Y|Y|||U|4||88||FOLLOW-UP|1969-05-02|1960-09-07|||||1967-07-13||1967-12-03|NA|1968-11-11
TRIAL STUDY 134XCP|LB|F149BD98-0802-4C18-8599-426C5258D513|1||||AMYLASEP|AMYLASE, PANCREATIC|||||||GPL U/ML|||||||POSITIVE||HPA||||NORMAL|NOT DONE||||GASTRIC CONTENTS|GELLED|NA|SCINTIGRAPHY|HEPASCORE FORMULA||N|NA|NA|NA|||NA|5||7||OBSERVATION|1960-07-07|1968-03-06|||||1961-08-01||1967-08-27|U|1961-07-29
TRIAL STUDY 134XCP|LB|F149BD98-0802-4C18-8599-426C5258D513|2||||CSEPI846|AGGRECAN CHONDROITIN SULFATE EPITOPE 846|||||||MM|||||||INDETERMINATE||KCAL||||LOW|NOT DONE||||DERMAL TISSUE|AGGLUTINATED|Y|LC/MS/MS|GMI % FORMULA||NA|NA|Y|Y|||Y|5||7||INDUCTION TREATMENT|1967-10-29|1973-07-15|||||1969-05-15||1968-11-18|NA|1971-03-23
TRIAL STUDY 134XCP|LB|5A31D035-90D2-4BD0-AE08-839862D6E0DF|1||||GLUCCRT|GLUCOSE/CREATININE|||||||MMOL/MIN/KPA/L|||||||INVALID||GENEQ/ML||||NORMAL|NOT DONE||||BUFFY COAT|LACTESCENT|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA||NA|NA|NA|U|||Y|1||38||BLINDED TREATMENT|1965-12-14|1965-07-20|||||1968-06-22||1968-09-12|NA|1970-01-09
TRIAL STUDY 134XCP|LB|5A31D035-90D2-4BD0-AE08-839862D6E0DF|2||||DHEAS|DEHYDROEPIANDROSTERONE SULFATE|||||||SCM|||||||POSITIVE||USP U||||LOW|NOT DONE||||BUFFY COAT|LIPEMIC|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|FIBROTEST FORMULA||Y|N|U|U|||N|1||38||SCREENING|1962-03-16|1965-04-22|||||1963-07-15||1973-01-19|U|1966-05-05
TRIAL STUDY 134XCP|LB|5A31D035-90D2-4BD0-AE08-839862D6E0DF|1||||BLASTERY|BASOPHILIC ERYTHROBLAST|||||||10^9 CFU/ML|||||||INVALID||G||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|SOLIDIFIED|NA|MRI WITHOUT CONTRAST|CKD-EPI FORMULA||U|U|NA|U|||U|2||58||RUN-IN|1967-04-10|1972-12-01|||||1972-09-13||1970-08-17|U|1962-05-12
TRIAL STUDY 134XCP|LB|5A31D035-90D2-4BD0-AE08-839862D6E0DF|2||||NEUTMY|NEUTROPHILIC MYELOCYTES|||||||POUCH|||||||NEGATIVE||MNFI||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|DRIED|N|SPIRAL CT SCAN WITHOUT CONTRAST|NASH FIBROSURE FORMULA||U|Y|Y|Y|||NA|2||58||LONG-TERM FOLLOW-UP|1969-08-04|1968-10-29|||||1966-01-08||1960-05-17|NA|1962-09-14
TRIAL STUDY 134XCP|LB|5A31D035-90D2-4BD0-AE08-839862D6E0DF|1||||ASYNP|ALPHA SYNUCLEIN PROTEIN|||||||DRUM|||||||TRACE||/CMH2O||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|FROZEN|Y|WHOLE EXOME SEQUENCING|MDRD ENZYMATIC FORMULA||Y|Y|U|U|||NA|3||39||FOLLOW-UP|1967-02-18|1970-05-06|||||1966-01-14||1969-01-11|U|1971-09-27
TRIAL STUDY 134XCP|LB|5A31D035-90D2-4BD0-AE08-839862D6E0DF|2||||MLATONIN|MELATONIN|||||||UCI|||||||POSITIVE||DNA COPIES/UG||||HIGH|NOT DONE||||PERITONEAL FLUID|CLOTTED|Y|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|N|||Y|3||39||OBSERVATION|1973-03-29|1968-09-24|||||1973-08-27||1969-10-16|U|1963-07-18
TRIAL STUDY 134XCP|LB|5A31D035-90D2-4BD0-AE08-839862D6E0DF|1||||CNTIGGAB|CENTROMERE IGG ANTIBODY|||||||RFU|||||||INDETERMINATE||10^6 IU||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|ROOM TEMPERATURE|NA|IMMUNOTURBIDIMETRY|ASH FIBROSURE FORMULA||U|NA|Y|Y|||Y|4||88||LONG-TERM FOLLOW-UP|1973-04-15|1967-11-12|||||1967-11-07||1964-09-13|N|1963-07-24
TRIAL STUDY 134XCP|LB|5A31D035-90D2-4BD0-AE08-839862D6E0DF|2||||EDMIGAAB|ENDOMYSIAL IGA ANTIBODY|||||||UCI|||||||POSITIVE||U/ANIMAL||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|AUTOLYZED|U|TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROTEST FORMULA||N|NA|Y|NA|||U|4||88||TREATMENT|1963-02-27|1960-11-22|||||1962-05-22||1966-10-23|Y|1969-12-31
TRIAL STUDY 134XCP|LB|5A31D035-90D2-4BD0-AE08-839862D6E0DF|1||||C5FR|COMPLEMENT C5, FREE|||||||UIU/DL|||||||TRACE||AMPULE||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|ROOM TEMPERATURE|NA|ELECTRONEUROGRAPHY|ASH FIBROSURE FORMULA||U|U|NA|Y|||Y|5||7||OPEN LABEL TREATMENT|1971-01-04|1960-11-14|||||1970-06-24||1960-07-14|U|1970-10-18
TRIAL STUDY 134XCP|LB|5A31D035-90D2-4BD0-AE08-839862D6E0DF|2||||PGD2S|PROSTAGLANDIN D2 SYNTHASE|||||||FFU|||||||BORDERLINE||DAGU||||HIGH|NOT DONE||||SOFT TISSUE|CLOTTED|NA|NO INFORMATION|NASH FIBROSURE FORMULA||NA|U|U|NA|||U|5||7||CONTINUATION TREATMENT|1970-05-18|1965-10-08|||||1964-10-25||1965-06-19|U|1969-01-31
TRIAL STUDY 134XCP|LB|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|1||||OLIGBAND|OLIGOCLONAL BANDS|||||||10^5/L|||||||INDETERMINATE||TSP EQ||||LOW|NOT DONE||||EXUDATE|DRIED|U|CHROMOGENIC ASSAY|GMI % FORMULA||N|U|Y|N|||U|1||38||CONTINUATION TREATMENT|1966-01-09|1971-03-15|||||1967-03-16||1960-07-04|NA|1968-10-21
TRIAL STUDY 134XCP|LB|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|2||||AFPA|ALPHA FETOPROTEIN ACTIVITY|||||||ABSORBANCE U/ML|||||||INDETERMINATE||/SEC||||HIGH|NOT DONE||||SEMEN|ICTERIC|Y|HPLC-UV|COCKCROFT-GAULT FORMULA||U|U|NA|Y|||NA|1||38||INDUCTION TREATMENT|1962-08-14|1972-11-01|||||1970-10-26||1964-12-17|Y|1970-06-02
TRIAL STUDY 134XCP|LB|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|1||||RETIRBC|RETICULOCYTES/ERYTHROCYTES|||||||MM3/MM2/YEAR|||||||INVALID||FOZ_BR||||ABNORMAL|NOT DONE||||LOCHIA|CLOTTED|U|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD FORMULA||Y|NA|N|N|||NA|2||58||FOLLOW-UP|1963-10-15|1970-03-10|||||1969-12-06||1960-02-14|NA|1961-01-08
TRIAL STUDY 134XCP|LB|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|2||||MCH|ERY. MEAN CORPUSCULAR HEMOGLOBIN|||||||10^9 ORGANISMS|||||||NEGATIVE||IU/KG/H||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|THAWED|Y|EIA|CKD-EPI FORMULA||U|Y|N|Y|||NA|2||58||WASHOUT|1970-05-29|1961-09-10|||||1963-07-01||1964-02-20|Y|1969-11-29
TRIAL STUDY 134XCP|LB|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|1||||THCCOOH|11-NOR-DELTA9-THC-9-CARBOXYLIC ACID|||||||QUANTITY SUFFICIENT|||||||TRACE||DNA COPIES/UG||||NORMAL|NOT DONE||||ALVEOLAR AIR|CALCIFIED|NA|OPTICAL MAPPING|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|Y|U|||N|3||39||CONTINUATION TREATMENT|1960-05-12|1970-10-02|||||1967-11-19||1965-05-26|NA|1973-04-16
TRIAL STUDY 134XCP|LB|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|2||||INSULIN|INSULIN|||||||/KG|||||||INDETERMINATE||UMOL/L/MIN||||HIGH|NOT DONE||||SKIN TISSUE|DRIED|Y|CRYOSCOPY|MDRD FORMULA||NA|NA|Y|U|||Y|3||39||BLINDED TREATMENT|1968-09-10|1964-03-04|||||1963-03-21||1970-01-18|Y|1972-06-06
TRIAL STUDY 134XCP|LB|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|1||||BDNF|BRAIN-DERIVED NEUROTROPHIC FACTOR|||||||FRAMES/S|||||||TRACE||FG||||ABNORMAL|NOT DONE||||BASAL TEAR|GELLED|N|MALDI-TOF|CKD-EPI CREATININE FORMULA||Y|U|N|NA|||Y|4||88||INDUCTION TREATMENT|1968-09-04|1964-06-02|||||1966-07-15||1961-11-18|Y|1966-08-04
TRIAL STUDY 134XCP|LB|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|2||||ANGTNSGN|ANGIOTENSINOGEN|||||||UM2|||||||NEGATIVE||AMP||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|ICTERIC|Y|MAMMOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|N|N|Y|||N|4||88||WASHOUT|1961-10-11|1965-08-04|||||1964-04-25||1966-04-17|U|1972-09-20
TRIAL STUDY 134XCP|LB|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|1||||IOHEXOL|IOHEXOL|||||||G/L|||||||TRACE||G/G||||NORMAL|NOT DONE||||URINE|HEMOLYZED|NA|ACID FAST STAIN|CKD-EPI FORMULA||U|NA|U|N|||U|5||7||FOLLOW-UP|1960-06-02|1968-11-24|||||1960-02-14||1965-12-07|NA|1973-03-20
TRIAL STUDY 134XCP|LB|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|2||||GFRBSCYC|GFR FROM CYSTATIN C ADJUSTED FOR BSA|||||||BAU/ML|||||||INDETERMINATE||UMOL/L/MIN||||LOW|NOT DONE||||EPIDERMAL TISSUE|GELLED|N|CONTRAST ENHANCED CT SCAN|ASH FIBROSURE FORMULA||U|Y|NA|NA|||N|5||7||BASELINE|1966-01-07|1968-12-11|||||1970-07-01||1973-05-08|N|1962-08-25
TRIAL STUDY 134XCP|LB|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|1||||STROPONI|SKELETAL TROPONIN I|||||||CONTAINER|||||||TRACE||CUP||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|AUTOLYZED|U|STRESS ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA||NA|Y|N|Y|||U|1||38||WASHOUT|1964-12-06|1960-06-04|||||1960-11-25||1967-08-21|NA|1973-05-14
TRIAL STUDY 134XCP|LB|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|2||||GFR|GLOMERULAR FILTRATION RATE|||||||CD|||||||INDETERMINATE||MG/KG/DOSE||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|NON-HEMOLYZED|N|PELLI-ROBSON EYE CHART|COCKCROFT-GAULT FORMULA||NA|U|U|NA|||U|1||38||SCREENING|1972-08-11|1973-09-04|||||1966-11-20||1969-05-22|U|1966-08-31
TRIAL STUDY 134XCP|LB|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|1||||LDH5|LDH ISOENZYME 5|||||||10^9 CFU/G|||||||TRACE||MG/MOL||||HIGH|NOT DONE||||LYMPH|REFRIGERATED|NA|OSCILLOMETRY|FIBROSIS 4 FORMULA||NA|NA|N|U|||U|2||58||CONTINUATION TREATMENT|1967-07-09|1969-08-14|||||1972-02-18||1967-03-10|U|1973-01-16
TRIAL STUDY 134XCP|LB|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|2||||IGHG2|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 2|||||||DAMOL/L|||||||POSITIVE||MILE||||LOW|NOT DONE||||LAVAGE FLUID|CLOTTED|Y|INDIRECT IMMUNOFLUORESCENCE|CKD-EPI CYSTATIN C FORMULA||NA|U|Y|Y|||Y|2||58||WASHOUT|1961-10-09|1963-11-16|||||1968-05-23||1967-08-13|U|1960-05-22
TRIAL STUDY 134XCP|LB|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|1||||GFRBSCCC|GFR FROM CYSTATIN C AND CREAT ADJ BSA|||||||CGY|||||||INVALID||%(W/V)||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|AGGLUTINATED|Y|PAP STAIN|MDRD 4 VARIABLE FORMULA||Y|U|N|Y|||NA|3||39||FOLLOW-UP|1960-10-16|1963-02-07|||||1971-05-01||1973-06-22|N|1965-04-01
TRIAL STUDY 134XCP|LB|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|2||||ELA1PMN|PANCREATIC ELASTASE 1, POLYMORPHONUCLEAR|||||||STEPS/MIN|||||||POSITIVE||PPM||||NORMAL|NOT DONE||||LAVAGE FLUID|CONTAMINATED|N|ELLA|COCKCROFT-GAULT FORMULA||U|Y|U|Y|||Y|3||39||WASHOUT|1962-04-23|1970-07-05|||||1965-11-11||1972-12-04|N|1960-10-05
TRIAL STUDY 134XCP|LB|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|1||||ACETAMIN|ACETAMINOPHEN|||||||GPL U|||||||INVALID||PFU/ML||||NORMAL|NOT DONE||||PLEURAL FLUID|GELLED|U|PULMONARY ANGIOGRAPHY|GMI % FORMULA||NA|U|U|N|||U|4||88||OBSERVATION|1961-01-16|1972-02-17|||||1965-07-01||1963-03-16|U|1965-09-29
TRIAL STUDY 134XCP|LB|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|2||||CLEPNSQE|COLUMNAR EPI CELLS/NON-SQUAM EPI CELLS|||||||MCI/KG|||||||NEGATIVE||10^6 CFU/G||||LOW|NOT DONE||||ADIPOSE TISSUE|AUTOLYZED|N|BAC ACGH|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|N|||N|4||88||CONTINUATION TREATMENT|1961-04-18|1971-05-17|||||1967-03-05||1963-06-01|NA|1967-02-21
TRIAL STUDY 134XCP|LB|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|1||||HIST3AB|HISTONE 3 ANTIBODY|||||||10^6 COPIES/ML|||||||INDETERMINATE||DYN||||NORMAL|NOT DONE||||AMNIOTIC FLUID|LIPEMIC|U|ORCHIDOMETERY|FIBROSIS 4 FORMULA||N|U|U|U|||N|5||7||TREATMENT|1965-08-05|1965-12-20|||||1971-05-06||1966-11-20|U|1971-11-12
TRIAL STUDY 134XCP|LB|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|2||||C130121|SHELLFISH MIX ANTIGEN IGG ANTIBODY|||||||KDA|||||||INDETERMINATE||SCOOPFUL||||ABNORMAL|NOT DONE||||CORD BLOOD|ICTERIC|Y|IRON HEMATOXYLIN STAIN|MDRD 5 VARIABLE FORMULA||U|Y|U|Y|||Y|5||7||CONTINUATION TREATMENT|1960-06-16|1961-12-01|||||1963-12-27||1961-09-12|U|1962-11-03
TRIAL STUDY 134XCP|LB|9C9398A4-38BC-40A7-880D-4549A676F69B|1||||C147283|WHITE ELM POLLEN IGG ANTIBODY|||||||HOURS|||||||INVALID||BAU/ML||||ABNORMAL|NOT DONE||||HAIR|CONCENTRATED|N|DIFFUSION WEIGHTED MRI|HEPASCORE FORMULA||Y|U|NA|N|||N|1||38||OBSERVATION|1971-12-06|1968-01-08|||||1965-04-25||1968-11-19|Y|1968-08-16
TRIAL STUDY 134XCP|LB|9C9398A4-38BC-40A7-880D-4549A676F69B|2||||ELA2|NEUTROPHIL ELASTASE|||||||LOG10 CFU/ML|||||||NEGATIVE||VIRTUAL PIXEL||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|SOLIDIFIED|N|SLIT LAMP PHOTOGRAPHY|NASH FIBROSURE FORMULA||U|N|N|N|||N|1||38||CONTINUATION TREATMENT|1968-01-12|1972-09-11|||||1972-12-31||1963-11-29|NA|1963-12-30
TRIAL STUDY 134XCP|LB|9C9398A4-38BC-40A7-880D-4549A676F69B|1||||HASIGEAB|HUMAN ANTI-SHEEP IGE ANTIBODY|||||||UG/ANIMAL|||||||INDETERMINATE||CUP||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|ROOM TEMPERATURE|N|PHYSICAL EXAMINATION|FIBROTEST FORMULA||U|Y|Y|U|||U|2||58||WASHOUT|1965-09-26|1961-11-01|||||1962-09-08||1960-07-22|NA|1968-09-01
TRIAL STUDY 134XCP|LB|9C9398A4-38BC-40A7-880D-4549A676F69B|2||||NGF|NERVE GROWTH FACTOR|||||||MMOL/DAY|||||||TRACE||MEQ/ML||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|NON-HEMOLYZED|NA|KINYOUN STAIN|ASH FIBROSURE FORMULA||N|U|U|N|||NA|2||58||INDUCTION TREATMENT|1972-11-16|1960-11-28|||||1965-01-09||1971-07-18|NA|1973-07-02
TRIAL STUDY 134XCP|LB|9C9398A4-38BC-40A7-880D-4549A676F69B|1||||KLHIGGAB|KEYHOLE LIMPET HEMOCYANIN IGG ANTIBODY|||||||SYRINGE|||||||BORDERLINE||OSM||||LOW|NOT DONE||||LOCHIA|DRIED|NA|MICROARRAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|U|U|||NA|3||39||OBSERVATION|1968-08-02|1972-06-17|||||1962-01-21||1960-11-08|NA|1967-10-07
TRIAL STUDY 134XCP|LB|9C9398A4-38BC-40A7-880D-4549A676F69B|2||||INTLK28|INTERLEUKIN 28|||||||DIP|||||||POSITIVE||FT3||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|CALCIFIED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|NASH FIBROSURE FORMULA||Y|NA|N|NA|||NA|3||39||TREATMENT|1966-10-07|1969-10-25|||||1970-04-15||1965-07-23|NA|1969-08-28
TRIAL STUDY 134XCP|LB|9C9398A4-38BC-40A7-880D-4549A676F69B|1||||C130105|GRASS MIX POLLEN ANTIGEN IGA ANTIBODY|||||||COPIES/UL|||||||POSITIVE||CI/ML||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|REFRIGERATED|Y|SECONDARY ION MASS SPECTOMETRY|MDRD 6 VARIABLE FORMULA||Y|NA|N|U|||U|4||88||RUN-IN|1963-06-05|1972-10-18|||||1960-05-14||1972-01-01|U|1971-01-25
TRIAL STUDY 134XCP|LB|9C9398A4-38BC-40A7-880D-4549A676F69B|2||||CSRBC|RBC CASTS|||||||DRUM|||||||INDETERMINATE||10^3 ORGANISMS/ML||||HIGH|NOT DONE||||KERATINOCYTE|UNEXPECTED ODOR|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|Y|||NA|4||88||BASELINE|1964-09-16|1960-08-06|||||1963-01-29||1963-03-21|Y|1960-05-13
TRIAL STUDY 134XCP|LB|9C9398A4-38BC-40A7-880D-4549A676F69B|1||||GSTMU|MU GLUTATHIONE-S-TRANSFERASE|||||||UV*SEC|||||||INDETERMINATE||10^5/HPF||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|LACTESCENT|NA|CYSTOMETRY|GMI % FORMULA||N|Y|NA|N|||U|5||7||RUN-IN|1961-11-27|1972-09-30|||||1963-07-10||1967-01-04|N|1961-06-06
TRIAL STUDY 134XCP|LB|9C9398A4-38BC-40A7-880D-4549A676F69B|2||||TGFB3|TRANSFORMING GROWTH FACTOR BETA 3|||||||C|||||||POSITIVE||10^6 CFU||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|CLOTTED|U|SURFACE PLASMON RESONANCE|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|N|Y|||NA|5||7||FOLLOW-UP|1963-03-05|1963-05-07|||||1967-07-08||1960-05-21|U|1972-09-11
TRIAL STUDY 134XCP|LB|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|1||||EDTACLR|EDTA CLEARANCE|||||||NMOL BCE/NMOL|||||||INDETERMINATE||10^6 IU||||LOW|NOT DONE||||ERYTHROCYTES|NON-HEMOLYZED|Y|IMMUNE REPERTOIRE DEEP SEQUENCING|FIBROSIS 4 FORMULA||N|NA|N|NA|||Y|1||38||INDUCTION TREATMENT|1965-12-09|1971-03-21|||||1964-11-28||1964-07-15|U|1972-11-04
TRIAL STUDY 134XCP|LB|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|2||||COQ10|UBIQUINONE 10|||||||SYRINGE|||||||INVALID||MIU/L||||NORMAL|NOT DONE||||ADIPOSE TISSUE|AGGLUTINATED|N|QUANTITATIVE ULTRASOUND|ASH FIBROSURE FORMULA||U|N|N|NA|||N|1||38||LONG-TERM FOLLOW-UP|1962-04-14|1962-06-16|||||1967-08-28||1966-07-31|N|1967-04-10
TRIAL STUDY 134XCP|LB|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|1||||FRUCT|FRUCTOSAMINE|||||||G/DAY|||||||INVALID||10^3 ORGANISMS/G||||HIGH|NOT DONE||||TISSUE|UNEXPECTED ODOR|Y|MAGNETIC RESONANCE ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|NA|Y|||N|2||58||BASELINE|1969-11-01|1968-10-10|||||1962-03-26||1962-03-13|Y|1967-06-13
TRIAL STUDY 134XCP|LB|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|2||||NOREPEXR|NOREPINEPHRINE EXCRETION RATE|||||||TSP EQ|||||||TRACE||ML/DAY||||LOW|NOT DONE||||EMESIS|GELLED|U|RULER MEASUREMENT METHOD|MDRD 6 VARIABLE FORMULA||N|Y|N|NA|||N|2||58||BLINDED TREATMENT|1968-08-20|1971-01-04|||||1973-03-18||1970-04-23|U|1961-08-17
TRIAL STUDY 134XCP|LB|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|1||||IGFBP2|INSULIN-LIKE GROWTH FACTOR BINDING PROT2|||||||CM/MIN|||||||POSITIVE||USIEMENS||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|FROZEN|U|U-HPLC/MS/MS|MDRD 6 VARIABLE FORMULA||U|Y|NA|N|||NA|3||39||OBSERVATION|1961-12-02|1960-04-19|||||1969-09-10||1971-09-28|U|1962-05-08
TRIAL STUDY 134XCP|LB|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|2||||LMBDLC|LAMBDA LIGHT CHAIN|||||||MG/ANIMAL|||||||INVALID||G/KG/DAY||||HIGH|NOT DONE||||SERUM|CLOTTED|NA|SLOAN LETTER EYE CHART 100%|COCKCROFT-GAULT FORMULA||U|NA|Y|NA|||N|3||39||BASELINE|1971-08-21|1966-09-29|||||1964-03-03||1963-02-02|U|1966-02-11
TRIAL STUDY 134XCP|LB|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|1||||IFNG|INTERFERON GAMMA|||||||DNA COPIES/UG|||||||INVALID||UG/G/DAY||||HIGH|NOT DONE||||FLUID|CONCENTRATED|N|CT SCAN|CKD-EPI CREATININE FORMULA||Y|Y|N|U|||N|4||88||CONTINUATION TREATMENT|1961-03-31|1966-10-27|||||1973-05-08||1966-08-18|N|1969-01-16
TRIAL STUDY 134XCP|LB|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|2||||HALPRZLM|HYDROXYALPRAZOLAM|||||||/2500 WBC|||||||BORDERLINE||U/G/MIN||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|REFRIGERATED|N|POLYSOMNOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|NA|||Y|4||88||TREATMENT|1963-09-20|1971-12-19|||||1965-07-21||1960-05-02|N|1967-09-20
TRIAL STUDY 134XCP|LB|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|1||||OXYSAT|OXYGEN SATURATION|||||||KA_U/DL|||||||INVALID||/CMH2O||||LOW|NOT DONE||||ARTERIAL BLOOD|ROOM TEMPERATURE|NA|ELECTROGASTROGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|Y|Y|||Y|5||7||TREATMENT|1962-10-24|1966-09-03|||||1962-08-08||1970-05-10|U|1969-09-04
TRIAL STUDY 134XCP|LB|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|2||||GCSF|GRANULOCYTE COLONY STIMULATING FACTOR|||||||SUPPOSITORY|||||||BORDERLINE||10^12/L||||NORMAL|NOT DONE||||CAPILLARY PLASMA|NON-HEMOLYZED|NA|LIQUID SCINTILLATION COUNTING|CKD-EPI CYSTATIN C FORMULA||U|Y|Y|Y|||Y|5||7||BASELINE|1968-12-10|1962-10-02|||||1964-01-19||1966-06-01|Y|1964-01-01
TRIAL STUDY 134XCP|LB|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|1||||PSDEPHD|PSEUDOEPHEDRINE|||||||MIN|||||||BORDERLINE||MMOL||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|UNEXPECTED ODOR|U|LIGHT MICROSCOPY|MDRD ENZYMATIC FORMULA||U|NA|NA|N|||U|1||38||CONTINUATION TREATMENT|1970-03-01|1968-02-17|||||1962-04-21||1960-01-03|U|1960-08-15
TRIAL STUDY 134XCP|LB|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|2||||BTLBARTL|BUTABARBITAL|||||||UG/KG/MIN|||||||NEGATIVE||MG2/DL2||||LOW|NOT DONE||||ABSCESS FLUID|LACTESCENT|Y|HIGH LEVEL AMINOGLYCOSIDE SCREEN|NASH FIBROSURE FORMULA||Y|U|U|NA|||N|1||38||RUN-IN|1969-02-14|1965-11-08|||||1965-03-15||1971-02-06|Y|1966-04-09
TRIAL STUDY 134XCP|LB|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|1||||LKM1IGAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGG AB|||||||CD/M2|||||||POSITIVE||CAPSULE||||HIGH|NOT DONE||||CALCULUS|FRESH|U|HEMOCYTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|N|U|||N|2||58||OPEN LABEL TREATMENT|1971-06-17|1963-01-03|||||1965-04-03||1969-04-21|NA|1960-10-31
TRIAL STUDY 134XCP|LB|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|2||||B1BGLP|BETA-1B GLYCOPROTEIN|||||||KBQ/UL|||||||POSITIVE||KA_U/DL||||LOW|NOT DONE||||SEBUM|REFRIGERATED|NA|WHOLE GENOME SEQUENCING|GMI MMOL/MOL FORMULA||N|U|NA|N|||NA|2||58||RUN-IN|1963-08-12|1967-12-14|||||1960-11-15||1972-09-09|U|1965-03-02
TRIAL STUDY 134XCP|LB|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|1||||KIM1EXR|KIDNEY INJURY MOLECULE-1 EXCRETION RATE|||||||APL U/ML|||||||POSITIVE||MG/CM2||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|FRESH|N|GRADIENT DIFFUSION|FIBROSIS 4 FORMULA||Y|U|Y|N|||N|3||39||WASHOUT|1972-12-21|1962-03-26|||||1963-06-26||1970-04-09|N|1963-11-01
TRIAL STUDY 134XCP|LB|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|2||||SRTONIN|SEROTONIN|||||||10^6 ORGANISMS|||||||INVALID||MEQ/ML||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|HEMOLYZED|N|CORONARY ANGIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|NA|U|||U|3||39||CONTINUATION TREATMENT|1970-12-28|1963-09-17|||||1962-02-11||1962-11-16|Y|1963-08-03
TRIAL STUDY 134XCP|LB|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|1||||APOC2|APOLIPOPROTEIN C2|||||||NMOL/ML/MIN|||||||POSITIVE||10^6/EJACULATE U||||LOW|NOT DONE||||VENOUS CORD BLOOD|FROZEN|Y|PET/CT SCAN|MDRD 4 VARIABLE FORMULA||Y|Y|NA|Y|||U|4||88||OPEN LABEL TREATMENT|1971-12-06|1971-04-12|||||1968-06-20||1960-12-03|U|1966-05-07
TRIAL STUDY 134XCP|LB|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|2||||CLCREAT|CHLORIDE/CREATININE|||||||PPTH|||||||TRACE||100 IU/ML||||HIGH|NOT DONE||||TRANSUDATE|REFRIGERATED|NA|AGAR PROPORTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|N|U|||Y|4||88||OBSERVATION|1962-10-07|1971-05-09|||||1969-06-26||1960-10-14|N|1965-01-16
TRIAL STUDY 134XCP|LB|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|1||||C165910|BEE MIX IGG AB RAST SCORE|||||||MEQ/UG|||||||TRACE||BQ/ML||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|HEMOLYZED|NA|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|FIBROMETER FORMULA||N|NA|NA|N|||Y|5||7||OPEN LABEL TREATMENT|1965-02-14|1963-07-20|||||1960-01-06||1966-12-14|U|1966-02-08
TRIAL STUDY 134XCP|LB|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|2||||C165898|BIRCH POLLEN IGG AB RAST SCORE|||||||AMOL|||||||TRACE||UG/L||||LOW|NOT DONE||||CORD SERUM|AUTOLYZED|NA|PALM METHOD|CKD-EPI CREATININE FORMULA||U|NA|Y|N|||N|5||7||BASELINE|1962-10-04|1967-08-05|||||1960-01-16||1965-11-24|NA|1963-04-21
TRIAL STUDY 134XCP|LB|1E049F70-8E29-458F-BF37-13450BC9227E|1||||PECAM|PLATELET ENDOTHELIAL ADHESION MOLECULE|||||||UM|||||||INVALID||BQ/KG||||HIGH|NOT DONE||||CELL PELLET|CALCIFIED|Y|TWO-COLOR MICROARRAY|GMI % FORMULA||N|NA|U|N|||NA|1||38||FOLLOW-UP|1964-07-24|1960-10-05|||||1960-10-24||1964-04-22|Y|1967-05-05
TRIAL STUDY 134XCP|LB|1E049F70-8E29-458F-BF37-13450BC9227E|2||||TATC|THROMBIN ANTITHROMBIN COMPLEX|||||||MOSM/KG|||||||TRACE||MET||||LOW|NOT DONE||||BASAL TEAR|AGGLUTINATED|N|PHASE-CONTRAST MRI|CKD-EPI FORMULA||Y|U|U|U|||NA|1||38||CONTINUATION TREATMENT|1967-07-20|1971-05-30|||||1965-12-29||1960-10-30|N|1972-10-27
TRIAL STUDY 134XCP|LB|1E049F70-8E29-458F-BF37-13450BC9227E|1||||HGBAHGB|HEMOGLOBIN A/TOTAL HEMOGLOBIN|||||||BISCUIT|||||||BORDERLINE||MOSM/KG||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|CONCENTRATED|U|CONTRAST ENHANCED MRI|MDRD FORMULA||NA|N|U|NA|||NA|2||58||BLINDED TREATMENT|1963-09-24|1965-11-03|||||1973-02-27||1966-08-24|U|1972-07-25
TRIAL STUDY 134XCP|LB|1E049F70-8E29-458F-BF37-13450BC9227E|2||||IL18EXR|INTERLEUKIN 18 EXCRETION RATE|||||||PKAT|||||||NEGATIVE||PPB||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|NA|AURAMINE STAIN|CKD-EPI CYSTATIN C FORMULA||NA|NA|U|U|||Y|2||58||OPEN LABEL TREATMENT|1969-04-06|1964-01-12|||||1961-04-04||1965-03-19|N|1960-07-04
TRIAL STUDY 134XCP|LB|1E049F70-8E29-458F-BF37-13450BC9227E|1||||C130124|CAT DANDER ANTIGEN IGE ANTIBODY|||||||U/G/MIN|||||||NEGATIVE||%/S||||HIGH|NOT DONE||||REFLEX TEAR|LACTESCENT|U|JAFFE REACTION|MDRD FORMULA||U|N|N|U|||Y|3||39||BLINDED TREATMENT|1968-03-29|1969-02-27|||||1965-07-30||1962-03-15|Y|1964-01-16
TRIAL STUDY 134XCP|LB|1E049F70-8E29-458F-BF37-13450BC9227E|2||||IBCU|UNSATURATED IRON BINDING CAPACITY|||||||UMOL/L/H|||||||POSITIVE||PACK||||ABNORMAL|NOT DONE||||TUMOR TISSUE|FRESH|Y|IHC|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|N|NA|||U|3||39||RUN-IN|1968-01-28|1963-07-25|||||1962-07-10||1960-03-10|N|1962-02-02
TRIAL STUDY 134XCP|LB|1E049F70-8E29-458F-BF37-13450BC9227E|1||||C165876|BIRCH POLLEN IGE AB RAST SCORE|||||||BAU|||||||BORDERLINE||GBQ/MG||||LOW|NOT DONE||||EXUDATE|FRESH|Y|TRANSVAGINAL ULTRASOUND|NASH FIBROSURE FORMULA||U|U|Y|N|||Y|4||88||OPEN LABEL TREATMENT|1963-04-01|1971-01-30|||||1965-07-11||1967-06-12|U|1973-02-05
TRIAL STUDY 134XCP|LB|1E049F70-8E29-458F-BF37-13450BC9227E|2||||TNF10|TNF SUPERFAMILY MEMBER 10|||||||PT_BR|||||||BORDERLINE||EQ||||LOW|NOT DONE||||CORD SERUM|GELLED|NA|KINYOUN STAIN|CKD-EPI FORMULA||N|Y|NA|NA|||NA|4||88||LONG-TERM FOLLOW-UP|1963-06-15|1973-05-18|||||1972-04-24||1960-04-25|Y|1971-03-20
TRIAL STUDY 134XCP|LB|1E049F70-8E29-458F-BF37-13450BC9227E|1||||DNASEBAB|DNASE-B ANTIBODY|||||||U/ML|||||||INVALID||LOG10 PFU||||NORMAL|NOT DONE||||URINE|CALCIFIED|U|X-RAY FLUORESCENCE SPECTROMETRY|MDRD ENZYMATIC FORMULA||U|U|U|U|||N|5||7||SCREENING|1973-05-20|1964-08-31|||||1960-08-27||1963-09-18|U|1961-07-28
TRIAL STUDY 134XCP|LB|1E049F70-8E29-458F-BF37-13450BC9227E|2||||CCL13|CHEMOKINE (C-C MOTIF) LIGAND 13|||||||10^9 CFU/ML|||||||INVALID||MSEC||||HIGH|NOT DONE||||AQUEOUS HUMOR|ROOM TEMPERATURE|NA|FISH|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|U|Y|||N|5||7||SCREENING|1961-06-01|1969-10-19|||||1970-06-20||1970-10-10|NA|1963-05-11
TRIAL STUDY 134XCP|LB|7A612F0F-943A-4283-9A11-B8E8E8D68D66|1||||CA242AG|CANCER ANTIGEN 242|||||||MASK|||||||INDETERMINATE||UV2||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|SOLIDIFIED|N|DIPSTICK|COCKCROFT-GAULT FORMULA||NA|U|U|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1964-01-16|1965-12-05|||||1963-06-17||1962-12-01|NA|1964-11-22
TRIAL STUDY 134XCP|LB|7A612F0F-943A-4283-9A11-B8E8E8D68D66|2||||CONSIST|CONSISTENCY|||||||MEQ|||||||POSITIVE||DDU||||LOW|NOT DONE||||GASTRIC FLUID|LACTESCENT|Y|IVY INCISION METHOD|FIBROMETER FORMULA||N|Y|NA|NA|||N|1||38||WASHOUT|1960-09-30|1973-05-06|||||1972-03-05||1969-08-31|N|1962-02-25
TRIAL STUDY 134XCP|LB|7A612F0F-943A-4283-9A11-B8E8E8D68D66|1||||UREAN|UREA NITROGEN|||||||P|||||||NEGATIVE||10^10/L||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LIPEMIC|NA|WESTERGREN|COCKCROFT-GAULT FORMULA||NA|NA|Y|NA|||N|2||58||INDUCTION TREATMENT|1968-08-25|1969-12-26|||||1966-04-20||1965-10-06|U|1967-03-08
TRIAL STUDY 134XCP|LB|7A612F0F-943A-4283-9A11-B8E8E8D68D66|2||||HLAMSC|HLA MISMATCH COUNT|||||||KCAL/DAY|||||||TRACE||10^3 CFU/ML||||ABNORMAL|NOT DONE||||EXUDATE|CONCENTRATED|U|TRYPAN BLUE STAIN|GMI MMOL/MOL FORMULA||U|NA|NA|N|||N|2||58||OBSERVATION|1964-01-24|1962-06-09|||||1971-11-17||1961-03-27|Y|1967-12-25
TRIAL STUDY 134XCP|LB|7A612F0F-943A-4283-9A11-B8E8E8D68D66|1||||ZINC|ZINC|||||||10^9 CFU/G|||||||INDETERMINATE||NEEDLE GAUGE||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|LIPEMIC|NA|REVERSE TRANSCRIPTASE PCR|FIBROTEST FORMULA||NA|NA|NA|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1962-08-28|1973-07-05|||||1963-01-29||1970-11-08|U|1967-06-16
TRIAL STUDY 134XCP|LB|7A612F0F-943A-4283-9A11-B8E8E8D68D66|2||||TAURCRT|TAURINE/CREATININE|||||||KBQ/UL|||||||INVALID||MG/L||||LOW|NOT DONE||||URINE|THAWED|N|SEQUENCING|CKD-EPI CYSTATIN C FORMULA||NA|N|NA|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1972-04-03|1963-03-20|||||1964-05-04||1963-06-07|NA|1965-12-08
TRIAL STUDY 134XCP|LB|7A612F0F-943A-4283-9A11-B8E8E8D68D66|1||||CSFAT|FATTY CASTS|||||||LOG EID 50/DOSE|||||||TRACE||ML/ANIMAL||||ABNORMAL|NOT DONE||||BREAST MILK|REFRIGERATED|NA|QUANTITATIVE CORONARY ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|N|N|||N|4||88||RUN-IN|1964-02-05|1972-01-09|||||1973-08-27||1965-11-15|N|1964-10-18
TRIAL STUDY 134XCP|LB|7A612F0F-943A-4283-9A11-B8E8E8D68D66|2||||PTHRP|PARATHYROID HORMONE-RELATED PROTEIN|||||||U/DL|||||||POSITIVE||MNFI||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|CONTAMINATED|U|DIRECT SEQUENCING|MDRD 5 VARIABLE FORMULA||Y|NA|N|U|||N|4||88||BLINDED TREATMENT|1964-08-26|1961-02-26|||||1962-07-27||1973-04-17|Y|1968-08-03
TRIAL STUDY 134XCP|LB|7A612F0F-943A-4283-9A11-B8E8E8D68D66|1||||MENGLCE|MENINGEAL CELLS/TOTAL CELLS|||||||/VF|||||||TRACE||MG/ML/DAY||||NORMAL|NOT DONE||||LYSATE|LIPEMIC|Y|AURAMINE STAIN|MDRD 5 VARIABLE FORMULA||N|N|Y|N|||U|5||7||CONTINUATION TREATMENT|1963-01-07|1966-06-10|||||1965-06-15||1963-04-03|NA|1966-10-07
TRIAL STUDY 134XCP|LB|7A612F0F-943A-4283-9A11-B8E8E8D68D66|2||||IC512AB|ISLET CELL 512 ANTIBODY|||||||NG/DAY|||||||INVALID||NCI||||LOW|NOT DONE||||TUMOR TISSUE|FROZEN|Y|MS/MS|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|N|U|||NA|5||7||OPEN LABEL TREATMENT|1962-12-16|1970-11-28|||||1960-09-13||1969-02-08|NA|1969-09-25
TRIAL STUDY 134XCP|LB|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|1||||HLAA|HLA CLASS IA ANTIGEN|||||||10^6 CFU/ML|||||||NEGATIVE||CMOL||||NORMAL|NOT DONE||||PERSPIRATION|ICTERIC|NA|POTENTIOMETRY|FIBROSIS 4 FORMULA||U|U|U|Y|||N|1||38||OBSERVATION|1970-03-27|1962-03-12|||||1962-12-13||1965-12-29|U|1962-06-02
TRIAL STUDY 134XCP|LB|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|2||||MONMPHLE|MONOCYTES AND MACROPHAGES/LEUKOCYTES|||||||% INHIBITION|||||||POSITIVE||CI||||NORMAL|NOT DONE||||ARTERIAL BLOOD|UNEXPECTED ODOR|U|IMMUNE REPERTOIRE DEEP SEQUENCING|CKD-EPI FORMULA||Y|Y|Y|Y|||N|1||38||SCREENING|1964-08-06|1970-06-21|||||1969-04-16||1965-09-23|U|1966-08-26
TRIAL STUDY 134XCP|LB|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|1||||SODIUM|SODIUM|||||||/MM|||||||NEGATIVE||NCI||||NORMAL|NOT DONE||||MUSCLE TISSUE|DRIED|U|MULTIPLE BREATH WASHOUT|FIBROMETER FORMULA||U|NA|N|N|||NA|2||58||OPEN LABEL TREATMENT|1962-01-03|1960-01-11|||||1964-04-04||1961-12-29|U|1962-09-15
TRIAL STUDY 134XCP|LB|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|2||||UROBIL|UROBILINOGEN|||||||U/G HB|||||||INVALID||BQ/MG||||HIGH|NOT DONE||||URINE|CONCENTRATED|NA|RADIAL IMMUNODIFFUSION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|U|Y|||U|2||58||TREATMENT|1966-09-23|1969-04-27|||||1960-11-05||1960-01-10|U|1963-11-28
TRIAL STUDY 134XCP|LB|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|1||||MPXI|MYELOPEROXIDASE INDEX|||||||PPB|||||||BORDERLINE||BOWL||||LOW|NOT DONE||||INFRANATANT, SERUM|UNEXPECTED ODOR|Y|ORCHIDOMETERY|HEPASCORE FORMULA||NA|Y|U|U|||N|3||39||TREATMENT|1968-05-04|1968-03-20|||||1961-05-21||1967-11-21|U|1968-11-28
TRIAL STUDY 134XCP|LB|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|2||||FACTIII|FACTOR III|||||||DIP|||||||POSITIVE||MEQ/DAY||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|AUTOLYZED|N|CT SCAN|MDRD 4 VARIABLE FORMULA||NA|Y|NA|Y|||N|3||39||BASELINE|1971-04-19|1970-08-05|||||1973-06-18||1965-06-09|NA|1965-08-11
TRIAL STUDY 134XCP|LB|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|1||||CYURIAC|URIC ACID CRYSTALS|||||||MOSM|||||||POSITIVE||/H||||ABNORMAL|NOT DONE||||MECONIUM|NON-HEMOLYZED|NA|EIA|CKD-EPI FORMULA||Y|Y|U|NA|||Y|4||88||OBSERVATION|1960-07-15|1963-03-22|||||1969-09-15||1965-01-19|Y|1963-08-31
TRIAL STUDY 134XCP|LB|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|2||||P50OXYGN|P50 OXYGEN|||||||NG/DL|||||||POSITIVE||L/S/KPA||||HIGH|NOT DONE||||EPITHELIAL CELL|REFRIGERATED|N|KNEMOMETRY|ASH FIBROSURE FORMULA||NA|Y|NA|NA|||NA|4||88||INDUCTION TREATMENT|1971-08-08|1969-08-24|||||1969-10-10||1961-10-18|U|1967-10-12
TRIAL STUDY 134XCP|LB|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|1||||LTF|LACTOFERRIN|||||||WEEKS|||||||NEGATIVE||PPTH||||LOW|NOT DONE||||ERYTHROCYTES|FRESH|U|ENZYMATIC COLORIMETRY|MDRD 6 VARIABLE FORMULA||Y|U|N|U|||Y|5||7||FOLLOW-UP|1971-05-25|1970-02-24|||||1962-05-13||1970-12-10|N|1970-08-01
TRIAL STUDY 134XCP|LB|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|2||||RSAD2|CYTOMEGALOVIRUS-INDUCED GENE 5 PROTEIN|||||||TSP|||||||INDETERMINATE||10^6 RNA COPIES/ML||||HIGH|NOT DONE||||HAIR FOLLICLE|DRIED|NA|CONFOCAL MICROSCOPY|FIBROTEST FORMULA||Y|U|U|N|||U|5||7||INDUCTION TREATMENT|1971-10-23|1966-07-13|||||1967-05-22||1960-02-29|NA|1961-12-04
TRIAL STUDY 134XCP|LB|8C86A799-2717-46E8-99C2-76D11AAB54D7|1||||HASIGGAB|HUMAN ANTI-SHEEP IGG ANTIBODY|||||||IU/MG|||||||BORDERLINE||V||||LOW|NOT DONE||||HAIR FOLLICLE|GELLED|U|CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE FORMULA||NA|NA|Y|U|||Y|1||38||WASHOUT|1971-12-26|1968-03-01|||||1960-11-10||1960-05-07|N|1962-12-06
TRIAL STUDY 134XCP|LB|8C86A799-2717-46E8-99C2-76D11AAB54D7|2||||BCEFNCTN|BETA-CELL FUNCTION|||||||BE/ML|||||||INDETERMINATE||U/KG||||NORMAL|NOT DONE||||EXPIRED AIR|LIPEMIC|NA|TRANSMISSION ELECTRON MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|N|NA|||NA|1||38||LONG-TERM FOLLOW-UP|1965-09-14|1961-02-16|||||1969-11-11||1960-08-07|N|1962-07-05
TRIAL STUDY 134XCP|LB|8C86A799-2717-46E8-99C2-76D11AAB54D7|1||||CKMT1CK|CK, MACROMOLECULAR TYPE 1/TOTAL CK|||||||GENEQ|||||||INDETERMINATE||EU||||LOW|NOT DONE||||MUSCLE TISSUE|THAWED|Y|ELECTROCHEMILUMINESCENCE|CKD-EPI FORMULA||U|U|U|N|||N|2||58||BLINDED TREATMENT|1967-04-20|1967-02-03|||||1960-06-13||1970-02-04|N|1963-08-17
TRIAL STUDY 134XCP|LB|8C86A799-2717-46E8-99C2-76D11AAB54D7|2||||NAGASECR|N-ACETYL-B-D-GLUCOSAMINIDASE/CREATININE|||||||HOMEOPATHIC DILUTION|||||||TRACE||APL U||||HIGH|NOT DONE||||MONOCYTE|CONTAMINATED|U|TARGETED TRANSCRIPTOME SEQUENCING|MDRD 6 VARIABLE FORMULA||U|U|U|N|||Y|2||58||OBSERVATION|1968-02-21|1966-06-08|||||1964-11-05||1968-09-07|N|1962-06-23
TRIAL STUDY 134XCP|LB|8C86A799-2717-46E8-99C2-76D11AAB54D7|1||||AMPHETD|DEXTROAMPHETAMINE|||||||U/KG/H|||||||NEGATIVE||/VF||||HIGH|NOT DONE||||BLOOD|CLOTTED|NA|OPTICAL COHERENCE TOMOGRAPHY|MDRD ENZYMATIC FORMULA||Y|N|NA|U|||N|3||39||FOLLOW-UP|1964-09-23|1966-03-30|||||1964-10-31||1971-08-29|Y|1971-05-20
TRIAL STUDY 134XCP|LB|8C86A799-2717-46E8-99C2-76D11AAB54D7|2||||TCHT|TAUROCHOLATE|||||||IU/L|||||||INVALID||PA||||LOW|NOT DONE||||EMESIS|GELLED|N|NUCLEIC ACID SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|NA|Y|||Y|3||39||SCREENING|1965-06-17|1962-05-03|||||1963-06-15||1963-09-11|Y|1964-10-28
TRIAL STUDY 134XCP|LB|8C86A799-2717-46E8-99C2-76D11AAB54D7|1||||HEXK|HEXOKINASE|||||||CI/KG|||||||NEGATIVE||GMFI||||LOW|NOT DONE||||GASTRIC FLUID|THAWED|NA|CELLULOSE TAPE|COCKCROFT-GAULT FORMULA||N|Y|Y|Y|||N|4||88||OPEN LABEL TREATMENT|1972-11-01|1971-07-04|||||1973-03-30||1961-06-05|U|1972-04-14
TRIAL STUDY 134XCP|LB|8C86A799-2717-46E8-99C2-76D11AAB54D7|2||||ETGETS|ETHYL GLUCURONIDE ETHYL SULFATE|||||||PL|||||||INDETERMINATE||DPM/ML||||LOW|NOT DONE||||DISCHARGE|SOLIDIFIED|N|DUCTOGRAPHY|MDRD ENZYMATIC FORMULA||NA|U|N|U|||NA|4||88||TREATMENT|1968-03-13|1969-12-30|||||1960-04-22||1972-01-10|NA|1965-12-12
TRIAL STUDY 134XCP|LB|8C86A799-2717-46E8-99C2-76D11AAB54D7|1||||UREACRT|UREA/CREATININE|||||||ML/CM H2O|||||||BORDERLINE||/SEC||||HIGH|NOT DONE||||CORD SERUM|PARAFFIN-EMBEDDED|NA|CLIP SEQUENCING|GMI % FORMULA||U|Y|Y|NA|||Y|5||7||CONTINUATION TREATMENT|1970-07-17|1972-04-16|||||1969-08-05||1967-08-02|N|1968-07-24
TRIAL STUDY 134XCP|LB|8C86A799-2717-46E8-99C2-76D11AAB54D7|2||||C165916|D. FARINAE IGG AB RAST SCORE|||||||MIN|||||||INVALID||MPA||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|CLOTTED|Y|SCINTIGRAPHY|CKD-EPI CYSTATIN C FORMULA||U|Y|Y|NA|||NA|5||7||OBSERVATION|1972-05-16|1968-10-15|||||1965-11-02||1972-09-27|NA|1962-01-27
TRIAL STUDY 134XCP|LB|727807A8-A180-4589-A553-E3C82E1D3CF2|1||||ACE|ANGIOTENSIN CONVERTING ENZYME|||||||PMOL/L/H|||||||BORDERLINE||U/CL||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|DRIED|N|SANGER SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|NA|||U|1||38||FOLLOW-UP|1962-11-13|1960-08-30|||||1969-10-14||1965-12-20|NA|1960-09-08
TRIAL STUDY 134XCP|LB|727807A8-A180-4589-A553-E3C82E1D3CF2|2||||BURRCE|BURR CELLS|||||||VOXEL|||||||BORDERLINE||APL U||||HIGH|NOT DONE||||PLATELET RICH PLASMA|ROOM TEMPERATURE|U|SLIT LAMP|MDRD FORMULA||U|U|Y|NA|||NA|1||38||WASHOUT|1966-01-04|1971-08-20|||||1964-08-05||1966-10-31|N|1965-10-23
TRIAL STUDY 134XCP|LB|727807A8-A180-4589-A553-E3C82E1D3CF2|1||||ACTH|ADRENOCORTICOTROPIC HORMONE|||||||SV|||||||POSITIVE||PUFF||||LOW|NOT DONE||||FLUID|FRESH|Y|CALIPER MEASUREMENT METHOD|ASH FIBROSURE FORMULA||N|U|N|N|||Y|2||58||OBSERVATION|1960-05-08|1966-02-12|||||1964-06-22||1962-07-05|N|1964-03-24
TRIAL STUDY 134XCP|LB|727807A8-A180-4589-A553-E3C82E1D3CF2|2||||BARB|BARBITURATES|||||||ENZYME U|||||||INDETERMINATE||10^4/HPF||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|PARAFFIN-EMBEDDED|N|MULTI-SLICE SPIRAL CT|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|U|N|||NA|2||58||INDUCTION TREATMENT|1962-11-09|1970-07-25|||||1963-09-25||1973-06-07|NA|1972-05-28
TRIAL STUDY 134XCP|LB|727807A8-A180-4589-A553-E3C82E1D3CF2|1||||EPICCE|EPITHELIAL CELLS/TOTAL CELLS|||||||G/DL|||||||TRACE||U/M2||||NORMAL|NOT DONE||||SPUTUM|ICTERIC|N|SNELLEN EYE CHART|GMI % FORMULA||NA|U|N|NA|||NA|3||39||OPEN LABEL TREATMENT|1961-04-06|1965-06-30|||||1970-03-23||1968-08-30|U|1965-10-12
TRIAL STUDY 134XCP|LB|727807A8-A180-4589-A553-E3C82E1D3CF2|2||||INTLK32|INTERLEUKIN 32|||||||NMOL/L/H|||||||NEGATIVE||ML/G/MIN||||HIGH|NOT DONE||||DISCHARGE|NON-HEMOLYZED|Y|ENZYMATIC COLORIMETRY|NASH FIBROSURE FORMULA||NA|NA|N|U|||U|3||39||OBSERVATION|1969-03-10|1970-09-09|||||1967-02-19||1964-10-23|N|1965-01-27
TRIAL STUDY 134XCP|LB|727807A8-A180-4589-A553-E3C82E1D3CF2|1||||FLUOXTN|FLUOXETINE|||||||MG/M2|||||||POSITIVE||CMOL/L||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|CLOTTED|Y|MRI WITHOUT CONTRAST|FIBROTEST FORMULA||Y|Y|NA|Y|||N|4||88||BLINDED TREATMENT|1968-04-12|1970-11-13|||||1966-08-28||1962-03-10|NA|1967-07-19
TRIAL STUDY 134XCP|LB|727807A8-A180-4589-A553-E3C82E1D3CF2|2||||CHDW|CORPUSCULAR HGB CONC DISTRIBUTION WIDTH|||||||PMOL/10^9 CELLS|||||||NEGATIVE||GPL U||||HIGH|NOT DONE||||VENOUS CORD BLOOD|CONTAMINATED|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|HEPASCORE FORMULA||N|Y|N|NA|||Y|4||88||TREATMENT|1967-06-08|1968-01-28|||||1963-06-15||1969-12-11|Y|1968-12-25
TRIAL STUDY 134XCP|LB|727807A8-A180-4589-A553-E3C82E1D3CF2|1||||SDMA|SYMMETRIC DIMETHYLARGININE|||||||/MIN|||||||INVALID||GRAIN||||NORMAL|NOT DONE||||EPITHELIAL CELL|FROZEN|U|GC/MS/MS|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|U|N|||NA|5||7||INDUCTION TREATMENT|1969-01-07|1969-07-03|||||1967-03-07||1971-11-28|NA|1968-03-03
TRIAL STUDY 134XCP|LB|727807A8-A180-4589-A553-E3C82E1D3CF2|2||||IFNA|INTERFERON ALPHA|||||||DB|||||||POSITIVE||MEQ||||LOW|NOT DONE||||VENOUS PLASMA|HEMOLYZED|N|IMMUNORADIOMETRIC ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|NA|U|U|||NA|5||7||RUN-IN|1964-05-16|1966-12-23|||||1963-04-19||1966-11-03|Y|1968-11-25
TRIAL STUDY 134XCP|LB|BFFB5321-5FC7-4465-8579-D75865306359|1||||HAMAB|HUMAN ANTI-MOUSE ANTIBODY|||||||HPA|||||||POSITIVE||U/KG||||NORMAL|NOT DONE||||SWABBED MATERIAL|NON-HEMOLYZED|N|MS/MS|GMI MMOL/MOL FORMULA||NA|NA|NA|N|||N|1||38||OBSERVATION|1970-09-16|1971-11-20|||||1972-01-22||1961-08-14|Y|1965-02-02
TRIAL STUDY 134XCP|LB|BFFB5321-5FC7-4465-8579-D75865306359|2||||TSIAC|TSI ACTUAL/CONTROL|||||||10^10/L|||||||POSITIVE||UG/L||||NORMAL|NOT DONE||||PUS|AUTOLYZED|NA|PET/MRI SCAN|CKD-EPI FORMULA||N|Y|NA|Y|||N|1||38||RUN-IN|1966-10-18|1964-09-02|||||1970-08-16||1970-08-16|U|1964-06-03
TRIAL STUDY 134XCP|LB|BFFB5321-5FC7-4465-8579-D75865306359|1||||C165911|DAIRY MIX IGG AB RAST SCORE|||||||MCI|||||||BORDERLINE||L/S/KPA||||HIGH|NOT DONE||||INTERSTITIAL FLUID|LIPEMIC|NA|TARGETED TRANSCRIPTOME SEQUENCING|MDRD 6 VARIABLE FORMULA||N|N|NA|N|||N|2||58||LONG-TERM FOLLOW-UP|1968-06-15|1971-08-15|||||1966-06-15||1960-04-07|N|1960-03-15
TRIAL STUDY 134XCP|LB|BFFB5321-5FC7-4465-8579-D75865306359|2||||NTELOCRT|N-TELOPEPTIDE/CREATININE|||||||IU/KG/H|||||||INVALID||BP||||HIGH|NOT DONE||||PROSTATIC FLUID|NON-HEMOLYZED|NA|DYNAMIC LIGHT SCATTERING|GMI MMOL/MOL FORMULA||NA|U|N|N|||Y|2||58||TREATMENT|1962-11-18|1963-05-23|||||1963-01-07||1967-11-07|Y|1961-04-01
TRIAL STUDY 134XCP|LB|BFFB5321-5FC7-4465-8579-D75865306359|1||||LYMIM|IMMATURE LYMPHOCYTES|||||||U/M2/DAY|||||||BORDERLINE||UCI/KG||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CLOTTED|Y|IMPULSE OSCILLOMETRY|CKD-EPI CREATININE FORMULA||NA|U|U|Y|||N|3||39||FOLLOW-UP|1963-11-02|1972-01-06|||||1972-11-01||1962-11-22|N|1969-08-03
TRIAL STUDY 134XCP|LB|BFFB5321-5FC7-4465-8579-D75865306359|2||||C147282|WHITE OAK POLLEN IGE ANTIBODY|||||||G/DAY|||||||INDETERMINATE||MMOL/S||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|GMI % FORMULA||NA|N|Y|U|||U|3||39||WASHOUT|1961-10-20|1964-02-06|||||1966-06-05||1971-12-17|Y|1966-07-14
TRIAL STUDY 134XCP|LB|BFFB5321-5FC7-4465-8579-D75865306359|1||||OLIGBAND|OLIGOCLONAL BANDS|||||||MET*MIN|||||||POSITIVE||MMOL/MOL||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|CONCENTRATED|N|RULER MEASUREMENT METHOD|CKD-EPI FORMULA||N|NA|NA|NA|||N|4||88||OBSERVATION|1964-10-28|1969-11-14|||||1960-02-05||1967-01-15|U|1971-06-30
TRIAL STUDY 134XCP|LB|BFFB5321-5FC7-4465-8579-D75865306359|2||||HDW|HEMOGLOBIN DISTRIBUTION WIDTH|||||||MG/L|||||||NEGATIVE||CI/G||||NORMAL|NOT DONE||||CALCULUS|AUTOLYZED|N|LC/MS|NASH FIBROSURE FORMULA||U|Y|Y|NA|||Y|4||88||OPEN LABEL TREATMENT|1967-12-16|1967-11-13|||||1962-06-21||1971-01-03|N|1971-12-13
TRIAL STUDY 134XCP|LB|BFFB5321-5FC7-4465-8579-D75865306359|1||||EOSNUCCE|EOSINOPHILS/NUCLEATED CELLS|||||||G/ANIMAL/DAY|||||||TRACE||SIEMENS||||NORMAL|NOT DONE||||DISCHARGE|CONTAMINATED|U|STRESS ECHOCARDIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|NA|N|||N|5||7||LONG-TERM FOLLOW-UP|1960-03-29|1973-08-30|||||1967-11-11||1969-01-17|N|1965-08-30
TRIAL STUDY 134XCP|LB|BFFB5321-5FC7-4465-8579-D75865306359|2||||PYDCREAT|PYRIDINOLINE/CREATININE|||||||BQ/ML|||||||INVALID||MM||||LOW|NOT DONE||||REFLEX TEAR|FROZEN|NA|COMPLEMENT FIXATION|CKD-EPI FORMULA||N|NA|N|Y|||Y|5||7||CONTINUATION TREATMENT|1966-07-19|1966-07-11|||||1965-02-15||1971-02-08|NA|1968-08-13
TRIAL STUDY 134XCP|LB|12F9A745-F76D-4222-B37E-22AF93981ECE|1||||GEC|GALACTOSE ELIMINATION CAPACITY|||||||KALLIKREIN INHIBITOR UNIT|||||||TRACE||CIGARETTE||||HIGH|NOT DONE||||BLOOD|CONTAMINATED|Y|IMMUNORADIOMETRIC ASSAY|CKD-EPI FORMULA||N|U|N|NA|||N|1||38||SCREENING|1967-02-03|1972-06-28|||||1968-05-14||1960-07-08|U|1969-02-18
TRIAL STUDY 134XCP|LB|12F9A745-F76D-4222-B37E-22AF93981ECE|2||||HOMOCY|HOMOCYSTEINE|||||||ML/CM H2O|||||||POSITIVE||/DAY||||NORMAL|NOT DONE||||CORD SERUM|ROOM TEMPERATURE|N|CHROMOGENIC ASSAY|FIBROTEST FORMULA||U|N|N|NA|||U|1||38||LONG-TERM FOLLOW-UP|1968-05-05|1969-02-22|||||1966-04-28||1960-04-20|Y|1964-05-15
TRIAL STUDY 134XCP|LB|12F9A745-F76D-4222-B37E-22AF93981ECE|1||||CHDW|CORPUSCULAR HGB CONC DISTRIBUTION WIDTH|||||||LOG10 ELISA UNIT|||||||TRACE||L/MIN/M2||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED|Y|PH METER MEASUREMENT METHOD|CKD-EPI FORMULA||Y|N|NA|NA|||NA|2||58||OPEN LABEL TREATMENT|1963-09-25|1964-07-04|||||1971-02-01||1962-12-05|Y|1964-03-23
TRIAL STUDY 134XCP|LB|12F9A745-F76D-4222-B37E-22AF93981ECE|2||||LEIM|IMMATURE LEUKOCYTES|||||||ML/G/H|||||||BORDERLINE||CMOL/L||||LOW|NOT DONE||||BONE|LIPEMIC|NA|MULTI-SLICE SPIRAL CT|MDRD FORMULA||NA|N|NA|N|||N|2||58||FOLLOW-UP|1967-08-19|1965-02-13|||||1970-06-28||1967-04-18|N|1965-06-01
TRIAL STUDY 134XCP|LB|12F9A745-F76D-4222-B37E-22AF93981ECE|1||||CDCACM|CHENODEOXYCHOLATE COMPOUNDS|||||||U|||||||NEGATIVE||FOZ_BR||||NORMAL|NOT DONE||||SERUM OR PLASMA|PARAFFIN-EMBEDDED|N|FLOCCULATION, CHARCOAL ENHANCED|FIBROMETER FORMULA||U|U|N|NA|||U|3||39||WASHOUT|1965-04-03|1972-04-26|||||1967-02-17||1971-01-09|N|1962-01-30
TRIAL STUDY 134XCP|LB|12F9A745-F76D-4222-B37E-22AF93981ECE|2||||MCP1|MONOCYTE CHEMOTACTIC PROTEIN 1|||||||MMOL/MIN/KPA/L|||||||TRACE||UG/KG/H||||HIGH|NOT DONE||||SKIN TISSUE|ICTERIC|Y|TEST STRIP|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|N|U|||N|3||39||BLINDED TREATMENT|1965-12-27|1968-09-02|||||1968-03-29||1962-07-01|N|1964-04-26
TRIAL STUDY 134XCP|LB|12F9A745-F76D-4222-B37E-22AF93981ECE|1||||GLYCREAT|GLYCINE/CREATININE|||||||ML/M2/H|||||||POSITIVE||PNU/ML||||HIGH|NOT DONE||||BASAL TEAR|UNEXPECTED ODOR|U|HPLC-UV|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|N|Y|||N|4||88||RUN-IN|1971-04-24|1964-12-06|||||1971-04-15||1973-07-06|NA|1970-08-01
TRIAL STUDY 134XCP|LB|12F9A745-F76D-4222-B37E-22AF93981ECE|2||||NAK|SODIUM/POTASSIUM|||||||KM|||||||NEGATIVE||POUCH||||HIGH|NOT DONE||||GASTRIC FLUID|LIPEMIC|Y|SICKLE CELL SOLUBILITY TEST|MDRD FORMULA||Y|Y|NA|N|||Y|4||88||TREATMENT|1963-11-02|1969-03-06|||||1970-07-04||1969-05-12|Y|1969-11-19
TRIAL STUDY 134XCP|LB|12F9A745-F76D-4222-B37E-22AF93981ECE|1||||PCO2ADJT|PARTIAL PRESSURE CARBON DIOXIDE ADJ TEMP|||||||LOG10 ELISA UNIT/DOSE|||||||BORDERLINE||DNA COPIES/ML||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|CALCIFIED|N|X-RAY FLUORESCENCE SPECTROMETRY|CKD-EPI FORMULA||N|U|Y|U|||N|5||7||TREATMENT|1962-10-19|1970-12-20|||||1973-06-18||1961-11-15|NA|1964-07-06
TRIAL STUDY 134XCP|LB|12F9A745-F76D-4222-B37E-22AF93981ECE|2||||PBG|PORPHOBILINOGEN|||||||IU/KG/H|||||||NEGATIVE||DNA COPIES/UG||||NORMAL|NOT DONE||||CORD BLOOD|FROZEN|N|HEMATOXYLIN AND EOSIN STAIN|FIBROMETER FORMULA||Y|Y|U|N|||U|5||7||INDUCTION TREATMENT|1964-08-16|1965-06-10|||||1963-06-30||1973-09-04|NA|1968-04-07
TRIAL STUDY 134XCP|LB|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|1||||ZINC|ZINC|||||||FIU|||||||TRACE||ECL UNIT||||LOW|NOT DONE||||LYSATE|FROZEN|NA|ELASTOGRAPHY|NASH FIBROSURE FORMULA||U|N|Y|U|||U|1||38||OPEN LABEL TREATMENT|1969-11-14|1969-04-11|||||1963-08-21||1967-03-09|NA|1961-02-25
TRIAL STUDY 134XCP|LB|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|2||||CYAMPPH|AMORPHOUS PHOSPHATE CRYSTALS|||||||BOLUS|||||||INVALID||ML/ANIMAL/WK||||HIGH|NOT DONE||||AQUEOUS HUMOR|AGGLUTINATED|NA|PERIODIC ACID SCHIFF STAIN|NASH FIBROSURE FORMULA||Y|NA|U|Y|||Y|1||38||WASHOUT|1971-04-02|1970-04-27|||||1970-08-07||1962-05-15|N|1964-06-08
TRIAL STUDY 134XCP|LB|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|1||||ASTCK|AST/CREATINE KINASE|||||||DYN|||||||NEGATIVE||10^6 IU||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|ICTERIC|NA|ELISPOT|MDRD ENZYMATIC FORMULA||NA|NA|NA|Y|||NA|2||58||OPEN LABEL TREATMENT|1970-11-14|1968-06-13|||||1971-12-30||1964-03-09|N|1969-04-06
TRIAL STUDY 134XCP|LB|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|2||||CCL18|CHEMOKINE (C-C MOTIF) LIGAND 18|||||||G/ANIMAL|||||||INDETERMINATE||ML*CMH2O||||NORMAL|NOT DONE||||BILE|CALCIFIED|Y|INFRARED SPECTROMETRY|MDRD ENZYMATIC FORMULA||N|Y|Y|N|||N|2||58||CONTINUATION TREATMENT|1963-12-19|1963-12-14|||||1968-09-06||1964-09-18|N|1962-08-21
TRIAL STUDY 134XCP|LB|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|1||||INTLK12|INTERLEUKIN 12|||||||PG/CELL|||||||POSITIVE||NG/MOL||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|ICTERIC|NA|IMMUNODIFFUSION|MDRD FORMULA||NA|U|NA|N|||NA|3||39||FOLLOW-UP|1970-05-20|1966-01-14|||||1964-05-21||1963-11-22|NA|1972-03-17
TRIAL STUDY 134XCP|LB|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|2||||STAT3PS3|PHOSPHORYLATED STAT3/STAT3|||||||UMOL/MIN|||||||BORDERLINE||CM2||||LOW|NOT DONE||||REFLEX TEAR|SOLIDIFIED|N|LC-FL|FIBROSIS 4 FORMULA||NA|NA|Y|N|||N|3||39||CONTINUATION TREATMENT|1966-01-21|1962-06-14|||||1972-08-03||1970-05-21|N|1960-07-14
TRIAL STUDY 134XCP|LB|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|1||||LRZPM|LORAZEPAM|||||||CMOL/L|||||||POSITIVE||MCI/L||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|ICTERIC|Y|SANGER SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|N|NA|||N|4||88||SCREENING|1966-08-09|1971-07-05|||||1962-04-25||1961-01-14|Y|1960-02-26
TRIAL STUDY 134XCP|LB|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|2||||TTGIGAAB|TISSUE TRANSGLUTAMINASE IGA ANTIBODY|||||||10^6 ORGANISMS/G|||||||TRACE||G/ANIMAL/DAY||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|DRIED|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|FIBROSIS 4 FORMULA||U|U|Y|NA|||U|4||88||WASHOUT|1967-01-25|1961-04-25|||||1966-10-02||1966-11-13|Y|1970-02-14
TRIAL STUDY 134XCP|LB|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|1||||PBG|PORPHOBILINOGEN|||||||/MONTH|||||||TRACE||MOL||||HIGH|NOT DONE||||PLEURAL FLUID|LACTESCENT|N|ETDRS EYE CHART|CKD-EPI FORMULA||NA|Y|Y|Y|||Y|5||7||BASELINE|1969-09-16|1969-12-17|||||1965-04-01||1961-05-16|NA|1969-03-18
TRIAL STUDY 134XCP|LB|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|2||||CMONOX|CARBON MONOXIDE|||||||NMOL/L/MIN|||||||POSITIVE||MMHG/L/MIN||||NORMAL|NOT DONE||||SPERMATOZOON|CONTAMINATED|U|NUCLEIC ACID HYBRIDIZATION|FIBROMETER FORMULA||U|N|U|U|||Y|5||7||FOLLOW-UP|1967-02-17|1966-06-26|||||1971-09-24||1964-04-28|Y|1969-07-13
TRIAL STUDY 134XCP|LB|37693A38-D8A0-4313-A4D1-56E282579636|1||||CSAB|CATHEPSIN ANTIBODY|||||||UV*SEC|||||||INDETERMINATE||L/H||||HIGH|NOT DONE||||SALIVA|AGGLUTINATED|U|ELECTROPHORESIS|HEPASCORE FORMULA||Y|Y|U|Y|||U|1||38||BASELINE|1969-08-23|1972-03-14|||||1967-03-21||1970-07-01|NA|1972-02-24
TRIAL STUDY 134XCP|LB|37693A38-D8A0-4313-A4D1-56E282579636|2||||CSUNCLA|UNCLASSIFIED CASTS|||||||CFU/G|||||||BORDERLINE||IU/DL||||LOW|NOT DONE||||AQUEOUS HUMOR|CONCENTRATED|Y|MAMMOGRAPHY|NASH FIBROSURE FORMULA||N|Y|U|U|||NA|1||38||BASELINE|1972-12-12|1970-01-02|||||1960-04-03||1966-01-10|N|1960-02-16
TRIAL STUDY 134XCP|LB|37693A38-D8A0-4313-A4D1-56E282579636|1||||CYSTATC|CYSTATIN C|||||||EJACULATE U|||||||BORDERLINE||MDFI||||HIGH|NOT DONE||||BLOOD|AGGLUTINATED|U|ANALYTICAL ULTRACENTRIFUGATION|COCKCROFT-GAULT FORMULA||N|NA|U|N|||N|2||58||RUN-IN|1969-02-21|1965-01-09|||||1970-12-24||1964-02-18|U|1963-01-21
TRIAL STUDY 134XCP|LB|37693A38-D8A0-4313-A4D1-56E282579636|2||||SCHISTO|SCHISTOCYTES|||||||PFU/ANIMAL|||||||BORDERLINE||10^6/HPF||||HIGH|NOT DONE||||LUNG SURFACTANT|REFRIGERATED|Y|POLYSOMNOGRAPHY|CKD-EPI CREATININE FORMULA||N|NA|NA|NA|||N|2||58||RUN-IN|1961-07-21|1969-04-16|||||1973-06-13||1964-02-21|NA|1970-12-25
TRIAL STUDY 134XCP|LB|37693A38-D8A0-4313-A4D1-56E282579636|1||||INTLK1|INTERLEUKIN 1|||||||UMOL/KG/MIN|||||||INVALID||MMOL/MOL||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|ICTERIC|NA|MEDIASTINOSCOPY|MDRD 6 VARIABLE FORMULA||NA|U|N|NA|||U|3||39||CONTINUATION TREATMENT|1971-07-02|1963-02-11|||||1973-01-06||1960-01-07|N|1965-07-07
TRIAL STUDY 134XCP|LB|37693A38-D8A0-4313-A4D1-56E282579636|2||||TSI|THYROID STIMULATING IMMUNOGLOBULIN|||||||UL/ML|||||||INDETERMINATE||VP/ML||||LOW|NOT DONE||||SALIVA|CLOTTED|N|THIN SMEAR|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|NA|||NA|3||39||INDUCTION TREATMENT|1973-04-20|1969-03-03|||||1964-11-07||1961-04-01|NA|1962-10-18
TRIAL STUDY 134XCP|LB|37693A38-D8A0-4313-A4D1-56E282579636|1||||UROBIL|UROBILINOGEN|||||||10^9/L|||||||TRACE||10^11/L||||NORMAL|NOT DONE||||STOOL|HEMOLYZED|Y|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|ASH FIBROSURE FORMULA||N|U|Y|N|||NA|4||88||CONTINUATION TREATMENT|1961-09-30|1970-04-12|||||1961-11-30||1966-04-13|N|1964-06-09
TRIAL STUDY 134XCP|LB|37693A38-D8A0-4313-A4D1-56E282579636|2||||GLOBG|GAMMA GLOBULIN|||||||KEV|||||||BORDERLINE||PA||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|DRIED|U|SPIRAL CT SCAN WITHOUT CONTRAST|HEPASCORE FORMULA||N|NA|NA|N|||Y|4||88||TREATMENT|1971-01-07|1968-07-15|||||1966-03-06||1964-07-04|N|1973-03-10
TRIAL STUDY 134XCP|LB|37693A38-D8A0-4313-A4D1-56E282579636|1||||YEASTHYP|YEAST HYPHAE|||||||BREATHS/MIN|||||||TRACE||GY||||ABNORMAL|NOT DONE||||SERUM|CLOTTED|Y|SIZE EXCLUSION CHROMATOGRAPHY|GMI MMOL/MOL FORMULA||N|N|NA|NA|||NA|5||7||OBSERVATION|1967-04-26|1970-12-21|||||1964-11-18||1964-08-30|NA|1960-08-15
TRIAL STUDY 134XCP|LB|37693A38-D8A0-4313-A4D1-56E282579636|2||||GFRBSCYC|GFR FROM CYSTATIN C ADJUSTED FOR BSA|||||||MU/G|||||||TRACE||ML/G/H||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|ROOM TEMPERATURE|Y|SINGLE-SLICE SPIRAL CT|FIBROTEST FORMULA||NA|NA|Y|Y|||NA|5||7||TREATMENT|1966-07-15|1973-04-19|||||1961-06-07||1961-01-21|Y|1968-12-13
TRIAL STUDY 134XCP|LB|5C48E0BB-FD52-47F5-8759-6126ECB47B80|1||||CIC|CIRCULATING IMMUNE COMPLEXES|||||||UMOL/MOL|||||||INDETERMINATE||ML/S/M2||||ABNORMAL|NOT DONE||||CORD BLOOD|FRESH|NA|OBSERVATION|MDRD 4 VARIABLE FORMULA||N|NA|Y|NA|||NA|1||38||INDUCTION TREATMENT|1971-05-11|1967-10-11|||||1972-10-15||1973-06-09|U|1972-01-29
TRIAL STUDY 134XCP|LB|5C48E0BB-FD52-47F5-8759-6126ECB47B80|2||||THEOPHYL|THEOPHYLLINE|||||||INHALATION|||||||POSITIVE||10^6 U||||NORMAL|NOT DONE||||URINE SEDIMENT|NON-HEMOLYZED|U|ANTIMICROBIAL COMBINATION TESTING|HEPASCORE FORMULA||NA|N|Y|Y|||NA|1||38||INDUCTION TREATMENT|1965-11-15|1961-05-23|||||1967-11-12||1970-09-05|Y|1965-06-15
TRIAL STUDY 134XCP|LB|5C48E0BB-FD52-47F5-8759-6126ECB47B80|1||||PO2ADJT|PARTIAL PRESSURE OXYGEN ADJ FOR TEMP|||||||1/(S*KPA)|||||||POSITIVE||U/M2/MIN||||LOW|NOT DONE||||INFRANATANT, PLASMA|NON-HEMOLYZED|U|CONFOCAL MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||U|U|U|U|||U|2||58||SCREENING|1960-08-05|1969-08-31|||||1971-11-19||1967-10-26|U|1965-02-01
TRIAL STUDY 134XCP|LB|5C48E0BB-FD52-47F5-8759-6126ECB47B80|2||||ANGTNS2|ANGIOTENSIN II|||||||10^6 CFU/G|||||||TRACE||ANTI-XA IU/ML||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|SOLIDIFIED|N|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|FIBROTEST FORMULA||Y|NA|NA|NA|||N|2||58||OPEN LABEL TREATMENT|1964-08-25|1965-07-05|||||1971-10-20||1967-10-17|U|1965-01-22
TRIAL STUDY 134XCP|LB|5C48E0BB-FD52-47F5-8759-6126ECB47B80|1||||PREALB|PREALBUMIN|||||||AMU|||||||NEGATIVE||KM/H||||NORMAL|NOT DONE||||TISSUE|CALCIFIED|NA|DIFFUSION TENSOR MRI|FIBROSIS 4 FORMULA||U|Y|N|Y|||N|3||39||WASHOUT|1969-06-17|1960-04-22|||||1967-06-14||1966-11-18|Y|1960-12-05
TRIAL STUDY 134XCP|LB|5C48E0BB-FD52-47F5-8759-6126ECB47B80|2||||WBCCE|LEUKOCYTES/TOTAL CELLS|||||||GTT|||||||BORDERLINE||NKAT/G HB||||NORMAL|NOT DONE||||SOFT TISSUE|AGGLUTINATED|Y|KNEMOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|U|Y|||U|3||39||LONG-TERM FOLLOW-UP|1962-03-02|1973-03-11|||||1963-01-21||1960-10-15|N|1973-06-05
TRIAL STUDY 134XCP|LB|5C48E0BB-FD52-47F5-8759-6126ECB47B80|1||||CSGRANF|GRANULAR FINE CASTS|||||||UMOL/KG/MIN|||||||NEGATIVE||USEC||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|THAWED|Y|PET SCAN|NASH FIBROSURE FORMULA||U|N|Y|N|||U|4||88||TREATMENT|1961-12-27|1964-07-18|||||1962-03-27||1961-08-10|NA|1966-04-07
TRIAL STUDY 134XCP|LB|5C48E0BB-FD52-47F5-8759-6126ECB47B80|2||||DKK1|DICKKOPF WNT SIGNALING PATH INHIBITOR 1|||||||MCI/L|||||||INVALID||10^3/HPF||||NORMAL|NOT DONE||||COLOSTRUM|SOLIDIFIED|U|RADIOGRAPHY|MDRD 5 VARIABLE FORMULA||U|U|N|NA|||N|4||88||INDUCTION TREATMENT|1973-07-16|1966-12-25|||||1962-08-13||1963-03-31|Y|1962-02-23
TRIAL STUDY 134XCP|LB|5C48E0BB-FD52-47F5-8759-6126ECB47B80|1||||CTXI|TYPE I COLLAGEN C-TELOPEPTIDES|||||||CP|||||||NEGATIVE||MCI||||NORMAL|NOT DONE||||EMOTIONAL TEAR|LACTESCENT|N|DC SHEATH FLOW|MDRD 4 VARIABLE FORMULA||U|U|Y|U|||U|5||7||FOLLOW-UP|1965-01-12|1967-02-10|||||1965-12-10||1960-09-23|NA|1971-04-06
TRIAL STUDY 134XCP|LB|5C48E0BB-FD52-47F5-8759-6126ECB47B80|2||||LH|LUTEINIZING HORMONE|||||||ELISA UNIT|||||||TRACE||UG/H||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|CONCENTRATED|Y|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD ENZYMATIC FORMULA||Y|Y|NA|N|||N|5||7||OBSERVATION|1962-04-10|1971-11-13|||||1962-03-14||1962-03-07|U|1965-05-14
TRIAL STUDY 134XCP|LB|5B420A5A-DB2C-48D2-8E9B-97639F49F182|1||||CKMT1CK|CK, MACROMOLECULAR TYPE 1/TOTAL CK|||||||AFU|||||||INDETERMINATE||MOL/DAY||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|CONTAMINATED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|GMI MMOL/MOL FORMULA||N|U|Y|Y|||N|1||38||FOLLOW-UP|1968-12-06|1970-05-01|||||1973-04-07||1964-05-25|Y|1973-07-26
TRIAL STUDY 134XCP|LB|5B420A5A-DB2C-48D2-8E9B-97639F49F182|2||||INTLK12|INTERLEUKIN 12|||||||IU/MMOL|||||||BORDERLINE||SUPPOSITORY||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|AUTOLYZED|Y|SMEAR|COCKCROFT-GAULT FORMULA||N|NA|Y|NA|||Y|1||38||WASHOUT|1973-01-08|1967-01-26|||||1970-05-09||1965-06-25|U|1962-04-29
TRIAL STUDY 134XCP|LB|5B420A5A-DB2C-48D2-8E9B-97639F49F182|1||||CITRTEXR|CITRATE EXCRETION RATE|||||||/LPF|||||||INVALID||KIU||||ABNORMAL|NOT DONE||||BASAL TEAR|DRIED|NA|PERFUSION MRI|FIBROTEST FORMULA||N|N|Y|NA|||U|2||58||WASHOUT|1962-05-25|1960-03-26|||||1960-07-16||1960-10-14|U|1960-01-18
TRIAL STUDY 134XCP|LB|5B420A5A-DB2C-48D2-8E9B-97639F49F182|2||||TRPCRT|TRYPTOPHAN/CREATININE|||||||NL|||||||BORDERLINE||NMOL BCE/L||||HIGH|NOT DONE||||BILE|CLOTTED|U|POLYMERASE CHAIN REACTION|GMI % FORMULA||NA|U|U|Y|||U|2||58||WASHOUT|1973-06-09|1966-11-20|||||1969-11-22||1961-10-15|U|1965-08-19
TRIAL STUDY 134XCP|LB|5B420A5A-DB2C-48D2-8E9B-97639F49F182|1||||DIHYDCDN|DIHYDROCODEINE|||||||BREATHS/30S|||||||POSITIVE||MPL U||||LOW|NOT DONE||||INTERSTITIAL FLUID|LACTESCENT|NA|IMMUNOFIXATION ELECTROPHORESIS|GMI % FORMULA||N|N|Y|N|||U|3||39||BASELINE|1961-05-13|1964-09-17|||||1961-10-13||1969-03-13|NA|1967-09-29
TRIAL STUDY 134XCP|LB|5B420A5A-DB2C-48D2-8E9B-97639F49F182|2||||EPISCECE|SQUAMOUS EPITHELIAL CELLS/TOTAL CELLS|||||||V|||||||BORDERLINE||GAUSS||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|CLOTTED|Y|ENZYMATIC COLORIMETRY|FIBROMETER FORMULA||Y|U|NA|N|||U|3||39||INDUCTION TREATMENT|1970-09-08|1962-05-21|||||1968-01-18||1969-08-01|N|1961-01-07
TRIAL STUDY 134XCP|LB|5B420A5A-DB2C-48D2-8E9B-97639F49F182|1||||FABP3|FATTY ACID BINDING PROTEIN 3|||||||/H|||||||POSITIVE||ML/CM H2O||||ABNORMAL|NOT DONE||||MUCUS|AGGLUTINATED|N|THICK SMEAR|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|Y|N|||N|4||88||OBSERVATION|1965-06-19|1964-02-03|||||1963-07-05||1966-06-08|N|1964-05-16
TRIAL STUDY 134XCP|LB|5B420A5A-DB2C-48D2-8E9B-97639F49F182|2||||CD56|CD56|||||||%(W/W)|||||||BORDERLINE||SACHET||||HIGH|NOT DONE||||SUPERNATANT, SERUM|DRIED|N|MAPH|FIBROTEST FORMULA||Y|U|Y|U|||U|4||88||BASELINE|1973-03-25|1973-08-07|||||1972-01-03||1965-10-31|NA|1972-04-02
TRIAL STUDY 134XCP|LB|5B420A5A-DB2C-48D2-8E9B-97639F49F182|1||||BNZLCGN|BENZOYLECGONINE|||||||10^3 CFU|||||||NEGATIVE||10^4/L||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CALCIFIED|Y|TRICHROME STAIN|MDRD 5 VARIABLE FORMULA||NA|NA|U|NA|||N|5||7||CONTINUATION TREATMENT|1970-09-22|1960-12-19|||||1972-03-19||1967-02-13|Y|1968-06-25
TRIAL STUDY 134XCP|LB|5B420A5A-DB2C-48D2-8E9B-97639F49F182|2||||IAA5OH|5-HYDROXYINDOLEACETIC ACID|||||||CMH2O*S2/ML|||||||TRACE||BLOCKS||||NORMAL|NOT DONE||||CORD SERUM|FROZEN|Y|ARTERIAL SPIN LABELING FUNCTIONAL MRI|NASH FIBROSURE FORMULA||NA|NA|N|Y|||U|5||7||BLINDED TREATMENT|1963-08-05|1963-07-27|||||1972-05-12||1968-12-19|U|1968-12-23
TRIAL STUDY 134XCP|LB|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|1||||METANEPH|METANEPHRINE|||||||TSP EQ|||||||POSITIVE||10^3 ORGANISMS/ML||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|SOLIDIFIED|N|HIGH RESOLUTION MELT ANALYSIS|MDRD FORMULA||NA|Y|NA|N|||Y|1||38||BASELINE|1972-04-08|1973-07-26|||||1968-10-22||1969-08-24|NA|1968-03-05
TRIAL STUDY 134XCP|LB|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|2||||CACRTP|CALCIUM CORRECTED FOR TOTAL PROTEIN|||||||BE/ML|||||||INVALID||ML/KG/DAY||||LOW|NOT DONE||||GASTRIC CONTENTS|PARAFFIN-EMBEDDED|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD ENZYMATIC FORMULA||Y|U|NA|U|||U|1||38||LONG-TERM FOLLOW-UP|1965-11-19|1964-10-24|||||1967-03-27||1972-12-16|U|1965-04-23
TRIAL STUDY 134XCP|LB|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|1||||MYBLAT1|TYPE I MYELOBLASTS|||||||SYRINGE|||||||INVALID||NMOL||||HIGH|NOT DONE||||TISSUE|CLOTTED|NA|IMMUNODIFFUSION|GMI MMOL/MOL FORMULA||NA|NA|U|N|||U|2||58||RUN-IN|1960-06-30|1969-11-25|||||1969-01-26||1971-12-17|NA|1962-09-26
TRIAL STUDY 134XCP|LB|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|2||||CYAMPURT|AMORPHOUS URATE CRYSTALS|||||||CYCLE/MIN|||||||TRACE||10^3 ORGANISMS/G||||HIGH|NOT DONE||||INFRANATANT, SERUM|FROZEN|U|PATHOLOGICAL EVALUATION|ASH FIBROSURE FORMULA||Y|Y|N|NA|||Y|2||58||OPEN LABEL TREATMENT|1960-02-12|1963-04-06|||||1972-06-13||1973-01-22|Y|1969-07-10
TRIAL STUDY 134XCP|LB|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|1||||FUNGIFIL|FUNGI, FILAMENTOUS|||||||SV|||||||BORDERLINE||UMOL||||HIGH|NOT DONE||||PLATELET RICH PLASMA|FRESH|Y|MALDI|ASH FIBROSURE FORMULA||Y|NA|U|U|||U|3||39||RUN-IN|1967-03-14|1972-05-15|||||1970-08-13||1964-10-05|NA|1968-09-15
TRIAL STUDY 134XCP|LB|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|2||||C147278|GLYCINE MAX ANTIGEN IGE ANTIBODY|||||||NMOL/MOL|||||||TRACE||PUFF||||ABNORMAL|NOT DONE||||DISCHARGE|LACTESCENT|N|KNEMOMETRY|MDRD ENZYMATIC FORMULA||Y|Y|U|U|||N|3||39||CONTINUATION TREATMENT|1971-05-04|1962-05-28|||||1968-10-06||1960-03-16|Y|1972-06-16
TRIAL STUDY 134XCP|LB|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|1||||TRIM38|TRIPARTITE MOTIF CONTAINING PROTEIN 38|||||||GBQ/UG|||||||TRACE||HOUNSFIELD UNIT||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|ICTERIC|U|PHOROPTER|GMI % FORMULA||N|U|NA|NA|||Y|4||88||CONTINUATION TREATMENT|1971-09-28|1965-07-05|||||1960-06-26||1973-06-26|U|1965-03-20
TRIAL STUDY 134XCP|LB|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|2||||FACTXIVA|FACTOR XIV ACTIVITY|||||||MM/2H|||||||INVALID||U/G HB||||LOW|NOT DONE||||PLEURAL FLUID|CALCIFIED|N|ORCHIDOMETERY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|U|NA|||Y|4||88||OBSERVATION|1962-03-22|1972-05-03|||||1966-08-29||1961-07-29|NA|1972-01-15
TRIAL STUDY 134XCP|LB|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|1||||MACROBLD|MACROSCOPIC BLOOD|||||||UMOL/L|||||||TRACE||CMH2O*S2/ML||||LOW|NOT DONE||||INFRANATANT, SERUM|THAWED|U|WRIGHT STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|NA|N|||NA|5||7||OBSERVATION|1966-06-02|1960-07-22|||||1972-03-23||1962-07-18|N|1973-09-01
TRIAL STUDY 134XCP|LB|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|2||||OPIATE|OPIATE|||||||10^6 COPIES/ML|||||||POSITIVE||MAC50||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|CLOTTED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|FIBROMETER FORMULA||NA|U|NA|NA|||U|5||7||OPEN LABEL TREATMENT|1969-09-10|1972-11-28|||||1973-06-11||1967-09-11|Y|1963-04-25
TRIAL STUDY 134XCP|LB|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|1||||GALM|GALACTOSE MUTAROTASE|||||||HOUNSFIELD UNIT|||||||NEGATIVE||AMOL||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|SOLIDIFIED|N|SCINTIGRAPHY|FIBROMETER FORMULA||Y|N|U|U|||U|1||38||SCREENING|1961-02-17|1960-12-15|||||1960-04-09||1960-05-31|NA|1972-02-14
TRIAL STUDY 134XCP|LB|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|2||||PREALB|PREALBUMIN|||||||BQ/KG|||||||TRACE||F||||HIGH|NOT DONE||||BASAL TEAR|CLOTTED|N|PHYSICAL EXAMINATION|CKD-EPI CREATININE FORMULA||NA|Y|U|Y|||Y|1||38||CONTINUATION TREATMENT|1973-07-30|1962-11-14|||||1966-10-09||1960-04-19|N|1961-02-05
TRIAL STUDY 134XCP|LB|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|1||||CD4CD8|CD4/CD8|||||||NG/DAY|||||||INVALID||UMOL/L||||LOW|NOT DONE||||ERYTHROCYTES|GELLED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|COCKCROFT-GAULT FORMULA||N|U|U|U|||NA|2||58||SCREENING|1969-08-08|1968-09-19|||||1972-05-12||1960-01-13|N|1968-10-17
TRIAL STUDY 134XCP|LB|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|2||||PKM1|PYRUVATE KINASE ISOZYME M1|||||||L/KG|||||||INVALID||CL||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|THAWED|NA|SPIRAL CT SCAN WITHOUT CONTRAST|FIBROMETER FORMULA||NA|NA|U|N|||U|2||58||LONG-TERM FOLLOW-UP|1962-09-30|1967-06-01|||||1962-03-15||1970-11-10|U|1966-04-14
TRIAL STUDY 134XCP|LB|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|1||||LVTRCTM|LEVETIRACETAM|||||||NG/DL|||||||INVALID||UCI/KG||||LOW|NOT DONE||||BASAL TEAR|CONTAMINATED|NA|PELLI-ROBSON EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|NA|N|||N|3||39||WASHOUT|1969-09-27|1968-11-28|||||1968-10-27||1971-09-09|U|1972-10-31
TRIAL STUDY 134XCP|LB|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|2||||B2G1GAAB|BETA-2 GLYCOPROTEIN 1 IGA ANTIBODY|||||||LOG10 CFU/ML|||||||TRACE||MOSM/L||||HIGH|NOT DONE||||GASTRIC FLUID|AGGLUTINATED|U|PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD FORMULA||N|Y|Y|Y|||NA|3||39||OBSERVATION|1966-05-21|1960-09-11|||||1972-08-16||1961-10-12|NA|1964-04-28
TRIAL STUDY 134XCP|LB|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|1||||C1QAB|COMPLEMENT C1Q ANTIBODY|||||||PHERESIS UNIT|||||||BORDERLINE||MMHG/L/MIN||||NORMAL|NOT DONE||||MUSCLE TISSUE|CALCIFIED|NA|CONTRAST ENHANCED PET/CT SCAN|MDRD 6 VARIABLE FORMULA||Y|N|Y|U|||U|4||88||WASHOUT|1967-10-22|1971-08-14|||||1961-06-30||1964-08-14|Y|1962-12-28
TRIAL STUDY 134XCP|LB|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|2||||C130073|BIRCH POLLEN IGA|||||||/7.5 ML|||||||BORDERLINE||MM/H||||HIGH|NOT DONE||||MENSTRUAL BLOOD|DRIED|U|MAGNETIC RESONANCE ELASTOGRAPHY|ASH FIBROSURE FORMULA||N|U|NA|U|||N|4||88||CONTINUATION TREATMENT|1965-01-29|1967-01-13|||||1965-05-21||1962-02-21|NA|1963-08-20
TRIAL STUDY 134XCP|LB|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|1||||APOA2|APOLIPOPROTEIN AII|||||||MONTHS|||||||INVALID||MG/DL||||LOW|NOT DONE||||EMOTIONAL TEAR|UNEXPECTED ODOR|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|GMI % FORMULA||NA|U|NA|U|||NA|5||7||INDUCTION TREATMENT|1965-06-15|1969-03-17|||||1961-12-05||1965-02-24|NA|1965-06-02
TRIAL STUDY 134XCP|LB|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|2||||MSPIKER|MONOCLONAL PROTEIN SPIKE REGION|||||||CS|||||||BORDERLINE||DAYS||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|CKD-EPI FORMULA||U|NA|N|N|||NA|5||7||SCREENING|1970-11-07|1965-04-14|||||1970-02-05||1967-06-09|U|1966-02-03
TRIAL STUDY 134XCP|LB|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|1||||MX1|INTERFERON-INDUCED PROTEIN P78|||||||CARTRIDGE|||||||BORDERLINE||MG/L FEU||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|AGGLUTINATED|Y|TOTAL BODY RADIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|Y|Y|U|||U|1||38||BASELINE|1963-02-05|1966-12-07|||||1965-07-30||1971-08-03|NA|1966-04-11
TRIAL STUDY 134XCP|LB|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|2||||PDW|PLATELET DISTRIBUTION WIDTH|||||||L/S/KPA|||||||INVALID||MESF||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|AUTOLYZED|U|JAFFE REACTION|MDRD 6 VARIABLE FORMULA||U|NA|N|Y|||Y|1||38||SCREENING|1961-07-10|1972-02-29|||||1971-09-22||1969-01-10|Y|1965-02-01
TRIAL STUDY 134XCP|LB|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|1||||FAI|FREE ANDROGEN INDEX|||||||INHALATION|||||||INDETERMINATE||10^9 CFU/G||||ABNORMAL|NOT DONE||||FLUID|CONCENTRATED|U|TEST STRIP|MDRD 5 VARIABLE FORMULA||Y|Y|N|N|||U|2||58||OBSERVATION|1970-02-16|1962-05-20|||||1960-09-10||1965-04-01|Y|1968-01-10
TRIAL STUDY 134XCP|LB|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|2||||IFIT3|INTERFERON-INDUCED 60 KDA PROTEIN|||||||JDF UNIT|||||||BORDERLINE||GBQ/G||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|ICTERIC|Y|SLOAN LETTER EYE CHART 1.25%|MDRD 4 VARIABLE FORMULA||N|N|N|N|||Y|2||58||SCREENING|1970-09-26|1961-06-29|||||1965-06-28||1962-12-15|NA|1960-06-07
TRIAL STUDY 134XCP|LB|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|1||||CKMT1CK|CK, MACROMOLECULAR TYPE 1/TOTAL CK|||||||100 IU/ML|||||||INDETERMINATE||NMOL/DAY||||NORMAL|NOT DONE||||SKIN TISSUE|ROOM TEMPERATURE|U|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROSIS 4 FORMULA||Y|Y|NA|Y|||NA|3||39||INDUCTION TREATMENT|1968-01-05|1964-01-25|||||1970-10-07||1972-01-03|N|1971-07-31
TRIAL STUDY 134XCP|LB|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|2||||IL1EXR|INTERLEUKIN 1 EXCRETION RATE|||||||QUANTITY SUFFICIENT|||||||INVALID||/MBP||||LOW|NOT DONE||||BREAST MILK|DRIED|N|BRDU CELLULAR PROLIFERATION ASSAY|HEPASCORE FORMULA||NA|N|NA|U|||U|3||39||LONG-TERM FOLLOW-UP|1960-01-02|1963-09-26|||||1969-08-17||1971-09-28|N|1971-01-24
TRIAL STUDY 134XCP|LB|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|1||||NSE|NEURON SPECIFIC ENOLASE|||||||ML/CAGE/DAY|||||||BORDERLINE||ML/ANIMAL||||HIGH|NOT DONE||||BLOOD|THAWED|Y|GC/FID|GMI MMOL/MOL FORMULA||NA|N|Y|NA|||Y|4||88||CONTINUATION TREATMENT|1967-07-15|1973-07-17|||||1962-07-30||1972-03-04|U|1972-04-23
TRIAL STUDY 134XCP|LB|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|2||||PREALB|PREALBUMIN|||||||KS|||||||POSITIVE||CPM||||LOW|NOT DONE||||EXUDATE|AUTOLYZED|Y|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI FORMULA||NA|N|N|U|||Y|4||88||BLINDED TREATMENT|1968-05-25|1973-03-12|||||1972-11-03||1971-10-08|Y|1972-12-10
TRIAL STUDY 134XCP|LB|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|1||||DPDCREAT|DEOXYPYRIDINOLINE/CREATININE|||||||PT_BR|||||||POSITIVE||M/SEC||||ABNORMAL|NOT DONE||||GASTRIC FLUID|SOLIDIFIED|Y|ELECTROCHEMILUMINESCENCE|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|N|U|||U|5||7||TREATMENT|1963-01-24|1967-06-11|||||1960-04-05||1963-01-08|N|1960-11-21
TRIAL STUDY 134XCP|LB|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|2||||HGBFHGB|HEMOGLOBIN F/TOTAL HEMOGLOBIN|||||||KDA|||||||TRACE||BEATS/MIN||||HIGH|NOT DONE||||GASTRIC FLUID|REFRIGERATED|NA|AGAR DILUTION|MDRD ENZYMATIC FORMULA||N|Y|Y|NA|||N|5||7||LONG-TERM FOLLOW-UP|1966-10-08|1962-07-14|||||1970-02-12||1968-04-03|U|1967-08-22
TRIAL STUDY 134XCP|LB|9B95CE9F-E755-463A-92EC-07A55EE8A58F|1||||LYMAT|LYMPHOCYTES ATYPICAL|||||||G/KG/DAY|||||||BORDERLINE||G/G/DAY||||NORMAL|NOT DONE||||SALIVA|LACTESCENT|Y|OBSERVATION|MDRD 6 VARIABLE FORMULA||NA|Y|NA|NA|||Y|1||38||OPEN LABEL TREATMENT|1963-01-22|1960-09-18|||||1960-01-13||1965-09-13|U|1971-07-17
TRIAL STUDY 134XCP|LB|9B95CE9F-E755-463A-92EC-07A55EE8A58F|2||||PLTMORPH|PLATELET MORPHOLOGY|||||||MPL U|||||||INVALID||PKAT||||HIGH|NOT DONE||||DISCHARGE|LIPEMIC|Y|QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROMETER FORMULA||N|N|NA|N|||Y|1||38||INDUCTION TREATMENT|1969-12-17|1961-07-19|||||1967-01-13||1967-12-04|NA|1971-06-07
TRIAL STUDY 134XCP|LB|9B95CE9F-E755-463A-92EC-07A55EE8A58F|1||||SICAM1|SOLUBLE INTERCELL ADHESION MOLECULE 1|||||||/2500 WBC|||||||TRACE||KIU||||HIGH|NOT DONE||||SOFT TISSUE|FRESH|NA|CYSTOMETRY|COCKCROFT-GAULT FORMULA||U|Y|U|Y|||U|2||58||OPEN LABEL TREATMENT|1968-05-26|1964-12-08|||||1962-09-28||1968-02-25|U|1969-04-18
TRIAL STUDY 134XCP|LB|9B95CE9F-E755-463A-92EC-07A55EE8A58F|2||||AAMBTAC|ALPHA-AMINOBUTYRIC ACID|||||||10^3 CFU/G|||||||POSITIVE||GBQ||||NORMAL|NOT DONE||||ALVEOLAR AIR|NON-HEMOLYZED|N|TEMPLATE INCISION METHOD|GMI % FORMULA||U|NA|U|NA|||U|2||58||CONTINUATION TREATMENT|1967-03-12|1965-08-19|||||1973-03-11||1964-05-18|N|1970-02-02
TRIAL STUDY 134XCP|LB|9B95CE9F-E755-463A-92EC-07A55EE8A58F|1||||EOSLE|EOSINOPHILS/LEUKOCYTES|||||||DPM/0.5 ML|||||||INDETERMINATE||GLOBULE||||NORMAL|NOT DONE||||SWABBED MATERIAL|GELLED|NA|RADIATION DOSIMETRY|HEPASCORE FORMULA||NA|NA|U|Y|||U|3||39||SCREENING|1968-10-12|1960-10-23|||||1973-02-15||1968-02-18|U|1961-03-21
TRIAL STUDY 134XCP|LB|9B95CE9F-E755-463A-92EC-07A55EE8A58F|2||||STOMCY|STOMATOCYTES|||||||CM H2O|||||||INVALID||MM3/MM2/YEAR||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|DRIED|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||U|Y|U|N|||NA|3||39||SCREENING|1965-07-29|1965-01-27|||||1960-10-23||1969-05-28|U|1969-11-14
TRIAL STUDY 134XCP|LB|9B95CE9F-E755-463A-92EC-07A55EE8A58F|1||||DGNWBC|DEGENERATED LEUKOCYTES|||||||KCAL|||||||POSITIVE||CD*S/M2||||NORMAL|NOT DONE||||SPUTUM|REFRIGERATED|U|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 6 VARIABLE FORMULA||NA|Y|N|NA|||U|4||88||OPEN LABEL TREATMENT|1969-09-01|1966-01-30|||||1971-05-11||1964-11-15|Y|1963-11-17
TRIAL STUDY 134XCP|LB|9B95CE9F-E755-463A-92EC-07A55EE8A58F|2||||HERC5|HECT DOMAIN AND RLD 5|||||||U/MMOL|||||||POSITIVE||FMOL/G||||ABNORMAL|NOT DONE||||DERMAL TISSUE|REFRIGERATED|U|JAFFE REACTION|COCKCROFT-GAULT FORMULA||U|U|U|NA|||NA|4||88||OBSERVATION|1963-03-19|1969-04-23|||||1967-03-15||1966-08-08|Y|1964-10-15
TRIAL STUDY 134XCP|LB|9B95CE9F-E755-463A-92EC-07A55EE8A58F|1||||AFPADJBW|ALPHA FETOPROTEIN ADJ FOR BODY WEIGHT|||||||MPL U/ML|||||||TRACE||ML/SEC/1.73M2||||NORMAL|NOT DONE||||LUNG SURFACTANT|HEMOLYZED|NA|MACRO BROTH DILUTION|MDRD FORMULA||U|Y|N|N|||NA|5||7||FOLLOW-UP|1965-03-15|1973-02-13|||||1963-09-05||1966-05-11|Y|1967-12-10
TRIAL STUDY 134XCP|LB|9B95CE9F-E755-463A-92EC-07A55EE8A58F|2||||GCDCA|GLYCOCHENODEOXYCHOLATE|||||||/MM|||||||INDETERMINATE||PPM||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|FROZEN|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD 4 VARIABLE FORMULA||U|N|U|N|||U|5||7||TREATMENT|1966-09-16|1965-11-02|||||1968-03-11||1960-04-07|U|1970-03-27
TRIAL STUDY 134XCP|LB|ED388A78-3B06-4529-861A-0174E7F345C2|1||||NTRLFAT|NEUTRAL FATS|||||||TBSP|||||||INVALID||G/DL||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|CLOTTED|NA|CELL BASED BIOASSAY|MDRD FORMULA||U|N|N|NA|||U|1||38||INDUCTION TREATMENT|1961-12-31|1963-02-04|||||1962-06-13||1963-07-26|NA|1961-08-01
TRIAL STUDY 134XCP|LB|ED388A78-3B06-4529-861A-0174E7F345C2|2||||HCGFR|CHORIOGONADOTROPIN BETA, FREE|||||||CAPSULE|||||||INDETERMINATE||10^7 TCID 50/DOSE||||HIGH|NOT DONE||||PLATELET|UNEXPECTED ODOR|NA|WRIGHT STAIN|MDRD FORMULA||NA|N|NA|N|||N|1||38||WASHOUT|1963-11-24|1972-07-18|||||1969-09-11||1969-07-24|N|1967-04-27
TRIAL STUDY 134XCP|LB|ED388A78-3B06-4529-861A-0174E7F345C2|1||||HGBA2HGB|HEMOGLOBIN A2/TOTAL HEMOGLOBIN|||||||ML/MIN/MMHG|||||||TRACE||ATM||||LOW|NOT DONE||||VITREOUS HUMOR|HEMOLYZED|NA|CONTRAST ENHANCED PET/CT SCAN|MDRD 5 VARIABLE FORMULA||Y|N|U|U|||NA|2||58||RUN-IN|1962-07-20|1965-09-09|||||1960-04-23||1964-03-09|NA|1969-07-12
TRIAL STUDY 134XCP|LB|ED388A78-3B06-4529-861A-0174E7F345C2|2||||LMBDLC|LAMBDA LIGHT CHAIN|||||||PPTH|||||||INVALID||10^4 CFU/ML||||LOW|NOT DONE||||CERUMEN|FRESH|U|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD ENZYMATIC JAPANESE FORMULA||U|N|NA|NA|||N|2||58||SCREENING|1965-03-14|1970-01-07|||||1972-10-23||1966-02-19|U|1970-12-31
TRIAL STUDY 134XCP|LB|ED388A78-3B06-4529-861A-0174E7F345C2|1||||FATACVLC|FATTY ACIDS, VERY LONG CHAIN|||||||NU/CL|||||||TRACE||AMU||||LOW|NOT DONE||||SOFT TISSUE|DRIED|NA|IMMUNOPRECIPITATION|GMI % FORMULA||Y|Y|U|U|||Y|3||39||OBSERVATION|1967-10-18|1965-05-11|||||1969-11-17||1967-10-19|U|1963-10-10
TRIAL STUDY 134XCP|LB|ED388A78-3B06-4529-861A-0174E7F345C2|2||||CREATEXR|CREATININE EXCRETION RATE|||||||L/KG|||||||POSITIVE||U/MMOL||||LOW|NOT DONE||||AMNIOTIC FLUID|AUTOLYZED|N|TOLUIDINE BLUE STAIN|CKD-EPI CREATININE FORMULA||U|Y|NA|Y|||N|3||39||OPEN LABEL TREATMENT|1961-12-31|1966-04-17|||||1962-05-04||1967-04-16|N|1962-05-17
TRIAL STUDY 134XCP|LB|ED388A78-3B06-4529-861A-0174E7F345C2|1||||BACT|BACTERIA|||||||PRESSOR UNITS|||||||TRACE||AG||||HIGH|NOT DONE||||AMNIOTIC FLUID|ROOM TEMPERATURE|Y|LASER CAPTURE MICRODISSECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|U|U|||NA|4||88||BLINDED TREATMENT|1960-08-21|1968-01-10|||||1962-03-01||1973-03-14|N|1965-08-15
TRIAL STUDY 134XCP|LB|ED388A78-3B06-4529-861A-0174E7F345C2|2||||C3DAB|COMPLEMENT C3D ANTIBODY|||||||UU/L|||||||BORDERLINE||MAC50||||HIGH|NOT DONE||||SMEGMA|LACTESCENT|N|FUNDUS PHOTOGRAPHY|MDRD ENZYMATIC FORMULA||U|U|Y|U|||Y|4||88||TREATMENT|1967-07-08|1971-07-17|||||1963-03-09||1962-12-27|N|1965-08-30
TRIAL STUDY 134XCP|LB|ED388A78-3B06-4529-861A-0174E7F345C2|1||||RETIHCR|HEMATOCRIT CORRECTED RETICULOCYTES|||||||BOTTLE|||||||INDETERMINATE||GPS U||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|HEMOLYZED|U|INTERRUPTER TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|NA|NA|||Y|5||7||CONTINUATION TREATMENT|1969-12-01|1965-04-01|||||1964-08-30||1962-08-22|U|1967-12-29
TRIAL STUDY 134XCP|LB|ED388A78-3B06-4529-861A-0174E7F345C2|2||||HDLCCHOL|HDL CHOLESTEROL/TOTAL CHOLESTEROL|||||||GLOBULE|||||||BORDERLINE||UG/DAY||||HIGH|NOT DONE||||PROSTATIC FLUID|REFRIGERATED|U|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI CREATININE FORMULA||N|U|U|NA|||N|5||7||INDUCTION TREATMENT|1970-05-06|1960-03-11|||||1970-11-16||1962-07-25|N|1964-06-14
TRIAL STUDY 134XCP|LB|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|1||||TPRONP|NON-PHOSPHORYLATED TAU PROTEIN|||||||MDFI|||||||TRACE||10^6 IU/ML||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|THAWED|U|AMSLER GRID|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|NA|U|||NA|1||38||RUN-IN|1970-07-20|1970-11-14|||||1963-10-21||1966-12-15|U|1968-06-07
TRIAL STUDY 134XCP|LB|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|2||||PLSNCE|NEOPLASTIC PLASMA CELLS|||||||CMH2O*S/ML|||||||INVALID||FG||||LOW|NOT DONE||||MIXED VENOUS BLOOD|CLOTTED|N|CONTRAST ENHANCED X-RAY|HEPASCORE FORMULA||U|Y|N|N|||N|1||38||OBSERVATION|1963-11-12|1960-07-15|||||1970-04-30||1970-09-23|N|1964-05-07
TRIAL STUDY 134XCP|LB|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|1||||SPERMP|SPERMATOZOA, PROGRESSIVE|||||||PHERESIS UNIT|||||||INDETERMINATE||MMOL/L||||NORMAL|NOT DONE||||COLOSTRUM|ROOM TEMPERATURE|N|COLORIMETRY|ASH FIBROSURE FORMULA||Y|N|U|N|||N|2||58||BLINDED TREATMENT|1971-08-24|1961-11-08|||||1971-07-30||1962-09-11|N|1965-12-06
TRIAL STUDY 134XCP|LB|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|2||||HASIGMAB|HUMAN ANTI-SHEEP IGM ANTIBODY|||||||/LSQN|||||||POSITIVE||10^12/L||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|UNEXPECTED ODOR|N|DIPSTICK|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|N|NA|||U|2||58||OBSERVATION|1961-10-06|1965-03-08|||||1962-03-25||1964-05-24|N|1970-10-06
TRIAL STUDY 134XCP|LB|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|1||||TUDCA|TAUROURSODEOXYCHOLATE|||||||KV|||||||NEGATIVE||UG/DOSE||||LOW|NOT DONE||||BREAST MILK|AGGLUTINATED|NA|MRI|HEPASCORE FORMULA||NA|NA|Y|NA|||NA|3||39||SCREENING|1961-10-11|1973-03-11|||||1962-08-23||1962-07-24|NA|1972-08-15
TRIAL STUDY 134XCP|LB|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|2||||ALBEXR|ALBUMIN EXCRETION RATE|||||||PG/DL|||||||INDETERMINATE||MG/KG/H||||NORMAL|NOT DONE||||URINE SEDIMENT|CALCIFIED|NA|QUANTITATIVE COMPUTED TOMOGRAPHY|MDRD ENZYMATIC FORMULA||U|U|Y|U|||NA|3||39||RUN-IN|1972-02-25|1973-07-18|||||1969-02-26||1967-04-22|N|1967-12-20
TRIAL STUDY 134XCP|LB|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|1||||PROGEST|PROGESTERONE|||||||G/M2|||||||BORDERLINE||FT||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|FROZEN|U|ACCELERATOR MASS SPECTROMETRY|MDRD FORMULA||N|Y|U|N|||N|4||88||OBSERVATION|1960-03-06|1961-03-16|||||1969-11-12||1965-04-01|N|1961-02-09
TRIAL STUDY 134XCP|LB|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|2||||VITB1|THIAMINE|||||||STEPS|||||||INVALID||MG/L||||NORMAL|NOT DONE||||VITREOUS HUMOR|CALCIFIED|Y|U-HPLC/MS/MS|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|Y|U|||N|4||88||TREATMENT|1962-12-19|1971-04-02|||||1961-09-09||1960-08-27|U|1968-05-15
TRIAL STUDY 134XCP|LB|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|1||||CGADJMW|CHORIOGONADOTROPIN ADJ FOR MATERNAL WT|||||||PFU/ML|||||||INDETERMINATE||UG/CM2||||HIGH|NOT DONE||||DISCHARGE|PARAFFIN-EMBEDDED|Y|RULER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA||U|N|U|NA|||Y|5||7||CONTINUATION TREATMENT|1972-10-29|1969-10-22|||||1961-01-16||1961-01-29|Y|1960-01-06
TRIAL STUDY 134XCP|LB|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|2||||HASIGEAB|HUMAN ANTI-SHEEP IGE ANTIBODY|||||||S*KPA|||||||NEGATIVE||10^9 ORGANISMS/ML||||ABNORMAL|NOT DONE||||SKIN TISSUE|LACTESCENT|U|RAJI CELL RIA|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|Y|||N|5||7||BLINDED TREATMENT|1962-07-08|1965-07-18|||||1962-03-17||1962-10-16|NA|1971-09-27
TRIAL STUDY 134XCP|LB|172AB680-362D-488C-9DF1-E1C8E386980D|1||||RETIMRTC|MEDIUM ABSORPTION RETIC/RETICULOCYTES|||||||NEWTON|||||||INDETERMINATE||UU/DL||||ABNORMAL|NOT DONE||||CORD SERUM|CONTAMINATED|N|LANDOLT RING|CKD-EPI CREATININE FORMULA||Y|U|N|U|||U|1||38||BASELINE|1960-05-20|1963-08-10|||||1965-07-11||1967-08-20|U|1964-06-18
TRIAL STUDY 134XCP|LB|172AB680-362D-488C-9DF1-E1C8E386980D|2||||C3|COMPLEMENT C3|||||||10^7 CFU/ML|||||||BORDERLINE||NM||||LOW|NOT DONE||||PROSTATIC FLUID|AUTOLYZED|NA|CENTRIFUGATION|MDRD 5 VARIABLE FORMULA||Y|Y|Y|N|||Y|1||38||RUN-IN|1971-08-17|1964-04-14|||||1972-03-11||1971-06-13|N|1960-03-05
TRIAL STUDY 134XCP|LB|172AB680-362D-488C-9DF1-E1C8E386980D|1||||MYCEPIDX|MYELOID PROLIFERATION INDEX|||||||MG|||||||INVALID||10^4/L||||LOW|NOT DONE||||PLATELET|CONTAMINATED|N|MAGNETIC RESONANCE ANGIOGRAPHY|ASH FIBROSURE FORMULA||U|N|Y|NA|||U|2||58||RUN-IN|1961-02-10|1971-11-23|||||1969-10-15||1966-03-01|N|1966-03-31
TRIAL STUDY 134XCP|LB|172AB680-362D-488C-9DF1-E1C8E386980D|2||||GFRBSCYC|GFR FROM CYSTATIN C ADJUSTED FOR BSA|||||||CM|||||||BORDERLINE||DPM/MG||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|FRESH|Y|PET/SPECT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|NA|||N|2||58||WASHOUT|1969-02-05|1972-06-24|||||1964-07-25||1968-04-26|Y|1969-04-23
TRIAL STUDY 134XCP|LB|172AB680-362D-488C-9DF1-E1C8E386980D|1||||KLCFR|KAPPA LIGHT CHAIN, FREE|||||||ENZYME U/G HB|||||||POSITIVE||1/(S*KPA)||||LOW|NOT DONE||||PERSPIRATION|REFRIGERATED|N|VENTILATION PERFUSION LUNG SCAN|GMI MMOL/MOL FORMULA||NA|U|U|Y|||NA|3||39||OPEN LABEL TREATMENT|1965-11-30|1965-12-16|||||1967-11-17||1961-04-17|U|1967-08-16
TRIAL STUDY 134XCP|LB|172AB680-362D-488C-9DF1-E1C8E386980D|2||||RBCFRAG|ERYTHROCYTE FRAGMENT|||||||PHERESIS UNIT|||||||BORDERLINE||RFU||||LOW|NOT DONE||||PLEURAL FLUID|LACTESCENT|U|GIEMSA STAIN|MDRD 4 VARIABLE FORMULA||NA|NA|U|Y|||Y|3||39||SCREENING|1966-05-13|1967-11-15|||||1972-04-11||1966-11-07|N|1972-05-14
TRIAL STUDY 134XCP|LB|172AB680-362D-488C-9DF1-E1C8E386980D|1||||MORPHINE|MORPHINE|||||||GLOBULE|||||||BORDERLINE||KG/CM2||||NORMAL|NOT DONE||||LUNG SURFACTANT|AUTOLYZED|U|SNP ARRAY|FIBROTEST FORMULA||NA|Y|Y|U|||N|4||88||INDUCTION TREATMENT|1967-06-04|1966-10-19|||||1964-02-08||1973-04-25|NA|1966-04-24
TRIAL STUDY 134XCP|LB|172AB680-362D-488C-9DF1-E1C8E386980D|2||||HLADRB1|HLA DR BETA1 ANTIGEN|||||||CAL|||||||INDETERMINATE||/4.0 ML||||NORMAL|NOT DONE||||PLASMA|ICTERIC|NA|MALDI-TOF|MDRD 6 VARIABLE FORMULA||N|U|N|N|||Y|4||88||LONG-TERM FOLLOW-UP|1965-04-15|1961-12-22|||||1962-02-12||1970-07-10|NA|1963-08-04
TRIAL STUDY 134XCP|LB|172AB680-362D-488C-9DF1-E1C8E386980D|1||||C165903|WESTERN RAGWEED POLLEN IGG AB RAST SCORE|||||||PACK|||||||INDETERMINATE||LOG10 IU/ML||||ABNORMAL|NOT DONE||||NAIL|LIPEMIC|N|CRYOSCOPY|GMI % FORMULA||NA|U|Y|Y|||N|5||7||SCREENING|1969-01-22|1973-06-19|||||1964-11-28||1961-09-01|U|1967-10-28
TRIAL STUDY 134XCP|LB|172AB680-362D-488C-9DF1-E1C8E386980D|2||||APOB100|APOLIPOPROTEIN B100|||||||UMOL/L/MIN|||||||NEGATIVE||AMFI||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|CALCIFIED|N|POTENTIOMETRY|GMI MMOL/MOL FORMULA||NA|NA|U|Y|||Y|5||7||BLINDED TREATMENT|1967-02-25|1966-07-08|||||1967-12-10||1969-03-16|NA|1968-10-15
TRIAL STUDY 134XCP|LB|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|1||||ENA78|EPITH NEUTROPHIL-ACTIVATING PEPTIDE 78|||||||BREATHS/30S|||||||INDETERMINATE||ML/M2/DAY||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|GELLED|N|DUCTOGRAPHY|FIBROSIS 4 FORMULA||U|U|Y|U|||Y|1||38||RUN-IN|1969-04-29|1963-08-14|||||1969-09-30||1964-02-01|U|1972-09-26
TRIAL STUDY 134XCP|LB|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|2||||MECONIUM|MECONIUM|||||||INHALATION|||||||POSITIVE||VIRTUAL PIXEL||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|N|THERMAL IONIZATION MASS SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|N|U|||N|1||38||CONTINUATION TREATMENT|1972-09-13|1972-03-21|||||1962-06-26||1966-08-09|NA|1972-10-09
TRIAL STUDY 134XCP|LB|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|1||||ALS|ACID LABILE SUBUNIT|||||||ML/G/H|||||||TRACE||FARAD||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|REFRIGERATED|U|SNP ARRAY|CKD-EPI CYSTATIN C FORMULA||U|U|Y|N|||N|2||58||WASHOUT|1960-09-01|1971-02-23|||||1968-11-19||1966-01-02|N|1969-06-22
TRIAL STUDY 134XCP|LB|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|2||||YEASTBUD|YEAST BUDDING|||||||10^6 CFU/ML|||||||NEGATIVE||F||||NORMAL|NOT DONE||||BONE MARROW|LACTESCENT|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD ENZYMATIC FORMULA||NA|Y|Y|U|||NA|2||58||CONTINUATION TREATMENT|1962-04-19|1964-07-30|||||1965-12-29||1970-06-08|U|1969-05-26
TRIAL STUDY 134XCP|LB|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|1||||ASMACT|ALPHA-SMOOTH MUSCLE ACTIN|||||||MBP|||||||NEGATIVE||MIN||||NORMAL|NOT DONE||||ABSCESS FLUID|CALCIFIED|N|TEMPLATE INCISION METHOD|FIBROSIS 4 FORMULA||U|Y|N|NA|||Y|3||39||BLINDED TREATMENT|1961-10-13|1961-04-13|||||1967-12-09||1969-08-27|U|1971-08-08
TRIAL STUDY 134XCP|LB|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|2||||B2MCREAT|BETA-2 MICROGLOBULIN/CREATININE|||||||10^7 TCID 50/DOSE|||||||INVALID||PSI||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|SOLIDIFIED|NA|TOTAL BODY RADIOGRAPHY|CKD-EPI CREATININE FORMULA||NA|U|Y|Y|||Y|3||39||BASELINE|1962-07-25|1972-02-18|||||1964-02-18||1963-09-21|NA|1960-09-27
TRIAL STUDY 134XCP|LB|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|1||||ENDOTH1|ENDOTHELIN-1|||||||U/M2/DAY|||||||INDETERMINATE||UL/DOSE||||HIGH|NOT DONE||||SMEGMA|UNEXPECTED ODOR|Y|MANUAL CLOT DETECTION|GMI MMOL/MOL FORMULA||Y|Y|Y|N|||NA|4||88||CONTINUATION TREATMENT|1960-09-21|1960-09-10|||||1963-04-26||1966-06-27|N|1960-03-21
TRIAL STUDY 134XCP|LB|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|2||||RBCAGGLU|ERYTHROCYTE AGGLUTINATION|||||||WEBER|||||||INVALID||KM/H||||LOW|NOT DONE||||MUCUS|NON-HEMOLYZED|U|RULER MEASUREMENT METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|NA|Y|||NA|4||88||INDUCTION TREATMENT|1973-08-12|1971-12-21|||||1971-10-03||1972-02-24|N|1969-11-02
TRIAL STUDY 134XCP|LB|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|1||||OPG|OSTEOPROTEGERIN|||||||IU/DL|||||||NEGATIVE||ML/M2/MIN||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|FROZEN|U|DIFFUSION WEIGHTED MRI|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|Y|N|||U|5||7||INDUCTION TREATMENT|1965-07-19|1970-05-19|||||1969-03-10||1962-08-20|U|1960-09-23
TRIAL STUDY 134XCP|LB|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|2||||LDH3|LDH ISOENZYME 3|||||||UCI/L|||||||INVALID||JAR||||LOW|NOT DONE||||DISCHARGE|UNEXPECTED ODOR|NA|X-RAY FLUORESCENCE SPECTROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|Y|Y|||U|5||7||BASELINE|1968-04-24|1971-08-11|||||1965-05-29||1967-09-27|U|1970-12-09
TRIAL STUDY 134XCP|LB|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|1||||CHOL|CHOLESTEROL|||||||CFU/ML|||||||POSITIVE||U/G/DAY||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|NON-HEMOLYZED|Y|FORCED OSCILLATION TECHNIQUE|CKD-EPI FORMULA||U|Y|Y|N|||U|1||38||WASHOUT|1969-12-07|1972-11-09|||||1970-11-05||1972-04-11|Y|1968-03-19
TRIAL STUDY 134XCP|LB|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|2||||VITD23OH|VITAMIN D2 D3 25-OH|||||||DRINK|||||||BORDERLINE||U/KG/H||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|CONCENTRATED|U|LIGHT MICROSCOPY|MDRD FORMULA||Y|Y|U|U|||Y|1||38||WASHOUT|1968-08-25|1972-01-23|||||1968-07-15||1961-02-26|Y|1961-04-14
TRIAL STUDY 134XCP|LB|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|1||||ACYCRNTN|ACYLCARNITINE|||||||ML/MMHG/MIN/L|||||||INVALID||DPM/0.5 ML||||LOW|NOT DONE||||PLEURAL TISSUE|REFRIGERATED|NA|NUCLEIC ACID AMPLIFICATION TEST|MDRD FORMULA||U|U|N|N|||U|2||58||BASELINE|1972-11-03|1970-07-16|||||1970-08-13||1969-05-26|N|1960-05-14
TRIAL STUDY 134XCP|LB|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|2||||C165917|D. PTERONYSSINUS IGG AB RAST SCORE|||||||PPTH|||||||INVALID||100 IU/ML||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|HEMOLYZED|N|PHOTOMETRY|FIBROTEST FORMULA||Y|N|NA|NA|||Y|2||58||OBSERVATION|1964-12-28|1966-02-24|||||1972-11-11||1966-12-21|NA|1960-08-20
TRIAL STUDY 134XCP|LB|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|1||||FLRZPM|FLURAZEPAM|||||||DEG|||||||POSITIVE||MMHG/SEC||||NORMAL|NOT DONE||||HAIR FOLLICLE|GELLED|Y|IMMUNO-PET SCAN|MDRD 6 VARIABLE FORMULA||N|NA|N|U|||Y|3||39||RUN-IN|1966-11-24|1970-02-04|||||1970-05-27||1973-06-20|NA|1972-11-24
TRIAL STUDY 134XCP|LB|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|2||||NTELOP|N-TELOPEPTIDE|||||||BOLUS|||||||BORDERLINE||UG/G/DAY||||HIGH|NOT DONE||||FLUID|CALCIFIED|NA|ELECTROPHORESIS|MDRD 6 VARIABLE FORMULA||N|U|Y|U|||Y|3||39||FOLLOW-UP|1966-04-02|1968-08-06|||||1961-12-10||1971-02-05|U|1973-01-16
TRIAL STUDY 134XCP|LB|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|1||||V25HD2|25-HYDROXYVITAMIN D2|||||||UKAT|||||||NEGATIVE||FL||||LOW|NOT DONE||||VENOUS PLASMA|CONTAMINATED|NA|MICRODENSITOMETRY|GMI % FORMULA||U|N|N|NA|||NA|4||88||FOLLOW-UP|1973-07-25|1965-03-29|||||1971-02-21||1973-01-22|N|1967-06-09
TRIAL STUDY 134XCP|LB|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|2||||IRF|IMMATURE RETICULOCYTE FRACTION|||||||MG/M2|||||||TRACE||10^5/HPF||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|DRIED|U|FUNCTIONAL MRI|FIBROMETER FORMULA||Y|Y|Y|NA|||N|4||88||TREATMENT|1968-12-13|1967-08-03|||||1963-06-18||1970-03-16|Y|1962-09-30
TRIAL STUDY 134XCP|LB|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|1||||POLYERY|POLYCHROMATOPHILIC ERYTHROBLAST|||||||NKAT/L|||||||POSITIVE||IU/L||||NORMAL|NOT DONE||||VENOUS PLASMA|GELLED|U|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI FORMULA||U|NA|N|U|||Y|5||7||SCREENING|1961-11-27|1964-03-10|||||1966-12-28||1969-03-22|N|1969-02-20
TRIAL STUDY 134XCP|LB|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|2||||MYCEMIDX|MYELOID MATURATION INDEX|||||||PFU/ANIMAL|||||||NEGATIVE||DAMOL/L||||LOW|NOT DONE||||CAPILLARY PLASMA|LACTESCENT|Y|PET SCAN|MDRD FORMULA||U|NA|NA|U|||NA|5||7||RUN-IN|1972-08-29|1970-10-29|||||1962-06-08||1973-04-24|NA|1961-01-25
TRIAL STUDY 134XCP|LB|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|1||||C165921|SILVER BIRCH POLLEN IGE AB RAST SCORE|||||||VG/ML|||||||POSITIVE||MONTHS||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|CALCIFIED|NA|CHROMATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|N|U|||U|1||38||LONG-TERM FOLLOW-UP|1968-12-08|1964-08-16|||||1960-05-20||1971-10-24|U|1964-04-28
TRIAL STUDY 134XCP|LB|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|2||||ANCPNCAB|NEUTROPHIL CYTOPLASMIC AB, PERINUCLEAR|||||||AMOL|||||||POSITIVE||YEARS||||NORMAL|NOT DONE||||VITREOUS HUMOR|GELLED|N|POLYGRAPHY|FIBROTEST FORMULA||Y|N|U|N|||NA|1||38||BLINDED TREATMENT|1969-07-24|1973-08-01|||||1971-08-04||1973-03-23|U|1963-07-23
TRIAL STUDY 134XCP|LB|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|1||||BLSTIMLY|IMMUNOBLASTS/LYMPHOCYTES|||||||DB|||||||INVALID||ATM||||NORMAL|NOT DONE||||ARTERIAL BLOOD|DRIED|NA|ENZYMATIC COLORIMETRY|CKD-EPI CREATININE FORMULA||NA|Y|U|N|||U|2||58||BLINDED TREATMENT|1964-06-03|1966-12-03|||||1962-01-03||1972-07-06|N|1970-04-28
TRIAL STUDY 134XCP|LB|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|2||||LYMNSQE|LYMPHOCYTES/NON-SQUAM EPI CELLS|||||||UIU/DL|||||||TRACE||MPH||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|AUTOLYZED|U|SLOAN LETTER EYE CHART 100%|CKD-EPI CYSTATIN C FORMULA||U|NA|NA|N|||N|2||58||BLINDED TREATMENT|1966-03-16|1964-12-02|||||1964-04-23||1971-07-31|Y|1965-10-05
TRIAL STUDY 134XCP|LB|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|1||||IL1EXR|INTERLEUKIN 1 EXCRETION RATE|||||||UM/DAY|||||||BORDERLINE||CM||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|CLOTTED|U|MICROSCOPY|MDRD 4 VARIABLE FORMULA||Y|Y|U|N|||N|3||39||FOLLOW-UP|1960-11-08|1967-07-07|||||1970-10-23||1964-04-30|N|1964-05-30
TRIAL STUDY 134XCP|LB|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|2||||IGGCALBC|IGG CLEARANCE/ALBUMIN CLEARANCE|||||||PACK YEAR|||||||POSITIVE||LOG10 ELISA UNIT||||ABNORMAL|NOT DONE||||BILE|UNEXPECTED ODOR|Y|MULTIPLE BREATH WASHOUT|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|N|N|||NA|3||39||RUN-IN|1971-01-29|1960-05-26|||||1972-04-07||1960-10-27|N|1973-04-25
TRIAL STUDY 134XCP|LB|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|1||||COCAM|COCAINE METABOLITES|||||||ABSORBANCE U/ML|||||||BORDERLINE||VG/KG||||LOW|NOT DONE||||ARTERIAL BLOOD|SOLIDIFIED|U|SPIRAL CT SCAN WITHOUT CONTRAST|GMI MMOL/MOL FORMULA||U|U|Y|Y|||NA|4||88||SCREENING|1967-12-06|1971-02-27|||||1966-11-28||1960-11-11|N|1972-09-29
TRIAL STUDY 134XCP|LB|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|2||||LDLPSZ|LDL PARTICLE SIZE|||||||MM/MIN|||||||BORDERLINE||MMOL/S||||HIGH|NOT DONE||||ARTERIAL BLOOD|DRIED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA||N|NA|N|NA|||U|4||88||INDUCTION TREATMENT|1962-03-25|1963-11-04|||||1969-10-09||1961-09-04|U|1967-07-24
TRIAL STUDY 134XCP|LB|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|1||||NEUTBNE|NEUTROPHILS BAND FORM/ NEUTROPHILS|||||||AFU|||||||INVALID||BP||||HIGH|NOT DONE||||INFRANATANT, SERUM|DRIED|Y|ISHIHARA COLOR PLATES|NASH FIBROSURE FORMULA||Y|NA|Y|NA|||N|5||7||WASHOUT|1963-06-20|1969-01-19|||||1967-03-25||1968-04-14|U|1973-03-05
TRIAL STUDY 134XCP|LB|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|2||||LDLP|LDL PARTICLES|||||||AMU|||||||INDETERMINATE||CAL||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|AGGLUTINATED|Y|ELECTROCHEMILUMINESCENCE|GMI MMOL/MOL FORMULA||N|NA|NA|Y|||U|5||7||OPEN LABEL TREATMENT|1962-09-13|1965-08-15|||||1970-08-28||1968-09-28|N|1964-03-21
TRIAL STUDY 134XCP|LB|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|1||||IA2AB|INSULINOMA-ASSOCIATED PROTEIN 2 ANTIBODY|||||||ML/M2/MIN|||||||INDETERMINATE||UM/DAY||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LACTESCENT|U|MODIFIED ACID FAST STAIN|MDRD FORMULA||U|NA|N|U|||U|1||38||BLINDED TREATMENT|1972-04-22|1961-01-21|||||1969-10-07||1961-04-25|U|1962-06-03
TRIAL STUDY 134XCP|LB|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|2||||CCL8|CHEMOKINE (C-C MOTIF) LIGAND 8|||||||DISK|||||||POSITIVE||IMPLANT||||HIGH|NOT DONE||||EMOTIONAL TEAR|UNEXPECTED ODOR|N|TEST STRIP|FIBROSIS 4 FORMULA||U|N|NA|NA|||N|1||38||WASHOUT|1973-01-19|1965-07-17|||||1965-02-08||1970-07-08|N|1971-12-08
TRIAL STUDY 134XCP|LB|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|1||||IGG2|IMMUNOGLOBULIN G SUBCLASS 2|||||||KHZ|||||||INVALID||DIOPTER||||HIGH|NOT DONE||||AMNIOTIC FLUID|FRESH|N|ELASTOGRAPHY|MDRD FORMULA||Y|N|Y|NA|||Y|2||58||TREATMENT|1966-03-08|1967-01-29|||||1972-11-21||1964-06-17|N|1965-03-28
TRIAL STUDY 134XCP|LB|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|2||||CYSTATC|CYSTATIN C|||||||KM/H|||||||BORDERLINE||LB||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|CONTAMINATED|N|RULER MEASUREMENT METHOD|GMI MMOL/MOL FORMULA||NA|Y|N|N|||N|2||58||BLINDED TREATMENT|1961-03-07|1960-08-19|||||1963-09-14||1973-03-14|N|1964-03-27
TRIAL STUDY 134XCP|LB|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|1||||PEMAB|PEMPHIGOID ANTIBODIES|||||||UKAT/L|||||||INVALID||DIP||||NORMAL|NOT DONE||||BILE|SOLIDIFIED|N|MEDIASTINOSCOPY|FIBROSIS 4 FORMULA||NA|NA|N|Y|||N|3||39||CONTINUATION TREATMENT|1973-07-29|1973-01-09|||||1969-05-10||1973-05-05|Y|1967-03-08
TRIAL STUDY 134XCP|LB|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|2||||LCN2|LIPOCALIN-2|||||||USIEMENS|||||||NEGATIVE||TESLA||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONCENTRATED|U|SPECTROPHOTOMETRY|CKD-EPI CREATININE FORMULA||NA|NA|U|U|||Y|3||39||BASELINE|1964-06-11|1966-08-05|||||1969-05-03||1960-10-26|NA|1966-03-17
TRIAL STUDY 134XCP|LB|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|1||||POLYCHR|POLYCHROMASIA|||||||MOL/MG|||||||POSITIVE||ML/ANIMAL||||ABNORMAL|NOT DONE||||SEMINAL FLUID|LACTESCENT|U|HIGH LEVEL AMINOGLYCOSIDE SCREEN|NASH FIBROSURE FORMULA||Y|U|NA|NA|||U|4||88||OPEN LABEL TREATMENT|1965-07-02|1966-01-30|||||1967-03-08||1971-05-27|NA|1961-05-22
TRIAL STUDY 134XCP|LB|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|2||||NHMCE|NONHEMATIC CELLS|||||||PACKAGE|||||||NEGATIVE||MET||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|REFRIGERATED|Y|NUCLEIC ACID BASED METHOD|FIBROSIS 4 FORMULA||NA|Y|NA|Y|||N|4||88||BASELINE|1968-07-14|1962-04-07|||||1969-06-21||1973-05-17|NA|1967-10-30
TRIAL STUDY 134XCP|LB|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|1||||CANNABM|CANNABINOID METABOLITES|||||||KS|||||||POSITIVE||MM/2H||||ABNORMAL|NOT DONE||||URINE SEDIMENT|ICTERIC|U|IMMUNOPRECIPITATION|COCKCROFT-GAULT FORMULA||N|Y|N|NA|||N|5||7||OPEN LABEL TREATMENT|1970-02-09|1961-02-21|||||1973-04-07||1972-07-02|N|1965-09-29
TRIAL STUDY 134XCP|LB|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|2||||KRCYMGLE|MEGAKARYOCYTES/LEUKOCYTES|||||||APPLICATION|||||||BORDERLINE||CONTAINER||||HIGH|NOT DONE||||MONOCYTE|PARAFFIN-EMBEDDED|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|CKD-EPI CREATININE FORMULA||Y|N|N|U|||Y|5||7||FOLLOW-UP|1969-09-03|1971-05-25|||||1971-12-04||1971-10-31|Y|1961-01-01
TRIAL STUDY 134XCP|LB|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|1||||VITB1|THIAMINE|||||||G/MOL|||||||TRACE||BLOCKS||||NORMAL|NOT DONE||||CORD BLOOD|AUTOLYZED|Y|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|COCKCROFT-GAULT FORMULA||U|N|U|U|||NA|1||38||RUN-IN|1961-12-07|1966-06-21|||||1971-05-23||1965-10-15|U|1965-12-16
TRIAL STUDY 134XCP|LB|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|2||||APRIL|A PROLIFERATION-INDUCING LIGAND|||||||PL|||||||INVALID||MILE||||HIGH|NOT DONE||||MONOCYTE|LACTESCENT|NA|LC-FL|MDRD 5 VARIABLE FORMULA||NA|U|U|N|||Y|1||38||SCREENING|1961-08-23|1971-08-22|||||1963-08-04||1971-07-24|U|1963-08-15
TRIAL STUDY 134XCP|LB|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|1||||PRGNENLN|PREGNENOLONE|||||||WAFER|||||||POSITIVE||BQ||||HIGH|NOT DONE||||EMESIS|CALCIFIED|N|ETDRS EYE CHART|ASH FIBROSURE FORMULA||Y|NA|Y|U|||NA|2||58||WASHOUT|1966-02-02|1962-10-22|||||1963-03-06||1966-09-20|U|1960-01-06
TRIAL STUDY 134XCP|LB|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|2||||APTTLAS|LUPUS ANTICOAGULANT SENSITIVE APTT|||||||IU/G|||||||TRACE||COPIES/UL||||LOW|NOT DONE||||URINE|CALCIFIED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA||N|Y|NA|NA|||N|2||58||INDUCTION TREATMENT|1969-02-18|1963-06-14|||||1973-01-10||1970-04-13|N|1965-08-17
TRIAL STUDY 134XCP|LB|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|1||||LLCFR|LAMBDA LIGHT CHAIN, FREE|||||||10^8/L|||||||BORDERLINE||FFU||||HIGH|NOT DONE||||REFLEX TEAR|UNEXPECTED ODOR|N|CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI CREATININE FORMULA||Y|Y|U|U|||U|3||39||RUN-IN|1973-05-08|1973-03-21|||||1969-09-21||1967-06-11|N|1965-02-17
TRIAL STUDY 134XCP|LB|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|2||||IGF1|INSULIN-LIKE GROWTH FACTOR-1|||||||CM|||||||INVALID||USEC||||LOW|NOT DONE||||SPUTUM|UNEXPECTED ODOR|U|FORCED OSCILLATION TECHNIQUE|GMI % FORMULA||N|U|U|Y|||N|3||39||TREATMENT|1963-12-12|1969-10-07|||||1965-07-27||1966-12-18|Y|1972-08-25
TRIAL STUDY 134XCP|LB|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|1||||CHOLATE|CHOLATE|||||||NMOL/DAY|||||||NEGATIVE||BOLUS||||HIGH|NOT DONE||||INFRANATANT, SERUM|ICTERIC|Y|SEQUENCING|MDRD ENZYMATIC FORMULA||U|Y|Y|N|||Y|4||88||CONTINUATION TREATMENT|1960-09-03|1965-11-04|||||1968-06-27||1966-11-13|N|1969-11-27
TRIAL STUDY 134XCP|LB|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|2||||RETI|RETICULOCYTES|||||||10^6 CFU/ML|||||||BORDERLINE||U/M2/H||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|GELLED|NA|RADIAL IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA||U|Y|Y|N|||N|4||88||LONG-TERM FOLLOW-UP|1973-02-03|1964-09-02|||||1968-09-05||1963-05-01|N|1966-07-07
TRIAL STUDY 134XCP|LB|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|1||||YEASTHYP|YEAST HYPHAE|||||||IU/G|||||||BORDERLINE||/MBP||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|THAWED|Y|HEMAGGLUTINATION INHIBITION ASSAY|MDRD ENZYMATIC FORMULA||U|NA|Y|NA|||NA|5||7||BLINDED TREATMENT|1962-01-01|1966-04-27|||||1963-03-17||1971-09-20|U|1961-03-26
TRIAL STUDY 134XCP|LB|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|2||||VITB12|VITAMIN B12|||||||U/KG/DAY|||||||NEGATIVE||NMOL||||LOW|NOT DONE||||PLATELET RICH PLASMA|ICTERIC|U|PERIPHERAL ANGIOGRAPHY|CKD-EPI FORMULA||U|N|NA|Y|||N|5||7||INDUCTION TREATMENT|1960-07-01|1970-08-12|||||1965-10-03||1960-10-31|U|1968-02-01
TRIAL STUDY 134XCP|LB|740D80F1-8BD5-4409-8087-E48F94363362|1||||INTLK31|INTERLEUKIN 31|||||||BQ/KG|||||||POSITIVE||PKAT/L||||LOW|NOT DONE||||GASTRIC FLUID|LIPEMIC|N|ELECTROMYOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|N|N|||N|1||38||LONG-TERM FOLLOW-UP|1964-03-14|1960-05-11|||||1972-04-15||1964-08-14|Y|1966-12-20
TRIAL STUDY 134XCP|LB|740D80F1-8BD5-4409-8087-E48F94363362|2||||HLAMSC|HLA MISMATCH COUNT|||||||10^6/L|||||||BORDERLINE||U/M2/MIN||||LOW|NOT DONE||||SERUM OR PLASMA|AUTOLYZED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|FIBROSIS 4 FORMULA||NA|NA|NA|U|||N|1||38||INDUCTION TREATMENT|1972-06-03|1972-12-09|||||1973-02-15||1967-07-04|NA|1963-03-02
TRIAL STUDY 134XCP|LB|740D80F1-8BD5-4409-8087-E48F94363362|1||||SECRETIN|SECRETIN|||||||CONTAINER|||||||NEGATIVE||LINEAR FT*LB||||ABNORMAL|NOT DONE||||MECONIUM|AGGLUTINATED|U|PLAQUE REDUCTION NEUTRALIZATION ASSAY|CKD-EPI CYSTATIN C FORMULA||NA|U|NA|U|||U|2||58||LONG-TERM FOLLOW-UP|1971-11-08|1969-04-28|||||1960-03-08||1972-11-21|U|1968-05-17
TRIAL STUDY 134XCP|LB|740D80F1-8BD5-4409-8087-E48F94363362|2||||FLT3|FMS-LIKE RECEPTOR TYROSINE KINASE 3|||||||BU/ML|||||||POSITIVE||MCI/KG||||HIGH|NOT DONE||||ABSCESS FLUID|LIPEMIC|N|ELECTROCHEMILUMINESCENCE|FIBROTEST FORMULA||N|U|NA|U|||Y|2||58||OBSERVATION|1961-04-26|1964-01-14|||||1962-04-25||1963-03-05|NA|1971-03-29
TRIAL STUDY 134XCP|LB|740D80F1-8BD5-4409-8087-E48F94363362|1||||ERCEPPOL|ERYTHROID PROLIFERATION POOL|||||||UG/L DDU|||||||BORDERLINE||%||||NORMAL|NOT DONE||||PLEURAL FLUID|ROOM TEMPERATURE|U|DIRECT SEQUENCING|FIBROSIS 4 FORMULA||Y|Y|N|Y|||Y|3||39||TREATMENT|1973-09-06|1970-11-15|||||1964-08-24||1968-09-09|Y|1961-03-29
TRIAL STUDY 134XCP|LB|740D80F1-8BD5-4409-8087-E48F94363362|2||||NTELOP|N-TELOPEPTIDE|||||||G/KG/DAY|||||||BORDERLINE||MMU/ML||||HIGH|NOT DONE||||AMNIOTIC FLUID|PARAFFIN-EMBEDDED|N|FISH|COCKCROFT-GAULT FORMULA||Y|N|U|U|||N|3||39||BASELINE|1971-10-25|1971-01-27|||||1964-04-07||1968-01-16|U|1962-11-10
TRIAL STUDY 134XCP|LB|740D80F1-8BD5-4409-8087-E48F94363362|1||||NRP1|NEUROPILIN-1|||||||UMOL/H/MMOL|||||||POSITIVE||FT2||||LOW|NOT DONE||||MUSCLE TISSUE|LACTESCENT|NA|CALCOFLUOR WHITE STAIN|CKD-EPI CYSTATIN C FORMULA||NA|N|U|NA|||U|4||88||WASHOUT|1972-01-14|1961-07-29|||||1973-02-09||1969-12-23|Y|1963-11-10
TRIAL STUDY 134XCP|LB|740D80F1-8BD5-4409-8087-E48F94363362|2||||MONOCE|MONOCYTES/TOTAL CELLS|||||||NG/DL|||||||INVALID||USEC||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONTAMINATED|NA|INTERRUPTER TECHNIQUE|MDRD 6 VARIABLE FORMULA||U|Y|Y|N|||U|4||88||CONTINUATION TREATMENT|1968-08-24|1970-04-11|||||1970-07-22||1973-05-05|U|1966-12-18
TRIAL STUDY 134XCP|LB|740D80F1-8BD5-4409-8087-E48F94363362|1||||PC3MPSAM|PCA3 MRNA/PSA MRNA|||||||FMOL/L/SEC|||||||INVALID||NMOL/L/H||||ABNORMAL|NOT DONE||||RETICULOCYTES|AGGLUTINATED|N|SPIROMETRY|FIBROMETER FORMULA||NA|Y|U|Y|||NA|5||7||TREATMENT|1967-05-01|1963-03-31|||||1972-09-24||1966-11-12|N|1961-03-05
TRIAL STUDY 134XCP|LB|740D80F1-8BD5-4409-8087-E48F94363362|2||||UNSPCE|UNSPECIFIED CELLS|||||||BOTTLE|||||||POSITIVE||10^5/L||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|ROOM TEMPERATURE|N|CELL OF ORIGIN ASSAY|COCKCROFT-GAULT FORMULA||N|Y|NA|N|||N|5||7||LONG-TERM FOLLOW-UP|1963-04-30|1961-03-05|||||1963-04-27||1964-01-20|N|1972-08-30
TRIAL STUDY 134XCP|LB|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|1||||TNFSR2|SOLUBLE TNF RECEPTOR TYPE II|||||||BU/ML|||||||INVALID||GBQ/MG||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|FRESH|N|QUANTITATIVE COMPUTED TOMOGRAPHY|CKD-EPI CREATININE FORMULA||U|N|Y|U|||U|1||38||OBSERVATION|1971-11-29|1972-01-18|||||1968-10-02||1966-02-28|U|1971-05-16
TRIAL STUDY 134XCP|LB|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|2||||SSTR2|SOMATOSTATIN RECEPTOR TYPE 2|||||||UL|||||||INVALID||NMOL/G||||ABNORMAL|NOT DONE||||CALCULUS|CALCIFIED|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 6 VARIABLE FORMULA||Y|NA|N|U|||NA|1||38||BLINDED TREATMENT|1961-08-06|1967-06-14|||||1973-05-31||1965-09-03|N|1973-03-29
TRIAL STUDY 134XCP|LB|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|1||||CD161LY|CD161/LYMPHOCYTES|||||||G|||||||TRACE||MMOL/L||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|PARAFFIN-EMBEDDED|U|TURBIDIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|U|N|||Y|2||58||SCREENING|1963-05-01|1962-10-19|||||1966-10-26||1962-12-17|NA|1969-02-03
TRIAL STUDY 134XCP|LB|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|2||||IAA5OHCR|5-HYDROXYINDOLEACETIC ACID/CREATININE|||||||CIGARETTE|||||||INVALID||PSI||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|UNEXPECTED ODOR|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|NA|||N|2||58||CONTINUATION TREATMENT|1964-08-15|1967-08-27|||||1963-02-28||1973-02-18|NA|1972-11-19
TRIAL STUDY 134XCP|LB|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|1||||NEUTLE|NEUTROPHILS/LEUKOCYTES|||||||GTT|||||||NEGATIVE||MIN*MG/ML||||NORMAL|NOT DONE||||ABSCESS FLUID|SOLIDIFIED|N|NEXT GENERATION TARGETED SEQUENCING|FIBROTEST FORMULA||NA|Y|U|Y|||NA|3||39||CONTINUATION TREATMENT|1968-08-11|1963-01-03|||||1966-04-27||1966-02-19|N|1968-12-21
TRIAL STUDY 134XCP|LB|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|2||||THR|THREONINE|||||||NMOL BCE/MMOL|||||||INVALID||10^6/L||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|CONTAMINATED|U|IMMUNOPRECIPITATION|FIBROSIS 4 FORMULA||NA|NA|N|U|||NA|3||39||OBSERVATION|1960-08-30|1962-12-22|||||1970-06-22||1964-05-01|U|1964-04-04
TRIAL STUDY 134XCP|LB|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|1||||LEPTO|LEPTOCYTES|||||||YD|||||||POSITIVE||GLOBULE||||NORMAL|NOT DONE||||EXPIRED AIR|DRIED|N|HPLC/MS|NASH FIBROSURE FORMULA||Y|Y|NA|NA|||N|4||88||OBSERVATION|1962-10-10|1973-05-20|||||1969-03-15||1962-01-20|Y|1964-07-07
TRIAL STUDY 134XCP|LB|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|2||||GRANULIN|GRANULIN|||||||U/M2/MIN|||||||BORDERLINE||10^9/G||||NORMAL|NOT DONE||||PROSTATIC FLUID|CONTAMINATED|Y|PATHOLOGICAL EVALUATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|NA|U|||Y|4||88||BASELINE|1966-06-20|1962-02-06|||||1960-05-30||1964-04-16|U|1965-12-18
TRIAL STUDY 134XCP|LB|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|1||||RETIH|HIGH ABSORPTION RETICULOCYTES|||||||DRINK|||||||TRACE||10^6 IU/ML||||ABNORMAL|NOT DONE||||STOOL|CONTAMINATED|NA|IODINE STAIN|MDRD 4 VARIABLE FORMULA||Y|Y|U|Y|||NA|5||7||WASHOUT|1963-01-02|1968-02-01|||||1970-10-29||1970-02-21|U|1967-08-01
TRIAL STUDY 134XCP|LB|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|2||||PCP|PHENCYCLIDINE|||||||U/KG/MIN|||||||INDETERMINATE||C||||HIGH|NOT DONE||||RETICULOCYTES|CONCENTRATED|Y|DYNAMOMETRY|MDRD 6 VARIABLE FORMULA||N|N|NA|U|||N|5||7||RUN-IN|1963-11-11|1963-05-21|||||1963-12-23||1967-11-23|U|1973-02-27
TRIAL STUDY 134XCP|LB|12AD3838-F986-4A27-8AEE-59C387988B0F|1||||GLOBB2PT|BETA-2 GLOBULIN/TOTAL PROTEIN|||||||LOG EID 50/DOSE|||||||TRACE||MV/SEC||||LOW|NOT DONE||||PLATELET RICH PLASMA|ROOM TEMPERATURE|Y|COLORIMETRY|GMI MMOL/MOL FORMULA||Y|U|U|N|||NA|1||38||OBSERVATION|1964-12-31|1968-05-02|||||1965-12-18||1963-05-04|U|1966-09-28
TRIAL STUDY 134XCP|LB|12AD3838-F986-4A27-8AEE-59C387988B0F|2||||CHOLATE|CHOLATE|||||||NMOL|||||||TRACE||10^8 PFU||||HIGH|NOT DONE||||CELL PELLET|CLOTTED|N|NEPHELOMETRY|HEPASCORE FORMULA||NA|N|N|N|||NA|1||38||SCREENING|1972-12-04|1960-10-21|||||1973-04-10||1960-02-29|U|1968-10-06
TRIAL STUDY 134XCP|LB|12AD3838-F986-4A27-8AEE-59C387988B0F|1||||MITOM2AB|MITOCHONDRIAL M2 ANTIBODY|||||||UG/KG/MIN|||||||POSITIVE||LOG10 CFU/G||||HIGH|NOT DONE||||PLEURAL FLUID|LACTESCENT|Y|RAJI CELL EIA|MDRD ENZYMATIC FORMULA||Y|U|NA|NA|||NA|2||58||CONTINUATION TREATMENT|1960-03-30|1963-10-12|||||1965-09-09||1961-03-11|Y|1961-08-12
TRIAL STUDY 134XCP|LB|12AD3838-F986-4A27-8AEE-59C387988B0F|2||||AMYLASEP|AMYLASE, PANCREATIC|||||||S^-1(%O2)^-1|||||||TRACE||FT2||||LOW|NOT DONE||||CERUMEN|ICTERIC|N|HPLC-FL|FIBROMETER FORMULA||U|NA|Y|U|||U|2||58||SCREENING|1972-06-05|1967-08-26|||||1972-10-14||1969-08-24|U|1966-06-02
TRIAL STUDY 134XCP|LB|12AD3838-F986-4A27-8AEE-59C387988B0F|1||||BLAST|BLASTS|||||||DEG|||||||INDETERMINATE||MOSM/KG||||LOW|NOT DONE||||ABSCESS FLUID|FRESH|N|DXA SCAN|GMI % FORMULA||U|N|NA|N|||N|3||39||BLINDED TREATMENT|1970-03-14|1971-09-07|||||1970-03-26||1973-02-25|N|1964-11-03
TRIAL STUDY 134XCP|LB|12AD3838-F986-4A27-8AEE-59C387988B0F|2||||BLASTLE|BLASTS/LEUKOCYTES|||||||KA_U/DL|||||||NEGATIVE||UGEQ||||LOW|NOT DONE||||CALCULUS|FRESH|U|DUCTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|Y|||NA|3||39||BASELINE|1973-08-24|1972-07-07|||||1972-11-29||1968-04-07|Y|1962-09-20
TRIAL STUDY 134XCP|LB|12AD3838-F986-4A27-8AEE-59C387988B0F|1||||VITDAT|1, 25-DIHYDROXYVITAMIN D|||||||TAMPON|||||||BORDERLINE||UL/DOSE||||ABNORMAL|NOT DONE||||ISOLATE|AGGLUTINATED|U|CELL BASED BIOASSAY|MDRD 4 VARIABLE FORMULA||Y|U|NA|U|||Y|4||88||LONG-TERM FOLLOW-UP|1966-09-24|1964-03-31|||||1963-04-23||1971-07-05|Y|1969-11-30
TRIAL STUDY 134XCP|LB|12AD3838-F986-4A27-8AEE-59C387988B0F|2||||SCCAG|SQUAMOUS CELL CARCINOMA ANTIGEN|||||||MG/DOSE|||||||BORDERLINE||FMOL||||HIGH|NOT DONE||||BASAL TEAR|GELLED|U|ORCHIDOMETERY|FIBROSIS 4 FORMULA||NA|N|NA|N|||NA|4||88||RUN-IN|1962-11-07|1970-04-28|||||1972-05-28||1964-08-10|NA|1966-10-15
TRIAL STUDY 134XCP|LB|12AD3838-F986-4A27-8AEE-59C387988B0F|1||||VITA|VITAMIN A|||||||SCM|||||||INVALID||PMOL/DL||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|SOLIDIFIED|U|PELLI-ROBSON EYE CHART|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|NA|U|||Y|5||7||BLINDED TREATMENT|1962-02-06|1960-06-27|||||1965-11-02||1970-09-18|NA|1972-01-13
TRIAL STUDY 134XCP|LB|12AD3838-F986-4A27-8AEE-59C387988B0F|2||||SAHOMC|S-ADENOSYLHOMOCYSTEINE|||||||ATM|||||||INDETERMINATE||UMOL/MIN||||NORMAL|NOT DONE||||ADIPOSE TISSUE|CONTAMINATED|N|APPLANATION TONOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|N|Y|N|||N|5||7||OPEN LABEL TREATMENT|1972-01-30|1972-03-15|||||1961-03-12||1967-09-15|Y|1972-01-12
TRIAL STUDY 134XCP|LB|441F1A21-6350-478A-9719-75B053182B78|1||||CD40|CD40|||||||HPA|||||||INDETERMINATE||/H||||ABNORMAL|NOT DONE||||SEMEN|THAWED|NA|GC/MS-CI|ASH FIBROSURE FORMULA||Y|NA|U|Y|||NA|1||38||INDUCTION TREATMENT|1966-10-08|1971-10-18|||||1961-03-16||1969-06-24|NA|1962-07-21
TRIAL STUDY 134XCP|LB|441F1A21-6350-478A-9719-75B053182B78|2||||C147278|GLYCINE MAX ANTIGEN IGE ANTIBODY|||||||NEBULE|||||||INVALID||L||||HIGH|NOT DONE||||RETICULOCYTES|LACTESCENT|U|PALPATION|HEPASCORE FORMULA||Y|N|U|NA|||Y|1||38||INDUCTION TREATMENT|1960-12-28|1965-09-30|||||1966-09-03||1965-04-16|Y|1964-01-01
TRIAL STUDY 134XCP|LB|441F1A21-6350-478A-9719-75B053182B78|1||||TRACP5B|TARTRATE-RESISTANT ACID PHOSPHATASE 5B|||||||LOG10 CFU/G|||||||BORDERLINE||NKAT/L||||HIGH|NOT DONE||||INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|N|MALDI|GMI % FORMULA||N|U|Y|Y|||Y|2||58||CONTINUATION TREATMENT|1966-10-20|1969-05-29|||||1970-04-11||1964-07-14|NA|1969-08-17
TRIAL STUDY 134XCP|LB|441F1A21-6350-478A-9719-75B053182B78|2||||SMUSCGAB|SMOOTH MUSCLE IGG ANTIBODY|||||||L|||||||BORDERLINE||DMOL||||LOW|NOT DONE||||BUFFY COAT|ROOM TEMPERATURE|N|DIFFUSION TENSOR MRI|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|U|||U|2||58||OBSERVATION|1961-10-17|1972-08-13|||||1969-12-26||1963-06-25|Y|1969-10-19
TRIAL STUDY 134XCP|LB|441F1A21-6350-478A-9719-75B053182B78|1||||IGG|IMMUNOGLOBULIN G|||||||DAYS/MONTH|||||||BORDERLINE||GENEQ/ML||||NORMAL|NOT DONE||||CELL PELLET|CLOTTED|Y|MODIFIED ACID FAST STAIN|HEPASCORE FORMULA||N|N|U|Y|||U|3||39||OBSERVATION|1967-09-17|1973-07-21|||||1970-10-30||1962-01-06|Y|1968-06-28
TRIAL STUDY 134XCP|LB|441F1A21-6350-478A-9719-75B053182B78|2||||IGG3|IMMUNOGLOBULIN G SUBCLASS 3|||||||L/MIN/M2|||||||TRACE||ML/SEC/1.73M2||||LOW|NOT DONE||||FLUID|ICTERIC|U|SLOAN LETTER EYE CHART 1.25%|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|NA|N|||NA|3||39||INDUCTION TREATMENT|1961-08-12|1964-08-09|||||1968-10-03||1966-03-27|NA|1964-12-21
TRIAL STUDY 134XCP|LB|441F1A21-6350-478A-9719-75B053182B78|1||||ROULEAUX|ROULEAUX FORMATION|||||||UG|||||||INVALID||MG/M2/DAY||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|CALCIFIED|Y|FLUORIMETRY|FIBROSIS 4 FORMULA||U|Y|N|U|||NA|4||88||OPEN LABEL TREATMENT|1966-09-25|1963-09-03|||||1971-10-20||1965-01-21|N|1972-04-28
TRIAL STUDY 134XCP|LB|441F1A21-6350-478A-9719-75B053182B78|2||||HIST2AAB|HISTONE 2A ANTIBODY|||||||UKAT/10^12 RBC|||||||BORDERLINE||MU||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|CALCIFIED|Y|PET/CT SCAN WITHOUT CONTRAST|MDRD FORMULA||N|U|NA|U|||Y|4||88||BLINDED TREATMENT|1965-03-06|1963-12-11|||||1972-01-20||1970-05-08|Y|1970-05-05
TRIAL STUDY 134XCP|LB|441F1A21-6350-478A-9719-75B053182B78|1||||GSTY1|GLUTATHIONE S-TRANSFERASE, Y1|||||||MCI/KG|||||||NEGATIVE||TRANSDUCING UNIT||||HIGH|NOT DONE||||SALIVA|REFRIGERATED|N|MYELOPEROXIDASE STAIN|CKD-EPI FORMULA||N|N|Y|NA|||U|5||7||INDUCTION TREATMENT|1964-10-21|1965-04-30|||||1970-05-12||1966-12-23|NA|1966-01-06
TRIAL STUDY 134XCP|LB|441F1A21-6350-478A-9719-75B053182B78|2||||GLUC|GLUCOSE|||||||MG|||||||NEGATIVE||CI/KG||||ABNORMAL|NOT DONE||||REFLEX TEAR|SOLIDIFIED|U|FLUORESCENT ENZYME IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||Y|N|N|N|||U|5||7||BLINDED TREATMENT|1962-07-05|1960-03-27|||||1968-02-21||1969-04-14|NA|1962-01-16
TRIAL STUDY 134XCP|LB|A69520E2-01A5-4CBC-AFC9-00324531779F|1||||CH100|COMPLEMENT CH100|||||||GRAVITATIONAL UNIT|||||||NEGATIVE||PPTH||||HIGH|NOT DONE||||MECONIUM|REFRIGERATED|NA|MUGA|MDRD ENZYMATIC FORMULA||NA|N|U|Y|||N|1||38||BLINDED TREATMENT|1964-05-14|1971-10-06|||||1972-06-19||1970-11-11|Y|1966-10-10
TRIAL STUDY 134XCP|LB|A69520E2-01A5-4CBC-AFC9-00324531779F|2||||FACTVA|FACTOR V ACTIVITY|||||||ML/BREATH|||||||BORDERLINE||10^3 ORGANISMS||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|U|FLUORESCEIN STAIN|CKD-EPI FORMULA||Y|U|N|NA|||Y|1||38||FOLLOW-UP|1968-11-22|1960-07-30|||||1961-12-06||1969-10-13|NA|1960-02-16
TRIAL STUDY 134XCP|LB|A69520E2-01A5-4CBC-AFC9-00324531779F|1||||TTGIGMAB|TISSUE TRANSGLUTAMINASE IGM ANTIBODY|||||||MG2/DL2|||||||BORDERLINE||10^6 DNA COPIES/ML||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|LIPEMIC|U|WESTERGREN|CKD-EPI CREATININE FORMULA||Y|NA|U|N|||N|2||58||CONTINUATION TREATMENT|1971-11-14|1969-02-02|||||1967-05-07||1973-02-10|N|1960-03-15
TRIAL STUDY 134XCP|LB|A69520E2-01A5-4CBC-AFC9-00324531779F|2||||FATBODOV|FAT BODIES, OVAL|||||||ML/SEC/1.73M2|||||||INDETERMINATE||DL||||LOW|NOT DONE||||LOCHIA|CONTAMINATED|N|MUGA|NASH FIBROSURE FORMULA||U|N|N|U|||N|2||58||TREATMENT|1970-02-13|1966-09-22|||||1960-09-20||1964-05-18|U|1962-02-04
TRIAL STUDY 134XCP|LB|A69520E2-01A5-4CBC-AFC9-00324531779F|1||||EPIN|EPINEPHRINE|||||||ENZYME U/G HB|||||||BORDERLINE||10^9/G||||LOW|NOT DONE||||EXPIRED AIR|HEMOLYZED|NA|PULSE OXIMETRY|FIBROMETER FORMULA||NA|Y|N|U|||Y|3||39||TREATMENT|1966-05-30|1962-08-06|||||1964-12-21||1972-01-23|NA|1964-10-05
TRIAL STUDY 134XCP|LB|A69520E2-01A5-4CBC-AFC9-00324531779F|2||||HDLPL|HDL PHOSPHOLIPID|||||||10^12/L|||||||INVALID||UIU/DL||||HIGH|NOT DONE||||NAIL|CONTAMINATED|NA|ETDRS EYE CHART|ASH FIBROSURE FORMULA||NA|Y|Y|Y|||NA|3||39||BASELINE|1961-03-07|1961-05-13|||||1968-01-28||1967-04-25|U|1960-03-17
TRIAL STUDY 134XCP|LB|A69520E2-01A5-4CBC-AFC9-00324531779F|1||||NEUTGT|GIANT NEUTROPHILS|||||||ENZYME U/L|||||||NEGATIVE||CL||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|ROOM TEMPERATURE|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA||U|NA|N|U|||NA|4||88||SCREENING|1960-03-19|1964-12-29|||||1960-03-29||1964-10-28|N|1970-12-26
TRIAL STUDY 134XCP|LB|A69520E2-01A5-4CBC-AFC9-00324531779F|2||||CA125AG|CANCER ANTIGEN 125|||||||UL|||||||INDETERMINATE||GY/H||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|LIPEMIC|Y|AUDIOMETRY|FIBROTEST FORMULA||U|Y|U|U|||Y|4||88||TREATMENT|1965-06-18|1970-05-08|||||1961-06-27||1972-07-09|N|1967-09-30
TRIAL STUDY 134XCP|LB|A69520E2-01A5-4CBC-AFC9-00324531779F|1||||LMBDLC|LAMBDA LIGHT CHAIN|||||||MG/KG/H|||||||BORDERLINE||AMPULE||||LOW|NOT DONE||||SUPERNATANT, PLASMA|CLOTTED|NA|MASS SPECTROMETRY|GMI MMOL/MOL FORMULA||NA|Y|Y|N|||U|5||7||WASHOUT|1965-04-05|1970-12-24|||||1970-09-16||1964-04-16|NA|1967-10-05
TRIAL STUDY 134XCP|LB|A69520E2-01A5-4CBC-AFC9-00324531779F|2||||ABNCE|ABNORMAL CELLS|||||||SEC|||||||TRACE||H*%||||NORMAL|NOT DONE||||SKIN TISSUE|FRESH|U|CLIP SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|N|||N|5||7||SCREENING|1972-08-24|1969-01-07|||||1973-04-10||1968-12-28|N|1972-06-01
TRIAL STUDY 134XCP|LB|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|1||||PMYCECE|PROLIFERATING MYELOID CELLS/TOTAL CELLS|||||||10^6 COPIES/ML|||||||TRACE||ML/G/MIN||||HIGH|NOT DONE||||HAIR|AUTOLYZED|Y|FORCED OSCILLATION TECHNIQUE|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|N|||N|1||38||TREATMENT|1963-10-10|1965-09-27|||||1963-08-19||1960-08-06|Y|1971-12-11
TRIAL STUDY 134XCP|LB|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|2||||KL6|KREBS VON DEN LUNGEN-6|||||||MG/DL|||||||NEGATIVE||ML/CAGE/WK||||ABNORMAL|NOT DONE||||HAIR|AUTOLYZED|U|FLUOROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|N|U|||NA|1||38||OPEN LABEL TREATMENT|1963-07-25|1963-02-09|||||1969-09-25||1972-04-26|U|1971-08-08
TRIAL STUDY 134XCP|LB|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|1||||ANABASN|ANABASINE|||||||PELLET|||||||INDETERMINATE||U/KG||||LOW|NOT DONE||||DIALYSIS FLUID|CALCIFIED|U|CONTRAST ENHANCED PET SCAN|FIBROTEST FORMULA||NA|Y|Y|Y|||NA|2||58||TREATMENT|1962-06-26|1966-07-30|||||1966-03-18||1970-08-20|Y|1970-06-14
TRIAL STUDY 134XCP|LB|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|2||||MICROCY|MICROCYTES|||||||GBQ/G|||||||POSITIVE||U/G||||ABNORMAL|NOT DONE||||PLATELET|GELLED|NA|IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CYSTATIN C FORMULA||U|N|U|Y|||U|2||58||BASELINE|1960-08-12|1960-09-14|||||1963-01-22||1963-01-29|U|1970-01-28
TRIAL STUDY 134XCP|LB|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|1||||GLBCREAT|GLOBULIN/CREATININE|||||||IU/KG/H|||||||NEGATIVE||M2||||ABNORMAL|NOT DONE||||CORD BLOOD|HEMOLYZED|Y|GC/MS|CKD-EPI FORMULA||U|NA|U|Y|||N|3||39||BASELINE|1969-06-17|1973-04-04|||||1968-01-25||1967-12-15|N|1968-03-30
TRIAL STUDY 134XCP|LB|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|2||||NRDZPM|NORDAZEPAM|||||||TUBERCULIN UNIT|||||||BORDERLINE||APL U||||ABNORMAL|NOT DONE||||BILE|LACTESCENT|NA|ELECTROMYOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|Y|NA|NA|||N|3||39||BASELINE|1964-04-04|1970-03-09|||||1967-08-20||1973-07-12|U|1972-03-21
TRIAL STUDY 134XCP|LB|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|1||||BLASTRUB|RUBRIBLAST|||||||UG/MIN|||||||POSITIVE||F||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|AUTOLYZED|U|AURAMINE STAIN|FIBROMETER FORMULA||NA|Y|NA|N|||U|4||88||BASELINE|1964-05-19|1964-04-25|||||1966-04-12||1972-03-20|U|1965-02-14
TRIAL STUDY 134XCP|LB|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|2||||HAHA|HUMAN ANTI-HUMAN ANTIBODY|||||||MG/H|||||||NEGATIVE||INHALATION||||NORMAL|NOT DONE||||ARTERIAL BLOOD|REFRIGERATED|Y|GC/MS/MS|MDRD FORMULA||Y|Y|N|Y|||NA|4||88||OBSERVATION|1967-01-07|1960-01-09|||||1971-11-02||1966-11-16|U|1973-04-09
TRIAL STUDY 134XCP|LB|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|1||||C130107|WEED MIX POLLEN ANTIGEN IGG ANTIBODY|||||||GY/MIN|||||||INDETERMINATE||MMHG||||LOW|NOT DONE||||LYMPH|CONTAMINATED|U|TRIPLE-PHASE SPIRAL CT SCAN|CKD-EPI CREATININE FORMULA||NA|Y|Y|NA|||Y|5||7||SCREENING|1973-01-28|1968-01-30|||||1973-09-01||1962-04-14|U|1963-05-27
TRIAL STUDY 134XCP|LB|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|2||||MONOBL|MONOBLASTS|||||||BOX|||||||INVALID||NEWTON||||HIGH|NOT DONE||||SPERMATOZOON|NON-HEMOLYZED|Y|ELECTROGASTROGRAPHY|GMI % FORMULA||U|Y|NA|NA|||U|5||7||OPEN LABEL TREATMENT|1962-03-01|1962-05-02|||||1962-05-23||1972-10-28|U|1966-11-01
TRIAL STUDY 134XCP|LB|C361B153-4623-4F03-9D81-8316B1046F35|1||||CMPK2|CYTIDINE-URIDINE MONOPHOSPHATE KINASE 2|||||||/MM2|||||||TRACE||/2000 RBC||||HIGH|NOT DONE||||STOOL|UNEXPECTED ODOR|Y|OBSERVATION|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|N|N|||U|1||38||WASHOUT|1960-07-24|1965-03-24|||||1969-07-04||1964-02-24|U|1965-06-21
TRIAL STUDY 134XCP|LB|C361B153-4623-4F03-9D81-8316B1046F35|2||||GGT|GAMMA GLUTAMYL TRANSFERASE|||||||MAMP|||||||BORDERLINE||M/SEC2||||ABNORMAL|NOT DONE||||PERSPIRATION|FRESH|N|FISH|MDRD ENZYMATIC FORMULA||N|N|Y|N|||Y|1||38||LONG-TERM FOLLOW-UP|1960-11-19|1973-03-18|||||1963-09-29||1971-03-02|NA|1964-04-30
TRIAL STUDY 134XCP|LB|C361B153-4623-4F03-9D81-8316B1046F35|1||||BJPROT|BENCE-JONES PROTEIN|||||||DAYS|||||||INVALID||COPIES/ML||||LOW|NOT DONE||||EMOTIONAL TEAR|NON-HEMOLYZED|NA|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|CKD-EPI FORMULA||N|U|NA|U|||U|2||58||RUN-IN|1971-06-25|1964-11-15|||||1969-10-27||1964-04-29|N|1972-10-09
TRIAL STUDY 134XCP|LB|C361B153-4623-4F03-9D81-8316B1046F35|2||||COPEP|COPEPTIN|||||||UKAT/L|||||||NEGATIVE||CD/M2||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|LIPEMIC|U|MOUSE PROTECTION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|Y|N|||Y|2||58||RUN-IN|1967-05-03|1966-02-08|||||1969-05-25||1963-10-23|U|1970-07-15
TRIAL STUDY 134XCP|LB|C361B153-4623-4F03-9D81-8316B1046F35|1||||C130072|BIRCH POLLEN IGE|||||||COPIES/UG|||||||TRACE||ML/S/M2||||HIGH|NOT DONE||||PERSPIRATION|CLOTTED|U|NEXT GENERATION SEQUENCING|GMI MMOL/MOL FORMULA||Y|NA|Y|N|||U|3||39||FOLLOW-UP|1960-05-28|1964-09-10|||||1973-04-11||1972-07-31|N|1965-09-02
TRIAL STUDY 134XCP|LB|C361B153-4623-4F03-9D81-8316B1046F35|2||||EPITCE|TRANSITIONAL EPITHELIAL CELLS|||||||FG|||||||INVALID||CM/S||||LOW|NOT DONE||||LYSATE|CALCIFIED|Y|GC/MS-CI|FIBROTEST FORMULA||NA|N|U|Y|||N|3||39||SCREENING|1969-12-18|1969-09-12|||||1972-09-30||1965-03-19|Y|1960-10-07
TRIAL STUDY 134XCP|LB|C361B153-4623-4F03-9D81-8316B1046F35|1||||IA5OHEXR|5-HYDROXYINDOLEACETICACID EXCRETION RATE|||||||H*%|||||||TRACE||PSEC||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|CONCENTRATED|U|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|Y|NA|||NA|4||88||OPEN LABEL TREATMENT|1966-09-09|1970-01-13|||||1968-09-26||1960-02-20|U|1973-07-27
TRIAL STUDY 134XCP|LB|C361B153-4623-4F03-9D81-8316B1046F35|2||||FACTXIII|FACTOR XIII|||||||C|||||||INVALID||MMHG/SEC||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|ICTERIC|N|POLYMERASE CHAIN REACTION|ASH FIBROSURE FORMULA||NA|U|N|Y|||Y|4||88||WASHOUT|1964-12-03|1965-08-18|||||1961-12-15||1964-04-19|N|1962-12-27
TRIAL STUDY 134XCP|LB|C361B153-4623-4F03-9D81-8316B1046F35|1||||HRYCECE|HAIRY CELLS/TOTAL CELLS|||||||LB|||||||NEGATIVE||ATM||||NORMAL|NOT DONE||||VITREOUS HUMOR|FROZEN|Y|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|FIBROTEST FORMULA||NA|NA|U|NA|||N|5||7||WASHOUT|1971-07-18|1961-12-20|||||1964-04-04||1973-08-06|U|1966-08-16
TRIAL STUDY 134XCP|LB|C361B153-4623-4F03-9D81-8316B1046F35|2||||HAIRYCE|HAIRY CELLS|||||||CIGAR|||||||POSITIVE||10^6/HPF||||ABNORMAL|NOT DONE||||PLASMA|UNEXPECTED ODOR|N|SISH|FIBROSIS 4 FORMULA||Y|U|N|NA|||NA|5||7||BLINDED TREATMENT|1970-01-14|1966-08-22|||||1962-03-29||1968-05-04|NA|1966-10-10
TRIAL STUDY 134XCP|LB|8FF0A93C-26D1-49E9-853F-B063A958FE1E|1||||LVFBRSC|LIVER FIBROSIS SCORE|||||||DAGU/ML|||||||INVALID||ENZYME U/M2||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|UNEXPECTED ODOR|U|CELLULOSE TAPE|FIBROSIS 4 FORMULA||N|N|N|NA|||Y|1||38||BLINDED TREATMENT|1970-09-23|1971-05-12|||||1962-10-24||1966-02-27|U|1967-01-07
TRIAL STUDY 134XCP|LB|8FF0A93C-26D1-49E9-853F-B063A958FE1E|2||||MMP1|MATRIX METALLOPROTEINASE 1|||||||BQ/UG|||||||TRACE||UMOL/MG/MIN||||HIGH|NOT DONE||||ALVEOLAR AIR|AGGLUTINATED|N|EEG|FIBROSIS 4 FORMULA||Y|N|NA|N|||U|1||38||FOLLOW-UP|1970-02-06|1973-04-04|||||1972-05-15||1966-07-23|Y|1970-06-21
TRIAL STUDY 134XCP|LB|8FF0A93C-26D1-49E9-853F-B063A958FE1E|1||||CAION|CALCIUM, IONIZED|||||||1/(S*KPA)|||||||INDETERMINATE||MG/CM2||||NORMAL|NOT DONE||||ADIPOSE TISSUE|AGGLUTINATED|U|FLUORIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|Y|U|||NA|2||58||FOLLOW-UP|1968-06-17|1972-03-01|||||1964-05-15||1961-02-21|N|1968-11-17
TRIAL STUDY 134XCP|LB|8FF0A93C-26D1-49E9-853F-B063A958FE1E|2||||ARGSAC|ARGININOSUCCINIC ACID|||||||EID 50/ML|||||||BORDERLINE||UEQ||||NORMAL|NOT DONE||||ARTERIAL BLOOD|ROOM TEMPERATURE|Y|MALDI-TOF|MDRD 5 VARIABLE FORMULA||Y|Y|NA|NA|||U|2||58||FOLLOW-UP|1970-06-12|1970-01-24|||||1964-06-29||1965-02-07|Y|1962-12-07
TRIAL STUDY 134XCP|LB|8FF0A93C-26D1-49E9-853F-B063A958FE1E|1||||CONDUCTU|URINE CONDUCTIVITY|||||||RING|||||||POSITIVE||UG/ANIMAL||||LOW|NOT DONE||||SUPERNATANT, SERUM|REFRIGERATED|N|MS/MS|FIBROSIS 4 FORMULA||N|Y|N|U|||Y|3||39||WASHOUT|1972-05-17|1964-01-29|||||1972-12-19||1963-06-07|N|1971-09-04
TRIAL STUDY 134XCP|LB|8FF0A93C-26D1-49E9-853F-B063A958FE1E|2||||FGF21|FIBROBLAST GROWTH FACTOR 21|||||||U/KG|||||||TRACE||MCI||||ABNORMAL|NOT DONE||||DISCHARGE|ROOM TEMPERATURE|U|MAMMOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||U|Y|U|NA|||Y|3||39||INDUCTION TREATMENT|1973-04-12|1962-08-03|||||1972-07-26||1968-09-21|Y|1963-08-22
TRIAL STUDY 134XCP|LB|8FF0A93C-26D1-49E9-853F-B063A958FE1E|1||||TESTOSFR|TESTOSTERONE, FREE|||||||U/L|||||||BORDERLINE||UMOL/DL||||HIGH|NOT DONE||||SALIVA|UNEXPECTED ODOR|N|MOUSE PROTECTION ASSAY|MDRD 5 VARIABLE FORMULA||U|NA|N|N|||Y|4||88||LONG-TERM FOLLOW-UP|1971-10-29|1973-04-30|||||1960-05-11||1969-08-06|NA|1969-12-22
TRIAL STUDY 134XCP|LB|8FF0A93C-26D1-49E9-853F-B063A958FE1E|2||||IFI44L|INTERFERON-INDUCED PROTEIN 44-LIKE|||||||UV*SEC|||||||NEGATIVE||MCI||||LOW|NOT DONE||||CAPILLARY BLOOD|DRIED|U|IMMUNORADIOMETRIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|N|NA|||N|4||88||OPEN LABEL TREATMENT|1960-05-02|1965-06-11|||||1964-04-22||1963-10-08|U|1971-02-17
TRIAL STUDY 134XCP|LB|8FF0A93C-26D1-49E9-853F-B063A958FE1E|1||||VLDLTCT|VLDL TRIGLYCERIDE + CHYLOMICRON TRIGLYCERIDE|||||||G/ANIMAL|||||||NEGATIVE||%(W/W)||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|REFRIGERATED|NA|ISHIHARA COLOR PLATES|FIBROSIS 4 FORMULA||N|NA|U|N|||Y|5||7||BASELINE|1964-10-05|1965-02-11|||||1962-03-02||1965-01-01|NA|1964-07-27
TRIAL STUDY 134XCP|LB|8FF0A93C-26D1-49E9-853F-B063A958FE1E|2||||FVAAC|FACTOR V ACTIVITY ACTUAL/CONTROL|||||||UMOL/L/H|||||||TRACE||10^7 CFU/ML||||NORMAL|NOT DONE||||SERUM OR PLASMA|CLOTTED|NA|DYNAMIC CONTRAST ENHANCED MRI|GMI MMOL/MOL FORMULA||Y|U|NA|Y|||Y|5||7||BLINDED TREATMENT|1960-07-18|1962-02-17|||||1972-06-08||1967-01-14|N|1963-11-17
TRIAL STUDY 134XCP|LB|31D8814B-5542-4540-B955-24410D42F1EF|1||||FLT3L|FMS-LIKE TYROSINE KINASE 3 LIGAND|||||||10^7 CFU|||||||INDETERMINATE||KG/CM2||||LOW|NOT DONE||||MECONIUM|HEMOLYZED|Y|WRIGHT-GIEMSA STAIN|GMI MMOL/MOL FORMULA||U|N|U|NA|||U|1||38||RUN-IN|1967-12-25|1965-11-25|||||1966-08-12||1965-10-13|NA|1971-02-24
TRIAL STUDY 134XCP|LB|31D8814B-5542-4540-B955-24410D42F1EF|2||||HVA|HOMOVANILLIC ACID|||||||PPTH|||||||NEGATIVE||DDU||||NORMAL|NOT DONE||||DERMAL TISSUE|CONTAMINATED|N|PHOTOMETRY|MDRD FORMULA||U|NA|U|Y|||N|1||38||OBSERVATION|1969-05-05|1972-11-10|||||1960-12-07||1965-02-05|U|1966-06-05
TRIAL STUDY 134XCP|LB|31D8814B-5542-4540-B955-24410D42F1EF|1||||UBQN|UBIQUITIN PROTEIN|||||||L/MIN|||||||NEGATIVE||H*%||||NORMAL|NOT DONE||||DERMAL TISSUE|ROOM TEMPERATURE|NA|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 6 VARIABLE FORMULA||NA|NA|N|U|||N|2||58||CONTINUATION TREATMENT|1960-09-21|1969-10-04|||||1969-08-05||1968-11-08|U|1972-01-20
TRIAL STUDY 134XCP|LB|31D8814B-5542-4540-B955-24410D42F1EF|2||||BLSTRBCE|RUBRIBLAST/TOTAL CELLS|||||||CI/L|||||||INDETERMINATE||CIGAR||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED|N|NUCLEAR RADIOLOGY|MDRD 6 VARIABLE FORMULA||NA|N|Y|U|||N|2||58||FOLLOW-UP|1961-10-29|1963-09-18|||||1972-01-23||1966-10-24|NA|1963-03-15
TRIAL STUDY 134XCP|LB|31D8814B-5542-4540-B955-24410D42F1EF|1||||ADSDNA|ANTI-DOUBLE STRANDED DNA|||||||NMOL/L|||||||BORDERLINE||10^4 CFU||||LOW|NOT DONE||||AQUEOUS HUMOR|NON-HEMOLYZED|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|CKD-EPI FORMULA||Y|U|Y|NA|||N|3||39||CONTINUATION TREATMENT|1971-01-31|1960-04-03|||||1968-12-02||1971-03-15|NA|1970-07-15
TRIAL STUDY 134XCP|LB|31D8814B-5542-4540-B955-24410D42F1EF|2||||TBG|THYROXINE BINDING GLOBULIN|||||||MPA|||||||BORDERLINE||DIOPTER||||HIGH|NOT DONE||||CAPILLARY PLASMA|AGGLUTINATED|N|MEDIASTINOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|U|NA|||U|3||39||CONTINUATION TREATMENT|1963-09-23|1967-12-20|||||1972-09-28||1962-12-24|NA|1964-09-05
TRIAL STUDY 134XCP|LB|31D8814B-5542-4540-B955-24410D42F1EF|1||||BCEFNCTN|BETA-CELL FUNCTION|||||||CONTAINER|||||||NEGATIVE||POUCH||||NORMAL|NOT DONE||||CELL PELLET|PARAFFIN-EMBEDDED|N|DIRECT SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|NA|N|||U|4||88||INDUCTION TREATMENT|1973-07-16|1972-09-30|||||1965-10-18||1967-09-08|N|1963-12-10
TRIAL STUDY 134XCP|LB|31D8814B-5542-4540-B955-24410D42F1EF|2||||T4FR|THYROXINE, FREE|||||||MEQ/UG|||||||BORDERLINE||HEP||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|LIPEMIC|N|CAPILLARY ELECTROPHORESIS|CKD-EPI CYSTATIN C FORMULA||NA|NA|N|Y|||N|4||88||INDUCTION TREATMENT|1961-10-05|1966-12-10|||||1969-03-31||1963-11-02|Y|1963-07-25
TRIAL STUDY 134XCP|LB|31D8814B-5542-4540-B955-24410D42F1EF|1||||MOCYCELE|MONOCYTOID CELLS/LEUKOCYTES|||||||UG/DAY|||||||BORDERLINE||IU/DAY||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED|NA|CONTRAST ENHANCED PET/CT SCAN|FIBROSIS 4 FORMULA||Y|NA|Y|NA|||N|5||7||INDUCTION TREATMENT|1964-01-01|1967-01-12|||||1973-03-20||1966-05-30|N|1960-08-19
TRIAL STUDY 134XCP|LB|31D8814B-5542-4540-B955-24410D42F1EF|2||||ACYCRNTN|ACYLCARNITINE|||||||10^8 PFU|||||||NEGATIVE||MEQ/UG||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|NON-HEMOLYZED|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|HEPASCORE FORMULA||NA|Y|U|U|||NA|5||7||CONTINUATION TREATMENT|1965-08-22|1963-02-27|||||1960-02-23||1969-05-10|NA|1968-07-13
TRIAL STUDY 134XCP|LB|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|1||||PYOCYTES|PYOCYTES|||||||HOMEOPATHIC DILUTION|||||||INVALID||ML/CAGE/DAY||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|ROOM TEMPERATURE|NA|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|NA|NA|||N|1||38||BLINDED TREATMENT|1970-03-01|1960-07-31|||||1973-07-20||1961-01-11|U|1972-05-24
TRIAL STUDY 134XCP|LB|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|2||||C165886|WHITE OAK POLLEN IGE AB RAST SCORE|||||||L/H|||||||POSITIVE||IU/KG/H||||HIGH|NOT DONE||||ERYTHROCYTES|AUTOLYZED|NA|SPECT/CT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|NA|||Y|1||38||BASELINE|1965-08-14|1972-10-20|||||1973-08-14||1967-07-17|U|1971-01-26
TRIAL STUDY 134XCP|LB|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|1||||LYMAT|LYMPHOCYTES ATYPICAL|||||||PPTH|||||||NEGATIVE||UG/L/H||||LOW|NOT DONE||||BLOOD|THAWED|U|FLUORESCENT IMMUNOASSAY|GMI % FORMULA||U|U|NA|U|||U|2||58||RUN-IN|1972-07-25|1963-03-24|||||1961-06-17||1966-09-20|Y|1969-08-25
TRIAL STUDY 134XCP|LB|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|2||||CYP2C9A|CYTOCHROME P450 2C9 ACTIVITY|||||||M3|||||||TRACE||FL||||HIGH|NOT DONE||||CORD BLOOD|ROOM TEMPERATURE|NA|SPECULAR MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||Y|U|U|U|||N|2||58||TREATMENT|1969-04-26|1961-11-17|||||1961-10-06||1973-06-29|N|1969-05-21
TRIAL STUDY 134XCP|LB|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|1||||INTLK26|INTERLEUKIN 26|||||||U/KG/MIN|||||||POSITIVE||APL U||||NORMAL|NOT DONE||||GASTRIC CONTENTS|FROZEN|NA|SNP ARRAY|FIBROMETER FORMULA||U|Y|N|Y|||NA|3||39||TREATMENT|1964-07-14|1973-04-28|||||1970-12-31||1960-04-21|NA|1964-11-11
TRIAL STUDY 134XCP|LB|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|2||||ICAIGGAB|ISLET CELL CYTOPLASMIC IGG ANTIBODY|||||||ENZYME U/M2|||||||INVALID||TABLET||||HIGH|NOT DONE||||BASAL TEAR|PARAFFIN-EMBEDDED|N|PET/CT SCAN WITHOUT CONTRAST|GMI MMOL/MOL FORMULA||Y|U|U|Y|||U|3||39||WASHOUT|1972-10-07|1970-06-22|||||1964-01-05||1968-02-03|U|1971-04-19
TRIAL STUDY 134XCP|LB|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|1||||ANIONG3|ANION GAP 3|||||||AMP|||||||INDETERMINATE||10^10/L||||HIGH|NOT DONE||||LEUKOCYTE|FROZEN|U|CRYOSCOPY|FIBROTEST FORMULA||N|Y|N|U|||U|4||88||OBSERVATION|1965-03-11|1964-08-07|||||1966-06-06||1960-10-23|N|1963-08-20
TRIAL STUDY 134XCP|LB|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|2||||BLSTNMCE|NORMOBLASTS/TOTAL CELLS|||||||G/MOL|||||||INVALID||G||||LOW|NOT DONE||||CALCULUS|ROOM TEMPERATURE|N|LYMPHANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||N|U|Y|Y|||N|4||88||BASELINE|1969-06-04|1970-11-11|||||1972-05-31||1973-01-30|U|1972-05-16
TRIAL STUDY 134XCP|LB|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|1||||LDLPATT|LDL SUBTYPE PATTERN|||||||G/DAY|||||||INDETERMINATE||MMOL||||LOW|NOT DONE||||INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|FIBROTEST FORMULA||Y|Y|Y|NA|||N|5||7||SCREENING|1971-09-05|1960-11-25|||||1965-12-17||1960-08-13|Y|1965-02-06
TRIAL STUDY 134XCP|LB|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|2||||ACRNCRNF|ACYLCARNITINE/CARNITINE, FREE|||||||MV*MIN|||||||NEGATIVE||PG/DL||||HIGH|NOT DONE||||BUFFY COAT|GELLED|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|GMI MMOL/MOL FORMULA||U|U|N|Y|||U|5||7||CONTINUATION TREATMENT|1967-04-28|1964-05-15|||||1964-04-21||1967-10-30|NA|1963-03-04
TRIAL STUDY 134XCP|LB|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|1||||T3|TRIIODOTHYRONINE|||||||CAPSULE|||||||NEGATIVE||LOG10 ELISA UNIT||||HIGH|NOT DONE||||INFRANATANT, PLASMA|PARAFFIN-EMBEDDED|Y|SMEAR|MDRD ENZYMATIC FORMULA||U|Y|NA|Y|||U|1||38||OBSERVATION|1967-02-01|1964-08-10|||||1963-05-12||1962-02-05|NA|1963-01-20
TRIAL STUDY 134XCP|LB|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|2||||GADAB|GLUTAMIC ACID DECARBOXYLASE ANTIBODY|||||||CP|||||||TRACE||TSP||||LOW|NOT DONE||||PLEURAL TISSUE|CONTAMINATED|NA|HPLC-UV|CKD-EPI FORMULA||Y|U|U|NA|||N|1||38||TREATMENT|1971-04-04|1964-01-27|||||1968-03-24||1963-06-18|NA|1969-06-20
TRIAL STUDY 134XCP|LB|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|1||||SCL70AB|SCL-70 ANTIBODY|||||||10^3/HPF|||||||POSITIVE||10^5/HPF||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|N|TRYPAN BLUE STAIN|ASH FIBROSURE FORMULA||NA|NA|Y|N|||Y|2||58||FOLLOW-UP|1968-01-20|1971-10-14|||||1961-03-04||1966-12-02|U|1961-10-04
TRIAL STUDY 134XCP|LB|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|2||||PCNAG|PROLIFERATING CELL NUCLEAR ANTIGEN|||||||BQ|||||||BORDERLINE||HEP||||NORMAL|NOT DONE||||CALCULUS|FRESH|N|MAPH|CKD-EPI CYSTATIN C FORMULA||U|N|N|NA|||U|2||58||OPEN LABEL TREATMENT|1968-11-19|1972-05-28|||||1962-07-15||1963-01-05|NA|1963-11-13
TRIAL STUDY 134XCP|LB|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|1||||GBP2|GUANYLATE BINDING PROTEIN 2|||||||10^9 ORGANISMS/G|||||||BORDERLINE||UMOL/L||||HIGH|NOT DONE||||PLATELET RICH PLASMA|NON-HEMOLYZED|U|HPLC-UV|CKD-EPI CYSTATIN C FORMULA||U|Y|Y|Y|||N|3||39||BLINDED TREATMENT|1960-09-07|1963-12-08|||||1960-01-04||1963-02-06|NA|1973-08-24
TRIAL STUDY 134XCP|LB|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|2||||C130114|INDUSTRIAL MIX ANTIGEN IGE ANTIBODY|||||||UV2|||||||BORDERLINE||CY/CM||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|FRESH|Y|NUCLEIC ACID HYBRIDIZATION|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|N|N|||N|3||39||WASHOUT|1972-06-30|1965-06-08|||||1965-05-05||1969-12-05|NA|1964-10-30
TRIAL STUDY 134XCP|LB|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|1||||CLNZPM|CLONAZEPAM|||||||PIXELS/CM|||||||TRACE||DRINK||||HIGH|NOT DONE||||VENOUS BLOOD|NON-HEMOLYZED|U|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|FIBROTEST FORMULA||U|N|N|NA|||NA|4||88||CONTINUATION TREATMENT|1967-11-05|1971-10-03|||||1966-02-11||1971-08-17|NA|1970-08-28
TRIAL STUDY 134XCP|LB|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|2||||FATACFRS|FREE FATTY ACID, SATURATED|||||||/LSQN|||||||NEGATIVE||AMU||||HIGH|NOT DONE||||DIALYSIS FLUID|REFRIGERATED|U|MODIFIED ACID FAST STAIN|MDRD 5 VARIABLE FORMULA||NA|N|U|U|||NA|4||88||RUN-IN|1972-01-18|1966-10-28|||||1962-05-04||1963-12-21|U|1960-12-25
TRIAL STUDY 134XCP|LB|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|1||||ECT|ECARIN CLOTTING TIME|||||||KG/CM2|||||||INDETERMINATE||BLOCKS||||LOW|NOT DONE||||AMNIOTIC FLUID|FROZEN|Y|SISH|MDRD ENZYMATIC FORMULA||N|Y|Y|Y|||Y|5||7||TREATMENT|1961-05-19|1965-02-25|||||1963-01-11||1967-02-25|U|1969-11-28
TRIAL STUDY 134XCP|LB|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|2||||GLOBB1BP|BETA-1 GLOBULIN/BETA PROTEIN|||||||UKAT/10^12 RBC|||||||NEGATIVE||ML/100G/MIN||||HIGH|NOT DONE||||PROSTATIC FLUID|GELLED|Y|OPTICAL DENSITY MEASUREMENT|GMI MMOL/MOL FORMULA||U|N|U|NA|||Y|5||7||TREATMENT|1970-06-01|1967-08-27|||||1966-11-08||1972-10-09|U|1973-03-10
TRIAL STUDY 134XCP|LB|15BFC17A-2F55-441A-AB99-76D270D62367|1||||TIMM10|TRANSLOCASE INNER MITOCHONDRIAL MEMBR 10|||||||GY|||||||TRACE||IU/G HB||||ABNORMAL|NOT DONE||||CERUMEN|FROZEN|U|LIQUID SCINTILLATION COUNTING|CKD-EPI FORMULA||U|U|Y|U|||Y|1||38||FOLLOW-UP|1969-08-25|1973-01-26|||||1965-09-09||1972-10-24|N|1965-10-26
TRIAL STUDY 134XCP|LB|15BFC17A-2F55-441A-AB99-76D270D62367|2||||MMP1|MATRIX METALLOPROTEINASE 1|||||||COULOMB|||||||BORDERLINE||UG/L||||LOW|NOT DONE||||PERSPIRATION|THAWED|Y|DIGITAL PCR ARRAY|GMI MMOL/MOL FORMULA||Y|N|U|U|||NA|1||38||BLINDED TREATMENT|1970-02-26|1962-04-24|||||1971-02-16||1969-04-21|N|1962-07-19
TRIAL STUDY 134XCP|LB|15BFC17A-2F55-441A-AB99-76D270D62367|1||||CAFFEINE|CAFFEINE|||||||10^9/DOSE|||||||TRACE||CMH2O*S/ML||||NORMAL|NOT DONE||||CORD BLOOD|ROOM TEMPERATURE|NA|PHASE-CONTRAST MRI|GMI MMOL/MOL FORMULA||NA|Y|U|Y|||N|2||58||RUN-IN|1968-09-28|1964-01-13|||||1964-10-09||1964-06-23|Y|1972-08-19
TRIAL STUDY 134XCP|LB|15BFC17A-2F55-441A-AB99-76D270D62367|2||||MIP1B|MACROPHAGE INFLAMMATORY PROTEIN 1 BETA|||||||CMHG|||||||INVALID||DRUM||||ABNORMAL|NOT DONE||||SERUM|GELLED|Y|ANGIOGRAPHY|GMI % FORMULA||U|Y|U|Y|||N|2||58||INDUCTION TREATMENT|1972-02-20|1970-11-06|||||1969-08-02||1969-06-22|Y|1967-02-02
TRIAL STUDY 134XCP|LB|15BFC17A-2F55-441A-AB99-76D270D62367|1||||GLOBB1|BETA-1 GLOBULIN|||||||ML/MIN/MMHG|||||||POSITIVE||TAMPON||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|ICTERIC|NA|MAGNETIC RESONANCE ANGIOGRAPHY|GMI % FORMULA||N|Y|N|Y|||N|3||39||WASHOUT|1971-12-20|1963-04-29|||||1961-03-25||1970-07-16|Y|1972-10-14
TRIAL STUDY 134XCP|LB|15BFC17A-2F55-441A-AB99-76D270D62367|2||||LDLOXAB|OXIDIZED LDL CHOLESTEROL ANTIBODY|||||||TUBERCULIN UNIT|||||||INDETERMINATE||BQ/MG||||NORMAL|NOT DONE||||HAIR|CLOTTED|U|TRANSTHORACIC ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||N|U|U|N|||N|3||39||TREATMENT|1964-01-08|1961-05-22|||||1970-03-08||1961-03-30|Y|1973-01-10
TRIAL STUDY 134XCP|LB|15BFC17A-2F55-441A-AB99-76D270D62367|1||||IOTCLR|IOTHALAMATE CLEARANCE|||||||M/SEC2|||||||BORDERLINE||U/G HB||||NORMAL|NOT DONE||||ISOLATE|SOLIDIFIED|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|ASH FIBROSURE FORMULA||Y|Y|NA|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1961-05-14|1972-07-04|||||1962-12-26||1973-06-20|N|1968-01-20
TRIAL STUDY 134XCP|LB|15BFC17A-2F55-441A-AB99-76D270D62367|2||||CA72_4AG|CANCER ANTIGEN 72-4|||||||MCI|||||||INDETERMINATE||SFC/10^6 PBMC||||ABNORMAL|NOT DONE||||PLASMA|UNEXPECTED ODOR|N|WESTERGREN|MDRD ENZYMATIC FORMULA||NA|Y|Y|NA|||U|4||88||BLINDED TREATMENT|1960-10-08|1961-03-30|||||1961-04-16||1963-07-27|NA|1971-05-26
TRIAL STUDY 134XCP|LB|15BFC17A-2F55-441A-AB99-76D270D62367|1||||PROPOX|PROPOXYPHENE|||||||MMHG|||||||BORDERLINE||NMOL/L/MIN||||LOW|NOT DONE||||AMNIOTIC FLUID|REFRIGERATED|Y|OSCILLOMETRY|MDRD 4 VARIABLE FORMULA||Y|Y|N|NA|||N|5||7||SCREENING|1962-12-25|1968-01-13|||||1962-01-07||1967-01-09|NA|1972-03-28
TRIAL STUDY 134XCP|LB|15BFC17A-2F55-441A-AB99-76D270D62367|2||||MUCTHR|MUCOUS THREADS|||||||UGEQ/L|||||||BORDERLINE||UIU/DL||||NORMAL|NOT DONE||||GASTRIC FLUID|CONCENTRATED|U|FLOW MICROSCOPY|HEPASCORE FORMULA||NA|N|N|U|||Y|5||7||RUN-IN|1966-07-05|1963-12-30|||||1966-08-27||1970-12-03|Y|1967-03-12
TRIAL STUDY 134XCP|LB|CA231D77-1A1F-49F3-8172-06709A1330B7|1||||CRYSTALS|CRYSTALS|||||||KIU|||||||NEGATIVE||PL||||NORMAL|NOT DONE||||RETICULOCYTES|NON-HEMOLYZED|N|CHROMOGENIC ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|Y|U|||U|1||38||FOLLOW-UP|1961-09-29|1966-11-05|||||1961-02-01||1966-06-10|U|1963-07-26
TRIAL STUDY 134XCP|LB|CA231D77-1A1F-49F3-8172-06709A1330B7|2||||HGBF|HEMOGLOBIN F|||||||10^3 DNA COPIES/ML|||||||POSITIVE||NG/DL||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|SOLIDIFIED|NA|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|COCKCROFT-GAULT FORMULA||U|NA|U|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1961-08-21|1973-06-10|||||1962-06-16||1967-02-16|N|1969-04-17
TRIAL STUDY 134XCP|LB|CA231D77-1A1F-49F3-8172-06709A1330B7|1||||MMP1|MATRIX METALLOPROTEINASE 1|||||||BOWL|||||||BORDERLINE||U/M2/MIN||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|LACTESCENT|Y|DOUBLE IMMUNODIFFUSION|MDRD 6 VARIABLE FORMULA||U|U|N|NA|||Y|2||58||TREATMENT|1971-05-27|1965-10-04|||||1965-05-18||1960-11-14|NA|1963-01-10
TRIAL STUDY 134XCP|LB|CA231D77-1A1F-49F3-8172-06709A1330B7|2||||RH|RH FACTOR|||||||BAU/ML|||||||POSITIVE||ROENTGEN||||LOW|NOT DONE||||VENOUS CORD BLOOD|PARAFFIN-EMBEDDED|U|DC SHEATH FLOW|GMI % FORMULA||N|Y|U|N|||U|2||58||TREATMENT|1962-08-04|1971-06-06|||||1964-12-26||1964-10-10|NA|1972-11-05
TRIAL STUDY 134XCP|LB|CA231D77-1A1F-49F3-8172-06709A1330B7|1||||HLADR52A|HLA-DR52 ANTIBODY|||||||F|||||||TRACE||PT_BR||||LOW|NOT DONE||||CORD SERUM|SOLIDIFIED|N|NUCLEIC ACID AMPLIFICATION TEST|HEPASCORE FORMULA||N|U|N|Y|||N|3||39||LONG-TERM FOLLOW-UP|1961-03-31|1960-09-10|||||1969-01-10||1965-11-01|Y|1970-06-19
TRIAL STUDY 134XCP|LB|CA231D77-1A1F-49F3-8172-06709A1330B7|2||||NTRLFAT|NEUTRAL FATS|||||||G/M2/DAY|||||||BORDERLINE||PT_BR||||LOW|NOT DONE||||EMESIS|LACTESCENT|NA|PERFUSION MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|Y|Y|||U|3||39||CONTINUATION TREATMENT|1971-08-01|1970-09-17|||||1965-10-07||1969-03-03|Y|1965-03-03
TRIAL STUDY 134XCP|LB|CA231D77-1A1F-49F3-8172-06709A1330B7|1||||THYPXD|THYROPEROXIDASE|||||||POUCH|||||||INDETERMINATE||/VF||||LOW|NOT DONE||||BASAL TEAR|ICTERIC|NA|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA||NA|NA|NA|N|||U|4||88||BASELINE|1966-12-22|1967-04-07|||||1973-07-29||1965-06-29|Y|1966-02-20
TRIAL STUDY 134XCP|LB|CA231D77-1A1F-49F3-8172-06709A1330B7|2||||C130118|BEE MIX ANTIGEN IGG4 ANTIBODY|||||||M/SEC|||||||BORDERLINE||10^6 ORGANISMS||||ABNORMAL|NOT DONE||||SPERMATOZOON|LACTESCENT|N|PHOTOMETRIC CLOT DETECTION|ASH FIBROSURE FORMULA||Y|N|NA|Y|||N|4||88||CONTINUATION TREATMENT|1969-03-15|1967-01-25|||||1961-11-03||1968-09-19|N|1963-10-15
TRIAL STUDY 134XCP|LB|CA231D77-1A1F-49F3-8172-06709A1330B7|1||||HEXK|HEXOKINASE|||||||MG/MIN|||||||INVALID||ML/KG/H||||ABNORMAL|NOT DONE||||MONOCYTE|GELLED|Y|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|HEPASCORE FORMULA||Y|Y|U|NA|||U|5||7||BLINDED TREATMENT|1965-04-07|1972-01-17|||||1961-09-02||1963-02-26|Y|1961-07-06
TRIAL STUDY 134XCP|LB|CA231D77-1A1F-49F3-8172-06709A1330B7|2||||BNPPRONT|N-TERMINAL PROB-TYPE NATRIURETIC PEPTIDE|||||||CL|||||||BORDERLINE||ML/M2/MIN||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|FRESH|NA|SNP ARRAY|MDRD 4 VARIABLE FORMULA||N|N|U|NA|||NA|5||7||OPEN LABEL TREATMENT|1968-09-08|1965-11-26|||||1969-12-08||1968-09-18|U|1961-01-21
TRIAL STUDY 134XCP|LB|7A4D6074-E870-40E8-B567-D069BCB7DA9F|1||||FLRZPM|FLURAZEPAM|||||||%(W/W)|||||||TRACE||KG||||LOW|NOT DONE||||LYSATE|AGGLUTINATED|U|NO INFORMATION|ASH FIBROSURE FORMULA||Y|Y|Y|N|||N|1||38||BLINDED TREATMENT|1969-11-16|1965-12-05|||||1970-04-21||1970-08-25|NA|1966-02-04
TRIAL STUDY 134XCP|LB|7A4D6074-E870-40E8-B567-D069BCB7DA9F|2||||ASSDNA|ANTI-SINGLE STRANDED DNA IGG|||||||PACK|||||||INVALID||FG||||HIGH|NOT DONE||||BREAST MILK|LACTESCENT|N|BIOIMPEDANCE SPECTROSCOPY|CKD-EPI CREATININE FORMULA||Y|NA|N|Y|||U|1||38||RUN-IN|1971-01-25|1967-10-13|||||1968-05-03||1962-10-24|U|1961-04-20
TRIAL STUDY 134XCP|LB|7A4D6074-E870-40E8-B567-D069BCB7DA9F|1||||SMUSCGAB|SMOOTH MUSCLE IGG ANTIBODY|||||||KN/CM2|||||||INVALID||UG/KG/H||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|PARAFFIN-EMBEDDED|N|X-RAY FLUORESCENCE SPECTROMETRY|GMI MMOL/MOL FORMULA||U|Y|N|U|||N|2||58||INDUCTION TREATMENT|1966-03-04|1962-03-03|||||1970-02-10||1973-08-06|Y|1965-09-26
TRIAL STUDY 134XCP|LB|7A4D6074-E870-40E8-B567-D069BCB7DA9F|2||||FACTXII|FACTOR XII|||||||FRAMES/S|||||||TRACE||GENEQ||||HIGH|NOT DONE||||INFRANATANT, SERUM|CALCIFIED|U|TRANSMISSION ELECTRON MICROSCOPY|MDRD 4 VARIABLE FORMULA||NA|NA|N|N|||N|2||58||BASELINE|1966-08-17|1966-12-25|||||1964-04-16||1965-01-14|N|1968-02-16
TRIAL STUDY 134XCP|LB|7A4D6074-E870-40E8-B567-D069BCB7DA9F|1||||CELLS|CELLS|||||||10^3 CFU/ML|||||||NEGATIVE||FINGERTIP UNIT||||HIGH|NOT DONE||||ABSCESS FLUID|CLOTTED|NA|HEMATOXYLIN AND EOSIN STAIN|HEPASCORE FORMULA||NA|Y|NA|U|||U|3||39||RUN-IN|1963-07-20|1963-03-09|||||1960-07-12||1965-04-07|N|1968-12-25
TRIAL STUDY 134XCP|LB|7A4D6074-E870-40E8-B567-D069BCB7DA9F|2||||MIP1B|MACROPHAGE INFLAMMATORY PROTEIN 1 BETA|||||||PA|||||||TRACE||HZ||||HIGH|NOT DONE||||VENOUS BLOOD|ICTERIC|U|CHROMATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|Y|Y|||U|3||39||CONTINUATION TREATMENT|1966-04-14|1964-04-27|||||1960-06-20||1968-10-09|U|1970-05-09
TRIAL STUDY 134XCP|LB|7A4D6074-E870-40E8-B567-D069BCB7DA9F|1||||TRIM38|TRIPARTITE MOTIF CONTAINING PROTEIN 38|||||||G/KG|||||||INDETERMINATE||/LPF||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|DRIED|Y|NUCLEIC ACID BASED METHOD|NASH FIBROSURE FORMULA||U|NA|Y|NA|||N|4||88||FOLLOW-UP|1972-06-02|1966-04-11|||||1961-10-26||1972-06-05|U|1971-08-07
TRIAL STUDY 134XCP|LB|7A4D6074-E870-40E8-B567-D069BCB7DA9F|2||||IMMGLB|IMMUNOGLOBULIN|||||||ENZYME U/M2|||||||NEGATIVE||UCI/L||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|NON-HEMOLYZED|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA||U|Y|N|N|||U|4||88||CONTINUATION TREATMENT|1960-10-24|1966-01-17|||||1963-12-11||1970-01-10|U|1969-01-04
TRIAL STUDY 134XCP|LB|7A4D6074-E870-40E8-B567-D069BCB7DA9F|1||||ALPBS|BONE SPECIFIC ALKALINE PHOSPHATASE|||||||MG/DOSE|||||||INDETERMINATE||CCID 50/ML||||LOW|NOT DONE||||PLATELET RICH PLASMA|LACTESCENT|N|RADIOGRAPHY|NASH FIBROSURE FORMULA||N|NA|NA|NA|||U|5||7||RUN-IN|1965-06-22|1967-11-10|||||1968-03-07||1961-04-08|U|1972-12-17
TRIAL STUDY 134XCP|LB|7A4D6074-E870-40E8-B567-D069BCB7DA9F|2||||GCDCA|GLYCOCHENODEOXYCHOLATE|||||||DPM/100MG|||||||TRACE||S*KPA||||NORMAL|NOT DONE||||FLUID|REFRIGERATED|N|HPLC/MS/MS|MDRD FORMULA||Y|U|Y|NA|||NA|5||7||OPEN LABEL TREATMENT|1967-05-14|1960-01-02|||||1963-09-02||1965-10-17|N|1962-06-23
TRIAL STUDY 134XCP|LB|3DDD2A7E-B955-424B-B485-54E81D0E0699|1||||C4|COMPLEMENT C4|||||||PG/DL|||||||TRACE||ML/CAGE/DAY||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|AGGLUTINATED|NA|ROMANOWSKY STAIN|MDRD FORMULA||N|U|N|Y|||Y|1||38||RUN-IN|1972-01-28|1970-12-26|||||1969-03-25||1972-08-27|Y|1961-12-29
TRIAL STUDY 134XCP|LB|3DDD2A7E-B955-424B-B485-54E81D0E0699|2||||T4FRIND|THYROXINE, FREE, INDIRECT|||||||/100 WBC|||||||POSITIVE||CAN||||NORMAL|NOT DONE||||SOFT TISSUE|CONTAMINATED|Y|WRIGHT STAIN|MDRD 5 VARIABLE FORMULA||NA|U|Y|NA|||Y|1||38||SCREENING|1962-10-12|1968-09-28|||||1965-11-02||1967-03-30|NA|1963-07-16
TRIAL STUDY 134XCP|LB|3DDD2A7E-B955-424B-B485-54E81D0E0699|1||||C165930|SHELLFISH MIX IGE AB RAST SCORE|||||||SFC/10^6 PBMC|||||||BORDERLINE||PT_US||||ABNORMAL|NOT DONE||||SERUM|ROOM TEMPERATURE|NA|MICROBIAL CULTURE, LIQUID|NASH FIBROSURE FORMULA||NA|Y|U|NA|||N|2||58||RUN-IN|1962-07-04|1972-12-26|||||1971-02-06||1971-12-02|NA|1972-08-10
TRIAL STUDY 134XCP|LB|3DDD2A7E-B955-424B-B485-54E81D0E0699|2||||CKBB|CREATINE KINASE BB|||||||G/DL|||||||INDETERMINATE||MEQ/KG||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|FROZEN|Y|GRAM STAIN|CKD-EPI FORMULA||N|U|Y|Y|||NA|2||58||SCREENING|1962-11-17|1972-02-21|||||1962-03-17||1967-08-10|U|1965-12-14
TRIAL STUDY 134XCP|LB|3DDD2A7E-B955-424B-B485-54E81D0E0699|1||||INTLK3|INTERLEUKIN 3|||||||GY|||||||NEGATIVE||PFU||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|LACTESCENT|NA|IMPEDANCE CONDUCTIVITY|CKD-EPI CREATININE FORMULA||U|U|N|Y|||U|3||39||OBSERVATION|1965-11-06|1961-11-02|||||1971-08-04||1968-05-28|Y|1964-11-07
TRIAL STUDY 134XCP|LB|3DDD2A7E-B955-424B-B485-54E81D0E0699|2||||CYSTINE|CYSTINE|||||||10^9 CFU/ML|||||||INDETERMINATE||MOL/MG||||HIGH|NOT DONE||||ERYTHROCYTES|HEMOLYZED|Y|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|U|||N|3||39||INDUCTION TREATMENT|1967-10-11|1973-05-16|||||1973-04-29||1966-04-17|N|1965-08-06
TRIAL STUDY 134XCP|LB|3DDD2A7E-B955-424B-B485-54E81D0E0699|1||||PSP100AB|P100 POLYMYOSITIS-SCLERODERMA AUTOAG AB|||||||U/MG|||||||POSITIVE||WATT||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|U|ANTIBIOTIC AGAR SCREEN|ASH FIBROSURE FORMULA||U|NA|N|N|||N|4||88||RUN-IN|1962-12-30|1962-07-18|||||1963-05-15||1968-12-20|NA|1965-08-21
TRIAL STUDY 134XCP|LB|3DDD2A7E-B955-424B-B485-54E81D0E0699|2||||OH8DXG2|8-HYDROXY-2'-DEOXYGUANOSINE|||||||CI/L|||||||NEGATIVE||LOG10 PFU||||HIGH|NOT DONE||||ABSCESS FLUID|FRESH|N|LAPAROSCOPY|HEPASCORE FORMULA||Y|Y|U|Y|||U|4||88||FOLLOW-UP|1967-05-16|1962-03-27|||||1964-08-15||1967-08-16|U|1961-03-29
TRIAL STUDY 134XCP|LB|3DDD2A7E-B955-424B-B485-54E81D0E0699|1||||RETILRTC|LOW ABSORPTION RETIC/RETICULOCYTES|||||||MMU/ML|||||||TRACE||/VF||||HIGH|NOT DONE||||CELL PELLET|LIPEMIC|Y|KINETIC MICROPARTICLE IMMUNOASSAY|GMI MMOL/MOL FORMULA||NA|N|U|Y|||NA|5||7||OPEN LABEL TREATMENT|1970-04-03|1969-09-09|||||1960-08-24||1968-02-18|N|1961-06-13
TRIAL STUDY 134XCP|LB|3DDD2A7E-B955-424B-B485-54E81D0E0699|2||||CTOT|COMPLEMENT TOTAL|||||||RNA COPIES/ML|||||||POSITIVE||UG/KG/DAY||||HIGH|NOT DONE||||PUS|CLOTTED|N|FLUORESCENT IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|U|N|||NA|5||7||RUN-IN|1967-06-02|1973-04-16|||||1969-08-12||1967-01-24|NA|1967-12-05
TRIAL STUDY 134XCP|LB|D6757E79-3104-468E-BADC-8CCB51BFAE87|1||||INSAB|INSULIN ANTIBODY|||||||UKAT/L|||||||INVALID||UM2||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|REFRIGERATED|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|Y|N|||N|1||38||FOLLOW-UP|1966-04-04|1965-04-12|||||1961-08-26||1963-01-01|U|1966-06-20
TRIAL STUDY 134XCP|LB|D6757E79-3104-468E-BADC-8CCB51BFAE87|2||||NPAP|NON-PROSTATIC ACID PHOSPHATASE|||||||10^7 PFU|||||||INVALID||10^12/L||||ABNORMAL|NOT DONE||||PLATELET|CALCIFIED|U|SICKLE CELL SOLUBILITY TEST|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|NA|Y|||NA|1||38||BASELINE|1961-07-08|1965-11-10|||||1962-05-27||1963-03-27|N|1960-03-11
TRIAL STUDY 134XCP|LB|D6757E79-3104-468E-BADC-8CCB51BFAE87|1||||COLOR|COLOR|||||||UG/L/H|||||||INVALID||1/(S*KPA)||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|UNEXPECTED ODOR|Y|LIGHT MICROSCOPY|MDRD 4 VARIABLE FORMULA||N|Y|U|N|||N|2||58||CONTINUATION TREATMENT|1967-03-02|1973-07-21|||||1968-06-18||1965-04-29|Y|1969-03-11
TRIAL STUDY 134XCP|LB|D6757E79-3104-468E-BADC-8CCB51BFAE87|2||||HLAIAB|HLA CLASS I ANTIBODY|||||||CG|||||||POSITIVE||U/KG||||NORMAL|NOT DONE||||BASAL TEAR|THAWED|N|ENDPOINT DILUTION ASSAY|COCKCROFT-GAULT FORMULA||U|NA|N|Y|||Y|2||58||CONTINUATION TREATMENT|1965-12-30|1972-08-24|||||1960-01-30||1966-12-05|NA|1969-05-29
TRIAL STUDY 134XCP|LB|D6757E79-3104-468E-BADC-8CCB51BFAE87|1||||MACROBLD|MACROSCOPIC BLOOD|||||||U/MG|||||||POSITIVE||NMOL/ML/MIN||||NORMAL|NOT DONE||||ALVEOLAR AIR|CONTAMINATED|NA|PULMONARY ANGIOGRAPHY|MDRD FORMULA||NA|Y|NA|U|||NA|3||39||SCREENING|1972-08-29|1962-12-27|||||1970-10-08||1968-03-10|N|1964-04-02
TRIAL STUDY 134XCP|LB|D6757E79-3104-468E-BADC-8CCB51BFAE87|2||||APTTLAAC|APTT-LA ACTUAL/CONTROL|||||||MOL/ML|||||||BORDERLINE||MET*MIN||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|AGGLUTINATED|Y|DOUBLE IMMUNODIFFUSION|MDRD FORMULA||N|Y|N|U|||NA|3||39||OBSERVATION|1969-10-16|1971-02-11|||||1963-08-27||1968-04-07|U|1973-06-14
TRIAL STUDY 134XCP|LB|D6757E79-3104-468E-BADC-8CCB51BFAE87|1||||ARG|ARGININE|||||||SHOCK WAVE|||||||BORDERLINE||NL||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|ICTERIC|Y|ELECTROGASTROGRAPHY|MDRD FORMULA||Y|U|N|N|||U|4||88||FOLLOW-UP|1968-12-20|1967-10-16|||||1960-06-18||1972-12-29|U|1963-07-27
TRIAL STUDY 134XCP|LB|D6757E79-3104-468E-BADC-8CCB51BFAE87|2||||CBS|CYSTATHIONINE BETA-SYNTHASE|||||||MG/DAY|||||||POSITIVE||SPRAY||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|GELLED|U|ELECTRONEUROGRAPHY|NASH FIBROSURE FORMULA||Y|NA|U|U|||U|4||88||SCREENING|1965-12-28|1962-06-08|||||1970-04-06||1960-12-11|NA|1968-01-12
TRIAL STUDY 134XCP|LB|D6757E79-3104-468E-BADC-8CCB51BFAE87|1||||DOPAMEXR|DOPAMINE EXCRETION RATE|||||||MG/MOL|||||||POSITIVE||TRANSDUCING UNIT||||HIGH|NOT DONE||||MUSCLE TISSUE|CALCIFIED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD 4 VARIABLE FORMULA||U|U|Y|N|||N|5||7||FOLLOW-UP|1966-11-23|1963-12-04|||||1961-07-25||1960-03-02|U|1970-01-29
TRIAL STUDY 134XCP|LB|D6757E79-3104-468E-BADC-8CCB51BFAE87|2||||ALUMINUM|ALUMINUM|||||||PMOL/L/H|||||||INVALID||UG/M2/DAY||||LOW|NOT DONE||||CEREBROSPINAL FLUID|CONTAMINATED|Y|NUCLEIC ACID AMPLIFICATION TEST|MDRD 5 VARIABLE FORMULA||N|U|U|N|||N|5||7||INDUCTION TREATMENT|1961-10-20|1970-07-30|||||1960-11-26||1963-04-19|N|1963-03-05
TRIAL STUDY 134XCP|LB|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|1||||TROPONT|TROPONIN T|||||||10^6 U|||||||INVALID||CCID 50/DOSE||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED|U|OPTICAL DENSITY MEASUREMENT|CKD-EPI FORMULA||Y|NA|U|N|||N|1||38||SCREENING|1970-04-07|1972-01-12|||||1971-03-06||1973-01-11|Y|1969-11-30
TRIAL STUDY 134XCP|LB|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|2||||MLIGCE|MALIGNANT CELLS, NOS|||||||CAPFUL|||||||NEGATIVE||IU||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|SOLIDIFIED|U|AGAR DILUTION|FIBROSIS 4 FORMULA||N|N|U|NA|||NA|1||38||BASELINE|1965-07-29|1966-09-02|||||1969-09-17||1961-05-29|NA|1968-04-18
TRIAL STUDY 134XCP|LB|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|1||||DDX58|DEAD BOX PROTEIN 58|||||||BQ/KG|||||||INDETERMINATE||L||||LOW|NOT DONE||||URINE SEDIMENT|CONCENTRATED|NA|TARGETED GENOME SEQUENCING|MDRD ENZYMATIC FORMULA||N|N|N|U|||Y|2||58||BASELINE|1962-10-14|1971-09-23|||||1964-07-04||1965-11-04|NA|1971-08-15
TRIAL STUDY 134XCP|LB|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|2||||RUB|RUBRICYTE|||||||UGEQ|||||||NEGATIVE||JAR||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED|U|IMPEDANCE CONDUCTIVITY|HEPASCORE FORMULA||NA|N|NA|NA|||U|2||58||INDUCTION TREATMENT|1972-12-12|1964-09-27|||||1961-02-17||1962-01-27|Y|1973-02-09
TRIAL STUDY 134XCP|LB|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|1||||IRON|IRON|||||||GRAIN|||||||NEGATIVE||PRESSOR UNITS||||HIGH|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|NA|RYAN BLUE STAIN|FIBROMETER FORMULA||U|U|N|Y|||Y|3||39||BASELINE|1960-12-12|1967-10-29|||||1969-05-12||1961-12-07|N|1968-06-24
TRIAL STUDY 134XCP|LB|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|2||||IL1SR1|SOLUBLE INTERLEUKIN-1 RECEPTOR TYPE I|||||||GTT|||||||TRACE||MASK||||NORMAL|NOT DONE||||VENOUS PLASMA|AUTOLYZED|N|CALIPER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA||Y|NA|U|NA|||N|3||39||BLINDED TREATMENT|1960-01-22|1966-11-02|||||1960-11-19||1965-09-04|N|1972-12-20
TRIAL STUDY 134XCP|LB|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|1||||RPTLAAC|REPTILASE ACTIVITY ACTUAL/CONTROL|||||||MMOL|||||||INDETERMINATE||CM2||||NORMAL|NOT DONE||||SALIVA|AUTOLYZED|N|MRI WITHOUT CONTRAST|COCKCROFT-GAULT FORMULA||U|U|N|Y|||U|4||88||CONTINUATION TREATMENT|1966-07-30|1967-11-06|||||1971-12-07||1968-02-12|N|1969-12-17
TRIAL STUDY 134XCP|LB|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|2||||PRABC|CALCULATED PANEL REACTIVE ANTIBODY|||||||MM2|||||||BORDERLINE||G/M2||||LOW|NOT DONE||||LYSATE|ROOM TEMPERATURE|Y|IN SITU HYBRIDIZATION|CKD-EPI FORMULA||N|U|U|N|||N|4||88||BASELINE|1972-04-29|1965-03-03|||||1967-10-13||1963-05-03|U|1960-07-05
TRIAL STUDY 134XCP|LB|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|1||||TNFSR|SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR|||||||EID 50/DOSE|||||||INVALID||NMOL/KG/DAY||||ABNORMAL|NOT DONE||||KERATINOCYTE|CLOTTED|N|NEPHELOMETRY|HEPASCORE FORMULA||Y|U|U|U|||Y|5||7||FOLLOW-UP|1960-11-19|1962-01-04|||||1965-02-25||1970-10-10|N|1961-01-28
TRIAL STUDY 134XCP|LB|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|2||||HDL2|HDL-CHOLESTEROL SUBCLASS 2|||||||CCID 50/DOSE|||||||NEGATIVE||VG/KG||||LOW|NOT DONE||||MONOCYTE|CLOTTED|NA|ENZYMATIC COLORIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|Y|U|||N|5||7||SCREENING|1960-05-22|1967-02-23|||||1965-05-24||1973-04-21|U|1961-04-02
TRIAL STUDY 134XCP|LB|FBAA59F4-154C-40CC-B740-A87769BFEC45|1||||ASP|ASPARTIC ACID|||||||10^3/HPF|||||||TRACE||MKAT||||HIGH|NOT DONE||||VENOUS BLOOD|THAWED|Y|CALIPER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA||U|NA|U|N|||NA|1||38||OPEN LABEL TREATMENT|1968-07-10|1967-01-11|||||1968-07-15||1967-06-17|Y|1971-02-24
TRIAL STUDY 134XCP|LB|FBAA59F4-154C-40CC-B740-A87769BFEC45|2||||MET|METHIONINE|||||||UMOL/KG/MIN|||||||INDETERMINATE||IU/ML||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LIPEMIC|Y|CELL BASED BIOASSAY|FIBROSIS 4 FORMULA||U|Y|Y|NA|||Y|1||38||CONTINUATION TREATMENT|1965-10-25|1961-12-25|||||1962-08-16||1965-10-01|N|1965-08-08
TRIAL STUDY 134XCP|LB|FBAA59F4-154C-40CC-B740-A87769BFEC45|1||||HEXK|HEXOKINASE|||||||MET*MIN|||||||INVALID||M||||HIGH|NOT DONE||||PERSPIRATION|REFRIGERATED|NA|FLOW CYTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|NA|N|||Y|2||58||TREATMENT|1968-02-10|1966-09-16|||||1963-05-14||1966-11-04|U|1960-01-05
TRIAL STUDY 134XCP|LB|FBAA59F4-154C-40CC-B740-A87769BFEC45|2||||PLATBIZ|BIZARRE PLATELETS|||||||GRAVITATIONAL UNIT|||||||INVALID||KV||||ABNORMAL|NOT DONE||||URINE SEDIMENT|REFRIGERATED|Y|FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||N|U|N|N|||Y|2||58||BLINDED TREATMENT|1970-01-25|1971-05-07|||||1960-03-19||1968-08-20|Y|1961-09-06
TRIAL STUDY 134XCP|LB|FBAA59F4-154C-40CC-B740-A87769BFEC45|1||||CD45LY|CD45/LYMPHOCYTES|||||||CMOL/L|||||||NEGATIVE||KG/MOL||||ABNORMAL|NOT DONE||||SEMINAL FLUID|DRIED|N|AUTOREFRACTION|MDRD 4 VARIABLE FORMULA||N|NA|Y|NA|||Y|3||39||CONTINUATION TREATMENT|1962-01-01|1963-01-19|||||1966-11-19||1963-04-29|NA|1963-10-02
TRIAL STUDY 134XCP|LB|FBAA59F4-154C-40CC-B740-A87769BFEC45|2||||NEUTMY|NEUTROPHILIC MYELOCYTES|||||||SFC/10^6 PBMC|||||||POSITIVE||YD||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|CONCENTRATED|Y|PALPATION|FIBROMETER FORMULA||N|U|U|Y|||U|3||39||INDUCTION TREATMENT|1961-10-25|1962-09-02|||||1971-10-27||1970-06-11|Y|1971-12-29
TRIAL STUDY 134XCP|LB|FBAA59F4-154C-40CC-B740-A87769BFEC45|1||||VITK|VITAMIN K|||||||V|||||||BORDERLINE||U/MG||||NORMAL|NOT DONE||||SEBUM|REFRIGERATED|N|DUCTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|NA|||U|4||88||SCREENING|1962-05-21|1973-01-19|||||1963-09-22||1960-01-18|U|1970-12-07
TRIAL STUDY 134XCP|LB|FBAA59F4-154C-40CC-B740-A87769BFEC45|2||||BLSTLMLY|LEUKEMIC BLASTS/LYMPHOCYTES|||||||LOG10 ELISA UNIT/DOSE|||||||TRACE||MMOL/MOL||||NORMAL|NOT DONE||||PLEURAL FLUID|SOLIDIFIED|N|POTENTIOMETRY|MDRD 6 VARIABLE FORMULA||U|N|Y|U|||N|4||88||RUN-IN|1961-05-14|1964-03-12|||||1972-04-27||1973-03-25|N|1963-04-01
TRIAL STUDY 134XCP|LB|FBAA59F4-154C-40CC-B740-A87769BFEC45|1||||PLSIMCE|IMMATURE PLASMA CELLS|||||||MEQ/G|||||||TRACE||IU/DL||||LOW|NOT DONE||||ALVEOLAR AIR|CONTAMINATED|Y|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|Y|Y|||Y|5||7||LONG-TERM FOLLOW-UP|1962-04-22|1960-11-29|||||1964-04-20||1973-05-03|NA|1966-08-24
TRIAL STUDY 134XCP|LB|FBAA59F4-154C-40CC-B740-A87769BFEC45|2||||NKINA|NEUROKININ A|||||||UKAT|||||||TRACE||JDF UNIT||||LOW|NOT DONE||||TISSUE|CONTAMINATED|U|IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD FORMULA||Y|Y|N|N|||Y|5||7||INDUCTION TREATMENT|1972-03-05|1972-11-12|||||1962-02-27||1971-12-14|Y|1973-06-12
TRIAL STUDY 134XCP|LB|9A9E638B-426B-4F3E-8363-50DC2617FD63|1||||FEP|ERYTHROCYTE PROTOPORPHYRIN, FREE|||||||10^5/HPF|||||||NEGATIVE||PG||||HIGH|NOT DONE||||INFRANATANT, SERUM|HEMOLYZED|N|ELECTROCHEMILUMINESCENCE|HEPASCORE FORMULA||NA|NA|Y|N|||Y|1||38||BLINDED TREATMENT|1973-03-12|1961-03-18|||||1966-02-24||1967-10-03|NA|1972-04-18
TRIAL STUDY 134XCP|LB|9A9E638B-426B-4F3E-8363-50DC2617FD63|2||||APTT|ACTIVATED PARTIAL THROMBOPLASTIN TIME|||||||LOG10 CFU/G|||||||INVALID||KIU||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|AGGLUTINATED|N|ELECTROCHEMILUMINESCENCE|FIBROSIS 4 FORMULA||N|NA|NA|N|||NA|1||38||OBSERVATION|1970-09-29|1967-03-04|||||1969-05-10||1971-01-15|U|1962-04-09
TRIAL STUDY 134XCP|LB|9A9E638B-426B-4F3E-8363-50DC2617FD63|1||||GUDCA|GLYCOURSODEOXYCHOLATE|||||||UV2|||||||INVALID||MMOL/G||||NORMAL|NOT DONE||||BILE|HEMOLYZED|U|SNELLEN EYE CHART|CKD-EPI CREATININE FORMULA||Y|U|U|Y|||Y|2||58||INDUCTION TREATMENT|1961-08-12|1970-04-17|||||1962-02-07||1965-08-01|N|1963-10-22
TRIAL STUDY 134XCP|LB|9A9E638B-426B-4F3E-8363-50DC2617FD63|2||||CRLPLSMN|CERULOPLASMIN|||||||10^6 DNA COPIES/ML|||||||NEGATIVE||UG||||LOW|NOT DONE||||ADIPOSE TISSUE|GELLED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|FIBROSIS 4 FORMULA||N|Y|U|U|||U|2||58||OPEN LABEL TREATMENT|1961-12-09|1971-07-30|||||1969-09-02||1967-11-18|Y|1962-05-10
TRIAL STUDY 134XCP|LB|9A9E638B-426B-4F3E-8363-50DC2617FD63|1||||CEMORPH|CELL MORPHOLOGY|||||||LOG10 CFU/ML|||||||POSITIVE||L/L||||HIGH|NOT DONE||||TISSUE|GELLED|U|GC/MS-EI|NASH FIBROSURE FORMULA||U|Y|U|U|||NA|3||39||BASELINE|1968-10-12|1971-12-09|||||1963-09-16||1969-09-22|N|1962-12-13
TRIAL STUDY 134XCP|LB|9A9E638B-426B-4F3E-8363-50DC2617FD63|2||||CD2LY|CD2/LYMPHOCYTES|||||||UG/L FEU|||||||INVALID||ML/ANIMAL/WK||||NORMAL|NOT DONE||||LEUKOCYTE|ROOM TEMPERATURE|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 4 VARIABLE FORMULA||NA|Y|U|NA|||Y|3||39||INDUCTION TREATMENT|1964-11-14|1963-04-14|||||1971-12-16||1963-05-28|U|1966-05-16
TRIAL STUDY 134XCP|LB|9A9E638B-426B-4F3E-8363-50DC2617FD63|1||||C130086|ENGLISH PLANTAIN POLLEN IGG|||||||BP|||||||BORDERLINE||MSEC||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|ICTERIC|N|CISH|MDRD ENZYMATIC JAPANESE FORMULA||U|N|Y|Y|||NA|4||88||OPEN LABEL TREATMENT|1960-07-23|1962-08-15|||||1969-10-27||1969-11-07|U|1960-12-25
TRIAL STUDY 134XCP|LB|9A9E638B-426B-4F3E-8363-50DC2617FD63|2||||KL6|KREBS VON DEN LUNGEN-6|||||||MG/CM2|||||||BORDERLINE||DEG2||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|FROZEN|U|IMMUNOCHROMATOGRAPHY|MDRD 5 VARIABLE FORMULA||N|U|NA|N|||N|4||88||OBSERVATION|1964-01-20|1971-02-16|||||1971-12-21||1973-06-20|U|1965-04-29
TRIAL STUDY 134XCP|LB|9A9E638B-426B-4F3E-8363-50DC2617FD63|1||||MOCYCECE|MONOCYTOID CELLS/TOTAL CELLS|||||||UG/G/H|||||||INDETERMINATE||UCI/L||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|AGGLUTINATED|NA|NUCLEIC ACID HYBRIDIZATION|ASH FIBROSURE FORMULA||N|U|N|NA|||U|5||7||OPEN LABEL TREATMENT|1960-03-25|1960-02-27|||||1964-02-15||1972-11-08|U|1972-09-06
TRIAL STUDY 134XCP|LB|9A9E638B-426B-4F3E-8363-50DC2617FD63|2||||BARB|BARBITURATES|||||||ML/M2|||||||BORDERLINE||DAGU/ML||||HIGH|NOT DONE||||WHITE MATTER TISSUE|THAWED|NA|DOPPLER ULTRASOUND|MDRD ENZYMATIC FORMULA||N|U|U|U|||U|5||7||LONG-TERM FOLLOW-UP|1964-02-22|1971-10-30|||||1970-04-28||1965-03-31|NA|1971-12-29
TRIAL STUDY 134XCP|LB|9995CD08-2650-4711-8F04-E41183E28B21|1||||C165905|GRASS MIX POLLEN IGG AB RAST SCORE|||||||FMOL|||||||BORDERLINE||ML/KG/DAY||||HIGH|NOT DONE||||EMOTIONAL TEAR|ICTERIC|Y|JAFFE REACTION|NASH FIBROSURE FORMULA||N|U|N|NA|||N|1||38||WASHOUT|1967-12-30|1967-07-08|||||1967-10-15||1971-03-09|U|1966-03-29
TRIAL STUDY 134XCP|LB|9995CD08-2650-4711-8F04-E41183E28B21|2||||APROTCRS|ACTIVATED PROTEIN C RESISTANCE|||||||KPA|||||||NEGATIVE||L/MIN/M2||||LOW|NOT DONE||||SPERMATOZOON|GELLED|N|SEQUENCING|NASH FIBROSURE FORMULA||Y|Y|NA|N|||NA|1||38||FOLLOW-UP|1970-07-27|1968-02-08|||||1967-01-21||1970-02-06|U|1971-05-03
TRIAL STUDY 134XCP|LB|9995CD08-2650-4711-8F04-E41183E28B21|1||||VTRNCTN|VITRONECTIN|||||||UG/KG/H|||||||INDETERMINATE||CM||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|REFRIGERATED|U|CONTRAST ENHANCED SPIRAL CT SCAN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|U|N|||N|2||58||SCREENING|1962-12-22|1965-12-08|||||1969-10-16||1967-11-02|U|1963-07-22
TRIAL STUDY 134XCP|LB|9995CD08-2650-4711-8F04-E41183E28B21|2||||ALT|ALANINE AMINOTRANSFERASE|||||||BOWL|||||||TRACE||KAT||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|AGGLUTINATED|NA|CLINICAL EVALUATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|N|NA|||U|2||58||LONG-TERM FOLLOW-UP|1961-01-20|1968-05-17|||||1971-03-08||1966-08-13|NA|1971-04-13
TRIAL STUDY 134XCP|LB|9995CD08-2650-4711-8F04-E41183E28B21|1||||ALPLALP|ALK PHOS, LIVER/TOTAL ALK PHOS|||||||MU/G|||||||POSITIVE||TROCHE||||NORMAL|NOT DONE||||CAPILLARY BLOOD|UNEXPECTED ODOR|Y|HANSEL STAIN|HEPASCORE FORMULA||NA|NA|NA|Y|||NA|3||39||TREATMENT|1969-04-15|1972-04-30|||||1971-09-07||1972-06-02|N|1971-05-07
TRIAL STUDY 134XCP|LB|9995CD08-2650-4711-8F04-E41183E28B21|2||||MPXI|MYELOPEROXIDASE INDEX|||||||HR/DAY|||||||TRACE||BEATS/MIN||||HIGH|NOT DONE||||AMNIOTIC FLUID|HEMOLYZED|Y|PALPATION|HEPASCORE FORMULA||U|Y|U|NA|||N|3||39||CONTINUATION TREATMENT|1963-11-01|1972-04-20|||||1973-01-16||1973-07-04|U|1962-04-08
TRIAL STUDY 134XCP|LB|9995CD08-2650-4711-8F04-E41183E28B21|1||||C130123|NUT MIX ANTIGEN IGG ANTIBODY|||||||IU/KG/H|||||||TRACE||AU/ML||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|FROZEN|Y|ATOMIC ABSORPTION SPECTROMETRY|HEPASCORE FORMULA||N|U|NA|N|||N|4||88||BLINDED TREATMENT|1966-03-15|1968-10-30|||||1969-07-07||1961-10-21|N|1970-02-17
TRIAL STUDY 134XCP|LB|9995CD08-2650-4711-8F04-E41183E28B21|2||||LSELS|SOLUBLE L-SELECTIN|||||||NEWTON|||||||INDETERMINATE||UG/DAY||||HIGH|NOT DONE||||FLUID|FROZEN|NA|KARYOTYPING|ASH FIBROSURE FORMULA||N|NA|NA|N|||N|4||88||CONTINUATION TREATMENT|1966-07-11|1960-06-02|||||1960-11-12||1973-01-29|NA|1966-05-17
TRIAL STUDY 134XCP|LB|9995CD08-2650-4711-8F04-E41183E28B21|1||||GSTMUCRT|MU GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||G/L|||||||TRACE||ML/MIN/1.73M2||||NORMAL|NOT DONE||||ALVEOLAR AIR|PARAFFIN-EMBEDDED|NA|TRYPAN BLUE STAIN|COCKCROFT-GAULT FORMULA||NA|U|NA|Y|||Y|5||7||OBSERVATION|1970-04-05|1972-11-25|||||1968-01-18||1964-07-24|Y|1961-02-14
TRIAL STUDY 134XCP|LB|9995CD08-2650-4711-8F04-E41183E28B21|2||||MNC|MONONUCLEAR CELLS|||||||GRAIN|||||||TRACE||LOG10 PFU||||HIGH|NOT DONE||||TRANSUDATE|ICTERIC|NA|GC/MS/MS|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|N|N|||NA|5||7||OPEN LABEL TREATMENT|1962-06-12|1967-06-08|||||1965-06-27||1962-06-24|Y|1963-12-02
TRIAL STUDY 134XCP|LB|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|1||||LYMPLLY|PLASMACYTOID LYMPHOCYTES/LYMPHOCYTES|||||||10^6 IU|||||||POSITIVE||ML/DOSE||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|LACTESCENT|NA|SCINTIGRAPHY|COCKCROFT-GAULT FORMULA||U|N|NA|Y|||NA|1||38||BASELINE|1969-02-12|1960-06-18|||||1971-08-25||1966-03-05|N|1966-06-03
TRIAL STUDY 134XCP|LB|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|2||||GSTMUCRT|MU GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||MM/SEC|||||||NEGATIVE||10^6 ORGANISMS/MG||||NORMAL|NOT DONE||||CALCULUS|CONCENTRATED|Y|MALDI-TOF|MDRD FORMULA||N|U|N|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1961-10-24|1963-06-08|||||1970-03-08||1960-03-29|N|1961-07-21
TRIAL STUDY 134XCP|LB|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|1||||THROMNUC|THROMBOCYTES|||||||MG/KG/WEEK|||||||NEGATIVE||GY/MIN||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|DRIED|N|IMMUNOASSAY|ASH FIBROSURE FORMULA||U|Y|N|U|||N|2||58||RUN-IN|1969-09-22|1962-10-03|||||1966-08-17||1965-08-24|U|1961-01-15
TRIAL STUDY 134XCP|LB|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|2||||ANPPRONT|N-TERMINAL PROA-TYPE NATRIURETIC PEPTIDE|||||||MIN*MG/ML|||||||INVALID||S^-1(%O2)^-1||||LOW|NOT DONE||||PUS|ICTERIC|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|FIBROMETER FORMULA||Y|NA|Y|NA|||NA|2||58||OPEN LABEL TREATMENT|1963-03-18|1971-05-29|||||1971-06-10||1972-08-12|NA|1963-10-05
TRIAL STUDY 134XCP|LB|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|1||||TK|THYMIDINE KINASE|||||||CP|||||||BORDERLINE||C||||LOW|NOT DONE||||EPIDERMAL TISSUE|ROOM TEMPERATURE|N|COULOMETRIC TITRATION|CKD-EPI CREATININE FORMULA||Y|N|NA|Y|||Y|3||39||WASHOUT|1962-07-16|1968-12-23|||||1966-01-21||1961-04-05|N|1967-10-16
TRIAL STUDY 134XCP|LB|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|2||||HGB|HEMOGLOBIN|||||||BAR|||||||INVALID||NG/L||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|CONTAMINATED|Y|LASER CAPTURE MICRODISSECTION|FIBROMETER FORMULA||NA|Y|NA|NA|||Y|3||39||LONG-TERM FOLLOW-UP|1960-12-08|1965-10-01|||||1972-06-15||1967-11-04|Y|1968-09-17
TRIAL STUDY 134XCP|LB|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|1||||LDH5LDH|LDH ISOENZYME 5/LDH|||||||PG/DL|||||||INDETERMINATE||U/10^12 RBC||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|SOLIDIFIED|U|PHOTOMETRY|MDRD 6 VARIABLE FORMULA||Y|Y|Y|NA|||Y|4||88||RUN-IN|1963-02-23|1962-07-29|||||1965-07-19||1964-04-16|N|1968-03-18
TRIAL STUDY 134XCP|LB|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|2||||AAMBTAC|ALPHA-AMINOBUTYRIC ACID|||||||UG/M2/DAY|||||||NEGATIVE||HOUNSFIELD UNIT||||NORMAL|NOT DONE||||EXUDATE|FRESH|U|BIOIMPEDANCE SPECTROSCOPY|FIBROMETER FORMULA||U|U|Y|NA|||NA|4||88||OPEN LABEL TREATMENT|1963-01-01|1967-12-12|||||1965-02-28||1972-12-08|Y|1967-02-12
TRIAL STUDY 134XCP|LB|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|1||||C5B9S|SOLUBLE COMPLEMENT C5B-9|||||||CG|||||||INVALID||FARAD||||ABNORMAL|NOT DONE||||LYSATE|CLOTTED|NA|PYROSEQUENCING|FIBROSIS 4 FORMULA||U|U|NA|Y|||Y|5||7||BLINDED TREATMENT|1968-03-03|1966-12-17|||||1962-01-26||1969-10-07|NA|1970-01-15
TRIAL STUDY 134XCP|LB|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|2||||COPPER|COPPER|||||||PL|||||||TRACE||ML/BREATH||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|SOLIDIFIED|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|Y|U|||NA|5||7||BLINDED TREATMENT|1966-11-29|1972-09-12|||||1970-10-09||1972-11-02|NA|1962-12-30
TRIAL STUDY 134XCP|LB|DE805225-C632-46E6-B673-DA0D864D47F7|1||||TROPONIN|TROPONIN|||||||MM3/MM2/YEAR|||||||TRACE||ENZYME U/M2||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|LIPEMIC|Y|FLUORESCEIN STAIN|CKD-EPI FORMULA||Y|U|U|NA|||N|1||38||RUN-IN|1971-03-26|1961-10-31|||||1963-05-29||1968-03-19|U|1965-01-06
TRIAL STUDY 134XCP|LB|DE805225-C632-46E6-B673-DA0D864D47F7|2||||AFPL3|ALPHA FETOPROTEIN L3|||||||U/KG/MIN|||||||POSITIVE||DEG2||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|UNEXPECTED ODOR|N|SURFACE PLASMON RESONANCE|ASH FIBROSURE FORMULA||N|Y|N|U|||NA|1||38||OBSERVATION|1966-04-09|1964-04-29|||||1968-08-12||1963-11-17|NA|1963-05-01
TRIAL STUDY 134XCP|LB|DE805225-C632-46E6-B673-DA0D864D47F7|1||||PLCGF|PLACENTAL GROWTH FACTOR|||||||UV2|||||||NEGATIVE||LOG10 ELISA UNIT||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|UNEXPECTED ODOR|N|CYSTOSCOPY|NASH FIBROSURE FORMULA||U|NA|U|NA|||Y|2||58||FOLLOW-UP|1961-05-25|1963-12-24|||||1968-05-12||1971-12-06|NA|1965-05-10
TRIAL STUDY 134XCP|LB|DE805225-C632-46E6-B673-DA0D864D47F7|2||||HALPRZLM|HYDROXYALPRAZOLAM|||||||COPIES/UG|||||||INDETERMINATE||10^7/L||||HIGH|NOT DONE||||HAIR|FROZEN|U|DISK DIFFUSION|ASH FIBROSURE FORMULA||Y|N|Y|NA|||NA|2||58||OPEN LABEL TREATMENT|1973-01-27|1966-08-10|||||1960-09-24||1963-07-29|NA|1965-12-29
TRIAL STUDY 134XCP|LB|DE805225-C632-46E6-B673-DA0D864D47F7|1||||TSI|THYROID STIMULATING IMMUNOGLOBULIN|||||||10^9 CFU/ML|||||||BORDERLINE||UG/M2||||NORMAL|NOT DONE||||LAVAGE FLUID|SOLIDIFIED|Y|ENZYMATIC ULTRACENTRIFUGATION|FIBROTEST FORMULA||N|Y|Y|Y|||Y|3||39||OPEN LABEL TREATMENT|1961-03-30|1971-05-02|||||1965-02-08||1960-07-30|NA|1969-09-23
TRIAL STUDY 134XCP|LB|DE805225-C632-46E6-B673-DA0D864D47F7|2||||C165924|GRASS MIX POLLEN IGE AB RAST SCORE|||||||MG/M2/DAY|||||||TRACE||PG||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|PARAFFIN-EMBEDDED|NA|SLOAN LETTER EYE CHART 100%|MDRD 4 VARIABLE FORMULA||Y|N|N|Y|||Y|3||39||RUN-IN|1964-12-23|1971-01-16|||||1969-02-19||1971-06-18|N|1968-04-25
TRIAL STUDY 134XCP|LB|DE805225-C632-46E6-B673-DA0D864D47F7|1||||ENRAGE|EXTRACELL NEWLY IDENT RAGE BIND PROTEIN|||||||NMOL/L|||||||INVALID||MG/KG/DAY||||LOW|NOT DONE||||CEREBROSPINAL FLUID|LACTESCENT|N|IMMUNORADIOMETRIC ASSAY|FIBROMETER FORMULA||Y|Y|N|N|||Y|4||88||TREATMENT|1970-10-31|1967-04-17|||||1966-06-29||1965-11-03|U|1973-04-29
TRIAL STUDY 134XCP|LB|DE805225-C632-46E6-B673-DA0D864D47F7|2||||PGD2S|PROSTAGLANDIN D2 SYNTHASE|||||||H*%|||||||BORDERLINE||APS U||||ABNORMAL|NOT DONE||||LAVAGE FLUID|FROZEN|Y|VENTILATION PERFUSION LUNG SCAN|MDRD 4 VARIABLE FORMULA||N|Y|NA|NA|||NA|4||88||CONTINUATION TREATMENT|1965-04-23|1972-01-24|||||1969-08-01||1967-07-28|Y|1964-12-22
TRIAL STUDY 134XCP|LB|DE805225-C632-46E6-B673-DA0D864D47F7|1||||EOSNUCCE|EOSINOPHILS/NUCLEATED CELLS|||||||QUANTITY SUFFICIENT|||||||BORDERLINE||UV||||HIGH|NOT DONE||||PERSPIRATION|ICTERIC|U|ENDOSCOPY|MDRD 4 VARIABLE FORMULA||N|NA|Y|U|||Y|5||7||WASHOUT|1968-12-27|1973-02-09|||||1972-08-17||1961-04-19|NA|1962-04-18
TRIAL STUDY 134XCP|LB|DE805225-C632-46E6-B673-DA0D864D47F7|2||||NTENS|NEUROTENSIN|||||||UEQ/L|||||||INVALID||10^6/EJACULATE U||||HIGH|NOT DONE||||DIALYSIS FLUID|NON-HEMOLYZED|NA|SEQUENCING|MDRD FORMULA||Y|U|Y|Y|||N|5||7||BASELINE|1972-10-13|1969-05-22|||||1971-10-29||1971-06-15|NA|1961-04-01
TRIAL STUDY 134XCP|LB|9C921E89-706F-46E8-ADE3-A806289D43A5|1||||GDIGA1|GALACTOSE-DEFICIENT IGA1|||||||STEPS|||||||TRACE||KHZ||||LOW|NOT DONE||||EMESIS|THAWED|NA|PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC FORMULA||U|Y|Y|U|||Y|1||38||BASELINE|1968-12-28|1972-04-09|||||1960-10-27||1970-11-04|N|1964-06-23
TRIAL STUDY 134XCP|LB|9C921E89-706F-46E8-ADE3-A806289D43A5|2||||CCL20|CHEMOKINE (C-C MOTIF) LIGAND 20|||||||ML/M2/H|||||||INVALID||ML/KG/DAY||||ABNORMAL|NOT DONE||||STOOL|UNEXPECTED ODOR|U|NON-CONTACT SPECULAR MICROSCOPY|MDRD ENZYMATIC FORMULA||N|Y|NA|U|||N|1||38||OPEN LABEL TREATMENT|1967-04-18|1961-04-27|||||1971-06-05||1960-01-12|U|1967-01-16
TRIAL STUDY 134XCP|LB|9C921E89-706F-46E8-ADE3-A806289D43A5|1||||C165904|TREE MIX POLLEN IGG AB RAST SCORE|||||||L/MIN/M2|||||||POSITIVE||BOLUS||||NORMAL|NOT DONE||||MONOCYTE|CONTAMINATED|NA|TRICHROME STAIN|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|Y|||N|2||58||OBSERVATION|1970-07-21|1972-10-11|||||1966-08-13||1970-09-15|U|1963-05-02
TRIAL STUDY 134XCP|LB|9C921E89-706F-46E8-ADE3-A806289D43A5|2||||ACHRAB|ACETYLCHOLINE RECEPTOR ANTIBODY|||||||CARTRIDGE|||||||NEGATIVE||10^6 ORGANISMS/MG||||NORMAL|NOT DONE||||KERATINOCYTE|FRESH|N|DOUBLE IMMUNODIFFUSION|GMI % FORMULA||N|NA|N|NA|||Y|2||58||FOLLOW-UP|1960-11-14|1968-01-28|||||1960-01-29||1970-11-29|Y|1963-06-24
TRIAL STUDY 134XCP|LB|9C921E89-706F-46E8-ADE3-A806289D43A5|1||||HCGND|CHORIOGONADOTROPIN|||||||FIU|||||||BORDERLINE||UMOL/L/MIN||||LOW|NOT DONE||||INFRANATANT, SERUM|DRIED|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|CKD-EPI CREATININE FORMULA||Y|Y|NA|NA|||U|3||39||RUN-IN|1963-07-14|1960-02-25|||||1963-01-06||1964-06-08|U|1965-09-03
TRIAL STUDY 134XCP|LB|9C921E89-706F-46E8-ADE3-A806289D43A5|2||||LYMMCELY|LYMPHOMA CELLS/LYMPHOCYTES|||||||MOSM/L|||||||INDETERMINATE||10^11/L||||ABNORMAL|NOT DONE||||LYSATE|FROZEN|NA|IMMUNOCHROMATOGRAPHY|ASH FIBROSURE FORMULA||Y|Y|U|Y|||NA|3||39||SCREENING|1972-09-20|1968-02-21|||||1972-04-11||1968-02-02|N|1960-07-23
TRIAL STUDY 134XCP|LB|9C921E89-706F-46E8-ADE3-A806289D43A5|1||||ADSDNA|ANTI-DOUBLE STRANDED DNA|||||||BQ/L|||||||NEGATIVE||UIU/L||||ABNORMAL|NOT DONE||||REFLEX TEAR|ROOM TEMPERATURE|U|PYROSEQUENCING|CKD-EPI CREATININE FORMULA||Y|N|U|Y|||N|4||88||FOLLOW-UP|1971-10-09|1967-09-09|||||1972-02-22||1961-09-02|Y|1969-08-12
TRIAL STUDY 134XCP|LB|9C921E89-706F-46E8-ADE3-A806289D43A5|2||||ANTIDPRS|ANTIDEPRESSANTS|||||||NMOL/L|||||||NEGATIVE||OD UNIT||||HIGH|NOT DONE||||EPIDERMAL TISSUE|DRIED|NA|SPECT SCAN|FIBROSIS 4 FORMULA||Y|N|U|U|||U|4||88||BLINDED TREATMENT|1966-01-05|1970-07-23|||||1972-06-28||1961-02-28|NA|1971-06-02
TRIAL STUDY 134XCP|LB|9C921E89-706F-46E8-ADE3-A806289D43A5|1||||HBLEPRHB|HEMOGLOBIN LEPORE/TOTAL HEMOGLOBIN|||||||MG/L FEU|||||||BORDERLINE||UL/DOSE||||HIGH|NOT DONE||||CERUMEN|CONCENTRATED|Y|COMPLEMENT FIXATION|COCKCROFT-GAULT FORMULA||U|Y|U|NA|||Y|5||7||OBSERVATION|1966-03-14|1966-03-14|||||1960-01-19||1970-09-14|U|1967-05-08
TRIAL STUDY 134XCP|LB|9C921E89-706F-46E8-ADE3-A806289D43A5|2||||C130094|WESTERN RAGWEED POLLEN IGG|||||||TUBERCULIN UNIT/ML|||||||INDETERMINATE||U/MMOL||||ABNORMAL|NOT DONE||||BREAST MILK|THAWED|N|LANDOLT RING|ASH FIBROSURE FORMULA||NA|N|NA|N|||N|5||7||FOLLOW-UP|1972-08-31|1971-10-07|||||1963-02-27||1971-06-18|Y|1960-12-16
TRIAL STUDY 134XCP|LB|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|1||||IGGSYNRT|IGG SYNTHESIS RATE|||||||L/S/KPA|||||||POSITIVE||IU/DAY||||HIGH|NOT DONE||||PERITONEAL FLUID|FROZEN|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|CKD-EPI FORMULA||N|N|N|N|||Y|1||38||OPEN LABEL TREATMENT|1962-05-11|1964-02-01|||||1966-10-30||1964-05-17|NA|1973-02-17
TRIAL STUDY 134XCP|LB|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|2||||INTLK29|INTERLEUKIN 29|||||||MU/L|||||||NEGATIVE||10^7 CFU/ML||||HIGH|NOT DONE||||INFRANATANT, PLASMA|REFRIGERATED|U|POLYMERASE CHAIN REACTION|MDRD FORMULA||Y|U|NA|U|||N|1||38||FOLLOW-UP|1964-08-21|1973-04-12|||||1966-05-09||1961-12-30|NA|1972-04-24
TRIAL STUDY 134XCP|LB|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|1||||GLYHLACD|GLYCOCHOLIC ACID|||||||/VF|||||||INDETERMINATE||RFU||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|LIPEMIC|NA|MICRONEUTRALIZATION ASSAY|MDRD ENZYMATIC FORMULA||NA|N|NA|N|||NA|2||58||TREATMENT|1972-01-02|1966-03-10|||||1968-04-15||1966-03-05|NA|1964-12-24
TRIAL STUDY 134XCP|LB|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|2||||HALPRZLM|HYDROXYALPRAZOLAM|||||||APL U|||||||INDETERMINATE||BOWL||||NORMAL|NOT DONE||||PERSPIRATION|GELLED|U|HPLC|FIBROMETER FORMULA||N|NA|Y|Y|||N|2||58||OBSERVATION|1961-03-23|1964-03-20|||||1960-05-06||1970-08-24|N|1967-11-17
TRIAL STUDY 134XCP|LB|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|1||||FGF23C|FIBROBLAST GROWTH FACTOR 23, C-TERMINAL|||||||UM/DAY|||||||INVALID||10^9 ORGANISMS/G||||HIGH|NOT DONE||||CAPILLARY BLOOD|REFRIGERATED|U|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|CKD-EPI FORMULA||N|U|Y|N|||NA|3||39||SCREENING|1972-03-14|1964-10-18|||||1972-04-28||1965-04-14|Y|1970-01-13
TRIAL STUDY 134XCP|LB|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|2||||IGAGM|IGG IGM IGA TOTAL|||||||G/DAY|||||||NEGATIVE||MOL/L||||ABNORMAL|NOT DONE||||PLEURAL FLUID|ICTERIC|Y|ENDPOINT DILUTION ASSAY|GMI % FORMULA||NA|Y|NA|Y|||Y|3||39||TREATMENT|1969-11-23|1967-11-25|||||1961-01-29||1969-12-08|U|1963-08-16
TRIAL STUDY 134XCP|LB|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|1||||IA2AB|INSULINOMA-ASSOCIATED PROTEIN 2 ANTIBODY|||||||10^6 RNA COPIES/ML|||||||NEGATIVE||ML/S||||HIGH|NOT DONE||||URINE SEDIMENT|ROOM TEMPERATURE|N|PET/CT SCAN WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA||U|N|Y|Y|||Y|4||88||BLINDED TREATMENT|1970-10-07|1963-06-04|||||1972-02-21||1969-10-31|NA|1960-04-22
TRIAL STUDY 134XCP|LB|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|2||||LEUKCRBC|LEUKS CORRECTED FOR NUCL ERYTHROCYTES|||||||MILE|||||||INVALID||LOG10 CCID 50/DOSE||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|AGGLUTINATED|N|CONTRAST ENHANCED PET/CT SCAN|ASH FIBROSURE FORMULA||Y|U|NA|Y|||N|4||88||INDUCTION TREATMENT|1964-06-06|1968-09-19|||||1963-07-15||1963-12-02|U|1960-09-18
TRIAL STUDY 134XCP|LB|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|1||||SECRETIN|SECRETIN|||||||MG2/DL2|||||||INDETERMINATE||CMH2O*S2/ML||||HIGH|NOT DONE||||BONE MARROW|DRIED|NA|DIGITAL PCR|CKD-EPI FORMULA||Y|U|NA|U|||Y|5||7||BASELINE|1973-05-04|1963-07-21|||||1972-04-24||1968-02-27|NA|1971-11-06
TRIAL STUDY 134XCP|LB|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|2||||LRG1|LEUCINE RICH ALPHA-2-GLYCOPROTEIN 1|||||||DISK|||||||INVALID||MMOL/MIN/KPA/L||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|THAWED|NA|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|ASH FIBROSURE FORMULA||NA|NA|U|N|||N|5||7||WASHOUT|1962-07-02|1968-07-12|||||1964-10-19||1972-05-08|NA|1960-10-29
TRIAL STUDY 134XCP|LB|17C2A52E-1232-4CBB-A809-9DC2C863366A|1||||VITB3|NIACIN|||||||U|||||||TRACE||PT_BR||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|REFRIGERATED|NA|MOUSE PROTECTION ASSAY|MDRD 6 VARIABLE FORMULA||NA|NA|Y|NA|||N|1||38||OPEN LABEL TREATMENT|1969-06-12|1972-02-27|||||1966-02-20||1971-02-14|N|1966-11-17
TRIAL STUDY 134XCP|LB|17C2A52E-1232-4CBB-A809-9DC2C863366A|2||||ASMACT|ALPHA-SMOOTH MUSCLE ACTIN|||||||MDFI|||||||BORDERLINE||EJACULATE U||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|LIPEMIC|N|TARGETED GENOME SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|N|NA|||NA|1||38||BLINDED TREATMENT|1967-11-19|1973-02-22|||||1970-01-11||1964-08-07|Y|1961-05-17
TRIAL STUDY 134XCP|LB|17C2A52E-1232-4CBB-A809-9DC2C863366A|1||||PLSTCELE|TOTAL PLASMA CELLS/LEUKOCYTES|||||||EID 50/DOSE|||||||POSITIVE||DISK||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|AGGLUTINATED|NA|GC/MS-CI|FIBROMETER FORMULA||U|N|Y|N|||N|2||58||BASELINE|1969-04-05|1962-11-30|||||1963-02-04||1963-01-20|N|1960-10-22
TRIAL STUDY 134XCP|LB|17C2A52E-1232-4CBB-A809-9DC2C863366A|2||||GLYHLACD|GLYCOCHOLIC ACID|||||||%/MIN|||||||BORDERLINE||V/SEC||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|FROZEN|N|CONGO RED STAIN|MDRD 4 VARIABLE FORMULA||U|N|Y|NA|||U|2||58||BASELINE|1973-03-23|1960-01-18|||||1964-04-23||1964-11-13|Y|1960-09-04
TRIAL STUDY 134XCP|LB|17C2A52E-1232-4CBB-A809-9DC2C863366A|1||||INTLK26|INTERLEUKIN 26|||||||CFU/ML|||||||INVALID||CD||||LOW|NOT DONE||||ALVEOLAR AIR|UNEXPECTED ODOR|Y|MANUAL CLOT DETECTION|COCKCROFT-GAULT FORMULA||Y|NA|U|NA|||N|3||39||SCREENING|1967-01-12|1966-03-13|||||1968-06-09||1970-09-24|NA|1962-09-30
TRIAL STUDY 134XCP|LB|17C2A52E-1232-4CBB-A809-9DC2C863366A|2||||NEUTHYGR|HYPOGRANULAR NEUTROPHILS|||||||MOL/G|||||||POSITIVE||MV2/HZ||||HIGH|NOT DONE||||DIALYSIS FLUID|LACTESCENT|NA|TURBIDIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|U|Y|||Y|3||39||BASELINE|1965-02-09|1963-01-28|||||1966-04-06||1965-12-24|U|1960-09-21
TRIAL STUDY 134XCP|LB|17C2A52E-1232-4CBB-A809-9DC2C863366A|1||||KLHIGGAB|KEYHOLE LIMPET HEMOCYANIN IGG ANTIBODY|||||||%|||||||POSITIVE||G/ANIMAL||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|UNEXPECTED ODOR|Y|SPECT SCAN|COCKCROFT-GAULT FORMULA||Y|NA|Y|U|||N|4||88||OPEN LABEL TREATMENT|1967-01-19|1972-05-15|||||1969-05-29||1967-02-18|N|1960-05-23
TRIAL STUDY 134XCP|LB|17C2A52E-1232-4CBB-A809-9DC2C863366A|2||||IFIT3|INTERFERON-INDUCED 60 KDA PROTEIN|||||||U/KG|||||||INVALID||PIXEL||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|CONTAMINATED|N|IMMUNOPRECIPITATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|NA|Y|||N|4||88||OBSERVATION|1972-11-28|1968-01-03|||||1965-01-04||1965-01-31|N|1960-05-06
TRIAL STUDY 134XCP|LB|17C2A52E-1232-4CBB-A809-9DC2C863366A|1||||NFLP|NEUROFILAMENT LIGHT CHAIN PROTEIN|||||||ELISA UNIT/DOSE|||||||POSITIVE||10^4 CFU/ML||||NORMAL|NOT DONE||||CORD BLOOD|CALCIFIED|U|CONTRAST ENHANCED CT SCAN|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|U|Y|||Y|5||7||WASHOUT|1962-02-22|1968-04-30|||||1967-12-01||1968-06-19|NA|1973-04-28
TRIAL STUDY 134XCP|LB|17C2A52E-1232-4CBB-A809-9DC2C863366A|2||||LDH2|LDH ISOENZYME 2|||||||MSEC|||||||TRACE||KBQ/UL||||LOW|NOT DONE||||STOOL|CONCENTRATED|N|CELLULAR PROLIFERATION ASSAY|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|Y|||N|5||7||WASHOUT|1966-12-13|1961-07-26|||||1972-04-12||1972-04-25|Y|1970-08-26
TRIAL STUDY 134XCP|LB|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|1||||TRACP5B|TARTRATE-RESISTANT ACID PHOSPHATASE 5B|||||||NKAT/G HB|||||||TRACE||VP/ML||||NORMAL|NOT DONE||||ISOLATE|FRESH|N|LIGHT SCATTERING SPECTROSCOPY|MDRD ENZYMATIC FORMULA||N|U|N|NA|||N|1||38||SCREENING|1971-03-09|1968-10-17|||||1973-03-18||1962-04-21|Y|1969-03-11
TRIAL STUDY 134XCP|LB|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|2||||NTRLFAT|NEUTRAL FATS|||||||10^6 COPIES/ML|||||||POSITIVE||V||||HIGH|NOT DONE||||PROSTATIC FLUID|GELLED|Y|FLUORESCENT IMMUNOASSAY|MDRD FORMULA||U|Y|NA|N|||NA|1||38||BLINDED TREATMENT|1967-05-28|1968-09-07|||||1971-11-07||1964-06-23|Y|1972-11-01
TRIAL STUDY 134XCP|LB|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|1||||GFRBSCUA|GFR FROM CREAT,UREAN,ALB ADJ BSA|||||||ML/ANIMAL|||||||INVALID||UMOL||||NORMAL|NOT DONE||||CAPILLARY BLOOD|REFRIGERATED|NA|DIRECT SEQUENCING|CKD-EPI CYSTATIN C FORMULA||U|U|Y|NA|||N|2||58||LONG-TERM FOLLOW-UP|1960-09-25|1967-04-07|||||1970-06-29||1962-12-01|N|1962-08-20
TRIAL STUDY 134XCP|LB|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|2||||PSIGAAB|PHOSPHATIDYLSERINE IGA ANTIBODY|||||||MG/DL|||||||TRACE||TORR||||HIGH|NOT DONE||||CALCULUS|CONCENTRATED|N|CINEANGIOGRAPHY|CKD-EPI CREATININE FORMULA||Y|NA|N|N|||Y|2||58||LONG-TERM FOLLOW-UP|1971-08-14|1960-09-06|||||1965-01-29||1963-07-22|NA|1971-08-26
TRIAL STUDY 134XCP|LB|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|1||||MDC|MACROPHAGE-DERIVED CHEMOKINE|||||||FMOL/L|||||||POSITIVE||KG/CM||||LOW|NOT DONE||||SEBUM|GELLED|U|DUKE INCISION METHOD|FIBROMETER FORMULA||U|N|U|Y|||U|3||39||INDUCTION TREATMENT|1962-11-13|1961-12-02|||||1963-11-06||1972-02-13|N|1972-01-01
TRIAL STUDY 134XCP|LB|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|2||||NORMEEXR|NORMETANEPHRINE EXCRETION RATE|||||||UG/KG/MIN|||||||NEGATIVE||U/DL||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|AGGLUTINATED|N|ELECTROCHEMILUMINESCENCE|MDRD 5 VARIABLE FORMULA||Y|NA|N|U|||N|3||39||RUN-IN|1966-06-28|1969-03-11|||||1965-02-03||1971-08-10|Y|1971-02-19
TRIAL STUDY 134XCP|LB|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|1||||ERCEMIDX|ERYTHROID MATURATION INDEX|||||||IMPLANT|||||||INVALID||SIEMENS||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|SOLIDIFIED|NA|MICROSCOPY|CKD-EPI FORMULA||U|N|N|Y|||NA|4||88||OPEN LABEL TREATMENT|1964-10-01|1966-03-19|||||1971-06-26||1960-08-22|U|1971-09-09
TRIAL STUDY 134XCP|LB|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|2||||C130116|BEE MIX ANTIGEN IGE ANTIBODY|||||||CCID 50/DOSE|||||||POSITIVE||KPA||||LOW|NOT DONE||||EPITHELIAL CELL|AUTOLYZED|Y|PHOTOMETRY|FIBROMETER FORMULA||Y|Y|U|U|||Y|4||88||FOLLOW-UP|1962-08-27|1969-05-20|||||1971-08-13||1967-05-09|N|1970-12-23
TRIAL STUDY 134XCP|LB|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|1||||CENTROAB|CENTROMERE B ANTIBODIES|||||||U/ANIMAL|||||||BORDERLINE||BQ/G||||HIGH|NOT DONE||||FLUID|ICTERIC|NA|DNA MICROARRAY|ASH FIBROSURE FORMULA||N|NA|N|U|||U|5||7||INDUCTION TREATMENT|1966-11-11|1965-10-13|||||1968-09-23||1971-05-03|Y|1963-09-07
TRIAL STUDY 134XCP|LB|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|2||||FATBODOV|FAT BODIES, OVAL|||||||M/SEC2|||||||POSITIVE||CD*S/M2||||HIGH|NOT DONE||||EPITHELIAL CELL|CLOTTED|Y|WRIGHT-GIEMSA STAIN|GMI % FORMULA||U|U|N|NA|||N|5||7||SCREENING|1973-06-30|1966-12-14|||||1963-05-06||1970-02-27|U|1969-01-22
TRIAL STUDY 134XCP|LB|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|1||||AMYLOIDB|AMYLOID, BETA|||||||KN/CM2|||||||TRACE||UGEQ/L||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|GELLED|NA|GEL ELECTROPHORESIS|CKD-EPI CYSTATIN C FORMULA||NA|N|U|U|||N|1||38||SCREENING|1962-02-19|1973-01-29|||||1966-09-20||1965-12-10|Y|1972-01-07
TRIAL STUDY 134XCP|LB|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|2||||PTHMM|PARATHYROID HORMONE, MID-MOLECULE|||||||TROCHE|||||||INDETERMINATE||PMOL/L/H||||HIGH|NOT DONE||||MECONIUM|HEMOLYZED|U|RADIOIMMUNOPRECIPITATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|Y|NA|||NA|1||38||BASELINE|1962-03-28|1968-05-21|||||1972-09-12||1972-11-13|NA|1963-12-11
TRIAL STUDY 134XCP|LB|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|1||||NORNCTN|NORNICOTINE|||||||LOG10 ELISA UNIT|||||||INDETERMINATE||UG/DAY||||LOW|NOT DONE||||PLEURAL TISSUE|ROOM TEMPERATURE|Y|BRDU CELLULAR PROLIFERATION ASSAY|GMI % FORMULA||NA|Y|N|U|||Y|2||58||WASHOUT|1969-03-05|1969-02-02|||||1966-07-04||1966-07-23|U|1964-06-22
TRIAL STUDY 134XCP|LB|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|2||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||/LPF|||||||INDETERMINATE||CGY||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|LACTESCENT|U|IMMUNORADIOMETRIC ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|NA|N|||N|2||58||OPEN LABEL TREATMENT|1963-05-08|1965-11-22|||||1972-04-23||1963-06-11|N|1973-08-09
TRIAL STUDY 134XCP|LB|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|1||||MSPIKEXR|MONOCLONAL PROTEIN SPIKE EXCRETION RATE|||||||BOX|||||||NEGATIVE||NMOL BCE/MMOL||||NORMAL|NOT DONE||||NAIL|UNEXPECTED ODOR|N|OLIGO ACGH|GMI % FORMULA||NA|N|N|Y|||N|3||39||WASHOUT|1960-12-06|1968-01-25|||||1970-10-25||1973-07-13|U|1962-05-17
TRIAL STUDY 134XCP|LB|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|2||||NUCCE|NUCLEATED CELLS|||||||COULOMB|||||||POSITIVE||MM||||LOW|NOT DONE||||EPITHELIAL CELL|CALCIFIED|U|PET/MRI SCAN|MDRD 5 VARIABLE FORMULA||N|NA|Y|Y|||Y|3||39||TREATMENT|1963-04-18|1965-05-03|||||1964-12-11||1969-01-09|NA|1971-11-09
TRIAL STUDY 134XCP|LB|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|1||||ROM|REACTIVE OXYGEN METABOLITE|||||||G/DAY|||||||POSITIVE||BAU/ML||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|ICTERIC|Y|MICROBIAL CULTURE, LIQUID|NASH FIBROSURE FORMULA||U|U|N|Y|||NA|4||88||OPEN LABEL TREATMENT|1972-09-19|1966-11-14|||||1960-05-10||1973-05-08|NA|1967-08-24
TRIAL STUDY 134XCP|LB|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|2||||CL|CHLORIDE|||||||/500 WBC|||||||BORDERLINE||10^8 PFU||||NORMAL|NOT DONE||||BLOOD|FROZEN|NA|LC/MS|GMI % FORMULA||N|N|N|U|||N|4||88||WASHOUT|1966-04-27|1964-07-06|||||1967-06-16||1972-12-03|NA|1972-10-22
TRIAL STUDY 134XCP|LB|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|1||||RLP|RLP CHOLESTEROL|||||||MEQ/DL|||||||TRACE||LOG10 CCID 50/DOSE||||ABNORMAL|NOT DONE||||COLOSTRUM|HEMOLYZED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|CKD-EPI CYSTATIN C FORMULA||N|N|U|U|||Y|5||7||RUN-IN|1967-08-27|1960-01-02|||||1962-08-08||1960-03-12|Y|1960-12-28
TRIAL STUDY 134XCP|LB|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|2||||GLDH|GLUTAMATE DEHYDROGENASE|||||||MCI|||||||INVALID||CGY||||HIGH|NOT DONE||||ARTERIAL BLOOD|FRESH|U|FLUORIMETRY|FIBROMETER FORMULA||N|Y|NA|N|||Y|5||7||RUN-IN|1960-01-04|1971-05-31|||||1961-10-18||1964-06-30|Y|1961-09-22
TRIAL STUDY 134XCP|LB|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|1||||BASOCE|BASOPHILS/TOTAL CELLS|||||||PFU/ML|||||||BORDERLINE||10^6 CFU/ML||||NORMAL|NOT DONE||||PLASMA|CLOTTED|N|X-RAY|CKD-EPI FORMULA||N|U|NA|NA|||N|1||38||OBSERVATION|1962-08-03|1969-08-04|||||1970-12-05||1964-05-19|NA|1970-09-20
TRIAL STUDY 134XCP|LB|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|2||||INTLK1A|INTERLEUKIN 1 ALPHA|||||||AMPULE|||||||TRACE||MEQ/KG||||ABNORMAL|NOT DONE||||GASTRIC FLUID|NON-HEMOLYZED|N|RULER MEASUREMENT METHOD|GMI % FORMULA||NA|U|NA|U|||U|1||38||BASELINE|1972-10-17|1966-02-24|||||1964-12-03||1964-08-11|U|1970-03-19
TRIAL STUDY 134XCP|LB|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|1||||CACREAT|CALCIUM/CREATININE|||||||10^7 CFU|||||||INVALID||MET*H||||NORMAL|NOT DONE||||NAIL|CONTAMINATED|Y|LC/MS|COCKCROFT-GAULT FORMULA||NA|NA|Y|NA|||N|2||58||CONTINUATION TREATMENT|1965-08-10|1963-10-22|||||1967-12-18||1967-07-07|N|1962-04-28
TRIAL STUDY 134XCP|LB|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|2||||MYCY|MYELOCYTES|||||||G/U|||||||INVALID||PIXELS/IN||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|DRIED|NA|PLETHYSMOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|N|||Y|2||58||SCREENING|1972-06-20|1969-03-29|||||1969-11-24||1968-04-20|U|1965-12-30
TRIAL STUDY 134XCP|LB|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|1||||DCA|DEOXYCHOLATE|||||||IU/DL|||||||TRACE||PMOL/DAY||||HIGH|NOT DONE||||SKIN TISSUE|SOLIDIFIED|U|EPSILOMETER|MDRD FORMULA||N|N|U|N|||NA|3||39||RUN-IN|1966-01-05|1964-05-04|||||1965-10-16||1963-05-19|U|1960-02-28
TRIAL STUDY 134XCP|LB|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|2||||INGAPAB|ISLET NEOGENESIS ASSOC PROTEIN ANTIBODY|||||||MS/MMHG|||||||INVALID||PUFF||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|CALCIFIED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA||N|Y|Y|Y|||N|3||39||RUN-IN|1969-06-15|1970-10-25|||||1962-07-12||1971-03-29|U|1962-09-18
TRIAL STUDY 134XCP|LB|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|1||||HALLUC|HALLUCINOGEN|||||||UG/MOL|||||||BORDERLINE||U/G/H||||ABNORMAL|NOT DONE||||STOOL|SOLIDIFIED|N|ANTIMICROBIAL COMBINATION TESTING|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|N|NA|||U|4||88||BASELINE|1972-11-19|1963-05-02|||||1969-05-22||1962-10-03|Y|1963-02-24
TRIAL STUDY 134XCP|LB|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|2||||NPY|NEUROPEPTIDE Y|||||||NG/L|||||||NEGATIVE||BQ/G||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|AUTOLYZED|U|ANGIOGRAPHY|COCKCROFT-GAULT FORMULA||NA|NA|U|Y|||N|4||88||WASHOUT|1965-06-12|1966-05-03|||||1968-12-24||1964-09-30|Y|1968-01-16
TRIAL STUDY 134XCP|LB|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|1||||NEUTAGR|AGRANULAR NEUTROPHILS|||||||UL/DOSE|||||||BORDERLINE||MG/KG/WEEK||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|CONCENTRATED|N|OPTICAL DENSITY MEASUREMENT|FIBROSIS 4 FORMULA||Y|N|N|N|||N|5||7||SCREENING|1965-02-27|1960-07-10|||||1970-03-11||1965-06-21|N|1970-02-10
TRIAL STUDY 134XCP|LB|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|2||||METARBLE|METARUBRICYTES/LEUKOCYTES|||||||IU/DL|||||||INDETERMINATE||/40 HPFS||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|HEMOLYZED|U|RYAN BLUE STAIN|MDRD 5 VARIABLE FORMULA||NA|N|NA|N|||N|5||7||WASHOUT|1965-01-01|1960-11-26|||||1970-01-17||1962-06-06|U|1970-04-26
TRIAL STUDY 134XCP|LB|585A17D7-12A3-40C8-811F-339497B9D09C|1||||BLSTLMLY|LEUKEMIC BLASTS/LYMPHOCYTES|||||||/100 HPFS|||||||INVALID||10^7 PFU||||LOW|NOT DONE||||SEMEN|UNEXPECTED ODOR|U|DUKE INCISION METHOD|MDRD 5 VARIABLE FORMULA||Y|Y|U|NA|||U|1||38||LONG-TERM FOLLOW-UP|1961-08-08|1973-02-26|||||1961-05-06||1971-10-03|U|1960-06-20
TRIAL STUDY 134XCP|LB|585A17D7-12A3-40C8-811F-339497B9D09C|2||||CRYOFBRN|CRYOFIBRINOGEN|||||||UG/KG/DAY|||||||INDETERMINATE||KM||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|HEMOLYZED|NA|JAFFE REACTION|HEPASCORE FORMULA||NA|N|U|N|||U|1||38||OPEN LABEL TREATMENT|1963-10-31|1961-03-16|||||1970-10-17||1963-01-19|U|1970-12-14
TRIAL STUDY 134XCP|LB|585A17D7-12A3-40C8-811F-339497B9D09C|1||||FACTXIVA|FACTOR XIV ACTIVITY|||||||P|||||||TRACE||MG/H||||LOW|NOT DONE||||VENOUS CORD BLOOD|PARAFFIN-EMBEDDED|Y|IMMUNOFIXATION ELECTROPHORESIS|MDRD 5 VARIABLE FORMULA||N|Y|NA|NA|||U|2||58||BLINDED TREATMENT|1964-02-29|1960-08-29|||||1970-08-01||1970-05-25|U|1968-08-30
TRIAL STUDY 134XCP|LB|585A17D7-12A3-40C8-811F-339497B9D09C|2||||PT|PROTHROMBIN TIME|||||||10^9/DOSE|||||||INDETERMINATE||MEQ/UG||||ABNORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|REFRIGERATED|Y|COLORIMETRY|MDRD 4 VARIABLE FORMULA||Y|Y|N|N|||N|2||58||SCREENING|1969-05-27|1961-07-06|||||1962-03-24||1972-05-10|NA|1967-05-23
TRIAL STUDY 134XCP|LB|585A17D7-12A3-40C8-811F-339497B9D09C|1||||ETPTP|ETP TIME TO PEAK|||||||UG/ANIMAL|||||||TRACE||NGEQ/L||||LOW|NOT DONE||||INFRANATANT, SERUM|GELLED|NA|SNP ARRAY|NASH FIBROSURE FORMULA||U|NA|Y|N|||U|3||39||RUN-IN|1970-12-12|1970-12-08|||||1968-02-01||1962-03-11|Y|1964-07-10
TRIAL STUDY 134XCP|LB|585A17D7-12A3-40C8-811F-339497B9D09C|2||||DECORIN|DECORIN|||||||NMOL BCE/MMOL|||||||BORDERLINE||TITER||||ABNORMAL|NOT DONE||||SERUM|SOLIDIFIED|Y|TRICHROME STAIN|CKD-EPI CREATININE FORMULA||N|Y|NA|N|||U|3||39||RUN-IN|1965-08-09|1960-12-11|||||1966-10-26||1964-10-02|Y|1962-02-07
TRIAL STUDY 134XCP|LB|585A17D7-12A3-40C8-811F-339497B9D09C|1||||CSGRAN|GRANULAR CASTS|||||||UG/H|||||||POSITIVE||MM||||LOW|NOT DONE||||SERUM OR PLASMA|AGGLUTINATED|Y|FUNCTIONAL MRI|CKD-EPI CYSTATIN C FORMULA||NA|NA|N|U|||Y|4||88||BASELINE|1962-11-19|1968-01-15|||||1964-06-22||1961-01-17|Y|1969-05-04
TRIAL STUDY 134XCP|LB|585A17D7-12A3-40C8-811F-339497B9D09C|2||||INLCLR|INULIN CLEARANCE|||||||/10^3|||||||POSITIVE||MS/MMHG||||LOW|NOT DONE||||PLATELET|CONCENTRATED|Y|AUDIOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|U|NA|||U|4||88||OBSERVATION|1966-04-23|1961-08-08|||||1967-08-18||1964-04-12|Y|1960-09-04
TRIAL STUDY 134XCP|LB|585A17D7-12A3-40C8-811F-339497B9D09C|1||||FUNGI|FUNGI|||||||KBQ|||||||NEGATIVE||UG/MIN||||LOW|NOT DONE||||WHITE MATTER TISSUE|AGGLUTINATED|N|DXA SCAN|FIBROTEST FORMULA||Y|NA|Y|U|||U|5||7||FOLLOW-UP|1967-02-09|1965-07-22|||||1964-03-16||1968-07-11|N|1973-04-04
TRIAL STUDY 134XCP|LB|585A17D7-12A3-40C8-811F-339497B9D09C|2||||CAEXR|CALCIUM EXCRETION RATE|||||||10^12 IU/L|||||||INDETERMINATE||MU||||HIGH|NOT DONE||||SPUTUM|CONTAMINATED|NA|MAMMOGRAPHY|FIBROSIS 4 FORMULA||N|Y|N|Y|||N|5||7||BASELINE|1965-05-02|1972-08-13|||||1966-04-16||1962-04-01|Y|1964-04-06
TRIAL STUDY 134XCP|LB|D777661E-DF03-4221-88CC-34EB805EF5DB|1||||RDWR|RET VOLUME DISTRIBUTION WIDTH|||||||KG/CM2|||||||TRACE||ABSORBANCE U/ML||||ABNORMAL|NOT DONE||||KERATINOCYTE|DRIED|N|RAJI CELL EIA|HEPASCORE FORMULA||U|U|N|N|||NA|1||38||OBSERVATION|1966-04-30|1965-03-01|||||1963-05-21||1972-09-30|NA|1968-09-02
TRIAL STUDY 134XCP|LB|D777661E-DF03-4221-88CC-34EB805EF5DB|2||||ALTCPHRL|ALPHA TOCOPHEROL|||||||JDF UNIT|||||||NEGATIVE||LOG10 TCID 50/DOSE||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|CLOTTED|NA|TARGETED TRANSCRIPTOME SEQUENCING|GMI % FORMULA||NA|U|U|Y|||Y|1||38||WASHOUT|1969-05-30|1961-05-08|||||1970-06-17||1965-12-15|NA|1961-08-16
TRIAL STUDY 134XCP|LB|D777661E-DF03-4221-88CC-34EB805EF5DB|1||||MYCEMIDX|MYELOID MATURATION INDEX|||||||ML/S|||||||INVALID||CD*S/M2||||HIGH|NOT DONE||||BUFFY COAT|DRIED|N|IMMUNO-PET SCAN|HEPASCORE FORMULA||N|U|U|NA|||Y|2||58||CONTINUATION TREATMENT|1967-07-03|1963-05-20|||||1963-02-21||1970-02-21|Y|1966-01-11
TRIAL STUDY 134XCP|LB|D777661E-DF03-4221-88CC-34EB805EF5DB|2||||C165886|WHITE OAK POLLEN IGE AB RAST SCORE|||||||GMFI|||||||TRACE||MV2/HZ||||LOW|NOT DONE||||DISCHARGE|AUTOLYZED|Y|MUGA|MDRD ENZYMATIC FORMULA||U|NA|NA|NA|||N|2||58||TREATMENT|1973-06-11|1969-05-06|||||1965-09-09||1960-03-20|Y|1971-11-05
TRIAL STUDY 134XCP|LB|D777661E-DF03-4221-88CC-34EB805EF5DB|1||||APOE4|APOLIPOPROTEIN E4|||||||UG/MOL|||||||NEGATIVE||UG/MIN||||HIGH|NOT DONE||||HAIR|DRIED|N|DYNAMOMETRY|NASH FIBROSURE FORMULA||U|U|U|Y|||U|3||39||INDUCTION TREATMENT|1967-08-12|1966-02-01|||||1972-05-15||1969-11-03|U|1968-02-20
TRIAL STUDY 134XCP|LB|D777661E-DF03-4221-88CC-34EB805EF5DB|2||||ADPNCTN|ADIPONECTIN|||||||PIXELS/CM|||||||BORDERLINE||VIRTUAL PIXEL||||NORMAL|NOT DONE||||REFLEX TEAR|ICTERIC|N|QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROTEST FORMULA||Y|Y|NA|U|||U|3||39||OPEN LABEL TREATMENT|1963-08-10|1967-09-13|||||1969-08-21||1961-03-21|U|1970-06-06
TRIAL STUDY 134XCP|LB|D777661E-DF03-4221-88CC-34EB805EF5DB|1||||HBGCHTHB|HEMOGLOBIN G COUSHATTA/TOTAL HEMOGLOBIN|||||||PT_BR|||||||POSITIVE||CL||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|N|BIOPSY|COCKCROFT-GAULT FORMULA||U|NA|N|U|||N|4||88||SCREENING|1972-03-14|1971-06-17|||||1973-04-20||1970-05-16|Y|1965-09-02
TRIAL STUDY 134XCP|LB|D777661E-DF03-4221-88CC-34EB805EF5DB|2||||LYMCLFLE|LYMPHOCYTES, CLEFTED/LEUKOCYTES|||||||PSEC|||||||INDETERMINATE||LOG10 ELISA UNIT/DOSE||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|AUTOLYZED|U|MYELOPEROXIDASE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|Y|NA|||Y|4||88||RUN-IN|1969-09-13|1973-07-18|||||1972-11-23||1966-07-30|NA|1971-11-03
TRIAL STUDY 134XCP|LB|D777661E-DF03-4221-88CC-34EB805EF5DB|1||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||BAG|||||||INVALID||FEU||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|CONTAMINATED|U|PALPATION|COCKCROFT-GAULT FORMULA||NA|Y|N|U|||U|5||7||OBSERVATION|1960-03-13|1969-12-01|||||1968-01-10||1967-06-02|Y|1969-05-30
TRIAL STUDY 134XCP|LB|D777661E-DF03-4221-88CC-34EB805EF5DB|2||||INTLK1A|INTERLEUKIN 1 ALPHA|||||||DEG|||||||POSITIVE||RAD||||HIGH|NOT DONE||||EMESIS|UNEXPECTED ODOR|NA|TEST STRIP|GMI MMOL/MOL FORMULA||U|NA|N|Y|||Y|5||7||BASELINE|1967-10-17|1965-04-22|||||1964-09-04||1970-05-25|Y|1961-04-11
TRIAL STUDY 134XCP|LB|67828FC5-94DE-4A68-83DE-F86AA8F86D72|1||||CARBXHGB|CARBOXYHEMOGLOBIN|||||||10^4 CFU/ML|||||||BORDERLINE||CAPFUL||||LOW|NOT DONE||||SUPERNATANT, SERUM|UNEXPECTED ODOR|N|IMMUNOBLOT|MDRD ENZYMATIC FORMULA||U|NA|U|N|||U|1||38||BLINDED TREATMENT|1970-03-13|1973-04-23|||||1967-11-25||1964-12-20|U|1961-08-04
TRIAL STUDY 134XCP|LB|67828FC5-94DE-4A68-83DE-F86AA8F86D72|2||||TROPONI3|TROPONIN I TYPE 3|||||||UCI/L|||||||BORDERLINE||YEARS||||HIGH|NOT DONE||||DIALYSIS FLUID|PARAFFIN-EMBEDDED|Y|TOTAL BODY IRRADIATION|CKD-EPI CREATININE FORMULA||U|N|Y|N|||N|1||38||SCREENING|1963-03-26|1971-05-27|||||1960-08-07||1965-04-04|Y|1961-01-04
TRIAL STUDY 134XCP|LB|67828FC5-94DE-4A68-83DE-F86AA8F86D72|1||||IGG1|IMMUNOGLOBULIN G SUBCLASS 1|||||||ML/(MIN*100ML)|||||||TRACE||BU||||LOW|NOT DONE||||AMNIOTIC FLUID|LIPEMIC|U|DARK FIELD MICROSCOPY|NASH FIBROSURE FORMULA||NA|U|Y|Y|||NA|2||58||OBSERVATION|1971-06-27|1961-04-20|||||1966-11-06||1967-05-30|Y|1966-02-23
TRIAL STUDY 134XCP|LB|67828FC5-94DE-4A68-83DE-F86AA8F86D72|2||||MYL3|MYOSIN LIGHT CHAIN 3|||||||UG/DL|||||||BORDERLINE||TORR||||LOW|NOT DONE||||SEMINAL FLUID|CONCENTRATED|NA|MALDI-TOF|ASH FIBROSURE FORMULA||N|U|U|U|||NA|2||58||WASHOUT|1963-01-11|1966-10-15|||||1969-07-05||1960-08-29|Y|1973-09-03
TRIAL STUDY 134XCP|LB|67828FC5-94DE-4A68-83DE-F86AA8F86D72|1||||SFTPD|SURFACTANT PROTEIN D|||||||NMOL BCE/MMOL|||||||INVALID||LOZENGE||||NORMAL|NOT DONE||||CORD BLOOD|NON-HEMOLYZED|N|BRDU CELLULAR PROLIFERATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|N|||N|3||39||CONTINUATION TREATMENT|1965-04-16|1966-07-29|||||1968-05-07||1967-12-30|Y|1971-06-06
TRIAL STUDY 134XCP|LB|67828FC5-94DE-4A68-83DE-F86AA8F86D72|2||||IGHG4|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 4|||||||UMOL/KG/MIN|||||||NEGATIVE||WEBER||||NORMAL|NOT DONE||||INFRANATANT, SERUM|DRIED|Y|LANDOLT RING|FIBROMETER FORMULA||N|U|Y|N|||N|3||39||RUN-IN|1970-09-08|1963-11-02|||||1972-04-15||1964-02-04|NA|1968-04-14
TRIAL STUDY 134XCP|LB|67828FC5-94DE-4A68-83DE-F86AA8F86D72|1||||CSGRANF|GRANULAR FINE CASTS|||||||MS2|||||||BORDERLINE||GY/MIN||||NORMAL|NOT DONE||||CERUMEN|HEMOLYZED|Y|NEXT GENERATION SEQUENCING|FIBROSIS 4 FORMULA||U|NA|U|Y|||U|4||88||BASELINE|1971-09-07|1973-08-08|||||1969-12-16||1966-05-11|U|1972-05-09
TRIAL STUDY 134XCP|LB|67828FC5-94DE-4A68-83DE-F86AA8F86D72|2||||HISTAB|HISTONE ANTIBODIES|||||||/100 HPFS|||||||INDETERMINATE||10^9/L||||NORMAL|NOT DONE||||PLASMA|THAWED|NA|CONTRAST ENHANCED MRI|GMI % FORMULA||Y|N|N|Y|||U|4||88||BASELINE|1965-06-06|1966-05-25|||||1968-01-17||1970-09-10|N|1970-03-30
TRIAL STUDY 134XCP|LB|67828FC5-94DE-4A68-83DE-F86AA8F86D72|1||||ALDEPX|ALDRIN EPOXIDASE|||||||UG|||||||INDETERMINATE||CAL||||LOW|NOT DONE||||REFLEX TEAR|CONCENTRATED|N|NUCLEIC ACID AMPLIFICATION TEST|CKD-EPI CYSTATIN C FORMULA||Y|U|Y|U|||Y|5||7||BASELINE|1963-12-13|1961-11-11|||||1968-06-14||1961-07-09|NA|1972-08-07
TRIAL STUDY 134XCP|LB|67828FC5-94DE-4A68-83DE-F86AA8F86D72|2||||ALTCPHRL|ALPHA TOCOPHEROL|||||||MMOL/L|||||||NEGATIVE||PSEC||||NORMAL|NOT DONE||||DIALYSIS FLUID|HEMOLYZED|Y|EPSILOMETER|FIBROMETER FORMULA||U|U|N|N|||Y|5||7||WASHOUT|1970-12-05|1961-09-19|||||1971-12-05||1972-07-01|N|1971-07-17
TRIAL STUDY 134XCP|LB|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|1||||LRZPM|LORAZEPAM|||||||CI|||||||TRACE||COULOMB||||LOW|NOT DONE||||MIXED VENOUS BLOOD|FRESH|NA|SNELLEN EYE CHART|CKD-EPI FORMULA||N|Y|N|Y|||NA|1||38||OBSERVATION|1961-04-21|1972-10-27|||||1969-02-09||1972-05-17|N|1970-01-05
TRIAL STUDY 134XCP|LB|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|2||||PORPH|PORPHYRIN|||||||UG/M2/MIN|||||||BORDERLINE||AFU||||NORMAL|NOT DONE||||SEBUM|THAWED|NA|X-RAY FLUORESCENCE SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA||U|Y|N|NA|||NA|1||38||RUN-IN|1971-11-08|1971-10-15|||||1965-04-27||1964-02-23|N|1960-12-29
TRIAL STUDY 134XCP|LB|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|1||||NEUTBNE|NEUTROPHILS BAND FORM/ NEUTROPHILS|||||||MIN/DAY|||||||NEGATIVE||UM/S||||HIGH|NOT DONE||||SEMEN|CONTAMINATED|NA|CONTRAST ENHANCED MRI|COCKCROFT-GAULT FORMULA||N|Y|NA|NA|||U|2||58||TREATMENT|1971-09-16|1968-02-03|||||1967-01-04||1966-05-26|U|1966-02-17
TRIAL STUDY 134XCP|LB|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|2||||TCDCA|TAUROCHENODEOXYCHOLATE|||||||UMOL/L/H|||||||INVALID||MMOL||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|HEMOLYZED|Y|TONOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|U|||Y|2||58||INDUCTION TREATMENT|1972-04-18|1962-11-27|||||1963-07-08||1968-11-03|N|1969-03-01
TRIAL STUDY 134XCP|LB|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|1||||INGAPAB|ISLET NEOGENESIS ASSOC PROTEIN ANTIBODY|||||||10^6 ORGANISMS/ML|||||||BORDERLINE||TSP EQ||||LOW|NOT DONE||||NAIL|CLOTTED|Y|SLOAN LETTER EYE CHART 1.25%|CKD-EPI FORMULA||NA|U|N|Y|||NA|3||39||OBSERVATION|1966-04-26|1966-12-05|||||1973-03-18||1966-03-07|N|1965-10-06
TRIAL STUDY 134XCP|LB|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|2||||APOA5|APOLIPOPROTEIN A5|||||||ML/KG/H|||||||INDETERMINATE||VG/ML||||LOW|NOT DONE||||CAPILLARY BLOOD|CALCIFIED|NA|LASER CAPTURE MICRODISSECTION|HEPASCORE FORMULA||NA|NA|N|U|||N|3||39||OBSERVATION|1963-07-10|1960-12-17|||||1965-09-22||1970-04-23|N|1962-01-17
TRIAL STUDY 134XCP|LB|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|1||||CKBBCK|CREATINE KINASE BB/TOTAL CREATINE KINASE|||||||MG/M2/MIN|||||||NEGATIVE||MKAT||||LOW|NOT DONE||||URINE SEDIMENT|DRIED|U|PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|N|N|||NA|4||88||TREATMENT|1973-02-13|1970-01-19|||||1965-02-03||1964-08-19|Y|1971-07-19
TRIAL STUDY 134XCP|LB|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|2||||C165913|NUT MIX IGG AB RAST SCORE|||||||10^9 ORGANISMS/MG|||||||INDETERMINATE||G/ANIMAL/WK||||LOW|NOT DONE||||BLOOD|ICTERIC|NA|DUCTOGRAPHY|GMI MMOL/MOL FORMULA||N|U|N|U|||Y|4||88||TREATMENT|1972-12-11|1966-02-16|||||1971-06-02||1965-08-28|Y|1962-12-09
TRIAL STUDY 134XCP|LB|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|1||||GUSA|GLUCURONIDASE, ALPHA|||||||TRANSDUCING UNIT/ML|||||||TRACE||UL/KG/DAY||||NORMAL|NOT DONE||||SYNOVIAL FLUID|LIPEMIC|NA|MRI WITHOUT CONTRAST|MDRD FORMULA||NA|NA|N|NA|||U|5||7||RUN-IN|1965-06-01|1966-01-16|||||1970-04-05||1964-08-02|Y|1962-09-29
TRIAL STUDY 134XCP|LB|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|2||||ALT|ALANINE AMINOTRANSFERASE|||||||P|||||||TRACE||MIN*MG/ML||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|LACTESCENT|Y|IMMUNOFIXATION ELECTROPHORESIS|FIBROTEST FORMULA||NA|U|U|N|||NA|5||7||LONG-TERM FOLLOW-UP|1964-07-23|1962-07-25|||||1968-11-16||1973-01-15|Y|1967-01-23
TRIAL STUDY 134XCP|LB|650E5DFA-08CC-413C-B43D-070E61353E6E|1||||TESTOSFR|TESTOSTERONE, FREE|||||||G/L|||||||BORDERLINE||CI||||HIGH|NOT DONE||||ARTERIAL BLOOD|UNEXPECTED ODOR|U|IMMUNOCHROMATOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|Y|N|U|||NA|1||38||OPEN LABEL TREATMENT|1965-07-08|1968-04-08|||||1963-02-02||1973-07-28|NA|1971-02-19
TRIAL STUDY 134XCP|LB|650E5DFA-08CC-413C-B43D-070E61353E6E|2||||MITOM2AB|MITOCHONDRIAL M2 ANTIBODY|||||||KPA/L/SEC|||||||POSITIVE||WEEKS||||HIGH|NOT DONE||||EXPIRED AIR|ICTERIC|U|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|HEPASCORE FORMULA||Y|N|Y|N|||Y|1||38||BASELINE|1969-08-10|1960-05-15|||||1964-04-14||1969-08-24|N|1967-02-16
TRIAL STUDY 134XCP|LB|650E5DFA-08CC-413C-B43D-070E61353E6E|1||||TPAAG|TISSUE PLASMINOGEN ACTIVATOR ANTIGEN|||||||MOL/G|||||||NEGATIVE||NU/CL||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|AGGLUTINATED|U|FREEZING POINT DEPRESSION|MDRD 6 VARIABLE FORMULA||Y|Y|U|N|||U|2||58||LONG-TERM FOLLOW-UP|1969-03-26|1962-10-22|||||1961-07-13||1969-08-12|NA|1961-10-25
TRIAL STUDY 134XCP|LB|650E5DFA-08CC-413C-B43D-070E61353E6E|2||||BURRCE|BURR CELLS|||||||OI50|||||||INDETERMINATE||MOL/MG||||HIGH|NOT DONE||||GASTRIC FLUID|GELLED|Y|MS/MS|FIBROTEST FORMULA||Y|Y|U|NA|||N|2||58||TREATMENT|1963-08-20|1964-08-29|||||1964-08-09||1973-01-11|U|1973-06-24
TRIAL STUDY 134XCP|LB|650E5DFA-08CC-413C-B43D-070E61353E6E|1||||ACRNCRNF|ACYLCARNITINE/CARNITINE, FREE|||||||LOG10 ELISA UNIT|||||||BORDERLINE||MMOL/MOL||||NORMAL|NOT DONE||||VENOUS PLASMA|FROZEN|NA|IMMUNODIFFUSION|MDRD 6 VARIABLE FORMULA||NA|Y|N|Y|||U|3||39||OPEN LABEL TREATMENT|1973-07-16|1970-02-22|||||1969-10-19||1962-10-17|U|1966-12-11
TRIAL STUDY 134XCP|LB|650E5DFA-08CC-413C-B43D-070E61353E6E|2||||CACRALB|CALCIUM CORRECTED FOR ALBUMIN|||||||S^-1(%O2)^-1|||||||BORDERLINE||NU/CL||||HIGH|NOT DONE||||CELL PELLET|AUTOLYZED|U|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|MDRD 4 VARIABLE FORMULA||N|NA|NA|N|||Y|3||39||OPEN LABEL TREATMENT|1967-04-25|1964-07-11|||||1963-07-05||1969-10-13|Y|1962-01-09
TRIAL STUDY 134XCP|LB|650E5DFA-08CC-413C-B43D-070E61353E6E|1||||PRORUBCE|PRORUBRICYTE/TOTAL CELLS|||||||ML/ANIMAL|||||||INDETERMINATE||MMHG*MIN/L||||ABNORMAL|NOT DONE||||BUFFY COAT|HEMOLYZED|U|CONTACT SPECULAR MICROSCOPY|GMI MMOL/MOL FORMULA||U|NA|Y|NA|||U|4||88||INDUCTION TREATMENT|1961-03-25|1971-07-27|||||1971-09-21||1964-06-27|N|1971-06-04
TRIAL STUDY 134XCP|LB|650E5DFA-08CC-413C-B43D-070E61353E6E|2||||GRWHIH|GROWTH HORMONE INHIBITING HORMONE|||||||MET*MIN|||||||POSITIVE||PUFF||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CONTAMINATED|N|CELLULAR PROLIFERATION ASSAY|FIBROMETER FORMULA||NA|Y|N|N|||NA|4||88||OBSERVATION|1969-06-17|1969-10-11|||||1960-07-18||1969-09-08|NA|1960-04-17
TRIAL STUDY 134XCP|LB|650E5DFA-08CC-413C-B43D-070E61353E6E|1||||FUNGI|FUNGI|||||||MM2|||||||BORDERLINE||CI/L||||ABNORMAL|NOT DONE||||EMESIS|PARAFFIN-EMBEDDED|NA|MASS SPECTROMETRY|MDRD 5 VARIABLE FORMULA||U|U|U|NA|||N|5||7||INDUCTION TREATMENT|1969-12-15|1964-07-06|||||1961-05-14||1961-08-19|N|1970-06-23
TRIAL STUDY 134XCP|LB|650E5DFA-08CC-413C-B43D-070E61353E6E|2||||PROTSFR|PROTEIN S, FREE|||||||ML/MIN/1.73M2|||||||POSITIVE||10^6 U||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|HEMOLYZED|NA|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|MDRD 6 VARIABLE FORMULA||Y|U|NA|U|||N|5||7||BLINDED TREATMENT|1967-03-13|1961-07-31|||||1961-10-19||1962-12-02|Y|1962-06-20
TRIAL STUDY 134XCP|LB|71716F05-3ABE-4A2A-B9DD-2201A63087ED|1||||ASP|ASPARTIC ACID|||||||GY/MIN|||||||POSITIVE||G/KG||||HIGH|NOT DONE||||STOOL|REFRIGERATED|Y|PALPATION|FIBROSIS 4 FORMULA||Y|U|Y|Y|||NA|1||38||WASHOUT|1969-12-19|1963-02-07|||||1970-12-12||1969-06-16|N|1964-04-19
TRIAL STUDY 134XCP|LB|71716F05-3ABE-4A2A-B9DD-2201A63087ED|2||||C130123|NUT MIX ANTIGEN IGG ANTIBODY|||||||PNU/ML|||||||INDETERMINATE||IU/G||||HIGH|NOT DONE||||VITREOUS HUMOR|LIPEMIC|Y|SPECT SCAN|MDRD 5 VARIABLE FORMULA||Y|NA|Y|N|||NA|1||38||BASELINE|1966-10-22|1972-04-11|||||1968-06-26||1971-04-10|NA|1968-04-02
TRIAL STUDY 134XCP|LB|71716F05-3ABE-4A2A-B9DD-2201A63087ED|1||||RDWR|RET VOLUME DISTRIBUTION WIDTH|||||||FT|||||||NEGATIVE||MEQ/UG||||LOW|NOT DONE||||ABSCESS FLUID|NON-HEMOLYZED|NA|QUANTITATIVE ULTRASOUND|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|U|Y|||N|2||58||OPEN LABEL TREATMENT|1968-09-21|1961-08-25|||||1972-08-19||1966-01-15|Y|1966-01-25
TRIAL STUDY 134XCP|LB|71716F05-3ABE-4A2A-B9DD-2201A63087ED|2||||NEOPTERN|NEOPTERIN|||||||ML/KG/MIN|||||||NEGATIVE||ML/100G/MIN||||LOW|NOT DONE||||ADIPOSE TISSUE|FRESH|NA|TRANSVAGINAL ULTRASOUND|CKD-EPI FORMULA||Y|NA|U|Y|||Y|2||58||WASHOUT|1969-09-20|1966-03-06|||||1969-11-28||1969-09-15|NA|1966-02-02
TRIAL STUDY 134XCP|LB|71716F05-3ABE-4A2A-B9DD-2201A63087ED|1||||GLDAB|GLIADIN ANTIBODY|||||||USP U|||||||BORDERLINE||APL U||||NORMAL|NOT DONE||||BONE MARROW|LACTESCENT|NA|PHOROPTER|ASH FIBROSURE FORMULA||N|Y|N|N|||N|3||39||BLINDED TREATMENT|1971-01-29|1969-03-20|||||1965-05-17||1968-06-18|U|1963-06-18
TRIAL STUDY 134XCP|LB|71716F05-3ABE-4A2A-B9DD-2201A63087ED|2||||CLNZPM|CLONAZEPAM|||||||ML/KG/H|||||||INDETERMINATE||CMH2O*S/ML||||NORMAL|NOT DONE||||BASAL TEAR|UNEXPECTED ODOR|Y|FLUOROSCOPY|CKD-EPI CYSTATIN C FORMULA||N|U|NA|NA|||NA|3||39||RUN-IN|1972-07-02|1962-01-26|||||1960-09-27||1960-09-27|NA|1967-08-07
TRIAL STUDY 134XCP|LB|71716F05-3ABE-4A2A-B9DD-2201A63087ED|1||||HYALUAC|HYALURONIC ACID|||||||UG/L/H|||||||INVALID||MV||||LOW|NOT DONE||||RETICULOCYTES|SOLIDIFIED|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|FIBROSIS 4 FORMULA||N|NA|NA|Y|||U|4||88||BASELINE|1973-04-10|1967-11-14|||||1971-08-01||1966-04-03|Y|1971-12-31
TRIAL STUDY 134XCP|LB|71716F05-3ABE-4A2A-B9DD-2201A63087ED|2||||KETONEBD|KETONE BODIES|||||||DPM/MG|||||||INVALID||10^6 IU||||HIGH|NOT DONE||||MUCUS|HEMOLYZED|NA|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|GMI % FORMULA||Y|U|N|NA|||N|4||88||SCREENING|1973-05-19|1963-07-13|||||1972-04-08||1963-05-29|N|1967-04-21
TRIAL STUDY 134XCP|LB|71716F05-3ABE-4A2A-B9DD-2201A63087ED|1||||RETIM|MEDIUM ABSORPTION RETICULOCYTES|||||||DEG2|||||||INDETERMINATE||/KG||||NORMAL|NOT DONE||||MECONIUM|LIPEMIC|N|KINETIC CHROMOGENIC ASSAY|ASH FIBROSURE FORMULA||N|NA|U|N|||U|5||7||BLINDED TREATMENT|1960-05-01|1963-07-29|||||1962-08-24||1965-10-04|N|1970-12-04
TRIAL STUDY 134XCP|LB|71716F05-3ABE-4A2A-B9DD-2201A63087ED|2||||CCL20|CHEMOKINE (C-C MOTIF) LIGAND 20|||||||ANTI-XA IU/ML|||||||NEGATIVE||TUBE||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CLOTTED|U|PHOTOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|Y|||N|5||7||INDUCTION TREATMENT|1969-01-22|1969-08-14|||||1966-06-01||1971-04-05|N|1971-04-01
TRIAL STUDY 134XCP|LB|EF9208B0-4DF0-4029-AB67-8F87662D3E90|1||||FGFBF|FIBROBLAST GROWTH FACTOR BASIC FORM|||||||APPLICATION|||||||BORDERLINE||KBQ/UL||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|CONTAMINATED|U|FLUORESCENCE ANGIOGRAPHY|NASH FIBROSURE FORMULA||N|U|NA|U|||Y|1||38||TREATMENT|1961-03-03|1962-04-04|||||1967-10-12||1962-08-03|N|1964-10-05
TRIAL STUDY 134XCP|LB|EF9208B0-4DF0-4029-AB67-8F87662D3E90|2||||TESTOS|TESTOSTERONE|||||||UM|||||||NEGATIVE||PIXELS/CM||||ABNORMAL|NOT DONE||||KERATINOCYTE|THAWED|N|LYMPHANGIOGRAPHY|FIBROSIS 4 FORMULA||Y|Y|NA|NA|||NA|1||38||SCREENING|1970-06-27|1960-10-28|||||1973-07-24||1970-02-16|Y|1967-07-03
TRIAL STUDY 134XCP|LB|EF9208B0-4DF0-4029-AB67-8F87662D3E90|1||||BTLBARTL|BUTABARBITAL|||||||PHERESIS UNIT|||||||BORDERLINE||LM||||LOW|NOT DONE||||BONE|CONCENTRATED|N|CHROMOGENIC ASSAY|HEPASCORE FORMULA||NA|N|N|Y|||NA|2||58||LONG-TERM FOLLOW-UP|1966-08-16|1971-02-03|||||1967-12-26||1966-01-28|NA|1961-07-31
TRIAL STUDY 134XCP|LB|EF9208B0-4DF0-4029-AB67-8F87662D3E90|2||||CLEPNSQE|COLUMNAR EPI CELLS/NON-SQUAM EPI CELLS|||||||PIXELS/CM|||||||BORDERLINE||SEC||||ABNORMAL|NOT DONE||||BILE|AGGLUTINATED|Y|SPECT SCAN|COCKCROFT-GAULT FORMULA||Y|Y|Y|Y|||N|2||58||RUN-IN|1965-07-29|1970-06-12|||||1963-01-13||1961-04-08|N|1963-01-05
TRIAL STUDY 134XCP|LB|EF9208B0-4DF0-4029-AB67-8F87662D3E90|1||||METHPHEN|METHYLPHENIDATE|||||||DRUM|||||||TRACE||LOG EID 50/DOSE||||HIGH|NOT DONE||||INFRANATANT, PLASMA|CALCIFIED|NA|X-RAY FLUORESCENCE SPECTROMETRY|HEPASCORE FORMULA||Y|N|N|N|||NA|3||39||BASELINE|1972-10-29|1967-05-28|||||1970-02-13||1961-06-06|NA|1964-10-23
TRIAL STUDY 134XCP|LB|EF9208B0-4DF0-4029-AB67-8F87662D3E90|2||||FLUOXTN|FLUOXETINE|||||||/4.0 ML|||||||BORDERLINE||GRAVITATIONAL UNIT||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|Y|AUSCULTATION|ASH FIBROSURE FORMULA||U|NA|Y|N|||Y|3||39||FOLLOW-UP|1970-03-25|1962-07-04|||||1962-07-25||1966-05-19|N|1968-12-08
TRIAL STUDY 134XCP|LB|EF9208B0-4DF0-4029-AB67-8F87662D3E90|1||||HDW|HEMOGLOBIN DISTRIBUTION WIDTH|||||||NMOL BCE/MMOL|||||||TRACE||M2||||ABNORMAL|NOT DONE||||LAVAGE FLUID|FRESH|NA|DIFFUSION WEIGHTED MRI|MDRD 5 VARIABLE FORMULA||NA|Y|N|NA|||Y|4||88||TREATMENT|1973-06-25|1971-11-23|||||1964-10-03||1963-08-14|N|1960-12-19
TRIAL STUDY 134XCP|LB|EF9208B0-4DF0-4029-AB67-8F87662D3E90|2||||C130131|DOG DANDER ANTIGEN IGG4 ANTIBODY|||||||U/MG|||||||TRACE||MAC50||||LOW|NOT DONE||||PLATELET|HEMOLYZED|Y|CHROMOGENIC ASSAY|ASH FIBROSURE FORMULA||NA|Y|U|NA|||U|4||88||BASELINE|1968-10-02|1961-04-17|||||1964-02-29||1960-12-27|NA|1961-01-17
TRIAL STUDY 134XCP|LB|EF9208B0-4DF0-4029-AB67-8F87662D3E90|1||||VEGFR1S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC1|||||||NKAT/G HB|||||||TRACE||10^6 ORGANISMS||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|UNEXPECTED ODOR|Y|MOUSE PROTECTION ASSAY|CKD-EPI FORMULA||U|U|NA|N|||Y|5||7||SCREENING|1973-07-01|1961-03-12|||||1966-12-19||1968-08-27|U|1963-09-17
TRIAL STUDY 134XCP|LB|EF9208B0-4DF0-4029-AB67-8F87662D3E90|2||||PSP100AB|P100 POLYMYOSITIS-SCLERODERMA AUTOAG AB|||||||/10^4|||||||POSITIVE||PA||||HIGH|NOT DONE||||FLUID|FRESH|U|MALDI-TOF|MDRD 5 VARIABLE FORMULA||Y|N|Y|NA|||N|5||7||SCREENING|1971-09-25|1967-04-22|||||1966-04-17||1970-07-14|N|1968-08-02
TRIAL STUDY 134XCP|LB|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|1||||C130124|CAT DANDER ANTIGEN IGE ANTIBODY|||||||IU/KG/H|||||||BORDERLINE||BAR||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|REFRIGERATED|U|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||U|Y|Y|U|||Y|1||38||OBSERVATION|1960-02-20|1964-09-17|||||1973-07-16||1971-09-20|U|1962-01-04
TRIAL STUDY 134XCP|LB|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|2||||TYR|TYROSINE|||||||/KG|||||||POSITIVE||MG/MOL||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|REFRIGERATED|N|JAEGER EYE CHART|MDRD 5 VARIABLE FORMULA||NA|NA|NA|N|||NA|1||38||TREATMENT|1971-11-17|1969-07-10|||||1968-01-04||1970-02-28|U|1969-04-03
TRIAL STUDY 134XCP|LB|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|1||||INHIBINB|INHIBIN B|||||||UGEQ/L|||||||NEGATIVE||10^6 ORGANISMS||||ABNORMAL|NOT DONE||||BONE MARROW|NON-HEMOLYZED|N|MALDI|COCKCROFT-GAULT FORMULA||N|Y|N|NA|||Y|2||58||CONTINUATION TREATMENT|1969-06-30|1971-04-24|||||1969-05-20||1962-04-02|NA|1962-12-14
TRIAL STUDY 134XCP|LB|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|2||||BGTCPHRL|BETA+GAMMA TOCOPHEROL|||||||SEC|||||||TRACE||CD*S/M2||||ABNORMAL|NOT DONE||||BASAL TEAR|CONTAMINATED|N|COLORIMETRY|FIBROMETER FORMULA||Y|U|Y|Y|||Y|2||58||OPEN LABEL TREATMENT|1964-07-10|1960-12-31|||||1966-01-18||1970-01-25|U|1967-12-08
TRIAL STUDY 134XCP|LB|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|1||||FRFEABS|FRACTIONAL IRON ABSORPTION|||||||UG/KG/DAY|||||||BORDERLINE||PT_BR||||NORMAL|NOT DONE||||SEMINAL FLUID|CONCENTRATED|NA|DARK FIELD MICROSCOPY|FIBROMETER FORMULA||Y|N|U|U|||NA|3||39||INDUCTION TREATMENT|1970-07-27|1969-05-28|||||1968-04-24||1960-10-03|Y|1969-10-02
TRIAL STUDY 134XCP|LB|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|2||||C130078|SILVER BIRCH POLLEN IGG|||||||MG/DL|||||||INVALID||NMOL/L/H||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|CONCENTRATED|NA|CLIP|ASH FIBROSURE FORMULA||NA|Y|U|NA|||Y|3||39||OPEN LABEL TREATMENT|1971-10-06|1973-06-11|||||1964-11-20||1963-07-25|Y|1968-09-03
TRIAL STUDY 134XCP|LB|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|1||||CD3|CD3|||||||FEU|||||||INDETERMINATE||V/SEC||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR|U|PALPATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|Y|N|||NA|4||88||OPEN LABEL TREATMENT|1971-10-05|1968-02-03|||||1969-06-24||1964-02-23|NA|1963-08-15
TRIAL STUDY 134XCP|LB|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|2||||MERCURY|MERCURY|||||||PG/DL|||||||BORDERLINE||COPIES/UG||||NORMAL|NOT DONE||||COLOSTRUM|UNEXPECTED ODOR|U|FLUORESCENT SPOT TEST|NASH FIBROSURE FORMULA||U|NA|Y|Y|||Y|4||88||OPEN LABEL TREATMENT|1969-08-10|1968-09-25|||||1973-03-13||1971-03-08|NA|1965-09-05
TRIAL STUDY 134XCP|LB|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|1||||PREALB|PREALBUMIN|||||||10^6 ORGANISMS/MG|||||||BORDERLINE||PPB||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|REFRIGERATED|Y|ACCELERATOR MASS SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA||Y|N|NA|Y|||N|5||7||CONTINUATION TREATMENT|1960-09-25|1968-06-25|||||1968-01-31||1970-11-06|NA|1970-05-06
TRIAL STUDY 134XCP|LB|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|2||||TTGIGAAB|TISSUE TRANSGLUTAMINASE IGA ANTIBODY|||||||AFU|||||||POSITIVE||FG||||NORMAL|NOT DONE||||SOFT TISSUE|ROOM TEMPERATURE|U|PHOTOMETRIC CLOT DETECTION|GMI % FORMULA||N|U|N|N|||NA|5||7||OPEN LABEL TREATMENT|1960-08-22|1962-09-22|||||1968-10-31||1964-03-17|U|1963-02-19
TRIAL STUDY 134XCP|LB|25580765-CB09-4BE3-8DED-C0068C69E9C4|1||||IC512AB|ISLET CELL 512 ANTIBODY|||||||CI/KG|||||||BORDERLINE||UGEQ||||NORMAL|NOT DONE||||CAPILLARY PLASMA|CLOTTED|N|NO INFORMATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|U|||U|1||38||BASELINE|1967-07-03|1966-12-09|||||1963-07-19||1966-02-05|Y|1972-03-28
TRIAL STUDY 134XCP|LB|25580765-CB09-4BE3-8DED-C0068C69E9C4|2||||HLADQB1|HLA DQ BETA1 ANTIGEN|||||||G/DAY|||||||INVALID||U/M2||||NORMAL|NOT DONE||||SEMEN|NON-HEMOLYZED|U|CONTRAST ENHANCED X-RAY|HEPASCORE FORMULA||Y|N|Y|NA|||N|1||38||WASHOUT|1969-02-07|1964-09-02|||||1967-04-29||1968-01-12|NA|1968-08-13
TRIAL STUDY 134XCP|LB|25580765-CB09-4BE3-8DED-C0068C69E9C4|1||||TPROTP|PHOSPHORYLATED TAU PROTEIN|||||||KV|||||||TRACE||FG||||LOW|NOT DONE||||BILE|CONTAMINATED|N|SPIRAL CT|FIBROSIS 4 FORMULA||NA|Y|NA|Y|||U|2||58||CONTINUATION TREATMENT|1973-06-09|1966-10-17|||||1961-07-08||1961-07-14|Y|1965-04-29
TRIAL STUDY 134XCP|LB|25580765-CB09-4BE3-8DED-C0068C69E9C4|2||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||UG/G/MIN|||||||NEGATIVE||COPIES/ML||||ABNORMAL|NOT DONE||||BILE|DRIED|Y|ACCELERATOR MASS SPECTROMETRY|NASH FIBROSURE FORMULA||U|N|Y|N|||NA|2||58||FOLLOW-UP|1962-07-10|1960-05-13|||||1971-09-25||1960-05-20|NA|1962-03-09
TRIAL STUDY 134XCP|LB|25580765-CB09-4BE3-8DED-C0068C69E9C4|1||||NUCCE|NUCLEATED CELLS|||||||SUPPOSITORY|||||||TRACE||MPH||||LOW|NOT DONE||||SERUM OR PLASMA|SOLIDIFIED|N|PULSE OXIMETRY|COCKCROFT-GAULT FORMULA||NA|Y|NA|Y|||U|3||39||BLINDED TREATMENT|1970-03-24|1969-03-26|||||1967-05-15||1960-11-28|U|1969-10-14
TRIAL STUDY 134XCP|LB|25580765-CB09-4BE3-8DED-C0068C69E9C4|2||||CCL21|CHEMOKINE (C-C MOTIF) LIGAND 21|||||||U/MG|||||||BORDERLINE||MJOULE/CM2||||LOW|NOT DONE||||ISOLATE|REFRIGERATED|NA|NUCLEIC ACID HYBRIDIZATION|FIBROMETER FORMULA||U|N|N|N|||Y|3||39||BASELINE|1960-04-07|1969-07-08|||||1972-03-24||1971-12-23|NA|1961-10-11
TRIAL STUDY 134XCP|LB|25580765-CB09-4BE3-8DED-C0068C69E9C4|1||||S6PHS|PHOS-S6 RIBOSOMAL PROTEIN|||||||10^3 ORGANISMS/ML|||||||INDETERMINATE||UG/M2/DAY||||NORMAL|NOT DONE||||HAIR|AUTOLYZED|NA|AGAR DILUTION|MDRD FORMULA||N|N|U|NA|||Y|4||88||INDUCTION TREATMENT|1961-12-10|1973-03-24|||||1960-03-24||1967-05-22|U|1968-04-02
TRIAL STUDY 134XCP|LB|25580765-CB09-4BE3-8DED-C0068C69E9C4|2||||APOBAPA1|APOLIPOPROTEIN B/APOLIPOPROTEIN A1|||||||ML/KG/DAY|||||||NEGATIVE||CD/M2||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|SOLIDIFIED|Y|SISH|MDRD 6 VARIABLE FORMULA||U|NA|Y|Y|||NA|4||88||FOLLOW-UP|1965-09-10|1962-09-04|||||1962-03-12||1971-12-05|U|1963-12-24
TRIAL STUDY 134XCP|LB|25580765-CB09-4BE3-8DED-C0068C69E9C4|1||||AMACR|ALPHA-METHYLACYL COENZYME A RACEMASE|||||||DPM/ML|||||||TRACE||10^3/HPF||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|UNEXPECTED ODOR|N|CONTRAST ENHANCED X-RAY|CKD-EPI CYSTATIN C FORMULA||NA|NA|NA|N|||N|5||7||CONTINUATION TREATMENT|1966-08-03|1964-10-30|||||1964-09-24||1973-06-19|NA|1964-01-28
TRIAL STUDY 134XCP|LB|25580765-CB09-4BE3-8DED-C0068C69E9C4|2||||BETAINES|BETAINES|||||||KG/MOL|||||||BORDERLINE||CI||||LOW|NOT DONE||||EPIDERMAL TISSUE|ROOM TEMPERATURE|U|DXA SCAN|COCKCROFT-GAULT FORMULA||U|N|U|NA|||Y|5||7||TREATMENT|1971-06-27|1973-03-04|||||1969-06-23||1973-01-14|U|1971-01-14
TRIAL STUDY 134XCP|LB|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|1||||MUG|MURINOGLOBULIN|||||||GPS U|||||||NEGATIVE||UG/ANIMAL||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|REFRIGERATED|Y|CONTRAST ENHANCED MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|U|U|||NA|1||38||SCREENING|1964-05-08|1966-09-09|||||1963-03-16||1960-01-14|U|1960-06-08
TRIAL STUDY 134XCP|LB|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|2||||ESTRIOLF|ESTRIOL, FREE|||||||ROENTGEN|||||||NEGATIVE||NEBULE||||NORMAL|NOT DONE||||PLASMA|DRIED|N|ELECTROGASTROGRAPHY|MDRD FORMULA||N|U|U|N|||NA|1||38||LONG-TERM FOLLOW-UP|1968-11-11|1965-04-25|||||1961-12-20||1971-10-10|U|1960-01-06
TRIAL STUDY 134XCP|LB|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|1||||MONONSQE|MONOCYTES/NON-SQUAM EPI CELLS|||||||MG/MOL|||||||NEGATIVE||SQU/ML||||LOW|NOT DONE||||RETICULOCYTES|GELLED|NA|EIA|GMI % FORMULA||U|NA|NA|U|||NA|2||58||CONTINUATION TREATMENT|1972-07-28|1969-02-10|||||1972-09-29||1968-06-17|Y|1970-05-18
TRIAL STUDY 134XCP|LB|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|2||||APOB48|APOLIPOPROTEIN B48|||||||10^5/HPF|||||||BORDERLINE||U/M2||||HIGH|NOT DONE||||PLEURAL FLUID|GELLED|Y|NON-INVASIVE DIELECTRIC SENSING|MDRD FORMULA||Y|U|Y|NA|||U|2||58||OPEN LABEL TREATMENT|1971-04-10|1961-05-12|||||1960-05-24||1961-10-30|Y|1962-12-08
TRIAL STUDY 134XCP|LB|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|1||||C4A|COMPLEMENT C4A|||||||ML/BEAT|||||||INDETERMINATE||UKAT||||HIGH|NOT DONE||||EPITHELIAL CELL|HEMOLYZED|NA|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|GMI MMOL/MOL FORMULA||U|N|U|NA|||N|3||39||FOLLOW-UP|1970-05-23|1971-12-17|||||1963-11-22||1961-05-23|NA|1962-09-21
TRIAL STUDY 134XCP|LB|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|2||||AFPL1|ALPHA FETOPROTEIN L1|||||||PMOL/L|||||||NEGATIVE||MM/MIN||||NORMAL|NOT DONE||||BUFFY COAT|CALCIFIED|NA|SLOAN LETTER EYE CHART 2.5%|MDRD 4 VARIABLE FORMULA||NA|NA|NA|U|||NA|3||39||CONTINUATION TREATMENT|1969-02-11|1973-03-02|||||1971-06-26||1966-12-12|U|1966-04-24
TRIAL STUDY 134XCP|LB|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|1||||NEUTCYBS|CYTOPLASMIC BASOPHILIA NEUTROPHIL|||||||UKAT/10^12 RBC|||||||TRACE||POUCH||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|NA|ELASTOGRAPHY|MDRD 6 VARIABLE FORMULA||N|NA|N|U|||N|4||88||RUN-IN|1964-04-07|1966-09-01|||||1965-01-22||1967-04-04|Y|1968-06-01
TRIAL STUDY 134XCP|LB|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|2||||HLADRMSC|HLA-DR MISMATCH COUNT|||||||EVENTS|||||||BORDERLINE||MCI/KG||||HIGH|NOT DONE||||ALVEOLAR AIR|FRESH|Y|PHYSICAL EXAMINATION|GMI MMOL/MOL FORMULA||U|NA|N|U|||Y|4||88||OBSERVATION|1966-09-26|1968-06-20|||||1964-09-21||1973-07-01|N|1967-03-14
TRIAL STUDY 134XCP|LB|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|1||||INR|PROTHROMBIN INTL. NORMALIZED RATIO|||||||/MM2|||||||BORDERLINE||BQ/UL||||LOW|NOT DONE||||VITREOUS HUMOR|PARAFFIN-EMBEDDED|Y|ELISPOT|HEPASCORE FORMULA||N|U|NA|Y|||Y|5||7||OBSERVATION|1963-11-22|1963-01-26|||||1970-11-24||1971-08-12|U|1972-07-29
TRIAL STUDY 134XCP|LB|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|2||||ALT|ALANINE AMINOTRANSFERASE|||||||ML/M2|||||||BORDERLINE||EID 50/ML||||LOW|NOT DONE||||CORD SERUM|HEMOLYZED|N|IMMUNORADIOMETRIC ASSAY|MDRD FORMULA||N|NA|NA|Y|||NA|5||7||INDUCTION TREATMENT|1961-11-15|1964-01-27|||||1963-05-07||1969-06-19|U|1963-07-30
TRIAL STUDY 134XCP|LB|A902F087-3BF4-4387-80F9-DDCDDCE1813E|1||||STSA|STEROID SULFATASE ACTIVITY|||||||SEC|||||||INVALID||F||||HIGH|NOT DONE||||LUNG SURFACTANT|CALCIFIED|Y|INDIRECT IMMUNOFLUORESCENCE|GMI % FORMULA||N|N|N|U|||U|1||38||TREATMENT|1973-02-12|1962-05-12|||||1970-07-29||1967-12-30|U|1960-05-06
TRIAL STUDY 134XCP|LB|A902F087-3BF4-4387-80F9-DDCDDCE1813E|2||||OPIATE|OPIATE|||||||LOG10 ELISA UNIT/DOSE|||||||NEGATIVE||MMOL/MIN/KPA||||NORMAL|NOT DONE||||REFLEX TEAR|NON-HEMOLYZED|NA|PHYSICAL EXAMINATION|GMI % FORMULA||N|N|N|NA|||NA|1||38||TREATMENT|1961-05-24|1960-08-16|||||1970-06-08||1967-06-13|N|1972-11-23
TRIAL STUDY 134XCP|LB|A902F087-3BF4-4387-80F9-DDCDDCE1813E|1||||PRORUBCE|PRORUBRICYTE/TOTAL CELLS|||||||L/MIN/M2|||||||TRACE||PPB||||NORMAL|NOT DONE||||LYMPH|FROZEN|Y|CLIP|MDRD 4 VARIABLE FORMULA||U|U|N|Y|||Y|2||58||SCREENING|1965-06-20|1962-09-12|||||1973-04-20||1968-05-08|Y|1965-09-13
TRIAL STUDY 134XCP|LB|A902F087-3BF4-4387-80F9-DDCDDCE1813E|2||||A1MCREAT|ALPHA-1 MICROGLOBULIN/CREATININE|||||||UG/ANIMAL|||||||POSITIVE||10^3 COPIES/ML||||ABNORMAL|NOT DONE||||SOFT TISSUE|NON-HEMOLYZED|U|FLUORESCENT MICROSCOPY|ASH FIBROSURE FORMULA||Y|U|U|U|||U|2||58||CONTINUATION TREATMENT|1961-04-25|1969-01-19|||||1967-12-11||1966-10-29|U|1960-01-05
TRIAL STUDY 134XCP|LB|A902F087-3BF4-4387-80F9-DDCDDCE1813E|1||||C130088|TIMOTHY GRASS POLLEN IGE|||||||AFU|||||||BORDERLINE||10^9 CFU||||ABNORMAL|NOT DONE||||SALIVA|HEMOLYZED|U|FLOW CYTOMETRY|FIBROTEST FORMULA||U|Y|N|Y|||U|3||39||WASHOUT|1970-05-31|1972-09-20|||||1964-03-28||1963-04-20|U|1971-11-12
TRIAL STUDY 134XCP|LB|A902F087-3BF4-4387-80F9-DDCDDCE1813E|2||||ICAM3|INTERCELLULAR ADHESION MOLECULE 3|||||||PMOL/L|||||||POSITIVE||MBQ||||LOW|NOT DONE||||CEREBROSPINAL FLUID|NON-HEMOLYZED|Y|IN SITU HYBRIDIZATION|CKD-EPI CREATININE FORMULA||U|U|U|N|||N|3||39||BLINDED TREATMENT|1962-04-17|1968-01-23|||||1962-10-23||1971-11-26|NA|1971-12-23
TRIAL STUDY 134XCP|LB|A902F087-3BF4-4387-80F9-DDCDDCE1813E|1||||CTXI|TYPE I COLLAGEN C-TELOPEPTIDES|||||||TAMPON|||||||INDETERMINATE||UMOL/MIN||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|AUTOLYZED|U|LC/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|U|||NA|4||88||INDUCTION TREATMENT|1972-11-30|1965-02-13|||||1963-10-20||1968-12-20|U|1966-03-19
TRIAL STUDY 134XCP|LB|A902F087-3BF4-4387-80F9-DDCDDCE1813E|2||||APLSMA2A|ALPHA-2 ANTIPLASMIN ACTIVITY|||||||10^7 TCID 50/DOSE|||||||POSITIVE||WEBER||||NORMAL|NOT DONE||||BONE MARROW|FROZEN|NA|FISH|FIBROTEST FORMULA||U|N|N|U|||N|4||88||LONG-TERM FOLLOW-UP|1973-04-22|1963-10-13|||||1962-09-12||1964-02-01|NA|1966-03-31
TRIAL STUDY 134XCP|LB|A902F087-3BF4-4387-80F9-DDCDDCE1813E|1||||OSMLTY|OSMOLALITY|||||||NM|||||||POSITIVE||VG/DOSE||||LOW|NOT DONE||||ABSCESS FLUID|PARAFFIN-EMBEDDED|N|CT SCAN|GMI MMOL/MOL FORMULA||NA|N|U|Y|||Y|5||7||OPEN LABEL TREATMENT|1961-12-23|1970-04-01|||||1972-11-07||1962-12-06|U|1964-11-27
TRIAL STUDY 134XCP|LB|A902F087-3BF4-4387-80F9-DDCDDCE1813E|2||||CA15_3AG|CANCER ANTIGEN 15-3|||||||CAN|||||||TRACE||UMOL/L||||HIGH|NOT DONE||||BILE|THAWED|U|SIZE EXCLUSION CHROMATOGRAPHY|ASH FIBROSURE FORMULA||Y|Y|NA|N|||Y|5||7||INDUCTION TREATMENT|1968-11-13|1966-09-05|||||1966-06-29||1964-11-08|N|1962-03-08
TRIAL STUDY 134XCP|LB|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|1||||BTKFR|BRUTON'S TYROSINE KINASE, FREE|||||||10^6 IU/ML|||||||INVALID||TUBERCULIN UNIT||||LOW|NOT DONE||||KERATINOCYTE|CONTAMINATED|N|WHOLE TRANSCRIPTOME SEQUENCING|ASH FIBROSURE FORMULA||U|U|NA|NA|||N|1||38||LONG-TERM FOLLOW-UP|1971-01-31|1970-10-08|||||1966-12-18||1971-06-24|N|1967-06-26
TRIAL STUDY 134XCP|LB|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|2||||WBCCE|LEUKOCYTES/TOTAL CELLS|||||||MIN|||||||BORDERLINE||CG||||HIGH|NOT DONE||||EPITHELIAL CELL|NON-HEMOLYZED|N|MRI|NASH FIBROSURE FORMULA||N|U|N|Y|||U|1||38||BLINDED TREATMENT|1962-07-02|1971-05-06|||||1968-12-05||1961-01-02|U|1963-06-10
TRIAL STUDY 134XCP|LB|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|1||||PCO2ADJT|PARTIAL PRESSURE CARBON DIOXIDE ADJ TEMP|||||||V|||||||BORDERLINE||DPM/0.5 ML||||ABNORMAL|NOT DONE||||MECONIUM|UNEXPECTED ODOR|NA|DNA MICROARRAY|CKD-EPI CREATININE FORMULA||U|NA|U|NA|||Y|2||58||SCREENING|1966-08-15|1961-06-19|||||1966-06-10||1966-03-15|N|1960-12-07
TRIAL STUDY 134XCP|LB|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|2||||VITB5|VITAMIN B5|||||||PA|||||||POSITIVE||VP/ML||||LOW|NOT DONE||||CAPILLARY PLASMA|LIPEMIC|Y|ELISPOT|MDRD 4 VARIABLE FORMULA||N|Y|N|U|||Y|2||58||SCREENING|1968-03-12|1967-01-06|||||1964-12-02||1964-05-07|NA|1962-12-02
TRIAL STUDY 134XCP|LB|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|1||||FGF23C|FIBROBLAST GROWTH FACTOR 23, C-TERMINAL|||||||U/G/MIN|||||||INDETERMINATE||MM/2H||||LOW|NOT DONE||||SWABBED MATERIAL|DRIED|U|IN SITU HYBRIDIZATION|MDRD 6 VARIABLE FORMULA||NA|NA|NA|Y|||NA|3||39||CONTINUATION TREATMENT|1968-03-07|1963-03-20|||||1968-12-19||1964-10-02|U|1972-05-30
TRIAL STUDY 134XCP|LB|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|2||||INTLK21|INTERLEUKIN 21|||||||CAN|||||||INVALID||AFU||||ABNORMAL|NOT DONE||||SEBUM|CLOTTED|U|ORCHIDOMETERY|MDRD FORMULA||Y|U|U|U|||U|3||39||BLINDED TREATMENT|1966-09-03|1966-02-10|||||1972-09-15||1971-05-31|N|1973-04-17
TRIAL STUDY 134XCP|LB|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|1||||PLAGMAMP|PLATELET AGGREGATION MEAN AMPLITUDE|||||||10^9/G|||||||BORDERLINE||/CMH2O||||NORMAL|NOT DONE||||PLEURAL FLUID|PARAFFIN-EMBEDDED|Y|FLOW CYTOMETRY|CKD-EPI CREATININE FORMULA||NA|U|U|U|||U|4||88||LONG-TERM FOLLOW-UP|1969-03-11|1960-12-05|||||1967-12-25||1963-09-10|NA|1964-12-21
TRIAL STUDY 134XCP|LB|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|2||||MASTCECE|MAST CELLS/TOTAL CELLS|||||||10^3 RNA COPIES/ML|||||||NEGATIVE||ML/G/DAY||||HIGH|NOT DONE||||LYSATE|CALCIFIED|N|ACID FAST STAIN|CKD-EPI CREATININE FORMULA||Y|Y|Y|Y|||NA|4||88||TREATMENT|1970-10-11|1969-12-04|||||1968-06-14||1970-04-10|U|1967-07-30
TRIAL STUDY 134XCP|LB|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|1||||CRTCREAT|CORTICOSTERONE/CREATININE|||||||CONTAINER|||||||NEGATIVE||MG/KG/WEEK||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|SOLIDIFIED|U|MIGET|GMI % FORMULA||N|N|N|Y|||NA|5||7||OPEN LABEL TREATMENT|1960-04-04|1972-07-08|||||1968-03-17||1961-08-24|Y|1967-01-10
TRIAL STUDY 134XCP|LB|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|2||||APOC2|APOLIPOPROTEIN C2|||||||UG/M2/H|||||||NEGATIVE||CM/MIN||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|PARAFFIN-EMBEDDED|U|IMPEDANCE CONDUCTIVITY|FIBROMETER FORMULA||N|U|N|U|||N|5||7||BASELINE|1972-09-14|1966-01-31|||||1968-12-09||1964-11-08|U|1966-11-19
TRIAL STUDY 134XCP|LB|415F9206-A793-437C-B227-BD245DBF40AB|1||||CHDW|CORPUSCULAR HGB CONC DISTRIBUTION WIDTH|||||||CPM|||||||BORDERLINE||MG/KG/MIN||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|U|MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA||Y|NA|NA|U|||U|1||38||CONTINUATION TREATMENT|1967-09-27|1966-08-08|||||1967-02-02||1969-01-07|N|1962-12-19
TRIAL STUDY 134XCP|LB|415F9206-A793-437C-B227-BD245DBF40AB|2||||CITRTEXR|CITRATE EXCRETION RATE|||||||MAMP|||||||NEGATIVE||UG/CM2||||NORMAL|NOT DONE||||VENOUS BLOOD|ICTERIC|U|NUCLEIC ACID BASED METHOD|NASH FIBROSURE FORMULA||Y|N|N|N|||NA|1||38||WASHOUT|1964-11-26|1963-05-17|||||1963-05-25||1968-11-20|Y|1961-12-01
TRIAL STUDY 134XCP|LB|415F9206-A793-437C-B227-BD245DBF40AB|1||||LYMPL|PLASMACYTOID LYMPHOCYTES|||||||CMHG|||||||INDETERMINATE||NMOL/L/MIN||||NORMAL|NOT DONE||||EPITHELIAL CELL|CONCENTRATED|U|NEURAMINIDASE INHIBITION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|NA|NA|||Y|2||58||CONTINUATION TREATMENT|1963-08-28|1972-07-22|||||1968-05-04||1965-08-26|Y|1960-07-29
TRIAL STUDY 134XCP|LB|415F9206-A793-437C-B227-BD245DBF40AB|2||||HGBFPATN|HEMOGLOBIN FRACTION PATTERN|||||||10^9 ORGANISMS/ML|||||||INDETERMINATE||10^6 CFU/G||||ABNORMAL|NOT DONE||||BONE MARROW|AGGLUTINATED|Y|U-HPLC/MS/MS|MDRD ENZYMATIC FORMULA||N|Y|N|NA|||U|2||58||BLINDED TREATMENT|1967-05-17|1966-02-07|||||1972-05-03||1965-09-23|N|1971-07-04
TRIAL STUDY 134XCP|LB|415F9206-A793-437C-B227-BD245DBF40AB|1||||C130136|AMERICAN COCKROACH ANTIGEN IGE ANTIBODY|||||||AMFI|||||||NEGATIVE||G/G/DAY||||NORMAL|NOT DONE||||COLOSTRUM|LACTESCENT|N|PUPILLOMETRY|NASH FIBROSURE FORMULA||Y|U|N|N|||Y|3||39||FOLLOW-UP|1972-04-13|1966-04-26|||||1960-05-06||1968-12-15|U|1965-09-18
TRIAL STUDY 134XCP|LB|415F9206-A793-437C-B227-BD245DBF40AB|2||||STIPBASO|BASOPHILIC STIPPLING|||||||NMOL BCE/NMOL|||||||INDETERMINATE||ECL UNIT||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|DRIED|U|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD 4 VARIABLE FORMULA||U|U|N|NA|||Y|3||39||OBSERVATION|1963-06-28|1965-10-24|||||1964-03-26||1964-04-27|N|1973-04-15
TRIAL STUDY 134XCP|LB|415F9206-A793-437C-B227-BD245DBF40AB|1||||ACETONE|ACETONE|||||||CFU/G|||||||INVALID||10^12/L||||NORMAL|NOT DONE||||CELL PELLET|DRIED|N|ELECTROPHORESIS|FIBROMETER FORMULA||Y|NA|NA|U|||NA|4||88||CONTINUATION TREATMENT|1961-06-10|1967-06-12|||||1970-08-16||1967-10-04|Y|1968-10-23
TRIAL STUDY 134XCP|LB|415F9206-A793-437C-B227-BD245DBF40AB|2||||GFRBSB2M|GFR FROM B-2 MICROGLOBULIN ADJ FOR BSA|||||||MG/M2/H|||||||TRACE||%/S||||ABNORMAL|NOT DONE||||LEUKOCYTE|LIPEMIC|N|IMMUNOTURBIDIMETRY|MDRD 4 VARIABLE FORMULA||NA|N|U|Y|||Y|4||88||FOLLOW-UP|1971-07-26|1972-03-01|||||1972-08-06||1969-11-01|U|1972-10-09
TRIAL STUDY 134XCP|LB|415F9206-A793-437C-B227-BD245DBF40AB|1||||MACROCY|MACROCYTES|||||||K|||||||TRACE||NFIU||||LOW|NOT DONE||||PLATELET RICH PLASMA|LIPEMIC|NA|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|NA|NA|||NA|5||7||BLINDED TREATMENT|1968-08-16|1961-06-27|||||1968-07-19||1972-06-04|Y|1968-03-23
TRIAL STUDY 134XCP|LB|415F9206-A793-437C-B227-BD245DBF40AB|2||||C165940|BOXELDER POLLEN IGE AB RAST SCORE|||||||GPELISA UNIT/ML|||||||TRACE||BOLUS||||HIGH|NOT DONE||||LYSATE|THAWED|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 5 VARIABLE FORMULA||NA|N|U|Y|||U|5||7||CONTINUATION TREATMENT|1965-09-15|1966-09-17|||||1970-09-27||1961-07-19|U|1970-07-26
TRIAL STUDY 134XCP|LB|C580BA02-D031-4875-AC02-347AA65C4C6C|1||||FACTVA|FACTOR V ACTIVITY|||||||PMOL/10^10 CELLS|||||||TRACE||GRAIN||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|CONCENTRATED|Y|ELECTROGASTROGRAPHY|GMI % FORMULA||U|NA|U|N|||N|1||38||BLINDED TREATMENT|1966-02-06|1968-07-13|||||1971-11-21||1970-12-31|NA|1969-05-02
TRIAL STUDY 134XCP|LB|C580BA02-D031-4875-AC02-347AA65C4C6C|2||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||H/WK|||||||TRACE||10^6 ORGANISMS/ML||||HIGH|NOT DONE||||DERMAL TISSUE|ROOM TEMPERATURE|NA|TOTAL BODY RADIOGRAPHY|NASH FIBROSURE FORMULA||U|Y|NA|NA|||N|1||38||OBSERVATION|1973-02-03|1972-10-07|||||1965-08-16||1969-06-28|U|1960-07-19
TRIAL STUDY 134XCP|LB|C580BA02-D031-4875-AC02-347AA65C4C6C|1||||EOS|EOSINOPHILS|||||||BQ/UG|||||||POSITIVE||PIXEL||||ABNORMAL|NOT DONE||||SALIVA|FROZEN|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|MDRD 6 VARIABLE FORMULA||Y|N|U|Y|||U|2||58||WASHOUT|1973-08-13|1960-08-16|||||1964-10-05||1961-07-14|Y|1969-12-12
TRIAL STUDY 134XCP|LB|C580BA02-D031-4875-AC02-347AA65C4C6C|2||||WBCCE|LEUKOCYTES/TOTAL CELLS|||||||IU/DAY|||||||INDETERMINATE||ML||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|FROZEN|NA|SISH|CKD-EPI FORMULA||Y|U|Y|U|||U|2||58||INDUCTION TREATMENT|1961-07-30|1963-07-21|||||1964-11-17||1962-02-20|U|1963-05-30
TRIAL STUDY 134XCP|LB|C580BA02-D031-4875-AC02-347AA65C4C6C|1||||DCCARNIT|DECANOYLCARNITINE|||||||GPL U/ML|||||||BORDERLINE||/LSQN||||LOW|NOT DONE||||CAPILLARY PLASMA|THAWED|N|ELLA|NASH FIBROSURE FORMULA||U|Y|N|NA|||NA|3||39||BASELINE|1968-08-06|1969-04-23|||||1970-08-27||1961-04-28|Y|1968-10-23
TRIAL STUDY 134XCP|LB|C580BA02-D031-4875-AC02-347AA65C4C6C|2||||ANTHRMAG|ANTITHROMBIN ANTIGEN|||||||S^-1(%O2)^-1|||||||TRACE||10^9 CFU||||NORMAL|NOT DONE||||TUMOR TISSUE|SOLIDIFIED|N|IN SITU HYBRIDIZATION|GMI % FORMULA||NA|N|U|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1965-10-27|1967-11-13|||||1971-12-02||1971-02-03|NA|1970-10-18
TRIAL STUDY 134XCP|LB|C580BA02-D031-4875-AC02-347AA65C4C6C|1||||PBG|PORPHOBILINOGEN|||||||GENEQ|||||||BORDERLINE||ML/DOSE||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|REFRIGERATED|Y|BAC ACGH|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|NA|N|||NA|4||88||SCREENING|1960-09-28|1970-03-16|||||1967-01-21||1973-01-14|NA|1970-07-28
TRIAL STUDY 134XCP|LB|C580BA02-D031-4875-AC02-347AA65C4C6C|2||||C165910|BEE MIX IGG AB RAST SCORE|||||||SBE/ML|||||||INDETERMINATE||G/DAY||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|UNEXPECTED ODOR|U|ULTRASOUND|CKD-EPI FORMULA||NA|Y|U|NA|||U|4||88||SCREENING|1964-03-07|1967-02-24|||||1966-05-20||1971-08-28|Y|1971-11-21
TRIAL STUDY 134XCP|LB|C580BA02-D031-4875-AC02-347AA65C4C6C|1||||LSD|LYSERGIC ACID DIETHYLAMIDE|||||||WATT|||||||NEGATIVE||UG/L DDU||||LOW|NOT DONE||||SOFT TISSUE|AGGLUTINATED|NA|DIPSTICK|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|U|||U|5||7||OBSERVATION|1960-03-08|1960-05-16|||||1970-04-20||1965-03-15|Y|1964-01-17
TRIAL STUDY 134XCP|LB|C580BA02-D031-4875-AC02-347AA65C4C6C|2||||MIP1B|MACROPHAGE INFLAMMATORY PROTEIN 1 BETA|||||||ML/M2/H|||||||INDETERMINATE||MEQ/UG||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|REFRIGERATED|U|CYSTOMETRY|MDRD 6 VARIABLE FORMULA||N|NA|NA|Y|||Y|5||7||CONTINUATION TREATMENT|1964-06-28|1965-11-01|||||1964-07-05||1968-12-01|N|1967-05-05
TRIAL STUDY 134XCP|LB|4DD6944D-662E-4C9A-A663-601B657BCF5E|1||||FATACVLC|FATTY ACIDS, VERY LONG CHAIN|||||||UV|||||||BORDERLINE||GPELISA UNIT/ML||||NORMAL|NOT DONE||||SOFT TISSUE|REFRIGERATED|N|RULER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA||Y|NA|Y|NA|||N|1||38||OBSERVATION|1961-05-22|1962-09-05|||||1964-09-03||1969-08-07|N|1964-10-15
TRIAL STUDY 134XCP|LB|4DD6944D-662E-4C9A-A663-601B657BCF5E|2||||GASTRIN|GASTRIN|||||||MG/DL|||||||INVALID||/5X10^4 WBC||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|N|PET/SPECT SCAN|ASH FIBROSURE FORMULA||N|U|Y|U|||Y|1||38||BLINDED TREATMENT|1961-02-22|1965-11-14|||||1960-02-08||1962-06-01|Y|1971-09-03
TRIAL STUDY 134XCP|LB|4DD6944D-662E-4C9A-A663-601B657BCF5E|1||||T3UP|TRIIODOTHYRONINE UPTAKE|||||||ENZYME U/M2|||||||BORDERLINE||10^6 RNA COPIES/ML||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|PARAFFIN-EMBEDDED|Y|CONTRAST ENHANCED CT SCAN|CKD-EPI FORMULA||NA|U|N|N|||U|2||58||LONG-TERM FOLLOW-UP|1969-03-19|1967-05-31|||||1968-08-27||1963-10-18|NA|1964-03-06
TRIAL STUDY 134XCP|LB|4DD6944D-662E-4C9A-A663-601B657BCF5E|2||||C165913|NUT MIX IGG AB RAST SCORE|||||||PMOL/L/H|||||||TRACE||10^5/L||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|DRIED|Y|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|GMI % FORMULA||NA|NA|U|U|||NA|2||58||INDUCTION TREATMENT|1962-07-25|1965-03-30|||||1963-04-26||1961-10-08|U|1972-06-25
TRIAL STUDY 134XCP|LB|4DD6944D-662E-4C9A-A663-601B657BCF5E|1||||EOSNUCCE|EOSINOPHILS/NUCLEATED CELLS|||||||CARTRIDGE|||||||POSITIVE||IU/L||||NORMAL|NOT DONE||||BLOOD|THAWED|Y|DUKE INCISION METHOD|MDRD 6 VARIABLE FORMULA||Y|U|U|N|||U|3||39||FOLLOW-UP|1971-02-17|1966-05-08|||||1962-04-11||1965-01-12|U|1962-03-22
TRIAL STUDY 134XCP|LB|4DD6944D-662E-4C9A-A663-601B657BCF5E|2||||FXAAC|FACTOR X ACTIVITY ACTUAL/CONTROL|||||||MET|||||||BORDERLINE||CGY||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|ICTERIC|N|SCANNING ELECTRON MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|NA|N|||NA|3||39||BLINDED TREATMENT|1961-05-07|1972-03-15|||||1973-05-31||1961-09-18|N|1965-07-12
TRIAL STUDY 134XCP|LB|4DD6944D-662E-4C9A-A663-601B657BCF5E|1||||CITCREAT|CITRATE/CREATININE|||||||KPA/L/SEC|||||||NEGATIVE||MM||||NORMAL|NOT DONE||||SWABBED MATERIAL|CALCIFIED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|GMI MMOL/MOL FORMULA||NA|NA|N|U|||N|4||88||OBSERVATION|1972-08-04|1969-12-15|||||1968-02-15||1963-11-25|U|1967-12-09
TRIAL STUDY 134XCP|LB|4DD6944D-662E-4C9A-A663-601B657BCF5E|2||||WBCMORPH|LEUKOCYTE CELL MORPHOLOGY|||||||10^9 CFU/G|||||||TRACE||MET*H||||HIGH|NOT DONE||||CERUMEN|PARAFFIN-EMBEDDED|Y|SEQUENCING|GMI % FORMULA||Y|NA|NA|N|||NA|4||88||BASELINE|1961-10-13|1971-07-07|||||1961-12-14||1960-11-15|NA|1973-03-10
TRIAL STUDY 134XCP|LB|4DD6944D-662E-4C9A-A663-601B657BCF5E|1||||PCT|PROCALCITONIN|||||||ML/CM|||||||POSITIVE||GLOBULE||||HIGH|NOT DONE||||URINE SEDIMENT|DRIED|NA|WRIGHT STAIN|MDRD ENZYMATIC FORMULA||Y|NA|N|Y|||U|5||7||WASHOUT|1969-12-03|1963-09-08|||||1962-06-19||1965-06-24|U|1967-03-22
TRIAL STUDY 134XCP|LB|4DD6944D-662E-4C9A-A663-601B657BCF5E|2||||APOH|APOLIPOPROTEIN H|||||||10^9/G|||||||BORDERLINE||WEEKS||||LOW|NOT DONE||||HAIR FOLLICLE|PARAFFIN-EMBEDDED|NA|CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|NA|U|||N|5||7||RUN-IN|1967-01-16|1965-06-28|||||1961-06-17||1968-04-27|N|1971-12-25
TRIAL STUDY 134XCP|LB|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|1||||CLCTRIOL|CALCITRIOL|||||||MG/ANIMAL|||||||TRACE||MV||||NORMAL|NOT DONE||||VENOUS BLOOD|AGGLUTINATED|U|CT SCAN WITHOUT CONTRAST|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|U|Y|||U|1||38||OPEN LABEL TREATMENT|1963-02-10|1960-10-08|||||1970-10-29||1966-09-24|NA|1966-02-12
TRIAL STUDY 134XCP|LB|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|2||||FLUVOXAM|FLUVOXAMINE|||||||NG/DAY|||||||TRACE||CCID 50/DOSE||||NORMAL|NOT DONE||||BREAST MILK|LACTESCENT|N|NUCLEIC ACID AMPLIFICATION TEST|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|N|N|||Y|1||38||FOLLOW-UP|1962-06-03|1969-08-07|||||1971-12-03||1965-03-09|U|1964-01-08
TRIAL STUDY 134XCP|LB|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|1||||SALCYLT|SALICYLATES|||||||MANSON U/ML|||||||NEGATIVE||MG/DL||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|DRIED|N|NUCLEIC ACID HYBRIDIZATION|MDRD 6 VARIABLE FORMULA||Y|NA|N|Y|||N|2||58||OPEN LABEL TREATMENT|1963-11-26|1965-07-08|||||1971-06-01||1963-11-03|N|1973-03-23
TRIAL STUDY 134XCP|LB|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|2||||PROMYCE|PROMYELOCYTES/TOTAL CELLS|||||||MM/SEC|||||||BORDERLINE||UG/KG/MIN||||ABNORMAL|NOT DONE||||NAIL|AUTOLYZED|NA|ZIEHL NEELSEN ACID FAST STAIN|COCKCROFT-GAULT FORMULA||N|Y|U|U|||NA|2||58||BLINDED TREATMENT|1971-08-23|1970-02-19|||||1972-11-26||1962-12-20|NA|1970-07-22
TRIAL STUDY 134XCP|LB|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|1||||RETPALM|RETINYL PALMITATE|||||||FIU|||||||INVALID||MV||||ABNORMAL|NOT DONE||||PLEURAL FLUID|CONTAMINATED|N|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD ENZYMATIC FORMULA||Y|N|NA|Y|||N|3||39||LONG-TERM FOLLOW-UP|1969-09-20|1968-07-30|||||1961-10-19||1963-10-14|Y|1963-06-08
TRIAL STUDY 134XCP|LB|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|2||||GSTPI|GLUTATHIONE S-TRANSFERASE, PI|||||||PIXELS/IN|||||||INVALID||TUBERCULIN UNIT||||ABNORMAL|NOT DONE||||RETICULOCYTES|ROOM TEMPERATURE|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|Y|NA|||Y|3||39||TREATMENT|1971-01-13|1962-08-30|||||1964-11-08||1971-08-27|U|1971-10-21
TRIAL STUDY 134XCP|LB|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|1||||COAGIDX|COAGULATION INDEX|||||||MIN/DAY|||||||BORDERLINE||G/U||||NORMAL|NOT DONE||||HAIR FOLLICLE|CLOTTED|Y|IMMUNOCHROMATOGRAPHY|GMI MMOL/MOL FORMULA||Y|U|Y|Y|||N|4||88||OBSERVATION|1964-04-01|1965-09-01|||||1966-05-27||1962-06-03|N|1970-05-22
TRIAL STUDY 134XCP|LB|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|2||||UREA|UREA|||||||UG/M2/MIN|||||||INVALID||10^3 CFU/ML||||NORMAL|NOT DONE||||KERATINOCYTE|LACTESCENT|N|FLUORESCENT IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|U|N|||N|4||88||INDUCTION TREATMENT|1967-03-09|1962-07-13|||||1966-02-20||1971-02-02|NA|1967-11-21
TRIAL STUDY 134XCP|LB|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|1||||ANAG|ALPHA-N-ACETYLGLUCOSAMINIDASE|||||||PL|||||||NEGATIVE||%(W/V)||||HIGH|NOT DONE||||LYMPH|UNEXPECTED ODOR|U|OBSERVATION|MDRD 4 VARIABLE FORMULA||Y|NA|N|U|||NA|5||7||TREATMENT|1965-04-26|1971-09-29|||||1971-05-03||1964-03-21|U|1973-04-09
TRIAL STUDY 134XCP|LB|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|2||||SCHISTO|SCHISTOCYTES|||||||DPM/100MG|||||||TRACE||UGEQ/L||||ABNORMAL|NOT DONE||||FLUID|REFRIGERATED|NA|STATIC PERIMETRY|ASH FIBROSURE FORMULA||N|U|U|NA|||N|5||7||INDUCTION TREATMENT|1963-05-22|1965-02-05|||||1969-05-23||1972-10-08|Y|1962-05-17
TRIAL STUDY 134XCP|LB|69A130F1-44A1-4091-BF0C-FF8087CC9940|1||||CD163S|SOLUBLE CD163|||||||PMOL/10^10 CELLS|||||||INVALID||10^9/DOSE||||NORMAL|NOT DONE||||REFLEX TEAR|LIPEMIC|U|REVERSE TRANSCRIPTASE PCR|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|Y|||Y|1||38||RUN-IN|1961-01-26|1963-02-16|||||1973-05-05||1962-05-31|N|1965-06-30
TRIAL STUDY 134XCP|LB|69A130F1-44A1-4091-BF0C-FF8087CC9940|2||||C130131|DOG DANDER ANTIGEN IGG4 ANTIBODY|||||||MV2/HZ|||||||INVALID||UG/M2/MIN||||LOW|NOT DONE||||CAPILLARY PLASMA|REFRIGERATED|U|PAP STAIN|GMI MMOL/MOL FORMULA||Y|N|N|Y|||Y|1||38||WASHOUT|1965-05-12|1970-05-05|||||1971-08-12||1961-06-04|U|1961-01-24
TRIAL STUDY 134XCP|LB|69A130F1-44A1-4091-BF0C-FF8087CC9940|1||||KAPPALC|KAPPA LIGHT CHAIN|||||||L/MIN/M2|||||||TRACE||ML/S||||LOW|NOT DONE||||VITREOUS HUMOR|CONTAMINATED|U|PULSE OXIMETRY|GMI % FORMULA||N|NA|NA|U|||Y|2||58||FOLLOW-UP|1966-02-01|1966-10-24|||||1971-01-01||1961-12-27|U|1965-11-26
TRIAL STUDY 134XCP|LB|69A130F1-44A1-4091-BF0C-FF8087CC9940|2||||RBCNUC|NUCLEATED ERYTHROCYTES|||||||MET*H|||||||BORDERLINE||10^3 ORGANISMS/ML||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|FROZEN|U|PHASE-CONTRAST MRI|MDRD ENZYMATIC FORMULA||N|NA|N|NA|||N|2||58||TREATMENT|1964-04-03|1973-04-13|||||1965-04-26||1961-08-27|U|1965-02-02
TRIAL STUDY 134XCP|LB|69A130F1-44A1-4091-BF0C-FF8087CC9940|1||||EOSPSDLE|PSEUDO-EOSINOPHILS/LEUKOCYTES|||||||ANSON U|||||||POSITIVE||LOG10 PFU/ML||||NORMAL|NOT DONE||||SOFT TISSUE|CALCIFIED|N|CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI CYSTATIN C FORMULA||N|NA|NA|NA|||NA|3||39||CONTINUATION TREATMENT|1967-03-28|1970-07-05|||||1961-10-25||1962-08-10|N|1966-05-16
TRIAL STUDY 134XCP|LB|69A130F1-44A1-4091-BF0C-FF8087CC9940|2||||ALBPROT|ALBUMIN/TOTAL PROTEIN|||||||UGEQ|||||||POSITIVE||RNA COPIES/ML||||NORMAL|NOT DONE||||URINE SEDIMENT|ICTERIC|NA|FLUORIMETRY|GMI MMOL/MOL FORMULA||U|U|Y|NA|||N|3||39||RUN-IN|1970-04-13|1969-06-15|||||1964-09-26||1966-01-11|U|1963-12-18
TRIAL STUDY 134XCP|LB|69A130F1-44A1-4091-BF0C-FF8087CC9940|1||||LYMCLF|LYMPHOCYTES, CLEFTED|||||||MMOL/MIN/KPA/L|||||||POSITIVE||MMHG*MIN/L||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|SOLIDIFIED|U|TOTAL BODY RADIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|Y|Y|||U|4||88||LONG-TERM FOLLOW-UP|1962-06-28|1967-10-12|||||1964-09-20||1964-05-31|U|1960-04-08
TRIAL STUDY 134XCP|LB|69A130F1-44A1-4091-BF0C-FF8087CC9940|2||||HGBFHGB|HEMOGLOBIN F/TOTAL HEMOGLOBIN|||||||PMOL/L|||||||INDETERMINATE||ENZYME U/L||||LOW|NOT DONE||||SERUM OR PLASMA|THAWED|N|PLETHYSMOGRAPHY|FIBROTEST FORMULA||Y|Y|Y|NA|||N|4||88||TREATMENT|1971-12-01|1960-11-10|||||1964-08-08||1961-07-12|U|1961-02-12
TRIAL STUDY 134XCP|LB|69A130F1-44A1-4091-BF0C-FF8087CC9940|1||||CMONOX|CARBON MONOXIDE|||||||COPIES/UG|||||||BORDERLINE||AFU||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|PARAFFIN-EMBEDDED|U|DIFFUSION WEIGHTED MRI|HEPASCORE FORMULA||U|NA|NA|N|||NA|5||7||RUN-IN|1972-11-17|1961-02-12|||||1973-01-24||1973-09-03|N|1970-09-25
TRIAL STUDY 134XCP|LB|69A130F1-44A1-4091-BF0C-FF8087CC9940|2||||A1ANTRYP|ALPHA-1 ANTITRYPSIN|||||||UG/L DDU|||||||TRACE||CI/KG||||HIGH|NOT DONE||||MUSCLE TISSUE|THAWED|N|MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||U|U|N|N|||NA|5||7||FOLLOW-UP|1966-12-31|1970-11-27|||||1967-02-19||1964-11-11|N|1965-03-07
TRIAL STUDY 134XCP|LB|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|1||||TFERRIN|TRANSFERRIN|||||||TORR|||||||BORDERLINE||FG||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONCENTRATED|U|OBSERVATION|MDRD 5 VARIABLE FORMULA||U|N|Y|Y|||U|1||38||FOLLOW-UP|1971-07-10|1971-04-15|||||1961-07-14||1963-08-27|U|1964-12-01
TRIAL STUDY 134XCP|LB|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|2||||FACTIXA|FACTOR IX ACTIVITY|||||||MMHG/SEC|||||||TRACE||UG||||LOW|NOT DONE||||SYNOVIAL FLUID|UNEXPECTED ODOR|NA|CONTRAST ENHANCED SPIRAL CT SCAN|HEPASCORE FORMULA||N|U|N|NA|||N|1||38||CONTINUATION TREATMENT|1969-03-08|1973-01-08|||||1968-11-26||1970-06-29|U|1973-06-03
TRIAL STUDY 134XCP|LB|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|1||||MONOMA|MONOCYTES/MACROCYTES|||||||ATM|||||||POSITIVE||MM/MIN||||LOW|NOT DONE||||TISSUE|CLOTTED|U|DIFFUSION WEIGHTED MRI|MDRD FORMULA||NA|U|N|NA|||NA|2||58||SCREENING|1967-02-25|1972-05-02|||||1966-09-19||1962-09-10|N|1962-11-25
TRIAL STUDY 134XCP|LB|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|2||||FVIIAAC|FACTOR VII ACTIVITY ACTUAL/CONTROL|||||||VG/DOSE|||||||INDETERMINATE||TUBE||||HIGH|NOT DONE||||SMEGMA|ICTERIC|U|NUCLEIC ACID AMPLIFICATION TEST|MDRD 5 VARIABLE FORMULA||N|N|Y|N|||NA|2||58||BASELINE|1963-09-24|1969-09-23|||||1973-03-25||1963-07-06|Y|1968-11-23
TRIAL STUDY 134XCP|LB|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|1||||HYPSEGCE|HYPERSEGMENTED CELLS|||||||MMOL/S|||||||POSITIVE||TUBERCULIN UNIT||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|NON-HEMOLYZED|N|CLOT DETECTION|GMI MMOL/MOL FORMULA||NA|N|U|N|||U|3||39||WASHOUT|1971-11-10|1968-08-24|||||1964-10-27||1960-12-12|N|1967-06-25
TRIAL STUDY 134XCP|LB|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|2||||CIC|CIRCULATING IMMUNE COMPLEXES|||||||ML/(MIN*100ML)|||||||BORDERLINE||COPIES/UG||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|CLOTTED|NA|PUPILLOMETRY|MDRD 5 VARIABLE FORMULA||U|U|U|NA|||NA|3||39||OPEN LABEL TREATMENT|1967-12-08|1963-04-08|||||1962-06-25||1971-04-09|Y|1969-10-28
TRIAL STUDY 134XCP|LB|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|1||||VEGFA|VASCULAR ENDOTHELIAL GROWTH FACTOR A|||||||PMOL/10^10 CELLS|||||||TRACE||BQ/MG||||HIGH|NOT DONE||||URINE SEDIMENT|FROZEN|U|AURAMINE STAIN|CKD-EPI FORMULA||NA|U|U|NA|||Y|4||88||BLINDED TREATMENT|1970-12-13|1960-06-19|||||1963-12-23||1972-09-20|NA|1962-02-17
TRIAL STUDY 134XCP|LB|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|2||||TSH|THYROTROPIN|||||||IU/KG/H|||||||NEGATIVE||BOLUS||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|LACTESCENT|N|DUCTOGRAPHY|FIBROMETER FORMULA||U|U|Y|Y|||Y|4||88||OPEN LABEL TREATMENT|1963-08-19|1961-02-04|||||1968-05-25||1967-06-16|N|1973-05-15
TRIAL STUDY 134XCP|LB|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|1||||ACT|ACTIVATED COAGULATION TIME|||||||MS2|||||||INDETERMINATE||G||||ABNORMAL|NOT DONE||||CALCULUS|GELLED|N|IMMUNOFLUORESCENT STAIN|FIBROTEST FORMULA||Y|Y|Y|N|||NA|5||7||OPEN LABEL TREATMENT|1973-01-30|1973-05-09|||||1972-07-10||1970-01-02|Y|1971-06-08
TRIAL STUDY 134XCP|LB|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|2||||UNSPCE|UNSPECIFIED CELLS|||||||ANTI-XA IU|||||||NEGATIVE||10^3/L||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|PARAFFIN-EMBEDDED|Y|ALCIAN BLUE STAIN|FIBROTEST FORMULA||U|N|U|U|||NA|5||7||FOLLOW-UP|1966-02-21|1971-07-25|||||1963-11-25||1969-09-09|NA|1968-02-29
TRIAL STUDY 134XCP|LB|96C60715-2EDE-40FD-B41C-ECD1E5065C81|1||||ACYGLYCN|ACYLGLYCINE|||||||UV2|||||||INVALID||CM/MIN||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|SOLIDIFIED|U|X-RAY|CKD-EPI FORMULA||N|NA|U|NA|||Y|1||38||SCREENING|1964-03-24|1967-06-24|||||1968-12-13||1967-10-01|N|1963-03-15
TRIAL STUDY 134XCP|LB|96C60715-2EDE-40FD-B41C-ECD1E5065C81|2||||PERCECE|PROLIFERATING ERYTHROID/TOTAL CELLS|||||||/LPF|||||||INVALID||PG/DL||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|FRESH|Y|TRICHROME STAIN|FIBROTEST FORMULA||U|N|Y|N|||NA|1||38||INDUCTION TREATMENT|1970-12-06|1969-07-27|||||1966-04-05||1971-03-07|N|1966-07-18
TRIAL STUDY 134XCP|LB|96C60715-2EDE-40FD-B41C-ECD1E5065C81|1||||OXYCDN|OXYCODONE|||||||PG/DL|||||||TRACE||LOG10 TCID 50/UL||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|GELLED|Y|TWO-COLOR MICROARRAY|CKD-EPI CREATININE FORMULA||NA|N|U|NA|||U|2||58||FOLLOW-UP|1972-01-17|1972-11-11|||||1969-06-15||1963-07-11|N|1963-10-24
TRIAL STUDY 134XCP|LB|96C60715-2EDE-40FD-B41C-ECD1E5065C81|2||||GGTEXR|GAMMAGLUTAMYL TRANSFERASE EXCRETION RATE|||||||UG/KG/H|||||||TRACE||LOG10 CFU/ML||||LOW|NOT DONE||||ABSCESS FLUID|DRIED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|U|NA|||N|2||58||RUN-IN|1962-02-09|1961-07-16|||||1973-03-15||1968-04-12|N|1973-05-14
TRIAL STUDY 134XCP|LB|96C60715-2EDE-40FD-B41C-ECD1E5065C81|1||||URATE|URATE|||||||L/S|||||||BORDERLINE||%(W/V)||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|THAWED|Y|PERFUSION MRI|NASH FIBROSURE FORMULA||Y|NA|U|U|||U|3||39||CONTINUATION TREATMENT|1966-06-08|1962-01-07|||||1972-06-02||1962-06-23|NA|1966-07-29
TRIAL STUDY 134XCP|LB|96C60715-2EDE-40FD-B41C-ECD1E5065C81|2||||ANDSTNDL|ANDROSTENEDIOL|||||||10^6 DNA COPIES/ML|||||||INDETERMINATE||ROENTGEN||||NORMAL|NOT DONE||||CELL PELLET|LIPEMIC|N|TONOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|U|U|||U|3||39||OBSERVATION|1966-01-16|1961-10-25|||||1962-06-28||1967-10-27|Y|1960-12-20
TRIAL STUDY 134XCP|LB|96C60715-2EDE-40FD-B41C-ECD1E5065C81|1||||TPRONP|NON-PHOSPHORYLATED TAU PROTEIN|||||||MEQ/MMOL|||||||INVALID||CCID 50/DOSE||||NORMAL|NOT DONE||||VENOUS PLASMA|THAWED|Y|COMPLEMENT FIXATION|HEPASCORE FORMULA||U|NA|U|Y|||U|4||88||OPEN LABEL TREATMENT|1969-11-01|1969-01-01|||||1967-11-08||1963-12-05|NA|1968-05-21
TRIAL STUDY 134XCP|LB|96C60715-2EDE-40FD-B41C-ECD1E5065C81|2||||EAGLUC|GLUCOSE, ESTIMATED AVERAGE|||||||NMOL/G|||||||POSITIVE||FFU||||NORMAL|NOT DONE||||SERUM|CALCIFIED|U|AUTOREFRACTION|MDRD 4 VARIABLE FORMULA||N|NA|U|U|||U|4||88||INDUCTION TREATMENT|1962-10-15|1963-07-29|||||1973-04-10||1965-09-17|U|1972-08-02
TRIAL STUDY 134XCP|LB|96C60715-2EDE-40FD-B41C-ECD1E5065C81|1||||TNFR1|TUMOR NECROSIS FACTOR RECEPTOR 1|||||||CAPLET|||||||POSITIVE||UMOL/DL||||ABNORMAL|NOT DONE||||PLATELET|AUTOLYZED|NA|RAJI CELL EIA|CKD-EPI FORMULA||Y|Y|NA|U|||NA|5||7||TREATMENT|1966-08-31|1966-09-27|||||1964-04-25||1973-05-04|U|1973-03-13
TRIAL STUDY 134XCP|LB|96C60715-2EDE-40FD-B41C-ECD1E5065C81|2||||C165905|GRASS MIX POLLEN IGG AB RAST SCORE|||||||PL|||||||POSITIVE||MG/L FEU||||NORMAL|NOT DONE||||SEMINAL FLUID|FROZEN|N|SCINTIGRAPHY|GMI % FORMULA||NA|U|NA|U|||NA|5||7||TREATMENT|1968-02-28|1961-05-12|||||1971-03-15||1966-02-22|N|1971-03-12
TRIAL STUDY 134XCP|LB|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|1||||APOE4|APOLIPOPROTEIN E4|||||||UU/L|||||||POSITIVE||PIXELS/IN||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|REFRIGERATED|NA|TONOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|Y|NA|||U|1||38||BASELINE|1970-01-30|1965-10-01|||||1969-12-26||1969-03-27|NA|1972-08-10
TRIAL STUDY 134XCP|LB|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|2||||VENLAFAX|VENLAFAXINE|||||||% INHIBITION|||||||BORDERLINE||MV2/HZ||||LOW|NOT DONE||||SERUM|PARAFFIN-EMBEDDED|Y|CHROMOGENIC ASSAY|NASH FIBROSURE FORMULA||NA|U|U|Y|||N|1||38||CONTINUATION TREATMENT|1968-03-23|1963-02-08|||||1960-07-03||1970-05-09|Y|1970-11-22
TRIAL STUDY 134XCP|LB|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|1||||BTKFR|BRUTON'S TYROSINE KINASE, FREE|||||||PL|||||||NEGATIVE||G/DL||||LOW|NOT DONE||||ALVEOLAR AIR|CONTAMINATED|NA|MANUAL CLOT DETECTION|FIBROMETER FORMULA||N|NA|N|Y|||NA|2||58||INDUCTION TREATMENT|1960-05-17|1960-04-26|||||1968-05-07||1967-05-17|NA|1961-04-16
TRIAL STUDY 134XCP|LB|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|2||||BETACRTN|BETA CAROTENE|||||||10^9 ORGANISMS|||||||POSITIVE||IU/MG||||ABNORMAL|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|NA|SECONDARY ION MASS SPECTOMETRY|MDRD 4 VARIABLE FORMULA||NA|NA|Y|Y|||U|2||58||LONG-TERM FOLLOW-UP|1965-02-08|1968-08-13|||||1962-12-12||1965-09-08|NA|1969-03-21
TRIAL STUDY 134XCP|LB|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|1||||CXCL1|CHEMOKINE (C-X-C MOTIF) LIGAND 1|||||||CMH2O/ML|||||||POSITIVE||M/SEC||||LOW|NOT DONE||||SYNOVIAL FLUID|SOLIDIFIED|NA|VENTILATION PERFUSION LUNG SCAN|MDRD 5 VARIABLE FORMULA||N|N|NA|Y|||N|3||39||TREATMENT|1960-03-11|1968-07-14|||||1967-04-02||1968-10-02|U|1968-11-30
TRIAL STUDY 134XCP|LB|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|2||||C165941|COMMON RAGWEED POLLEN IGE AB RAST SCORE|||||||BQ/UL|||||||NEGATIVE||ENZYME U||||NORMAL|NOT DONE||||PERITONEAL FLUID|NON-HEMOLYZED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|Y|NA|||U|3||39||FOLLOW-UP|1966-06-21|1966-10-02|||||1966-07-15||1967-06-13|Y|1964-12-02
TRIAL STUDY 134XCP|LB|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|1||||CYBILI|BILIRUBIN CRYSTALS|||||||NMOL|||||||INVALID||FIU||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|THAWED|NA|AMSLER GRID|MDRD FORMULA||Y|U|Y|NA|||N|4||88||TREATMENT|1965-05-01|1966-07-09|||||1972-01-31||1969-02-08|N|1972-08-14
TRIAL STUDY 134XCP|LB|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|2||||DZPM|DIAZEPAM|||||||PIPE|||||||INDETERMINATE||10^6 U||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|CONCENTRATED|N|LANDOLT RING|FIBROMETER FORMULA||N|Y|N|N|||NA|4||88||OPEN LABEL TREATMENT|1960-08-07|1967-12-26|||||1972-08-27||1961-06-07|U|1968-08-23
TRIAL STUDY 134XCP|LB|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|1||||PLAGGCVT|PLATELET AGGREGATION CURVE TYPE|||||||% INHIBITION|||||||INDETERMINATE||PSI||||HIGH|NOT DONE||||BONE|AUTOLYZED|Y|PEAK FLOWMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|U|N|||Y|5||7||WASHOUT|1970-04-04|1963-06-21|||||1962-09-17||1969-12-31|U|1962-01-31
TRIAL STUDY 134XCP|LB|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|2||||C130089|TIMOTHY GRASS POLLEN IGA|||||||10^6/HPF|||||||INVALID||/CMH2O||||HIGH|NOT DONE||||LYSATE|CALCIFIED|NA|MICROBIAL BIOCHEMICAL IDENTIFICATION|FIBROMETER FORMULA||NA|N|U|U|||NA|5||7||INDUCTION TREATMENT|1960-10-16|1968-05-27|||||1964-03-27||1965-11-01|U|1963-06-06
TRIAL STUDY 134XCP|LB|8452DD7A-4DC9-4BDF-B670-AE5B49292805|1||||HGBF|HEMOGLOBIN F|||||||MMAL|||||||INVALID||/LPF||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|CONTAMINATED|NA|RULER MEASUREMENT METHOD|NASH FIBROSURE FORMULA||U|U|Y|U|||NA|1||38||FOLLOW-UP|1964-04-05|1962-11-04|||||1970-11-20||1971-03-20|U|1964-06-13
TRIAL STUDY 134XCP|LB|8452DD7A-4DC9-4BDF-B670-AE5B49292805|2||||CYSTATC|CYSTATIN C|||||||10^9/L|||||||POSITIVE||CI/UG||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|AUTOLYZED|Y|EPSILOMETER|MDRD ENZYMATIC JAPANESE FORMULA||N|N|Y|Y|||N|1||38||OPEN LABEL TREATMENT|1970-05-08|1971-03-01|||||1964-11-23||1967-08-02|Y|1961-12-06
TRIAL STUDY 134XCP|LB|8452DD7A-4DC9-4BDF-B670-AE5B49292805|1||||MUCTHR|MUCOUS THREADS|||||||UMOL/L/SEC|||||||NEGATIVE||10^6 IU||||LOW|NOT DONE||||TUMOR TISSUE|CONTAMINATED|Y|DIFFUSION TENSOR MRI|MDRD ENZYMATIC FORMULA||N|NA|N|N|||U|2||58||CONTINUATION TREATMENT|1972-09-06|1960-11-07|||||1960-08-23||1966-08-23|U|1963-04-01
TRIAL STUDY 134XCP|LB|8452DD7A-4DC9-4BDF-B670-AE5B49292805|2||||TROPONI3|TROPONIN I TYPE 3|||||||/LPF|||||||POSITIVE||MIU/L||||NORMAL|NOT DONE||||LYSATE|NON-HEMOLYZED|U|MULTIPLEXED BEAD BASED IMMUNOASSAY|GMI % FORMULA||N|Y|Y|NA|||NA|2||58||CONTINUATION TREATMENT|1962-11-16|1966-02-10|||||1971-05-26||1965-08-12|Y|1963-12-13
TRIAL STUDY 134XCP|LB|8452DD7A-4DC9-4BDF-B670-AE5B49292805|1||||CIT|CITRULLINE|||||||10^6 ORGANISMS/G|||||||BORDERLINE||KCAL||||NORMAL|NOT DONE||||EPITHELIAL CELL|FROZEN|U|PULSE OXIMETRY|MDRD 4 VARIABLE FORMULA||NA|Y|NA|Y|||NA|3||39||CONTINUATION TREATMENT|1963-09-13|1963-07-03|||||1965-06-15||1960-11-18|NA|1969-03-05
TRIAL STUDY 134XCP|LB|8452DD7A-4DC9-4BDF-B670-AE5B49292805|2||||PROTSFR|PROTEIN S, FREE|||||||NMOL/MOL|||||||POSITIVE||STEPS||||HIGH|NOT DONE||||PLEURAL TISSUE|SOLIDIFIED|NA|ANTIBIOTIC AGAR SCREEN|MDRD 6 VARIABLE FORMULA||Y|NA|U|N|||N|3||39||RUN-IN|1962-07-10|1970-06-20|||||1971-04-02||1969-04-20|N|1969-09-13
TRIAL STUDY 134XCP|LB|8452DD7A-4DC9-4BDF-B670-AE5B49292805|1||||PTHNT|PARATHYROID HORMONE, N-TERMINAL|||||||MONTHS|||||||BORDERLINE||ATM||||ABNORMAL|NOT DONE||||BREAST MILK|LACTESCENT|Y|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI FORMULA||N|NA|N|NA|||N|4||88||BASELINE|1967-02-18|1961-10-12|||||1965-04-06||1971-08-21|Y|1972-05-03
TRIAL STUDY 134XCP|LB|8452DD7A-4DC9-4BDF-B670-AE5B49292805|2||||TNFR1B|TNF RECEPTOR 1B|||||||FRACTION OF 1|||||||NEGATIVE||VP/ML||||LOW|NOT DONE||||SMEGMA|CLOTTED|U|FLUORESCENT ENZYME IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|Y|N|||U|4||88||FOLLOW-UP|1969-08-21|1969-01-22|||||1964-12-03||1964-07-20|Y|1971-05-31
TRIAL STUDY 134XCP|LB|8452DD7A-4DC9-4BDF-B670-AE5B49292805|1||||BLYCECE|B-LYMPHOCYTES/TOTAL CELLS|||||||MG/KG/MIN|||||||INDETERMINATE||COAT||||NORMAL|NOT DONE||||CAPILLARY PLASMA|AUTOLYZED|Y|AURAMINE STAIN|MDRD 5 VARIABLE FORMULA||NA|Y|NA|NA|||Y|5||7||OPEN LABEL TREATMENT|1961-01-26|1966-11-12|||||1973-08-21||1966-11-13|NA|1965-02-04
TRIAL STUDY 134XCP|LB|8452DD7A-4DC9-4BDF-B670-AE5B49292805|2||||HELMOV10|HELICASE MOV-10 PROTEIN|||||||MMHG/L/MIN|||||||TRACE||PM||||ABNORMAL|NOT DONE||||VENOUS PLASMA|FRESH|NA|LC/MS/MS|MDRD 5 VARIABLE FORMULA||Y|Y|Y|U|||Y|5||7||BLINDED TREATMENT|1963-06-19|1967-07-12|||||1970-05-11||1966-06-25|Y|1971-09-17
TRIAL STUDY 134XCP|LB|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|1||||UREACRT|UREA/CREATININE|||||||MOL/DAY|||||||POSITIVE||OSM||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|FRESH|U|PATHOLOGICAL EVALUATION|GMI % FORMULA||N|N|N|Y|||Y|1||38||BASELINE|1972-10-17|1968-08-18|||||1964-06-19||1962-09-03|NA|1963-02-17
TRIAL STUDY 134XCP|LB|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|2||||NEUTHYGR|HYPOGRANULAR NEUTROPHILS|||||||U/G/DAY|||||||TRACE||10^3 DNA COPIES/ML||||ABNORMAL|NOT DONE||||LOCHIA|AUTOLYZED|NA|GRADIENT DIFFUSION|MDRD 6 VARIABLE FORMULA||Y|U|N|U|||NA|1||38||OPEN LABEL TREATMENT|1966-02-23|1964-11-20|||||1964-08-08||1966-10-31|Y|1966-03-31
TRIAL STUDY 134XCP|LB|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|1||||URATE|URATE|||||||ML/(MIN*100ML)|||||||NEGATIVE||MG/MIN||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|FROZEN|U|POPULATION SEQUENCING|FIBROTEST FORMULA||NA|N|U|U|||N|2||58||FOLLOW-UP|1963-05-01|1962-05-13|||||1971-04-23||1967-01-22|Y|1966-07-20
TRIAL STUDY 134XCP|LB|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|2||||GSTAL|ALPHA GLUTATHIONE-S-TRANSFERASE|||||||10^6 ORGANISMS/MG|||||||TRACE||KA_U/DL||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|SOLIDIFIED|NA|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|GMI % FORMULA||U|U|U|NA|||Y|2||58||RUN-IN|1972-06-09|1970-12-27|||||1969-12-01||1962-03-30|N|1963-11-07
TRIAL STUDY 134XCP|LB|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|1||||LEAD|LEAD|||||||10^4/HPF|||||||INDETERMINATE||PSEC||||LOW|NOT DONE||||GASTRIC FLUID|AUTOLYZED|N|OLIGO ACGH|MDRD ENZYMATIC FORMULA||NA|NA|Y|Y|||Y|3||39||LONG-TERM FOLLOW-UP|1965-06-17|1961-06-30|||||1971-10-20||1964-01-28|NA|1971-08-26
TRIAL STUDY 134XCP|LB|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|2||||CDTTFRN|CARB-DEFICIENT TRANSFERRIN/TRANSFERRIN|||||||10^8 PFU|||||||INVALID||TRANSDUCING UNIT||||NORMAL|NOT DONE||||SEMINAL FLUID|SOLIDIFIED|NA|DISK DIFFUSION|GMI % FORMULA||NA|Y|NA|U|||U|3||39||SCREENING|1964-10-09|1965-07-17|||||1972-01-08||1967-08-31|Y|1965-09-14
TRIAL STUDY 134XCP|LB|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|1||||IMMGLC|IMMUNOGLOBULIN LIGHT CHAINS|||||||PIPE|||||||BORDERLINE||M3||||LOW|NOT DONE||||ABSCESS FLUID|AUTOLYZED|Y|MANUAL COUNT|COCKCROFT-GAULT FORMULA||N|Y|Y|NA|||N|4||88||INDUCTION TREATMENT|1971-05-01|1960-10-07|||||1972-02-05||1965-11-10|N|1960-09-11
TRIAL STUDY 134XCP|LB|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|2||||C165894|D. FARINAE ANTIGEN IGG4 ANTIBODY|||||||RATIO|||||||POSITIVE||PA||||HIGH|NOT DONE||||EXPIRED AIR|NON-HEMOLYZED|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|COCKCROFT-GAULT FORMULA||Y|NA|N|U|||NA|4||88||CONTINUATION TREATMENT|1966-04-09|1970-02-08|||||1962-09-25||1962-04-08|N|1972-02-10
TRIAL STUDY 134XCP|LB|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|1||||GRANIM|IMMATURE GRANULOCYTES|||||||NG/MOL|||||||INDETERMINATE||KN/CM2||||NORMAL|NOT DONE||||EMOTIONAL TEAR|UNEXPECTED ODOR|Y|DYNAMOMETRY|COCKCROFT-GAULT FORMULA||NA|U|U|Y|||NA|5||7||OBSERVATION|1971-05-23|1970-07-24|||||1960-01-02||1969-07-31|NA|1963-12-16
TRIAL STUDY 134XCP|LB|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|2||||APOA1|APOLIPOPROTEIN A1|||||||CARTRIDGE|||||||BORDERLINE||PG/L||||HIGH|NOT DONE||||LAVAGE FLUID|DRIED|NA|PYROSEQUENCING|MDRD FORMULA||U|U|Y|NA|||Y|5||7||INDUCTION TREATMENT|1968-07-01|1962-12-01|||||1965-10-10||1970-02-01|N|1972-09-06
TRIAL STUDY 134XCP|LB|30108497-140B-499E-8924-8BFCDC57457A|1||||BTLBARTL|BUTABARBITAL|||||||BQ/G|||||||INVALID||ML||||ABNORMAL|NOT DONE||||EXPIRED AIR|SOLIDIFIED|NA|NUCLEAR RADIOLOGY|CKD-EPI FORMULA||Y|Y|NA|Y|||Y|1||38||OBSERVATION|1962-05-10|1961-11-17|||||1960-03-07||1965-09-12|NA|1962-06-28
TRIAL STUDY 134XCP|LB|30108497-140B-499E-8924-8BFCDC57457A|2||||DFI|DNA FRAGMENTATION INDEX|||||||MG/M2/DAY|||||||TRACE||MMOL/MOL||||LOW|NOT DONE||||PLATELET|NON-HEMOLYZED|Y|CELLULOSE TAPE|ASH FIBROSURE FORMULA||U|Y|Y|NA|||N|1||38||BLINDED TREATMENT|1960-11-29|1971-08-25|||||1967-09-14||1966-05-27|U|1968-11-20
TRIAL STUDY 134XCP|LB|30108497-140B-499E-8924-8BFCDC57457A|1||||GRANULIN|GRANULIN|||||||PMOL|||||||POSITIVE||MG/KG/H||||NORMAL|NOT DONE||||BREAST MILK|ICTERIC|U|FLOW CYTOMETRY|MDRD 6 VARIABLE FORMULA||U|NA|U|Y|||NA|2||58||TREATMENT|1965-01-11|1963-01-08|||||1961-07-23||1973-01-26|Y|1966-03-19
TRIAL STUDY 134XCP|LB|30108497-140B-499E-8924-8BFCDC57457A|2||||MONONSQE|MONOCYTES/NON-SQUAM EPI CELLS|||||||KDA|||||||NEGATIVE||L||||LOW|NOT DONE||||AMNIOTIC FLUID|PARAFFIN-EMBEDDED|Y|REFRACTOMETRY|MDRD 5 VARIABLE FORMULA||U|U|U|N|||N|2||58||OPEN LABEL TREATMENT|1969-10-31|1962-04-20|||||1963-01-17||1971-04-16|Y|1973-02-04
TRIAL STUDY 134XCP|LB|30108497-140B-499E-8924-8BFCDC57457A|1||||FACTXIA|FACTOR XI ACTIVITY|||||||DIP|||||||INDETERMINATE||BQ/ML||||LOW|NOT DONE||||MONOCYTE|LIPEMIC|U|IVY INCISION METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|U|||NA|3||39||RUN-IN|1962-02-16|1965-06-05|||||1960-03-22||1965-09-10|N|1971-04-11
TRIAL STUDY 134XCP|LB|30108497-140B-499E-8924-8BFCDC57457A|2||||VWFAAC|VON WILL FACTOR ACT ACTUAL/CONTROL|||||||AMP|||||||NEGATIVE||MG/M2/H||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|HEMOLYZED|NA|ELECTRONEUROGRAPHY|FIBROTEST FORMULA||N|Y|N|N|||Y|3||39||OPEN LABEL TREATMENT|1960-09-01|1961-05-09|||||1967-01-28||1970-09-03|U|1972-12-25
TRIAL STUDY 134XCP|LB|30108497-140B-499E-8924-8BFCDC57457A|1||||G6PDA|GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACT|||||||%(W/W)|||||||TRACE||LOG EID 50/DOSE||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|LIPEMIC|Y|LASER CAPTURE MICRODISSECTION|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|N|U|||N|4||88||RUN-IN|1965-07-13|1973-01-15|||||1963-01-27||1971-01-14|NA|1964-10-21
TRIAL STUDY 134XCP|LB|30108497-140B-499E-8924-8BFCDC57457A|2||||TRIGHDL|TRIGLYCERIDES/HDL CHOLESTEROL|||||||JDF UNIT|||||||INVALID||KIU||||NORMAL|NOT DONE||||CELL PELLET|CONCENTRATED|N|ECHOCARDIOGRAPHY|FIBROMETER FORMULA||U|NA|Y|Y|||Y|4||88||INDUCTION TREATMENT|1969-02-17|1964-12-15|||||1969-02-08||1973-05-26|U|1966-07-04
TRIAL STUDY 134XCP|LB|30108497-140B-499E-8924-8BFCDC57457A|1||||PROT|PROTEIN|||||||ML/CM3/MIN|||||||BORDERLINE||UMOL/L||||HIGH|NOT DONE||||ABSCESS FLUID|CALCIFIED|N|FLUORIMETRY|ASH FIBROSURE FORMULA||U|Y|N|N|||Y|5||7||TREATMENT|1965-04-27|1963-01-28|||||1971-01-31||1965-10-08|U|1971-10-14
TRIAL STUDY 134XCP|LB|30108497-140B-499E-8924-8BFCDC57457A|2||||BJPROT|BENCE-JONES PROTEIN|||||||10^9/G|||||||NEGATIVE||BEL||||HIGH|NOT DONE||||INTERSTITIAL FLUID|CONTAMINATED|U|CONTRAST ENHANCED SPIRAL CT SCAN|FIBROTEST FORMULA||Y|N|U|N|||Y|5||7||LONG-TERM FOLLOW-UP|1965-02-23|1971-01-15|||||1966-11-07||1964-11-24|Y|1972-07-18
TRIAL STUDY 134XCP|LB|5FFEF358-5014-497F-A091-6EF27A1BCF7D|1||||HGBCS|HEMOGLOBIN CASTS|||||||PFU/DOSE|||||||BORDERLINE||KV||||NORMAL|NOT DONE||||EMOTIONAL TEAR|DRIED|Y|ACID FAST STAIN|FIBROMETER FORMULA||Y|U|U|N|||Y|1||38||TREATMENT|1972-06-15|1969-07-19|||||1973-05-03||1963-01-20|NA|1964-08-31
TRIAL STUDY 134XCP|LB|5FFEF358-5014-497F-A091-6EF27A1BCF7D|2||||C165939|EGG WHITE IGE AB RAST SCORE|||||||UIU/L|||||||INVALID||ANTI-XA IU/ML||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|U|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE FORMULA||Y|Y|U|U|||Y|1||38||BLINDED TREATMENT|1962-07-27|1972-05-13|||||1970-10-08||1969-08-04|NA|1960-07-03
TRIAL STUDY 134XCP|LB|5FFEF358-5014-497F-A091-6EF27A1BCF7D|1||||HYPRLN|HYDROXYPROLINE|||||||TRANSDUCING UNIT|||||||INVALID||PG/DL||||NORMAL|NOT DONE||||PERSPIRATION|UNEXPECTED ODOR|N|HPLC|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|NA|||N|2||58||BASELINE|1967-07-09|1964-07-11|||||1970-08-10||1969-03-14|U|1960-05-09
TRIAL STUDY 134XCP|LB|5FFEF358-5014-497F-A091-6EF27A1BCF7D|2||||PF2AI8CR|8-ISO-PGF2ALPHA/CREATININE|||||||NMOL/L|||||||INVALID||10^9/DOSE||||HIGH|NOT DONE||||URINE SEDIMENT|FRESH|U|MASS SPECTROMETRY|CKD-EPI CREATININE FORMULA||Y|U|N|Y|||NA|2||58||OBSERVATION|1969-03-30|1967-03-24|||||1970-04-08||1968-10-07|N|1965-08-09
TRIAL STUDY 134XCP|LB|5FFEF358-5014-497F-A091-6EF27A1BCF7D|1||||HIST2AAB|HISTONE 2A ANTIBODY|||||||MMOL2/L2|||||||INVALID||GMFI||||NORMAL|NOT DONE||||MECONIUM|LACTESCENT|NA|WESTERGREN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|NA|NA|||N|3||39||LONG-TERM FOLLOW-UP|1970-11-27|1960-11-04|||||1969-12-25||1961-05-07|U|1967-03-05
TRIAL STUDY 134XCP|LB|5FFEF358-5014-497F-A091-6EF27A1BCF7D|2||||RNPSMAB|RIBONUCLEOPROTEIN SMITH COMPLEX ANTIBODY|||||||PACKET|||||||BORDERLINE||ML/M2/H||||ABNORMAL|NOT DONE||||LYSATE|AUTOLYZED|U|CELL BASED BIOASSAY|MDRD FORMULA||N|N|N|NA|||Y|3||39||WASHOUT|1968-06-08|1963-06-09|||||1960-09-30||1965-10-20|NA|1964-04-26
TRIAL STUDY 134XCP|LB|5FFEF358-5014-497F-A091-6EF27A1BCF7D|1||||OXZPM|OXAZEPAM|||||||MEQ/UL|||||||NEGATIVE||SCM||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|GELLED|N|INTRAVASCULAR ULTRASOUND|FIBROSIS 4 FORMULA||NA|N|NA|NA|||N|4||88||BASELINE|1970-05-24|1967-03-07|||||1962-09-01||1971-03-26|NA|1968-02-06
TRIAL STUDY 134XCP|LB|5FFEF358-5014-497F-A091-6EF27A1BCF7D|2||||VLDLTCT|VLDL TRIGLYCERIDE + CHYLOMICRON TRIGLYCERIDE|||||||SCM|||||||BORDERLINE||FT3||||NORMAL|NOT DONE||||LYSATE|REFRIGERATED|Y|POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA||N|U|Y|U|||U|4||88||WASHOUT|1960-05-23|1964-11-22|||||1960-09-30||1970-11-25|NA|1971-10-05
TRIAL STUDY 134XCP|LB|5FFEF358-5014-497F-A091-6EF27A1BCF7D|1||||INTLK17|INTERLEUKIN 17|||||||MG/ML/DAY|||||||BORDERLINE||NKAT/L||||NORMAL|NOT DONE||||AQUEOUS HUMOR|NON-HEMOLYZED|Y|EPSILOMETER|FIBROSIS 4 FORMULA||N|N|N|NA|||NA|5||7||BASELINE|1965-04-11|1963-10-24|||||1961-06-30||1969-09-25|N|1971-03-03
TRIAL STUDY 134XCP|LB|5FFEF358-5014-497F-A091-6EF27A1BCF7D|2||||TURB|TURBIDITY|||||||UG/G/MIN|||||||BORDERLINE||ML/CAGE/DAY||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|CONCENTRATED|N|TRIPLE-PHASE MRI SCAN|CKD-EPI CREATININE FORMULA||NA|U|N|NA|||NA|5||7||TREATMENT|1960-12-03|1960-08-24|||||1965-04-18||1965-04-28|NA|1964-05-06
TRIAL STUDY 134XCP|LB|9DFBE459-22E4-4BA7-A993-AC06D6644562|1||||IGSOL|SOLUBLE IMMUNOGLOBULIN|||||||IU/KG|||||||INDETERMINATE||UMOL/H/MMOL||||LOW|NOT DONE||||CEREBROSPINAL FLUID|CONTAMINATED|NA|INTRAVASCULAR ULTRASOUND|GMI MMOL/MOL FORMULA||Y|U|Y|U|||Y|1||38||FOLLOW-UP|1968-07-28|1973-04-05|||||1969-01-07||1962-10-09|Y|1966-11-16
TRIAL STUDY 134XCP|LB|9DFBE459-22E4-4BA7-A993-AC06D6644562|2||||ALB|ALBUMIN|||||||ENZYME U/G HB|||||||INVALID||UU/L||||ABNORMAL|NOT DONE||||NAIL|CALCIFIED|Y|MANUAL CLOT DETECTION|MDRD FORMULA||NA|NA|U|NA|||N|1||38||OBSERVATION|1965-03-30|1964-03-14|||||1965-08-22||1970-03-22|U|1973-07-30
TRIAL STUDY 134XCP|LB|9DFBE459-22E4-4BA7-A993-AC06D6644562|1||||IAA5OH|5-HYDROXYINDOLEACETIC ACID|||||||JAR|||||||INVALID||USP U||||ABNORMAL|NOT DONE||||SPERMATOZOON|LACTESCENT|Y|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI FORMULA||U|N|NA|Y|||Y|2||58||SCREENING|1971-12-21|1968-10-17|||||1964-09-07||1968-10-16|NA|1973-06-16
TRIAL STUDY 134XCP|LB|9DFBE459-22E4-4BA7-A993-AC06D6644562|2||||FECL|FRACTIONAL CHLORIDE EXCRETION|||||||ML/H|||||||TRACE||CM H2O||||HIGH|NOT DONE||||DISCHARGE|LACTESCENT|U|PANENDOSCOPY|MDRD FORMULA||NA|N|N|NA|||N|2||58||INDUCTION TREATMENT|1966-12-29|1968-01-30|||||1962-09-15||1970-06-27|Y|1967-08-15
TRIAL STUDY 134XCP|LB|9DFBE459-22E4-4BA7-A993-AC06D6644562|1||||LVFBRSC|LIVER FIBROSIS SCORE|||||||NM|||||||TRACE||ML/CAGE||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ICTERIC|NA|ELASTOGRAPHY|MDRD 6 VARIABLE FORMULA||Y|U|Y|Y|||NA|3||39||FOLLOW-UP|1963-05-09|1968-01-24|||||1964-04-10||1965-08-26|Y|1962-01-25
TRIAL STUDY 134XCP|LB|9DFBE459-22E4-4BA7-A993-AC06D6644562|2||||NOHDLHDL|NON-HDL CHOLESTEROL/HDL CHOLESTEROL|||||||/10^4|||||||POSITIVE||UG/L/H||||NORMAL|NOT DONE||||SEBUM|FRESH|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD 5 VARIABLE FORMULA||U|NA|U|N|||Y|3||39||OPEN LABEL TREATMENT|1967-06-03|1965-10-04|||||1967-02-02||1968-08-06|NA|1964-05-31
TRIAL STUDY 134XCP|LB|9DFBE459-22E4-4BA7-A993-AC06D6644562|1||||ENDOTH1|ENDOTHELIN-1|||||||SQU/ML|||||||INDETERMINATE||TUBERCULIN UNIT||||LOW|NOT DONE||||BASAL TEAR|PARAFFIN-EMBEDDED|U|ELECTRICAL IMPEDANCE MYOGRAPHY|COCKCROFT-GAULT FORMULA||Y|U|Y|N|||N|4||88||TREATMENT|1961-03-17|1963-08-08|||||1967-11-14||1969-05-02|NA|1968-06-02
TRIAL STUDY 134XCP|LB|9DFBE459-22E4-4BA7-A993-AC06D6644562|2||||BASEDEF|BASE DEFICIT|||||||DPM/ML|||||||BORDERLINE||MPL U||||LOW|NOT DONE||||CAPILLARY BLOOD|LIPEMIC|N|ICC|FIBROTEST FORMULA||N|U|N|N|||N|4||88||INDUCTION TREATMENT|1962-04-11|1966-08-15|||||1963-02-17||1961-09-22|Y|1967-02-08
TRIAL STUDY 134XCP|LB|9DFBE459-22E4-4BA7-A993-AC06D6644562|1||||GUDCA|GLYCOURSODEOXYCHOLATE|||||||DAMOL/L|||||||INDETERMINATE||ML/CAGE||||LOW|NOT DONE||||VENOUS BLOOD|GELLED|NA|SANGER SEQUENCING|GMI MMOL/MOL FORMULA||NA|N|U|N|||U|5||7||INDUCTION TREATMENT|1961-10-29|1971-03-04|||||1960-08-03||1973-07-14|Y|1966-09-14
TRIAL STUDY 134XCP|LB|9DFBE459-22E4-4BA7-A993-AC06D6644562|2||||ICAM|INTERCELLULAR ADHESION MOLECULE|||||||V|||||||NEGATIVE||MMOL/G||||LOW|NOT DONE||||MUCUS|CONTAMINATED|N|MRI|HEPASCORE FORMULA||NA|Y|NA|N|||Y|5||7||BASELINE|1961-07-15|1970-08-16|||||1971-12-24||1968-12-22|NA|1970-12-20
TRIAL STUDY 134XCP|LB|850B35FA-69C7-44AD-A471-964C59C4CFD8|1||||AMPHETD|DEXTROAMPHETAMINE|||||||KS|||||||BORDERLINE||UG/M2/DAY||||HIGH|NOT DONE||||VENOUS CORD BLOOD|LIPEMIC|U|OPHTHALMOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|Y|U|||NA|1||38||CONTINUATION TREATMENT|1973-02-12|1965-08-10|||||1968-09-17||1960-01-07|N|1971-06-26
TRIAL STUDY 134XCP|LB|850B35FA-69C7-44AD-A471-964C59C4CFD8|2||||MPOAB|MYELOPEROXIDASE ANTIBODY|||||||DRINK|||||||TRACE||MEQ/UG||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|THAWED|NA|ACCELERATOR MASS SPECTROMETRY|MDRD 6 VARIABLE FORMULA||NA|N|NA|N|||N|1||38||OBSERVATION|1963-12-31|1972-04-23|||||1968-10-14||1964-04-01|U|1961-09-21
TRIAL STUDY 134XCP|LB|850B35FA-69C7-44AD-A471-964C59C4CFD8|1||||HBLEPRHB|HEMOGLOBIN LEPORE/TOTAL HEMOGLOBIN|||||||UKAT|||||||NEGATIVE||STEPS/MIN||||ABNORMAL|NOT DONE||||EXPIRED AIR|THAWED|Y|INTRAVASCULAR ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|N|U|||N|2||58||LONG-TERM FOLLOW-UP|1960-01-23|1970-09-01|||||1960-07-09||1966-11-10|N|1961-07-31
TRIAL STUDY 134XCP|LB|850B35FA-69C7-44AD-A471-964C59C4CFD8|2||||PHOSCLR|PHOSPHATE CLEARANCE|||||||PMOL/10^9 CELLS|||||||TRACE||10^6 RNA COPIES/ML||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|THAWED|NA|THERMAL IONIZATION MASS SPECTROMETRY|MDRD FORMULA||NA|N|NA|U|||U|2||58||FOLLOW-UP|1965-08-11|1973-07-16|||||1969-09-08||1965-11-23|U|1969-05-02
TRIAL STUDY 134XCP|LB|850B35FA-69C7-44AD-A471-964C59C4CFD8|1||||GUSB|GLUCURONIDASE, BETA|||||||PACK|||||||NEGATIVE||U/10^12 RBC||||NORMAL|NOT DONE||||EMOTIONAL TEAR|CALCIFIED|NA|DXA SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|NA|Y|||N|3||39||LONG-TERM FOLLOW-UP|1972-05-30|1963-06-28|||||1961-12-05||1964-12-13|N|1960-08-29
TRIAL STUDY 134XCP|LB|850B35FA-69C7-44AD-A471-964C59C4CFD8|2||||TSHRAB|THYROTROPIN RECEPTOR ANTIBODY|||||||G/KG|||||||BORDERLINE||/100 WBC||||NORMAL|NOT DONE||||MUSCLE TISSUE|SOLIDIFIED|NA|HEMOCYTOMETRY|MDRD ENZYMATIC FORMULA||U|Y|Y|Y|||N|3||39||INDUCTION TREATMENT|1972-01-22|1964-11-22|||||1963-12-22||1963-06-12|N|1971-01-16
TRIAL STUDY 134XCP|LB|850B35FA-69C7-44AD-A471-964C59C4CFD8|1||||LCN2|LIPOCALIN-2|||||||CPM|||||||BORDERLINE||UU/L||||HIGH|NOT DONE||||PUS|HEMOLYZED|N|SLIT LAMP PHOTOGRAPHY|FIBROSIS 4 FORMULA||NA|Y|Y|N|||U|4||88||OPEN LABEL TREATMENT|1970-06-09|1962-09-22|||||1969-11-20||1969-02-06|N|1962-01-04
TRIAL STUDY 134XCP|LB|850B35FA-69C7-44AD-A471-964C59C4CFD8|2||||APPEAR|SPECIMEN APPEARANCE|||||||F|||||||NEGATIVE||ML/CM3/MIN||||LOW|NOT DONE||||HAIR|UNEXPECTED ODOR|U|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI FORMULA||U|N|NA|NA|||U|4||88||SCREENING|1960-11-06|1970-08-31|||||1964-01-06||1964-04-15|NA|1963-05-17
TRIAL STUDY 134XCP|LB|850B35FA-69C7-44AD-A471-964C59C4CFD8|1||||FACTX|FACTOR X|||||||ML/BEAT|||||||POSITIVE||CAPLET||||NORMAL|NOT DONE||||BUFFY COAT|CONCENTRATED|U|CLINICAL EVALUATION|MDRD FORMULA||N|Y|Y|N|||N|5||7||FOLLOW-UP|1969-01-02|1967-09-19|||||1971-06-18||1964-11-23|NA|1969-04-22
TRIAL STUDY 134XCP|LB|850B35FA-69C7-44AD-A471-964C59C4CFD8|2||||RETIHCR|HEMATOCRIT CORRECTED RETICULOCYTES|||||||TRANSDUCING UNIT|||||||INDETERMINATE||MS/MMHG||||HIGH|NOT DONE||||TRANSUDATE|REFRIGERATED|NA|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD ENZYMATIC FORMULA||U|Y|U|N|||N|5||7||LONG-TERM FOLLOW-UP|1963-04-24|1971-01-29|||||1971-10-14||1966-05-05|NA|1968-02-11
TRIAL STUDY 134XCP|LB|981B890E-1257-4F04-A974-6006401F78CC|1||||PHADJT|PH ADJUSTED FOR BODY TEMP|||||||UV*SEC|||||||INVALID||FINGERTIP UNIT||||NORMAL|NOT DONE||||URINE|LIPEMIC|Y|FLOCCULATION, CHARCOAL ENHANCED|MDRD 5 VARIABLE FORMULA||NA|U|U|Y|||NA|1||38||OPEN LABEL TREATMENT|1961-01-30|1969-10-07|||||1965-02-26||1969-12-01|N|1973-06-16
TRIAL STUDY 134XCP|LB|981B890E-1257-4F04-A974-6006401F78CC|2||||AZURGRAN|AZUROPHILIC GRANULES|||||||PSI|||||||INVALID||G/CAGE/WK||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|CALCIFIED|N|GEL ELECTROPHORESIS|HEPASCORE FORMULA||N|Y|U|Y|||N|1||38||LONG-TERM FOLLOW-UP|1963-01-29|1967-05-05|||||1971-05-11||1973-06-08|N|1963-04-06
TRIAL STUDY 134XCP|LB|981B890E-1257-4F04-A974-6006401F78CC|1||||GLYCRL|GLYCEROL|||||||VIAL|||||||INDETERMINATE||POINT||||HIGH|NOT DONE||||ARTERIAL BLOOD|HEMOLYZED|NA|KARYOTYPING|MDRD 5 VARIABLE FORMULA||Y|NA|U|Y|||N|2||58||OPEN LABEL TREATMENT|1963-11-14|1973-08-07|||||1968-05-12||1961-02-24|Y|1964-11-30
TRIAL STUDY 134XCP|LB|981B890E-1257-4F04-A974-6006401F78CC|2||||CRYSTALS|CRYSTALS|||||||STRIP|||||||BORDERLINE||10^6 IU/ML||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|AUTOLYZED|Y|TOTAL BODY RADIOGRAPHY|FIBROSIS 4 FORMULA||N|Y|NA|NA|||N|2||58||WASHOUT|1962-01-23|1969-04-27|||||1969-01-13||1960-03-03|Y|1966-08-19
TRIAL STUDY 134XCP|LB|981B890E-1257-4F04-A974-6006401F78CC|1||||HLADRMSC|HLA-DR MISMATCH COUNT|||||||NMOL/DAY|||||||TRACE||ARBITRARY U||||NORMAL|NOT DONE||||SALIVA|NON-HEMOLYZED|NA|LC/MS/MS|CKD-EPI FORMULA||U|Y|N|N|||U|3||39||TREATMENT|1972-03-25|1963-01-10|||||1961-07-17||1963-10-29|U|1972-05-14
TRIAL STUDY 134XCP|LB|981B890E-1257-4F04-A974-6006401F78CC|2||||KETONES|KETONES|||||||ML/CAGE/WK|||||||INDETERMINATE||CIGAR||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|CALCIFIED|N|DARK FIELD MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|N|NA|||N|3||39||OPEN LABEL TREATMENT|1967-04-13|1969-10-28|||||1968-08-17||1969-05-05|NA|1966-05-22
TRIAL STUDY 134XCP|LB|981B890E-1257-4F04-A974-6006401F78CC|1||||CXCL10|CHEMOKINE (C-X-C MOTIF) LIGAND 10|||||||FMOL|||||||INDETERMINATE||L||||NORMAL|NOT DONE||||CAPILLARY PLASMA|CLOTTED|N|MICROBIAL CULTURE, SOLID|MDRD 6 VARIABLE FORMULA||NA|N|Y|U|||NA|4||88||RUN-IN|1963-03-12|1967-12-21|||||1966-09-10||1960-11-23|N|1962-05-14
TRIAL STUDY 134XCP|LB|981B890E-1257-4F04-A974-6006401F78CC|2||||IRONEXR|IRON EXCRETION RATE|||||||UMOL/DAY|||||||POSITIVE||GY||||NORMAL|NOT DONE||||TISSUE|CALCIFIED|Y|FLUOROSCOPY|MDRD 6 VARIABLE FORMULA||U|U|U|NA|||Y|4||88||FOLLOW-UP|1971-08-27|1969-08-29|||||1967-03-04||1972-01-22|NA|1966-12-10
TRIAL STUDY 134XCP|LB|981B890E-1257-4F04-A974-6006401F78CC|1||||LH|LUTEINIZING HORMONE|||||||G|||||||POSITIVE||UG/DL||||LOW|NOT DONE||||CAPILLARY BLOOD|CALCIFIED|U|HPLC-UV|MDRD 5 VARIABLE FORMULA||Y|N|NA|U|||N|5||7||FOLLOW-UP|1967-09-05|1967-12-04|||||1969-12-08||1971-01-19|NA|1968-12-29
TRIAL STUDY 134XCP|LB|981B890E-1257-4F04-A974-6006401F78CC|2||||GSTPIEXR|PI-GST EXCRETION RATE|||||||KDA|||||||NEGATIVE||PT_BR||||HIGH|NOT DONE||||REFLEX TEAR|LACTESCENT|U|MUGA|GMI MMOL/MOL FORMULA||Y|U|N|N|||N|5||7||WASHOUT|1964-09-22|1960-03-30|||||1969-03-06||1970-05-07|U|1967-03-20
TRIAL STUDY 134XCP|LB|52FF8D96-64AD-498D-8B28-3DDD015796E3|1||||APOE|APOLIPOPROTEIN E|||||||INHALATION|||||||INVALID||APL U||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|REFRIGERATED|N|MALDI|FIBROMETER FORMULA||N|U|Y|U|||Y|1||38||WASHOUT|1965-11-15|1968-08-13|||||1969-01-13||1971-05-26|NA|1971-04-09
TRIAL STUDY 134XCP|LB|52FF8D96-64AD-498D-8B28-3DDD015796E3|2||||APLIGMAB|ANTI-PHOSPHOLIPID IGM ANTIBODY|||||||NG|||||||INDETERMINATE||BEL||||HIGH|NOT DONE||||BUFFY COAT|AUTOLYZED|NA|COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD ENZYMATIC FORMULA||NA|Y|Y|U|||NA|1||38||WASHOUT|1966-04-15|1964-06-24|||||1966-07-29||1961-07-11|U|1969-08-24
TRIAL STUDY 134XCP|LB|52FF8D96-64AD-498D-8B28-3DDD015796E3|1||||HGBTET|HEMOGLOBIN TETRAMER|||||||MV*MIN|||||||TRACE||10^6 CFU/G||||HIGH|NOT DONE||||DIALYSIS FLUID|CONTAMINATED|N|DXA SCAN|GMI MMOL/MOL FORMULA||Y|U|U|Y|||N|2||58||RUN-IN|1964-05-03|1964-04-09|||||1973-03-30||1967-06-18|NA|1969-05-28
TRIAL STUDY 134XCP|LB|52FF8D96-64AD-498D-8B28-3DDD015796E3|2||||FXIVAAC|FACTOR XIV ACTIVITY ACTUAL/CONTROL|||||||10^9/DOSE|||||||INDETERMINATE||MM/MIN||||ABNORMAL|NOT DONE||||SOFT TISSUE|CLOTTED|Y|POLYGRAPHY|MDRD ENZYMATIC FORMULA||U|U|N|U|||Y|2||58||OPEN LABEL TREATMENT|1966-01-16|1968-05-17|||||1964-04-22||1968-08-23|U|1969-01-31
TRIAL STUDY 134XCP|LB|52FF8D96-64AD-498D-8B28-3DDD015796E3|1||||DSVLFXN|DESVENLAFAXINE|||||||LOG10 COPIES/ML|||||||TRACE||VG/KG||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|LACTESCENT|NA|GC/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|Y|NA|||Y|3||39||WASHOUT|1973-04-23|1965-02-14|||||1966-05-07||1968-06-25|NA|1962-11-21
TRIAL STUDY 134XCP|LB|52FF8D96-64AD-498D-8B28-3DDD015796E3|2||||LYMMCELY|LYMPHOMA CELLS/LYMPHOCYTES|||||||MU/G|||||||TRACE||SPRAY||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|THAWED|N|WHOLE GENOME SEQUENCING|FIBROMETER FORMULA||N|Y|Y|U|||Y|3||39||LONG-TERM FOLLOW-UP|1972-02-21|1960-04-23|||||1964-04-18||1967-09-01|Y|1968-05-25
TRIAL STUDY 134XCP|LB|52FF8D96-64AD-498D-8B28-3DDD015796E3|1||||SARCOSIN|SARCOSINE|||||||U/DL|||||||NEGATIVE||PG/CELL||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|NON-HEMOLYZED|U|ENZYMATIC ULTRACENTRIFUGATION|GMI MMOL/MOL FORMULA||Y|N|Y|N|||NA|4||88||LONG-TERM FOLLOW-UP|1960-02-21|1960-11-18|||||1963-03-05||1968-05-12|NA|1963-03-14
TRIAL STUDY 134XCP|LB|52FF8D96-64AD-498D-8B28-3DDD015796E3|2||||C165923|TREE MIX POLLEN IGE AB RAST SCORE|||||||UG/H|||||||INVALID||CM||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|REFRIGERATED|U|VENTILATION PERFUSION LUNG SCAN|FIBROMETER FORMULA||Y|NA|NA|NA|||Y|4||88||WASHOUT|1960-11-21|1972-09-20|||||1964-05-10||1962-09-09|NA|1970-10-20
TRIAL STUDY 134XCP|LB|52FF8D96-64AD-498D-8B28-3DDD015796E3|1||||BCEFNCTN|BETA-CELL FUNCTION|||||||U/ML|||||||TRACE||OSM||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|ICTERIC|Y|MS/MS|MDRD 6 VARIABLE FORMULA||N|Y|N|NA|||Y|5||7||BLINDED TREATMENT|1962-07-24|1973-04-14|||||1973-02-16||1970-10-13|NA|1973-02-18
TRIAL STUDY 134XCP|LB|52FF8D96-64AD-498D-8B28-3DDD015796E3|2||||VEGFR2S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC2|||||||1/(S*KPA)|||||||POSITIVE||FMOL/L/SEC||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|Y|SNP ARRAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|NA|NA|||N|5||7||INDUCTION TREATMENT|1961-09-11|1970-02-07|||||1971-01-22||1963-04-24|U|1968-04-02
TRIAL STUDY 134XCP|LB|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|1||||HIS|HISTIDINE|||||||TITER|||||||INDETERMINATE||MS2||||HIGH|NOT DONE||||REFLEX TEAR|CONTAMINATED|U|CISH|MDRD ENZYMATIC FORMULA||U|N|Y|Y|||U|1||38||TREATMENT|1960-01-06|1961-07-11|||||1968-03-18||1962-11-07|Y|1963-05-21
TRIAL STUDY 134XCP|LB|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|2||||KLK2|KALLIKREIN-2|||||||C|||||||POSITIVE||FT3||||HIGH|NOT DONE||||KERATINOCYTE|CLOTTED|NA|GRAM STAIN|FIBROMETER FORMULA||NA|Y|U|Y|||NA|1||38||SCREENING|1962-06-23|1960-02-11|||||1973-04-13||1969-05-15|U|1961-07-16
TRIAL STUDY 134XCP|LB|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|1||||C130083|ORCHARD GRASS POLLEN IGG4|||||||PPTR|||||||TRACE||UG/KG/H||||NORMAL|NOT DONE||||COLOSTRUM|SOLIDIFIED|U|MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|U|NA|||NA|2||58||CONTINUATION TREATMENT|1970-03-29|1967-06-10|||||1961-03-02||1965-11-19|N|1973-02-15
TRIAL STUDY 134XCP|LB|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|2||||TPROTFR|TAU PROTEIN, FREE|||||||ML/MIN/1.73M2|||||||NEGATIVE||CM H2O||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|FROZEN|U|CT SCAN WITHOUT CONTRAST|MDRD 4 VARIABLE FORMULA||U|N|N|NA|||U|2||58||WASHOUT|1966-05-23|1966-10-16|||||1962-02-20||1963-08-02|N|1968-03-25
TRIAL STUDY 134XCP|LB|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|1||||PCNAG|PROLIFERATING CELL NUCLEAR ANTIGEN|||||||UGEQ/L|||||||INVALID||VP/DOSE||||HIGH|NOT DONE||||SEMINAL FLUID|AUTOLYZED|NA|TRANSMISSION ELECTRON MICROSCOPY|NASH FIBROSURE FORMULA||N|U|Y|Y|||NA|3||39||OBSERVATION|1969-01-15|1966-04-01|||||1966-08-06||1971-04-18|NA|1971-04-27
TRIAL STUDY 134XCP|LB|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|2||||SO2|SULFUR DIOXIDE|||||||10^7 CFU/ML|||||||TRACE||GMFI||||HIGH|NOT DONE||||URINE|AUTOLYZED|U|DIGITAL PCR ARRAY|GMI MMOL/MOL FORMULA||U|U|U|N|||NA|3||39||WASHOUT|1966-09-05|1972-09-14|||||1970-12-17||1963-01-11|N|1970-04-01
TRIAL STUDY 134XCP|LB|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|1||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||CUP|||||||BORDERLINE||ML/ANIMAL||||ABNORMAL|NOT DONE||||SKIN TISSUE|SOLIDIFIED|U|ANTIMICROBIAL COMBINATION TESTING|MDRD 4 VARIABLE FORMULA||NA|NA|NA|NA|||N|4||88||OPEN LABEL TREATMENT|1968-09-11|1961-03-13|||||1962-10-21||1966-04-13|NA|1964-04-02
TRIAL STUDY 134XCP|LB|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|2||||BTK|BRUTON'S TYROSINE KINASE|||||||MHZ|||||||POSITIVE||U/KG||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|LIPEMIC|NA|KNEMOMETRY|ASH FIBROSURE FORMULA||NA|NA|Y|NA|||NA|4||88||INDUCTION TREATMENT|1966-03-09|1963-08-16|||||1970-11-16||1968-03-14|NA|1964-09-09
TRIAL STUDY 134XCP|LB|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|1||||AMACR|ALPHA-METHYLACYL COENZYME A RACEMASE|||||||MOSM|||||||INDETERMINATE||UG/ANIMAL||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|CONCENTRATED|Y|CALCULATION|MDRD 4 VARIABLE FORMULA||U|Y|N|N|||U|5||7||WASHOUT|1963-05-03|1970-12-27|||||1969-01-16||1972-09-16|N|1967-07-21
TRIAL STUDY 134XCP|LB|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|2||||GATCPHRL|GAMMA TOCOPHEROL|||||||MG/G/H|||||||INVALID||UL/ML||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|CALCIFIED|Y|PATHOLOGICAL EVALUATION|NASH FIBROSURE FORMULA||NA|Y|U|N|||Y|5||7||OPEN LABEL TREATMENT|1965-12-11|1967-04-16|||||1972-12-20||1965-01-29|NA|1973-05-28
TRIAL STUDY 134XCP|LB|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|1||||HGBMET|METHEMOGLOBIN|||||||UG/CM2|||||||INDETERMINATE||10^4/HPF||||HIGH|NOT DONE||||AMNIOTIC FLUID|ICTERIC|Y|WRIGHT-GIEMSA STAIN|MDRD 5 VARIABLE FORMULA||U|NA|N|Y|||NA|1||38||INDUCTION TREATMENT|1961-06-20|1963-03-14|||||1968-08-25||1968-02-16|N|1960-08-10
TRIAL STUDY 134XCP|LB|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|2||||CAEXR|CALCIUM EXCRETION RATE|||||||NMOL/L|||||||INVALID||SBE/ML||||NORMAL|NOT DONE||||SWABBED MATERIAL|CONTAMINATED|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|HEPASCORE FORMULA||N|NA|NA|Y|||NA|1||38||SCREENING|1960-05-16|1966-08-09|||||1969-11-28||1969-03-23|Y|1961-10-26
TRIAL STUDY 134XCP|LB|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|1||||ANGTNSGN|ANGIOTENSINOGEN|||||||VIAL|||||||TRACE||DAYS||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CALCIFIED|Y|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|Y|||NA|2||58||WASHOUT|1970-10-28|1966-08-23|||||1971-05-24||1967-12-31|NA|1966-01-05
TRIAL STUDY 134XCP|LB|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|2||||SCHISTO|SCHISTOCYTES|||||||DAYS/WK|||||||BORDERLINE||U/G/MIN||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|PARAFFIN-EMBEDDED|U|AGAR DILUTION|HEPASCORE FORMULA||N|U|NA|Y|||N|2||58||CONTINUATION TREATMENT|1963-10-09|1970-05-15|||||1965-11-01||1965-09-06|N|1960-04-05
TRIAL STUDY 134XCP|LB|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|1||||C147278|GLYCINE MAX ANTIGEN IGE ANTIBODY|||||||NG/DL|||||||INVALID||ATM||||NORMAL|NOT DONE||||SOFT TISSUE|DRIED|NA|FLAME PHOTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|Y|N|||U|3||39||INDUCTION TREATMENT|1960-05-09|1971-02-20|||||1960-11-30||1973-06-19|U|1962-06-16
TRIAL STUDY 134XCP|LB|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|2||||BACT|BACTERIA|||||||U/KG/DAY|||||||INVALID||MMHG/L/MIN||||NORMAL|NOT DONE||||ERYTHROCYTES|FROZEN|Y|X-RAY FLUORESCENCE SPECTROMETRY|MDRD 6 VARIABLE FORMULA||U|U|U|NA|||NA|3||39||BASELINE|1965-03-16|1971-12-23|||||1966-08-23||1972-11-14|N|1962-05-05
TRIAL STUDY 134XCP|LB|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|1||||GLYCREAT|GLYCINE/CREATININE|||||||G/U|||||||BORDERLINE||LOG10 ELISA UNIT||||NORMAL|NOT DONE||||LYMPH|SOLIDIFIED|NA|RAJI CELL RIA|NASH FIBROSURE FORMULA||U|N|U|U|||U|4||88||OBSERVATION|1969-04-11|1970-09-26|||||1967-02-23||1970-08-20|Y|1967-09-23
TRIAL STUDY 134XCP|LB|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|2||||C130113|ANIMAL MIX ANTIGEN IGG ANTIBODY|||||||/KG|||||||BORDERLINE||MS2||||HIGH|NOT DONE||||FLUID|LIPEMIC|Y|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|FIBROSIS 4 FORMULA||Y|U|N|NA|||NA|4||88||SCREENING|1973-08-19|1972-06-12|||||1973-07-27||1962-10-13|Y|1964-08-22
TRIAL STUDY 134XCP|LB|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|1||||VEGF|VASCULAR ENDOTHELIAL GROWTH FACTOR|||||||GRAIN|||||||POSITIVE||UGEQ||||LOW|NOT DONE||||FLUID|UNEXPECTED ODOR|Y|HPLC/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|Y|NA|||NA|5||7||TREATMENT|1969-09-22|1963-01-30|||||1972-09-28||1966-11-21|NA|1969-01-20
TRIAL STUDY 134XCP|LB|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|2||||TTAC|THROMBIN TIME ACTUAL/CONTROL|||||||RAD|||||||TRACE||10^4/L||||LOW|NOT DONE||||INTERSTITIAL FLUID|FROZEN|Y|PHASE-CONTRAST MRI|MDRD FORMULA||NA|Y|Y|N|||Y|5||7||LONG-TERM FOLLOW-UP|1968-09-16|1970-03-31|||||1966-04-21||1960-04-23|U|1972-02-18
TRIAL STUDY 134XCP|LB|CD65CBB8-D056-4738-93A8-FF465534961B|1||||C130114|INDUSTRIAL MIX ANTIGEN IGE ANTIBODY|||||||MIU/L|||||||POSITIVE||TUBERCULIN UNIT/ML||||NORMAL|NOT DONE||||AMNIOTIC FLUID|ROOM TEMPERATURE|U|IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD 4 VARIABLE FORMULA||N|NA|U|NA|||U|1||38||TREATMENT|1968-01-08|1972-04-09|||||1967-11-26||1966-04-02|Y|1965-11-14
TRIAL STUDY 134XCP|LB|CD65CBB8-D056-4738-93A8-FF465534961B|2||||EOSBLE|EOSINOPHILS BAND FORM/LEUKOCYTES|||||||MMAL|||||||POSITIVE||PMOL/10^9 CELLS||||LOW|NOT DONE||||STOOL|GELLED|NA|WEBER GREEN STAIN|GMI MMOL/MOL FORMULA||U|Y|NA|Y|||NA|1||38||WASHOUT|1960-12-24|1962-01-15|||||1965-02-19||1972-06-24|N|1963-02-19
TRIAL STUDY 134XCP|LB|CD65CBB8-D056-4738-93A8-FF465534961B|1||||HIST4AB|HISTONE 4 ANTIBODY|||||||LOG10 TCID 50/UL|||||||INDETERMINATE||IU/KG/H||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|ROOM TEMPERATURE|N|SINGLE-SLICE SPIRAL CT|MDRD 4 VARIABLE FORMULA||Y|Y|NA|N|||NA|2||58||SCREENING|1963-07-15|1960-02-12|||||1971-07-12||1970-12-23|Y|1964-03-16
TRIAL STUDY 134XCP|LB|CD65CBB8-D056-4738-93A8-FF465534961B|2||||GLOBA1PT|ALPHA-1 GLOBULIN/TOTAL PROTEIN|||||||ML/M2|||||||POSITIVE||DEG2||||LOW|NOT DONE||||DERMAL TISSUE|LIPEMIC|N|CHROMATOGRAPHY|FIBROTEST FORMULA||NA|NA|Y|NA|||NA|2||58||RUN-IN|1970-05-09|1971-11-22|||||1962-08-27||1965-04-20|NA|1973-01-13
TRIAL STUDY 134XCP|LB|CD65CBB8-D056-4738-93A8-FF465534961B|1||||C130122|NUT MIX ANTIGEN IGE ANTIBODY|||||||K|||||||INVALID||100 IU/ML||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|CALCIFIED|N|MICROPARTICLE ENZYME IMMUNOASSAY|FIBROMETER FORMULA||U|NA|N|NA|||U|3||39||RUN-IN|1972-05-17|1965-11-08|||||1968-07-20||1969-01-05|NA|1960-02-08
TRIAL STUDY 134XCP|LB|CD65CBB8-D056-4738-93A8-FF465534961B|2||||CYCYSTIN|CYSTINE CRYSTALS|||||||MG/KG/WEEK|||||||BORDERLINE||UMOL/H/MMOL||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|CONCENTRATED|N|TOTAL BODY RADIOGRAPHY|MDRD 4 VARIABLE FORMULA||N|Y|Y|Y|||N|3||39||OBSERVATION|1967-04-21|1961-03-23|||||1966-12-25||1965-05-18|Y|1962-11-04
TRIAL STUDY 134XCP|LB|CD65CBB8-D056-4738-93A8-FF465534961B|1||||C5A|COMPLEMENT C5A|||||||BOLUS|||||||POSITIVE||RNA COPIES/ML||||ABNORMAL|NOT DONE||||MECONIUM|AGGLUTINATED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI CYSTATIN C FORMULA||U|N|U|N|||Y|4||88||OPEN LABEL TREATMENT|1960-05-22|1966-06-17|||||1963-03-18||1963-10-25|N|1963-07-05
TRIAL STUDY 134XCP|LB|CD65CBB8-D056-4738-93A8-FF465534961B|2||||TRP|TRYPTOPHAN|||||||MV*MIN|||||||POSITIVE||DPM/ML||||ABNORMAL|NOT DONE||||LYMPH|PARAFFIN-EMBEDDED|Y|RAJI CELL EIA|FIBROTEST FORMULA||Y|NA|N|NA|||Y|4||88||OPEN LABEL TREATMENT|1961-04-02|1965-06-11|||||1963-10-14||1968-11-23|N|1960-01-12
TRIAL STUDY 134XCP|LB|CD65CBB8-D056-4738-93A8-FF465534961B|1||||CYFRA18|CYTOKERATIN 18 FRAGMENT|||||||FMOL/L/SEC|||||||POSITIVE||KCAL||||LOW|NOT DONE||||PERSPIRATION|GELLED|U|MAGNETIC RESONANCE ENTEROGRAPHY|FIBROTEST FORMULA||NA|NA|Y|NA|||NA|5||7||BASELINE|1973-05-17|1962-09-09|||||1968-04-12||1971-09-12|NA|1968-10-23
TRIAL STUDY 134XCP|LB|CD65CBB8-D056-4738-93A8-FF465534961B|2||||ERCEPPOL|ERYTHROID PROLIFERATION POOL|||||||MG/KG/DOSE|||||||INDETERMINATE||ML/G/MIN||||HIGH|NOT DONE||||GASTRIC CONTENTS|UNEXPECTED ODOR|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|N|N|||Y|5||7||INDUCTION TREATMENT|1969-09-05|1964-05-09|||||1972-11-12||1967-03-06|U|1962-01-18
TRIAL STUDY 134XCP|LB|7F014394-ABE2-45F8-891F-2DE808762532|1||||POIKRBC|POIKILOCYTES/ERYTHROCYTES|||||||U/10^12 RBC|||||||TRACE||NL||||NORMAL|NOT DONE||||EPITHELIAL CELL|AUTOLYZED|Y|MRI WITHOUT CONTRAST|FIBROSIS 4 FORMULA||U|U|N|Y|||NA|1||38||WASHOUT|1960-05-10|1972-09-06|||||1964-04-10||1966-01-30|Y|1972-08-02
TRIAL STUDY 134XCP|LB|7F014394-ABE2-45F8-891F-2DE808762532|2||||GLUCEXR|GLUCOSE EXCRETION RATE|||||||LOG10 CFU/G|||||||INDETERMINATE||JDF UNIT||||HIGH|NOT DONE||||BONE|ICTERIC|NA|IMMUNODIFFUSION|GMI % FORMULA||U|U|Y|NA|||Y|1||38||WASHOUT|1960-09-16|1966-01-02|||||1965-10-07||1965-06-23|U|1965-10-18
TRIAL STUDY 134XCP|LB|7F014394-ABE2-45F8-891F-2DE808762532|1||||TROPONI|TROPONIN I|||||||KG/M2|||||||BORDERLINE||PACK||||ABNORMAL|NOT DONE||||LYSATE|AGGLUTINATED|U|POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA||Y|N|U|N|||U|2||58||TREATMENT|1962-12-18|1972-01-10|||||1963-12-18||1968-11-13|N|1966-06-08
TRIAL STUDY 134XCP|LB|7F014394-ABE2-45F8-891F-2DE808762532|2||||IA5OHEXR|5-HYDROXYINDOLEACETICACID EXCRETION RATE|||||||NKAT/L|||||||TRACE||/4.0 ML||||LOW|NOT DONE||||SUPERNATANT, SERUM|NON-HEMOLYZED|U|IODINE STAIN|ASH FIBROSURE FORMULA||U|NA|Y|NA|||U|2||58||RUN-IN|1961-12-10|1967-05-26|||||1969-05-12||1969-09-12|NA|1973-07-05
TRIAL STUDY 134XCP|LB|7F014394-ABE2-45F8-891F-2DE808762532|1||||ANIONG3|ANION GAP 3|||||||/40 HPFS|||||||INDETERMINATE||10^3 DNA COPIES/ML||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|THAWED|NA|KINETIC MICROPARTICLE IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||Y|U|NA|NA|||Y|3||39||RUN-IN|1973-07-16|1960-04-05|||||1965-12-25||1960-04-03|Y|1964-11-27
TRIAL STUDY 134XCP|LB|7F014394-ABE2-45F8-891F-2DE808762532|2||||SPERMP|SPERMATOZOA, PROGRESSIVE|||||||10^4/L|||||||TRACE||/MBP||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|UNEXPECTED ODOR|Y|GC/MS-EI|MDRD ENZYMATIC FORMULA||U|U|NA|U|||Y|3||39||FOLLOW-UP|1960-06-02|1969-01-09|||||1961-02-11||1969-12-01|U|1973-08-12
TRIAL STUDY 134XCP|LB|7F014394-ABE2-45F8-891F-2DE808762532|1||||HBLEPRHB|HEMOGLOBIN LEPORE/TOTAL HEMOGLOBIN|||||||MPH|||||||INDETERMINATE||MIN/DAY||||LOW|NOT DONE||||SMEGMA|CALCIFIED|NA|SURFACE PLASMON RESONANCE|FIBROTEST FORMULA||N|N|N|N|||N|4||88||FOLLOW-UP|1960-09-16|1970-08-23|||||1970-10-04||1970-08-31|Y|1962-08-18
TRIAL STUDY 134XCP|LB|7F014394-ABE2-45F8-891F-2DE808762532|2||||GFRBSB2M|GFR FROM B-2 MICROGLOBULIN ADJ FOR BSA|||||||COPIES/UG|||||||INDETERMINATE||MG/KG/DAY||||NORMAL|NOT DONE||||HAIR FOLLICLE|NON-HEMOLYZED|NA|POLYGRAPHY|COCKCROFT-GAULT FORMULA||U|NA|Y|NA|||U|4||88||RUN-IN|1968-10-07|1965-08-25|||||1967-11-30||1964-03-08|N|1962-04-29
TRIAL STUDY 134XCP|LB|7F014394-ABE2-45F8-891F-2DE808762532|1||||IRON|IRON|||||||SBE/ML|||||||BORDERLINE||IN||||LOW|NOT DONE||||SYNOVIAL FLUID|PARAFFIN-EMBEDDED|Y|QUANTITATIVE COMPUTED TOMOGRAPHY|GMI % FORMULA||Y|Y|N|Y|||N|5||7||CONTINUATION TREATMENT|1968-08-01|1972-09-20|||||1971-02-02||1973-08-11|Y|1968-01-16
TRIAL STUDY 134XCP|LB|7F014394-ABE2-45F8-891F-2DE808762532|2||||INTLK29|INTERLEUKIN 29|||||||POUCH|||||||INDETERMINATE||10^6 ORGANISMS||||ABNORMAL|NOT DONE||||EXPIRED AIR|THAWED|N|RAJI CELL RIA|GMI MMOL/MOL FORMULA||NA|Y|N|NA|||Y|5||7||OBSERVATION|1963-03-21|1965-12-28|||||1962-07-10||1968-12-16|NA|1968-05-14
TRIAL STUDY 134XCP|LB|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|1||||TIMP1|TISSUE INHIBITOR OF METALLOPROTEINASE 1|||||||MG/ML/MIN|||||||NEGATIVE||UG/KG/MIN||||NORMAL|NOT DONE||||ISOLATE|AGGLUTINATED|U|BIOIMPEDANCE SPECTROSCOPY|NASH FIBROSURE FORMULA||N|Y|Y|N|||N|1||38||TREATMENT|1970-01-23|1962-09-18|||||1969-04-06||1964-08-06|N|1973-02-19
TRIAL STUDY 134XCP|LB|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|2||||FABP1|FATTY ACID BINDING PROTEIN 1|||||||ML/H|||||||TRACE||GBQ/MG||||ABNORMAL|NOT DONE||||BASAL TEAR|UNEXPECTED ODOR|Y|NUCLEIC ACID HYBRIDIZATION|MDRD 6 VARIABLE FORMULA||Y|Y|NA|NA|||Y|1||38||TREATMENT|1967-08-29|1962-10-28|||||1967-09-04||1964-03-25|Y|1961-05-25
TRIAL STUDY 134XCP|LB|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|1||||BETAINES|BETAINES|||||||DISK|||||||POSITIVE||10^3 ORGANISMS/G||||NORMAL|NOT DONE||||LYMPH|GELLED|U|CLOT DETECTION|MDRD 6 VARIABLE FORMULA||U|Y|NA|U|||U|2||58||SCREENING|1968-05-05|1970-04-10|||||1968-11-04||1970-08-22|U|1967-01-02
TRIAL STUDY 134XCP|LB|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|2||||EOSSG|EOSINOPHILS, SEGMENTED|||||||UG/MOL|||||||BORDERLINE||SHOCK WAVE||||HIGH|NOT DONE||||SPERMATOZOON|FRESH|U|FLUORESCEIN STAIN|MDRD FORMULA||NA|Y|Y|N|||Y|2||58||BLINDED TREATMENT|1970-02-17|1968-09-04|||||1970-08-27||1973-06-25|NA|1966-06-22
TRIAL STUDY 134XCP|LB|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|1||||INSULINR|INSULIN RESISTANCE|||||||PT_BR|||||||BORDERLINE||TABLET||||HIGH|NOT DONE||||EXPIRED AIR|ROOM TEMPERATURE|U|JAEGER EYE CHART|MDRD 6 VARIABLE FORMULA||U|U|Y|NA|||N|3||39||OBSERVATION|1967-12-04|1972-07-28|||||1968-01-13||1963-05-19|NA|1964-09-02
TRIAL STUDY 134XCP|LB|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|2||||SULFATE|SULFATE|||||||BISCUIT|||||||NEGATIVE||AMFI||||HIGH|NOT DONE||||ADIPOSE TISSUE|GELLED|NA|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|NASH FIBROSURE FORMULA||NA|Y|Y|Y|||Y|3||39||BLINDED TREATMENT|1962-09-21|1961-10-25|||||1965-03-01||1962-11-28|U|1967-11-29
TRIAL STUDY 134XCP|LB|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|1||||APAPCYS|ACETAMINOPHEN-CYSTEINE ADDUCT|||||||DPM|||||||BORDERLINE||FFU||||NORMAL|NOT DONE||||FLUID|LIPEMIC|N|CLIP SEQUENCING|MDRD 6 VARIABLE FORMULA||Y|U|NA|NA|||N|4||88||WASHOUT|1970-10-18|1964-08-23|||||1971-11-09||1965-01-29|Y|1972-09-10
TRIAL STUDY 134XCP|LB|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|2||||ANTIDPRS|ANTIDEPRESSANTS|||||||LM|||||||BORDERLINE||SFC/10^6 PBMC||||ABNORMAL|NOT DONE||||LYSATE|HEMOLYZED|Y|SINGLE-SLICE SPIRAL CT|MDRD 4 VARIABLE FORMULA||NA|Y|U|Y|||NA|4||88||CONTINUATION TREATMENT|1973-01-17|1963-12-17|||||1967-10-26||1969-05-06|N|1961-09-16
TRIAL STUDY 134XCP|LB|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|1||||FLUDOUTE|FLUID OUTPUT, ESTIMATED|||||||/LSQN|||||||TRACE||HZ||||NORMAL|NOT DONE||||INFRANATANT, SERUM|AUTOLYZED|U|LASER CAPTURE MICRODISSECTION|MDRD ENZYMATIC FORMULA||N|Y|Y|U|||NA|5||7||RUN-IN|1968-10-21|1969-07-25|||||1970-09-20||1969-03-20|NA|1973-03-16
TRIAL STUDY 134XCP|LB|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|2||||SJSA60AB|SJOGRENS SS-A60 ANTIBODY|||||||PFU/ANIMAL|||||||BORDERLINE||MG/ANIMAL||||ABNORMAL|NOT DONE||||BONE|ICTERIC|NA|CONTRAST ENHANCED SPIRAL CT SCAN|HEPASCORE FORMULA||NA|Y|NA|N|||NA|5||7||TREATMENT|1970-09-19|1969-06-25|||||1960-05-06||1971-11-26|Y|1971-07-15
TRIAL STUDY 134XCP|LB|FB781158-BB8A-4A75-BD55-00D6A5C72720|1||||GLYCREAT|GLYCINE/CREATININE|||||||U/KG/MIN|||||||BORDERLINE||UKAT||||ABNORMAL|NOT DONE||||SOFT TISSUE|GELLED|Y|FLUORESCENT IMMUNOASSAY|CKD-EPI FORMULA||U|N|U|NA|||N|1||38||OBSERVATION|1971-11-09|1968-01-02|||||1973-06-16||1966-05-14|NA|1963-05-12
TRIAL STUDY 134XCP|LB|FB781158-BB8A-4A75-BD55-00D6A5C72720|2||||LTE4|LEUKOTRIENE E4|||||||10^9 ORGANISMS/MG|||||||INVALID||/VF||||LOW|NOT DONE||||AQUEOUS HUMOR|LIPEMIC|Y|IMPULSE OSCILLOMETRY|GMI % FORMULA||NA|NA|U|U|||Y|1||38||LONG-TERM FOLLOW-UP|1968-11-19|1964-03-10|||||1967-02-20||1964-06-26|N|1960-06-04
TRIAL STUDY 134XCP|LB|FB781158-BB8A-4A75-BD55-00D6A5C72720|1||||CABOT|CABOT RINGS|||||||FT3|||||||NEGATIVE||V/SEC||||ABNORMAL|NOT DONE||||TISSUE|CONCENTRATED|Y|HANSEL STAIN|MDRD ENZYMATIC FORMULA||NA|Y|Y|Y|||N|2||58||FOLLOW-UP|1965-10-10|1969-08-25|||||1972-07-24||1965-09-29|U|1967-10-09
TRIAL STUDY 134XCP|LB|FB781158-BB8A-4A75-BD55-00D6A5C72720|2||||HDLPL|HDL PHOSPHOLIPID|||||||PL|||||||POSITIVE||BQ/UG||||LOW|NOT DONE||||DIALYSIS FLUID|FRESH|U|SCINTIGRAPHY|COCKCROFT-GAULT FORMULA||U|Y|U|NA|||U|2||58||TREATMENT|1972-02-20|1967-08-07|||||1971-10-06||1966-05-08|Y|1970-02-26
TRIAL STUDY 134XCP|LB|FB781158-BB8A-4A75-BD55-00D6A5C72720|1||||FIO2|FRACTION OF INSPIRED OXYGEN|||||||/2000 RBC|||||||NEGATIVE||NKAT/L||||LOW|NOT DONE||||BILE|CLOTTED|U|PET/SPECT SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|NA|Y|||U|3||39||OPEN LABEL TREATMENT|1964-07-12|1965-08-02|||||1964-10-06||1965-12-31|N|1971-02-04
TRIAL STUDY 134XCP|LB|FB781158-BB8A-4A75-BD55-00D6A5C72720|2||||CSEPI|EPITHELIAL CASTS|||||||S/H|||||||TRACE||MPL U/ML||||LOW|NOT DONE||||KERATINOCYTE|DRIED|Y|PATHOLOGICAL EVALUATION|MDRD FORMULA||NA|N|NA|NA|||N|3||39||OBSERVATION|1967-03-26|1963-07-18|||||1961-03-09||1961-01-06|NA|1971-04-29
TRIAL STUDY 134XCP|LB|FB781158-BB8A-4A75-BD55-00D6A5C72720|1||||APROTCRS|ACTIVATED PROTEIN C RESISTANCE|||||||UMOL/L/SEC|||||||INVALID||UG/DAY||||ABNORMAL|NOT DONE||||BONE|LACTESCENT|U|FLUORESCEIN STAIN|ASH FIBROSURE FORMULA||NA|N|U|U|||NA|4||88||WASHOUT|1966-12-10|1971-03-30|||||1965-12-27||1963-05-14|N|1965-12-30
TRIAL STUDY 134XCP|LB|FB781158-BB8A-4A75-BD55-00D6A5C72720|2||||LVFBRSC|LIVER FIBROSIS SCORE|||||||CMOL|||||||POSITIVE||UKAT||||HIGH|NOT DONE||||LYSATE|SOLIDIFIED|Y|TARGETED GENOME SEQUENCING|MDRD ENZYMATIC FORMULA||Y|NA|N|NA|||Y|4||88||FOLLOW-UP|1973-03-10|1966-11-19|||||1970-10-11||1972-03-29|U|1969-03-28
TRIAL STUDY 134XCP|LB|FB781158-BB8A-4A75-BD55-00D6A5C72720|1||||C130106|WEED MIX POLLEN ANTIGEN IGE ANTIBODY|||||||KG/L|||||||NEGATIVE||PMOL/10^10 CELLS||||ABNORMAL|NOT DONE||||SALIVA|AGGLUTINATED|Y|IMMUNOPRECIPITATION|MDRD 5 VARIABLE FORMULA||U|Y|Y|Y|||U|5||7||TREATMENT|1966-03-07|1967-03-20|||||1961-09-22||1961-09-18|NA|1966-09-20
TRIAL STUDY 134XCP|LB|FB781158-BB8A-4A75-BD55-00D6A5C72720|2||||C130076|SILVER BIRCH POLLEN IGE|||||||ML*CMH2O|||||||INVALID||UCI/KG||||NORMAL|NOT DONE||||COLOSTRUM|GELLED|Y|ZIEHL NEELSEN ACID FAST STAIN|FIBROTEST FORMULA||U|NA|Y|Y|||Y|5||7||FOLLOW-UP|1962-11-05|1966-08-01|||||1970-11-09||1966-03-24|NA|1968-11-05
TRIAL STUDY 134XCP|LB|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|1||||B2GLYAB|BETA-2 GLYCOPROTEIN ANTIBODY|||||||KA_U/DL|||||||INDETERMINATE||PNU/ML||||ABNORMAL|NOT DONE||||MECONIUM|UNEXPECTED ODOR|N|BIOIMPEDANCE SPECTROSCOPY|FIBROSIS 4 FORMULA||NA|U|U|U|||N|1||38||INDUCTION TREATMENT|1972-08-19|1962-07-23|||||1970-08-31||1972-09-11|U|1970-10-20
TRIAL STUDY 134XCP|LB|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|2||||APOB|APOLIPOPROTEIN B|||||||10^4/HPF|||||||BORDERLINE||BQ/UG||||LOW|NOT DONE||||ARTERIAL BLOOD|THAWED|U|SXA SCAN|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|Y|NA|||NA|1||38||RUN-IN|1972-11-28|1973-07-30|||||1966-09-22||1970-09-02|NA|1960-11-13
TRIAL STUDY 134XCP|LB|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|1||||TAP1|PEPTIDE TRANSPORTER TAP1|||||||MBQ/UL|||||||INVALID||DMOL||||HIGH|NOT DONE||||ISOLATE|AGGLUTINATED|N|SISH|GMI % FORMULA||U|NA|NA|Y|||U|2||58||INDUCTION TREATMENT|1961-12-17|1961-05-29|||||1969-03-04||1964-05-05|N|1968-04-09
TRIAL STUDY 134XCP|LB|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|2||||FACTX|FACTOR X|||||||PMOL/G|||||||INDETERMINATE||UOSM||||NORMAL|NOT DONE||||LYMPH|PARAFFIN-EMBEDDED|NA|DIFFUSION WEIGHTED MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|U|N|||N|2||58||RUN-IN|1972-08-09|1971-11-01|||||1966-01-14||1961-06-21|U|1964-11-13
TRIAL STUDY 134XCP|LB|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|1||||FCTXIIIA|FACTOR XIII ACTIVITY|||||||10^11/L|||||||INDETERMINATE||FT||||HIGH|NOT DONE||||PLEURAL TISSUE|CONTAMINATED|N|COMPLEMENT FIXATION|MDRD 5 VARIABLE FORMULA||NA|Y|N|N|||Y|3||39||FOLLOW-UP|1965-03-26|1972-09-21|||||1969-01-20||1970-12-11|NA|1962-10-25
TRIAL STUDY 134XCP|LB|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|2||||FXIVAAC|FACTOR XIV ACTIVITY ACTUAL/CONTROL|||||||10^7 TCID 50/DOSE|||||||INDETERMINATE||10^9 ORGANISMS/ML||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|FRESH|U|PHOTOGRAPHY|MDRD ENZYMATIC FORMULA||NA|NA|Y|U|||NA|3||39||TREATMENT|1966-10-24|1966-02-02|||||1966-11-19||1964-08-23|NA|1970-08-22
TRIAL STUDY 134XCP|LB|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|1||||CLEPNSQE|COLUMNAR EPI CELLS/NON-SQUAM EPI CELLS|||||||IU/G HB|||||||TRACE||IU/G||||NORMAL|NOT DONE||||COLOSTRUM|CONCENTRATED|NA|OPHTHALMOSCOPY|MDRD 6 VARIABLE FORMULA||Y|NA|U|Y|||NA|4||88||CONTINUATION TREATMENT|1966-08-15|1971-09-05|||||1961-01-08||1971-09-28|N|1967-08-04
TRIAL STUDY 134XCP|LB|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|2||||BAFF|B-CELL ACTIVATING FACTOR|||||||MG/KG/DAY|||||||NEGATIVE||TRACE||||NORMAL|NOT DONE||||SEBUM|AUTOLYZED|N|SPECT SCAN|COCKCROFT-GAULT FORMULA||Y|U|N|NA|||NA|4||88||LONG-TERM FOLLOW-UP|1966-03-28|1971-10-04|||||1965-05-18||1968-11-12|N|1961-06-15
TRIAL STUDY 134XCP|LB|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|1||||METAMY|METAMYELOCYTES|||||||CI/MG|||||||BORDERLINE||EJACULATE U||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|ICTERIC|N|SMEAR|FIBROMETER FORMULA||N|NA|Y|N|||NA|5||7||CONTINUATION TREATMENT|1965-11-11|1962-01-01|||||1966-09-11||1960-10-23|U|1967-10-22
TRIAL STUDY 134XCP|LB|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|2||||LYMATLE|LYMPHOCYTES ATYPICAL/LEUKOCYTES|||||||VIRTUAL PIXEL|||||||INVALID||MPA||||NORMAL|NOT DONE||||BONE|AUTOLYZED|U|ISHIHARA COLOR PLATES|FIBROMETER FORMULA||NA|NA|N|NA|||NA|5||7||OBSERVATION|1965-02-01|1960-04-08|||||1972-07-12||1968-06-16|NA|1973-09-07
TRIAL STUDY 134XCP|LB|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|1||||MONOMA|MONOCYTES/MACROCYTES|||||||U/DL|||||||INVALID||STEPS/MIN||||NORMAL|NOT DONE||||ADIPOSE TISSUE|REFRIGERATED|NA|DYNAMIC LIGHT SCATTERING|GMI % FORMULA||N|N|N|U|||NA|1||38||BASELINE|1960-04-16|1972-12-19|||||1970-01-06||1966-08-23|N|1963-09-19
TRIAL STUDY 134XCP|LB|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|2||||INTLK19|INTERLEUKIN 19|||||||CM H2O|||||||TRACE||UV*SEC||||NORMAL|NOT DONE||||TISSUE|ROOM TEMPERATURE|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI CYSTATIN C FORMULA||U|Y|N|N|||Y|1||38||RUN-IN|1965-05-06|1962-08-22|||||1963-04-03||1973-02-04|U|1972-12-12
TRIAL STUDY 134XCP|LB|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|1||||FAI|FREE ANDROGEN INDEX|||||||PACK|||||||BORDERLINE||CYLINDER||||NORMAL|NOT DONE||||ARTERIAL BLOOD|ICTERIC|U|ZIEHL NEELSEN ACID FAST STAIN|MDRD ENZYMATIC FORMULA||U|U|NA|U|||N|2||58||INDUCTION TREATMENT|1966-04-10|1968-07-18|||||1972-04-22||1969-09-19|NA|1966-05-11
TRIAL STUDY 134XCP|LB|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|2||||THYPXD|THYROPEROXIDASE|||||||CG|||||||BORDERLINE||UIU/DL||||NORMAL|NOT DONE||||VENOUS BLOOD|NON-HEMOLYZED|NA|POPULATION SEQUENCING|CKD-EPI CREATININE FORMULA||NA|N|U|N|||N|2||58||OBSERVATION|1964-02-05|1967-11-11|||||1960-05-23||1968-01-23|N|1968-09-30
TRIAL STUDY 134XCP|LB|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|1||||NMH|N-METHYLHISTAMINE|||||||MMHG|||||||TRACE||10^3 COPIES/ML||||LOW|NOT DONE||||RETICULOCYTES|HEMOLYZED|Y|ICC|MDRD 5 VARIABLE FORMULA||U|N|Y|U|||Y|3||39||BLINDED TREATMENT|1964-07-01|1971-08-19|||||1965-01-24||1960-09-30|Y|1960-02-18
TRIAL STUDY 134XCP|LB|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|2||||IDLP|IDL PARTICLES|||||||GPL U|||||||BORDERLINE||PIXELS/IN||||LOW|NOT DONE||||REFLEX TEAR|PARAFFIN-EMBEDDED|NA|SPECT SCAN|MDRD 4 VARIABLE FORMULA||U|N|Y|Y|||U|3||39||WASHOUT|1964-10-26|1971-03-03|||||1969-10-24||1960-03-03|N|1968-03-11
TRIAL STUDY 134XCP|LB|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|1||||THYPXD|THYROPEROXIDASE|||||||HZ|||||||INVALID||HZ/S||||NORMAL|NOT DONE||||SEMINAL FLUID|REFRIGERATED|NA|MICROBIAL CULTURE, LIQUID|MDRD 4 VARIABLE FORMULA||N|Y|NA|NA|||NA|4||88||OBSERVATION|1966-10-27|1968-03-03|||||1966-05-23||1970-07-09|Y|1962-07-16
TRIAL STUDY 134XCP|LB|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|2||||ARA|ARACHIDONIC ACID|||||||CI/ML|||||||INVALID||KS||||LOW|NOT DONE||||ARTERIAL BLOOD|SOLIDIFIED|N|IHC|NASH FIBROSURE FORMULA||Y|NA|Y|Y|||U|4||88||RUN-IN|1964-04-06|1968-04-25|||||1972-05-04||1969-03-06|U|1971-08-14
TRIAL STUDY 134XCP|LB|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|1||||UROTHCE|UROTHELIAL CELLS|||||||BQ/ML|||||||BORDERLINE||BQ/MG||||HIGH|NOT DONE||||LOCHIA|LACTESCENT|U|PHYSICAL EXAMINATION|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|U|Y|||N|5||7||INDUCTION TREATMENT|1969-11-06|1962-04-09|||||1973-03-26||1968-08-24|U|1962-01-22
TRIAL STUDY 134XCP|LB|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|2||||MCH|ERY. MEAN CORPUSCULAR HEMOGLOBIN|||||||UG/MOL|||||||INDETERMINATE||YEARS||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|FROZEN|Y|CHROMATOGRAPHY|FIBROMETER FORMULA||NA|NA|U|Y|||U|5||7||WASHOUT|1963-04-05|1965-04-29|||||1966-12-23||1972-04-18|NA|1969-02-04
TRIAL STUDY 134XCP|LB|505A1BB6-135A-4839-BB9E-6DD37F49DC45|1||||C130081|ORCHARD GRASS POLLEN IGA|||||||BAG|||||||INDETERMINATE||CONTAINER||||LOW|NOT DONE||||EPIDERMAL TISSUE|LACTESCENT|N|DOUBLE IMMUNODIFFUSION|COCKCROFT-GAULT FORMULA||NA|U|N|NA|||Y|1||38||OBSERVATION|1965-09-22|1961-01-16|||||1962-12-23||1962-10-03|NA|1960-04-26
TRIAL STUDY 134XCP|LB|505A1BB6-135A-4839-BB9E-6DD37F49DC45|2||||TT|THROMBIN TIME|||||||10^3 ORGANISMS/G|||||||POSITIVE||MASK||||LOW|NOT DONE||||EMOTIONAL TEAR|CALCIFIED|N|FLUORIMETRY|HEPASCORE FORMULA||U|U|N|U|||U|1||38||LONG-TERM FOLLOW-UP|1973-07-05|1965-06-09|||||1967-07-02||1960-01-06|NA|1964-03-21
TRIAL STUDY 134XCP|LB|505A1BB6-135A-4839-BB9E-6DD37F49DC45|1||||TYR|TYROSINE|||||||PPB|||||||INVALID||PKAT||||ABNORMAL|NOT DONE||||BREAST MILK|AUTOLYZED|NA|AMSLER GRID|MDRD 5 VARIABLE FORMULA||Y|U|NA|N|||Y|2||58||OBSERVATION|1962-02-04|1962-03-31|||||1972-04-11||1961-10-23|Y|1970-07-06
TRIAL STUDY 134XCP|LB|505A1BB6-135A-4839-BB9E-6DD37F49DC45|2||||CTXI|TYPE I COLLAGEN C-TELOPEPTIDES|||||||NMOL BCE/L|||||||NEGATIVE||TITER||||HIGH|NOT DONE||||SOFT TISSUE|CONCENTRATED|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA||U|Y|U|Y|||N|2||58||TREATMENT|1967-01-02|1970-04-11|||||1961-08-25||1962-11-11|N|1960-12-17
TRIAL STUDY 134XCP|LB|505A1BB6-135A-4839-BB9E-6DD37F49DC45|1||||SODIUM|SODIUM|||||||FOZ_US|||||||TRACE||UMOL/MOL||||LOW|NOT DONE||||INTERSTITIAL FLUID|CONCENTRATED|U|FLUORIMETRY|GMI % FORMULA||U|N|Y|U|||U|3||39||INDUCTION TREATMENT|1971-09-29|1960-09-05|||||1967-06-22||1969-06-19|N|1971-07-24
TRIAL STUDY 134XCP|LB|505A1BB6-135A-4839-BB9E-6DD37F49DC45|2||||CHCM|CORPUSCULAR HGB CONCENTRATION MEAN|||||||ML/M2|||||||NEGATIVE||YEARS||||ABNORMAL|NOT DONE||||BLOOD|CONTAMINATED|N|LEAD CITRATE STAIN|FIBROMETER FORMULA||Y|N|U|N|||U|3||39||INDUCTION TREATMENT|1963-08-11|1972-09-19|||||1971-01-01||1966-03-26|NA|1960-04-30
TRIAL STUDY 134XCP|LB|505A1BB6-135A-4839-BB9E-6DD37F49DC45|1||||CD56|CD56|||||||BLOCKS|||||||BORDERLINE||LOG EID 50/DOSE||||LOW|NOT DONE||||TUMOR TISSUE|GELLED|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|FIBROMETER FORMULA||U|N|NA|U|||Y|4||88||OBSERVATION|1973-02-09|1967-08-21|||||1968-08-27||1967-01-13|Y|1964-10-07
TRIAL STUDY 134XCP|LB|505A1BB6-135A-4839-BB9E-6DD37F49DC45|2||||PSIGMAB|PHOSPHATIDYLSERINE IGM ANTIBODY|||||||FOZ_BR|||||||INDETERMINATE||MG2/DL2||||HIGH|NOT DONE||||SPERMATOZOON|FRESH|Y|INFRARED SPECTROMETRY|MDRD ENZYMATIC FORMULA||NA|U|N|U|||N|4||88||BASELINE|1967-07-05|1966-09-19|||||1973-08-08||1967-10-18|U|1969-01-05
TRIAL STUDY 134XCP|LB|505A1BB6-135A-4839-BB9E-6DD37F49DC45|1||||C165930|SHELLFISH MIX IGE AB RAST SCORE|||||||10^6 DNA COPIES/ML|||||||POSITIVE||DMOL||||NORMAL|NOT DONE||||SALIVA|GELLED|U|RADIAL IMMUNODIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|U|||U|5||7||FOLLOW-UP|1970-09-14|1969-07-30|||||1961-05-30||1965-01-10|NA|1964-05-26
TRIAL STUDY 134XCP|LB|505A1BB6-135A-4839-BB9E-6DD37F49DC45|2||||GLUCEXR|GLUCOSE EXCRETION RATE|||||||G/KG/DAY|||||||INDETERMINATE||/7.5 ML||||NORMAL|NOT DONE||||STOOL|UNEXPECTED ODOR|NA|PLETHYSMOGRAPHY|GMI MMOL/MOL FORMULA||U|Y|N|N|||NA|5||7||LONG-TERM FOLLOW-UP|1968-10-13|1961-01-26|||||1969-12-30||1965-04-17|Y|1970-06-26
TRIAL STUDY 134XCP|LB|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|1||||FLUORIDE|FLUORIDE|||||||ML/100G/MIN|||||||TRACE||U/G HB||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|UNEXPECTED ODOR|U|LIGHT MICROSCOPY|FIBROSIS 4 FORMULA||U|NA|N|Y|||Y|1||38||FOLLOW-UP|1967-10-11|1964-06-16|||||1968-12-10||1962-09-10|Y|1971-08-05
TRIAL STUDY 134XCP|LB|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|2||||TTGIGAAB|TISSUE TRANSGLUTAMINASE IGA ANTIBODY|||||||CMHG|||||||BORDERLINE||ENZYME U/M2||||LOW|NOT DONE||||BREAST MILK|CONTAMINATED|N|NEXT GENERATION TARGETED SEQUENCING|ASH FIBROSURE FORMULA||N|N|N|U|||Y|1||38||OBSERVATION|1960-03-09|1966-10-26|||||1966-06-11||1962-07-12|NA|1969-02-20
TRIAL STUDY 134XCP|LB|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|1||||CLEPNSQE|COLUMNAR EPI CELLS/NON-SQUAM EPI CELLS|||||||MASK|||||||INVALID||UG/DOSE||||ABNORMAL|NOT DONE||||SPUTUM|CLOTTED|Y|SNELLEN EYE CHART|CKD-EPI FORMULA||NA|NA|Y|N|||U|2||58||TREATMENT|1961-09-11|1960-05-07|||||1964-05-04||1961-01-29|Y|1969-11-02
TRIAL STUDY 134XCP|LB|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|2||||FLUOXTN|FLUOXETINE|||||||V/V|||||||INVALID||TESLA||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|Y|MAGNETIC RESONANCE ELASTOGRAPHY|HEPASCORE FORMULA||N|N|NA|Y|||N|2||58||FOLLOW-UP|1967-12-13|1971-04-11|||||1972-02-11||1962-06-04|Y|1964-07-02
TRIAL STUDY 134XCP|LB|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|1||||TSHRAB|THYROTROPIN RECEPTOR ANTIBODY|||||||G/CAGE|||||||INVALID||MAMP||||NORMAL|NOT DONE||||CALCULUS|GELLED|U|BALLPOINT PEN TECHNIQUE|FIBROMETER FORMULA||NA|U|N|Y|||Y|3||39||OBSERVATION|1972-11-05|1968-06-22|||||1960-11-27||1966-04-28|U|1962-08-24
TRIAL STUDY 134XCP|LB|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|2||||CAMP|CYCLIC ADENOSINE 3,5-MONOPHOSPHATE|||||||APS U|||||||INDETERMINATE||10^3 DNA COPIES/ML||||NORMAL|NOT DONE||||SYNOVIAL FLUID|GELLED|NA|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||U|NA|NA|Y|||U|3||39||SCREENING|1961-09-12|1961-05-26|||||1965-09-07||1966-07-13|NA|1966-06-21
TRIAL STUDY 134XCP|LB|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|1||||CRYOGLBN|CRYOGLOBULIN|||||||STEPS/MIN|||||||NEGATIVE||OI50||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH|U|EPSILOMETER|GMI MMOL/MOL FORMULA||N|N|U|NA|||NA|4||88||WASHOUT|1971-12-01|1963-03-23|||||1962-01-29||1966-03-19|NA|1972-10-07
TRIAL STUDY 134XCP|LB|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|2||||C130127|CAT DANDER ANTIGEN IGG4 ANTIBODY|||||||MS/MMHG|||||||INVALID||ML/S/M2||||ABNORMAL|NOT DONE||||KERATINOCYTE|FRESH|NA|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA||NA|U|N|Y|||U|4||88||FOLLOW-UP|1973-08-10|1963-04-05|||||1966-01-11||1960-05-03|Y|1971-02-23
TRIAL STUDY 134XCP|LB|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|1||||BUPREN|BUPRENORPHINE|||||||AG|||||||BORDERLINE||U/G/MIN||||ABNORMAL|NOT DONE||||TUMOR TISSUE|CONCENTRATED|Y|MRI WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA||NA|NA|N|N|||NA|5||7||CONTINUATION TREATMENT|1960-09-16|1969-02-11|||||1969-10-28||1961-02-24|NA|1960-05-29
TRIAL STUDY 134XCP|LB|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|2||||BASEDEF|BASE DEFICIT|||||||BREATHS/30S|||||||TRACE||HPA||||HIGH|NOT DONE||||SWABBED MATERIAL|FROZEN|Y|X-RAY FLUORESCENCE SPECTROMETRY|GMI MMOL/MOL FORMULA||Y|U|U|N|||Y|5||7||OBSERVATION|1962-04-29|1968-08-08|||||1970-03-16||1968-07-08|U|1973-01-04
TRIAL STUDY 134XCP|LB|16F375DC-DC27-461B-969E-1269DC53F4D9|1||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||PLUG|||||||POSITIVE||UMOL/L/MIN||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|REFRIGERATED|Y|FLUORESCENT MICROSCOPY|CKD-EPI CREATININE FORMULA||N|Y|N|NA|||U|1||38||OPEN LABEL TREATMENT|1963-06-11|1966-09-23|||||1970-07-31||1973-01-19|Y|1967-07-08
TRIAL STUDY 134XCP|LB|16F375DC-DC27-461B-969E-1269DC53F4D9|2||||ILE|ISOLEUCINE|||||||ML/(MIN*100ML)|||||||INVALID||ML/MIN||||NORMAL|NOT DONE||||FLUID|LACTESCENT|Y|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CYSTATIN C FORMULA||U|Y|U|Y|||U|1||38||RUN-IN|1965-09-18|1970-04-20|||||1967-05-24||1960-07-21|N|1960-12-11
TRIAL STUDY 134XCP|LB|16F375DC-DC27-461B-969E-1269DC53F4D9|1||||GLP1IAC|GLUCAGON-LIKE PEPTIDE-1, INACTIVE FORM|||||||KCAL/DAY|||||||POSITIVE||GY||||ABNORMAL|NOT DONE||||TISSUE|FROZEN|NA|IN SITU HYBRIDIZATION|CKD-EPI CYSTATIN C FORMULA||N|NA|N|N|||U|2||58||TREATMENT|1970-04-02|1966-11-19|||||1965-03-24||1969-07-07|U|1969-08-18
TRIAL STUDY 134XCP|LB|16F375DC-DC27-461B-969E-1269DC53F4D9|2||||FACTXA|FACTOR X ACTIVITY|||||||JAR|||||||NEGATIVE||SCOOPFUL||||HIGH|NOT DONE||||PERITONEAL FLUID|NON-HEMOLYZED|Y|FLUORESCENT IMMUNOASSAY|MDRD ENZYMATIC FORMULA||U|NA|NA|NA|||N|2||58||FOLLOW-UP|1966-05-06|1969-10-23|||||1970-08-10||1967-04-06|NA|1968-02-10
TRIAL STUDY 134XCP|LB|16F375DC-DC27-461B-969E-1269DC53F4D9|1||||A1AGLP|ALPHA-1 ACID GLYCOPROTEIN|||||||FMOL|||||||INVALID||MG/KG/DAY||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|LACTESCENT|U|ICP-MS|FIBROMETER FORMULA||NA|U|NA|Y|||U|3||39||OPEN LABEL TREATMENT|1960-12-19|1962-01-26|||||1964-07-16||1973-06-25|Y|1967-07-29
TRIAL STUDY 134XCP|LB|16F375DC-DC27-461B-969E-1269DC53F4D9|2||||FATBODOV|FAT BODIES, OVAL|||||||MMHG/L/MIN|||||||POSITIVE||MILE||||HIGH|NOT DONE||||CORD BLOOD|FROZEN|N|LIGHT MICROSCOPY|FIBROSIS 4 FORMULA||Y|N|N|NA|||Y|3||39||INDUCTION TREATMENT|1964-02-15|1967-07-13|||||1961-04-02||1966-12-28|Y|1963-06-03
TRIAL STUDY 134XCP|LB|16F375DC-DC27-461B-969E-1269DC53F4D9|1||||IGG3|IMMUNOGLOBULIN G SUBCLASS 3|||||||GY/H|||||||TRACE||DPM/0.5 ML||||HIGH|NOT DONE||||KERATINOCYTE|FROZEN|U|TONOMETRY|CKD-EPI CREATININE FORMULA||Y|U|U|NA|||N|4||88||INDUCTION TREATMENT|1960-06-14|1961-08-28|||||1967-04-10||1962-03-09|U|1960-01-24
TRIAL STUDY 134XCP|LB|16F375DC-DC27-461B-969E-1269DC53F4D9|2||||C165892|WILD RYE POLLEN IGE ANTIBODY|||||||ML/CAGE/WK|||||||NEGATIVE||MSEC||||ABNORMAL|NOT DONE||||BONE|CONTAMINATED|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|ASH FIBROSURE FORMULA||U|Y|Y|NA|||NA|4||88||TREATMENT|1970-08-22|1970-12-13|||||1968-12-16||1965-04-11|N|1964-05-29
TRIAL STUDY 134XCP|LB|16F375DC-DC27-461B-969E-1269DC53F4D9|1||||MMP8|MATRIX METALLOPROTEINASE 8|||||||CMOL/L|||||||NEGATIVE||TUBERCULIN UNIT||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|UNEXPECTED ODOR|N|MRI|FIBROMETER FORMULA||NA|U|Y|U|||Y|5||7||OBSERVATION|1970-03-26|1971-09-13|||||1964-12-04||1965-05-06|NA|1972-10-29
TRIAL STUDY 134XCP|LB|16F375DC-DC27-461B-969E-1269DC53F4D9|2||||FRUCT|FRUCTOSAMINE|||||||PA|||||||BORDERLINE||U/DL||||LOW|NOT DONE||||SWABBED MATERIAL|AUTOLYZED|NA|ELASTOGRAPHY|NASH FIBROSURE FORMULA||N|N|U|Y|||NA|5||7||BLINDED TREATMENT|1970-02-12|1973-01-16|||||1964-01-18||1970-11-10|N|1961-03-02
TRIAL STUDY 134XCP|LB|17BF9A68-265F-4FCC-A499-615A1B71A8D6|1||||IGGC|IGG CLEARANCE|||||||UIU/L|||||||POSITIVE||PFU/DOSE||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CONTAMINATED|NA|MYELOPEROXIDASE STAIN|GMI MMOL/MOL FORMULA||Y|N|U|U|||U|1||38||INDUCTION TREATMENT|1972-09-06|1965-08-11|||||1965-04-18||1966-03-19|U|1963-12-09
TRIAL STUDY 134XCP|LB|17BF9A68-265F-4FCC-A499-615A1B71A8D6|2||||SEZCELE|SEZARY CELLS/LEUKOCYTES|||||||CMH2O*S2/ML|||||||POSITIVE||UMOL/L/SEC||||LOW|NOT DONE||||INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|N|MRI|FIBROSIS 4 FORMULA||U|N|Y|NA|||U|1||38||RUN-IN|1964-10-07|1969-02-11|||||1963-05-05||1968-08-24|U|1967-11-27
TRIAL STUDY 134XCP|LB|17BF9A68-265F-4FCC-A499-615A1B71A8D6|1||||BTECERBC|BITE CELLS/ERYTHROCYTES|||||||C|||||||POSITIVE||LOG10 IU/ML||||NORMAL|NOT DONE||||KERATINOCYTE|CONCENTRATED|N|URANYL ACETATE STAIN|MDRD FORMULA||Y|N|U|Y|||U|2||58||WASHOUT|1966-07-08|1972-03-10|||||1964-12-22||1968-11-07|NA|1972-05-26
TRIAL STUDY 134XCP|LB|17BF9A68-265F-4FCC-A499-615A1B71A8D6|2||||APLSMA2|ALPHA-2 ANTIPLASMIN|||||||10^3 CFU|||||||BORDERLINE||G/CM2||||HIGH|NOT DONE||||STOOL|GELLED|U|FLOCCULATION, CHARCOAL ENHANCED|MDRD 6 VARIABLE FORMULA||Y|U|N|Y|||U|2||58||FOLLOW-UP|1971-07-06|1966-06-17|||||1967-12-12||1964-02-12|Y|1968-05-08
TRIAL STUDY 134XCP|LB|17BF9A68-265F-4FCC-A499-615A1B71A8D6|1||||C130092|WESTERN RAGWEED POLLEN IGE|||||||EQ|||||||NEGATIVE||MOSM||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|THAWED|N|ELECTROMYOGRAPHY|MDRD 4 VARIABLE FORMULA||N|U|U|N|||Y|3||39||SCREENING|1968-10-31|1963-08-10|||||1971-01-15||1972-01-26|NA|1966-07-13
TRIAL STUDY 134XCP|LB|17BF9A68-265F-4FCC-A499-615A1B71A8D6|2||||LH|LUTEINIZING HORMONE|||||||MV2/HZ|||||||TRACE||DPM/100MG||||ABNORMAL|NOT DONE||||HAIR|PARAFFIN-EMBEDDED|Y|FISH|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|U|U|||NA|3||39||SCREENING|1968-08-25|1964-04-02|||||1962-05-09||1963-11-23|NA|1968-08-28
TRIAL STUDY 134XCP|LB|17BF9A68-265F-4FCC-A499-615A1B71A8D6|1||||HBLEPRHB|HEMOGLOBIN LEPORE/TOTAL HEMOGLOBIN|||||||ML/BEAT|||||||INVALID||L/MIN||||NORMAL|NOT DONE||||INFRANATANT, SERUM|ICTERIC|Y|DIGITAL PCR ARRAY|MDRD ENZYMATIC FORMULA||N|U|N|U|||Y|4||88||BLINDED TREATMENT|1961-07-01|1968-04-08|||||1969-11-01||1962-03-16|U|1963-07-30
TRIAL STUDY 134XCP|LB|17BF9A68-265F-4FCC-A499-615A1B71A8D6|2||||NAK|SODIUM/POTASSIUM|||||||NG/MOL|||||||INVALID||DIOPTER||||HIGH|NOT DONE||||PLASMA|LIPEMIC|U|COLORIMETRY|MDRD ENZYMATIC FORMULA||NA|Y|Y|U|||N|4||88||LONG-TERM FOLLOW-UP|1963-06-04|1965-01-27|||||1968-01-07||1971-08-20|Y|1966-12-24
TRIAL STUDY 134XCP|LB|17BF9A68-265F-4FCC-A499-615A1B71A8D6|1||||MLIGCE|MALIGNANT CELLS, NOS|||||||TBSP|||||||NEGATIVE||COPIES/UG||||LOW|NOT DONE||||BUFFY COAT|CONCENTRATED|N|AUTOMATED COUNT|MDRD FORMULA||U|NA|NA|NA|||Y|5||7||FOLLOW-UP|1963-11-11|1970-09-20|||||1961-12-19||1961-04-22|Y|1973-06-09
TRIAL STUDY 134XCP|LB|17BF9A68-265F-4FCC-A499-615A1B71A8D6|2||||EPICCE|EPITHELIAL CELLS/TOTAL CELLS|||||||YD|||||||BORDERLINE||UV||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|HEMOLYZED|U|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 5 VARIABLE FORMULA||Y|Y|NA|NA|||N|5||7||OBSERVATION|1972-11-28|1964-05-29|||||1968-01-12||1968-03-16|NA|1964-08-24
TRIAL STUDY 134XCP|LB|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|1||||ATHPIDX|ATHEROGENIC INDEX OF PLASMA|||||||10^9 ORGANISMS/MG|||||||TRACE||10^7 CFU/ML||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|SOLIDIFIED|N|NO INFORMATION|FIBROMETER FORMULA||NA|N|Y|Y|||N|1||38||WASHOUT|1966-05-20|1961-01-09|||||1972-11-08||1968-02-17|U|1963-04-12
TRIAL STUDY 134XCP|LB|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|2||||CCL12|CHEMOKINE (C-C MOTIF) LIGAND 12|||||||DL|||||||INDETERMINATE||GBQ/UG||||ABNORMAL|NOT DONE||||VENOUS BLOOD|THAWED|U|CLOT DETECTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|Y|N|||Y|1||38||BLINDED TREATMENT|1971-12-11|1970-04-12|||||1971-07-09||1963-03-11|NA|1972-10-08
TRIAL STUDY 134XCP|LB|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|1||||RETPALM|RETINYL PALMITATE|||||||UG/L FEU|||||||BORDERLINE||OZ EQ||||ABNORMAL|NOT DONE||||COLOSTRUM|GELLED|NA|IMMUNORADIOMETRIC ASSAY|HEPASCORE FORMULA||Y|U|N|Y|||N|2||58||FOLLOW-UP|1969-10-26|1964-08-19|||||1961-12-31||1960-05-06|U|1962-07-06
TRIAL STUDY 134XCP|LB|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|2||||FACTXII|FACTOR XII|||||||FFU|||||||POSITIVE||G/G||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|NON-HEMOLYZED|NA|CYSTOMETRY|MDRD 4 VARIABLE FORMULA||Y|N|NA|N|||NA|2||58||BLINDED TREATMENT|1969-04-06|1968-05-21|||||1960-09-27||1972-10-26|U|1972-01-22
TRIAL STUDY 134XCP|LB|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|1||||CAN|COEFFICIENT OF NITROGEN ABSORPTION|||||||PACK|||||||INVALID||UU/L||||ABNORMAL|NOT DONE||||EXUDATE|ROOM TEMPERATURE|Y|RAJI CELL RIA|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|NA|U|||N|3||39||BASELINE|1966-11-27|1972-08-10|||||1964-10-06||1971-04-18|NA|1967-07-27
TRIAL STUDY 134XCP|LB|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|2||||C130090|TIMOTHY GRASS POLLEN IGG|||||||BQ/ML|||||||INVALID||PIXEL||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|THAWED|Y|PHASE CONTRAST MICROSCOPY|MDRD 4 VARIABLE FORMULA||NA|N|Y|U|||N|3||39||WASHOUT|1967-06-18|1969-11-16|||||1960-07-12||1971-02-19|U|1972-07-05
TRIAL STUDY 134XCP|LB|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|1||||TNFR5S|SOLUBLE TNF RECEPTOR SUPERFAMILY MEM 5|||||||10^4/L|||||||POSITIVE||10^9 ORGANISMS/MG||||NORMAL|NOT DONE||||MUSCLE TISSUE|HEMOLYZED|NA|MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|U|||U|4||88||BASELINE|1968-08-17|1962-06-11|||||1964-06-03||1965-08-18|NA|1965-05-05
TRIAL STUDY 134XCP|LB|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|2||||ALPCREAT|ALKALINE PHOSPHATASE/CREATININE|||||||BP|||||||INDETERMINATE||/LPF||||HIGH|NOT DONE||||PERSPIRATION|AGGLUTINATED|NA|WHOLE GENOME SEQUENCING|COCKCROFT-GAULT FORMULA||N|U|N|U|||N|4||88||WASHOUT|1973-08-17|1962-07-11|||||1960-06-08||1963-10-17|NA|1961-06-06
TRIAL STUDY 134XCP|LB|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|1||||GLYCRLFR|FREE GLYCEROL|||||||AFU|||||||NEGATIVE||CD*S/M2||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|CALCIFIED|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|CKD-EPI CYSTATIN C FORMULA||U|N|N|Y|||Y|5||7||TREATMENT|1961-02-26|1970-09-17|||||1972-09-03||1968-08-03|U|1960-06-06
TRIAL STUDY 134XCP|LB|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|2||||PDGFAB|PLATELET DERIVED GROWTH FACTOR ISOFORMAB|||||||PMOL/DAY|||||||NEGATIVE||V/SEC||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|CALCIFIED|U|MYELOPEROXIDASE STAIN|GMI % FORMULA||Y|U|Y|U|||Y|5||7||WASHOUT|1962-04-17|1965-03-14|||||1969-03-28||1964-04-03|Y|1968-11-22
TRIAL STUDY 134XCP|LB|B842981B-AD7A-4A03-8E84-D5FC887BAD60|1||||RF|RHEUMATOID FACTOR|||||||10^3 CFU/G|||||||POSITIVE||GENEQ||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|CONCENTRATED|N|TONOMETRY|FIBROTEST FORMULA||NA|Y|U|NA|||NA|1||38||BLINDED TREATMENT|1970-06-09|1962-05-04|||||1970-12-09||1972-11-27|Y|1963-02-16
TRIAL STUDY 134XCP|LB|B842981B-AD7A-4A03-8E84-D5FC887BAD60|2||||PSELECT|P-SELECTIN|||||||MNFI|||||||POSITIVE||10^6 RNA COPIES/ML||||NORMAL|NOT DONE||||ERYTHROCYTES|AUTOLYZED|N|FUNCTIONAL MRI|FIBROMETER FORMULA||N|N|NA|U|||N|1||38||LONG-TERM FOLLOW-UP|1960-08-08|1968-03-12|||||1960-01-10||1960-06-20|N|1972-07-27
TRIAL STUDY 134XCP|LB|B842981B-AD7A-4A03-8E84-D5FC887BAD60|1||||ENRAGE|EXTRACELL NEWLY IDENT RAGE BIND PROTEIN|||||||10^3 ORGANISMS/ML|||||||INVALID||UIU/L||||NORMAL|NOT DONE||||EMESIS|REFRIGERATED|NA|SECONDARY ION MASS SPECTOMETRY|FIBROMETER FORMULA||Y|NA|NA|N|||N|2||58||SCREENING|1961-12-10|1961-04-07|||||1972-05-18||1966-09-02|U|1970-08-25
TRIAL STUDY 134XCP|LB|B842981B-AD7A-4A03-8E84-D5FC887BAD60|2||||KETONEBD|KETONE BODIES|||||||UMOL/DAY|||||||TRACE||PACKET||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|FRESH|U|PET/CT SCAN|GMI % FORMULA||N|U|U|N|||U|2||58||OBSERVATION|1972-03-18|1964-11-04|||||1962-08-13||1965-10-15|U|1962-12-22
TRIAL STUDY 134XCP|LB|B842981B-AD7A-4A03-8E84-D5FC887BAD60|1||||A1MICG|ALPHA-1 MICROGLOBULIN|||||||CI/MG|||||||INVALID||POUCH||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|SOLIDIFIED|NA|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|MDRD 4 VARIABLE FORMULA||Y|U|U|N|||Y|3||39||INDUCTION TREATMENT|1970-05-08|1973-06-07|||||1972-04-25||1962-11-28|NA|1965-08-03
TRIAL STUDY 134XCP|LB|B842981B-AD7A-4A03-8E84-D5FC887BAD60|2||||RT3|TRIIODOTHYRONINE, REVERSE|||||||MCI/L|||||||INVALID||UG/M2/DAY||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|FRESH|U|ENDOSCOPY|MDRD 6 VARIABLE FORMULA||N|N|U|U|||N|3||39||CONTINUATION TREATMENT|1965-10-06|1961-07-02|||||1972-12-03||1966-03-29|U|1964-04-30
TRIAL STUDY 134XCP|LB|B842981B-AD7A-4A03-8E84-D5FC887BAD60|1||||FATBODOV|FAT BODIES, OVAL|||||||H*%|||||||INVALID||ML/M2/DAY||||NORMAL|NOT DONE||||HAIR FOLLICLE|ICTERIC|Y|TOTAL BODY IRRADIATION|ASH FIBROSURE FORMULA||N|Y|N|NA|||NA|4||88||BASELINE|1966-10-03|1965-04-25|||||1971-11-16||1969-10-14|Y|1972-01-28
TRIAL STUDY 134XCP|LB|B842981B-AD7A-4A03-8E84-D5FC887BAD60|2||||CHOLCM|CHOLATE COMPOUNDS|||||||LOG10 PFU|||||||NEGATIVE||ML/(MIN*100ML)||||ABNORMAL|NOT DONE||||PUS|HEMOLYZED|N|IN SITU HYBRIDIZATION|COCKCROFT-GAULT FORMULA||N|Y|U|N|||N|4||88||BLINDED TREATMENT|1971-09-30|1970-08-09|||||1968-05-05||1970-10-03|N|1962-05-19
TRIAL STUDY 134XCP|LB|B842981B-AD7A-4A03-8E84-D5FC887BAD60|1||||CRYOGLBN|CRYOGLOBULIN|||||||CM2|||||||BORDERLINE||GLOBULE||||NORMAL|NOT DONE||||BILE|UNEXPECTED ODOR|Y|PATHOLOGICAL EVALUATION|CKD-EPI CREATININE FORMULA||N|Y|U|U|||Y|5||7||WASHOUT|1972-03-05|1962-07-15|||||1967-04-04||1962-10-08|NA|1963-07-29
TRIAL STUDY 134XCP|LB|B842981B-AD7A-4A03-8E84-D5FC887BAD60|2||||GRANSGCE|GRANULOCYTES SEGMENTED/TOTAL CELLS|||||||KAT|||||||POSITIVE||U/MG||||HIGH|NOT DONE||||CALCULUS|CONCENTRATED|N|ETDRS EYE CHART|MDRD 4 VARIABLE FORMULA||NA|Y|NA|NA|||NA|5||7||BLINDED TREATMENT|1960-05-26|1967-07-05|||||1965-05-19||1969-03-24|Y|1969-10-19
TRIAL STUDY 134XCP|LB|07F7C4E7-7722-4916-AB89-46EF540E2BD7|1||||GLDIGAAB|GLIADIN IGA ANTIBODY|||||||LOG10 CCID 50/DOSE|||||||NEGATIVE||/MIN||||LOW|NOT DONE||||ADIPOSE TISSUE|FROZEN|NA|DIFFUSION WEIGHTED MRI|FIBROMETER FORMULA||U|Y|NA|NA|||N|1||38||WASHOUT|1962-11-28|1960-03-10|||||1960-05-16||1961-02-26|NA|1963-05-10
TRIAL STUDY 134XCP|LB|07F7C4E7-7722-4916-AB89-46EF540E2BD7|2||||C165885|OLIVE TREE POLLEN IGE AB RAST SCORE|||||||IU/KG|||||||BORDERLINE||GPELISA UNIT/ML||||LOW|NOT DONE||||SPUTUM|THAWED|U|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|GMI % FORMULA||U|NA|NA|N|||N|1||38||LONG-TERM FOLLOW-UP|1970-09-17|1960-02-15|||||1962-01-20||1960-04-18|N|1968-08-19
TRIAL STUDY 134XCP|LB|07F7C4E7-7722-4916-AB89-46EF540E2BD7|1||||EOTAXIN1|EOTAXIN-1|||||||/10^5|||||||INVALID||UKAT||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|AGGLUTINATED|NA|CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI CYSTATIN C FORMULA||NA|NA|N|Y|||N|2||58||FOLLOW-UP|1968-11-05|1970-01-02|||||1960-01-25||1969-07-04|Y|1973-04-18
TRIAL STUDY 134XCP|LB|07F7C4E7-7722-4916-AB89-46EF540E2BD7|2||||GSTTH|GLUTATHIONE S-TRANSFERASE, THETA|||||||PIPE|||||||NEGATIVE||10^6 IU||||ABNORMAL|NOT DONE||||BUFFY COAT|CONCENTRATED|N|AGAR DILUTION|CKD-EPI CYSTATIN C FORMULA||Y|NA|NA|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1970-04-20|1960-06-17|||||1963-03-29||1965-06-14|N|1964-12-05
TRIAL STUDY 134XCP|LB|07F7C4E7-7722-4916-AB89-46EF540E2BD7|1||||IGAGM|IGG IGM IGA TOTAL|||||||LOG10 TCID 50/DOSE|||||||INDETERMINATE||PELLET||||LOW|NOT DONE||||GASTRIC CONTENTS|AGGLUTINATED|Y|SCINTIGRAPHY|FIBROTEST FORMULA||N|Y|N|NA|||U|3||39||RUN-IN|1966-09-14|1961-11-14|||||1968-12-14||1960-06-23|N|1963-10-23
TRIAL STUDY 134XCP|LB|07F7C4E7-7722-4916-AB89-46EF540E2BD7|2||||GCDCA|GLYCOCHENODEOXYCHOLATE|||||||PFU/DOSE|||||||NEGATIVE||10^8 PFU||||HIGH|NOT DONE||||ISOLATE|PARAFFIN-EMBEDDED|Y|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|HEPASCORE FORMULA||U|NA|Y|NA|||U|3||39||OPEN LABEL TREATMENT|1964-02-02|1969-10-19|||||1972-10-09||1973-06-19|N|1966-01-20
TRIAL STUDY 134XCP|LB|07F7C4E7-7722-4916-AB89-46EF540E2BD7|1||||CNTIGGAB|CENTROMERE IGG ANTIBODY|||||||NMOL/L/MIN|||||||INDETERMINATE||ML/CAGE/WK||||NORMAL|NOT DONE||||NAIL|GELLED|U|GC/MS/MS|MDRD 4 VARIABLE FORMULA||U|U|N|N|||Y|4||88||INDUCTION TREATMENT|1962-09-05|1970-07-18|||||1973-04-15||1969-08-05|Y|1961-10-22
TRIAL STUDY 134XCP|LB|07F7C4E7-7722-4916-AB89-46EF540E2BD7|2||||AFPL1|ALPHA FETOPROTEIN L1|||||||ML/G/H|||||||NEGATIVE||10^3/HPF||||ABNORMAL|NOT DONE||||PLEURAL FLUID|FRESH|Y|MYELOPEROXIDASE STAIN|FIBROTEST FORMULA||NA|U|N|N|||N|4||88||SCREENING|1960-12-12|1960-08-23|||||1965-08-08||1963-01-06|N|1968-05-24
TRIAL STUDY 134XCP|LB|07F7C4E7-7722-4916-AB89-46EF540E2BD7|1||||TRGTCE|TARGET CELLS|||||||UV*SEC|||||||POSITIVE||DRAM||||HIGH|NOT DONE||||ADIPOSE TISSUE|CALCIFIED|NA|GC/MS/MS|CKD-EPI CYSTATIN C FORMULA||NA|N|NA|Y|||Y|5||7||SCREENING|1963-08-20|1972-02-13|||||1969-06-18||1966-08-07|Y|1963-10-04
TRIAL STUDY 134XCP|LB|07F7C4E7-7722-4916-AB89-46EF540E2BD7|2||||SERTRAL|SERTRALINE|||||||EQ|||||||INVALID||MEQ/DAY||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|HEMOLYZED|U|FLUORESCEIN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|N|||Y|5||7||OPEN LABEL TREATMENT|1971-07-06|1972-05-08|||||1966-04-18||1960-02-29|N|1970-10-01
TRIAL STUDY 134XCP|LB|58661394-906E-43F3-8935-150DF240A04C|1||||HLADRAGT|HLA-DR ANTIGEN TYPE|||||||TSP|||||||INDETERMINATE||VG/DOSE||||ABNORMAL|NOT DONE||||PLATELET POOR PLASMA|UNEXPECTED ODOR|U|HEMATOXYLIN AND EOSIN STAIN|FIBROMETER FORMULA||N|Y|U|Y|||N|1||38||OBSERVATION|1960-05-09|1963-08-15|||||1961-10-13||1963-07-17|N|1973-03-01
TRIAL STUDY 134XCP|LB|58661394-906E-43F3-8935-150DF240A04C|2||||CYBILI|BILIRUBIN CRYSTALS|||||||CCID 50/DOSE|||||||BORDERLINE||UG/M2||||HIGH|NOT DONE||||PLATELET POOR PLASMA|FRESH|NA|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA||N|NA|N|U|||Y|1||38||SCREENING|1960-03-15|1973-03-13|||||1969-05-20||1971-01-14|NA|1960-12-27
TRIAL STUDY 134XCP|LB|58661394-906E-43F3-8935-150DF240A04C|1||||ANISO|ANISOCYTES|||||||NG/L|||||||INVALID||IU/MG||||NORMAL|NOT DONE||||VENOUS PLASMA|SOLIDIFIED|U|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA||Y|U|NA|N|||U|2||58||FOLLOW-UP|1965-04-09|1966-09-20|||||1963-05-11||1972-03-09|Y|1968-03-16
TRIAL STUDY 134XCP|LB|58661394-906E-43F3-8935-150DF240A04C|2||||FAS|FAS CELL SURFACE DEATH RECEPTOR|||||||%/S|||||||INVALID||G/MOL||||NORMAL|NOT DONE||||ERYTHROCYTES|GELLED|Y|PANENDOSCOPY|ASH FIBROSURE FORMULA||Y|N|N|U|||Y|2||58||OBSERVATION|1964-12-21|1970-12-24|||||1971-10-09||1968-10-15|NA|1963-05-27
TRIAL STUDY 134XCP|LB|58661394-906E-43F3-8935-150DF240A04C|1||||KLHIGGAB|KEYHOLE LIMPET HEMOCYANIN IGG ANTIBODY|||||||UV*SEC|||||||INDETERMINATE||MU||||NORMAL|NOT DONE||||PUS|ROOM TEMPERATURE|NA|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA||NA|NA|NA|N|||NA|3||39||FOLLOW-UP|1961-08-05|1972-01-25|||||1966-10-08||1970-01-15|N|1960-04-16
TRIAL STUDY 134XCP|LB|58661394-906E-43F3-8935-150DF240A04C|2||||HDLPSZ|HDL PARTICLE SIZE|||||||PA|||||||TRACE||L/S||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CALCIFIED|Y|WHOLE EXOME SEQUENCING|MDRD 4 VARIABLE FORMULA||Y|N|U|NA|||U|3||39||LONG-TERM FOLLOW-UP|1970-10-31|1962-10-20|||||1968-09-24||1961-07-06|U|1971-11-17
TRIAL STUDY 134XCP|LB|58661394-906E-43F3-8935-150DF240A04C|1||||ALPIS|INTESTINAL SPECIFIC ALKALINE PHOSPHATASE|||||||TESLA|||||||INVALID||G/M2/DAY||||LOW|NOT DONE||||CAPILLARY PLASMA|UNEXPECTED ODOR|U|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD FORMULA||N|U|N|NA|||Y|4||88||OBSERVATION|1962-11-13|1966-10-22|||||1971-02-07||1962-07-30|N|1968-04-27
TRIAL STUDY 134XCP|LB|58661394-906E-43F3-8935-150DF240A04C|2||||PTHI|PARATHYROID HORMONE, INTACT|||||||BOTTLE|||||||NEGATIVE||10^3 CFU/G||||ABNORMAL|NOT DONE||||BONE MARROW|CLOTTED|N|PHYSICAL EXAMINATION|GMI MMOL/MOL FORMULA||U|NA|U|U|||Y|4||88||OBSERVATION|1970-07-15|1973-04-03|||||1964-10-09||1969-02-03|U|1972-11-11
TRIAL STUDY 134XCP|LB|58661394-906E-43F3-8935-150DF240A04C|1||||C165876|BIRCH POLLEN IGE AB RAST SCORE|||||||10^3/HPF|||||||NEGATIVE||MMHG/SEC||||LOW|NOT DONE||||WHITE MATTER TISSUE|DRIED|U|IMMUNO-PET SCAN|CKD-EPI FORMULA||N|NA|N|NA|||U|5||7||FOLLOW-UP|1965-09-29|1969-01-09|||||1968-05-23||1963-11-05|U|1967-01-04
TRIAL STUDY 134XCP|LB|58661394-906E-43F3-8935-150DF240A04C|2||||V25HD2|25-HYDROXYVITAMIN D2|||||||MOL/ML|||||||INVALID||PACKET||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|ROOM TEMPERATURE|Y|LASER CAPTURE MICRODISSECTION|MDRD 5 VARIABLE FORMULA||Y|Y|NA|U|||N|5||7||RUN-IN|1971-10-15|1966-02-20|||||1973-03-23||1963-09-16|Y|1963-12-24
TRIAL STUDY 134XCP|LB|B70F3694-B764-4B39-BFB9-B1281ED091B8|1||||SAO2FIO2|OXYGEN SATURATION/FRACTION INSPIRED O2|||||||ML/MMHG/MIN/L|||||||BORDERLINE||UL||||HIGH|NOT DONE||||KERATINOCYTE|FRESH|NA|IMMUNODIFFUSION|FIBROMETER FORMULA||Y|N|NA|U|||U|1||38||TREATMENT|1969-10-21|1960-07-19|||||1972-04-08||1963-01-10|U|1968-03-09
TRIAL STUDY 134XCP|LB|B70F3694-B764-4B39-BFB9-B1281ED091B8|2||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||10^3 CFU|||||||BORDERLINE||PMOL/10^9 CELLS||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|HEMOLYZED|U|ELECTROMYOGRAPHY|COCKCROFT-GAULT FORMULA||NA|U|U|NA|||Y|1||38||BASELINE|1970-12-26|1960-07-22|||||1963-02-04||1970-06-01|U|1966-11-08
TRIAL STUDY 134XCP|LB|B70F3694-B764-4B39-BFB9-B1281ED091B8|1||||TNF12S|SOLUBLE TNF SUPERFAMILY MEMBER 12|||||||CAL|||||||NEGATIVE||ANTIBODY UNIT||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|CONTAMINATED|Y|REFRACTOMETRY|MDRD 6 VARIABLE FORMULA||NA|NA|N|N|||N|2||58||SCREENING|1964-05-13|1966-11-19|||||1970-09-10||1961-10-18|Y|1960-06-27
TRIAL STUDY 134XCP|LB|B70F3694-B764-4B39-BFB9-B1281ED091B8|2||||EOS|EOSINOPHILS|||||||HZ|||||||BORDERLINE||MEQ/MMOL||||ABNORMAL|NOT DONE||||BONE|AUTOLYZED|N|NEXT GENERATION TARGETED SEQUENCING|CKD-EPI FORMULA||N|Y|U|U|||N|2||58||TREATMENT|1960-08-23|1967-03-12|||||1963-07-17||1961-06-14|U|1962-06-21
TRIAL STUDY 134XCP|LB|B70F3694-B764-4B39-BFB9-B1281ED091B8|1||||GLUC|GLUCOSE|||||||UOSM|||||||POSITIVE||BAR||||LOW|NOT DONE||||MECONIUM|NON-HEMOLYZED|U|QUANTITATIVE COMPUTED TOMOGRAPHY|CKD-EPI CREATININE FORMULA||N|U|NA|N|||Y|3||39||TREATMENT|1964-04-21|1962-11-15|||||1968-01-05||1961-12-20|N|1961-05-25
TRIAL STUDY 134XCP|LB|B70F3694-B764-4B39-BFB9-B1281ED091B8|2||||ANCAB|ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY|||||||U/G/DAY|||||||INVALID||CY/CM||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|ICTERIC|Y|VENTILATION PERFUSION LUNG SCAN|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|NA|||N|3||39||RUN-IN|1969-11-02|1962-06-11|||||1965-08-22||1972-11-21|Y|1966-05-24
TRIAL STUDY 134XCP|LB|B70F3694-B764-4B39-BFB9-B1281ED091B8|1||||C165907|MOLD MIX IGG AB RAST SCORE|||||||DAGU/ML|||||||TRACE||NMOL||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|LIPEMIC|U|MEDIASTINOSCOPY|CKD-EPI FORMULA||N|N|N|N|||Y|4||88||RUN-IN|1972-12-24|1965-04-09|||||1961-09-15||1970-11-03|NA|1970-08-03
TRIAL STUDY 134XCP|LB|B70F3694-B764-4B39-BFB9-B1281ED091B8|2||||ELA1PMN|PANCREATIC ELASTASE 1, POLYMORPHONUCLEAR|||||||M|||||||INDETERMINATE||FT||||NORMAL|NOT DONE||||LUNG SURFACTANT|FROZEN|N|DIFFUSION TENSOR MRI|MDRD FORMULA||Y|NA|N|Y|||Y|4||88||TREATMENT|1963-01-05|1969-11-29|||||1961-04-12||1966-08-01|Y|1970-10-13
TRIAL STUDY 134XCP|LB|B70F3694-B764-4B39-BFB9-B1281ED091B8|1||||LDLOXAB|OXIDIZED LDL CHOLESTEROL ANTIBODY|||||||TRANSDUCING UNIT/ML|||||||NEGATIVE||10^6/G||||LOW|NOT DONE||||LUNG SURFACTANT|SOLIDIFIED|NA|CHROMOGENIC ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|U|U|||NA|5||7||CONTINUATION TREATMENT|1969-06-19|1964-10-22|||||1963-12-01||1966-05-05|NA|1967-12-08
TRIAL STUDY 134XCP|LB|B70F3694-B764-4B39-BFB9-B1281ED091B8|2||||OXMORPHN|OXYMORPHONE|||||||UG/KG/H|||||||INVALID||EID 50/DOSE||||LOW|NOT DONE||||SUPERNATANT, SERUM|CONCENTRATED|NA|IMMUNOCHROMATOGRAPHY|COCKCROFT-GAULT FORMULA||NA|U|NA|N|||NA|5||7||INDUCTION TREATMENT|1967-10-04|1965-12-03|||||1963-05-14||1970-12-31|U|1972-06-14
TRIAL STUDY 134XCP|LB|5B2471DB-807A-44F8-9529-D2319CCFE017|1||||C165941|COMMON RAGWEED POLLEN IGE AB RAST SCORE|||||||NCI|||||||TRACE||NG/MOL||||ABNORMAL|NOT DONE||||BASAL TEAR|AGGLUTINATED|Y|ELECTRONEUROGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|N|U|||NA|1||38||INDUCTION TREATMENT|1963-08-06|1966-09-08|||||1969-07-02||1964-08-13|N|1971-10-27
TRIAL STUDY 134XCP|LB|5B2471DB-807A-44F8-9529-D2319CCFE017|2||||LDLHDL|LDL CHOLESTEROL/HDL CHOLESTEROL|||||||UG/KG/DAY|||||||BORDERLINE||L/MIN||||HIGH|NOT DONE||||BASAL TEAR|LACTESCENT|N|PERIODIC ACID SCHIFF STAIN|GMI % FORMULA||NA|NA|Y|N|||U|1||38||RUN-IN|1968-11-15|1963-05-31|||||1969-03-19||1962-01-03|NA|1970-02-28
TRIAL STUDY 134XCP|LB|5B2471DB-807A-44F8-9529-D2319CCFE017|1||||HLAIPRA|HLA CLASS I PANEL REACTIVE ANTIBODY|||||||BLOCKS|||||||BORDERLINE||G/DAY||||NORMAL|NOT DONE||||EXUDATE|CONCENTRATED|U|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|ASH FIBROSURE FORMULA||U|U|N|Y|||NA|2||58||BASELINE|1970-07-03|1966-12-17|||||1963-11-16||1969-09-14|NA|1971-07-21
TRIAL STUDY 134XCP|LB|5B2471DB-807A-44F8-9529-D2319CCFE017|2||||LMBDLC|LAMBDA LIGHT CHAIN|||||||MG/ANIMAL|||||||POSITIVE||FFU||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|UNEXPECTED ODOR|U|MUGA|FIBROMETER FORMULA||N|U|NA|U|||Y|2||58||CONTINUATION TREATMENT|1963-10-04|1972-10-07|||||1968-02-06||1970-02-08|N|1971-05-22
TRIAL STUDY 134XCP|LB|5B2471DB-807A-44F8-9529-D2319CCFE017|1||||PLTLPLT|LARGE PLATELETS/TOTAL PLATELETS|||||||MCI/KG|||||||BORDERLINE||U/G||||NORMAL|NOT DONE||||GASTRIC CONTENTS|CALCIFIED|Y|FLUORESCENT MICROSCOPY|ASH FIBROSURE FORMULA||U|U|Y|Y|||U|3||39||TREATMENT|1962-06-11|1965-04-26|||||1967-07-19||1968-10-27|Y|1967-12-07
TRIAL STUDY 134XCP|LB|5B2471DB-807A-44F8-9529-D2319CCFE017|2||||B2GLYAB|BETA-2 GLYCOPROTEIN ANTIBODY|||||||U/M2/MIN|||||||TRACE||DIOPTER||||ABNORMAL|NOT DONE||||DISCHARGE|FROZEN|U|MEDIASTINOSCOPY|CKD-EPI FORMULA||NA|Y|U|NA|||NA|3||39||RUN-IN|1968-09-15|1963-11-02|||||1965-04-10||1973-07-18|N|1970-08-17
TRIAL STUDY 134XCP|LB|5B2471DB-807A-44F8-9529-D2319CCFE017|1||||C165905|GRASS MIX POLLEN IGG AB RAST SCORE|||||||HOMEOPATHIC DILUTION|||||||INDETERMINATE||10^9/DOSE||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|AUTOLYZED|Y|ELECTROCHEMILUMINESCENCE|MDRD FORMULA||Y|NA|Y|U|||U|4||88||FOLLOW-UP|1963-08-26|1968-05-27|||||1970-07-11||1972-02-06|NA|1972-10-06
TRIAL STUDY 134XCP|LB|5B2471DB-807A-44F8-9529-D2319CCFE017|2||||NEUTCE|NEUTROPHILS/TOTAL CELLS|||||||RING|||||||INDETERMINATE||10^9/DOSE||||ABNORMAL|NOT DONE||||VENOUS BLOOD|FRESH|U|MICRODENSITOMETRY|HEPASCORE FORMULA||Y|U|U|Y|||N|4||88||CONTINUATION TREATMENT|1972-10-04|1972-08-21|||||1969-12-28||1971-06-16|NA|1969-08-20
TRIAL STUDY 134XCP|LB|5B2471DB-807A-44F8-9529-D2319CCFE017|1||||CACR|CALCIUM CORRECTED|||||||ML/M2|||||||NEGATIVE||/MBP||||NORMAL|NOT DONE||||PUS|AUTOLYZED|N|IVY INCISION METHOD|FIBROTEST FORMULA||Y|N|Y|N|||U|5||7||BASELINE|1968-12-31|1968-07-22|||||1969-04-07||1972-12-08|NA|1965-09-24
TRIAL STUDY 134XCP|LB|5B2471DB-807A-44F8-9529-D2319CCFE017|2||||IL2SRA|SOLUBLE INTERLEUKIN 2 RECEPTOR ACTIVITY|||||||KG/CM2|||||||BORDERLINE||LOG10 CFU/ML||||LOW|NOT DONE||||SOFT TISSUE|FROZEN|U|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|FIBROMETER FORMULA||NA|Y|Y|U|||U|5||7||CONTINUATION TREATMENT|1967-01-29|1960-01-31|||||1960-08-15||1965-03-07|U|1971-07-03
TRIAL STUDY 134XCP|LB|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|1||||NEUTAGR|AGRANULAR NEUTROPHILS|||||||POUCH|||||||BORDERLINE||G/ANIMAL/WK||||LOW|NOT DONE||||URINE SEDIMENT|PARAFFIN-EMBEDDED|NA|HPLC-UV|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|Y|Y|||N|1||38||FOLLOW-UP|1972-10-14|1963-04-05|||||1962-07-07||1963-05-12|N|1961-06-14
TRIAL STUDY 134XCP|LB|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|2||||RFIGGAB|RHEUMATOID FACTOR IGG ANTIBODY|||||||GBQ/MG|||||||INVALID||KM||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|AUTOLYZED|N|ELECTRONEUROGRAPHY|CKD-EPI FORMULA||U|NA|N|Y|||NA|1||38||OPEN LABEL TREATMENT|1971-07-30|1971-06-19|||||1965-10-13||1963-06-09|NA|1965-07-07
TRIAL STUDY 134XCP|LB|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|1||||TUDCA|TAUROURSODEOXYCHOLATE|||||||UG/M2/H|||||||INDETERMINATE||BLOCKS||||LOW|NOT DONE||||BONE MARROW|CONTAMINATED|NA|HEMATOXYLIN AND EOSIN STAIN|MDRD 5 VARIABLE FORMULA||N|NA|Y|U|||NA|2||58||TREATMENT|1969-01-26|1967-03-04|||||1961-04-05||1965-04-03|N|1965-08-29
TRIAL STUDY 134XCP|LB|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|2||||OAS3|2-5-OLIGOADENYLATE SYNTHASE 3|||||||CM/MIN|||||||BORDERLINE||FMOL/L||||NORMAL|NOT DONE||||REFLEX TEAR|SOLIDIFIED|U|SISH|CKD-EPI CREATININE FORMULA||NA|NA|U|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1960-09-11|1968-05-11|||||1961-08-04||1972-11-19|Y|1968-01-05
TRIAL STUDY 134XCP|LB|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|1||||BILI|BILIRUBIN|||||||MMHG*MIN/L|||||||INVALID||FEU||||HIGH|NOT DONE||||ERYTHROCYTES|LACTESCENT|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|ASH FIBROSURE FORMULA||NA|NA|NA|NA|||N|3||39||BLINDED TREATMENT|1966-08-08|1971-10-17|||||1972-01-14||1965-01-21|N|1970-02-19
TRIAL STUDY 134XCP|LB|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|2||||TRICH|TRICHOMONAS|||||||ABSORBANCE U/MIN|||||||BORDERLINE||EID 50/DOSE||||HIGH|NOT DONE||||VITREOUS HUMOR|AUTOLYZED|N|MAPH|FIBROSIS 4 FORMULA||N|N|N|Y|||NA|3||39||WASHOUT|1973-04-18|1968-04-26|||||1962-09-23||1961-04-10|N|1973-01-19
TRIAL STUDY 134XCP|LB|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|1||||ESTRIOLF|ESTRIOL, FREE|||||||UU/L|||||||INDETERMINATE||PL||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ICTERIC|U|CHROMATOGRAPHY|COCKCROFT-GAULT FORMULA||U|N|NA|N|||NA|4||88||OPEN LABEL TREATMENT|1967-06-07|1961-03-07|||||1961-08-12||1971-03-14|Y|1968-03-22
TRIAL STUDY 134XCP|LB|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|2||||BLSTLMLY|LEUKEMIC BLASTS/LYMPHOCYTES|||||||MG/ML/DAY|||||||INDETERMINATE||MM/2H||||LOW|NOT DONE||||EXUDATE|PARAFFIN-EMBEDDED|U|LYMPHANGIOGRAPHY|FIBROMETER FORMULA||N|NA|U|Y|||Y|4||88||FOLLOW-UP|1965-03-09|1960-06-04|||||1968-11-14||1962-11-10|U|1970-09-07
TRIAL STUDY 134XCP|LB|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|1||||C130141|GERMAN COCKROACH ANTIGEN IGA ANTIBODY|||||||BAR|||||||POSITIVE||U/MG||||NORMAL|NOT DONE||||ARTERIAL BLOOD|LACTESCENT|U|RADIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|N|U|||NA|5||7||LONG-TERM FOLLOW-UP|1969-01-24|1961-08-20|||||1962-10-04||1970-07-24|N|1964-05-18
TRIAL STUDY 134XCP|LB|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|2||||TGFB1|TRANSFORMING GROWTH FACTOR BETA 1|||||||DAGU|||||||TRACE||FMOL/L/SEC||||LOW|NOT DONE||||BILE|SOLIDIFIED|NA|FLUORESCEIN STAIN|GMI MMOL/MOL FORMULA||N|Y|U|N|||NA|5||7||OBSERVATION|1966-01-25|1960-03-17|||||1970-10-20||1963-05-15|NA|1973-01-05
TRIAL STUDY 134XCP|LB|A6E00A2C-7DBC-4577-8873-C780F5A6B400|1||||ICAM1|INTERCELLULAR ADHESION MOLECULE 1|||||||DEG2|||||||BORDERLINE||NEBULE||||LOW|NOT DONE||||BONE|GELLED|U|CARDIAC THERMODILUTION|CKD-EPI CYSTATIN C FORMULA||N|Y|N|U|||NA|1||38||CONTINUATION TREATMENT|1969-11-20|1968-04-02|||||1970-04-02||1965-11-02|N|1966-05-31
TRIAL STUDY 134XCP|LB|A6E00A2C-7DBC-4577-8873-C780F5A6B400|2||||MIP1A|MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA|||||||G/KG/DAY|||||||INVALID||KCAL/DAY||||HIGH|NOT DONE||||SEBUM|THAWED|U|PET/SPECT SCAN|GMI MMOL/MOL FORMULA||N|N|N|U|||U|1||38||FOLLOW-UP|1970-10-27|1969-03-13|||||1965-01-13||1960-11-16|NA|1967-10-23
TRIAL STUDY 134XCP|LB|A6E00A2C-7DBC-4577-8873-C780F5A6B400|1||||PAI1AG|PLASMINOGEN ACTIVATOR INHIBITOR-1 AG|||||||MEQ/UG|||||||INVALID||G/KG||||ABNORMAL|NOT DONE||||BLOOD|REFRIGERATED|N|REFLECTANCE SPECTROSCOPY|FIBROTEST FORMULA||N|NA|NA|Y|||Y|2||58||INDUCTION TREATMENT|1965-12-02|1971-11-24|||||1972-08-07||1963-10-21|Y|1960-01-19
TRIAL STUDY 134XCP|LB|A6E00A2C-7DBC-4577-8873-C780F5A6B400|2||||PSDGLSRF|PHOSPHATIDYLGLYCEROL/LUNG SURFACTANT|||||||CI/MG|||||||INVALID||UMOL/DAY||||NORMAL|NOT DONE||||TISSUE|CONTAMINATED|NA|IVY INCISION METHOD|FIBROMETER FORMULA||NA|N|N|Y|||U|2||58||INDUCTION TREATMENT|1971-09-04|1964-06-18|||||1964-03-15||1962-03-18|N|1966-01-02
TRIAL STUDY 134XCP|LB|A6E00A2C-7DBC-4577-8873-C780F5A6B400|1||||C130125|CAT DANDER ANTIGEN IGG ANTIBODY|||||||U/G/MIN|||||||NEGATIVE||UU/L||||NORMAL|NOT DONE||||MUSCLE TISSUE|SOLIDIFIED|N|FLOCCULATION, CHARCOAL ENHANCED|GMI % FORMULA||NA|N|U|N|||Y|3||39||CONTINUATION TREATMENT|1962-11-19|1961-10-04|||||1970-12-21||1965-02-26|Y|1964-02-29
TRIAL STUDY 134XCP|LB|A6E00A2C-7DBC-4577-8873-C780F5A6B400|2||||TSH|THYROTROPIN|||||||AMU|||||||INDETERMINATE||COAT||||LOW|NOT DONE||||SEMINAL FLUID|UNEXPECTED ODOR|Y|MIGET|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|N|Y|||NA|3||39||OPEN LABEL TREATMENT|1972-11-26|1972-04-10|||||1968-03-06||1969-03-27|N|1970-08-08
TRIAL STUDY 134XCP|LB|A6E00A2C-7DBC-4577-8873-C780F5A6B400|1||||MIP1G|MACROPHAGE INFLAMMATORY PROTEIN 1 GAMMA|||||||MM/H|||||||INVALID||MOSM||||NORMAL|NOT DONE||||SKIN TISSUE|REFRIGERATED|NA|WESTERN BLOT|FIBROMETER FORMULA||U|Y|NA|NA|||N|4||88||BASELINE|1963-04-15|1971-06-13|||||1965-07-13||1972-04-20|Y|1967-05-27
TRIAL STUDY 134XCP|LB|A6E00A2C-7DBC-4577-8873-C780F5A6B400|2||||NGF|NERVE GROWTH FACTOR|||||||S/H|||||||INDETERMINATE||PG/CELL||||NORMAL|NOT DONE||||VENOUS PLASMA|CLOTTED|NA|CHROMOGENIC ASSAY|MDRD ENZYMATIC FORMULA||N|U|U|U|||Y|4||88||SCREENING|1969-04-15|1960-10-12|||||1968-08-28||1967-04-05|Y|1969-04-14
TRIAL STUDY 134XCP|LB|A6E00A2C-7DBC-4577-8873-C780F5A6B400|1||||INTLK5|INTERLEUKIN 5|||||||LOG10 COPIES/ML|||||||INDETERMINATE||LENS||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|NA|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC FORMULA||U|N|NA|NA|||N|5||7||SCREENING|1966-10-24|1963-04-29|||||1973-07-01||1972-06-06|Y|1960-09-01
TRIAL STUDY 134XCP|LB|A6E00A2C-7DBC-4577-8873-C780F5A6B400|2||||CPEPTIDE|C-PEPTIDE|||||||AFU|||||||POSITIVE||FMOL/G||||LOW|NOT DONE||||STOOL|LIPEMIC|Y|TRIPLE-PHASE MRI SCAN|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|NA|U|||N|5||7||BASELINE|1969-08-03|1963-02-20|||||1972-08-25||1964-05-12|N|1968-01-13
TRIAL STUDY 134XCP|LB|06611015-E99C-466B-B0B3-EBE10EA9E627|1||||PHOS|PHOSPHATE|||||||BOWL|||||||POSITIVE||UEQ/L||||ABNORMAL|NOT DONE||||SOFT TISSUE|LACTESCENT|Y|IMMUNORADIOMETRIC ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|N|NA|||NA|1||38||FOLLOW-UP|1961-08-02|1971-01-20|||||1973-08-16||1968-06-10|U|1961-11-04
TRIAL STUDY 134XCP|LB|06611015-E99C-466B-B0B3-EBE10EA9E627|2||||EGFR|EPIDERMAL GROWTH FACTOR RECEPTOR|||||||CYLINDER|||||||INVALID||G/MOL||||NORMAL|NOT DONE||||LUNG SURFACTANT|REFRIGERATED|NA|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|FIBROMETER FORMULA||Y|N|U|Y|||NA|1||38||LONG-TERM FOLLOW-UP|1961-01-19|1969-06-21|||||1968-04-16||1968-12-06|N|1967-07-07
TRIAL STUDY 134XCP|LB|06611015-E99C-466B-B0B3-EBE10EA9E627|1||||VITB17|VITAMIN B17|||||||TUBE|||||||INDETERMINATE||BAG||||NORMAL|NOT DONE||||MECONIUM|CONTAMINATED|NA|X-RAY|GMI % FORMULA||Y|N|Y|N|||NA|2||58||BLINDED TREATMENT|1963-05-21|1967-10-18|||||1963-07-01||1965-01-29|NA|1969-08-07
TRIAL STUDY 134XCP|LB|06611015-E99C-466B-B0B3-EBE10EA9E627|2||||PEPSNGC|PEPSINOGEN C|||||||10^11/L|||||||INDETERMINATE||10^9 ORGANISMS/MG||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|LIPEMIC|Y|CHROMATOGRAPHY|CKD-EPI FORMULA||N|N|NA|U|||U|2||58||BLINDED TREATMENT|1968-03-26|1964-07-15|||||1963-11-20||1964-02-11|Y|1964-05-12
TRIAL STUDY 134XCP|LB|06611015-E99C-466B-B0B3-EBE10EA9E627|1||||HLABAGT|HLA-B ANTIGEN TYPE|||||||EJACULATE U|||||||INDETERMINATE||MM/MIN||||ABNORMAL|NOT DONE||||CELL PELLET|THAWED|U|ENZYMATIC SPECTROPHOTOMETRY|GMI MMOL/MOL FORMULA||N|U|Y|N|||NA|3||39||SCREENING|1964-09-16|1969-02-26|||||1969-03-07||1965-04-18|NA|1962-05-21
TRIAL STUDY 134XCP|LB|06611015-E99C-466B-B0B3-EBE10EA9E627|2||||BASOIM|IMMATURE BASOPHILS|||||||MBQ/UL|||||||POSITIVE||TESLA||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|SOLIDIFIED|Y|NUCLEIC ACID BASED METHOD|FIBROMETER FORMULA||U|U|N|NA|||N|3||39||BLINDED TREATMENT|1970-04-12|1961-01-12|||||1965-07-17||1969-11-01|N|1966-07-07
TRIAL STUDY 134XCP|LB|06611015-E99C-466B-B0B3-EBE10EA9E627|1||||ACE|ANGIOTENSIN CONVERTING ENZYME|||||||PPB|||||||INDETERMINATE||CM2||||HIGH|NOT DONE||||CAPILLARY PLASMA|FRESH|NA|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA||U|N|N|NA|||Y|4||88||FOLLOW-UP|1962-03-08|1969-10-01|||||1965-08-03||1972-10-28|Y|1962-02-24
TRIAL STUDY 134XCP|LB|06611015-E99C-466B-B0B3-EBE10EA9E627|2||||MUCTHR|MUCOUS THREADS|||||||G/ANIMAL/DAY|||||||TRACE||K||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|UNEXPECTED ODOR|NA|SANGER SEQUENCING|MDRD 4 VARIABLE FORMULA||Y|Y|U|NA|||U|4||88||SCREENING|1964-04-01|1963-12-23|||||1968-12-17||1971-02-20|NA|1967-11-27
TRIAL STUDY 134XCP|LB|06611015-E99C-466B-B0B3-EBE10EA9E627|1||||BICARB|BICARBONATE|||||||UU/DL|||||||NEGATIVE||MPH||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|DRIED|N|CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI CREATININE FORMULA||NA|NA|NA|NA|||N|5||7||WASHOUT|1973-09-02|1961-02-27|||||1960-08-25||1968-07-25|U|1970-06-01
TRIAL STUDY 134XCP|LB|06611015-E99C-466B-B0B3-EBE10EA9E627|2||||CAION|CALCIUM, IONIZED|||||||MIN|||||||INVALID||U/M2/DAY||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|DRIED|N|OSCILLOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|NA|||NA|5||7||OBSERVATION|1967-10-26|1968-10-04|||||1970-01-25||1973-06-11|N|1971-04-08
TRIAL STUDY 134XCP|LB|5AF91C46-87FC-4714-B956-A4ECFC87C30A|1||||TATC|THROMBIN ANTITHROMBIN COMPLEX|||||||BQ/KG|||||||INVALID||10^9/G||||ABNORMAL|NOT DONE||||TUMOR TISSUE|THAWED|N|PHYSICAL EXAMINATION|MDRD 5 VARIABLE FORMULA||U|NA|U|U|||Y|1||38||OPEN LABEL TREATMENT|1961-10-03|1966-03-06|||||1965-08-09||1966-07-17|NA|1964-10-24
TRIAL STUDY 134XCP|LB|5AF91C46-87FC-4714-B956-A4ECFC87C30A|2||||HRYCECE|HAIRY CELLS/TOTAL CELLS|||||||MEQ/ML|||||||BORDERLINE||RNA COPIES/ML||||NORMAL|NOT DONE||||FLUID|NON-HEMOLYZED|N|WHOLE TRANSCRIPTOME SEQUENCING|NASH FIBROSURE FORMULA||N|N|N|U|||NA|1||38||CONTINUATION TREATMENT|1963-03-28|1961-05-30|||||1968-02-01||1971-08-02|NA|1971-08-03
TRIAL STUDY 134XCP|LB|5AF91C46-87FC-4714-B956-A4ECFC87C30A|1||||C1QAB|COMPLEMENT C1Q ANTIBODY|||||||CMOL|||||||BORDERLINE||MG/KG/DOSE||||HIGH|NOT DONE||||SYNOVIAL FLUID|FROZEN|NA|JAEGER EYE CHART|COCKCROFT-GAULT FORMULA||N|NA|U|NA|||Y|2||58||OBSERVATION|1961-12-22|1962-08-24|||||1961-03-18||1961-10-01|Y|1969-06-19
TRIAL STUDY 134XCP|LB|5AF91C46-87FC-4714-B956-A4ECFC87C30A|2||||APOC1|APOLIPOPROTEIN CI|||||||UM2|||||||BORDERLINE||UMOL/L/SEC||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|REFRIGERATED|N|KLEIHAUER-BETKE|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|Y|Y|||Y|2||58||OPEN LABEL TREATMENT|1966-09-22|1963-02-02|||||1968-04-06||1967-12-11|Y|1971-01-11
TRIAL STUDY 134XCP|LB|5AF91C46-87FC-4714-B956-A4ECFC87C30A|1||||SMDGCELE|SMUDGE CELLS/LEUKOCYTES|||||||ML/MIN/1.73M2|||||||POSITIVE||UG/L DDU||||ABNORMAL|NOT DONE||||SMEGMA|PARAFFIN-EMBEDDED|U|FARR ASSAY|MDRD 6 VARIABLE FORMULA||U|U|N|N|||Y|3||39||BLINDED TREATMENT|1971-08-10|1961-11-27|||||1969-09-07||1972-06-20|U|1966-02-26
TRIAL STUDY 134XCP|LB|5AF91C46-87FC-4714-B956-A4ECFC87C30A|2||||PLATEST|PLATELETS, ESTIMATED|||||||TUBERCULIN UNIT/ML|||||||TRACE||POUCH||||HIGH|NOT DONE||||CALCULUS|UNEXPECTED ODOR|U|LC-FL|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|NA|U|||N|3||39||OBSERVATION|1967-12-13|1969-04-02|||||1968-06-07||1961-11-08|Y|1968-07-22
TRIAL STUDY 134XCP|LB|5AF91C46-87FC-4714-B956-A4ECFC87C30A|1||||GGT|GAMMA GLUTAMYL TRANSFERASE|||||||MET*H|||||||TRACE||BAR||||ABNORMAL|NOT DONE||||SEMINAL FLUID|NON-HEMOLYZED|Y|EPSILOMETER|MDRD ENZYMATIC FORMULA||NA|NA|U|NA|||U|4||88||WASHOUT|1961-03-15|1966-05-13|||||1962-07-16||1972-01-13|Y|1972-04-12
TRIAL STUDY 134XCP|LB|5AF91C46-87FC-4714-B956-A4ECFC87C30A|2||||INTLK17|INTERLEUKIN 17|||||||GPS U|||||||NEGATIVE||MCI||||HIGH|NOT DONE||||VITREOUS HUMOR|THAWED|U|NUCLEIC ACID HYBRIDIZATION|CKD-EPI CREATININE FORMULA||N|NA|NA|N|||N|4||88||RUN-IN|1970-01-01|1973-05-13|||||1968-11-20||1968-05-04|U|1962-06-28
TRIAL STUDY 134XCP|LB|5AF91C46-87FC-4714-B956-A4ECFC87C30A|1||||HLADRB1|HLA DR BETA1 ANTIGEN|||||||NG/L|||||||NEGATIVE||ML/CM3/MIN||||LOW|NOT DONE||||SPUTUM|AUTOLYZED|U|ANALYTICAL ULTRACENTRIFUGATION|MDRD ENZYMATIC FORMULA||U|NA|U|Y|||NA|5||7||CONTINUATION TREATMENT|1968-07-26|1960-09-05|||||1968-06-20||1968-08-24|NA|1972-08-09
TRIAL STUDY 134XCP|LB|5AF91C46-87FC-4714-B956-A4ECFC87C30A|2||||C165878|GERMAN COCKROACH IGE AB RAST SCORE|||||||PA|||||||INVALID||GBQ||||LOW|NOT DONE||||EXPIRED AIR|HEMOLYZED|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD 4 VARIABLE FORMULA||U|NA|N|NA|||Y|5||7||WASHOUT|1970-06-26|1971-07-18|||||1972-04-06||1973-01-25|Y|1972-03-19
TRIAL STUDY 134XCP|LB|3DEA7E00-77B9-4710-A37E-577F925BFBD8|1||||CLCREAT|CHLORIDE/CREATININE|||||||YD|||||||NEGATIVE||GTT||||ABNORMAL|NOT DONE||||SEBUM|AGGLUTINATED|Y|ANALYTICAL ULTRACENTRIFUGATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|U|||N|1||38||OPEN LABEL TREATMENT|1966-11-20|1964-12-09|||||1972-07-15||1961-02-02|N|1962-02-22
TRIAL STUDY 134XCP|LB|3DEA7E00-77B9-4710-A37E-577F925BFBD8|2||||TPRONP|NON-PHOSPHORYLATED TAU PROTEIN|||||||KS|||||||POSITIVE||PA||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|AGGLUTINATED|NA|ROMANOWSKY STAIN|MDRD FORMULA||NA|N|N|U|||N|1||38||CONTINUATION TREATMENT|1960-12-02|1967-01-07|||||1967-09-12||1969-11-25|Y|1962-01-20
TRIAL STUDY 134XCP|LB|3DEA7E00-77B9-4710-A37E-577F925BFBD8|1||||LPA|LIPOPROTEIN-A|||||||G/CM2|||||||INVALID||LOG10 PFU||||HIGH|NOT DONE||||BILE|REFRIGERATED|N|ELECTROMYOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|NA|U|||Y|2||58||BLINDED TREATMENT|1972-04-06|1967-01-29|||||1961-03-21||1968-09-19|U|1966-01-31
TRIAL STUDY 134XCP|LB|3DEA7E00-77B9-4710-A37E-577F925BFBD8|2||||KIM1|KIDNEY INJURY MOLECULE-1|||||||NKAT/L|||||||BORDERLINE||MOL||||HIGH|NOT DONE||||EMESIS|SOLIDIFIED|U|WESTERGREN|GMI MMOL/MOL FORMULA||N|U|Y|NA|||NA|2||58||FOLLOW-UP|1968-09-13|1963-11-24|||||1963-07-12||1973-05-03|U|1961-11-07
TRIAL STUDY 134XCP|LB|3DEA7E00-77B9-4710-A37E-577F925BFBD8|1||||MSPIKEXR|MONOCLONAL PROTEIN SPIKE EXCRETION RATE|||||||PFU/ANIMAL|||||||POSITIVE||ML/H||||HIGH|NOT DONE||||AMNIOTIC FLUID|HEMOLYZED|U|MAGNETIC RESONANCE ELASTOGRAPHY|CKD-EPI FORMULA||NA|N|Y|U|||U|3||39||BASELINE|1962-01-29|1966-04-14|||||1969-02-19||1960-11-28|N|1970-12-06
TRIAL STUDY 134XCP|LB|3DEA7E00-77B9-4710-A37E-577F925BFBD8|2||||ACPHOS|ACID PHOSPHATASE|||||||/10^5|||||||BORDERLINE||IU/DL||||ABNORMAL|NOT DONE||||FLUID|CONCENTRATED|Y|COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI CREATININE FORMULA||N|U|U|NA|||N|3||39||BASELINE|1965-05-18|1962-07-09|||||1969-08-21||1963-06-11|N|1970-03-22
TRIAL STUDY 134XCP|LB|3DEA7E00-77B9-4710-A37E-577F925BFBD8|1||||OXAEXR|OXALATE EXCRETION RATE|||||||10^8/L|||||||TRACE||MG/DAY||||LOW|NOT DONE||||DISCHARGE|FRESH|NA|REVERSE TRANSCRIPTASE PCR|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|Y|||Y|4||88||OPEN LABEL TREATMENT|1969-09-03|1965-12-10|||||1963-12-20||1960-10-11|Y|1970-11-14
TRIAL STUDY 134XCP|LB|3DEA7E00-77B9-4710-A37E-577F925BFBD8|2||||NEUTIM|IMMATURE NEUTROPHILS|||||||UM/DAY|||||||INDETERMINATE||TORR||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|HEMOLYZED|U|JAEGER EYE CHART|GMI MMOL/MOL FORMULA||U|N|U|N|||NA|4||88||SCREENING|1967-03-09|1964-04-09|||||1962-11-08||1972-09-24|U|1970-01-23
TRIAL STUDY 134XCP|LB|3DEA7E00-77B9-4710-A37E-577F925BFBD8|1||||LCN2|LIPOCALIN-2|||||||10^8/L|||||||TRACE||TCID 50/DOSE||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|LACTESCENT|U|AURAMINE STAIN|MDRD ENZYMATIC FORMULA||U|NA|N|U|||U|5||7||WASHOUT|1970-08-08|1973-02-06|||||1961-04-02||1964-09-14|U|1968-11-12
TRIAL STUDY 134XCP|LB|3DEA7E00-77B9-4710-A37E-577F925BFBD8|2||||GATCPHRL|GAMMA TOCOPHEROL|||||||MANSON U/ML|||||||POSITIVE||UCI/KG||||LOW|NOT DONE||||SWABBED MATERIAL|ROOM TEMPERATURE|NA|MICROBIAL BIOCHEMICAL IDENTIFICATION|FIBROTEST FORMULA||U|N|NA|NA|||U|5||7||BLINDED TREATMENT|1965-10-12|1961-07-15|||||1972-08-15||1961-06-11|Y|1961-12-27
TRIAL STUDY 134XCP|LB|DC79E350-1B89-4518-8B42-5858F5270928|1||||PLSPCE|PRECURSOR PLASMA CELLS|||||||U/10^12 RBC|||||||TRACE||HZ/S||||NORMAL|NOT DONE||||SPERMATOZOON|CONCENTRATED|N|ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||U|Y|Y|Y|||N|1||38||SCREENING|1963-05-18|1967-05-28|||||1964-11-26||1966-11-24|U|1967-03-05
TRIAL STUDY 134XCP|LB|DC79E350-1B89-4518-8B42-5858F5270928|2||||C165924|GRASS MIX POLLEN IGE AB RAST SCORE|||||||CL|||||||POSITIVE||NMOL/L||||LOW|NOT DONE||||PLATELET|AUTOLYZED|U|AUSCULTATION|MDRD FORMULA||U|N|NA|N|||U|1||38||INDUCTION TREATMENT|1961-09-01|1964-01-10|||||1964-04-18||1972-12-14|NA|1961-10-09
TRIAL STUDY 134XCP|LB|DC79E350-1B89-4518-8B42-5858F5270928|1||||NRP1|NEUROPILIN-1|||||||MPL U|||||||POSITIVE||GENEQ/ML||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|CLOTTED|U|PYROSEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|Y|NA|||Y|2||58||RUN-IN|1967-05-31|1969-02-25|||||1972-04-05||1971-05-05|NA|1961-04-08
TRIAL STUDY 134XCP|LB|DC79E350-1B89-4518-8B42-5858F5270928|2||||STAT3PS3|PHOSPHORYLATED STAT3/STAT3|||||||UG/KG/MIN|||||||INVALID||10^7 TCID 50/DOSE||||NORMAL|NOT DONE||||HAIR|FROZEN|Y|ENZYMATIC COLORIMETRY|HEPASCORE FORMULA||U|N|NA|U|||U|2||58||OPEN LABEL TREATMENT|1966-10-07|1967-03-04|||||1968-11-12||1968-07-14|NA|1968-06-12
TRIAL STUDY 134XCP|LB|DC79E350-1B89-4518-8B42-5858F5270928|1||||SPWEIGHT|SPECIMEN WEIGHT|||||||10^12/L|||||||INDETERMINATE||ML/MMHG/MIN/L||||HIGH|NOT DONE||||ERYTHROCYTES|LACTESCENT|N|NUCLEIC ACID HYBRIDIZATION|GMI MMOL/MOL FORMULA||U|U|N|NA|||N|3||39||SCREENING|1966-07-27|1969-06-13|||||1971-04-27||1963-09-03|U|1966-08-08
TRIAL STUDY 134XCP|LB|DC79E350-1B89-4518-8B42-5858F5270928|2||||TEARDCY|DACRYOCYTES|||||||RAD|||||||TRACE||NMOL/DAY||||ABNORMAL|NOT DONE||||PUS|REFRIGERATED|U|AURAMINE STAIN|COCKCROFT-GAULT FORMULA||NA|NA|NA|Y|||N|3||39||BLINDED TREATMENT|1964-02-23|1961-04-05|||||1966-10-04||1966-04-08|N|1963-08-18
TRIAL STUDY 134XCP|LB|DC79E350-1B89-4518-8B42-5858F5270928|1||||ERCEPPOL|ERYTHROID PROLIFERATION POOL|||||||KV|||||||INVALID||S*KPA||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|CONCENTRATED|NA|IMMUNOPRECIPITATION|MDRD 6 VARIABLE FORMULA||NA|N|NA|U|||U|4||88||FOLLOW-UP|1968-12-26|1961-02-06|||||1960-01-20||1961-02-26|U|1962-05-22
TRIAL STUDY 134XCP|LB|DC79E350-1B89-4518-8B42-5858F5270928|2||||HLAIIPRA|HLA CLASS II PANEL REACTIVE ANTIBODY|||||||NEWTON|||||||INVALID||UIU/DL||||NORMAL|NOT DONE||||BILE|FROZEN|U|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|ASH FIBROSURE FORMULA||Y|U|Y|U|||N|4||88||CONTINUATION TREATMENT|1971-09-12|1962-03-16|||||1969-06-06||1968-03-04|NA|1973-01-01
TRIAL STUDY 134XCP|LB|DC79E350-1B89-4518-8B42-5858F5270928|1||||NEUTSG|NEUTROPHILS, SEGMENTED|||||||BQ|||||||INVALID||10^3 ORGANISMS/ML||||HIGH|NOT DONE||||CORD BLOOD|UNEXPECTED ODOR|N|HPLC-FL|MDRD ENZYMATIC FORMULA||Y|U|Y|NA|||N|5||7||CONTINUATION TREATMENT|1962-07-07|1972-06-30|||||1972-12-18||1961-03-01|NA|1966-07-19
TRIAL STUDY 134XCP|LB|DC79E350-1B89-4518-8B42-5858F5270928|2||||LDH5LDH|LDH ISOENZYME 5/LDH|||||||UCI/L|||||||BORDERLINE||MIN/DAY||||HIGH|NOT DONE||||REFLEX TEAR|THAWED|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|FIBROMETER FORMULA||Y|Y|U|N|||U|5||7||WASHOUT|1960-01-15|1962-07-04|||||1970-02-19||1962-08-27|NA|1962-01-27
TRIAL STUDY 134XCP|LB|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|1||||GLUCWBE|WHOLE BLOOD EQUIVALENT GLUCOSE|||||||FG|||||||BORDERLINE||DEG2||||NORMAL|NOT DONE||||SALIVA|FRESH|N|INFRARED SPECTROMETRY|MDRD 4 VARIABLE FORMULA||Y|U|NA|Y|||U|1||38||FOLLOW-UP|1962-11-12|1969-10-20|||||1965-05-08||1973-04-09|Y|1967-01-16
TRIAL STUDY 134XCP|LB|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|2||||VEGFD|VASCULAR ENDOTHELIAL GROWTH FACTOR D|||||||KG/CM2|||||||INDETERMINATE||KEV||||LOW|NOT DONE||||LEUKOCYTE|CONTAMINATED|N|HIGH RESOLUTION CT|CKD-EPI CREATININE FORMULA||Y|Y|N|N|||U|1||38||BASELINE|1960-08-29|1969-04-10|||||1971-04-16||1969-11-22|N|1970-10-27
TRIAL STUDY 134XCP|LB|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|1||||C165937|ZEA MAYS IGE AB RAST SCORE|||||||FMOL/G|||||||INDETERMINATE||GTT||||ABNORMAL|NOT DONE||||TUMOR TISSUE|CONCENTRATED|NA|SPECT/CT SCAN|ASH FIBROSURE FORMULA||NA|N|Y|NA|||NA|2||58||LONG-TERM FOLLOW-UP|1968-02-24|1961-09-21|||||1961-07-19||1964-03-06|Y|1972-01-02
TRIAL STUDY 134XCP|LB|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|2||||MASTCECE|MAST CELLS/TOTAL CELLS|||||||BQ/KG|||||||NEGATIVE||PT_US||||NORMAL|NOT DONE||||PLASMA|UNEXPECTED ODOR|Y|RAJI CELL RIA|FIBROTEST FORMULA||U|NA|Y|N|||U|2||58||LONG-TERM FOLLOW-UP|1966-01-07|1966-11-09|||||1960-06-25||1960-03-01|N|1973-06-03
TRIAL STUDY 134XCP|LB|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|1||||AMYLB38|AMYLOID BETA 1-38|||||||MJOULE/CM2|||||||TRACE||/10^3||||HIGH|NOT DONE||||BASAL TEAR|GELLED|NA|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|U|NA|||U|3||39||CONTINUATION TREATMENT|1962-12-29|1968-05-28|||||1968-09-20||1968-10-11|Y|1966-05-14
TRIAL STUDY 134XCP|LB|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|2||||GRAN|GRANULOCYTES|||||||MV|||||||INVALID||H*%||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|GELLED|U|MANUAL CLOT DETECTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|N|NA|||Y|3||39||FOLLOW-UP|1967-10-30|1970-12-26|||||1962-04-08||1962-08-10|N|1962-02-06
TRIAL STUDY 134XCP|LB|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|1||||HYPGST17|17-HYDROXYPROGESTERONE|||||||CL|||||||INVALID||DIOPTER||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CALCIFIED|U|HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI FORMULA||N|N|N|U|||N|4||88||RUN-IN|1970-01-05|1969-06-07|||||1972-05-31||1964-09-20|U|1968-07-16
TRIAL STUDY 134XCP|LB|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|2||||C130092|WESTERN RAGWEED POLLEN IGE|||||||NKAT/G HB|||||||NEGATIVE||COAT||||ABNORMAL|NOT DONE||||FLUID|CLOTTED|NA|JAFFE REACTION|GMI % FORMULA||N|U|NA|N|||U|4||88||LONG-TERM FOLLOW-UP|1962-08-25|1970-06-26|||||1966-11-03||1970-04-13|NA|1966-05-19
TRIAL STUDY 134XCP|LB|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|1||||NPY|NEUROPEPTIDE Y|||||||BQ|||||||BORDERLINE||COAT||||LOW|NOT DONE||||ARTERIAL BLOOD|SOLIDIFIED|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|FIBROTEST FORMULA||NA|NA|NA|N|||N|5||7||OPEN LABEL TREATMENT|1961-11-12|1964-10-07|||||1967-07-03||1970-11-10|U|1971-05-24
TRIAL STUDY 134XCP|LB|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|2||||GSTMUCRT|MU GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||RFU|||||||INDETERMINATE||FRAMES/S||||LOW|NOT DONE||||SYNOVIAL FLUID|CONTAMINATED|U|LEAD CITRATE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|NA|Y|||NA|5||7||CONTINUATION TREATMENT|1960-12-06|1971-11-08|||||1972-06-03||1973-03-08|NA|1964-05-17
TRIAL STUDY 134XCP|LB|7F51014D-D2B5-4956-9DD6-52676EB66ED7|1||||CTXICRT|TYPE I COLLAGEN C-TELOPEPTIDES/CREAT|||||||UG/M2|||||||POSITIVE||F||||LOW|NOT DONE||||ABSCESS FLUID|ICTERIC|N|WESTERGREN|FIBROMETER FORMULA||NA|Y|Y|N|||NA|1||38||BASELINE|1960-08-18|1968-04-25|||||1968-06-19||1964-08-13|U|1960-12-13
TRIAL STUDY 134XCP|LB|7F51014D-D2B5-4956-9DD6-52676EB66ED7|2||||UREANEXR|UREA NITROGEN EXCRETION RATE|||||||G/CAGE/WK|||||||POSITIVE||NMOL BCE/MMOL||||HIGH|NOT DONE||||SMEGMA|LACTESCENT|U|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|MDRD ENZYMATIC FORMULA||Y|N|Y|U|||NA|1||38||TREATMENT|1964-04-20|1970-01-16|||||1971-05-21||1966-06-29|U|1964-12-15
TRIAL STUDY 134XCP|LB|7F51014D-D2B5-4956-9DD6-52676EB66ED7|1||||HGBA1HGB|HEMOGLOBIN A1/TOTAL HEMOGLOBIN|||||||KM/H|||||||BORDERLINE||MV2/HZ||||ABNORMAL|NOT DONE||||URINE|GELLED|Y|SPECULAR MICROSCOPY|COCKCROFT-GAULT FORMULA||U|NA|U|N|||U|2||58||FOLLOW-UP|1971-09-16|1969-03-19|||||1962-07-05||1967-08-04|U|1961-11-17
TRIAL STUDY 134XCP|LB|7F51014D-D2B5-4956-9DD6-52676EB66ED7|2||||HGBDOXY|DEOXYHEMOGLOBIN|||||||CY/CM|||||||POSITIVE||JDF UNIT||||LOW|NOT DONE||||WHITE MATTER TISSUE|FRESH|Y|CELLULOSE TAPE|MDRD 4 VARIABLE FORMULA||U|Y|NA|NA|||N|2||58||RUN-IN|1969-08-01|1968-04-24|||||1969-08-27||1966-04-07|N|1961-08-05
TRIAL STUDY 134XCP|LB|7F51014D-D2B5-4956-9DD6-52676EB66ED7|1||||PERCECE|PROLIFERATING ERYTHROID/TOTAL CELLS|||||||FRAMES/S|||||||BORDERLINE||HOURS||||HIGH|NOT DONE||||HAIR|GELLED|N|CALIPER MEASUREMENT METHOD|FIBROSIS 4 FORMULA||N|Y|NA|Y|||U|3||39||INDUCTION TREATMENT|1961-11-18|1963-04-05|||||1964-09-05||1966-01-13|NA|1961-12-28
TRIAL STUDY 134XCP|LB|7F51014D-D2B5-4956-9DD6-52676EB66ED7|2||||APPB|AMYLOID BETA PRECURSOR PROTEIN|||||||KEV|||||||POSITIVE||KA_U/DL||||LOW|NOT DONE||||SMOOTH MUSCLE TISSUE|LACTESCENT|NA|SEQUENCING|CKD-EPI CYSTATIN C FORMULA||U|N|N|U|||N|3||39||RUN-IN|1970-11-12|1965-05-20|||||1961-06-29||1966-08-10|U|1968-06-08
TRIAL STUDY 134XCP|LB|7F51014D-D2B5-4956-9DD6-52676EB66ED7|1||||CPEPTIDE|C-PEPTIDE|||||||CIGAR|||||||TRACE||UG/M2/DAY||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|UNEXPECTED ODOR|N|HEMAGGLUTINATION ASSAY|MDRD 4 VARIABLE FORMULA||U|U|Y|NA|||NA|4||88||BLINDED TREATMENT|1966-09-15|1971-07-05|||||1966-05-11||1965-09-10|NA|1969-08-04
TRIAL STUDY 134XCP|LB|7F51014D-D2B5-4956-9DD6-52676EB66ED7|2||||SEZCELE|SEZARY CELLS/LEUKOCYTES|||||||BE/ML|||||||NEGATIVE||SCOOPFUL||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|THAWED|Y|ELLA|CKD-EPI FORMULA||NA|U|N|N|||N|4||88||WASHOUT|1960-09-20|1970-10-15|||||1964-02-07||1968-08-16|U|1968-02-13
TRIAL STUDY 134XCP|LB|7F51014D-D2B5-4956-9DD6-52676EB66ED7|1||||PLAT|PLATELETS|||||||ML/M2|||||||INDETERMINATE||10^12/L||||NORMAL|NOT DONE||||BLOOD|FROZEN|N|SINGLE-SLICE SPIRAL CT|MDRD FORMULA||N|NA|N|N|||NA|5||7||RUN-IN|1967-08-09|1966-01-15|||||1961-12-07||1972-04-07|U|1971-04-12
TRIAL STUDY 134XCP|LB|7F51014D-D2B5-4956-9DD6-52676EB66ED7|2||||FATACFRU|FREE FATTY ACID, UNSATURATED|||||||U/MMOL|||||||INDETERMINATE||U.CARR||||NORMAL|NOT DONE||||PLASMA|CALCIFIED|N|CONFOCAL MICROSCOPY|MDRD 6 VARIABLE FORMULA||NA|U|U|U|||NA|5||7||RUN-IN|1969-11-18|1967-03-09|||||1971-11-09||1960-10-23|N|1962-07-04
TRIAL STUDY 134XCP|LB|0568B2DD-3184-472D-89C6-66A5CE8AE00F|1||||LYMIMLE|IMMATURE LYMPHOCYTES/LEUKOCYTES|||||||ENZYME U/M2|||||||INDETERMINATE||TRANSDUCING UNIT/ML||||LOW|NOT DONE||||MIXED VENOUS BLOOD|DRIED|Y|SURFACE PLASMON RESONANCE|CKD-EPI FORMULA||N|Y|NA|NA|||N|1||38||BLINDED TREATMENT|1963-06-04|1962-06-05|||||1970-09-09||1962-05-03|NA|1969-03-06
TRIAL STUDY 134XCP|LB|0568B2DD-3184-472D-89C6-66A5CE8AE00F|2||||TAURCRT|TAURINE/CREATININE|||||||MNFI|||||||NEGATIVE||MEQ/MMOL||||ABNORMAL|NOT DONE||||HAIR|CLOTTED|NA|CONTRAST ENHANCED MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|Y|||U|1||38||LONG-TERM FOLLOW-UP|1967-05-13|1972-02-28|||||1960-08-25||1961-10-12|U|1971-05-02
TRIAL STUDY 134XCP|LB|0568B2DD-3184-472D-89C6-66A5CE8AE00F|1||||PGE2|PROSTAGLANDIN E2|||||||USP U|||||||BORDERLINE||KCAL||||LOW|NOT DONE||||ISOLATE|LIPEMIC|N|PET/CT SCAN|MDRD FORMULA||NA|N|Y|N|||NA|2||58||FOLLOW-UP|1961-04-29|1968-02-24|||||1960-08-11||1966-01-12|NA|1971-12-30
TRIAL STUDY 134XCP|LB|0568B2DD-3184-472D-89C6-66A5CE8AE00F|2||||INTLK1RA|INTERLEUKIN 1 RECEPTOR ANTAGONIST|||||||ML/DAY|||||||NEGATIVE||NCI||||NORMAL|NOT DONE||||BILE|UNEXPECTED ODOR|NA|SLOAN LETTER EYE CHART 100%|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|N|N|||N|2||58||LONG-TERM FOLLOW-UP|1966-07-25|1966-01-27|||||1970-03-09||1970-03-07|U|1961-12-15
TRIAL STUDY 134XCP|LB|0568B2DD-3184-472D-89C6-66A5CE8AE00F|1||||C130135|D. PTERONYSSINUS ANTIGEN IGG ANTIBODY|||||||ML/MMHG/MIN/L|||||||TRACE||BEL||||HIGH|NOT DONE||||PLEURAL TISSUE|ICTERIC|NA|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||N|NA|NA|Y|||Y|3||39||BASELINE|1969-07-17|1970-10-10|||||1970-05-31||1971-01-04|U|1964-01-21
TRIAL STUDY 134XCP|LB|0568B2DD-3184-472D-89C6-66A5CE8AE00F|2||||PLATSAT|PLATELET SATELLITISM|||||||NMOL/L/MIN|||||||BORDERLINE||DEG/S||||HIGH|NOT DONE||||ABSCESS FLUID|CONCENTRATED|N|TEST STRIP|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|N|Y|||U|3||39||OBSERVATION|1963-07-30|1960-01-27|||||1968-04-04||1968-01-26|U|1970-07-26
TRIAL STUDY 134XCP|LB|0568B2DD-3184-472D-89C6-66A5CE8AE00F|1||||MX1|INTERFERON-INDUCED PROTEIN P78|||||||KPA/L/SEC|||||||POSITIVE||PMOL/10^10 CELLS||||ABNORMAL|NOT DONE||||EMESIS|CLOTTED|NA|EEG|MDRD 4 VARIABLE FORMULA||NA|U|Y|N|||NA|4||88||FOLLOW-UP|1961-07-30|1971-09-30|||||1960-04-21||1964-09-19|N|1962-07-05
TRIAL STUDY 134XCP|LB|0568B2DD-3184-472D-89C6-66A5CE8AE00F|2||||FACTXII|FACTOR XII|||||||PHERESIS UNIT|||||||TRACE||MU/L||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|LIPEMIC|N|FLUORESCEIN STAIN|HEPASCORE FORMULA||N|N|Y|N|||U|4||88||INDUCTION TREATMENT|1971-04-09|1967-01-26|||||1969-05-10||1966-01-20|N|1969-12-05
TRIAL STUDY 134XCP|LB|0568B2DD-3184-472D-89C6-66A5CE8AE00F|1||||APAPCYS|ACETAMINOPHEN-CYSTEINE ADDUCT|||||||GAUSS|||||||POSITIVE||COULOMB||||HIGH|NOT DONE||||MUCUS|CONTAMINATED|N|RADIATION DOSIMETRY|ASH FIBROSURE FORMULA||Y|U|N|Y|||N|5||7||SCREENING|1962-10-04|1970-10-21|||||1971-07-21||1961-01-17|N|1970-08-13
TRIAL STUDY 134XCP|LB|0568B2DD-3184-472D-89C6-66A5CE8AE00F|2||||NEUTLE|NEUTROPHILS/LEUKOCYTES|||||||HOMEOPATHIC DILUTION|||||||BORDERLINE||AMPULE||||NORMAL|NOT DONE||||BREAST MILK|AUTOLYZED|U|PERCUSSION|HEPASCORE FORMULA||U|U|N|NA|||NA|5||7||OPEN LABEL TREATMENT|1969-05-22|1966-11-29|||||1965-12-07||1968-02-14|N|1961-02-17
TRIAL STUDY 134XCP|LB|275DC6A6-598C-4997-A442-4A3916AC42BD|1||||NEUTAGR|AGRANULAR NEUTROPHILS|||||||PACKET|||||||POSITIVE||CM||||HIGH|NOT DONE||||INTERSTITIAL FLUID|DRIED|Y|ANTIMICROBIAL COMBINATION TESTING|MDRD 4 VARIABLE FORMULA||NA|U|NA|N|||Y|1||38||LONG-TERM FOLLOW-UP|1961-09-12|1969-10-18|||||1963-08-11||1962-07-07|N|1965-03-15
TRIAL STUDY 134XCP|LB|275DC6A6-598C-4997-A442-4A3916AC42BD|2||||HBCOHGB|CARBOXYHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||DL|||||||TRACE||MOL/L||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|ROOM TEMPERATURE|Y|INFRARED SPECTROMETRY|NASH FIBROSURE FORMULA||N|Y|NA|U|||U|1||38||CONTINUATION TREATMENT|1971-03-13|1963-08-13|||||1967-07-20||1965-04-28|Y|1965-02-17
TRIAL STUDY 134XCP|LB|275DC6A6-598C-4997-A442-4A3916AC42BD|1||||HER2|HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2|||||||ATM|||||||INVALID||MV*MIN||||NORMAL|NOT DONE||||GASTRIC FLUID|AGGLUTINATED|U|MULTIPLEXED BEAD BASED IMMUNOASSAY|MDRD 6 VARIABLE FORMULA||N|N|U|NA|||Y|2||58||OPEN LABEL TREATMENT|1972-03-03|1972-06-24|||||1960-03-06||1972-08-30|U|1969-03-17
TRIAL STUDY 134XCP|LB|275DC6A6-598C-4997-A442-4A3916AC42BD|2||||CXCL12|CHEMOKINE (C-X-C MOTIF) LIGAND 12|||||||CAPLET|||||||INDETERMINATE||/LPF||||ABNORMAL|NOT DONE||||CORD BLOOD|GELLED|NA|ELISPOT|GMI % FORMULA||U|Y|N|Y|||Y|2||58||BASELINE|1969-10-19|1968-11-25|||||1963-02-08||1960-12-02|N|1972-09-13
TRIAL STUDY 134XCP|LB|275DC6A6-598C-4997-A442-4A3916AC42BD|1||||UNSPCECE|UNSPECIFIED CELLS/TOTAL CELLS|||||||UG/DOSE|||||||NEGATIVE||MG/MOL||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|NON-HEMOLYZED|Y|TOTAL BODY IRRADIATION|MDRD 5 VARIABLE FORMULA||N|N|Y|U|||Y|3||39||OPEN LABEL TREATMENT|1960-12-22|1971-10-30|||||1965-02-28||1965-11-22|N|1965-05-02
TRIAL STUDY 134XCP|LB|275DC6A6-598C-4997-A442-4A3916AC42BD|2||||PLAGMAMP|PLATELET AGGREGATION MEAN AMPLITUDE|||||||PIPE|||||||NEGATIVE||UG/M2/H||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|AUTOLYZED|N|ELECTROMYOGRAPHY|CKD-EPI CYSTATIN C FORMULA||N|Y|N|Y|||Y|3||39||FOLLOW-UP|1963-06-20|1973-07-16|||||1970-05-27||1973-03-04|NA|1969-02-10
TRIAL STUDY 134XCP|LB|275DC6A6-598C-4997-A442-4A3916AC42BD|1||||OCCBLD|OCCULT BLOOD|||||||/10^4|||||||INDETERMINATE||L/KG||||ABNORMAL|NOT DONE||||SMEGMA|DRIED|N|CELL OF ORIGIN ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|U|||NA|4||88||BASELINE|1960-09-18|1966-12-14|||||1966-05-08||1965-10-06|Y|1967-09-15
TRIAL STUDY 134XCP|LB|275DC6A6-598C-4997-A442-4A3916AC42BD|2||||NRP1|NEUROPILIN-1|||||||G/DL|||||||NEGATIVE||IN2||||HIGH|NOT DONE||||EXUDATE|LACTESCENT|N|RAJI CELL RIA|GMI % FORMULA||U|NA|U|U|||NA|4||88||INDUCTION TREATMENT|1960-01-21|1965-12-31|||||1972-10-23||1971-09-14|NA|1973-04-07
TRIAL STUDY 134XCP|LB|275DC6A6-598C-4997-A442-4A3916AC42BD|1||||PRGNENLN|PREGNENOLONE|||||||ELISA UNIT/ML|||||||NEGATIVE||U/M2/MIN||||HIGH|NOT DONE||||ALVEOLAR AIR|CALCIFIED|NA|IMMUNOFIXATION ELECTROPHORESIS|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|Y|||U|5||7||BASELINE|1968-08-03|1972-03-24|||||1962-07-21||1971-04-06|NA|1962-04-11
TRIAL STUDY 134XCP|LB|275DC6A6-598C-4997-A442-4A3916AC42BD|2||||MONOIMLE|IMMATURE MONOCYTES/LEUKOCYTES|||||||MIN*MG/ML|||||||BORDERLINE||RING||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|DRIED|Y|ANTIBIOTIC AGAR SCREEN|CKD-EPI CYSTATIN C FORMULA||NA|U|U|NA|||NA|5||7||INDUCTION TREATMENT|1969-10-09|1968-01-28|||||1967-07-21||1964-06-03|U|1965-07-11
TRIAL STUDY 134XCP|LB|B949F90F-524D-4494-A63C-A05F56421EA1|1||||C165897|BERMUDA GRASS POLLEN IGG AB RAST SCORE|||||||AMOL|||||||TRACE||NG||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|REFRIGERATED|NA|ENZYMATIC SPECTROPHOTOMETRY|CKD-EPI CREATININE FORMULA||NA|Y|N|NA|||N|1||38||OPEN LABEL TREATMENT|1960-04-14|1963-11-04|||||1967-02-20||1961-01-18|NA|1969-11-19
TRIAL STUDY 134XCP|LB|B949F90F-524D-4494-A63C-A05F56421EA1|2||||CYSTHION|CYSTATHIONINE|||||||MOL/MOL|||||||INDETERMINATE||UG/L DDU||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|FROZEN|U|IVY INCISION METHOD|MDRD 5 VARIABLE FORMULA||U|U|U|U|||NA|1||38||RUN-IN|1971-12-20|1970-01-18|||||1966-04-30||1972-01-11|U|1969-07-01
TRIAL STUDY 134XCP|LB|B949F90F-524D-4494-A63C-A05F56421EA1|1||||APLIGGAB|ANTI-PHOSPHOLIPID IGG ANTIBODY|||||||CD*S/M2|||||||INDETERMINATE||CYLINDER||||LOW|NOT DONE||||SPUTUM|ROOM TEMPERATURE|N|IMPULSE OSCILLOMETRY|GMI MMOL/MOL FORMULA||NA|NA|NA|U|||N|2||58||WASHOUT|1973-05-08|1965-05-10|||||1967-11-08||1972-03-25|Y|1969-09-04
TRIAL STUDY 134XCP|LB|B949F90F-524D-4494-A63C-A05F56421EA1|2||||C165932|DOG DANDER IGE AB RAST SCORE|||||||CL|||||||INDETERMINATE||BOX||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|NA|AGAR PROPORTION|MDRD 5 VARIABLE FORMULA||N|U|U|U|||U|2||58||LONG-TERM FOLLOW-UP|1962-07-16|1962-02-13|||||1973-03-14||1966-11-30|NA|1963-10-05
TRIAL STUDY 134XCP|LB|B949F90F-524D-4494-A63C-A05F56421EA1|1||||ELA1PMN|PANCREATIC ELASTASE 1, POLYMORPHONUCLEAR|||||||HZ/S|||||||BORDERLINE||U/DL||||HIGH|NOT DONE||||MECONIUM|NON-HEMOLYZED|Y|TEMPLATE INCISION METHOD|ASH FIBROSURE FORMULA||NA|U|N|Y|||N|3||39||LONG-TERM FOLLOW-UP|1969-03-02|1963-05-30|||||1968-06-23||1961-04-28|NA|1968-04-12
TRIAL STUDY 134XCP|LB|B949F90F-524D-4494-A63C-A05F56421EA1|2||||KIM1|KIDNEY INJURY MOLECULE-1|||||||CI/L|||||||INDETERMINATE||MBP||||HIGH|NOT DONE||||ERYTHROCYTES|UNEXPECTED ODOR|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|CKD-EPI CREATININE FORMULA||Y|N|N|N|||N|3||39||WASHOUT|1973-02-28|1964-04-23|||||1964-02-21||1962-01-29|NA|1972-10-25
TRIAL STUDY 134XCP|LB|B949F90F-524D-4494-A63C-A05F56421EA1|1||||FDP|FIBRIN DEGRADATION PRODUCTS|||||||DPM/ML|||||||BORDERLINE||MCI/KG||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|FRESH|Y|LIQUID SCINTILLATION COUNTING|FIBROTEST FORMULA||U|U|U|Y|||Y|4||88||FOLLOW-UP|1961-06-23|1970-07-14|||||1966-10-10||1969-08-04|Y|1967-03-24
TRIAL STUDY 134XCP|LB|B949F90F-524D-4494-A63C-A05F56421EA1|2||||FRTNHC|FERRITIN HEAVY CHAIN|||||||MG/ML/MIN|||||||INDETERMINATE||UG/L FEU||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|FRESH|N|MECHANICAL CLOT DETECTION|FIBROMETER FORMULA||Y|Y|NA|N|||NA|4||88||FOLLOW-UP|1966-09-29|1971-12-10|||||1972-12-28||1970-07-12|NA|1970-02-28
TRIAL STUDY 134XCP|LB|B949F90F-524D-4494-A63C-A05F56421EA1|1||||PROLCTN|PROLACTIN|||||||APPLICATION|||||||BORDERLINE||BISCUIT||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|LIPEMIC|N|NEXT GENERATION SEQUENCING|MDRD FORMULA||Y|N|NA|U|||Y|5||7||SCREENING|1961-08-21|1970-02-21|||||1972-10-30||1965-03-08|Y|1962-09-25
TRIAL STUDY 134XCP|LB|B949F90F-524D-4494-A63C-A05F56421EA1|2||||PRORUBCE|PRORUBRICYTE/TOTAL CELLS|||||||/H|||||||POSITIVE||CYCLE/MIN||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|CONCENTRATED|N|MICROBIAL CULTURE, LIQUID|FIBROTEST FORMULA||NA|Y|Y|Y|||U|5||7||LONG-TERM FOLLOW-UP|1960-12-12|1965-06-03|||||1960-11-03||1973-02-10|Y|1967-08-03
TRIAL STUDY 134XCP|LB|152411EA-E7DA-4230-A8A6-163C8A8C0A58|1||||TESTOSBA|BIOAVAILABLE TESTOSTERONE|||||||DYN|||||||BORDERLINE||UKAT/L||||NORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|HEMOLYZED|Y|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|HEPASCORE FORMULA||Y|N|N|U|||NA|1||38||INDUCTION TREATMENT|1960-09-29|1972-12-24|||||1969-08-15||1971-04-22|U|1967-07-16
TRIAL STUDY 134XCP|LB|152411EA-E7DA-4230-A8A6-163C8A8C0A58|2||||ENRAGE|EXTRACELL NEWLY IDENT RAGE BIND PROTEIN|||||||MHZ|||||||NEGATIVE||U/G/MIN||||ABNORMAL|NOT DONE||||BASAL TEAR|CALCIFIED|Y|INDIA INK STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|Y|||U|1||38||OBSERVATION|1963-06-20|1971-12-11|||||1970-08-15||1966-01-11|N|1972-01-24
TRIAL STUDY 134XCP|LB|152411EA-E7DA-4230-A8A6-163C8A8C0A58|1||||DNAAB|ANTI-DNA ANTIBODIES|||||||10^3 CFU|||||||NEGATIVE||MV/SEC||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|UNEXPECTED ODOR|N|LIQUID SCINTILLATION COUNTING|GMI MMOL/MOL FORMULA||NA|U|N|Y|||U|2||58||WASHOUT|1966-01-09|1962-03-16|||||1961-08-29||1966-09-18|NA|1963-09-16
TRIAL STUDY 134XCP|LB|152411EA-E7DA-4230-A8A6-163C8A8C0A58|2||||METHANOL|METHANOL|||||||G/L|||||||INVALID||UIU/DL||||HIGH|NOT DONE||||LYMPH|AGGLUTINATED|Y|ELECTROPHORESIS|ASH FIBROSURE FORMULA||U|Y|NA|NA|||Y|2||58||OBSERVATION|1971-11-01|1973-05-21|||||1973-05-31||1971-08-02|NA|1968-10-07
TRIAL STUDY 134XCP|LB|152411EA-E7DA-4230-A8A6-163C8A8C0A58|1||||LDH2LDH|LDH ISOENZYME 2/LDH|||||||HPA|||||||TRACE||10^7 CFU/ML||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|AUTOLYZED|U|TELLER ACUITY CARDS|COCKCROFT-GAULT FORMULA||Y|Y|NA|NA|||U|3||39||INDUCTION TREATMENT|1968-07-25|1965-08-12|||||1966-12-27||1971-08-29|U|1968-06-02
TRIAL STUDY 134XCP|LB|152411EA-E7DA-4230-A8A6-163C8A8C0A58|2||||METAMYCE|METAMYELOCYTES/TOTAL CELLS|||||||ML|||||||POSITIVE||%(W/W)||||ABNORMAL|NOT DONE||||BILE|PARAFFIN-EMBEDDED|Y|PANENDOSCOPY|CKD-EPI CREATININE FORMULA||N|N|N|Y|||NA|3||39||INDUCTION TREATMENT|1966-03-15|1968-07-04|||||1968-06-19||1969-10-30|NA|1968-02-28
TRIAL STUDY 134XCP|LB|152411EA-E7DA-4230-A8A6-163C8A8C0A58|1||||C165888|RUSSIAN THISTLE POLLEN IGE ANTIBODY|||||||FL|||||||POSITIVE||UG/L FEU||||NORMAL|NOT DONE||||CAPILLARY PLASMA|AUTOLYZED|NA|FLUOROSCOPY|CKD-EPI CYSTATIN C FORMULA||U|N|Y|U|||NA|4||88||OPEN LABEL TREATMENT|1963-12-18|1966-06-17|||||1969-10-19||1967-02-27|N|1961-05-28
TRIAL STUDY 134XCP|LB|152411EA-E7DA-4230-A8A6-163C8A8C0A58|2||||PMDW|PLATELET MASS DISTRIBUTION WIDTH|||||||MG/M2/H|||||||BORDERLINE||PMOL||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|THAWED|U|SECONDARY ION MASS SPECTOMETRY|HEPASCORE FORMULA||Y|Y|NA|U|||NA|4||88||SCREENING|1964-05-05|1969-05-23|||||1960-01-11||1963-04-26|U|1960-06-22
TRIAL STUDY 134XCP|LB|152411EA-E7DA-4230-A8A6-163C8A8C0A58|1||||CFA|COEFFICIENT OF FAT ABSORPTION|||||||100 IU/ML|||||||NEGATIVE||ML/ANIMAL||||HIGH|NOT DONE||||LYSATE|ICTERIC|NA|LC/MS|FIBROMETER FORMULA||U|N|NA|N|||U|5||7||CONTINUATION TREATMENT|1960-05-01|1965-08-31|||||1963-02-16||1960-01-08|NA|1965-07-12
TRIAL STUDY 134XCP|LB|152411EA-E7DA-4230-A8A6-163C8A8C0A58|2||||CRTCLRE|CREATININE CLEARANCE, ESTIMATED|||||||CUP EQ|||||||NEGATIVE||/10^3||||NORMAL|NOT DONE||||SALIVA|ICTERIC|Y|KINETIC MICROPARTICLE IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||N|U|NA|NA|||Y|5||7||TREATMENT|1972-08-28|1973-09-03|||||1972-08-21||1961-01-30|Y|1967-10-09
TRIAL STUDY 134XCP|LB|AB78662C-F90A-4193-9AC7-5621B497A18F|1||||PROTPATN|PROTEIN PATTERN|||||||1/(S*KPA)|||||||POSITIVE||M2||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|REFRIGERATED|U|ICC|MDRD 6 VARIABLE FORMULA||N|NA|NA|Y|||N|1||38||FOLLOW-UP|1970-02-14|1964-01-13|||||1973-04-06||1962-02-16|U|1966-09-18
TRIAL STUDY 134XCP|LB|AB78662C-F90A-4193-9AC7-5621B497A18F|2||||ENDOSTN|ENDOSTATIN|||||||G/CAGE|||||||POSITIVE||MM/H||||LOW|NOT DONE||||GASTRIC FLUID|ROOM TEMPERATURE|NA|QUANTITATIVE ULTRASOUND|FIBROTEST FORMULA||U|Y|U|Y|||U|1||38||SCREENING|1972-05-05|1970-06-27|||||1964-09-10||1971-02-22|NA|1964-01-19
TRIAL STUDY 134XCP|LB|AB78662C-F90A-4193-9AC7-5621B497A18F|1||||PSAMRNA|PROSTATE SPECIFIC ANTIGEN MRNA|||||||ATM|||||||NEGATIVE||UG/M2||||NORMAL|NOT DONE||||ISOLATE|CONCENTRATED|U|NUCLEAR RADIOLOGY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|Y|U|||N|2||58||WASHOUT|1963-06-30|1969-05-18|||||1971-01-10||1970-10-02|NA|1969-04-16
TRIAL STUDY 134XCP|LB|AB78662C-F90A-4193-9AC7-5621B497A18F|2||||KETONES|KETONES|||||||UG/CM2|||||||TRACE||ANTI-XA IU||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR|U|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD ENZYMATIC FORMULA||U|U|Y|N|||N|2||58||FOLLOW-UP|1970-11-23|1965-03-14|||||1969-02-17||1962-08-22|NA|1965-09-02
TRIAL STUDY 134XCP|LB|AB78662C-F90A-4193-9AC7-5621B497A18F|1||||FIBRINOF|FIBRINOGEN, FUNCTIONAL|||||||U/KG/H|||||||NEGATIVE||CIGAR||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|CONTAMINATED|NA|NEURAMINIDASE INHIBITION ASSAY|MDRD ENZYMATIC FORMULA||Y|Y|NA|Y|||NA|3||39||INDUCTION TREATMENT|1964-09-22|1962-08-08|||||1966-07-19||1961-08-17|N|1960-07-11
TRIAL STUDY 134XCP|LB|AB78662C-F90A-4193-9AC7-5621B497A18F|2||||EOSNSQE|EOSINOPHILS/NON-SQUAM EPI CELLS|||||||ML/MIN|||||||INVALID||ML/100G/MIN||||LOW|NOT DONE||||CERUMEN|GELLED|N|PEAK FLOWMETRY|CKD-EPI CYSTATIN C FORMULA||U|U|N|Y|||NA|3||39||BASELINE|1967-07-24|1962-05-19|||||1963-08-28||1966-04-06|NA|1962-05-07
TRIAL STUDY 134XCP|LB|AB78662C-F90A-4193-9AC7-5621B497A18F|1||||METAMY|METAMYELOCYTES|||||||DPM/ML|||||||TRACE||ML/ANIMAL/WK||||HIGH|NOT DONE||||MONOCYTE|HEMOLYZED|Y|LC/MS|ASH FIBROSURE FORMULA||N|NA|U|N|||U|4||88||BASELINE|1964-10-30|1969-11-16|||||1973-08-24||1961-06-22|U|1967-08-07
TRIAL STUDY 134XCP|LB|AB78662C-F90A-4193-9AC7-5621B497A18F|2||||HELMETCE|HELMET CELLS|||||||MM|||||||BORDERLINE||MEQ/MMOL||||HIGH|NOT DONE||||STOOL|REFRIGERATED|NA|DYNAMOMETRY|MDRD 4 VARIABLE FORMULA||Y|U|Y|NA|||NA|4||88||BLINDED TREATMENT|1970-12-31|1970-12-12|||||1960-04-08||1973-02-04|Y|1971-01-01
TRIAL STUDY 134XCP|LB|AB78662C-F90A-4193-9AC7-5621B497A18F|1||||C5A|COMPLEMENT C5A|||||||TRANSDUCING UNIT/ML|||||||BORDERLINE||UOSM||||HIGH|NOT DONE||||SPERMATOZOON|ROOM TEMPERATURE|NA|CYSTOMETRY|GMI MMOL/MOL FORMULA||N|N|NA|Y|||NA|5||7||CONTINUATION TREATMENT|1968-04-05|1970-12-10|||||1963-10-09||1964-09-19|NA|1968-05-13
TRIAL STUDY 134XCP|LB|AB78662C-F90A-4193-9AC7-5621B497A18F|2||||CREAT|CREATININE|||||||IU|||||||BORDERLINE||GENEQ||||NORMAL|NOT DONE||||GASTRIC CONTENTS|CONCENTRATED|N|IMMUNOASSAY|CKD-EPI FORMULA||U|Y|Y|U|||U|5||7||RUN-IN|1968-11-26|1972-04-08|||||1960-11-17||1973-01-15|U|1970-06-20
TRIAL STUDY 134XCP|LB|84CD31FD-BCB9-4439-84F7-11C63D578108|1||||MLIGCE|MALIGNANT CELLS, NOS|||||||FINGERTIP UNIT|||||||NEGATIVE||MM/2H||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|ICTERIC|Y|IN SITU HYBRIDIZATION|CKD-EPI CREATININE FORMULA||N|Y|Y|NA|||U|1||38||OPEN LABEL TREATMENT|1963-05-12|1963-06-03|||||1962-09-05||1972-03-08|Y|1969-05-06
TRIAL STUDY 134XCP|LB|84CD31FD-BCB9-4439-84F7-11C63D578108|2||||CHOLOH4B|4-BETA-HYDROXYCHOLESTEROL|||||||10^9 CFU/ML|||||||NEGATIVE||MPH||||HIGH|NOT DONE||||SPERMATOZOON|PARAFFIN-EMBEDDED|NA|ERGOSPIROMETRY|CKD-EPI FORMULA||NA|U|N|N|||NA|1||38||CONTINUATION TREATMENT|1972-05-13|1968-07-03|||||1961-03-24||1966-05-07|N|1970-05-18
TRIAL STUDY 134XCP|LB|84CD31FD-BCB9-4439-84F7-11C63D578108|1||||GSTPIEXR|PI-GST EXCRETION RATE|||||||/2000 RBC|||||||BORDERLINE||UG/G/H||||LOW|NOT DONE||||LUNG SURFACTANT|UNEXPECTED ODOR|U|BRDU CELLULAR PROLIFERATION ASSAY|MDRD 6 VARIABLE FORMULA||Y|NA|Y|NA|||N|2||58||INDUCTION TREATMENT|1961-03-31|1970-04-30|||||1969-04-02||1963-07-26|U|1969-07-14
TRIAL STUDY 134XCP|LB|84CD31FD-BCB9-4439-84F7-11C63D578108|2||||LDH2LDH|LDH ISOENZYME 2/LDH|||||||S/H|||||||BORDERLINE||MU||||HIGH|NOT DONE||||MENSTRUAL BLOOD|AUTOLYZED|N|TRIPLE-PHASE MRI SCAN|FIBROSIS 4 FORMULA||Y|Y|Y|NA|||U|2||58||BASELINE|1965-08-24|1965-11-11|||||1961-01-24||1964-12-24|Y|1962-01-26
TRIAL STUDY 134XCP|LB|84CD31FD-BCB9-4439-84F7-11C63D578108|1||||PLTMORPH|PLATELET MORPHOLOGY|||||||AMPULE|||||||INDETERMINATE||ML/ANIMAL/DAY||||LOW|NOT DONE||||ABSCESS FLUID|LACTESCENT|Y|RAJI CELL RIA|MDRD 4 VARIABLE FORMULA||U|N|Y|U|||U|3||39||TREATMENT|1963-07-19|1964-08-10|||||1962-02-06||1967-10-02|NA|1962-10-12
TRIAL STUDY 134XCP|LB|84CD31FD-BCB9-4439-84F7-11C63D578108|2||||OXZPM|OXAZEPAM|||||||DL|||||||NEGATIVE||KEV||||HIGH|NOT DONE||||ISOLATE|AUTOLYZED|Y|BETA LACTAMASE|FIBROTEST FORMULA||NA|NA|Y|Y|||Y|3||39||BASELINE|1963-01-11|1971-12-16|||||1960-01-24||1968-02-21|Y|1961-02-23
TRIAL STUDY 134XCP|LB|84CD31FD-BCB9-4439-84F7-11C63D578108|1||||A2MACG|ALPHA-2 MACROGLOBULIN|||||||MMOL/MOL|||||||NEGATIVE||UG/M2/MIN||||NORMAL|NOT DONE||||STOOL|FRESH|Y|HEMATOXYLIN AND EOSIN STAIN|CKD-EPI CYSTATIN C FORMULA||NA|Y|N|N|||NA|4||88||LONG-TERM FOLLOW-UP|1965-01-11|1969-10-28|||||1967-12-13||1962-12-21|N|1966-04-26
TRIAL STUDY 134XCP|LB|84CD31FD-BCB9-4439-84F7-11C63D578108|2||||OPN|OSTEOPONTIN|||||||BE/ML|||||||POSITIVE||BQ/MG||||ABNORMAL|NOT DONE||||CORD BLOOD|HEMOLYZED|U|NON-CONTACT SPECULAR MICROSCOPY|GMI MMOL/MOL FORMULA||NA|U|Y|NA|||NA|4||88||OPEN LABEL TREATMENT|1970-05-08|1963-05-01|||||1964-05-21||1965-10-27|Y|1973-08-01
TRIAL STUDY 134XCP|LB|84CD31FD-BCB9-4439-84F7-11C63D578108|1||||C1QAB|COMPLEMENT C1Q ANTIBODY|||||||/MM2|||||||INDETERMINATE||BQ/ML||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|AUTOLYZED|N|SMEAR|CKD-EPI CREATININE FORMULA||Y|U|U|U|||NA|5||7||RUN-IN|1960-09-24|1972-12-26|||||1967-11-01||1971-02-24|U|1970-08-24
TRIAL STUDY 134XCP|LB|84CD31FD-BCB9-4439-84F7-11C63D578108|2||||SLTFRNRC|SOLUBLE TRANSFERRIN RECEPTOR|||||||10^3 CFU/G|||||||INDETERMINATE||/40 HPFS||||HIGH|NOT DONE||||URINE SEDIMENT|UNEXPECTED ODOR|Y|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|GMI MMOL/MOL FORMULA||U|NA|NA|U|||U|5||7||OPEN LABEL TREATMENT|1972-06-29|1960-10-10|||||1972-01-20||1969-03-26|Y|1968-09-27
TRIAL STUDY 134XCP|LB|BB9A976D-48AC-4618-9BA1-683D97240F2B|1||||VITDAT|1, 25-DIHYDROXYVITAMIN D|||||||MMOL/MIN/KPA|||||||POSITIVE||10^3 ORGANISMS/G||||NORMAL|NOT DONE||||ADIPOSE TISSUE|CALCIFIED|NA|CLINICAL EVALUATION|MDRD 6 VARIABLE FORMULA||NA|NA|Y|N|||NA|1||38||SCREENING|1973-03-15|1966-05-27|||||1967-05-04||1963-07-17|N|1960-09-21
TRIAL STUDY 134XCP|LB|BB9A976D-48AC-4618-9BA1-683D97240F2B|2||||METANEPH|METANEPHRINE|||||||EID 50/DOSE|||||||BORDERLINE||IU/KG||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|ROOM TEMPERATURE|N|BIOIMPEDANCE SPECTROSCOPY|CKD-EPI CREATININE FORMULA||Y|N|Y|U|||NA|1||38||RUN-IN|1966-06-12|1963-08-22|||||1966-01-10||1967-03-24|Y|1967-04-02
TRIAL STUDY 134XCP|LB|BB9A976D-48AC-4618-9BA1-683D97240F2B|1||||APOB|APOLIPOPROTEIN B|||||||MET*MIN|||||||INDETERMINATE||L/MIN/M2||||LOW|NOT DONE||||PERSPIRATION|LIPEMIC|Y|WESTERGREN|MDRD FORMULA||U|Y|U|Y|||NA|2||58||FOLLOW-UP|1969-09-28|1972-06-30|||||1968-11-24||1972-11-23|U|1965-12-31
TRIAL STUDY 134XCP|LB|BB9A976D-48AC-4618-9BA1-683D97240F2B|2||||T4FRIND|THYROXINE, FREE, INDIRECT|||||||UG/KG/DAY|||||||TRACE||DAGU/ML||||NORMAL|NOT DONE||||BASAL TEAR|AGGLUTINATED|Y|PET/CT SCAN WITHOUT CONTRAST|CKD-EPI CYSTATIN C FORMULA||N|N|N|NA|||U|2||58||SCREENING|1960-12-24|1973-02-28|||||1971-11-06||1971-09-22|U|1970-05-31
TRIAL STUDY 134XCP|LB|BB9A976D-48AC-4618-9BA1-683D97240F2B|1||||PCO2|PARTIAL PRESSURE CARBON DIOXIDE|||||||FG|||||||NEGATIVE||UMOL/KG/MIN||||NORMAL|NOT DONE||||TUMOR TISSUE|CALCIFIED|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CREATININE FORMULA||Y|N|U|Y|||Y|3||39||SCREENING|1966-12-21|1970-09-18|||||1973-08-23||1964-07-01|U|1971-03-08
TRIAL STUDY 134XCP|LB|BB9A976D-48AC-4618-9BA1-683D97240F2B|2||||RENINA|RENIN ACTIVITY|||||||APPLICATION|||||||INDETERMINATE||PMOL/DL||||HIGH|NOT DONE||||AQUEOUS HUMOR|CONCENTRATED|NA|TRANSTHORACIC ECHOCARDIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|N|N|||U|3||39||RUN-IN|1966-10-01|1969-10-10|||||1964-08-23||1972-01-08|NA|1962-08-31
TRIAL STUDY 134XCP|LB|BB9A976D-48AC-4618-9BA1-683D97240F2B|1||||MDMA|3,4-METHYLENEDIOXYMETHAMPHETAMINE|||||||KCAL|||||||INDETERMINATE||U/ANIMAL||||NORMAL|NOT DONE||||SKELETAL MUSCLE TISSUE|AGGLUTINATED|N|LIGHT SCATTERING SPECTROSCOPY|NASH FIBROSURE FORMULA||Y|NA|N|Y|||Y|4||88||TREATMENT|1967-03-11|1969-01-28|||||1964-06-25||1969-07-31|NA|1969-08-11
TRIAL STUDY 134XCP|LB|BB9A976D-48AC-4618-9BA1-683D97240F2B|2||||ISOPRF2|F2-ISOPROSTANE|||||||AMU|||||||POSITIVE||10^12/L||||HIGH|NOT DONE||||AMNIOTIC FLUID|AUTOLYZED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD ENZYMATIC FORMULA||N|NA|N|U|||U|4||88||BLINDED TREATMENT|1966-08-28|1967-01-30|||||1967-08-30||1967-01-29|U|1966-02-19
TRIAL STUDY 134XCP|LB|BB9A976D-48AC-4618-9BA1-683D97240F2B|1||||OXYCAP|OXYGEN CAPACITY|||||||MG/KG/H|||||||INDETERMINATE||IU/G||||ABNORMAL|NOT DONE||||TISSUE|THAWED|Y|LYMPHANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|U|NA|||Y|5||7||WASHOUT|1961-05-26|1961-03-06|||||1962-07-19||1960-10-24|U|1966-11-28
TRIAL STUDY 134XCP|LB|BB9A976D-48AC-4618-9BA1-683D97240F2B|2||||RDWRCV|RET RDW COEFFICIENT OF VARIATION|||||||YEARS|||||||INDETERMINATE||FEU||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|CONTAMINATED|N|NON-INVASIVE DIELECTRIC SENSING|GMI % FORMULA||NA|U|N|U|||U|5||7||RUN-IN|1971-12-12|1973-07-11|||||1964-06-11||1971-03-23|NA|1971-06-02
TRIAL STUDY 134XCP|LB|FA440C9B-0D7A-4656-BF17-D46289567FB0|1||||DSG3AB|DESMOGLEIN 3 ANTIBODY|||||||UCI|||||||NEGATIVE||MG/DOSE||||NORMAL|NOT DONE||||EXUDATE|CLOTTED|Y|DISK DIFFUSION|HEPASCORE FORMULA||U|NA|Y|Y|||NA|1||38||FOLLOW-UP|1962-08-14|1967-02-10|||||1968-06-24||1966-09-26|U|1966-06-19
TRIAL STUDY 134XCP|LB|FA440C9B-0D7A-4656-BF17-D46289567FB0|2||||ANTHRMAG|ANTITHROMBIN ANTIGEN|||||||PSEC|||||||NEGATIVE||BP||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|GELLED|Y|HEMOCYTOMETRY|HEPASCORE FORMULA||N|N|NA|U|||Y|1||38||BASELINE|1970-01-09|1962-12-06|||||1961-03-02||1961-11-26|U|1970-03-23
TRIAL STUDY 134XCP|LB|FA440C9B-0D7A-4656-BF17-D46289567FB0|1||||FACTVIIA|FACTOR VII ACTIVITY|||||||FG|||||||BORDERLINE||V||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|AUTOLYZED|N|MULTI-SLICE SPIRAL CT|FIBROTEST FORMULA||NA|N|N|Y|||Y|2||58||OPEN LABEL TREATMENT|1966-10-03|1968-12-26|||||1968-11-28||1971-04-01|U|1970-08-17
TRIAL STUDY 134XCP|LB|FA440C9B-0D7A-4656-BF17-D46289567FB0|2||||THBD|THROMBOMODULIN|||||||PLUG|||||||TRACE||FT3||||HIGH|NOT DONE||||CALCULUS|AUTOLYZED|N|PET/SPECT SCAN|FIBROTEST FORMULA||N|NA|NA|U|||Y|2||58||OPEN LABEL TREATMENT|1961-07-04|1965-02-23|||||1963-06-07||1971-12-29|U|1972-12-09
TRIAL STUDY 134XCP|LB|FA440C9B-0D7A-4656-BF17-D46289567FB0|1||||B2G1GGAB|BETA-2 GLYCOPROTEIN 1 IGG ANTIBODY|||||||10^6 RNA COPIES/ML|||||||BORDERLINE||UL/ML||||LOW|NOT DONE||||SERUM|HEMOLYZED|Y|KARYOTYPING|FIBROSIS 4 FORMULA||N|NA|NA|N|||N|3||39||OPEN LABEL TREATMENT|1962-11-22|1963-05-19|||||1972-01-12||1972-10-21|U|1963-12-17
TRIAL STUDY 134XCP|LB|FA440C9B-0D7A-4656-BF17-D46289567FB0|2||||INLCLR|INULIN CLEARANCE|||||||ENZYME U|||||||BORDERLINE||NKAT/G HB||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|FROZEN|NA|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|FIBROSIS 4 FORMULA||N|U|NA|NA|||U|3||39||OPEN LABEL TREATMENT|1965-03-08|1972-05-28|||||1963-02-20||1972-08-21|NA|1960-07-20
TRIAL STUDY 134XCP|LB|FA440C9B-0D7A-4656-BF17-D46289567FB0|1||||CREATEXR|CREATININE EXCRETION RATE|||||||ML/ANIMAL/WK|||||||NEGATIVE||HPA||||HIGH|NOT DONE||||ADIPOSE TISSUE|HEMOLYZED|Y|SLIT LAMP|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|NA|N|||N|4||88||BLINDED TREATMENT|1962-08-11|1961-10-24|||||1961-04-07||1963-03-23|NA|1973-04-06
TRIAL STUDY 134XCP|LB|FA440C9B-0D7A-4656-BF17-D46289567FB0|2||||OAS1|2-5-OLIGOADENYLATE SYNTHASE 1|||||||HENRY|||||||BORDERLINE||ENZYME U/L||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED|U|CALCULATION|GMI % FORMULA||U|U|U|U|||Y|4||88||BASELINE|1962-02-06|1967-02-09|||||1970-09-27||1970-02-02|N|1961-03-03
TRIAL STUDY 134XCP|LB|FA440C9B-0D7A-4656-BF17-D46289567FB0|1||||BNPPRONT|N-TERMINAL PROB-TYPE NATRIURETIC PEPTIDE|||||||EIA UNIT|||||||POSITIVE||MG/L FEU||||NORMAL|NOT DONE||||BASAL TEAR|FROZEN|NA|DYNAMIC LIGHT SCATTERING|MDRD ENZYMATIC FORMULA||Y|Y|N|Y|||U|5||7||BASELINE|1961-08-20|1963-06-14|||||1968-09-16||1960-08-10|Y|1972-03-06
TRIAL STUDY 134XCP|LB|FA440C9B-0D7A-4656-BF17-D46289567FB0|2||||DGNWBC|DEGENERATED LEUKOCYTES|||||||CD|||||||TRACE||MG/M2||||ABNORMAL|NOT DONE||||URINE SEDIMENT|HEMOLYZED|Y|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|NASH FIBROSURE FORMULA||U|U|NA|NA|||N|5||7||OBSERVATION|1965-02-21|1964-08-27|||||1963-12-11||1964-01-19|N|1962-12-09
TRIAL STUDY 134XCP|LB|1706BA4E-D2AB-4877-974A-17BDBD834FFF|1||||IGGALB|IMMUNOGLOBULIN G/ALBUMIN|||||||KIU|||||||TRACE||ANTI-XA IU/ML||||LOW|NOT DONE||||INTERSTITIAL FLUID|SOLIDIFIED|Y|MYELOPEROXIDASE STAIN|FIBROMETER FORMULA||N|Y|N|U|||U|1||38||WASHOUT|1973-06-25|1961-06-27|||||1963-09-03||1972-03-15|U|1965-12-12
TRIAL STUDY 134XCP|LB|1706BA4E-D2AB-4877-974A-17BDBD834FFF|2||||INULIN|INULIN|||||||NMOL/L|||||||NEGATIVE||MG/M2/MIN||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD ENZYMATIC FORMULA||N|Y|U|N|||N|1||38||OBSERVATION|1970-06-02|1973-05-16|||||1969-03-25||1973-02-04|N|1964-01-15
TRIAL STUDY 134XCP|LB|1706BA4E-D2AB-4877-974A-17BDBD834FFF|1||||CSEPIRT|RENAL TUBULAR EPITHELIAL CASTS|||||||UOSM|||||||NEGATIVE||MM3/MM2/YEAR||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|FROZEN|N|MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CREATININE FORMULA||Y|N|N|N|||NA|2||58||BLINDED TREATMENT|1973-07-08|1960-11-26|||||1965-09-16||1961-10-22|N|1960-03-02
TRIAL STUDY 134XCP|LB|1706BA4E-D2AB-4877-974A-17BDBD834FFF|2||||CARNITF|CARNITINE, FREE|||||||G/MOL|||||||INVALID||10^4 CFU/ML||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|FRESH|Y|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|NASH FIBROSURE FORMULA||Y|Y|Y|U|||NA|2||58||INDUCTION TREATMENT|1970-08-05|1971-05-18|||||1967-02-14||1966-04-16|Y|1964-06-20
TRIAL STUDY 134XCP|LB|1706BA4E-D2AB-4877-974A-17BDBD834FFF|1||||ANIONG3|ANION GAP 3|||||||CM|||||||POSITIVE||MMOL/MIN/KPA/L||||HIGH|NOT DONE||||PERITONEAL FLUID|GELLED|N|MICROBIAL CULTURE|CKD-EPI CYSTATIN C FORMULA||N|Y|N|N|||NA|3||39||WASHOUT|1961-07-07|1966-06-17|||||1964-11-19||1961-05-19|NA|1962-01-26
TRIAL STUDY 134XCP|LB|1706BA4E-D2AB-4877-974A-17BDBD834FFF|2||||MYCYCE|MYELOCYTES/TOTAL CELLS|||||||UU/DL|||||||POSITIVE||DPM/0.5 ML||||NORMAL|NOT DONE||||PLATELET|FROZEN|U|FISH|CKD-EPI CREATININE FORMULA||Y|NA|Y|Y|||U|3||39||SCREENING|1973-05-06|1963-08-09|||||1960-09-12||1969-10-27|N|1972-10-19
TRIAL STUDY 134XCP|LB|1706BA4E-D2AB-4877-974A-17BDBD834FFF|1||||CD5|CD5|||||||U/G/MIN|||||||BORDERLINE||10^6/HPF||||HIGH|NOT DONE||||PERITONEAL FLUID|CONCENTRATED|U|MULTIPLEXED BEAD BASED IMMUNOASSAY|GMI MMOL/MOL FORMULA||NA|U|Y|N|||Y|4||88||RUN-IN|1969-12-09|1969-07-24|||||1963-04-30||1960-12-02|NA|1961-11-13
TRIAL STUDY 134XCP|LB|1706BA4E-D2AB-4877-974A-17BDBD834FFF|2||||TNF5S|SOLUBLE TNF SUPERFAMILY MEMBER 5|||||||MV/SEC|||||||BORDERLINE||IMPLANT||||HIGH|NOT DONE||||DIALYSIS FLUID|CLOTTED|Y|ELECTROPHORESIS|FIBROMETER FORMULA||U|U|Y|N|||Y|4||88||OPEN LABEL TREATMENT|1963-11-13|1961-06-15|||||1968-01-19||1961-02-03|U|1971-06-21
TRIAL STUDY 134XCP|LB|1706BA4E-D2AB-4877-974A-17BDBD834FFF|1||||CCL16|CHEMOKINE (C-C MOTIF) LIGAND 16|||||||MOL/ML|||||||INDETERMINATE||PPB||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|HEMOLYZED|N|SINGLE-SLICE SPIRAL CT|FIBROSIS 4 FORMULA||Y|NA|U|U|||N|5||7||TREATMENT|1965-09-26|1971-08-16|||||1970-06-22||1964-04-22|NA|1971-06-24
TRIAL STUDY 134XCP|LB|1706BA4E-D2AB-4877-974A-17BDBD834FFF|2||||NMH|N-METHYLHISTAMINE|||||||MMOL/MIN/KPA|||||||POSITIVE||U/G HB||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|SOLIDIFIED|N|THERMAL IONIZATION MASS SPECTROMETRY|GMI % FORMULA||NA|N|N|N|||N|5||7||OPEN LABEL TREATMENT|1970-07-24|1960-12-06|||||1973-07-10||1966-01-21|Y|1961-10-06
TRIAL STUDY 134XCP|LB|15E3DD06-7F28-499B-9CF5-6EE5875095B5|1||||ANCIGAB|ANTI-NEUTROPHIL CYTOPLASMIC IGG ANTIBODY|||||||IU/MG|||||||BORDERLINE||PMOL/L/H||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|SOLIDIFIED|NA|SMEAR|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|N|U|||Y|1||38||LONG-TERM FOLLOW-UP|1963-08-27|1972-07-03|||||1964-05-04||1969-05-22|N|1964-12-17
TRIAL STUDY 134XCP|LB|15E3DD06-7F28-499B-9CF5-6EE5875095B5|2||||CH50|COMPLEMENT CH50|||||||% INHIBITION|||||||INVALID||G/KG/DAY||||HIGH|NOT DONE||||EMOTIONAL TEAR|LIPEMIC|U|FORCED OSCILLATION TECHNIQUE|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|U|N|||N|1||38||OPEN LABEL TREATMENT|1965-06-29|1964-04-24|||||1962-02-22||1964-10-06|N|1970-11-25
TRIAL STUDY 134XCP|LB|15E3DD06-7F28-499B-9CF5-6EE5875095B5|1||||GLCHT|GLYCOLITHOCHOLATE|||||||DAGU|||||||POSITIVE||CFU/G||||ABNORMAL|NOT DONE||||EXUDATE|CONTAMINATED|U|NON-INVASIVE DIELECTRIC SENSING|GMI MMOL/MOL FORMULA||U|U|Y|NA|||NA|2||58||LONG-TERM FOLLOW-UP|1972-05-20|1969-01-07|||||1967-05-09||1970-11-04|N|1965-12-01
TRIAL STUDY 134XCP|LB|15E3DD06-7F28-499B-9CF5-6EE5875095B5|2||||NITRITE|NITRITE|||||||KBQ/UL|||||||POSITIVE||CMH2O/ML||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|NON-HEMOLYZED|N|DUKE INCISION METHOD|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|N|U|||U|2||58||TREATMENT|1970-03-12|1964-06-05|||||1962-06-27||1960-12-16|Y|1966-12-24
TRIAL STUDY 134XCP|LB|15E3DD06-7F28-499B-9CF5-6EE5875095B5|1||||URATE|URATE|||||||MBQ/UL|||||||POSITIVE||G/CAGE||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|DRIED|Y|CORONARY ANGIOGRAPHY|FIBROSIS 4 FORMULA||Y|Y|Y|U|||NA|3||39||OBSERVATION|1960-10-21|1972-08-04|||||1971-02-08||1961-03-24|NA|1965-06-10
TRIAL STUDY 134XCP|LB|15E3DD06-7F28-499B-9CF5-6EE5875095B5|2||||PLATLRG|LARGE PLATELETS|||||||UEQ|||||||INVALID||10^6 RNA COPIES/ML||||HIGH|NOT DONE||||WHITE MATTER TISSUE|GELLED|N|NEPHELOMETRY|GMI MMOL/MOL FORMULA||NA|NA|NA|Y|||N|3||39||BASELINE|1972-02-29|1960-10-12|||||1960-03-26||1969-06-18|NA|1966-09-07
TRIAL STUDY 134XCP|LB|15E3DD06-7F28-499B-9CF5-6EE5875095B5|1||||GLUC|GLUCOSE|||||||MBQ|||||||NEGATIVE||UKAT||||NORMAL|NOT DONE||||CAPILLARY BLOOD|NON-HEMOLYZED|U|IN VITRO GENE EXPRESSION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|N|NA|||Y|4||88||TREATMENT|1964-01-23|1967-12-22|||||1963-12-24||1972-10-05|U|1964-10-17
TRIAL STUDY 134XCP|LB|15E3DD06-7F28-499B-9CF5-6EE5875095B5|2||||PTSFAC|PROTEIN S, FREE ACTUAL/CONTROL|||||||CGY|||||||INVALID||CS||||ABNORMAL|NOT DONE||||SKIN TISSUE|CALCIFIED|NA|NEXT GENERATION SEQUENCING|MDRD 5 VARIABLE FORMULA||NA|U|U|Y|||Y|4||88||TREATMENT|1971-08-13|1960-01-12|||||1968-03-29||1971-11-04|U|1969-07-08
TRIAL STUDY 134XCP|LB|15E3DD06-7F28-499B-9CF5-6EE5875095B5|1||||UDCACM|URSODEOXYCHOLATE COMPOUNDS|||||||NSEC|||||||TRACE||/HPF||||LOW|NOT DONE||||SEBUM|THAWED|Y|IHC|HEPASCORE FORMULA||NA|N|Y|U|||U|5||7||RUN-IN|1963-03-25|1965-12-13|||||1965-09-11||1966-01-15|NA|1972-11-09
TRIAL STUDY 134XCP|LB|15E3DD06-7F28-499B-9CF5-6EE5875095B5|2||||EOTAXIN1|EOTAXIN-1|||||||10^6/HPF|||||||NEGATIVE||G/L||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|AUTOLYZED|N|ENDPOINT DILUTION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|N|N|||NA|5||7||BASELINE|1972-11-03|1969-07-28|||||1962-12-27||1964-03-02|U|1962-10-17
TRIAL STUDY 134XCP|LB|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|1||||C165926|MOLD MIX IGE AB RAST SCORE|||||||AMP|||||||NEGATIVE||CD*S/M2||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|LIPEMIC|N|DXA SCAN|FIBROMETER FORMULA||U|N|N|NA|||Y|1||38||RUN-IN|1971-09-29|1962-01-24|||||1961-05-27||1962-05-14|NA|1962-03-04
TRIAL STUDY 134XCP|LB|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|2||||LYM|LYMPHOCYTES|||||||MBQ/UL|||||||NEGATIVE||UCI/L||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|HEPASCORE FORMULA||Y|NA|NA|N|||N|1||38||CONTINUATION TREATMENT|1966-11-23|1967-04-01|||||1966-09-20||1963-05-21|U|1965-07-24
TRIAL STUDY 134XCP|LB|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|1||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||UL|||||||INDETERMINATE||MMHG/L/MIN||||LOW|NOT DONE||||ABSCESS FLUID|SOLIDIFIED|NA|POPULATION SEQUENCING|MDRD FORMULA||N|N|U|U|||NA|2||58||INDUCTION TREATMENT|1967-03-22|1964-07-24|||||1973-01-31||1962-04-02|U|1973-05-02
TRIAL STUDY 134XCP|LB|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|2||||CYFRA211|CYTOKERATIN 19 FRAGMENT 21-1|||||||CAPFUL|||||||POSITIVE||BQ/L||||NORMAL|NOT DONE||||COLOSTRUM|PARAFFIN-EMBEDDED|U|DYNAMIC LIGHT SCATTERING|ASH FIBROSURE FORMULA||U|NA|Y|Y|||N|2||58||SCREENING|1971-03-02|1973-04-12|||||1960-10-17||1965-04-14|NA|1964-08-04
TRIAL STUDY 134XCP|LB|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|1||||OXYCDN|OXYCODONE|||||||MG/KG|||||||INVALID||TAMPON||||ABNORMAL|NOT DONE||||BREAST MILK|DRIED|N|CORONARY ANGIOGRAPHY|COCKCROFT-GAULT FORMULA||U|NA|N|Y|||NA|3||39||CONTINUATION TREATMENT|1964-07-16|1960-10-15|||||1968-09-26||1972-04-19|U|1969-08-20
TRIAL STUDY 134XCP|LB|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|2||||SODMEXR|SODIUM EXCRETION RATE|||||||UIU/DL|||||||INDETERMINATE||UM/DAY||||HIGH|NOT DONE||||PERSPIRATION|REFRIGERATED|NA|CHROMOGENIC ASSAY|MDRD 4 VARIABLE FORMULA||NA|Y|U|Y|||U|3||39||OPEN LABEL TREATMENT|1964-07-28|1971-08-10|||||1965-12-06||1970-12-01|U|1969-08-29
TRIAL STUDY 134XCP|LB|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|1||||MPXI|MYELOPEROXIDASE INDEX|||||||/500 WBC|||||||BORDERLINE||UGEQ/L||||HIGH|NOT DONE||||CORD BLOOD|UNEXPECTED ODOR|Y|MALDI|FIBROTEST FORMULA||NA|NA|U|N|||Y|4||88||CONTINUATION TREATMENT|1965-08-21|1969-03-13|||||1961-05-08||1968-08-19|NA|1966-11-12
TRIAL STUDY 134XCP|LB|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|2||||GLOBB2|BETA-2 GLOBULIN|||||||MU/L|||||||NEGATIVE||MEQ/MMOL||||HIGH|NOT DONE||||ERYTHROCYTES|LACTESCENT|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|CKD-EPI FORMULA||Y|U|NA|N|||NA|4||88||RUN-IN|1968-10-29|1960-10-08|||||1969-05-21||1969-03-01|NA|1964-08-06
TRIAL STUDY 134XCP|LB|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|1||||PMYCECE|PROLIFERATING MYELOID CELLS/TOTAL CELLS|||||||CYLINDER|||||||INDETERMINATE||PACKET||||ABNORMAL|NOT DONE||||TISSUE|CONTAMINATED|NA|CINEANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||U|Y|Y|N|||NA|5||7||OBSERVATION|1971-03-19|1969-06-06|||||1962-04-11||1966-09-17|NA|1961-10-19
TRIAL STUDY 134XCP|LB|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|2||||CD2|CD2|||||||L/H/M2|||||||NEGATIVE||10^9/L||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|FROZEN|Y|DIRECT SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|N|N|||U|5||7||TREATMENT|1963-12-24|1966-12-17|||||1963-07-16||1960-02-05|N|1966-05-13
TRIAL STUDY 134XCP|LB|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|1||||MMP9|MATRIX METALLOPROTEINASE 9|||||||UG/H|||||||POSITIVE||G/M2||||HIGH|NOT DONE||||SPUTUM|CONTAMINATED|U|IMPEDANCE CONDUCTIVITY|GMI MMOL/MOL FORMULA||U|U|NA|U|||U|1||38||BLINDED TREATMENT|1972-10-09|1964-10-03|||||1964-10-01||1962-07-01|U|1963-10-10
TRIAL STUDY 134XCP|LB|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|2||||ODMTASE|O-DEMETHYLASE|||||||U/ML|||||||POSITIVE||G/ANIMAL||||NORMAL|NOT DONE||||BREAST MILK|GELLED|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|NASH FIBROSURE FORMULA||U|U|Y|NA|||U|1||38||CONTINUATION TREATMENT|1965-08-20|1966-06-16|||||1965-09-09||1960-07-14|NA|1972-07-15
TRIAL STUDY 134XCP|LB|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|1||||BASOIM|IMMATURE BASOPHILS|||||||MG/CM2|||||||INDETERMINATE||EP U||||LOW|NOT DONE||||PROSTATIC FLUID|ROOM TEMPERATURE|Y|RADIATION DOSIMETRY|NASH FIBROSURE FORMULA||NA|U|N|N|||U|2||58||SCREENING|1963-03-06|1961-04-07|||||1965-02-01||1960-12-20|N|1973-01-28
TRIAL STUDY 134XCP|LB|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|2||||RETIL|LOW ABSORPTION RETICULOCYTES|||||||MET|||||||BORDERLINE||WEEKS||||HIGH|NOT DONE||||ARTERIAL BLOOD|CONTAMINATED|NA|HPLC-FL|FIBROMETER FORMULA||U|N|N|Y|||Y|2||58||FOLLOW-UP|1961-01-29|1972-09-05|||||1966-12-13||1970-08-23|N|1966-05-27
TRIAL STUDY 134XCP|LB|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|1||||HTTP|HUNTINGTIN PROTEIN|||||||MMAL|||||||BORDERLINE||POINT||||ABNORMAL|NOT DONE||||PERSPIRATION|ICTERIC|Y|CONTRAST ENHANCED PET/CT SCAN|NASH FIBROSURE FORMULA||NA|N|Y|N|||Y|3||39||FOLLOW-UP|1961-10-30|1971-12-13|||||1970-11-17||1964-11-28|U|1970-12-09
TRIAL STUDY 134XCP|LB|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|2||||VITD2|VITAMIN D2|||||||MIN|||||||TRACE||H*%||||HIGH|NOT DONE||||DIALYSIS FLUID, PERITONEAL|UNEXPECTED ODOR|NA|ROMANOWSKY STAIN|CKD-EPI CREATININE FORMULA||U|Y|Y|Y|||N|3||39||RUN-IN|1962-08-02|1966-07-20|||||1967-06-14||1964-02-27|U|1972-09-25
TRIAL STUDY 134XCP|LB|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|1||||MBP|MYELIN BASIC PROTEIN|||||||TRANSDUCING UNIT|||||||NEGATIVE||10^6 CFU/G||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|CONCENTRATED|Y|AGAR PROPORTION|GMI % FORMULA||N|N|U|N|||U|4||88||BLINDED TREATMENT|1966-09-22|1962-01-08|||||1963-11-28||1972-10-19|U|1963-01-25
TRIAL STUDY 134XCP|LB|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|2||||STAT3P|PHOSPHORYLATED STAT3|||||||TORR|||||||POSITIVE||DPM/MG||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|HEMOLYZED|NA|INFRARED SPECTROMETRY|FIBROSIS 4 FORMULA||NA|U|N|NA|||Y|4||88||FOLLOW-UP|1970-02-04|1965-12-02|||||1965-04-16||1964-11-13|U|1963-02-26
TRIAL STUDY 134XCP|LB|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|1||||APOA1|APOLIPOPROTEIN A1|||||||IU|||||||POSITIVE||ML/M2/DAY||||LOW|NOT DONE||||PUS|LIPEMIC|N|COULOMETRIC TITRATION|MDRD ENZYMATIC JAPANESE FORMULA||U|U|Y|Y|||U|5||7||SCREENING|1963-12-02|1966-06-18|||||1963-02-07||1964-06-24|U|1973-05-30
TRIAL STUDY 134XCP|LB|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|2||||WDR26|WD REPEAT-CONTAINING PROTEIN 26|||||||MAC50|||||||TRACE||GRAVITATIONAL UNIT||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|DRIED|N|COLORIMETRY|MDRD 4 VARIABLE FORMULA||U|U|Y|N|||U|5||7||WASHOUT|1961-09-14|1970-08-07|||||1966-02-20||1972-06-09|N|1961-09-22
TRIAL STUDY 134XCP|LB|87ED1C08-AF47-4827-A897-E8FC24A69ECC|1||||PKM2|PYRUVATE KINASE ISOZYME M2|||||||/10^3|||||||NEGATIVE||KCAL/DAY||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|LIPEMIC|U|MICROSCOPY|MDRD 4 VARIABLE FORMULA||N|U|N|NA|||U|1||38||RUN-IN|1969-03-22|1969-11-13|||||1963-03-19||1972-05-10|Y|1965-06-02
TRIAL STUDY 134XCP|LB|87ED1C08-AF47-4827-A897-E8FC24A69ECC|2||||MIDCEF|MID CELL FRACTION|||||||U/10^12 RBC|||||||NEGATIVE||MM/SEC||||HIGH|NOT DONE||||RETICULOCYTES|LACTESCENT|Y|FARR ASSAY|FIBROTEST FORMULA||N|U|NA|NA|||N|1||38||INDUCTION TREATMENT|1971-11-15|1968-12-07|||||1967-09-08||1971-04-10|U|1960-01-21
TRIAL STUDY 134XCP|LB|87ED1C08-AF47-4827-A897-E8FC24A69ECC|1||||FXAAC|FACTOR X ACTIVITY ACTUAL/CONTROL|||||||SBE/ML|||||||INDETERMINATE||MOL/DAY||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|GELLED|U|MAPH|GMI % FORMULA||NA|U|Y|Y|||NA|2||58||INDUCTION TREATMENT|1968-01-11|1965-09-29|||||1965-05-11||1962-05-08|Y|1973-01-19
TRIAL STUDY 134XCP|LB|87ED1C08-AF47-4827-A897-E8FC24A69ECC|2||||TCHT|TAUROCHOLATE|||||||L/MIN|||||||TRACE||BU||||LOW|NOT DONE||||CIRCULATING TUMOR CELL|ROOM TEMPERATURE|Y|CORONARY ANGIOGRAPHY|NASH FIBROSURE FORMULA||U|U|Y|NA|||N|2||58||WASHOUT|1963-12-08|1964-06-07|||||1971-04-20||1971-09-11|N|1973-09-08
TRIAL STUDY 134XCP|LB|87ED1C08-AF47-4827-A897-E8FC24A69ECC|1||||PLATEST|PLATELETS, ESTIMATED|||||||NG/L|||||||NEGATIVE||UG/DOSE||||ABNORMAL|NOT DONE||||BLOOD|DRIED|N|INTERRUPTER TECHNIQUE|GMI MMOL/MOL FORMULA||N|Y|U|NA|||Y|3||39||CONTINUATION TREATMENT|1966-06-04|1968-08-26|||||1967-02-03||1971-04-18|N|1971-03-04
TRIAL STUDY 134XCP|LB|87ED1C08-AF47-4827-A897-E8FC24A69ECC|2||||IL2SR|SOLUBLE INTERLEUKIN 2 RECEPTOR|||||||CI/UL|||||||NEGATIVE||UMOL||||NORMAL|NOT DONE||||SPUTUM|FROZEN|Y|PYROSEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|NA|||U|3||39||RUN-IN|1961-10-10|1960-02-28|||||1961-05-07||1971-09-07|Y|1961-10-25
TRIAL STUDY 134XCP|LB|87ED1C08-AF47-4827-A897-E8FC24A69ECC|1||||ADP|ADENOSINE DIPHOSPHATE|||||||DPM/0.5 ML|||||||INVALID||VG/KG||||LOW|NOT DONE||||SWABBED MATERIAL|HEMOLYZED|N|FUNDUS PHOTOGRAPHY|GMI % FORMULA||N|U|NA|N|||Y|4||88||OPEN LABEL TREATMENT|1960-01-11|1971-12-29|||||1961-10-26||1968-10-05|Y|1970-04-21
TRIAL STUDY 134XCP|LB|87ED1C08-AF47-4827-A897-E8FC24A69ECC|2||||LEUKCE|LEUKEMIC CELLS|||||||U.CARR|||||||INDETERMINATE||NG/DL||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|FRESH|U|MICROBIAL CULTURE|MDRD 4 VARIABLE FORMULA||N|NA|Y|U|||N|4||88||FOLLOW-UP|1965-01-09|1972-02-22|||||1970-11-21||1972-05-20|N|1972-12-21
TRIAL STUDY 134XCP|LB|87ED1C08-AF47-4827-A897-E8FC24A69ECC|1||||GFRBSCCC|GFR FROM CYSTATIN C AND CREAT ADJ BSA|||||||MEQ/ML|||||||INDETERMINATE||10^3/HPF||||ABNORMAL|NOT DONE||||URINE|CALCIFIED|NA|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|GMI % FORMULA||Y|NA|NA|N|||U|5||7||OPEN LABEL TREATMENT|1966-07-29|1969-05-11|||||1965-11-07||1967-03-08|Y|1962-07-04
TRIAL STUDY 134XCP|LB|87ED1C08-AF47-4827-A897-E8FC24A69ECC|2||||RFIGAAB|RHEUMATOID FACTOR IGA ANTIBODY|||||||LOG10 CFU/ML|||||||TRACE||10^12/L||||HIGH|NOT DONE||||SPERMATOZOON|NON-HEMOLYZED|NA|IMMUNOFIXATION ELECTROPHORESIS|ASH FIBROSURE FORMULA||Y|N|Y|Y|||N|5||7||OBSERVATION|1970-12-25|1970-10-25|||||1962-03-13||1961-08-04|U|1966-05-05
TRIAL STUDY 134XCP|LB|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|1||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||U/MG|||||||TRACE||CS||||NORMAL|NOT DONE||||SMEGMA|NON-HEMOLYZED|U|IRON HEMATOXYLIN STAIN|GMI % FORMULA||N|Y|NA|Y|||Y|1||38||LONG-TERM FOLLOW-UP|1966-06-12|1969-01-23|||||1964-06-12||1965-07-19|N|1964-10-18
TRIAL STUDY 134XCP|LB|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|2||||LSELS|SOLUBLE L-SELECTIN|||||||ML*CMH2O|||||||NEGATIVE||MEQ/KG||||ABNORMAL|NOT DONE||||SERUM|DRIED|N|MACRO BROTH DILUTION|FIBROTEST FORMULA||U|Y|NA|NA|||N|1||38||CONTINUATION TREATMENT|1969-06-25|1964-07-10|||||1961-08-06||1961-07-31|Y|1964-09-22
TRIAL STUDY 134XCP|LB|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|1||||C130119|DAIRY MIX ANTIGEN IGG ANTIBODY|||||||PMOL/10^10 CELLS|||||||POSITIVE||MBQ/UL||||NORMAL|NOT DONE||||EXPIRED AIR|FRESH|NA|LIGHT MICROSCOPY|GMI MMOL/MOL FORMULA||U|N|U|NA|||N|2||58||TREATMENT|1964-03-10|1970-07-25|||||1965-09-18||1963-02-01|NA|1970-06-19
TRIAL STUDY 134XCP|LB|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|2||||FACTXIV|FACTOR XIV|||||||CAN|||||||TRACE||NG/L||||ABNORMAL|NOT DONE||||LAVAGE FLUID|HEMOLYZED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||N|NA|U|N|||Y|2||58||INDUCTION TREATMENT|1962-07-14|1965-10-10|||||1973-07-12||1973-07-19|U|1967-02-10
TRIAL STUDY 134XCP|LB|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|1||||EDMIGAAB|ENDOMYSIAL IGA ANTIBODY|||||||KPA/L/SEC|||||||NEGATIVE||MEQ/KG||||NORMAL|NOT DONE||||BASAL TEAR|ICTERIC|U|WHOLE EXOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|U|Y|||N|3||39||CONTINUATION TREATMENT|1972-02-02|1960-08-07|||||1968-09-19||1970-02-03|N|1965-05-14
TRIAL STUDY 134XCP|LB|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|2||||HEINZRBC|HEINZ BODIES/ERYTHROCYTES|||||||MEQ/UG|||||||BORDERLINE||TABLET||||LOW|NOT DONE||||GASTRIC CONTENTS|AGGLUTINATED|Y|MRI|HEPASCORE FORMULA||Y|NA|Y|N|||U|3||39||INDUCTION TREATMENT|1970-09-21|1964-11-23|||||1973-01-28||1964-09-05|Y|1962-11-17
TRIAL STUDY 134XCP|LB|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|1||||INTLK10|INTERLEUKIN 10|||||||LOG10 TCID 50/UL|||||||TRACE||EID 50/ML||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|HEMOLYZED|U|X-RAY|CKD-EPI CYSTATIN C FORMULA||N|N|NA|N|||NA|4||88||WASHOUT|1963-02-06|1969-07-14|||||1971-01-14||1973-07-24|Y|1967-10-29
TRIAL STUDY 134XCP|LB|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|2||||HEINZ|HEINZ BODIES|||||||DEG2|||||||NEGATIVE||CCID 50/DOSE||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|THAWED|Y|RADIATION DOSIMETRY|COCKCROFT-GAULT FORMULA||Y|N|NA|NA|||U|4||88||BASELINE|1968-03-13|1967-09-09|||||1970-06-01||1964-04-04|NA|1963-06-15
TRIAL STUDY 134XCP|LB|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|1||||CARTP|COCAINE AMPHETAMINE-REG TRANSCRIPT PROT|||||||UG/L DDU|||||||POSITIVE||MKAT||||HIGH|NOT DONE||||PLEURAL TISSUE|LACTESCENT|Y|QUANTITATIVE CORONARY ANGIOGRAPHY|MDRD FORMULA||U|U|N|N|||NA|5||7||FOLLOW-UP|1964-05-05|1966-11-27|||||1960-03-06||1968-03-27|N|1972-02-19
TRIAL STUDY 134XCP|LB|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|2||||PTHNT|PARATHYROID HORMONE, N-TERMINAL|||||||NM|||||||NEGATIVE||PLUG||||HIGH|NOT DONE||||LUNG SURFACTANT|PARAFFIN-EMBEDDED|N|MS/MS|GMI MMOL/MOL FORMULA||N|N|Y|N|||U|5||7||OBSERVATION|1962-02-25|1964-07-30|||||1971-07-27||1960-07-26|Y|1971-03-07
TRIAL STUDY 134XCP|LB|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|1||||HETRPH|HETEROPHILS|||||||UG/CM2|||||||INDETERMINATE||STRIP||||LOW|NOT DONE||||BILE|CONTAMINATED|Y|ALCIAN BLUE STAIN|CKD-EPI CYSTATIN C FORMULA||N|U|Y|Y|||U|1||38||LONG-TERM FOLLOW-UP|1973-01-13|1961-09-04|||||1972-11-09||1965-05-19|Y|1970-12-28
TRIAL STUDY 134XCP|LB|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|2||||CYAMMOX|AMMONIUM OXALATE CRYSTALS|||||||MMOL/DAY|||||||TRACE||PLUG||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|CALCIFIED|Y|OPTICAL DENSITY MEASUREMENT|CKD-EPI CYSTATIN C FORMULA||Y|NA|NA|Y|||Y|1||38||CONTINUATION TREATMENT|1964-11-13|1965-06-27|||||1969-09-10||1966-06-12|N|1967-01-16
TRIAL STUDY 134XCP|LB|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|1||||RANKL|RECEPTOR ACTIVATOR NUCLEAR KAPPAB LIGAND|||||||UG/M2|||||||BORDERLINE||S*KPA||||ABNORMAL|NOT DONE||||NAIL|LACTESCENT|N|TONOMETRY|COCKCROFT-GAULT FORMULA||U|U|Y|N|||Y|2||58||TREATMENT|1963-01-07|1971-12-14|||||1967-02-22||1966-12-19|Y|1962-07-05
TRIAL STUDY 134XCP|LB|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|2||||HBGCHTHB|HEMOGLOBIN G COUSHATTA/TOTAL HEMOGLOBIN|||||||IU/DAY|||||||TRACE||U/G||||ABNORMAL|NOT DONE||||TRANSUDATE|THAWED|U|DARK FIELD MICROSCOPY|CKD-EPI CREATININE FORMULA||NA|U|Y|U|||N|2||58||CONTINUATION TREATMENT|1968-03-10|1967-05-16|||||1968-09-30||1964-08-17|U|1973-01-18
TRIAL STUDY 134XCP|LB|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|1||||VIP|VASOACTIVE INTESTINAL POLYPEPTIDE|||||||MG/DL|||||||NEGATIVE||NMOL BCE/NMOL||||ABNORMAL|NOT DONE||||LEUKOCYTE|REFRIGERATED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|U|U|||NA|3||39||LONG-TERM FOLLOW-UP|1971-01-05|1971-01-18|||||1967-08-14||1971-12-03|Y|1973-01-12
TRIAL STUDY 134XCP|LB|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|2||||ABNCELE|ABNORMAL CELLS/LEUKOCYTES|||||||KG/CM|||||||INVALID||NMOL BCE/L||||HIGH|NOT DONE||||SYNOVIAL FLUID|SOLIDIFIED|NA|DYNAMIC CONTRAST ENHANCED MRI|MDRD 4 VARIABLE FORMULA||NA|U|NA|NA|||U|3||39||BASELINE|1960-01-27|1968-11-10|||||1965-03-06||1964-09-12|NA|1960-10-02
TRIAL STUDY 134XCP|LB|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|1||||G6PD|GLUCOSE-6-PHOSPHATE DEHYDROGENASE|||||||/5X10^4 WBC|||||||INDETERMINATE||MOSM||||HIGH|NOT DONE||||INFRANATANT, SERUM|REFRIGERATED|N|RYAN BLUE STAIN|CKD-EPI CYSTATIN C FORMULA||U|NA|Y|NA|||U|4||88||TREATMENT|1964-05-06|1961-10-14|||||1969-12-28||1968-12-10|N|1964-02-06
TRIAL STUDY 134XCP|LB|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|2||||INSAB|INSULIN ANTIBODY|||||||U/KG/MIN|||||||POSITIVE||ECL UNIT||||ABNORMAL|NOT DONE||||CALCULUS|AGGLUTINATED|N|ENDPOINT DILUTION ASSAY|FIBROSIS 4 FORMULA||N|Y|U|N|||N|4||88||OBSERVATION|1973-02-26|1967-12-05|||||1966-12-10||1961-04-02|N|1968-06-19
TRIAL STUDY 134XCP|LB|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|1||||APOE|APOLIPOPROTEIN E|||||||M|||||||INDETERMINATE||L/DAY||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|ROOM TEMPERATURE|Y|PHYSICAL EXAMINATION|MDRD 6 VARIABLE FORMULA||Y|U|N|N|||NA|5||7||LONG-TERM FOLLOW-UP|1972-01-04|1969-04-30|||||1962-09-19||1964-02-25|U|1965-08-29
TRIAL STUDY 134XCP|LB|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|2||||SECRETIN|SECRETIN|||||||GENEQ/ML|||||||NEGATIVE||MG/MOL||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|HEMOLYZED|Y|HILLMEN COLOR CHART|MDRD 4 VARIABLE FORMULA||NA|Y|N|Y|||Y|5||7||INDUCTION TREATMENT|1969-09-20|1967-08-13|||||1965-08-23||1963-11-08|Y|1973-07-16
TRIAL STUDY 134XCP|LB|C817A043-1331-47AB-A627-D85893F9D61A|1||||CLEXR|CHLORIDE EXCRETION RATE|||||||FL|||||||BORDERLINE||PMOL/L||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|NON-HEMOLYZED|NA|MECHANICAL CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|N|Y|||U|1||38||FOLLOW-UP|1960-11-08|1963-04-23|||||1961-11-27||1963-09-02|Y|1964-04-09
TRIAL STUDY 134XCP|LB|C817A043-1331-47AB-A627-D85893F9D61A|2||||CSWAX|WAXY CASTS|||||||UG/M2/DAY|||||||INDETERMINATE||DPM||||LOW|NOT DONE||||ABSCESS FLUID|CALCIFIED|Y|PEAK FLOWMETRY|HEPASCORE FORMULA||Y|N|Y|U|||NA|1||38||BLINDED TREATMENT|1965-06-04|1961-08-03|||||1960-07-19||1966-04-11|NA|1965-03-16
TRIAL STUDY 134XCP|LB|C817A043-1331-47AB-A627-D85893F9D61A|1||||EPICCE|EPITHELIAL CELLS/TOTAL CELLS|||||||ML/BREATH|||||||NEGATIVE||KV||||ABNORMAL|NOT DONE||||SEMINAL FLUID|FROZEN|Y|THIN SMEAR|CKD-EPI FORMULA||NA|Y|Y|N|||U|2||58||SCREENING|1967-03-26|1962-10-24|||||1973-07-14||1970-04-08|N|1972-03-15
TRIAL STUDY 134XCP|LB|C817A043-1331-47AB-A627-D85893F9D61A|2||||HOMOCIT|HOMOCITRULLINE|||||||KHZ|||||||INVALID||YEARS||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CONTAMINATED|U|AURAMINE STAIN|MDRD FORMULA||N|Y|NA|N|||Y|2||58||INDUCTION TREATMENT|1969-06-12|1965-01-20|||||1961-08-23||1963-08-28|N|1970-09-02
TRIAL STUDY 134XCP|LB|C817A043-1331-47AB-A627-D85893F9D61A|1||||EOTAXIN2|EOTAXIN-2|||||||UEQ|||||||INVALID||/MM||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONCENTRATED|N|IMMUNOFLUORESCENT STAIN|FIBROSIS 4 FORMULA||U|N|Y|NA|||Y|3||39||SCREENING|1964-05-25|1968-08-11|||||1967-08-22||1972-09-13|N|1968-09-21
TRIAL STUDY 134XCP|LB|C817A043-1331-47AB-A627-D85893F9D61A|2||||C130095|WESTERN RAGWEED POLLEN IGG4|||||||PPB|||||||BORDERLINE||BQ/L||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|CALCIFIED|NA|MICROPARTICLE ENZYME IMMUNOASSAY|FIBROSIS 4 FORMULA||U|NA|U|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1971-03-25|1968-05-19|||||1966-06-15||1961-08-31|NA|1960-10-21
TRIAL STUDY 134XCP|LB|C817A043-1331-47AB-A627-D85893F9D61A|1||||MOCYCELE|MONOCYTOID CELLS/LEUKOCYTES|||||||PA|||||||POSITIVE||NG||||NORMAL|NOT DONE||||SERUM|GELLED|Y|NUCLEIC ACID BASED METHOD|FIBROTEST FORMULA||NA|N|NA|N|||U|4||88||INDUCTION TREATMENT|1967-06-10|1966-11-24|||||1962-11-04||1963-01-30|NA|1972-08-08
TRIAL STUDY 134XCP|LB|C817A043-1331-47AB-A627-D85893F9D61A|2||||C130084|ENGLISH PLANTAIN POLLEN IGE|||||||/500 WBC|||||||TRACE||/2500 WBC||||HIGH|NOT DONE||||CORD SERUM|UNEXPECTED ODOR|N|RADIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|N|U|Y|||NA|4||88||OPEN LABEL TREATMENT|1962-05-11|1966-11-21|||||1968-07-05||1971-10-10|NA|1971-02-20
TRIAL STUDY 134XCP|LB|C817A043-1331-47AB-A627-D85893F9D61A|1||||FACTVWMU|VON WILLEBRAND FACTOR MULTIMERS|||||||FOZ_US|||||||INDETERMINATE||CP||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED|NA|WRIGHT-GIEMSA STAIN|ASH FIBROSURE FORMULA||NA|U|NA|N|||N|5||7||INDUCTION TREATMENT|1966-07-23|1969-08-03|||||1970-12-09||1972-01-16|U|1965-10-19
TRIAL STUDY 134XCP|LB|C817A043-1331-47AB-A627-D85893F9D61A|2||||CRH|CORTICOTROPIN RELEASING HORMONE|||||||UU/DL|||||||INVALID||BQ/UL||||NORMAL|NOT DONE||||LYSATE|HEMOLYZED|N|CONTRAST ENHANCED PET SCAN|MDRD 5 VARIABLE FORMULA||Y|Y|U|U|||N|5||7||BASELINE|1966-08-18|1970-06-08|||||1971-01-04||1968-06-05|U|1970-03-14
TRIAL STUDY 134XCP|LB|DDD6F5D1-AE97-412C-A161-869C4178223A|1||||BTLBTL|BUTALBITAL|||||||ML/CAGE/DAY|||||||INDETERMINATE||UL/ML||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|CALCIFIED|U|LASER CAPTURE MICRODISSECTION|FIBROSIS 4 FORMULA||NA|Y|U|NA|||Y|1||38||INDUCTION TREATMENT|1970-01-11|1973-03-18|||||1962-11-05||1961-11-13|N|1962-06-11
TRIAL STUDY 134XCP|LB|DDD6F5D1-AE97-412C-A161-869C4178223A|2||||TNFAPIA|TNF-A PRODUCTION INHIBITORY ACTIVITY|||||||U/MG|||||||INVALID||UGEQ||||HIGH|NOT DONE||||NAIL|UNEXPECTED ODOR|Y|WHOLE GENOME SEQUENCING|FIBROMETER FORMULA||N|NA|U|U|||N|1||38||BLINDED TREATMENT|1972-09-01|1962-09-20|||||1963-06-11||1967-05-07|NA|1960-12-07
TRIAL STUDY 134XCP|LB|DDD6F5D1-AE97-412C-A161-869C4178223A|1||||C165896|D. PTERONYSSINUS ANTIGEN IGG4 ANTIBODY|||||||TCID 50/DOSE|||||||BORDERLINE||WEEKS||||NORMAL|NOT DONE||||BLOOD|CALCIFIED|NA|LANDOLT RING|MDRD 4 VARIABLE FORMULA||U|U|NA|N|||N|2||58||BLINDED TREATMENT|1964-05-02|1965-05-29|||||1971-10-22||1963-05-11|NA|1968-09-12
TRIAL STUDY 134XCP|LB|DDD6F5D1-AE97-412C-A161-869C4178223A|2||||BLYCELY|B-LYMPHOCYTES/LYMPHOCYTES|||||||MG/ML/MIN|||||||POSITIVE||BEAM BREAKS||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|SOLIDIFIED|NA|REFRACTOMETRY|MDRD 4 VARIABLE FORMULA||U|NA|NA|NA|||NA|2||58||INDUCTION TREATMENT|1961-04-08|1967-03-12|||||1971-04-02||1970-11-22|Y|1971-12-27
TRIAL STUDY 134XCP|LB|DDD6F5D1-AE97-412C-A161-869C4178223A|1||||MDA|3,4-METHYLENEDIOXYAMPHETAMINE|||||||FINGERTIP UNIT|||||||INDETERMINATE||CG||||LOW|NOT DONE||||SMEGMA|UNEXPECTED ODOR|Y|LC/MS/MS|CKD-EPI CYSTATIN C FORMULA||N|NA|N|N|||N|3||39||WASHOUT|1964-02-16|1968-01-27|||||1960-09-19||1968-05-27|Y|1970-06-15
TRIAL STUDY 134XCP|LB|DDD6F5D1-AE97-412C-A161-869C4178223A|2||||FATACVLC|FATTY ACIDS, VERY LONG CHAIN|||||||QUANTITY SUFFICIENT|||||||INDETERMINATE||UCI/L||||HIGH|NOT DONE||||EPITHELIAL CELL|ICTERIC|U|FUNCTIONAL MRI|FIBROTEST FORMULA||N|Y|N|NA|||Y|3||39||CONTINUATION TREATMENT|1970-08-23|1963-03-07|||||1970-09-27||1967-12-04|Y|1968-12-27
TRIAL STUDY 134XCP|LB|DDD6F5D1-AE97-412C-A161-869C4178223A|1||||CD3LY|CD3/LYMPHOCYTES|||||||PMOL/L|||||||NEGATIVE||MEQ/G||||LOW|NOT DONE||||EMESIS|HEMOLYZED|U|NEXT GENERATION TARGETED SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|Y|N|||NA|4||88||INDUCTION TREATMENT|1962-08-02|1964-11-19|||||1962-11-03||1961-07-11|Y|1971-07-21
TRIAL STUDY 134XCP|LB|DDD6F5D1-AE97-412C-A161-869C4178223A|2||||MCHC|ERY. MEAN CORPUSCULAR HGB CONCENTRATION|||||||ML/G/MIN|||||||INVALID||ML/BREATH||||ABNORMAL|NOT DONE||||CALCULUS|CONCENTRATED|N|POTENTIOMETRY|CKD-EPI CREATININE FORMULA||Y|N|Y|NA|||Y|4||88||WASHOUT|1967-12-26|1962-08-18|||||1965-05-08||1970-02-16|NA|1965-02-02
TRIAL STUDY 134XCP|LB|DDD6F5D1-AE97-412C-A161-869C4178223A|1||||ANTHRMAG|ANTITHROMBIN ANTIGEN|||||||KUSP|||||||NEGATIVE||PG/DL||||NORMAL|NOT DONE||||PLEURAL TISSUE|PARAFFIN-EMBEDDED|NA|NUCLEIC ACID HYBRIDIZATION|NASH FIBROSURE FORMULA||U|U|Y|NA|||U|5||7||OPEN LABEL TREATMENT|1961-02-05|1967-04-21|||||1973-06-15||1961-03-05|Y|1968-03-10
TRIAL STUDY 134XCP|LB|DDD6F5D1-AE97-412C-A161-869C4178223A|2||||SMTHAB|SMITH ANTIBODY|||||||MG/M2|||||||INDETERMINATE||NU/CL||||LOW|NOT DONE||||BONE MARROW|THAWED|N|ZIEHL NEELSEN ACID FAST STAIN|HEPASCORE FORMULA||U|Y|NA|Y|||U|5||7||BASELINE|1967-01-22|1962-06-05|||||1967-10-20||1962-06-01|U|1964-06-30
TRIAL STUDY 134XCP|LB|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|1||||DALACRT|DELTA AMINOLEVULINATE/CREATININE|||||||UEQ/L|||||||BORDERLINE||ML/DAY||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|REFRIGERATED|N|GC/MS/MS|GMI % FORMULA||Y|U|U|U|||N|1||38||TREATMENT|1969-07-10|1961-05-01|||||1967-01-21||1968-11-20|NA|1971-06-29
TRIAL STUDY 134XCP|LB|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|2||||INTLK10|INTERLEUKIN 10|||||||L/S|||||||BORDERLINE||WEEKS||||HIGH|NOT DONE||||GASTRIC CONTENTS|NON-HEMOLYZED|NA|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|ASH FIBROSURE FORMULA||U|N|U|NA|||U|1||38||FOLLOW-UP|1960-02-21|1965-05-25|||||1964-01-02||1971-03-17|Y|1960-03-03
TRIAL STUDY 134XCP|LB|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|1||||LRZPM|LORAZEPAM|||||||NCI|||||||INDETERMINATE||NMOL/KG/DAY||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|ROOM TEMPERATURE|U|FISH|MDRD ENZYMATIC FORMULA||Y|Y|Y|Y|||N|2||58||RUN-IN|1967-10-17|1965-02-11|||||1971-04-27||1966-11-11|U|1971-05-04
TRIAL STUDY 134XCP|LB|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|2||||PAPPA|PREGNANCY-ASSOCIATED PLASMA PROTEIN-A|||||||HZ|||||||POSITIVE||UG/KG||||LOW|NOT DONE||||STOOL|DRIED|U|BRDU CELLULAR PROLIFERATION ASSAY|FIBROMETER FORMULA||U|N|U|N|||U|2||58||OPEN LABEL TREATMENT|1962-08-28|1962-11-26|||||1968-06-28||1965-12-28|N|1972-10-13
TRIAL STUDY 134XCP|LB|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|1||||GRN|PROGRANULIN|||||||HZ|||||||NEGATIVE||BAU/ML||||NORMAL|NOT DONE||||HAIR FOLLICLE|DRIED|NA|SCINTIGRAPHY|MDRD ENZYMATIC FORMULA||N|U|N|NA|||NA|3||39||WASHOUT|1967-03-22|1970-03-21|||||1968-03-21||1963-07-20|N|1970-07-05
TRIAL STUDY 134XCP|LB|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|2||||TESTOSWB|TESTOSTERONE, WEAKLY BOUND|||||||EVENTS|||||||INDETERMINATE||MOL/MG||||ABNORMAL|NOT DONE||||MONOCYTE|CONCENTRATED|U|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|FIBROMETER FORMULA||NA|U|Y|U|||Y|3||39||OBSERVATION|1963-08-15|1970-04-10|||||1965-09-19||1969-10-19|U|1965-07-12
TRIAL STUDY 134XCP|LB|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|1||||CITCREAT|CITRATE/CREATININE|||||||TUBERCULIN UNIT/ML|||||||BORDERLINE||UV||||HIGH|NOT DONE||||URINE SEDIMENT|HEMOLYZED|N|ISHIHARA COLOR PLATES|FIBROMETER FORMULA||NA|N|N|N|||U|4||88||INDUCTION TREATMENT|1964-05-04|1964-02-08|||||1972-03-23||1964-07-23|NA|1972-07-29
TRIAL STUDY 134XCP|LB|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|2||||PYDCREAT|PYRIDINOLINE/CREATININE|||||||SHOCK WAVE|||||||NEGATIVE||LOZENGE||||NORMAL|NOT DONE||||AQUEOUS HUMOR|NON-HEMOLYZED|N|FARR ASSAY|NASH FIBROSURE FORMULA||Y|NA|N|Y|||NA|4||88||RUN-IN|1970-06-09|1972-04-04|||||1961-05-08||1967-02-09|NA|1965-04-21
TRIAL STUDY 134XCP|LB|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|1||||FLT3L|FMS-LIKE TYROSINE KINASE 3 LIGAND|||||||MOL/G|||||||NEGATIVE||PPTH||||ABNORMAL|NOT DONE||||VENOUS PLASMA|CONTAMINATED|N|CLINICAL EVALUATION|CKD-EPI CYSTATIN C FORMULA||Y|N|NA|Y|||NA|5||7||FOLLOW-UP|1969-03-30|1972-02-07|||||1969-12-19||1973-08-08|Y|1964-04-06
TRIAL STUDY 134XCP|LB|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|2||||IGG4|IMMUNOGLOBULIN G SUBCLASS 4|||||||PFU/ML|||||||BORDERLINE||STRIP||||HIGH|NOT DONE||||ADIPOSE TISSUE|LIPEMIC|Y|GRAM STAIN|GMI % FORMULA||NA|U|N|U|||Y|5||7||BLINDED TREATMENT|1960-07-09|1970-11-08|||||1971-05-23||1962-06-06|NA|1965-12-11
TRIAL STUDY 134XCP|LB|25FB07EA-3CB8-430D-B775-CA0E9918C069|1||||GFRBSCRT|GFR FROM CREATININE ADJUSTED FOR BSA|||||||CI|||||||INDETERMINATE||ML/G/MIN||||HIGH|NOT DONE||||CALCULUS|PARAFFIN-EMBEDDED|Y|SMEAR|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|Y|Y|||U|1||38||FOLLOW-UP|1970-05-30|1961-04-01|||||1970-04-12||1964-06-07|N|1964-05-09
TRIAL STUDY 134XCP|LB|25FB07EA-3CB8-430D-B775-CA0E9918C069|2||||C165905|GRASS MIX POLLEN IGG AB RAST SCORE|||||||10^8 PFU|||||||INDETERMINATE||PLUG||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|CLOTTED|U|MECHANICAL CLOT DETECTION|GMI % FORMULA||NA|Y|U|Y|||U|1||38||BLINDED TREATMENT|1968-11-22|1964-02-07|||||1970-12-02||1968-05-20|NA|1967-11-03
TRIAL STUDY 134XCP|LB|25FB07EA-3CB8-430D-B775-CA0E9918C069|1||||NUCCE|NUCLEATED CELLS|||||||L/S/KPA|||||||INVALID||MEQ/G||||HIGH|NOT DONE||||PLATELET POOR PLASMA|CONCENTRATED|NA|QUANTITATIVE COMPUTED TOMOGRAPHY|ASH FIBROSURE FORMULA||U|N|NA|NA|||Y|2||58||RUN-IN|1968-07-07|1967-06-07|||||1973-01-19||1970-07-21|NA|1969-03-17
TRIAL STUDY 134XCP|LB|25FB07EA-3CB8-430D-B775-CA0E9918C069|2||||NITRITE|NITRITE|||||||MOSM/L|||||||NEGATIVE||CS||||ABNORMAL|NOT DONE||||SKIN TISSUE|DRIED|NA|ALCIAN BLUE STAIN|MDRD 4 VARIABLE FORMULA||U|NA|Y|U|||NA|2||58||OBSERVATION|1963-07-27|1962-01-24|||||1961-02-16||1968-07-26|U|1973-03-23
TRIAL STUDY 134XCP|LB|25FB07EA-3CB8-430D-B775-CA0E9918C069|1||||LACTICAC|LACTIC ACID|||||||M/SEC|||||||NEGATIVE||10^5/L||||LOW|NOT DONE||||EMOTIONAL TEAR|HEMOLYZED|Y|IN VITRO GENE EXPRESSION ASSAY|COCKCROFT-GAULT FORMULA||Y|NA|U|Y|||N|3||39||CONTINUATION TREATMENT|1960-09-28|1967-01-01|||||1963-01-19||1969-02-14|U|1967-08-04
TRIAL STUDY 134XCP|LB|25FB07EA-3CB8-430D-B775-CA0E9918C069|2||||NEUTLE|NEUTROPHILS/LEUKOCYTES|||||||ML/M2/DAY|||||||INDETERMINATE||DEG/S||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|AUTOLYZED|Y|ATOMIC ABSORPTION SPECTROMETRY|CKD-EPI CREATININE FORMULA||NA|U|U|N|||Y|3||39||FOLLOW-UP|1966-10-27|1970-05-08|||||1968-02-21||1970-12-04|NA|1969-05-30
TRIAL STUDY 134XCP|LB|25FB07EA-3CB8-430D-B775-CA0E9918C069|1||||FENTANYL|FENTANYL|||||||ML/MIN/MMHG|||||||POSITIVE||CM H2O||||HIGH|NOT DONE||||INFRANATANT, SERUM|THAWED|N|IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD 5 VARIABLE FORMULA||U|Y|N|Y|||NA|4||88||BASELINE|1973-06-08|1963-07-14|||||1968-11-12||1967-01-15|U|1972-03-15
TRIAL STUDY 134XCP|LB|25FB07EA-3CB8-430D-B775-CA0E9918C069|2||||RPTLTIME|REPTILASE TIME|||||||NMOL|||||||NEGATIVE||ML/(MIN*100ML)||||NORMAL|NOT DONE||||VENOUS PLASMA|GELLED|Y|ELECTRONEUROGRAPHY|COCKCROFT-GAULT FORMULA||Y|N|Y|U|||NA|4||88||TREATMENT|1973-06-03|1960-04-03|||||1972-07-18||1968-06-15|Y|1973-03-30
TRIAL STUDY 134XCP|LB|25FB07EA-3CB8-430D-B775-CA0E9918C069|1||||KCREAT|POTASSIUM/CREATININE|||||||PNU/ML|||||||BORDERLINE||DEG||||HIGH|NOT DONE||||GASTRIC FLUID|UNEXPECTED ODOR|U|TRIPLE-PHASE MRI SCAN|MDRD 4 VARIABLE FORMULA||N|NA|N|N|||N|5||7||TREATMENT|1964-07-26|1969-01-29|||||1965-09-08||1968-06-23|N|1964-12-24
TRIAL STUDY 134XCP|LB|25FB07EA-3CB8-430D-B775-CA0E9918C069|2||||RDCSUG|REDUCING SUGARS|||||||KA_U/DL|||||||TRACE||BQ/MG||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|DRIED|NA|CLAUSS METHOD|MDRD 6 VARIABLE FORMULA||Y|U|U|Y|||NA|5||7||FOLLOW-UP|1965-07-09|1973-05-19|||||1971-05-03||1968-06-18|Y|1964-05-29
TRIAL STUDY 134XCP|LB|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|1||||HLAAMSC|HLA-A MISMATCH COUNT|||||||UG/DOSE|||||||BORDERLINE||EVENTS||||HIGH|NOT DONE||||TRANSUDATE|ICTERIC|Y|THIN SMEAR|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|Y|Y|||U|1||38||SCREENING|1973-03-17|1965-05-20|||||1966-08-27||1962-10-08|NA|1971-05-16
TRIAL STUDY 134XCP|LB|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|2||||CRTCLRE|CREATININE CLEARANCE, ESTIMATED|||||||NL|||||||TRACE||F||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|HEMOLYZED|NA|HPLC-UV|MDRD FORMULA||Y|Y|U|Y|||U|1||38||OPEN LABEL TREATMENT|1972-09-07|1964-07-31|||||1962-04-22||1966-02-22|U|1963-11-06
TRIAL STUDY 134XCP|LB|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|1||||PROLYM|PROLYMPHOCYTES|||||||ARBITRARY U|||||||TRACE||KV||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|DRIED|Y|CALCULATION|MDRD 5 VARIABLE FORMULA||NA|NA|NA|U|||NA|2||58||SCREENING|1969-06-20|1969-06-07|||||1972-12-16||1968-01-09|N|1966-06-07
TRIAL STUDY 134XCP|LB|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|2||||PDW|PLATELET DISTRIBUTION WIDTH|||||||FL|||||||NEGATIVE||U/MMOL||||NORMAL|NOT DONE||||TRANSUDATE|FROZEN|U|CLIP SEQUENCING|GMI % FORMULA||U|Y|U|Y|||U|2||58||CONTINUATION TREATMENT|1967-03-03|1966-05-13|||||1961-03-07||1960-04-11|U|1962-07-20
TRIAL STUDY 134XCP|LB|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|1||||PLSPCE|PRECURSOR PLASMA CELLS|||||||PMOL/DAY|||||||NEGATIVE||WEEKS||||NORMAL|NOT DONE||||SERUM OR PLASMA|CALCIFIED|U|DIPSTICK|CKD-EPI CREATININE FORMULA||U|N|NA|NA|||U|3||39||TREATMENT|1964-05-06|1967-07-13|||||1967-05-01||1971-03-15|Y|1966-08-15
TRIAL STUDY 134XCP|LB|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|2||||HGF|HEPATOCYTE GROWTH FACTOR|||||||APS U|||||||TRACE||LOG10 CFU/G||||LOW|NOT DONE||||PROSTATIC FLUID|ROOM TEMPERATURE|Y|DIPSTICK|GMI MMOL/MOL FORMULA||Y|U|N|N|||Y|3||39||INDUCTION TREATMENT|1962-05-19|1973-05-26|||||1970-04-24||1964-06-14|NA|1960-08-25
TRIAL STUDY 134XCP|LB|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|1||||SFTPD|SURFACTANT PROTEIN D|||||||/2000 RBC|||||||INDETERMINATE||EID 50/DOSE||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|ICTERIC|NA|NON-INVASIVE DIELECTRIC SENSING|CKD-EPI CYSTATIN C FORMULA||Y|Y|U|NA|||U|4||88||OBSERVATION|1969-03-02|1965-07-20|||||1964-05-10||1963-04-21|N|1967-07-05
TRIAL STUDY 134XCP|LB|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|2||||KLHIGMAB|KEYHOLE LIMPET HEMOCYANIN IGM ANTIBODY|||||||/10^3|||||||NEGATIVE||UL/ML||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|ICTERIC|U|TRANSMISSION ELECTRON MICROSCOPY|FIBROTEST FORMULA||N|NA|Y|U|||Y|4||88||TREATMENT|1967-01-26|1970-09-11|||||1962-12-19||1971-06-03|NA|1967-04-11
TRIAL STUDY 134XCP|LB|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|1||||SJSA60AB|SJOGRENS SS-A60 ANTIBODY|||||||G|||||||BORDERLINE||MG2/DL2||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|LIPEMIC|Y|DIPSTICK|GMI % FORMULA||NA|Y|NA|N|||U|5||7||BASELINE|1960-05-17|1961-11-24|||||1971-10-26||1970-01-27|Y|1969-12-23
TRIAL STUDY 134XCP|LB|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|2||||SVCAM1|SOLUBLE VASC CELL ADHESION MOLECULE 1|||||||U/DL|||||||TRACE||IU/L||||NORMAL|NOT DONE||||BONE|LACTESCENT|U|NUCLEIC ACID HYBRIDIZATION|MDRD 6 VARIABLE FORMULA||Y|U|N|Y|||Y|5||7||CONTINUATION TREATMENT|1968-08-20|1964-01-30|||||1962-08-03||1962-01-23|N|1970-02-24
TRIAL STUDY 134XCP|LB|B49B9695-9815-4B7B-9F96-4EE6A4432062|1||||GRAN|GRANULOCYTES|||||||KG/CM2|||||||INVALID||VIRTUAL PIXEL||||HIGH|NOT DONE||||SEMEN|LIPEMIC|Y|TONOMETRY|FIBROSIS 4 FORMULA||U|Y|U|N|||U|1||38||INDUCTION TREATMENT|1961-04-28|1961-06-02|||||1966-10-19||1960-07-09|Y|1963-08-24
TRIAL STUDY 134XCP|LB|B49B9695-9815-4B7B-9F96-4EE6A4432062|2||||ATHMBAAC|ANTITHROMBIN ACTIVITY ACTUAL/CONTROL|||||||UGEQ|||||||INVALID||CD/M2||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|GELLED|Y|PLETHYSMOGRAPHY|CKD-EPI CREATININE FORMULA||NA|NA|Y|Y|||NA|1||38||BLINDED TREATMENT|1964-07-29|1961-11-28|||||1964-01-31||1961-05-26|N|1970-11-20
TRIAL STUDY 134XCP|LB|B49B9695-9815-4B7B-9F96-4EE6A4432062|1||||PICP|PROCOLLAGEN TYPE I CARBOXY TERM PEPTIDE|||||||IU/G HB|||||||NEGATIVE||BOLUS||||NORMAL|NOT DONE||||REFLEX TEAR|REFRIGERATED|N|DUKE INCISION METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|Y|N|||N|2||58||BLINDED TREATMENT|1972-02-06|1965-04-14|||||1970-10-06||1971-09-10|U|1971-10-20
TRIAL STUDY 134XCP|LB|B49B9695-9815-4B7B-9F96-4EE6A4432062|2||||CSEPI|EPITHELIAL CASTS|||||||/40 HPFS|||||||INVALID||CM/S||||NORMAL|NOT DONE||||CALCULUS|FROZEN|NA|CHROMATOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|Y|Y|||U|2||58||OPEN LABEL TREATMENT|1964-12-14|1970-12-22|||||1964-11-26||1970-12-18|N|1962-07-01
TRIAL STUDY 134XCP|LB|B49B9695-9815-4B7B-9F96-4EE6A4432062|1||||C165924|GRASS MIX POLLEN IGE AB RAST SCORE|||||||ML/DL|||||||INVALID||GENEQ/ML||||LOW|NOT DONE||||SMEGMA|FROZEN|NA|COMPLEMENT FIXATION|CKD-EPI FORMULA||NA|Y|N|NA|||Y|3||39||WASHOUT|1966-04-22|1962-01-20|||||1964-06-19||1963-06-07|U|1965-05-23
TRIAL STUDY 134XCP|LB|B49B9695-9815-4B7B-9F96-4EE6A4432062|2||||GLOBGPT|GAMMA GLOBULIN/TOTAL PROTEIN|||||||PA|||||||NEGATIVE||TAMPON||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|REFRIGERATED|NA|HIGH RESOLUTION MELT ANALYSIS|GMI MMOL/MOL FORMULA||U|Y|NA|NA|||Y|3||39||LONG-TERM FOLLOW-UP|1972-12-06|1961-05-08|||||1961-12-19||1961-07-08|N|1965-08-08
TRIAL STUDY 134XCP|LB|B49B9695-9815-4B7B-9F96-4EE6A4432062|1||||C4A|COMPLEMENT C4A|||||||GRAIN|||||||TRACE||PMOL/DL||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|CLOTTED|NA|TRANSVAGINAL ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|NA|U|||N|4||88||OBSERVATION|1967-10-12|1971-07-23|||||1961-11-18||1968-06-25|U|1972-03-23
TRIAL STUDY 134XCP|LB|B49B9695-9815-4B7B-9F96-4EE6A4432062|2||||HYPGST17|17-HYDROXYPROGESTERONE|||||||UEQ|||||||INDETERMINATE||MIN*MG/ML||||NORMAL|NOT DONE||||LOCHIA|AUTOLYZED|NA|DUCTOGRAPHY|FIBROMETER FORMULA||NA|NA|N|NA|||N|4||88||OBSERVATION|1967-05-12|1967-09-08|||||1971-11-23||1960-10-25|N|1970-07-30
TRIAL STUDY 134XCP|LB|B49B9695-9815-4B7B-9F96-4EE6A4432062|1||||CYTYRO|TYROSINE CRYSTALS|||||||TSP EQ|||||||INVALID||NMOL BCE/NMOL||||LOW|NOT DONE||||SPUTUM|LACTESCENT|N|ELISA|MDRD ENZYMATIC JAPANESE FORMULA||N|U|NA|Y|||NA|5||7||TREATMENT|1968-12-04|1961-04-20|||||1964-02-22||1960-11-23|Y|1960-12-26
TRIAL STUDY 134XCP|LB|B49B9695-9815-4B7B-9F96-4EE6A4432062|2||||CD4LY|CD4/LYMPHOCYTES|||||||UMOL/L/H|||||||NEGATIVE||ECL UNIT||||NORMAL|NOT DONE||||EXUDATE|AGGLUTINATED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|Y|NA|||N|5||7||SCREENING|1960-04-28|1964-08-21|||||1967-08-12||1962-10-21|N|1969-06-12
TRIAL STUDY 134XCP|LB|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|1||||SOMATRO|SOMATOTROPHIN|||||||ML/BEAT|||||||INVALID||ML/CAGE/DAY||||NORMAL|NOT DONE||||TRANSUDATE|CALCIFIED|Y|TOLUIDINE BLUE STAIN|GMI % FORMULA||Y|NA|N|NA|||U|1||38||OPEN LABEL TREATMENT|1963-01-10|1968-11-19|||||1968-12-10||1967-07-09|NA|1964-05-28
TRIAL STUDY 134XCP|LB|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|2||||TROPONI1|TROPONIN I TYPE 1|||||||UL/DOSE|||||||POSITIVE||MEQ/MMOL||||NORMAL|NOT DONE||||SWABBED MATERIAL|ICTERIC|Y|PANENDOSCOPY|HEPASCORE FORMULA||NA|N|N|U|||Y|1||38||OBSERVATION|1973-08-27|1970-07-25|||||1966-09-27||1960-06-19|NA|1973-03-17
TRIAL STUDY 134XCP|LB|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|1||||ETPLTR|ETP LAG TIME RELATIVE|||||||10^6/EJACULATE U|||||||POSITIVE||EP U||||LOW|NOT DONE||||SEMINAL FLUID|NON-HEMOLYZED|Y|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROTEST FORMULA||Y|U|N|Y|||N|2||58||OPEN LABEL TREATMENT|1969-02-24|1962-08-02|||||1963-05-20||1960-10-25|N|1967-10-08
TRIAL STUDY 134XCP|LB|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|2||||TNFSR2|SOLUBLE TNF RECEPTOR TYPE II|||||||RAD|||||||NEGATIVE||10^9 CFU||||LOW|NOT DONE||||WHITE MATTER TISSUE|SOLIDIFIED|NA|ENDPOINT DILUTION ASSAY|GMI % FORMULA||Y|N|U|U|||N|2||58||OBSERVATION|1969-07-20|1969-07-17|||||1973-04-02||1972-02-22|Y|1960-09-11
TRIAL STUDY 134XCP|LB|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|1||||HGBMHGB|METHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||NMOL/G|||||||POSITIVE||ML/G/DAY||||ABNORMAL|NOT DONE||||DISCHARGE|AUTOLYZED|NA|PERCUSSION|ASH FIBROSURE FORMULA||U|NA|Y|NA|||Y|3||39||BASELINE|1973-08-15|1965-05-16|||||1968-05-04||1966-08-12|NA|1964-08-17
TRIAL STUDY 134XCP|LB|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|2||||ALBIDX|ALBUMIN INDEX|||||||G/M2|||||||POSITIVE||MU||||LOW|NOT DONE||||MIXED VENOUS BLOOD|AUTOLYZED|U|AGAR DILUTION|MDRD ENZYMATIC FORMULA||N|U|Y|Y|||U|3||39||CONTINUATION TREATMENT|1963-02-17|1966-10-18|||||1962-05-16||1966-05-29|U|1963-03-04
TRIAL STUDY 134XCP|LB|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|1||||CBA|COMPLEMENT BA|||||||IU/ML|||||||BORDERLINE||G/U||||ABNORMAL|NOT DONE||||REFLEX TEAR|HEMOLYZED|Y|SLIT LAMP PHOTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|N|Y|U|||Y|4||88||OBSERVATION|1967-06-01|1960-04-21|||||1972-10-24||1963-02-11|U|1970-10-25
TRIAL STUDY 134XCP|LB|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|2||||C130120|SHELLFISH MIX ANTIGEN IGE ANTIBODY|||||||EQ|||||||TRACE||MMU/ML||||HIGH|NOT DONE||||CAPILLARY BLOOD|PARAFFIN-EMBEDDED|NA|HPLC-UV|NASH FIBROSURE FORMULA||NA|NA|Y|U|||U|4||88||CONTINUATION TREATMENT|1970-02-27|1967-01-01|||||1963-04-27||1961-04-06|N|1965-09-25
TRIAL STUDY 134XCP|LB|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|1||||SJSSBAB|SJOGRENS SS-B ANTIBODY|||||||HOUNSFIELD UNIT|||||||POSITIVE||ARBITRARY U||||NORMAL|NOT DONE||||DIALYSIS FLUID|UNEXPECTED ODOR|U|OLIGO ACGH|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|N|U|||U|5||7||RUN-IN|1961-10-27|1972-11-21|||||1965-06-24||1970-05-09|U|1970-11-22
TRIAL STUDY 134XCP|LB|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|2||||LGUNSCE|LARGE UNSTAINED CELLS|||||||MS/MMHG|||||||POSITIVE||MASK||||ABNORMAL|NOT DONE||||BONE|ROOM TEMPERATURE|NA|CAPILLARY ELECTROPHORESIS|CKD-EPI CYSTATIN C FORMULA||U|Y|Y|U|||N|5||7||OPEN LABEL TREATMENT|1970-12-29|1963-06-29|||||1968-01-06||1967-04-23|U|1970-10-08
TRIAL STUDY 134XCP|LB|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|1||||CCL12|CHEMOKINE (C-C MOTIF) LIGAND 12|||||||UIU/DL|||||||INVALID||PSI||||HIGH|NOT DONE||||DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED|U|COULOMETRIC TITRATION|MDRD ENZYMATIC FORMULA||U|U|Y|Y|||N|1||38||SCREENING|1962-01-09|1960-07-13|||||1965-05-03||1968-11-18|Y|1964-10-26
TRIAL STUDY 134XCP|LB|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|2||||ENAAB|EXTRACTABLE NUCLEAR ANTIGEN ANTIBODY|||||||BU|||||||INDETERMINATE||10^7 CFU||||ABNORMAL|NOT DONE||||LAVAGE FLUID|NON-HEMOLYZED|NA|ECHOCARDIOGRAPHY|GMI MMOL/MOL FORMULA||NA|Y|Y|U|||NA|1||38||OPEN LABEL TREATMENT|1972-03-20|1966-10-21|||||1967-11-02||1962-05-18|NA|1972-03-09
TRIAL STUDY 134XCP|LB|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|1||||ABNCE|ABNORMAL CELLS|||||||COPIES/ML|||||||POSITIVE||OD UNIT||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|FRESH|U|FLUOROSCOPY|NASH FIBROSURE FORMULA||Y|U|NA|N|||Y|2||58||BLINDED TREATMENT|1966-05-21|1963-03-24|||||1964-12-24||1968-01-25|NA|1973-04-09
TRIAL STUDY 134XCP|LB|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|2||||MDZPM|MEDAZEPAM|||||||MG/CM2|||||||POSITIVE||CD/M2||||NORMAL|NOT DONE||||SMEGMA|LIPEMIC|Y|GC/MS-EI|MDRD FORMULA||U|Y|N|N|||Y|2||58||OBSERVATION|1963-06-30|1970-09-05|||||1965-05-29||1968-01-02|U|1968-05-08
TRIAL STUDY 134XCP|LB|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|1||||KRCYMGCE|MEGAKARYOCYTES/TOTAL CELLS|||||||NCI|||||||NEGATIVE||L/H/M2||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|CONCENTRATED|NA|IMMUNOCHEMILUMINOMETRIC ASSAY|MDRD 5 VARIABLE FORMULA||Y|Y|NA|NA|||U|3||39||LONG-TERM FOLLOW-UP|1972-11-15|1965-11-27|||||1961-04-27||1964-03-19|Y|1962-04-24
TRIAL STUDY 134XCP|LB|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|2||||THEOPHYL|THEOPHYLLINE|||||||AG|||||||NEGATIVE||UG/DAY||||NORMAL|NOT DONE||||CALCULUS|HEMOLYZED|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI FORMULA||NA|Y|NA|NA|||NA|3||39||TREATMENT|1968-07-25|1969-11-10|||||1965-07-26||1972-08-25|N|1969-12-13
TRIAL STUDY 134XCP|LB|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|1||||ADPNHMW|ADIPONECTIN, HIGH MOLECULAR WEIGHT|||||||UG/KG/DAY|||||||BORDERLINE||BAU/ML||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|DRIED|U|NO INFORMATION|ASH FIBROSURE FORMULA||NA|Y|N|NA|||NA|4||88||OBSERVATION|1971-01-24|1962-07-07|||||1970-07-31||1973-08-05|NA|1962-08-15
TRIAL STUDY 134XCP|LB|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|2||||SJSA52AB|SJOGRENS SS-A52 ANTIBODY|||||||LOG10 TCID 50/ML|||||||INDETERMINATE||UG/MOL||||NORMAL|NOT DONE||||SALIVA|HEMOLYZED|Y|WEBER GREEN STAIN|MDRD FORMULA||Y|N|Y|NA|||N|4||88||OPEN LABEL TREATMENT|1967-10-07|1972-04-10|||||1964-11-14||1963-04-14|U|1961-02-20
TRIAL STUDY 134XCP|LB|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|1||||IFI27|INTERFERON ALPHA-INDUCIBLE PROTEIN 27|||||||MMAL|||||||TRACE||10^3 RNA COPIES/ML||||LOW|NOT DONE||||AMNIOTIC FLUID|LIPEMIC|Y|GRADIENT DIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA||N|U|Y|U|||NA|5||7||INDUCTION TREATMENT|1963-07-03|1964-04-19|||||1970-03-17||1963-11-29|NA|1966-07-22
TRIAL STUDY 134XCP|LB|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|2||||ATPVITE|ALPHA TOCOPHEROL/VITAMIN E|||||||MMOL/G|||||||BORDERLINE||TUBE||||LOW|NOT DONE||||VENOUS BLOOD|FRESH|U|IMMUNORADIOMETRIC ASSAY|FIBROSIS 4 FORMULA||Y|N|Y|Y|||Y|5||7||WASHOUT|1962-12-10|1962-08-24|||||1970-11-23||1971-03-02|Y|1961-03-28
TRIAL STUDY 134XCP|LB|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|1||||MM2IGAB|MITOCHONDRIAL M2 IGG ANTIBODY|||||||BE/ML|||||||BORDERLINE||/H||||LOW|NOT DONE||||COLOSTRUM|UNEXPECTED ODOR|U|ISHIHARA COLOR PLATES|FIBROTEST FORMULA||N|Y|U|N|||N|1||38||FOLLOW-UP|1969-09-14|1964-06-23|||||1963-10-20||1967-10-15|Y|1973-06-02
TRIAL STUDY 134XCP|LB|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|2||||FLRZPM|FLURAZEPAM|||||||PFU|||||||POSITIVE||UG/DAY||||ABNORMAL|NOT DONE||||LEUKOCYTE|NON-HEMOLYZED|U|ACID FAST STAIN|MDRD 5 VARIABLE FORMULA||Y|Y|N|Y|||U|1||38||OBSERVATION|1970-01-05|1972-12-12|||||1967-02-08||1969-02-17|NA|1972-08-01
TRIAL STUDY 134XCP|LB|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|1||||TSHRAB|THYROTROPIN RECEPTOR ANTIBODY|||||||PG/CELL|||||||INDETERMINATE||MG/KG/DOSE||||NORMAL|NOT DONE||||SWABBED MATERIAL|CONTAMINATED|U|CT SCAN WITHOUT CONTRAST|MDRD FORMULA||NA|U|U|U|||N|2||58||FOLLOW-UP|1963-11-14|1968-05-14|||||1960-07-20||1961-03-19|NA|1971-03-12
TRIAL STUDY 134XCP|LB|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|2||||CD4CD8|CD4/CD8|||||||BQ/G|||||||TRACE||UOSM||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|CLOTTED|NA|ELASTOGRAPHY|MDRD 6 VARIABLE FORMULA||N|NA|N|Y|||Y|2||58||SCREENING|1970-07-31|1965-11-03|||||1967-07-18||1967-07-06|Y|1968-06-30
TRIAL STUDY 134XCP|LB|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|1||||CREATCLR|CREATININE CLEARANCE|||||||SFC/10^6 PBMC|||||||POSITIVE||TRACE||||HIGH|NOT DONE||||ALVEOLAR AIR|UNEXPECTED ODOR|N|PANENDOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|U|U|||N|3||39||SCREENING|1960-11-07|1966-12-19|||||1960-05-01||1961-02-17|NA|1972-10-26
TRIAL STUDY 134XCP|LB|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|2||||HYDCDN|HYDROCODONE|||||||UG/G/MIN|||||||INDETERMINATE||U/G/H||||LOW|NOT DONE||||SALIVA|GELLED|NA|IN SITU HYBRIDIZATION|NASH FIBROSURE FORMULA||NA|Y|U|NA|||Y|3||39||LONG-TERM FOLLOW-UP|1973-03-11|1972-07-20|||||1966-07-20||1969-06-04|Y|1970-07-02
TRIAL STUDY 134XCP|LB|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|1||||LYMNSQE|LYMPHOCYTES/NON-SQUAM EPI CELLS|||||||10^7 PFU|||||||NEGATIVE||DPM/100MG||||NORMAL|NOT DONE||||EMOTIONAL TEAR|AGGLUTINATED|Y|CELLULOSE TAPE|COCKCROFT-GAULT FORMULA||Y|U|Y|NA|||U|4||88||LONG-TERM FOLLOW-UP|1967-08-14|1969-05-20|||||1966-11-15||1961-07-30|U|1965-10-20
TRIAL STUDY 134XCP|LB|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|2||||LVTRCTM|LEVETIRACETAM|||||||NMOL/MOL|||||||POSITIVE||MMOL/DAY||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|FROZEN|N|PELLI-ROBSON EYE CHART|MDRD 6 VARIABLE FORMULA||U|U|Y|N|||Y|4||88||WASHOUT|1963-01-06|1964-09-13|||||1972-12-26||1966-07-01|N|1972-10-03
TRIAL STUDY 134XCP|LB|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|1||||ADMA|ASYMMETRIC DIMETHYLARGININE|||||||ML/G/DAY|||||||INVALID||PUFF||||HIGH|NOT DONE||||SERUM|DRIED|NA|WESTERGREN|MDRD ENZYMATIC JAPANESE FORMULA||U|U|Y|Y|||NA|5||7||SCREENING|1973-05-24|1971-04-12|||||1963-06-09||1962-05-05|Y|1966-07-03
TRIAL STUDY 134XCP|LB|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|2||||NEUTSGBP|NEUTROPHILS, SEG + BAND FORM + PRECURSOR|||||||NG/DL|||||||POSITIVE||LX||||ABNORMAL|NOT DONE||||SERUM|LACTESCENT|N|AUSCULTATION|MDRD 4 VARIABLE FORMULA||NA|N|Y|U|||N|5||7||WASHOUT|1962-08-15|1971-07-27|||||1962-09-03||1968-07-20|N|1967-11-20
TRIAL STUDY 134XCP|LB|07A934C8-0237-4B37-9FDD-503B8BF94357|1||||HDLPL|HDL PHOSPHOLIPID|||||||MIN|||||||POSITIVE||DYN||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|THAWED|U|CRYOSCOPY|GMI % FORMULA||U|N|U|Y|||U|1||38||OBSERVATION|1968-08-04|1970-09-28|||||1970-12-08||1969-01-10|Y|1962-01-06
TRIAL STUDY 134XCP|LB|07A934C8-0237-4B37-9FDD-503B8BF94357|2||||ELA1PMN|PANCREATIC ELASTASE 1, POLYMORPHONUCLEAR|||||||/2500 WBC|||||||POSITIVE||MMOL/S||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CONTAMINATED|Y|RULER MEASUREMENT METHOD|MDRD FORMULA||Y|Y|NA|N|||N|1||38||FOLLOW-UP|1973-08-23|1965-01-23|||||1968-12-12||1962-11-12|Y|1970-11-04
TRIAL STUDY 134XCP|LB|07A934C8-0237-4B37-9FDD-503B8BF94357|1||||ANGTNS2|ANGIOTENSIN II|||||||ML/KG/DAY|||||||POSITIVE||UMOL/MIN||||NORMAL|NOT DONE||||HAIR|PARAFFIN-EMBEDDED|NA|PET/SPECT SCAN|MDRD 6 VARIABLE FORMULA||NA|Y|N|NA|||N|2||58||LONG-TERM FOLLOW-UP|1960-03-11|1962-07-29|||||1960-11-20||1968-09-04|N|1960-12-28
TRIAL STUDY 134XCP|LB|07A934C8-0237-4B37-9FDD-503B8BF94357|2||||TSH|THYROTROPIN|||||||NG/MOL|||||||NEGATIVE||MM||||LOW|NOT DONE||||LYMPH|SOLIDIFIED|N|ANTIMICROBIAL COMBINATION TESTING|CKD-EPI FORMULA||Y|U|Y|U|||Y|2||58||BASELINE|1963-11-26|1965-06-24|||||1972-03-09||1968-10-06|N|1966-12-07
TRIAL STUDY 134XCP|LB|07A934C8-0237-4B37-9FDD-503B8BF94357|1||||SEZCELY|SEZARY CELLS/LYMPHOCYTES|||||||ELISA UNIT/DOSE|||||||TRACE||USIEMENS||||LOW|NOT DONE||||BILE|REFRIGERATED|NA|LYMPHANGIOGRAPHY|HEPASCORE FORMULA||Y|Y|NA|N|||NA|3||39||WASHOUT|1966-02-05|1964-05-18|||||1966-01-22||1962-08-25|N|1971-02-01
TRIAL STUDY 134XCP|LB|07A934C8-0237-4B37-9FDD-503B8BF94357|2||||CARNITF|CARNITINE, FREE|||||||MG/KG/DAY|||||||INDETERMINATE||/H||||NORMAL|NOT DONE||||DIALYSIS FLUID|SOLIDIFIED|N|MAGNETIC RESONANCE ELASTOGRAPHY|COCKCROFT-GAULT FORMULA||U|Y|NA|N|||U|3||39||SCREENING|1961-04-18|1964-06-23|||||1972-11-19||1960-12-01|NA|1968-03-24
TRIAL STUDY 134XCP|LB|07A934C8-0237-4B37-9FDD-503B8BF94357|1||||MIP1A|MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA|||||||MMHG*MIN/L|||||||INVALID||GPS U||||NORMAL|NOT DONE||||SKIN TISSUE|NON-HEMOLYZED|U|FARNSWORTH-MUNSELL 100 HUE TEST|MDRD 4 VARIABLE FORMULA||U|N|N|Y|||NA|4||88||LONG-TERM FOLLOW-UP|1964-03-26|1969-11-22|||||1960-07-22||1971-04-06|NA|1971-02-23
TRIAL STUDY 134XCP|LB|07A934C8-0237-4B37-9FDD-503B8BF94357|2||||ENDOTH1|ENDOTHELIN-1|||||||/MM|||||||BORDERLINE||DL||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|REFRIGERATED|U|CLIP SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||U|U|N|N|||Y|4||88||RUN-IN|1971-01-02|1973-03-27|||||1971-12-22||1970-01-13|U|1970-02-13
TRIAL STUDY 134XCP|LB|07A934C8-0237-4B37-9FDD-503B8BF94357|1||||IRF|IMMATURE RETICULOCYTE FRACTION|||||||KS|||||||TRACE||L/L||||NORMAL|NOT DONE||||ARTERIAL BLOOD|CONCENTRATED|Y|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|CKD-EPI CREATININE FORMULA||U|Y|NA|NA|||N|5||7||OBSERVATION|1963-12-15|1960-02-18|||||1970-08-20||1972-06-19|U|1964-07-30
TRIAL STUDY 134XCP|LB|07A934C8-0237-4B37-9FDD-503B8BF94357|2||||CCPAB|CYCLIC CITRULLINATED PEPTIDE ANTIBODY|||||||G/MOL|||||||POSITIVE||KBQ/UL||||ABNORMAL|NOT DONE||||GASTRIC FLUID|CLOTTED|NA|DIRECT SEQUENCING|CKD-EPI CYSTATIN C FORMULA||U|U|N|N|||Y|5||7||OBSERVATION|1972-08-06|1965-11-03|||||1968-09-23||1968-04-15|Y|1965-10-23
TRIAL STUDY 134XCP|LB|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|1||||C130133|D. FARINAE ANTIGEN IGG ANTIBODY|||||||/MM2|||||||NEGATIVE||C||||NORMAL|NOT DONE||||SEMINAL FLUID|DRIED|NA|RAJI CELL EIA|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|Y|||U|1||38||BASELINE|1961-03-20|1964-02-05|||||1961-05-02||1960-06-07|NA|1971-06-03
TRIAL STUDY 134XCP|LB|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|2||||RHD|RHD FACTOR|||||||MESF|||||||TRACE||ML/KG/H||||HIGH|NOT DONE||||VENOUS BLOOD|DRIED|U|STRESS ECHOCARDIOGRAPHY|MDRD 4 VARIABLE FORMULA||NA|NA|U|N|||Y|1||38||SCREENING|1972-01-28|1962-04-24|||||1969-10-26||1971-09-12|Y|1967-08-11
TRIAL STUDY 134XCP|LB|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|1||||C3A|COMPLEMENT C3A|||||||UM/S|||||||BORDERLINE||SCM||||NORMAL|NOT DONE||||PUS|ICTERIC|NA|PET/CT SCAN|MDRD 4 VARIABLE FORMULA||NA|NA|N|NA|||U|2||58||CONTINUATION TREATMENT|1960-06-14|1967-09-12|||||1966-11-16||1961-03-25|Y|1966-01-20
TRIAL STUDY 134XCP|LB|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|2||||BGTCPHRL|BETA+GAMMA TOCOPHEROL|||||||/VF|||||||POSITIVE||NGEQ/L||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LACTESCENT|U|DISK DIFFUSION|MDRD 4 VARIABLE FORMULA||U|N|NA|Y|||U|2||58||BASELINE|1965-03-20|1967-11-08|||||1960-08-28||1965-09-29|NA|1962-08-07
TRIAL STUDY 134XCP|LB|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|1||||IGG4|IMMUNOGLOBULIN G SUBCLASS 4|||||||DPM/MG|||||||BORDERLINE||LOG10 PFU/ML||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|PARAFFIN-EMBEDDED|N|HANSEL STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|Y|Y|||NA|3||39||FOLLOW-UP|1960-09-13|1965-05-07|||||1969-07-01||1971-10-11|NA|1972-08-04
TRIAL STUDY 134XCP|LB|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|2||||TRAMADOL|TRAMADOL|||||||CUP|||||||TRACE||PM||||LOW|NOT DONE||||SEBUM|DRIED|N|MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|NA|N|||U|3||39||WASHOUT|1963-01-14|1968-11-05|||||1963-02-17||1960-02-07|U|1973-04-03
TRIAL STUDY 134XCP|LB|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|1||||LEAD|LEAD|||||||PT_BR|||||||TRACE||CS||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|HEMOLYZED|NA|MAGNETIC RESONANCE ELASTOGRAPHY|NASH FIBROSURE FORMULA||N|U|U|Y|||U|4||88||CONTINUATION TREATMENT|1967-11-12|1968-02-13|||||1969-06-29||1968-08-26|NA|1970-03-29
TRIAL STUDY 134XCP|LB|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|2||||GLUCWBE|WHOLE BLOOD EQUIVALENT GLUCOSE|||||||CS|||||||INVALID||CARTRIDGE||||HIGH|NOT DONE||||HAIR|ICTERIC|N|HEMAGGLUTINATION INHIBITION ASSAY|FIBROSIS 4 FORMULA||U|U|Y|NA|||N|4||88||OBSERVATION|1964-11-14|1965-12-15|||||1962-06-29||1966-07-26|Y|1972-08-17
TRIAL STUDY 134XCP|LB|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|1||||BLSTNMCE|NORMOBLASTS/TOTAL CELLS|||||||MG/DL|||||||POSITIVE||L||||NORMAL|NOT DONE||||KERATINOCYTE|AUTOLYZED|NA|NEURAMINIDASE INHIBITION ASSAY|CKD-EPI FORMULA||N|N|U|Y|||Y|5||7||BASELINE|1963-12-24|1964-08-06|||||1969-02-25||1973-03-15|Y|1966-11-04
TRIAL STUDY 134XCP|LB|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|2||||SEZCE|SEZARY CELLS|||||||SEC|||||||TRACE||UMOL/L/SEC||||HIGH|NOT DONE||||EXPIRED AIR|ROOM TEMPERATURE|N|TRANSVAGINAL ULTRASOUND|MDRD 6 VARIABLE FORMULA||NA|U|N|U|||NA|5||7||SCREENING|1964-08-13|1966-05-15|||||1967-01-11||1968-07-25|NA|1971-11-27
TRIAL STUDY 134XCP|LB|10E1249E-10AC-45E8-9896-84C7B0F548BC|1||||ADSDNA|ANTI-DOUBLE STRANDED DNA|||||||ML/M2/H|||||||BORDERLINE||PA||||NORMAL|NOT DONE||||AQUEOUS HUMOR|FRESH|Y|DC SHEATH FLOW|CKD-EPI FORMULA||NA|N|U|NA|||NA|1||38||FOLLOW-UP|1969-03-24|1962-05-27|||||1963-07-21||1972-09-18|U|1965-04-17
TRIAL STUDY 134XCP|LB|10E1249E-10AC-45E8-9896-84C7B0F548BC|2||||GRANIMLE|IMMATURE GRANULOCYTES/LEUKOCYTES|||||||MG/G/MIN|||||||NEGATIVE||MMHG/SEC||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|THAWED|N|AUDIOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|NA|Y|||U|1||38||INDUCTION TREATMENT|1969-12-10|1968-08-31|||||1963-02-16||1970-04-04|U|1970-09-29
TRIAL STUDY 134XCP|LB|10E1249E-10AC-45E8-9896-84C7B0F548BC|1||||GRANLE|GRANULOCYTES/LEUKOCYTES|||||||VG/DOSE|||||||NEGATIVE||KUSP||||HIGH|NOT DONE||||EXUDATE|CONCENTRATED|U|PERIPHERAL ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||U|N|N|U|||Y|2||58||BLINDED TREATMENT|1964-06-03|1964-06-26|||||1968-11-26||1968-01-02|Y|1967-03-26
TRIAL STUDY 134XCP|LB|10E1249E-10AC-45E8-9896-84C7B0F548BC|2||||INTLK7|INTERLEUKIN 7|||||||MOL/MG|||||||NEGATIVE||COPIES/UG||||NORMAL|NOT DONE||||PLASMA|CLOTTED|U|ACID FAST STAIN|COCKCROFT-GAULT FORMULA||U|Y|N|Y|||U|2||58||WASHOUT|1960-03-09|1972-06-07|||||1969-10-10||1961-03-06|NA|1965-11-29
TRIAL STUDY 134XCP|LB|10E1249E-10AC-45E8-9896-84C7B0F548BC|1||||CXCL3|CHEMOKINE (C-X-C MOTIF) LIGAND 3|||||||VOXEL|||||||POSITIVE||MG||||LOW|NOT DONE||||SEMEN|LACTESCENT|Y|SCINTIGRAPHY|HEPASCORE FORMULA||N|NA|Y|NA|||Y|3||39||FOLLOW-UP|1969-09-27|1960-09-21|||||1960-06-13||1972-04-17|NA|1961-08-21
TRIAL STUDY 134XCP|LB|10E1249E-10AC-45E8-9896-84C7B0F548BC|2||||TESTOSWB|TESTOSTERONE, WEAKLY BOUND|||||||ML/ANIMAL/WK|||||||BORDERLINE||ML/H||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|DRIED|U|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|Y|NA|||NA|3||39||CONTINUATION TREATMENT|1962-06-16|1970-11-22|||||1965-04-14||1961-07-27|U|1972-05-02
TRIAL STUDY 134XCP|LB|10E1249E-10AC-45E8-9896-84C7B0F548BC|1||||ANIONG3|ANION GAP 3|||||||ENZYME U/G HB|||||||POSITIVE||STEPS/MIN||||ABNORMAL|NOT DONE||||SEBUM|GELLED|Y|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||U|N|Y|U|||NA|4||88||FOLLOW-UP|1964-02-29|1962-02-12|||||1964-12-07||1965-02-09|U|1963-05-15
TRIAL STUDY 134XCP|LB|10E1249E-10AC-45E8-9896-84C7B0F548BC|2||||FBNCTPL|FIBRONECTIN, PLASMA|||||||GMFI|||||||TRACE||MPL U/ML||||NORMAL|NOT DONE||||SEMINAL FLUID|LIPEMIC|NA|ACRIDINE ORANGE STAIN|GMI % FORMULA||Y|Y|NA|Y|||N|4||88||LONG-TERM FOLLOW-UP|1965-01-07|1962-10-28|||||1964-03-13||1965-02-20|N|1961-10-25
TRIAL STUDY 134XCP|LB|10E1249E-10AC-45E8-9896-84C7B0F548BC|1||||GRANCE|GRANULOCYTES/TOTAL CELLS|||||||MG/M2|||||||NEGATIVE||NMOL/L/MIN||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CONTAMINATED|N|LAPAROSCOPY|COCKCROFT-GAULT FORMULA||Y|NA|Y|NA|||Y|5||7||TREATMENT|1961-09-21|1966-05-07|||||1968-12-01||1960-11-10|N|1971-11-06
TRIAL STUDY 134XCP|LB|10E1249E-10AC-45E8-9896-84C7B0F548BC|2||||FENA|FRACTIONAL SODIUM EXCRETION|||||||LOG10 TCID 50/ML|||||||POSITIVE||FINGERTIP UNIT||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|UNEXPECTED ODOR|U|AUTOREFRACTION|MDRD 6 VARIABLE FORMULA||Y|U|NA|Y|||N|5||7||TREATMENT|1968-12-19|1962-09-25|||||1969-01-08||1966-10-26|N|1964-11-06
TRIAL STUDY 134XCP|LB|6CA97CE0-D120-4E14-A82F-4799D2699110|1||||INTLK12B|INTERLEUKIN 12 BETA|||||||LOG10 CFU/ML|||||||INVALID||DB||||NORMAL|NOT DONE||||SKIN TISSUE|ICTERIC|U|QUANTITATIVE CORONARY ANGIOGRAPHY|NASH FIBROSURE FORMULA||NA|U|U|Y|||Y|1||38||CONTINUATION TREATMENT|1973-07-15|1966-07-01|||||1961-10-13||1973-01-18|NA|1966-07-28
TRIAL STUDY 134XCP|LB|6CA97CE0-D120-4E14-A82F-4799D2699110|2||||CKMM|CREATINE KINASE MM|||||||LOG10 ELISA UNIT|||||||INVALID||MKAT||||HIGH|NOT DONE||||SEBUM|PARAFFIN-EMBEDDED|NA|MALDI-TOF|MDRD 5 VARIABLE FORMULA||NA|NA|U|U|||U|1||38||BLINDED TREATMENT|1972-12-23|1963-07-30|||||1965-04-07||1961-10-31|N|1963-08-03
TRIAL STUDY 134XCP|LB|6CA97CE0-D120-4E14-A82F-4799D2699110|1||||HDW|HEMOGLOBIN DISTRIBUTION WIDTH|||||||MOSM/L|||||||INVALID||VP/ML||||HIGH|NOT DONE||||PLEURAL TISSUE|DRIED|Y|SLOAN LETTER EYE CHART 2.5%|MDRD FORMULA||U|Y|U|U|||NA|2||58||LONG-TERM FOLLOW-UP|1972-08-17|1971-01-02|||||1972-03-07||1966-11-23|NA|1961-07-09
TRIAL STUDY 134XCP|LB|6CA97CE0-D120-4E14-A82F-4799D2699110|2||||FATACFR|FREE FATTY ACID|||||||L/MIN/M2|||||||POSITIVE||UG/KG/MIN||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|AGGLUTINATED|N|TOTAL BODY RADIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|U|Y|||N|2||58||RUN-IN|1961-09-10|1964-10-26|||||1967-09-05||1968-09-03|N|1965-09-11
TRIAL STUDY 134XCP|LB|6CA97CE0-D120-4E14-A82F-4799D2699110|1||||TRP|TRYPTOPHAN|||||||MMHG*MIN/L|||||||NEGATIVE||MM3/MM2/YEAR||||LOW|NOT DONE||||DERMAL TISSUE|THAWED|U|LC/MS|CKD-EPI FORMULA||N|Y|Y|NA|||Y|3||39||SCREENING|1965-09-23|1964-03-02|||||1967-06-19||1967-11-03|N|1966-01-12
TRIAL STUDY 134XCP|LB|6CA97CE0-D120-4E14-A82F-4799D2699110|2||||AZURGRAN|AZUROPHILIC GRANULES|||||||ML/M2|||||||INVALID||PG/DL||||LOW|NOT DONE||||BASAL TEAR|AGGLUTINATED|NA|ELASTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|U|U|N|||N|3||39||FOLLOW-UP|1971-09-07|1962-07-06|||||1972-06-02||1972-09-13|U|1960-11-24
TRIAL STUDY 134XCP|LB|6CA97CE0-D120-4E14-A82F-4799D2699110|1||||MONOBLLE|MONOBLASTS/LEUKOCYTES|||||||MG/M2/DAY|||||||BORDERLINE||DDU||||HIGH|NOT DONE||||BONE|AUTOLYZED|N|BIOPSY|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|N|||Y|4||88||WASHOUT|1962-08-14|1963-12-13|||||1973-02-06||1960-07-17|Y|1966-08-05
TRIAL STUDY 134XCP|LB|6CA97CE0-D120-4E14-A82F-4799D2699110|2||||S100B|S100 CALCIUM-BINDING PROTEIN B|||||||DROP|||||||BORDERLINE||KA_U/DL||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FROZEN|U|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|FIBROSIS 4 FORMULA||U|N|U|N|||N|4||88||INDUCTION TREATMENT|1964-03-24|1966-02-18|||||1962-12-08||1963-06-06|N|1968-09-30
TRIAL STUDY 134XCP|LB|6CA97CE0-D120-4E14-A82F-4799D2699110|1||||MICA|MHC CLASS I CHAIN RELATED PROTEIN A|||||||FEU|||||||BORDERLINE||AMPULE||||NORMAL|NOT DONE||||EPITHELIAL CELL|LACTESCENT|N|COLORIMETRY|FIBROMETER FORMULA||U|Y|N|N|||NA|5||7||OPEN LABEL TREATMENT|1960-03-04|1964-04-13|||||1961-03-15||1962-12-09|NA|1967-06-24
TRIAL STUDY 134XCP|LB|6CA97CE0-D120-4E14-A82F-4799D2699110|2||||CORTISOL|CORTISOL|||||||NG/MOL|||||||INVALID||MBQ||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|LACTESCENT|NA|PYROSEQUENCING|MDRD 4 VARIABLE FORMULA||U|Y|U|N|||U|5||7||OPEN LABEL TREATMENT|1965-01-10|1969-06-17|||||1963-09-03||1961-07-17|U|1965-06-16
TRIAL STUDY 134XCP|LB|D807C3F6-0955-4742-A29B-815682559530|1||||PROTSFR|PROTEIN S, FREE|||||||MMHG*MIN/L|||||||NEGATIVE||TROCHE||||NORMAL|NOT DONE||||TUMOR TISSUE|CALCIFIED|N|APPLANATION TONOMETRY|CKD-EPI FORMULA||U|Y|Y|NA|||U|1||38||WASHOUT|1973-03-01|1972-10-26|||||1964-11-02||1973-05-28|NA|1966-03-19
TRIAL STUDY 134XCP|LB|D807C3F6-0955-4742-A29B-815682559530|2||||TYR|TYROSINE|||||||FMOL/G|||||||INDETERMINATE||ECL UNIT||||HIGH|NOT DONE||||STOOL|LACTESCENT|NA|IMPULSE OSCILLOMETRY|FIBROSIS 4 FORMULA||N|Y|NA|U|||NA|1||38||LONG-TERM FOLLOW-UP|1972-04-01|1973-05-09|||||1962-01-08||1963-10-13|U|1970-02-23
TRIAL STUDY 134XCP|LB|D807C3F6-0955-4742-A29B-815682559530|1||||KI67|KI-67|||||||ML/MIN|||||||INVALID||10^9 CFU/ML||||HIGH|NOT DONE||||VENOUS BLOOD|LACTESCENT|NA|LAPAROSCOPY|MDRD 6 VARIABLE FORMULA||U|U|N|NA|||NA|2||58||LONG-TERM FOLLOW-UP|1971-07-31|1961-10-23|||||1963-10-11||1960-12-30|U|1971-05-25
TRIAL STUDY 134XCP|LB|D807C3F6-0955-4742-A29B-815682559530|2||||RESISTIN|RESISTIN|||||||MET*H|||||||INVALID||NU/CL||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|REFRIGERATED|NA|FLOW CYTOMETRY|CKD-EPI CYSTATIN C FORMULA||U|NA|N|U|||U|2||58||TREATMENT|1971-12-22|1970-01-02|||||1969-08-01||1970-07-10|Y|1970-06-20
TRIAL STUDY 134XCP|LB|D807C3F6-0955-4742-A29B-815682559530|1||||HYDROGEN|HYDROGEN|||||||CI/L|||||||NEGATIVE||HOURS||||LOW|NOT DONE||||SPUTUM|AUTOLYZED|U|ANALYTICAL ULTRACENTRIFUGATION|COCKCROFT-GAULT FORMULA||NA|Y|N|Y|||U|3||39||OPEN LABEL TREATMENT|1966-10-08|1968-09-12|||||1973-08-13||1970-04-17|N|1970-10-28
TRIAL STUDY 134XCP|LB|D807C3F6-0955-4742-A29B-815682559530|2||||CEACAM1|CEA CELL ADHESION MOLECULE 1|||||||G/M2|||||||NEGATIVE||/500 WBC||||LOW|NOT DONE||||PLATELET RICH PLASMA|FROZEN|N|CONFOCAL MICROSCOPY|CKD-EPI FORMULA||U|U|U|U|||U|3||39||INDUCTION TREATMENT|1973-01-02|1968-05-23|||||1963-02-14||1970-02-21|U|1972-11-20
TRIAL STUDY 134XCP|LB|D807C3F6-0955-4742-A29B-815682559530|1||||CYP2C9|CYTOCHROME P450 2C9|||||||G/G|||||||INVALID||/DAY||||ABNORMAL|NOT DONE||||BREAST MILK|CALCIFIED|N|PHOROPTER|ASH FIBROSURE FORMULA||Y|Y|N|N|||U|4||88||BLINDED TREATMENT|1964-04-09|1972-02-02|||||1969-09-03||1967-03-21|N|1968-05-09
TRIAL STUDY 134XCP|LB|D807C3F6-0955-4742-A29B-815682559530|2||||FACTVII|FACTOR VII|||||||G|||||||INDETERMINATE||/10^5||||LOW|NOT DONE||||ARTERIAL BLOOD|AGGLUTINATED|Y|WHOLE GENOME SEQUENCING|MDRD 5 VARIABLE FORMULA||N|NA|Y|U|||U|4||88||TREATMENT|1960-05-16|1966-04-29|||||1969-03-04||1965-01-02|N|1970-02-12
TRIAL STUDY 134XCP|LB|D807C3F6-0955-4742-A29B-815682559530|1||||RETIRBC|RETICULOCYTES/ERYTHROCYTES|||||||10^4/HPF|||||||TRACE||CFU/G||||HIGH|NOT DONE||||CAPILLARY PLASMA|CONTAMINATED|Y|CYSTOMETRY|GMI MMOL/MOL FORMULA||NA|NA|NA|NA|||U|5||7||BLINDED TREATMENT|1965-08-06|1966-07-23|||||1971-11-20||1967-01-29|N|1964-08-14
TRIAL STUDY 134XCP|LB|D807C3F6-0955-4742-A29B-815682559530|2||||MMP2|MATRIX METALLOPROTEINASE 2|||||||10^6 ORGANISMS/G|||||||INDETERMINATE||AMPULE||||ABNORMAL|NOT DONE||||TUMOR TISSUE|NON-HEMOLYZED|N|SPECULAR MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|Y|NA|NA|||NA|5||7||OBSERVATION|1965-04-29|1969-08-09|||||1966-06-02||1962-09-15|Y|1961-02-03
TRIAL STUDY 134XCP|LB|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|1||||ERCEPIDX|ERYTHROID PROLIFERATION INDEX|||||||NG/DAY|||||||INVALID||OSM||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|LIPEMIC|Y|THICK SMEAR|HEPASCORE FORMULA||Y|N|U|U|||N|1||38||SCREENING|1961-05-11|1962-02-17|||||1960-12-15||1964-09-09|N|1966-11-29
TRIAL STUDY 134XCP|LB|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|2||||INTLK25|INTERLEUKIN 25|||||||BQ/ML|||||||TRACE||/LPF||||ABNORMAL|NOT DONE||||LOCHIA|CONCENTRATED|N|SXA SCAN|COCKCROFT-GAULT FORMULA||N|NA|NA|NA|||NA|1||38||CONTINUATION TREATMENT|1968-05-31|1962-10-25|||||1963-02-02||1964-09-25|Y|1966-07-18
TRIAL STUDY 134XCP|LB|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|1||||KLOTHO|KLOTHO|||||||EJACULATE U|||||||INDETERMINATE||UIU/L||||HIGH|NOT DONE||||EXPIRED AIR|CALCIFIED|Y|SANGER SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|NA|N|||Y|2||58||INDUCTION TREATMENT|1970-06-02|1966-09-24|||||1962-10-26||1960-04-24|NA|1962-02-22
TRIAL STUDY 134XCP|LB|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|2||||MONOLE|MONOCYTES/LEUKOCYTES|||||||/HPF|||||||NEGATIVE||G/L||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|ROOM TEMPERATURE|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|GMI % FORMULA||Y|NA|U|N|||NA|2||58||OBSERVATION|1973-07-06|1973-04-27|||||1968-10-31||1969-04-04|U|1972-03-25
TRIAL STUDY 134XCP|LB|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|1||||VMA|VANILLYL MANDELIC ACID|||||||10^6/HPF|||||||TRACE||TITER||||ABNORMAL|NOT DONE||||TRANSUDATE|REFRIGERATED|NA|URANYL ACETATE STAIN|MDRD 5 VARIABLE FORMULA||N|N|U|U|||U|3||39||OPEN LABEL TREATMENT|1966-04-14|1968-09-04|||||1973-01-12||1962-03-23|Y|1963-02-20
TRIAL STUDY 134XCP|LB|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|2||||CACRALB|CALCIUM CORRECTED FOR ALBUMIN|||||||NKAT|||||||BORDERLINE||HR/DAY||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|LACTESCENT|U|OLIGO ACGH|CKD-EPI CYSTATIN C FORMULA||Y|U|Y|U|||N|3||39||RUN-IN|1966-09-16|1961-10-10|||||1964-05-07||1960-02-07|NA|1964-03-02
TRIAL STUDY 134XCP|LB|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|1||||CD14|CD14|||||||GRAVITATIONAL UNIT|||||||POSITIVE||ML/KG/MIN||||ABNORMAL|NOT DONE||||PLATELET|THAWED|Y|HILLMEN COLOR CHART|FIBROTEST FORMULA||N|U|N|Y|||NA|4||88||OBSERVATION|1971-05-02|1972-08-31|||||1963-06-01||1972-06-25|NA|1971-12-30
TRIAL STUDY 134XCP|LB|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|2||||OXMORPHN|OXYMORPHONE|||||||L/DAY|||||||TRACE||ANTI-XA IU||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|CALCIFIED|NA|COULOMETRIC TITRATION|FIBROMETER FORMULA||Y|U|Y|N|||N|4||88||SCREENING|1966-06-17|1968-07-09|||||1970-05-15||1960-04-15|Y|1967-08-20
TRIAL STUDY 134XCP|LB|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|1||||VWFAAC|VON WILL FACTOR ACT ACTUAL/CONTROL|||||||DPM/MG|||||||BORDERLINE||NU/CL||||ABNORMAL|NOT DONE||||KERATINOCYTE|AGGLUTINATED|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|MDRD FORMULA||Y|Y|NA|Y|||NA|5||7||CONTINUATION TREATMENT|1963-11-13|1963-05-25|||||1970-10-24||1971-08-01|U|1968-09-28
TRIAL STUDY 134XCP|LB|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|2||||AMYLOIDB|AMYLOID, BETA|||||||G/KG|||||||BORDERLINE||PPTR||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|LACTESCENT|Y|ISHIHARA COLOR PLATES|MDRD 6 VARIABLE FORMULA||Y|U|NA|NA|||U|5||7||BASELINE|1973-07-12|1969-05-27|||||1962-04-06||1966-11-17|N|1962-06-26
TRIAL STUDY 134XCP|LB|38C36B22-EC60-4D40-A1B6-71B17F8C8625|1||||IGGSYNRT|IGG SYNTHESIS RATE|||||||MG/MIN|||||||BORDERLINE||10^6 DNA COPIES/ML||||HIGH|NOT DONE||||GASTRIC CONTENTS|DRIED|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 6 VARIABLE FORMULA||N|Y|NA|NA|||N|1||38||CONTINUATION TREATMENT|1964-11-13|1970-07-26|||||1970-03-30||1964-12-22|Y|1969-05-25
TRIAL STUDY 134XCP|LB|38C36B22-EC60-4D40-A1B6-71B17F8C8625|2||||SCKLCE|SICKLE CELLS|||||||AMPULE|||||||NEGATIVE||KCAL||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|PARAFFIN-EMBEDDED|N|CONFOCAL MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|NA|NA|||Y|1||38||BASELINE|1965-04-10|1964-06-23|||||1967-12-13||1967-07-03|NA|1966-08-24
TRIAL STUDY 134XCP|LB|38C36B22-EC60-4D40-A1B6-71B17F8C8625|1||||INSAAB|INSULIN AUTOANTIBODY|||||||UG/M2/H|||||||INDETERMINATE||10^6 IU/ML||||NORMAL|NOT DONE||||AQUEOUS HUMOR|DRIED|NA|ULTRASOUND|FIBROSIS 4 FORMULA||N|N|N|U|||Y|2||58||SCREENING|1971-04-06|1971-11-02|||||1972-07-03||1960-06-14|NA|1966-01-18
TRIAL STUDY 134XCP|LB|38C36B22-EC60-4D40-A1B6-71B17F8C8625|2||||GLOBA1PT|ALPHA-1 GLOBULIN/TOTAL PROTEIN|||||||10^7 PFU|||||||NEGATIVE||UG/G/MIN||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CLOTTED|U|PULMONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||N|N|N|NA|||U|2||58||TREATMENT|1964-02-24|1963-12-25|||||1967-01-08||1960-10-26|Y|1963-07-16
TRIAL STUDY 134XCP|LB|38C36B22-EC60-4D40-A1B6-71B17F8C8625|1||||MIP1B|MACROPHAGE INFLAMMATORY PROTEIN 1 BETA|||||||10^3 ORGANISMS|||||||POSITIVE||UG/ANIMAL||||HIGH|NOT DONE||||HAIR|FROZEN|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI CYSTATIN C FORMULA||N|NA|Y|NA|||NA|3||39||CONTINUATION TREATMENT|1966-05-09|1964-10-21|||||1968-07-01||1968-03-21|N|1965-06-15
TRIAL STUDY 134XCP|LB|38C36B22-EC60-4D40-A1B6-71B17F8C8625|2||||ALP|ALKALINE PHOSPHATASE|||||||M3|||||||INDETERMINATE||MCI/KG||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CONTAMINATED|Y|ROMANOWSKY STAIN|COCKCROFT-GAULT FORMULA||N|Y|NA|Y|||Y|3||39||WASHOUT|1973-03-27|1969-09-23|||||1961-10-14||1973-06-11|Y|1966-01-24
TRIAL STUDY 134XCP|LB|38C36B22-EC60-4D40-A1B6-71B17F8C8625|1||||INTLK5|INTERLEUKIN 5|||||||U/MG|||||||POSITIVE||/KG||||LOW|NOT DONE||||MENSTRUAL BLOOD|CALCIFIED|NA|STRESS ECHOCARDIOGRAPHY|NASH FIBROSURE FORMULA||Y|NA|N|N|||Y|4||88||SCREENING|1966-10-02|1967-07-09|||||1967-03-04||1965-04-08|Y|1970-04-02
TRIAL STUDY 134XCP|LB|38C36B22-EC60-4D40-A1B6-71B17F8C8625|2||||LYS|LYSINE|||||||% INHIBITION|||||||INDETERMINATE||/WK||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|LIPEMIC|U|IODINE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|NA|U|||U|4||88||LONG-TERM FOLLOW-UP|1967-06-23|1971-10-03|||||1971-07-24||1961-01-10|Y|1964-10-01
TRIAL STUDY 134XCP|LB|38C36B22-EC60-4D40-A1B6-71B17F8C8625|1||||CAPHOS|CALCIUM/PHOSPHORUS|||||||BOTTLE|||||||TRACE||10^9 ORGANISMS/MG||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|NA|TELLER ACUITY CARDS|NASH FIBROSURE FORMULA||NA|NA|N|NA|||N|5||7||WASHOUT|1968-07-08|1960-04-13|||||1964-03-26||1972-02-06|NA|1973-07-26
TRIAL STUDY 134XCP|LB|38C36B22-EC60-4D40-A1B6-71B17F8C8625|2||||GLOBA1|ALPHA-1 GLOBULIN|||||||IU/G|||||||INDETERMINATE||MG/KG/WEEK||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|AUTOLYZED|N|NUCLEIC ACID HYBRIDIZATION|MDRD FORMULA||NA|U|NA|U|||Y|5||7||BASELINE|1962-05-18|1969-03-25|||||1970-04-10||1960-01-02|U|1966-04-23
TRIAL STUDY 134XCP|LB|E2F4144C-543D-4F55-A94E-58F244FB21D1|1||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||IU/KG/H|||||||POSITIVE||/H||||NORMAL|NOT DONE||||STOOL|CALCIFIED|Y|PEAK FLOWMETRY|MDRD 6 VARIABLE FORMULA||U|NA|N|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1961-09-21|1969-04-27|||||1971-04-22||1970-03-06|U|1969-07-17
TRIAL STUDY 134XCP|LB|E2F4144C-543D-4F55-A94E-58F244FB21D1|2||||FDP|FIBRIN DEGRADATION PRODUCTS|||||||MBQ/UL|||||||BORDERLINE||VIRTUAL PIXEL||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|LIPEMIC|N|IMMUNODIFFUSION|MDRD FORMULA||N|NA|NA|NA|||U|1||38||CONTINUATION TREATMENT|1968-10-07|1965-06-30|||||1971-04-10||1969-02-12|Y|1963-07-19
TRIAL STUDY 134XCP|LB|E2F4144C-543D-4F55-A94E-58F244FB21D1|1||||ACANTRBC|ACANTHOCYTES/ERYTHROCYTES|||||||PMOL/L|||||||NEGATIVE||SV||||NORMAL|NOT DONE||||MENSTRUAL BLOOD|SOLIDIFIED|U|DYNAMIC LIGHT SCATTERING|MDRD 6 VARIABLE FORMULA||N|NA|N|N|||N|2||58||OBSERVATION|1963-09-29|1964-11-09|||||1963-07-04||1963-06-17|U|1968-07-13
TRIAL STUDY 134XCP|LB|E2F4144C-543D-4F55-A94E-58F244FB21D1|2||||IL6SR|SOLUBLE INTERLEUKIN 6 RECEPTOR|||||||ELISA UNIT|||||||TRACE||UL/KG/DAY||||ABNORMAL|NOT DONE||||TUMOR TISSUE|ICTERIC|Y|DUKE INCISION METHOD|FIBROSIS 4 FORMULA||U|N|NA|N|||N|2||58||OPEN LABEL TREATMENT|1963-02-06|1969-10-20|||||1962-06-29||1961-06-03|Y|1971-05-01
TRIAL STUDY 134XCP|LB|E2F4144C-543D-4F55-A94E-58F244FB21D1|1||||CYSCREAT|CYSTATIN C/CREATININE|||||||/DAY|||||||INVALID||MIN*MG/ML||||HIGH|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LACTESCENT|U|CONTRAST ENHANCED CT SCAN|ASH FIBROSURE FORMULA||Y|Y|NA|NA|||Y|3||39||OBSERVATION|1965-08-02|1973-07-18|||||1967-05-30||1973-06-21|NA|1966-06-15
TRIAL STUDY 134XCP|LB|E2F4144C-543D-4F55-A94E-58F244FB21D1|2||||SPMAGGLU|SPERM AGGLUTINATION|||||||COULOMB|||||||NEGATIVE||10^9 ORGANISMS/G||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|THAWED|NA|CYSTOMETRY|MDRD 5 VARIABLE FORMULA||Y|U|Y|N|||U|3||39||FOLLOW-UP|1967-09-28|1972-01-10|||||1970-08-30||1972-11-09|Y|1972-06-06
TRIAL STUDY 134XCP|LB|E2F4144C-543D-4F55-A94E-58F244FB21D1|1||||MDC|MACROPHAGE-DERIVED CHEMOKINE|||||||PLUG|||||||TRACE||KPA/L/SEC||||LOW|NOT DONE||||SERUM|FROZEN|U|SNELLEN EYE CHART|CKD-EPI CYSTATIN C FORMULA||Y|N|N|NA|||U|4||88||INDUCTION TREATMENT|1970-02-04|1960-10-13|||||1969-10-18||1968-05-26|N|1965-07-27
TRIAL STUDY 134XCP|LB|E2F4144C-543D-4F55-A94E-58F244FB21D1|2||||CTXICRT|TYPE I COLLAGEN C-TELOPEPTIDES/CREAT|||||||NMOL BCE/NMOL|||||||INVALID||10^3 DNA COPIES/ML||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|THAWED|Y|AMSLER GRID|HEPASCORE FORMULA||N|N|U|NA|||NA|4||88||INDUCTION TREATMENT|1966-04-28|1968-05-04|||||1962-04-03||1972-06-19|U|1963-10-19
TRIAL STUDY 134XCP|LB|E2F4144C-543D-4F55-A94E-58F244FB21D1|1||||IFNB|INTERFERON BETA|||||||MG/L|||||||POSITIVE||G/KG/DAY||||HIGH|NOT DONE||||LUNG SURFACTANT|CONCENTRATED|U|LC/MS/MS|HEPASCORE FORMULA||NA|NA|Y|Y|||Y|5||7||WASHOUT|1970-05-07|1971-01-22|||||1969-02-24||1960-04-11|U|1970-10-14
TRIAL STUDY 134XCP|LB|E2F4144C-543D-4F55-A94E-58F244FB21D1|2||||COCAINE|COCAINE|||||||SFC/10^6 PBMC|||||||POSITIVE||LENS||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT|NA|PLAQUE REDUCTION NEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA||Y|NA|Y|N|||U|5||7||TREATMENT|1971-02-11|1972-09-22|||||1964-06-02||1964-07-04|N|1971-12-06
TRIAL STUDY 134XCP|LB|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|1||||VLDL3|VLDL CHOLESTEROL SUBTYPE 3|||||||KG/MOL|||||||POSITIVE||BEATS/MIN||||NORMAL|NOT DONE||||LOCHIA|FRESH|N|CELLULAR PROLIFERATION ASSAY|FIBROSIS 4 FORMULA||N|NA|U|NA|||NA|1||38||BLINDED TREATMENT|1960-12-17|1970-04-04|||||1961-04-24||1964-10-23|N|1961-11-30
TRIAL STUDY 134XCP|LB|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|2||||GLTRCE|GLITTER CELLS|||||||GBQ/MG|||||||BORDERLINE||MEQ/KG||||ABNORMAL|NOT DONE||||TRANSUDATE|NON-HEMOLYZED|N|BALLPOINT PEN TECHNIQUE|CKD-EPI FORMULA||U|NA|Y|NA|||Y|1||38||FOLLOW-UP|1972-01-07|1971-11-27|||||1968-02-12||1969-11-07|N|1969-01-09
TRIAL STUDY 134XCP|LB|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|1||||ELA1|PANCREATIC ELASTASE 1|||||||SPRAY|||||||NEGATIVE||MNFI||||LOW|NOT DONE||||KERATINOCYTE|REFRIGERATED|N|POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA||NA|NA|N|U|||Y|2||58||OPEN LABEL TREATMENT|1965-06-05|1967-05-29|||||1964-09-20||1966-04-20|Y|1966-08-16
TRIAL STUDY 134XCP|LB|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|2||||CYURIAC|URIC ACID CRYSTALS|||||||U/G|||||||POSITIVE||ARBITRARY U||||NORMAL|NOT DONE||||SPERMATOZOON|ROOM TEMPERATURE|NA|QUANTITATIVE ULTRASOUND|CKD-EPI CREATININE FORMULA||NA|NA|Y|NA|||NA|2||58||BLINDED TREATMENT|1970-05-15|1973-07-13|||||1962-03-15||1971-06-05|U|1970-01-09
TRIAL STUDY 134XCP|LB|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|1||||MSTHCE|MESOTHELIAL CELLS|||||||APL U|||||||NEGATIVE||ML/CM3/MIN||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|ROOM TEMPERATURE|NA|AUDIOMETRY|MDRD 6 VARIABLE FORMULA||NA|N|NA|Y|||U|3||39||SCREENING|1969-08-15|1969-07-28|||||1969-07-26||1970-10-19|N|1970-06-18
TRIAL STUDY 134XCP|LB|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|2||||CARNITAT|CARNITINE ACETYL TRANSFERASE|||||||CIGAR|||||||POSITIVE||U/MMOL||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|REFRIGERATED|N|SINGLE-MOLECULE ARRAY|NASH FIBROSURE FORMULA||N|N|Y|Y|||N|3||39||SCREENING|1960-07-18|1969-09-25|||||1965-11-19||1973-01-14|NA|1965-07-16
TRIAL STUDY 134XCP|LB|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|1||||EPHD|EPHEDRINE|||||||AMU|||||||INVALID||AU/ML||||HIGH|NOT DONE||||BUFFY COAT|FROZEN|NA|BAC ACGH|ASH FIBROSURE FORMULA||NA|Y|N|U|||U|4||88||LONG-TERM FOLLOW-UP|1970-03-09|1972-05-30|||||1971-07-18||1961-08-01|Y|1962-07-20
TRIAL STUDY 134XCP|LB|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|2||||FLUVOXAM|FLUVOXAMINE|||||||CI|||||||INDETERMINATE||MET*H||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|CALCIFIED|N|CELLULOSE TAPE|FIBROTEST FORMULA||N|U|U|N|||Y|4||88||CONTINUATION TREATMENT|1973-05-27|1965-04-16|||||1967-09-02||1969-05-29|U|1973-01-13
TRIAL STUDY 134XCP|LB|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|1||||EPINEXR|EPINEPHRINE EXCRETION RATE|||||||TRANSDUCING UNIT/ML|||||||TRACE||PKAT||||LOW|NOT DONE||||PERITONEAL FLUID|ROOM TEMPERATURE|U|PHOTOMETRY|COCKCROFT-GAULT FORMULA||N|N|U|NA|||Y|5||7||BASELINE|1972-01-28|1960-05-10|||||1965-04-21||1960-04-10|U|1962-07-15
TRIAL STUDY 134XCP|LB|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|2||||A1MCREAT|ALPHA-1 MICROGLOBULIN/CREATININE|||||||/5X10^4 WBC|||||||BORDERLINE||MDFI||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|CONCENTRATED|U|ICP-MS|ASH FIBROSURE FORMULA||U|Y|U|N|||N|5||7||SCREENING|1969-01-19|1969-11-06|||||1961-04-07||1966-06-19|N|1963-03-25
TRIAL STUDY 134XCP|LB|49B857CF-22F2-406F-A269-54944B23C236|1||||TCHT|TAUROCHOLATE|||||||COPIES/ML|||||||NEGATIVE||MS/MMHG||||LOW|NOT DONE||||MIXED VENOUS BLOOD|PARAFFIN-EMBEDDED|Y|TRYPAN BLUE STAIN|CKD-EPI CYSTATIN C FORMULA||N|N|Y|N|||Y|1||38||CONTINUATION TREATMENT|1961-09-04|1961-05-14|||||1973-04-23||1972-06-09|U|1970-10-08
TRIAL STUDY 134XCP|LB|49B857CF-22F2-406F-A269-54944B23C236|2||||PHOSCLR|PHOSPHATE CLEARANCE|||||||MG/ANIMAL|||||||BORDERLINE||LOZENGE||||NORMAL|NOT DONE||||VENOUS BLOOD|AUTOLYZED|NA|NEXT GENERATION TARGETED SEQUENCING|MDRD 5 VARIABLE FORMULA||NA|NA|N|N|||Y|1||38||BASELINE|1966-07-06|1972-01-04|||||1968-11-27||1970-11-15|N|1965-01-17
TRIAL STUDY 134XCP|LB|49B857CF-22F2-406F-A269-54944B23C236|1||||C5B9S|SOLUBLE COMPLEMENT C5B-9|||||||MOSM|||||||TRACE||S/H||||NORMAL|NOT DONE||||SEBUM|DRIED|U|LC-FL|GMI % FORMULA||NA|NA|NA|NA|||NA|2||58||WASHOUT|1967-10-04|1972-07-01|||||1971-09-13||1970-06-13|Y|1965-06-16
TRIAL STUDY 134XCP|LB|49B857CF-22F2-406F-A269-54944B23C236|2||||FACTVIIA|FACTOR VII ACTIVITY|||||||UG/L FEU|||||||BORDERLINE||U/G||||HIGH|NOT DONE||||SERUM OR PLASMA|FROZEN|NA|IMMUNODIFFUSION|ASH FIBROSURE FORMULA||N|U|U|NA|||Y|2||58||RUN-IN|1966-04-13|1964-07-19|||||1962-09-30||1965-07-11|NA|1966-04-06
TRIAL STUDY 134XCP|LB|49B857CF-22F2-406F-A269-54944B23C236|1||||CMONOX|CARBON MONOXIDE|||||||DYN|||||||TRACE||KUSP||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|LIPEMIC|N|CONTRAST ENHANCED X-RAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|Y|||Y|3||39||FOLLOW-UP|1968-07-29|1972-04-25|||||1961-07-07||1967-03-19|Y|1970-06-02
TRIAL STUDY 134XCP|LB|49B857CF-22F2-406F-A269-54944B23C236|2||||PGD2S|PROSTAGLANDIN D2 SYNTHASE|||||||PNU/ML|||||||BORDERLINE||YEARS||||NORMAL|NOT DONE||||BONE|LIPEMIC|N|SPECTROPHOTOMETRY|COCKCROFT-GAULT FORMULA||NA|N|Y|N|||N|3||39||BLINDED TREATMENT|1961-03-02|1968-09-17|||||1968-09-27||1967-11-23|N|1971-12-23
TRIAL STUDY 134XCP|LB|49B857CF-22F2-406F-A269-54944B23C236|1||||TNF12|TNF SUPERFAMILY MEMBER 12|||||||/MS|||||||NEGATIVE||FT2||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|REFRIGERATED|Y|ELECTROGASTROGRAPHY|HEPASCORE FORMULA||U|NA|Y|U|||Y|4||88||RUN-IN|1971-10-11|1968-01-28|||||1971-01-19||1961-05-20|U|1962-11-26
TRIAL STUDY 134XCP|LB|49B857CF-22F2-406F-A269-54944B23C236|2||||PROMY|PROMYELOCYTES|||||||CI/UL|||||||INVALID||TROCHE||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|LACTESCENT|N|MYELOPEROXIDASE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|Y|U|||Y|4||88||TREATMENT|1961-07-06|1961-04-04|||||1962-10-18||1963-04-26|U|1961-07-21
TRIAL STUDY 134XCP|LB|49B857CF-22F2-406F-A269-54944B23C236|1||||FACTXI|FACTOR XI|||||||KPA/L/SEC|||||||INVALID||NG||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|REFRIGERATED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|HEPASCORE FORMULA||N|Y|N|Y|||N|5||7||BLINDED TREATMENT|1970-06-17|1968-03-17|||||1973-05-17||1973-01-28|Y|1966-01-02
TRIAL STUDY 134XCP|LB|49B857CF-22F2-406F-A269-54944B23C236|2||||FCTVIIIA|FACTOR VIII ACTIVITY|||||||MG/MOL|||||||POSITIVE||% INHIBITION||||LOW|NOT DONE||||VITREOUS HUMOR|CLOTTED|NA|MICROBIAL CONCENTRATION|MDRD 4 VARIABLE FORMULA||NA|Y|U|U|||Y|5||7||OBSERVATION|1972-01-03|1970-02-18|||||1963-01-21||1967-04-28|NA|1967-04-03
TRIAL STUDY 134XCP|LB|E09B394B-9E48-4132-B430-991DF1953A81|1||||INTLK3|INTERLEUKIN 3|||||||KUSP|||||||INDETERMINATE||FT3||||NORMAL|NOT DONE||||ALVEOLAR AIR|NON-HEMOLYZED|U|DNA MICROARRAY|NASH FIBROSURE FORMULA||U|Y|U|N|||Y|1||38||OPEN LABEL TREATMENT|1960-12-29|1964-12-22|||||1968-12-05||1972-02-16|NA|1967-06-12
TRIAL STUDY 134XCP|LB|E09B394B-9E48-4132-B430-991DF1953A81|2||||ACHE|ACETYLCHOLINESTERASE|||||||MMAL|||||||INVALID||ELISA UNIT/ML||||LOW|NOT DONE||||SUPERNATANT, SERUM|NON-HEMOLYZED|NA|BALLPOINT PEN TECHNIQUE|HEPASCORE FORMULA||NA|Y|U|U|||N|1||38||BASELINE|1960-07-29|1970-09-13|||||1962-03-05||1970-07-29|U|1963-01-28
TRIAL STUDY 134XCP|LB|E09B394B-9E48-4132-B430-991DF1953A81|1||||C165938|COW MILK PROTEIN IGE AB RAST SCORE|||||||HOUNSFIELD UNIT|||||||BORDERLINE||ML/MMHG/MIN/L||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|FROZEN|Y|ARTERIAL SPIN LABELING FUNCTIONAL MRI|COCKCROFT-GAULT FORMULA||N|U|Y|NA|||N|2||58||OBSERVATION|1962-08-14|1965-01-22|||||1967-10-25||1968-01-11|N|1970-10-22
TRIAL STUDY 134XCP|LB|E09B394B-9E48-4132-B430-991DF1953A81|2||||MAYHEG|MAY-HEGGLIN ANOMALY|||||||UV*SEC|||||||BORDERLINE||BQ/UG||||NORMAL|NOT DONE||||ADIPOSE TISSUE|CONCENTRATED|Y|CONTRAST ENHANCED MRI|COCKCROFT-GAULT FORMULA||N|Y|Y|U|||Y|2||58||BLINDED TREATMENT|1966-11-24|1966-11-16|||||1962-12-28||1964-08-25|Y|1970-09-26
TRIAL STUDY 134XCP|LB|E09B394B-9E48-4132-B430-991DF1953A81|1||||GSTPIEXR|PI-GST EXCRETION RATE|||||||VG/ML|||||||TRACE||KHZ||||LOW|NOT DONE||||LYMPH|CONTAMINATED|N|PHOROPTER|GMI MMOL/MOL FORMULA||N|N|NA|NA|||Y|3||39||BLINDED TREATMENT|1960-04-06|1962-08-06|||||1973-02-05||1962-05-28|N|1963-12-14
TRIAL STUDY 134XCP|LB|E09B394B-9E48-4132-B430-991DF1953A81|2||||CODEINE|CODEINE|||||||MAMP|||||||INDETERMINATE||UG/M2/H||||ABNORMAL|NOT DONE||||TUMOR TISSUE|AUTOLYZED|U|FARR ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|N|||U|3||39||WASHOUT|1971-04-09|1973-03-23|||||1972-09-28||1966-03-29|U|1966-05-25
TRIAL STUDY 134XCP|LB|E09B394B-9E48-4132-B430-991DF1953A81|1||||APOA4|APOLIPOPROTEIN A4|||||||10^9/G|||||||INVALID||MKAT||||LOW|NOT DONE||||DISCHARGE|REFRIGERATED|U|CONTRAST ENHANCED CT SCAN|MDRD ENZYMATIC FORMULA||N|Y|NA|NA|||U|4||88||BASELINE|1968-08-04|1969-07-13|||||1961-06-16||1965-06-24|Y|1960-08-19
TRIAL STUDY 134XCP|LB|E09B394B-9E48-4132-B430-991DF1953A81|2||||THYATAB|THYROID ANTITHYROGLOBULIN ANTIBODIES|||||||MS2|||||||POSITIVE||KCAL/DAY||||NORMAL|NOT DONE||||MONOCYTE|CONCENTRATED|U|ACRIDINE ORANGE STAIN|CKD-EPI CREATININE FORMULA||N|Y|Y|U|||U|4||88||SCREENING|1960-07-10|1971-11-22|||||1971-08-07||1969-07-18|NA|1962-01-02
TRIAL STUDY 134XCP|LB|E09B394B-9E48-4132-B430-991DF1953A81|1||||PROMYB|PROMYELOBLASTS|||||||/2500 WBC|||||||INVALID||G/DAY||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|FRESH|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD ENZYMATIC FORMULA||N|U|U|Y|||U|5||7||WASHOUT|1973-03-13|1962-01-27|||||1969-03-22||1972-10-04|NA|1963-11-27
TRIAL STUDY 134XCP|LB|E09B394B-9E48-4132-B430-991DF1953A81|2||||APLIGGAB|ANTI-PHOSPHOLIPID IGG ANTIBODY|||||||G/DAY|||||||TRACE||GENEQ||||NORMAL|NOT DONE||||CELL PELLET|FRESH|Y|HPLC-UV|FIBROMETER FORMULA||N|Y|Y|NA|||U|5||7||OPEN LABEL TREATMENT|1961-08-06|1966-12-27|||||1964-03-08||1965-10-10|Y|1962-08-18
TRIAL STUDY 134XCP|LB|5FB65CB2-DB12-4D00-818E-C51992DC7273|1||||SMTHAB|SMITH ANTIBODY|||||||10^6 ORGANISMS/ML|||||||POSITIVE||CAL||||HIGH|NOT DONE||||GASTRIC FLUID|HEMOLYZED|U|RULER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA||Y|U|U|NA|||Y|1||38||BLINDED TREATMENT|1969-09-01|1967-09-17|||||1967-09-10||1972-11-05|N|1965-04-30
TRIAL STUDY 134XCP|LB|5FB65CB2-DB12-4D00-818E-C51992DC7273|2||||NEUTVAC|VACUOLATED NEUTROPHILS|||||||10^9 ORGANISMS/G|||||||POSITIVE||SACHET||||ABNORMAL|NOT DONE||||LYSATE|ROOM TEMPERATURE|Y|SPECULAR MICROSCOPY|FIBROTEST FORMULA||N|NA|Y|NA|||N|1||38||TREATMENT|1964-12-17|1965-09-01|||||1970-09-13||1965-02-05|N|1969-08-23
TRIAL STUDY 134XCP|LB|5FB65CB2-DB12-4D00-818E-C51992DC7273|1||||CYFRA211|CYTOKERATIN 19 FRAGMENT 21-1|||||||10^5/HPF|||||||INDETERMINATE||10^3 CFU/ML||||LOW|NOT DONE||||GASTRIC FLUID|SOLIDIFIED|Y|PERCUSSION|CKD-EPI CYSTATIN C FORMULA||NA|U|U|Y|||NA|2||58||TREATMENT|1972-09-30|1973-05-23|||||1970-08-12||1960-10-29|Y|1962-12-14
TRIAL STUDY 134XCP|LB|5FB65CB2-DB12-4D00-818E-C51992DC7273|2||||HRYCELE|HAIRY CELLS/LEUKOCYTES|||||||G/MOL|||||||POSITIVE||10^9/L||||ABNORMAL|NOT DONE||||EMOTIONAL TEAR|GELLED|Y|TOLUIDINE BLUE STAIN|MDRD 5 VARIABLE FORMULA||Y|NA|U|U|||Y|2||58||BLINDED TREATMENT|1965-07-03|1964-01-31|||||1961-09-28||1966-01-31|U|1965-04-19
TRIAL STUDY 134XCP|LB|5FB65CB2-DB12-4D00-818E-C51992DC7273|1||||MMP9|MATRIX METALLOPROTEINASE 9|||||||AMOL|||||||POSITIVE||IU||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|GELLED|U|ENZYMATIC SPECTROPHOTOMETRY|FIBROSIS 4 FORMULA||U|NA|Y|U|||NA|3||39||INDUCTION TREATMENT|1965-03-10|1966-06-25|||||1967-09-28||1965-11-28|Y|1971-08-24
TRIAL STUDY 134XCP|LB|5FB65CB2-DB12-4D00-818E-C51992DC7273|2||||ICAIGGAB|ISLET CELL CYTOPLASMIC IGG ANTIBODY|||||||VG/ML|||||||POSITIVE||AMOL||||HIGH|NOT DONE||||MONOCYTE|REFRIGERATED|N|ULTRASONOGRAPHIC ELASTOGRAPHY|NASH FIBROSURE FORMULA||Y|NA|N|N|||Y|3||39||FOLLOW-UP|1962-06-17|1961-05-10|||||1966-02-26||1969-07-12|Y|1967-10-05
TRIAL STUDY 134XCP|LB|5FB65CB2-DB12-4D00-818E-C51992DC7273|1||||ACE|ANGIOTENSIN CONVERTING ENZYME|||||||DIP|||||||INDETERMINATE||UG/KG/H||||HIGH|NOT DONE||||TUMOR TISSUE|HEMOLYZED|N|NUCLEIC ACID SEQUENCING|ASH FIBROSURE FORMULA||NA|NA|U|U|||Y|4||88||BLINDED TREATMENT|1961-09-29|1961-10-06|||||1966-03-24||1962-11-11|U|1972-05-08
TRIAL STUDY 134XCP|LB|5FB65CB2-DB12-4D00-818E-C51992DC7273|2||||EPISCECE|SQUAMOUS EPITHELIAL CELLS/TOTAL CELLS|||||||/10^5|||||||TRACE||KALLIKREIN INHIBITOR UNIT||||LOW|NOT DONE||||ARTERIAL BLOOD|AGGLUTINATED|N|MICROARRAY|CKD-EPI FORMULA||Y|U|NA|U|||Y|4||88||INDUCTION TREATMENT|1966-11-05|1962-10-13|||||1967-12-26||1960-06-22|U|1970-11-07
TRIAL STUDY 134XCP|LB|5FB65CB2-DB12-4D00-818E-C51992DC7273|1||||C130091|TIMOTHY GRASS POLLEN IGG4|||||||MHZ|||||||BORDERLINE||UV2||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|GELLED|Y|PATHOLOGICAL EVALUATION|FIBROMETER FORMULA||NA|NA|U|NA|||Y|5||7||CONTINUATION TREATMENT|1961-07-23|1961-04-19|||||1960-10-22||1968-05-19|N|1962-11-10
TRIAL STUDY 134XCP|LB|5FB65CB2-DB12-4D00-818E-C51992DC7273|2||||AMABARAB|ACH RECEPTOR MODULATN AB/ACH RECEPTOR AB|||||||ML/100G/MIN|||||||NEGATIVE||UG/DL||||HIGH|NOT DONE||||FLUID|UNEXPECTED ODOR|NA|CONFOCAL MICROSCOPY|MDRD ENZYMATIC FORMULA||Y|NA|U|U|||NA|5||7||INDUCTION TREATMENT|1963-09-06|1965-07-21|||||1969-03-02||1963-11-23|N|1961-08-07
TRIAL STUDY 134XCP|LB|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|1||||IDLP|IDL PARTICLES|||||||ML/G/H|||||||TRACE||100 IU/ML||||ABNORMAL|NOT DONE||||WHITE MATTER TISSUE|SOLIDIFIED|N|SCANNING ELECTRON MICROSCOPY|MDRD 5 VARIABLE FORMULA||NA|Y|Y|NA|||U|1||38||TREATMENT|1970-10-17|1961-04-08|||||1971-05-23||1962-11-14|U|1966-11-02
TRIAL STUDY 134XCP|LB|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|2||||G6PD|GLUCOSE-6-PHOSPHATE DEHYDROGENASE|||||||MG/KG/DOSE|||||||TRACE||CM H2O||||LOW|NOT DONE||||AMNIOTIC FLUID|LIPEMIC|U|IRON HEMATOXYLIN STAIN|MDRD FORMULA||NA|Y|NA|Y|||Y|1||38||BLINDED TREATMENT|1968-03-17|1969-01-02|||||1960-04-16||1973-01-26|U|1971-06-07
TRIAL STUDY 134XCP|LB|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|1||||EOSCE|EOSINOPHILS/TOTAL CELLS|||||||MCI/KG|||||||TRACE||KM||||NORMAL|NOT DONE||||VITREOUS HUMOR|NON-HEMOLYZED|NA|ELECTROPHORESIS|COCKCROFT-GAULT FORMULA||Y|N|NA|U|||NA|2||58||SCREENING|1970-07-26|1962-02-23|||||1971-09-21||1960-03-20|U|1966-06-14
TRIAL STUDY 134XCP|LB|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|2||||PTHCT|PARATHYROID HORMONE, C-TERMINAL|||||||BQ/UL|||||||TRACE||VG/DOSE||||HIGH|NOT DONE||||BUFFY COAT|LACTESCENT|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD FORMULA||U|Y|N|Y|||U|2||58||BLINDED TREATMENT|1960-05-03|1966-11-23|||||1963-06-03||1962-06-20|N|1963-11-22
TRIAL STUDY 134XCP|LB|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|1||||IC512AG|ISLET CELL 512 ANTIGEN|||||||BU/ML|||||||BORDERLINE||TITER||||NORMAL|NOT DONE||||BASAL TEAR|CALCIFIED|NA|TRANSMISSION ELECTRON MICROSCOPY|MDRD FORMULA||NA|N|Y|N|||U|3||39||RUN-IN|1964-03-26|1972-05-27|||||1960-10-07||1970-08-31|U|1964-09-15
TRIAL STUDY 134XCP|LB|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|2||||BNPPRONT|N-TERMINAL PROB-TYPE NATRIURETIC PEPTIDE|||||||10^4 CFU|||||||NEGATIVE||VG/ML||||NORMAL|NOT DONE||||HAIR FOLLICLE|THAWED|U|AMSLER GRID|FIBROMETER FORMULA||U|Y|N|N|||NA|3||39||OPEN LABEL TREATMENT|1963-10-13|1973-06-24|||||1962-05-02||1963-11-12|Y|1960-02-25
TRIAL STUDY 134XCP|LB|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|1||||CD45LY|CD45/LYMPHOCYTES|||||||KG|||||||POSITIVE||DRINK||||NORMAL|NOT DONE||||EXUDATE|ROOM TEMPERATURE|U|FUNCTIONAL MRI|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|NA|N|||NA|4||88||FOLLOW-UP|1961-10-21|1973-03-30|||||1966-02-03||1962-10-12|Y|1969-02-13
TRIAL STUDY 134XCP|LB|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|2||||ALBGLOB|ALBUMIN/GLOBULIN|||||||DRINK|||||||NEGATIVE||MG/ML/DAY||||ABNORMAL|NOT DONE||||MECONIUM|AUTOLYZED|NA|TURBIDIMETRY|MDRD 5 VARIABLE FORMULA||U|U|Y|N|||N|4||88||FOLLOW-UP|1961-09-28|1960-02-05|||||1963-04-17||1965-02-25|U|1965-06-21
TRIAL STUDY 134XCP|LB|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|1||||ALPCREAT|ALKALINE PHOSPHATASE/CREATININE|||||||UU/DL|||||||INDETERMINATE||/MM||||NORMAL|NOT DONE||||URINE SEDIMENT|REFRIGERATED|Y|QUANTITATIVE COMPUTED TOMOGRAPHY|FIBROSIS 4 FORMULA||N|N|NA|N|||Y|5||7||BASELINE|1966-07-16|1973-02-25|||||1973-03-02||1967-02-01|Y|1963-04-14
TRIAL STUDY 134XCP|LB|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|2||||C130131|DOG DANDER ANTIGEN IGG4 ANTIBODY|||||||TUBERCULIN UNIT/ML|||||||NEGATIVE||DPM/ML||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|CONTAMINATED|NA|TRIPLE-PHASE SPIRAL CT SCAN|MDRD FORMULA||N|N|NA|U|||Y|5||7||WASHOUT|1968-08-23|1968-10-28|||||1965-04-26||1966-02-21|Y|1971-03-13
TRIAL STUDY 134XCP|LB|CB6A1101-1EF8-476D-BD15-B60EF323D740|1||||APLIGMAB|ANTI-PHOSPHOLIPID IGM ANTIBODY|||||||IN|||||||NEGATIVE||/LSQN||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|CLOTTED|U|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI FORMULA||Y|N|NA|Y|||U|1||38||OPEN LABEL TREATMENT|1970-07-31|1970-01-08|||||1972-01-26||1967-03-03|U|1966-01-20
TRIAL STUDY 134XCP|LB|CB6A1101-1EF8-476D-BD15-B60EF323D740|2||||BLYCELE|B-LYMPHOCYTES/LEUKOCYTES|||||||JOULE|||||||INDETERMINATE||MMOL/S||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|ROOM TEMPERATURE|NA|HPLC-UV|COCKCROFT-GAULT FORMULA||U|Y|NA|N|||Y|1||38||BASELINE|1970-05-13|1966-02-11|||||1966-11-14||1972-05-25|Y|1969-10-17
TRIAL STUDY 134XCP|LB|CB6A1101-1EF8-476D-BD15-B60EF323D740|1||||APLASCPD|APTT-LA SCREEN TO CONFIRM PCT DIFFERENCE|||||||G/DL|||||||TRACE||M/SEC2||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|UNEXPECTED ODOR|N|KINYOUN STAIN|MDRD FORMULA||Y|N|U|Y|||U|2||58||OPEN LABEL TREATMENT|1973-05-14|1971-06-14|||||1962-04-01||1966-12-11|NA|1965-04-27
TRIAL STUDY 134XCP|LB|CB6A1101-1EF8-476D-BD15-B60EF323D740|2||||WBCDIFF|LEUKOCYTE CELL DIFFERENTIAL|||||||DRAM|||||||INVALID||MG/CM2||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|REFRIGERATED|Y|SEQUENCING|CKD-EPI CREATININE FORMULA||N|Y|U|NA|||U|2||58||TREATMENT|1963-07-21|1967-12-07|||||1968-06-17||1969-09-18|N|1964-04-13
TRIAL STUDY 134XCP|LB|CB6A1101-1EF8-476D-BD15-B60EF323D740|1||||WBCCE|LEUKOCYTES/TOTAL CELLS|||||||U/ML|||||||INDETERMINATE||CP||||ABNORMAL|NOT DONE||||NAIL|AGGLUTINATED|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|FIBROTEST FORMULA||Y|N|U|U|||N|3||39||SCREENING|1970-05-02|1964-05-06|||||1965-09-28||1968-03-17|N|1966-01-22
TRIAL STUDY 134XCP|LB|CB6A1101-1EF8-476D-BD15-B60EF323D740|2||||SMUSCGAB|SMOOTH MUSCLE IGG ANTIBODY|||||||MOL/G|||||||INDETERMINATE||HR/DAY||||HIGH|NOT DONE||||PERITONEAL FLUID|CLOTTED|U|PHOTOMETRY|FIBROMETER FORMULA||NA|N|N|Y|||U|3||39||OPEN LABEL TREATMENT|1961-01-05|1960-03-17|||||1961-05-07||1964-05-21|Y|1968-06-16
TRIAL STUDY 134XCP|LB|CB6A1101-1EF8-476D-BD15-B60EF323D740|1||||IRF|IMMATURE RETICULOCYTE FRACTION|||||||DDU|||||||INVALID||MG/L||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|U|HPLC/MS|MDRD ENZYMATIC JAPANESE FORMULA||N|N|U|Y|||N|4||88||LONG-TERM FOLLOW-UP|1969-10-13|1969-07-13|||||1961-09-22||1964-01-29|Y|1962-07-07
TRIAL STUDY 134XCP|LB|CB6A1101-1EF8-476D-BD15-B60EF323D740|2||||PHOSEXR|PHOSPHORUS EXCRETION RATE|||||||ML/DOSE|||||||POSITIVE||COULOMB||||NORMAL|NOT DONE||||GASTRIC CONTENTS|HEMOLYZED|NA|SPECT SCAN|ASH FIBROSURE FORMULA||U|U|N|N|||U|4||88||OPEN LABEL TREATMENT|1966-08-09|1961-04-19|||||1972-10-22||1967-01-17|U|1969-04-01
TRIAL STUDY 134XCP|LB|CB6A1101-1EF8-476D-BD15-B60EF323D740|1||||C130070|BERMUDA GRASS POLLEN IGG|||||||MMOL2/L2|||||||TRACE||ELISA UNIT/DOSE||||LOW|NOT DONE||||MECONIUM|PARAFFIN-EMBEDDED|U|DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|N|Y|||NA|5||7||OBSERVATION|1970-10-10|1967-09-11|||||1970-11-18||1961-05-23|N|1965-11-17
TRIAL STUDY 134XCP|LB|CB6A1101-1EF8-476D-BD15-B60EF323D740|2||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||MMHG/L/MIN|||||||POSITIVE||UG/DAY||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|LIPEMIC|U|RULER MEASUREMENT METHOD|MDRD 4 VARIABLE FORMULA||Y|U|NA|Y|||N|5||7||LONG-TERM FOLLOW-UP|1960-06-17|1972-11-28|||||1965-10-20||1961-04-23|Y|1970-10-06
TRIAL STUDY 134XCP|LB|3AED1654-6D9A-40EE-A560-99F51C469D63|1||||FLRZPM|FLURAZEPAM|||||||10^6 COPIES/ML|||||||INVALID||STEPS||||HIGH|NOT DONE||||BLOOD|REFRIGERATED|NA|NEXT GENERATION TARGETED SEQUENCING|MDRD FORMULA||N|NA|N|N|||NA|1||38||OBSERVATION|1965-05-17|1964-12-19|||||1972-08-02||1969-08-23|Y|1967-11-18
TRIAL STUDY 134XCP|LB|3AED1654-6D9A-40EE-A560-99F51C469D63|2||||ETGETS|ETHYL GLUCURONIDE ETHYL SULFATE|||||||M/SEC2|||||||POSITIVE||YEARS||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED|NA|CLIP SEQUENCING|GMI MMOL/MOL FORMULA||N|U|NA|N|||N|1||38||LONG-TERM FOLLOW-UP|1966-01-07|1960-05-14|||||1970-05-26||1962-01-30|N|1962-06-27
TRIAL STUDY 134XCP|LB|3AED1654-6D9A-40EE-A560-99F51C469D63|1||||S100A8|S100 CALCIUM BINDING PROTEIN A8|||||||OHM|||||||NEGATIVE||10^3/HPF||||ABNORMAL|NOT DONE||||CERUMEN|LIPEMIC|NA|WESTERGREN|CKD-EPI CREATININE FORMULA||N|Y|Y|N|||NA|2||58||BLINDED TREATMENT|1962-11-28|1966-11-12|||||1967-03-11||1973-07-11|U|1970-10-08
TRIAL STUDY 134XCP|LB|3AED1654-6D9A-40EE-A560-99F51C469D63|2||||C165890|TIMOTHY GRASS POLLEN IGE AB RAST SCORE|||||||MEQ|||||||INVALID||MM/2H||||ABNORMAL|NOT DONE||||DERMAL TISSUE|AUTOLYZED|NA|ATOMIC ABSORPTION SPECTROMETRY|MDRD 4 VARIABLE FORMULA||U|N|NA|Y|||Y|2||58||WASHOUT|1971-10-12|1966-10-17|||||1960-10-21||1973-08-01|N|1961-11-29
TRIAL STUDY 134XCP|LB|3AED1654-6D9A-40EE-A560-99F51C469D63|1||||CCL23|CHEMOKINE (C-C MOTIF) LIGAND 23|||||||10^6 U|||||||INDETERMINATE||UG/M2/H||||HIGH|NOT DONE||||BLOOD|UNEXPECTED ODOR|NA|MICROARRAY|MDRD FORMULA||NA|N|NA|NA|||Y|3||39||BLINDED TREATMENT|1970-12-15|1962-03-23|||||1968-02-02||1961-09-20|N|1962-01-25
TRIAL STUDY 134XCP|LB|3AED1654-6D9A-40EE-A560-99F51C469D63|2||||CREATEXR|CREATININE EXCRETION RATE|||||||FG|||||||NEGATIVE||NMOL/G||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|ICTERIC|U|FISH|MDRD 4 VARIABLE FORMULA||Y|N|N|NA|||Y|3||39||INDUCTION TREATMENT|1963-11-15|1963-10-06|||||1969-06-01||1965-04-08|NA|1964-10-04
TRIAL STUDY 134XCP|LB|3AED1654-6D9A-40EE-A560-99F51C469D63|1||||C165886|WHITE OAK POLLEN IGE AB RAST SCORE|||||||LB|||||||BORDERLINE||DRAM||||HIGH|NOT DONE||||CALCULUS|CONTAMINATED|U|FARR ASSAY|MDRD 6 VARIABLE FORMULA||U|U|N|Y|||N|4||88||INDUCTION TREATMENT|1960-03-26|1965-04-05|||||1967-03-27||1970-01-10|N|1966-01-13
TRIAL STUDY 134XCP|LB|3AED1654-6D9A-40EE-A560-99F51C469D63|2||||CODEINE|CODEINE|||||||CI/ML|||||||INDETERMINATE||SACHET||||LOW|NOT DONE||||BLOOD|AGGLUTINATED|N|ICP-MS|GMI MMOL/MOL FORMULA||N|U|NA|N|||N|4||88||OPEN LABEL TREATMENT|1961-01-29|1970-04-29|||||1967-09-26||1973-07-09|NA|1965-04-03
TRIAL STUDY 134XCP|LB|3AED1654-6D9A-40EE-A560-99F51C469D63|1||||BUCHE|BUTYRYLCHOLINESTERASE|||||||AMFI|||||||INVALID||MOL/DAY||||HIGH|NOT DONE||||URINE|FRESH|N|MICRONEUTRALIZATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|NA|Y|||U|5||7||TREATMENT|1965-09-11|1961-09-03|||||1971-08-31||1966-04-12|U|1971-03-24
TRIAL STUDY 134XCP|LB|3AED1654-6D9A-40EE-A560-99F51C469D63|2||||CAION|CALCIUM, IONIZED|||||||10^4/L|||||||NEGATIVE||STEPS/MIN||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|NON-HEMOLYZED|Y|RADIOGRAPHY|GMI % FORMULA||U|U|N|NA|||Y|5||7||OPEN LABEL TREATMENT|1969-02-25|1963-09-11|||||1969-04-13||1969-03-21|Y|1962-08-12
TRIAL STUDY 134XCP|LB|4C13FD80-8950-4194-B76C-F46B643BED82|1||||INTLK24|INTERLEUKIN 24|||||||JAR|||||||POSITIVE||UV2||||LOW|NOT DONE||||BREAST MILK|LACTESCENT|NA|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|Y|NA|||NA|1||38||OBSERVATION|1967-06-22|1968-01-08|||||1968-01-30||1963-10-30|NA|1973-03-05
TRIAL STUDY 134XCP|LB|4C13FD80-8950-4194-B76C-F46B643BED82|2||||HRYCELY|HAIRY CELLS/LYMPHOCYTES|||||||NG/DL|||||||TRACE||UMOL/MOL||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|FROZEN|U|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|CKD-EPI CREATININE FORMULA||N|N|Y|U|||NA|1||38||BASELINE|1967-02-11|1961-07-24|||||1964-06-11||1971-06-12|N|1969-11-21
TRIAL STUDY 134XCP|LB|4C13FD80-8950-4194-B76C-F46B643BED82|1||||NEUTMY|NEUTROPHILIC MYELOCYTES|||||||LOG10 TCID 50/DOSE|||||||INVALID||VIAL||||LOW|NOT DONE||||MECONIUM|CONTAMINATED|Y|KINETIC MICROPARTICLE IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||Y|NA|Y|NA|||Y|2||58||BASELINE|1961-03-04|1970-07-22|||||1969-07-24||1962-09-28|N|1961-12-13
TRIAL STUDY 134XCP|LB|4C13FD80-8950-4194-B76C-F46B643BED82|2||||CYCHOL|CHOLESTEROL CRYSTALS|||||||CD*S/M2|||||||INVALID||CYLINDER||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED|NA|ENDPOINT DILUTION ASSAY|CKD-EPI FORMULA||Y|N|U|N|||N|2||58||OBSERVATION|1972-12-19|1968-05-31|||||1960-09-12||1963-07-24|N|1967-06-10
TRIAL STUDY 134XCP|LB|4C13FD80-8950-4194-B76C-F46B643BED82|1||||BLSTMBCE|MYELOBLASTS/TOTAL CELLS|||||||KUSP|||||||BORDERLINE||U/G/DAY||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|U|RADIATION DOSIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|N|||NA|3||39||BASELINE|1963-06-24|1969-12-12|||||1965-12-11||1969-05-18|NA|1970-05-14
TRIAL STUDY 134XCP|LB|4C13FD80-8950-4194-B76C-F46B643BED82|2||||FACTXII|FACTOR XII|||||||ML/M2/H|||||||INDETERMINATE||/7.5 ML||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|ROOM TEMPERATURE|NA|SEQUENCING|MDRD 6 VARIABLE FORMULA||Y|N|U|N|||NA|3||39||OPEN LABEL TREATMENT|1966-03-31|1965-12-18|||||1972-03-21||1971-12-05|U|1968-07-25
TRIAL STUDY 134XCP|LB|4C13FD80-8950-4194-B76C-F46B643BED82|1||||RPTLAAC|REPTILASE ACTIVITY ACTUAL/CONTROL|||||||CY/CM|||||||POSITIVE||DL||||ABNORMAL|NOT DONE||||INTERSTITIAL FLUID|CLOTTED|U|DYNAMIC CONTRAST ENHANCED MRI|HEPASCORE FORMULA||U|N|Y|N|||N|4||88||BASELINE|1961-11-05|1968-03-23|||||1971-06-29||1973-03-04|NA|1960-08-20
TRIAL STUDY 134XCP|LB|4C13FD80-8950-4194-B76C-F46B643BED82|2||||COCAM|COCAINE METABOLITES|||||||/MBP|||||||POSITIVE||PACK||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|LIPEMIC|Y|GRAM STAIN|CKD-EPI FORMULA||NA|U|N|NA|||NA|4||88||SCREENING|1967-06-02|1971-04-08|||||1969-01-23||1966-01-31|Y|1963-02-08
TRIAL STUDY 134XCP|LB|4C13FD80-8950-4194-B76C-F46B643BED82|1||||C130126|CAT DANDER ANTIGEN IGA ANTIBODY|||||||CMH2O*S/ML|||||||TRACE||UM/DAY||||NORMAL|NOT DONE||||SEMEN|LACTESCENT|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD ENZYMATIC FORMULA||NA|NA|NA|NA|||U|5||7||RUN-IN|1966-09-01|1960-03-05|||||1968-12-30||1961-11-27|N|1966-12-23
TRIAL STUDY 134XCP|LB|4C13FD80-8950-4194-B76C-F46B643BED82|2||||MYPC|MYELOID PROGENITOR CELLS|||||||COPIES/ML|||||||TRACE||MU/G||||NORMAL|NOT DONE||||HAIR FOLLICLE|FROZEN|N|IMMUNOFIXATION ELECTROPHORESIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|N|NA|||U|5||7||TREATMENT|1972-12-04|1964-06-05|||||1965-10-12||1966-02-25|U|1966-02-21
TRIAL STUDY 134XCP|LB|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|1||||PSDEPHD|PSEUDOEPHEDRINE|||||||ML/S/M2|||||||TRACE||CM/MIN||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|REFRIGERATED|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|U|||NA|1||38||OPEN LABEL TREATMENT|1962-08-11|1964-11-10|||||1972-02-26||1961-06-29|Y|1960-07-21
TRIAL STUDY 134XCP|LB|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|2||||POLYCHR|POLYCHROMASIA|||||||KG|||||||INVALID||BQ/L||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|AGGLUTINATED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|GMI MMOL/MOL FORMULA||U|N|N|N|||Y|1||38||WASHOUT|1971-05-16|1966-07-10|||||1968-07-31||1965-10-07|NA|1970-02-11
TRIAL STUDY 134XCP|LB|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|1||||IA2AB|INSULINOMA-ASSOCIATED PROTEIN 2 ANTIBODY|||||||10^3 RNA COPIES/ML|||||||TRACE||VG/ML||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|REFRIGERATED|NA|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI FORMULA||Y|Y|Y|U|||Y|2||58||BLINDED TREATMENT|1966-08-31|1962-04-22|||||1969-09-16||1971-06-04|Y|1962-09-23
TRIAL STUDY 134XCP|LB|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|2||||TRANK1|TPR-ANKYRIN REPEAT-CONTAINING PROTEIN 1|||||||10^3 CFU|||||||TRACE||CG||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|NON-HEMOLYZED|U|NON-INVASIVE DIELECTRIC SENSING|CKD-EPI CYSTATIN C FORMULA||NA|N|Y|U|||N|2||58||BLINDED TREATMENT|1964-11-29|1969-02-17|||||1963-11-16||1965-08-07|NA|1973-05-30
TRIAL STUDY 134XCP|LB|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|1||||C130086|ENGLISH PLANTAIN POLLEN IGG|||||||ML/DAY|||||||INDETERMINATE||LOG10 TCID 50/ML||||HIGH|NOT DONE||||LUNG SURFACTANT|LIPEMIC|Y|ENDPOINT DILUTION ASSAY|FIBROMETER FORMULA||N|Y|Y|N|||U|3||39||TREATMENT|1969-12-06|1966-08-25|||||1970-11-01||1968-09-26|Y|1967-07-30
TRIAL STUDY 134XCP|LB|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|2||||CORCREAT|CORTISOL/CREATININE|||||||NL|||||||BORDERLINE||IMPLANT||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|ROOM TEMPERATURE|NA|DISK DIFFUSION|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|U|NA|||Y|3||39||CONTINUATION TREATMENT|1963-09-12|1965-05-08|||||1962-03-08||1963-12-27|N|1963-03-19
TRIAL STUDY 134XCP|LB|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|1||||CHLMCRNT|CHYLOMICRON TRIGLYCERIDE|||||||UG/M2|||||||INDETERMINATE||BEL||||ABNORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|PARAFFIN-EMBEDDED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD 5 VARIABLE FORMULA||N|U|U|N|||N|4||88||FOLLOW-UP|1973-04-16|1962-12-29|||||1964-08-21||1966-12-19|NA|1964-09-23
TRIAL STUDY 134XCP|LB|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|2||||INCLBOD|INCLUSION BODIES|||||||UV2|||||||INDETERMINATE||RAD||||LOW|NOT DONE||||CAPILLARY PLASMA|CONTAMINATED|Y|URANYL ACETATE STAIN|HEPASCORE FORMULA||Y|U|U|NA|||NA|4||88||INDUCTION TREATMENT|1973-04-17|1963-06-23|||||1971-03-20||1964-12-15|N|1972-09-25
TRIAL STUDY 134XCP|LB|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|1||||HRYCELE|HAIRY CELLS/LEUKOCYTES|||||||CIGARETTE|||||||POSITIVE||SYRINGE||||LOW|NOT DONE||||PLEURAL FLUID|PARAFFIN-EMBEDDED|N|BETA LACTAMASE|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|NA|Y|||Y|5||7||BASELINE|1961-01-21|1973-06-20|||||1972-01-01||1967-04-10|U|1966-10-05
TRIAL STUDY 134XCP|LB|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|2||||ACTH|ADRENOCORTICOTROPIC HORMONE|||||||CIGARETTE|||||||TRACE||MG/G/MIN||||ABNORMAL|NOT DONE||||SEMINAL FLUID|LACTESCENT|Y|GC/MS/MS|HEPASCORE FORMULA||Y|Y|Y|N|||N|5||7||FOLLOW-UP|1969-02-15|1968-06-26|||||1962-01-06||1969-08-20|U|1967-01-04
TRIAL STUDY 134XCP|LB|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|1||||TRYPSIN|TRYPSIN|||||||DEG2|||||||INVALID||TBSP||||HIGH|NOT DONE||||CORD SERUM|AGGLUTINATED|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|COCKCROFT-GAULT FORMULA||N|NA|NA|NA|||U|1||38||BASELINE|1969-05-30|1972-12-25|||||1968-05-16||1970-01-17|U|1970-04-24
TRIAL STUDY 134XCP|LB|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|2||||MSPIKEXR|MONOCLONAL PROTEIN SPIKE EXCRETION RATE|||||||MOL/MOL|||||||INDETERMINATE||UCI||||LOW|NOT DONE||||EXUDATE|LACTESCENT|NA|ENZYMATIC ULTRACENTRIFUGATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|NA|||U|1||38||BASELINE|1964-07-13|1971-08-06|||||1970-05-06||1965-02-14|U|1965-09-24
TRIAL STUDY 134XCP|LB|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|1||||C147282|WHITE OAK POLLEN IGE ANTIBODY|||||||ML/H|||||||TRACE||OSM||||NORMAL|NOT DONE||||SPUTUM|UNEXPECTED ODOR|Y|CELL OF ORIGIN ASSAY|GMI % FORMULA||NA|U|U|N|||U|2||58||INDUCTION TREATMENT|1968-07-28|1969-01-04|||||1972-03-22||1973-05-21|NA|1965-01-06
TRIAL STUDY 134XCP|LB|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|2||||ABNCE|ABNORMAL CELLS|||||||DYN|||||||INDETERMINATE||CFU/G||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|REFRIGERATED|NA|POLYSOMNOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|NA|||Y|2||58||RUN-IN|1971-07-07|1964-12-23|||||1962-10-30||1960-11-14|NA|1962-09-22
TRIAL STUDY 134XCP|LB|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|1||||CD23|CD23|||||||U/KG/DAY|||||||POSITIVE||MEQ/L||||LOW|NOT DONE||||SWABBED MATERIAL|THAWED|N|WHOLE TRANSCRIPTOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|U|Y|||U|3||39||SCREENING|1973-04-25|1970-05-12|||||1964-08-30||1960-06-02|Y|1963-01-04
TRIAL STUDY 134XCP|LB|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|2||||C130105|GRASS MIX POLLEN ANTIGEN IGA ANTIBODY|||||||UG/DL|||||||INDETERMINATE||CAPLET||||ABNORMAL|NOT DONE||||VENOUS BLOOD|NON-HEMOLYZED|Y|MEDIASTINOSCOPY|FIBROTEST FORMULA||N|Y|U|U|||Y|3||39||CONTINUATION TREATMENT|1968-11-09|1963-06-06|||||1964-12-22||1971-08-10|Y|1961-11-08
TRIAL STUDY 134XCP|LB|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|1||||GLOBB|BETA GLOBULIN|||||||PIXEL|||||||POSITIVE||VG/DOSE||||NORMAL|NOT DONE||||ISOLATE|SOLIDIFIED|N|DISK DIFFUSION|CKD-EPI FORMULA||U|Y|NA|Y|||U|4||88||LONG-TERM FOLLOW-UP|1968-03-24|1961-12-04|||||1966-12-26||1961-04-17|N|1964-07-23
TRIAL STUDY 134XCP|LB|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|2||||RNA|RIBONUCLEIC ACID|||||||CY/CM|||||||BORDERLINE||/2500 WBC||||ABNORMAL|NOT DONE||||KERATINOCYTE|UNEXPECTED ODOR|NA|PUPILLOMETRY|CKD-EPI CREATININE FORMULA||N|Y|Y|U|||U|4||88||BASELINE|1970-12-03|1970-05-21|||||1972-02-11||1966-05-09|NA|1962-07-06
TRIAL STUDY 134XCP|LB|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|1||||CRTCLRE|CREATININE CLEARANCE, ESTIMATED|||||||ML/G/H|||||||NEGATIVE||LENS||||LOW|NOT DONE||||PLEURAL FLUID|AUTOLYZED|N|PULSE OXIMETRY|MDRD ENZYMATIC FORMULA||Y|NA|N|NA|||U|5||7||FOLLOW-UP|1967-11-26|1970-09-26|||||1971-06-07||1972-03-08|N|1966-03-18
TRIAL STUDY 134XCP|LB|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|2||||APOC1|APOLIPOPROTEIN CI|||||||MOL/DAY|||||||POSITIVE||DYN||||ABNORMAL|NOT DONE||||EMESIS|REFRIGERATED|U|ATOMIC ABSORPTION SPECTROMETRY|GMI MMOL/MOL FORMULA||U|Y|Y|N|||Y|5||7||BASELINE|1964-10-09|1971-10-06|||||1963-09-14||1960-11-12|NA|1970-11-11
TRIAL STUDY 134XCP|LB|CFFA0003-098B-486E-82DB-30838F6541DD|1||||GFRBSCRT|GFR FROM CREATININE ADJUSTED FOR BSA|||||||UG/L DDU|||||||INVALID||TBSP||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|GELLED|NA|MICROARRAY|CKD-EPI CYSTATIN C FORMULA||N|Y|Y|N|||Y|1||38||LONG-TERM FOLLOW-UP|1971-08-04|1970-09-10|||||1968-06-11||1971-05-14|NA|1969-09-26
TRIAL STUDY 134XCP|LB|CFFA0003-098B-486E-82DB-30838F6541DD|2||||BLASTCE|BLASTS/TOTAL CELLS|||||||FARAD|||||||POSITIVE||%||||NORMAL|NOT DONE||||COLOSTRUM|UNEXPECTED ODOR|N|EIA|ASH FIBROSURE FORMULA||Y|U|NA|Y|||Y|1||38||FOLLOW-UP|1969-11-10|1968-09-17|||||1965-03-28||1972-06-19|NA|1960-02-11
TRIAL STUDY 134XCP|LB|CFFA0003-098B-486E-82DB-30838F6541DD|1||||METAMY|METAMYELOCYTES|||||||MG/M2/DAY|||||||BORDERLINE||/10^4||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|CONTAMINATED|NA|FLUORESCENCE ANGIOGRAPHY|FIBROTEST FORMULA||Y|NA|N|U|||U|2||58||SCREENING|1971-09-08|1961-11-09|||||1968-07-20||1961-10-19|NA|1965-11-19
TRIAL STUDY 134XCP|LB|CFFA0003-098B-486E-82DB-30838F6541DD|2||||FSH|FOLLICLE STIMULATING HORMONE|||||||UG|||||||NEGATIVE||TRACE||||LOW|NOT DONE||||PLATELET POOR PLASMA|CONTAMINATED|Y|MICROPARTICLE ENZYME IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||NA|NA|N|Y|||Y|2||58||BLINDED TREATMENT|1968-01-12|1967-02-23|||||1967-03-06||1964-09-11|NA|1960-03-17
TRIAL STUDY 134XCP|LB|CFFA0003-098B-486E-82DB-30838F6541DD|1||||CDT|CARBOHYDRATE-DEFICIENT TRANSFERRIN|||||||IN2|||||||INVALID||UMOL/H/MMOL||||ABNORMAL|NOT DONE||||SPUTUM|CONTAMINATED|U|BALLPOINT PEN TECHNIQUE|HEPASCORE FORMULA||U|N|U|Y|||U|3||39||INDUCTION TREATMENT|1972-04-19|1967-04-01|||||1972-04-29||1972-05-11|U|1964-09-20
TRIAL STUDY 134XCP|LB|CFFA0003-098B-486E-82DB-30838F6541DD|2||||C165908|ANIMAL MIX IGG AB RAST SCORE|||||||JDF UNIT|||||||TRACE||PACK YEAR||||HIGH|NOT DONE||||BILE|DRIED|NA|MACRO BROTH DILUTION|MDRD 5 VARIABLE FORMULA||Y|U|U|U|||U|3||39||WASHOUT|1972-06-10|1960-10-21|||||1964-04-16||1971-01-03|NA|1969-02-01
TRIAL STUDY 134XCP|LB|CFFA0003-098B-486E-82DB-30838F6541DD|1||||P3NP|PROCOLLAGEN 3 N-TERMINAL PROPEPTIDE|||||||10^3/L|||||||NEGATIVE||GRAIN||||ABNORMAL|NOT DONE||||ABSCESS FLUID|REFRIGERATED|Y|BALLPOINT PEN TECHNIQUE|CKD-EPI CREATININE FORMULA||NA|N|NA|N|||U|4||88||OPEN LABEL TREATMENT|1966-06-11|1961-03-03|||||1965-11-30||1968-05-21|Y|1962-11-01
TRIAL STUDY 134XCP|LB|CFFA0003-098B-486E-82DB-30838F6541DD|2||||C165937|ZEA MAYS IGE AB RAST SCORE|||||||10^6 CFU/ML|||||||INVALID||CFU/ML||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|CALCIFIED|N|IMMUNODIFFUSION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|N|Y|||Y|4||88||INDUCTION TREATMENT|1964-07-17|1962-09-23|||||1962-04-19||1973-07-30|Y|1967-03-30
TRIAL STUDY 134XCP|LB|CFFA0003-098B-486E-82DB-30838F6541DD|1||||ATP|ADENOSINE TRIPHOSPHATE|||||||MM3/MM2/YEAR|||||||POSITIVE||CI/UL||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|FRESH|U|NON-INVASIVE DIELECTRIC SENSING|CKD-EPI FORMULA||N|N|U|N|||NA|5||7||OBSERVATION|1965-07-04|1968-07-13|||||1970-12-09||1971-09-24|Y|1965-08-14
TRIAL STUDY 134XCP|LB|CFFA0003-098B-486E-82DB-30838F6541DD|2||||IDLP|IDL PARTICLES|||||||PFU/DOSE|||||||TRACE||FRAMES/S||||LOW|NOT DONE||||AQUEOUS HUMOR|PARAFFIN-EMBEDDED|Y|PET/SPECT SCAN|GMI % FORMULA||Y|NA|Y|Y|||U|5||7||BASELINE|1964-10-14|1971-02-05|||||1969-01-11||1966-01-30|NA|1969-12-25
TRIAL STUDY 134XCP|LB|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|1||||DRVVT|DILUTE RUSSELL'S VIPER VENOM TIME|||||||TUBE|||||||INVALID||LOG10 PFU/ML||||HIGH|NOT DONE||||SEMINAL FLUID|DRIED|Y|MALDI-TOF|NASH FIBROSURE FORMULA||U|Y|Y|NA|||N|1||38||LONG-TERM FOLLOW-UP|1962-10-14|1960-11-21|||||1970-10-10||1965-10-22|N|1972-10-24
TRIAL STUDY 134XCP|LB|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|2||||VITD23OH|VITAMIN D2 D3 25-OH|||||||UV2|||||||BORDERLINE||NMOL BCE/L||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|ROOM TEMPERATURE|N|SANGER SEQUENCING|MDRD ENZYMATIC FORMULA||NA|NA|U|NA|||U|1||38||INDUCTION TREATMENT|1971-02-18|1969-06-15|||||1967-05-27||1965-10-18|Y|1962-11-16
TRIAL STUDY 134XCP|LB|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|1||||GHRELINA|ACTIVE GHRELIN|||||||ELISA UNIT/ML|||||||POSITIVE||MOL/DAY||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|GELLED|NA|FLUORESCENT IMMUNOASSAY|ASH FIBROSURE FORMULA||N|Y|NA|U|||NA|2||58||LONG-TERM FOLLOW-UP|1969-07-01|1971-10-27|||||1971-06-24||1966-01-19|N|1969-05-06
TRIAL STUDY 134XCP|LB|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|2||||FBNCTFT|FIBRONECTIN, FETAL|||||||PSEC|||||||BORDERLINE||MOSM/KG||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|HEMOLYZED|N|QUANTITATIVE COMPUTED TOMOGRAPHY|NASH FIBROSURE FORMULA||Y|U|N|U|||N|2||58||CONTINUATION TREATMENT|1973-07-14|1965-10-16|||||1970-03-14||1960-07-13|U|1968-08-22
TRIAL STUDY 134XCP|LB|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|1||||GLYCREAT|GLYCINE/CREATININE|||||||DL|||||||INVALID||H/WK||||HIGH|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|PARAFFIN-EMBEDDED|NA|PANENDOSCOPY|MDRD 5 VARIABLE FORMULA||Y|NA|N|N|||Y|3||39||WASHOUT|1963-07-14|1962-02-07|||||1964-01-31||1961-01-02|Y|1960-07-10
TRIAL STUDY 134XCP|LB|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|2||||HAPTOG|HAPTOGLOBIN|||||||BOWL|||||||POSITIVE||KA_U/DL||||ABNORMAL|NOT DONE||||PUS|GELLED|U|IMMUNOFIXATION ELECTROPHORESIS|GMI % FORMULA||Y|NA|N|U|||Y|3||39||INDUCTION TREATMENT|1972-07-09|1971-09-08|||||1970-02-01||1971-05-11|NA|1964-03-09
TRIAL STUDY 134XCP|LB|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|1||||CSBACT|BACTERIAL CASTS|||||||/LSQN|||||||NEGATIVE||MG/L FEU||||NORMAL|NOT DONE||||PERSPIRATION|LIPEMIC|Y|TRYPAN BLUE STAIN|CKD-EPI FORMULA||NA|U|NA|Y|||N|4||88||INDUCTION TREATMENT|1960-03-03|1968-10-17|||||1972-07-25||1967-10-16|NA|1960-08-19
TRIAL STUDY 134XCP|LB|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|2||||TCDCA|TAUROCHENODEOXYCHOLATE|||||||SEC|||||||TRACE||MCI/L||||LOW|NOT DONE||||LYSATE|DRIED|NA|QUANTITATIVE COMPUTED TOMOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|NA|U|||NA|4||88||WASHOUT|1967-11-10|1964-12-19|||||1966-04-28||1971-09-04|Y|1963-11-01
TRIAL STUDY 134XCP|LB|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|1||||HYPSEGCE|HYPERSEGMENTED CELLS|||||||TAMPON|||||||BORDERLINE||NSEC||||LOW|NOT DONE||||VENOUS PLASMA|LACTESCENT|NA|SIZE EXCLUSION CHROMATOGRAPHY|GMI % FORMULA||NA|NA|Y|N|||U|5||7||BASELINE|1972-10-13|1964-11-07|||||1961-08-14||1973-07-19|NA|1965-08-11
TRIAL STUDY 134XCP|LB|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|2||||IL18BP|INTERLEUKIN 18 BINDING PROTEIN|||||||NEWTON|||||||NEGATIVE||UL/DOSE||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|FROZEN|U|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|FIBROMETER FORMULA||Y|NA|U|Y|||U|5||7||OPEN LABEL TREATMENT|1969-04-24|1971-04-24|||||1967-12-23||1960-10-10|Y|1972-11-25
TRIAL STUDY 134XCP|LB|3F29184F-1963-4EC7-881A-61C9DEF95D2D|1||||FBRTST|FIBROTEST SCORE|||||||CMHG|||||||POSITIVE||PSEC||||ABNORMAL|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FROZEN|U|PET SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|U|N|||NA|1||38||INDUCTION TREATMENT|1965-08-15|1971-04-15|||||1965-11-26||1973-09-07|Y|1961-11-03
TRIAL STUDY 134XCP|LB|3F29184F-1963-4EC7-881A-61C9DEF95D2D|2||||HTTP|HUNTINGTIN PROTEIN|||||||BOLUS|||||||INDETERMINATE||10^6 ORGANISMS/MG||||LOW|NOT DONE||||CERUMEN|CONTAMINATED|NA|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|Y|||NA|1||38||FOLLOW-UP|1971-08-01|1963-02-26|||||1972-02-07||1966-02-24|U|1968-08-10
TRIAL STUDY 134XCP|LB|3F29184F-1963-4EC7-881A-61C9DEF95D2D|1||||PPA|PHENYLPROPANOLAMINE|||||||PFU|||||||INDETERMINATE||MGEQ||||LOW|NOT DONE||||PLATELET RICH PLASMA|PARAFFIN-EMBEDDED|Y|CELLULAR PROLIFERATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|U|NA|U|||NA|2||58||TREATMENT|1968-12-23|1970-01-03|||||1970-08-18||1961-07-01|Y|1968-01-19
TRIAL STUDY 134XCP|LB|3F29184F-1963-4EC7-881A-61C9DEF95D2D|2||||INTLK26|INTERLEUKIN 26|||||||ARBITRARY U|||||||NEGATIVE||SQU/ML||||HIGH|NOT DONE||||MENSTRUAL BLOOD|HEMOLYZED|N|HPLC/MS/MS|ASH FIBROSURE FORMULA||U|Y|U|NA|||U|2||58||FOLLOW-UP|1969-03-27|1964-11-21|||||1965-11-08||1972-09-30|N|1972-11-13
TRIAL STUDY 134XCP|LB|3F29184F-1963-4EC7-881A-61C9DEF95D2D|1||||HCHT|HYOCHOLATE|||||||EID 50/DOSE|||||||INVALID||/7.5 ML||||HIGH|NOT DONE||||PERSPIRATION|CONCENTRATED|NA|FARR ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||U|U|N|N|||NA|3||39||WASHOUT|1966-05-01|1966-06-03|||||1969-10-24||1970-07-20|NA|1972-06-25
TRIAL STUDY 134XCP|LB|3F29184F-1963-4EC7-881A-61C9DEF95D2D|2||||BICARB|BICARBONATE|||||||MG2/DL2|||||||INDETERMINATE||MPH||||LOW|NOT DONE||||BASAL TEAR|DRIED|NA|FLUOROSCOPY|NASH FIBROSURE FORMULA||N|Y|Y|Y|||U|3||39||RUN-IN|1969-03-26|1963-11-13|||||1967-09-29||1965-07-30|U|1965-04-02
TRIAL STUDY 134XCP|LB|3F29184F-1963-4EC7-881A-61C9DEF95D2D|1||||GEC|GALACTOSE ELIMINATION CAPACITY|||||||MONTHS|||||||BORDERLINE||PA||||NORMAL|NOT DONE||||KERATINOCYTE|CONCENTRATED|U|IN VITRO GENE EXPRESSION ASSAY|ASH FIBROSURE FORMULA||NA|U|N|Y|||Y|4||88||RUN-IN|1963-10-23|1973-07-18|||||1965-07-26||1967-10-04|NA|1968-09-22
TRIAL STUDY 134XCP|LB|3F29184F-1963-4EC7-881A-61C9DEF95D2D|2||||NEUTSG|NEUTROPHILS, SEGMENTED|||||||MCI|||||||POSITIVE||MMOL/L||||LOW|NOT DONE||||SERUM|CONCENTRATED|U|CRYOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|Y|NA|||NA|4||88||OBSERVATION|1963-06-19|1966-07-18|||||1964-09-12||1971-08-22|NA|1964-04-12
TRIAL STUDY 134XCP|LB|3F29184F-1963-4EC7-881A-61C9DEF95D2D|1||||CSRBC|RBC CASTS|||||||10^3 DNA COPIES/ML|||||||BORDERLINE||100 IU/ML||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONCENTRATED|N|EEG|NASH FIBROSURE FORMULA||N|N|Y|NA|||U|5||7||SCREENING|1960-09-30|1962-07-29|||||1965-06-12||1960-10-07|N|1968-08-11
TRIAL STUDY 134XCP|LB|3F29184F-1963-4EC7-881A-61C9DEF95D2D|2||||CA242AG|CANCER ANTIGEN 242|||||||ABSORBANCE U/MIN|||||||INVALID||10^8 PFU||||NORMAL|NOT DONE||||KERATINOCYTE|DRIED|U|TARGETED GENOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|Y|U|||Y|5||7||BASELINE|1966-10-07|1972-10-25|||||1960-08-04||1965-04-11|NA|1971-04-29
TRIAL STUDY 134XCP|LB|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|1||||TESTOSBA|BIOAVAILABLE TESTOSTERONE|||||||GPS U|||||||INVALID||IU||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|CALCIFIED|Y|COMPUTERIZED CORNEAL TOPOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|NA|U|||U|1||38||INDUCTION TREATMENT|1966-05-26|1965-05-03|||||1960-09-27||1968-05-25|Y|1964-01-25
TRIAL STUDY 134XCP|LB|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|2||||ESTFR|ESTRADIOL, FREE|||||||DAGU|||||||INVALID||MG/ML/MIN||||HIGH|NOT DONE||||BREAST MILK|CONTAMINATED|N|TWO-COLOR MICROARRAY|MDRD 4 VARIABLE FORMULA||U|N|Y|U|||NA|1||38||OBSERVATION|1969-10-05|1971-09-07|||||1961-02-10||1960-10-07|N|1966-09-05
TRIAL STUDY 134XCP|LB|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|1||||CSGRANC|GRANULAR COARSE CASTS|||||||10^6 ORGANISMS/MG|||||||TRACE||UG/DL||||ABNORMAL|NOT DONE||||SERUM|HEMOLYZED|N|LAPAROSCOPY|HEPASCORE FORMULA||U|U|NA|U|||U|2||58||RUN-IN|1962-11-14|1965-04-14|||||1971-04-24||1966-09-04|U|1970-08-11
TRIAL STUDY 134XCP|LB|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|2||||IGG3|IMMUNOGLOBULIN G SUBCLASS 3|||||||U/G/H|||||||TRACE||10^9 ORGANISMS/MG||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|PARAFFIN-EMBEDDED|Y|CYSTOSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|NA|NA|||Y|2||58||BLINDED TREATMENT|1964-09-16|1966-08-17|||||1969-04-01||1966-06-29|U|1970-11-20
TRIAL STUDY 134XCP|LB|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|1||||FCTXIIIA|FACTOR XIII ACTIVITY|||||||UIU/DL|||||||INDETERMINATE||COPIES/UG||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|HEMOLYZED|NA|IMPULSE OSCILLOMETRY|ASH FIBROSURE FORMULA||U|Y|Y|U|||NA|3||39||OPEN LABEL TREATMENT|1961-03-01|1964-09-01|||||1972-11-23||1961-12-16|NA|1964-11-13
TRIAL STUDY 134XCP|LB|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|2||||PGAG|PLATELET-GRANULOCYTE AGG|||||||ROENTGEN|||||||NEGATIVE||DAYS||||HIGH|NOT DONE||||BONE|ROOM TEMPERATURE|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD 4 VARIABLE FORMULA||Y|NA|N|NA|||Y|3||39||BLINDED TREATMENT|1962-01-15|1964-02-24|||||1965-08-30||1967-12-24|Y|1965-12-18
TRIAL STUDY 134XCP|LB|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|1||||C165932|DOG DANDER IGE AB RAST SCORE|||||||10^7 CFU|||||||INVALID||KPA||||NORMAL|NOT DONE||||CAPILLARY BLOOD|PARAFFIN-EMBEDDED|Y|GC/MS|MDRD FORMULA||N|Y|N|N|||Y|4||88||WASHOUT|1965-01-25|1964-09-08|||||1962-01-28||1967-04-30|Y|1972-01-27
TRIAL STUDY 134XCP|LB|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|2||||EPIROCE|ROUND EPITHELIAL CELLS|||||||DRAM|||||||BORDERLINE||BOTTLE||||HIGH|NOT DONE||||EMOTIONAL TEAR|ICTERIC|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|FIBROTEST FORMULA||N|N|N|U|||N|4||88||FOLLOW-UP|1971-12-14|1970-12-20|||||1964-09-27||1972-12-19|Y|1965-04-22
TRIAL STUDY 134XCP|LB|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|1||||CYCAOXA|CALCIUM OXALATE CRYSTALS|||||||ML/CAGE/DAY|||||||INDETERMINATE||M3||||LOW|NOT DONE||||VENOUS BLOOD|ICTERIC|Y|MYELOPEROXIDASE STAIN|GMI % FORMULA||NA|U|Y|Y|||U|5||7||INDUCTION TREATMENT|1969-09-07|1962-04-04|||||1966-05-06||1966-04-10|U|1965-01-05
TRIAL STUDY 134XCP|LB|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|2||||C130112|ANIMAL MIX ANTIGEN IGE ANTIBODY|||||||EID 50/ML|||||||NEGATIVE||U/KG/H||||LOW|NOT DONE||||SALIVA|ROOM TEMPERATURE|U|RADIOIMMUNOPRECIPITATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|Y|NA|||N|5||7||LONG-TERM FOLLOW-UP|1972-05-21|1972-11-24|||||1968-06-25||1971-01-21|NA|1969-11-01
TRIAL STUDY 134XCP|LB|D9C32CF1-51C7-412D-A030-682B2860F89D|1||||LDLP|LDL PARTICLES|||||||OD UNIT|||||||INVALID||LOG10 ELISA UNIT||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|LIPEMIC|Y|INDIA INK STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|N|N|||Y|1||38||WASHOUT|1970-06-16|1973-06-27|||||1971-06-13||1967-09-16|U|1970-10-06
TRIAL STUDY 134XCP|LB|D9C32CF1-51C7-412D-A030-682B2860F89D|2||||NTXICRT|T1 COLLAGEN X-LINK N-TELOPEPTIDES/CREAT|||||||KHZ|||||||BORDERLINE||MMOL/MIN/KPA||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|CALCIFIED|N|MODIFIED ACID FAST STAIN|MDRD 5 VARIABLE FORMULA||NA|U|NA|NA|||NA|1||38||BASELINE|1966-07-10|1972-04-03|||||1962-11-07||1961-03-19|Y|1972-08-18
TRIAL STUDY 134XCP|LB|D9C32CF1-51C7-412D-A030-682B2860F89D|1||||IFIT3|INTERFERON-INDUCED 60 KDA PROTEIN|||||||CIGAR|||||||NEGATIVE||1/(S*KPA)||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|FRESH|NA|X-RAY FLUORESCENCE SPECTROMETRY|MDRD FORMULA||N|Y|NA|NA|||N|2||58||TREATMENT|1966-06-29|1965-08-29|||||1968-04-02||1973-09-06|U|1969-09-10
TRIAL STUDY 134XCP|LB|D9C32CF1-51C7-412D-A030-682B2860F89D|2||||BNPPRO|PROB-TYPE NATRIURETIC PEPTIDE|||||||NSEC|||||||POSITIVE||BOX||||HIGH|NOT DONE||||URINE SEDIMENT|PARAFFIN-EMBEDDED|NA|PEAK FLOWMETRY|MDRD FORMULA||N|U|N|N|||NA|2||58||BLINDED TREATMENT|1967-08-30|1965-05-20|||||1960-06-30||1963-11-20|N|1968-12-04
TRIAL STUDY 134XCP|LB|D9C32CF1-51C7-412D-A030-682B2860F89D|1||||PPTDCALB|PHOSPHATIDYLCHOLINE/ALBUMIN|||||||IU/DL|||||||POSITIVE||U/G HB||||ABNORMAL|NOT DONE||||COLOSTRUM|REFRIGERATED|NA|RYAN BLUE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|U|N|||N|3||39||OPEN LABEL TREATMENT|1965-02-23|1973-06-07|||||1961-12-13||1964-06-30|N|1960-11-25
TRIAL STUDY 134XCP|LB|D9C32CF1-51C7-412D-A030-682B2860F89D|2||||CYSTARCH|STARCH CRYSTALS|||||||PACKET|||||||NEGATIVE||PIXELS/IN||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|ICTERIC|Y|WRIGHT STAIN|GMI MMOL/MOL FORMULA||Y|NA|NA|NA|||NA|3||39||SCREENING|1967-05-07|1965-03-15|||||1971-04-06||1965-05-12|NA|1963-10-07
TRIAL STUDY 134XCP|LB|D9C32CF1-51C7-412D-A030-682B2860F89D|1||||ERCEPPOL|ERYTHROID PROLIFERATION POOL|||||||MS2|||||||INVALID||CG||||LOW|NOT DONE||||SERUM OR PLASMA OR BLOOD|SOLIDIFIED|NA|COMPUTERIZED CORNEAL TOPOGRAPHY|FIBROTEST FORMULA||N|Y|U|Y|||N|4||88||CONTINUATION TREATMENT|1962-11-16|1967-01-01|||||1965-01-10||1965-08-02|U|1968-12-14
TRIAL STUDY 134XCP|LB|D9C32CF1-51C7-412D-A030-682B2860F89D|2||||OPN|OSTEOPONTIN|||||||MCI/L|||||||BORDERLINE||V/V||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|ICTERIC|NA|FUNCTIONAL MRI|MDRD ENZYMATIC FORMULA||NA|U|N|U|||Y|4||88||OBSERVATION|1972-06-13|1961-04-28|||||1973-08-15||1962-03-28|U|1965-09-19
TRIAL STUDY 134XCP|LB|D9C32CF1-51C7-412D-A030-682B2860F89D|1||||PLG|PLASMINOGEN|||||||/100 WBC|||||||BORDERLINE||YD||||NORMAL|NOT DONE||||AMNIOTIC FLUID|CLOTTED|N|FLUORESCENT MICROSCOPY|MDRD 4 VARIABLE FORMULA||Y|Y|N|N|||NA|5||7||FOLLOW-UP|1968-03-20|1965-01-07|||||1971-08-19||1960-10-22|Y|1971-11-29
TRIAL STUDY 134XCP|LB|D9C32CF1-51C7-412D-A030-682B2860F89D|2||||BNZLCGN|BENZOYLECGONINE|||||||STEPS|||||||INDETERMINATE||CAL||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|ROOM TEMPERATURE|Y|TELLER ACUITY CARDS|MDRD ENZYMATIC FORMULA||NA|U|U|NA|||Y|5||7||BLINDED TREATMENT|1968-07-27|1963-04-12|||||1964-05-22||1967-10-11|Y|1966-12-27
TRIAL STUDY 134XCP|LB|102F6B51-5A86-497B-A36D-13FB77928C39|1||||MONO|MONOCYTES|||||||ABSORBANCE U|||||||BORDERLINE||10^12 IU/L||||LOW|NOT DONE||||CELL PELLET|UNEXPECTED ODOR|Y|COULOMETRIC TITRATION|MDRD 4 VARIABLE FORMULA||Y|Y|U|NA|||U|1||38||FOLLOW-UP|1962-01-19|1968-02-24|||||1965-06-04||1968-05-26|N|1970-11-30
TRIAL STUDY 134XCP|LB|102F6B51-5A86-497B-A36D-13FB77928C39|2||||VITK1|VITAMIN K1|||||||PACKAGE|||||||INVALID||NMOL/DAY||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|REFRIGERATED|U|ORCHIDOMETERY|NASH FIBROSURE FORMULA||N|NA|U|N|||NA|1||38||LONG-TERM FOLLOW-UP|1964-03-30|1963-01-06|||||1971-07-14||1961-08-22|NA|1969-01-02
TRIAL STUDY 134XCP|LB|102F6B51-5A86-497B-A36D-13FB77928C39|1||||LDL|LDL CHOLESTEROL|||||||FOZ_US|||||||TRACE||MMOL||||LOW|NOT DONE||||PLATELET|HEMOLYZED|U|MRI WITHOUT CONTRAST|NASH FIBROSURE FORMULA||U|N|Y|U|||NA|2||58||TREATMENT|1961-06-20|1960-01-10|||||1972-01-31||1964-08-02|NA|1972-03-21
TRIAL STUDY 134XCP|LB|102F6B51-5A86-497B-A36D-13FB77928C39|2||||CAFFEINE|CAFFEINE|||||||LOG10 CFU/G|||||||INVALID||KHZ||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|REFRIGERATED|N|TURBIDIMETRY|HEPASCORE FORMULA||U|NA|U|N|||U|2||58||RUN-IN|1965-01-17|1961-08-21|||||1973-08-22||1966-11-01|N|1963-06-02
TRIAL STUDY 134XCP|LB|102F6B51-5A86-497B-A36D-13FB77928C39|1||||LTFAB|LACTOFERRIN ANTIBODY|||||||SQU/ML|||||||BORDERLINE||10^4/HPF||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|REFRIGERATED|Y|PEAK FLOWMETRY|ASH FIBROSURE FORMULA||N|NA|U|N|||U|3||39||LONG-TERM FOLLOW-UP|1966-02-21|1970-06-26|||||1960-09-26||1968-09-19|U|1971-03-15
TRIAL STUDY 134XCP|LB|102F6B51-5A86-497B-A36D-13FB77928C39|2||||OSMLTY|OSMOLALITY|||||||MPH|||||||BORDERLINE||UMOL/DAY||||HIGH|NOT DONE||||TRANSUDATE|THAWED|U|IMMUNOPRECIPITATION|FIBROSIS 4 FORMULA||U|NA|U|N|||U|3||39||OBSERVATION|1968-07-05|1968-09-04|||||1970-02-10||1969-09-14|U|1962-04-29
TRIAL STUDY 134XCP|LB|102F6B51-5A86-497B-A36D-13FB77928C39|1||||BLASTIMM|IMMUNOBLASTS|||||||V|||||||INVALID||ENZYME U/G HB||||LOW|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|THAWED|NA|MAPH|FIBROSIS 4 FORMULA||NA|U|N|N|||N|4||88||OPEN LABEL TREATMENT|1961-06-27|1970-09-02|||||1961-07-12||1968-06-03|Y|1971-02-21
TRIAL STUDY 134XCP|LB|102F6B51-5A86-497B-A36D-13FB77928C39|2||||ABNCECE|ABNORMAL CELLS/TOTAL CELLS|||||||ML/G/H|||||||INDETERMINATE||NEBULE||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|LACTESCENT|N|OPHTHALMOSCOPY|CKD-EPI FORMULA||N|NA|NA|Y|||N|4||88||LONG-TERM FOLLOW-UP|1964-08-25|1964-01-09|||||1965-06-16||1969-10-11|U|1964-06-12
TRIAL STUDY 134XCP|LB|102F6B51-5A86-497B-A36D-13FB77928C39|1||||FLUOXTN|FLUOXETINE|||||||LOG10 ELISA UNIT|||||||POSITIVE||10^9/L||||LOW|NOT DONE||||SUPERNATANT, SERUM|CONTAMINATED|U|MASS SPECTROMETRY|GMI % FORMULA||U|U|Y|N|||NA|5||7||OBSERVATION|1965-11-13|1964-07-13|||||1963-09-08||1973-07-02|U|1972-06-30
TRIAL STUDY 134XCP|LB|102F6B51-5A86-497B-A36D-13FB77928C39|2||||CDTTFRN|CARB-DEFICIENT TRANSFERRIN/TRANSFERRIN|||||||NG/L|||||||BORDERLINE||10^9/G||||LOW|NOT DONE||||PLATELET POOR PLASMA|PARAFFIN-EMBEDDED|N|CONTACT SPECULAR MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||NA|N|N|Y|||Y|5||7||OPEN LABEL TREATMENT|1968-01-21|1967-07-16|||||1966-05-25||1960-12-29|NA|1966-03-29
TRIAL STUDY 134XCP|LB|C123D04C-1AA4-418D-B68C-EC9D410376F0|1||||CYCASULF|CALCIUM SULFATE CRYSTALS|||||||EID 50/ML|||||||POSITIVE||OD UNIT||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|AUTOLYZED|NA|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD 6 VARIABLE FORMULA||N|Y|U|U|||Y|1||38||BASELINE|1972-07-31|1967-06-26|||||1960-04-04||1960-06-22|NA|1966-01-06
TRIAL STUDY 134XCP|LB|C123D04C-1AA4-418D-B68C-EC9D410376F0|2||||ARGSAC|ARGININOSUCCINIC ACID|||||||ML/M2/DAY|||||||NEGATIVE||10^6 COPIES/ML||||ABNORMAL|NOT DONE||||HAIR|CLOTTED|U|ORCHIDOMETERY|CKD-EPI CREATININE FORMULA||NA|N|Y|NA|||N|1||38||OBSERVATION|1971-06-01|1961-04-25|||||1960-06-01||1962-05-05|NA|1964-06-07
TRIAL STUDY 134XCP|LB|C123D04C-1AA4-418D-B68C-EC9D410376F0|1||||VEGFR1S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC1|||||||BEATS/MIN|||||||POSITIVE||COAT||||NORMAL|NOT DONE||||LEUKOCYTE|CLOTTED|Y|PET SCAN|FIBROTEST FORMULA||NA|Y|NA|NA|||NA|2||58||OPEN LABEL TREATMENT|1972-08-04|1968-06-25|||||1961-05-27||1972-11-13|NA|1966-11-14
TRIAL STUDY 134XCP|LB|C123D04C-1AA4-418D-B68C-EC9D410376F0|2||||NEUTB|NEUTROPHILS BAND FORM|||||||COULOMB|||||||INVALID||SFC/10^6 PBMC||||LOW|NOT DONE||||FLUID|NON-HEMOLYZED|N|PULMONARY ANGIOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|N|U|Y|||NA|2||58||FOLLOW-UP|1966-07-16|1969-03-23|||||1966-10-19||1962-04-12|N|1971-12-25
TRIAL STUDY 134XCP|LB|C123D04C-1AA4-418D-B68C-EC9D410376F0|1||||AFPA|ALPHA FETOPROTEIN ACTIVITY|||||||/40 HPFS|||||||BORDERLINE||NEBULE||||HIGH|NOT DONE||||LEUKOCYTE|SOLIDIFIED|Y|PET/MRI SCAN|CKD-EPI CREATININE FORMULA||NA|NA|NA|NA|||Y|3||39||WASHOUT|1961-10-25|1964-09-03|||||1960-09-20||1964-12-05|U|1964-11-22
TRIAL STUDY 134XCP|LB|C123D04C-1AA4-418D-B68C-EC9D410376F0|2||||C4D|COMPLEMENT C4D|||||||ANTI-XA IU/ML|||||||TRACE||UGEQ/L||||LOW|NOT DONE||||INFRANATANT, PLASMA|HEMOLYZED|U|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD 5 VARIABLE FORMULA||N|Y|NA|NA|||N|3||39||LONG-TERM FOLLOW-UP|1968-06-04|1969-07-08|||||1970-03-23||1960-09-01|U|1966-02-09
TRIAL STUDY 134XCP|LB|C123D04C-1AA4-418D-B68C-EC9D410376F0|1||||GLBCREAT|GLOBULIN/CREATININE|||||||UG/H|||||||BORDERLINE||LOG10 PFU||||HIGH|NOT DONE||||SEMINAL FLUID|CALCIFIED|U|IRON HEMATOXYLIN STAIN|MDRD FORMULA||U|NA|U|N|||U|4||88||FOLLOW-UP|1965-11-16|1960-03-13|||||1968-11-03||1964-04-27|NA|1967-09-04
TRIAL STUDY 134XCP|LB|C123D04C-1AA4-418D-B68C-EC9D410376F0|2||||VEGFC|VASCULAR ENDOTHELIAL GROWTH FACTOR C|||||||LOG10 IU/ML|||||||TRACE||BLOCKS||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|SOLIDIFIED|Y|TEMPLATE INCISION METHOD|FIBROTEST FORMULA||U|N|Y|NA|||NA|4||88||CONTINUATION TREATMENT|1971-02-28|1962-04-22|||||1964-02-06||1961-05-12|U|1966-12-15
TRIAL STUDY 134XCP|LB|C123D04C-1AA4-418D-B68C-EC9D410376F0|1||||C165896|D. PTERONYSSINUS ANTIGEN IGG4 ANTIBODY|||||||10^9 CFU/G|||||||INVALID||IN2||||NORMAL|NOT DONE||||CAPILLARY BLOOD|CONTAMINATED|NA|MALDI|MDRD FORMULA||N|N|N|N|||N|5||7||CONTINUATION TREATMENT|1963-04-04|1963-12-09|||||1968-10-01||1964-04-16|Y|1966-01-10
TRIAL STUDY 134XCP|LB|C123D04C-1AA4-418D-B68C-EC9D410376F0|2||||HGBFR|HEMOGLOBIN, FREE|||||||ELISA UNIT|||||||INVALID||L/KG||||ABNORMAL|NOT DONE||||SOFT TISSUE|ICTERIC|N|ENDPOINT DILUTION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|N|N|||NA|5||7||INDUCTION TREATMENT|1967-10-28|1969-02-08|||||1972-08-22||1966-11-03|NA|1968-06-01
TRIAL STUDY 134XCP|LB|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|1||||CYHIPPAC|HIPPURIC ACID CRYSTALS|||||||MG/CM2|||||||INDETERMINATE||BEATS/MIN||||NORMAL|NOT DONE||||PLASMA|CLOTTED|NA|TRANSMISSION ELECTRON MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|U|U|||NA|1||38||BASELINE|1972-01-08|1967-08-12|||||1970-03-13||1970-08-10|N|1968-06-07
TRIAL STUDY 134XCP|LB|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|2||||HIST4AB|HISTONE 4 ANTIBODY|||||||MM|||||||TRACE||PMOL/DAY||||LOW|NOT DONE||||ABSCESS FLUID|CONTAMINATED|N|MICRONEUTRALIZATION ASSAY|ASH FIBROSURE FORMULA||Y|N|N|Y|||NA|1||38||INDUCTION TREATMENT|1968-05-27|1969-09-17|||||1970-02-25||1961-01-19|N|1967-01-04
TRIAL STUDY 134XCP|LB|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|1||||EOSMYL|EOSINOPHILIC MYELOCYTES|||||||DNA COPIES/ML|||||||BORDERLINE||YEARS||||LOW|NOT DONE||||BASAL TEAR|UNEXPECTED ODOR|NA|TRYPAN BLUE STAIN|NASH FIBROSURE FORMULA||N|NA|Y|U|||N|2||58||BASELINE|1962-01-15|1972-03-09|||||1973-01-28||1967-03-03|NA|1961-12-01
TRIAL STUDY 134XCP|LB|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|2||||APLAB|ANTIPHOSPHOLIPID ANTIBODIES|||||||PELLET|||||||BORDERLINE||FT2||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|HEMOLYZED|U|FLOCCULATION|FIBROMETER FORMULA||U|Y|Y|NA|||NA|2||58||SCREENING|1971-11-14|1963-09-12|||||1970-07-11||1965-02-15|Y|1971-06-15
TRIAL STUDY 134XCP|LB|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|1||||DRVVTRT|DILUTE RUSSELL'S VIPER VENOM TIME RATIO|||||||EU|||||||TRACE||/200 HPFS||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|CLOTTED|NA|ELASTOGRAPHY|MDRD FORMULA||Y|N|U|N|||U|3||39||RUN-IN|1970-08-14|1971-05-06|||||1968-02-08||1961-03-19|Y|1972-06-24
TRIAL STUDY 134XCP|LB|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|2||||PCA3MRNA|PROSTATE CANCER ANTIGEN 3 MRNA|||||||KCAL|||||||NEGATIVE||MOL/MG||||HIGH|NOT DONE||||CAPILLARY BLOOD|DRIED|U|ELLA|FIBROTEST FORMULA||U|N|U|NA|||Y|3||39||TREATMENT|1966-01-20|1966-03-24|||||1968-05-10||1969-11-10|Y|1967-11-17
TRIAL STUDY 134XCP|LB|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|1||||GSTCREAT|GLUTATHIONE-S-TRANSFERASE/CREATININE|||||||BEATS/MIN|||||||NEGATIVE||SBE/ML||||ABNORMAL|NOT DONE||||LYMPH|CONTAMINATED|U|ELECTRONEUROGRAPHY|CKD-EPI CREATININE FORMULA||N|Y|NA|NA|||U|4||88||RUN-IN|1971-04-30|1968-02-13|||||1969-06-11||1968-01-30|Y|1970-12-07
TRIAL STUDY 134XCP|LB|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|2||||G6PDRBC|G6PD-DEFICIENT ERYTHROCYTES|||||||CMOL/L|||||||POSITIVE||HPA||||ABNORMAL|NOT DONE||||SEBUM|CALCIFIED|Y|MICROBIAL CULTURE, LIQUID|HEPASCORE FORMULA||N|N|U|N|||N|4||88||LONG-TERM FOLLOW-UP|1963-10-17|1967-04-12|||||1968-05-26||1964-12-12|N|1965-06-07
TRIAL STUDY 134XCP|LB|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|1||||PLATSAT|PLATELET SATELLITISM|||||||MG/ML/DAY|||||||TRACE||ML/MIN/MMHG||||NORMAL|NOT DONE||||DERMAL TISSUE|LIPEMIC|N|POLYSOMNOGRAPHY|COCKCROFT-GAULT FORMULA||N|N|Y|N|||NA|5||7||TREATMENT|1960-05-15|1965-05-13|||||1961-01-14||1972-06-26|N|1967-01-03
TRIAL STUDY 134XCP|LB|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|2||||ERCECE|ERYTHROID CELLS/TOTAL CELLS|||||||HOURS|||||||BORDERLINE||MIU/L||||ABNORMAL|NOT DONE||||URINE SEDIMENT|CLOTTED|NA|MAGNETIC RESONANCE ENTEROGRAPHY|MDRD 6 VARIABLE FORMULA||N|N|Y|N|||Y|5||7||OPEN LABEL TREATMENT|1967-05-24|1970-08-04|||||1969-03-21||1970-09-16|NA|1960-07-28
TRIAL STUDY 134XCP|LB|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|1||||IGE|IMMUNOGLOBULIN E|||||||DAGU/ML|||||||POSITIVE||DROP||||HIGH|NOT DONE||||COLOSTRUM|THAWED|Y|FLOCCULATION, CHARCOAL ENHANCED|CKD-EPI CYSTATIN C FORMULA||NA|NA|U|U|||Y|1||38||OBSERVATION|1973-01-07|1969-07-09|||||1968-03-15||1966-10-14|N|1966-10-11
TRIAL STUDY 134XCP|LB|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|2||||PO2FIO2|PP ARTERIAL O2/FRACTION INSPIRED O2|||||||GBQ/UG|||||||TRACE||L/MIN||||HIGH|NOT DONE||||PLATELET POOR PLASMA|REFRIGERATED|NA|MOUSE PROTECTION ASSAY|FIBROSIS 4 FORMULA||N|U|U|U|||NA|1||38||BASELINE|1970-07-28|1973-02-02|||||1973-06-22||1963-12-19|Y|1962-01-12
TRIAL STUDY 134XCP|LB|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|1||||C147276|ARACHIS HYPOGAEA ANTIGEN IGE ANTIBODY|||||||U/G HB|||||||INDETERMINATE||OZ||||LOW|NOT DONE||||VENOUS BLOOD|CONCENTRATED|U|PULMONARY ANGIOGRAPHY|FIBROMETER FORMULA||N|N|Y|Y|||U|2||58||RUN-IN|1971-12-18|1968-12-10|||||1968-08-31||1967-10-22|N|1966-01-23
TRIAL STUDY 134XCP|LB|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|2||||ESTRDIOL|ESTRADIOL|||||||CMH2O/ML|||||||NEGATIVE||KV||||NORMAL|NOT DONE||||BASAL TEAR|CLOTTED|N|SANGER SEQUENCING|COCKCROFT-GAULT FORMULA||NA|N|U|Y|||N|2||58||RUN-IN|1967-09-08|1966-02-09|||||1962-10-24||1961-01-21|NA|1968-12-12
TRIAL STUDY 134XCP|LB|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|1||||TRACP5B|TARTRATE-RESISTANT ACID PHOSPHATASE 5B|||||||UGEQ/L|||||||POSITIVE||U/KG/H||||NORMAL|NOT DONE||||EMESIS|ROOM TEMPERATURE|U|TELLER ACUITY CARDS|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|NA|Y|||NA|3||39||FOLLOW-UP|1972-09-01|1972-01-23|||||1973-06-08||1972-07-09|U|1962-07-05
TRIAL STUDY 134XCP|LB|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|2||||C130072|BIRCH POLLEN IGE|||||||U/DL|||||||NEGATIVE||/MONTH||||LOW|NOT DONE||||TUMOR TISSUE|ROOM TEMPERATURE|Y|CHROMATOGRAPHY|FIBROMETER FORMULA||NA|U|Y|Y|||U|3||39||OPEN LABEL TREATMENT|1968-11-15|1972-04-16|||||1960-02-23||1972-01-07|N|1962-06-21
TRIAL STUDY 134XCP|LB|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|1||||TNFSR|SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR|||||||U/M2/DAY|||||||NEGATIVE||ABSORBANCE U/MIN||||HIGH|NOT DONE||||PERITONEAL FLUID|NON-HEMOLYZED|NA|NON-INVASIVE DIELECTRIC SENSING|MDRD 4 VARIABLE FORMULA||U|N|NA|NA|||U|4||88||BASELINE|1960-12-07|1960-01-23|||||1960-12-10||1972-05-15|Y|1963-05-25
TRIAL STUDY 134XCP|LB|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|2||||TYR|TYROSINE|||||||G/U|||||||BORDERLINE||NFIU||||LOW|NOT DONE||||TUMOR TISSUE|LIPEMIC|Y|PLETHYSMOGRAPHY|COCKCROFT-GAULT FORMULA||N|NA|Y|Y|||U|4||88||FOLLOW-UP|1969-09-04|1965-04-13|||||1962-07-13||1971-01-11|U|1963-08-07
TRIAL STUDY 134XCP|LB|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|1||||KEXR|POTASSIUM EXCRETION RATE|||||||KG/CM|||||||TRACE||/SEC||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|CONTAMINATED|U|MIGET|FIBROTEST FORMULA||NA|NA|N|U|||U|5||7||FOLLOW-UP|1965-09-03|1962-07-24|||||1971-01-17||1960-03-01|NA|1966-08-14
TRIAL STUDY 134XCP|LB|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|2||||DENSITY|DENSITY|||||||MNFI|||||||POSITIVE||BAR||||HIGH|NOT DONE||||SERUM|UNEXPECTED ODOR|NA|SANGER SEQUENCING|GMI % FORMULA||N|N|NA|NA|||Y|5||7||BLINDED TREATMENT|1967-04-13|1971-02-26|||||1971-11-03||1961-12-20|N|1961-05-16
TRIAL STUDY 134XCP|LB|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|1||||METARBLE|METARUBRICYTES/LEUKOCYTES|||||||ML/M2/H|||||||INDETERMINATE||TUBERCULIN UNIT||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|FRESH|U|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD FORMULA||U|Y|N|U|||Y|1||38||SCREENING|1964-08-19|1967-11-18|||||1972-09-14||1972-11-29|NA|1972-12-17
TRIAL STUDY 134XCP|LB|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|2||||NMH|N-METHYLHISTAMINE|||||||MMHG/SEC|||||||BORDERLINE||ML/KG/DAY||||HIGH|NOT DONE||||SEMEN|CONCENTRATED|Y|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|CKD-EPI FORMULA||U|NA|Y|NA|||U|1||38||RUN-IN|1967-05-15|1969-03-14|||||1970-10-18||1972-03-24|N|1967-04-05
TRIAL STUDY 134XCP|LB|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|1||||HLADRMSC|HLA-DR MISMATCH COUNT|||||||PIXELS/IN|||||||NEGATIVE||C||||ABNORMAL|NOT DONE||||VENOUS PLASMA|CONCENTRATED|NA|FREEZING POINT DEPRESSION|HEPASCORE FORMULA||U|N|U|Y|||N|2||58||TREATMENT|1972-03-05|1967-12-05|||||1972-06-30||1960-09-20|Y|1965-12-19
TRIAL STUDY 134XCP|LB|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|2||||CARNITF|CARNITINE, FREE|||||||GBQ/UG|||||||INDETERMINATE||MOL/MG||||HIGH|NOT DONE||||REFLEX TEAR|GELLED|Y|RADIATION DOSIMETRY|CKD-EPI CREATININE FORMULA||N|U|N|NA|||Y|2||58||CONTINUATION TREATMENT|1973-05-14|1968-11-03|||||1962-04-25||1961-12-11|N|1966-03-20
TRIAL STUDY 134XCP|LB|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|1||||FBNCTCE|FIBRONECTIN, CELLULAR|||||||BE/ML|||||||BORDERLINE||MG/KG/DOSE||||NORMAL|NOT DONE||||MONOCYTE|HEMOLYZED|Y|FARNSWORTH-MUNSELL 100 HUE TEST|FIBROSIS 4 FORMULA||U|N|U|U|||N|3||39||TREATMENT|1972-02-07|1965-05-19|||||1962-11-06||1965-09-06|U|1962-12-22
TRIAL STUDY 134XCP|LB|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|2||||GUSA|GLUCURONIDASE, ALPHA|||||||U/L|||||||TRACE||SEC||||NORMAL|NOT DONE||||PROSTATIC FLUID|CONTAMINATED|NA|CLAUSS METHOD|CKD-EPI CREATININE FORMULA||N|Y|NA|NA|||N|3||39||SCREENING|1965-02-09|1967-03-10|||||1972-03-14||1970-11-28|N|1970-02-20
TRIAL STUDY 134XCP|LB|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|1||||LMBDLC|LAMBDA LIGHT CHAIN|||||||DPM/ML|||||||BORDERLINE||ML/KG||||ABNORMAL|NOT DONE||||URINE SEDIMENT|ROOM TEMPERATURE|NA|DROPLET DIGITAL PCR|COCKCROFT-GAULT FORMULA||NA|N|Y|N|||NA|4||88||OBSERVATION|1973-01-15|1963-07-10|||||1970-07-15||1973-02-27|NA|1964-03-14
TRIAL STUDY 134XCP|LB|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|2||||BLSTSID|SIDEROBLAST|||||||PSI|||||||NEGATIVE||CAPSULE||||HIGH|NOT DONE||||PUS|CONTAMINATED|NA|SIZE EXCLUSION CHROMATOGRAPHY|CKD-EPI CREATININE FORMULA||U|N|U|NA|||U|4||88||RUN-IN|1969-12-16|1966-09-28|||||1971-12-17||1963-08-28|Y|1962-04-03
TRIAL STUDY 134XCP|LB|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|1||||FACTXIIA|FACTOR XII ACTIVITY|||||||CD/M2|||||||NEGATIVE||M3||||NORMAL|NOT DONE||||COLOSTRUM|CLOTTED|U|BIOPSY|CKD-EPI FORMULA||NA|NA|N|N|||NA|5||7||SCREENING|1964-06-04|1965-07-22|||||1965-06-08||1965-08-11|Y|1971-02-12
TRIAL STUDY 134XCP|LB|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|2||||RBCNUCLE|NUCLEATED ERYTHROCYTES/LEUKOCYTES|||||||AMFI|||||||INVALID||PIXELS/IN||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|SOLIDIFIED|U|TONOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|NA|||Y|5||7||OBSERVATION|1963-11-26|1963-09-17|||||1964-05-28||1971-03-21|NA|1963-10-20
TRIAL STUDY 134XCP|LB|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|1||||ALPIS|INTESTINAL SPECIFIC ALKALINE PHOSPHATASE|||||||BQ/KG|||||||BORDERLINE||TROCHE||||NORMAL|NOT DONE||||CERUMEN|CLOTTED|Y|CRYOSCOPY|GMI MMOL/MOL FORMULA||U|U|U|U|||Y|1||38||WASHOUT|1968-11-21|1971-06-24|||||1972-08-22||1968-09-29|NA|1960-03-05
TRIAL STUDY 134XCP|LB|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|2||||SAMETH|S-ADENOSYLMETHIONINE|||||||10^6 COPIES/ML|||||||POSITIVE||MG/DL||||HIGH|NOT DONE||||PERSPIRATION|AGGLUTINATED|NA|FLUORESCENT LIFETIME IMAGING MICROSCOPY|HEPASCORE FORMULA||U|NA|NA|NA|||NA|1||38||OPEN LABEL TREATMENT|1965-09-06|1971-05-31|||||1968-05-25||1965-08-29|NA|1963-06-02
TRIAL STUDY 134XCP|LB|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|1||||NEUTBLE|NEUTROPHILS BAND FORM/LEUKOCYTES|||||||ELISA UNIT/ML|||||||TRACE||TBSP||||NORMAL|NOT DONE||||SALIVA|CALCIFIED|U|ENDOSCOPY|GMI % FORMULA||U|Y|Y|NA|||NA|2||58||TREATMENT|1962-12-23|1970-08-24|||||1964-11-27||1967-03-06|N|1969-02-05
TRIAL STUDY 134XCP|LB|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|2||||PSAMRNA|PROSTATE SPECIFIC ANTIGEN MRNA|||||||PFU/ANIMAL|||||||INDETERMINATE||BOTTLE||||HIGH|NOT DONE||||BLOOD|GELLED|NA|DIRECT SEQUENCING|GMI % FORMULA||NA|Y|NA|Y|||NA|2||58||INDUCTION TREATMENT|1961-04-29|1961-01-08|||||1963-04-13||1966-05-23|NA|1970-10-29
TRIAL STUDY 134XCP|LB|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|1||||A2MACG|ALPHA-2 MACROGLOBULIN|||||||CMH2O/ML|||||||POSITIVE||U/MG||||NORMAL|NOT DONE||||LYMPH|UNEXPECTED ODOR|Y|BAC ACGH|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|NA|N|||N|3||39||CONTINUATION TREATMENT|1964-01-31|1973-04-18|||||1966-01-13||1965-03-19|U|1973-02-03
TRIAL STUDY 134XCP|LB|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|2||||LDH2LDH|LDH ISOENZYME 2/LDH|||||||KIU|||||||INDETERMINATE||AMFI||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|LACTESCENT|N|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NASH FIBROSURE FORMULA||N|Y|NA|Y|||N|3||39||BLINDED TREATMENT|1965-02-08|1971-10-15|||||1962-05-09||1967-01-16|N|1961-02-09
TRIAL STUDY 134XCP|LB|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|1||||BD2|BETA-DEFENSIN 2|||||||CIGARETTE|||||||NEGATIVE||PIPE||||LOW|NOT DONE||||ATHEROSCLEROTIC PLAQUE|AGGLUTINATED|NA|PERIPHERAL ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||N|U|U|N|||NA|4||88||WASHOUT|1962-01-28|1965-04-01|||||1969-08-19||1960-07-04|Y|1961-10-26
TRIAL STUDY 134XCP|LB|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|2||||ESTRCPT|ESTROGEN RECEPTOR|||||||10^10/L|||||||NEGATIVE||MG/ML/DAY||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|CONTAMINATED|U|PYROSEQUENCING|MDRD ENZYMATIC FORMULA||U|NA|N|Y|||NA|4||88||TREATMENT|1964-11-12|1969-05-25|||||1972-06-12||1971-09-22|Y|1967-12-31
TRIAL STUDY 134XCP|LB|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|1||||B2MICG|BETA-2 MICROGLOBULIN|||||||NEEDLE GAUGE|||||||POSITIVE||U/M2/H||||ABNORMAL|NOT DONE||||DERMAL TISSUE|LIPEMIC|U|WHOLE EXOME SEQUENCING|GMI MMOL/MOL FORMULA||N|Y|NA|U|||Y|5||7||BLINDED TREATMENT|1973-02-04|1960-08-25|||||1971-03-18||1964-03-11|Y|1961-02-16
TRIAL STUDY 134XCP|LB|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|2||||MTNEPHFR|METANEPHRINE, FREE|||||||G/ANIMAL/DAY|||||||INVALID||WEBER||||HIGH|NOT DONE||||SEBUM|CALCIFIED|NA|REVERSE TRANSCRIPTASE PCR|FIBROMETER FORMULA||U|Y|Y|N|||U|5||7||BASELINE|1960-09-30|1971-04-28|||||1963-09-29||1962-11-21|U|1963-08-26
TRIAL STUDY 134XCP|LB|E3310689-5727-4970-A675-A58931E406FA|1||||MDA|3,4-METHYLENEDIOXYAMPHETAMINE|||||||TSP EQ|||||||INVALID||UG/M2/DAY||||ABNORMAL|NOT DONE||||SMEGMA|ROOM TEMPERATURE|N|GC/MS|COCKCROFT-GAULT FORMULA||U|U|Y|N|||Y|1||38||TREATMENT|1967-09-02|1967-06-13|||||1966-06-10||1960-03-06|U|1962-02-18
TRIAL STUDY 134XCP|LB|E3310689-5727-4970-A675-A58931E406FA|2||||TRANK1|TPR-ANKYRIN REPEAT-CONTAINING PROTEIN 1|||||||CM/MIN|||||||INVALID||MOSM||||HIGH|NOT DONE||||ARTERIAL BLOOD|ROOM TEMPERATURE|N|COULOMETRIC TITRATION|MDRD FORMULA||U|N|NA|N|||N|1||38||LONG-TERM FOLLOW-UP|1966-10-02|1969-03-19|||||1971-02-13||1962-11-25|NA|1973-06-22
TRIAL STUDY 134XCP|LB|E3310689-5727-4970-A675-A58931E406FA|1||||CYSTHION|CYSTATHIONINE|||||||/4.0 ML|||||||BORDERLINE||MMOL/MOL||||LOW|NOT DONE||||SEMEN|CONTAMINATED|N|INCISION-INDUCED BLEEDING METHOD|MDRD 5 VARIABLE FORMULA||Y|NA|NA|Y|||Y|2||58||OBSERVATION|1963-01-08|1968-04-15|||||1971-04-09||1962-03-05|U|1960-10-19
TRIAL STUDY 134XCP|LB|E3310689-5727-4970-A675-A58931E406FA|2||||CATNINB|BETA CATENIN|||||||BQ/G|||||||TRACE||AMU||||LOW|NOT DONE||||SYNOVIAL FLUID|CLOTTED|N|NON-INVASIVE DIELECTRIC SENSING|HEPASCORE FORMULA||NA|NA|N|N|||U|2||58||BLINDED TREATMENT|1960-06-07|1961-06-08|||||1961-01-31||1968-02-03|Y|1967-01-04
TRIAL STUDY 134XCP|LB|E3310689-5727-4970-A675-A58931E406FA|1||||GLP1AC|GLUCAGON-LIKE PEPTIDE-1, ACTIVE FORM|||||||/100 HPFS|||||||INDETERMINATE||NG/L||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CLOTTED|Y|PLAQUE REDUCTION NEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|NA|||Y|3||39||BASELINE|1968-08-13|1972-03-28|||||1963-08-27||1971-05-18|NA|1970-04-27
TRIAL STUDY 134XCP|LB|E3310689-5727-4970-A675-A58931E406FA|2||||URATECRT|URATE/CREATININE|||||||DIP|||||||TRACE||NEWTON||||NORMAL|NOT DONE||||LUNG SURFACTANT|HEMOLYZED|U|MAMMOGRAPHY|MDRD 5 VARIABLE FORMULA||N|U|U|U|||N|3||39||BLINDED TREATMENT|1968-11-09|1967-01-10|||||1960-11-17||1970-05-19|N|1972-06-02
TRIAL STUDY 134XCP|LB|E3310689-5727-4970-A675-A58931E406FA|1||||GFRBSCRT|GFR FROM CREATININE ADJUSTED FOR BSA|||||||PFU|||||||TRACE||MMOL||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|GELLED|NA|HILLMEN COLOR CHART|FIBROTEST FORMULA||U|Y|Y|NA|||NA|4||88||INDUCTION TREATMENT|1969-08-26|1963-06-08|||||1962-04-03||1967-06-17|N|1963-10-15
TRIAL STUDY 134XCP|LB|E3310689-5727-4970-A675-A58931E406FA|2||||CKBBCK|CREATINE KINASE BB/TOTAL CREATINE KINASE|||||||IU/KG|||||||BORDERLINE||ML/MMHG/MIN/L||||LOW|NOT DONE||||EPIDERMAL TISSUE|CLOTTED|N|GC/MS-EI|MDRD 4 VARIABLE FORMULA||N|NA|N|Y|||N|4||88||TREATMENT|1964-06-19|1969-11-30|||||1967-08-17||1967-08-05|U|1960-06-28
TRIAL STUDY 134XCP|LB|E3310689-5727-4970-A675-A58931E406FA|1||||CD22|CD22|||||||PMOL/L/H|||||||NEGATIVE||S*KPA||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED|N|ACID FAST STAIN|FIBROTEST FORMULA||Y|Y|U|U|||N|5||7||CONTINUATION TREATMENT|1972-06-30|1963-09-22|||||1969-06-25||1963-09-07|N|1969-06-23
TRIAL STUDY 134XCP|LB|E3310689-5727-4970-A675-A58931E406FA|2||||TFRRNSAT|TRANSFERRIN SATURATION|||||||DL|||||||NEGATIVE||CAPFUL||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|NON-HEMOLYZED|NA|SISH|NASH FIBROSURE FORMULA||NA|N|U|NA|||N|5||7||FOLLOW-UP|1969-08-17|1963-11-29|||||1970-08-19||1971-01-01|N|1962-01-07
TRIAL STUDY 134XCP|LB|D5359BBA-960E-4392-996A-BCDD8637894A|1||||PTSFAC|PROTEIN S, FREE ACTUAL/CONTROL|||||||GPELISA UNIT/ML|||||||POSITIVE||MM2||||LOW|NOT DONE||||KERATINOCYTE|CONCENTRATED|U|SCANNING ELECTRON MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||U|U|NA|N|||N|1||38||BLINDED TREATMENT|1964-05-25|1964-05-24|||||1964-05-29||1973-08-10|U|1965-01-17
TRIAL STUDY 134XCP|LB|D5359BBA-960E-4392-996A-BCDD8637894A|2||||STOMCY|STOMATOCYTES|||||||SCM|||||||INDETERMINATE||MM/MIN||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|THAWED|Y|X-RAY FLUORESCENCE SPECTROMETRY|FIBROMETER FORMULA||N|U|Y|NA|||NA|1||38||BASELINE|1973-07-05|1964-07-27|||||1969-10-27||1960-07-09|N|1973-07-18
TRIAL STUDY 134XCP|LB|D5359BBA-960E-4392-996A-BCDD8637894A|1||||PHADJT|PH ADJUSTED FOR BODY TEMP|||||||ML/(MIN*100ML)|||||||BORDERLINE||RPM||||HIGH|NOT DONE||||LAVAGE FLUID|ROOM TEMPERATURE|NA|SEQUENCING|FIBROMETER FORMULA||NA|NA|Y|N|||Y|2||58||LONG-TERM FOLLOW-UP|1966-02-08|1961-12-08|||||1971-01-28||1965-12-25|U|1973-05-12
TRIAL STUDY 134XCP|LB|D5359BBA-960E-4392-996A-BCDD8637894A|2||||KIM1|KIDNEY INJURY MOLECULE-1|||||||COPIES/UG|||||||TRACE||MIN||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|FROZEN|N|SANGER SEQUENCING|GMI % FORMULA||N|N|Y|NA|||NA|2||58||FOLLOW-UP|1967-06-02|1960-04-10|||||1965-06-12||1963-06-27|U|1967-03-19
TRIAL STUDY 134XCP|LB|D5359BBA-960E-4392-996A-BCDD8637894A|1||||V25HD3|25-HYDROXYVITAMIN D3|||||||UMOL/MOL|||||||NEGATIVE||UG/L||||NORMAL|NOT DONE||||PROSTATIC FLUID|FRESH|NA|OPHTHALMOSCOPY|FIBROTEST FORMULA||NA|NA|Y|N|||N|3||39||FOLLOW-UP|1960-07-24|1969-03-01|||||1964-07-15||1960-07-05|U|1961-04-13
TRIAL STUDY 134XCP|LB|D5359BBA-960E-4392-996A-BCDD8637894A|2||||LIF|LEUKEMIA INHIBITORY FACTOR|||||||KDA|||||||TRACE||RING||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|NON-HEMOLYZED|Y|GC/MS/MS|MDRD FORMULA||U|U|U|N|||Y|3||39||TREATMENT|1966-12-07|1967-07-15|||||1966-08-26||1971-10-24|NA|1960-11-11
TRIAL STUDY 134XCP|LB|D5359BBA-960E-4392-996A-BCDD8637894A|1||||HLADR53A|HLA-DR53 ANTIBODY|||||||PM|||||||NEGATIVE||ML/CAGE/WK||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM|PARAFFIN-EMBEDDED|N|MRI|CKD-EPI FORMULA||NA|N|U|N|||N|4||88||FOLLOW-UP|1971-09-06|1973-01-04|||||1969-09-10||1964-11-30|Y|1966-02-01
TRIAL STUDY 134XCP|LB|D5359BBA-960E-4392-996A-BCDD8637894A|2||||PCDW|PLATELET COMPONENT DISTRIBUTION WIDTH|||||||M/SEC|||||||INVALID||GRAIN||||LOW|NOT DONE||||BASAL TEAR|CONTAMINATED|NA|VENTILATION PERFUSION LUNG SCAN|MDRD ENZYMATIC FORMULA||Y|Y|N|N|||N|4||88||INDUCTION TREATMENT|1965-03-14|1969-01-14|||||1966-02-22||1962-06-15|Y|1970-01-02
TRIAL STUDY 134XCP|LB|D5359BBA-960E-4392-996A-BCDD8637894A|1||||C130079|SILVER BIRCH POLLEN IGG4|||||||G/ANIMAL/WK|||||||INDETERMINATE||CIGAR||||NORMAL|NOT DONE||||REFLEX TEAR|SOLIDIFIED|Y|WESTERGREN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|NA|Y|||N|5||7||CONTINUATION TREATMENT|1966-12-28|1961-02-02|||||1964-02-21||1972-07-16|N|1969-06-21
TRIAL STUDY 134XCP|LB|D5359BBA-960E-4392-996A-BCDD8637894A|2||||CRLPLSMN|CERULOPLASMIN|||||||BU/ML|||||||POSITIVE||CM/S||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|CONTAMINATED|N|CELL BASED BIOASSAY|CKD-EPI CREATININE FORMULA||U|NA|NA|NA|||U|5||7||INDUCTION TREATMENT|1961-01-04|1969-04-10|||||1961-01-03||1960-12-17|NA|1972-06-16
TRIAL STUDY 134XCP|LB|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|1||||CPEPTIDE|C-PEPTIDE|||||||IU/G|||||||TRACE||MU||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|GELLED|N|TONOMETRY|CKD-EPI FORMULA||Y|Y|U|Y|||U|1||38||SCREENING|1971-06-14|1965-03-22|||||1961-05-06||1968-09-17|N|1966-07-22
TRIAL STUDY 134XCP|LB|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|2||||SPMAGGLU|SPERM AGGLUTINATION|||||||LB|||||||POSITIVE||ML/CAGE||||HIGH|NOT DONE||||SEBUM|THAWED|Y|FLUOROSCOPY|MDRD FORMULA||NA|NA|Y|N|||NA|1||38||INDUCTION TREATMENT|1965-06-01|1967-02-21|||||1963-03-14||1961-04-14|NA|1960-02-20
TRIAL STUDY 134XCP|LB|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|1||||CHRMTNAB|CHROMATIN ANTIBODIES|||||||AU/ML|||||||NEGATIVE||10^9 CFU/G||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|FROZEN|Y|FLUOROSCOPY|NASH FIBROSURE FORMULA||NA|U|N|U|||Y|2||58||TREATMENT|1966-03-18|1963-09-05|||||1972-07-08||1964-06-26|U|1967-10-29
TRIAL STUDY 134XCP|LB|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|2||||CACRTP|CALCIUM CORRECTED FOR TOTAL PROTEIN|||||||DMOL|||||||TRACE||HEP||||LOW|NOT DONE||||CELL PELLET|LACTESCENT|N|KINYOUN STAIN|CKD-EPI CYSTATIN C FORMULA||NA|N|NA|Y|||Y|2||58||TREATMENT|1963-02-20|1972-03-28|||||1970-07-14||1967-08-08|U|1970-03-24
TRIAL STUDY 134XCP|LB|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|1||||FGF23|FIBROBLAST GROWTH FACTOR 23|||||||MNFI|||||||NEGATIVE||CYCLE/MIN||||LOW|NOT DONE||||BUFFY COAT|CONCENTRATED|Y|ARTERIAL SPIN LABELING FUNCTIONAL MRI|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|NA|NA|||N|3||39||LONG-TERM FOLLOW-UP|1970-10-13|1967-01-01|||||1966-06-26||1970-11-11|NA|1971-12-13
TRIAL STUDY 134XCP|LB|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|2||||PLSIMCE|IMMATURE PLASMA CELLS|||||||PACK|||||||POSITIVE||ML/M2/DAY||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|GELLED|N|CONTRAST ENHANCED X-RAY|HEPASCORE FORMULA||U|NA|Y|NA|||N|3||39||WASHOUT|1966-02-01|1968-07-21|||||1967-09-13||1968-09-12|U|1969-08-11
TRIAL STUDY 134XCP|LB|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|1||||HCT|HEMATOCRIT|||||||10^3 CFU/ML|||||||POSITIVE||RNA COPIES/ML||||NORMAL|NOT DONE||||ABSCESS FLUID|CONTAMINATED|NA|LIGHT SCATTERING SPECTROSCOPY|GMI MMOL/MOL FORMULA||NA|U|NA|Y|||NA|4||88||BASELINE|1969-04-28|1968-05-07|||||1972-04-20||1965-04-26|N|1967-05-03
TRIAL STUDY 134XCP|LB|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|2||||VTRNCTN|VITRONECTIN|||||||M2|||||||INVALID||ML/M2||||LOW|NOT DONE||||PERSPIRATION|FRESH|N|MS/MS|GMI % FORMULA||NA|U|U|NA|||Y|4||88||SCREENING|1963-11-09|1972-08-31|||||1973-02-02||1972-11-16|U|1966-10-15
TRIAL STUDY 134XCP|LB|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|1||||MITOM2AB|MITOCHONDRIAL M2 ANTIBODY|||||||K|||||||POSITIVE||ML/G/DAY||||LOW|NOT DONE||||HAIR FOLLICLE|PARAFFIN-EMBEDDED|Y|ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|Y|Y|||N|5||7||OBSERVATION|1961-04-01|1965-08-18|||||1966-11-15||1971-12-11|Y|1962-03-13
TRIAL STUDY 134XCP|LB|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|2||||CSHYAL|HYALINE CASTS|||||||/WK|||||||NEGATIVE||10^8 PFU||||HIGH|NOT DONE||||SYNOVIAL FLUID|PARAFFIN-EMBEDDED|N|CYSTOSCOPY|GMI MMOL/MOL FORMULA||Y|N|N|U|||Y|5||7||OBSERVATION|1973-08-06|1961-06-06|||||1965-05-03||1970-01-08|NA|1963-04-21
TRIAL STUDY 134XCP|LB|EED3F55E-892E-46C6-8B0A-30D2E1112072|1||||SCKLCE|SICKLE CELLS|||||||UG/KG/DAY|||||||BORDERLINE||UV2||||NORMAL|NOT DONE||||SPERMATOZOON|LIPEMIC|U|FLAME PHOTOMETRY|MDRD FORMULA||Y|NA|U|N|||Y|1||38||BLINDED TREATMENT|1967-07-20|1968-12-10|||||1970-08-05||1968-08-18|N|1961-05-28
TRIAL STUDY 134XCP|LB|EED3F55E-892E-46C6-8B0A-30D2E1112072|2||||APLAB|ANTIPHOSPHOLIPID ANTIBODIES|||||||10^6 IU|||||||INDETERMINATE||BQ/L||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|NA|FLUORESCENT SPOT TEST|CKD-EPI FORMULA||U|Y|N|N|||U|1||38||FOLLOW-UP|1973-02-17|1966-04-19|||||1960-06-01||1964-01-20|NA|1960-06-29
TRIAL STUDY 134XCP|LB|EED3F55E-892E-46C6-8B0A-30D2E1112072|1||||FRUCT|FRUCTOSAMINE|||||||KEV|||||||POSITIVE||UCI/KG||||HIGH|NOT DONE||||ADIPOSE TISSUE|GELLED|U|IN VITRO GENE EXPRESSION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|N|||Y|2||58||BASELINE|1966-11-03|1972-10-20|||||1964-02-14||1969-04-09|N|1965-12-17
TRIAL STUDY 134XCP|LB|EED3F55E-892E-46C6-8B0A-30D2E1112072|2||||PROTCRT|PROTEIN/CREATININE|||||||H*%|||||||POSITIVE||BP||||HIGH|NOT DONE||||REFLEX TEAR|THAWED|NA|AUDIOMETRY|MDRD 5 VARIABLE FORMULA||U|NA|N|Y|||U|2||58||BASELINE|1963-02-10|1973-08-14|||||1964-10-18||1967-10-07|Y|1967-10-24
TRIAL STUDY 134XCP|LB|EED3F55E-892E-46C6-8B0A-30D2E1112072|1||||HPOCROM|HYPOCHROMIA|||||||STEPS/MIN|||||||INVALID||MG/KG/DAY||||HIGH|NOT DONE||||PLEURAL FLUID|PARAFFIN-EMBEDDED|NA|CONTACT SPECULAR MICROSCOPY|NASH FIBROSURE FORMULA||Y|U|Y|Y|||Y|3||39||OPEN LABEL TREATMENT|1971-02-28|1970-03-02|||||1964-11-16||1969-09-21|N|1969-01-08
TRIAL STUDY 134XCP|LB|EED3F55E-892E-46C6-8B0A-30D2E1112072|2||||MAYHEG|MAY-HEGGLIN ANOMALY|||||||KG/M2|||||||BORDERLINE||10^7 PFU||||HIGH|NOT DONE||||DISCHARGE|ROOM TEMPERATURE|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|CKD-EPI FORMULA||U|Y|Y|U|||Y|3||39||BLINDED TREATMENT|1970-03-26|1973-06-28|||||1967-11-02||1964-10-20|Y|1962-12-04
TRIAL STUDY 134XCP|LB|EED3F55E-892E-46C6-8B0A-30D2E1112072|1||||INTLK16|INTERLEUKIN 16|||||||ML/G/MIN|||||||TRACE||OZ||||NORMAL|NOT DONE||||COLOSTRUM|GELLED|N|CONTRAST ENHANCED CT SCAN|FIBROMETER FORMULA||N|U|U|U|||NA|4||88||SCREENING|1969-08-08|1963-08-04|||||1971-11-10||1964-08-03|N|1971-05-01
TRIAL STUDY 134XCP|LB|EED3F55E-892E-46C6-8B0A-30D2E1112072|2||||ANAIGGAB|ANTINUCLEAR IGG ANTIBODY|||||||DPM/100MG|||||||TRACE||FMOL/L/SEC||||HIGH|NOT DONE||||BUFFY COAT|FRESH|U|PHASE-CONTRAST MRI|MDRD FORMULA||Y|N|N|N|||Y|4||88||SCREENING|1964-05-25|1967-06-03|||||1968-09-03||1961-12-10|U|1971-06-01
TRIAL STUDY 134XCP|LB|EED3F55E-892E-46C6-8B0A-30D2E1112072|1||||EOS|EOSINOPHILS|||||||MV2/HZ|||||||POSITIVE||/10^5||||HIGH|NOT DONE||||SMEGMA|DRIED|U|PET SCAN|CKD-EPI CREATININE FORMULA||Y|NA|NA|NA|||NA|5||7||TREATMENT|1971-09-17|1968-01-08|||||1969-12-30||1965-10-24|N|1962-09-06
TRIAL STUDY 134XCP|LB|EED3F55E-892E-46C6-8B0A-30D2E1112072|2||||CYAMMOX|AMMONIUM OXALATE CRYSTALS|||||||KUSP|||||||NEGATIVE||LOG EID 50/DOSE||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|SOLIDIFIED|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD FORMULA||N|U|Y|Y|||NA|5||7||TREATMENT|1969-03-23|1969-08-28|||||1961-05-14||1961-08-28|U|1963-12-14
TRIAL STUDY 134XCP|LB|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|1||||RBCNUC|NUCLEATED ERYTHROCYTES|||||||GMFI|||||||POSITIVE||H*%||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|NON-HEMOLYZED|Y|CHROMOGENIC ASSAY|FIBROTEST FORMULA||NA|Y|NA|U|||U|1||38||RUN-IN|1963-11-26|1968-04-18|||||1969-09-01||1973-03-21|N|1965-11-18
TRIAL STUDY 134XCP|LB|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|2||||CD56|CD56|||||||GRAVITATIONAL UNIT|||||||POSITIVE||MEQ/UG||||HIGH|NOT DONE||||VENOUS CORD BLOOD|PARAFFIN-EMBEDDED|N|FUNCTIONAL MRI|FIBROMETER FORMULA||NA|U|Y|Y|||Y|1||38||CONTINUATION TREATMENT|1963-02-15|1965-04-04|||||1964-03-29||1965-05-05|U|1970-03-29
TRIAL STUDY 134XCP|LB|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|1||||KRCYMG|MEGAKARYOCYTES|||||||ML/(MIN*100ML)|||||||TRACE||UMOL/MG/MIN||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FRESH|U|WEBER GREEN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|NA|Y|||U|2||58||SCREENING|1968-07-01|1960-07-03|||||1961-02-18||1962-06-18|Y|1963-07-04
TRIAL STUDY 134XCP|LB|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|2||||HGBFPATN|HEMOGLOBIN FRACTION PATTERN|||||||ML/KG/MIN|||||||TRACE||SACHET||||ABNORMAL|NOT DONE||||CALCULUS|NON-HEMOLYZED|N|TELLER ACUITY CARDS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|N|N|||U|2||58||FOLLOW-UP|1973-03-22|1962-08-21|||||1968-06-27||1972-05-07|NA|1966-01-05
TRIAL STUDY 134XCP|LB|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|1||||GLOBB2|BETA-2 GLOBULIN|||||||CY/CM|||||||TRACE||KG/MOL||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|FRESH|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|HEPASCORE FORMULA||NA|Y|U|NA|||U|3||39||INDUCTION TREATMENT|1970-10-20|1965-12-08|||||1970-07-24||1961-07-31|U|1961-05-19
TRIAL STUDY 134XCP|LB|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|2||||CKMBCK|CREATINE KINASE MB/TOTAL CREATINE KINASE|||||||UV2|||||||INDETERMINATE||PT_US||||NORMAL|NOT DONE||||BONE|NON-HEMOLYZED|U|CELLULOSE TAPE|CKD-EPI CREATININE FORMULA||N|Y|Y|U|||NA|3||39||SCREENING|1961-12-18|1969-05-04|||||1972-12-09||1972-12-26|N|1972-04-12
TRIAL STUDY 134XCP|LB|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|1||||C130112|ANIMAL MIX ANTIGEN IGE ANTIBODY|||||||SYRINGE|||||||INDETERMINATE||TSP EQ||||LOW|NOT DONE||||BONE|CLOTTED|NA|MICROBIAL CULTURE|COCKCROFT-GAULT FORMULA||NA|Y|NA|N|||U|4||88||FOLLOW-UP|1963-04-24|1972-04-19|||||1968-10-28||1963-01-02|NA|1963-12-28
TRIAL STUDY 134XCP|LB|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|2||||INTLK29|INTERLEUKIN 29|||||||MG/DL|||||||NEGATIVE||UG/G/DAY||||LOW|NOT DONE||||CALCULUS|FROZEN|U|ELECTRONEUROGRAPHY|MDRD FORMULA||N|U|N|N|||Y|4||88||INDUCTION TREATMENT|1971-12-05|1964-01-04|||||1965-02-03||1969-04-14|NA|1972-10-24
TRIAL STUDY 134XCP|LB|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|1||||ANPPRONT|N-TERMINAL PROA-TYPE NATRIURETIC PEPTIDE|||||||SEC|||||||TRACE||CFU/ML||||NORMAL|NOT DONE||||LYSATE|AGGLUTINATED|NA|DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|N|NA|||N|5||7||INDUCTION TREATMENT|1965-07-26|1966-07-17|||||1963-10-02||1968-04-08|U|1970-10-14
TRIAL STUDY 134XCP|LB|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|2||||PTHNT|PARATHYROID HORMONE, N-TERMINAL|||||||APL U/ML|||||||INVALID||TESLA||||LOW|NOT DONE||||SEBUM|DRIED|N|AUTOREFRACTION|FIBROSIS 4 FORMULA||Y|Y|N|N|||NA|5||7||BASELINE|1962-01-26|1965-03-18|||||1963-10-23||1960-04-14|U|1969-02-07
TRIAL STUDY 134XCP|LB|B865DADD-9A4E-4521-A2E8-104D709F4144|1||||ADH|ANTIDIURETIC HORMONE|||||||MG/MIN|||||||NEGATIVE||BOX||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|NON-HEMOLYZED|Y|ANTIMICROBIAL COMBINATION TESTING|CKD-EPI CYSTATIN C FORMULA||U|Y|Y|NA|||Y|1||38||FOLLOW-UP|1965-04-29|1968-09-05|||||1963-08-06||1964-09-12|U|1964-04-30
TRIAL STUDY 134XCP|LB|B865DADD-9A4E-4521-A2E8-104D709F4144|2||||PPA|PHENYLPROPANOLAMINE|||||||10^3 ORGANISMS|||||||POSITIVE||BE/ML||||NORMAL|NOT DONE||||MECONIUM|ICTERIC|NA|RULER MEASUREMENT METHOD|COCKCROFT-GAULT FORMULA||N|NA|NA|N|||Y|1||38||SCREENING|1970-02-22|1973-02-26|||||1972-03-06||1961-10-08|N|1968-03-12
TRIAL STUDY 134XCP|LB|B865DADD-9A4E-4521-A2E8-104D709F4144|1||||C165931|NUT MIX IGE AB RAST SCORE|||||||PELLET|||||||TRACE||FT3||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED|U|IMPULSE OSCILLOMETRY|ASH FIBROSURE FORMULA||U|N|NA|NA|||N|2||58||INDUCTION TREATMENT|1963-06-23|1971-05-14|||||1971-03-01||1960-02-28|NA|1969-12-11
TRIAL STUDY 134XCP|LB|B865DADD-9A4E-4521-A2E8-104D709F4144|2||||STSA|STEROID SULFATASE ACTIVITY|||||||CFU/ML|||||||NEGATIVE||UG/L DDU||||LOW|NOT DONE||||URINE SEDIMENT|CALCIFIED|N|MALDI|FIBROMETER FORMULA||N|U|NA|U|||N|2||58||OPEN LABEL TREATMENT|1962-09-23|1970-09-01|||||1970-10-19||1964-03-23|N|1963-05-24
TRIAL STUDY 134XCP|LB|B865DADD-9A4E-4521-A2E8-104D709F4144|1||||CD8LY|CD8/LYMPHOCYTES|||||||EQ|||||||POSITIVE||GPELISA UNIT/ML||||NORMAL|NOT DONE||||VENOUS BLOOD|AGGLUTINATED|U|MULTI-SLICE SPIRAL CT|MDRD 6 VARIABLE FORMULA||Y|N|N|Y|||U|3||39||RUN-IN|1969-02-24|1968-10-04|||||1968-10-22||1969-07-27|N|1968-10-03
TRIAL STUDY 134XCP|LB|B865DADD-9A4E-4521-A2E8-104D709F4144|2||||OSM|ONCOSTATIN M|||||||GY/MIN|||||||BORDERLINE||UG/M2/MIN||||HIGH|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CALCIFIED|NA|SECONDARY ION MASS SPECTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|Y|U|||Y|3||39||OBSERVATION|1962-06-04|1970-11-21|||||1962-04-19||1971-11-14|Y|1970-09-23
TRIAL STUDY 134XCP|LB|B865DADD-9A4E-4521-A2E8-104D709F4144|1||||MMP7|MATRIX METALLOPROTEINASE 7|||||||USEC|||||||INDETERMINATE||LOG10 TCID 50/UL||||LOW|NOT DONE||||LEUKOCYTE|REFRIGERATED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA||U|N|NA|Y|||N|4||88||TREATMENT|1963-07-28|1967-10-06|||||1960-10-05||1968-02-04|N|1962-01-13
TRIAL STUDY 134XCP|LB|B865DADD-9A4E-4521-A2E8-104D709F4144|2||||RT3|TRIIODOTHYRONINE, REVERSE|||||||KAT|||||||POSITIVE||UL/ML||||ABNORMAL|NOT DONE||||HAIR|CLOTTED|Y|HEMATOXYLIN AND EOSIN STAIN|MDRD ENZYMATIC FORMULA||Y|NA|U|NA|||Y|4||88||CONTINUATION TREATMENT|1969-09-21|1973-03-20|||||1966-12-25||1961-12-22|U|1960-12-24
TRIAL STUDY 134XCP|LB|B865DADD-9A4E-4521-A2E8-104D709F4144|1||||C165934|ARACHIS HYPOGAEA IGE AB RAST SCORE|||||||L/H|||||||TRACE||CS||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED|Y|DIFFUSION TENSOR MRI|FIBROTEST FORMULA||U|N|Y|Y|||U|5||7||RUN-IN|1961-06-17|1963-07-02|||||1966-09-24||1968-05-27|Y|1968-05-02
TRIAL STUDY 134XCP|LB|B865DADD-9A4E-4521-A2E8-104D709F4144|2||||HVA|HOMOVANILLIC ACID|||||||NG|||||||BORDERLINE||MG/ANIMAL||||LOW|NOT DONE||||SKIN TISSUE|CONTAMINATED|U|HEMAGGLUTINATION INHIBITION ASSAY|CKD-EPI CREATININE FORMULA||N|N|U|U|||Y|5||7||INDUCTION TREATMENT|1972-06-06|1962-02-26|||||1968-03-18||1966-07-10|Y|1963-04-14
TRIAL STUDY 134XCP|LB|D8C78860-7893-4239-8F29-A0EE98C90310|1||||C165909|INDUSTRIAL MIX IGG AB RAST SCORE|||||||RFU|||||||INDETERMINATE||G/G||||LOW|NOT DONE||||VENOUS PLASMA|LIPEMIC|Y|CINEANGIOGRAPHY|FIBROTEST FORMULA||NA|Y|N|U|||N|1||38||SCREENING|1963-04-27|1964-04-07|||||1972-09-07||1960-01-08|U|1970-12-05
TRIAL STUDY 134XCP|LB|D8C78860-7893-4239-8F29-A0EE98C90310|2||||NEUT|NEUTROPHILS|||||||MILE|||||||INDETERMINATE||MET*H||||LOW|NOT DONE||||BREAST MILK|CONTAMINATED|N|DYNAMOMETRY|HEPASCORE FORMULA||U|Y|U|U|||NA|1||38||CONTINUATION TREATMENT|1960-08-21|1963-09-13|||||1972-03-31||1972-10-28|U|1966-12-04
TRIAL STUDY 134XCP|LB|D8C78860-7893-4239-8F29-A0EE98C90310|1||||DNPSEPHD|D-NORPSEUDOEPHEDRINE|||||||10^9/L|||||||INDETERMINATE||10^3 COPIES/ML||||HIGH|NOT DONE||||SERUM OR PLASMA|GELLED|U|SPIROMETRY|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|NA|N|||U|2||58||RUN-IN|1961-09-05|1973-06-04|||||1964-02-23||1965-09-30|Y|1964-08-08
TRIAL STUDY 134XCP|LB|D8C78860-7893-4239-8F29-A0EE98C90310|2||||HLAIAB|HLA CLASS I ANTIBODY|||||||U/G/MIN|||||||NEGATIVE||FRAMES/S||||LOW|NOT DONE||||EXPIRED AIR|REFRIGERATED|NA|LISSAMINE GREEN STAIN|HEPASCORE FORMULA||NA|Y|N|NA|||Y|2||58||RUN-IN|1971-07-21|1962-07-01|||||1972-05-21||1971-07-31|U|1960-02-13
TRIAL STUDY 134XCP|LB|D8C78860-7893-4239-8F29-A0EE98C90310|1||||PKM|PYRUVATE KINASE MUSCLE ISOZYME|||||||LOG10 PFU/ML|||||||NEGATIVE||UMOL/L||||ABNORMAL|NOT DONE||||CERUMEN|GELLED|N|ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA||U|U|Y|Y|||NA|3||39||SCREENING|1972-12-15|1969-09-02|||||1964-12-18||1969-05-29|N|1968-06-01
TRIAL STUDY 134XCP|LB|D8C78860-7893-4239-8F29-A0EE98C90310|2||||HGBS|HEMOGLOBIN S|||||||U/M2/MIN|||||||INVALID||ML/DOSE||||LOW|NOT DONE||||VENOUS PLASMA|CONTAMINATED|Y|CONGO RED STAIN|CKD-EPI CYSTATIN C FORMULA||Y|NA|NA|U|||N|3||39||FOLLOW-UP|1972-02-21|1972-09-23|||||1960-01-21||1960-02-03|Y|1973-08-27
TRIAL STUDY 134XCP|LB|D8C78860-7893-4239-8F29-A0EE98C90310|1||||TAURCRT|TAURINE/CREATININE|||||||MU|||||||TRACE||K||||HIGH|NOT DONE||||PLATELET POOR PLASMA|HEMOLYZED|Y|CALCOFLUOR WHITE STAIN|MDRD FORMULA||NA|U|NA|NA|||Y|4||88||LONG-TERM FOLLOW-UP|1968-03-11|1960-03-23|||||1965-09-09||1960-12-01|Y|1969-06-12
TRIAL STUDY 134XCP|LB|D8C78860-7893-4239-8F29-A0EE98C90310|2||||C147284|BOXELDER POLLEN IGE ANTIBODY|||||||H/WK|||||||NEGATIVE||PIXELS/CM||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|PARAFFIN-EMBEDDED|Y|CONGO RED STAIN|ASH FIBROSURE FORMULA||Y|U|U|N|||Y|4||88||OPEN LABEL TREATMENT|1960-03-12|1966-02-15|||||1973-02-05||1973-06-26|N|1971-11-05
TRIAL STUDY 134XCP|LB|D8C78860-7893-4239-8F29-A0EE98C90310|1||||TESTOSBA|BIOAVAILABLE TESTOSTERONE|||||||PELLET|||||||NEGATIVE||WAFER||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|ROOM TEMPERATURE|U|TARGETED GENOME SEQUENCING|NASH FIBROSURE FORMULA||N|N|Y|U|||U|5||7||CONTINUATION TREATMENT|1961-04-13|1969-08-28|||||1970-04-16||1964-04-04|U|1973-05-28
TRIAL STUDY 134XCP|LB|D8C78860-7893-4239-8F29-A0EE98C90310|2||||IAPP|ISLET AMYLOID POLYPEPTIDE|||||||CMHG|||||||BORDERLINE||10^9 ORGANISMS||||ABNORMAL|NOT DONE||||STOOL|UNEXPECTED ODOR|N|ELECTROPHORESIS|MDRD 6 VARIABLE FORMULA||U|Y|U|NA|||Y|5||7||BLINDED TREATMENT|1968-02-15|1967-07-07|||||1971-01-13||1964-06-15|NA|1969-10-12
TRIAL STUDY 134XCP|LB|841D0118-C3F9-4169-B43E-D88CEB2795BA|1||||SLAIGGAB|SOLUBLE LIVER ANTIGEN IGG ANTIBODY|||||||MG/M2/H|||||||INDETERMINATE||TORR||||ABNORMAL|NOT DONE||||DISCHARGE|PARAFFIN-EMBEDDED|N|AUTOMATED COUNT|GMI MMOL/MOL FORMULA||U|Y|NA|U|||N|1||38||WASHOUT|1969-01-28|1965-10-10|||||1968-07-18||1969-04-10|N|1972-01-04
TRIAL STUDY 134XCP|LB|841D0118-C3F9-4169-B43E-D88CEB2795BA|2||||C165929|BEE MIX IGE AB RAST SCORE|||||||10^6/G|||||||NEGATIVE||MG/H||||NORMAL|NOT DONE||||BONE MARROW|CONTAMINATED|Y|MANUAL CLOT DETECTION|COCKCROFT-GAULT FORMULA||Y|U|Y|Y|||NA|1||38||INDUCTION TREATMENT|1972-11-05|1964-06-22|||||1971-06-25||1972-10-12|N|1960-03-04
TRIAL STUDY 134XCP|LB|841D0118-C3F9-4169-B43E-D88CEB2795BA|1||||FACTXA|FACTOR X ACTIVITY|||||||IU/G|||||||INDETERMINATE||AFU||||LOW|NOT DONE||||SEBUM|CONCENTRATED|N|MRI|GMI MMOL/MOL FORMULA||N|N|U|Y|||Y|2||58||RUN-IN|1972-06-01|1971-05-24|||||1964-05-26||1969-02-13|U|1961-01-15
TRIAL STUDY 134XCP|LB|841D0118-C3F9-4169-B43E-D88CEB2795BA|2||||ELA2|NEUTROPHIL ELASTASE|||||||UG/DL|||||||POSITIVE||DAMOL/L||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|AGGLUTINATED|U|WRIGHT-GIEMSA STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|Y|Y|||Y|2||58||OPEN LABEL TREATMENT|1962-12-07|1972-08-14|||||1972-12-12||1969-12-13|U|1963-04-22
TRIAL STUDY 134XCP|LB|841D0118-C3F9-4169-B43E-D88CEB2795BA|1||||C130094|WESTERN RAGWEED POLLEN IGG|||||||DAMOL/L|||||||INVALID||COAT||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|AUTOLYZED|U|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|COCKCROFT-GAULT FORMULA||N|Y|N|U|||NA|3||39||SCREENING|1971-02-07|1965-11-06|||||1967-01-01||1967-12-07|NA|1964-09-08
TRIAL STUDY 134XCP|LB|841D0118-C3F9-4169-B43E-D88CEB2795BA|2||||TIMM10|TRANSLOCASE INNER MITOCHONDRIAL MEMBR 10|||||||UKAT/10^12 RBC|||||||POSITIVE||GBQ/MG||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|NON-HEMOLYZED|Y|MULTIPLE BREATH WASHOUT|CKD-EPI CREATININE FORMULA||U|NA|Y|U|||Y|3||39||CONTINUATION TREATMENT|1970-04-18|1966-02-02|||||1969-12-27||1973-06-05|U|1972-07-07
TRIAL STUDY 134XCP|LB|841D0118-C3F9-4169-B43E-D88CEB2795BA|1||||ABNCECE|ABNORMAL CELLS/TOTAL CELLS|||||||HOMEOPATHIC DILUTION|||||||POSITIVE||100 IU/ML||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|AUTOLYZED|U|TRANSTHORACIC ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA||Y|N|NA|Y|||U|4||88||INDUCTION TREATMENT|1972-07-03|1970-04-30|||||1960-11-28||1971-07-27|NA|1964-11-29
TRIAL STUDY 134XCP|LB|841D0118-C3F9-4169-B43E-D88CEB2795BA|2||||CRTCLRBS|CREATININE CLEARANCE ADJUSTED FOR BSA|||||||IU/ML|||||||TRACE||GAUSS||||HIGH|NOT DONE||||BREAST MILK|REFRIGERATED|N|EPSILOMETER|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|N|||U|4||88||RUN-IN|1963-07-14|1968-12-16|||||1963-06-25||1967-03-05|NA|1965-01-23
TRIAL STUDY 134XCP|LB|841D0118-C3F9-4169-B43E-D88CEB2795BA|1||||PFCT|PLATELET FUNCTION CLOSURE TIME|||||||DYN|||||||POSITIVE||GPS U||||HIGH|NOT DONE||||VENOUS PLASMA|NON-HEMOLYZED|Y|HPLC|FIBROMETER FORMULA||NA|Y|Y|Y|||N|5||7||SCREENING|1960-01-20|1961-10-27|||||1962-04-04||1969-05-19|Y|1970-10-27
TRIAL STUDY 134XCP|LB|841D0118-C3F9-4169-B43E-D88CEB2795BA|2||||MPXI|MYELOPEROXIDASE INDEX|||||||%(V/V)|||||||INDETERMINATE||MGEQ||||LOW|NOT DONE||||EMOTIONAL TEAR|CONTAMINATED|Y|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD 5 VARIABLE FORMULA||N|N|NA|U|||U|5||7||WASHOUT|1960-04-15|1964-05-06|||||1971-10-19||1972-03-31|U|1963-01-15
TRIAL STUDY 134XCP|LB|9C3C0334-F7A4-4530-A6D3-574C039979E7|1||||MACROBLD|MACROSCOPIC BLOOD|||||||UCI|||||||POSITIVE||MG/KG/H||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|AUTOLYZED|NA|OLIGO ACGH|MDRD 5 VARIABLE FORMULA||Y|NA|N|NA|||NA|1||38||CONTINUATION TREATMENT|1969-09-24|1962-07-08|||||1971-06-09||1961-07-02|NA|1967-04-27
TRIAL STUDY 134XCP|LB|9C3C0334-F7A4-4530-A6D3-574C039979E7|2||||IA5OHEXR|5-HYDROXYINDOLEACETICACID EXCRETION RATE|||||||LM|||||||INVALID||ML/S/M2||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|AGGLUTINATED|NA|MAGNETIC RESONANCE ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|Y|N|U|||N|1||38||BLINDED TREATMENT|1966-08-03|1970-03-05|||||1968-12-28||1966-03-24|NA|1967-12-17
TRIAL STUDY 134XCP|LB|9C3C0334-F7A4-4530-A6D3-574C039979E7|1||||LDH3|LDH ISOENZYME 3|||||||/2000 RBC|||||||INDETERMINATE||/200 HPFS||||LOW|NOT DONE||||CAPILLARY BLOOD|FROZEN|NA|HPLC/MS/MS|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|NA|NA|||NA|2||58||WASHOUT|1962-01-21|1961-07-16|||||1971-02-15||1963-03-11|U|1966-07-05
TRIAL STUDY 134XCP|LB|9C3C0334-F7A4-4530-A6D3-574C039979E7|2||||C130111|MOLD MIX ANTIGEN IGA ANTIBODY|||||||/MBP|||||||NEGATIVE||CY/CM||||NORMAL|NOT DONE||||KERATINOCYTE|FRESH|N|ICC|MDRD 6 VARIABLE FORMULA||NA|NA|Y|U|||U|2||58||INDUCTION TREATMENT|1971-11-28|1968-08-16|||||1973-02-16||1968-08-05|N|1972-03-06
TRIAL STUDY 134XCP|LB|9C3C0334-F7A4-4530-A6D3-574C039979E7|1||||NEUTTOXC|NEUTROPHILIC TOXIC CHANGE|||||||QUANTITY SUFFICIENT|||||||INDETERMINATE||CAPSULE||||ABNORMAL|NOT DONE||||CERUMEN|NON-HEMOLYZED|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|Y|Y|||U|3||39||FOLLOW-UP|1961-06-22|1973-09-04|||||1969-05-07||1971-05-25|NA|1966-05-14
TRIAL STUDY 134XCP|LB|9C3C0334-F7A4-4530-A6D3-574C039979E7|2||||PSDGLSRF|PHOSPHATIDYLGLYCEROL/LUNG SURFACTANT|||||||BOX|||||||TRACE||CIGARETTE||||NORMAL|NOT DONE||||PERITONEAL FLUID|PARAFFIN-EMBEDDED|NA|MUGA|HEPASCORE FORMULA||Y|Y|N|N|||U|3||39||INDUCTION TREATMENT|1972-06-26|1971-11-28|||||1965-12-22||1960-10-26|N|1968-07-30
TRIAL STUDY 134XCP|LB|9C3C0334-F7A4-4530-A6D3-574C039979E7|1||||LYMIM|IMMATURE LYMPHOCYTES|||||||10^6 ORGANISMS|||||||INVALID||G/ANIMAL||||ABNORMAL|NOT DONE||||ARTERIAL CORD BLOOD|LACTESCENT|N|KARYOTYPING|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|U|||N|4||88||OBSERVATION|1964-01-31|1967-01-01|||||1964-06-27||1961-03-19|N|1969-11-19
TRIAL STUDY 134XCP|LB|9C3C0334-F7A4-4530-A6D3-574C039979E7|2||||BLASTLE|BLASTS/LEUKOCYTES|||||||AMOL|||||||BORDERLINE||MSEC||||NORMAL|NOT DONE||||PLEURAL FLUID|HEMOLYZED|NA|DIFFUSION WEIGHTED MRI|MDRD 5 VARIABLE FORMULA||Y|NA|NA|N|||N|4||88||LONG-TERM FOLLOW-UP|1961-09-20|1961-01-13|||||1973-07-29||1968-08-06|U|1973-01-20
TRIAL STUDY 134XCP|LB|9C3C0334-F7A4-4530-A6D3-574C039979E7|1||||BLSTRBCE|RUBRIBLAST/TOTAL CELLS|||||||10^3/HPF|||||||INVALID||TRANSDUCING UNIT/ML||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|DRIED|Y|IMPULSE OSCILLOMETRY|MDRD FORMULA||Y|U|N|NA|||NA|5||7||TREATMENT|1965-03-21|1971-03-29|||||1964-05-16||1967-05-17|Y|1961-04-16
TRIAL STUDY 134XCP|LB|9C3C0334-F7A4-4530-A6D3-574C039979E7|2||||CHLMCRNT|CHYLOMICRON TRIGLYCERIDE|||||||PSEC|||||||BORDERLINE||CY/CM||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|ICTERIC|Y|PHOTOMETRIC CLOT DETECTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|U|N|||N|5||7||RUN-IN|1973-07-04|1964-09-13|||||1961-03-30||1973-06-13|N|1969-11-25
TRIAL STUDY 134XCP|LB|FE955CB9-9992-4521-8788-7597AF40F214|1||||NEUTSGB|NEUTROPHILS, SEGMENTED + BAND FORM|||||||G/ANIMAL|||||||TRACE||LOG10 TCID 50/UL||||NORMAL|NOT DONE||||SEMEN|THAWED|N|NUCLEIC ACID SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|N|N|||Y|1||38||TREATMENT|1972-06-30|1963-06-06|||||1966-05-07||1965-03-09|Y|1973-07-03
TRIAL STUDY 134XCP|LB|FE955CB9-9992-4521-8788-7597AF40F214|2||||SJSSAAB|SJOGRENS SS-A ANTIBODY|||||||RPM|||||||INVALID||NMOL BCE/L||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LIPEMIC|N|CAPILLARY ELECTROPHORESIS|MDRD ENZYMATIC JAPANESE FORMULA||U|U|Y|NA|||NA|1||38||SCREENING|1966-05-09|1965-06-28|||||1969-07-31||1968-06-02|U|1972-08-14
TRIAL STUDY 134XCP|LB|FE955CB9-9992-4521-8788-7597AF40F214|1||||IFI44|INTERFERON-INDUCED PROTEIN 44|||||||ML/DL|||||||INDETERMINATE||U/MMOL||||LOW|NOT DONE||||EMESIS|THAWED|NA|NEURAMINIDASE INHIBITION ASSAY|GMI % FORMULA||NA|U|NA|N|||NA|2||58||OPEN LABEL TREATMENT|1969-05-30|1972-09-28|||||1968-04-23||1968-07-18|U|1962-03-01
TRIAL STUDY 134XCP|LB|FE955CB9-9992-4521-8788-7597AF40F214|2||||C165905|GRASS MIX POLLEN IGG AB RAST SCORE|||||||LINEAR FT*LB|||||||NEGATIVE||KDA||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED|U|MICROPARTICLE ENZYME IMMUNOASSAY|CKD-EPI CREATININE FORMULA||N|N|NA|NA|||N|2||58||OBSERVATION|1962-12-30|1963-09-25|||||1960-08-17||1969-08-19|N|1963-07-01
TRIAL STUDY 134XCP|LB|FE955CB9-9992-4521-8788-7597AF40F214|1||||NAK|SODIUM/POTASSIUM|||||||NEEDLE GAUGE|||||||TRACE||USIEMENS||||HIGH|NOT DONE||||SEBUM|AUTOLYZED|N|ELISPOT|FIBROMETER FORMULA||U|N|U|N|||U|3||39||OPEN LABEL TREATMENT|1970-06-28|1966-07-30|||||1964-02-11||1969-04-18|U|1960-12-13
TRIAL STUDY 134XCP|LB|FE955CB9-9992-4521-8788-7597AF40F214|2||||MCPROT|MONOCLONAL PROTEIN|||||||KV|||||||TRACE||TRACE||||HIGH|NOT DONE||||MUSCLE TISSUE|CLOTTED|NA|SCANNING ELECTRON MICROSCOPY|MDRD ENZYMATIC FORMULA||U|Y|U|NA|||NA|3||39||OBSERVATION|1970-04-12|1966-02-08|||||1967-03-26||1972-10-29|Y|1960-12-19
TRIAL STUDY 134XCP|LB|FE955CB9-9992-4521-8788-7597AF40F214|1||||CHOLCM|CHOLATE COMPOUNDS|||||||MG/L|||||||NEGATIVE||FT3||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|LACTESCENT|NA|LYMPHANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||U|NA|Y|Y|||U|4||88||SCREENING|1967-07-07|1967-08-01|||||1972-04-19||1960-07-21|NA|1970-11-11
TRIAL STUDY 134XCP|LB|FE955CB9-9992-4521-8788-7597AF40F214|2||||HLAA23A|HLA-A23 ANTIBODY|||||||TABLET|||||||INVALID||AGU/ML||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|CLOTTED|U|CLIP|CKD-EPI FORMULA||NA|N|N|U|||Y|4||88||LONG-TERM FOLLOW-UP|1972-07-19|1969-02-24|||||1965-10-13||1971-03-11|NA|1963-04-14
TRIAL STUDY 134XCP|LB|FE955CB9-9992-4521-8788-7597AF40F214|1||||C165911|DAIRY MIX IGG AB RAST SCORE|||||||UU/L|||||||BORDERLINE||ML/M2/MIN||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|CALCIFIED|U|LEAD CITRATE STAIN|CKD-EPI CREATININE FORMULA||N|NA|NA|NA|||Y|5||7||LONG-TERM FOLLOW-UP|1969-05-28|1962-04-04|||||1960-02-24||1966-06-15|NA|1964-03-17
TRIAL STUDY 134XCP|LB|FE955CB9-9992-4521-8788-7597AF40F214|2||||AG1_5|1,5-ANHYDROGLUCITOL|||||||UM/S|||||||TRACE||ML/M2/MIN||||ABNORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|THAWED|U|DUCTOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|NA|||U|5||7||LONG-TERM FOLLOW-UP|1968-01-18|1960-09-10|||||1973-07-28||1961-04-15|Y|1961-04-04
TRIAL STUDY 134XCP|LB|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|1||||INTLK3|INTERLEUKIN 3|||||||/7.5 ML|||||||INVALID||KV||||NORMAL|NOT DONE||||KERATINOCYTE|ICTERIC|Y|WESTERGREN|FIBROSIS 4 FORMULA||N|N|NA|NA|||Y|1||38||RUN-IN|1960-04-05|1970-10-03|||||1966-05-02||1965-03-06|N|1972-09-04
TRIAL STUDY 134XCP|LB|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|2||||AUERRODS|AUER RODS|||||||SEC|||||||BORDERLINE||%(W/W)||||LOW|NOT DONE||||BONE MARROW|PARAFFIN-EMBEDDED|U|CONFOCAL MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|U|||Y|1||38||OBSERVATION|1960-07-18|1971-12-22|||||1962-03-23||1969-05-15|U|1972-08-25
TRIAL STUDY 134XCP|LB|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|1||||CELLSIM|IMMATURE CELLS|||||||MONTHS|||||||INDETERMINATE||G/ANIMAL/DAY||||LOW|NOT DONE||||VENOUS PLASMA|THAWED|N|PERFUSION MRI|FIBROMETER FORMULA||NA|U|Y|N|||N|2||58||INDUCTION TREATMENT|1969-04-17|1964-09-29|||||1970-11-02||1963-04-17|U|1969-11-23
TRIAL STUDY 134XCP|LB|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|2||||TROPONI3|TROPONIN I TYPE 3|||||||MU/G|||||||INVALID||DPM/100MG||||HIGH|NOT DONE||||INFRANATANT, PLASMA|CLOTTED|Y|NON-CONTACT SPECULAR MICROSCOPY|CKD-EPI FORMULA||Y|NA|NA|Y|||N|2||58||LONG-TERM FOLLOW-UP|1967-12-31|1969-04-17|||||1973-01-17||1970-10-03|U|1973-07-07
TRIAL STUDY 134XCP|LB|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|1||||TUDCA|TAUROURSODEOXYCHOLATE|||||||KN/CM2|||||||TRACE||MIN||||LOW|NOT DONE||||GASTRIC FLUID|ROOM TEMPERATURE|U|SNELLEN EYE CHART|MDRD ENZYMATIC FORMULA||U|U|N|N|||N|3||39||OPEN LABEL TREATMENT|1960-07-02|1967-12-19|||||1972-10-26||1967-09-20|N|1964-06-27
TRIAL STUDY 134XCP|LB|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|2||||CTOT|COMPLEMENT TOTAL|||||||KM|||||||NEGATIVE||MASK||||ABNORMAL|NOT DONE||||DERMAL TISSUE|NON-HEMOLYZED|U|PHASE-CONTRAST MRI|CKD-EPI FORMULA||Y|NA|N|Y|||Y|3||39||RUN-IN|1967-03-02|1969-02-04|||||1966-07-15||1964-09-10|Y|1971-11-13
TRIAL STUDY 134XCP|LB|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|1||||GAMBTAC|GAMMA-AMINOBUTYRIC ACID|||||||FMOL/L|||||||INDETERMINATE||10^8 PFU||||LOW|NOT DONE||||HAIR|DRIED|U|ANALYTICAL ULTRACENTRIFUGATION|HEPASCORE FORMULA||NA|U|NA|U|||U|4||88||BLINDED TREATMENT|1968-12-20|1971-12-21|||||1964-07-27||1972-09-20|U|1960-09-25
TRIAL STUDY 134XCP|LB|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|2||||MMP9|MATRIX METALLOPROTEINASE 9|||||||ML/MMHG/MIN/L|||||||TRACE||PL||||HIGH|NOT DONE||||EXPIRED AIR|ICTERIC|N|GRADIENT DIFFUSION|ASH FIBROSURE FORMULA||N|Y|N|NA|||NA|4||88||BLINDED TREATMENT|1973-06-03|1972-03-17|||||1970-09-07||1970-10-25|Y|1965-09-02
TRIAL STUDY 134XCP|LB|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|1||||APOA5|APOLIPOPROTEIN A5|||||||IU/MG|||||||NEGATIVE||KPA/L/SEC||||NORMAL|NOT DONE||||PLEURAL FLUID|ROOM TEMPERATURE|N|IMMUNOFIXATION ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA||U|U|U|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1969-09-10|1961-11-02|||||1965-06-18||1961-02-27|N|1971-11-24
TRIAL STUDY 134XCP|LB|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|2||||PO2|PARTIAL PRESSURE OXYGEN|||||||GY/H|||||||INVALID||MEQ/DAY||||HIGH|NOT DONE||||PROSTATIC FLUID|LIPEMIC|U|EIA|COCKCROFT-GAULT FORMULA||Y|U|Y|N|||NA|5||7||WASHOUT|1972-11-21|1961-06-13|||||1971-11-24||1961-02-22|N|1967-01-24
TRIAL STUDY 134XCP|LB|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|1||||MCPHG|MACROPHAGES|||||||QUANTITY SUFFICIENT|||||||NEGATIVE||MEQ/L||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|DRIED|N|KARYOTYPING|GMI % FORMULA||U|Y|U|NA|||NA|1||38||BASELINE|1970-06-30|1962-06-01|||||1968-05-11||1960-10-04|Y|1970-01-07
TRIAL STUDY 134XCP|LB|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|2||||PEMAB|PEMPHIGOID ANTIBODIES|||||||NMOL/G|||||||POSITIVE||EQ||||HIGH|NOT DONE||||EXUDATE|ROOM TEMPERATURE|U|RYAN BLUE STAIN|CKD-EPI FORMULA||Y|U|N|N|||N|1||38||BASELINE|1960-08-23|1969-04-12|||||1973-07-21||1964-01-27|NA|1965-05-11
TRIAL STUDY 134XCP|LB|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|1||||EOSCE|EOSINOPHILS/TOTAL CELLS|||||||U/KG/DAY|||||||BORDERLINE||ABSORBANCE U/ML||||NORMAL|NOT DONE||||ARTERIAL BLOOD|THAWED|NA|CINEANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|N|NA|||NA|2||58||WASHOUT|1973-01-26|1962-12-13|||||1963-02-01||1968-02-06|NA|1967-11-03
TRIAL STUDY 134XCP|LB|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|2||||COCAINE|COCAINE|||||||IU/L|||||||INDETERMINATE||PACKET||||NORMAL|NOT DONE||||LYSATE|PARAFFIN-EMBEDDED|N|PET/SPECT SCAN|COCKCROFT-GAULT FORMULA||NA|NA|U|Y|||Y|2||58||SCREENING|1965-05-19|1964-03-02|||||1961-03-08||1964-09-07|NA|1965-07-07
TRIAL STUDY 134XCP|LB|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|1||||RH|RH FACTOR|||||||G/G/DAY|||||||NEGATIVE||MCI/L||||ABNORMAL|NOT DONE||||SOFT TISSUE|ICTERIC|Y|MAPH|GMI MMOL/MOL FORMULA||NA|U|Y|U|||NA|3||39||RUN-IN|1968-11-30|1963-01-10|||||1966-07-14||1967-03-05|U|1973-05-22
TRIAL STUDY 134XCP|LB|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|2||||FENTANYL|FENTANYL|||||||U/G HB|||||||POSITIVE||MEQ/DAY||||NORMAL|NOT DONE||||ADIPOSE TISSUE|PARAFFIN-EMBEDDED|NA|ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA||Y|N|U|NA|||NA|3||39||WASHOUT|1971-12-24|1963-02-16|||||1962-04-14||1965-12-25|N|1970-07-25
TRIAL STUDY 134XCP|LB|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|1||||SJSSBAB|SJOGRENS SS-B ANTIBODY|||||||CS|||||||INVALID||AMU||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|AGGLUTINATED|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|FIBROSIS 4 FORMULA||N|U|NA|U|||Y|4||88||SCREENING|1970-01-04|1966-03-11|||||1971-07-21||1968-08-30|NA|1960-02-01
TRIAL STUDY 134XCP|LB|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|2||||HGBTET|HEMOGLOBIN TETRAMER|||||||PMOL/10^10 CELLS|||||||INVALID||FMOL/L/SEC||||NORMAL|NOT DONE||||LEUKOCYTE|ROOM TEMPERATURE|NA|HEMAGGLUTINATION ASSAY|FIBROMETER FORMULA||U|Y|U|N|||NA|4||88||OBSERVATION|1972-01-11|1960-09-14|||||1965-02-12||1969-08-03|NA|1964-11-12
TRIAL STUDY 134XCP|LB|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|1||||SOMATRO|SOMATOTROPHIN|||||||VIAL|||||||BORDERLINE||CD*S/M2||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|CONTAMINATED|N|ANTIMICROBIAL COMBINATION TESTING|MDRD ENZYMATIC FORMULA||N|N|N|Y|||N|5||7||RUN-IN|1971-10-15|1967-12-13|||||1970-12-15||1964-09-21|NA|1960-05-30
TRIAL STUDY 134XCP|LB|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|2||||NEUTSG|NEUTROPHILS, SEGMENTED|||||||DEG2|||||||NEGATIVE||S*KPA||||ABNORMAL|NOT DONE||||PLEURAL FLUID|AUTOLYZED|U|POPULATION SEQUENCING|MDRD 6 VARIABLE FORMULA||NA|Y|U|Y|||N|5||7||INDUCTION TREATMENT|1966-10-14|1960-03-10|||||1962-06-10||1962-11-15|Y|1971-04-25
TRIAL STUDY 134XCP|LB|28B6CF51-A007-4CED-8247-37BD468F41C5|1||||C165939|EGG WHITE IGE AB RAST SCORE|||||||CI/MG|||||||INVALID||/MBP||||LOW|NOT DONE||||VENOUS BLOOD|GELLED|U|LEAD CITRATE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|U|U|||NA|1||38||INDUCTION TREATMENT|1969-11-30|1967-07-06|||||1968-05-26||1967-01-16|U|1964-04-05
TRIAL STUDY 134XCP|LB|28B6CF51-A007-4CED-8247-37BD468F41C5|2||||PPTDCALB|PHOSPHATIDYLCHOLINE/ALBUMIN|||||||TCID 50/DOSE|||||||TRACE||GENEQ/ML||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|PARAFFIN-EMBEDDED|Y|FLUORESCENCE ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|N|U|U|||NA|1||38||SCREENING|1965-06-30|1968-02-18|||||1965-08-31||1972-02-23|U|1962-05-27
TRIAL STUDY 134XCP|LB|28B6CF51-A007-4CED-8247-37BD468F41C5|1||||KYNURNN|KYNURENINE|||||||MSEC|||||||TRACE||CMH2O*S/ML||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|UNEXPECTED ODOR|N|ENDPOINT DILUTION ASSAY|FIBROTEST FORMULA||N|N|Y|N|||NA|2||58||OBSERVATION|1965-04-23|1961-05-10|||||1965-10-08||1962-06-03|N|1971-09-07
TRIAL STUDY 134XCP|LB|28B6CF51-A007-4CED-8247-37BD468F41C5|2||||DHEAS|DEHYDROEPIANDROSTERONE SULFATE|||||||L/KG|||||||POSITIVE||FOZ_BR||||LOW|NOT DONE||||TRANSUDATE|LACTESCENT|NA|DUCTOGRAPHY|ASH FIBROSURE FORMULA||U|U|Y|N|||Y|2||58||SCREENING|1962-06-18|1966-02-18|||||1966-08-15||1966-04-14|N|1967-07-14
TRIAL STUDY 134XCP|LB|28B6CF51-A007-4CED-8247-37BD468F41C5|1||||LKM1AB|LIVER KIDNEY MICROSOMAL TYPE 1 ANTIBODY|||||||IU/ML|||||||NEGATIVE||APS U||||HIGH|NOT DONE||||PLEURAL FLUID|AUTOLYZED|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD 6 VARIABLE FORMULA||N|NA|U|NA|||NA|3||39||BLINDED TREATMENT|1963-11-21|1960-02-24|||||1963-01-04||1966-03-09|U|1970-09-30
TRIAL STUDY 134XCP|LB|28B6CF51-A007-4CED-8247-37BD468F41C5|2||||ANGPT1|ANGIOPOIETIN 1|||||||/MM2|||||||POSITIVE||GENEQ||||HIGH|NOT DONE||||PLEURAL TISSUE|FRESH|N|TOTAL BODY IRRADIATION|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|N|N|||U|3||39||FOLLOW-UP|1961-01-04|1966-09-09|||||1964-08-13||1967-11-17|N|1969-09-14
TRIAL STUDY 134XCP|LB|28B6CF51-A007-4CED-8247-37BD468F41C5|1||||FUNGIFIL|FUNGI, FILAMENTOUS|||||||MM/H|||||||TRACE||10^6 IU||||LOW|NOT DONE||||SPUTUM|CLOTTED|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|FIBROTEST FORMULA||U|NA|N|N|||NA|4||88||SCREENING|1967-06-07|1963-09-28|||||1966-11-02||1972-12-23|NA|1965-10-09
TRIAL STUDY 134XCP|LB|28B6CF51-A007-4CED-8247-37BD468F41C5|2||||IFI44L|INTERFERON-INDUCED PROTEIN 44-LIKE|||||||MOL/G|||||||TRACE||/CMH2O||||LOW|NOT DONE||||CELL PELLET|AUTOLYZED|N|HIGH RESOLUTION MELT ANALYSIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|NA|U|||U|4||88||BASELINE|1971-03-06|1970-12-16|||||1968-07-22||1962-02-02|N|1970-09-19
TRIAL STUDY 134XCP|LB|28B6CF51-A007-4CED-8247-37BD468F41C5|1||||CALPRO|CALPROTECTIN|||||||FRAMES/S|||||||BORDERLINE||NMOL/L/H||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|LIPEMIC|Y|SINGLE-SLICE SPIRAL CT|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|N|Y|||Y|5||7||OPEN LABEL TREATMENT|1970-09-18|1963-04-03|||||1961-08-16||1973-08-20|U|1972-06-10
TRIAL STUDY 134XCP|LB|28B6CF51-A007-4CED-8247-37BD468F41C5|2||||ANTIDPRS|ANTIDEPRESSANTS|||||||KM/H|||||||POSITIVE||BE/ML||||NORMAL|NOT DONE||||EMOTIONAL TEAR|UNEXPECTED ODOR|Y|BIOIMPEDANCE SPECTROSCOPY|GMI % FORMULA||NA|U|NA|NA|||Y|5||7||OBSERVATION|1961-03-15|1963-08-06|||||1972-05-13||1961-06-20|N|1962-07-13
TRIAL STUDY 134XCP|LB|4E600C41-1B27-4042-B48E-B60489701D2D|1||||ROULEAUX|ROULEAUX FORMATION|||||||LX|||||||INVALID||MOL/MG||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|LACTESCENT|U|FLUORESCENT SPOT TEST|CKD-EPI CYSTATIN C FORMULA||NA|N|Y|Y|||NA|1||38||SCREENING|1969-02-21|1965-05-20|||||1962-08-31||1966-05-16|NA|1966-07-18
TRIAL STUDY 134XCP|LB|4E600C41-1B27-4042-B48E-B60489701D2D|2||||A1ANTRYP|ALPHA-1 ANTITRYPSIN|||||||UM|||||||TRACE||S/H||||LOW|NOT DONE||||VENOUS PLASMA|CONCENTRATED|Y|CELLULAR PROLIFERATION ASSAY|MDRD ENZYMATIC FORMULA||U|Y|N|Y|||NA|1||38||TREATMENT|1970-02-05|1962-12-01|||||1971-11-08||1970-03-12|N|1968-11-26
TRIAL STUDY 134XCP|LB|4E600C41-1B27-4042-B48E-B60489701D2D|1||||PLSTCE|TOTAL PLASMA CELLS|||||||ML/CAGE|||||||POSITIVE||10^11/L||||NORMAL|NOT DONE||||ADIPOSE TISSUE|HEMOLYZED|U|CALCOFLUOR WHITE STAIN|MDRD 5 VARIABLE FORMULA||NA|U|N|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1968-10-13|1972-04-04|||||1965-12-20||1966-09-24|N|1969-01-18
TRIAL STUDY 134XCP|LB|4E600C41-1B27-4042-B48E-B60489701D2D|2||||PSELECTS|SOLUBLE P-SELECTIN|||||||V|||||||NEGATIVE||10^4 CFU/ML||||HIGH|NOT DONE||||HAIR|THAWED|NA|ELECTROGASTROGRAPHY|ASH FIBROSURE FORMULA||NA|Y|Y|Y|||Y|2||58||BASELINE|1964-01-03|1963-09-21|||||1961-05-02||1968-02-18|U|1967-01-17
TRIAL STUDY 134XCP|LB|4E600C41-1B27-4042-B48E-B60489701D2D|1||||VEGF|VASCULAR ENDOTHELIAL GROWTH FACTOR|||||||APL U/ML|||||||NEGATIVE||10^9 ORGANISMS/G||||NORMAL|NOT DONE||||DISCHARGE|FROZEN|N|MODIFIED ACID FAST STAIN|CKD-EPI FORMULA||NA|U|NA|N|||NA|3||39||FOLLOW-UP|1964-12-16|1973-09-03|||||1961-12-17||1960-04-11|Y|1967-12-26
TRIAL STUDY 134XCP|LB|4E600C41-1B27-4042-B48E-B60489701D2D|2||||SMUSCAB|SMOOTH MUSCLE ANTIBODY|||||||KCAL|||||||BORDERLINE||10^4/HPF||||LOW|NOT DONE||||PROSTATIC FLUID|AGGLUTINATED|U|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|U|||U|3||39||TREATMENT|1960-07-25|1968-12-21|||||1968-07-10||1973-06-20|U|1969-06-15
TRIAL STUDY 134XCP|LB|4E600C41-1B27-4042-B48E-B60489701D2D|1||||PCP|PHENCYCLIDINE|||||||KV|||||||BORDERLINE||SEC||||HIGH|NOT DONE||||MUSCLE TISSUE|ICTERIC|N|GIEMSA STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|U|Y|||NA|4||88||WASHOUT|1964-12-04|1969-04-22|||||1969-03-26||1973-09-08|N|1965-11-14
TRIAL STUDY 134XCP|LB|4E600C41-1B27-4042-B48E-B60489701D2D|2||||YEAST|YEAST CELLS|||||||10^9 ORGANISMS|||||||NEGATIVE||UMOL/MIN||||ABNORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|ICTERIC|N|NEURAMINIDASE INHIBITION ASSAY|MDRD 5 VARIABLE FORMULA||N|U|Y|U|||U|4||88||LONG-TERM FOLLOW-UP|1968-10-25|1966-06-11|||||1961-01-06||1968-08-25|NA|1968-12-26
TRIAL STUDY 134XCP|LB|4E600C41-1B27-4042-B48E-B60489701D2D|1||||CA72_4AG|CANCER ANTIGEN 72-4|||||||U/KG/H|||||||TRACE||/SEC||||ABNORMAL|NOT DONE||||EMESIS|AGGLUTINATED|U|AMSLER GRID|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|NA|NA|||U|5||7||BLINDED TREATMENT|1962-04-25|1968-11-13|||||1969-10-04||1972-10-25|NA|1967-03-01
TRIAL STUDY 134XCP|LB|4E600C41-1B27-4042-B48E-B60489701D2D|2||||C165917|D. PTERONYSSINUS IGG AB RAST SCORE|||||||CFU/G|||||||INVALID||TSP||||HIGH|NOT DONE||||SEBUM|UNEXPECTED ODOR|N|POLYMERASE CHAIN REACTION|CKD-EPI CREATININE FORMULA||NA|N|U|U|||U|5||7||SCREENING|1972-07-12|1972-06-29|||||1966-07-22||1970-05-27|N|1971-09-15
TRIAL STUDY 134XCP|LB|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|1||||TRIG|TRIGLYCERIDES|||||||L/S/KPA|||||||INVALID||NG/L||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|U|CONTRAST ENHANCED CT SCAN|NASH FIBROSURE FORMULA||N|Y|U|N|||NA|1||38||OBSERVATION|1968-03-24|1973-07-31|||||1961-06-07||1964-12-31|N|1968-09-21
TRIAL STUDY 134XCP|LB|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|2||||PLATIM|IMMATURE PLATELETS|||||||CFU/ML|||||||NEGATIVE||EVENTS||||ABNORMAL|NOT DONE||||INFRANATANT, PLASMA|DRIED|Y|DXA SCAN|HEPASCORE FORMULA||N|U|NA|NA|||Y|1||38||WASHOUT|1967-05-26|1967-07-20|||||1967-03-09||1972-01-12|NA|1970-07-28
TRIAL STUDY 134XCP|LB|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|1||||TNFSR2|SOLUBLE TNF RECEPTOR TYPE II|||||||ML/ANIMAL/WK|||||||NEGATIVE||UG/KG/MIN||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|LIPEMIC|NA|OBSERVATION|HEPASCORE FORMULA||U|Y|U|Y|||N|2||58||OBSERVATION|1960-01-31|1969-07-13|||||1971-11-24||1972-08-04|NA|1969-01-02
TRIAL STUDY 134XCP|LB|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|2||||MCV|ERY. MEAN CORPUSCULAR VOLUME|||||||NM|||||||BORDERLINE||GENEQ||||HIGH|NOT DONE||||ARTERIAL BLOOD|NON-HEMOLYZED|Y|HPLC/IEX|CKD-EPI CYSTATIN C FORMULA||NA|U|Y|Y|||U|2||58||OPEN LABEL TREATMENT|1967-08-22|1973-07-26|||||1970-01-02||1971-12-11|Y|1968-05-14
TRIAL STUDY 134XCP|LB|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|1||||HOMOCY|HOMOCYSTEINE|||||||UGEQ/L|||||||INVALID||MM/H||||NORMAL|NOT DONE||||COLOSTRUM|FROZEN|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROMETER FORMULA||Y|Y|N|N|||N|3||39||INDUCTION TREATMENT|1972-02-19|1966-03-18|||||1962-01-14||1969-11-09|Y|1967-10-19
TRIAL STUDY 134XCP|LB|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|2||||HLADRMSC|HLA-DR MISMATCH COUNT|||||||SCOOPFUL|||||||TRACE||L/L||||ABNORMAL|NOT DONE||||LOCHIA|HEMOLYZED|N|IHC|MDRD ENZYMATIC FORMULA||Y|U|N|U|||U|3||39||OPEN LABEL TREATMENT|1969-06-02|1964-02-21|||||1966-09-18||1965-03-09|N|1962-12-13
TRIAL STUDY 134XCP|LB|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|1||||PAI1|PLASMINOGEN ACTIVATOR INHIBITOR-1|||||||NKAT|||||||BORDERLINE||BREATHS/MIN||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|CONCENTRATED|U|RADIOIMMUNOPRECIPITATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|U|U|||N|4||88||OBSERVATION|1973-05-26|1968-08-19|||||1965-08-12||1962-05-05|NA|1970-11-29
TRIAL STUDY 134XCP|LB|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|2||||C130133|D. FARINAE ANTIGEN IGG ANTIBODY|||||||LOG10 PFU|||||||TRACE||S^-1(%O2)^-1||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|UNEXPECTED ODOR|U|IMPEDANCE CONDUCTIVITY|NASH FIBROSURE FORMULA||NA|Y|N|NA|||Y|4||88||TREATMENT|1963-08-02|1968-08-12|||||1965-04-09||1970-11-30|Y|1970-06-18
TRIAL STUDY 134XCP|LB|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|1||||FACTVWMU|VON WILLEBRAND FACTOR MULTIMERS|||||||UMOL/DAY|||||||POSITIVE||10^11/L||||NORMAL|NOT DONE||||LEUKOCYTE|THAWED|Y|IN VITRO GENE EXPRESSION ASSAY|MDRD 6 VARIABLE FORMULA||U|N|N|Y|||N|5||7||FOLLOW-UP|1968-05-27|1967-03-14|||||1962-03-11||1971-06-01|NA|1971-09-02
TRIAL STUDY 134XCP|LB|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|2||||CRDIGAAB|CARDIOLIPIN IGA ANTIBODY|||||||BAU|||||||INDETERMINATE||FT2||||NORMAL|NOT DONE||||SOFT TISSUE|REFRIGERATED|Y|ENZYMATIC SPECTROPHOTOMETRY|FIBROSIS 4 FORMULA||Y|Y|U|N|||U|5||7||RUN-IN|1968-10-11|1965-06-27|||||1971-03-31||1963-02-06|N|1970-03-29
TRIAL STUDY 134XCP|LB|00D760E7-DC21-41A8-AD28-FF48A5C21E83|1||||PGE2|PROSTAGLANDIN E2|||||||TORR|||||||INDETERMINATE||MV2/HZ||||LOW|NOT DONE||||SMEGMA|THAWED|N|MECHANICAL CLOT DETECTION|MDRD 6 VARIABLE FORMULA||Y|Y|U|NA|||Y|1||38||SCREENING|1962-12-19|1970-05-17|||||1962-11-13||1973-08-20|Y|1964-07-08
TRIAL STUDY 134XCP|LB|00D760E7-DC21-41A8-AD28-FF48A5C21E83|2||||MDC|MACROPHAGE-DERIVED CHEMOKINE|||||||MMOL/MIN/KPA|||||||BORDERLINE||APL U||||HIGH|NOT DONE||||BUFFY COAT|UNEXPECTED ODOR|N|PULSE OXIMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|Y|N|||NA|1||38||LONG-TERM FOLLOW-UP|1961-08-25|1964-07-30|||||1965-08-07||1961-03-01|NA|1968-08-17
TRIAL STUDY 134XCP|LB|00D760E7-DC21-41A8-AD28-FF48A5C21E83|1||||ANCPNCAB|NEUTROPHIL CYTOPLASMIC AB, PERINUCLEAR|||||||DPM/0.5 ML|||||||POSITIVE||% INHIBITION||||HIGH|NOT DONE||||MENSTRUAL BLOOD|CONCENTRATED|U|DUCTOGRAPHY|FIBROMETER FORMULA||NA|NA|N|U|||N|2||58||FOLLOW-UP|1961-04-16|1963-05-21|||||1968-11-30||1973-08-07|NA|1963-12-09
TRIAL STUDY 134XCP|LB|00D760E7-DC21-41A8-AD28-FF48A5C21E83|2||||IMMGLB|IMMUNOGLOBULIN|||||||LINEAR FT*LB|||||||INVALID||CM2||||NORMAL|NOT DONE||||HAIR|UNEXPECTED ODOR|U|CENTRIFUGATION|CKD-EPI FORMULA||U|U|U|Y|||Y|2||58||CONTINUATION TREATMENT|1965-03-17|1971-03-09|||||1960-07-23||1961-09-06|N|1970-09-09
TRIAL STUDY 134XCP|LB|00D760E7-DC21-41A8-AD28-FF48A5C21E83|1||||FOLHMRNA|FOLATE HYDROLASE MRNA|||||||/40 HPFS|||||||INDETERMINATE||NMOL/L||||LOW|NOT DONE||||SOFT TISSUE|REFRIGERATED|U|STRESS ECHOCARDIOGRAPHY|CKD-EPI FORMULA||NA|Y|U|U|||NA|3||39||INDUCTION TREATMENT|1964-10-21|1967-01-03|||||1960-06-07||1973-04-08|NA|1971-12-31
TRIAL STUDY 134XCP|LB|00D760E7-DC21-41A8-AD28-FF48A5C21E83|2||||ANCATYAB|NEUTROPHIL CYTOPLASMIC AB, ATYPICAL|||||||AMOL|||||||BORDERLINE||PRESSOR UNITS||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|DRIED|Y|HPLC-FL|MDRD 4 VARIABLE FORMULA||U|N|NA|Y|||Y|3||39||RUN-IN|1960-05-20|1962-09-10|||||1963-07-03||1961-06-09|N|1968-04-30
TRIAL STUDY 134XCP|LB|00D760E7-DC21-41A8-AD28-FF48A5C21E83|1||||CRH|CORTICOTROPIN RELEASING HORMONE|||||||G/ANIMAL/WK|||||||INVALID||10^9 ORGANISMS/G||||LOW|NOT DONE||||MUSCLE TISSUE|UNEXPECTED ODOR|NA|TEST STRIP|FIBROSIS 4 FORMULA||N|N|NA|Y|||Y|4||88||LONG-TERM FOLLOW-UP|1965-04-13|1963-09-18|||||1964-01-23||1968-04-09|N|1962-06-30
TRIAL STUDY 134XCP|LB|00D760E7-DC21-41A8-AD28-FF48A5C21E83|2||||MGCREAT|MAGNESIUM/CREATININE|||||||MMOL2/L2|||||||INDETERMINATE||UCI/KG||||HIGH|NOT DONE||||VITREOUS HUMOR|CALCIFIED|NA|EPSILOMETER|CKD-EPI CREATININE FORMULA||NA|N|Y|N|||N|4||88||FOLLOW-UP|1961-07-20|1965-08-21|||||1962-03-12||1968-10-20|N|1964-09-21
TRIAL STUDY 134XCP|LB|00D760E7-DC21-41A8-AD28-FF48A5C21E83|1||||TDTAG|TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE AG|||||||%/MIN|||||||INDETERMINATE||VG/KG||||ABNORMAL|NOT DONE||||VENOUS PLASMA|UNEXPECTED ODOR|NA|OPTICAL DENSITY MEASUREMENT|CKD-EPI CYSTATIN C FORMULA||U|NA|NA|Y|||U|5||7||TREATMENT|1960-07-22|1960-07-15|||||1964-06-28||1965-12-24|U|1968-05-11
TRIAL STUDY 134XCP|LB|00D760E7-DC21-41A8-AD28-FF48A5C21E83|2||||PLATHCT|PLATELET HEMATOCRIT|||||||NG/L|||||||BORDERLINE||L/S/KPA||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|LACTESCENT|NA|HPLC/IEX|GMI MMOL/MOL FORMULA||Y|Y|NA|N|||Y|5||7||FOLLOW-UP|1964-11-27|1973-07-29|||||1965-07-13||1964-03-01|NA|1962-05-16
TRIAL STUDY 134XCP|LB|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|1||||ACETOAC|ACETOACETIC ACID|||||||/H|||||||NEGATIVE||10^3 ORGANISMS/ML||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|LACTESCENT|Y|ELECTROPHORESIS|MDRD 4 VARIABLE FORMULA||U|U|U|N|||U|1||38||TREATMENT|1967-09-04|1971-04-30|||||1964-02-27||1961-04-26|NA|1966-12-17
TRIAL STUDY 134XCP|LB|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|2||||RBCDIPOP|DIMORPHIC ERYTHROCYTE POPULATION|||||||HZ/S|||||||TRACE||10^9 CFU/G||||HIGH|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED|Y|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|MDRD 4 VARIABLE FORMULA||NA|Y|Y|U|||Y|1||38||TREATMENT|1972-05-25|1963-04-29|||||1967-09-29||1966-10-19|NA|1963-10-11
TRIAL STUDY 134XCP|LB|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|1||||IL2SRA|SOLUBLE INTERLEUKIN 2 RECEPTOR ACTIVITY|||||||SHOCK WAVE|||||||INDETERMINATE||H*%||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|AGGLUTINATED|U|TARGETED TRANSCRIPTOME SEQUENCING|MDRD 5 VARIABLE FORMULA||N|U|U|U|||U|2||58||BLINDED TREATMENT|1968-02-25|1968-02-16|||||1964-10-26||1966-04-04|NA|1969-02-28
TRIAL STUDY 134XCP|LB|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|2||||AFPL3AFP|A FETOPROTEIN L3/A FETOPROTEIN|||||||1/(S*KPA)|||||||INDETERMINATE||ML/M2/MIN||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|NON-HEMOLYZED|U|FARR ASSAY|MDRD FORMULA||U|Y|N|U|||N|2||58||LONG-TERM FOLLOW-UP|1964-04-18|1962-12-31|||||1968-01-22||1971-04-28|Y|1965-01-17
TRIAL STUDY 134XCP|LB|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|1||||BICARB|BICARBONATE|||||||MBQ|||||||BORDERLINE||PA||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|FRESH|NA|MICROBIAL CONCENTRATION|FIBROTEST FORMULA||Y|N|Y|N|||U|3||39||RUN-IN|1962-09-18|1966-09-04|||||1963-10-25||1962-01-24|U|1966-10-09
TRIAL STUDY 134XCP|LB|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|2||||LACTULOS|LACTULOSE|||||||VP/ML|||||||TRACE||ML/ANIMAL/DAY||||ABNORMAL|NOT DONE||||BUFFY COAT|FRESH|U|KINYOUN STAIN|MDRD 4 VARIABLE FORMULA||U|U|NA|N|||U|3||39||SCREENING|1972-04-03|1965-05-22|||||1970-03-08||1971-04-25|NA|1970-11-23
TRIAL STUDY 134XCP|LB|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|1||||ALT|ALANINE AMINOTRANSFERASE|||||||TRANSDUCING UNIT|||||||INDETERMINATE||CM2||||NORMAL|NOT DONE||||MONOCYTE|CONTAMINATED|U|IMPULSE OSCILLOMETRY|GMI MMOL/MOL FORMULA||N|N|Y|U|||Y|4||88||INDUCTION TREATMENT|1968-04-02|1968-12-02|||||1971-01-01||1964-07-29|N|1960-07-22
TRIAL STUDY 134XCP|LB|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|2||||MG|MAGNESIUM|||||||VOXEL|||||||INVALID||FINGERTIP UNIT||||NORMAL|NOT DONE||||BLOOD|HEMOLYZED|N|RADIOIMMUNOPRECIPITATION ASSAY|MDRD 5 VARIABLE FORMULA||N|NA|U|NA|||U|4||88||TREATMENT|1965-06-02|1961-06-24|||||1966-10-29||1963-03-28|U|1968-12-04
TRIAL STUDY 134XCP|LB|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|1||||INULIN|INULIN|||||||BOWL|||||||INDETERMINATE||GBQ/MG||||LOW|NOT DONE||||EPITHELIAL CELL|CALCIFIED|N|ACRIDINE ORANGE STAIN|MDRD 6 VARIABLE FORMULA||NA|U|N|NA|||U|5||7||INDUCTION TREATMENT|1966-01-04|1963-11-20|||||1969-09-26||1960-08-10|N|1970-07-11
TRIAL STUDY 134XCP|LB|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|2||||TESTOS|TESTOSTERONE|||||||U/KG/MIN|||||||NEGATIVE||UM/DAY||||HIGH|NOT DONE||||SMEGMA|GELLED|Y|NEXT GENERATION TARGETED SEQUENCING|MDRD 6 VARIABLE FORMULA||U|Y|Y|U|||U|5||7||BASELINE|1964-10-29|1962-01-17|||||1961-04-04||1960-06-25|N|1963-02-11
TRIAL STUDY 134XCP|LB|4EC25C9E-F259-405B-8B7D-3C9640FB9748|1||||GFRBSCYC|GFR FROM CYSTATIN C ADJUSTED FOR BSA|||||||CMH2O*S/ML|||||||TRACE||IU/G||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|FRESH|NA|HILLMEN COLOR CHART|FIBROMETER FORMULA||N|NA|N|Y|||U|1||38||OPEN LABEL TREATMENT|1960-11-02|1962-04-03|||||1966-07-23||1972-08-05|NA|1964-02-11
TRIAL STUDY 134XCP|LB|4EC25C9E-F259-405B-8B7D-3C9640FB9748|2||||TESTOSFR|TESTOSTERONE, FREE|||||||STEPS|||||||POSITIVE||TITER||||ABNORMAL|NOT DONE||||CELL PELLET|CALCIFIED|NA|LEAD CITRATE STAIN|COCKCROFT-GAULT FORMULA||N|U|U|U|||Y|1||38||INDUCTION TREATMENT|1966-05-14|1967-05-30|||||1968-12-05||1971-01-13|Y|1963-05-07
TRIAL STUDY 134XCP|LB|4EC25C9E-F259-405B-8B7D-3C9640FB9748|1||||CYMSU|MONOSODIUM URATE CRYSTALS|||||||ML/SEC/1.73M2|||||||POSITIVE||MPA||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|AUTOLYZED|NA|NUCLEIC ACID BASED METHOD|ASH FIBROSURE FORMULA||NA|NA|NA|Y|||Y|2||58||BASELINE|1973-05-13|1965-04-03|||||1963-02-16||1968-04-27|Y|1963-10-01
TRIAL STUDY 134XCP|LB|4EC25C9E-F259-405B-8B7D-3C9640FB9748|2||||IA5OHEXR|5-HYDROXYINDOLEACETICACID EXCRETION RATE|||||||PM|||||||INDETERMINATE||MGEQ||||HIGH|NOT DONE||||MENSTRUAL BLOOD|ICTERIC|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA||NA|U|U|N|||NA|2||58||INDUCTION TREATMENT|1973-01-18|1969-05-08|||||1968-11-25||1971-08-18|N|1962-06-21
TRIAL STUDY 134XCP|LB|4EC25C9E-F259-405B-8B7D-3C9640FB9748|1||||PHTRMN|PHENTERMINE|||||||/WK|||||||INDETERMINATE||MEQ/G||||ABNORMAL|NOT DONE||||SMEGMA|SOLIDIFIED|U|MICROBIAL CONCENTRATION|CKD-EPI FORMULA||N|N|U|U|||NA|3||39||INDUCTION TREATMENT|1972-08-22|1967-07-20|||||1961-08-20||1973-05-07|N|1961-02-12
TRIAL STUDY 134XCP|LB|4EC25C9E-F259-405B-8B7D-3C9640FB9748|2||||ADMA|ASYMMETRIC DIMETHYLARGININE|||||||%(V/V)|||||||BORDERLINE||MDFI||||LOW|NOT DONE||||CALCULUS|FRESH|Y|DUCTOGRAPHY|HEPASCORE FORMULA||U|Y|N|N|||NA|3||39||BLINDED TREATMENT|1963-08-31|1970-05-20|||||1962-10-10||1969-09-25|U|1969-04-03
TRIAL STUDY 134XCP|LB|4EC25C9E-F259-405B-8B7D-3C9640FB9748|1||||GCDCA|GLYCOCHENODEOXYCHOLATE|||||||BQ/L|||||||INDETERMINATE||RNA COPIES/ML||||HIGH|NOT DONE||||VENOUS BLOOD|LIPEMIC|N|FLOCCULATION|MDRD ENZYMATIC FORMULA||U|Y|NA|N|||N|4||88||OPEN LABEL TREATMENT|1972-01-27|1968-09-25|||||1970-09-15||1973-08-31|NA|1964-06-23
TRIAL STUDY 134XCP|LB|4EC25C9E-F259-405B-8B7D-3C9640FB9748|2||||ALPISOE|ALKALINE PHOSPHATASE ISOENZYME|||||||SQU/ML|||||||TRACE||GENEQ||||HIGH|NOT DONE||||SALIVA|CALCIFIED|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|GMI MMOL/MOL FORMULA||N|NA|Y|NA|||U|4||88||SCREENING|1963-08-09|1969-06-09|||||1971-09-21||1971-07-26|N|1963-08-17
TRIAL STUDY 134XCP|LB|4EC25C9E-F259-405B-8B7D-3C9640FB9748|1||||LCN2|LIPOCALIN-2|||||||MOL|||||||INVALID||KM/H||||LOW|NOT DONE||||SMEGMA|NON-HEMOLYZED|Y|JAFFE REACTION|MDRD 4 VARIABLE FORMULA||Y|N|Y|N|||N|5||7||RUN-IN|1960-10-30|1963-06-20|||||1970-04-25||1961-02-10|NA|1962-09-28
TRIAL STUDY 134XCP|LB|4EC25C9E-F259-405B-8B7D-3C9640FB9748|2||||COPEP|COPEPTIN|||||||GPELISA UNIT/ML|||||||NEGATIVE||SACHET||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|PARAFFIN-EMBEDDED|U|CHROMATOGRAPHY|CKD-EPI FORMULA||Y|Y|U|N|||Y|5||7||SCREENING|1972-02-22|1965-08-26|||||1961-05-03||1961-02-11|NA|1963-04-29
TRIAL STUDY 134XCP|LB|FF1CC617-040D-42E9-AD31-32E7B8DAED24|1||||HTTP|HUNTINGTIN PROTEIN|||||||TUBE|||||||BORDERLINE||UV||||HIGH|NOT DONE||||TUMOR TISSUE|LACTESCENT|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|CKD-EPI FORMULA||NA|N|U|U|||N|1||38||RUN-IN|1970-02-04|1967-01-14|||||1964-09-17||1961-09-18|Y|1970-01-14
TRIAL STUDY 134XCP|LB|FF1CC617-040D-42E9-AD31-32E7B8DAED24|2||||ACYCRNTN|ACYLCARNITINE|||||||SHOCK WAVE|||||||BORDERLINE||MM2||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|FROZEN|NA|MANUAL COUNT|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|U|Y|||NA|1||38||OBSERVATION|1964-04-28|1962-02-12|||||1965-06-09||1964-08-25|Y|1963-01-16
TRIAL STUDY 134XCP|LB|FF1CC617-040D-42E9-AD31-32E7B8DAED24|1||||OXYTOCIN|OXYTOCIN|||||||CG|||||||INVALID||TUBE||||NORMAL|NOT DONE||||VENOUS BLOOD|CALCIFIED|U|TRIPLE-PHASE MRI SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|N|Y|||N|2||58||CONTINUATION TREATMENT|1966-01-31|1969-05-23|||||1963-05-20||1973-03-09|N|1966-01-28
TRIAL STUDY 134XCP|LB|FF1CC617-040D-42E9-AD31-32E7B8DAED24|2||||C165916|D. FARINAE IGG AB RAST SCORE|||||||RATIO|||||||INVALID||UOSM||||NORMAL|NOT DONE||||BASAL TEAR|FROZEN|NA|LASER CAPTURE MICRODISSECTION|MDRD 4 VARIABLE FORMULA||U|Y|NA|NA|||N|2||58||OPEN LABEL TREATMENT|1966-12-08|1961-12-13|||||1960-01-23||1969-10-29|N|1962-04-18
TRIAL STUDY 134XCP|LB|FF1CC617-040D-42E9-AD31-32E7B8DAED24|1||||AFP|ALPHA FETOPROTEIN|||||||ML/MIN|||||||INDETERMINATE||DAGU||||LOW|NOT DONE||||EMOTIONAL TEAR|LACTESCENT|U|DIFFUSION TENSOR MRI|MDRD 6 VARIABLE FORMULA||NA|U|NA|Y|||U|3||39||BLINDED TREATMENT|1970-07-03|1972-06-25|||||1972-02-03||1968-11-20|N|1969-08-06
TRIAL STUDY 134XCP|LB|FF1CC617-040D-42E9-AD31-32E7B8DAED24|2||||DDIMER|D-DIMER|||||||10^6 ORGANISMS/G|||||||INDETERMINATE||UG/L FEU||||ABNORMAL|NOT DONE||||PUS|REFRIGERATED|NA|ELECTROGASTROGRAPHY|FIBROSIS 4 FORMULA||N|Y|Y|U|||N|3||39||TREATMENT|1964-05-15|1964-05-14|||||1963-02-04||1968-06-24|NA|1965-03-23
TRIAL STUDY 134XCP|LB|FF1CC617-040D-42E9-AD31-32E7B8DAED24|1||||PSDEPHD|PSEUDOEPHEDRINE|||||||GAUSS|||||||BORDERLINE||ML/M2/DAY||||HIGH|NOT DONE||||INFRANATANT, PLASMA|CONCENTRATED|U|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|U|NA|||U|4||88||BASELINE|1966-01-23|1969-06-25|||||1968-01-07||1967-02-07|NA|1967-08-10
TRIAL STUDY 134XCP|LB|FF1CC617-040D-42E9-AD31-32E7B8DAED24|2||||GRWHIH|GROWTH HORMONE INHIBITING HORMONE|||||||TSP|||||||NEGATIVE||IU||||NORMAL|NOT DONE||||SUPERNATANT, PLASMA|GELLED|Y|COLORIMETRY|HEPASCORE FORMULA||U|U|N|U|||U|4||88||BLINDED TREATMENT|1972-02-16|1961-09-24|||||1968-07-15||1970-09-09|U|1965-06-16
TRIAL STUDY 134XCP|LB|FF1CC617-040D-42E9-AD31-32E7B8DAED24|1||||FOLHMRNA|FOLATE HYDROLASE MRNA|||||||ML/DL|||||||INDETERMINATE||LOG10 TCID 50/UL||||LOW|NOT DONE||||VITREOUS HUMOR|NON-HEMOLYZED|NA|CORONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||N|Y|Y|U|||N|5||7||BASELINE|1966-12-03|1971-02-17|||||1960-10-16||1963-05-18|N|1965-05-20
TRIAL STUDY 134XCP|LB|FF1CC617-040D-42E9-AD31-32E7B8DAED24|2||||APPA|AMYLOID ALPHA PRECURSOR PROTEIN|||||||UG|||||||INVALID||TORR||||LOW|NOT DONE||||BILE|AGGLUTINATED|N|DYNAMIC CONTRAST ENHANCED MRI|CKD-EPI CREATININE FORMULA||NA|NA|NA|N|||Y|5||7||WASHOUT|1970-01-11|1968-07-03|||||1969-04-21||1963-10-04|Y|1962-10-12
TRIAL STUDY 134XCP|LB|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|1||||CELLULAR|CELLULARITY|||||||PIPE|||||||INVALID||MPA||||ABNORMAL|NOT DONE||||NAIL|ICTERIC|N|CALCOFLUOR WHITE STAIN|FIBROTEST FORMULA||Y|NA|Y|N|||U|1||38||TREATMENT|1967-10-31|1961-11-03|||||1970-07-12||1968-10-09|N|1970-04-02
TRIAL STUDY 134XCP|LB|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|2||||C165877|CAT DANDER IGE AB RAST SCORE|||||||10^3 ORGANISMS/ML|||||||INVALID||KG/M2||||NORMAL|NOT DONE||||SALIVA|CONTAMINATED|U|EPSILOMETER|MDRD ENZYMATIC FORMULA||U|Y|U|NA|||NA|1||38||SCREENING|1964-08-04|1971-06-10|||||1963-03-23||1960-08-26|U|1969-08-16
TRIAL STUDY 134XCP|LB|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|1||||HLAIAB|HLA CLASS I ANTIBODY|||||||PSI|||||||POSITIVE||MMHG||||HIGH|NOT DONE||||TUMOR TISSUE|FRESH|N|KNEMOMETRY|MDRD 5 VARIABLE FORMULA||N|Y|U|NA|||N|2||58||LONG-TERM FOLLOW-UP|1970-12-12|1972-11-19|||||1961-09-27||1973-06-08|Y|1973-08-27
TRIAL STUDY 134XCP|LB|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|2||||RETI|RETICULOCYTES|||||||10^3 ORGANISMS|||||||NEGATIVE||100 IU/ML||||HIGH|NOT DONE||||SOFT TISSUE|LIPEMIC|U|COLORIMETRY|MDRD ENZYMATIC FORMULA||Y|Y|NA|N|||Y|2||58||CONTINUATION TREATMENT|1963-08-07|1969-07-07|||||1972-01-13||1972-07-07|Y|1971-07-21
TRIAL STUDY 134XCP|LB|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|1||||PTHFG|PARATHYROID HORMONE, FRAGMENTED|||||||WATT|||||||BORDERLINE||ML/H||||ABNORMAL|NOT DONE||||SPERMATOZOON|THAWED|U|ORCHIDOMETERY|ASH FIBROSURE FORMULA||N|Y|NA|Y|||NA|3||39||CONTINUATION TREATMENT|1963-12-23|1968-06-17|||||1962-04-14||1967-03-21|NA|1960-07-10
TRIAL STUDY 134XCP|LB|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|2||||CCL17|CHEMOKINE (C-C MOTIF) LIGAND 17|||||||MM2|||||||INVALID||%(W/V)||||NORMAL|NOT DONE||||ISOLATE|AGGLUTINATED|NA|SISH|GMI % FORMULA||NA|N|U|Y|||NA|3||39||WASHOUT|1965-11-04|1964-07-28|||||1963-06-10||1966-01-01|Y|1962-05-19
TRIAL STUDY 134XCP|LB|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|1||||MDA|3,4-METHYLENEDIOXYAMPHETAMINE|||||||TSP|||||||INDETERMINATE||KIT||||HIGH|NOT DONE||||GASTRIC CONTENTS|CALCIFIED|U|X-RAY|COCKCROFT-GAULT FORMULA||Y|U|N|N|||Y|4||88||OBSERVATION|1972-09-29|1961-01-09|||||1964-12-18||1961-03-14|Y|1971-06-02
TRIAL STUDY 134XCP|LB|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|2||||PROGRP|PRO-GASTRIN RELEASING PEPTIDE|||||||WEBER|||||||NEGATIVE||MMAL||||NORMAL|NOT DONE||||ARTERIAL BLOOD|CLOTTED|N|CONTRAST ENHANCED X-RAY|NASH FIBROSURE FORMULA||NA|U|NA|U|||N|4||88||SCREENING|1964-06-22|1965-01-06|||||1960-01-14||1960-01-25|U|1963-02-07
TRIAL STUDY 134XCP|LB|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|1||||THYAB|THYROID ANTIBODIES|||||||10^3 COPIES/ML|||||||TRACE||MG/KG/H||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|FROZEN|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|CKD-EPI FORMULA||U|NA|N|N|||N|5||7||LONG-TERM FOLLOW-UP|1973-08-29|1962-08-27|||||1971-04-04||1971-10-17|NA|1970-05-26
TRIAL STUDY 134XCP|LB|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|2||||SAA1|SERUM AMYLOID A1|||||||PMOL/DL|||||||BORDERLINE||APPLICATION||||HIGH|NOT DONE||||WHITE MATTER TISSUE|FRESH|NA|MOUSE PROTECTION ASSAY|NASH FIBROSURE FORMULA||N|U|N|Y|||Y|5||7||INDUCTION TREATMENT|1971-02-24|1964-11-18|||||1971-11-23||1965-05-09|U|1962-05-04
TRIAL STUDY 134XCP|LB|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|1||||PLAGMAMP|PLATELET AGGREGATION MEAN AMPLITUDE|||||||CG|||||||NEGATIVE||MG/DAY||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|PARAFFIN-EMBEDDED|NA|QUANTITATIVE COMPUTED TOMOGRAPHY|MDRD ENZYMATIC FORMULA||U|NA|U|N|||U|1||38||TREATMENT|1973-05-03|1961-08-19|||||1970-12-09||1970-10-26|Y|1971-11-30
TRIAL STUDY 134XCP|LB|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|2||||FOLHMRNA|FOLATE HYDROLASE MRNA|||||||MG2/DL2|||||||TRACE||PIXELS/CM||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|AGGLUTINATED|Y|COULOMETRIC TITRATION|MDRD ENZYMATIC FORMULA||U|U|NA|N|||Y|1||38||OBSERVATION|1971-09-13|1961-12-14|||||1963-08-26||1970-06-14|N|1969-10-26
TRIAL STUDY 134XCP|LB|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|1||||HLAAMSC|HLA-A MISMATCH COUNT|||||||UG/KG|||||||POSITIVE||NMOL/KG/DAY||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|U|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|FIBROSIS 4 FORMULA||NA|U|NA|Y|||NA|2||58||BASELINE|1966-05-06|1962-02-17|||||1960-04-05||1970-04-19|Y|1968-05-20
TRIAL STUDY 134XCP|LB|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|2||||PCP|PHENCYCLIDINE|||||||IU/ML|||||||NEGATIVE||COAT||||NORMAL|NOT DONE||||AQUEOUS HUMOR|FRESH|U|TRYPAN BLUE STAIN|MDRD 5 VARIABLE FORMULA||N|N|NA|U|||N|2||58||CONTINUATION TREATMENT|1964-08-14|1968-10-11|||||1962-05-13||1973-08-13|NA|1973-08-03
TRIAL STUDY 134XCP|LB|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|1||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||FMOL/G|||||||POSITIVE||DPM||||HIGH|NOT DONE||||SYNOVIAL FLUID|CLOTTED|U|PERFUSION MRI|FIBROMETER FORMULA||N|U|NA|U|||U|3||39||BASELINE|1971-07-16|1968-05-31|||||1961-07-14||1972-10-21|N|1961-01-11
TRIAL STUDY 134XCP|LB|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|2||||FSH|FOLLICLE STIMULATING HORMONE|||||||NMOL/G|||||||NEGATIVE||GPS U||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CALCIFIED|U|PERIODIC ACID SCHIFF STAIN|HEPASCORE FORMULA||U|U|Y|Y|||U|3||39||SCREENING|1965-07-25|1973-04-08|||||1963-03-25||1962-03-29|Y|1968-06-15
TRIAL STUDY 134XCP|LB|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|1||||AMYLASEP|AMYLASE, PANCREATIC|||||||CMH2O/ML|||||||INDETERMINATE||ML/M2/DAY||||NORMAL|NOT DONE||||PROSTATIC FLUID|THAWED|NA|ARTERIAL SPIN LABELING FUNCTIONAL MRI|CKD-EPI CREATININE FORMULA||N|U|NA|Y|||U|4||88||BLINDED TREATMENT|1966-12-03|1969-03-18|||||1962-06-16||1962-09-16|U|1969-08-25
TRIAL STUDY 134XCP|LB|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|2||||VITB7|VITAMIN B7|||||||10^3 CFU/ML|||||||NEGATIVE||C||||ABNORMAL|NOT DONE||||MONOCYTE|ICTERIC|N|MUGA|MDRD 4 VARIABLE FORMULA||N|NA|Y|NA|||NA|4||88||BASELINE|1967-05-17|1963-09-16|||||1962-02-15||1961-04-16|NA|1965-08-20
TRIAL STUDY 134XCP|LB|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|1||||CHOLATE|CHOLATE|||||||G/CM2|||||||POSITIVE||VG/ML||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|GELLED|N|TRIPLE-PHASE SPIRAL CT SCAN|GMI % FORMULA||NA|Y|NA|U|||NA|5||7||OPEN LABEL TREATMENT|1961-01-07|1969-06-06|||||1972-01-31||1971-07-27|Y|1970-06-18
TRIAL STUDY 134XCP|LB|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|2||||MUCTHR|MUCOUS THREADS|||||||ABSORBANCE U|||||||TRACE||JDF UNIT||||HIGH|NOT DONE||||ABSCESS FLUID|AGGLUTINATED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|GMI MMOL/MOL FORMULA||Y|NA|Y|Y|||NA|5||7||BASELINE|1973-06-26|1970-12-09|||||1965-05-03||1972-07-18|Y|1963-01-16
TRIAL STUDY 134XCP|LB|BFA83769-F31F-49AE-8C43-49046C719D69|1||||FUNGYLK|FUNGI, YEAST-LIKE|||||||FMOL|||||||INDETERMINATE||UG/G/H||||NORMAL|NOT DONE||||BREAST MILK|AUTOLYZED|Y|NEXT GENERATION TARGETED SEQUENCING|FIBROSIS 4 FORMULA||NA|Y|Y|U|||N|1||38||RUN-IN|1968-08-29|1963-07-13|||||1960-01-29||1969-08-22|NA|1961-11-17
TRIAL STUDY 134XCP|LB|BFA83769-F31F-49AE-8C43-49046C719D69|2||||HALPRZLM|HYDROXYALPRAZOLAM|||||||10^7 CFU|||||||POSITIVE||EU||||LOW|NOT DONE||||ABSCESS FLUID|CONCENTRATED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|GMI MMOL/MOL FORMULA||U|Y|N|Y|||U|1||38||SCREENING|1967-10-30|1961-05-01|||||1960-05-29||1966-09-25|U|1971-12-12
TRIAL STUDY 134XCP|LB|BFA83769-F31F-49AE-8C43-49046C719D69|1||||CYHIPPAC|HIPPURIC ACID CRYSTALS|||||||WEEKS|||||||POSITIVE||TORR||||HIGH|NOT DONE||||TISSUE|CLOTTED|NA|RULER MEASUREMENT METHOD|HEPASCORE FORMULA||NA|N|N|NA|||Y|2||58||LONG-TERM FOLLOW-UP|1966-07-23|1969-05-12|||||1964-12-25||1970-02-15|N|1963-01-07
TRIAL STUDY 134XCP|LB|BFA83769-F31F-49AE-8C43-49046C719D69|2||||ERCEMPOL|ERYTHROID MATURATION POOL|||||||MOL/L|||||||POSITIVE||UM2||||ABNORMAL|NOT DONE||||SALIVA|HEMOLYZED|Y|MASS SPECTROMETRY|CKD-EPI FORMULA||Y|U|N|N|||NA|2||58||SCREENING|1965-01-19|1970-07-30|||||1971-10-27||1966-11-29|Y|1969-07-04
TRIAL STUDY 134XCP|LB|BFA83769-F31F-49AE-8C43-49046C719D69|1||||MYBLAT1|TYPE I MYELOBLASTS|||||||NCI|||||||INVALID||10^6 IU/ML||||HIGH|NOT DONE||||PLATELET RICH PLASMA|PARAFFIN-EMBEDDED|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA||U|U|U|N|||N|3||39||OBSERVATION|1968-01-04|1972-09-05|||||1973-07-25||1966-02-26|Y|1968-12-30
TRIAL STUDY 134XCP|LB|BFA83769-F31F-49AE-8C43-49046C719D69|2||||DRVVTSCR|DRVVT SCREEN TO CONFIRM RATIO|||||||TROCHE|||||||NEGATIVE||LOG EID 50/DOSE||||ABNORMAL|NOT DONE||||MUCUS|FROZEN|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|FIBROTEST FORMULA||U|U|U|N|||N|3||39||TREATMENT|1965-06-03|1963-12-07|||||1961-11-13||1968-12-12|U|1973-02-08
TRIAL STUDY 134XCP|LB|BFA83769-F31F-49AE-8C43-49046C719D69|1||||TRP|TRYPTOPHAN|||||||10^3 ORGANISMS/G|||||||POSITIVE||10^12 IU/L||||LOW|NOT DONE||||SMEGMA|FROZEN|NA|PLETHYSMOGRAPHY|NASH FIBROSURE FORMULA||U|NA|U|N|||Y|4||88||FOLLOW-UP|1964-11-03|1973-04-20|||||1966-07-22||1966-06-20|NA|1961-11-22
TRIAL STUDY 134XCP|LB|BFA83769-F31F-49AE-8C43-49046C719D69|2||||FIXAAC|FACTOR IX ACTIVITY ACTUAL/CONTROL|||||||10^9 ORGANISMS|||||||BORDERLINE||UMOL||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED|N|CONFOCAL MICROSCOPY|MDRD 4 VARIABLE FORMULA||Y|NA|U|N|||Y|4||88||OPEN LABEL TREATMENT|1973-02-04|1964-06-07|||||1961-04-25||1971-04-26|NA|1966-11-13
TRIAL STUDY 134XCP|LB|BFA83769-F31F-49AE-8C43-49046C719D69|1||||IAA5OH|5-HYDROXYINDOLEACETIC ACID|||||||MS/MMHG|||||||INDETERMINATE||MPL U||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|FROZEN|NA|JAFFE REACTION|COCKCROFT-GAULT FORMULA||NA|NA|Y|Y|||NA|5||7||BASELINE|1966-06-25|1971-10-16|||||1971-05-29||1973-03-01|Y|1960-07-26
TRIAL STUDY 134XCP|LB|BFA83769-F31F-49AE-8C43-49046C719D69|2||||INHIBINA|INHIBIN A|||||||CAN|||||||INDETERMINATE||JOULE||||ABNORMAL|NOT DONE||||MUCUS|ICTERIC|NA|ANTIMICROBIAL COMBINATION TESTING|MDRD 5 VARIABLE FORMULA||NA|U|N|Y|||N|5||7||CONTINUATION TREATMENT|1964-12-15|1972-09-01|||||1970-09-17||1971-06-16|N|1966-02-17
TRIAL STUDY 134XCP|LB|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|1||||HLAA|HLA CLASS IA ANTIGEN|||||||10^12/L|||||||INVALID||MESF||||HIGH|NOT DONE||||INFRANATANT, SERUM|CONTAMINATED|NA|INTERRUPTER TECHNIQUE|FIBROMETER FORMULA||Y|NA|N|Y|||U|1||38||BASELINE|1970-02-12|1973-04-23|||||1963-04-11||1965-12-23|Y|1971-05-04
TRIAL STUDY 134XCP|LB|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|2||||FENTANYL|FENTANYL|||||||10^9 CFU/ML|||||||POSITIVE||DIP||||LOW|NOT DONE||||VITREOUS HUMOR|DRIED|Y|SPIRAL CT|GMI % FORMULA||Y|Y|NA|Y|||Y|1||38||TREATMENT|1961-06-05|1973-08-30|||||1969-07-08||1971-11-16|Y|1964-01-01
TRIAL STUDY 134XCP|LB|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|1||||EPSTI1|EPITHELIAL STROMAL INTERACTION PROTEIN 1|||||||G/CAGE/DAY|||||||TRACE||UL/KG/DAY||||HIGH|NOT DONE||||EPIDERMAL TISSUE|SOLIDIFIED|N|LINE PROBE ASSAY|COCKCROFT-GAULT FORMULA||N|Y|U|Y|||NA|2||58||WASHOUT|1966-02-12|1968-08-22|||||1969-06-22||1972-12-24|U|1964-05-12
TRIAL STUDY 134XCP|LB|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|2||||DNASEBAB|DNASE-B ANTIBODY|||||||10^9 CFU/G|||||||INDETERMINATE||10^6 CFU/G||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED|N|PET/CT SCAN WITHOUT CONTRAST|HEPASCORE FORMULA||NA|Y|U|Y|||NA|2||58||WASHOUT|1973-06-03|1971-01-11|||||1973-05-11||1970-03-13|NA|1972-03-02
TRIAL STUDY 134XCP|LB|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|1||||CARNTEXR|CARNITINE EXCRETION RATE|||||||BOX|||||||NEGATIVE||HENRY||||LOW|NOT DONE||||BONE|LACTESCENT|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|FIBROSIS 4 FORMULA||N|NA|N|U|||NA|3||39||FOLLOW-UP|1971-12-19|1960-03-12|||||1965-02-27||1967-02-14|Y|1969-01-06
TRIAL STUDY 134XCP|LB|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|2||||C5B9|COMPLEMENT C5B-9|||||||CD|||||||BORDERLINE||ML/BEAT||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|FROZEN|Y|DARK FIELD MICROSCOPY|ASH FIBROSURE FORMULA||U|Y|Y|Y|||Y|3||39||CONTINUATION TREATMENT|1963-03-03|1964-03-23|||||1967-08-25||1971-08-13|Y|1963-12-11
TRIAL STUDY 134XCP|LB|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|1||||MIP1A|MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA|||||||TAMPON|||||||INVALID||ELISA UNIT/DOSE||||ABNORMAL|NOT DONE||||BLOOD|FROZEN|U|LANDOLT RING|CKD-EPI FORMULA||U|Y|N|U|||Y|4||88||OPEN LABEL TREATMENT|1963-01-10|1963-10-24|||||1963-10-20||1965-04-15|N|1962-05-16
TRIAL STUDY 134XCP|LB|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|2||||HLAMSC|HLA MISMATCH COUNT|||||||NMOL/DAY|||||||INVALID||MOSM||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|HEMOLYZED|U|FLUOROSCOPY|MDRD ENZYMATIC FORMULA||Y|NA|Y|NA|||U|4||88||LONG-TERM FOLLOW-UP|1970-09-17|1967-01-07|||||1973-03-10||1968-10-14|N|1971-04-22
TRIAL STUDY 134XCP|LB|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|1||||PROMYCE|PROMYELOCYTES/TOTAL CELLS|||||||ML/KG/H|||||||TRACE||CI/KG||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|AGGLUTINATED|N|ELECTROMYOGRAPHY|FIBROTEST FORMULA||NA|NA|Y|NA|||NA|5||7||SCREENING|1972-02-07|1967-06-25|||||1965-03-28||1968-02-20|N|1964-07-19
TRIAL STUDY 134XCP|LB|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|2||||LYMPLLE|PLASMACYTOID LYMPHOCYTES/LEUKOCYTES|||||||FMOL|||||||TRACE||G||||ABNORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|LIPEMIC|NA|IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|Y|||Y|5||7||BLINDED TREATMENT|1967-03-16|1971-05-29|||||1968-04-08||1963-01-02|Y|1962-11-02
TRIAL STUDY 134XCP|LB|91838668-D463-4728-A581-2E1987592885|1||||PSIGGAB|PHOSPHATIDYLSERINE IGG ANTIBODY|||||||NG|||||||TRACE||G/CAGE/DAY||||HIGH|NOT DONE||||SPERMATOZOON|REFRIGERATED|U|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|U|NA|U|||Y|1||38||RUN-IN|1960-11-14|1962-02-12|||||1966-08-13||1968-10-30|U|1960-02-20
TRIAL STUDY 134XCP|LB|91838668-D463-4728-A581-2E1987592885|2||||FBRTST|FIBROTEST SCORE|||||||MBQ|||||||BORDERLINE||DAYS||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|HEMOLYZED|U|QUANTITATIVE CORONARY ANGIOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|U|||N|1||38||BLINDED TREATMENT|1960-10-30|1973-05-18|||||1962-10-21||1967-07-02|U|1969-09-12
TRIAL STUDY 134XCP|LB|91838668-D463-4728-A581-2E1987592885|1||||TXB2D11R|11-DEHYDRO-THROMBOXANE B2 EXCRETION RATE|||||||BAG|||||||NEGATIVE||UG/DAY||||HIGH|NOT DONE||||SOFT TISSUE|LIPEMIC|N|ELECTRICAL IMPEDANCE MYOGRAPHY|MDRD 4 VARIABLE FORMULA||NA|Y|Y|U|||NA|2||58||BLINDED TREATMENT|1967-10-13|1961-06-09|||||1971-07-14||1970-01-31|NA|1969-11-08
TRIAL STUDY 134XCP|LB|91838668-D463-4728-A581-2E1987592885|2||||C130069|BERMUDA GRASS POLLEN IGA|||||||GENEQ|||||||POSITIVE||KM/H||||ABNORMAL|NOT DONE||||SERUM|SOLIDIFIED|Y|HIGH RESOLUTION MELT ANALYSIS|MDRD 6 VARIABLE FORMULA||U|NA|U|NA|||U|2||58||WASHOUT|1965-08-17|1963-07-11|||||1960-09-22||1969-07-23|NA|1969-12-11
TRIAL STUDY 134XCP|LB|91838668-D463-4728-A581-2E1987592885|1||||PAH|P-AMINOHIPPURATE SODIUM|||||||VG/ML|||||||INDETERMINATE||DNA COPIES/UG||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CALCIFIED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|NA|NA|||Y|3||39||FOLLOW-UP|1967-11-04|1964-05-12|||||1960-02-11||1965-04-16|U|1962-10-01
TRIAL STUDY 134XCP|LB|91838668-D463-4728-A581-2E1987592885|2||||CA72_4AG|CANCER ANTIGEN 72-4|||||||DEG2|||||||TRACE||HZ/S||||HIGH|NOT DONE||||CERUMEN|FRESH|Y|IMMUNOFIXATION ELECTROPHORESIS|CKD-EPI CYSTATIN C FORMULA||Y|Y|Y|N|||NA|3||39||OBSERVATION|1969-12-09|1962-04-27|||||1968-11-02||1966-05-04|NA|1972-10-18
TRIAL STUDY 134XCP|LB|91838668-D463-4728-A581-2E1987592885|1||||CCL16|CHEMOKINE (C-C MOTIF) LIGAND 16|||||||MG/H|||||||NEGATIVE||PELLET||||LOW|NOT DONE||||SALIVA|CONTAMINATED|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|NA|U|NA|||U|4||88||CONTINUATION TREATMENT|1960-09-23|1965-10-12|||||1960-09-02||1962-08-25|Y|1968-06-13
TRIAL STUDY 134XCP|LB|91838668-D463-4728-A581-2E1987592885|2||||TNFR5S|SOLUBLE TNF RECEPTOR SUPERFAMILY MEM 5|||||||UV*SEC|||||||INDETERMINATE||IU/KG/H||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|ROOM TEMPERATURE|NA|MALDI-TOF|COCKCROFT-GAULT FORMULA||U|NA|N|U|||NA|4||88||SCREENING|1966-11-05|1963-10-17|||||1971-03-10||1968-07-07|N|1971-12-13
TRIAL STUDY 134XCP|LB|91838668-D463-4728-A581-2E1987592885|1||||INTLK1B|INTERLEUKIN 1 BETA|||||||AMPULE|||||||POSITIVE||ML/H||||LOW|NOT DONE||||LUNG SURFACTANT|REFRIGERATED|U|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD ENZYMATIC FORMULA||Y|Y|NA|U|||NA|5||7||CONTINUATION TREATMENT|1967-10-22|1970-02-21|||||1971-05-06||1971-03-20|NA|1967-11-18
TRIAL STUDY 134XCP|LB|91838668-D463-4728-A581-2E1987592885|2||||DHEA|DEHYDROEPIANDROSTERONE|||||||MMAL|||||||TRACE||BU||||NORMAL|NOT DONE||||ERYTHROCYTES|CALCIFIED|U|AUSCULTATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|Y|U|||U|5||7||CONTINUATION TREATMENT|1966-11-19|1962-11-27|||||1962-06-28||1961-02-08|N|1963-07-04
TRIAL STUDY 134XCP|LB|DE440A90-82D5-4269-A48B-47E2F5495440|1||||C165900|ORCHARD GRASS POLLEN IGG AB RAST SCORE|||||||APL U|||||||BORDERLINE||DPM/ML||||HIGH|NOT DONE||||MUCUS|REFRIGERATED|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 4 VARIABLE FORMULA||NA|NA|NA|N|||NA|1||38||CONTINUATION TREATMENT|1960-02-22|1965-02-03|||||1969-01-03||1964-10-26|N|1973-09-05
TRIAL STUDY 134XCP|LB|DE440A90-82D5-4269-A48B-47E2F5495440|2||||LKM1AB|LIVER KIDNEY MICROSOMAL TYPE 1 ANTIBODY|||||||ML/ANIMAL/WK|||||||INVALID||HR/DAY||||ABNORMAL|NOT DONE||||SKIN TISSUE|UNEXPECTED ODOR|U|FLOCCULATION|CKD-EPI FORMULA||NA|NA|N|Y|||N|1||38||BLINDED TREATMENT|1969-04-19|1968-05-09|||||1968-03-16||1968-05-10|NA|1965-12-04
TRIAL STUDY 134XCP|LB|DE440A90-82D5-4269-A48B-47E2F5495440|1||||SODMEXR|SODIUM EXCRETION RATE|||||||U/DL|||||||INDETERMINATE||MG2/DL2||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|THAWED|N|PLETHYSMOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|Y|N|||U|2||58||OPEN LABEL TREATMENT|1962-06-12|1962-11-29|||||1966-05-27||1965-09-24|N|1969-06-03
TRIAL STUDY 134XCP|LB|DE440A90-82D5-4269-A48B-47E2F5495440|2||||C130141|GERMAN COCKROACH ANTIGEN IGA ANTIBODY|||||||BAR|||||||NEGATIVE||CFU/ML||||HIGH|NOT DONE||||EPIDERMAL TISSUE|THAWED|NA|X-RAY|CKD-EPI FORMULA||U|Y|NA|Y|||Y|2||58||LONG-TERM FOLLOW-UP|1961-11-16|1971-10-06|||||1960-07-23||1962-01-29|Y|1965-02-06
TRIAL STUDY 134XCP|LB|DE440A90-82D5-4269-A48B-47E2F5495440|1||||NTELOP|N-TELOPEPTIDE|||||||KUSP|||||||INVALID||UG/L/H||||NORMAL|NOT DONE||||SALIVA|HEMOLYZED|NA|QUANTITATIVE ULTRASOUND|HEPASCORE FORMULA||N|U|Y|U|||N|3||39||TREATMENT|1966-07-05|1973-03-21|||||1967-08-09||1971-05-03|N|1968-01-22
TRIAL STUDY 134XCP|LB|DE440A90-82D5-4269-A48B-47E2F5495440|2||||LDLP|LDL PARTICLES|||||||ML/MIN/1.73M2|||||||TRACE||DNA COPIES/ML||||ABNORMAL|NOT DONE||||URINE SEDIMENT|CONTAMINATED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|MDRD ENZYMATIC FORMULA||N|Y|N|N|||NA|3||39||BASELINE|1963-05-25|1972-11-24|||||1967-09-11||1973-04-09|U|1965-07-30
TRIAL STUDY 134XCP|LB|DE440A90-82D5-4269-A48B-47E2F5495440|1||||KI67|KI-67|||||||GRAVITATIONAL UNIT|||||||INDETERMINATE||UCI/L||||NORMAL|NOT DONE||||ERYTHROCYTES|REFRIGERATED|N|COLORIMETRY|MDRD 6 VARIABLE FORMULA||U|N|NA|NA|||U|4||88||INDUCTION TREATMENT|1967-02-01|1964-03-03|||||1961-03-15||1970-05-30|N|1960-08-03
TRIAL STUDY 134XCP|LB|DE440A90-82D5-4269-A48B-47E2F5495440|2||||NEUTBLE|NEUTROPHILS BAND FORM/LEUKOCYTES|||||||LOG10 PFU/ML|||||||TRACE||BQ/KG||||HIGH|NOT DONE||||DERMAL TISSUE|PARAFFIN-EMBEDDED|U|NON-INVASIVE DIELECTRIC SENSING|GMI % FORMULA||U|Y|Y|U|||U|4||88||BLINDED TREATMENT|1972-05-18|1961-06-21|||||1966-07-10||1963-05-13|N|1964-02-06
TRIAL STUDY 134XCP|LB|DE440A90-82D5-4269-A48B-47E2F5495440|1||||INTLK11|INTERLEUKIN 11|||||||MEQ|||||||POSITIVE||UMOL/L/H||||NORMAL|NOT DONE||||CAPILLARY PLASMA|AUTOLYZED|N|IMMUNOTURBIDIMETRY|GMI % FORMULA||N|U|U|N|||U|5||7||TREATMENT|1972-05-01|1968-04-30|||||1961-04-30||1962-01-22|U|1960-10-19
TRIAL STUDY 134XCP|LB|DE440A90-82D5-4269-A48B-47E2F5495440|2||||HETRPHLE|HETEROPHILS/LEUKOCYTES|||||||PIXELS/IN|||||||INDETERMINATE||MMOL/KG||||HIGH|NOT DONE||||SYNOVIAL FLUID|LACTESCENT|N|DOUBLE IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA||N|NA|Y|Y|||Y|5||7||BASELINE|1960-02-20|1961-11-25|||||1961-07-01||1960-03-07|N|1966-10-14
TRIAL STUDY 134XCP|LB|74CA3A61-3179-43F1-8721-2582F50C44EF|1||||CREATEXR|CREATININE EXCRETION RATE|||||||G/ANIMAL/WK|||||||BORDERLINE||ANTI-XA IU||||HIGH|NOT DONE||||SPERMATOZOON|LACTESCENT|U|CLOT DETECTION|MDRD ENZYMATIC FORMULA||NA|N|Y|Y|||U|1||38||OBSERVATION|1961-07-25|1973-03-06|||||1960-05-07||1962-01-21|NA|1972-11-16
TRIAL STUDY 134XCP|LB|74CA3A61-3179-43F1-8721-2582F50C44EF|2||||CAEXR|CALCIUM EXCRETION RATE|||||||MANSON U/ML|||||||NEGATIVE||ANTIBODY UNIT||||NORMAL|NOT DONE||||EMESIS|LIPEMIC|N|WRIGHT STAIN|MDRD FORMULA||NA|NA|Y|Y|||NA|1||38||TREATMENT|1969-06-19|1963-10-14|||||1964-03-11||1962-07-12|N|1964-12-15
TRIAL STUDY 134XCP|LB|74CA3A61-3179-43F1-8721-2582F50C44EF|1||||PLTIMPLT|IMMATURE PLATELETS/TOTAL PLATELETS|||||||ML/MIN/MMHG|||||||NEGATIVE||GLOBULE||||ABNORMAL|NOT DONE||||MONOCYTE|NON-HEMOLYZED|Y|SLIT LAMP PHOTOGRAPHY|ASH FIBROSURE FORMULA||Y|Y|Y|N|||NA|2||58||CONTINUATION TREATMENT|1968-11-09|1960-08-09|||||1961-07-29||1967-11-09|NA|1962-05-15
TRIAL STUDY 134XCP|LB|74CA3A61-3179-43F1-8721-2582F50C44EF|2||||ETP|ENDOGENOUS THROMBIN POTENTIAL|||||||%|||||||NEGATIVE||GY/H||||HIGH|NOT DONE||||ARTERIAL BLOOD|CONCENTRATED|Y|DUCTOGRAPHY|ASH FIBROSURE FORMULA||U|N|U|NA|||NA|2||58||SCREENING|1970-02-01|1963-07-06|||||1972-08-04||1966-01-08|U|1969-01-06
TRIAL STUDY 134XCP|LB|74CA3A61-3179-43F1-8721-2582F50C44EF|1||||AFPL1|ALPHA FETOPROTEIN L1|||||||10^9/DOSE|||||||TRACE||UG/MOL||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|CONCENTRATED|N|MS/MS|CKD-EPI CREATININE FORMULA||Y|N|N|N|||NA|3||39||SCREENING|1971-12-21|1960-12-04|||||1964-04-27||1968-03-19|NA|1968-09-02
TRIAL STUDY 134XCP|LB|74CA3A61-3179-43F1-8721-2582F50C44EF|2||||GLUC|GLUCOSE|||||||BQ/ML|||||||INVALID||SYRINGE||||LOW|NOT DONE||||ALVEOLAR AIR|ROOM TEMPERATURE|Y|AGAR DILUTION|HEPASCORE FORMULA||NA|NA|Y|Y|||U|3||39||TREATMENT|1965-08-08|1970-05-02|||||1960-03-06||1972-07-31|NA|1962-06-02
TRIAL STUDY 134XCP|LB|74CA3A61-3179-43F1-8721-2582F50C44EF|1||||TRH|THYROTROPIN RELEASING HORMONE|||||||LOG10 ELISA UNIT/DOSE|||||||BORDERLINE||UG/G/MIN||||NORMAL|NOT DONE||||COLOSTRUM|THAWED|NA|GRAM STAIN|CKD-EPI CYSTATIN C FORMULA||Y|U|N|NA|||Y|4||88||CONTINUATION TREATMENT|1962-06-18|1971-05-29|||||1967-08-23||1963-01-22|N|1964-09-11
TRIAL STUDY 134XCP|LB|74CA3A61-3179-43F1-8721-2582F50C44EF|2||||OSTEOC|OSTEOCALCIN|||||||PACK|||||||INDETERMINATE||MEQ/ML||||NORMAL|NOT DONE||||LAVAGE FLUID|LACTESCENT|NA|KINYOUN STAIN|COCKCROFT-GAULT FORMULA||NA|U|NA|NA|||U|4||88||BASELINE|1967-04-22|1961-01-28|||||1967-04-18||1971-08-13|NA|1961-01-12
TRIAL STUDY 134XCP|LB|74CA3A61-3179-43F1-8721-2582F50C44EF|1||||STAT3P|PHOSPHORYLATED STAT3|||||||10^6 DNA COPIES/ML|||||||INDETERMINATE||KAT||||LOW|NOT DONE||||TISSUE|ICTERIC|U|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|Y|NA|NA|||U|5||7||FOLLOW-UP|1973-04-03|1964-10-20|||||1971-07-19||1971-06-04|U|1969-04-21
TRIAL STUDY 134XCP|LB|74CA3A61-3179-43F1-8721-2582F50C44EF|2||||ALPLS|LIVER SPECIFIC ALKALINE PHOSPHATASE|||||||ML/CAGE|||||||INVALID||UM/DAY||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|FROZEN|N|OPTICAL DENSITY MEASUREMENT|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|Y|NA|||NA|5||7||SCREENING|1965-07-13|1963-12-16|||||1960-05-03||1969-01-16|NA|1963-10-18
TRIAL STUDY 134XCP|LB|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|1||||C130108|WEED MIX POLLEN ANTIGEN IGA ANTIBODY|||||||10^4 CFU/ML|||||||TRACE||UM2||||LOW|NOT DONE||||TUMOR TISSUE|AGGLUTINATED|Y|ELISPOT|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|NA|U|||N|1||38||CONTINUATION TREATMENT|1962-07-05|1966-12-22|||||1964-03-25||1962-09-23|NA|1969-02-05
TRIAL STUDY 134XCP|LB|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|2||||ESELS|SOLUBLE E-SELECTIN|||||||/200 HPFS|||||||INDETERMINATE||MMHG*MIN/L||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|SOLIDIFIED|U|HIGH RESOLUTION CT|CKD-EPI FORMULA||Y|N|U|U|||NA|1||38||FOLLOW-UP|1964-03-11|1961-10-15|||||1960-01-08||1970-04-10|NA|1972-09-14
TRIAL STUDY 134XCP|LB|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|1||||BASO|BASOPHILS|||||||IU|||||||TRACE||10^4 CFU/ML||||ABNORMAL|NOT DONE||||TRANSUDATE|PARAFFIN-EMBEDDED|NA|HPLC-UV|FIBROSIS 4 FORMULA||N|Y|N|Y|||N|2||58||OPEN LABEL TREATMENT|1960-05-08|1964-10-12|||||1961-07-03||1971-09-21|Y|1969-09-14
TRIAL STUDY 134XCP|LB|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|2||||OXZPM|OXAZEPAM|||||||IU/G HB|||||||BORDERLINE||AMOL||||ABNORMAL|NOT DONE||||MECONIUM|THAWED|NA|SECONDARY ION MASS SPECTOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|NA|U|NA|||Y|2||58||SCREENING|1964-01-24|1971-03-25|||||1970-06-30||1971-11-10|U|1963-08-20
TRIAL STUDY 134XCP|LB|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|1||||DCCARNIT|DECANOYLCARNITINE|||||||MV2/HZ|||||||BORDERLINE||IU/KG/H||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE|Y|HPLC/MS|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|Y|U|||U|3||39||OPEN LABEL TREATMENT|1960-03-09|1966-09-10|||||1965-08-25||1972-10-25|Y|1965-05-27
TRIAL STUDY 134XCP|LB|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|2||||PRABC|CALCULATED PANEL REACTIVE ANTIBODY|||||||UG/KG/DAY|||||||BORDERLINE||MIN/DAY||||NORMAL|NOT DONE||||SERUM OR PLASMA|UNEXPECTED ODOR|N|EPSILOMETER|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|Y|N|||NA|3||39||TREATMENT|1971-02-09|1963-06-16|||||1961-05-18||1966-09-13|Y|1972-05-20
TRIAL STUDY 134XCP|LB|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|1||||HRYCECE|HAIRY CELLS/TOTAL CELLS|||||||UMOL|||||||TRACE||MOSM/L||||HIGH|NOT DONE||||PLATELET POOR PLASMA|UNEXPECTED ODOR|NA|CONFOCAL MICROSCOPY|FIBROSIS 4 FORMULA||N|Y|Y|Y|||N|4||88||WASHOUT|1960-02-22|1971-05-03|||||1968-05-26||1969-09-03|U|1966-07-11
TRIAL STUDY 134XCP|LB|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|2||||C130084|ENGLISH PLANTAIN POLLEN IGE|||||||GPS U|||||||BORDERLINE||ML/CAGE||||NORMAL|NOT DONE||||COLOSTRUM|SOLIDIFIED|U|LASER CAPTURE MICRODISSECTION|MDRD 6 VARIABLE FORMULA||U|U|U|N|||U|4||88||OBSERVATION|1968-09-12|1970-08-28|||||1960-04-12||1968-10-23|Y|1972-12-04
TRIAL STUDY 134XCP|LB|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|1||||VEGFR3S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC3|||||||ML/S/M2|||||||TRACE||U/G||||HIGH|NOT DONE||||SERUM|ROOM TEMPERATURE|U|EPSILOMETER|CKD-EPI FORMULA||N|U|Y|Y|||N|5||7||BASELINE|1966-07-31|1962-09-07|||||1965-08-04||1963-04-18|NA|1968-05-03
TRIAL STUDY 134XCP|LB|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|2||||CHDWR|RET CORPUSCULAR HGB CONC DISTR WIDTH|||||||CG|||||||POSITIVE||TUBERCULIN UNIT||||NORMAL|NOT DONE||||TUMOR TISSUE|AUTOLYZED|U|CONTRAST ENHANCED PET SCAN|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|N|||Y|5||7||SCREENING|1972-03-13|1973-03-01|||||1960-12-13||1968-02-02|N|1960-06-21
TRIAL STUDY 134XCP|LB|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|1||||GRANLE|GRANULOCYTES/LEUKOCYTES|||||||LOG10 TCID 50/ML|||||||TRACE||EIA UNIT||||LOW|NOT DONE||||SEMINAL FLUID|CONTAMINATED|U|WEBER GREEN STAIN|FIBROTEST FORMULA||U|N|NA|N|||NA|1||38||TREATMENT|1962-12-04|1969-06-10|||||1965-07-27||1966-05-09|U|1970-12-25
TRIAL STUDY 134XCP|LB|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|2||||ACANTRBC|ACANTHOCYTES/ERYTHROCYTES|||||||10^9 ORGANISMS|||||||POSITIVE||POINT||||HIGH|NOT DONE||||STOOL|CALCIFIED|U|TWO-COLOR MICROARRAY|MDRD ENZYMATIC JAPANESE FORMULA||N|N|NA|NA|||U|1||38||INDUCTION TREATMENT|1971-07-05|1968-07-02|||||1968-01-08||1964-07-15|N|1973-03-19
TRIAL STUDY 134XCP|LB|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|1||||CRP|C REACTIVE PROTEIN|||||||BQ/G|||||||INVALID||UM/S||||ABNORMAL|NOT DONE||||SEMEN|REFRIGERATED|NA|THERMAL IONIZATION MASS SPECTROMETRY|ASH FIBROSURE FORMULA||N|NA|N|NA|||NA|2||58||WASHOUT|1971-08-19|1967-04-24|||||1965-11-11||1968-11-19|N|1965-06-13
TRIAL STUDY 134XCP|LB|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|2||||PLTMORPH|PLATELET MORPHOLOGY|||||||BP|||||||INVALID||MG/M2/H||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED|N|MUGA|FIBROSIS 4 FORMULA||Y|Y|U|U|||U|2||58||LONG-TERM FOLLOW-UP|1967-04-25|1968-01-08|||||1964-08-06||1962-06-06|N|1962-08-17
TRIAL STUDY 134XCP|LB|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|1||||CAPHOSPD|CALCIUM - PHOSPHORUS PRODUCT|||||||DPM/0.5 ML|||||||INVALID||PFU/ANIMAL||||HIGH|NOT DONE||||CAPILLARY PLASMA|FROZEN|NA|DISK DIFFUSION|FIBROTEST FORMULA||U|Y|N|Y|||U|3||39||OPEN LABEL TREATMENT|1966-11-16|1967-11-09|||||1971-11-14||1966-04-17|N|1971-03-04
TRIAL STUDY 134XCP|LB|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|2||||BGTCPHRL|BETA+GAMMA TOCOPHEROL|||||||KG/CM2|||||||TRACE||G/G/DAY||||NORMAL|NOT DONE||||CALCULUS|AGGLUTINATED|Y|SPECT SCAN|ASH FIBROSURE FORMULA||U|Y|Y|U|||NA|3||39||BLINDED TREATMENT|1972-06-11|1963-08-31|||||1961-04-09||1970-07-12|U|1961-12-25
TRIAL STUDY 134XCP|LB|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|1||||C1QAB|COMPLEMENT C1Q ANTIBODY|||||||MET*MIN|||||||INVALID||HEP||||LOW|NOT DONE||||BLOOD|ICTERIC|U|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|Y|Y|||U|4||88||TREATMENT|1964-10-07|1968-01-29|||||1970-03-28||1973-04-20|N|1966-10-07
TRIAL STUDY 134XCP|LB|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|2||||MYCEPIDX|MYELOID PROLIFERATION INDEX|||||||H*%|||||||TRACE||U/G/H||||ABNORMAL|NOT DONE||||SEBUM|UNEXPECTED ODOR|NA|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI FORMULA||N|N|N|Y|||Y|4||88||OPEN LABEL TREATMENT|1968-01-25|1972-02-04|||||1962-10-04||1961-08-10|NA|1973-03-12
TRIAL STUDY 134XCP|LB|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|1||||TGFB2|TRANSFORMING GROWTH FACTOR BETA 2|||||||MMOL/DAY|||||||INVALID||IU/DL||||NORMAL|NOT DONE||||BLOOD|CALCIFIED|U|CARDIAC THERMODILUTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|N|||U|5||7||CONTINUATION TREATMENT|1968-11-05|1960-01-04|||||1969-01-11||1970-11-12|NA|1966-02-07
TRIAL STUDY 134XCP|LB|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|2||||IDL|IDL CHOLESTEROL|||||||LOG10 ELISA UNIT/DOSE|||||||BORDERLINE||10^6 ORGANISMS/G||||NORMAL|NOT DONE||||URINE SEDIMENT|THAWED|U|HIGH RESOLUTION MELT ANALYSIS|MDRD 4 VARIABLE FORMULA||N|N|Y|U|||Y|5||7||WASHOUT|1960-01-22|1969-09-08|||||1965-06-28||1961-11-06|N|1962-09-25
TRIAL STUDY 134XCP|LB|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|1||||HYPSEGCE|HYPERSEGMENTED CELLS|||||||NMOL/L/MIN|||||||INVALID||NKAT||||HIGH|NOT DONE||||ERYTHROCYTES|UNEXPECTED ODOR|U|CELLULOSE TAPE|NASH FIBROSURE FORMULA||U|Y|Y|Y|||Y|1||38||BLINDED TREATMENT|1962-06-09|1968-10-15|||||1969-09-29||1965-08-31|NA|1966-11-05
TRIAL STUDY 134XCP|LB|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|2||||PDW|PLATELET DISTRIBUTION WIDTH|||||||UG/KG/H|||||||POSITIVE||UEQ/L||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|CLOTTED|N|WEBER GREEN STAIN|GMI % FORMULA||N|Y|N|NA|||Y|1||38||SCREENING|1961-11-08|1961-01-18|||||1962-09-20||1967-07-29|N|1966-12-27
TRIAL STUDY 134XCP|LB|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|1||||PTSAAC|PROTEIN S ACTIVITY ACTUAL/CONTROL|||||||NG/MOL|||||||INVALID||ML*CMH2O||||LOW|NOT DONE||||EMESIS|SOLIDIFIED|N|EEG|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|NA|N|||N|2||58||BLINDED TREATMENT|1964-03-11|1964-11-03|||||1963-09-30||1972-06-16|NA|1970-01-05
TRIAL STUDY 134XCP|LB|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|2||||PGF2A|PROSTAGLANDIN F2 ALPHA|||||||RING|||||||BORDERLINE||UG/G/MIN||||NORMAL|NOT DONE||||BONE|ROOM TEMPERATURE|NA|RADIOGRAPHY|ASH FIBROSURE FORMULA||N|U|NA|Y|||Y|2||58||OPEN LABEL TREATMENT|1967-06-03|1969-02-11|||||1971-01-01||1966-10-19|NA|1968-12-18
TRIAL STUDY 134XCP|LB|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|1||||GUSA|GLUCURONIDASE, ALPHA|||||||CMOL/L|||||||NEGATIVE||LOZENGE||||LOW|NOT DONE||||SYNOVIAL FLUID|AUTOLYZED|Y|COULOMETRIC TITRATION|FIBROTEST FORMULA||NA|N|Y|Y|||N|3||39||OPEN LABEL TREATMENT|1972-06-17|1970-05-18|||||1969-04-08||1967-09-24|N|1965-03-06
TRIAL STUDY 134XCP|LB|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|2||||RDW|ERYTHROCYTES DISTRIBUTION WIDTH|||||||FFU|||||||BORDERLINE||SBE/ML||||NORMAL|NOT DONE||||MUCUS|ICTERIC|N|CONTRAST ENHANCED PET/CT SCAN|MDRD 4 VARIABLE FORMULA||U|N|NA|Y|||Y|3||39||WASHOUT|1966-02-06|1973-06-27|||||1969-11-29||1965-02-05|Y|1960-07-31
TRIAL STUDY 134XCP|LB|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|1||||CLRZPT|CLORAZEPATE|||||||RFU|||||||TRACE||FEU||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|FROZEN|N|MS/MS|MDRD 4 VARIABLE FORMULA||Y|N|Y|NA|||Y|4||88||RUN-IN|1967-12-25|1972-02-08|||||1970-05-23||1963-06-14|Y|1967-02-28
TRIAL STUDY 134XCP|LB|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|2||||LDH5LDH|LDH ISOENZYME 5/LDH|||||||KG/MOL|||||||INVALID||CD/M2||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|REFRIGERATED|U|CONTRAST ENHANCED X-RAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|U|NA|||U|4||88||TREATMENT|1971-08-09|1973-08-21|||||1966-03-18||1966-02-06|NA|1963-02-27
TRIAL STUDY 134XCP|LB|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|1||||BLEEDT|BLEEDING TIME|||||||/MM2|||||||INDETERMINATE||IU/MG||||NORMAL|NOT DONE||||ERYTHROCYTES|UNEXPECTED ODOR|NA|NEXT GENERATION TARGETED SEQUENCING|HEPASCORE FORMULA||Y|NA|NA|Y|||U|5||7||CONTINUATION TREATMENT|1968-09-19|1963-06-03|||||1963-04-14||1968-06-21|Y|1972-06-03
TRIAL STUDY 134XCP|LB|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|2||||ANA|ANTINUCLEAR ANTIBODIES|||||||WEBER|||||||POSITIVE||UEQ||||HIGH|NOT DONE||||CAPILLARY PLASMA|AGGLUTINATED|Y|PHOTOMETRIC CLOT DETECTION|GMI MMOL/MOL FORMULA||N|Y|N|Y|||N|5||7||OPEN LABEL TREATMENT|1964-12-14|1973-01-16|||||1968-12-10||1972-03-02|N|1966-04-14
TRIAL STUDY 134XCP|LB|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|1||||ANP|ATRIAL NATRIURETIC PEPTIDE|||||||GBQ/UG|||||||NEGATIVE||PPM||||LOW|NOT DONE||||SERUM OR PLASMA|REFRIGERATED|U|LC/MS/MS|COCKCROFT-GAULT FORMULA||N|NA|Y|NA|||Y|1||38||INDUCTION TREATMENT|1973-04-07|1969-01-20|||||1966-09-08||1964-10-07|N|1967-12-08
TRIAL STUDY 134XCP|LB|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|2||||PLATAGRN|PLATELETS, AGRANULAR|||||||10^3 DNA COPIES/ML|||||||NEGATIVE||UG||||HIGH|NOT DONE||||CAPILLARY BLOOD|GELLED|NA|MYELOPEROXIDASE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|U|U|||Y|1||38||OPEN LABEL TREATMENT|1964-07-04|1972-03-25|||||1961-01-04||1969-11-04|U|1964-12-20
TRIAL STUDY 134XCP|LB|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|1||||ALPIALP|ALK PHOS, INTESTINAL/TOTAL ALK PHOS|||||||KG/MOL|||||||INDETERMINATE||MPH||||LOW|NOT DONE||||PERITONEAL FLUID|AUTOLYZED|Y|AUTOMATED COUNT|MDRD ENZYMATIC FORMULA||Y|U|Y|U|||N|2||58||FOLLOW-UP|1961-04-25|1960-03-28|||||1961-01-07||1972-08-15|U|1962-01-08
TRIAL STUDY 134XCP|LB|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|2||||ACETONE|ACETONE|||||||UG/M2|||||||POSITIVE||MIN*MG/ML||||ABNORMAL|NOT DONE||||BONE MARROW|DRIED|NA|SLOAN LETTER EYE CHART 100%|ASH FIBROSURE FORMULA||NA|U|U|N|||N|2||58||LONG-TERM FOLLOW-UP|1968-11-08|1962-01-10|||||1960-06-04||1961-07-22|N|1969-12-06
TRIAL STUDY 134XCP|LB|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|1||||CSRBC|RBC CASTS|||||||JAR|||||||NEGATIVE||MV||||HIGH|NOT DONE||||LEUKOCYTE|LIPEMIC|N|IMMUNOPRECIPITATION|CKD-EPI CYSTATIN C FORMULA||U|NA|N|N|||U|3||39||FOLLOW-UP|1971-09-15|1964-03-08|||||1965-07-26||1964-12-29|N|1961-07-15
TRIAL STUDY 134XCP|LB|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|2||||C130091|TIMOTHY GRASS POLLEN IGG4|||||||CMOL|||||||INVALID||KPA/L/SEC||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|PARAFFIN-EMBEDDED|NA|MICROSCOPY|FIBROTEST FORMULA||Y|N|NA|U|||N|3||39||SCREENING|1973-06-30|1960-01-29|||||1966-08-16||1968-10-22|N|1963-06-26
TRIAL STUDY 134XCP|LB|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|1||||GHRELINA|ACTIVE GHRELIN|||||||NMOL/G|||||||INVALID||IN||||ABNORMAL|NOT DONE||||KERATINOCYTE|CLOTTED|NA|CINEANGIOGRAPHY|GMI % FORMULA||NA|N|NA|U|||NA|4||88||WASHOUT|1966-06-24|1972-05-29|||||1965-05-27||1971-12-02|NA|1969-07-31
TRIAL STUDY 134XCP|LB|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|2||||GHB|GAMMA-HYDROXYBUTYRATE|||||||FT|||||||BORDERLINE||RATIO||||NORMAL|NOT DONE||||DISCHARGE|LACTESCENT|NA|TELLER ACUITY CARDS|FIBROTEST FORMULA||U|NA|N|Y|||NA|4||88||WASHOUT|1963-08-28|1960-11-23|||||1963-12-31||1962-04-16|U|1961-03-20
TRIAL STUDY 134XCP|LB|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|1||||HYDCDN|HYDROCODONE|||||||NMOL/L/H|||||||INVALID||COULOMB||||NORMAL|NOT DONE||||ABSCESS FLUID|LACTESCENT|N|HEMAGGLUTINATION ASSAY|FIBROTEST FORMULA||N|N|Y|N|||Y|5||7||WASHOUT|1969-08-06|1968-09-24|||||1962-08-09||1971-02-19|NA|1962-02-25
TRIAL STUDY 134XCP|LB|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|2||||INTLK24|INTERLEUKIN 24|||||||MIN*MG/ML|||||||INDETERMINATE||ML/MIN/MMHG||||NORMAL|NOT DONE||||EXUDATE|GELLED|NA|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 4 VARIABLE FORMULA||N|Y|N|N|||N|5||7||RUN-IN|1961-07-11|1960-12-24|||||1970-01-09||1969-03-23|N|1968-04-21
TRIAL STUDY 134XCP|LB|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|1||||ETPAUC|ETP AREA UNDER CURVE|||||||PMOL/L/H|||||||INVALID||PFU/ANIMAL||||HIGH|NOT DONE||||PLATELET RICH PLASMA|FROZEN|NA|MODIFIED ACID FAST STAIN|NASH FIBROSURE FORMULA||U|U|U|NA|||U|1||38||SCREENING|1972-11-30|1965-09-18|||||1963-03-23||1969-09-27|NA|1960-02-28
TRIAL STUDY 134XCP|LB|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|2||||OXYCDN|OXYCODONE|||||||UG/L FEU|||||||INVALID||SACHET||||LOW|NOT DONE||||SPUTUM|CONCENTRATED|N|PHASE-CONTRAST MRI|FIBROTEST FORMULA||NA|NA|N|N|||N|1||38||OBSERVATION|1963-12-10|1971-06-20|||||1962-07-08||1963-12-28|NA|1965-07-31
TRIAL STUDY 134XCP|LB|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|1||||CRYGLBSR|CRYOGLOBULIN VOLUME/SERUM VOLUME|||||||ML/DL|||||||TRACE||PFU/DOSE||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|DRIED|N|KINETIC CHROMOGENIC ASSAY|MDRD 5 VARIABLE FORMULA||N|Y|Y|U|||U|2||58||TREATMENT|1964-02-06|1972-07-20|||||1967-10-25||1968-04-02|NA|1963-07-22
TRIAL STUDY 134XCP|LB|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|2||||VLDLTCT|VLDL TRIGLYCERIDE + CHYLOMICRON TRIGLYCERIDE|||||||LOG10 CFU/ML|||||||POSITIVE||IU/G HB||||LOW|NOT DONE||||STOOL|FROZEN|NA|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|HEPASCORE FORMULA||U|U|NA|Y|||N|2||58||WASHOUT|1972-03-23|1964-11-14|||||1962-04-30||1968-09-01|NA|1972-06-27
TRIAL STUDY 134XCP|LB|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|1||||PLATAGRN|PLATELETS, AGRANULAR|||||||PELLET|||||||NEGATIVE||MU/G||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|CALCIFIED|U|LANDOLT RING|GMI MMOL/MOL FORMULA||Y|Y|Y|U|||U|3||39||WASHOUT|1970-10-04|1968-11-12|||||1969-09-25||1970-10-16|NA|1972-12-29
TRIAL STUDY 134XCP|LB|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|2||||MPO|MYELOPEROXIDASE|||||||ML/CAGE/WK|||||||INVALID||NCI||||HIGH|NOT DONE||||PLASMA ULTRAFILTRATE|LACTESCENT|NA|CONTACT SPECULAR MICROSCOPY|MDRD FORMULA||U|NA|U|U|||U|3||39||FOLLOW-UP|1969-11-10|1968-06-02|||||1962-11-06||1963-02-13|NA|1960-07-22
TRIAL STUDY 134XCP|LB|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|1||||CSGRAN|GRANULAR CASTS|||||||/MM2|||||||POSITIVE||CP||||ABNORMAL|NOT DONE||||SKIN TISSUE|FROZEN|Y|THIN SMEAR|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|Y|Y|||NA|4||88||WASHOUT|1965-07-26|1960-05-23|||||1963-05-22||1964-04-20|U|1965-04-09
TRIAL STUDY 134XCP|LB|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|2||||ADH|ANTIDIURETIC HORMONE|||||||SQU/ML|||||||POSITIVE||ML/DL||||HIGH|NOT DONE||||EXUDATE|LIPEMIC|NA|QUANTITATIVE ULTRASOUND|FIBROMETER FORMULA||U|N|U|N|||N|4||88||TREATMENT|1971-07-13|1962-03-11|||||1968-07-02||1962-03-30|U|1972-04-20
TRIAL STUDY 134XCP|LB|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|1||||LACTULOS|LACTULOSE|||||||FRACTION OF 1|||||||INVALID||ML/CM H2O||||NORMAL|NOT DONE||||BASAL TEAR|SOLIDIFIED|Y|DIFFUSION WEIGHTED MRI|GMI % FORMULA||N|NA|N|Y|||NA|5||7||INDUCTION TREATMENT|1969-03-06|1967-03-05|||||1964-05-14||1970-11-10|Y|1962-12-14
TRIAL STUDY 134XCP|LB|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|2||||CA15_3AG|CANCER ANTIGEN 15-3|||||||BEL|||||||INVALID||FOZ_US||||LOW|NOT DONE||||LYSATE|THAWED|NA|CLINICAL EVALUATION|MDRD 4 VARIABLE FORMULA||N|N|U|Y|||U|5||7||TREATMENT|1968-12-13|1965-08-11|||||1960-05-31||1963-02-06|N|1966-12-24
TRIAL STUDY 134XCP|LB|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|1||||ACH|ACETYLCHOLINE|||||||NMOL BCE/MMOL|||||||TRACE||IU/DL||||NORMAL|NOT DONE||||MECONIUM|CONTAMINATED|N|TELLER ACUITY CARDS|NASH FIBROSURE FORMULA||NA|U|NA|NA|||U|1||38||FOLLOW-UP|1964-08-29|1965-11-24|||||1960-01-15||1972-09-02|U|1960-12-21
TRIAL STUDY 134XCP|LB|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|2||||HDLCLDLC|HDL CHOLESTEROL/LDL CHOLESTEROL|||||||UV|||||||POSITIVE||MG/KG/WEEK||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|GELLED|N|EPSILOMETER|MDRD FORMULA||NA|U|N|N|||Y|1||38||OPEN LABEL TREATMENT|1961-04-19|1966-07-24|||||1960-11-02||1966-02-23|U|1964-07-08
TRIAL STUDY 134XCP|LB|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|1||||AMORPHSD|AMORPHOUS SEDIMENT|||||||CAPLET|||||||POSITIVE||G/CM2||||NORMAL|NOT DONE||||TUMOR TISSUE|CLOTTED|N|FLUOROSCOPY|CKD-EPI CREATININE FORMULA||Y|N|Y|Y|||U|2||58||BLINDED TREATMENT|1969-10-28|1967-07-10|||||1969-09-24||1960-04-06|Y|1962-12-03
TRIAL STUDY 134XCP|LB|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|2||||LAM|LIPOARABINOMANNAN|||||||SQU/ML|||||||BORDERLINE||IU/ML||||LOW|NOT DONE||||MONOCYTE|CONTAMINATED|Y|ELISA|COCKCROFT-GAULT FORMULA||Y|Y|Y|Y|||N|2||58||BASELINE|1962-03-08|1973-08-23|||||1967-09-21||1967-09-20|N|1971-10-19
TRIAL STUDY 134XCP|LB|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|1||||PGF1A|PROSTAGLANDIN F1 ALPHA|||||||CM2|||||||BORDERLINE||KAT||||NORMAL|NOT DONE||||PLEURAL TISSUE|FRESH|N|COMPUTERIZED CORNEAL TOPOGRAPHY|ASH FIBROSURE FORMULA||U|U|Y|Y|||U|3||39||OPEN LABEL TREATMENT|1968-12-30|1960-10-26|||||1972-08-05||1962-04-01|N|1969-09-04
TRIAL STUDY 134XCP|LB|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|2||||CRTCREAT|CORTICOSTERONE/CREATININE|||||||ML/DAY|||||||POSITIVE||NKAT/G HB||||HIGH|NOT DONE||||CORD SERUM|THAWED|NA|FUNCTIONAL MRI|MDRD 6 VARIABLE FORMULA||NA|N|N|N|||U|3||39||WASHOUT|1964-09-10|1963-06-21|||||1969-09-18||1966-01-20|Y|1966-09-16
TRIAL STUDY 134XCP|LB|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|1||||CAFFEINE|CAFFEINE|||||||FARAD|||||||NEGATIVE||RPM||||ABNORMAL|NOT DONE||||URINE|REFRIGERATED|N|FLOW MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|Y|NA|||U|4||88||OBSERVATION|1969-06-08|1969-04-14|||||1960-09-10||1960-06-23|Y|1963-06-23
TRIAL STUDY 134XCP|LB|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|2||||G6PD|GLUCOSE-6-PHOSPHATE DEHYDROGENASE|||||||IU|||||||BORDERLINE||MS/MMHG||||LOW|NOT DONE||||SPERMATOZOON|CONTAMINATED|N|APPLANATION TONOMETRY|HEPASCORE FORMULA||Y|N|NA|U|||NA|4||88||FOLLOW-UP|1973-08-25|1965-10-28|||||1967-03-08||1972-05-20|U|1969-01-07
TRIAL STUDY 134XCP|LB|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|1||||ENAAB|EXTRACTABLE NUCLEAR ANTIGEN ANTIBODY|||||||%(V/V)|||||||INDETERMINATE||ML/M2||||LOW|NOT DONE||||VITREOUS HUMOR|NON-HEMOLYZED|U|CELLULOSE TAPE|MDRD 5 VARIABLE FORMULA||NA|NA|N|NA|||N|5||7||BASELINE|1964-12-30|1973-07-22|||||1970-08-08||1962-09-12|N|1968-04-12
TRIAL STUDY 134XCP|LB|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|2||||HGFR|HEPATOCYTE GROWTH FACTOR RECEPTOR|||||||ML/H|||||||POSITIVE||MJOULE/CM2||||LOW|NOT DONE||||ABSCESS FLUID|AGGLUTINATED|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|U|NA|U|||NA|5||7||OBSERVATION|1967-10-23|1963-03-02|||||1960-06-28||1970-09-26|NA|1963-02-07
TRIAL STUDY 134XCP|LB|687E56D1-7E45-4598-819A-A0D8D770F406|1||||POLYCHR|POLYCHROMASIA|||||||G/CAGE/WK|||||||INDETERMINATE||KPA||||LOW|NOT DONE||||LOCHIA|ROOM TEMPERATURE|Y|CONTRAST ENHANCED SPIRAL CT SCAN|COCKCROFT-GAULT FORMULA||Y|U|N|N|||NA|1||38||INDUCTION TREATMENT|1969-05-06|1973-07-21|||||1967-07-13||1969-12-28|NA|1964-06-05
TRIAL STUDY 134XCP|LB|687E56D1-7E45-4598-819A-A0D8D770F406|2||||ANPPROMR|MID-REG PRO-ATRIAL NATRIURETIC PEPTIDE|||||||M2|||||||INVALID||WEBER||||ABNORMAL|NOT DONE||||BLOOD|CLOTTED|NA|CELLULOSE TAPE|GMI MMOL/MOL FORMULA||U|NA|N|NA|||Y|1||38||INDUCTION TREATMENT|1973-08-01|1963-05-04|||||1963-12-09||1972-06-01|U|1967-07-16
TRIAL STUDY 134XCP|LB|687E56D1-7E45-4598-819A-A0D8D770F406|1||||FACTIX|FACTOR IX|||||||KS|||||||POSITIVE||MOL/L||||ABNORMAL|NOT DONE||||COLOSTRUM|LACTESCENT|NA|MYELOPEROXIDASE STAIN|FIBROTEST FORMULA||Y|U|N|U|||Y|2||58||BLINDED TREATMENT|1966-02-02|1966-03-22|||||1960-06-15||1972-04-12|NA|1963-04-03
TRIAL STUDY 134XCP|LB|687E56D1-7E45-4598-819A-A0D8D770F406|2||||CHDW|CORPUSCULAR HGB CONC DISTRIBUTION WIDTH|||||||MS/MMHG|||||||INDETERMINATE||ML/MIN/MMHG||||HIGH|NOT DONE||||GASTRIC FLUID|GELLED|U|SICKLE CELL SOLUBILITY TEST|COCKCROFT-GAULT FORMULA||Y|Y|Y|U|||N|2||58||INDUCTION TREATMENT|1967-09-08|1973-05-17|||||1970-10-08||1966-12-10|NA|1972-03-26
TRIAL STUDY 134XCP|LB|687E56D1-7E45-4598-819A-A0D8D770F406|1||||B2G1GGAB|BETA-2 GLYCOPROTEIN 1 IGG ANTIBODY|||||||UG/ML/H|||||||POSITIVE||10^6 U||||LOW|NOT DONE||||CERUMEN|UNEXPECTED ODOR|U|CALCOFLUOR WHITE STAIN|ASH FIBROSURE FORMULA||NA|N|Y|NA|||NA|3||39||INDUCTION TREATMENT|1962-12-28|1970-01-11|||||1971-10-31||1962-03-06|NA|1970-04-15
TRIAL STUDY 134XCP|LB|687E56D1-7E45-4598-819A-A0D8D770F406|2||||CCL18|CHEMOKINE (C-C MOTIF) LIGAND 18|||||||MEQ/L|||||||POSITIVE||AG||||HIGH|NOT DONE||||VENOUS PLASMA|ICTERIC|N|PALM METHOD|GMI % FORMULA||Y|NA|NA|Y|||NA|3||39||TREATMENT|1973-04-18|1960-04-17|||||1965-12-10||1963-10-01|U|1962-12-21
TRIAL STUDY 134XCP|LB|687E56D1-7E45-4598-819A-A0D8D770F406|1||||AFP|ALPHA FETOPROTEIN|||||||BP|||||||INVALID||ABSORBANCE U||||HIGH|NOT DONE||||SEBUM|LACTESCENT|U|NUCLEAR RADIOLOGY|HEPASCORE FORMULA||Y|NA|NA|NA|||NA|4||88||OBSERVATION|1972-02-25|1970-06-16|||||1969-03-23||1965-05-20|Y|1970-02-19
TRIAL STUDY 134XCP|LB|687E56D1-7E45-4598-819A-A0D8D770F406|2||||CRDIGGAB|CARDIOLIPIN IGG ANTIBODY|||||||G/ANIMAL/DAY|||||||TRACE||G/DAY||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|GELLED|Y|IVY INCISION METHOD|NASH FIBROSURE FORMULA||U|U|NA|N|||Y|4||88||BLINDED TREATMENT|1965-08-14|1969-03-17|||||1969-01-25||1965-05-07|U|1970-01-05
TRIAL STUDY 134XCP|LB|687E56D1-7E45-4598-819A-A0D8D770F406|1||||KETONES|KETONES|||||||KIT|||||||NEGATIVE||10^6/L||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|AGGLUTINATED|N|CLAUSS METHOD|MDRD 5 VARIABLE FORMULA||Y|NA|Y|N|||NA|5||7||WASHOUT|1962-03-03|1966-07-10|||||1964-04-23||1965-03-10|Y|1970-01-09
TRIAL STUDY 134XCP|LB|687E56D1-7E45-4598-819A-A0D8D770F406|2||||LYMVACLE|VACUOLATED LYMPHOCYTES/LEUKOCYTES|||||||MG/ML/MIN|||||||POSITIVE||10^6 DNA COPIES/ML||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|HEMOLYZED|NA|PET/CT SCAN|GMI % FORMULA||N|Y|NA|Y|||N|5||7||OBSERVATION|1962-05-21|1960-09-17|||||1973-04-07||1965-08-27|U|1969-12-04
TRIAL STUDY 134XCP|LB|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|1||||APPT|TOTAL AMYLOID PRECURSOR PROTEIN|||||||UG/KG/DAY|||||||POSITIVE||CYLINDER||||NORMAL|NOT DONE||||PLEURAL TISSUE|LACTESCENT|U|MACRO BROTH DILUTION|CKD-EPI CYSTATIN C FORMULA||Y|NA|U|NA|||N|1||38||FOLLOW-UP|1964-03-25|1960-10-24|||||1970-03-16||1970-06-06|N|1965-01-02
TRIAL STUDY 134XCP|LB|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|2||||GLCHT|GLYCOLITHOCHOLATE|||||||PPB|||||||TRACE||TRANSDUCING UNIT||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|NA|COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI CYSTATIN C FORMULA||Y|N|N|N|||Y|1||38||WASHOUT|1965-01-07|1961-03-12|||||1962-08-05||1964-03-19|Y|1961-11-05
TRIAL STUDY 134XCP|LB|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|1||||CXCL1|CHEMOKINE (C-X-C MOTIF) LIGAND 1|||||||LOG10 CFU/ML|||||||INVALID||CM/S||||LOW|NOT DONE||||BUFFY COAT|LACTESCENT|Y|RYAN BLUE STAIN|MDRD 4 VARIABLE FORMULA||Y|U|N|Y|||N|2||58||INDUCTION TREATMENT|1965-05-14|1968-06-11|||||1969-10-23||1968-07-27|U|1970-03-21
TRIAL STUDY 134XCP|LB|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|2||||ELLIPCY|ELLIPTOCYTES|||||||G/U|||||||POSITIVE||OSM||||ABNORMAL|NOT DONE||||STOOL|CLOTTED|U|COULOMETRIC TITRATION|CKD-EPI CREATININE FORMULA||Y|Y|N|N|||N|2||58||FOLLOW-UP|1963-02-09|1960-11-20|||||1963-12-11||1966-10-30|Y|1962-10-31
TRIAL STUDY 134XCP|LB|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|1||||MCPHGCE|MACROPHAGES/TOTAL CELLS|||||||MOSM|||||||BORDERLINE||VIRTUAL PIXEL||||HIGH|NOT DONE||||SERUM OR PLASMA|FRESH|Y|AGAR PROPORTION|NASH FIBROSURE FORMULA||Y|N|NA|U|||Y|3||39||BASELINE|1964-01-03|1962-07-11|||||1970-05-12||1967-11-25|NA|1967-06-05
TRIAL STUDY 134XCP|LB|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|2||||HGBFHGB|HEMOGLOBIN F/TOTAL HEMOGLOBIN|||||||DNA COPIES/ML|||||||POSITIVE||CPM||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|NON-HEMOLYZED|NA|PET/CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|Y|U|||N|3||39||OBSERVATION|1972-02-07|1964-01-21|||||1960-01-20||1964-02-19|U|1967-02-09
TRIAL STUDY 134XCP|LB|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|1||||CKMMCK|CREATINE KINASE MM/TOTAL CREATINE KINASE|||||||PA|||||||TRACE||ML/M2/H||||LOW|NOT DONE||||PLATELET|NON-HEMOLYZED|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|Y|U|NA|||N|4||88||TREATMENT|1968-12-14|1968-06-24|||||1964-03-01||1961-03-23|U|1972-10-22
TRIAL STUDY 134XCP|LB|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|2||||DSG1AB|DESMOGLEIN 1 ANTIBODY|||||||ML/DOSE|||||||NEGATIVE||YEARS||||HIGH|NOT DONE||||BUFFY COAT|UNEXPECTED ODOR|NA|CELLULAR PROLIFERATION ASSAY|MDRD 5 VARIABLE FORMULA||N|N|U|Y|||Y|4||88||BLINDED TREATMENT|1971-03-11|1966-02-21|||||1965-04-03||1961-02-13|U|1969-03-26
TRIAL STUDY 134XCP|LB|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|1||||C130108|WEED MIX POLLEN ANTIGEN IGA ANTIBODY|||||||ABSORBANCE U/ML|||||||TRACE||NSEC||||HIGH|NOT DONE||||BLOOD|CALCIFIED|N|CAPILLARY ELECTROPHORESIS|GMI % FORMULA||NA|N|U|U|||NA|5||7||RUN-IN|1970-11-18|1971-01-04|||||1971-06-16||1972-11-23|NA|1972-07-07
TRIAL STUDY 134XCP|LB|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|2||||GEC|GALACTOSE ELIMINATION CAPACITY|||||||STEPS|||||||TRACE||MOL/G||||ABNORMAL|NOT DONE||||SPERMATOZOON|DRIED|NA|PET/MRI SCAN|FIBROSIS 4 FORMULA||Y|N|NA|N|||NA|5||7||RUN-IN|1969-12-19|1972-04-11|||||1963-01-26||1964-05-02|U|1971-03-28
TRIAL STUDY 134XCP|LB|F536FDD9-881B-41AD-B863-FE8AB14062A1|1||||RETICH|RET. CORPUSCULAR HEMOGLOBIN CONTENT|||||||INHALATION|||||||BORDERLINE||IU/KG/H||||LOW|NOT DONE||||AMNIOTIC FLUID|FROZEN|U|IN SITU HYBRIDIZATION|NASH FIBROSURE FORMULA||N|Y|NA|N|||U|1||38||BASELINE|1972-08-15|1971-08-06|||||1970-09-14||1970-06-25|U|1971-05-09
TRIAL STUDY 134XCP|LB|F536FDD9-881B-41AD-B863-FE8AB14062A1|2||||EOTAXIN1|EOTAXIN-1|||||||CMH2O*S2/ML|||||||TRACE||TAMPON||||LOW|NOT DONE||||WHITE MATTER TISSUE|LIPEMIC|NA|OLIGO ACGH|HEPASCORE FORMULA||U|NA|NA|U|||N|1||38||LONG-TERM FOLLOW-UP|1967-10-23|1960-10-23|||||1972-02-15||1965-09-13|NA|1962-01-02
TRIAL STUDY 134XCP|LB|F536FDD9-881B-41AD-B863-FE8AB14062A1|1||||SPERMMTL|SPERM MOTILITY|||||||/MM|||||||TRACE||MG/M2/DAY||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|CLOTTED|U|LIQUID SCINTILLATION COUNTING|MDRD FORMULA||N|U|U|U|||NA|2||58||RUN-IN|1967-10-17|1972-01-23|||||1966-03-30||1968-07-08|NA|1964-04-21
TRIAL STUDY 134XCP|LB|F536FDD9-881B-41AD-B863-FE8AB14062A1|2||||CXCL1|CHEMOKINE (C-X-C MOTIF) LIGAND 1|||||||ML/M2|||||||INDETERMINATE||MEQ/L||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED|U|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|HEPASCORE FORMULA||NA|Y|N|Y|||NA|2||58||OBSERVATION|1963-09-02|1964-11-10|||||1964-07-06||1962-06-04|U|1968-05-19
TRIAL STUDY 134XCP|LB|F536FDD9-881B-41AD-B863-FE8AB14062A1|1||||LEPTIN|LEPTIN|||||||CL|||||||INVALID||%(W/V)||||ABNORMAL|NOT DONE||||PERSPIRATION|THAWED|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|MDRD 6 VARIABLE FORMULA||U|U|N|Y|||Y|3||39||INDUCTION TREATMENT|1960-06-24|1971-03-14|||||1961-06-14||1967-09-12|Y|1964-07-12
TRIAL STUDY 134XCP|LB|F536FDD9-881B-41AD-B863-FE8AB14062A1|2||||NEUTSGBP|NEUTROPHILS, SEG + BAND FORM + PRECURSOR|||||||PA|||||||POSITIVE||LOG10 ELISA UNIT/DOSE||||ABNORMAL|NOT DONE||||SPERMATOZOON|PARAFFIN-EMBEDDED|U|ULTRASOUND|FIBROMETER FORMULA||U|N|NA|Y|||N|3||39||CONTINUATION TREATMENT|1960-02-15|1967-04-16|||||1968-04-16||1973-08-06|NA|1966-02-04
TRIAL STUDY 134XCP|LB|F536FDD9-881B-41AD-B863-FE8AB14062A1|1||||PROINSUL|PROINSULIN|||||||STRIP|||||||BORDERLINE||10^7 TCID 50/DOSE||||NORMAL|NOT DONE||||MUSCLE TISSUE|DRIED|NA|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|MDRD 6 VARIABLE FORMULA||NA|Y|N|NA|||Y|4||88||BLINDED TREATMENT|1970-09-22|1960-02-02|||||1972-03-13||1961-05-08|U|1968-06-12
TRIAL STUDY 134XCP|LB|F536FDD9-881B-41AD-B863-FE8AB14062A1|2||||APOB|APOLIPOPROTEIN B|||||||ECL UNIT|||||||BORDERLINE||PIXEL||||HIGH|NOT DONE||||ENDOMETRIAL TISSUE|THAWED|Y|MICROBIAL CULTURE, SOLID|MDRD 4 VARIABLE FORMULA||Y|NA|N|U|||N|4||88||OPEN LABEL TREATMENT|1967-05-29|1965-02-12|||||1963-09-28||1970-11-08|U|1963-11-18
TRIAL STUDY 134XCP|LB|F536FDD9-881B-41AD-B863-FE8AB14062A1|1||||EOSNSQE|EOSINOPHILS/NON-SQUAM EPI CELLS|||||||10^11/L|||||||POSITIVE||TRACE||||LOW|NOT DONE||||URINE SEDIMENT|FROZEN|N|SLOAN LETTER EYE CHART 2.5%|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|N|N|||NA|5||7||INDUCTION TREATMENT|1970-01-06|1969-07-13|||||1971-05-29||1965-11-13|Y|1973-04-16
TRIAL STUDY 134XCP|LB|F536FDD9-881B-41AD-B863-FE8AB14062A1|2||||CMPK2|CYTIDINE-URIDINE MONOPHOSPHATE KINASE 2|||||||ML/G/MIN|||||||NEGATIVE||HZ/S||||HIGH|NOT DONE||||LUNG SURFACTANT|CLOTTED|N|GC/MS-CI|FIBROTEST FORMULA||Y|N|NA|U|||Y|5||7||BASELINE|1972-10-14|1971-09-14|||||1963-08-24||1973-06-30|NA|1963-06-05
TRIAL STUDY 134XCP|LB|CB726766-A812-45B3-95CA-D1AD8F697FD3|1||||LDLOXI|OXIDIZED LDL CHOLESTEROL|||||||%(V/V)|||||||TRACE||NMOL/MOL||||NORMAL|NOT DONE||||VENOUS PLASMA|AGGLUTINATED|NA|URANYL ACETATE STAIN|HEPASCORE FORMULA||U|Y|N|NA|||Y|1||38||BASELINE|1967-05-18|1961-05-25|||||1970-11-23||1961-02-27|NA|1968-09-04
TRIAL STUDY 134XCP|LB|CB726766-A812-45B3-95CA-D1AD8F697FD3|2||||HCGNDI|CHORIOGONADOTROPIN, INTACT|||||||HOMEOPATHIC DILUTION|||||||TRACE||USP U||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONCENTRATED|N|MECHANICAL CLOT DETECTION|CKD-EPI CYSTATIN C FORMULA||Y|U|N|Y|||NA|1||38||INDUCTION TREATMENT|1966-01-01|1970-08-14|||||1964-12-07||1963-07-05|NA|1968-10-14
TRIAL STUDY 134XCP|LB|CB726766-A812-45B3-95CA-D1AD8F697FD3|1||||GMI|GLUCOSE MANAGEMENT INDICATOR|||||||LOG10 ELISA UNIT|||||||TRACE||/MM||||NORMAL|NOT DONE||||SEBUM|AGGLUTINATED|NA|IN VITRO GENE EXPRESSION ASSAY|ASH FIBROSURE FORMULA||NA|NA|Y|U|||U|2||58||FOLLOW-UP|1961-08-26|1963-10-14|||||1967-02-10||1966-02-03|N|1966-08-25
TRIAL STUDY 134XCP|LB|CB726766-A812-45B3-95CA-D1AD8F697FD3|2||||CXCL12|CHEMOKINE (C-X-C MOTIF) LIGAND 12|||||||NEBULE|||||||TRACE||PKAT/L||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|FRESH|Y|FUNCTIONAL MRI|MDRD 6 VARIABLE FORMULA||U|U|U|Y|||N|2||58||RUN-IN|1960-01-27|1963-08-07|||||1972-09-26||1972-02-14|NA|1972-10-02
TRIAL STUDY 134XCP|LB|CB726766-A812-45B3-95CA-D1AD8F697FD3|1||||FACTXII|FACTOR XII|||||||MM/SEC|||||||INDETERMINATE||JAR||||LOW|NOT DONE||||LUNG SURFACTANT|SOLIDIFIED|NA|POLYGRAPHY|MDRD 6 VARIABLE FORMULA||U|U|NA|NA|||N|3||39||OBSERVATION|1968-08-23|1972-11-16|||||1964-02-12||1968-10-05|N|1970-11-16
TRIAL STUDY 134XCP|LB|CB726766-A812-45B3-95CA-D1AD8F697FD3|2||||INTLK23|INTERLEUKIN 23|||||||MET*MIN|||||||POSITIVE||ROENTGEN||||NORMAL|NOT DONE||||AMNIOTIC FLUID|HEMOLYZED|Y|HANSEL STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|U|N|||U|3||39||BASELINE|1963-06-22|1969-11-02|||||1960-06-23||1968-12-08|N|1966-01-12
TRIAL STUDY 134XCP|LB|CB726766-A812-45B3-95CA-D1AD8F697FD3|1||||HLAIIPRA|HLA CLASS II PANEL REACTIVE ANTIBODY|||||||10^4 CFU/ML|||||||BORDERLINE||MIN||||LOW|NOT DONE||||DIALYSIS FLUID|AGGLUTINATED|Y|CALIPER MEASUREMENT METHOD|GMI % FORMULA||N|NA|N|U|||NA|4||88||BLINDED TREATMENT|1965-11-01|1961-05-23|||||1969-05-29||1960-09-28|Y|1964-05-31
TRIAL STUDY 134XCP|LB|CB726766-A812-45B3-95CA-D1AD8F697FD3|2||||IGA|IMMUNOGLOBULIN A|||||||UM/DAY|||||||INVALID||ANSON U||||NORMAL|NOT DONE||||ADIPOSE TISSUE|ROOM TEMPERATURE|NA|TRYPAN BLUE STAIN|FIBROTEST FORMULA||NA|U|Y|NA|||NA|4||88||TREATMENT|1966-06-08|1973-03-14|||||1971-04-07||1968-10-11|Y|1972-03-01
TRIAL STUDY 134XCP|LB|CB726766-A812-45B3-95CA-D1AD8F697FD3|1||||FOLHMRNA|FOLATE HYDROLASE MRNA|||||||L/DAY|||||||TRACE||NL||||NORMAL|NOT DONE||||AMNIOTIC FLUID|DRIED|Y|MRI|FIBROTEST FORMULA||N|U|U|N|||N|5||7||LONG-TERM FOLLOW-UP|1964-10-24|1961-12-23|||||1968-03-04||1962-10-15|U|1962-03-27
TRIAL STUDY 134XCP|LB|CB726766-A812-45B3-95CA-D1AD8F697FD3|2||||CYAMPURT|AMORPHOUS URATE CRYSTALS|||||||DEG/MM|||||||INVALID||MM3/MM2/YEAR||||LOW|NOT DONE||||CAPILLARY PLASMA|AGGLUTINATED|Y|ISHIHARA COLOR PLATES|NASH FIBROSURE FORMULA||NA|Y|NA|N|||Y|5||7||OPEN LABEL TREATMENT|1965-09-12|1969-03-04|||||1973-08-22||1968-10-27|NA|1963-10-07
TRIAL STUDY 134XCP|LB|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|1||||LYMMCELY|LYMPHOMA CELLS/LYMPHOCYTES|||||||MG2/DL2|||||||TRACE||MESF||||NORMAL|NOT DONE||||SWABBED MATERIAL|FROZEN|N|SEQUENCING|MDRD 4 VARIABLE FORMULA||U|N|Y|Y|||N|1||38||CONTINUATION TREATMENT|1973-06-18|1970-04-02|||||1960-01-18||1962-08-02|U|1965-02-05
TRIAL STUDY 134XCP|LB|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|2||||INTLK31|INTERLEUKIN 31|||||||10^6 CFU/ML|||||||INDETERMINATE||MEQ/DL||||LOW|NOT DONE||||LYMPH|LACTESCENT|N|GC/MS-EI|MDRD FORMULA||U|NA|N|N|||U|1||38||FOLLOW-UP|1962-04-17|1970-02-28|||||1964-07-02||1962-07-22|U|1965-06-17
TRIAL STUDY 134XCP|LB|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|1||||NKINA|NEUROKININ A|||||||UEQ|||||||TRACE||10^9 CFU/G||||LOW|NOT DONE||||KERATINOCYTE|AUTOLYZED|U|NO INFORMATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|Y|Y|||N|2||58||FOLLOW-UP|1972-06-04|1964-10-03|||||1967-09-16||1968-05-01|U|1969-09-27
TRIAL STUDY 134XCP|LB|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|2||||NEUTBLE|NEUTROPHILS BAND FORM/LEUKOCYTES|||||||PPM|||||||TRACE||10^12/L||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED|N|STATIC PERIMETRY|HEPASCORE FORMULA||N|U|Y|N|||U|2||58||TREATMENT|1969-08-26|1966-03-31|||||1972-05-02||1963-06-07|N|1972-10-04
TRIAL STUDY 134XCP|LB|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|1||||APPEAR|SPECIMEN APPEARANCE|||||||/100 HPFS|||||||TRACE||/VF||||HIGH|NOT DONE||||DERMAL TISSUE|THAWED|U|TWO-COLOR MICROARRAY|CKD-EPI FORMULA||N|Y|Y|NA|||NA|3||39||BLINDED TREATMENT|1960-12-22|1970-05-17|||||1962-04-22||1971-11-07|Y|1969-06-24
TRIAL STUDY 134XCP|LB|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|2||||ALB|ALBUMIN|||||||UL/DOSE|||||||INDETERMINATE||10^5/HPF||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|HEMOLYZED|U|VIRUS PLAQUE ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|Y|N|||N|3||39||RUN-IN|1968-06-29|1965-05-22|||||1972-04-02||1964-08-25|Y|1967-09-29
TRIAL STUDY 134XCP|LB|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|1||||PDGFAB|PLATELET DERIVED GROWTH FACTOR ISOFORMAB|||||||BOWL|||||||BORDERLINE||ENZYME U/G HB||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|SOLIDIFIED|U|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD FORMULA||N|N|U|NA|||N|4||88||INDUCTION TREATMENT|1960-10-03|1966-09-17|||||1970-12-08||1963-05-30|Y|1971-01-09
TRIAL STUDY 134XCP|LB|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|2||||NEUTLE|NEUTROPHILS/LEUKOCYTES|||||||UG/DL|||||||POSITIVE||HZ/S||||HIGH|NOT DONE||||COLOSTRUM|AUTOLYZED|NA|WHOLE EXOME SEQUENCING|GMI % FORMULA||NA|N|N|U|||N|4||88||TREATMENT|1968-04-28|1973-09-02|||||1972-07-09||1968-11-13|U|1971-02-02
TRIAL STUDY 134XCP|LB|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|1||||FATACFR|FREE FATTY ACID|||||||S^-1(%O2)^-1|||||||TRACE||S/H||||HIGH|NOT DONE||||ERYTHROCYTES|UNEXPECTED ODOR|Y|NEXT GENERATION TARGETED SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|NA|NA|||U|5||7||LONG-TERM FOLLOW-UP|1966-11-27|1963-10-28|||||1973-01-31||1962-10-16|NA|1969-03-28
TRIAL STUDY 134XCP|LB|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|2||||MMP1|MATRIX METALLOPROTEINASE 1|||||||UG/DOSE|||||||INVALID||OZ||||LOW|NOT DONE||||ENDOMETRIAL TISSUE|AUTOLYZED|Y|KLEIHAUER-BETKE|MDRD 4 VARIABLE FORMULA||Y|N|U|NA|||N|5||7||OBSERVATION|1961-07-19|1968-04-26|||||1968-07-05||1968-08-17|U|1973-03-02
TRIAL STUDY 134XCP|LB|20DC654F-595C-410D-A340-465A23434D42|1||||MIP1B|MACROPHAGE INFLAMMATORY PROTEIN 1 BETA|||||||MKAT|||||||BORDERLINE||CGY||||HIGH|NOT DONE||||BONE MARROW MONONUCLEAR CELL|REFRIGERATED|U|MRS|MDRD ENZYMATIC JAPANESE FORMULA||U|N|U|Y|||Y|1||38||SCREENING|1968-10-15|1964-09-30|||||1973-06-12||1960-06-08|U|1964-10-16
TRIAL STUDY 134XCP|LB|20DC654F-595C-410D-A340-465A23434D42|2||||PRORUB|PRORUBRICYTE|||||||LOG10 PFU/ML|||||||BORDERLINE||NG/MOL||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|REFRIGERATED|N|OPTICAL MAPPING|FIBROSIS 4 FORMULA||NA|Y|N|N|||Y|1||38||INDUCTION TREATMENT|1964-03-14|1973-01-01|||||1962-02-22||1967-06-18|Y|1961-04-09
TRIAL STUDY 134XCP|LB|20DC654F-595C-410D-A340-465A23434D42|1||||AMYLB42|AMYLOID BETA 1-42|||||||10^3 CFU|||||||POSITIVE||10^3 ORGANISMS/ML||||ABNORMAL|NOT DONE||||LEUKOCYTE|THAWED|Y|ENZYMATIC ULTRACENTRIFUGATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|N|N|||Y|2||58||CONTINUATION TREATMENT|1966-01-17|1969-10-10|||||1964-04-02||1964-10-18|Y|1967-09-24
TRIAL STUDY 134XCP|LB|20DC654F-595C-410D-A340-465A23434D42|2||||PSA|PROSTATE SPECIFIC ANTIGEN|||||||FT3|||||||TRACE||LOG10 TCID 50/DOSE||||NORMAL|NOT DONE||||PLASMA|CONCENTRATED|NA|MALDI-TOF|FIBROMETER FORMULA||Y|U|U|N|||NA|2||58||SCREENING|1968-03-23|1961-01-15|||||1961-08-05||1968-09-02|Y|1969-04-28
TRIAL STUDY 134XCP|LB|20DC654F-595C-410D-A340-465A23434D42|1||||C130083|ORCHARD GRASS POLLEN IGG4|||||||CIGAR|||||||TRACE||BQ/UL||||NORMAL|NOT DONE||||BLOOD|CALCIFIED|U|SIZE EXCLUSION CHROMATOGRAPHY|HEPASCORE FORMULA||U|N|NA|U|||U|3||39||FOLLOW-UP|1966-01-18|1965-01-25|||||1971-02-18||1963-10-20|Y|1968-08-15
TRIAL STUDY 134XCP|LB|20DC654F-595C-410D-A340-465A23434D42|2||||PROTEXR|PROTEIN EXCRETION RATE|||||||MG/G/MIN|||||||INVALID||YD||||HIGH|NOT DONE||||NAIL|UNEXPECTED ODOR|N|PALPATION|MDRD ENZYMATIC FORMULA||N|U|Y|N|||U|3||39||SCREENING|1966-09-02|1969-07-13|||||1961-02-15||1963-04-22|Y|1969-05-20
TRIAL STUDY 134XCP|LB|20DC654F-595C-410D-A340-465A23434D42|1||||CKMT2CK|CK, MACROMOLECULAR TYPE 2/TOTAL CK|||||||UG/G/MIN|||||||NEGATIVE||MANSON U/ML||||LOW|NOT DONE||||INTERSTITIAL FLUID|LIPEMIC|NA|DUCTOGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|N|N|Y|||U|4||88||CONTINUATION TREATMENT|1961-01-23|1972-12-20|||||1970-05-29||1968-02-06|Y|1960-10-19
TRIAL STUDY 134XCP|LB|20DC654F-595C-410D-A340-465A23434D42|2||||VEGFR3S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC3|||||||RING|||||||INVALID||/2500 WBC||||NORMAL|NOT DONE||||SOFT TISSUE|THAWED|U|RADIOGRAPHY|FIBROMETER FORMULA||U|U|U|NA|||U|4||88||OPEN LABEL TREATMENT|1964-01-24|1963-05-27|||||1964-07-29||1969-12-16|N|1966-05-05
TRIAL STUDY 134XCP|LB|20DC654F-595C-410D-A340-465A23434D42|1||||HLAA|HLA CLASS IA ANTIGEN|||||||/LSQN|||||||INDETERMINATE||LINEAR FT*LB||||LOW|NOT DONE||||GASTRIC FLUID|THAWED|U|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD 6 VARIABLE FORMULA||NA|Y|N|N|||Y|5||7||TREATMENT|1968-10-17|1961-08-01|||||1965-08-26||1967-11-08|Y|1966-06-20
TRIAL STUDY 134XCP|LB|20DC654F-595C-410D-A340-465A23434D42|2||||SPHERO|SPHEROCYTES|||||||CMH2O*S2/ML|||||||INDETERMINATE||IU/ML||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|THAWED|U|ERGOSPIROMETRY|MDRD 6 VARIABLE FORMULA||Y|N|Y|N|||NA|5||7||INDUCTION TREATMENT|1965-04-05|1961-04-03|||||1963-07-31||1963-12-19|N|1966-09-21
TRIAL STUDY 134XCP|LB|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|1||||MMP8|MATRIX METALLOPROTEINASE 8|||||||PT_US|||||||BORDERLINE||L/MIN/M2||||LOW|NOT DONE||||PUS|REFRIGERATED|Y|TURBIDIMETRY|NASH FIBROSURE FORMULA||Y|Y|U|NA|||Y|1||38||WASHOUT|1967-09-08|1965-11-01|||||1962-11-14||1962-04-29|Y|1967-12-29
TRIAL STUDY 134XCP|LB|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|2||||GLOBA2|ALPHA-2 GLOBULIN|||||||ELISA UNIT|||||||INDETERMINATE||UG||||LOW|NOT DONE||||MENSTRUAL BLOOD|AUTOLYZED|Y|OPTICAL DENSITY MEASUREMENT|MDRD 6 VARIABLE FORMULA||U|U|N|Y|||NA|1||38||OPEN LABEL TREATMENT|1962-06-19|1970-06-29|||||1969-07-07||1970-01-26|N|1973-08-30
TRIAL STUDY 134XCP|LB|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|1||||C130090|TIMOTHY GRASS POLLEN IGG|||||||IU|||||||NEGATIVE||MEQ/ML||||ABNORMAL|NOT DONE||||SKIN TISSUE|FRESH|NA|PULMONARY ANGIOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|N|N|Y|||NA|2||58||LONG-TERM FOLLOW-UP|1971-06-18|1973-07-06|||||1965-05-02||1970-08-22|U|1970-03-16
TRIAL STUDY 134XCP|LB|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|2||||AMYLOIDA|AMYLOID A|||||||UG/MIN|||||||NEGATIVE||ML/MIN||||NORMAL|NOT DONE||||ABSCESS FLUID|CLOTTED|NA|NON-INVASIVE DIELECTRIC SENSING|FIBROTEST FORMULA||N|NA|Y|N|||NA|2||58||LONG-TERM FOLLOW-UP|1965-10-25|1961-04-25|||||1973-08-09||1968-06-16|Y|1961-11-11
TRIAL STUDY 134XCP|LB|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|1||||EPHD|EPHEDRINE|||||||VG/KG|||||||INVALID||KS||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|REFRIGERATED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|N|N|||N|3||39||BASELINE|1966-09-25|1962-02-11|||||1963-02-06||1963-06-05|U|1970-08-23
TRIAL STUDY 134XCP|LB|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|2||||BICARB|BICARBONATE|||||||FT3|||||||TRACE||CI/KG||||HIGH|NOT DONE||||VENOUS PLASMA|THAWED|NA|SPIROMETRY|ASH FIBROSURE FORMULA||NA|U|N|Y|||NA|3||39||TREATMENT|1963-10-27|1964-01-08|||||1962-10-27||1973-09-04|U|1966-03-03
TRIAL STUDY 134XCP|LB|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|1||||C130118|BEE MIX ANTIGEN IGG4 ANTIBODY|||||||CMHG|||||||POSITIVE||NMOL/DAY||||HIGH|NOT DONE||||ALVEOLAR AIR|REFRIGERATED|Y|IMMUNOBLOT|MDRD ENZYMATIC JAPANESE FORMULA||U|U|Y|U|||Y|4||88||BLINDED TREATMENT|1966-05-14|1972-05-28|||||1964-03-06||1966-09-03|NA|1968-01-08
TRIAL STUDY 134XCP|LB|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|2||||FACTVIII|FACTOR VIII|||||||LOG10 TCID 50/ML|||||||INVALID||LOZENGE||||NORMAL|NOT DONE||||MECONIUM|AUTOLYZED|Y|NUCLEIC ACID AMPLIFICATION TEST|MDRD 5 VARIABLE FORMULA||NA|NA|NA|Y|||U|4||88||BASELINE|1973-07-16|1973-03-20|||||1968-03-03||1964-07-26|NA|1961-11-18
TRIAL STUDY 134XCP|LB|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|1||||ALPIS|INTESTINAL SPECIFIC ALKALINE PHOSPHATASE|||||||JOULE|||||||INVALID||LOG10 CFU/ML||||HIGH|NOT DONE||||EXPIRED AIR|LIPEMIC|Y|FLUORESCENT LIFETIME IMAGING MICROSCOPY|ASH FIBROSURE FORMULA||U|Y|NA|N|||N|5||7||BASELINE|1964-07-16|1962-08-30|||||1969-10-24||1966-09-13|U|1973-05-12
TRIAL STUDY 134XCP|LB|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|2||||PLATIM|IMMATURE PLATELETS|||||||L|||||||POSITIVE||GRAVITATIONAL UNIT||||ABNORMAL|NOT DONE||||ABSCESS FLUID|LIPEMIC|NA|TOTAL BODY IRRADIATION|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|U|Y|||NA|5||7||BLINDED TREATMENT|1971-05-04|1964-01-28|||||1967-07-29||1969-08-30|U|1966-03-10
TRIAL STUDY 134XCP|LB|4EA8DC88-09C8-4954-A469-D8E12F01CB56|1||||RP3IGGAB|RNA POLYMERASE III IGG ANTIBODY|||||||MG/L FEU|||||||TRACE||FIU||||LOW|NOT DONE||||CERUMEN|GELLED|NA|INCISION-INDUCED BLEEDING METHOD|CKD-EPI FORMULA||U|Y|Y|U|||N|1||38||OBSERVATION|1961-08-17|1961-12-26|||||1969-04-06||1972-12-17|N|1964-12-29
TRIAL STUDY 134XCP|LB|4EA8DC88-09C8-4954-A469-D8E12F01CB56|2||||CHOLINES|CHOLINESTERASE|||||||10^5/L|||||||BORDERLINE||DRINK||||HIGH|NOT DONE||||INFRANATANT, PLASMA|ROOM TEMPERATURE|NA|SPIROMETRY|MDRD ENZYMATIC FORMULA||NA|N|Y|NA|||N|1||38||WASHOUT|1966-09-05|1965-09-09|||||1968-03-11||1965-05-02|Y|1970-11-05
TRIAL STUDY 134XCP|LB|4EA8DC88-09C8-4954-A469-D8E12F01CB56|1||||PLAT|PLATELETS|||||||UG/KG/H|||||||TRACE||CONTAINER||||ABNORMAL|NOT DONE||||SERUM|ICTERIC|Y|FREEZING POINT DEPRESSION|MDRD FORMULA||Y|N|N|U|||N|2||58||BASELINE|1967-07-17|1969-11-07|||||1966-07-08||1973-03-27|N|1961-02-19
TRIAL STUDY 134XCP|LB|4EA8DC88-09C8-4954-A469-D8E12F01CB56|2||||AMYLASES|AMYLASE, SALIVARY|||||||UG/G/H|||||||POSITIVE||DL||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|ROOM TEMPERATURE|U|FISH|FIBROTEST FORMULA||N|NA|U|U|||NA|2||58||OPEN LABEL TREATMENT|1963-01-28|1965-08-15|||||1972-10-10||1973-02-06|Y|1965-03-07
TRIAL STUDY 134XCP|LB|4EA8DC88-09C8-4954-A469-D8E12F01CB56|1||||AMH|ANTI-MULLERIAN HORMONE|||||||MEQ/L|||||||NEGATIVE||ML/S/M2||||ABNORMAL|NOT DONE||||PLATELET|DRIED|NA|OPTICAL MAPPING|GMI MMOL/MOL FORMULA||NA|NA|U|U|||U|3||39||TREATMENT|1968-02-18|1971-10-14|||||1960-04-18||1973-05-31|NA|1960-09-05
TRIAL STUDY 134XCP|LB|4EA8DC88-09C8-4954-A469-D8E12F01CB56|2||||C130104|GRASS MIX POLLEN ANTIGEN IGG ANTIBODY|||||||COPIES/UG|||||||BORDERLINE||UG/CM2||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|ICTERIC|U|JAFFE REACTION|MDRD ENZYMATIC JAPANESE FORMULA||U|N|NA|Y|||N|3||39||CONTINUATION TREATMENT|1963-11-18|1962-08-09|||||1967-05-24||1968-12-29|U|1965-12-06
TRIAL STUDY 134XCP|LB|4EA8DC88-09C8-4954-A469-D8E12F01CB56|1||||GSTPI|GLUTATHIONE S-TRANSFERASE, PI|||||||10^9 CFU/ML|||||||TRACE||IN||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|CALCIFIED|NA|RIA|MDRD 5 VARIABLE FORMULA||U|U|NA|U|||U|4||88||OPEN LABEL TREATMENT|1962-09-26|1965-09-02|||||1964-01-07||1965-07-25|NA|1960-02-28
TRIAL STUDY 134XCP|LB|4EA8DC88-09C8-4954-A469-D8E12F01CB56|2||||BLSTSID|SIDEROBLAST|||||||BAR|||||||INDETERMINATE||MMU/ML||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|FRESH|Y|SISH|COCKCROFT-GAULT FORMULA||NA|Y|NA|N|||Y|4||88||BLINDED TREATMENT|1962-11-06|1971-08-31|||||1973-04-19||1967-03-08|U|1971-09-25
TRIAL STUDY 134XCP|LB|4EA8DC88-09C8-4954-A469-D8E12F01CB56|1||||NAGASE|N-ACETYL-BETA-D-GLUCOSAMINIDASE|||||||G/DAY|||||||INVALID||PFU||||NORMAL|NOT DONE||||AMNIOTIC FLUID|AUTOLYZED|N|FORCED OSCILLATION TECHNIQUE|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|N|NA|||N|5||7||INDUCTION TREATMENT|1973-05-26|1961-11-15|||||1970-11-13||1964-12-03|NA|1971-01-23
TRIAL STUDY 134XCP|LB|4EA8DC88-09C8-4954-A469-D8E12F01CB56|2||||MYPC|MYELOID PROGENITOR CELLS|||||||EID 50/ML|||||||NEGATIVE||GBQ/UG||||HIGH|NOT DONE||||EXHALED BREATH CONDENSATE|UNEXPECTED ODOR|N|HIGH RESOLUTION MELT ANALYSIS|CKD-EPI CREATININE FORMULA||Y|U|Y|N|||U|5||7||INDUCTION TREATMENT|1973-08-09|1964-10-14|||||1965-05-17||1970-03-14|Y|1968-03-19
TRIAL STUDY 134XCP|LB|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|1||||ALB|ALBUMIN|||||||UG/G/DAY|||||||NEGATIVE||MMU/ML||||LOW|NOT DONE||||CEREBROSPINAL FLUID|ROOM TEMPERATURE|N|CALIPER MEASUREMENT METHOD|MDRD 6 VARIABLE FORMULA||U|N|NA|N|||NA|1||38||CONTINUATION TREATMENT|1966-07-08|1967-01-14|||||1965-02-04||1963-04-20|NA|1968-02-23
TRIAL STUDY 134XCP|LB|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|2||||FBNCTCE|FIBRONECTIN, CELLULAR|||||||PACK YEAR|||||||INDETERMINATE||S/H||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|NON-HEMOLYZED|NA|MYELOPEROXIDASE STAIN|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|N|||N|1||38||BLINDED TREATMENT|1970-05-15|1962-01-28|||||1973-04-12||1963-09-08|N|1960-09-23
TRIAL STUDY 134XCP|LB|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|1||||ASTCK|AST/CREATINE KINASE|||||||ML/S|||||||INDETERMINATE||G/KG||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|THAWED|Y|GRADIENT DIFFUSION|ASH FIBROSURE FORMULA||U|U|Y|U|||N|2||58||TREATMENT|1962-06-06|1967-12-11|||||1963-06-19||1960-06-16|Y|1967-12-06
TRIAL STUDY 134XCP|LB|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|2||||NRP1|NEUROPILIN-1|||||||LENS|||||||BORDERLINE||MMAL||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|HEMOLYZED|N|TRANSVAGINAL ULTRASOUND|MDRD FORMULA||Y|NA|U|N|||N|2||58||WASHOUT|1961-12-10|1967-11-01|||||1961-09-07||1967-06-04|U|1965-11-07
TRIAL STUDY 134XCP|LB|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|1||||FACTX|FACTOR X|||||||CAPLET|||||||TRACE||PMOL/L/H||||HIGH|NOT DONE||||CORD SERUM|AUTOLYZED|NA|IMMUNO-PET SCAN|GMI MMOL/MOL FORMULA||N|Y|Y|NA|||NA|3||39||CONTINUATION TREATMENT|1966-04-16|1972-05-24|||||1961-02-17||1969-12-24|Y|1962-03-26
TRIAL STUDY 134XCP|LB|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|2||||SLAIGGAB|SOLUBLE LIVER ANTIGEN IGG ANTIBODY|||||||G/DAY|||||||NEGATIVE||PIXEL||||NORMAL|NOT DONE||||VENOUS CORD BLOOD|LACTESCENT|U|URANYL ACETATE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|NA|N|N|||Y|3||39||WASHOUT|1960-05-19|1964-05-24|||||1967-05-02||1967-12-26|U|1961-12-21
TRIAL STUDY 134XCP|LB|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|1||||GDA|GUANINE DEAMINASE|||||||NSEC|||||||NEGATIVE||CD||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|AGGLUTINATED|Y|SCANNING ELECTRON MICROSCOPY|COCKCROFT-GAULT FORMULA||NA|Y|Y|NA|||N|4||88||RUN-IN|1963-04-18|1968-12-20|||||1961-12-12||1964-06-27|U|1965-04-09
TRIAL STUDY 134XCP|LB|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|2||||TNF12S|SOLUBLE TNF SUPERFAMILY MEMBER 12|||||||LOZENGE|||||||INDETERMINATE||S^-1(%O2)^-1||||LOW|NOT DONE||||SKIN TISSUE|NON-HEMOLYZED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||N|NA|N|N|||N|4||88||FOLLOW-UP|1970-12-17|1970-05-31|||||1973-01-04||1962-02-22|N|1964-03-05
TRIAL STUDY 134XCP|LB|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|1||||MGCREAT|MAGNESIUM/CREATININE|||||||PSEC|||||||TRACE||%/S||||ABNORMAL|NOT DONE||||ERYTHROCYTES|FROZEN|NA|RAJI CELL EIA|MDRD 4 VARIABLE FORMULA||N|N|Y|N|||NA|5||7||OBSERVATION|1962-09-05|1965-03-21|||||1969-12-10||1962-02-27|NA|1960-04-08
TRIAL STUDY 134XCP|LB|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|2||||C165936|GLYCINE MAX IGE AB RAST SCORE|||||||%|||||||TRACE||ENZYME U||||LOW|NOT DONE||||VITREOUS HUMOR|UNEXPECTED ODOR|U|INTRAVASCULAR ULTRASOUND|MDRD FORMULA||NA|N|N|Y|||NA|5||7||BLINDED TREATMENT|1962-02-21|1963-10-16|||||1961-05-08||1966-12-30|U|1970-04-29
TRIAL STUDY 134XCP|LB|521B1614-9092-4F89-A47F-728C66E01B23|1||||AMYLOIDP|AMYLOID P|||||||MG/H|||||||POSITIVE||L/H/M2||||LOW|NOT DONE||||KERATINOCYTE|FROZEN|U|NEXT GENERATION TARGETED SEQUENCING|FIBROSIS 4 FORMULA||N|Y|NA|NA|||NA|1||38||TREATMENT|1962-11-12|1971-08-23|||||1967-11-14||1972-05-25|Y|1967-08-10
TRIAL STUDY 134XCP|LB|521B1614-9092-4F89-A47F-728C66E01B23|2||||CSEPIRT|RENAL TUBULAR EPITHELIAL CASTS|||||||CMH2O/ML|||||||TRACE||CAN||||LOW|NOT DONE||||LEUKOCYTE|ICTERIC|Y|DOPPLER ULTRASOUND|MDRD 6 VARIABLE FORMULA||Y|NA|Y|U|||Y|1||38||INDUCTION TREATMENT|1966-05-11|1969-05-09|||||1967-08-03||1960-04-16|NA|1964-07-26
TRIAL STUDY 134XCP|LB|521B1614-9092-4F89-A47F-728C66E01B23|1||||CCL20|CHEMOKINE (C-C MOTIF) LIGAND 20|||||||APPLICATION|||||||NEGATIVE||CI/KG||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|ICTERIC|U|WESTERGREN|NASH FIBROSURE FORMULA||Y|Y|Y|N|||U|2||58||RUN-IN|1963-02-06|1966-07-10|||||1970-09-21||1970-06-28|N|1962-09-03
TRIAL STUDY 134XCP|LB|521B1614-9092-4F89-A47F-728C66E01B23|2||||POIKILO|POIKILOCYTES|||||||MMOL/DAY|||||||BORDERLINE||U/G||||LOW|NOT DONE||||HAIR FOLLICLE|LACTESCENT|N|ENZYMATIC COLORIMETRY|MDRD 6 VARIABLE FORMULA||Y|N|Y|U|||Y|2||58||WASHOUT|1965-04-13|1968-09-12|||||1970-07-19||1965-04-07|U|1971-02-12
TRIAL STUDY 134XCP|LB|521B1614-9092-4F89-A47F-728C66E01B23|1||||HAPTOG|HAPTOGLOBIN|||||||ML/H|||||||BORDERLINE||GBQ/MG||||HIGH|NOT DONE||||COLOSTRUM|LIPEMIC|U|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NASH FIBROSURE FORMULA||Y|NA|NA|U|||N|3||39||LONG-TERM FOLLOW-UP|1968-03-04|1972-12-28|||||1973-02-17||1970-11-20|Y|1973-05-22
TRIAL STUDY 134XCP|LB|521B1614-9092-4F89-A47F-728C66E01B23|2||||CEMORPH|CELL MORPHOLOGY|||||||ML|||||||INVALID||MBQ/UL||||LOW|NOT DONE||||LOCHIA|NON-HEMOLYZED|NA|BIOPSY|COCKCROFT-GAULT FORMULA||Y|NA|NA|Y|||N|3||39||BLINDED TREATMENT|1965-10-13|1967-09-21|||||1968-04-12||1964-11-07|Y|1968-06-03
TRIAL STUDY 134XCP|LB|521B1614-9092-4F89-A47F-728C66E01B23|1||||MLIGCE|MALIGNANT CELLS, NOS|||||||TSP EQ|||||||INDETERMINATE||DEG/MM||||LOW|NOT DONE||||PUS|GELLED|U|RADIATION DOSIMETRY|CKD-EPI CREATININE FORMULA||U|NA|NA|NA|||N|4||88||OBSERVATION|1969-10-30|1963-01-20|||||1965-01-19||1972-01-02|Y|1970-11-25
TRIAL STUDY 134XCP|LB|521B1614-9092-4F89-A47F-728C66E01B23|2||||HLADR53A|HLA-DR53 ANTIBODY|||||||TRANSDUCING UNIT|||||||POSITIVE||TRACE||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|GELLED|NA|JAFFE REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|NA|Y|||N|4||88||BLINDED TREATMENT|1970-02-05|1961-07-30|||||1960-02-09||1965-02-25|U|1962-01-18
TRIAL STUDY 134XCP|LB|521B1614-9092-4F89-A47F-728C66E01B23|1||||VWFAAC|VON WILL FACTOR ACT ACTUAL/CONTROL|||||||10^7 TCID 50/DOSE|||||||INDETERMINATE||NMOL/L/H||||NORMAL|NOT DONE||||LYMPH|PARAFFIN-EMBEDDED|N|FORCED OSCILLATION TECHNIQUE|MDRD ENZYMATIC FORMULA||N|N|N|N|||Y|5||7||WASHOUT|1973-08-29|1962-04-08|||||1961-03-15||1961-09-18|Y|1972-06-02
TRIAL STUDY 134XCP|LB|521B1614-9092-4F89-A47F-728C66E01B23|2||||HYPERCHR|HYPERCHROMIA|||||||/SEC|||||||NEGATIVE||NG||||LOW|NOT DONE||||INFRANATANT, PLASMA|NON-HEMOLYZED|N|GC/MS|FIBROTEST FORMULA||Y|N|U|U|||Y|5||7||OPEN LABEL TREATMENT|1967-03-11|1970-08-10|||||1966-11-18||1966-03-10|NA|1966-06-21
TRIAL STUDY 134XCP|LB|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|1||||RESISTIN|RESISTIN|||||||GMFI|||||||NEGATIVE||UG/DAY||||NORMAL|NOT DONE||||ALVEOLAR AIR|GELLED|N|FARNSWORTH-MUNSELL 100 HUE TEST|CKD-EPI CYSTATIN C FORMULA||U|Y|NA|NA|||N|1||38||RUN-IN|1973-08-09|1961-09-14|||||1969-11-01||1970-08-13|Y|1967-01-30
TRIAL STUDY 134XCP|LB|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|2||||MYCY|MYELOCYTES|||||||UG/L/H|||||||INVALID||FRAMES/S||||NORMAL|NOT DONE||||EPIDERMAL TISSUE|UNEXPECTED ODOR|NA|ANTIBIOTIC AGAR SCREEN|FIBROSIS 4 FORMULA||U|NA|Y|Y|||Y|1||38||OBSERVATION|1964-01-10|1965-09-09|||||1969-05-18||1963-08-19|U|1965-10-16
TRIAL STUDY 134XCP|LB|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|1||||HBBARTHB|HEMOGLOBIN BARTS/TOTAL HEMOGLOBIN|||||||MMHG/L/MIN|||||||BORDERLINE||/MONTH||||HIGH|NOT DONE||||ERYTHROCYTES|FRESH|N|ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||N|NA|U|NA|||NA|2||58||OPEN LABEL TREATMENT|1967-02-04|1967-05-19|||||1970-05-05||1962-03-29|N|1973-07-10
TRIAL STUDY 134XCP|LB|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|2||||VLDLTCT|VLDL TRIGLYCERIDE + CHYLOMICRON TRIGLYCERIDE|||||||L/KG|||||||POSITIVE||CG||||NORMAL|NOT DONE||||SERUM|AGGLUTINATED|Y|ANTIMICROBIAL COMBINATION TESTING|ASH FIBROSURE FORMULA||NA|N|U|U|||Y|2||58||INDUCTION TREATMENT|1972-01-19|1964-06-20|||||1967-08-13||1970-09-07|Y|1968-05-05
TRIAL STUDY 134XCP|LB|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|1||||C165877|CAT DANDER IGE AB RAST SCORE|||||||KIU|||||||TRACE||UG/L||||HIGH|NOT DONE||||DIALYSIS FLUID|SOLIDIFIED|NA|PEAK FLOWMETRY|MDRD ENZYMATIC FORMULA||N|Y|NA|N|||N|3||39||OBSERVATION|1969-05-24|1966-02-10|||||1971-12-24||1961-11-29|N|1967-05-18
TRIAL STUDY 134XCP|LB|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|2||||ICAM1|INTERCELLULAR ADHESION MOLECULE 1|||||||COPIES/ML|||||||INDETERMINATE||FRAMES/S||||ABNORMAL|NOT DONE||||SMEGMA|LACTESCENT|N|IMMUNOFLUORESCENT STAIN|MDRD FORMULA||U|U|U|N|||U|3||39||CONTINUATION TREATMENT|1962-09-04|1967-08-29|||||1965-06-08||1963-11-02|Y|1969-06-30
TRIAL STUDY 134XCP|LB|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|1||||CYSTATC|CYSTATIN C|||||||MPH|||||||BORDERLINE||UMOL||||HIGH|NOT DONE||||VENOUS BLOOD|CONCENTRATED|Y|HIGH RESOLUTION CT|MDRD FORMULA||U|NA|NA|Y|||N|4||88||CONTINUATION TREATMENT|1962-01-14|1973-03-25|||||1960-08-28||1964-01-06|N|1964-12-30
TRIAL STUDY 134XCP|LB|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|2||||E1S|ESTRONE SULFATE|||||||LINEAR FT*LB|||||||INVALID||ELISA UNIT||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|AGGLUTINATED|U|ICC|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|U|U|||Y|4||88||INDUCTION TREATMENT|1961-09-20|1961-06-06|||||1967-03-24||1967-12-15|U|1970-04-02
TRIAL STUDY 134XCP|LB|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|1||||APRIL|A PROLIFERATION-INDUCING LIGAND|||||||10^6/HPF|||||||POSITIVE||MMOL/MIN/KPA/L||||ABNORMAL|NOT DONE||||MONOCYTE|REFRIGERATED|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|Y|N|||Y|5||7||BASELINE|1962-11-03|1973-06-25|||||1963-07-08||1967-09-02|U|1964-05-27
TRIAL STUDY 134XCP|LB|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|2||||PROLYM|PROLYMPHOCYTES|||||||%|||||||TRACE||CI/KG||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|CLOTTED|NA|DYNAMOMETRY|MDRD FORMULA||U|U|Y|N|||N|5||7||RUN-IN|1964-02-22|1969-09-05|||||1969-02-13||1970-09-11|U|1973-08-31
TRIAL STUDY 134XCP|LB|FF6B8B49-3C82-459D-A35D-61136FC594D2|1||||FGF23|FIBROBLAST GROWTH FACTOR 23|||||||MEQ|||||||NEGATIVE||UMOL/MOL||||HIGH|NOT DONE||||ADIPOSE TISSUE|UNEXPECTED ODOR|NA|OSCILLOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|N|||Y|1||38||SCREENING|1963-10-04|1961-05-20|||||1971-01-15||1966-08-15|Y|1960-10-31
TRIAL STUDY 134XCP|LB|FF6B8B49-3C82-459D-A35D-61136FC594D2|2||||SECRETIN|SECRETIN|||||||UEQ|||||||NEGATIVE||L/DAY||||LOW|NOT DONE||||SKIN TISSUE|PARAFFIN-EMBEDDED|NA|COULOMETRIC TITRATION|ASH FIBROSURE FORMULA||Y|U|N|Y|||Y|1||38||LONG-TERM FOLLOW-UP|1970-08-14|1964-02-16|||||1967-09-07||1962-02-04|N|1968-09-01
TRIAL STUDY 134XCP|LB|FF6B8B49-3C82-459D-A35D-61136FC594D2|1||||CMPK2|CYTIDINE-URIDINE MONOPHOSPHATE KINASE 2|||||||V/V|||||||TRACE||MV2/HZ||||HIGH|NOT DONE||||BASAL TEAR|UNEXPECTED ODOR|N|DYNAMOMETRY|ASH FIBROSURE FORMULA||N|N|U|Y|||NA|2||58||BLINDED TREATMENT|1962-02-21|1961-11-20|||||1965-06-07||1968-09-26|NA|1961-02-15
TRIAL STUDY 134XCP|LB|FF6B8B49-3C82-459D-A35D-61136FC594D2|2||||NEUTB|NEUTROPHILS BAND FORM|||||||MBQ|||||||BORDERLINE||LM||||LOW|NOT DONE||||ADIPOSE TISSUE|HEMOLYZED|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|CKD-EPI CREATININE FORMULA||U|NA|N|Y|||Y|2||58||SCREENING|1970-01-17|1961-06-01|||||1970-08-21||1967-11-04|U|1964-07-04
TRIAL STUDY 134XCP|LB|FF6B8B49-3C82-459D-A35D-61136FC594D2|1||||MEPRDN|MEPERIDINE|||||||CONTAINER|||||||NEGATIVE||NG/MOL||||LOW|NOT DONE||||CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED|Y|STRESS ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA||N|NA|N|N|||N|3||39||OPEN LABEL TREATMENT|1961-07-06|1966-04-27|||||1967-10-29||1964-01-13|U|1964-11-15
TRIAL STUDY 134XCP|LB|FF6B8B49-3C82-459D-A35D-61136FC594D2|2||||BLISTCE|BLISTER CELL|||||||ML/G/MIN|||||||TRACE||MM3/MM2/YEAR||||HIGH|NOT DONE||||MUCUS|CONCENTRATED|NA|EIA|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|Y|N|||Y|3||39||OPEN LABEL TREATMENT|1972-10-11|1968-02-18|||||1960-09-03||1973-01-15|U|1962-10-08
TRIAL STUDY 134XCP|LB|FF6B8B49-3C82-459D-A35D-61136FC594D2|1||||TSTFWTST|TESTOSTERONE FREE+WEAKLY BOUND/TESTOST|||||||ML/ANIMAL/DAY|||||||INVALID||GBQ||||LOW|NOT DONE||||INFRANATANT, SERUM|LACTESCENT|U|ELECTROGASTROGRAPHY|HEPASCORE FORMULA||N|U|N|Y|||NA|4||88||INDUCTION TREATMENT|1972-06-24|1960-12-17|||||1970-11-07||1972-08-11|NA|1960-09-27
TRIAL STUDY 134XCP|LB|FF6B8B49-3C82-459D-A35D-61136FC594D2|2||||CAN|COEFFICIENT OF NITROGEN ABSORPTION|||||||TBSP|||||||POSITIVE||CI/G||||LOW|NOT DONE||||DISCHARGE|ICTERIC|U|MRI WITHOUT CONTRAST|HEPASCORE FORMULA||U|NA|N|NA|||U|4||88||OBSERVATION|1963-10-28|1960-03-30|||||1966-09-25||1968-09-29|U|1972-06-05
TRIAL STUDY 134XCP|LB|FF6B8B49-3C82-459D-A35D-61136FC594D2|1||||UREANEXR|UREA NITROGEN EXCRETION RATE|||||||CI|||||||INDETERMINATE||PFU||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|NON-HEMOLYZED|Y|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|NA|NA|||NA|5||7||LONG-TERM FOLLOW-UP|1970-07-12|1965-11-06|||||1960-05-31||1966-04-16|N|1965-07-18
TRIAL STUDY 134XCP|LB|FF6B8B49-3C82-459D-A35D-61136FC594D2|2||||NTELOP|N-TELOPEPTIDE|||||||MG2/DL2|||||||POSITIVE||LOG10 IU/ML||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|ICTERIC|U|PATHOLOGICAL EVALUATION|ASH FIBROSURE FORMULA||NA|Y|U|Y|||Y|5||7||BLINDED TREATMENT|1967-11-27|1972-02-01|||||1965-03-10||1970-03-25|Y|1969-04-04
TRIAL STUDY 134XCP|LB|2196D9F4-937A-4662-B24B-AC9D472E0393|1||||INSAAB|INSULIN AUTOANTIBODY|||||||UCI/L|||||||INDETERMINATE||G/G||||ABNORMAL|NOT DONE||||ALVEOLAR AIR|THAWED|U|OPTICAL MAPPING|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|U|U|||Y|1||38||INDUCTION TREATMENT|1968-07-14|1969-02-11|||||1960-11-20||1963-11-05|Y|1972-04-21
TRIAL STUDY 134XCP|LB|2196D9F4-937A-4662-B24B-AC9D472E0393|2||||PLG|PLASMINOGEN|||||||UG/L|||||||TRACE||MG2/DL2||||ABNORMAL|NOT DONE||||SERUM OR PLASMA|HEMOLYZED|Y|LC/MS|ASH FIBROSURE FORMULA||NA|NA|U|N|||U|1||38||OPEN LABEL TREATMENT|1962-08-31|1964-09-27|||||1960-05-31||1966-08-30|NA|1960-03-12
TRIAL STUDY 134XCP|LB|2196D9F4-937A-4662-B24B-AC9D472E0393|1||||KETONES|KETONES|||||||MV|||||||POSITIVE||USIEMENS||||NORMAL|NOT DONE||||LOCHIA|LACTESCENT|Y|ELECTROMYOGRAPHY|GMI MMOL/MOL FORMULA||N|NA|N|NA|||U|2||58||SCREENING|1971-12-01|1965-02-05|||||1967-07-20||1971-12-11|U|1968-03-08
TRIAL STUDY 134XCP|LB|2196D9F4-937A-4662-B24B-AC9D472E0393|2||||C130086|ENGLISH PLANTAIN POLLEN IGG|||||||BQ/UG|||||||TRACE||U/ML||||HIGH|NOT DONE||||VENOUS BLOOD|AUTOLYZED|N|OPTICAL DENSITY MEASUREMENT|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|NA|NA|||U|2||58||CONTINUATION TREATMENT|1972-10-18|1960-07-03|||||1966-01-26||1969-04-07|Y|1964-08-04
TRIAL STUDY 134XCP|LB|2196D9F4-937A-4662-B24B-AC9D472E0393|1||||ACHRAB|ACETYLCHOLINE RECEPTOR ANTIBODY|||||||LOG10 COPIES/ML|||||||TRACE||PKAT||||HIGH|NOT DONE||||SALIVA|FROZEN|NA|NUCLEIC ACID SEQUENCING|CKD-EPI FORMULA||Y|U|U|U|||U|3||39||RUN-IN|1972-10-11|1972-02-11|||||1964-04-19||1965-08-12|N|1970-12-26
TRIAL STUDY 134XCP|LB|2196D9F4-937A-4662-B24B-AC9D472E0393|2||||VLDLPSZ|VLDL PARTICLE SIZE|||||||FRAMES/S|||||||INDETERMINATE||/4.0 ML||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|UNEXPECTED ODOR|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|GMI MMOL/MOL FORMULA||U|U|NA|N|||Y|3||39||OPEN LABEL TREATMENT|1968-04-29|1965-07-16|||||1965-05-20||1970-09-29|NA|1968-05-07
TRIAL STUDY 134XCP|LB|2196D9F4-937A-4662-B24B-AC9D472E0393|1||||LAM|LIPOARABINOMANNAN|||||||/2000 RBC|||||||POSITIVE||KA_U/DL||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|REFRIGERATED|Y|DYNAMIC LIGHT SCATTERING|ASH FIBROSURE FORMULA||NA|Y|NA|U|||Y|4||88||LONG-TERM FOLLOW-UP|1965-04-08|1964-04-30|||||1967-09-11||1962-10-14|N|1961-09-11
TRIAL STUDY 134XCP|LB|2196D9F4-937A-4662-B24B-AC9D472E0393|2||||FENTANYL|FENTANYL|||||||WAFER|||||||BORDERLINE||PMOL||||LOW|NOT DONE||||REFLEX TEAR|NON-HEMOLYZED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|COCKCROFT-GAULT FORMULA||U|N|U|N|||NA|4||88||INDUCTION TREATMENT|1960-04-04|1963-10-19|||||1971-08-02||1961-12-22|U|1965-11-24
TRIAL STUDY 134XCP|LB|2196D9F4-937A-4662-B24B-AC9D472E0393|1||||C165889|RUSSIAN THISTLE POLLEN IGE AB RAST SCORE|||||||FL|||||||INDETERMINATE||UKAT||||NORMAL|NOT DONE||||REFLEX TEAR|AGGLUTINATED|NA|TELLER ACUITY CARDS|FIBROSIS 4 FORMULA||NA|Y|Y|Y|||U|5||7||INDUCTION TREATMENT|1967-01-15|1965-07-01|||||1971-08-04||1963-06-23|NA|1971-01-07
TRIAL STUDY 134XCP|LB|2196D9F4-937A-4662-B24B-AC9D472E0393|2||||TROPONIN|TROPONIN|||||||NG/DAY|||||||NEGATIVE||UG/G/MIN||||ABNORMAL|NOT DONE||||BLOOD|LACTESCENT|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|CKD-EPI FORMULA||Y|U|Y|Y|||NA|5||7||INDUCTION TREATMENT|1964-12-28|1966-09-01|||||1969-05-22||1968-02-06|U|1969-06-20
TRIAL STUDY 134XCP|LB|F192452A-4088-46AA-9DD1-8D14809E18F6|1||||HBCOHGB|CARBOXYHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||BQ/G|||||||BORDERLINE||MG/MOL||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|REFRIGERATED|Y|HPLC/MS/MS|HEPASCORE FORMULA||Y|N|U|Y|||U|1||38||FOLLOW-UP|1963-01-18|1969-11-06|||||1967-09-24||1966-07-04|NA|1971-01-14
TRIAL STUDY 134XCP|LB|F192452A-4088-46AA-9DD1-8D14809E18F6|2||||CHOLOH4B|4-BETA-HYDROXYCHOLESTEROL|||||||MMHG/L/MIN|||||||INVALID||MOL/MOL||||ABNORMAL|NOT DONE||||BILE|SOLIDIFIED|N|POPULATION SEQUENCING|MDRD 4 VARIABLE FORMULA||N|N|N|Y|||Y|1||38||INDUCTION TREATMENT|1972-05-16|1966-02-07|||||1962-09-05||1966-12-07|NA|1968-09-30
TRIAL STUDY 134XCP|LB|F192452A-4088-46AA-9DD1-8D14809E18F6|1||||CSMIX|MIXED CASTS|||||||/MIN|||||||INDETERMINATE||PATCH||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|N|CISH|MDRD ENZYMATIC FORMULA||U|Y|NA|N|||U|2||58||WASHOUT|1964-01-20|1961-02-06|||||1969-12-03||1962-05-15|U|1965-03-06
TRIAL STUDY 134XCP|LB|F192452A-4088-46AA-9DD1-8D14809E18F6|2||||HGBMET|METHEMOGLOBIN|||||||U|||||||NEGATIVE||PL||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|FRESH|N|WESTERGREN|FIBROTEST FORMULA||U|Y|U|Y|||NA|2||58||BASELINE|1964-06-19|1973-02-27|||||1969-01-29||1967-04-20|Y|1972-12-07
TRIAL STUDY 134XCP|LB|F192452A-4088-46AA-9DD1-8D14809E18F6|1||||APOA1|APOLIPOPROTEIN A1|||||||WEEKS|||||||NEGATIVE||MG/MIN||||NORMAL|NOT DONE||||LEUKOCYTE|REFRIGERATED|U|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|FIBROSIS 4 FORMULA||U|NA|Y|N|||N|3||39||BLINDED TREATMENT|1968-03-19|1962-07-30|||||1967-11-03||1973-04-16|Y|1969-11-04
TRIAL STUDY 134XCP|LB|F192452A-4088-46AA-9DD1-8D14809E18F6|2||||PHOSEXR|PHOSPHORUS EXCRETION RATE|||||||/500 WBC|||||||INDETERMINATE||EP U||||LOW|NOT DONE||||EMOTIONAL TEAR|CONTAMINATED|Y|PALPATION|MDRD 4 VARIABLE FORMULA||U|N|N|NA|||N|3||39||RUN-IN|1964-10-16|1969-09-27|||||1971-08-08||1970-01-02|NA|1965-05-21
TRIAL STUDY 134XCP|LB|F192452A-4088-46AA-9DD1-8D14809E18F6|1||||CANNAB|CANNABINOIDS|||||||PKAT|||||||TRACE||YD||||HIGH|NOT DONE||||GASTRIC CONTENTS|FROZEN|NA|GIEMSA STAIN|HEPASCORE FORMULA||N|Y|U|Y|||N|4||88||SCREENING|1966-04-13|1971-03-13|||||1969-01-12||1972-09-15|NA|1964-08-13
TRIAL STUDY 134XCP|LB|F192452A-4088-46AA-9DD1-8D14809E18F6|2||||RDWRSD|RET RDW STANDARD DEVIATION|||||||IU/ML|||||||INVALID||ANSON U||||NORMAL|NOT DONE||||VENOUS BLOOD|DRIED|NA|PHASE CONTRAST MICROSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|NA|N|||U|4||88||CONTINUATION TREATMENT|1964-07-13|1965-02-10|||||1964-10-08||1965-10-09|U|1973-02-01
TRIAL STUDY 134XCP|LB|F192452A-4088-46AA-9DD1-8D14809E18F6|1||||CANNABM|CANNABINOID METABOLITES|||||||FRACTION OF 1|||||||BORDERLINE||NSEC||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|LIPEMIC|NA|GC/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|N|Y|||Y|5||7||INDUCTION TREATMENT|1967-02-22|1960-04-29|||||1967-04-14||1969-11-14|U|1969-06-18
TRIAL STUDY 134XCP|LB|F192452A-4088-46AA-9DD1-8D14809E18F6|2||||ERCEMPOL|ERYTHROID MATURATION POOL|||||||UU/L|||||||TRACE||NU/CL||||HIGH|NOT DONE||||AMNIOTIC FLUID|ICTERIC|NA|ANTIBIOTIC AGAR SCREEN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|U|NA|||NA|5||7||SCREENING|1969-03-01|1968-12-31|||||1970-02-07||1965-07-07|Y|1972-09-14
TRIAL STUDY 134XCP|LB|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|1||||LH|LUTEINIZING HORMONE|||||||TUBERCULIN UNIT|||||||INVALID||10^6/HPF||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC|N|MICROBIAL CULTURE, LIQUID|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|NA|||U|1||38||TREATMENT|1973-02-21|1973-01-07|||||1967-06-10||1971-02-28|Y|1968-06-26
TRIAL STUDY 134XCP|LB|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|2||||HBA1B|HEMOGLOBIN A1B|||||||ABSORBANCE U/ML|||||||TRACE||PMOL/L||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|CONCENTRATED|Y|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI FORMULA||Y|U|U|N|||U|1||38||BLINDED TREATMENT|1966-03-06|1973-01-20|||||1973-04-15||1973-02-14|N|1965-04-09
TRIAL STUDY 134XCP|LB|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|1||||SCHISTO|SCHISTOCYTES|||||||MG/KG/H|||||||POSITIVE||UG||||LOW|NOT DONE||||EPITHELIAL CELL|HEMOLYZED|U|OPTICAL DENSITY MEASUREMENT|MDRD 6 VARIABLE FORMULA||NA|N|N|U|||NA|2||58||FOLLOW-UP|1963-09-21|1961-08-07|||||1968-01-11||1969-01-09|N|1968-08-25
TRIAL STUDY 134XCP|LB|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|2||||LIPASEP|LIPASE, PANCREATIC|||||||10^3/L|||||||INVALID||ANSON U||||HIGH|NOT DONE||||BASAL TEAR|FROZEN|N|IMMUNOPRECIPITATION|MDRD 4 VARIABLE FORMULA||NA|Y|NA|N|||N|2||58||TREATMENT|1964-11-08|1968-10-09|||||1972-07-30||1972-03-20|N|1966-11-28
TRIAL STUDY 134XCP|LB|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|1||||LPA|LIPOPROTEIN-A|||||||HR/DAY|||||||BORDERLINE||NMOL BCE/MMOL||||HIGH|NOT DONE||||PLATELET POOR PLASMA|THAWED|NA|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|CKD-EPI CREATININE FORMULA||Y|N|N|Y|||Y|3||39||LONG-TERM FOLLOW-UP|1960-12-27|1972-09-10|||||1971-12-09||1973-06-10|Y|1973-04-10
TRIAL STUDY 134XCP|LB|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|2||||NEUTAGR|AGRANULAR NEUTROPHILS|||||||10^6/EJACULATE U|||||||NEGATIVE||MG2/DL2||||HIGH|NOT DONE||||VITREOUS HUMOR|NON-HEMOLYZED|NA|PYROSEQUENCING|CKD-EPI CREATININE FORMULA||N|NA|NA|N|||U|3||39||INDUCTION TREATMENT|1961-10-31|1962-04-29|||||1967-06-27||1960-01-27|Y|1970-09-02
TRIAL STUDY 134XCP|LB|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|1||||BTLBARTL|BUTABARBITAL|||||||TSP|||||||INVALID||ML/MMHG/MIN/L||||HIGH|NOT DONE||||VENOUS PLASMA|CONTAMINATED|Y|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|HEPASCORE FORMULA||U|N|Y|U|||U|4||88||SCREENING|1963-05-31|1960-10-14|||||1973-09-03||1961-10-30|U|1960-11-22
TRIAL STUDY 134XCP|LB|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|2||||PTSAC|PROTEIN S ACTUAL/CONTROL|||||||VP/DOSE|||||||TRACE||UV||||LOW|NOT DONE||||SUPERNATANT, PLEURAL FLUID|HEMOLYZED|Y|HPLC/MS|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|N|Y|||NA|4||88||CONTINUATION TREATMENT|1960-03-21|1964-04-30|||||1962-11-20||1973-05-12|N|1966-04-11
TRIAL STUDY 134XCP|LB|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|1||||FACTVII|FACTOR VII|||||||OHM|||||||TRACE||DAGU/ML||||HIGH|NOT DONE||||HAIR FOLLICLE|ROOM TEMPERATURE|U|WRIGHT-GIEMSA STAIN|MDRD 4 VARIABLE FORMULA||N|U|U|Y|||N|5||7||OPEN LABEL TREATMENT|1966-02-11|1967-01-23|||||1971-12-29||1963-07-29|Y|1971-04-21
TRIAL STUDY 134XCP|LB|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|2||||ALBPROT|ALBUMIN/TOTAL PROTEIN|||||||MG/M2/MIN|||||||INVALID||MG2/DL2||||LOW|NOT DONE||||URINE SEDIMENT|LIPEMIC|Y|RAJI CELL EIA|HEPASCORE FORMULA||N|NA|N|Y|||U|5||7||WASHOUT|1967-08-23|1972-01-03|||||1967-11-16||1964-03-15|Y|1962-12-31
TRIAL STUDY 134XCP|LB|0D51A87E-2597-4B2D-A7B5-E533790E917D|1||||NEUTSGB|NEUTROPHILS, SEGMENTED + BAND FORM|||||||MG/ML/DAY|||||||POSITIVE||CFU/G||||ABNORMAL|NOT DONE||||RETICULOCYTES|CONCENTRATED|U|PULMONARY ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||N|Y|Y|U|||NA|1||38||OPEN LABEL TREATMENT|1964-12-23|1969-02-27|||||1971-01-21||1961-09-29|N|1966-12-31
TRIAL STUDY 134XCP|LB|0D51A87E-2597-4B2D-A7B5-E533790E917D|2||||RETICH|RET. CORPUSCULAR HEMOGLOBIN CONTENT|||||||FMOL/L|||||||INDETERMINATE||EU||||ABNORMAL|NOT DONE||||LYSATE|LACTESCENT|Y|TELLER ACUITY CARDS|MDRD 5 VARIABLE FORMULA||NA|N|U|Y|||Y|1||38||TREATMENT|1971-01-22|1962-08-20|||||1960-02-15||1969-11-11|N|1962-05-10
TRIAL STUDY 134XCP|LB|0D51A87E-2597-4B2D-A7B5-E533790E917D|1||||ALA1ALB|APOLIPOPROTEIN A1/APOLIPOPROTEIN B|||||||JAR|||||||POSITIVE||DRAM||||HIGH|NOT DONE||||TISSUE|NON-HEMOLYZED|N|CISH|FIBROTEST FORMULA||N|U|NA|U|||Y|2||58||TREATMENT|1969-10-18|1960-05-18|||||1971-09-25||1968-04-18|U|1972-10-17
TRIAL STUDY 134XCP|LB|0D51A87E-2597-4B2D-A7B5-E533790E917D|2||||DALACRT|DELTA AMINOLEVULINATE/CREATININE|||||||MG/ANIMAL|||||||POSITIVE||LOG10 ELISA UNIT||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|HEMOLYZED|N|CALIPER MEASUREMENT METHOD|CKD-EPI FORMULA||Y|N|NA|NA|||Y|2||58||FOLLOW-UP|1961-09-27|1960-12-07|||||1973-06-03||1963-01-23|U|1962-09-03
TRIAL STUDY 134XCP|LB|0D51A87E-2597-4B2D-A7B5-E533790E917D|1||||FACTIXA|FACTOR IX ACTIVITY|||||||UM/DAY|||||||NEGATIVE||UMOL||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|HEMOLYZED|NA|AGAR DILUTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|N|NA|||NA|3||39||FOLLOW-UP|1962-02-26|1972-12-14|||||1961-04-07||1972-04-24|U|1960-09-02
TRIAL STUDY 134XCP|LB|0D51A87E-2597-4B2D-A7B5-E533790E917D|2||||B2G1GMAB|BETA-2 GLYCOPROTEIN 1 IGM ANTIBODY|||||||MG/H|||||||BORDERLINE||UL||||ABNORMAL|NOT DONE||||FLUID|FROZEN|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||U|U|Y|NA|||U|3||39||INDUCTION TREATMENT|1965-02-17|1966-08-02|||||1961-07-29||1965-09-07|Y|1964-01-14
TRIAL STUDY 134XCP|LB|0D51A87E-2597-4B2D-A7B5-E533790E917D|1||||FACTXA|FACTOR X ACTIVITY|||||||NMOL/ML/MIN|||||||POSITIVE||ENZYME U/M2||||ABNORMAL|NOT DONE||||BASAL TEAR|LIPEMIC|NA|IMMUNO-PET SCAN|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|Y|Y|||Y|4||88||INDUCTION TREATMENT|1969-02-02|1970-01-24|||||1964-09-08||1970-06-12|N|1964-01-17
TRIAL STUDY 134XCP|LB|0D51A87E-2597-4B2D-A7B5-E533790E917D|2||||CHCM|CORPUSCULAR HGB CONCENTRATION MEAN|||||||GPL U/ML|||||||POSITIVE||PACKAGE||||ABNORMAL|NOT DONE||||COLOSTRUM|CONCENTRATED|N|FORCED OSCILLATION TECHNIQUE|HEPASCORE FORMULA||NA|N|NA|U|||Y|4||88||INDUCTION TREATMENT|1969-07-21|1967-12-06|||||1968-10-02||1960-03-26|U|1963-08-17
TRIAL STUDY 134XCP|LB|0D51A87E-2597-4B2D-A7B5-E533790E917D|1||||ALDEPX|ALDRIN EPOXIDASE|||||||EVENTS|||||||INVALID||G/L||||HIGH|NOT DONE||||LAVAGE FLUID|LIPEMIC|N|TRYPAN BLUE STAIN|GMI MMOL/MOL FORMULA||N|NA|N|NA|||N|5||7||CONTINUATION TREATMENT|1963-04-16|1969-04-15|||||1960-08-31||1968-02-05|NA|1971-03-06
TRIAL STUDY 134XCP|LB|0D51A87E-2597-4B2D-A7B5-E533790E917D|2||||CYAMMOX|AMMONIUM OXALATE CRYSTALS|||||||10^3 ORGANISMS|||||||NEGATIVE||MEQ/MMOL||||HIGH|NOT DONE||||EMOTIONAL TEAR|LACTESCENT|NA|COMPLEMENT FIXATION|CKD-EPI FORMULA||N|N|U|Y|||U|5||7||BLINDED TREATMENT|1960-06-28|1963-10-27|||||1969-10-16||1970-05-07|U|1961-09-30
TRIAL STUDY 134XCP|LB|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|1||||NEUTSGLE|NEUTROPHILS, SEGMENTED/LEUKOCYTES|||||||VIRTUAL PIXEL|||||||BORDERLINE||U/M2/MIN||||LOW|NOT DONE||||GASTRIC FLUID|GELLED|NA|SLOAN LETTER EYE CHART 1.25%|FIBROMETER FORMULA||NA|N|Y|N|||NA|1||38||SCREENING|1961-12-14|1971-11-09|||||1969-08-12||1968-03-15|N|1962-08-18
TRIAL STUDY 134XCP|LB|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|2||||NEUTIMLE|IMMATURE NEUTROPHILS/LEUKOCYTES|||||||CI|||||||NEGATIVE||GY/H||||NORMAL|NOT DONE||||TUMOR TISSUE|LIPEMIC|N|MODIFIED ACID FAST STAIN|MDRD ENZYMATIC FORMULA||NA|N|N|N|||U|1||38||RUN-IN|1968-05-28|1973-06-02|||||1963-04-24||1965-09-07|N|1972-05-17
TRIAL STUDY 134XCP|LB|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|1||||VEGFR1S|SOLUBLE VASC ENDOTH GROWTH FACTOR REC1|||||||/10^3|||||||NEGATIVE||UG/CM2||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|CALCIFIED|U|ECHOCARDIOGRAPHY|COCKCROFT-GAULT FORMULA||N|U|NA|N|||U|2||58||WASHOUT|1972-03-30|1967-12-04|||||1962-01-15||1972-08-07|U|1967-06-29
TRIAL STUDY 134XCP|LB|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|2||||MSTHCELE|MESOTHELIAL CELLS/LEUKOCYTES|||||||MV*MIN|||||||NEGATIVE||FRACTION OF 1||||HIGH|NOT DONE||||SUPERNATANT, SERUM|LACTESCENT|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CYSTATIN C FORMULA||N|N|U|NA|||NA|2||58||BASELINE|1968-12-03|1961-06-01|||||1964-08-09||1968-08-23|N|1964-06-04
TRIAL STUDY 134XCP|LB|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|1||||LDH4LDH|LDH ISOENZYME 4/LDH|||||||L|||||||INDETERMINATE||G/CAGE||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|CALCIFIED|Y|ENZYMATIC ULTRACENTRIFUGATION|GMI % FORMULA||NA|NA|Y|U|||NA|3||39||RUN-IN|1962-05-11|1963-09-07|||||1964-11-23||1972-08-08|Y|1969-01-31
TRIAL STUDY 134XCP|LB|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|2||||PMDW|PLATELET MASS DISTRIBUTION WIDTH|||||||MET*H|||||||NEGATIVE||G/CAGE||||ABNORMAL|NOT DONE||||EXUDATE|CLOTTED|N|COLORIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|N|NA|||N|3||39||OBSERVATION|1970-02-23|1968-08-27|||||1966-08-07||1965-06-06|N|1960-06-29
TRIAL STUDY 134XCP|LB|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|1||||TGLOB|THYROGLOBULIN|||||||STEPS|||||||TRACE||MOL||||HIGH|NOT DONE||||VITREOUS HUMOR|DRIED|N|LEAD CITRATE STAIN|MDRD 5 VARIABLE FORMULA||N|NA|NA|N|||U|4||88||WASHOUT|1965-12-12|1960-08-30|||||1971-05-04||1965-10-27|U|1964-07-17
TRIAL STUDY 134XCP|LB|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|2||||CYFRA211|CYTOKERATIN 19 FRAGMENT 21-1|||||||10^7 CFU/ML|||||||INDETERMINATE||ELISA UNIT/DOSE||||NORMAL|NOT DONE||||EPITHELIAL CELL|CLOTTED|NA|EPSILOMETER|MDRD FORMULA||NA|U|Y|N|||U|4||88||OBSERVATION|1968-01-18|1964-12-14|||||1960-10-25||1965-04-22|Y|1961-08-08
TRIAL STUDY 134XCP|LB|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|1||||VITB6|VITAMIN B6|||||||PACK|||||||INDETERMINATE||APPLICATION||||LOW|NOT DONE||||BONE MARROW|FRESH|U|WHOLE EXOME SEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|Y|||N|5||7||WASHOUT|1964-01-30|1965-12-20|||||1967-03-24||1971-01-31|N|1971-04-19
TRIAL STUDY 134XCP|LB|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|2||||METHDN|METHADONE|||||||/7.5 ML|||||||BORDERLINE||MMOL/S||||HIGH|NOT DONE||||PLEURAL FLUID|LACTESCENT|NA|TRIPLE-PHASE SPIRAL CT SCAN|MDRD FORMULA||U|U|N|U|||N|5||7||OBSERVATION|1964-05-28|1964-11-18|||||1965-05-08||1965-10-08|N|1968-11-23
TRIAL STUDY 134XCP|LB|16075684-F04D-4CB8-970A-0819378790EB|1||||LYM|LYMPHOCYTES|||||||GENEQ/ML|||||||INDETERMINATE||U/KG||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|CALCIFIED|NA|POPULATION SEQUENCING|MDRD 6 VARIABLE FORMULA||Y|NA|Y|N|||NA|1||38||RUN-IN|1966-05-07|1969-08-25|||||1963-01-22||1964-08-06|U|1960-09-15
TRIAL STUDY 134XCP|LB|16075684-F04D-4CB8-970A-0819378790EB|2||||GUDCA|GLYCOURSODEOXYCHOLATE|||||||DAGU/ML|||||||TRACE||IU/MG||||LOW|NOT DONE||||LYSATE|ROOM TEMPERATURE|U|SCANNING ELECTRON MICROSCOPY|COCKCROFT-GAULT FORMULA||U|U|NA|U|||U|1||38||OPEN LABEL TREATMENT|1960-02-16|1962-01-27|||||1961-07-07||1969-06-27|U|1965-04-14
TRIAL STUDY 134XCP|LB|16075684-F04D-4CB8-970A-0819378790EB|1||||MYBLAT2|TYPE II MYELOBLASTS|||||||UL/ML|||||||NEGATIVE||S*KPA||||ABNORMAL|NOT DONE||||LAVAGE FLUID|ROOM TEMPERATURE|NA|NEPHELOMETRY|CKD-EPI CYSTATIN C FORMULA||U|U|U|U|||NA|2||58||SCREENING|1969-10-04|1966-03-08|||||1970-05-28||1963-10-29|U|1969-12-25
TRIAL STUDY 134XCP|LB|16075684-F04D-4CB8-970A-0819378790EB|2||||LTB4|LEUKOTRIENE B4|||||||10^6 CFU|||||||BORDERLINE||CM||||HIGH|NOT DONE||||LAVAGE FLUID|SOLIDIFIED|NA|FLUORESCENT LIFETIME IMAGING MICROSCOPY|CKD-EPI CREATININE FORMULA||NA|NA|NA|Y|||NA|2||58||OPEN LABEL TREATMENT|1960-12-30|1966-06-02|||||1971-05-29||1967-12-13|U|1970-06-29
TRIAL STUDY 134XCP|LB|16075684-F04D-4CB8-970A-0819378790EB|1||||VAL|VALINE|||||||DISK|||||||INDETERMINATE||EID 50/DOSE||||NORMAL|NOT DONE||||GASTRIC FLUID|THAWED|Y|IMMUNORADIOMETRIC ASSAY|MDRD 4 VARIABLE FORMULA||Y|U|U|NA|||N|3||39||CONTINUATION TREATMENT|1967-09-22|1971-09-05|||||1971-09-14||1966-06-30|N|1971-06-09
TRIAL STUDY 134XCP|LB|16075684-F04D-4CB8-970A-0819378790EB|2||||MDZPM|MEDAZEPAM|||||||F|||||||BORDERLINE||CMH2O/ML||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|DRIED|U|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|CKD-EPI CREATININE FORMULA||U|U|NA|NA|||Y|3||39||TREATMENT|1970-09-22|1971-02-07|||||1960-03-07||1968-05-24|U|1968-06-18
TRIAL STUDY 134XCP|LB|16075684-F04D-4CB8-970A-0819378790EB|1||||C165928|INDUSTRIAL MIX IGE AB RAST SCORE|||||||CCID 50/ML|||||||INVALID||KHZ||||ABNORMAL|NOT DONE||||BONE|UNEXPECTED ODOR|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD FORMULA||NA|U|Y|N|||N|4||88||LONG-TERM FOLLOW-UP|1972-01-13|1968-02-20|||||1972-01-11||1964-06-08|U|1969-10-09
TRIAL STUDY 134XCP|LB|16075684-F04D-4CB8-970A-0819378790EB|2||||NAGCREAT|N-ACETYL GLUCOSAMIDE/CREATININE|||||||UG/M2|||||||INDETERMINATE||KBQ/UL||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|NON-HEMOLYZED|NA|PHOTOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|U|U|NA|||NA|4||88||BASELINE|1962-03-02|1967-05-17|||||1972-03-04||1969-08-17|N|1971-03-12
TRIAL STUDY 134XCP|LB|16075684-F04D-4CB8-970A-0819378790EB|1||||CACRALB|CALCIUM CORRECTED FOR ALBUMIN|||||||MOL/L|||||||INVALID||ML/SEC/1.73M2||||HIGH|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LIPEMIC|Y|LISSAMINE GREEN STAIN|CKD-EPI CYSTATIN C FORMULA||N|Y|U|U|||N|5||7||SCREENING|1963-02-20|1966-08-02|||||1961-02-01||1970-04-24|N|1970-01-26
TRIAL STUDY 134XCP|LB|16075684-F04D-4CB8-970A-0819378790EB|2||||OXZPM|OXAZEPAM|||||||10^9/DOSE|||||||INDETERMINATE||MG/DOSE||||HIGH|NOT DONE||||PLASMA|ICTERIC|Y|SMEAR|MDRD 6 VARIABLE FORMULA||U|Y|NA|NA|||NA|5||7||SCREENING|1972-01-16|1964-05-26|||||1973-02-23||1963-04-04|NA|1970-10-22
TRIAL STUDY 134XCP|LB|3527E844-D4D5-480A-B6D6-04C5DC0A3380|1||||RBCNUCLE|NUCLEATED ERYTHROCYTES/LEUKOCYTES|||||||U/G/MIN|||||||INDETERMINATE||MDFI||||ABNORMAL|NOT DONE||||SWABBED MATERIAL|UNEXPECTED ODOR|N|TRANSVAGINAL ULTRASOUND|MDRD 5 VARIABLE FORMULA||U|Y|N|Y|||NA|1||38||OBSERVATION|1972-02-15|1961-04-18|||||1964-10-05||1971-06-12|Y|1967-04-11
TRIAL STUDY 134XCP|LB|3527E844-D4D5-480A-B6D6-04C5DC0A3380|2||||MYPC|MYELOID PROGENITOR CELLS|||||||ML/KG/DAY|||||||TRACE||G/M2||||HIGH|NOT DONE||||DISCHARGE|CONTAMINATED|Y|ELISPOT|COCKCROFT-GAULT FORMULA||NA|Y|NA|N|||Y|1||38||OPEN LABEL TREATMENT|1961-09-27|1972-01-13|||||1960-09-02||1972-11-06|NA|1968-11-08
TRIAL STUDY 134XCP|LB|3527E844-D4D5-480A-B6D6-04C5DC0A3380|1||||C165922|MIXED ANTIGEN IGE AB RAST SCORE|||||||10^3 ORGANISMS/ML|||||||TRACE||DPM/ML||||ABNORMAL|NOT DONE||||MECONIUM|NON-HEMOLYZED|Y|GEL ELECTROPHORESIS|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|NA|NA|||Y|2||58||SCREENING|1973-03-29|1961-07-22|||||1962-05-30||1962-06-10|U|1963-04-06
TRIAL STUDY 134XCP|LB|3527E844-D4D5-480A-B6D6-04C5DC0A3380|2||||NTENS|NEUROTENSIN|||||||MET|||||||BORDERLINE||U/DL||||ABNORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|LIPEMIC|Y|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|GMI % FORMULA||U|U|N|U|||N|2||58||BASELINE|1970-02-04|1961-02-13|||||1964-07-04||1969-04-09|N|1971-07-07
TRIAL STUDY 134XCP|LB|3527E844-D4D5-480A-B6D6-04C5DC0A3380|1||||INTLK1|INTERLEUKIN 1|||||||ML|||||||NEGATIVE||TUBERCULIN UNIT||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|NON-HEMOLYZED|U|RYAN BLUE STAIN|COCKCROFT-GAULT FORMULA||N|NA|Y|N|||Y|3||39||FOLLOW-UP|1971-08-08|1970-02-23|||||1961-03-22||1960-11-15|N|1962-11-15
TRIAL STUDY 134XCP|LB|3527E844-D4D5-480A-B6D6-04C5DC0A3380|2||||CD22|CD22|||||||KALLIKREIN INHIBITOR UNIT|||||||TRACE||NG/MOL||||ABNORMAL|NOT DONE||||PLEURAL FLUID|THAWED|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|FIBROSIS 4 FORMULA||U|NA|N|NA|||U|3||39||FOLLOW-UP|1967-06-14|1962-01-05|||||1971-02-18||1965-03-08|NA|1972-09-11
TRIAL STUDY 134XCP|LB|3527E844-D4D5-480A-B6D6-04C5DC0A3380|1||||RETIL|LOW ABSORPTION RETICULOCYTES|||||||ML/ANIMAL/WK|||||||TRACE||UG/M2/DAY||||NORMAL|NOT DONE||||LYMPH|CONCENTRATED|NA|WRIGHT-GIEMSA STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|NA|N|||N|4||88||FOLLOW-UP|1960-08-19|1965-01-29|||||1968-06-05||1971-11-18|NA|1963-07-08
TRIAL STUDY 134XCP|LB|3527E844-D4D5-480A-B6D6-04C5DC0A3380|2||||GFRBSCYC|GFR FROM CYSTATIN C ADJUSTED FOR BSA|||||||IU/L|||||||INDETERMINATE||NMOL BCE/NMOL||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|CONTAMINATED|NA|LC/MS|FIBROTEST FORMULA||Y|N|U|U|||Y|4||88||SCREENING|1963-07-25|1969-12-20|||||1973-04-01||1971-10-02|NA|1960-08-08
TRIAL STUDY 134XCP|LB|3527E844-D4D5-480A-B6D6-04C5DC0A3380|1||||LYMCE|LYMPHOCYTES/TOTAL CELLS|||||||DPM/ML|||||||INDETERMINATE||UKAT/10^12 RBC||||LOW|NOT DONE||||ARTERIAL BLOOD|CALCIFIED|NA|HPLC-FL|CKD-EPI CYSTATIN C FORMULA||NA|NA|U|N|||N|5||7||LONG-TERM FOLLOW-UP|1965-05-21|1967-08-22|||||1964-10-26||1963-12-10|NA|1970-09-08
TRIAL STUDY 134XCP|LB|3527E844-D4D5-480A-B6D6-04C5DC0A3380|2||||RBCGHOST|ERYTHROCYTE GHOSTS|||||||TITER|||||||POSITIVE||ML/BREATH||||NORMAL|NOT DONE||||SEMEN|LIPEMIC|NA|CARDIAC THERMODILUTION|CKD-EPI CREATININE FORMULA||Y|NA|N|U|||N|5||7||RUN-IN|1968-12-31|1969-08-03|||||1967-09-26||1973-05-12|NA|1968-08-29
TRIAL STUDY 134XCP|LB|DFB0DF52-4D95-4A26-B28F-071774D78426|1||||CONSIST|CONSISTENCY|||||||G/M2|||||||INVALID||NFIU||||NORMAL|NOT DONE||||SEBUM|NON-HEMOLYZED|Y|OLIGO ACGH|MDRD 4 VARIABLE FORMULA||U|U|U|N|||U|1||38||INDUCTION TREATMENT|1963-07-19|1968-03-27|||||1969-11-30||1972-05-19|N|1967-05-06
TRIAL STUDY 134XCP|LB|DFB0DF52-4D95-4A26-B28F-071774D78426|2||||GIPI|GLUCOSE-DEP INSULINOTROPIC PEP, INTACT|||||||DYN|||||||NEGATIVE||L/L||||NORMAL|NOT DONE||||SKIN TISSUE|LACTESCENT|NA|HPLC-UV|FIBROSIS 4 FORMULA||U|N|N|N|||Y|1||38||TREATMENT|1961-03-23|1967-09-16|||||1971-09-10||1970-08-30|Y|1963-01-20
TRIAL STUDY 134XCP|LB|DFB0DF52-4D95-4A26-B28F-071774D78426|1||||TSH|THYROTROPIN|||||||WEEKS|||||||BORDERLINE||PSI||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|DRIED|U|WHOLE GENOME SEQUENCING|GMI MMOL/MOL FORMULA||Y|Y|N|N|||Y|2||58||BASELINE|1967-09-26|1962-10-02|||||1972-01-23||1968-05-13|U|1971-02-17
TRIAL STUDY 134XCP|LB|DFB0DF52-4D95-4A26-B28F-071774D78426|2||||FIBRINO|FIBRINOGEN|||||||MMOL/MIN/KPA/L|||||||BORDERLINE||KEV||||LOW|NOT DONE||||PUS|SOLIDIFIED|NA|CONFOCAL MICROSCOPY|FIBROTEST FORMULA||U|U|Y|N|||N|2||58||WASHOUT|1973-01-22|1968-04-10|||||1969-09-12||1964-03-05|N|1960-04-11
TRIAL STUDY 134XCP|LB|DFB0DF52-4D95-4A26-B28F-071774D78426|1||||TTAC|THROMBIN TIME ACTUAL/CONTROL|||||||G/G/DAY|||||||TRACE||U/G/DAY||||ABNORMAL|NOT DONE||||STOOL|FRESH|NA|LIGHT SCATTERING SPECTROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|NA|U|||U|3||39||FOLLOW-UP|1962-04-23|1968-02-07|||||1960-09-01||1969-12-02|Y|1973-04-14
TRIAL STUDY 134XCP|LB|DFB0DF52-4D95-4A26-B28F-071774D78426|2||||SVCAM1|SOLUBLE VASC CELL ADHESION MOLECULE 1|||||||G/G/DAY|||||||NEGATIVE||IU/G HB||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|DRIED|NA|INCISION-INDUCED BLEEDING METHOD|FIBROSIS 4 FORMULA||Y|NA|NA|U|||N|3||39||FOLLOW-UP|1965-03-05|1963-07-27|||||1966-07-25||1960-10-21|U|1963-04-22
TRIAL STUDY 134XCP|LB|DFB0DF52-4D95-4A26-B28F-071774D78426|1||||C165930|SHELLFISH MIX IGE AB RAST SCORE|||||||CAN|||||||TRACE||MOSM/L||||ABNORMAL|NOT DONE||||LYSATE|UNEXPECTED ODOR|N|AURAMINE STAIN|FIBROSIS 4 FORMULA||NA|U|Y|NA|||N|4||88||BASELINE|1962-07-23|1971-07-14|||||1960-03-22||1962-05-22|U|1965-03-28
TRIAL STUDY 134XCP|LB|DFB0DF52-4D95-4A26-B28F-071774D78426|2||||C165887|ENGLISHPLANTAIN POLLEN IGE AB RAST SCORE|||||||GTT|||||||TRACE||MET*H||||ABNORMAL|NOT DONE||||LYSATE|REFRIGERATED|Y|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|MDRD 5 VARIABLE FORMULA||N|NA|U|N|||N|4||88||BLINDED TREATMENT|1965-01-04|1964-08-02|||||1970-09-08||1971-06-26|N|1960-10-17
TRIAL STUDY 134XCP|LB|DFB0DF52-4D95-4A26-B28F-071774D78426|1||||BASOMYL|BASOPHILIC MYELOCYTES|||||||DYN|||||||BORDERLINE||L/MIN||||ABNORMAL|NOT DONE||||CERUMEN|UNEXPECTED ODOR|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|MDRD ENZYMATIC FORMULA||U|N|U|NA|||U|5||7||OPEN LABEL TREATMENT|1967-08-08|1961-01-18|||||1965-05-22||1968-04-22|U|1971-10-21
TRIAL STUDY 134XCP|LB|DFB0DF52-4D95-4A26-B28F-071774D78426|2||||CBS|CYSTATHIONINE BETA-SYNTHASE|||||||PIXEL|||||||INVALID||/5X10^4 WBC||||NORMAL|NOT DONE||||EXUDATE|FROZEN|Y|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|NASH FIBROSURE FORMULA||U|NA|NA|N|||N|5||7||SCREENING|1973-04-23|1968-11-05|||||1968-02-03||1968-11-05|NA|1966-03-08
TRIAL STUDY 134XCP|LB|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|1||||CA72_4AG|CANCER ANTIGEN 72-4|||||||C|||||||INDETERMINATE||BEAM BREAKS||||HIGH|NOT DONE||||BILE|GELLED|Y|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|MDRD ENZYMATIC FORMULA||N|Y|Y|Y|||Y|1||38||WASHOUT|1969-03-22|1964-08-25|||||1960-06-05||1966-12-11|N|1969-03-22
TRIAL STUDY 134XCP|LB|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|2||||RBCFRAG|ERYTHROCYTE FRAGMENT|||||||10^3 CFU/ML|||||||INDETERMINATE||AMP||||ABNORMAL|NOT DONE||||BLOOD|FRESH|U|AGAR PROPORTION|GMI % FORMULA||U|NA|N|N|||NA|1||38||WASHOUT|1961-11-05|1963-12-16|||||1963-02-23||1965-04-02|NA|1962-04-28
TRIAL STUDY 134XCP|LB|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|1||||IMMGLB|IMMUNOGLOBULIN|||||||NM|||||||POSITIVE||HZ/S||||ABNORMAL|NOT DONE||||PLEURAL TISSUE|NON-HEMOLYZED|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|CKD-EPI FORMULA||NA|NA|N|U|||N|2||58||SCREENING|1967-06-19|1964-08-27|||||1964-07-17||1967-12-27|NA|1963-02-14
TRIAL STUDY 134XCP|LB|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|2||||GLY|GLYCINE|||||||MASK|||||||NEGATIVE||UMOL/L/H||||LOW|NOT DONE||||SWABBED MATERIAL|FROZEN|N|BIOIMPEDANCE SPECTROSCOPY|COCKCROFT-GAULT FORMULA||Y|N|Y|N|||NA|2||58||INDUCTION TREATMENT|1966-03-23|1965-07-05|||||1965-02-26||1968-11-21|Y|1966-03-14
TRIAL STUDY 134XCP|LB|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|1||||RBCDYSM|DYSMORPHIC ERYTHROCYTES|||||||U/M2/MIN|||||||BORDERLINE||G/CAGE/WK||||LOW|NOT DONE||||DERMAL TISSUE|FRESH|U|STATIC PERIMETRY|FIBROTEST FORMULA||N|NA|U|Y|||Y|3||39||OPEN LABEL TREATMENT|1968-10-14|1960-12-27|||||1963-09-12||1972-10-05|N|1965-08-06
TRIAL STUDY 134XCP|LB|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|2||||TRIM38|TRIPARTITE MOTIF CONTAINING PROTEIN 38|||||||FMOL/L|||||||INVALID||FT2||||LOW|NOT DONE||||CEREBROSPINAL FLUID|ICTERIC|NA|SPECT/CT SCAN|MDRD 4 VARIABLE FORMULA||N|N|Y|NA|||NA|3||39||BASELINE|1971-07-23|1961-07-15|||||1967-08-02||1972-03-31|U|1960-03-03
TRIAL STUDY 134XCP|LB|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|1||||TOXGRAN|TOXIC GRANULATION|||||||CG|||||||INVALID||1/(S*KPA)||||LOW|NOT DONE||||CELL PELLET|FROZEN|NA|ENDOSCOPY|CKD-EPI CYSTATIN C FORMULA||NA|NA|Y|NA|||N|4||88||FOLLOW-UP|1965-03-16|1969-11-16|||||1961-04-03||1972-06-23|Y|1967-12-08
TRIAL STUDY 134XCP|LB|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|2||||BDNF|BRAIN-DERIVED NEUROTROPHIC FACTOR|||||||MAC50|||||||TRACE||FMOL/G||||ABNORMAL|NOT DONE||||LYMPH|CONCENTRATED|U|FLUORESCENCE ANGIOGRAPHY|FIBROTEST FORMULA||Y|NA|U|Y|||NA|4||88||CONTINUATION TREATMENT|1968-02-02|1960-03-09|||||1962-02-02||1961-02-27|U|1969-03-31
TRIAL STUDY 134XCP|LB|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|1||||CRDIGAAB|CARDIOLIPIN IGA ANTIBODY|||||||NMOL/KG/DAY|||||||BORDERLINE||MM||||HIGH|NOT DONE||||EMESIS|CONCENTRATED|Y|LISSAMINE GREEN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|U|N|||U|5||7||LONG-TERM FOLLOW-UP|1966-06-30|1971-03-12|||||1966-07-27||1967-06-27|NA|1970-03-05
TRIAL STUDY 134XCP|LB|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|2||||FRUCT|FRUCTOSAMINE|||||||10^3 COPIES/ML|||||||INVALID||G/M2/DAY||||ABNORMAL|NOT DONE||||BASAL TEAR|LACTESCENT|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|COCKCROFT-GAULT FORMULA||N|U|NA|NA|||Y|5||7||BASELINE|1961-08-01|1964-12-06|||||1973-03-10||1968-06-23|NA|1963-06-27
TRIAL STUDY 134XCP|LB|CFF20837-0091-467E-ABDE-72645BAFC849|1||||CAMP|CYCLIC ADENOSINE 3,5-MONOPHOSPHATE|||||||ML/H|||||||NEGATIVE||NMOL/MOL||||NORMAL|NOT DONE||||VENOUS BLOOD|CLOTTED|U|FLUOROSCOPY|MDRD FORMULA||N|NA|U|N|||NA|1||38||RUN-IN|1969-01-17|1967-07-31|||||1967-02-06||1969-01-07|Y|1966-11-21
TRIAL STUDY 134XCP|LB|CFF20837-0091-467E-ABDE-72645BAFC849|2||||ETPTPR|ETP TIME TO PEAK RELATIVE|||||||ML/CM3/MIN|||||||POSITIVE||IN2||||HIGH|NOT DONE||||PLATELET RICH PLASMA|SOLIDIFIED|N|PHOTOGRAPHY|MDRD ENZYMATIC FORMULA||N|NA|N|N|||N|1||38||OBSERVATION|1969-01-21|1962-04-12|||||1970-01-03||1969-10-12|U|1963-10-02
TRIAL STUDY 134XCP|LB|CFF20837-0091-467E-ABDE-72645BAFC849|1||||NSE|NEURON SPECIFIC ENOLASE|||||||H/WK|||||||BORDERLINE||10^6 ORGANISMS/ML||||LOW|NOT DONE||||EXPIRED AIR|AUTOLYZED|Y|NO INFORMATION|MDRD 4 VARIABLE FORMULA||Y|NA|Y|N|||Y|2||58||INDUCTION TREATMENT|1968-03-17|1967-06-17|||||1971-09-21||1970-12-08|Y|1972-10-10
TRIAL STUDY 134XCP|LB|CFF20837-0091-467E-ABDE-72645BAFC849|2||||FRUMCRTP|FRUCTOSAMINE CORRECTED FOR TOTAL PROTEIN|||||||UG/KG/DAY|||||||TRACE||PKAT||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|PARAFFIN-EMBEDDED|U|QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROMETER FORMULA||N|U|N|U|||Y|2||58||LONG-TERM FOLLOW-UP|1969-04-18|1961-12-06|||||1961-02-21||1963-01-19|NA|1967-08-18
TRIAL STUDY 134XCP|LB|CFF20837-0091-467E-ABDE-72645BAFC849|1||||PMDW|PLATELET MASS DISTRIBUTION WIDTH|||||||MKAT|||||||BORDERLINE||U/KG/DAY||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|U|CONTACT SPECULAR MICROSCOPY|MDRD 6 VARIABLE FORMULA||Y|Y|NA|U|||NA|3||39||BASELINE|1969-12-04|1963-06-27|||||1971-05-21||1964-07-26|U|1962-03-30
TRIAL STUDY 134XCP|LB|CFF20837-0091-467E-ABDE-72645BAFC849|2||||EOSNSQE|EOSINOPHILS/NON-SQUAM EPI CELLS|||||||UKAT/10^12 RBC|||||||NEGATIVE||HPA||||LOW|NOT DONE||||AQUEOUS HUMOR|ICTERIC|U|ELISA|CKD-EPI FORMULA||NA|Y|NA|U|||Y|3||39||LONG-TERM FOLLOW-UP|1970-08-28|1963-05-24|||||1969-06-16||1961-03-03|U|1973-04-17
TRIAL STUDY 134XCP|LB|CFF20837-0091-467E-ABDE-72645BAFC849|1||||HBA1A|HEMOGLOBIN A1A|||||||ANTI-XA IU/ML|||||||NEGATIVE||MG/MOL||||LOW|NOT DONE||||WHITE MATTER TISSUE|HEMOLYZED|NA|ELECTROCHEMILUMINESCENCE|CKD-EPI CREATININE FORMULA||U|Y|NA|U|||N|4||88||OPEN LABEL TREATMENT|1960-08-17|1968-05-29|||||1969-08-04||1969-05-22|Y|1962-07-12
TRIAL STUDY 134XCP|LB|CFF20837-0091-467E-ABDE-72645BAFC849|2||||CA72_4AG|CANCER ANTIGEN 72-4|||||||MMHG*MIN/L|||||||INVALID||UV2||||LOW|NOT DONE||||CAPILLARY BLOOD|AGGLUTINATED|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI CYSTATIN C FORMULA||NA|Y|U|NA|||U|4||88||RUN-IN|1965-01-06|1964-09-02|||||1961-01-30||1963-11-19|Y|1973-08-25
TRIAL STUDY 134XCP|LB|CFF20837-0091-467E-ABDE-72645BAFC849|1||||TRANK1|TPR-ANKYRIN REPEAT-CONTAINING PROTEIN 1|||||||CFU/ML|||||||INDETERMINATE||ELISA UNIT/DOSE||||LOW|NOT DONE||||TISSUE|CLOTTED|N|SLIT LAMP|GMI % FORMULA||U|NA|Y|NA|||U|5||7||WASHOUT|1967-06-01|1960-12-03|||||1965-12-03||1969-12-06|NA|1969-10-04
TRIAL STUDY 134XCP|LB|CFF20837-0091-467E-ABDE-72645BAFC849|2||||CSFAT|FATTY CASTS|||||||ML/SEC/1.73M2|||||||NEGATIVE||PNU/ML||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|CLOTTED|N|OPTICAL MAPPING|NASH FIBROSURE FORMULA||Y|Y|N|N|||N|5||7||BASELINE|1968-08-19|1966-05-08|||||1964-03-12||1971-07-15|N|1970-05-29
TRIAL STUDY 134XCP|LB|C79756C8-8601-4770-8BC2-7A530428BA82|1||||YEAST|YEAST CELLS|||||||/10^3|||||||INVALID||U/DL||||HIGH|NOT DONE||||SEBUM|GELLED|NA|PYROSEQUENCING|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|NA|Y|||N|1||38||OPEN LABEL TREATMENT|1972-03-17|1963-10-30|||||1965-10-04||1971-12-19|U|1966-05-25
TRIAL STUDY 134XCP|LB|C79756C8-8601-4770-8BC2-7A530428BA82|2||||EPO|ERYTHROPOIETIN|||||||PT_US|||||||TRACE||KCAL/DAY||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|SOLIDIFIED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|FIBROTEST FORMULA||NA|Y|N|Y|||Y|1||38||BASELINE|1967-07-26|1969-12-04|||||1966-02-04||1968-03-17|U|1960-09-11
TRIAL STUDY 134XCP|LB|C79756C8-8601-4770-8BC2-7A530428BA82|1||||ASSDNA|ANTI-SINGLE STRANDED DNA IGG|||||||CM/MIN|||||||INVALID||AU/ML||||LOW|NOT DONE||||SOFT TISSUE|PARAFFIN-EMBEDDED|U|SEQUENCING|MDRD 6 VARIABLE FORMULA||NA|U|NA|N|||Y|2||58||BASELINE|1961-11-18|1966-12-17|||||1969-02-24||1965-03-21|Y|1960-09-27
TRIAL STUDY 134XCP|LB|C79756C8-8601-4770-8BC2-7A530428BA82|2||||CCPAB|CYCLIC CITRULLINATED PEPTIDE ANTIBODY|||||||ML/MMHG/MIN/L|||||||NEGATIVE||10^3 COPIES/ML||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|HEMOLYZED|N|FLOCCULATION, CHARCOAL ENHANCED|COCKCROFT-GAULT FORMULA||U|N|Y|N|||N|2||58||OPEN LABEL TREATMENT|1972-05-25|1960-05-04|||||1972-11-04||1972-12-19|N|1967-01-11
TRIAL STUDY 134XCP|LB|C79756C8-8601-4770-8BC2-7A530428BA82|1||||ILE|ISOLEUCINE|||||||GPL U|||||||INVALID||UG/KG/DAY||||NORMAL|NOT DONE||||SKIN TISSUE|DRIED|U|CT SCAN|FIBROMETER FORMULA||N|N|U|N|||NA|3||39||LONG-TERM FOLLOW-UP|1970-11-09|1972-02-10|||||1973-03-10||1961-03-19|N|1966-03-14
TRIAL STUDY 134XCP|LB|C79756C8-8601-4770-8BC2-7A530428BA82|2||||MSTHCELE|MESOTHELIAL CELLS/LEUKOCYTES|||||||L/MIN|||||||INVALID||10^6 DNA COPIES/ML||||HIGH|NOT DONE||||INFRANATANT, SERUM|ROOM TEMPERATURE|U|MICRO BROTH DILUTION|CKD-EPI CYSTATIN C FORMULA||Y|U|N|U|||NA|3||39||LONG-TERM FOLLOW-UP|1966-10-09|1970-05-09|||||1960-09-21||1967-05-13|U|1972-12-29
TRIAL STUDY 134XCP|LB|C79756C8-8601-4770-8BC2-7A530428BA82|1||||CTC|CIRCULATING TUMOR CELLS|||||||LOG10 CFU/G|||||||INVALID||VG/KG||||NORMAL|NOT DONE||||BILE|CONCENTRATED|Y|POLYMERASE CHAIN REACTION|MDRD 5 VARIABLE FORMULA||U|N|N|U|||U|4||88||WASHOUT|1967-02-14|1972-08-05|||||1969-06-12||1965-05-05|NA|1971-02-07
TRIAL STUDY 134XCP|LB|C79756C8-8601-4770-8BC2-7A530428BA82|2||||C130134|D. PTERONYSSINUS ANTIGEN IGE ANTIBODY|||||||SCM|||||||TRACE||10^4/HPF||||NORMAL|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|ICTERIC|Y|CORONARY ANGIOGRAPHY|CKD-EPI CREATININE FORMULA||NA|N|N|U|||N|4||88||CONTINUATION TREATMENT|1966-10-20|1971-08-19|||||1966-10-01||1963-09-13|Y|1966-07-19
TRIAL STUDY 134XCP|LB|C79756C8-8601-4770-8BC2-7A530428BA82|1||||UROBIL|UROBILINOGEN|||||||G/CM2|||||||BORDERLINE||10^9 ORGANISMS/MG||||LOW|NOT DONE||||CORD SERUM|LACTESCENT|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|HEPASCORE FORMULA||U|U|NA|N|||N|5||7||RUN-IN|1966-02-02|1963-09-16|||||1969-10-29||1966-02-24|Y|1963-07-09
TRIAL STUDY 134XCP|LB|C79756C8-8601-4770-8BC2-7A530428BA82|2||||ACYCRNTN|ACYLCARNITINE|||||||UG/M2/H|||||||INVALID||COPIES/UL||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|DRIED|N|QUANTITATIVE COMPUTED TOMOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|Y|N|||NA|5||7||SCREENING|1964-08-19|1963-08-25|||||1968-06-04||1967-10-26|NA|1965-08-24
TRIAL STUDY 134XCP|LB|5533A669-828B-4CA3-BEC3-849CE7384167|1||||APOC2|APOLIPOPROTEIN C2|||||||DAGU|||||||INDETERMINATE||BQ/KG||||NORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|DRIED|U|ECHOCARDIOGRAPHY|MDRD 5 VARIABLE FORMULA||N|U|NA|NA|||NA|1||38||RUN-IN|1966-09-08|1969-03-14|||||1966-08-29||1969-07-31|U|1971-12-14
TRIAL STUDY 134XCP|LB|5533A669-828B-4CA3-BEC3-849CE7384167|2||||NCCPTN|NOCICEPTIN|||||||MEQ/UL|||||||INDETERMINATE||CFU/G||||ABNORMAL|NOT DONE||||GASTRIC FLUID|DRIED|N|WRIGHT-GIEMSA STAIN|CKD-EPI FORMULA||Y|NA|Y|N|||NA|1||38||LONG-TERM FOLLOW-UP|1960-07-24|1960-02-13|||||1962-07-24||1966-07-31|NA|1967-10-07
TRIAL STUDY 134XCP|LB|5533A669-828B-4CA3-BEC3-849CE7384167|1||||ALBGLOB|ALBUMIN/GLOBULIN|||||||LOG10 CCID 50/DOSE|||||||NEGATIVE||UM/DAY||||NORMAL|NOT DONE||||REFLEX TEAR|DRIED|Y|MAPH|MDRD 4 VARIABLE FORMULA||U|Y|N|N|||N|2||58||LONG-TERM FOLLOW-UP|1964-02-27|1972-09-29|||||1960-03-20||1968-05-01|N|1968-06-06
TRIAL STUDY 134XCP|LB|5533A669-828B-4CA3-BEC3-849CE7384167|2||||CCL12|CHEMOKINE (C-C MOTIF) LIGAND 12|||||||UIU/L|||||||TRACE||% INHIBITION||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|AGGLUTINATED|N|SIZE EXCLUSION CHROMATOGRAPHY|HEPASCORE FORMULA||U|NA|Y|N|||U|2||58||CONTINUATION TREATMENT|1971-08-02|1965-07-16|||||1965-11-25||1969-12-13|U|1962-03-06
TRIAL STUDY 134XCP|LB|5533A669-828B-4CA3-BEC3-849CE7384167|1||||GLUCWBE|WHOLE BLOOD EQUIVALENT GLUCOSE|||||||/VF|||||||TRACE||NKAT/L||||ABNORMAL|NOT DONE||||KERATINOCYTE|REFRIGERATED|U|MACRO BROTH DILUTION|MDRD 5 VARIABLE FORMULA||NA|Y|U|Y|||N|3||39||OPEN LABEL TREATMENT|1965-07-04|1970-08-12|||||1971-11-17||1964-01-21|U|1968-04-06
TRIAL STUDY 134XCP|LB|5533A669-828B-4CA3-BEC3-849CE7384167|2||||MLIGCEBC|MALIGNANT CELLS, NOS/BLOOD CELLS|||||||IU/G|||||||BORDERLINE||UCI/KG||||LOW|NOT DONE||||RETICULOCYTES|AUTOLYZED|Y|HEMOCYTOMETRY|GMI % FORMULA||N|NA|NA|N|||N|3||39||RUN-IN|1963-04-06|1972-01-13|||||1972-05-05||1966-08-26|NA|1966-01-08
TRIAL STUDY 134XCP|LB|5533A669-828B-4CA3-BEC3-849CE7384167|1||||GLOBA2|ALPHA-2 GLOBULIN|||||||KIT|||||||NEGATIVE||10^3/L||||NORMAL|NOT DONE||||BONE|NON-HEMOLYZED|Y|TURBIDIMETRY|GMI % FORMULA||Y|NA|N|NA|||N|4||88||TREATMENT|1964-07-05|1960-10-08|||||1961-06-20||1963-11-14|Y|1960-12-27
TRIAL STUDY 134XCP|LB|5533A669-828B-4CA3-BEC3-849CE7384167|2||||PLG|PLASMINOGEN|||||||DRINK|||||||BORDERLINE||AGU/ML||||LOW|NOT DONE||||BLOOD|AGGLUTINATED|N|SPECULAR MICROSCOPY|ASH FIBROSURE FORMULA||N|NA|U|N|||NA|4||88||CONTINUATION TREATMENT|1967-10-30|1964-11-04|||||1972-04-04||1961-06-19|NA|1970-07-10
TRIAL STUDY 134XCP|LB|5533A669-828B-4CA3-BEC3-849CE7384167|1||||CD3LY|CD3/LYMPHOCYTES|||||||DDU|||||||NEGATIVE||U.CARR||||NORMAL|NOT DONE||||PLATELET POOR PLASMA|THAWED|NA|MICROARRAY|MDRD 4 VARIABLE FORMULA||N|U|NA|NA|||NA|5||7||RUN-IN|1966-05-01|1970-04-30|||||1961-02-12||1961-12-30|N|1962-10-08
TRIAL STUDY 134XCP|LB|5533A669-828B-4CA3-BEC3-849CE7384167|2||||PO2ADJT|PARTIAL PRESSURE OXYGEN ADJ FOR TEMP|||||||EU|||||||TRACE||LOG10 TCID 50/DOSE||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|LIPEMIC|N|PAP STAIN|MDRD 5 VARIABLE FORMULA||U|NA|Y|N|||U|5||7||WASHOUT|1964-11-16|1968-11-22|||||1970-05-17||1961-10-16|Y|1960-08-02
TRIAL STUDY 134XCP|LB|C711ADD3-F398-4161-BE13-B75BEDF91402|1||||KLOTHO|KLOTHO|||||||KBQ/UL|||||||POSITIVE||CYLINDER||||HIGH|NOT DONE||||TRANSUDATE|LIPEMIC|NA|MRS|NASH FIBROSURE FORMULA||U|U|Y|U|||Y|1||38||TREATMENT|1972-09-27|1960-01-02|||||1972-05-29||1972-03-21|N|1973-06-08
TRIAL STUDY 134XCP|LB|C711ADD3-F398-4161-BE13-B75BEDF91402|2||||IAA5OHCR|5-HYDROXYINDOLEACETIC ACID/CREATININE|||||||/LSQN|||||||INDETERMINATE||MV*MIN||||NORMAL|NOT DONE||||EXUDATE|HEMOLYZED|U|CORONARY ANGIOGRAPHY|CKD-EPI CREATININE FORMULA||Y|NA|Y|U|||N|1||38||SCREENING|1968-08-12|1967-03-21|||||1964-09-14||1973-07-16|Y|1973-02-22
TRIAL STUDY 134XCP|LB|C711ADD3-F398-4161-BE13-B75BEDF91402|1||||PSAF|PROSTATE SPECIFIC ANTIGEN, FREE|||||||UG/KG/DAY|||||||BORDERLINE||10^3 RNA COPIES/ML||||HIGH|NOT DONE||||SMEGMA|ROOM TEMPERATURE|N|INTRAVASCULAR ULTRASOUND|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|NA|||NA|2||58||WASHOUT|1968-10-04|1963-04-16|||||1969-04-11||1961-11-02|U|1963-04-28
TRIAL STUDY 134XCP|LB|C711ADD3-F398-4161-BE13-B75BEDF91402|2||||VAL|VALINE|||||||KIT|||||||TRACE||L/S||||LOW|NOT DONE||||PERSPIRATION|THAWED|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|FIBROMETER FORMULA||Y|NA|U|NA|||Y|2||58||CONTINUATION TREATMENT|1964-09-29|1967-11-26|||||1973-07-10||1972-12-01|NA|1962-10-29
TRIAL STUDY 134XCP|LB|C711ADD3-F398-4161-BE13-B75BEDF91402|1||||BTECERBC|BITE CELLS/ERYTHROCYTES|||||||BQ/L|||||||NEGATIVE||UMOL||||HIGH|NOT DONE||||EMESIS|CONCENTRATED|Y|SLIT LAMP|CKD-EPI CYSTATIN C FORMULA||Y|N|NA|U|||U|3||39||TREATMENT|1970-01-28|1967-11-08|||||1971-09-20||1972-07-10|N|1965-01-15
TRIAL STUDY 134XCP|LB|C711ADD3-F398-4161-BE13-B75BEDF91402|2||||BAMBTAC|BETA-AMINOBUTYRIC ACID|||||||TUBERCULIN UNIT|||||||TRACE||CCID 50/DOSE||||NORMAL|NOT DONE||||EXPIRED AIR|CALCIFIED|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROTEST FORMULA||Y|U|Y|NA|||N|3||39||RUN-IN|1972-10-25|1969-02-08|||||1969-04-23||1962-05-04|NA|1972-09-18
TRIAL STUDY 134XCP|LB|C711ADD3-F398-4161-BE13-B75BEDF91402|1||||A1AGLP|ALPHA-1 ACID GLYCOPROTEIN|||||||/4.0 ML|||||||INDETERMINATE||ELISA UNIT||||NORMAL|NOT DONE||||GASTRIC CONTENTS|AGGLUTINATED|Y|HIGH LEVEL AMINOGLYCOSIDE SCREEN|MDRD 5 VARIABLE FORMULA||N|N|Y|U|||N|4||88||TREATMENT|1972-09-06|1970-02-01|||||1962-06-06||1971-12-06|N|1963-08-11
TRIAL STUDY 134XCP|LB|C711ADD3-F398-4161-BE13-B75BEDF91402|2||||ACETONE|ACETONE|||||||ABSORBANCE U|||||||POSITIVE||L/H||||ABNORMAL|NOT DONE||||SERUM|LIPEMIC|Y|IN VITRO GENE EXPRESSION ASSAY|MDRD 6 VARIABLE FORMULA||U|U|N|U|||NA|4||88||OBSERVATION|1960-01-07|1971-07-15|||||1966-08-14||1970-05-25|Y|1972-06-14
TRIAL STUDY 134XCP|LB|C711ADD3-F398-4161-BE13-B75BEDF91402|1||||SCKLCE|SICKLE CELLS|||||||BQ/L|||||||POSITIVE||10^7 CFU/ML||||ABNORMAL|NOT DONE||||DISCHARGE|SOLIDIFIED|U|CLINICAL EVALUATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|N|Y|||NA|5||7||BLINDED TREATMENT|1960-11-21|1960-11-14|||||1960-07-01||1960-06-03|U|1968-10-12
TRIAL STUDY 134XCP|LB|C711ADD3-F398-4161-BE13-B75BEDF91402|2||||METAMY|METAMYELOCYTES|||||||FG|||||||POSITIVE||UG/DOSE||||NORMAL|NOT DONE||||SWABBED MATERIAL|CONCENTRATED|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|FIBROMETER FORMULA||U|NA|N|NA|||N|5||7||WASHOUT|1973-07-12|1967-08-16|||||1962-10-30||1972-05-07|Y|1961-09-03
TRIAL STUDY 134XCP|LB|2CD70FFA-5977-4718-961B-6D67368F99B8|1||||XNTHCHR|XANTHOCHROMIA|||||||CMH2O/ML|||||||POSITIVE||PMOL/10^10 CELLS||||LOW|NOT DONE||||SMEGMA|SOLIDIFIED|U|MASS SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA||U|N|N|U|||U|1||38||OPEN LABEL TREATMENT|1966-10-03|1960-01-12|||||1965-03-26||1961-02-04|N|1966-09-01
TRIAL STUDY 134XCP|LB|2CD70FFA-5977-4718-961B-6D67368F99B8|2||||CYHGBC|HEMOGLOBIN C CRYSTALS|||||||L/MIN/M2|||||||INDETERMINATE||% INHIBITION||||NORMAL|NOT DONE||||AMNIOTIC FLUID|GELLED|Y|IVY INCISION METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|NA|Y|||NA|1||38||WASHOUT|1960-01-21|1962-04-05|||||1971-04-23||1962-06-21|N|1965-09-04
TRIAL STUDY 134XCP|LB|2CD70FFA-5977-4718-961B-6D67368F99B8|1||||ACETAMIN|ACETAMINOPHEN|||||||ML*CMH2O|||||||NEGATIVE||PIXELS/CM||||ABNORMAL|NOT DONE||||BASAL TEAR|LACTESCENT|Y|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD FORMULA||NA|Y|Y|Y|||Y|2||58||FOLLOW-UP|1972-10-24|1966-04-16|||||1972-09-06||1961-01-22|NA|1969-03-27
TRIAL STUDY 134XCP|LB|2CD70FFA-5977-4718-961B-6D67368F99B8|2||||HSP90A|HEAT SHOCK PROTEIN 90 ALPHA|||||||NSEC|||||||INDETERMINATE||10^6 COPIES/ML||||ABNORMAL|NOT DONE||||SEMINAL FLUID|DRIED|NA|NEXT GENERATION TARGETED SEQUENCING|CKD-EPI CREATININE FORMULA||N|U|Y|NA|||U|2||58||BLINDED TREATMENT|1965-06-21|1966-08-21|||||1963-04-29||1962-11-04|N|1962-02-04
TRIAL STUDY 134XCP|LB|2CD70FFA-5977-4718-961B-6D67368F99B8|1||||C130140|GERMAN COCKROACH ANTIGEN IGE ANTIBODY|||||||KCAL/DAY|||||||INVALID||TRACE||||LOW|NOT DONE||||SWABBED MATERIAL|LIPEMIC|Y|INDIRECT IMMUNOFLUORESCENCE|GMI % FORMULA||U|N|Y|NA|||Y|3||39||LONG-TERM FOLLOW-UP|1968-03-04|1964-05-17|||||1972-06-06||1966-05-24|U|1972-01-16
TRIAL STUDY 134XCP|LB|2CD70FFA-5977-4718-961B-6D67368F99B8|2||||PYDCREAT|PYRIDINOLINE/CREATININE|||||||KM|||||||NEGATIVE||ELISA UNIT||||HIGH|NOT DONE||||ARTERIAL BLOOD|FROZEN|Y|TELLER ACUITY CARDS|MDRD 4 VARIABLE FORMULA||Y|Y|NA|NA|||U|3||39||FOLLOW-UP|1966-04-25|1967-09-19|||||1963-12-18||1971-08-17|NA|1964-09-04
TRIAL STUDY 134XCP|LB|2CD70FFA-5977-4718-961B-6D67368F99B8|1||||FLT3L|FMS-LIKE TYROSINE KINASE 3 LIGAND|||||||UG/L/H|||||||INVALID||ML/MIN||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|CONTAMINATED|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|ASH FIBROSURE FORMULA||N|NA|N|N|||U|4||88||OBSERVATION|1963-12-12|1961-08-11|||||1962-02-23||1966-02-05|Y|1962-06-13
TRIAL STUDY 134XCP|LB|2CD70FFA-5977-4718-961B-6D67368F99B8|2||||T4FR|THYROXINE, FREE|||||||LINEAR FT*LB|||||||TRACE||10^6 COPIES/ML||||NORMAL|NOT DONE||||SERUM|THAWED|Y|URANYL ACETATE STAIN|FIBROTEST FORMULA||NA|NA|NA|U|||Y|4||88||SCREENING|1970-04-17|1973-06-29|||||1962-02-09||1972-12-15|NA|1971-08-23
TRIAL STUDY 134XCP|LB|2CD70FFA-5977-4718-961B-6D67368F99B8|1||||ATPVITE|ALPHA TOCOPHEROL/VITAMIN E|||||||ML/ANIMAL/DAY|||||||BORDERLINE||NMOL BCE/MMOL||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|CONTAMINATED|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|COCKCROFT-GAULT FORMULA||N|Y|NA|Y|||Y|5||7||INDUCTION TREATMENT|1964-07-08|1966-09-17|||||1964-08-23||1965-04-13|U|1968-03-22
TRIAL STUDY 134XCP|LB|2CD70FFA-5977-4718-961B-6D67368F99B8|2||||ABOA1|ABO A1 SUBTYPE|||||||/MONTH|||||||BORDERLINE||HR/DAY||||LOW|NOT DONE||||MENSTRUAL BLOOD|CONTAMINATED|U|APPLANATION TONOMETRY|HEPASCORE FORMULA||NA|N|N|U|||U|5||7||CONTINUATION TREATMENT|1962-06-09|1963-06-09|||||1971-10-20||1966-11-11|U|1969-03-04
TRIAL STUDY 134XCP|LB|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|1||||CXCL4|CHEMOKINE (C-X-C MOTIF) LIGAND 4|||||||APL U|||||||BORDERLINE||CI||||LOW|NOT DONE||||SERUM|CONTAMINATED|NA|NUCLEIC ACID SEQUENCING|FIBROTEST FORMULA||U|NA|Y|U|||U|1||38||CONTINUATION TREATMENT|1973-08-02|1965-03-27|||||1963-06-08||1965-04-15|U|1962-03-12
TRIAL STUDY 134XCP|LB|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|2||||ETS|ETHYL SULFATE|||||||/VF|||||||BORDERLINE||ABSORBANCE U||||NORMAL|NOT DONE||||KERATINOCYTE|FRESH|Y|LC-FL|CKD-EPI CREATININE FORMULA||N|Y|Y|U|||NA|1||38||CONTINUATION TREATMENT|1972-11-01|1965-04-30|||||1972-09-22||1963-11-11|N|1961-04-06
TRIAL STUDY 134XCP|LB|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|1||||C165912|SHELLFISH MIX IGG AB RAST SCORE|||||||G|||||||INVALID||IU/L||||LOW|NOT DONE||||VENOUS BLOOD|PARAFFIN-EMBEDDED|NA|MECHANICAL CLOT DETECTION|FIBROMETER FORMULA||N|NA|Y|Y|||Y|2||58||CONTINUATION TREATMENT|1966-08-13|1960-05-07|||||1964-05-02||1973-07-02|NA|1970-02-20
TRIAL STUDY 134XCP|LB|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|2||||ANIONG3|ANION GAP 3|||||||/HPF|||||||TRACE||SPRAY||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|FRESH|U|INDIRECT IMMUNOFLUORESCENCE|MDRD FORMULA||N|N|U|Y|||Y|2||58||INDUCTION TREATMENT|1972-02-26|1960-05-14|||||1965-09-20||1960-01-15|U|1968-12-27
TRIAL STUDY 134XCP|LB|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|1||||SAA1|SERUM AMYLOID A1|||||||/200 HPFS|||||||POSITIVE||MG/KG/H||||LOW|NOT DONE||||CAPILLARY PLASMA|CONTAMINATED|U|ACRIDINE ORANGE STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|U|Y|||N|3||39||CONTINUATION TREATMENT|1961-11-15|1960-02-02|||||1969-01-23||1966-09-11|U|1970-11-07
TRIAL STUDY 134XCP|LB|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|2||||STAT3|STAT3|||||||WAFER|||||||INDETERMINATE||MG/G/MIN||||HIGH|NOT DONE||||ISOLATE|FROZEN|U|FLOW MICROSCOPY|MDRD 5 VARIABLE FORMULA||NA|NA|Y|Y|||NA|3||39||INDUCTION TREATMENT|1969-10-22|1973-03-21|||||1960-05-03||1968-06-27|Y|1964-09-18
TRIAL STUDY 134XCP|LB|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|1||||BICARB|BICARBONATE|||||||ML/100G/MIN|||||||POSITIVE||IU/ML||||HIGH|NOT DONE||||URINE|CONCENTRATED|N|FLUORESCENT IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||Y|N|Y|N|||NA|4||88||FOLLOW-UP|1970-04-07|1972-05-21|||||1964-11-29||1973-07-16|N|1962-03-28
TRIAL STUDY 134XCP|LB|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|2||||NEUTSGNE|NEUTROPHILS, SEGMENTED/NEUTROPHILS|||||||GBQ|||||||BORDERLINE||EU||||ABNORMAL|NOT DONE||||SMEGMA|ROOM TEMPERATURE|U|ELECTROPHORESIS|NASH FIBROSURE FORMULA||N|NA|Y|NA|||N|4||88||SCREENING|1972-05-18|1969-10-08|||||1965-03-07||1963-05-27|Y|1960-03-30
TRIAL STUDY 134XCP|LB|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|1||||GLOBB|BETA GLOBULIN|||||||UEQ|||||||POSITIVE||L/MIN/M2||||HIGH|NOT DONE||||CORD SERUM|NON-HEMOLYZED|NA|KLEIHAUER-BETKE|MDRD FORMULA||N|U|Y|N|||N|5||7||TREATMENT|1963-10-10|1971-10-22|||||1972-12-10||1966-01-07|N|1967-07-25
TRIAL STUDY 134XCP|LB|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|2||||C165915|DOG DANDER IGG AB RAST SCORE|||||||U/ML|||||||POSITIVE||KDA||||HIGH|NOT DONE||||CALCULUS|CONTAMINATED|N|CONTACT SPECULAR MICROSCOPY|NASH FIBROSURE FORMULA||NA|NA|U|NA|||NA|5||7||OPEN LABEL TREATMENT|1963-01-08|1967-11-01|||||1970-08-09||1969-06-03|Y|1966-02-26
TRIAL STUDY 134XCP|LB|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|1||||ALBGALB|GLYCATED ALBUMIN/ALBUMIN|||||||MCI|||||||TRACE||10^4/HPF||||LOW|NOT DONE||||EXUDATE|DRIED|Y|MAPH|ASH FIBROSURE FORMULA||U|U|Y|NA|||U|1||38||SCREENING|1964-11-27|1968-02-04|||||1960-11-08||1960-02-16|Y|1972-08-12
TRIAL STUDY 134XCP|LB|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|2||||KRCYMGCE|MEGAKARYOCYTES/TOTAL CELLS|||||||UCI/L|||||||NEGATIVE||10^6 CFU||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|THAWED|Y|FLOCCULATION|FIBROTEST FORMULA||NA|Y|Y|U|||N|1||38||FOLLOW-UP|1966-08-27|1967-02-10|||||1973-01-13||1971-03-11|U|1973-01-03
TRIAL STUDY 134XCP|LB|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|1||||ANABASN|ANABASINE|||||||NMOL BCE/L|||||||POSITIVE||H/WK||||LOW|NOT DONE||||DIALYSIS FLUID|CONCENTRATED|NA|APPLANATION TONOMETRY|MDRD FORMULA||NA|N|Y|Y|||NA|2||58||RUN-IN|1963-05-07|1965-04-18|||||1970-02-01||1966-11-09|Y|1965-08-22
TRIAL STUDY 134XCP|LB|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|2||||NSE|NEURON SPECIFIC ENOLASE|||||||LOG10 COPIES/ML|||||||INDETERMINATE||10^9 CFU/ML||||HIGH|NOT DONE||||DERMAL TISSUE|THAWED|Y|MICROBIAL CONCENTRATION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|N|NA|||NA|2||58||SCREENING|1973-03-20|1973-07-31|||||1970-04-13||1966-03-21|N|1961-05-07
TRIAL STUDY 134XCP|LB|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|1||||PD1S|SOLUBLE PROGRAMMED DEATH-1|||||||MEQ/UL|||||||INDETERMINATE||UU/DL||||LOW|NOT DONE||||VENOUS CORD BLOOD|FROZEN|N|MICROSCOPY|MDRD 6 VARIABLE FORMULA||Y|Y|N|U|||Y|3||39||SCREENING|1960-10-29|1970-04-18|||||1960-09-26||1966-12-27|U|1970-03-08
TRIAL STUDY 134XCP|LB|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|2||||ORNITHIN|ORNITHINE|||||||ML/S/M2|||||||INVALID||GY||||HIGH|NOT DONE||||INTERSTITIAL FLUID|UNEXPECTED ODOR|U|PULSE OXIMETRY|MDRD 5 VARIABLE FORMULA||NA|NA|NA|Y|||U|3||39||OPEN LABEL TREATMENT|1960-08-09|1968-12-23|||||1971-06-27||1968-04-03|U|1963-09-24
TRIAL STUDY 134XCP|LB|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|1||||ANDSTNDL|ANDROSTENEDIOL|||||||COPIES/UL|||||||BORDERLINE||10^9 ORGANISMS||||NORMAL|NOT DONE||||COLOSTRUM|CONTAMINATED|NA|MYELOPEROXIDASE STAIN|GMI % FORMULA||Y|N|N|NA|||U|4||88||FOLLOW-UP|1962-02-19|1965-10-30|||||1973-06-10||1960-10-03|N|1964-05-02
TRIAL STUDY 134XCP|LB|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|2||||CKBBCK|CREATINE KINASE BB/TOTAL CREATINE KINASE|||||||KG/CM|||||||BORDERLINE||MSEC||||NORMAL|NOT DONE||||SKIN TISSUE|THAWED|Y|MIGET|GMI % FORMULA||NA|Y|N|U|||NA|4||88||SCREENING|1965-11-03|1960-11-21|||||1965-06-04||1964-07-05|N|1960-01-07
TRIAL STUDY 134XCP|LB|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|1||||TROPONI3|TROPONIN I TYPE 3|||||||LOG10 PFU|||||||BORDERLINE||PG||||LOW|NOT DONE||||BILE|FROZEN|NA|MOUSE PROTECTION ASSAY|GMI MMOL/MOL FORMULA||U|N|U|NA|||U|5||7||CONTINUATION TREATMENT|1965-07-15|1962-08-18|||||1966-01-06||1964-07-05|Y|1960-06-30
TRIAL STUDY 134XCP|LB|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|2||||ANTHRMAG|ANTITHROMBIN ANTIGEN|||||||MG/ANIMAL|||||||BORDERLINE||10^3/L||||LOW|NOT DONE||||PERSPIRATION|AGGLUTINATED|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|Y|Y|||U|5||7||RUN-IN|1970-10-21|1970-12-20|||||1960-08-05||1971-05-12|NA|1973-08-07
TRIAL STUDY 134XCP|LB|43E00B7D-684F-4BAC-A135-E65C22B191AD|1||||NEUTMY|NEUTROPHILIC MYELOCYTES|||||||MV2/HZ|||||||NEGATIVE||NG/MOL||||NORMAL|NOT DONE||||EXPIRED AIR|CONCENTRATED|Y|ELECTRONEUROGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|Y|NA|||Y|1||38||CONTINUATION TREATMENT|1965-08-26|1961-03-21|||||1967-12-09||1968-11-08|N|1968-02-11
TRIAL STUDY 134XCP|LB|43E00B7D-684F-4BAC-A135-E65C22B191AD|2||||PLSIMCCE|IMMATURE PLASMA CELLS/TOTAL CELLS|||||||10^9 ORGANISMS|||||||INVALID||RATIO||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CALCIFIED|U|OSCILLOMETRY|CKD-EPI CYSTATIN C FORMULA||U|U|NA|U|||NA|1||38||INDUCTION TREATMENT|1964-01-01|1972-01-27|||||1962-11-26||1968-02-18|Y|1972-05-03
TRIAL STUDY 134XCP|LB|43E00B7D-684F-4BAC-A135-E65C22B191AD|1||||LDLPATT|LDL SUBTYPE PATTERN|||||||TSP|||||||INVALID||MG2/DL2||||HIGH|NOT DONE||||HAIR FOLLICLE|LIPEMIC|NA|ANALYTICAL ULTRACENTRIFUGATION|FIBROTEST FORMULA||Y|U|N|U|||U|2||58||FOLLOW-UP|1972-08-20|1971-06-13|||||1969-11-01||1961-07-08|N|1963-09-08
TRIAL STUDY 134XCP|LB|43E00B7D-684F-4BAC-A135-E65C22B191AD|2||||HALLUC|HALLUCINOGEN|||||||DPM/0.5 ML|||||||INDETERMINATE||MG/G/MIN||||ABNORMAL|NOT DONE||||SPERMATOZOON|PARAFFIN-EMBEDDED|NA|BIOPSY|FIBROTEST FORMULA||Y|NA|NA|Y|||N|2||58||SCREENING|1960-08-24|1966-08-02|||||1973-03-26||1966-05-14|NA|1971-04-17
TRIAL STUDY 134XCP|LB|43E00B7D-684F-4BAC-A135-E65C22B191AD|1||||ACHE|ACETYLCHOLINESTERASE|||||||KALLIKREIN INHIBITOR UNIT|||||||NEGATIVE||UG||||ABNORMAL|NOT DONE||||SEBUM|CLOTTED|Y|DIPSTICK|NASH FIBROSURE FORMULA||N|N|N|N|||Y|3||39||OBSERVATION|1961-07-11|1968-02-24|||||1963-09-08||1968-11-06|N|1973-07-29
TRIAL STUDY 134XCP|LB|43E00B7D-684F-4BAC-A135-E65C22B191AD|2||||IGG1|IMMUNOGLOBULIN G SUBCLASS 1|||||||KG/CM|||||||NEGATIVE||U/M2/MIN||||NORMAL|NOT DONE||||EMOTIONAL TEAR|FROZEN|NA|MICROSCOPY|MDRD 5 VARIABLE FORMULA||NA|NA|N|Y|||N|3||39||WASHOUT|1965-10-10|1960-04-19|||||1972-08-09||1972-03-13|Y|1962-04-08
TRIAL STUDY 134XCP|LB|43E00B7D-684F-4BAC-A135-E65C22B191AD|1||||ZPP|ZINC PROTOPORPHYRIN|||||||SYRINGE|||||||NEGATIVE||G/ANIMAL||||HIGH|NOT DONE||||INTERSTITIAL FLUID|AGGLUTINATED|Y|MAGNETIC RESONANCE ENTEROGRAPHY|MDRD 5 VARIABLE FORMULA||N|N|N|NA|||U|4||88||RUN-IN|1965-04-18|1960-01-20|||||1965-04-11||1968-12-10|N|1971-09-18
TRIAL STUDY 134XCP|LB|43E00B7D-684F-4BAC-A135-E65C22B191AD|2||||BALA|BETA ALANINE|||||||10^3 CFU/ML|||||||NEGATIVE||PATCH||||LOW|NOT DONE||||ISOLATE|LACTESCENT|NA|ELECTROGASTROGRAPHY|FIBROMETER FORMULA||NA|N|Y|U|||U|4||88||OBSERVATION|1968-01-29|1969-03-13|||||1967-08-10||1964-10-02|Y|1961-04-05
TRIAL STUDY 134XCP|LB|43E00B7D-684F-4BAC-A135-E65C22B191AD|1||||AMCRMRNA|AMACR MRNA|||||||G/MOL|||||||POSITIVE||U/G/H||||ABNORMAL|NOT DONE||||PERITONEAL FLUID|FRESH|U|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|CKD-EPI CREATININE FORMULA||U|U|N|U|||Y|5||7||INDUCTION TREATMENT|1967-11-12|1969-12-27|||||1972-06-05||1962-07-02|U|1964-09-27
TRIAL STUDY 134XCP|LB|43E00B7D-684F-4BAC-A135-E65C22B191AD|2||||TMZPM|TEMAZEPAM|||||||CMOL/L|||||||POSITIVE||KBQ/UL||||HIGH|NOT DONE||||STRIATED MUSCLE TISSUE|CALCIFIED|U|RIA|FIBROTEST FORMULA||Y|N|N|U|||U|5||7||SCREENING|1973-08-07|1972-11-05|||||1972-05-17||1973-03-06|N|1968-05-22
TRIAL STUDY 134XCP|LB|25680BE0-7CE5-4B76-A48E-2D977A07E749|1||||EDTACLR|EDTA CLEARANCE|||||||ELISA UNIT/ML|||||||NEGATIVE||L/KG||||ABNORMAL|NOT DONE||||TUMOR TISSUE|LACTESCENT|U|SNP ARRAY|NASH FIBROSURE FORMULA||NA|NA|N|NA|||N|1||38||BLINDED TREATMENT|1962-06-05|1964-07-28|||||1968-08-28||1962-03-15|NA|1967-05-28
TRIAL STUDY 134XCP|LB|25680BE0-7CE5-4B76-A48E-2D977A07E749|2||||ANTHRMA|ANTITHROMBIN ACTIVITY|||||||U/CL|||||||BORDERLINE||PMOL/DL||||LOW|NOT DONE||||BILE|AUTOLYZED|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI FORMULA||NA|Y|N|Y|||Y|1||38||SCREENING|1965-08-08|1968-01-11|||||1966-04-18||1972-12-02|NA|1968-07-02
TRIAL STUDY 134XCP|LB|25680BE0-7CE5-4B76-A48E-2D977A07E749|1||||CEA|CARCINOEMBRYONIC ANTIGEN|||||||GPL U/ML|||||||INDETERMINATE||UOSM||||ABNORMAL|NOT DONE||||KERATINOCYTE|FRESH|U|HPLC|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|U|Y|||N|2||58||OPEN LABEL TREATMENT|1961-09-22|1969-02-06|||||1968-08-30||1964-09-12|Y|1971-12-03
TRIAL STUDY 134XCP|LB|25680BE0-7CE5-4B76-A48E-2D977A07E749|2||||C130075|BIRCH POLLEN IGG4|||||||BISCUIT|||||||BORDERLINE||PPB||||NORMAL|NOT DONE||||LUNG SURFACTANT|SOLIDIFIED|N|IMMUNE REPERTOIRE DEEP SEQUENCING|MDRD FORMULA||U|U|N|Y|||N|2||58||WASHOUT|1964-07-29|1963-04-03|||||1965-06-18||1967-08-07|N|1968-08-12
TRIAL STUDY 134XCP|LB|25680BE0-7CE5-4B76-A48E-2D977A07E749|1||||ADP|ADENOSINE DIPHOSPHATE|||||||ML/ANIMAL|||||||TRACE||CM/MIN||||HIGH|NOT DONE||||ARTERIAL CORD BLOOD|FROZEN|Y|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|ASH FIBROSURE FORMULA||Y|NA|U|Y|||N|3||39||OPEN LABEL TREATMENT|1966-11-06|1970-03-27|||||1969-12-30||1969-05-25|NA|1966-04-02
TRIAL STUDY 134XCP|LB|25680BE0-7CE5-4B76-A48E-2D977A07E749|2||||RBPCREAT|RETINOL BINDING PROTEIN/CREATININE|||||||/WK|||||||POSITIVE||KCAL/DAY||||NORMAL|NOT DONE||||MUCUS|FROZEN|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|HEPASCORE FORMULA||U|U|Y|N|||Y|3||39||FOLLOW-UP|1972-09-08|1962-05-03|||||1964-06-12||1966-09-18|Y|1969-03-05
TRIAL STUDY 134XCP|LB|25680BE0-7CE5-4B76-A48E-2D977A07E749|1||||PYRIDNLN|PYRIDINOLINE|||||||MMOL2/L2|||||||INDETERMINATE||NSEC||||LOW|NOT DONE||||URINE|LACTESCENT|U|PERIODIC ACID SCHIFF STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|U|||N|4||88||OPEN LABEL TREATMENT|1970-04-27|1960-10-10|||||1972-11-10||1960-08-07|Y|1966-01-08
TRIAL STUDY 134XCP|LB|25680BE0-7CE5-4B76-A48E-2D977A07E749|2||||HBBARTHB|HEMOGLOBIN BARTS/TOTAL HEMOGLOBIN|||||||BQ/MG|||||||INDETERMINATE||DAGU/ML||||NORMAL|NOT DONE||||CAPILLARY PLASMA|AUTOLYZED|Y|CELLULAR PROLIFERATION ASSAY|FIBROSIS 4 FORMULA||N|NA|N|U|||NA|4||88||TREATMENT|1965-07-02|1970-03-19|||||1963-01-28||1963-11-16|NA|1960-11-13
TRIAL STUDY 134XCP|LB|25680BE0-7CE5-4B76-A48E-2D977A07E749|1||||THYATAB|THYROID ANTITHYROGLOBULIN ANTIBODIES|||||||LX|||||||INVALID||TROCHE||||LOW|NOT DONE||||SKIN TISSUE|UNEXPECTED ODOR|Y|HPLC|FIBROMETER FORMULA||Y|U|NA|NA|||Y|5||7||WASHOUT|1971-06-16|1960-05-02|||||1960-07-03||1970-10-19|NA|1960-06-23
TRIAL STUDY 134XCP|LB|25680BE0-7CE5-4B76-A48E-2D977A07E749|2||||SAA1|SERUM AMYLOID A1|||||||MG/KG/DOSE|||||||INVALID||IU||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|CONTAMINATED|Y|STATIC PERIMETRY|CKD-EPI FORMULA||N|Y|U|NA|||N|5||7||RUN-IN|1965-07-18|1967-02-14|||||1966-08-29||1967-02-16|U|1969-01-13
TRIAL STUDY 134XCP|LB|67CA2619-351F-493E-93B2-5CDC9AF99C8B|1||||ALDEPX|ALDRIN EPOXIDASE|||||||PFU/ML|||||||INVALID||ML||||HIGH|NOT DONE||||CAPILLARY PLASMA|PARAFFIN-EMBEDDED|U|IMPULSE OSCILLOMETRY|MDRD FORMULA||Y|N|N|Y|||N|1||38||OPEN LABEL TREATMENT|1967-01-13|1964-08-18|||||1965-04-25||1971-07-02|N|1960-12-12
TRIAL STUDY 134XCP|LB|67CA2619-351F-493E-93B2-5CDC9AF99C8B|2||||ALPRZLM|ALPRAZOLAM|||||||CI|||||||INVALID||L/L||||HIGH|NOT DONE||||BILE|NON-HEMOLYZED|Y|AUDIOMETRY|CKD-EPI CYSTATIN C FORMULA||NA|NA|Y|Y|||NA|1||38||SCREENING|1972-02-08|1960-09-08|||||1968-05-01||1973-01-14|Y|1964-10-01
TRIAL STUDY 134XCP|LB|67CA2619-351F-493E-93B2-5CDC9AF99C8B|1||||C3M|COLLAGEN III NEO-PEPTIDE C3M|||||||CI/UG|||||||POSITIVE||/10^4||||ABNORMAL|NOT DONE||||ADIPOSE TISSUE|LIPEMIC|N|LANDOLT RING|MDRD 6 VARIABLE FORMULA||Y|Y|NA|U|||N|2||58||OPEN LABEL TREATMENT|1969-02-18|1965-10-23|||||1973-02-20||1969-05-21|U|1964-02-27
TRIAL STUDY 134XCP|LB|67CA2619-351F-493E-93B2-5CDC9AF99C8B|2||||CHYTRYP|CHYMOTRYPSIN|||||||EJACULATE U|||||||BORDERLINE||UGEQ||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|DRIED|NA|CARDIAC THERMODILUTION|CKD-EPI CYSTATIN C FORMULA||U|U|NA|N|||N|2||58||OBSERVATION|1962-09-22|1969-11-11|||||1962-07-24||1967-04-13|U|1964-01-18
TRIAL STUDY 134XCP|LB|67CA2619-351F-493E-93B2-5CDC9AF99C8B|1||||C165937|ZEA MAYS IGE AB RAST SCORE|||||||ECL UNIT|||||||INVALID||DAYS||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|SOLIDIFIED|NA|TRICHROME STAIN|ASH FIBROSURE FORMULA||N|NA|NA|NA|||NA|3||39||CONTINUATION TREATMENT|1961-03-01|1967-10-09|||||1969-10-26||1965-08-07|U|1972-03-25
TRIAL STUDY 134XCP|LB|67CA2619-351F-493E-93B2-5CDC9AF99C8B|2||||TSTSFRPT|TESTOSTERONE, FREE/TOTAL PROTEIN|||||||KA_U/DL|||||||POSITIVE||L/KG||||LOW|NOT DONE||||PLEURAL FLUID|SOLIDIFIED|N|SNP ARRAY|MDRD FORMULA||U|N|NA|Y|||Y|3||39||RUN-IN|1973-05-10|1971-05-19|||||1972-04-30||1960-09-22|U|1969-09-14
TRIAL STUDY 134XCP|LB|67CA2619-351F-493E-93B2-5CDC9AF99C8B|1||||ICAM|INTERCELLULAR ADHESION MOLECULE|||||||ML/MIN/MMHG|||||||TRACE||USEC||||HIGH|NOT DONE||||URINE|CONCENTRATED|NA|PET SCAN|MDRD 5 VARIABLE FORMULA||U|NA|Y|N|||N|4||88||INDUCTION TREATMENT|1965-12-14|1968-02-16|||||1963-08-27||1969-04-30|N|1968-05-31
TRIAL STUDY 134XCP|LB|67CA2619-351F-493E-93B2-5CDC9AF99C8B|2||||HDLPSZ|HDL PARTICLE SIZE|||||||AMU|||||||TRACE||WATT||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|PARAFFIN-EMBEDDED|N|NEXT GENERATION SEQUENCING|ASH FIBROSURE FORMULA||U|NA|Y|NA|||N|4||88||RUN-IN|1964-03-13|1964-03-28|||||1965-01-18||1961-09-19|Y|1967-12-03
TRIAL STUDY 134XCP|LB|67CA2619-351F-493E-93B2-5CDC9AF99C8B|1||||MEPRDN|MEPERIDINE|||||||TUBE|||||||POSITIVE||10^6 CFU||||NORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONCENTRATED|Y|REFLECTANCE SPECTROSCOPY|NASH FIBROSURE FORMULA||U|N|Y|NA|||U|5||7||BLINDED TREATMENT|1968-02-22|1962-04-07|||||1964-11-19||1972-09-06|NA|1965-12-24
TRIAL STUDY 134XCP|LB|67CA2619-351F-493E-93B2-5CDC9AF99C8B|2||||PSDEPHD|PSEUDOEPHEDRINE|||||||MSEC|||||||POSITIVE||APL U/ML||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LIPEMIC|N|MALDI-TOF|NASH FIBROSURE FORMULA||U|U|N|Y|||U|5||7||BLINDED TREATMENT|1969-03-10|1973-03-16|||||1963-04-12||1967-07-15|U|1964-08-17
TRIAL STUDY 134XCP|LB|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|1||||UROBIL|UROBILINOGEN|||||||ML/CM|||||||BORDERLINE||DAGU||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|CONTAMINATED|U|WHOLE EXOME SEQUENCING|MDRD 4 VARIABLE FORMULA||NA|Y|Y|NA|||N|1||38||TREATMENT|1973-09-03|1961-01-14|||||1973-04-18||1967-12-22|NA|1969-03-11
TRIAL STUDY 134XCP|LB|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|2||||NEUTVAC|VACUOLATED NEUTROPHILS|||||||CY/CM|||||||BORDERLINE||%||||LOW|NOT DONE||||EPITHELIAL CELL|CLOTTED|N|ENZYMATIC ULTRACENTRIFUGATION|GMI MMOL/MOL FORMULA||NA|NA|N|U|||N|1||38||OBSERVATION|1966-09-24|1970-09-15|||||1967-06-16||1968-04-15|NA|1966-02-17
TRIAL STUDY 134XCP|LB|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|1||||RDWR|RET VOLUME DISTRIBUTION WIDTH|||||||ML/CAGE|||||||TRACE||KEV||||HIGH|NOT DONE||||COLOSTRUM|CONCENTRATED|Y|X-RAY|CKD-EPI CREATININE FORMULA||N|N|Y|U|||NA|2||58||OBSERVATION|1972-07-21|1966-05-21|||||1971-08-01||1967-08-23|U|1967-02-11
TRIAL STUDY 134XCP|LB|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|2||||PKM2|PYRUVATE KINASE ISOZYME M2|||||||ML/M2|||||||BORDERLINE||UIU/L||||HIGH|NOT DONE||||GASTRIC CONTENTS|GELLED|NA|PERIPHERAL ANGIOGRAPHY|NASH FIBROSURE FORMULA||Y|NA|Y|NA|||U|2||58||LONG-TERM FOLLOW-UP|1969-11-18|1961-04-13|||||1966-06-06||1962-12-25|U|1965-01-17
TRIAL STUDY 134XCP|LB|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|1||||CHOLINES|CHOLINESTERASE|||||||OZ|||||||POSITIVE||UG/DL||||HIGH|NOT DONE||||LAVAGE FLUID|LIPEMIC|Y|MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|Y|Y|||N|3||39||TREATMENT|1960-01-24|1972-10-04|||||1961-04-18||1962-09-16|NA|1972-04-02
TRIAL STUDY 134XCP|LB|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|2||||GLUCPE|PLASMA EQUIVALENT GLUCOSE|||||||IU/MG|||||||TRACE||ML/CAGE/WK||||HIGH|NOT DONE||||CORD SERUM|ROOM TEMPERATURE|Y|PET/MRI SCAN|GMI MMOL/MOL FORMULA||N|N|Y|N|||Y|3||39||WASHOUT|1965-12-05|1971-11-19|||||1965-01-21||1967-02-14|Y|1970-03-21
TRIAL STUDY 134XCP|LB|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|1||||COAGIDX|COAGULATION INDEX|||||||ML/(MIN*100ML)|||||||INVALID||MN||||NORMAL|NOT DONE||||PERITONEAL FLUID|DRIED|N|SNP ARRAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|NA|Y|Y|||N|4||88||TREATMENT|1967-11-16|1962-03-08|||||1965-02-08||1961-08-07|N|1962-09-03
TRIAL STUDY 134XCP|LB|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|2||||CAPHOSPD|CALCIUM - PHOSPHORUS PRODUCT|||||||DAYS|||||||INVALID||U/M2||||HIGH|NOT DONE||||SKIN TISSUE|CALCIFIED|Y|BIOIMPEDANCE SPECTROSCOPY|MDRD FORMULA||U|NA|U|N|||N|4||88||OBSERVATION|1967-07-21|1973-02-28|||||1966-03-15||1966-03-05|NA|1962-03-10
TRIAL STUDY 134XCP|LB|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|1||||TGLOBRR|THYROGLOBULIN RECOVERY RATE|||||||HZ/S|||||||INDETERMINATE||UIU/DL||||HIGH|NOT DONE||||SPERMATOZOON|THAWED|N|CONTRAST ENHANCED PET SCAN|CKD-EPI FORMULA||U|U|N|N|||N|5||7||SCREENING|1971-11-15|1961-05-07|||||1971-08-26||1971-05-27|NA|1960-08-29
TRIAL STUDY 134XCP|LB|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|2||||KRCYMGCE|MEGAKARYOCYTES/TOTAL CELLS|||||||MMHG/SEC|||||||INDETERMINATE||COAT||||NORMAL|NOT DONE||||SKIN TISSUE|FRESH|Y|NO INFORMATION|NASH FIBROSURE FORMULA||NA|Y|Y|NA|||NA|5||7||WASHOUT|1966-12-19|1961-01-25|||||1968-08-22||1970-03-06|Y|1967-01-06
TRIAL STUDY 134XCP|LB|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|1||||KEXR|POTASSIUM EXCRETION RATE|||||||MGEQ|||||||INDETERMINATE||DPM/MG||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|CALCIFIED|NA|SANGER SEQUENCING|FIBROSIS 4 FORMULA||NA|NA|NA|NA|||Y|1||38||RUN-IN|1971-01-12|1964-05-11|||||1961-01-21||1973-06-20|Y|1965-05-15
TRIAL STUDY 134XCP|LB|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|2||||DCCARNIT|DECANOYLCARNITINE|||||||MN|||||||BORDERLINE||CMH2O*S/ML||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|HEMOLYZED|NA|MANUAL COUNT|MDRD 6 VARIABLE FORMULA||Y|U|Y|U|||N|1||38||BLINDED TREATMENT|1964-11-19|1964-01-19|||||1966-12-20||1972-07-01|NA|1964-06-30
TRIAL STUDY 134XCP|LB|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|1||||SER|SERINE|||||||ENZYME U|||||||POSITIVE||GPS U||||LOW|NOT DONE||||PERSPIRATION|AGGLUTINATED|U|PHASE CONTRAST MICROSCOPY|COCKCROFT-GAULT FORMULA||U|U|Y|NA|||U|2||58||SCREENING|1973-05-23|1966-09-05|||||1968-06-13||1971-03-24|U|1966-05-25
TRIAL STUDY 134XCP|LB|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|2||||E1S|ESTRONE SULFATE|||||||ML/MIN|||||||INDETERMINATE||UM2||||HIGH|NOT DONE||||BILE|ROOM TEMPERATURE|NA|INDIA INK STAIN|GMI % FORMULA||N|Y|Y|N|||U|2||58||CONTINUATION TREATMENT|1966-08-21|1965-03-14|||||1962-02-07||1963-07-07|NA|1970-05-12
TRIAL STUDY 134XCP|LB|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|1||||CD27|CD27|||||||CM H2O|||||||NEGATIVE||TROCHE||||LOW|NOT DONE||||SKIN TISSUE|CALCIFIED|Y|SINGLE-MOLECULE ARRAY|MDRD 4 VARIABLE FORMULA||U|NA|U|NA|||Y|3||39||INDUCTION TREATMENT|1963-07-16|1971-08-26|||||1962-11-27||1971-04-16|Y|1960-04-18
TRIAL STUDY 134XCP|LB|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|2||||ANISOCHR|ANISOCHROMIA|||||||GMFI|||||||INVALID||PSEC||||HIGH|NOT DONE||||MUCUS|DRIED|Y|ECHOCARDIOGRAPHY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|Y|Y|||NA|3||39||SCREENING|1969-03-14|1963-04-01|||||1969-12-25||1966-12-11|U|1961-01-27
TRIAL STUDY 134XCP|LB|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|1||||HGBEHGB|HEMOGLOBIN E/TOTAL HEMOGLOBIN|||||||PL|||||||INDETERMINATE||10^3 ORGANISMS/G||||NORMAL|NOT DONE||||SEMINAL FLUID|THAWED|N|IMMUNORADIOMETRIC ASSAY|COCKCROFT-GAULT FORMULA||Y|U|N|U|||NA|4||88||LONG-TERM FOLLOW-UP|1967-04-15|1971-01-08|||||1962-12-09||1964-12-12|N|1970-11-21
TRIAL STUDY 134XCP|LB|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|2||||MIP1A|MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA|||||||SCOOPFUL|||||||NEGATIVE||10^6 ORGANISMS||||HIGH|NOT DONE||||SALIVA|CLOTTED|N|ANTIBIOTIC AGAR SCREEN|MDRD ENZYMATIC FORMULA||N|Y|Y|U|||NA|4||88||WASHOUT|1960-05-15|1969-12-05|||||1973-02-08||1962-04-14|N|1964-06-20
TRIAL STUDY 134XCP|LB|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|1||||CSEPI|EPITHELIAL CASTS|||||||BISCUIT|||||||TRACE||NMOL||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR|Y|TEST STRIP|CKD-EPI CREATININE FORMULA||U|NA|Y|U|||N|5||7||TREATMENT|1970-03-06|1971-09-15|||||1961-01-26||1963-03-01|NA|1966-03-16
TRIAL STUDY 134XCP|LB|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|2||||NACREAT|SODIUM/CREATININE|||||||UMOL|||||||BORDERLINE||KM/H||||NORMAL|NOT DONE||||CALCULUS|NON-HEMOLYZED|N|SCANNING ELECTRON MICROSCOPY|CKD-EPI CREATININE FORMULA||N|U|N|Y|||N|5||7||RUN-IN|1963-05-09|1971-09-08|||||1969-12-10||1971-10-22|NA|1967-10-08
TRIAL STUDY 134XCP|LB|51B01BE3-230D-4AE0-A229-81EF519EA932|1||||TK1|THYMIDINE KINASE 1|||||||CI/L|||||||POSITIVE||PKAT||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|THAWED|NA|ICC|CKD-EPI FORMULA||U|N|U|NA|||Y|1||38||INDUCTION TREATMENT|1964-09-11|1967-05-13|||||1962-06-30||1964-04-12|U|1966-08-21
TRIAL STUDY 134XCP|LB|51B01BE3-230D-4AE0-A229-81EF519EA932|2||||INTLK16|INTERLEUKIN 16|||||||CAN|||||||NEGATIVE||FEU||||ABNORMAL|NOT DONE||||EXPIRED AIR|LACTESCENT|N|KARYOTYPING|MDRD 5 VARIABLE FORMULA||NA|Y|NA|NA|||Y|1||38||BASELINE|1969-11-19|1973-01-15|||||1969-03-08||1960-12-11|N|1966-12-09
TRIAL STUDY 134XCP|LB|51B01BE3-230D-4AE0-A229-81EF519EA932|1||||IGHG4|IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 4|||||||PL|||||||INVALID||UG/G/DAY||||ABNORMAL|NOT DONE||||SKIN TISSUE|AGGLUTINATED|NA|CELLULOSE TAPE|ASH FIBROSURE FORMULA||NA|Y|Y|NA|||NA|2||58||LONG-TERM FOLLOW-UP|1962-12-27|1969-10-03|||||1963-01-14||1960-08-22|N|1966-04-05
TRIAL STUDY 134XCP|LB|51B01BE3-230D-4AE0-A229-81EF519EA932|2||||C165890|TIMOTHY GRASS POLLEN IGE AB RAST SCORE|||||||/HPF|||||||INVALID||MMOL2/L2||||LOW|NOT DONE||||LYMPH|REFRIGERATED|NA|CLOT DETECTION|GMI % FORMULA||N|N|U|Y|||N|2||58||FOLLOW-UP|1967-12-21|1972-03-21|||||1960-07-16||1972-01-10|NA|1968-12-13
TRIAL STUDY 134XCP|LB|51B01BE3-230D-4AE0-A229-81EF519EA932|1||||MYCYCE|MYELOCYTES/TOTAL CELLS|||||||MANSON U/ML|||||||BORDERLINE||CIGARETTE||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|CLOTTED|N|MUGA|FIBROTEST FORMULA||NA|N|U|N|||NA|3||39||BASELINE|1969-09-26|1961-03-17|||||1970-11-20||1961-08-26|Y|1970-03-28
TRIAL STUDY 134XCP|LB|51B01BE3-230D-4AE0-A229-81EF519EA932|2||||HMOSIDRN|HEMOSIDERIN|||||||MEQ/G|||||||INVALID||10^3 ORGANISMS/ML||||HIGH|NOT DONE||||REFLEX TEAR|DRIED|U|DARK FIELD MICROSCOPY|ASH FIBROSURE FORMULA||N|NA|Y|N|||U|3||39||LONG-TERM FOLLOW-UP|1963-05-23|1972-03-31|||||1970-09-28||1960-03-16|Y|1970-04-10
TRIAL STUDY 134XCP|LB|51B01BE3-230D-4AE0-A229-81EF519EA932|1||||TNF12S|SOLUBLE TNF SUPERFAMILY MEMBER 12|||||||LOG10 IU/ML|||||||POSITIVE||HPA||||LOW|NOT DONE||||VENOUS BLOOD|SOLIDIFIED|N|OPTICAL MAPPING|CKD-EPI CYSTATIN C FORMULA||N|NA|Y|N|||U|4||88||OPEN LABEL TREATMENT|1969-04-26|1963-07-08|||||1969-03-26||1963-08-01|NA|1966-12-24
TRIAL STUDY 134XCP|LB|51B01BE3-230D-4AE0-A229-81EF519EA932|2||||CRP|C REACTIVE PROTEIN|||||||OZ EQ|||||||INVALID||MBQ||||ABNORMAL|NOT DONE||||CIRCULATING TUMOR CELL|THAWED|U|DYNAMIC CONTRAST ENHANCED MRI|MDRD 5 VARIABLE FORMULA||Y|N|NA|N|||NA|4||88||WASHOUT|1960-02-18|1968-10-23|||||1964-03-15||1960-11-15|NA|1972-12-13
TRIAL STUDY 134XCP|LB|51B01BE3-230D-4AE0-A229-81EF519EA932|1||||PBGCREAT|PORPHOBILINOGEN/CREATININE|||||||L/H|||||||TRACE||%(W/W)||||ABNORMAL|NOT DONE||||DISCHARGE|NON-HEMOLYZED|U|FARNSWORTH-MUNSELL 100 HUE TEST|GMI % FORMULA||N|U|N|Y|||Y|5||7||LONG-TERM FOLLOW-UP|1964-07-27|1970-09-19|||||1970-03-30||1967-11-11|NA|1972-05-14
TRIAL STUDY 134XCP|LB|51B01BE3-230D-4AE0-A229-81EF519EA932|2||||KLOTHO|KLOTHO|||||||JAR|||||||NEGATIVE||LOG10 CFU/ML||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|PARAFFIN-EMBEDDED|Y|ALCIAN BLUE STAIN|HEPASCORE FORMULA||N|NA|U|NA|||Y|5||7||OPEN LABEL TREATMENT|1965-11-21|1961-06-23|||||1964-04-04||1962-04-27|U|1962-08-01
TRIAL STUDY 134XCP|LB|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|1||||CRTRONE|CORTICOSTERONE|||||||MG/ML/MIN|||||||NEGATIVE||/200 HPFS||||ABNORMAL|NOT DONE||||SALIVA|CONCENTRATED|N|IMMUNOTURBIDIMETRY|MDRD ENZYMATIC FORMULA||NA|N|N|N|||NA|1||38||INDUCTION TREATMENT|1970-03-20|1961-08-15|||||1964-08-05||1969-08-11|U|1962-06-15
TRIAL STUDY 134XCP|LB|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|2||||HIS|HISTIDINE|||||||ENZYME U/L|||||||POSITIVE||SCM||||NORMAL|NOT DONE||||MONOCYTE|LIPEMIC|N|IMMUNO-PET SCAN|GMI MMOL/MOL FORMULA||N|Y|NA|Y|||U|1||38||BLINDED TREATMENT|1969-08-07|1972-11-05|||||1970-07-25||1964-02-10|N|1969-02-21
TRIAL STUDY 134XCP|LB|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|1||||FATBODOV|FAT BODIES, OVAL|||||||NEWTON|||||||INDETERMINATE||MANSON U/ML||||NORMAL|NOT DONE||||BONE MARROW|ROOM TEMPERATURE|U|AUTOREFRACTION|NASH FIBROSURE FORMULA||U|U|Y|N|||U|2||58||OBSERVATION|1971-12-07|1960-09-05|||||1966-03-16||1964-02-20|U|1965-11-10
TRIAL STUDY 134XCP|LB|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|2||||AAP|ALANINE AMINOPEPTIDASE|||||||UG/ML/H|||||||POSITIVE||KV||||ABNORMAL|NOT DONE||||SOFT TISSUE|ICTERIC|N|BRDU CELLULAR PROLIFERATION ASSAY|CKD-EPI CREATININE FORMULA||U|U|NA|U|||Y|2||58||OBSERVATION|1962-12-12|1962-06-09|||||1971-06-01||1963-04-03|N|1969-11-09
TRIAL STUDY 134XCP|LB|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|1||||LEUKCE|LEUKEMIC CELLS|||||||MOSM/L|||||||TRACE||ML/S||||ABNORMAL|NOT DONE||||SALIVA|LIPEMIC|U|MANUAL CLOT DETECTION|MDRD 5 VARIABLE FORMULA||Y|N|NA|NA|||N|3||39||TREATMENT|1969-11-19|1971-06-11|||||1966-05-13||1971-07-08|Y|1971-03-16
TRIAL STUDY 134XCP|LB|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|2||||C165886|WHITE OAK POLLEN IGE AB RAST SCORE|||||||10^9 ORGANISMS/G|||||||INDETERMINATE||ML/G/H||||LOW|NOT DONE||||SWABBED MATERIAL|PARAFFIN-EMBEDDED|N|LAPAROSCOPY|CKD-EPI FORMULA||NA|Y|N|N|||NA|3||39||BASELINE|1963-06-27|1970-01-25|||||1965-01-06||1962-08-01|U|1971-09-18
TRIAL STUDY 134XCP|LB|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|1||||NEUTMY|NEUTROPHILIC MYELOCYTES|||||||10^6 ORGANISMS/ML|||||||INVALID||NL||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|FRESH|Y|SINGLE-MOLECULE ARRAY|CKD-EPI FORMULA||U|N|Y|U|||N|4||88||LONG-TERM FOLLOW-UP|1960-09-14|1965-05-23|||||1961-01-12||1967-01-28|U|1968-04-02
TRIAL STUDY 134XCP|LB|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|2||||RITALAC|RITALINIC ACID|||||||G/G|||||||TRACE||G/DL||||HIGH|NOT DONE||||MENSTRUAL BLOOD|LACTESCENT|N|OPTICAL COHERENCE TOMOGRAPHY|MDRD 5 VARIABLE FORMULA||N|N|U|U|||U|4||88||OPEN LABEL TREATMENT|1965-11-26|1966-07-20|||||1969-07-16||1969-11-12|Y|1964-03-18
TRIAL STUDY 134XCP|LB|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|1||||CALB|CALBINDIN|||||||VIRTUAL PIXEL|||||||BORDERLINE||EU||||LOW|NOT DONE||||SKIN TISSUE|FRESH|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|U|N|||NA|5||7||OBSERVATION|1966-09-18|1961-08-16|||||1965-01-19||1971-03-10|NA|1969-07-18
TRIAL STUDY 134XCP|LB|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|2||||HLADRB1|HLA DR BETA1 ANTIGEN|||||||HOMEOPATHIC DILUTION|||||||NEGATIVE||U/KG/H||||NORMAL|NOT DONE||||ERYTHROCYTES|PARAFFIN-EMBEDDED|NA|MULTI-SLICE SPIRAL CT|CKD-EPI CYSTATIN C FORMULA||Y|NA|NA|U|||Y|5||7||OBSERVATION|1971-07-21|1970-10-10|||||1962-03-27||1961-10-07|NA|1973-07-25
TRIAL STUDY 134XCP|LB|01FD66DA-C67B-48A7-9320-F29C6C226155|1||||HBOARBHB|HEMOGLOBIN O-ARAB/TOTAL HEMOGLOBIN|||||||MOL/ML|||||||POSITIVE||DPM/0.5 ML||||NORMAL|NOT DONE||||MUCUS|GELLED|Y|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|N|NA|||Y|1||38||WASHOUT|1966-08-25|1962-11-16|||||1962-08-09||1973-07-01|N|1964-11-15
TRIAL STUDY 134XCP|LB|01FD66DA-C67B-48A7-9320-F29C6C226155|2||||KEXR|POTASSIUM EXCRETION RATE|||||||PG/L|||||||POSITIVE||G/U||||HIGH|NOT DONE||||SUPERNATANT, SERUM|NON-HEMOLYZED|Y|HIGH RESOLUTION MELT ANALYSIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|U|||N|1||38||SCREENING|1971-02-27|1960-01-06|||||1967-12-11||1970-11-07|N|1970-03-31
TRIAL STUDY 134XCP|LB|01FD66DA-C67B-48A7-9320-F29C6C226155|1||||CRTCREAT|CORTICOSTERONE/CREATININE|||||||AFU|||||||INVALID||MG/KG/DAY||||ABNORMAL|NOT DONE||||SPERMATOZOON|ROOM TEMPERATURE|U|MICROBIAL BIOCHEMICAL IDENTIFICATION|MDRD ENZYMATIC FORMULA||N|Y|NA|Y|||Y|2||58||WASHOUT|1966-12-05|1970-08-17|||||1962-06-26||1968-01-22|Y|1973-02-20
TRIAL STUDY 134XCP|LB|01FD66DA-C67B-48A7-9320-F29C6C226155|2||||HGBS|HEMOGLOBIN S|||||||UGEQ/L|||||||INDETERMINATE||10^9/L||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|LIPEMIC|U|LIGHT SCATTERING SPECTROSCOPY|HEPASCORE FORMULA||NA|NA|U|Y|||NA|2||58||LONG-TERM FOLLOW-UP|1964-02-17|1966-07-04|||||1972-06-12||1969-09-08|NA|1964-10-19
TRIAL STUDY 134XCP|LB|01FD66DA-C67B-48A7-9320-F29C6C226155|1||||FXAC|FACTOR X ACTUAL/CONTROL|||||||MET*H|||||||POSITIVE||U/G||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|UNEXPECTED ODOR|U|FUNCTIONAL MRI|CKD-EPI FORMULA||U|N|NA|Y|||NA|3||39||SCREENING|1971-01-15|1969-12-26|||||1964-08-08||1965-09-26|U|1967-10-11
TRIAL STUDY 134XCP|LB|01FD66DA-C67B-48A7-9320-F29C6C226155|2||||GLUCWBE|WHOLE BLOOD EQUIVALENT GLUCOSE|||||||MKAT|||||||INDETERMINATE||EJACULATE U||||HIGH|NOT DONE||||DISCHARGE|DRIED|N|GRADIENT DIFFUSION|MDRD 5 VARIABLE FORMULA||Y|N|U|U|||N|3||39||TREATMENT|1970-05-18|1961-09-29|||||1969-02-02||1972-07-30|U|1971-02-24
TRIAL STUDY 134XCP|LB|01FD66DA-C67B-48A7-9320-F29C6C226155|1||||FGFBF|FIBROBLAST GROWTH FACTOR BASIC FORM|||||||MV*MIN|||||||BORDERLINE||RATIO||||LOW|NOT DONE||||HAIR|REFRIGERATED|NA|KARYOTYPING|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|N|U|N|||NA|4||88||WASHOUT|1960-04-13|1968-08-10|||||1968-08-28||1960-12-21|U|1967-07-11
TRIAL STUDY 134XCP|LB|01FD66DA-C67B-48A7-9320-F29C6C226155|2||||FATACVLC|FATTY ACIDS, VERY LONG CHAIN|||||||MM/SEC|||||||TRACE||MEQ/MMOL||||ABNORMAL|NOT DONE||||PLEURAL FLUID|UNEXPECTED ODOR|N|IODINE STAIN|NASH FIBROSURE FORMULA||Y|Y|Y|NA|||U|4||88||BASELINE|1965-03-28|1963-03-15|||||1968-09-09||1962-06-12|Y|1969-05-23
TRIAL STUDY 134XCP|LB|01FD66DA-C67B-48A7-9320-F29C6C226155|1||||C165895|JOHNSON GRASS POLLEN IGG4 ANTIBODY|||||||OSM|||||||TRACE||PG/L||||ABNORMAL|NOT DONE||||SEMEN|REFRIGERATED|Y|X-RAY FLUORESCENCE SPECTROMETRY|CKD-EPI CYSTATIN C FORMULA||U|U|N|U|||Y|5||7||INDUCTION TREATMENT|1962-01-11|1960-01-19|||||1973-06-28||1970-12-11|N|1965-09-12
TRIAL STUDY 134XCP|LB|01FD66DA-C67B-48A7-9320-F29C6C226155|2||||A1MICG|ALPHA-1 MICROGLOBULIN|||||||CMOL/L|||||||POSITIVE||ML/KG/MIN||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|SOLIDIFIED|N|SPIROMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|NA|NA|||U|5||7||BASELINE|1968-12-10|1968-02-07|||||1964-12-24||1967-05-05|N|1972-07-04
TRIAL STUDY 134XCP|LB|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|1||||MSTHCE|MESOTHELIAL CELLS|||||||MPS U|||||||TRACE||ML/G/DAY||||NORMAL|NOT DONE||||INFRANATANT, SERUM|AGGLUTINATED|N|ATOMIC ABSORPTION SPECTROMETRY|HEPASCORE FORMULA||N|U|Y|U|||N|1||38||WASHOUT|1966-07-24|1969-06-05|||||1967-01-05||1966-06-03|N|1973-08-06
TRIAL STUDY 134XCP|LB|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|2||||METARUB|METARUBRICYTE|||||||MV|||||||INVALID||SBE/ML||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|CONTAMINATED|N|DYNAMIC CONTRAST ENHANCED MRI|MDRD 4 VARIABLE FORMULA||Y|Y|NA|Y|||NA|1||38||BLINDED TREATMENT|1970-10-27|1967-09-18|||||1962-12-23||1963-07-26|N|1961-10-29
TRIAL STUDY 134XCP|LB|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|1||||CCR5|C-C CHEMOKINE RECEPTOR TYPE 5|||||||JOULE|||||||INDETERMINATE||MV*MIN||||NORMAL|NOT DONE||||NAIL|AUTOLYZED|U|NUCLEAR RADIOLOGY|FIBROSIS 4 FORMULA||Y|Y|Y|N|||NA|2||58||RUN-IN|1963-03-04|1970-10-07|||||1964-08-23||1966-08-26|NA|1963-10-14
TRIAL STUDY 134XCP|LB|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|2||||TMZPM|TEMAZEPAM|||||||AMFI|||||||INVALID||UG/L FEU||||HIGH|NOT DONE||||SEMINAL FLUID|CONCENTRATED|Y|CELLULOSE TAPE|FIBROSIS 4 FORMULA||U|NA|Y|NA|||U|2||58||BASELINE|1966-08-06|1965-04-11|||||1969-11-01||1965-01-05|N|1965-02-06
TRIAL STUDY 134XCP|LB|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|1||||IGFBP7|INSULIN-LIKE GROWTH FACTOR BINDING PROT7|||||||MG/M2/MIN|||||||POSITIVE||/200 HPFS||||HIGH|NOT DONE||||COLOSTRUM|AUTOLYZED|NA|IMMUNOTURBIDIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|U|||Y|3||39||FOLLOW-UP|1969-04-06|1964-11-13|||||1962-01-21||1961-02-12|N|1970-12-30
TRIAL STUDY 134XCP|LB|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|2||||CLRZPT|CLORAZEPATE|||||||LOG10 COPIES/ML|||||||TRACE||G||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FROZEN|Y|AUDIOMETRY|GMI MMOL/MOL FORMULA||N|NA|U|N|||U|3||39||TREATMENT|1961-07-16|1968-12-26|||||1967-11-19||1961-02-23|Y|1964-09-14
TRIAL STUDY 134XCP|LB|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|1||||C130138|AMERICAN COCKROACH ANTIGEN IGG ANTIBODY|||||||NEBULE|||||||TRACE||UKAT/10^12 RBC||||HIGH|NOT DONE||||CELL PELLET|CLOTTED|U|ULTRASOUND|GMI MMOL/MOL FORMULA||N|Y|NA|U|||NA|4||88||TREATMENT|1971-02-27|1968-06-11|||||1971-02-18||1966-10-31|Y|1963-08-08
TRIAL STUDY 134XCP|LB|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|2||||TRIG|TRIGLYCERIDES|||||||HOURS|||||||BORDERLINE||UG/M2||||NORMAL|NOT DONE||||PERSPIRATION|CLOTTED|N|IRON HEMATOXYLIN STAIN|NASH FIBROSURE FORMULA||U|N|N|N|||U|4||88||BLINDED TREATMENT|1969-06-18|1960-02-22|||||1962-05-10||1960-07-19|Y|1961-06-15
TRIAL STUDY 134XCP|LB|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|1||||CRLPLSMN|CERULOPLASMIN|||||||DIOPTER|||||||BORDERLINE||CI/ML||||HIGH|NOT DONE||||BONE|ROOM TEMPERATURE|N|HEMAGGLUTINATION ASSAY|NASH FIBROSURE FORMULA||Y|U|N|U|||NA|5||7||FOLLOW-UP|1971-12-23|1970-04-01|||||1973-03-19||1961-02-14|U|1962-05-23
TRIAL STUDY 134XCP|LB|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|2||||FACTXI|FACTOR XI|||||||MASK|||||||INVALID||PUFF||||LOW|NOT DONE||||EXUDATE|THAWED|U|SPIRAL CT SCAN WITHOUT CONTRAST|MDRD 6 VARIABLE FORMULA||NA|NA|N|N|||NA|5||7||SCREENING|1962-01-28|1964-02-08|||||1964-08-20||1964-05-25|U|1969-01-01
TRIAL STUDY 134XCP|LB|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|1||||GHRELINA|ACTIVE GHRELIN|||||||MAMP|||||||INDETERMINATE||CYCLE/MIN||||LOW|NOT DONE||||LEUKOCYTE|FROZEN|Y|FUNDUS PHOTOGRAPHY|MDRD 4 VARIABLE FORMULA||Y|NA|NA|N|||U|1||38||BASELINE|1964-11-05|1970-02-20|||||1966-11-24||1962-12-11|N|1968-07-31
TRIAL STUDY 134XCP|LB|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|2||||FIBRINOF|FIBRINOGEN, FUNCTIONAL|||||||UU/DL|||||||TRACE||VG/ML||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|ROOM TEMPERATURE|U|WEBER GREEN STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|U|Y|||Y|1||38||CONTINUATION TREATMENT|1971-02-10|1965-11-24|||||1969-02-06||1960-05-27|N|1973-02-03
TRIAL STUDY 134XCP|LB|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|1||||AMA|ANTIMITOCHONDRIAL ANTIBODIES|||||||/SEC|||||||BORDERLINE||FARAD||||LOW|NOT DONE||||DERMAL TISSUE|FROZEN|N|CYSTOSCOPY|CKD-EPI CYSTATIN C FORMULA||U|U|NA|NA|||N|2||58||OBSERVATION|1968-09-24|1960-12-29|||||1965-02-02||1972-06-10|NA|1960-10-16
TRIAL STUDY 134XCP|LB|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|2||||FLUVOXAM|FLUVOXAMINE|||||||MMOL/S|||||||BORDERLINE||L/DAY||||LOW|NOT DONE||||SEBUM|GELLED|U|CT SCAN|FIBROMETER FORMULA||NA|Y|NA|U|||U|2||58||INDUCTION TREATMENT|1970-12-27|1970-11-13|||||1960-02-19||1973-06-23|U|1962-09-25
TRIAL STUDY 134XCP|LB|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|1||||HETRPH|HETEROPHILS|||||||APS U|||||||INVALID||DYN||||HIGH|NOT DONE||||PERITONEAL FLUID|CALCIFIED|NA|FUNDUS PHOTOGRAPHY|GMI MMOL/MOL FORMULA||U|NA|N|U|||U|3||39||RUN-IN|1962-06-29|1971-08-27|||||1964-09-05||1971-02-06|Y|1966-03-19
TRIAL STUDY 134XCP|LB|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|2||||DTPACLR|DTPA CLEARANCE|||||||/LSQN|||||||INVALID||LB||||LOW|NOT DONE||||SPUTUM|HEMOLYZED|Y|CONTRAST ENHANCED SPIRAL CT SCAN|CKD-EPI CREATININE FORMULA||U|NA|U|NA|||N|3||39||OPEN LABEL TREATMENT|1967-07-27|1965-02-12|||||1966-03-22||1969-08-25|U|1967-03-03
TRIAL STUDY 134XCP|LB|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|1||||GDA|GUANINE DEAMINASE|||||||MM/MIN|||||||POSITIVE||GY/MIN||||LOW|NOT DONE||||ARTERIAL BLOOD|REFRIGERATED|U|SLIT LAMP|MDRD ENZYMATIC FORMULA||Y|NA|U|Y|||U|4||88||FOLLOW-UP|1969-03-03|1961-02-18|||||1960-08-07||1966-05-14|Y|1968-03-22
TRIAL STUDY 134XCP|LB|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|2||||C165879|D. FARINAE IGE AB RAST SCORE|||||||KPA/L/SEC|||||||NEGATIVE||UM||||ABNORMAL|NOT DONE||||DIALYSIS FLUID|DRIED|U|ICP-MS|CKD-EPI CREATININE FORMULA||N|U|U|U|||NA|4||88||CONTINUATION TREATMENT|1965-04-17|1971-07-23|||||1962-05-27||1966-07-21|U|1965-03-19
TRIAL STUDY 134XCP|LB|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|1||||C165878|GERMAN COCKROACH IGE AB RAST SCORE|||||||IU/L|||||||POSITIVE||ENZYME U/G HB||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|ICTERIC|N|AMSLER GRID|NASH FIBROSURE FORMULA||Y|N|N|U|||NA|5||7||WASHOUT|1969-05-28|1971-06-25|||||1967-09-08||1971-06-16|U|1969-07-28
TRIAL STUDY 134XCP|LB|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|2||||INTLK3|INTERLEUKIN 3|||||||IU/KG/H|||||||TRACE||L/H/M2||||NORMAL|NOT DONE||||ADIPOSE TISSUE|CONTAMINATED|N|OPTICAL MAPPING|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|N|U|||Y|5||7||CONTINUATION TREATMENT|1972-01-08|1964-07-20|||||1969-01-28||1972-07-08|NA|1970-11-24
TRIAL STUDY 134XCP|LB|81E3641F-6145-4B3C-9E26-8DEC1200509D|1||||INTLK32|INTERLEUKIN 32|||||||DYN|||||||POSITIVE||NMOL/KG/DAY||||NORMAL|NOT DONE||||MUCUS|LACTESCENT|N|PELLI-ROBSON EYE CHART|ASH FIBROSURE FORMULA||U|Y|N|U|||NA|1||38||BLINDED TREATMENT|1973-03-02|1969-09-01|||||1966-09-18||1969-02-10|N|1972-12-29
TRIAL STUDY 134XCP|LB|81E3641F-6145-4B3C-9E26-8DEC1200509D|2||||ETPTPR|ETP TIME TO PEAK RELATIVE|||||||BAU/ML|||||||NEGATIVE||UG/L/H||||LOW|NOT DONE||||EXPIRED AIR|LACTESCENT|NA|IN VITRO GENE EXPRESSION ASSAY|FIBROSIS 4 FORMULA||NA|NA|Y|Y|||N|1||38||OPEN LABEL TREATMENT|1960-10-24|1966-03-29|||||1970-06-22||1969-08-01|NA|1965-12-02
TRIAL STUDY 134XCP|LB|81E3641F-6145-4B3C-9E26-8DEC1200509D|1||||NFHP|PHOSPHORYLATED NEUROFILAMENT HEAVY CHAIN|||||||SUPPOSITORY|||||||INVALID||ML/DOSE||||NORMAL|NOT DONE||||BLOOD|CONCENTRATED|Y|LAPAROSCOPY|FIBROMETER FORMULA||Y|NA|Y|Y|||Y|2||58||WASHOUT|1967-01-13|1968-10-26|||||1964-05-29||1961-12-21|Y|1963-10-27
TRIAL STUDY 134XCP|LB|81E3641F-6145-4B3C-9E26-8DEC1200509D|2||||BLYMXM|B-LYMPHOCYTE CROSSMATCH|||||||CARTRIDGE|||||||POSITIVE||IU/G HB||||LOW|NOT DONE||||EXHALED BREATH CONDENSATE|AGGLUTINATED|U|HIGH RESOLUTION CT|CKD-EPI CREATININE FORMULA||NA|Y|Y|Y|||U|2||58||CONTINUATION TREATMENT|1961-01-29|1965-10-12|||||1966-03-16||1963-09-15|U|1966-06-10
TRIAL STUDY 134XCP|LB|81E3641F-6145-4B3C-9E26-8DEC1200509D|1||||RBPCREAT|RETINOL BINDING PROTEIN/CREATININE|||||||TESLA|||||||INVALID||MMHG*MIN/L||||NORMAL|NOT DONE||||REFLEX TEAR|HEMOLYZED|Y|POLYSOMNOGRAPHY|MDRD 4 VARIABLE FORMULA||U|Y|U|N|||Y|3||39||TREATMENT|1966-06-12|1970-10-20|||||1964-11-03||1972-09-14|Y|1970-09-29
TRIAL STUDY 134XCP|LB|81E3641F-6145-4B3C-9E26-8DEC1200509D|2||||CARTP|COCAINE AMPHETAMINE-REG TRANSCRIPT PROT|||||||U/KG/H|||||||NEGATIVE||ML/SEC/1.73M2||||LOW|NOT DONE||||AQUEOUS HUMOR|LACTESCENT|Y|IMMUNOPRECIPITATION|MDRD ENZYMATIC FORMULA||NA|Y|NA|Y|||N|3||39||SCREENING|1964-12-08|1963-07-19|||||1961-01-12||1969-02-09|Y|1963-12-23
TRIAL STUDY 134XCP|LB|81E3641F-6145-4B3C-9E26-8DEC1200509D|1||||BETAINES|BETAINES|||||||NKAT/G HB|||||||INVALID||NMOL/L/MIN||||NORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|CONCENTRATED|N|POTENTIOMETRY|MDRD ENZYMATIC FORMULA||Y|U|U|N|||U|4||88||INDUCTION TREATMENT|1967-01-02|1967-06-29|||||1967-05-18||1961-04-13|NA|1968-02-06
TRIAL STUDY 134XCP|LB|81E3641F-6145-4B3C-9E26-8DEC1200509D|2||||FACTIX|FACTOR IX|||||||GENEQ/ML|||||||INDETERMINATE||NMOL BCE/NMOL||||ABNORMAL|NOT DONE||||LYMPH|ROOM TEMPERATURE|Y|THICK SMEAR|CKD-EPI FORMULA||Y|Y|Y|N|||U|4||88||BASELINE|1960-04-05|1966-07-20|||||1963-05-14||1973-02-26|NA|1969-02-17
TRIAL STUDY 134XCP|LB|81E3641F-6145-4B3C-9E26-8DEC1200509D|1||||SPMPSPM|SPERMATOZOA, PROGRESSIVE/SPERMATOZOA|||||||10^8/L|||||||NEGATIVE||COPIES/ML||||ABNORMAL|NOT DONE||||MIXED VENOUS BLOOD|LACTESCENT|N|IRON HEMATOXYLIN STAIN|GMI MMOL/MOL FORMULA||Y|U|N|Y|||U|5||7||SCREENING|1972-09-11|1970-12-20|||||1965-08-18||1967-05-09|N|1965-01-01
TRIAL STUDY 134XCP|LB|81E3641F-6145-4B3C-9E26-8DEC1200509D|2||||BASOIMLE|IMMATURE BASOPHILS/LEUKOCYTES|||||||CM2|||||||NEGATIVE||G/CAGE/DAY||||HIGH|NOT DONE||||LAVAGE FLUID|CALCIFIED|U|CONTRAST ENHANCED SPIRAL CT SCAN|MDRD 5 VARIABLE FORMULA||Y|Y|NA|Y|||NA|5||7||LONG-TERM FOLLOW-UP|1967-04-01|1961-03-12|||||1963-05-10||1965-12-27|Y|1965-10-04
TRIAL STUDY 134XCP|LB|8F3D0A71-FD09-4E43-BC54-0562AF99306E|1||||TDTAG|TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE AG|||||||MEQ/DL|||||||TRACE||/HPF||||LOW|NOT DONE||||CELL PELLET|CONTAMINATED|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|ASH FIBROSURE FORMULA||Y|N|NA|Y|||U|1||38||RUN-IN|1970-08-01|1965-04-03|||||1972-02-01||1960-10-08|U|1961-11-07
TRIAL STUDY 134XCP|LB|8F3D0A71-FD09-4E43-BC54-0562AF99306E|2||||GAD1|GLUTAMIC ACID DECARBOXYLASE 1|||||||MAMP|||||||INVALID||KG/CM2||||LOW|NOT DONE||||PUS|LACTESCENT|Y|COLORIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|N|Y|||N|1||38||BASELINE|1964-11-04|1967-12-05|||||1962-11-10||1971-06-07|NA|1963-05-23
TRIAL STUDY 134XCP|LB|8F3D0A71-FD09-4E43-BC54-0562AF99306E|1||||OSMLTY|OSMOLALITY|||||||MMOL/G|||||||INDETERMINATE||MOL/L||||ABNORMAL|NOT DONE||||MONOCYTE|ROOM TEMPERATURE|Y|EPSILOMETER|ASH FIBROSURE FORMULA||N|N|NA|NA|||Y|2||58||TREATMENT|1963-04-06|1971-12-29|||||1973-04-17||1970-01-06|NA|1967-10-21
TRIAL STUDY 134XCP|LB|8F3D0A71-FD09-4E43-BC54-0562AF99306E|2||||ACE|ANGIOTENSIN CONVERTING ENZYME|||||||BOLUS|||||||INVALID||POINT||||ABNORMAL|NOT DONE||||PERSPIRATION|UNEXPECTED ODOR|U|X-RAY|FIBROMETER FORMULA||NA|NA|U|U|||N|2||58||BLINDED TREATMENT|1962-06-18|1963-04-07|||||1963-02-14||1971-12-26|U|1961-08-29
TRIAL STUDY 134XCP|LB|8F3D0A71-FD09-4E43-BC54-0562AF99306E|1||||LIPASET|LIPASE|||||||TRACE|||||||NEGATIVE||PLUG||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|LACTESCENT|Y|ACCELERATOR MASS SPECTROMETRY|MDRD 5 VARIABLE FORMULA||NA|N|N|Y|||Y|3||39||INDUCTION TREATMENT|1969-09-03|1963-03-04|||||1967-04-14||1969-12-13|Y|1963-02-07
TRIAL STUDY 134XCP|LB|8F3D0A71-FD09-4E43-BC54-0562AF99306E|2||||NONHDL|NON-HDL CHOLESTEROL|||||||MMHG/L/MIN|||||||BORDERLINE||MEQ/UG||||HIGH|NOT DONE||||INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|Y|OLIGO ACGH|MDRD 6 VARIABLE FORMULA||N|N|Y|NA|||N|3||39||FOLLOW-UP|1965-08-01|1970-02-06|||||1963-10-21||1962-06-13|N|1961-10-19
TRIAL STUDY 134XCP|LB|8F3D0A71-FD09-4E43-BC54-0562AF99306E|1||||HGBA2HGB|HEMOGLOBIN A2/TOTAL HEMOGLOBIN|||||||10^9 ORGANISMS|||||||INDETERMINATE||ML/KG/DAY||||ABNORMAL|NOT DONE||||CORD BLOOD|ICTERIC|U|WRIGHT STAIN|GMI % FORMULA||Y|Y|N|N|||N|4||88||OBSERVATION|1962-02-06|1972-09-18|||||1965-05-03||1967-06-22|NA|1969-01-23
TRIAL STUDY 134XCP|LB|8F3D0A71-FD09-4E43-BC54-0562AF99306E|2||||LYMVAC|VACUOLATED LYMPHOCYTES|||||||ML/MIN/MMHG|||||||TRACE||L/S/KPA||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|CLOTTED|U|PHASE CONTRAST MICROSCOPY|MDRD FORMULA||N|Y|Y|NA|||NA|4||88||CONTINUATION TREATMENT|1971-12-13|1967-04-15|||||1967-09-16||1968-09-27|Y|1973-06-22
TRIAL STUDY 134XCP|LB|8F3D0A71-FD09-4E43-BC54-0562AF99306E|1||||ETPAUC|ETP AREA UNDER CURVE|||||||WATT|||||||INVALID||PIXEL||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONCENTRATED|Y|IN SITU HYBRIDIZATION|GMI MMOL/MOL FORMULA||N|U|Y|U|||N|5||7||LONG-TERM FOLLOW-UP|1964-11-29|1971-08-15|||||1968-12-01||1967-04-22|NA|1971-05-08
TRIAL STUDY 134XCP|LB|8F3D0A71-FD09-4E43-BC54-0562AF99306E|2||||TPAAG|TISSUE PLASMINOGEN ACTIVATOR ANTIGEN|||||||NG/DL|||||||INDETERMINATE||JDF UNIT||||ABNORMAL|NOT DONE||||PLASMA|FRESH|U|STRESS ECHOCARDIOGRAPHY|MDRD FORMULA||Y|NA|Y|U|||U|5||7||OBSERVATION|1960-01-10|1968-08-20|||||1960-05-03||1961-07-10|U|1960-07-08
TRIAL STUDY 134XCP|LB|BE750F04-5992-42B5-A084-A33D6FBBFD2E|1||||CYCACAR|CALCIUM CARBONATE CRYSTALS|||||||PSI|||||||POSITIVE||10^6 ORGANISMS/G||||HIGH|NOT DONE||||EXUDATE|DRIED|NA|CELL OF ORIGIN ASSAY|GMI MMOL/MOL FORMULA||U|N|Y|N|||NA|1||38||BASELINE|1964-07-09|1969-12-13|||||1969-04-09||1962-05-02|N|1965-06-19
TRIAL STUDY 134XCP|LB|BE750F04-5992-42B5-A084-A33D6FBBFD2E|2||||AFPL3|ALPHA FETOPROTEIN L3|||||||M2|||||||TRACE||UM||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|GELLED|U|CELLULOSE TAPE|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|NA|||NA|1||38||RUN-IN|1961-02-08|1968-06-16|||||1960-01-01||1972-10-20|NA|1971-02-14
TRIAL STUDY 134XCP|LB|BE750F04-5992-42B5-A084-A33D6FBBFD2E|1||||FLNTRZPM|FLUNITRAZEPAM|||||||ML/SEC/1.73M2|||||||TRACE||CM/S||||HIGH|NOT DONE||||SPERMATOZOON|CONCENTRATED|NA|SPIROMETRY|FIBROSIS 4 FORMULA||NA|N|N|Y|||Y|2||58||FOLLOW-UP|1960-02-11|1968-07-19|||||1972-09-03||1967-09-09|U|1970-09-17
TRIAL STUDY 134XCP|LB|BE750F04-5992-42B5-A084-A33D6FBBFD2E|2||||MTNEPHFR|METANEPHRINE, FREE|||||||MMOL|||||||INDETERMINATE||MG/M2/H||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|U|INTRAVASCULAR ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|N|Y|||Y|2||58||TREATMENT|1969-01-26|1960-07-06|||||1965-05-17||1963-08-10|U|1967-04-02
TRIAL STUDY 134XCP|LB|BE750F04-5992-42B5-A084-A33D6FBBFD2E|1||||ICAM3|INTERCELLULAR ADHESION MOLECULE 3|||||||UG/M2/DAY|||||||BORDERLINE||ML/H||||LOW|NOT DONE||||CEREBROSPINAL FLUID|NON-HEMOLYZED|N|X-RAY|GMI % FORMULA||U|Y|U|U|||N|3||39||INDUCTION TREATMENT|1961-03-28|1967-10-19|||||1965-07-10||1962-12-24|N|1960-05-29
TRIAL STUDY 134XCP|LB|BE750F04-5992-42B5-A084-A33D6FBBFD2E|2||||C130088|TIMOTHY GRASS POLLEN IGE|||||||NMOL|||||||INVALID||ATM||||ABNORMAL|NOT DONE||||BLOOD|ICTERIC|U|ACID FAST STAIN|CKD-EPI CREATININE FORMULA||U|NA|U|NA|||NA|3||39||FOLLOW-UP|1968-04-26|1967-03-16|||||1971-03-27||1963-03-26|Y|1973-06-16
TRIAL STUDY 134XCP|LB|BE750F04-5992-42B5-A084-A33D6FBBFD2E|1||||BICARB|BICARBONATE|||||||CMH2O*S2/ML|||||||BORDERLINE||LB||||NORMAL|NOT DONE||||NAIL|REFRIGERATED|U|POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||NA|N|Y|NA|||Y|4||88||CONTINUATION TREATMENT|1966-07-15|1961-11-14|||||1967-08-15||1970-11-02|N|1962-05-27
TRIAL STUDY 134XCP|LB|BE750F04-5992-42B5-A084-A33D6FBBFD2E|2||||GMCSF|GRANULOCYTE MACROPHAGE COLONY STM FACTOR|||||||MMHG|||||||INVALID||MG/M2/DAY||||LOW|NOT DONE||||AMNIOTIC FLUID|CONTAMINATED|NA|ANTIBIOTIC AGAR SCREEN|GMI % FORMULA||U|Y|N|Y|||N|4||88||WASHOUT|1972-07-26|1966-03-25|||||1966-01-14||1967-08-19|U|1960-12-09
TRIAL STUDY 134XCP|LB|BE750F04-5992-42B5-A084-A33D6FBBFD2E|1||||OXYCAP|OXYGEN CAPACITY|||||||GRAVITATIONAL UNIT|||||||BORDERLINE||LOG10 IU/ML||||NORMAL|NOT DONE||||PLATELET RICH PLASMA|HEMOLYZED|N|CALCULATION|GMI MMOL/MOL FORMULA||NA|NA|Y|U|||Y|5||7||OPEN LABEL TREATMENT|1965-12-02|1971-02-03|||||1963-04-22||1963-11-07|Y|1972-08-03
TRIAL STUDY 134XCP|LB|BE750F04-5992-42B5-A084-A33D6FBBFD2E|2||||C147285|COMMON RAGWEED POLLEN IGE ANTIBODY|||||||BQ/L|||||||BORDERLINE||CD||||LOW|NOT DONE||||PLATELET|GELLED|Y|MICRO BROTH DILUTION|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|Y|NA|||U|5||7||FOLLOW-UP|1966-02-25|1972-09-04|||||1960-08-05||1967-01-08|U|1972-08-20
TRIAL STUDY 134XCP|LB|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|1||||C3|COMPLEMENT C3|||||||BLOCKS|||||||NEGATIVE||10^6 ORGANISMS||||HIGH|NOT DONE||||SYNOVIAL FLUID|CLOTTED|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|CKD-EPI FORMULA||NA|NA|Y|Y|||N|1||38||SCREENING|1966-07-07|1968-01-04|||||1971-04-14||1966-02-13|Y|1965-10-14
TRIAL STUDY 134XCP|LB|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|2||||VMAEXR|VANILLYL MANDELIC ACID EXCRETION RATE|||||||MG/KG/DOSE|||||||POSITIVE||MEQ/L||||ABNORMAL|NOT DONE||||MECONIUM|GELLED|N|GC/MS-EI|MDRD 5 VARIABLE FORMULA||Y|N|NA|N|||Y|1||38||OPEN LABEL TREATMENT|1965-08-06|1962-10-07|||||1962-07-16||1968-03-08|N|1962-05-11
TRIAL STUDY 134XCP|LB|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|1||||INTLK15|INTERLEUKIN 15|||||||ML/G/DAY|||||||INVALID||CM||||NORMAL|NOT DONE||||ALVEOLAR AIR|ROOM TEMPERATURE|N|BALLPOINT PEN TECHNIQUE|FIBROTEST FORMULA||U|NA|Y|Y|||NA|2||58||RUN-IN|1970-02-28|1973-09-01|||||1961-03-06||1971-11-16|U|1961-10-29
TRIAL STUDY 134XCP|LB|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|2||||BLSTMKCE|MEGAKARYOBLASTS/TOTAL CELLS|||||||MPL U|||||||INVALID||MM||||NORMAL|NOT DONE||||WHITE MATTER TISSUE|ROOM TEMPERATURE|U|DIPSTICK|MDRD FORMULA||Y|U|Y|U|||N|2||58||CONTINUATION TREATMENT|1970-02-22|1971-06-16|||||1968-08-10||1965-01-25|N|1963-06-06
TRIAL STUDY 134XCP|LB|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|1||||S100A8|S100 CALCIUM BINDING PROTEIN A8|||||||UG/M2/MIN|||||||INVALID||UG/L FEU||||LOW|NOT DONE||||BREAST MILK|PARAFFIN-EMBEDDED|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|MDRD ENZYMATIC FORMULA||N|Y|NA|Y|||Y|3||39||INDUCTION TREATMENT|1970-03-31|1967-02-26|||||1971-05-26||1972-10-10|Y|1964-12-15
TRIAL STUDY 134XCP|LB|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|2||||T4|THYROXINE|||||||LOG10 ELISA UNIT|||||||POSITIVE||TCID 50/DOSE||||HIGH|NOT DONE||||SUPERNATANT, SERUM|PARAFFIN-EMBEDDED|N|HPLC-UV|HEPASCORE FORMULA||Y|U|Y|N|||N|3||39||LONG-TERM FOLLOW-UP|1969-04-15|1972-09-04|||||1962-10-29||1967-01-21|Y|1968-10-01
TRIAL STUDY 134XCP|LB|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|1||||OSTEOC|OSTEOCALCIN|||||||MCI|||||||NEGATIVE||MM/MIN||||NORMAL|NOT DONE||||MIXED VENOUS BLOOD|GELLED|U|IMMUNE REPERTOIRE DEEP SEQUENCING|FIBROMETER FORMULA||N|N|U|NA|||NA|4||88||RUN-IN|1972-01-06|1968-12-19|||||1970-12-29||1963-02-14|N|1960-06-11
TRIAL STUDY 134XCP|LB|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|2||||TDTAG|TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE AG|||||||MM|||||||INVALID||LOG10 IU/ML||||NORMAL|NOT DONE||||ADIPOSE TISSUE|LACTESCENT|U|HPLC-FL|MDRD 6 VARIABLE FORMULA||U|NA|U|N|||Y|4||88||OPEN LABEL TREATMENT|1964-06-25|1969-07-26|||||1966-02-07||1961-10-05|N|1963-12-14
TRIAL STUDY 134XCP|LB|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|1||||TRYPSIN|TRYPSIN|||||||DRUM|||||||BORDERLINE||DPM/100MG||||LOW|NOT DONE||||INFRANATANT, PLEURAL FLUID|CALCIFIED|NA|MALDI|FIBROTEST FORMULA||Y|N|N|U|||Y|5||7||OBSERVATION|1961-09-14|1972-03-28|||||1969-02-09||1972-11-11|Y|1965-05-29
TRIAL STUDY 134XCP|LB|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|2||||APAPCYS|ACETAMINOPHEN-CYSTEINE ADDUCT|||||||MG/KG/H|||||||INDETERMINATE||UG/MOL||||ABNORMAL|NOT DONE||||COLOSTRUM|NON-HEMOLYZED|Y|HPLC/MS|COCKCROFT-GAULT FORMULA||Y|U|N|Y|||U|5||7||LONG-TERM FOLLOW-UP|1971-08-09|1968-03-21|||||1969-08-21||1972-04-09|Y|1968-03-05
TRIAL STUDY 134XCP|LB|8417B146-336C-4777-A566-C1D086F39430|1||||GIPI|GLUCOSE-DEP INSULINOTROPIC PEP, INTACT|||||||MG/G/H|||||||BORDERLINE||10^7 PFU||||ABNORMAL|NOT DONE||||VITREOUS HUMOR|REFRIGERATED|NA|LYMPHANGIOGRAPHY|ASH FIBROSURE FORMULA||NA|U|N|N|||N|1||38||BASELINE|1969-07-16|1972-10-04|||||1961-09-18||1966-08-29|NA|1967-07-21
TRIAL STUDY 134XCP|LB|8417B146-336C-4777-A566-C1D086F39430|2||||CD45RALY|CD45RA/LYMPHOCYTES|||||||EID 50/ML|||||||TRACE||ML/MIN/1.73M2||||ABNORMAL|NOT DONE||||LOCHIA|LACTESCENT|N|PELLI-ROBSON EYE CHART|CKD-EPI CYSTATIN C FORMULA||NA|N|NA|NA|||Y|1||38||SCREENING|1969-12-15|1969-01-21|||||1965-07-15||1973-05-16|NA|1971-12-18
TRIAL STUDY 134XCP|LB|8417B146-336C-4777-A566-C1D086F39430|1||||CX3CL1|CHEMOKINE (C-X3-C MOTIF) LIGAND 1|||||||PIXEL|||||||POSITIVE||UKAT/10^12 RBC||||HIGH|NOT DONE||||AQUEOUS HUMOR|AUTOLYZED|U|MAGNETIC RESONANCE ENTEROGRAPHY|MDRD FORMULA||N|N|N|U|||Y|2||58||BLINDED TREATMENT|1963-01-18|1970-03-03|||||1965-03-05||1962-08-16|NA|1960-04-18
TRIAL STUDY 134XCP|LB|8417B146-336C-4777-A566-C1D086F39430|2||||FACTVL|FACTOR V LEIDEN|||||||/LPF|||||||BORDERLINE||MSEC||||NORMAL|NOT DONE||||SMEGMA|DRIED|U|PLETHYSMOGRAPHY|GMI % FORMULA||NA|U|NA|NA|||N|2||58||TREATMENT|1960-06-01|1964-11-11|||||1969-09-16||1961-09-14|U|1967-09-18
TRIAL STUDY 134XCP|LB|8417B146-336C-4777-A566-C1D086F39430|1||||TIMP1CRE|TIMP1/CREATININE|||||||G/U|||||||TRACE||10^12/L||||ABNORMAL|NOT DONE||||PROSTATIC FLUID|SOLIDIFIED|NA|DISK DIFFUSION|MDRD 5 VARIABLE FORMULA||N|Y|NA|Y|||NA|3||39||TREATMENT|1972-09-01|1973-04-11|||||1965-03-29||1963-01-05|NA|1973-03-10
TRIAL STUDY 134XCP|LB|8417B146-336C-4777-A566-C1D086F39430|2||||MCH|ERY. MEAN CORPUSCULAR HEMOGLOBIN|||||||TBSP|||||||POSITIVE||WEBER||||ABNORMAL|NOT DONE||||BUFFY COAT|HEMOLYZED|N|CELLULAR PROLIFERATION ASSAY|GMI % FORMULA||Y|NA|NA|NA|||N|3||39||CONTINUATION TREATMENT|1969-04-17|1968-07-12|||||1969-05-05||1966-02-08|NA|1972-10-25
TRIAL STUDY 134XCP|LB|8417B146-336C-4777-A566-C1D086F39430|1||||ELA2PMN|NEUTROPHIL ELASTASE, POLYMORPHONUCLEAR|||||||UCI/L|||||||NEGATIVE||CMHG||||NORMAL|NOT DONE||||MUSCLE TISSUE|ICTERIC|N|DOUBLE IMMUNODIFFUSION|GMI MMOL/MOL FORMULA||U|NA|Y|NA|||U|4||88||BLINDED TREATMENT|1968-03-06|1973-03-01|||||1969-02-02||1963-03-03|NA|1967-05-05
TRIAL STUDY 134XCP|LB|8417B146-336C-4777-A566-C1D086F39430|2||||VITD3|VITAMIN D3|||||||ANTI-XA IU|||||||TRACE||KG/MOL||||LOW|NOT DONE||||SALIVA|CLOTTED|N|QUANTITATIVE ULTRASOUND|MDRD ENZYMATIC FORMULA||NA|NA|N|Y|||U|4||88||BASELINE|1963-05-02|1973-03-01|||||1963-08-26||1968-07-07|N|1962-08-07
TRIAL STUDY 134XCP|LB|8417B146-336C-4777-A566-C1D086F39430|1||||HLAIAB|HLA CLASS I ANTIBODY|||||||P|||||||NEGATIVE||TESLA||||NORMAL|NOT DONE||||PERITONEAL FLUID|CLOTTED|N|DOPPLER ULTRASOUND|ASH FIBROSURE FORMULA||NA|U|Y|N|||NA|5||7||WASHOUT|1969-11-20|1970-03-04|||||1969-05-23||1965-11-04|NA|1969-05-16
TRIAL STUDY 134XCP|LB|8417B146-336C-4777-A566-C1D086F39430|2||||C165875|BERMUDA GRASS POLLEN IGE AB RAST SCORE|||||||M/SEC2|||||||TRACE||AFU||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED|U|MALDI-TOF|MDRD FORMULA||NA|N|Y|Y|||N|5||7||CONTINUATION TREATMENT|1962-04-03|1973-03-29|||||1965-01-17||1960-03-23|U|1967-09-21
TRIAL STUDY 134XCP|LB|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|1||||PMYCECE|PROLIFERATING MYELOID CELLS/TOTAL CELLS|||||||CL|||||||NEGATIVE||FG||||NORMAL|NOT DONE||||GASTRIC FLUID|UNEXPECTED ODOR|NA|MICROBIAL CONCENTRATION|HEPASCORE FORMULA||U|N|N|N|||NA|1||38||INDUCTION TREATMENT|1962-08-18|1971-07-26|||||1960-05-19||1967-07-09|U|1971-04-18
TRIAL STUDY 134XCP|LB|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|2||||C130117|BEE MIX ANTIGEN IGG ANTIBODY|||||||CMOL/L|||||||POSITIVE||DROP||||LOW|NOT DONE||||SOFT TISSUE|ICTERIC|U|FLOCCULATION, CHARCOAL ENHANCED|CKD-EPI CYSTATIN C FORMULA||U|NA|N|U|||NA|1||38||LONG-TERM FOLLOW-UP|1971-06-13|1972-01-10|||||1969-02-13||1961-05-18|N|1962-03-15
TRIAL STUDY 134XCP|LB|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|1||||MENGL|MENINGEAL CELLS|||||||10^5/HPF|||||||TRACE||UGEQ/L||||HIGH|NOT DONE||||TUMOR TISSUE|PARAFFIN-EMBEDDED|U|INFRARED SPECTROMETRY|GMI MMOL/MOL FORMULA||N|N|N|Y|||N|2||58||OBSERVATION|1964-04-07|1964-08-14|||||1971-09-03||1965-03-15|N|1965-09-11
TRIAL STUDY 134XCP|LB|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|2||||DHEA|DEHYDROEPIANDROSTERONE|||||||M2|||||||POSITIVE||CIGAR||||HIGH|NOT DONE||||HAIR|UNEXPECTED ODOR|U|ACRIDINE ORANGE STAIN|MDRD FORMULA||N|U|NA|NA|||U|2||58||LONG-TERM FOLLOW-UP|1971-11-26|1961-04-11|||||1967-01-23||1968-11-30|U|1960-03-16
TRIAL STUDY 134XCP|LB|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|1||||INTLK26|INTERLEUKIN 26|||||||APL U/ML|||||||BORDERLINE||ENZYME U/L||||ABNORMAL|NOT DONE||||SPERMATOZOON|UNEXPECTED ODOR|U|COMPLEMENT FIXATION|MDRD 4 VARIABLE FORMULA||NA|NA|N|N|||Y|3||39||OBSERVATION|1961-01-12|1972-01-15|||||1961-05-13||1968-07-06|Y|1961-08-19
TRIAL STUDY 134XCP|LB|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|2||||AHBDH|ALPHA HYDROXYBUTYRATE DEHYDROGENASE|||||||M/SEC|||||||TRACE||USP U||||ABNORMAL|NOT DONE||||EMESIS|UNEXPECTED ODOR|U|COMPUTERIZED CORNEAL TOPOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|U|Y|N|||U|3||39||WASHOUT|1971-03-09|1960-07-05|||||1972-08-07||1972-10-24|Y|1969-01-23
TRIAL STUDY 134XCP|LB|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|1||||KLOTHO|KLOTHO|||||||MOL|||||||TRACE||NSEC||||LOW|NOT DONE||||AQUEOUS HUMOR|CALCIFIED|Y|CYSTOSCOPY|CKD-EPI CYSTATIN C FORMULA||Y|NA|U|NA|||NA|4||88||BASELINE|1962-02-15|1970-10-19|||||1968-08-03||1962-07-01|U|1970-05-07
TRIAL STUDY 134XCP|LB|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|2||||CRTCLRE|CREATININE CLEARANCE, ESTIMATED|||||||TABLET|||||||INVALID||CFU/ML||||ABNORMAL|NOT DONE||||COLOSTRUM|AGGLUTINATED|Y|SLOAN LETTER EYE CHART 1.25%|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|U|N|Y|||N|4||88||BASELINE|1972-03-10|1964-03-08|||||1967-04-28||1973-08-17|U|1965-11-20
TRIAL STUDY 134XCP|LB|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|1||||OPIATE|OPIATE|||||||M2|||||||POSITIVE||OZ||||LOW|NOT DONE||||ADIPOSE TISSUE|DRIED|U|TRANSMISSION ELECTRON MICROSCOPY|MDRD 6 VARIABLE FORMULA||Y|U|Y|U|||U|5||7||SCREENING|1963-10-29|1963-03-31|||||1971-02-18||1966-11-25|N|1962-03-28
TRIAL STUDY 134XCP|LB|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|2||||IL1SR1|SOLUBLE INTERLEUKIN-1 RECEPTOR TYPE I|||||||ANSON U|||||||INVALID||NG/DL||||NORMAL|NOT DONE||||PLEURAL FLUID|GELLED|NA|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|NA|||NA|5||7||RUN-IN|1963-05-03|1967-07-02|||||1972-07-12||1964-08-11|Y|1965-10-01
TRIAL STUDY 134XCP|LB|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|1||||ICAM|INTERCELLULAR ADHESION MOLECULE|||||||UL/ML|||||||INVALID||10^11/L||||NORMAL|NOT DONE||||SEMEN|SOLIDIFIED|N|MICRODENSITOMETRY|GMI MMOL/MOL FORMULA||U|U|U|Y|||NA|1||38||FOLLOW-UP|1961-08-27|1960-09-07|||||1960-04-17||1969-10-11|U|1969-02-11
TRIAL STUDY 134XCP|LB|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|2||||HLAAAGT|HLA-A ANTIGEN TYPE|||||||MMOL2/L2|||||||TRACE||CM H2O||||HIGH|NOT DONE||||KERATINOCYTE|CONCENTRATED|U|MODIFIED ACID FAST STAIN|MDRD 5 VARIABLE FORMULA||N|N|Y|U|||N|1||38||BASELINE|1967-12-17|1970-03-03|||||1970-07-17||1963-01-26|Y|1965-11-06
TRIAL STUDY 134XCP|LB|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|1||||IL1R2|INTERLEUKIN 1 RECEPTOR TYPE 2|||||||UU/DL|||||||TRACE||HZ/S||||NORMAL|NOT DONE||||AMNIOTIC FLUID|FRESH|N|WHOLE EXOME SEQUENCING|ASH FIBROSURE FORMULA||Y|NA|Y|N|||Y|2||58||SCREENING|1964-12-05|1961-05-31|||||1961-11-19||1962-01-07|U|1967-03-20
TRIAL STUDY 134XCP|LB|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|2||||CHCMR|RET. CORPUSCULAR HGB CONCENTRATION MEAN|||||||DEG2|||||||INDETERMINATE||PIPE||||LOW|NOT DONE||||TUMOR TISSUE|CLOTTED|U|WEBER GREEN STAIN|MDRD 4 VARIABLE FORMULA||NA|NA|N|Y|||U|2||58||LONG-TERM FOLLOW-UP|1968-12-19|1960-04-16|||||1963-05-22||1962-01-03|N|1966-09-17
TRIAL STUDY 134XCP|LB|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|1||||PLP|PYRIDOXAL PHOSPHATE|||||||DEG/S|||||||POSITIVE||CI/UG||||LOW|NOT DONE||||HAIR FOLLICLE|LIPEMIC|NA|REFLECTANCE SPECTROSCOPY|HEPASCORE FORMULA||U|N|N|NA|||NA|3||39||SCREENING|1968-01-30|1963-08-09|||||1962-04-28||1964-01-15|NA|1970-07-28
TRIAL STUDY 134XCP|LB|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|2||||LIPEMIAI|LIPEMIC INDEX|||||||UKAT/L|||||||POSITIVE||U/KG||||HIGH|NOT DONE||||SUPERNATANT, SERUM|HEMOLYZED|NA|OSCILLOMETRY|ASH FIBROSURE FORMULA||U|U|Y|N|||N|3||39||OPEN LABEL TREATMENT|1969-10-15|1967-06-24|||||1970-09-13||1964-10-18|U|1966-05-06
TRIAL STUDY 134XCP|LB|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|1||||NEUTB|NEUTROPHILS BAND FORM|||||||UKAT/10^12 RBC|||||||INDETERMINATE||MG/ML/MIN||||NORMAL|NOT DONE||||SEMEN|PARAFFIN-EMBEDDED|U|LASER CAPTURE MICRODISSECTION|GMI MMOL/MOL FORMULA||N|U|U|Y|||N|4||88||CONTINUATION TREATMENT|1972-11-29|1966-07-03|||||1970-05-13||1961-08-06|Y|1972-12-22
TRIAL STUDY 134XCP|LB|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|2||||TRIM38|TRIPARTITE MOTIF CONTAINING PROTEIN 38|||||||DEG|||||||INDETERMINATE||CI/ML||||LOW|NOT DONE||||ENDOTRACHEAL FLUID|AGGLUTINATED|Y|TRANSVAGINAL ULTRASOUND|NASH FIBROSURE FORMULA||N|N|NA|NA|||NA|4||88||BASELINE|1971-02-15|1962-02-27|||||1960-03-31||1971-06-22|U|1963-05-16
TRIAL STUDY 134XCP|LB|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|1||||ACRNCRNF|ACYLCARNITINE/CARNITINE, FREE|||||||H/WK|||||||POSITIVE||ANSON U||||NORMAL|NOT DONE||||SOFT TISSUE|NON-HEMOLYZED|Y|IMMUNE REPERTOIRE DEEP SEQUENCING|CKD-EPI FORMULA||NA|NA|Y|U|||Y|5||7||FOLLOW-UP|1969-12-26|1972-02-19|||||1960-09-23||1964-04-27|U|1970-01-10
TRIAL STUDY 134XCP|LB|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|2||||C147277|TRITICUM AESTIVUM ANTIGEN IGE ANTIBODY|||||||UG/G/DAY|||||||POSITIVE||DAMOL/L||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|AGGLUTINATED|N|IODINE STAIN|COCKCROFT-GAULT FORMULA||N|U|U|NA|||NA|5||7||CONTINUATION TREATMENT|1961-10-04|1968-07-27|||||1968-11-28||1966-10-01|U|1963-10-12
TRIAL STUDY 134XCP|LB|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|1||||HGBB|HEMOGLOBIN B|||||||10^6 IU/ML|||||||TRACE||LOG10 TCID 50/DOSE||||HIGH|NOT DONE||||ISOLATE|CLOTTED|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|FIBROTEST FORMULA||Y|NA|Y|Y|||Y|1||38||OPEN LABEL TREATMENT|1961-07-07|1964-03-13|||||1967-04-22||1964-01-28|N|1972-07-26
TRIAL STUDY 134XCP|LB|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|2||||LACTULOS|LACTULOSE|||||||G/ANIMAL|||||||INDETERMINATE||LOZENGE||||ABNORMAL|NOT DONE||||CORD SERUM|HEMOLYZED|N|FLOCCULATION|MDRD 6 VARIABLE FORMULA||U|NA|U|NA|||NA|1||38||WASHOUT|1963-11-11|1967-05-16|||||1964-06-29||1963-08-08|NA|1969-04-14
TRIAL STUDY 134XCP|LB|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|1||||CFA|COEFFICIENT OF FAT ABSORPTION|||||||ML/CM H2O|||||||NEGATIVE||G/KG||||ABNORMAL|NOT DONE||||ARTERIAL BLOOD|LACTESCENT|N|DIGITAL PCR|MDRD FORMULA||N|U|NA|N|||NA|2||58||WASHOUT|1965-07-22|1967-08-13|||||1961-02-16||1966-06-13|Y|1966-02-28
TRIAL STUDY 134XCP|LB|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|2||||LY6E|LYMPHOCYTE ANTIGEN 6E|||||||FT|||||||INDETERMINATE||/LSQN||||LOW|NOT DONE||||CORD SERUM|CLOTTED|U|OPTICAL COHERENCE TOMOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|NA|Y|NA|||N|2||58||INDUCTION TREATMENT|1966-07-09|1960-08-19|||||1971-07-27||1973-07-16|NA|1965-08-30
TRIAL STUDY 134XCP|LB|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|1||||SCHISTO|SCHISTOCYTES|||||||UM2|||||||BORDERLINE||ML/CM3/MIN||||HIGH|NOT DONE||||SPERMATOZOON|NON-HEMOLYZED|U|ISHIHARA COLOR PLATES|ASH FIBROSURE FORMULA||NA|NA|NA|N|||Y|3||39||BASELINE|1964-08-30|1966-09-14|||||1972-03-17||1971-08-10|U|1966-09-24
TRIAL STUDY 134XCP|LB|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|2||||INSULIN|INSULIN|||||||FT3|||||||POSITIVE||10^3 COPIES/ML||||NORMAL|NOT DONE||||LAVAGE FLUID|SOLIDIFIED|N|NEURAMINIDASE INHIBITION ASSAY|MDRD ENZYMATIC FORMULA||N|NA|N|U|||U|3||39||BASELINE|1960-02-22|1970-01-02|||||1972-03-16||1970-10-07|Y|1968-07-15
TRIAL STUDY 134XCP|LB|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|1||||KLHIGMAB|KEYHOLE LIMPET HEMOCYANIN IGM ANTIBODY|||||||ML/G/MIN|||||||INVALID||PACKET||||NORMAL|NOT DONE||||LAVAGE FLUID|DRIED|Y|MAGNETIC RESONANCE ANGIOGRAPHY|HEPASCORE FORMULA||N|NA|Y|Y|||N|4||88||OBSERVATION|1961-03-12|1969-02-08|||||1964-10-30||1966-03-02|Y|1966-03-30
TRIAL STUDY 134XCP|LB|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|2||||ANIONG3|ANION GAP 3|||||||OI50|||||||TRACE||KBQ/UL||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|FRESH|U|SPECULAR MICROSCOPY|FIBROSIS 4 FORMULA||N|U|Y|N|||N|4||88||LONG-TERM FOLLOW-UP|1969-12-11|1965-06-14|||||1971-12-31||1967-05-04|Y|1961-03-19
TRIAL STUDY 134XCP|LB|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|1||||C165932|DOG DANDER IGE AB RAST SCORE|||||||10^7 PFU|||||||POSITIVE||BEL||||LOW|NOT DONE||||CAPILLARY PLASMA|FROZEN|Y|URANYL ACETATE STAIN|MDRD 6 VARIABLE FORMULA||N|N|N|Y|||NA|5||7||OPEN LABEL TREATMENT|1968-10-22|1964-01-07|||||1962-03-09||1971-08-31|NA|1965-07-20
TRIAL STUDY 134XCP|LB|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|2||||NEUTSGNE|NEUTROPHILS, SEGMENTED/NEUTROPHILS|||||||L/S/KPA|||||||NEGATIVE||MMHG*MIN/L||||NORMAL|NOT DONE||||BONE MARROW|LACTESCENT|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|HEPASCORE FORMULA||NA|Y|N|NA|||N|5||7||OPEN LABEL TREATMENT|1963-05-31|1962-06-27|||||1972-04-02||1960-09-12|Y|1967-06-07
TRIAL STUDY 134XCP|LB|2926D795-9C17-4440-8411-68525E93E78D|1||||PAF|PLATELET ACTIVATING FACTOR|||||||10^3 ORGANISMS/ML|||||||NEGATIVE||ML/MIN||||HIGH|NOT DONE||||GASTRIC CONTENTS|CONCENTRATED|NA|ECHOCARDIOGRAPHY|GMI % FORMULA||Y|U|N|NA|||NA|1||38||BLINDED TREATMENT|1971-06-11|1964-02-01|||||1962-08-06||1960-01-15|N|1960-02-16
TRIAL STUDY 134XCP|LB|2926D795-9C17-4440-8411-68525E93E78D|2||||HYPSEGCE|HYPERSEGMENTED CELLS|||||||KG/M2|||||||INDETERMINATE||MOSM/KG||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|AUTOLYZED|Y|MICRO BROTH DILUTION|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|NA|U|||N|1||38||LONG-TERM FOLLOW-UP|1968-08-11|1968-06-02|||||1963-02-22||1970-12-09|NA|1971-12-18
TRIAL STUDY 134XCP|LB|2926D795-9C17-4440-8411-68525E93E78D|1||||CYPHOS|PHOSPHATE CRYSTALS|||||||PNU/ML|||||||INDETERMINATE||MV2/HZ||||LOW|NOT DONE||||CARDIAC MUSCLE TISSUE|CONCENTRATED|U|PANENDOSCOPY|MDRD FORMULA||N|U|NA|NA|||N|2||58||TREATMENT|1969-12-24|1968-11-18|||||1971-02-19||1970-02-10|U|1966-03-30
TRIAL STUDY 134XCP|LB|2926D795-9C17-4440-8411-68525E93E78D|2||||POIKILO|POIKILOCYTES|||||||ML/CM|||||||BORDERLINE||10^9/L||||ABNORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|NA|WRIGHT STAIN|ASH FIBROSURE FORMULA||N|Y|N|Y|||NA|2||58||SCREENING|1968-10-12|1962-07-08|||||1964-03-07||1961-10-24|Y|1969-03-17
TRIAL STUDY 134XCP|LB|2926D795-9C17-4440-8411-68525E93E78D|1||||TROPONI|TROPONIN I|||||||IU/G|||||||INVALID||PA||||HIGH|NOT DONE||||HAIR|AGGLUTINATED|Y|VIRUS PLAQUE ASSAY|CKD-EPI CYSTATIN C FORMULA||N|U|NA|U|||N|3||39||OPEN LABEL TREATMENT|1972-05-03|1972-03-02|||||1967-04-15||1968-06-11|U|1965-10-16
TRIAL STUDY 134XCP|LB|2926D795-9C17-4440-8411-68525E93E78D|2||||RBCGHOST|ERYTHROCYTE GHOSTS|||||||/MS|||||||INDETERMINATE||BP||||ABNORMAL|NOT DONE||||TRANSUDATE|REFRIGERATED|N|HPLC|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|U|NA|Y|||U|3||39||RUN-IN|1971-06-17|1962-04-14|||||1970-12-30||1971-11-18|NA|1966-05-09
TRIAL STUDY 134XCP|LB|2926D795-9C17-4440-8411-68525E93E78D|1||||MCP1|MONOCYTE CHEMOTACTIC PROTEIN 1|||||||BQ/ML|||||||NEGATIVE||SBE/ML||||LOW|NOT DONE||||PERSPIRATION|NON-HEMOLYZED|N|IMMUNOFIXATION ELECTROPHORESIS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|NA|Y|Y|||U|4||88||SCREENING|1966-06-16|1970-08-16|||||1967-11-03||1963-08-19|NA|1960-03-19
TRIAL STUDY 134XCP|LB|2926D795-9C17-4440-8411-68525E93E78D|2||||RETI|RETICULOCYTES|||||||NMOL/KG/DAY|||||||BORDERLINE||CPM||||HIGH|NOT DONE||||SEBUM|FRESH|NA|LAPAROSCOPY|CKD-EPI CREATININE FORMULA||U|NA|U|N|||U|4||88||CONTINUATION TREATMENT|1968-01-19|1973-07-06|||||1960-09-10||1971-02-03|N|1971-06-09
TRIAL STUDY 134XCP|LB|2926D795-9C17-4440-8411-68525E93E78D|1||||INTLK8|INTERLEUKIN 8|||||||10^6 DNA COPIES/ML|||||||TRACE||/MM||||HIGH|NOT DONE||||MONOCYTE|HEMOLYZED|Y|FUNCTIONAL MRI|CKD-EPI CYSTATIN C FORMULA||Y|U|NA|U|||N|5||7||RUN-IN|1963-06-28|1964-11-14|||||1966-10-04||1972-06-26|Y|1962-04-11
TRIAL STUDY 134XCP|LB|2926D795-9C17-4440-8411-68525E93E78D|2||||ALTCPHRL|ALPHA TOCOPHEROL|||||||EP U|||||||INVALID||TITER||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|LACTESCENT|NA|MULTIPLE BREATH WASHOUT|GMI % FORMULA||U|N|NA|U|||Y|5||7||BLINDED TREATMENT|1964-11-26|1970-08-04|||||1961-06-02||1968-01-18|NA|1964-08-03
TRIAL STUDY 134XCP|LB|BA3378F3-C308-469F-9818-9AD811086548|1||||HASIGGAB|HUMAN ANTI-SHEEP IGG ANTIBODY|||||||NMOL/ML/MIN|||||||BORDERLINE||DMOL||||ABNORMAL|NOT DONE||||EPITHELIAL CELL|FRESH|Y|KARYOTYPING|FIBROMETER FORMULA||NA|NA|U|U|||Y|1||38||INDUCTION TREATMENT|1972-07-30|1971-03-29|||||1973-05-20||1964-08-03|U|1967-01-12
TRIAL STUDY 134XCP|LB|BA3378F3-C308-469F-9818-9AD811086548|2||||LIPEMIAI|LIPEMIC INDEX|||||||ML/G/DAY|||||||NEGATIVE||MDFI||||NORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|DRIED|U|DNA MICROARRAY|MDRD 4 VARIABLE FORMULA||U|NA|NA|NA|||N|1||38||OBSERVATION|1966-09-23|1964-04-25|||||1969-10-03||1960-11-16|NA|1972-08-22
TRIAL STUDY 134XCP|LB|BA3378F3-C308-469F-9818-9AD811086548|1||||PEMAB|PEMPHIGOID ANTIBODIES|||||||U/MMOL|||||||INDETERMINATE||KUSP||||NORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|NA|MICRODENSITOMETRY|CKD-EPI CREATININE FORMULA||U|N|Y|U|||NA|2||58||WASHOUT|1970-08-19|1962-06-01|||||1965-04-16||1965-08-17|N|1968-02-28
TRIAL STUDY 134XCP|LB|BA3378F3-C308-469F-9818-9AD811086548|2||||CYHIPPAC|HIPPURIC ACID CRYSTALS|||||||10^6 COPIES/ML|||||||BORDERLINE||G/CAGE/DAY||||ABNORMAL|NOT DONE||||MUSCLE TISSUE|AGGLUTINATED|Y|MALDI|FIBROSIS 4 FORMULA||N|N|Y|Y|||U|2||58||LONG-TERM FOLLOW-UP|1972-09-08|1973-08-02|||||1971-03-08||1970-10-13|U|1963-05-08
TRIAL STUDY 134XCP|LB|BA3378F3-C308-469F-9818-9AD811086548|1||||GUDCA|GLYCOURSODEOXYCHOLATE|||||||FFU|||||||NEGATIVE||1/(S*KPA)||||ABNORMAL|NOT DONE||||SMEGMA|AUTOLYZED|U|OPTICAL DENSITY MEASUREMENT|FIBROMETER FORMULA||Y|N|U|Y|||U|3||39||SCREENING|1970-01-20|1973-06-25|||||1969-10-22||1970-03-22|N|1971-03-08
TRIAL STUDY 134XCP|LB|BA3378F3-C308-469F-9818-9AD811086548|2||||IFI44|INTERFERON-INDUCED PROTEIN 44|||||||S/H|||||||BORDERLINE||NL||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|ICTERIC|Y|FARNSWORTH-MUNSELL 100 HUE TEST|FIBROMETER FORMULA||NA|Y|N|N|||N|3||39||OPEN LABEL TREATMENT|1971-04-07|1965-08-10|||||1967-07-28||1966-01-03|NA|1967-06-09
TRIAL STUDY 134XCP|LB|BA3378F3-C308-469F-9818-9AD811086548|1||||PLTIMPLT|IMMATURE PLATELETS/TOTAL PLATELETS|||||||TUBE|||||||INDETERMINATE||10^9/L||||HIGH|NOT DONE||||ABSCESS FLUID|NON-HEMOLYZED|Y|FLUORIMETRY|MDRD ENZYMATIC FORMULA||U|NA|Y|Y|||U|4||88||RUN-IN|1966-02-15|1964-03-19|||||1966-06-16||1970-08-15|N|1969-03-06
TRIAL STUDY 134XCP|LB|BA3378F3-C308-469F-9818-9AD811086548|2||||C130138|AMERICAN COCKROACH ANTIGEN IGG ANTIBODY|||||||ML/(MIN*100ML)|||||||INVALID||KHZ||||HIGH|NOT DONE||||SUPERNATANT, SERUM|LACTESCENT|NA|NEURAMINIDASE INHIBITION ASSAY|ASH FIBROSURE FORMULA||NA|N|NA|U|||N|4||88||BLINDED TREATMENT|1972-02-16|1967-02-20|||||1964-06-19||1968-10-10|NA|1961-08-26
TRIAL STUDY 134XCP|LB|BA3378F3-C308-469F-9818-9AD811086548|1||||TRANK1|TPR-ANKYRIN REPEAT-CONTAINING PROTEIN 1|||||||%(W/W)|||||||INDETERMINATE||JOULE||||ABNORMAL|NOT DONE||||BONE MARROW|AGGLUTINATED|U|WHOLE GENOME SEQUENCING|MDRD 6 VARIABLE FORMULA||Y|NA|U|N|||U|5||7||TREATMENT|1963-03-27|1970-01-23|||||1972-01-02||1967-07-22|Y|1970-12-02
TRIAL STUDY 134XCP|LB|BA3378F3-C308-469F-9818-9AD811086548|2||||OVALCY|OVALOCYTES|||||||10^6 RNA COPIES/ML|||||||NEGATIVE||G/CAGE/WK||||NORMAL|NOT DONE||||TISSUE|ROOM TEMPERATURE|N|DIFFUSION WEIGHTED MRI|CKD-EPI FORMULA||NA|Y|Y|N|||N|5||7||OBSERVATION|1963-08-27|1963-11-25|||||1960-02-02||1961-10-11|Y|1960-12-09
TRIAL STUDY 134XCP|LB|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|1||||CBANH9|CARBONIC ANHYDRASE 9|||||||LOZENGE|||||||NEGATIVE||ML*CMH2O||||ABNORMAL|NOT DONE||||URINE|LIPEMIC|U|KINETIC CHROMOGENIC ASSAY|COCKCROFT-GAULT FORMULA||NA|NA|N|N|||N|1||38||LONG-TERM FOLLOW-UP|1962-03-16|1966-08-28|||||1962-07-16||1971-03-24|N|1968-01-09
TRIAL STUDY 134XCP|LB|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|2||||CHCMR|RET. CORPUSCULAR HGB CONCENTRATION MEAN|||||||BOX|||||||INVALID||FT||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR|N|TRANSMISSION ELECTRON MICROSCOPY|MDRD FORMULA||Y|NA|U|U|||NA|1||38||RUN-IN|1964-03-20|1965-03-24|||||1968-07-26||1964-10-27|NA|1968-12-12
TRIAL STUDY 134XCP|LB|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|1||||METAMYLE|METAMYELOCYTES/LEUKOCYTES|||||||10^6 CFU/G|||||||POSITIVE||GTT||||HIGH|NOT DONE||||CEREBROSPINAL FLUID|FROZEN|U|ELISPOT|CKD-EPI CREATININE FORMULA||Y|U|NA|N|||Y|2||58||BLINDED TREATMENT|1973-01-18|1972-11-25|||||1965-07-20||1962-11-03|Y|1965-10-10
TRIAL STUDY 134XCP|LB|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|2||||IFI6|INTERFERON ALPHA-INDUCIBLE PROTEIN 6|||||||MS/MMHG|||||||TRACE||COULOMB||||ABNORMAL|NOT DONE||||INFRANATANT, SERUM|FROZEN|Y|MICRODENSITOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|N|NA|||NA|2||58||BASELINE|1963-03-23|1970-05-17|||||1972-04-16||1961-07-15|U|1961-08-17
TRIAL STUDY 134XCP|LB|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|1||||CD4|CD4|||||||CS|||||||BORDERLINE||TUBE||||HIGH|NOT DONE||||PUS|SOLIDIFIED|N|PAP STAIN|CKD-EPI CYSTATIN C FORMULA||U|Y|U|N|||NA|3||39||CONTINUATION TREATMENT|1969-08-07|1960-12-26|||||1961-02-01||1969-01-02|NA|1960-07-30
TRIAL STUDY 134XCP|LB|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|2||||C130115|INDUSTRIAL MIX ANTIGEN IGG ANTIBODY|||||||RAD|||||||NEGATIVE||MS/MMHG||||HIGH|NOT DONE||||MENSTRUAL BLOOD|PARAFFIN-EMBEDDED|NA|AGAR DILUTION|FIBROMETER FORMULA||Y|N|N|U|||NA|3||39||SCREENING|1971-08-13|1964-07-20|||||1969-04-09||1966-10-11|NA|1965-08-12
TRIAL STUDY 134XCP|LB|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|1||||AMYLB38|AMYLOID BETA 1-38|||||||MM/2H|||||||TRACE||HOUNSFIELD UNIT||||LOW|NOT DONE||||PLATELET POOR PLASMA|THAWED|NA|IRON HEMATOXYLIN STAIN|MDRD 5 VARIABLE FORMULA||N|N|U|N|||U|4||88||OPEN LABEL TREATMENT|1967-03-26|1970-04-28|||||1967-01-09||1973-01-24|U|1970-05-29
TRIAL STUDY 134XCP|LB|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|2||||GSTTH|GLUTATHIONE S-TRANSFERASE, THETA|||||||KG|||||||POSITIVE||10^6 ORGANISMS/ML||||HIGH|NOT DONE||||BREAST MILK|FROZEN|U|CONTRAST ENHANCED MRI|MDRD FORMULA||U|U|U|Y|||Y|4||88||SCREENING|1960-08-24|1973-07-06|||||1960-05-20||1964-06-19|Y|1961-10-29
TRIAL STUDY 134XCP|LB|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|1||||TIMM10|TRANSLOCASE INNER MITOCHONDRIAL MEMBR 10|||||||PM|||||||INVALID||ML/MIN||||LOW|NOT DONE||||REFLEX TEAR|CALCIFIED|Y|NUCLEIC ACID SEQUENCING|NASH FIBROSURE FORMULA||N|U|Y|U|||Y|5||7||BASELINE|1965-05-05|1970-01-17|||||1968-06-21||1967-09-24|Y|1960-06-06
TRIAL STUDY 134XCP|LB|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|2||||SMUSCAB|SMOOTH MUSCLE ANTIBODY|||||||/VF|||||||NEGATIVE||ML/MMHG/MIN/L||||LOW|NOT DONE||||GASTRIC FLUID|UNEXPECTED ODOR|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|MDRD ENZYMATIC FORMULA||N|U|NA|Y|||N|5||7||OBSERVATION|1972-08-19|1962-09-08|||||1973-06-09||1971-12-11|U|1963-02-19
TRIAL STUDY 134XCP|LB|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|1||||OPG|OSTEOPROTEGERIN|||||||DPM/0.5 ML|||||||TRACE||NMOL/L/MIN||||LOW|NOT DONE||||AMNIOTIC FLUID|REFRIGERATED|N|CALCOFLUOR WHITE STAIN|FIBROSIS 4 FORMULA||Y|NA|NA|N|||Y|1||38||SCREENING|1972-04-25|1971-11-17|||||1970-06-14||1961-04-03|N|1961-08-21
TRIAL STUDY 134XCP|LB|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|2||||MDA|3,4-METHYLENEDIOXYAMPHETAMINE|||||||UG/KG|||||||INVALID||MHZ||||HIGH|NOT DONE||||PLEURAL FLUID|GELLED|U|CALCOFLUOR WHITE STAIN|CKD-EPI FORMULA||N|NA|NA|U|||Y|1||38||BLINDED TREATMENT|1966-03-19|1966-02-10|||||1971-02-02||1966-04-22|N|1965-12-13
TRIAL STUDY 134XCP|LB|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|1||||POLYCHR|POLYCHROMASIA|||||||GBQ/MG|||||||NEGATIVE||COPIES/ML||||ABNORMAL|NOT DONE||||DISCHARGE|AUTOLYZED|U|MRS|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|Y|N|U|||NA|2||58||TREATMENT|1962-01-03|1963-01-02|||||1966-03-13||1966-12-07|NA|1961-05-07
TRIAL STUDY 134XCP|LB|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|2||||SPLA2II|TYPE II SECRETORY PHOSPHOLIPASE A2|||||||PMOL/G|||||||BORDERLINE||/40 HPFS||||NORMAL|NOT DONE||||BONE MARROW|HEMOLYZED|NA|ICP-MS|MDRD 5 VARIABLE FORMULA||NA|Y|Y|N|||Y|2||58||BLINDED TREATMENT|1963-01-08|1973-08-10|||||1971-05-16||1960-10-18|N|1960-09-03
TRIAL STUDY 134XCP|LB|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|1||||GLOBA2PT|ALPHA-2 GLOBULIN/TOTAL PROTEIN|||||||MG/M2/H|||||||INDETERMINATE||BQ/L||||LOW|NOT DONE||||BUFFY COAT|ICTERIC|NA|CHROMOGENIC ASSAY|GMI MMOL/MOL FORMULA||NA|N|N|N|||NA|3||39||BLINDED TREATMENT|1965-11-01|1966-03-20|||||1964-06-18||1968-02-27|Y|1965-10-11
TRIAL STUDY 134XCP|LB|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|2||||BLSTLYLE|LYMPHOBLASTS/LEUKOCYTES|||||||LOG10 ELISA UNIT|||||||POSITIVE||UMOL/DL||||ABNORMAL|NOT DONE||||EXPIRED AIR|CLOTTED|U|SMEAR|HEPASCORE FORMULA||U|U|NA|Y|||N|3||39||BLINDED TREATMENT|1968-11-07|1966-07-07|||||1972-08-31||1961-09-20|U|1961-07-26
TRIAL STUDY 134XCP|LB|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|1||||APOA|APOLIPOPROTEIN A|||||||10^6 ORGANISMS/G|||||||INVALID||U/MG||||NORMAL|NOT DONE||||CERVICOVAGINAL SECRETION|SOLIDIFIED|NA|FLUORESCENCE ANGIOGRAPHY|MDRD FORMULA||Y|NA|NA|NA|||NA|4||88||OBSERVATION|1961-06-26|1962-11-30|||||1969-12-04||1961-07-30|N|1967-09-24
TRIAL STUDY 134XCP|LB|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|2||||BLASTERY|BASOPHILIC ERYTHROBLAST|||||||%/S|||||||INDETERMINATE||NMOL/G||||HIGH|NOT DONE||||URINE|DRIED|Y|GC/MS/MS|CKD-EPI CREATININE FORMULA||NA|N|Y|N|||U|4||88||OPEN LABEL TREATMENT|1968-09-09|1971-07-14|||||1965-10-09||1961-01-11|Y|1968-12-02
TRIAL STUDY 134XCP|LB|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|1||||PLAGMCVT|PLATELET AGGREGATION MEAN CURVE TYPE|||||||G/M2|||||||TRACE||ML/KG/H||||HIGH|NOT DONE||||BREAST MILK|ROOM TEMPERATURE|NA|HPLC-FL|HEPASCORE FORMULA||N|NA|U|NA|||Y|5||7||SCREENING|1968-02-23|1965-12-26|||||1965-03-16||1970-06-23|N|1970-12-19
TRIAL STUDY 134XCP|LB|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|2||||APOC2|APOLIPOPROTEIN C2|||||||BQ/L|||||||TRACE||CMOL/L||||LOW|NOT DONE||||PLASMA ULTRAFILTRATE|CLOTTED|Y|SIZE EXCLUSION CHROMATOGRAPHY|GMI MMOL/MOL FORMULA||N|U|U|NA|||NA|5||7||SCREENING|1961-02-21|1971-12-25|||||1973-08-05||1968-08-21|NA|1973-06-11
TRIAL STUDY 134XCP|LB|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|1||||S100B|S100 CALCIUM-BINDING PROTEIN B|||||||MMHG|||||||POSITIVE||U/MG||||NORMAL|NOT DONE||||EXHALED BREATH CONDENSATE|FRESH|NA|MALDI-TOF|ASH FIBROSURE FORMULA||N|NA|N|Y|||NA|1||38||CONTINUATION TREATMENT|1973-07-28|1964-09-14|||||1968-06-29||1962-12-09|Y|1965-12-29
TRIAL STUDY 134XCP|LB|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|2||||MDEA|3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE|||||||MG/H|||||||POSITIVE||DYN||||HIGH|NOT DONE||||DISCHARGE|CLOTTED|N|ELECTRONEUROGRAPHY|FIBROTEST FORMULA||U|NA|U|NA|||NA|1||38||RUN-IN|1967-02-21|1960-09-13|||||1966-03-19||1970-05-03|Y|1971-01-28
TRIAL STUDY 134XCP|LB|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|1||||CYAMORPH|AMORPHOUS CRYSTALS|||||||PMOL/DL|||||||INVALID||KV||||LOW|NOT DONE||||SKELETAL MUSCLE TISSUE|LACTESCENT|NA|INDIA INK STAIN|MDRD 4 VARIABLE FORMULA||NA|U|Y|NA|||NA|2||58||CONTINUATION TREATMENT|1967-04-15|1970-05-22|||||1962-04-21||1966-10-06|N|1971-08-08
TRIAL STUDY 134XCP|LB|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|2||||C165926|MOLD MIX IGE AB RAST SCORE|||||||MG/DL|||||||TRACE||KA_U/DL||||ABNORMAL|NOT DONE||||BONE MARROW|AGGLUTINATED|NA|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|Y|Y|||U|2||58||LONG-TERM FOLLOW-UP|1969-09-07|1970-02-28|||||1972-03-07||1966-11-21|N|1967-10-04
TRIAL STUDY 134XCP|LB|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|1||||IDL|IDL CHOLESTEROL|||||||CYCLE/MIN|||||||INVALID||LOG EID 50/DOSE||||LOW|NOT DONE||||BONE MARROW|DRIED|U|TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA||N|U|N|U|||N|3||39||OBSERVATION|1960-02-18|1971-04-26|||||1967-02-08||1972-07-21|N|1964-09-05
TRIAL STUDY 134XCP|LB|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|2||||CIC|CIRCULATING IMMUNE COMPLEXES|||||||MOL|||||||BORDERLINE||10^8/L||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|CONTAMINATED|N|PERFUSION MRI|HEPASCORE FORMULA||U|Y|U|N|||Y|3||39||BLINDED TREATMENT|1969-09-10|1960-04-16|||||1973-05-27||1961-04-03|Y|1967-01-19
TRIAL STUDY 134XCP|LB|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|1||||IOTCLRBS|IOTHALAMATE CLEARANCE ADJUSTED FOR BSA|||||||KG/MOL|||||||TRACE||BQ/UG||||NORMAL|NOT DONE||||ENDOTRACHEAL FLUID|CALCIFIED|N|HEMATOXYLIN AND EOSIN STAIN|MDRD 6 VARIABLE FORMULA||Y|N|U|Y|||NA|4||88||INDUCTION TREATMENT|1973-04-04|1965-09-05|||||1964-02-04||1963-08-16|N|1972-10-19
TRIAL STUDY 134XCP|LB|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|2||||CFA|COEFFICIENT OF FAT ABSORPTION|||||||VOXEL|||||||POSITIVE||DISK||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|THAWED|N|COMPUTERIZED CORNEAL TOPOGRAPHY|MDRD ENZYMATIC FORMULA||NA|N|NA|U|||U|4||88||TREATMENT|1966-03-24|1968-09-29|||||1961-01-05||1962-02-19|NA|1967-05-31
TRIAL STUDY 134XCP|LB|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|1||||HGBTET|HEMOGLOBIN TETRAMER|||||||NG/DAY|||||||INDETERMINATE||SCOOPFUL||||LOW|NOT DONE||||MECONIUM|ROOM TEMPERATURE|U|X-RAY|FIBROSIS 4 FORMULA||N|N|NA|NA|||U|5||7||FOLLOW-UP|1970-01-04|1964-04-23|||||1969-02-10||1972-06-26|Y|1969-12-08
TRIAL STUDY 134XCP|LB|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|2||||PEPSNGII|PEPSINOGEN II|||||||ML/SEC/1.73M2|||||||TRACE||PKAT/L||||NORMAL|NOT DONE||||SEMINAL FLUID|GELLED|N|LIGHT MICROSCOPY|CKD-EPI CYSTATIN C FORMULA||NA|NA|Y|Y|||N|5||7||CONTINUATION TREATMENT|1963-11-10|1967-04-18|||||1968-05-23||1968-09-16|U|1963-05-01
TRIAL STUDY 134XCP|LB|15594D4E-1DAE-449F-AA52-9B0A926D9985|1||||HELMETCE|HELMET CELLS|||||||ENZYME U|||||||TRACE||CFU/G||||HIGH|NOT DONE||||LUNG SURFACTANT|SOLIDIFIED|NA|FLUORESCENT LIFETIME IMAGING MICROSCOPY|GMI MMOL/MOL FORMULA||U|U|U|U|||Y|1||38||LONG-TERM FOLLOW-UP|1962-08-27|1964-11-26|||||1960-02-21||1967-04-11|N|1962-02-08
TRIAL STUDY 134XCP|LB|15594D4E-1DAE-449F-AA52-9B0A926D9985|2||||C130085|ENGLISH PLANTAIN POLLEN IGA|||||||CI/G|||||||NEGATIVE||NG/DAY||||HIGH|NOT DONE||||PERSPIRATION|GELLED|N|MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|N|Y|||U|1||38||LONG-TERM FOLLOW-UP|1969-01-14|1960-09-21|||||1961-01-23||1970-02-03|N|1966-10-08
TRIAL STUDY 134XCP|LB|15594D4E-1DAE-449F-AA52-9B0A926D9985|1||||LKM1IGAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGG AB|||||||MEQ/DL|||||||INDETERMINATE||DMOL||||LOW|NOT DONE||||BREAST MILK|ROOM TEMPERATURE|U|BIOIMPEDANCE SPECTROSCOPY|FIBROMETER FORMULA||N|N|NA|Y|||U|2||58||SCREENING|1962-08-15|1971-06-05|||||1969-09-02||1967-11-20|N|1973-06-30
TRIAL STUDY 134XCP|LB|15594D4E-1DAE-449F-AA52-9B0A926D9985|2||||HETRPH|HETEROPHILS|||||||UM2|||||||TRACE||BQ/MG||||LOW|NOT DONE||||CERUMEN|LACTESCENT|Y|PHOROPTER|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|Y|N|||U|2||58||CONTINUATION TREATMENT|1965-02-23|1964-05-04|||||1968-10-30||1972-03-03|NA|1972-10-11
TRIAL STUDY 134XCP|LB|15594D4E-1DAE-449F-AA52-9B0A926D9985|1||||THEOPHYL|THEOPHYLLINE|||||||PMOL/L|||||||NEGATIVE||DDU||||NORMAL|NOT DONE||||NAIL|CONTAMINATED|NA|DIRECT SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|N|U|||Y|3||39||LONG-TERM FOLLOW-UP|1961-10-02|1968-09-30|||||1960-07-09||1968-07-10|NA|1970-07-22
TRIAL STUDY 134XCP|LB|15594D4E-1DAE-449F-AA52-9B0A926D9985|2||||CYSTATC|CYSTATIN C|||||||MOSM/KG|||||||POSITIVE||/200 HPFS||||LOW|NOT DONE||||PLEURAL TISSUE|LIPEMIC|NA|GRADIENT DIFFUSION|MDRD ENZYMATIC FORMULA||U|U|U|Y|||NA|3||39||OBSERVATION|1970-07-04|1967-05-13|||||1965-11-18||1961-11-07|NA|1971-11-04
TRIAL STUDY 134XCP|LB|15594D4E-1DAE-449F-AA52-9B0A926D9985|1||||MCV|ERY. MEAN CORPUSCULAR VOLUME|||||||U/KG/MIN|||||||POSITIVE||QUANTITY SUFFICIENT||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|SOLIDIFIED|N|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|HEPASCORE FORMULA||NA|NA|NA|Y|||U|4||88||TREATMENT|1970-07-09|1967-11-22|||||1967-03-06||1967-01-21|NA|1966-11-06
TRIAL STUDY 134XCP|LB|15594D4E-1DAE-449F-AA52-9B0A926D9985|2||||HLADRMSC|HLA-DR MISMATCH COUNT|||||||ML/CM H2O|||||||NEGATIVE||BQ/UG||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|NA|PUPILLOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|U|Y|N|||NA|4||88||TREATMENT|1971-01-31|1964-05-02|||||1969-04-23||1970-10-27|U|1972-01-13
TRIAL STUDY 134XCP|LB|15594D4E-1DAE-449F-AA52-9B0A926D9985|1||||PRORUB|PRORUBRICYTE|||||||GPL U/ML|||||||INDETERMINATE||10^6 CFU/G||||NORMAL|NOT DONE||||BILE|LACTESCENT|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|MDRD ENZYMATIC FORMULA||Y|NA|NA|Y|||N|5||7||OPEN LABEL TREATMENT|1964-04-02|1961-05-13|||||1971-04-03||1960-03-25|N|1966-10-30
TRIAL STUDY 134XCP|LB|15594D4E-1DAE-449F-AA52-9B0A926D9985|2||||BLYCELY|B-LYMPHOCYTES/LYMPHOCYTES|||||||PFU/ML|||||||INVALID||KPA||||ABNORMAL|NOT DONE||||ENDOTRACHEAL FLUID|AGGLUTINATED|U|REBOUND TONOMETRY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|U|Y|U|||U|5||7||INDUCTION TREATMENT|1970-03-23|1969-09-26|||||1966-01-23||1967-07-14|U|1969-09-18
TRIAL STUDY 134XCP|LB|079DEA7B-A617-4787-9872-025F4248ABFF|1||||NEUTCYBS|CYTOPLASMIC BASOPHILIA NEUTROPHIL|||||||PSI|||||||BORDERLINE||MG/G/MIN||||HIGH|NOT DONE||||WHITE MATTER TISSUE|DRIED|U|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD 5 VARIABLE FORMULA||NA|Y|Y|N|||Y|1||38||TREATMENT|1965-08-29|1966-01-18|||||1962-08-06||1972-10-05|U|1972-12-15
TRIAL STUDY 134XCP|LB|079DEA7B-A617-4787-9872-025F4248ABFF|2||||ALPBS|BONE SPECIFIC ALKALINE PHOSPHATASE|||||||DRAM|||||||INDETERMINATE||10^6 COPIES/ML||||LOW|NOT DONE||||COLOSTRUM|FRESH|Y|CELLULAR PROLIFERATION ASSAY|NASH FIBROSURE FORMULA||NA|NA|N|U|||U|1||38||OPEN LABEL TREATMENT|1967-04-28|1961-04-01|||||1960-01-28||1963-11-04|NA|1967-07-12
TRIAL STUDY 134XCP|LB|079DEA7B-A617-4787-9872-025F4248ABFF|1||||IGGALB|IMMUNOGLOBULIN G/ALBUMIN|||||||G/DL|||||||TRACE||PUFF||||ABNORMAL|NOT DONE||||SERUM|ROOM TEMPERATURE|U|OSCILLOMETRY|MDRD ENZYMATIC JAPANESE FORMULA||Y|N|U|NA|||Y|2||58||TREATMENT|1971-04-14|1970-08-10|||||1962-10-23||1969-09-15|NA|1967-11-04
TRIAL STUDY 134XCP|LB|079DEA7B-A617-4787-9872-025F4248ABFF|2||||TPROT|TAU PROTEIN|||||||GPL U|||||||INDETERMINATE||BU/ML||||LOW|NOT DONE||||DIALYSIS FLUID, PERITONEAL|THAWED|U|RADIAL IMMUNODIFFUSION|MDRD ENZYMATIC FORMULA||N|NA|Y|N|||N|2||58||CONTINUATION TREATMENT|1967-08-25|1969-05-20|||||1967-06-07||1966-01-19|NA|1969-03-09
TRIAL STUDY 134XCP|LB|079DEA7B-A617-4787-9872-025F4248ABFF|1||||HBA1B|HEMOGLOBIN A1B|||||||/200 HPFS|||||||TRACE||FL||||NORMAL|NOT DONE||||PLASMA|PARAFFIN-EMBEDDED|Y|THICK SMEAR|MDRD 6 VARIABLE FORMULA||NA|U|NA|N|||U|3||39||FOLLOW-UP|1962-11-25|1966-03-26|||||1964-07-01||1960-05-28|Y|1961-11-20
TRIAL STUDY 134XCP|LB|079DEA7B-A617-4787-9872-025F4248ABFF|2||||BGTCPHRL|BETA+GAMMA TOCOPHEROL|||||||VG/DOSE|||||||INVALID||DEG/S||||NORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|LACTESCENT|N|DIGITAL PCR|MDRD ENZYMATIC FORMULA||U|N|NA|NA|||Y|3||39||WASHOUT|1962-10-01|1962-12-17|||||1968-08-19||1969-06-30|NA|1968-11-14
TRIAL STUDY 134XCP|LB|079DEA7B-A617-4787-9872-025F4248ABFF|1||||IGFBP3|INSULIN-LIKE GROWTH FACTOR BINDING PROT3|||||||LOG10 TCID 50/UL|||||||NEGATIVE||CD/M2||||NORMAL|NOT DONE||||ERYTHROCYTES|ICTERIC|NA|THIN SMEAR|COCKCROFT-GAULT FORMULA||U|Y|Y|N|||N|4||88||CONTINUATION TREATMENT|1963-07-17|1961-04-19|||||1960-07-17||1965-12-20|N|1969-06-13
TRIAL STUDY 134XCP|LB|079DEA7B-A617-4787-9872-025F4248ABFF|2||||ENDOSTN|ENDOSTATIN|||||||ROENTGEN|||||||TRACE||%/S||||NORMAL|NOT DONE||||BREAST MILK|PARAFFIN-EMBEDDED|U|LYMPHANGIOGRAPHY|FIBROMETER FORMULA||Y|Y|Y|Y|||N|4||88||OBSERVATION|1968-11-29|1970-03-08|||||1968-04-18||1972-09-13|N|1970-09-02
TRIAL STUDY 134XCP|LB|079DEA7B-A617-4787-9872-025F4248ABFF|1||||HOWJOL|HOWELL-JOLLY BODIES|||||||VIAL|||||||POSITIVE||MG/M2/MIN||||LOW|NOT DONE||||VENOUS PLASMA|FRESH|U|CELL OF ORIGIN ASSAY|MDRD FORMULA||Y|NA|N|U|||U|5||7||SCREENING|1970-09-18|1963-05-30|||||1963-12-24||1960-03-09|Y|1965-07-01
TRIAL STUDY 134XCP|LB|079DEA7B-A617-4787-9872-025F4248ABFF|2||||MCSF|MACROPHAGE COLONY STIMULATING FACTOR|||||||ML/DAY|||||||INDETERMINATE||MS2||||HIGH|NOT DONE||||GASTRIC CONTENTS|DRIED|NA|FLOW MICROSCOPY|MDRD FORMULA||Y|U|NA|U|||Y|5||7||FOLLOW-UP|1961-10-17|1969-08-26|||||1962-07-01||1964-01-29|N|1964-09-19
TRIAL STUDY 134XCP|LB|3178AE30-9653-4470-84E4-FB0E4587DF6B|1||||ANGTNS2|ANGIOTENSIN II|||||||FINGERTIP UNIT|||||||BORDERLINE||IU||||HIGH|NOT DONE||||SEBUM|NON-HEMOLYZED|NA|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|CKD-EPI CREATININE FORMULA||U|NA|Y|NA|||N|1||38||SCREENING|1971-04-17|1965-04-20|||||1963-12-31||1969-09-19|U|1961-06-10
TRIAL STUDY 134XCP|LB|3178AE30-9653-4470-84E4-FB0E4587DF6B|2||||CCL20|CHEMOKINE (C-C MOTIF) LIGAND 20|||||||ML/G/DAY|||||||NEGATIVE||PMOL||||NORMAL|NOT DONE||||NAIL|SOLIDIFIED|NA|DNA MICROARRAY|MDRD 5 VARIABLE FORMULA||NA|U|N|NA|||Y|1||38||LONG-TERM FOLLOW-UP|1968-01-25|1969-04-12|||||1972-09-08||1967-05-02|Y|1967-05-19
TRIAL STUDY 134XCP|LB|3178AE30-9653-4470-84E4-FB0E4587DF6B|1||||C3ADARG|COMPLEMENT C3A DESARG|||||||DRUM|||||||TRACE||P||||ABNORMAL|NOT DONE||||TUMOR TISSUE|REFRIGERATED|U|VIRUS PLAQUE ASSAY|MDRD 5 VARIABLE FORMULA||NA|N|NA|N|||U|2||58||OPEN LABEL TREATMENT|1965-09-12|1965-02-06|||||1970-01-04||1964-11-08|NA|1968-06-16
TRIAL STUDY 134XCP|LB|3178AE30-9653-4470-84E4-FB0E4587DF6B|2||||C165899|SILVER BIRCH POLLEN IGG AB RAST SCORE|||||||UCI|||||||TRACE||/500 WBC||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|CONTAMINATED|U|POLYMERASE CHAIN REACTION|MDRD 4 VARIABLE FORMULA||Y|NA|N|Y|||N|2||58||CONTINUATION TREATMENT|1961-03-27|1972-07-25|||||1965-11-30||1971-06-16|U|1964-09-09
TRIAL STUDY 134XCP|LB|3178AE30-9653-4470-84E4-FB0E4587DF6B|1||||CXCR3|CHEMOKINE (C-X-C MOTIF) RECEPTOR 3|||||||TROCHE|||||||BORDERLINE||MHZ||||HIGH|NOT DONE||||FLUID|UNEXPECTED ODOR|NA|GIEMSA STAIN|GMI % FORMULA||U|NA|U|NA|||Y|3||39||WASHOUT|1965-10-18|1965-09-11|||||1968-12-09||1964-10-27|U|1960-06-15
TRIAL STUDY 134XCP|LB|3178AE30-9653-4470-84E4-FB0E4587DF6B|2||||LKM1IMAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGM AB|||||||PFU/ML|||||||TRACE||UG/ML/H||||ABNORMAL|NOT DONE||||COLOSTRUM|NON-HEMOLYZED|NA|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|FIBROTEST FORMULA||N|U|U|NA|||U|3||39||BLINDED TREATMENT|1967-08-23|1963-02-26|||||1973-01-17||1964-10-08|U|1970-01-01
TRIAL STUDY 134XCP|LB|3178AE30-9653-4470-84E4-FB0E4587DF6B|1||||CLEXR|CHLORIDE EXCRETION RATE|||||||TRANSDUCING UNIT/ML|||||||INDETERMINATE||UG/M2/H||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|NA|TONOMETRY|CKD-EPI CYSTATIN C FORMULA||Y|Y|NA|N|||Y|4||88||RUN-IN|1972-11-01|1966-10-11|||||1962-01-26||1962-02-04|N|1961-02-24
TRIAL STUDY 134XCP|LB|3178AE30-9653-4470-84E4-FB0E4587DF6B|2||||BLSTRSID|RINGED SIDEROBLASTS|||||||CMOL|||||||INDETERMINATE||CYLINDER||||HIGH|NOT DONE||||SERUM|THAWED|NA|SLOAN LETTER EYE CHART 1.25%|CKD-EPI CYSTATIN C FORMULA||U|NA|NA|Y|||NA|4||88||BASELINE|1965-09-16|1967-11-11|||||1965-09-15||1961-10-19|NA|1960-10-24
TRIAL STUDY 134XCP|LB|3178AE30-9653-4470-84E4-FB0E4587DF6B|1||||SEZCE|SEZARY CELLS|||||||UG/ANIMAL|||||||INVALID||EU||||HIGH|NOT DONE||||CERUMEN|CONCENTRATED|NA|CALCOFLUOR WHITE STAIN|MDRD 4 VARIABLE FORMULA||U|NA|Y|NA|||N|5||7||SCREENING|1960-10-03|1965-01-06|||||1961-08-26||1971-02-25|N|1961-10-27
TRIAL STUDY 134XCP|LB|3178AE30-9653-4470-84E4-FB0E4587DF6B|2||||LIQUFT|LIQUEFACTION TIME|||||||L/KG|||||||NEGATIVE||IU/ML||||ABNORMAL|NOT DONE||||SERUM|FROZEN|Y|SXA SCAN|MDRD 4 VARIABLE FORMULA||Y|N|NA|Y|||N|5||7||OBSERVATION|1961-09-04|1962-01-31|||||1970-08-11||1966-01-12|N|1971-07-30
TRIAL STUDY 134XCP|LB|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|1||||HCG|CHORIOGONADOTROPIN BETA|||||||HOUNSFIELD UNIT|||||||TRACE||UEQ/L||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|NON-HEMOLYZED|NA|FLUORESCENT ENZYME IMMUNOASSAY|CKD-EPI CYSTATIN C FORMULA||NA|N|N|N|||NA|1||38||OBSERVATION|1969-09-13|1969-09-16|||||1968-01-17||1972-09-24|NA|1969-06-03
TRIAL STUDY 134XCP|LB|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|2||||GALM|GALACTOSE MUTAROTASE|||||||DAGU|||||||TRACE||MMAL||||HIGH|NOT DONE||||EPITHELIAL CELL|LIPEMIC|N|MAGNETIC RESONANCE ENTEROGRAPHY|ASH FIBROSURE FORMULA||U|N|N|NA|||U|1||38||RUN-IN|1968-10-19|1971-01-21|||||1965-06-28||1968-07-18|U|1970-10-29
TRIAL STUDY 134XCP|LB|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|1||||IDLP|IDL PARTICLES|||||||DNA COPIES/ML|||||||INVALID||%(W/W)||||ABNORMAL|NOT DONE||||SERUM|FROZEN|NA|ELECTRICAL IMPEDANCE MYOGRAPHY|HEPASCORE FORMULA||Y|N|Y|NA|||Y|2||58||WASHOUT|1972-10-11|1960-04-14|||||1961-12-19||1971-12-21|U|1967-10-12
TRIAL STUDY 134XCP|LB|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|2||||BLAST|BLASTS|||||||10^3 RNA COPIES/ML|||||||TRACE||BP||||ABNORMAL|NOT DONE||||BASAL TEAR|DRIED|Y|QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROSIS 4 FORMULA||N|U|Y|U|||Y|2||58||OBSERVATION|1966-05-29|1964-11-06|||||1969-01-28||1964-06-21|N|1970-05-24
TRIAL STUDY 134XCP|LB|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|1||||SIXMAM|6-MONOACETYLMORPHINE|||||||LM|||||||NEGATIVE||MEQ/DAY||||HIGH|NOT DONE||||PROSTATIC FLUID|REFRIGERATED|NA|TOLUIDINE BLUE STAIN|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|N|Y|||U|3||39||BLINDED TREATMENT|1961-07-10|1963-01-11|||||1966-07-16||1970-02-24|NA|1969-07-03
TRIAL STUDY 134XCP|LB|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|2||||IAA5OHCR|5-HYDROXYINDOLEACETIC ACID/CREATININE|||||||NKAT/L|||||||TRACE||MIN/DAY||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|CONTAMINATED|U|COULOMETRIC TITRATION|COCKCROFT-GAULT FORMULA||U|N|N|NA|||N|3||39||SCREENING|1973-02-21|1963-01-09|||||1969-04-14||1965-12-10|NA|1965-06-16
TRIAL STUDY 134XCP|LB|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|1||||FLRZPM|FLURAZEPAM|||||||L|||||||NEGATIVE||GTT||||LOW|NOT DONE||||STRIATED MUSCLE TISSUE|FRESH|NA|ANGIOGRAPHY|MDRD FORMULA||Y|U|U|Y|||NA|4||88||OPEN LABEL TREATMENT|1973-04-18|1965-12-17|||||1972-01-03||1961-06-04|Y|1968-08-02
TRIAL STUDY 134XCP|LB|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|2||||KLHIGMAB|KEYHOLE LIMPET HEMOCYANIN IGM ANTIBODY|||||||MG/M2/DAY|||||||INDETERMINATE||10^9/L||||ABNORMAL|NOT DONE||||ENDOMETRIAL TISSUE|CLOTTED|NA|MICROSCOPY|GMI % FORMULA||U|N|N|U|||U|4||88||INDUCTION TREATMENT|1966-09-15|1971-11-26|||||1961-08-03||1964-10-24|U|1963-07-02
TRIAL STUDY 134XCP|LB|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|1||||PSA|PROSTATE SPECIFIC ANTIGEN|||||||UU/L|||||||NEGATIVE||DAYS/WK||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|NON-HEMOLYZED|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|N|U|||N|5||7||OBSERVATION|1963-12-14|1964-04-09|||||1971-11-19||1960-06-22|Y|1960-03-19
TRIAL STUDY 134XCP|LB|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|2||||ANIONG3|ANION GAP 3|||||||SEC|||||||POSITIVE||CAPLET||||NORMAL|NOT DONE||||FLUID|CONCENTRATED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|MDRD 6 VARIABLE FORMULA||NA|NA|NA|NA|||NA|5||7||WASHOUT|1967-01-14|1963-06-11|||||1961-02-04||1964-07-27|U|1964-04-08
TRIAL STUDY 134XCP|LB|D274C760-A607-4DA8-ACD3-346EF6E191D2|1||||MCVRETIC|MCV RETICULOCYTES|||||||10^6 ORGANISMS/MG|||||||POSITIVE||L/MIN||||LOW|NOT DONE||||MUCUS|NON-HEMOLYZED|N|MRI|FIBROSIS 4 FORMULA||NA|Y|NA|NA|||U|1||38||FOLLOW-UP|1965-03-29|1966-12-29|||||1970-06-18||1966-02-06|N|1968-04-27
TRIAL STUDY 134XCP|LB|D274C760-A607-4DA8-ACD3-346EF6E191D2|2||||STROPONI|SKELETAL TROPONIN I|||||||KIU|||||||NEGATIVE||10^7 TCID 50/DOSE||||HIGH|NOT DONE||||SKIN TISSUE|THAWED|N|IMPEDANCE CONDUCTIVITY|GMI MMOL/MOL FORMULA||Y|Y|N|NA|||U|1||38||WASHOUT|1964-05-22|1960-10-18|||||1968-07-29||1960-10-28|U|1969-04-27
TRIAL STUDY 134XCP|LB|D274C760-A607-4DA8-ACD3-346EF6E191D2|1||||CRP|C REACTIVE PROTEIN|||||||U/DL|||||||INVALID||10^6 RNA COPIES/ML||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|CLOTTED|Y|CHROMOGENIC ASSAY|HEPASCORE FORMULA||U|N|NA|NA|||Y|2||58||OBSERVATION|1972-01-09|1961-04-04|||||1973-03-17||1972-09-02|N|1960-04-06
TRIAL STUDY 134XCP|LB|D274C760-A607-4DA8-ACD3-346EF6E191D2|2||||NORMEEXR|NORMETANEPHRINE EXCRETION RATE|||||||SYRINGE|||||||INVALID||KPA||||HIGH|NOT DONE||||URINE|ICTERIC|N|WHOLE GENOME SEQUENCING|MDRD 6 VARIABLE FORMULA||N|N|U|U|||U|2||58||BLINDED TREATMENT|1961-10-23|1967-07-20|||||1969-01-03||1967-05-25|Y|1964-04-25
TRIAL STUDY 134XCP|LB|D274C760-A607-4DA8-ACD3-346EF6E191D2|1||||FVIIIAAC|FACTOR VIII ACTIVITY ACTUAL/CONTROL|||||||DMOL|||||||POSITIVE||PMOL/DAY||||LOW|NOT DONE||||EXUDATE|UNEXPECTED ODOR|Y|CLAUSS METHOD|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|Y|U|||Y|3||39||CONTINUATION TREATMENT|1964-07-09|1966-08-23|||||1971-07-22||1967-08-09|NA|1964-02-04
TRIAL STUDY 134XCP|LB|D274C760-A607-4DA8-ACD3-346EF6E191D2|2||||ALTCPHRL|ALPHA TOCOPHEROL|||||||NCI|||||||BORDERLINE||FT3||||LOW|NOT DONE||||BONE MARROW MONONUCLEAR CELL|SOLIDIFIED|U|MANUAL COUNT|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|U|NA|||N|3||39||CONTINUATION TREATMENT|1961-09-17|1968-07-28|||||1966-11-13||1972-02-25|NA|1969-05-31
TRIAL STUDY 134XCP|LB|D274C760-A607-4DA8-ACD3-346EF6E191D2|1||||BUPREN|BUPRENORPHINE|||||||MEQ/L|||||||INVALID||10^9 CFU||||HIGH|NOT DONE||||EMESIS|CONTAMINATED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|NA|NA|||N|4||88||FOLLOW-UP|1968-10-02|1970-08-05|||||1964-06-02||1961-05-19|N|1964-02-15
TRIAL STUDY 134XCP|LB|D274C760-A607-4DA8-ACD3-346EF6E191D2|2||||MACROBLD|MACROSCOPIC BLOOD|||||||MG/H|||||||NEGATIVE||UM/DAY||||HIGH|NOT DONE||||ERYTHROCYTES|SOLIDIFIED|U|TRANSVAGINAL ULTRASOUND|MDRD 4 VARIABLE FORMULA||U|U|NA|N|||Y|4||88||INDUCTION TREATMENT|1969-07-09|1968-04-08|||||1967-02-17||1966-01-15|NA|1973-05-12
TRIAL STUDY 134XCP|LB|D274C760-A607-4DA8-ACD3-346EF6E191D2|1||||LSELS|SOLUBLE L-SELECTIN|||||||ABSORBANCE U/MIN|||||||POSITIVE||TITER||||HIGH|NOT DONE||||MENSTRUAL BLOOD|GELLED|Y|MICRO BROTH DILUTION|CKD-EPI CYSTATIN C FORMULA||NA|NA|U|Y|||U|5||7||BASELINE|1960-01-18|1965-05-15|||||1960-03-12||1967-12-24|U|1966-06-15
TRIAL STUDY 134XCP|LB|D274C760-A607-4DA8-ACD3-346EF6E191D2|2||||C130131|DOG DANDER ANTIGEN IGG4 ANTIBODY|||||||/40 HPFS|||||||POSITIVE||FINGERTIP UNIT||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|NON-HEMOLYZED|U|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|CKD-EPI FORMULA||NA|Y|U|N|||Y|5||7||OBSERVATION|1971-11-23|1965-12-19|||||1960-02-27||1960-10-29|U|1965-08-03
TRIAL STUDY 134XCP|LB|F5B7E82D-49AD-422E-9C38-5681105094AA|1||||ESTRCPT|ESTROGEN RECEPTOR|||||||LOG10 IU/ML|||||||INVALID||MM||||LOW|NOT DONE||||AMNIOTIC FLUID|NON-HEMOLYZED|NA|HEMAGGLUTINATION ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|Y|N|||Y|1||38||INDUCTION TREATMENT|1963-03-08|1968-11-16|||||1967-06-19||1967-06-11|Y|1967-11-07
TRIAL STUDY 134XCP|LB|F5B7E82D-49AD-422E-9C38-5681105094AA|2||||ANIONG3|ANION GAP 3|||||||AFU|||||||BORDERLINE||C||||ABNORMAL|NOT DONE||||VENOUS PLASMA|NON-HEMOLYZED|NA|CONGO RED STAIN|CKD-EPI FORMULA||Y|NA|Y|U|||N|1||38||WASHOUT|1971-02-18|1963-04-19|||||1966-01-25||1973-08-31|U|1961-10-03
TRIAL STUDY 134XCP|LB|F5B7E82D-49AD-422E-9C38-5681105094AA|1||||DRVTSCPD|DRVVT SCREEN TO CONFIRM PCT DIFFERENCE|||||||PELLET|||||||BORDERLINE||CI/MG||||LOW|NOT DONE||||SEMEN|AUTOLYZED|NA|NEPHELOMETRY|HEPASCORE FORMULA||NA|U|U|NA|||NA|2||58||WASHOUT|1970-09-25|1971-07-29|||||1966-06-20||1961-06-05|NA|1964-04-15
TRIAL STUDY 134XCP|LB|F5B7E82D-49AD-422E-9C38-5681105094AA|2||||TPAG|TISSUE POLYPEPTIDE ANTIGEN|||||||10^6 ORGANISMS/MG|||||||TRACE||IU/DAY||||HIGH|NOT DONE||||CALCULUS|CONTAMINATED|U|TOTAL BODY RADIOGRAPHY|ASH FIBROSURE FORMULA||N|Y|N|N|||Y|2||58||OPEN LABEL TREATMENT|1962-02-22|1965-06-09|||||1967-07-10||1968-07-26|Y|1963-08-13
TRIAL STUDY 134XCP|LB|F5B7E82D-49AD-422E-9C38-5681105094AA|1||||BPIAB|BACTERICIDAL/PERMEABILITY-INC PROTEIN AB|||||||MV*MIN|||||||INVALID||10^9 ORGANISMS||||NORMAL|NOT DONE||||INFRANATANT, PLASMA|CLOTTED|Y|CLOT DETECTION|NASH FIBROSURE FORMULA||NA|NA|NA|Y|||NA|3||39||OBSERVATION|1968-05-27|1970-05-25|||||1964-04-11||1973-01-17|NA|1964-07-20
TRIAL STUDY 134XCP|LB|F5B7E82D-49AD-422E-9C38-5681105094AA|2||||HE4|HUMAN EPIDIDYMIS PROTEIN 4|||||||10^6 COPIES/ML|||||||INVALID||GPELISA UNIT/ML||||ABNORMAL|NOT DONE||||LOCHIA|CONCENTRATED|Y|FISH|MDRD 4 VARIABLE FORMULA||U|U|Y|U|||U|3||39||LONG-TERM FOLLOW-UP|1973-03-15|1961-10-07|||||1962-12-30||1966-04-02|NA|1966-05-02
TRIAL STUDY 134XCP|LB|F5B7E82D-49AD-422E-9C38-5681105094AA|1||||BTLBARTL|BUTABARBITAL|||||||10^3/L|||||||NEGATIVE||G/G/DAY||||ABNORMAL|NOT DONE||||LAVAGE FLUID|FRESH|Y|CHROMOGENIC ASSAY|FIBROSIS 4 FORMULA||NA|Y|NA|U|||Y|4||88||BASELINE|1962-09-19|1966-11-25|||||1962-06-13||1964-01-06|NA|1961-02-20
TRIAL STUDY 134XCP|LB|F5B7E82D-49AD-422E-9C38-5681105094AA|2||||PLAGGCVT|PLATELET AGGREGATION CURVE TYPE|||||||ABSORBANCE U/ML|||||||BORDERLINE||KALLIKREIN INHIBITOR UNIT||||LOW|NOT DONE||||CELL PELLET|CONTAMINATED|NA|CLINICAL EVALUATION|GMI MMOL/MOL FORMULA||U|NA|U|N|||Y|4||88||OBSERVATION|1969-08-24|1961-11-13|||||1969-09-05||1969-10-17|N|1972-08-04
TRIAL STUDY 134XCP|LB|F5B7E82D-49AD-422E-9C38-5681105094AA|1||||C165893|WILD RYE POLLEN IGE AB RAST SCORE|||||||MM/H|||||||POSITIVE||10^9 CFU/G||||NORMAL|NOT DONE||||EMESIS|PARAFFIN-EMBEDDED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|MDRD ENZYMATIC JAPANESE FORMULA||U|U|N|Y|||NA|5||7||CONTINUATION TREATMENT|1966-11-16|1960-03-17|||||1962-11-25||1968-12-26|NA|1960-11-24
TRIAL STUDY 134XCP|LB|F5B7E82D-49AD-422E-9C38-5681105094AA|2||||C130089|TIMOTHY GRASS POLLEN IGA|||||||EJACULATE U|||||||TRACE||PG||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|LIPEMIC|Y|CLIP SEQUENCING|CKD-EPI CREATININE FORMULA||Y|Y|Y|NA|||N|5||7||OBSERVATION|1969-04-29|1971-07-12|||||1968-05-29||1962-12-30|Y|1960-06-18
TRIAL STUDY 134XCP|LB|AF8D32B4-B2CC-4EE3-A612-179814C691B8|1||||BLSTRSID|RINGED SIDEROBLASTS|||||||KCAL/DAY|||||||BORDERLINE||IU/KG/H||||ABNORMAL|NOT DONE||||SKIN TISSUE|CONCENTRATED|NA|DROPLET DIGITAL PCR|CKD-EPI CYSTATIN C FORMULA||Y|NA|Y|NA|||U|1||38||OPEN LABEL TREATMENT|1967-04-01|1972-06-27|||||1973-07-12||1968-06-10|N|1973-08-29
TRIAL STUDY 134XCP|LB|AF8D32B4-B2CC-4EE3-A612-179814C691B8|2||||CYFRA18|CYTOKERATIN 18 FRAGMENT|||||||GAUSS|||||||INVALID||UM||||LOW|NOT DONE||||EMOTIONAL TEAR|THAWED|NA|POTENTIOMETRY|CKD-EPI CYSTATIN C FORMULA||Y|Y|NA|NA|||U|1||38||INDUCTION TREATMENT|1972-10-12|1969-05-16|||||1967-03-19||1968-02-23|Y|1960-06-25
TRIAL STUDY 134XCP|LB|AF8D32B4-B2CC-4EE3-A612-179814C691B8|1||||GFRBSBTP|GFR FROM BETA-TRACE PROTEIN ADJ FOR BSA|||||||MMOL2/L2|||||||BORDERLINE||IU/DAY||||ABNORMAL|NOT DONE||||URINE|AUTOLYZED|Y|IMMUNODIFFUSION|CKD-EPI CYSTATIN C FORMULA||N|NA|Y|U|||NA|2||58||LONG-TERM FOLLOW-UP|1965-11-05|1969-02-21|||||1963-05-26||1973-04-07|Y|1961-11-22
TRIAL STUDY 134XCP|LB|AF8D32B4-B2CC-4EE3-A612-179814C691B8|2||||ANCATYAB|NEUTROPHIL CYTOPLASMIC AB, ATYPICAL|||||||MPH|||||||TRACE||TBSP||||NORMAL|NOT DONE||||KERATINOCYTE|GELLED|NA|AUSCULTATION|COCKCROFT-GAULT FORMULA||NA|N|NA|U|||NA|2||58||CONTINUATION TREATMENT|1960-10-29|1963-07-20|||||1966-01-30||1961-08-10|NA|1967-10-30
TRIAL STUDY 134XCP|LB|AF8D32B4-B2CC-4EE3-A612-179814C691B8|1||||LAP|LEUCINE AMINOPEPTIDASE|||||||NL|||||||INDETERMINATE||UG/M2||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|REFRIGERATED|NA|STATIC PERIMETRY|MDRD ENZYMATIC JAPANESE FORMULA||N|U|N|U|||U|3||39||OPEN LABEL TREATMENT|1969-02-08|1966-03-07|||||1962-08-09||1973-03-16|N|1971-04-02
TRIAL STUDY 134XCP|LB|AF8D32B4-B2CC-4EE3-A612-179814C691B8|2||||CSFAT|FATTY CASTS|||||||LOG10 TCID 50/UL|||||||INDETERMINATE||PACK||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|ROOM TEMPERATURE|Y|MAGNETIC RESONANCE ENTEROGRAPHY|CKD-EPI CREATININE FORMULA||Y|NA|U|U|||NA|3||39||BLINDED TREATMENT|1969-06-25|1969-09-09|||||1962-01-23||1972-08-03|U|1966-02-22
TRIAL STUDY 134XCP|LB|AF8D32B4-B2CC-4EE3-A612-179814C691B8|1||||TTAC|THROMBIN TIME ACTUAL/CONTROL|||||||KPA|||||||TRACE||10^10/L||||ABNORMAL|NOT DONE||||SKIN TISSUE|GELLED|U|ALCIAN BLUE STAIN|ASH FIBROSURE FORMULA||NA|U|N|Y|||N|4||88||SCREENING|1966-04-27|1967-02-24|||||1962-02-14||1969-08-25|N|1965-04-02
TRIAL STUDY 134XCP|LB|AF8D32B4-B2CC-4EE3-A612-179814C691B8|2||||GHBP|GROWTH HORMONE BINDING PROTEIN|||||||L/MIN|||||||BORDERLINE||MG/L FEU||||NORMAL|NOT DONE||||BUFFY COAT|HEMOLYZED|NA|OLIGO ACGH|MDRD ENZYMATIC FORMULA||Y|Y|Y|U|||Y|4||88||OPEN LABEL TREATMENT|1965-08-20|1972-06-17|||||1972-01-22||1965-12-12|U|1967-12-13
TRIAL STUDY 134XCP|LB|AF8D32B4-B2CC-4EE3-A612-179814C691B8|1||||MMP7|MATRIX METALLOPROTEINASE 7|||||||NMOL/DAY|||||||TRACE||UMOL/DL||||LOW|NOT DONE||||DERMAL TISSUE|FROZEN|U|RADIOIMMUNOPRECIPITATION ASSAY|GMI MMOL/MOL FORMULA||Y|NA|N|N|||U|5||7||OPEN LABEL TREATMENT|1973-04-10|1971-01-12|||||1973-01-27||1970-09-29|N|1969-06-02
TRIAL STUDY 134XCP|LB|AF8D32B4-B2CC-4EE3-A612-179814C691B8|2||||DKK1|DICKKOPF WNT SIGNALING PATH INHIBITOR 1|||||||ML/KG/H|||||||TRACE||100 IU/ML||||ABNORMAL|NOT DONE||||TRANSUDATE|CLOTTED|Y|CLOT DETECTION|CKD-EPI FORMULA||NA|U|Y|Y|||Y|5||7||TREATMENT|1971-05-15|1964-12-13|||||1965-08-24||1972-08-19|N|1969-01-27
TRIAL STUDY 134XCP|LB|64153B43-9DDC-473D-97E1-0E2E8C3E8116|1||||AMYLOIDB|AMYLOID, BETA|||||||P|||||||INVALID||UKAT||||ABNORMAL|NOT DONE||||LUNG SURFACTANT|LACTESCENT|N|ULTRASOUND|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|U|Y|||NA|1||38||INDUCTION TREATMENT|1971-12-03|1973-05-16|||||1969-05-27||1965-06-07|NA|1972-02-23
TRIAL STUDY 134XCP|LB|64153B43-9DDC-473D-97E1-0E2E8C3E8116|2||||GGT|GAMMA GLUTAMYL TRANSFERASE|||||||KG|||||||TRACE||ML/DOSE||||LOW|NOT DONE||||SYNOVIAL FLUID|FROZEN|NA|RYAN BLUE STAIN|NASH FIBROSURE FORMULA||NA|U|NA|NA|||N|1||38||LONG-TERM FOLLOW-UP|1965-02-11|1972-07-21|||||1965-01-30||1969-05-02|N|1970-12-24
TRIAL STUDY 134XCP|LB|64153B43-9DDC-473D-97E1-0E2E8C3E8116|1||||GCSF|GRANULOCYTE COLONY STIMULATING FACTOR|||||||UV*SEC|||||||TRACE||/KG||||HIGH|NOT DONE||||ERYTHROCYTES|FRESH|Y|SXA SCAN|CKD-EPI FORMULA||N|U|U|Y|||NA|2||58||FOLLOW-UP|1963-09-01|1966-12-06|||||1964-12-26||1963-09-07|Y|1967-12-04
TRIAL STUDY 134XCP|LB|64153B43-9DDC-473D-97E1-0E2E8C3E8116|2||||INTLK12|INTERLEUKIN 12|||||||/500 WBC|||||||INVALID||CD||||NORMAL|NOT DONE||||SPUTUM|UNEXPECTED ODOR|Y|CAPILLARY ELECTROPHORESIS|MDRD 5 VARIABLE FORMULA||U|Y|N|N|||NA|2||58||WASHOUT|1969-01-08|1972-12-09|||||1973-03-02||1966-03-12|NA|1967-02-19
TRIAL STUDY 134XCP|LB|64153B43-9DDC-473D-97E1-0E2E8C3E8116|1||||GALANIN|GALANIN|||||||UG/KG/DAY|||||||NEGATIVE||MS2||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|PARAFFIN-EMBEDDED|NA|SPECULAR MICROSCOPY|HEPASCORE FORMULA||Y|Y|NA|U|||Y|3||39||WASHOUT|1964-01-30|1972-03-23|||||1967-04-17||1970-09-15|Y|1968-08-13
TRIAL STUDY 134XCP|LB|64153B43-9DDC-473D-97E1-0E2E8C3E8116|2||||PKM1|PYRUVATE KINASE ISOZYME M1|||||||CONTAINER|||||||NEGATIVE||10^9/G||||HIGH|NOT DONE||||CORD BLOOD|NON-HEMOLYZED|Y|PELLI-ROBSON EYE CHART|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|Y|N|||Y|3||39||BASELINE|1971-02-16|1964-02-14|||||1960-08-12||1972-02-02|Y|1964-01-27
TRIAL STUDY 134XCP|LB|64153B43-9DDC-473D-97E1-0E2E8C3E8116|1||||ATHMBAAC|ANTITHROMBIN ACTIVITY ACTUAL/CONTROL|||||||PG|||||||POSITIVE||UM/S||||LOW|NOT DONE||||LYMPH|CALCIFIED|N|SLOAN LETTER EYE CHART 100%|HEPASCORE FORMULA||NA|U|Y|Y|||N|4||88||FOLLOW-UP|1962-02-27|1971-01-12|||||1960-03-22||1963-11-04|U|1971-12-26
TRIAL STUDY 134XCP|LB|64153B43-9DDC-473D-97E1-0E2E8C3E8116|2||||PBGCREAT|PORPHOBILINOGEN/CREATININE|||||||ML/MMHG|||||||TRACE||10^7 TCID 50/DOSE||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|DRIED|NA|TRIPLE-PHASE MRI SCAN|MDRD 6 VARIABLE FORMULA||U|Y|N|Y|||NA|4||88||CONTINUATION TREATMENT|1962-08-25|1962-07-31|||||1968-05-18||1960-10-23|NA|1966-07-05
TRIAL STUDY 134XCP|LB|64153B43-9DDC-473D-97E1-0E2E8C3E8116|1||||BCEFNCTN|BETA-CELL FUNCTION|||||||MEQ/UL|||||||NEGATIVE||CI/UG||||NORMAL|NOT DONE||||CIRCULATING TUMOR CELL|CONTAMINATED|NA|AGAR DILUTION|HEPASCORE FORMULA||NA|U|N|Y|||U|5||7||RUN-IN|1961-12-03|1970-06-09|||||1963-03-01||1966-04-07|N|1963-02-01
TRIAL STUDY 134XCP|LB|64153B43-9DDC-473D-97E1-0E2E8C3E8116|2||||ETPPHR|ETP PEAK HEIGHT RELATIVE|||||||UL/DOSE|||||||BORDERLINE||MPA||||LOW|NOT DONE||||HAIR|CONCENTRATED|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|NA|U|Y|||N|5||7||BLINDED TREATMENT|1967-07-19|1969-03-12|||||1967-09-20||1966-07-14|U|1966-10-25
TRIAL STUDY 134XCP|LB|0F5775AD-1D20-4B59-8558-8A41C12E03D0|1||||POIKILO|POIKILOCYTES|||||||DB|||||||INDETERMINATE||/SEC||||ABNORMAL|NOT DONE||||SEMEN|CONCENTRATED|Y|OPTICAL MAPPING|FIBROTEST FORMULA||NA|Y|U|N|||Y|1||38||RUN-IN|1960-11-04|1961-09-04|||||1967-02-06||1970-10-02|N|1965-03-26
TRIAL STUDY 134XCP|LB|0F5775AD-1D20-4B59-8558-8A41C12E03D0|2||||PLATLRG|LARGE PLATELETS|||||||UKAT/L|||||||INDETERMINATE||BISCUIT||||ABNORMAL|NOT DONE||||SYNOVIAL FLUID|PARAFFIN-EMBEDDED|N|DISK DIFFUSION|NASH FIBROSURE FORMULA||U|N|U|Y|||Y|1||38||LONG-TERM FOLLOW-UP|1969-02-28|1962-12-25|||||1963-08-16||1961-05-07|N|1967-05-07
TRIAL STUDY 134XCP|LB|0F5775AD-1D20-4B59-8558-8A41C12E03D0|1||||PROC6|PRO-C6|||||||MBQ/UL|||||||TRACE||10^7 CFU||||LOW|NOT DONE||||FLUID|HEMOLYZED|Y|AUTOMATED COUNT|ASH FIBROSURE FORMULA||U|Y|N|NA|||NA|2||58||OBSERVATION|1960-07-31|1960-07-11|||||1969-05-21||1960-03-18|Y|1973-04-04
TRIAL STUDY 134XCP|LB|0F5775AD-1D20-4B59-8558-8A41C12E03D0|2||||IRON|IRON|||||||%(W/W)|||||||INDETERMINATE||UGEQ/L||||NORMAL|NOT DONE||||NAIL|DRIED|U|OPTICAL DENSITY MEASUREMENT|GMI % FORMULA||U|N|NA|U|||NA|2||58||WASHOUT|1964-10-31|1962-11-21|||||1966-09-22||1965-12-30|N|1972-06-26
TRIAL STUDY 134XCP|LB|0F5775AD-1D20-4B59-8558-8A41C12E03D0|1||||BUPREN|BUPRENORPHINE|||||||KCAL|||||||POSITIVE||OI50||||HIGH|NOT DONE||||DIALYSIS FLUID, PERITONEAL|THAWED|Y|DYNAMOMETRY|CKD-EPI FORMULA||N|U|N|NA|||NA|3||39||TREATMENT|1965-12-03|1967-06-11|||||1960-07-18||1960-01-14|U|1960-02-08
TRIAL STUDY 134XCP|LB|0F5775AD-1D20-4B59-8558-8A41C12E03D0|2||||T4|THYROXINE|||||||USIEMENS|||||||TRACE||MOL/MG||||NORMAL|NOT DONE||||LAVAGE FLUID|ROOM TEMPERATURE|U|SLIT LAMP|CKD-EPI CYSTATIN C FORMULA||U|Y|N|U|||U|3||39||CONTINUATION TREATMENT|1964-11-25|1972-02-05|||||1966-04-23||1971-03-04|N|1969-05-31
TRIAL STUDY 134XCP|LB|0F5775AD-1D20-4B59-8558-8A41C12E03D0|1||||THROMNUC|THROMBOCYTES|||||||PG/DL|||||||TRACE||MIU/L||||LOW|NOT DONE||||LOCHIA|THAWED|NA|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|NA|NA|||NA|4||88||CONTINUATION TREATMENT|1972-08-02|1970-06-24|||||1961-05-25||1973-03-25|Y|1970-03-15
TRIAL STUDY 134XCP|LB|0F5775AD-1D20-4B59-8558-8A41C12E03D0|2||||LKM1IGAB|LIVER KIDNEY MICROSOMAL TYPE 1 IGG AB|||||||MMOL|||||||TRACE||FINGERTIP UNIT||||HIGH|NOT DONE||||PLEURAL TISSUE|THAWED|N|HIGH RESOLUTION CT|GMI MMOL/MOL FORMULA||NA|U|N|Y|||U|4||88||FOLLOW-UP|1961-09-21|1965-02-09|||||1970-10-27||1972-02-06|N|1972-04-15
TRIAL STUDY 134XCP|LB|0F5775AD-1D20-4B59-8558-8A41C12E03D0|1||||CA1AG|CANCER ANTIGEN 1|||||||CI/MG|||||||INDETERMINATE||BE/ML||||HIGH|NOT DONE||||SERUM OR PLASMA|CONCENTRATED|N|ELECTROGASTROGRAPHY|MDRD 6 VARIABLE FORMULA||NA|U|U|N|||N|5||7||INDUCTION TREATMENT|1972-08-11|1969-03-18|||||1964-06-20||1969-09-06|N|1972-04-13
TRIAL STUDY 134XCP|LB|0F5775AD-1D20-4B59-8558-8A41C12E03D0|2||||INTLK14|INTERLEUKIN 14|||||||%(W/W)|||||||TRACE||UOSM||||ABNORMAL|NOT DONE||||SEBUM|NON-HEMOLYZED|Y|MODIFIED ACID FAST STAIN|FIBROTEST FORMULA||U|NA|NA|N|||Y|5||7||TREATMENT|1968-10-12|1968-11-22|||||1971-01-22||1967-02-02|Y|1964-05-30
TRIAL STUDY 134XCP|LB|DF533087-690C-489A-9163-9D4503B7BCC9|1||||AMA|ANTIMITOCHONDRIAL ANTIBODIES|||||||G/M2/DAY|||||||TRACE||G/CM2||||NORMAL|NOT DONE||||SKIN TISSUE|NON-HEMOLYZED|U|PAP STAIN|FIBROTEST FORMULA||NA|NA|NA|U|||Y|1||38||TREATMENT|1967-04-19|1960-10-08|||||1969-05-01||1960-03-11|Y|1968-09-21
TRIAL STUDY 134XCP|LB|DF533087-690C-489A-9163-9D4503B7BCC9|2||||LYMPLLE|PLASMACYTOID LYMPHOCYTES/LEUKOCYTES|||||||MG/KG/MIN|||||||INVALID||DAGU/ML||||LOW|NOT DONE||||BONE|ROOM TEMPERATURE|U|ANALYTICAL ULTRACENTRIFUGATION|CKD-EPI CYSTATIN C FORMULA||N|NA|N|N|||U|1||38||CONTINUATION TREATMENT|1964-09-13|1966-05-21|||||1960-08-26||1966-10-23|N|1968-12-26
TRIAL STUDY 134XCP|LB|DF533087-690C-489A-9163-9D4503B7BCC9|1||||BASOBLE|BASOPHILS BAND FORM/LEUKOCYTES|||||||KAT|||||||BORDERLINE||PIXEL||||ABNORMAL|NOT DONE||||PLATELET RICH PLASMA|CLOTTED|U|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|ASH FIBROSURE FORMULA||U|U|NA|U|||Y|2||58||CONTINUATION TREATMENT|1966-06-25|1961-03-13|||||1965-12-11||1961-04-22|Y|1971-09-18
TRIAL STUDY 134XCP|LB|DF533087-690C-489A-9163-9D4503B7BCC9|2||||FRUCTOSE|FRUCTOSE|||||||UG|||||||BORDERLINE||G/KG/DAY||||HIGH|NOT DONE||||GASTRIC CONTENTS|LACTESCENT|U|WESTERGREN|GMI % FORMULA||NA|N|N|N|||Y|2||58||BASELINE|1964-05-10|1966-01-04|||||1964-09-09||1969-01-03|U|1966-05-31
TRIAL STUDY 134XCP|LB|DF533087-690C-489A-9163-9D4503B7BCC9|1||||FEK|FRACTIONAL POTASSIUM EXCRETION|||||||HENRY|||||||INVALID||ML/KG/DAY||||NORMAL|NOT DONE||||BONE MARROW|HEMOLYZED|Y|POPULATION SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|U|NA|||NA|3||39||FOLLOW-UP|1973-07-13|1966-09-24|||||1965-05-31||1965-09-20|NA|1960-03-02
TRIAL STUDY 134XCP|LB|DF533087-690C-489A-9163-9D4503B7BCC9|2||||INTLK16|INTERLEUKIN 16|||||||UG/MOL|||||||BORDERLINE||MIN*MG/ML||||ABNORMAL|NOT DONE||||PLATELET POOR PLASMA|CONTAMINATED|Y|ISHIHARA COLOR PLATES|MDRD FORMULA||Y|U|N|U|||NA|3||39||WASHOUT|1965-09-17|1965-03-16|||||1965-02-28||1963-07-06|U|1966-08-13
TRIAL STUDY 134XCP|LB|DF533087-690C-489A-9163-9D4503B7BCC9|1||||CHYTRYP|CHYMOTRYPSIN|||||||SFC/10^6 PBMC|||||||NEGATIVE||MG/L||||HIGH|NOT DONE||||ALVEOLAR AIR|AGGLUTINATED|U|ERGOSPIROMETRY|COCKCROFT-GAULT FORMULA||U|U|N|NA|||U|4||88||BLINDED TREATMENT|1960-05-25|1971-12-16|||||1960-05-28||1968-05-26|Y|1966-12-29
TRIAL STUDY 134XCP|LB|DF533087-690C-489A-9163-9D4503B7BCC9|2||||RDWRCV|RET RDW COEFFICIENT OF VARIATION|||||||CGY|||||||INVALID||GENEQ/ML||||NORMAL|NOT DONE||||COLOSTRUM|ROOM TEMPERATURE|U|SLIT LAMP PHOTOGRAPHY|FIBROTEST FORMULA||N|U|U|NA|||NA|4||88||BASELINE|1971-11-07|1961-08-28|||||1965-05-04||1969-02-08|U|1971-08-14
TRIAL STUDY 134XCP|LB|DF533087-690C-489A-9163-9D4503B7BCC9|1||||CTXI|TYPE I COLLAGEN C-TELOPEPTIDES|||||||CGY|||||||POSITIVE||10^3/L||||HIGH|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LACTESCENT|N|KINETIC MICROPARTICLE IMMUNOASSAY|MDRD 5 VARIABLE FORMULA||U|N|Y|NA|||NA|5||7||INDUCTION TREATMENT|1962-09-29|1971-06-16|||||1973-03-03||1961-06-21|N|1967-06-20
TRIAL STUDY 134XCP|LB|DF533087-690C-489A-9163-9D4503B7BCC9|2||||GLOBA2PT|ALPHA-2 GLOBULIN/TOTAL PROTEIN|||||||KG/MOL|||||||INVALID||CFU/G||||LOW|NOT DONE||||CELL PELLET|SOLIDIFIED|N|SPECTROPHOTOMETRY|MDRD ENZYMATIC FORMULA||U|N|Y|NA|||Y|5||7||CONTINUATION TREATMENT|1966-07-15|1967-06-20|||||1962-03-26||1965-04-16|NA|1960-12-03
TRIAL STUDY 134XCP|LB|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|1||||IFNB|INTERFERON BETA|||||||/LSQN|||||||POSITIVE||QUANTITY SUFFICIENT||||HIGH|NOT DONE||||SALIVA|CLOTTED|N|PUPILLOMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||U|Y|Y|N|||N|1||38||INDUCTION TREATMENT|1966-07-17|1963-07-10|||||1969-03-22||1967-12-31|Y|1969-12-09
TRIAL STUDY 134XCP|LB|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|2||||THMBAAC|THROMBIN ACTIVITY ACTUAL/CONTROL|||||||PT_BR|||||||TRACE||INHALATION||||LOW|NOT DONE||||COLOSTRUM|ROOM TEMPERATURE|Y|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|MDRD 6 VARIABLE FORMULA||U|Y|N|U|||N|1||38||BASELINE|1963-06-29|1970-03-13|||||1969-12-11||1960-01-21|U|1971-11-01
TRIAL STUDY 134XCP|LB|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|1||||METANEXR|METANEPHRINE EXCRETION RATE|||||||COAT|||||||INDETERMINATE||10^3 CFU/ML||||LOW|NOT DONE||||PLATELET RICH PLASMA|DRIED|Y|IMMUNOBLOT|MDRD 4 VARIABLE FORMULA||U|N|NA|Y|||N|2||58||BASELINE|1973-07-11|1972-05-16|||||1964-10-29||1964-03-10|NA|1967-03-03
TRIAL STUDY 134XCP|LB|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|2||||CXCL1|CHEMOKINE (C-X-C MOTIF) LIGAND 1|||||||10^4/HPF|||||||BORDERLINE||/VF||||HIGH|NOT DONE||||CALCULUS|LACTESCENT|Y|ACRIDINE ORANGE STAIN|MDRD 4 VARIABLE FORMULA||N|NA|N|NA|||NA|2||58||BLINDED TREATMENT|1970-09-20|1966-11-04|||||1962-09-26||1966-01-19|U|1964-10-03
TRIAL STUDY 134XCP|LB|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|1||||C130077|SILVER BIRCH POLLEN IGA|||||||DPM/100MG|||||||POSITIVE||IU/L||||ABNORMAL|NOT DONE||||MONOCYTE|FROZEN|NA|MAGNETIC RESONANCE ELASTOGRAPHY|CKD-EPI FORMULA||NA|N|N|NA|||U|3||39||BLINDED TREATMENT|1966-07-07|1964-11-21|||||1969-07-29||1970-03-28|NA|1964-06-05
TRIAL STUDY 134XCP|LB|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|2||||LTE4|LEUKOTRIENE E4|||||||MEQ|||||||POSITIVE||10^6 CFU/ML||||HIGH|NOT DONE||||DERMAL TISSUE|ROOM TEMPERATURE|U|POLYGRAPHY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|NA|NA|N|||U|3||39||BLINDED TREATMENT|1972-12-15|1966-04-21|||||1962-10-07||1960-04-08|NA|1971-11-17
TRIAL STUDY 134XCP|LB|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|1||||C130135|D. PTERONYSSINUS ANTIGEN IGG ANTIBODY|||||||/KG|||||||BORDERLINE||HENRY||||NORMAL|NOT DONE||||ABSCESS FLUID|CALCIFIED|N|SPIROMETRY|MDRD 4 VARIABLE FORMULA||N|N|N|N|||N|4||88||LONG-TERM FOLLOW-UP|1961-06-12|1960-05-07|||||1961-04-12||1961-10-04|N|1971-01-16
TRIAL STUDY 134XCP|LB|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|2||||PH|PH|||||||VOXEL|||||||BORDERLINE||MG/L FEU||||LOW|NOT DONE||||STOOL|FROZEN|Y|PHOTOMETRY|FIBROMETER FORMULA||N|U|N|U|||Y|4||88||FOLLOW-UP|1966-07-18|1966-06-18|||||1968-08-03||1961-03-11|U|1967-06-08
TRIAL STUDY 134XCP|LB|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|1||||AUERRODS|AUER RODS|||||||IU/DL|||||||POSITIVE||DPM||||NORMAL|NOT DONE||||VENOUS BLOOD|FRESH|NA|THICK SMEAR|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|U|N|||NA|5||7||OBSERVATION|1966-01-15|1960-08-31|||||1962-05-27||1973-01-09|NA|1964-05-11
TRIAL STUDY 134XCP|LB|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|2||||APOC1|APOLIPOPROTEIN CI|||||||ELISA UNIT/ML|||||||INVALID||CI/UL||||NORMAL|NOT DONE||||INFRANATANT, SERUM|LIPEMIC|NA|VENTILATION PERFUSION LUNG SCAN|FIBROSIS 4 FORMULA||NA|Y|U|Y|||N|5||7||TREATMENT|1962-11-29|1967-03-11|||||1964-05-13||1973-01-16|N|1963-05-23
TRIAL STUDY 134XCP|LB|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|1||||GDA|GUANINE DEAMINASE|||||||MG/CM2|||||||TRACE||MOL/L||||ABNORMAL|NOT DONE||||PLATELET|SOLIDIFIED|U|RADIOIMMUNOPRECIPITATION ASSAY|MDRD FORMULA||NA|U|N|Y|||N|1||38||OPEN LABEL TREATMENT|1960-12-27|1960-08-29|||||1971-11-29||1971-05-12|Y|1963-04-13
TRIAL STUDY 134XCP|LB|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|2||||TSTSFRPT|TESTOSTERONE, FREE/TOTAL PROTEIN|||||||MG/G/MIN|||||||POSITIVE||/10^4||||ABNORMAL|NOT DONE||||BASAL TEAR|ICTERIC|NA|NEXT GENERATION TARGETED SEQUENCING|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|NA|U|||Y|1||38||WASHOUT|1964-11-25|1968-07-22|||||1961-10-13||1967-11-26|U|1972-05-27
TRIAL STUDY 134XCP|LB|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|1||||GDA|GUANINE DEAMINASE|||||||MCI|||||||TRACE||TRANSDUCING UNIT||||LOW|NOT DONE||||INFRANATANT, PLASMA|CLOTTED|U|ANTIBIOTIC AGAR SCREEN|COCKCROFT-GAULT FORMULA||N|U|N|NA|||U|2||58||INDUCTION TREATMENT|1966-05-05|1971-02-24|||||1969-02-21||1966-05-30|U|1973-08-29
TRIAL STUDY 134XCP|LB|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|2||||APOA4|APOLIPOPROTEIN A4|||||||V/SEC|||||||NEGATIVE||MV||||LOW|NOT DONE||||FLUID|FRESH|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|MDRD ENZYMATIC JAPANESE FORMULA||NA|N|U|U|||U|2||58||CONTINUATION TREATMENT|1960-01-21|1963-02-24|||||1972-07-24||1970-04-21|U|1965-10-12
TRIAL STUDY 134XCP|LB|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|1||||C130140|GERMAN COCKROACH ANTIGEN IGE ANTIBODY|||||||ELISA UNIT/ML|||||||INDETERMINATE||MOL/ML||||HIGH|NOT DONE||||SWABBED MATERIAL|NON-HEMOLYZED|Y|ENDOSCOPY|FIBROSIS 4 FORMULA||U|Y|Y|NA|||Y|3||39||LONG-TERM FOLLOW-UP|1961-11-02|1961-09-28|||||1960-08-17||1961-09-03|N|1969-02-22
TRIAL STUDY 134XCP|LB|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|2||||PTHFG|PARATHYROID HORMONE, FRAGMENTED|||||||UG/H|||||||INVALID||APPLICATION||||LOW|NOT DONE||||PUS|LIPEMIC|Y|MULTIPLE BREATH WASHOUT|FIBROSIS 4 FORMULA||U|N|Y|N|||NA|3||39||CONTINUATION TREATMENT|1972-03-16|1966-07-17|||||1967-01-18||1967-06-30|N|1972-05-01
TRIAL STUDY 134XCP|LB|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|1||||PNTBRBTL|PENTOBARBITAL|||||||ANTIBODY UNIT|||||||BORDERLINE||CIGARETTE||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|FROZEN|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|FIBROSIS 4 FORMULA||Y|NA|U|Y|||N|4||88||TREATMENT|1966-12-18|1961-09-07|||||1969-09-19||1970-10-07|N|1966-03-07
TRIAL STUDY 134XCP|LB|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|2||||C165882|WHITE ELM POLLEN IGE AB RAST SCORE|||||||U/G HB|||||||INDETERMINATE||10^7/L||||ABNORMAL|NOT DONE||||CAPILLARY BLOOD|HEMOLYZED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|MDRD 6 VARIABLE FORMULA||N|N|U|Y|||NA|4||88||OBSERVATION|1962-03-31|1965-12-03|||||1965-01-19||1965-01-03|U|1967-07-25
TRIAL STUDY 134XCP|LB|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|1||||ANTIDPRS|ANTIDEPRESSANTS|||||||10^6 ORGANISMS|||||||INDETERMINATE||10^6/HPF||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|ICTERIC|NA|ELECTROCHEMILUMINESCENCE|MDRD 5 VARIABLE FORMULA||U|N|Y|U|||NA|5||7||OBSERVATION|1972-08-01|1967-12-19|||||1972-09-21||1967-08-07|N|1962-06-06
TRIAL STUDY 134XCP|LB|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|2||||CASULPH|CALCIUM SULPHATE|||||||LOG10 TCID 50/UL|||||||NEGATIVE||MV2/HZ||||HIGH|NOT DONE||||PLEURAL FLUID|THAWED|N|PET SCAN|MDRD FORMULA||N|N|Y|U|||NA|5||7||INDUCTION TREATMENT|1965-11-22|1963-08-19|||||1960-01-05||1971-12-19|N|1967-05-13
TRIAL STUDY 134XCP|LB|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|1||||C165901|ENGLISHPLANTAIN POLLEN IGG AB RAST SCORE|||||||VOXEL|||||||INVALID||LOG EID 50/DOSE||||ABNORMAL|NOT DONE||||LYSATE|HEMOLYZED|U|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|ASH FIBROSURE FORMULA||U|NA|U|NA|||U|1||38||FOLLOW-UP|1961-02-22|1971-04-17|||||1964-04-06||1970-10-13|U|1971-02-06
TRIAL STUDY 134XCP|LB|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|2||||SPHERO|SPHEROCYTES|||||||UG/DOSE|||||||INVALID||KAT||||NORMAL|NOT DONE||||BASAL TEAR|REFRIGERATED|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|FIBROSIS 4 FORMULA||NA|N|Y|Y|||U|1||38||OPEN LABEL TREATMENT|1970-09-22|1971-03-19|||||1967-01-30||1972-11-29|Y|1965-09-15
TRIAL STUDY 134XCP|LB|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|1||||CDCA|CHENODEOXYCHOLATE|||||||USEC|||||||NEGATIVE||MHZ||||HIGH|NOT DONE||||SUPERNATANT, SERUM|DRIED|Y|LC/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|NA|N|||NA|2||58||WASHOUT|1965-10-22|1969-09-18|||||1964-05-13||1964-11-15|N|1968-09-03
TRIAL STUDY 134XCP|LB|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|2||||BNPPRO|PROB-TYPE NATRIURETIC PEPTIDE|||||||10^9 ORGANISMS/G|||||||INDETERMINATE||PMOL/L||||NORMAL|NOT DONE||||GASTRIC FLUID|CONTAMINATED|N|MIGET|CKD-EPI CREATININE FORMULA||N|N|NA|Y|||N|2||58||TREATMENT|1969-06-25|1968-06-10|||||1960-05-03||1961-06-28|U|1960-11-30
TRIAL STUDY 134XCP|LB|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|1||||VITD2425|24,25-DIHYDROXYVITAMIN D|||||||PG/L|||||||NEGATIVE||CY/CM||||NORMAL|NOT DONE||||MONOCYTE|THAWED|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|COCKCROFT-GAULT FORMULA||U|Y|NA|Y|||Y|3||39||BASELINE|1967-12-13|1968-05-01|||||1971-03-29||1967-02-13|Y|1964-01-31
TRIAL STUDY 134XCP|LB|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|2||||MSPIKEPT|MONOCLONAL PROTEIN SPIKE/TOTAL PROTEIN|||||||TBSP|||||||NEGATIVE||BU/ML||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|CONCENTRATED|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|MDRD ENZYMATIC FORMULA||Y|U|NA|N|||N|3||39||RUN-IN|1970-06-22|1964-06-23|||||1967-05-07||1962-04-28|N|1964-08-25
TRIAL STUDY 134XCP|LB|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|1||||S100B|S100 CALCIUM-BINDING PROTEIN B|||||||SBE/ML|||||||TRACE||KS||||LOW|NOT DONE||||LOCHIA|HEMOLYZED|NA|FREEZING POINT DEPRESSION|CKD-EPI CREATININE FORMULA||N|U|U|Y|||NA|4||88||OBSERVATION|1968-01-09|1963-12-13|||||1972-11-05||1973-06-08|Y|1965-01-22
TRIAL STUDY 134XCP|LB|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|2||||BTKFR|BRUTON'S TYROSINE KINASE, FREE|||||||LOG10 ELISA UNIT/DOSE|||||||INDETERMINATE||/100 HPFS||||HIGH|NOT DONE||||INFRANATANT, PLASMA|PARAFFIN-EMBEDDED|U|NUCLEIC ACID AMPLIFICATION TEST|MDRD ENZYMATIC FORMULA||NA|Y|NA|Y|||Y|4||88||CONTINUATION TREATMENT|1960-02-01|1969-09-05|||||1961-12-20||1967-08-13|U|1971-12-07
TRIAL STUDY 134XCP|LB|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|1||||THC|TETRAHYDROCANNABINOL|||||||CI/UG|||||||INDETERMINATE||MBQ||||NORMAL|NOT DONE||||NAIL|THAWED|U|CONTRAST ENHANCED MRI|CKD-EPI FORMULA||NA|U|U|N|||N|5||7||BLINDED TREATMENT|1970-07-30|1963-06-26|||||1963-01-15||1963-05-11|NA|1960-02-01
TRIAL STUDY 134XCP|LB|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|2||||CRYOFBRN|CRYOFIBRINOGEN|||||||DAYS/MONTH|||||||TRACE||MIN/DAY||||HIGH|NOT DONE||||VENOUS PLASMA|HEMOLYZED|Y|IMMUNOTURBIDIMETRY|CKD-EPI CYSTATIN C FORMULA||N|Y|N|Y|||Y|5||7||OBSERVATION|1960-11-06|1968-02-08|||||1966-10-04||1971-08-15|U|1965-05-31
TRIAL STUDY 134XCP|LB|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|1||||FATLVIDX|FATTY LIVER INDEX|||||||MILE|||||||TRACE||UG/CM2||||ABNORMAL|NOT DONE||||GASTRIC CONTENTS|AUTOLYZED|U|ACID FAST STAIN|MDRD FORMULA||NA|NA|Y|Y|||N|1||38||RUN-IN|1965-02-09|1965-01-27|||||1970-09-03||1961-01-13|U|1967-01-24
TRIAL STUDY 134XCP|LB|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|2||||C130100|MIXED ANTIGEN IGE ANTIBODY|||||||UG/M2/DAY|||||||NEGATIVE||10^9 ORGANISMS||||LOW|NOT DONE||||EPIDERMAL TISSUE|REFRIGERATED|N|SLIT LAMP PHOTOGRAPHY|FIBROMETER FORMULA||NA|N|U|Y|||NA|1||38||SCREENING|1962-08-16|1970-03-24|||||1961-06-24||1971-06-27|NA|1970-02-03
TRIAL STUDY 134XCP|LB|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|1||||LPL|LIPOPROTEIN LIPASE|||||||U/DL|||||||NEGATIVE||10^4 CFU/ML||||NORMAL|NOT DONE||||SMOOTH MUSCLE TISSUE|SOLIDIFIED|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|NASH FIBROSURE FORMULA||N|N|NA|Y|||Y|2||58||RUN-IN|1970-07-31|1971-02-02|||||1970-09-19||1966-08-28|NA|1971-07-15
TRIAL STUDY 134XCP|LB|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|2||||CRLPLSMN|CERULOPLASMIN|||||||SQU/ML|||||||POSITIVE||CMH2O*S2/ML||||NORMAL|NOT DONE||||LYMPH|AUTOLYZED|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|CKD-EPI FORMULA||Y|N|N|NA|||Y|2||58||RUN-IN|1967-02-19|1963-05-21|||||1961-10-20||1970-01-17|NA|1968-07-08
TRIAL STUDY 134XCP|LB|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|1||||MYBLAT3|TYPE III MYELOBLASTS|||||||/500 WBC|||||||TRACE||GTT||||LOW|NOT DONE||||EPIDERMAL TISSUE|LACTESCENT|N|HPLC|CKD-EPI FORMULA||Y|NA|U|U|||N|3||39||CONTINUATION TREATMENT|1972-04-11|1960-09-24|||||1964-08-31||1971-03-26|N|1972-07-23
TRIAL STUDY 134XCP|LB|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|2||||BLASTNCE|BLASTS/NUCLEATED CELLS|||||||ELISA UNIT/DOSE|||||||BORDERLINE||MG/KG/H||||LOW|NOT DONE||||DISCHARGE|SOLIDIFIED|U|LC-FL|CKD-EPI FORMULA||Y|N|NA|N|||N|3||39||SCREENING|1973-02-23|1969-12-18|||||1972-11-25||1966-05-15|NA|1970-04-20
TRIAL STUDY 134XCP|LB|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|1||||TRANK1|TPR-ANKYRIN REPEAT-CONTAINING PROTEIN 1|||||||PIPE|||||||BORDERLINE||JAR||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|Y|PHOROPTER|GMI % FORMULA||N|U|N|Y|||N|4||88||LONG-TERM FOLLOW-UP|1971-11-07|1967-07-05|||||1973-05-03||1971-11-02|N|1964-03-05
TRIAL STUDY 134XCP|LB|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|2||||FCTVIIIA|FACTOR VIII ACTIVITY|||||||DIP|||||||POSITIVE||MESF||||NORMAL|NOT DONE||||CEREBROSPINAL FLUID|FROZEN|U|ENZYMATIC ULTRACENTRIFUGATION|GMI % FORMULA||Y|NA|U|NA|||U|4||88||INDUCTION TREATMENT|1973-01-19|1966-12-18|||||1962-02-20||1972-10-16|NA|1965-07-06
TRIAL STUDY 134XCP|LB|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|1||||SODIUM|SODIUM|||||||L/S|||||||POSITIVE||ML/CM||||NORMAL|NOT DONE||||SERUM OR PLASMA|SOLIDIFIED|Y|REFLECTANCE SPECTROSCOPY|CKD-EPI FORMULA||U|N|N|N|||N|5||7||INDUCTION TREATMENT|1961-06-23|1963-04-22|||||1962-11-26||1968-04-02|Y|1973-05-28
TRIAL STUDY 134XCP|LB|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|2||||RDWSD|RDW STANDARD DEVIATION|||||||MG/KG/MIN|||||||INDETERMINATE||10^6/L||||LOW|NOT DONE||||GASTRIC FLUID|PARAFFIN-EMBEDDED|U|CLIP SEQUENCING|FIBROTEST FORMULA||NA|NA|U|NA|||U|5||7||RUN-IN|1967-02-14|1962-06-23|||||1966-06-23||1961-07-24|N|1973-08-07
TRIAL STUDY 134XCP|LB|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|1||||OCCBLD|OCCULT BLOOD|||||||10^11/L|||||||BORDERLINE||10^6 IU||||HIGH|NOT DONE||||MIXED VENOUS BLOOD|CLOTTED|U|HPLC/IEX|MDRD FORMULA||N|Y|NA|N|||U|1||38||LONG-TERM FOLLOW-UP|1964-07-17|1969-05-12|||||1969-08-14||1973-03-10|NA|1967-04-10
TRIAL STUDY 134XCP|LB|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|2||||CLARITY|CLARITY|||||||POUCH|||||||BORDERLINE||CY/CM||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED|U|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|MDRD ENZYMATIC FORMULA||U|NA|NA|NA|||U|1||38||CONTINUATION TREATMENT|1965-09-26|1966-03-01|||||1963-10-19||1967-07-24|U|1968-05-08
TRIAL STUDY 134XCP|LB|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|1||||LCTHSPGM|LECITHIN/SPHINGOMYELIN|||||||USIEMENS|||||||TRACE||RPM||||NORMAL|NOT DONE||||BONE|FRESH|NA|POLYSOMNOGRAPHY|CKD-EPI CREATININE FORMULA||Y|N|NA|U|||U|2||58||SCREENING|1967-03-31|1968-02-22|||||1971-08-18||1966-12-11|Y|1969-10-25
TRIAL STUDY 134XCP|LB|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|2||||GFRBSCRT|GFR FROM CREATININE ADJUSTED FOR BSA|||||||MG/MOL|||||||NEGATIVE||BOX||||HIGH|NOT DONE||||PLEURAL FLUID|SOLIDIFIED|Y|DROPLET DIGITAL PCR|MDRD ENZYMATIC FORMULA||U|NA|NA|NA|||U|2||58||CONTINUATION TREATMENT|1965-02-19|1970-11-13|||||1965-06-21||1962-12-04|Y|1964-02-03
TRIAL STUDY 134XCP|LB|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|1||||ISG15|UBIQUITIN-LIKE PROTEIN ISG15|||||||UL|||||||INDETERMINATE||NG||||HIGH|NOT DONE||||MUCUS|AUTOLYZED|NA|KINYOUN STAIN|GMI MMOL/MOL FORMULA||U|Y|N|Y|||Y|3||39||OPEN LABEL TREATMENT|1968-11-03|1968-04-09|||||1973-03-05||1965-12-28|NA|1962-05-18
TRIAL STUDY 134XCP|LB|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|2||||HBGCHTHB|HEMOGLOBIN G COUSHATTA/TOTAL HEMOGLOBIN|||||||HZ|||||||BORDERLINE||10^6 RNA COPIES/ML||||ABNORMAL|NOT DONE||||BONE MARROW MONONUCLEAR CELL|ROOM TEMPERATURE|NA|FLOW MICROSCOPY|CKD-EPI FORMULA||U|NA|U|NA|||Y|3||39||BASELINE|1969-02-14|1968-05-31|||||1963-04-30||1960-08-12|N|1965-01-14
TRIAL STUDY 134XCP|LB|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|1||||SVCAM1|SOLUBLE VASC CELL ADHESION MOLECULE 1|||||||UG/G/H|||||||INDETERMINATE||PG/CELL||||ABNORMAL|NOT DONE||||SALIVA|GELLED|Y|MULTIPLE BREATH WASHOUT|GMI MMOL/MOL FORMULA||N|Y|Y|Y|||U|4||88||LONG-TERM FOLLOW-UP|1967-06-15|1968-10-02|||||1973-03-14||1968-12-17|Y|1973-02-24
TRIAL STUDY 134XCP|LB|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|2||||SO2|SULFUR DIOXIDE|||||||G/M2/DAY|||||||TRACE||GLOBULE||||LOW|NOT DONE||||HAIR FOLLICLE|DRIED|N|MICROARRAY|GMI MMOL/MOL FORMULA||N|NA|N|NA|||N|4||88||CONTINUATION TREATMENT|1963-03-07|1970-01-21|||||1964-05-24||1965-06-24|N|1960-10-26
TRIAL STUDY 134XCP|LB|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|1||||GLY|GLYCINE|||||||SFC/10^6 PBMC|||||||POSITIVE||OZ||||NORMAL|NOT DONE||||LYSATE|SOLIDIFIED|NA|MICROSCOPY|CKD-EPI CREATININE FORMULA||U|U|U|Y|||U|5||7||OPEN LABEL TREATMENT|1967-11-11|1961-08-02|||||1973-02-27||1969-01-07|NA|1970-05-12
TRIAL STUDY 134XCP|LB|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|2||||NACLR|SODIUM CLEARANCE|||||||KG/M2|||||||INVALID||BQ||||HIGH|NOT DONE||||INFRANATANT, SERUM|UNEXPECTED ODOR|U|TOLUIDINE BLUE STAIN|MDRD ENZYMATIC FORMULA||U|Y|NA|N|||Y|5||7||BASELINE|1965-04-25|1971-01-03|||||1965-05-12||1962-08-05|Y|1972-06-04
TRIAL STUDY 134XCP|LB|219A70B2-48A6-407C-B901-9847583DB5F4|1||||BASEDEF|BASE DEFICIT|||||||MCI/L|||||||NEGATIVE||V/V||||LOW|NOT DONE||||CEREBROSPINAL FLUID|DRIED|Y|APPLANATION TONOMETRY|FIBROMETER FORMULA||NA|Y|NA|NA|||Y|1||38||RUN-IN|1960-12-18|1969-10-20|||||1964-07-11||1970-01-09|Y|1969-07-08
TRIAL STUDY 134XCP|LB|219A70B2-48A6-407C-B901-9847583DB5F4|2||||PELGERH|PELGER HUET ANOMALY|||||||ML/M2/H|||||||NEGATIVE||IU/MMOL||||HIGH|NOT DONE||||TUMOR TISSUE|GELLED|Y|WHOLE TRANSCRIPTOME SEQUENCING|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|Y|NA|||Y|1||38||WASHOUT|1967-11-11|1966-03-31|||||1973-03-29||1971-06-12|N|1960-09-13
TRIAL STUDY 134XCP|LB|219A70B2-48A6-407C-B901-9847583DB5F4|1||||FRFEABS|FRACTIONAL IRON ABSORPTION|||||||ABSORBANCE U/ML|||||||BORDERLINE||KM||||ABNORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|CLOTTED|NA|OBSERVATION|FIBROSIS 4 FORMULA||U|U|Y|Y|||Y|2||58||INDUCTION TREATMENT|1972-03-28|1969-06-22|||||1962-04-07||1971-04-17|U|1971-12-07
TRIAL STUDY 134XCP|LB|219A70B2-48A6-407C-B901-9847583DB5F4|2||||CITRTEXR|CITRATE EXCRETION RATE|||||||MOL|||||||INDETERMINATE||%(W/V)||||LOW|NOT DONE||||CAPILLARY BLOOD|NON-HEMOLYZED|Y|MASS SPECTROMETRY|MDRD ENZYMATIC FORMULA||NA|NA|Y|U|||N|2||58||SCREENING|1965-08-19|1972-06-06|||||1967-10-17||1962-04-12|NA|1967-05-17
TRIAL STUDY 134XCP|LB|219A70B2-48A6-407C-B901-9847583DB5F4|1||||APRIL|A PROLIFERATION-INDUCING LIGAND|||||||NMOL/G|||||||BORDERLINE||COPIES/ML||||NORMAL|NOT DONE||||BUFFY COAT|NON-HEMOLYZED|NA|COLORIMETRY|FIBROMETER FORMULA||NA|N|NA|N|||NA|3||39||BLINDED TREATMENT|1963-07-22|1971-08-11|||||1963-08-01||1966-05-15|NA|1972-12-22
TRIAL STUDY 134XCP|LB|219A70B2-48A6-407C-B901-9847583DB5F4|2||||C5A|COMPLEMENT C5A|||||||MG/DAY|||||||INVALID||TAMPON||||NORMAL|NOT DONE||||SPERMATOZOON|LACTESCENT|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|MDRD 6 VARIABLE FORMULA||N|N|NA|Y|||Y|3||39||OBSERVATION|1965-07-18|1970-05-16|||||1960-04-13||1973-04-27|NA|1968-11-21
TRIAL STUDY 134XCP|LB|219A70B2-48A6-407C-B901-9847583DB5F4|1||||ACETONE|ACETONE|||||||HPA|||||||NEGATIVE||KM/H||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FRESH|NA|MANUAL CLOT DETECTION|CKD-EPI CREATININE FORMULA||Y|NA|U|Y|||N|4||88||BASELINE|1960-09-12|1969-11-16|||||1962-10-03||1968-06-10|U|1965-05-29
TRIAL STUDY 134XCP|LB|219A70B2-48A6-407C-B901-9847583DB5F4|2||||PAI1|PLASMINOGEN ACTIVATOR INHIBITOR-1|||||||U/MG|||||||BORDERLINE||10^3 ORGANISMS/G||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED|NA|MICROSCOPY|CKD-EPI CREATININE FORMULA||NA|N|Y|U|||NA|4||88||SCREENING|1962-05-13|1965-06-11|||||1973-08-17||1965-10-21|NA|1969-08-02
TRIAL STUDY 134XCP|LB|219A70B2-48A6-407C-B901-9847583DB5F4|1||||MPOAB|MYELOPEROXIDASE ANTIBODY|||||||DISK|||||||TRACE||LB||||NORMAL|NOT DONE||||CALCULUS|THAWED|U|PALM METHOD|NASH FIBROSURE FORMULA||N|Y|NA|U|||Y|5||7||INDUCTION TREATMENT|1968-06-28|1973-04-19|||||1968-12-17||1970-07-25|Y|1961-12-24
TRIAL STUDY 134XCP|LB|219A70B2-48A6-407C-B901-9847583DB5F4|2||||IGGSYNRT|IGG SYNTHESIS RATE|||||||ML/CAGE|||||||TRACE||FINGERTIP UNIT||||LOW|NOT DONE||||SUPERNATANT, PLASMA|NON-HEMOLYZED|Y|ELASTOGRAPHY|MDRD ENZYMATIC FORMULA||N|N|NA|Y|||N|5||7||OBSERVATION|1973-08-30|1964-11-10|||||1964-11-08||1972-09-26|Y|1961-11-09
TRIAL STUDY 134XCP|LB|CF3AC42D-DFBA-448E-A688-46A87D6264EB|1||||VOLUME|VOLUME|||||||GRAVITATIONAL UNIT|||||||BORDERLINE||UG/L FEU||||NORMAL|NOT DONE||||SEBUM|SOLIDIFIED|U|GRADIENT DIFFUSION|GMI % FORMULA||U|NA|N|NA|||U|1||38||INDUCTION TREATMENT|1962-07-13|1961-12-17|||||1968-08-13||1960-09-06|Y|1973-05-24
TRIAL STUDY 134XCP|LB|CF3AC42D-DFBA-448E-A688-46A87D6264EB|2||||TPROTFR|TAU PROTEIN, FREE|||||||V/V|||||||POSITIVE||UV||||HIGH|NOT DONE||||COLOSTRUM|DRIED|Y|SNP ARRAY|GMI % FORMULA||NA|Y|U|NA|||U|1||38||TREATMENT|1962-10-01|1964-07-05|||||1972-12-12||1963-05-02|NA|1966-12-22
TRIAL STUDY 134XCP|LB|CF3AC42D-DFBA-448E-A688-46A87D6264EB|1||||MONOMA|MONOCYTES/MACROCYTES|||||||10^6 ORGANISMS/ML|||||||INVALID||IU/MMOL||||HIGH|NOT DONE||||CAPILLARY PLASMA|LACTESCENT|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|N|U|Y|||Y|2||58||RUN-IN|1970-06-07|1970-03-12|||||1965-11-03||1962-07-03|U|1960-02-26
TRIAL STUDY 134XCP|LB|CF3AC42D-DFBA-448E-A688-46A87D6264EB|2||||BJPROT|BENCE-JONES PROTEIN|||||||ML/G/MIN|||||||INDETERMINATE||KALLIKREIN INHIBITOR UNIT||||ABNORMAL|NOT DONE||||HAIR|FRESH|Y|LIGHT SCATTERING SPECTROSCOPY|CKD-EPI FORMULA||N|U|N|Y|||U|2||58||SCREENING|1969-10-07|1972-03-20|||||1967-05-22||1962-12-09|U|1962-11-01
TRIAL STUDY 134XCP|LB|CF3AC42D-DFBA-448E-A688-46A87D6264EB|1||||LYMPLLE|PLASMACYTOID LYMPHOCYTES/LEUKOCYTES|||||||UMOL/H/MMOL|||||||NEGATIVE||DISK||||HIGH|NOT DONE||||TUMOR TISSUE|PARAFFIN-EMBEDDED|U|NEPHELOMETRY|MDRD 6 VARIABLE FORMULA||Y|Y|NA|NA|||NA|3||39||LONG-TERM FOLLOW-UP|1961-03-14|1969-11-08|||||1973-01-23||1968-06-10|N|1969-09-14
TRIAL STUDY 134XCP|LB|CF3AC42D-DFBA-448E-A688-46A87D6264EB|2||||IL1R2|INTERLEUKIN 1 RECEPTOR TYPE 2|||||||U/L|||||||INVALID||PIXELS/IN||||NORMAL|NOT DONE||||BREAST MILK|ROOM TEMPERATURE|Y|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|GMI % FORMULA||U|NA|NA|NA|||U|3||39||OPEN LABEL TREATMENT|1966-03-09|1966-07-03|||||1960-03-20||1966-06-12|N|1964-05-28
TRIAL STUDY 134XCP|LB|CF3AC42D-DFBA-448E-A688-46A87D6264EB|1||||THBD|THROMBOMODULIN|||||||CI/MG|||||||NEGATIVE||UG/DAY||||LOW|NOT DONE||||SMEGMA|UNEXPECTED ODOR|Y|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|GMI MMOL/MOL FORMULA||N|N|N|NA|||Y|4||88||CONTINUATION TREATMENT|1962-05-11|1961-09-03|||||1970-06-17||1969-01-04|N|1965-05-11
TRIAL STUDY 134XCP|LB|CF3AC42D-DFBA-448E-A688-46A87D6264EB|2||||TLYMXM|T-LYMPHOCYTE CROSSMATCH|||||||DEG/MM|||||||INDETERMINATE||MEQ||||LOW|NOT DONE||||SEMINAL FLUID|FRESH|NA|MICROSCOPY|FIBROTEST FORMULA||NA|U|Y|U|||U|4||88||LONG-TERM FOLLOW-UP|1960-10-21|1963-02-23|||||1963-10-20||1965-04-20|Y|1960-06-04
TRIAL STUDY 134XCP|LB|CF3AC42D-DFBA-448E-A688-46A87D6264EB|1||||BLSTMGK|MEGAKARYOBLASTS|||||||G/DL|||||||POSITIVE||CUP||||LOW|NOT DONE||||SEMEN|FRESH|U|NEURAMINIDASE INHIBITION ASSAY|MDRD 6 VARIABLE FORMULA||N|NA|U|Y|||Y|5||7||TREATMENT|1969-07-11|1970-02-14|||||1962-02-12||1970-10-31|N|1961-01-02
TRIAL STUDY 134XCP|LB|CF3AC42D-DFBA-448E-A688-46A87D6264EB|2||||AMA|ANTIMITOCHONDRIAL ANTIBODIES|||||||10^6 ORGANISMS/MG|||||||INDETERMINATE||PIXELS/CM||||LOW|NOT DONE||||REFLEX TEAR|PARAFFIN-EMBEDDED|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|CKD-EPI CREATININE-CYSTATIN C FORMULA||N|U|U|Y|||NA|5||7||OPEN LABEL TREATMENT|1962-06-03|1968-09-26|||||1964-09-25||1960-04-07|NA|1964-07-07
TRIAL STUDY 134XCP|LB|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|1||||TRIGHDL|TRIGLYCERIDES/HDL CHOLESTEROL|||||||PA|||||||INVALID||MG/G/MIN||||LOW|NOT DONE||||PROSTATIC FLUID|AGGLUTINATED|U|CT SCAN WITHOUT CONTRAST|MDRD ENZYMATIC JAPANESE FORMULA||U|NA|U|NA|||N|1||38||LONG-TERM FOLLOW-UP|1962-07-15|1960-12-02|||||1964-12-05||1969-04-14|NA|1970-12-11
TRIAL STUDY 134XCP|LB|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|2||||MASTCECE|MAST CELLS/TOTAL CELLS|||||||/2500 WBC|||||||POSITIVE||CAN||||NORMAL|NOT DONE||||CORD SERUM|CONCENTRATED|N|BIOIMPEDANCE SPECTROSCOPY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|NA|N|NA|||U|1||38||OBSERVATION|1966-10-13|1970-05-15|||||1965-07-05||1961-06-15|U|1968-11-12
TRIAL STUDY 134XCP|LB|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|1||||HCGFR|CHORIOGONADOTROPIN BETA, FREE|||||||MG/M2|||||||NEGATIVE||NKAT||||NORMAL|NOT DONE||||BLOOD|ICTERIC|Y|CHROMATOGRAPHY|CKD-EPI FORMULA||Y|N|U|NA|||NA|2||58||BLINDED TREATMENT|1963-08-13|1969-08-13|||||1973-04-16||1969-03-27|U|1973-07-11
TRIAL STUDY 134XCP|LB|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|2||||HLAMSC|HLA MISMATCH COUNT|||||||GBQ/UG|||||||NEGATIVE||KG/M2||||NORMAL|NOT DONE||||PERITONEAL FLUID|ICTERIC|NA|QUANTITATIVE CORONARY ANGIOGRAPHY|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|Y|Y|NA|||U|2||58||RUN-IN|1968-06-12|1960-12-27|||||1964-12-01||1967-07-27|U|1967-08-11
TRIAL STUDY 134XCP|LB|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|1||||DHT|DIHYDROTESTOSTERONE|||||||BU|||||||POSITIVE||KN/CM2||||HIGH|NOT DONE||||SMEGMA|CALCIFIED|N|X-RAY|FIBROSIS 4 FORMULA||Y|U|Y|NA|||Y|3||39||OBSERVATION|1962-04-24|1971-03-21|||||1967-08-26||1969-05-01|Y|1965-06-07
TRIAL STUDY 134XCP|LB|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|2||||LEPTIN|LEPTIN|||||||OSM|||||||POSITIVE||ELISA UNIT/ML||||HIGH|NOT DONE||||SERUM OR PLASMA|NON-HEMOLYZED|N|DISK DIFFUSION|MDRD 6 VARIABLE FORMULA||U|U|Y|N|||N|3||39||WASHOUT|1969-01-23|1961-09-16|||||1966-09-29||1968-01-09|Y|1965-05-27
TRIAL STUDY 134XCP|LB|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|1||||VITC|VITAMIN C|||||||UGEQ|||||||INVALID||SCM||||ABNORMAL|NOT DONE||||BONE MARROW|AUTOLYZED|U|TONOMETRY|COCKCROFT-GAULT FORMULA||NA|Y|Y|U|||U|4||88||BLINDED TREATMENT|1973-07-29|1967-01-17|||||1967-08-14||1962-11-17|NA|1969-03-06
TRIAL STUDY 134XCP|LB|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|2||||HEINZRBC|HEINZ BODIES/ERYTHROCYTES|||||||ML/KG/DAY|||||||POSITIVE||PG/L||||ABNORMAL|NOT DONE||||COLOSTRUM|PARAFFIN-EMBEDDED|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|MDRD 5 VARIABLE FORMULA||NA|Y|N|Y|||N|4||88||INDUCTION TREATMENT|1960-01-19|1966-01-14|||||1960-06-22||1960-09-19|NA|1971-07-23
TRIAL STUDY 134XCP|LB|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|1||||PLTAGAMP|PLATELET AGGREGATION AMPLITUDE|||||||L/S|||||||TRACE||MG/CM2||||LOW|NOT DONE||||BILE|ICTERIC|N|SURFACE PLASMON RESONANCE|MDRD ENZYMATIC JAPANESE FORMULA||N|U|U|NA|||NA|5||7||SCREENING|1965-11-27|1972-04-02|||||1963-04-30||1964-11-03|N|1965-02-08
TRIAL STUDY 134XCP|LB|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|2||||TLYMXM|T-LYMPHOCYTE CROSSMATCH|||||||FIU|||||||POSITIVE||USIEMENS||||HIGH|NOT DONE||||TISSUE|CALCIFIED|U|GEL ELECTROPHORESIS|FIBROMETER FORMULA||NA|N|U|NA|||N|5||7||WASHOUT|1967-11-25|1968-06-11|||||1961-12-17||1966-10-07|Y|1966-02-12
TRIAL STUDY 134XCP|LB|D19D43A5-DFE6-415D-86B7-6A767A357BC9|1||||ANIONG4|ANION GAP 4|||||||MMHG/L/MIN|||||||INDETERMINATE||CP||||ABNORMAL|NOT DONE||||ERYTHROCYTES|SOLIDIFIED|Y|HPLC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|Y|U|||Y|1||38||FOLLOW-UP|1972-11-09|1966-02-24|||||1972-09-13||1969-11-23|NA|1966-05-02
TRIAL STUDY 134XCP|LB|D19D43A5-DFE6-415D-86B7-6A767A357BC9|2||||APPA|AMYLOID ALPHA PRECURSOR PROTEIN|||||||FINGERTIP UNIT|||||||TRACE||G/DL||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|AUTOLYZED|NA|WRIGHT-GIEMSA STAIN|FIBROTEST FORMULA||NA|N|N|U|||NA|1||38||TREATMENT|1964-03-18|1972-11-07|||||1961-07-11||1960-10-10|N|1972-11-25
TRIAL STUDY 134XCP|LB|D19D43A5-DFE6-415D-86B7-6A767A357BC9|1||||APOC1|APOLIPOPROTEIN CI|||||||KM|||||||INDETERMINATE||MBQ/UL||||HIGH|NOT DONE||||SERUM OR PLASMA OR BLOOD|NON-HEMOLYZED|N|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|NASH FIBROSURE FORMULA||Y|U|Y|NA|||U|2||58||OPEN LABEL TREATMENT|1963-03-14|1969-04-09|||||1966-10-06||1964-02-22|NA|1967-02-14
TRIAL STUDY 134XCP|LB|D19D43A5-DFE6-415D-86B7-6A767A357BC9|2||||CYSTHION|CYSTATHIONINE|||||||TESLA|||||||TRACE||CMHG||||NORMAL|NOT DONE||||ARTERIAL CORD BLOOD|LIPEMIC|Y|MIGET|FIBROMETER FORMULA||N|N|Y|Y|||N|2||58||CONTINUATION TREATMENT|1967-05-02|1969-11-02|||||1970-08-16||1969-11-22|NA|1960-04-09
TRIAL STUDY 134XCP|LB|D19D43A5-DFE6-415D-86B7-6A767A357BC9|1||||INTLK23|INTERLEUKIN 23|||||||TABLET|||||||TRACE||10^7/L||||HIGH|NOT DONE||||EXPIRED AIR|AGGLUTINATED|NA|ACCELERATOR MASS SPECTROMETRY|GMI MMOL/MOL FORMULA||NA|N|U|NA|||NA|3||39||FOLLOW-UP|1967-07-08|1966-04-19|||||1964-02-10||1964-05-22|U|1968-09-23
TRIAL STUDY 134XCP|LB|D19D43A5-DFE6-415D-86B7-6A767A357BC9|2||||NOHDLHDL|NON-HDL CHOLESTEROL/HDL CHOLESTEROL|||||||SCOOPFUL|||||||NEGATIVE||UL/ML||||NORMAL|NOT DONE||||SPUTUM|PARAFFIN-EMBEDDED|N|DIFFUSION WEIGHTED MRI|FIBROTEST FORMULA||U|NA|Y|U|||Y|3||39||OPEN LABEL TREATMENT|1964-11-29|1967-07-17|||||1972-08-13||1968-09-05|U|1970-07-23
TRIAL STUDY 134XCP|LB|D19D43A5-DFE6-415D-86B7-6A767A357BC9|1||||CHYTRYP|CHYMOTRYPSIN|||||||10^3/HPF|||||||INDETERMINATE||L/H/M2||||HIGH|NOT DONE||||RETICULOCYTES|CALCIFIED|NA|INDIRECT IMMUNOFLUORESCENCE|CKD-EPI FORMULA||Y|Y|NA|NA|||U|4||88||CONTINUATION TREATMENT|1965-02-19|1961-02-02|||||1969-11-29||1970-11-15|Y|1972-10-19
TRIAL STUDY 134XCP|LB|D19D43A5-DFE6-415D-86B7-6A767A357BC9|2||||HYDROGEN|HYDROGEN|||||||KIT|||||||INDETERMINATE||BAG||||HIGH|NOT DONE||||VENOUS BLOOD|CONTAMINATED|Y|POPULATION SEQUENCING|MDRD 5 VARIABLE FORMULA||NA|Y|U|NA|||U|4||88||OPEN LABEL TREATMENT|1967-02-07|1969-05-09|||||1961-12-16||1961-11-01|N|1968-03-19
TRIAL STUDY 134XCP|LB|D19D43A5-DFE6-415D-86B7-6A767A357BC9|1||||ANCIGAB|ANTI-NEUTROPHIL CYTOPLASMIC IGG ANTIBODY|||||||U/G/H|||||||TRACE||CUP EQ||||LOW|NOT DONE||||CAPILLARY BLOOD|CLOTTED|NA|LASER CAPTURE MICRODISSECTION|FIBROMETER FORMULA||Y|Y|N|Y|||Y|5||7||OBSERVATION|1970-10-20|1970-09-06|||||1973-09-04||1972-12-14|Y|1961-05-19
TRIAL STUDY 134XCP|LB|D19D43A5-DFE6-415D-86B7-6A767A357BC9|2||||FACTV|FACTOR V|||||||TRANSDUCING UNIT/ML|||||||NEGATIVE||/7.5 ML||||HIGH|NOT DONE||||SKELETAL MUSCLE TISSUE|CALCIFIED|N|DNA MICROARRAY|FIBROMETER FORMULA||Y|NA|U|N|||N|5||7||OBSERVATION|1972-02-04|1961-12-18|||||1971-10-13||1961-06-16|Y|1966-08-23
TRIAL STUDY 134XCP|LB|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|1||||MBP|MYELIN BASIC PROTEIN|||||||IU/G|||||||NEGATIVE||CI||||ABNORMAL|NOT DONE||||CEREBROSPINAL FLUID|DRIED|U|MAPH|CKD-EPI FORMULA||Y|NA|Y|Y|||U|1||38||TREATMENT|1968-02-06|1965-10-31|||||1972-08-17||1964-09-06|U|1962-02-11
TRIAL STUDY 134XCP|LB|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|2||||METANEPH|METANEPHRINE|||||||UOSM|||||||INVALID||GLOBULE||||LOW|NOT DONE||||EMESIS|NON-HEMOLYZED|Y|NO INFORMATION|CKD-EPI CYSTATIN C FORMULA||Y|N|N|U|||U|1||38||INDUCTION TREATMENT|1965-05-24|1967-09-02|||||1964-04-26||1972-06-13|N|1968-03-21
TRIAL STUDY 134XCP|LB|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|1||||SODMEXR|SODIUM EXCRETION RATE|||||||EU|||||||NEGATIVE||CI||||ABNORMAL|NOT DONE||||VENOUS CORD BLOOD|HEMOLYZED|Y|GC/MS|MDRD FORMULA||U|NA|NA|U|||Y|2||58||BLINDED TREATMENT|1969-10-18|1961-12-17|||||1971-09-10||1964-11-15|NA|1968-05-14
TRIAL STUDY 134XCP|LB|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|2||||HLAAMSC|HLA-A MISMATCH COUNT|||||||ML/MIN|||||||NEGATIVE||BP||||ABNORMAL|NOT DONE||||STRIATED MUSCLE TISSUE|NON-HEMOLYZED|U|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE FORMULA||Y|Y|Y|U|||N|2||58||RUN-IN|1968-01-02|1961-06-27|||||1964-02-04||1962-06-11|U|1965-02-08
TRIAL STUDY 134XCP|LB|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|1||||APLIGGAB|ANTI-PHOSPHOLIPID IGG ANTIBODY|||||||CM/S|||||||INVALID||/MIN||||LOW|NOT DONE||||TRANSUDATE|HEMOLYZED|U|DXA SCAN|MDRD 6 VARIABLE FORMULA||NA|U|U|NA|||U|3||39||BLINDED TREATMENT|1967-10-07|1960-07-06|||||1965-04-21||1972-02-20|NA|1966-01-21
TRIAL STUDY 134XCP|LB|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|2||||GALM|GALACTOSE MUTAROTASE|||||||DNA COPIES/ML|||||||BORDERLINE||LINEAR FT*LB||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|CONTAMINATED|NA|SURFACE PLASMON RESONANCE|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|NA|U|||U|3||39||BLINDED TREATMENT|1964-11-27|1962-05-15|||||1964-09-29||1968-02-01|Y|1971-07-02
TRIAL STUDY 134XCP|LB|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|1||||ELA2PMN|NEUTROPHIL ELASTASE, POLYMORPHONUCLEAR|||||||GBQ/UG|||||||BORDERLINE||ML/G/MIN||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|DRIED|NA|TELLER ACUITY CARDS|HEPASCORE FORMULA||N|Y|NA|Y|||Y|4||88||CONTINUATION TREATMENT|1966-12-23|1970-06-19|||||1969-04-13||1972-02-28|Y|1969-03-13
TRIAL STUDY 134XCP|LB|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|2||||CONDUCTU|URINE CONDUCTIVITY|||||||BU/ML|||||||INDETERMINATE||LOG EID 50/DOSE||||LOW|NOT DONE||||DISCHARGE|CONTAMINATED|N|FLUORESCENT MICROSCOPY|GMI MMOL/MOL FORMULA||Y|U|U|NA|||U|4||88||CONTINUATION TREATMENT|1971-04-03|1962-03-10|||||1965-11-08||1970-12-12|Y|1971-10-29
TRIAL STUDY 134XCP|LB|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|1||||CARNTEXR|CARNITINE EXCRETION RATE|||||||UMOL/KG/MIN|||||||INVALID||MOL/MOL||||NORMAL|NOT DONE||||ENDOMETRIAL TISSUE|PARAFFIN-EMBEDDED|N|PHASE CONTRAST MICROSCOPY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|NA|NA|U|||NA|5||7||SCREENING|1961-10-05|1967-05-10|||||1960-05-25||1971-12-31|U|1973-09-01
TRIAL STUDY 134XCP|LB|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|2||||LYMCLFLE|LYMPHOCYTES, CLEFTED/LEUKOCYTES|||||||G/KG/DAY|||||||BORDERLINE||LOG10 ELISA UNIT/DOSE||||LOW|NOT DONE||||AMNIOTIC FLUID|AUTOLYZED|N|TARGETED TRANSCRIPTOME SEQUENCING|FIBROSIS 4 FORMULA||U|NA|Y|U|||NA|5||7||OPEN LABEL TREATMENT|1963-05-13|1967-11-15|||||1973-07-14||1962-05-25|N|1972-11-24
TRIAL STUDY 134XCP|LB|7D307F63-4A25-4E7D-9980-16764AE5C4A4|1||||PAF|PLATELET ACTIVATING FACTOR|||||||MG/CM2|||||||BORDERLINE||10^6/G||||NORMAL|NOT DONE||||SPUTUM|CLOTTED|NA|REVERSE TRANSCRIPTASE PCR|FIBROTEST FORMULA||NA|NA|U|U|||NA|1||38||SCREENING|1962-10-13|1960-06-13|||||1964-08-08||1966-05-22|Y|1964-07-23
TRIAL STUDY 134XCP|LB|7D307F63-4A25-4E7D-9980-16764AE5C4A4|2||||NAGCREAT|N-ACETYL GLUCOSAMIDE/CREATININE|||||||U/KG|||||||INDETERMINATE||CUP EQ||||ABNORMAL|NOT DONE||||CAPILLARY PLASMA|UNEXPECTED ODOR|U|CAPILLARY ELECTROPHORESIS|NASH FIBROSURE FORMULA||N|N|Y|NA|||N|1||38||INDUCTION TREATMENT|1961-04-13|1965-02-08|||||1961-10-17||1970-05-13|U|1972-03-08
TRIAL STUDY 134XCP|LB|7D307F63-4A25-4E7D-9980-16764AE5C4A4|1||||LYMCE|LYMPHOCYTES/TOTAL CELLS|||||||PMOL/10^9 CELLS|||||||BORDERLINE||IU/KG/H||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|CONTAMINATED|Y|FLUORIMETRY|GMI MMOL/MOL FORMULA||U|NA|NA|N|||U|2||58||OPEN LABEL TREATMENT|1971-10-11|1965-06-07|||||1963-12-31||1968-06-21|NA|1963-04-21
TRIAL STUDY 134XCP|LB|7D307F63-4A25-4E7D-9980-16764AE5C4A4|2||||B2MICG|BETA-2 MICROGLOBULIN|||||||GBQ/G|||||||INVALID||UL||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|SOLIDIFIED|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|N|NA|Y|||NA|2||58||BASELINE|1963-02-05|1963-12-24|||||1970-01-28||1969-10-27|N|1970-01-05
TRIAL STUDY 134XCP|LB|7D307F63-4A25-4E7D-9980-16764AE5C4A4|1||||CSFAT|FATTY CASTS|||||||MHZ|||||||INVALID||DAYS/WK||||LOW|NOT DONE||||PUS|SOLIDIFIED|U|IMMUNOCHEMILUMINOMETRIC ASSAY|ASH FIBROSURE FORMULA||U|NA|Y|Y|||NA|3||39||LONG-TERM FOLLOW-UP|1968-09-21|1960-10-20|||||1965-02-09||1961-11-30|NA|1970-01-30
TRIAL STUDY 134XCP|LB|7D307F63-4A25-4E7D-9980-16764AE5C4A4|2||||PYK|PYRUVATE KINASE|||||||UMOL/L/MIN|||||||INDETERMINATE||TSP||||ABNORMAL|NOT DONE||||URINE SEDIMENT|AUTOLYZED|Y|SLIT LAMP PHOTOGRAPHY|CKD-EPI CYSTATIN C FORMULA||NA|Y|U|NA|||U|3||39||FOLLOW-UP|1964-08-10|1972-08-20|||||1966-05-24||1962-11-17|U|1972-07-09
TRIAL STUDY 134XCP|LB|7D307F63-4A25-4E7D-9980-16764AE5C4A4|1||||LGLUCLE|LARGE UNSTAINED CELLS/LEUKOCYTES|||||||LOG10 CFU/G|||||||NEGATIVE||BQ/UG||||NORMAL|NOT DONE||||PLEURAL TISSUE|DRIED|N|ICC|HEPASCORE FORMULA||N|NA|N|NA|||U|4||88||RUN-IN|1971-11-23|1971-03-28|||||1972-01-09||1965-05-27|NA|1961-04-25
TRIAL STUDY 134XCP|LB|7D307F63-4A25-4E7D-9980-16764AE5C4A4|2||||PROTSFR|PROTEIN S, FREE|||||||MOL|||||||POSITIVE||LOZENGE||||HIGH|NOT DONE||||ENDOTRACHEAL FLUID|DRIED|NA|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|MDRD FORMULA||N|N|N|NA|||NA|4||88||SCREENING|1973-08-20|1972-07-15|||||1965-07-26||1971-03-28|N|1972-09-04
TRIAL STUDY 134XCP|LB|7D307F63-4A25-4E7D-9980-16764AE5C4A4|1||||HYDROGEN|HYDROGEN|||||||CI/KG|||||||INVALID||BU/ML||||ABNORMAL|NOT DONE||||AQUEOUS HUMOR|FRESH|NA|MANUAL CLOT DETECTION|GMI MMOL/MOL FORMULA||U|Y|Y|NA|||N|5||7||WASHOUT|1964-03-27|1967-10-21|||||1969-04-23||1968-10-11|NA|1964-09-08
TRIAL STUDY 134XCP|LB|7D307F63-4A25-4E7D-9980-16764AE5C4A4|2||||NRDZPM|NORDAZEPAM|||||||10^6/L|||||||INVALID||IN2||||LOW|NOT DONE||||PUS|DRIED|NA|KINYOUN STAIN|MDRD ENZYMATIC JAPANESE FORMULA||N|NA|U|Y|||N|5||7||BASELINE|1972-05-24|1960-04-16|||||1964-01-25||1964-10-30|NA|1970-08-26
TRIAL STUDY 134XCP|LB|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|1||||MCSF|MACROPHAGE COLONY STIMULATING FACTOR|||||||PT_US|||||||NEGATIVE||LOG10 CFU/G||||ABNORMAL|NOT DONE||||EXUDATE|UNEXPECTED ODOR|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|CKD-EPI CYSTATIN C FORMULA||Y|NA|NA|U|||Y|1||38||SCREENING|1969-07-03|1966-04-03|||||1963-07-21||1964-04-15|Y|1960-05-21
TRIAL STUDY 134XCP|LB|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|2||||INLCLR|INULIN CLEARANCE|||||||ABSORBANCE U/MIN|||||||INDETERMINATE||UG/ANIMAL||||NORMAL|NOT DONE||||ABSCESS FLUID|CALCIFIED|N|FLUORESCEIN STAIN|MDRD FORMULA||NA|N|U|N|||Y|1||38||OBSERVATION|1973-07-20|1963-06-18|||||1966-07-01||1973-04-28|U|1971-08-08
TRIAL STUDY 134XCP|LB|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|1||||INTLK1RA|INTERLEUKIN 1 RECEPTOR ANTAGONIST|||||||MG/G/MIN|||||||BORDERLINE||DNA COPIES/ML||||HIGH|NOT DONE||||PLASMA|CLOTTED|N|APPLANATION TONOMETRY|MDRD 6 VARIABLE FORMULA||U|Y|Y|NA|||U|2||58||OBSERVATION|1968-02-04|1969-04-02|||||1962-06-19||1966-05-31|Y|1968-08-29
TRIAL STUDY 134XCP|LB|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|2||||VAL|VALINE|||||||UG/M2/DAY|||||||POSITIVE||10^6 U||||ABNORMAL|NOT DONE||||ABSCESS FLUID|NON-HEMOLYZED|NA|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|MDRD FORMULA||Y|NA|Y|NA|||Y|2||58||OPEN LABEL TREATMENT|1961-02-24|1965-11-04|||||1961-11-12||1961-07-14|N|1966-01-16
TRIAL STUDY 134XCP|LB|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|1||||BILDIR|DIRECT BILIRUBIN|||||||MET|||||||INVALID||CP||||LOW|NOT DONE||||INFRANATANT, PLASMA|CALCIFIED|NA|CONTACT SPECULAR MICROSCOPY|ASH FIBROSURE FORMULA||N|Y|NA|N|||N|3||39||INDUCTION TREATMENT|1961-11-06|1962-03-04|||||1971-01-16||1972-01-19|N|1968-05-20
TRIAL STUDY 134XCP|LB|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|2||||PO2FIO2|PP ARTERIAL O2/FRACTION INSPIRED O2|||||||OHM|||||||BORDERLINE||MU/G||||HIGH|NOT DONE||||INFRANATANT, PLASMA|THAWED|Y|REVERSE TRANSCRIPTASE PCR|MDRD 5 VARIABLE FORMULA||Y|N|NA|N|||Y|3||39||LONG-TERM FOLLOW-UP|1961-10-19|1973-06-07|||||1970-06-22||1967-05-10|Y|1971-10-11
TRIAL STUDY 134XCP|LB|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|1||||HBA2PHB|HEMOGLOBIN A2 PRIME/TOTAL HEMOGLOBIN|||||||/MONTH|||||||NEGATIVE||MMHG||||LOW|NOT DONE||||MECONIUM|UNEXPECTED ODOR|NA|HPLC/IEX|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|Y|Y|Y|||N|4||88||BASELINE|1969-07-18|1962-12-20|||||1968-10-15||1963-05-07|N|1960-11-07
TRIAL STUDY 134XCP|LB|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|2||||DOPAMINE|DOPAMINE|||||||BOLUS|||||||INDETERMINATE||UG/G/H||||LOW|NOT DONE||||AQUEOUS HUMOR|CLOTTED|Y|RADIOGRAPHY|MDRD 5 VARIABLE FORMULA||Y|Y|Y|NA|||U|4||88||CONTINUATION TREATMENT|1963-05-15|1968-12-07|||||1972-02-21||1966-01-17|Y|1968-11-03
TRIAL STUDY 134XCP|LB|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|1||||C165880|D. PTERONYSSINUS IGE AB RAST SCORE|||||||CG|||||||INDETERMINATE||BQ||||ABNORMAL|NOT DONE||||DIALYSIS FLUID, PERITONEAL|LIPEMIC|NA|FLOW MICROSCOPY|CKD-EPI CREATININE FORMULA||N|N|U|Y|||Y|5||7||TREATMENT|1964-08-13|1971-11-23|||||1972-07-09||1967-07-23|U|1960-11-06
TRIAL STUDY 134XCP|LB|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|2||||CRLPLSMN|CERULOPLASMIN|||||||NMOL/L|||||||INDETERMINATE||NCI||||LOW|NOT DONE||||TRANSUDATE|FROZEN|U|HIGH RESOLUTION MELT ANALYSIS|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|U|U|NA|||U|5||7||BASELINE|1964-02-05|1972-01-13|||||1973-02-20||1964-04-15|NA|1968-11-15
TRIAL STUDY 134XCP|LB|F4718E0D-4DD9-442E-8907-076551C83AEE|1||||G6PDA|GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACT|||||||U/DL|||||||TRACE||PMOL/10^9 CELLS||||ABNORMAL|NOT DONE||||BUFFY COAT|ROOM TEMPERATURE|Y|DUKE INCISION METHOD|MDRD FORMULA||Y|Y|U|N|||N|1||38||TREATMENT|1973-04-24|1972-03-29|||||1963-01-09||1971-01-12|NA|1969-01-12
TRIAL STUDY 134XCP|LB|F4718E0D-4DD9-442E-8907-076551C83AEE|2||||PRZPM|PRAZEPAM|||||||10^6 ORGANISMS/MG|||||||POSITIVE||ANTI-XA IU||||LOW|NOT DONE||||PLEURAL TISSUE|ROOM TEMPERATURE|NA|NUCLEIC ACID SEQUENCING|NASH FIBROSURE FORMULA||U|Y|NA|Y|||U|1||38||OPEN LABEL TREATMENT|1973-03-22|1962-01-06|||||1968-07-11||1968-08-17|N|1961-02-08
TRIAL STUDY 134XCP|LB|F4718E0D-4DD9-442E-8907-076551C83AEE|1||||NITRATE|NITRATE|||||||10^7 CFU/ML|||||||TRACE||CS||||ABNORMAL|NOT DONE||||VENOUS PLASMA|NON-HEMOLYZED|U|LC/MS/MS|MDRD 4 VARIABLE FORMULA||NA|N|U|N|||NA|2||58||BLINDED TREATMENT|1964-09-16|1967-01-24|||||1964-12-15||1962-12-31|NA|1960-06-01
TRIAL STUDY 134XCP|LB|F4718E0D-4DD9-442E-8907-076551C83AEE|2||||PGES|PROSTAGLANDIN E SYNTHASE|||||||MMOL|||||||NEGATIVE||10^6/HPF||||NORMAL|NOT DONE||||TISSUE|DRIED|Y|IHC|FIBROSIS 4 FORMULA||NA|Y|NA|U|||N|2||58||OBSERVATION|1971-11-17|1965-03-29|||||1967-03-18||1969-11-12|N|1970-09-27
TRIAL STUDY 134XCP|LB|F4718E0D-4DD9-442E-8907-076551C83AEE|1||||CENTROAB|CENTROMERE B ANTIBODIES|||||||10^4 CFU/ML|||||||POSITIVE||UMOL/L||||ABNORMAL|NOT DONE||||SERUM|ICTERIC|U|OPHTHALMOSCOPY|MDRD ENZYMATIC FORMULA||NA|U|NA|N|||N|3||39||OBSERVATION|1971-09-03|1967-05-14|||||1969-10-02||1971-09-09|U|1966-07-14
TRIAL STUDY 134XCP|LB|F4718E0D-4DD9-442E-8907-076551C83AEE|2||||HYPGST17|17-HYDROXYPROGESTERONE|||||||ML/CAGE/DAY|||||||INDETERMINATE||UV||||NORMAL|NOT DONE||||PLASMA ULTRAFILTRATE|THAWED|NA|MULTI-SLICE SPIRAL CT|MDRD 5 VARIABLE FORMULA||U|Y|U|N|||NA|3||39||TREATMENT|1964-01-22|1973-03-17|||||1973-03-30||1964-07-18|N|1964-05-28
TRIAL STUDY 134XCP|LB|F4718E0D-4DD9-442E-8907-076551C83AEE|1||||SULFATE|SULFATE|||||||/200 HPFS|||||||BORDERLINE||MM/2H||||NORMAL|NOT DONE||||CERUMEN|GELLED|NA|WRIGHT-GIEMSA STAIN|MDRD 6 VARIABLE FORMULA||N|U|U|Y|||N|4||88||LONG-TERM FOLLOW-UP|1961-04-02|1970-12-03|||||1963-07-02||1960-11-06|Y|1972-09-19
TRIAL STUDY 134XCP|LB|F4718E0D-4DD9-442E-8907-076551C83AEE|2||||OH8DXG2|8-HYDROXY-2'-DEOXYGUANOSINE|||||||KIU|||||||TRACE||UG/G/MIN||||NORMAL|NOT DONE||||PERITONEAL FLUID|ICTERIC|N|COMPLEMENT FIXATION|MDRD 6 VARIABLE FORMULA||U|Y|NA|N|||Y|4||88||BLINDED TREATMENT|1965-08-17|1960-08-26|||||1969-09-11||1970-05-02|NA|1967-01-29
TRIAL STUDY 134XCP|LB|F4718E0D-4DD9-442E-8907-076551C83AEE|1||||APOA|APOLIPOPROTEIN A|||||||GPS U|||||||INVALID||/40 HPFS||||ABNORMAL|NOT DONE||||NAIL|CLOTTED|U|INFRARED SPECTROMETRY|MDRD 5 VARIABLE FORMULA||N|U|U|N|||U|5||7||LONG-TERM FOLLOW-UP|1969-06-07|1968-08-14|||||1967-09-22||1966-05-15|Y|1967-08-02
TRIAL STUDY 134XCP|LB|F4718E0D-4DD9-442E-8907-076551C83AEE|2||||CELLS|CELLS|||||||APL U/ML|||||||BORDERLINE||M3||||NORMAL|NOT DONE||||BONE MARROW|AUTOLYZED|NA|GC/MS-EI|MDRD 5 VARIABLE FORMULA||Y|Y|N|N|||NA|5||7||INDUCTION TREATMENT|1972-08-30|1970-10-23|||||1966-07-11||1968-11-19|Y|1970-09-02
TRIAL STUDY 134XCP|LB|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|1||||ERCEMIDX|ERYTHROID MATURATION INDEX|||||||PIXELS/IN|||||||BORDERLINE||IU/G||||ABNORMAL|NOT DONE||||AMNIOTIC FLUID|CLOTTED|N|MALDI|FIBROTEST FORMULA||N|U|N|NA|||U|1||38||FOLLOW-UP|1965-04-02|1966-09-25|||||1965-05-01||1964-06-08|NA|1968-03-24
TRIAL STUDY 134XCP|LB|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|2||||HGBA|HEMOGLOBIN A|||||||MOL/L|||||||INDETERMINATE||MG||||HIGH|NOT DONE||||PLASMA|CLOTTED|U|COLORIMETRY|MDRD 4 VARIABLE FORMULA||N|N|N|Y|||NA|1||38||RUN-IN|1960-06-03|1961-08-19|||||1962-02-13||1967-10-19|U|1962-01-16
TRIAL STUDY 134XCP|LB|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|1||||LKM1AB|LIVER KIDNEY MICROSOMAL TYPE 1 ANTIBODY|||||||10^4 CFU|||||||NEGATIVE||NMOL/ML/MIN||||ABNORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED|Y|PH METER MEASUREMENT METHOD|CKD-EPI CREATININE FORMULA||NA|U|Y|Y|||U|2||58||INDUCTION TREATMENT|1970-04-25|1961-07-17|||||1967-10-26||1961-06-28|N|1968-06-12
TRIAL STUDY 134XCP|LB|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|2||||TTGIGMAB|TISSUE TRANSGLUTAMINASE IGM ANTIBODY|||||||/CMH2O|||||||NEGATIVE||UG/KG||||LOW|NOT DONE||||ALVEOLAR AIR|AGGLUTINATED|Y|PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD 4 VARIABLE FORMULA||Y|N|N|U|||U|2||58||CONTINUATION TREATMENT|1970-05-21|1967-03-11|||||1969-04-13||1960-01-07|NA|1962-02-24
TRIAL STUDY 134XCP|LB|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|1||||UBQN|UBIQUITIN PROTEIN|||||||TORR|||||||TRACE||CIGARETTE||||LOW|NOT DONE||||SEMINAL FLUID|DRIED|Y|MACRO BROTH DILUTION|CKD-EPI CYSTATIN C FORMULA||Y|Y|NA|U|||Y|3||39||LONG-TERM FOLLOW-UP|1963-06-13|1965-09-14|||||1973-07-31||1967-03-11|U|1968-09-25
TRIAL STUDY 134XCP|LB|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|2||||FLUOXTN|FLUOXETINE|||||||VG/KG|||||||NEGATIVE||UG/H||||LOW|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|CONCENTRATED|U|MRI WITHOUT CONTRAST|GMI MMOL/MOL FORMULA||U|Y|Y|NA|||U|3||39||OBSERVATION|1964-12-07|1960-06-05|||||1968-05-16||1961-09-10|N|1966-05-23
TRIAL STUDY 134XCP|LB|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|1||||BCEFNCTN|BETA-CELL FUNCTION|||||||NKAT|||||||POSITIVE||/10^3||||HIGH|NOT DONE||||PUS|AGGLUTINATED|NA|CHROMATOGRAPHY|COCKCROFT-GAULT FORMULA||U|U|Y|NA|||NA|4||88||OPEN LABEL TREATMENT|1968-10-01|1971-08-06|||||1973-03-18||1968-02-23|N|1963-07-21
TRIAL STUDY 134XCP|LB|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|2||||NEOPTERN|NEOPTERIN|||||||NEBULE|||||||NEGATIVE||PMOL/G||||ABNORMAL|NOT DONE||||ATHEROSCLEROTIC PLAQUE|CONTAMINATED|Y|FISH|MDRD 4 VARIABLE FORMULA||Y|NA|NA|N|||NA|4||88||SCREENING|1968-12-11|1962-04-14|||||1965-11-08||1964-07-01|NA|1969-08-20
TRIAL STUDY 134XCP|LB|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|1||||PCP|PHENCYCLIDINE|||||||/2000 RBC|||||||INDETERMINATE||PG/CELL||||NORMAL|NOT DONE||||CELL PELLET|FROZEN|Y|INDIA INK STAIN|MDRD ENZYMATIC JAPANESE FORMULA||NA|Y|N|N|||Y|5||7||OPEN LABEL TREATMENT|1972-07-31|1972-10-13|||||1972-10-17||1963-01-16|NA|1964-10-18
TRIAL STUDY 134XCP|LB|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|2||||TNF12S|SOLUBLE TNF SUPERFAMILY MEMBER 12|||||||UG/M2/H|||||||BORDERLINE||ML/BREATH||||HIGH|NOT DONE||||AQUEOUS HUMOR|FRESH|Y|NEURAMINIDASE INHIBITION ASSAY|HEPASCORE FORMULA||Y|U|NA|NA|||NA|5||7||RUN-IN|1968-02-05|1961-06-04|||||1967-10-30||1967-12-26|NA|1963-03-29
TRIAL STUDY 134XCP|LB|E86F996D-3A96-4C36-82B2-1AC4B4906F49|1||||AMPEA|ALPHA-METHYLPHENETHYLAMINE|||||||MG/M2|||||||INDETERMINATE||MG/ML/MIN||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|REFRIGERATED|Y|CONGO RED STAIN|CKD-EPI FORMULA||U|NA|N|Y|||N|1||38||TREATMENT|1968-02-19|1970-08-05|||||1966-05-31||1961-05-16|N|1963-05-15
TRIAL STUDY 134XCP|LB|E86F996D-3A96-4C36-82B2-1AC4B4906F49|2||||ILE|ISOLEUCINE|||||||UM/S|||||||INVALID||LOG10 TCID 50/DOSE||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|NON-HEMOLYZED|NA|OPTICAL DENSITY MEASUREMENT|MDRD ENZYMATIC JAPANESE FORMULA||Y|NA|N|Y|||NA|1||38||BASELINE|1967-10-09|1966-03-23|||||1966-03-17||1964-06-10|Y|1966-04-21
TRIAL STUDY 134XCP|LB|E86F996D-3A96-4C36-82B2-1AC4B4906F49|1||||GOLD|GOLD|||||||OI50|||||||NEGATIVE||UG/ML/H||||ABNORMAL|NOT DONE||||SPERMATOZOON|NON-HEMOLYZED|U|IMMUNOCHEMILUMINOMETRIC ASSAY|CKD-EPI CYSTATIN C FORMULA||NA|N|U|N|||Y|2||58||INDUCTION TREATMENT|1961-10-18|1966-04-19|||||1964-09-01||1962-04-22|U|1960-03-29
TRIAL STUDY 134XCP|LB|E86F996D-3A96-4C36-82B2-1AC4B4906F49|2||||PO2FIO2|PP ARTERIAL O2/FRACTION INSPIRED O2|||||||10^9/G|||||||BORDERLINE||AMU||||LOW|NOT DONE||||COLOSTRUM|ICTERIC|Y|CHROMATOGRAPHY|MDRD 6 VARIABLE FORMULA||NA|N|NA|Y|||Y|2||58||WASHOUT|1973-06-04|1966-07-06|||||1970-02-07||1969-11-07|N|1969-12-13
TRIAL STUDY 134XCP|LB|E86F996D-3A96-4C36-82B2-1AC4B4906F49|1||||IMMGLCFR|IMMUNOGLOBULIN LIGHT CHAINS, FREE|||||||10^3 COPIES/ML|||||||INDETERMINATE||M/SEC2||||NORMAL|NOT DONE||||EXPIRED AIR|LACTESCENT|Y|DYNAMOMETRY|CKD-EPI CREATININE FORMULA||Y|Y|Y|U|||U|3||39||BLINDED TREATMENT|1973-06-22|1966-05-28|||||1964-07-15||1960-09-18|N|1960-12-04
TRIAL STUDY 134XCP|LB|E86F996D-3A96-4C36-82B2-1AC4B4906F49|2||||VTD2D3IT|25-HYDROXYVIT D2 + 25-HYDROXYVIT D3|||||||10^8/L|||||||INDETERMINATE||G||||ABNORMAL|NOT DONE||||MUCUS|FROZEN|NA|RADIATION DOSIMETRY|CKD-EPI CREATININE-CYSTATIN C FORMULA||Y|N|U|N|||NA|3||39||TREATMENT|1973-02-11|1968-12-04|||||1964-07-30||1966-07-14|NA|1969-05-20
TRIAL STUDY 134XCP|LB|E86F996D-3A96-4C36-82B2-1AC4B4906F49|1||||DSVLFXN|DESVENLAFAXINE|||||||UM/DAY|||||||INDETERMINATE||U||||LOW|NOT DONE||||ADIPOSE TISSUE|LIPEMIC|NA|SINGLE-MOLECULE ARRAY|FIBROSIS 4 FORMULA||U|NA|U|N|||U|4||88||WASHOUT|1971-02-23|1964-09-15|||||1972-03-02||1970-04-22|N|1965-09-22
TRIAL STUDY 134XCP|LB|E86F996D-3A96-4C36-82B2-1AC4B4906F49|2||||GLOBB1|BETA-1 GLOBULIN|||||||DL|||||||POSITIVE||FMOL/G||||NORMAL|NOT DONE||||AQUEOUS HUMOR|HEMOLYZED|NA|MICROBIAL CONCENTRATION|MDRD 6 VARIABLE FORMULA||NA|Y|U|U|||Y|4||88||BLINDED TREATMENT|1968-05-07|1964-05-15|||||1968-11-01||1967-01-27|U|1962-06-30
TRIAL STUDY 134XCP|LB|E86F996D-3A96-4C36-82B2-1AC4B4906F49|1||||ANCPNCAB|NEUTROPHIL CYTOPLASMIC AB, PERINUCLEAR|||||||NG/DAY|||||||BORDERLINE||PG/CELL||||HIGH|NOT DONE||||SOFT TISSUE|PARAFFIN-EMBEDDED|N|MS/MS|FIBROTEST FORMULA||NA|N|N|U|||U|5||7||TREATMENT|1970-09-24|1972-01-05|||||1961-08-30||1966-06-21|Y|1963-11-04
TRIAL STUDY 134XCP|LB|E86F996D-3A96-4C36-82B2-1AC4B4906F49|2||||CRNTESTR|CARNITINE ESTERS|||||||SUPPOSITORY|||||||TRACE||ML/CAGE||||NORMAL|NOT DONE||||GASTRIC CONTENTS|NON-HEMOLYZED|Y|STATIC PERIMETRY|FIBROMETER FORMULA||N|Y|N|U|||NA|5||7||FOLLOW-UP|1965-04-08|1967-12-04|||||1971-06-05||1968-11-12|U|1970-08-04
TRIAL STUDY 134XCP|LB|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|1||||BLASTLE|BLASTS/LEUKOCYTES|||||||10^3/L|||||||BORDERLINE||U/DL||||LOW|NOT DONE||||PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH|Y|ALCIAN BLUE STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|Y|NA|NA|||U|1||38||BASELINE|1968-04-03|1963-06-01|||||1968-08-10||1965-12-21|U|1970-06-05
TRIAL STUDY 134XCP|LB|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|2||||HDLCLDLC|HDL CHOLESTEROL/LDL CHOLESTEROL|||||||MG2/DL2|||||||NEGATIVE||MMOL/DAY||||LOW|NOT DONE||||PERSPIRATION|DRIED|Y|ICC|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|Y|N|U|||N|1||38||BLINDED TREATMENT|1960-03-30|1961-05-07|||||1971-07-01||1971-10-28|U|1968-11-06
TRIAL STUDY 134XCP|LB|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|1||||LIPASEP|LIPASE, PANCREATIC|||||||MG/DOSE|||||||INDETERMINATE||VG/ML||||NORMAL|NOT DONE||||SUPERNATANT, SERUM|CALCIFIED|N|IMPEDANCE CONDUCTIVITY|FIBROSIS 4 FORMULA||U|N|Y|NA|||NA|2||58||FOLLOW-UP|1969-08-20|1967-07-26|||||1967-03-21||1973-07-18|Y|1965-09-11
TRIAL STUDY 134XCP|LB|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|2||||THCCOOH|11-NOR-DELTA9-THC-9-CARBOXYLIC ACID|||||||PA|||||||POSITIVE||BEAM BREAKS||||NORMAL|NOT DONE||||PLEURAL FLUID|ROOM TEMPERATURE|Y|GC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||NA|N|N|N|||U|2||58||BASELINE|1962-08-24|1961-04-01|||||1960-01-08||1966-07-10|N|1973-01-31
TRIAL STUDY 134XCP|LB|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|1||||C165937|ZEA MAYS IGE AB RAST SCORE|||||||IMPLANT|||||||POSITIVE||DB||||NORMAL|NOT DONE||||ADIPOSE TISSUE|AUTOLYZED|U|GRAM STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||Y|N|U|Y|||NA|3||39||CONTINUATION TREATMENT|1960-10-08|1967-09-14|||||1971-09-11||1970-01-01|Y|1963-01-04
TRIAL STUDY 134XCP|LB|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|2||||GLUCWBE|WHOLE BLOOD EQUIVALENT GLUCOSE|||||||MGEQ|||||||BORDERLINE||/10^4||||ABNORMAL|NOT DONE||||BLOOD|LIPEMIC|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|MDRD FORMULA||NA|Y|Y|U|||U|3||39||RUN-IN|1970-12-08|1963-09-12|||||1969-06-14||1969-10-06|N|1967-04-10
TRIAL STUDY 134XCP|LB|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|1||||INSULINR|INSULIN RESISTANCE|||||||MOL/G|||||||INDETERMINATE||10^3 ORGANISMS/ML||||HIGH|NOT DONE||||CIRCULATING TUMOR CELL|HEMOLYZED|Y|FLUOROSCOPY|CKD-EPI CYSTATIN C FORMULA||N|Y|Y|Y|||U|4||88||CONTINUATION TREATMENT|1963-02-12|1966-09-22|||||1966-01-18||1964-08-27|Y|1964-11-29
TRIAL STUDY 134XCP|LB|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|2||||FLUDOUTE|FLUID OUTPUT, ESTIMATED|||||||IU/DAY|||||||INDETERMINATE||DAYS/WK||||ABNORMAL|NOT DONE||||EPIDERMAL TISSUE|NON-HEMOLYZED|U|HANSEL STAIN|GMI MMOL/MOL FORMULA||Y|NA|U|N|||N|4||88||WASHOUT|1972-10-10|1965-10-24|||||1967-06-10||1964-05-30|NA|1963-10-10
TRIAL STUDY 134XCP|LB|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|1||||SARCOSIN|SARCOSINE|||||||MPS U|||||||TRACE||UG/KG||||LOW|NOT DONE||||DERMAL TISSUE|PARAFFIN-EMBEDDED|NA|SLOAN LETTER EYE CHART 2.5%|MDRD 5 VARIABLE FORMULA||N|U|Y|N|||Y|5||7||CONTINUATION TREATMENT|1966-12-16|1963-03-26|||||1972-04-15||1967-08-31|N|1966-05-10
TRIAL STUDY 134XCP|LB|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|2||||C5B9|COMPLEMENT C5B-9|||||||EJACULATE U|||||||NEGATIVE||UCI/L||||ABNORMAL|NOT DONE||||SKIN TISSUE|CONCENTRATED|NA|CALCULATION|GMI % FORMULA||U|Y|Y|N|||N|5||7||TREATMENT|1969-01-19|1972-06-01|||||1967-12-30||1971-05-24|Y|1963-09-14
TRIAL STUDY 134XCP|LB|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|1||||CYFRA18|CYTOKERATIN 18 FRAGMENT|||||||NL|||||||TRACE||RPM||||ABNORMAL|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FRESH|Y|OSCILLOMETRY|CKD-EPI FORMULA||NA|U|U|U|||N|1||38||INDUCTION TREATMENT|1973-04-23|1970-07-07|||||1968-11-16||1973-08-30|U|1973-06-17
TRIAL STUDY 134XCP|LB|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|2||||SJSSBAB|SJOGRENS SS-B ANTIBODY|||||||HPA|||||||TRACE||MEQ/ML||||HIGH|NOT DONE||||CERVICOVAGINAL SECRETION|CALCIFIED|Y|ULTRASOUND|FIBROTEST FORMULA||NA|U|U|NA|||U|1||38||WASHOUT|1965-07-25|1969-05-20|||||1966-04-12||1962-08-17|Y|1970-11-10
TRIAL STUDY 134XCP|LB|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|1||||APLAB|ANTIPHOSPHOLIPID ANTIBODIES|||||||10^3/HPF|||||||TRACE||MMOL/MOL||||LOW|NOT DONE||||DISCHARGE|PARAFFIN-EMBEDDED|U|DOUBLE IMMUNODIFFUSION|MDRD 4 VARIABLE FORMULA||U|Y|U|N|||U|2||58||OBSERVATION|1964-02-14|1966-08-01|||||1970-12-20||1970-01-01|U|1971-07-31
TRIAL STUDY 134XCP|LB|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|2||||HEXK|HEXOKINASE|||||||MG/KG/H|||||||BORDERLINE||/10^4||||HIGH|NOT DONE||||SUPERNATANT, PLEURAL FLUID|FRESH|NA|ELECTRONEUROGRAPHY|GMI % FORMULA||Y|NA|NA|U|||N|2||58||TREATMENT|1962-04-01|1965-04-05|||||1966-04-27||1969-08-28|N|1966-06-29
TRIAL STUDY 134XCP|LB|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|1||||HYDMRPHN|HYDROMORPHONE|||||||GPELISA UNIT/ML|||||||TRACE||/CMH2O||||LOW|NOT DONE||||CERUMEN|LACTESCENT|N|FREEZING POINT DEPRESSION|MDRD 6 VARIABLE FORMULA||NA|NA|NA|Y|||N|3||39||BLINDED TREATMENT|1960-11-05|1964-03-26|||||1966-11-20||1963-02-04|N|1964-03-09
TRIAL STUDY 134XCP|LB|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|2||||CD13|CD13|||||||PHERESIS UNIT|||||||NEGATIVE||NL||||HIGH|NOT DONE||||URINE SEDIMENT|HEMOLYZED|NA|MANUAL CLOT DETECTION|MDRD 5 VARIABLE FORMULA||N|U|Y|NA|||Y|3||39||BASELINE|1973-08-01|1963-12-23|||||1972-04-11||1970-12-16|N|1960-11-27
TRIAL STUDY 134XCP|LB|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|1||||C165923|TREE MIX POLLEN IGE AB RAST SCORE|||||||ML/CM3/MIN|||||||POSITIVE||CD/M2||||NORMAL|NOT DONE||||SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT|NA|WESTERN BLOT|ASH FIBROSURE FORMULA||Y|NA|U|Y|||U|4||88||SCREENING|1971-01-04|1960-04-07|||||1964-09-25||1968-09-26|Y|1965-05-06
TRIAL STUDY 134XCP|LB|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|2||||IGGALB|IMMUNOGLOBULIN G/ALBUMIN|||||||10^6/HPF|||||||INVALID||ML/DAY||||NORMAL|NOT DONE||||EMOTIONAL TEAR|ICTERIC|U|URANYL ACETATE STAIN|FIBROMETER FORMULA||NA|NA|N|NA|||N|4||88||RUN-IN|1963-02-27|1967-03-13|||||1969-02-03||1962-08-10|U|1966-07-22
TRIAL STUDY 134XCP|LB|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|1||||GRAN|GRANULOCYTES|||||||BQ|||||||BORDERLINE||COAT||||ABNORMAL|NOT DONE||||REFLEX TEAR|ICTERIC|NA|MULTIPLE BREATH WASHOUT|CKD-EPI CREATININE FORMULA||Y|NA|NA|U|||Y|5||7||INDUCTION TREATMENT|1961-04-04|1970-04-08|||||1966-06-02||1970-04-04|NA|1963-04-02
TRIAL STUDY 134XCP|LB|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|2||||OXMORPHN|OXYMORPHONE|||||||AMPULE|||||||INDETERMINATE||PSI||||HIGH|NOT DONE||||BREAST MILK|AGGLUTINATED|U|DYNAMIC LIGHT SCATTERING|MDRD 6 VARIABLE FORMULA||NA|NA|NA|NA|||NA|5||7||OBSERVATION|1969-05-09|1973-08-12|||||1972-02-22||1964-09-04|NA|1964-10-14
TRIAL STUDY 134XCP|LB|28E9B15E-4757-42F5-8AE7-2C868904F88B|1||||PROTPATN|PROTEIN PATTERN|||||||PA|||||||NEGATIVE||NSEC||||HIGH|NOT DONE||||SOFT TISSUE|UNEXPECTED ODOR|Y|AUDIOMETRY|MDRD 6 VARIABLE FORMULA||U|NA|NA|N|||NA|1||38||INDUCTION TREATMENT|1960-12-11|1965-07-04|||||1970-12-12||1971-03-27|U|1969-07-29
TRIAL STUDY 134XCP|LB|28E9B15E-4757-42F5-8AE7-2C868904F88B|2||||EOSIMLE|IMMATURE EOSINOPHILS/LEUKOCYTES|||||||U/L|||||||POSITIVE||UG/H||||LOW|NOT DONE||||ARTERIAL CORD BLOOD|ROOM TEMPERATURE|NA|PYROSEQUENCING|FIBROMETER FORMULA||NA|N|U|NA|||NA|1||38||SCREENING|1969-12-07|1970-01-12|||||1961-04-07||1964-03-12|N|1964-05-17
TRIAL STUDY 134XCP|LB|28E9B15E-4757-42F5-8AE7-2C868904F88B|1||||C165891|WESTERN RAGWEED POLLEN IGE AB RAST SCORE|||||||UMOL/MIN|||||||INDETERMINATE||DRUM||||ABNORMAL|NOT DONE||||LYSATE|LIPEMIC|U|THICK SMEAR|CKD-EPI CYSTATIN C FORMULA||U|U|Y|N|||U|2||58||FOLLOW-UP|1966-02-26|1965-03-01|||||1962-09-18||1969-09-04|NA|1973-01-03
TRIAL STUDY 134XCP|LB|28E9B15E-4757-42F5-8AE7-2C868904F88B|2||||CCPIGGAB|CYCLIC CITRULLINATED PEPTIDE IGG AB|||||||K|||||||TRACE||CM/S||||NORMAL|NOT DONE||||EXPIRED AIR|CALCIFIED|U|ENDOSCOPY|MDRD 6 VARIABLE FORMULA||N|N|NA|U|||N|2||58||OPEN LABEL TREATMENT|1965-03-29|1971-08-01|||||1968-04-25||1967-12-29|NA|1970-08-16
TRIAL STUDY 134XCP|LB|28E9B15E-4757-42F5-8AE7-2C868904F88B|1||||LYSOZYME|LYSOZYME|||||||MG2/DL2|||||||NEGATIVE||10^6/HPF||||ABNORMAL|NOT DONE||||REFLEX TEAR|SOLIDIFIED|NA|INTERRUPTER TECHNIQUE|MDRD 5 VARIABLE FORMULA||NA|Y|NA|Y|||U|3||39||WASHOUT|1967-12-15|1969-08-22|||||1967-03-03||1969-01-21|NA|1971-02-04
TRIAL STUDY 134XCP|LB|28E9B15E-4757-42F5-8AE7-2C868904F88B|2||||SPERM|SPERMATOZOA|||||||MSEC|||||||INDETERMINATE||10^6 CFU/G||||ABNORMAL|NOT DONE||||URINE SEDIMENT|FRESH|N|ZIEHL NEELSEN ACID FAST STAIN|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|NA|||Y|3||39||INDUCTION TREATMENT|1971-04-13|1962-09-06|||||1960-10-04||1967-08-30|N|1967-10-15
TRIAL STUDY 134XCP|LB|28E9B15E-4757-42F5-8AE7-2C868904F88B|1||||PCNAG|PROLIFERATING CELL NUCLEAR ANTIGEN|||||||DISK|||||||INDETERMINATE||SFC/10^6 PBMC||||LOW|NOT DONE||||BLOOD|CALCIFIED|N|RADIOIMMUNOPRECIPITATION ASSAY|MDRD ENZYMATIC JAPANESE FORMULA||Y|Y|N|Y|||NA|4||88||WASHOUT|1961-02-23|1962-06-28|||||1962-08-19||1968-12-29|U|1967-05-15
TRIAL STUDY 134XCP|LB|28E9B15E-4757-42F5-8AE7-2C868904F88B|2||||PCA3MRNA|PROSTATE CANCER ANTIGEN 3 MRNA|||||||U/KG/DAY|||||||INDETERMINATE||PMOL/10^10 CELLS||||ABNORMAL|NOT DONE||||SUPERNATANT, PLASMA|SOLIDIFIED|U|FLOW CYTOMETRY|GMI MMOL/MOL FORMULA||NA|NA|U|Y|||N|4||88||BASELINE|1973-07-20|1969-06-17|||||1960-04-26||1963-08-20|Y|1969-08-18
TRIAL STUDY 134XCP|LB|28E9B15E-4757-42F5-8AE7-2C868904F88B|1||||ACETAMIN|ACETAMINOPHEN|||||||U/KG|||||||INDETERMINATE||NG||||HIGH|NOT DONE||||PLEURAL FLUID|FROZEN|Y|IMMUNOPRECIPITATION|NASH FIBROSURE FORMULA||NA|U|Y|U|||U|5||7||OPEN LABEL TREATMENT|1966-03-01|1968-07-11|||||1963-01-09||1962-04-07|U|1961-12-09
TRIAL STUDY 134XCP|LB|28E9B15E-4757-42F5-8AE7-2C868904F88B|2||||CA15_3AG|CANCER ANTIGEN 15-3|||||||OZ|||||||INVALID||UM||||NORMAL|NOT DONE||||CORD BLOOD|LIPEMIC|Y|CYSTOSCOPY|COCKCROFT-GAULT FORMULA||U|N|Y|Y|||U|5||7||BASELINE|1973-02-02|1966-05-17|||||1960-11-12||1963-07-20|NA|1964-05-04
TRIAL STUDY 134XCP|LB|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|1||||OHDG8|8-HYDROXYDEOXYGUANOSINE|||||||S^-1(%O2)^-1|||||||TRACE||MOL/MOL||||ABNORMAL|NOT DONE||||PLEURAL FLUID|CALCIFIED|Y|GC/FID|FIBROTEST FORMULA||U|NA|N|U|||NA|1||38||SCREENING|1969-04-19|1964-08-02|||||1971-01-14||1972-01-16|Y|1967-10-27
TRIAL STUDY 134XCP|LB|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|2||||CPEPCRT|C-PEPTIDE/CREATININE|||||||MM/H|||||||INDETERMINATE||NKAT/G HB||||HIGH|NOT DONE||||CAPILLARY PLASMA|UNEXPECTED ODOR|U|IHC|NASH FIBROSURE FORMULA||N|Y|NA|NA|||NA|1||38||BASELINE|1963-12-27|1969-03-24|||||1969-11-28||1963-06-05|NA|1968-05-26
TRIAL STUDY 134XCP|LB|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|1||||EPISQCE|SQUAMOUS EPITHELIAL CELLS|||||||LB|||||||NEGATIVE||SBE/ML||||NORMAL|NOT DONE||||TRANSUDATE|CLOTTED|U|WHOLE EXOME SEQUENCING|MDRD 4 VARIABLE FORMULA||N|Y|U|NA|||U|2||58||CONTINUATION TREATMENT|1970-02-28|1961-01-14|||||1960-09-09||1971-10-25|U|1963-03-26
TRIAL STUDY 134XCP|LB|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|2||||MITOM2AB|MITOCHONDRIAL M2 ANTIBODY|||||||PG/CELL|||||||NEGATIVE||UM||||LOW|NOT DONE||||MONOCYTE|THAWED|U|RADIATION DOSIMETRY|COCKCROFT-GAULT FORMULA||Y|N|NA|Y|||NA|2||58||TREATMENT|1969-09-12|1968-02-22|||||1961-03-09||1972-08-08|U|1961-02-19
TRIAL STUDY 134XCP|LB|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|1||||LDLPSZ|LDL PARTICLE SIZE|||||||10^12 IU/L|||||||INDETERMINATE||CYCLE/MIN||||ABNORMAL|NOT DONE||||SERUM OR PLASMA OR BLOOD|NON-HEMOLYZED|U|FLUORESCENT MICROSCOPY|NASH FIBROSURE FORMULA||Y|Y|N|NA|||U|3||39||INDUCTION TREATMENT|1963-07-03|1970-11-29|||||1971-02-07||1972-11-22|N|1969-10-08
TRIAL STUDY 134XCP|LB|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|2||||CRH|CORTICOTROPIN RELEASING HORMONE|||||||CI/L|||||||NEGATIVE||DRAM||||HIGH|NOT DONE||||SMOOTH MUSCLE TISSUE|HEMOLYZED|Y|MULTIPLE BREATH WASHOUT|FIBROMETER FORMULA||Y|Y|U|NA|||N|3||39||LONG-TERM FOLLOW-UP|1966-05-09|1961-07-17|||||1966-09-09||1965-12-09|U|1962-12-12
TRIAL STUDY 134XCP|LB|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|1||||ABOA1|ABO A1 SUBTYPE|||||||DISK|||||||POSITIVE||CMOL/L||||HIGH|NOT DONE||||CERUMEN|PARAFFIN-EMBEDDED|Y|PHASE-CONTRAST MRI|MDRD ENZYMATIC JAPANESE FORMULA||N|Y|NA|N|||U|4||88||BLINDED TREATMENT|1963-12-27|1969-07-06|||||1968-05-31||1972-12-27|Y|1963-08-09
TRIAL STUDY 134XCP|LB|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|2||||HIST3AB|HISTONE 3 ANTIBODY|||||||LOG10 ELISA UNIT|||||||NEGATIVE||UG/L DDU||||HIGH|NOT DONE||||INFRANATANT, PLEURAL FLUID|LACTESCENT|Y|RYAN BLUE STAIN|HEPASCORE FORMULA||U|U|U|U|||N|4||88||CONTINUATION TREATMENT|1964-03-23|1964-04-07|||||1964-04-03||1966-01-02|U|1971-01-10
TRIAL STUDY 134XCP|LB|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|1||||GLOBG|GAMMA GLOBULIN|||||||FRACTION OF 1|||||||POSITIVE||BQ/ML||||ABNORMAL|NOT DONE||||ISOLATE|PARAFFIN-EMBEDDED|N|FARNSWORTH-MUNSELL 100 HUE TEST|FIBROMETER FORMULA||U|U|Y|U|||NA|5||7||RUN-IN|1971-10-09|1960-01-09|||||1960-02-20||1961-08-23|NA|1960-02-29
TRIAL STUDY 134XCP|LB|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|2||||LYMPHOID|LYMPHOID CELLS|||||||UG/KG/H|||||||BORDERLINE||KG/L||||NORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|PARAFFIN-EMBEDDED|Y|CORONARY ANGIOGRAPHY|HEPASCORE FORMULA||NA|Y|U|N|||NA|5||7||LONG-TERM FOLLOW-UP|1962-06-26|1968-10-06|||||1966-11-05||1971-01-20|NA|1961-01-15
TRIAL STUDY 134XCP|LB|2E1011F1-A091-4E7E-B661-477A1F6DD39A|1||||HGBEHGB|HEMOGLOBIN E/TOTAL HEMOGLOBIN|||||||MM/MIN|||||||TRACE||IU/G HB||||ABNORMAL|NOT DONE||||SOFT TISSUE|REFRIGERATED|U|FARR ASSAY|MDRD 6 VARIABLE FORMULA||Y|N|NA|Y|||Y|1||38||FOLLOW-UP|1972-08-29|1963-07-17|||||1963-10-02||1969-07-16|U|1961-02-02
TRIAL STUDY 134XCP|LB|2E1011F1-A091-4E7E-B661-477A1F6DD39A|2||||PLATGNT|GIANT PLATELETS|||||||10^7 PFU|||||||TRACE||ML/M2/H||||LOW|NOT DONE||||EPIDERMAL TISSUE|SOLIDIFIED|U|KARYOTYPING|FIBROMETER FORMULA||N|Y|Y|NA|||U|1||38||FOLLOW-UP|1964-10-31|1973-02-04|||||1968-08-29||1962-09-22|Y|1965-04-09
TRIAL STUDY 134XCP|LB|2E1011F1-A091-4E7E-B661-477A1F6DD39A|1||||CD4CD8|CD4/CD8|||||||L|||||||BORDERLINE||MOSM||||HIGH|NOT DONE||||ISOLATE|AUTOLYZED|Y|PET/SPECT SCAN|MDRD ENZYMATIC JAPANESE FORMULA||U|U|U|NA|||NA|2||58||LONG-TERM FOLLOW-UP|1961-06-20|1968-01-28|||||1961-03-22||1964-09-22|NA|1963-08-07
TRIAL STUDY 134XCP|LB|2E1011F1-A091-4E7E-B661-477A1F6DD39A|2||||E1S|ESTRONE SULFATE|||||||MMOL|||||||INDETERMINATE||IU/DAY||||NORMAL|NOT DONE||||SERUM|THAWED|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|CKD-EPI CREATININE-CYSTATIN C FORMULA||NA|Y|N|U|||U|2||58||WASHOUT|1961-09-13|1973-03-13|||||1970-06-08||1968-08-26|Y|1961-01-30
TRIAL STUDY 134XCP|LB|2E1011F1-A091-4E7E-B661-477A1F6DD39A|1||||CD79A|CD79A|||||||ML/CAGE/WK|||||||INDETERMINATE||U/G/H||||LOW|NOT DONE||||ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED|U|QUANTITATIVE CORONARY ANGIOGRAPHY|FIBROTEST FORMULA||U|U|NA|N|||NA|3||39||INDUCTION TREATMENT|1971-04-23|1971-09-12|||||1972-05-02||1970-12-19|U|1968-08-11
TRIAL STUDY 134XCP|LB|2E1011F1-A091-4E7E-B661-477A1F6DD39A|2||||SDH|SORBITOL DEHYDROGENASE|||||||L|||||||INVALID||MMOL||||NORMAL|NOT DONE||||CARDIAC MUSCLE TISSUE|HEMOLYZED|U|RADIAL IMMUNODIFFUSION|ASH FIBROSURE FORMULA||Y|U|NA|U|||U|3||39||LONG-TERM FOLLOW-UP|1966-10-11|1960-12-05|||||1962-05-03||1973-02-22|NA|1963-08-06
TRIAL STUDY 134XCP|LB|2E1011F1-A091-4E7E-B661-477A1F6DD39A|1||||IBCT|TOTAL IRON BINDING CAPACITY|||||||AMOL|||||||INDETERMINATE||ML/G/DAY||||ABNORMAL|NOT DONE||||REFLEX TEAR|LIPEMIC|U|LASER CAPTURE MICRODISSECTION|MDRD FORMULA||N|NA|Y|N|||NA|4||88||OPEN LABEL TREATMENT|1968-06-21|1966-08-04|||||1963-07-16||1971-07-09|U|1971-02-22
TRIAL STUDY 134XCP|LB|2E1011F1-A091-4E7E-B661-477A1F6DD39A|2||||GSTMU|MU GLUTATHIONE-S-TRANSFERASE|||||||ML/MIN/1.73M2|||||||POSITIVE||ML/CM H2O||||NORMAL|NOT DONE||||SERUM OR PLASMA|LIPEMIC|Y|HPLC/MS/MS|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|N|N|NA|||N|4||88||BASELINE|1970-02-17|1967-01-27|||||1967-01-10||1970-04-23|NA|1960-09-13
TRIAL STUDY 134XCP|LB|2E1011F1-A091-4E7E-B661-477A1F6DD39A|1||||IGG3|IMMUNOGLOBULIN G SUBCLASS 3|||||||PNU/ML|||||||INVALID||DIOPTER||||NORMAL|NOT DONE||||INFRANATANT, PLEURAL FLUID|UNEXPECTED ODOR|NA|PERIODIC ACID SCHIFF STAIN|CKD-EPI CREATININE FORMULA||NA|U|U|N|||NA|5||7||OPEN LABEL TREATMENT|1960-05-28|1966-09-02|||||1970-04-25||1971-05-18|U|1960-02-28
TRIAL STUDY 134XCP|LB|2E1011F1-A091-4E7E-B661-477A1F6DD39A|2||||KL6|KREBS VON DEN LUNGEN-6|||||||HOUNSFIELD UNIT|||||||POSITIVE||MG/DOSE||||HIGH|NOT DONE||||KERATINOCYTE|THAWED|N|TRIPLE-PHASE MRI SCAN|FIBROSIS 4 FORMULA||NA|U|N|U|||N|5||7||LONG-TERM FOLLOW-UP|1973-08-10|1961-02-20|||||1969-10-09||1965-08-14|U|1965-12-29
TRIAL STUDY 134XCP|LB|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|1||||SO2|SULFUR DIOXIDE|||||||KBQ/UL|||||||INDETERMINATE||/SEC||||ABNORMAL|NOT DONE||||EMESIS|UNEXPECTED ODOR|U|ELISPOT|MDRD ENZYMATIC JAPANESE FORMULA||NA|U|Y|U|||Y|1||38||SCREENING|1961-08-31|1963-11-29|||||1966-01-10||1973-07-08|NA|1962-01-21
TRIAL STUDY 134XCP|LB|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|2||||HAMAB|HUMAN ANTI-MOUSE ANTIBODY|||||||U/M2/DAY|||||||INVALID||ML/KG||||HIGH|NOT DONE||||ATHEROSCLEROTIC PLAQUE|FRESH|NA|STRESS ECHOCARDIOGRAPHY|MDRD ENZYMATIC FORMULA||Y|N|Y|U|||Y|1||38||RUN-IN|1963-10-08|1969-05-30|||||1962-02-01||1968-05-23|Y|1968-12-19
TRIAL STUDY 134XCP|LB|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|1||||CSGRANF|GRANULAR FINE CASTS|||||||CAPLET|||||||TRACE||KCAL/DAY||||HIGH|NOT DONE||||LEUKOCYTE|CALCIFIED|N|MEDIASTINOSCOPY|MDRD ENZYMATIC JAPANESE FORMULA||Y|U|U|U|||U|2||58||OBSERVATION|1962-12-23|1971-01-09|||||1970-04-25||1973-01-08|U|1968-05-23
TRIAL STUDY 134XCP|LB|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|2||||ETPLTR|ETP LAG TIME RELATIVE|||||||PPM|||||||INVALID||MG/L FEU||||ABNORMAL|NOT DONE||||GASTRIC FLUID|ROOM TEMPERATURE|NA|GC/FID|ASH FIBROSURE FORMULA||U|N|NA|NA|||Y|2||58||OPEN LABEL TREATMENT|1971-09-28|1967-05-20|||||1968-01-22||1964-03-23|N|1964-08-09
TRIAL STUDY 134XCP|LB|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|1||||LDH3|LDH ISOENZYME 3|||||||MNFI|||||||NEGATIVE||PUFF||||HIGH|NOT DONE||||SEMEN|LACTESCENT|N|SISH|SCHWARTZ METHOD FOR CHILDREN FORMULA||U|NA|N|N|||U|3||39||OPEN LABEL TREATMENT|1965-04-26|1962-08-03|||||1972-08-14||1962-06-17|Y|1962-10-18
TRIAL STUDY 134XCP|LB|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|2||||SPMPSPM|SPERMATOZOA, PROGRESSIVE/SPERMATOZOA|||||||10^4 CFU|||||||TRACE||IU/DAY||||LOW|NOT DONE||||PLATELET RICH PLASMA|LACTESCENT|NA|SLOAN LETTER EYE CHART 2.5%|GMI % FORMULA||NA|NA|N|N|||N|3||39||BLINDED TREATMENT|1973-06-27|1972-03-14|||||1960-01-09||1965-06-02|Y|1961-08-15
TRIAL STUDY 134XCP|LB|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|1||||ANCPNCAB|NEUTROPHIL CYTOPLASMIC AB, PERINUCLEAR|||||||PRESSOR UNITS|||||||NEGATIVE||CAPFUL||||ABNORMAL|NOT DONE||||MENSTRUAL BLOOD|REFRIGERATED|NA|MICROSCOPY|MDRD 5 VARIABLE FORMULA||U|U|N|NA|||NA|4||88||FOLLOW-UP|1966-07-15|1971-06-21|||||1962-06-27||1962-02-12|Y|1965-12-11
TRIAL STUDY 134XCP|LB|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|2||||NTELOCRT|N-TELOPEPTIDE/CREATININE|||||||MG/M2/DAY|||||||TRACE||UG/DAY||||ABNORMAL|NOT DONE||||MONOCYTE|PARAFFIN-EMBEDDED|N|FISH|FIBROSIS 4 FORMULA||U|Y|U|NA|||U|4||88||INDUCTION TREATMENT|1968-06-11|1970-03-22|||||1971-07-01||1963-08-18|Y|1970-08-22
TRIAL STUDY 134XCP|LB|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|1||||HGBMHGB|METHEMOGLOBIN/TOTAL HEMOGLOBIN|||||||/MBP|||||||BORDERLINE||NG/DL||||ABNORMAL|NOT DONE||||DERMAL TISSUE|ROOM TEMPERATURE|Y|SLOAN LETTER EYE CHART 100%|MDRD 6 VARIABLE FORMULA||U|NA|N|N|||N|5||7||OBSERVATION|1962-07-19|1972-02-06|||||1968-06-11||1960-01-30|N|1963-04-27
TRIAL STUDY 134XCP|LB|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|2||||CONSIST|CONSISTENCY|||||||G|||||||TRACE||UCI||||HIGH|NOT DONE||||MENSTRUAL BLOOD|CLOTTED|NA|EEG|CKD-EPI CYSTATIN C FORMULA||N|N|N|NA|||NA|5||7||RUN-IN|1966-02-02|1962-11-16|||||1970-02-04||1960-12-18|N|1968-12-09
TRIAL STUDY 134XCP|LB|176B6882-0C9E-435E-9842-FF8714BC9CAF|1||||PLATAGRN|PLATELETS, AGRANULAR|||||||FIU|||||||TRACE||GENEQ||||NORMAL|NOT DONE||||SWABBED MATERIAL|FROZEN|NA|NEURAMINIDASE INHIBITION ASSAY|HEPASCORE FORMULA||NA|N|NA|NA|||Y|1||38||SCREENING|1960-07-07|1960-12-01|||||1969-02-25||1961-05-14|N|1968-10-24
TRIAL STUDY 134XCP|LB|176B6882-0C9E-435E-9842-FF8714BC9CAF|2||||GLUCWBE|WHOLE BLOOD EQUIVALENT GLUCOSE|||||||IU/ML|||||||INVALID||STEPS||||NORMAL|NOT DONE||||SALIVA|AUTOLYZED|U|MICRO BROTH DILUTION|MDRD ENZYMATIC FORMULA||Y|U|U|NA|||NA|1||38||OBSERVATION|1972-02-10|1960-10-27|||||1967-06-03||1964-09-04|Y|1964-12-08
TRIAL STUDY 134XCP|LB|176B6882-0C9E-435E-9842-FF8714BC9CAF|1||||UNSPCECE|UNSPECIFIED CELLS/TOTAL CELLS|||||||KG/CM2|||||||INVALID||TABLET||||LOW|NOT DONE||||SPUTUM|PARAFFIN-EMBEDDED|Y|SLOAN LETTER EYE CHART 2.5%|ASH FIBROSURE FORMULA||N|Y|N|Y|||Y|2||58||BASELINE|1965-02-27|1968-09-29|||||1972-01-31||1968-08-14|Y|1970-02-25
TRIAL STUDY 134XCP|LB|176B6882-0C9E-435E-9842-FF8714BC9CAF|2||||TRIM38|TRIPARTITE MOTIF CONTAINING PROTEIN 38|||||||NMOL/L|||||||INDETERMINATE||ML/G/MIN||||LOW|NOT DONE||||TISSUE|UNEXPECTED ODOR|Y|TOTAL BODY IRRADIATION|MDRD 5 VARIABLE FORMULA||Y|U|N|N|||NA|2||58||WASHOUT|1968-03-11|1962-05-04|||||1970-08-29||1970-01-08|U|1965-02-12
TRIAL STUDY 134XCP|LB|176B6882-0C9E-435E-9842-FF8714BC9CAF|1||||C165915|DOG DANDER IGG AB RAST SCORE|||||||ROENTGEN|||||||TRACE||/MBP||||NORMAL|NOT DONE||||INTERSTITIAL FLUID|ICTERIC|NA|PAP STAIN|MDRD FORMULA||Y|U|U|Y|||N|3||39||OBSERVATION|1965-11-29|1971-01-02|||||1968-05-10||1973-03-08|Y|1965-09-03
TRIAL STUDY 134XCP|LB|176B6882-0C9E-435E-9842-FF8714BC9CAF|2||||BARB|BARBITURATES|||||||COPIES/UL|||||||NEGATIVE||MBQ||||ABNORMAL|NOT DONE||||HAIR FOLLICLE|AGGLUTINATED|NA|ELECTRICAL IMPEDANCE MYOGRAPHY|NASH FIBROSURE FORMULA||Y|U|N|U|||Y|3||39||BLINDED TREATMENT|1963-02-28|1971-11-26|||||1962-03-10||1968-04-17|N|1970-02-22
TRIAL STUDY 134XCP|LB|176B6882-0C9E-435E-9842-FF8714BC9CAF|1||||CD19|CD19|||||||FINGERTIP UNIT|||||||INDETERMINATE||PA||||HIGH|NOT DONE||||SUPERNATANT, PLASMA|CLOTTED|N|MS/MS|FIBROTEST FORMULA||Y|NA|NA|Y|||Y|4||88||OBSERVATION|1966-06-19|1973-09-04|||||1968-02-22||1968-12-08|U|1960-06-03
TRIAL STUDY 134XCP|LB|176B6882-0C9E-435E-9842-FF8714BC9CAF|2||||PROTEXR|PROTEIN EXCRETION RATE|||||||NMOL BCE/NMOL|||||||NEGATIVE||EQ||||HIGH|NOT DONE||||CARDIAC MUSCLE TISSUE|CLOTTED|N|ELECTRICAL IMPEDANCE MYOGRAPHY|CKD-EPI CREATININE FORMULA||N|U|Y|N|||U|4||88||TREATMENT|1965-02-14|1966-12-29|||||1962-07-23||1969-01-12|N|1960-08-08
TRIAL STUDY 134XCP|LB|176B6882-0C9E-435E-9842-FF8714BC9CAF|1||||ALA|ALANINE|||||||CI/L|||||||INVALID||10^6 COPIES/ML||||ABNORMAL|NOT DONE||||SUPERNATANT, SERUM OR PLASMA|LACTESCENT|U|KNEMOMETRY|FIBROSIS 4 FORMULA||Y|NA|U|NA|||U|5||7||SCREENING|1962-02-01|1967-06-12|||||1973-01-24||1973-06-12|U|1962-11-02
TRIAL STUDY 134XCP|LB|176B6882-0C9E-435E-9842-FF8714BC9CAF|2||||S6PHS|PHOS-S6 RIBOSOMAL PROTEIN|||||||WATT|||||||TRACE||10^3/L||||LOW|NOT DONE||||VENOUS BLOOD|PARAFFIN-EMBEDDED|U|KINETIC MICROPARTICLE IMMUNOASSAY|SCHWARTZ METHOD FOR CHILDREN FORMULA||N|NA|U|U|||NA|5||7||LONG-TERM FOLLOW-UP|1964-05-31|1970-12-14|||||1966-12-23||1962-05-31|U|1961-03-23
